Lab Test Result Name API for:
common_name = laboratory.test-type
OID = 2.16.840.1.114222.4.11.1002
Code System Version = 20090501
Code System = http://hl7projects.hl7.nscee.edu/frs/download.php/622/hl7_rimrepos-2.26.2.zip
| Code | Description | Link |
|---|---|---|
| OTH | other | ./2.16.840.1.114222.4.11.1002/OTH.json |
| 100018-1 | Hospice care Note | ./2.16.840.1.114222.4.11.1002/100018-1.json |
| 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100019-9.json |
| 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100020-7.json |
| 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Moleculargenetics method Nominal | ./2.16.840.1.114222.4.11.1002/100021-5.json |
| 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100022-3.json |
| 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100023-1.json |
| 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100024-9.json |
| 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100025-6.json |
| 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100026-4.json |
| 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100027-2.json |
| 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100028-0.json |
| 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100029-8.json |
| 100041-3 | Aminoglycoside [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100041-3.json |
| 100042-1 | Atovaquone [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100042-1.json |
| 100043-9 | Azithromycin+Ethambutol [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100043-9.json |
| 100044-7 | Cefcapene [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100044-7.json |
| 100045-4 | Cefozopran [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100045-4.json |
| 100046-2 | Cefquinome [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100046-2.json |
| 100047-0 | Cefteram [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100047-0.json |
| 100048-8 | Clarithromycin+Ethambutol [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100048-8.json |
| 100049-6 | Eravacycline [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100049-6.json |
| 100050-4 | Erythromycin+Ethambutol [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100050-4.json |
| 100051-2 | Ethambutol+rifAMPin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100051-2.json |
| 100052-0 | Flomoxef [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100052-0.json |
| 100053-8 | Fluoroquinolone [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100053-8.json |
| 100054-6 | Gamithromycin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100054-6.json |
| 100055-3 | Optochin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100055-3.json |
| 100056-1 | Panipenem [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100056-1.json |
| 100057-9 | Prothionamide [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100057-9.json |
| 100058-7 | Prulifloxacin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100058-7.json |
| 100059-5 | Rifapentine [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100059-5.json |
| 100060-3 | Tildipirosin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100060-3.json |
| 100061-1 | Tosufloxacin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/100061-1.json |
| 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100156-9.json |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/100157-7.json |
| 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/100158-5.json |
| 100164-3 | Knee AP instability W 90 degree flexion | ./2.16.840.1.114222.4.11.1002/100164-3.json |
| 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100213-8.json |
| 100214-6 | Dental model prior authorization Document | ./2.16.840.1.114222.4.11.1002/100214-6.json |
| 100215-3 | Episode of care medical records Document Transplant surgery | ./2.16.840.1.114222.4.11.1002/100215-3.json |
| 100216-1 | Surgical synoptic report | ./2.16.840.1.114222.4.11.1002/100216-1.json |
| 100217-9 | Synoptic report Narrative Surgical oncology | ./2.16.840.1.114222.4.11.1002/100217-9.json |
| 100218-7 | Surgical oncology of colon cancer synoptic report | ./2.16.840.1.114222.4.11.1002/100218-7.json |
| 100219-5 | Surgical oncology of melanoma cancer synoptic report | ./2.16.840.1.114222.4.11.1002/100219-5.json |
| 100220-3 | Surgical oncology of breast cancer synoptic report | ./2.16.840.1.114222.4.11.1002/100220-3.json |
| 100221-1 | Surgical oncology of thyroid cancer synoptic report | ./2.16.840.1.114222.4.11.1002/100221-1.json |
| 100222-9 | Surgical oncology of pancreas cancer synoptic report | ./2.16.840.1.114222.4.11.1002/100222-9.json |
| 100228-6 | Upper gastrointestinal capsule endoscopy study Document | ./2.16.840.1.114222.4.11.1002/100228-6.json |
| 100229-4 | Endoscopic ultrasound study Document | ./2.16.840.1.114222.4.11.1002/100229-4.json |
| 100231-0 | Endobronchial ultrasound study | ./2.16.840.1.114222.4.11.1002/100231-0.json |
| 100281-5 | D Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100281-5.json |
| 100282-3 | Vaccine exemption certificate | ./2.16.840.1.114222.4.11.1002/100282-3.json |
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100305-2.json |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1003-3.json |
| 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/100341-7.json |
| 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | ./2.16.840.1.114222.4.11.1002/100342-5.json |
| 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100343-3.json |
| 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100344-1.json |
| 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100345-8.json |
| 100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | ./2.16.840.1.114222.4.11.1002/100346-6.json |
| 100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | ./2.16.840.1.114222.4.11.1002/100347-4.json |
| 100349-0 | US.doppler Penis vessels W vasodilator IV | ./2.16.840.1.114222.4.11.1002/100349-0.json |
| 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100350-8.json |
| 100351-6 | Pioglitazone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100351-6.json |
| 100352-4 | Rosiglitazone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100352-4.json |
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100356-5.json |
| 100357-3 | Naloxone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/100357-3.json |
| 100358-1 | Phentermine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/100358-1.json |
| 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/100359-9.json |
| 100369-8 | NM Thyroid gland Views W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/100369-8.json |
| 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100370-6.json |
| 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/100371-4.json |
| 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100372-2.json |
| 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100373-0.json |
| 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100374-8.json |
| 100375-5 | Anise IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100375-5.json |
| 100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100376-3.json |
| 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100377-1.json |
| 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100378-9.json |
| 100379-7 | Leeks IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100379-7.json |
| 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100380-5.json |
| 100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100381-3.json |
| 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100383-9.json |
| 100384-7 | Rapeseed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100384-7.json |
| 100385-4 | Corn salad IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100385-4.json |
| 100386-2 | Rosemary IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100386-2.json |
| 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100387-0.json |
| 100388-8 | Cocoa IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100388-8.json |
| 100389-6 | Pistachio IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100389-6.json |
| 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100390-4.json |
| 100391-2 | Dates IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100391-2.json |
| 100392-0 | Duck meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100392-0.json |
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100393-8.json |
| 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100394-6.json |
| 100395-3 | Carob IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100395-3.json |
| 100396-1 | Brassica napus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100396-1.json |
| 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100397-9.json |
| 100398-7 | Goose meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100398-7.json |
| 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100399-5.json |
| 100400-1 | Quail meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100400-1.json |
| 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100401-9.json |
| 100402-7 | Venison meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100402-7.json |
| 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100403-5.json |
| 100404-3 | Horse meat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100404-3.json |
| 100405-0 | Kefir IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100405-0.json |
| 100406-8 | Butter IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100406-8.json |
| 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100407-6.json |
| 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100408-4.json |
| 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100409-2.json |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1004-1.json |
| 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100410-0.json |
| 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100411-8.json |
| 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100412-6.json |
| 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100413-4.json |
| 100414-2 | Gourd IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100414-2.json |
| 100415-9 | Kale IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100415-9.json |
| 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100416-7.json |
| 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100417-5.json |
| 100418-3 | Liquorice IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100418-3.json |
| 100419-1 | Snow pea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100419-1.json |
| 100420-9 | Fava bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100420-9.json |
| 100421-7 | Chick Pea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100421-7.json |
| 100422-5 | Chicory IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100422-5.json |
| 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100423-3.json |
| 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100424-1.json |
| 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100425-8.json |
| 100426-6 | Squalene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100426-6.json |
| 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100427-4.json |
| 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/100431-6.json |
| 100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/100432-4.json |
| 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100434-0.json |
| 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/100435-7.json |
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/100436-5.json |
| 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/100437-3.json |
| 100438-1 | Adolescent medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100438-1.json |
| 100439-9 | Allergy and Immunology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100439-9.json |
| 100440-7 | Allergy Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100440-7.json |
| 100441-5 | Attending Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100441-5.json |
| 100442-3 | Audiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100442-3.json |
| 100443-1 | Bariatric surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100443-1.json |
| 100444-9 | Blood banking and transfusion medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100444-9.json |
| 100445-6 | Bone Marrow Transplant Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100445-6.json |
| 100446-4 | Breastfeeding Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100446-4.json |
| 100447-2 | Burn management Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100447-2.json |
| 100448-0 | Cardiac surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100448-0.json |
| 100449-8 | Cardiopulmonary Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100449-8.json |
| 100450-6 | Child and adolescent psychiatry Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100450-6.json |
| 100451-4 | Chiropractic medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100451-4.json |
| 100452-2 | Clinical cardiac electrophysiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100452-2.json |
| 100453-0 | Clinical genetics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100453-0.json |
| 100454-8 | Clinical neurophysiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100454-8.json |
| 100455-5 | Clinical pathology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100455-5.json |
| 100456-3 | Colon and rectal surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100456-3.json |
| 100457-1 | Consultant Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100457-1.json |
| 100458-9 | Outpatient COVID-19 Intubation Progress note | ./2.16.840.1.114222.4.11.1002/100458-9.json |
| 100459-7 | Outpatient COVID-19 Progress note | ./2.16.840.1.114222.4.11.1002/100459-7.json |
| 100460-5 | Dermatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100460-5.json |
| 100461-3 | Developmental-behavioral pediatrics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100461-3.json |
| 100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100462-1.json |
| 100463-9 | Eating disorders Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100463-9.json |
| 100464-7 | Endocrinology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100464-7.json |
| 100465-4 | Family medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100465-4.json |
| 100466-2 | Gastroenterology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100466-2.json |
| 100467-0 | Geriatric medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100467-0.json |
| 100468-8 | Gynecologic oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100468-8.json |
| 100469-6 | Gynecology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100469-6.json |
| 100470-4 | Healthcare navigator Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100470-4.json |
| 100471-2 | Heart failure Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100471-2.json |
| 100472-0 | Heart failure+Transplant cardiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100472-0.json |
| 100473-8 | Hematology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100473-8.json |
| 100474-6 | Hematology+Medical oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100474-6.json |
| 100475-3 | Hepatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100475-3.json |
| 100476-1 | Immunology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100476-1.json |
| 100477-9 | Infectious disease Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100477-9.json |
| 100478-7 | Internal medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100478-7.json |
| 100479-5 | Interventional cardiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100479-5.json |
| 100480-3 | Interventional radiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100480-3.json |
| 100481-1 | Outpatient Mechanical circulatory support Progress note | ./2.16.840.1.114222.4.11.1002/100481-1.json |
| 100482-9 | Medical Aid in Dying Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100482-9.json |
| 100483-7 | Mental health Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100483-7.json |
| 100484-5 | Multi-specialty program Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100484-5.json |
| 100485-2 | Neonatal perinatal medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100485-2.json |
| 100486-0 | Nephrology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100486-0.json |
| 100487-8 | Neurological surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100487-8.json |
| 100488-6 | Neurology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100488-6.json |
| 100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100489-4.json |
| 100490-2 | Nurse practitioner Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100490-2.json |
| 100491-0 | Nurse Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100491-0.json |
| 100492-8 | Nutrition and dietetics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100492-8.json |
| 100493-6 | Obstetrics and Gynecology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100493-6.json |
| 100494-4 | Obstetrics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100494-4.json |
| 100495-1 | Occupational therapy Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100495-1.json |
| 100496-9 | Oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100496-9.json |
| 100497-7 | Ophthalmology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100497-7.json |
| 100498-5 | Optometry Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100498-5.json |
| 100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100499-3.json |
| 100500-8 | Orthopaedic surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100500-8.json |
| 100501-6 | Orthotics prosthetics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100501-6.json |
| 100502-4 | Otolaryngology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100502-4.json |
| 100503-2 | Pain medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100503-2.json |
| 100504-0 | Palliative care Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100504-0.json |
| 100505-7 | Pediatric cardiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100505-7.json |
| 100506-5 | Pediatric dermatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100506-5.json |
| 100507-3 | Pediatric endocrinology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100507-3.json |
| 100508-1 | Pediatric gastroenterology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100508-1.json |
| 100509-9 | Pediatric hematology-oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100509-9.json |
| 100510-7 | Pediatric infectious diseases Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100510-7.json |
| 100511-5 | Pediatric otolaryngology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100511-5.json |
| 100512-3 | Pediatric pulmonology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100512-3.json |
| 100513-1 | Pediatric rheumatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100513-1.json |
| 100514-9 | Pediatric surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100514-9.json |
| 100515-6 | Pediatric transplant hepatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100515-6.json |
| 100516-4 | Pediatric urology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100516-4.json |
| 100517-2 | Pharmacogenomics Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100517-2.json |
| 100518-0 | Physical medicine and rehab Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100518-0.json |
| 100519-8 | Physical therapy Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100519-8.json |
| 100520-6 | Plastic surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100520-6.json |
| 100521-4 | Podiatry Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100521-4.json |
| 100522-2 | Psychiatry Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100522-2.json |
| 100523-0 | Psychology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100523-0.json |
| 100524-8 | Pulmonary Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100524-8.json |
| 100525-5 | Radiation oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100525-5.json |
| 100526-3 | Radiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100526-3.json |
| 100527-1 | Recreational therapy Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100527-1.json |
| 100528-9 | Reproductive endocrinology and infertility Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100528-9.json |
| 100529-7 | Research Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100529-7.json |
| 100530-5 | Rheumatology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100530-5.json |
| 100531-3 | Sleep medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100531-3.json |
| 100532-1 | Social worker Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100532-1.json |
| 100533-9 | Solid Organ Transplant Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100533-9.json |
| 100534-7 | Speech-language pathology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100534-7.json |
| 100535-4 | Spinal surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100535-4.json |
| 100536-2 | Sports medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100536-2.json |
| 100537-0 | Surgery of the hand Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100537-0.json |
| 100538-8 | Telehealth+Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100538-8.json |
| 100539-6 | Thromboembolism Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100539-6.json |
| 100540-4 | Transplant surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100540-4.json |
| 100541-2 | Trauma Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100541-2.json |
| 100542-0 | Urology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100542-0.json |
| 100543-8 | Vascular neurology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100543-8.json |
| 100544-6 | Vascular surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100544-6.json |
| 100545-3 | Wound care management Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100545-3.json |
| 100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100546-1.json |
| 100547-9 | Adolescent medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100547-9.json |
| 100548-7 | Allergy and Immunology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100548-7.json |
| 100549-5 | Allergy Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100549-5.json |
| 100550-3 | Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100550-3.json |
| 100551-1 | Audiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100551-1.json |
| 100552-9 | Bariatric surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100552-9.json |
| 100553-7 | Blood banking and transfusion medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100553-7.json |
| 100554-5 | Bone Marrow Transplant Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100554-5.json |
| 100555-2 | Breastfeeding Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100555-2.json |
| 100556-0 | Burn management Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100556-0.json |
| 100557-8 | Cardiac surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100557-8.json |
| 100558-6 | Cardiopulmonary Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100558-6.json |
| 100559-4 | Child and adolescent psychiatry Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100559-4.json |
| 100560-2 | Clinical cardiac electrophysiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100560-2.json |
| 100561-0 | Clinical genetics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100561-0.json |
| 100562-8 | Clinical neurophysiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100562-8.json |
| 100563-6 | Clinical pathology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100563-6.json |
| 100564-4 | Colon and rectal surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100564-4.json |
| 100565-1 | Consultant Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100565-1.json |
| 100566-9 | Dentistry Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100566-9.json |
| 100567-7 | Dermatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100567-7.json |
| 100568-5 | Developmental-behavioral pediatrics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100568-5.json |
| 100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100569-3.json |
| 100570-1 | Eating disorders Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100570-1.json |
| 100571-9 | Endocrinology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100571-9.json |
| 100572-7 | Family medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100572-7.json |
| 100573-5 | Gastroenterology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100573-5.json |
| 100574-3 | General medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100574-3.json |
| 100575-0 | Geriatric medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100575-0.json |
| 100576-8 | Gynecologic oncology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100576-8.json |
| 100577-6 | Gynecology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100577-6.json |
| 100578-4 | Healthcare navigator Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100578-4.json |
| 100579-2 | Heart failure Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100579-2.json |
| 100580-0 | Heart failure+Transplant cardiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100580-0.json |
| 100581-8 | Hematology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100581-8.json |
| 100582-6 | Hematology+Medical oncology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100582-6.json |
| 100583-4 | Hepatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100583-4.json |
| 100584-2 | Immunology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100584-2.json |
| 100585-9 | Infectious disease Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100585-9.json |
| 100586-7 | Internal medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100586-7.json |
| 100587-5 | Interventional cardiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100587-5.json |
| 100588-3 | Interventional radiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100588-3.json |
| 100589-1 | Hospital Mechanical circulatory support Progress note | ./2.16.840.1.114222.4.11.1002/100589-1.json |
| 100590-9 | Medical Aid in Dying Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100590-9.json |
| 100591-7 | Mental health Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100591-7.json |
| 100592-5 | Multi-specialty program Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100592-5.json |
| 100593-3 | Neonatal perinatal medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100593-3.json |
| 100594-1 | Nephrology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100594-1.json |
| 100595-8 | Neurological surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100595-8.json |
| 100596-6 | Neurology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100596-6.json |
| 100597-4 | Neurology with special qualifications in child neurology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100597-4.json |
| 100598-2 | Nurse practitioner Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100598-2.json |
| 100599-0 | Nurse Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100599-0.json |
| 100600-6 | Nutrition and dietetics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100600-6.json |
| 100601-4 | Obstetrics and Gynecology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100601-4.json |
| 100602-2 | Obstetrics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100602-2.json |
| 100603-0 | Occupational therapy Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100603-0.json |
| 100604-8 | Oncology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100604-8.json |
| 100605-5 | Ophthalmology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100605-5.json |
| 100606-3 | Oral and Maxillofacial Surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100606-3.json |
| 100607-1 | Orthopaedic surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100607-1.json |
| 100608-9 | Orthotics prosthetics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100608-9.json |
| 100609-7 | Otolaryngology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100609-7.json |
| 100610-5 | Pain medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100610-5.json |
| 100611-3 | Palliative care Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100611-3.json |
| 100612-1 | Pastoral care Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100612-1.json |
| 100613-9 | Pediatric cardiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100613-9.json |
| 100614-7 | Pediatric dermatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100614-7.json |
| 100615-4 | Pediatric endocrinology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100615-4.json |
| 100616-2 | Pediatric gastroenterology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100616-2.json |
| 100617-0 | Pediatric hematology-oncology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100617-0.json |
| 100618-8 | Pediatric infectious diseases Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100618-8.json |
| 100619-6 | Pediatric otolaryngology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100619-6.json |
| 100620-4 | Pediatric pulmonology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100620-4.json |
| 100621-2 | Pediatric rheumatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100621-2.json |
| 100622-0 | Pediatric surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100622-0.json |
| 100623-8 | Pediatric transplant hepatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100623-8.json |
| 100624-6 | Pharmacogenomics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100624-6.json |
| 100625-3 | Pharmacology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100625-3.json |
| 100626-1 | Physical medicine and rehab Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100626-1.json |
| 100627-9 | Physical therapy Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100627-9.json |
| 100628-7 | Plastic surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100628-7.json |
| 100629-5 | Podiatry Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100629-5.json |
| 100630-3 | Psychology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100630-3.json |
| 100631-1 | Radiation oncology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100631-1.json |
| 100632-9 | Radiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100632-9.json |
| 100633-7 | Rapid response team Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100633-7.json |
| 100634-5 | Recreational therapy Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100634-5.json |
| 100635-2 | Reproductive endocrinology and infertility Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100635-2.json |
| 100636-0 | Research Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100636-0.json |
| 100637-8 | Rheumatology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100637-8.json |
| 100638-6 | Sleep medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100638-6.json |
| 100639-4 | Social worker Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100639-4.json |
| 100640-2 | Solid Organ Transplant Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100640-2.json |
| 100641-0 | Speech-language pathology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100641-0.json |
| 100642-8 | Spinal surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100642-8.json |
| 100643-6 | Surgery of the hand Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100643-6.json |
| 100644-4 | Thromboembolism Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100644-4.json |
| 100645-1 | Trauma Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100645-1.json |
| 100646-9 | Urology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100646-9.json |
| 100647-7 | Vascular neurology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100647-7.json |
| 100648-5 | Vascular surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100648-5.json |
| 100649-3 | Wound care management Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100649-3.json |
| 100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100650-1.json |
| 100651-9 | Hospital COVID-19 Intubation Progress note | ./2.16.840.1.114222.4.11.1002/100651-9.json |
| 100654-3 | Pyruvate kinase M2 [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/100654-3.json |
| 100655-0 | XR Sella turcica Lateral | ./2.16.840.1.114222.4.11.1002/100655-0.json |
| 100656-8 | Maternal and fetal medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100656-8.json |
| 100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100657-6.json |
| 100658-4 | Hospital COVID-19 Progress note | ./2.16.840.1.114222.4.11.1002/100658-4.json |
| 100659-2 | Maternal and fetal medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/100659-2.json |
| 100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100660-0.json |
| 100661-8 | Psychiatry Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/100661-8.json |
| 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100663-4.json |
| 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100664-2.json |
| 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100665-9.json |
| 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100666-7.json |
| 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100667-5.json |
| 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100668-3.json |
| 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100669-1.json |
| 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | ./2.16.840.1.114222.4.11.1002/100670-9.json |
| 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100671-7.json |
| 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100672-5.json |
| 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100673-3.json |
| 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100674-1.json |
| 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100675-8.json |
| 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100676-6.json |
| 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100677-4.json |
| 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100678-2.json |
| 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100679-0.json |
| 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100680-8.json |
| 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100681-6.json |
| 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100682-4.json |
| 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100683-2.json |
| 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100684-0.json |
| 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100685-7.json |
| 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100686-5.json |
| 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100687-3.json |
| 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100688-1.json |
| 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100689-9.json |
| 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100690-7.json |
| 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100691-5.json |
| 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100692-3.json |
| 100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100693-1.json |
| 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100694-9.json |
| 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/100695-6.json |
| 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/100696-4.json |
| 100697-2 | Interventional radiology Outpatient Note | ./2.16.840.1.114222.4.11.1002/100697-2.json |
| 100698-0 | Social Determinants of Health screening report Document | ./2.16.840.1.114222.4.11.1002/100698-0.json |
| 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100700-4.json |
| 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100701-2.json |
| 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100702-0.json |
| 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100703-8.json |
| 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100704-6.json |
| 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100705-3.json |
| 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100706-1.json |
| 100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | ./2.16.840.1.114222.4.11.1002/100707-9.json |
| 100708-7 | Plasma cells/100 leukocytes in Synovial fluid | ./2.16.840.1.114222.4.11.1002/100708-7.json |
| 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD | ./2.16.840.1.114222.4.11.1002/100709-5.json |
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/100711-1.json |
| 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100712-9.json |
| 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100713-7.json |
| 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100714-5.json |
| 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100715-2.json |
| 100716-0 | Prostate specific Ag [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/100716-0.json |
| 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100717-8.json |
| 100718-6 | Undersea and hyperbaric medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/100718-6.json |
| 100719-4 | Surgical oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/100719-4.json |
| 100720-2 | Reproductive endocrinology and infertility Discharge summary | ./2.16.840.1.114222.4.11.1002/100720-2.json |
| 100721-0 | Community health care Discharge summary | ./2.16.840.1.114222.4.11.1002/100721-0.json |
| 100722-8 | Integrative medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/100722-8.json |
| 100723-6 | Sports medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/100723-6.json |
| 100724-4 | Diabetology Discharge summary | ./2.16.840.1.114222.4.11.1002/100724-4.json |
| 100725-1 | Optometry Discharge summary | ./2.16.840.1.114222.4.11.1002/100725-1.json |
| 100726-9 | Podiatry Discharge summary | ./2.16.840.1.114222.4.11.1002/100726-9.json |
| 100727-7 | Chiropractic medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/100727-7.json |
| 100728-5 | Cardiac surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/100728-5.json |
| 100729-3 | Breastfeeding Discharge summary | ./2.16.840.1.114222.4.11.1002/100729-3.json |
| 100730-1 | Transplant surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/100730-1.json |
| 100731-9 | Urgent care center Discharge summary | ./2.16.840.1.114222.4.11.1002/100731-9.json |
| 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document | ./2.16.840.1.114222.4.11.1002/100736-8.json |
| 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1007-4.json |
| 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100748-3.json |
| 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100749-1.json |
| 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100750-9.json |
| 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/100754-1.json |
| 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | ./2.16.840.1.114222.4.11.1002/100755-8.json |
| 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | ./2.16.840.1.114222.4.11.1002/100756-6.json |
| 100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry | ./2.16.840.1.114222.4.11.1002/100759-0.json |
| 100760-8 | XR Radius and Ulna - left Single view | ./2.16.840.1.114222.4.11.1002/100760-8.json |
| 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100761-6.json |
| 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100762-4.json |
| 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative | ./2.16.840.1.114222.4.11.1002/100763-2.json |
| 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | ./2.16.840.1.114222.4.11.1002/100764-0.json |
| 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100788-9.json |
| 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100789-7.json |
| 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100790-5.json |
| 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100791-3.json |
| 100792-1 | Forsythia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/100792-1.json |
| 100793-9 | Testosterone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/100793-9.json |
| 100794-7 | Follitropin [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/100794-7.json |
| 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/100795-4.json |
| 100796-2 | Thyroglobulin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/100796-2.json |
| 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100797-0.json |
| 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100798-8.json |
| 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100799-6.json |
| 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100800-2.json |
| 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100802-8.json |
| 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100803-6.json |
| 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100804-4.json |
| 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100805-1.json |
| 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100806-9.json |
| 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100807-7.json |
| 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100808-5.json |
| 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100809-3.json |
| 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100810-1.json |
| 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100811-9.json |
| 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100812-7.json |
| 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100813-5.json |
| 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100814-3.json |
| 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100815-0.json |
| 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100816-8.json |
| 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100817-6.json |
| 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100818-4.json |
| 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100819-2.json |
| 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100820-0.json |
| 100822-6 | Cardiopulmonary resuscitation orders | ./2.16.840.1.114222.4.11.1002/100822-6.json |
| 100823-4 | Initial portable medical treatment orders | ./2.16.840.1.114222.4.11.1002/100823-4.json |
| 100824-2 | Additional portable medical orders or instructions | ./2.16.840.1.114222.4.11.1002/100824-2.json |
| 100825-9 | Medically assisted nutrition orders | ./2.16.840.1.114222.4.11.1002/100825-9.json |
| 100826-7 | Portable medical order AndOr advance directive review | ./2.16.840.1.114222.4.11.1002/100826-7.json |
| 100827-5 | Portable medical order discussion participants | ./2.16.840.1.114222.4.11.1002/100827-5.json |
| 100828-3 | Portable medical order administrative information | ./2.16.840.1.114222.4.11.1002/100828-3.json |
| 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100829-1.json |
| 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100830-9.json |
| 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100831-7.json |
| 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100832-5.json |
| 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100833-3.json |
| 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100834-1.json |
| 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100835-8.json |
| 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100836-6.json |
| 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100837-4.json |
| 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100838-2.json |
| 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100839-0.json |
| 100840-8 | IgE [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/100840-8.json |
| 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/100841-6.json |
| 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | ./2.16.840.1.114222.4.11.1002/100842-4.json |
| 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | ./2.16.840.1.114222.4.11.1002/100843-2.json |
| 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | ./2.16.840.1.114222.4.11.1002/100844-0.json |
| 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/100845-7.json |
| 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100846-5.json |
| 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count | ./2.16.840.1.114222.4.11.1002/100849-9.json |
| 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count | ./2.16.840.1.114222.4.11.1002/100850-7.json |
| 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count | ./2.16.840.1.114222.4.11.1002/100851-5.json |
| 100852-3 | NM Bones Views for metastasis W Sr-89 IV | ./2.16.840.1.114222.4.11.1002/100852-3.json |
| 100853-1 | NM Pericardial space Pericardial effusion | ./2.16.840.1.114222.4.11.1002/100853-1.json |
| 100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | ./2.16.840.1.114222.4.11.1002/100854-9.json |
| 100855-6 | CD3 cells/100 cells in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/100855-6.json |
| 100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/100856-4.json |
| 100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/100857-2.json |
| 100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | ./2.16.840.1.114222.4.11.1002/100858-0.json |
| 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | ./2.16.840.1.114222.4.11.1002/100859-8.json |
| 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | ./2.16.840.1.114222.4.11.1002/100860-6.json |
| 100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/100861-4.json |
| 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/100862-2.json |
| 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/100863-0.json |
| 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100864-8.json |
| 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100865-5.json |
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/100867-1.json |
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100868-9.json |
| 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100869-7.json |
| 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100870-5.json |
| 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100871-3.json |
| 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/100872-1.json |
| 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/100873-9.json |
| 100874-7 | Basidiobolus sp [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/100874-7.json |
| 100875-4 | Fetal Heart Document limited US | ./2.16.840.1.114222.4.11.1002/100875-4.json |
| 100876-2 | Fetal Heart Document US | ./2.16.840.1.114222.4.11.1002/100876-2.json |
| 100877-0 | US Heart Transesophageal during surgery | ./2.16.840.1.114222.4.11.1002/100877-0.json |
| 100878-8 | Endoscopic ultrasound study Upper GI tract Document | ./2.16.840.1.114222.4.11.1002/100878-8.json |
| 100879-6 | US Guidance for cryoablation of Breast - right | ./2.16.840.1.114222.4.11.1002/100879-6.json |
| 100880-4 | US Guidance for cryoablation of Breast - left | ./2.16.840.1.114222.4.11.1002/100880-4.json |
| 100881-2 | MR Guidance for cryoablation of Bone | ./2.16.840.1.114222.4.11.1002/100881-2.json |
| 100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal | ./2.16.840.1.114222.4.11.1002/100882-0.json |
| 100883-8 | MR Guidance for biopsy of Kidney - left | ./2.16.840.1.114222.4.11.1002/100883-8.json |
| 100884-6 | MR Guidance for biopsy of Kidney - right | ./2.16.840.1.114222.4.11.1002/100884-6.json |
| 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100885-3.json |
| 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100886-1.json |
| 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100887-9.json |
| 100888-7 | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100888-7.json |
| 100889-5 | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100889-5.json |
| 100890-3 | Poxvirus DNA panel | ./2.16.840.1.114222.4.11.1002/100890-3.json |
| 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100891-1.json |
| 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100892-9.json |
| 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100893-7.json |
| 100894-5 | Recommended screening frequency Narrative | ./2.16.840.1.114222.4.11.1002/100894-5.json |
| 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum | ./2.16.840.1.114222.4.11.1002/100895-2.json |
| 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/100896-0.json |
| 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100897-8.json |
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100899-4.json |
| 100901-8 | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100901-8.json |
| 100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100902-6.json |
| 100905-9 | Gram positive bacteria identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100905-9.json |
| 100906-7 | Bacteria [#/volume] in Urine by Culture | ./2.16.840.1.114222.4.11.1002/100906-7.json |
| 100907-5 | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100907-5.json |
| 100908-3 | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100908-3.json |
| 100909-1 | Cronobacter sakazakii [Presence] by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100909-1.json |
| 100910-9 | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100910-9.json |
| 100911-7 | Campylobacter sp [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/100911-7.json |
| 100914-1 | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/100914-1.json |
| 100915-8 | Burr cells [Presence] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/100915-8.json |
| 100963-8 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100963-8.json |
| 100964-6 | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/100964-6.json |
| 100965-3 | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/100965-3.json |
| 100966-1 | Oncofertility consultation note | ./2.16.840.1.114222.4.11.1002/100966-1.json |
| 100967-9 | Fetal Document Fetal Heart Tracing | ./2.16.840.1.114222.4.11.1002/100967-9.json |
| 100969-5 | Pathology report additional specified observation in Specimen Narrative | ./2.16.840.1.114222.4.11.1002/100969-5.json |
| 100972-9 | Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/100972-9.json |
| 100973-7 | Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/100973-7.json |
| 100974-5 | Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/100974-5.json |
| 100975-2 | Induced abortion method | ./2.16.840.1.114222.4.11.1002/100975-2.json |
| 100976-0 | Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/100976-0.json |
| 100977-8 | JC virus Ab Index in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100977-8.json |
| 100978-6 | Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/100978-6.json |
| 100979-4 | Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100979-4.json |
| 100980-2 | BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100980-2.json |
| 100981-0 | Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100981-0.json |
| 100982-8 | Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/100982-8.json |
| 100983-6 | HIV reverse transcriptase failed codons [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/100983-6.json |
| 100984-4 | HIV 1 group M RNA genotype [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/100984-4.json |
| 100985-1 | HIV protease failed codons [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/100985-1.json |
| 100986-9 | HIV integrase failed codons [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/100986-9.json |
| 100988-5 | Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast | ./2.16.840.1.114222.4.11.1002/100988-5.json |
| 100989-3 | Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/100989-3.json |
| 100995-0 | Laceyella sacchari IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/100995-0.json |
| 100996-8 | Neurofilament light chain [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/100996-8.json |
| 101003-2 | Monkeypox virus clade [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/101003-2.json |
| 101004-0 | Monkeypox virus lineage [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/101004-0.json |
| 101005-7 | Hospitalist Discharge summary | ./2.16.840.1.114222.4.11.1002/101005-7.json |
| 101006-5 | Osteopathic medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/101006-5.json |
| 101007-3 | Chiropody Discharge summary | ./2.16.840.1.114222.4.11.1002/101007-3.json |
| 101008-1 | Medical Aid in Dying History and physical note | ./2.16.840.1.114222.4.11.1002/101008-1.json |
| 101009-9 | Integrative medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101009-9.json |
| 101010-7 | Bariatric surgery History and physical note | ./2.16.840.1.114222.4.11.1002/101010-7.json |
| 101011-5 | Chiropody History and physical note | ./2.16.840.1.114222.4.11.1002/101011-5.json |
| 101012-3 | Chiropractic medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101012-3.json |
| 101013-1 | Community health care History and physical note | ./2.16.840.1.114222.4.11.1002/101013-1.json |
| 101014-9 | Clinical cardiac electrophysiology History and physical note | ./2.16.840.1.114222.4.11.1002/101014-9.json |
| 101015-6 | Surgical oncology History and physical note | ./2.16.840.1.114222.4.11.1002/101015-6.json |
| 101016-4 | Undersea and hyperbaric medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101016-4.json |
| 101017-2 | Kinesiotherapy History and physical note | ./2.16.840.1.114222.4.11.1002/101017-2.json |
| 101018-0 | Hospitalist History and physical note | ./2.16.840.1.114222.4.11.1002/101018-0.json |
| 101019-8 | Nuclear medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101019-8.json |
| 101020-6 | Diabetology History and physical note | ./2.16.840.1.114222.4.11.1002/101020-6.json |
| 101021-4 | Optometry History and physical note | ./2.16.840.1.114222.4.11.1002/101021-4.json |
| 101022-2 | Osteopathic medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101022-2.json |
| 101023-0 | Orthotics prosthetics History and physical note | ./2.16.840.1.114222.4.11.1002/101023-0.json |
| 101024-8 | Reproductive endocrinology and infertility History and physical note | ./2.16.840.1.114222.4.11.1002/101024-8.json |
| 101025-5 | Sports medicine History and physical note | ./2.16.840.1.114222.4.11.1002/101025-5.json |
| 101026-3 | Urgent care center History and physical note | ./2.16.840.1.114222.4.11.1002/101026-3.json |
| 101027-1 | Child and adolescent psychology History and physical note | ./2.16.840.1.114222.4.11.1002/101027-1.json |
| 101028-9 | Cardiac surgery History and physical note | ./2.16.840.1.114222.4.11.1002/101028-9.json |
| 101029-7 | Hematology+Medical oncology History and physical note | ./2.16.840.1.114222.4.11.1002/101029-7.json |
| 101030-5 | Neuropsychology History and physical note | ./2.16.840.1.114222.4.11.1002/101030-5.json |
| 101031-3 | Chiropody Consult note | ./2.16.840.1.114222.4.11.1002/101031-3.json |
| 101032-1 | Physician assistant Consult note | ./2.16.840.1.114222.4.11.1002/101032-1.json |
| 101033-9 | Chiropody procedure note | ./2.16.840.1.114222.4.11.1002/101033-9.json |
| 101034-7 | Chiropractic medicine procedure note | ./2.16.840.1.114222.4.11.1002/101034-7.json |
| 101035-4 | Osteopathic medicine Procedure note | ./2.16.840.1.114222.4.11.1002/101035-4.json |
| 101036-2 | Integrative medicine Progress note | ./2.16.840.1.114222.4.11.1002/101036-2.json |
| 101037-0 | Chiropody Progress note | ./2.16.840.1.114222.4.11.1002/101037-0.json |
| 101038-8 | Aerospace medicine Consult note | ./2.16.840.1.114222.4.11.1002/101038-8.json |
| 101039-6 | Aerospace medicine Progress note | ./2.16.840.1.114222.4.11.1002/101039-6.json |
| 101040-4 | Integrative medicine procedure note | ./2.16.840.1.114222.4.11.1002/101040-4.json |
| 101041-2 | Aerospace medicine procedure note | ./2.16.840.1.114222.4.11.1002/101041-2.json |
| 101042-0 | Urgent care center Progress note | ./2.16.840.1.114222.4.11.1002/101042-0.json |
| 101043-8 | Urgent care center Consult note | ./2.16.840.1.114222.4.11.1002/101043-8.json |
| 101044-6 | Bariatric surgery procedure note | ./2.16.840.1.114222.4.11.1002/101044-6.json |
| 101045-3 | Hospitalist procedure note | ./2.16.840.1.114222.4.11.1002/101045-3.json |
| 101046-1 | Hospitalist Progress note | ./2.16.840.1.114222.4.11.1002/101046-1.json |
| 101047-9 | Undersea and hyperbaric medicine Consult note | ./2.16.840.1.114222.4.11.1002/101047-9.json |
| 101048-7 | Hospitalist Consult note | ./2.16.840.1.114222.4.11.1002/101048-7.json |
| 101049-5 | Anesthesiology Surgical operation note | ./2.16.840.1.114222.4.11.1002/101049-5.json |
| 101050-3 | Bariatric surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/101050-3.json |
| 101051-1 | Reproductive endocrinology and infertility Surgical operation note | ./2.16.840.1.114222.4.11.1002/101051-1.json |
| 101052-9 | Osteopathic medicine Consult note | ./2.16.840.1.114222.4.11.1002/101052-9.json |
| 101053-7 | Obstetrics Midwife Evaluation note | ./2.16.840.1.114222.4.11.1002/101053-7.json |
| 101054-5 | Chiropody Outpatient Note | ./2.16.840.1.114222.4.11.1002/101054-5.json |
| 101055-2 | Critical care medicine.team Conference note | ./2.16.840.1.114222.4.11.1002/101055-2.json |
| 101056-0 | Rapid response team Conference note | ./2.16.840.1.114222.4.11.1002/101056-0.json |
| 101057-8 | Psychiatry Telehealth Admission evaluation note | ./2.16.840.1.114222.4.11.1002/101057-8.json |
| 101058-6 | Geriatric medicine Team Conference note | ./2.16.840.1.114222.4.11.1002/101058-6.json |
| 101059-4 | Geriatric medicine Letter | ./2.16.840.1.114222.4.11.1002/101059-4.json |
| 101115-4 | Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101115-4.json |
| 101116-2 | THSD7A Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101116-2.json |
| 101117-0 | Sezary syndrome monitoring in Blood Document by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/101117-0.json |
| 101118-8 | Sezary syndrome diagnosis in Blood Document by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/101118-8.json |
| 101119-6 | Leukemia and lymphoma immunophenotyping in Specimen Document by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/101119-6.json |
| 101122-0 | Mephobarbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101122-0.json |
| 101123-8 | Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/101123-8.json |
| 101124-6 | Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/101124-6.json |
| 101125-3 | Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/101125-3.json |
| 101126-1 | Bacterial carbapenem resistance blaOXA-24+blaOXA-40 genes [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/101126-1.json |
| 101127-9 | Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/101127-9.json |
| 101131-1 | B-cell precursors in Bone marrow by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/101131-1.json |
| 101133-7 | Organ AndOr tissue donation consent Document | ./2.16.840.1.114222.4.11.1002/101133-7.json |
| 101134-5 | Appointment reminder | ./2.16.840.1.114222.4.11.1002/101134-5.json |
| 101135-2 | Ambulance Discharge summary | ./2.16.840.1.114222.4.11.1002/101135-2.json |
| 101136-0 | Radiation oncology End of treatment letter | ./2.16.840.1.114222.4.11.1002/101136-0.json |
| 101140-2 | Salmonella sp Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101140-2.json |
| 101141-0 | NAT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101141-0.json |
| 101142-8 | NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/101142-8.json |
| 101145-1 | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay --trough | ./2.16.840.1.114222.4.11.1002/101145-1.json |
| 101150-1 | Right ventricular Cardiac output by Fick method | ./2.16.840.1.114222.4.11.1002/101150-1.json |
| 101151-9 | Right ventricular Cardiac output by Indicator dilution | ./2.16.840.1.114222.4.11.1002/101151-9.json |
| 101152-7 | Mitochondria whole genome analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101152-7.json |
| 101153-5 | Chemokine (C-C motif) ligand 14 [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/101153-5.json |
| 101154-3 | Calprotectin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101154-3.json |
| 101155-0 | Alpha hydroxyetizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101155-0.json |
| 101156-8 | Alpha hydroxyetizolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101156-8.json |
| 101157-6 | Flualprazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101157-6.json |
| 101158-4 | Flualprazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101158-4.json |
| 101159-2 | Flubromazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101159-2.json |
| 101160-0 | Flubromazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101160-0.json |
| 101161-8 | p-Fluorofentanyl/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101161-8.json |
| 101162-6 | p-Fluorofentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101162-6.json |
| 101163-4 | Brorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101163-4.json |
| 101164-2 | Brorphine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101164-2.json |
| 101165-9 | Brorphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101165-9.json |
| 101166-7 | Metonitazene [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101166-7.json |
| 101167-5 | Metonitazene/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101167-5.json |
| 101168-3 | Metonitazene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101168-3.json |
| 101169-1 | 2-methyl AP-237 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101169-1.json |
| 101170-9 | Soluble urokinase plasminogen activator receptor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101170-9.json |
| 101171-7 | 2-methyl AP-237/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101171-7.json |
| 101173-3 | Melatonin [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/101173-3.json |
| 101174-1 | 17-Hydroxyprogesterone [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/101174-1.json |
| 101175-8 | 3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101175-8.json |
| 101176-6 | Normetanephrine Free/Creatinine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101176-6.json |
| 101177-4 | Metanephrine Free/Creatinine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101177-4.json |
| 101179-0 | Immunoglobulin light chains.free/Protein.total in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101179-0.json |
| 101180-8 | 2-methyl AP-237 [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101180-8.json |
| 101181-6 | MDMB-4en-PINACA [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101181-6.json |
| 101182-4 | MDMB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101182-4.json |
| 101183-2 | MDMB-4en-PINACA [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101183-2.json |
| 101184-0 | 4F-MDMB-BINACA [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101184-0.json |
| 101185-7 | 4F-MDMB-BINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101185-7.json |
| 101186-5 | 4F-MDMB-BINACA [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101186-5.json |
| 101187-3 | ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101187-3.json |
| 101188-1 | ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101188-1.json |
| 101189-9 | ADB-BUTINACA [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101189-9.json |
| 101190-7 | 5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101190-7.json |
| 101191-5 | 5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101191-5.json |
| 101192-3 | 5F-MDMB-PICA [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101192-3.json |
| 101198-0 | Albumin [Mass/volume] in Serum or Plasma by Nephelometry | ./2.16.840.1.114222.4.11.1002/101198-0.json |
| 101204-6 | Varicella zoster virus IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101204-6.json |
| 101205-3 | Plasmodium sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101205-3.json |
| 101206-1 | Dengue virus NS1 Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101206-1.json |
| 101207-9 | Hepatitis E virus IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/101207-9.json |
| 101208-7 | Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/101208-7.json |
| 101220-2 | SUMO-activating enzyme subunit 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101220-2.json |
| 101221-0 | PM-SCL-100 extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101221-0.json |
| 101222-8 | Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/101222-8.json |
| 101224-4 | PKD1 and PKD2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/101224-4.json |
| 101225-1 | Hemosiderin [Presence] in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/101225-1.json |
| 101226-9 | Recoverin Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/101226-9.json |
| 101227-7 | Recoverin Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101227-7.json |
| 101228-5 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101228-5.json |
| 101229-3 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/101229-3.json |
| 101230-1 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101230-1.json |
| 101231-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101231-9.json |
| 101232-7 | Glutamate decarboxylase 65 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101232-7.json |
| 101233-5 | Glutamate decarboxylase 65 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/101233-5.json |
| 101234-3 | Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101234-3.json |
| 101235-0 | Glial nuclear type 1 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/101235-0.json |
| 101236-8 | Titin Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/101236-8.json |
| 101237-6 | Titin Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/101237-6.json |
| 101240-0 | Contactin-associated protein 2 Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101240-0.json |
| 101241-8 | Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101241-8.json |
| 101242-6 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101242-6.json |
| 101243-4 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101243-4.json |
| 101244-2 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101244-2.json |
| 101245-9 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101245-9.json |
| 101246-7 | NMDAR Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101246-7.json |
| 101247-5 | NMDAR Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101247-5.json |
| 101248-3 | Pathologic casts [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/101248-3.json |
| 101250-9 | Aspergillus fumigatus [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/101250-9.json |
| 101251-7 | Dense fine speckled 70 protein Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101251-7.json |
| 101254-1 | Herpes virus 6 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101254-1.json |
| 101255-8 | Herpes virus 6 DNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101255-8.json |
| 101281-4 | Neurofilament light chain [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101281-4.json |
| 101282-2 | Mitragynine [Presence] in Cord tissue | ./2.16.840.1.114222.4.11.1002/101282-2.json |
| 101283-0 | Speciociliatine [Presence] in Cord tissue | ./2.16.840.1.114222.4.11.1002/101283-0.json |
| 101284-8 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101284-8.json |
| 101286-3 | Adenovirus DNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101286-3.json |
| 101287-1 | Chlamydophila pneumoniae DNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101287-1.json |
| 101288-9 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101288-9.json |
| 101289-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101289-7.json |
| 101290-5 | Human metapneumovirus RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101290-5.json |
| 101291-3 | Rhinovirus+Enterovirus RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101291-3.json |
| 101292-1 | Influenza virus A RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101292-1.json |
| 101293-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101293-9.json |
| 101294-7 | Influenza virus A H3 RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101294-7.json |
| 101295-4 | Influenza virus B RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101295-4.json |
| 101296-2 | Mycoplasma pneumoniae DNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101296-2.json |
| 101297-0 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101297-0.json |
| 101298-8 | Respiratory syncytial virus RNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101298-8.json |
| 101299-6 | Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101299-6.json |
| 101300-2 | Streptococcus pyogenes DNA [Presence] in Throat by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101300-2.json |
| 101301-0 | XR Thoracic spine Views 2 and Abdomen AP and Lateral | ./2.16.840.1.114222.4.11.1002/101301-0.json |
| 101302-8 | Leptospira sp DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101302-8.json |
| 101303-6 | Chikungunya virus RNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101303-6.json |
| 101304-4 | Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101304-4.json |
| 101305-1 | Plasmodium sp DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101305-1.json |
| 101306-9 | Plasmodium falciparum DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101306-9.json |
| 101307-7 | Plasmodium vivax+ovale DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101307-7.json |
| 101309-3 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose arginine | ./2.16.840.1.114222.4.11.1002/101309-3.json |
| 101334-1 | Etizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101334-1.json |
| 101335-8 | Etizolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101335-8.json |
| 101336-6 | Wr sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/101336-6.json |
| 101338-2 | Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/101338-2.json |
| 101339-0 | Cholesterol [Presence] in Fibroblast by Filipin stain | ./2.16.840.1.114222.4.11.1002/101339-0.json |
| 101340-8 | Aeromonas sp DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101340-8.json |
| 101341-6 | BK virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101341-6.json |
| 101342-4 | JC virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101342-4.json |
| 101345-7 | Candida krusei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101345-7.json |
| 101350-7 | Orthopaedic and Trauma Surgery Consult note | ./2.16.840.1.114222.4.11.1002/101350-7.json |
| 101353-1 | Borrelia burgdorferi Ab [Interpretation] in Serum Qualitative by IA.MTTT | ./2.16.840.1.114222.4.11.1002/101353-1.json |
| 101354-9 | Borrelia afzelii+burgdorferi+garinii IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101354-9.json |
| 101355-6 | Borrelia afzelii+burgdorferi+garinii IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101355-6.json |
| 101356-4 | Borrelia afzelii+burgdorferi+garinii Ab [Interpretation] in Serum by IA.MTTT | ./2.16.840.1.114222.4.11.1002/101356-4.json |
| 101357-2 | Borrelia burgdorferi.VlsE+OspC IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101357-2.json |
| 101358-0 | Borrelia burgdorferi Ab [Interpretation] in Serum by IA.MTTT | ./2.16.840.1.114222.4.11.1002/101358-0.json |
| 101360-6 | Bacillus anthracis plasmid pXO1 DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101360-6.json |
| 101361-4 | Bacillus anthracis plasmid pXO2 DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101361-4.json |
| 101362-2 | Bacillus anthracis DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101362-2.json |
| 101363-0 | Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101363-0.json |
| 101364-8 | Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101364-8.json |
| 101365-5 | Coxiella burnetii DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101365-5.json |
| 101366-3 | Ebola virus RNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101366-3.json |
| 101367-1 | Marburg virus RNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101367-1.json |
| 101368-9 | Bacillus anthracis DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/101368-9.json |
| 101369-7 | Bacillus anthracis plasmid pXO1 DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/101369-7.json |
| 101370-5 | Bacillus anthracis plasmid pXO2 DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/101370-5.json |
| 101371-3 | Yersinia pestis DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/101371-3.json |
| 101372-1 | Yersinia pestis DNA [Presence] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101372-1.json |
| 101373-9 | Francisella tularensis DNA [Presence] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/101373-9.json |
| 101377-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101377-0.json |
| 101378-8 | Lung cancer targeted gene fusion transcript analysis in Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/101378-8.json |
| 101379-6 | DDIT3 gene rearrangement in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101379-6.json |
| 101380-4 | ETV6 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101380-4.json |
| 101381-2 | BAP1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101381-2.json |
| 101382-0 | FH gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101382-0.json |
| 101383-8 | FUS gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101383-8.json |
| 101384-6 | MYC gene amplification in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101384-6.json |
| 101385-3 | NF1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101385-3.json |
| 101386-1 | RET gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101386-1.json |
| 101387-9 | HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101387-9.json |
| 101388-7 | GP1BB full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101388-7.json |
| 101389-5 | GP1BA gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101389-5.json |
| 101390-3 | GP9 gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101390-3.json |
| 101391-1 | PAH gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101391-1.json |
| 101392-9 | ADA gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101392-9.json |
| 101393-7 | CLCN7 gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101393-7.json |
| 101394-5 | Sex [Type] in Embryo by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101394-5.json |
| 101395-2 | Translocation analysis in Embryo by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101395-2.json |
| 101396-0 | Preimplantation multigene analysis in Embryo by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101396-0.json |
| 101397-8 | Copy number variation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/101397-8.json |
| 101399-4 | Monkeypox virus and Orthopoxvirus.non-variola DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101399-4.json |
| 101403-4 | Borrelia burgdorferi.VlsE1+pepC10 IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101403-4.json |
| 101405-9 | Amyloid protein in Tissue Document | ./2.16.840.1.114222.4.11.1002/101405-9.json |
| 101406-7 | Sudan virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101406-7.json |
| 101407-5 | Laceyella sacchari IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/101407-5.json |
| 101411-7 | Dupilumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough | ./2.16.840.1.114222.4.11.1002/101411-7.json |
| 101412-5 | Dolutegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough | ./2.16.840.1.114222.4.11.1002/101412-5.json |
| 101413-3 | Bictegravir [Mass/volume] in Serum or Plasma by LC/MS/MS --trough | ./2.16.840.1.114222.4.11.1002/101413-3.json |
| 101419-0 | Human coronavirus 229E RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101419-0.json |
| 101420-8 | Human coronavirus HKU1 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101420-8.json |
| 101421-6 | Human coronavirus NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101421-6.json |
| 101422-4 | Human coronavirus OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101422-4.json |
| 101423-2 | Influenza virus A H1 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101423-2.json |
| 101424-0 | Influenza virus A H3 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101424-0.json |
| 101425-7 | Respiratory syncytial virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101425-7.json |
| 101426-5 | Respiratory syncytial virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101426-5.json |
| 101427-3 | Shigella sp DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101427-3.json |
| 101428-1 | Varicella zoster virus DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101428-1.json |
| 101434-9 | 2-Ketobutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101434-9.json |
| 101437-2 | FDA product label Intentional animal genomic alteration label | ./2.16.840.1.114222.4.11.1002/101437-2.json |
| 101443-0 | Soluble urokinase plasminogen activator receptor [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/101443-0.json |
| 101444-8 | Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify XL2 | ./2.16.840.1.114222.4.11.1002/101444-8.json |
| 101445-5 | Solitary lung nod malignancy risk [Scale] Qualitative by Calculated.Nodify CDT | ./2.16.840.1.114222.4.11.1002/101445-5.json |
| 101446-3 | Creatine kinase.MB [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101446-3.json |
| 101448-9 | Contactin-associated protein 1 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101448-9.json |
| 101449-7 | Neurochondrin Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101449-7.json |
| 101450-5 | Neurochondrin Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101450-5.json |
| 101451-3 | Neurochondrin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101451-3.json |
| 101452-1 | Neurochondrin Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101452-1.json |
| 101453-9 | Neurochondrin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101453-9.json |
| 101454-7 | Neurochondrin Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101454-7.json |
| 101456-2 | Septin-7 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101456-2.json |
| 101457-0 | Septin-7 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101457-0.json |
| 101458-8 | Septin-5 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101458-8.json |
| 101459-6 | Septin-5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101459-6.json |
| 101460-4 | Septin-5 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101460-4.json |
| 101461-2 | Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101461-2.json |
| 101462-0 | Septin-5 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101462-0.json |
| 101463-8 | Septin-5 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101463-8.json |
| 101464-6 | Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101464-6.json |
| 101465-3 | Septin-7 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101465-3.json |
| 101466-1 | Septin-7 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101466-1.json |
| 101467-9 | Septin-7 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101467-9.json |
| 101468-7 | Risk adjustment coding gap report Document | ./2.16.840.1.114222.4.11.1002/101468-7.json |
| 101469-5 | HBA1+2 gene FIL deletion [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101469-5.json |
| 101470-3 | HBA1+2 gene THAI deletion [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101470-3.json |
| 101472-9 | Catalase [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/101472-9.json |
| 101475-2 | Creatinine [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/101475-2.json |
| 101476-0 | Fasting glucose [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/101476-0.json |
| 101507-2 | Suicide screening report | ./2.16.840.1.114222.4.11.1002/101507-2.json |
| 101508-0 | Salmonella serogroup D1 [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/101508-0.json |
| 101509-8 | Colony count [#/volume] in Specimen by Culture Standard Plate Count | ./2.16.840.1.114222.4.11.1002/101509-8.json |
| 101510-6 | Porcine DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101510-6.json |
| 101511-4 | Salmonella enterica serotype 1,4,[5],12:i:- [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101511-4.json |
| 101512-2 | Salmonella typhimurium DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101512-2.json |
| 101513-0 | Mycoplasma flocculare DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101513-0.json |
| 101514-8 | Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101514-8.json |
| 101515-5 | Equine herpesvirus 1 neuropathogenic G2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101515-5.json |
| 101516-3 | Salmonella dublin Ab in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/101516-3.json |
| 101517-1 | Canine parvovirus DNA VP2 gene [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101517-1.json |
| 101518-9 | Canine Parvovirus 2 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101518-9.json |
| 101519-7 | Hemorrhagic enteritis virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101519-7.json |
| 101520-5 | Avian reovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101520-5.json |
| 101521-3 | Hemorrhagic enteritis virus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101521-3.json |
| 101522-1 | Porcine deltacoronavirus S gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101522-1.json |
| 101523-9 | Bovine parainfluenza virus 3 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/101523-9.json |
| 101524-7 | Mycoplasma hyopneumoniae [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/101524-7.json |
| 101525-4 | Valnemulin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/101525-4.json |
| 101526-2 | Tylvalosin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/101526-2.json |
| 101527-0 | Porcine epidemic diarrhea virus S1 gene [Identifier] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101527-0.json |
| 101528-8 | Mycoplasma sp DNA [Identifier] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101528-8.json |
| 101529-6 | Mycoplasma sp DNA [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101529-6.json |
| 101530-4 | Porcine epidemic diarrhea virus IgG Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/101530-4.json |
| 101531-2 | Porcine epidemic diarrhea virus S1 gene IgA Ab [Units/volume] in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/101531-2.json |
| 101533-8 | Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101533-8.json |
| 101534-6 | Fungal 18s rRNA gene [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/101534-6.json |
| 101535-3 | Fungal 18s rRNA gene [Nucleotide sequence] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/101535-3.json |
| 101536-1 | Salmonella sp whole genome [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/101536-1.json |
| 101538-7 | SMA residual risk [Interpretation] in Blood by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/101538-7.json |
| 101541-1 | Multidisciplinary Comprehensive plan of care note | ./2.16.840.1.114222.4.11.1002/101541-1.json |
| 101543-7 | Tumor necrosis factor ligand superfamily member 10 [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/101543-7.json |
| 101545-2 | FCGR3A gene.p.Phe158 [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/101545-2.json |
| 101546-0 | FCGR3A gene.p.Val158 [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/101546-0.json |
| 101547-8 | Hepatocyte Ag by paraffin 1 in Blood or Tissue Qualitative by Immune stain | ./2.16.840.1.114222.4.11.1002/101547-8.json |
| 101548-6 | P63 protein [Interpretation] in Blood or Tissue Qualitative | ./2.16.840.1.114222.4.11.1002/101548-6.json |
| 101552-8 | Campylobacter coli DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101552-8.json |
| 101553-6 | Aeromonas hydrophila DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101553-6.json |
| 101554-4 | Campylobacter jejuni DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101554-4.json |
| 101555-1 | Campylobacter upsaliensis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101555-1.json |
| 101556-9 | Candida krusei DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101556-9.json |
| 101557-7 | Clostridioides difficile DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101557-7.json |
| 101558-5 | Escherichia coli enteroinvasive DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101558-5.json |
| 101559-3 | Listeria monocytogenes DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101559-3.json |
| 101560-1 | Rotavirus B RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101560-1.json |
| 101561-9 | Rotavirus C RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101561-9.json |
| 101562-7 | Sapovirus genogroups I+II+IV RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101562-7.json |
| 101563-5 | Sapovirus genogroup V RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101563-5.json |
| 101564-3 | Gliadin peptide IgA+IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101564-3.json |
| 101565-0 | Electrolytes panel - Venous blood | ./2.16.840.1.114222.4.11.1002/101565-0.json |
| 101566-8 | Human coronavirus RNA in Specimen Document | ./2.16.840.1.114222.4.11.1002/101566-8.json |
| 101567-6 | Parainfluenza virus RNA in Specimen Document | ./2.16.840.1.114222.4.11.1002/101567-6.json |
| 1015-7 | E sup(w) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1015-7.json |
| 101570-0 | Spermatozoa Normal chromatin/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/101570-0.json |
| 101571-8 | Candida glabrata+krusei DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101571-8.json |
| 101573-4 | Diet at discharge | ./2.16.840.1.114222.4.11.1002/101573-4.json |
| 101577-5 | Cardioversion report Heart Document | ./2.16.840.1.114222.4.11.1002/101577-5.json |
| 101578-3 | Cardiac device monitoring report | ./2.16.840.1.114222.4.11.1002/101578-3.json |
| 101579-1 | Heart Multisection transthoracic limited by US | ./2.16.840.1.114222.4.11.1002/101579-1.json |
| 101580-9 | US Heart Transthoracic limited for congenital disease | ./2.16.840.1.114222.4.11.1002/101580-9.json |
| 101581-7 | US Heart Transthoracic for congenital disease | ./2.16.840.1.114222.4.11.1002/101581-7.json |
| 101582-5 | NM Gastrointestinal tract Views for protein-losing enteropathy W Tc-99m HSA IV | ./2.16.840.1.114222.4.11.1002/101582-5.json |
| 101583-3 | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative | ./2.16.840.1.114222.4.11.1002/101583-3.json |
| 101584-1 | Bacterial Vaginosis Associated Bacteria-2+Atopobium vaginae+Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101584-1.json |
| 101585-8 | Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101585-8.json |
| 101586-6 | Cortisol [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/101586-6.json |
| 101588-2 | Histoplasma capsulatum+Blastomyces dermatitidis Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101588-2.json |
| 101589-0 | Histoplasma capsulatum+Blastomyces dermatitidis Ag [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101589-0.json |
| 101590-8 | VKORC1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/101590-8.json |
| 101627-8 | Thyroglobulin heterophile Ab interference [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/101627-8.json |
| 101628-6 | Thyroglobulin heterophile Ab interference [Interpretation] in Serum Narrative | ./2.16.840.1.114222.4.11.1002/101628-6.json |
| 101630-2 | JAK2 gene rearrangements in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/101630-2.json |
| 101631-0 | JAK2 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101631-0.json |
| 101633-6 | MT-RNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101633-6.json |
| 101634-4 | HBB gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/101634-4.json |
| 101635-1 | USP6 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101635-1.json |
| 101636-9 | TCRB gene and TCRG gene rearrangements in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101636-9.json |
| 101637-7 | TCRB gene and TCRG gene rearrangements in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101637-7.json |
| 101638-5 | TCRB gene and TCRG gene rearrangements in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101638-5.json |
| 101639-3 | PDGFB gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101639-3.json |
| 101640-1 | NUTM1 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101640-1.json |
| 101641-9 | Myeloid sarcoma analysis in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101641-9.json |
| 101643-5 | CD3 cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/101643-5.json |
| 101644-3 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/101644-3.json |
| 101645-0 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | ./2.16.840.1.114222.4.11.1002/101645-0.json |
| 101646-8 | Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101646-8.json |
| 101648-4 | 14-3-3 Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/101648-4.json |
| 101649-2 | Tau protein [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/101649-2.json |
| 101650-0 | Prion disease risk [Interpretation] in Cerebral spinal fluid by Immunoassay Narrative | ./2.16.840.1.114222.4.11.1002/101650-0.json |
| 101657-5 | Special investigation unit (SIU) medical record request Document | ./2.16.840.1.114222.4.11.1002/101657-5.json |
| 101658-3 | Cancer staging after multimodality therapy | ./2.16.840.1.114222.4.11.1002/101658-3.json |
| 101659-1 | Cancer staging after tumor recurrence | ./2.16.840.1.114222.4.11.1002/101659-1.json |
| 101660-9 | Cancer staging during autopsy | ./2.16.840.1.114222.4.11.1002/101660-9.json |
| 101661-7 | Tumor marker level Serum | ./2.16.840.1.114222.4.11.1002/101661-7.json |
| 101662-5 | Abnormal Prion Protein [Presence] in Cerebral spinal fluid by RT-QuIC | ./2.16.840.1.114222.4.11.1002/101662-5.json |
| 101663-3 | T-Cell acute lymphoblastic leukemia in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101663-3.json |
| 101664-1 | in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101664-1.json |
| 101667-4 | Protein.monoclonal [Presence] in 24 hour Urine by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/101667-4.json |
| 101669-0 | Protein.monoclonal isotype [Identifier] in Urine by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/101669-0.json |
| 101670-8 | Protein.monoclonal [Presence] in Urine by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/101670-8.json |
| 101671-6 | Hereditary Wilms tumor multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101671-6.json |
| 101673-2 | KPC carbapenemase [Presence] in Isolate by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101673-2.json |
| 101674-0 | OXA-48-like carbapenemase [Presence] in Isolate by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101674-0.json |
| 101675-7 | IMP Carbapenemase [Presence] in Isolate by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101675-7.json |
| 101676-5 | VIM Carbapenemase [Presence] in Isolate by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101676-5.json |
| 101677-3 | NDM Carbapenemase [Presence] in Isolate by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/101677-3.json |
| 101678-1 | Blood group antibody screen [Presence] in Blood from Newborn | ./2.16.840.1.114222.4.11.1002/101678-1.json |
| 101682-3 | T-cell lymphoma in Blood or Tissue Document by FISH | ./2.16.840.1.114222.4.11.1002/101682-3.json |
| 101719-3 | Nickel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/101719-3.json |
| 101727-6 | JC virus DNA [log units/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101727-6.json |
| 101729-2 | JC virus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101729-2.json |
| 101731-8 | JC virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101731-8.json |
| 101732-6 | JC virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101732-6.json |
| 101733-4 | JC virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101733-4.json |
| 101734-2 | Sodium Urate crystals [Energy Difference] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101734-2.json |
| 101735-9 | Urate crystals [Energy Difference] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101735-9.json |
| 101736-7 | Calcium hydrogen phosphate dihydrate (CHPD) in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101736-7.json |
| 101738-3 | Platelet aggregation ristocetin induced in Platelet rich plasma --250 ug/mL | ./2.16.840.1.114222.4.11.1002/101738-3.json |
| 101739-1 | Platelet aggregation ristocetin induced in Platelet rich plasma --125 ug/mL | ./2.16.840.1.114222.4.11.1002/101739-1.json |
| 101741-7 | Nonspermatozoal cells [#/area] in Semen by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/101741-7.json |
| 101742-5 | Mitochondria M2-3E Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/101742-5.json |
| 101744-1 | Toxoplasma gondii DNA [Presence] in Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101744-1.json |
| 101745-8 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101745-8.json |
| 101746-6 | PCA-Tr Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101746-6.json |
| 101747-4 | PCA-Tr Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101747-4.json |
| 101748-2 | Maraviroc anticipated activity in Blood Qualitative by RT-PCR | ./2.16.840.1.114222.4.11.1002/101748-2.json |
| 101749-0 | Borrelia miyamotoi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101749-0.json |
| 101750-8 | Adeno-associated virus (AAV) serotype Rh74 [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101750-8.json |
| 101751-6 | Lithium [Moles/volume] in Blood by Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) | ./2.16.840.1.114222.4.11.1002/101751-6.json |
| 101752-4 | Tau protein/Tau protein.phosphorilated 181 [Mass Ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/101752-4.json |
| 101753-2 | Dermatophytes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101753-2.json |
| 101754-0 | Trichophyton tonsurans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101754-0.json |
| 101755-7 | Trichophyton equinum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101755-7.json |
| 101756-5 | Trichophyton interdigitale DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101756-5.json |
| 101757-3 | Trichophyton mentagrophytes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101757-3.json |
| 101758-1 | Trichophyton quinckeanum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101758-1.json |
| 101759-9 | Trichophyton schoenleinii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101759-9.json |
| 101760-7 | Trichophyton simii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101760-7.json |
| 101761-5 | Trichophyton concentricum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101761-5.json |
| 101762-3 | Trichophyton bullosum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101762-3.json |
| 101763-1 | Trichophyton benhamiae (Afr.) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101763-1.json |
| 101764-9 | Trichophyton benhamiae (white) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101764-9.json |
| 101765-6 | Trichophyton benhamiae (yellow) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101765-6.json |
| 101766-4 | Trichophyton erinacei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101766-4.json |
| 101767-2 | Trichophyton verrucosum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101767-2.json |
| 101768-0 | Trichophyton eriotrephon DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101768-0.json |
| 101769-8 | Trichophyton rubrum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101769-8.json |
| 101770-6 | Trichophyton violaceum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101770-6.json |
| 101771-4 | Epidermophyton floccosum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101771-4.json |
| 101772-2 | Microsporum canis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101772-2.json |
| 101773-0 | Microsporum audouinii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101773-0.json |
| 101774-8 | Microsporum ferrugineum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101774-8.json |
| 101775-5 | Nannizzia fulva DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101775-5.json |
| 101776-3 | Nannizzia gypsea DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101776-3.json |
| 101777-1 | Nannizzia incurvata DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101777-1.json |
| 101778-9 | Nannizzia persicolor DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101778-9.json |
| 101781-3 | Candida guilliermondii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101781-3.json |
| 101782-1 | Fusarium solani DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101782-1.json |
| 101783-9 | Fusarium oxysporum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101783-9.json |
| 101784-7 | Scopulariopsis brevicaulis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101784-7.json |
| 101785-4 | CYP2C Cluster Allele [Genotype] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101785-4.json |
| 101786-2 | Toxoplasma gondii DNA [Presence] in Serum by RT-PCR | ./2.16.840.1.114222.4.11.1002/101786-2.json |
| 101787-0 | B-cell lymphoma chromosome analysis in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/101787-0.json |
| 101788-8 | Chronic lymphocytic leukemia gene rearrangements in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/101788-8.json |
| 101793-8 | Tianeptine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101793-8.json |
| 101794-6 | Tianeptine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101794-6.json |
| 101795-3 | Tianeptine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101795-3.json |
| 101800-1 | Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101800-1.json |
| 101801-9 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101801-9.json |
| 101802-7 | Brucella sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/101802-7.json |
| 101804-3 | Bone DXA Calcaneus [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/101804-3.json |
| 101805-0 | Bone DXA Calcaneus [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/101805-0.json |
| 101806-8 | Beta-Amyloid [Ratio] in Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/101806-8.json |
| 101808-4 | Xylazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101808-4.json |
| 101809-2 | Xylazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101809-2.json |
| 101810-0 | Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101810-0.json |
| 101811-8 | 2,6-dimethylaniline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101811-8.json |
| 101812-6 | 2,6-dimethylaniline/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101812-6.json |
| 101813-4 | 2,6-dimethylaniline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/101813-4.json |
| 101814-2 | BK virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101814-2.json |
| 101815-9 | Cytomegalovirus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101815-9.json |
| 101816-7 | Cytomegalovirus DNA [Units/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101816-7.json |
| 101817-5 | Epstein Barr virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101817-5.json |
| 101818-3 | Herpes virus 6 DNA [Units/volume] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101818-3.json |
| 101820-9 | Preimplantation targeted mutation analysis in Embryo by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101820-9.json |
| 101823-3 | Apolipoprotein C-III [Presence] in Serum or Plasma by Isoelectric focusing | ./2.16.840.1.114222.4.11.1002/101823-3.json |
| 101824-1 | Aspartylglucosaminidase [Enzymatic activity/mass] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101824-1.json |
| 101825-8 | Brushite crystals [Saturation Fraction] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101825-8.json |
| 101826-6 | Sodium Urate crystals [Saturation Fraction] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101826-6.json |
| 101827-4 | Urate crystals [Saturation Fraction] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/101827-4.json |
| 101829-0 | Tetrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101829-0.json |
| 101830-8 | Medazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101830-8.json |
| 101831-6 | Beclomethasone dipropionate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101831-6.json |
| 101832-4 | Betamethasone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101832-4.json |
| 101833-2 | Budesonide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101833-2.json |
| 101834-0 | Dexamethasone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101834-0.json |
| 101835-7 | Fludrocortisone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101835-7.json |
| 101836-5 | Flunisolide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101836-5.json |
| 101837-3 | Fluorometholone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101837-3.json |
| 101838-1 | Fluticasone propionate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101838-1.json |
| 101839-9 | Megestrol acetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101839-9.json |
| 101840-7 | Methylprednisolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101840-7.json |
| 101841-5 | prednisoLONE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101841-5.json |
| 101843-1 | Triamcinolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101843-1.json |
| 101844-9 | Triamcinolone acetonide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101844-9.json |
| 101846-4 | Beclomethasone dipropionate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101846-4.json |
| 101847-2 | Betamethasone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101847-2.json |
| 101848-0 | Budesonide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101848-0.json |
| 101849-8 | Dexamethasone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101849-8.json |
| 101850-6 | Fludrocortisone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101850-6.json |
| 101851-4 | Flunisolide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101851-4.json |
| 101852-2 | Fluorometholone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101852-2.json |
| 101853-0 | Fluticasone propionate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101853-0.json |
| 101854-8 | Megestrol acetate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101854-8.json |
| 101855-5 | Methylprednisolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101855-5.json |
| 101856-3 | prednisoLONE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101856-3.json |
| 101857-1 | predniSONE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101857-1.json |
| 101858-9 | Triamcinolone acetonide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101858-9.json |
| 101859-7 | Triamcinolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/101859-7.json |
| 101863-9 | Complement factor H Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101863-9.json |
| 101864-7 | Oxygen/Total gas setting ECMO device | ./2.16.840.1.114222.4.11.1002/101864-7.json |
| 101867-0 | Ma2 Antibody [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/101867-0.json |
| 101868-8 | Ma2 Antibody [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/101868-8.json |
| 101870-4 | GABAAR IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101870-4.json |
| 101871-2 | IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101871-2.json |
| 101872-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101872-0.json |
| 101873-8 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101873-8.json |
| 101874-6 | GABAAR IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101874-6.json |
| 101875-3 | GABAAR IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101875-3.json |
| 101876-1 | IgLON5 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101876-1.json |
| 101877-9 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101877-9.json |
| 101878-7 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/101878-7.json |
| 101879-5 | Osmolality of Arterial blood by calculation | ./2.16.840.1.114222.4.11.1002/101879-5.json |
| 101880-3 | Osmolality of Venous blood by calculation | ./2.16.840.1.114222.4.11.1002/101880-3.json |
| 101902-5 | little c Ag [Presence] on Red Blood Cells from Fetus | ./2.16.840.1.114222.4.11.1002/101902-5.json |
| 101903-3 | K Ag [Presence] on Red Blood Cells from Fetus | ./2.16.840.1.114222.4.11.1002/101903-3.json |
| 101906-6 | Noninvasive esophageal cancer DNA and esophageal cell screening [Presence] in Esophagus by Sequencing | ./2.16.840.1.114222.4.11.1002/101906-6.json |
| 101907-4 | AP-3 complex IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/101907-4.json |
| 101908-2 | AP-3 complex Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/101908-2.json |
| 101911-6 | Troponin T. cardiac [Mass/volume] in 2 hour 5th generation Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101911-6.json |
| 101912-4 | Troponin T.cardiac delta [Mass concentration difference] in 2 hour Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101912-4.json |
| 101913-2 | Troponin T.cardiac delta/Troponin T.cardiac in 2 hour Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/101913-2.json |
| 101914-0 | Troponin T.cardiac delta [Interpretation] in 2 hour Serum or Plasma Qualitative | ./2.16.840.1.114222.4.11.1002/101914-0.json |
| 101915-7 | Troponin T.cardiac [Mass/volume] in 6 hour Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101915-7.json |
| 101916-5 | Troponin T.cardiac delta [Mass concentration difference] in 6 hour Serum or Plasma | ./2.16.840.1.114222.4.11.1002/101916-5.json |
| 101917-3 | Troponin T.cardiac delta/Troponin T.cardiac in 6 hour Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/101917-3.json |
| 101918-1 | Troponin T.cardiac delta [Interpretation] in 6 hour Serum or Plasma Qualitative | ./2.16.840.1.114222.4.11.1002/101918-1.json |
| 101920-7 | Chronic lymphocytic leukemia gene targeted rearrangements in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/101920-7.json |
| 101924-9 | Transforming growth factor beta 1 [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/101924-9.json |
| 101925-6 | Epidermal growth factor [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/101925-6.json |
| 101926-4 | Connective tissue growth factor [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101926-4.json |
| 101927-2 | Calbindin D28K [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/101927-2.json |
| 101928-0 | SARS-CoV-2 Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/101928-0.json |
| 101931-4 | Calcium oxalate crystals [Energy Difference] in Urine | ./2.16.840.1.114222.4.11.1002/101931-4.json |
| 101932-2 | Calcium hydrogen phosphate dihydrate crystals [Energy Difference] in Urine | ./2.16.840.1.114222.4.11.1002/101932-2.json |
| 101933-0 | Hydroxyapatite crystals [Energy Difference] in Urine | ./2.16.840.1.114222.4.11.1002/101933-0.json |
| 101934-8 | Urate crystals [Energy Difference] in Urine | ./2.16.840.1.114222.4.11.1002/101934-8.json |
| 101935-5 | Sodium urate crystals [Energy Difference] in Urine | ./2.16.840.1.114222.4.11.1002/101935-5.json |
| 101936-3 | Candida albicans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101936-3.json |
| 101937-1 | Candida albicans+glabrata+tropicalis+parapsilosis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101937-1.json |
| 101938-9 | Candida dubliniensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101938-9.json |
| 101939-7 | Candida dubliniensis+lusitaniae+krusei+auris DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101939-7.json |
| 101940-5 | Candida glabrata DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101940-5.json |
| 101941-3 | Candida glabrata DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101941-3.json |
| 101942-1 | Candida lusitaniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101942-1.json |
| 101943-9 | Candida parapsilosis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101943-9.json |
| 101944-7 | Candida parapsilosis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101944-7.json |
| 101945-4 | Candida tropicalis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101945-4.json |
| 101946-2 | Candida tropicalis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101946-2.json |
| 101947-0 | Cytomegalovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101947-0.json |
| 101948-8 | Cytomegalovirus DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101948-8.json |
| 101949-6 | Mycoplasma genitalium+hominis DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101949-6.json |
| 101950-4 | Streptococcus pyogenes DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101950-4.json |
| 101952-0 | MTTP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101952-0.json |
| 101953-8 | COL4A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101953-8.json |
| 101954-6 | SLC35A3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101954-6.json |
| 101955-3 | DNAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101955-3.json |
| 101956-1 | COQ4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101956-1.json |
| 101957-9 | RTEL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101957-9.json |
| 101958-7 | ADAMTS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101958-7.json |
| 101959-5 | TCIRG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101959-5.json |
| 101960-3 | PEX2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101960-3.json |
| 101961-1 | PHGDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101961-1.json |
| 101962-9 | DHDDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101962-9.json |
| 101963-7 | SLC1A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101963-7.json |
| 101964-5 | HPS3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101964-5.json |
| 101965-2 | NDUFAF5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/101965-2.json |
| 101968-6 | Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/101968-6.json |
| 101976-9 | Voltage-gated calcium channel P/Q type binding Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/101976-9.json |
| 101981-9 | Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG | ./2.16.840.1.114222.4.11.1002/101981-9.json |
| 101983-5 | Influenza virus A+B RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/101983-5.json |
| 101984-3 | Candida albicans DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101984-3.json |
| 101985-0 | Candida parapsilosis DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101985-0.json |
| 101986-8 | Candida krusei DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101986-8.json |
| 101987-6 | Candida glabrata DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101987-6.json |
| 101988-4 | Candida tropicalis DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101988-4.json |
| 101989-2 | Candida dubliniensis DNA [Presence] in Body fluid by Probe.amp.tar | ./2.16.840.1.114222.4.11.1002/101989-2.json |
| 101990-0 | Xanthurenate [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/101990-0.json |
| 101991-8 | 3-hydroxypropyl mercapturate [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/101991-8.json |
| 101992-6 | Quinolinate [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/101992-6.json |
| 101993-4 | Kynurenate [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/101993-4.json |
| 101994-2 | Foundation pain index Document by based on lab data | ./2.16.840.1.114222.4.11.1002/101994-2.json |
| 101997-5 | Clot initiation.kaolin induced [Time] in Blood by Thromboelastography | ./2.16.840.1.114222.4.11.1002/101997-5.json |
| 101998-3 | Clot formation.kaolin induced [Time] in Blood by Thromboelastography | ./2.16.840.1.114222.4.11.1002/101998-3.json |
| 102000-7 | Maximum amplitude kaolin induced [Length] in Blood by Thromboelastography | ./2.16.840.1.114222.4.11.1002/102000-7.json |
| 102001-5 | Clot initiation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase | ./2.16.840.1.114222.4.11.1002/102001-5.json |
| 102002-3 | Clot formation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinase | ./2.16.840.1.114222.4.11.1002/102002-3.json |
| 102003-1 | Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinase | ./2.16.840.1.114222.4.11.1002/102003-1.json |
| 102004-9 | Clot angle.kaolin induced in Blood by Thromboelastography^after addition of heparinase | ./2.16.840.1.114222.4.11.1002/102004-9.json |
| 102005-6 | Chromium IgE Ab RAST class [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/102005-6.json |
| 102006-4 | von Willebrand factor.platelet binding activity without ristocetin [Units/volume] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/102006-4.json |
| 102007-2 | Heterophile ACTH Interpretation in Plasma Narrative | ./2.16.840.1.114222.4.11.1002/102007-2.json |
| 102009-8 | Clinical pathology Laboratory report | ./2.16.840.1.114222.4.11.1002/102009-8.json |
| 102018-9 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucagon | ./2.16.840.1.114222.4.11.1002/102018-9.json |
| 102019-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102019-7.json |
| 102020-5 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102020-5.json |
| 102021-3 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102021-3.json |
| 102022-1 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102022-1.json |
| 102023-9 | Cortisol [[Mass/volume] in Serum or Plasma --30 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/102023-9.json |
| 102024-7 | Cortisol [Moles/volume] in Serum or Plasma --60M post dose glucagon | ./2.16.840.1.114222.4.11.1002/102024-7.json |
| 102025-4 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102025-4.json |
| 102026-2 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102026-2.json |
| 102027-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102027-0.json |
| 102028-8 | Cortisol [Mass/volume] in Serum or Plasma --3 hours post dose glucagon | ./2.16.840.1.114222.4.11.1002/102028-8.json |
| 102029-6 | Somatotropin [Mass/volume] in Serum or Plasma --Fasting post dose insulin IV | ./2.16.840.1.114222.4.11.1002/102029-6.json |
| 102030-4 | Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Body fluid by Immune stain | ./2.16.840.1.114222.4.11.1002/102030-4.json |
| 102031-2 | Ki-67 Nuclear Ag and p16INK4a Ag Ag [Presence] in Cervix by Immune stain | ./2.16.840.1.114222.4.11.1002/102031-2.json |
| 102032-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose insulin IV | ./2.16.840.1.114222.4.11.1002/102032-0.json |
| 102034-6 | Pathology report microscopic observation in Specimen | ./2.16.840.1.114222.4.11.1002/102034-6.json |
| 102035-3 | Anti-hypertensive and Anti-thrombotic drug [Presence] in Serum by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/102035-3.json |
| 102036-1 | Abnormal Prion Protein [Interpretation] in Cerebral spinal fluid Document by RT-QuIC | ./2.16.840.1.114222.4.11.1002/102036-1.json |
| 102038-7 | ROS proto-oncogene 1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/102038-7.json |
| 102039-5 | MET gene amplification in Blood or Tissue by Molgen | ./2.16.840.1.114222.4.11.1002/102039-5.json |
| 102041-1 | Carboxy tetrahydrocannabinol Delta 9/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/102041-1.json |
| 102043-7 | Surgical oncology of lung cancer synoptic report | ./2.16.840.1.114222.4.11.1002/102043-7.json |
| 102044-5 | Surgical oncology of stomach cancer synoptic report | ./2.16.840.1.114222.4.11.1002/102044-5.json |
| 102045-2 | Synoptic report for adrenal gland cancer surgery | ./2.16.840.1.114222.4.11.1002/102045-2.json |
| 102046-0 | Surgical oncology of sarcoma cancer synoptic report | ./2.16.840.1.114222.4.11.1002/102046-0.json |
| 102047-8 | Surgical oncology of rectum cancer synoptic report | ./2.16.840.1.114222.4.11.1002/102047-8.json |
| 102048-6 | SARS coronavirus 2 and Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/102048-6.json |
| 102052-8 | 1-Deoxysphingosine [Mass/volume] in Serum by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/102052-8.json |
| 102053-6 | 1-deoxymethylsphinganine [Mass/volume] in Serum by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/102053-6.json |
| 102075-9 | NASEM Summation Value [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/102075-9.json |
| 102076-7 | Insulin [Units/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/102076-7.json |
| 102079-1 | CAR-T dose [#/mass] | ./2.16.840.1.114222.4.11.1002/102079-1.json |
| 102086-6 | Endometrial stromal tumor in Tissue Document by FISH | ./2.16.840.1.114222.4.11.1002/102086-6.json |
| 102090-8 | Ceruloplasmin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/102090-8.json |
| 102091-6 | HBA1 and HBA2 gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/102091-6.json |
| 102097-3 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine, Cystatin C and Urea-based formula (CKiD) | ./2.16.840.1.114222.4.11.1002/102097-3.json |
| 102098-1 | Acute myeloid leukemia minimal residual disease in Bone marrow by Flow cytometry (FC) Narrative | ./2.16.840.1.114222.4.11.1002/102098-1.json |
| 102099-9 | B-cell acute lymphocytic leukemia in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/102099-9.json |
| 102100-5 | B-cell acute lymphoblastic leukemia in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/102100-5.json |
| 102101-3 | Acute myeloid leukemia in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/102101-3.json |
| 102105-4 | Pecan or Hickory Tree IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/102105-4.json |
| 102106-2 | Glycolate [Moles/volume] in Serum or Plasma by Gas chromatography-mass spectrometry | ./2.16.840.1.114222.4.11.1002/102106-2.json |
| 102111-2 | Gastrin 34 [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/102111-2.json |
| 102112-0 | Melatonin [Moles/volume] in Saliva (oral fluid) by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/102112-0.json |
| 102120-3 | Carbapenemase [Type] in Isolate by Immunoassay | ./2.16.840.1.114222.4.11.1002/102120-3.json |
| 102121-1 | Bacteria.extended spectrum beta lactamase (ESBL) [Presence] in Stool based on lab data | ./2.16.840.1.114222.4.11.1002/102121-1.json |
| 102122-9 | Oxygen/Gas total [Partial pressure] in Arterial blood and Inhaled gas | ./2.16.840.1.114222.4.11.1002/102122-9.json |
| 102123-7 | Oxygen/Gas total [Partial pressure] adjusted to patient's actual temperature in Arterial blood and Inhaled gas | ./2.16.840.1.114222.4.11.1002/102123-7.json |
| 102124-5 | Sesamum indicum 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/102124-5.json |
| 1021-5 | E Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1021-5.json |
| 10226-9 | Oxygen content in Intravascular space | ./2.16.840.1.114222.4.11.1002/10226-9.json |
| 10244-2 | Oxygen content in Left pulmonary artery | ./2.16.840.1.114222.4.11.1002/10244-2.json |
| 10245-9 | Oxygen content in Main pulmonary artery | ./2.16.840.1.114222.4.11.1002/10245-9.json |
| 10246-7 | Oxygen content in Right pulmonary artery | ./2.16.840.1.114222.4.11.1002/10246-7.json |
| 10247-5 | Oxygen content in Pulmonary wedge | ./2.16.840.1.114222.4.11.1002/10247-5.json |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1027-2.json |
| 103131-9 | Staphylococcus aureus enterotoxin E IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103131-9.json |
| 103132-7 | Maltose binding protein IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103132-7.json |
| 103133-5 | Celery recombinant (rApi g) 1 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103133-5.json |
| 103134-3 | Ascorbate oxidase IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103134-3.json |
| 103135-0 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103135-0.json |
| 103136-8 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103136-8.json |
| 103137-6 | Dog recombinant 6 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103137-6.json |
| 103138-4 | Cat recombinant (rFel d) 7 IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103138-4.json |
| 103141-8 | Staphylococcus aureus MLVA complex [Type] in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103141-8.json |
| 103142-6 | Cell-free DNA.donor/Cell-free DNA.total in Blood by Sequencing --post transplant | ./2.16.840.1.114222.4.11.1002/103142-6.json |
| 103143-4 | Genetic disease DNA and RNA analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103143-4.json |
| 103151-7 | Kidney transplant acute cellular rejection risk [Score] in Plasma cell-free DNA by Calculated by AlloMap | ./2.16.840.1.114222.4.11.1002/103151-7.json |
| 103154-1 | Single nucleotide polymorphisms.recipient derived cf.dna/Single nucleotide polymorphisms.total cf dna in Plasma cell-free DNA by Sequencing --post bone marrow transplant | ./2.16.840.1.114222.4.11.1002/103154-1.json |
| 103155-8 | Single nucleotide polymorphisms.donor derived cf.dna/Single nucleotide polymorphisms.total cf dna in Blood from Donor | ./2.16.840.1.114222.4.11.1002/103155-8.json |
| 103156-6 | CD3 cells recipient derived/Cells.CD3 in Blood by Molecular genetics method --post bone marrow transplant | ./2.16.840.1.114222.4.11.1002/103156-6.json |
| 103157-4 | CD3 cells [#/volume] in Blood from Donor | ./2.16.840.1.114222.4.11.1002/103157-4.json |
| 103158-2 | Cells.CD15.recipient derived/Cells.CD15 in Blood --post bone marrow transplant | ./2.16.840.1.114222.4.11.1002/103158-2.json |
| 103159-0 | CD15 cells [#/volume] in Blood from Donor | ./2.16.840.1.114222.4.11.1002/103159-0.json |
| 103160-8 | Cells.CD33.recipient derived/Cells.CD33 in Blood --post bone marrow transplant | ./2.16.840.1.114222.4.11.1002/103160-8.json |
| 103161-6 | CD33 cells [#/volume] in Blood from Donor | ./2.16.840.1.114222.4.11.1002/103161-6.json |
| 103162-4 | Escherichia coli enteropathogenic DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103162-4.json |
| 103163-2 | Staphylococcus aureus enterotoxin A + Staphylococcus aureus enterotoxin B DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103163-2.json |
| 103164-0 | Cryptococcus neoformans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103164-0.json |
| 103165-7 | Adenovirus 1 and 2 Alpha DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103165-7.json |
| 103166-5 | Adenovirus 1 and 2 Beta DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103166-5.json |
| 103167-3 | Blastomyces dermatitidis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103167-3.json |
| 103168-1 | Campylobacter coli+jejuni DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103168-1.json |
| 103169-9 | Citrobacter freundii DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103169-9.json |
| 103170-7 | Clostridium botulinum DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103170-7.json |
| 103171-5 | Clostridioides difficile toxin A+B DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103171-5.json |
| 103172-3 | Clostridium perfringens DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103172-3.json |
| 103173-1 | Enterobacter aerogenes+Enterobacter cloacae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103173-1.json |
| 103174-9 | Enterobacter spp DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103174-9.json |
| 103175-6 | Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103175-6.json |
| 103176-4 | Escherichia coli enteroinvasive DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103176-4.json |
| 103177-2 | Escherichia coli enterotoxigenic DNA [Presence] in Wound by NAA with probedetection | ./2.16.840.1.114222.4.11.1002/103177-2.json |
| 103178-0 | Enterovirus D68 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103178-0.json |
| 103179-8 | Haemophilus ducreyi DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103179-8.json |
| 103180-6 | Herpes simplex virus 1 DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103180-6.json |
| 103181-4 | Herpes simplex virus 2 DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103181-4.json |
| 103182-2 | Human papilloma virus 16 DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103182-2.json |
| 103183-0 | Human papilloma virus 18 DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103183-0.json |
| 103184-8 | Human Rhinovirus 1 and 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103184-8.json |
| 103185-5 | Human Rhinovirus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103185-5.json |
| 103186-3 | Klebsiella pneumoniae oxytoca DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103186-3.json |
| 103187-1 | Klebsiella pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103187-1.json |
| 103188-9 | Morganella morganii DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103188-9.json |
| 103189-7 | Mycobacterium abscessus DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103189-7.json |
| 103190-5 | Mycobacterium fortuitum+chelonae DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103190-5.json |
| 103191-3 | Mycobacterium kansasii DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103191-3.json |
| 103192-1 | Mycobacterium marinum DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103192-1.json |
| 103193-9 | Mycobacterium ulcerans DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103193-9.json |
| 103194-7 | Proteus mirabilis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103194-7.json |
| 103195-4 | Proteus vulgaris DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103195-4.json |
| 103196-2 | Proteus vulgaris DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103196-2.json |
| 103197-0 | Sarcoptes scabiei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103197-0.json |
| 103198-8 | Staphylococcus aureus DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103198-8.json |
| 103199-6 | Treponema pallidum DNA [Presence] in Urine by Probe with amplification | ./2.16.840.1.114222.4.11.1002/103199-6.json |
| 103200-2 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103200-2.json |
| 103201-0 | Yersinia enterocolitica DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103201-0.json |
| 103203-6 | Cells.CD65/100 cells in Blood or Marrow by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/103203-6.json |
| 103205-1 | Mean heart rate | ./2.16.840.1.114222.4.11.1002/103205-1.json |
| 103225-9 | Enterovirus RNA [Log #/volume] (viral load) in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103225-9.json |
| 103226-7 | Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/103226-7.json |
| 103227-5 | Testosterone Free [Mass/volume] in Serum or Plasma by Calculation | ./2.16.840.1.114222.4.11.1002/103227-5.json |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1033-0.json |
| 10331-7 | Rh [Type] in Blood | ./2.16.840.1.114222.4.11.1002/10331-7.json |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10334-1.json |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10336-6.json |
| 10337-4 | Procollagen type I [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10337-4.json |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10338-2.json |
| 10339-0 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10339-0.json |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10340-8.json |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10341-6.json |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10342-4.json |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10343-2.json |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10344-0.json |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10345-7.json |
| 10347-3 | Babesia microti identified in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/10347-3.json |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/10348-1.json |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10349-9.json |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/10350-7.json |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10351-5.json |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/10352-3.json |
| 10353-1 | Bacteria identified in Nose by Aerobe culture | ./2.16.840.1.114222.4.11.1002/10353-1.json |
| 10354-9 | Bacteria identified in Urethra by Culture | ./2.16.840.1.114222.4.11.1002/10354-9.json |
| 103555-9 | Escherichia coli O157:H7 DNA [Presence] in Wound by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103555-9.json |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | ./2.16.840.1.114222.4.11.1002/10355-6.json |
| 103556-7 | PLA2G7 and PLAC8 gene expression level [Score] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103556-7.json |
| 103557-5 | SARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/103557-5.json |
| 103558-3 | NR4A3 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/103558-3.json |
| 103559-1 | Rhinovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/103559-1.json |
| 103560-9 | Aldosterone/Renin [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/103560-9.json |
| 103562-5 | AB-Fubinaca metabolite 3 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103562-5.json |
| 103565-8 | HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103565-8.json |
| 103566-6 | Metagenomic DNA and RNA Sequencing | ./2.16.840.1.114222.4.11.1002/103566-6.json |
| 103570-8 | AAV serotype rh74 Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103570-8.json |
| 103571-6 | Study observation Ocular fundus Angiography W fluorescein IV | ./2.16.840.1.114222.4.11.1002/103571-6.json |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain | ./2.16.840.1.114222.4.11.1002/10357-2.json |
| 103572-4 | FDA package insert Cosmetic product listing | ./2.16.840.1.114222.4.11.1002/103572-4.json |
| 103573-2 | FDA package insert Cosmetic facility registration | ./2.16.840.1.114222.4.11.1002/103573-2.json |
| 103577-3 | Albumin [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/103577-3.json |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/10358-0.json |
| 103588-0 | Etizolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103588-0.json |
| 103589-8 | Flualprazolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103589-8.json |
| 103590-6 | Bacterial vaginosis RNA [Presence] in Vagina by Probe with amplification | ./2.16.840.1.114222.4.11.1002/103590-6.json |
| 103591-4 | Comprehensive foot screening report Document | ./2.16.840.1.114222.4.11.1002/103591-4.json |
| 103592-2 | Retinal eye screening report Document | ./2.16.840.1.114222.4.11.1002/103592-2.json |
| 103593-0 | Cell growth [Presence] of Amniocytes Qualitative by Tissue culture | ./2.16.840.1.114222.4.11.1002/103593-0.json |
| 103594-8 | Acetyl norfentanyl [Mass/volume] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103594-8.json |
| 103595-5 | Certificate of Medical Necessity | ./2.16.840.1.114222.4.11.1002/103595-5.json |
| 103599-7 | Reason for discharge from the intensive care unit | ./2.16.840.1.114222.4.11.1002/103599-7.json |
| 103600-3 | Baclofen [Mass/volume] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103600-3.json |
| 103601-1 | Staphylococcus aureus MLVA type in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103601-1.json |
| 103602-9 | 6-Hydroxychlorzoxazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/103602-9.json |
| 103604-5 | Carbamazepine 10,11-Epoxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/103604-5.json |
| 103605-2 | Paroxetine metabolite I [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103605-2.json |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10360-6.json |
| 103606-0 | Paroxetine M-II [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103606-0.json |
| 103607-8 | Paroxetine metabolite III [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103607-8.json |
| 103609-4 | Imatinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103609-4.json |
| 103610-2 | Pazopanib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103610-2.json |
| 103611-0 | Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103611-0.json |
| 103612-8 | N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103612-8.json |
| 103613-6 | Sunitinib total [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103613-6.json |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10361-4.json |
| 103614-4 | Gefitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103614-4.json |
| 103615-1 | Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose | ./2.16.840.1.114222.4.11.1002/103615-1.json |
| 103616-9 | Creatinine [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103616-9.json |
| 103617-7 | Helicobacter pylori IgG Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/103617-7.json |
| 103618-5 | Hepatitis B virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103618-5.json |
| 103619-3 | Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/103619-3.json |
| 103621-9 | Small lymphocytic lymphoma chromosome deletions AndOr rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/103621-9.json |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/10362-2.json |
| 103622-7 | Enterobacter spp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103622-7.json |
| 103623-5 | Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103623-5.json |
| 103624-3 | Klebsiella pneumoniae oxytoca DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103624-3.json |
| 103625-0 | Mycobacterium marinum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103625-0.json |
| 103626-8 | Mycobacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103626-8.json |
| 103627-6 | Streptococcus pyogenes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103627-6.json |
| 103628-4 | Monkeypox virus neutralizing antibody [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/103628-4.json |
| 103629-2 | Monkeypox virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/103629-2.json |
| 10363-0 | Barbiturates [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/10363-0.json |
| 103630-0 | Monkeypox virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/103630-0.json |
| 103634-2 | Coccidioides sp IgG and IgM [Units/volume] in Serum and CSF Qualitative by Immunoassay | ./2.16.840.1.114222.4.11.1002/103634-2.json |
| 103635-9 | Chromium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/103635-9.json |
| 103636-7 | Atlantic wreckfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103636-7.json |
| 103637-5 | Atlantic wreckfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/103637-5.json |
| 103638-3 | 4-hydroxy Xylazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103638-3.json |
| 103639-1 | 4-hydroxy Xylazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103639-1.json |
| 103640-9 | 4-hydroxy Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103640-9.json |
| 103641-7 | Herpes virus 6A DNA [#/volume] (viral load) in Serum or Plasma by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/103641-7.json |
| 103642-5 | Herpes virus 6B DNA [Units/volume] (viral load) in Serum or Plasma by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/103642-5.json |
| 103643-3 | Iloperidone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103643-3.json |
| 103644-1 | N-Desmethylasenapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103644-1.json |
| 103645-8 | Asenapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103645-8.json |
| 103646-6 | clozapine N-oxide [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103646-6.json |
| 103647-4 | Cortisol [Mass/volume] in Serum or Plasma --2 hour post dose corticotropin | ./2.16.840.1.114222.4.11.1002/103647-4.json |
| 10364-8 | Cotinine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/10364-8.json |
| 103648-2 | Follitropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone | ./2.16.840.1.114222.4.11.1002/103648-2.json |
| 103649-0 | Lutropin [Units/volume] in Serum or Plasma --10 minutes post dose gonadotropin releasing hormone | ./2.16.840.1.114222.4.11.1002/103649-0.json |
| 103651-6 | Atomoxetine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103651-6.json |
| 103652-4 | 4-Hydroxyatomoxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103652-4.json |
| 103653-2 | Ciprofloxacin [Susceptibility] for meningitis | ./2.16.840.1.114222.4.11.1002/103653-2.json |
| 103654-0 | Meropenem [Susceptibility] for meningitis | ./2.16.840.1.114222.4.11.1002/103654-0.json |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10365-5.json |
| 103655-7 | Color of Spun Pleural fluid | ./2.16.840.1.114222.4.11.1002/103655-7.json |
| 103656-5 | Color of Spun Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/103656-5.json |
| 103657-3 | Color of Spun Pericardial fluid | ./2.16.840.1.114222.4.11.1002/103657-3.json |
| 103659-9 | Cells.chromosome Y deletion/Cells counted in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/103659-9.json |
| 103660-7 | Entamoeba coli DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103660-7.json |
| 103661-5 | Campylobacter and Salmonella and Shigella sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/103661-5.json |
| 103662-3 | Campylobacter and Salmonella and Shigella and Yersinia sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/103662-3.json |
| 10366-3 | Cotinine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10366-3.json |
| 103663-1 | Salmonella and Shigella and Campylobacter and E. coli sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/103663-1.json |
| 103664-9 | Dehydronorketamine [Mass/volume] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103664-9.json |
| 103665-6 | CD4+ CD26- Cells/100 CD4 cells in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/103665-6.json |
| 103666-4 | Cells.CD200/100 cells in Bone marrow by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/103666-4.json |
| 103667-2 | Cells.chromosome region 1p32 deletion/Cells counted in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/103667-2.json |
| 103668-0 | Gabapentin [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/103668-0.json |
| 103669-8 | Mitragynine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/103669-8.json |
| 103670-6 | Gabapentin [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103670-6.json |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/10367-1.json |
| 103671-4 | Mitragynine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/103671-4.json |
| 103672-2 | Amoxicillin+Clavulanate [Susceptibility] for UTI | ./2.16.840.1.114222.4.11.1002/103672-2.json |
| 103673-0 | Isavuconazole [Susceptibility] in Isolate by Gradient strip | ./2.16.840.1.114222.4.11.1002/103673-0.json |
| 103674-8 | Cells.chromosome region 1q21 duplication in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/103674-8.json |
| 103675-5 | Phosphorylated tau 181 [Mass/volume] in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103675-5.json |
| 103676-3 | Soluble triggering receptor expressed on myeloid cells-1 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103676-3.json |
| 103677-1 | HMEP-Hemiplegic migraine multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103677-1.json |
| 103678-9 | CTNNB1 gene targeted mutation analysis in Tumor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103678-9.json |
| 103680-5 | TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103680-5.json |
| 103684-7 | Vortioxetine [Presence] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103684-7.json |
| 103685-4 | Citalopram [Mass/volume] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103685-4.json |
| 103686-2 | Pneumocystis jiroveci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103686-2.json |
| 103687-0 | Coccidioides sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103687-0.json |
| 103688-8 | Blastomyces sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103688-8.json |
| 10368-9 | Lead [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/10368-9.json |
| 103689-6 | Histoplasma sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103689-6.json |
| 103690-4 | Fungal pathogens panel - Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103690-4.json |
| 103691-2 | MDA5 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/103691-2.json |
| 103692-0 | Body height during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/103692-0.json |
| 103693-8 | Body weight during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/103693-8.json |
| 103694-6 | Brief interview for mental status during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/103694-6.json |
| 10369-7 | Opiates [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/10369-7.json |
| 10370-5 | Phencyclidine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/10370-5.json |
| 103708-4 | Race during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/103708-4.json |
| 103711-8 | Nickel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/103711-8.json |
| 103712-6 | Entamoeba hartmanni DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103712-6.json |
| 103713-4 | Cell growth [Presence] of Chorionic villus sample Qualitative by Tissue culture | ./2.16.840.1.114222.4.11.1002/103713-4.json |
| 103714-2 | Karyotype [Identifier] in Tissue from Fetus Narrative | ./2.16.840.1.114222.4.11.1002/103714-2.json |
| 103715-9 | GABAAR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/103715-9.json |
| 103724-1 | Suvorexant [Presence] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103724-1.json |
| 103725-8 | Suvorexant [Mass/volume] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103725-8.json |
| 103726-6 | Cells.chromosome region 20q12 deletion/Cells counted in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/103726-6.json |
| 103727-4 | Hereditary Motor Neuropathy multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103727-4.json |
| 103728-2 | Hereditary motor and sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103728-2.json |
| 103729-0 | Hereditary sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103729-0.json |
| 103730-8 | Hereditary spastic paraplegia multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103730-8.json |
| 103731-6 | Distal weakness multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103731-6.json |
| 103732-4 | Hereditary congenital myasthenic syndrome multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103732-4.json |
| 103733-2 | Hereditary emery dreifuss multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103733-2.json |
| 103734-0 | Dyserythropoietic anemia multigene analysis in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/103734-0.json |
| 103735-7 | Erythrocytosis multigene analysis in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/103735-7.json |
| 103736-5 | Erythrocytosis focused multigene analysis in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/103736-5.json |
| 103737-3 | CYB5 and CYB5 Reductase multigene analysis in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/103737-3.json |
| 103738-1 | RBC membrane multigene analysis in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/103738-1.json |
| 103739-9 | EBV Lymphoproliferation multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103739-9.json |
| 103740-7 | Hyper igE syndrome multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103740-7.json |
| 103742-3 | Viral Susceptibility multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103742-3.json |
| 103744-9 | Other cells/100 leukocytes in Bronchoalveolar lavage by Manual count | ./2.16.840.1.114222.4.11.1002/103744-9.json |
| 103745-6 | Time interval between troponin I.high-sensitivity assays | ./2.16.840.1.114222.4.11.1002/103745-6.json |
| 103746-4 | Human papilloma virus 16 and 18+45 mRNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103746-4.json |
| 103749-8 | Oxygen consumption (VO2) --peak | ./2.16.840.1.114222.4.11.1002/103749-8.json |
| 103751-4 | Mental health Mental health directive form | ./2.16.840.1.114222.4.11.1002/103751-4.json |
| 103772-0 | Scientist will protect each other even when they are wrong | ./2.16.840.1.114222.4.11.1002/103772-0.json |
| 103777-9 | PAINAD.Negative vocalization Observed | ./2.16.840.1.114222.4.11.1002/103777-9.json |
| 103779-5 | PAINAD.Body language Observed | ./2.16.840.1.114222.4.11.1002/103779-5.json |
| 103780-3 | PAINAD pain assessment panel | ./2.16.840.1.114222.4.11.1002/103780-3.json |
| 103784-5 | Chemokine (C-C motif) ligand 26 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103784-5.json |
| 103785-2 | Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103785-2.json |
| 103786-0 | Macrophage derived chemokine [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/103786-0.json |
| 103787-8 | Influenza A H3N2V RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/103787-8.json |
| 103788-6 | Bacteria Identification and Susceptibilty in Positive blood culture Document | ./2.16.840.1.114222.4.11.1002/103788-6.json |
| 103789-4 | Aeromonas and plesiomonas sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/103789-4.json |
| 103790-2 | Renal calculus risk assessment [Likelihood] in 24 hour Urine Narrative | ./2.16.840.1.114222.4.11.1002/103790-2.json |
| 103792-8 | Mental health Annual evaluation note | ./2.16.840.1.114222.4.11.1002/103792-8.json |
| 103793-6 | Mental health Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/103793-6.json |
| 103794-4 | Psychiatry Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/103794-4.json |
| 103795-1 | Outpatient Discharge instructions | ./2.16.840.1.114222.4.11.1002/103795-1.json |
| 103796-9 | Outpatient Instructions | ./2.16.840.1.114222.4.11.1002/103796-9.json |
| 103797-7 | Audiology Outpatient Note | ./2.16.840.1.114222.4.11.1002/103797-7.json |
| 103798-5 | Child and adolescent psychiatry Outpatient Note | ./2.16.840.1.114222.4.11.1002/103798-5.json |
| 103799-3 | Healthcare navigator Consult note | ./2.16.840.1.114222.4.11.1002/103799-3.json |
| 103800-9 | Mental health Summary note | ./2.16.840.1.114222.4.11.1002/103800-9.json |
| 103801-7 | Speech-language pathology Outpatient Note | ./2.16.840.1.114222.4.11.1002/103801-7.json |
| 103802-5 | Medical oncology.team Conference note | ./2.16.840.1.114222.4.11.1002/103802-5.json |
| 103803-3 | Surgery Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/103803-3.json |
| 103804-1 | Surgical oncology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/103804-1.json |
| 103805-8 | Bariatric surgery Referral note | ./2.16.840.1.114222.4.11.1002/103805-8.json |
| 103806-6 | Oncology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/103806-6.json |
| 103807-4 | Hematology Referral note | ./2.16.840.1.114222.4.11.1002/103807-4.json |
| 103812-4 | Patient state index Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/103812-4.json |
| 103813-2 | Domestic violence screening report | ./2.16.840.1.114222.4.11.1002/103813-2.json |
| 103828-0 | 1-Hydroxymidazolam [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103828-0.json |
| 103829-8 | Dihydrocodeine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103829-8.json |
| 103830-6 | Gabapentin [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103830-6.json |
| 103831-4 | Midazolam [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103831-4.json |
| 103832-2 | Naloxone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103832-2.json |
| 103833-0 | N-nortramadol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103833-0.json |
| 103834-8 | Norbuprenorphine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103834-8.json |
| 103835-5 | Norhydrocodone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103835-5.json |
| 103836-3 | Noroxycodone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103836-3.json |
| 103837-1 | O-desmethyltraMADol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103837-1.json |
| 103838-9 | oxyMORphone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103838-9.json |
| 103839-7 | Phentermine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103839-7.json |
| 103840-5 | Tapentadol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103840-5.json |
| 103841-3 | Zolpidem [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/103841-3.json |
| 103842-1 | Phosphodiesterase 10A Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/103842-1.json |
| 103843-9 | Tripartite motif containing 46 [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/103843-9.json |
| 103844-7 | HBA1 and HBA2 gene deletion in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103844-7.json |
| 103845-4 | Fat/Total solids [Mass Ratio] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/103845-4.json |
| 103848-8 | RF Spine Lumbar and Sacrum Views W contrast IT | ./2.16.840.1.114222.4.11.1002/103848-8.json |
| 103849-6 | RF Guidance for removal of foreign body from Esophagus | ./2.16.840.1.114222.4.11.1002/103849-6.json |
| 103850-4 | RF Kidney Views W contrast via nephrostomy tube | ./2.16.840.1.114222.4.11.1002/103850-4.json |
| 103851-2 | RF Urethra Views W contrast retrograde via urethra | ./2.16.840.1.114222.4.11.1002/103851-2.json |
| 103852-0 | RFA Guidance for angioplasty of Extremity vessels - bilateral -- W contrast | ./2.16.840.1.114222.4.11.1002/103852-0.json |
| 103853-8 | RFA Guidance for angioplasty of Extremity vessels - left -- W contrast | ./2.16.840.1.114222.4.11.1002/103853-8.json |
| 103854-6 | RFA Guidance for angioplasty of Extremity vessels - right -- W contrast | ./2.16.840.1.114222.4.11.1002/103854-6.json |
| 103855-3 | RFA Carotid artery.internal - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/103855-3.json |
| 103856-1 | RFA Vertebral vessels Left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/103856-1.json |
| 103857-9 | RFA Vertebral vessels Right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/103857-9.json |
| 103858-7 | XR and RF Chest GE 2 Views and Views | ./2.16.840.1.114222.4.11.1002/103858-7.json |
| 103859-5 | CT Abdomen and Pelvis W contrast PO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103859-5.json |
| 103860-3 | CT Abdomen W contrast PO | ./2.16.840.1.114222.4.11.1002/103860-3.json |
| 103861-1 | CT Abdomen W contrast PO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103861-1.json |
| 103862-9 | CT Facial bones WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103862-9.json |
| 103863-7 | CT Kidney and Ureter and Urinary bladder W contrast IV | ./2.16.840.1.114222.4.11.1002/103863-7.json |
| 103864-5 | CT Sella turcica and Orbit W contrast IV | ./2.16.840.1.114222.4.11.1002/103864-5.json |
| 103865-2 | CT Shoulder - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103865-2.json |
| 103866-0 | CT Lower leg - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/103866-0.json |
| 103867-8 | CT Lower leg - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103867-8.json |
| 103868-6 | CT Sella turcica and Orbit WO contrast | ./2.16.840.1.114222.4.11.1002/103868-6.json |
| 103869-4 | CT Sella turcica and Orbit WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103869-4.json |
| 103870-2 | CT Sella turcica and Orbit - bilateral | ./2.16.840.1.114222.4.11.1002/103870-2.json |
| 103871-0 | CT Sella turcica and Orbit - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/103871-0.json |
| 103872-8 | CT Sella turcica and Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/103872-8.json |
| 103873-6 | CT Sella turcica and Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103873-6.json |
| 103874-4 | CT Chest and Abdomen | ./2.16.840.1.114222.4.11.1002/103874-4.json |
| 103875-1 | CT Pelvis W contrast PO | ./2.16.840.1.114222.4.11.1002/103875-1.json |
| 103876-9 | CT Pelvis W contrast PO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103876-9.json |
| 103877-7 | CT Forearm - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/103877-7.json |
| 103878-5 | CT Forearm - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/103878-5.json |
| 103879-3 | CT Forearm - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103879-3.json |
| 103880-1 | CT Ankle - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103880-1.json |
| 103881-9 | CT Mastoid WO contrast | ./2.16.840.1.114222.4.11.1002/103881-9.json |
| 103882-7 | CT Mastoid WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103882-7.json |
| 103883-5 | CT Foot - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103883-5.json |
| 103884-3 | CT Wrist - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/103884-3.json |
| 103885-0 | MG Breast - left Screening for implant | ./2.16.840.1.114222.4.11.1002/103885-0.json |
| 103886-8 | MG Breast - right Screening for implant | ./2.16.840.1.114222.4.11.1002/103886-8.json |
| 103887-6 | MG Breast duct - bilateral Single view W contrast intra duct | ./2.16.840.1.114222.4.11.1002/103887-6.json |
| 103888-4 | MG Guidance for needle localization of Breast | ./2.16.840.1.114222.4.11.1002/103888-4.json |
| 103889-2 | MG stereo Guidance for localization of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/103889-2.json |
| 103890-0 | MG stereo Guidance for localization of Breast - left | ./2.16.840.1.114222.4.11.1002/103890-0.json |
| 103891-8 | MG stereo Guidance for localization of Breast - right | ./2.16.840.1.114222.4.11.1002/103891-8.json |
| 103892-6 | DBT Breast screening | ./2.16.840.1.114222.4.11.1002/103892-6.json |
| 103893-4 | MG Breast Screening for implant | ./2.16.840.1.114222.4.11.1002/103893-4.json |
| 103894-2 | MG Breast Diagnostic for implant | ./2.16.840.1.114222.4.11.1002/103894-2.json |
| 103901-5 | US Abdomen and Pelvis | ./2.16.840.1.114222.4.11.1002/103901-5.json |
| 103902-3 | US.doppler Abdomen and Pelvis | ./2.16.840.1.114222.4.11.1002/103902-3.json |
| 103903-1 | US Kidney - left limited | ./2.16.840.1.114222.4.11.1002/103903-1.json |
| 103904-9 | US Kidney - right limited | ./2.16.840.1.114222.4.11.1002/103904-9.json |
| 103905-6 | US.doppler Renal vessels - left | ./2.16.840.1.114222.4.11.1002/103905-6.json |
| 103906-4 | US.doppler Renal vessels - right | ./2.16.840.1.114222.4.11.1002/103906-4.json |
| 103909-8 | US Abdominal Aorta limited | ./2.16.840.1.114222.4.11.1002/103909-8.json |
| 103910-6 | US Chest - left | ./2.16.840.1.114222.4.11.1002/103910-6.json |
| 103911-4 | US Chest - right | ./2.16.840.1.114222.4.11.1002/103911-4.json |
| 103912-2 | US Extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/103912-2.json |
| 103913-0 | US Groin - left | ./2.16.840.1.114222.4.11.1002/103913-0.json |
| 103914-8 | US Groin - right | ./2.16.840.1.114222.4.11.1002/103914-8.json |
| 103915-5 | US Vein - left | ./2.16.840.1.114222.4.11.1002/103915-5.json |
| 103916-3 | US Vein - right | ./2.16.840.1.114222.4.11.1002/103916-3.json |
| 103917-1 | US Axilla - bilateral | ./2.16.840.1.114222.4.11.1002/103917-1.json |
| 103918-9 | US.doppler Thoracic and abdominal aorta limited | ./2.16.840.1.114222.4.11.1002/103918-9.json |
| 103919-7 | US.doppler Abdominal Aorta | ./2.16.840.1.114222.4.11.1002/103919-7.json |
| 103920-5 | US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava | ./2.16.840.1.114222.4.11.1002/103920-5.json |
| 103921-3 | US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava limited | ./2.16.840.1.114222.4.11.1002/103921-3.json |
| 103922-1 | US Lower extremity vein - left limited | ./2.16.840.1.114222.4.11.1002/103922-1.json |
| 103923-9 | US Lower extremity vein - right limited | ./2.16.840.1.114222.4.11.1002/103923-9.json |
| 103924-7 | US Lower extremity artery - left limited | ./2.16.840.1.114222.4.11.1002/103924-7.json |
| 103925-4 | US Lower extremity artery - right limited | ./2.16.840.1.114222.4.11.1002/103925-4.json |
| 103926-2 | US.doppler Vein - bilateral | ./2.16.840.1.114222.4.11.1002/103926-2.json |
| 103927-0 | US.doppler Lower extremity artery - left limited | ./2.16.840.1.114222.4.11.1002/103927-0.json |
| 103928-8 | US.doppler Lower extremity artery - right limited | ./2.16.840.1.114222.4.11.1002/103928-8.json |
| 103944-5 | CT Neck+Chest+Abdomen WO contrast | ./2.16.840.1.114222.4.11.1002/103944-5.json |
| 103945-2 | CT Neck+Chest+Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/103945-2.json |
| 103950-2 | NOTCH3 gene full mutation analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103950-2.json |
| 103951-0 | Motor neuron disease multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103951-0.json |
| 103952-8 | Muscular dystrophy multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103952-8.json |
| 103953-6 | HIF2A gene targeted mutation analysis in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103953-6.json |
| 103954-4 | Peripheral neuropathy multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103954-4.json |
| 103955-1 | KRAS Somatic mutation analysis in Tumor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103955-1.json |
| 103956-9 | Parkinson Disease multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103956-9.json |
| 103957-7 | Neuromuscular multigene analysis in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103957-7.json |
| 103958-5 | Ofloxacin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/103958-5.json |
| 103959-3 | cycloSERINE [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/103959-3.json |
| 103960-1 | Prothionamide [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/103960-1.json |
| 103961-9 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/103961-9.json |
| 103962-7 | 11-Ketotestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/103962-7.json |
| 103963-5 | Zika virus lineage [Identifier] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/103963-5.json |
| 103964-3 | Hospice care social worker Note | ./2.16.840.1.114222.4.11.1002/103964-3.json |
| 103965-0 | Hospice care Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/103965-0.json |
| 103966-8 | Hospice care case manager Note | ./2.16.840.1.114222.4.11.1002/103966-8.json |
| 103967-6 | Hospice care nurse Note | ./2.16.840.1.114222.4.11.1002/103967-6.json |
| 103968-4 | Hospice care Consult note | ./2.16.840.1.114222.4.11.1002/103968-4.json |
| 103969-2 | Hospice care Progress note | ./2.16.840.1.114222.4.11.1002/103969-2.json |
| 103970-0 | Cardiology Rehabilitation Note | ./2.16.840.1.114222.4.11.1002/103970-0.json |
| 103971-8 | Cardiology Rehabilitation progress note | ./2.16.840.1.114222.4.11.1002/103971-8.json |
| 103972-6 | Cardiology Outpatient Rehabilitation Note | ./2.16.840.1.114222.4.11.1002/103972-6.json |
| 103981-7 | Do you feel physically or emotionally unsafe where you currently live | ./2.16.840.1.114222.4.11.1002/103981-7.json |
| 10400-0 | I Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/10400-0.json |
| 104004-7 | US for pregnancy in third trimester | ./2.16.840.1.114222.4.11.1002/104004-7.json |
| 104030-2 | Symptomatic depression | ./2.16.840.1.114222.4.11.1002/104030-2.json |
| 104031-0 | Altered elimination | ./2.16.840.1.114222.4.11.1002/104031-0.json |
| 104032-8 | Dizziness, vertigo | ./2.16.840.1.114222.4.11.1002/104032-8.json |
| 104033-6 | Gender [born male or identifies as male] | ./2.16.840.1.114222.4.11.1002/104033-6.json |
| 104034-4 | Any administered antiepileptics [Anticonvulsants] | ./2.16.840.1.114222.4.11.1002/104034-4.json |
| 104035-1 | Any administered [Benzodiazepines] | ./2.16.840.1.114222.4.11.1002/104035-1.json |
| 104036-9 | Get-up-and-go test: rising from a chair | ./2.16.840.1.114222.4.11.1002/104036-9.json |
| 104037-7 | Hendrich II total score | ./2.16.840.1.114222.4.11.1002/104037-7.json |
| 104045-0 | Tracheobronchial toileting | ./2.16.840.1.114222.4.11.1002/104045-0.json |
| 104046-8 | Number of steps to walk 10-meters | ./2.16.840.1.114222.4.11.1002/104046-8.json |
| 104047-6 | 10-meter walking distance [Time] | ./2.16.840.1.114222.4.11.1002/104047-6.json |
| 104051-8 | Fetal Pelvis for pregnancy in second trimester | ./2.16.840.1.114222.4.11.1002/104051-8.json |
| 104059-1 | Have you been to any other places or events not yet specified | ./2.16.840.1.114222.4.11.1002/104059-1.json |
| 104062-5 | HISGT Histone genes targeted mutation analysis in Tumor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104062-5.json |
| 104063-3 | Body temperature - Groin | ./2.16.840.1.114222.4.11.1002/104063-3.json |
| 104065-8 | CTA Head W contrast and CTA Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/104065-8.json |
| 104066-6 | Hospitalist Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/104066-6.json |
| 104067-4 | Hospitalist Assessment note | ./2.16.840.1.114222.4.11.1002/104067-4.json |
| 104068-2 | Hospitalist Admission evaluation note | ./2.16.840.1.114222.4.11.1002/104068-2.json |
| 104069-0 | Hospitalist Transfer summary note | ./2.16.840.1.114222.4.11.1002/104069-0.json |
| 104070-8 | Outpatient Audiology note | ./2.16.840.1.114222.4.11.1002/104070-8.json |
| 104071-6 | Cystoscopy study Document | ./2.16.840.1.114222.4.11.1002/104071-6.json |
| 104075-7 | Gas and Lactate panel - Venous blood | ./2.16.840.1.114222.4.11.1002/104075-7.json |
| 104076-5 | Basic metabolic with hemoglobin and hematocrit panel - Blood | ./2.16.840.1.114222.4.11.1002/104076-5.json |
| 10408-3 | little i Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/10408-3.json |
| 104085-6 | FDA product label Cosmetic facility registration | ./2.16.840.1.114222.4.11.1002/104085-6.json |
| 104086-4 | FDA product label Cosmetic facility registration-amendment | ./2.16.840.1.114222.4.11.1002/104086-4.json |
| 104087-2 | FDA product label Cosmetic facility registration-abbreviated renewal | ./2.16.840.1.114222.4.11.1002/104087-2.json |
| 104088-0 | FDA product label Cosmetic facility registration-cancellation | ./2.16.840.1.114222.4.11.1002/104088-0.json |
| 104089-8 | FDA product label Cosmetic facility registration-biennial renewal | ./2.16.840.1.114222.4.11.1002/104089-8.json |
| 104090-6 | FDA product label Cosmetic-abbreviated renewal | ./2.16.840.1.114222.4.11.1002/104090-6.json |
| 104091-4 | FDA product label Animal drug for further processing | ./2.16.840.1.114222.4.11.1002/104091-4.json |
| 104117-7 | 11-Hydroxytestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/104117-7.json |
| 104118-5 | CD34 recipient derived/CD34 cells in Bone marrow by Molecular genetics method --post stem cell transplant | ./2.16.840.1.114222.4.11.1002/104118-5.json |
| 104121-9 | Vascular Access Consult note | ./2.16.840.1.114222.4.11.1002/104121-9.json |
| 104122-7 | Vascular Access Progress Note | ./2.16.840.1.114222.4.11.1002/104122-7.json |
| 104123-5 | Vascular Access Outpatient Note | ./2.16.840.1.114222.4.11.1002/104123-5.json |
| 104124-3 | Vascular Access History and physical note | ./2.16.840.1.114222.4.11.1002/104124-3.json |
| 104125-0 | Child Life Note | ./2.16.840.1.114222.4.11.1002/104125-0.json |
| 104126-8 | Child Life Group counseling note | ./2.16.840.1.114222.4.11.1002/104126-8.json |
| 104127-6 | Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/104127-6.json |
| 104128-4 | XR Salivary gland Single view for salivary calculus | ./2.16.840.1.114222.4.11.1002/104128-4.json |
| 104129-2 | XR Salivary gland - bilateral Single view for salivary calculus | ./2.16.840.1.114222.4.11.1002/104129-2.json |
| 1041-3 | G Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1041-3.json |
| 104130-0 | XR Salivary gland - right Single view for salivary calculus | ./2.16.840.1.114222.4.11.1002/104130-0.json |
| 104131-8 | XR Salivary gland - left Single view for salivary calculus | ./2.16.840.1.114222.4.11.1002/104131-8.json |
| 104144-1 | Mental health Advance directives | ./2.16.840.1.114222.4.11.1002/104144-1.json |
| 104148-2 | Left ventricular Ejection fraction - upper limit by US.3D.A4C+Estimated | ./2.16.840.1.114222.4.11.1002/104148-2.json |
| 104149-0 | Left ventricular Ejection fraction by US.2D.A2C+Calculated by biplane method | ./2.16.840.1.114222.4.11.1002/104149-0.json |
| 104150-8 | Left ventricular Ejection fraction by US.2D.A3C+Calculated by biplane method | ./2.16.840.1.114222.4.11.1002/104150-8.json |
| 104151-6 | Left ventricular Ejection fraction by US.2D.A4C+Calculed by biplane method | ./2.16.840.1.114222.4.11.1002/104151-6.json |
| 104152-4 | Left ventricular Ejection fraction by US.3D.A2C+Calculated by biplanemethod | ./2.16.840.1.114222.4.11.1002/104152-4.json |
| 104153-2 | Left ventricular Ejection fraction by US.3D.A3C+Calculated by biplane method | ./2.16.840.1.114222.4.11.1002/104153-2.json |
| 104154-0 | Left ventricular Ejection fraction by US.3D.A4C+Calculated by biplane method | ./2.16.840.1.114222.4.11.1002/104154-0.json |
| 104159-9 | Left ventricular Maximum longitudinal strain by US.2D+Calculated by average triplane method | ./2.16.840.1.114222.4.11.1002/104159-9.json |
| 104160-7 | Left ventricular End-systolic volume (by US.2D.A2C+Calculated by biplane area-length method)/Body surface area | ./2.16.840.1.114222.4.11.1002/104160-7.json |
| 104161-5 | Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calculated by biplane area-length method | ./2.16.840.1.114222.4.11.1002/104161-5.json |
| 104162-3 | Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.3D.A2C+Calculated by biplane area-length method | ./2.16.840.1.114222.4.11.1002/104162-3.json |
| 104163-1 | Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.3D.A4C+Calculated by biplane area-length method | ./2.16.840.1.114222.4.11.1002/104163-1.json |
| 104164-9 | Pulmonary artery Pressure by US.doppler | ./2.16.840.1.114222.4.11.1002/104164-9.json |
| 104165-6 | Aortic valve Orifice area/Body surface area [Area/Area] by US 2D | ./2.16.840.1.114222.4.11.1002/104165-6.json |
| 104166-4 | Apolipoprotein E phenotype [Identifier] in Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/104166-4.json |
| 104167-2 | TRCA+TCRD gene rearrangements in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/104167-2.json |
| 104168-0 | TCL-1A gene rearrangements in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/104168-0.json |
| 104169-8 | D13S319 deletion in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/104169-8.json |
| 104170-6 | Human papilloma virus 31+33+52+58 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104170-6.json |
| 104171-4 | DPYD gene.c.2846A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104171-4.json |
| 104172-2 | DPYD gene.c.1236G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104172-2.json |
| 104173-0 | DPYD gene.c.1905+1G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104173-0.json |
| 104174-8 | DPYD gene.c.1679T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104174-8.json |
| 104175-5 | Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/104175-5.json |
| 104176-3 | Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104176-3.json |
| 104177-1 | Clostridium tetani toxin [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/104177-1.json |
| 104178-9 | Clostridium tetani toxin [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/104178-9.json |
| 104179-7 | Clostridium tetani toxin [Presence] in Specimen by Endopeptidase Assay | ./2.16.840.1.114222.4.11.1002/104179-7.json |
| 104180-5 | Clostridium tetani toxin [Presence] in Serum or Plasma by Endopeptidase Assay | ./2.16.840.1.114222.4.11.1002/104180-5.json |
| 104181-3 | Clostridium tetani toxin [Presence] in Serum or Plasma by Mouse bioassay | ./2.16.840.1.114222.4.11.1002/104181-3.json |
| 104182-1 | Clostridium tetani toxin [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/104182-1.json |
| 104183-9 | Adenovirus DNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104183-9.json |
| 104185-4 | Fetal Secondary cause of death | ./2.16.840.1.114222.4.11.1002/104185-4.json |
| 104192-0 | Guanidinoacetate methyltransferase deficiency newborn screen interpretation | ./2.16.840.1.114222.4.11.1002/104192-0.json |
| 104193-8 | Guanidinoacetate methyltransferase deficiency comment [Text] in DBS Narrative | ./2.16.840.1.114222.4.11.1002/104193-8.json |
| 104194-6 | Creatine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/104194-6.json |
| 104195-3 | Guanidinoacetate/Creatinine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/104195-3.json |
| 104196-1 | Creatine/Creatinine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/104196-1.json |
| 104197-9 | Fetal Pelvis for pregnancy in first trimester US | ./2.16.840.1.114222.4.11.1002/104197-9.json |
| 104198-7 | Immunoglobulin lambda light chain gene 22q11.22 rearrangement in Specimen by FISH | ./2.16.840.1.114222.4.11.1002/104198-7.json |
| 104199-5 | Immunoglobulin kappa light chain gene 2p11.2 rearrangement in Specimen by FISH | ./2.16.840.1.114222.4.11.1002/104199-5.json |
| 104200-1 | CRLF2 gene rearrangements in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/104200-1.json |
| 104201-9 | Eszopiclone and Zopiclone [Mass/volume] in Urine by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/104201-9.json |
| 104211-8 | Heart Multisection transesophageal for congenital disease Document by US --W agitated saline IV | ./2.16.840.1.114222.4.11.1002/104211-8.json |
| 104212-6 | Views screening for diabetic retinopathy of Eyes | ./2.16.840.1.114222.4.11.1002/104212-6.json |
| 104213-4 | Views screening for diabetic retinopathy of Left eye | ./2.16.840.1.114222.4.11.1002/104213-4.json |
| 104214-2 | Views screening for diabetic retinopathy of Right eye | ./2.16.840.1.114222.4.11.1002/104214-2.json |
| 104215-9 | MG stereo Breast - left Views post radioactive seed localization | ./2.16.840.1.114222.4.11.1002/104215-9.json |
| 104216-7 | MG stereo Breast - right Views post radioactive seed localization | ./2.16.840.1.114222.4.11.1002/104216-7.json |
| 104217-5 | Additional treatment [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/104217-5.json |
| 104218-3 | Spermatozoa Nonprogressive/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104218-3.json |
| 104219-1 | Spermatozoa Immotile/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104219-1.json |
| 104220-9 | Spermatozoa Viable/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104220-9.json |
| 104221-7 | Spermatozoa.progressive.rapid/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104221-7.json |
| 104222-5 | Spermatozoa.progressive.slow/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104222-5.json |
| 104223-3 | Spermatozoa.progressive.slow+rapid/100 spermatozoa in Urine --post ejaculation | ./2.16.840.1.114222.4.11.1002/104223-3.json |
| 104227-4 | Rizatriptan [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104227-4.json |
| 104228-2 | Alpha-Pyrrolidinoisohexanophenone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104228-2.json |
| 104229-0 | Carfentanil [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104229-0.json |
| 104230-8 | MDMB-Fubinaca [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104230-8.json |
| 104231-6 | N-Ethylpentylone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104231-6.json |
| 104232-4 | Naproxen [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104232-4.json |
| 104233-2 | Norcocaine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104233-2.json |
| 104234-0 | Atomoxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104234-0.json |
| 104235-7 | Dibutylone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104235-7.json |
| 104236-5 | 3-fluorophenmetrazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104236-5.json |
| 104237-3 | Zopiclone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/104237-3.json |
| 104240-7 | Histiocytic neoplasm multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104240-7.json |
| 104241-5 | Plasma cell myeloma multigene analysis in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104241-5.json |
| 104243-1 | Left ventricular Ejection fraction - lower limit by US.2D.A3C+Estimated | ./2.16.840.1.114222.4.11.1002/104243-1.json |
| 104245-6 | Left ventricular Ejection fraction - lower limit by US.3D.A2C+Estimated | ./2.16.840.1.114222.4.11.1002/104245-6.json |
| 104247-2 | Left ventricular Ejection fraction - lower limit by US.3D.A4C+Estimated | ./2.16.840.1.114222.4.11.1002/104247-2.json |
| 104248-0 | Pepsinogen I/Pepsinogen II [Mass Ratio] in Serum | ./2.16.840.1.114222.4.11.1002/104248-0.json |
| 104249-8 | Platelet aggregation ADP induced ATP secretion in Blood --2 umol/L | ./2.16.840.1.114222.4.11.1002/104249-8.json |
| 104250-6 | Platelet aggregation collagen induced in Platelet rich plasma --2 ug/mL | ./2.16.840.1.114222.4.11.1002/104250-6.json |
| 104251-4 | Left ventricular Ejection fraction by US.2D.A2C+Estimated | ./2.16.840.1.114222.4.11.1002/104251-4.json |
| 104252-2 | Left ventricular Ejection fraction by US.2D.A3C+Estimated | ./2.16.840.1.114222.4.11.1002/104252-2.json |
| 104253-0 | Left ventricular Ejection fraction by US.2D.A4C Estimated | ./2.16.840.1.114222.4.11.1002/104253-0.json |
| 104254-8 | Left ventricular Ejection fraction by US.3D.A2C+Estimated | ./2.16.840.1.114222.4.11.1002/104254-8.json |
| 104255-5 | Left ventricular Ejection fraction by US.3D.A3C+Estimated | ./2.16.840.1.114222.4.11.1002/104255-5.json |
| 104256-3 | Left ventricular Ejection fraction by US.3D.A4C+Estimated | ./2.16.840.1.114222.4.11.1002/104256-3.json |
| 104259-7 | Fibroblast growth factor 23 [Presence] in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/104259-7.json |
| 104260-5 | Hepatitis A virus cellular receptor 1 [Ratio] in Urine by Calculation | ./2.16.840.1.114222.4.11.1002/104260-5.json |
| 104261-3 | Eosinophil derived neurotoxin [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104261-3.json |
| 104262-1 | Diagnostic peripheral vascular disease study Heart | ./2.16.840.1.114222.4.11.1002/104262-1.json |
| 104263-9 | Galactosylceramidase [Enzymatic activity/volume] in Serum by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/104263-9.json |
| 104264-7 | Galactosylceramidase [Enzymatic activity/volume] in Cerebral spinal fluid by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/104264-7.json |
| 104265-4 | Ethanol cutoff [Volume Fraction] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/104265-4.json |
| 104275-3 | Hematopoietic progenitor cells/Cells.total in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/104275-3.json |
| 104276-1 | ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104276-1.json |
| 104277-9 | MET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104277-9.json |
| 104278-7 | BRAF gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104278-7.json |
| 104279-5 | ERBB2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104279-5.json |
| 104280-3 | ABCG2 gene.p.Q141K [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104280-3.json |
| 104281-1 | ABCB1 gene.c.1236C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104281-1.json |
| 104282-9 | ABCB1 gene.c.2677G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104282-9.json |
| 104283-7 | DPYD gene.c.2846A>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104283-7.json |
| 104284-5 | DPYD gene.c.1679T>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104284-5.json |
| 104285-2 | UGT1A1 gene.p.G71R [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104285-2.json |
| 104286-0 | UGT1A1 gene.p.P229Q [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104286-0.json |
| 104287-8 | SLCO1B1 gene.c.521T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104287-8.json |
| 104288-6 | HLA-B gene.g.31431780T>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104288-6.json |
| 104289-4 | Chromosome 5 and 9 and 15 aneuploidy in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/104289-4.json |
| 104291-0 | KIT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104291-0.json |
| 104292-8 | PDGFRA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104292-8.json |
| 104293-6 | PDGFRA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104293-6.json |
| 104294-4 | CDH1 gene rearrangements [Interpretation] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/104294-4.json |
| 104295-1 | ESR1 gene mutation [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104295-1.json |
| 104296-9 | DPYD gene.c.1905+1G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104296-9.json |
| 104297-7 | CYP3A4 gene c.6C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104297-7.json |
| 104298-5 | CYP3A4 gene.c.IVS10+12G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104298-5.json |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10429-9.json |
| 104299-3 | UGT1A9 gene.1b-118(dT)9>10 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104299-3.json |
| 104300-9 | UGT1A9 gene.p.M33T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104300-9.json |
| 104301-7 | UGT1A9 gene.c.-2152C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104301-7.json |
| 104302-5 | UGT1A9 gene.c.-275T>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104302-5.json |
| 104303-3 | N-Desmethyl imatinib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104303-3.json |
| 104304-1 | Regorafenib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104304-1.json |
| 104305-8 | Regorafenib N-oxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104305-8.json |
| 104306-6 | Sorafenib N-Oxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104306-6.json |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10430-7.json |
| 104307-4 | Letrozole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104307-4.json |
| 104308-2 | Palbociclib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104308-2.json |
| 104309-0 | Ribociclib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104309-0.json |
| 104310-8 | Abemaciclib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104310-8.json |
| 104311-6 | Olaparib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104311-6.json |
| 104312-4 | Rucaparib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104312-4.json |
| 104313-2 | Niraparib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104313-2.json |
| 104314-0 | Lenvatinib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104314-0.json |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10431-5.json |
| 104315-7 | Sunitinib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104315-7.json |
| 104316-5 | N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/104316-5.json |
| 104317-3 | Common myeloid progenitor cell [#/volume] in Blood by Visual count | ./2.16.840.1.114222.4.11.1002/104317-3.json |
| 104318-1 | Common myeloid progenitor cell [#/mass] in Blood | ./2.16.840.1.114222.4.11.1002/104318-1.json |
| 104319-9 | Burst forming unit erythroid [#/volume] in Blood by Visual count | ./2.16.840.1.114222.4.11.1002/104319-9.json |
| 104320-7 | Burst forming unit erythroid [#/mass] in Blood | ./2.16.840.1.114222.4.11.1002/104320-7.json |
| 104321-5 | CXCR4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/104321-5.json |
| 104322-3 | Lambda lymphocytes/100 lymphocytes in Bone marrow | ./2.16.840.1.114222.4.11.1002/104322-3.json |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10432-3.json |
| 104323-1 | IDH1 and IDH2 gene full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/104323-1.json |
| 104324-9 | Acinetobacter sp identified [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/104324-9.json |
| 104326-4 | Adenovirus sp identified [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/104326-4.json |
| 104327-2 | Bacillus anthracis Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104327-2.json |
| 104328-0 | Bacillus anthracis Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104328-0.json |
| 104330-6 | Bacillus anthracis protective antigen Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104330-6.json |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10433-1.json |
| 104331-4 | Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104331-4.json |
| 104332-2 | Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104332-2.json |
| 104334-8 | Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104334-8.json |
| 104335-5 | Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104335-5.json |
| 104337-1 | Borna disease virus RNA [Presence] in Brain tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104337-1.json |
| 104338-9 | Borna disease virus RNA [Presence] in Brain tissue by Probe | ./2.16.840.1.114222.4.11.1002/104338-9.json |
| 104339-7 | Borna disease virus RNA [Presence] in Brain tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/104339-7.json |
| 104340-5 | Borna disease virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104340-5.json |
| 104341-3 | Borna disease virus [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/104341-3.json |
| 104342-1 | Borna disease virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104342-1.json |
| 104343-9 | Borna disease virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104343-9.json |
| 104344-7 | Borna disease virus RNA [Presence] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/104344-7.json |
| 104345-4 | Borna disease virus Ag [Presence] in Brain tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/104345-4.json |
| 104346-2 | Borna disease virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/104346-2.json |
| 104347-0 | Borrelia recurrentis [Presence] in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104347-0.json |
| 104348-8 | Borrelia recurrentis [Presence] in Blood by Microscopy | ./2.16.840.1.114222.4.11.1002/104348-8.json |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10434-9.json |
| 104349-6 | Borrelia recurrentis [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104349-6.json |
| 104350-4 | Borrelia recurrentis [Presence] in Specimen by Microscopy | ./2.16.840.1.114222.4.11.1002/104350-4.json |
| 104351-2 | Borrelia recurrentis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104351-2.json |
| 104352-0 | Borrelia recurrentis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104352-0.json |
| 104353-8 | Borrelia recurrentis DNA [Presence] in Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/104353-8.json |
| 104354-6 | Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104354-6.json |
| 104355-3 | Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by Sequencing | ./2.16.840.1.114222.4.11.1002/104355-3.json |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10435-6.json |
| 104356-1 | Borrelia recurrentis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104356-1.json |
| 104357-9 | Borrelia recurrentis DNA [Presence] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/104357-9.json |
| 104358-7 | Spirochete [Identifier] in Specimen by Microscopy | ./2.16.840.1.114222.4.11.1002/104358-7.json |
| 104359-5 | Brucella melitensis DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/104359-5.json |
| 104360-3 | Brucella sp Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104360-3.json |
| 104361-1 | Brucella sp Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104361-1.json |
| 104362-9 | Brucella sp DNA [Identifier] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/104362-9.json |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10436-4.json |
| 104364-5 | Chikungunya virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104364-5.json |
| 104366-0 | Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104366-0.json |
| 104368-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104368-6.json |
| 104369-4 | Clostridium baratii [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/104369-4.json |
| 104370-2 | Clostridium butyricum [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/104370-2.json |
| 104371-0 | Corynebacterium pseudotuberculosis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104371-0.json |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10437-2.json |
| 104372-8 | Corynebacterium pseudotuberculosis [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104372-8.json |
| 104373-6 | Corynebacterium ulcerans [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104373-6.json |
| 104374-4 | Corynebacterium ulcerans [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/104374-4.json |
| 104375-1 | Corynebacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104375-1.json |
| 104376-9 | Diphtheria toxin DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104376-9.json |
| 104377-7 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104377-7.json |
| 104378-5 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104378-5.json |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10438-0.json |
| 104380-1 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104380-1.json |
| 104381-9 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104381-9.json |
| 104383-5 | Dengue virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104383-5.json |
| 104384-3 | Dengue virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104384-3.json |
| 104386-8 | Dengue virus IgM Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104386-8.json |
| 104387-6 | Dengue virus IgM Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104387-6.json |
| 104389-2 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104389-2.json |
| 104390-0 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104390-0.json |
| 104391-8 | Echinococcus sp [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/104391-8.json |
| 104393-4 | European tick borne encephalitis virus IgA Ab index in Serum and CSF | ./2.16.840.1.114222.4.11.1002/104393-4.json |
| 104394-2 | European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104394-2.json |
| 104395-9 | European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104395-9.json |
| 104397-5 | European tick borne encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/104397-5.json |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10439-8.json |
| 104398-3 | European tick borne encephalitis virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104398-3.json |
| 104399-1 | European tick borne encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104399-1.json |
| 104400-7 | European tick borne encephalitis virus RNA [Presence] in Tissue postmortem by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104400-7.json |
| 104401-5 | Francisella tularensis Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104401-5.json |
| 104402-3 | Francisella tularensis Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104402-3.json |
| 104404-9 | Giardia lamblia cysts [Presence] in Stool by Microscopy | ./2.16.840.1.114222.4.11.1002/104404-9.json |
| 104405-6 | Giardia lamblia trophozoites [Presence] in Stool by Microscopy | ./2.16.840.1.114222.4.11.1002/104405-6.json |
| 104406-4 | Hantavirus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104406-4.json |
| 104407-2 | Hantavirus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104407-2.json |
| 104409-8 | Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104409-8.json |
| 104410-6 | Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104410-6.json |
| 104412-2 | Hepatitis A virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/104412-2.json |
| 104413-0 | Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104413-0.json |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10441-4.json |
| 104414-8 | Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104414-8.json |
| 104416-3 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104416-3.json |
| 104417-1 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104417-1.json |
| 104419-7 | Legionella sp Ab [Titer] in Serum Qualitative by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104419-7.json |
| 104421-3 | Legionella sp Ag [Identifier] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/104421-3.json |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10442-2.json |
| 104422-1 | Leptospira sp Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104422-1.json |
| 104424-7 | Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104424-7.json |
| 104425-4 | Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104425-4.json |
| 104427-0 | Measles virus genotype [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/104427-0.json |
| 104428-8 | Measles virus IgG Ab avidity [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104428-8.json |
| 104429-6 | Measles virus IgM Ab [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104429-6.json |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10443-0.json |
| 104430-4 | Middle East respiratory syndrome coronavirus (MERS-CoV) [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/104430-4.json |
| 104431-2 | Mumps virus IgM Ab [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/104431-2.json |
| 104432-0 | Mycobacterium leprae Ab. anti-PGL-1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/104432-0.json |
| 104433-8 | Mycobacterium leprae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104433-8.json |
| 104434-6 | Norovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/104434-6.json |
| 104435-3 | Norovirus genogroup II Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104435-3.json |
| 104436-1 | Polio virus 1 Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104436-1.json |
| 104437-9 | Polio virus 1 Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104437-9.json |
| 104439-5 | Polio virus 3 Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104439-5.json |
| 104440-3 | Polio virus 3 Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104440-3.json |
| 104443-7 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104443-7.json |
| 104444-5 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104444-5.json |
| 104446-0 | Rubella virus IgM Ab index [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/104446-0.json |
| 104447-8 | Salmonella paratyphi DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104447-8.json |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10444-8.json |
| 104448-6 | Salmonella paratyphi [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/104448-6.json |
| 104449-4 | Salmonella paratyphi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104449-4.json |
| 104450-2 | Salmonella typhi DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/104450-2.json |
| 104451-0 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen | ./2.16.840.1.114222.4.11.1002/104451-0.json |
| 104452-8 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/104452-8.json |
| 104453-6 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104453-6.json |
| 104454-4 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104454-4.json |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10445-5.json |
| 104456-9 | Varicella zoster virus Ab.IgA index in Serum and CSF | ./2.16.840.1.114222.4.11.1002/104456-9.json |
| 104457-7 | Varicella zoster virus IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/104457-7.json |
| 104459-3 | Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/104459-3.json |
| 104461-9 | Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/104461-9.json |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10446-3.json |
| 104463-5 | Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104463-5.json |
| 104464-3 | Yersinia enterocolitica biotype [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104464-3.json |
| 104465-0 | Yersinia enterocolitica O:3 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104465-0.json |
| 104466-8 | Yersinia enterocolitica O:5 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104466-8.json |
| 104467-6 | Yersinia enterocolitica O:8 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104467-6.json |
| 104468-4 | Yersinia enterocolitica O:9 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104468-4.json |
| 104469-2 | Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104469-2.json |
| 104470-0 | Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104470-0.json |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10447-1.json |
| 104472-6 | Yersinia pseudotuberculosis 1 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104472-6.json |
| 104473-4 | Yersinia pseudotuberculosis 2 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104473-4.json |
| 104474-2 | Yersinia pseudotuberculosis 3 Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/104474-2.json |
| 104475-9 | Zika virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/104475-9.json |
| 104476-7 | Zika virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/104476-7.json |
| 104478-3 | ITpA-Index Serum and CSF | ./2.16.840.1.114222.4.11.1002/104478-3.json |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10448-9.json |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | ./2.16.840.1.114222.4.11.1002/10449-7.json |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | ./2.16.840.1.114222.4.11.1002/10450-5.json |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/10451-3.json |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10457-0.json |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10458-8.json |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10459-6.json |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10460-4.json |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10461-2.json |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10462-0.json |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10463-8.json |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10464-6.json |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10465-3.json |
| 10466-1 | Anion gap 3 in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10466-1.json |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10467-9.json |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10468-7.json |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10469-5.json |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10470-3.json |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10471-1.json |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10472-9.json |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10473-7.json |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10474-5.json |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10475-2.json |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10476-0.json |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10477-8.json |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10478-6.json |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10479-4.json |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10480-2.json |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10481-0.json |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10482-8.json |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10483-6.json |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10484-4.json |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10485-1.json |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10486-9.json |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10487-7.json |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10488-5.json |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10489-3.json |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10490-1.json |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10491-9.json |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10492-7.json |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10493-5.json |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10494-3.json |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10495-0.json |
| 10496-8 | Kappa light chains Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10496-8.json |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10497-6.json |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10498-4.json |
| 10499-2 | Lambda light chains Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10499-2.json |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10500-7.json |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10501-5.json |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10502-3.json |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10503-1.json |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10504-9.json |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10505-6.json |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10506-4.json |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10507-2.json |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10508-0.json |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10509-8.json |
| 10510-6 | S-100 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10510-6.json |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10511-4.json |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10512-2.json |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10513-0.json |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10514-8.json |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10515-5.json |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10516-3.json |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10517-1.json |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10518-9.json |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10519-7.json |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10520-5.json |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10521-3.json |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10522-1.json |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10523-9.json |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain | ./2.16.840.1.114222.4.11.1002/10524-7.json |
| 10525-4 | Microscopic observation [Identifier] in Specimen by Cyto stain | ./2.16.840.1.114222.4.11.1002/10525-4.json |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain | ./2.16.840.1.114222.4.11.1002/10526-2.json |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain | ./2.16.840.1.114222.4.11.1002/10527-0.json |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10528-8.json |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10529-6.json |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10530-4.json |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10531-2.json |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10533-8.json |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10534-6.json |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10535-3.json |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10536-1.json |
| 10539-5 | glipiZIDE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10539-5.json |
| 10540-3 | glyBURIDE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10540-3.json |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10541-1.json |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10542-9.json |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10543-7.json |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10544-5.json |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10545-2.json |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10546-0.json |
| 10547-8 | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10547-8.json |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10549-4.json |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10551-0.json |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10552-8.json |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | ./2.16.840.1.114222.4.11.1002/10553-6.json |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10557-7.json |
| 10558-5 | Albumin [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10558-5.json |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10560-1.json |
| 10561-9 | Carnitine [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10561-9.json |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10565-0.json |
| 10567-6 | Citrate [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10567-6.json |
| 10573-4 | Ferning [Type] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/10573-4.json |
| 10574-2 | Fructose [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10574-2.json |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma | ./2.16.840.1.114222.4.11.1002/10577-5.json |
| 10582-5 | pH of Cervical mucus | ./2.16.840.1.114222.4.11.1002/10582-5.json |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10583-3.json |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | ./2.16.840.1.114222.4.11.1002/10599-9.json |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | ./2.16.840.1.114222.4.11.1002/10600-5.json |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | ./2.16.840.1.114222.4.11.1002/10601-3.json |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/10630-2.json |
| 10631-0 | Testosterone [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10631-0.json |
| 10633-6 | Zinc [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/10633-6.json |
| 10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10634-4.json |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10635-1.json |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation | ./2.16.840.1.114222.4.11.1002/10636-9.json |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain | ./2.16.840.1.114222.4.11.1002/10637-7.json |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10638-5.json |
| 10639-3 | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10639-3.json |
| 10641-9 | Amoeba identified in Aspirate by Immune stain | ./2.16.840.1.114222.4.11.1002/10641-9.json |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation | ./2.16.840.1.114222.4.11.1002/10642-7.json |
| 10643-5 | Amoeba identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10643-5.json |
| 10644-3 | Arthropod identified in Specimen | ./2.16.840.1.114222.4.11.1002/10644-3.json |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10645-0.json |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10646-8.json |
| 10647-6 | Babesia sp identified in Blood by Thick film | ./2.16.840.1.114222.4.11.1002/10647-6.json |
| 10648-4 | Babesia sp identified in Blood by Thin film | ./2.16.840.1.114222.4.11.1002/10648-4.json |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10649-2.json |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10650-0.json |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | ./2.16.840.1.114222.4.11.1002/10651-8.json |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10652-6.json |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/10655-9.json |
| 10656-7 | Coccidia identified in Stool by Acid fast stain | ./2.16.840.1.114222.4.11.1002/10656-7.json |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy | ./2.16.840.1.114222.4.11.1002/10658-3.json |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain | ./2.16.840.1.114222.4.11.1002/10659-1.json |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10660-9.json |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy | ./2.16.840.1.114222.4.11.1002/10661-7.json |
| 10662-5 | Filaria identified in Blood by Concentration | ./2.16.840.1.114222.4.11.1002/10662-5.json |
| 10663-3 | Filaria identified in Blood by Thick film | ./2.16.840.1.114222.4.11.1002/10663-3.json |
| 10664-1 | Filaria identified in Blood by Thin film | ./2.16.840.1.114222.4.11.1002/10664-1.json |
| 10665-8 | Fungus colony count [#/volume] in Specimen by Environmental culture | ./2.16.840.1.114222.4.11.1002/10665-8.json |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain | ./2.16.840.1.114222.4.11.1002/10666-6.json |
| 10667-4 | Fungus identified in Specimen by Animal inoculation | ./2.16.840.1.114222.4.11.1002/10667-4.json |
| 10668-2 | Fungus identified in Specimen by Environmental culture | ./2.16.840.1.114222.4.11.1002/10668-2.json |
| 10669-0 | Fungus identified in Specimen by Sticky tape for environmental fungus | ./2.16.840.1.114222.4.11.1002/10669-0.json |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10670-8.json |
| 10671-6 | Helminth identified in Specimen | ./2.16.840.1.114222.4.11.1002/10671-6.json |
| 10672-4 | Helminth+Arthropod identified in Specimen | ./2.16.840.1.114222.4.11.1002/10672-4.json |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10673-2.json |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10674-0.json |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | ./2.16.840.1.114222.4.11.1002/10675-7.json |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10676-5.json |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10677-3.json |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10678-1.json |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10679-9.json |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10680-7.json |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10681-5.json |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain | ./2.16.840.1.114222.4.11.1002/10683-1.json |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation | ./2.16.840.1.114222.4.11.1002/10684-9.json |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation | ./2.16.840.1.114222.4.11.1002/10685-6.json |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/10686-4.json |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10687-2.json |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation | ./2.16.840.1.114222.4.11.1002/10688-0.json |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation | ./2.16.840.1.114222.4.11.1002/10689-8.json |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified | ./2.16.840.1.114222.4.11.1002/10690-6.json |
| 10691-4 | Mushroom.toxic identified by Inspection | ./2.16.840.1.114222.4.11.1002/10691-4.json |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy | ./2.16.840.1.114222.4.11.1002/10692-2.json |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy | ./2.16.840.1.114222.4.11.1002/10693-0.json |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10694-8.json |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation | ./2.16.840.1.114222.4.11.1002/10695-5.json |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10696-3.json |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation | ./2.16.840.1.114222.4.11.1002/10699-7.json |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10700-3.json |
| 10701-1 | Ova and parasites identified in Stool by Concentration | ./2.16.840.1.114222.4.11.1002/10701-1.json |
| 10702-9 | Ova and parasites identified in Stool by Immune stain | ./2.16.840.1.114222.4.11.1002/10702-9.json |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/10703-7.json |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/10704-5.json |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/10705-2.json |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10706-0.json |
| 10707-8 | Toxic Plant identified in Plant specimen by Inspection | ./2.16.840.1.114222.4.11.1002/10707-8.json |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy | ./2.16.840.1.114222.4.11.1002/10708-6.json |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10709-4.json |
| 10710-2 | Plasmodium sp identified in Blood by Thin film | ./2.16.840.1.114222.4.11.1002/10710-2.json |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10711-0.json |
| 10712-8 | Pneumocystis sp identified in Lung tissue | ./2.16.840.1.114222.4.11.1002/10712-8.json |
| 10713-6 | Prototheca identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/10713-6.json |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/10715-1.json |
| 10716-9 | Schistosoma sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10716-9.json |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/10717-7.json |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/10718-5.json |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/10719-3.json |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10722-7.json |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/10723-5.json |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/10724-3.json |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10725-0.json |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/10726-8.json |
| 10727-6 | Toxoplasma gondii identified in Tissue | ./2.16.840.1.114222.4.11.1002/10727-6.json |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1072-8.json |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10728-4.json |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/10729-2.json |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10730-0.json |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film | ./2.16.840.1.114222.4.11.1002/10731-8.json |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film | ./2.16.840.1.114222.4.11.1002/10732-6.json |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation | ./2.16.840.1.114222.4.11.1002/10733-4.json |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10734-2.json |
| 10735-9 | Viral sequencing [Identifier] in Serum by Sequencing | ./2.16.840.1.114222.4.11.1002/10735-9.json |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10736-7.json |
| 10737-5 | Virus identified in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10737-5.json |
| 10738-3 | Virus identified in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10738-3.json |
| 10739-1 | Virus identified in Specimen by Electron microscopy | ./2.16.840.1.114222.4.11.1002/10739-1.json |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | ./2.16.840.1.114222.4.11.1002/10751-6.json |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | ./2.16.840.1.114222.4.11.1002/10753-2.json |
| 10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain | ./2.16.840.1.114222.4.11.1002/10758-1.json |
| 10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain | ./2.16.840.1.114222.4.11.1002/10759-9.json |
| 10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain | ./2.16.840.1.114222.4.11.1002/10760-7.json |
| 10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain | ./2.16.840.1.114222.4.11.1002/10761-5.json |
| 10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain | ./2.16.840.1.114222.4.11.1002/10763-1.json |
| 10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain | ./2.16.840.1.114222.4.11.1002/10765-6.json |
| 10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain | ./2.16.840.1.114222.4.11.1002/10778-9.json |
| 10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain | ./2.16.840.1.114222.4.11.1002/10780-5.json |
| 10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain | ./2.16.840.1.114222.4.11.1002/10782-1.json |
| 1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1078-5.json |
| 10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain | ./2.16.840.1.114222.4.11.1002/10813-4.json |
| 10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale | ./2.16.840.1.114222.4.11.1002/10823-3.json |
| 10829-0 | Silicon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10829-0.json |
| 10834-0 | Globulin [Mass/volume] in Serum by calculation | ./2.16.840.1.114222.4.11.1002/10834-0.json |
| 10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10835-7.json |
| 10836-5 | Niacin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/10836-5.json |
| 10837-3 | Organic acids [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10837-3.json |
| 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10839-9.json |
| 10840-7 | Atropine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10840-7.json |
| 10841-5 | methazolAMIDE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10841-5.json |
| 1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1084-3.json |
| 10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10846-4.json |
| 10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification | ./2.16.840.1.114222.4.11.1002/10847-2.json |
| 10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10848-0.json |
| 10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10849-8.json |
| 10850-6 | Cyclospora cayetanensis [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/10850-6.json |
| 10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10851-4.json |
| 10853-0 | Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/10853-0.json |
| 10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/10855-5.json |
| 10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain | ./2.16.840.1.114222.4.11.1002/10856-3.json |
| 10857-1 | Microsporidia identified in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/10857-1.json |
| 10858-9 | Teichoate Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/10858-9.json |
| 10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain | ./2.16.840.1.114222.4.11.1002/10859-7.json |
| 10860-5 | Varicella zoster virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/10860-5.json |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/10861-3.json |
| 10862-1 | Basement membrane Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/10862-1.json |
| 10863-9 | Endomysium IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/10863-9.json |
| 10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay | ./2.16.840.1.114222.4.11.1002/10864-7.json |
| 10865-4 | Intercellular substance Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/10865-4.json |
| 10866-2 | Sulfatide IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/10866-2.json |
| 10867-0 | Sulfatide IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/10867-0.json |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/10873-8.json |
| 10874-6 | Bombesin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/10874-6.json |
| 10875-3 | Carnitine esters [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10875-3.json |
| 10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10876-1.json |
| 10877-9 | Carnitine free (C0) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10877-9.json |
| 10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10878-7.json |
| 10880-3 | Magnesium [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10880-3.json |
| 10883-7 | Phenolphthalein [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10883-7.json |
| 10884-5 | Phosphate [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10884-5.json |
| 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10886-0.json |
| 10887-8 | Pyridinoline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/10887-8.json |
| 10888-6 | Lipase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10888-6.json |
| 10889-4 | Bisacodyl [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10889-4.json |
| 10891-0 | Oxyphenisatin [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10891-0.json |
| 10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10892-8.json |
| 10893-6 | Trenbolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10893-6.json |
| 10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/10894-4.json |
| 10895-1 | Clostridioides difficile toxin B [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/10895-1.json |
| 10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10896-9.json |
| 10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10897-7.json |
| 10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10898-5.json |
| 10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10899-3.json |
| 1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1090-0.json |
| 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/10900-9.json |
| 10903-3 | Hyaluronidase Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/10903-3.json |
| 10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10904-1.json |
| 10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10905-8.json |
| 10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10906-6.json |
| 10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/10907-4.json |
| 10909-0 | Benzidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10909-0.json |
| 10910-8 | Borate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10910-8.json |
| 10911-6 | Dichlorobenzidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10911-6.json |
| 10912-4 | Lead [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10912-4.json |
| 10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10913-2.json |
| 10914-0 | Methylenediamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10914-0.json |
| 10915-7 | Phencyclidine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/10915-7.json |
| 10916-5 | Platinum [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/10916-5.json |
| 10917-3 | Zinc [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/10917-3.json |
| 10918-1 | Zinc [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/10918-1.json |
| 10919-9 | Anisakis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10919-9.json |
| 10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10920-7.json |
| 10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10921-5.json |
| 10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10922-3.json |
| 10923-1 | Bromelin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10923-1.json |
| 10924-9 | Starfruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10924-9.json |
| 10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10925-6.json |
| 10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10926-4.json |
| 10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10927-2.json |
| 10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10928-0.json |
| 10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10929-8.json |
| 10930-6 | Fish Feed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10930-6.json |
| 10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10931-4.json |
| 10932-2 | Tetramin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10932-2.json |
| 10933-0 | Guar gum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10933-0.json |
| 10934-8 | Guava IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10934-8.json |
| 10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10935-5.json |
| 10936-3 | Mare milk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10936-3.json |
| 10937-1 | Marjoram IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10937-1.json |
| 10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10938-9.json |
| 10939-7 | Whiff IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10939-7.json |
| 10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10940-5.json |
| 10941-3 | Milk powder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10941-3.json |
| 10942-1 | Cockspur IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10942-1.json |
| 10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10943-9.json |
| 10944-7 | Octopus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10944-7.json |
| 10945-4 | Papain IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10945-4.json |
| 10946-2 | Passion fruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10946-2.json |
| 10947-0 | Persimmon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10947-0.json |
| 10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10948-8.json |
| 10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10949-6.json |
| 10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10950-4.json |
| 10951-2 | Sericin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10951-2.json |
| 10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10952-0.json |
| 10953-8 | Timothy IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10953-8.json |
| 10954-6 | Pine Nut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10954-6.json |
| 10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10955-3.json |
| 10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10956-1.json |
| 10957-9 | Slash Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10957-9.json |
| 10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10958-7.json |
| 10959-5 | Plaice IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10959-5.json |
| 10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10960-3.json |
| 10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10961-1.json |
| 10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/10963-7.json |
| 1096-7 | K Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1096-7.json |
| 10969-4 | Cystine+Homocysteine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/10969-4.json |
| 10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/10970-2.json |
| 10971-0 | Lysozyme [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10971-0.json |
| 10972-8 | Organic acids [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10972-8.json |
| 10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10973-6.json |
| 10974-4 | 5-Fluorocytosine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10974-4.json |
| 10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10975-1.json |
| 10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/10976-9.json |
| 10977-7 | ALPRAZolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/10977-7.json |
| 10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10978-5.json |
| 10979-3 | Carisoprodol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10979-3.json |
| 10980-1 | Cephapirin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10980-1.json |
| 10981-9 | cloNIDine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/10981-9.json |
| 10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10982-7.json |
| 10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10983-5.json |
| 10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10984-3.json |
| 10985-0 | Doxapram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10985-0.json |
| 10986-8 | Doxycycline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10986-8.json |
| 10987-6 | Fluconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10987-6.json |
| 10988-4 | fluvoxaMINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10988-4.json |
| 10989-2 | Itraconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10989-2.json |
| 10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10990-0.json |
| 10991-8 | metroNIDAZOLE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10991-8.json |
| 10992-6 | Norclozapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10992-6.json |
| 10993-4 | Nafcillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10993-4.json |
| 10994-2 | Naltrexone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10994-2.json |
| 10995-9 | Neomycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10995-9.json |
| 10996-7 | Normeperidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10996-7.json |
| 10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10997-5.json |
| 10998-3 | oxyCODONE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/10998-3.json |
| 10999-1 | Paramethadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/10999-1.json |
| 11000-7 | Promethazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/11000-7.json |
| 11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11001-5.json |
| 11002-3 | Scopolamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/11002-3.json |
| 11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11003-1.json |
| 11004-9 | Tricyclic antidepressants [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/11004-9.json |
| 11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11005-6.json |
| 11006-4 | Borrelia burgdorferi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11006-4.json |
| 11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11007-2.json |
| 11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/11008-0.json |
| 11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/11009-8.json |
| 11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/11010-6.json |
| 11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/11011-4.json |
| 11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/11012-2.json |
| 11013-0 | DNA double strand Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11013-0.json |
| 11014-8 | Somatotropin Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11014-8.json |
| 11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11015-5.json |
| 11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain | ./2.16.840.1.114222.4.11.1002/11017-1.json |
| 11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain | ./2.16.840.1.114222.4.11.1002/11018-9.json |
| 11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain | ./2.16.840.1.114222.4.11.1002/11019-7.json |
| 11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain | ./2.16.840.1.114222.4.11.1002/11020-5.json |
| 11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain | ./2.16.840.1.114222.4.11.1002/11021-3.json |
| 11022-1 | Barbiturates [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/11022-1.json |
| 1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1102-3.json |
| 11023-9 | Benzodiazepines [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/11023-9.json |
| 11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11024-7.json |
| 11025-4 | Methadone [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/11025-4.json |
| 11026-2 | Methaqualone [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/11026-2.json |
| 11027-0 | Propoxyphene [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/11027-0.json |
| 11028-8 | Zinc [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/11028-8.json |
| 11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11030-4.json |
| 11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11034-6.json |
| 11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11035-3.json |
| 11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11037-9.json |
| 11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11038-7.json |
| 11039-5 | C reactive protein [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11039-5.json |
| 11040-3 | Cortisol Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11040-3.json |
| 11043-7 | Cryofibrinogen [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/11043-7.json |
| 11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11044-5.json |
| 11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11045-2.json |
| 11046-0 | EPINEPHrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11046-0.json |
| 11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11047-8.json |
| 11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11048-6.json |
| 11050-2 | Kappa light chains [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11050-2.json |
| 11051-0 | Lambda light chains [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11051-0.json |
| 11052-8 | Ketamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11052-8.json |
| 11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11053-6.json |
| 11055-1 | Melatonin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11055-1.json |
| 11056-9 | Melatonin [Flow] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/11056-9.json |
| 11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11057-7.json |
| 11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11058-5.json |
| 11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11059-3.json |
| 11060-1 | Reducing substances [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/11060-1.json |
| 11061-9 | 11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/11061-9.json |
| 11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11062-7.json |
| 11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11063-5.json |
| 11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/11064-3.json |
| 11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis | ./2.16.840.1.114222.4.11.1002/11065-0.json |
| 11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/11066-8.json |
| 11067-6 | Bleeding time | ./2.16.840.1.114222.4.11.1002/11067-6.json |
| 11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/11068-4.json |
| 11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/11069-2.json |
| 11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain | ./2.16.840.1.114222.4.11.1002/11070-0.json |
| 11071-8 | Butalbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11071-8.json |
| 11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11072-6.json |
| 11073-4 | Despropionylfentanyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11073-4.json |
| 11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11074-2.json |
| 11075-9 | Norfentanyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11075-9.json |
| 11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/11077-5.json |
| 1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1108-0.json |
| 11083-3 | Human papilloma virus identified in Cervix | ./2.16.840.1.114222.4.11.1002/11083-3.json |
| 11084-1 | Reagin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11084-1.json |
| 11085-8 | Schistosoma sp identified in Stool by Concentration | ./2.16.840.1.114222.4.11.1002/11085-8.json |
| 11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11086-6.json |
| 11087-4 | Insulin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11087-4.json |
| 11088-2 | Neuronal nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11088-2.json |
| 11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/11089-0.json |
| 11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11090-8.json |
| 11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11091-6.json |
| 11092-4 | Barbiturates [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/11092-4.json |
| 11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11093-2.json |
| 11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11094-0.json |
| 11095-7 | Dieldrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11095-7.json |
| 11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11096-5.json |
| 11097-3 | Lindane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11097-3.json |
| 11098-1 | Malaoxon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11098-1.json |
| 11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11099-9.json |
| 11100-5 | Tetrachloroethylene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/11100-5.json |
| 11102-1 | Charcot-leyden crystals [type] in Specimen by Trichrome stain | ./2.16.840.1.114222.4.11.1002/11102-1.json |
| 11133-6 | Catecholamines Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11133-6.json |
| 11139-3 | Metanephrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11139-3.json |
| 11140-1 | Metanephrine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/11140-1.json |
| 11144-3 | Homovanillate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11144-3.json |
| 11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11145-0.json |
| 11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11146-8.json |
| 11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11147-6.json |
| 11148-4 | Potassium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11148-4.json |
| 11149-2 | Sodium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11149-2.json |
| 11151-8 | Hematocrit [Volume Fraction] of Cord blood | ./2.16.840.1.114222.4.11.1002/11151-8.json |
| 11153-4 | Hematocrit [Volume Fraction] of Body fluid | ./2.16.840.1.114222.4.11.1002/11153-4.json |
| 11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/11154-2.json |
| 1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1115-5.json |
| 11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/11155-9.json |
| 11159-1 | Alkalase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11159-1.json |
| 11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11160-9.json |
| 11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11161-7.json |
| 11163-3 | Carageenan IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11163-3.json |
| 11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11164-1.json |
| 11165-8 | Chinchilla IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11165-8.json |
| 11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11166-6.json |
| 11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11167-4.json |
| 11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11168-2.json |
| 11169-0 | Deer hair IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11169-0.json |
| 11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11170-8.json |
| 11171-6 | Erythromycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11171-6.json |
| 11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11172-4.json |
| 11173-2 | Fig IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11173-2.json |
| 11174-0 | Grain weevel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11174-0.json |
| 11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11175-7.json |
| 11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11176-5.json |
| 11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11177-3.json |
| 11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11178-1.json |
| 11179-9 | Linden IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11179-9.json |
| 11180-7 | Lupin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11180-7.json |
| 11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11181-5.json |
| 11182-3 | Lysozyme IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11182-3.json |
| 11183-1 | Macadamia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11183-1.json |
| 11184-9 | Scad IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11184-9.json |
| 11185-6 | Maxatase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11185-6.json |
| 11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11186-4.json |
| 11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11187-2.json |
| 11188-0 | Cayenne IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11188-0.json |
| 11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11189-8.json |
| 11190-6 | Mint IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11190-6.json |
| 11191-4 | Pollock IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11191-4.json |
| 11192-2 | Protamine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11192-2.json |
| 11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11193-0.json |
| 11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11194-8.json |
| 11195-5 | Rapeseed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11195-5.json |
| 11196-3 | Orange roughy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11196-3.json |
| 11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11197-1.json |
| 11198-9 | Shark IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11198-9.json |
| 11199-7 | Silver IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11199-7.json |
| 11200-3 | Escargot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11200-3.json |
| 11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11201-1.json |
| 11202-9 | Tarragon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11202-9.json |
| 11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11203-7.json |
| 11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11204-5.json |
| 11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11206-0.json |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/11207-8.json |
| 11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/11208-6.json |
| 11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/11209-4.json |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/11210-2.json |
| 11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/11211-0.json |
| 1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1121-3.json |
| 11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11213-6.json |
| 11215-1 | Delta aminolevulinate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11215-1.json |
| 11216-9 | Deoxypyridinoline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11216-9.json |
| 11218-5 | Microalbumin [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/11218-5.json |
| 11219-3 | Immunoglobulin light chains [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11219-3.json |
| 11220-1 | Iodine Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/11220-1.json |
| 11225-0 | Porphyrins [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11225-0.json |
| 11226-8 | Prorenin [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/11226-8.json |
| 11227-6 | Pyruvate kinase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/11227-6.json |
| 11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11229-2.json |
| 11230-0 | Amobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11230-0.json |
| 11231-8 | Astemizole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11231-8.json |
| 11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11232-6.json |
| 11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11233-4.json |
| 11234-2 | Propoxyphene [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/11234-2.json |
| 11235-9 | fentaNYL [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/11235-9.json |
| 11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11236-7.json |
| 11237-5 | hydrALAZINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11237-5.json |
| 11238-3 | Hydroxyalprazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11238-3.json |
| 11240-9 | hydrOXYzine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11240-9.json |
| 11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11241-7.json |
| 11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11242-5.json |
| 11243-3 | Methadone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/11243-3.json |
| 11244-1 | Morphine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11244-1.json |
| 11246-6 | oxyCODONE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/11246-6.json |
| 11247-4 | oxyMORphone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/11247-4.json |
| 11248-2 | Pergolide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11248-2.json |
| 11249-0 | Phenacemide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11249-0.json |
| 11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11250-8.json |
| 11251-6 | Piroxicam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11251-6.json |
| 11252-4 | Scopolamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11252-4.json |
| 11253-2 | Tacrolimus [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/11253-2.json |
| 11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11254-0.json |
| 11255-7 | Haemophilus ducreyi [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/11255-7.json |
| 11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11256-5.json |
| 11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/11257-3.json |
| 11258-1 | Hepatitis B virus DNA [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11258-1.json |
| 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/11259-9.json |
| 11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/11260-7.json |
| 11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/11261-5.json |
| 11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11262-3.json |
| 11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/11263-1.json |
| 11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/11264-9.json |
| 11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/11265-6.json |
| 11266-4 | Streptococcus agalactiae Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/11266-4.json |
| 11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/11267-2.json |
| 11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/11268-0.json |
| 11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/11269-8.json |
| 1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1138-7.json |
| 11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/11467-8.json |
| 11468-6 | Bacillus anthracis Ab [Units/volume] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/11468-6.json |
| 11469-4 | Bacillus anthracis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/11469-4.json |
| 11470-2 | Clostridium botulinum toxin [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/11470-2.json |
| 11473-6 | Cryptococcus sp Ag [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/11473-6.json |
| 11474-4 | Hydatid cyst identified in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/11474-4.json |
| 11475-1 | Microorganism identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/11475-1.json |
| 11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11476-9.json |
| 11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11477-7.json |
| 1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1147-8.json |
| 11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11478-5.json |
| 11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11479-3.json |
| 11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11480-1.json |
| 11481-9 | Human papilloma virus identified in Specimen | ./2.16.840.1.114222.4.11.1002/11481-9.json |
| 11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/11482-7.json |
| 11483-5 | Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/11483-5.json |
| 11484-3 | Virus identified in Amniotic fluid by Culture | ./2.16.840.1.114222.4.11.1002/11484-3.json |
| 11485-0 | Anesthesia records | ./2.16.840.1.114222.4.11.1002/11485-0.json |
| 11486-8 | Chemotherapy records | ./2.16.840.1.114222.4.11.1002/11486-8.json |
| 11488-4 | Consult note | ./2.16.840.1.114222.4.11.1002/11488-4.json |
| 11490-0 | Physician Discharge summary | ./2.16.840.1.114222.4.11.1002/11490-0.json |
| 11492-6 | Provider-unspecifed, History and physical note | ./2.16.840.1.114222.4.11.1002/11492-6.json |
| 11502-2 | Laboratory report | ./2.16.840.1.114222.4.11.1002/11502-2.json |
| 11503-0 | Medical records | ./2.16.840.1.114222.4.11.1002/11503-0.json |
| 11504-8 | Surgical operation note | ./2.16.840.1.114222.4.11.1002/11504-8.json |
| 11505-5 | Physician procedure note | ./2.16.840.1.114222.4.11.1002/11505-5.json |
| 11506-3 | Progress note | ./2.16.840.1.114222.4.11.1002/11506-3.json |
| 11507-1 | Occupational therapy Progress note | ./2.16.840.1.114222.4.11.1002/11507-1.json |
| 11508-9 | Physical therapy Progress note | ./2.16.840.1.114222.4.11.1002/11508-9.json |
| 11509-7 | Podiatry Progress note | ./2.16.840.1.114222.4.11.1002/11509-7.json |
| 11510-5 | Psychology Progress note | ./2.16.840.1.114222.4.11.1002/11510-5.json |
| 11512-1 | Speech-language pathology Progress note | ./2.16.840.1.114222.4.11.1002/11512-1.json |
| 11514-7 | Chiropractic Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11514-7.json |
| 11515-4 | Physical therapy Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11515-4.json |
| 11516-2 | Physician Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11516-2.json |
| 11517-0 | Podiatry Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11517-0.json |
| 11518-8 | Psychology Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11518-8.json |
| 11519-6 | Social service Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11519-6.json |
| 11520-4 | Speech therapy Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11520-4.json |
| 11521-2 | Occupational therapy Episode of care medical records | ./2.16.840.1.114222.4.11.1002/11521-2.json |
| 11523-8 | EEG study | ./2.16.840.1.114222.4.11.1002/11523-8.json |
| 11524-6 | EKG study | ./2.16.840.1.114222.4.11.1002/11524-6.json |
| 11525-3 | US for pregnancy | ./2.16.840.1.114222.4.11.1002/11525-3.json |
| 11526-1 | Pathology study | ./2.16.840.1.114222.4.11.1002/11526-1.json |
| 11527-9 | Psychiatry study | ./2.16.840.1.114222.4.11.1002/11527-9.json |
| 11529-5 | Surgical pathology study | ./2.16.840.1.114222.4.11.1002/11529-5.json |
| 11534-5 | Temperature charts | ./2.16.840.1.114222.4.11.1002/11534-5.json |
| 11543-6 | Nursery records | ./2.16.840.1.114222.4.11.1002/11543-6.json |
| 11545-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/11545-1.json |
| 11546-9 | Microscopic observation [Identifier] in Specimen by Other stain | ./2.16.840.1.114222.4.11.1002/11546-9.json |
| 11550-1 | Borrelia burgdorferi [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/11550-1.json |
| 11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification | ./2.16.840.1.114222.4.11.1002/11551-9.json |
| 11556-8 | Oxygen [Partial pressure] in Blood | ./2.16.840.1.114222.4.11.1002/11556-8.json |
| 11557-6 | Carbon dioxide [Partial pressure] in Blood | ./2.16.840.1.114222.4.11.1002/11557-6.json |
| 11558-4 | pH of Blood | ./2.16.840.1.114222.4.11.1002/11558-4.json |
| 11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11560-0.json |
| 11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11561-8.json |
| 11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11562-6.json |
| 11564-2 | Intrinsic factor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11564-2.json |
| 11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11565-9.json |
| 11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11566-7.json |
| 11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11568-3.json |
| 11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11569-1.json |
| 11570-9 | Platelet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11570-9.json |
| 11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11571-7.json |
| 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/11572-5.json |
| 11573-3 | Rheumatoid factor IgM [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11573-3.json |
| 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L | ./2.16.840.1.114222.4.11.1002/11579-0.json |
| 11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L | ./2.16.840.1.114222.4.11.1002/11580-8.json |
| 11581-6 | Ebola virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11581-6.json |
| 11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11582-4.json |
| 11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11583-2.json |
| 11584-0 | Aureobasidium pullulans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11584-0.json |
| 11585-7 | Bordetella pertussis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11585-7.json |
| 11586-5 | Brucella abortus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11586-5.json |
| 11587-3 | Brucella canis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11587-3.json |
| 11588-1 | Brucella melitensis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11588-1.json |
| 11589-9 | Brucella suis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11589-9.json |
| 11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11590-7.json |
| 11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11591-5.json |
| 11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/11592-3.json |
| 1159-3 | little c Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1159-3.json |
| 11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11593-1.json |
| 11594-9 | Echovirus 16 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11594-9.json |
| 11595-6 | Echovirus 18 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11595-6.json |
| 11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11596-4.json |
| 11597-2 | Treponema pallidum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11597-2.json |
| 11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11598-0.json |
| 11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11599-8.json |
| 11600-4 | Shigella flexneri Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11600-4.json |
| 11601-2 | Echovirus 7 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11601-2.json |
| 11602-0 | Shigella boydii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11602-0.json |
| 11603-8 | Salmonella sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11603-8.json |
| 11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11604-6.json |
| 11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11605-3.json |
| 11606-1 | Leptospira interrogans Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11606-1.json |
| 11607-9 | Junin virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11607-9.json |
| 11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11608-7.json |
| 11609-5 | HTLV I Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11609-5.json |
| 11610-3 | Heterophile Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11610-3.json |
| 11611-1 | Shigella sonnei Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/11611-1.json |
| 1165-0 | little e Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1165-0.json |
| 1171-8 | little f Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1171-8.json |
| 1195-7 | little k Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1195-7.json |
| 1213-8 | little s Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1213-8.json |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12172-3.json |
| 12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12173-1.json |
| 12176-4 | Amino acids [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12176-4.json |
| 12177-2 | Amino acids/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/12177-2.json |
| 12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/12178-0.json |
| 12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/12180-6.json |
| 12181-4 | Calcium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12181-4.json |
| 12183-0 | Cholesterol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12183-0.json |
| 12184-8 | Choriogonadotropin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/12184-8.json |
| 12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma | ./2.16.840.1.114222.4.11.1002/12186-3.json |
| 12190-5 | Creatinine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12190-5.json |
| 12191-3 | Creatinine [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/12191-3.json |
| 1219-5 | LW Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1219-5.json |
| 12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation | ./2.16.840.1.114222.4.11.1002/12196-2.json |
| 12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation | ./2.16.840.1.114222.4.11.1002/12197-0.json |
| 12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation | ./2.16.840.1.114222.4.11.1002/12198-8.json |
| 12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation | ./2.16.840.1.114222.4.11.1002/12199-6.json |
| 12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count | ./2.16.840.1.114222.4.11.1002/12210-1.json |
| 12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/12212-7.json |
| 12217-6 | Globulin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12217-6.json |
| 12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/12218-4.json |
| 12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/12220-0.json |
| 12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/12221-8.json |
| 12222-6 | Human papilloma virus Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/12222-6.json |
| 12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/12223-4.json |
| 12228-3 | Triglyceride [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12228-3.json |
| 12232-5 | Measles virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/12232-5.json |
| 12237-4 | Mumps virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/12237-4.json |
| 12239-0 | Oligosaccharides [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12239-0.json |
| 12240-8 | Orotidine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12240-8.json |
| 12242-4 | Phosphate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12242-4.json |
| 12245-7 | Porphobilinogen [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12245-7.json |
| 12247-3 | Pyruvate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12247-3.json |
| 12251-5 | Rubella virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/12251-5.json |
| 1225-2 | Mg Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1225-2.json |
| 12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy | ./2.16.840.1.114222.4.11.1002/12256-4.json |
| 12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/12259-8.json |
| 12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells | ./2.16.840.1.114222.4.11.1002/12260-6.json |
| 12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/12261-4.json |
| 12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/12262-2.json |
| 12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/12265-5.json |
| 12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/12266-3.json |
| 12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/12267-1.json |
| 12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/12268-9.json |
| 12269-7 | Urobilinogen [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12269-7.json |
| 12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/12271-3.json |
| 12272-1 | Virus identified in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/12272-1.json |
| 12274-7 | Xylose [Mass/time] in 5 hour Urine | ./2.16.840.1.114222.4.11.1002/12274-7.json |
| 12275-4 | Yeast [Presence] in Genital specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/12275-4.json |
| 12277-0 | DNA double strand Ab [Presence] in Serum by Farr method | ./2.16.840.1.114222.4.11.1002/12277-0.json |
| 12281-2 | Bacteria identified in Cervix by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/12281-2.json |
| 12282-0 | Warfarin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12282-0.json |
| 12283-8 | Corticotropin releasing hormone [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12283-8.json |
| 12284-6 | Growth hormone-releasing hormone [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12284-6.json |
| 12286-1 | Drugs identified in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/12286-1.json |
| 12287-9 | Drugs identified in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/12287-9.json |
| 12288-7 | Diuretics [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12288-7.json |
| 12289-5 | Drugs identified in Vitreous fluid by Screen method | ./2.16.840.1.114222.4.11.1002/12289-5.json |
| 12290-3 | Procyclidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12290-3.json |
| 12291-1 | Mephentermine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12291-1.json |
| 12292-9 | Dimethyltryptamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12292-9.json |
| 12293-7 | Cotinine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12293-7.json |
| 12294-5 | Nicotine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12294-5.json |
| 12295-2 | Hallucinogens [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12295-2.json |
| 12296-0 | Mescaline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12296-0.json |
| 12297-8 | Chlorate [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12297-8.json |
| 12298-6 | Erythromycin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12298-6.json |
| 12299-4 | Ethinamate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12299-4.json |
| 12300-0 | Polythiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12300-0.json |
| 12301-8 | Procaine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12301-8.json |
| 12302-6 | Theobromine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12302-6.json |
| 12303-4 | Theobromine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12303-4.json |
| 12304-2 | Benzyl alcohol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12304-2.json |
| 12305-9 | Chlordecone [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12305-9.json |
| 12306-7 | Cyclohexane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12306-7.json |
| 12307-5 | Dichloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12307-5.json |
| 12308-3 | HYDROcodone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12308-3.json |
| 12309-1 | Naltrexone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12309-1.json |
| 1231-0 | M Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1231-0.json |
| 12310-9 | Phenytoin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12310-9.json |
| 12311-7 | Prazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12311-7.json |
| 12312-5 | Cyclopropane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12312-5.json |
| 12313-3 | Aprobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12313-3.json |
| 12314-1 | Clorazepate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12314-1.json |
| 12315-8 | Mephobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12315-8.json |
| 12317-4 | Phenolphthalein [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12317-4.json |
| 12318-2 | Spironolactone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12318-2.json |
| 12319-0 | Thioridazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12319-0.json |
| 12320-8 | Thiothixene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12320-8.json |
| 12321-6 | Trifluoperazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12321-6.json |
| 12322-4 | Triflupromazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12322-4.json |
| 12323-2 | Trimeprazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12323-2.json |
| 12324-0 | hydrOXYzine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12324-0.json |
| 12325-7 | Tetrahydrocortisone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12325-7.json |
| 12326-5 | Diamorphine [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/12326-5.json |
| 12327-3 | Ketamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12327-3.json |
| 12328-1 | Beta blockers [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12328-1.json |
| 12329-9 | chlorproPAMIDE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12329-9.json |
| 12330-7 | Hypoglycemics.oral [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12330-7.json |
| 12331-5 | Phenethylamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12331-5.json |
| 12332-3 | Antihistamines [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12332-3.json |
| 12333-1 | Butorphanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12333-1.json |
| 12334-9 | Para aminophenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12334-9.json |
| 12335-6 | Halothane [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12335-6.json |
| 12336-4 | hydrALAZINE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12336-4.json |
| 12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12337-2.json |
| 12338-0 | Pentachlorophenol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12338-0.json |
| 12339-8 | Diquat [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12339-8.json |
| 12340-6 | Ethylene [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12340-6.json |
| 12341-4 | Mazindol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12341-4.json |
| 12342-2 | oxyMORphone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12342-2.json |
| 12343-0 | Thiazides [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12343-0.json |
| 1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1234-4.json |
| 12344-8 | Antipsychotics [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12344-8.json |
| 12345-5 | Cyclothiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12345-5.json |
| 12346-3 | Methyclothiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12346-3.json |
| 12347-1 | metOLazone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12347-1.json |
| 12348-9 | Quinethazone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12348-9.json |
| 12349-7 | Trichlormethiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12349-7.json |
| 12350-5 | Amphetamines [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12350-5.json |
| 12351-3 | Tetrahydrocannabinol [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12351-3.json |
| 12352-1 | Benzoylecgonine [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12352-1.json |
| 12353-9 | Methaqualone [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12353-9.json |
| 12354-7 | Opiates [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12354-7.json |
| 12355-4 | Phencyclidine [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12355-4.json |
| 12356-2 | Methadone [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12356-2.json |
| 12357-0 | Propoxyphene [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12357-0.json |
| 12358-8 | Barbiturates [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12358-8.json |
| 12359-6 | Benzodiazepines [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12359-6.json |
| 12360-4 | Barbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12360-4.json |
| 12361-2 | Oxazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12361-2.json |
| 12362-0 | Oxazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12362-0.json |
| 12363-8 | carBAMazepine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12363-8.json |
| 12364-6 | Benzodiazepines [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12364-6.json |
| 12365-3 | dimenhyDRINATE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12365-3.json |
| 12366-1 | Disopyramide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12366-1.json |
| 12367-9 | Mesoridazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12367-9.json |
| 12368-7 | Phenacetin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/12368-7.json |
| 12369-5 | Sympathomimetics [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12369-5.json |
| 12370-3 | Thiopental [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12370-3.json |
| 12371-1 | Isopropyl ether [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12371-1.json |
| 12372-9 | Dimethylacetamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12372-9.json |
| 12374-5 | cloBAZam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12374-5.json |
| 12375-2 | cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12375-2.json |
| 12377-8 | Demoxepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12377-8.json |
| 12378-6 | diazePAM [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12378-6.json |
| 12379-4 | Halazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12379-4.json |
| 12380-2 | LORazepam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12380-2.json |
| 12381-0 | Oxazepam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12381-0.json |
| 12382-8 | Temazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12382-8.json |
| 12383-6 | Hydroxytriazolam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12383-6.json |
| 12384-4 | Triazolam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12384-4.json |
| 12386-9 | Nordoxepin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12386-9.json |
| 12387-7 | Primidone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12387-7.json |
| 12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12388-5.json |
| 12389-3 | OLANZapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12389-3.json |
| 12390-1 | sulfaSALAzine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12390-1.json |
| 12391-9 | dimenhyDRINATE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12391-9.json |
| 12394-3 | Butorphanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12394-3.json |
| 12395-0 | Butorphanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12395-0.json |
| 12396-8 | chlorproPAMIDE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12396-8.json |
| 12397-6 | Colchicine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12397-6.json |
| 12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12398-4.json |
| 12399-2 | Emetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12399-2.json |
| 12400-8 | Emetine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12400-8.json |
| 12401-6 | Ethinamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12401-6.json |
| 12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12402-4.json |
| 12403-2 | Mephentermine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12403-2.json |
| 12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12404-0.json |
| 12405-7 | Nabumetone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12405-7.json |
| 12406-5 | Nadolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12406-5.json |
| 12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12408-1.json |
| 12410-7 | Pimozide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12410-7.json |
| 12411-5 | Promazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12411-5.json |
| 12412-3 | Pyridine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12412-3.json |
| 12413-1 | Resperine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12413-1.json |
| 12414-9 | Resperine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12414-9.json |
| 12415-6 | Selegiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12415-6.json |
| 12416-4 | Sotalol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12416-4.json |
| 12417-2 | Sulindac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12417-2.json |
| 12418-0 | Terfenadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12418-0.json |
| 12419-8 | Terfenadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12419-8.json |
| 12420-6 | Thiosulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12420-6.json |
| 12421-4 | Thiosulfate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/12421-4.json |
| 12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12422-2.json |
| 12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12423-0.json |
| 12424-8 | Triprolidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12424-8.json |
| 12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12425-5.json |
| 12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12426-3.json |
| 12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12427-1.json |
| 12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12428-9.json |
| 12429-7 | Succinylcholine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12429-7.json |
| 12430-5 | Cumene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12430-5.json |
| 12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12431-3.json |
| 12432-1 | Hydroxytriazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12432-1.json |
| 12433-9 | Bufotenine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12433-9.json |
| 12434-7 | predniSONE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12434-7.json |
| 12435-4 | Naphthalene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12435-4.json |
| 12436-2 | Naphthol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12436-2.json |
| 12437-0 | traMADol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12437-0.json |
| 12438-8 | Nortramadol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12438-8.json |
| 12439-6 | FLUoxetine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12439-6.json |
| 12440-4 | Midazolam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12440-4.json |
| 12441-2 | Tolmetin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12441-2.json |
| 12442-0 | Acetaminophen [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/12442-0.json |
| 12443-8 | Trimipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12443-8.json |
| 12444-6 | Nortrimipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12444-6.json |
| 12445-3 | Norfluoxetine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12445-3.json |
| 12446-1 | Halogenated organic molecules [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12446-1.json |
| 12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting | ./2.16.840.1.114222.4.11.1002/12448-7.json |
| 12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/12455-2.json |
| 12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/12456-0.json |
| 12465-1 | Ethanol [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/12465-1.json |
| 12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry | ./2.16.840.1.114222.4.11.1002/12466-9.json |
| 12467-7 | Amino acids [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12467-7.json |
| 12468-5 | Amino acids [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12468-5.json |
| 12470-1 | Homocysteine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12470-1.json |
| 12471-9 | Amino beta guanidinopropionate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12471-9.json |
| 12472-7 | Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12472-7.json |
| 12475-0 | Delta aminolevulinate [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/12475-0.json |
| 12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct | ./2.16.840.1.114222.4.11.1002/12476-8.json |
| 12477-6 | Dextromethamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12477-6.json |
| 12478-4 | Levomethamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12478-4.json |
| 12479-2 | Androsterone [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/12479-2.json |
| 12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/12480-0.json |
| 12481-8 | Arsenic.inorganic [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12481-8.json |
| 12482-6 | Ascorbate [Mass/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/12482-6.json |
| 12483-4 | Tungsten [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12483-4.json |
| 12484-2 | PHENobarbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12484-2.json |
| 12485-9 | Amobarbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12485-9.json |
| 12486-7 | Butabarbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12486-7.json |
| 12487-5 | Butalbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12487-5.json |
| 12488-3 | PENTobarbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12488-3.json |
| 12489-1 | Secobarbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/12489-1.json |
| 12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12490-9.json |
| 12491-7 | Methohexital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12491-7.json |
| 1249-2 | M1 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1249-2.json |
| 12492-5 | Thiamylal [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12492-5.json |
| 12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12493-3.json |
| 12494-1 | Amobarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12494-1.json |
| 12495-8 | Barbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12495-8.json |
| 12496-6 | Butabarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12496-6.json |
| 12497-4 | Butalbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12497-4.json |
| 12498-2 | Metharbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12498-2.json |
| 12499-0 | PENTobarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12499-0.json |
| 12500-5 | Secobarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12500-5.json |
| 12501-3 | PHENobarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12501-3.json |
| 12502-1 | Allobarbital [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12502-1.json |
| 12505-4 | Cadmium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/12505-4.json |
| 12511-2 | Calcium [Mass/volume] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/12511-2.json |
| 12513-8 | Bicarbonate [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/12513-8.json |
| 12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/12514-6.json |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12515-3.json |
| 1251-8 | Major crossmatch [Interpretation] by Immediate spin | ./2.16.840.1.114222.4.11.1002/1251-8.json |
| 12530-2 | Chloride [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/12530-2.json |
| 12532-8 | Meclizine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12532-8.json |
| 12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12533-6.json |
| 12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/12534-4.json |
| 12535-1 | Amyl nitrite [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12535-1.json |
| 12536-9 | Butyl nitrate [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/12536-9.json |
| 12537-7 | Phenylglyoxylate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12537-7.json |
| 12538-5 | Nitrate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12538-5.json |
| 12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12541-9.json |
| 12542-7 | N-methylacetamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12542-7.json |
| 12543-5 | Methyl formamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12543-5.json |
| 12544-3 | Nefazodone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12544-3.json |
| 12545-0 | Zomepirac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12545-0.json |
| 12546-8 | Quinethazone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12546-8.json |
| 12547-6 | Phorate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12547-6.json |
| 12548-4 | Tybamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12548-4.json |
| 12549-2 | Turpentine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12549-2.json |
| 12550-0 | Papaverine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12550-0.json |
| 12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12551-8.json |
| 12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12552-6.json |
| 12553-4 | Stimulants [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12553-4.json |
| 12554-2 | Narcotics and opioids [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12554-2.json |
| 12555-9 | Turpentine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12555-9.json |
| 12556-7 | Copper [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12556-7.json |
| 12566-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/12566-6.json |
| 12567-4 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/12567-4.json |
| 12569-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/12569-0.json |
| 12572-4 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen | ./2.16.840.1.114222.4.11.1002/12572-4.json |
| 12573-2 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen | ./2.16.840.1.114222.4.11.1002/12573-2.json |
| 12584-9 | Creatinine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/12584-9.json |
| 12585-6 | Creatinine [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/12585-6.json |
| 12586-4 | Creatinine [Mass/time] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/12586-4.json |
| 12587-2 | Creatinine [Mass/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/12587-2.json |
| 12588-0 | Creatinine [Mass/time] in 8 hour Urine | ./2.16.840.1.114222.4.11.1002/12588-0.json |
| 12589-8 | Creatinine [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/12589-8.json |
| 12595-5 | Estradiol (E2) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12595-5.json |
| 12598-9 | Fat.neutral [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12598-9.json |
| 12601-1 | Fluoride [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/12601-1.json |
| 12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12602-9.json |
| 12603-7 | N-desalkylflurazepam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12603-7.json |
| 12604-5 | Hydroxyethylflurazepam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12604-5.json |
| 12605-2 | Flurazepam [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/12605-2.json |
| 12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/12610-2.json |
| 12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal | ./2.16.840.1.114222.4.11.1002/12614-4.json |
| 1261-7 | N Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1261-7.json |
| 12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/12628-4.json |
| 12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/12629-2.json |
| 12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/12646-6.json |
| 12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/12647-4.json |
| 12702-7 | Antimony [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12702-7.json |
| 12703-5 | Gallium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12703-5.json |
| 12705-0 | Strontium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12705-0.json |
| 12706-8 | Tellurium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12706-8.json |
| 12707-6 | Thorium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12707-6.json |
| 12708-4 | Tin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12708-4.json |
| 12709-2 | Norastemizole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12709-2.json |
| 12714-2 | N-methylhistamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12714-2.json |
| 12715-9 | Homovanillate [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/12715-9.json |
| 12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/12720-9.json |
| 12721-7 | Melatonin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12721-7.json |
| 12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12722-5.json |
| 12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12723-3.json |
| 12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/12724-1.json |
| 12725-8 | IgA.secretory [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12725-8.json |
| 12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12726-6.json |
| 12727-4 | prednisoLONE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12727-4.json |
| 12728-2 | Alpha subunit [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12728-2.json |
| 12729-0 | Interferon gamma [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12729-0.json |
| 12730-8 | Interferon beta [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12730-8.json |
| 12731-6 | Interferon alpha [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12731-6.json |
| 12732-4 | Interleukin 12 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12732-4.json |
| 12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12733-2.json |
| 12734-0 | Soluble liver Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/12734-0.json |
| 12735-7 | Collagen Ab [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12735-7.json |
| 12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12736-5.json |
| 12737-3 | Endothelin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12737-3.json |
| 12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12769-6.json |
| 12770-4 | Lead [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/12770-4.json |
| 12774-6 | Mercury [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/12774-6.json |
| 12775-3 | Mercury [Mass/volume] in Dentin | ./2.16.840.1.114222.4.11.1002/12775-3.json |
| 12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12776-1.json |
| 12777-9 | Kappa light chains.free [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12777-9.json |
| 12778-7 | Lambda light chains.free [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12778-7.json |
| 12779-5 | Nickel [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/12779-5.json |
| 12780-3 | Nickel [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/12780-3.json |
| 12784-5 | Codeine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12784-5.json |
| 12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12785-2.json |
| 12786-0 | HYDROcodone Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12786-0.json |
| 12787-8 | HYDROmorphone Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12787-8.json |
| 12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12788-6.json |
| 12789-4 | oxyCODONE Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12789-4.json |
| 12799-3 | Parathyrin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/12799-3.json |
| 12801-7 | Methdilazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12801-7.json |
| 12802-5 | Propiomazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12802-5.json |
| 12803-3 | Phenylalanine [Presence] in Blood by Guthrie test | ./2.16.840.1.114222.4.11.1002/12803-3.json |
| 12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12804-1.json |
| 12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12805-8.json |
| 12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12810-8.json |
| 12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12811-6.json |
| 12814-0 | Potassium [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/12814-0.json |
| 12820-7 | Progesterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12820-7.json |
| 12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12836-3.json |
| 12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12837-1.json |
| 12838-9 | Prostaglandin D2 [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12838-9.json |
| 12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12839-7.json |
| 12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12840-5.json |
| 12842-1 | Protein [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/12842-1.json |
| 12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/12843-9.json |
| 12851-2 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/12851-2.json |
| 12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/12852-0.json |
| 12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/12853-8.json |
| 12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/12854-6.json |
| 12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/12897-5.json |
| 12898-3 | Chloride [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/12898-3.json |
| 12899-1 | Acetylene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12899-1.json |
| 12907-2 | Sodium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/12907-2.json |
| 12908-0 | Sodium [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/12908-0.json |
| 12912-2 | Lipids [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/12912-2.json |
| 12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/12913-0.json |
| 1291-4 | P1 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1291-4.json |
| 12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/12915-5.json |
| 12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12916-3.json |
| 12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12917-1.json |
| 12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/12918-9.json |
| 12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12919-7.json |
| 12920-5 | Sulfate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12920-5.json |
| 12922-1 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/12922-1.json |
| 12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12949-4.json |
| 12960-1 | Alpha 1 antitrypsin fecal clearance | ./2.16.840.1.114222.4.11.1002/12960-1.json |
| 12961-9 | Urea nitrogen [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/12961-9.json |
| 12962-7 | Urea nitrogen [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/12962-7.json |
| 12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood | ./2.16.840.1.114222.4.11.1002/12963-5.json |
| 12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/12967-6.json |
| 12983-3 | Volatiles and gases [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/12983-3.json |
| 12987-4 | Acetonitrile [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/12987-4.json |
| 12988-2 | Acrylamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12988-2.json |
| 12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12989-0.json |
| 12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12990-8.json |
| 12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12991-6.json |
| 12992-4 | Isobutane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12992-4.json |
| 12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/12993-2.json |
| 12994-0 | Oxychlordane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12994-0.json |
| 12995-7 | Cyclohexanone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12995-7.json |
| 12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12996-5.json |
| 12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12997-3.json |
| 12998-1 | Methylene chloride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/12998-1.json |
| 12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/12999-9.json |
| 13000-5 | Mandelate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13000-5.json |
| 13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13001-3.json |
| 13002-1 | Mesityl oxide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13002-1.json |
| 13003-9 | Halogenated organic molecules [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/13003-9.json |
| 13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/13004-7.json |
| 13007-0 | Ethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13007-0.json |
| 13008-8 | Methyl propyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13008-8.json |
| 13009-6 | Methyl ethyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13009-6.json |
| 13010-4 | Methyl amyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13010-4.json |
| 13011-2 | Methyl ethyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13011-2.json |
| 13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13012-0.json |
| 13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13013-8.json |
| 13014-6 | Methyl butyl ketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13014-6.json |
| 13015-3 | Diisobutylketone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13015-3.json |
| 13016-1 | Nitrophenol [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13016-1.json |
| 13018-7 | Pesticides [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/13018-7.json |
| 13019-5 | Pesticides [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13019-5.json |
| 13020-3 | Pesticides [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/13020-3.json |
| 13021-1 | Pesticides [Identifier] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/13021-1.json |
| 13022-9 | Propane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13022-9.json |
| 13023-7 | Trichlorofluoromethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13023-7.json |
| 13024-5 | Trichlorofluoroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13024-5.json |
| 13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13025-2.json |
| 13026-0 | Orthocresol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13026-0.json |
| 13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13027-8.json |
| 13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/13037-7.json |
| 13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/13050-0.json |
| 13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/13052-6.json |
| 13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/13053-4.json |
| 13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13054-2.json |
| 13055-9 | Heparin [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/13055-9.json |
| 13056-7 | Platelets [#/volume] in Plasma by Automated count | ./2.16.840.1.114222.4.11.1002/13056-7.json |
| 13061-7 | Platelet IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13061-7.json |
| 13062-5 | Platelet IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13062-5.json |
| 13063-3 | Drug induced platelet Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13063-3.json |
| 13064-1 | Platelet associated IgA Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13064-1.json |
| 13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13066-6.json |
| 13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13069-0.json |
| 13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13070-8.json |
| 13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13071-6.json |
| 13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13072-4.json |
| 13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13073-2.json |
| 13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13074-0.json |
| 13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13075-7.json |
| 13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13076-5.json |
| 13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13077-3.json |
| 13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13078-1.json |
| 13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13079-9.json |
| 13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13080-7.json |
| 13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13081-5.json |
| 13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13082-3.json |
| 13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13083-1.json |
| 13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13084-9.json |
| 13085-6 | C4 nephritic factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13085-6.json |
| 13086-4 | C3 nephritic factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13086-4.json |
| 13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13087-2.json |
| 13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13088-0.json |
| 13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13091-4.json |
| 13092-2 | Endomysium Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13092-2.json |
| 13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13117-7.json |
| 13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/13119-3.json |
| 13120-1 | Ovary Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13120-1.json |
| 13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13127-6.json |
| 13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13129-2.json |
| 131-3 | Cefsulodin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/131-3.json |
| 13130-0 | Motilin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13130-0.json |
| 13133-4 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13133-4.json |
| 13136-7 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13136-7.json |
| 1314-4 | Rh immune globulin screen [interpretation] | ./2.16.840.1.114222.4.11.1002/1314-4.json |
| 13145-8 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/13145-8.json |
| 13146-6 | Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13146-6.json |
| 13147-4 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/13147-4.json |
| 13148-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13148-2.json |
| 13157-3 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/13157-3.json |
| 13158-1 | Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13158-1.json |
| 13164-9 | Human antimouse Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13164-9.json |
| 13167-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13167-2.json |
| 13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay | ./2.16.840.1.114222.4.11.1002/13170-6.json |
| 13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay | ./2.16.840.1.114222.4.11.1002/13171-4.json |
| 13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay | ./2.16.840.1.114222.4.11.1002/13172-2.json |
| 13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13173-0.json |
| 13175-5 | Liver cytosol Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13175-5.json |
| 13176-3 | Wasp venom IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13176-3.json |
| 13177-1 | Russian olive IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13177-1.json |
| 13178-9 | Wasp venom IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13178-9.json |
| 13179-7 | English Walnut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13179-7.json |
| 13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13180-5.json |
| 13181-3 | Bahia grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13181-3.json |
| 13182-1 | Mesquite IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13182-1.json |
| 13183-9 | White Elm IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13183-9.json |
| 13184-7 | Cottonwood IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13184-7.json |
| 13185-4 | Nettle IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13185-4.json |
| 13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13186-2.json |
| 13187-0 | False ragweed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13187-0.json |
| 13188-8 | Mugwort IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13188-8.json |
| 13189-6 | English plantain IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13189-6.json |
| 13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13190-4.json |
| 13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13192-0.json |
| 13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13193-8.json |
| 13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13194-6.json |
| 13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13195-3.json |
| 13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13196-1.json |
| 13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13197-9.json |
| 13198-7 | Thermoactinomyces Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13198-7.json |
| 13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13199-5.json |
| 13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13200-1.json |
| 1320-1 | S Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1320-1.json |
| 13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13201-9.json |
| 13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/13202-7.json |
| 13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/13203-5.json |
| 13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13204-3.json |
| 13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13205-0.json |
| 13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/13206-8.json |
| 13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/13207-6.json |
| 13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13208-4.json |
| 13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13209-2.json |
| 13210-0 | Brucella sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13210-0.json |
| 13211-8 | Brucella sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13211-8.json |
| 13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13212-6.json |
| 13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13213-4.json |
| 13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13214-2.json |
| 13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13215-9.json |
| 13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13216-7.json |
| 13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13217-5.json |
| 13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13218-3.json |
| 13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13219-1.json |
| 13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13220-9.json |
| 13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13221-7.json |
| 13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --1st specimen | ./2.16.840.1.114222.4.11.1002/13225-8.json |
| 13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13226-6.json |
| 13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13227-4.json |
| 13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13228-2.json |
| 13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13229-0.json |
| 13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13230-8.json |
| 13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13231-6.json |
| 13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13232-4.json |
| 13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13233-2.json |
| 13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13234-0.json |
| 13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13235-7.json |
| 13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13236-5.json |
| 13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13237-3.json |
| 13238-1 | Epstein Barr virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13238-1.json |
| 13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13240-7.json |
| 13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13241-5.json |
| 13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13242-3.json |
| 13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13243-1.json |
| 13244-9 | Filaria IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13244-9.json |
| 13245-6 | Filaria IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13245-6.json |
| 13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13246-4.json |
| 13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13247-2.json |
| 13248-0 | Hepatitis D virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13248-0.json |
| 13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13249-8.json |
| 13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13250-6.json |
| 13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13251-4.json |
| 13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13252-2.json |
| 13253-0 | Legionella non-pneumophila Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13253-0.json |
| 13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13254-8.json |
| 13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13255-5.json |
| 13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13256-3.json |
| 13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13257-1.json |
| 13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13258-9.json |
| 13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13259-7.json |
| 13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13260-5.json |
| 13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13261-3.json |
| 13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13262-1.json |
| 13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13263-9.json |
| 13264-7 | Leptospira sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13264-7.json |
| 13265-4 | Leptospira sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13265-4.json |
| 13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13266-2.json |
| 13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13267-0.json |
| 13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/13268-8.json |
| 13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13269-6.json |
| 13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13270-4.json |
| 13271-2 | Neisseria meningitidis serogroup A Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13271-2.json |
| 13272-0 | Neisseria meningitidis serogroup C Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13272-0.json |
| 13273-8 | Sporothrix schenckii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13273-8.json |
| 13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13274-6.json |
| 13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13275-3.json |
| 13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13276-1.json |
| 13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13277-9.json |
| 13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13278-7.json |
| 13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/13279-5.json |
| 13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13280-3.json |
| 13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13281-1.json |
| 13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13282-9.json |
| 13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13283-7.json |
| 1328-4 | U Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1328-4.json |
| 13284-5 | Salmonella typhi H D Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13284-5.json |
| 13285-2 | Salmonella typhi O D Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13285-2.json |
| 13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/13286-0.json |
| 13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13287-8.json |
| 13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13288-6.json |
| 13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13289-4.json |
| 13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13290-2.json |
| 13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13291-0.json |
| 13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13292-8.json |
| 13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13293-6.json |
| 13294-4 | Hepatitis E virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13294-4.json |
| 13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13295-1.json |
| 13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13297-7.json |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/13309-0.json |
| 13310-8 | Kell group Ag [Type] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/13310-8.json |
| 13311-6 | MNS group Ag [Type] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/13311-6.json |
| 13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13312-4.json |
| 13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13313-2.json |
| 13314-0 | Bacteria identified in Semen | ./2.16.840.1.114222.4.11.1002/13314-0.json |
| 13315-7 | Bacteria identified in 24 hour Urine by Culture | ./2.16.840.1.114222.4.11.1002/13315-7.json |
| 13316-5 | Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/13316-5.json |
| 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/13317-3.json |
| 13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/13318-1.json |
| 13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen | ./2.16.840.1.114222.4.11.1002/13319-9.json |
| 13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen | ./2.16.840.1.114222.4.11.1002/13320-7.json |
| 13321-5 | Human papilloma virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13321-5.json |
| 13322-3 | Human papilloma virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13322-3.json |
| 13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13323-1.json |
| 13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13324-9.json |
| 13325-6 | Bartonella sp identified in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/13325-6.json |
| 13326-4 | Pneumocystis sp identified in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/13326-4.json |
| 13327-2 | Parainfluenza virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13327-2.json |
| 13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13328-0.json |
| 13329-8 | Escherichia coli labile toxin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/13329-8.json |
| 1334-2 | V Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1334-2.json |
| 13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13347-0.json |
| 13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13348-8.json |
| 13349-6 | Leukocytes [#/volume] in Stool by Manual count | ./2.16.840.1.114222.4.11.1002/13349-6.json |
| 13356-1 | Fat [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/13356-1.json |
| 13364-5 | Amino beta guanidinopropionate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/13364-5.json |
| 13365-2 | Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13365-2.json |
| 13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13374-4.json |
| 13382-7 | Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/13382-7.json |
| 13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/13401-5.json |
| 13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/13409-8.json |
| 1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1341-7.json |
| 13440-3 | Immunofixation for Urine | ./2.16.840.1.114222.4.11.1002/13440-3.json |
| 13441-1 | Creatinine renal clearance in 4 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13441-1.json |
| 13442-9 | Creatinine renal clearance in 6 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13442-9.json |
| 13443-7 | Creatinine renal clearance in 8 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13443-7.json |
| 13451-0 | Creatinine dialysis fluid clearance | ./2.16.840.1.114222.4.11.1002/13451-0.json |
| 13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/13456-9.json |
| 13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13461-9.json |
| 13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13463-5.json |
| 13464-3 | Chromium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13464-3.json |
| 13465-0 | Mercury/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13465-0.json |
| 13466-8 | Lead/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13466-8.json |
| 13467-6 | Selenium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13467-6.json |
| 13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13468-4.json |
| 13469-2 | Thallium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13469-2.json |
| 13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13470-0.json |
| 13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13471-8.json |
| 13472-6 | Nickel/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13472-6.json |
| 13473-4 | Zinc/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13473-4.json |
| 1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1347-4.json |
| 13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13474-2.json |
| 13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13475-9.json |
| 13476-7 | Silver/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13476-7.json |
| 13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13477-5.json |
| 13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13478-3.json |
| 13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13479-1.json |
| 13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13481-7.json |
| 13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13482-5.json |
| 13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13483-3.json |
| 13484-1 | Creatine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13484-1.json |
| 13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13485-8.json |
| 13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13486-6.json |
| 13487-4 | Phenol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13487-4.json |
| 13489-0 | Follitropin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13489-0.json |
| 13490-8 | Lutropin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13490-8.json |
| 13506-1 | Urea nitrogen renal clearance in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13506-1.json |
| 13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation | ./2.16.840.1.114222.4.11.1002/13508-7.json |
| 13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain | ./2.16.840.1.114222.4.11.1002/13509-5.json |
| 13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain | ./2.16.840.1.114222.4.11.1002/13510-3.json |
| 13511-1 | Cyanide ascorbate screen [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/13511-1.json |
| 13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain | ./2.16.840.1.114222.4.11.1002/13512-9.json |
| 13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain | ./2.16.840.1.114222.4.11.1002/13513-7.json |
| 13514-5 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative | ./2.16.840.1.114222.4.11.1002/13514-5.json |
| 1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1353-2.json |
| 13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative | ./2.16.840.1.114222.4.11.1002/13532-7.json |
| 13533-5 | Acid hemolysis [Presence] of Blood | ./2.16.840.1.114222.4.11.1002/13533-5.json |
| 13534-3 | Sucrose hemolysis [Presence] of Blood | ./2.16.840.1.114222.4.11.1002/13534-3.json |
| 13536-8 | Globulin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/13536-8.json |
| 13538-4 | Carbon dioxide, total [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13538-4.json |
| 13539-2 | Phosphate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13539-2.json |
| 13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13540-0.json |
| 13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13542-6.json |
| 13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13544-2.json |
| 13545-9 | ALPRAZolam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13545-9.json |
| 13546-7 | Amikacin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/13546-7.json |
| 13547-5 | Butriptyline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13547-5.json |
| 13548-3 | chlorproMAZINE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13548-3.json |
| 13549-1 | clomiPRAMINE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13549-1.json |
| 13550-9 | clonazePAM [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13550-9.json |
| 13551-7 | Clorazepate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13551-7.json |
| 13552-5 | cloZAPine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13552-5.json |
| 13553-3 | Cocaethylene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13553-3.json |
| 13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13554-1.json |
| 13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13555-8.json |
| 13556-6 | Demoxepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13556-6.json |
| 13557-4 | Norsertraline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13557-4.json |
| 13558-2 | Disopyramide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13558-2.json |
| 13559-0 | Flecainide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13559-0.json |
| 13560-8 | fluvoxaMINE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13560-8.json |
| 13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13561-6.json |
| 13562-4 | Gentamicin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/13562-4.json |
| 13563-2 | Glutethimide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13563-2.json |
| 13564-0 | Ibuprofen [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13564-0.json |
| 13565-7 | LORazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13565-7.json |
| 13566-5 | Mesoridazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13566-5.json |
| 13567-3 | Mexiletine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13567-3.json |
| 13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13568-1.json |
| 13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13569-9.json |
| 13570-7 | Norclomipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13570-7.json |
| 13571-5 | Norclozapine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13571-5.json |
| 13572-3 | Nordiazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13572-3.json |
| 13573-1 | Nordoxepin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13573-1.json |
| 13574-9 | Norfluoxetine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13574-9.json |
| 13575-6 | Normaprotiline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13575-6.json |
| 13576-4 | oxyCODONE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13576-4.json |
| 13577-2 | PARoxetine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13577-2.json |
| 13578-0 | Promazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13578-0.json |
| 13579-8 | Sertraline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13579-8.json |
| 13580-6 | Temazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13580-6.json |
| 13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13581-4.json |
| 13582-2 | Theophylline [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/13582-2.json |
| 13583-0 | Thioridazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13583-0.json |
| 13584-8 | Tobramycin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/13584-8.json |
| 13585-5 | Trifluoperazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13585-5.json |
| 13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13586-3.json |
| 13587-1 | Vancomycin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/13587-1.json |
| 13588-9 | Venlafaxine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13588-9.json |
| 13589-7 | Activated protein C resistance [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/13589-7.json |
| 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/13590-5.json |
| 13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/13591-3.json |
| 13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/13594-7.json |
| 13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13610-1.json |
| 13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13611-9.json |
| 13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13612-7.json |
| 13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13614-3.json |
| 13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13618-4.json |
| 13622-6 | Acetaminophen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13622-6.json |
| 13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13623-4.json |
| 13624-2 | DOXOrubicin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13624-2.json |
| 13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13625-9.json |
| 13626-7 | Mitotane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13626-7.json |
| 13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13629-1.json |
| 13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay | ./2.16.840.1.114222.4.11.1002/13631-7.json |
| 13632-5 | Insulin receptor Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13632-5.json |
| 13633-3 | Insulin receptor Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13633-3.json |
| 13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/13634-1.json |
| 13635-8 | Ribosomal Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13635-8.json |
| 13636-6 | Ribosomal P Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13636-6.json |
| 13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13637-4.json |
| 13638-2 | Chlordecone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13638-2.json |
| 13639-0 | Chlordecone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13639-0.json |
| 13640-8 | Vinyl chloride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13640-8.json |
| 13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/13641-6.json |
| 13643-2 | Lindane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13643-2.json |
| 13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13644-0.json |
| 13646-5 | Methaqualone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/13646-5.json |
| 13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/13648-1.json |
| 13649-9 | Nickel [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/13649-9.json |
| 13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13650-7.json |
| 13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13651-5.json |
| 13652-3 | Zinc [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/13652-3.json |
| 13655-6 | Leukocytes [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/13655-6.json |
| 13658-0 | Urobilinogen [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/13658-0.json |
| 13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/13659-8.json |
| 13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13660-6.json |
| 13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13664-8.json |
| 13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13671-3.json |
| 13676-2 | 2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13676-2.json |
| 13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13678-8.json |
| 13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13682-0.json |
| 13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13696-0.json |
| 13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13701-8.json |
| 13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13702-6.json |
| 13703-4 | Adipate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13703-4.json |
| 13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13705-9.json |
| 13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13709-1.json |
| 13712-5 | Azelate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13712-5.json |
| 13713-3 | Benzoate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13713-3.json |
| 1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1371-4.json |
| 13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13715-8.json |
| 13716-6 | C peptide/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13716-6.json |
| 13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13717-4.json |
| 13718-2 | Carnitine free (C0)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13718-2.json |
| 13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13721-6.json |
| 13722-4 | Citrate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13722-4.json |
| 13725-7 | Cystine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13725-7.json |
| 13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13728-1.json |
| 13729-9 | Deoxypyridinoline/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13729-9.json |
| 13730-7 | Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13730-7.json |
| 13731-5 | Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/13731-5.json |
| 13733-1 | DOPamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13733-1.json |
| 13734-9 | EPINEPHrine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13734-9.json |
| 13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13735-6.json |
| 13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13736-4.json |
| 13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13737-2.json |
| 13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13738-0.json |
| 13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13739-8.json |
| 13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13741-4.json |
| 13742-2 | Formate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13742-2.json |
| 13743-0 | Fumarate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13743-0.json |
| 13744-8 | Galactose/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13744-8.json |
| 13745-5 | Glutaconate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13745-5.json |
| 13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13748-9.json |
| 13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13749-7.json |
| 13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13751-3.json |
| 13752-1 | Glyoxylate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13752-1.json |
| 13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13753-9.json |
| 13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13754-7.json |
| 13755-4 | Histamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13755-4.json |
| 13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13756-2.json |
| 13758-8 | Homocysteine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13758-8.json |
| 13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13760-4.json |
| 13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13763-8.json |
| 13764-6 | Isocitrate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13764-6.json |
| 13767-9 | Lactate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13767-9.json |
| 13770-3 | Malate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13770-3.json |
| 13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13771-1.json |
| 13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13774-5.json |
| 13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13775-2.json |
| 13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13776-0.json |
| 13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13777-8.json |
| 13778-6 | Mevalonate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13778-6.json |
| 13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13779-4.json |
| 13780-2 | N-acetyltyrosine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13780-2.json |
| 13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13781-0.json |
| 13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13782-8.json |
| 13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13783-6.json |
| 13787-7 | Orotate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13787-7.json |
| 13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13788-5.json |
| 13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13790-1.json |
| 13791-9 | Phenylacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13791-9.json |
| 13792-7 | Phenyllactate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13792-7.json |
| 13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13793-5.json |
| 13794-3 | Phenylpyruvate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13794-3.json |
| 13795-0 | Phosphate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13795-0.json |
| 13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13797-6.json |
| 13798-4 | Potassium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13798-4.json |
| 13800-8 | Propionylglycine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13800-8.json |
| 13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13801-6.json |
| 13802-4 | Pyridinoline/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13802-4.json |
| 13803-2 | Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13803-2.json |
| 13804-0 | Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/13804-0.json |
| 13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13805-7.json |
| 13809-9 | Sodium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13809-9.json |
| 13810-7 | Suberate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13810-7.json |
| 13812-3 | Succinate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13812-3.json |
| 13816-4 | Tiglylglycine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13816-4.json |
| 13819-8 | Uracil/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13819-8.json |
| 13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13820-6.json |
| 13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13821-4.json |
| 13823-0 | Antimony/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13823-0.json |
| 13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13824-8.json |
| 13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13825-5.json |
| 13826-3 | Barium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13826-3.json |
| 13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13827-1.json |
| 13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13828-9.json |
| 13829-7 | Copper/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13829-7.json |
| 13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13830-5.json |
| 13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13831-3.json |
| 13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13832-1.json |
| 13833-9 | Finch feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13833-9.json |
| 13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) | ./2.16.840.1.114222.4.11.1002/13834-7.json |
| 13840-4 | CD19 blasts/100 blasts in Blood | ./2.16.840.1.114222.4.11.1002/13840-4.json |
| 13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13872-7.json |
| 13876-8 | Beta-2 transferrin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/13876-8.json |
| 13877-6 | Bilirubin.total [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/13877-6.json |
| 13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13878-4.json |
| 13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13879-2.json |
| 13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13880-0.json |
| 13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/13881-8.json |
| 13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13884-2.json |
| 13891-7 | Motilin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13891-7.json |
| 13892-5 | Nitrosonaphthol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/13892-5.json |
| 13894-1 | Pregnenolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13894-1.json |
| 13895-8 | Sodium [Moles/volume] in Milk | ./2.16.840.1.114222.4.11.1002/13895-8.json |
| 13896-6 | Insulin-like growth factor-I [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13896-6.json |
| 13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13897-4.json |
| 13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13898-2.json |
| 13902-2 | Urate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/13902-2.json |
| 13903-0 | Vasopressin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13903-0.json |
| 13904-8 | Meclizine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13904-8.json |
| 13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13905-5.json |
| 13907-1 | Norethindrone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13907-1.json |
| 13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13908-9.json |
| 13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13909-7.json |
| 13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13913-9.json |
| 13914-7 | Adenovirus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13914-7.json |
| 13915-4 | Adenovirus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13915-4.json |
| 13916-2 | Bordetella parapertussis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13916-2.json |
| 13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/13917-0.json |
| 13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/13918-8.json |
| 13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13919-6.json |
| 13921-2 | Mumps virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/13921-2.json |
| 13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13922-0.json |
| 13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13923-8.json |
| 13924-6 | Calcitonin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13924-6.json |
| 13925-3 | Soluble liver Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13925-3.json |
| 13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/13926-1.json |
| 13927-9 | Pancreatic islet cell Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13927-9.json |
| 13928-7 | Parathyrin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13928-7.json |
| 13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/13929-5.json |
| 13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination | ./2.16.840.1.114222.4.11.1002/13930-3.json |
| 13931-1 | Striated muscle Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/13931-1.json |
| 13932-9 | Testes IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13932-9.json |
| 13933-7 | Benzodiazepines [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/13933-7.json |
| 13934-5 | Butanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13934-5.json |
| 13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13935-2.json |
| 13936-0 | Diethyl ether [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13936-0.json |
| 13937-8 | Ethyl acetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13937-8.json |
| 13938-6 | Trichloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13938-6.json |
| 13940-2 | Dimethylbenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/13940-2.json |
| 13942-8 | Spermatozoa Motile [Presence] in Semen by Light microscopy | ./2.16.840.1.114222.4.11.1002/13942-8.json |
| 13943-6 | Fructose [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/13943-6.json |
| 13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/13946-9.json |
| 13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13947-7.json |
| 13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13948-5.json |
| 13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13949-3.json |
| 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13950-1.json |
| 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/13951-9.json |
| 13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13952-7.json |
| 13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13953-5.json |
| 13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13954-3.json |
| 13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/13955-0.json |
| 13956-8 | Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/13956-8.json |
| 13957-6 | Clostridioides difficile toxin A [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/13957-6.json |
| 13958-4 | Arsenic [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13958-4.json |
| 13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/13959-2.json |
| 13961-8 | Mercury [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13961-8.json |
| 13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13962-6.json |
| 13963-4 | Orotate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/13963-4.json |
| 13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13964-2.json |
| 13965-9 | Homocysteine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13965-9.json |
| 13966-7 | Cystine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13966-7.json |
| 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13967-5.json |
| 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13969-1.json |
| 13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13970-9.json |
| 13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/13971-7.json |
| 1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting | ./2.16.840.1.114222.4.11.1002/1397-9.json |
| 1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst | ./2.16.840.1.114222.4.11.1002/1399-5.json |
| 13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/13996-4.json |
| 13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13997-2.json |
| 13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/13998-0.json |
| 13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/13999-8.json |
| 14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14000-4.json |
| 14001-2 | IgE [Units/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/14001-2.json |
| 14002-0 | IgM [Units/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/14002-0.json |
| 14003-8 | Carbon dioxide [Partial pressure] in Cord blood | ./2.16.840.1.114222.4.11.1002/14003-8.json |
| 14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14004-6.json |
| 14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14005-3.json |
| 14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14006-1.json |
| 14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14007-9.json |
| 14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/14008-7.json |
| 14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/14009-5.json |
| 14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/14010-3.json |
| 14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/14012-9.json |
| 14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/14013-7.json |
| 14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14014-5.json |
| 14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14016-0.json |
| 14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/14027-7.json |
| 14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/14030-1.json |
| 14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/14031-9.json |
| 14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/14032-7.json |
| 14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography | ./2.16.840.1.114222.4.11.1002/14033-5.json |
| 14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14034-3.json |
| 14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14035-0.json |
| 14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14036-8.json |
| 14037-6 | Fox IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14037-6.json |
| 14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14038-4.json |
| 14040-0 | Carbon dioxide, total [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/14040-0.json |
| 14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14041-8.json |
| 14042-6 | Corticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14042-6.json |
| 14043-4 | Cortisol Free [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/14043-4.json |
| 14044-2 | Cortisone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14044-2.json |
| 14045-9 | D-Lactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14045-9.json |
| 14046-7 | D-Lactate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14046-7.json |
| 14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14047-5.json |
| 14048-3 | Elastase.pancreatic [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14048-3.json |
| 14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14049-1.json |
| 14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14050-9.json |
| 14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14051-7.json |
| 14052-5 | Formate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14052-5.json |
| 14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14054-1.json |
| 14055-8 | Sodium [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/14055-8.json |
| 14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14056-6.json |
| 14057-4 | carBAMazepine free [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/14057-4.json |
| 14060-8 | Cyclobenzaprine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14060-8.json |
| 14061-6 | Cyclobenzaprine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14061-6.json |
| 14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14062-4.json |
| 14063-2 | Dezocine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14063-2.json |
| 14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14064-0.json |
| 14065-7 | Diflunisal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14065-7.json |
| 14066-5 | Dihydrocodeine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14066-5.json |
| 14067-3 | Dihydrocodeine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14067-3.json |
| 14068-1 | Triamterene+hydroCHLOROthiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14068-1.json |
| 14069-9 | Estazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14069-9.json |
| 14070-7 | fluPHENAZine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14070-7.json |
| 14071-5 | Ibuprofen [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14071-5.json |
| 14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14072-3.json |
| 14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/14073-1.json |
| 14074-9 | Spironolactone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14074-9.json |
| 14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14075-6.json |
| 14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/14076-4.json |
| 14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/14077-2.json |
| 14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/14078-0.json |
| 14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14079-8.json |
| 14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14080-6.json |
| 14081-4 | Coliform bacteria [Presence] in Water | ./2.16.840.1.114222.4.11.1002/14081-4.json |
| 14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/14082-2.json |
| 14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14083-0.json |
| 14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14084-8.json |
| 14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14085-5.json |
| 14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14086-3.json |
| 14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14087-1.json |
| 14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14089-7.json |
| 14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14090-5.json |
| 14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14092-1.json |
| 14093-9 | Bacteria identified in Water by Culture | ./2.16.840.1.114222.4.11.1002/14093-9.json |
| 14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14094-7.json |
| 14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14095-4.json |
| 14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14096-2.json |
| 14097-0 | Antimony [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14097-0.json |
| 14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14098-8.json |
| 14099-6 | Nickel [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14099-6.json |
| 14100-2 | Strontium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14100-2.json |
| 14101-0 | Strychnine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14101-0.json |
| 14102-8 | Strychnine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14102-8.json |
| 14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14104-4.json |
| 14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14115-0.json |
| 14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation | ./2.16.840.1.114222.4.11.1002/14116-8.json |
| 14118-4 | Lactate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14118-4.json |
| 14121-8 | Pyruvate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14121-8.json |
| 14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14122-6.json |
| 14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain | ./2.16.840.1.114222.4.11.1002/14125-9.json |
| 14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14127-5.json |
| 14128-3 | Rabies virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14128-3.json |
| 14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14129-1.json |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14130-9.json |
| 14131-7 | PM-1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14131-7.json |
| 14133-3 | Silver Maple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14133-3.json |
| 14135-8 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14135-8.json |
| 1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst | ./2.16.840.1.114222.4.11.1002/1414-2.json |
| 14142-4 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/14142-4.json |
| 14144-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/14144-0.json |
| 14146-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/14146-5.json |
| 14147-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/14147-3.json |
| 14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14148-1.json |
| 14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14149-9.json |
| 14151-5 | Bicarbonate [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/14151-5.json |
| 14152-3 | Bilirubin.direct [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/14152-3.json |
| 14153-1 | Carnitine esters/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14153-1.json |
| 14154-9 | Cholesterol sulfate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14154-9.json |
| 14158-0 | Cortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14158-0.json |
| 14159-8 | Cortisone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14159-8.json |
| 14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14162-2.json |
| 14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14163-0.json |
| 14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14164-8.json |
| 14165-5 | Lactate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/14165-5.json |
| 14166-3 | Methane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14166-3.json |
| 14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14167-1.json |
| 14168-9 | Palatinase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14168-9.json |
| 14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14169-7.json |
| 14170-5 | Pituitary glycoprotein hormone.alpha subunit [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14170-5.json |
| 14172-1 | Potassium [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14172-1.json |
| 14173-9 | Progesterone Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14173-9.json |
| 14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14174-7.json |
| 14176-2 | Pyrroles [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14176-2.json |
| 14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14177-0.json |
| 14178-8 | Sucrase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14178-8.json |
| 14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14179-6.json |
| 14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/14182-0.json |
| 14183-8 | Aprobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14183-8.json |
| 14184-6 | Atropine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14184-6.json |
| 14185-3 | methIMAzole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14185-3.json |
| 14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14186-1.json |
| 14187-9 | OKT3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14187-9.json |
| 14188-7 | Omeprazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14188-7.json |
| 14189-5 | Phenyltoloxamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14189-5.json |
| 14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/14190-3.json |
| 14191-1 | Prazosin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14191-1.json |
| 14192-9 | Triazolam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14192-9.json |
| 14193-7 | Tripelennamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14193-7.json |
| 14195-2 | Complement C3b Inactive [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14195-2.json |
| 14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/14197-8.json |
| 14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14198-6.json |
| 14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14199-4.json |
| 14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14200-0.json |
| 14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14201-8.json |
| 14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14202-6.json |
| 14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14203-4.json |
| 14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14204-2.json |
| 14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/14205-9.json |
| 14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/14206-7.json |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14207-5.json |
| 14208-3 | Filaria IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14208-3.json |
| 14209-1 | Francisella tularensis IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14209-1.json |
| 14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14210-9.json |
| 14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14211-7.json |
| 14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14212-5.json |
| 14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14213-3.json |
| 14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/14214-1.json |
| 14215-8 | HTLV I g46 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14215-8.json |
| 14224-0 | HTLV I rgp21 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14224-0.json |
| 14225-7 | HTLV II g46 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14225-7.json |
| 14226-5 | Nocardia sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14226-5.json |
| 14227-3 | Salmonella typhi H D Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14227-3.json |
| 14228-1 | Cells.estrogen receptor/100 cells in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/14228-1.json |
| 14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/14229-9.json |
| 14230-7 | Cells.progesterone receptor/100 cells in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/14230-7.json |
| 14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14231-5.json |
| 14232-3 | Adrenal Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14232-3.json |
| 14233-1 | Beta tubulin IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14233-1.json |
| 14234-9 | Beta tubulin IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14234-9.json |
| 14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14235-6.json |
| 14236-4 | Mitochondria Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14236-4.json |
| 14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14237-2.json |
| 14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14238-0.json |
| 14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14239-8.json |
| 14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14240-6.json |
| 14241-4 | Parietal cell Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14241-4.json |
| 14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14242-2.json |
| 14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14243-0.json |
| 14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14244-8.json |
| 14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14245-5.json |
| 14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14246-3.json |
| 14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14247-1.json |
| 14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14248-9.json |
| 14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14249-7.json |
| 14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14250-5.json |
| 14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14251-3.json |
| 14252-1 | Smooth muscle Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14252-1.json |
| 14253-9 | Somatotropin Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14253-9.json |
| 14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14255-4.json |
| 14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14256-2.json |
| 14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14257-0.json |
| 14258-8 | 1,4-Dioxane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14258-8.json |
| 14259-6 | 1-Pentanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14259-6.json |
| 14260-4 | Bromoform [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14260-4.json |
| 14261-2 | Codeine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14261-2.json |
| 14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14262-0.json |
| 14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/14263-8.json |
| 14264-6 | Enflurane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14264-6.json |
| 14265-3 | Isobutyl acetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14265-3.json |
| 14266-1 | Methoxyflurane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14266-1.json |
| 14267-9 | Methylenedioxymethamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14267-9.json |
| 14268-7 | Butyl acetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14268-7.json |
| 14269-5 | Sec-butyl acetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14269-5.json |
| 14270-3 | Tert-butyl acetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14270-3.json |
| 14272-9 | Liver kidney microsomal Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14272-9.json |
| 14273-7 | Reticulin IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14273-7.json |
| 14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay | ./2.16.840.1.114222.4.11.1002/14275-2.json |
| 14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14277-8.json |
| 14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14278-6.json |
| 14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14282-8.json |
| 14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14284-4.json |
| 14285-1 | Carnitine free (C0) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14285-1.json |
| 14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14286-9.json |
| 14287-7 | Carnitine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14287-7.json |
| 14288-5 | Carnitine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14288-5.json |
| 14292-7 | IgE [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14292-7.json |
| 14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine | ./2.16.840.1.114222.4.11.1002/14294-3.json |
| 14295-0 | Organic acids/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14295-0.json |
| 14296-8 | Thyroperoxidase Ab [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14296-8.json |
| 14297-6 | Thyrotropin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14297-6.json |
| 14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/14304-0.json |
| 14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/14305-7.json |
| 14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/14306-5.json |
| 14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/14307-3.json |
| 14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL | ./2.16.840.1.114222.4.11.1002/14308-1.json |
| 14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL | ./2.16.840.1.114222.4.11.1002/14309-9.json |
| 14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL | ./2.16.840.1.114222.4.11.1002/14310-7.json |
| 14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL | ./2.16.840.1.114222.4.11.1002/14311-5.json |
| 14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL | ./2.16.840.1.114222.4.11.1002/14312-3.json |
| 14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/14313-1.json |
| 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/14314-9.json |
| 14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/14315-6.json |
| 14316-4 | Benzodiazepines [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/14316-4.json |
| 14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/14317-2.json |
| 14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation | ./2.16.840.1.114222.4.11.1002/14318-0.json |
| 14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/14319-8.json |
| 14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/14321-4.json |
| 14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/14322-2.json |
| 14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/14323-0.json |
| 14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/14324-8.json |
| 14325-5 | Bacteria identified in Specimen by Environmental culture | ./2.16.840.1.114222.4.11.1002/14325-5.json |
| 14333-9 | Lead [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14333-9.json |
| 14334-7 | Lithium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14334-7.json |
| 14335-4 | Optical density of Amniotic fluid by Spectrophotometry | ./2.16.840.1.114222.4.11.1002/14335-4.json |
| 14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography | ./2.16.840.1.114222.4.11.1002/14336-2.json |
| 14338-8 | Prealbumin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14338-8.json |
| 14345-3 | Specific gravity of Amniotic fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14345-3.json |
| 14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14346-1.json |
| 14347-9 | Specific gravity of Gastric fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14347-9.json |
| 14348-7 | Specific gravity of Peritoneal fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14348-7.json |
| 14349-5 | Specific gravity of Pleural fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14349-5.json |
| 14350-3 | Specific gravity of Synovial fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/14350-3.json |
| 14351-1 | Specific gravity of Stool by Refractometry | ./2.16.840.1.114222.4.11.1002/14351-1.json |
| 14352-9 | Specific gravity of Water by Refractometry | ./2.16.840.1.114222.4.11.1002/14352-9.json |
| 14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/14353-7.json |
| 14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/14354-5.json |
| 14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation | ./2.16.840.1.114222.4.11.1002/14355-2.json |
| 14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation | ./2.16.840.1.114222.4.11.1002/14356-0.json |
| 14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/14357-8.json |
| 14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain | ./2.16.840.1.114222.4.11.1002/14358-6.json |
| 14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/14359-4.json |
| 14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/14360-2.json |
| 14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/14361-0.json |
| 14362-8 | Microscopic observation [Identifier] in Throat by Gram stain | ./2.16.840.1.114222.4.11.1002/14362-8.json |
| 14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/14363-6.json |
| 14364-4 | Microscopic observation [Identifier] in Eye by Gram stain | ./2.16.840.1.114222.4.11.1002/14364-4.json |
| 14365-1 | Microscopic observation [Identifier] in Ear by Gram stain | ./2.16.840.1.114222.4.11.1002/14365-1.json |
| 14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation | ./2.16.840.1.114222.4.11.1002/14366-9.json |
| 14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/14367-7.json |
| 14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation | ./2.16.840.1.114222.4.11.1002/14368-5.json |
| 14369-3 | Yeast [Presence] in Cervix by Wet preparation | ./2.16.840.1.114222.4.11.1002/14369-3.json |
| 14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/14370-1.json |
| 14371-9 | Yeast [Presence] in Urethra by Wet preparation | ./2.16.840.1.114222.4.11.1002/14371-9.json |
| 14386-7 | Glucose [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14386-7.json |
| 14387-5 | Protein [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14387-5.json |
| 14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14388-3.json |
| 14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14389-1.json |
| 14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/14390-9.json |
| 14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14391-7.json |
| 14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14392-5.json |
| 14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14393-3.json |
| 14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14394-1.json |
| 14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14396-6.json |
| 14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14397-4.json |
| 14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14398-2.json |
| 14399-0 | Creatinine [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14399-0.json |
| 14401-4 | Creatinine [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14401-4.json |
| 14402-2 | Creatinine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14402-2.json |
| 14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14403-0.json |
| 14404-8 | Phosphate [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14404-8.json |
| 14405-5 | Phosphate [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14405-5.json |
| 14406-3 | Phosphate [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14406-3.json |
| 1440-7 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight | ./2.16.840.1.114222.4.11.1002/1440-7.json |
| 14407-1 | Phosphate [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14407-1.json |
| 14408-9 | Phosphate [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14408-9.json |
| 14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14409-7.json |
| 14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14410-5.json |
| 14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14411-3.json |
| 14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14412-1.json |
| 14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14413-9.json |
| 14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/14414-7.json |
| 14415-4 | Calcium [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14415-4.json |
| 14416-2 | Calcium [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14416-2.json |
| 14417-0 | Calcium [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14417-0.json |
| 14418-8 | Calcium [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14418-8.json |
| 14419-6 | Calcium [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14419-6.json |
| 14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/14420-4.json |
| 14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14421-2.json |
| 14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14422-0.json |
| 14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14423-8.json |
| 14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14424-6.json |
| 14425-3 | Globulin [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14425-3.json |
| 14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14426-1.json |
| 14427-9 | Globulin [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14427-9.json |
| 14428-7 | Globulin [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14428-7.json |
| 14429-5 | Globulin [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/14429-5.json |
| 14430-3 | Globulin [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14430-3.json |
| 14431-1 | Globulin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14431-1.json |
| 14438-6 | Cholesterol [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14438-6.json |
| 14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14439-4.json |
| 14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14441-0.json |
| 14442-8 | Cholesterol [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/14442-8.json |
| 14443-6 | Cholesterol [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14443-6.json |
| 14444-4 | Cholesterol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14444-4.json |
| 14445-1 | Triglyceride [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14445-1.json |
| 14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14446-9.json |
| 14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14447-7.json |
| 14448-5 | Triglyceride [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/14448-5.json |
| 1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast | ./2.16.840.1.114222.4.11.1002/1444-9.json |
| 14449-3 | Triglyceride [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14449-3.json |
| 14450-1 | Triglyceride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14450-1.json |
| 14451-9 | Virus identified in Eye by Culture | ./2.16.840.1.114222.4.11.1002/14451-9.json |
| 14452-7 | Virus identified in Cervix by Culture | ./2.16.840.1.114222.4.11.1002/14452-7.json |
| 14453-5 | Virus identified in Vaginal fluid by Culture | ./2.16.840.1.114222.4.11.1002/14453-5.json |
| 14454-3 | Virus identified in Nose by Culture | ./2.16.840.1.114222.4.11.1002/14454-3.json |
| 14455-0 | Virus identified in Pleural fluid by Culture | ./2.16.840.1.114222.4.11.1002/14455-0.json |
| 14456-8 | Virus identified in Peritoneal fluid by Culture | ./2.16.840.1.114222.4.11.1002/14456-8.json |
| 14457-6 | Virus identified in Urine by Culture | ./2.16.840.1.114222.4.11.1002/14457-6.json |
| 14458-4 | Virus identified in Sputum by Culture | ./2.16.840.1.114222.4.11.1002/14458-4.json |
| 14459-2 | Virus identified in Penis by Culture | ./2.16.840.1.114222.4.11.1002/14459-2.json |
| 14460-0 | Virus identified in Urethra by Culture | ./2.16.840.1.114222.4.11.1002/14460-0.json |
| 14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14461-8.json |
| 14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14462-6.json |
| 14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14463-4.json |
| 14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14464-2.json |
| 14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14465-9.json |
| 14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14467-5.json |
| 14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/14468-3.json |
| 14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/14469-1.json |
| 14470-9 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay | ./2.16.840.1.114222.4.11.1002/14470-9.json |
| 14471-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/14471-7.json |
| 14472-5 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay | ./2.16.840.1.114222.4.11.1002/14472-5.json |
| 14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay | ./2.16.840.1.114222.4.11.1002/14474-1.json |
| 14475-8 | Bacteria identified in Cervix by Aerobe culture | ./2.16.840.1.114222.4.11.1002/14475-8.json |
| 14477-4 | Bacteria identified in Urethra by Aerobe culture | ./2.16.840.1.114222.4.11.1002/14477-4.json |
| 14478-2 | Bacteria identified in Penis by Aerobe culture | ./2.16.840.1.114222.4.11.1002/14478-2.json |
| 14479-0 | Diphtheria identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14479-0.json |
| 14480-8 | Diphtheria identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14480-8.json |
| 14481-6 | Diphtheria identified in Nose by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14481-6.json |
| 14482-4 | Diphtheria identified in Skin by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14482-4.json |
| 14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14483-2.json |
| 14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14484-0.json |
| 14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14485-7.json |
| 14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14486-5.json |
| 14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14487-3.json |
| 14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14488-1.json |
| 14489-9 | Virus identified in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14489-9.json |
| 14490-7 | Virus identified in Semen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14490-7.json |
| 14491-5 | Virus identified in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14491-5.json |
| 14492-3 | Virus identified in Eye by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14492-3.json |
| 14493-1 | Virus identified in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14493-1.json |
| 14494-9 | Virus identified in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14494-9.json |
| 14495-6 | Virus identified in Urine sediment by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14495-6.json |
| 14496-4 | Virus identified in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14496-4.json |
| 14497-2 | Virus identified in Penis by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14497-2.json |
| 14498-0 | Virus identified in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14498-0.json |
| 14499-8 | Human papilloma virus Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/14499-8.json |
| 14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/14500-3.json |
| 14501-1 | Human papilloma virus Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/14501-1.json |
| 14502-9 | Human papilloma virus Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/14502-9.json |
| 14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/14503-7.json |
| 14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/14504-5.json |
| 14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/14505-2.json |
| 14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/14506-0.json |
| 14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14507-8.json |
| 14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14508-6.json |
| 14509-4 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14509-4.json |
| 14510-2 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14510-2.json |
| 14511-0 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14511-0.json |
| 14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14513-6.json |
| 14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14514-4.json |
| 14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14515-1.json |
| 14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14516-9.json |
| 14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14517-7.json |
| 14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14518-5.json |
| 14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14519-3.json |
| 14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14520-1.json |
| 14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14521-9.json |
| 14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14522-7.json |
| 14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14523-5.json |
| 14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14524-3.json |
| 14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14525-0.json |
| 14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14526-8.json |
| 14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14527-6.json |
| 14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14528-4.json |
| 14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14529-2.json |
| 14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14530-0.json |
| 14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14531-8.json |
| 14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14532-6.json |
| 14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14533-4.json |
| 14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14534-2.json |
| 14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14535-9.json |
| 14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14536-7.json |
| 14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14537-5.json |
| 14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14538-3.json |
| 14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14539-1.json |
| 14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14540-9.json |
| 14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14541-7.json |
| 14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14542-5.json |
| 14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14543-3.json |
| 14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14544-1.json |
| 14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14545-8.json |
| 14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14546-6.json |
| 14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14547-4.json |
| 14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14548-2.json |
| 14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14549-0.json |
| 14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14550-8.json |
| 14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14551-6.json |
| 14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14552-4.json |
| 14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14553-2.json |
| 14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14554-0.json |
| 14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/14555-7.json |
| 14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14556-5.json |
| 14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14557-3.json |
| 14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14558-1.json |
| 14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14559-9.json |
| 14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14560-7.json |
| 14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14561-5.json |
| 14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14562-3.json |
| 14563-1 | Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen | ./2.16.840.1.114222.4.11.1002/14563-1.json |
| 14566-4 | Calcitriol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14566-4.json |
| 14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14567-2.json |
| 14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14568-0.json |
| 14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14569-8.json |
| 14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14570-6.json |
| 14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14571-4.json |
| 14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14572-2.json |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14573-0.json |
| 14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14574-8.json |
| 14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC | ./2.16.840.1.114222.4.11.1002/14575-5.json |
| 14580-5 | ABO group [Type] in Blood from Newborn | ./2.16.840.1.114222.4.11.1002/14580-5.json |
| 14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14581-3.json |
| 14582-1 | Acetone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14582-1.json |
| 14583-9 | Acidity.titratable [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14583-9.json |
| 14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14584-7.json |
| 14585-4 | Albumin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14585-4.json |
| 14586-2 | Aldosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14586-2.json |
| 14587-0 | Aldosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14587-0.json |
| 14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14590-4.json |
| 14591-2 | ALPRAZolam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14591-2.json |
| 14592-0 | Aluminum [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14592-0.json |
| 14593-8 | Aluminum [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14593-8.json |
| 14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14594-6.json |
| 14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14595-3.json |
| 14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14596-1.json |
| 14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14597-9.json |
| 14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14598-7.json |
| 14599-5 | Ammonium [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/14599-5.json |
| 14600-1 | Amoxapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14600-1.json |
| 14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14601-9.json |
| 14603-5 | Androstenedione [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14603-5.json |
| 14607-6 | Nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/14607-6.json |
| 14608-4 | Nuclear Ab [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14608-4.json |
| 14609-2 | Nuclear Ab [Presence] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14609-2.json |
| 14610-0 | Nuclear Ab [Presence] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14610-0.json |
| 14611-8 | Nuclear Ab pattern [Interpretation] in Serum | ./2.16.840.1.114222.4.11.1002/14611-8.json |
| 14612-6 | Nuclear Ab [Titer] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/14612-6.json |
| 14613-4 | Nuclear Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/14613-4.json |
| 14614-2 | Nuclear Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14614-2.json |
| 14615-9 | Nuclear Ab [Titer] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14615-9.json |
| 14616-7 | Nuclear Ab [Titer] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14616-7.json |
| 14622-5 | Ascorbate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14622-5.json |
| 14623-3 | Barbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14623-3.json |
| 14624-1 | Barbiturates [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14624-1.json |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14626-6.json |
| 14627-4 | Bicarbonate [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/14627-4.json |
| 14628-2 | Bile acid [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14628-2.json |
| 14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14629-0.json |
| 14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14630-8.json |
| 14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14631-6.json |
| 14633-2 | C peptide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14633-2.json |
| 14634-0 | C reactive protein [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14634-0.json |
| 14635-7 | 25-hydroxyvitamin D3 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14635-7.json |
| 14636-5 | Calcium [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/14636-5.json |
| 14637-3 | Calcium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14637-3.json |
| 14639-9 | carBAMazepine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14639-9.json |
| 14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/14640-7.json |
| 14641-5 | Carbonate [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/14641-5.json |
| 14642-3 | Carotene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14642-3.json |
| 14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14643-1.json |
| 14644-9 | chlorproMAZINE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14644-9.json |
| 14645-6 | chlorproMAZINE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14645-6.json |
| 14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14646-4.json |
| 14647-2 | Cholesterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14647-2.json |
| 14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14648-0.json |
| 14649-8 | Cimetidine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14649-8.json |
| 14650-6 | Citrate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14650-6.json |
| 14651-4 | cloBAZam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14651-4.json |
| 14652-2 | clomiPRAMINE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14652-2.json |
| 14653-0 | clomiPRAMINE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14653-0.json |
| 1465-4 | EPINEPHrine [Mass/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/1465-4.json |
| 14655-5 | clonazePAM [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14655-5.json |
| 14656-3 | cloZAPine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14656-3.json |
| 14657-1 | cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14657-1.json |
| 14658-9 | Cold agglutinin [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14658-9.json |
| 14665-4 | Copper [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14665-4.json |
| 14666-2 | Copper [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14666-2.json |
| 14674-6 | Corticotropin [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14674-6.json |
| 14675-3 | Cortisol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14675-3.json |
| 14676-1 | Cortisol Free [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14676-1.json |
| 14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen | ./2.16.840.1.114222.4.11.1002/14678-7.json |
| 14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen | ./2.16.840.1.114222.4.11.1002/14679-5.json |
| 14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/14681-1.json |
| 14682-9 | Creatinine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14682-9.json |
| 14683-7 | Creatinine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14683-7.json |
| 14684-5 | Creatinine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14684-5.json |
| 14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14685-2.json |
| 14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14688-6.json |
| 14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14689-4.json |
| 14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14690-2.json |
| 14691-0 | Desipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14691-0.json |
| 14692-8 | Desipramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14692-8.json |
| 14693-6 | Norclobazam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14693-6.json |
| 14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14694-4.json |
| 14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14695-1.json |
| 14697-7 | diazePAM [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14697-7.json |
| 14698-5 | Digoxin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14698-5.json |
| 14699-3 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14699-3.json |
| 14700-9 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14700-9.json |
| 14701-7 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14701-7.json |
| 14702-5 | Disopyramide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14702-5.json |
| 14703-3 | DOPamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14703-3.json |
| 14704-1 | Doxepin [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14704-1.json |
| 14705-8 | Doxepin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14705-8.json |
| 14706-6 | Doxepin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14706-6.json |
| 14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14707-4.json |
| 14708-2 | Endomysium Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/14708-2.json |
| 14710-8 | ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14710-8.json |
| 14711-6 | EPINEPHrine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14711-6.json |
| 14712-4 | EPINEPHrine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14712-4.json |
| 14714-0 | Erythropoietin (EPO) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14714-0.json |
| 14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14715-7.json |
| 14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14716-5.json |
| 14717-3 | Estriol (E3) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14717-3.json |
| 14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14718-1.json |
| 14719-9 | Ethanol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14719-9.json |
| 14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14720-7.json |
| 14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14721-5.json |
| 14722-3 | Extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14722-3.json |
| 14723-1 | Ferritin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14723-1.json |
| 14726-4 | Fluoride [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14726-4.json |
| 14727-2 | FLUoxetine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14727-2.json |
| 14728-0 | FLUoxetine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14728-0.json |
| 14729-8 | Flurazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14729-8.json |
| 14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14730-6.json |
| 14731-4 | Folate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/14731-4.json |
| 14732-2 | Folate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14732-2.json |
| 14734-8 | Follitropin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14734-8.json |
| 14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer | ./2.16.840.1.114222.4.11.1002/14743-9.json |
| 14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/14744-7.json |
| 14745-4 | Glucose [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/14745-4.json |
| 14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/14746-2.json |
| 14747-0 | Glucose [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/14747-0.json |
| 14748-8 | Glucose [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/14748-8.json |
| 14749-6 | Glucose [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14749-6.json |
| 14750-4 | Glucose [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/14750-4.json |
| 14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/14753-8.json |
| 14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO | ./2.16.840.1.114222.4.11.1002/14754-6.json |
| 14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/14755-3.json |
| 14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/14756-1.json |
| 14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/14757-9.json |
| 14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/14758-7.json |
| 14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/14759-5.json |
| 14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal | ./2.16.840.1.114222.4.11.1002/14760-3.json |
| 14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal | ./2.16.840.1.114222.4.11.1002/14761-1.json |
| 14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast | ./2.16.840.1.114222.4.11.1002/14769-4.json |
| 14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer | ./2.16.840.1.114222.4.11.1002/14770-2.json |
| 14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14771-0.json |
| 14772-8 | Gold [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14772-8.json |
| 14774-4 | Haloperidol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14774-4.json |
| 14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry | ./2.16.840.1.114222.4.11.1002/14775-1.json |
| 14776-9 | Heptacarboxylate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14776-9.json |
| 14777-7 | Heptacarboxylate [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/14777-7.json |
| 14778-5 | Heptacarboxylate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14778-5.json |
| 14779-3 | Hexacarboxylate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14779-3.json |
| 14780-1 | Hexacarboxylate [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/14780-1.json |
| 14781-9 | Hexacarboxylate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14781-9.json |
| 14782-7 | Homovanillate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14782-7.json |
| 14783-5 | Homovanillate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14783-5.json |
| 14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14784-3.json |
| 14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14785-0.json |
| 14787-6 | Arthropod identified in Specimen by Permanent mount | ./2.16.840.1.114222.4.11.1002/14787-6.json |
| 14788-4 | Helminth+Arthropod identified in Specimen by Rearing/Culture | ./2.16.840.1.114222.4.11.1002/14788-4.json |
| 14789-2 | Helminth identified in Specimen by Macro/micro identification | ./2.16.840.1.114222.4.11.1002/14789-2.json |
| 14790-0 | Helminth identified in Specimen by Permanent mount | ./2.16.840.1.114222.4.11.1002/14790-0.json |
| 14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14791-8.json |
| 14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14792-6.json |
| 14793-4 | Imipramine+Desipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14793-4.json |
| 14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14794-2.json |
| 14796-7 | Insulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14796-7.json |
| 14798-3 | Iron [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14798-3.json |
| 14799-1 | Iron [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14799-1.json |
| 14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14800-7.json |
| 14801-5 | Iron saturation [Molar fraction] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14801-5.json |
| 14802-3 | Isopropanol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14802-3.json |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/14803-1.json |
| 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/14804-9.json |
| 14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/14805-6.json |
| 14807-2 | Lead [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/14807-2.json |
| 14808-0 | Lead [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14808-0.json |
| 14809-8 | Lead [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14809-8.json |
| 14812-2 | Lidocaine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14812-2.json |
| 14817-1 | LORazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14817-1.json |
| 14825-4 | Maprotiline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14825-4.json |
| 14826-2 | Meperidine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14826-2.json |
| 14832-0 | Metanephrines [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14832-0.json |
| 14833-8 | Metanephrines [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14833-8.json |
| 14834-6 | Methamphetamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14834-6.json |
| 14835-3 | Methanol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14835-3.json |
| 14836-1 | Methotrexate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14836-1.json |
| 14837-9 | Methsuximide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14837-9.json |
| 14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/14838-7.json |
| 14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy | ./2.16.840.1.114222.4.11.1002/14839-5.json |
| 14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/14840-3.json |
| 14841-1 | Microscopic observation [Identifier] in Specimen by Iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/14841-1.json |
| 14842-9 | Microscopic observation [Identifier] in Specimen by Kinyoun iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/14842-9.json |
| 14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14843-7.json |
| 14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14844-5.json |
| 14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14846-0.json |
| 14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14849-4.json |
| 14850-2 | Nitrazepam [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14850-2.json |
| 14851-0 | Norclozapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14851-0.json |
| 14852-8 | Norepinephrine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14852-8.json |
| 14853-6 | Norepinephrine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14853-6.json |
| 14854-4 | Norepinephrine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14854-4.json |
| 14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14855-1.json |
| 14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14856-9.json |
| 14862-7 | Oxalate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14862-7.json |
| 14863-5 | oxyCODONE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14863-5.json |
| 14864-3 | Oxygen [Partial pressure] in Cord blood | ./2.16.840.1.114222.4.11.1002/14864-3.json |
| 14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14866-8.json |
| 14867-6 | PARoxetine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14867-6.json |
| 14869-2 | Pathologist review of Blood tests | ./2.16.840.1.114222.4.11.1002/14869-2.json |
| 14870-0 | Pentacarboxylate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14870-0.json |
| 14871-8 | Pentacarboxylate [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/14871-8.json |
| 14872-6 | Pentacarboxylate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14872-6.json |
| 14873-4 | pH of Cord blood | ./2.16.840.1.114222.4.11.1002/14873-4.json |
| 14874-2 | PHENobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14874-2.json |
| 14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14875-9.json |
| 14876-7 | Phenylpropanolamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14876-7.json |
| 14877-5 | Phenytoin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14877-5.json |
| 14878-3 | Phosphate [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/14878-3.json |
| 14879-1 | Phosphate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14879-1.json |
| 14881-7 | Phosphate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14881-7.json |
| 14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14882-5.json |
| 14885-8 | Pregnanediol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14885-8.json |
| 14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14886-6.json |
| 14887-4 | Primidone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14887-4.json |
| 14888-2 | Procainamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14888-2.json |
| 14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14889-0.json |
| 14890-8 | Progesterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14890-8.json |
| 14891-6 | Propranolol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14891-6.json |
| 14892-4 | Propranolol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14892-4.json |
| 14893-2 | Propranolol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14893-2.json |
| 14894-0 | Propylene glycol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14894-0.json |
| 14898-1 | Protriptyline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14898-1.json |
| 14899-9 | quiNIDine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14899-9.json |
| 14900-5 | raNITIdine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/14900-5.json |
| 14901-3 | raNITIdine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14901-3.json |
| 14902-1 | raNITIdine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/14902-1.json |
| 14904-7 | Reagin Ab [Presence] in Specimen by VDRL | ./2.16.840.1.114222.4.11.1002/14904-7.json |
| 14905-4 | Retinol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14905-4.json |
| 14906-2 | Rh [Type] in Cord blood | ./2.16.840.1.114222.4.11.1002/14906-2.json |
| 14908-8 | Rh [Type] in Blood from Newborn | ./2.16.840.1.114222.4.11.1002/14908-8.json |
| 14909-6 | Salicylates [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14909-6.json |
| 14910-4 | Serotonin [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14910-4.json |
| 14911-2 | Sertraline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14911-2.json |
| 14913-8 | Testosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14913-8.json |
| 14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14914-6.json |
| 14915-3 | Theophylline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14915-3.json |
| 14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14916-1.json |
| 14917-9 | Thioridazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14917-9.json |
| 14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14918-7.json |
| 14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/14919-5.json |
| 14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14920-3.json |
| 14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14921-1.json |
| 14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/14922-9.json |
| 14923-7 | Toxoplasma gondii Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/14923-7.json |
| 14924-5 | Transfusion reaction [Interpretation] in Plasma or RBC Narrative | ./2.16.840.1.114222.4.11.1002/14924-5.json |
| 14925-2 | traZODone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14925-2.json |
| 14926-0 | Triazolam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14926-0.json |
| 14927-8 | Triglyceride [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14927-8.json |
| 14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14928-6.json |
| 14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14929-4.json |
| 14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14930-2.json |
| 14931-0 | Trimipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14931-0.json |
| 14932-8 | Urate [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/14932-8.json |
| 14933-6 | Urate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14933-6.json |
| 14934-4 | Urate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14934-4.json |
| 14935-1 | Urate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14935-1.json |
| 1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting | ./2.16.840.1.114222.4.11.1002/1493-6.json |
| 14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/14936-9.json |
| 14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14937-7.json |
| 14938-5 | Urea nitrogen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14938-5.json |
| 14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14939-3.json |
| 14946-8 | Valproate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14946-8.json |
| 14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14947-6.json |
| 14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14948-4.json |
| 14949-2 | Vasopressin [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/14949-2.json |
| 14950-0 | Viscosity of Synovial fluid Qualitative | ./2.16.840.1.114222.4.11.1002/14950-0.json |
| 14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/14951-8.json |
| 14955-9 | Zinc [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14955-9.json |
| 14956-7 | Microalbumin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14956-7.json |
| 14957-5 | Microalbumin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/14957-5.json |
| 14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/14958-3.json |
| 14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/14959-1.json |
| 14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood | ./2.16.840.1.114222.4.11.1002/14964-1.json |
| 14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/14970-8.json |
| 14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14972-4.json |
| 14973-2 | Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14973-2.json |
| 14974-0 | Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/14974-0.json |
| 14975-7 | Human antimouse Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/14975-7.json |
| 14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/14976-5.json |
| 14977-3 | Immunoglobulin light chains.free [Type] in Urine | ./2.16.840.1.114222.4.11.1002/14977-3.json |
| 14978-1 | cycloSPORINE [Mass/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/14978-1.json |
| 14979-9 | aPTT in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/14979-9.json |
| 1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV | ./2.16.840.1.114222.4.11.1002/1499-3.json |
| 14994-8 | O group [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/14994-8.json |
| 14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/14995-5.json |
| 15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15003-7.json |
| 15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15004-5.json |
| 15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15005-2.json |
| 15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15006-0.json |
| 15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/15007-8.json |
| 1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst | ./2.16.840.1.114222.4.11.1002/1500-8.json |
| 15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15008-6.json |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15009-4.json |
| 15010-2 | Aldosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15010-2.json |
| 15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine | ./2.16.840.1.114222.4.11.1002/15011-0.json |
| 15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright | ./2.16.840.1.114222.4.11.1002/15012-8.json |
| 1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/1501-6.json |
| 15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/15019-3.json |
| 15026-8 | Androstanediol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15026-8.json |
| 15027-6 | Androstenedione [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15027-6.json |
| 15028-4 | Androstenedione [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15028-4.json |
| 15029-2 | Androsterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15029-2.json |
| 15030-0 | Androsterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15030-0.json |
| 15031-8 | Angiotensin I [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/15031-8.json |
| 1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/1503-2.json |
| 15032-6 | Angiotensin II [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/15032-6.json |
| 15033-4 | Ascorbate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15033-4.json |
| 15034-2 | Bromide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15034-2.json |
| 15035-9 | Calcitonin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15035-9.json |
| 15036-7 | Catecholamines [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15036-7.json |
| 15037-5 | Chymotrypsin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/15037-5.json |
| 15038-3 | Citrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15038-3.json |
| 1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO | ./2.16.840.1.114222.4.11.1002/1504-0.json |
| 15042-5 | Corticotropin [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15042-5.json |
| 15043-3 | Cortisol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15043-3.json |
| 15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15044-1.json |
| 15045-8 | Creatine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15045-8.json |
| 15046-6 | Creatine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15046-6.json |
| 15047-4 | Creatine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15047-4.json |
| 15050-8 | Creatinine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/15050-8.json |
| 15051-6 | Creatinine [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/15051-6.json |
| 15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15052-4.json |
| 15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15053-2.json |
| 15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15054-0.json |
| 15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15055-7.json |
| 1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO | ./2.16.840.1.114222.4.11.1002/1505-7.json |
| 15057-3 | Androstanolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15057-3.json |
| 15058-1 | DOPamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15058-1.json |
| 15059-9 | DOPamine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15059-9.json |
| 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15060-7.json |
| 15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15061-5.json |
| 15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15062-3.json |
| 15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15063-1.json |
| 15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15064-9.json |
| 1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/1506-5.json |
| 15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15065-6.json |
| 15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15066-4.json |
| 15067-2 | Follitropin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15067-2.json |
| 15068-0 | Follitropin [Units] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15068-0.json |
| 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15069-8.json |
| 15070-6 | Fructose [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15070-6.json |
| 15071-4 | Galactose [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15071-4.json |
| 15072-2 | Gastrin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15072-2.json |
| 1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/1507-3.json |
| 15073-0 | Glucagon [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15073-0.json |
| 15074-8 | Glucose [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15074-8.json |
| 15075-5 | Glucose [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/15075-5.json |
| 15076-3 | Glucose [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15076-3.json |
| 15077-1 | Glucose [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15077-1.json |
| 15078-9 | Lactate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15078-9.json |
| 15079-7 | Lutropin [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15079-7.json |
| 15080-5 | Lutropin [Units] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15080-5.json |
| 15081-3 | Prolactin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15081-3.json |
| 15082-1 | Methemoglobin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15082-1.json |
| 15083-9 | Normetanephrine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15083-9.json |
| 15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15084-7.json |
| 15085-4 | Oxalate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15085-4.json |
| 15086-2 | Oxalate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15086-2.json |
| 15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15087-0.json |
| 15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15088-8.json |
| 15089-6 | Phospholipid [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15089-6.json |
| 15091-2 | Pregnanediol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15091-2.json |
| 15092-0 | Pregnanetriol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15092-0.json |
| 15094-6 | Testosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15094-6.json |
| 15095-3 | Testosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15095-3.json |
| 15097-9 | Vanillylmandelate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15097-9.json |
| 15098-7 | Amikacin [Moles/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/15098-7.json |
| 1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/1509-9.json |
| 15099-5 | Amiodarone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15099-5.json |
| 15100-1 | Barbiturates [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15100-1.json |
| 15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15101-9.json |
| 15102-7 | Codeine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15102-7.json |
| 15103-5 | cycloSPORINE [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15103-5.json |
| 15104-3 | Digitoxin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15104-3.json |
| 15105-0 | Flecainide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15105-0.json |
| 15106-8 | Gentamicin [Moles/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/15106-8.json |
| 1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | ./2.16.840.1.114222.4.11.1002/1510-7.json |
| 15107-6 | Imipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15107-6.json |
| 15108-4 | Methadone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15108-4.json |
| 15109-2 | Midazolam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15109-2.json |
| 15110-0 | Morphine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15110-0.json |
| 15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15111-8.json |
| 15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/15112-6.json |
| 15113-4 | Aluminum [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/15113-4.json |
| 15114-2 | Arsenic [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15114-2.json |
| 15115-9 | Arsenic [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15115-9.json |
| 15117-5 | Cadmium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15117-5.json |
| 15118-3 | Chromium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15118-3.json |
| 15119-1 | Cobalt [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15119-1.json |
| 15120-9 | Ethanol [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15120-9.json |
| 15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15130-8.json |
| 15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15131-6.json |
| 15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15133-2.json |
| 15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15134-0.json |
| 15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15135-7.json |
| 15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15136-5.json |
| 15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15137-3.json |
| 15138-1 | Isoleucine+Leucine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15138-1.json |
| 15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15139-9.json |
| 15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15140-7.json |
| 15142-3 | Alanine+Ethanolamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15142-3.json |
| 15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15143-1.json |
| 15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15144-9.json |
| 15145-6 | Methionine+Tryptophan [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15145-6.json |
| 15146-4 | Acetone [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15146-4.json |
| 15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15148-0.json |
| 1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/1514-9.json |
| 15149-8 | Ammonia [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15149-8.json |
| 15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15151-4.json |
| 15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15152-2.json |
| 15155-5 | Calcium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15155-5.json |
| 15158-9 | Chloride [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/15158-9.json |
| 15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15161-3.json |
| 15162-1 | Complement C1q [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15162-1.json |
| 15163-9 | Complement C2 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15163-9.json |
| 1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/1516-4.json |
| 15164-7 | Complement C3 [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/15164-7.json |
| 15165-4 | Complement C4 [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/15165-4.json |
| 15166-2 | Complement C5 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15166-2.json |
| 15167-0 | Complement C6 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15167-0.json |
| 15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/15168-8.json |
| 15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/15169-6.json |
| 15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/15170-4.json |
| 15171-2 | Cryoglobulin.IgA [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15171-2.json |
| 1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/1517-2.json |
| 15172-0 | Cryoglobulin.IgG [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15172-0.json |
| 15173-8 | Cryoglobulin.IgM [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15173-8.json |
| 15174-6 | Cryocrit of Serum by Spun Westergren | ./2.16.840.1.114222.4.11.1002/15174-6.json |
| 15176-1 | Cryoproteins identified in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15176-1.json |
| 15177-9 | DNA double strand Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15177-9.json |
| 15178-7 | Complement factor B [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15178-7.json |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/15179-5.json |
| 1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/1518-0.json |
| 15181-1 | IgA [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15181-1.json |
| 15183-7 | IgG [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15183-7.json |
| 15185-2 | IgM [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15185-2.json |
| 15187-8 | Lambda light chains [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15187-8.json |
| 15188-6 | Kappa light chains [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15188-6.json |
| 15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/15191-0.json |
| 15200-9 | Osmolality of Body fluid | ./2.16.840.1.114222.4.11.1002/15200-9.json |
| 15202-5 | Potassium [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/15202-5.json |
| 15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephelometry | ./2.16.840.1.114222.4.11.1002/15203-3.json |
| 15204-1 | Rheumatoid factor [Titer] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/15204-1.json |
| 15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/15205-8.json |
| 1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/1520-6.json |
| 15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry | ./2.16.840.1.114222.4.11.1002/15206-6.json |
| 15207-4 | Sodium [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/15207-4.json |
| 15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15209-0.json |
| 15210-8 | Thyroglobulin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15210-8.json |
| 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/15212-4.json |
| 15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15213-2.json |
| 1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal | ./2.16.840.1.114222.4.11.1002/1521-4.json |
| 15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15214-0.json |
| 15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15215-7.json |
| 15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15216-5.json |
| 15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15217-3.json |
| 15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15218-1.json |
| 15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15219-9.json |
| 15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15220-7.json |
| 15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15221-5.json |
| 15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15222-3.json |
| 15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15223-1.json |
| 15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15224-9.json |
| 15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15225-6.json |
| 15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15226-4.json |
| 15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15227-2.json |
| 15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15228-0.json |
| 15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15229-8.json |
| 1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst | ./2.16.840.1.114222.4.11.1002/1523-0.json |
| 15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15230-6.json |
| 15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15231-4.json |
| 15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japanese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15232-2.json |
| 15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15233-0.json |
| 15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15234-8.json |
| 15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15235-5.json |
| 15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15236-3.json |
| 15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15237-1.json |
| 15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15238-9.json |
| 15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15239-7.json |
| 15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15240-5.json |
| 15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15241-3.json |
| 15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15242-1.json |
| 15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15243-9.json |
| 15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15244-7.json |
| 15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15245-4.json |
| 15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15246-2.json |
| 15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15247-0.json |
| 15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15248-8.json |
| 15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15249-6.json |
| 15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15250-4.json |
| 15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15251-2.json |
| 15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15252-0.json |
| 15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15253-8.json |
| 15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15254-6.json |
| 15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15255-3.json |
| 15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15256-1.json |
| 15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15257-9.json |
| 15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15258-7.json |
| 15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15259-5.json |
| 15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15260-3.json |
| 15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15261-1.json |
| 15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15262-9.json |
| 1526-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/1526-3.json |
| 15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15263-7.json |
| 15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15264-5.json |
| 15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15265-2.json |
| 15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15266-0.json |
| 15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15267-8.json |
| 15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15268-6.json |
| 15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15269-4.json |
| 15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15270-2.json |
| 15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15271-0.json |
| 15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15272-8.json |
| 15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15273-6.json |
| 15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15274-4.json |
| 15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15275-1.json |
| 15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/15276-9.json |
| 15278-5 | Lovage IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15278-5.json |
| 15279-3 | Cardamon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15279-3.json |
| 15280-1 | Mace IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15280-1.json |
| 15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15281-9.json |
| 15283-5 | Silver Birch IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15283-5.json |
| 15284-3 | Grey Alder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15284-3.json |
| 15285-0 | London Plane IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15285-0.json |
| 15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15339-5.json |
| 15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15340-3.json |
| 15341-1 | Black Fly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15341-1.json |
| 15342-9 | European Hornet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/15342-9.json |
| 15343-7 | Blood group antibody screen [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15343-7.json |
| 15345-2 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/15345-2.json |
| 15347-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/15347-8.json |
| 15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/15350-2.json |
| 15351-0 | Apolipoprotein E2 [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/15351-0.json |
| 15352-8 | Apolipoprotein E3 [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/15352-8.json |
| 15353-6 | Apolipoprotein E4 [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/15353-6.json |
| 15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/15354-4.json |
| 15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15355-1.json |
| 15356-9 | Globulin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/15356-9.json |
| 15357-7 | Iron [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/15357-7.json |
| 15358-5 | Macroamylase [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15358-5.json |
| 15360-1 | dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/15360-1.json |
| 15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/15362-7.json |
| 15363-5 | Busulfan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15363-5.json |
| 15364-3 | Codeine [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/15364-3.json |
| 15366-8 | Dextroamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15366-8.json |
| 15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15367-6.json |
| 15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15368-4.json |
| 15370-0 | Morphine [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/15370-0.json |
| 15372-6 | Nordiazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/15372-6.json |
| 15373-4 | Phenyltoloxamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/15373-4.json |
| 15374-2 | Sulfonylurea [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15374-2.json |
| 15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/15375-9.json |
| 15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/15377-5.json |
| 15378-3 | Fungus identified in Isolate by Culture | ./2.16.840.1.114222.4.11.1002/15378-3.json |
| 15379-1 | Haemophilus influenzae B Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/15379-1.json |
| 15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15380-9.json |
| 15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15381-7.json |
| 15382-5 | Leishmania donovani IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15382-5.json |
| 15383-3 | Leishmania donovani IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15383-3.json |
| 15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15384-1.json |
| 15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15385-8.json |
| 15386-6 | Leishmania tropica IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15386-6.json |
| 15387-4 | Leishmania tropica IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15387-4.json |
| 15388-2 | Mycoplasma hominis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/15388-2.json |
| 15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15389-0.json |
| 15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15390-8.json |
| 15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15391-6.json |
| 15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15392-4.json |
| 15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15393-2.json |
| 15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15394-0.json |
| 15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15395-7.json |
| 15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15397-3.json |
| 15398-1 | Neuronal nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/15398-1.json |
| 15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/15399-9.json |
| 15400-5 | Platelet IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15400-5.json |
| 15401-3 | Drugs identified in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/15401-3.json |
| 15402-1 | Ethanol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/15402-1.json |
| 15403-9 | Isopropanol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/15403-9.json |
| 15405-4 | Methamphetamine [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/15405-4.json |
| 15407-0 | Methanol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/15407-0.json |
| 15408-8 | Thallium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/15408-8.json |
| 15409-6 | Thallium [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/15409-6.json |
| 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15410-4.json |
| 15411-2 | Ergosterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/15411-2.json |
| 15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15433-6.json |
| 15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15434-4.json |
| 15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15435-1.json |
| 15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15436-9.json |
| 15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15437-7.json |
| 15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15438-5.json |
| 15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15439-3.json |
| 15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15440-1.json |
| 15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15441-9.json |
| 15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15442-7.json |
| 15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15443-5.json |
| 15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15444-3.json |
| 15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15445-0.json |
| 15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay | ./2.16.840.1.114222.4.11.1002/15446-8.json |
| 15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15447-6.json |
| 15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15448-4.json |
| 15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15449-2.json |
| 15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15450-0.json |
| 15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15451-8.json |
| 15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15452-6.json |
| 15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15453-4.json |
| 15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15454-2.json |
| 15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15455-9.json |
| 15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15456-7.json |
| 15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15457-5.json |
| 15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15458-3.json |
| 15459-1 | Bovine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15459-1.json |
| 15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15460-9.json |
| 15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15461-7.json |
| 15462-5 | Bovine diarrhea virus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15462-5.json |
| 15463-3 | Bovine diarrhea virus 2 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15463-3.json |
| 15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15464-1.json |
| 15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15465-8.json |
| 15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15466-6.json |
| 15467-4 | Equine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15467-4.json |
| 15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15468-2.json |
| 15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15469-0.json |
| 15470-8 | Equine influenza virus A2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/15470-8.json |
| 15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15471-6.json |
| 15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay | ./2.16.840.1.114222.4.11.1002/15472-4.json |
| 15473-2 | Equine arteritis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15473-2.json |
| 15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15474-0.json |
| 15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15475-7.json |
| 15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15476-5.json |
| 15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15477-3.json |
| 15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15478-1.json |
| 15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15479-9.json |
| 15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15480-7.json |
| 15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15481-5.json |
| 15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/15482-3.json |
| 15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15483-1.json |
| 15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15484-9.json |
| 15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15485-6.json |
| 15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe | ./2.16.840.1.114222.4.11.1002/15486-4.json |
| 15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15487-2.json |
| 15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15488-0.json |
| 15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15489-8.json |
| 15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15490-6.json |
| 15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/15491-4.json |
| 15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15492-2.json |
| 15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/15493-0.json |
| 15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15494-8.json |
| 15495-5 | PRRSV Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15495-5.json |
| 15496-3 | PRRSV Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/15496-3.json |
| 15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15497-1.json |
| 15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/15498-9.json |
| 15499-7 | Pseudorabies virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/15499-7.json |
| 15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15500-2.json |
| 15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15501-0.json |
| 15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15502-8.json |
| 1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast | ./2.16.840.1.114222.4.11.1002/1550-3.json |
| 15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/15503-6.json |
| 15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15504-4.json |
| 15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15505-1.json |
| 15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/15506-9.json |
| 15507-7 | Emergency department Progress note | ./2.16.840.1.114222.4.11.1002/15507-7.json |
| 15508-5 | Labor and delivery records | ./2.16.840.1.114222.4.11.1002/15508-5.json |
| 1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/1554-5.json |
| 1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting | ./2.16.840.1.114222.4.11.1002/1555-2.json |
| 1556-0 | Fasting glucose [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/1556-0.json |
| 1557-8 | Fasting glucose [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/1557-8.json |
| 1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1558-6.json |
| 1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/1573-5.json |
| 1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast | ./2.16.840.1.114222.4.11.1002/1585-9.json |
| 16101-8 | Cumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16101-8.json |
| 16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16102-6.json |
| 16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16103-4.json |
| 16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16104-2.json |
| 16105-9 | Pheasant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16105-9.json |
| 16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/16110-9.json |
| 16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/16111-7.json |
| 16114-1 | Amitriptyline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16114-1.json |
| 16115-8 | Doxepin [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16115-8.json |
| 16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/16116-6.json |
| 16117-4 | Babesia microti IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16117-4.json |
| 16118-2 | Babesia microti IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16118-2.json |
| 16119-0 | Brucella abortus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16119-0.json |
| 16120-8 | Brucella abortus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16120-8.json |
| 16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16121-6.json |
| 16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16122-4.json |
| 16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16123-2.json |
| 16124-0 | Cryptococcus sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16124-0.json |
| 16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16125-7.json |
| 16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16126-5.json |
| 16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16127-3.json |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16128-1.json |
| 16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16129-9.json |
| 16130-7 | Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16130-7.json |
| 16131-5 | Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16131-5.json |
| 16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16133-1.json |
| 16134-9 | Neisseria meningitidis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16134-9.json |
| 16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16135-6.json |
| 16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16136-4.json |
| 16137-2 | Centromere Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16137-2.json |
| 16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16139-8.json |
| 16140-6 | Tellurium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16140-6.json |
| 16141-4 | Nitrogen [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/16141-4.json |
| 16142-2 | Fat [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/16142-2.json |
| 16144-8 | Droperidol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16144-8.json |
| 16145-5 | Mescaline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16145-5.json |
| 16146-3 | Psilocin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16146-3.json |
| 16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16150-5.json |
| 16151-3 | Dechlorane [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16151-3.json |
| 16171-1 | Cocaethylene [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/16171-1.json |
| 16172-9 | Magnesium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/16172-9.json |
| 16173-7 | Amyl ether [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16173-7.json |
| 16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16174-5.json |
| 16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16175-2.json |
| 16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16176-0.json |
| 16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16177-8.json |
| 16178-6 | Beryllium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16178-6.json |
| 16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16179-4.json |
| 16180-2 | Zinc [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16180-2.json |
| 16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16181-0.json |
| 16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability | ./2.16.840.1.114222.4.11.1002/16182-8.json |
| 16183-6 | Phenolphthalein [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/16183-6.json |
| 16184-4 | Temazepam [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/16184-4.json |
| 16185-1 | chlordiazePOXIDE [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/16185-1.json |
| 16186-9 | Hydroxyalprazolam [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/16186-9.json |
| 16187-7 | ALPRAZolam [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/16187-7.json |
| 16190-1 | Amobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16190-1.json |
| 16191-9 | Butabarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16191-9.json |
| 16192-7 | PHENobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16192-7.json |
| 16193-5 | PENTobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16193-5.json |
| 16194-3 | Secobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16194-3.json |
| 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16195-0.json |
| 16196-8 | Morphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16196-8.json |
| 16197-6 | Codeine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16197-6.json |
| 16198-4 | Diamorphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16198-4.json |
| 16199-2 | Methadone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16199-2.json |
| 16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16200-8.json |
| 16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16201-6.json |
| 16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16202-4.json |
| 16203-2 | ALPRAZolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16203-2.json |
| 16204-0 | clonazePAM [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16204-0.json |
| 16205-7 | LORazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16205-7.json |
| 16206-5 | Temazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16206-5.json |
| 16207-3 | Meperidine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16207-3.json |
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16208-1.json |
| 16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16209-9.json |
| 16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16210-7.json |
| 16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16211-5.json |
| 16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16212-3.json |
| 16213-1 | Levorphanol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16213-1.json |
| 16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16214-9.json |
| 16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16215-6.json |
| 16216-4 | MethylePHEDrine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16216-4.json |
| 16217-2 | Methyprylon [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16217-2.json |
| 16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16218-0.json |
| 16219-8 | Pentazocine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16219-8.json |
| 16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16220-6.json |
| 16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16221-4.json |
| 16222-2 | Phentermine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16222-2.json |
| 16223-0 | Thiopental [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16223-0.json |
| 16224-8 | Triazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16224-8.json |
| 16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16225-5.json |
| 16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16226-3.json |
| 16227-1 | diazePAM [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16227-1.json |
| 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16228-9.json |
| 16229-7 | clonazePAM [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16229-7.json |
| 16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16230-5.json |
| 16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16231-3.json |
| 16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16232-1.json |
| 16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16233-9.json |
| 16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16234-7.json |
| 16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16235-4.json |
| 16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16236-2.json |
| 16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16237-0.json |
| 16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16238-8.json |
| 16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16239-6.json |
| 16240-4 | PENTobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16240-4.json |
| 16241-2 | PHENobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16241-2.json |
| 16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16242-0.json |
| 16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16243-8.json |
| 16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16244-6.json |
| 16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16245-3.json |
| 16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16246-1.json |
| 16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16247-9.json |
| 16249-5 | oxyCODONE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16249-5.json |
| 16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16250-3.json |
| 16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16251-1.json |
| 16252-9 | HYDROcodone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16252-9.json |
| 16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16253-7.json |
| 16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16254-5.json |
| 16255-2 | Troponin I.cardiac [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16255-2.json |
| 16273-5 | Calcium [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16273-5.json |
| 16275-0 | Bartonella sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16275-0.json |
| 16276-8 | Bartonella henselae DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16276-8.json |
| 16277-6 | Bartonella quintana DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16277-6.json |
| 16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16278-4.json |
| 16279-2 | Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16279-2.json |
| 16280-0 | Human papilloma virus DNA [Presence] in Specimen by Probe with amplification | ./2.16.840.1.114222.4.11.1002/16280-0.json |
| 16281-8 | traZODone [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16281-8.json |
| 16282-6 | Acetaminophen [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16282-6.json |
| 16283-4 | Escherichia coli verotoxin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/16283-4.json |
| 16284-2 | Polio virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16284-2.json |
| 16291-7 | Herpes simplex virus 1 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16291-7.json |
| 16292-5 | 1,4-Dioxane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16292-5.json |
| 16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/16293-3.json |
| 16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16296-6.json |
| 16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16297-4.json |
| 16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine | ./2.16.840.1.114222.4.11.1002/16300-6.json |
| 16305-5 | 2-Methoxyethanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16305-5.json |
| 16307-1 | Acetate [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/16307-1.json |
| 16308-9 | Acetazolamide [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16308-9.json |
| 16309-7 | Acetazolamide [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16309-7.json |
| 16310-5 | Acetone [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/16310-5.json |
| 16311-3 | Acetone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16311-3.json |
| 16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16312-1.json |
| 16313-9 | Acetylene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16313-9.json |
| 16314-7 | Acetylsalicylate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16314-7.json |
| 16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited | ./2.16.840.1.114222.4.11.1002/16315-4.json |
| 16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16316-2.json |
| 16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/16317-0.json |
| 16318-8 | Acrylamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16318-8.json |
| 16319-6 | Acrylamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16319-6.json |
| 16322-0 | Biperiden [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16322-0.json |
| 16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16324-6.json |
| 16325-3 | Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16325-3.json |
| 16327-9 | Allyl alcohol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16327-9.json |
| 16328-7 | Benzyl alcohol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16328-7.json |
| 16333-7 | Aldrin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16333-7.json |
| 16334-5 | Alfentanil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16334-5.json |
| 16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/16335-2.json |
| 16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16337-8.json |
| 16346-9 | Alpha chlordane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16346-9.json |
| 16347-7 | Alpha chlordane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16347-7.json |
| 16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16348-5.json |
| 16349-3 | Aluminum [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16349-3.json |
| 16351-9 | aMILoride [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16351-9.json |
| 16352-7 | aMILoride [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16352-7.json |
| 16353-5 | Amino beta guanidinopropionate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16353-5.json |
| 16355-0 | Amino beta guanidinopropionate [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/16355-0.json |
| 16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/16360-0.json |
| 16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/16361-8.json |
| 16362-6 | Ammonia [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/16362-6.json |
| 16363-4 | Ammonia [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16363-4.json |
| 16364-2 | Amobarbital [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/16364-2.json |
| 16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16366-7.json |
| 16369-1 | Amphetamines [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16369-1.json |
| 16370-9 | Amphotericin B [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16370-9.json |
| 16373-3 | Amyl ether [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16373-3.json |
| 16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16374-1.json |
| 16388-1 | Anticonvulsants [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/16388-1.json |
| 16389-9 | Antidepressants [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16389-9.json |
| 16390-7 | Antidiuretics [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/16390-7.json |
| 16391-5 | Antimony [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16391-5.json |
| 16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate | ./2.16.840.1.114222.4.11.1002/16392-3.json |
| 16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate | ./2.16.840.1.114222.4.11.1002/16393-1.json |
| 16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16394-9.json |
| 16395-6 | Antipsychotics [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/16395-6.json |
| 16402-0 | Aromatic solvents [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/16402-0.json |
| 16403-8 | Arsenic [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16403-8.json |
| 16404-6 | Arsenic [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16404-6.json |
| 16405-3 | Arylamidase [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16405-3.json |
| 16406-1 | Arylamidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16406-1.json |
| 16407-9 | Asbestos identified in Sputum by Light microscopy | ./2.16.840.1.114222.4.11.1002/16407-9.json |
| 16408-7 | Ascorbate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16408-7.json |
| 16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16412-9.json |
| 16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16414-5.json |
| 16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16415-2.json |
| 16416-0 | Aspergillus terreus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16416-0.json |
| 16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16417-8.json |
| 16418-6 | Azatadine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16418-6.json |
| 16419-4 | azaTHIOprine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16419-4.json |
| 16420-2 | Azithromycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16420-2.json |
| 16422-8 | Azlocillin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16422-8.json |
| 16423-6 | Aztreonam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16423-6.json |
| 16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16425-1.json |
| 16426-9 | Babesia sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16426-9.json |
| 16427-7 | Babesia microti Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16427-7.json |
| 16428-5 | Bacitracin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16428-5.json |
| 16429-3 | Barbiturates [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16429-3.json |
| 16430-1 | Barbiturates [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16430-1.json |
| 16431-9 | Barium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16431-9.json |
| 16432-7 | Barium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16432-7.json |
| 16433-5 | Basement membrane Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16433-5.json |
| 16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16434-3.json |
| 16437-6 | Bendroflumethiazide [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16437-6.json |
| 16438-4 | Benzaldehyde [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16438-4.json |
| 16439-2 | Benzene [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16439-2.json |
| 16440-0 | Benzene ring IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16440-0.json |
| 16441-8 | Benzene ring IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16441-8.json |
| 16442-6 | Benzene ring IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16442-6.json |
| 16443-4 | Benzonatate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16443-4.json |
| 1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/1644-4.json |
| 16444-2 | Benzophenone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16444-2.json |
| 16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16446-7.json |
| 16447-5 | Cocaine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16447-5.json |
| 16448-3 | Cocaine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16448-3.json |
| 16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16449-1.json |
| 16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16450-9.json |
| 16451-7 | Beryllium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16451-7.json |
| 16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16454-1.json |
| 16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16455-8.json |
| 16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16456-6.json |
| 16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/16457-4.json |
| 16458-2 | Bethanechol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16458-2.json |
| 16459-0 | Bicarbonate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16459-0.json |
| 16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16460-8.json |
| 16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16461-6.json |
| 16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/16462-4.json |
| 16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16463-2.json |
| 16464-0 | Bile acid [Units/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/16464-0.json |
| 16465-7 | Bile acid [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16465-7.json |
| 16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16466-5.json |
| 16467-3 | Bismuth [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16467-3.json |
| 16468-1 | Bismuth [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16468-1.json |
| 16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/16469-9.json |
| 16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16470-7.json |
| 16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16471-5.json |
| 16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16472-3.json |
| 16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16473-1.json |
| 16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16474-9.json |
| 16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16475-6.json |
| 16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16476-4.json |
| 16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/16477-2.json |
| 16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/16478-0.json |
| 16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16479-8.json |
| 16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16480-6.json |
| 16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16481-4.json |
| 16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16482-2.json |
| 16483-0 | Borrelia hermsii [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16483-0.json |
| 16484-8 | Boysenberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16484-8.json |
| 16485-5 | Bromodiphenhydramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16485-5.json |
| 16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16486-3.json |
| 16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/16487-1.json |
| 16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16488-9.json |
| 16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16489-7.json |
| 16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16490-5.json |
| 16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16491-3.json |
| 16492-1 | Bufotenine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16492-1.json |
| 1649-3 | Calcitriol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1649-3.json |
| 16493-9 | Bufotenine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16493-9.json |
| 16494-7 | Bumetanide [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16494-7.json |
| 16495-4 | Buprenorphine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16495-4.json |
| 16496-2 | Buprenorphine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16496-2.json |
| 16497-0 | Butabarbital [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/16497-0.json |
| 16498-8 | Butalbital [Units/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/16498-8.json |
| 16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16499-6.json |
| 1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/1650-1.json |
| 16503-5 | C reactive protein [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16503-5.json |
| 16518-3 | Calcium [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/16518-3.json |
| 16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16528-2.json |
| 16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16529-0.json |
| 16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16530-8.json |
| 16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16531-6.json |
| 16532-4 | Campylobacter lari rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16532-4.json |
| 16533-2 | Helicobacter pylori Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16533-2.json |
| 16534-0 | Campylobacter sp rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/16534-0.json |
| 16535-7 | Canary droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16535-7.json |
| 16536-5 | Canary serum proteins Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16536-5.json |
| 16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/16537-3.json |
| 16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/16538-1.json |
| 16539-9 | Candida sp Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16539-9.json |
| 16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16542-3.json |
| 1654-3 | 1-Naphthalene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1654-3.json |
| 16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16543-1.json |
| 16544-9 | Canrenone [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16544-9.json |
| 16545-6 | Capreomycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16545-6.json |
| 16546-4 | Captopril [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16546-4.json |
| 16547-2 | Carbamate pesticides [Type] in Urine | ./2.16.840.1.114222.4.11.1002/16547-2.json |
| 16548-0 | carBAMazepine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16548-0.json |
| 16549-8 | Carbinoxamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16549-8.json |
| 16550-6 | Carbohydrates [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/16550-6.json |
| 16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/16551-4.json |
| 16553-0 | Carnitine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/16553-0.json |
| 16555-5 | Carnitine [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16555-5.json |
| 16556-3 | Carnitine [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/16556-3.json |
| 16562-1 | Cathartic laxatives [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/16562-1.json |
| 16564-7 | Cefaclor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16564-7.json |
| 16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16565-4.json |
| 16566-2 | ceFAZolin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16566-2.json |
| 16567-0 | Cefixime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16567-0.json |
| 1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1656-8.json |
| 16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16568-8.json |
| 16569-6 | cefTRIAXone IgE Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16569-6.json |
| 16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16570-4.json |
| 16571-2 | Cephadrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16571-2.json |
| 16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16572-0.json |
| 1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1657-6.json |
| 16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16581-1.json |
| 16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16582-9.json |
| 16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16583-7.json |
| 1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1658-4.json |
| 16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe | ./2.16.840.1.114222.4.11.1002/16584-5.json |
| 16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe | ./2.16.840.1.114222.4.11.1002/16585-2.json |
| 16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16586-0.json |
| 16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16587-8.json |
| 16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16588-6.json |
| 16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16589-4.json |
| 16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16590-2.json |
| 16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16591-0.json |
| 1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1659-2.json |
| 16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16592-8.json |
| 16593-6 | Chlamydia sp Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16593-6.json |
| 16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16594-4.json |
| 16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16595-1.json |
| 16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16596-9.json |
| 16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16597-7.json |
| 16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16598-5.json |
| 16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16599-3.json |
| 1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1660-0.json |
| 16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe | ./2.16.840.1.114222.4.11.1002/16600-9.json |
| 16601-7 | Chlamydia trachomatis rRNA [Presence] in Urine by Probe | ./2.16.840.1.114222.4.11.1002/16601-7.json |
| 16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/16603-3.json |
| 16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/16604-1.json |
| 16605-8 | Chlorocycline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16605-8.json |
| 16606-6 | Chlorine [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/16606-6.json |
| 16608-2 | Chlorpheniramine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16608-2.json |
| 16609-0 | Chlorphentermine [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16609-0.json |
| 16610-8 | Chlorphentermine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16610-8.json |
| 16611-6 | Chlorpyrifos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16611-6.json |
| 16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16612-4.json |
| 16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/16617-3.json |
| 1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1661-8.json |
| 16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16618-1.json |
| 16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16619-9.json |
| 16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/16621-5.json |
| 16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/16622-3.json |
| 16624-9 | clomiPRAMINE [Units/volume] in Milk | ./2.16.840.1.114222.4.11.1002/16624-9.json |
| 16625-6 | clomiPRAMINE [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/16625-6.json |
| 1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1662-6.json |
| 16626-4 | Clostridium tetani Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/16626-4.json |
| 16627-2 | Clostridium tetani Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/16627-2.json |
| 16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16628-0.json |
| 16631-4 | aPTT in Blood by Coagulation 1:1 saline | ./2.16.840.1.114222.4.11.1002/16631-4.json |
| 16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16632-2.json |
| 16633-0 | Cocaine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16633-0.json |
| 1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1663-4.json |
| 16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16634-8.json |
| 16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/16635-5.json |
| 16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16636-3.json |
| 16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16637-1.json |
| 16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16638-9.json |
| 16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16639-7.json |
| 16641-3 | Cockatiel droppings Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16641-3.json |
| 1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1664-2.json |
| 16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16642-1.json |
| 16643-9 | Cockatoo droppings Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16643-9.json |
| 16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16644-7.json |
| 16645-4 | Colistin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16645-4.json |
| 16647-0 | Collagen Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16647-0.json |
| 16648-8 | Copper [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16648-8.json |
| 16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16649-6.json |
| 16650-4 | Cilantro IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16650-4.json |
| 16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/16652-0.json |
| 16653-8 | Corticotropin Canine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/16653-8.json |
| 1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1665-9.json |
| 1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1666-7.json |
| 16667-8 | Cortisol Free [Mass/time] in 48 hour Urine | ./2.16.840.1.114222.4.11.1002/16667-8.json |
| 16668-6 | Cortisol Free [Mass/time] in 72 hour Urine | ./2.16.840.1.114222.4.11.1002/16668-6.json |
| 1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1667-5.json |
| 16676-9 | Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16676-9.json |
| 16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16677-7.json |
| 16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16678-5.json |
| 16679-3 | Coxsackievirus A Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16679-3.json |
| 16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16680-1.json |
| 16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16681-9.json |
| 16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16682-7.json |
| 1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1668-3.json |
| 16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16683-5.json |
| 16684-3 | Coxsackievirus B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16684-3.json |
| 16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/16685-0.json |
| 16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/16686-8.json |
| 16687-6 | Creatine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/16687-6.json |
| 16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16688-4.json |
| 16689-2 | Creatinine [Mass/time] in 48 hour Urine | ./2.16.840.1.114222.4.11.1002/16689-2.json |
| 16690-0 | Creatinine [Mass/time] in 72 hour Urine | ./2.16.840.1.114222.4.11.1002/16690-0.json |
| 16691-8 | Cresols [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/16691-8.json |
| 16692-6 | Cryptococcus sp Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/16692-6.json |
| 16693-4 | Cryptococcus sp Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16693-4.json |
| 16694-2 | Cumene [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16694-2.json |
| 16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16695-9.json |
| 16697-5 | Cyclohexane [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16697-5.json |
| 16698-3 | Cyclohexanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16698-3.json |
| 16699-1 | Cyclohexanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16699-1.json |
| 16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/16700-7.json |
| 16701-5 | Cyclopropane [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16701-5.json |
| 16702-3 | cycloSERINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16702-3.json |
| 16703-1 | cycloSPORINE [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/16703-1.json |
| 16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16704-9.json |
| 16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16706-4.json |
| 16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16707-2.json |
| 16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16708-0.json |
| 1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1670-9.json |
| 16709-8 | Cystine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16709-8.json |
| 16711-4 | Cystine+Homocystine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16711-4.json |
| 16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16712-2.json |
| 16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16713-0.json |
| 16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16714-8.json |
| 16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16715-5.json |
| 16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/16716-3.json |
| 1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1671-7.json |
| 16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/16717-1.json |
| 16718-9 | Cytomegalovirus Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16718-9.json |
| 16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation | ./2.16.840.1.114222.4.11.1002/16719-7.json |
| 16720-5 | Dechlorane [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16720-5.json |
| 16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/16721-3.json |
| 1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1673-3.json |
| 16736-1 | Dengue virus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16736-1.json |
| 16737-9 | Dengue virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16737-9.json |
| 16738-7 | Dengue virus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16738-7.json |
| 16739-5 | Dengue virus 4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16739-5.json |
| 16740-3 | Dengue virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16740-3.json |
| 1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1674-1.json |
| 16741-1 | American house dust mite IgG Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16741-1.json |
| 16742-9 | European house dust mite IgG Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16742-9.json |
| 16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16746-0.json |
| 16747-8 | Dextromoramide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16747-8.json |
| 16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16748-6.json |
| 16749-4 | Propoxyphene + Norpropoxyphene [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16749-4.json |
| 16750-2 | Dezocine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16750-2.json |
| 16751-0 | Dezocine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16751-0.json |
| 16754-4 | Diamorphine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/16754-4.json |
| 16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16755-1.json |
| 16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16756-9.json |
| 16757-7 | diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16757-7.json |
| 1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1675-8.json |
| 16758-5 | Dicamba [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16758-5.json |
| 16759-3 | Dicamba [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16759-3.json |
| 16762-7 | Dichlorobenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16762-7.json |
| 16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16763-5.json |
| 16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16764-3.json |
| 16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/16765-0.json |
| 1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1676-6.json |
| 16766-8 | Dichloroethane [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16766-8.json |
| 16768-4 | Dichlorvos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16768-4.json |
| 16769-2 | Dicloxacillin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16769-2.json |
| 16770-0 | Dicoumarol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16770-0.json |
| 16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16771-8.json |
| 16772-6 | Dieldrin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16772-6.json |
| 16773-4 | Dieldrin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16773-4.json |
| 1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1677-4.json |
| 16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16774-2.json |
| 16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16775-9.json |
| 16776-7 | dilTIAZem [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16776-7.json |
| 16777-5 | Dimethylacetamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16777-5.json |
| 16778-3 | Dinitrophenol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16778-3.json |
| 16779-1 | Dinitrophenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16779-1.json |
| 16780-9 | Disopyramide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16780-9.json |
| 16781-7 | Disulfiram [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16781-7.json |
| 1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1678-2.json |
| 1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1679-0.json |
| 16791-6 | Doxylamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16791-6.json |
| 16792-4 | Doxylamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16792-4.json |
| 16793-2 | Drugs identified in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/16793-2.json |
| 16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16794-0.json |
| 16795-7 | Echovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16795-7.json |
| 16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16796-5.json |
| 16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16797-3.json |
| 16798-1 | Echovirus 14 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16798-1.json |
| 16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16800-5.json |
| 16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16801-3.json |
| 16802-1 | Echovirus 30 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16802-1.json |
| 16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16803-9.json |
| 16804-7 | Echovirus 40 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16804-7.json |
| 16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16805-4.json |
| 16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16806-2.json |
| 16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16807-0.json |
| 1680-8 | 3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1680-8.json |
| 16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16808-8.json |
| 16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16809-6.json |
| 16812-0 | Emetine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16812-0.json |
| 16813-8 | Emetine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16813-8.json |
| 16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16814-6.json |
| 16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16815-3.json |
| 1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1681-6.json |
| 16816-1 | Enoxacin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16816-1.json |
| 16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/16817-9.json |
| 16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16818-7.json |
| 16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16819-5.json |
| 16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16820-3.json |
| 16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/16823-7.json |
| 1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1682-4.json |
| 16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16824-5.json |
| 16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/16825-2.json |
| 16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16826-0.json |
| 16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16827-8.json |
| 16829-4 | Erythromycin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16829-4.json |
| 16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16832-8.json |
| 16833-6 | Escherichia coli K1 Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/16833-6.json |
| 16834-4 | Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16834-4.json |
| 16835-1 | Escherichia coli shiga-like toxin identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16835-1.json |
| 16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/16836-9.json |
| 16838-5 | Estriol (E3) [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16838-5.json |
| 1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1684-0.json |
| 16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16840-1.json |
| 16842-7 | Ethanol [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/16842-7.json |
| 16843-5 | Ethanol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16843-5.json |
| 16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16844-3.json |
| 16845-0 | Ethionamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16845-0.json |
| 16847-6 | Ethoheptazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16847-6.json |
| 16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16848-4.json |
| 16849-2 | Ethyl benzene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16849-2.json |
| 16850-0 | Ethylene oxide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16850-0.json |
| 16851-8 | Ethylmorphine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16851-8.json |
| 16852-6 | Etodolac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16852-6.json |
| 16853-4 | Fat [Mass] in Stool | ./2.16.840.1.114222.4.11.1002/16853-4.json |
| 16855-9 | Fat [Mass/time] in 48 hour Stool | ./2.16.840.1.114222.4.11.1002/16855-9.json |
| 16857-5 | Fenclorvos [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/16857-5.json |
| 16858-3 | fentaNYL [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/16858-3.json |
| 16859-1 | Fibrinogen [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/16859-1.json |
| 16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/16860-9.json |
| 16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16861-7.json |
| 16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16862-5.json |
| 16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16863-3.json |
| 16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16864-1.json |
| 16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16865-8.json |
| 16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/16866-6.json |
| 16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16867-4.json |
| 16868-2 | Finch droppings IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16868-2.json |
| 16870-8 | Fluconazole [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16870-8.json |
| 16871-6 | Fluoride [Units/volume] in Bone | ./2.16.840.1.114222.4.11.1002/16871-6.json |
| 16872-4 | Fluorocarbons [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16872-4.json |
| 16874-0 | Formate+Formaldehyde [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16874-0.json |
| 16875-7 | Francisella tularensis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/16875-7.json |
| 16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16876-5.json |
| 16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16877-3.json |
| 16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16878-1.json |
| 16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16879-9.json |
| 1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1688-1.json |
| 16881-5 | Gallium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16881-5.json |
| 16888-0 | Gamma chlordane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16888-0.json |
| 16898-9 | Giardia lamblia 65 Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/16898-9.json |
| 1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1689-9.json |
| 16899-7 | Giardia lamblia Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/16899-7.json |
| 16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/16900-3.json |
| 16901-1 | Gliadin IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16901-1.json |
| 16902-9 | Gliadin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16902-9.json |
| 16903-7 | Glucose [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/16903-7.json |
| 1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1690-7.json |
| 16913-6 | Fasting glucose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16913-6.json |
| 1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1691-5.json |
| 16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal | ./2.16.840.1.114222.4.11.1002/16915-1.json |
| 16918-5 | Glutathione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16918-5.json |
| 16920-1 | Glycoproteins [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16920-1.json |
| 16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16921-9.json |
| 16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16922-7.json |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1692-3.json |
| 16923-5 | guaiFENesin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/16923-5.json |
| 16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16924-3.json |
| 16925-0 | Haemophilus influenzae A Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16925-0.json |
| 16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16926-8.json |
| 16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16927-6.json |
| 16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16928-4.json |
| 16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16929-2.json |
| 16930-0 | Helminth IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16930-0.json |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1693-1.json |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16933-4.json |
| 16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16934-2.json |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16935-9.json |
| 16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16936-7.json |
| 16937-5 | Hepatitis G virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16937-5.json |
| 16939-1 | Heptachlor [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16939-1.json |
| 16940-9 | Heptachlorepoxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16940-9.json |
| 16941-7 | Herbicide [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/16941-7.json |
| 16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/16942-5.json |
| 16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16943-3.json |
| 16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16944-1.json |
| 16945-8 | Herpes simplex virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/16945-8.json |
| 16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/16947-4.json |
| 16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16948-2.json |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1694-9.json |
| 16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/16949-0.json |
| 16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/16950-8.json |
| 16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16952-4.json |
| 16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16953-2.json |
| 16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16954-0.json |
| 16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/16955-7.json |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1695-6.json |
| 16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16956-5.json |
| 16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/16957-3.json |
| 16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/16958-1.json |
| 16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16959-9.json |
| 16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16960-7.json |
| 16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/16962-3.json |
| 1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1696-4.json |
| 16965-6 | Lindane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16965-6.json |
| 16966-4 | Hexachloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/16966-4.json |
| 16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16967-2.json |
| 16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/16968-0.json |
| 16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/16969-8.json |
| 16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/16970-6.json |
| 16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/16971-4.json |
| 1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1697-2.json |
| 16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/16972-2.json |
| 16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/16973-0.json |
| 16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16974-8.json |
| 16975-5 | HIV 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/16975-5.json |
| 16976-3 | HIV 1 Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/16976-3.json |
| 16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/16977-1.json |
| 1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1698-0.json |
| 16980-5 | HTLV II DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16980-5.json |
| 16981-3 | HTLV I DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/16981-3.json |
| 16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/16982-1.json |
| 16983-9 | hydrALAZINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16983-9.json |
| 16984-7 | Hydrastine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/16984-7.json |
| 1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1699-8.json |
| 16998-7 | HYDROmorphone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/16998-7.json |
| 16999-5 | Hydroquinone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/16999-5.json |
| 17001-9 | Hydroxyproline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17001-9.json |
| 17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17002-7.json |
| 17003-5 | Serotonin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17003-5.json |
| 1700-4 | Acetaldehyde [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1700-4.json |
| 17004-3 | Hypoxanthine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17004-3.json |
| 17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17005-0.json |
| 17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17006-8.json |
| 17007-6 | IgG [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17007-6.json |
| 17009-2 | IgM [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17009-2.json |
| 17010-0 | Imipenem [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17010-0.json |
| 1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1701-2.json |
| 17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17012-6.json |
| 17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17013-4.json |
| 17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17014-2.json |
| 17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17015-9.json |
| 17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17016-7.json |
| 1702-0 | Acetoacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1702-0.json |
| 17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17020-9.json |
| 17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17021-7.json |
| 17022-5 | Interleukin 1+2 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17022-5.json |
| 17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17024-1.json |
| 17026-6 | Isocyanate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17026-6.json |
| 17027-4 | Isocyanate IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17027-4.json |
| 17028-2 | Isocyanate IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17028-2.json |
| 17030-8 | Isopropyl ether [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/17030-8.json |
| 17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17031-6.json |
| 17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17032-4.json |
| 17033-2 | Ketamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17033-2.json |
| 17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17034-0.json |
| 17035-7 | Ketorolac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17035-7.json |
| 17036-5 | La Crosse virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17036-5.json |
| 17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17037-3.json |
| 1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1703-8.json |
| 17038-1 | La Crosse virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17038-1.json |
| 17039-9 | La Crosse virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17039-9.json |
| 17040-7 | Labetalol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17040-7.json |
| 17041-5 | Lactate dehydrogenase [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17041-5.json |
| 17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17042-3.json |
| 17043-1 | Lactose [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17043-1.json |
| 17044-9 | Lamellar bodies [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/17044-9.json |
| 17045-6 | Latex IgE Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17045-6.json |
| 1704-6 | Acetoacetate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1704-6.json |
| 17046-4 | Latex IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17046-4.json |
| 17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17047-2.json |
| 17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17048-0.json |
| 17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17049-8.json |
| 17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17050-6.json |
| 17051-4 | Laxatives [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/17051-4.json |
| 17052-2 | Lead [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/17052-2.json |
| 1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1705-3.json |
| 17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17053-0.json |
| 17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17054-8.json |
| 17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17055-5.json |
| 17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17056-3.json |
| 17057-1 | Legionella pneumophila Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17057-1.json |
| 17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17058-9.json |
| 17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17059-7.json |
| 17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17060-5.json |
| 1706-1 | Acetonitrile [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1706-1.json |
| 17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17061-3.json |
| 17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17062-1.json |
| 17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17063-9.json |
| 17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17064-7.json |
| 17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17065-4.json |
| 17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17066-2.json |
| 17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17067-0.json |
| 17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17068-8.json |
| 17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17069-6.json |
| 17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17070-4.json |
| 17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17071-2.json |
| 17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17072-0.json |
| 17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17073-8.json |
| 17075-3 | Lidocaine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17075-3.json |
| 17076-1 | Lidocaine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17076-1.json |
| 1707-9 | Acetylcholine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1707-9.json |
| 17086-0 | Lithium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17086-0.json |
| 1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1708-7.json |
| 17087-8 | Loperamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17087-8.json |
| 17088-6 | LORazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17088-6.json |
| 17089-4 | Lorcainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17089-4.json |
| 17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17090-2.json |
| 17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17091-0.json |
| 17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17092-8.json |
| 1709-5 | Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1709-5.json |
| 17100-9 | CD103 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/17100-9.json |
| 1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1710-3.json |
| 1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1711-1.json |
| 1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/1712-9.json |
| 1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1713-7.json |
| 1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1714-5.json |
| 17148-8 | CD41 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/17148-8.json |
| 1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1715-2.json |
| 1716-0 | Acidity.titratable [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1716-0.json |
| 1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1718-6.json |
| 1719-4 | Adenine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1719-4.json |
| 1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1720-2.json |
| 1721-0 | Adenosine triphosphate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1721-0.json |
| 1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1722-8.json |
| 17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17228-8.json |
| 17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17229-6.json |
| 17231-2 | Lysosomal enzymes [Identifier] in Plasma | ./2.16.840.1.114222.4.11.1002/17231-2.json |
| 17232-0 | Lysozyme [Enzymatic activity/volume] in Tear | ./2.16.840.1.114222.4.11.1002/17232-0.json |
| 17235-3 | Magnesium [Moles/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/17235-3.json |
| 1723-6 | Adenosine deaminase binding protein [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1723-6.json |
| 17236-1 | Magnesium [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/17236-1.json |
| 17237-9 | Magnesium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/17237-9.json |
| 17238-7 | Malignin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17238-7.json |
| 1724-4 | Adenosine diphosphate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1724-4.json |
| 17244-5 | Manganese [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/17244-5.json |
| 17246-0 | Mefenamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17246-0.json |
| 17247-8 | Melanin [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17247-8.json |
| 17248-6 | Melanin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17248-6.json |
| 17249-4 | Menthol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17249-4.json |
| 17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17250-2.json |
| 1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1725-1.json |
| 17251-0 | Mepivacaine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17251-0.json |
| 17252-8 | Mercaptopurine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17252-8.json |
| 17253-6 | Mercury [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/17253-6.json |
| 17254-4 | Mercury [Mass/volume] in Food | ./2.16.840.1.114222.4.11.1002/17254-4.json |
| 17255-1 | Mercury [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/17255-1.json |
| 17256-9 | Mesoridazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17256-9.json |
| 17258-5 | Metandienone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17258-5.json |
| 17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17259-3.json |
| 17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17260-1.json |
| 17261-9 | Methapyrilene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17261-9.json |
| 17263-5 | Methemalbumin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17263-5.json |
| 17265-0 | Methocarbamol [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17265-0.json |
| 17266-8 | Methotrexate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17266-8.json |
| 17267-6 | Methoxychlor [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17267-6.json |
| 1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1726-9.json |
| 17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17269-2.json |
| 17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17270-0.json |
| 17272-6 | Methylenedianiline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17272-6.json |
| 17273-4 | MethylePHEDrine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17273-4.json |
| 17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17274-2.json |
| 17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17275-9.json |
| 17276-7 | 2-Methylpentane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17276-7.json |
| 1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1727-7.json |
| 17277-5 | metOLazone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17277-5.json |
| 17278-3 | Miconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17278-3.json |
| 17279-1 | Bacteria identified in Pleural fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/17279-1.json |
| 17280-9 | Plasmodium sp identified in Tissue by Thick film | ./2.16.840.1.114222.4.11.1002/17280-9.json |
| 17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation | ./2.16.840.1.114222.4.11.1002/17281-7.json |
| 17282-5 | Minoxidil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17282-5.json |
| 17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17283-3.json |
| 17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17284-1.json |
| 1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1728-5.json |
| 17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17285-8.json |
| 17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17289-0.json |
| 17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17290-8.json |
| 17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17292-4.json |
| 1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1729-3.json |
| 17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17293-2.json |
| 17294-0 | Mushroom toxins [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/17294-0.json |
| 17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/17296-5.json |
| 17299-9 | Mycoplasma fermentans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17299-9.json |
| 17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/17300-5.json |
| 1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1730-1.json |
| 17301-3 | Mycoplasma hominis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17301-3.json |
| 17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17302-1.json |
| 17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17303-9.json |
| 17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17304-7.json |
| 17305-4 | Myelin IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17305-4.json |
| 17306-2 | Myelin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17306-2.json |
| 17307-0 | Myelin IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17307-0.json |
| 17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/17308-8.json |
| 17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17310-4.json |
| 17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17311-2.json |
| 17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17312-0.json |
| 17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17313-8.json |
| 17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17314-6.json |
| 17315-3 | Myelin basic protein Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17315-3.json |
| 17316-1 | Myeloperoxidase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17316-1.json |
| 17317-9 | N-acetylprocainamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17317-9.json |
| 17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17318-7.json |
| 1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1731-9.json |
| 17319-5 | Nalidixate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17319-5.json |
| 17320-3 | Nefazodone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17320-3.json |
| 17321-1 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17321-1.json |
| 17322-9 | Neisseria meningitidis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17322-9.json |
| 17323-7 | Neisseria meningitidis Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17323-7.json |
| 17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17324-5.json |
| 17325-2 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17325-2.json |
| 17326-0 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17326-0.json |
| 1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1732-7.json |
| 17327-8 | Neisseria meningitidis serogroup B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17327-8.json |
| 17328-6 | Neisseria meningitidis serogroup B Ag [Presence] in Urine by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17328-6.json |
| 17329-4 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17329-4.json |
| 17330-2 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17330-2.json |
| 17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17331-0.json |
| 17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17332-8.json |
| 17333-6 | Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17333-6.json |
| 17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17334-4.json |
| 1733-5 | Adipate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1733-5.json |
| 17335-1 | Neostigmine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17335-1.json |
| 17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17336-9.json |
| 17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17337-7.json |
| 17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17338-5.json |
| 17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17339-3.json |
| 17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/17340-1.json |
| 17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17341-9.json |
| 17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17342-7.json |
| 1734-3 | Aldosterone renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1734-3.json |
| 17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17343-5.json |
| 17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17344-3.json |
| 17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17346-8.json |
| 17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17347-6.json |
| 17348-4 | Neutrophil IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17348-4.json |
| 17349-2 | Neutrophil IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17349-2.json |
| 17350-0 | Neutrophil IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17350-0.json |
| 17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17351-8.json |
| 17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17353-4.json |
| 17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17354-2.json |
| 17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17355-9.json |
| 17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17356-7.json |
| 17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17357-5.json |
| 17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17358-3.json |
| 17360-9 | Heptane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17360-9.json |
| 17362-5 | Nicotinamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17362-5.json |
| 17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17363-3.json |
| 17364-1 | Nitrophenol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17364-1.json |
| 17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17365-8.json |
| 17366-6 | Nizatidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17366-6.json |
| 17367-4 | Nomifensine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17367-4.json |
| 17375-7 | Norflunitrazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17375-7.json |
| 17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17376-5.json |
| 17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17377-3.json |
| 17378-1 | Novobiocin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17378-1.json |
| 17379-9 | Propanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17379-9.json |
| 17380-7 | Nuclear Ab.histone reactive [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17380-7.json |
| 17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17384-9.json |
| 17385-6 | Organic acids [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17385-6.json |
| 17386-4 | Organic acids [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17386-4.json |
| 17387-2 | Organic acids [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17387-2.json |
| 17388-0 | Organochlorine pesticides [Type] in Urine | ./2.16.840.1.114222.4.11.1002/17388-0.json |
| 17390-6 | Orphenadrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17390-6.json |
| 17391-4 | Orthocresol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17391-4.json |
| 17392-2 | Osmium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17392-2.json |
| 17393-0 | Ovary Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17393-0.json |
| 17394-8 | Oxychlordane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17394-8.json |
| 17395-5 | oxyMORphone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17395-5.json |
| 17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17396-3.json |
| 17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17397-1.json |
| 17398-9 | Human papilloma virus 11 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17398-9.json |
| 17399-7 | Human papilloma virus 16 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17399-7.json |
| 1740-0 | Alanine aminopeptidase [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1740-0.json |
| 17400-3 | Human papilloma virus 16+18 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17400-3.json |
| 17401-1 | Human papilloma virus 18 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17401-1.json |
| 17402-9 | Human papilloma virus 31 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17402-9.json |
| 17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17403-7.json |
| 17404-5 | Human papilloma virus 33 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17404-5.json |
| 17405-2 | Human papilloma virus 42 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17405-2.json |
| 17406-0 | Human papilloma virus 43 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17406-0.json |
| 17407-8 | Human papilloma virus 44 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17407-8.json |
| 17408-6 | Human papilloma virus 45 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17408-6.json |
| 17409-4 | Human papilloma virus 5 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17409-4.json |
| 17410-2 | Human papilloma virus 51 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17410-2.json |
| 17411-0 | Human papilloma virus 6 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17411-0.json |
| 17412-8 | Human papilloma virus 6+11 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17412-8.json |
| 17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17413-6.json |
| 17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/17414-4.json |
| 17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17415-1.json |
| 17416-9 | Parakeet droppings Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17416-9.json |
| 17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17417-7.json |
| 1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1741-8.json |
| 17418-5 | Parakeet serum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17418-5.json |
| 17419-3 | Parathion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17419-3.json |
| 17420-1 | Parrot droppings Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17420-1.json |
| 17421-9 | Parrot serum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17421-9.json |
| 17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17422-7.json |
| 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1742-6.json |
| 17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17426-8.json |
| 17427-6 | Penicillium sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17427-6.json |
| 17429-2 | Pentachlorophenol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17429-2.json |
| 17430-0 | Pentane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17430-0.json |
| 17431-8 | PENTobarbital [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/17431-8.json |
| 17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17432-6.json |
| 17433-4 | pH of Specimen | ./2.16.840.1.114222.4.11.1002/17433-4.json |
| 1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | ./2.16.840.1.114222.4.11.1002/1743-4.json |
| 17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17434-2.json |
| 17435-9 | Pheniramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17435-9.json |
| 17436-7 | PHENobarbital [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/17436-7.json |
| 17437-5 | Phenolphthalein [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17437-5.json |
| 17438-3 | Phenolphthalein [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17438-3.json |
| 17439-1 | Phenols [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17439-1.json |
| 17440-9 | Phenothiazines [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17440-9.json |
| 17441-7 | Phenothiazines [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17441-7.json |
| 1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | ./2.16.840.1.114222.4.11.1002/1744-2.json |
| 17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17442-5.json |
| 17443-3 | Phenylpropanolamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17443-3.json |
| 17444-1 | Phenytoin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17444-1.json |
| 17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17445-8.json |
| 17446-6 | Phoma sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17446-6.json |
| 17447-4 | Phosphate [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/17447-4.json |
| 17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17448-2.json |
| 17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17449-0.json |
| 17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17450-8.json |
| 17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17451-6.json |
| 17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17452-4.json |
| 17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17453-2.json |
| 17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17454-0.json |
| 17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17455-7.json |
| 17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17456-5.json |
| 1745-9 | Albumin [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1745-9.json |
| 17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17459-9.json |
| 17462-3 | Picloram [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17462-3.json |
| 17463-1 | Pigeon droppings Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17463-1.json |
| 17464-9 | Pigeon feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17464-9.json |
| 17465-6 | Pigeon serum IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17465-6.json |
| 1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1746-7.json |
| 17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/17467-2.json |
| 17468-0 | Plutonium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17468-0.json |
| 17469-8 | PM-1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17469-8.json |
| 17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17470-6.json |
| 17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17471-4.json |
| 17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17472-2.json |
| 17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17473-0.json |
| 1747-5 | Albumin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/1747-5.json |
| 17476-3 | Porphyrins [Units/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/17476-3.json |
| 17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17479-7.json |
| 17480-5 | Pregnenolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17480-5.json |
| 17481-3 | Probenecid [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17481-3.json |
| 17482-1 | Procainamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17482-1.json |
| 1748-3 | Albumin [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/1748-3.json |
| 17483-9 | Progesterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17483-9.json |
| 1749-1 | Albumin [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/1749-1.json |
| 17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17493-8.json |
| 17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17494-6.json |
| 17495-3 | Prostaglandins [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17495-3.json |
| 17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17502-6.json |
| 17504-2 | Psilocybin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17504-2.json |
| 17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17505-9.json |
| 17506-7 | Quinacrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17506-7.json |
| 17507-5 | quiNIDine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17507-5.json |
| 17508-3 | quiNINE [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17508-3.json |
| 1750-9 | Albumin [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1750-9.json |
| 17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17509-1.json |
| 17510-9 | Raisin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17510-9.json |
| 17511-7 | Red dye IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17511-7.json |
| 17512-5 | Redfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17512-5.json |
| 17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/17516-6.json |
| 1751-7 | Albumin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1751-7.json |
| 17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17517-4.json |
| 17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17518-2.json |
| 17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17519-0.json |
| 17520-8 | Respiratory syncytial virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17520-8.json |
| 17521-6 | Reticulin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17521-6.json |
| 17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17522-4.json |
| 17523-2 | Reticulin IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17523-2.json |
| 17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17524-0.json |
| 1752-5 | Albumin [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/1752-5.json |
| 17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17525-7.json |
| 17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17526-5.json |
| 17527-3 | Retinol Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17527-3.json |
| 17530-7 | Retrovirus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17530-7.json |
| 17531-5 | Rh [Type] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/17531-5.json |
| 17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17532-3.json |
| 1753-3 | Albumin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/1753-3.json |
| 17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17533-1.json |
| 17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/17534-9.json |
| 17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17535-6.json |
| 17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17536-4.json |
| 17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/17537-2.json |
| 17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/17538-0.json |
| 17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17539-8.json |
| 17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17540-6.json |
| 1754-1 | Albumin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1754-1.json |
| 17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17541-4.json |
| 17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17544-8.json |
| 17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17545-5.json |
| 17546-3 | Bartonella quintana rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/17546-3.json |
| 17547-1 | Rotavirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/17547-1.json |
| 17548-9 | Rotavirus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/17548-9.json |
| 17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17549-7.json |
| 17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17550-5.json |
| 17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/17551-3.json |
| 17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17552-1.json |
| 17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17553-9.json |
| 17554-7 | Measles virus IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17554-7.json |
| 17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/17555-4.json |
| 17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/17556-2.json |
| 17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17557-0.json |
| 17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17558-8.json |
| 17559-6 | Salicylates [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/17559-6.json |
| 17560-4 | Salicylates [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/17560-4.json |
| 17561-2 | Salmon roe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17561-2.json |
| 17562-0 | Salmonella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17562-0.json |
| 17563-8 | Salmonella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17563-8.json |
| 17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17564-6.json |
| 17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17565-3.json |
| 1756-6 | Albumin in CSF/Albumin in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1756-6.json |
| 17566-1 | Salmonella typhi O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17566-1.json |
| 17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17567-9.json |
| 17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17569-5.json |
| 17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17570-3.json |
| 17571-1 | Scopolamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17571-1.json |
| 17573-7 | Secobarbital [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/17573-7.json |
| 1757-4 | Albumin renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1757-4.json |
| 17574-5 | Selenium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17574-5.json |
| 17576-0 | Shigella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17576-0.json |
| 1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1758-2.json |
| 17582-8 | Silver [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/17582-8.json |
| 17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17583-6.json |
| 17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17584-4.json |
| 17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17585-1.json |
| 17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17586-9.json |
| 17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17587-7.json |
| 17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17588-5.json |
| 17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/17589-3.json |
| 17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17590-1.json |
| 17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17591-9.json |
| 17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17592-7.json |
| 17593-5 | Smooth muscle Ab [Presence] in Sweat | ./2.16.840.1.114222.4.11.1002/17593-5.json |
| 17598-4 | Specific gravity of Synovial fluid | ./2.16.840.1.114222.4.11.1002/17598-4.json |
| 1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1760-8.json |
| 17611-5 | Stimulants [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17611-5.json |
| 1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1761-6.json |
| 1762-4 | Aldosterone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1762-4.json |
| 1763-2 | Aldosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1763-2.json |
| 17635-4 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17635-4.json |
| 17638-8 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/17638-8.json |
| 17639-6 | Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/17639-6.json |
| 1764-0 | Aldosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1764-0.json |
| 17640-4 | Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/17640-4.json |
| 17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17647-9.json |
| 17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17648-7.json |
| 17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/17650-3.json |
| 17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/17651-1.json |
| 17652-9 | Streptococcus pneumoniae Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17652-9.json |
| 17656-0 | Streptococcus pyogenes [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17656-0.json |
| 1765-7 | Aldosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1765-7.json |
| 17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/17657-8.json |
| 17658-6 | Strontium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17658-6.json |
| 17659-4 | Strychnine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17659-4.json |
| 17660-2 | Strychnine [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17660-2.json |
| 17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17661-0.json |
| 17662-8 | Succinylpurines [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17662-8.json |
| 17663-6 | sulfADIAZINE IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17663-6.json |
| 17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17664-4.json |
| 1766-5 | Aldosterone receptors [#] in Leukocytes | ./2.16.840.1.114222.4.11.1002/1766-5.json |
| 17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17665-1.json |
| 17666-9 | Sulfate [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/17666-9.json |
| 17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17668-5.json |
| 17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17669-3.json |
| 17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17670-1.json |
| 17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/17671-9.json |
| 17672-7 | Sulfide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17672-7.json |
| 1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine | ./2.16.840.1.114222.4.11.1002/1767-3.json |
| 17673-5 | sulfiSOXAZOLE IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17673-5.json |
| 17674-3 | Sulfonamide [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17674-3.json |
| 17675-0 | Sulfonamide [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17675-0.json |
| 17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17676-8.json |
| 1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright | ./2.16.840.1.114222.4.11.1002/1768-1.json |
| 17681-8 | Tellurium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17681-8.json |
| 17682-6 | Terpineol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/17682-6.json |
| 17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17683-4.json |
| 17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/17685-9.json |
| 17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17686-7.json |
| 17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17687-5.json |
| 17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17695-8.json |
| 17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17696-6.json |
| 17697-4 | Tetrachloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17697-4.json |
| 17698-2 | Tetraethyl lead [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17698-2.json |
| 1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1769-9.json |
| 17699-0 | Thebaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17699-0.json |
| 17700-6 | Theophylline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17700-6.json |
| 17701-4 | Thiazides [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17701-4.json |
| 17703-0 | Thorium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17703-0.json |
| 17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17705-5.json |
| 17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17706-3.json |
| 17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17707-1.json |
| 17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17708-9.json |
| 17709-7 | Ticlopidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17709-7.json |
| 17710-5 | Tin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17710-5.json |
| 17712-1 | Toluene diisocyanate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17712-1.json |
| 17713-9 | Topiramate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17713-9.json |
| 17714-7 | Toxaphene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17714-7.json |
| 17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/17715-4.json |
| 17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17716-2.json |
| 17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17717-0.json |
| 17718-8 | traMADol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17718-8.json |
| 17719-6 | traMADol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17719-6.json |
| 17720-4 | Trans nonachlor [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17720-4.json |
| 17721-2 | Trans nonachlor [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17721-2.json |
| 17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization | ./2.16.840.1.114222.4.11.1002/17723-8.json |
| 17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17724-6.json |
| 17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17725-3.json |
| 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17726-1.json |
| 17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17727-9.json |
| 17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17728-7.json |
| 17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17729-5.json |
| 17730-3 | Triamterene [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17730-3.json |
| 17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/17732-9.json |
| 17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17733-7.json |
| 17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17734-5.json |
| 17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17735-2.json |
| 17736-0 | Trichloroacetate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17736-0.json |
| 17737-8 | Trichloroethane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17737-8.json |
| 17738-6 | Chloral hydrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17738-6.json |
| 17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/17739-4.json |
| 17740-2 | Trichlorophenoxyacetate [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/17740-2.json |
| 17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17741-0.json |
| 17742-8 | Trichlorothiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17742-8.json |
| 17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17744-4.json |
| 17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17745-1.json |
| 17746-9 | Trimeprazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17746-9.json |
| 17747-7 | Trimethoprim [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17747-7.json |
| 17748-5 | Trimethylamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/17748-5.json |
| 17749-3 | Tromethamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17749-3.json |
| 17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17750-1.json |
| 17751-9 | Tryptamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17751-9.json |
| 17753-5 | Tungsten [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17753-5.json |
| 17755-0 | Urate [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/17755-0.json |
| 1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/1775-6.json |
| 17756-8 | Urate [Mass/time] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/17756-8.json |
| 17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/17757-6.json |
| 17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/17758-4.json |
| 17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis | ./2.16.840.1.114222.4.11.1002/17759-2.json |
| 17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis | ./2.16.840.1.114222.4.11.1002/17760-0.json |
| 17761-8 | Urobilinogen [Mass/time] in 48 hour Stool | ./2.16.840.1.114222.4.11.1002/17761-8.json |
| 17762-6 | Valproate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17762-6.json |
| 17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17763-4.json |
| 1776-4 | Alkaline phosphatase [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1776-4.json |
| 17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17764-2.json |
| 17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17765-9.json |
| 17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/17766-7.json |
| 17767-5 | Verapamil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17767-5.json |
| 17768-3 | Vinyl chloride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17768-3.json |
| 17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17769-1.json |
| 17770-9 | Western equine encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17770-9.json |
| 17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17771-7.json |
| 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1777-2.json |
| 17772-5 | Dimethylbenzene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17772-5.json |
| 17774-1 | Yellow dye IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17774-1.json |
| 17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17775-8.json |
| 17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17776-6.json |
| 17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17777-4.json |
| 17778-2 | Zinc [Mass/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/17778-2.json |
| 17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/17780-8.json |
| 17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17781-6.json |
| 17784-0 | Parasite identified in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/17784-0.json |
| 17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17791-5.json |
| 17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17792-3.json |
| 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/17793-1.json |
| 17794-9 | Osmolality of Hyperal solution | ./2.16.840.1.114222.4.11.1002/17794-9.json |
| 17795-6 | Potassium [Moles/volume] in Hyperal solution | ./2.16.840.1.114222.4.11.1002/17795-6.json |
| 17796-4 | Sodium [Moles/volume] in Hyperal solution | ./2.16.840.1.114222.4.11.1002/17796-4.json |
| 17797-2 | Thyroid colloidal Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17797-2.json |
| 17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/17798-0.json |
| 17805-3 | Procainamide [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17805-3.json |
| 17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17806-1.json |
| 17807-9 | cycloSPORINE [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17807-9.json |
| 17808-7 | Tobramycin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17808-7.json |
| 17809-5 | Hematocrit [Volume Fraction] of Urine | ./2.16.840.1.114222.4.11.1002/17809-5.json |
| 17824-4 | CD3+CD8+ (T8 suppressor) cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/17824-4.json |
| 17829-3 | CD19 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/17829-3.json |
| 1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1783-0.json |
| 17830-1 | Centromere Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17830-1.json |
| 17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/17837-6.json |
| 17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17838-4.json |
| 17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17839-2.json |
| 17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/17840-0.json |
| 17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/17841-8.json |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17842-6.json |
| 17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17843-4.json |
| 17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17844-2.json |
| 1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1784-8.json |
| 17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/17849-1.json |
| 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17850-9.json |
| 17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/17851-7.json |
| 17852-5 | Ureaplasma urealyticum [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/17852-5.json |
| 1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1785-5.json |
| 17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation | ./2.16.840.1.114222.4.11.1002/17855-8.json |
| 17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC | ./2.16.840.1.114222.4.11.1002/17856-6.json |
| 17857-4 | Rheumatoid factor [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/17857-4.json |
| 17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/17858-2.json |
| 17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/17859-0.json |
| 17861-6 | Calcium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17861-6.json |
| 17862-4 | Calcium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/17862-4.json |
| 17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/17863-2.json |
| 17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/17864-0.json |
| 17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting | ./2.16.840.1.114222.4.11.1002/17865-7.json |
| 17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17867-3.json |
| 17869-9 | Orotate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17869-9.json |
| 17870-7 | Orotidine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/17870-7.json |
| 17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation | ./2.16.840.1.114222.4.11.1002/17871-5.json |
| 17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL | ./2.16.840.1.114222.4.11.1002/17872-3.json |
| 17898-8 | Bacteria identified in Throat by Aerobe culture | ./2.16.840.1.114222.4.11.1002/17898-8.json |
| 17909-3 | Bacteria identified in Wound deep by Aerobe culture | ./2.16.840.1.114222.4.11.1002/17909-3.json |
| 17915-0 | Bacteria identified in Wound shallow by Aerobe culture | ./2.16.840.1.114222.4.11.1002/17915-0.json |
| 17925-9 | Bacteria identified in Wound deep by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/17925-9.json |
| 17928-3 | Bacteria identified in Blood by Aerobe culture | ./2.16.840.1.114222.4.11.1002/17928-3.json |
| 17934-1 | Bacteria identified in Blood by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/17934-1.json |
| 1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid | ./2.16.840.1.114222.4.11.1002/1794-7.json |
| 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/1795-4.json |
| 17956-4 | Bacteria identified in Body fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/17956-4.json |
| 1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/1796-2.json |
| 1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/1797-0.json |
| 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1798-8.json |
| 1799-6 | Amylase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1799-6.json |
| 1-8 | Acyclovir [Susceptibility] | ./2.16.840.1.114222.4.11.1002/1-8.json |
| 1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1800-2.json |
| 1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1812-7.json |
| 1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1813-5.json |
| 1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1814-3.json |
| 1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1815-0.json |
| 1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/1816-8.json |
| 1817-6 | Alpha ketoglutarate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1817-6.json |
| 18183-4 | Melatonin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18183-4.json |
| 1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1818-4.json |
| 18184-2 | Erythrocyte sedimentation rate by 2H Westergren method | ./2.16.840.1.114222.4.11.1002/18184-2.json |
| 18186-7 | Calcium [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/18186-7.json |
| 18187-5 | LORazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18187-5.json |
| 18188-3 | Acebutolol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/18188-3.json |
| 18189-1 | Acetone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18189-1.json |
| 18190-9 | Acid phosphatase tartrate resistant [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/18190-9.json |
| 18191-7 | Amino acids [Identifier] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18191-7.json |
| 1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1819-2.json |
| 18192-5 | Bacteria [Presence] in Nose by Light microscopy | ./2.16.840.1.114222.4.11.1002/18192-5.json |
| 18194-1 | Barium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18194-1.json |
| 18195-8 | Glucosylceramidase [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18195-8.json |
| 18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18196-6.json |
| 18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18197-4.json |
| 18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18198-2.json |
| 18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18199-0.json |
| 1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1820-0.json |
| 18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18200-6.json |
| 18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/18201-4.json |
| 18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/18202-2.json |
| 18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/18203-0.json |
| 18204-8 | Caffeine renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18204-8.json |
| 18205-5 | Carbon disulfide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18205-5.json |
| 18208-9 | Cocaine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/18208-9.json |
| 18209-7 | Coenzyme Q10 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18209-7.json |
| 18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18210-5.json |
| 18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18211-3.json |
| 18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18212-1.json |
| 18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18213-9.json |
| 18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18214-7.json |
| 18215-4 | Delta alanine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18215-4.json |
| 18216-2 | Dezocine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18216-2.json |
| 18217-0 | Epidermis IgA Ab [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18217-0.json |
| 1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1821-8.json |
| 18218-8 | Epidermis IgM Ab [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18218-8.json |
| 1822-6 | Alpha thymosin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1822-6.json |
| 18227-9 | Glucose [Mass/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/18227-9.json |
| 18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18228-7.json |
| 18229-5 | Heparan sulfate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18229-5.json |
| 18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18230-3.json |
| 18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/18231-1.json |
| 18232-9 | Hydrocorticosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18232-9.json |
| 18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18233-7.json |
| 1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1823-4.json |
| 18234-5 | Insulin [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/18234-5.json |
| 18235-2 | Ketone solvents [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/18235-2.json |
| 18236-0 | Lead [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18236-0.json |
| 18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18237-8.json |
| 18238-6 | Lithium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/18238-6.json |
| 18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination | ./2.16.840.1.114222.4.11.1002/18239-4.json |
| 18241-0 | cefOXitin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18241-0.json |
| 1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1824-2.json |
| 18242-8 | Methyprylon [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18242-8.json |
| 18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18243-6.json |
| 18244-4 | Niacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18244-4.json |
| 18245-1 | Nickel [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/18245-1.json |
| 18246-9 | Nitrogen [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/18246-9.json |
| 18247-7 | Nitrogen [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/18247-7.json |
| 18248-5 | Nordiazepam [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/18248-5.json |
| 18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18249-3.json |
| 18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18251-9.json |
| 18252-7 | predniSONE [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18252-7.json |
| 18253-5 | Serotonin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18253-5.json |
| 18254-3 | Silicate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/18254-3.json |
| 18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18255-0.json |
| 18256-8 | Sulfonylurea [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18256-8.json |
| 18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18258-4.json |
| 1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1825-9.json |
| 18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18259-2.json |
| 18260-0 | Zinc [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/18260-0.json |
| 18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | ./2.16.840.1.114222.4.11.1002/18262-6.json |
| 18265-9 | Acetaminophen [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/18265-9.json |
| 18267-5 | CD16+CD56+ cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/18267-5.json |
| 18268-3 | CD16+CD56+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/18268-3.json |
| 18269-1 | Immune complex [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/18269-1.json |
| 18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18270-9.json |
| 18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour | ./2.16.840.1.114222.4.11.1002/18271-7.json |
| 18272-5 | RNA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18272-5.json |
| 18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit | ./2.16.840.1.114222.4.11.1002/18273-3.json |
| 18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from Donor | ./2.16.840.1.114222.4.11.1002/18274-1.json |
| 18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method | ./2.16.840.1.114222.4.11.1002/18277-4.json |
| 18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method | ./2.16.840.1.114222.4.11.1002/18278-2.json |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/18282-4.json |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/18286-5.json |
| 18297-2 | Acid hemolysis [Mass/volume] of Red Blood Cells | ./2.16.840.1.114222.4.11.1002/18297-2.json |
| 18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/18305-3.json |
| 18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/18306-1.json |
| 18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/18307-9.json |
| 18308-7 | Pneumocystis sp identified in Lung tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/18308-7.json |
| 18320-2 | Globulin [Mass/volume] in Urine by calculation | ./2.16.840.1.114222.4.11.1002/18320-2.json |
| 18321-0 | Benzidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18321-0.json |
| 18322-8 | Norketamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18322-8.json |
| 18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18323-6.json |
| 18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18324-4.json |
| 1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1832-5.json |
| 18325-1 | oxyMORphone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18325-1.json |
| 18326-9 | Microscopic observation [Identifier] in Cervix by Other stain | ./2.16.840.1.114222.4.11.1002/18326-9.json |
| 18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain | ./2.16.840.1.114222.4.11.1002/18327-7.json |
| 18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain | ./2.16.840.1.114222.4.11.1002/18328-5.json |
| 18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18329-3.json |
| 18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18330-1.json |
| 18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18331-9.json |
| 18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18332-7.json |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1833-3.json |
| 18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18333-5.json |
| 18334-3 | Naltrexone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18334-3.json |
| 18335-0 | Antihistamines [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18335-0.json |
| 18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/18336-8.json |
| 18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18337-6.json |
| 18338-4 | Nortramadol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18338-4.json |
| 18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18339-2.json |
| 18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18340-0.json |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1834-1.json |
| 18341-8 | Propylene glycol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18341-8.json |
| 18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/18343-4.json |
| 18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets | ./2.16.840.1.114222.4.11.1002/18344-2.json |
| 18345-9 | Protein S Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/18345-9.json |
| 18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18348-3.json |
| 18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/18354-1.json |
| 18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18355-8.json |
| 18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18356-6.json |
| 18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/18357-4.json |
| 1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1835-8.json |
| 18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18358-2.json |
| 18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/18359-0.json |
| 18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18360-8.json |
| 18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/18361-6.json |
| 18362-4 | Retinol binding protein [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18362-4.json |
| 18363-2 | Carnitine free (C0) [Units/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/18363-2.json |
| 18364-0 | Chondroitin sulfate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18364-0.json |
| 18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/18365-7.json |
| 1836-6 | Retinol binding protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1836-6.json |
| 18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/18366-5.json |
| 18367-3 | Iodine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18367-3.json |
| 18368-1 | Magnesium [Moles/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/18368-1.json |
| 18369-9 | Magnesium [Moles/time] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/18369-9.json |
| 18371-5 | Methyl parathion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18371-5.json |
| 18372-3 | Potassium [Moles/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/18372-3.json |
| 18373-1 | Protein [Mass/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/18373-1.json |
| 1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1837-4.json |
| 18374-9 | Riboflavin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18374-9.json |
| 18376-4 | Sodium [Moles/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/18376-4.json |
| 18377-2 | Sodium [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/18377-2.json |
| 18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18378-0.json |
| 18379-8 | Urate [Mass/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/18379-8.json |
| 18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/18380-6.json |
| 18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/18381-4.json |
| 1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1838-2.json |
| 18383-0 | Alfentanil [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18383-0.json |
| 18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18384-8.json |
| 18385-5 | Butalbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18385-5.json |
| 18386-3 | Chlorothiazide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18386-3.json |
| 18387-1 | Diamorphine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18387-1.json |
| 18388-9 | diazePAM [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18388-9.json |
| 18389-7 | Methaqualone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18389-7.json |
| 1839-0 | Ammonia [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1839-0.json |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18390-5.json |
| 18391-3 | Paraldehyde [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18391-3.json |
| 18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18392-1.json |
| 18393-9 | quiNIDine+Quinine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18393-9.json |
| 18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18395-4.json |
| 18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/18397-0.json |
| 18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/18398-8.json |
| 18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/18399-6.json |
| 18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/18400-2.json |
| 18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/18401-0.json |
| 18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/18402-8.json |
| 18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/18403-6.json |
| 18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/18404-4.json |
| 18405-1 | Arsenate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18405-1.json |
| 18406-9 | Arsenic trioxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18406-9.json |
| 1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1840-8.json |
| 18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18409-3.json |
| 18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18410-1.json |
| 18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18411-9.json |
| 18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18412-7.json |
| 18414-3 | Psilocin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18414-3.json |
| 18415-0 | Psilocin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18415-0.json |
| 1841-6 | Ammonia [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1841-6.json |
| 18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18416-8.json |
| 18417-6 | Black Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18417-6.json |
| 18418-4 | Casein IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18418-4.json |
| 18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18419-2.json |
| 18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18420-0.json |
| 18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18421-8.json |
| 18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18423-4.json |
| 1842-4 | Ammonia [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1842-4.json |
| 18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18424-2.json |
| 18425-9 | Zucchini IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/18425-9.json |
| 18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18426-7.json |
| 18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/18427-5.json |
| 18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18428-3.json |
| 18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18429-1.json |
| 18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18430-9.json |
| 18431-7 | Amphetamines [Presence] in Stool by Screen method | ./2.16.840.1.114222.4.11.1002/18431-7.json |
| 1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1843-2.json |
| 18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method | ./2.16.840.1.114222.4.11.1002/18432-5.json |
| 18435-8 | SUFentanil [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18435-8.json |
| 18436-6 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18436-6.json |
| 1844-0 | Ammonium ion [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/1844-0.json |
| 1845-7 | Ammonium ion [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1845-7.json |
| 1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1846-5.json |
| 18467-1 | Venlafaxine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18467-1.json |
| 18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/18468-9.json |
| 18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18469-7.json |
| 18470-5 | Norclomipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18470-5.json |
| 18471-3 | Metoclopramide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/18471-3.json |
| 18472-1 | Organophosphate pesticides [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/18472-1.json |
| 1847-3 | Amyloid associated protein [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1847-3.json |
| 18473-9 | HYDROmorphone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/18473-9.json |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/18474-7.json |
| 18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/18476-2.json |
| 18477-0 | Lithium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18477-0.json |
| 18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/18478-8.json |
| 18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/18479-6.json |
| 18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/18480-4.json |
| 1848-1 | Androstanolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1848-1.json |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/18481-2.json |
| 18482-0 | Yeast [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/18482-0.json |
| 18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/18483-8.json |
| 18484-6 | Ku Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18484-6.json |
| 18485-3 | Mi-2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/18485-3.json |
| 18486-1 | Methylenediamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/18486-1.json |
| 18488-7 | Calcium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/18488-7.json |
| 18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/18489-5.json |
| 18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/18490-3.json |
| 18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/18491-1.json |
| 18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/18492-9.json |
| 18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen | ./2.16.840.1.114222.4.11.1002/18493-7.json |
| 18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen | ./2.16.840.1.114222.4.11.1002/18494-5.json |
| 18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen | ./2.16.840.1.114222.4.11.1002/18495-2.json |
| 18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen | ./2.16.840.1.114222.4.11.1002/18496-0.json |
| 18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/18497-8.json |
| 18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/18498-6.json |
| 1849-9 | Androstanolone [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1849-9.json |
| 18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain | ./2.16.840.1.114222.4.11.1002/18499-4.json |
| 18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep | ./2.16.840.1.114222.4.11.1002/18500-9.json |
| 18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain | ./2.16.840.1.114222.4.11.1002/18501-7.json |
| 18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/18502-5.json |
| 18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/18503-3.json |
| 1850-7 | Androstanediol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1850-7.json |
| 1851-5 | Androstenedione [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1851-5.json |
| 1852-3 | Androstenedione [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/1852-3.json |
| 1853-1 | Androstenedione [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1853-1.json |
| 1854-9 | Androstenedione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1854-9.json |
| 1855-6 | Androstenedione [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1855-6.json |
| 1856-4 | Androsterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1856-4.json |
| 1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1857-2.json |
| 1858-0 | Angiotensin I [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1858-0.json |
| 18594-2 | Psychiatric service attachment | ./2.16.840.1.114222.4.11.1002/18594-2.json |
| 1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1859-8.json |
| 1860-6 | Angiotensin II [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1860-6.json |
| 1861-4 | Angiotensinogen [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/1861-4.json |
| 1862-2 | Aniline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1862-2.json |
| 18682-5 | Ambulance records | ./2.16.840.1.114222.4.11.1002/18682-5.json |
| 1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/1868-9.json |
| 1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1869-7.json |
| 1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1870-5.json |
| 1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1871-3.json |
| 18733-6 | Attending Progress note | ./2.16.840.1.114222.4.11.1002/18733-6.json |
| 18734-4 | Occupational therapy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18734-4.json |
| 18735-1 | Physical therapy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18735-1.json |
| 18736-9 | Physician Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18736-9.json |
| 18737-7 | Podiatry Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18737-7.json |
| 18738-5 | Psychology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18738-5.json |
| 18739-3 | Social worker Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18739-3.json |
| 18740-1 | Speech-language pathology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18740-1.json |
| 18742-7 | Arthroscopy study | ./2.16.840.1.114222.4.11.1002/18742-7.json |
| 18743-5 | Autopsy report | ./2.16.840.1.114222.4.11.1002/18743-5.json |
| 18744-3 | Bronchoscopy study | ./2.16.840.1.114222.4.11.1002/18744-3.json |
| 18745-0 | Cardiac catheterization study | ./2.16.840.1.114222.4.11.1002/18745-0.json |
| 18746-8 | Colonoscopy study | ./2.16.840.1.114222.4.11.1002/18746-8.json |
| 18748-4 | Diagnostic imaging study | ./2.16.840.1.114222.4.11.1002/18748-4.json |
| 18749-2 | Electromyogram study | ./2.16.840.1.114222.4.11.1002/18749-2.json |
| 18750-0 | Cardiac electrophysiology study | ./2.16.840.1.114222.4.11.1002/18750-0.json |
| 18751-8 | Endoscopy study | ./2.16.840.1.114222.4.11.1002/18751-8.json |
| 18752-6 | Exercise stress test study | ./2.16.840.1.114222.4.11.1002/18752-6.json |
| 18753-4 | Flexible sigmoidoscopy study | ./2.16.840.1.114222.4.11.1002/18753-4.json |
| 1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1875-4.json |
| 18754-2 | Ambulatory cardiac rhythm monitor (Holter) study | ./2.16.840.1.114222.4.11.1002/18754-2.json |
| 18759-1 | Spirometry study | ./2.16.840.1.114222.4.11.1002/18759-1.json |
| 18761-7 | Transfer summary note | ./2.16.840.1.114222.4.11.1002/18761-7.json |
| 1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1876-2.json |
| 18763-3 | Consultant Initial evaluation note | ./2.16.840.1.114222.4.11.1002/18763-3.json |
| 1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1877-0.json |
| 18776-5 | Plan of care note | ./2.16.840.1.114222.4.11.1002/18776-5.json |
| 1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1878-8.json |
| 1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1879-6.json |
| 1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1880-4.json |
| 1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1881-2.json |
| 18823-5 | Alcohol and/or substance abuse service attachment | ./2.16.840.1.114222.4.11.1002/18823-5.json |
| 18824-3 | Cardiac service attachment | ./2.16.840.1.114222.4.11.1002/18824-3.json |
| 18825-0 | Medical social services attachment | ./2.16.840.1.114222.4.11.1002/18825-0.json |
| 18826-8 | Occupational therapy service attachment | ./2.16.840.1.114222.4.11.1002/18826-8.json |
| 18836-7 | Cardiac stress study Procedure | ./2.16.840.1.114222.4.11.1002/18836-7.json |
| 1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1883-8.json |
| 18841-7 | Hospital consultations Document | ./2.16.840.1.114222.4.11.1002/18841-7.json |
| 18842-5 | Discharge summary | ./2.16.840.1.114222.4.11.1002/18842-5.json |
| 1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1884-6.json |
| 1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1885-3.json |
| 1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1886-1.json |
| 1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1888-7.json |
| 1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1890-3.json |
| 18929-0 | Gentamicin.high potency [Susceptibility] | ./2.16.840.1.114222.4.11.1002/18929-0.json |
| 1896-0 | Argininosuccinate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1896-0.json |
| 1897-8 | Argininosuccinate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1897-8.json |
| 1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1898-6.json |
| 1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1899-4.json |
| 1900-0 | Arylamidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1900-0.json |
| 19002-5 | Physical therapy service attachment | ./2.16.840.1.114222.4.11.1002/19002-5.json |
| 19003-3 | Respiratory therapy service attachment | ./2.16.840.1.114222.4.11.1002/19003-3.json |
| 1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1901-8.json |
| 19022-3 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/19022-3.json |
| 1902-6 | Ascorbate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1902-6.json |
| 1903-4 | Ascorbate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1903-4.json |
| 1904-2 | Ascorbate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/1904-2.json |
| 19049-6 | Metanephrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/19049-6.json |
| 19050-4 | Metanephrines [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/19050-4.json |
| 19051-2 | Saquinavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19051-2.json |
| 19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification | ./2.16.840.1.114222.4.11.1002/19052-0.json |
| 19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/19053-8.json |
| 19054-6 | Mycoplasma pneumoniae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/19054-6.json |
| 19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/19055-3.json |
| 19056-1 | Mercury [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/19056-1.json |
| 19057-9 | ABO and Rh group [Type] in Blood from Newborn | ./2.16.840.1.114222.4.11.1002/19057-9.json |
| 19058-7 | Allergens identified in Serum | ./2.16.840.1.114222.4.11.1002/19058-7.json |
| 1905-9 | Ascorbate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1905-9.json |
| 19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19074-4.json |
| 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19080-1.json |
| 19090-0 | Colony count [#/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19090-0.json |
| 19091-8 | Colony count [#] in Urine by Visual count | ./2.16.840.1.114222.4.11.1002/19091-8.json |
| 19101-5 | Fungus colony count [#/volume] in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/19101-5.json |
| 19102-3 | Genetic screen in Specimen by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/19102-3.json |
| 19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19106-4.json |
| 19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/19107-2.json |
| 19108-0 | Histoplasma capsulatum Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19108-0.json |
| 19109-8 | Histoplasma capsulatum Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/19109-8.json |
| 19113-0 | IgE [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19113-0.json |
| 19114-8 | Lamellar bodies [#/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19114-8.json |
| 19122-1 | CD42 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/19122-1.json |
| 19123-9 | Magnesium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19123-9.json |
| 19124-7 | Magnesium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19124-7.json |
| 19126-2 | Bacteria identified in Bone marrow by Aerobe culture | ./2.16.840.1.114222.4.11.1002/19126-2.json |
| 19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture | ./2.16.840.1.114222.4.11.1002/19127-0.json |
| 19128-8 | Bacteria identified in Catheter tip by Culture | ./2.16.840.1.114222.4.11.1002/19128-8.json |
| 19133-8 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/19133-8.json |
| 19134-6 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/19134-6.json |
| 19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/19137-9.json |
| 19140-3 | Phospholipid Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19140-3.json |
| 19141-1 | Propoxyphene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/19141-1.json |
| 19161-9 | Urobilinogen [Units/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/19161-9.json |
| 19162-7 | Varicella zoster virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19162-7.json |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19163-5.json |
| 19164-3 | Cancer Ag 72-4 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19164-3.json |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19165-0.json |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19166-8.json |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19167-6.json |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19168-4.json |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19169-2.json |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19170-0.json |
| 19171-8 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19171-8.json |
| 19172-6 | Alpha-1-Fetoprotein [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19172-6.json |
| 19173-4 | Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19173-4.json |
| 1917-4 | Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1917-4.json |
| 19174-2 | Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19174-2.json |
| 19175-9 | Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19175-9.json |
| 19176-7 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19176-7.json |
| 19177-5 | Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19177-5.json |
| 19178-3 | Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19178-3.json |
| 19179-1 | Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/19179-1.json |
| 19180-9 | Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19180-9.json |
| 1918-2 | Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1918-2.json |
| 19182-5 | Cytokeratin 19 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19182-5.json |
| 19183-3 | Cytokeratin 19 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19183-3.json |
| 19184-1 | Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19184-1.json |
| 19185-8 | Tissue polypeptide specific Ag [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19185-8.json |
| 19186-6 | Cancer Ag 15-3 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19186-6.json |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19187-4.json |
| 19188-2 | Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19188-2.json |
| 19189-0 | Cancer Ag 549 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19189-0.json |
| 1919-0 | Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/1919-0.json |
| 19190-8 | Cancer Ag 549 [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19190-8.json |
| 19193-2 | Enolase.neuron specific [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19193-2.json |
| 19194-0 | Enolase.neuron specific [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19194-0.json |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19195-7.json |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19197-3.json |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19198-1.json |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19199-9.json |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19200-5.json |
| 19201-3 | Prostate Specific Ag Free [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19201-3.json |
| 19203-9 | Prostate Specific Ag Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19203-9.json |
| 19204-7 | Prostate Specific Ag Free [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19204-7.json |
| 19205-4 | Prostate Specific Ag Free [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19205-4.json |
| 19206-2 | Prostate Specific Ag Free [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/19206-2.json |
| 19207-0 | Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19207-0.json |
| 1920-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1920-8.json |
| 19208-8 | Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/19208-8.json |
| 19209-6 | Squamous cell carcinoma Ag [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19209-6.json |
| 19210-4 | Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/19210-4.json |
| 19211-2 | Oxygen [Partial pressure] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19211-2.json |
| 19212-0 | Carbon dioxide [Partial pressure] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19212-0.json |
| 19213-8 | pH of Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19213-8.json |
| 1921-6 | Atrial natriuretic factor [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/1921-6.json |
| 19223-7 | Carbon dioxide, total [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19223-7.json |
| 19229-4 | Bicarbonate [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19229-4.json |
| 19239-3 | Lactate [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/19239-3.json |
| 19240-1 | Lactate [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/19240-1.json |
| 19243-5 | Brucella abortus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/19243-5.json |
| 19245-0 | clonazePAM [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/19245-0.json |
| 19247-6 | Doxepin+Metabolites [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19247-6.json |
| 19253-4 | Trichinella spiralis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/19253-4.json |
| 19259-1 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/19259-1.json |
| 19260-9 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/19260-9.json |
| 19261-7 | Amphetamines [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19261-7.json |
| 19270-8 | Barbiturates [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19270-8.json |
| 1928-1 | Immunoglobulin light chains [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/1928-1.json |
| 19289-8 | Cannabinoids [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19289-8.json |
| 19290-6 | Cannabinoids positive [Identifier] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19290-6.json |
| 19295-5 | Opiates [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19295-5.json |
| 19298-9 | Opiates positive [Identifier] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19298-9.json |
| 1929-9 | Immunoglobulin light chains [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1929-9.json |
| 19303-7 | Thiazides [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19303-7.json |
| 19306-0 | Thiazides [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19306-0.json |
| 1930-7 | Benzoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1930-7.json |
| 19312-8 | Tricyclic antidepressants [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19312-8.json |
| 19315-1 | Tricyclic antidepressants [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19315-1.json |
| 19321-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19321-9.json |
| 19322-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19322-7.json |
| 19325-0 | Alpha hydroxyalprazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19325-0.json |
| 19326-8 | Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19326-8.json |
| 19328-4 | Alpha hydroxyalprazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19328-4.json |
| 19331-8 | Amitriptyline [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19331-8.json |
| 19335-9 | Amitriptyline+Nortriptyline [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19335-9.json |
| 19336-7 | Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19336-7.json |
| 19339-1 | Amobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19339-1.json |
| 19341-7 | Amobarbital cutoff [Mass/volume] in Urine for Screen method | ./2.16.840.1.114222.4.11.1002/19341-7.json |
| 19343-3 | Amphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19343-3.json |
| 19344-1 | Amphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19344-1.json |
| 19346-6 | Amphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19346-6.json |
| 19349-0 | Aprobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19349-0.json |
| 19350-8 | Aprobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19350-8.json |
| 19353-2 | Barbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19353-2.json |
| 19354-0 | Barbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19354-0.json |
| 19359-9 | Cocaine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19359-9.json |
| 19360-7 | Cocaine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19360-7.json |
| 19364-9 | Bromazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19364-9.json |
| 19365-6 | Bromazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19365-6.json |
| 19368-0 | Butabarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19368-0.json |
| 19370-6 | Butabarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19370-6.json |
| 1937-2 | Beta endorphin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1937-2.json |
| 19373-0 | Butalbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19373-0.json |
| 19377-1 | Butorphanol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19377-1.json |
| 19378-9 | Butorphanol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19378-9.json |
| 1938-0 | Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1938-0.json |
| 19381-3 | Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19381-3.json |
| 19382-1 | Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19382-1.json |
| 19385-4 | chlordiazePOXIDE [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19385-4.json |
| 19386-2 | chlordiazePOXIDE [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19386-2.json |
| 19389-6 | Chlorpheniramine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19389-6.json |
| 19391-2 | Chlorpheniramine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19391-2.json |
| 19392-0 | Chlorpheniramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19392-0.json |
| 19395-3 | chlorproMAZINE [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19395-3.json |
| 19396-1 | chlorproMAZINE [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19396-1.json |
| 1939-8 | Beta fructofuranosidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1939-8.json |
| 19399-5 | clonazePAM [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19399-5.json |
| 19402-7 | clonazePAM [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19402-7.json |
| 19405-0 | Cocaethylene [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19405-0.json |
| 1940-6 | Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/1940-6.json |
| 19406-8 | Cocaethylene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19406-8.json |
| 19408-4 | Cocaethylene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19408-4.json |
| 19411-8 | Codeine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19411-8.json |
| 1941-4 | Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1941-4.json |
| 19415-9 | Tetrahydrocannabinol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19415-9.json |
| 19416-7 | Tetrahydrocannabinol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19416-7.json |
| 19419-1 | Dextroamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19419-1.json |
| 19420-9 | Dextroamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19420-9.json |
| 1942-2 | Beta galactosidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1942-2.json |
| 19423-3 | Dextromethamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19423-3.json |
| 19424-1 | Dextromethamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19424-1.json |
| 19425-8 | Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19425-8.json |
| 19429-0 | Propoxyphene [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19429-0.json |
| 1943-0 | Glucosylceramidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/1943-0.json |
| 19433-2 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19433-2.json |
| 19434-0 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19434-0.json |
| 19435-7 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19435-7.json |
| 19436-5 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19436-5.json |
| 19439-9 | Diamorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19439-9.json |
| 19443-1 | diazePAM [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19443-1.json |
| 19446-4 | Dihydrocodeine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19446-4.json |
| 1944-8 | Beta glucuronidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1944-8.json |
| 19448-0 | Dihydrocodeine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19448-0.json |
| 19449-8 | Dihydrocodeine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19449-8.json |
| 19452-2 | Dimetamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19452-2.json |
| 19453-0 | Dimetamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19453-0.json |
| 1945-5 | Beta glucuronidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1945-5.json |
| 19456-3 | Ethylamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19456-3.json |
| 19458-9 | Ethylamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19458-9.json |
| 19459-7 | Ethylamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19459-7.json |
| 19462-1 | Ethylmorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19462-1.json |
| 1946-3 | Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1946-3.json |
| 19463-9 | Ethylmorphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19463-9.json |
| 19466-2 | Flunitrazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19466-2.json |
| 19467-0 | Flunitrazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19467-0.json |
| 19470-4 | FLUoxetine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19470-4.json |
| 1947-1 | Beta hydroxybutyrate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1947-1.json |
| 19471-2 | FLUoxetine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19471-2.json |
| 19474-6 | Flurazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19474-6.json |
| 19475-3 | Flurazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19475-3.json |
| 19478-7 | Haloperidol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19478-7.json |
| 19479-5 | Haloperidol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19479-5.json |
| 19482-9 | HYDROcodone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19482-9.json |
| 19483-7 | HYDROcodone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19483-7.json |
| 19486-0 | HYDROmorphone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19486-0.json |
| 19489-4 | Hydroxyalprazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19489-4.json |
| 19490-2 | Hydroxyalprazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19490-2.json |
| 19493-6 | Hydroxyethylflurazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19493-6.json |
| 19494-4 | Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19494-4.json |
| 1949-7 | Beta lipotropin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1949-7.json |
| 19497-7 | Hydroxytriazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19497-7.json |
| 19499-3 | Ketamine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19499-3.json |
| 19502-4 | Methotrimeprazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19502-4.json |
| 19503-2 | Methotrimeprazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19503-2.json |
| 1950-5 | Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1950-5.json |
| 19510-7 | Levomethamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19510-7.json |
| 19511-5 | Levomethamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19511-5.json |
| 19512-3 | Levomethamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19512-3.json |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1951-3.json |
| 19516-4 | Levorphanol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19516-4.json |
| 19520-6 | LORazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19520-6.json |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1952-1.json |
| 19524-8 | Lormetazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19524-8.json |
| 19525-5 | Lormetazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19525-5.json |
| 19528-9 | Lysergate diethylamide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19528-9.json |
| 19532-1 | Meperidine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19532-1.json |
| 19536-2 | Mephobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19536-2.json |
| 19537-0 | Mephobarbital [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19537-0.json |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1953-9.json |
| 19539-6 | Mephobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19539-6.json |
| 19542-0 | Mescaline [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19542-0.json |
| 19543-8 | Mescaline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19543-8.json |
| 19546-1 | Mesoridazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19546-1.json |
| 1954-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1954-7.json |
| 19547-9 | Mesoridazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19547-9.json |
| 19550-3 | Methadone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19550-3.json |
| 1955-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/1955-4.json |
| 19554-5 | Methamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19554-5.json |
| 19555-2 | Methamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19555-2.json |
| 19558-6 | Methaqualone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19558-6.json |
| 19561-0 | Methylenediamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19561-0.json |
| 1956-2 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1956-2.json |
| 19562-8 | Methylenediamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19562-8.json |
| 19565-1 | Methylenedioxyamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19565-1.json |
| 19566-9 | Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19566-9.json |
| 19568-5 | Methylenedioxymethamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19568-5.json |
| 19569-3 | Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19569-3.json |
| 1957-0 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1957-0.json |
| 19570-1 | Methylenedioxymethamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19570-1.json |
| 19573-5 | MethylePHEDrine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19573-5.json |
| 19577-6 | Methylphenidate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19577-6.json |
| 19578-4 | Methylphenidate [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19578-4.json |
| 19581-8 | Methyprylon [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19581-8.json |
| 19585-9 | Midazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19585-9.json |
| 19586-7 | Midazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19586-7.json |
| 1958-8 | Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1958-8.json |
| 19588-3 | Midazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19588-3.json |
| 19593-3 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19593-3.json |
| 1959-6 | Bicarbonate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1959-6.json |
| 19597-4 | Morphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19597-4.json |
| 19601-4 | Morphine Free [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19601-4.json |
| 19602-2 | Morphine Free [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19602-2.json |
| 1960-4 | Bicarbonate [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/1960-4.json |
| 19605-5 | Nalbuphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19605-5.json |
| 19609-7 | Naltrexone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19609-7.json |
| 19610-5 | Naltrexone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19610-5.json |
| 19611-3 | Naltrexone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19611-3.json |
| 1961-2 | Bicarbonate [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/1961-2.json |
| 19614-7 | N-desalkylflurazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19614-7.json |
| 19615-4 | N-desalkylflurazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19615-4.json |
| 19617-0 | N-desalkylflurazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19617-0.json |
| 19620-4 | Nitrazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19620-4.json |
| 19621-2 | Nitrazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19621-2.json |
| 19624-6 | Nordiazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19624-6.json |
| 19628-7 | Norfluoxetine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19628-7.json |
| 19629-5 | Norfluoxetine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19629-5.json |
| 19632-9 | Norpropoxyphene [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19632-9.json |
| 19635-2 | Norpropoxyphene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19635-2.json |
| 1963-8 | Bicarbonate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1963-8.json |
| 19638-6 | Oxazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19638-6.json |
| 19639-4 | Oxazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19639-4.json |
| 19642-8 | oxyCODONE [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19642-8.json |
| 19643-6 | oxyCODONE [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19643-6.json |
| 1964-6 | Bicarbonate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1964-6.json |
| 19646-9 | oxyMORphone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19646-9.json |
| 19648-5 | oxyMORphone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19648-5.json |
| 19651-9 | Para hydroxyamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19651-9.json |
| 19652-7 | Para hydroxyamphetamine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19652-7.json |
| 1965-3 | Bile [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/1965-3.json |
| 19655-0 | PENTobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19655-0.json |
| 19659-2 | Phencyclidine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19659-2.json |
| 1966-1 | Bile acid [Mass/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/1966-1.json |
| 19662-6 | Phenmetrazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19662-6.json |
| 19666-7 | PHENobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19666-7.json |
| 19670-9 | Phenothiazines [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19670-9.json |
| 19674-1 | Phentermine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19674-1.json |
| 19678-2 | Prazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19678-2.json |
| 1967-9 | Bile acid [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1967-9.json |
| 19679-0 | Prazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19679-0.json |
| 19682-4 | Psilocin [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19682-4.json |
| 19683-2 | Psilocin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19683-2.json |
| 19686-5 | Psilocybin [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19686-5.json |
| 1968-7 | Bilirubin.direct [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1968-7.json |
| 19687-3 | Psilocybin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19687-3.json |
| 19688-1 | Psilocybin [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19688-1.json |
| 19692-3 | Secobarbital [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19692-3.json |
| 1969-5 | Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1969-5.json |
| 19695-6 | Secobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19695-6.json |
| 19698-0 | Temazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19698-0.json |
| 1970-3 | Bilirubin.delta [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1970-3.json |
| 19706-1 | Thioridazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19706-1.json |
| 19707-9 | Thioridazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19707-9.json |
| 19710-3 | traMADol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19710-3.json |
| 1971-1 | Bilirubin.indirect [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1971-1.json |
| 19714-5 | Triazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19714-5.json |
| 19718-6 | Trichlorothiazide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/19718-6.json |
| 19719-4 | Trichlorothiazide [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19719-4.json |
| 19720-2 | Trichlorothiazide [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/19720-2.json |
| 19721-0 | Trichlorothiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/19721-0.json |
| 19724-4 | Abachi Wood Dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19724-4.json |
| 19725-1 | Aspergillus flavus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19725-1.json |
| 19726-9 | Aspergillus fumigatus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19726-9.json |
| 19727-7 | Aspergillus niger IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19727-7.json |
| 19728-5 | Beet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19728-5.json |
| 1972-9 | Bilirubin.total [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/1972-9.json |
| 19729-3 | Blue vetch IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19729-3.json |
| 19732-7 | Cat serum albumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19732-7.json |
| 19733-5 | Cefaclor IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19733-5.json |
| 19734-3 | Chicken droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19734-3.json |
| 19736-8 | Coralbumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19736-8.json |
| 1973-7 | Bilirubin.total [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1973-7.json |
| 19737-6 | Cotton fibers IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19737-6.json |
| 19738-4 | Dog serum albumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19738-4.json |
| 19739-2 | Fenugreek IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19739-2.json |
| 19740-0 | Fox epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19740-0.json |
| 19741-8 | Hake IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19741-8.json |
| 19742-6 | Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19742-6.json |
| 19743-4 | Horse meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19743-4.json |
| 19744-2 | Jackfruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19744-2.json |
| 1974-5 | Bilirubin.total [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/1974-5.json |
| 19746-7 | Maleic anhydride IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19746-7.json |
| 19747-5 | Mealworm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19747-5.json |
| 19748-3 | Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19748-3.json |
| 19749-1 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19749-1.json |
| 19751-7 | Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19751-7.json |
| 1975-2 | Bilirubin.total [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1975-2.json |
| 19752-5 | Pigeon serum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19752-5.json |
| 19753-3 | Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19753-3.json |
| 19754-1 | Red Currant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19754-1.json |
| 19755-8 | Saffron IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19755-8.json |
| 19756-6 | Sheep milk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19756-6.json |
| 19757-4 | Sheep whey IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19757-4.json |
| 19758-2 | Silk waste IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19758-2.json |
| 19759-0 | Swine serum albumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19759-0.json |
| 1976-0 | Bilirubin.total [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/1976-0.json |
| 19760-8 | Clostridium tetani toxoid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/19760-8.json |
| 19761-6 | Thermoactinomyces vulgaris IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/19761-6.json |
| 19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain | ./2.16.840.1.114222.4.11.1002/19765-7.json |
| 19766-5 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative | ./2.16.840.1.114222.4.11.1002/19766-5.json |
| 1977-8 | Bilirubin.total [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/1977-8.json |
| 1978-6 | Bilirubin.total [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1978-6.json |
| 1979-4 | Biopterin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/1979-4.json |
| 1980-2 | Biotin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1980-2.json |
| 1981-0 | Biotinidase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/1981-0.json |
| 1982-8 | Biotinidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1982-8.json |
| 1983-6 | Bradykinin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1983-6.json |
| 1984-4 | Bromide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1984-4.json |
| 1985-1 | Bromide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1985-1.json |
| 1986-9 | C peptide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1986-9.json |
| 1987-7 | C peptide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/1987-7.json |
| 1988-5 | C reactive protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1988-5.json |
| 1989-3 | 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1989-3.json |
| 1990-1 | Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1990-1.json |
| 1991-9 | Calciferol binding proteins [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/1991-9.json |
| 1992-7 | Calcitonin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1992-7.json |
| 1993-5 | Calcium renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1993-5.json |
| 1994-3 | Calcium.ionized [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1994-3.json |
| 1995-0 | Calcium.ionized [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/1995-0.json |
| 1996-8 | Calcium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/1996-8.json |
| 1997-6 | Calcium [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/1997-6.json |
| 1998-4 | Calcium [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/1998-4.json |
| 1999-2 | Calcium [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/1999-2.json |
| 2000-8 | Calcium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2000-8.json |
| 2001-6 | Calcium [Moles/volume] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/2001-6.json |
| 2002-4 | Calcium [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/2002-4.json |
| 2004-0 | Calcium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2004-0.json |
| 2005-7 | Calcium [Moles/time] in 2 hour Urine --12 hours fasting | ./2.16.840.1.114222.4.11.1002/2005-7.json |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2006-5.json |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2007-3.json |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2009-9.json |
| 2011-5 | Cancer Ag 242 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2011-5.json |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2012-3.json |
| 2013-1 | Cancer Ag 50 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2013-1.json |
| 2014-9 | Cancer Ag 549 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2014-9.json |
| 2015-6 | Cancer Ag 72-4 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2015-6.json |
| 2016-4 | Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2016-4.json |
| 2017-2 | Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2017-2.json |
| 2018-0 | Carbon dioxide [Partial pressure] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2018-0.json |
| 2019-8 | Carbon dioxide [Partial pressure] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2019-8.json |
| 2020-6 | Carbon dioxide [Partial pressure] in Capillary blood | ./2.16.840.1.114222.4.11.1002/2020-6.json |
| 2021-4 | Carbon dioxide [Partial pressure] in Venous blood | ./2.16.840.1.114222.4.11.1002/2021-4.json |
| 2022-2 | Carbon dioxide [Partial pressure] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2022-2.json |
| 2023-0 | Carbon dioxide [Partial pressure] in Body fluid | ./2.16.840.1.114222.4.11.1002/2023-0.json |
| 2024-8 | Carbon dioxide dissolved [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2024-8.json |
| 2025-5 | Carbon dioxide dissolved [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2025-5.json |
| 2026-3 | Carbon dioxide, total [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2026-3.json |
| 2027-1 | Carbon dioxide, total [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/2027-1.json |
| 2028-9 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2028-9.json |
| 2033-9 | Carbonate [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2033-9.json |
| 2034-7 | Carbonate [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/2034-7.json |
| 2035-4 | Carbonate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2035-4.json |
| 2036-2 | Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2036-2.json |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2037-0.json |
| 20375-2 | Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/20375-2.json |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2038-8.json |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2039-6.json |
| 20398-4 | Homogenous nuclear Ab pattern [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20398-4.json |
| 20399-2 | Nucleolar nuclear Ab pattern [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20399-2.json |
| 20400-8 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20400-8.json |
| 20401-6 | Speckled nuclear Ab pattern [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20401-6.json |
| 20402-4 | CD16+CD56+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/20402-4.json |
| 20403-2 | Fibronectin.fetal [Mass/volume] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/20403-2.json |
| 2040-4 | Cardiolipin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2040-4.json |
| 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/20404-0.json |
| 20405-7 | Urobilinogen [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/20405-7.json |
| 20410-7 | Amphetamines [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20410-7.json |
| 20411-5 | Barbiturates [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20411-5.json |
| 2041-2 | Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2041-2.json |
| 20412-3 | Benzodiazepines [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20412-3.json |
| 20413-1 | Cannabinoids [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20413-1.json |
| 20414-9 | Thiazides [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20414-9.json |
| 20415-6 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS | ./2.16.840.1.114222.4.11.1002/20415-6.json |
| 20416-4 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20416-4.json |
| 20417-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20417-2.json |
| 20418-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20418-0.json |
| 20419-8 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP | ./2.16.840.1.114222.4.11.1002/20419-8.json |
| 2042-0 | Carnitine free (C0) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2042-0.json |
| 20420-6 | Prostatic acid phosphatase [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/20420-6.json |
| 20421-4 | Barbiturates [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20421-4.json |
| 20423-0 | Beta lactamase organism identified in Isolate | ./2.16.840.1.114222.4.11.1002/20423-0.json |
| 20427-1 | Acetylcholine receptor Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/20427-1.json |
| 20428-9 | Phospholipid IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20428-9.json |
| 20429-7 | Phospholipid IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20429-7.json |
| 20430-5 | Culture medium [Type] in Isolate | ./2.16.840.1.114222.4.11.1002/20430-5.json |
| 20431-3 | Microscopic observation [Identifier] in Specimen by Smear | ./2.16.840.1.114222.4.11.1002/20431-3.json |
| 20432-1 | Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20432-1.json |
| 20433-9 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP | ./2.16.840.1.114222.4.11.1002/20433-9.json |
| 20434-7 | Prolactin [Units/volume] in Serum or Plasma by 3rd IS | ./2.16.840.1.114222.4.11.1002/20434-7.json |
| 20435-4 | Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20435-4.json |
| 20436-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/20436-2.json |
| 20437-0 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/20437-0.json |
| 2043-8 | Carnitine free (C0) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2043-8.json |
| 20438-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/20438-8.json |
| 20439-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/20439-6.json |
| 20442-0 | Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/20442-0.json |
| 20444-6 | Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20444-6.json |
| 20445-3 | Herpes virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20445-3.json |
| 2044-6 | Carnitine [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2044-6.json |
| 20447-9 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20447-9.json |
| 20448-7 | Insulin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20448-7.json |
| 20449-5 | Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20449-5.json |
| 20451-1 | Thyroxine (T4) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/20451-1.json |
| 20452-9 | Thyrotropin [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/20452-9.json |
| 2045-3 | Carnitine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2045-3.json |
| 20459-4 | Streptococcus agalactiae Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/20459-4.json |
| 2046-1 | Carnitine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2046-1.json |
| 20463-6 | Mycobacterium avium complex rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20463-6.json |
| 20468-5 | Thiamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20468-5.json |
| 20469-3 | Acetone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20469-3.json |
| 20470-1 | Ethanol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20470-1.json |
| 20471-9 | Isopropanol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20471-9.json |
| 20474-3 | Bacteria identified in Tissue by Biopsy culture | ./2.16.840.1.114222.4.11.1002/20474-3.json |
| 2047-9 | Carnitine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2047-9.json |
| 20479-2 | Measles virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20479-2.json |
| 20483-4 | Mitochondria Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20483-4.json |
| 20484-2 | Cardiolipin IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20484-2.json |
| 20485-9 | Cardiolipin IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20485-9.json |
| 20486-7 | Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/20486-7.json |
| 20487-5 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/20487-5.json |
| 20488-3 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/20488-3.json |
| 20489-1 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/20489-1.json |
| 20490-9 | Epstein Barr virus capsid IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20490-9.json |
| 20491-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20491-7.json |
| 20495-8 | Gliadin IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20495-8.json |
| 20496-6 | Gliadin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20496-6.json |
| 20497-4 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20497-4.json |
| 20498-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20498-2.json |
| 20500-5 | Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20500-5.json |
| 20501-3 | Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20501-3.json |
| 20502-1 | Clue cells [Presence] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/20502-1.json |
| 20507-0 | Reagin Ab [Presence] in Serum by RPR | ./2.16.840.1.114222.4.11.1002/20507-0.json |
| 20508-8 | Reagin Ab [Units/volume] in Serum or Plasma by RPR | ./2.16.840.1.114222.4.11.1002/20508-8.json |
| 20515-3 | Amitriptyline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20515-3.json |
| 20516-1 | Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20516-1.json |
| 20517-9 | Aprobarbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20517-9.json |
| 20518-7 | Barbital [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20518-7.json |
| 20519-5 | Cocaine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20519-5.json |
| 20520-3 | Bromazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20520-3.json |
| 20521-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20521-1.json |
| 20522-9 | chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20522-9.json |
| 20523-7 | chlorproMAZINE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20523-7.json |
| 20525-2 | Dextroamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20525-2.json |
| 20526-0 | Dimetamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20526-0.json |
| 20527-8 | Ethylmorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20527-8.json |
| 20528-6 | Flunitrazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20528-6.json |
| 2052-9 | Carotene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2052-9.json |
| 20529-4 | FLUoxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20529-4.json |
| 20530-2 | Haloperidol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20530-2.json |
| 20532-8 | Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20532-8.json |
| 20533-6 | Hydroxytriazolam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20533-6.json |
| 2053-7 | Carotene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2053-7.json |
| 20537-7 | Ketamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20537-7.json |
| 20538-5 | Methotrimeprazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20538-5.json |
| 20540-1 | Levorphanol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20540-1.json |
| 20541-9 | Lormetazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20541-9.json |
| 20542-7 | Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20542-7.json |
| 20543-5 | Mescaline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20543-5.json |
| 20544-3 | Mesoridazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20544-3.json |
| 2054-5 | Catalase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2054-5.json |
| 20545-0 | Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20545-0.json |
| 20547-6 | MethylePHEDrine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20547-6.json |
| 20548-4 | Methylphenidate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20548-4.json |
| 20549-2 | Methyprylon [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20549-2.json |
| 20550-0 | Morphine Free [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20550-0.json |
| 20551-8 | Nalbuphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20551-8.json |
| 2055-2 | Catecholamines [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2055-2.json |
| 20552-6 | Nitrazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20552-6.json |
| 20553-4 | Norfluoxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20553-4.json |
| 20554-2 | Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20554-2.json |
| 20555-9 | Phenmetrazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20555-9.json |
| 20556-7 | Phenothiazines [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20556-7.json |
| 20557-5 | Phentermine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20557-5.json |
| 20558-3 | Psilocin [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20558-3.json |
| 20559-1 | Temazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20559-1.json |
| 2056-0 | Catecholamines [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2056-0.json |
| 20560-9 | Thioridazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20560-9.json |
| 20561-7 | traMADol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/20561-7.json |
| 20563-3 | Carboxyhemoglobin/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/20563-3.json |
| 20564-1 | Oxygen saturation in Blood | ./2.16.840.1.114222.4.11.1002/20564-1.json |
| 20565-8 | Carbon dioxide, total [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/20565-8.json |
| 20566-6 | Colony count [#/volume] in Catheter tip by Culture | ./2.16.840.1.114222.4.11.1002/20566-6.json |
| 20567-4 | Ferritin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/20567-4.json |
| 20568-2 | Prolactin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/20568-2.json |
| 20570-8 | Hematocrit [Volume Fraction] of Blood | ./2.16.840.1.114222.4.11.1002/20570-8.json |
| 20571-6 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/20571-6.json |
| 20573-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20573-2.json |
| 20574-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20574-0.json |
| 20575-7 | Hepatitis A virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20575-7.json |
| 20576-5 | Galactose 1 phosphate uridyl transferase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/20576-5.json |
| 2057-8 | Catecholamines [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2057-8.json |
| 20578-1 | Vancomycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20578-1.json |
| 20579-9 | Methanol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20579-9.json |
| 2058-6 | Catecholamines [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2058-6.json |
| 20592-2 | CD19 cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20592-2.json |
| 20593-0 | CD19 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/20593-0.json |
| 2059-4 | Cerebroside sulfatase [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2059-4.json |
| 20598-9 | CD3 cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20598-9.json |
| 2060-2 | Cerebroside sulfatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2060-2.json |
| 20603-7 | CD38 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/20603-7.json |
| 20608-6 | CD41 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/20608-6.json |
| 20609-4 | CD42 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/20609-4.json |
| 2061-0 | Cerebroside sulfatase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2061-0.json |
| 20620-1 | CD16+CD56+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/20620-1.json |
| 20621-9 | Albumin/Creatinine [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/20621-9.json |
| 20622-7 | Cortisol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/20622-7.json |
| 20624-3 | Creatinine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/20624-3.json |
| 20625-0 | Lead [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/20625-0.json |
| 2062-8 | Cerebroside sulfatase [Presence] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2062-8.json |
| 2063-6 | Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2063-6.json |
| 20640-9 | Citrulline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20640-9.json |
| 2064-4 | Ceruloplasmin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2064-4.json |
| 20646-6 | Homocystine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20646-6.json |
| 20647-4 | Hydroxyproline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20647-4.json |
| 20660-7 | Tyrosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20660-7.json |
| 20662-3 | Allergens tested for in Serum | ./2.16.840.1.114222.4.11.1002/20662-3.json |
| 20663-1 | Tricyclic antidepressants [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/20663-1.json |
| 20664-9 | Barbiturates [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/20664-9.json |
| 20665-6 | Echovirus 14 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20665-6.json |
| 20669-8 | Cardiolipin IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/20669-8.json |
| 20672-2 | Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20672-2.json |
| 20673-0 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20673-0.json |
| 20674-8 | Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20674-8.json |
| 20675-5 | Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20675-5.json |
| 20676-3 | Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20676-3.json |
| 20677-1 | Equine adenovirus Ag [Presence] in Lung by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20677-1.json |
| 20678-9 | Alkaloid identified in Urine by Thin layer chromatography (TLC) | ./2.16.840.1.114222.4.11.1002/20678-9.json |
| 20679-7 | Alkaloid identified in Plant by Thin layer chromatography (TLC) | ./2.16.840.1.114222.4.11.1002/20679-7.json |
| 20680-5 | Alkaloid identified in Ingesta by Thin layer chromatography (TLC) | ./2.16.840.1.114222.4.11.1002/20680-5.json |
| 20681-3 | Alpha tocopherol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20681-3.json |
| 20682-1 | Ammonia [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/20682-1.json |
| 20683-9 | Ammonia [Mass/volume] in Ingesta | ./2.16.840.1.114222.4.11.1002/20683-9.json |
| 20684-7 | Ammonia [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/20684-7.json |
| 2068-5 | Chloride [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2068-5.json |
| 20685-4 | Anaplasma marginale Ab [Presence] in Serum by Card agglutination | ./2.16.840.1.114222.4.11.1002/20685-4.json |
| 20686-2 | Anaplasma marginale Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20686-2.json |
| 20687-0 | Arsenic [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20687-0.json |
| 20688-8 | Aspergillus sp identified in Litter by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20688-8.json |
| 20689-6 | Babesia caballi Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20689-6.json |
| 20690-4 | Theileria equi Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20690-4.json |
| 20692-0 | Bacillus cereus [Presence] in Food by Culture FDA method | ./2.16.840.1.114222.4.11.1002/20692-0.json |
| 2069-3 | Chloride [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2069-3.json |
| 20693-8 | Bacteria identified in Litter by Aerobe culture | ./2.16.840.1.114222.4.11.1002/20693-8.json |
| 20694-6 | Bacteria identified in Embryo by Aerobe culture | ./2.16.840.1.114222.4.11.1002/20694-6.json |
| 20695-3 | Bacteria [#/volume] in Mother's milk | ./2.16.840.1.114222.4.11.1002/20695-3.json |
| 20696-1 | Bifidobacterium sp [#/volume] in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20696-1.json |
| 20697-9 | Amines.biogenic [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20697-9.json |
| 20698-7 | Bluetongue virus serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20698-7.json |
| 20699-5 | Bluetongue virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20699-5.json |
| 20700-1 | Bluetongue virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20700-1.json |
| 2070-1 | Chloride [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2070-1.json |
| 20701-9 | Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20701-9.json |
| 20702-7 | Bluetongue virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20702-7.json |
| 20703-5 | Border disease virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20703-5.json |
| 20704-3 | Border disease virus Ag [Presence] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20704-3.json |
| 20705-0 | Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation | ./2.16.840.1.114222.4.11.1002/20705-0.json |
| 20706-8 | Clostridium botulinum toxin [Identifier] in Specimen by Animal inoculation | ./2.16.840.1.114222.4.11.1002/20706-8.json |
| 20708-4 | Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20708-4.json |
| 20709-2 | Bovine diarrhea virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20709-2.json |
| 20710-0 | Bovine diarrhea virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20710-0.json |
| 20711-8 | Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20711-8.json |
| 20712-6 | Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20712-6.json |
| 20713-4 | Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20713-4.json |
| 20714-2 | Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20714-2.json |
| 20715-9 | Bovine diarrhea virus Ag [Presence] in Serum by Immune stain | ./2.16.840.1.114222.4.11.1002/20715-9.json |
| 20716-7 | Bovine diarrhea virus [Presence] in Serum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20716-7.json |
| 20717-5 | Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20717-5.json |
| 20718-3 | Bromide [Mass/volume] in Ocular fluid | ./2.16.840.1.114222.4.11.1002/20718-3.json |
| 2071-9 | Chloride [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2071-9.json |
| 20719-1 | Brucella abortus Ab [Titer] in Serum by Tube agglutination | ./2.16.840.1.114222.4.11.1002/20719-1.json |
| 20720-9 | Brucella abortus Ab [Presence] in Milk by Serial ring agglutination | ./2.16.840.1.114222.4.11.1002/20720-9.json |
| 20721-7 | Brucella abortus Ab [Presence] in Semen by Agglutination | ./2.16.840.1.114222.4.11.1002/20721-7.json |
| 20722-5 | Brucella abortus Ab [Titer] in Serum by Rivanol agglutination | ./2.16.840.1.114222.4.11.1002/20722-5.json |
| 20723-3 | Brucella abortus Ab [Presence] in Serum by Rapid agglutination | ./2.16.840.1.114222.4.11.1002/20723-3.json |
| 20724-1 | Brucella abortus Ab [Presence] in Whey by Ring agglutination | ./2.16.840.1.114222.4.11.1002/20724-1.json |
| 20725-8 | Brucella abortus Ab [Presence] in Milk by Ring agglutination | ./2.16.840.1.114222.4.11.1002/20725-8.json |
| 20726-6 | Brucella abortus Ab [Presence] in Serum by Card agglutination | ./2.16.840.1.114222.4.11.1002/20726-6.json |
| 2072-7 | Chloride [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2072-7.json |
| 20727-4 | Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination | ./2.16.840.1.114222.4.11.1002/20727-4.json |
| 20728-2 | Brucella abortus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20728-2.json |
| 20729-0 | Brucella abortus Ab [Titer] in Serum by Plate agglutination | ./2.16.840.1.114222.4.11.1002/20729-0.json |
| 20730-8 | Brucella abortus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20730-8.json |
| 20731-6 | Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST | ./2.16.840.1.114222.4.11.1002/20731-6.json |
| 20732-4 | Brucella ovis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20732-4.json |
| 20733-2 | Brucella ovis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20733-2.json |
| 20734-0 | Brucella sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20734-0.json |
| 2073-5 | Chloride [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2073-5.json |
| 20735-7 | Brucella sp identified in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20735-7.json |
| 20736-5 | Cache valley virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20736-5.json |
| 20737-3 | Cadmium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20737-3.json |
| 20738-1 | Campylobacter sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20738-1.json |
| 20739-9 | Campylobacter sp identified in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20739-9.json |
| 20740-7 | Campylobacter sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20740-7.json |
| 20741-5 | Canarypox virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20741-5.json |
| 20742-3 | Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20742-3.json |
| 2074-3 | Chloride [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2074-3.json |
| 20745-6 | Carbamates [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/20745-6.json |
| 20746-4 | Carbamates [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/20746-4.json |
| 20747-2 | Carbamates [Presence] in Ingesta by Screen method | ./2.16.840.1.114222.4.11.1002/20747-2.json |
| 20748-0 | Carbamates [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/20748-0.json |
| 20749-8 | Carbamates [Presence] in Feed by Screen method | ./2.16.840.1.114222.4.11.1002/20749-8.json |
| 2075-0 | Chloride [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2075-0.json |
| 20750-6 | Chicken anemia virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20750-6.json |
| 20751-4 | Chicken anemia virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20751-4.json |
| 20752-2 | Chlamydophila psittaci [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20752-2.json |
| 20753-0 | Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20753-0.json |
| 20754-8 | Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20754-8.json |
| 20755-5 | Chlamydia sp Ag [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/20755-5.json |
| 20756-3 | Chlamydia sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/20756-3.json |
| 20757-1 | Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20757-1.json |
| 20758-9 | Cholinesterase [Enzymatic activity/mass] in Brain | ./2.16.840.1.114222.4.11.1002/20758-9.json |
| 20759-7 | Chromium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20759-7.json |
| 20760-5 | Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20760-5.json |
| 20761-3 | Clostridioides difficile [Presence] in Stool by Agglutination | ./2.16.840.1.114222.4.11.1002/20761-3.json |
| 20762-1 | Clostridioides difficile [Presence] in Stool by Aerobe culture | ./2.16.840.1.114222.4.11.1002/20762-1.json |
| 20763-9 | Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20763-9.json |
| 20764-7 | Clostridium perfringens genotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20764-7.json |
| 20765-4 | Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20765-4.json |
| 20766-2 | Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20766-2.json |
| 20767-0 | Coccidioides immitis [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/20767-0.json |
| 2076-8 | Chloride [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/2076-8.json |
| 20768-8 | Coccidioides immitis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20768-8.json |
| 20769-6 | Coliform bacteria [#/volume] in Water by Viability count | ./2.16.840.1.114222.4.11.1002/20769-6.json |
| 20770-4 | Coliform bacteria [#/volume] by Viability count | ./2.16.840.1.114222.4.11.1002/20770-4.json |
| 20771-2 | Coliform bacteria [#/mass] in Egg by Viability count | ./2.16.840.1.114222.4.11.1002/20771-2.json |
| 20772-0 | Coliform colony count [#/volume] in Milk | ./2.16.840.1.114222.4.11.1002/20772-0.json |
| 20773-8 | Colony count [#/volume] in Milk by Culture Standard Plate Count | ./2.16.840.1.114222.4.11.1002/20773-8.json |
| 20774-6 | Colony count [Units/volume] in Specimen by Visual count | ./2.16.840.1.114222.4.11.1002/20774-6.json |
| 20775-3 | Colony count [Units/volume] in Specimen by Viability count FDA method | ./2.16.840.1.114222.4.11.1002/20775-3.json |
| 2077-6 | Chloride [Moles/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/2077-6.json |
| 20776-1 | Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20776-1.json |
| 20777-9 | Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20777-9.json |
| 20778-7 | Copper [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20778-7.json |
| 20779-5 | Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20779-5.json |
| 20780-3 | Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain | ./2.16.840.1.114222.4.11.1002/20780-3.json |
| 20781-1 | Cryptosporidium sp [Presence] in Stool by Acid fast stain | ./2.16.840.1.114222.4.11.1002/20781-1.json |
| 20782-9 | Cyanide [Mass/mass] in Plant | ./2.16.840.1.114222.4.11.1002/20782-9.json |
| 20783-7 | Cyanide [Units/mass] in Plant Qualitative | ./2.16.840.1.114222.4.11.1002/20783-7.json |
| 2078-4 | Chloride [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2078-4.json |
| 20784-5 | Cyanide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20784-5.json |
| 20785-2 | Drugs identified in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/20785-2.json |
| 20786-0 | Drugs identified in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/20786-0.json |
| 20787-8 | Drugs identified in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/20787-8.json |
| 20788-6 | Duck enteritis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20788-6.json |
| 20789-4 | Escherichia coli serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20789-4.json |
| 20790-2 | Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/20790-2.json |
| 20791-0 | Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20791-0.json |
| 2079-2 | Chloride [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2079-2.json |
| 20792-8 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20792-8.json |
| 20793-6 | Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20793-6.json |
| 20794-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/20794-4.json |
| 20795-1 | Eastern equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20795-1.json |
| 20796-9 | Endophyte identified in Plant | ./2.16.840.1.114222.4.11.1002/20796-9.json |
| 20797-7 | Endotoxin identified in Specimen | ./2.16.840.1.114222.4.11.1002/20797-7.json |
| 20798-5 | Clostridium perfringens enterotoxin [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/20798-5.json |
| 20799-3 | Clostridium perfringens enterotoxin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/20799-3.json |
| 2080-0 | Cholate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2080-0.json |
| 20800-9 | Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed | ./2.16.840.1.114222.4.11.1002/20800-9.json |
| 20801-7 | Encephalitozoon cuniculi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20801-7.json |
| 20802-5 | Epizootic hemorrhagic disease virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20802-5.json |
| 20803-3 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20803-3.json |
| 20804-1 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20804-1.json |
| 20805-8 | Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20805-8.json |
| 20806-6 | Saint Louis encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/20806-6.json |
| 20807-4 | Equine arteritis virus [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20807-4.json |
| 20808-2 | Ergot alkaloid [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20808-2.json |
| 20809-0 | Ergot alkaloid [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20809-0.json |
| 20811-6 | Escherichia coli [Presence] in Specimen by Culture FDA method | ./2.16.840.1.114222.4.11.1002/20811-6.json |
| 20812-4 | Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20812-4.json |
| 20813-2 | Escherichia coli F41 [Presence] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/20813-2.json |
| 20814-0 | Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20814-0.json |
| 20815-7 | Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination | ./2.16.840.1.114222.4.11.1002/20815-7.json |
| 20816-5 | Escherichia coli K88 [Presence] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/20816-5.json |
| 20817-3 | Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20817-3.json |
| 2081-8 | Cholecystokinin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2081-8.json |
| 20818-1 | Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination | ./2.16.840.1.114222.4.11.1002/20818-1.json |
| 20819-9 | Escherichia coli K99 [Presence] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/20819-9.json |
| 20821-5 | Escherichia coli K99 [Presence] in Stool by Agglutination | ./2.16.840.1.114222.4.11.1002/20821-5.json |
| 20822-3 | Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20822-3.json |
| 20823-1 | Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20823-1.json |
| 20825-6 | Fumonisin [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20825-6.json |
| 2082-6 | Cholestanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2082-6.json |
| 20826-4 | Gallotannin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20826-4.json |
| 20827-2 | Gallotannin [Mass/mass] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20827-2.json |
| 20828-0 | Gallotannin [Mass/mass] in Plant | ./2.16.840.1.114222.4.11.1002/20828-0.json |
| 20829-8 | Glycol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20829-8.json |
| 20830-6 | Glycol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/20830-6.json |
| 20831-4 | Glycolate [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20831-4.json |
| 20832-2 | Gossypol [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20832-2.json |
| 20833-0 | Haemophilus paragallinarum serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20833-0.json |
| 2083-4 | Cholesterol esterase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2083-4.json |
| 20835-5 | Herbicide [Identifier] in Ingesta | ./2.16.840.1.114222.4.11.1002/20835-5.json |
| 20836-3 | Herbicide [Identifier] in Tissue | ./2.16.840.1.114222.4.11.1002/20836-3.json |
| 20837-1 | Herbicide [Identifier] in Feed | ./2.16.840.1.114222.4.11.1002/20837-1.json |
| 20838-9 | Herbicide [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/20838-9.json |
| 20839-7 | Herbicide [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/20839-7.json |
| 20840-5 | Herbicide [Presence] in Ingesta by Screen method | ./2.16.840.1.114222.4.11.1002/20840-5.json |
| 20841-3 | Herbicide [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/20841-3.json |
| 2084-2 | Cholesterol esters [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2084-2.json |
| 20842-1 | Herbicide [Presence] in Feed by Screen method | ./2.16.840.1.114222.4.11.1002/20842-1.json |
| 20843-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20843-9.json |
| 20844-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20844-7.json |
| 20845-4 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20845-4.json |
| 20846-2 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20846-2.json |
| 20847-0 | Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20847-0.json |
| 20848-8 | Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20848-8.json |
| 20849-6 | Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20849-6.json |
| 20850-4 | Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20850-4.json |
| 20851-2 | Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20851-2.json |
| 20852-0 | Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20852-0.json |
| 20853-8 | Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20853-8.json |
| 20854-6 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20854-6.json |
| 20855-3 | IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20855-3.json |
| 20856-1 | IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20856-1.json |
| 20857-9 | IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20857-9.json |
| 20858-7 | Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/20858-7.json |
| 2085-9 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2085-9.json |
| 20859-5 | Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test | ./2.16.840.1.114222.4.11.1002/20859-5.json |
| 20860-3 | Infectious bronchitis virus [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20860-3.json |
| 20861-1 | Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/20861-1.json |
| 20862-9 | Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/20862-9.json |
| 20864-5 | Iodine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/20864-5.json |
| 20865-2 | Iodine [Mass/mass] in Liver | ./2.16.840.1.114222.4.11.1002/20865-2.json |
| 20866-0 | Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20866-0.json |
| 20867-8 | Lead [Mass/mass] in Bone | ./2.16.840.1.114222.4.11.1002/20867-8.json |
| 20868-6 | Leptospira sp [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20868-6.json |
| 20869-4 | Leptospira sp [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20869-4.json |
| 20870-2 | Listeria sp [Presence] in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20870-2.json |
| 20871-0 | Listeria sp [Presence] in Cheese by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20871-0.json |
| 20872-8 | Magnesium [Mass/volume] in Ocular fluid | ./2.16.840.1.114222.4.11.1002/20872-8.json |
| 20873-6 | Alcelaphine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20873-6.json |
| 20874-4 | Manganese [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20874-4.json |
| 20875-1 | Manganese [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20875-1.json |
| 20876-9 | Mercury [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20876-9.json |
| 20877-7 | Bacteria identified in Isolate by Animal inoculation | ./2.16.840.1.114222.4.11.1002/20877-7.json |
| 20878-5 | Bacteria identified in Isolate by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/20878-5.json |
| 20879-3 | Bacteria identified in Milk by Aerobe culture | ./2.16.840.1.114222.4.11.1002/20879-3.json |
| 20881-9 | Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion | ./2.16.840.1.114222.4.11.1002/20881-9.json |
| 20882-7 | Microscopic observation [Identifier] in Stool by Electron microscopy negative stain | ./2.16.840.1.114222.4.11.1002/20882-7.json |
| 20883-5 | Microscopic observation [Identifier] in Urine by Dark field examination | ./2.16.840.1.114222.4.11.1002/20883-5.json |
| 20884-3 | Microscopic observation [Identifier] in Stool by Dark field examination | ./2.16.840.1.114222.4.11.1002/20884-3.json |
| 20885-0 | Microscopic observation [Identifier] in Gastric fluid by Dark field examination | ./2.16.840.1.114222.4.11.1002/20885-0.json |
| 20886-8 | Molybdenum [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/20886-8.json |
| 20887-6 | Molybdenum [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20887-6.json |
| 20888-4 | Molybdenum [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20888-4.json |
| 20889-2 | Monensin [Mass/mass] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20889-2.json |
| 20890-0 | Monensin [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20890-0.json |
| 2089-1 | Cholesterol in LDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2089-1.json |
| 20891-8 | Mushroom identified | ./2.16.840.1.114222.4.11.1002/20891-8.json |
| 20892-6 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20892-6.json |
| 20893-4 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20893-4.json |
| 20894-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20894-2.json |
| 20895-9 | Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/20895-9.json |
| 20896-7 | Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan) | ./2.16.840.1.114222.4.11.1002/20896-7.json |
| 20897-5 | Mycoplasma sp serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/20897-5.json |
| 20898-3 | Mycoplasma sp [Presence] in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20898-3.json |
| 20899-1 | Mycoplasma sp [Presence] in Exudate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20899-1.json |
| 20900-7 | Mycoplasma sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/20900-7.json |
| 20901-5 | Mycoplasma sp Ag [Presence] in Isolate by Immune stain | ./2.16.840.1.114222.4.11.1002/20901-5.json |
| 20902-3 | Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20902-3.json |
| 20903-1 | Mycotoxin identified in Feed | ./2.16.840.1.114222.4.11.1002/20903-1.json |
| 20904-9 | Neospora caninum Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20904-9.json |
| 20905-6 | Oleandrin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/20905-6.json |
| 20906-4 | Oleandrin [Mass/volume] in Ingesta | ./2.16.840.1.114222.4.11.1002/20906-4.json |
| 20907-2 | Organochlorine pesticides [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/20907-2.json |
| 20908-0 | Organochlorine pesticides [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/20908-0.json |
| 20909-8 | Organochlorine pesticides [Identifier] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20909-8.json |
| 20910-6 | Organochlorine pesticides [Identifier] in Milk | ./2.16.840.1.114222.4.11.1002/20910-6.json |
| 20911-4 | Organochlorine pesticides [Identifier] in Tissue | ./2.16.840.1.114222.4.11.1002/20911-4.json |
| 20912-2 | Organochlorine pesticides [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/20912-2.json |
| 20913-0 | Organochlorine pesticides [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/20913-0.json |
| 20914-8 | Organochlorine pesticides [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/20914-8.json |
| 20915-5 | Organochlorine pesticides [Presence] in Milk by Screen method | ./2.16.840.1.114222.4.11.1002/20915-5.json |
| 20916-3 | Organochlorine pesticides [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/20916-3.json |
| 20917-1 | Organophosphate pesticides [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/20917-1.json |
| 20918-9 | Organophosphate pesticides [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/20918-9.json |
| 20919-7 | Organophosphate pesticides [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/20919-7.json |
| 20920-5 | Organophosphate pesticides [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/20920-5.json |
| 20921-3 | Organophosphate pesticides [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/20921-3.json |
| 20922-1 | Organophosphate pesticides [Identifier] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20922-1.json |
| 20923-9 | Organophosphate pesticides [Identifier] in Tissue | ./2.16.840.1.114222.4.11.1002/20923-9.json |
| 20924-7 | Ova and parasites identified in Stool by Parasite sedimentation | ./2.16.840.1.114222.4.11.1002/20924-7.json |
| 20925-4 | Ova and parasites identified in Stool by McMaster concentration | ./2.16.840.1.114222.4.11.1002/20925-4.json |
| 20926-2 | Ova and parasites identified in Stool by Baermann concentration | ./2.16.840.1.114222.4.11.1002/20926-2.json |
| 20927-0 | Oxalate [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20927-0.json |
| 20928-8 | Oxalate [Mass/mass] in Plant | ./2.16.840.1.114222.4.11.1002/20928-8.json |
| 20929-6 | Paraquat [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20929-6.json |
| 20930-4 | Paraquat [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20930-4.json |
| 20931-2 | Parasites [#/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20931-2.json |
| 20932-0 | Parasite identified in Specimen by Inspection | ./2.16.840.1.114222.4.11.1002/20932-0.json |
| 2093-3 | Cholesterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2093-3.json |
| 20933-8 | Parasite identified in Serum by Light microscopy | ./2.16.840.1.114222.4.11.1002/20933-8.json |
| 20934-6 | Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20934-6.json |
| 20935-3 | Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/20935-3.json |
| 20936-1 | Pentachlorophenol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20936-1.json |
| 20937-9 | Pentachlorophenol [Mass/mass] in Fat | ./2.16.840.1.114222.4.11.1002/20937-9.json |
| 20938-7 | Phenols [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20938-7.json |
| 20939-5 | Phosphide [Mass/mass] in Gastrointestinal content | ./2.16.840.1.114222.4.11.1002/20939-5.json |
| 20940-3 | Phosphide [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20940-3.json |
| 2094-1 | Cholesterol.non-esterified [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2094-1.json |
| 20942-9 | Plant identified [Type] in Plant | ./2.16.840.1.114222.4.11.1002/20942-9.json |
| 20943-7 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain | ./2.16.840.1.114222.4.11.1002/20943-7.json |
| 20944-5 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay | ./2.16.840.1.114222.4.11.1002/20944-5.json |
| 20945-2 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20945-2.json |
| 20946-0 | Retinol [Mass/mass] in Liver | ./2.16.840.1.114222.4.11.1002/20946-0.json |
| 20947-8 | Retinol [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20947-8.json |
| 20948-6 | Retinol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20948-6.json |
| 20949-4 | Rickettsia sp [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/20949-4.json |
| 20950-2 | Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20950-2.json |
| 20951-0 | Salmonella sp serotype [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/20951-0.json |
| 20952-8 | Salmonella sp identified in Egg by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20952-8.json |
| 20953-6 | Salmonella sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20953-6.json |
| 20955-1 | Salmonella sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20955-1.json |
| 20956-9 | Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/20956-9.json |
| 20957-7 | Sarcocystis neurona Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/20957-7.json |
| 2095-8 | Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2095-8.json |
| 20958-5 | Sarcocystis neurona Ab [Presence] in Blood by Immunoblot | ./2.16.840.1.114222.4.11.1002/20958-5.json |
| 20959-3 | Sarcocystis neurona Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/20959-3.json |
| 20960-1 | Selenium [Mass/mass] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20960-1.json |
| 20961-9 | Selenium [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20961-9.json |
| 20962-7 | Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20962-7.json |
| 20963-5 | Serpulina hyodysenteria [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20963-5.json |
| 20964-3 | Shigella sp identified in Feed by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20964-3.json |
| 20965-0 | Somatic cells [#/volume] in Milk | ./2.16.840.1.114222.4.11.1002/20965-0.json |
| 20966-8 | Staphylococcus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20966-8.json |
| 20967-6 | Staphylococcus sp identified in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20967-6.json |
| 20968-4 | Staphylococcus sp identified in Cheese by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20968-4.json |
| 20969-2 | Strychnine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20969-2.json |
| 20970-0 | Strychnine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/20970-0.json |
| 20972-6 | Strychnine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20972-6.json |
| 20973-4 | Sulfate [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20973-4.json |
| 2097-4 | Cholinesterase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2097-4.json |
| 20974-2 | Sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/20974-2.json |
| 20975-9 | Thallium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/20975-9.json |
| 20976-7 | Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20976-7.json |
| 20977-5 | Urea [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/20977-5.json |
| 20978-3 | Urea [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/20978-3.json |
| 20979-1 | Urea [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/20979-1.json |
| 20980-9 | Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20980-9.json |
| 20981-7 | Verotoxin identified in Isolate | ./2.16.840.1.114222.4.11.1002/20981-7.json |
| 2098-2 | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2098-2.json |
| 20982-5 | Western equine encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/20982-5.json |
| 20983-3 | Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20983-3.json |
| 20984-1 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/20984-1.json |
| 20985-8 | Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/20985-8.json |
| 20986-6 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/20986-6.json |
| 20987-4 | Yersinia sp identified in Dairy product by Organism specific culture | ./2.16.840.1.114222.4.11.1002/20987-4.json |
| 20988-2 | Zinc phosphide [Mass/mass] in Gastrointestinal content | ./2.16.840.1.114222.4.11.1002/20988-2.json |
| 20989-0 | Zinc phosphide [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/20989-0.json |
| 2099-0 | Cholinesterase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2099-0.json |
| 20990-8 | APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/20990-8.json |
| 20992-4 | Bordetella pertussis Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/20992-4.json |
| 21003-9 | Fungus identified in Specimen by Fungus stain | ./2.16.840.1.114222.4.11.1002/21003-9.json |
| 21005-4 | Hepatitis B virus core Ab [Units/volume] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/21005-4.json |
| 2100-6 | Cholylglycine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2100-6.json |
| 21006-2 | Hepatitis B virus surface Ab [Units/volume] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/21006-2.json |
| 21007-0 | HIV 1 Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/21007-0.json |
| 21008-8 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe | ./2.16.840.1.114222.4.11.1002/21008-8.json |
| 2101-4 | Cholylglycine.conjugated [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2101-4.json |
| 21016-1 | CD41 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/21016-1.json |
| 21018-7 | CD61 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/21018-7.json |
| 21019-5 | Metanephrine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21019-5.json |
| 21020-3 | Bacteria identified in Specimen by Anaerobe+Aerobe culture | ./2.16.840.1.114222.4.11.1002/21020-3.json |
| 21021-1 | Microscopic observation [Identifier] in Bronchial specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/21021-1.json |
| 2102-2 | Chondroitin sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2102-2.json |
| 21022-9 | Microscopic observation [Identifier] in Dialysis fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/21022-9.json |
| 21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21023-7.json |
| 2103-0 | Choriomammotropin [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2103-0.json |
| 21030-2 | Reagin Ab [Presence] in Serum from Donor by VDRL | ./2.16.840.1.114222.4.11.1002/21030-2.json |
| 21034-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen | ./2.16.840.1.114222.4.11.1002/21034-4.json |
| 21035-1 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen | ./2.16.840.1.114222.4.11.1002/21035-1.json |
| 21036-9 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21036-9.json |
| 21037-7 | 17-Hydroxypregnenolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21037-7.json |
| 21038-5 | 17-Ketosteroids [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21038-5.json |
| 21039-3 | 18-Hydroxycortisol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21039-3.json |
| 21043-5 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21043-5.json |
| 21044-3 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21044-3.json |
| 21045-0 | 5-Hydroxytryptophan [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21045-0.json |
| 21046-8 | 7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21046-8.json |
| 21047-6 | 8-Hydroxyloxapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21047-6.json |
| 2104-8 | Choriomammotropin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2104-8.json |
| 21048-4 | Acetaldehyde [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21048-4.json |
| 21049-2 | Acetone [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/21049-2.json |
| 21051-8 | Acrylaldehyde [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21051-8.json |
| 21052-6 | Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21052-6.json |
| 21053-4 | Adenovirus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21053-4.json |
| 21054-2 | Adenovirus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21054-2.json |
| 2105-5 | Choriogonadotropin [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2105-5.json |
| 21055-9 | Adenovirus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21055-9.json |
| 21056-7 | Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/21056-7.json |
| 21057-5 | Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21057-5.json |
| 21059-1 | Albumin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21059-1.json |
| 21062-5 | Allobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21062-5.json |
| 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2106-3.json |
| 21064-1 | Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/21064-1.json |
| 21066-6 | Ampicillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/21066-6.json |
| 2107-1 | Choriogonadotropin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2107-1.json |
| 21071-6 | Antimony [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21071-6.json |
| 21074-0 | Arsenic [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21074-0.json |
| 21075-7 | Ascaris lumbricoides IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21075-7.json |
| 21077-3 | Black Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21077-3.json |
| 21078-1 | Green Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21078-1.json |
| 21081-5 | ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21081-5.json |
| 21084-9 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/21084-9.json |
| 21085-6 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/21085-6.json |
| 21086-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/21086-4.json |
| 21088-0 | Azinphos-methyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21088-0.json |
| 2108-9 | Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2108-9.json |
| 21089-8 | Babesia microti DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21089-8.json |
| 21095-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21095-5.json |
| 21096-3 | Black Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21096-3.json |
| 2109-7 | Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2109-7.json |
| 2110-5 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2110-5.json |
| 21107-8 | Bendiocarb [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21107-8.json |
| 21108-6 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21108-6.json |
| 2111-3 | Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2111-3.json |
| 21113-6 | Bismuth [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21113-6.json |
| 21118-5 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/21118-5.json |
| 21119-3 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/21119-3.json |
| 21120-1 | Borrelia burgdorferi DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21120-1.json |
| 2112-1 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2112-1.json |
| 21121-9 | Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21121-9.json |
| 21122-7 | Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21122-7.json |
| 21125-0 | Brush border Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21125-0.json |
| 21128-4 | Cadmium [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/21128-4.json |
| 21129-2 | Cadmium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21129-2.json |
| 21130-0 | Cadmium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21130-0.json |
| 21135-9 | Canrenone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21135-9.json |
| 2113-9 | Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2113-9.json |
| 21139-1 | Carbofuran [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21139-1.json |
| 21140-9 | Carbophenothion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21140-9.json |
| 21142-5 | Carisoprodol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/21142-5.json |
| 21143-3 | Carp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21143-3.json |
| 2114-7 | Choriogonadotropin.beta subunit [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2114-7.json |
| 21148-2 | White Cedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21148-2.json |
| 21151-6 | cefTAZidime [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/21151-6.json |
| 2115-4 | Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2115-4.json |
| 2116-2 | Choriogonadotropin.intact [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2116-2.json |
| 2117-0 | Choriogonadotropin.intact [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2117-0.json |
| 21173-0 | Cephaeline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21173-0.json |
| 21174-8 | Cephaeline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21174-8.json |
| 21175-5 | Cephalexin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/21175-5.json |
| 21184-7 | Chlamydophila pneumoniae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/21184-7.json |
| 21185-4 | Chlamydia sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21185-4.json |
| 21186-2 | Chlamydia sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21186-2.json |
| 21187-0 | Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21187-0.json |
| 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2118-8.json |
| 21188-8 | Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by Probe | ./2.16.840.1.114222.4.11.1002/21188-8.json |
| 21189-6 | Chlamydia trachomatis DNA [Presence] in Cervical mucus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21189-6.json |
| 21190-4 | Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21190-4.json |
| 21191-2 | Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21191-2.json |
| 21192-0 | Chlamydia trachomatis rRNA [Presence] in Urethra by Probe | ./2.16.840.1.114222.4.11.1002/21192-0.json |
| 21193-8 | chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21193-8.json |
| 21194-6 | Chloride [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21194-6.json |
| 21195-3 | Chlorzoxazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21195-3.json |
| 2119-6 | Choriogonadotropin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2119-6.json |
| 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21198-7.json |
| 21199-5 | Chromium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/21199-5.json |
| 21200-1 | Chromium [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/21200-1.json |
| 21201-9 | Chromium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21201-9.json |
| 21203-5 | Citrate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21203-5.json |
| 2120-4 | Chylomicrons [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2120-4.json |
| 21206-8 | Sweet Clover IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21206-8.json |
| 21207-6 | CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21207-6.json |
| 21208-4 | Cobalt [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21208-4.json |
| 21209-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/21209-2.json |
| 2121-2 | Chylomicrons [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2121-2.json |
| 21215-9 | Collagen crosslinked N-telopeptide [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21215-9.json |
| 21216-7 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21216-7.json |
| 21217-5 | Complement C4d [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/21217-5.json |
| 21218-3 | Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/21218-3.json |
| 21219-1 | Copper [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21219-1.json |
| 2122-0 | Chymopapain [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2122-0.json |
| 21224-1 | Cortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/21224-1.json |
| 21225-8 | Cortisol [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/21225-8.json |
| 21229-0 | Coumaphos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21229-0.json |
| 21232-4 | Creatinine [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/21232-4.json |
| 21233-2 | Cryptosporidium sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/21233-2.json |
| 21236-5 | Cyclohexanone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21236-5.json |
| 21237-3 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21237-3.json |
| 2123-8 | Chymotrypsin [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2123-8.json |
| 21239-9 | Desalkylhalazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21239-9.json |
| 21240-7 | Dextromethorphan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21240-7.json |
| 21241-5 | diazePAM+Nordiazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21241-5.json |
| 21243-1 | Diethyl ether [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21243-1.json |
| 21245-6 | Diisobutylketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21245-6.json |
| 2124-6 | Chymotrypsin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2124-6.json |
| 21246-4 | Dimethoate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21246-4.json |
| 21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21247-2.json |
| 21248-0 | Dobutamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21248-0.json |
| 21250-6 | Doxycycline [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/21250-6.json |
| 21252-2 | Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/21252-2.json |
| 2125-3 | Chymotrypsin [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/2125-3.json |
| 21259-7 | Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/21259-7.json |
| 21260-5 | Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21260-5.json |
| 2126-1 | Citrate [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2126-1.json |
| 21262-1 | Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/21262-1.json |
| 21263-9 | Estradiol (E2) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21263-9.json |
| 21266-2 | Ethion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21266-2.json |
| 21267-0 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21267-0.json |
| 21268-8 | Fenchlorphos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21268-8.json |
| 21269-6 | Fenthion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21269-6.json |
| 21271-2 | Fireweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21271-2.json |
| 2127-9 | Citrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2127-9.json |
| 21280-3 | Fonofos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21280-3.json |
| 21284-5 | Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/21284-5.json |
| 2128-7 | Citrate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2128-7.json |
| 21300-9 | Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21300-9.json |
| 21301-7 | Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21301-7.json |
| 21302-5 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/21302-5.json |
| 21303-3 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen | ./2.16.840.1.114222.4.11.1002/21303-3.json |
| 21305-8 | Glucose [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21305-8.json |
| 21306-6 | Glucose [Mass/time] in 8 hour Urine | ./2.16.840.1.114222.4.11.1002/21306-6.json |
| 21307-4 | Glucose [Mass/time] in 10 hour Urine | ./2.16.840.1.114222.4.11.1002/21307-4.json |
| 21312-4 | Gold [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/21312-4.json |
| 21320-7 | Haemophilus influenzae B Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/21320-7.json |
| 21322-3 | Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21322-3.json |
| 21323-1 | Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21323-1.json |
| 21326-4 | Herpes simplex virus 1 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21326-4.json |
| 21327-2 | Herpes simplex virus 2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21327-2.json |
| 2132-9 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2132-9.json |
| 21330-6 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/21330-6.json |
| 21333-0 | HIV 1 RNA [#/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21333-0.json |
| 2133-7 | Collagenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2133-7.json |
| 21345-4 | HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/21345-4.json |
| 21348-8 | HTLV I+II IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/21348-8.json |
| 21361-1 | Laxatives present [Identifier] in Stool by Screen method | ./2.16.840.1.114222.4.11.1002/21361-1.json |
| 21362-9 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21362-9.json |
| 21363-7 | Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21363-7.json |
| 21365-2 | Leptin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21365-2.json |
| 21368-6 | levoFLOXacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21368-6.json |
| 21377-7 | Magnesium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/21377-7.json |
| 21378-5 | Malathion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21378-5.json |
| 21380-1 | Prolactin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21380-1.json |
| 21382-7 | Manganese [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21382-7.json |
| 21383-5 | Mercury [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21383-5.json |
| 21385-0 | Metasystox [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21385-0.json |
| 2138-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2138-6.json |
| 21386-8 | Methamphetamine [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/21386-8.json |
| 21387-6 | Methylhippurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21387-6.json |
| 21388-4 | Mevinphos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21388-4.json |
| 21389-2 | Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21389-2.json |
| 21391-8 | Microscopic observation [Identifier] in Bone by Acid phosphatase stain | ./2.16.840.1.114222.4.11.1002/21391-8.json |
| 2139-4 | Corticosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2139-4.json |
| 21401-5 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21401-5.json |
| 2140-2 | Corticotropin [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2140-2.json |
| 21402-3 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21402-3.json |
| 21405-6 | Mycobacterium sp DNA [Presence] in Bronchial specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21405-6.json |
| 21406-4 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21406-4.json |
| 21407-2 | Myelin IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21407-2.json |
| 21408-0 | Myelin IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21408-0.json |
| 21409-8 | Myelin IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21409-8.json |
| 2141-0 | Corticotropin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2141-0.json |
| 21410-6 | Myelin associated glycoprotein IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21410-6.json |
| 21411-4 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21411-4.json |
| 21413-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21413-0.json |
| 21414-8 | Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21414-8.json |
| 21415-5 | Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21415-5.json |
| 21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21416-3.json |
| 21417-1 | Neurokinin A [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21417-1.json |
| 21418-9 | Neutrophil Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21418-9.json |
| 21419-7 | Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21419-7.json |
| 21420-5 | Nitrate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21420-5.json |
| 21421-3 | Norketamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21421-3.json |
| 21422-1 | Normetanephrine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21422-1.json |
| 21423-9 | Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver | ./2.16.840.1.114222.4.11.1002/21423-9.json |
| 21424-7 | Nuclear IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21424-7.json |
| 2142-8 | Cortisol [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2142-8.json |
| 21428-8 | Olive IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21428-8.json |
| 21431-2 | Opiates [Presence] in Urine by Screen method >2000 ng/mL | ./2.16.840.1.114222.4.11.1002/21431-2.json |
| 21435-3 | Osteocalcin.bovine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21435-3.json |
| 2143-6 | Cortisol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2143-6.json |
| 21436-1 | Ovary Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21436-1.json |
| 21437-9 | Oxychlordane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21437-9.json |
| 21440-3 | Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/21440-3.json |
| 21441-1 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/21441-1.json |
| 21442-9 | Parainfluenza virus identified in Nose by Organism specific culture | ./2.16.840.1.114222.4.11.1002/21442-9.json |
| 21443-7 | Paraoxon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21443-7.json |
| 2144-4 | Cortisol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2144-4.json |
| 2145-1 | Cortisol Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2145-1.json |
| 21457-7 | Phorate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21457-7.json |
| 21458-5 | Phosphate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21458-5.json |
| 21461-9 | Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21461-9.json |
| 21464-3 | Plasminogen activator urokinase type [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/21464-3.json |
| 21465-0 | Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21465-0.json |
| 21466-8 | Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21466-8.json |
| 21467-6 | Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21467-6.json |
| 21468-4 | Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21468-4.json |
| 21471-8 | Pomegranate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21471-8.json |
| 21473-4 | White Poplar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21473-4.json |
| 21476-7 | Potassium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21476-7.json |
| 2147-7 | Cortisol Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2147-7.json |
| 21480-9 | Propoxur [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21480-9.json |
| 21481-7 | Propranolol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/21481-7.json |
| 21482-5 | Protein [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21482-5.json |
| 21483-3 | quiNIDine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/21483-3.json |
| 2148-5 | Creatine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2148-5.json |
| 21487-4 | Ribosomal P Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/21487-4.json |
| 21489-0 | Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/21489-0.json |
| 21490-8 | Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/21490-8.json |
| 21491-6 | Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/21491-6.json |
| 21492-4 | Rickettsia conorii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21492-4.json |
| 2149-3 | Creatine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2149-3.json |
| 21493-2 | Rickettsia conorii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21493-2.json |
| 21494-0 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21494-0.json |
| 21495-7 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21495-7.json |
| 21496-5 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21496-5.json |
| 21497-3 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21497-3.json |
| 21498-1 | Orientia tsutsugamushi IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21498-1.json |
| 21500-4 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21500-4.json |
| 2150-1 | Creatine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2150-1.json |
| 21501-2 | Measles virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21501-2.json |
| 21502-0 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21502-0.json |
| 21503-8 | Measles virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21503-8.json |
| 21509-5 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21509-5.json |
| 21510-3 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21510-3.json |
| 21511-1 | Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/21511-1.json |
| 21512-9 | Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21512-9.json |
| 21513-7 | Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/21513-7.json |
| 21514-5 | Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21514-5.json |
| 21518-6 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21518-6.json |
| 2151-9 | Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2151-9.json |
| 21522-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21522-8.json |
| 21523-6 | Smith extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21523-6.json |
| 21525-1 | Sodium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21525-1.json |
| 21526-9 | Sodium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21526-9.json |
| 2152-7 | Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/2152-7.json |
| 21527-7 | Sodium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21527-7.json |
| 2153-5 | Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2153-5.json |
| 21536-8 | Acid sphingomyelinase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/21536-8.json |
| 2154-3 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/2154-3.json |
| 21545-9 | Sulfatide IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/21545-9.json |
| 21546-7 | Sulfatide IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/21546-7.json |
| 2155-0 | Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/2155-0.json |
| 21551-7 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21551-7.json |
| 21554-1 | Terbufos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/21554-1.json |
| 21556-6 | Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL | ./2.16.840.1.114222.4.11.1002/21556-6.json |
| 21557-4 | Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL | ./2.16.840.1.114222.4.11.1002/21557-4.json |
| 21558-2 | Thallium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21558-2.json |
| 21559-0 | Theophylline [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/21559-0.json |
| 21560-8 | Thermoactinomyces candidus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21560-8.json |
| 21561-6 | Laceyella sacchari Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21561-6.json |
| 21562-4 | Thiocyanate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/21562-4.json |
| 21563-2 | Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/21563-2.json |
| 21564-0 | Thiosulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21564-0.json |
| 21565-7 | tiaGABine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21565-7.json |
| 21566-5 | TOLAZamide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21566-5.json |
| 21567-3 | TOLBUTamide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21567-3.json |
| 2156-8 | Creatine kinase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2156-8.json |
| 21569-9 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21569-9.json |
| 21570-7 | Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test | ./2.16.840.1.114222.4.11.1002/21570-7.json |
| 21571-5 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21571-5.json |
| 2157-6 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2157-6.json |
| 21579-8 | Trichloroethylene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/21579-8.json |
| 21580-6 | Trimethobenzamide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/21580-6.json |
| 21582-2 | Tryptase [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/21582-2.json |
| 21585-5 | Uranium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21585-5.json |
| 21586-3 | Uranium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21586-3.json |
| 21587-1 | Urate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21587-1.json |
| 21588-9 | Urobilinogen [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/21588-9.json |
| 2159-2 | Creatinine [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2159-2.json |
| 21592-1 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/21592-1.json |
| 21594-7 | Varicella zoster virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/21594-7.json |
| 21595-4 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21595-4.json |
| 21596-2 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/21596-2.json |
| 21597-0 | Varicella zoster virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/21597-0.json |
| 21598-8 | Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21598-8.json |
| 2160-0 | Creatinine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2160-0.json |
| 21603-6 | Wheat dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/21603-6.json |
| 21610-1 | Zinc [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/21610-1.json |
| 21613-5 | Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/21613-5.json |
| 21614-3 | CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21614-3.json |
| 21615-0 | CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21615-0.json |
| 21617-6 | APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21617-6.json |
| 2161-8 | Creatinine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2161-8.json |
| 21619-2 | APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21619-2.json |
| 21620-0 | STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21620-0.json |
| 21622-6 | ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21622-6.json |
| 21624-2 | ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21624-2.json |
| 2162-6 | Creatinine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2162-6.json |
| 21626-7 | ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21626-7.json |
| 21627-5 | ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21627-5.json |
| 21628-3 | ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21628-3.json |
| 21629-1 | ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21629-1.json |
| 21630-9 | ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21630-9.json |
| 21631-7 | ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21631-7.json |
| 21632-5 | ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21632-5.json |
| 21633-3 | ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21633-3.json |
| 2163-4 | Creatinine renal clearance in 12 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2163-4.json |
| 21634-1 | ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21634-1.json |
| 21635-8 | ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21635-8.json |
| 21636-6 | BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21636-6.json |
| 21637-4 | BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21637-4.json |
| 21638-2 | BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21638-2.json |
| 21640-8 | BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21640-8.json |
| 21641-6 | CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21641-6.json |
| 2164-2 | Creatinine renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2164-2.json |
| 21642-4 | CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21642-4.json |
| 21643-2 | CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21643-2.json |
| 21644-0 | CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21644-0.json |
| 21646-5 | CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21646-5.json |
| 21652-3 | CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21652-3.json |
| 21654-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21654-9.json |
| 21655-6 | CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21655-6.json |
| 21656-4 | CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21656-4.json |
| 21657-2 | COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21657-2.json |
| 2165-9 | Cryofibrinogen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2165-9.json |
| 21659-8 | CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21659-8.json |
| 21661-4 | CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21661-4.json |
| 21662-2 | CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21662-2.json |
| 21664-8 | CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21664-8.json |
| 21665-5 | EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21665-5.json |
| 2166-7 | Cryoglobulin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2166-7.json |
| 21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21667-1.json |
| 21668-9 | F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21668-9.json |
| 21670-5 | F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21670-5.json |
| 21672-1 | F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21672-1.json |
| 21674-7 | FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21674-7.json |
| 2167-5 | Cryoglobulin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2167-5.json |
| 21676-2 | FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21676-2.json |
| 21677-0 | FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21677-0.json |
| 21678-8 | FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21678-8.json |
| 21679-6 | FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21679-6.json |
| 21680-4 | G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21680-4.json |
| 2168-3 | Cryoglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2168-3.json |
| 21685-3 | HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21685-3.json |
| 21687-9 | HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21687-9.json |
| 21689-5 | HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21689-5.json |
| 21690-3 | HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21690-3.json |
| 2169-1 | Cobalamin (Vitamin B12) renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2169-1.json |
| 21692-9 | PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21692-9.json |
| 21694-5 | HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21694-5.json |
| 21695-2 | HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21695-2.json |
| 21696-0 | HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21696-0.json |
| 21698-6 | HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21698-6.json |
| 21700-0 | Kallmann syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21700-0.json |
| 21702-6 | KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21702-6.json |
| 21704-2 | MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21704-2.json |
| 21705-9 | MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21705-9.json |
| 21707-5 | MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21707-5.json |
| 21709-1 | MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21709-1.json |
| 21713-3 | MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21713-3.json |
| 21714-1 | MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21714-1.json |
| 21715-8 | MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21715-8.json |
| 21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21716-6.json |
| 2171-7 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2171-7.json |
| 21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21717-4.json |
| 21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21719-0.json |
| 21721-6 | OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21721-6.json |
| 21723-2 | SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21723-2.json |
| 21724-0 | SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21724-0.json |
| 21725-7 | SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21725-7.json |
| 21727-3 | PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21727-3.json |
| 21729-9 | PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21729-9.json |
| 21731-5 | RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21731-5.json |
| 21733-1 | RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21733-1.json |
| 21735-6 | SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21735-6.json |
| 21736-4 | SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21736-4.json |
| 21737-2 | SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21737-2.json |
| 21739-8 | TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21739-8.json |
| 21740-6 | TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21740-6.json |
| 21742-2 | WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/21742-2.json |
| 21744-8 | CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21744-8.json |
| 21746-3 | BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21746-3.json |
| 21747-1 | HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21747-1.json |
| 21748-9 | Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21748-9.json |
| 21749-7 | Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21749-7.json |
| 21750-5 | MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21750-5.json |
| 21751-3 | TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21751-3.json |
| 21752-1 | TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21752-1.json |
| 21753-9 | TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21753-9.json |
| 21754-7 | AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21754-7.json |
| 21755-4 | CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21755-4.json |
| 21756-2 | ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21756-2.json |
| 21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21757-0.json |
| 21759-6 | FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21759-6.json |
| 21760-4 | FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21760-4.json |
| 21762-0 | FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21762-0.json |
| 21763-8 | HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21763-8.json |
| 21764-6 | MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21764-6.json |
| 21765-3 | SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21765-3.json |
| 21766-1 | SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21766-1.json |
| 21767-9 | SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21767-9.json |
| 21769-5 | SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21769-5.json |
| 21770-3 | Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/21770-3.json |
| 21771-1 | Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/21771-1.json |
| 21772-9 | Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/21772-9.json |
| 21773-7 | Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/21773-7.json |
| 21774-5 | Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/21774-5.json |
| 2178-2 | Cystine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2178-2.json |
| 2179-0 | Cystine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2179-0.json |
| 21801-6 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21801-6.json |
| 2180-8 | Cystine+Cysteine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2180-8.json |
| 21809-9 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21809-9.json |
| 21810-7 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21810-7.json |
| 2181-6 | Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2181-6.json |
| 21819-8 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21819-8.json |
| 21822-2 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21822-2.json |
| 21823-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/21823-0.json |
| 2182-4 | Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2182-4.json |
| 2183-2 | Cytochrome B5 reductase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2183-2.json |
| 2184-0 | Cytochrome C oxidase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2184-0.json |
| 21843-8 | History of Usual occupation | ./2.16.840.1.114222.4.11.1002/21843-8.json |
| 2185-7 | Cytochrome C oxidase [Enzymatic activity/volume] in Platelets | ./2.16.840.1.114222.4.11.1002/2185-7.json |
| 2186-5 | Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2186-5.json |
| 2187-3 | Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2187-3.json |
| 2188-1 | Cytosol aminopeptidase [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2188-1.json |
| 2189-9 | Cytosol aminopeptidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2189-9.json |
| 2190-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2190-7.json |
| 2191-5 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2191-5.json |
| 2192-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2192-3.json |
| 2193-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2193-1.json |
| 2194-9 | Dehydroepiandrosterone (DHEA) [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2194-9.json |
| 2195-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2195-6.json |
| 2196-4 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2196-4.json |
| 2197-2 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2197-2.json |
| 2198-0 | Delta aminolevulinate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2198-0.json |
| 2199-8 | Delta aminolevulinate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2199-8.json |
| 2200-4 | Delta aminolevulinate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2200-4.json |
| 2201-2 | Deoxycholate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2201-2.json |
| 2202-0 | Deoxycholylglycine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2202-0.json |
| 2203-8 | Dermatan sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2203-8.json |
| 2204-6 | Dermatan sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2204-6.json |
| 2206-1 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2206-1.json |
| 22070-7 | HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/22070-7.json |
| 22071-5 | Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/22071-5.json |
| 22072-3 | Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/22072-3.json |
| 22073-1 | Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/22073-1.json |
| 22077-2 | Acanthamoeba sp Ab [Presence] in Cornea | ./2.16.840.1.114222.4.11.1002/22077-2.json |
| 22078-0 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22078-0.json |
| 2207-9 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2207-9.json |
| 22079-8 | Actinomyces sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22079-8.json |
| 22080-6 | Adenovirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22080-6.json |
| 22081-4 | Afipia felis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22081-4.json |
| 22082-2 | Afipia felis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22082-2.json |
| 22083-0 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22083-0.json |
| 22084-8 | Anaplasma marginale Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22084-8.json |
| 22085-5 | Aspergillus fumigatus 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22085-5.json |
| 22086-3 | Aspergillus niger Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22086-3.json |
| 2208-7 | Diethyl ether [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2208-7.json |
| 22087-1 | Aspergillus sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22087-1.json |
| 22088-9 | Avian adenovirus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22088-9.json |
| 22089-7 | Avian adenovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22089-7.json |
| 22090-5 | Avian encephalomyelitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22090-5.json |
| 22091-3 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22091-3.json |
| 22092-1 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22092-1.json |
| 22093-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22093-9.json |
| 22094-7 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22094-7.json |
| 2209-5 | Dihydrofolate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2209-5.json |
| 22095-4 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22095-4.json |
| 22096-2 | Influenza virus A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22096-2.json |
| 22097-0 | Avian paramyxovirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22097-0.json |
| 22098-8 | Avian paramyxovirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22098-8.json |
| 22099-6 | Avian paramyxovirus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22099-6.json |
| 22100-2 | Avian paramyxovirus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22100-2.json |
| 22101-0 | Avian pox virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22101-0.json |
| 22102-8 | Avian reovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22102-8.json |
| 2210-3 | Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2210-3.json |
| 22103-6 | Reticuloendotheliosis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22103-6.json |
| 22104-4 | Babesia caballi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22104-4.json |
| 22105-1 | Theileria equi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22105-1.json |
| 22106-9 | Babesia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22106-9.json |
| 22107-7 | Babesia sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22107-7.json |
| 22108-5 | Babesia sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22108-5.json |
| 22109-3 | Bacillus anthracis Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22109-3.json |
| 22110-1 | Bartonella henselae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22110-1.json |
| 2211-1 | Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2211-1.json |
| 22111-9 | Bartonella henselae IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22111-9.json |
| 22112-7 | Blastomyces dermatitidis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22112-7.json |
| 22113-5 | Bluetongue virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22113-5.json |
| 22114-3 | Bordetella avium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22114-3.json |
| 22115-0 | Bordetella avium Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22115-0.json |
| 22116-8 | Bordetella pertussis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22116-8.json |
| 22117-6 | Bordetella pertussis Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/22117-6.json |
| 22118-4 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22118-4.json |
| 22119-2 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22119-2.json |
| 22120-0 | Borrelia burgdorferi Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/22120-0.json |
| 22121-8 | Borrelia burgdorferi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22121-8.json |
| 22122-6 | Borrelia burgdorferi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22122-6.json |
| 22123-4 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22123-4.json |
| 22124-2 | Borrelia burgdorferi IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22124-2.json |
| 22125-9 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22125-9.json |
| 22126-7 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22126-7.json |
| 22127-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/22127-5.json |
| 22128-3 | Borrelia burgdorferi IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22128-3.json |
| 2212-9 | Dihydropteridine reductase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2212-9.json |
| 22129-1 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/22129-1.json |
| 22130-9 | Borrelia burgdorferi IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22130-9.json |
| 22131-7 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22131-7.json |
| 22132-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22132-5.json |
| 22133-3 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22133-3.json |
| 22134-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/22134-1.json |
| 22135-8 | Borrelia burgdorferi IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22135-8.json |
| 22136-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/22136-6.json |
| 2213-7 | Dimethadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2213-7.json |
| 22137-4 | Borrelia burgdorferi IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22137-4.json |
| 22138-2 | Borrelia hermsii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22138-2.json |
| 22139-0 | Borrelia hermsii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22139-0.json |
| 22140-8 | Bovine diarrhea virus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22140-8.json |
| 22141-6 | Bovine diarrhea virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22141-6.json |
| 22142-4 | Bovine herpesvirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22142-4.json |
| 22143-2 | Bovine herpesvirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22143-2.json |
| 22144-0 | Bovine leukemia virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22144-0.json |
| 2214-5 | Dinitrobenzene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2214-5.json |
| 22146-5 | Brucella abortus Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22146-5.json |
| 22147-3 | Brucella abortus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22147-3.json |
| 22148-1 | Brucella abortus Ab [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/22148-1.json |
| 22149-9 | Brucella abortus Ab [Presence] in Whey | ./2.16.840.1.114222.4.11.1002/22149-9.json |
| 22150-7 | Brucella abortus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22150-7.json |
| 22151-5 | Brucella abortus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22151-5.json |
| 2215-2 | Dipalmitoylphosphatidylcholine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2215-2.json |
| 22152-3 | Brucella canis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22152-3.json |
| 22153-1 | Brucella canis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22153-1.json |
| 22154-9 | Brucella canis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22154-9.json |
| 22155-6 | Brucella canis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22155-6.json |
| 22156-4 | Brucella canis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22156-4.json |
| 22157-2 | Brucella melitensis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22157-2.json |
| 22158-0 | Brucella ovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22158-0.json |
| 22159-8 | Brucella sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22159-8.json |
| 2216-0 | DOPamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2216-0.json |
| 22160-6 | Brucella suis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22160-6.json |
| 22161-4 | Cache valley virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22161-4.json |
| 22162-2 | Candida albicans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22162-2.json |
| 22163-0 | Candida albicans Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22163-0.json |
| 22164-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22164-8.json |
| 22166-3 | Caprine parapoxvirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22166-3.json |
| 22167-1 | Caprine parapoxvirus Ab [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/22167-1.json |
| 22168-9 | Chicken anemia virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22168-9.json |
| 22169-7 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22169-7.json |
| 22170-5 | Chlamydophila pneumoniae IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22170-5.json |
| 22171-3 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22171-3.json |
| 22172-1 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22172-1.json |
| 22173-9 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22173-9.json |
| 22174-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22174-7.json |
| 22175-4 | Chlamydophila psittaci Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22175-4.json |
| 22176-2 | Chlamydophila psittaci Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22176-2.json |
| 22177-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22177-0.json |
| 2217-8 | DOPamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2217-8.json |
| 22178-8 | Chlamydophila psittaci IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22178-8.json |
| 22179-6 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22179-6.json |
| 22180-4 | Chlamydophila psittaci IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22180-4.json |
| 22181-2 | Chlamydophila psittaci IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22181-2.json |
| 22182-0 | Chlamydia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22182-0.json |
| 22183-8 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22183-8.json |
| 22184-6 | Chlamydia sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22184-6.json |
| 22185-3 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22185-3.json |
| 2218-6 | DOPamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2218-6.json |
| 22186-1 | Chlamydia sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22186-1.json |
| 22187-9 | Chlamydia trachomatis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22187-9.json |
| 22188-7 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22188-7.json |
| 22189-5 | Chlamydia trachomatis IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22189-5.json |
| 22190-3 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22190-3.json |
| 22191-1 | Chlamydia trachomatis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22191-1.json |
| 22192-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22192-9.json |
| 22193-7 | Chlamydia trachomatis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22193-7.json |
| 2219-4 | Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2219-4.json |
| 22194-5 | Chlamydia trachomatis B IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22194-5.json |
| 22195-2 | Chlamydia trachomatis B IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22195-2.json |
| 22196-0 | Chlamydia trachomatis B IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22196-0.json |
| 22197-8 | Chlamydia trachomatis C IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22197-8.json |
| 22198-6 | Chlamydia trachomatis C IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22198-6.json |
| 22199-4 | Chlamydia trachomatis C IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22199-4.json |
| 22200-0 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22200-0.json |
| 22201-8 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22201-8.json |
| 2220-2 | Elastase.pancreatic Free [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2220-2.json |
| 22202-6 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22202-6.json |
| 22203-4 | Clostridium tetani IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22203-4.json |
| 22204-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22204-2.json |
| 22205-9 | Coccidioides immitis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22205-9.json |
| 22206-7 | Coccidioides immitis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22206-7.json |
| 22207-5 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22207-5.json |
| 22208-3 | Coccidioides immitis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22208-3.json |
| 22209-1 | Coccidioides immitis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22209-1.json |
| 2221-0 | Elastase.pancreatic [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2221-0.json |
| 22210-9 | Coccidioides immitis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22210-9.json |
| 22211-7 | Coxiella burnetii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22211-7.json |
| 22212-5 | Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22212-5.json |
| 22213-3 | Coxsackievirus A10 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22213-3.json |
| 22214-1 | Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22214-1.json |
| 22215-8 | Coxsackievirus A16 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22215-8.json |
| 22216-6 | Coxsackievirus A2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22216-6.json |
| 22217-4 | Coxsackievirus A21 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22217-4.json |
| 22218-2 | Coxsackievirus A4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22218-2.json |
| 22219-0 | Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22219-0.json |
| 22220-8 | Coxsackievirus A7 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22220-8.json |
| 22221-6 | Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22221-6.json |
| 22222-4 | Coxsackievirus A9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22222-4.json |
| 22223-2 | Coxsackievirus B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22223-2.json |
| 22224-0 | Coxsackievirus B IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22224-0.json |
| 22225-7 | Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22225-7.json |
| 22226-5 | Coxsackievirus B1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22226-5.json |
| 22227-3 | Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22227-3.json |
| 2222-8 | Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2222-8.json |
| 22228-1 | Coxsackievirus B2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22228-1.json |
| 22229-9 | Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22229-9.json |
| 22230-7 | Coxsackievirus B3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22230-7.json |
| 22231-5 | Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22231-5.json |
| 22232-3 | Coxsackievirus B4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22232-3.json |
| 22233-1 | Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22233-1.json |
| 22234-9 | Coxsackievirus B5 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22234-9.json |
| 22235-6 | Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22235-6.json |
| 2223-6 | Elastase.leukocyte [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2223-6.json |
| 22236-4 | Coxsackievirus B6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22236-4.json |
| 22237-2 | Cryptococcus neoformans Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22237-2.json |
| 22238-0 | Taenia solium larva Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22238-0.json |
| 22239-8 | Cytomegalovirus Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22239-8.json |
| 22240-6 | Cytomegalovirus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22240-6.json |
| 22241-4 | Cytomegalovirus Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22241-4.json |
| 22243-0 | Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22243-0.json |
| 2224-4 | Enolase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2224-4.json |
| 22244-8 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22244-8.json |
| 22245-5 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22245-5.json |
| 22246-3 | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22246-3.json |
| 22247-1 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen | ./2.16.840.1.114222.4.11.1002/22247-1.json |
| 22248-9 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22248-9.json |
| 22249-7 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22249-7.json |
| 22250-5 | Dengue virus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22250-5.json |
| 2225-1 | Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2225-1.json |
| 22251-3 | Dengue virus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22251-3.json |
| 22252-1 | Dengue virus 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22252-1.json |
| 22253-9 | Dengue virus 4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22253-9.json |
| 22254-7 | Duck enteritis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22254-7.json |
| 22255-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22255-4.json |
| 22256-2 | Eastern equine encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22256-2.json |
| 22257-0 | Eastern equine encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22257-0.json |
| 22258-8 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22258-8.json |
| 22259-6 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22259-6.json |
| 22260-4 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22260-4.json |
| 22261-2 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22261-2.json |
| 22263-8 | Ebola virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22263-8.json |
| 22264-6 | Echinococcus granulosus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22264-6.json |
| 22265-3 | Echinococcus sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22265-3.json |
| 22266-1 | Echovirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22266-1.json |
| 22267-9 | Echovirus 11 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22267-9.json |
| 22268-7 | Echovirus 11 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22268-7.json |
| 2226-9 | Enteroglucagon [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2226-9.json |
| 22269-5 | Echovirus 14 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22269-5.json |
| 22271-1 | Echovirus 16 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22271-1.json |
| 22272-9 | Echovirus 18 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22272-9.json |
| 22273-7 | Echovirus 19 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22273-7.json |
| 22274-5 | Echovirus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22274-5.json |
| 22275-2 | Echovirus 30 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22275-2.json |
| 22276-0 | Echovirus 4 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22276-0.json |
| 2227-7 | Enteropeptidase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2227-7.json |
| 22277-8 | Echovirus 4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22277-8.json |
| 22278-6 | Echovirus 6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22278-6.json |
| 22279-4 | Echovirus 7 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22279-4.json |
| 22280-2 | Echovirus 9 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22280-2.json |
| 22281-0 | Echovirus 9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22281-0.json |
| 22282-8 | Echovirus NOS Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22282-8.json |
| 22283-6 | Ehrlichia chaffeensis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22283-6.json |
| 22284-4 | Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22284-4.json |
| 2228-5 | Enterotoxin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2228-5.json |
| 22285-1 | Entamoeba histolytica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22285-1.json |
| 22286-9 | Entamoeba histolytica Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22286-9.json |
| 22287-7 | Entamoeba histolytica IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22287-7.json |
| 22288-5 | Entamoeba histolytica IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22288-5.json |
| 22289-3 | Entamoeba histolytica IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22289-3.json |
| 22290-1 | Epstein Barr virus capsid IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22290-1.json |
| 22291-9 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22291-9.json |
| 22292-7 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22292-7.json |
| 2229-3 | Epiandrosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2229-3.json |
| 22293-5 | Epstein Barr virus early Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22293-5.json |
| 22294-3 | Epstein Barr virus early Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22294-3.json |
| 22295-0 | Epstein Barr virus early IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22295-0.json |
| 22296-8 | Epstein Barr virus nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22296-8.json |
| 22297-6 | Epstein Barr virus nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22297-6.json |
| 22298-4 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22298-4.json |
| 22299-2 | Equine arteritis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22299-2.json |
| 22300-8 | Equine herpesvirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22300-8.json |
| 2230-1 | EPINEPHrine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2230-1.json |
| 22301-6 | Equine infectious anemia virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22301-6.json |
| 22302-4 | Equine influenza virus A1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22302-4.json |
| 22303-2 | Equine influenza virus A2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22303-2.json |
| 22304-0 | Giardia lamblia Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22304-0.json |
| 22305-7 | Giardia lamblia IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22305-7.json |
| 22306-5 | Giardia lamblia IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22306-5.json |
| 22307-3 | Giardia lamblia IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22307-3.json |
| 22308-1 | Hantavirus puumala IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22308-1.json |
| 22309-9 | Hantavirus puumala IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22309-9.json |
| 22310-7 | Helicobacter pylori Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22310-7.json |
| 22312-3 | Hepatitis A virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22312-3.json |
| 22313-1 | Hepatitis A virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22313-1.json |
| 22314-9 | Hepatitis A virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22314-9.json |
| 22315-6 | Hepatitis A virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22315-6.json |
| 22316-4 | Hepatitis B virus core Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22316-4.json |
| 22317-2 | Hepatitis B virus core Ab [Units/volume] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/22317-2.json |
| 22318-0 | Hepatitis B virus core IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22318-0.json |
| 22319-8 | Hepatitis B virus core IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22319-8.json |
| 22320-6 | Hepatitis B virus e Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22320-6.json |
| 22321-4 | Hepatitis B virus e Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22321-4.json |
| 22322-2 | Hepatitis B virus surface Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22322-2.json |
| 22323-0 | Hepatitis B virus surface Ab [Units/volume] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/22323-0.json |
| 2232-7 | EPINEPHrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2232-7.json |
| 22327-1 | Hepatitis C virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22327-1.json |
| 22328-9 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22328-9.json |
| 22330-5 | Hepatitis D virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22330-5.json |
| 22331-3 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22331-3.json |
| 22333-9 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22333-9.json |
| 22334-7 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22334-7.json |
| 2233-5 | Epitestosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2233-5.json |
| 22337-0 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22337-0.json |
| 22338-8 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22338-8.json |
| 22339-6 | Herpes simplex virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22339-6.json |
| 22340-4 | Herpes simplex virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22340-4.json |
| 22341-2 | Herpes simplex virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22341-2.json |
| 2234-3 | Epitestosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2234-3.json |
| 22343-8 | Herpes simplex virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22343-8.json |
| 22344-6 | Heterophile Ab after absorption [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22344-6.json |
| 22345-3 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22345-3.json |
| 22346-1 | Histoplasma capsulatum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22346-1.json |
| 22347-9 | Histoplasma capsulatum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22347-9.json |
| 22348-7 | Histoplasma capsulatum IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22348-7.json |
| 22349-5 | Histoplasma capsulatum IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22349-5.json |
| 2235-0 | Epitestosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2235-0.json |
| 22350-3 | Histoplasma capsulatum IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22350-3.json |
| 22351-1 | Histoplasma capsulatum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22351-1.json |
| 22352-9 | Histoplasma capsulatum IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22352-9.json |
| 22353-7 | Histoplasma capsulatum IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22353-7.json |
| 22354-5 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22354-5.json |
| 22355-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22355-2.json |
| 22356-0 | HIV 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22356-0.json |
| 22357-8 | HIV 1+2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22357-8.json |
| 22358-6 | HIV 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22358-6.json |
| 22359-4 | HTLV I Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22359-4.json |
| 22360-2 | HTLV I IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22360-2.json |
| 22361-0 | HTLV I+II Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22361-0.json |
| 22362-8 | HTLV I+II Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22362-8.json |
| 22363-6 | HTLV I+II Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22363-6.json |
| 22364-4 | Infectious bursal disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22364-4.json |
| 22365-1 | Influenza virus A Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22365-1.json |
| 22366-9 | Influenza virus A+B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22366-9.json |
| 22367-7 | Influenza virus B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22367-7.json |
| 2236-8 | Calciferol (Vit D2) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2236-8.json |
| 22368-5 | Influenza virus C Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22368-5.json |
| 22369-3 | Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22369-3.json |
| 22370-1 | Japanese encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22370-1.json |
| 22371-9 | Junin virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22371-9.json |
| 22373-5 | La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22373-5.json |
| 22375-0 | La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22375-0.json |
| 2237-6 | Erythropoietin (EPO) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2237-6.json |
| 22377-6 | Lassa virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22377-6.json |
| 22378-4 | Lassa virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22378-4.json |
| 22379-2 | Lassa virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22379-2.json |
| 22380-0 | Lassa virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22380-0.json |
| 22381-8 | Legionella pneumophila 1 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22381-8.json |
| 22382-6 | Legionella pneumophila 1 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22382-6.json |
| 22383-4 | Legionella pneumophila 2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22383-4.json |
| 2238-4 | Estradiol (E2) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2238-4.json |
| 22384-2 | Legionella pneumophila 2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22384-2.json |
| 22385-9 | Legionella pneumophila 3 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22385-9.json |
| 22386-7 | Legionella pneumophila 3 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22386-7.json |
| 22387-5 | Legionella pneumophila 4 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22387-5.json |
| 22388-3 | Legionella pneumophila 4 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22388-3.json |
| 22389-1 | Legionella pneumophila 5 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22389-1.json |
| 22390-9 | Legionella pneumophila 5 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22390-9.json |
| 22391-7 | Legionella pneumophila 6 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22391-7.json |
| 2239-2 | Estradiol (E2) [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2239-2.json |
| 22392-5 | Legionella pneumophila 6 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22392-5.json |
| 22393-3 | Legionella pneumophila 7 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22393-3.json |
| 22394-1 | Legionella pneumophila 8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22394-1.json |
| 22395-8 | Legionella pneumophila 9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22395-8.json |
| 22396-6 | Legionella pneumophila Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22396-6.json |
| 22397-4 | Legionella pneumophila IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22397-4.json |
| 22398-2 | Legionella pneumophila IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22398-2.json |
| 22399-0 | Legionella sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22399-0.json |
| 2240-0 | Estradiol (E2) Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2240-0.json |
| 22400-6 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22400-6.json |
| 22401-4 | Leptospira interrogans sv Canicola Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22401-4.json |
| 22402-2 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22402-2.json |
| 22403-0 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22403-0.json |
| 22404-8 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22404-8.json |
| 22405-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22405-5.json |
| 22406-3 | Listeria monocytogenes Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22406-3.json |
| 22408-9 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22408-9.json |
| 22409-7 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22409-7.json |
| 22410-5 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22410-5.json |
| 22411-3 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22411-3.json |
| 22412-1 | Saccharopolyspora rectivirgula Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22412-1.json |
| 22413-9 | Mumps virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22413-9.json |
| 22414-7 | Mumps virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22414-7.json |
| 22415-4 | Mumps virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22415-4.json |
| 22416-2 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22416-2.json |
| 22417-0 | Mumps virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22417-0.json |
| 2241-8 | Estradiol (E2) Free [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2241-8.json |
| 22418-8 | Mumps virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22418-8.json |
| 22419-6 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22419-6.json |
| 22420-4 | Mumps virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22420-4.json |
| 22421-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22421-2.json |
| 22422-0 | Mycoplasma gallisepticum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22422-0.json |
| 22423-8 | Mycoplasma hominis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22423-8.json |
| 22424-6 | Mycoplasma meleagridis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22424-6.json |
| 22425-3 | Mycoplasma pneumoniae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22425-3.json |
| 22426-1 | Mycoplasma pneumoniae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22426-1.json |
| 22427-9 | Mycoplasma pneumoniae IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22427-9.json |
| 22428-7 | Mycoplasma sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22428-7.json |
| 22429-5 | Mycoplasma synoviae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22429-5.json |
| 22430-3 | Neisseria gonorrhoeae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22430-3.json |
| 22431-1 | Neisseria meningitidis serogroup Y Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/22431-1.json |
| 22432-9 | Neospora caninum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22432-9.json |
| 2243-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2243-4.json |
| 22434-5 | Human papilloma virus Ab [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/22434-5.json |
| 22435-2 | Paracoccidioides brasiliensis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22435-2.json |
| 22436-0 | Paragonimus sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22436-0.json |
| 22437-8 | Parainfluenza virus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22437-8.json |
| 22438-6 | Parainfluenza virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22438-6.json |
| 22439-4 | Parainfluenza virus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22439-4.json |
| 22440-2 | Pasteurella multocida Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22440-2.json |
| 22441-0 | Plasmodium falciparum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22441-0.json |
| 22442-8 | Plasmodium malariae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22442-8.json |
| 22443-6 | Plasmodium ovale Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22443-6.json |
| 22444-4 | Plasmodium vivax Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22444-4.json |
| 22445-1 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22445-1.json |
| 22446-9 | Polio virus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22446-9.json |
| 22447-7 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22447-7.json |
| 22448-5 | Polio virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22448-5.json |
| 22449-3 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22449-3.json |
| 22450-1 | Polio virus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22450-1.json |
| 22451-9 | PRRSV Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22451-9.json |
| 22452-7 | Pseudorabies virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22452-7.json |
| 22453-5 | Pseudorabies virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22453-5.json |
| 22454-3 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22454-3.json |
| 22455-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22455-0.json |
| 22456-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22456-8.json |
| 22457-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22457-6.json |
| 22458-4 | Rabies virus Ab [Units/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/22458-4.json |
| 2245-9 | Estradiol (E2) [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2245-9.json |
| 22459-2 | Reagin Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22459-2.json |
| 22460-0 | Reagin Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22460-0.json |
| 22461-8 | Reagin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22461-8.json |
| 22462-6 | Reagin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22462-6.json |
| 22463-4 | Reagin Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/22463-4.json |
| 22464-2 | Reagin Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/22464-2.json |
| 22465-9 | Reovirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22465-9.json |
| 22466-7 | Respiratory syncytial virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22466-7.json |
| 2246-7 | Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2246-7.json |
| 22467-5 | Respiratory syncytial virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22467-5.json |
| 22468-3 | Rickettsia (Proteus OX19) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22468-3.json |
| 22469-1 | Rickettsia (Proteus OX19) Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22469-1.json |
| 22470-9 | Rickettsia (Proteus OX2) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22470-9.json |
| 22471-7 | Rickettsia (Proteus OX2) Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22471-7.json |
| 22472-5 | Rickettsia (Proteus OXK) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22472-5.json |
| 22473-3 | Rickettsia (Proteus OXK) Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22473-3.json |
| 22474-1 | Rickettsia spotted fever group Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22474-1.json |
| 2247-5 | Estriol (E3).conjugated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2247-5.json |
| 22475-8 | Rickettsia spotted fever group Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22475-8.json |
| 22476-6 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22476-6.json |
| 22477-4 | Rickettsia spotted fever group IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22477-4.json |
| 22478-2 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22478-2.json |
| 22479-0 | Rickettsia spotted fever group IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22479-0.json |
| 22480-8 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22480-8.json |
| 22481-6 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22481-6.json |
| 22482-4 | Rickettsia rickettsii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22482-4.json |
| 2248-3 | Estriol (E3) [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2248-3.json |
| 22483-2 | Rickettsia rickettsii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22483-2.json |
| 22484-0 | Rickettsia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22484-0.json |
| 22485-7 | Orientia tsutsugamushi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22485-7.json |
| 22486-5 | Rickettsia typhi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22486-5.json |
| 22487-3 | Rickettsia typhi IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22487-3.json |
| 22488-1 | Rickettsia typhi IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22488-1.json |
| 22489-9 | Rickettsia typhi IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22489-9.json |
| 22490-7 | Rickettsia typhi IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22490-7.json |
| 2249-1 | Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2249-1.json |
| 22491-5 | Rickettsia typhus group Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22491-5.json |
| 22492-3 | Rickettsia typhus group Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22492-3.json |
| 22493-1 | Rickettsia typhus group IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22493-1.json |
| 22494-9 | Rickettsia typhus group IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22494-9.json |
| 22495-6 | Rotavirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22495-6.json |
| 22496-4 | Rubella virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22496-4.json |
| 22497-2 | Rubella virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22497-2.json |
| 22498-0 | Measles virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22498-0.json |
| 22499-8 | Measles virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22499-8.json |
| 22500-3 | Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22500-3.json |
| 22501-1 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22501-1.json |
| 22502-9 | Measles virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22502-9.json |
| 22503-7 | Measles virus IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/22503-7.json |
| 22504-5 | Measles virus IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/22504-5.json |
| 22505-2 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22505-2.json |
| 22506-0 | Measles virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22506-0.json |
| 22507-8 | Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22507-8.json |
| 2250-9 | Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2250-9.json |
| 22509-4 | Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22509-4.json |
| 22510-2 | Saint Louis encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22510-2.json |
| 22511-0 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22511-0.json |
| 22512-8 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22512-8.json |
| 22513-6 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22513-6.json |
| 22514-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22514-4.json |
| 22515-1 | Salmonella arizonae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22515-1.json |
| 22516-9 | Salmonella paratyphi A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22516-9.json |
| 2251-7 | Estriol (E3) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2251-7.json |
| 22517-7 | Salmonella paratyphi A H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22517-7.json |
| 22518-5 | Salmonella paratyphi A H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22518-5.json |
| 22519-3 | Salmonella paratyphi A O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22519-3.json |
| 22520-1 | Salmonella paratyphi B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22520-1.json |
| 22521-9 | Salmonella paratyphi B H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22521-9.json |
| 22522-7 | Salmonella paratyphi B H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22522-7.json |
| 22523-5 | Salmonella paratyphi B O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22523-5.json |
| 22524-3 | Salmonella paratyphi C H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22524-3.json |
| 2252-5 | Estriol (E3) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2252-5.json |
| 22525-0 | Salmonella paratyphi C O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22525-0.json |
| 22526-8 | Salmonella pullorum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22526-8.json |
| 22527-6 | Salmonella sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22527-6.json |
| 22529-2 | Salmonella typhi H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22529-2.json |
| 22531-8 | Salmonella typhimurium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22531-8.json |
| 22532-6 | Sarcocystis neurona Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/22532-6.json |
| 2253-3 | Estriol (E3) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2253-3.json |
| 22533-4 | Sarcocystis neurona Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/22533-4.json |
| 22534-2 | Sarcocystis neurona Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22534-2.json |
| 22535-9 | Schistosoma japonicum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22535-9.json |
| 22536-7 | Schistosoma mansoni Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22536-7.json |
| 22537-5 | Shigella boydii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22537-5.json |
| 22538-3 | Shigella dysenteriae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22538-3.json |
| 22539-1 | Shigella flexneri Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22539-1.json |
| 22540-9 | Shigella sonnei Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22540-9.json |
| 2254-1 | Estrogen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2254-1.json |
| 22552-4 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22552-4.json |
| 22555-7 | Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/22555-7.json |
| 2255-8 | Estrogen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2255-8.json |
| 22562-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/22562-3.json |
| 22564-9 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/22564-9.json |
| 2256-6 | Estrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2256-6.json |
| 22566-4 | Streptococcus pyogenes enzyme Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22566-4.json |
| 22567-2 | Streptococcus pyogenes enzyme Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22567-2.json |
| 22568-0 | Streptolysin O Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22568-0.json |
| 22571-4 | Teichoate Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22571-4.json |
| 22572-2 | Saccharomonospora viridis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22572-2.json |
| 22573-0 | Thermoactinomyces vulgaris Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22573-0.json |
| 2257-4 | Estrone (E1) [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2257-4.json |
| 22575-5 | Toxocara canis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22575-5.json |
| 22577-1 | Toxoplasma gondii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22577-1.json |
| 22578-9 | Toxoplasma gondii IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22578-9.json |
| 22579-7 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22579-7.json |
| 22580-5 | Toxoplasma gondii IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22580-5.json |
| 22581-3 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22581-3.json |
| 2258-2 | Estrone (E1) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2258-2.json |
| 22582-1 | Toxoplasma gondii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22582-1.json |
| 22583-9 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22583-9.json |
| 22584-7 | Toxoplasma gondii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22584-7.json |
| 22585-4 | Treponema pallidum Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/22585-4.json |
| 22586-2 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22586-2.json |
| 22587-0 | Treponema pallidum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22587-0.json |
| 2259-0 | Estrone (E1) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2259-0.json |
| 22590-4 | Treponema pallidum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22590-4.json |
| 22592-0 | Treponema pallidum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22592-0.json |
| 22594-6 | Treponema pallidum IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22594-6.json |
| 22595-3 | Trichinella spiralis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22595-3.json |
| 22596-1 | Trichinella spiralis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22596-1.json |
| 22599-5 | Trypanosoma cruzi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22599-5.json |
| 22600-1 | Varicella zoster virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22600-1.json |
| 22601-9 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22601-9.json |
| 22602-7 | Varicella zoster virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22602-7.json |
| 22603-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/22603-5.json |
| 22604-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/22604-3.json |
| 22605-0 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22605-0.json |
| 22606-8 | Varicella zoster virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22606-8.json |
| 22607-6 | Venezuelan equine encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22607-6.json |
| 2260-8 | Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2260-8.json |
| 22608-4 | Escherichia coli verotoxin 1 Ab [Titer] in Stool | ./2.16.840.1.114222.4.11.1002/22608-4.json |
| 22609-2 | Escherichia coli verotoxin 2 Ab [Titer] in Stool | ./2.16.840.1.114222.4.11.1002/22609-2.json |
| 22610-0 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22610-0.json |
| 22611-8 | Western equine encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22611-8.json |
| 22613-4 | Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22613-4.json |
| 22614-2 | Western equine encephalitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22614-2.json |
| 22615-9 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/22615-9.json |
| 2261-6 | Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2261-6.json |
| 22616-7 | Western equine encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22616-7.json |
| 22617-5 | Wuchereria bancrofti Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22617-5.json |
| 22618-3 | Yellow fever virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22618-3.json |
| 22619-1 | Yersinia enterocolitica IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22619-1.json |
| 22620-9 | Yersinia enterocolitica IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22620-9.json |
| 22621-7 | Yersinia enterocolitica IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22621-7.json |
| 2262-4 | Estrone (E1).unconjugated [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2262-4.json |
| 2265-7 | Ethylmalonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2265-7.json |
| 22663-9 | Estrone (E1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22663-9.json |
| 22664-7 | Urea [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22664-7.json |
| 2266-5 | Etiocholanolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2266-5.json |
| 22665-4 | Bilirubin.delta [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22665-4.json |
| 22666-2 | Busulfan [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22666-2.json |
| 22668-8 | Propylene glycol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22668-8.json |
| 2267-3 | Etiocholanolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2267-3.json |
| 22674-6 | Transferrin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22674-6.json |
| 22676-1 | 7-Dehydrocholesterol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22676-1.json |
| 22678-7 | Ethylene glycol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/22678-7.json |
| 22680-3 | Mercury/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/22680-3.json |
| 2268-1 | Etiocholanolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2268-1.json |
| 22687-8 | Cystine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/22687-8.json |
| 22689-4 | Zinc [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/22689-4.json |
| 22696-9 | Cadmium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/22696-9.json |
| 2269-9 | Complement factor B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2269-9.json |
| 22700-9 | Urea [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/22700-9.json |
| 22701-7 | Salicylates [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/22701-7.json |
| 22702-5 | Ketones [Moles/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/22702-5.json |
| 22704-1 | Carnitine free (C0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/22704-1.json |
| 22705-8 | Glucose [Moles/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/22705-8.json |
| 2270-7 | Fat [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/2270-7.json |
| 22708-2 | Homovanillate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/22708-2.json |
| 22712-4 | Adenosine monophosphate.cyclic [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/22712-4.json |
| 2271-5 | Fat [Mass/time] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/2271-5.json |
| 2272-3 | Fat [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2272-3.json |
| 22726-4 | Creatinine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22726-4.json |
| 22731-4 | Triglyceride [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22731-4.json |
| 22732-2 | Salicylates [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22732-2.json |
| 22733-0 | Phosphate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22733-0.json |
| 22734-8 | Ethylene glycol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22734-8.json |
| 22735-5 | Bicarbonate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22735-5.json |
| 22736-3 | Acetaminophen [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22736-3.json |
| 22738-9 | Urea [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22738-9.json |
| 22742-1 | Propylene glycol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22742-1.json |
| 22744-7 | Copper [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/22744-7.json |
| 22745-4 | Ethanol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/22745-4.json |
| 22746-2 | Gentamicin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/22746-2.json |
| 22747-0 | Gentamicin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/22747-0.json |
| 22748-8 | Cholesterol in LDL [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22748-8.json |
| 22750-4 | Tobramycin [Moles/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/22750-4.json |
| 22751-2 | Tobramycin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/22751-2.json |
| 22752-0 | Tobramycin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/22752-0.json |
| 22753-8 | Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22753-8.json |
| 22755-3 | Haemophilus influenzae B Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22755-3.json |
| 22758-7 | Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/22758-7.json |
| 22759-5 | Platelet Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22759-5.json |
| 22760-3 | Potassium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/22760-3.json |
| 22763-7 | Ammonia [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/22763-7.json |
| 2276-4 | Ferritin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2276-4.json |
| 22764-5 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22764-5.json |
| 22765-2 | Adult fly identified in Specimen | ./2.16.840.1.114222.4.11.1002/22765-2.json |
| 22766-0 | African horse sickness virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22766-0.json |
| 22767-8 | African horse sickness virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/22767-8.json |
| 22768-6 | African horse sickness virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22768-6.json |
| 22769-4 | African horse sickness virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22769-4.json |
| 22770-2 | African horse sickness virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22770-2.json |
| 22771-0 | African horse sickness virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22771-0.json |
| 2277-2 | Ferrochelatase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2277-2.json |
| 22772-8 | African horse sickness virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/22772-8.json |
| 22773-6 | African horse sickness virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/22773-6.json |
| 22774-4 | African horse sickness virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22774-4.json |
| 22775-1 | African horse sickness virus serotype [Identifier] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22775-1.json |
| 22776-9 | African horse sickness virus serotype [Identifier] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/22776-9.json |
| 22777-7 | African swine fever virus Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/22777-7.json |
| 22778-5 | African swine fever virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/22778-5.json |
| 22779-3 | African swine fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22779-3.json |
| 2278-0 | Fibrinopeptide B [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2278-0.json |
| 22780-1 | African swine fever virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22780-1.json |
| 22781-9 | African swine fever virus Ag [Presence] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/22781-9.json |
| 22782-7 | African swine fever virus Ag [Presence] in Tissue by Agglutination | ./2.16.840.1.114222.4.11.1002/22782-7.json |
| 22783-5 | African swine fever virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22783-5.json |
| 22784-3 | African swine fever virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22784-3.json |
| 22785-0 | African swine fever virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22785-0.json |
| 22786-8 | Alcelaphine herpesvirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22786-8.json |
| 22787-6 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22787-6.json |
| 22788-4 | Alcelaphine herpesvirus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22788-4.json |
| 22789-2 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22789-2.json |
| 22790-0 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22790-0.json |
| 22791-8 | Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22791-8.json |
| 22792-6 | Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) | ./2.16.840.1.114222.4.11.1002/22792-6.json |
| 22793-4 | Aleutian disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22793-4.json |
| 22794-2 | Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22794-2.json |
| 22795-9 | Anaplasma marginale Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22795-9.json |
| 22796-7 | Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22796-7.json |
| 22797-5 | Anaplasma marginale DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22797-5.json |
| 2279-8 | Fibrinopeptide A [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2279-8.json |
| 22798-3 | Anaplasma marginale rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/22798-3.json |
| 22799-1 | Anaplasma sp identified in Tissue by Modified Giemsa stain | ./2.16.840.1.114222.4.11.1002/22799-1.json |
| 22800-7 | Anaplasma sp identified in Blood by Modified Giemsa stain | ./2.16.840.1.114222.4.11.1002/22800-7.json |
| 22801-5 | Infectious bronchitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22801-5.json |
| 22802-3 | Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/22802-3.json |
| 22803-1 | Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22803-1.json |
| 22804-9 | Infectious bronchitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22804-9.json |
| 22805-6 | Infectious bronchitis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/22805-6.json |
| 2280-6 | Fibronectin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2280-6.json |
| 22806-4 | Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/22806-4.json |
| 22807-2 | Infectious bronchitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22807-2.json |
| 22808-0 | Infectious bronchitis virus [Presence] in Specimen by Electron microscopy | ./2.16.840.1.114222.4.11.1002/22808-0.json |
| 22809-8 | Infectious bronchitis virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/22809-8.json |
| 22810-6 | Infectious bronchitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22810-6.json |
| 22811-4 | Avian infectious laryngotracheitis virus [Presence] in Specimen by Electron microscopy | ./2.16.840.1.114222.4.11.1002/22811-4.json |
| 22813-0 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22813-0.json |
| 2281-4 | Flavin adenine dinucleotide [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2281-4.json |
| 22814-8 | Avian infectious laryngotracheitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22814-8.json |
| 22815-5 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22815-5.json |
| 22816-3 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/22816-3.json |
| 22817-1 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22817-1.json |
| 22818-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay | ./2.16.840.1.114222.4.11.1002/22818-9.json |
| 22819-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22819-7.json |
| 22820-5 | Avian orthoreovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/22820-5.json |
| 2282-2 | Folate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2282-2.json |
| 22822-1 | Influenza virus A Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22822-1.json |
| 22823-9 | Influenza virus A Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22823-9.json |
| 22824-7 | Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/22824-7.json |
| 22825-4 | Influenza virus A Ag [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22825-4.json |
| 22826-2 | Influenza virus A identified in Specimen by Bioassay | ./2.16.840.1.114222.4.11.1002/22826-2.json |
| 22827-0 | Influenza virus A subtype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22827-0.json |
| 22828-8 | Influenza virus A subtype [Identifier] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22828-8.json |
| 22829-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/22829-6.json |
| 2283-0 | Folate [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2283-0.json |
| 22830-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22830-4.json |
| 22831-2 | Avian paramyxovirus 1 Ag [Presence] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/22831-2.json |
| 22832-0 | Avian paramyxovirus 1 identified in Specimen by Bioassay | ./2.16.840.1.114222.4.11.1002/22832-0.json |
| 22833-8 | Avian paramyxovirus 1 [Units/volume] in Specimen by Bioassay | ./2.16.840.1.114222.4.11.1002/22833-8.json |
| 22834-6 | Avian metapneumovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22834-6.json |
| 22836-1 | Avian pox virus [Presence] in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/22836-1.json |
| 22837-9 | Avian pox virus Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22837-9.json |
| 22838-7 | Avian pox virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22838-7.json |
| 22839-5 | Avian pox virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22839-5.json |
| 22840-3 | Avian pox virus Ab [Presence] in Serum by Immune stain | ./2.16.840.1.114222.4.11.1002/22840-3.json |
| 22841-1 | Avian pox virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22841-1.json |
| 22842-9 | Avian pox virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22842-9.json |
| 22843-7 | Avian pox virus DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/22843-7.json |
| 22844-5 | Babesia bigemina Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22844-5.json |
| 22845-2 | Babesia bigemina Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22845-2.json |
| 22846-0 | Babesia bigemina Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22846-0.json |
| 22847-8 | Babesia bovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22847-8.json |
| 2284-8 | Folate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2284-8.json |
| 22848-6 | Babesia bovis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22848-6.json |
| 22849-4 | Babesia bovis Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22849-4.json |
| 22850-2 | Babesia caballi Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22850-2.json |
| 22851-0 | Babesia caballi Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22851-0.json |
| 22853-6 | Babesia caballi rRNA [Presence] in Blood by Probe | ./2.16.840.1.114222.4.11.1002/22853-6.json |
| 22854-4 | Babesia divergens Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22854-4.json |
| 2285-5 | Follitropin [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2285-5.json |
| 22855-1 | Babesia divergens Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22855-1.json |
| 22856-9 | Babesia sp rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/22856-9.json |
| 22857-7 | Babesia sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22857-7.json |
| 22858-5 | Babesia sp identified in Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/22858-5.json |
| 22859-3 | Bacillus anthracis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22859-3.json |
| 22860-1 | Bacillus anthracis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22860-1.json |
| 22861-9 | Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22861-9.json |
| 22862-7 | Bacillus anthracis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22862-7.json |
| 2286-3 | Follitropin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2286-3.json |
| 22863-5 | Bacillus anthracis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22863-5.json |
| 22864-3 | Bacillus anthracis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22864-3.json |
| 22865-0 | Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22865-0.json |
| 22866-8 | Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22866-8.json |
| 22867-6 | Bacillus anthracis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22867-6.json |
| 22868-4 | Bluetongue virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22868-4.json |
| 22869-2 | Bluetongue virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22869-2.json |
| 22870-0 | Bluetongue virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/22870-0.json |
| 2287-1 | Follitropin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2287-1.json |
| 22871-8 | Bluetongue virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/22871-8.json |
| 22872-6 | Bluetongue virus Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/22872-6.json |
| 22873-4 | Bluetongue virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22873-4.json |
| 22874-2 | Bluetongue virus serotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22874-2.json |
| 22875-9 | Border disease virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22875-9.json |
| 22876-7 | Border disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22876-7.json |
| 22877-5 | Border disease virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22877-5.json |
| 22878-3 | Border disease virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22878-3.json |
| 22879-1 | Border disease virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22879-1.json |
| 22880-9 | Border disease virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22880-9.json |
| 22881-7 | Border disease virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/22881-7.json |
| 22882-5 | Border disease virus Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/22882-5.json |
| 22883-3 | Border disease virus RNA [Presence] in Tissue from Fetus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22883-3.json |
| 22884-1 | Border disease virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22884-1.json |
| 22885-8 | Border disease virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22885-8.json |
| 22886-6 | Bordetella bronchiseptica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22886-6.json |
| 22887-4 | Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22887-4.json |
| 22888-2 | Bordetella bronchiseptica Ag [Presence] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/22888-2.json |
| 2288-9 | Follitropin.alpha subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2288-9.json |
| 22889-0 | Bovine diarrhea virus Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22889-0.json |
| 22890-8 | Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/22890-8.json |
| 22891-6 | Bovine diarrhea virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/22891-6.json |
| 22892-4 | Bovine diarrhea virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22892-4.json |
| 22893-2 | Bovine diarrhea virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22893-2.json |
| 22894-0 | Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22894-0.json |
| 22895-7 | Bovine diarrhea virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22895-7.json |
| 22896-5 | Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/22896-5.json |
| 2289-7 | Follitropin.beta subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2289-7.json |
| 22897-3 | Bovine diarrhea virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22897-3.json |
| 22898-1 | Bovine diarrhea virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22898-1.json |
| 22899-9 | Bovine diarrhea virus RNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/22899-9.json |
| 22900-5 | Bovine diarrhea virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22900-5.json |
| 22901-3 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22901-3.json |
| 22902-1 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22902-1.json |
| 22903-9 | Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/22903-9.json |
| 22904-7 | Bovine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22904-7.json |
| 22905-4 | Bovine herpesvirus 1 Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22905-4.json |
| 22906-2 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/22906-2.json |
| 22907-0 | Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22907-0.json |
| 22908-8 | Bovine herpesvirus 1 Ag [Units/volume] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/22908-8.json |
| 22909-6 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22909-6.json |
| 22910-4 | Bovine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22910-4.json |
| 22911-2 | Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22911-2.json |
| 22912-0 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/22912-0.json |
| 2291-3 | Formate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2291-3.json |
| 22913-8 | Bovine herpesvirus 1 DNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22913-8.json |
| 22914-6 | Bovine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22914-6.json |
| 22915-3 | Bovine leukemia virus Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22915-3.json |
| 22916-1 | Bovine leukemia virus Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/22916-1.json |
| 22917-9 | Bovine leukemia virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/22917-9.json |
| 22918-7 | Bovine leukemia virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22918-7.json |
| 22919-5 | Bovine leukemia virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22919-5.json |
| 22920-3 | Brucella abortus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22920-3.json |
| 2292-1 | Formate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2292-1.json |
| 22921-1 | Brucella abortus Ab [Units/volume] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22921-1.json |
| 22922-9 | Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22922-9.json |
| 22923-7 | Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/22923-7.json |
| 22924-5 | Brucella abortus IgG1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22924-5.json |
| 22925-2 | Brucella abortus IgG1 Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22925-2.json |
| 22926-0 | Brucella abortus rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/22926-0.json |
| 22927-8 | Brucella abortus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22927-8.json |
| 22928-6 | Brucella canis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22928-6.json |
| 22929-4 | Brucella canis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22929-4.json |
| 22930-2 | Brucella canis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22930-2.json |
| 22931-0 | Brucella melitensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22931-0.json |
| 22932-8 | Brucella melitensis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22932-8.json |
| 22933-6 | Brucella melitensis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22933-6.json |
| 22934-4 | Brucella melitensis Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22934-4.json |
| 22935-1 | Brucella melitensis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22935-1.json |
| 22936-9 | Brucella melitensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22936-9.json |
| 22937-7 | Brucella ovis Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22937-7.json |
| 22938-5 | Brucella ovis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22938-5.json |
| 2293-9 | Fructokinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2293-9.json |
| 22939-3 | Brucella ovis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/22939-3.json |
| 22940-1 | Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22940-1.json |
| 22943-5 | Brucella sp Ag [Presence] in Placenta by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22943-5.json |
| 22944-3 | Brucella sp Ag [Presence] in Vaginal fluid by Immune stain | ./2.16.840.1.114222.4.11.1002/22944-3.json |
| 22945-0 | Brucella sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/22945-0.json |
| 22946-8 | Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22946-8.json |
| 22947-6 | Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22947-6.json |
| 22948-4 | Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain | ./2.16.840.1.114222.4.11.1002/22948-4.json |
| 22949-2 | Brucella sp Ag [Presence] in Placenta by Immune stain | ./2.16.840.1.114222.4.11.1002/22949-2.json |
| 22950-0 | Brucella suis Ab [Presence] in Serum by Plate agglutination | ./2.16.840.1.114222.4.11.1002/22950-0.json |
| 22951-8 | Brucella suis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22951-8.json |
| 22952-6 | Brucella suis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22952-6.json |
| 22953-4 | Brucella suis Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22953-4.json |
| 2295-4 | Fructose [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2295-4.json |
| 22954-2 | Brucella suis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/22954-2.json |
| 22955-9 | Brucella suis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22955-9.json |
| 22956-7 | Burkholderia mallei Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22956-7.json |
| 22958-3 | Burkholderia mallei Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22958-3.json |
| 22959-1 | Burkholderia mallei Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/22959-1.json |
| 2296-2 | Fructose [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2296-2.json |
| 22962-5 | Campylobacter fetus Ab [Presence] in Genital mucus | ./2.16.840.1.114222.4.11.1002/22962-5.json |
| 22963-3 | Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination | ./2.16.840.1.114222.4.11.1002/22963-3.json |
| 22964-1 | Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22964-1.json |
| 22965-8 | Campylobacter fetus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22965-8.json |
| 22966-6 | Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22966-6.json |
| 22967-4 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus | ./2.16.840.1.114222.4.11.1002/22967-4.json |
| 22968-2 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination | ./2.16.840.1.114222.4.11.1002/22968-2.json |
| 22969-0 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay | ./2.16.840.1.114222.4.11.1002/22969-0.json |
| 2297-0 | Fructose [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2297-0.json |
| 22970-8 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus | ./2.16.840.1.114222.4.11.1002/22970-8.json |
| 22971-6 | Caprine arthritis encephalitis virus [Presence] in Specimen by Electron microscopy | ./2.16.840.1.114222.4.11.1002/22971-6.json |
| 22972-4 | Caprine arthritis encephalitis virus Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/22972-4.json |
| 22973-2 | Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/22973-2.json |
| 22974-0 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22974-0.json |
| 22975-7 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22975-7.json |
| 22976-5 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22976-5.json |
| 22977-3 | Caprine arthritis encephalitis virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/22977-3.json |
| 22978-1 | Caprine arthritis encephalitis virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/22978-1.json |
| 22979-9 | Caprine herpesvirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22979-9.json |
| 22980-7 | Caprine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22980-7.json |
| 22981-5 | Capripox virus [Presence] in Tissue by Animal inoculation | ./2.16.840.1.114222.4.11.1002/22981-5.json |
| 22982-3 | Capripox virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/22982-3.json |
| 22983-1 | Capripox virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/22983-1.json |
| 22984-9 | Capripox virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/22984-9.json |
| 22986-4 | Capripox virus Ag [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22986-4.json |
| 22987-2 | Capripox virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/22987-2.json |
| 22988-0 | Capripox virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/22988-0.json |
| 22989-8 | Capripox virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/22989-8.json |
| 22990-6 | Capripox virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/22990-6.json |
| 22991-4 | Capripox virus DNA [Presence] in Specimen by RFLP | ./2.16.840.1.114222.4.11.1002/22991-4.json |
| 22992-2 | Chlamydophila psittaci [Presence] in Specimen by Giemsa stain | ./2.16.840.1.114222.4.11.1002/22992-2.json |
| 22993-0 | Chlamydophila psittaci [Presence] in Placenta by Electron microscopy | ./2.16.840.1.114222.4.11.1002/22993-0.json |
| 22994-8 | Chlamydophila psittaci Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/22994-8.json |
| 22995-5 | Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/22995-5.json |
| 2299-6 | Aldolase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2299-6.json |
| 22996-3 | Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/22996-3.json |
| 22997-1 | Chlamydophila psittaci Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/22997-1.json |
| 22998-9 | Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/22998-9.json |
| 22999-7 | Chlamydophila psittaci Ag [Presence] in Stool by Immune stain | ./2.16.840.1.114222.4.11.1002/22999-7.json |
| 23000-3 | Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain | ./2.16.840.1.114222.4.11.1002/23000-3.json |
| 23001-1 | Chlamydophila psittaci DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23001-1.json |
| 23002-9 | Classical swine fever virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23002-9.json |
| 23003-7 | Classical swine fever virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23003-7.json |
| 23004-5 | Classical swine fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23004-5.json |
| 23005-2 | Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23005-2.json |
| 23006-0 | Classical swine fever virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23006-0.json |
| 23007-8 | Classical swine fever virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23007-8.json |
| 23008-6 | Classical swine fever virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23008-6.json |
| 23009-4 | Cowdria ruminantium [Presence] in Brain by Giemsa stain | ./2.16.840.1.114222.4.11.1002/23009-4.json |
| 23010-2 | Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23010-2.json |
| 23011-0 | Cowdria ruminantium Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23011-0.json |
| 23012-8 | Cowdria ruminantium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23012-8.json |
| 23013-6 | Cowdria ruminantium Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/23013-6.json |
| 23014-4 | Cowdria ruminantium DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23014-4.json |
| 23015-1 | Cowdria ruminantium rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23015-1.json |
| 23016-9 | Coxiella burnetii [Presence] in Placenta by Light microscopy | ./2.16.840.1.114222.4.11.1002/23016-9.json |
| 23017-7 | Coxiella burnetii Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23017-7.json |
| 23018-5 | Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23018-5.json |
| 23019-3 | Coxiella burnetii Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23019-3.json |
| 23020-1 | Coxiella burnetii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23020-1.json |
| 23021-9 | Coxiella burnetii Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23021-9.json |
| 23022-7 | Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23022-7.json |
| 23023-5 | Coxiella burnetii Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23023-5.json |
| 23024-3 | Coxiella burnetii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23024-3.json |
| 23025-0 | Dermatophilus congolensis [Presence] in Skin by Giemsa stain | ./2.16.840.1.114222.4.11.1002/23025-0.json |
| 23026-8 | Dermatophilus congolensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23026-8.json |
| 23027-6 | Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23027-6.json |
| 2302-8 | Fumarase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2302-8.json |
| 23028-4 | Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23028-4.json |
| 23029-2 | Dirofilaria immitis Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/23029-2.json |
| 23030-0 | Duck enteritis virus [Presence] in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/23030-0.json |
| 23031-8 | Duck enteritis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23031-8.json |
| 23032-6 | Duck enteritis virus Ag [Presence] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23032-6.json |
| 23033-4 | Duck hepatitis virus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23033-4.json |
| 23034-2 | Duck hepatitis virus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23034-2.json |
| 23035-9 | Duck hepatitis virus 1 Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23035-9.json |
| 2303-6 | Fumarate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2303-6.json |
| 23036-7 | Duck hepatitis virus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23036-7.json |
| 23037-5 | Duck hepatitis virus 2 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23037-5.json |
| 23038-3 | Duck hepatitis virus 2 Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23038-3.json |
| 23039-1 | Duck hepatitis virus 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23039-1.json |
| 23040-9 | Duck hepatitis virus 3 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23040-9.json |
| 23041-7 | Duck hepatitis virus 3 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23041-7.json |
| 23042-5 | Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23042-5.json |
| 23043-3 | Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23043-3.json |
| 2304-4 | Fumarylacetoacetate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2304-4.json |
| 23044-1 | Eastern equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23044-1.json |
| 23045-8 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23045-8.json |
| 23046-6 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23046-6.json |
| 23047-4 | Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation | ./2.16.840.1.114222.4.11.1002/23047-4.json |
| 23048-2 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23048-2.json |
| 23049-0 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23049-0.json |
| 23050-8 | Eastern equine encephalitis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23050-8.json |
| 2305-1 | Galactokinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2305-1.json |
| 23051-6 | Eastern equine encephalitis virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23051-6.json |
| 23052-4 | Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23052-4.json |
| 23053-2 | Echinococcus sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/23053-2.json |
| 23054-0 | Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23054-0.json |
| 23055-7 | Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23055-7.json |
| 23056-5 | Ehrlichia risticii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23056-5.json |
| 23057-3 | Ephemeral fever virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23057-3.json |
| 23058-1 | Ephemeral fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23058-1.json |
| 23059-9 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23059-9.json |
| 23060-7 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23060-7.json |
| 23061-5 | Epizootic hemorrhagic disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23061-5.json |
| 23062-3 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/23062-3.json |
| 23063-1 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23063-1.json |
| 23064-9 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23064-9.json |
| 23065-6 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23065-6.json |
| 23066-4 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23066-4.json |
| 23067-2 | Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23067-2.json |
| 23068-0 | Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23068-0.json |
| 2306-9 | Galactose [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2306-9.json |
| 23069-8 | Equine arteritis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23069-8.json |
| 23070-6 | Equine arteritis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23070-6.json |
| 23071-4 | Equine arteritis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23071-4.json |
| 23072-2 | Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23072-2.json |
| 23073-0 | Equine arteritis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23073-0.json |
| 23074-8 | Equine arteritis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23074-8.json |
| 23075-5 | Equine arteritis virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23075-5.json |
| 23076-3 | Equine arteritis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23076-3.json |
| 2307-7 | Galactose [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2307-7.json |
| 23077-1 | Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23077-1.json |
| 23078-9 | Equine arteritis virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23078-9.json |
| 23079-7 | Equine arteritis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23079-7.json |
| 23080-5 | Equine herpesvirus 1 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23080-5.json |
| 23081-3 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23081-3.json |
| 23082-1 | Equine herpesvirus 1 DNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23082-1.json |
| 23083-9 | Equine herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23083-9.json |
| 23084-7 | Equine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23084-7.json |
| 2308-5 | Galactose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2308-5.json |
| 23085-4 | Equine herpesvirus 1+4 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23085-4.json |
| 23086-2 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23086-2.json |
| 23087-0 | Equine herpesvirus 1+4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23087-0.json |
| 23088-8 | Equine herpesvirus 1+4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23088-8.json |
| 23089-6 | Equine herpesvirus 1+4 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23089-6.json |
| 23090-4 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23090-4.json |
| 23091-2 | Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23091-2.json |
| 23092-0 | Equine herpesvirus 4 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23092-0.json |
| 2309-3 | Galactose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2309-3.json |
| 23093-8 | Equine herpesvirus 4 DNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23093-8.json |
| 23094-6 | Equine herpesvirus 4 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23094-6.json |
| 23095-3 | Equine herpesvirus 4 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23095-3.json |
| 23096-1 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/23096-1.json |
| 23097-9 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23097-9.json |
| 23098-7 | Equine infectious anemia virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23098-7.json |
| 23099-5 | Equine infectious anemia virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23099-5.json |
| 23100-1 | Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23100-1.json |
| 2310-1 | Galactose [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2310-1.json |
| 23101-9 | Equine influenza virus A1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23101-9.json |
| 23102-7 | Equine influenza virus A1 Ag [Titer] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23102-7.json |
| 23103-5 | Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23103-5.json |
| 23104-3 | Equine influenza virus A2 Ag [Titer] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23104-3.json |
| 23105-0 | Fly larvae identified in Specimen | ./2.16.840.1.114222.4.11.1002/23105-0.json |
| 23106-8 | Foot and mouth disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23106-8.json |
| 23107-6 | Foot and mouth disease virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23107-6.json |
| 23108-4 | Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23108-4.json |
| 23109-2 | Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23109-2.json |
| 23110-0 | Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23110-0.json |
| 23111-8 | Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/23111-8.json |
| 23112-6 | Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation | ./2.16.840.1.114222.4.11.1002/23112-6.json |
| 23113-4 | Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation | ./2.16.840.1.114222.4.11.1002/23113-4.json |
| 23114-2 | Foot and mouth disease virus RNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23114-2.json |
| 23115-9 | Foot and mouth disease virus serotype [Identifier] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23115-9.json |
| 23116-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23116-7.json |
| 23117-5 | Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23117-5.json |
| 23118-3 | Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23118-3.json |
| 2311-9 | Galactose renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2311-9.json |
| 23119-1 | Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation | ./2.16.840.1.114222.4.11.1002/23119-1.json |
| 23120-9 | Foot and mouth disease virus serotype [Identifier] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23120-9.json |
| 23121-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23121-7.json |
| 23122-5 | Francisella tularensis A DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23122-5.json |
| 23123-3 | Francisella tularensis A rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23123-3.json |
| 23124-1 | Francisella tularensis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23124-1.json |
| 23125-8 | Francisella tularensis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23125-8.json |
| 23126-6 | Francisella tularensis Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23126-6.json |
| 2312-7 | Galactose 1 phosphate [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2312-7.json |
| 23127-4 | Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23127-4.json |
| 23128-2 | Francisella tularensis B DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23128-2.json |
| 23129-0 | Francisella tularensis B rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23129-0.json |
| 23130-8 | Francisella tularensis DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23130-8.json |
| 23131-6 | Francisella tularensis rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23131-6.json |
| 23132-4 | Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23132-4.json |
| 23133-2 | Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23133-2.json |
| 23134-0 | Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23134-0.json |
| 2313-5 | Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2313-5.json |
| 23135-7 | Histoplasma farciminosum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23135-7.json |
| 23139-9 | Infectious bursal disease virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23139-9.json |
| 23140-7 | Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23140-7.json |
| 23141-5 | Infectious bursal disease virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23141-5.json |
| 23142-3 | Infectious bursal disease virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23142-3.json |
| 2314-3 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2314-3.json |
| 23143-1 | Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23143-1.json |
| 23144-9 | Japanese encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23144-9.json |
| 23145-6 | Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23145-6.json |
| 23146-4 | Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23146-4.json |
| 23147-2 | Japanese encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23147-2.json |
| 23148-0 | Japanese encephalitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23148-0.json |
| 23149-8 | Japanese encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23149-8.json |
| 2315-0 | Galactosylceramidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2315-0.json |
| 23150-6 | Leishmania donovani Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23150-6.json |
| 23152-2 | Leishmania sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23152-2.json |
| 23153-0 | Leishmania sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23153-0.json |
| 23154-8 | Leishmania sp Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23154-8.json |
| 23155-5 | Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/23155-5.json |
| 23156-3 | Leishmania sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23156-3.json |
| 23157-1 | Leishmania sp Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23157-1.json |
| 23158-9 | Leishmania sp rRNA [Identifier] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23158-9.json |
| 23159-7 | Leishmania sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23159-7.json |
| 23160-5 | Leishmania sp identified in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23160-5.json |
| 23161-3 | Leishmania sp identified in Tissue by Electrophoresis | ./2.16.840.1.114222.4.11.1002/23161-3.json |
| 23162-1 | Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/23162-1.json |
| 23163-9 | Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23163-9.json |
| 23164-7 | Leptospira interrogans sv Australis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23164-7.json |
| 23165-4 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23165-4.json |
| 23166-2 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23166-2.json |
| 23167-0 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23167-0.json |
| 2316-8 | Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2316-8.json |
| 23168-8 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23168-8.json |
| 23169-6 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23169-6.json |
| 23170-4 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23170-4.json |
| 23171-2 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23171-2.json |
| 23172-0 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23172-0.json |
| 23173-8 | Leptospira interrogans sv Canicola Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23173-8.json |
| 23174-6 | Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23174-6.json |
| 23175-3 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23175-3.json |
| 23176-1 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23176-1.json |
| 23177-9 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23177-9.json |
| 23178-7 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23178-7.json |
| 23179-5 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23179-5.json |
| 23180-3 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23180-3.json |
| 23181-1 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23181-1.json |
| 23182-9 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23182-9.json |
| 23183-7 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23183-7.json |
| 23184-5 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23184-5.json |
| 23185-2 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23185-2.json |
| 23186-0 | Leptospira interrogans Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23186-0.json |
| 23187-8 | Leptospira interrogans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23187-8.json |
| 23188-6 | Leptospira interrogans Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23188-6.json |
| 23189-4 | Leptospira interrogans sv Mitis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23189-4.json |
| 23190-2 | Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23190-2.json |
| 23191-0 | Leptospira interrogans sv Pomona Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23191-0.json |
| 23192-8 | Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23192-8.json |
| 23193-6 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23193-6.json |
| 23194-4 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23194-4.json |
| 23195-1 | Leptospira sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23195-1.json |
| 23196-9 | Leptospira sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23196-9.json |
| 23197-7 | Leptospira sp Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23197-7.json |
| 23198-5 | Leptospira sp Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23198-5.json |
| 23199-3 | Leptospira sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23199-3.json |
| 2320-0 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2320-0.json |
| 23200-9 | Leptospira sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23200-9.json |
| 23201-7 | Leptospira sp IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23201-7.json |
| 23202-5 | Leptospira sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23202-5.json |
| 23203-3 | Leptospira sp Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23203-3.json |
| 23204-1 | Leptospira sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23204-1.json |
| 23205-8 | Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23205-8.json |
| 23206-6 | Leptospira sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23206-6.json |
| 23207-4 | Leptospira subtype [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/23207-4.json |
| 23208-2 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23208-2.json |
| 23209-0 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23209-0.json |
| 23210-8 | Listeria sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23210-8.json |
| 23211-6 | Listeria sp Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23211-6.json |
| 23212-4 | Lumpy skin disease virus [Presence] in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/23212-4.json |
| 23213-2 | Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23213-2.json |
| 23214-0 | Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/23214-0.json |
| 23215-7 | Lumpy skin disease virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23215-7.json |
| 23216-5 | Lumpy skin disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23216-5.json |
| 23217-3 | Lumpy skin disease virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23217-3.json |
| 2321-8 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2321-8.json |
| 23218-1 | Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23218-1.json |
| 23219-9 | Lumpy skin disease virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23219-9.json |
| 23220-7 | Lumpy skin disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23220-7.json |
| 23221-5 | Lumpy skin disease virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23221-5.json |
| 23222-3 | Lumpy skin disease virus Ag [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23222-3.json |
| 23223-1 | Lumpy skin disease virus DNA [Presence] in Specimen by RFLP | ./2.16.840.1.114222.4.11.1002/23223-1.json |
| 23224-9 | Mareks disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23224-9.json |
| 23225-6 | Mareks disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23225-6.json |
| 2322-6 | Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2322-6.json |
| 23226-4 | Mareks disease virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23226-4.json |
| 23227-2 | Mareks disease virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23227-2.json |
| 23228-0 | Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23228-0.json |
| 23229-8 | Mareks disease virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23229-8.json |
| 23230-6 | Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23230-6.json |
| 23231-4 | Mareks disease virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23231-4.json |
| 23232-2 | Mite identified in Skin by Flotation | ./2.16.840.1.114222.4.11.1002/23232-2.json |
| 23233-0 | Mite identified in Skin by Parasite sedimentation | ./2.16.840.1.114222.4.11.1002/23233-0.json |
| 2323-4 | Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2323-4.json |
| 23234-8 | Mycobacterium avium ss avium Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/23234-8.json |
| 23235-5 | Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/23235-5.json |
| 23236-3 | Mycobacterium avium ss avium rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23236-3.json |
| 23237-1 | Mycobacterium avium ss avium identified in Specimen by Bioassay | ./2.16.840.1.114222.4.11.1002/23237-1.json |
| 23238-9 | Mycobacterium avium ss avium serotype [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/23238-9.json |
| 23239-7 | Mycobacterium bovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23239-7.json |
| 23240-5 | Mycobacterium bovis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23240-5.json |
| 23241-3 | Mycobacterium bovis Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23241-3.json |
| 2324-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2324-2.json |
| 23242-1 | Mycobacterium bovis Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/23242-1.json |
| 23243-9 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/23243-9.json |
| 23244-7 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/23244-7.json |
| 23245-4 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23245-4.json |
| 23246-2 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23246-2.json |
| 23247-0 | Mycobacterium sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23247-0.json |
| 23248-8 | Mycoplasma agalactiae neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23248-8.json |
| 23249-6 | Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23249-6.json |
| 23250-4 | Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23250-4.json |
| 23251-2 | Mycoplasma agalactiae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23251-2.json |
| 23252-0 | Mycoplasma agalactiae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23252-0.json |
| 23253-8 | Mycoplasma arginini Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23253-8.json |
| 23254-6 | Mycoplasma arginini Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23254-6.json |
| 23255-3 | Mycoplasma bovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23255-3.json |
| 23256-1 | Mycoplasma bovis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23256-1.json |
| 23257-9 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23257-9.json |
| 23258-7 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23258-7.json |
| 23259-5 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23259-5.json |
| 23260-3 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23260-3.json |
| 23262-9 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23262-9.json |
| 23263-7 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23263-7.json |
| 23264-5 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/23264-5.json |
| 23265-2 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23265-2.json |
| 23266-0 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23266-0.json |
| 2326-7 | Gastric inhibitory polypeptide [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2326-7.json |
| 23267-8 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23267-8.json |
| 23268-6 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23268-6.json |
| 23269-4 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23269-4.json |
| 23270-2 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/23270-2.json |
| 23271-0 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23271-0.json |
| 23272-8 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23272-8.json |
| 23273-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23273-6.json |
| 23274-4 | Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23274-4.json |
| 2327-5 | Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2327-5.json |
| 23275-1 | Mycoplasma gallisepticum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23275-1.json |
| 23276-9 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23276-9.json |
| 23277-7 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23277-7.json |
| 23278-5 | Mycoplasma gallisepticum Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23278-5.json |
| 23279-3 | Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23279-3.json |
| 23280-1 | Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23280-1.json |
| 23281-9 | Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23281-9.json |
| 23282-7 | Mycoplasma mycoides ss capri Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23282-7.json |
| 2328-3 | Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2328-3.json |
| 23283-5 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23283-5.json |
| 23284-3 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23284-3.json |
| 23285-0 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23285-0.json |
| 23286-8 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/23286-8.json |
| 23287-6 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23287-6.json |
| 23288-4 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23288-4.json |
| 23289-2 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23289-2.json |
| 23290-0 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23290-0.json |
| 2329-1 | Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2329-1.json |
| 23291-8 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23291-8.json |
| 23292-6 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23292-6.json |
| 23293-4 | Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23293-4.json |
| 23294-2 | Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23294-2.json |
| 23295-9 | Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23295-9.json |
| 23296-7 | Mycoplasma putrefaciens Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23296-7.json |
| 23297-5 | Mycoplasma sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23297-5.json |
| 23298-3 | Mycoplasma sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23298-3.json |
| 23299-1 | Mycoplasma sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23299-1.json |
| 23300-7 | Mycoplasma sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23300-7.json |
| 23301-5 | Mycoplasma sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23301-5.json |
| 23302-3 | Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23302-3.json |
| 23303-1 | Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23303-1.json |
| 23304-9 | Myxoma virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23304-9.json |
| 23305-6 | Myxoma virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23305-6.json |
| 23306-4 | Myxoma virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23306-4.json |
| 23307-2 | Myxoma virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23307-2.json |
| 23308-0 | Myxoma virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23308-0.json |
| 2330-9 | Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2330-9.json |
| 23309-8 | Myxoma virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23309-8.json |
| 23310-6 | Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23310-6.json |
| 23311-4 | Myxoma virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23311-4.json |
| 23313-0 | Nairobi sheep disease virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23313-0.json |
| 23314-8 | Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23314-8.json |
| 23315-5 | Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23315-5.json |
| 23316-3 | Nairobi sheep disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23316-3.json |
| 2331-7 | Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2331-7.json |
| 23318-9 | Nairobi sheep disease virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23318-9.json |
| 23319-7 | Nairobi sheep disease virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23319-7.json |
| 23320-5 | Nairobi sheep disease virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23320-5.json |
| 23321-3 | Ovine herpesvirus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23321-3.json |
| 23322-1 | Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23322-1.json |
| 23324-7 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23324-7.json |
| 2332-5 | Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2332-5.json |
| 23325-4 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23325-4.json |
| 23326-2 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain | ./2.16.840.1.114222.4.11.1002/23326-2.json |
| 23327-0 | Ovine herpesvirus 2 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23327-0.json |
| 23328-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk | ./2.16.840.1.114222.4.11.1002/23328-8.json |
| 23329-6 | Ovine progressive pneumonia virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23329-6.json |
| 23330-4 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23330-4.json |
| 23332-0 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23332-0.json |
| 2333-3 | Gastrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2333-3.json |
| 23333-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/23333-8.json |
| 23334-6 | Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23334-6.json |
| 23335-3 | Ovine progressive pneumonia virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23335-3.json |
| 23336-1 | Ovine progressive pneumonia virus DNA [Presence] in Specimen by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/23336-1.json |
| 23337-9 | Ovine progressive pneumonia virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23337-9.json |
| 23338-7 | Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23338-7.json |
| 2334-1 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/2334-1.json |
| 23341-1 | Pasteurella multocida Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23341-1.json |
| 23342-9 | Pasteurella multocida Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23342-9.json |
| 23343-7 | Pasteurella multocida Ag [Titer] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23343-7.json |
| 23344-5 | Pasteurella multocida rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23344-5.json |
| 23345-2 | Pasteurella multocida serotype [Identifier] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23345-2.json |
| 23346-0 | Pasteurella multocida serotype [Identifier] in Specimen by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/23346-0.json |
| 23347-8 | Pasteurella multocida serotype [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23347-8.json |
| 23349-4 | Pasteurella multocida toxin [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23349-4.json |
| 23350-2 | Peste des petits ruminants virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23350-2.json |
| 23351-0 | Peste des petits ruminants virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23351-0.json |
| 23352-8 | Peste des petits ruminants virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23352-8.json |
| 23354-4 | Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23354-4.json |
| 23355-1 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23355-1.json |
| 23356-9 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/23356-9.json |
| 23357-7 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23357-7.json |
| 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/2335-8.json |
| 23358-5 | Peste des petits ruminants virus RNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/23358-5.json |
| 23359-3 | Peste des petits ruminants virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23359-3.json |
| 23360-1 | Porcine enterovirus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23360-1.json |
| 23361-9 | Porcine enterovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23361-9.json |
| 23362-7 | Porcine enterovirus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23362-7.json |
| 23363-5 | Porcine enterovirus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23363-5.json |
| 23364-3 | Porcine enterovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23364-3.json |
| 23365-0 | Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23365-0.json |
| 2336-6 | Globulin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2336-6.json |
| 23366-8 | Porcine parvovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23366-8.json |
| 23367-6 | PRRSV Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23367-6.json |
| 23368-4 | PRRSV neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23368-4.json |
| 23369-2 | PRRSV Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23369-2.json |
| 23370-0 | PRRSV Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23370-0.json |
| 23371-8 | PRRSV RNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23371-8.json |
| 23372-6 | Porcine respiratory coronavirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23372-6.json |
| 23373-4 | Porcine respiratory coronavirus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23373-4.json |
| 2337-4 | Glucagon [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2337-4.json |
| 23374-2 | Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23374-2.json |
| 23376-7 | Porcine respiratory coronavirus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23376-7.json |
| 23377-5 | Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23377-5.json |
| 23378-3 | Porcine respiratory coronavirus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23378-3.json |
| 23379-1 | Abnormal Prion Protein [Presence] in Brain by Immunoblot | ./2.16.840.1.114222.4.11.1002/23379-1.json |
| 23380-9 | Abnormal Prion Protein [Presence] in Brain by Immune stain | ./2.16.840.1.114222.4.11.1002/23380-9.json |
| 23381-7 | Abnormal Prion Protein [Presence] in Brain by Electron microscopy | ./2.16.840.1.114222.4.11.1002/23381-7.json |
| 2338-2 | Glucagon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2338-2.json |
| 23382-5 | Pseudorabies virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23382-5.json |
| 23383-3 | Pseudorabies virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23383-3.json |
| 23384-1 | Pseudorabies virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23384-1.json |
| 23385-8 | Pseudorabies virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23385-8.json |
| 23386-6 | Pseudorabies virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23386-6.json |
| 23387-4 | Pseudorabies virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23387-4.json |
| 23388-2 | Rabies virus [Presence] in Brain by Light microscopy | ./2.16.840.1.114222.4.11.1002/23388-2.json |
| 23389-0 | Rabies virus Ag [Presence] in Brain by Immunoassay | ./2.16.840.1.114222.4.11.1002/23389-0.json |
| 2339-0 | Glucose [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2339-0.json |
| 23390-8 | Rabies virus Ag [Presence] in Brain by Immune stain | ./2.16.840.1.114222.4.11.1002/23390-8.json |
| 23391-6 | Rabies virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23391-6.json |
| 23396-5 | Rift valley fever virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23396-5.json |
| 23397-3 | Rift valley fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23397-3.json |
| 23398-1 | Rift valley fever virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23398-1.json |
| 23399-9 | Rift valley fever virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23399-9.json |
| 23400-5 | Rift valley fever virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23400-5.json |
| 23401-3 | Rift valley fever virus Ag [Presence] in Tissue by Neutralization test | ./2.16.840.1.114222.4.11.1002/23401-3.json |
| 23402-1 | Rift valley fever virus Ag [Presence] in Blood by Neutralization test | ./2.16.840.1.114222.4.11.1002/23402-1.json |
| 23403-9 | Rift valley fever virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23403-9.json |
| 23404-7 | Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23404-7.json |
| 23405-4 | Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23405-4.json |
| 23406-2 | Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23406-2.json |
| 23407-0 | Rinderpest virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23407-0.json |
| 2340-8 | Glucose [Mass/volume] in Blood by Automated test strip | ./2.16.840.1.114222.4.11.1002/2340-8.json |
| 23408-8 | Rinderpest virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23408-8.json |
| 23409-6 | Rinderpest virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23409-6.json |
| 23410-4 | Rinderpest virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23410-4.json |
| 23411-2 | Rinderpest virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23411-2.json |
| 23412-0 | Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23412-0.json |
| 23413-8 | Rinderpest virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23413-8.json |
| 23414-6 | Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/23414-6.json |
| 23415-3 | Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23415-3.json |
| 2341-6 | Glucose [Mass/volume] in Blood by Test strip manual | ./2.16.840.1.114222.4.11.1002/2341-6.json |
| 23416-1 | Rinderpest virus Ag [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23416-1.json |
| 23417-9 | Rinderpest virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23417-9.json |
| 23418-7 | Salmonella abortus equi Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23418-7.json |
| 23419-5 | Salmonella abortus equi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23419-5.json |
| 23420-3 | Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23420-3.json |
| 23421-1 | Salmonella abortus ovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23421-1.json |
| 23422-9 | Salmonella enteritidis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23422-9.json |
| 23423-7 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay | ./2.16.840.1.114222.4.11.1002/23423-7.json |
| 2342-4 | Glucose [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2342-4.json |
| 23424-5 | Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23424-5.json |
| 23425-2 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk | ./2.16.840.1.114222.4.11.1002/23425-2.json |
| 23426-0 | Salmonella gallinarum Ab [Presence] in Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/23426-0.json |
| 23427-8 | Salmonella gallinarum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23427-8.json |
| 23428-6 | Salmonella gallinarum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23428-6.json |
| 23429-4 | Salmonella gallinarum Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23429-4.json |
| 23431-0 | Salmonella gallinarum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23431-0.json |
| 2343-2 | Glucose [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2343-2.json |
| 23432-8 | Salmonella gallinarum rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23432-8.json |
| 23433-6 | Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23433-6.json |
| 23434-4 | Salmonella pullorum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23434-4.json |
| 23435-1 | Salmonella pullorum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23435-1.json |
| 23436-9 | Salmonella pullorum rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23436-9.json |
| 23437-7 | Swine influenza virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23437-7.json |
| 23438-5 | Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23438-5.json |
| 2344-0 | Glucose [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2344-0.json |
| 23440-1 | Swine vesicular disease virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23440-1.json |
| 23441-9 | Swine vesicular disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23441-9.json |
| 23442-7 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23442-7.json |
| 23443-5 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/23443-5.json |
| 23444-3 | Swine vesicular disease virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23444-3.json |
| 23445-0 | Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation | ./2.16.840.1.114222.4.11.1002/23445-0.json |
| 23446-8 | Swine vesicular disease virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23446-8.json |
| 23447-6 | Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay | ./2.16.840.1.114222.4.11.1002/23447-6.json |
| 23448-4 | Swine vesicular disease virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23448-4.json |
| 23449-2 | Taenia hydatigena Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/23449-2.json |
| 23450-0 | Taenia sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/23450-0.json |
| 23451-8 | Taenia sp eggs [Presence] in Stool by Probe | ./2.16.840.1.114222.4.11.1002/23451-8.json |
| 23452-6 | Taenia sp eggs [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23452-6.json |
| 23453-4 | Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23453-4.json |
| 23454-2 | Taylorella equigenitalis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23454-2.json |
| 23455-9 | Taylorella equigenitalis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23455-9.json |
| 23456-7 | Taylorella equigenitalis Ag [Presence] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23456-7.json |
| 2345-7 | Glucose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2345-7.json |
| 23458-3 | Taylorella equigenitalis DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23458-3.json |
| 23459-1 | Theileria annulata Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23459-1.json |
| 23460-9 | Theileria annulata Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23460-9.json |
| 23461-7 | Theileria annulata Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23461-7.json |
| 23462-5 | Theileria annulata Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23462-5.json |
| 23463-3 | Theileria annulata rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/23463-3.json |
| 23464-1 | Theileria equi Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23464-1.json |
| 2346-5 | Glucose [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/2346-5.json |
| 23465-8 | Theileria equi rRNA [Presence] in Blood by Probe | ./2.16.840.1.114222.4.11.1002/23465-8.json |
| 23466-6 | Theileria equi Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23466-6.json |
| 23467-4 | Theileria mutans Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23467-4.json |
| 23468-2 | Theileria mutans Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23468-2.json |
| 23469-0 | Theileria mutans Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23469-0.json |
| 23470-8 | Theileria mutans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23470-8.json |
| 23471-6 | Theileria mutans Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23471-6.json |
| 23472-4 | Theileria mutans rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/23472-4.json |
| 2347-3 | Glucose [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2347-3.json |
| 23473-2 | Theileria mutans DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23473-2.json |
| 23474-0 | Theileria parva Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23474-0.json |
| 23475-7 | Theileria parva Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23475-7.json |
| 23476-5 | Theileria parva Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23476-5.json |
| 23477-3 | Theileria parva Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23477-3.json |
| 23478-1 | Theileria parva Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23478-1.json |
| 23479-9 | Theileria parva rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/23479-9.json |
| 23480-7 | Theileria parva DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23480-7.json |
| 2348-1 | Glucose [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/2348-1.json |
| 23482-3 | Theileria sp [Presence] in Blood by Giemsa stain | ./2.16.840.1.114222.4.11.1002/23482-3.json |
| 23483-1 | Theileria sp [Presence] in Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/23483-1.json |
| 23485-6 | Toxoplasma gondii Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23485-6.json |
| 23486-4 | Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/23486-4.json |
| 23487-2 | Transmissible gastroenteritis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23487-2.json |
| 23488-0 | Transmissible gastroenteritis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23488-0.json |
| 23489-8 | Transmissible gastroenteritis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23489-8.json |
| 23491-4 | Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23491-4.json |
| 23492-2 | Transmissible gastroenteritis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23492-2.json |
| 23493-0 | Transmissible gastroenteritis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23493-0.json |
| 23494-8 | Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/23494-8.json |
| 23495-5 | Transmissible gastroenteritis virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/23495-5.json |
| 23496-3 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23496-3.json |
| 23497-1 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23497-1.json |
| 23498-9 | Transmissible gastroenteritis virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23498-9.json |
| 2349-9 | Glucose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2349-9.json |
| 23499-7 | Trichinella spiralis [Presence] in Tissue by Light microscopy | ./2.16.840.1.114222.4.11.1002/23499-7.json |
| 23500-2 | Tritrichomonas foetus Ab [Presence] in Genital mucus | ./2.16.840.1.114222.4.11.1002/23500-2.json |
| 23501-0 | Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination | ./2.16.840.1.114222.4.11.1002/23501-0.json |
| 23502-8 | Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain | ./2.16.840.1.114222.4.11.1002/23502-8.json |
| 23503-6 | Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain | ./2.16.840.1.114222.4.11.1002/23503-6.json |
| 23504-4 | Tritrichomonas foetus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23504-4.json |
| 23505-1 | Tritrichomonas foetus DNA [Presence] in Genital fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23505-1.json |
| 2350-7 | Glucose [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2350-7.json |
| 23507-7 | Trypanosoma brucei DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23507-7.json |
| 23508-5 | Trypanosoma congolense DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23508-5.json |
| 23509-3 | Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/23509-3.json |
| 23510-1 | Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23510-1.json |
| 23511-9 | Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23511-9.json |
| 23512-7 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23512-7.json |
| 23513-5 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23513-5.json |
| 23514-3 | Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23514-3.json |
| 2351-5 | Glucose [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2351-5.json |
| 23515-0 | Trypanosoma equiperdum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23515-0.json |
| 23517-6 | Trypanosoma equiperdum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23517-6.json |
| 23518-4 | Trypanosoma evansi [Presence] in Aspirate by Thick film | ./2.16.840.1.114222.4.11.1002/23518-4.json |
| 23519-2 | Trypanosoma evansi [Presence] in Aspirate by Thin film | ./2.16.840.1.114222.4.11.1002/23519-2.json |
| 23520-0 | Trypanosoma evansi [Presence] in Aspirate by Wet preparation | ./2.16.840.1.114222.4.11.1002/23520-0.json |
| 23521-8 | Trypanosoma evansi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23521-8.json |
| 23522-6 | Trypanosoma evansi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23522-6.json |
| 23523-4 | Trypanosoma evansi Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23523-4.json |
| 23524-2 | Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23524-2.json |
| 23526-7 | Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23526-7.json |
| 23528-3 | Trypanosoma evansi Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/23528-3.json |
| 23529-1 | Trypanosoma evansi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23529-1.json |
| 23530-9 | Trypanosoma evansi rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/23530-9.json |
| 2353-1 | Glucose phosphate isomerase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2353-1.json |
| 23531-7 | Trypanosoma sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23531-7.json |
| 23532-5 | Trypanosoma sp Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23532-5.json |
| 23533-3 | Trypanosoma sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23533-3.json |
| 23534-1 | Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23534-1.json |
| 23535-8 | Trypanosoma sp Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/23535-8.json |
| 23536-6 | Trypanosoma sp identified in Blood by Concentration | ./2.16.840.1.114222.4.11.1002/23536-6.json |
| 23540-8 | Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23540-8.json |
| 23541-6 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23541-6.json |
| 23542-4 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23542-4.json |
| 23543-2 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23543-2.json |
| 23544-0 | Venezuelan equine encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23544-0.json |
| 23545-7 | Venezuelan equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23545-7.json |
| 23546-5 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23546-5.json |
| 23547-3 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23547-3.json |
| 23548-1 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23548-1.json |
| 2354-9 | Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2354-9.json |
| 23549-9 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23549-9.json |
| 23550-7 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23550-7.json |
| 23551-5 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23551-5.json |
| 23552-3 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23552-3.json |
| 23553-1 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23553-1.json |
| 23554-9 | Venezuelan equine encephalitis virus subtype [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23554-9.json |
| 23555-6 | Vesicular stomatitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23555-6.json |
| 2355-6 | Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2355-6.json |
| 23557-2 | Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay | ./2.16.840.1.114222.4.11.1002/23557-2.json |
| 23558-0 | Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/23558-0.json |
| 23559-8 | Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation | ./2.16.840.1.114222.4.11.1002/23559-8.json |
| 23560-6 | Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation | ./2.16.840.1.114222.4.11.1002/23560-6.json |
| 23561-4 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23561-4.json |
| 23562-2 | Vesicular stomatitis Indiana virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23562-2.json |
| 23563-0 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23563-0.json |
| 2356-4 | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2356-4.json |
| 23564-8 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23564-8.json |
| 23565-5 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23565-5.json |
| 23566-3 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23566-3.json |
| 23567-1 | Vesicular stomatitis New Jersey virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23567-1.json |
| 23568-9 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23568-9.json |
| 23569-7 | Vesicular stomatitis virus serotype [Identifier] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23569-7.json |
| 23570-5 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation | ./2.16.840.1.114222.4.11.1002/23570-5.json |
| 23571-3 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23571-3.json |
| 2357-2 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2357-2.json |
| 23572-1 | Vesicular stomatitis virus serotype [Identifier] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/23572-1.json |
| 23573-9 | Rabbit hemorrhagic disease virus [Presence] in Tissue by Electron microscopy | ./2.16.840.1.114222.4.11.1002/23573-9.json |
| 23574-7 | Rabbit hemorrhagic disease virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23574-7.json |
| 23575-4 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23575-4.json |
| 23576-2 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23576-2.json |
| 23577-0 | Rabbit hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23577-0.json |
| 23578-8 | Rabbit hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23578-8.json |
| 23579-6 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23579-6.json |
| 2358-0 | Glucose-6-Phosphate dehydrogenase [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/2358-0.json |
| 23580-4 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/23580-4.json |
| 23581-2 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination | ./2.16.840.1.114222.4.11.1002/23581-2.json |
| 23582-0 | Rabbit hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23582-0.json |
| 23583-8 | Western equine encephalitis virus Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23583-8.json |
| 23584-6 | Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23584-6.json |
| 23585-3 | Western equine encephalitis virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23585-3.json |
| 23586-1 | Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutinationinhibition | ./2.16.840.1.114222.4.11.1002/23586-1.json |
| 23587-9 | Western equine encephalitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23587-9.json |
| 23588-7 | Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23588-7.json |
| 23589-5 | Western equine encephalitis virus Ag [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/23589-5.json |
| 23590-3 | Western equine encephalitis virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23590-3.json |
| 23591-1 | Western equine encephalitis virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/23591-1.json |
| 23592-9 | African swine fever virus Ab [Presence] in Serum by Immune stain | ./2.16.840.1.114222.4.11.1002/23592-9.json |
| 23593-7 | Bovine leukemia virus [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23593-7.json |
| 23594-5 | Brucella sp identified in Semen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23594-5.json |
| 23595-2 | Dermatophilus congolensis [Presence] in Exudate by Giemsa stain | ./2.16.840.1.114222.4.11.1002/23595-2.json |
| 23596-0 | Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain | ./2.16.840.1.114222.4.11.1002/23596-0.json |
| 23597-8 | Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain | ./2.16.840.1.114222.4.11.1002/23597-8.json |
| 2359-8 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2359-8.json |
| 23598-6 | Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23598-6.json |
| 23599-4 | Leptospira sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23599-4.json |
| 23600-0 | Leptospira sp identified in Milk by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23600-0.json |
| 23601-8 | Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23601-8.json |
| 23602-6 | Salmonella enteritidis [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23602-6.json |
| 23603-4 | Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23603-4.json |
| 23604-2 | Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23604-2.json |
| 23605-9 | Tritrichomonas foetus [Presence] in Placenta by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23605-9.json |
| 2360-6 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2360-6.json |
| 23606-7 | Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/23606-7.json |
| 2361-4 | Glucosylceramidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2361-4.json |
| 23644-8 | Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23644-8.json |
| 23645-5 | Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23645-5.json |
| 23646-3 | Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23646-3.json |
| 23647-1 | Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23647-1.json |
| 23648-9 | Actinobacillus pleuropneumoniae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23648-9.json |
| 23649-7 | Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23649-7.json |
| 23650-5 | Actinobacillus pleuropneumoniae serotype [Identifier] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/23650-5.json |
| 23651-3 | Actinobacillus suis serotype [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/23651-3.json |
| 23652-1 | Aeromonas salmonicida DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23652-1.json |
| 23653-9 | Aflatoxin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23653-9.json |
| 23654-7 | Aflatoxin [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/23654-7.json |
| 23655-4 | Aflatoxin [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/23655-4.json |
| 23656-2 | Ammonia [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23656-2.json |
| 23657-0 | Anaplasma marginale Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23657-0.json |
| 23660-4 | Aspergillus sp Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23660-4.json |
| 23661-2 | Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23661-2.json |
| 23662-0 | Babesia bigemina Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23662-0.json |
| 23663-8 | Babesia bovis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23663-8.json |
| 23664-6 | Babesia canis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23664-6.json |
| 23665-3 | Babesia divergens Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23665-3.json |
| 23666-1 | Babesia sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23666-1.json |
| 23667-9 | Bacteria identified in Specimen | ./2.16.840.1.114222.4.11.1002/23667-9.json |
| 23668-7 | Bartonella henselae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23668-7.json |
| 23669-5 | Biochanin A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23669-5.json |
| 2367-1 | Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2367-1.json |
| 23671-1 | Bluetongue virus 10 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23671-1.json |
| 23672-9 | Bluetongue virus 11 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23672-9.json |
| 23673-7 | Bluetongue virus 13 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23673-7.json |
| 23674-5 | Bluetongue virus 17 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23674-5.json |
| 23675-2 | Bluetongue virus 2 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23675-2.json |
| 23676-0 | Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23676-0.json |
| 23677-8 | Bovine leukemia virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23677-8.json |
| 23678-6 | Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23678-6.json |
| 23679-4 | Bovine respiratory syncytial virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23679-4.json |
| 23680-2 | Bromide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23680-2.json |
| 23681-0 | Brucella canis Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23681-0.json |
| 23682-8 | Brucella canis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23682-8.json |
| 23683-6 | Brucella canis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23683-6.json |
| 23684-4 | Brucella ovis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23684-4.json |
| 23685-1 | Canine adenovirus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23685-1.json |
| 23686-9 | Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23686-9.json |
| 23687-7 | Canine coronavirus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23687-7.json |
| 23688-5 | Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23688-5.json |
| 2368-9 | Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2368-9.json |
| 23689-3 | Canine distemper virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23689-3.json |
| 23690-1 | Canine distemper virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23690-1.json |
| 23691-9 | Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23691-9.json |
| 23692-7 | Canine distemper virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23692-7.json |
| 23693-5 | Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23693-5.json |
| 23694-3 | Canine distemper virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23694-3.json |
| 23695-0 | Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23695-0.json |
| 23696-8 | Canine distemper virus Ag [Presence] in Conjunctival specimen | ./2.16.840.1.114222.4.11.1002/23696-8.json |
| 2369-7 | Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2369-7.json |
| 23697-6 | Canine herpesvirus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23697-6.json |
| 23698-4 | Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23698-4.json |
| 23699-2 | Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23699-2.json |
| 23700-8 | Canine parvovirus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23700-8.json |
| 23701-6 | Canine parvovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23701-6.json |
| 23702-4 | Canine parvovirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23702-4.json |
| 23703-2 | Canine parvovirus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23703-2.json |
| 23704-0 | Canine parvovirus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23704-0.json |
| 23705-7 | Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23705-7.json |
| 23706-5 | Canine parvovirus Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23706-5.json |
| 23707-3 | Canine parvovirus DNA [Presence] in Stool by Probe | ./2.16.840.1.114222.4.11.1002/23707-3.json |
| 23708-1 | Caprine arthritis encephalitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23708-1.json |
| 23710-7 | Dirofilaria immitis Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23710-7.json |
| 23711-5 | Ehrlichia canis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23711-5.json |
| 23713-1 | Ethylene glycol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23713-1.json |
| 23714-9 | Fat [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/23714-9.json |
| 23715-6 | Feline calicivirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23715-6.json |
| 23716-4 | Feline coronavirus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23716-4.json |
| 23717-2 | Feline coronavirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23717-2.json |
| 23718-0 | Feline coronavirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23718-0.json |
| 23719-8 | Feline herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23719-8.json |
| 23720-6 | Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23720-6.json |
| 23721-4 | Feline herpesvirus 1 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23721-4.json |
| 23722-2 | Feline herpesvirus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23722-2.json |
| 23723-0 | Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23723-0.json |
| 23724-8 | Feline immunodeficiency virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23724-8.json |
| 23725-5 | Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23725-5.json |
| 23726-3 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23726-3.json |
| 23727-1 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23727-1.json |
| 23728-9 | Feline infectious peritonitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23728-9.json |
| 23729-7 | Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23729-7.json |
| 23730-5 | Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23730-5.json |
| 23731-3 | Feline leukemia provirus [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23731-3.json |
| 23732-1 | Feline leukemia virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23732-1.json |
| 23733-9 | Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23733-9.json |
| 23734-7 | Feline leukemia virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23734-7.json |
| 23735-4 | Feline leukemia virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23735-4.json |
| 23736-2 | Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23736-2.json |
| 23737-0 | Feline panleukopenia virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23737-0.json |
| 23738-8 | Feline herpesvirus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23738-8.json |
| 23739-6 | Feline syncytial virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23739-6.json |
| 23741-2 | Francisella tularensis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23741-2.json |
| 23742-0 | Fumonisin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23742-0.json |
| 23743-8 | Genistein [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23743-8.json |
| 23744-6 | Giardia lamblia Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23744-6.json |
| 23745-3 | Gossypol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23745-3.json |
| 23746-1 | Gossypol Free [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23746-1.json |
| 23747-9 | Heavy metals [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23747-9.json |
| 23749-5 | Lead [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23749-5.json |
| 23750-3 | Leptospira sp Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23750-3.json |
| 23751-1 | Metaldehyde [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23751-1.json |
| 23752-9 | Mite identified in Skin | ./2.16.840.1.114222.4.11.1002/23752-9.json |
| 23753-7 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23753-7.json |
| 2375-4 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2375-4.json |
| 23754-5 | Mycoplasma sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23754-5.json |
| 23755-2 | Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23755-2.json |
| 23756-0 | Neospora caninum Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23756-0.json |
| 23757-8 | Neospora caninum Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23757-8.json |
| 23758-6 | Neospora caninum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23758-6.json |
| 23759-4 | Neospora caninum Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23759-4.json |
| 23760-2 | Neospora caninum Ag [Presence] in Fixed tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23760-2.json |
| 2376-2 | Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2376-2.json |
| 23762-8 | Nitrate+Nitrite [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23762-8.json |
| 23763-6 | Pasteurella multocida serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/23763-6.json |
| 23764-4 | Pesticides [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/23764-4.json |
| 23765-1 | Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23765-1.json |
| 23766-9 | Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23766-9.json |
| 23767-7 | Porcine circovirus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23767-7.json |
| 23768-5 | Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/23768-5.json |
| 23769-3 | Porcine influenza virus A Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23769-3.json |
| 2377-0 | Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2377-0.json |
| 23770-1 | Porcine parvovirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23770-1.json |
| 23771-9 | Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23771-9.json |
| 23772-7 | PRRSV Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23772-7.json |
| 23773-5 | Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23773-5.json |
| 23774-3 | Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23774-3.json |
| 23775-0 | Rhodococcus equi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23775-0.json |
| 23776-8 | Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23776-8.json |
| 23777-6 | Salmonella pullorum Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23777-6.json |
| 23778-4 | Salmonella typhimurium Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23778-4.json |
| 23779-2 | Selenium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23779-2.json |
| 23780-0 | Strychnine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23780-0.json |
| 23781-8 | Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23781-8.json |
| 23782-6 | Swine influenza virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/23782-6.json |
| 23783-4 | Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23783-4.json |
| 23784-2 | Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/23784-2.json |
| 23785-9 | Trypanosoma cruzi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23785-9.json |
| 23786-7 | Urea [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23786-7.json |
| 23787-5 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23787-5.json |
| 2378-8 | Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2378-8.json |
| 23788-3 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23788-3.json |
| 23789-1 | Vesicular stomatitis Indiana virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23789-1.json |
| 23790-9 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/23790-9.json |
| 23791-7 | Vesicular stomatitis New Jersey virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/23791-7.json |
| 23792-5 | Western equine encephalitis virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23792-5.json |
| 23793-3 | Canine parvovirus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/23793-3.json |
| 23794-1 | Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23794-1.json |
| 23795-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23795-8.json |
| 2379-6 | Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2379-6.json |
| 23797-4 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23797-4.json |
| 23798-2 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23798-2.json |
| 23799-0 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23799-0.json |
| 23800-6 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23800-6.json |
| 23801-4 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23801-4.json |
| 23802-2 | Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23802-2.json |
| 23803-0 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/23803-0.json |
| 2380-4 | Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2380-4.json |
| 23805-5 | 5-Fluorocytosine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23805-5.json |
| 23808-9 | Aldosterone free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/23808-9.json |
| 23810-5 | Alpha fucosidase [Units/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/23810-5.json |
| 2381-2 | Glutathione.oxidized [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2381-2.json |
| 23814-7 | Amantadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/23814-7.json |
| 23815-4 | Androstanediol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/23815-4.json |
| 23816-2 | Other Antibiotic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23816-2.json |
| 23819-6 | Antibody coated bacteria [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23819-6.json |
| 2382-0 | Glutathione.reduced [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2382-0.json |
| 23820-4 | Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23820-4.json |
| 23821-2 | Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23821-2.json |
| 23822-0 | Azinphos-methyl [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/23822-0.json |
| 23826-1 | Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23826-1.json |
| 23827-9 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23827-9.json |
| 23828-7 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23828-7.json |
| 23829-5 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23829-5.json |
| 23830-3 | Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23830-3.json |
| 23831-1 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23831-1.json |
| 23832-9 | Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23832-9.json |
| 23833-7 | Borrelia burgdorferi Ab index [Presence] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/23833-7.json |
| 23835-2 | Carbon disulfide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/23835-2.json |
| 23836-0 | Carbon disulfide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23836-0.json |
| 2383-8 | Glutathione [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2383-8.json |
| 23838-6 | Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe | ./2.16.840.1.114222.4.11.1002/23838-6.json |
| 23842-8 | Cobalt [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/23842-8.json |
| 23843-6 | Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/23843-6.json |
| 23844-4 | C3 nephritic factor [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23844-4.json |
| 2384-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2384-6.json |
| 23848-5 | Creosol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23848-5.json |
| 23849-3 | Creosol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23849-3.json |
| 23850-1 | Creosol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/23850-1.json |
| 23851-9 | Cyclohexanone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23851-9.json |
| 2385-3 | Glycerate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2385-3.json |
| 23853-5 | Dimethylformamide/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/23853-5.json |
| 23854-3 | Dioxin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23854-3.json |
| 23855-0 | Echinococcus granulosus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23855-0.json |
| 23856-8 | Endrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23856-8.json |
| 23858-4 | Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/23858-4.json |
| 2386-1 | Glycerate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2386-1.json |
| 23861-8 | Ethanol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/23861-8.json |
| 23862-6 | Famotidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23862-6.json |
| 23864-2 | Flunitrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23864-2.json |
| 23865-9 | FLUoxetine+Norfluoxetine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/23865-9.json |
| 23866-7 | Glutaraldehyde [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/23866-7.json |
| 23867-5 | Hantavirus sin nombre IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23867-5.json |
| 23868-3 | Hantavirus sin nombre IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23868-3.json |
| 23869-1 | Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe | ./2.16.840.1.114222.4.11.1002/23869-1.json |
| 23876-6 | HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/23876-6.json |
| 23877-4 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23877-4.json |
| 23878-2 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23878-2.json |
| 23879-0 | Immune complex [Units/volume] in Body fluid by C1q binding assay | ./2.16.840.1.114222.4.11.1002/23879-0.json |
| 23880-8 | Immune complex [Units/volume] in Body fluid by Raji cell assay | ./2.16.840.1.114222.4.11.1002/23880-8.json |
| 23881-6 | Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay | ./2.16.840.1.114222.4.11.1002/23881-6.json |
| 23882-4 | Immune complex [Units/volume] in Body fluid by Conglutinin assay | ./2.16.840.1.114222.4.11.1002/23882-4.json |
| 23883-2 | Inhibin A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23883-2.json |
| 23884-0 | Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay | ./2.16.840.1.114222.4.11.1002/23884-0.json |
| 23888-1 | Isopropanol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/23888-1.json |
| 23889-9 | Kanamycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/23889-9.json |
| 23890-7 | Lead [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/23890-7.json |
| 23891-5 | Magnesium [Moles/volume] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/23891-5.json |
| 23892-3 | Magnesium [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/23892-3.json |
| 23893-1 | Malaoxon [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/23893-1.json |
| 23896-4 | Mercury [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/23896-4.json |
| 23899-8 | Methanol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/23899-8.json |
| 23900-4 | Methanol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/23900-4.json |
| 23901-2 | Microscopic observation [Identifier] in Body fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/23901-2.json |
| 23905-3 | Mycophenolate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23905-3.json |
| 23906-1 | Mycophenolate glucuronide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23906-1.json |
| 23907-9 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23907-9.json |
| 23929-3 | Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23929-3.json |
| 23930-1 | Salmonella typhi O D Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/23930-1.json |
| 23931-9 | Salmonella typhi O D [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23931-9.json |
| 23933-5 | Staphylococcus aureus enterotoxin B [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23933-5.json |
| 23934-3 | Staphylococcus aureus enterotoxin B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23934-3.json |
| 23935-0 | Staphylococcus aureus toxic shock syndrome toxin 1 [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/23935-0.json |
| 23936-8 | Staphylococcus aureus toxic shock syndrome toxin 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/23936-8.json |
| 23937-6 | Trans nonachlor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/23937-6.json |
| 2394-5 | Glycogen synthase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2394-5.json |
| 23950-9 | Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/23950-9.json |
| 2395-2 | Glycolate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2395-2.json |
| 23953-3 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/23953-3.json |
| 23954-1 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23954-1.json |
| 23955-8 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23955-8.json |
| 23956-6 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23956-6.json |
| 23957-4 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23957-4.json |
| 23958-2 | Dengue virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23958-2.json |
| 23959-0 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23959-0.json |
| 2396-0 | Glycolate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2396-0.json |
| 23960-8 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23960-8.json |
| 23961-6 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23961-6.json |
| 23962-4 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23962-4.json |
| 23963-2 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23963-2.json |
| 23964-0 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23964-0.json |
| 23965-7 | Burkholderia pseudomallei IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23965-7.json |
| 23966-5 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23966-5.json |
| 23967-3 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23967-3.json |
| 23968-1 | Dengue virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/23968-1.json |
| 23969-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23969-9.json |
| 23970-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23970-7.json |
| 23971-5 | Epstein Barr virus early IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23971-5.json |
| 23972-3 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/23972-3.json |
| 23973-1 | Burkholderia pseudomallei IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/23973-1.json |
| 23974-9 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23974-9.json |
| 23975-6 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23975-6.json |
| 23976-4 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/23976-4.json |
| 23977-2 | Borrelia burgdorferi Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23977-2.json |
| 2397-8 | Glycoproteins [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2397-8.json |
| 23978-0 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23978-0.json |
| 23980-6 | Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/23980-6.json |
| 23982-2 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/23982-2.json |
| 23984-8 | Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23984-8.json |
| 2398-6 | Glycosaminoglycans [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2398-6.json |
| 23986-3 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23986-3.json |
| 23987-1 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23987-1.json |
| 23988-9 | Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23988-9.json |
| 23989-7 | Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23989-7.json |
| 23990-5 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/23990-5.json |
| 23991-3 | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23991-3.json |
| 23992-1 | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/23992-1.json |
| 23993-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/23993-9.json |
| 2399-4 | Glycosaminoglycans [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2399-4.json |
| 23994-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23994-7.json |
| 23995-4 | Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23995-4.json |
| 23996-2 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/23996-2.json |
| 2400-0 | Guanine deaminase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2400-0.json |
| 24002-8 | Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/24002-8.json |
| 24003-6 | Brucella sp identified in Bone marrow by Organism specific culture | ./2.16.840.1.114222.4.11.1002/24003-6.json |
| 24004-4 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24004-4.json |
| 24005-1 | Chlamydia sp identified in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/24005-1.json |
| 24007-7 | Epstein Barr virus early IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24007-7.json |
| 24008-5 | Echovirus 14 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/24008-5.json |
| 24009-3 | Fungus identified in Bronchial specimen by Culture | ./2.16.840.1.114222.4.11.1002/24009-3.json |
| 24010-1 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/24010-1.json |
| 24012-7 | HIV 1 Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24012-7.json |
| 24014-3 | Herpes simplex virus 2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/24014-3.json |
| 24015-0 | Influenza virus A+B Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/24015-0.json |
| 24017-6 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/24017-6.json |
| 2401-8 | Guanine deaminase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2401-8.json |
| 24018-4 | Neisseria meningitidis serogroup B Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/24018-4.json |
| 24020-0 | Streptococcus agalactiae Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/24020-0.json |
| 2402-6 | Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2402-6.json |
| 24027-5 | Streptococcus pneumoniae Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/24027-5.json |
| 24028-3 | Toxocara canis IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24028-3.json |
| 24029-1 | Toxocara canis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24029-1.json |
| 24030-9 | Toxocara canis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24030-9.json |
| 24031-7 | 14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/24031-7.json |
| 24032-5 | Rifabutin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24032-5.json |
| 24033-3 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24033-3.json |
| 2403-4 | Hemopexin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2403-4.json |
| 24034-1 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24034-1.json |
| 24035-8 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24035-8.json |
| 24036-6 | Borrelia sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/24036-6.json |
| 24041-6 | Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/24041-6.json |
| 2404-2 | Hemopexin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2404-2.json |
| 24042-4 | Ehrlichia chaffeensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/24042-4.json |
| 24043-2 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24043-2.json |
| 24044-0 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24044-0.json |
| 24045-7 | Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24045-7.json |
| 24046-5 | Alpha fucosidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24046-5.json |
| 24047-3 | Alpha fucosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24047-3.json |
| 24048-1 | Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24048-1.json |
| 24049-9 | Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24049-9.json |
| 24050-7 | Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24050-7.json |
| 24051-5 | Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24051-5.json |
| 24052-3 | Alpha mannosidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24052-3.json |
| 24053-1 | Alpha mannosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24053-1.json |
| 24054-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24054-9.json |
| 24055-6 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24055-6.json |
| 24056-4 | Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24056-4.json |
| 24057-2 | Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24057-2.json |
| 24058-0 | Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24058-0.json |
| 2405-9 | Heparan sulfate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2405-9.json |
| 24059-8 | Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24059-8.json |
| 24060-6 | Beta galactosidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24060-6.json |
| 24061-4 | Beta galactosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24061-4.json |
| 24064-8 | Beta glucuronidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24064-8.json |
| 24065-5 | Beta glucuronidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24065-5.json |
| 24066-3 | Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24066-3.json |
| 2406-7 | Heparan sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2406-7.json |
| 24067-1 | Beta mannosidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24067-1.json |
| 24068-9 | Beta mannosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24068-9.json |
| 24072-1 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24072-1.json |
| 24073-9 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24073-9.json |
| 24074-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24074-7.json |
| 24075-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24075-4.json |
| 24076-2 | Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24076-2.json |
| 24077-0 | Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24077-0.json |
| 24078-8 | Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24078-8.json |
| 24079-6 | Cholesterol esterase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24079-6.json |
| 24080-4 | Cholesterol esterase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24080-4.json |
| 24081-2 | Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24081-2.json |
| 24082-0 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/24082-0.json |
| 2408-3 | Hexachlorophene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2408-3.json |
| 24083-8 | Galactosylceramidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24083-8.json |
| 24084-6 | Galactosylceramidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24084-6.json |
| 24085-3 | Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24085-3.json |
| 24086-1 | Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24086-1.json |
| 24087-9 | Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24087-9.json |
| 24088-7 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24088-7.json |
| 24089-5 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24089-5.json |
| 2409-1 | Hexokinase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2409-1.json |
| 24091-1 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24091-1.json |
| 24092-9 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24092-9.json |
| 24093-7 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24093-7.json |
| 24094-5 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24094-5.json |
| 24095-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24095-2.json |
| 24096-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24096-0.json |
| 24097-8 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24097-8.json |
| 24098-6 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24098-6.json |
| 24099-4 | Sialidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24099-4.json |
| 24100-0 | Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/24100-0.json |
| 24101-8 | Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/24101-8.json |
| 24102-6 | Corynebacterium toxin [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24102-6.json |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24108-3.json |
| 2410-9 | Hexokinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2410-9.json |
| 24109-1 | Progesterone [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/24109-1.json |
| 24110-9 | Treponema pallidum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24110-9.json |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/24111-7.json |
| 24113-3 | Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/24113-3.json |
| 24114-1 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24114-1.json |
| 24115-8 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24115-8.json |
| 24116-6 | Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/24116-6.json |
| 24117-4 | Ross River virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24117-4.json |
| 24118-2 | Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24118-2.json |
| 24119-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/24119-0.json |
| 24120-8 | Ross River virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24120-8.json |
| 24121-6 | Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24121-6.json |
| 24126-5 | Adenovirus type [Identifier] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/24126-5.json |
| 24127-3 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24127-3.json |
| 24128-1 | Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24128-1.json |
| 24129-9 | Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24129-9.json |
| 24130-7 | Bordetella pertussis secretory IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/24130-7.json |
| 24132-3 | Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24132-3.json |
| 2413-3 | Hippuran renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2413-3.json |
| 24136-4 | Black Walnut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24136-4.json |
| 24137-2 | White Hickory IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24137-2.json |
| 24138-0 | Johnson grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24138-0.json |
| 24139-8 | Cockroach IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24139-8.json |
| 24140-6 | White Ash IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24140-6.json |
| 2414-1 | Hippurate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2414-1.json |
| 24141-4 | Rough Marsh Elder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24141-4.json |
| 24142-2 | Red mulberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24142-2.json |
| 24143-0 | Sheep Sorrel IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24143-0.json |
| 24144-8 | Brome IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24144-8.json |
| 24145-5 | American Sycamore IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24145-5.json |
| 24146-3 | Western Water Hemp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24146-3.json |
| 24147-1 | Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24147-1.json |
| 24148-9 | Kentucky blue grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24148-9.json |
| 24149-7 | Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24149-7.json |
| 24150-5 | Red Maple IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24150-5.json |
| 24151-3 | Giant Ragweed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24151-3.json |
| 24153-9 | Kamut flour IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24153-9.json |
| 24154-7 | Goosefoot IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24154-7.json |
| 24155-4 | Mango IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24155-4.json |
| 24156-2 | Maple syrup IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24156-2.json |
| 2415-8 | Histamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2415-8.json |
| 24158-8 | White+Black Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24158-8.json |
| 24159-6 | White+Black Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24159-6.json |
| 24163-8 | Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24163-8.json |
| 24165-3 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24165-3.json |
| 2416-6 | Histamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2416-6.json |
| 24169-5 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24169-5.json |
| 24170-3 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24170-3.json |
| 24171-1 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24171-1.json |
| 24172-9 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24172-9.json |
| 24173-7 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24173-7.json |
| 2417-4 | Histamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2417-4.json |
| 24174-5 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24174-5.json |
| 24175-2 | Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24175-2.json |
| 24176-0 | Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24176-0.json |
| 24177-8 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24177-8.json |
| 24178-6 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24178-6.json |
| 24179-4 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24179-4.json |
| 24180-2 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24180-2.json |
| 24181-0 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24181-0.json |
| 24182-8 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24182-8.json |
| 24183-6 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24183-6.json |
| 24184-4 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24184-4.json |
| 24185-1 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24185-1.json |
| 24186-9 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24186-9.json |
| 24187-7 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24187-7.json |
| 24188-5 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24188-5.json |
| 24189-3 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24189-3.json |
| 24190-1 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24190-1.json |
| 24191-9 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24191-9.json |
| 24192-7 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24192-7.json |
| 24193-5 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24193-5.json |
| 24194-3 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24194-3.json |
| 24195-0 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24195-0.json |
| 24196-8 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24196-8.json |
| 24197-6 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24197-6.json |
| 24198-4 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24198-4.json |
| 24199-2 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/24199-2.json |
| 24200-8 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/24200-8.json |
| 24201-6 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24201-6.json |
| 24202-4 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24202-4.json |
| 24203-2 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24203-2.json |
| 24204-0 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24204-0.json |
| 24205-7 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24205-7.json |
| 24206-5 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24206-5.json |
| 24207-3 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24207-3.json |
| 24208-1 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24208-1.json |
| 24209-9 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24209-9.json |
| 24210-7 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24210-7.json |
| 24211-5 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24211-5.json |
| 24212-3 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24212-3.json |
| 24213-1 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/24213-1.json |
| 24214-9 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/24214-9.json |
| 24215-6 | Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24215-6.json |
| 24216-4 | Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24216-4.json |
| 24217-2 | Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24217-2.json |
| 24218-0 | Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24218-0.json |
| 24219-8 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24219-8.json |
| 24220-6 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24220-6.json |
| 24221-4 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24221-4.json |
| 24222-2 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24222-2.json |
| 24223-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24223-0.json |
| 24224-8 | Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24224-8.json |
| 24225-5 | Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24225-5.json |
| 24226-3 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24226-3.json |
| 24227-1 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24227-1.json |
| 24228-9 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24228-9.json |
| 24229-7 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24229-7.json |
| 24230-5 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24230-5.json |
| 24231-3 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24231-3.json |
| 24232-1 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24232-1.json |
| 24233-9 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24233-9.json |
| 24234-7 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24234-7.json |
| 24235-4 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24235-4.json |
| 24236-2 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen | ./2.16.840.1.114222.4.11.1002/24236-2.json |
| 24237-0 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/24237-0.json |
| 24238-8 | Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24238-8.json |
| 24239-6 | Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24239-6.json |
| 24240-4 | Mumps virus IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24240-4.json |
| 24241-2 | Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24241-2.json |
| 24242-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24242-0.json |
| 24243-8 | Polio virus 1 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24243-8.json |
| 24244-6 | Polio virus 1 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24244-6.json |
| 24245-3 | Polio virus 2 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24245-3.json |
| 24246-1 | Polio virus 2 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24246-1.json |
| 24247-9 | Polio virus 3 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24247-9.json |
| 24248-7 | Polio virus 3 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24248-7.json |
| 24249-5 | Adenovirus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24249-5.json |
| 24250-3 | Adenovirus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24250-3.json |
| 24251-1 | Coxsackievirus B1 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24251-1.json |
| 24252-9 | Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24252-9.json |
| 24255-2 | Coxsackievirus B2 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24255-2.json |
| 24256-0 | Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24256-0.json |
| 2425-7 | Histidine ammonia lyase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2425-7.json |
| 24259-4 | Coxsackievirus B3 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24259-4.json |
| 24260-2 | Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24260-2.json |
| 24263-6 | Coxsackievirus B4 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24263-6.json |
| 24264-4 | Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24264-4.json |
| 24267-7 | Coxsackievirus B5 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24267-7.json |
| 24268-5 | Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24268-5.json |
| 24271-9 | Coxsackievirus B6 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24271-9.json |
| 24272-7 | Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24272-7.json |
| 24275-0 | Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24275-0.json |
| 24276-8 | Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24276-8.json |
| 24277-6 | Legionella pneumophila Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24277-6.json |
| 24278-4 | Legionella pneumophila Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24278-4.json |
| 24279-2 | Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24279-2.json |
| 24280-0 | Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24280-0.json |
| 2428-1 | Homocysteine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2428-1.json |
| 24281-8 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24281-8.json |
| 24282-6 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24282-6.json |
| 24283-4 | La Crosse virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24283-4.json |
| 24284-2 | La Crosse virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24284-2.json |
| 24285-9 | Western equine encephalitis virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24285-9.json |
| 24286-7 | Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24286-7.json |
| 24287-5 | Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24287-5.json |
| 24288-3 | Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24288-3.json |
| 24289-1 | Influenza virus A Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24289-1.json |
| 24290-9 | Influenza virus A Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24290-9.json |
| 24291-7 | Influenza virus B Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24291-7.json |
| 24292-5 | Influenza virus B Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24292-5.json |
| 24293-3 | Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24293-3.json |
| 24294-1 | Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24294-1.json |
| 24295-8 | Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24295-8.json |
| 24296-6 | Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24296-6.json |
| 24297-4 | Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24297-4.json |
| 24298-2 | Respiratory syncytial virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24298-2.json |
| 24299-0 | Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24299-0.json |
| 24300-6 | Coxsackievirus A10 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24300-6.json |
| 24301-4 | Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24301-4.json |
| 24302-2 | Coxsackievirus A16 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24302-2.json |
| 24303-0 | Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24303-0.json |
| 24304-8 | Coxsackievirus A7 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24304-8.json |
| 24305-5 | Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24305-5.json |
| 24306-3 | Coxsackievirus A9 Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24306-3.json |
| 24307-1 | Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24307-1.json |
| 24310-5 | Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/24310-5.json |
| 24311-3 | Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/24311-3.json |
| 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/24312-1.json |
| 2432-3 | Homogentisate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2432-3.json |
| 2433-1 | Homogentisate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2433-1.json |
| 2434-9 | Homovanillate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2434-9.json |
| 2435-6 | Homovanillate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2435-6.json |
| 2436-4 | Homovanillate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2436-4.json |
| 24373-3 | Ferritin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/24373-3.json |
| 24374-1 | Platelet associated Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/24374-1.json |
| 24375-8 | Platelet Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24375-8.json |
| 24376-6 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/24376-6.json |
| 24377-4 | Platelet aggregation ADP induced [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/24377-4.json |
| 24378-2 | Platelet aggregation EPINEPHrine induced [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/24378-2.json |
| 24379-0 | Platelet aggregation collagen induced [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/24379-0.json |
| 24380-8 | Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/24380-8.json |
| 24381-6 | Platelet aggregation arachidonate induced [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/24381-6.json |
| 24382-4 | Neutrophil associated Ab [Identifier] in Serum | ./2.16.840.1.114222.4.11.1002/24382-4.json |
| 24383-2 | Intrinsic factor Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24383-2.json |
| 24385-7 | Cardiolipin IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24385-7.json |
| 24386-5 | Cardiolipin IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24386-5.json |
| 24387-3 | Brucella sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24387-3.json |
| 24388-1 | Brucella sp IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24388-1.json |
| 24396-4 | Brucella sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24396-4.json |
| 24397-2 | Brucella sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/24397-2.json |
| 2439-8 | Hydroxycalcidiol [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2439-8.json |
| 24400-4 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/24400-4.json |
| 24401-2 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/24401-2.json |
| 24402-0 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Specimen by Probe with amplification | ./2.16.840.1.114222.4.11.1002/24402-0.json |
| 24403-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/24403-8.json |
| 24404-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/24404-6.json |
| 24405-3 | Aeromonas salmonicida [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/24405-3.json |
| 2440-6 | Hydroxocobalamin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2440-6.json |
| 24406-1 | Aeromonas salmonicida serotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/24406-1.json |
| 24408-7 | Babesia canis [Presence] in Blood by Giemsa stain | ./2.16.840.1.114222.4.11.1002/24408-7.json |
| 24409-5 | Brachyspira sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/24409-5.json |
| 24410-3 | Brucella canis Ab [Presence] in Serum by Plate agglutination | ./2.16.840.1.114222.4.11.1002/24410-3.json |
| 24411-1 | Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/24411-1.json |
| 24412-9 | Coccidia identified in Small intestine Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/24412-9.json |
| 24413-7 | Eperythrozoon sp [Presence] in Blood by Giemsa stain | ./2.16.840.1.114222.4.11.1002/24413-7.json |
| 24415-2 | Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/24415-2.json |
| 24416-0 | Filovirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/24416-0.json |
| 24418-6 | Formononetin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24418-6.json |
| 24420-2 | Haemophilus somnus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/24420-2.json |
| 24421-0 | Haemobartonella felis [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/24421-0.json |
| 24422-8 | Hydrocarbons.chlorinated [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/24422-8.json |
| 24427-7 | Mycobacterium avium ss paratuberculosis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/24427-7.json |
| 24428-5 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/24428-5.json |
| 24429-3 | Parasite identified in Blood | ./2.16.840.1.114222.4.11.1002/24429-3.json |
| 24430-1 | Streptococcus suis serotype [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/24430-1.json |
| 24431-9 | IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24431-9.json |
| 24432-7 | IgG.canine [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24432-7.json |
| 24433-5 | IgG.equine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24433-5.json |
| 24434-3 | IgM.canine [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24434-3.json |
| 24438-4 | Hexanoylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24438-4.json |
| 24441-8 | Phenylpropionylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24441-8.json |
| 24442-6 | Propionylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24442-6.json |
| 24444-2 | Tiglylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24444-2.json |
| 24446-7 | Porphobilinogen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/24446-7.json |
| 24447-5 | Magnesium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/24447-5.json |
| 2444-8 | Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2444-8.json |
| 24448-3 | Carnitine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/24448-3.json |
| 24449-1 | Carnitine esters [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/24449-1.json |
| 24450-9 | Carnitine esters [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/24450-9.json |
| 24451-7 | Carnitine [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/24451-7.json |
| 24452-5 | Carnitine free (C0) [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/24452-5.json |
| 2445-5 | Hydroxyproline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2445-5.json |
| 24456-6 | Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/24456-6.json |
| 24458-2 | Interleukin 2 receptor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/24458-2.json |
| 2446-3 | Hydroxyproline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2446-3.json |
| 24463-2 | Keratan sulfate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/24463-2.json |
| 24464-0 | Chondroitin sulfate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/24464-0.json |
| 24465-7 | Urea nitrogen [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/24465-7.json |
| 24467-3 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/24467-3.json |
| 2447-1 | Hydroxyproline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2447-1.json |
| 24471-5 | Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood | ./2.16.840.1.114222.4.11.1002/24471-5.json |
| 24472-3 | Platelet function (closure time) collagen+ADP induced [Time] in Blood | ./2.16.840.1.114222.4.11.1002/24472-3.json |
| 24474-9 | Cancer associated serum Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24474-9.json |
| 24475-6 | F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/24475-6.json |
| 24476-4 | F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/24476-4.json |
| 24480-6 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+Englishplantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24480-6.json |
| 2448-9 | Hydroxyproline Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2448-9.json |
| 24491-3 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24491-3.json |
| 24493-9 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24493-9.json |
| 2449-7 | Hydroxyproline Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2449-7.json |
| 24497-0 | Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24497-0.json |
| 24498-8 | Chicken serum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24498-8.json |
| 24499-6 | Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24499-6.json |
| 24500-1 | Parrot serum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24500-1.json |
| 24501-9 | Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24501-9.json |
| 24502-7 | Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24502-7.json |
| 24503-5 | Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24503-5.json |
| 24504-3 | Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24504-3.json |
| 2450-5 | Hydroxyproline Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2450-5.json |
| 24505-0 | Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24505-0.json |
| 24507-6 | Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24507-6.json |
| 24508-4 | Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24508-4.json |
| 24509-2 | Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/24509-2.json |
| 24511-8 | Western wheatgrass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24511-8.json |
| 24512-6 | Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24512-6.json |
| 2451-3 | Hydroxyproline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2451-3.json |
| 24515-9 | Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/24515-9.json |
| 24517-5 | Phoma sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/24517-5.json |
| 24518-3 | Calcium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24518-3.json |
| 24519-1 | Phosphate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/24519-1.json |
| 24520-9 | Phosphate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/24520-9.json |
| 2452-1 | Hypoxanthine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2452-1.json |
| 24521-7 | EPINEPHrine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/24521-7.json |
| 24522-5 | EPINEPHrine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24522-5.json |
| 24523-3 | Norepinephrine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24523-3.json |
| 24524-1 | DOPamine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/24524-1.json |
| 24531-6 | US Retroperitoneum | ./2.16.840.1.114222.4.11.1002/24531-6.json |
| 24532-4 | US Abdomen RUQ | ./2.16.840.1.114222.4.11.1002/24532-4.json |
| 24533-2 | MRA Abdominal vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24533-2.json |
| 24534-0 | US.doppler Abdominal vessels | ./2.16.840.1.114222.4.11.1002/24534-0.json |
| 24535-7 | XR Acetabulum Views | ./2.16.840.1.114222.4.11.1002/24535-7.json |
| 24536-5 | XR Acromioclavicular Joint Views | ./2.16.840.1.114222.4.11.1002/24536-5.json |
| 24537-3 | US Guidance for aspiration of amniotic fluid of Uterus | ./2.16.840.1.114222.4.11.1002/24537-3.json |
| 24538-1 | MR Ankle | ./2.16.840.1.114222.4.11.1002/24538-1.json |
| 2453-9 | Hypoxanthine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2453-9.json |
| 24539-9 | MR Ankle WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24539-9.json |
| 24540-7 | XR Ankle 2 Views | ./2.16.840.1.114222.4.11.1002/24540-7.json |
| 24541-5 | XR Ankle Views | ./2.16.840.1.114222.4.11.1002/24541-5.json |
| 24542-3 | US Anus | ./2.16.840.1.114222.4.11.1002/24542-3.json |
| 24543-1 | RFA Guidance for angioplasty of Thoracic and abdominal aorta-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24543-1.json |
| 24544-9 | CT Thoracic Aorta | ./2.16.840.1.114222.4.11.1002/24544-9.json |
| 24545-6 | CT Thoracic Aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/24545-6.json |
| 2454-7 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2454-7.json |
| 24547-2 | US Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/24547-2.json |
| 24548-0 | US Appendix | ./2.16.840.1.114222.4.11.1002/24548-0.json |
| 24549-8 | MRA Upper extremity vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24549-8.json |
| 24550-6 | RFA Upper extremity veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/24550-6.json |
| 24551-4 | RFA AV fistula Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24551-4.json |
| 24552-2 | RF Stent Views W contrast intra stent | ./2.16.840.1.114222.4.11.1002/24552-2.json |
| 24553-0 | RFA Guidance for embolectomy of Intracranial vessel-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24553-0.json |
| 2455-4 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2455-4.json |
| 24554-8 | RFA Guidance for embolization of Artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24554-8.json |
| 24555-5 | RFA Guidance for placement of stent in Artery | ./2.16.840.1.114222.4.11.1002/24555-5.json |
| 24556-3 | MR Abdomen | ./2.16.840.1.114222.4.11.1002/24556-3.json |
| 24557-1 | MR Abdomen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24557-1.json |
| 24558-9 | US Abdomen | ./2.16.840.1.114222.4.11.1002/24558-9.json |
| 24559-7 | US Guidance for drainage and placement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/24559-7.json |
| 24560-5 | Portable XR Abdomen AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24560-5.json |
| 24561-3 | XR Abdomen AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24561-3.json |
| 2456-2 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2456-2.json |
| 24562-1 | XR Abdomen Left lateral-decubitus and Right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24562-1.json |
| 24563-9 | XR Abdomen AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24563-9.json |
| 24564-7 | Portable XR Abdomen AP upright | ./2.16.840.1.114222.4.11.1002/24564-7.json |
| 24566-2 | CT Retroperitoneum | ./2.16.840.1.114222.4.11.1002/24566-2.json |
| 24568-8 | RFA Guidance for atherectomy of AV fistula-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24568-8.json |
| 24569-6 | RFA AV shunt Views W contrast IV | ./2.16.840.1.114222.4.11.1002/24569-6.json |
| 2457-0 | IgA [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2457-0.json |
| 24570-4 | RF Guidance for removal of calculus from Biliary duct common-- W contrast retrograde intra biliary | ./2.16.840.1.114222.4.11.1002/24570-4.json |
| 24571-2 | NM Biliary ducts and Gallbladder Views for patency of biliary structures and ejection fraction W sincalide and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/24571-2.json |
| 24572-0 | NM Biliary ducts and Gallbladder Views for patency of biliary structures W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/24572-0.json |
| 24573-8 | XR Biliary ducts and Gallbladder Views W contrast IV | ./2.16.840.1.114222.4.11.1002/24573-8.json |
| 24574-6 | RF Biliary ducts and Gallbladder Views during surgery W contrast biliary duct | ./2.16.840.1.114222.4.11.1002/24574-6.json |
| 24575-3 | RF Biliary ducts and Gallbladder Views W contrast percutaneous transhepatic | ./2.16.840.1.114222.4.11.1002/24575-3.json |
| 24576-1 | RFA Urinary bladder arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24576-1.json |
| 24577-9 | XR Bone Views during surgery | ./2.16.840.1.114222.4.11.1002/24577-9.json |
| 24578-7 | SPECT Bones | ./2.16.840.1.114222.4.11.1002/24578-7.json |
| 24579-5 | XR Long bones Survey Views | ./2.16.840.1.114222.4.11.1002/24579-5.json |
| 24580-3 | RFA Guidance for angioplasty of Brachiocephalic artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24580-3.json |
| 24581-1 | RFA Subclavian artery and Brachial artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24581-1.json |
| 24582-9 | MR Brachial plexus | ./2.16.840.1.114222.4.11.1002/24582-9.json |
| 24583-7 | MR Brachial plexus WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24583-7.json |
| 24584-5 | MRA Thoracic inlet vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24584-5.json |
| 24585-2 | CT Guidance for stereotactic biopsy of Head-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24585-2.json |
| 24586-0 | MR Brain W anesthesia | ./2.16.840.1.114222.4.11.1002/24586-0.json |
| 24587-8 | MR Brain WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24587-8.json |
| 2458-8 | IgA [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2458-8.json |
| 24588-6 | MR Brain WO and W contrast IV and W anesthesia | ./2.16.840.1.114222.4.11.1002/24588-6.json |
| 24589-4 | MR Brain W contrast IV | ./2.16.840.1.114222.4.11.1002/24589-4.json |
| 24590-2 | MR Brain | ./2.16.840.1.114222.4.11.1002/24590-2.json |
| 24591-0 | NM Brain Brain death protocol Views W Tc-99m HMPAO IV | ./2.16.840.1.114222.4.11.1002/24591-0.json |
| 24593-6 | MRA Head vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24593-6.json |
| 24594-4 | MG Guidance for aspiration of cyst of Breast | ./2.16.840.1.114222.4.11.1002/24594-4.json |
| 24595-1 | MG Guidance for needle localization of mass of Breast | ./2.16.840.1.114222.4.11.1002/24595-1.json |
| 2459-6 | IgA.monoclonal [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2459-6.json |
| 24596-9 | US Breast specimen | ./2.16.840.1.114222.4.11.1002/24596-9.json |
| 24597-7 | MG Breast specimen Views | ./2.16.840.1.114222.4.11.1002/24597-7.json |
| 24598-5 | MG Guidance for fluid aspiration of Breast | ./2.16.840.1.114222.4.11.1002/24598-5.json |
| 24599-3 | US Breast limited | ./2.16.840.1.114222.4.11.1002/24599-3.json |
| 24600-9 | US Guidance for needle localization of Breast | ./2.16.840.1.114222.4.11.1002/24600-9.json |
| 24601-7 | US Breast | ./2.16.840.1.114222.4.11.1002/24601-7.json |
| 24602-5 | MG Guidance for biopsy of Breast | ./2.16.840.1.114222.4.11.1002/24602-5.json |
| 24603-3 | MG stereo Guidance for biopsy of Breast | ./2.16.840.1.114222.4.11.1002/24603-3.json |
| 2460-4 | IgD [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2460-4.json |
| 24604-1 | MG Breast Diagnostic Limited Views | ./2.16.840.1.114222.4.11.1002/24604-1.json |
| 24605-8 | MG Breast Diagnostic | ./2.16.840.1.114222.4.11.1002/24605-8.json |
| 24606-6 | MG Breast Screening | ./2.16.840.1.114222.4.11.1002/24606-6.json |
| 24609-0 | MG Guidance for percutaneous biopsy.core needle of Breast | ./2.16.840.1.114222.4.11.1002/24609-0.json |
| 24610-8 | MG Breast Limited Views | ./2.16.840.1.114222.4.11.1002/24610-8.json |
| 24611-6 | Outpatient Consultation 2nd opinion | ./2.16.840.1.114222.4.11.1002/24611-6.json |
| 2461-2 | IgD.monoclonal [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2461-2.json |
| 24612-4 | XR Calcaneus Views | ./2.16.840.1.114222.4.11.1002/24612-4.json |
| 24614-0 | RFA Guidance for angioplasty of Carotid artery extracranial-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24614-0.json |
| 24615-7 | RFA Guidance for angioplasty of Carotid artery.intracranial-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24615-7.json |
| 24616-5 | US Carotid arteries | ./2.16.840.1.114222.4.11.1002/24616-5.json |
| 24617-3 | RFA Carotid arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24617-3.json |
| 24619-9 | XR Wrist Views | ./2.16.840.1.114222.4.11.1002/24619-9.json |
| 2462-0 | IgE [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2462-0.json |
| 24620-7 | RF Catheter Views for patency check W contrast via catheter | ./2.16.840.1.114222.4.11.1002/24620-7.json |
| 24621-5 | RF Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/24621-5.json |
| 24622-3 | RFA Celiac artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24622-3.json |
| 24623-1 | CT Guidance for nerve block of Celiac plexus | ./2.16.840.1.114222.4.11.1002/24623-1.json |
| 24624-9 | RFA Guidance for change of CV catheter in Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24624-9.json |
| 24625-6 | RFA Guidance for placement of CV catheter in Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24625-6.json |
| 24626-4 | RFA Guidance for reposition of CV catheter in Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24626-4.json |
| 24627-2 | CT Chest | ./2.16.840.1.114222.4.11.1002/24627-2.json |
| 24628-0 | CT Chest W contrast IV | ./2.16.840.1.114222.4.11.1002/24628-0.json |
| 24629-8 | MR Chest | ./2.16.840.1.114222.4.11.1002/24629-8.json |
| 24630-6 | US Chest | ./2.16.840.1.114222.4.11.1002/24630-6.json |
| 24631-4 | RF Unspecified body region Views for central venous catheter placement check | ./2.16.840.1.114222.4.11.1002/24631-4.json |
| 24632-2 | Portable XR Chest Views AP | ./2.16.840.1.114222.4.11.1002/24632-2.json |
| 24634-8 | Portable XR Chest Views W inspiration and expiration | ./2.16.840.1.114222.4.11.1002/24634-8.json |
| 24635-5 | XR Chest PA upright Views W inspiration and expiration | ./2.16.840.1.114222.4.11.1002/24635-5.json |
| 24636-3 | Portable XR Chest AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24636-3.json |
| 24637-1 | XR Chest AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24637-1.json |
| 2463-8 | IgE.monoclonal [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2463-8.json |
| 24638-9 | Portable XR Chest Left lateral upright | ./2.16.840.1.114222.4.11.1002/24638-9.json |
| 24639-7 | XR Chest Left lateral upright | ./2.16.840.1.114222.4.11.1002/24639-7.json |
| 24640-5 | XR Chest Apical lordotic | ./2.16.840.1.114222.4.11.1002/24640-5.json |
| 24641-3 | Portable XR Chest Left oblique | ./2.16.840.1.114222.4.11.1002/24641-3.json |
| 24642-1 | XR Chest AP and PA upright | ./2.16.840.1.114222.4.11.1002/24642-1.json |
| 24643-9 | XR Chest PA and Lateral and Oblique upright | ./2.16.840.1.114222.4.11.1002/24643-9.json |
| 24644-7 | Portable XR Chest PA and Lateral upright | ./2.16.840.1.114222.4.11.1002/24644-7.json |
| 24645-4 | Portable XR Chest PA and Right lateral and Right oblique and Left oblique upright | ./2.16.840.1.114222.4.11.1002/24645-4.json |
| 2464-6 | IgG [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2464-6.json |
| 24646-2 | XR Chest PA and Right lateral and Right oblique and Left oblique upright | ./2.16.840.1.114222.4.11.1002/24646-2.json |
| 24647-0 | XR Chest PA and Lateral upright | ./2.16.840.1.114222.4.11.1002/24647-0.json |
| 24648-8 | XR Chest PA upright | ./2.16.840.1.114222.4.11.1002/24648-8.json |
| 24649-6 | Portable XR Chest Right lateral-decubitus and Left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24649-6.json |
| 24650-4 | XR Chest Right lateral-decubitus and Left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24650-4.json |
| 24651-2 | XR Chest Right oblique and Left oblique upright | ./2.16.840.1.114222.4.11.1002/24651-2.json |
| 24652-0 | Portable XR Chest AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24652-0.json |
| 2465-3 | IgG [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2465-3.json |
| 24653-8 | XR Chest AP and AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24653-8.json |
| 24654-6 | Portable XR Chest AP and AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24654-6.json |
| 24655-3 | RF Chest Image intensifier during surgery | ./2.16.840.1.114222.4.11.1002/24655-3.json |
| 24656-1 | RF Chest Single view during surgery | ./2.16.840.1.114222.4.11.1002/24656-1.json |
| 24657-9 | XR tomography Chest | ./2.16.840.1.114222.4.11.1002/24657-9.json |
| 24658-7 | RFA Thoracic and abdominal aorta Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24658-7.json |
| 24659-5 | MRA Chest vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24659-5.json |
| 24660-3 | MRA Thoracic Aorta | ./2.16.840.1.114222.4.11.1002/24660-3.json |
| 2466-1 | IgG subclass 1 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2466-1.json |
| 24661-1 | RF Pleural space Views W contrast intra pleural space | ./2.16.840.1.114222.4.11.1002/24661-1.json |
| 24662-9 | US Guidance for fluid aspiration of Pleural space | ./2.16.840.1.114222.4.11.1002/24662-9.json |
| 24663-7 | NM Cerebral cisterns Views W radionuclide IT | ./2.16.840.1.114222.4.11.1002/24663-7.json |
| 24664-5 | XR Clavicle Views | ./2.16.840.1.114222.4.11.1002/24664-5.json |
| 24665-2 | XR Sacrum and Coccyx Views | ./2.16.840.1.114222.4.11.1002/24665-2.json |
| 24666-0 | RF Colon Views W air and barium contrast PR | ./2.16.840.1.114222.4.11.1002/24666-0.json |
| 24667-8 | RF Colon Views W contrast PR | ./2.16.840.1.114222.4.11.1002/24667-8.json |
| 24668-6 | RF Colon Single view for transit Post solid contrast | ./2.16.840.1.114222.4.11.1002/24668-6.json |
| 24669-4 | RF Colon Views W water soluble contrast PR | ./2.16.840.1.114222.4.11.1002/24669-4.json |
| 24670-2 | US Guidance for biopsy of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/24670-2.json |
| 24671-0 | RF Guidance for aspiration of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/24671-0.json |
| 24672-8 | US Diaphragm for motion | ./2.16.840.1.114222.4.11.1002/24672-8.json |
| 24674-4 | MR Elbow | ./2.16.840.1.114222.4.11.1002/24674-4.json |
| 24675-1 | MR Elbow WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24675-1.json |
| 24676-9 | XR Elbow Views | ./2.16.840.1.114222.4.11.1002/24676-9.json |
| 24677-7 | US Pelvis transvaginal | ./2.16.840.1.114222.4.11.1002/24677-7.json |
| 24678-5 | RF Esophagus Views W contrast PO | ./2.16.840.1.114222.4.11.1002/24678-5.json |
| 2467-9 | IgG subclass 2 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2467-9.json |
| 24679-3 | RF Esophagus Views W gastrografin PO | ./2.16.840.1.114222.4.11.1002/24679-3.json |
| 24680-1 | RF Guidance for dilation of Esophagus | ./2.16.840.1.114222.4.11.1002/24680-1.json |
| 24681-9 | RF videography Hypopharynx and Esophagus Views | ./2.16.840.1.114222.4.11.1002/24681-9.json |
| 24682-7 | RF videography Hypopharynx and Esophagus Views W liquid and paste contrast PO during swallowing | ./2.16.840.1.114222.4.11.1002/24682-7.json |
| 24683-5 | NM Esophagus+Stomach Views W Tc-99m SC PO | ./2.16.840.1.114222.4.11.1002/24683-5.json |
| 24684-3 | RFA Guidance for embolectomy of Extracranial vessels-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24684-3.json |
| 24685-0 | RFA Peripheral veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/24685-0.json |
| 24686-8 | XR Lower extremity Views | ./2.16.840.1.114222.4.11.1002/24686-8.json |
| 2468-7 | IgG subclass 3 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2468-7.json |
| 24687-6 | MR Lower Extremity Joint | ./2.16.840.1.114222.4.11.1002/24687-6.json |
| 24688-4 | MR Upper extremity | ./2.16.840.1.114222.4.11.1002/24688-4.json |
| 24689-2 | XR Upper extremity Views | ./2.16.840.1.114222.4.11.1002/24689-2.json |
| 24690-0 | CT Extremity | ./2.16.840.1.114222.4.11.1002/24690-0.json |
| 24691-8 | CT Extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/24691-8.json |
| 24692-6 | US Guidance for drainage and placement of drainage catheter of Extremity | ./2.16.840.1.114222.4.11.1002/24692-6.json |
| 24693-4 | US Extremity | ./2.16.840.1.114222.4.11.1002/24693-4.json |
| 24694-2 | MR Face WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24694-2.json |
| 2469-5 | IgG subclass 4 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2469-5.json |
| 24695-9 | XR Facial bones Views | ./2.16.840.1.114222.4.11.1002/24695-9.json |
| 24696-7 | CT Facial bones | ./2.16.840.1.114222.4.11.1002/24696-7.json |
| 24697-5 | CT Facial bones W contrast IV | ./2.16.840.1.114222.4.11.1002/24697-5.json |
| 24698-3 | RFA Guidance for angioplasty of Femoral artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24698-3.json |
| 24699-1 | RFA Femoral artery Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/24699-1.json |
| 24700-7 | XR Femur and Tibia Views for leg length | ./2.16.840.1.114222.4.11.1002/24700-7.json |
| 24702-3 | MR Thigh | ./2.16.840.1.114222.4.11.1002/24702-3.json |
| 24703-1 | MR Thigh WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24703-1.json |
| 24704-9 | XR Femur Views | ./2.16.840.1.114222.4.11.1002/24704-9.json |
| 24705-6 | MR Finger | ./2.16.840.1.114222.4.11.1002/24705-6.json |
| 24706-4 | XR Finger Views | ./2.16.840.1.114222.4.11.1002/24706-4.json |
| 24707-2 | MR Foot | ./2.16.840.1.114222.4.11.1002/24707-2.json |
| 24708-0 | XR Foot Views W standing | ./2.16.840.1.114222.4.11.1002/24708-0.json |
| 24709-8 | XR Foot Views | ./2.16.840.1.114222.4.11.1002/24709-8.json |
| 24710-6 | MR Forearm | ./2.16.840.1.114222.4.11.1002/24710-6.json |
| 2471-1 | IgM [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2471-1.json |
| 24711-4 | US Gallbladder | ./2.16.840.1.114222.4.11.1002/24711-4.json |
| 24712-2 | XR Gallbladder Views W contrast PO | ./2.16.840.1.114222.4.11.1002/24712-2.json |
| 24713-0 | XR Gallbladder Views 48H post contrast PO | ./2.16.840.1.114222.4.11.1002/24713-0.json |
| 24714-8 | NM Gastrointestinal tract Views for gastrointestinal bleeding W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/24714-8.json |
| 24715-5 | RF Gastrointestinal tract upper Single view W contrast PO | ./2.16.840.1.114222.4.11.1002/24715-5.json |
| 24716-3 | RF Guidance for placement of decompression tube in Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/24716-3.json |
| 24718-9 | RF Guidance for transjugular biopsy of Liver-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24718-9.json |
| 24719-7 | US Groin | ./2.16.840.1.114222.4.11.1002/24719-7.json |
| 24720-5 | MR Hand | ./2.16.840.1.114222.4.11.1002/24720-5.json |
| 24721-3 | XR Hand 2 Views | ./2.16.840.1.114222.4.11.1002/24721-3.json |
| 24722-1 | XR Hand 3 Views | ./2.16.840.1.114222.4.11.1002/24722-1.json |
| 24723-9 | XR Hand Arthritis | ./2.16.840.1.114222.4.11.1002/24723-9.json |
| 24724-7 | XR Wrist and Hand Bone age Views | ./2.16.840.1.114222.4.11.1002/24724-7.json |
| 24725-4 | CT Head | ./2.16.840.1.114222.4.11.1002/24725-4.json |
| 24726-2 | CT Head WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24726-2.json |
| 24727-0 | CT Head W contrast IV | ./2.16.840.1.114222.4.11.1002/24727-0.json |
| 24728-8 | CT perfusion Head | ./2.16.840.1.114222.4.11.1002/24728-8.json |
| 2472-9 | IgM [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2472-9.json |
| 24729-6 | CT perfusion Head WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24729-6.json |
| 24730-4 | NM Brain Views | ./2.16.840.1.114222.4.11.1002/24730-4.json |
| 24731-2 | US Head | ./2.16.840.1.114222.4.11.1002/24731-2.json |
| 24732-0 | US Head during surgery | ./2.16.840.1.114222.4.11.1002/24732-0.json |
| 24733-8 | US.doppler Head vessels | ./2.16.840.1.114222.4.11.1002/24733-8.json |
| 24734-6 | CT Cerebral cisterns W contrast IT | ./2.16.840.1.114222.4.11.1002/24734-6.json |
| 24735-3 | MR Internal auditory canal and Posterior fossa | ./2.16.840.1.114222.4.11.1002/24735-3.json |
| 2473-7 | IgM.monoclonal [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2473-7.json |
| 24740-3 | MR Internal auditory canal and Posterior fossa WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24740-3.json |
| 2474-5 | Indicans [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2474-5.json |
| 24745-2 | XR Petrous part of temporal bone Views | ./2.16.840.1.114222.4.11.1002/24745-2.json |
| 24748-6 | MR Heart | ./2.16.840.1.114222.4.11.1002/24748-6.json |
| 24750-2 | NM Heart Views at rest and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/24750-2.json |
| 24751-0 | NM Parathyroid gland Views W TI-201 subtraction Tc-99m IV | ./2.16.840.1.114222.4.11.1002/24751-0.json |
| 2475-2 | Indicans [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2475-2.json |
| 24752-8 | RF videography Heart Views | ./2.16.840.1.114222.4.11.1002/24752-8.json |
| 24753-6 | CT Unspecified body region W contrast IV | ./2.16.840.1.114222.4.11.1002/24753-6.json |
| 24754-4 | Administration of vasodilator into catheter Vein | ./2.16.840.1.114222.4.11.1002/24754-4.json |
| 24755-1 | RFA Guidance for atherectomy of Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/24755-1.json |
| 24756-9 | RFA Guidance for placement of stent in Vein | ./2.16.840.1.114222.4.11.1002/24756-9.json |
| 2476-0 | Indolamine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2476-0.json |
| 24760-1 | US Hip | ./2.16.840.1.114222.4.11.1002/24760-1.json |
| 24761-9 | XR Hip Single view | ./2.16.840.1.114222.4.11.1002/24761-9.json |
| 24762-7 | XR Hip Views | ./2.16.840.1.114222.4.11.1002/24762-7.json |
| 24764-3 | RF Hip Arthrogram | ./2.16.840.1.114222.4.11.1002/24764-3.json |
| 24765-0 | XR Humerus 2 Views | ./2.16.840.1.114222.4.11.1002/24765-0.json |
| 24766-8 | RFA Guidance for angioplasty of Iliac artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24766-8.json |
| 24767-6 | XR tomography Internal auditory canal | ./2.16.840.1.114222.4.11.1002/24767-6.json |
| 24769-2 | CT Guidance for injection of Joint space | ./2.16.840.1.114222.4.11.1002/24769-2.json |
| 24770-0 | NM Joint Views W In-111 intrajoint | ./2.16.840.1.114222.4.11.1002/24770-0.json |
| 24771-8 | RF Guidance for arthrocentesis of Joint space | ./2.16.840.1.114222.4.11.1002/24771-8.json |
| 24772-6 | US Guidance for biopsy of Kidney | ./2.16.840.1.114222.4.11.1002/24772-6.json |
| 24773-4 | NM Kidney Views W radionuclide transplant scan | ./2.16.840.1.114222.4.11.1002/24773-4.json |
| 24776-7 | NM Kidney Views | ./2.16.840.1.114222.4.11.1002/24776-7.json |
| 2477-8 | Indole [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2477-8.json |
| 24778-3 | XR Kidney - bilateral 3 Serial Views WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24778-3.json |
| 24779-1 | RF Guidance for percutaneous placement of nephrostomy tube of Kidney - bilateral-- W contrast via tube | ./2.16.840.1.114222.4.11.1002/24779-1.json |
| 24780-9 | RF Kidney - bilateral Views W contrast via nephrostomy tube | ./2.16.840.1.114222.4.11.1002/24780-9.json |
| 24781-7 | RF Guidance for exchange of nephrostomy tube of Kidney - bilateral-- W contrast | ./2.16.840.1.114222.4.11.1002/24781-7.json |
| 24782-5 | RF Guidance for percutaneous placement of nephroureteral stent of Kidney - bilateral-- W contrast via stent | ./2.16.840.1.114222.4.11.1002/24782-5.json |
| 24783-3 | RF Kidney - bilateral Views for urodynamics | ./2.16.840.1.114222.4.11.1002/24783-3.json |
| 24784-1 | XR tomography Kidney - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24784-1.json |
| 2478-6 | Inhibin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2478-6.json |
| 24787-4 | XR tomography Kidney - bilateral WO contrast and 10M post contrast IV | ./2.16.840.1.114222.4.11.1002/24787-4.json |
| 24788-2 | XR Kidney - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/24788-2.json |
| 24789-0 | XR tomography Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/24789-0.json |
| 24790-8 | XR tomography Kidney - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/24790-8.json |
| 24792-4 | Portable XR Abdomen AP and AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24792-4.json |
| 24793-2 | Portable XR Abdomen AP and Lateral | ./2.16.840.1.114222.4.11.1002/24793-2.json |
| 2479-4 | Inosine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2479-4.json |
| 24794-0 | XR Abdomen AP and Lateral | ./2.16.840.1.114222.4.11.1002/24794-0.json |
| 24795-7 | Portable XR Abdomen Supine and Upright | ./2.16.840.1.114222.4.11.1002/24795-7.json |
| 24796-5 | XR Abdomen AP and AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/24796-5.json |
| 24797-3 | XR Abdomen AP and Oblique prone | ./2.16.840.1.114222.4.11.1002/24797-3.json |
| 24798-1 | XR Abdomen Supine and Upright | ./2.16.840.1.114222.4.11.1002/24798-1.json |
| 24799-9 | XR Abdomen AP | ./2.16.840.1.114222.4.11.1002/24799-9.json |
| 24800-5 | RF Knee Arthrogram | ./2.16.840.1.114222.4.11.1002/24800-5.json |
| 24801-3 | XR Knee Merchants | ./2.16.840.1.114222.4.11.1002/24801-3.json |
| 2480-2 | Inositol Free [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2480-2.json |
| 24802-1 | MR Knee | ./2.16.840.1.114222.4.11.1002/24802-1.json |
| 24803-9 | MR Knee WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24803-9.json |
| 24804-7 | NM Knee Views | ./2.16.840.1.114222.4.11.1002/24804-7.json |
| 24805-4 | XR Knee AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/24805-4.json |
| 24806-2 | XR Knee 2 Views | ./2.16.840.1.114222.4.11.1002/24806-2.json |
| 24807-0 | XR Knee AP W standing | ./2.16.840.1.114222.4.11.1002/24807-0.json |
| 24808-8 | XR Knee AP and PA W standing | ./2.16.840.1.114222.4.11.1002/24808-8.json |
| 24809-6 | XR Knee Views W standing | ./2.16.840.1.114222.4.11.1002/24809-6.json |
| 2481-0 | Insulin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/2481-0.json |
| 24811-2 | CT Guidance for fluid aspiration of Liver | ./2.16.840.1.114222.4.11.1002/24811-2.json |
| 24812-0 | CT Guidance for biopsy of Liver | ./2.16.840.1.114222.4.11.1002/24812-0.json |
| 24813-8 | CT Guidance for core needle biopsy of Liver | ./2.16.840.1.114222.4.11.1002/24813-8.json |
| 24814-6 | CT Liver | ./2.16.840.1.114222.4.11.1002/24814-6.json |
| 24815-3 | CT Liver W contrast IV | ./2.16.840.1.114222.4.11.1002/24815-3.json |
| 24816-1 | US Guidance for biopsy of Liver | ./2.16.840.1.114222.4.11.1002/24816-1.json |
| 24817-9 | SPECT Liver W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/24817-9.json |
| 24818-7 | US Diaphragm and Liver | ./2.16.840.1.114222.4.11.1002/24818-7.json |
| 24820-3 | MRA Lower leg vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24820-3.json |
| 24821-1 | MR Lower leg | ./2.16.840.1.114222.4.11.1002/24821-1.json |
| 24822-9 | CT Guidance for fluid aspiration of Lung | ./2.16.840.1.114222.4.11.1002/24822-9.json |
| 24823-7 | CT Guidance for biopsy of Lung | ./2.16.840.1.114222.4.11.1002/24823-7.json |
| 24824-5 | NM Lung Portable Views | ./2.16.840.1.114222.4.11.1002/24824-5.json |
| 24825-2 | XR Lung Views W contrast intrabronchial | ./2.16.840.1.114222.4.11.1002/24825-2.json |
| 24826-0 | NM Lymphatic vessels Views W radionuclide intra lymphatic | ./2.16.840.1.114222.4.11.1002/24826-0.json |
| 24827-8 | RFA Lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/24827-8.json |
| 2482-8 | Insulin Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2482-8.json |
| 24828-6 | XR tomography Mandible Panoramic | ./2.16.840.1.114222.4.11.1002/24828-6.json |
| 24829-4 | XR Mandible Views | ./2.16.840.1.114222.4.11.1002/24829-4.json |
| 24830-2 | XR Mastoid Views | ./2.16.840.1.114222.4.11.1002/24830-2.json |
| 24831-0 | NM Small bowel Views for Meckel's diverticulum W Tc-99m M04 IV | ./2.16.840.1.114222.4.11.1002/24831-0.json |
| 24832-8 | RFA Guidance for angioplasty of Mesenteric artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24832-8.json |
| 24833-6 | RFA Mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24833-6.json |
| 24834-4 | XR Nasal bones Views | ./2.16.840.1.114222.4.11.1002/24834-4.json |
| 24835-1 | CT Nasopharynx and Neck | ./2.16.840.1.114222.4.11.1002/24835-1.json |
| 2483-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2483-6.json |
| 24836-9 | CT Nasopharynx and Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/24836-9.json |
| 24837-7 | CT Guidance for fluid aspiration of Neck | ./2.16.840.1.114222.4.11.1002/24837-7.json |
| 24838-5 | CT Guidance for biopsy of Neck | ./2.16.840.1.114222.4.11.1002/24838-5.json |
| 24839-3 | MR Neck | ./2.16.840.1.114222.4.11.1002/24839-3.json |
| 24840-1 | MR Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24840-1.json |
| 24841-9 | MR Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/24841-9.json |
| 24842-7 | US Neck | ./2.16.840.1.114222.4.11.1002/24842-7.json |
| 24843-5 | XR Neck Lateral | ./2.16.840.1.114222.4.11.1002/24843-5.json |
| 2484-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2484-4.json |
| 24844-3 | MRA Neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24844-3.json |
| 24845-0 | RF Neck Views W contrast intra larynx | ./2.16.840.1.114222.4.11.1002/24845-0.json |
| 24846-8 | XR Optic foramen Views | ./2.16.840.1.114222.4.11.1002/24846-8.json |
| 24848-4 | CT Orbit - bilateral | ./2.16.840.1.114222.4.11.1002/24848-4.json |
| 24849-2 | CT Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24849-2.json |
| 24850-0 | CT Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/24850-0.json |
| 2485-1 | Insulin-like growth factor-II [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2485-1.json |
| 24851-8 | MR Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24851-8.json |
| 24852-6 | MR Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/24852-6.json |
| 24853-4 | US Eye+Orbit - bilateral | ./2.16.840.1.114222.4.11.1002/24853-4.json |
| 24854-2 | XR Orbit - bilateral Views | ./2.16.840.1.114222.4.11.1002/24854-2.json |
| 24855-9 | RF videography Oropharynx Views | ./2.16.840.1.114222.4.11.1002/24855-9.json |
| 24856-7 | CT Guidance for fluid aspiration of Pancreas | ./2.16.840.1.114222.4.11.1002/24856-7.json |
| 24857-5 | CT Pancreas | ./2.16.840.1.114222.4.11.1002/24857-5.json |
| 24858-3 | CT Pancreas W contrast IV | ./2.16.840.1.114222.4.11.1002/24858-3.json |
| 24859-1 | US Pancreas | ./2.16.840.1.114222.4.11.1002/24859-1.json |
| 24860-9 | RFA Pancreatic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24860-9.json |
| 24861-7 | XR Patella 2 Views | ./2.16.840.1.114222.4.11.1002/24861-7.json |
| 24862-5 | RFA Iliac artery Internal Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24862-5.json |
| 24863-3 | CT Guidance for fluid aspiration of Pelvis | ./2.16.840.1.114222.4.11.1002/24863-3.json |
| 24864-1 | CT Guidance for biopsy of Pelvis | ./2.16.840.1.114222.4.11.1002/24864-1.json |
| 24865-8 | CT Pelvis | ./2.16.840.1.114222.4.11.1002/24865-8.json |
| 24866-6 | CT Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/24866-6.json |
| 24867-4 | MR Pelvis | ./2.16.840.1.114222.4.11.1002/24867-4.json |
| 24868-2 | US Guidance for drainage and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/24868-2.json |
| 2486-9 | Somatomedins [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2486-9.json |
| 24869-0 | US Pelvis | ./2.16.840.1.114222.4.11.1002/24869-0.json |
| 24870-8 | US.doppler Pelvis vessels | ./2.16.840.1.114222.4.11.1002/24870-8.json |
| 24871-6 | XR Pelvis Pelvimetry | ./2.16.840.1.114222.4.11.1002/24871-6.json |
| 24872-4 | MR Pelvis and Hip | ./2.16.840.1.114222.4.11.1002/24872-4.json |
| 24873-2 | MRA Pelvis vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/24873-2.json |
| 24874-0 | RFA Peripheral arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24874-0.json |
| 24876-5 | NM Head to Pelvis Views for shunt patency W Tc-99m DTPA IT | ./2.16.840.1.114222.4.11.1002/24876-5.json |
| 2487-7 | Inter alpha trypsin inhibitor [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2487-7.json |
| 24877-3 | CT Petrous part of temporal bone | ./2.16.840.1.114222.4.11.1002/24877-3.json |
| 24878-1 | CT Petrous part of temporal bone W contrast IV | ./2.16.840.1.114222.4.11.1002/24878-1.json |
| 24879-9 | MR Pituitary and Sella turcica WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24879-9.json |
| 24880-7 | MR Pituitary and Sella turcica | ./2.16.840.1.114222.4.11.1002/24880-7.json |
| 24881-5 | US Popliteal space | ./2.16.840.1.114222.4.11.1002/24881-5.json |
| 24882-3 | RFA Guidance for percutaneous transluminal angioplasty of Popliteal artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24882-3.json |
| 24883-1 | US Guidance for percutaneous biopsy of Prostate | ./2.16.840.1.114222.4.11.1002/24883-1.json |
| 24884-9 | US Prostate transrectal | ./2.16.840.1.114222.4.11.1002/24884-9.json |
| 2488-5 | Intrinsic factor [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2488-5.json |
| 24887-2 | RFA Guidance for embolectomy of Pulmonary arteries-- W contrast IA | ./2.16.840.1.114222.4.11.1002/24887-2.json |
| 24888-0 | NM Pulmonary system Ventilation and Perfusion W Xe-133 IH and W Tc-99m MAA IV | ./2.16.840.1.114222.4.11.1002/24888-0.json |
| 24889-8 | US Pylorus for pyloric stenosis | ./2.16.840.1.114222.4.11.1002/24889-8.json |
| 24891-4 | XR Radius and Ulna Views | ./2.16.840.1.114222.4.11.1002/24891-4.json |
| 24892-2 | US Rectum | ./2.16.840.1.114222.4.11.1002/24892-2.json |
| 2489-3 | Intrinsic factor blocking Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/2489-3.json |
| 24893-0 | RF Rectum Single view post contrast PR during defecation | ./2.16.840.1.114222.4.11.1002/24893-0.json |
| 24894-8 | RF Rectum and Urinary bladder Views W contrast PR and intra bladder during defecation and voiding | ./2.16.840.1.114222.4.11.1002/24894-8.json |
| 24896-3 | US Guidance for drainage and placement of drainage catheter of Kidney | ./2.16.840.1.114222.4.11.1002/24896-3.json |
| 24899-7 | XR Ribs Views | ./2.16.840.1.114222.4.11.1002/24899-7.json |
| 24900-3 | XR Sacroiliac Joint Views | ./2.16.840.1.114222.4.11.1002/24900-3.json |
| 2490-1 | Inulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2490-1.json |
| 24901-1 | CT Guidance for injection of Sacroiliac Joint | ./2.16.840.1.114222.4.11.1002/24901-1.json |
| 24902-9 | RF Salivary gland Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/24902-9.json |
| 24903-7 | XR Scapula Views | ./2.16.840.1.114222.4.11.1002/24903-7.json |
| 24904-5 | CT Pituitary and Sella turcica WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24904-5.json |
| 24905-2 | MR Shoulder | ./2.16.840.1.114222.4.11.1002/24905-2.json |
| 24906-0 | MR Shoulder WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24906-0.json |
| 24907-8 | US Shoulder | ./2.16.840.1.114222.4.11.1002/24907-8.json |
| 24908-6 | XR Shoulder 3 Views | ./2.16.840.1.114222.4.11.1002/24908-6.json |
| 24909-4 | XR Shoulder Views | ./2.16.840.1.114222.4.11.1002/24909-4.json |
| 24910-2 | RF Shoulder Arthrogram | ./2.16.840.1.114222.4.11.1002/24910-2.json |
| 24911-0 | RF Shunt Views | ./2.16.840.1.114222.4.11.1002/24911-0.json |
| 24912-8 | RF Sinus tract Views W contrast intra sinus tract | ./2.16.840.1.114222.4.11.1002/24912-8.json |
| 24913-6 | CT Sinuses limited | ./2.16.840.1.114222.4.11.1002/24913-6.json |
| 24914-4 | MR Sinuses | ./2.16.840.1.114222.4.11.1002/24914-4.json |
| 24915-1 | MR Sinuses W contrast IV | ./2.16.840.1.114222.4.11.1002/24915-1.json |
| 24916-9 | XR Sinuses Views | ./2.16.840.1.114222.4.11.1002/24916-9.json |
| 24917-7 | XR Skull Single view | ./2.16.840.1.114222.4.11.1002/24917-7.json |
| 24918-5 | XR Skull 3 Views | ./2.16.840.1.114222.4.11.1002/24918-5.json |
| 2491-9 | Inulin renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2491-9.json |
| 24919-3 | XR Skull AP and Lateral | ./2.16.840.1.114222.4.11.1002/24919-3.json |
| 24920-1 | XR Skull Lateral | ./2.16.840.1.114222.4.11.1002/24920-1.json |
| 24921-9 | XR Skull Waters | ./2.16.840.1.114222.4.11.1002/24921-9.json |
| 24922-7 | XR Skull 5 Views | ./2.16.840.1.114222.4.11.1002/24922-7.json |
| 24923-5 | RF Small bowel Views W positive contrast via enteroclysis tube | ./2.16.840.1.114222.4.11.1002/24923-5.json |
| 24924-3 | RF Small bowel Views W contrast PO | ./2.16.840.1.114222.4.11.1002/24924-3.json |
| 24925-0 | RFA Spinal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24925-0.json |
| 24926-8 | US Spine | ./2.16.840.1.114222.4.11.1002/24926-8.json |
| 2492-7 | Iodine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2492-7.json |
| 24927-6 | RF Spine Views W contrast intradisc | ./2.16.840.1.114222.4.11.1002/24927-6.json |
| 24928-4 | XR Spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/24928-4.json |
| 24929-2 | XR Thoracic and lumbar spine Views for scoliosis W flexion and W extension | ./2.16.840.1.114222.4.11.1002/24929-2.json |
| 24930-0 | XR Thoracic and lumbar spine Views for scoliosis | ./2.16.840.1.114222.4.11.1002/24930-0.json |
| 24931-8 | RF Guidance for injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/24931-8.json |
| 24932-6 | CT Cervical spine | ./2.16.840.1.114222.4.11.1002/24932-6.json |
| 24933-4 | CT Cervical spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24933-4.json |
| 24934-2 | CT Cervical spine W contrast IT | ./2.16.840.1.114222.4.11.1002/24934-2.json |
| 2493-5 | Iodine Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2493-5.json |
| 24935-9 | MR Cervical spine | ./2.16.840.1.114222.4.11.1002/24935-9.json |
| 24936-7 | MR Cervical spine W anesthesia | ./2.16.840.1.114222.4.11.1002/24936-7.json |
| 24937-5 | MR Cervical spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24937-5.json |
| 24938-3 | MR Cervical spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24938-3.json |
| 24939-1 | XR Cervical spine 5 Views | ./2.16.840.1.114222.4.11.1002/24939-1.json |
| 24940-9 | XR Cervical spine Single view | ./2.16.840.1.114222.4.11.1002/24940-9.json |
| 24941-7 | XR Cervical spine 3 Views | ./2.16.840.1.114222.4.11.1002/24941-7.json |
| 24942-5 | XR Cervical spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/24942-5.json |
| 2494-3 | Iodine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2494-3.json |
| 24943-3 | XR Cervical spine Lateral | ./2.16.840.1.114222.4.11.1002/24943-3.json |
| 24944-1 | XR Cervical spine Swimmers | ./2.16.840.1.114222.4.11.1002/24944-1.json |
| 24945-8 | XR Cervical spine Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/24945-8.json |
| 24946-6 | XR Cervical spine Views | ./2.16.840.1.114222.4.11.1002/24946-6.json |
| 24947-4 | RF Cervical spine Views W contrast IT | ./2.16.840.1.114222.4.11.1002/24947-4.json |
| 24948-2 | XR Spine Cervical Odontoid and Cervical axis AP | ./2.16.840.1.114222.4.11.1002/24948-2.json |
| 2495-0 | Iodine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2495-0.json |
| 24963-1 | CT Lumbar spine | ./2.16.840.1.114222.4.11.1002/24963-1.json |
| 24964-9 | CT Lumbar spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24964-9.json |
| 24965-6 | CT Lumbar spine W contrast IT | ./2.16.840.1.114222.4.11.1002/24965-6.json |
| 24967-2 | MR Lumbar spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24967-2.json |
| 2496-8 | Iodohippuran renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2496-8.json |
| 24968-0 | MR Lumbar spine | ./2.16.840.1.114222.4.11.1002/24968-0.json |
| 24969-8 | XR Lumbar spine Lateral | ./2.16.840.1.114222.4.11.1002/24969-8.json |
| 24970-6 | XR Lumbar spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/24970-6.json |
| 24971-4 | XR Lumbar spine Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/24971-4.json |
| 24972-2 | XR Lumbar spine Views | ./2.16.840.1.114222.4.11.1002/24972-2.json |
| 24973-0 | RF Guidance for fluid aspiration of Lumbar spine space | ./2.16.840.1.114222.4.11.1002/24973-0.json |
| 24974-8 | RF Lumbar spine Views W contrast IT | ./2.16.840.1.114222.4.11.1002/24974-8.json |
| 24975-5 | XR Spine.lumbar and Sacroiliac joint - bilateral Views | ./2.16.840.1.114222.4.11.1002/24975-5.json |
| 2497-6 | Iron [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/2497-6.json |
| 24977-1 | MR Lumbar spine W anesthesia | ./2.16.840.1.114222.4.11.1002/24977-1.json |
| 24978-9 | CT Thoracic spine | ./2.16.840.1.114222.4.11.1002/24978-9.json |
| 24979-7 | CT Thoracic spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24979-7.json |
| 24980-5 | MR Thoracic spine | ./2.16.840.1.114222.4.11.1002/24980-5.json |
| 24981-3 | MR Thoracic spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24981-3.json |
| 24982-1 | MR Thoracic spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24982-1.json |
| 24983-9 | XR Thoracic spine Views | ./2.16.840.1.114222.4.11.1002/24983-9.json |
| 2498-4 | Iron [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2498-4.json |
| 24984-7 | XR Thoracic and lumbar spine 2 Views | ./2.16.840.1.114222.4.11.1002/24984-7.json |
| 24985-4 | RF Thoracic spine Views W contrast IT | ./2.16.840.1.114222.4.11.1002/24985-4.json |
| 24986-2 | CT Guidance for biopsy of Spine | ./2.16.840.1.114222.4.11.1002/24986-2.json |
| 24987-0 | CT Spine W contrast IV | ./2.16.840.1.114222.4.11.1002/24987-0.json |
| 24988-8 | CT Spleen | ./2.16.840.1.114222.4.11.1002/24988-8.json |
| 24989-6 | CT Spleen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/24989-6.json |
| 24990-4 | US Spleen | ./2.16.840.1.114222.4.11.1002/24990-4.json |
| 24991-2 | RFA Splenic vein and Portal vein Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24991-2.json |
| 2499-2 | Iron [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2499-2.json |
| 24992-0 | RFA Splenic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/24992-0.json |
| 24994-6 | XR Sternum Views | ./2.16.840.1.114222.4.11.1002/24994-6.json |
| 24995-3 | RF Guidance for placement of tube in Stomach | ./2.16.840.1.114222.4.11.1002/24995-3.json |
| 24996-1 | RF Guidance for percutaneous replacement of gastrostomy of Stomach | ./2.16.840.1.114222.4.11.1002/24996-1.json |
| 24997-9 | NM Stomach Views for gastric emptying solid phase W Tc-99m SC PO | ./2.16.840.1.114222.4.11.1002/24997-9.json |
| 24998-7 | RF Placement check of gastrostomy tube W contrast via GI tube | ./2.16.840.1.114222.4.11.1002/24998-7.json |
| 24999-5 | MR Temporomandibular joint | ./2.16.840.1.114222.4.11.1002/24999-5.json |
| 25000-1 | XR Temporomandibular joint Views | ./2.16.840.1.114222.4.11.1002/25000-1.json |
| 25001-9 | NM Scrotum and testicle Views W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/25001-9.json |
| 25002-7 | US Scrotum and testicle | ./2.16.840.1.114222.4.11.1002/25002-7.json |
| 25003-5 | MRA Thigh vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/25003-5.json |
| 25005-0 | RFA Three vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/25005-0.json |
| 25006-8 | XR Thumb Views | ./2.16.840.1.114222.4.11.1002/25006-8.json |
| 2500-7 | Iron binding capacity [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2500-7.json |
| 25007-6 | NM Thyroid gland Views W I-131 IV | ./2.16.840.1.114222.4.11.1002/25007-6.json |
| 25008-4 | NM Thyroid gland Views and Views uptake W I-131 IV | ./2.16.840.1.114222.4.11.1002/25008-4.json |
| 25009-2 | US Guidance for biopsy of Thyroid gland | ./2.16.840.1.114222.4.11.1002/25009-2.json |
| 25010-0 | US Thyroid gland | ./2.16.840.1.114222.4.11.1002/25010-0.json |
| 25011-8 | XR Tibia and Fibula Views | ./2.16.840.1.114222.4.11.1002/25011-8.json |
| 25013-4 | XR Toes Views | ./2.16.840.1.114222.4.11.1002/25013-4.json |
| 25014-2 | RFA Two vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/25014-2.json |
| 2501-5 | Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2501-5.json |
| 25015-9 | Replacement of percutaneous gastrojejunostomy Upper GI tract Document | ./2.16.840.1.114222.4.11.1002/25015-9.json |
| 25016-7 | RF Urethra Views W contrast intra urethra | ./2.16.840.1.114222.4.11.1002/25016-7.json |
| 25017-5 | RF Urinary bladder and Urethra Views W contrast intra bladder | ./2.16.840.1.114222.4.11.1002/25017-5.json |
| 25018-3 | NM Urinary bladder Views | ./2.16.840.1.114222.4.11.1002/25018-3.json |
| 25019-1 | US Urinary bladder | ./2.16.840.1.114222.4.11.1002/25019-1.json |
| 25020-9 | RF Urinary bladder and Urethra Views W contrast retrograde via urethra | ./2.16.840.1.114222.4.11.1002/25020-9.json |
| 25022-5 | RF Uterus and Fallopian tubes Views W contrast IU | ./2.16.840.1.114222.4.11.1002/25022-5.json |
| 2502-3 | Iron saturation [Mass Fraction] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2502-3.json |
| 25023-3 | RFA Vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/25023-3.json |
| 25024-1 | RFA Guidance for placement of peripherally-inserted central venous catheter in Vein | ./2.16.840.1.114222.4.11.1002/25024-1.json |
| 25025-8 | RFA Vena cava Views W contrast IV | ./2.16.840.1.114222.4.11.1002/25025-8.json |
| 25026-6 | RFA Guidance for placement of venous filter in Inferior vena cava-- W contrast IV | ./2.16.840.1.114222.4.11.1002/25026-6.json |
| 25027-4 | Guidance for placement of large bore CV catheter in Vein | ./2.16.840.1.114222.4.11.1002/25027-4.json |
| 25028-2 | RFA Guidance for placement of catheter for infusion of thrombolytic in Vessel-- W contrast intravascular | ./2.16.840.1.114222.4.11.1002/25028-2.json |
| 25029-0 | RFA Guidance for placement of catheter for vasoconstrictor infusion in Vessels | ./2.16.840.1.114222.4.11.1002/25029-0.json |
| 25030-8 | RFA Abdominal arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/25030-8.json |
| 2503-1 | Iron.chelated [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2503-1.json |
| 25031-6 | NM Bone Views | ./2.16.840.1.114222.4.11.1002/25031-6.json |
| 25032-4 | NM Bone Views W In-111 tagged WBC IV | ./2.16.840.1.114222.4.11.1002/25032-4.json |
| 25033-2 | MR Wrist | ./2.16.840.1.114222.4.11.1002/25033-2.json |
| 25034-0 | RF Wrist Arthrogram | ./2.16.840.1.114222.4.11.1002/25034-0.json |
| 25035-7 | MR Wrist WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/25035-7.json |
| 25036-5 | US Wrist | ./2.16.840.1.114222.4.11.1002/25036-5.json |
| 25038-1 | Courtesy consultation Document | ./2.16.840.1.114222.4.11.1002/25038-1.json |
| 25039-9 | CT Unspecified body region limited | ./2.16.840.1.114222.4.11.1002/25039-9.json |
| 25041-5 | CT Guidance for aspiration or biopsy of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/25041-5.json |
| 25042-3 | CT Guidance for aspiration or biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25042-3.json |
| 25043-1 | CT Guidance for fluid aspiration of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25043-1.json |
| 25044-9 | CT Guidance for biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25044-9.json |
| 25045-6 | CT Unspecified body region | ./2.16.840.1.114222.4.11.1002/25045-6.json |
| 25046-4 | CT Unspecified body region W anesthesia | ./2.16.840.1.114222.4.11.1002/25046-4.json |
| 25047-2 | CT Unspecified body region W conscious sedation | ./2.16.840.1.114222.4.11.1002/25047-2.json |
| 2504-9 | Iron [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2504-9.json |
| 25053-0 | CT Guidance for radiosurgery of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25053-0.json |
| 25054-8 | CT Guidance for radiosurgery of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/25054-8.json |
| 25056-3 | MR Unspecified body region | ./2.16.840.1.114222.4.11.1002/25056-3.json |
| 25057-1 | MR Unspecified body region W conscious sedation | ./2.16.840.1.114222.4.11.1002/25057-1.json |
| 25058-9 | MRA Unspecified body region W contrast IV | ./2.16.840.1.114222.4.11.1002/25058-9.json |
| 25059-7 | US Guidance for biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25059-7.json |
| 25060-5 | US Unspecified body region No charge | ./2.16.840.1.114222.4.11.1002/25060-5.json |
| 25061-3 | US Unspecified body region | ./2.16.840.1.114222.4.11.1002/25061-3.json |
| 25062-1 | XR Unspecified body region Comparison view | ./2.16.840.1.114222.4.11.1002/25062-1.json |
| 25063-9 | RFA Vessel Single view W contrast IA | ./2.16.840.1.114222.4.11.1002/25063-9.json |
| 2506-4 | Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2506-4.json |
| 25064-7 | RFA Vessel Views for angioplasty W contrast IA | ./2.16.840.1.114222.4.11.1002/25064-7.json |
| 25065-4 | RF 15 minutes | ./2.16.840.1.114222.4.11.1002/25065-4.json |
| 25066-2 | RF 30 minutes | ./2.16.840.1.114222.4.11.1002/25066-2.json |
| 25067-0 | RF 45 minutes | ./2.16.840.1.114222.4.11.1002/25067-0.json |
| 25068-8 | RF 1 hour | ./2.16.840.1.114222.4.11.1002/25068-8.json |
| 25069-6 | RF Guidance for biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/25069-6.json |
| 25070-4 | RF Unspecified body region Views during surgery | ./2.16.840.1.114222.4.11.1002/25070-4.json |
| 25071-2 | XR tomography Unspecified body region | ./2.16.840.1.114222.4.11.1002/25071-2.json |
| 25072-0 | Guidance for placement of infusion port | ./2.16.840.1.114222.4.11.1002/25072-0.json |
| 25073-8 | RFA Guidance for removal of foreign body from Vessel | ./2.16.840.1.114222.4.11.1002/25073-8.json |
| 25074-6 | XR Zygomatic arch Views | ./2.16.840.1.114222.4.11.1002/25074-6.json |
| 25076-1 | RFA Hepatic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/25076-1.json |
| 25077-9 | RFA Guidance for placement of catheter in Hepatic artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/25077-9.json |
| 25078-7 | RF Guidance for placement of stent in Intrahepatic portal system | ./2.16.840.1.114222.4.11.1002/25078-7.json |
| 25079-5 | RFA Renal arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/25079-5.json |
| 25080-3 | RFA Renal vein - bilateral Views for renin sampling W contrast IV | ./2.16.840.1.114222.4.11.1002/25080-3.json |
| 25081-1 | RFA Guidance for angioplasty of Renal vessel-- W contrast IA | ./2.16.840.1.114222.4.11.1002/25081-1.json |
| 25083-7 | 2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25083-7.json |
| 25088-6 | 4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25088-6.json |
| 25090-2 | Benzoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25090-2.json |
| 25091-0 | C peptide/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25091-0.json |
| 25095-1 | Deoxypyridinoline/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25095-1.json |
| 25096-9 | Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/25096-9.json |
| 25099-3 | Ethylmalonate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25099-3.json |
| 25100-9 | Formate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25100-9.json |
| 25101-7 | Fumarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25101-7.json |
| 25102-5 | Galactose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25102-5.json |
| 25103-3 | Glutaconate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25103-3.json |
| 25104-1 | Glutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25104-1.json |
| 25105-8 | Glycerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25105-8.json |
| 25106-6 | Glycolate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25106-6.json |
| 25107-4 | Glyoxylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25107-4.json |
| 25110-8 | Hydroxyproline/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25110-8.json |
| 25111-6 | Isocitrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25111-6.json |
| 25112-4 | Lactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25112-4.json |
| 25113-2 | Malate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25113-2.json |
| 2511-4 | Keratan sulfate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2511-4.json |
| 25115-7 | Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25115-7.json |
| 25116-5 | Methylmalonate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25116-5.json |
| 25117-3 | Methylsuccinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25117-3.json |
| 25118-1 | Mevalonate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25118-1.json |
| 25119-9 | N-acetyltyrosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25119-9.json |
| 2512-2 | Keratan sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2512-2.json |
| 25123-1 | Para nitrophenol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25123-1.json |
| 25124-9 | Phenylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25124-9.json |
| 25125-6 | Phenyllactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25125-6.json |
| 25126-4 | Phenylpyruvate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25126-4.json |
| 25129-8 | Pyridinoline/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25129-8.json |
| 2513-0 | Ketones [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2513-0.json |
| 25130-6 | Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25130-6.json |
| 25131-4 | Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/25131-4.json |
| 25132-2 | Pyruvate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25132-2.json |
| 25135-5 | Suberate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25135-5.json |
| 25136-3 | Succinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25136-3.json |
| 25140-5 | Uracil/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25140-5.json |
| 25141-3 | Carnitine esters/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25141-3.json |
| 25142-1 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/25142-1.json |
| 25143-9 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/25143-9.json |
| 2514-8 | Ketones [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/2514-8.json |
| 2515-5 | Kynurenate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2515-5.json |
| 25156-1 | Eosinophils [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/25156-1.json |
| 2516-3 | L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2516-3.json |
| 25168-6 | Perhexiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25168-6.json |
| 25169-4 | Nickel [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25169-4.json |
| 25170-2 | Mercury [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25170-2.json |
| 2517-1 | L-iditol dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2517-1.json |
| 25171-0 | Bromide [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25171-0.json |
| 25172-8 | Fluoride [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25172-8.json |
| 25173-6 | Thallium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25173-6.json |
| 2518-9 | Lactate [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2518-9.json |
| 2519-7 | Lactate [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/2519-7.json |
| 2520-5 | Lactate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2520-5.json |
| 2521-3 | Lactate [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/2521-3.json |
| 2522-1 | Lactate [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/2522-1.json |
| 25232-0 | Nafcillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25232-0.json |
| 25233-8 | Azithromycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25233-8.json |
| 25234-6 | Aztreonam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25234-6.json |
| 25235-3 | ceFAZolin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25235-3.json |
| 25236-1 | Cefixime [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25236-1.json |
| 25237-9 | Cefonicid [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25237-9.json |
| 25238-7 | Cefotaxime [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25238-7.json |
| 2523-9 | Lactate [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2523-9.json |
| 25239-5 | cefoTEtan [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25239-5.json |
| 25240-3 | cefOXitin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25240-3.json |
| 25241-1 | Cefpodoxime [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25241-1.json |
| 25242-9 | Cefsulodin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25242-9.json |
| 25243-7 | Ceftizoxime [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25243-7.json |
| 25244-5 | cefTRIAXone [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25244-5.json |
| 25245-2 | Cefuroxime Parenteral [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25245-2.json |
| 25246-0 | Cephalothin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25246-0.json |
| 2524-7 | Lactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2524-7.json |
| 25247-8 | Chloramphenicol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25247-8.json |
| 25248-6 | Ciprofloxacin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25248-6.json |
| 25249-4 | Clindamycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25249-4.json |
| 25250-2 | Cloxacillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25250-2.json |
| 25251-0 | cycloSERINE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25251-0.json |
| 25252-8 | Dicloxacillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25252-8.json |
| 25253-6 | Clarithromycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25253-6.json |
| 2525-4 | Lactate [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/2525-4.json |
| 25254-4 | Ticarcillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25254-4.json |
| 25255-1 | Fluconazole [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25255-1.json |
| 25256-9 | Ganciclovir [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25256-9.json |
| 25257-7 | Imipenem [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25257-7.json |
| 25258-5 | Itraconazole [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25258-5.json |
| 25259-3 | Ketoconazole [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25259-3.json |
| 25261-9 | Nalidixate [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25261-9.json |
| 2526-2 | Lactate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2526-2.json |
| 25262-7 | Neomycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25262-7.json |
| 25263-5 | Netilmicin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25263-5.json |
| 25264-3 | Ofloxacin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25264-3.json |
| 25265-0 | Oxacillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25265-0.json |
| 25266-8 | Oxytetracycline [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25266-8.json |
| 25267-6 | Penicillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25267-6.json |
| 25268-4 | Piperacillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25268-4.json |
| 25269-2 | Polymyxin B [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25269-2.json |
| 2527-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2527-0.json |
| 25270-0 | Pyrazinamide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25270-0.json |
| 25271-8 | Sulfamethoxazole [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25271-8.json |
| 25272-6 | Tetracycline [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25272-6.json |
| 25274-2 | Amoxicillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25274-2.json |
| 25275-9 | Erythromycin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/25275-9.json |
| 25278-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/25278-3.json |
| 25279-1 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/25279-1.json |
| 25280-9 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/25280-9.json |
| 25285-8 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/25285-8.json |
| 2528-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2528-8.json |
| 25289-0 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/25289-0.json |
| 25295-7 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25295-7.json |
| 2529-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2529-6.json |
| 25296-5 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25296-5.json |
| 25297-3 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen | ./2.16.840.1.114222.4.11.1002/25297-3.json |
| 25302-1 | Alanine aminotransferase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25302-1.json |
| 25303-9 | Alpha 1 antitrypsin [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/25303-9.json |
| 2530-4 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/2530-4.json |
| 25308-8 | Ammonia [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25308-8.json |
| 25309-6 | Amobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25309-6.json |
| 25311-2 | Amylase [Enzymatic activity/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25311-2.json |
| 2531-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2531-2.json |
| 25314-6 | Androstenediol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25314-6.json |
| 25315-3 | 11-Deoxycortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25315-3.json |
| 25316-1 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25316-1.json |
| 25317-9 | 17-Ketosteroids [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25317-9.json |
| 2532-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2532-0.json |
| 25321-1 | Antimony [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25321-1.json |
| 25323-7 | Arsenic [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25323-7.json |
| 25324-5 | Arsenic/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25324-5.json |
| 25325-2 | Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25325-2.json |
| 25331-0 | Bordetella pertussis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25331-0.json |
| 25332-8 | Bordetella pertussis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25332-8.json |
| 25333-6 | Campylobacter fetus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25333-6.json |
| 25335-1 | Coxiella burnetii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25335-1.json |
| 25336-9 | Coxiella burnetii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25336-9.json |
| 25337-7 | Taenia solium larva IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25337-7.json |
| 2533-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/2533-8.json |
| 25338-5 | Dengue virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25338-5.json |
| 25339-3 | Echinococcus sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25339-3.json |
| 25342-7 | Fasciola sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25342-7.json |
| 25343-5 | Fasciola sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25343-5.json |
| 25344-3 | Filaria Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25344-3.json |
| 2534-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2534-6.json |
| 25349-2 | Silver Birch IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25349-2.json |
| 25351-8 | Bismuth [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25351-8.json |
| 25352-6 | Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25352-6.json |
| 25353-4 | Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25353-4.json |
| 25354-2 | Wheat Bran IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25354-2.json |
| 25357-5 | Butabarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25357-5.json |
| 25358-3 | C peptide [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25358-3.json |
| 25359-1 | Cadmium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25359-1.json |
| 25360-9 | Cadmium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25360-9.json |
| 25361-7 | Caffeine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25361-7.json |
| 25362-5 | Calcium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25362-5.json |
| 25363-3 | Campylobacter fetus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25363-3.json |
| 25364-1 | Campylobacter jejuni Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25364-1.json |
| 25369-0 | Chlamydia sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25369-0.json |
| 25372-4 | Choriogonadotropin [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25372-4.json |
| 25373-2 | Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25373-2.json |
| 25374-0 | Chromium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25374-0.json |
| 25375-7 | Chymotrypsin [Enzymatic activity/mass] in Stool | ./2.16.840.1.114222.4.11.1002/25375-7.json |
| 25378-1 | Cobalt [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25378-1.json |
| 25379-9 | Cobalt [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25379-9.json |
| 25381-5 | Corticosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25381-5.json |
| 25382-3 | Cortisone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25382-3.json |
| 25384-9 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25384-9.json |
| 25385-6 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25385-6.json |
| 25386-4 | Creatinine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25386-4.json |
| 25387-2 | Cyanide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25387-2.json |
| 25389-8 | Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25389-8.json |
| 25390-6 | Cytokeratin 19 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25390-6.json |
| 25391-4 | Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25391-4.json |
| 25392-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/25392-2.json |
| 25393-0 | Desethylamiodarone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25393-0.json |
| 25394-8 | Nortrimipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25394-8.json |
| 25397-1 | Echinococcus sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25397-1.json |
| 25398-9 | Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) | ./2.16.840.1.114222.4.11.1002/25398-9.json |
| 25399-7 | Endomysium Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25399-7.json |
| 25400-3 | Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25400-3.json |
| 25401-1 | Estradiol (E2) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25401-1.json |
| 25402-9 | Estrogen [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25402-9.json |
| 25403-7 | Estrone (E1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25403-7.json |
| 25404-5 | Ethambutol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25404-5.json |
| 25406-0 | Fasciola sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25406-0.json |
| 25407-8 | Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25407-8.json |
| 25409-4 | Filaria Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25409-4.json |
| 25410-2 | Filaria IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25410-2.json |
| 25412-8 | Flunitrazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25412-8.json |
| 25413-6 | Fluoride [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25413-6.json |
| 25415-1 | Folate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25415-1.json |
| 25416-9 | Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25416-9.json |
| 25417-7 | Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25417-7.json |
| 25418-5 | Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25418-5.json |
| 25419-3 | Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25419-3.json |
| 25420-1 | Rubella virus IgM Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/25420-1.json |
| 25421-9 | Measles virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25421-9.json |
| 25422-7 | Schistosoma sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25422-7.json |
| 25423-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25423-5.json |
| 25424-3 | Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25424-3.json |
| 25425-0 | Gabapentin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25425-0.json |
| 25426-8 | Galactose [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25426-8.json |
| 25428-4 | Glucose [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/25428-4.json |
| 25432-6 | Haemophilus influenzae Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25432-6.json |
| 25433-4 | Free Hemoglobin [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/25433-4.json |
| 25435-9 | Herpes simplex virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25435-9.json |
| 25439-1 | Histamine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25439-1.json |
| 25447-4 | Insulin Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25447-4.json |
| 25448-2 | Iodine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25448-2.json |
| 25449-0 | Iodine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25449-0.json |
| 25451-6 | Isoniazid [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25451-6.json |
| 25453-2 | Lactalbumin alpha IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25453-2.json |
| 25455-7 | Lactoglobulin IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25455-7.json |
| 25458-1 | lamoTRIgine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25458-1.json |
| 25459-9 | Lead [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25459-9.json |
| 25461-5 | Lithium, [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25461-5.json |
| 25462-3 | Lithium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/25462-3.json |
| 25463-1 | Lithium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25463-1.json |
| 25466-4 | Manganese [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25466-4.json |
| 25467-2 | Manganese [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25467-2.json |
| 25468-0 | Mephenytoin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25468-0.json |
| 25469-8 | Meprobamate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25469-8.json |
| 25470-6 | Mercury [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/25470-6.json |
| 25471-4 | Mercury [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25471-4.json |
| 25472-2 | Mesoridazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25472-2.json |
| 25473-0 | Metanephrine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25473-0.json |
| 25474-8 | Metanephrines [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25474-8.json |
| 25475-5 | Methaqualone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25475-5.json |
| 25477-1 | Methionine sulfoxide [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25477-1.json |
| 25478-9 | Methyprylon [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25478-9.json |
| 25479-7 | Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25479-7.json |
| 25481-3 | Molybdenum [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25481-3.json |
| 25484-7 | Nefazodone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25484-7.json |
| 25486-2 | Nickel [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25486-2.json |
| 25487-0 | Nickel [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25487-0.json |
| 25488-8 | Nicotinamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25488-8.json |
| 25489-6 | Normetanephrine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25489-6.json |
| 25492-0 | Oxipurinol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25492-0.json |
| 25498-7 | Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25498-7.json |
| 25499-5 | Adrenal cortex Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25499-5.json |
| 25500-0 | Phenylbutazone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25500-0.json |
| 25501-8 | Phosphate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25501-8.json |
| 25505-9 | Pituitary glycoprotein hormone.alpha subunit [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25505-9.json |
| 25506-7 | Potassium [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/25506-7.json |
| 25507-5 | Pregnenolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25507-5.json |
| 2551-0 | Lactoferrin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2551-0.json |
| 25511-7 | Propafenone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25511-7.json |
| 25514-1 | Rubella virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25514-1.json |
| 25520-8 | Secobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25520-8.json |
| 25521-6 | Selenium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25521-6.json |
| 25524-0 | Serotonin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/25524-0.json |
| 25526-5 | Silicon [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25526-5.json |
| 25527-3 | Silver [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25527-3.json |
| 2552-8 | Lactose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2552-8.json |
| 25528-1 | Insulin-like growth factor [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25528-1.json |
| 25529-9 | Somatotropin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25529-9.json |
| 25531-5 | Streptococcus pneumoniae Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25531-5.json |
| 25534-9 | Teicoplanin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/25534-9.json |
| 25535-6 | Teicoplanin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/25535-6.json |
| 2553-6 | Lactose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2553-6.json |
| 25537-2 | Thallium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25537-2.json |
| 25538-0 | Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25538-0.json |
| 25541-4 | Topiramate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25541-4.json |
| 25542-2 | Toxoplasma gondii IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25542-2.json |
| 25543-0 | Lipase [Enzymatic activity/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25543-0.json |
| 2554-4 | Lactose [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2554-4.json |
| 25548-9 | Urate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25548-9.json |
| 25549-7 | Urea [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25549-7.json |
| 25550-5 | Urea [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25550-5.json |
| 2555-1 | Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2555-1.json |
| 25551-3 | Urobilinogen [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/25551-3.json |
| 25555-4 | Wuchereria bancrofti Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25555-4.json |
| 25556-2 | Xylose [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25556-2.json |
| 25557-0 | Zinc [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/25557-0.json |
| 25559-6 | Zolpidem [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25559-6.json |
| 25560-4 | Allobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25560-4.json |
| 25561-2 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25561-2.json |
| 25562-0 | Angiotensin II [Moles/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/25562-0.json |
| 25563-8 | Angiotensin II [Moles/volume] in Plasma --upright | ./2.16.840.1.114222.4.11.1002/25563-8.json |
| 25564-6 | Bilirubin.direct [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/25564-6.json |
| 25565-3 | Bougainvillea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25565-3.json |
| 2556-9 | Lecithin phosphorus [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2556-9.json |
| 2557-7 | Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2557-7.json |
| 25583-6 | Calcium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/25583-6.json |
| 25587-7 | Chromogranin A [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25587-7.json |
| 25589-3 | Citalopram [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25589-3.json |
| 25593-5 | Rotavirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25593-5.json |
| 25598-4 | Cladosporium cladosporioides IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25598-4.json |
| 25599-2 | Rotavirus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25599-2.json |
| 25600-8 | Rotavirus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25600-8.json |
| 25601-6 | Rotavirus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/25601-6.json |
| 25603-2 | Rickettsia prowazekii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25603-2.json |
| 25604-0 | Rickettsia prowazekii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25604-0.json |
| 25609-9 | Cochineal extract IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25609-9.json |
| 25611-5 | Oriental Cockroach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25611-5.json |
| 25613-1 | Smoky Brown Cockroach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25613-1.json |
| 25615-6 | Conalbumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25615-6.json |
| 25630-5 | Parvovirus B19 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25630-5.json |
| 25631-3 | Parvovirus B19 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25631-3.json |
| 25632-1 | Plasmodium sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25632-1.json |
| 25633-9 | Leishmania donovani Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25633-9.json |
| 2563-5 | Leukocyte esterase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2563-5.json |
| 25638-8 | Eosinophil cationic protein (ECP) [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25638-8.json |
| 25639-6 | Follitropin [Units/volume] in Urine by 2nd IRP | ./2.16.840.1.114222.4.11.1002/25639-6.json |
| 25664-4 | Glucose [Mass/volume] in Urine --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/25664-4.json |
| 25665-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/25665-1.json |
| 25667-7 | Glucose [Mass/volume] in Urine --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/25667-7.json |
| 25668-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/25668-5.json |
| 2567-6 | Phospholipid phosphorus [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2567-6.json |
| 256-8 | Foscarnet [Susceptibility] | ./2.16.840.1.114222.4.11.1002/256-8.json |
| 25681-8 | Kappa light chains [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/25681-8.json |
| 25682-6 | Kappa light chains [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25682-6.json |
| 25683-4 | Lambda light chains [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/25683-4.json |
| 2568-4 | Phospholipid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2568-4.json |
| 25684-2 | Lambda light chains [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25684-2.json |
| 2569-2 | Lipids [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2569-2.json |
| 2570-0 | Fat [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/2570-0.json |
| 25703-0 | Jujube IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25703-0.json |
| 25708-9 | Leishmania donovani Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25708-9.json |
| 25709-7 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25709-7.json |
| 25710-5 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25710-5.json |
| 25711-3 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25711-3.json |
| 25712-1 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25712-1.json |
| 25714-7 | Litchi IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25714-7.json |
| 25716-2 | Lutropin [Units/volume] in Urine by 1st IRP | ./2.16.840.1.114222.4.11.1002/25716-2.json |
| 2571-8 | Triglyceride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2571-8.json |
| 25721-2 | Mianserin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25721-2.json |
| 25725-3 | Ovary Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25725-3.json |
| 2572-6 | Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2572-6.json |
| 25726-1 | OXcarbazepine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25726-1.json |
| 25729-5 | Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25729-5.json |
| 25730-3 | Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25730-3.json |
| 25731-1 | Plasmodium sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25731-1.json |
| 25732-9 | Pregnanetriolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25732-9.json |
| 25733-7 | Procollagen type III [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25733-7.json |
| 2573-4 | Lipoprotein.alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2573-4.json |
| 25742-8 | Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25742-8.json |
| 25743-6 | Quinoa IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25743-6.json |
| 25745-1 | Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/25745-1.json |
| 25746-9 | Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/25746-9.json |
| 25747-7 | Ribosomal Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25747-7.json |
| 25748-5 | Ribosomal Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25748-5.json |
| 25749-3 | Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25749-3.json |
| 25750-1 | Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25750-1.json |
| 25751-9 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25751-9.json |
| 25752-7 | Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25752-7.json |
| 25753-5 | Rotavirus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25753-5.json |
| 25754-3 | Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25754-3.json |
| 25755-0 | Rotavirus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25755-0.json |
| 25756-8 | Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25756-8.json |
| 25757-6 | Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/25757-6.json |
| 2577-5 | Lithocholate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2577-5.json |
| 25779-0 | Stachybotrys chartarum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25779-0.json |
| 2578-3 | Lutropin [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2578-3.json |
| 25788-1 | Streptolysin O Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/25788-1.json |
| 2579-1 | Lutropin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2579-1.json |
| 25799-8 | Tissue polypeptide specific Ag [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/25799-8.json |
| 25801-2 | Trichophyton mentagrophytes var interdigitale IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25801-2.json |
| 2580-9 | Lutropin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2580-9.json |
| 25812-9 | Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25812-9.json |
| 25813-7 | Trypanosoma cruzi Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25813-7.json |
| 25816-0 | Vigabatrin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/25816-0.json |
| 2581-7 | Gonadotropin releasing hormone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2581-7.json |
| 25821-0 | Staphylococcus aureus enterotoxin A IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25821-0.json |
| 25822-8 | Staphylococcus aureus enterotoxin B IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25822-8.json |
| 25824-4 | Staphylococcus aureus enterotoxin C IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25824-4.json |
| 2582-5 | Lutropin.alpha subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2582-5.json |
| 25826-9 | Staphylococcus aureus enterotoxin D IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25826-9.json |
| 25828-5 | Palo verde IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/25828-5.json |
| 25829-3 | Glucosylceramidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/25829-3.json |
| 25831-9 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/25831-9.json |
| 2583-3 | Lutropin.beta subunit [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2583-3.json |
| 25834-3 | Cancer associated retinopathy Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/25834-3.json |
| 25835-0 | HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/25835-0.json |
| 25836-8 | HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/25836-8.json |
| 25837-6 | Herpes simplex virus 1 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25837-6.json |
| 25838-4 | Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25838-4.json |
| 25839-2 | Herpes simplex virus 2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25839-2.json |
| 25840-0 | Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25840-0.json |
| 25841-8 | HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/25841-8.json |
| 25842-6 | HIV 2 proviral DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/25842-6.json |
| 25845-9 | Aldosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25845-9.json |
| 25850-9 | Ammonia [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25850-9.json |
| 25851-7 | Ammonia/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25851-7.json |
| 25852-5 | 17-Hydroxycorticosteroids [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25852-5.json |
| 25855-8 | 3-Alpha-Androstanediol glucuronide [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25855-8.json |
| 25866-5 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25866-5.json |
| 25867-3 | Echinococcus sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/25867-3.json |
| 25872-3 | C peptide [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25872-3.json |
| 25876-4 | Citrate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25876-4.json |
| 25879-8 | Copper [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25879-8.json |
| 25880-6 | Copper/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/25880-6.json |
| 2588-2 | Lysolecithin acyltransferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2588-2.json |
| 25882-2 | Cortisol Free [Moles/volume] in 24 hour Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/25882-2.json |
| 25883-0 | Cortisol Free [Moles/volume] in 24 hour Urine by HPLC | ./2.16.840.1.114222.4.11.1002/25883-0.json |
| 25884-8 | Cortisol Free [Moles/time] in 24 hour Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/25884-8.json |
| 25885-5 | Cortisol Free [Moles/time] in 24 hour Urine by HPLC | ./2.16.840.1.114222.4.11.1002/25885-5.json |
| 25886-3 | Creatinine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25886-3.json |
| 2589-0 | Lysozyme [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2589-0.json |
| 25894-7 | Cystine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25894-7.json |
| 25895-4 | Dehydroepiandrosterone (DHEA) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25895-4.json |
| 25896-2 | Delta aminolevulinate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25896-2.json |
| 25897-0 | Delta aminolevulinate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25897-0.json |
| 25898-8 | Deoxypyridinoline [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25898-8.json |
| 25906-9 | DOPamine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25906-9.json |
| 25907-7 | Elastase.pancreatic [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/25907-7.json |
| 2590-8 | Lysozyme [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2590-8.json |
| 25908-5 | EPINEPHrine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25908-5.json |
| 25909-3 | EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25909-3.json |
| 25912-7 | Fluoride [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25912-7.json |
| 25913-5 | Fluoride/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25913-5.json |
| 2591-6 | Macroamylase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2591-6.json |
| 25916-8 | Glucose [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25916-8.json |
| 2592-4 | Macroglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2592-4.json |
| 25925-9 | Histamine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25925-9.json |
| 25930-9 | Homovanillate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25930-9.json |
| 25931-7 | Homovanillate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25931-7.json |
| 2593-2 | Magnesium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2593-2.json |
| 25934-1 | Hydroxyproline [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25934-1.json |
| 25936-6 | Iodine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25936-6.json |
| 25937-4 | Iron [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25937-4.json |
| 2594-0 | Magnesium [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2594-0.json |
| 25940-8 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/25940-8.json |
| 25954-9 | Magnesium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25954-9.json |
| 25955-6 | Metanephrine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25955-6.json |
| 2595-7 | Magnesium [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2595-7.json |
| 25957-2 | Methionine sulfoxide [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25957-2.json |
| 25958-0 | Methionine sulfoxide/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25958-0.json |
| 25961-4 | Nickel [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25961-4.json |
| 25962-2 | Nickel/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25962-2.json |
| 25963-0 | Norepinephrine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25963-0.json |
| 25964-8 | Normetanephrine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25964-8.json |
| 2596-5 | Magnesium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2596-5.json |
| 25971-3 | 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25971-3.json |
| 25972-1 | Adenosine monophosphate.cyclic/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25972-1.json |
| 2597-3 | Magnesium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2597-3.json |
| 25973-9 | Phosphate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25973-9.json |
| 25977-0 | Pyridinoline [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25977-0.json |
| 2598-1 | Magnesium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2598-1.json |
| 25981-2 | Serotonin [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25981-2.json |
| 25986-1 | Testosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25986-1.json |
| 25987-9 | Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/25987-9.json |
| 25992-9 | Lipase [Enzymatic activity/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25992-9.json |
| 25993-7 | Trichinella spiralis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/25993-7.json |
| 25997-8 | Urate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25997-8.json |
| 25998-6 | Urea [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25998-6.json |
| 2599-9 | Magnesium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2599-9.json |
| 25999-4 | Urea/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/25999-4.json |
| 26003-4 | Vanillylmandelate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26003-4.json |
| 26004-2 | Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26004-2.json |
| 2600-5 | Magnesium Ionized [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2600-5.json |
| 26006-7 | Borrelia burgdorferi Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/26006-7.json |
| 26007-5 | Echinococcus sp Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/26007-5.json |
| 26008-3 | Echinococcus sp Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/26008-3.json |
| 26009-1 | Treponema pallidum Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/26009-1.json |
| 2601-3 | Magnesium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2601-3.json |
| 26014-1 | Arbovirus NOS Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/26014-1.json |
| 2602-1 | Malate dehydrogenase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2602-1.json |
| 26021-6 | Nordiazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26021-6.json |
| 26022-4 | Enterovirus NOS Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/26022-4.json |
| 26023-2 | Extractable nuclear Ab identified in Serum | ./2.16.840.1.114222.4.11.1002/26023-2.json |
| 26024-0 | Gastrin [Moles/volume] in Serum or Plasma --post meal | ./2.16.840.1.114222.4.11.1002/26024-0.json |
| 26028-1 | HLA-B27 [Presence] by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/26028-1.json |
| 26029-9 | Lactoferrin bovine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26029-9.json |
| 26031-5 | Sialate.lipid bound [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26031-5.json |
| 26035-6 | Serotonin [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/26035-6.json |
| 26037-2 | Trichophyton mentagrophytes var goetzii IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26037-2.json |
| 2603-9 | Malonate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2603-9.json |
| 26039-8 | Norflunitrazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26039-8.json |
| 26040-6 | Norcitalopram [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26040-6.json |
| 26041-4 | Normephenytoin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26041-4.json |
| 26042-2 | Didesmethylcitalopram [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26042-2.json |
| 26043-0 | HLA-B27 [Presence] by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/26043-0.json |
| 26044-8 | Pepsin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26044-8.json |
| 26045-5 | Pheneturide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26045-5.json |
| 26046-3 | 5-Hydroxypropafenone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26046-3.json |
| 2604-7 | Mannitol renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2604-7.json |
| 26047-1 | Phytate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26047-1.json |
| 26049-7 | Cedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26049-7.json |
| 26053-9 | N-methylhistamine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26053-9.json |
| 2605-4 | Meat fibers [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/2605-4.json |
| 26054-7 | Mitochondria M2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26054-7.json |
| 26058-8 | European tick borne encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/26058-8.json |
| 26059-6 | European tick borne encephalitis virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26059-6.json |
| 26060-4 | European tick borne encephalitis virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26060-4.json |
| 26061-2 | European tick borne encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/26061-2.json |
| 2606-2 | Melanin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2606-2.json |
| 26062-0 | European tick borne encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26062-0.json |
| 26063-8 | European tick borne encephalitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26063-8.json |
| 26064-6 | RFA Vein - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/26064-6.json |
| 26065-3 | RFA Vein - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/26065-3.json |
| 26066-1 | RFA Vein - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/26066-1.json |
| 26067-9 | RF Salivary gland - bilateral Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/26067-9.json |
| 26068-7 | RF Salivary gland - left Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/26068-7.json |
| 26069-5 | RF Salivary gland - right Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/26069-5.json |
| 2607-0 | Melanin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2607-0.json |
| 26070-3 | RF Hip - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/26070-3.json |
| 26071-1 | RF Hip - left Arthrogram | ./2.16.840.1.114222.4.11.1002/26071-1.json |
| 26072-9 | RF Hip - right Arthrogram | ./2.16.840.1.114222.4.11.1002/26072-9.json |
| 26073-7 | RF Knee - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/26073-7.json |
| 26074-5 | RF Knee - left Arthrogram | ./2.16.840.1.114222.4.11.1002/26074-5.json |
| 26075-2 | RF Knee - right Arthrogram | ./2.16.840.1.114222.4.11.1002/26075-2.json |
| 26076-0 | RF Shoulder - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/26076-0.json |
| 26077-8 | RF Shoulder - left Arthrogram | ./2.16.840.1.114222.4.11.1002/26077-8.json |
| 26078-6 | RF Shoulder - right Arthrogram | ./2.16.840.1.114222.4.11.1002/26078-6.json |
| 26079-4 | RFA Carotid arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26079-4.json |
| 26080-2 | RFA Carotid arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26080-2.json |
| 26081-0 | RFA Carotid arteries -right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26081-0.json |
| 26082-8 | RFA Spinal artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26082-8.json |
| 26083-6 | RFA Spinal artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26083-6.json |
| 26084-4 | RFA Spinal artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/26084-4.json |
| 26085-1 | XR Knee - bilateral Views W standing | ./2.16.840.1.114222.4.11.1002/26085-1.json |
| 26086-9 | XR Knee - left Views W standing | ./2.16.840.1.114222.4.11.1002/26086-9.json |
| 26087-7 | XR Knee - right Views W standing | ./2.16.840.1.114222.4.11.1002/26087-7.json |
| 2608-8 | Metanephrines [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2608-8.json |
| 26088-5 | NM Knee - bilateral Views | ./2.16.840.1.114222.4.11.1002/26088-5.json |
| 26089-3 | NM Knee - left Views | ./2.16.840.1.114222.4.11.1002/26089-3.json |
| 26090-1 | NM Knee - right Views | ./2.16.840.1.114222.4.11.1002/26090-1.json |
| 26091-9 | NM Scrotum and Testicle - bilateral Views W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/26091-9.json |
| 26092-7 | NM Scrotum and Testicle - left Views W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/26092-7.json |
| 26093-5 | NM Scrotum and Testicle - right Views W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/26093-5.json |
| 26094-3 | XR Foot - bilateral Views W standing | ./2.16.840.1.114222.4.11.1002/26094-3.json |
| 26095-0 | XR Foot - left Views W standing | ./2.16.840.1.114222.4.11.1002/26095-0.json |
| 2609-6 | Metanephrines [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2609-6.json |
| 26096-8 | XR Foot - right Views W standing | ./2.16.840.1.114222.4.11.1002/26096-8.json |
| 26097-6 | XR Ankle - bilateral Views | ./2.16.840.1.114222.4.11.1002/26097-6.json |
| 26098-4 | XR Ankle - left Views | ./2.16.840.1.114222.4.11.1002/26098-4.json |
| 26099-2 | XR Ankle - right Views | ./2.16.840.1.114222.4.11.1002/26099-2.json |
| 26100-8 | XR Calcaneus - bilateral Views | ./2.16.840.1.114222.4.11.1002/26100-8.json |
| 26101-6 | XR Calcaneus - left Views | ./2.16.840.1.114222.4.11.1002/26101-6.json |
| 26102-4 | XR Calcaneus - right Views | ./2.16.840.1.114222.4.11.1002/26102-4.json |
| 2610-4 | Methane [Mass/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/2610-4.json |
| 26106-5 | XR Clavicle - bilateral Views | ./2.16.840.1.114222.4.11.1002/26106-5.json |
| 26107-3 | XR Clavicle - left Views | ./2.16.840.1.114222.4.11.1002/26107-3.json |
| 26108-1 | XR Clavicle - right Views | ./2.16.840.1.114222.4.11.1002/26108-1.json |
| 26109-9 | XR Elbow - bilateral Views | ./2.16.840.1.114222.4.11.1002/26109-9.json |
| 26110-7 | XR Elbow - left Views | ./2.16.840.1.114222.4.11.1002/26110-7.json |
| 26111-5 | XR Elbow - right Views | ./2.16.840.1.114222.4.11.1002/26111-5.json |
| 26112-3 | XR Lower extremity - bilateral Views | ./2.16.840.1.114222.4.11.1002/26112-3.json |
| 26113-1 | XR Lower extremity - left Views | ./2.16.840.1.114222.4.11.1002/26113-1.json |
| 26114-9 | XR Lower extremity - right Views | ./2.16.840.1.114222.4.11.1002/26114-9.json |
| 26115-6 | XR Upper extremity - bilateral Views | ./2.16.840.1.114222.4.11.1002/26115-6.json |
| 26116-4 | XR Upper extremity - left Views | ./2.16.840.1.114222.4.11.1002/26116-4.json |
| 26117-2 | XR Upper extremity - right Views | ./2.16.840.1.114222.4.11.1002/26117-2.json |
| 26118-0 | XR Femur - bilateral Views | ./2.16.840.1.114222.4.11.1002/26118-0.json |
| 2612-0 | Methemalbumin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2612-0.json |
| 26120-6 | XR Femur - left Views | ./2.16.840.1.114222.4.11.1002/26120-6.json |
| 26122-2 | XR Femur - right Views | ./2.16.840.1.114222.4.11.1002/26122-2.json |
| 26124-8 | XR Finger - bilateral Views | ./2.16.840.1.114222.4.11.1002/26124-8.json |
| 26125-5 | XR Finger - left Views | ./2.16.840.1.114222.4.11.1002/26125-5.json |
| 26126-3 | XR Finger - right Views | ./2.16.840.1.114222.4.11.1002/26126-3.json |
| 26127-1 | XR Foot - bilateral Views | ./2.16.840.1.114222.4.11.1002/26127-1.json |
| 26128-9 | XR Foot - left Views | ./2.16.840.1.114222.4.11.1002/26128-9.json |
| 26129-7 | XR Foot - right Views | ./2.16.840.1.114222.4.11.1002/26129-7.json |
| 26130-5 | XR Hip - bilateral Views | ./2.16.840.1.114222.4.11.1002/26130-5.json |
| 26131-3 | XR Hip - left Views | ./2.16.840.1.114222.4.11.1002/26131-3.json |
| 26132-1 | XR Hip - right Views | ./2.16.840.1.114222.4.11.1002/26132-1.json |
| 26133-9 | XR Acetabulum - bilateral Views | ./2.16.840.1.114222.4.11.1002/26133-9.json |
| 26134-7 | XR Acetabulum - left Views | ./2.16.840.1.114222.4.11.1002/26134-7.json |
| 26135-4 | XR Acetabulum - right Views | ./2.16.840.1.114222.4.11.1002/26135-4.json |
| 26136-2 | XR Acromioclavicular joint - bilateral Views | ./2.16.840.1.114222.4.11.1002/26136-2.json |
| 26137-0 | XR Acromioclavicular joint - left Views | ./2.16.840.1.114222.4.11.1002/26137-0.json |
| 2613-8 | Methemoglobin [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2613-8.json |
| 26138-8 | XR Acromioclavicular joint - right Views | ./2.16.840.1.114222.4.11.1002/26138-8.json |
| 26139-6 | XR Mastoid - bilateral Views | ./2.16.840.1.114222.4.11.1002/26139-6.json |
| 26140-4 | XR Mastoid - left Views | ./2.16.840.1.114222.4.11.1002/26140-4.json |
| 26141-2 | XR Mastoid - right Views | ./2.16.840.1.114222.4.11.1002/26141-2.json |
| 26142-0 | XR Optic foramen - bilateral Views | ./2.16.840.1.114222.4.11.1002/26142-0.json |
| 26143-8 | XR Optic foramen - left Views | ./2.16.840.1.114222.4.11.1002/26143-8.json |
| 26144-6 | XR Optic foramen - right Views | ./2.16.840.1.114222.4.11.1002/26144-6.json |
| 2614-6 | Methemoglobin/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/2614-6.json |
| 26146-1 | XR Radius and Ulna - bilateral Views | ./2.16.840.1.114222.4.11.1002/26146-1.json |
| 26148-7 | XR Radius and Ulna - left Views | ./2.16.840.1.114222.4.11.1002/26148-7.json |
| 26150-3 | XR Radius and Ulna - right Views | ./2.16.840.1.114222.4.11.1002/26150-3.json |
| 26151-1 | XR Ribs - bilateral Views | ./2.16.840.1.114222.4.11.1002/26151-1.json |
| 26152-9 | XR Ribs - left Views | ./2.16.840.1.114222.4.11.1002/26152-9.json |
| 26153-7 | XR Ribs - right Views | ./2.16.840.1.114222.4.11.1002/26153-7.json |
| 26154-5 | XR Scapula - bilateral Views | ./2.16.840.1.114222.4.11.1002/26154-5.json |
| 26155-2 | XR Scapula - left Views | ./2.16.840.1.114222.4.11.1002/26155-2.json |
| 26156-0 | XR Scapula - right Views | ./2.16.840.1.114222.4.11.1002/26156-0.json |
| 26157-8 | XR Shoulder - bilateral Views | ./2.16.840.1.114222.4.11.1002/26157-8.json |
| 26158-6 | XR Shoulder - left Views | ./2.16.840.1.114222.4.11.1002/26158-6.json |
| 26159-4 | XR Shoulder - right Views | ./2.16.840.1.114222.4.11.1002/26159-4.json |
| 26160-2 | XR Thumb - bilateral Views | ./2.16.840.1.114222.4.11.1002/26160-2.json |
| 26161-0 | XR Thumb - left Views | ./2.16.840.1.114222.4.11.1002/26161-0.json |
| 26162-8 | XR Thumb - right Views | ./2.16.840.1.114222.4.11.1002/26162-8.json |
| 26163-6 | XR Tibia and Fibula - bilateral Views | ./2.16.840.1.114222.4.11.1002/26163-6.json |
| 26164-4 | XR Tibia and Fibula - left Views | ./2.16.840.1.114222.4.11.1002/26164-4.json |
| 26165-1 | XR Tibia and Fibula - right Views | ./2.16.840.1.114222.4.11.1002/26165-1.json |
| 26166-9 | XR Toes - bilateral Views | ./2.16.840.1.114222.4.11.1002/26166-9.json |
| 26167-7 | XR Toes - left Views | ./2.16.840.1.114222.4.11.1002/26167-7.json |
| 26168-5 | XR Toes - right Views | ./2.16.840.1.114222.4.11.1002/26168-5.json |
| 26169-3 | XR Wrist - bilateral Views | ./2.16.840.1.114222.4.11.1002/26169-3.json |
| 26170-1 | XR Wrist - left Views | ./2.16.840.1.114222.4.11.1002/26170-1.json |
| 26171-9 | XR Wrist - right Views | ./2.16.840.1.114222.4.11.1002/26171-9.json |
| 26172-7 | XR Zygomatic arch - bilateral Views | ./2.16.840.1.114222.4.11.1002/26172-7.json |
| 26173-5 | XR Zygomatic arch - left Views | ./2.16.840.1.114222.4.11.1002/26173-5.json |
| 26174-3 | XR Zygomatic arch - right Views | ./2.16.840.1.114222.4.11.1002/26174-3.json |
| 26175-0 | MG Breast - bilateral Screening | ./2.16.840.1.114222.4.11.1002/26175-0.json |
| 26176-8 | MG Breast - left Screening | ./2.16.840.1.114222.4.11.1002/26176-8.json |
| 26177-6 | MG Breast - right Screening | ./2.16.840.1.114222.4.11.1002/26177-6.json |
| 26178-4 | RFA Femoral artery - bilateral Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/26178-4.json |
| 26179-2 | RFA Femoral artery - left Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/26179-2.json |
| 26180-0 | RFA Femoral artery - right Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/26180-0.json |
| 26181-8 | MRA Thoracic inlet vessels - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/26181-8.json |
| 26182-6 | MRA Thoracic inlet vessels - left W contrast IV | ./2.16.840.1.114222.4.11.1002/26182-6.json |
| 26183-4 | MRA Thoracic inlet vessels - right W contrast IV | ./2.16.840.1.114222.4.11.1002/26183-4.json |
| 26184-2 | CT Extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/26184-2.json |
| 26185-9 | CT Extremity - left W contrast IV | ./2.16.840.1.114222.4.11.1002/26185-9.json |
| 26186-7 | CT Extremity - right W contrast IV | ./2.16.840.1.114222.4.11.1002/26186-7.json |
| 26187-5 | MR Ankle - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26187-5.json |
| 26188-3 | MR Ankle - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26188-3.json |
| 26189-1 | MR Ankle - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26189-1.json |
| 26190-9 | MR Brachial plexus - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26190-9.json |
| 26191-7 | MR Brachial plexus - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26191-7.json |
| 26192-5 | MR Brachial plexus - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26192-5.json |
| 26193-3 | MR Elbow - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26193-3.json |
| 26194-1 | MR Elbow - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26194-1.json |
| 2619-5 | Methemoglobin [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2619-5.json |
| 26195-8 | MR Elbow - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26195-8.json |
| 26196-6 | MR Thigh - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26196-6.json |
| 26197-4 | MR Thigh - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26197-4.json |
| 26198-2 | MR Thigh - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26198-2.json |
| 26199-0 | MR Knee - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26199-0.json |
| 26200-6 | MR Knee - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26200-6.json |
| 26201-4 | MR Knee - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26201-4.json |
| 26202-2 | MR Shoulder - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26202-2.json |
| 2620-3 | Methionine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2620-3.json |
| 26203-0 | MR Shoulder - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26203-0.json |
| 26204-8 | MR Shoulder - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26204-8.json |
| 26205-5 | MR Wrist - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26205-5.json |
| 26206-3 | MR Wrist - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26206-3.json |
| 26207-1 | MR Wrist - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/26207-1.json |
| 26208-9 | MR Ankle - bilateral | ./2.16.840.1.114222.4.11.1002/26208-9.json |
| 26209-7 | MR Ankle - left | ./2.16.840.1.114222.4.11.1002/26209-7.json |
| 26210-5 | MR Ankle - right | ./2.16.840.1.114222.4.11.1002/26210-5.json |
| 26211-3 | MR Brachial plexus - bilateral | ./2.16.840.1.114222.4.11.1002/26211-3.json |
| 26212-1 | MR Brachial plexus - left | ./2.16.840.1.114222.4.11.1002/26212-1.json |
| 26213-9 | MR Brachial plexus - right | ./2.16.840.1.114222.4.11.1002/26213-9.json |
| 26214-7 | US Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26214-7.json |
| 26215-4 | US Breast - left | ./2.16.840.1.114222.4.11.1002/26215-4.json |
| 26216-2 | US Breast - right | ./2.16.840.1.114222.4.11.1002/26216-2.json |
| 26217-0 | US Carotid arteries - bilateral | ./2.16.840.1.114222.4.11.1002/26217-0.json |
| 26218-8 | US Carotid arteries - left | ./2.16.840.1.114222.4.11.1002/26218-8.json |
| 26219-6 | US Carotid arteries -right | ./2.16.840.1.114222.4.11.1002/26219-6.json |
| 26220-4 | MR Elbow - bilateral | ./2.16.840.1.114222.4.11.1002/26220-4.json |
| 26221-2 | MR Elbow - left | ./2.16.840.1.114222.4.11.1002/26221-2.json |
| 26222-0 | MR Elbow - right | ./2.16.840.1.114222.4.11.1002/26222-0.json |
| 26223-8 | US Extremity - bilateral | ./2.16.840.1.114222.4.11.1002/26223-8.json |
| 26224-6 | CT Extremity - bilateral | ./2.16.840.1.114222.4.11.1002/26224-6.json |
| 26225-3 | US Extremity - left | ./2.16.840.1.114222.4.11.1002/26225-3.json |
| 26226-1 | CT Extremity - left | ./2.16.840.1.114222.4.11.1002/26226-1.json |
| 26227-9 | MR Lower extremity joint - bilateral | ./2.16.840.1.114222.4.11.1002/26227-9.json |
| 26228-7 | MR Lower extremity joint - left | ./2.16.840.1.114222.4.11.1002/26228-7.json |
| 26229-5 | MR Lower extremity joint - right | ./2.16.840.1.114222.4.11.1002/26229-5.json |
| 26230-3 | US Extremity - right | ./2.16.840.1.114222.4.11.1002/26230-3.json |
| 26231-1 | CT Extremity - right | ./2.16.840.1.114222.4.11.1002/26231-1.json |
| 26232-9 | MR Upper extremity - bilateral | ./2.16.840.1.114222.4.11.1002/26232-9.json |
| 26233-7 | MR Upper extremity - left | ./2.16.840.1.114222.4.11.1002/26233-7.json |
| 26234-5 | MR Upper extremity - right | ./2.16.840.1.114222.4.11.1002/26234-5.json |
| 26235-2 | MR Thigh - bilateral | ./2.16.840.1.114222.4.11.1002/26235-2.json |
| 26236-0 | MR Thigh - left | ./2.16.840.1.114222.4.11.1002/26236-0.json |
| 26237-8 | MR Thigh - right | ./2.16.840.1.114222.4.11.1002/26237-8.json |
| 26238-6 | MR Finger - bilateral | ./2.16.840.1.114222.4.11.1002/26238-6.json |
| 26239-4 | MR Finger - left | ./2.16.840.1.114222.4.11.1002/26239-4.json |
| 26240-2 | MR Finger - right | ./2.16.840.1.114222.4.11.1002/26240-2.json |
| 26241-0 | MR Foot - bilateral | ./2.16.840.1.114222.4.11.1002/26241-0.json |
| 26242-8 | MR Foot - left | ./2.16.840.1.114222.4.11.1002/26242-8.json |
| 26243-6 | MR Foot - right | ./2.16.840.1.114222.4.11.1002/26243-6.json |
| 26244-4 | MR Forearm - bilateral | ./2.16.840.1.114222.4.11.1002/26244-4.json |
| 26245-1 | MR Forearm - left | ./2.16.840.1.114222.4.11.1002/26245-1.json |
| 26246-9 | MR Forearm - right | ./2.16.840.1.114222.4.11.1002/26246-9.json |
| 26247-7 | MR Hand - bilateral | ./2.16.840.1.114222.4.11.1002/26247-7.json |
| 26248-5 | MR Hand - left | ./2.16.840.1.114222.4.11.1002/26248-5.json |
| 26249-3 | MR Hand - right | ./2.16.840.1.114222.4.11.1002/26249-3.json |
| 26250-1 | US Hip - bilateral | ./2.16.840.1.114222.4.11.1002/26250-1.json |
| 26251-9 | US Hip - left | ./2.16.840.1.114222.4.11.1002/26251-9.json |
| 2625-2 | Methionine adenosyltransferase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2625-2.json |
| 26252-7 | US Hip - right | ./2.16.840.1.114222.4.11.1002/26252-7.json |
| 26253-5 | XR tomography Internal auditory canal - bilateral | ./2.16.840.1.114222.4.11.1002/26253-5.json |
| 26254-3 | XR tomography Internal auditory canal - left | ./2.16.840.1.114222.4.11.1002/26254-3.json |
| 26255-0 | XR tomography Internal auditory canal - right | ./2.16.840.1.114222.4.11.1002/26255-0.json |
| 26256-8 | MR Knee - bilateral | ./2.16.840.1.114222.4.11.1002/26256-8.json |
| 26257-6 | MR Knee - left | ./2.16.840.1.114222.4.11.1002/26257-6.json |
| 26258-4 | MR Knee - right | ./2.16.840.1.114222.4.11.1002/26258-4.json |
| 26259-2 | MR Pelvis and Hip - bilateral | ./2.16.840.1.114222.4.11.1002/26259-2.json |
| 2626-0 | Methoxyacetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2626-0.json |
| 26260-0 | MR Pelvis and Hip - left | ./2.16.840.1.114222.4.11.1002/26260-0.json |
| 26261-8 | MR Pelvis and Hip - right | ./2.16.840.1.114222.4.11.1002/26261-8.json |
| 26262-6 | US Popliteal space - bilateral | ./2.16.840.1.114222.4.11.1002/26262-6.json |
| 26263-4 | US Popliteal space - left | ./2.16.840.1.114222.4.11.1002/26263-4.json |
| 26264-2 | US Popliteal space - right | ./2.16.840.1.114222.4.11.1002/26264-2.json |
| 26265-9 | US Shoulder - bilateral | ./2.16.840.1.114222.4.11.1002/26265-9.json |
| 26266-7 | MR Shoulder - bilateral | ./2.16.840.1.114222.4.11.1002/26266-7.json |
| 26267-5 | US Shoulder - left | ./2.16.840.1.114222.4.11.1002/26267-5.json |
| 26268-3 | MR Shoulder - left | ./2.16.840.1.114222.4.11.1002/26268-3.json |
| 26269-1 | US Shoulder - right | ./2.16.840.1.114222.4.11.1002/26269-1.json |
| 26270-9 | MR Shoulder - right | ./2.16.840.1.114222.4.11.1002/26270-9.json |
| 26271-7 | US Scrotum and Testicle - bilateral | ./2.16.840.1.114222.4.11.1002/26271-7.json |
| 26272-5 | US Scrotum and Testicle - left | ./2.16.840.1.114222.4.11.1002/26272-5.json |
| 26273-3 | US Scrotum and Testicle - right | ./2.16.840.1.114222.4.11.1002/26273-3.json |
| 26277-4 | MR Wrist - bilateral | ./2.16.840.1.114222.4.11.1002/26277-4.json |
| 2627-8 | Methylenetetrahydrofolate dehydrogenase NAD [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2627-8.json |
| 26278-2 | US Wrist - bilateral | ./2.16.840.1.114222.4.11.1002/26278-2.json |
| 26279-0 | MR Wrist - left | ./2.16.840.1.114222.4.11.1002/26279-0.json |
| 26280-8 | US Wrist - left | ./2.16.840.1.114222.4.11.1002/26280-8.json |
| 26281-6 | MR Wrist - right | ./2.16.840.1.114222.4.11.1002/26281-6.json |
| 26282-4 | US Wrist - right | ./2.16.840.1.114222.4.11.1002/26282-4.json |
| 26283-2 | XR Knee - bilateral Merchants | ./2.16.840.1.114222.4.11.1002/26283-2.json |
| 26284-0 | XR Knee - left Merchants | ./2.16.840.1.114222.4.11.1002/26284-0.json |
| 26285-7 | XR Knee - right Merchants | ./2.16.840.1.114222.4.11.1002/26285-7.json |
| 2628-6 | Methylenetetrahydrofolate dehydrogenase NADP [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2628-6.json |
| 26286-5 | US Breast - bilateral limited | ./2.16.840.1.114222.4.11.1002/26286-5.json |
| 26287-3 | MG Breast - bilateral Limited Views | ./2.16.840.1.114222.4.11.1002/26287-3.json |
| 26288-1 | US Breast - left limited | ./2.16.840.1.114222.4.11.1002/26288-1.json |
| 26289-9 | MG Breast - left Limited Views | ./2.16.840.1.114222.4.11.1002/26289-9.json |
| 26290-7 | US Breast - right limited | ./2.16.840.1.114222.4.11.1002/26290-7.json |
| 26291-5 | MG Breast - right Limited Views | ./2.16.840.1.114222.4.11.1002/26291-5.json |
| 26292-3 | MG stereo Guidance for biopsy of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26292-3.json |
| 26293-1 | MG stereo Guidance for biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/26293-1.json |
| 2629-4 | Methylmalonate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2629-4.json |
| 26294-9 | MG stereo Guidance for biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/26294-9.json |
| 26295-6 | RFA Guidance for reposition of CV catheter in Vein - bilateral-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26295-6.json |
| 26296-4 | RFA Guidance for reposition of CV catheter in Vein - left-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26296-4.json |
| 26297-2 | RFA Guidance for reposition of CV catheter in Vein - right-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26297-2.json |
| 26298-0 | RFA Guidance for atherectomy of Vein - bilateral-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26298-0.json |
| 26299-8 | RFA Guidance for atherectomy of Vein - left-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26299-8.json |
| 26300-4 | RFA Guidance for atherectomy of Vein - right-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26300-4.json |
| 26301-2 | RFA Guidance for placement of stent in Vein - bilateral | ./2.16.840.1.114222.4.11.1002/26301-2.json |
| 2630-2 | Methylmalonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2630-2.json |
| 26302-0 | RFA Guidance for placement of stent in Vein - left | ./2.16.840.1.114222.4.11.1002/26302-0.json |
| 26303-8 | RFA Guidance for placement of stent in Vein - right | ./2.16.840.1.114222.4.11.1002/26303-8.json |
| 26304-6 | RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - bilateral | ./2.16.840.1.114222.4.11.1002/26304-6.json |
| 26305-3 | RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - left | ./2.16.840.1.114222.4.11.1002/26305-3.json |
| 26306-1 | RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - right | ./2.16.840.1.114222.4.11.1002/26306-1.json |
| 26307-9 | Guidance for placement of large bore CV catheter in Vein - bilateral | ./2.16.840.1.114222.4.11.1002/26307-9.json |
| 26308-7 | Guidance for placement of large bore CV catheter in Vein - left | ./2.16.840.1.114222.4.11.1002/26308-7.json |
| 26309-5 | Guidance for placement of large bore CV catheter in Vein - right | ./2.16.840.1.114222.4.11.1002/26309-5.json |
| 2631-0 | Methylmalonyl CoA mutase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2631-0.json |
| 26310-3 | RFA Guidance for placement of CV catheter in Vein - bilateral-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26310-3.json |
| 26311-1 | RFA Guidance for placement of CV catheter in Vein - left-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26311-1.json |
| 26312-9 | RFA Guidance for placement of CV catheter in Vein - right-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26312-9.json |
| 26313-7 | US Guidance for needle localization of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26313-7.json |
| 26314-5 | US Guidance for needle localization of Breast - left | ./2.16.840.1.114222.4.11.1002/26314-5.json |
| 26315-2 | MG Guidance for needle localization of mass of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26315-2.json |
| 26316-0 | MG Guidance for needle localization of mass of Breast - left | ./2.16.840.1.114222.4.11.1002/26316-0.json |
| 26317-8 | MG Guidance for needle localization of mass of Breast - right | ./2.16.840.1.114222.4.11.1002/26317-8.json |
| 26318-6 | US Guidance for needle localization of Breast - right | ./2.16.840.1.114222.4.11.1002/26318-6.json |
| 26319-4 | CT Guidance for injection of Sacroiliac joint - bilateral | ./2.16.840.1.114222.4.11.1002/26319-4.json |
| 26320-2 | CT Guidance for injection of Sacroiliac joint - left | ./2.16.840.1.114222.4.11.1002/26320-2.json |
| 26321-0 | CT Guidance for injection of Sacroiliac joint - right | ./2.16.840.1.114222.4.11.1002/26321-0.json |
| 26322-8 | RF Guidance for injection of Spine facet joint - bilateral | ./2.16.840.1.114222.4.11.1002/26322-8.json |
| 26323-6 | RF Guidance for injection of Spine facet joint - left | ./2.16.840.1.114222.4.11.1002/26323-6.json |
| 26324-4 | RF Guidance for injection of Spine facet joint - right | ./2.16.840.1.114222.4.11.1002/26324-4.json |
| 26325-1 | US Guidance for drainage and placement of drainage catheter of Extremity - bilateral | ./2.16.840.1.114222.4.11.1002/26325-1.json |
| 26326-9 | US Guidance for drainage and placement of drainage catheter of Extremity - left | ./2.16.840.1.114222.4.11.1002/26326-9.json |
| 26327-7 | US Guidance for drainage and placement of drainage catheter of Extremity - right | ./2.16.840.1.114222.4.11.1002/26327-7.json |
| 2632-8 | Methyltestosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2632-8.json |
| 26328-5 | US Guidance for drainage and placement of drainage catheter of Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/26328-5.json |
| 26329-3 | US Guidance for drainage and placement of drainage catheter of Kidney - left | ./2.16.840.1.114222.4.11.1002/26329-3.json |
| 26330-1 | US Guidance for drainage and placement of drainage catheter of Kidney - right | ./2.16.840.1.114222.4.11.1002/26330-1.json |
| 26331-9 | RFA Guidance for change of CV catheter in Vein - bilateral-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26331-9.json |
| 26332-7 | RFA Guidance for change of CV catheter in Vein - left-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26332-7.json |
| 26333-5 | RFA Guidance for change of CV catheter in Vein - right-- W contrast IV | ./2.16.840.1.114222.4.11.1002/26333-5.json |
| 26334-3 | MG Guidance for percutaneous biopsy.core needle of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26334-3.json |
| 26335-0 | MG Guidance for percutaneous biopsy.core needle of Breast - left | ./2.16.840.1.114222.4.11.1002/26335-0.json |
| 2633-6 | Methyltestosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2633-6.json |
| 26336-8 | MG Guidance for percutaneous biopsy.core needle of Breast - right | ./2.16.840.1.114222.4.11.1002/26336-8.json |
| 26337-6 | MG Guidance for biopsy of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26337-6.json |
| 26338-4 | MG Guidance for biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/26338-4.json |
| 26339-2 | MG Guidance for biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/26339-2.json |
| 26340-0 | US Guidance for biopsy of Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/26340-0.json |
| 26341-8 | US Guidance for biopsy of Kidney - left | ./2.16.840.1.114222.4.11.1002/26341-8.json |
| 26342-6 | US Guidance for biopsy of Kidney - right | ./2.16.840.1.114222.4.11.1002/26342-6.json |
| 26343-4 | MG Guidance for aspiration of cyst of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/26343-4.json |
| 2634-4 | Methyltestosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2634-4.json |
| 26344-2 | MG Guidance for aspiration of cyst of Breast - left | ./2.16.840.1.114222.4.11.1002/26344-2.json |
| 26345-9 | MG Guidance for aspiration of cyst of Breast - right | ./2.16.840.1.114222.4.11.1002/26345-9.json |
| 26346-7 | MG Breast - bilateral Diagnostic | ./2.16.840.1.114222.4.11.1002/26346-7.json |
| 26347-5 | MG Breast - left Diagnostic | ./2.16.840.1.114222.4.11.1002/26347-5.json |
| 26348-3 | MG Breast - right Diagnostic | ./2.16.840.1.114222.4.11.1002/26348-3.json |
| 26349-1 | MG Breast - bilateral Diagnostic Limited Views | ./2.16.840.1.114222.4.11.1002/26349-1.json |
| 26350-9 | MG Breast - left Diagnostic Limited Views | ./2.16.840.1.114222.4.11.1002/26350-9.json |
| 2635-1 | Mianserin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2635-1.json |
| 26351-7 | MG Breast - right Diagnostic Limited Views | ./2.16.840.1.114222.4.11.1002/26351-7.json |
| 26352-5 | XR Wrist - bilateral and Hand - bilateral Bone age Views | ./2.16.840.1.114222.4.11.1002/26352-5.json |
| 26353-3 | XR Wrist - left and Hand - left Bone age Views | ./2.16.840.1.114222.4.11.1002/26353-3.json |
| 26354-1 | XR Wrist - right and Hand - right Bone age Views | ./2.16.840.1.114222.4.11.1002/26354-1.json |
| 26355-8 | XR Hand - bilateral Arthritis | ./2.16.840.1.114222.4.11.1002/26355-8.json |
| 26356-6 | XR Hand - left Arthritis | ./2.16.840.1.114222.4.11.1002/26356-6.json |
| 26357-4 | XR Hand - right Arthritis | ./2.16.840.1.114222.4.11.1002/26357-4.json |
| 26358-2 | XR Knee - bilateral AP W standing | ./2.16.840.1.114222.4.11.1002/26358-2.json |
| 26359-0 | XR Knee - left AP W standing | ./2.16.840.1.114222.4.11.1002/26359-0.json |
| 26360-8 | XR Knee - right AP W standing | ./2.16.840.1.114222.4.11.1002/26360-8.json |
| 26361-6 | XR Knee - bilateral AP and PA W standing | ./2.16.840.1.114222.4.11.1002/26361-6.json |
| 26362-4 | XR Knee - left AP and PA W standing | ./2.16.840.1.114222.4.11.1002/26362-4.json |
| 26363-2 | XR Knee - right AP and PA W standing | ./2.16.840.1.114222.4.11.1002/26363-2.json |
| 26364-0 | XR Knee - bilateral AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/26364-0.json |
| 26365-7 | XR Knee - left AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/26365-7.json |
| 26366-5 | XR Knee - right AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/26366-5.json |
| 2636-9 | Mianserin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2636-9.json |
| 26370-7 | RFA Guidance for angioplasty of Iliac artery - bilateral-- W contrast IA | ./2.16.840.1.114222.4.11.1002/26370-7.json |
| 26371-5 | RFA Guidance for angioplasty of Iliac artery - left-- W contrast IA | ./2.16.840.1.114222.4.11.1002/26371-5.json |
| 26372-3 | RFA Guidance for angioplasty of Iliac artery - right-- W contrast IA | ./2.16.840.1.114222.4.11.1002/26372-3.json |
| 26376-4 | Administration of vasodilator into catheter Vein - bilateral | ./2.16.840.1.114222.4.11.1002/26376-4.json |
| 2637-7 | Mucoprotein [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2637-7.json |
| 26377-2 | Administration of vasodilator into catheter Vein - left | ./2.16.840.1.114222.4.11.1002/26377-2.json |
| 26378-0 | Administration of vasodilator into catheter Vein - right | ./2.16.840.1.114222.4.11.1002/26378-0.json |
| 26379-8 | XR Hand - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/26379-8.json |
| 26380-6 | XR Hand - left 3 Views | ./2.16.840.1.114222.4.11.1002/26380-6.json |
| 26381-4 | XR Hand - right 3 Views | ./2.16.840.1.114222.4.11.1002/26381-4.json |
| 26382-2 | XR Shoulder - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/26382-2.json |
| 26383-0 | XR Shoulder - left 3 Views | ./2.16.840.1.114222.4.11.1002/26383-0.json |
| 26384-8 | XR Shoulder - right 3 Views | ./2.16.840.1.114222.4.11.1002/26384-8.json |
| 2638-5 | Myelin basic protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2638-5.json |
| 26385-5 | XR Ankle - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/26385-5.json |
| 26386-3 | XR Ankle - left 2 Views | ./2.16.840.1.114222.4.11.1002/26386-3.json |
| 26387-1 | XR Ankle - right 2 Views | ./2.16.840.1.114222.4.11.1002/26387-1.json |
| 26388-9 | XR Hand - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/26388-9.json |
| 26389-7 | XR Hand - left 2 Views | ./2.16.840.1.114222.4.11.1002/26389-7.json |
| 26390-5 | XR Hand - right 2 Views | ./2.16.840.1.114222.4.11.1002/26390-5.json |
| 26391-3 | XR Humerus - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/26391-3.json |
| 26392-1 | XR Humerus - left 2 Views | ./2.16.840.1.114222.4.11.1002/26392-1.json |
| 2639-3 | Myoglobin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2639-3.json |
| 26393-9 | XR Humerus - right 2 Views | ./2.16.840.1.114222.4.11.1002/26393-9.json |
| 26394-7 | XR Knee - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/26394-7.json |
| 26395-4 | XR Knee - left 2 Views | ./2.16.840.1.114222.4.11.1002/26395-4.json |
| 26396-2 | XR Knee - right 2 Views | ./2.16.840.1.114222.4.11.1002/26396-2.json |
| 26397-0 | XR Patella - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/26397-0.json |
| 26398-8 | XR Patella - left 2 Views | ./2.16.840.1.114222.4.11.1002/26398-8.json |
| 26399-6 | XR Patella - right 2 Views | ./2.16.840.1.114222.4.11.1002/26399-6.json |
| 26400-2 | XR Hip - bilateral Single view | ./2.16.840.1.114222.4.11.1002/26400-2.json |
| 2640-1 | Myoglobin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2640-1.json |
| 26401-0 | XR Hip - left Single view | ./2.16.840.1.114222.4.11.1002/26401-0.json |
| 26402-8 | XR Hip - right Single view | ./2.16.840.1.114222.4.11.1002/26402-8.json |
| 26403-6 | Alternaria alternata IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26403-6.json |
| 26405-1 | Aspergillus fumigatus IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26405-1.json |
| 26407-7 | Honey bee IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26407-7.json |
| 26409-3 | Silver Birch IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26409-3.json |
| 26411-9 | Wheat Bran IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26411-9.json |
| 26413-5 | Candida albicans IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26413-5.json |
| 26415-0 | Casein IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26415-0.json |
| 26417-6 | Cladosporium herbarum IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26417-6.json |
| 2641-9 | Myoglobin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2641-9.json |
| 26419-2 | American house dust mite IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26419-2.json |
| 26421-8 | European house dust mite IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26421-8.json |
| 26423-4 | Egg white IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26423-4.json |
| 26425-9 | Lactalbumin alpha IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26425-9.json |
| 2642-7 | Myoglobin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2642-7.json |
| 26427-5 | Lactoglobulin IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26427-5.json |
| 26428-3 | Rice IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26428-3.json |
| 26430-9 | Timothy IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26430-9.json |
| 26432-5 | Wasp venom IgG4 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26432-5.json |
| 2643-5 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2643-5.json |
| 2644-3 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2644-3.json |
| 26449-9 | Eosinophils [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26449-9.json |
| 2645-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2645-0.json |
| 26455-6 | Erythrocytes [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/26455-6.json |
| 26464-8 | Leukocytes [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26464-8.json |
| 2646-8 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2646-8.json |
| 2647-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2647-6.json |
| 2648-4 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/2648-4.json |
| 2649-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2649-2.json |
| 2650-0 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2650-0.json |
| 26515-7 | Platelets [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26515-7.json |
| 26516-5 | Platelets [#/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/26516-5.json |
| 2651-8 | NADH dehydrogenase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2651-8.json |
| 2652-6 | NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2652-6.json |
| 26528-0 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin | ./2.16.840.1.114222.4.11.1002/26528-0.json |
| 2653-4 | Cytochrome B5 reductase [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2653-4.json |
| 2654-2 | Neurophysin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2654-2.json |
| 26546-2 | Glucose [Presence] in Urine by Test strip --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/26546-2.json |
| 26547-0 | Glucose [Presence] in Urine by Test strip --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/26547-0.json |
| 26556-1 | CD103 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/26556-1.json |
| 2655-9 | Neurotensin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2655-9.json |
| 26561-1 | CD16+CD56+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/26561-1.json |
| 2656-7 | Niacin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2656-7.json |
| 26582-7 | Homocysteine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/26582-7.json |
| 2658-3 | Nitrogen [Mass/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/2658-3.json |
| 26583-5 | 3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/26583-5.json |
| 265-9 | Ganciclovir [Susceptibility] | ./2.16.840.1.114222.4.11.1002/265-9.json |
| 26596-7 | Hydroxyproline [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/26596-7.json |
| 2660-9 | Nitrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2660-9.json |
| 2661-7 | Nitrogen.nonprotein [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2661-7.json |
| 26617-1 | Trypanosoma brucei gambiense Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26617-1.json |
| 26618-9 | Trypanosoma brucei rhodesiense Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26618-9.json |
| 26619-7 | Campylobacter sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26619-7.json |
| 26620-5 | Hantavirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26620-5.json |
| 26621-3 | Legionella sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/26621-3.json |
| 26622-1 | Babesia duncani Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26622-1.json |
| 26623-9 | Chikungunya virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26623-9.json |
| 26624-7 | Rickettsia conorii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26624-7.json |
| 2662-5 | Nitrogen.nonprotein [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2662-5.json |
| 26625-4 | Coccidioides sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26625-4.json |
| 26626-2 | Chlamydia trachomatis L2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26626-2.json |
| 26627-0 | Legionella polyvalent A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26627-0.json |
| 26628-8 | Legionella polyvalent B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26628-8.json |
| 26629-6 | Legionella polyvalent C Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26629-6.json |
| 26630-4 | Corynebacterium diphtheriae toxin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26630-4.json |
| 26631-2 | Borrelia hermsii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26631-2.json |
| 26632-0 | Legionella dumoffii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26632-0.json |
| 2663-3 | Nitrogen.nonprotein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2663-3.json |
| 26633-8 | Legionella bozemaniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26633-8.json |
| 26634-6 | Legionella gormanii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26634-6.json |
| 26635-3 | Legionella micdadei Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26635-3.json |
| 26636-1 | Candida sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26636-1.json |
| 26637-9 | Leishmania brasilensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26637-9.json |
| 26638-7 | Leishmania donovani Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26638-7.json |
| 26639-5 | Leishmania tropica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26639-5.json |
| 26640-3 | Paracoccidioides brasiliensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26640-3.json |
| 26642-9 | Jamestown canyon virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26642-9.json |
| 26643-7 | Clostridium tetani toxoid Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26643-7.json |
| 26644-5 | Getah virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26644-5.json |
| 26645-2 | BK virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26645-2.json |
| 26646-0 | Powassan virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26646-0.json |
| 26647-8 | Semliki Forest virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26647-8.json |
| 26648-6 | Sindbis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26648-6.json |
| 26649-4 | Snowshoe hare virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26649-4.json |
| 26650-2 | Hantavirus sin nombre IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26650-2.json |
| 26651-0 | Rhizopus arrhizus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26651-0.json |
| 26652-8 | Banzi virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26652-8.json |
| 26653-6 | Colorado tick fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26653-6.json |
| 26654-4 | Hantavirus sin nombre IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26654-4.json |
| 26655-1 | Entamoeba sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26655-1.json |
| 26656-9 | HTLV II Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26656-9.json |
| 26657-7 | Schistosoma haematobium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26657-7.json |
| 2665-8 | Nitrogen [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/2665-8.json |
| 26658-5 | Treponema sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26658-5.json |
| 26660-1 | Toxocara sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26660-1.json |
| 26661-9 | Trichinella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26661-9.json |
| 26662-7 | Bebaru virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26662-7.json |
| 26663-5 | Chlamydia trachomatis D Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26663-5.json |
| 26664-3 | Chlamydia trachomatis E Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26664-3.json |
| 26665-0 | Chlamydia trachomatis F Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26665-0.json |
| 2666-6 | Norepinephrine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2666-6.json |
| 26666-8 | Chlamydia trachomatis H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26666-8.json |
| 26667-6 | Chlamydia trachomatis I Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26667-6.json |
| 26668-4 | Chlamydia trachomatis L1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26668-4.json |
| 26669-2 | Absidia corymbifera Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26669-2.json |
| 26670-0 | Rhizomucor pusillus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26670-0.json |
| 26671-8 | Ascaris sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26671-8.json |
| 26672-6 | Ross River virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26672-6.json |
| 26673-4 | Echinococcus granulosus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26673-4.json |
| 2667-4 | Norepinephrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2667-4.json |
| 26674-2 | Legionella longbeachae 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26674-2.json |
| 26675-9 | Legionella longbeachae 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26675-9.json |
| 26676-7 | Bartonella henselae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26676-7.json |
| 26677-5 | Bartonella quintana Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26677-5.json |
| 26678-3 | Bartonella elizabethae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26678-3.json |
| 26679-1 | Secobarbital [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26679-1.json |
| 2668-2 | Norepinephrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2668-2.json |
| 26682-5 | Glycolate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26682-5.json |
| 26683-3 | Estazolam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26683-3.json |
| 26684-1 | Mycoplasma pneumoniae IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26684-1.json |
| 26686-6 | Triazolam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26686-6.json |
| 26687-4 | Amobarbital [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26687-4.json |
| 26688-2 | Mercury/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26688-2.json |
| 26689-0 | Butabarbital [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26689-0.json |
| 2669-0 | Normetanephrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2669-0.json |
| 26690-8 | Western equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/26690-8.json |
| 26694-0 | Clostridioides difficile IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26694-0.json |
| 26696-5 | Morphine Free [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26696-5.json |
| 26697-3 | Clostridioides difficile IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26697-3.json |
| 26698-1 | Listeria monocytogenes IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26698-1.json |
| 26699-9 | Indicans [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26699-9.json |
| 26700-5 | Amino beta guanidinopropionate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26700-5.json |
| 26702-1 | Clostridioides difficile IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26702-1.json |
| 26703-9 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26703-9.json |
| 26704-7 | Isospora belli [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26704-7.json |
| 26705-4 | Epstein Barr virus nuclear IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/26705-4.json |
| 26706-2 | Vanillylmandelate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26706-2.json |
| 26707-0 | Aluminum [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26707-0.json |
| 2670-8 | Normetanephrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2670-8.json |
| 26708-8 | Magnesium [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26708-8.json |
| 26711-2 | Phendimetrazine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26711-2.json |
| 26712-0 | Phenmetrazine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26712-0.json |
| 26713-8 | Phentermine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26713-8.json |
| 26714-6 | Phenylpropanolamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26714-6.json |
| 26715-3 | Chlamydia trachomatis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26715-3.json |
| 2671-6 | Normetanephrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2671-6.json |
| 26716-1 | Chlorphentermine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26716-1.json |
| 26718-7 | HYDROmorphone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26718-7.json |
| 26719-5 | HYDROcodone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26719-5.json |
| 26720-3 | Codeine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26720-3.json |
| 26721-1 | 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26721-1.json |
| 26722-9 | oxyCODONE [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26722-9.json |
| 26723-7 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26723-7.json |
| 2672-4 | Octopamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2672-4.json |
| 26727-8 | ePHEDrine+Pseudoephedrine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26727-8.json |
| 26728-6 | CD38 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26728-6.json |
| 26729-4 | Ovary IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26729-4.json |
| 26731-0 | Tetrahydrocannabinol [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26731-0.json |
| 26732-8 | Carboxy tetrahydrocannabinol [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26732-8.json |
| 26733-6 | Butabarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26733-6.json |
| 26734-4 | Methamphetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26734-4.json |
| 26735-1 | Rhodococcus equi Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/26735-1.json |
| 26736-9 | Promethazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26736-9.json |
| 26740-1 | Hydroxyproline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26740-1.json |
| 26742-7 | Methylenedioxyamphetamine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26742-7.json |
| 26743-5 | Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26743-5.json |
| 26744-3 | Opiates [Mass/mass] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/26744-3.json |
| 26746-8 | Magnesium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/26746-8.json |
| 26747-6 | Cannabinoids/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/26747-6.json |
| 26748-4 | Osmium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26748-4.json |
| 26751-8 | Adipate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26751-8.json |
| 26752-6 | Creatinine renal clearance in 2 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26752-6.json |
| 26753-4 | Carnitine esters [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26753-4.json |
| 26754-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26754-2.json |
| 26755-9 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26755-9.json |
| 26756-7 | Isoniazid [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26756-7.json |
| 26757-5 | Carnitine free (C0) [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26757-5.json |
| 26758-3 | Cocaine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26758-3.json |
| 26760-9 | Cannabinoids [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26760-9.json |
| 26761-7 | Sodium renal clearance in 2 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26761-7.json |
| 26762-5 | Chloride [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26762-5.json |
| 26763-3 | Sodium [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/26763-3.json |
| 26764-1 | Cannabinoids [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/26764-1.json |
| 2676-5 | Organic acids [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2676-5.json |
| 26765-8 | Antimony [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/26765-8.json |
| 26766-6 | Bacteroides fragilis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26766-6.json |
| 26767-4 | Clostridium perfringens IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26767-4.json |
| 26768-2 | Clostridium perfringens IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26768-2.json |
| 26769-0 | Endothelin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26769-0.json |
| 26770-8 | Trichloroacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/26770-8.json |
| 26771-6 | ePHEDrine+Pseudoephedrine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26771-6.json |
| 26772-4 | Mephentermine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26772-4.json |
| 2677-3 | Organochloride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2677-3.json |
| 26773-2 | Benzfetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26773-2.json |
| 26774-0 | Flurazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26774-0.json |
| 26775-7 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26775-7.json |
| 26776-5 | QUEtiapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26776-5.json |
| 26778-1 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose lactose PO | ./2.16.840.1.114222.4.11.1002/26778-1.json |
| 26780-7 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose lactose PO | ./2.16.840.1.114222.4.11.1002/26780-7.json |
| 26781-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO | ./2.16.840.1.114222.4.11.1002/26781-5.json |
| 26784-9 | diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/26784-9.json |
| 26785-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26785-6.json |
| 26786-4 | Mephentermine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26786-4.json |
| 26788-0 | Carnitine [Units/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/26788-0.json |
| 26789-8 | Escherichia coli IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26789-8.json |
| 26790-6 | chlordiazePOXIDE [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26790-6.json |
| 26791-4 | Amphetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26791-4.json |
| 26792-2 | Methylenedioxyamphetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26792-2.json |
| 26793-0 | Methylenedioxymethamphetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26793-0.json |
| 26796-3 | Oxalate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26796-3.json |
| 26797-1 | Alpha hydroxybutyrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26797-1.json |
| 26798-9 | Succinate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26798-9.json |
| 26799-7 | Fumarate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26799-7.json |
| 26800-3 | Escherichia coli IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26800-3.json |
| 26801-1 | Protein [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/26801-1.json |
| 26802-9 | Midazolam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26802-9.json |
| 26810-2 | Hydroxyproline [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26810-2.json |
| 26813-6 | Acidity.titratable [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/26813-6.json |
| 26814-4 | IgG.monoclonal [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26814-4.json |
| 26815-1 | Cocaethylene [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26815-1.json |
| 26816-9 | Nordiazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26816-9.json |
| 26817-7 | Glucose [Mass/volume] in Serum or Plasma --11 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/26817-7.json |
| 26818-5 | Campylobacter jejuni Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26818-5.json |
| 26820-1 | Stachybotrys chartarum IgA Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26820-1.json |
| 2682-3 | Ornithine carbamoyltransferase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2682-3.json |
| 26823-5 | Lutropin.beta subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26823-5.json |
| 26825-0 | Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/26825-0.json |
| 26826-8 | Testosterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26826-8.json |
| 26827-6 | Testosterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26827-6.json |
| 26828-4 | Cortisol [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/26828-4.json |
| 26829-2 | Phencyclidine [Mass/mass] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/26829-2.json |
| 26830-0 | Prochlorperazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26830-0.json |
| 2683-1 | Ornithine carbamoyltransferase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2683-1.json |
| 26831-8 | Suberate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26831-8.json |
| 26832-6 | Aconitate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26832-6.json |
| 26833-4 | Hippurate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/26833-4.json |
| 26834-2 | Temazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26834-2.json |
| 26836-7 | Hydroxyethylflurazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26836-7.json |
| 26837-5 | diazePAM [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26837-5.json |
| 26838-3 | LORazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26838-3.json |
| 26839-1 | Oxazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26839-1.json |
| 26840-9 | Nordiazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26840-9.json |
| 26841-7 | N-desalkylflurazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26841-7.json |
| 26842-5 | Iodine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26842-5.json |
| 26843-3 | Cystine [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26843-3.json |
| 26845-8 | Sialate.lipid bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26845-8.json |
| 26846-6 | Perphenazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26846-6.json |
| 26847-4 | Haloperidol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26847-4.json |
| 26848-2 | Interleukin 10 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26848-2.json |
| 2684-9 | Alpha-1-acid glycoprotein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2684-9.json |
| 26849-0 | IgA.secretory [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/26849-0.json |
| 26850-8 | Oxazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26850-8.json |
| 26851-6 | LORazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26851-6.json |
| 26852-4 | Amino beta guanidinopropionate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/26852-4.json |
| 26855-7 | Parainfluenza virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26855-7.json |
| 2685-6 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2685-6.json |
| 26856-5 | Cannabinoids [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26856-5.json |
| 26857-3 | Mephentermine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26857-3.json |
| 26859-9 | Phencyclidine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26859-9.json |
| 26860-7 | Morphine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26860-7.json |
| 26862-3 | HYDROmorphone [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26862-3.json |
| 26863-1 | HYDROcodone [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26863-1.json |
| 2686-4 | Orotate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2686-4.json |
| 26864-9 | Sporothrix schenckii Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/26864-9.json |
| 26865-6 | Codeine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26865-6.json |
| 26866-4 | N-desalkylflurazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26866-4.json |
| 26867-2 | fentaNYL [Units/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26867-2.json |
| 26868-0 | Phenolphthalein [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/26868-0.json |
| 26869-8 | oxyCODONE [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26869-8.json |
| 26871-4 | IgA [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26871-4.json |
| 2687-2 | Orotate phosphoribosyltransferase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2687-2.json |
| 26872-2 | Orotate [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26872-2.json |
| 26874-8 | Follitropin.beta subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26874-8.json |
| 26877-1 | Hydroxytriazolam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26877-1.json |
| 26878-9 | ALPRAZolam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26878-9.json |
| 26879-7 | Triiodothyronine (T3) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/26879-7.json |
| 2688-0 | Orotidine-5'-Phosphate decarboxylase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2688-0.json |
| 26880-5 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26880-5.json |
| 26881-3 | Interleukin 6 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26881-3.json |
| 26885-4 | Ova and parasites identified in Specimen by Concentration | ./2.16.840.1.114222.4.11.1002/26885-4.json |
| 26886-2 | ALPRAZolam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26886-2.json |
| 26887-0 | Alpha hydroxyalprazolam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26887-0.json |
| 26888-8 | Sulfate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26888-8.json |
| 26889-6 | Sulfate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26889-6.json |
| 26890-4 | Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26890-4.json |
| 26891-2 | Nordiazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26891-2.json |
| 26892-0 | Intrinsic factor blocking IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/26892-0.json |
| 26893-8 | Tetrahydrocannabinol [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26893-8.json |
| 26895-3 | Amphetamines [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26895-3.json |
| 2689-8 | Osmolality of Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2689-8.json |
| 26898-7 | Temazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26898-7.json |
| 26899-5 | Midazolam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26899-5.json |
| 26900-1 | chlordiazePOXIDE [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26900-1.json |
| 26901-9 | Flurazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/26901-9.json |
| 26902-7 | Doxycycline [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/26902-7.json |
| 26903-5 | Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26903-5.json |
| 26905-0 | PHENobarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26905-0.json |
| 2690-6 | Osmolality of Pleural fluid | ./2.16.840.1.114222.4.11.1002/2690-6.json |
| 26906-8 | Mephobarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26906-8.json |
| 26907-6 | Listeria sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/26907-6.json |
| 26908-4 | 17-Hydroxyprogesterone [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26908-4.json |
| 26910-0 | Alpha hydroxyalprazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26910-0.json |
| 26911-8 | ALPRAZolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26911-8.json |
| 26912-6 | Hydroxytriazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26912-6.json |
| 26913-4 | Triazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26913-4.json |
| 2691-4 | Osmolality of Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2691-4.json |
| 26914-2 | Estazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26914-2.json |
| 26915-9 | Pyridoxine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/26915-9.json |
| 26916-7 | Cobalamin (Vitamin B12) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/26916-7.json |
| 26918-3 | PENTobarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26918-3.json |
| 26920-9 | Amobarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26920-9.json |
| 2692-2 | Osmolality of Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2692-2.json |
| 26923-3 | Butabarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26923-3.json |
| 26924-1 | Cancer Ag 19-9 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/26924-1.json |
| 26925-8 | Acetophenazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26925-8.json |
| 26927-4 | Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26927-4.json |
| 26928-2 | Vasopressin [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26928-2.json |
| 2693-0 | Osmolality of Stool | ./2.16.840.1.114222.4.11.1002/2693-0.json |
| 26930-8 | Secobarbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26930-8.json |
| 26931-6 | Complement C4 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26931-6.json |
| 26933-2 | Oxazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26933-2.json |
| 26934-0 | LORazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26934-0.json |
| 26935-7 | diazePAM [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26935-7.json |
| 26936-5 | Hydroxyethylflurazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26936-5.json |
| 26937-3 | Temazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26937-3.json |
| 26938-1 | chlordiazePOXIDE [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26938-1.json |
| 26940-7 | Myelin basic protein [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/26940-7.json |
| 26942-3 | Mumps virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26942-3.json |
| 26943-1 | 11-Ketoandrosterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26943-1.json |
| 26944-9 | 11-Ketoandrosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26944-9.json |
| 26945-6 | Triazolam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/26945-6.json |
| 26946-4 | Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26946-4.json |
| 26947-2 | Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26947-2.json |
| 2694-8 | Osmolality of 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2694-8.json |
| 26948-0 | Saccharopolyspora rectivirgula IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26948-0.json |
| 26949-8 | Thermoactinomyces IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26949-8.json |
| 26950-6 | 11-Hydroxyetiocholanolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26950-6.json |
| 26951-4 | Alternaria alternata IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26951-4.json |
| 26952-2 | Phoma herbarum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26952-2.json |
| 26953-0 | Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26953-0.json |
| 26954-8 | Aspergillus fumigatus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26954-8.json |
| 2695-5 | Osmolality of Urine | ./2.16.840.1.114222.4.11.1002/2695-5.json |
| 26955-5 | Aureobasidium pullulans IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26955-5.json |
| 26956-3 | Cocaine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26956-3.json |
| 26957-1 | Penicillium notatum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/26957-1.json |
| 26958-9 | IgM [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26958-9.json |
| 26959-7 | Amphetamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26959-7.json |
| 26960-5 | Trypsin [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/26960-5.json |
| 26962-1 | Cystine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26962-1.json |
| 2696-3 | Osmolality of Specimen | ./2.16.840.1.114222.4.11.1002/2696-3.json |
| 26969-6 | Parietal cell Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26969-6.json |
| 26970-4 | Reticulin IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26970-4.json |
| 2697-1 | Osteocalcin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2697-1.json |
| 26971-2 | Smooth muscle Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26971-2.json |
| 26972-0 | Herpes virus 7 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26972-0.json |
| 26974-6 | Delta aminolevulinate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26974-6.json |
| 26975-3 | SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/26975-3.json |
| 26976-1 | Hydroxytriazolam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/26976-1.json |
| 26978-7 | Protriptyline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/26978-7.json |
| 26979-5 | Flurazepam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/26979-5.json |
| 26980-3 | Coccidioides immitis Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/26980-3.json |
| 26981-1 | Phenylalanine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/26981-1.json |
| 26984-5 | Helicobacter pylori IgG Ab [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/26984-5.json |
| 26986-0 | Trichoderma viride IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/26986-0.json |
| 26987-8 | Pentachlorophenol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/26987-8.json |
| 26988-6 | 18-Hydroxydeoxycorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/26988-6.json |
| 2698-9 | Osteonectin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2698-9.json |
| 26989-4 | Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/26989-4.json |
| 26990-2 | Phentermine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26990-2.json |
| 26991-0 | Phenylpropanolamine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26991-0.json |
| 26992-8 | Mephentermine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26992-8.json |
| 26993-6 | Benzfetamine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26993-6.json |
| 26994-4 | Phencyclidine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/26994-4.json |
| 26995-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/26995-1.json |
| 26996-9 | Complement C7 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/26996-9.json |
| 2699-7 | Oxalate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2699-7.json |
| 26998-5 | Thyrotropin [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/26998-5.json |
| 27000-9 | Thyroxine (T4) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27000-9.json |
| 27001-7 | Diethyl ether [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27001-7.json |
| 27002-5 | Secobarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27002-5.json |
| 2700-3 | Oxalate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2700-3.json |
| 27003-3 | Mephobarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27003-3.json |
| 27004-1 | Benzfetamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27004-1.json |
| 27007-4 | Acetohexamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27007-4.json |
| 27009-0 | Coccidioides sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27009-0.json |
| 2701-1 | Oxalate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2701-1.json |
| 27012-4 | Benzaldehyde [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27012-4.json |
| 27014-0 | Inhibin A [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27014-0.json |
| 27015-7 | Polychlorinated biphenyl (PCB) [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/27015-7.json |
| 27017-3 | Allyl alcohol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27017-3.json |
| 27018-1 | IgG.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27018-1.json |
| 27019-9 | IgA.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27019-9.json |
| 27020-7 | IgM.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27020-7.json |
| 27021-5 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/27021-5.json |
| 27022-3 | Para aminophenol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/27022-3.json |
| 27024-9 | Cannabinoids [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27024-9.json |
| 27025-6 | glipiZIDE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27025-6.json |
| 27026-4 | Benzoylecgonine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27026-4.json |
| 2702-9 | Oxalate renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2702-9.json |
| 27029-8 | Norpropoxyphene [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27029-8.json |
| 27030-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27030-6.json |
| 27031-4 | Oxyphenisatin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27031-4.json |
| 27032-2 | Zirconium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27032-2.json |
| 27034-8 | Drugs identified in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/27034-8.json |
| 27035-5 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27035-5.json |
| 27036-3 | Norchlordiazepoxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27036-3.json |
| 2703-7 | Oxygen [Partial pressure] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2703-7.json |
| 27037-1 | Calcium/Creatinine [Mass Ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/27037-1.json |
| 27038-9 | Endomysium IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27038-9.json |
| 27039-7 | Ammonia [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27039-7.json |
| 27041-3 | Norpropoxyphene [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27041-3.json |
| 27042-1 | Methohexital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27042-1.json |
| 2704-5 | Oxygen [Partial pressure] in Capillary blood | ./2.16.840.1.114222.4.11.1002/2704-5.json |
| 27048-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27048-8.json |
| 27049-6 | Secobarbital [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27049-6.json |
| 27050-4 | Mephobarbital [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27050-4.json |
| 27051-2 | PHENobarbital [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27051-2.json |
| 2705-2 | Oxygen [Partial pressure] in Venous blood | ./2.16.840.1.114222.4.11.1002/2705-2.json |
| 27052-0 | Methadone [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27052-0.json |
| 27053-8 | Morphine [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27053-8.json |
| 27054-6 | Morphine Free [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27054-6.json |
| 27055-3 | Catecholamines Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27055-3.json |
| 27057-9 | Serotonin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27057-9.json |
| 27059-5 | traZODone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27059-5.json |
| 2706-0 | Oxygen [Partial pressure] in Body fluid | ./2.16.840.1.114222.4.11.1002/2706-0.json |
| 27060-3 | Melatonin [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27060-3.json |
| 27061-1 | Butabarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27061-1.json |
| 27063-7 | Benzodiazepines [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27063-7.json |
| 27064-5 | Opiates [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27064-5.json |
| 27067-8 | Propoxyphene [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27067-8.json |
| 27068-6 | Purkinje cells Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27068-6.json |
| 27069-4 | Cisapride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27069-4.json |
| 27070-2 | Loratadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27070-2.json |
| 27072-8 | 14-3-3 Ag [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/27072-8.json |
| 27074-4 | Methylenedioxyethylamphetamine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27074-4.json |
| 27075-1 | Lycopene [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/27075-1.json |
| 27076-9 | Dextromethorphan+Levorphanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27076-9.json |
| 27077-7 | Enterococcus sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27077-7.json |
| 27078-5 | Carotene.alpha [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/27078-5.json |
| 27079-3 | Methylenedioxyethylamphetamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27079-3.json |
| 27080-1 | Methylenedioxyethylamphetamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27080-1.json |
| 27081-9 | Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27081-9.json |
| 27082-7 | Delavirdine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27082-7.json |
| 27083-5 | Norflunitrazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27083-5.json |
| 27084-3 | 7-Aminoflunitrazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27084-3.json |
| 27085-0 | Methylenedioxyethylamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27085-0.json |
| 2708-6 | Oxygen saturation in Arterial blood | ./2.16.840.1.114222.4.11.1002/2708-6.json |
| 27086-8 | Cannabinoids [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27086-8.json |
| 27087-6 | Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27087-6.json |
| 27088-4 | Folate [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27088-4.json |
| 27090-0 | Entamoeba histolytica IgA Ab [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27090-0.json |
| 27091-8 | Calcium [Mass/time] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/27091-8.json |
| 27093-4 | Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/27093-4.json |
| 2709-4 | Oxygen saturation in Capillary blood | ./2.16.840.1.114222.4.11.1002/2709-4.json |
| 27095-9 | Parvovirus B19 IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27095-9.json |
| 27099-1 | Riboflavin [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27099-1.json |
| 27100-7 | Probenecid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27100-7.json |
| 27101-5 | Phenmetrazine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27101-5.json |
| 27102-3 | Phendimetrazine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27102-3.json |
| 27103-1 | Procyclidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27103-1.json |
| 27105-6 | Amphetamines [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27105-6.json |
| 27106-4 | Zinc [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27106-4.json |
| 27109-8 | PARoxetine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27109-8.json |
| 2711-0 | Oxygen saturation in Venous blood | ./2.16.840.1.114222.4.11.1002/2711-0.json |
| 27110-6 | Androsterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27110-6.json |
| 27112-2 | Microscopic observation [Identifier] in Body fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/27112-2.json |
| 27114-8 | Cocaine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/27114-8.json |
| 27115-5 | Parvovirus B19 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27115-5.json |
| 27116-3 | Methamphetamine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27116-3.json |
| 27117-1 | Cadmium [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27117-1.json |
| 27118-9 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27118-9.json |
| 27120-5 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/27120-5.json |
| 27121-3 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/27121-3.json |
| 27122-1 | Magnesium [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27122-1.json |
| 27123-9 | Phosphate [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27123-9.json |
| 27124-7 | Copper [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27124-7.json |
| 27125-4 | Zinc [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27125-4.json |
| 27127-0 | Arsenic [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27127-0.json |
| 27129-6 | Lead [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27129-6.json |
| 27130-4 | Mercury [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27130-4.json |
| 27131-2 | Phencyclidine [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27131-2.json |
| 27132-0 | Acetoacetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27132-0.json |
| 27133-8 | Citrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27133-8.json |
| 27134-6 | Argininosuccinate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27134-6.json |
| 27136-1 | Opiates [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27136-1.json |
| 27137-9 | Antimony [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27137-9.json |
| 27140-3 | Follitropin.alpha subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27140-3.json |
| 27149-4 | Thiamine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27149-4.json |
| 27150-2 | Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum--1st specimen | ./2.16.840.1.114222.4.11.1002/27150-2.json |
| 27151-0 | Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/27151-0.json |
| 27159-3 | Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27159-3.json |
| 27160-1 | Hydrastine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27160-1.json |
| 27161-9 | Interleukin 4 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27161-9.json |
| 27163-5 | N-methylacetamide/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/27163-5.json |
| 27164-3 | Acetohexamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27164-3.json |
| 27165-0 | Hexobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27165-0.json |
| 27166-8 | TOLAZamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27166-8.json |
| 27167-6 | Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27167-6.json |
| 27168-4 | Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27168-4.json |
| 27170-0 | TOLBUTamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27170-0.json |
| 27171-8 | Chlorphentermine [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27171-8.json |
| 27172-6 | Calcium [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/27172-6.json |
| 27173-4 | Propylthiouracil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27173-4.json |
| 27174-2 | Inhibin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27174-2.json |
| 27175-9 | glyBURIDE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27175-9.json |
| 27177-5 | Herpes virus 7 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27177-5.json |
| 27178-3 | Phendimetrazine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27178-3.json |
| 27180-9 | Bisacodyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27180-9.json |
| 27181-7 | Hydroxyproline [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/27181-7.json |
| 27182-5 | Calcium [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27182-5.json |
| 27183-3 | Cardiolipin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27183-3.json |
| 2718-5 | Oxytocin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2718-5.json |
| 27185-8 | Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27185-8.json |
| 27186-6 | Lysozyme [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/27186-6.json |
| 27187-4 | Methohexital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27187-4.json |
| 27188-2 | Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27188-2.json |
| 27189-0 | Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27189-0.json |
| 27190-8 | Propoxyphene [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27190-8.json |
| 27191-6 | PHENobarbital [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27191-6.json |
| 27192-4 | diazePAM [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27192-4.json |
| 27193-2 | Tetrahydrocannabinol [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27193-2.json |
| 27194-0 | N-desalkylflurazepam [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27194-0.json |
| 27196-5 | HYDROmorphone Free [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27196-5.json |
| 27197-3 | Benzodiazepines [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27197-3.json |
| 27198-1 | Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct | ./2.16.840.1.114222.4.11.1002/27198-1.json |
| 27199-9 | 18-Hydroxycortisol/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27199-9.json |
| 27200-5 | Nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27200-5.json |
| 27201-3 | Zinc/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27201-3.json |
| 27202-1 | Halothane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/27202-1.json |
| 27203-9 | Follitropin [Units/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27203-9.json |
| 27204-7 | Cocaine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27204-7.json |
| 27205-4 | Amphetamines [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27205-4.json |
| 27206-2 | Morphine Free [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27206-2.json |
| 27207-0 | Methadone [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27207-0.json |
| 27208-8 | Drugs identified in Stool by Screen method | ./2.16.840.1.114222.4.11.1002/27208-8.json |
| 27209-6 | Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/27209-6.json |
| 27210-4 | Magnesium [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27210-4.json |
| 27211-2 | Norpropoxyphene [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/27211-2.json |
| 27212-0 | DOPamine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27212-0.json |
| 27213-8 | Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27213-8.json |
| 27214-6 | Purkinje cells Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27214-6.json |
| 27216-1 | sulfADIAZINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27216-1.json |
| 27218-7 | quiNINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27218-7.json |
| 2721-9 | Pancreatic polypeptide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2721-9.json |
| 27220-3 | Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/27220-3.json |
| 27221-1 | Norepinephrine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27221-1.json |
| 27222-9 | Oxalate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27222-9.json |
| 27224-5 | Barbiturates [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27224-5.json |
| 27225-2 | Estriol (E3) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27225-2.json |
| 27226-0 | Cocaethylene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27226-0.json |
| 2722-7 | Pantothenate [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/2722-7.json |
| 27232-8 | Lead [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27232-8.json |
| 27233-6 | Lecithin [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/27233-6.json |
| 27234-4 | Phentermine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27234-4.json |
| 2723-5 | Para aminohippurate renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2723-5.json |
| 27235-1 | PHENobarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27235-1.json |
| 27236-9 | Azatadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27236-9.json |
| 27237-7 | LORazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27237-7.json |
| 27238-5 | Oxazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27238-5.json |
| 27239-3 | Nordiazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27239-3.json |
| 27240-1 | PHENobarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27240-1.json |
| 27241-9 | Mephobarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27241-9.json |
| 27242-7 | Secobarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27242-7.json |
| 2724-3 | Para aminohippurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2724-3.json |
| 27243-5 | PENTobarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27243-5.json |
| 27244-3 | Methylenedioxyamphetamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27244-3.json |
| 27245-0 | Amobarbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27245-0.json |
| 27246-8 | Butalbital [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27246-8.json |
| 27247-6 | Hydroxyethylflurazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27247-6.json |
| 27248-4 | Benzoylecgonine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27248-4.json |
| 27249-2 | Temazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27249-2.json |
| 2725-0 | Para methylhippurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2725-0.json |
| 27250-0 | Phenmetrazine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27250-0.json |
| 27251-8 | Phenylpropanolamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27251-8.json |
| 27252-6 | Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27252-6.json |
| 27253-4 | Chlorphentermine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27253-4.json |
| 27254-2 | Amino beta guanidinopropionate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/27254-2.json |
| 27255-9 | Magnesium [Moles/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/27255-9.json |
| 27257-5 | Sodium [Moles/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/27257-5.json |
| 27259-1 | Estriol (E3).unconjugated [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27259-1.json |
| 27260-9 | Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/27260-9.json |
| 27261-7 | Polio virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/27261-7.json |
| 27262-5 | Methaqualone [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27262-5.json |
| 27263-3 | Amphetamines [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27263-3.json |
| 27264-1 | Aluminum [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27264-1.json |
| 27265-8 | Giardia sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/27265-8.json |
| 27266-6 | Histoplasma capsulatum Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27266-6.json |
| 27267-4 | Homovanillate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27267-4.json |
| 2726-8 | Para nitrophenol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2726-8.json |
| 27269-0 | Isocitrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27269-0.json |
| 27270-8 | 4-Hydroxyphenylacetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27270-8.json |
| 27271-6 | Alpha ketoglutarate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27271-6.json |
| 27273-2 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27273-2.json |
| 27275-7 | diazePAM [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27275-7.json |
| 2727-6 | Para nitrophenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2727-6.json |
| 27276-5 | Azatadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27276-5.json |
| 27277-3 | Methamphetamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27277-3.json |
| 27279-9 | Paraoxon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27279-9.json |
| 27280-7 | Tripelennamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27280-7.json |
| 27281-5 | Propoxyphene [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27281-5.json |
| 27282-3 | Carbinoxamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27282-3.json |
| 27283-1 | Methadone [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27283-1.json |
| 2728-4 | Parathion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2728-4.json |
| 27284-9 | Brompheniramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27284-9.json |
| 27285-6 | Estazolam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27285-6.json |
| 27286-4 | Triazolam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27286-4.json |
| 27287-2 | Flurazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27287-2.json |
| 27288-0 | Midazolam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27288-0.json |
| 27289-8 | Methamphetamine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27289-8.json |
| 27290-6 | Phenmetrazine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27290-6.json |
| 2729-2 | Parathyrin related protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2729-2.json |
| 27293-0 | oxyCODONE Free [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27293-0.json |
| 27295-5 | Cocaethylene [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27295-5.json |
| 27297-1 | Leukocyte esterase [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27297-1.json |
| 27299-7 | Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27299-7.json |
| 2730-0 | Parathyrin.C-terminal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2730-0.json |
| 27300-3 | Mephentermine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27300-3.json |
| 27301-1 | Glutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27301-1.json |
| 27302-9 | Midazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27302-9.json |
| 27303-7 | Phendimetrazine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27303-7.json |
| 27305-2 | Phentermine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27305-2.json |
| 27306-0 | Testosterone [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27306-0.json |
| 27307-8 | Chlorphentermine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27307-8.json |
| 27308-6 | PENTobarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27308-6.json |
| 27309-4 | Aspergillus flavus Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27309-4.json |
| 27311-0 | Codeine Free [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27311-0.json |
| 27312-8 | HYDROcodone Free [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27312-8.json |
| 27313-6 | Aspergillus niger Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27313-6.json |
| 27314-4 | HYDROmorphone Free [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27314-4.json |
| 27315-1 | Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27315-1.json |
| 27316-9 | Dioxin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27316-9.json |
| 2731-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2731-8.json |
| 27318-5 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27318-5.json |
| 27320-1 | Parietal cell Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/27320-1.json |
| 27321-9 | Opiates [Mass/volume] in Milk | ./2.16.840.1.114222.4.11.1002/27321-9.json |
| 27324-3 | Amobarbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27324-3.json |
| 2732-6 | Parathyrin.mid molecule [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2732-6.json |
| 27329-2 | Feline panleukopenia virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/27329-2.json |
| 27331-8 | Imipenem [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/27331-8.json |
| 27332-6 | Feline panleukopenia virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/27332-6.json |
| 2733-4 | Parathyrin.N-terminal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2733-4.json |
| 27336-7 | Amino acids [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/27336-7.json |
| 27337-5 | Amino beta guanidinopropionate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27337-5.json |
| 27339-1 | Nicotinamide [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/27339-1.json |
| 27340-9 | Cholesterol in HDL [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27340-9.json |
| 2734-2 | Pentoses [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2734-2.json |
| 27342-5 | Fasciola hepatica Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27342-5.json |
| 27343-3 | Molybdenum [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/27343-3.json |
| 27344-1 | Aspartate aminotransferase [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27344-1.json |
| 27346-6 | Benzfetamine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27346-6.json |
| 27347-4 | Methaqualone [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27347-4.json |
| 27351-6 | Pantothenate [Presence] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/27351-6.json |
| 27354-0 | Toxoplasma gondii IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27354-0.json |
| 27356-5 | Phencyclidine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27356-5.json |
| 27357-3 | HYDROcodone Free [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27357-3.json |
| 27358-1 | Benzoylecgonine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27358-1.json |
| 2735-9 | Pepsinogen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2735-9.json |
| 27360-7 | Myelin basic protein Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27360-7.json |
| 27361-5 | Tyrosine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27361-5.json |
| 27362-3 | Phenylalanine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27362-3.json |
| 27364-9 | Aspergillus niger Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27364-9.json |
| 27365-6 | Kappa light chains [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27365-6.json |
| 2736-7 | Pepsinogen I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2736-7.json |
| 27367-2 | Manganese/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/27367-2.json |
| 27368-0 | Chlamydia trachomatis B Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27368-0.json |
| 27369-8 | Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/27369-8.json |
| 27370-6 | Chlamydia trachomatis C Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27370-6.json |
| 27371-4 | Chlamydia trachomatis G+F+K Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27371-4.json |
| 27373-0 | Calcium [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/27373-0.json |
| 2737-5 | Pepsinogen I [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2737-5.json |
| 27375-5 | Aspergillus fumigatus Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27375-5.json |
| 27377-1 | Aspergillus flavus Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27377-1.json |
| 27378-9 | pH of 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27378-9.json |
| 27379-7 | Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/27379-7.json |
| 27382-1 | Porphobilinogen [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27382-1.json |
| 2738-3 | Pepsinogen II [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2738-3.json |
| 27383-9 | Feline herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27383-9.json |
| 27384-7 | Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/27384-7.json |
| 27386-2 | Blastomyces dermatitidis Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/27386-2.json |
| 2739-1 | Pepsinogen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2739-1.json |
| 27391-2 | Candida sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27391-2.json |
| 27394-6 | Lambda light chains [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27394-6.json |
| 27395-3 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27395-3.json |
| 27396-1 | Hemoglobin.gastrointestinal [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27396-1.json |
| 27402-7 | Norparamethadione [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27402-7.json |
| 27403-5 | Gamma glutamyl transferase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27403-5.json |
| 27404-3 | Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27404-3.json |
| 2740-9 | Pepsins [Enzymatic activity/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/2740-9.json |
| 27409-2 | Methylenedianiline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27409-2.json |
| 27411-8 | Iron/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/27411-8.json |
| 27412-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27412-6.json |
| 27413-4 | Dextromethorphan [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27413-4.json |
| 27414-2 | Fungus identified in Stool by Culture | ./2.16.840.1.114222.4.11.1002/27414-2.json |
| 27415-9 | Interferon gamma [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27415-9.json |
| 27416-7 | SCL-70 extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27416-7.json |
| 2741-7 | Pepsins [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2741-7.json |
| 27417-5 | Candida sp IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27417-5.json |
| 27418-3 | chlordiazePOXIDE [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27418-3.json |
| 27419-1 | Sodium [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/27419-1.json |
| 27420-9 | Phosphatidylglycerol [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/27420-9.json |
| 27423-3 | 1,4-Dioxane [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27423-3.json |
| 27424-1 | Deoxypyridinoline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27424-1.json |
| 2742-5 | Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2742-5.json |
| 27426-6 | Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27426-6.json |
| 27427-4 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/27427-4.json |
| 2743-3 | pH of Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2743-3.json |
| 27433-2 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/27433-2.json |
| 27436-5 | N-desalkylflurazepam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27436-5.json |
| 27438-1 | Protein C Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27438-1.json |
| 27439-9 | Alpha hydroxyalprazolam [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27439-9.json |
| 27440-7 | Candida sp Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27440-7.json |
| 2744-1 | pH of Arterial blood | ./2.16.840.1.114222.4.11.1002/2744-1.json |
| 27441-5 | Potassium [Moles/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/27441-5.json |
| 27442-3 | Phenylpropanolamine [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/27442-3.json |
| 2745-8 | pH of Capillary blood | ./2.16.840.1.114222.4.11.1002/2745-8.json |
| 2746-6 | pH of Venous blood | ./2.16.840.1.114222.4.11.1002/2746-6.json |
| 2747-4 | pH of Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2747-4.json |
| 2748-2 | pH of Body fluid | ./2.16.840.1.114222.4.11.1002/2748-2.json |
| 2749-0 | pH of Gastric fluid | ./2.16.840.1.114222.4.11.1002/2749-0.json |
| 2750-8 | pH of Pleural fluid | ./2.16.840.1.114222.4.11.1002/2750-8.json |
| 2751-6 | pH of Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2751-6.json |
| 2752-4 | pH of Semen | ./2.16.840.1.114222.4.11.1002/2752-4.json |
| 2753-2 | pH of Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2753-2.json |
| 2754-0 | pH of Synovial fluid | ./2.16.840.1.114222.4.11.1002/2754-0.json |
| 2755-7 | pH of Stool | ./2.16.840.1.114222.4.11.1002/2755-7.json |
| 2756-5 | pH of Urine | ./2.16.840.1.114222.4.11.1002/2756-5.json |
| 2757-3 | Phenol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2757-3.json |
| 2758-1 | Phenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2758-1.json |
| 2759-9 | Phenols [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2759-9.json |
| 2760-7 | Phenolsulphonphthalein [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2760-7.json |
| 2761-5 | Phenylketones [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2761-5.json |
| 2762-3 | Phenylalanine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2762-3.json |
| 2764-9 | Phenylalanine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2764-9.json |
| 2765-6 | Phenylalanine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2765-6.json |
| 2769-8 | Phenylketones [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2769-8.json |
| 2770-6 | Phenylpyruvate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2770-6.json |
| 2771-4 | Phenylpyruvate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2771-4.json |
| 2772-2 | Phenylpyruvate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2772-2.json |
| 2773-0 | Phenylpyruvate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2773-0.json |
| 2774-8 | Phosphate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2774-8.json |
| 2775-5 | Phosphate [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2775-5.json |
| 2776-3 | Phosphate renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2776-3.json |
| 2777-1 | Phosphate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2777-1.json |
| 2778-9 | Phosphate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2778-9.json |
| 2779-7 | Phosphate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2779-7.json |
| 2780-5 | Phosphate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2780-5.json |
| 27811-9 | Antithrombin actual/normal in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/27811-9.json |
| 27812-7 | Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27812-7.json |
| 27816-8 | von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27816-8.json |
| 27817-6 | Beta 2 glycoprotein 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27817-6.json |
| 27818-4 | Protein C actual/normal in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/27818-4.json |
| 27819-2 | Protein C actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/27819-2.json |
| 27820-0 | Protein C Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27820-0.json |
| 27821-8 | Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27821-8.json |
| 27822-6 | Protein S actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/27822-6.json |
| 27823-4 | Protein S Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27823-4.json |
| 27824-2 | Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/27824-2.json |
| 27831-7 | Immune complex [Units/volume] in Serum or Plasma by C1q binding assay | ./2.16.840.1.114222.4.11.1002/27831-7.json |
| 2783-9 | Lecithin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2783-9.json |
| 2784-7 | Phosphatidylcholine.saturated [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2784-7.json |
| 2785-4 | Phosphatidylglycerol [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2785-4.json |
| 27859-8 | Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27859-8.json |
| 2786-2 | Phosphatidylglycerol [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2786-2.json |
| 27866-3 | 17-Ketogenic steroids [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27866-3.json |
| 2787-0 | Phosphatidylinositol [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2787-0.json |
| 27871-3 | Interferon beta IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27871-3.json |
| 27873-9 | Insulin [Units/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/27873-9.json |
| 27882-0 | Proinsulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27882-0.json |
| 2788-8 | Phosphoenolpyruvate carboxykinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2788-8.json |
| 27894-5 | Sulfatide IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27894-5.json |
| 27900-0 | Lactobacillus sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27900-0.json |
| 27901-8 | Lactobacillus sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27901-8.json |
| 27902-6 | Enterococcus sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27902-6.json |
| 27903-4 | Coxsackievirus B2 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27903-4.json |
| 27905-9 | Bacteroides fragilis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/27905-9.json |
| 27907-5 | Cryptosporidium sp [Identifier] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/27907-5.json |
| 27908-3 | Coxsackievirus B1 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27908-3.json |
| 2791-2 | Phosphofructokinase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2791-2.json |
| 27912-5 | Butalbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/27912-5.json |
| 27914-1 | Gamma aminoadipate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27914-1.json |
| 27915-8 | Alpha-1-Antichymotrypsin [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/27915-8.json |
| 27917-4 | Coxsackievirus B3 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27917-4.json |
| 27918-2 | Coxsackievirus B4 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27918-2.json |
| 2792-0 | Phosphofructokinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2792-0.json |
| 27920-8 | Normeperidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27920-8.json |
| 27921-6 | Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27921-6.json |
| 27922-4 | Echovirus 4 RNA [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27922-4.json |
| 27923-2 | Coenzyme Q10 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27923-2.json |
| 27924-0 | Ascaris sp Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27924-0.json |
| 27927-3 | Butalbital [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/27927-3.json |
| 27928-1 | Echovirus 30 RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27928-1.json |
| 27929-9 | Mandelate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/27929-9.json |
| 27931-5 | Bile acid [Moles/volume] in Serum --2 hours post meal | ./2.16.840.1.114222.4.11.1002/27931-5.json |
| 27934-9 | Echovirus 11 RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27934-9.json |
| 27937-2 | Sporothrix schenckii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/27937-2.json |
| 27938-0 | Salmonella paratyphi B O Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/27938-0.json |
| 27939-8 | Collagen crosslinked N-telopeptide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27939-8.json |
| 27941-4 | Lactate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/27941-4.json |
| 27942-2 | Follitropin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27942-2.json |
| 27943-0 | Interferon omega [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27943-0.json |
| 27944-8 | C peptide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27944-8.json |
| 27945-5 | Coxiella burnetii phase 2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27945-5.json |
| 27947-1 | Coxsackievirus A7 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27947-1.json |
| 27948-9 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/27948-9.json |
| 27950-5 | Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27950-5.json |
| 27951-3 | Coxiella burnetii phase 1 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27951-3.json |
| 27952-1 | Enterovirus RNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27952-1.json |
| 27954-7 | Coxsackievirus B6 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27954-7.json |
| 27960-4 | Coxsackievirus B5 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27960-4.json |
| 27962-0 | Butalbital [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/27962-0.json |
| 27965-3 | Babesia microti IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/27965-3.json |
| 27966-1 | Legionella pneumophila atypical Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/27966-1.json |
| 27969-5 | Coxsackievirus A9 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/27969-5.json |
| 27975-2 | Thyrotropin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27975-2.json |
| 27976-0 | Lactate [Mass/volume] in Blood --fasting | ./2.16.840.1.114222.4.11.1002/27976-0.json |
| 27977-8 | Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27977-8.json |
| 27978-6 | Metanephrines/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27978-6.json |
| 2797-9 | Phosphoglucomutase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2797-9.json |
| 27979-4 | 17-Ketogenic steroids [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/27979-4.json |
| 27980-2 | Thyroxine binding globulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/27980-2.json |
| 27984-4 | SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/27984-4.json |
| 2798-7 | Phosphoglycerate kinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2798-7.json |
| 27990-1 | Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/27990-1.json |
| 27991-9 | Fibrinogen fragments [Mass/volume] in Urine by Latex agglutination | ./2.16.840.1.114222.4.11.1002/27991-9.json |
| 27993-5 | Sympathomimetics [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/27993-5.json |
| 27994-3 | Ehrlichia chaffeensis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/27994-3.json |
| 2799-5 | Phosphoglyceromutase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2799-5.json |
| 27998-4 | Estrone (E1) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/27998-4.json |
| 27999-2 | Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/27999-2.json |
| 28001-6 | Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/28001-6.json |
| 28003-2 | Sodium/Potassium [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28003-2.json |
| 28004-0 | HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/28004-0.json |
| 28005-7 | MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/28005-7.json |
| 28006-5 | Hemoglobin F [Presence] in Vomitus | ./2.16.840.1.114222.4.11.1002/28006-5.json |
| 28007-3 | Urobilinogen [Units] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/28007-3.json |
| 28008-1 | Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/28008-1.json |
| 28011-5 | Emergency department Medical records | ./2.16.840.1.114222.4.11.1002/28011-5.json |
| 28035-4 | Escherichia coli shiga-like toxin [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/28035-4.json |
| 28038-8 | Gamma hydroxybutyrate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/28038-8.json |
| 28041-2 | Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28041-2.json |
| 28042-0 | Organophosphate pesticides [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/28042-0.json |
| 28044-6 | Gamma hydroxybutyrate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/28044-6.json |
| 28047-9 | Carbamate pesticides [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/28047-9.json |
| 2805-0 | Pipecolate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2805-0.json |
| 28060-2 | MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/28060-2.json |
| 28061-0 | Naloxone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28061-0.json |
| 28064-4 | amLODIPine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28064-4.json |
| 28066-9 | Celecoxib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28066-9.json |
| 28067-7 | Hemoglobin F [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/28067-7.json |
| 2806-8 | Pipecolate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2806-8.json |
| 28069-3 | Meat fibers [#/area] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/28069-3.json |
| 28071-9 | E selectin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/28071-9.json |
| 28072-7 | Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/28072-7.json |
| 28074-3 | Tritium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/28074-3.json |
| 28075-0 | Sildenafil citrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28075-0.json |
| 2807-6 | Pipecolate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2807-6.json |
| 28076-8 | SUMAtriptan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28076-8.json |
| 28077-6 | Hexachlorobutadiene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28077-6.json |
| 28078-4 | Bladder tumor Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/28078-4.json |
| 2809-2 | Porphobilinogen [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2809-2.json |
| 2810-0 | Porphobilinogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2810-0.json |
| 2811-8 | Porphobilinogen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2811-8.json |
| 2812-6 | Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2812-6.json |
| 2813-4 | Porphobilinogen synthase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2813-4.json |
| 2814-2 | Porphyrins [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2814-2.json |
| 2815-9 | Porphyrins [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2815-9.json |
| 2816-7 | Porphyrins [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/2816-7.json |
| 2818-3 | Porphyrins [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2818-3.json |
| 2819-1 | Potassium [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2819-1.json |
| 2820-9 | Potassium [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2820-9.json |
| 2821-7 | Potassium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2821-7.json |
| 2822-5 | Potassium [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/2822-5.json |
| 2823-3 | Potassium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2823-3.json |
| 2824-1 | Potassium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2824-1.json |
| 2825-8 | Potassium [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2825-8.json |
| 2826-6 | Potassium [Moles/time] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/2826-6.json |
| 2827-4 | Potassium [Moles/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/2827-4.json |
| 2828-2 | Potassium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2828-2.json |
| 2829-0 | Potassium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2829-0.json |
| 2830-8 | Potassium renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2830-8.json |
| 2831-6 | Pregnancy specific protein 1 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2831-6.json |
| 2832-4 | Pregnanediol [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2832-4.json |
| 2833-2 | Pregnanediol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2833-2.json |
| 2834-0 | Pregnanediol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2834-0.json |
| 2835-7 | Pregnanetriol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2835-7.json |
| 2836-5 | Pregnanetriol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2836-5.json |
| 2837-3 | Pregnenolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2837-3.json |
| 2838-1 | Progesterone [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2838-1.json |
| 2839-9 | Progesterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2839-9.json |
| 2840-7 | Proinsulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2840-7.json |
| 2841-5 | Prolactin [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2841-5.json |
| 2842-3 | Prolactin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2842-3.json |
| 2851-4 | Prostaglandin E [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2851-4.json |
| 2852-2 | Prostaglandin E1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2852-2.json |
| 2853-0 | Prostaglandin E2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2853-0.json |
| 28546-0 | Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/28546-0.json |
| 28547-8 | Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/28547-8.json |
| 2854-8 | Prostaglandin F [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2854-8.json |
| 28548-6 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/28548-6.json |
| 28549-4 | Yersinia sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/28549-4.json |
| 28550-2 | Cortisol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/28550-2.json |
| 28551-0 | Bladder tumor Ag [Units/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/28551-0.json |
| 28552-8 | Cladosporium herbarum IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/28552-8.json |
| 28554-4 | Triglyceride [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/28554-4.json |
| 2855-5 | Prostaglandin F2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2855-5.json |
| 28555-1 | Nicotine+Cotinine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/28555-1.json |
| 28556-9 | Chlamydia trachomatis D+K IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/28556-9.json |
| 28557-7 | Chlamydia trachomatis D+K IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/28557-7.json |
| 28558-5 | Chlamydia trachomatis D+K IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/28558-5.json |
| 28559-3 | Hemoglobin A2 [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/28559-3.json |
| 28560-1 | Neuronal thread protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/28560-1.json |
| 28561-9 | XR Pelvis Views | ./2.16.840.1.114222.4.11.1002/28561-9.json |
| 2856-3 | Prostaglandin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2856-3.json |
| 28564-3 | XR Skull Views | ./2.16.840.1.114222.4.11.1002/28564-3.json |
| 28565-0 | XR Knee Views | ./2.16.840.1.114222.4.11.1002/28565-0.json |
| 28566-8 | CT Spine | ./2.16.840.1.114222.4.11.1002/28566-8.json |
| 28567-6 | XR Humerus Views | ./2.16.840.1.114222.4.11.1002/28567-6.json |
| 28568-4 | Physician Emergency department Note | ./2.16.840.1.114222.4.11.1002/28568-4.json |
| 28569-2 | Consultant Progress note | ./2.16.840.1.114222.4.11.1002/28569-2.json |
| 28570-0 | Procedure note | ./2.16.840.1.114222.4.11.1002/28570-0.json |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2857-1.json |
| 28571-8 | Speech-language pathology Note | ./2.16.840.1.114222.4.11.1002/28571-8.json |
| 28572-6 | Dentistry Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28572-6.json |
| 28573-4 | Physician, Operation note | ./2.16.840.1.114222.4.11.1002/28573-4.json |
| 28575-9 | Nurse practitioner Progress note | ./2.16.840.1.114222.4.11.1002/28575-9.json |
| 28576-7 | MR Joint | ./2.16.840.1.114222.4.11.1002/28576-7.json |
| 28577-5 | Dentistry procedure note | ./2.16.840.1.114222.4.11.1002/28577-5.json |
| 28578-3 | Occupational therapy Note | ./2.16.840.1.114222.4.11.1002/28578-3.json |
| 28579-1 | Physical therapy Note | ./2.16.840.1.114222.4.11.1002/28579-1.json |
| 28580-9 | Chiropractic medicine Progress note | ./2.16.840.1.114222.4.11.1002/28580-9.json |
| 28581-7 | Chiropractic medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28581-7.json |
| 28582-5 | XR Hand Views | ./2.16.840.1.114222.4.11.1002/28582-5.json |
| 28583-3 | Dentist Operation note | ./2.16.840.1.114222.4.11.1002/28583-3.json |
| 28585-8 | 4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/28585-8.json |
| 28587-4 | Benzoate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/28587-4.json |
| 28589-0 | Carnitine esters/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/28589-0.json |
| 28591-6 | Amino beta guanidinopropionate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/28591-6.json |
| 2859-7 | Protein kinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2859-7.json |
| 28601-3 | Hydroxyproline/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/28601-3.json |
| 2860-5 | Protein nitrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2860-5.json |
| 28607-0 | Canine parvovirus Ab [Presence] in Stool by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/28607-0.json |
| 28612-0 | Legionella sp IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/28612-0.json |
| 28613-8 | XR Spine Views | ./2.16.840.1.114222.4.11.1002/28613-8.json |
| 28614-6 | US Liver | ./2.16.840.1.114222.4.11.1002/28614-6.json |
| 28615-3 | Audiology study | ./2.16.840.1.114222.4.11.1002/28615-3.json |
| 28616-1 | Physician Transfer note | ./2.16.840.1.114222.4.11.1002/28616-1.json |
| 28617-9 | Dentistry Progress note | ./2.16.840.1.114222.4.11.1002/28617-9.json |
| 28618-7 | Dentistry Note | ./2.16.840.1.114222.4.11.1002/28618-7.json |
| 28621-1 | Nurse practitioner Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28621-1.json |
| 28623-7 | Nurse Progress note | ./2.16.840.1.114222.4.11.1002/28623-7.json |
| 28624-5 | Podiatry Operation note | ./2.16.840.1.114222.4.11.1002/28624-5.json |
| 28625-2 | Podiatry procedure note | ./2.16.840.1.114222.4.11.1002/28625-2.json |
| 28626-0 | Physician History and physical note | ./2.16.840.1.114222.4.11.1002/28626-0.json |
| 28627-8 | Psychiatry Progress note | ./2.16.840.1.114222.4.11.1002/28627-8.json |
| 28628-6 | Psychiatry Note | ./2.16.840.1.114222.4.11.1002/28628-6.json |
| 28629-4 | Perimetry study | ./2.16.840.1.114222.4.11.1002/28629-4.json |
| 28630-2 | Tonometry study | ./2.16.840.1.114222.4.11.1002/28630-2.json |
| 28631-0 | Visual acuity study | ./2.16.840.1.114222.4.11.1002/28631-0.json |
| 28632-8 | Heterophoria study | ./2.16.840.1.114222.4.11.1002/28632-8.json |
| 28633-6 | Polysomnography (sleep) study | ./2.16.840.1.114222.4.11.1002/28633-6.json |
| 28635-1 | Psychiatry Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28635-1.json |
| 28636-9 | Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28636-9.json |
| 28640-1 | Bicarbonate [Moles/volume] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/28640-1.json |
| 28641-9 | Bicarbonate [Moles/volume] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/28641-9.json |
| 28644-3 | Carbon dioxide [Partial pressure] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/28644-3.json |
| 28645-0 | Carbon dioxide [Partial pressure] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/28645-0.json |
| 28646-8 | pH of Arterial cord blood | ./2.16.840.1.114222.4.11.1002/28646-8.json |
| 28647-6 | pH of Venous cord blood | ./2.16.840.1.114222.4.11.1002/28647-6.json |
| 28648-4 | Oxygen [Partial pressure] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/28648-4.json |
| 28649-2 | Oxygen [Partial pressure] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/28649-2.json |
| 28651-8 | Nurse Transfer note | ./2.16.840.1.114222.4.11.1002/28651-8.json |
| 28652-6 | Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/28652-6.json |
| 28653-4 | Social worker Note | ./2.16.840.1.114222.4.11.1002/28653-4.json |
| 28654-2 | Attending Initial evaluation note | ./2.16.840.1.114222.4.11.1002/28654-2.json |
| 28655-9 | Attending Discharge summary | ./2.16.840.1.114222.4.11.1002/28655-9.json |
| 28656-7 | Social worker Progress note | ./2.16.840.1.114222.4.11.1002/28656-7.json |
| 2878-7 | Protein [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2878-7.json |
| 2879-5 | Protein [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2879-5.json |
| 2880-3 | Protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2880-3.json |
| 2881-1 | Protein [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2881-1.json |
| 2882-9 | Protein [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/2882-9.json |
| 2883-7 | Protein [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/2883-7.json |
| 2884-5 | Protein [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2884-5.json |
| 2885-2 | Protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2885-2.json |
| 2886-0 | Protein [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/2886-0.json |
| 2888-6 | Protein [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2888-6.json |
| 2889-4 | Protein [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2889-4.json |
| 2890-2 | Protein/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/2890-2.json |
| 2893-6 | Protoporphyrin.zinc [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2893-6.json |
| 2894-4 | Protoporphyrin.zinc [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2894-4.json |
| 2895-1 | Protoporphyrin.zinc [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2895-1.json |
| 2899-3 | Purine nucleoside phosphorylase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2899-3.json |
| 2900-9 | Pyridoxine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2900-9.json |
| 2901-7 | Pyridoxine congeners [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2901-7.json |
| 2902-5 | Pyrimidine-5'-Nucleotidase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/2902-5.json |
| 2903-3 | Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2903-3.json |
| 2905-8 | Pyruvate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2905-8.json |
| 2906-6 | Pyruvate [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/2906-6.json |
| 2907-4 | Pyruvate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2907-4.json |
| 2908-2 | Pyruvate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2908-2.json |
| 2909-0 | Pyruvate carboxylase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2909-0.json |
| 2910-8 | Pyruvate dehydrogenase.cytochrome [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2910-8.json |
| 29113-8 | Abacavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29113-8.json |
| 29114-6 | Amprenavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29114-6.json |
| 29115-3 | Delavirdine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29115-3.json |
| 2911-6 | Pyruvate dehydrogenase.lipoamide [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2911-6.json |
| 29116-1 | Didanosine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29116-1.json |
| 29117-9 | Efavirenz [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29117-9.json |
| 29118-7 | Indinavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29118-7.json |
| 29119-5 | lamiVUDine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29119-5.json |
| 29120-3 | Nelfinavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29120-3.json |
| 29121-1 | Nevirapine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29121-1.json |
| 29122-9 | Ritonavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29122-9.json |
| 29123-7 | Saquinavir [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29123-7.json |
| 2912-4 | Pyruvate kinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/2912-4.json |
| 29124-5 | Stavudine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29124-5.json |
| 29125-2 | Zalcitabine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29125-2.json |
| 29126-0 | Zidovudine [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29126-0.json |
| 2913-2 | Pyruvate kinase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2913-2.json |
| 2914-0 | Pyruvate oxidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2914-0.json |
| 29141-9 | Metanephrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29141-9.json |
| 29142-7 | Metanephrines [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29142-7.json |
| 29143-5 | 1,4-Dimethylbenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29143-5.json |
| 29144-3 | 1,2-Dimethylbenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29144-3.json |
| 29145-0 | 1,3-Dimethylbenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29145-0.json |
| 29146-8 | Alpha 1 antitrypsin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29146-8.json |
| 29147-6 | Carbamazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29147-6.json |
| 29148-4 | carBAMazepine.bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29148-4.json |
| 29149-2 | Mefloquine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29149-2.json |
| 29150-0 | Mefloquine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29150-0.json |
| 29153-4 | Cancer Ag 15-3 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29153-4.json |
| 29154-2 | Choriogonadotropin.beta subunit [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29154-2.json |
| 29155-9 | Follitropin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29155-9.json |
| 29156-7 | Lutropin [Units/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29156-7.json |
| 2915-7 | Renin [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2915-7.json |
| 29157-5 | Lutropin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29157-5.json |
| 29158-3 | Opiates [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/29158-3.json |
| 29159-1 | Methadone [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/29159-1.json |
| 29160-9 | Benzodiazepines [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/29160-9.json |
| 29161-7 | Barbiturates [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/29161-7.json |
| 2916-5 | Renin renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2916-5.json |
| 2917-3 | Renin [Mass/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/2917-3.json |
| 2918-1 | Renin [Enzymatic activity/volume] in Plasma --upright | ./2.16.840.1.114222.4.11.1002/2918-1.json |
| 2919-9 | Reticulin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2919-9.json |
| 29206-0 | Speech therapy service attachment | ./2.16.840.1.114222.4.11.1002/29206-0.json |
| 29207-8 | Amiodarone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29207-8.json |
| 29208-6 | Streptolysin O Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29208-6.json |
| 29209-4 | Benzodiazepines [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29209-4.json |
| 29210-2 | Bilirubin.indirect [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29210-2.json |
| 29211-0 | Caffeine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29211-0.json |
| 29212-8 | carBAMazepine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29212-8.json |
| 29213-6 | Ceruloplasmin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29213-6.json |
| 29214-4 | Chloramphenicol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29214-4.json |
| 2921-5 | Retinoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2921-5.json |
| 29215-1 | Digitoxin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29215-1.json |
| 29216-9 | Digoxin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29216-9.json |
| 29217-7 | Disopyramide [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29217-7.json |
| 29218-5 | Ethosuximide [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29218-5.json |
| 29219-3 | FLUoxetine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29219-3.json |
| 29220-1 | Haptoglobin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29220-1.json |
| 29221-9 | Mercury [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29221-9.json |
| 29222-7 | Mexiletine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29222-7.json |
| 2922-3 | Retinol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2922-3.json |
| 29223-5 | PHENobarbital [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29223-5.json |
| 29224-3 | Phenytoin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29224-3.json |
| 29225-0 | Primidone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29225-0.json |
| 29226-8 | quiNIDine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29226-8.json |
| 29227-6 | Salicylates [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29227-6.json |
| 29228-4 | Tricyclic antidepressants [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29228-4.json |
| 29229-2 | Valproate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29229-2.json |
| 29230-0 | Coxsackievirus B1 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29230-0.json |
| 2923-1 | Retinol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2923-1.json |
| 29231-8 | Coxsackievirus B2 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29231-8.json |
| 29232-6 | Coxsackievirus B3 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29232-6.json |
| 29233-4 | Coxsackievirus B4 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29233-4.json |
| 29234-2 | Coxsackievirus B5 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29234-2.json |
| 29235-9 | Coxsackievirus B6 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29235-9.json |
| 29236-7 | Herpes simplex virus 2 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29236-7.json |
| 29237-5 | Herpes simplex virus 1 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29237-5.json |
| 29238-3 | Insulin [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29238-3.json |
| 29239-1 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis | ./2.16.840.1.114222.4.11.1002/29239-1.json |
| 29240-9 | Hyaluronate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29240-9.json |
| 29241-7 | Mumps virus IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29241-7.json |
| 29242-5 | Measles virus IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29242-5.json |
| 29243-3 | Thiodiglycolate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29243-3.json |
| 29244-1 | Thiodiglycolate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29244-1.json |
| 29245-8 | Zinc [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/29245-8.json |
| 29246-6 | Lactate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29246-6.json |
| 29247-4 | Sirolimus [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/29247-4.json |
| 29248-2 | Varicella zoster virus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29248-2.json |
| 2924-9 | Riboflavin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2924-9.json |
| 29249-0 | Varicella zoster virus IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29249-0.json |
| 29250-8 | Brucella sp Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/29250-8.json |
| 29251-6 | Brucella sp Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/29251-6.json |
| 29252-4 | CT Chest WO contrast | ./2.16.840.1.114222.4.11.1002/29252-4.json |
| 2925-6 | Ribonuclease [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2925-6.json |
| 29257-3 | Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29257-3.json |
| 29263-1 | Fibrin degradation products [Presence] in Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/29263-1.json |
| 2926-4 | Ribose [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2926-4.json |
| 2927-2 | Ribulose [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2927-2.json |
| 29272-2 | Eye ultrasound study | ./2.16.840.1.114222.4.11.1002/29272-2.json |
| 29276-3 | Calcium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29276-3.json |
| 29277-1 | Carbon disulfide [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/29277-1.json |
| 29278-9 | Codeine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/29278-9.json |
| 29279-7 | Ethylene glycol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29279-7.json |
| 29280-5 | Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/29280-5.json |
| 29281-3 | Glutathione reductase [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/29281-3.json |
| 29282-1 | Glutethimide [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29282-1.json |
| 29283-9 | Hydrogen sulfide [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/29283-9.json |
| 29285-4 | Methadone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29285-4.json |
| 29286-2 | Methamphetamine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/29286-2.json |
| 29287-0 | Morphine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/29287-0.json |
| 29288-8 | Orphenadrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29288-8.json |
| 29289-6 | Phenylethylmalonamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29289-6.json |
| 29290-4 | Carbon disulfide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/29290-4.json |
| 29291-2 | Glutethimide [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29291-2.json |
| 29292-0 | Hydrogen sulfide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/29292-0.json |
| 29294-6 | Methadone [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29294-6.json |
| 29295-3 | Phenylethylmalonamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29295-3.json |
| 29296-1 | Dimethylbenzene [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/29296-1.json |
| 2929-8 | Saccharides [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2929-8.json |
| 29310-0 | Treponema pallidum [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29310-0.json |
| 29311-8 | Neisseria gonorrhoeae Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29311-8.json |
| 29314-2 | Adenovirus Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29314-2.json |
| 29321-7 | Rickettsia typhi IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/29321-7.json |
| 29322-5 | Rickettsia typhi IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/29322-5.json |
| 29323-3 | Cocaine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29323-3.json |
| 29324-1 | Cocaethylene [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29324-1.json |
| 29325-8 | Cocaethylene [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/29325-8.json |
| 29326-6 | Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29326-6.json |
| 29327-4 | HIV 1 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/29327-4.json |
| 2933-0 | Secretin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2933-0.json |
| 29334-0 | Aspergillus fumigatus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29334-0.json |
| 29335-7 | Mexiletine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29335-7.json |
| 29336-5 | Mexiletine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29336-5.json |
| 29337-3 | Morphine Free [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29337-3.json |
| 29338-1 | Flecainide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29338-1.json |
| 29339-9 | Flecainide [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29339-9.json |
| 29342-3 | Methylmalonate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29342-3.json |
| 29343-1 | Rubella virus IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29343-1.json |
| 29344-9 | LORazepam [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29344-9.json |
| 29345-6 | 6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/29345-6.json |
| 29346-4 | Chloramphenicol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29346-4.json |
| 29347-2 | Chloramphenicol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29347-2.json |
| 29348-0 | ALPRAZolam [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29348-0.json |
| 29350-6 | CD42 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/29350-6.json |
| 29351-4 | Rheumatoid factor [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29351-4.json |
| 29352-2 | Salicylates [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29352-2.json |
| 29353-0 | 17-Ketosteroids.total neutral [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/29353-0.json |
| 29354-8 | Reovirus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29354-8.json |
| 29355-5 | Reovirus Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29355-5.json |
| 29356-3 | fentaNYL [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29356-3.json |
| 29357-1 | Cyanide [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29357-1.json |
| 29359-7 | Parainfluenza virus 2 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29359-7.json |
| 29363-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/29363-9.json |
| 29364-7 | Magnesium [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29364-7.json |
| 29365-4 | Magnesium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29365-4.json |
| 29366-2 | Parainfluenza virus 1 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29366-2.json |
| 29367-0 | Parainfluenza virus 2 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29367-0.json |
| 29368-8 | Parainfluenza virus 3 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29368-8.json |
| 29369-6 | N-acetylprocainamide/Procainamide [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29369-6.json |
| 29370-4 | cloZAPine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/29370-4.json |
| 29371-2 | cloZAPine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/29371-2.json |
| 29372-0 | Codeine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29372-0.json |
| 29373-8 | Ethchlorvynol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29373-8.json |
| 29374-6 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29374-6.json |
| 29375-3 | Methanol [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/29375-3.json |
| 29376-1 | Narcotics and opioids [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/29376-1.json |
| 29377-9 | Narcotics and opioids [Identifier] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29377-9.json |
| 29380-3 | chlordiazePOXIDE [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29380-3.json |
| 29381-1 | Meprobamate [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29381-1.json |
| 29382-9 | Warfarin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29382-9.json |
| 29383-7 | Warfarin [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29383-7.json |
| 29384-5 | diazePAM [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29384-5.json |
| 29385-2 | Nordiazepam [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29385-2.json |
| 29386-0 | chlorproMAZINE [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29386-0.json |
| 29387-8 | Norpropoxyphene [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29387-8.json |
| 29388-6 | Methaqualone [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29388-6.json |
| 29389-4 | Acetaminophen [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29389-4.json |
| 29390-2 | Parathyrin.mid molecule [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29390-2.json |
| 29395-1 | Gastrin [Mass/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/29395-1.json |
| 2939-7 | Serotonin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2939-7.json |
| 29399-3 | clonazePAM [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29399-3.json |
| 29400-9 | Meperidine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29400-9.json |
| 29401-7 | Disopyramide [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29401-7.json |
| 29402-5 | Trimipramine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29402-5.json |
| 29403-3 | Thiothixene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29403-3.json |
| 29404-1 | Thiothixene [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29404-1.json |
| 2940-5 | Serotonin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2940-5.json |
| 29405-8 | Maprotiline [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29405-8.json |
| 29406-6 | Amitriptyline [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29406-6.json |
| 29407-4 | Nortriptyline [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29407-4.json |
| 29408-2 | Imipramine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29408-2.json |
| 29409-0 | Desipramine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29409-0.json |
| 29410-8 | Doxepin [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29410-8.json |
| 29411-6 | Nordoxepin [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/29411-6.json |
| 2941-3 | Serotonin [Mass/volume] in Platelets | ./2.16.840.1.114222.4.11.1002/2941-3.json |
| 29413-2 | Reovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/29413-2.json |
| 29414-0 | Parainfluenza virus 3 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29414-0.json |
| 29415-7 | Reovirus Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29415-7.json |
| 29416-5 | Adenovirus Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29416-5.json |
| 29417-3 | Parainfluenza virus 1 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/29417-3.json |
| 2942-1 | Sex hormone binding globulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2942-1.json |
| 2943-9 | Sialate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2943-9.json |
| 2944-7 | Sialate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2944-7.json |
| 2945-4 | Sialidase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/2945-4.json |
| 2946-2 | Sialidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/2946-2.json |
| 2947-0 | Sodium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2947-0.json |
| 2948-8 | Sodium [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/2948-8.json |
| 29492-6 | Methicillin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29492-6.json |
| 29493-4 | Colistin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29493-4.json |
| 29494-2 | Demeclocycline [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29494-2.json |
| 29495-9 | Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29495-9.json |
| 2949-6 | Sodium [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/2949-6.json |
| 29496-7 | Platelet associated IgA Ab [Presence] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/29496-7.json |
| 29497-5 | Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/29497-5.json |
| 29498-3 | Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/29498-3.json |
| 29499-1 | Selenium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/29499-1.json |
| 2950-4 | Sodium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/2950-4.json |
| 29507-1 | Alpha ketoglutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29507-1.json |
| 2951-2 | Sodium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2951-2.json |
| 29512-1 | Beta hydroxybutyrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29512-1.json |
| 2952-0 | Sodium [Molar amount] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/2952-0.json |
| 29520-4 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29520-4.json |
| 29524-6 | Acetoacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29524-6.json |
| 29525-3 | Aconitate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29525-3.json |
| 29526-1 | Azelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29526-1.json |
| 29527-9 | Citrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29527-9.json |
| 29528-7 | Hippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29528-7.json |
| 29529-5 | Acetaminophen [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29529-5.json |
| 29530-3 | Amphetamines [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29530-3.json |
| 29531-1 | diphenhydrAMINE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29531-1.json |
| 29532-9 | Methadone [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29532-9.json |
| 29533-7 | Cryptococcus sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29533-7.json |
| 29535-2 | West Nile virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29535-2.json |
| 29536-0 | West Nile virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29536-0.json |
| 29537-8 | West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29537-8.json |
| 2953-8 | Sodium [Molar amount] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/2953-8.json |
| 29538-6 | West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29538-6.json |
| 29539-4 | HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/29539-4.json |
| 29540-2 | E-cadherin [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29540-2.json |
| 29541-0 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29541-0.json |
| 29542-8 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/29542-8.json |
| 2954-6 | Sodium [Moles/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/2954-6.json |
| 2955-3 | Sodium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2955-3.json |
| 29558-4 | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29558-4.json |
| 29559-2 | Haemophilus ducreyi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29559-2.json |
| 29560-0 | Anaplasma phagocytophilum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29560-0.json |
| 2956-1 | Sodium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2956-1.json |
| 29561-8 | Jamestown canyon virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29561-8.json |
| 29562-6 | Jamestown canyon virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29562-6.json |
| 29563-4 | La Crosse virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29563-4.json |
| 29564-2 | Powassan virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29564-2.json |
| 29565-9 | Powassan virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29565-9.json |
| 29566-7 | West Nile virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29566-7.json |
| 29567-5 | West Nile virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29567-5.json |
| 29568-3 | West Nile virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29568-3.json |
| 29569-1 | West Nile virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/29569-1.json |
| 29570-9 | West Nile virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/29570-9.json |
| 29571-7 | Phenylalanine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/29571-7.json |
| 29572-5 | Phenylalanine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/29572-5.json |
| 29573-3 | Phenylalanine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/29573-3.json |
| 29574-1 | Thyrotropin [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/29574-1.json |
| 29575-8 | Thyrotropin [Units/volume] in DBS | ./2.16.840.1.114222.4.11.1002/29575-8.json |
| 2957-9 | Sodium renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2957-9.json |
| 2958-7 | Sodium/Potassium [Molar ratio] in Sweat | ./2.16.840.1.114222.4.11.1002/2958-7.json |
| 29590-7 | Cytomegalovirus DNA [Mass/volume] (viral load) in Blood by Probe | ./2.16.840.1.114222.4.11.1002/29590-7.json |
| 29591-5 | Enterovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29591-5.json |
| 29592-3 | Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29592-3.json |
| 29593-1 | Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29593-1.json |
| 29594-9 | CD45RO Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29594-9.json |
| 2959-5 | Sodium/Potassium [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/2959-5.json |
| 29596-4 | CD25 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29596-4.json |
| 29597-2 | Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29597-2.json |
| 29598-0 | Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29598-0.json |
| 29599-8 | Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29599-8.json |
| 29600-4 | Benzfetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29600-4.json |
| 29601-2 | Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29601-2.json |
| 29602-0 | Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29602-0.json |
| 2960-3 | Somatostatin [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/2960-3.json |
| 29603-8 | CD5 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29603-8.json |
| 29604-6 | Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29604-6.json |
| 29607-9 | Tropheryma whipplei DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29607-9.json |
| 29608-7 | Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29608-7.json |
| 29609-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/29609-5.json |
| 29610-3 | Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29610-3.json |
| 2961-1 | Somatostatin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2961-1.json |
| 29611-1 | Ethchlorvynol [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29611-1.json |
| 29612-9 | ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29612-9.json |
| 29613-7 | Phendimetrazine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29613-7.json |
| 29614-5 | Phenmetrazine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29614-5.json |
| 29615-2 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29615-2.json |
| 29616-0 | Stachybotrys chartarum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29616-0.json |
| 29617-8 | CD23 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29617-8.json |
| 29619-4 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/29619-4.json |
| 29620-2 | Zonisamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29620-2.json |
| 29622-8 | Beta hydroxybutyrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29622-8.json |
| 2962-9 | Somatotropin [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2962-9.json |
| 29632-7 | N-acetyltyrosine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29632-7.json |
| 29633-5 | CD122 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29633-5.json |
| 29634-3 | Terbutaline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29634-3.json |
| 29635-0 | Albuterol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29635-0.json |
| 2963-7 | Somatotropin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2963-7.json |
| 29639-2 | Alkaline phosphatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/29639-2.json |
| 29640-0 | Isomaltase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/29640-0.json |
| 29641-8 | Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29641-8.json |
| 29642-6 | Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29642-6.json |
| 29643-4 | Myeloperoxidase Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29643-4.json |
| 29644-2 | Proteinase 3 [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29644-2.json |
| 2964-5 | Specific gravity of Body fluid | ./2.16.840.1.114222.4.11.1002/2964-5.json |
| 29645-9 | Echovirus+Coxsackievirus IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29645-9.json |
| 29646-7 | Parainfluenza virus 2 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29646-7.json |
| 29647-5 | Interferon beta Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29647-5.json |
| 29648-3 | Rickettsia australis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29648-3.json |
| 29649-1 | Rickettsia australis Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29649-1.json |
| 29650-9 | Rickettsia honei Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29650-9.json |
| 29651-7 | Rickettsia honei Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29651-7.json |
| 2965-2 | Specific gravity of Urine | ./2.16.840.1.114222.4.11.1002/2965-2.json |
| 29652-5 | Dothiepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29652-5.json |
| 29653-3 | Dothiepin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29653-3.json |
| 29654-1 | Temazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29654-1.json |
| 29655-8 | Oxazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29655-8.json |
| 29656-6 | Sympathomimetics [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29656-6.json |
| 29657-4 | Bordetella pertussis IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29657-4.json |
| 29658-2 | Bordetella pertussis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29658-2.json |
| 29659-0 | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29659-0.json |
| 2966-0 | Specific gravity of 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2966-0.json |
| 29660-8 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29660-8.json |
| 29661-6 | Dengue virus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/29661-6.json |
| 29662-4 | Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29662-4.json |
| 29663-2 | Dengue virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/29663-2.json |
| 29664-0 | Chlamydia sp IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29664-0.json |
| 29665-7 | Rickettsia conorii Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29665-7.json |
| 29666-5 | Echovirus+Coxsackievirus IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29666-5.json |
| 29667-3 | Parainfluenza virus 2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29667-3.json |
| 29668-1 | Rickettsia australis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29668-1.json |
| 29669-9 | Rickettsia australis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29669-9.json |
| 29670-7 | Rickettsia honei Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29670-7.json |
| 29671-5 | Rickettsia honei Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29671-5.json |
| 29672-3 | Bordetella pertussis IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29672-3.json |
| 29673-1 | Bordetella pertussis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29673-1.json |
| 29674-9 | Bordetella pertussis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29674-9.json |
| 29675-6 | Parvovirus B19 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29675-6.json |
| 29676-4 | Dengue virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29676-4.json |
| 29677-2 | Chlamydia sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29677-2.json |
| 2967-8 | Starch granules [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/2967-8.json |
| 29678-0 | Rickettsia conorii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29678-0.json |
| 29679-8 | Rickettsia sibirica Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29679-8.json |
| 29680-6 | Rickettsia akari Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29680-6.json |
| 29681-4 | Rickettsia akari Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29681-4.json |
| 29682-2 | Rickettsia prowazekii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29682-2.json |
| 29683-0 | Rickettsia prowazekii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29683-0.json |
| 29684-8 | Rickettsia typhi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29684-8.json |
| 29685-5 | Rickettsia typhi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29685-5.json |
| 29686-3 | Orientia tsutsugamushi Gilliam Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29686-3.json |
| 29687-1 | Orientia tsutsugamushi Gilliam Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29687-1.json |
| 29688-9 | Orientia tsutsugamushi Karp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29688-9.json |
| 29689-7 | Orientia tsutsugamushi Karp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29689-7.json |
| 29690-5 | Orientia tsutsugamushi Kato Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29690-5.json |
| 29691-3 | Orientia tsutsugamushi Kato Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29691-3.json |
| 29692-1 | Orientia tsutsugamushi Litchfield Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29692-1.json |
| 29693-9 | Orientia tsutsugamushi Litchfield Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29693-9.json |
| 2969-4 | Stercobilin [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/2969-4.json |
| 29694-7 | Leptospira interrogans sv Celledoni Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29694-7.json |
| 29695-4 | Leptospira interrogans sv Bulgarica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29695-4.json |
| 29696-2 | Leptospira interrogans sv Cynopteri Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29696-2.json |
| 29697-0 | Leptospira interrogans sv Djasiman Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29697-0.json |
| 29698-8 | Leptospira interrogans sv Javanica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29698-8.json |
| 29699-6 | Leptospira interrogans sv Panama Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29699-6.json |
| 29700-2 | Leptospira interrogans sv Shermani Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29700-2.json |
| 29701-0 | Leptospira interrogans sv Zanoni Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29701-0.json |
| 2970-2 | Streptomyces proteinase [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/2970-2.json |
| 29702-8 | Rickettsia conorii Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29702-8.json |
| 29703-6 | Rickettsia sibirica Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29703-6.json |
| 29704-4 | Rickettsia sibirica Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29704-4.json |
| 29705-1 | Rickettsia rickettsii Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29705-1.json |
| 29706-9 | Rickettsia rickettsii Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29706-9.json |
| 29707-7 | Rickettsia akari Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29707-7.json |
| 29708-5 | Rickettsia akari Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29708-5.json |
| 29709-3 | Rickettsia prowazekii Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29709-3.json |
| 2971-0 | Substance P [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2971-0.json |
| 29710-1 | Rickettsia prowazekii Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29710-1.json |
| 29711-9 | Rickettsia typhi Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29711-9.json |
| 29712-7 | Rickettsia typhi Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29712-7.json |
| 29713-5 | Orientia tsutsugamushi Gilliam Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29713-5.json |
| 29714-3 | Orientia tsutsugamushi Gilliam Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29714-3.json |
| 29715-0 | Orientia tsutsugamushi Karp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29715-0.json |
| 29716-8 | Orientia tsutsugamushi Karp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29716-8.json |
| 29717-6 | Orientia tsutsugamushi Kato Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29717-6.json |
| 29718-4 | Orientia tsutsugamushi Kato Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29718-4.json |
| 29719-2 | Orientia tsutsugamushi Litchfield Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29719-2.json |
| 29720-0 | Orientia tsutsugamushi Litchfield Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29720-0.json |
| 29721-8 | Influenza virus C Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29721-8.json |
| 29722-6 | Chlamydophila pneumoniae Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29722-6.json |
| 29723-4 | Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29723-4.json |
| 29724-2 | Leptospira interrogans sv Celledoni Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29724-2.json |
| 29725-9 | Leptospira interrogans sv Bulgarica Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29725-9.json |
| 29726-7 | Leptospira interrogans sv Cynopteri Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29726-7.json |
| 29727-5 | Leptospira interrogans sv Djasiman Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29727-5.json |
| 2972-8 | Succinate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2972-8.json |
| 29728-3 | Leptospira interrogans sv Javanica Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29728-3.json |
| 29729-1 | Leptospira interrogans sv Panama Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29729-1.json |
| 29730-9 | Leptospira interrogans sv Shermani Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29730-9.json |
| 29731-7 | Leptospira interrogans sv Zanoni Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29731-7.json |
| 29732-5 | Leptospira interrogans sv Robinsoni Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29732-5.json |
| 29733-3 | Leptospira interrogans sv Kremastos Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29733-3.json |
| 29734-1 | Leptospira interrogans sv Szwajizak Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29734-1.json |
| 29735-8 | Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/29735-8.json |
| 29736-6 | Rickettsia sibirica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29736-6.json |
| 29737-4 | Rickettsia rickettsii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29737-4.json |
| 29738-2 | Leptospira interrogans sv Robinsoni Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29738-2.json |
| 29739-0 | Leptospira interrogans sv Kremastos Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29739-0.json |
| 29740-8 | Leptospira interrogans sv Szwajizak Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29740-8.json |
| 29741-6 | Leptospira interrogans sv Medanensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29741-6.json |
| 29743-2 | Cryofibrinogen [Presence] in Plasma by 3 day RT incubation | ./2.16.840.1.114222.4.11.1002/29743-2.json |
| 2974-4 | Sucrose [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/2974-4.json |
| 29744-0 | Cryofibrinogen [Presence] in Plasma by 3 day 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/29744-0.json |
| 29747-3 | Tocopherols [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29747-3.json |
| 29748-1 | Protein [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/29748-1.json |
| 29749-9 | Dialysis records | ./2.16.840.1.114222.4.11.1002/29749-9.json |
| 29750-7 | Neonatal intensive care records | ./2.16.840.1.114222.4.11.1002/29750-7.json |
| 2975-1 | Sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2975-1.json |
| 29751-5 | Critical care records | ./2.16.840.1.114222.4.11.1002/29751-5.json |
| 29752-3 | Perioperative records | ./2.16.840.1.114222.4.11.1002/29752-3.json |
| 29753-1 | Nurse Initial evaluation note | ./2.16.840.1.114222.4.11.1002/29753-1.json |
| 29754-9 | Nystagmogram study | ./2.16.840.1.114222.4.11.1002/29754-9.json |
| 29755-6 | Nerve conduction study | ./2.16.840.1.114222.4.11.1002/29755-6.json |
| 29756-4 | Peritoneoscopy study | ./2.16.840.1.114222.4.11.1002/29756-4.json |
| 29757-2 | Colposcopy study | ./2.16.840.1.114222.4.11.1002/29757-2.json |
| 29760-6 | Bilirubin.conjugated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29760-6.json |
| 29761-4 | Dentistry Discharge summary | ./2.16.840.1.114222.4.11.1002/29761-4.json |
| 29763-0 | Protoporphyrin.zinc [Molar ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/29763-0.json |
| 29764-8 | Iron [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29764-8.json |
| 29765-5 | Cholesterol [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29765-5.json |
| 29766-3 | Triglyceride [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29766-3.json |
| 29767-1 | Bilirubin.total [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29767-1.json |
| 2976-9 | Sulfate.inorganic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2976-9.json |
| 29770-5 | Karyotype [Identifier] in Blood or Tissue Nominal | ./2.16.840.1.114222.4.11.1002/29770-5.json |
| 29771-3 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/29771-3.json |
| 29772-1 | Coxiella burnetii phase 2 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/29772-1.json |
| 29773-9 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29773-9.json |
| 29774-7 | Coxiella burnetii phase 1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/29774-7.json |
| 29775-4 | Insulin-like growth factor-I [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29775-4.json |
| 29776-2 | Microscopic observation [Identifier] in Blood by Brilliant cresyl blue | ./2.16.840.1.114222.4.11.1002/29776-2.json |
| 2977-7 | Sulfite oxidase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2977-7.json |
| 29777-0 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29777-0.json |
| 29778-8 | West Nile virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/29778-8.json |
| 29779-6 | West Nile virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/29779-6.json |
| 29780-4 | West Nile virus IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29780-4.json |
| 29781-2 | West Nile virus Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/29781-2.json |
| 29782-0 | Trivittatus virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/29782-0.json |
| 29783-8 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/29783-8.json |
| 29784-6 | Highlands J virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/29784-6.json |
| 2978-5 | Superoxide dismutase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2978-5.json |
| 29785-3 | Eastern equine encephalitis virus IgG Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29785-3.json |
| 29786-1 | Jamestown canyon virus IgM Ab [Units/volume] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29786-1.json |
| 29787-9 | Jamestown canyon virus IgM Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29787-9.json |
| 29788-7 | Jamestown canyon virus IgG Ab [Units/volume] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29788-7.json |
| 29789-5 | La Crosse virus IgG Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29789-5.json |
| 29790-3 | La Crosse virus IgM Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29790-3.json |
| 29791-1 | Powassan virus IgG Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29791-1.json |
| 29792-9 | Powassan virus IgM Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29792-9.json |
| 29793-7 | Anaplasma phagocytophilum IgG Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/29793-7.json |
| 29794-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/29794-5.json |
| 29795-2 | Trivittatus virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/29795-2.json |
| 29796-0 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/29796-0.json |
| 29797-8 | Highlands J virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/29797-8.json |
| 29798-6 | Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29798-6.json |
| 29799-4 | Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29799-4.json |
| 29800-0 | Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29800-0.json |
| 29801-8 | Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29801-8.json |
| 29802-6 | La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29802-6.json |
| 29803-4 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29803-4.json |
| 29804-2 | Powassan virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29804-2.json |
| 29805-9 | Powassan virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29805-9.json |
| 29806-7 | Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/29806-7.json |
| 29807-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/29807-5.json |
| 29808-3 | Trivittatus virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29808-3.json |
| 29809-1 | Saint Louis encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29809-1.json |
| 29810-9 | Highlands J virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29810-9.json |
| 29811-7 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29811-7.json |
| 29812-5 | Jamestown canyon virus IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29812-5.json |
| 29813-3 | Jamestown canyon virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29813-3.json |
| 29814-1 | Jamestown canyon virus IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29814-1.json |
| 29815-8 | La Crosse virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29815-8.json |
| 29816-6 | La Crosse virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29816-6.json |
| 29817-4 | Powassan virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29817-4.json |
| 29818-2 | Powassan virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29818-2.json |
| 29819-0 | Anaplasma phagocytophilum IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/29819-0.json |
| 29820-8 | Anaplasma phagocytophilum IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/29820-8.json |
| 29821-6 | Trivittatus virus Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/29821-6.json |
| 29822-4 | Saint Louis encephalitis virus Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/29822-4.json |
| 29823-2 | Highlands J virus Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/29823-2.json |
| 29824-0 | Eastern equine encephalitis virus IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29824-0.json |
| 29825-7 | Jamestown canyon virus IgM Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29825-7.json |
| 29826-5 | Jamestown canyon virus IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29826-5.json |
| 29827-3 | Jamestown canyon virus IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29827-3.json |
| 29828-1 | La Crosse virus IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29828-1.json |
| 29829-9 | La Crosse virus IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29829-9.json |
| 29830-7 | Powassan virus IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29830-7.json |
| 29831-5 | Powassan virus IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29831-5.json |
| 29832-3 | Anaplasma phagocytophilum IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29832-3.json |
| 29833-1 | Anaplasma phagocytophilum IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/29833-1.json |
| 29834-9 | Trivittatus virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29834-9.json |
| 2983-5 | Terminal deoxyribonucleotidyl transferase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2983-5.json |
| 29835-6 | Highlands J virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29835-6.json |
| 29836-4 | Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29836-4.json |
| 29837-2 | Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29837-2.json |
| 29838-0 | Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29838-0.json |
| 29839-8 | Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29839-8.json |
| 29840-6 | La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29840-6.json |
| 29841-4 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29841-4.json |
| 29842-2 | Powassan virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29842-2.json |
| 2984-3 | Testosterone [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/2984-3.json |
| 29843-0 | Powassan virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29843-0.json |
| 29844-8 | Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29844-8.json |
| 29845-5 | Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/29845-5.json |
| 29846-3 | Trivittatus virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29846-3.json |
| 29847-1 | Highlands J virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29847-1.json |
| 29848-9 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29848-9.json |
| 29849-7 | Jamestown canyon virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29849-7.json |
| 2985-0 | Testosterone [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/2985-0.json |
| 29850-5 | Jamestown canyon virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29850-5.json |
| 29851-3 | Jamestown canyon virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/29851-3.json |
| 29852-1 | La Crosse virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29852-1.json |
| 29853-9 | La Crosse virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29853-9.json |
| 29854-7 | Powassan virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29854-7.json |
| 29855-4 | Powassan virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29855-4.json |
| 29856-2 | Anaplasma phagocytophilum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29856-2.json |
| 29857-0 | Anaplasma phagocytophilum IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29857-0.json |
| 29858-8 | Alpha hydroxybutyrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29858-8.json |
| 29859-6 | Adipate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29859-6.json |
| 29860-4 | Cardiolipin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29860-4.json |
| 29863-8 | IgD Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/29863-8.json |
| 29864-6 | 2-Oxo,3-Methylvalerate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29864-6.json |
| 29867-9 | 3-Hydroxy,3-Methylglutarate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29867-9.json |
| 2986-8 | Testosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2986-8.json |
| 29868-7 | Gamma hydroxybutyrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29868-7.json |
| 29869-5 | 4-Hydroxycyclohexylacetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29869-5.json |
| 29875-2 | Lactate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29875-2.json |
| 2987-6 | Testosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/2987-6.json |
| 29877-8 | Methylmalonate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29877-8.json |
| 29878-6 | Argininosuccinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/29878-6.json |
| 29879-4 | Dehydroepiandrosterone (DHEA)/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29879-4.json |
| 29883-6 | 2-Hydroxyphenylacetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/29883-6.json |
| 2988-4 | Testosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/2988-4.json |
| 29885-1 | Actinobacillus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/29885-1.json |
| 29886-9 | Encephalomyocarditis virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/29886-9.json |
| 29887-7 | Pasteurella multocida type [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/29887-7.json |
| 29888-5 | Pseudorabies virus G1 gene deletion Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29888-5.json |
| 29889-3 | Encephalomyocarditis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29889-3.json |
| 29890-1 | Pseudorabies virus G1 gene deletion Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/29890-1.json |
| 29891-9 | Helicobacter pylori [Presence] in Stomach by urea breath test | ./2.16.840.1.114222.4.11.1002/29891-9.json |
| 2989-2 | Testosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2989-2.json |
| 29892-7 | Helicobacter pylori [Quantitative] in Stomach by urea breath test | ./2.16.840.1.114222.4.11.1002/29892-7.json |
| 29893-5 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/29893-5.json |
| 29896-8 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/29896-8.json |
| 29897-6 | Styrene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29897-6.json |
| 29898-4 | Borrelia burgdorferi IgG Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/29898-4.json |
| 2990-0 | Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2990-0.json |
| 29900-8 | Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/29900-8.json |
| 29901-6 | HTLV I+II Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29901-6.json |
| 29902-4 | Chlorobenzene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/29902-4.json |
| 29903-2 | Cryptococcus sp Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29903-2.json |
| 29904-0 | Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29904-0.json |
| 29905-7 | Entamoeba histolytica Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/29905-7.json |
| 29906-5 | Haemophilus influenzae A DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29906-5.json |
| 29907-3 | Haemophilus influenzae B DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29907-3.json |
| 29908-1 | Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29908-1.json |
| 29909-9 | Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29909-9.json |
| 29910-7 | Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/29910-7.json |
| 29911-5 | Magnesium [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/29911-5.json |
| 29912-3 | Magnesium [Mass/time] in Stool | ./2.16.840.1.114222.4.11.1002/29912-3.json |
| 29914-9 | Arsenic [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/29914-9.json |
| 29915-6 | Tellurium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29915-6.json |
| 29916-4 | Cobalt [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29916-4.json |
| 29917-2 | Selenium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29917-2.json |
| 2991-8 | Testosterone Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2991-8.json |
| 29918-0 | Bismuth [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29918-0.json |
| 29919-8 | Chromium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29919-8.json |
| 29920-6 | Beryllium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29920-6.json |
| 29921-4 | Boron [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29921-4.json |
| 29922-2 | Boron/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29922-2.json |
| 29923-0 | Scandium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29923-0.json |
| 29924-8 | Scandium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29924-8.json |
| 29925-5 | Scandium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29925-5.json |
| 2992-6 | Testosterone [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/2992-6.json |
| 29926-3 | Boron [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29926-3.json |
| 29927-1 | Beryllium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29927-1.json |
| 29928-9 | Titanium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29928-9.json |
| 29929-7 | Titanium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29929-7.json |
| 29930-5 | Titanium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29930-5.json |
| 29931-3 | Vanadium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29931-3.json |
| 29932-1 | Vanadium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29932-1.json |
| 29933-9 | Vanadium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29933-9.json |
| 29934-7 | Cobalt/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29934-7.json |
| 29935-4 | Manganese/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29935-4.json |
| 29936-2 | Nickel [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29936-2.json |
| 29937-0 | Aluminum/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29937-0.json |
| 29938-8 | Thallium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29938-8.json |
| 29939-6 | Tellurium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29939-6.json |
| 29940-4 | Bismuth/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29940-4.json |
| 29941-2 | Antimony/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29941-2.json |
| 29942-0 | Copper/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29942-0.json |
| 29943-8 | Lead/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29943-8.json |
| 29944-6 | Alpha-2-Macroglobulin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/29944-6.json |
| 29946-1 | Albumin [Presence] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/29946-1.json |
| 29948-7 | Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/29948-7.json |
| 29949-5 | Sjogrens syndrome-B extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/29949-5.json |
| 29950-3 | Nuclear IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29950-3.json |
| 29952-9 | Borrelia burgdorferi Ag [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/29952-9.json |
| 29953-7 | Nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/29953-7.json |
| 29954-5 | Extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29954-5.json |
| 29955-2 | Legionella pneumophila IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29955-2.json |
| 29956-0 | Lysozyme [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/29956-0.json |
| 29957-8 | Herpes simplex virus Ag [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/29957-8.json |
| 29958-6 | Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29958-6.json |
| 2995-9 | Tetrahydrocortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2995-9.json |
| 29963-6 | Parietal cell IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29963-6.json |
| 29964-4 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29964-4.json |
| 29965-1 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29965-1.json |
| 29966-9 | Centromere IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29966-9.json |
| 2996-7 | Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/2996-7.json |
| 29967-7 | Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29967-7.json |
| 29968-5 | Rubidium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29968-5.json |
| 29969-3 | Rubidium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29969-3.json |
| 29970-1 | Rubidium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29970-1.json |
| 29971-9 | Strontium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29971-9.json |
| 29972-7 | Strontium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29972-7.json |
| 29973-5 | Strontium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29973-5.json |
| 29974-3 | Molybdenum [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29974-3.json |
| 2997-5 | Tetrahydrofolate [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/2997-5.json |
| 29975-0 | Molybdenum [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29975-0.json |
| 29976-8 | Molybdenum/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29976-8.json |
| 29977-6 | Silver [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29977-6.json |
| 29978-4 | Silver/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29978-4.json |
| 29979-2 | Tin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29979-2.json |
| 29980-0 | Tin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29980-0.json |
| 29981-8 | Tin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29981-8.json |
| 29982-6 | Cesium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29982-6.json |
| 2998-3 | Thiamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/2998-3.json |
| 29983-4 | Cesium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29983-4.json |
| 29984-2 | Cesium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29984-2.json |
| 29985-9 | Barium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29985-9.json |
| 29986-7 | Barium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29986-7.json |
| 29987-5 | Gold [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29987-5.json |
| 29988-3 | Gold/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29988-3.json |
| 29989-1 | Uranium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/29989-1.json |
| 29990-9 | Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy | ./2.16.840.1.114222.4.11.1002/29990-9.json |
| 2999-1 | Thiamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/2999-1.json |
| 29991-7 | Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/29991-7.json |
| 29992-5 | Eosinophils [Presence] in Nose by Wright stain | ./2.16.840.1.114222.4.11.1002/29992-5.json |
| 29994-1 | Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29994-1.json |
| 29995-8 | Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29995-8.json |
| 29996-6 | Histone IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29996-6.json |
| 29997-4 | Basement membrane IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/29997-4.json |
| 29998-2 | Striated muscle IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/29998-2.json |
| 29999-0 | Xylose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/29999-0.json |
| 30000-4 | Microalbumin/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30000-4.json |
| 30001-2 | Microalbumin/Creatinine [Ratio] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/30001-2.json |
| 30002-0 | Creatinine [Moles/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/30002-0.json |
| 30003-8 | Microalbumin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/30003-8.json |
| 30004-6 | Creatinine [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/30004-6.json |
| 30005-3 | CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/30005-3.json |
| 3000-7 | Thiamine pyrophosphate [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3000-7.json |
| 30009-5 | Fibrin+Fibrinogen fragments [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30009-5.json |
| 3001-5 | Thiocyanate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3001-5.json |
| 30022-8 | Botrytis cinerea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30022-8.json |
| 3002-3 | Thiocyanate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3002-3.json |
| 30023-6 | Bacillus subtilis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30023-6.json |
| 30024-4 | Carbophenothion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30024-4.json |
| 30025-1 | Coumaphos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30025-1.json |
| 30026-9 | Dichlorvos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30026-9.json |
| 30027-7 | Dimethoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30027-7.json |
| 30028-5 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30028-5.json |
| 30029-3 | Dehydroepiandrosterone (DHEA) [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/30029-3.json |
| 30030-1 | Iron [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/30030-1.json |
| 3003-1 | Thiocyanate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3003-1.json |
| 30031-9 | Alternaria alternata+American house dust mite IgG Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30031-9.json |
| 30032-7 | Phoma betae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30032-7.json |
| 30034-3 | Bovine herpesvirus 1 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30034-3.json |
| 30036-8 | Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/30036-8.json |
| 30037-6 | Alternaria alternata+American house dust mite IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30037-6.json |
| 30038-4 | Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/30038-4.json |
| 30039-2 | Anaplasma phagocytophilum DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30039-2.json |
| 30040-0 | Dirofilaria immitis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30040-0.json |
| 30041-8 | Turmeric IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30041-8.json |
| 30042-6 | Vigabatrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30042-6.json |
| 30043-4 | Rosemary IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30043-4.json |
| 30044-2 | Dirofilaria immitis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/30044-2.json |
| 30045-9 | Mycobacterium sp identified in Dialysis fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/30045-9.json |
| 30046-7 | Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/30046-7.json |
| 3004-9 | Thiocyanate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3004-9.json |
| 3005-6 | Thiosulfate renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3005-6.json |
| 30060-8 | Amino beta guanidinopropionate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30060-8.json |
| 30065-7 | Cystine/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30065-7.json |
| 30069-9 | Tyrosine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/30069-9.json |
| 30071-5 | Trichoderma viride IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30071-5.json |
| 30072-3 | Cortisone [Mass/volume] in 24 hour Urine by HPLC | ./2.16.840.1.114222.4.11.1002/30072-3.json |
| 30073-1 | Voltage-gated calcium channel Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30073-1.json |
| 30074-9 | Hemoglobin F [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/30074-9.json |
| 30075-6 | Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30075-6.json |
| 30076-4 | Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30076-4.json |
| 30077-2 | Amylase/Creatinine renal clearance [Ratio] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30077-2.json |
| 30080-6 | Cathepsin D [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/30080-6.json |
| 30083-0 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/30083-0.json |
| 30084-8 | Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/30084-8.json |
| 30085-5 | Legionella pneumophila IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30085-5.json |
| 30086-3 | Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/30086-3.json |
| 30087-1 | Cow hair+Cow dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30087-1.json |
| 30088-9 | Horse hair+Horse dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30088-9.json |
| 30090-5 | Burkholderia pseudomallei IgG Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30090-5.json |
| 30091-3 | Burkholderia pseudomallei IgM Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30091-3.json |
| 30092-1 | Brucella canis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30092-1.json |
| 30093-9 | Brucella canis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30093-9.json |
| 30094-7 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30094-7.json |
| 30095-4 | Neisseria meningitidis serogroup B Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30095-4.json |
| 30096-2 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30096-2.json |
| 30097-0 | Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30097-0.json |
| 30098-8 | Neisseria meningitidis serogroup Y Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30098-8.json |
| 30099-6 | Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/30099-6.json |
| 30100-2 | Yersinia enterocolitica O:3 Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30100-2.json |
| 30101-0 | Yersinia enterocolitica O:5 Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30101-0.json |
| 30102-8 | Yersinia enterocolitica O:8 Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30102-8.json |
| 30103-6 | Yersinia enterocolitica O:9 Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30103-6.json |
| 30104-4 | Trypanosoma cruzi IgG Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30104-4.json |
| 30105-1 | Trypanosoma cruzi IgM Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/30105-1.json |
| 30106-9 | Acetylcholinesterase [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/30106-9.json |
| 30107-7 | Ecgonine methyl ester [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30107-7.json |
| 30108-5 | Ecgonine methyl ester [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/30108-5.json |
| 30109-3 | Ecgonine methyl ester [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/30109-3.json |
| 30110-1 | Ecgonine methyl ester [Mass/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/30110-1.json |
| 30111-9 | Thermoactinomyces vulgaris 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30111-9.json |
| 30112-7 | Amphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30112-7.json |
| 3011-4 | Thromboxane alpha 2 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3011-4.json |
| 30121-8 | Colony count [#/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/30121-8.json |
| 3012-2 | Thromboxane beta 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3012-2.json |
| 30122-6 | Aeromonas sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/30122-6.json |
| 30123-4 | Testosterone.bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30123-4.json |
| 30124-2 | Amylase [Enzymatic activity/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/30124-2.json |
| 30127-5 | Gerbil hair IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30127-5.json |
| 30128-3 | Borrelia burgdorferi Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30128-3.json |
| 30129-1 | Brucella sp Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30129-1.json |
| 3013-0 | Thyroglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3013-0.json |
| 30130-9 | Brucella sp Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30130-9.json |
| 30131-7 | Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30131-7.json |
| 30132-5 | Coxsackievirus Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30132-5.json |
| 30133-3 | Coxsackievirus Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30133-3.json |
| 30134-1 | Echovirus Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30134-1.json |
| 30135-8 | Echovirus Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30135-8.json |
| 30136-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30136-6.json |
| 30137-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30137-4.json |
| 30138-2 | Epstein Barr virus nuclear Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30138-2.json |
| 30139-0 | Hydroxyproline Free [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/30139-0.json |
| 30143-2 | Legionella sp Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30143-2.json |
| 30144-0 | Legionella sp Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30144-0.json |
| 30146-5 | Mumps virus Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30146-5.json |
| 30147-3 | Respiratory syncytial virus Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30147-3.json |
| 3014-8 | Thyroid stimulating immunoglobulins [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3014-8.json |
| 30148-1 | Respiratory syncytial virus Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30148-1.json |
| 30149-9 | Streptolysin O Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30149-9.json |
| 30150-7 | Streptolysin O Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30150-7.json |
| 30151-5 | Thyrotropin.long acting [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30151-5.json |
| 30152-3 | Mannose-binding protein [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30152-3.json |
| 30153-1 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30153-1.json |
| 30154-9 | Protein/Creatinine [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30154-9.json |
| 3015-5 | Thyrotropin [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3015-5.json |
| 30158-0 | Toxoplasma gondii [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/30158-0.json |
| 30159-8 | HTLV I+II DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30159-8.json |
| 30160-6 | Tau protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/30160-6.json |
| 30162-2 | Artichoke IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30162-2.json |
| 3016-3 | Thyrotropin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3016-3.json |
| 30163-0 | Sweat Bee IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30163-0.json |
| 30164-8 | Nut Allergen Mix (Cashew+Pecan or Hickory nut+English walnut) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30164-8.json |
| 30165-5 | Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/30165-5.json |
| 30166-3 | Thyroid stimulating immunoglobulins actual/normal in Serum | ./2.16.840.1.114222.4.11.1002/30166-3.json |
| 30167-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/30167-1.json |
| 30168-9 | Oneseed Juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30168-9.json |
| 30169-7 | Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/30169-7.json |
| 30170-5 | American Cockroach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30170-5.json |
| 3017-1 | Thyrotropin binding inhibitory immunoglobulins [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3017-1.json |
| 30171-3 | Cortisol Free/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/30171-3.json |
| 30172-1 | Cortisol Free/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30172-1.json |
| 30173-9 | Cortisol Free [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/30173-9.json |
| 30174-7 | Jamestown canyon virus IgG Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30174-7.json |
| 30175-4 | Jamestown canyon virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/30175-4.json |
| 30176-2 | La Crosse virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/30176-2.json |
| 30177-0 | Powassan virus IgG Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30177-0.json |
| 30178-8 | West Nile virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/30178-8.json |
| 30179-6 | Powassan virus IgM Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30179-6.json |
| 30182-0 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30182-0.json |
| 30183-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30183-8.json |
| 30184-6 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30184-6.json |
| 30185-3 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30185-3.json |
| 30186-1 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30186-1.json |
| 30187-9 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30187-9.json |
| 30188-7 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30188-7.json |
| 3018-9 | Thyrotropin releasing hormone [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3018-9.json |
| 30189-5 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/30189-5.json |
| 30191-1 | Acetylcarnitine (C2) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30191-1.json |
| 30192-9 | Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum | ./2.16.840.1.114222.4.11.1002/30192-9.json |
| 3019-7 | Thyrotropin.long acting [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3019-7.json |
| 30199-4 | Alpha subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30199-4.json |
| 30202-6 | Brucella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30202-6.json |
| 30204-2 | Chlamydia trachomatis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30204-2.json |
| 3020-5 | Thyroxine binding globulin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3020-5.json |
| 30205-9 | Chlamydophila pneumoniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30205-9.json |
| 30206-7 | Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30206-7.json |
| 30207-5 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/30207-5.json |
| 30208-3 | Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/30208-3.json |
| 30209-1 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/30209-1.json |
| 30212-5 | Coxiella burnetii IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30212-5.json |
| 3021-3 | Thyroxine binding globulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3021-3.json |
| 30213-3 | Coxiella burnetii IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30213-3.json |
| 30214-1 | Coxsackievirus A10 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30214-1.json |
| 30215-8 | Coxsackievirus A16 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30215-8.json |
| 30216-6 | Coxsackievirus A2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30216-6.json |
| 30217-4 | Coxsackievirus A4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30217-4.json |
| 30218-2 | Coxsackievirus A7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30218-2.json |
| 30219-0 | Coxsackievirus A9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30219-0.json |
| 30220-8 | Coxsackievirus B1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30220-8.json |
| 30221-6 | Coxsackievirus B2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30221-6.json |
| 30222-4 | Coxsackievirus B3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30222-4.json |
| 30223-2 | Coxsackievirus B4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30223-2.json |
| 30224-0 | Coxsackievirus B5 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30224-0.json |
| 30225-7 | Coxsackievirus B6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30225-7.json |
| 30226-5 | Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/30226-5.json |
| 30231-5 | Rheumatoid factor [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/30231-5.json |
| 30239-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | ./2.16.840.1.114222.4.11.1002/30239-8.json |
| 30241-4 | Lactate [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/30241-4.json |
| 30242-2 | Lactate [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/30242-2.json |
| 30243-0 | Choriogonadotropin.intact [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30243-0.json |
| 30244-8 | Acetylcholinesterase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/30244-8.json |
| 30246-3 | Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30246-3.json |
| 3024-7 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3024-7.json |
| 30247-1 | Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30247-1.json |
| 30248-9 | Transferrin receptor.soluble [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30248-9.json |
| 30249-7 | Barbiturates [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/30249-7.json |
| 30250-5 | Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/30250-5.json |
| 3025-4 | Thyroxine (T4) [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3025-4.json |
| 3026-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3026-2.json |
| 3028-8 | Thyroxine (T4)/Triiodothyronine (T3) uptake index [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3028-8.json |
| 3029-6 | Transcobalamin I [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3029-6.json |
| 3030-4 | Transcobalamin II [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3030-4.json |
| 3031-2 | Transcobalamin III [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3031-2.json |
| 30313-1 | Hemoglobin [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/30313-1.json |
| 30315-6 | Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/30315-6.json |
| 30316-4 | Alpha subunit free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30316-4.json |
| 30319-8 | Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/30319-8.json |
| 3032-0 | Transcobalamin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3032-0.json |
| 30322-2 | aPTT.factor substitution in Platelet poor plasma --1 hour post incubation | ./2.16.840.1.114222.4.11.1002/30322-2.json |
| 30324-8 | Cryptococcus sp Ag [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/30324-8.json |
| 30325-5 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30325-5.json |
| 30326-3 | Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30326-3.json |
| 30333-9 | Echovirus 11 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30333-9.json |
| 30334-7 | Echovirus 30 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30334-7.json |
| 30335-4 | Echovirus 4 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30335-4.json |
| 30336-2 | Echovirus 7 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30336-2.json |
| 30337-0 | Echovirus 9 Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30337-0.json |
| 3033-8 | Transcortin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3033-8.json |
| 30338-8 | Anaplasma phagocytophilum Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30338-8.json |
| 30339-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30339-6.json |
| 30340-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30340-4.json |
| 30341-2 | Erythrocyte sedimentation rate | ./2.16.840.1.114222.4.11.1002/30341-2.json |
| 30342-0 | Extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30342-0.json |
| 30343-8 | Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/30343-8.json |
| 30344-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 1.2 g/kg lactose PO | ./2.16.840.1.114222.4.11.1002/30344-6.json |
| 30345-3 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 1.2 g/kg lactose PO | ./2.16.840.1.114222.4.11.1002/30345-3.json |
| 3034-6 | Transferrin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3034-6.json |
| 30347-9 | Glutamate decarboxylase 65 Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30347-9.json |
| 30350-3 | Hemoglobin [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/30350-3.json |
| 30351-1 | Hemoglobin [Mass/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/30351-1.json |
| 30352-9 | Hemoglobin [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/30352-9.json |
| 3035-3 | Transferrin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3035-3.json |
| 30353-7 | Hemoglobin [Mass/volume] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/30353-7.json |
| 30354-5 | Hemoglobin [Mass/volume] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/30354-5.json |
| 30355-2 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30355-2.json |
| 30359-4 | Histone Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30359-4.json |
| 30360-2 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/30360-2.json |
| 3036-1 | Transketolase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3036-1.json |
| 30361-0 | HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/30361-0.json |
| 30363-6 | Insulin [Units/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/30363-6.json |
| 30372-7 | Sucrase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/30372-7.json |
| 30378-4 | Eosinophils/100 leukocytes in Nose | ./2.16.840.1.114222.4.11.1002/30378-4.json |
| 3038-7 | Trehalase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3038-7.json |
| 3039-5 | Lipase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/3039-5.json |
| 30398-2 | Hematocrit [Volume Fraction] of Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/30398-2.json |
| 3040-3 | Lipase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3040-3.json |
| 3041-1 | Trichloroacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3041-1.json |
| 3042-9 | Chloral hydrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3042-9.json |
| 3043-7 | Triglyceride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3043-7.json |
| 3044-5 | Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3044-5.json |
| 3045-2 | Triglyceride+ester in IDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3045-2.json |
| 3046-0 | Triglyceride+ester in LDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3046-0.json |
| 30470-9 | Cardiolipin IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30470-9.json |
| 30471-7 | levETIRAcetam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30471-7.json |
| 30472-5 | Ethylmalonate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30472-5.json |
| 30473-3 | Glutaconate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30473-3.json |
| 30474-1 | Glutarate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30474-1.json |
| 30475-8 | Glycerate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30475-8.json |
| 30476-6 | Glyoxylate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30476-6.json |
| 30477-4 | Hexanoylglycine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30477-4.json |
| 3047-8 | Triglyceride+ester in VLDL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3047-8.json |
| 30478-2 | Malonate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30478-2.json |
| 30479-0 | Methylsuccinate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30479-0.json |
| 30480-8 | Orotate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30480-8.json |
| 30481-6 | Pyruvate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30481-6.json |
| 30484-0 | Tiglylglycine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30484-0.json |
| 30485-7 | Uracil [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30485-7.json |
| 3048-6 | Triglyceride [Mass/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/3048-6.json |
| 30490-7 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30490-7.json |
| 30491-5 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30491-5.json |
| 30498-0 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30498-0.json |
| 30499-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30499-8.json |
| 30500-3 | Phosphatidylserine IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30500-3.json |
| 30501-1 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/30501-1.json |
| 3050-2 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3050-2.json |
| 30502-9 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/30502-9.json |
| 30507-8 | Cumene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/30507-8.json |
| 30508-6 | Etiocholanolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30508-6.json |
| 30509-4 | Androsterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30509-4.json |
| 3051-0 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3051-0.json |
| 30510-2 | Estriol (E3)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30510-2.json |
| 30511-0 | Cortisone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30511-0.json |
| 30512-8 | Pregnanetriol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30512-8.json |
| 30513-6 | Pregnanetriolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30513-6.json |
| 30514-4 | Tetrahydrocortisone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30514-4.json |
| 30515-1 | Tetrahydroaldosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/30515-1.json |
| 30516-9 | Bromodiphenhydramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30516-9.json |
| 30517-7 | Carbinoxamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30517-7.json |
| 30518-5 | Cholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30518-5.json |
| 30520-1 | Deoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30520-1.json |
| 30521-9 | Inhibin B [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30521-9.json |
| 30522-7 | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/30522-7.json |
| 30523-5 | Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/30523-5.json |
| 30524-3 | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting | ./2.16.840.1.114222.4.11.1002/30524-3.json |
| 30526-8 | Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30526-8.json |
| 30527-6 | Calcium [Mass/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/30527-6.json |
| 3052-8 | Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3052-8.json |
| 30530-0 | Intrinsic factor Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30530-0.json |
| 30532-6 | levoFLOXacin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/30532-6.json |
| 30533-4 | levoFLOXacin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/30533-4.json |
| 30535-9 | Liver kidney microsomal 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30535-9.json |
| 3053-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3053-6.json |
| 30536-7 | Magnesium [Mass/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/30536-7.json |
| 30537-5 | Myocardium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30537-5.json |
| 30538-3 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30538-3.json |
| 30539-1 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30539-1.json |
| 3054-4 | Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3054-4.json |
| 30544-1 | Phosphate [Mass/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/30544-1.json |
| 30546-6 | Polio virus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30546-6.json |
| 30547-4 | Polio virus 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30547-4.json |
| 30548-2 | Polio virus 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30548-2.json |
| 30549-0 | Potassium [Moles/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/30549-0.json |
| 30552-4 | Pyridoxal phosphate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30552-4.json |
| 30553-2 | Rabies virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30553-2.json |
| 30554-0 | HIV reverse transcriptase gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/30554-0.json |
| 30555-7 | Rickettsia typhus group IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30555-7.json |
| 30556-5 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/30556-5.json |
| 30557-3 | Smooth muscle IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30557-3.json |
| 30558-1 | Sodium [Moles/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/30558-1.json |
| 30559-9 | Spermatozoa Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/30559-9.json |
| 30562-3 | Surfactant/Albumin [Mass Ratio] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/30562-3.json |
| 30567-2 | Thyroid stimulating immunoglobulins [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30567-2.json |
| 30568-0 | Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/30568-0.json |
| 3056-9 | Trimethylamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3056-9.json |
| 30569-8 | Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/30569-8.json |
| 30570-6 | Triglyceride [Percentile] | ./2.16.840.1.114222.4.11.1002/30570-6.json |
| 30571-4 | Vanillylmandelate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/30571-4.json |
| 30572-2 | Pyridoxal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30572-2.json |
| 30574-8 | Acetoacetate+Acetone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30574-8.json |
| 3057-7 | Triokinase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3057-7.json |
| 30578-9 | CT Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30578-9.json |
| 30579-7 | CT Guidance for injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/30579-7.json |
| 30580-5 | CT Guidance for fine needle aspiration of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30580-5.json |
| 30581-3 | CT Guidance for radiation treatment of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/30581-3.json |
| 30582-1 | CT Guidance for radiation treatment of Unspecified body region-- WO contrast | ./2.16.840.1.114222.4.11.1002/30582-1.json |
| 30583-9 | CT Internal auditory canal W contrast IV | ./2.16.840.1.114222.4.11.1002/30583-9.json |
| 30584-7 | CT Internal auditory canal WO contrast | ./2.16.840.1.114222.4.11.1002/30584-7.json |
| 3058-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3058-5.json |
| 30585-4 | CT Nasopharynx and Neck WO contrast | ./2.16.840.1.114222.4.11.1002/30585-4.json |
| 30586-2 | CT Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30586-2.json |
| 30587-0 | CT Orbit - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/30587-0.json |
| 30588-8 | CT Sinuses | ./2.16.840.1.114222.4.11.1002/30588-8.json |
| 30589-6 | CT Petrous part of temporal bone WO contrast | ./2.16.840.1.114222.4.11.1002/30589-6.json |
| 30590-4 | CT Pituitary and Sella turcica W contrast IV | ./2.16.840.1.114222.4.11.1002/30590-4.json |
| 30591-2 | CT Pituitary and Sella turcica WO contrast | ./2.16.840.1.114222.4.11.1002/30591-2.json |
| 30592-0 | CT Cervical spine WO contrast | ./2.16.840.1.114222.4.11.1002/30592-0.json |
| 3059-3 | Trypsin [Enzymatic activity/volume] in Duodenal fluid | ./2.16.840.1.114222.4.11.1002/3059-3.json |
| 30593-8 | CTA Head vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30593-8.json |
| 30594-6 | CTA Neck vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30594-6.json |
| 30595-3 | CT Guidance for fine needle aspiration of Lung | ./2.16.840.1.114222.4.11.1002/30595-3.json |
| 30596-1 | CT Thoracic spine W contrast IT | ./2.16.840.1.114222.4.11.1002/30596-1.json |
| 30597-9 | CT Thoracic spine WO contrast | ./2.16.840.1.114222.4.11.1002/30597-9.json |
| 30598-7 | CT Chest WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30598-7.json |
| 30600-1 | CT Small bowel W positive contrast via enteroclysis tube | ./2.16.840.1.114222.4.11.1002/30600-1.json |
| 3060-1 | Trypsin [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3060-1.json |
| 30601-9 | CT Guidance for biopsy of Abdomen | ./2.16.840.1.114222.4.11.1002/30601-9.json |
| 30602-7 | CT Guidance for fine needle aspiration of Abdomen | ./2.16.840.1.114222.4.11.1002/30602-7.json |
| 30603-5 | CT Guidance for fine needle aspiration of Liver | ./2.16.840.1.114222.4.11.1002/30603-5.json |
| 30604-3 | CT Guidance for biopsy of Pancreas | ./2.16.840.1.114222.4.11.1002/30604-3.json |
| 30605-0 | CT Guidance for fine needle aspiration of Pancreas | ./2.16.840.1.114222.4.11.1002/30605-0.json |
| 30606-8 | CT Guidance for fine needle aspiration of Pelvis | ./2.16.840.1.114222.4.11.1002/30606-8.json |
| 30607-6 | CT Guidance for biopsy of Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/30607-6.json |
| 30608-4 | CT Guidance for fine needle aspiration of Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/30608-4.json |
| 30609-2 | CT Guidance for biopsy of Spleen | ./2.16.840.1.114222.4.11.1002/30609-2.json |
| 30610-0 | CT Guidance for fine needle aspiration of Spleen | ./2.16.840.1.114222.4.11.1002/30610-0.json |
| 30611-8 | CT Liver WO contrast | ./2.16.840.1.114222.4.11.1002/30611-8.json |
| 30612-6 | CT Liver WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30612-6.json |
| 30613-4 | CT Pancreas WO contrast | ./2.16.840.1.114222.4.11.1002/30613-4.json |
| 30614-2 | CT Pancreas WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30614-2.json |
| 30615-9 | CT Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/30615-9.json |
| 30616-7 | CT Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30616-7.json |
| 30619-1 | CT Sacroiliac Joint | ./2.16.840.1.114222.4.11.1002/30619-1.json |
| 30620-9 | CT Lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/30620-9.json |
| 30621-7 | CT Spleen WO contrast | ./2.16.840.1.114222.4.11.1002/30621-7.json |
| 30622-5 | CT Spleen W contrast IV | ./2.16.840.1.114222.4.11.1002/30622-5.json |
| 30623-3 | CTA Pelvis vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30623-3.json |
| 30624-1 | CT Lower extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/30624-1.json |
| 30625-8 | CT Lower extremity WO contrast | ./2.16.840.1.114222.4.11.1002/30625-8.json |
| 30626-6 | CT Upper extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/30626-6.json |
| 3062-7 | Trypsin [Enzymatic activity/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/3062-7.json |
| 30627-4 | CT Upper extremity WO contrast | ./2.16.840.1.114222.4.11.1002/30627-4.json |
| 30628-2 | RF Guidance for removal of foreign body of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30628-2.json |
| 30629-0 | RF Guidance for procedure of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30629-0.json |
| 30630-8 | RF videography Cerebral cisterns Views W contrast | ./2.16.840.1.114222.4.11.1002/30630-8.json |
| 30631-6 | RF Chest Views | ./2.16.840.1.114222.4.11.1002/30631-6.json |
| 30632-4 | RF Diaphragm for motion | ./2.16.840.1.114222.4.11.1002/30632-4.json |
| 30633-2 | RF Esophagus Views W barium contrast PO | ./2.16.840.1.114222.4.11.1002/30633-2.json |
| 30634-0 | RF Guidance for biopsy of Lung | ./2.16.840.1.114222.4.11.1002/30634-0.json |
| 3063-5 | Trypsin [Enzymatic activity/volume] in Stool | ./2.16.840.1.114222.4.11.1002/3063-5.json |
| 30636-5 | RF Colon Views for reduction W contrast PR | ./2.16.840.1.114222.4.11.1002/30636-5.json |
| 30637-3 | RF Guidance for placement of tube in Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/30637-3.json |
| 30638-1 | RF Guidance for injection of Hip | ./2.16.840.1.114222.4.11.1002/30638-1.json |
| 30639-9 | RFA Vessel Single view W contrast | ./2.16.840.1.114222.4.11.1002/30639-9.json |
| 30640-7 | RFA Guidance for angioplasty of Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/30640-7.json |
| 30641-5 | RFA Guidance for Additional angioplasty of Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/30641-5.json |
| 30642-3 | RF Unspecified body region Single view | ./2.16.840.1.114222.4.11.1002/30642-3.json |
| 3064-3 | Trypsin+Trypsinogen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3064-3.json |
| 30643-1 | US Guidance for placement of CV catheter in Vein | ./2.16.840.1.114222.4.11.1002/30643-1.json |
| 30644-9 | US Guidance for placement of tunneled CV catheter | ./2.16.840.1.114222.4.11.1002/30644-9.json |
| 30645-6 | RFA Superior vena cava Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30645-6.json |
| 30646-4 | RF Guidance for change of tube in Sinus tract-- W contrast | ./2.16.840.1.114222.4.11.1002/30646-4.json |
| 30647-2 | RF Biliary ducts and Gallbladder Views W contrast via T-tube | ./2.16.840.1.114222.4.11.1002/30647-2.json |
| 30648-0 | RFA Peripheral artery Views for angioplasty W contrast IA | ./2.16.840.1.114222.4.11.1002/30648-0.json |
| 30649-8 | RFA Guidance for Additional angioplasty of Peripheral artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/30649-8.json |
| 3065-0 | Trypsinogen [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3065-0.json |
| 30650-6 | RF Unspecified body region Views for shunt | ./2.16.840.1.114222.4.11.1002/30650-6.json |
| 30651-4 | US Guidance for percutaneous biopsy.core needle of Breast | ./2.16.840.1.114222.4.11.1002/30651-4.json |
| 30652-2 | US Guidance for fine needle biopsy of Breast | ./2.16.840.1.114222.4.11.1002/30652-2.json |
| 30653-0 | US Guidance for aspiration of cyst of Breast | ./2.16.840.1.114222.4.11.1002/30653-0.json |
| 30654-8 | MR Brachial plexus WO contrast | ./2.16.840.1.114222.4.11.1002/30654-8.json |
| 30655-5 | MR Cerebral cisterns | ./2.16.840.1.114222.4.11.1002/30655-5.json |
| 30656-3 | MR Guidance for stereotactic localization of Brain-- W contrast IV | ./2.16.840.1.114222.4.11.1002/30656-3.json |
| 30657-1 | MR Brain WO contrast | ./2.16.840.1.114222.4.11.1002/30657-1.json |
| 30658-9 | MR Internal auditory canal WO contrast | ./2.16.840.1.114222.4.11.1002/30658-9.json |
| 30659-7 | MR Internal auditory canal WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30659-7.json |
| 30660-5 | MR Neck WO contrast | ./2.16.840.1.114222.4.11.1002/30660-5.json |
| 30661-3 | MR Orbit - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/30661-3.json |
| 30662-1 | MR Sinuses WO contrast | ./2.16.840.1.114222.4.11.1002/30662-1.json |
| 30663-9 | MR Sinuses WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30663-9.json |
| 30664-7 | MR Guidance for radiation treatment of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/30664-7.json |
| 30665-4 | MR Guidance for radiation treatment of Unspecified body region-- WO contrast | ./2.16.840.1.114222.4.11.1002/30665-4.json |
| 30666-2 | MR Pituitary and Sella turcica WO contrast | ./2.16.840.1.114222.4.11.1002/30666-2.json |
| 30667-0 | MR Cervical spine WO contrast | ./2.16.840.1.114222.4.11.1002/30667-0.json |
| 3066-8 | Trypsinogen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3066-8.json |
| 30668-8 | MR Abdomen WO contrast | ./2.16.840.1.114222.4.11.1002/30668-8.json |
| 30669-6 | MR Liver WO contrast | ./2.16.840.1.114222.4.11.1002/30669-6.json |
| 30670-4 | MR Liver WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30670-4.json |
| 30671-2 | MR Pelvis and Hip WO contrast | ./2.16.840.1.114222.4.11.1002/30671-2.json |
| 30672-0 | MR Pelvis and Hip WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30672-0.json |
| 30673-8 | MR Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/30673-8.json |
| 30674-6 | MR Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30674-6.json |
| 30675-3 | MR Prostate | ./2.16.840.1.114222.4.11.1002/30675-3.json |
| 3067-6 | Trypsinogen I Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3067-6.json |
| 30678-7 | MR Lumbar spine W contrast IV | ./2.16.840.1.114222.4.11.1002/30678-7.json |
| 30679-5 | MR Lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/30679-5.json |
| 30680-3 | MR Ankle WO contrast | ./2.16.840.1.114222.4.11.1002/30680-3.json |
| 30681-1 | MR Foot WO contrast | ./2.16.840.1.114222.4.11.1002/30681-1.json |
| 30682-9 | MR Foot WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30682-9.json |
| 30683-7 | MR Forearm WO contrast | ./2.16.840.1.114222.4.11.1002/30683-7.json |
| 30684-5 | MR Forearm WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30684-5.json |
| 30685-2 | MR Hand WO contrast | ./2.16.840.1.114222.4.11.1002/30685-2.json |
| 30686-0 | MR Hand WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30686-0.json |
| 30687-8 | MR Hip WO contrast | ./2.16.840.1.114222.4.11.1002/30687-8.json |
| 30688-6 | MR Hip WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30688-6.json |
| 30689-4 | MR Upper arm WO contrast | ./2.16.840.1.114222.4.11.1002/30689-4.json |
| 30690-2 | MR Upper arm WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30690-2.json |
| 30691-0 | MR Knee WO contrast | ./2.16.840.1.114222.4.11.1002/30691-0.json |
| 30692-8 | MR Lower extremity | ./2.16.840.1.114222.4.11.1002/30692-8.json |
| 30693-6 | MR Shoulder WO contrast | ./2.16.840.1.114222.4.11.1002/30693-6.json |
| 30694-4 | NM Thyroid gland and uptake single view | ./2.16.840.1.114222.4.11.1002/30694-4.json |
| 30695-1 | NM Thyroid gland Views | ./2.16.840.1.114222.4.11.1002/30695-1.json |
| 30696-9 | NM Scrotum and testicle Views | ./2.16.840.1.114222.4.11.1002/30696-9.json |
| 30697-7 | NM Pulmonary system Ventilation and Perfusion | ./2.16.840.1.114222.4.11.1002/30697-7.json |
| 30698-5 | US Guidance for aspiration of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30698-5.json |
| 30699-3 | US Guidance for drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30699-3.json |
| 3070-0 | Tryptophan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3070-0.json |
| 30701-7 | US Unspecified body region during surgery | ./2.16.840.1.114222.4.11.1002/30701-7.json |
| 30702-5 | US Guidance for injection of Thyroid gland | ./2.16.840.1.114222.4.11.1002/30702-5.json |
| 30703-3 | US Guidance for fluid aspiration of Pericardial space | ./2.16.840.1.114222.4.11.1002/30703-3.json |
| 30704-1 | US Abdomen limited | ./2.16.840.1.114222.4.11.1002/30704-1.json |
| 30705-8 | US Uterus and Fallopian tubes | ./2.16.840.1.114222.4.11.1002/30705-8.json |
| 30706-6 | US Liver during surgery | ./2.16.840.1.114222.4.11.1002/30706-6.json |
| 30709-0 | US Lower extremity | ./2.16.840.1.114222.4.11.1002/30709-0.json |
| 30710-8 | US Upper extremity | ./2.16.840.1.114222.4.11.1002/30710-8.json |
| 30711-6 | US Hip developmental joint assessment | ./2.16.840.1.114222.4.11.1002/30711-6.json |
| 30712-4 | US Hip WO developmental joint assessment | ./2.16.840.1.114222.4.11.1002/30712-4.json |
| 30713-2 | XR Spine Views W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/30713-2.json |
| 30714-0 | XR Thoracic and lumbar spine AP for scoliosis | ./2.16.840.1.114222.4.11.1002/30714-0.json |
| 30715-7 | XR Thoracic and lumbar spine AP and lateral for scoliosis | ./2.16.840.1.114222.4.11.1002/30715-7.json |
| 30716-5 | XR Thoracic and lumbar spine Lateral Views for scoliosis | ./2.16.840.1.114222.4.11.1002/30716-5.json |
| 30717-3 | XR Thoracic and lumbar spine Views for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/30717-3.json |
| 30719-9 | XR tomography Temporomandibular joint | ./2.16.840.1.114222.4.11.1002/30719-9.json |
| 30720-7 | XR Orbit - bilateral Views for foreign body | ./2.16.840.1.114222.4.11.1002/30720-7.json |
| 30721-5 | XR Sinuses PA and Lateral | ./2.16.840.1.114222.4.11.1002/30721-5.json |
| 30722-3 | Portable XR Skull Single view | ./2.16.840.1.114222.4.11.1002/30722-3.json |
| 30723-1 | Portable XR Skull Views | ./2.16.840.1.114222.4.11.1002/30723-1.json |
| 30724-9 | Portable XR Cervical spine Single view | ./2.16.840.1.114222.4.11.1002/30724-9.json |
| 30725-6 | XR Cervical spine AP | ./2.16.840.1.114222.4.11.1002/30725-6.json |
| 30726-4 | Portable XR Cervical spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/30726-4.json |
| 30727-2 | Portable XR Cervical spine AP | ./2.16.840.1.114222.4.11.1002/30727-2.json |
| 30729-8 | Portable XR Spine Cervical Odontoid and Cervical axis AP | ./2.16.840.1.114222.4.11.1002/30729-8.json |
| 30730-6 | Portable XR Zygomatic arch - bilateral Views | ./2.16.840.1.114222.4.11.1002/30730-6.json |
| 30731-4 | Portable XR Zygomatic arch Views | ./2.16.840.1.114222.4.11.1002/30731-4.json |
| 30733-0 | Portable XR Chest Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/30733-0.json |
| 30734-8 | XR Chest AP lateral-decubitus | ./2.16.840.1.114222.4.11.1002/30734-8.json |
| 30735-5 | Portable XR Chest AP lateral-decubitus | ./2.16.840.1.114222.4.11.1002/30735-5.json |
| 30736-3 | XR Chest Views W inspiration and expiration | ./2.16.840.1.114222.4.11.1002/30736-3.json |
| 30737-1 | XR Chest Left lateral | ./2.16.840.1.114222.4.11.1002/30737-1.json |
| 30738-9 | Portable XR Chest Left lateral | ./2.16.840.1.114222.4.11.1002/30738-9.json |
| 30739-7 | Portable XR Chest Oblique | ./2.16.840.1.114222.4.11.1002/30739-7.json |
| 30740-5 | XR Chest Oblique | ./2.16.840.1.114222.4.11.1002/30740-5.json |
| 30741-3 | XR Chest PA and Lateral and Lordotic upright | ./2.16.840.1.114222.4.11.1002/30741-3.json |
| 3074-2 | Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3074-2.json |
| 30742-1 | XR Chest PA and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/30742-1.json |
| 30743-9 | Portable XR Chest PA and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/30743-9.json |
| 30744-7 | XR Chest PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/30744-7.json |
| 30745-4 | XR Chest Views | ./2.16.840.1.114222.4.11.1002/30745-4.json |
| 30746-2 | Portable XR Chest Views | ./2.16.840.1.114222.4.11.1002/30746-2.json |
| 30747-0 | Portable XR Ribs Views | ./2.16.840.1.114222.4.11.1002/30747-0.json |
| 30748-8 | XR Shoulder Single view | ./2.16.840.1.114222.4.11.1002/30748-8.json |
| 30749-6 | Portable XR Shoulder Single view | ./2.16.840.1.114222.4.11.1002/30749-6.json |
| 30750-4 | XR Shoulder 5 Views | ./2.16.840.1.114222.4.11.1002/30750-4.json |
| 30751-2 | XR Shoulder West Point | ./2.16.840.1.114222.4.11.1002/30751-2.json |
| 30752-0 | XR Thoracic spine AP | ./2.16.840.1.114222.4.11.1002/30752-0.json |
| 30753-8 | XR Thoracic spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/30753-8.json |
| 30754-6 | Portable XR Thoracic spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/30754-6.json |
| 30755-3 | Portable XR Thoracic spine AP | ./2.16.840.1.114222.4.11.1002/30755-3.json |
| 30756-1 | XR Thoracic spine Lateral | ./2.16.840.1.114222.4.11.1002/30756-1.json |
| 30757-9 | Portable XR Thoracic spine Lateral | ./2.16.840.1.114222.4.11.1002/30757-9.json |
| 30758-7 | XR Thoracic spine Oblique | ./2.16.840.1.114222.4.11.1002/30758-7.json |
| 3075-9 | Tyramine [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/3075-9.json |
| 30759-5 | Portable XR Thoracic spine Oblique | ./2.16.840.1.114222.4.11.1002/30759-5.json |
| 30760-3 | XR tomography Kidney - bilateral 3 views W contrast IV | ./2.16.840.1.114222.4.11.1002/30760-3.json |
| 30762-9 | XR tomography Abdomen | ./2.16.840.1.114222.4.11.1002/30762-9.json |
| 30763-7 | Portable XR Abdomen AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/30763-7.json |
| 30764-5 | Portable XR Acetabulum - bilateral Views | ./2.16.840.1.114222.4.11.1002/30764-5.json |
| 30765-2 | Portable XR Acetabulum Views | ./2.16.840.1.114222.4.11.1002/30765-2.json |
| 30766-0 | XR Pelvis 3 Views | ./2.16.840.1.114222.4.11.1002/30766-0.json |
| 3076-7 | Tyramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3076-7.json |
| 30767-8 | XR Pelvis and Hip Views | ./2.16.840.1.114222.4.11.1002/30767-8.json |
| 30768-6 | XR Pelvis and Hip - bilateral Views | ./2.16.840.1.114222.4.11.1002/30768-6.json |
| 30769-4 | XR Pelvis and Hip - bilateral Maximum abduction Views | ./2.16.840.1.114222.4.11.1002/30769-4.json |
| 30770-2 | XR Pelvis and Hip AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/30770-2.json |
| 30771-0 | XR Pelvis Inlet and Outlet | ./2.16.840.1.114222.4.11.1002/30771-0.json |
| 30772-8 | Portable XR Pelvis Views | ./2.16.840.1.114222.4.11.1002/30772-8.json |
| 30773-6 | XR Lumbar spine Single view | ./2.16.840.1.114222.4.11.1002/30773-6.json |
| 30774-4 | Portable XR Lumbar spine Single view | ./2.16.840.1.114222.4.11.1002/30774-4.json |
| 30775-1 | XR Lumbar spine 3 Views | ./2.16.840.1.114222.4.11.1002/30775-1.json |
| 30776-9 | Portable XR Lumbar spine 3 Views | ./2.16.840.1.114222.4.11.1002/30776-9.json |
| 30777-7 | XR Lumbar spine AP | ./2.16.840.1.114222.4.11.1002/30777-7.json |
| 30778-5 | XR Lumbar spine Oblique | ./2.16.840.1.114222.4.11.1002/30778-5.json |
| 30779-3 | XR Ankle AP and Lateral | ./2.16.840.1.114222.4.11.1002/30779-3.json |
| 30780-1 | XR Finger second Views | ./2.16.840.1.114222.4.11.1002/30780-1.json |
| 30781-9 | XR Finger third Views | ./2.16.840.1.114222.4.11.1002/30781-9.json |
| 30782-7 | XR Finger fourth Views | ./2.16.840.1.114222.4.11.1002/30782-7.json |
| 3078-3 | Tyrosine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3078-3.json |
| 30783-5 | XR Finger fifth Views | ./2.16.840.1.114222.4.11.1002/30783-5.json |
| 30784-3 | XR Foot 2 Views | ./2.16.840.1.114222.4.11.1002/30784-3.json |
| 30785-0 | XR Foot Views W forced dorsiflexion | ./2.16.840.1.114222.4.11.1002/30785-0.json |
| 30786-8 | XR Hip Lateral frog | ./2.16.840.1.114222.4.11.1002/30786-8.json |
| 30787-6 | XR Joint Single view | ./2.16.840.1.114222.4.11.1002/30787-6.json |
| 30788-4 | XR Knee 3 Views | ./2.16.840.1.114222.4.11.1002/30788-4.json |
| 30789-2 | XR Knee 4 Views | ./2.16.840.1.114222.4.11.1002/30789-2.json |
| 30790-0 | XR Knee Tunnel | ./2.16.840.1.114222.4.11.1002/30790-0.json |
| 3079-1 | Tyrosine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3079-1.json |
| 30791-8 | XR Patella Views | ./2.16.840.1.114222.4.11.1002/30791-8.json |
| 30792-6 | Portable XR Patella Views | ./2.16.840.1.114222.4.11.1002/30792-6.json |
| 30793-4 | XR Wrist AP and Lateral | ./2.16.840.1.114222.4.11.1002/30793-4.json |
| 30794-2 | MR Breast | ./2.16.840.1.114222.4.11.1002/30794-2.json |
| 30795-9 | MR Breast - bilateral | ./2.16.840.1.114222.4.11.1002/30795-9.json |
| 30796-7 | MR Elbow WO contrast | ./2.16.840.1.114222.4.11.1002/30796-7.json |
| 30797-5 | XR Lumbar spine 5 Views | ./2.16.840.1.114222.4.11.1002/30797-5.json |
| 30799-1 | CT Head WO contrast | ./2.16.840.1.114222.4.11.1002/30799-1.json |
| 30800-7 | MR Guidance for stereotactic localization of Brain-- WO contrast | ./2.16.840.1.114222.4.11.1002/30800-7.json |
| 30801-5 | CT Maxillofacial region W contrast IV | ./2.16.840.1.114222.4.11.1002/30801-5.json |
| 30802-3 | CT Maxillofacial region WO contrast | ./2.16.840.1.114222.4.11.1002/30802-3.json |
| 30803-1 | CT Maxillofacial region WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30803-1.json |
| 30804-9 | CTA Chest vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30804-9.json |
| 30805-6 | CTA Abdominal vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30805-6.json |
| 30807-2 | CTA Lower extremity vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30807-2.json |
| 30808-0 | RF Cervical and thoracic and lumbar spine Views W contrast IT | ./2.16.840.1.114222.4.11.1002/30808-0.json |
| 30809-8 | RF Upper gastrointestinal tract and Small bowel Single view W contrast PO | ./2.16.840.1.114222.4.11.1002/30809-8.json |
| 30810-6 | RF Lacrimal duct Views W contrast intra lacrimal duct | ./2.16.840.1.114222.4.11.1002/30810-6.json |
| 30811-4 | RF Posterior fossa Views W contrast IT | ./2.16.840.1.114222.4.11.1002/30811-4.json |
| 30812-2 | RF Guidance for injection of Spine Cervical Facet Joint | ./2.16.840.1.114222.4.11.1002/30812-2.json |
| 30813-0 | XR Lung - bilateral Views W contrast intrabronchial | ./2.16.840.1.114222.4.11.1002/30813-0.json |
| 30814-8 | RF Guidance for injection of Spine Thoracic Facet Joint | ./2.16.840.1.114222.4.11.1002/30814-8.json |
| 30815-5 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- W contrast retrograde | ./2.16.840.1.114222.4.11.1002/30815-5.json |
| 30816-3 | RFA Peritoneum Views W contrast percutaneous intraperitoneal | ./2.16.840.1.114222.4.11.1002/30816-3.json |
| 30817-1 | RF Guidance for injection of Lumbar Spine Facet Joint | ./2.16.840.1.114222.4.11.1002/30817-1.json |
| 30818-9 | RF Guidance for placement of catheter in Fallopian tubes-- transcervical | ./2.16.840.1.114222.4.11.1002/30818-9.json |
| 30819-7 | RFA Epidural veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30819-7.json |
| 30820-5 | RFA Carotid artery.external - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30820-5.json |
| 30821-3 | RFA Carotid artery.external Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30821-3.json |
| 30822-1 | RFA Head artery - bilateral and Neck artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30822-1.json |
| 30823-9 | RFA Head artery and Neck artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30823-9.json |
| 30824-7 | RFA Intercranial vessel and Neck Vessel Views W contrast | ./2.16.840.1.114222.4.11.1002/30824-7.json |
| 3082-5 | Tyrosine aminotransferase [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3082-5.json |
| 30825-4 | RFA Orbit veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30825-4.json |
| 30828-8 | RFA Brachial artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30828-8.json |
| 30829-6 | RFA Internal thoracic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30829-6.json |
| 30830-4 | RFA Pulmonary artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30830-4.json |
| 30831-2 | RFA Adrenal artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30831-2.json |
| 30832-0 | RFA Adrenal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30832-0.json |
| 3083-3 | Urate [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/3083-3.json |
| 30833-8 | RFA Pelvis arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30833-8.json |
| 30834-6 | RFA Renal artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30834-6.json |
| 30836-1 | RFA Guidance for angioplasty of Visceral artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/30836-1.json |
| 30837-9 | RFA Abdominal Aorta Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30837-9.json |
| 30838-7 | RFA Aorta and Femoral artery - bilateral Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/30838-7.json |
| 30839-5 | RFA Abdominal lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/30839-5.json |
| 30840-3 | RFA Abdominal lymphatic vessels - bilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/30840-3.json |
| 3084-1 | Urate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3084-1.json |
| 30841-1 | RFA Portal vein Views W contrast transhepatic | ./2.16.840.1.114222.4.11.1002/30841-1.json |
| 30842-9 | RFA Portal vein Views for hemodynamics W contrast transhepatic | ./2.16.840.1.114222.4.11.1002/30842-9.json |
| 30843-7 | RFA Adrenal vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30843-7.json |
| 30844-5 | RFA Adrenal vein - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30844-5.json |
| 30845-2 | RFA Inferior vena cava Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30845-2.json |
| 30846-0 | RFA Renal vein - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30846-0.json |
| 30847-8 | RFA Renal vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30847-8.json |
| 30848-6 | RFA Extremity arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30848-6.json |
| 30849-4 | RFA Extremity arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/30849-4.json |
| 30850-2 | RFA Extremity lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/30850-2.json |
| 30851-0 | RFA Extremity lymphatic vessels - bilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/30851-0.json |
| 30852-8 | RFA XXX>Peripheral veins - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/30852-8.json |
| 30853-6 | US Breast duct W contrast intra duct | ./2.16.840.1.114222.4.11.1002/30853-6.json |
| 30854-4 | MR Cervical and thoracic and lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/30854-4.json |
| 30855-1 | MR Cervical and thoracic and lumbar spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30855-1.json |
| 30856-9 | MRA Head vessels | ./2.16.840.1.114222.4.11.1002/30856-9.json |
| 30857-7 | MR Nerves cranial | ./2.16.840.1.114222.4.11.1002/30857-7.json |
| 3085-8 | Urate [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/3085-8.json |
| 30858-5 | MRA Head veins | ./2.16.840.1.114222.4.11.1002/30858-5.json |
| 30859-3 | MRA Carotid vessels and Neck vessels | ./2.16.840.1.114222.4.11.1002/30859-3.json |
| 30860-1 | MR Nasopharynx | ./2.16.840.1.114222.4.11.1002/30860-1.json |
| 30861-9 | MRA Aortic arch and Neck vessels | ./2.16.840.1.114222.4.11.1002/30861-9.json |
| 30862-7 | MRA Chest vessels | ./2.16.840.1.114222.4.11.1002/30862-7.json |
| 30864-3 | MRA Abdominal veins and IVC | ./2.16.840.1.114222.4.11.1002/30864-3.json |
| 30865-0 | MRA Celiac vessels and Superior mesenteric Vessels | ./2.16.840.1.114222.4.11.1002/30865-0.json |
| 3086-6 | Urate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3086-6.json |
| 30866-8 | MR Lumbosacral plexus | ./2.16.840.1.114222.4.11.1002/30866-8.json |
| 30867-6 | MRA Pelvis vessels | ./2.16.840.1.114222.4.11.1002/30867-6.json |
| 30868-4 | MRA Renal vessels | ./2.16.840.1.114222.4.11.1002/30868-4.json |
| 30869-2 | MR Lower leg WO contrast | ./2.16.840.1.114222.4.11.1002/30869-2.json |
| 30870-0 | MR Lower leg WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/30870-0.json |
| 30871-8 | MRA Femoral vessels | ./2.16.840.1.114222.4.11.1002/30871-8.json |
| 30872-6 | MRA Foot vessels | ./2.16.840.1.114222.4.11.1002/30872-6.json |
| 30873-4 | MRA Forearm vessels | ./2.16.840.1.114222.4.11.1002/30873-4.json |
| 3087-4 | Urate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3087-4.json |
| 30874-2 | MRA Lower extremity vessels | ./2.16.840.1.114222.4.11.1002/30874-2.json |
| 30875-9 | MR Upper extremity.joint | ./2.16.840.1.114222.4.11.1002/30875-9.json |
| 30876-7 | MRA Extremity veins | ./2.16.840.1.114222.4.11.1002/30876-7.json |
| 30877-5 | NM Kidney+Renal vessels Views | ./2.16.840.1.114222.4.11.1002/30877-5.json |
| 30878-3 | US Guidance for fluid aspiration of Unspecified body region | ./2.16.840.1.114222.4.11.1002/30878-3.json |
| 30880-9 | US.doppler Head vessels and Neck vessels | ./2.16.840.1.114222.4.11.1002/30880-9.json |
| 30881-7 | US.doppler Lower extremity vein | ./2.16.840.1.114222.4.11.1002/30881-7.json |
| 3088-2 | Urate renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3088-2.json |
| 30882-5 | US.doppler Upper extremity vein | ./2.16.840.1.114222.4.11.1002/30882-5.json |
| 30883-3 | XR Coccyx Views | ./2.16.840.1.114222.4.11.1002/30883-3.json |
| 30884-1 | XR Sacrum Views | ./2.16.840.1.114222.4.11.1002/30884-1.json |
| 30885-8 | XR Pelvis symphysis pubis Views | ./2.16.840.1.114222.4.11.1002/30885-8.json |
| 30887-4 | MRA Renal vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/30887-4.json |
| 30888-2 | MRA Tibioperoneal vessels | ./2.16.840.1.114222.4.11.1002/30888-2.json |
| 30889-0 | XR Temporomandibular joint - left Views | ./2.16.840.1.114222.4.11.1002/30889-0.json |
| 3089-0 | Urate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/3089-0.json |
| 30890-8 | XR Temporomandibular joint - right Views | ./2.16.840.1.114222.4.11.1002/30890-8.json |
| 30892-4 | RF Guidance for placement of catheter in Biliary ducts and Pancreatic duct-- W contrast retrograde | ./2.16.840.1.114222.4.11.1002/30892-4.json |
| 30894-0 | Aldosterone/Renin [Ratio] in Plasma | ./2.16.840.1.114222.4.11.1002/30894-0.json |
| 30895-7 | Renin [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/30895-7.json |
| 30900-5 | Cold agglutinin [Titer] in Serum or Plasma by Adult RBC Agglutination | ./2.16.840.1.114222.4.11.1002/30900-5.json |
| 30901-3 | Cold agglutinin [Titer] in Serum or Plasma by Cord RBC agglutination | ./2.16.840.1.114222.4.11.1002/30901-3.json |
| 30902-1 | Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation | ./2.16.840.1.114222.4.11.1002/30902-1.json |
| 30903-9 | Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/30903-9.json |
| 3090-8 | Urea [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/3090-8.json |
| 30910-4 | Antimicrobials [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/30910-4.json |
| 30911-2 | DNA ploidy [Identifier] in Specimen by Flow cytometry (FC) Nominal | ./2.16.840.1.114222.4.11.1002/30911-2.json |
| 30912-0 | DNA index in Specimen by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/30912-0.json |
| 30913-8 | S-phase cells/100 cells in Specimen by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/30913-8.json |
| 30914-6 | Hyperdiploid cells/100 cells in Specimen by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/30914-6.json |
| 30915-3 | Aneuploid cells/100 cells in Specimen by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/30915-3.json |
| 3091-6 | Urea [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3091-6.json |
| 30916-1 | Euploid+Aneuploid cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/30916-1.json |
| 30918-7 | Gold [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30918-7.json |
| 30919-5 | Iron [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30919-5.json |
| 30920-3 | Copper [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30920-3.json |
| 30921-1 | Mercury [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30921-1.json |
| 30922-9 | Magnesium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30922-9.json |
| 30923-7 | Chromium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30923-7.json |
| 3092-4 | Urea [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3092-4.json |
| 30924-5 | Arsenic [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30924-5.json |
| 30925-2 | Cadmium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30925-2.json |
| 30926-0 | Aluminum [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30926-0.json |
| 30927-8 | Selenium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30927-8.json |
| 30928-6 | Silver [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30928-6.json |
| 30929-4 | Thallium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30929-4.json |
| 30930-2 | Zinc [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30930-2.json |
| 30931-0 | Lead [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30931-0.json |
| 3093-2 | Urea nitrogen [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/3093-2.json |
| 30932-8 | Manganese [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30932-8.json |
| 30933-6 | Nickel [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/30933-6.json |
| 30934-4 | Natriuretic peptide B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/30934-4.json |
| 3094-0 | Urea nitrogen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3094-0.json |
| 3095-7 | Urea nitrogen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3095-7.json |
| 3096-5 | Urea nitrogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3096-5.json |
| 3097-3 | Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3097-3.json |
| 3098-1 | Urea renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3098-1.json |
| 30983-1 | Horse Chestnut IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/30983-1.json |
| 30984-9 | Silver Birch recombinant (rBet v) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30984-9.json |
| 30985-6 | Silver Birch recombinant (rBet v) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30985-6.json |
| 30986-4 | Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30986-4.json |
| 30987-2 | Chinchilla epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30987-2.json |
| 30989-8 | Sardine (Sardinops melanosticta) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30989-8.json |
| 30990-6 | Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30990-6.json |
| 30991-4 | Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30991-4.json |
| 30992-2 | Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30992-2.json |
| 30993-0 | Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30993-0.json |
| 30994-8 | Timothy recombinant (rPhl p) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30994-8.json |
| 30995-5 | Timothy recombinant (rPhl p) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30995-5.json |
| 30996-3 | Timothy recombinant (rPhl p) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30996-3.json |
| 30997-1 | Timothy native (nPhl p) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30997-1.json |
| 30998-9 | Timothy recombinant (rPhl p) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30998-9.json |
| 3099-9 | Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3099-9.json |
| 30999-7 | Timothy recombinant (rPhl p) 7 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/30999-7.json |
| 31000-3 | Timothy recombinant (rPhl p) 11 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31000-3.json |
| 31002-9 | Dates IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31002-9.json |
| 31003-7 | Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31003-7.json |
| 31004-5 | Mold Allergen Mix 3 (Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31004-5.json |
| 3100-5 | Uridyl transferase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/3100-5.json |
| 31005-2 | Epidermal Allergen Mix B (Budgerigar feather+Canary feather+Parrot feather+Finch feather) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31005-2.json |
| 31006-0 | Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31006-0.json |
| 31007-8 | Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31007-8.json |
| 31008-6 | Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31008-6.json |
| 31009-4 | Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31009-4.json |
| 31010-2 | Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31010-2.json |
| 31012-8 | Vancomycin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31012-8.json |
| 3101-3 | Uridyl transferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/3101-3.json |
| 31013-6 | Dehydrochlormethyltestosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31013-6.json |
| 31014-4 | Corynebacterium diphtheriae Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/31014-4.json |
| 31015-1 | Ethylestrenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31015-1.json |
| 31017-7 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31017-7.json |
| 31018-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/31018-5.json |
| 31019-3 | 10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31019-3.json |
| 31020-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/31020-1.json |
| 3102-1 | Urobilin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/3102-1.json |
| 31021-9 | Interferon.beta 1 neutralizing antibody [Titer] in Serum or Plasma by Neutralization test | ./2.16.840.1.114222.4.11.1002/31021-9.json |
| 31022-7 | Filaria identified in Specimen by Concentration | ./2.16.840.1.114222.4.11.1002/31022-7.json |
| 31023-5 | Myelin associated glycoprotein IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/31023-5.json |
| 31024-3 | Voltage-gated calcium channel Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31024-3.json |
| 31027-6 | Ritonavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31027-6.json |
| 31028-4 | Amprenavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31028-4.json |
| 31029-2 | Stenbolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31029-2.json |
| 31030-0 | Testosterone/Epitestosterone [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/31030-0.json |
| 31032-6 | Baker's yeast IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31032-6.json |
| 31033-4 | Indinavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31033-4.json |
| 3103-9 | Urobilin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3103-9.json |
| 31046-6 | Rheumatoid factor [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31046-6.json |
| 3104-7 | Urobilin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3104-7.json |
| 31047-4 | Rubella virus IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31047-4.json |
| 31048-2 | Coccidioides immitis Ab [Presence] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31048-2.json |
| 31049-0 | Coxsackievirus A7 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31049-0.json |
| 31050-8 | Coxsackievirus A9 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31050-8.json |
| 31051-6 | Coxsackievirus A10 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31051-6.json |
| 31052-4 | Coxsackievirus A16 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31052-4.json |
| 31053-2 | Coxsackievirus B1 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31053-2.json |
| 3105-4 | Urobilinogen [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/3105-4.json |
| 31054-0 | Coxsackievirus B2 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31054-0.json |
| 31055-7 | Coxsackievirus B3 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31055-7.json |
| 31056-5 | Coxsackievirus B4 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31056-5.json |
| 31057-3 | Coxsackievirus B5 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31057-3.json |
| 31058-1 | Coxsackievirus B6 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31058-1.json |
| 31059-9 | Echovirus 4 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31059-9.json |
| 31060-7 | Echovirus 9 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31060-7.json |
| 31061-5 | Echovirus 11 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31061-5.json |
| 3106-2 | Urobilinogen [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/3106-2.json |
| 31062-3 | Echovirus 30 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31062-3.json |
| 31063-1 | Polio virus 1 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31063-1.json |
| 31064-9 | Polio virus 2 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31064-9.json |
| 31065-6 | Polio virus 3 Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31065-6.json |
| 31066-4 | Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31066-4.json |
| 31067-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31067-2.json |
| 31068-0 | Herpes simplex virus 1 IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31068-0.json |
| 31069-8 | Herpes simplex virus 2 IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/31069-8.json |
| 3107-0 | Urobilinogen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3107-0.json |
| 31070-6 | Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31070-6.json |
| 31071-4 | Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/31071-4.json |
| 31075-5 | Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/31075-5.json |
| 31076-3 | Rickettsia typhi IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/31076-3.json |
| 31077-1 | Rickettsia typhi IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/31077-1.json |
| 31080-5 | Cannabinoids [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/31080-5.json |
| 31081-3 | Benzodiazepines [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/31081-3.json |
| 31082-1 | Ethylene glycol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/31082-1.json |
| 31083-9 | Lead [Mass/time] in 8 hour Urine | ./2.16.840.1.114222.4.11.1002/31083-9.json |
| 31084-7 | Methadone [Mass/volume] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31084-7.json |
| 31085-4 | Methaqualone [Mass/volume] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31085-4.json |
| 31086-2 | Morphine Free [Mass/volume] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31086-2.json |
| 31087-0 | Thioridazine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/31087-0.json |
| 3108-8 | Urobilinogen [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3108-8.json |
| 31088-8 | Narcotics and opioids [Identifier] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31088-8.json |
| 31089-6 | Acetaminophen [Presence] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31089-6.json |
| 31090-4 | Ethchlorvynol [Presence] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31090-4.json |
| 31091-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31091-2.json |
| 31092-0 | Gentamicin [Mass/volume] in Serum or Plasma --trough post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31092-0.json |
| 31093-8 | Gentamicin [Mass/volume] in Serum or Plasma --random post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31093-8.json |
| 31094-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31094-6.json |
| 31095-3 | Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31095-3.json |
| 3109-6 | Urobilinogen [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/3109-6.json |
| 31096-1 | Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31096-1.json |
| 31097-9 | Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31097-9.json |
| 31098-7 | Amikacin [Mass/volume] in Serum or Plasma --trough post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31098-7.json |
| 31099-5 | Amikacin [Mass/volume] in Serum or Plasma --random post extended interval dosing | ./2.16.840.1.114222.4.11.1002/31099-5.json |
| 31100-1 | Hematocrit [Volume Fraction] of Blood by Impedance | ./2.16.840.1.114222.4.11.1002/31100-1.json |
| 31101-9 | Creatinine [Mass/time] in 24 hour Body fluid | ./2.16.840.1.114222.4.11.1002/31101-9.json |
| 3110-4 | Uronate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3110-4.json |
| 31114-2 | Aneuploid cell population 1/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/31114-2.json |
| 31115-9 | Aneuploid cell population 2/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/31115-9.json |
| 31116-7 | Euploid+Aneuploid cells population 1/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/31116-7.json |
| 31117-5 | Euploid+Aneuploid cells population 2/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/31117-5.json |
| 31118-3 | G2+M phase cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/31118-3.json |
| 31130-8 | Mumps virus soluble Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/31130-8.json |
| 31131-6 | Mumps virus particle-bound Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/31131-6.json |
| 31132-4 | Mumps virus soluble Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31132-4.json |
| 31133-2 | Mumps virus particle-bound Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31133-2.json |
| 31134-0 | Nuclear matrix protein 22 [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31134-0.json |
| 31135-7 | Cocaethylene [Mass/volume] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31135-7.json |
| 31136-5 | Carboxy tetrahydrocannabinol [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/31136-5.json |
| 31137-3 | Cocaine [Mass/volume] in Bile fluid | ./2.16.840.1.114222.4.11.1002/31137-3.json |
| 31144-9 | Thyroxine (T4) [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/31144-9.json |
| 31145-6 | Thyroxine (T4) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/31145-6.json |
| 3114-6 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3114-6.json |
| 31146-4 | Reagin Ab [Titer] in Cerebral spinal fluid by VDRL | ./2.16.840.1.114222.4.11.1002/31146-4.json |
| 31147-2 | Reagin Ab [Titer] in Serum by RPR | ./2.16.840.1.114222.4.11.1002/31147-2.json |
| 31148-0 | Heavy metals [Identifier] in Tissue | ./2.16.840.1.114222.4.11.1002/31148-0.json |
| 31149-8 | P53 protein Ag/100 cells in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/31149-8.json |
| 31150-6 | ERBB2 gene duplication [Presence] in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/31150-6.json |
| 31151-4 | Alpha-2-Microglobulin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/31151-4.json |
| 31152-2 | Immunoglobulin light chains [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/31152-2.json |
| 3115-3 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3115-3.json |
| 31153-0 | Coccidioides sp Ab [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/31153-0.json |
| 31154-8 | Coccidioides sp IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/31154-8.json |
| 31155-5 | Borrelia burgdorferi Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/31155-5.json |
| 31157-1 | Carboxyhemoglobin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31157-1.json |
| 31158-9 | Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/31158-9.json |
| 31159-7 | Heparin anti Xa [Units/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/31159-7.json |
| 31161-3 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/31161-3.json |
| 31162-1 | Sulfate-3-Glucuronyl paragloboside Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/31162-1.json |
| 31165-4 | Methyl butyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31165-4.json |
| 31166-2 | Methyl isoamyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31166-2.json |
| 31167-0 | Methyl propyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31167-0.json |
| 31168-8 | Mesityl oxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31168-8.json |
| 31169-6 | Theobromine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31169-6.json |
| 31172-0 | Fonofos [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31172-0.json |
| 31173-8 | Mevinphos [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31173-8.json |
| 31174-6 | Terbufos [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31174-6.json |
| 31175-3 | Metasystox [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31175-3.json |
| 31176-1 | Estradiol (E2) [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/31176-1.json |
| 31177-9 | Estrone (E1) [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/31177-9.json |
| 31178-7 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/31178-7.json |
| 31179-5 | Lopinavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31179-5.json |
| 31181-1 | Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31181-1.json |
| 31182-9 | 7-Aminonitrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31182-9.json |
| 31184-5 | Methyl amyl ketone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31184-5.json |
| 31185-2 | Platelet IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31185-2.json |
| 31186-0 | Platelet IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31186-0.json |
| 31187-8 | Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31187-8.json |
| 31188-6 | Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31188-6.json |
| 31189-4 | Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31189-4.json |
| 31190-2 | Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31190-2.json |
| 31191-0 | Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31191-0.json |
| 31192-8 | Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31192-8.json |
| 31193-6 | Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31193-6.json |
| 31194-4 | Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31194-4.json |
| 31195-1 | Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31195-1.json |
| 31196-9 | Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31196-9.json |
| 31197-7 | Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31197-7.json |
| 31198-5 | Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31198-5.json |
| 31199-3 | Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain | ./2.16.840.1.114222.4.11.1002/31199-3.json |
| 31200-9 | Histoplasma capsulatum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31200-9.json |
| 31201-7 | HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/31201-7.json |
| 31202-5 | Mycoplasma pneumoniae Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/31202-5.json |
| 31203-3 | 5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/31203-3.json |
| 31204-1 | Hepatitis B virus core IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31204-1.json |
| 31207-4 | Progesterone receptor [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/31207-4.json |
| 31209-0 | Islet cell 512 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31209-0.json |
| 3121-1 | Vanillylmandelate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3121-1.json |
| 31212-4 | Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31212-4.json |
| 31213-2 | Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31213-2.json |
| 31214-0 | Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31214-0.json |
| 31215-7 | Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31215-7.json |
| 31216-5 | Actinobacillus pleuropneumoniae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31216-5.json |
| 31217-3 | Adenovirus Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31217-3.json |
| 31218-1 | Afipia felis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31218-1.json |
| 31219-9 | Afipia felis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31219-9.json |
| 31220-7 | African horse sickness virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31220-7.json |
| 31221-5 | Alcelaphine herpesvirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31221-5.json |
| 31222-3 | Anaplasma marginale Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31222-3.json |
| 31223-1 | Arbovirus NOS Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31223-1.json |
| 31224-9 | Ascaris sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31224-9.json |
| 31228-0 | Aspergillus clavatus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31228-0.json |
| 3122-9 | Vanillylmandelate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3122-9.json |
| 31229-8 | Aspergillus flavus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31229-8.json |
| 31230-6 | Aspergillus flavus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31230-6.json |
| 31231-4 | Aspergillus nidulans Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31231-4.json |
| 31232-2 | Aspergillus niger Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31232-2.json |
| 31233-0 | Aspergillus sp Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31233-0.json |
| 31234-8 | Aspergillus terreus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31234-8.json |
| 31235-5 | Aureobasidium pullulans IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31235-5.json |
| 31236-3 | Infectious bronchitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31236-3.json |
| 3123-7 | Vanillylmandelate/Creatine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/3123-7.json |
| 31237-1 | Infectious bronchitis virus Ark-99 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31237-1.json |
| 31238-9 | Infectious bronchitis virus Conn-42 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31238-9.json |
| 31239-7 | Infectious bronchitis virus Mass-41 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31239-7.json |
| 31240-5 | Avian infectious laryngotracheitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31240-5.json |
| 31242-1 | Avian paramyxovirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31242-1.json |
| 31243-9 | Avian paramyxovirus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31243-9.json |
| 31244-7 | Babesia microti IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31244-7.json |
| 3124-5 | Vanillylmandelate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/3124-5.json |
| 31245-4 | Babesia microti IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31245-4.json |
| 31246-2 | Babesia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31246-2.json |
| 31247-0 | Barmah forest virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31247-0.json |
| 31248-8 | Barmah forest virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31248-8.json |
| 31249-6 | Bartonella henselae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31249-6.json |
| 31250-4 | Bartonella henselae IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31250-4.json |
| 31251-2 | Bartonella henselae IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31251-2.json |
| 3125-2 | Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3125-2.json |
| 31252-0 | Basement membrane Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31252-0.json |
| 31253-8 | Basement membrane IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31253-8.json |
| 31254-6 | Basement membrane IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31254-6.json |
| 31255-3 | Basement membrane IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31255-3.json |
| 31256-1 | Beta 2 glycoprotein 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31256-1.json |
| 31257-9 | Beta tubulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31257-9.json |
| 31258-7 | Beta tubulin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31258-7.json |
| 31259-5 | Blastomyces dermatitidis Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31259-5.json |
| 3126-0 | Vasopressin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3126-0.json |
| 31260-3 | Bluetongue virus 10 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31260-3.json |
| 31261-1 | Bluetongue virus 11 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31261-1.json |
| 31262-9 | Bluetongue virus 13 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31262-9.json |
| 31263-7 | Bluetongue virus 17 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31263-7.json |
| 31264-5 | Bluetongue virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31264-5.json |
| 31265-2 | Bordetella avium Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31265-2.json |
| 31266-0 | Bordetella pertussis Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31266-0.json |
| 31267-8 | Bordetella pertussis secretory IgA Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31267-8.json |
| 31268-6 | Borrelia burgdorferi IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31268-6.json |
| 31269-4 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31269-4.json |
| 31270-2 | Bovine diarrhea virus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31270-2.json |
| 31271-0 | Bovine diarrhea virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31271-0.json |
| 31272-8 | Bovine diarrhea virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31272-8.json |
| 31273-6 | Bovine herpesvirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31273-6.json |
| 31274-4 | Bovine leukemia virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31274-4.json |
| 31275-1 | Brush border Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31275-1.json |
| 31276-9 | Burkholderia pseudomallei IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31276-9.json |
| 31277-7 | Burkholderia pseudomallei IgM Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31277-7.json |
| 3127-8 | Viscosity of Body fluid | ./2.16.840.1.114222.4.11.1002/3127-8.json |
| 31278-5 | Campylobacter fetus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31278-5.json |
| 31279-3 | Campylobacter jejuni Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31279-3.json |
| 31280-1 | Canary serum proteins Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31280-1.json |
| 31281-9 | Cancer associated retinopathy Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31281-9.json |
| 31282-7 | Canine adenovirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31282-7.json |
| 31283-5 | Canine coronavirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31283-5.json |
| 31284-3 | Canine distemper virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31284-3.json |
| 31285-0 | Canine distemper virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31285-0.json |
| 3128-6 | Viscosity of Serum | ./2.16.840.1.114222.4.11.1002/3128-6.json |
| 31286-8 | Canine parvovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31286-8.json |
| 31287-6 | Canine parvovirus Ab [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31287-6.json |
| 31288-4 | Canine parvovirus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31288-4.json |
| 31289-2 | Canine parvovirus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31289-2.json |
| 31290-0 | Centromere IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31290-0.json |
| 31291-8 | Chicken serum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31291-8.json |
| 31292-6 | Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31292-6.json |
| 31293-4 | Chlamydia trachomatis IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31293-4.json |
| 3129-4 | Menadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3129-4.json |
| 31294-2 | Chlamydia trachomatis B IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31294-2.json |
| 31295-9 | Chlamydia trachomatis B IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31295-9.json |
| 31296-7 | Chlamydia trachomatis D+K IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31296-7.json |
| 31297-5 | Chlamydia trachomatis D+K IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31297-5.json |
| 31298-3 | Chlamydia trachomatis D+K IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31298-3.json |
| 31299-1 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31299-1.json |
| 31300-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31300-7.json |
| 31301-5 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31301-5.json |
| 3130-2 | Vitronectin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/3130-2.json |
| 31302-3 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31302-3.json |
| 31303-1 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31303-1.json |
| 31304-9 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31304-9.json |
| 31305-6 | Chlamydophila psittaci IgA Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31305-6.json |
| 31306-4 | Chlamydophila psittaci IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31306-4.json |
| 31307-2 | Chlamydophila psittaci IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31307-2.json |
| 31308-0 | Clostridioides difficile Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31308-0.json |
| 31309-8 | Coccidioides immitis Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31309-8.json |
| 3131-0 | Xanthine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3131-0.json |
| 31310-6 | Cockatiel droppings Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31310-6.json |
| 31311-4 | Coxiella burnetii phase 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31311-4.json |
| 31312-2 | Coxiella burnetii phase 1 IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31312-2.json |
| 31313-0 | Coxiella burnetii phase 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31313-0.json |
| 31314-8 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31314-8.json |
| 31315-5 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31315-5.json |
| 31316-3 | Coxiella burnetii phase 2 IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31316-3.json |
| 31317-1 | Coxsackievirus A10 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31317-1.json |
| 31318-9 | Coxsackievirus A16 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31318-9.json |
| 31319-7 | Coxsackievirus A7 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31319-7.json |
| 31320-5 | Coxsackievirus A7 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31320-5.json |
| 31321-3 | Coxsackievirus A9 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31321-3.json |
| 31322-1 | Coxsackievirus A9 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31322-1.json |
| 31323-9 | Coxsackievirus B1 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31323-9.json |
| 31324-7 | Coxsackievirus B1 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31324-7.json |
| 31325-4 | Coxsackievirus B2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31325-4.json |
| 31326-2 | Coxsackievirus B2 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31326-2.json |
| 31327-0 | Coxsackievirus B3 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31327-0.json |
| 3132-8 | Xanthine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3132-8.json |
| 31328-8 | Coxsackievirus B3 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31328-8.json |
| 31329-6 | Coxsackievirus B4 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31329-6.json |
| 31330-4 | Coxsackievirus B4 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31330-4.json |
| 31331-2 | Coxsackievirus B5 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31331-2.json |
| 31332-0 | Coxsackievirus B5 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31332-0.json |
| 31333-8 | Coxsackievirus B6 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31333-8.json |
| 31334-6 | Coxsackievirus B6 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31334-6.json |
| 31335-3 | Cryptococcus sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31335-3.json |
| 3133-6 | Xanthurenate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3133-6.json |
| 31336-1 | Cryptostroma corticale Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31336-1.json |
| 31337-9 | Cytotoxic percent reactive Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31337-9.json |
| 31338-7 | Dengue virus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31338-7.json |
| 31339-5 | Dengue virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31339-5.json |
| 31340-3 | Dengue virus 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31340-3.json |
| 31341-1 | Dengue virus 4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31341-1.json |
| 31342-9 | Dengue virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31342-9.json |
| 31343-7 | Dengue virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31343-7.json |
| 3134-4 | Xylose [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3134-4.json |
| 31348-6 | DNA double strand Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31348-6.json |
| 31350-2 | Echovirus 11 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31350-2.json |
| 3135-1 | Xylose [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3135-1.json |
| 31351-0 | Echovirus 30 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31351-0.json |
| 31352-8 | Echovirus 30 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31352-8.json |
| 31353-6 | Echovirus 30 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31353-6.json |
| 31354-4 | Echovirus 4 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31354-4.json |
| 31355-1 | Echovirus 4 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31355-1.json |
| 31356-9 | Echovirus 4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31356-9.json |
| 31357-7 | Echovirus 7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31357-7.json |
| 31358-5 | Echovirus 9 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31358-5.json |
| 31359-3 | Echovirus 9 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31359-3.json |
| 31360-1 | Echovirus 9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31360-1.json |
| 31361-9 | Ehrlichia canis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31361-9.json |
| 31362-7 | Ehrlichia chaffeensis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31362-7.json |
| 31363-5 | Anaplasma phagocytophilum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31363-5.json |
| 31364-3 | Encephalomyocarditis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31364-3.json |
| 31365-0 | Endomysium Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31365-0.json |
| 31366-8 | Endomysium IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31366-8.json |
| 31367-6 | Enterovirus NOS Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31367-6.json |
| 31368-4 | Epidermis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31368-4.json |
| 3136-9 | Xylulose [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3136-9.json |
| 31369-2 | Epstein Barr virus capsid IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31369-2.json |
| 31370-0 | Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31370-0.json |
| 31371-8 | Epstein Barr virus early IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31371-8.json |
| 31372-6 | Epstein Barr virus nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31372-6.json |
| 31373-4 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31373-4.json |
| 31374-2 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31374-2.json |
| 31375-9 | Epstein Barr virus nuclear IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31375-9.json |
| 31376-7 | Equine arteritis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31376-7.json |
| 3137-7 | Body height Measured | ./2.16.840.1.114222.4.11.1002/3137-7.json |
| 31377-5 | Equine herpesvirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31377-5.json |
| 31378-3 | Equine herpesvirus 1+4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31378-3.json |
| 31379-1 | Equine influenza virus A1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31379-1.json |
| 31380-9 | Equine influenza virus A2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31380-9.json |
| 31381-7 | Escherichia coli verotoxin 1 Ab [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/31381-7.json |
| 31382-5 | Escherichia coli verotoxin 2 Ab [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/31382-5.json |
| 31383-3 | European tick borne encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31383-3.json |
| 31384-1 | Feline calicivirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31384-1.json |
| 31385-8 | Feline coronavirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31385-8.json |
| 31386-6 | Feline herpesvirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31386-6.json |
| 31387-4 | Feline herpesvirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31387-4.json |
| 31388-2 | Feline immunodeficiency virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31388-2.json |
| 31389-0 | Feline leukemia virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31389-0.json |
| 31390-8 | Feline panleukopenia virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31390-8.json |
| 31391-6 | Feline panleukopenia virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31391-6.json |
| 31392-4 | Feline panleukopenia virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31392-4.json |
| 31393-2 | Feline herpesvirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31393-2.json |
| 31394-0 | Feline syncytial virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31394-0.json |
| 31395-7 | Filovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31395-7.json |
| 31396-5 | Francisella tularensis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31396-5.json |
| 31406-2 | Glomerular basement membrane IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31406-2.json |
| 31407-0 | Haemophilus somnus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31407-0.json |
| 31408-8 | Hantavirus sin nombre IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31408-8.json |
| 31409-6 | Hantavirus sin nombre IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31409-6.json |
| 31410-4 | Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31410-4.json |
| 31411-2 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31411-2.json |
| 31412-0 | Herpes simplex virus 2 IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31412-0.json |
| 31413-8 | Herpes simplex virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31413-8.json |
| 31414-6 | Herpes virus 6 IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31414-6.json |
| 31415-3 | Herpes virus 6 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31415-3.json |
| 31416-1 | Herpes virus 7 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31416-1.json |
| 31417-9 | Herpes virus 7 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31417-9.json |
| 31418-7 | Heterophile Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31418-7.json |
| 3141-9 | Body weight Measured | ./2.16.840.1.114222.4.11.1002/3141-9.json |
| 31419-5 | Heterophile Ab [Presence] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/31419-5.json |
| 31420-3 | Highlands J virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31420-3.json |
| 31421-1 | Highlands J virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31421-1.json |
| 31422-9 | Highlands J virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31422-9.json |
| 31423-7 | Histone IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31423-7.json |
| 31424-5 | Histone H2a+H2b Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31424-5.json |
| 31425-2 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31425-2.json |
| 31426-0 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31426-0.json |
| 31427-8 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31427-8.json |
| 31428-6 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31428-6.json |
| 31430-2 | HIV 1 IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31430-2.json |
| 31431-0 | HTLV I+II IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31431-0.json |
| 31435-1 | Hyaluronidase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31435-1.json |
| 31436-9 | Infectious bursal disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31436-9.json |
| 31437-7 | Influenza virus A IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31437-7.json |
| 31438-5 | Influenza virus A IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31438-5.json |
| 31439-3 | Insulin receptor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31439-3.json |
| 31440-1 | Intercalated disk Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31440-1.json |
| 31441-9 | Intercellular substance Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31441-9.json |
| 31442-7 | Interferon.beta 1 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31442-7.json |
| 31443-5 | Intrinsic factor blocking Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31443-5.json |
| 31444-3 | Intrinsic factor blocking Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31444-3.json |
| 31445-0 | Intrinsic factor blocking IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31445-0.json |
| 31446-8 | Jamestown canyon virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31446-8.json |
| 31448-4 | La Crosse virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31448-4.json |
| 31449-2 | La Crosse virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31449-2.json |
| 31450-0 | La Crosse virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31450-0.json |
| 31451-8 | La Crosse virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31451-8.json |
| 31452-6 | Lassa virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31452-6.json |
| 31453-4 | Lassa virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31453-4.json |
| 31454-2 | Legionella pneumophila 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31454-2.json |
| 31455-9 | Legionella pneumophila 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31455-9.json |
| 31456-7 | Legionella pneumophila 1 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31456-7.json |
| 31457-5 | Legionella pneumophila 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31457-5.json |
| 31458-3 | Legionella pneumophila 2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31458-3.json |
| 31459-1 | Legionella pneumophila 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31459-1.json |
| 31460-9 | Legionella pneumophila 3 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31460-9.json |
| 31461-7 | Legionella pneumophila 4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31461-7.json |
| 31462-5 | Legionella pneumophila 4 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31462-5.json |
| 31463-3 | Legionella pneumophila 5 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31463-3.json |
| 31464-1 | Legionella pneumophila 5 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31464-1.json |
| 31465-8 | Legionella pneumophila 6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31465-8.json |
| 31466-6 | Legionella pneumophila 6 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31466-6.json |
| 31467-4 | Legionella pneumophila 6 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31467-4.json |
| 31468-2 | Legionella pneumophila 7 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31468-2.json |
| 31469-0 | Legionella pneumophila 8 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31469-0.json |
| 31470-8 | Legionella pneumophila 9 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31470-8.json |
| 31471-6 | Legionella pneumophila Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31471-6.json |
| 31472-4 | Legionella pneumophila IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31472-4.json |
| 31473-2 | Legionella pneumophila atypical Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31473-2.json |
| 31474-0 | Legionella sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31474-0.json |
| 31475-7 | Leishmania donovani Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31475-7.json |
| 3147-6 | Oxygen [Partial pressure] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/3147-6.json |
| 31476-5 | Leptospira borgpetersenii sv Sejroe Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31476-5.json |
| 31477-3 | Leptospira interrogans sv Bratislava Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31477-3.json |
| 31478-1 | Leptospira interrogans sv Canicola Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31478-1.json |
| 31479-9 | Leptospira interrogans sv Grippotyphosa Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31479-9.json |
| 31480-7 | Leptospira interrogans sv Hardjo Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31480-7.json |
| 31481-5 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31481-5.json |
| 31482-3 | Leptospira interrogans sv Pomona Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31482-3.json |
| 31483-1 | Leptospira sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31483-1.json |
| 3148-4 | Oxygen [Partial pressure] in Gas | ./2.16.840.1.114222.4.11.1002/3148-4.json |
| 31484-9 | Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31484-9.json |
| 31485-6 | Leptospira sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31485-6.json |
| 31486-4 | Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31486-4.json |
| 31487-2 | Leptospira sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31487-2.json |
| 31488-0 | Listeria sp Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31488-0.json |
| 31489-8 | Lumpy skin disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31489-8.json |
| 31490-6 | Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31490-6.json |
| 31491-4 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31491-4.json |
| 3149-2 | Oxygen [Partial pressure] in Inhaled gas | ./2.16.840.1.114222.4.11.1002/3149-2.json |
| 31492-2 | Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31492-2.json |
| 31493-0 | Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31493-0.json |
| 31494-8 | Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31494-8.json |
| 31495-5 | Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31495-5.json |
| 31499-7 | Ganglioside GM1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31499-7.json |
| 31502-8 | Ganglioside GM1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31502-8.json |
| 31503-6 | Mumps virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31503-6.json |
| 31504-4 | Mumps virus soluble Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31504-4.json |
| 31505-1 | Mumps virus soluble Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31505-1.json |
| 31506-9 | Mumps virus particle-bound Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31506-9.json |
| 31507-7 | Mumps virus particle-bound Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31507-7.json |
| 31508-5 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31508-5.json |
| 31509-3 | Mycoplasma capricolum ss capripneumonia Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31509-3.json |
| 31510-1 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31510-1.json |
| 31511-9 | Mycoplasma gallisepticum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31511-9.json |
| 31512-7 | Mycoplasma hominis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31512-7.json |
| 31513-5 | Mycoplasma hyopneumoniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31513-5.json |
| 31514-3 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31514-3.json |
| 31515-0 | Mycoplasma pneumoniae IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31515-0.json |
| 31516-8 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31516-8.json |
| 31517-6 | Mycoplasma sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31517-6.json |
| 31518-4 | Mycoplasma synoviae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31518-4.json |
| 31519-2 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31519-2.json |
| 31520-0 | Myelin associated glycoprotein Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31520-0.json |
| 31521-8 | Myelin associated glycoprotein Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31521-8.json |
| 31522-6 | Myelin associated glycoprotein IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31522-6.json |
| 31523-4 | Myxoma virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31523-4.json |
| 31524-2 | Nairobi sheep disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31524-2.json |
| 31525-9 | Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31525-9.json |
| 31526-7 | Neisseria meningitidis serogroup A IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31526-7.json |
| 31527-5 | Neisseria meningitidis serogroup C IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31527-5.json |
| 31528-3 | Neisseria meningitidis serogroup Y Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31528-3.json |
| 31529-1 | Neospora caninum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31529-1.json |
| 31530-9 | Neuronal Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31530-9.json |
| 31531-7 | Neuronal Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31531-7.json |
| 31532-5 | Neuronal Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31532-5.json |
| 31533-3 | Neuronal Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31533-3.json |
| 31534-1 | Neuronal IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31534-1.json |
| 31535-8 | Neuronal nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31535-8.json |
| 31536-6 | Neuronal nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31536-6.json |
| 31537-4 | Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31537-4.json |
| 31538-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31538-2.json |
| 31539-0 | Neuronal nuclear type 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31539-0.json |
| 31540-8 | Nuclear Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31540-8.json |
| 31541-6 | Nuclear Ab [Units/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/31541-6.json |
| 31542-4 | Nuclear Ab [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/31542-4.json |
| 31543-2 | Nuclear Ab [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/31543-2.json |
| 31544-0 | Nuclear Ab [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/31544-0.json |
| 31545-7 | Nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31545-7.json |
| 31546-5 | Ovary IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31546-5.json |
| 31547-3 | Pancreatic islet cell Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31547-3.json |
| 31548-1 | Parainfluenza virus 1 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31548-1.json |
| 31549-9 | Parainfluenza virus 1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31549-9.json |
| 31550-7 | Parainfluenza virus 2 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31550-7.json |
| 31551-5 | Parainfluenza virus 2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31551-5.json |
| 31552-3 | Parainfluenza virus 3 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31552-3.json |
| 31553-1 | Parainfluenza virus 3 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31553-1.json |
| 31554-9 | Parainfluenza virus 3 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31554-9.json |
| 31555-6 | Parainfluenza virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31555-6.json |
| 31556-4 | Parietal cell IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31556-4.json |
| 31557-2 | Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31557-2.json |
| 31558-0 | Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31558-0.json |
| 31559-8 | Pasteurella multocida Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31559-8.json |
| 31560-6 | Peste des petits ruminants virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31560-6.json |
| 31561-4 | Phospholipid IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31561-4.json |
| 31562-2 | PM-SCL extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31562-2.json |
| 31563-0 | PM-SCL extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31563-0.json |
| 31564-8 | Polio virus 1 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31564-8.json |
| 31565-5 | Polio virus 1 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31565-5.json |
| 31566-3 | Polio virus 2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31566-3.json |
| 31567-1 | Polio virus 2 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31567-1.json |
| 31568-9 | Polio virus 3 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31568-9.json |
| 31569-7 | Polio virus 3 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31569-7.json |
| 31570-5 | Porcine influenza virus A Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31570-5.json |
| 31571-3 | Porcine parvovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31571-3.json |
| 31572-1 | PRRSV Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31572-1.json |
| 31573-9 | Powassan virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31573-9.json |
| 31574-7 | Powassan virus IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31574-7.json |
| 31575-4 | Powassan virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31575-4.json |
| 31576-2 | Powassan virus IgM Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31576-2.json |
| 31577-0 | Pseudorabies virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31577-0.json |
| 31578-8 | Pullularia sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31578-8.json |
| 31579-6 | Purkinje cells Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31579-6.json |
| 31580-4 | Purkinje cells IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31580-4.json |
| 31581-2 | Reovirus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31581-2.json |
| 31582-0 | Reovirus Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31582-0.json |
| 31583-8 | Respiratory syncytial virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31583-8.json |
| 31584-6 | Reticulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31584-6.json |
| 31585-3 | Reticulin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31585-3.json |
| 31586-1 | Rhodococcus equi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31586-1.json |
| 31587-9 | Rhodococcus equi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31587-9.json |
| 31588-7 | Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31588-7.json |
| 31589-5 | Ribosomal Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31589-5.json |
| 31590-3 | Ribosomal Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31590-3.json |
| 31592-9 | Ribosomal P Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31592-9.json |
| 31593-7 | Rickettsia (Proteus OX19) Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31593-7.json |
| 31594-5 | Rickettsia (Proteus OXK) Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31594-5.json |
| 31595-2 | Rickettsia akari Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31595-2.json |
| 31596-0 | Rickettsia australis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31596-0.json |
| 31597-8 | Rickettsia conorii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31597-8.json |
| 31598-6 | Rickettsia honei Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31598-6.json |
| 31599-4 | Rickettsia prowazekii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31599-4.json |
| 31600-0 | Rickettsia prowazekii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31600-0.json |
| 31601-8 | Rickettsia spotted fever group IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31601-8.json |
| 31602-6 | Rickettsia typhus group IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31602-6.json |
| 31603-4 | Rickettsia rickettsii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31603-4.json |
| 31604-2 | Rickettsia rickettsii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31604-2.json |
| 31605-9 | Rickettsia sibirica Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31605-9.json |
| 31606-7 | Orientia tsutsugamushi IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31606-7.json |
| 31607-5 | Orientia tsutsugamushi Gilliam Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31607-5.json |
| 31608-3 | Orientia tsutsugamushi Karp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31608-3.json |
| 31609-1 | Orientia tsutsugamushi Kato Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31609-1.json |
| 31610-9 | Orientia tsutsugamushi Litchfield Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31610-9.json |
| 31611-7 | Rickettsia typhi IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/31611-7.json |
| 31612-5 | Rift valley fever virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31612-5.json |
| 31613-3 | Rinderpest virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31613-3.json |
| 31614-1 | Ross River virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31614-1.json |
| 31615-8 | Ross River virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31615-8.json |
| 31616-6 | Rubella virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31616-6.json |
| 31617-4 | Saint Louis encephalitis virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31617-4.json |
| 31618-2 | Salmonella paratyphi B H Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31618-2.json |
| 31619-0 | Salmonella paratyphi B O Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31619-0.json |
| 31620-8 | Salmonella pullorum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31620-8.json |
| 31621-6 | Salmonella typhi H D Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31621-6.json |
| 31622-4 | Salmonella typhi O D Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31622-4.json |
| 31623-2 | Salmonella typhimurium Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31623-2.json |
| 31624-0 | Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31624-0.json |
| 31625-7 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31625-7.json |
| 31626-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31626-5.json |
| 31627-3 | Smith extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31627-3.json |
| 31628-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31628-1.json |
| 31629-9 | Smooth muscle Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31629-9.json |
| 31630-7 | Spermatozoa Ab [Presence] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/31630-7.json |
| 31631-5 | Spermatozoa Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31631-5.json |
| 31632-3 | Spermatozoa Ab [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/31632-3.json |
| 31633-1 | Sporothrix schenckii Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31633-1.json |
| 31634-9 | Stachybotrys chartarum IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31634-9.json |
| 31639-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/31639-8.json |
| 31645-5 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/31645-5.json |
| 31646-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/31646-3.json |
| 31647-1 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/31647-1.json |
| 31650-5 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31650-5.json |
| 31658-8 | Streptococcus pyogenes enzyme Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31658-8.json |
| 31659-6 | Striated muscle Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31659-6.json |
| 31660-4 | Striated muscle IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31660-4.json |
| 31661-2 | Sulfate-3-Glucuronyl paragloboside Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31661-2.json |
| 31662-0 | Sulfate-3-Glucuronyl paragloboside Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31662-0.json |
| 31663-8 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31663-8.json |
| 31664-6 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31664-6.json |
| 31665-3 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31665-3.json |
| 31666-1 | Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31666-1.json |
| 31667-9 | Sulfatide Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31667-9.json |
| 31668-7 | Sulfatide Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31668-7.json |
| 31669-5 | Sulfatide IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31669-5.json |
| 31670-3 | Sulfatide IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31670-3.json |
| 31671-1 | Sulfatide IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31671-1.json |
| 31672-9 | Taylorella equigenitalis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31672-9.json |
| 31673-7 | Teichoate Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31673-7.json |
| 31680-2 | Theileria annulata Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31680-2.json |
| 31681-0 | Theileria mutans Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31681-0.json |
| 31682-8 | Theileria parva Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31682-8.json |
| 31683-6 | Thermoactinomyces IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31683-6.json |
| 31685-1 | Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31685-1.json |
| 31686-9 | Transmissible gastroenteritis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31686-9.json |
| 31687-7 | Trichinella sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31687-7.json |
| 31688-5 | Trivittatus virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31688-5.json |
| 31689-3 | Trivittatus virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31689-3.json |
| 31690-1 | Trivittatus virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31690-1.json |
| 31691-9 | Trypanosoma cruzi IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31691-9.json |
| 31692-7 | Trypanosoma equiperdum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31692-7.json |
| 31693-5 | Unidentified extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31693-5.json |
| 31694-3 | Varicella zoster virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31694-3.json |
| 31695-0 | Varicella zoster virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31695-0.json |
| 31696-8 | Vesicular stomatitis Indiana virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31696-8.json |
| 31697-6 | Vesicular stomatitis New Jersey virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31697-6.json |
| 31698-4 | Vibrio cholerae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31698-4.json |
| 31699-2 | Rabbit hemorrhagic disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31699-2.json |
| 31700-8 | West Nile virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31700-8.json |
| 31701-6 | West Nile virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31701-6.json |
| 31702-4 | West Nile virus IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31702-4.json |
| 31703-2 | West Nile virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31703-2.json |
| 31704-0 | West Nile virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31704-0.json |
| 31705-7 | Western equine encephalitis virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31705-7.json |
| 31706-5 | Western equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31706-5.json |
| 31707-3 | Yersinia enterocolitica O:5 Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31707-3.json |
| 31708-1 | Yersinia enterocolitica Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31708-1.json |
| 31709-9 | Adenovirus 40+41 Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31709-9.json |
| 31710-7 | Adenovirus Ag [Presence] in Conjunctival specimen | ./2.16.840.1.114222.4.11.1002/31710-7.json |
| 31711-5 | Adenovirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31711-5.json |
| 31712-3 | Adenovirus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31712-3.json |
| 31713-1 | Adenovirus Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31713-1.json |
| 31714-9 | Adenovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31714-9.json |
| 31715-6 | African horse sickness virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31715-6.json |
| 31716-4 | African swine fever virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31716-4.json |
| 31717-2 | Alcelaphine herpesvirus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31717-2.json |
| 31718-0 | Astrovirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31718-0.json |
| 31719-8 | Infectious bronchitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31719-8.json |
| 31720-6 | Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue | ./2.16.840.1.114222.4.11.1002/31720-6.json |
| 31721-4 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea | ./2.16.840.1.114222.4.11.1002/31721-4.json |
| 31722-2 | Avian infectious laryngotracheitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31722-2.json |
| 31723-0 | Avian leukosis virus Ag [Units/volume] in Egg yolk | ./2.16.840.1.114222.4.11.1002/31723-0.json |
| 31724-8 | Avian leukosis virus Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31724-8.json |
| 31725-5 | Avian paramyxovirus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31725-5.json |
| 31726-3 | Bacillus anthracis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31726-3.json |
| 31727-1 | Bacteroides fragilis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31727-1.json |
| 31728-9 | Bacteroides melaninogenicus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31728-9.json |
| 31729-7 | Bladder tumor Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31729-7.json |
| 31730-5 | Bladder tumor Ag [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31730-5.json |
| 31731-3 | Blastomyces dermatitidis Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31731-3.json |
| 3173-2 | aPTT in Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3173-2.json |
| 31732-1 | Bluetongue virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31732-1.json |
| 31733-9 | Border disease virus Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31733-9.json |
| 31734-7 | Border disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31734-7.json |
| 31735-4 | Bordetella bronchiseptica Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31735-4.json |
| 31736-2 | Bordetella parapertussis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31736-2.json |
| 31737-0 | Bordetella pertussis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31737-0.json |
| 31738-8 | Borrelia burgdorferi Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31738-8.json |
| 31739-6 | Borrelia sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31739-6.json |
| 3174-0 | Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3174-0.json |
| 31740-4 | Bovine diarrhea virus Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31740-4.json |
| 31741-2 | Bovine diarrhea virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31741-2.json |
| 31742-0 | Bovine diarrhea virus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31742-0.json |
| 31743-8 | Bovine diarrhea virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31743-8.json |
| 31744-6 | Bovine herpesvirus 1 Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31744-6.json |
| 31745-3 | Bovine herpesvirus 1 Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31745-3.json |
| 31746-1 | Bovine herpesvirus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31746-1.json |
| 31747-9 | Bovine herpesvirus 1 Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31747-9.json |
| 31748-7 | Bovine herpesvirus 2 Ag [Presence] in Exudate | ./2.16.840.1.114222.4.11.1002/31748-7.json |
| 31749-5 | Bovine herpesvirus 4 Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31749-5.json |
| 31750-3 | Bovine inner ear Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31750-3.json |
| 31751-1 | Bovine respiratory syncytial virus Ag [Presence] in Lung | ./2.16.840.1.114222.4.11.1002/31751-1.json |
| 31753-7 | Brucella sp Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/31753-7.json |
| 31754-5 | Brucella sp Ag [Presence] in Placenta | ./2.16.840.1.114222.4.11.1002/31754-5.json |
| 31755-2 | Campylobacter fetus Ag [Presence] in Genital fluid | ./2.16.840.1.114222.4.11.1002/31755-2.json |
| 31756-0 | Campylobacter fetus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31756-0.json |
| 3175-7 | Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3175-7.json |
| 31757-8 | Canarypox virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31757-8.json |
| 31758-6 | Candida albicans Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31758-6.json |
| 31759-4 | Candida albicans Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31759-4.json |
| 31760-2 | Candida sp Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31760-2.json |
| 31761-0 | Canine parvovirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31761-0.json |
| 31762-8 | Capripox virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31762-8.json |
| 31763-6 | Chlamydia sp Ag [Presence] in Conjunctival specimen | ./2.16.840.1.114222.4.11.1002/31763-6.json |
| 31764-4 | Chlamydia sp Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31764-4.json |
| 3176-5 | Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3176-5.json |
| 31765-1 | Chlamydia sp Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31765-1.json |
| 31766-9 | Chlamydia sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31766-9.json |
| 31767-7 | Chlamydia sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31767-7.json |
| 31768-5 | Chlamydia trachomatis Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31768-5.json |
| 31769-3 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen | ./2.16.840.1.114222.4.11.1002/31769-3.json |
| 31770-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31770-1.json |
| 31771-9 | Chlamydia trachomatis Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/31771-9.json |
| 31772-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/31772-7.json |
| 3177-3 | Antithrombin Ag [Moles/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3177-3.json |
| 31774-3 | Chlamydia trachomatis Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31774-3.json |
| 31775-0 | Chlamydia trachomatis Ag [Presence] in Urine sediment | ./2.16.840.1.114222.4.11.1002/31775-0.json |
| 31776-8 | Chlamydia trachomatis Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/31776-8.json |
| 31777-6 | Chlamydia trachomatis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31777-6.json |
| 31778-4 | Chlamydophila pneumoniae Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31778-4.json |
| 31779-2 | Chlamydophila psittaci Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31779-2.json |
| 31780-0 | Chlamydophila psittaci Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31780-0.json |
| 3178-1 | Bleeding time by Duke method | ./2.16.840.1.114222.4.11.1002/3178-1.json |
| 31781-8 | Classical swine fever virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31781-8.json |
| 31782-6 | Coccidioides immitis Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/31782-6.json |
| 31783-4 | Coxiella burnetii Ag [Presence] in Placenta | ./2.16.840.1.114222.4.11.1002/31783-4.json |
| 31784-2 | Coxiella burnetii Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31784-2.json |
| 31788-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31788-3.json |
| 31789-1 | Cryptococcus sp Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31789-1.json |
| 31790-9 | Cryptococcus sp Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31790-9.json |
| 31791-7 | Cryptococcus sp Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31791-7.json |
| 31792-5 | Cryptococcus sp Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31792-5.json |
| 31793-3 | Cryptosporidium sp Ag [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/31793-3.json |
| 31794-1 | Cryptosporidium sp Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31794-1.json |
| 31795-8 | Cytomegalovirus Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31795-8.json |
| 31796-6 | Cytomegalovirus Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31796-6.json |
| 31797-4 | Cytomegalovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31797-4.json |
| 31798-2 | Dengue virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31798-2.json |
| 3179-9 | Bleeding time by Ivy method | ./2.16.840.1.114222.4.11.1002/3179-9.json |
| 31799-0 | Dengue virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31799-0.json |
| 31800-6 | Dermatophilus congolensis Ag [Presence] in Exudate | ./2.16.840.1.114222.4.11.1002/31800-6.json |
| 31801-4 | Dirofilaria immitis Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31801-4.json |
| 31802-2 | Duck enteritis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31802-2.json |
| 31803-0 | Duck hepatitis virus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31803-0.json |
| 31804-8 | Duck hepatitis virus 2 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31804-8.json |
| 31805-5 | Duck hepatitis virus 3 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31805-5.json |
| 31806-3 | Eastern equine encephalitis virus Ag [Presence] in Brain | ./2.16.840.1.114222.4.11.1002/31806-3.json |
| 3180-7 | Cardiolipin Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3180-7.json |
| 31807-1 | Eastern equine encephalitis virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31807-1.json |
| 31808-9 | Eastern equine encephalitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31808-9.json |
| 31809-7 | Echinococcus sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31809-7.json |
| 31810-5 | Entamoeba histolytica Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31810-5.json |
| 31811-3 | Entamoeba histolytica Ag [Units/volume] in Stool | ./2.16.840.1.114222.4.11.1002/31811-3.json |
| 31812-1 | Entamoeba histolytica Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31812-1.json |
| 31813-9 | Epizootic hemorrhagic disease virus Ag [Presence] in Lung | ./2.16.840.1.114222.4.11.1002/31813-9.json |
| 31814-7 | Equine adenovirus Ag [Presence] in Lung | ./2.16.840.1.114222.4.11.1002/31814-7.json |
| 3181-5 | Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3181-5.json |
| 31815-4 | Equine arteritis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31815-4.json |
| 31816-2 | Equine herpesvirus 1 Ag [Presence] in Tracheal swab | ./2.16.840.1.114222.4.11.1002/31816-2.json |
| 31817-0 | Equine herpesvirus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31817-0.json |
| 31818-8 | Equine herpesvirus 1+4 Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/31818-8.json |
| 31819-6 | Equine herpesvirus 4 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31819-6.json |
| 31820-4 | Equine infectious anemia virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31820-4.json |
| 31821-2 | Equine influenza virus A1 Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31821-2.json |
| 31822-0 | Equine influenza virus A2 Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31822-0.json |
| 3182-3 | Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3182-3.json |
| 31823-8 | Equine influenza virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31823-8.json |
| 31824-6 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31824-6.json |
| 31825-3 | Escherichia coli K1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31825-3.json |
| 31826-1 | Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/31826-1.json |
| 31827-9 | Foot and mouth disease virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31827-9.json |
| 31828-7 | Francisella tularensis Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31828-7.json |
| 31829-5 | Francisella tularensis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31829-5.json |
| 31830-3 | Giardia lamblia Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31830-3.json |
| 3183-1 | Clotting time of Blood by Lee White method | ./2.16.840.1.114222.4.11.1002/3183-1.json |
| 31831-1 | Giardia lamblia Ag [Presence] in Stool --2nd specimen | ./2.16.840.1.114222.4.11.1002/31831-1.json |
| 31832-9 | Giardia lamblia Ag [Presence] in Stool --3rd specimen | ./2.16.840.1.114222.4.11.1002/31832-9.json |
| 31833-7 | Haemophilus influenzae A Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31833-7.json |
| 31834-5 | Haemophilus influenzae B Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31834-5.json |
| 31835-2 | Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31835-2.json |
| 31836-0 | Haemophilus influenzae C Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31836-0.json |
| 31837-8 | Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31837-8.json |
| 31838-6 | Haemophilus influenzae D Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31838-6.json |
| 31839-4 | Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31839-4.json |
| 31840-2 | Haemophilus influenzae E Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31840-2.json |
| 31841-0 | Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31841-0.json |
| 31842-8 | Haemophilus influenzae F Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31842-8.json |
| 31843-6 | Helicobacter pylori Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31843-6.json |
| 31844-4 | Hepatitis B virus e Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31844-4.json |
| 31845-1 | Hepatitis B virus e Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31845-1.json |
| 31846-9 | Herpes simplex virus 1 Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31846-9.json |
| 31847-7 | Herpes simplex virus 1 Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31847-7.json |
| 31848-5 | Herpes simplex virus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31848-5.json |
| 3184-9 | Activated clotting time (ACT) of Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3184-9.json |
| 31849-3 | Herpes simplex virus 2 Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31849-3.json |
| 31850-1 | Herpes simplex virus 2 Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31850-1.json |
| 31851-9 | Herpes simplex virus 2 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31851-9.json |
| 31852-7 | Herpes simplex virus Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31852-7.json |
| 31853-5 | Herpes simplex virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31853-5.json |
| 31854-3 | Herpes simplex virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31854-3.json |
| 31855-0 | Histoplasma capsulatum Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/31855-0.json |
| 3185-6 | Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3185-6.json |
| 31856-8 | Histoplasma capsulatum Ag [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/31856-8.json |
| 31857-6 | Infectious bursal disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31857-6.json |
| 31858-4 | Influenza virus A Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31858-4.json |
| 31859-2 | Influenza virus A Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31859-2.json |
| 31860-0 | Influenza virus A+B Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31860-0.json |
| 31861-8 | Influenza virus A+B+C Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31861-8.json |
| 31862-6 | Influenza virus A+B+C Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31862-6.json |
| 31863-4 | Influenza virus B Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31863-4.json |
| 3186-4 | Coagulation factor IX activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3186-4.json |
| 31864-2 | Influenza virus B Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31864-2.json |
| 31865-9 | Influenza virus C Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31865-9.json |
| 31866-7 | Japanese encephalitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31866-7.json |
| 31867-5 | Lassa virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31867-5.json |
| 31868-3 | Legionella pneumophila 1 Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31868-3.json |
| 31869-1 | Legionella pneumophila Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31869-1.json |
| 31870-9 | Legionella pneumophila Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31870-9.json |
| 31871-7 | Leptospira interrogans Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31871-7.json |
| 3187-2 | Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3187-2.json |
| 31872-5 | Leptospira sp Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31872-5.json |
| 31873-3 | Mareks disease virus Ag [Presence] in Feather | ./2.16.840.1.114222.4.11.1002/31873-3.json |
| 31874-1 | Mareks disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31874-1.json |
| 31875-8 | Measles virus Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31875-8.json |
| 31876-6 | Measles virus Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/31876-6.json |
| 31877-4 | Measles virus Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/31877-4.json |
| 31878-2 | Measles virus Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/31878-2.json |
| 31879-0 | Measles virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31879-0.json |
| 3188-0 | Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3188-0.json |
| 31880-8 | Measles virus Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/31880-8.json |
| 31881-6 | Measles virus Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31881-6.json |
| 31882-4 | Measles virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31882-4.json |
| 31883-2 | Measles virus Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31883-2.json |
| 31884-0 | Measles virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31884-0.json |
| 31885-7 | Measles virus Ag [Presence] in Urine sediment | ./2.16.840.1.114222.4.11.1002/31885-7.json |
| 31886-5 | Measles virus Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/31886-5.json |
| 31887-3 | Measles virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31887-3.json |
| 31888-1 | Mumps virus Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31888-1.json |
| 31889-9 | Mumps virus Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/31889-9.json |
| 31890-7 | Mumps virus Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/31890-7.json |
| 31891-5 | Mumps virus Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/31891-5.json |
| 31892-3 | Mumps virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31892-3.json |
| 31893-1 | Mumps virus Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/31893-1.json |
| 31894-9 | Mumps virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31894-9.json |
| 31895-6 | Mumps virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31895-6.json |
| 31896-4 | Mumps virus Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31896-4.json |
| 31897-2 | Mumps virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31897-2.json |
| 3189-8 | Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3189-8.json |
| 31898-0 | Mumps virus Ag [Presence] in Urine sediment | ./2.16.840.1.114222.4.11.1002/31898-0.json |
| 31899-8 | Mumps virus Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/31899-8.json |
| 31900-4 | Mumps virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31900-4.json |
| 31901-2 | Mycoplasma gallisepticum Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31901-2.json |
| 31902-0 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31902-0.json |
| 31903-8 | Myxoma virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31903-8.json |
| 31904-6 | Nairobi sheep disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31904-6.json |
| 31905-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31905-3.json |
| 31906-1 | Neisseria gonorrhoeae Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31906-1.json |
| 31907-9 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31907-9.json |
| 31908-7 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31908-7.json |
| 31909-5 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31909-5.json |
| 31910-3 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31910-3.json |
| 31911-1 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31911-1.json |
| 31912-9 | Neisseria meningitidis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31912-9.json |
| 31913-7 | Neisseria meningitidis serogroup B Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31913-7.json |
| 3191-4 | Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3191-4.json |
| 31914-5 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31914-5.json |
| 31915-2 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31915-2.json |
| 31916-0 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31916-0.json |
| 31917-8 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31917-8.json |
| 31918-6 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31918-6.json |
| 31919-4 | Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31919-4.json |
| 31920-2 | Neisseria meningitidis serogroup w135 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31920-2.json |
| 31921-0 | Neisseria meningitidis serogroup Y Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31921-0.json |
| 3192-2 | Coagulation factor V activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3192-2.json |
| 31922-8 | Ovine progressive pneumonia virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31922-8.json |
| 31923-6 | Parainfluenza virus 1 Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31923-6.json |
| 31924-4 | Parainfluenza virus 1 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31924-4.json |
| 31925-1 | Parainfluenza virus 2 Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31925-1.json |
| 31926-9 | Parainfluenza virus 2 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31926-9.json |
| 31927-7 | Parainfluenza virus 3 Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31927-7.json |
| 31928-5 | Parainfluenza virus 3 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31928-5.json |
| 31929-3 | Parainfluenza virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31929-3.json |
| 3193-0 | Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3193-0.json |
| 31930-1 | Pasteurella multocida Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31930-1.json |
| 31931-9 | Plasmodium vivax Ag [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/31931-9.json |
| 31932-7 | Pneumocystis jiroveci Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31932-7.json |
| 31933-5 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/31933-5.json |
| 31934-3 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31934-3.json |
| 31935-0 | Pneumocystis jiroveci Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/31935-0.json |
| 31936-8 | Pneumocystis jiroveci Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31936-8.json |
| 31937-6 | Pneumocystis jiroveci Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31937-6.json |
| 31938-4 | Pneumocystis jiroveci Ag [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/31938-4.json |
| 31939-2 | Pneumocystis jiroveci Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31939-2.json |
| 31940-0 | Pneumocystis jiroveci Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31940-0.json |
| 31941-8 | Pneumocystis jiroveci Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31941-8.json |
| 31942-6 | Pneumocystis jiroveci Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/31942-6.json |
| 31943-4 | Pneumocystis jiroveci Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31943-4.json |
| 31944-2 | Porcine enterovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31944-2.json |
| 31945-9 | Pseudorabies virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31945-9.json |
| 31946-7 | Rabies virus Ag [Presence] in Brain | ./2.16.840.1.114222.4.11.1002/31946-7.json |
| 31947-5 | Rabies virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31947-5.json |
| 3194-8 | Coagulation factor V Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3194-8.json |
| 31948-3 | Rabies virus Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31948-3.json |
| 31949-1 | Respiratory syncytial virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31949-1.json |
| 31950-9 | Respiratory syncytial virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31950-9.json |
| 31951-7 | Rift valley fever virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31951-7.json |
| 31952-5 | Rinderpest virus Ag [Presence] in Exudate | ./2.16.840.1.114222.4.11.1002/31952-5.json |
| 31953-3 | Rinderpest virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31953-3.json |
| 31954-1 | Rinderpest virus Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/31954-1.json |
| 31955-8 | Rubella virus Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31955-8.json |
| 31956-6 | Rubella virus Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/31956-6.json |
| 31957-4 | Rubella virus Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/31957-4.json |
| 31958-2 | Rubella virus Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/31958-2.json |
| 31959-0 | Rubella virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/31959-0.json |
| 31960-8 | Rubella virus Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/31960-8.json |
| 31961-6 | Rubella virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31961-6.json |
| 31962-4 | Rubella virus Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31962-4.json |
| 3196-3 | Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3196-3.json |
| 31963-2 | Rubella virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31963-2.json |
| 31964-0 | Rubella virus Ag [Presence] in Urine sediment | ./2.16.840.1.114222.4.11.1002/31964-0.json |
| 31965-7 | Rubella virus Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/31965-7.json |
| 31966-5 | Rubella virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31966-5.json |
| 31967-3 | Streptococcus agalactiae Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31967-3.json |
| 31968-1 | Streptococcus pneumoniae Ag [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/31968-1.json |
| 31969-9 | Streptococcus pneumoniae Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31969-9.json |
| 31970-7 | Streptococcus pyogenes Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31970-7.json |
| 3197-1 | Coagulation factor VII activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3197-1.json |
| 31971-5 | Streptococcus pyogenes Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31971-5.json |
| 31972-3 | Swine vesicular disease virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31972-3.json |
| 31973-1 | Swine vesicular disease virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31973-1.json |
| 31974-9 | Taenia hydatigena Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31974-9.json |
| 31975-6 | Taenia sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/31975-6.json |
| 31976-4 | Taylorella equigenitalis Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31976-4.json |
| 31977-2 | Transmissible gastroenteritis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31977-2.json |
| 31978-0 | Trichomonas vaginalis Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/31978-0.json |
| 31979-8 | Trypanosoma evansi Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31979-8.json |
| 31980-6 | Trypanosoma sp Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31980-6.json |
| 31981-4 | Varicella zoster virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31981-4.json |
| 31982-2 | Varicella zoster virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31982-2.json |
| 31983-0 | Venezuelan equine encephalitis virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31983-0.json |
| 31984-8 | Venezuelan equine encephalitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31984-8.json |
| 31985-5 | Vesicular stomatitis virus Ag [Presence] in Skin | ./2.16.840.1.114222.4.11.1002/31985-5.json |
| 31986-3 | Vesicular stomatitis virus Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/31986-3.json |
| 31987-1 | Western equine encephalitis virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31987-1.json |
| 31988-9 | Western equine encephalitis virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/31988-9.json |
| 3198-9 | Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3198-9.json |
| 31989-7 | 14-3-3 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31989-7.json |
| 31990-5 | 14-3-3 Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/31990-5.json |
| 31991-3 | Acylcarnitine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31991-3.json |
| 31992-1 | Aldosterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/31992-1.json |
| 31993-9 | Alpha-1-Fetoprotein [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/31993-9.json |
| 3199-7 | Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3199-7.json |
| 31997-0 | Biotin [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/31997-0.json |
| 31998-8 | Bordetella pertussis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/31998-8.json |
| 32000-2 | Catecholamines [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32000-2.json |
| 32001-0 | Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/32001-0.json |
| 3200-3 | Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3200-3.json |
| 32003-6 | Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/32003-6.json |
| 32004-4 | Chlamydia sp Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/32004-4.json |
| 32005-1 | Chlamydia trachomatis B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32005-1.json |
| 32006-9 | Chlamydia trachomatis C Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32006-9.json |
| 32007-7 | Chlamydia trachomatis G+F+K Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32007-7.json |
| 32009-3 | Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32009-3.json |
| 32010-1 | Diuretics [Identifier] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/32010-1.json |
| 3201-1 | Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3201-1.json |
| 32011-9 | Ehrlichia sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32011-9.json |
| 32012-7 | Ehrlichia sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32012-7.json |
| 32014-3 | Eosinophils/100 leukocytes in Urine by Manual count | ./2.16.840.1.114222.4.11.1002/32014-3.json |
| 32015-0 | EPINEPHrine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32015-0.json |
| 32016-8 | Glucose [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/32016-8.json |
| 32018-4 | Hepatitis A virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32018-4.json |
| 32019-2 | Hepatitis B virus surface Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32019-2.json |
| 32020-0 | Homocysteine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32020-0.json |
| 32021-8 | HTLV I DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32021-8.json |
| 32022-6 | Hydroxyproline Free [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32022-6.json |
| 32023-4 | Insulin-like growth factor-I [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/32023-4.json |
| 32024-2 | Magnesium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32024-2.json |
| 32025-9 | Malignin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32025-9.json |
| 32026-7 | Microscopic observation [Identifier] in Nose by Gram stain | ./2.16.840.1.114222.4.11.1002/32026-7.json |
| 3202-9 | Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3202-9.json |
| 32030-9 | Nitrate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32030-9.json |
| 32031-7 | Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32031-7.json |
| 32032-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32032-5.json |
| 32033-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32033-3.json |
| 32040-8 | Respiratory syncytial virus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/32040-8.json |
| 32041-6 | Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32041-6.json |
| 32042-4 | Thyroperoxidase Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32042-4.json |
| 32044-0 | Volatiles and gases [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32044-0.json |
| 3204-5 | Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3204-5.json |
| 32045-7 | Parathyrin.biointact [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32045-7.json |
| 32046-5 | Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32046-5.json |
| 32047-3 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/32047-3.json |
| 32048-1 | Amitriptyline+Nortriptyline [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32048-1.json |
| 32049-9 | Amobarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32049-9.json |
| 32050-7 | Barbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32050-7.json |
| 32051-5 | Barbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32051-5.json |
| 3205-2 | Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3205-2.json |
| 32052-3 | Benzodiazepines [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32052-3.json |
| 32053-1 | Bupivacaine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32053-1.json |
| 32054-9 | Butabarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32054-9.json |
| 32055-6 | Butalbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32055-6.json |
| 32056-4 | Butalbital [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32056-4.json |
| 32057-2 | Butalbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32057-2.json |
| 32058-0 | carBAMazepine free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32058-0.json |
| 32059-8 | chlordiazePOXIDE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32059-8.json |
| 3206-0 | Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3206-0.json |
| 32060-6 | Chloroquine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32060-6.json |
| 32061-4 | chlorproMAZINE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32061-4.json |
| 32062-2 | chlorproPAMIDE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32062-2.json |
| 32063-0 | Cimetidine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32063-0.json |
| 32064-8 | Clorazepate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32064-8.json |
| 32065-5 | cloZAPine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32065-5.json |
| 32066-3 | cloZAPine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32066-3.json |
| 32068-9 | diphenhydrAMINE+dimenhyDRINATE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32068-9.json |
| 32069-7 | ePHEDrine+Pseudoephedrine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32069-7.json |
| 32070-5 | Ethanol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32070-5.json |
| 32071-3 | Ethchlorvynol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32071-3.json |
| 32072-1 | FLUoxetine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32072-1.json |
| 32073-9 | fluvoxaMINE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32073-9.json |
| 32074-7 | fluvoxaMINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32074-7.json |
| 32075-4 | fluvoxaMINE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32075-4.json |
| 32076-2 | Glutethimide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32076-2.json |
| 32077-0 | Glutethimide [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32077-0.json |
| 3207-8 | Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3207-8.json |
| 32078-8 | glyBURIDE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32078-8.json |
| 32079-6 | Gold [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32079-6.json |
| 32080-4 | HYDROcodone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32080-4.json |
| 32081-2 | HYDROmorphone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32081-2.json |
| 32082-0 | Ibuprofen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32082-0.json |
| 32083-8 | Imipramine+Desipramine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32083-8.json |
| 32084-6 | Isopropanol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32084-6.json |
| 32085-3 | Isopropanol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32085-3.json |
| 3208-6 | Coagulation factor VIII activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3208-6.json |
| 32086-1 | Lidocaine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32086-1.json |
| 32087-9 | Loxapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32087-9.json |
| 32088-7 | Meperidine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32088-7.json |
| 32089-5 | Mephobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32089-5.json |
| 32090-3 | Mepivacaine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32090-3.json |
| 32091-1 | Meprobamate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32091-1.json |
| 32092-9 | Meprobamate [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32092-9.json |
| 32093-7 | Methadone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32093-7.json |
| 3209-4 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3209-4.json |
| 32094-5 | Methanol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32094-5.json |
| 32095-2 | Methanol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32095-2.json |
| 32096-0 | Methaqualone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32096-0.json |
| 32097-8 | Methyprylon [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32097-8.json |
| 32098-6 | Mexiletine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32098-6.json |
| 32099-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32099-4.json |
| 32100-0 | Morphine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32100-0.json |
| 32101-8 | oxyCODONE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32101-8.json |
| 3210-2 | Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3210-2.json |
| 32102-6 | PARoxetine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32102-6.json |
| 32103-4 | PENTobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32103-4.json |
| 32104-2 | PENTobarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32104-2.json |
| 32105-9 | Perphenazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32105-9.json |
| 32106-7 | Perphenazine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32106-7.json |
| 32107-5 | Phencyclidine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32107-5.json |
| 32108-3 | PHENobarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32108-3.json |
| 32110-9 | Procyclidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32110-9.json |
| 32111-7 | Secobarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32111-7.json |
| 32112-5 | Sertraline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32112-5.json |
| 32113-3 | Sertraline [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32113-3.json |
| 32114-1 | Thallium [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/32114-1.json |
| 32115-8 | Theophylline [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/32115-8.json |
| 32116-6 | Theophylline [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/32116-6.json |
| 32117-4 | Thiopental [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32117-4.json |
| 32118-2 | TOLBUTamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32118-2.json |
| 32120-8 | Venlafaxine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32120-8.json |
| 32121-6 | Venlafaxine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32121-6.json |
| 32124-0 | Bromazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32124-0.json |
| 32125-7 | Propoxyphene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32125-7.json |
| 32126-5 | Propylene glycol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32126-5.json |
| 32127-3 | raNITIdine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32127-3.json |
| 3212-8 | Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3212-8.json |
| 32128-1 | risperiDONE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32128-1.json |
| 32129-9 | risperiDONE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32129-9.json |
| 32130-7 | risperiDONE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32130-7.json |
| 32131-5 | Hantavirus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32131-5.json |
| 32132-3 | Lactate [Moles/volume] in Arterial plasma | ./2.16.840.1.114222.4.11.1002/32132-3.json |
| 32133-1 | Lactate [Moles/volume] in Plasma venous | ./2.16.840.1.114222.4.11.1002/32133-1.json |
| 32134-9 | Adenovirus+Rotavirus [Identifier] in Stool | ./2.16.840.1.114222.4.11.1002/32134-9.json |
| 3213-6 | Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3213-6.json |
| 32136-4 | Antidepressants [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32136-4.json |
| 32139-8 | Haemophilus influenzae Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32139-8.json |
| 32140-6 | Hemoglobin F [Presence] in Blood by Kleihauer-Betke method | ./2.16.840.1.114222.4.11.1002/32140-6.json |
| 32141-4 | Herpes simplex virus 1+2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32141-4.json |
| 3214-4 | Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/3214-4.json |
| 32147-1 | Reducing substances [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32147-1.json |
| 32148-9 | Toxic substance identified in Urine | ./2.16.840.1.114222.4.11.1002/32148-9.json |
| 3215-1 | Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3215-1.json |
| 32151-3 | Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method | ./2.16.840.1.114222.4.11.1002/32151-3.json |
| 32152-1 | 17-Hydroxyketosteroids [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32152-1.json |
| 32153-9 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32153-9.json |
| 32158-8 | Klebsiella granulomatis [Presence] in Genital specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/32158-8.json |
| 32160-4 | Carboxyhemoglobin [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/32160-4.json |
| 32161-2 | Catecholamines [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32161-2.json |
| 3216-9 | Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3216-9.json |
| 32169-5 | Cystine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32169-5.json |
| 32170-3 | Cytomegalovirus Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/32170-3.json |
| 32171-1 | Echinococcus sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32171-1.json |
| 32172-9 | Ehrlichia chaffeensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32172-9.json |
| 32174-5 | Glucose [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32174-5.json |
| 3217-7 | Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3217-7.json |
| 32178-6 | Hepatitis B virus e Ag [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32178-6.json |
| 32180-2 | Herpes simplex virus 1 Ab [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/32180-2.json |
| 32181-0 | Herpes simplex virus 2 Ab [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/32181-0.json |
| 32182-8 | Herpes virus 6 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32182-8.json |
| 32183-6 | Hydroxyproline Free [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32183-6.json |
| 32184-4 | Itraconazole [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/32184-4.json |
| 3218-5 | Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3218-5.json |
| 32185-1 | Itraconazole [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/32185-1.json |
| 32186-9 | Microscopic observation [Identifier] in Penis by Tzanck smear | ./2.16.840.1.114222.4.11.1002/32186-9.json |
| 32187-7 | Microscopic observation [Identifier] in Skin by Tzanck smear | ./2.16.840.1.114222.4.11.1002/32187-7.json |
| 32188-5 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/32188-5.json |
| 32189-3 | Microscopic observation [Identifier] in Body fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/32189-3.json |
| 32190-1 | Microscopic observation [Identifier] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32190-1.json |
| 3219-3 | Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3219-3.json |
| 32197-6 | Myoglobin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32197-6.json |
| 32198-4 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/32198-4.json |
| 32199-2 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe | ./2.16.840.1.114222.4.11.1002/32199-2.json |
| 3220-1 | Coagulation factor X Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3220-1.json |
| 32206-5 | Plasmodium sp identified in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/32206-5.json |
| 32211-5 | Reducing substances [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/32211-5.json |
| 32212-3 | Salmonella paratyphi A Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32212-3.json |
| 32213-1 | Salmonella paratyphi B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32213-1.json |
| 32214-9 | Thyroid stimulating immunoglobulins [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32214-9.json |
| 32215-6 | Thyroxine (T4) free index in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/32215-6.json |
| 32217-2 | von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/32217-2.json |
| 32218-0 | Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32218-0.json |
| 32219-8 | Soluble liver Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32219-8.json |
| 32220-6 | Liver kidney microsomal 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32220-6.json |
| 3222-7 | Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3222-7.json |
| 32227-1 | Argininosuccinate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32227-1.json |
| 32228-9 | Argininosuccinate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/32228-9.json |
| 32229-7 | Argininosuccinate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32229-7.json |
| 32233-9 | Carbamoyl phosphate synthetase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/32233-9.json |
| 32240-4 | Fructose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32240-4.json |
| 3224-3 | Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3224-3.json |
| 32249-5 | Hydroxyproline [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/32249-5.json |
| 32250-3 | Hydroxyproline [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/32250-3.json |
| 32259-4 | Methylmalonate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32259-4.json |
| 32262-8 | Orotate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32262-8.json |
| 32263-6 | Phenylalanine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/32263-6.json |
| 32264-4 | Phenylalanine [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/32264-4.json |
| 3226-8 | Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3226-8.json |
| 32268-5 | Ribose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32268-5.json |
| 32274-3 | Thiosulfate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32274-3.json |
| 3227-6 | Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3227-6.json |
| 32280-0 | Acylglycines [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32280-0.json |
| 3228-4 | Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3228-4.json |
| 32284-2 | BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32284-2.json |
| 32285-9 | BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32285-9.json |
| 32286-7 | Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32286-7.json |
| 32287-5 | Methylmalonate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32287-5.json |
| 32289-1 | 7-Dehydrocholesterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32289-1.json |
| 32290-9 | Acetone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32290-9.json |
| 32291-7 | Acetone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32291-7.json |
| 32292-5 | Acetone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32292-5.json |
| 32293-3 | Albumin [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32293-3.json |
| 32294-1 | Albumin/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32294-1.json |
| 32295-8 | Aluminum [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32295-8.json |
| 32298-2 | Amylase [Enzymatic activity/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32298-2.json |
| 3230-0 | Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3230-0.json |
| 32301-4 | Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32301-4.json |
| 32302-2 | Beta-2-Microglobulin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32302-2.json |
| 32303-0 | Bilirubin.total [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32303-0.json |
| 32304-8 | Cadmium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32304-8.json |
| 32305-5 | Calcium [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32305-5.json |
| 32306-3 | Carbon dioxide [Partial pressure] in Urine | ./2.16.840.1.114222.4.11.1002/32306-3.json |
| 32307-1 | Chloride [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32307-1.json |
| 32308-9 | Cholesterol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32308-9.json |
| 32310-5 | Cortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32310-5.json |
| 3231-8 | Coagulation factor XII activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3231-8.json |
| 32318-8 | Glucose [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32318-8.json |
| 32323-8 | Ketones [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32323-8.json |
| 32324-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32324-6.json |
| 32325-3 | Lead [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32325-3.json |
| 3232-6 | Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3232-6.json |
| 32329-5 | Magnesium [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32329-5.json |
| 32330-3 | Mercury [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32330-3.json |
| 32331-1 | Myoglobin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32331-1.json |
| 32333-7 | Phenylpropanolamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32333-7.json |
| 3233-4 | Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3233-4.json |
| 32334-5 | Pipecolate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32334-5.json |
| 32335-2 | Pipecolate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32335-2.json |
| 32336-0 | Potassium [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32336-0.json |
| 32337-8 | Protein [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32337-8.json |
| 32338-6 | Pyruvate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32338-6.json |
| 32339-4 | Serotonin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32339-4.json |
| 32340-2 | Sodium [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32340-2.json |
| 32341-0 | Transcobalamin II [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32341-0.json |
| 3234-2 | Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3234-2.json |
| 32343-6 | Urate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/32343-6.json |
| 32344-4 | Urobilin [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/32344-4.json |
| 32347-7 | Xylose [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32347-7.json |
| 32348-5 | Zinc [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32348-5.json |
| 32351-9 | Alkaline phosphatase.heat labile [Enzymatic activity/volume] in Serum or Plasma by Heat stability | ./2.16.840.1.114222.4.11.1002/32351-9.json |
| 32352-7 | Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability | ./2.16.840.1.114222.4.11.1002/32352-7.json |
| 32354-3 | Hematocrit [Volume Fraction] of Arterial blood | ./2.16.840.1.114222.4.11.1002/32354-3.json |
| 32355-0 | Bacteria identified in Specimen by Respiratory culture | ./2.16.840.1.114222.4.11.1002/32355-0.json |
| 32358-4 | Oligoclonal bands [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32358-4.json |
| 32361-8 | West Nile virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32361-8.json |
| 32362-6 | BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32362-6.json |
| 32363-4 | JC virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32363-4.json |
| 32364-2 | Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32364-2.json |
| 32365-9 | Torque teno virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32365-9.json |
| 32366-7 | Hepatitis B virus genotype [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32366-7.json |
| 3236-7 | Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3236-7.json |
| 32367-5 | Bacteria identified in Isolate by Aerobe culture | ./2.16.840.1.114222.4.11.1002/32367-5.json |
| 32368-3 | Ureaplasma sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/32368-3.json |
| 32369-1 | Clostridium perfringens enterotoxin [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/32369-1.json |
| 32370-9 | West Nile virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32370-9.json |
| 32371-7 | West Nile virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/32371-7.json |
| 3237-5 | Coagulation factor XIII activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3237-5.json |
| 3238-3 | Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3238-3.json |
| 3240-9 | Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3240-9.json |
| 3241-7 | Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3241-7.json |
| 3242-5 | Recalcification time in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3242-5.json |
| 3243-3 | Thrombin time | ./2.16.840.1.114222.4.11.1002/3243-3.json |
| 3244-1 | Clot Lysis [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3244-1.json |
| 3245-8 | Clot Retraction [Time] in Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3245-8.json |
| 3248-2 | Fibrin fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3248-2.json |
| 3249-0 | Fibrin fragments [Identifier] in Platelet poor plasma by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/3249-0.json |
| 3250-8 | Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/3250-8.json |
| 3251-6 | Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/3251-6.json |
| 3252-4 | Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/3252-4.json |
| 32524-1 | CD19 cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/32524-1.json |
| 32525-8 | CD19 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/32525-8.json |
| 32528-2 | CD3 cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/32528-2.json |
| 3253-2 | Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3253-2.json |
| 3254-0 | Fibrin.soluble [Units/volume] in Serum by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3254-0.json |
| 32540-7 | Glucosylceramidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/32540-7.json |
| 32541-5 | Calcium [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32541-5.json |
| 32542-3 | Chloride [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32542-3.json |
| 32543-1 | Creatinine [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32543-1.json |
| 32545-6 | Fat [Moles/time] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/32545-6.json |
| 32546-4 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32546-4.json |
| 32547-2 | Ketones [Moles/volume] in Serum or Plasma by Test strip | ./2.16.840.1.114222.4.11.1002/32547-2.json |
| 32548-0 | Nitroprusside reacting substances [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32548-0.json |
| 32549-8 | Norepinephrine/Creatinine [Molar ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32549-8.json |
| 32550-6 | Potassium [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32550-6.json |
| 32552-2 | Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32552-2.json |
| 32553-0 | Sodium [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32553-0.json |
| 32554-8 | Thiamine [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/32554-8.json |
| 32555-5 | Urate [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32555-5.json |
| 32556-3 | Urea [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/32556-3.json |
| 3255-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3255-7.json |
| 32559-7 | Tau protein [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32559-7.json |
| 3256-5 | Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3256-5.json |
| 32566-2 | Coxiella burnetii Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32566-2.json |
| 32569-6 | Corynebacterium diphtheriae Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/32569-6.json |
| 32570-4 | Tetrahydroaldosterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32570-4.json |
| 32571-2 | HIV 1 Ab [Presence] in Urine by Immunoblot | ./2.16.840.1.114222.4.11.1002/32571-2.json |
| 32572-0 | Tilapia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32572-0.json |
| 32574-6 | Zaleplon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32574-6.json |
| 32575-3 | Bartonella henselae IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32575-3.json |
| 32576-1 | Bartonella henselae IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32576-1.json |
| 32577-9 | Bartonella quintana IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32577-9.json |
| 32578-7 | Bartonella quintana IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32578-7.json |
| 32579-5 | Phentermine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32579-5.json |
| 32580-3 | Chromatin IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32580-3.json |
| 32581-1 | Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/32581-1.json |
| 32582-9 | Phenylpropionylglycine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32582-9.json |
| 32583-7 | Phenyllactate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32583-7.json |
| 32584-5 | Propionylglycine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32584-5.json |
| 32585-2 | Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32585-2.json |
| 32591-0 | Heavy metals [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32591-0.json |
| 3259-9 | Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3259-9.json |
| 32602-5 | HIV 1+2 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32602-5.json |
| 32604-1 | Leptospira sp Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/32604-1.json |
| 32605-8 | Leptospira sp Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/32605-8.json |
| 3260-7 | Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3260-7.json |
| 32609-0 | Amino acids [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/32609-0.json |
| 32610-8 | Amino acids [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32610-8.json |
| 32611-6 | Amino acids [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/32611-6.json |
| 32612-4 | Amino acids [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/32612-4.json |
| 3261-5 | Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3261-5.json |
| 32615-7 | Homocysteine cysteine disulfide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32615-7.json |
| 32616-5 | Homocysteine cysteine disulfide/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32616-5.json |
| 32617-3 | Ornithine carbamoyltransferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/32617-3.json |
| 32618-1 | 3-Methoxytyramine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32618-1.json |
| 32619-9 | Biotinidase [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32619-9.json |
| 32620-7 | Corynebacterium diphtheriae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32620-7.json |
| 32622-3 | Hyaluronidase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32622-3.json |
| 3262-3 | Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3262-3.json |
| 32625-6 | Spermatozoa IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32625-6.json |
| 32626-4 | Spermatozoa IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32626-4.json |
| 32627-2 | Argininosuccinate lyase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32627-2.json |
| 32628-0 | ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/32628-0.json |
| 32630-6 | MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32630-6.json |
| 3263-1 | Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3263-1.json |
| 32631-4 | Nitroblue Tetrazolium Test (NBT) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/32631-4.json |
| 32632-2 | HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32632-2.json |
| 32634-8 | Metanephrine Free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32634-8.json |
| 32635-5 | Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/32635-5.json |
| 32636-3 | Islet cell 512 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32636-3.json |
| 32637-1 | Urease [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/32637-1.json |
| 32639-7 | FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32639-7.json |
| 32640-5 | BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32640-5.json |
| 32641-3 | SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32641-3.json |
| 32644-7 | Coxiella burnetii phase 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32644-7.json |
| 32645-4 | Coxiella burnetii phase 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32645-4.json |
| 32646-2 | Nevirapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32646-2.json |
| 32647-0 | Nelfinavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32647-0.json |
| 32648-8 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32648-8.json |
| 3264-9 | Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3264-9.json |
| 32649-6 | Hydroxytriazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32649-6.json |
| 32650-4 | Norflunitrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32650-4.json |
| 32651-2 | Ethion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32651-2.json |
| 32652-0 | Fenthion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32652-0.json |
| 32653-8 | DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/32653-8.json |
| 32654-6 | 6-Methylmercaptopurine [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32654-6.json |
| 32655-3 | Metanephrines/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32655-3.json |
| 3265-6 | Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3265-6.json |
| 32656-1 | Aflatoxin IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32656-1.json |
| 32657-9 | Aflatoxin IgA Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32657-9.json |
| 32658-7 | Aflatoxin IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32658-7.json |
| 32659-5 | Aflatoxin IgE Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32659-5.json |
| 32660-3 | 6-Thioguanine [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32660-3.json |
| 32661-1 | Adrenal Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32661-1.json |
| 32662-9 | Afipia felis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32662-9.json |
| 32663-7 | Afipia felis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32663-7.json |
| 32664-5 | Ammonia [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/32664-5.json |
| 32665-2 | Anticonvulsants [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32665-2.json |
| 32667-8 | Borrelia burgdorferi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32667-8.json |
| 32668-6 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32668-6.json |
| 32669-4 | Borrelia burgdorferi DNA [Presence] in Synovial fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32669-4.json |
| 32671-0 | Chlamydia sp Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/32671-0.json |
| 32672-8 | Cold agglutinin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32672-8.json |
| 32673-6 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32673-6.json |
| 32674-4 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32674-4.json |
| 32675-1 | Cytomegalovirus [Presence] in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/32675-1.json |
| 32676-9 | Diuretics [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32676-9.json |
| 32677-7 | DNA double strand Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32677-7.json |
| 32678-5 | Ehrlichia chaffeensis IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32678-5.json |
| 32679-3 | Ehrlichia chaffeensis IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/32679-3.json |
| 3268-0 | Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3268-0.json |
| 32684-3 | LMW Heparin [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/32684-3.json |
| 32685-0 | Hepatitis B virus core IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32685-0.json |
| 32686-8 | Hepatitis B virus DNA [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32686-8.json |
| 32687-6 | Herpes simplex virus 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32687-6.json |
| 32688-4 | Herpes simplex virus 2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32688-4.json |
| 32689-2 | Herpes simplex virus identified in Eye by Organism specific culture | ./2.16.840.1.114222.4.11.1002/32689-2.json |
| 32690-0 | Homocysteine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/32690-0.json |
| 32691-8 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32691-8.json |
| 32692-6 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32692-6.json |
| 32693-4 | Lactate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/32693-4.json |
| 32694-2 | Legionella longbeachae 1+2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32694-2.json |
| 32695-9 | Legionella pneumophila atypical Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32695-9.json |
| 32696-7 | Legionella pneumophila 1+2+3+4+5+6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32696-7.json |
| 3269-8 | Heparin neutralization [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/3269-8.json |
| 32698-3 | Magnesium Ionized [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32698-3.json |
| 32699-1 | Microscopic observation [Identifier] in Blood by Acid fast stain | ./2.16.840.1.114222.4.11.1002/32699-1.json |
| 32700-7 | Microscopic observation [Identifier] in Blood by Malaria smear | ./2.16.840.1.114222.4.11.1002/32700-7.json |
| 32701-5 | Microsporidia identified in Stool by Trichrome stain modified | ./2.16.840.1.114222.4.11.1002/32701-5.json |
| 32702-3 | Muscle sarcolemma Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32702-3.json |
| 32703-1 | Cytochrome B5 reductase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32703-1.json |
| 32704-9 | Neisseria gonorrhoeae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32704-9.json |
| 32705-6 | Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32705-6.json |
| 3270-6 | LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3270-6.json |
| 32706-4 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32706-4.json |
| 32707-2 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32707-2.json |
| 32708-0 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32708-0.json |
| 32710-6 | Nitrite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32710-6.json |
| 32713-0 | Potassium [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/32713-0.json |
| 3271-4 | LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3271-4.json |
| 32714-8 | Rickettsia typhus group IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32714-8.json |
| 32715-5 | SCL-70 extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/32715-5.json |
| 32716-3 | Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32716-3.json |
| 32717-1 | Sodium [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/32717-1.json |
| 32718-9 | Spermatozoa IgA Ab [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/32718-9.json |
| 32719-7 | Spermatozoa IgG Ab [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/32719-7.json |
| 32720-5 | Spermatozoa IgM Ab [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/32720-5.json |
| 32721-3 | Tacrolimus [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32721-3.json |
| 3272-2 | LMW Heparin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3272-2.json |
| 32722-1 | Lipase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/32722-1.json |
| 32723-9 | Trichinella sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32723-9.json |
| 32724-7 | Trichomonas sp [Presence] in Urine by Light microscopy | ./2.16.840.1.114222.4.11.1002/32724-7.json |
| 32725-4 | Trypanosoma cruzi IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32725-4.json |
| 32726-2 | Trypanosoma cruzi IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32726-2.json |
| 32727-0 | Urobilinogen [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/32727-0.json |
| 3273-0 | Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3273-0.json |
| 3274-8 | Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/3274-8.json |
| 32749-4 | Cyclin D1 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/32749-4.json |
| 3275-5 | Heparin unfractionated [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3275-5.json |
| 32755-1 | CD19 cells/100 cells in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/32755-1.json |
| 3276-3 | Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3276-3.json |
| 32763-5 | Bacteria [Presence] in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/32763-5.json |
| 32764-3 | Clue cells [Presence] in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/32764-3.json |
| 32765-0 | Yeast [Presence] in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/32765-0.json |
| 32766-8 | Trichomonas vaginalis [Presence] in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/32766-8.json |
| 32768-4 | Trichinella sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32768-4.json |
| 3277-1 | Kininogen HMW [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3277-1.json |
| 32774-2 | Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/32774-2.json |
| 32775-9 | Clostridium tetani toxoid Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32775-9.json |
| 32777-5 | Escherichia coli O157:H7 Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/32777-5.json |
| 32779-1 | Glucose-6-Phosphatase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/32779-1.json |
| 32781-7 | Legionella sp Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/32781-7.json |
| 32783-3 | Leucine+Isoleucine+Valine [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32783-3.json |
| 32785-8 | Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method | ./2.16.840.1.114222.4.11.1002/32785-8.json |
| 32786-6 | Thyroperoxidase Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/32786-6.json |
| 32787-4 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/32787-4.json |
| 32789-0 | Viscosity of Semen Qualitative | ./2.16.840.1.114222.4.11.1002/32789-0.json |
| 32792-4 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/32792-4.json |
| 32794-0 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/32794-0.json |
| 32795-7 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/32795-7.json |
| 3279-7 | Kininogen LMW [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3279-7.json |
| 32797-3 | Drugs identified in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/32797-3.json |
| 32799-9 | Glycosaminoglycans/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/32799-9.json |
| 32800-5 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/32800-5.json |
| 3280-5 | Kininogen LMW [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3280-5.json |
| 32809-6 | Fungus identified in Bronchial specimen by Fungus stain | ./2.16.840.1.114222.4.11.1002/32809-6.json |
| 32810-4 | Bacteria identified in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/32810-4.json |
| 32811-2 | Microscopic observation [Identifier] in Bronchial specimen by Iron hematoxylin stain | ./2.16.840.1.114222.4.11.1002/32811-2.json |
| 32812-0 | Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain | ./2.16.840.1.114222.4.11.1002/32812-0.json |
| 32814-6 | Microscopic observation [Identifier] in Specimen by Chloracetate esterase stain | ./2.16.840.1.114222.4.11.1002/32814-6.json |
| 32815-3 | Microscopic observation [Identifier] in Specimen by Sudan black B stain | ./2.16.840.1.114222.4.11.1002/32815-3.json |
| 32816-1 | Microscopic observation [Identifier] in Specimen by Terminal deoxynucleotidyl transferase stain | ./2.16.840.1.114222.4.11.1002/32816-1.json |
| 32817-9 | Microscopic observation [Identifier] in Specimen by Myeloperoxidase stain | ./2.16.840.1.114222.4.11.1002/32817-9.json |
| 32818-7 | Microscopic observation [Identifier] in Specimen by Acetate esterase stain | ./2.16.840.1.114222.4.11.1002/32818-7.json |
| 32819-5 | Microsporidia identified in Stool by Trichrome stain | ./2.16.840.1.114222.4.11.1002/32819-5.json |
| 3282-1 | aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3282-1.json |
| 32824-5 | Microscopic observation [Identifier] in Specimen by Tartrate-resistant acid phosphatase stain | ./2.16.840.1.114222.4.11.1002/32824-5.json |
| 32826-0 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/32826-0.json |
| 32828-6 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/32828-6.json |
| 32829-4 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/32829-4.json |
| 32836-9 | Parvovirus B19 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/32836-9.json |
| 32837-7 | Parvovirus B19 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/32837-7.json |
| 3283-9 | Lupus anticoagulant neutralization high phospholipid [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3283-9.json |
| 32839-3 | Parvovirus B19 IgM Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/32839-3.json |
| 32841-9 | Neisseria meningitidis serogroups C+w135 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32841-9.json |
| 32843-5 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/32843-5.json |
| 32844-3 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/32844-3.json |
| 3284-7 | Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3284-7.json |
| 32848-4 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/32848-4.json |
| 32851-8 | Neisseria meningitidis serogroups A+Y Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/32851-8.json |
| 32853-4 | Neuronal Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/32853-4.json |
| 3285-4 | Phospholipid Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3285-4.json |
| 32854-2 | 17-Hydroxyprogesterone [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/32854-2.json |
| 3286-2 | Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3286-2.json |
| 3287-0 | Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/3287-0.json |
| 3288-8 | Prothrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/3288-8.json |
| 3289-6 | Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/3289-6.json |
| 3291-2 | 2-Pyridone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3291-2.json |
| 3292-0 | 2-Pyridone/N'-methylnicotinamide [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3292-0.json |
| 3293-8 | Acebutolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3293-8.json |
| 3294-6 | Acebutolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3294-6.json |
| 3295-3 | Acebutolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3295-3.json |
| 3296-1 | Acepromazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3296-1.json |
| 3297-9 | Acetaminophen [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3297-9.json |
| 3298-7 | Acetaminophen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3298-7.json |
| 3299-5 | Acetaminophen [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3299-5.json |
| 32996-1 | HER2 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32996-1.json |
| 32997-9 | cycloSPORINE [Mass/volume] in Blood --2 hours post dose | ./2.16.840.1.114222.4.11.1002/32997-9.json |
| 32998-7 | Tissue transglutaminase IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/32998-7.json |
| 32999-5 | Rickettsia spotted fever group IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/32999-5.json |
| 33000-1 | Rickettsia spotted fever group IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33000-1.json |
| 3300-1 | Acetazolamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3300-1.json |
| 33001-9 | Rickettsia typhi IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33001-9.json |
| 33002-7 | Spelt IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33002-7.json |
| 33004-3 | Kelp or Seaweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33004-3.json |
| 33006-8 | Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33006-8.json |
| 33007-6 | Protoporphyrin.zinc [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33007-6.json |
| 33008-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33008-4.json |
| 33009-2 | Chylomicrons [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/33009-2.json |
| 33010-0 | Colby Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33010-0.json |
| 33012-6 | Provolone Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33012-6.json |
| 33014-2 | Romano Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33014-2.json |
| 33016-7 | Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33016-7.json |
| 3301-9 | Acetazolamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3301-9.json |
| 3302-7 | Acetazolamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3302-7.json |
| 33027-4 | Herpes simplex virus+Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33027-4.json |
| 3303-5 | Acetazolamide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3303-5.json |
| 33037-3 | Anion gap in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33037-3.json |
| 33038-1 | Candida sp identified in Vaginal fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/33038-1.json |
| 33039-9 | Fungus identified in Body fluid by Fungus stain | ./2.16.840.1.114222.4.11.1002/33039-9.json |
| 33040-7 | Hypnotics [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/33040-7.json |
| 33041-5 | Hypnotics [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33041-5.json |
| 3304-3 | Acetyldigitoxin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3304-3.json |
| 33043-1 | Ketones [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/33043-1.json |
| 33045-6 | Respiratory syncytial virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/33045-6.json |
| 33046-4 | Tranquilizers [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/33046-4.json |
| 33047-2 | Tranquilizers [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33047-2.json |
| 3305-0 | Acetylsalicylate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3305-0.json |
| 33050-6 | Pseudocholinesterase phenotype [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33050-6.json |
| 33054-8 | BCL2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/33054-8.json |
| 33055-5 | Ki-67 nuclear Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/33055-5.json |
| 33058-9 | Ketones [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33058-9.json |
| 33059-7 | Fluorescence polarization [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/33059-7.json |
| 33060-5 | chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33060-5.json |
| 33063-9 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Levamisole inhibition | ./2.16.840.1.114222.4.11.1002/33063-9.json |
| 33064-7 | Chromate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33064-7.json |
| 3306-8 | Acetylsalicylate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3306-8.json |
| 3307-6 | Alfentanil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3307-6.json |
| 3308-4 | Alphaprodine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3308-4.json |
| 3309-2 | Alphaprodine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3309-2.json |
| 3310-0 | Alphaprodine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3310-0.json |
| 3311-8 | Alphaprodine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3311-8.json |
| 3312-6 | ALPRAZolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3312-6.json |
| 3313-4 | ALPRAZolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3313-4.json |
| 3314-2 | Alprenolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3314-2.json |
| 3315-9 | Alprenolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3315-9.json |
| 3316-7 | Alprenolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3316-7.json |
| 3317-5 | Amantadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3317-5.json |
| 3318-3 | Amdinocillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3318-3.json |
| 3319-1 | Amikacin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/3319-1.json |
| 33200-7 | Amyloid beta 42 peptide [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/33200-7.json |
| 33203-1 | Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33203-1.json |
| 33204-9 | Troponin T.cardiac [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33204-9.json |
| 3320-9 | Amikacin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/3320-9.json |
| 33210-6 | Transferrin receptor.soluble [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33210-6.json |
| 33211-4 | Interleukin 8 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33211-4.json |
| 33212-2 | N-acetyl-L-aspartate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/33212-2.json |
| 3321-7 | Amikacin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3321-7.json |
| 33217-1 | Spermatozoa Agglutinated [Presence] in Semen | ./2.16.840.1.114222.4.11.1002/33217-1.json |
| 3322-5 | aMILoride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3322-5.json |
| 3323-3 | aMILoride [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3323-3.json |
| 3324-1 | aMILoride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3324-1.json |
| 33244-5 | Guanidinoacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33244-5.json |
| 33245-2 | Amylase [Catalytic Activity] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/33245-2.json |
| 33246-0 | Ovary Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33246-0.json |
| 33253-6 | Nuclear Ab [Titer] in Serum by Hep2 substrate | ./2.16.840.1.114222.4.11.1002/33253-6.json |
| 33257-7 | Cortisol [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33257-7.json |
| 3325-8 | aMILoride [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3325-8.json |
| 33265-0 | Toxoplasma gondii IgA Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33265-0.json |
| 3326-6 | Aminocaproate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3326-6.json |
| 33266-8 | Aspergillus sp Ab [Titer] in Urine | ./2.16.840.1.114222.4.11.1002/33266-8.json |
| 33267-6 | Aspergillus sp IgG Ab [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33267-6.json |
| 33268-4 | Bordetella pertussis.pertussis toxin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33268-4.json |
| 33270-0 | Microscopic observation [Identifier] in Buffy Coat by Light microscopy | ./2.16.840.1.114222.4.11.1002/33270-0.json |
| 33271-8 | Microscopic observation [Identifier] in Blood by Malaria thin smear | ./2.16.840.1.114222.4.11.1002/33271-8.json |
| 3327-4 | Aminopyrine [Mass/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/3327-4.json |
| 33274-2 | 5-Methyltetrahydrofolate [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33274-2.json |
| 33275-9 | 7-Dehydrocholesterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33275-9.json |
| 33277-5 | Acetaminophen+Phenacetin [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33277-5.json |
| 33278-3 | Acetylcholine receptor blocking Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33278-3.json |
| 33279-1 | Acetylcholine receptor modulation Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33279-1.json |
| 33280-9 | Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33280-9.json |
| 3328-2 | Aminopyrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3328-2.json |
| 33282-5 | Cannabinoids [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/33282-5.json |
| 33285-8 | Cytomegalovirus IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/33285-8.json |
| 33287-4 | Glucose-6-Phosphate dehydrogenase [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/33287-4.json |
| 33288-2 | Galactose 1 phosphate uridyl transferase [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/33288-2.json |
| 3329-0 | Aminosalicylate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3329-0.json |
| 33290-8 | Histamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33290-8.json |
| 33291-6 | Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33291-6.json |
| 33292-4 | Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33292-4.json |
| 33293-2 | Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/33293-2.json |
| 33294-0 | Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33294-0.json |
| 33295-7 | JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33295-7.json |
| 33299-9 | N-acetyl-L-aspartate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33299-9.json |
| 33300-5 | Naproxen [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33300-5.json |
| 33301-3 | Norchlordiazepoxide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33301-3.json |
| 33306-2 | Phosphatidate Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33306-2.json |
| 33307-0 | Phosphatidylcholine Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33307-0.json |
| 3330-8 | Amiodarone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3330-8.json |
| 33308-8 | Phosphatidylethanolamine Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33308-8.json |
| 33309-6 | Phosphatidylinositol Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33309-6.json |
| 33310-4 | Phosphatidylserine Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33310-4.json |
| 33311-2 | Porphyrins [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33311-2.json |
| 33313-8 | Rheumatoid factor IgA [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33313-8.json |
| 33314-6 | Rheumatoid factor IgG [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33314-6.json |
| 3331-6 | Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3331-6.json |
| 33316-1 | Salmonella paratyphi A O Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33316-1.json |
| 33317-9 | Schistosoma sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33317-9.json |
| 33318-7 | Spermatozoa IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33318-7.json |
| 33320-3 | Toxoplasma gondii IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/33320-3.json |
| 33321-1 | Toxoplasma gondii IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/33321-1.json |
| 33323-7 | Theophylline [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33323-7.json |
| 3332-4 | Amitriptyline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3332-4.json |
| 33325-2 | Trypsin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33325-2.json |
| 33327-8 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/33327-8.json |
| 33328-6 | West Nile virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33328-6.json |
| 33329-4 | West Nile virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33329-4.json |
| 33330-2 | West Nile virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33330-2.json |
| 33331-0 | West Nile virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33331-0.json |
| 3333-2 | Amitriptyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3333-2.json |
| 33335-1 | Diphenylmethoxyacetate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33335-1.json |
| 33336-9 | Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/33336-9.json |
| 33338-5 | Zolpidem [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33338-5.json |
| 33339-3 | Zolpidem [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33339-3.json |
| 3334-0 | Amitriptyline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3334-0.json |
| 33340-1 | Zolpidem [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33340-1.json |
| 33345-0 | Histrelin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33345-0.json |
| 33346-8 | Cortisol Free [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/33346-8.json |
| 33347-6 | 17-Ketosteroids/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33347-6.json |
| 33348-4 | Pemoline [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33348-4.json |
| 33349-2 | Pemoline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/33349-2.json |
| 33350-0 | Lysergate diethylamide [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/33350-0.json |
| 33351-8 | 11-Dehydro thromboxane beta 2 [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33351-8.json |
| 33352-6 | Glucose/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33352-6.json |
| 33353-4 | Alanine aminopeptidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33353-4.json |
| 33354-2 | N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33354-2.json |
| 33355-9 | Urea nitrogen [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/33355-9.json |
| 3335-7 | Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3335-7.json |
| 33357-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1 hour post incubation | ./2.16.840.1.114222.4.11.1002/33357-5.json |
| 33359-1 | Branched chain keto-acid dehydrogenase complex [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/33359-1.json |
| 33360-9 | Galactose 1 phosphate [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/33360-9.json |
| 3336-5 | Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose | ./2.16.840.1.114222.4.11.1002/3336-5.json |
| 33366-6 | Chloride [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/33366-6.json |
| 33367-4 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/33367-4.json |
| 33368-2 | Amylase [Enzymatic activity/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/33368-2.json |
| 3337-3 | Amobarbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3337-3.json |
| 33375-7 | Chylomicrons [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/33375-7.json |
| 33379-9 | Coccidioides sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/33379-9.json |
| 33380-7 | Coccidioides sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/33380-7.json |
| 3338-1 | Amobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3338-1.json |
| 33381-5 | Coccidioides sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33381-5.json |
| 33382-3 | Respiratory syncytial virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33382-3.json |
| 33383-1 | Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33383-1.json |
| 33390-6 | Respiratory syncytial virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33390-6.json |
| 33391-4 | Coxsackievirus A8 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33391-4.json |
| 33392-2 | Coxsackievirus A8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33392-2.json |
| 33394-8 | Myelin associated glycoprotein Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33394-8.json |
| 33395-5 | Epstein Barr virus capsid Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33395-5.json |
| 33396-3 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33396-3.json |
| 33397-1 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/33397-1.json |
| 33398-9 | Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine by Latex agglutination | ./2.16.840.1.114222.4.11.1002/33398-9.json |
| 3339-9 | Amobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3339-9.json |
| 33399-7 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33399-7.json |
| 33400-3 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/33400-3.json |
| 33401-1 | Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination | ./2.16.840.1.114222.4.11.1002/33401-1.json |
| 33402-9 | Coccidioides sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33402-9.json |
| 33405-2 | Glucose [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/33405-2.json |
| 33406-0 | Candida albicans Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/33406-0.json |
| 3340-7 | Amoxapine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3340-7.json |
| 33407-8 | Protein [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/33407-8.json |
| 33408-6 | Complement C2 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33408-6.json |
| 33410-2 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33410-2.json |
| 33411-0 | Free Hemoglobin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33411-0.json |
| 3341-5 | Amoxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3341-5.json |
| 33415-1 | IgG [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33415-1.json |
| 33416-9 | Coccidioides sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33416-9.json |
| 33417-7 | pH of Pericardial fluid | ./2.16.840.1.114222.4.11.1002/33417-7.json |
| 33418-5 | Neuronal IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33418-5.json |
| 33422-7 | Amphiphysin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33422-7.json |
| 3342-3 | Amoxapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3342-3.json |
| 33423-5 | Amphiphysin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33423-5.json |
| 3343-1 | Amoxapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3343-1.json |
| 3344-9 | Amoxicillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3344-9.json |
| 3345-6 | Diethylpropion [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3345-6.json |
| 33458-1 | Bilirubin.conjugated [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/33458-1.json |
| 33459-9 | Toxoplasma gondii IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33459-9.json |
| 33460-7 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33460-7.json |
| 33461-5 | Candida albicans Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33461-5.json |
| 33462-3 | Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33462-3.json |
| 33463-1 | Hepatitis B virus e IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33463-1.json |
| 3346-4 | Diethylpropion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3346-4.json |
| 33464-9 | Hepatitis D virus Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33464-9.json |
| 33465-6 | Francisella tularensis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33465-6.json |
| 33466-4 | Francisella tularensis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33466-4.json |
| 33467-2 | Prealbumin [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/33467-2.json |
| 33468-0 | West Nile virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33468-0.json |
| 33469-8 | Clostridium tetani IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33469-8.json |
| 33470-6 | Salmonella paratyphi A O Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/33470-6.json |
| 3347-2 | Diethylpropion [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3347-2.json |
| 33479-7 | Epstein Barr virus early restricted Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33479-7.json |
| 3348-0 | Amphetamines [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3348-0.json |
| 3349-8 | Amphetamines [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3349-8.json |
| 3350-6 | Amphetaminil [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3350-6.json |
| 33507-5 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33507-5.json |
| 33509-1 | Hemoglobin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/33509-1.json |
| 33510-9 | Coccidioides immitis IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/33510-9.json |
| 33513-3 | Specific gravity of Specimen | ./2.16.840.1.114222.4.11.1002/33513-3.json |
| 3351-4 | Amphetaminil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3351-4.json |
| 33517-4 | Hemoglobin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/33517-4.json |
| 3352-2 | Amphetaminil [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3352-2.json |
| 33527-3 | Methadone.long acting metabolite [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33527-3.json |
| 3353-0 | Amphotericin B [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/3353-0.json |
| 33534-9 | Coccidioides immitis IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33534-9.json |
| 33535-6 | Influenza virus A+B Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/33535-6.json |
| 3354-8 | Amphotericin B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3354-8.json |
| 33549-7 | Hantavirus sin nombre Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33549-7.json |
| 3355-5 | Ampicillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3355-5.json |
| 33558-8 | Creatinine renal clearance in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/33558-8.json |
| 33560-4 | Benzodiazepines [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/33560-4.json |
| 33561-2 | Cannabinoids [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/33561-2.json |
| 33562-0 | Ampicillin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/33562-0.json |
| 3356-3 | Anileridine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3356-3.json |
| 33563-8 | Pancreatic islet cell IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33563-8.json |
| 33564-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33564-6.json |
| 33565-3 | Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33565-3.json |
| 33566-1 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33566-1.json |
| 33567-9 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33567-9.json |
| 33568-7 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33568-7.json |
| 33569-5 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33569-5.json |
| 33570-3 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33570-3.json |
| 3357-1 | Anileridine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3357-1.json |
| 33571-1 | Jo-1 extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33571-1.json |
| 33572-9 | Aureobasidium pullulans IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33572-9.json |
| 33573-7 | Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33573-7.json |
| 33574-5 | Chlamydia trachomatis I IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33574-5.json |
| 33575-2 | Chlamydia trachomatis I Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33575-2.json |
| 33576-0 | Francisella tularensis IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33576-0.json |
| 33577-8 | Rheumatoid factor IgM [Titer] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/33577-8.json |
| 33578-6 | Dengue virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33578-6.json |
| 33583-6 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33583-6.json |
| 33587-7 | Trichinella sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33587-7.json |
| 33588-5 | Phosphatidylethanolamine Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33588-5.json |
| 33589-3 | Phosphatidylinositol Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33589-3.json |
| 33590-1 | Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33590-1.json |
| 33591-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/33591-9.json |
| 33594-3 | Platelet factor 4 [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/33594-3.json |
| 3359-7 | Anileridine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3359-7.json |
| 33598-4 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33598-4.json |
| 33599-2 | Amylase [Enzymatic activity/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/33599-2.json |
| 33600-8 | Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33600-8.json |
| 33602-4 | Myelin associated glycoprotein IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33602-4.json |
| 33603-2 | Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33603-2.json |
| 33604-0 | Chlamydia trachomatis I IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33604-0.json |
| 3360-5 | Atenolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3360-5.json |
| 33605-7 | Chlamydia trachomatis I Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33605-7.json |
| 33606-5 | Dengue virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33606-5.json |
| 33609-9 | Anaplasma phagocytophilum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33609-9.json |
| 33610-7 | Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33610-7.json |
| 33611-5 | Phosphatidylethanolamine Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33611-5.json |
| 33612-3 | Phosphatidylinositol Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33612-3.json |
| 3361-3 | Atenolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3361-3.json |
| 33613-1 | Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33613-1.json |
| 33615-6 | Neuronal nuclear type 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33615-6.json |
| 33616-4 | Cytomegalovirus early Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33616-4.json |
| 3362-1 | Atenolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3362-1.json |
| 33629-7 | Hepatitis B virus sequencing [Identifier] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33629-7.json |
| 33630-5 | HIV protease gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/33630-5.json |
| 33631-3 | Cytomegalovirus UL54 gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/33631-3.json |
| 33632-1 | Cytomegalovirus UL54+UL97 gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/33632-1.json |
| 33633-9 | Hepatitis B virus precore TAG [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33633-9.json |
| 33634-7 | Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33634-7.json |
| 33635-4 | PM-SCL extractable nuclear Ab [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/33635-4.json |
| 33636-2 | IgA.secretory [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/33636-2.json |
| 33637-0 | Phagocytic index of Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/33637-0.json |
| 33638-8 | Lymphocyte proliferation stimulated by phytohemagglutinin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33638-8.json |
| 3363-9 | Anthraquinone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3363-9.json |
| 33639-6 | Lymphocyte proliferation stimulated by Candida albicans [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33639-6.json |
| 33640-4 | Lymphocyte proliferation stimulated by tetanus toxoid [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33640-4.json |
| 33641-2 | Lymphocyte proliferation stimulated by tuberculin [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33641-2.json |
| 33642-0 | Lymphocyte Ab [Units/volume] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/33642-0.json |
| 33643-8 | Limulus amebocyte lysate test [Units/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/33643-8.json |
| 33646-1 | Methylenedianiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33646-1.json |
| 3364-7 | Antipyrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3364-7.json |
| 33648-7 | Cryoglobulin Rheumatoid Factor [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33648-7.json |
| 33649-5 | Cryoglobulin.IgG [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33649-5.json |
| 33650-3 | Cryoglobulin.IgA [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33650-3.json |
| 33651-1 | Cryoglobulin.IgM [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33651-1.json |
| 33653-7 | Beta galactosidase [Entitic Catalytic Activity] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33653-7.json |
| 3365-4 | Antipyrine renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3365-4.json |
| 33655-2 | Beta-N-acetylhexosaminidase [Moles/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33655-2.json |
| 33656-0 | Beta-N-acetylhexosaminidase.B [Moles/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33656-0.json |
| 33657-8 | Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33657-8.json |
| 33659-4 | Pipecolate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33659-4.json |
| 33661-0 | Glucosylceramidase [Entitic Catalytic Activity] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33661-0.json |
| 3366-2 | Atenolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3366-2.json |
| 33666-9 | Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy | ./2.16.840.1.114222.4.11.1002/33666-9.json |
| 33667-7 | Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33667-7.json |
| 33669-3 | Trypsin [Titer] in Stool | ./2.16.840.1.114222.4.11.1002/33669-3.json |
| 3367-0 | Atropine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3367-0.json |
| 33676-8 | Francisella tularensis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33676-8.json |
| 33677-6 | Francisella tularensis [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33677-6.json |
| 33678-4 | Francisella tularensis Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33678-4.json |
| 33679-2 | Francisella tularensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33679-2.json |
| 33680-0 | Francisella tularensis DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33680-0.json |
| 33681-8 | Francisella tularensis [Presence] in Specimen by Cell wall fatty acid analysis | ./2.16.840.1.114222.4.11.1002/33681-8.json |
| 33682-6 | Francisella tularensis [Presence] in Isolate by Cell wall fatty acid analysis | ./2.16.840.1.114222.4.11.1002/33682-6.json |
| 33683-4 | Francisella tularensis Ab [Titer] in Serum by Microagglutination | ./2.16.840.1.114222.4.11.1002/33683-4.json |
| 33684-2 | Francisella tularensis Ab [Titer] in Serum by Tube agglutination | ./2.16.840.1.114222.4.11.1002/33684-2.json |
| 33685-9 | Yersinia pestis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33685-9.json |
| 33686-7 | Yersinia pestis [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33686-7.json |
| 33687-5 | Yersinia pestis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33687-5.json |
| 3368-8 | Azlocillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3368-8.json |
| 33688-3 | Yersinia pestis Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33688-3.json |
| 33689-1 | Yersinia pestis Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/33689-1.json |
| 33690-9 | Yersinia pestis Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33690-9.json |
| 33691-7 | Yersinia pestis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33691-7.json |
| 33692-5 | Yersinia pestis DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33692-5.json |
| 33693-3 | Yersinia pestis [Presence] in Isolate by Phage lysis | ./2.16.840.1.114222.4.11.1002/33693-3.json |
| 33694-1 | Clostridium botulinum [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33694-1.json |
| 33695-8 | Clostridium botulinum [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/33695-8.json |
| 3369-6 | Aztreonam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3369-6.json |
| 33696-6 | Clostridium botulinum toxin [Presence] in Specimen by Mouse bioassay | ./2.16.840.1.114222.4.11.1002/33696-6.json |
| 33697-4 | Bacillus anthracis Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33697-4.json |
| 33698-2 | Bacillus anthracis [Presence] in Isolate by Phage lysis | ./2.16.840.1.114222.4.11.1002/33698-2.json |
| 33699-0 | Microscopic observation [Identifier] in Specimen by Malachite green stain | ./2.16.840.1.114222.4.11.1002/33699-0.json |
| 33700-6 | Spore [Identifier] in Specimen by Malachite green stain | ./2.16.840.1.114222.4.11.1002/33700-6.json |
| 33701-4 | Clostridium botulinum toxin A [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/33701-4.json |
| 33702-2 | Clostridium botulinum toxin E [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/33702-2.json |
| 33703-0 | Clostridium botulinum toxin F [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/33703-0.json |
| 3370-4 | Barbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3370-4.json |
| 33704-8 | Clostridium botulinum toxin A+B+E [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/33704-8.json |
| 33705-5 | Clostridium botulinum toxin B [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/33705-5.json |
| 33706-3 | Yersinia pestis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33706-3.json |
| 33707-1 | Yersinia pestis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33707-1.json |
| 33708-9 | Clostridium botulinum toxin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33708-9.json |
| 33709-7 | Clostridium botulinum toxin A [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33709-7.json |
| 33710-5 | Clostridium botulinum toxin E [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33710-5.json |
| 33711-3 | Clostridium botulinum toxin F [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33711-3.json |
| 3371-2 | Barbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3371-2.json |
| 33712-1 | Clostridium botulinum toxin A+B+E [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33712-1.json |
| 33713-9 | Clostridium botulinum toxin B [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33713-9.json |
| 33714-7 | Francisella tularensis Ab [Presence] in Specimen by Slide agglutination | ./2.16.840.1.114222.4.11.1002/33714-7.json |
| 33715-4 | Francisella tularensis Ab [Presence] in Isolate by Slide agglutination | ./2.16.840.1.114222.4.11.1002/33715-4.json |
| 33716-2 | Non-gynecological cytology study | ./2.16.840.1.114222.4.11.1002/33716-2.json |
| 33717-0 | Cervical AndOr vaginal cytology study | ./2.16.840.1.114222.4.11.1002/33717-0.json |
| 33718-8 | Cytology report of Tissue fine needle aspirate Cyto stain | ./2.16.840.1.114222.4.11.1002/33718-8.json |
| 33719-6 | Flow cytometry study | ./2.16.840.1.114222.4.11.1002/33719-6.json |
| 33720-4 | Blood bank consult | ./2.16.840.1.114222.4.11.1002/33720-4.json |
| 33721-2 | Bone marrow Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/33721-2.json |
| 3376-1 | Barbiturates [Presence] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/3376-1.json |
| 33762-6 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33762-6.json |
| 33763-4 | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33763-4.json |
| 33764-2 | Shiga toxin stx gene [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33764-2.json |
| 33767-5 | Acidity.total [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/33767-5.json |
| 33771-7 | PL-12 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33771-7.json |
| 33772-5 | PL-7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33772-5.json |
| 33773-3 | Karyotype [Identifier] in Amniotic fluid Nominal | ./2.16.840.1.114222.4.11.1002/33773-3.json |
| 33774-1 | Karyotype [Identifier] in Chorionic villus sample Nominal | ./2.16.840.1.114222.4.11.1002/33774-1.json |
| 33778-2 | SmIg Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/33778-2.json |
| 3377-9 | Barbiturates [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3377-9.json |
| 33779-0 | IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/33779-0.json |
| 33780-8 | Galactose 1 phosphate uridyl transferase phenotype [Type] in Blood | ./2.16.840.1.114222.4.11.1002/33780-8.json |
| 33781-6 | Alpha-1-acid glycoprotein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33781-6.json |
| 33782-4 | Retinol binding protein [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33782-4.json |
| 33783-2 | Atrial natriuretic factor [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/33783-2.json |
| 3378-7 | Bendroflumethiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3378-7.json |
| 3379-5 | Bendroflumethiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3379-5.json |
| 33796-4 | Cotinine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33796-4.json |
| 33797-2 | Creatine [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/33797-2.json |
| 33798-0 | Creatinine [Moles/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/33798-0.json |
| 33799-8 | DNA double strand IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/33799-8.json |
| 33800-4 | DNA double strand IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33800-4.json |
| 33801-2 | E selectin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33801-2.json |
| 3380-3 | Bendroflumethiazide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3380-3.json |
| 33805-3 | Fructosamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33805-3.json |
| 33806-1 | HIV 2 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/33806-1.json |
| 33807-9 | HIV 2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33807-9.json |
| 33808-7 | Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33808-7.json |
| 3381-1 | Benzfetamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3381-1.json |
| 33820-2 | Interferon alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33820-2.json |
| 33821-0 | Interleukin 1 alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33821-0.json |
| 33822-8 | Interleukin 13 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33822-8.json |
| 33823-6 | Interleukin 18 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33823-6.json |
| 33824-4 | Iron [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33824-4.json |
| 3382-9 | Benzfetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3382-9.json |
| 3383-7 | Benzfetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3383-7.json |
| 33838-4 | Mannitol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33838-4.json |
| 3384-5 | Benzfetamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3384-5.json |
| 33858-2 | Somatotropin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33858-2.json |
| 33859-0 | Somatotropin/Creatinine [Ratio] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/33859-0.json |
| 33860-8 | Somatotropin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/33860-8.json |
| 33863-2 | Cystatin C [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33863-2.json |
| 33864-0 | Elastase.leukocyte [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/33864-0.json |
| 33865-7 | Staphylococcus aureus enterotoxin [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/33865-7.json |
| 33866-5 | HIV 1 Ab [Presence] in Capillary blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/33866-5.json |
| 33870-7 | Bilirubin.total [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33870-7.json |
| 33872-3 | Cystine [Moles/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33872-3.json |
| 33873-1 | DOPamine/Creatinine [Molar ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/33873-1.json |
| 33874-9 | EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/33874-9.json |
| 33893-9 | Karyotype [Identifier] in Bone marrow Nominal | ./2.16.840.1.114222.4.11.1002/33893-9.json |
| 3389-4 | Benzodiazepines [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3389-4.json |
| 33895-4 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2 hours post incubation | ./2.16.840.1.114222.4.11.1002/33895-4.json |
| 33896-2 | Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/33896-2.json |
| 33897-0 | Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33897-0.json |
| 33898-8 | Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33898-8.json |
| 33899-6 | Bilirubin.conjugated+indirect [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33899-6.json |
| 33900-2 | Fetal cell screen [Presence] in Blood by Rosette test | ./2.16.840.1.114222.4.11.1002/33900-2.json |
| 3390-2 | Benzodiazepines [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3390-2.json |
| 33903-6 | Ketones [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/33903-6.json |
| 33904-4 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by Probe | ./2.16.840.1.114222.4.11.1002/33904-4.json |
| 3391-0 | Benzoylecgonine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3391-0.json |
| 33910-1 | Rheumatoid factor [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33910-1.json |
| 33913-5 | pH of Capillary blood from Fetus | ./2.16.840.1.114222.4.11.1002/33913-5.json |
| 33914-3 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) | ./2.16.840.1.114222.4.11.1002/33914-3.json |
| 33915-0 | Anabasine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33915-0.json |
| 33916-8 | Trans-3-Hydroxycotinine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33916-8.json |
| 33917-6 | Nornicotine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33917-6.json |
| 33918-4 | Acetoacetate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33918-4.json |
| 33919-2 | Ampicillin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/33919-2.json |
| 33921-8 | Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33921-8.json |
| 33923-4 | Hemosiderin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/33923-4.json |
| 33924-2 | Neuronal nuclear type 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33924-2.json |
| 33925-9 | PCA-2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33925-9.json |
| 33926-7 | PCA-Tr Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33926-7.json |
| 33927-5 | Amphiphysin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33927-5.json |
| 3392-8 | Benzoylecgonine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3392-8.json |
| 33928-3 | Efavirenz [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33928-3.json |
| 33929-1 | Tacrolimus [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/33929-1.json |
| 33930-9 | aPTT W excess hexagonal phospholipid (StaClot LA confirm) | ./2.16.840.1.114222.4.11.1002/33930-9.json |
| 33931-7 | Lymphocyte proliferation stimulated by Borrelia burgdorferi [Ratio] in Blood | ./2.16.840.1.114222.4.11.1002/33931-7.json |
| 33932-5 | Borrelia burgdorferi Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33932-5.json |
| 33933-3 | Glutaraldehyde IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33933-3.json |
| 33934-1 | Methylmethacrylate IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33934-1.json |
| 33935-8 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33935-8.json |
| 3393-6 | Benzoylecgonine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3393-6.json |
| 33936-6 | Homocystine Free [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/33936-6.json |
| 33937-4 | Homocystine Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33937-4.json |
| 33938-2 | Interleukin 5 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33938-2.json |
| 33939-0 | Interleukin 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33939-0.json |
| 33940-8 | Herpes virus 6 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33940-8.json |
| 33941-6 | Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33941-6.json |
| 33942-4 | Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33942-4.json |
| 33943-2 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33943-2.json |
| 3394-4 | Benzoylecgonine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3394-4.json |
| 33944-0 | Lambda light chains.free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33944-0.json |
| 33945-7 | Brucella abortus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/33945-7.json |
| 33946-5 | Ziprasidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33946-5.json |
| 33947-3 | Clostridioides difficile toxin neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/33947-3.json |
| 33948-1 | IgG/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33948-1.json |
| 33949-9 | Potassium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33949-9.json |
| 33950-7 | Magnesium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33950-7.json |
| 3395-1 | Cocaine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3395-1.json |
| 33951-5 | Sodium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/33951-5.json |
| 33952-3 | Immune complex.IgM [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33952-3.json |
| 33953-1 | Immune complex IgA [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33953-1.json |
| 33954-9 | Immune complex.IgG [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33954-9.json |
| 33955-6 | cycloSPORINE.monoclonal [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33955-6.json |
| 33956-4 | cycloSPORINE.polyclonal [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/33956-4.json |
| 33958-0 | Cholecalciferol (Vit D3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33958-0.json |
| 33959-8 | Procalcitonin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33959-8.json |
| 33960-6 | Immune complex IgE [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33960-6.json |
| 33961-4 | Sulthiame [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33961-4.json |
| 33962-2 | Melanoma inhibitory activity protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/33962-2.json |
| 33964-8 | SARS coronavirus Urbani RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33964-8.json |
| 33965-5 | SARS coronavirus Urbani RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33965-5.json |
| 33966-3 | SARS coronavirus Urbani RNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33966-3.json |
| 33967-1 | SARS coronavirus Urbani RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33967-1.json |
| 33968-9 | SARS coronavirus Urbani Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33968-9.json |
| 3396-9 | Cocaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3396-9.json |
| 33969-7 | SARS coronavirus Urbani Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/33969-7.json |
| 33970-5 | SARS coronavirus Urbani Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33970-5.json |
| 33971-3 | SARS coronavirus Urbani Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/33971-3.json |
| 33972-1 | SARS coronavirus Urbani Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33972-1.json |
| 33973-9 | SARS coronavirus Urbani Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33973-9.json |
| 33974-7 | SARS coronavirus Urbani Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/33974-7.json |
| 33975-4 | SARS coronavirus Urbani RNA [Presence] in Sputum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33975-4.json |
| 3397-7 | Cocaine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3397-7.json |
| 33978-8 | BK virus DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33978-8.json |
| 33979-6 | Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33979-6.json |
| 33980-4 | Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33980-4.json |
| 33981-2 | TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/33981-2.json |
| 33982-0 | California Walnut Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33982-0.json |
| 33983-8 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/33983-8.json |
| 3398-5 | Cocaine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3398-5.json |
| 33985-3 | Bartonella henselae DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33985-3.json |
| 33986-1 | Bartonella henselae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/33986-1.json |
| 33988-7 | Thymidine phosphorylase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/33988-7.json |
| 33989-5 | quiNINE induced platelet Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/33989-5.json |
| 3399-3 | Benzthiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3399-3.json |
| 3400-9 | Benzthiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3400-9.json |
| 3401-7 | Benzthiazide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3401-7.json |
| 3402-5 | Bolasterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3402-5.json |
| 3403-3 | Bolasterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3403-3.json |
| 3404-1 | Bolasterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3404-1.json |
| 3405-8 | Bromazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3405-8.json |
| 3406-6 | Bromazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3406-6.json |
| 3407-4 | Brompheniramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3407-4.json |
| 3408-2 | Brompheniramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3408-2.json |
| 3409-0 | Bumetanide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3409-0.json |
| 34094-3 | Cardiology Hospital Admission history and physical note | ./2.16.840.1.114222.4.11.1002/34094-3.json |
| 34095-0 | Comprehensive history and physical note | ./2.16.840.1.114222.4.11.1002/34095-0.json |
| 34096-8 | Nursing facility Comprehensive history and physical note | ./2.16.840.1.114222.4.11.1002/34096-8.json |
| 34097-6 | Nursing facility Conference note | ./2.16.840.1.114222.4.11.1002/34097-6.json |
| 34098-4 | Conference note | ./2.16.840.1.114222.4.11.1002/34098-4.json |
| 34099-2 | Cardiology Consult note | ./2.16.840.1.114222.4.11.1002/34099-2.json |
| 34100-8 | Intensive care unit Consult note | ./2.16.840.1.114222.4.11.1002/34100-8.json |
| 34101-6 | General medicine Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/34101-6.json |
| 34102-4 | Psychiatry Hospital Consult note | ./2.16.840.1.114222.4.11.1002/34102-4.json |
| 34103-2 | Pulmonary Consult note | ./2.16.840.1.114222.4.11.1002/34103-2.json |
| 34104-0 | Hospital Consult note | ./2.16.840.1.114222.4.11.1002/34104-0.json |
| 34105-7 | Hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/34105-7.json |
| 34106-5 | Physician Hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/34106-5.json |
| 34107-3 | Patient's home Education note | ./2.16.840.1.114222.4.11.1002/34107-3.json |
| 3410-8 | Bumetanide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3410-8.json |
| 34108-1 | Outpatient Note | ./2.16.840.1.114222.4.11.1002/34108-1.json |
| 34109-9 | Note | ./2.16.840.1.114222.4.11.1002/34109-9.json |
| 34110-7 | Diabetology Outpatient Note | ./2.16.840.1.114222.4.11.1002/34110-7.json |
| 34111-5 | Emergency department Note | ./2.16.840.1.114222.4.11.1002/34111-5.json |
| 34112-3 | Hospital Note | ./2.16.840.1.114222.4.11.1002/34112-3.json |
| 34113-1 | Nursing facility Note | ./2.16.840.1.114222.4.11.1002/34113-1.json |
| 34114-9 | Hospital Group counseling note | ./2.16.840.1.114222.4.11.1002/34114-9.json |
| 34115-6 | Medical student Hospital History and physical note | ./2.16.840.1.114222.4.11.1002/34115-6.json |
| 3411-6 | Bumetanide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3411-6.json |
| 34116-4 | Physician Nursing facility History and physical note | ./2.16.840.1.114222.4.11.1002/34116-4.json |
| 34117-2 | History and physical note | ./2.16.840.1.114222.4.11.1002/34117-2.json |
| 34118-0 | Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/34118-0.json |
| 34119-8 | Nursing facility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/34119-8.json |
| 34120-6 | Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/34120-6.json |
| 34121-4 | Interventional procedure note | ./2.16.840.1.114222.4.11.1002/34121-4.json |
| 34122-2 | Pathology procedure note | ./2.16.840.1.114222.4.11.1002/34122-2.json |
| 34123-0 | Anesthesiology Hospital Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34123-0.json |
| 3412-4 | Bupivacaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3412-4.json |
| 34124-8 | Cardiology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34124-8.json |
| 34125-5 | Case manager Patient's home Progress note | ./2.16.840.1.114222.4.11.1002/34125-5.json |
| 34126-3 | Intensive care unit Progress note | ./2.16.840.1.114222.4.11.1002/34126-3.json |
| 34127-1 | Dentistry Hygienist Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34127-1.json |
| 34128-9 | Dentistry Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34128-9.json |
| 34129-7 | Patient's home Progress note | ./2.16.840.1.114222.4.11.1002/34129-7.json |
| 34130-5 | Hospital Progress note | ./2.16.840.1.114222.4.11.1002/34130-5.json |
| 34131-3 | Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34131-3.json |
| 3413-2 | Buprenorphine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3413-2.json |
| 34132-1 | Pharmacology Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34132-1.json |
| 34133-9 | Summary of episode note | ./2.16.840.1.114222.4.11.1002/34133-9.json |
| 34134-7 | Attending Outpatient Supervisory note | ./2.16.840.1.114222.4.11.1002/34134-7.json |
| 34135-4 | Cardiology Attending Outpatient Supervisory note | ./2.16.840.1.114222.4.11.1002/34135-4.json |
| 34136-2 | Gastroenterology Attending Outpatient Supervisory note | ./2.16.840.1.114222.4.11.1002/34136-2.json |
| 34137-0 | Outpatient Surgical operation note | ./2.16.840.1.114222.4.11.1002/34137-0.json |
| 34138-8 | Targeted history and physical note | ./2.16.840.1.114222.4.11.1002/34138-8.json |
| 34139-6 | Nurse Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/34139-6.json |
| 3414-0 | Buprenorphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3414-0.json |
| 34142-0 | Paraneoplastic Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/34142-0.json |
| 34145-3 | Human antichimeric Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34145-3.json |
| 34146-1 | Neopterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34146-1.json |
| 34147-9 | Treponema pallidum IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34147-9.json |
| 34148-7 | Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34148-7.json |
| 34149-5 | N-acetyl-L-aspartate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/34149-5.json |
| 34150-3 | Mycoplasma fermentans DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34150-3.json |
| 34152-9 | Herpes simplex virus 1+2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34152-9.json |
| 34153-7 | Influenza virus A Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/34153-7.json |
| 34154-5 | Influenza virus B Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/34154-5.json |
| 34155-2 | Guanidinoacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34155-2.json |
| 34156-0 | Insulin.bound [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34156-0.json |
| 3415-7 | Buprenorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3415-7.json |
| 34158-6 | Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34158-6.json |
| 34159-4 | Tau protein [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/34159-4.json |
| 34160-2 | Creatine kinase [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/34160-2.json |
| 34161-0 | Cancer Ag 72-4 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34161-0.json |
| 34164-4 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/34164-4.json |
| 3416-5 | Buprenorphine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3416-5.json |
| 34166-9 | Microscopic observation [Identifier] in Specimen by Electron microscopy | ./2.16.840.1.114222.4.11.1002/34166-9.json |
| 34170-1 | Biopterin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34170-1.json |
| 34171-9 | Histoplasma capsulatum Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/34171-9.json |
| 34172-7 | Streptococcus pneumoniae Danish serotype 6B Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34172-7.json |
| 3417-3 | Butabarbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3417-3.json |
| 34175-0 | Analgesics [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34175-0.json |
| 34176-8 | Tricyclic antidepressants [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/34176-8.json |
| 34177-6 | Opiates [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/34177-6.json |
| 34178-4 | Phenothiazines [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/34178-4.json |
| 34179-2 | Herpes virus 6 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/34179-2.json |
| 34180-0 | Ethanol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/34180-0.json |
| 3418-1 | Butabarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3418-1.json |
| 34181-8 | Methanol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/34181-8.json |
| 34182-6 | Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/34182-6.json |
| 34185-9 | methIMAzole [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34185-9.json |
| 34186-7 | Para aminobenzoate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34186-7.json |
| 34187-5 | DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae | ./2.16.840.1.114222.4.11.1002/34187-5.json |
| 34190-9 | Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34190-9.json |
| 34191-7 | Beta glucuronidase [Enzymatic activity/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/34191-7.json |
| 34192-5 | Beta galactosidase [Presence] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/34192-5.json |
| 34194-1 | Fructose [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34194-1.json |
| 34197-4 | Salicylamide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/34197-4.json |
| 34198-2 | Salicylamide [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/34198-2.json |
| 3419-9 | Butabarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3419-9.json |
| 34201-4 | Cytomegalovirus [Presence] in Amniotic fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/34201-4.json |
| 34202-2 | Linezolid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34202-2.json |
| 34203-0 | SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34203-0.json |
| 34204-8 | 11-Deoxycortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34204-8.json |
| 34205-5 | 11-Deoxycortisol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34205-5.json |
| 3420-7 | Butalbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3420-7.json |
| 34207-1 | 11-Hydroxyandrosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34207-1.json |
| 34208-9 | 11-Hydroxyandrosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34208-9.json |
| 34209-7 | 11-Hydroxyandrosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34209-7.json |
| 34210-5 | 11-Hydroxyetiocholanolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34210-5.json |
| 34211-3 | 11-Hydroxyetiocholanolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34211-3.json |
| 34212-1 | 11-Hydroxyetiocholanolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34212-1.json |
| 34213-9 | 11-Ketoandrosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34213-9.json |
| 34214-7 | 11-Ketoandrosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34214-7.json |
| 3421-5 | Butalbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3421-5.json |
| 34215-4 | 11-Ketoandrosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34215-4.json |
| 34216-2 | 11-Ketoetiocholanolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34216-2.json |
| 34217-0 | 11-Ketoetiocholanolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34217-0.json |
| 34218-8 | 17-Hydroxycorticosteroids [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34218-8.json |
| 34219-6 | 17-Hydroxycorticosteroids/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34219-6.json |
| 34220-4 | 17-Hydroxyprogesterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34220-4.json |
| 34221-2 | 17-Hydroxyprogesterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34221-2.json |
| 34222-0 | 17-Ketosteroids [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34222-0.json |
| 3422-3 | Caffeine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3422-3.json |
| 34223-8 | 17-Ketosteroids/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34223-8.json |
| 34224-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34224-6.json |
| 34225-3 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34225-3.json |
| 34226-1 | 3-Alpha-Androstanediol glucuronide/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34226-1.json |
| 34230-3 | Adenosine monophosphate.cyclic [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34230-3.json |
| 3423-1 | Caffeine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3423-1.json |
| 34231-1 | Aldosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34231-1.json |
| 34232-9 | Pseudallescheria boydii IgG Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/34232-9.json |
| 34233-7 | Alternaria sp IgG Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/34233-7.json |
| 34234-5 | Ampicillin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34234-5.json |
| 34236-0 | Androstenediol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34236-0.json |
| 34237-8 | Androstenediol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34237-8.json |
| 34238-6 | Androstenediol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34238-6.json |
| 34239-4 | Androstenedione [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34239-4.json |
| 34240-2 | Androstenedione/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34240-2.json |
| 34241-0 | Androsterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34241-0.json |
| 34242-8 | Androsterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34242-8.json |
| 34243-6 | Androsterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34243-6.json |
| 34244-4 | Arsenic [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34244-4.json |
| 34245-1 | Arsenic [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34245-1.json |
| 34246-9 | Ascorbate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34246-9.json |
| 34247-7 | Ascorbate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34247-7.json |
| 34248-5 | Ascorbate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34248-5.json |
| 3424-9 | Caffeine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3424-9.json |
| 34250-1 | Silver Birch recombinant (rBet v) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34250-1.json |
| 34251-9 | Borrelia garinii IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/34251-9.json |
| 34252-7 | Borrelia garinii IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/34252-7.json |
| 34253-5 | C peptide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34253-5.json |
| 34254-3 | Cadmium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34254-3.json |
| 34255-0 | Cadmium [Moles/time] in Urine | ./2.16.840.1.114222.4.11.1002/34255-0.json |
| 3425-6 | Cannabinoids [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3425-6.json |
| 34256-8 | Cancer Ag 50 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34256-8.json |
| 34257-6 | Carnitine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34257-6.json |
| 34258-4 | Carnitine free (C0) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34258-4.json |
| 34259-2 | Carnitine free (C0) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34259-2.json |
| 34260-0 | Catecholamines [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34260-0.json |
| 34261-8 | Catecholamines [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34261-8.json |
| 34262-6 | Catecholamines/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34262-6.json |
| 34263-4 | Cefaclor IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34263-4.json |
| 3426-4 | Tetrahydrocannabinol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3426-4.json |
| 34264-2 | Chlamydia sp IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34264-2.json |
| 34265-9 | Chloride/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34265-9.json |
| 34266-7 | Citrate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34266-7.json |
| 34267-5 | Cladosporium sp IgG Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/34267-5.json |
| 34268-3 | Cobalt [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34268-3.json |
| 34269-1 | Cobalt [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34269-1.json |
| 34270-9 | Cobalt/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34270-9.json |
| 34271-7 | Collagen crosslinked N-telopeptide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34271-7.json |
| 3427-2 | Cannabinoids [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3427-2.json |
| 34272-5 | Collagen crosslinked N-telopeptide/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34272-5.json |
| 34273-3 | Copper [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34273-3.json |
| 34274-1 | Creatine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34274-1.json |
| 34275-8 | Creatine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34275-8.json |
| 34278-2 | Cystine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34278-2.json |
| 34279-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34279-0.json |
| 3428-0 | Canrenone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3428-0.json |
| 34280-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34280-8.json |
| 34281-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34281-6.json |
| 34282-4 | Dehydroepiandrosterone sulfate (DHEA-S)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34282-4.json |
| 34283-2 | Dehydroepiandrosterone (DHEA)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34283-2.json |
| 34284-0 | Delta aminolevulinate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34284-0.json |
| 34285-7 | Ehrlichia sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/34285-7.json |
| 34286-5 | Estradiol (E2) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34286-5.json |
| 34287-3 | Estradiol (E2) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34287-3.json |
| 34288-1 | Estradiol (E2).unconjugated [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34288-1.json |
| 34289-9 | Estradiol (E2).unconjugated [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34289-9.json |
| 34290-7 | Estradiol (E2).unconjugated/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34290-7.json |
| 34291-5 | Estradiol (E2)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34291-5.json |
| 34292-3 | Estriol (E3) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34292-3.json |
| 34293-1 | Estriol (E3)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34293-1.json |
| 34294-9 | Estrogen [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34294-9.json |
| 34295-6 | Estrogen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34295-6.json |
| 34296-4 | Estrogen/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34296-4.json |
| 34297-2 | Estrone (E1) [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34297-2.json |
| 3429-8 | Canrenone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3429-8.json |
| 34298-0 | Estrone (E1) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34298-0.json |
| 34299-8 | Estrone (E1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34299-8.json |
| 34301-2 | Etiocholanolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34301-2.json |
| 34302-0 | Etiocholanolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34302-0.json |
| 34303-8 | Etiocholanolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34303-8.json |
| 34304-6 | Fluoride [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34304-6.json |
| 34305-3 | Flupenthixol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34305-3.json |
| 3430-6 | Canrenone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3430-6.json |
| 34306-1 | Follitropin [Units/volume] in 24 hour Urine by 2nd IRP | ./2.16.840.1.114222.4.11.1002/34306-1.json |
| 34307-9 | Fructose [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34307-9.json |
| 34308-7 | Fructose [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34308-7.json |
| 34309-5 | Fructose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34309-5.json |
| 34310-3 | Galactose [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34310-3.json |
| 34311-1 | Galactose [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34311-1.json |
| 34312-9 | Glucose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34312-9.json |
| 3431-4 | carBAMazepine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3431-4.json |
| 34316-0 | Histamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34316-0.json |
| 34317-8 | Histamine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34317-8.json |
| 34318-6 | HTLV I+II Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/34318-6.json |
| 34319-4 | Inhibin B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34319-4.json |
| 34320-2 | Iodine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34320-2.json |
| 34321-0 | Iodine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34321-0.json |
| 3432-2 | carBAMazepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3432-2.json |
| 34322-8 | Iron/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34322-8.json |
| 34323-6 | Lactate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34323-6.json |
| 34324-4 | Lactate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34324-4.json |
| 34325-1 | Lead [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34325-1.json |
| 34327-7 | Lead/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34327-7.json |
| 34328-5 | Levodopa [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34328-5.json |
| 34329-3 | Fat [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/34329-3.json |
| 3433-0 | carBAMazepine free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3433-0.json |
| 34330-1 | Lithium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34330-1.json |
| 34331-9 | Lithium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34331-9.json |
| 34332-7 | Lormetazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34332-7.json |
| 34333-5 | Lutropin [Units/volume] in 24 hour Urine by 1st IRP | ./2.16.840.1.114222.4.11.1002/34333-5.json |
| 34334-3 | Lutropin/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34334-3.json |
| 34335-0 | Lysozyme [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34335-0.json |
| 34336-8 | Lysozyme/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34336-8.json |
| 34337-6 | Mercury [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34337-6.json |
| 34338-4 | Mercury [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34338-4.json |
| 34339-2 | Metanephrine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34339-2.json |
| 34340-0 | Methionine sulfoxide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34340-0.json |
| 34341-8 | Mianserin+Normianserin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34341-8.json |
| 34342-6 | Niacin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34342-6.json |
| 34343-4 | Nickel [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34343-4.json |
| 34344-2 | N-methylhistamine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34344-2.json |
| 34345-9 | N-methylhistamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34345-9.json |
| 34346-7 | N-methylhistamine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34346-7.json |
| 34347-5 | Normetanephrine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34347-5.json |
| 34348-3 | Normetanephrine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34348-3.json |
| 34349-1 | Oxalate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34349-1.json |
| 34350-9 | Oxalate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34350-9.json |
| 3435-5 | Carboxy tetrahydrocannabinol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3435-5.json |
| 34356-6 | Porphobilinogen [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34356-6.json |
| 34357-4 | Porphobilinogen/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34357-4.json |
| 34358-2 | Pregnanediol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34358-2.json |
| 34359-0 | Pregnanediol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34359-0.json |
| 34360-8 | Pregnanetriol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34360-8.json |
| 34361-6 | Pregnanetriol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34361-6.json |
| 34362-4 | Pregnanetriolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34362-4.json |
| 3436-3 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3436-3.json |
| 34363-2 | Pregnanetriolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34363-2.json |
| 34364-0 | Pregnanetriolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34364-0.json |
| 34365-7 | Primidone+PHENobarbital [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34365-7.json |
| 34366-5 | Protein/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34366-5.json |
| 34367-3 | Pyridinoline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34367-3.json |
| 34368-1 | Pyridinoline [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34368-1.json |
| 34369-9 | Salmonella paratyphi C H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34369-9.json |
| 34370-7 | Salmonella paratyphi C O Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34370-7.json |
| 3437-1 | Carisoprodol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3437-1.json |
| 34371-5 | Salmonella typhi H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34371-5.json |
| 34372-3 | Salmonella typhi O Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34372-3.json |
| 34373-1 | Serotonin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34373-1.json |
| 34374-9 | Serotonin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34374-9.json |
| 34375-6 | Streptokinase Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34375-6.json |
| 34376-4 | Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/34376-4.json |
| 34377-2 | Sulthiame [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34377-2.json |
| 34378-0 | Teicoplanin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/34378-0.json |
| 34379-8 | Teicoplanin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/34379-8.json |
| 34380-6 | Testosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34380-6.json |
| 34381-4 | Thioguanine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34381-4.json |
| 34382-2 | Treponema pallidum Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34382-2.json |
| 34383-0 | Trypanosoma brucei Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34383-0.json |
| 34385-5 | Urate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34385-5.json |
| 34386-3 | Venlafaxine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34386-3.json |
| 34387-1 | Zinc [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34387-1.json |
| 34388-9 | Zinc [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34388-9.json |
| 3438-9 | Cathine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3438-9.json |
| 34389-7 | Zinc/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34389-7.json |
| 34392-1 | Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/34392-1.json |
| 34393-9 | Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/34393-9.json |
| 34394-7 | Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/34394-7.json |
| 34395-4 | Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/34395-4.json |
| 34396-2 | 11-Ketoetiocholanolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34396-2.json |
| 3439-7 | Cathine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3439-7.json |
| 34397-0 | Amilsulpride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34397-0.json |
| 34398-8 | Biotin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34398-8.json |
| 34399-6 | Buccal mucosa Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34399-6.json |
| 34400-2 | Colon Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34400-2.json |
| 34401-0 | Complement C3d [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34401-0.json |
| 34404-4 | Cytoskeleton Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34404-4.json |
| 3440-5 | Cathine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3440-5.json |
| 34405-1 | Escitalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34405-1.json |
| 34406-9 | Exocrine pancreas Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34406-9.json |
| 34407-7 | Interleukin 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34407-7.json |
| 34408-5 | Interleukin 2 Receptor Soluble [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34408-5.json |
| 34409-3 | Keratin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34409-3.json |
| 34410-1 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/34410-1.json |
| 34411-9 | Mitochondria M4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34411-9.json |
| 34412-7 | Mitochondria M9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34412-7.json |
| 3441-3 | Cefamandole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3441-3.json |
| 34413-5 | Moclobemide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34413-5.json |
| 34414-3 | Normianserin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34414-3.json |
| 34415-0 | Normirtazapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34415-0.json |
| 34416-8 | Nucleosome Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/34416-8.json |
| 34417-6 | Protoporphyrin.zinc [Mass/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/34417-6.json |
| 34421-8 | Rubella virus IgG Ab avidity [Ratio] in Serum | ./2.16.840.1.114222.4.11.1002/34421-8.json |
| 34422-6 | Toxoplasma gondii IgG Ab avidity [Ratio] in Serum | ./2.16.840.1.114222.4.11.1002/34422-6.json |
| 34423-4 | Salmonella enteritidis H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34423-4.json |
| 34424-2 | Salmonella typhimurium H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34424-2.json |
| 34425-9 | Silver Birch recombinant (rBet v) 1 + 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34425-9.json |
| 34426-7 | cycloSPORINE.monoclonal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34426-7.json |
| 34427-5 | Methadone.R [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34427-5.json |
| 34428-3 | Timothy recombinant (rPhl p) 12 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34428-3.json |
| 34429-1 | Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34429-1.json |
| 34430-9 | Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34430-9.json |
| 34431-7 | Salmonella enteritidis H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34431-7.json |
| 34432-5 | Salmonella typhimurium H Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/34432-5.json |
| 34433-3 | Bartonella henselae Ab [Titer] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/34433-3.json |
| 34436-6 | Diethylene glycol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34436-6.json |
| 34437-4 | Coxsackievirus B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34437-4.json |
| 34438-2 | Apolipoprotein E phenotype [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/34438-2.json |
| 3443-9 | ceFAZolin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3443-9.json |
| 34439-0 | Natural killer cell function [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/34439-0.json |
| 34443-2 | ZOLMitriptan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34443-2.json |
| 34444-0 | Acarboxyprothrombin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34444-0.json |
| 3444-7 | Cefonicid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3444-7.json |
| 34447-3 | Cache valley virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34447-3.json |
| 34448-1 | Cache valley virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34448-1.json |
| 34449-9 | Eastern equine encephalitis virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34449-9.json |
| 34450-7 | Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34450-7.json |
| 34451-5 | Herpes simplex virus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34451-5.json |
| 34452-3 | Jamestown canyon virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34452-3.json |
| 34453-1 | Jamestown canyon virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34453-1.json |
| 3445-4 | Cefoperazone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3445-4.json |
| 34454-9 | La Crosse virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34454-9.json |
| 34455-6 | La Crosse virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34455-6.json |
| 34456-4 | Powassan virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34456-4.json |
| 34457-2 | Powassan virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34457-2.json |
| 34458-0 | Saint Louis encephalitis virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34458-0.json |
| 34459-8 | Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34459-8.json |
| 34460-6 | West Nile virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34460-6.json |
| 34461-4 | West Nile virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34461-4.json |
| 3446-2 | Cefotaxime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3446-2.json |
| 34462-2 | California serogroup RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34462-2.json |
| 34463-0 | California serogroup RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34463-0.json |
| 34466-3 | Carbohydrates [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/34466-3.json |
| 34467-1 | Cholesterol.in chylomicrons [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34467-1.json |
| 34468-9 | Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/34468-9.json |
| 3447-0 | cefoTEtan [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3447-0.json |
| 34470-5 | Giardia lamblia Ag [Presence] in Bile fluid | ./2.16.840.1.114222.4.11.1002/34470-5.json |
| 34474-7 | ABO and Rh group [Type] in Cord blood | ./2.16.840.1.114222.4.11.1002/34474-7.json |
| 34485-3 | Avian paramyxovirus 1.exotic RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34485-3.json |
| 34486-1 | Avian paramyxovirus 1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34486-1.json |
| 34487-9 | Influenza virus A RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34487-9.json |
| 3448-8 | cefOXitin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3448-8.json |
| 34488-7 | Avian paramyxovirus 1 subtype [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34488-7.json |
| 34489-5 | TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34489-5.json |
| 34490-3 | MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34490-3.json |
| 34491-1 | PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34491-1.json |
| 34492-9 | NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34492-9.json |
| 34493-7 | PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34493-7.json |
| 34494-5 | SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34494-5.json |
| 34495-2 | TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34495-2.json |
| 3449-6 | cefTAZidime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3449-6.json |
| 34496-0 | Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/34496-0.json |
| 34497-8 | SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34497-8.json |
| 34498-6 | ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34498-6.json |
| 34499-4 | GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34499-4.json |
| 34500-9 | SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34500-9.json |
| 34501-7 | HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/34501-7.json |
| 34502-5 | VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34502-5.json |
| 34503-3 | Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/34503-3.json |
| 3450-4 | Ceftizoxime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3450-4.json |
| 34504-1 | GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34504-1.json |
| 34505-8 | NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34505-8.json |
| 34506-6 | EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34506-6.json |
| 34507-4 | PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34507-4.json |
| 34508-2 | PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34508-2.json |
| 34509-0 | UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34509-0.json |
| 34510-8 | SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34510-8.json |
| 34511-6 | SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34511-6.json |
| 3451-2 | cefTRIAXone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3451-2.json |
| 34512-4 | NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34512-4.json |
| 34513-2 | NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34513-2.json |
| 34514-0 | SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34514-0.json |
| 34515-7 | GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34515-7.json |
| 34516-5 | SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34516-5.json |
| 34517-3 | CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34517-3.json |
| 34518-1 | SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34518-1.json |
| 34519-9 | HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34519-9.json |
| 3452-0 | Cefuroxime Parenteral [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3452-0.json |
| 34520-7 | Carbon dioxide, total [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/34520-7.json |
| 34521-5 | Carnitine acyltransferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/34521-5.json |
| 34522-3 | Phosphorylase kinase [Enzymatic activity/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/34522-3.json |
| 34523-1 | Succinate semialdehyde dehydrogenase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/34523-1.json |
| 34526-4 | Sialooligosaccharides/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/34526-4.json |
| 3453-8 | Cephalexin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3453-8.json |
| 3454-6 | Cephalothin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3454-6.json |
| 3455-3 | Chloramphenicol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3455-3.json |
| 3456-1 | chlordiazePOXIDE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3456-1.json |
| 34568-6 | Alkaline phosphatase [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/34568-6.json |
| 34571-0 | aPTT.lupus sensitive (LA screen) | ./2.16.840.1.114222.4.11.1002/34571-0.json |
| 34575-1 | 8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/34575-1.json |
| 34576-9 | Adenovirus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34576-9.json |
| 34578-5 | Barbiturates [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/34578-5.json |
| 3457-9 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3457-9.json |
| 34581-9 | Calcium.ionized [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/34581-9.json |
| 34582-7 | Candida sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34582-7.json |
| 34583-5 | Candida sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34583-5.json |
| 34584-3 | Candida sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34584-3.json |
| 34585-0 | Inner ear 68kD Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34585-0.json |
| 34586-8 | JC virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34586-8.json |
| 3458-7 | chlordiazePOXIDE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3458-7.json |
| 34587-6 | Palmitoyl protein thioesterase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34587-6.json |
| 34588-4 | Tick feeding duration | ./2.16.840.1.114222.4.11.1002/34588-4.json |
| 34589-2 | von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/34589-2.json |
| 34590-0 | von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/34590-0.json |
| 34591-8 | HIV 1 Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/34591-8.json |
| 34592-6 | HIV 1 Ab [Presence] in Body fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/34592-6.json |
| 34593-4 | Epstein Barr virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34593-4.json |
| 34594-2 | Schistosoma sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34594-2.json |
| 3459-5 | chlordiazePOXIDE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3459-5.json |
| 34596-7 | 3-O-Methyldopa [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34596-7.json |
| 34597-5 | Hepatitis D virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34597-5.json |
| 34598-3 | Sialate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/34598-3.json |
| 34599-1 | Methotrexate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34599-1.json |
| 34600-7 | HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34600-7.json |
| 34601-5 | Drugs identified in Body fluid | ./2.16.840.1.114222.4.11.1002/34601-5.json |
| 3460-3 | Chlormerodrin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3460-3.json |
| 34605-6 | Collagen type 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34605-6.json |
| 34606-4 | Minocycline [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34606-4.json |
| 34607-2 | Interferon beta Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34607-2.json |
| 34608-0 | Leishmania sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34608-0.json |
| 34609-8 | Transketolase [Enzymatic activity/mass] in Blood | ./2.16.840.1.114222.4.11.1002/34609-8.json |
| 3461-1 | Chlormerodrin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3461-1.json |
| 34611-4 | Prostate specific Ag [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34611-4.json |
| 34612-2 | Iron [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/34612-2.json |
| 34613-0 | Herpes simplex virus 1+2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34613-0.json |
| 34614-8 | Spermatozoa IgM Ab [Units/volume] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/34614-8.json |
| 34615-5 | Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain | ./2.16.840.1.114222.4.11.1002/34615-5.json |
| 34616-3 | Amino acids [Identifier] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34616-3.json |
| 34617-1 | Other Antibiotic [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/34617-1.json |
| 34618-9 | Hemoglobin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/34618-9.json |
| 34619-7 | Complement C1 esterase inhibitor.functional [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34619-7.json |
| 34620-5 | Camphor [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34620-5.json |
| 34621-3 | Liver cytosol Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34621-3.json |
| 34623-9 | Colorado tick fever virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34623-9.json |
| 34624-7 | Cystine Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34624-7.json |
| 34625-4 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34625-4.json |
| 34627-0 | Methylmalonate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/34627-0.json |
| 34628-8 | Methotrexate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34628-8.json |
| 3462-9 | Chlormerodrin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3462-9.json |
| 34629-6 | CISplatin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34629-6.json |
| 34630-4 | Substance P [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34630-4.json |
| 34631-2 | Cyproheptadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34631-2.json |
| 34632-0 | hydrALAZINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34632-0.json |
| 34633-8 | Hypoglycemics.sulfonyluric [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/34633-8.json |
| 34635-3 | Citalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34635-3.json |
| 34636-1 | Ciprofloxacin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34636-1.json |
| 3463-7 | Chloroquine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3463-7.json |
| 34637-9 | 5-Methyltetrahydrofolate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34637-9.json |
| 34638-7 | Clarithromycin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34638-7.json |
| 34639-5 | Epstein Barr virus capsid IgA Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34639-5.json |
| 34640-3 | Bile acid [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/34640-3.json |
| 34642-9 | Thyroid colloidal Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34642-9.json |
| 3464-5 | Chlorothiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3464-5.json |
| 34645-2 | Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34645-2.json |
| 34646-0 | Sulfatides [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/34646-0.json |
| 34647-8 | PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34647-8.json |
| 34649-4 | MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34649-4.json |
| 34650-2 | TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34650-2.json |
| 34651-0 | CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34651-0.json |
| 3465-2 | Chlorpheniramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3465-2.json |
| 34652-8 | Pancreatic islet cell Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/34652-8.json |
| 34653-6 | GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34653-6.json |
| 34654-4 | MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34654-4.json |
| 34655-1 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34655-1.json |
| 34656-9 | KEL gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34656-9.json |
| 34658-5 | MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/34658-5.json |
| 34659-3 | ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34659-3.json |
| 3466-0 | Chlorpheniramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3466-0.json |
| 34661-9 | Actin IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34661-9.json |
| 34662-7 | Mephenytoin+Normephenytoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34662-7.json |
| 34663-5 | Hemoglobin S [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/34663-5.json |
| 34664-3 | Clostridium botulinum toxin A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34664-3.json |
| 34666-8 | Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34666-8.json |
| 34668-4 | Prilocaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34668-4.json |
| 34669-2 | Pyrimethamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34669-2.json |
| 34670-0 | Choriogonadotropin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34670-0.json |
| 34671-8 | 8-Dehydrocholesterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34671-8.json |
| 34673-4 | Propofol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34673-4.json |
| 34674-2 | Tripeptide aminopeptidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34674-2.json |
| 34675-9 | Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34675-9.json |
| 34677-5 | Mitotic spindle apparatus Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34677-5.json |
| 3467-8 | Chlorpheniramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3467-8.json |
| 34678-3 | MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34678-3.json |
| 34679-1 | PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34679-1.json |
| 34680-9 | Ceramide trihexoside [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/34680-9.json |
| 3468-6 | Chlorphentermine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3468-6.json |
| 34689-0 | Sulfatidase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/34689-0.json |
| 34690-8 | CV2 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34690-8.json |
| 34691-6 | Erythroamino alcohol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34691-6.json |
| 34692-4 | Threoamino alcohol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34692-4.json |
| 34693-2 | GALOP Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34693-2.json |
| 3469-4 | Chlorphentermine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3469-4.json |
| 34694-0 | Vascular endothelial growth factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34694-0.json |
| 34698-1 | CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34698-1.json |
| 34699-9 | HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34699-9.json |
| 34700-5 | HIV reverse transcriptase+protease gene mutations tested for | ./2.16.840.1.114222.4.11.1002/34700-5.json |
| 34701-3 | Heparin induced platelet Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/34701-3.json |
| 3470-2 | Chlorphentermine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3470-2.json |
| 34702-1 | Mycoplasma sp [Presence] in Specimen by Hoechst stain | ./2.16.840.1.114222.4.11.1002/34702-1.json |
| 34703-9 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL | ./2.16.840.1.114222.4.11.1002/34703-9.json |
| 34704-7 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL | ./2.16.840.1.114222.4.11.1002/34704-7.json |
| 34706-2 | CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34706-2.json |
| 34707-0 | Chlamydophila pneumoniae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/34707-0.json |
| 34708-8 | Chlamydia sp DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34708-8.json |
| 34709-6 | Chlamydia trachomatis Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/34709-6.json |
| 3471-0 | chlorproMAZINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3471-0.json |
| 34710-4 | Chlamydia trachomatis Ag [Presence] in Anal | ./2.16.840.1.114222.4.11.1002/34710-4.json |
| 34711-2 | Cholinesterase [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34711-2.json |
| 34712-0 | Clostridioides difficile [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/34712-0.json |
| 34713-8 | Clostridioides difficile toxin A+B [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/34713-8.json |
| 34714-6 | INR in Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/34714-6.json |
| 34715-3 | Cocaine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/34715-3.json |
| 34716-1 | Coxiella burnetii phase 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34716-1.json |
| 34717-9 | Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34717-9.json |
| 34718-7 | CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/34718-7.json |
| 34719-5 | Cytomegalovirus DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34719-5.json |
| 34720-3 | Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34720-3.json |
| 34721-1 | Dengue virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34721-1.json |
| 34722-9 | EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/34722-9.json |
| 34723-7 | Eastern equine encephalitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34723-7.json |
| 34724-5 | Echovirus 4 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34724-5.json |
| 34725-2 | Echovirus 7 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34725-2.json |
| 34727-8 | DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/34727-8.json |
| 3472-8 | chlorproMAZINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3472-8.json |
| 34728-6 | Carbon dioxide, total [Moles/volume] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/34728-6.json |
| 34729-4 | CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34729-4.json |
| 3473-6 | chlorproMAZINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3473-6.json |
| 34736-9 | Calcium oxalate index in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/34736-9.json |
| 34739-3 | NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34739-3.json |
| 34740-1 | NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/34740-1.json |
| 34741-9 | RHCE gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/34741-9.json |
| 34742-7 | Chromosome breakage [Units/volume] in Blood by Diepoxybutane | ./2.16.840.1.114222.4.11.1002/34742-7.json |
| 34743-5 | Stable Hemoglobin [Presence] in Blood by Isopropanol stability | ./2.16.840.1.114222.4.11.1002/34743-5.json |
| 3474-4 | chlorproPAMIDE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3474-4.json |
| 34744-3 | Nurse Admission evaluation note | ./2.16.840.1.114222.4.11.1002/34744-3.json |
| 34745-0 | Nurse Discharge summary | ./2.16.840.1.114222.4.11.1002/34745-0.json |
| 34746-8 | Nurse Note | ./2.16.840.1.114222.4.11.1002/34746-8.json |
| 34747-6 | Nurse Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34747-6.json |
| 34748-4 | Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/34748-4.json |
| 34749-2 | Anesthesiology Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/34749-2.json |
| 34750-0 | Anesthesiology Note | ./2.16.840.1.114222.4.11.1002/34750-0.json |
| 3475-1 | Chlorprothixene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3475-1.json |
| 34751-8 | Anesthesiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34751-8.json |
| 34752-6 | Cardiology Note | ./2.16.840.1.114222.4.11.1002/34752-6.json |
| 34753-4 | Cardiology Outpatient Note | ./2.16.840.1.114222.4.11.1002/34753-4.json |
| 34754-2 | Critical care medicine Note | ./2.16.840.1.114222.4.11.1002/34754-2.json |
| 34755-9 | Critical care medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/34755-9.json |
| 34756-7 | Dentistry Consult note | ./2.16.840.1.114222.4.11.1002/34756-7.json |
| 34757-5 | Dentistry Evaluation note | ./2.16.840.1.114222.4.11.1002/34757-5.json |
| 34758-3 | Dermatology Consult note | ./2.16.840.1.114222.4.11.1002/34758-3.json |
| 34759-1 | Dermatology Note | ./2.16.840.1.114222.4.11.1002/34759-1.json |
| 34760-9 | Diabetology Consult note | ./2.16.840.1.114222.4.11.1002/34760-9.json |
| 34761-7 | Gastroenterology Consult note | ./2.16.840.1.114222.4.11.1002/34761-7.json |
| 34762-5 | Gastroenterology Note | ./2.16.840.1.114222.4.11.1002/34762-5.json |
| 34763-3 | General medicine Admission history and physical note | ./2.16.840.1.114222.4.11.1002/34763-3.json |
| 34764-1 | General medicine Consult note | ./2.16.840.1.114222.4.11.1002/34764-1.json |
| 34765-8 | General medicine Note | ./2.16.840.1.114222.4.11.1002/34765-8.json |
| 34766-6 | General medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/34766-6.json |
| 34767-4 | General medicine Medical student Note | ./2.16.840.1.114222.4.11.1002/34767-4.json |
| 34768-2 | General medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/34768-2.json |
| 3476-9 | Chlorprothixene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3476-9.json |
| 34769-0 | General medicine Attending Note | ./2.16.840.1.114222.4.11.1002/34769-0.json |
| 34770-8 | General medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/34770-8.json |
| 34773-2 | Surgery Attending Note | ./2.16.840.1.114222.4.11.1002/34773-2.json |
| 34774-0 | Surgery History and physical note | ./2.16.840.1.114222.4.11.1002/34774-0.json |
| 34776-5 | Geriatric medicine Consult note | ./2.16.840.1.114222.4.11.1002/34776-5.json |
| 3477-7 | Chlorprothixene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3477-7.json |
| 34777-3 | Obstetrics and Gynecology Consult note | ./2.16.840.1.114222.4.11.1002/34777-3.json |
| 34778-1 | Obstetrics and Gynecology Note | ./2.16.840.1.114222.4.11.1002/34778-1.json |
| 34779-9 | Hematology+Medical oncology Consult note | ./2.16.840.1.114222.4.11.1002/34779-9.json |
| 34780-7 | Hematology+Medical oncology Note | ./2.16.840.1.114222.4.11.1002/34780-7.json |
| 34781-5 | Infectious disease Consult note | ./2.16.840.1.114222.4.11.1002/34781-5.json |
| 34782-3 | Infectious disease Note | ./2.16.840.1.114222.4.11.1002/34782-3.json |
| 34783-1 | Kinesiotherapy Consult note | ./2.16.840.1.114222.4.11.1002/34783-1.json |
| 34784-9 | Kinesiotherapy Note | ./2.16.840.1.114222.4.11.1002/34784-9.json |
| 3478-5 | Chlorthalidone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3478-5.json |
| 34785-6 | Mental health Consult note | ./2.16.840.1.114222.4.11.1002/34785-6.json |
| 34786-4 | Mental health Note | ./2.16.840.1.114222.4.11.1002/34786-4.json |
| 34787-2 | Mental health Group counseling note | ./2.16.840.1.114222.4.11.1002/34787-2.json |
| 34788-0 | Psychiatry Consult note | ./2.16.840.1.114222.4.11.1002/34788-0.json |
| 34790-6 | Psychiatry Group counseling note | ./2.16.840.1.114222.4.11.1002/34790-6.json |
| 34791-4 | Psychology Consult note | ./2.16.840.1.114222.4.11.1002/34791-4.json |
| 34792-2 | Psychology Note | ./2.16.840.1.114222.4.11.1002/34792-2.json |
| 3479-3 | Chlorthalidone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3479-3.json |
| 34793-0 | Psychology Group counseling note | ./2.16.840.1.114222.4.11.1002/34793-0.json |
| 34794-8 | Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/34794-8.json |
| 34795-5 | Nephrology Consult note | ./2.16.840.1.114222.4.11.1002/34795-5.json |
| 34796-3 | Nephrology Note | ./2.16.840.1.114222.4.11.1002/34796-3.json |
| 34797-1 | Neurology Consult note | ./2.16.840.1.114222.4.11.1002/34797-1.json |
| 34798-9 | Neurological surgery Consult note | ./2.16.840.1.114222.4.11.1002/34798-9.json |
| 34799-7 | Neurological surgery Note | ./2.16.840.1.114222.4.11.1002/34799-7.json |
| 34800-3 | Nutrition and dietetics Consult note | ./2.16.840.1.114222.4.11.1002/34800-3.json |
| 3480-1 | Chlorthalidone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3480-1.json |
| 34801-1 | Nutrition and dietetics Note | ./2.16.840.1.114222.4.11.1002/34801-1.json |
| 34802-9 | Occupational medicine Note | ./2.16.840.1.114222.4.11.1002/34802-9.json |
| 34803-7 | Occupational medicine Consult note | ./2.16.840.1.114222.4.11.1002/34803-7.json |
| 34805-2 | Oncology Consult note | ./2.16.840.1.114222.4.11.1002/34805-2.json |
| 34806-0 | Oncology Note | ./2.16.840.1.114222.4.11.1002/34806-0.json |
| 34807-8 | Ophthalmology Consult note | ./2.16.840.1.114222.4.11.1002/34807-8.json |
| 34808-6 | Ophthalmology Note | ./2.16.840.1.114222.4.11.1002/34808-6.json |
| 34809-4 | Ophthalmology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34809-4.json |
| 34810-2 | Optometry Consult note | ./2.16.840.1.114222.4.11.1002/34810-2.json |
| 34811-0 | Optometry Note | ./2.16.840.1.114222.4.11.1002/34811-0.json |
| 34812-8 | Oral and Maxillofacial Surgery Consult note | ./2.16.840.1.114222.4.11.1002/34812-8.json |
| 34813-6 | Oral and Maxillofacial Surgery Note | ./2.16.840.1.114222.4.11.1002/34813-6.json |
| 34814-4 | Orthopaedic surgery Consult note | ./2.16.840.1.114222.4.11.1002/34814-4.json |
| 34815-1 | Orthopaedic surgery Note | ./2.16.840.1.114222.4.11.1002/34815-1.json |
| 34816-9 | Otolaryngology Consult note | ./2.16.840.1.114222.4.11.1002/34816-9.json |
| 34817-7 | Otolaryngology Note | ./2.16.840.1.114222.4.11.1002/34817-7.json |
| 34818-5 | Otolaryngology Surgical operation note | ./2.16.840.1.114222.4.11.1002/34818-5.json |
| 3481-9 | Cimetidine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3481-9.json |
| 34819-3 | Pathology Note | ./2.16.840.1.114222.4.11.1002/34819-3.json |
| 34820-1 | Pharmacology Consult note | ./2.16.840.1.114222.4.11.1002/34820-1.json |
| 34821-9 | Pharmacology Note | ./2.16.840.1.114222.4.11.1002/34821-9.json |
| 34822-7 | Physical medicine and rehab Consult note | ./2.16.840.1.114222.4.11.1002/34822-7.json |
| 34823-5 | Physical medicine and rehab Note | ./2.16.840.1.114222.4.11.1002/34823-5.json |
| 34824-3 | Physical therapy Consult note | ./2.16.840.1.114222.4.11.1002/34824-3.json |
| 34825-0 | Physical therapy Evaluation note | ./2.16.840.1.114222.4.11.1002/34825-0.json |
| 34826-8 | Plastic surgery Consult note | ./2.16.840.1.114222.4.11.1002/34826-8.json |
| 3482-7 | Cimetidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3482-7.json |
| 34827-6 | Plastic surgery Note | ./2.16.840.1.114222.4.11.1002/34827-6.json |
| 34828-4 | Podiatry Consult note | ./2.16.840.1.114222.4.11.1002/34828-4.json |
| 34829-2 | Podiatry Note | ./2.16.840.1.114222.4.11.1002/34829-2.json |
| 34830-0 | Pulmonary Note | ./2.16.840.1.114222.4.11.1002/34830-0.json |
| 34831-8 | Radiation oncology Consult note | ./2.16.840.1.114222.4.11.1002/34831-8.json |
| 34832-6 | Radiation oncology Note | ./2.16.840.1.114222.4.11.1002/34832-6.json |
| 34833-4 | Recreational therapy Consult note | ./2.16.840.1.114222.4.11.1002/34833-4.json |
| 34834-2 | Recreational therapy Note | ./2.16.840.1.114222.4.11.1002/34834-2.json |
| 3483-5 | Cimetidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3483-5.json |
| 34837-5 | Respiratory therapy Consult note | ./2.16.840.1.114222.4.11.1002/34837-5.json |
| 34838-3 | Respiratory therapy Note | ./2.16.840.1.114222.4.11.1002/34838-3.json |
| 34839-1 | Rheumatology Consult note | ./2.16.840.1.114222.4.11.1002/34839-1.json |
| 34840-9 | Rheumatology Note | ./2.16.840.1.114222.4.11.1002/34840-9.json |
| 34841-7 | Social worker Consult note | ./2.16.840.1.114222.4.11.1002/34841-7.json |
| 34842-5 | Social worker Evaluation note | ./2.16.840.1.114222.4.11.1002/34842-5.json |
| 3484-3 | Ciprofloxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3484-3.json |
| 34843-3 | Social worker Group counseling note | ./2.16.840.1.114222.4.11.1002/34843-3.json |
| 34844-1 | Social worker Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/34844-1.json |
| 34845-8 | Speech-language pathology+Audiology Consult note | ./2.16.840.1.114222.4.11.1002/34845-8.json |
| 34846-6 | Speech-language pathology+Audiology Note | ./2.16.840.1.114222.4.11.1002/34846-6.json |
| 34847-4 | Surgery Consult note | ./2.16.840.1.114222.4.11.1002/34847-4.json |
| 34848-2 | Surgery Note | ./2.16.840.1.114222.4.11.1002/34848-2.json |
| 34849-0 | Cardiothoracic surgery Consult note | ./2.16.840.1.114222.4.11.1002/34849-0.json |
| 3485-0 | CISplatin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3485-0.json |
| 34850-8 | Cardiothoracic surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/34850-8.json |
| 34851-6 | Urology Consult note | ./2.16.840.1.114222.4.11.1002/34851-6.json |
| 34852-4 | Urology Note | ./2.16.840.1.114222.4.11.1002/34852-4.json |
| 34853-2 | Vascular surgery Consult note | ./2.16.840.1.114222.4.11.1002/34853-2.json |
| 34854-0 | Vascular surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/34854-0.json |
| 34855-7 | Occupational therapy Consult note | ./2.16.840.1.114222.4.11.1002/34855-7.json |
| 34856-5 | Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/34856-5.json |
| 34857-3 | Addiction medicine Note | ./2.16.840.1.114222.4.11.1002/34857-3.json |
| 34858-1 | Pain medicine Note | ./2.16.840.1.114222.4.11.1002/34858-1.json |
| 34859-9 | Evaluation and management of hyperlipidemia note | ./2.16.840.1.114222.4.11.1002/34859-9.json |
| 34860-7 | Evaluation and management of hypertension note | ./2.16.840.1.114222.4.11.1002/34860-7.json |
| 34861-5 | Diabetology Note | ./2.16.840.1.114222.4.11.1002/34861-5.json |
| 34862-3 | General medicine Attending Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/34862-3.json |
| 34864-9 | Mental health Counseling note | ./2.16.840.1.114222.4.11.1002/34864-9.json |
| 34865-6 | Psychiatry Counseling note | ./2.16.840.1.114222.4.11.1002/34865-6.json |
| 34866-4 | Psychology Counseling note | ./2.16.840.1.114222.4.11.1002/34866-4.json |
| 34867-2 | Ophthalmology Outpatient Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34867-2.json |
| 3486-8 | Clindamycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3486-8.json |
| 34868-0 | Orthopaedic surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/34868-0.json |
| 34869-8 | Pharmacology Counseling note | ./2.16.840.1.114222.4.11.1002/34869-8.json |
| 34870-6 | Plastic surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/34870-6.json |
| 34872-2 | Social worker Counseling note | ./2.16.840.1.114222.4.11.1002/34872-2.json |
| 34873-0 | Surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/34873-0.json |
| 34874-8 | Surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/34874-8.json |
| 34875-5 | Surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34875-5.json |
| 3487-6 | cloBAZam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3487-6.json |
| 34876-3 | Surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34876-3.json |
| 34877-1 | Urology Surgical operation note | ./2.16.840.1.114222.4.11.1002/34877-1.json |
| 34878-9 | Emergency medicine Note | ./2.16.840.1.114222.4.11.1002/34878-9.json |
| 34879-7 | Endocrinology Consult note | ./2.16.840.1.114222.4.11.1002/34879-7.json |
| 34880-5 | Surgery Nurse Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34880-5.json |
| 34881-3 | Surgery Nurse Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/34881-3.json |
| 34882-1 | Ethanol [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/34882-1.json |
| 34883-9 | Mycoplasma sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/34883-9.json |
| 3488-4 | Clobenzorex [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3488-4.json |
| 34884-7 | Haemophilus paragallinarum Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/34884-7.json |
| 34885-4 | African horse sickness virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34885-4.json |
| 34886-2 | Rabbit hemorrhagic disease virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/34886-2.json |
| 34887-0 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/34887-0.json |
| 34888-8 | Aino virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/34888-8.json |
| 34889-6 | Akabane virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/34889-6.json |
| 34890-4 | Coliform bacteria [#/volume] in Specimen by Viability count | ./2.16.840.1.114222.4.11.1002/34890-4.json |
| 34891-2 | Salmonella enteritidis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/34891-2.json |
| 3489-2 | Clobenzorex [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3489-2.json |
| 34892-0 | West Nile virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/34892-0.json |
| 34893-8 | Aino virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34893-8.json |
| 34894-6 | Akabane virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/34894-6.json |
| 34895-3 | Education note | ./2.16.840.1.114222.4.11.1002/34895-3.json |
| 34896-1 | Cardiology Interventional procedure note | ./2.16.840.1.114222.4.11.1002/34896-1.json |
| 34897-9 | Diabetology Education note | ./2.16.840.1.114222.4.11.1002/34897-9.json |
| 34898-7 | Endocrinology Note | ./2.16.840.1.114222.4.11.1002/34898-7.json |
| 34899-5 | Gastroenterology Interventional procedure note | ./2.16.840.1.114222.4.11.1002/34899-5.json |
| 3490-0 | Clofibrate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3490-0.json |
| 34900-1 | General medicine Progress note | ./2.16.840.1.114222.4.11.1002/34900-1.json |
| 34901-9 | General medicine Outpatient Progress note | ./2.16.840.1.114222.4.11.1002/34901-9.json |
| 34902-7 | Geriatric medicine Outpatient Education note | ./2.16.840.1.114222.4.11.1002/34902-7.json |
| 34904-3 | Mental health Progress note | ./2.16.840.1.114222.4.11.1002/34904-3.json |
| 34905-0 | Neurology Note | ./2.16.840.1.114222.4.11.1002/34905-0.json |
| 34906-8 | Pastoral care Note | ./2.16.840.1.114222.4.11.1002/34906-8.json |
| 34908-4 | Neopterin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34908-4.json |
| 34909-2 | Cortisol Free [Mass/volume] in 24 hour Urine by HPLC | ./2.16.840.1.114222.4.11.1002/34909-2.json |
| 3491-8 | clomiPRAMINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3491-8.json |
| 3492-6 | clomiPRAMINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3492-6.json |
| 34927-4 | Urobilinogen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/34927-4.json |
| 34928-2 | Urobilinogen [Moles/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/34928-2.json |
| 34938-1 | Phosphate [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/34938-1.json |
| 34939-9 | Tumor necrosis factor.alpha [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/34939-9.json |
| 3494-2 | clonazePAM [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3494-2.json |
| 34956-3 | Western equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34956-3.json |
| 34957-1 | Eosinophils [#/volume] in Cerebral spinal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/34957-1.json |
| 34958-9 | Eosinophils [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/34958-9.json |
| 3495-9 | cloNIDine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3495-9.json |
| 34959-7 | Microscopic observation [Identifier] in Blood by Myeloperoxidase stain | ./2.16.840.1.114222.4.11.1002/34959-7.json |
| 3496-7 | Clopenthixol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3496-7.json |
| 34971-2 | Neutrophil associated Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/34971-2.json |
| 3497-5 | Clopenthixol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3497-5.json |
| 34975-3 | DNA index in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/34975-3.json |
| 34977-9 | Platelet genotype [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/34977-9.json |
| 3498-3 | Clorazepate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3498-3.json |
| 3499-1 | Clorprenaline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3499-1.json |
| 3500-6 | Clorprenaline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3500-6.json |
| 3501-4 | Clorprenaline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3501-4.json |
| 3502-2 | Clostebol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3502-2.json |
| 3503-0 | Clostebol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3503-0.json |
| 3504-8 | Clostebol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3504-8.json |
| 3505-5 | Codeine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3505-5.json |
| 3506-3 | Codeine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3506-3.json |
| 35063-7 | Eosinophils [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/35063-7.json |
| 3507-1 | Codeine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3507-1.json |
| 3508-9 | Codeine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3508-9.json |
| 3509-7 | Prochlorperazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3509-7.json |
| 35100-7 | Enterovirus IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35100-7.json |
| 35102-3 | Acenocoumarol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35102-3.json |
| 35103-1 | Acyclovir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/35103-1.json |
| 35104-9 | Acyclovir [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/35104-9.json |
| 3510-5 | Prochlorperazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3510-5.json |
| 35105-6 | Bromperidol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35105-6.json |
| 35106-4 | Norcitalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35106-4.json |
| 35107-2 | Norclobazam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35107-2.json |
| 35108-0 | Normaprotiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35108-0.json |
| 35109-8 | Phenprocoumon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35109-8.json |
| 35110-6 | Flecainide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/35110-6.json |
| 35111-4 | Flecainide [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/35111-4.json |
| 35112-2 | Floxacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35112-2.json |
| 3511-3 | Cropropamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3511-3.json |
| 35113-0 | Nelfinavir M8 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35113-0.json |
| 35114-8 | Nordothiepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35114-8.json |
| 35115-5 | Pipamperone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35115-5.json |
| 35116-3 | Sulforidazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35116-3.json |
| 35117-1 | Sulpiride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35117-1.json |
| 35118-9 | Acetaldehyde [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35118-9.json |
| 35119-7 | Chloral hydrate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35119-7.json |
| 35120-5 | Dothiepin sulfoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35120-5.json |
| 3512-1 | Cropropamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3512-1.json |
| 35121-3 | E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35121-3.json |
| 35122-1 | MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35122-1.json |
| 35123-9 | Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/35123-9.json |
| 35124-7 | Dysferlin [Presence] in Leukocytes | ./2.16.840.1.114222.4.11.1002/35124-7.json |
| 35128-8 | Perforin [Units/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/35128-8.json |
| 35129-6 | Karyotype [Identifier] in Specimen Nominal | ./2.16.840.1.114222.4.11.1002/35129-6.json |
| 35130-4 | Salicylates [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/35130-4.json |
| 35131-2 | L-dopa decarboxylase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/35131-2.json |
| 35132-0 | MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35132-0.json |
| 35133-8 | Glutarate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35133-8.json |
| 35134-6 | Thyrotropin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35134-6.json |
| 35137-9 | MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35137-9.json |
| 3513-9 | Cropropamide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3513-9.json |
| 35139-5 | Interferon beta Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35139-5.json |
| 35140-3 | Trans-3-Hydroxycotinine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35140-3.json |
| 35141-1 | Purine nucleoside phosphorylase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35141-1.json |
| 35142-9 | Amphiphysin Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35142-9.json |
| 35143-7 | PCA-2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35143-7.json |
| 35144-5 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35144-5.json |
| 3514-7 | Crotethamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3514-7.json |
| 3515-4 | Crotethamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3515-4.json |
| 3516-2 | Crotethamide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3516-2.json |
| 3517-0 | Cyclacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3517-0.json |
| 35183-3 | Hemoglobin [Mass or Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/35183-3.json |
| 35184-1 | Fasting glucose [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35184-1.json |
| 35185-8 | Aldosterone [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35185-8.json |
| 35186-6 | Aldosterone [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35186-6.json |
| 35187-4 | Aldosterone [Mass or Moles/volume] in Serum or Plasma --supine | ./2.16.840.1.114222.4.11.1002/35187-4.json |
| 3518-8 | Cyclizine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3518-8.json |
| 35188-2 | Aldosterone [Mass or Moles/volume] in Serum or Plasma --upright | ./2.16.840.1.114222.4.11.1002/35188-2.json |
| 35189-0 | Androstanolone [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35189-0.json |
| 35190-8 | Androstenedione [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35190-8.json |
| 35191-6 | Bilirubin.direct [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35191-6.json |
| 35192-4 | Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35192-4.json |
| 35193-2 | Bilirubin.total [Mass or Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/35193-2.json |
| 35194-0 | Bilirubin.total [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35194-0.json |
| 35195-7 | C peptide [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35195-7.json |
| 3519-6 | cycloSERINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3519-6.json |
| 35196-5 | 25-hydroxyvitamin D3 [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35196-5.json |
| 35197-3 | Cholesterol in HDL [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35197-3.json |
| 35198-1 | Cholesterol in LDL [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35198-1.json |
| 35200-5 | Cholesterol [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35200-5.json |
| 35201-3 | Cobalamin (Vitamin B12) [Mass or Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35201-3.json |
| 35202-1 | Cortisol [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35202-1.json |
| 35203-9 | Creatinine [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35203-9.json |
| 3520-4 | cycloSPORINE [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3520-4.json |
| 35204-7 | Creatinine [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35204-7.json |
| 35205-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35205-4.json |
| 35206-2 | Dehydroepiandrosterone (DHEA) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35206-2.json |
| 35207-0 | Estradiol (E2) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35207-0.json |
| 35208-8 | Estrone (E1) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35208-8.json |
| 35209-6 | Ferritin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35209-6.json |
| 35210-4 | Folate [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35210-4.json |
| 35211-2 | Glucose [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35211-2.json |
| 3521-2 | cycloSPORINE [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/3521-2.json |
| 35212-0 | Glucose [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35212-0.json |
| 35213-8 | Insulin-like growth factor-I [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35213-8.json |
| 35214-6 | Iron [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35214-6.json |
| 35215-3 | Iron binding capacity [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35215-3.json |
| 35216-1 | Iron binding capacity.unsaturated [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35216-1.json |
| 35217-9 | Triglyceride [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35217-9.json |
| 35218-7 | Osteocalcin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35218-7.json |
| 35219-5 | Parathyrin.intact [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35219-5.json |
| 3522-0 | cycloSPORINE+Metabolites [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3522-0.json |
| 35220-3 | Phosphate [Mass or Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/35220-3.json |
| 35221-1 | Phosphate [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35221-1.json |
| 35222-9 | Phosphate [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35222-9.json |
| 35223-7 | Progesterone [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35223-7.json |
| 35224-5 | Testosterone [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35224-5.json |
| 35225-2 | Testosterone Free [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35225-2.json |
| 35226-0 | Thyroxine (T4) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35226-0.json |
| 35227-8 | Thyroxine binding globulin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35227-8.json |
| 35228-6 | Thyroxine (T4) free [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35228-6.json |
| 35229-4 | Transferrin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35229-4.json |
| 35230-2 | Triiodothyronine (T3) Free [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35230-2.json |
| 35231-0 | Triiodothyronine (T3) [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35231-0.json |
| 35232-8 | Urate [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35232-8.json |
| 35233-6 | Urate [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35233-6.json |
| 35234-4 | Urea nitrogen [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35234-4.json |
| 35235-1 | Urea nitrogen [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35235-1.json |
| 35236-9 | Urobilinogen [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35236-9.json |
| 35237-7 | carBAMazepine [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35237-7.json |
| 3523-8 | cycloSPORINE [Mass/volume] in Blood --12 hours post dose | ./2.16.840.1.114222.4.11.1002/3523-8.json |
| 35238-5 | Theophylline [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35238-5.json |
| 35239-3 | Tobramycin [Mass or Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/35239-3.json |
| 35240-1 | Ethanol [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35240-1.json |
| 35241-9 | Urea nitrogen [Mass or Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/35241-9.json |
| 35242-7 | Creatinine [Mass or Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/35242-7.json |
| 35244-3 | Digoxin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35244-3.json |
| 35245-0 | Lactate [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35245-0.json |
| 3524-6 | cycloSPORINE [Mass/volume] in Serum --12 hours post dose | ./2.16.840.1.114222.4.11.1002/3524-6.json |
| 35246-8 | Calcium [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35246-8.json |
| 35247-6 | Calcium [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35247-6.json |
| 35248-4 | Calcium [Mass or Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35248-4.json |
| 35249-2 | Magnesium [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35249-2.json |
| 35250-0 | Magnesium [Mass or Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35250-0.json |
| 35251-8 | Creatinine [Mass or Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35251-8.json |
| 35252-6 | Magnesium [Mass or Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35252-6.json |
| 3525-3 | cycloSPORINE [Mass/volume] in Blood --24 hours post dose | ./2.16.840.1.114222.4.11.1002/3525-3.json |
| 35253-4 | Urate [Mass or Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35253-4.json |
| 35254-2 | Ammonia [Mass or Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/35254-2.json |
| 35255-9 | Beta hydroxybutyrate [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35255-9.json |
| 35256-7 | Iron [Mass or Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35256-7.json |
| 35257-5 | Natriuretic peptide B [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35257-5.json |
| 35259-1 | Neopterin [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35259-1.json |
| 35260-9 | Histamine [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35260-9.json |
| 3526-1 | cycloSPORINE [Mass/volume] in Serum --24 hours post dose | ./2.16.840.1.114222.4.11.1002/3526-1.json |
| 35261-7 | Cortisol Free [Mass or Moles/volume] in 24 hour Urine by HPLC | ./2.16.840.1.114222.4.11.1002/35261-7.json |
| 35262-5 | Creatinine [Mass or Moles] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35262-5.json |
| 35263-3 | Phosphate [Mass or Moles] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35263-3.json |
| 35264-1 | Calcium intake 24 hour | ./2.16.840.1.114222.4.11.1002/35264-1.json |
| 35268-2 | Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35268-2.json |
| 35269-0 | Bartonella henselae Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/35269-0.json |
| 35270-8 | Candida sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/35270-8.json |
| 35271-6 | Candida sp Ag [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/35271-6.json |
| 35272-4 | Centromere IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35272-4.json |
| 35273-2 | Hepatitis D virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35273-2.json |
| 35274-0 | Histone IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35274-0.json |
| 35275-7 | Measles virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35275-7.json |
| 35276-5 | Measles virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35276-5.json |
| 35277-3 | Myocardium IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35277-3.json |
| 35278-1 | Neuronal nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/35278-1.json |
| 3527-9 | Dantron [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3527-9.json |
| 35279-9 | Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/35279-9.json |
| 35280-7 | Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35280-7.json |
| 35281-5 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/35281-5.json |
| 35282-3 | Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/35282-3.json |
| 35283-1 | Hepatitis D virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35283-1.json |
| 35284-9 | Histone IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35284-9.json |
| 35285-6 | Tissue transglutaminase IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35285-6.json |
| 3528-7 | Tetrahydrocannabinol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3528-7.json |
| 35287-2 | Toxoplasma gondii HS Ab [Units/volume] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/35287-2.json |
| 35288-0 | MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35288-0.json |
| 35289-8 | Peroxide hemolysis of Red Blood Cells | ./2.16.840.1.114222.4.11.1002/35289-8.json |
| 35290-6 | RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35290-6.json |
| 35291-4 | UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35291-4.json |
| 35292-2 | Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics | ./2.16.840.1.114222.4.11.1002/35292-2.json |
| 35293-0 | TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35293-0.json |
| 35294-8 | PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35294-8.json |
| 35295-5 | BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35295-5.json |
| 35296-3 | PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35296-3.json |
| 35297-1 | LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35297-1.json |
| 35298-9 | FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35298-9.json |
| 35299-7 | PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35299-7.json |
| 35300-3 | GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35300-3.json |
| 35302-9 | HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35302-9.json |
| 3530-3 | Tetrahydrocannabinol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3530-3.json |
| 35303-7 | Glucosylceramidase [Enzymatic activity/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/35303-7.json |
| 35304-5 | CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35304-5.json |
| 35305-2 | Toxoplasma gondii AC Ab [Units/volume] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/35305-2.json |
| 3531-1 | Desipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3531-1.json |
| 35317-7 | Thermoactinomyces vulgaris 1 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/35317-7.json |
| 35318-5 | Laceyella sacchari Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/35318-5.json |
| 3532-9 | Desipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3532-9.json |
| 35331-8 | OXcarbazepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35331-8.json |
| 35333-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35333-4.json |
| 35334-2 | Collagen crosslinked N-telopeptide [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35334-2.json |
| 3533-7 | Desipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3533-7.json |
| 35340-9 | ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35340-9.json |
| 35341-7 | ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35341-7.json |
| 3534-5 | Desipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3534-5.json |
| 35347-4 | Microscopic observation [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/35347-4.json |
| 35348-2 | Corynebacterium diphtheriae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/35348-2.json |
| 35349-0 | Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/35349-0.json |
| 35351-6 | Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35351-6.json |
| 3535-2 | Desipramine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3535-2.json |
| 35352-4 | Mycobacterium tuberculosis genotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/35352-4.json |
| 35353-2 | FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35353-2.json |
| 35354-0 | COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35354-0.json |
| 35355-7 | PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35355-7.json |
| 35356-5 | TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35356-5.json |
| 35357-3 | PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35357-3.json |
| 35358-1 | LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35358-1.json |
| 35359-9 | AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35359-9.json |
| 3536-0 | Norclomipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3536-0.json |
| 35360-7 | Triglyceride in Lipoprotein a [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35360-7.json |
| 35361-5 | Triglyceride in Lipoprotein a [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35361-5.json |
| 35362-3 | Triglyceride in Chylomicrons [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35362-3.json |
| 35363-1 | Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35363-1.json |
| 35365-6 | Vitamin D+Metabolites [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35365-6.json |
| 35372-2 | GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35372-2.json |
| 3537-8 | Nordiazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3537-8.json |
| 35379-7 | HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35379-7.json |
| 35380-5 | HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35380-5.json |
| 35381-3 | HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35381-3.json |
| 35382-1 | HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35382-1.json |
| 35383-9 | Galactomannan Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35383-9.json |
| 35384-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/35384-7.json |
| 35385-4 | CV2 IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35385-4.json |
| 3538-6 | Dextromethorphan [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3538-6.json |
| 35386-2 | CV2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/35386-2.json |
| 35387-0 | Cholesterol. in Lipoprotein (a) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35387-0.json |
| 35388-8 | Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35388-8.json |
| 35389-6 | Cholesterol.in chylomicrons [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35389-6.json |
| 35390-4 | Vaccinia virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35390-4.json |
| 35391-2 | Taenia solium larva IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35391-2.json |
| 35392-0 | Hantavirus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35392-0.json |
| 35393-8 | Hantavirus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35393-8.json |
| 3539-4 | Dextromethorphan [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3539-4.json |
| 35394-6 | Legionella pneumophila 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35394-6.json |
| 35395-3 | Legionella pneumophila 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35395-3.json |
| 35396-1 | Enterovirus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35396-1.json |
| 35397-9 | Epstein Barr virus DNA [Presence] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35397-9.json |
| 35398-7 | Epstein Barr virus DNA [Presence] in Mouth by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35398-7.json |
| 35399-5 | Varicella zoster virus DNA [Presence] in Eye by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35399-5.json |
| 35400-1 | Varicella zoster virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35400-1.json |
| 35401-9 | Cytomegalovirus DNA [Presence] in Bronchial specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35401-9.json |
| 3540-2 | Dextromoramide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3540-2.json |
| 35402-7 | Leishmania donovani IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35402-7.json |
| 35403-5 | Leishmania donovani IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35403-5.json |
| 35404-3 | Leishmania brasilensis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35404-3.json |
| 35405-0 | Leishmania brasilensis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35405-0.json |
| 35406-8 | Leishmania mexicana IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35406-8.json |
| 35407-6 | Leishmania mexicana IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35407-6.json |
| 35408-4 | Leishmania tropica IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35408-4.json |
| 35409-2 | Leishmania tropica IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35409-2.json |
| 3541-0 | Dextromoramide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3541-0.json |
| 35412-6 | Chlamydia sp DNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35412-6.json |
| 35414-2 | Specific gravity of Body fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/35414-2.json |
| 35415-9 | Oxytocin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35415-9.json |
| 35416-7 | Echinococcus granulosus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/35416-7.json |
| 35417-5 | Herpes simplex virus identified in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35417-5.json |
| 35418-3 | Herpes simplex virus identified in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35418-3.json |
| 35419-1 | Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35419-1.json |
| 35420-9 | Herpes simplex virus identified in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35420-9.json |
| 35421-7 | Herpes simplex virus identified in Ear by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35421-7.json |
| 35422-5 | Herpes simplex virus identified in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35422-5.json |
| 35423-3 | Herpes simplex virus identified in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35423-3.json |
| 35424-1 | Herpes simplex virus identified in Penis by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35424-1.json |
| 35425-8 | Herpes simplex virus identified in Placenta by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35425-8.json |
| 35426-6 | Herpes simplex virus identified in Pleural fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35426-6.json |
| 35427-4 | Herpes simplex virus identified in Peritoneal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35427-4.json |
| 3542-8 | Propoxyphene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3542-8.json |
| 35428-2 | Herpes simplex virus identified in Synovial fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35428-2.json |
| 35429-0 | Herpes simplex virus identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35429-0.json |
| 35430-8 | Herpes simplex virus identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35430-8.json |
| 35431-6 | Herpes simplex virus identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35431-6.json |
| 35432-4 | Herpes simplex virus identified in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35432-4.json |
| 35433-2 | Herpes simplex virus identified in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35433-2.json |
| 35434-0 | Herpes simplex virus identified in Wound by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35434-0.json |
| 35435-7 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/35435-7.json |
| 3543-6 | Propoxyphene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3543-6.json |
| 35436-5 | Spermatozoa [Presence] in Semen by Light microscopy --post reanastomosis | ./2.16.840.1.114222.4.11.1002/35436-5.json |
| 35437-3 | HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/35437-3.json |
| 35438-1 | HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/35438-1.json |
| 35439-9 | HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot | ./2.16.840.1.114222.4.11.1002/35439-9.json |
| 3545-1 | Propoxyphene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3545-1.json |
| 35451-4 | Herpes simplex virus identified in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/35451-4.json |
| 35453-0 | ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35453-0.json |
| 35454-8 | MLL gene rearrangements in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35454-8.json |
| 35455-5 | X chromosome inactivation [Identifier] in Blood or Tissue Narrative | ./2.16.840.1.114222.4.11.1002/35455-5.json |
| 35456-3 | Y chromosome deletion [Identifier] in Blood or Tissue Nominal | ./2.16.840.1.114222.4.11.1002/35456-3.json |
| 35457-1 | Maternal cell contamination [Identifier] in Amniotic fluid Nominal | ./2.16.840.1.114222.4.11.1002/35457-1.json |
| 35458-9 | Ma+Ta Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/35458-9.json |
| 35460-5 | Platelet genotype [Identifier] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/35460-5.json |
| 35461-3 | ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35461-3.json |
| 35462-1 | SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35462-1.json |
| 35463-9 | Telomere analysis [Identifier] in Blood or Tissue Nominal | ./2.16.840.1.114222.4.11.1002/35463-9.json |
| 35464-7 | CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35464-7.json |
| 35465-4 | RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35465-4.json |
| 35466-2 | AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35466-2.json |
| 35467-0 | M-chlorophenylpiperazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35467-0.json |
| 35468-8 | FLAER cells [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/35468-8.json |
| 3546-9 | Diamorphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3546-9.json |
| 35470-4 | Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35470-4.json |
| 35471-2 | HLA Ab [Presence] | ./2.16.840.1.114222.4.11.1002/35471-2.json |
| 35472-0 | HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35472-0.json |
| 35473-8 | HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35473-8.json |
| 35474-6 | Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35474-6.json |
| 35476-1 | OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/35476-1.json |
| 3547-7 | Diamorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3547-7.json |
| 35477-9 | Ciliated columnar lining cells/100 leukocytes [# Ratio] in Body fluid | ./2.16.840.1.114222.4.11.1002/35477-9.json |
| 35478-7 | Cytosol aminopeptidase [Enzymatic activity/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/35478-7.json |
| 35479-5 | Diazinon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35479-5.json |
| 35480-3 | 1-Naphthol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35480-3.json |
| 35481-1 | Terbufos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35481-1.json |
| 35482-9 | Para nitrophenol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35482-9.json |
| 35483-7 | Mevinphos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35483-7.json |
| 35484-5 | Methyl parathion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35484-5.json |
| 3548-5 | diazePAM [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3548-5.json |
| 35485-2 | Metasystox [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35485-2.json |
| 35486-0 | Fonofos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35486-0.json |
| 35487-8 | Fenchlorphos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35487-8.json |
| 35488-6 | Diazinon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35488-6.json |
| 35489-4 | Chlorpyrifos [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35489-4.json |
| 35490-2 | Azinphos-methyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35490-2.json |
| 35491-0 | Leptospira sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35491-0.json |
| 35492-8 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35492-8.json |
| 3549-3 | diazePAM [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3549-3.json |
| 35493-6 | Ricin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/35493-6.json |
| 35494-4 | Succinate dehydrogenase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/35494-4.json |
| 35495-1 | Citrate synthase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/35495-1.json |
| 35496-9 | NADH dehydrogenase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/35496-9.json |
| 35497-7 | NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/35497-7.json |
| 35498-5 | Succinate cytochrome C reductase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/35498-5.json |
| 3550-1 | diazePAM [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3550-1.json |
| 35506-5 | Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35506-5.json |
| 3551-9 | diazePAM [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3551-9.json |
| 3552-7 | diazePAM [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3552-7.json |
| 35529-7 | Beef IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35529-7.json |
| 35530-5 | Candida albicans IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35530-5.json |
| 35531-3 | Sugar Cane IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35531-3.json |
| 35532-1 | Chicken IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35532-1.json |
| 35533-9 | Coffee IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35533-9.json |
| 35534-7 | Corn IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35534-7.json |
| 3553-5 | Dibenzepin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3553-5.json |
| 35535-4 | Egg white IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35535-4.json |
| 35536-2 | Egg yolk IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35536-2.json |
| 35537-0 | Wheat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35537-0.json |
| 35538-8 | Baker's yeast IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35538-8.json |
| 35539-6 | Cow milk IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35539-6.json |
| 35540-4 | Mushroom IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35540-4.json |
| 35541-2 | Onion IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35541-2.json |
| 35542-0 | Peanut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35542-0.json |
| 35543-8 | Pork IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35543-8.json |
| 35544-6 | Potato IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35544-6.json |
| 35545-3 | Rice IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35545-3.json |
| 35546-1 | Soybean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35546-1.json |
| 35547-9 | Tomato IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35547-9.json |
| 35548-7 | Fusarium moniliforme IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35548-7.json |
| 35549-5 | Mucor racemosus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35549-5.json |
| 3555-0 | Dichlorphenamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3555-0.json |
| 35550-3 | Phthalic anhydride IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35550-3.json |
| 35551-1 | Phoma betae IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35551-1.json |
| 35552-9 | Rhizopus nigricans IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35552-9.json |
| 35553-7 | Stemphylium botryosum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35553-7.json |
| 35554-5 | Chocolate IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35554-5.json |
| 35555-2 | Setomelanomma rostrata IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35555-2.json |
| 35556-0 | Trichophyton rubrum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35556-0.json |
| 35557-8 | Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35557-8.json |
| 35562-8 | Bile acid [Moles/volume] in Serum --fasting | ./2.16.840.1.114222.4.11.1002/35562-8.json |
| 35566-9 | Parathyrin [Mass/volume] in Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/35566-9.json |
| 35567-7 | Parathyrin [Mass/volume] in Serum or Plasma --10 minutes post excision | ./2.16.840.1.114222.4.11.1002/35567-7.json |
| 3556-8 | Dichlorphenamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3556-8.json |
| 35568-5 | Oligoclonal bands [#] in Cerebral spinal fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/35568-5.json |
| 35569-3 | Oligoclonal bands [#] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35569-3.json |
| 35570-1 | Renin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/35570-1.json |
| 35571-9 | Tyrosine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/35571-9.json |
| 35573-5 | Procollagen+Collagen [Identifier] in Fibroblast by Electrophoresis | ./2.16.840.1.114222.4.11.1002/35573-5.json |
| 3557-6 | Dichlorphenamide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3557-6.json |
| 35578-4 | 1,2-Glyceryl dinitrate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35578-4.json |
| 35579-2 | Tetrahydrofuran [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35579-2.json |
| 35580-0 | N-methyl valine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35580-0.json |
| 35582-6 | Hydrazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35582-6.json |
| 35583-4 | Hydrazine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/35583-4.json |
| 3558-4 | Dicoumarol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3558-4.json |
| 35584-2 | Aniline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35584-2.json |
| 35585-9 | 2-Butoxyacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35585-9.json |
| 35586-7 | 4-Tert-Butylphenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35586-7.json |
| 35587-5 | 2-Ethoxyacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35587-5.json |
| 35588-3 | Ethylene glycol dinitrate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35588-3.json |
| 35589-1 | Furoate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/35589-1.json |
| 35590-9 | Aniline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/35590-9.json |
| 3559-2 | Digitoxin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3559-2.json |
| 35595-8 | Acetaminophen [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35595-8.json |
| 35596-6 | Theophylline [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35596-6.json |
| 35597-4 | Salicylates [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35597-4.json |
| 35598-2 | Butalbital [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35598-2.json |
| 35599-0 | carBAMazepine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35599-0.json |
| 3560-0 | Digitoxin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3560-0.json |
| 35600-6 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35600-6.json |
| 35601-4 | chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35601-4.json |
| 35602-2 | clomiPRAMINE [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35602-2.json |
| 35603-0 | clonazePAM [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35603-0.json |
| 35604-8 | Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35604-8.json |
| 35605-5 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35605-5.json |
| 35606-3 | Desipramine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35606-3.json |
| 35607-1 | diazePAM [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35607-1.json |
| 35608-9 | diphenhydrAMINE [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35608-9.json |
| 35609-7 | Doxepin [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35609-7.json |
| 35610-5 | FLUoxetine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35610-5.json |
| 35611-3 | Flurazepam [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35611-3.json |
| 35612-1 | fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35612-1.json |
| 35613-9 | Glutethimide [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35613-9.json |
| 35614-7 | Ibuprofen [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35614-7.json |
| 35615-4 | Lidocaine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35615-4.json |
| 35616-2 | LORazepam [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35616-2.json |
| 35617-0 | Meperidine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35617-0.json |
| 3561-8 | Digitoxin>6h post dose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3561-8.json |
| 35618-8 | Methadone [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35618-8.json |
| 35619-6 | Methaqualone [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35619-6.json |
| 35620-4 | Metoprolol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35620-4.json |
| 35621-2 | Norclomipramine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35621-2.json |
| 35622-0 | Nordiazepam [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35622-0.json |
| 35623-8 | Nordoxepin [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35623-8.json |
| 35624-6 | Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35624-6.json |
| 35625-3 | Normeperidine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35625-3.json |
| 35626-1 | Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35626-1.json |
| 35627-9 | Nortriptyline [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35627-9.json |
| 35628-7 | Norverapamil [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35628-7.json |
| 35629-5 | Oxazepam [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35629-5.json |
| 35630-3 | PENTobarbital [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35630-3.json |
| 35631-1 | PHENobarbital [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35631-1.json |
| 35632-9 | Phenytoin [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35632-9.json |
| 35633-7 | Propranolol [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35633-7.json |
| 3563-4 | Digoxin>12 hours post dose [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3563-4.json |
| 35634-5 | Secobarbital [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35634-5.json |
| 35635-2 | traZODone [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35635-2.json |
| 35636-0 | Amitriptyline [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35636-0.json |
| 35637-8 | 4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35637-8.json |
| 35638-6 | Borrelia burgdorferi DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35638-6.json |
| 35639-4 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35639-4.json |
| 3564-2 | Dimetamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3564-2.json |
| 35642-8 | Cotinine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/35642-8.json |
| 35643-6 | Collagen type 2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/35643-6.json |
| 35645-1 | NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35645-1.json |
| 35646-9 | Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35646-9.json |
| 35647-7 | Pyridinoline+Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35647-7.json |
| 35649-3 | Propoxyphene [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35649-3.json |
| 35653-5 | CD158 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/35653-5.json |
| 3565-9 | Dimetamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3565-9.json |
| 35661-8 | JC virus DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35661-8.json |
| 35662-6 | Glucose [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35662-6.json |
| 35663-4 | Protein [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35663-4.json |
| 35664-2 | Ethanol [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35664-2.json |
| 35665-9 | Acetone [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35665-9.json |
| 3566-7 | Dimetamphetamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3566-7.json |
| 35667-5 | Atomoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35667-5.json |
| 35668-3 | Gentamicin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35668-3.json |
| 35669-1 | Amikacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35669-1.json |
| 35670-9 | Tobramycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35670-9.json |
| 35671-7 | Galactomannan Ag [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/35671-7.json |
| 35673-3 | Phosphate [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35673-3.json |
| 35674-1 | Creatinine [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35674-1.json |
| 3567-5 | Dimethyltryptamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3567-5.json |
| 35675-8 | Calcium [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35675-8.json |
| 35676-6 | Chloride [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35676-6.json |
| 35677-4 | Potassium [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35677-4.json |
| 35678-2 | Sodium [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35678-2.json |
| 3568-3 | Dimethyltryptamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3568-3.json |
| 35685-7 | Carbon dioxide [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/35685-7.json |
| 35686-5 | GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35686-5.json |
| 35687-3 | GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35687-3.json |
| 35688-1 | GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35688-1.json |
| 35689-9 | GBA gene c.84insG [Presence] in Blood or Tissue by Molecular geneticsmethod | ./2.16.840.1.114222.4.11.1002/35689-9.json |
| 35690-7 | GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35690-7.json |
| 3569-1 | diphenhydrAMINE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3569-1.json |
| 35691-5 | XXX microorganism DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35691-5.json |
| 35693-1 | GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35693-1.json |
| 35694-9 | California encephalitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/35694-9.json |
| 35695-6 | California encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/35695-6.json |
| 35696-4 | California encephalitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35696-4.json |
| 35697-2 | La Crosse virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/35697-2.json |
| 35698-0 | metFORMIN [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35698-0.json |
| 35699-8 | Anti-hyperglycemics [Identifier] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/35699-8.json |
| 35700-4 | Acetaminophen [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/35700-4.json |
| 35701-2 | Acetylcholinesterase [Enzymatic activity/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/35701-2.json |
| 35702-0 | Acid hemolysis fraction in Blood | ./2.16.840.1.114222.4.11.1002/35702-0.json |
| 35703-8 | Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35703-8.json |
| 35704-6 | Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/35704-6.json |
| 35705-3 | Adenovirus Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/35705-3.json |
| 3570-9 | diphenhydrAMINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3570-9.json |
| 35709-5 | La Crosse virus Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/35709-5.json |
| 35710-3 | Chlamydia sp DNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35710-3.json |
| 35711-1 | Chlamydia sp DNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35711-1.json |
| 35712-9 | Chlamydia sp rRNA [Presence] in Conjunctival specimen by Probe | ./2.16.840.1.114222.4.11.1002/35712-9.json |
| 35713-7 | Chlamydia sp DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35713-7.json |
| 35714-5 | Chlamydia sp rRNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/35714-5.json |
| 35715-2 | Chlamydia sp rRNA [Presence] in Genital specimen by Probe | ./2.16.840.1.114222.4.11.1002/35715-2.json |
| 35716-0 | Chlamydia sp DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35716-0.json |
| 3571-7 | diphenhydrAMINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3571-7.json |
| 35717-8 | Chlamydia sp rRNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/35717-8.json |
| 35718-6 | Chlamydia sp rRNA [Presence] in Nose by Probe | ./2.16.840.1.114222.4.11.1002/35718-6.json |
| 35721-0 | Chlamydia sp rRNA [Presence] in Anal by Probe | ./2.16.840.1.114222.4.11.1002/35721-0.json |
| 35722-8 | Chlamydia sp DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35722-8.json |
| 35723-6 | Chlamydia sp rRNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/35723-6.json |
| 35724-4 | Chlamydia sp DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35724-4.json |
| 3572-5 | diphenhydrAMINE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3572-5.json |
| 35725-1 | Chlamydia sp rRNA [Presence] in Throat by Probe | ./2.16.840.1.114222.4.11.1002/35725-1.json |
| 35726-9 | Chlamydia sp rRNA [Presence] in Urine by Probe | ./2.16.840.1.114222.4.11.1002/35726-9.json |
| 35727-7 | Chlamydia sp DNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35727-7.json |
| 35728-5 | Chlamydia sp rRNA [Presence] in Urethra by Probe | ./2.16.840.1.114222.4.11.1002/35728-5.json |
| 35729-3 | Chlamydia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35729-3.json |
| 35730-1 | Chlamydia sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/35730-1.json |
| 35732-7 | Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/35732-7.json |
| 3573-3 | Dipipanone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3573-3.json |
| 35733-5 | Histoplasma capsulatum M Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/35733-5.json |
| 35734-3 | Histoplasma capsulatum Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/35734-3.json |
| 35735-0 | Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/35735-0.json |
| 35736-8 | Chlamydia sp rRNA [Presence] in Nasopharynx by Probe | ./2.16.840.1.114222.4.11.1002/35736-8.json |
| 3574-1 | Dipipanone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3574-1.json |
| 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL | ./2.16.840.1.114222.4.11.1002/35741-8.json |
| 35742-6 | SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35742-6.json |
| 35744-2 | TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/35744-2.json |
| 35753-3 | Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/35753-3.json |
| 3575-8 | Dipipanone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3575-8.json |
| 3576-6 | Disopyramide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3576-6.json |
| 3577-4 | Disulfiram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3577-4.json |
| 3578-2 | Doxepin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3578-2.json |
| 3579-0 | Doxepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3579-0.json |
| 3580-8 | Doxepin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3580-8.json |
| 3581-6 | Doxepin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3581-6.json |
| 3582-4 | Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3582-4.json |
| 3583-2 | Doxepin+Metabolites [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3583-2.json |
| 3584-0 | Doxepin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3584-0.json |
| 3585-7 | Doxylamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3585-7.json |
| 3586-5 | Doxylamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3586-5.json |
| 35865-5 | Lipoprotein.intermediate density [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35865-5.json |
| 35867-1 | Acetoacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35867-1.json |
| 35869-7 | 2-Oxo,3-Methylvalerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35869-7.json |
| 35871-3 | Succinate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/35871-3.json |
| 3587-3 | Dyphylline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3587-3.json |
| 35875-4 | Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/35875-4.json |
| 35876-2 | Rickettsia sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35876-2.json |
| 35877-0 | Rickettsia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35877-0.json |
| 35878-8 | Escherichia coli O157:H7 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35878-8.json |
| 35879-6 | Escherichia coli O157:H7 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35879-6.json |
| 35880-4 | Tissue transglutaminase IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/35880-4.json |
| 3588-1 | Emetine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3588-1.json |
| 35881-2 | RFA Guidance for angioplasty of Extremity artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/35881-2.json |
| 35882-0 | RFA Guidance for angioplasty of Inferior vena cava-- W contrast IV | ./2.16.840.1.114222.4.11.1002/35882-0.json |
| 35883-8 | RFA Guidance for atherectomy of Thoracic and abdominal aorta-- W contrast IA | ./2.16.840.1.114222.4.11.1002/35883-8.json |
| 35884-6 | CT Guidance for drainage of abscess and placement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/35884-6.json |
| 35885-3 | RF Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/35885-3.json |
| 35886-1 | CT Guidance for fluid aspiration of Breast | ./2.16.840.1.114222.4.11.1002/35886-1.json |
| 35887-9 | CT Guidance for aspiration of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/35887-9.json |
| 35888-7 | RF Guidance for arthrocentesis of Hip | ./2.16.840.1.114222.4.11.1002/35888-7.json |
| 35889-5 | RF Guidance for bronchoscopy of Chest | ./2.16.840.1.114222.4.11.1002/35889-5.json |
| 35890-3 | RF Guidance for biopsy of Abdomen | ./2.16.840.1.114222.4.11.1002/35890-3.json |
| 35891-1 | CT guidance for percutaneous biopsy of Bone | ./2.16.840.1.114222.4.11.1002/35891-1.json |
| 35892-9 | CT Guidance for biopsy of Head | ./2.16.840.1.114222.4.11.1002/35892-9.json |
| 35893-7 | CT Guidance for biopsy of Breast | ./2.16.840.1.114222.4.11.1002/35893-7.json |
| 35894-5 | RF Guidance for biopsy of Chest | ./2.16.840.1.114222.4.11.1002/35894-5.json |
| 35895-2 | CT Guidance for biopsy of Chest | ./2.16.840.1.114222.4.11.1002/35895-2.json |
| 35896-0 | CT Guidance for biopsy of Lower extremity | ./2.16.840.1.114222.4.11.1002/35896-0.json |
| 35897-8 | CT Guidance for biopsy of Upper extremity | ./2.16.840.1.114222.4.11.1002/35897-8.json |
| 35898-6 | CT Guidance for biopsy of Salivary gland | ./2.16.840.1.114222.4.11.1002/35898-6.json |
| 3589-9 | Encainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3589-9.json |
| 35899-4 | RF Guidance for biopsy of Kidney | ./2.16.840.1.114222.4.11.1002/35899-4.json |
| 35900-0 | RF Guidance for percutaneous biopsy of Liver | ./2.16.840.1.114222.4.11.1002/35900-0.json |
| 35901-8 | CT Guidance for biopsy of Lymph node | ./2.16.840.1.114222.4.11.1002/35901-8.json |
| 35902-6 | RF Guidance for biopsy of Pancreas | ./2.16.840.1.114222.4.11.1002/35902-6.json |
| 35903-4 | CT Guidance for biopsy of Prostate | ./2.16.840.1.114222.4.11.1002/35903-4.json |
| 35904-2 | CT Guidance for biopsy of Cervical spine | ./2.16.840.1.114222.4.11.1002/35904-2.json |
| 35905-9 | CT Guidance for biopsy of Lumbar spine | ./2.16.840.1.114222.4.11.1002/35905-9.json |
| 35906-7 | CT Guidance for biopsy of Thoracic spine | ./2.16.840.1.114222.4.11.1002/35906-7.json |
| 3590-7 | Enoxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3590-7.json |
| 35907-5 | RF Guidance for biopsy of Spleen | ./2.16.840.1.114222.4.11.1002/35907-5.json |
| 35908-3 | CT Guidance for biopsy of Thyroid gland | ./2.16.840.1.114222.4.11.1002/35908-3.json |
| 35909-1 | CT Guidance for biopsy of Chest-- W contrast IV | ./2.16.840.1.114222.4.11.1002/35909-1.json |
| 35910-9 | CT Guidance for biopsy of Chest-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/35910-9.json |
| 35911-7 | CT Guidance for biopsy of Chest-- WO contrast | ./2.16.840.1.114222.4.11.1002/35911-7.json |
| 35912-5 | RF Guidance for placement of catheter in Unspecified body region | ./2.16.840.1.114222.4.11.1002/35912-5.json |
| 35913-3 | CT Guidance for drainage and placement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/35913-3.json |
| 35914-1 | CT Guidance for drainage and placement of drainage catheter of Anus | ./2.16.840.1.114222.4.11.1002/35914-1.json |
| 3591-5 | ePHEDrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3591-5.json |
| 35915-8 | CT Guidance for drainage and placement of drainage catheter of Appendix | ./2.16.840.1.114222.4.11.1002/35915-8.json |
| 35916-6 | CT Guidance for drainage and placement of drainage catheter of Chest | ./2.16.840.1.114222.4.11.1002/35916-6.json |
| 35917-4 | CT Guidance for drainage and placement of drainage catheter of Gallbladder | ./2.16.840.1.114222.4.11.1002/35917-4.json |
| 35918-2 | CT Guidance for drainage and placement of drainage catheter of Kidney | ./2.16.840.1.114222.4.11.1002/35918-2.json |
| 35919-0 | CT Guidance for drainage and placement of drainage catheter of Liver | ./2.16.840.1.114222.4.11.1002/35919-0.json |
| 35920-8 | CT Guidance for drainage of Lymph node | ./2.16.840.1.114222.4.11.1002/35920-8.json |
| 35921-6 | CT Guidance for drainage and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/35921-6.json |
| 35922-4 | CT Guidance for drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/35922-4.json |
| 3592-3 | ePHEDrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3592-3.json |
| 35923-2 | CT Guidance for drainage and placement of drainage catheter of Chest-- W contrast IV | ./2.16.840.1.114222.4.11.1002/35923-2.json |
| 35924-0 | CT Guidance for drainage and placement of drainage catheter of Chest-- WO contrast | ./2.16.840.1.114222.4.11.1002/35924-0.json |
| 35925-7 | RF Guidance for endoscopy of Stomach | ./2.16.840.1.114222.4.11.1002/35925-7.json |
| 35926-5 | RF Guidance for gastrostomy of Stomach | ./2.16.840.1.114222.4.11.1002/35926-5.json |
| 35927-3 | RF Guidance for injection of Sacroiliac Joint | ./2.16.840.1.114222.4.11.1002/35927-3.json |
| 35928-1 | CT Guidance for localization of Breast - left | ./2.16.840.1.114222.4.11.1002/35928-1.json |
| 35929-9 | CT Guidance for localization of Breast - right | ./2.16.840.1.114222.4.11.1002/35929-9.json |
| 35930-7 | CT Guidance for nerve block of Abdomen | ./2.16.840.1.114222.4.11.1002/35930-7.json |
| 3593-1 | ePHEDrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3593-1.json |
| 35931-5 | CT Guidance for nerve block of Pelvis | ./2.16.840.1.114222.4.11.1002/35931-5.json |
| 35932-3 | CT Guidance for nerve block of Lumbar spine | ./2.16.840.1.114222.4.11.1002/35932-3.json |
| 35933-1 | CT Guidance for percutaneous vertebroplasty of Spine | ./2.16.840.1.114222.4.11.1002/35933-1.json |
| 35934-9 | CT Guidance for percutaneous vertebroplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/35934-9.json |
| 35935-6 | CT Guidance for percutaneous vertebroplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/35935-6.json |
| 35936-4 | RF Guidance for percutaneous vertebroplasty of Spine | ./2.16.840.1.114222.4.11.1002/35936-4.json |
| 35937-2 | CT Guidance for placement of radiation therapy fields in Unspecified body region | ./2.16.840.1.114222.4.11.1002/35937-2.json |
| 35938-0 | CT Guidance for placement of tube in Chest | ./2.16.840.1.114222.4.11.1002/35938-0.json |
| 35939-8 | XR tomography Ankle | ./2.16.840.1.114222.4.11.1002/35939-8.json |
| 35940-6 | CT Ankle | ./2.16.840.1.114222.4.11.1002/35940-6.json |
| 35941-4 | CT Ankle - bilateral | ./2.16.840.1.114222.4.11.1002/35941-4.json |
| 35942-2 | CT Ankle - left | ./2.16.840.1.114222.4.11.1002/35942-2.json |
| 35943-0 | XR tomography Ankle - left | ./2.16.840.1.114222.4.11.1002/35943-0.json |
| 35944-8 | CT Ankle - right | ./2.16.840.1.114222.4.11.1002/35944-8.json |
| 35945-5 | CT Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/35945-5.json |
| 35946-3 | MRA Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/35946-3.json |
| 35947-1 | MR Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/35947-1.json |
| 35948-9 | CT Abdominal Aorta | ./2.16.840.1.114222.4.11.1002/35948-9.json |
| 3594-9 | ePHEDrine+Pseudoephedrine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3594-9.json |
| 35949-7 | MR Abdominal Aorta | ./2.16.840.1.114222.4.11.1002/35949-7.json |
| 35950-5 | MR Thoracic Aorta | ./2.16.840.1.114222.4.11.1002/35950-5.json |
| 35951-3 | MRA Aortic arch | ./2.16.840.1.114222.4.11.1002/35951-3.json |
| 35952-1 | CT Appendix | ./2.16.840.1.114222.4.11.1002/35952-1.json |
| 35953-9 | MR Face | ./2.16.840.1.114222.4.11.1002/35953-9.json |
| 35954-7 | MR Breast - left | ./2.16.840.1.114222.4.11.1002/35954-7.json |
| 35955-4 | MR Breast - right | ./2.16.840.1.114222.4.11.1002/35955-4.json |
| 3595-6 | ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3595-6.json |
| 35956-2 | MR Internal auditory canal | ./2.16.840.1.114222.4.11.1002/35956-2.json |
| 35957-0 | CT Internal auditory canal - left | ./2.16.840.1.114222.4.11.1002/35957-0.json |
| 35958-8 | CT Internal auditory canal | ./2.16.840.1.114222.4.11.1002/35958-8.json |
| 35959-6 | XR tomography Clavicle | ./2.16.840.1.114222.4.11.1002/35959-6.json |
| 35960-4 | CT Clavicle | ./2.16.840.1.114222.4.11.1002/35960-4.json |
| 35961-2 | MR Clavicle | ./2.16.840.1.114222.4.11.1002/35961-2.json |
| 35962-0 | CT Elbow | ./2.16.840.1.114222.4.11.1002/35962-0.json |
| 35963-8 | XR tomography Elbow | ./2.16.840.1.114222.4.11.1002/35963-8.json |
| 3596-4 | ePHEDrine+Pseudoephedrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3596-4.json |
| 35964-6 | XR tomography Elbow - bilateral | ./2.16.840.1.114222.4.11.1002/35964-6.json |
| 35965-3 | CT Elbow - bilateral | ./2.16.840.1.114222.4.11.1002/35965-3.json |
| 35966-1 | CT Elbow - left | ./2.16.840.1.114222.4.11.1002/35966-1.json |
| 35967-9 | XR tomography Elbow - left | ./2.16.840.1.114222.4.11.1002/35967-9.json |
| 35968-7 | CT Elbow - right | ./2.16.840.1.114222.4.11.1002/35968-7.json |
| 35969-5 | CT Esophagus | ./2.16.840.1.114222.4.11.1002/35969-5.json |
| 35970-3 | XR tomography Extremity | ./2.16.840.1.114222.4.11.1002/35970-3.json |
| 35971-1 | CT Lower extremity | ./2.16.840.1.114222.4.11.1002/35971-1.json |
| 3597-2 | Erythromycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3597-2.json |
| 35972-9 | XR tomography Lower extremity | ./2.16.840.1.114222.4.11.1002/35972-9.json |
| 35973-7 | CT Lower extremity - bilateral | ./2.16.840.1.114222.4.11.1002/35973-7.json |
| 35974-5 | MRA Lower extremity vessels - bilateral | ./2.16.840.1.114222.4.11.1002/35974-5.json |
| 35975-2 | MR Lower extremity - bilateral | ./2.16.840.1.114222.4.11.1002/35975-2.json |
| 35976-0 | CT Lower extremity - left | ./2.16.840.1.114222.4.11.1002/35976-0.json |
| 35977-8 | XR tomography Lower extremity - left | ./2.16.840.1.114222.4.11.1002/35977-8.json |
| 35978-6 | MR Lower extremity - left | ./2.16.840.1.114222.4.11.1002/35978-6.json |
| 35979-4 | CT Lower extremity - right | ./2.16.840.1.114222.4.11.1002/35979-4.json |
| 3598-0 | Estazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3598-0.json |
| 35980-2 | MR Lower extremity - right | ./2.16.840.1.114222.4.11.1002/35980-2.json |
| 35981-0 | CT Upper extremity | ./2.16.840.1.114222.4.11.1002/35981-0.json |
| 35982-8 | CT Upper extremity - left | ./2.16.840.1.114222.4.11.1002/35982-8.json |
| 35983-6 | CT Upper extremity - right | ./2.16.840.1.114222.4.11.1002/35983-6.json |
| 35984-4 | CT Thigh | ./2.16.840.1.114222.4.11.1002/35984-4.json |
| 35985-1 | XR tomography Femur | ./2.16.840.1.114222.4.11.1002/35985-1.json |
| 35986-9 | XR tomography Femur - bilateral | ./2.16.840.1.114222.4.11.1002/35986-9.json |
| 35987-7 | CT Thigh - left | ./2.16.840.1.114222.4.11.1002/35987-7.json |
| 35988-5 | XR tomography Femur - left | ./2.16.840.1.114222.4.11.1002/35988-5.json |
| 35989-3 | CT Thigh - right | ./2.16.840.1.114222.4.11.1002/35989-3.json |
| 35990-1 | MR Fetal | ./2.16.840.1.114222.4.11.1002/35990-1.json |
| 35991-9 | CT Foot | ./2.16.840.1.114222.4.11.1002/35991-9.json |
| 35992-7 | XR tomography Foot | ./2.16.840.1.114222.4.11.1002/35992-7.json |
| 35993-5 | CT Foot - bilateral | ./2.16.840.1.114222.4.11.1002/35993-5.json |
| 35994-3 | CT Foot - left | ./2.16.840.1.114222.4.11.1002/35994-3.json |
| 35995-0 | XR tomography Foot - left | ./2.16.840.1.114222.4.11.1002/35995-0.json |
| 35996-8 | CT Foot - right | ./2.16.840.1.114222.4.11.1002/35996-8.json |
| 35997-6 | CT Forearm | ./2.16.840.1.114222.4.11.1002/35997-6.json |
| 3599-8 | Etafedrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3599-8.json |
| 35998-4 | CT Forearm - bilateral | ./2.16.840.1.114222.4.11.1002/35998-4.json |
| 35999-2 | CT Forearm - left | ./2.16.840.1.114222.4.11.1002/35999-2.json |
| 36000-8 | CT Forearm - right | ./2.16.840.1.114222.4.11.1002/36000-8.json |
| 36001-6 | XR tomography Gallbladder | ./2.16.840.1.114222.4.11.1002/36001-6.json |
| 36002-4 | CT Hand | ./2.16.840.1.114222.4.11.1002/36002-4.json |
| 36003-2 | XR tomography Hand | ./2.16.840.1.114222.4.11.1002/36003-2.json |
| 3600-4 | Etafedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3600-4.json |
| 36004-0 | CT Hand - bilateral | ./2.16.840.1.114222.4.11.1002/36004-0.json |
| 36005-7 | CT Hand - left | ./2.16.840.1.114222.4.11.1002/36005-7.json |
| 36006-5 | XR tomography Hand - left | ./2.16.840.1.114222.4.11.1002/36006-5.json |
| 36007-3 | CT Hand - right | ./2.16.840.1.114222.4.11.1002/36007-3.json |
| 36008-1 | MR Wrist and Hand | ./2.16.840.1.114222.4.11.1002/36008-1.json |
| 36009-9 | MRA Heart | ./2.16.840.1.114222.4.11.1002/36009-9.json |
| 36011-5 | XR tomography Calcaneus | ./2.16.840.1.114222.4.11.1002/36011-5.json |
| 3601-2 | Etafedrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3601-2.json |
| 36012-3 | XR tomography Hip | ./2.16.840.1.114222.4.11.1002/36012-3.json |
| 36013-1 | MR Hip | ./2.16.840.1.114222.4.11.1002/36013-1.json |
| 36014-9 | CT Hip | ./2.16.840.1.114222.4.11.1002/36014-9.json |
| 36015-6 | XR tomography Hip - bilateral | ./2.16.840.1.114222.4.11.1002/36015-6.json |
| 36016-4 | CT Hip - bilateral | ./2.16.840.1.114222.4.11.1002/36016-4.json |
| 36017-2 | MR Hip - bilateral | ./2.16.840.1.114222.4.11.1002/36017-2.json |
| 36018-0 | CT Hip - left | ./2.16.840.1.114222.4.11.1002/36018-0.json |
| 36019-8 | XR tomography Hip - left | ./2.16.840.1.114222.4.11.1002/36019-8.json |
| 3602-0 | Etamivan [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3602-0.json |
| 36020-6 | MR Hip - left | ./2.16.840.1.114222.4.11.1002/36020-6.json |
| 36021-4 | CT Hip - right | ./2.16.840.1.114222.4.11.1002/36021-4.json |
| 36022-2 | MR Hip - right | ./2.16.840.1.114222.4.11.1002/36022-2.json |
| 36023-0 | CT Upper arm | ./2.16.840.1.114222.4.11.1002/36023-0.json |
| 36024-8 | XR tomography Humerus | ./2.16.840.1.114222.4.11.1002/36024-8.json |
| 36025-5 | MR Upper arm | ./2.16.840.1.114222.4.11.1002/36025-5.json |
| 36026-3 | CT Upper arm - bilateral | ./2.16.840.1.114222.4.11.1002/36026-3.json |
| 36027-1 | CT Upper arm - left | ./2.16.840.1.114222.4.11.1002/36027-1.json |
| 36028-9 | MR Upper arm - left | ./2.16.840.1.114222.4.11.1002/36028-9.json |
| 36029-7 | CT Upper arm - right | ./2.16.840.1.114222.4.11.1002/36029-7.json |
| 36030-5 | MR Upper arm - right | ./2.16.840.1.114222.4.11.1002/36030-5.json |
| 36031-3 | MR Sacroiliac Joint | ./2.16.840.1.114222.4.11.1002/36031-3.json |
| 36032-1 | XR tomography Kidney | ./2.16.840.1.114222.4.11.1002/36032-1.json |
| 36033-9 | MR Kidney | ./2.16.840.1.114222.4.11.1002/36033-9.json |
| 36034-7 | MR Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/36034-7.json |
| 36035-4 | MR Kidney - left | ./2.16.840.1.114222.4.11.1002/36035-4.json |
| 36036-2 | MR Kidney - right | ./2.16.840.1.114222.4.11.1002/36036-2.json |
| 36037-0 | CT Knee | ./2.16.840.1.114222.4.11.1002/36037-0.json |
| 3603-8 | Etamivan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3603-8.json |
| 36038-8 | XR tomography Knee | ./2.16.840.1.114222.4.11.1002/36038-8.json |
| 36039-6 | XR tomography Knee - bilateral | ./2.16.840.1.114222.4.11.1002/36039-6.json |
| 36040-4 | CT Knee - bilateral | ./2.16.840.1.114222.4.11.1002/36040-4.json |
| 36041-2 | CT Knee - left | ./2.16.840.1.114222.4.11.1002/36041-2.json |
| 36042-0 | XR tomography Knee - left | ./2.16.840.1.114222.4.11.1002/36042-0.json |
| 36043-8 | CT Knee - right | ./2.16.840.1.114222.4.11.1002/36043-8.json |
| 36044-6 | XR tomography Larynx | ./2.16.840.1.114222.4.11.1002/36044-6.json |
| 36045-3 | MR Larynx | ./2.16.840.1.114222.4.11.1002/36045-3.json |
| 3604-6 | Etamivan [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3604-6.json |
| 36046-1 | MR Liver | ./2.16.840.1.114222.4.11.1002/36046-1.json |
| 36047-9 | CT Mandible | ./2.16.840.1.114222.4.11.1002/36047-9.json |
| 36048-7 | XR tomography Mandible | ./2.16.840.1.114222.4.11.1002/36048-7.json |
| 36049-5 | CT Maxilla and Mandible | ./2.16.840.1.114222.4.11.1002/36049-5.json |
| 36050-3 | CT Maxilla | ./2.16.840.1.114222.4.11.1002/36050-3.json |
| 36051-1 | CT Neck | ./2.16.840.1.114222.4.11.1002/36051-1.json |
| 36052-9 | MR Pancreas | ./2.16.840.1.114222.4.11.1002/36052-9.json |
| 3605-3 | Ethacrynate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3605-3.json |
| 36053-7 | MR Parathyroid gland | ./2.16.840.1.114222.4.11.1002/36053-7.json |
| 36054-5 | CT Brachial plexus | ./2.16.840.1.114222.4.11.1002/36054-5.json |
| 36055-2 | CT Posterior fossa | ./2.16.840.1.114222.4.11.1002/36055-2.json |
| 36056-0 | MR Posterior fossa | ./2.16.840.1.114222.4.11.1002/36056-0.json |
| 36057-8 | CT Prostate | ./2.16.840.1.114222.4.11.1002/36057-8.json |
| 36058-6 | CT Sacrum | ./2.16.840.1.114222.4.11.1002/36058-6.json |
| 36059-4 | MR Sacrum | ./2.16.840.1.114222.4.11.1002/36059-4.json |
| 36060-2 | MR Sacrum and Coccyx | ./2.16.840.1.114222.4.11.1002/36060-2.json |
| 3606-1 | Ethacrynate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3606-1.json |
| 36061-0 | MR Scapula | ./2.16.840.1.114222.4.11.1002/36061-0.json |
| 36062-8 | CT Shoulder | ./2.16.840.1.114222.4.11.1002/36062-8.json |
| 36063-6 | CT Shoulder - bilateral | ./2.16.840.1.114222.4.11.1002/36063-6.json |
| 36064-4 | CT Shoulder - left | ./2.16.840.1.114222.4.11.1002/36064-4.json |
| 36065-1 | XR tomography Shoulder - left | ./2.16.840.1.114222.4.11.1002/36065-1.json |
| 36066-9 | CT Shoulder - right | ./2.16.840.1.114222.4.11.1002/36066-9.json |
| 36067-7 | MR Spine | ./2.16.840.1.114222.4.11.1002/36067-7.json |
| 36068-5 | XR tomography Cervical spine | ./2.16.840.1.114222.4.11.1002/36068-5.json |
| 36069-3 | XR tomography Lumbar spine | ./2.16.840.1.114222.4.11.1002/36069-3.json |
| 36070-1 | MR Spleen | ./2.16.840.1.114222.4.11.1002/36070-1.json |
| 36071-9 | CT Sternum | ./2.16.840.1.114222.4.11.1002/36071-9.json |
| 36072-7 | MR Sternum | ./2.16.840.1.114222.4.11.1002/36072-7.json |
| 36073-5 | MR Scrotum and testicle | ./2.16.840.1.114222.4.11.1002/36073-5.json |
| 36074-3 | CT Lower leg | ./2.16.840.1.114222.4.11.1002/36074-3.json |
| 36075-0 | MR Lower leg - left | ./2.16.840.1.114222.4.11.1002/36075-0.json |
| 36076-8 | MR Lower leg - right | ./2.16.840.1.114222.4.11.1002/36076-8.json |
| 36077-6 | MRA Portal vein | ./2.16.840.1.114222.4.11.1002/36077-6.json |
| 36078-4 | MRA Renal vein | ./2.16.840.1.114222.4.11.1002/36078-4.json |
| 3607-9 | Ethambutol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3607-9.json |
| 36079-2 | MRA Lower extremity veins | ./2.16.840.1.114222.4.11.1002/36079-2.json |
| 36080-0 | MRA Upper extremity veins | ./2.16.840.1.114222.4.11.1002/36080-0.json |
| 36081-8 | MRA Vena cava | ./2.16.840.1.114222.4.11.1002/36081-8.json |
| 36082-6 | MRA Inferior vena cava | ./2.16.840.1.114222.4.11.1002/36082-6.json |
| 36083-4 | MR Inferior vena cava | ./2.16.840.1.114222.4.11.1002/36083-4.json |
| 36084-2 | MRA Upper extremity vessels | ./2.16.840.1.114222.4.11.1002/36084-2.json |
| 36085-9 | MRA Neck vessels | ./2.16.840.1.114222.4.11.1002/36085-9.json |
| 36086-7 | CT Abdomen limited | ./2.16.840.1.114222.4.11.1002/36086-7.json |
| 3608-7 | Ethchlorvynol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3608-7.json |
| 36087-5 | CT Head limited | ./2.16.840.1.114222.4.11.1002/36087-5.json |
| 36088-3 | MR Internal auditory canal limited | ./2.16.840.1.114222.4.11.1002/36088-3.json |
| 36089-1 | CT Chest limited | ./2.16.840.1.114222.4.11.1002/36089-1.json |
| 36090-9 | CT Extremity limited | ./2.16.840.1.114222.4.11.1002/36090-9.json |
| 36091-7 | MR Heart limited | ./2.16.840.1.114222.4.11.1002/36091-7.json |
| 36092-5 | CT Hip limited | ./2.16.840.1.114222.4.11.1002/36092-5.json |
| 36093-3 | MR Lower Extremity Joint limited | ./2.16.840.1.114222.4.11.1002/36093-3.json |
| 36094-1 | MR Upper extremity.joint limited | ./2.16.840.1.114222.4.11.1002/36094-1.json |
| 3609-5 | Ethchlorvynol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3609-5.json |
| 36095-8 | CT Abdomen limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36095-8.json |
| 36096-6 | MR Brain limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36096-6.json |
| 36097-4 | CT Upper extremity limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36097-4.json |
| 36098-2 | CT Pelvis limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36098-2.json |
| 36099-0 | CT Cervical spine limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36099-0.json |
| 36100-6 | MR Lumbar spine limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36100-6.json |
| 36101-4 | MR Thoracic spine limited W contrast IV | ./2.16.840.1.114222.4.11.1002/36101-4.json |
| 36102-2 | CT Abdomen limited WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36102-2.json |
| 3610-3 | Ethchlorvynol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3610-3.json |
| 36103-0 | CT Abdomen limited WO contrast | ./2.16.840.1.114222.4.11.1002/36103-0.json |
| 36104-8 | CT Head limited WO contrast | ./2.16.840.1.114222.4.11.1002/36104-8.json |
| 36105-5 | MR Brain limited WO contrast | ./2.16.840.1.114222.4.11.1002/36105-5.json |
| 36106-3 | CT Lower extremity limited WO contrast | ./2.16.840.1.114222.4.11.1002/36106-3.json |
| 36107-1 | MR Lower extremity joint - left limited WO contrast | ./2.16.840.1.114222.4.11.1002/36107-1.json |
| 36108-9 | CT Pelvis limited WO contrast | ./2.16.840.1.114222.4.11.1002/36108-9.json |
| 36109-7 | CT Cervical spine limited WO contrast | ./2.16.840.1.114222.4.11.1002/36109-7.json |
| 36110-5 | CT Lumbar spine limited WO contrast | ./2.16.840.1.114222.4.11.1002/36110-5.json |
| 3611-1 | Ethchlorvynol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3611-1.json |
| 36111-3 | MR Lumbar spine limited WO contrast | ./2.16.840.1.114222.4.11.1002/36111-3.json |
| 36112-1 | MR Thoracic spine limited WO contrast | ./2.16.840.1.114222.4.11.1002/36112-1.json |
| 36113-9 | MR Kidney W contrast IV | ./2.16.840.1.114222.4.11.1002/36113-9.json |
| 36114-7 | MR Breast - bilateral dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/36114-7.json |
| 36115-4 | MR Ankle Arthrogram | ./2.16.840.1.114222.4.11.1002/36115-4.json |
| 36116-2 | MR Ankle - left Arthrogram | ./2.16.840.1.114222.4.11.1002/36116-2.json |
| 36117-0 | MR Ankle - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36117-0.json |
| 36118-8 | MR Elbow - left Arthrogram | ./2.16.840.1.114222.4.11.1002/36118-8.json |
| 36119-6 | MR Elbow - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36119-6.json |
| 36120-4 | MR Hip Arthrogram | ./2.16.840.1.114222.4.11.1002/36120-4.json |
| 36121-2 | MR Hip - left Arthrogram | ./2.16.840.1.114222.4.11.1002/36121-2.json |
| 36122-0 | MR Hip - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36122-0.json |
| 36123-8 | CT Sacroiliac Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/36123-8.json |
| 36124-6 | CT Knee Arthrogram | ./2.16.840.1.114222.4.11.1002/36124-6.json |
| 36125-3 | MR Knee Arthrogram | ./2.16.840.1.114222.4.11.1002/36125-3.json |
| 36126-1 | MR Knee - left Arthrogram | ./2.16.840.1.114222.4.11.1002/36126-1.json |
| 36127-9 | MR Knee - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36127-9.json |
| 36128-7 | CT Shoulder Arthrogram | ./2.16.840.1.114222.4.11.1002/36128-7.json |
| 3612-9 | Ethchlorvynol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3612-9.json |
| 36129-5 | MR Shoulder Arthrogram | ./2.16.840.1.114222.4.11.1002/36129-5.json |
| 36130-3 | MR Shoulder - left Arthrogram | ./2.16.840.1.114222.4.11.1002/36130-3.json |
| 36131-1 | CT Shoulder - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36131-1.json |
| 36132-9 | MR Shoulder - right Arthrogram | ./2.16.840.1.114222.4.11.1002/36132-9.json |
| 36134-5 | MR Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/36134-5.json |
| 36135-2 | CT Ankle W contrast IV | ./2.16.840.1.114222.4.11.1002/36135-2.json |
| 36136-0 | MR Ankle W contrast IV | ./2.16.840.1.114222.4.11.1002/36136-0.json |
| 3613-7 | Ethoheptazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3613-7.json |
| 36137-8 | CT Ankle - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36137-8.json |
| 36138-6 | MR Ankle - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36138-6.json |
| 36139-4 | CT Ankle - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36139-4.json |
| 36140-2 | MR Ankle - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36140-2.json |
| 36141-0 | CTA Thoracic and abdominal aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/36141-0.json |
| 36142-8 | CT Thoracic and abdominal aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/36142-8.json |
| 36143-6 | CT Abdominal Aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/36143-6.json |
| 36144-4 | CTA Aortic arch W contrast IV | ./2.16.840.1.114222.4.11.1002/36144-4.json |
| 3614-5 | Ethoheptazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3614-5.json |
| 36145-1 | CT Appendix W contrast IV | ./2.16.840.1.114222.4.11.1002/36145-1.json |
| 36146-9 | CTA Carotid artery W contrast IV | ./2.16.840.1.114222.4.11.1002/36146-9.json |
| 36147-7 | CTA Pulmonary arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/36147-7.json |
| 36148-5 | MR Face W contrast IV | ./2.16.840.1.114222.4.11.1002/36148-5.json |
| 36149-3 | MR Breast W contrast IV | ./2.16.840.1.114222.4.11.1002/36149-3.json |
| 36150-1 | MR Breast - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36150-1.json |
| 36151-9 | MR Breast - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36151-9.json |
| 3615-2 | Ethoheptazine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3615-2.json |
| 36152-7 | MR Breast - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36152-7.json |
| 36155-0 | MR Internal auditory canal W contrast IV | ./2.16.840.1.114222.4.11.1002/36155-0.json |
| 36156-8 | MR Chest W contrast IV | ./2.16.840.1.114222.4.11.1002/36156-8.json |
| 36157-6 | CT Elbow W contrast IV | ./2.16.840.1.114222.4.11.1002/36157-6.json |
| 36158-4 | MR Elbow W contrast IV | ./2.16.840.1.114222.4.11.1002/36158-4.json |
| 36159-2 | CT Elbow - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36159-2.json |
| 3616-0 | Ethosuximide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3616-0.json |
| 36160-0 | MR Elbow - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36160-0.json |
| 36161-8 | CT Elbow - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36161-8.json |
| 36162-6 | MR Elbow - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36162-6.json |
| 36163-4 | MR Lower extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36163-4.json |
| 36164-2 | CT Lower extremity - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36164-2.json |
| 36165-9 | MR Lower extremity - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36165-9.json |
| 36166-7 | CT Lower extremity - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36166-7.json |
| 36167-5 | MR Lower extremity - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36167-5.json |
| 36168-3 | CT Upper extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36168-3.json |
| 36169-1 | CT Upper extremity - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36169-1.json |
| 36170-9 | CT Upper extremity - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36170-9.json |
| 36171-7 | MR Upper extremity - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36171-7.json |
| 36172-5 | CT Thigh W contrast IV | ./2.16.840.1.114222.4.11.1002/36172-5.json |
| 36173-3 | MR Thigh W contrast IV | ./2.16.840.1.114222.4.11.1002/36173-3.json |
| 36174-1 | CT Thigh - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36174-1.json |
| 36175-8 | MR Thigh - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36175-8.json |
| 36176-6 | CT Thigh - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36176-6.json |
| 36177-4 | MR Thigh - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36177-4.json |
| 3617-8 | Ethotoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3617-8.json |
| 36178-2 | CT Foot W contrast IV | ./2.16.840.1.114222.4.11.1002/36178-2.json |
| 36179-0 | MR Foot W contrast IV | ./2.16.840.1.114222.4.11.1002/36179-0.json |
| 36180-8 | MR Foot - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36180-8.json |
| 36181-6 | CT Foot - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36181-6.json |
| 36182-4 | MR Foot - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36182-4.json |
| 36183-2 | CT Foot - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36183-2.json |
| 36184-0 | MR Foot - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36184-0.json |
| 36185-7 | CT Forearm W contrast IV | ./2.16.840.1.114222.4.11.1002/36185-7.json |
| 3618-6 | Ethylmorphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3618-6.json |
| 36186-5 | MR Forearm W contrast IV | ./2.16.840.1.114222.4.11.1002/36186-5.json |
| 36187-3 | CT Forearm - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36187-3.json |
| 36188-1 | MR Forearm - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36188-1.json |
| 36189-9 | CT Forearm - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36189-9.json |
| 36190-7 | MR Forearm - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36190-7.json |
| 36191-5 | CT Hand W contrast IV | ./2.16.840.1.114222.4.11.1002/36191-5.json |
| 36192-3 | MR Hand W contrast IV | ./2.16.840.1.114222.4.11.1002/36192-3.json |
| 36193-1 | CT Hand - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36193-1.json |
| 3619-4 | Ethylmorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3619-4.json |
| 36194-9 | MR Hand - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36194-9.json |
| 36195-6 | CT Hand - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36195-6.json |
| 36196-4 | MR Hand - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36196-4.json |
| 36197-2 | MR Heart W contrast IV | ./2.16.840.1.114222.4.11.1002/36197-2.json |
| 36199-8 | MR Hip W contrast IV | ./2.16.840.1.114222.4.11.1002/36199-8.json |
| 36200-4 | CT Hip W contrast IV | ./2.16.840.1.114222.4.11.1002/36200-4.json |
| 36201-2 | CT Hip - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36201-2.json |
| 3620-2 | N-ethylnicotinamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3620-2.json |
| 36202-0 | MR Hip - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36202-0.json |
| 36203-8 | CT Hip - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36203-8.json |
| 36204-6 | MR Hip - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36204-6.json |
| 36205-3 | CT Hip - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36205-3.json |
| 36206-1 | MR Hip - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36206-1.json |
| 36207-9 | CT Upper arm W contrast IV | ./2.16.840.1.114222.4.11.1002/36207-9.json |
| 36208-7 | MR Upper arm W contrast IV | ./2.16.840.1.114222.4.11.1002/36208-7.json |
| 36209-5 | CT Upper arm - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36209-5.json |
| 3621-0 | Etilefrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3621-0.json |
| 36210-3 | MR Upper arm - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36210-3.json |
| 36211-1 | CT Upper arm - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36211-1.json |
| 36212-9 | MR Upper arm - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36212-9.json |
| 36213-7 | MR Lower Extremity Joint W contrast IV | ./2.16.840.1.114222.4.11.1002/36213-7.json |
| 36214-5 | MR Lower extremity joint - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36214-5.json |
| 36215-2 | MR Lower extremity joint - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36215-2.json |
| 36216-0 | MR Upper extremity.joint W contrast IV | ./2.16.840.1.114222.4.11.1002/36216-0.json |
| 36217-8 | CT Sacroiliac Joint W contrast IV | ./2.16.840.1.114222.4.11.1002/36217-8.json |
| 36218-6 | MR Sacroiliac Joint W contrast IV | ./2.16.840.1.114222.4.11.1002/36218-6.json |
| 36219-4 | MR Kidney - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36219-4.json |
| 36220-2 | MR Kidney - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36220-2.json |
| 36221-0 | MR Kidney - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36221-0.json |
| 36222-8 | CT Knee W contrast IV | ./2.16.840.1.114222.4.11.1002/36222-8.json |
| 36223-6 | MR Knee W contrast IV | ./2.16.840.1.114222.4.11.1002/36223-6.json |
| 36224-4 | MR Knee - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36224-4.json |
| 36225-1 | CT Knee - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36225-1.json |
| 36226-9 | MR Knee - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36226-9.json |
| 36227-7 | CT Knee - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36227-7.json |
| 3622-8 | Etilefrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3622-8.json |
| 36228-5 | MR Knee - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36228-5.json |
| 36229-3 | CT Larynx W contrast IV | ./2.16.840.1.114222.4.11.1002/36229-3.json |
| 36230-1 | MR Larynx W contrast IV | ./2.16.840.1.114222.4.11.1002/36230-1.json |
| 36231-9 | MR Liver W contrast IV | ./2.16.840.1.114222.4.11.1002/36231-9.json |
| 36232-7 | CT Mandible W contrast IV | ./2.16.840.1.114222.4.11.1002/36232-7.json |
| 36233-5 | MR Nasopharynx W contrast IV | ./2.16.840.1.114222.4.11.1002/36233-5.json |
| 36234-3 | CTA Neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36234-3.json |
| 36235-0 | CT Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/36235-0.json |
| 3623-6 | Etilefrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3623-6.json |
| 36236-8 | MR Pancreas W contrast IV | ./2.16.840.1.114222.4.11.1002/36236-8.json |
| 36237-6 | MR Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/36237-6.json |
| 36238-4 | MR Pituitary and Sella turcica W contrast IV | ./2.16.840.1.114222.4.11.1002/36238-4.json |
| 36239-2 | MR Brachial plexus W contrast IV | ./2.16.840.1.114222.4.11.1002/36239-2.json |
| 36240-0 | MR Brachial plexus - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36240-0.json |
| 36241-8 | MR Brachial plexus - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36241-8.json |
| 36242-6 | CT Posterior fossa W contrast IV | ./2.16.840.1.114222.4.11.1002/36242-6.json |
| 36243-4 | MR Posterior fossa W contrast IV | ./2.16.840.1.114222.4.11.1002/36243-4.json |
| 3624-4 | Fencamfamin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3624-4.json |
| 36244-2 | MR Prostate W contrast IV | ./2.16.840.1.114222.4.11.1002/36244-2.json |
| 36245-9 | CT Sacrum W contrast IV | ./2.16.840.1.114222.4.11.1002/36245-9.json |
| 36246-7 | MR Sacrum W contrast IV | ./2.16.840.1.114222.4.11.1002/36246-7.json |
| 36247-5 | MR Sacrum and Coccyx W contrast IV | ./2.16.840.1.114222.4.11.1002/36247-5.json |
| 36248-3 | MR Scapula - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36248-3.json |
| 36249-1 | MR Scapula - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36249-1.json |
| 36250-9 | CT Shoulder W contrast IV | ./2.16.840.1.114222.4.11.1002/36250-9.json |
| 3625-1 | Fencamfamin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3625-1.json |
| 36251-7 | MR Shoulder W contrast IV | ./2.16.840.1.114222.4.11.1002/36251-7.json |
| 36252-5 | CT Shoulder - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36252-5.json |
| 36253-3 | CT Shoulder - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36253-3.json |
| 36254-1 | MR Shoulder - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36254-1.json |
| 36255-8 | CT Sinuses W contrast IV | ./2.16.840.1.114222.4.11.1002/36255-8.json |
| 36256-6 | MR Spine W contrast IV | ./2.16.840.1.114222.4.11.1002/36256-6.json |
| 36257-4 | CT Sternum W contrast IV | ./2.16.840.1.114222.4.11.1002/36257-4.json |
| 36258-2 | CT Lower leg W contrast IV | ./2.16.840.1.114222.4.11.1002/36258-2.json |
| 36259-0 | MR Lower leg W contrast IV | ./2.16.840.1.114222.4.11.1002/36259-0.json |
| 36260-8 | CT Lower leg - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36260-8.json |
| 36261-6 | MR Lower leg - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36261-6.json |
| 36262-4 | CT Lower leg - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36262-4.json |
| 36263-2 | MR Lower leg - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36263-2.json |
| 36264-0 | CT Uterus W contrast IV | ./2.16.840.1.114222.4.11.1002/36264-0.json |
| 36265-7 | MR Uterus W contrast IV | ./2.16.840.1.114222.4.11.1002/36265-7.json |
| 36266-5 | CTA Chest vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36266-5.json |
| 36267-3 | CT Abdomen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36267-3.json |
| 36268-1 | CT Ankle WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36268-1.json |
| 3626-9 | Fencamfamin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3626-9.json |
| 36269-9 | CT Ankle - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36269-9.json |
| 36270-7 | CT Ankle - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36270-7.json |
| 36271-5 | CT Abdominal Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36271-5.json |
| 36272-3 | MRA Abdominal Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36272-3.json |
| 36273-1 | MR Abdominal Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36273-1.json |
| 36274-9 | MRA Thoracic Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36274-9.json |
| 36275-6 | MRA Renal artery WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36275-6.json |
| 36276-4 | MR Breast WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36276-4.json |
| 3627-7 | Fenetylline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3627-7.json |
| 36277-2 | MR Breast - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36277-2.json |
| 36278-0 | MR Breast - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36278-0.json |
| 36279-8 | MR Breast - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36279-8.json |
| 36282-2 | CT Internal auditory canal WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36282-2.json |
| 36283-0 | MR Chest WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36283-0.json |
| 36284-8 | MR Chest and Abdomen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36284-8.json |
| 3628-5 | Fenetylline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3628-5.json |
| 36285-5 | CT Elbow WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36285-5.json |
| 36286-3 | CT Elbow - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36286-3.json |
| 36287-1 | CT Elbow - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36287-1.json |
| 36288-9 | CT Lower extremity WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36288-9.json |
| 36289-7 | MR Lower extremity - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36289-7.json |
| 36290-5 | CT Lower extremity - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36290-5.json |
| 36291-3 | MR Lower extremity - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36291-3.json |
| 36292-1 | CT Lower extremity - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36292-1.json |
| 3629-3 | Fenetylline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3629-3.json |
| 36293-9 | XR Abdomen 3 Views | ./2.16.840.1.114222.4.11.1002/36293-9.json |
| 36294-7 | XR Ankle 3 Views | ./2.16.840.1.114222.4.11.1002/36294-7.json |
| 36295-4 | XR Ankle - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36295-4.json |
| 36296-2 | XR Ankle - left 3 Views | ./2.16.840.1.114222.4.11.1002/36296-2.json |
| 36297-0 | XR Facial bones 3 Views | ./2.16.840.1.114222.4.11.1002/36297-0.json |
| 36298-8 | XR Chest 3 Views | ./2.16.840.1.114222.4.11.1002/36298-8.json |
| 36299-6 | XR Elbow 3 Views | ./2.16.840.1.114222.4.11.1002/36299-6.json |
| 36300-2 | XR Elbow - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36300-2.json |
| 3630-1 | Fenfluramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3630-1.json |
| 36301-0 | XR Elbow - left 3 Views | ./2.16.840.1.114222.4.11.1002/36301-0.json |
| 36302-8 | XR Femur 3 Views | ./2.16.840.1.114222.4.11.1002/36302-8.json |
| 36303-6 | XR Finger 3 Views | ./2.16.840.1.114222.4.11.1002/36303-6.json |
| 36304-4 | XR Finger - left 3 Views | ./2.16.840.1.114222.4.11.1002/36304-4.json |
| 36305-1 | XR Foot 3 Views | ./2.16.840.1.114222.4.11.1002/36305-1.json |
| 36306-9 | XR Foot - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36306-9.json |
| 36307-7 | XR Foot - left 3 Views | ./2.16.840.1.114222.4.11.1002/36307-7.json |
| 36308-5 | XR Hip - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36308-5.json |
| 36309-3 | XR Hip - left 3 Views | ./2.16.840.1.114222.4.11.1002/36309-3.json |
| 36310-1 | XR Knee - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36310-1.json |
| 36311-9 | XR Knee - left 3 Views | ./2.16.840.1.114222.4.11.1002/36311-9.json |
| 36312-7 | XR Mandible 3 Views | ./2.16.840.1.114222.4.11.1002/36312-7.json |
| 36313-5 | XR Ribs - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/36313-5.json |
| 36314-3 | XR Ribs - left 3 Views | ./2.16.840.1.114222.4.11.1002/36314-3.json |
| 36315-0 | XR Thumb - left 3 Views | ./2.16.840.1.114222.4.11.1002/36315-0.json |
| 36316-8 | XR Toes - left 3 Views | ./2.16.840.1.114222.4.11.1002/36316-8.json |
| 36317-6 | XR Ankle 4 Views | ./2.16.840.1.114222.4.11.1002/36317-6.json |
| 36318-4 | XR Facial bones 4 Views | ./2.16.840.1.114222.4.11.1002/36318-4.json |
| 3631-9 | Fenfluramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3631-9.json |
| 36319-2 | MG Breast 4 Views | ./2.16.840.1.114222.4.11.1002/36319-2.json |
| 36320-0 | XR Chest 4 Views | ./2.16.840.1.114222.4.11.1002/36320-0.json |
| 36321-8 | XR and RF Chest 4 Views and Views | ./2.16.840.1.114222.4.11.1002/36321-8.json |
| 36322-6 | XR Elbow - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/36322-6.json |
| 36323-4 | XR Elbow - left 4 Views | ./2.16.840.1.114222.4.11.1002/36323-4.json |
| 36324-2 | XR Femur - left 4 Views | ./2.16.840.1.114222.4.11.1002/36324-2.json |
| 36325-9 | XR Knee - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/36325-9.json |
| 36326-7 | XR Knee - left 4 Views | ./2.16.840.1.114222.4.11.1002/36326-7.json |
| 3632-7 | Fenoprofen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3632-7.json |
| 36327-5 | XR Mandible 4 Views | ./2.16.840.1.114222.4.11.1002/36327-5.json |
| 36328-3 | XR Ribs - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/36328-3.json |
| 36329-1 | XR Shoulder - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/36329-1.json |
| 36330-9 | XR Shoulder - left 4 Views | ./2.16.840.1.114222.4.11.1002/36330-9.json |
| 36331-7 | XR Cervical spine 4 Views | ./2.16.840.1.114222.4.11.1002/36331-7.json |
| 36332-5 | XR Lumbar spine 4 Views | ./2.16.840.1.114222.4.11.1002/36332-5.json |
| 36333-3 | MR Lower extremity - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36333-3.json |
| 36334-1 | CT Upper extremity WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36334-1.json |
| 3633-5 | Fenproporex [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3633-5.json |
| 36335-8 | CT Upper extremity - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36335-8.json |
| 36336-6 | CT Upper extremity - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36336-6.json |
| 36337-4 | MR Upper extremity - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36337-4.json |
| 36338-2 | CT Thigh WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36338-2.json |
| 36339-0 | CT Thigh - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36339-0.json |
| 36340-8 | CT Thigh - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36340-8.json |
| 36341-6 | CT Foot WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36341-6.json |
| 36342-4 | MR Foot - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36342-4.json |
| 3634-3 | Fenproporex [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3634-3.json |
| 36343-2 | CT Foot - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36343-2.json |
| 36344-0 | MR Foot - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36344-0.json |
| 36345-7 | CT Foot - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36345-7.json |
| 36346-5 | MR Foot - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36346-5.json |
| 36347-3 | CT Forearm WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36347-3.json |
| 36348-1 | CT Forearm - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36348-1.json |
| 36349-9 | MR Forearm - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36349-9.json |
| 3635-0 | Fenproporex [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3635-0.json |
| 36350-7 | CT Forearm - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36350-7.json |
| 36351-5 | MR Forearm - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36351-5.json |
| 36352-3 | CT Hand WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36352-3.json |
| 36353-1 | CT Hand - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36353-1.json |
| 36354-9 | MR Hand - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36354-9.json |
| 36355-6 | CT Hand - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36355-6.json |
| 36356-4 | MR Hand - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36356-4.json |
| 36357-2 | MR Heart WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36357-2.json |
| 36359-8 | CT Hip WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36359-8.json |
| 36360-6 | CT Hip - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36360-6.json |
| 36361-4 | MR Hip - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36361-4.json |
| 36362-2 | CT Hip - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36362-2.json |
| 36363-0 | MR Hip - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36363-0.json |
| 36364-8 | CT Hip - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36364-8.json |
| 36365-5 | MR Hip - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36365-5.json |
| 36366-3 | CT Upper arm WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36366-3.json |
| 36367-1 | CT Upper arm - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36367-1.json |
| 3636-8 | fentaNYL [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3636-8.json |
| 36368-9 | MR Upper arm - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36368-9.json |
| 36369-7 | CT Upper arm - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36369-7.json |
| 36370-5 | MR Upper arm - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36370-5.json |
| 36371-3 | MR Lower Extremity Joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36371-3.json |
| 36372-1 | MR Lower extremity joint - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36372-1.json |
| 36373-9 | MR Lower extremity joint - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36373-9.json |
| 36374-7 | MR Upper extremity.joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36374-7.json |
| 36375-4 | CT Sacroiliac Joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36375-4.json |
| 3637-6 | fentaNYL [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3637-6.json |
| 36376-2 | MR Sacroiliac Joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36376-2.json |
| 36377-0 | CT Kidney - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36377-0.json |
| 36378-8 | MR Kidney - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36378-8.json |
| 36379-6 | CT Knee WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36379-6.json |
| 36380-4 | CT Knee - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36380-4.json |
| 36381-2 | CT Knee - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36381-2.json |
| 36382-0 | MR Larynx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36382-0.json |
| 36383-8 | CT Mandible WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36383-8.json |
| 3638-4 | Flecainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3638-4.json |
| 36384-6 | MR Nasopharynx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36384-6.json |
| 36385-3 | MR Pancreas WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36385-3.json |
| 36387-9 | CT Posterior fossa WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36387-9.json |
| 36388-7 | MR Posterior fossa WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36388-7.json |
| 36389-5 | MR Prostate WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36389-5.json |
| 36390-3 | CT Sacrum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36390-3.json |
| 36391-1 | MR Sacrum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36391-1.json |
| 3639-2 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3639-2.json |
| 36392-9 | MR Sacrum and Coccyx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36392-9.json |
| 36393-7 | MR Scapula - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36393-7.json |
| 36394-5 | MR Scapula - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36394-5.json |
| 36395-2 | CT Shoulder WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36395-2.json |
| 36396-0 | CT Shoulder - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36396-0.json |
| 36397-8 | CT Shoulder - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36397-8.json |
| 36398-6 | CT Sinuses WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36398-6.json |
| 36399-4 | CT Spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36399-4.json |
| 3640-0 | Flunitrazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3640-0.json |
| 36400-0 | MR Spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36400-0.json |
| 36401-8 | CT Cervical spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36401-8.json |
| 36402-6 | CT Lumbar spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36402-6.json |
| 36403-4 | CT Thoracic spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36403-4.json |
| 36404-2 | MR Spleen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36404-2.json |
| 36405-9 | CT Sternum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36405-9.json |
| 36406-7 | MR Scrotum and testicle WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36406-7.json |
| 36407-5 | MR Thyroid gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36407-5.json |
| 36408-3 | CT Lower leg WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36408-3.json |
| 36409-1 | CT Lower leg - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36409-1.json |
| 36410-9 | MR Lower leg - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36410-9.json |
| 36411-7 | CT Lower leg - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36411-7.json |
| 36412-5 | MR Lower leg - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36412-5.json |
| 36413-3 | MR Uterus WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36413-3.json |
| 36414-1 | MRA Portal vein WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36414-1.json |
| 36415-8 | MRA Renal vein WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36415-8.json |
| 36416-6 | MRA Lower extremity veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36416-6.json |
| 36417-4 | MRA Upper extremity veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36417-4.json |
| 3641-8 | Flunitrazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3641-8.json |
| 36418-2 | MR Inferior vena cava WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36418-2.json |
| 36419-0 | MR Superior vena cava WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36419-0.json |
| 36420-8 | MRA Chest vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36420-8.json |
| 36421-6 | CTA Upper extremity vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36421-6.json |
| 36422-4 | MRA Upper extremity vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36422-4.json |
| 36423-2 | MRA Neck vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36423-2.json |
| 36424-0 | CT Abdomen WO contrast | ./2.16.840.1.114222.4.11.1002/36424-0.json |
| 36425-7 | CT Ankle WO contrast | ./2.16.840.1.114222.4.11.1002/36425-7.json |
| 3642-6 | Fluorouracil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3642-6.json |
| 36426-5 | CT Ankle - left WO contrast | ./2.16.840.1.114222.4.11.1002/36426-5.json |
| 36427-3 | MR Ankle - left WO contrast | ./2.16.840.1.114222.4.11.1002/36427-3.json |
| 36428-1 | CT Ankle - right WO contrast | ./2.16.840.1.114222.4.11.1002/36428-1.json |
| 36429-9 | MR Ankle - right WO contrast | ./2.16.840.1.114222.4.11.1002/36429-9.json |
| 36430-7 | CT Thoracic and abdominal aorta WO contrast | ./2.16.840.1.114222.4.11.1002/36430-7.json |
| 36431-5 | CT Abdominal Aorta WO contrast | ./2.16.840.1.114222.4.11.1002/36431-5.json |
| 36432-3 | MRA Abdominal Aorta WO contrast | ./2.16.840.1.114222.4.11.1002/36432-3.json |
| 36433-1 | MRA Thoracic Aorta WO contrast | ./2.16.840.1.114222.4.11.1002/36433-1.json |
| 3643-4 | FLUoxetine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3643-4.json |
| 36434-9 | CT Appendix WO contrast | ./2.16.840.1.114222.4.11.1002/36434-9.json |
| 36435-6 | MR Face WO contrast | ./2.16.840.1.114222.4.11.1002/36435-6.json |
| 36436-4 | MR Breast WO contrast | ./2.16.840.1.114222.4.11.1002/36436-4.json |
| 36437-2 | MR Breast - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36437-2.json |
| 36438-0 | MR Breast - left WO contrast | ./2.16.840.1.114222.4.11.1002/36438-0.json |
| 36439-8 | MR Breast - right WO contrast | ./2.16.840.1.114222.4.11.1002/36439-8.json |
| 3644-2 | FLUoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3644-2.json |
| 36442-2 | MR Chest WO contrast | ./2.16.840.1.114222.4.11.1002/36442-2.json |
| 36443-0 | CT Elbow WO contrast | ./2.16.840.1.114222.4.11.1002/36443-0.json |
| 36444-8 | CT Elbow - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36444-8.json |
| 36445-5 | CT Elbow - left WO contrast | ./2.16.840.1.114222.4.11.1002/36445-5.json |
| 36446-3 | MR Elbow - left WO contrast | ./2.16.840.1.114222.4.11.1002/36446-3.json |
| 36447-1 | CT Elbow - right WO contrast | ./2.16.840.1.114222.4.11.1002/36447-1.json |
| 36448-9 | MR Elbow - right WO contrast | ./2.16.840.1.114222.4.11.1002/36448-9.json |
| 36449-7 | CT Lower extremity - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36449-7.json |
| 36450-5 | MRA Lower extremity vessels - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36450-5.json |
| 36451-3 | MR Lower extremity - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36451-3.json |
| 36452-1 | CT Lower extremity - left WO contrast | ./2.16.840.1.114222.4.11.1002/36452-1.json |
| 36453-9 | MR Lower extremity - left WO contrast | ./2.16.840.1.114222.4.11.1002/36453-9.json |
| 36454-7 | CT Lower extremity - right WO contrast | ./2.16.840.1.114222.4.11.1002/36454-7.json |
| 36455-4 | MR Lower extremity - right WO contrast | ./2.16.840.1.114222.4.11.1002/36455-4.json |
| 36456-2 | CT Upper extremity - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36456-2.json |
| 36457-0 | CT Upper extremity - left WO contrast | ./2.16.840.1.114222.4.11.1002/36457-0.json |
| 36458-8 | CT Upper extremity - right WO contrast | ./2.16.840.1.114222.4.11.1002/36458-8.json |
| 3645-9 | FLUoxetine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3645-9.json |
| 36459-6 | MR Upper extremity - right WO contrast | ./2.16.840.1.114222.4.11.1002/36459-6.json |
| 36460-4 | CT Thigh WO contrast | ./2.16.840.1.114222.4.11.1002/36460-4.json |
| 36461-2 | MR Thigh WO contrast | ./2.16.840.1.114222.4.11.1002/36461-2.json |
| 36462-0 | CT Thigh - left WO contrast | ./2.16.840.1.114222.4.11.1002/36462-0.json |
| 36463-8 | MR Thigh - left WO contrast | ./2.16.840.1.114222.4.11.1002/36463-8.json |
| 36464-6 | CT Thigh - right WO contrast | ./2.16.840.1.114222.4.11.1002/36464-6.json |
| 36465-3 | MR Thigh - right WO contrast | ./2.16.840.1.114222.4.11.1002/36465-3.json |
| 36466-1 | CT Foot WO contrast | ./2.16.840.1.114222.4.11.1002/36466-1.json |
| 3646-7 | Fluoxymesterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3646-7.json |
| 36467-9 | MR Foot - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36467-9.json |
| 36468-7 | CT Foot - left WO contrast | ./2.16.840.1.114222.4.11.1002/36468-7.json |
| 36469-5 | MR Foot - left WO contrast | ./2.16.840.1.114222.4.11.1002/36469-5.json |
| 36470-3 | CT Foot - right WO contrast | ./2.16.840.1.114222.4.11.1002/36470-3.json |
| 36471-1 | MR Foot - right WO contrast | ./2.16.840.1.114222.4.11.1002/36471-1.json |
| 36472-9 | CT Forearm WO contrast | ./2.16.840.1.114222.4.11.1002/36472-9.json |
| 36473-7 | CT Forearm - left WO contrast | ./2.16.840.1.114222.4.11.1002/36473-7.json |
| 36474-5 | MR Forearm - left WO contrast | ./2.16.840.1.114222.4.11.1002/36474-5.json |
| 3647-5 | Fluoxymesterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3647-5.json |
| 36475-2 | CT Forearm - right WO contrast | ./2.16.840.1.114222.4.11.1002/36475-2.json |
| 36476-0 | MR Forearm - right WO contrast | ./2.16.840.1.114222.4.11.1002/36476-0.json |
| 36477-8 | CT Hand WO contrast | ./2.16.840.1.114222.4.11.1002/36477-8.json |
| 36478-6 | CT Hand - left WO contrast | ./2.16.840.1.114222.4.11.1002/36478-6.json |
| 36479-4 | MR Hand - left WO contrast | ./2.16.840.1.114222.4.11.1002/36479-4.json |
| 36480-2 | CT Hand - right WO contrast | ./2.16.840.1.114222.4.11.1002/36480-2.json |
| 36481-0 | MR Hand - right WO contrast | ./2.16.840.1.114222.4.11.1002/36481-0.json |
| 36482-8 | MR Heart WO contrast | ./2.16.840.1.114222.4.11.1002/36482-8.json |
| 3648-3 | Fluoxymesterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3648-3.json |
| 36484-4 | CT Hip WO contrast | ./2.16.840.1.114222.4.11.1002/36484-4.json |
| 36485-1 | CT Hip - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36485-1.json |
| 36486-9 | MR Hip - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36486-9.json |
| 36487-7 | CT Hip - left WO contrast | ./2.16.840.1.114222.4.11.1002/36487-7.json |
| 36488-5 | MR Hip - left WO contrast | ./2.16.840.1.114222.4.11.1002/36488-5.json |
| 36489-3 | CT Hip - right WO contrast | ./2.16.840.1.114222.4.11.1002/36489-3.json |
| 36490-1 | MR Hip - right WO contrast | ./2.16.840.1.114222.4.11.1002/36490-1.json |
| 3649-1 | Flupenthixol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3649-1.json |
| 36491-9 | CT Upper arm WO contrast | ./2.16.840.1.114222.4.11.1002/36491-9.json |
| 36492-7 | CT Upper arm - left WO contrast | ./2.16.840.1.114222.4.11.1002/36492-7.json |
| 36493-5 | MR Upper arm - left WO contrast | ./2.16.840.1.114222.4.11.1002/36493-5.json |
| 36494-3 | CT Upper arm - right WO contrast | ./2.16.840.1.114222.4.11.1002/36494-3.json |
| 36495-0 | MR Upper arm - right WO contrast | ./2.16.840.1.114222.4.11.1002/36495-0.json |
| 36496-8 | MR Acromioclavicular Joint WO contrast | ./2.16.840.1.114222.4.11.1002/36496-8.json |
| 36497-6 | MR Lower Extremity Joint WO contrast | ./2.16.840.1.114222.4.11.1002/36497-6.json |
| 36498-4 | MR Lower extremity joint - left WO contrast | ./2.16.840.1.114222.4.11.1002/36498-4.json |
| 36499-2 | MR Lower extremity joint - right WO contrast | ./2.16.840.1.114222.4.11.1002/36499-2.json |
| 36500-7 | MR Upper extremity.joint WO contrast | ./2.16.840.1.114222.4.11.1002/36500-7.json |
| 36501-5 | CT Sacroiliac Joint WO contrast | ./2.16.840.1.114222.4.11.1002/36501-5.json |
| 36502-3 | MR Sacroiliac Joint WO contrast | ./2.16.840.1.114222.4.11.1002/36502-3.json |
| 36503-1 | CT Kidney - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36503-1.json |
| 36504-9 | MR Kidney - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36504-9.json |
| 36505-6 | CT Knee WO contrast | ./2.16.840.1.114222.4.11.1002/36505-6.json |
| 36506-4 | MR Knee - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36506-4.json |
| 36507-2 | CT Knee - left WO contrast | ./2.16.840.1.114222.4.11.1002/36507-2.json |
| 36508-0 | MR Knee - left WO contrast | ./2.16.840.1.114222.4.11.1002/36508-0.json |
| 3650-9 | fluPHENAZine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3650-9.json |
| 36509-8 | CT Knee - right WO contrast | ./2.16.840.1.114222.4.11.1002/36509-8.json |
| 36510-6 | MR Knee - right WO contrast | ./2.16.840.1.114222.4.11.1002/36510-6.json |
| 36511-4 | CT Larynx WO contrast | ./2.16.840.1.114222.4.11.1002/36511-4.json |
| 36512-2 | CT Mandible WO contrast | ./2.16.840.1.114222.4.11.1002/36512-2.json |
| 36513-0 | MR Nasopharynx WO contrast | ./2.16.840.1.114222.4.11.1002/36513-0.json |
| 36514-8 | CT Neck WO contrast | ./2.16.840.1.114222.4.11.1002/36514-8.json |
| 36515-5 | MR Pancreas WO contrast | ./2.16.840.1.114222.4.11.1002/36515-5.json |
| 36516-3 | MR Brachial plexus - right WO contrast | ./2.16.840.1.114222.4.11.1002/36516-3.json |
| 3651-7 | fluPHENAZine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3651-7.json |
| 36517-1 | CT Posterior fossa WO contrast | ./2.16.840.1.114222.4.11.1002/36517-1.json |
| 36518-9 | MR Posterior fossa WO contrast | ./2.16.840.1.114222.4.11.1002/36518-9.json |
| 36519-7 | MR Prostate WO contrast | ./2.16.840.1.114222.4.11.1002/36519-7.json |
| 36520-5 | CT Sacrum WO contrast | ./2.16.840.1.114222.4.11.1002/36520-5.json |
| 36521-3 | MR Sacrum WO contrast | ./2.16.840.1.114222.4.11.1002/36521-3.json |
| 36522-1 | MR Sacrum and Coccyx WO contrast | ./2.16.840.1.114222.4.11.1002/36522-1.json |
| 36523-9 | MR Scapula - left WO contrast | ./2.16.840.1.114222.4.11.1002/36523-9.json |
| 36524-7 | CT Shoulder WO contrast | ./2.16.840.1.114222.4.11.1002/36524-7.json |
| 3652-5 | Flurazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3652-5.json |
| 36525-4 | MR Shoulder - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/36525-4.json |
| 36526-2 | CT Shoulder - left WO contrast | ./2.16.840.1.114222.4.11.1002/36526-2.json |
| 36527-0 | CT Shoulder - right WO contrast | ./2.16.840.1.114222.4.11.1002/36527-0.json |
| 36528-8 | MR Shoulder - right WO contrast | ./2.16.840.1.114222.4.11.1002/36528-8.json |
| 36529-6 | CT Sinuses WO contrast | ./2.16.840.1.114222.4.11.1002/36529-6.json |
| 36530-4 | CT Spine WO contrast | ./2.16.840.1.114222.4.11.1002/36530-4.json |
| 36531-2 | MR Spine WO contrast | ./2.16.840.1.114222.4.11.1002/36531-2.json |
| 36532-0 | MR Thoracic spine WO contrast | ./2.16.840.1.114222.4.11.1002/36532-0.json |
| 3653-3 | Flurazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3653-3.json |
| 36533-8 | MR Spleen WO contrast | ./2.16.840.1.114222.4.11.1002/36533-8.json |
| 36534-6 | CT Sternum WO contrast | ./2.16.840.1.114222.4.11.1002/36534-6.json |
| 36535-3 | MR Scrotum and testicle WO contrast | ./2.16.840.1.114222.4.11.1002/36535-3.json |
| 36536-1 | MR Thyroid gland WO contrast | ./2.16.840.1.114222.4.11.1002/36536-1.json |
| 36537-9 | CT Lower leg WO contrast | ./2.16.840.1.114222.4.11.1002/36537-9.json |
| 36538-7 | CT Lower leg - left WO contrast | ./2.16.840.1.114222.4.11.1002/36538-7.json |
| 36539-5 | MR Lower leg - left WO contrast | ./2.16.840.1.114222.4.11.1002/36539-5.json |
| 36540-3 | CT Lower leg - right WO contrast | ./2.16.840.1.114222.4.11.1002/36540-3.json |
| 3654-1 | Flurazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3654-1.json |
| 36541-1 | MR Lower leg - right WO contrast | ./2.16.840.1.114222.4.11.1002/36541-1.json |
| 36542-9 | MR Uterus WO contrast | ./2.16.840.1.114222.4.11.1002/36542-9.json |
| 36543-7 | MRA Portal vein WO contrast | ./2.16.840.1.114222.4.11.1002/36543-7.json |
| 36544-5 | MRA Renal vein WO contrast | ./2.16.840.1.114222.4.11.1002/36544-5.json |
| 36545-2 | MR Inferior vena cava WO contrast | ./2.16.840.1.114222.4.11.1002/36545-2.json |
| 36546-0 | MR Superior vena cava WO contrast | ./2.16.840.1.114222.4.11.1002/36546-0.json |
| 36547-8 | MRA Chest vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36547-8.json |
| 36548-6 | MRA Upper extremity vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36548-6.json |
| 36549-4 | MRA Neck vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36549-4.json |
| 36550-2 | XR Abdomen Single view | ./2.16.840.1.114222.4.11.1002/36550-2.json |
| 36551-0 | XR Ankle Single view | ./2.16.840.1.114222.4.11.1002/36551-0.json |
| 36554-4 | XR Chest Single view | ./2.16.840.1.114222.4.11.1002/36554-4.json |
| 36555-1 | XR Clavicle Single view | ./2.16.840.1.114222.4.11.1002/36555-1.json |
| 36556-9 | XR Elbow Single view | ./2.16.840.1.114222.4.11.1002/36556-9.json |
| 36557-7 | XR Lower extremity - bilateral Single view | ./2.16.840.1.114222.4.11.1002/36557-7.json |
| 3655-8 | Flurazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3655-8.json |
| 36558-5 | XR Lower extremity - left Single view | ./2.16.840.1.114222.4.11.1002/36558-5.json |
| 36559-3 | XR Femur Single view | ./2.16.840.1.114222.4.11.1002/36559-3.json |
| 36560-1 | XR Femur - left Single view | ./2.16.840.1.114222.4.11.1002/36560-1.json |
| 36561-9 | XR Foot Single view | ./2.16.840.1.114222.4.11.1002/36561-9.json |
| 36563-5 | XR Hand Single view | ./2.16.840.1.114222.4.11.1002/36563-5.json |
| 36564-3 | XR Calcaneus Single view | ./2.16.840.1.114222.4.11.1002/36564-3.json |
| 36565-0 | XR Humerus Single view | ./2.16.840.1.114222.4.11.1002/36565-0.json |
| 3656-6 | Furfenorex [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3656-6.json |
| 36566-8 | XR Knee - bilateral Single view | ./2.16.840.1.114222.4.11.1002/36566-8.json |
| 36567-6 | XR Knee - left Single view | ./2.16.840.1.114222.4.11.1002/36567-6.json |
| 36568-4 | XR Shoulder - bilateral Single view | ./2.16.840.1.114222.4.11.1002/36568-4.json |
| 36569-2 | XR Shoulder - left Single view | ./2.16.840.1.114222.4.11.1002/36569-2.json |
| 36570-0 | XR Wrist - left Single view | ./2.16.840.1.114222.4.11.1002/36570-0.json |
| 36571-8 | XR Ankle AP | ./2.16.840.1.114222.4.11.1002/36571-8.json |
| 36572-6 | XR Chest AP | ./2.16.840.1.114222.4.11.1002/36572-6.json |
| 36573-4 | XR Clavicle AP | ./2.16.840.1.114222.4.11.1002/36573-4.json |
| 3657-4 | Furfenorex [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3657-4.json |
| 36574-2 | XR Lower extremity AP | ./2.16.840.1.114222.4.11.1002/36574-2.json |
| 36575-9 | XR Femur AP | ./2.16.840.1.114222.4.11.1002/36575-9.json |
| 36576-7 | XR Finger fifth AP | ./2.16.840.1.114222.4.11.1002/36576-7.json |
| 36577-5 | XR Finger fourth AP | ./2.16.840.1.114222.4.11.1002/36577-5.json |
| 36578-3 | XR Finger third AP | ./2.16.840.1.114222.4.11.1002/36578-3.json |
| 36579-1 | XR Foot AP | ./2.16.840.1.114222.4.11.1002/36579-1.json |
| 36580-9 | XR Foot - bilateral AP | ./2.16.840.1.114222.4.11.1002/36580-9.json |
| 36581-7 | XR Hip AP | ./2.16.840.1.114222.4.11.1002/36581-7.json |
| 3658-2 | Furfenorex [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3658-2.json |
| 36582-5 | XR Hip - left AP | ./2.16.840.1.114222.4.11.1002/36582-5.json |
| 36583-3 | XR Acromioclavicular joint - left AP | ./2.16.840.1.114222.4.11.1002/36583-3.json |
| 36584-1 | XR Knee AP | ./2.16.840.1.114222.4.11.1002/36584-1.json |
| 36585-8 | XR Knee - bilateral AP | ./2.16.840.1.114222.4.11.1002/36585-8.json |
| 36586-6 | XR Shoulder - bilateral AP | ./2.16.840.1.114222.4.11.1002/36586-6.json |
| 36587-4 | XR Shoulder - left AP | ./2.16.840.1.114222.4.11.1002/36587-4.json |
| 36588-2 | Portable XR Abdomen AP | ./2.16.840.1.114222.4.11.1002/36588-2.json |
| 36589-0 | Portable XR Chest AP single view | ./2.16.840.1.114222.4.11.1002/36589-0.json |
| 3659-0 | Furosemide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3659-0.json |
| 36590-8 | XR Knee - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36590-8.json |
| 36591-6 | XR Abdomen Lateral | ./2.16.840.1.114222.4.11.1002/36591-6.json |
| 36592-4 | XR Ankle Lateral | ./2.16.840.1.114222.4.11.1002/36592-4.json |
| 36593-2 | XR Femur Lateral | ./2.16.840.1.114222.4.11.1002/36593-2.json |
| 36594-0 | XR Finger fifth Lateral | ./2.16.840.1.114222.4.11.1002/36594-0.json |
| 36595-7 | XR Finger fourth Lateral | ./2.16.840.1.114222.4.11.1002/36595-7.json |
| 36596-5 | XR Finger second Lateral | ./2.16.840.1.114222.4.11.1002/36596-5.json |
| 36597-3 | XR Finger third Lateral | ./2.16.840.1.114222.4.11.1002/36597-3.json |
| 36598-1 | XR Foot - left Lateral | ./2.16.840.1.114222.4.11.1002/36598-1.json |
| 36599-9 | XR Hand Lateral | ./2.16.840.1.114222.4.11.1002/36599-9.json |
| 36600-5 | XR Hand - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/36600-5.json |
| 36601-3 | XR Hand - left Lateral | ./2.16.840.1.114222.4.11.1002/36601-3.json |
| 36602-1 | XR Hip Lateral | ./2.16.840.1.114222.4.11.1002/36602-1.json |
| 36603-9 | XR Hip - left Lateral | ./2.16.840.1.114222.4.11.1002/36603-9.json |
| 36604-7 | XR Knee Lateral | ./2.16.840.1.114222.4.11.1002/36604-7.json |
| 36605-4 | XR Knee - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/36605-4.json |
| 36606-2 | XR Knee - left Lateral | ./2.16.840.1.114222.4.11.1002/36606-2.json |
| 36607-0 | XR Abdomen Oblique | ./2.16.840.1.114222.4.11.1002/36607-0.json |
| 3660-8 | Furosemide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3660-8.json |
| 36608-8 | XR Elbow Oblique Views | ./2.16.840.1.114222.4.11.1002/36608-8.json |
| 36609-6 | XR Femur Oblique | ./2.16.840.1.114222.4.11.1002/36609-6.json |
| 36610-4 | XR Finger fifth Oblique | ./2.16.840.1.114222.4.11.1002/36610-4.json |
| 36611-2 | XR Finger fourth Oblique | ./2.16.840.1.114222.4.11.1002/36611-2.json |
| 36612-0 | XR Finger second Oblique | ./2.16.840.1.114222.4.11.1002/36612-0.json |
| 36613-8 | XR Finger third Oblique | ./2.16.840.1.114222.4.11.1002/36613-8.json |
| 36614-6 | XR Foot Oblique | ./2.16.840.1.114222.4.11.1002/36614-6.json |
| 36615-3 | XR Foot - left Oblique | ./2.16.840.1.114222.4.11.1002/36615-3.json |
| 3661-6 | Furosemide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3661-6.json |
| 36616-1 | XR Hand Oblique | ./2.16.840.1.114222.4.11.1002/36616-1.json |
| 36617-9 | XR Hip Oblique | ./2.16.840.1.114222.4.11.1002/36617-9.json |
| 36618-7 | XR Hip - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/36618-7.json |
| 36619-5 | XR Knee Oblique Views | ./2.16.840.1.114222.4.11.1002/36619-5.json |
| 36620-3 | XR Chest Left anterior oblique | ./2.16.840.1.114222.4.11.1002/36620-3.json |
| 36621-1 | XR Hand PA | ./2.16.840.1.114222.4.11.1002/36621-1.json |
| 36622-9 | XR Hand - bilateral PA | ./2.16.840.1.114222.4.11.1002/36622-9.json |
| 36623-7 | XR Hand - left PA | ./2.16.840.1.114222.4.11.1002/36623-7.json |
| 3662-4 | Furosemide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3662-4.json |
| 36624-5 | XR Wrist - bilateral PA | ./2.16.840.1.114222.4.11.1002/36624-5.json |
| 36625-2 | MG Breast Views | ./2.16.840.1.114222.4.11.1002/36625-2.json |
| 36626-0 | MG Breast - bilateral Views | ./2.16.840.1.114222.4.11.1002/36626-0.json |
| 36627-8 | MG Breast - left Views | ./2.16.840.1.114222.4.11.1002/36627-8.json |
| 36628-6 | XR Internal auditory canal Views | ./2.16.840.1.114222.4.11.1002/36628-6.json |
| 36629-4 | XR Hand - bilateral Views | ./2.16.840.1.114222.4.11.1002/36629-4.json |
| 36630-2 | XR Hand - left Views | ./2.16.840.1.114222.4.11.1002/36630-2.json |
| 36631-0 | XR Pelvis and Hip - left Views | ./2.16.840.1.114222.4.11.1002/36631-0.json |
| 3663-2 | Gentamicin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/3663-2.json |
| 36632-8 | XR Humerus - left Views | ./2.16.840.1.114222.4.11.1002/36632-8.json |
| 36633-6 | XR Sacroiliac joint - bilateral Views | ./2.16.840.1.114222.4.11.1002/36633-6.json |
| 36634-4 | XR Sacroiliac joint - left Views | ./2.16.840.1.114222.4.11.1002/36634-4.json |
| 36635-1 | XR Knee - bilateral Views | ./2.16.840.1.114222.4.11.1002/36635-1.json |
| 36636-9 | XR Knee - left Views | ./2.16.840.1.114222.4.11.1002/36636-9.json |
| 36637-7 | XR Maxilla Views | ./2.16.840.1.114222.4.11.1002/36637-7.json |
| 36638-5 | XR Patella - bilateral Views | ./2.16.840.1.114222.4.11.1002/36638-5.json |
| 36639-3 | XR Patella - left Views | ./2.16.840.1.114222.4.11.1002/36639-3.json |
| 3664-0 | Gentamicin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/3664-0.json |
| 36640-1 | RF Cervical spine Views | ./2.16.840.1.114222.4.11.1002/36640-1.json |
| 36641-9 | XR Abdomen 2 Views | ./2.16.840.1.114222.4.11.1002/36641-9.json |
| 36642-7 | MG Breast - left 2 Views | ./2.16.840.1.114222.4.11.1002/36642-7.json |
| 36643-5 | XR Chest 2 Views | ./2.16.840.1.114222.4.11.1002/36643-5.json |
| 36644-3 | XR and RF Chest 2 Views and Views | ./2.16.840.1.114222.4.11.1002/36644-3.json |
| 36645-0 | XR Clavicle 2 Views | ./2.16.840.1.114222.4.11.1002/36645-0.json |
| 36646-8 | XR Clavicle - left 2 Views | ./2.16.840.1.114222.4.11.1002/36646-8.json |
| 36647-6 | XR Coccyx 2 Views | ./2.16.840.1.114222.4.11.1002/36647-6.json |
| 36648-4 | XR Elbow 2 Views | ./2.16.840.1.114222.4.11.1002/36648-4.json |
| 36649-2 | XR Elbow - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36649-2.json |
| 36650-0 | XR Elbow - left 2 Views | ./2.16.840.1.114222.4.11.1002/36650-0.json |
| 36651-8 | XR Lower extremity 2 Views | ./2.16.840.1.114222.4.11.1002/36651-8.json |
| 36652-6 | XR Femur 2 Views | ./2.16.840.1.114222.4.11.1002/36652-6.json |
| 36653-4 | XR Femur - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36653-4.json |
| 36654-2 | XR Femur - left 2 Views | ./2.16.840.1.114222.4.11.1002/36654-2.json |
| 36655-9 | XR Finger 2 Views | ./2.16.840.1.114222.4.11.1002/36655-9.json |
| 36656-7 | XR Finger - left 2 Views | ./2.16.840.1.114222.4.11.1002/36656-7.json |
| 3665-7 | Gentamicin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3665-7.json |
| 36657-5 | XR Foot - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36657-5.json |
| 36658-3 | XR Radius and Ulna 2 Views | ./2.16.840.1.114222.4.11.1002/36658-3.json |
| 36659-1 | XR Radius and Ulna - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36659-1.json |
| 36660-9 | XR Radius and Ulna - left 2 Views | ./2.16.840.1.114222.4.11.1002/36660-9.json |
| 36661-7 | XR Calcaneus 2 Views | ./2.16.840.1.114222.4.11.1002/36661-7.json |
| 36662-5 | XR Calcaneus - left 2 Views | ./2.16.840.1.114222.4.11.1002/36662-5.json |
| 36663-3 | XR Hip 2 Views | ./2.16.840.1.114222.4.11.1002/36663-3.json |
| 36664-1 | XR Hip - left 2 Views | ./2.16.840.1.114222.4.11.1002/36664-1.json |
| 3666-5 | Glutethimide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3666-5.json |
| 36665-8 | XR Acromioclavicular joint - left 2 Views | ./2.16.840.1.114222.4.11.1002/36665-8.json |
| 36666-6 | XR Scapula - left 2 Views | ./2.16.840.1.114222.4.11.1002/36666-6.json |
| 36667-4 | XR Shoulder - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36667-4.json |
| 36668-2 | XR Shoulder - left 2 Views | ./2.16.840.1.114222.4.11.1002/36668-2.json |
| 36669-0 | XR Cervical spine 2 Views | ./2.16.840.1.114222.4.11.1002/36669-0.json |
| 36670-8 | XR Lumbar spine 2 Views | ./2.16.840.1.114222.4.11.1002/36670-8.json |
| 36671-6 | XR Tibia and Fibula - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/36671-6.json |
| 36672-4 | XR Tibia and Fibula - left 2 Views | ./2.16.840.1.114222.4.11.1002/36672-4.json |
| 3667-3 | Glutethimide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3667-3.json |
| 36673-2 | XR Toes - left 2 Views | ./2.16.840.1.114222.4.11.1002/36673-2.json |
| 36674-0 | Portable XR Lumbar spine 2 Views | ./2.16.840.1.114222.4.11.1002/36674-0.json |
| 36675-7 | XR Facial bones 5 Views | ./2.16.840.1.114222.4.11.1002/36675-7.json |
| 36676-5 | XR Knee - left 5 Views | ./2.16.840.1.114222.4.11.1002/36676-5.json |
| 36677-3 | XR Shoulder - left 5 Views | ./2.16.840.1.114222.4.11.1002/36677-3.json |
| 36678-1 | XR Knee - bilateral 6 Views | ./2.16.840.1.114222.4.11.1002/36678-1.json |
| 36679-9 | XR Shoulder - left 6 Views | ./2.16.840.1.114222.4.11.1002/36679-9.json |
| 36680-7 | XR Cervical spine 7 Views | ./2.16.840.1.114222.4.11.1002/36680-7.json |
| 3668-1 | Glutethimide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3668-1.json |
| 36681-5 | XR Lumbar spine 7 Views | ./2.16.840.1.114222.4.11.1002/36681-5.json |
| 36682-3 | XR Knee - bilateral 8 Views | ./2.16.840.1.114222.4.11.1002/36682-3.json |
| 36683-1 | XR Wrist - left 8 Views | ./2.16.840.1.114222.4.11.1002/36683-1.json |
| 36684-9 | XR Ankle - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36684-9.json |
| 36685-6 | XR Ankle - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36685-6.json |
| 36686-4 | XR Calcaneus - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36686-4.json |
| 36687-2 | XR Chest AP and Lateral | ./2.16.840.1.114222.4.11.1002/36687-2.json |
| 36688-0 | XR Coccyx AP and Lateral | ./2.16.840.1.114222.4.11.1002/36688-0.json |
| 36689-8 | XR Elbow AP and Lateral | ./2.16.840.1.114222.4.11.1002/36689-8.json |
| 36690-6 | XR Elbow - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36690-6.json |
| 36691-4 | XR Elbow - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36691-4.json |
| 36692-2 | XR Lower extremity AP and Lateral | ./2.16.840.1.114222.4.11.1002/36692-2.json |
| 36693-0 | XR Femur AP and Lateral | ./2.16.840.1.114222.4.11.1002/36693-0.json |
| 36694-8 | XR Femur - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36694-8.json |
| 36695-5 | XR Femur - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36695-5.json |
| 36696-3 | XR Foot - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36696-3.json |
| 36697-1 | XR Foot - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36697-1.json |
| 36698-9 | XR Radius and Ulna AP and Lateral | ./2.16.840.1.114222.4.11.1002/36698-9.json |
| 3669-9 | Haloperidol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3669-9.json |
| 36699-7 | XR Radius and Ulna - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36699-7.json |
| 36700-3 | XR Radius and Ulna - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36700-3.json |
| 36701-1 | XR Calcaneus - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36701-1.json |
| 36702-9 | XR Hip AP and Lateral | ./2.16.840.1.114222.4.11.1002/36702-9.json |
| 36703-7 | XR Hip - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36703-7.json |
| 36704-5 | XR Hip - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36704-5.json |
| 36705-2 | XR Pelvis and Hip AP and Lateral | ./2.16.840.1.114222.4.11.1002/36705-2.json |
| 36706-0 | XR Humerus AP and Lateral | ./2.16.840.1.114222.4.11.1002/36706-0.json |
| 3670-7 | Haloperidol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3670-7.json |
| 36707-8 | XR Humerus - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36707-8.json |
| 36708-6 | XR Humerus - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36708-6.json |
| 36709-4 | XR Knee AP and Lateral | ./2.16.840.1.114222.4.11.1002/36709-4.json |
| 36710-2 | XR Knee - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36710-2.json |
| 36711-0 | XR Mandible AP and Lateral | ./2.16.840.1.114222.4.11.1002/36711-0.json |
| 36712-8 | XR Patella - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36712-8.json |
| 36713-6 | XR Patella - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36713-6.json |
| 36714-4 | XR Scapula - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36714-4.json |
| 3671-5 | Haloperidol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3671-5.json |
| 36715-1 | XR Scapula - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36715-1.json |
| 36716-9 | XR Shoulder - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36716-9.json |
| 36717-7 | XR Tibia and Fibula - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/36717-7.json |
| 36718-5 | XR Tibia and Fibula - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36718-5.json |
| 36719-3 | XR Toes - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/36719-3.json |
| 36720-1 | XR Ankle - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36720-1.json |
| 36721-9 | XR Ankle - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36721-9.json |
| 36722-7 | XR Elbow AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36722-7.json |
| 3672-3 | Heptaminol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3672-3.json |
| 36723-5 | XR Elbow - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36723-5.json |
| 36724-3 | XR Elbow - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36724-3.json |
| 36725-0 | XR Finger AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36725-0.json |
| 36726-8 | XR Finger - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36726-8.json |
| 36727-6 | XR Finger - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36727-6.json |
| 36728-4 | XR Foot AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36728-4.json |
| 36729-2 | XR Foot - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36729-2.json |
| 36730-0 | XR Foot - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36730-0.json |
| 3673-1 | Heptaminol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3673-1.json |
| 36731-8 | XR Calcaneus AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36731-8.json |
| 36732-6 | XR Knee - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36732-6.json |
| 36733-4 | XR Knee - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36733-4.json |
| 36734-2 | XR Cervical spine AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36734-2.json |
| 36735-9 | XR Lumbar spine AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36735-9.json |
| 36736-7 | XR Thumb - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/36736-7.json |
| 36737-5 | XR Facial bones Limited Views | ./2.16.840.1.114222.4.11.1002/36737-5.json |
| 36738-3 | XR Mandible Limited Views | ./2.16.840.1.114222.4.11.1002/36738-3.json |
| 36739-1 | XR Wrist - bilateral Limited Views | ./2.16.840.1.114222.4.11.1002/36739-1.json |
| 36740-9 | XR Elbow - bilateral Oblique Views | ./2.16.840.1.114222.4.11.1002/36740-9.json |
| 36741-7 | XR Elbow - left Oblique Views | ./2.16.840.1.114222.4.11.1002/36741-7.json |
| 36742-5 | XR Radius and Ulna - bilateral Oblique Views | ./2.16.840.1.114222.4.11.1002/36742-5.json |
| 36743-3 | XR Radius and Ulna - left Oblique Views | ./2.16.840.1.114222.4.11.1002/36743-3.json |
| 36744-1 | XR Humerus - left Oblique Views | ./2.16.840.1.114222.4.11.1002/36744-1.json |
| 36745-8 | XR Knee - bilateral Oblique Views | ./2.16.840.1.114222.4.11.1002/36745-8.json |
| 36746-6 | XR Knee - left Oblique Views | ./2.16.840.1.114222.4.11.1002/36746-6.json |
| 36747-4 | XR Mandible Oblique Views | ./2.16.840.1.114222.4.11.1002/36747-4.json |
| 36748-2 | XR Cervical spine Oblique Views | ./2.16.840.1.114222.4.11.1002/36748-2.json |
| 3674-9 | Heptaminol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3674-9.json |
| 36749-0 | XR Tibia and Fibula - left Oblique Views | ./2.16.840.1.114222.4.11.1002/36749-0.json |
| 36750-8 | XR Chest PA and AP lateral-decubitus | ./2.16.840.1.114222.4.11.1002/36750-8.json |
| 36751-6 | XR and RF Chest PA and Lateral and Views | ./2.16.840.1.114222.4.11.1002/36751-6.json |
| 36752-4 | XR Hand - bilateral PA and Lateral | ./2.16.840.1.114222.4.11.1002/36752-4.json |
| 36753-2 | XR Hand - left PA and Lateral | ./2.16.840.1.114222.4.11.1002/36753-2.json |
| 36754-0 | XR Mandible PA and Lateral | ./2.16.840.1.114222.4.11.1002/36754-0.json |
| 36755-7 | XR Hand PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/36755-7.json |
| 3675-6 | hydroCHLOROthiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3675-6.json |
| 36756-5 | XR Hand - bilateral PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/36756-5.json |
| 36757-3 | XR Hand - left PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/36757-3.json |
| 36758-1 | XR Chest PA and Lateral and Oblique and Apical lordotic | ./2.16.840.1.114222.4.11.1002/36758-1.json |
| 36759-9 | XR Chest PA and Apical lordotic | ./2.16.840.1.114222.4.11.1002/36759-9.json |
| 36760-7 | RFA Guidance for angioplasty of AV shunt-- W contrast | ./2.16.840.1.114222.4.11.1002/36760-7.json |
| 36761-5 | RF Guidance for balloon dilatation of Biliary ducts-- W contrast | ./2.16.840.1.114222.4.11.1002/36761-5.json |
| 36762-3 | RFA Guidance for angioplasty of Extremity vessel-- W contrast | ./2.16.840.1.114222.4.11.1002/36762-3.json |
| 36763-1 | RFA Guidance for angioplasty of Femoral artery and Popliteal artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/36763-1.json |
| 3676-4 | hydroCHLOROthiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3676-4.json |
| 36764-9 | RFA Guidance for atherectomy of Femoral vessel and Popliteal artery-- W contrast | ./2.16.840.1.114222.4.11.1002/36764-9.json |
| 36765-6 | RFA Guidance for atherectomy of Vessel-- W contrast | ./2.16.840.1.114222.4.11.1002/36765-6.json |
| 36766-4 | RFA Guidance for atherectomy of Coronary arteries-- W contrast IA | ./2.16.840.1.114222.4.11.1002/36766-4.json |
| 36767-2 | CT Guidance for biopsy of Adrenal gland | ./2.16.840.1.114222.4.11.1002/36767-2.json |
| 36768-0 | CT Guidance for percutaneous biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/36768-0.json |
| 36769-8 | CT Guidance for exchange of nephrostomy tube of Kidney | ./2.16.840.1.114222.4.11.1002/36769-8.json |
| 36770-6 | CT Guidance for drainage and placement of drainage catheter of Biliary ducts and Gallbladder | ./2.16.840.1.114222.4.11.1002/36770-6.json |
| 36771-4 | RF Guidance for injection of Joint | ./2.16.840.1.114222.4.11.1002/36771-4.json |
| 3677-2 | hydroCHLOROthiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3677-2.json |
| 36772-2 | CT Guidance for placement of nephrostomy tube in Kidney | ./2.16.840.1.114222.4.11.1002/36772-2.json |
| 36773-0 | CT Temporal bone | ./2.16.840.1.114222.4.11.1002/36773-0.json |
| 36774-8 | MR Upper extremity joint - left | ./2.16.840.1.114222.4.11.1002/36774-8.json |
| 36775-5 | MR Upper extremity joint - right | ./2.16.840.1.114222.4.11.1002/36775-5.json |
| 36776-3 | XR tomography Mastoid | ./2.16.840.1.114222.4.11.1002/36776-3.json |
| 36777-1 | MR Orbit | ./2.16.840.1.114222.4.11.1002/36777-1.json |
| 36778-9 | MR Orbit - right | ./2.16.840.1.114222.4.11.1002/36778-9.json |
| 36779-7 | MR Ovary | ./2.16.840.1.114222.4.11.1002/36779-7.json |
| 3678-0 | hydroCHLOROthiazide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3678-0.json |
| 36780-5 | MR Toe | ./2.16.840.1.114222.4.11.1002/36780-5.json |
| 36781-3 | MRA Abdominal veins | ./2.16.840.1.114222.4.11.1002/36781-3.json |
| 36782-1 | MRA Subclavian artery | ./2.16.840.1.114222.4.11.1002/36782-1.json |
| 36783-9 | MRA Veins | ./2.16.840.1.114222.4.11.1002/36783-9.json |
| 36784-7 | MRA Lower extremity veins - left | ./2.16.840.1.114222.4.11.1002/36784-7.json |
| 36785-4 | MRA Lower extremity veins - right | ./2.16.840.1.114222.4.11.1002/36785-4.json |
| 36786-2 | MRA Upper extremity veins - left | ./2.16.840.1.114222.4.11.1002/36786-2.json |
| 36787-0 | MRA Upper extremity veins - right | ./2.16.840.1.114222.4.11.1002/36787-0.json |
| 36788-8 | MRA Neck veins | ./2.16.840.1.114222.4.11.1002/36788-8.json |
| 36789-6 | MRA Pelvis veins | ./2.16.840.1.114222.4.11.1002/36789-6.json |
| 36790-4 | MRA Inferior vena cava + tributaries | ./2.16.840.1.114222.4.11.1002/36790-4.json |
| 36791-2 | MRA Abdominal vessels | ./2.16.840.1.114222.4.11.1002/36791-2.json |
| 36792-0 | MRA Adrenal vessels | ./2.16.840.1.114222.4.11.1002/36792-0.json |
| 36794-6 | MRA Extremity vessels | ./2.16.840.1.114222.4.11.1002/36794-6.json |
| 36795-3 | MRA Lower extremity vessels - left | ./2.16.840.1.114222.4.11.1002/36795-3.json |
| 36796-1 | MRA Lower extremity vessels - right | ./2.16.840.1.114222.4.11.1002/36796-1.json |
| 36797-9 | MRA Upper extremity vessels - left | ./2.16.840.1.114222.4.11.1002/36797-9.json |
| 3679-8 | HYDROcodone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3679-8.json |
| 36798-7 | MRA Upper extremity vessels - right | ./2.16.840.1.114222.4.11.1002/36798-7.json |
| 36799-5 | MRA Knee vessels | ./2.16.840.1.114222.4.11.1002/36799-5.json |
| 36800-1 | MRA Knee vessels - left | ./2.16.840.1.114222.4.11.1002/36800-1.json |
| 36801-9 | MRA Knee vessels - right | ./2.16.840.1.114222.4.11.1002/36801-9.json |
| 36802-7 | MRA Orbit vessels | ./2.16.840.1.114222.4.11.1002/36802-7.json |
| 36803-5 | MRA Pulmonary vessels | ./2.16.840.1.114222.4.11.1002/36803-5.json |
| 36804-3 | MRA Renal vessels - bilateral | ./2.16.840.1.114222.4.11.1002/36804-3.json |
| 36805-0 | MRA Shoulder vessels | ./2.16.840.1.114222.4.11.1002/36805-0.json |
| 3680-6 | HYDROcodone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3680-6.json |
| 36806-8 | MRA Shoulder vessels - left | ./2.16.840.1.114222.4.11.1002/36806-8.json |
| 36807-6 | MRA Shoulder vessels - right | ./2.16.840.1.114222.4.11.1002/36807-6.json |
| 36808-4 | MRA Head vessels limited | ./2.16.840.1.114222.4.11.1002/36808-4.json |
| 36809-2 | CTA Hepatic artery W contrast IA | ./2.16.840.1.114222.4.11.1002/36809-2.json |
| 36811-8 | CT Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/36811-8.json |
| 36812-6 | MR Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/36812-6.json |
| 36813-4 | CT Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/36813-4.json |
| 3681-4 | HYDROcodone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3681-4.json |
| 36814-2 | CTA Head Arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/36814-2.json |
| 36815-9 | CT Temporal bone W contrast IV | ./2.16.840.1.114222.4.11.1002/36815-9.json |
| 36816-7 | CT Temporal bone - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36816-7.json |
| 36817-5 | MR Upper extremity joint - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/36817-5.json |
| 36818-3 | MR Upper extremity joint - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36818-3.json |
| 36819-1 | MR Upper extremity joint - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36819-1.json |
| 36820-9 | MR Orbit W contrast IV | ./2.16.840.1.114222.4.11.1002/36820-9.json |
| 36821-7 | MR Orbit - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36821-7.json |
| 3682-2 | HYDROmorphone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3682-2.json |
| 36822-5 | MR Orbit - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36822-5.json |
| 36823-3 | MR Ovary W contrast IV | ./2.16.840.1.114222.4.11.1002/36823-3.json |
| 36824-1 | CTA Lower extremity veins - left W contrast IV | ./2.16.840.1.114222.4.11.1002/36824-1.json |
| 36825-8 | CTA Lower extremity veins - right W contrast IV | ./2.16.840.1.114222.4.11.1002/36825-8.json |
| 36826-6 | MRA Head veins W contrast IV | ./2.16.840.1.114222.4.11.1002/36826-6.json |
| 36827-4 | MRA Neck veins W contrast IV | ./2.16.840.1.114222.4.11.1002/36827-4.json |
| 36828-2 | CTA Abdominal vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36828-2.json |
| 3683-0 | HYDROmorphone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3683-0.json |
| 36830-8 | CTA Head vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36830-8.json |
| 36831-6 | CTA Lower extremity vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36831-6.json |
| 36832-4 | MRA Orbit vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36832-4.json |
| 36833-2 | CTA Renal vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/36833-2.json |
| 36834-0 | CTA Vessel W contrast IV | ./2.16.840.1.114222.4.11.1002/36834-0.json |
| 36835-7 | CT Petrous part of temporal bone WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36835-7.json |
| 36837-3 | CT Temporal bone WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36837-3.json |
| 36838-1 | XR Mastoid 3 Views | ./2.16.840.1.114222.4.11.1002/36838-1.json |
| 36839-9 | XR Mastoid 4 Views | ./2.16.840.1.114222.4.11.1002/36839-9.json |
| 36840-7 | MR Upper extremity joint - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36840-7.json |
| 36841-5 | MR Upper extremity joint - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36841-5.json |
| 36842-3 | MR Orbit WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36842-3.json |
| 36843-1 | MR Orbit - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36843-1.json |
| 36844-9 | MR Orbit - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36844-9.json |
| 36845-6 | MR Ovary WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36845-6.json |
| 36846-4 | MRA Abdominal veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36846-4.json |
| 36847-2 | MRA Head veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36847-2.json |
| 3684-8 | Hydroxychloroquine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3684-8.json |
| 36848-0 | MRA Chest veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36848-0.json |
| 36849-8 | MRA Lower extremity veins - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36849-8.json |
| 36850-6 | MRA Lower extremity veins - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36850-6.json |
| 36851-4 | MRA Upper extremity veins - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36851-4.json |
| 36852-2 | MRA Upper extremity veins - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36852-2.json |
| 36853-0 | MRA Neck veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36853-0.json |
| 36854-8 | MRA Pelvis veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36854-8.json |
| 3685-5 | Hydroxymethoxyphenamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3685-5.json |
| 36855-5 | MRA Abdominal vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36855-5.json |
| 36857-1 | MRA Head vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36857-1.json |
| 36858-9 | MRA Lower extremity vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36858-9.json |
| 36859-7 | MRA Lower extremity vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36859-7.json |
| 36860-5 | MRA Upper extremity vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36860-5.json |
| 36861-3 | MRA Upper extremity vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36861-3.json |
| 36862-1 | MRA Knee vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36862-1.json |
| 3686-3 | hydrOXYzine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3686-3.json |
| 36863-9 | MRA Pelvis vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36863-9.json |
| 36864-7 | MRA Shoulder vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36864-7.json |
| 36865-4 | MRA Shoulder vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36865-4.json |
| 36866-2 | CT Temporal bone WO contrast | ./2.16.840.1.114222.4.11.1002/36866-2.json |
| 36867-0 | CT Temporal bone - left WO contrast | ./2.16.840.1.114222.4.11.1002/36867-0.json |
| 36868-8 | CT Temporal bone - right WO contrast | ./2.16.840.1.114222.4.11.1002/36868-8.json |
| 36869-6 | MR Upper extremity joint - left WO contrast | ./2.16.840.1.114222.4.11.1002/36869-6.json |
| 36870-4 | MR Upper extremity joint - right WO contrast | ./2.16.840.1.114222.4.11.1002/36870-4.json |
| 3687-1 | Ibuprofen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3687-1.json |
| 36871-2 | MR Joint WO contrast | ./2.16.840.1.114222.4.11.1002/36871-2.json |
| 36872-0 | MR Orbit WO contrast | ./2.16.840.1.114222.4.11.1002/36872-0.json |
| 36873-8 | MR Orbit - left WO contrast | ./2.16.840.1.114222.4.11.1002/36873-8.json |
| 36874-6 | MR Orbit - right WO contrast | ./2.16.840.1.114222.4.11.1002/36874-6.json |
| 36875-3 | MR Ovary WO contrast | ./2.16.840.1.114222.4.11.1002/36875-3.json |
| 36876-1 | MRA Head veins WO contrast | ./2.16.840.1.114222.4.11.1002/36876-1.json |
| 36877-9 | MRA Neck veins WO contrast | ./2.16.840.1.114222.4.11.1002/36877-9.json |
| 36878-7 | MRA Abdominal vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36878-7.json |
| 36879-5 | MRA Ankle vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36879-5.json |
| 36881-1 | MRA Head vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36881-1.json |
| 36882-9 | MRA Lower extremity vessels - left WO contrast | ./2.16.840.1.114222.4.11.1002/36882-9.json |
| 36883-7 | MRA Pelvis vessels WO contrast | ./2.16.840.1.114222.4.11.1002/36883-7.json |
| 36886-0 | XR Orbit Views | ./2.16.840.1.114222.4.11.1002/36886-0.json |
| 36887-8 | XR Orbit - left Views | ./2.16.840.1.114222.4.11.1002/36887-8.json |
| 36890-2 | XR Mastoid 5 Views | ./2.16.840.1.114222.4.11.1002/36890-2.json |
| 36893-6 | XR Mastoid Limited Views | ./2.16.840.1.114222.4.11.1002/36893-6.json |
| 36894-4 | XR Tibia and Fibula Oblique Views | ./2.16.840.1.114222.4.11.1002/36894-4.json |
| 36895-1 | Arbovirus Ab [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/36895-1.json |
| 36896-9 | West Nile virus polyvalent E Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/36896-9.json |
| 3689-7 | Imipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3689-7.json |
| 36897-7 | West Nile virus Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/36897-7.json |
| 36898-5 | West Nile virus NS5 Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/36898-5.json |
| 36899-3 | Arbovirus Ab [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/36899-3.json |
| 36900-9 | West Nile virus polyvalent E Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/36900-9.json |
| 36901-7 | West Nile virus NS5 Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/36901-7.json |
| 36902-5 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimenby NAA with probe detection | ./2.16.840.1.114222.4.11.1002/36902-5.json |
| 36903-3 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/36903-3.json |
| 3690-5 | Imipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3690-5.json |
| 36906-6 | Complement C1 esterase inhibitor [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/36906-6.json |
| 36907-4 | Chromosome 8 trisomy [Percentile] by Cytogenetics | ./2.16.840.1.114222.4.11.1002/36907-4.json |
| 36911-6 | SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/36911-6.json |
| 3691-3 | Imipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3691-3.json |
| 36913-2 | FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/36913-2.json |
| 36916-5 | Kappa light chains.free [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/36916-5.json |
| 36917-3 | Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/36917-3.json |
| 36918-1 | ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/36918-1.json |
| 36920-7 | PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/36920-7.json |
| 3692-1 | Imipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3692-1.json |
| 36921-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/36921-5.json |
| 36922-3 | TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/36922-3.json |
| 36923-1 | Epstein Barr virus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/36923-1.json |
| 36924-9 | 14-3-3 Ag [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/36924-9.json |
| 36925-6 | MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/36925-6.json |
| 36927-2 | CT Guidance for biopsy of Maxillofacial region | ./2.16.840.1.114222.4.11.1002/36927-2.json |
| 36928-0 | CT Guidance for stereotactic biopsy of Head | ./2.16.840.1.114222.4.11.1002/36928-0.json |
| 36929-8 | CT Guidance for stereotactic biopsy of Head-- WO contrast | ./2.16.840.1.114222.4.11.1002/36929-8.json |
| 36930-6 | CT Adrenal gland | ./2.16.840.1.114222.4.11.1002/36930-6.json |
| 36931-4 | MR Adrenal gland | ./2.16.840.1.114222.4.11.1002/36931-4.json |
| 36932-2 | CT Pituitary and Sella turcica | ./2.16.840.1.114222.4.11.1002/36932-2.json |
| 36933-0 | MR Salivary gland | ./2.16.840.1.114222.4.11.1002/36933-0.json |
| 36934-8 | CT Heart for calcium scoring | ./2.16.840.1.114222.4.11.1002/36934-8.json |
| 36935-5 | CT Heart for calcium scoring W contrast IV | ./2.16.840.1.114222.4.11.1002/36935-5.json |
| 36936-3 | MR Guidance for stereotactic biopsy of Brain | ./2.16.840.1.114222.4.11.1002/36936-3.json |
| 36937-1 | CT Maxillofacial region limited | ./2.16.840.1.114222.4.11.1002/36937-1.json |
| 36938-9 | CT Maxillofacial region limited WO contrast | ./2.16.840.1.114222.4.11.1002/36938-9.json |
| 3693-9 | Imipramine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3693-9.json |
| 36941-3 | CT Salivary gland W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/36941-3.json |
| 36942-1 | MR Chest and Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/36942-1.json |
| 36943-9 | CT Adrenal gland W contrast IV | ./2.16.840.1.114222.4.11.1002/36943-9.json |
| 36944-7 | MR Biliary ducts and Pancreatic duct WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36944-7.json |
| 36945-4 | XR Knee - bilateral 2 Views W standing | ./2.16.840.1.114222.4.11.1002/36945-4.json |
| 36946-2 | XR Lumbar spine 2 Views W standing | ./2.16.840.1.114222.4.11.1002/36946-2.json |
| 3694-7 | Indomethacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3694-7.json |
| 36947-0 | XR Foot - bilateral 3 Views W standing | ./2.16.840.1.114222.4.11.1002/36947-0.json |
| 36948-8 | XR Foot - left 3 Views W standing | ./2.16.840.1.114222.4.11.1002/36948-8.json |
| 36949-6 | XR Lumbar spine 3 Views W standing | ./2.16.840.1.114222.4.11.1002/36949-6.json |
| 36950-4 | CT Adrenal gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36950-4.json |
| 36951-2 | MR Adrenal gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/36951-2.json |
| 36952-0 | CT Abdomen and Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/36952-0.json |
| 36953-8 | CT Adrenal gland WO contrast | ./2.16.840.1.114222.4.11.1002/36953-8.json |
| 3695-4 | Insulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3695-4.json |
| 36954-6 | MR Adrenal gland WO contrast | ./2.16.840.1.114222.4.11.1002/36954-6.json |
| 36955-3 | CT Thyroid gland WO contrast | ./2.16.840.1.114222.4.11.1002/36955-3.json |
| 36956-1 | MR Orbit and Face WO contrast | ./2.16.840.1.114222.4.11.1002/36956-1.json |
| 36958-7 | XR Ribs - bilateral AP | ./2.16.840.1.114222.4.11.1002/36958-7.json |
| 36959-5 | XR Ribs - left AP | ./2.16.840.1.114222.4.11.1002/36959-5.json |
| 36960-3 | Portable XR Chest AP upright | ./2.16.840.1.114222.4.11.1002/36960-3.json |
| 36961-1 | XR Shoulder - left AP and West Point and Outlet | ./2.16.840.1.114222.4.11.1002/36961-1.json |
| 36962-9 | MG Breast Axillary | ./2.16.840.1.114222.4.11.1002/36962-9.json |
| 36963-7 | XR Shoulder - bilateral Axillary | ./2.16.840.1.114222.4.11.1002/36963-7.json |
| 36964-5 | XR Shoulder - left Axillary | ./2.16.840.1.114222.4.11.1002/36964-5.json |
| 36965-2 | XR Hand Ball Catcher | ./2.16.840.1.114222.4.11.1002/36965-2.json |
| 36966-0 | XR Hand - bilateral Brewerton | ./2.16.840.1.114222.4.11.1002/36966-0.json |
| 36967-8 | XR Hand - left Brewerton | ./2.16.840.1.114222.4.11.1002/36967-8.json |
| 36968-6 | XR Wrist - bilateral Single view W clenched fist | ./2.16.840.1.114222.4.11.1002/36968-6.json |
| 3697-0 | Isoniazid [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3697-0.json |
| 36971-0 | XR Wrist - left Lateral W extension | ./2.16.840.1.114222.4.11.1002/36971-0.json |
| 36972-8 | XR Wrist - left Lateral W flexion | ./2.16.840.1.114222.4.11.1002/36972-8.json |
| 36973-6 | XR Hip Friedman | ./2.16.840.1.114222.4.11.1002/36973-6.json |
| 36974-4 | XR Shoulder - left Garth | ./2.16.840.1.114222.4.11.1002/36974-4.json |
| 36975-1 | XR Calcaneus - bilateral Harris | ./2.16.840.1.114222.4.11.1002/36975-1.json |
| 36976-9 | XR Foot Harris | ./2.16.840.1.114222.4.11.1002/36976-9.json |
| 36977-7 | XR Calcaneus - left Harris | ./2.16.840.1.114222.4.11.1002/36977-7.json |
| 36978-5 | XR Knee Holmblad | ./2.16.840.1.114222.4.11.1002/36978-5.json |
| 36979-3 | XR Elbow Jones | ./2.16.840.1.114222.4.11.1002/36979-3.json |
| 36980-1 | XR Elbow - left Jones | ./2.16.840.1.114222.4.11.1002/36980-1.json |
| 36981-9 | XR Hip Judet | ./2.16.840.1.114222.4.11.1002/36981-9.json |
| 36982-7 | XR Hip - bilateral Judet | ./2.16.840.1.114222.4.11.1002/36982-7.json |
| 36983-5 | XR Hip - left Judet | ./2.16.840.1.114222.4.11.1002/36983-5.json |
| 36984-3 | XR Abdomen Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36984-3.json |
| 36985-0 | XR Hip Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36985-0.json |
| 36986-8 | XR Hip - bilateral Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36986-8.json |
| 36987-6 | XR Hip - left Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36987-6.json |
| 3698-8 | Kanamycin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/3698-8.json |
| 36988-4 | XR Knee Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36988-4.json |
| 36989-2 | XR Cervical spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36989-2.json |
| 36990-0 | XR Lumbar spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36990-0.json |
| 36991-8 | Portable XR Cervical spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36991-8.json |
| 36992-6 | Portable XR Lumbar spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/36992-6.json |
| 36993-4 | XR Hip - bilateral Lateral frog | ./2.16.840.1.114222.4.11.1002/36993-4.json |
| 36994-2 | XR Hip - left Lateral frog | ./2.16.840.1.114222.4.11.1002/36994-2.json |
| 36995-9 | XR Abdomen Left lateral | ./2.16.840.1.114222.4.11.1002/36995-9.json |
| 3699-6 | Kanamycin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/3699-6.json |
| 36996-7 | XR Abdomen Right lateral | ./2.16.840.1.114222.4.11.1002/36996-7.json |
| 36997-5 | XR Cervical spine Lateral W extension | ./2.16.840.1.114222.4.11.1002/36997-5.json |
| 36998-3 | XR Cervical spine Lateral W flexion | ./2.16.840.1.114222.4.11.1002/36998-3.json |
| 36999-1 | XR Knee - bilateral Lateral W extension | ./2.16.840.1.114222.4.11.1002/36999-1.json |
| 37000-7 | XR Knee - left Lateral W extension | ./2.16.840.1.114222.4.11.1002/37000-7.json |
| 37001-5 | XR Foot Lateral W standing | ./2.16.840.1.114222.4.11.1002/37001-5.json |
| 3700-2 | Kanamycin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3700-2.json |
| 37002-3 | XR Knee - left Lateral W standing | ./2.16.840.1.114222.4.11.1002/37002-3.json |
| 37003-1 | XR Lumbar spine Lateral W standing | ./2.16.840.1.114222.4.11.1002/37003-1.json |
| 37004-9 | XR Knee Laurin | ./2.16.840.1.114222.4.11.1002/37004-9.json |
| 37005-6 | MG Breast - left Magnification | ./2.16.840.1.114222.4.11.1002/37005-6.json |
| 37006-4 | MG Breast - bilateral MLO | ./2.16.840.1.114222.4.11.1002/37006-4.json |
| 37007-2 | XR Ankle Mortise | ./2.16.840.1.114222.4.11.1002/37007-2.json |
| 37008-0 | XR Chest Left oblique | ./2.16.840.1.114222.4.11.1002/37008-0.json |
| 37009-8 | XR Lumbar spine Left oblique | ./2.16.840.1.114222.4.11.1002/37009-8.json |
| 3701-0 | Ketamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3701-0.json |
| 37010-6 | XR Chest Right oblique | ./2.16.840.1.114222.4.11.1002/37010-6.json |
| 37011-4 | XR Lumbar spine Right oblique | ./2.16.840.1.114222.4.11.1002/37011-4.json |
| 37012-2 | XR Shoulder - bilateral Outlet | ./2.16.840.1.114222.4.11.1002/37012-2.json |
| 37013-0 | XR Shoulder - left Outlet | ./2.16.840.1.114222.4.11.1002/37013-0.json |
| 37014-8 | XR Knee - left PA W standing | ./2.16.840.1.114222.4.11.1002/37014-8.json |
| 37015-5 | XR Abdomen PA prone | ./2.16.840.1.114222.4.11.1002/37015-5.json |
| 37016-3 | MG Breast - bilateral Rolled Views | ./2.16.840.1.114222.4.11.1002/37016-3.json |
| 37017-1 | MG Breast - left Rolled Views | ./2.16.840.1.114222.4.11.1002/37017-1.json |
| 37018-9 | XR Knee Rosenberg W standing | ./2.16.840.1.114222.4.11.1002/37018-9.json |
| 37019-7 | XR Knee - left Rosenberg W standing | ./2.16.840.1.114222.4.11.1002/37019-7.json |
| 37020-5 | XR Knee - bilateral Rosenberg W standing | ./2.16.840.1.114222.4.11.1002/37020-5.json |
| 37021-3 | XR Calcaneus - bilateral Ski jump Views | ./2.16.840.1.114222.4.11.1002/37021-3.json |
| 37022-1 | XR Calcaneus Ski jump Views | ./2.16.840.1.114222.4.11.1002/37022-1.json |
| 37023-9 | XR Calcaneus - left Ski jump Views | ./2.16.840.1.114222.4.11.1002/37023-9.json |
| 37024-7 | XR Shoulder - bilateral Stryker Notch | ./2.16.840.1.114222.4.11.1002/37024-7.json |
| 37025-4 | XR Shoulder - left Stryker Notch | ./2.16.840.1.114222.4.11.1002/37025-4.json |
| 37026-2 | XR Skull Submentovertex | ./2.16.840.1.114222.4.11.1002/37026-2.json |
| 37027-0 | XR Knee - bilateral Sunrise | ./2.16.840.1.114222.4.11.1002/37027-0.json |
| 3702-8 | Ketobemidone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3702-8.json |
| 37028-8 | MG Breast Tangential | ./2.16.840.1.114222.4.11.1002/37028-8.json |
| 37029-6 | MG Breast - bilateral Tangential | ./2.16.840.1.114222.4.11.1002/37029-6.json |
| 37030-4 | MG Breast - left Tangential | ./2.16.840.1.114222.4.11.1002/37030-4.json |
| 37031-2 | XR Humerus Transthoracic | ./2.16.840.1.114222.4.11.1002/37031-2.json |
| 37032-0 | XR Humerus - bilateral Transthoracic | ./2.16.840.1.114222.4.11.1002/37032-0.json |
| 37033-8 | XR Humerus - left Transthoracic | ./2.16.840.1.114222.4.11.1002/37033-8.json |
| 37034-6 | XR Shoulder - left Transthoracic | ./2.16.840.1.114222.4.11.1002/37034-6.json |
| 37035-3 | XR Shoulder - bilateral Grashey | ./2.16.840.1.114222.4.11.1002/37035-3.json |
| 3703-6 | Ketobemidone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3703-6.json |
| 37037-9 | MG Breast True lateral | ./2.16.840.1.114222.4.11.1002/37037-9.json |
| 37038-7 | MG Breast - bilateral True lateral | ./2.16.840.1.114222.4.11.1002/37038-7.json |
| 37039-5 | XR Hip True lateral | ./2.16.840.1.114222.4.11.1002/37039-5.json |
| 37040-3 | XR Hip - left True lateral | ./2.16.840.1.114222.4.11.1002/37040-3.json |
| 37041-1 | XR Knee - bilateral Tunnel | ./2.16.840.1.114222.4.11.1002/37041-1.json |
| 37042-9 | XR Knee - left Tunnel | ./2.16.840.1.114222.4.11.1002/37042-9.json |
| 37043-7 | XR Knee - left Tunnel W standing | ./2.16.840.1.114222.4.11.1002/37043-7.json |
| 3704-4 | Labetalol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3704-4.json |
| 37044-5 | XR Wrist - left Ulnar deviation | ./2.16.840.1.114222.4.11.1002/37044-5.json |
| 37045-2 | XR Wrist - bilateral Ulnar deviation | ./2.16.840.1.114222.4.11.1002/37045-2.json |
| 37046-0 | XR Abdomen Upright | ./2.16.840.1.114222.4.11.1002/37046-0.json |
| 37047-8 | XR Shoulder - bilateral Velpeau axillary | ./2.16.840.1.114222.4.11.1002/37047-8.json |
| 37048-6 | XR Shoulder - left Velpeau axillary | ./2.16.840.1.114222.4.11.1002/37048-6.json |
| 37049-4 | XR Hip Von Rosen | ./2.16.840.1.114222.4.11.1002/37049-4.json |
| 37050-2 | XR Shoulder - bilateral West Point | ./2.16.840.1.114222.4.11.1002/37050-2.json |
| 3705-1 | Labetalol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3705-1.json |
| 37051-0 | XR Shoulder - left West Point | ./2.16.840.1.114222.4.11.1002/37051-0.json |
| 37052-8 | MG Breast - bilateral XCCL | ./2.16.840.1.114222.4.11.1002/37052-8.json |
| 37053-6 | MG Breast - left XCCL | ./2.16.840.1.114222.4.11.1002/37053-6.json |
| 37054-4 | XR Scapula - left Y | ./2.16.840.1.114222.4.11.1002/37054-4.json |
| 37055-1 | XR Scapula - bilateral Y | ./2.16.840.1.114222.4.11.1002/37055-1.json |
| 37056-9 | XR Acromioclavicular joint - bilateral Zanca | ./2.16.840.1.114222.4.11.1002/37056-9.json |
| 37057-7 | XR Acromioclavicular joint - left Zanca | ./2.16.840.1.114222.4.11.1002/37057-7.json |
| 37058-5 | XR Calcaneus - bilateral Single view W standing | ./2.16.840.1.114222.4.11.1002/37058-5.json |
| 37059-3 | XR Hip - bilateral Single view W standing | ./2.16.840.1.114222.4.11.1002/37059-3.json |
| 37060-1 | XR Fetal Views | ./2.16.840.1.114222.4.11.1002/37060-1.json |
| 37062-7 | XR Humerus - bilateral Views | ./2.16.840.1.114222.4.11.1002/37062-7.json |
| 37063-5 | RF Unspecified body region Views for foreign body | ./2.16.840.1.114222.4.11.1002/37063-5.json |
| 37064-3 | XR Acetabulum - left 2 Views | ./2.16.840.1.114222.4.11.1002/37064-3.json |
| 37066-8 | XR Ribs - left 2 Views | ./2.16.840.1.114222.4.11.1002/37066-8.json |
| 37067-6 | XR Chest 2 Views W nipple markers | ./2.16.840.1.114222.4.11.1002/37067-6.json |
| 37068-4 | XR Foot - bilateral 2 Views W standing | ./2.16.840.1.114222.4.11.1002/37068-4.json |
| 3706-9 | Labetalol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3706-9.json |
| 37069-2 | XR Foot - left 2 Views W standing | ./2.16.840.1.114222.4.11.1002/37069-2.json |
| 37070-0 | XR Wrist - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/37070-0.json |
| 37071-8 | XR Wrist - left 4 Views | ./2.16.840.1.114222.4.11.1002/37071-8.json |
| 37072-6 | XR Wrist - left 5 Views | ./2.16.840.1.114222.4.11.1002/37072-6.json |
| 37073-4 | XR Lumbar spine 5 Views W standing | ./2.16.840.1.114222.4.11.1002/37073-4.json |
| 37074-2 | XR Wrist - left 6 Views | ./2.16.840.1.114222.4.11.1002/37074-2.json |
| 37075-9 | Portable XR Hip Views AP | ./2.16.840.1.114222.4.11.1002/37075-9.json |
| 37076-7 | Portable XR Abdomen Supine and Lateral-decubitus | ./2.16.840.1.114222.4.11.1002/37076-7.json |
| 3707-7 | Labetalol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3707-7.json |
| 37077-5 | Portable XR Hip AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37077-5.json |
| 37078-3 | Portable XR Lumbar spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/37078-3.json |
| 37079-1 | Portable XR Cervical spine AP and Lateral and Odontoid | ./2.16.840.1.114222.4.11.1002/37079-1.json |
| 37080-9 | XR Shoulder - bilateral AP and Axillary | ./2.16.840.1.114222.4.11.1002/37080-9.json |
| 37081-7 | XR Shoulder - bilateral AP and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/37081-7.json |
| 37082-5 | XR Shoulder - left AP and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/37082-5.json |
| 37083-3 | XR Shoulder - left AP and Axillary and Outlet and Zanca | ./2.16.840.1.114222.4.11.1002/37083-3.json |
| 37084-1 | XR Shoulder - left AP and Axillary and Y | ./2.16.840.1.114222.4.11.1002/37084-1.json |
| 3708-5 | Methotrimeprazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3708-5.json |
| 37085-8 | XR Abdomen Supine and Lateral-decubitus | ./2.16.840.1.114222.4.11.1002/37085-8.json |
| 37086-6 | XR Hip AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37086-6.json |
| 37087-4 | XR Hip - left AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37087-4.json |
| 37088-2 | XR Pelvis and Hip - left AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37088-2.json |
| 37089-0 | XR Pelvis and Hip AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37089-0.json |
| 37090-8 | XR Knee AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37090-8.json |
| 37091-6 | XR Hip AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/37091-6.json |
| 37092-4 | XR Hip - bilateral AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/37092-4.json |
| 37093-2 | XR Hip - left AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/37093-2.json |
| 37094-0 | XR Pelvis and Hip - left AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/37094-0.json |
| 37095-7 | XR Ankle AP and Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37095-7.json |
| 37096-5 | XR Ankle - bilateral AP and Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37096-5.json |
| 37097-3 | XR Ankle - left AP and Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37097-3.json |
| 37098-1 | XR Cervical spine AP and Oblique and (Lateral W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/37098-1.json |
| 37099-9 | XR Cervical spine AP and Lateral and Oblique and Odontoid | ./2.16.840.1.114222.4.11.1002/37099-9.json |
| 37100-5 | XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/37100-5.json |
| 3710-1 | Levorphanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3710-1.json |
| 37101-3 | XR Lumbar spine AP and Lateral and Oblique and Spot | ./2.16.840.1.114222.4.11.1002/37101-3.json |
| 37102-1 | XR Knee - bilateral AP and Lateral and Oblique and Sunrise | ./2.16.840.1.114222.4.11.1002/37102-1.json |
| 37103-9 | XR Cervical spine AP and Lateral and Odontoid | ./2.16.840.1.114222.4.11.1002/37103-9.json |
| 37104-7 | XR Cervical spine AP and Odontoid and (Lateral W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/37104-7.json |
| 37105-4 | XR Lumbar spine AP and Lateral and Spot | ./2.16.840.1.114222.4.11.1002/37105-4.json |
| 37106-2 | XR Knee AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37106-2.json |
| 37107-0 | XR Knee - bilateral AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37107-0.json |
| 37108-8 | XR Knee - left AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37108-8.json |
| 37109-6 | XR Patella - bilateral AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37109-6.json |
| 37110-4 | XR Patella - left AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37110-4.json |
| 37111-2 | XR Knee AP and Lateral and Sunrise and tunnel | ./2.16.840.1.114222.4.11.1002/37111-2.json |
| 37112-0 | XR Knee AP and Lateral and Tunnel | ./2.16.840.1.114222.4.11.1002/37112-0.json |
| 37113-8 | XR Knee - bilateral AP and Lateral and Tunnel | ./2.16.840.1.114222.4.11.1002/37113-8.json |
| 37114-6 | XR Knee - left AP and Lateral and Tunnel | ./2.16.840.1.114222.4.11.1002/37114-6.json |
| 37115-3 | XR Knee AP and Lateral and Oblique and Tunnel | ./2.16.840.1.114222.4.11.1002/37115-3.json |
| 37116-1 | XR Knee - bilateral AP and Lateral and Sunrise and tunnel | ./2.16.840.1.114222.4.11.1002/37116-1.json |
| 37117-9 | XR Knee - left AP and Lateral and Sunrise and tunnel | ./2.16.840.1.114222.4.11.1002/37117-9.json |
| 37118-7 | XR Knee - bilateral AP and Lateral and Oblique and Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/37118-7.json |
| 3711-9 | Levorphanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3711-9.json |
| 37119-5 | XR Abdomen AP and Oblique | ./2.16.840.1.114222.4.11.1002/37119-5.json |
| 37120-3 | XR Cervical spine AP and Odontoid and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37120-3.json |
| 37121-1 | XR Clavicle - left AP and Serendipity | ./2.16.840.1.114222.4.11.1002/37121-1.json |
| 37122-9 | XR Shoulder - left AP and Stryker Notch | ./2.16.840.1.114222.4.11.1002/37122-9.json |
| 37123-7 | XR Shoulder - left AP and West Point | ./2.16.840.1.114222.4.11.1002/37123-7.json |
| 37124-5 | XR Scapula - left AP and Y | ./2.16.840.1.114222.4.11.1002/37124-5.json |
| 37125-2 | XR Shoulder - left AP and Y | ./2.16.840.1.114222.4.11.1002/37125-2.json |
| 37126-0 | XR Shoulder - bilateral AP and Axillary and Y | ./2.16.840.1.114222.4.11.1002/37126-0.json |
| 3712-7 | Levorphanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3712-7.json |
| 37127-8 | XR Shoulder - bilateral Axillary and Y | ./2.16.840.1.114222.4.11.1002/37127-8.json |
| 37128-6 | XR Shoulder - left Axillary and Y | ./2.16.840.1.114222.4.11.1002/37128-6.json |
| 37131-0 | XR Abdomen Right lateral and Left lateral | ./2.16.840.1.114222.4.11.1002/37131-0.json |
| 37132-8 | XR Lumbar spine Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/37132-8.json |
| 37133-6 | XR Cervical spine Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/37133-6.json |
| 37134-4 | XR Ankle - bilateral Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37134-4.json |
| 3713-5 | Levorphanol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3713-5.json |
| 37135-1 | XR Ankle - left Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37135-1.json |
| 37136-9 | XR Shoulder - left Lateral and Y | ./2.16.840.1.114222.4.11.1002/37136-9.json |
| 37137-7 | XR Kidney Limited Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37137-7.json |
| 37138-5 | XR Abdomen Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/37138-5.json |
| 37139-3 | XR Cervical spine Oblique and (Lateral W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/37139-3.json |
| 37140-1 | XR Shoulder - left Outlet and Y | ./2.16.840.1.114222.4.11.1002/37140-1.json |
| 37141-9 | XR Chest PA and Right lateral | ./2.16.840.1.114222.4.11.1002/37141-9.json |
| 37142-7 | XR Hand - bilateral PA and Lateral and Ball Catcher | ./2.16.840.1.114222.4.11.1002/37142-7.json |
| 3714-3 | Lidocaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3714-3.json |
| 37143-5 | XR Chest PA and Lateral and AP lateral-decubitus | ./2.16.840.1.114222.4.11.1002/37143-5.json |
| 37144-3 | XR Chest PA and Lateral and AP left lateral-decubitus | ./2.16.840.1.114222.4.11.1002/37144-3.json |
| 37145-0 | XR Chest PA and Lateral and AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/37145-0.json |
| 37146-8 | XR Chest PA and Lateral and Left oblique | ./2.16.840.1.114222.4.11.1002/37146-8.json |
| 37147-6 | XR Chest PA and Lateral and Right oblique | ./2.16.840.1.114222.4.11.1002/37147-6.json |
| 37148-4 | XR Mandible PA and Lateral and Oblique and Towne | ./2.16.840.1.114222.4.11.1002/37148-4.json |
| 37149-2 | XR Patella - left PA and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37149-2.json |
| 3715-0 | Lidocaine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3715-0.json |
| 37150-0 | XR Chest PA and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/37150-0.json |
| 37151-8 | Portable RF Unspecified body region Views | ./2.16.840.1.114222.4.11.1002/37151-8.json |
| 37152-6 | XR Shoulder - bilateral Outlet and Y | ./2.16.840.1.114222.4.11.1002/37152-6.json |
| 37153-4 | XR Mastoid Stenver and Arcelin | ./2.16.840.1.114222.4.11.1002/37153-4.json |
| 37154-2 | XR Knee Oblique and Sunrise | ./2.16.840.1.114222.4.11.1002/37154-2.json |
| 37155-9 | XR Knee Oblique and Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/37155-9.json |
| 37156-7 | XR Knee - left Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/37156-7.json |
| 37157-5 | XR Shoulder - left Grashey and Outlet | ./2.16.840.1.114222.4.11.1002/37157-5.json |
| 37158-3 | XR Shoulder - left Grashey and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/37158-3.json |
| 37160-9 | XR Shoulder - left Grashey and Axillary | ./2.16.840.1.114222.4.11.1002/37160-9.json |
| 37161-7 | XR Shoulder - bilateral Grashey and Axillary and Outlet and Zanca | ./2.16.840.1.114222.4.11.1002/37161-7.json |
| 37162-5 | XR Shoulder - left Grashey and Outlet and Serendipity | ./2.16.840.1.114222.4.11.1002/37162-5.json |
| 37163-3 | XR Knee - bilateral Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/37163-3.json |
| 37164-1 | XR Facial bones Lateral and Caldwell and Waters | ./2.16.840.1.114222.4.11.1002/37164-1.json |
| 37165-8 | XR Facial bones Lateral and Caldwell and Waters and Submentovertex | ./2.16.840.1.114222.4.11.1002/37165-8.json |
| 37166-6 | XR Facial bones Lateral and Caldwell and Waters and Submentovertex and Towne | ./2.16.840.1.114222.4.11.1002/37166-6.json |
| 37167-4 | XR Shoulder - left Grashey and West Point | ./2.16.840.1.114222.4.11.1002/37167-4.json |
| 3716-8 | Lidocaine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3716-8.json |
| 37168-2 | Portable XR Hip Views | ./2.16.840.1.114222.4.11.1002/37168-2.json |
| 37169-0 | Portable XR Hip - left Views | ./2.16.840.1.114222.4.11.1002/37169-0.json |
| 37170-8 | Portable XR Humerus Views | ./2.16.840.1.114222.4.11.1002/37170-8.json |
| 37171-6 | Portable XR Cervical spine Views | ./2.16.840.1.114222.4.11.1002/37171-6.json |
| 37172-4 | Portable XR Lumbar spine Views | ./2.16.840.1.114222.4.11.1002/37172-4.json |
| 37173-2 | RFA Cerebral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37173-2.json |
| 37174-0 | RFA Coronary arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37174-0.json |
| 37175-7 | RFA Femoral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37175-7.json |
| 3717-6 | Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose | ./2.16.840.1.114222.4.11.1002/3717-6.json |
| 37176-5 | RFA Femoral artery and Popliteal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37176-5.json |
| 37177-3 | RFA Iliac artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37177-3.json |
| 37178-1 | RFA Iliac artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37178-1.json |
| 37179-9 | RFA Inferior mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37179-9.json |
| 37180-7 | RFA Superior mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37180-7.json |
| 37181-5 | RFA Popliteal artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37181-5.json |
| 37182-3 | RFA Pulmonary arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37182-3.json |
| 37183-1 | RF Ankle Arthrogram | ./2.16.840.1.114222.4.11.1002/37183-1.json |
| 3718-4 | Lithium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/3718-4.json |
| 37184-9 | RF Ankle - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/37184-9.json |
| 37185-6 | RF Ankle - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37185-6.json |
| 37186-4 | RF Elbow Arthrogram | ./2.16.840.1.114222.4.11.1002/37186-4.json |
| 37187-2 | RF Elbow - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/37187-2.json |
| 37188-0 | RF Elbow - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37188-0.json |
| 37189-8 | RF Sacroiliac joint - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/37189-8.json |
| 37190-6 | RF Sacroiliac joint - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37190-6.json |
| 37191-4 | RF Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/37191-4.json |
| 3719-2 | Lithium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3719-2.json |
| 37192-2 | RF Cervical spine Views W contrast intradisc | ./2.16.840.1.114222.4.11.1002/37192-2.json |
| 37193-0 | RF Lumbar spine Views W contrast intradisc | ./2.16.840.1.114222.4.11.1002/37193-0.json |
| 37195-5 | RFA Cerebral vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37195-5.json |
| 37196-3 | RFA Lower extremity veins - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37196-3.json |
| 37198-9 | XR Esophagus Views W contrast PO | ./2.16.840.1.114222.4.11.1002/37198-9.json |
| 37199-7 | RF Chest Views W contrast PO | ./2.16.840.1.114222.4.11.1002/37199-7.json |
| 3720-0 | Lithium [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3720-0.json |
| 37200-3 | XR Chest Views W contrast PO | ./2.16.840.1.114222.4.11.1002/37200-3.json |
| 37201-1 | XR Ankle Views W standing | ./2.16.840.1.114222.4.11.1002/37201-1.json |
| 37202-9 | XR Ankle - bilateral Views W standing | ./2.16.840.1.114222.4.11.1002/37202-9.json |
| 37203-7 | XR Ankle - left Views W standing | ./2.16.840.1.114222.4.11.1002/37203-7.json |
| 37204-5 | XR Lower extremity Views W standing | ./2.16.840.1.114222.4.11.1002/37204-5.json |
| 37205-2 | XR Calcaneus Views W standing | ./2.16.840.1.114222.4.11.1002/37205-2.json |
| 37206-0 | XR Calcaneus - left Views W standing | ./2.16.840.1.114222.4.11.1002/37206-0.json |
| 37207-8 | XR Hip - left Single view W standing | ./2.16.840.1.114222.4.11.1002/37207-8.json |
| 37208-6 | XR Lumbar spine Views W standing | ./2.16.840.1.114222.4.11.1002/37208-6.json |
| 37209-4 | XR Toes - left Views W standing | ./2.16.840.1.114222.4.11.1002/37209-4.json |
| 37210-2 | CT Guidance for aspiration of cyst of Abdomen | ./2.16.840.1.114222.4.11.1002/37210-2.json |
| 37211-0 | CT Guidance for biopsy of Bone marrow | ./2.16.840.1.114222.4.11.1002/37211-0.json |
| 37212-8 | CT Guidance for biopsy of Epididymis | ./2.16.840.1.114222.4.11.1002/37212-8.json |
| 37213-6 | CT Guidance for biopsy of Mediastinum | ./2.16.840.1.114222.4.11.1002/37213-6.json |
| 37214-4 | CT Guidance for superficial biopsy of Tissue | ./2.16.840.1.114222.4.11.1002/37214-4.json |
| 37215-1 | MR Brain and Larynx W contrast IV | ./2.16.840.1.114222.4.11.1002/37215-1.json |
| 37217-7 | MR Brain stem and Cranial nerves | ./2.16.840.1.114222.4.11.1002/37217-7.json |
| 3721-8 | Lithium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3721-8.json |
| 37218-5 | MR Brain.temporal | ./2.16.840.1.114222.4.11.1002/37218-5.json |
| 37219-3 | MR Biliary ducts | ./2.16.840.1.114222.4.11.1002/37219-3.json |
| 37220-1 | MR Biliary ducts and Pancreatic duct | ./2.16.840.1.114222.4.11.1002/37220-1.json |
| 37221-9 | CT Unspecified body region for fistula | ./2.16.840.1.114222.4.11.1002/37221-9.json |
| 37222-7 | MR Ankle and Foot | ./2.16.840.1.114222.4.11.1002/37222-7.json |
| 37223-5 | CT Parotid gland | ./2.16.840.1.114222.4.11.1002/37223-5.json |
| 37224-3 | MR Parotid gland | ./2.16.840.1.114222.4.11.1002/37224-3.json |
| 37225-0 | CT Sternoclavicular Joint | ./2.16.840.1.114222.4.11.1002/37225-0.json |
| 3722-6 | Lithium renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3722-6.json |
| 37226-8 | CT Temporomandibular joint | ./2.16.840.1.114222.4.11.1002/37226-8.json |
| 37227-6 | XR tomography Temporomandibular joint - bilateral | ./2.16.840.1.114222.4.11.1002/37227-6.json |
| 37228-4 | MR Temporomandibular joint - bilateral | ./2.16.840.1.114222.4.11.1002/37228-4.json |
| 37229-2 | XR tomography Temporomandibular joint - left | ./2.16.840.1.114222.4.11.1002/37229-2.json |
| 37230-0 | MR Temporomandibular joint - left | ./2.16.840.1.114222.4.11.1002/37230-0.json |
| 37231-8 | MR Temporomandibular joint - right | ./2.16.840.1.114222.4.11.1002/37231-8.json |
| 37232-6 | CT Spine lumbosacral junction | ./2.16.840.1.114222.4.11.1002/37232-6.json |
| 37233-4 | XR tomography Mediastinum | ./2.16.840.1.114222.4.11.1002/37233-4.json |
| 3723-4 | Lithium [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3723-4.json |
| 37234-2 | MR Mediastinum | ./2.16.840.1.114222.4.11.1002/37234-2.json |
| 37235-9 | MRA Circle of Willis | ./2.16.840.1.114222.4.11.1002/37235-9.json |
| 37237-5 | CT Sinus tract W contrast intra sinus tract | ./2.16.840.1.114222.4.11.1002/37237-5.json |
| 37238-3 | CT Lower Extremity Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/37238-3.json |
| 37239-1 | MR Brain and Internal auditory canal W contrast IV | ./2.16.840.1.114222.4.11.1002/37239-1.json |
| 37240-9 | CT Parotid gland W contrast IV | ./2.16.840.1.114222.4.11.1002/37240-9.json |
| 37241-7 | MR Parotid gland W contrast IV | ./2.16.840.1.114222.4.11.1002/37241-7.json |
| 3724-2 | LORazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3724-2.json |
| 37242-5 | CT Sternoclavicular Joint W contrast IV | ./2.16.840.1.114222.4.11.1002/37242-5.json |
| 37243-3 | CT Temporomandibular joint W contrast IV | ./2.16.840.1.114222.4.11.1002/37243-3.json |
| 37244-1 | MR Temporomandibular joint W contrast IV | ./2.16.840.1.114222.4.11.1002/37244-1.json |
| 37245-8 | MR Temporomandibular joint - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/37245-8.json |
| 37246-6 | CT Temporomandibular joint - left W contrast IV | ./2.16.840.1.114222.4.11.1002/37246-6.json |
| 37247-4 | MR Temporomandibular joint - left W contrast IV | ./2.16.840.1.114222.4.11.1002/37247-4.json |
| 37248-2 | CT Temporomandibular joint - right W contrast IV | ./2.16.840.1.114222.4.11.1002/37248-2.json |
| 37249-0 | MR Temporomandibular joint - right W contrast IV | ./2.16.840.1.114222.4.11.1002/37249-0.json |
| 37253-2 | MR Soft tissue W contrast IV | ./2.16.840.1.114222.4.11.1002/37253-2.json |
| 37254-0 | MRA Circle of Willis W contrast IV | ./2.16.840.1.114222.4.11.1002/37254-0.json |
| 37256-5 | XR Pelvis and Spine Lumbar 3 Views | ./2.16.840.1.114222.4.11.1002/37256-5.json |
| 37257-3 | XR Spine Lumbar and Sacroiliac Joint 3 Views | ./2.16.840.1.114222.4.11.1002/37257-3.json |
| 3725-9 | LORazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3725-9.json |
| 37259-9 | XR Spine Lumbar and Sacrum 3 Views | ./2.16.840.1.114222.4.11.1002/37259-9.json |
| 37260-7 | XR Spine Lumbar and Sacrum and Coccyx 3 Views | ./2.16.840.1.114222.4.11.1002/37260-7.json |
| 37261-5 | XR Lumbar spine and Sacrum and SI joint and Coccyx 3 Views | ./2.16.840.1.114222.4.11.1002/37261-5.json |
| 37265-6 | MR Parotid gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37265-6.json |
| 37266-4 | CT Sternoclavicular Joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37266-4.json |
| 3726-7 | Lormetazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3726-7.json |
| 37267-2 | CT Temporomandibular joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37267-2.json |
| 37268-0 | MR Temporomandibular joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37268-0.json |
| 37269-8 | MR Temporomandibular joint - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37269-8.json |
| 37270-6 | MR Temporomandibular joint - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37270-6.json |
| 37271-4 | MR Temporomandibular joint - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37271-4.json |
| 37272-2 | MR Mediastinum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37272-2.json |
| 3727-5 | Loxapine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3727-5.json |
| 37277-1 | MRA Spinal veins WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37277-1.json |
| 37278-9 | MR Brain and Internal auditory canal WO contrast | ./2.16.840.1.114222.4.11.1002/37278-9.json |
| 37279-7 | MR Brain and Larynx WO contrast | ./2.16.840.1.114222.4.11.1002/37279-7.json |
| 37280-5 | CT Parotid gland WO contrast | ./2.16.840.1.114222.4.11.1002/37280-5.json |
| 37281-3 | MR Parotid gland WO contrast | ./2.16.840.1.114222.4.11.1002/37281-3.json |
| 37282-1 | CT Sternoclavicular Joint WO contrast | ./2.16.840.1.114222.4.11.1002/37282-1.json |
| 3728-3 | Loxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3728-3.json |
| 37283-9 | CT Temporomandibular joint WO contrast | ./2.16.840.1.114222.4.11.1002/37283-9.json |
| 37284-7 | MR Temporomandibular joint WO contrast | ./2.16.840.1.114222.4.11.1002/37284-7.json |
| 37285-4 | MR Temporomandibular joint - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/37285-4.json |
| 37286-2 | MR Temporomandibular joint - left WO contrast | ./2.16.840.1.114222.4.11.1002/37286-2.json |
| 37287-0 | MR Temporomandibular joint - right WO contrast | ./2.16.840.1.114222.4.11.1002/37287-0.json |
| 37288-8 | CT Spine lumbosacral junction WO contrast | ./2.16.840.1.114222.4.11.1002/37288-8.json |
| 3729-1 | Loxapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3729-1.json |
| 37293-8 | MR Soft tissue WO contrast | ./2.16.840.1.114222.4.11.1002/37293-8.json |
| 37297-9 | XR Abdomen and Fetal Single view for fetal age | ./2.16.840.1.114222.4.11.1002/37297-9.json |
| 37298-7 | XR Sternoclavicular joint - bilateral Serendipity | ./2.16.840.1.114222.4.11.1002/37298-7.json |
| 37299-5 | XR Sternoclavicular joint - left Serendipity | ./2.16.840.1.114222.4.11.1002/37299-5.json |
| 37300-1 | XR Spine lumbosacral junction True AP | ./2.16.840.1.114222.4.11.1002/37300-1.json |
| 37302-7 | XR Wrist - left Scaphoid Views | ./2.16.840.1.114222.4.11.1002/37302-7.json |
| 37303-5 | XR Facial bones and Zygomatic arch Views | ./2.16.840.1.114222.4.11.1002/37303-5.json |
| 37304-3 | XR Wrist - bilateral Scaphoid Views | ./2.16.840.1.114222.4.11.1002/37304-3.json |
| 3730-9 | Lysergate diethylamide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3730-9.json |
| 3731-7 | Lysergate diethylamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3731-7.json |
| 37319-1 | XR Humerus bicipital groove Views | ./2.16.840.1.114222.4.11.1002/37319-1.json |
| 37320-9 | XR Humerus bicipital groove - left Views | ./2.16.840.1.114222.4.11.1002/37320-9.json |
| 37321-7 | XR Humerus bicipital groove - bilateral Views | ./2.16.840.1.114222.4.11.1002/37321-7.json |
| 37323-3 | XR Sternoclavicular joint - bilateral Views | ./2.16.840.1.114222.4.11.1002/37323-3.json |
| 37324-1 | XR Sternoclavicular joint - left Views | ./2.16.840.1.114222.4.11.1002/37324-1.json |
| 3732-5 | Lysergate diethylamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3732-5.json |
| 37325-8 | XR Temporomandibular joint - bilateral Views | ./2.16.840.1.114222.4.11.1002/37325-8.json |
| 37332-4 | XR Olecranon - left Views | ./2.16.840.1.114222.4.11.1002/37332-4.json |
| 37338-1 | XR Skull and Facial bones and Mandible Views | ./2.16.840.1.114222.4.11.1002/37338-1.json |
| 37340-7 | XR Spine Lumbar and Sacrum Views | ./2.16.840.1.114222.4.11.1002/37340-7.json |
| 3734-1 | Maprotiline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3734-1.json |
| 37341-5 | XR Spine Lumbar and Sacrum and Coccyx Views | ./2.16.840.1.114222.4.11.1002/37341-5.json |
| 37342-3 | XR Lumbar spine and Sacrum and SI joint and Coccyx Views | ./2.16.840.1.114222.4.11.1002/37342-3.json |
| 37348-0 | XR Toes - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/37348-0.json |
| 37350-6 | XR Temporomandibular joint - bilateral 5 Views | ./2.16.840.1.114222.4.11.1002/37350-6.json |
| 37351-4 | XR Pelvis and Spine Lumbar 5 Views | ./2.16.840.1.114222.4.11.1002/37351-4.json |
| 37353-0 | XR Spine Lumbar and Sacroiliac Joint 5 Views | ./2.16.840.1.114222.4.11.1002/37353-0.json |
| 37355-5 | XR Spine Lumbar and Sacrum 5 Views | ./2.16.840.1.114222.4.11.1002/37355-5.json |
| 37356-3 | XR Spine Lumbar and Sacrum and Coccyx 5 Views | ./2.16.840.1.114222.4.11.1002/37356-3.json |
| 37357-1 | XR Lumbar spine and Sacrum and SI joint and Coccyx 5 Views | ./2.16.840.1.114222.4.11.1002/37357-1.json |
| 3735-8 | Maprotiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3735-8.json |
| 37361-3 | XR Cervical and thoracic spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/37361-3.json |
| 37362-1 | XR Bones Bone age Views | ./2.16.840.1.114222.4.11.1002/37362-1.json |
| 37364-7 | RFA Aorta and Femoral artery - left Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/37364-7.json |
| 37365-4 | XR Bones Survey Views for metastasis | ./2.16.840.1.114222.4.11.1002/37365-4.json |
| 3737-4 | Maprotiline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3737-4.json |
| 37379-5 | RFA Aortic arch and Upper Extremity artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37379-5.json |
| 37380-3 | RFA Aortic arch and Brachial artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37380-3.json |
| 37381-1 | RFA Carotid artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37381-1.json |
| 3738-2 | Maprotiline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3738-2.json |
| 37382-9 | RFA Aortic arch and Subclavian artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37382-9.json |
| 37383-7 | RFA Aortic arch and Subclavian artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37383-7.json |
| 37384-5 | RFA Vertebral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37384-5.json |
| 37385-2 | RFA Aortic arch and Vertebral artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37385-2.json |
| 37386-0 | RFA Aortic arch and Vertebral artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37386-0.json |
| 37387-8 | RFA Adrenal artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37387-8.json |
| 37388-6 | RFA Brachial artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37388-6.json |
| 37389-4 | RFA Bronchial artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37389-4.json |
| 3739-0 | Medazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3739-0.json |
| 37390-2 | RFA Carotid artery.external - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37390-2.json |
| 37391-0 | RFA Carotid arteries and Vertebral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37391-0.json |
| 37392-8 | RFA Carotid arteries and Vertebral artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37392-8.json |
| 37393-6 | RFA Carotid arteries and Vertebral artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37393-6.json |
| 37394-4 | RFA Celiac artery and Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37394-4.json |
| 37395-1 | RFA Extremity arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37395-1.json |
| 37396-9 | RFA Upper extremity arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37396-9.json |
| 37397-7 | RFA Gastric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37397-7.json |
| 37398-5 | RFA Gastric artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37398-5.json |
| 37399-3 | RFA Gastroduodenal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37399-3.json |
| 37401-7 | RFA Internal maxillary artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37401-7.json |
| 37402-5 | RFA Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37402-5.json |
| 37403-3 | RFA Celiac artery and Gastric artery - left and Superior mesenteric artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37403-3.json |
| 37404-1 | RFA Internal pudendal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37404-1.json |
| 37405-8 | RFA Subclavian artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37405-8.json |
| 37406-6 | RFA Subclavian artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37406-6.json |
| 37407-4 | RFA Vertebral artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37407-4.json |
| 3740-8 | Medazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3740-8.json |
| 37409-0 | RF Temporomandibular joint - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/37409-0.json |
| 37410-8 | RF Temporomandibular joint - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37410-8.json |
| 37411-6 | RFA Azygos vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37411-6.json |
| 37412-4 | RFA Extremity veins - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37412-4.json |
| 37413-2 | RFA Extremity veins - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37413-2.json |
| 37414-0 | RFA Lower extremity veins - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37414-0.json |
| 37415-7 | RFA Upper extremity veins - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37415-7.json |
| 3741-6 | Mefenorex [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3741-6.json |
| 37416-5 | RFA Femoral vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37416-5.json |
| 37419-9 | RFA Intraosseous veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37419-9.json |
| 37421-5 | RFA Inferior mesenteric vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37421-5.json |
| 37422-3 | RFA Orbit veins - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37422-3.json |
| 37423-1 | RFA Renal vein - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37423-1.json |
| 3742-4 | Mefenorex [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3742-4.json |
| 37424-9 | Perchlorate [Mass/volume] in Specimen by HPLC | ./2.16.840.1.114222.4.11.1002/37424-9.json |
| 37425-6 | Abnormal Prion Protein [Presence] in Brain by Immunoassay | ./2.16.840.1.114222.4.11.1002/37425-6.json |
| 37426-4 | RFA Guidance for angioplasty of Lower extremity vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/37426-4.json |
| 37427-2 | RF Guidance for injection of Spine | ./2.16.840.1.114222.4.11.1002/37427-2.json |
| 37428-0 | CT Wrist | ./2.16.840.1.114222.4.11.1002/37428-0.json |
| 37429-8 | XR tomography Wrist - bilateral | ./2.16.840.1.114222.4.11.1002/37429-8.json |
| 37430-6 | CT Wrist - bilateral | ./2.16.840.1.114222.4.11.1002/37430-6.json |
| 37431-4 | CT Wrist - left | ./2.16.840.1.114222.4.11.1002/37431-4.json |
| 3743-2 | Mefenorex [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3743-2.json |
| 37432-2 | XR tomography Wrist - left | ./2.16.840.1.114222.4.11.1002/37432-2.json |
| 37433-0 | CT Wrist - right | ./2.16.840.1.114222.4.11.1002/37433-0.json |
| 37434-8 | MR Heart cine for function | ./2.16.840.1.114222.4.11.1002/37434-8.json |
| 37435-5 | MR Temporomandibular joint cine | ./2.16.840.1.114222.4.11.1002/37435-5.json |
| 37437-1 | MR Breast dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/37437-1.json |
| 37439-7 | CT Lung parenchyma | ./2.16.840.1.114222.4.11.1002/37439-7.json |
| 3744-0 | Meperidine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3744-0.json |
| 37440-5 | CT Lung parenchyma W contrast IV | ./2.16.840.1.114222.4.11.1002/37440-5.json |
| 37441-3 | CT Lung parenchyma WO contrast | ./2.16.840.1.114222.4.11.1002/37441-3.json |
| 37442-1 | MR spectroscopy Brain | ./2.16.840.1.114222.4.11.1002/37442-1.json |
| 37443-9 | MR spectroscopy Unspecified body region | ./2.16.840.1.114222.4.11.1002/37443-9.json |
| 37444-7 | MR Wrist Arthrogram | ./2.16.840.1.114222.4.11.1002/37444-7.json |
| 37445-4 | MR Wrist - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37445-4.json |
| 37446-2 | MR Wrist - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37446-2.json |
| 37447-0 | CT Wrist W contrast IV | ./2.16.840.1.114222.4.11.1002/37447-0.json |
| 37448-8 | MR Wrist W contrast IV | ./2.16.840.1.114222.4.11.1002/37448-8.json |
| 37449-6 | MR Wrist - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/37449-6.json |
| 37450-4 | CT Wrist - left W contrast IV | ./2.16.840.1.114222.4.11.1002/37450-4.json |
| 37451-2 | MR Wrist - left W contrast IV | ./2.16.840.1.114222.4.11.1002/37451-2.json |
| 37452-0 | CT Wrist - right W contrast IV | ./2.16.840.1.114222.4.11.1002/37452-0.json |
| 37453-8 | MR Wrist - right W contrast IV | ./2.16.840.1.114222.4.11.1002/37453-8.json |
| 37454-6 | XR Wrist - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/37454-6.json |
| 37455-3 | XR Wrist - left 3 Views | ./2.16.840.1.114222.4.11.1002/37455-3.json |
| 3745-7 | Meperidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3745-7.json |
| 37457-9 | CT Wrist WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37457-9.json |
| 37458-7 | CT Wrist - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37458-7.json |
| 37459-5 | CT Wrist WO contrast | ./2.16.840.1.114222.4.11.1002/37459-5.json |
| 37460-3 | MR Wrist WO contrast | ./2.16.840.1.114222.4.11.1002/37460-3.json |
| 37461-1 | CT Wrist - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/37461-1.json |
| 37462-9 | MR Wrist - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/37462-9.json |
| 37463-7 | CT Wrist - left WO contrast | ./2.16.840.1.114222.4.11.1002/37463-7.json |
| 37464-5 | MR Wrist - left WO contrast | ./2.16.840.1.114222.4.11.1002/37464-5.json |
| 3746-5 | Meperidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3746-5.json |
| 37465-2 | CT Wrist - right WO contrast | ./2.16.840.1.114222.4.11.1002/37465-2.json |
| 37466-0 | MR Wrist - right WO contrast | ./2.16.840.1.114222.4.11.1002/37466-0.json |
| 37467-8 | XR Acromioclavicular Joint 10 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/37467-8.json |
| 37468-6 | XR Shoulder - bilateral 30 degree caudal angle | ./2.16.840.1.114222.4.11.1002/37468-6.json |
| 37469-4 | XR Clavicle - bilateral 45 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/37469-4.json |
| 37470-2 | XR Clavicle - left 45 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/37470-2.json |
| 37471-0 | XR Hand - bilateral Bora | ./2.16.840.1.114222.4.11.1002/37471-0.json |
| 37472-8 | XR Hand - left Bora | ./2.16.840.1.114222.4.11.1002/37472-8.json |
| 3747-3 | Meperidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3747-3.json |
| 37473-6 | XR Shoulder - left Grashey | ./2.16.840.1.114222.4.11.1002/37473-6.json |
| 37474-4 | XR Ankle - left Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/37474-4.json |
| 37475-1 | XR Ankle - left Mortise W manual stress | ./2.16.840.1.114222.4.11.1002/37475-1.json |
| 37476-9 | XR Knee PA 45 degree flexion | ./2.16.840.1.114222.4.11.1002/37476-9.json |
| 37477-7 | XR Knee PA 45 degree flexion W standing | ./2.16.840.1.114222.4.11.1002/37477-7.json |
| 3748-1 | Meperidine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3748-1.json |
| 37481-9 | XR Cervical and thoracic spine Views | ./2.16.840.1.114222.4.11.1002/37481-9.json |
| 37482-7 | XR Wrist - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/37482-7.json |
| 37483-5 | XR Wrist - left 2 Views | ./2.16.840.1.114222.4.11.1002/37483-5.json |
| 37484-3 | XR Knee - left Views AP W manual stress | ./2.16.840.1.114222.4.11.1002/37484-3.json |
| 37485-0 | XR Humerus AP and Transthoracic | ./2.16.840.1.114222.4.11.1002/37485-0.json |
| 37486-8 | XR Ankle Broden Views W manual stress | ./2.16.840.1.114222.4.11.1002/37486-8.json |
| 37487-6 | RFA Lower extremity arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37487-6.json |
| 37488-4 | RFA Upper extremity arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37488-4.json |
| 37489-2 | RFA Tibioperoneal arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37489-2.json |
| 37490-0 | RFA Vertebral artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37490-0.json |
| 37491-8 | CT Guidance for fluid aspiration of Pleural space | ./2.16.840.1.114222.4.11.1002/37491-8.json |
| 37492-6 | CT Guidance for biopsy of Chest Pleura | ./2.16.840.1.114222.4.11.1002/37492-6.json |
| 37493-4 | CT Guidance for injection of Cervical spine Intervertebral disc | ./2.16.840.1.114222.4.11.1002/37493-4.json |
| 37494-2 | RF Guidance for injection of Tendon | ./2.16.840.1.114222.4.11.1002/37494-2.json |
| 37495-9 | CT Skull base | ./2.16.840.1.114222.4.11.1002/37495-9.json |
| 37496-7 | CT Cervical spine W contrast intradisc | ./2.16.840.1.114222.4.11.1002/37496-7.json |
| 37497-5 | MRA Spine vessels | ./2.16.840.1.114222.4.11.1002/37497-5.json |
| 37498-3 | CTA Head vessels and Neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/37498-3.json |
| 3749-9 | Mephenytoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3749-9.json |
| 37500-6 | MRA Spine vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/37500-6.json |
| 37501-4 | MRA Cervical spine vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/37501-4.json |
| 37502-2 | MRA Lumbar spine vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/37502-2.json |
| 37503-0 | MRA Thoracic spine vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/37503-0.json |
| 37505-5 | MRA Spine vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37505-5.json |
| 37506-3 | MRA Cervical spine vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37506-3.json |
| 3750-7 | Mephobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3750-7.json |
| 37507-1 | MRA Lumbar spine vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37507-1.json |
| 37508-9 | MRA Thoracic spine vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/37508-9.json |
| 37509-7 | CT Lumbar spine W contrast intradisc | ./2.16.840.1.114222.4.11.1002/37509-7.json |
| 37510-5 | MRA Spine vessels WO contrast | ./2.16.840.1.114222.4.11.1002/37510-5.json |
| 37511-3 | MRA Cervical spine vessels WO contrast | ./2.16.840.1.114222.4.11.1002/37511-3.json |
| 37512-1 | MRA Thoracic spine vessels WO contrast | ./2.16.840.1.114222.4.11.1002/37512-1.json |
| 37513-9 | XR Tibia - bilateral 10 degree caudal angle | ./2.16.840.1.114222.4.11.1002/37513-9.json |
| 37514-7 | XR Tibia - left 10 degree caudal angle | ./2.16.840.1.114222.4.11.1002/37514-7.json |
| 37515-4 | XR Spine lumbosacral junction Lateral spot | ./2.16.840.1.114222.4.11.1002/37515-4.json |
| 37516-2 | XR Spine lumbosacral junction Lateral spot W standing | ./2.16.840.1.114222.4.11.1002/37516-2.json |
| 37517-0 | XR Finger fifth - bilateral Views | ./2.16.840.1.114222.4.11.1002/37517-0.json |
| 37518-8 | XR Finger fifth - left Views | ./2.16.840.1.114222.4.11.1002/37518-8.json |
| 37519-6 | XR Finger fourth - bilateral Views | ./2.16.840.1.114222.4.11.1002/37519-6.json |
| 37520-4 | XR Finger fourth - left Views | ./2.16.840.1.114222.4.11.1002/37520-4.json |
| 37521-2 | XR Finger second - bilateral Views | ./2.16.840.1.114222.4.11.1002/37521-2.json |
| 37522-0 | XR Finger second - left Views | ./2.16.840.1.114222.4.11.1002/37522-0.json |
| 3752-3 | Meprobamate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3752-3.json |
| 37523-8 | XR Finger third - bilateral Views | ./2.16.840.1.114222.4.11.1002/37523-8.json |
| 37524-6 | XR Finger third - left Views | ./2.16.840.1.114222.4.11.1002/37524-6.json |
| 37530-3 | XR Toe fifth - left Views | ./2.16.840.1.114222.4.11.1002/37530-3.json |
| 3753-1 | Meprobamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3753-1.json |
| 37531-1 | XR Toe fourth - left Views | ./2.16.840.1.114222.4.11.1002/37531-1.json |
| 37532-9 | XR Great toe - bilateral Views | ./2.16.840.1.114222.4.11.1002/37532-9.json |
| 37533-7 | XR Great toe - left Views | ./2.16.840.1.114222.4.11.1002/37533-7.json |
| 37534-5 | XR Toe second - left Views | ./2.16.840.1.114222.4.11.1002/37534-5.json |
| 37535-2 | XR Toe third - left Views | ./2.16.840.1.114222.4.11.1002/37535-2.json |
| 37538-6 | XR Shoulder - left Grashey and Axillary and Y | ./2.16.840.1.114222.4.11.1002/37538-6.json |
| 37539-4 | MG Breast Grid Views | ./2.16.840.1.114222.4.11.1002/37539-4.json |
| 37540-2 | XR Knee - bilateral Holmblad Views W standing | ./2.16.840.1.114222.4.11.1002/37540-2.json |
| 37541-0 | XR Mastoid - bilateral Law and Mayer and Stenver and Towne | ./2.16.840.1.114222.4.11.1002/37541-0.json |
| 37542-8 | MG Breast Magnification Views | ./2.16.840.1.114222.4.11.1002/37542-8.json |
| 37543-6 | MG Breast - bilateral Magnification Views | ./2.16.840.1.114222.4.11.1002/37543-6.json |
| 37544-4 | XR Wrist - bilateral Oblique Views | ./2.16.840.1.114222.4.11.1002/37544-4.json |
| 37545-1 | XR Hip - left Oblique crosstable | ./2.16.840.1.114222.4.11.1002/37545-1.json |
| 37546-9 | XR Temporomandibular joint - bilateral Open and Closed mouth | ./2.16.840.1.114222.4.11.1002/37546-9.json |
| 37547-7 | XR Wrist - bilateral PA and Lateral | ./2.16.840.1.114222.4.11.1002/37547-7.json |
| 37548-5 | XR Wrist - left PA and Lateral | ./2.16.840.1.114222.4.11.1002/37548-5.json |
| 3754-9 | Meprobamate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3754-9.json |
| 37549-3 | XR Wrist - bilateral PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/37549-3.json |
| 37550-1 | XR Wrist - left PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/37550-1.json |
| 37551-9 | MG Breast Spot Views | ./2.16.840.1.114222.4.11.1002/37551-9.json |
| 37552-7 | MG Breast - bilateral Spot Views | ./2.16.840.1.114222.4.11.1002/37552-7.json |
| 37553-5 | MG Breast - left Spot Views compression | ./2.16.840.1.114222.4.11.1002/37553-5.json |
| 37554-3 | MG Breast - bilateral Magnification and Spot | ./2.16.840.1.114222.4.11.1002/37554-3.json |
| 37555-0 | XR Wrist - left Ulnar deviation and Radial deviation | ./2.16.840.1.114222.4.11.1002/37555-0.json |
| 3755-6 | Meprobamate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3755-6.json |
| 37556-8 | XR Ankle Views W manual stress | ./2.16.840.1.114222.4.11.1002/37556-8.json |
| 37557-6 | XR Ankle - bilateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/37557-6.json |
| 37558-4 | XR Ankle - left Views W manual stress | ./2.16.840.1.114222.4.11.1002/37558-4.json |
| 37559-2 | XR Foot - left Views W manual stress | ./2.16.840.1.114222.4.11.1002/37559-2.json |
| 37560-0 | XR Knee Views W manual stress | ./2.16.840.1.114222.4.11.1002/37560-0.json |
| 37561-8 | XR Knee - bilateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/37561-8.json |
| 37562-6 | XR Knee - left Views W manual stress | ./2.16.840.1.114222.4.11.1002/37562-6.json |
| 37563-4 | XR Thumb - bilateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/37563-4.json |
| 3756-4 | Mersalyl [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3756-4.json |
| 37564-2 | XR Thumb - left Views W manual stress | ./2.16.840.1.114222.4.11.1002/37564-2.json |
| 37565-9 | RF Unspecified body region Views W barium contrast via fistula | ./2.16.840.1.114222.4.11.1002/37565-9.json |
| 37566-7 | RF Unspecified body region Views W contrast via catheter | ./2.16.840.1.114222.4.11.1002/37566-7.json |
| 37567-5 | RF Colon Views W contrast via colostomy | ./2.16.840.1.114222.4.11.1002/37567-5.json |
| 37568-3 | RF Unspecified body region Views W contrast via fistula | ./2.16.840.1.114222.4.11.1002/37568-3.json |
| 37569-1 | RF Urinary bladder Views W contrast via suprapubic tube | ./2.16.840.1.114222.4.11.1002/37569-1.json |
| 37570-9 | RF Wrist - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/37570-9.json |
| 37571-7 | RF Wrist - left Arthrogram | ./2.16.840.1.114222.4.11.1002/37571-7.json |
| 3757-2 | Mersalyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3757-2.json |
| 37572-5 | RF Spine Views W contrast IT | ./2.16.840.1.114222.4.11.1002/37572-5.json |
| 37574-1 | RFA Lower extremity vessels Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37574-1.json |
| 37575-8 | XR Gallbladder Views W contrast and fatty meal PO | ./2.16.840.1.114222.4.11.1002/37575-8.json |
| 37576-6 | RF Unspecified body region Views W gastrografin via fistula | ./2.16.840.1.114222.4.11.1002/37576-6.json |
| 37577-4 | XR Acromioclavicular Joint Views W weight | ./2.16.840.1.114222.4.11.1002/37577-4.json |
| 37578-2 | XR Acromioclavicular joint - bilateral Views W weight | ./2.16.840.1.114222.4.11.1002/37578-2.json |
| 37579-0 | XR Acromioclavicular Joint Views WO and W weight | ./2.16.840.1.114222.4.11.1002/37579-0.json |
| 3758-0 | Mersalyl [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3758-0.json |
| 37580-8 | XR Acromioclavicular joint - bilateral Views WO and W weight | ./2.16.840.1.114222.4.11.1002/37580-8.json |
| 37581-6 | XR Acromioclavicular joint - left Views WO and W weight | ./2.16.840.1.114222.4.11.1002/37581-6.json |
| 37582-4 | XR Acromioclavicular Joint Views WO weight | ./2.16.840.1.114222.4.11.1002/37582-4.json |
| 37583-2 | XR Pelvis and Hip - bilateral Views and Lateral frog | ./2.16.840.1.114222.4.11.1002/37583-2.json |
| 37584-0 | XR Great toe - left Views W standing | ./2.16.840.1.114222.4.11.1002/37584-0.json |
| 37585-7 | RF Jejunum Views W contrast | ./2.16.840.1.114222.4.11.1002/37585-7.json |
| 37586-5 | RF Penis Views W contrast intra corpus cavernosum | ./2.16.840.1.114222.4.11.1002/37586-5.json |
| 37587-3 | RFA Aortic arch and Carotid artery - bilateral and Vertebral artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37587-3.json |
| 37588-1 | RFA Common carotid artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37588-1.json |
| 37589-9 | RFA Common carotid artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37589-9.json |
| 37590-7 | RFA Common carotid artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37590-7.json |
| 37591-5 | RFA Aortic arch and External carotid artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37591-5.json |
| 37592-3 | RFA Aortic arch and External carotid artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37592-3.json |
| 37593-1 | RFA Aortic arch and External carotid artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37593-1.json |
| 37594-9 | RFA Carotid artery and Vertebral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37594-9.json |
| 37595-6 | RFA Coronary arteries Views for graft W contrast IA | ./2.16.840.1.114222.4.11.1002/37595-6.json |
| 37596-4 | RFA Abdominal and pelvic lymphatic vessels - left Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37596-4.json |
| 37597-2 | RFA Abdominal and pelvic lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37597-2.json |
| 37598-0 | RFA Abdominal and pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37598-0.json |
| 37599-8 | RFA Extremity lymphatic vessels - left Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37599-8.json |
| 37600-4 | RFA Lymphatic vessels - left Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37600-4.json |
| 37601-2 | RFA Pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/37601-2.json |
| 37602-0 | RFA Adrenal vein - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37602-0.json |
| 37604-6 | XR Nasal bones 3 Views | ./2.16.840.1.114222.4.11.1002/37604-6.json |
| 37605-3 | XR Nasal bones Lateral and Waters | ./2.16.840.1.114222.4.11.1002/37605-3.json |
| 3760-6 | Mesoridazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3760-6.json |
| 37606-1 | XR tomography Nasal bones | ./2.16.840.1.114222.4.11.1002/37606-1.json |
| 37607-9 | XR Kidney Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37607-9.json |
| 37608-7 | US Guidance for localization of foreign body of Eye | ./2.16.840.1.114222.4.11.1002/37608-7.json |
| 37609-5 | XR Optic foramen 4 Views | ./2.16.840.1.114222.4.11.1002/37609-5.json |
| 37611-1 | XR tomography Orbit - bilateral | ./2.16.840.1.114222.4.11.1002/37611-1.json |
| 37612-9 | XR Orbit - bilateral 4 Views | ./2.16.840.1.114222.4.11.1002/37612-9.json |
| 37613-7 | XR Orbit - bilateral Waters | ./2.16.840.1.114222.4.11.1002/37613-7.json |
| 3761-4 | Mesterolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3761-4.json |
| 37614-5 | XR Patella Single view | ./2.16.840.1.114222.4.11.1002/37614-5.json |
| 37615-2 | RFA Pelvis vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37615-2.json |
| 37616-0 | XR Pelvis Single view | ./2.16.840.1.114222.4.11.1002/37616-0.json |
| 37617-8 | XR Pelvis 2 Views | ./2.16.840.1.114222.4.11.1002/37617-8.json |
| 37618-6 | XR Pelvis AP and Inlet | ./2.16.840.1.114222.4.11.1002/37618-6.json |
| 37619-4 | XR Pelvis AP and Judet | ./2.16.840.1.114222.4.11.1002/37619-4.json |
| 37620-2 | XR Pelvis AP and Lateral | ./2.16.840.1.114222.4.11.1002/37620-2.json |
| 37621-0 | XR Pelvis AP and Oblique | ./2.16.840.1.114222.4.11.1002/37621-0.json |
| 3762-2 | Mesterolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3762-2.json |
| 37622-8 | XR Pelvis AP | ./2.16.840.1.114222.4.11.1002/37622-8.json |
| 37623-6 | XR Pelvis AP and Inlet and Outlet | ./2.16.840.1.114222.4.11.1002/37623-6.json |
| 37624-4 | XR Pelvis AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37624-4.json |
| 37625-1 | XR Pelvis Ferguson | ./2.16.840.1.114222.4.11.1002/37625-1.json |
| 37626-9 | XR Pelvis Lateral frog | ./2.16.840.1.114222.4.11.1002/37626-9.json |
| 37627-7 | XR Pelvis Inlet and Outlet and Oblique | ./2.16.840.1.114222.4.11.1002/37627-7.json |
| 37628-5 | XR Pelvis Inlet | ./2.16.840.1.114222.4.11.1002/37628-5.json |
| 37629-3 | XR Pelvis Lateral | ./2.16.840.1.114222.4.11.1002/37629-3.json |
| 3763-0 | Mesterolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3763-0.json |
| 37630-1 | XR Pelvis Oblique Views | ./2.16.840.1.114222.4.11.1002/37630-1.json |
| 37631-9 | XR Pelvis Outlet | ./2.16.840.1.114222.4.11.1002/37631-9.json |
| 37632-7 | XR tomography Pelvis | ./2.16.840.1.114222.4.11.1002/37632-7.json |
| 37633-5 | XR Pelvis Single view W standing | ./2.16.840.1.114222.4.11.1002/37633-5.json |
| 37634-3 | XR Pelvis AP 20 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/37634-3.json |
| 37635-0 | XR Acetabulum 3 Views | ./2.16.840.1.114222.4.11.1002/37635-0.json |
| 37636-8 | XR Abdomen Views | ./2.16.840.1.114222.4.11.1002/37636-8.json |
| 37637-6 | XR Extremity Views | ./2.16.840.1.114222.4.11.1002/37637-6.json |
| 37639-2 | XR Neck Views | ./2.16.840.1.114222.4.11.1002/37639-2.json |
| 37640-0 | RFA Renal vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37640-0.json |
| 37641-8 | RF Wrist - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37641-8.json |
| 37642-6 | XR Wrist - right Limited Views | ./2.16.840.1.114222.4.11.1002/37642-6.json |
| 37643-4 | XR Wrist - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37643-4.json |
| 37644-2 | XR tomography Wrist - right | ./2.16.840.1.114222.4.11.1002/37644-2.json |
| 37645-9 | XR Wrist - right Ulnar deviation | ./2.16.840.1.114222.4.11.1002/37645-9.json |
| 37646-7 | XR Sacroiliac Joint Limited Views | ./2.16.840.1.114222.4.11.1002/37646-7.json |
| 37647-5 | RF Sacroiliac Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/37647-5.json |
| 3764-8 | Metandienone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3764-8.json |
| 37648-3 | XR Sacroiliac Joint 3 Views | ./2.16.840.1.114222.4.11.1002/37648-3.json |
| 37649-1 | XR Sacroiliac Joint AP and Oblique | ./2.16.840.1.114222.4.11.1002/37649-1.json |
| 37650-9 | XR Sacroiliac Joint Ferguson | ./2.16.840.1.114222.4.11.1002/37650-9.json |
| 37651-7 | XR Sacrum 2 Views | ./2.16.840.1.114222.4.11.1002/37651-7.json |
| 37652-5 | XR Sacrum AP and Lateral | ./2.16.840.1.114222.4.11.1002/37652-5.json |
| 37653-3 | XR tomography Sacrum | ./2.16.840.1.114222.4.11.1002/37653-3.json |
| 37654-1 | XR Scapula Single view | ./2.16.840.1.114222.4.11.1002/37654-1.json |
| 3765-5 | Metandienone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3765-5.json |
| 37655-8 | XR Scapula 2 Views | ./2.16.840.1.114222.4.11.1002/37655-8.json |
| 37656-6 | XR Scapula Y | ./2.16.840.1.114222.4.11.1002/37656-6.json |
| 37658-2 | XR Thoracic and lumbar spine 2 Views for scoliosis | ./2.16.840.1.114222.4.11.1002/37658-2.json |
| 37659-0 | XR Thoracic and lumbar spine AP for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/37659-0.json |
| 37660-8 | XR Thoracic and lumbar spine Lateral for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/37660-8.json |
| 37661-6 | XR Acromioclavicular joint - right 2 Views | ./2.16.840.1.114222.4.11.1002/37661-6.json |
| 37662-4 | XR Acromioclavicular joint - right AP | ./2.16.840.1.114222.4.11.1002/37662-4.json |
| 3766-3 | Metandienone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3766-3.json |
| 37663-2 | XR Acromioclavicular joint - right Views WO and W weight | ./2.16.840.1.114222.4.11.1002/37663-2.json |
| 37664-0 | XR Acetabulum - right 2 Views | ./2.16.840.1.114222.4.11.1002/37664-0.json |
| 37665-7 | XR Ankle - right 3 Views | ./2.16.840.1.114222.4.11.1002/37665-7.json |
| 37666-5 | XR Ankle - right AP and Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37666-5.json |
| 37667-3 | XR Ankle - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37667-3.json |
| 37668-1 | XR Ankle - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37668-1.json |
| 37669-9 | XR Ankle - right Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/37669-9.json |
| 37670-7 | XR Ankle - right Lateral and Mortise | ./2.16.840.1.114222.4.11.1002/37670-7.json |
| 3767-1 | Metaraminol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3767-1.json |
| 37671-5 | XR Ankle - right Mortise W manual stress | ./2.16.840.1.114222.4.11.1002/37671-5.json |
| 37672-3 | XR Ankle - right 2 Views W manual stress | ./2.16.840.1.114222.4.11.1002/37672-3.json |
| 37673-1 | XR Ankle - right Views W manual stress | ./2.16.840.1.114222.4.11.1002/37673-1.json |
| 37674-9 | XR tomography Ankle - right | ./2.16.840.1.114222.4.11.1002/37674-9.json |
| 37675-6 | XR Ankle - right 2 Views W standing | ./2.16.840.1.114222.4.11.1002/37675-6.json |
| 37676-4 | XR Ankle - right Views W standing | ./2.16.840.1.114222.4.11.1002/37676-4.json |
| 37677-2 | XR Wrist - right Carpal tunnel | ./2.16.840.1.114222.4.11.1002/37677-2.json |
| 37678-0 | XR Wrist - right 2 Carpal tunnel Views | ./2.16.840.1.114222.4.11.1002/37678-0.json |
| 37679-8 | XR Clavicle - right 2 Views | ./2.16.840.1.114222.4.11.1002/37679-8.json |
| 37680-6 | XR Clavicle - right AP and Serendipity | ./2.16.840.1.114222.4.11.1002/37680-6.json |
| 37681-4 | XR Elbow - right 2 Views | ./2.16.840.1.114222.4.11.1002/37681-4.json |
| 37682-2 | XR Elbow - right 3 Views | ./2.16.840.1.114222.4.11.1002/37682-2.json |
| 37683-0 | XR Elbow - right 4 Views | ./2.16.840.1.114222.4.11.1002/37683-0.json |
| 37684-8 | XR Elbow - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37684-8.json |
| 37685-5 | XR Elbow - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37685-5.json |
| 37686-3 | XR Elbow - right 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/37686-3.json |
| 37687-1 | XR Elbow - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37687-1.json |
| 37688-9 | XR tomography Elbow - right | ./2.16.840.1.114222.4.11.1002/37688-9.json |
| 3768-9 | Metenolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3768-9.json |
| 37689-7 | XR Femur - right Single view | ./2.16.840.1.114222.4.11.1002/37689-7.json |
| 37690-5 | XR Femur - right 2 Views | ./2.16.840.1.114222.4.11.1002/37690-5.json |
| 37691-3 | XR Femur - right 4 Views | ./2.16.840.1.114222.4.11.1002/37691-3.json |
| 37692-1 | XR Femur - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37692-1.json |
| 37693-9 | XR Femur - right Views W standing | ./2.16.840.1.114222.4.11.1002/37693-9.json |
| 37694-7 | XR Finger - right 2 Views | ./2.16.840.1.114222.4.11.1002/37694-7.json |
| 37695-4 | XR Finger - right 3 Views | ./2.16.840.1.114222.4.11.1002/37695-4.json |
| 37696-2 | XR Finger - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37696-2.json |
| 3769-7 | Metenolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3769-7.json |
| 37697-0 | XR Foot - right 2 Views | ./2.16.840.1.114222.4.11.1002/37697-0.json |
| 37698-8 | XR Foot - right 2 Views W standing | ./2.16.840.1.114222.4.11.1002/37698-8.json |
| 37699-6 | XR Foot - right 3 Views | ./2.16.840.1.114222.4.11.1002/37699-6.json |
| 37700-2 | XR Foot - right 3 Views W standing | ./2.16.840.1.114222.4.11.1002/37700-2.json |
| 37701-0 | XR Foot - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37701-0.json |
| 37702-8 | XR Foot - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37702-8.json |
| 37703-6 | XR Foot - right Lateral | ./2.16.840.1.114222.4.11.1002/37703-6.json |
| 37704-4 | XR Foot - right Oblique | ./2.16.840.1.114222.4.11.1002/37704-4.json |
| 3770-5 | Metenolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3770-5.json |
| 37705-1 | XR Foot - right Views W manual stress | ./2.16.840.1.114222.4.11.1002/37705-1.json |
| 37706-9 | XR tomography Foot - right | ./2.16.840.1.114222.4.11.1002/37706-9.json |
| 37707-7 | XR Radius and Ulna - right 2 Views | ./2.16.840.1.114222.4.11.1002/37707-7.json |
| 37708-5 | XR Radius and Ulna - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37708-5.json |
| 37709-3 | XR Radius and Ulna - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37709-3.json |
| 37710-1 | XR Hand - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37710-1.json |
| 37711-9 | XR Hand - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37711-9.json |
| 37712-7 | XR Hand - right Lateral | ./2.16.840.1.114222.4.11.1002/37712-7.json |
| 3771-3 | Methadone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3771-3.json |
| 37713-5 | XR Hand - right PA and Lateral | ./2.16.840.1.114222.4.11.1002/37713-5.json |
| 37714-3 | XR Hand - right PA | ./2.16.840.1.114222.4.11.1002/37714-3.json |
| 37715-0 | XR Hand - right PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/37715-0.json |
| 37716-8 | XR Hand - right Views | ./2.16.840.1.114222.4.11.1002/37716-8.json |
| 37717-6 | XR tomography Hand - right | ./2.16.840.1.114222.4.11.1002/37717-6.json |
| 37718-4 | XR Calcaneus - right 2 Views | ./2.16.840.1.114222.4.11.1002/37718-4.json |
| 37719-2 | XR Calcaneus - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37719-2.json |
| 37720-0 | XR Calcaneus - right Views W standing | ./2.16.840.1.114222.4.11.1002/37720-0.json |
| 3772-1 | Methadone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3772-1.json |
| 37721-8 | XR Hip - right 2 Views | ./2.16.840.1.114222.4.11.1002/37721-8.json |
| 37722-6 | XR Hip - right 3 Views | ./2.16.840.1.114222.4.11.1002/37722-6.json |
| 37723-4 | XR Hip - right AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37723-4.json |
| 37724-2 | XR Hip - right AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/37724-2.json |
| 37725-9 | XR Hip - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37725-9.json |
| 37726-7 | XR Hip - right AP | ./2.16.840.1.114222.4.11.1002/37726-7.json |
| 37727-5 | XR Hip - right Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37727-5.json |
| 37728-3 | XR Hip - right Oblique crosstable | ./2.16.840.1.114222.4.11.1002/37728-3.json |
| 37729-1 | XR Hip - right Lateral frog | ./2.16.840.1.114222.4.11.1002/37729-1.json |
| 37730-9 | XR Hip - right Lateral | ./2.16.840.1.114222.4.11.1002/37730-9.json |
| 37731-7 | XR Hip - right Single view W standing | ./2.16.840.1.114222.4.11.1002/37731-7.json |
| 37732-5 | XR Hip - right Judet | ./2.16.840.1.114222.4.11.1002/37732-5.json |
| 37733-3 | XR Lower extremity - right AP W standing | ./2.16.840.1.114222.4.11.1002/37733-3.json |
| 37734-1 | XR Lower extremity - right Single view W standing | ./2.16.840.1.114222.4.11.1002/37734-1.json |
| 37735-8 | XR tomography Hip - right | ./2.16.840.1.114222.4.11.1002/37735-8.json |
| 37736-6 | XR Humerus - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37736-6.json |
| 37737-4 | XR Humerus - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37737-4.json |
| 37738-2 | XR Humerus - right Views | ./2.16.840.1.114222.4.11.1002/37738-2.json |
| 3773-9 | Methadone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3773-9.json |
| 37739-0 | RFA Iliac artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37739-0.json |
| 37740-8 | XR Knee - right AP and Lateral and Sunrise and tunnel | ./2.16.840.1.114222.4.11.1002/37740-8.json |
| 37741-6 | XR Knee - right Single view | ./2.16.840.1.114222.4.11.1002/37741-6.json |
| 37742-4 | XR Knee - right 3 Views | ./2.16.840.1.114222.4.11.1002/37742-4.json |
| 37743-2 | XR Knee - right 4 Views | ./2.16.840.1.114222.4.11.1002/37743-2.json |
| 37744-0 | XR Knee - right 5 Views | ./2.16.840.1.114222.4.11.1002/37744-0.json |
| 37745-7 | XR Knee - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37745-7.json |
| 37746-5 | XR Knee - right Views AP W manual stress | ./2.16.840.1.114222.4.11.1002/37746-5.json |
| 3774-7 | Methadone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3774-7.json |
| 37747-3 | XR Knee - right AP and Lateral and Tunnel | ./2.16.840.1.114222.4.11.1002/37747-3.json |
| 37748-1 | XR Knee - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37748-1.json |
| 37749-9 | XR Knee - right AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/37749-9.json |
| 37750-7 | XR Knee - right Lateral W extension | ./2.16.840.1.114222.4.11.1002/37750-7.json |
| 37751-5 | XR Knee - right Lateral | ./2.16.840.1.114222.4.11.1002/37751-5.json |
| 37752-3 | XR Knee - right Rosenberg W standing | ./2.16.840.1.114222.4.11.1002/37752-3.json |
| 37753-1 | XR Knee - right Views W manual stress | ./2.16.840.1.114222.4.11.1002/37753-1.json |
| 3775-4 | Methadone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3775-4.json |
| 37754-9 | XR Knee - right Lateral W standing | ./2.16.840.1.114222.4.11.1002/37754-9.json |
| 37755-6 | XR Knee - right PA W standing | ./2.16.840.1.114222.4.11.1002/37755-6.json |
| 37756-4 | XR Knee - right Tunnel W standing | ./2.16.840.1.114222.4.11.1002/37756-4.json |
| 37757-2 | XR Knee - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37757-2.json |
| 37758-0 | XR Knee - right Views | ./2.16.840.1.114222.4.11.1002/37758-0.json |
| 37759-8 | XR Knee - right Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/37759-8.json |
| 37760-6 | XR tomography Knee - right | ./2.16.840.1.114222.4.11.1002/37760-6.json |
| 37761-4 | XR Knee - right Tunnel | ./2.16.840.1.114222.4.11.1002/37761-4.json |
| 3776-2 | Methamphetamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3776-2.json |
| 37762-2 | XR Knee - right 2 Views W standing | ./2.16.840.1.114222.4.11.1002/37762-2.json |
| 37763-0 | XR Knee - right 4 Views W standing | ./2.16.840.1.114222.4.11.1002/37763-0.json |
| 37764-8 | XR Lower extremity - right Single view | ./2.16.840.1.114222.4.11.1002/37764-8.json |
| 37765-5 | RFA Lower extremity vessels - right Views W contrast | ./2.16.840.1.114222.4.11.1002/37765-5.json |
| 37766-3 | XR tomography Lower extremity - right | ./2.16.840.1.114222.4.11.1002/37766-3.json |
| 37767-1 | RFA Lower extremity veins - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37767-1.json |
| 37768-9 | MG Breast - right 2 Views | ./2.16.840.1.114222.4.11.1002/37768-9.json |
| 37769-7 | MG Breast - right Magnification and Spot | ./2.16.840.1.114222.4.11.1002/37769-7.json |
| 3777-0 | Methamphetamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3777-0.json |
| 37770-5 | MG Breast - right Tangential | ./2.16.840.1.114222.4.11.1002/37770-5.json |
| 37771-3 | MG Breast - right True lateral | ./2.16.840.1.114222.4.11.1002/37771-3.json |
| 37772-1 | MG Breast - right XCCL | ./2.16.840.1.114222.4.11.1002/37772-1.json |
| 37773-9 | MG Breast - right Magnification | ./2.16.840.1.114222.4.11.1002/37773-9.json |
| 37774-7 | MG Breast - right Views | ./2.16.840.1.114222.4.11.1002/37774-7.json |
| 37775-4 | MG Breast - right Rolled Views | ./2.16.840.1.114222.4.11.1002/37775-4.json |
| 37776-2 | XR Patella - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37776-2.json |
| 37777-0 | XR Patella - right Views | ./2.16.840.1.114222.4.11.1002/37777-0.json |
| 37778-8 | RFA Popliteal artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37778-8.json |
| 37779-6 | RFA Right pulmonary arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37779-6.json |
| 37780-4 | XR Ribs - right 2 Views | ./2.16.840.1.114222.4.11.1002/37780-4.json |
| 37781-2 | XR Ribs - right 3 Views | ./2.16.840.1.114222.4.11.1002/37781-2.json |
| 37782-0 | XR Ribs - right Anterior and Lateral | ./2.16.840.1.114222.4.11.1002/37782-0.json |
| 37783-8 | XR Ribs - right AP | ./2.16.840.1.114222.4.11.1002/37783-8.json |
| 37784-6 | XR Ribs - right Lateral | ./2.16.840.1.114222.4.11.1002/37784-6.json |
| 37785-3 | RF Sacroiliac joint - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37785-3.json |
| 37786-1 | XR Sacroiliac joint - right Views | ./2.16.840.1.114222.4.11.1002/37786-1.json |
| 37787-9 | XR Scapula - right 2 Views | ./2.16.840.1.114222.4.11.1002/37787-9.json |
| 3778-8 | Methamphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3778-8.json |
| 37788-7 | XR Scapula - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37788-7.json |
| 37789-5 | XR Scapula - right AP and Y | ./2.16.840.1.114222.4.11.1002/37789-5.json |
| 37790-3 | XR Scapula - right Y | ./2.16.840.1.114222.4.11.1002/37790-3.json |
| 37791-1 | XR Shoulder - right Stryker Notch | ./2.16.840.1.114222.4.11.1002/37791-1.json |
| 37792-9 | XR Shoulder - right Single view | ./2.16.840.1.114222.4.11.1002/37792-9.json |
| 37793-7 | XR Shoulder - right 2 Views | ./2.16.840.1.114222.4.11.1002/37793-7.json |
| 37794-5 | XR Shoulder - right 4 Views | ./2.16.840.1.114222.4.11.1002/37794-5.json |
| 37795-2 | XR Shoulder - right 5 Views | ./2.16.840.1.114222.4.11.1002/37795-2.json |
| 3779-6 | Methamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3779-6.json |
| 37796-0 | XR Shoulder - right 6 Views | ./2.16.840.1.114222.4.11.1002/37796-0.json |
| 37797-8 | XR Shoulder - right AP and Stryker Notch | ./2.16.840.1.114222.4.11.1002/37797-8.json |
| 37798-6 | XR Shoulder - right AP | ./2.16.840.1.114222.4.11.1002/37798-6.json |
| 37799-4 | XR Shoulder - right AP and West Point and Outlet | ./2.16.840.1.114222.4.11.1002/37799-4.json |
| 37800-0 | XR Shoulder - right Axillary | ./2.16.840.1.114222.4.11.1002/37800-0.json |
| 37801-8 | XR Shoulder - right Garth | ./2.16.840.1.114222.4.11.1002/37801-8.json |
| 37802-6 | XR Shoulder - right Outlet | ./2.16.840.1.114222.4.11.1002/37802-6.json |
| 37803-4 | XR Shoulder - right Lateral and Y | ./2.16.840.1.114222.4.11.1002/37803-4.json |
| 3780-4 | Methamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3780-4.json |
| 37804-2 | XR Shoulder - right Outlet and Y | ./2.16.840.1.114222.4.11.1002/37804-2.json |
| 37805-9 | XR Shoulder - right Y | ./2.16.840.1.114222.4.11.1002/37805-9.json |
| 37806-7 | XR Shoulder - right Grashey and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/37806-7.json |
| 37807-5 | XR Shoulder - right Axillary and Y | ./2.16.840.1.114222.4.11.1002/37807-5.json |
| 37808-3 | XR Sternoclavicular joint - right Serendipity | ./2.16.840.1.114222.4.11.1002/37808-3.json |
| 37809-1 | XR Shoulder - right West Point | ./2.16.840.1.114222.4.11.1002/37809-1.json |
| 37810-9 | XR Acromioclavicular joint - right Zanca | ./2.16.840.1.114222.4.11.1002/37810-9.json |
| 37811-7 | XR tomography Shoulder - right | ./2.16.840.1.114222.4.11.1002/37811-7.json |
| 3781-2 | Methapyrilene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3781-2.json |
| 37812-5 | XR Thumb - right 3 Views | ./2.16.840.1.114222.4.11.1002/37812-5.json |
| 37813-3 | XR Thumb - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37813-3.json |
| 37814-1 | XR Thumb - right Views W manual stress | ./2.16.840.1.114222.4.11.1002/37814-1.json |
| 37815-8 | XR Tibia and Fibula - right 2 Views | ./2.16.840.1.114222.4.11.1002/37815-8.json |
| 37816-6 | XR Tibia and Fibula - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37816-6.json |
| 37817-4 | XR Tibia and Fibula - right Oblique Views | ./2.16.840.1.114222.4.11.1002/37817-4.json |
| 37818-2 | RF Temporomandibular joint - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37818-2.json |
| 37819-0 | XR tomography Temporomandibular joint - right | ./2.16.840.1.114222.4.11.1002/37819-0.json |
| 3782-0 | Methapyrilene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3782-0.json |
| 37820-8 | XR Toes - right 3 Views | ./2.16.840.1.114222.4.11.1002/37820-8.json |
| 37821-6 | XR Toes - right 2 Views | ./2.16.840.1.114222.4.11.1002/37821-6.json |
| 37822-4 | XR Toes - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37822-4.json |
| 37823-2 | XR Toes - right Views W standing | ./2.16.840.1.114222.4.11.1002/37823-2.json |
| 37824-0 | RFA Upper extremity veins - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37824-0.json |
| 37825-7 | XR Wrist - right Single view | ./2.16.840.1.114222.4.11.1002/37825-7.json |
| 37826-5 | XR Wrist - right 2 Views | ./2.16.840.1.114222.4.11.1002/37826-5.json |
| 37827-3 | XR Wrist - right 3 Views | ./2.16.840.1.114222.4.11.1002/37827-3.json |
| 37828-1 | XR Wrist - right 4 Views | ./2.16.840.1.114222.4.11.1002/37828-1.json |
| 37829-9 | XR Wrist - right 5 Views | ./2.16.840.1.114222.4.11.1002/37829-9.json |
| 37830-7 | XR Wrist - right 6 Views | ./2.16.840.1.114222.4.11.1002/37830-7.json |
| 37831-5 | XR Wrist - right 8 Views | ./2.16.840.1.114222.4.11.1002/37831-5.json |
| 37832-3 | XR Wrist - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/37832-3.json |
| 37833-1 | XR Wrist - right Lateral W extension | ./2.16.840.1.114222.4.11.1002/37833-1.json |
| 37834-9 | XR Wrist - right Lateral W flexion | ./2.16.840.1.114222.4.11.1002/37834-9.json |
| 37835-6 | XR Wrist - right PA and Lateral | ./2.16.840.1.114222.4.11.1002/37835-6.json |
| 37836-4 | XR Wrist - right PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/37836-4.json |
| 3783-8 | Methapyrilene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3783-8.json |
| 37839-8 | XR Shoulder AP and Lateral and Axillary | ./2.16.840.1.114222.4.11.1002/37839-8.json |
| 37840-6 | XR Shoulder 2 Views | ./2.16.840.1.114222.4.11.1002/37840-6.json |
| 37841-4 | XR Shoulder AP and Lateral | ./2.16.840.1.114222.4.11.1002/37841-4.json |
| 37842-2 | XR Shoulder AP | ./2.16.840.1.114222.4.11.1002/37842-2.json |
| 37843-0 | XR Shoulder Garth | ./2.16.840.1.114222.4.11.1002/37843-0.json |
| 37844-8 | XR Shoulder Grashey | ./2.16.840.1.114222.4.11.1002/37844-8.json |
| 37845-5 | XR Shoulder Outlet | ./2.16.840.1.114222.4.11.1002/37845-5.json |
| 3784-6 | Methaqualone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3784-6.json |
| 37846-3 | XR Sternoclavicular Joint Serendipity | ./2.16.840.1.114222.4.11.1002/37846-3.json |
| 37847-1 | XR Shoulder Y | ./2.16.840.1.114222.4.11.1002/37847-1.json |
| 37848-9 | XR Acromioclavicular Joint Zanca | ./2.16.840.1.114222.4.11.1002/37848-9.json |
| 37849-7 | XR Shoulder Axillary | ./2.16.840.1.114222.4.11.1002/37849-7.json |
| 37850-5 | XR tomography Shoulder | ./2.16.840.1.114222.4.11.1002/37850-5.json |
| 37851-3 | XR Sinuses Single view | ./2.16.840.1.114222.4.11.1002/37851-3.json |
| 37852-1 | XR Sinuses Caldwell and Waters | ./2.16.840.1.114222.4.11.1002/37852-1.json |
| 3785-3 | Methaqualone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3785-3.json |
| 37853-9 | XR Sinuses 2 Views | ./2.16.840.1.114222.4.11.1002/37853-9.json |
| 37854-7 | XR Sinuses 3 Views | ./2.16.840.1.114222.4.11.1002/37854-7.json |
| 37855-4 | XR Sinuses 4 Views | ./2.16.840.1.114222.4.11.1002/37855-4.json |
| 37856-2 | XR Sinuses 5 Views | ./2.16.840.1.114222.4.11.1002/37856-2.json |
| 37857-0 | XR Sinuses Caldwell | ./2.16.840.1.114222.4.11.1002/37857-0.json |
| 37858-8 | XR Sinuses Lateral | ./2.16.840.1.114222.4.11.1002/37858-8.json |
| 37859-6 | XR Sinuses PA and Lateral and Waters | ./2.16.840.1.114222.4.11.1002/37859-6.json |
| 37860-4 | XR Sinuses PA and Lateral and Caldwell and Waters | ./2.16.840.1.114222.4.11.1002/37860-4.json |
| 3786-1 | Methaqualone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3786-1.json |
| 37861-2 | XR Sinuses Submentovertex | ./2.16.840.1.114222.4.11.1002/37861-2.json |
| 37862-0 | XR Sinuses Lateral and Waters | ./2.16.840.1.114222.4.11.1002/37862-0.json |
| 37863-8 | XR Sinuses Waters | ./2.16.840.1.114222.4.11.1002/37863-8.json |
| 37864-6 | XR Sinuses Lateral and Caldwell and Waters | ./2.16.840.1.114222.4.11.1002/37864-6.json |
| 37866-1 | XR tomography Sinuses | ./2.16.840.1.114222.4.11.1002/37866-1.json |
| 37867-9 | XR Skull 2 Views | ./2.16.840.1.114222.4.11.1002/37867-9.json |
| 37868-7 | XR Skull 4 Views | ./2.16.840.1.114222.4.11.1002/37868-7.json |
| 37869-5 | XR Skull Lateral and Towne | ./2.16.840.1.114222.4.11.1002/37869-5.json |
| 37870-3 | XR Skull Towne | ./2.16.840.1.114222.4.11.1002/37870-3.json |
| 37871-1 | XR Skull Lateral and Caldwell and Waters and Towne | ./2.16.840.1.114222.4.11.1002/37871-1.json |
| 37872-9 | XR Skull Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37872-9.json |
| 37874-5 | XR tomography Skull | ./2.16.840.1.114222.4.11.1002/37874-5.json |
| 37875-2 | XR Spine Single view | ./2.16.840.1.114222.4.11.1002/37875-2.json |
| 37876-0 | XR Spine 4 Views | ./2.16.840.1.114222.4.11.1002/37876-0.json |
| 37877-8 | XR Spine AP | ./2.16.840.1.114222.4.11.1002/37877-8.json |
| 37878-6 | XR Spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37878-6.json |
| 3787-9 | Methaqualone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3787-9.json |
| 37879-4 | XR Spine 2 Views | ./2.16.840.1.114222.4.11.1002/37879-4.json |
| 37880-2 | XR Sternoclavicular Joint AP | ./2.16.840.1.114222.4.11.1002/37880-2.json |
| 37881-0 | XR Sternoclavicular Joint 3 Views | ./2.16.840.1.114222.4.11.1002/37881-0.json |
| 37882-8 | XR Sternoclavicular Joint 4 Views | ./2.16.840.1.114222.4.11.1002/37882-8.json |
| 37883-6 | XR Sternum 2 Views | ./2.16.840.1.114222.4.11.1002/37883-6.json |
| 37884-4 | XR Sternum PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/37884-4.json |
| 37885-1 | XR tomography Sternum | ./2.16.840.1.114222.4.11.1002/37885-1.json |
| 37886-9 | RFA Subclavian artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37886-9.json |
| 3788-7 | Methicillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3788-7.json |
| 37887-7 | RF Guidance for fluid aspiration of Pleural space | ./2.16.840.1.114222.4.11.1002/37887-7.json |
| 37888-5 | XR Thumb 3 Views | ./2.16.840.1.114222.4.11.1002/37888-5.json |
| 37889-3 | XR Thumb AP and Lateral | ./2.16.840.1.114222.4.11.1002/37889-3.json |
| 37890-1 | XR Thumb AP | ./2.16.840.1.114222.4.11.1002/37890-1.json |
| 37891-9 | XR Thumb Lateral | ./2.16.840.1.114222.4.11.1002/37891-9.json |
| 37892-7 | XR Thumb Oblique | ./2.16.840.1.114222.4.11.1002/37892-7.json |
| 37893-5 | XR Tibia and Fibula Lateral | ./2.16.840.1.114222.4.11.1002/37893-5.json |
| 37894-3 | XR Tibia and Fibula Single view | ./2.16.840.1.114222.4.11.1002/37894-3.json |
| 3789-5 | Methocarbamol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3789-5.json |
| 37895-0 | XR Tibia and Fibula 2 Views | ./2.16.840.1.114222.4.11.1002/37895-0.json |
| 37896-8 | XR Tibia and Fibula AP and Lateral | ./2.16.840.1.114222.4.11.1002/37896-8.json |
| 37897-6 | XR Tibia and Fibula AP | ./2.16.840.1.114222.4.11.1002/37897-6.json |
| 37898-4 | XR tomography Tibia and Fibula | ./2.16.840.1.114222.4.11.1002/37898-4.json |
| 37899-2 | XR Tibia and Fibula Views W standing | ./2.16.840.1.114222.4.11.1002/37899-2.json |
| 37901-6 | RF Temporomandibular joint Arthrogram | ./2.16.840.1.114222.4.11.1002/37901-6.json |
| 37902-4 | XR Toes 2 Views | ./2.16.840.1.114222.4.11.1002/37902-4.json |
| 3790-3 | Methocarbamol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3790-3.json |
| 37903-2 | XR Thoracic spine Lateral crosstable | ./2.16.840.1.114222.4.11.1002/37903-2.json |
| 37904-0 | XR Thoracic spine Single view | ./2.16.840.1.114222.4.11.1002/37904-0.json |
| 37905-7 | XR Thoracic spine 2 Views | ./2.16.840.1.114222.4.11.1002/37905-7.json |
| 37906-5 | XR Thoracic spine 3 Views | ./2.16.840.1.114222.4.11.1002/37906-5.json |
| 37907-3 | XR Thoracic spine 4 Views | ./2.16.840.1.114222.4.11.1002/37907-3.json |
| 37908-1 | XR Thoracic spine AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37908-1.json |
| 37909-9 | XR Thoracic spine Lateral W hyperextension | ./2.16.840.1.114222.4.11.1002/37909-9.json |
| 37910-7 | XR Thoracic spine Lateral W standing | ./2.16.840.1.114222.4.11.1002/37910-7.json |
| 3791-1 | Methocarbamol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3791-1.json |
| 37911-5 | XR tomography Thoracic spine | ./2.16.840.1.114222.4.11.1002/37911-5.json |
| 37912-3 | US Guidance for biopsy of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/37912-3.json |
| 37913-1 | US Guidance for biopsy of Abdomen | ./2.16.840.1.114222.4.11.1002/37913-1.json |
| 37914-9 | US Guidance for biopsy of Breast | ./2.16.840.1.114222.4.11.1002/37914-9.json |
| 37915-6 | US Guidance for biopsy of Chest | ./2.16.840.1.114222.4.11.1002/37915-6.json |
| 37917-2 | US Guidance for percutaneous biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/37917-2.json |
| 37918-0 | US Guidance for biopsy of Neck | ./2.16.840.1.114222.4.11.1002/37918-0.json |
| 37919-8 | US Guidance for biopsy of Pancreas | ./2.16.840.1.114222.4.11.1002/37919-8.json |
| 37920-6 | US Guidance for biopsy of Salivary gland | ./2.16.840.1.114222.4.11.1002/37920-6.json |
| 37921-4 | US Guidance for needle localization of Chest | ./2.16.840.1.114222.4.11.1002/37921-4.json |
| 37922-2 | XR Upper extremity 2 Views | ./2.16.840.1.114222.4.11.1002/37922-2.json |
| 37923-0 | XR tomography Upper extremity | ./2.16.840.1.114222.4.11.1002/37923-0.json |
| 37924-8 | XR Wrist Single view | ./2.16.840.1.114222.4.11.1002/37924-8.json |
| 37925-5 | XR Wrist 2 Views | ./2.16.840.1.114222.4.11.1002/37925-5.json |
| 37926-3 | XR Wrist 3 Views | ./2.16.840.1.114222.4.11.1002/37926-3.json |
| 37927-1 | XR Wrist AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/37927-1.json |
| 37928-9 | XR Wrist Brewerton | ./2.16.840.1.114222.4.11.1002/37928-9.json |
| 3792-9 | Methotrexate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/3792-9.json |
| 37929-7 | XR Wrist Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/37929-7.json |
| 37930-5 | XR Wrist Lateral | ./2.16.840.1.114222.4.11.1002/37930-5.json |
| 37931-3 | XR Wrist PA | ./2.16.840.1.114222.4.11.1002/37931-3.json |
| 37932-1 | XR tomography Wrist | ./2.16.840.1.114222.4.11.1002/37932-1.json |
| 37933-9 | XR Zygomatic arch 3 Views | ./2.16.840.1.114222.4.11.1002/37933-9.json |
| 37934-7 | XR Zygomatic arch 4 Views | ./2.16.840.1.114222.4.11.1002/37934-7.json |
| 37935-4 | RFA Pelvis arteries and Lower extremity arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37935-4.json |
| 37936-2 | RFA Peripheral vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37936-2.json |
| 3793-7 | Methotrexate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3793-7.json |
| 37937-0 | XR Ribs anterior Views | ./2.16.840.1.114222.4.11.1002/37937-0.json |
| 37938-8 | XR Ribs posterior Views | ./2.16.840.1.114222.4.11.1002/37938-8.json |
| 37939-6 | RFA Adrenal artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37939-6.json |
| 37940-4 | RFA Adrenal vein - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37940-4.json |
| 37941-2 | RFA Ankle arteries - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37941-2.json |
| 37942-0 | RF Ankle - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37942-0.json |
| 37943-8 | RFA Carotid arteries and Vertebral artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37943-8.json |
| 37944-6 | RFA Carotid artery and Cerebral artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37944-6.json |
| 3794-5 | Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose | ./2.16.840.1.114222.4.11.1002/3794-5.json |
| 37945-3 | RFA Carotid artery.cervical - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37945-3.json |
| 37947-9 | RF Elbow - right Arthrogram | ./2.16.840.1.114222.4.11.1002/37947-9.json |
| 37948-7 | RFA Carotid artery.external - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37948-7.json |
| 37949-5 | RFA Extremity arteries - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37949-5.json |
| 37950-3 | RFA Extremity veins - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37950-3.json |
| 3795-2 | Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose | ./2.16.840.1.114222.4.11.1002/3795-2.json |
| 37952-9 | RFA Carotid artery.internal - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37952-9.json |
| 37953-7 | RFA Carotid artery and Cerebral artery internal - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37953-7.json |
| 37958-6 | RFA Orbit veins - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37958-6.json |
| 37959-4 | RFA Renal vein - right Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37959-4.json |
| 3796-0 | Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose | ./2.16.840.1.114222.4.11.1002/3796-0.json |
| 37960-2 | XR Ribs lower - right Views | ./2.16.840.1.114222.4.11.1002/37960-2.json |
| 37961-0 | XR Ribs upper - right Views | ./2.16.840.1.114222.4.11.1002/37961-0.json |
| 37962-8 | XR Ribs anterior and posterior - right Views | ./2.16.840.1.114222.4.11.1002/37962-8.json |
| 37963-6 | XR Ribs anterior - right Views | ./2.16.840.1.114222.4.11.1002/37963-6.json |
| 37964-4 | XR Ribs posterior - right Views | ./2.16.840.1.114222.4.11.1002/37964-4.json |
| 37965-1 | XR Sternoclavicular joint - right Views | ./2.16.840.1.114222.4.11.1002/37965-1.json |
| 37966-9 | RFA Subclavian artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37966-9.json |
| 37967-7 | RFA Upper extremity arteries - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37967-7.json |
| 37968-5 | RFA Vertebral artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37968-5.json |
| 37969-3 | RFA Sinus vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37969-3.json |
| 37970-1 | RFA Splenic vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37970-1.json |
| 37971-9 | RFA Subclavian vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37971-9.json |
| 37972-7 | RFA Superior mesenteric vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/37972-7.json |
| 37973-5 | RF Testicular vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37973-5.json |
| 37974-3 | XR Spine thoracolumbar junction AP and Lateral | ./2.16.840.1.114222.4.11.1002/37974-3.json |
| 37975-0 | XR Spine thoracolumbar junction Views | ./2.16.840.1.114222.4.11.1002/37975-0.json |
| 37976-8 | RFA Upper extremity vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37976-8.json |
| 37977-6 | RFA Upper extremity arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37977-6.json |
| 3797-8 | Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose | ./2.16.840.1.114222.4.11.1002/3797-8.json |
| 37979-2 | RFA Uterine artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/37979-2.json |
| 37980-0 | RFA Vertebral vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37980-0.json |
| 37981-8 | RFA Visceral vessels Views W contrast | ./2.16.840.1.114222.4.11.1002/37981-8.json |
| 37982-6 | Avian paramyxovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/37982-6.json |
| 37983-4 | Eastern equine encephalitis virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/37983-4.json |
| 37984-2 | Saint Louis encephalitis virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/37984-2.json |
| 37985-9 | West Nile virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/37985-9.json |
| 3798-6 | Methoxyphenamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3798-6.json |
| 37986-7 | California serogroup RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/37986-7.json |
| 37987-5 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/37987-5.json |
| 37988-3 | Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/37988-3.json |
| 37989-1 | Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/37989-1.json |
| 37990-9 | Corticotropin releasing hormone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/37990-9.json |
| 37991-7 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/37991-7.json |
| 37992-5 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/37992-5.json |
| 37993-3 | DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/37993-3.json |
| 3799-4 | Methoxyphenamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3799-4.json |
| 37994-1 | MRA Lumbar spine vessels WO contrast | ./2.16.840.1.114222.4.11.1002/37994-1.json |
| 37995-8 | XR Calcaneus - bilateral Broden Views | ./2.16.840.1.114222.4.11.1002/37995-8.json |
| 37996-6 | XR Calcaneus Broden Views | ./2.16.840.1.114222.4.11.1002/37996-6.json |
| 37997-4 | XR Calcaneus - left Broden Views | ./2.16.840.1.114222.4.11.1002/37997-4.json |
| 37998-2 | XR Elbow Radial head capitellar | ./2.16.840.1.114222.4.11.1002/37998-2.json |
| 37999-0 | XR Elbow - bilateral Radial head capitellar | ./2.16.840.1.114222.4.11.1002/37999-0.json |
| 3800-0 | Methoxyphenamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3800-0.json |
| 38000-6 | XR Elbow - left Radial head capitellar | ./2.16.840.1.114222.4.11.1002/38000-6.json |
| 38001-4 | XR Chest Single view W expiration | ./2.16.840.1.114222.4.11.1002/38001-4.json |
| 38002-2 | XR Chest Single view W inspiration | ./2.16.840.1.114222.4.11.1002/38002-2.json |
| 38003-0 | XR Foot - left Views AP W standing | ./2.16.840.1.114222.4.11.1002/38003-0.json |
| 38004-8 | XR Shoulder - left Grashey Views WO and W weight | ./2.16.840.1.114222.4.11.1002/38004-8.json |
| 38006-3 | XR Elbow - right Radial head capitellar | ./2.16.840.1.114222.4.11.1002/38006-3.json |
| 38007-1 | XR Humerus - right Transthoracic | ./2.16.840.1.114222.4.11.1002/38007-1.json |
| 38008-9 | XR Cervical and thoracic and lumbar spine Views | ./2.16.840.1.114222.4.11.1002/38008-9.json |
| 38009-7 | XR Thoracic spine AP and Lateral and Swimmers | ./2.16.840.1.114222.4.11.1002/38009-7.json |
| 38010-5 | XR Thoracic spine Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/38010-5.json |
| 38011-3 | US Thoracic and abdominal aorta limited | ./2.16.840.1.114222.4.11.1002/38011-3.json |
| 38012-1 | US Guidance for aspiration of cyst of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/38012-1.json |
| 38013-9 | US Lower extremity - bilateral | ./2.16.840.1.114222.4.11.1002/38013-9.json |
| 38014-7 | US Upper extremity artery - bilateral | ./2.16.840.1.114222.4.11.1002/38014-7.json |
| 38015-4 | US Carotid arteries limited | ./2.16.840.1.114222.4.11.1002/38015-4.json |
| 38016-2 | US Chest wall | ./2.16.840.1.114222.4.11.1002/38016-2.json |
| 38017-0 | US Guidance for FNA of Prostate | ./2.16.840.1.114222.4.11.1002/38017-0.json |
| 3801-8 | Methsuximide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3801-8.json |
| 38018-8 | US Guidance for fine needle aspiration of Unspecified body region | ./2.16.840.1.114222.4.11.1002/38018-8.json |
| 38019-6 | US Guidance for fine needle aspiration of Thyroid gland | ./2.16.840.1.114222.4.11.1002/38019-6.json |
| 38020-4 | US Gallbladder limited | ./2.16.840.1.114222.4.11.1002/38020-4.json |
| 38021-2 | US Biliary ducts and Gallbladder | ./2.16.840.1.114222.4.11.1002/38021-2.json |
| 38022-0 | US Gallbladder W cholecystokinin | ./2.16.840.1.114222.4.11.1002/38022-0.json |
| 38023-8 | US Guidance for percutaneous biopsy.core needle of Breast - left | ./2.16.840.1.114222.4.11.1002/38023-8.json |
| 38024-6 | US Guidance for core needle biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/38024-6.json |
| 38025-3 | US Guidance for percutaneous biopsy.core needle of Breast - right | ./2.16.840.1.114222.4.11.1002/38025-3.json |
| 3802-6 | Methyldopa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3802-6.json |
| 38026-1 | US Guidance for fine needle aspiration of Breast - left | ./2.16.840.1.114222.4.11.1002/38026-1.json |
| 38030-3 | US Guidance for biopsy of Spleen | ./2.16.840.1.114222.4.11.1002/38030-3.json |
| 38032-9 | US Guidance for needle localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/38032-9.json |
| 38033-7 | US Guidance for fine needle aspiration of Breast - right | ./2.16.840.1.114222.4.11.1002/38033-7.json |
| 3803-4 | MethylePHEDrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3803-4.json |
| 38034-5 | US Head limited | ./2.16.840.1.114222.4.11.1002/38034-5.json |
| 38035-2 | US Kidney limited | ./2.16.840.1.114222.4.11.1002/38035-2.json |
| 38036-0 | US Kidney | ./2.16.840.1.114222.4.11.1002/38036-0.json |
| 38037-8 | US Femur - left | ./2.16.840.1.114222.4.11.1002/38037-8.json |
| 38038-6 | US Kidney - left | ./2.16.840.1.114222.4.11.1002/38038-6.json |
| 38039-4 | US Lower extremity - left limited | ./2.16.840.1.114222.4.11.1002/38039-4.json |
| 38040-2 | US Lower extremity - left | ./2.16.840.1.114222.4.11.1002/38040-2.json |
| 38041-0 | US Upper extremity - left | ./2.16.840.1.114222.4.11.1002/38041-0.json |
| 3804-2 | MethylePHEDrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3804-2.json |
| 38042-8 | US.doppler Lower extremity artery limited | ./2.16.840.1.114222.4.11.1002/38042-8.json |
| 38043-6 | US Mastoid | ./2.16.840.1.114222.4.11.1002/38043-6.json |
| 38044-4 | US Mediastinum | ./2.16.840.1.114222.4.11.1002/38044-4.json |
| 38045-1 | US Parathyroid gland | ./2.16.840.1.114222.4.11.1002/38045-1.json |
| 38046-9 | US Pelvis limited | ./2.16.840.1.114222.4.11.1002/38046-9.json |
| 38047-7 | US Retroperitoneum limited | ./2.16.840.1.114222.4.11.1002/38047-7.json |
| 38048-5 | US Femur - right | ./2.16.840.1.114222.4.11.1002/38048-5.json |
| 38049-3 | US Kidney - right | ./2.16.840.1.114222.4.11.1002/38049-3.json |
| 38050-1 | US Lower extremity - right limited | ./2.16.840.1.114222.4.11.1002/38050-1.json |
| 38051-9 | US Lower extremity - right | ./2.16.840.1.114222.4.11.1002/38051-9.json |
| 38052-7 | US Upper extremity - right | ./2.16.840.1.114222.4.11.1002/38052-7.json |
| 38053-5 | US Sacrum | ./2.16.840.1.114222.4.11.1002/38053-5.json |
| 38054-3 | US Visceral artery | ./2.16.840.1.114222.4.11.1002/38054-3.json |
| 38057-6 | MR Breast - left for implant | ./2.16.840.1.114222.4.11.1002/38057-6.json |
| 38058-4 | MR Breast - right for implant | ./2.16.840.1.114222.4.11.1002/38058-4.json |
| 3805-9 | MethylePHEDrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3805-9.json |
| 38061-8 | MR Spine Cervical and Spine Thoracic and Spine Lumbar and Sacrum W contrast IV | ./2.16.840.1.114222.4.11.1002/38061-8.json |
| 38062-6 | MR Breast - right for implant WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/38062-6.json |
| 38064-2 | MR Breast - left for implant WO contrast | ./2.16.840.1.114222.4.11.1002/38064-2.json |
| 38065-9 | XR Hip - left Single view during surgery | ./2.16.840.1.114222.4.11.1002/38065-9.json |
| 38066-7 | XR Hip - left Lateral during surgery | ./2.16.840.1.114222.4.11.1002/38066-7.json |
| 3806-7 | Methylphenidate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3806-7.json |
| 38068-3 | XR Chest Right anterior oblique | ./2.16.840.1.114222.4.11.1002/38068-3.json |
| 38069-1 | XR Abdomen Left posterior oblique | ./2.16.840.1.114222.4.11.1002/38069-1.json |
| 38070-9 | MG Breast Views for implant | ./2.16.840.1.114222.4.11.1002/38070-9.json |
| 38071-7 | MG Breast - bilateral Views for implant | ./2.16.840.1.114222.4.11.1002/38071-7.json |
| 38072-5 | MG Breast - left Views for implant | ./2.16.840.1.114222.4.11.1002/38072-5.json |
| 38073-3 | XR Ribs anterior - bilateral Views | ./2.16.840.1.114222.4.11.1002/38073-3.json |
| 38074-1 | XR Ribs anterior - left Views | ./2.16.840.1.114222.4.11.1002/38074-1.json |
| 3807-5 | Methylphenidate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3807-5.json |
| 38079-0 | MG Breast specimen - bilateral Views | ./2.16.840.1.114222.4.11.1002/38079-0.json |
| 38080-8 | MG Breast specimen - left Views | ./2.16.840.1.114222.4.11.1002/38080-8.json |
| 38082-4 | XR Shoulder - left AP and Transthoracic | ./2.16.840.1.114222.4.11.1002/38082-4.json |
| 3808-3 | Methylphenidate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3808-3.json |
| 38083-2 | XR Cervical spine AP and Lateral and Oblique and Odontoid and Swimmers | ./2.16.840.1.114222.4.11.1002/38083-2.json |
| 38084-0 | XR Abdomen AP and Left posterior oblique | ./2.16.840.1.114222.4.11.1002/38084-0.json |
| 38086-5 | XR Knee Merchants 30 and 45 and 60 degrees | ./2.16.840.1.114222.4.11.1002/38086-5.json |
| 38087-3 | XR Knee - left Sunrise 20 and 40 and 60 degrees | ./2.16.840.1.114222.4.11.1002/38087-3.json |
| 38088-1 | XR Knee - bilateral Sunrise 20 and 40 and 60 degrees | ./2.16.840.1.114222.4.11.1002/38088-1.json |
| 38089-9 | XR Bones Limited Survey Views for metastasis | ./2.16.840.1.114222.4.11.1002/38089-9.json |
| 38090-7 | MG Breast - bilateral Air gap Views | ./2.16.840.1.114222.4.11.1002/38090-7.json |
| 3809-1 | Methylphenidate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3809-1.json |
| 38091-5 | MG Breast - left Air gap Views | ./2.16.840.1.114222.4.11.1002/38091-5.json |
| 38092-3 | RF Urinary bladder Views W chain and contrast intra bladder | ./2.16.840.1.114222.4.11.1002/38092-3.json |
| 38093-1 | XR Chest Views W nipple markers | ./2.16.840.1.114222.4.11.1002/38093-1.json |
| 38094-9 | RF Spinal cavity Views W contrast | ./2.16.840.1.114222.4.11.1002/38094-9.json |
| 38095-6 | MG Breast duct - bilateral Views W contrast intra duct | ./2.16.840.1.114222.4.11.1002/38095-6.json |
| 38096-4 | MG Breast duct - left Views W contrast intra duct | ./2.16.840.1.114222.4.11.1002/38096-4.json |
| 38097-2 | RF Parotid gland - left Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/38097-2.json |
| 38098-0 | RF Lacrimal duct - bilateral Views W contrast intra lacrimal duct | ./2.16.840.1.114222.4.11.1002/38098-0.json |
| 38099-8 | RF Lacrimal duct - left Views W contrast intra lacrimal duct | ./2.16.840.1.114222.4.11.1002/38099-8.json |
| 38100-4 | RF Urinary bladder and Urethra Views W contrast antegrade | ./2.16.840.1.114222.4.11.1002/38100-4.json |
| 38101-2 | XR Kidney Views W contrast antegrade | ./2.16.840.1.114222.4.11.1002/38101-2.json |
| 38102-0 | XR Kidney Views W contrast antegrade via pyelostomy | ./2.16.840.1.114222.4.11.1002/38102-0.json |
| 38103-8 | RF Spine Cervical and Spine Lumbar Views W contrast IT | ./2.16.840.1.114222.4.11.1002/38103-8.json |
| 38104-6 | RF Spine epidural space Views W contrast IT | ./2.16.840.1.114222.4.11.1002/38104-6.json |
| 38105-3 | XR Kidney Views W contrast retrograde | ./2.16.840.1.114222.4.11.1002/38105-3.json |
| 38107-9 | XR Wrist Scaphoid Views | ./2.16.840.1.114222.4.11.1002/38107-9.json |
| 38108-7 | XR Knee - right 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/38108-7.json |
| 3810-9 | Methylphenidate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3810-9.json |
| 38112-9 | RF Kidney - right Views W contrast via nephrostomy tube | ./2.16.840.1.114222.4.11.1002/38112-9.json |
| 38114-5 | XR Tibia and Fibula - right 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/38114-5.json |
| 38115-2 | XR Wrist - right Scaphoid Views | ./2.16.840.1.114222.4.11.1002/38115-2.json |
| 38116-0 | RF Parotid gland Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/38116-0.json |
| 3811-7 | Methyprylon [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3811-7.json |
| 38117-8 | XR Sinuses Waters upright | ./2.16.840.1.114222.4.11.1002/38117-8.json |
| 38118-6 | XR Neck 2 Lateral Views | ./2.16.840.1.114222.4.11.1002/38118-6.json |
| 38119-4 | RFA Thoracic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38119-4.json |
| 38120-2 | RF Thoracic spine Limited Views W contrast IT | ./2.16.840.1.114222.4.11.1002/38120-2.json |
| 38121-0 | XR Thoracic and lumbar spine Single view | ./2.16.840.1.114222.4.11.1002/38121-0.json |
| 38123-6 | XR Thoracic and lumbar spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/38123-6.json |
| 38124-4 | XR Thoracic and lumbar spine Views W standing | ./2.16.840.1.114222.4.11.1002/38124-4.json |
| 3812-5 | Methyprylon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3812-5.json |
| 38125-1 | RF Cervical and thoracic and lumbar spine Limited Views W contrast IT | ./2.16.840.1.114222.4.11.1002/38125-1.json |
| 38126-9 | US Guidance for aspiration of cyst of Kidney | ./2.16.840.1.114222.4.11.1002/38126-9.json |
| 38127-7 | US Guidance for aspiration of CSF of Spine | ./2.16.840.1.114222.4.11.1002/38127-7.json |
| 38128-5 | US Femoral vessels - bilateral | ./2.16.840.1.114222.4.11.1002/38128-5.json |
| 38129-3 | US Iliac vessels - bilateral | ./2.16.840.1.114222.4.11.1002/38129-3.json |
| 38130-1 | US Lower extremity artery - bilateral | ./2.16.840.1.114222.4.11.1002/38130-1.json |
| 38131-9 | US Subclavian vessels - bilateral | ./2.16.840.1.114222.4.11.1002/38131-9.json |
| 38132-7 | US Guidance for biopsy of Scrotum and testicle | ./2.16.840.1.114222.4.11.1002/38132-7.json |
| 3813-3 | Methyprylon [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3813-3.json |
| 38133-5 | US Guidance for aspiration of cyst of Pancreas | ./2.16.840.1.114222.4.11.1002/38133-5.json |
| 38134-3 | US Femoral vessels | ./2.16.840.1.114222.4.11.1002/38134-3.json |
| 38135-0 | US Guidance for deep aspiration.fine needle of Tissue | ./2.16.840.1.114222.4.11.1002/38135-0.json |
| 38136-8 | US Guidance for superficial aspiration.fine needle of Tissue | ./2.16.840.1.114222.4.11.1002/38136-8.json |
| 38137-6 | US Iliac vessels - left | ./2.16.840.1.114222.4.11.1002/38137-6.json |
| 38138-4 | US Parotid gland | ./2.16.840.1.114222.4.11.1002/38138-4.json |
| 38139-2 | US Penis vessels | ./2.16.840.1.114222.4.11.1002/38139-2.json |
| 38140-0 | US Penis | ./2.16.840.1.114222.4.11.1002/38140-0.json |
| 3814-1 | Methyprylon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3814-1.json |
| 38141-8 | US Iliac vessels - right | ./2.16.840.1.114222.4.11.1002/38141-8.json |
| 38142-6 | US Guidance for drainage and placement of drainage catheter of Chest | ./2.16.840.1.114222.4.11.1002/38142-6.json |
| 38143-4 | US.doppler Upper extremity artery limited | ./2.16.840.1.114222.4.11.1002/38143-4.json |
| 38144-2 | XR Finger second - right Views | ./2.16.840.1.114222.4.11.1002/38144-2.json |
| 38145-9 | XR Finger third - right Views | ./2.16.840.1.114222.4.11.1002/38145-9.json |
| 38146-7 | XR Finger fourth - right Views | ./2.16.840.1.114222.4.11.1002/38146-7.json |
| 38147-5 | XR Finger fifth - right Views | ./2.16.840.1.114222.4.11.1002/38147-5.json |
| 38148-3 | XR Toe second - right Views | ./2.16.840.1.114222.4.11.1002/38148-3.json |
| 38149-1 | XR Toe third - right Views | ./2.16.840.1.114222.4.11.1002/38149-1.json |
| 38150-9 | XR Toe fourth - right Views | ./2.16.840.1.114222.4.11.1002/38150-9.json |
| 38151-7 | XR Toe fifth - right Views | ./2.16.840.1.114222.4.11.1002/38151-7.json |
| 38152-5 | XR Great toe - right Views | ./2.16.840.1.114222.4.11.1002/38152-5.json |
| 38153-3 | RF Submandibular gland Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/38153-3.json |
| 38154-1 | RF Guidance for superficial biopsy of Bone | ./2.16.840.1.114222.4.11.1002/38154-1.json |
| 38155-8 | XR Wrist 4 Views | ./2.16.840.1.114222.4.11.1002/38155-8.json |
| 38156-6 | XR Wrist 6 Views | ./2.16.840.1.114222.4.11.1002/38156-6.json |
| 3815-8 | Metoprolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3815-8.json |
| 38159-0 | levETIRAcetam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/38159-0.json |
| 38160-8 | Porphyrins/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/38160-8.json |
| 3816-6 | Metoprolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3816-6.json |
| 38166-5 | West Nile virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/38166-5.json |
| 38169-9 | Lambda light chains.free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38169-9.json |
| 38172-3 | Organic acids [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38172-3.json |
| 3817-4 | Metoprolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3817-4.json |
| 38175-6 | Heptacarboxylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/38175-6.json |
| 38176-4 | Kappa light chains.free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/38176-4.json |
| 38177-2 | Kappa light chains.free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38177-2.json |
| 38178-0 | Lambda light chains.free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/38178-0.json |
| 38179-8 | Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38179-8.json |
| 38180-6 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38180-6.json |
| 3818-2 | Metoprolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3818-2.json |
| 38182-2 | Parainfluenza virus 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/38182-2.json |
| 38183-0 | Parainfluenza virus 2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/38183-0.json |
| 38185-5 | Beta galactosidase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/38185-5.json |
| 38187-1 | Bile acid.dihydroxy [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38187-1.json |
| 38188-9 | Bile acid.trihydroxy [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38188-9.json |
| 3819-0 | Mexiletine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3819-0.json |
| 38192-1 | Amylase [Enzymatic activity/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/38192-1.json |
| 38193-9 | Amylase [Enzymatic activity/time] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/38193-9.json |
| 38194-7 | Antidepressants [Identifier] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/38194-7.json |
| 38195-4 | Antihistamines [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/38195-4.json |
| 38197-0 | Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38197-0.json |
| 38198-8 | Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38198-8.json |
| 3820-8 | Mezlocillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3820-8.json |
| 3821-6 | Midazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3821-6.json |
| 3822-4 | Minocycline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3822-4.json |
| 38230-9 | Calcium.ionized [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38230-9.json |
| 3823-2 | Morazone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3823-2.json |
| 38233-3 | CD3+CD62L+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38233-3.json |
| 38235-8 | CD3+TCR gamma delta+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38235-8.json |
| 38237-4 | CD4+CD28+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38237-4.json |
| 38239-0 | CD4+CD95+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38239-0.json |
| 3824-0 | Morazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3824-0.json |
| 38241-6 | CD8+CD95+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38241-6.json |
| 38243-2 | Brucella abortus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38243-2.json |
| 38244-0 | Brucella abortus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38244-0.json |
| 38245-7 | Brucella canis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38245-7.json |
| 38246-5 | Brucella canis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38246-5.json |
| 38247-3 | Brucella sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38247-3.json |
| 38248-1 | Brucella sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38248-1.json |
| 38250-7 | Calcium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38250-7.json |
| 38251-5 | Calcium oxalate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38251-5.json |
| 38253-1 | Carbon dioxide, total [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38253-1.json |
| 38254-9 | Carbonated calcium phosphate [Presence] in Stone | ./2.16.840.1.114222.4.11.1002/38254-9.json |
| 38255-6 | Cat dander IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/38255-6.json |
| 3825-7 | Morazone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3825-7.json |
| 3826-5 | Morphine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3826-5.json |
| 38268-9 | DXA Skeletal system Views for bone density | ./2.16.840.1.114222.4.11.1002/38268-9.json |
| 38269-7 | Study report Skeletal system DXA | ./2.16.840.1.114222.4.11.1002/38269-7.json |
| 38270-5 | Influenza virus A H7 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38270-5.json |
| 38271-3 | Influenza virus A H6 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38271-3.json |
| 38272-1 | Influenza virus A H5 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38272-1.json |
| 3827-3 | Morphine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3827-3.json |
| 38273-9 | Influenza virus A Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/38273-9.json |
| 38274-7 | Columbid circovirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38274-7.json |
| 38275-4 | Transmissible spongiform encephalopathy [Presence] in Brain by Light microscopy | ./2.16.840.1.114222.4.11.1002/38275-4.json |
| 38277-0 | Lymphocyte proliferation stimulated by 0.5 ug/mL Candida albicans [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38277-0.json |
| 38278-8 | Lymphocyte proliferation stimulated by 1.0 ug/mL Candida albicans [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38278-8.json |
| 38279-6 | Lymphocyte proliferation stimulated by 2.5 ug/mL Candida albicans [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38279-6.json |
| 38280-4 | Lymphocyte proliferation stimulated by 5.0 ug/mL Candida albicans [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38280-4.json |
| 3828-1 | Morphine Free [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3828-1.json |
| 38281-2 | Lymphocyte proliferation stimulated by 2.41 ug/mL tetanus toxoid [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38281-2.json |
| 38282-0 | Lymphocyte proliferation stimulated by 4.83 ug/mL tetanus toxoid [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38282-0.json |
| 38283-8 | Lymphocyte proliferation stimulated by 9.67 ug/mL tetanus toxoid [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38283-8.json |
| 38284-6 | Lymphocyte proliferation stimulated by 19.3 ug/mL tetanus toxoid [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38284-6.json |
| 38285-3 | Erythrocytes [Presence] in Duodenal fluid | ./2.16.840.1.114222.4.11.1002/38285-3.json |
| 3829-9 | Morphine Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3829-9.json |
| 3830-7 | Morphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3830-7.json |
| 3831-5 | Morphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3831-5.json |
| 3832-3 | Morphine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3832-3.json |
| 3833-1 | Moxalactam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3833-1.json |
| 38345-5 | Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/38345-5.json |
| 38347-1 | XXX microorganism DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38347-1.json |
| 38348-9 | Herpes virus 6 DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38348-9.json |
| 3834-9 | N-acetylprocainamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3834-9.json |
| 38349-7 | Herpes virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38349-7.json |
| 38350-5 | Herpes virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38350-5.json |
| 38352-1 | Interleukin 2 receptor [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38352-1.json |
| 38353-9 | Streptococcus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38353-9.json |
| 38354-7 | Bartonella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38354-7.json |
| 38355-4 | Chitotriosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38355-4.json |
| 38356-2 | Thyroxine (T4) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38356-2.json |
| 38358-8 | A Ab [Titer] in Serum or Plasma by Antihuman globulin | ./2.16.840.1.114222.4.11.1002/38358-8.json |
| 38359-6 | A Ab [Titer] in Serum or Plasma by Immediate spin | ./2.16.840.1.114222.4.11.1002/38359-6.json |
| 38361-2 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG Ab [Mass/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/38361-2.json |
| 38362-0 | Muscle specific receptor tyrosine kinase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38362-0.json |
| 38363-8 | Cefepime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38363-8.json |
| 3836-4 | Nadolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3836-4.json |
| 38364-6 | Haloperidol reduced [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38364-6.json |
| 38366-1 | Hypoxanthine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/38366-1.json |
| 38368-7 | Pigeon droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/38368-7.json |
| 38369-5 | U1 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38369-5.json |
| 38370-3 | Voriconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38370-3.json |
| 38371-1 | Xanthine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/38371-1.json |
| 3837-2 | Nadolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3837-2.json |
| 38372-9 | Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/38372-9.json |
| 38373-7 | Buprenorphine+Norbuprenorphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/38373-7.json |
| 38374-5 | Tenofovir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38374-5.json |
| 38375-2 | Adenovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38375-2.json |
| 38376-0 | Cryptococcus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38376-0.json |
| 38377-8 | Cryptococcus neoformans [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38377-8.json |
| 38379-4 | Mycobacterium tuberculosis complex DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38379-4.json |
| 3838-0 | Nadolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3838-0.json |
| 38380-2 | HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38380-2.json |
| 38381-0 | Influenza virus A cDNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38381-0.json |
| 38382-8 | Influenza virus B [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38382-8.json |
| 38384-4 | Cocaine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/38384-4.json |
| 38385-1 | Coccidioides immitis Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/38385-1.json |
| 38387-7 | C3 nephritic factor [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38387-7.json |
| 38388-5 | Complement C3 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38388-5.json |
| 38389-3 | Coxiella burnetii phase 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38389-3.json |
| 38392-7 | Legionella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38392-7.json |
| 38393-5 | Legionella sp identified in Pleural fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38393-5.json |
| 38394-3 | Legionella sp identified in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/38394-3.json |
| 38395-0 | Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38395-0.json |
| 38396-8 | Parainfluenza virus 1 Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38396-8.json |
| 38397-6 | Crystals [type] in Amniotic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/38397-6.json |
| 3839-8 | Nalbuphine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3839-8.json |
| 38398-4 | Crystals [type] in Pericardial fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/38398-4.json |
| 38399-2 | Crystals [type] in Peritoneal fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/38399-2.json |
| 38400-8 | Parainfluenza virus 1+2+3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38400-8.json |
| 38401-6 | Protozoa identified in Specimen | ./2.16.840.1.114222.4.11.1002/38401-6.json |
| 38402-4 | Parasite identified in Tissue | ./2.16.840.1.114222.4.11.1002/38402-4.json |
| 38403-2 | Cyclospora sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/38403-2.json |
| 38404-0 | CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38404-0.json |
| 38405-7 | MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38405-7.json |
| 3840-6 | Nalbuphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3840-6.json |
| 38406-5 | PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38406-5.json |
| 38407-3 | PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38407-3.json |
| 38408-1 | PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38408-1.json |
| 38409-9 | SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38409-9.json |
| 38410-7 | Basement membrane zone Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38410-7.json |
| 38411-5 | TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38411-5.json |
| 38412-3 | FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38412-3.json |
| 38413-1 | FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38413-1.json |
| 3841-4 | Nalbuphine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3841-4.json |
| 38414-9 | Iron [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/38414-9.json |
| 38415-6 | MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38415-6.json |
| 38416-4 | Parasite identified in Body fluid by Inspection | ./2.16.840.1.114222.4.11.1002/38416-4.json |
| 38418-0 | Pigeon droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38418-0.json |
| 38420-6 | Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/38420-6.json |
| 3842-2 | Nalorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3842-2.json |
| 38427-1 | Thiocyanate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38427-1.json |
| 3843-0 | Nandrolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3843-0.json |
| 38436-2 | Colony count [#/mass] in Specimen by Visual count | ./2.16.840.1.114222.4.11.1002/38436-2.json |
| 38437-0 | Cashew nut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/38437-0.json |
| 38438-8 | Aspergillus fumigatus IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/38438-8.json |
| 38439-6 | Barbiturates [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/38439-6.json |
| 38440-4 | Basement membrane zone Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38440-4.json |
| 38441-2 | Benzodiazepines [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/38441-2.json |
| 38443-8 | Blastomyces dermatitidis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/38443-8.json |
| 38444-6 | Bromide [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38444-6.json |
| 38445-3 | Calprotectin [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/38445-3.json |
| 38446-1 | Catecholamines [Mass/time] in 72 hour Urine | ./2.16.840.1.114222.4.11.1002/38446-1.json |
| 38447-9 | CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38447-9.json |
| 3844-8 | Nandrolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3844-8.json |
| 38448-7 | CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38448-7.json |
| 38449-5 | CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38449-5.json |
| 38450-3 | CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38450-3.json |
| 38451-1 | CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38451-1.json |
| 38452-9 | CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38452-9.json |
| 38453-7 | CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38453-7.json |
| 38454-5 | CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38454-5.json |
| 3845-5 | Nandrolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3845-5.json |
| 38455-2 | CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38455-2.json |
| 38456-0 | CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38456-0.json |
| 38457-8 | Immune complex.C3d+IgG [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38457-8.json |
| 38458-6 | Crystals [Presence] in Synovial fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/38458-6.json |
| 38459-4 | Crystals [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/38459-4.json |
| 38460-2 | Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38460-2.json |
| 38461-0 | Legionella sp Ag [Presence] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38461-0.json |
| 38462-8 | Legionella sp Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38462-8.json |
| 3846-3 | Naproxen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3846-3.json |
| 38463-6 | Legionella sp Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38463-6.json |
| 38464-4 | Mountain Juniper IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/38464-4.json |
| 38465-1 | Chicken IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/38465-1.json |
| 38466-9 | Chicken serum proteins IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38466-9.json |
| 38467-7 | Chlamydia sp IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/38467-7.json |
| 38468-5 | Chlamydia sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/38468-5.json |
| 38469-3 | Chlamydia trachomatis rRNA [Presence] in Blood by Probe | ./2.16.840.1.114222.4.11.1002/38469-3.json |
| 38470-1 | chlorproPAMIDE [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38470-1.json |
| 3847-1 | Neopterin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3847-1.json |
| 38471-9 | Karyotype [Identifier] in Urine Nominal | ./2.16.840.1.114222.4.11.1002/38471-9.json |
| 38472-7 | 17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/38472-7.json |
| 38473-5 | 17-Hydroxyprogesterone [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/38473-5.json |
| 38475-0 | Acid alpha glucosidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38475-0.json |
| 38476-8 | Mullerian inhibiting substance [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38476-8.json |
| 38477-6 | Glucosylceramidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38477-6.json |
| 38478-4 | Biotinidase [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/38478-4.json |
| 38479-2 | Branched chain keto-acid dehydrogenase complex [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/38479-2.json |
| 38480-0 | Carnitine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/38480-0.json |
| 38481-8 | Carnitine free (C0) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/38481-8.json |
| 38482-6 | Creatine kinase.MB [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38482-6.json |
| 38483-4 | Creatinine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38483-4.json |
| 38485-9 | Galactose 1 phosphate [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/38485-9.json |
| 38486-7 | Homocystine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/38486-7.json |
| 38488-3 | IgG [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/38488-3.json |
| 3848-9 | Netilmicin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/3848-9.json |
| 38489-1 | Insulin bovine Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38489-1.json |
| 38490-9 | Insulin porcine Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/38490-9.json |
| 38491-7 | Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38491-7.json |
| 38492-5 | Insulin-like growth factor-I [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38492-5.json |
| 38493-3 | Ketones [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38493-3.json |
| 38494-1 | Metanephrine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38494-1.json |
| 38496-6 | Retinyl palmitate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38496-6.json |
| 3849-7 | Netilmicin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/3849-7.json |
| 38504-7 | Thyroglobulin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/38504-7.json |
| 3850-5 | Netilmicin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/3850-5.json |
| 38505-4 | Thyroglobulin recovery in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38505-4.json |
| 38506-2 | Thyroxine (T4) [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/38506-2.json |
| 38507-0 | Urobilinogen [Units/mass] in Stool | ./2.16.840.1.114222.4.11.1002/38507-0.json |
| 3851-3 | Nicomorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3851-3.json |
| 38513-8 | CD2+CD3+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38513-8.json |
| 38515-3 | Cytoplasmic Ig mu cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/38515-3.json |
| 38519-5 | Microscopic observation [Identifier] in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/38519-5.json |
| 38520-3 | Capillary fragility [Presence] | ./2.16.840.1.114222.4.11.1002/38520-3.json |
| 3852-1 | Nicotinamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3852-1.json |
| 38523-7 | Fibrinopeptide A [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/38523-7.json |
| 38525-2 | Oligoclonal bands [Mass/volume] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/38525-2.json |
| 38529-4 | CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38529-4.json |
| 38530-2 | BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38530-2.json |
| 38532-8 | SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38532-8.json |
| 38533-6 | TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38533-6.json |
| 38534-4 | COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38534-4.json |
| 38535-1 | LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38535-1.json |
| 38536-9 | MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38536-9.json |
| 38537-7 | ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38537-7.json |
| 3853-9 | Nicotine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3853-9.json |
| 38542-7 | Repaglinide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38542-7.json |
| 38545-0 | Methylmercury [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/38545-0.json |
| 38546-8 | HLA-B locus [Type] | ./2.16.840.1.114222.4.11.1002/38546-8.json |
| 3854-7 | Nicotine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3854-7.json |
| 38548-4 | HLA-A locus [Type] | ./2.16.840.1.114222.4.11.1002/38548-4.json |
| 38550-0 | MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38550-0.json |
| 38552-6 | Acylcarnitine short chain [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38552-6.json |
| 38553-4 | Narcolepsy associated Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38553-4.json |
| 3855-4 | Nikethamide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3855-4.json |
| 3856-2 | Nikethamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3856-2.json |
| 38567-4 | Aniline [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38567-4.json |
| 38568-2 | Asbestos [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38568-2.json |
| 38569-0 | Arsenic [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38569-0.json |
| 3857-0 | Nikethamide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3857-0.json |
| 38570-8 | Azinphos-methyl [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38570-8.json |
| 38571-6 | Barium [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38571-6.json |
| 38572-4 | Benzidine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38572-4.json |
| 38573-2 | Acrylamide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38573-2.json |
| 38574-0 | Beryllium [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38574-0.json |
| 38575-7 | Bromoform [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38575-7.json |
| 38576-5 | Butane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38576-5.json |
| 38577-3 | Carbon disulfide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38577-3.json |
| 38578-1 | Carbon tetrachloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38578-1.json |
| 38579-9 | Chlordane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38579-9.json |
| 38580-7 | Cresols [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38580-7.json |
| 38581-5 | Cumene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38581-5.json |
| 38584-9 | Acetaldehyde [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38584-9.json |
| 38585-6 | Acetone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38585-6.json |
| 38586-4 | Acetonitrile [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38586-4.json |
| 38587-2 | Acrylaldehyde [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38587-2.json |
| 3858-8 | Nitrazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3858-8.json |
| 38588-0 | Acrylonitrile [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38588-0.json |
| 38589-8 | Ammonia [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38589-8.json |
| 38591-4 | Dichlorvos [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38591-4.json |
| 38592-2 | Dimethylformamide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38592-2.json |
| 38593-0 | 1,4-Dioxane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38593-0.json |
| 38594-8 | Epichlorohydrin [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38594-8.json |
| 38595-5 | Ethylene dibromide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38595-5.json |
| 3859-6 | Nitrazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3859-6.json |
| 38596-3 | Ethylene glycol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38596-3.json |
| 38597-1 | Heptachlor [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38597-1.json |
| 38598-9 | Hexachlorobenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38598-9.json |
| 38599-7 | Hexachlorobutadiene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38599-7.json |
| 38600-3 | Hexachloroethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38600-3.json |
| 38601-1 | Hexane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38601-1.json |
| 38602-9 | Hydrazine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38602-9.json |
| 38603-7 | Hydrogen sulfide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38603-7.json |
| 3860-4 | Nitrofurantoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3860-4.json |
| 38604-5 | Hydroquinone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38604-5.json |
| 38605-2 | Lindane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38605-2.json |
| 38606-0 | Maleic anhydride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38606-0.json |
| 38607-8 | Methoxychlor [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38607-8.json |
| 38608-6 | Methyl bromide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38608-6.json |
| 38609-4 | Methyl tert-butyl ether [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38609-4.json |
| 38610-2 | Methylene chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38610-2.json |
| 38611-0 | Methyl isobutyl ketone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38611-0.json |
| 3861-2 | Nordiazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3861-2.json |
| 38612-8 | Naphthalene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38612-8.json |
| 38613-6 | Parathion [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38613-6.json |
| 38614-4 | Pentachlorophenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38614-4.json |
| 38615-1 | Phenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38615-1.json |
| 38616-9 | Propoxur [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38616-9.json |
| 38618-5 | Styrene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38618-5.json |
| 38619-3 | Dioxin [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38619-3.json |
| 3862-0 | Nordoxepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3862-0.json |
| 38620-1 | Tetrachloroethylene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38620-1.json |
| 38621-9 | Toluene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38621-9.json |
| 38622-7 | Toxaphene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38622-7.json |
| 38625-0 | Trichloroethylene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38625-0.json |
| 38626-8 | Vinyl chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38626-8.json |
| 38627-6 | Benzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38627-6.json |
| 38628-4 | Benzo alpha pyrene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38628-4.json |
| 38629-2 | Acetamide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38629-2.json |
| 38630-0 | Acrylate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38630-0.json |
| 38631-8 | Allyl chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38631-8.json |
| 38632-6 | 4-Biphenylamine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38632-6.json |
| 38633-4 | Benzotrichloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38633-4.json |
| 38634-2 | Benzyl chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38634-2.json |
| 38635-9 | Biphenyl [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38635-9.json |
| 38636-7 | Di(2-Ethylhexyl) phthalate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38636-7.json |
| 38637-5 | Bis(Chloromethyl) Ether [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38637-5.json |
| 3863-8 | Norethandrolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3863-8.json |
| 38638-3 | Boron oxide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38638-3.json |
| 38639-1 | Boron trifluoride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38639-1.json |
| 38640-9 | Bromine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38640-9.json |
| 38641-7 | Ethyl bromide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38641-7.json |
| 38642-5 | 1,3-Butadiene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38642-5.json |
| 38643-3 | Calcium cyanamide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38643-3.json |
| 38644-1 | Caprolactam [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38644-1.json |
| 38645-8 | Captan [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38645-8.json |
| 3864-6 | Norethandrolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3864-6.json |
| 38646-6 | Catechol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38646-6.json |
| 38647-4 | Chlorine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38647-4.json |
| 38648-2 | Chlorobenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38648-2.json |
| 38649-0 | Chloroform [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38649-0.json |
| 38650-8 | Chloromethyl methyl ether [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38650-8.json |
| 38651-6 | 2-Chloro-1,3-Butadiene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38651-6.json |
| 38652-4 | Carbonyl sulfide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38652-4.json |
| 3865-3 | Norethandrolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3865-3.json |
| 38653-2 | Amiben [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38653-2.json |
| 38654-0 | Chloroacetate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38654-0.json |
| 38655-7 | 2-Chloroacetophenone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38655-7.json |
| 38656-5 | Chlorobenzilate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38656-5.json |
| 38657-3 | Diazomethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38657-3.json |
| 38658-1 | Acetate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38658-1.json |
| 38659-9 | Acetophenone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38659-9.json |
| 38660-7 | Acetylene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38660-7.json |
| 3866-1 | Norfenefrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3866-1.json |
| 38661-5 | Aldrin [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38661-5.json |
| 38662-3 | Aluminum oxide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38662-3.json |
| 38663-1 | Dichlorobenzidine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38663-1.json |
| 38664-9 | Bis(2-Chloroethyl) ether [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38664-9.json |
| 38665-6 | Diethanolamine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38665-6.json |
| 38666-4 | Diethylsulfate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38666-4.json |
| 38667-2 | 3,3'-Dimethoxybenzidine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38667-2.json |
| 38668-0 | N,N-Dimethylaniline [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38668-0.json |
| 38669-8 | Dichlorodiphenyldichloroethylene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38669-8.json |
| 38670-6 | Orthocresol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38670-6.json |
| 38671-4 | M-cresol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38671-4.json |
| 38672-2 | P-cresol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38672-2.json |
| 38673-0 | Dimethylphthalate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38673-0.json |
| 3867-9 | Norfloxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3867-9.json |
| 3868-7 | Norfluoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3868-7.json |
| 38687-0 | 2-Acetylaminofluorene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38687-0.json |
| 38688-8 | 1,1-Dimethylhydrazine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38688-8.json |
| 38689-6 | Dimethyl sulfate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38689-6.json |
| 38690-4 | 4,6-Dinitro-O-Cresol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38690-4.json |
| 38691-2 | 1,2-Diphenylhydrazine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38691-2.json |
| 38692-0 | 1-Butene oxide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38692-0.json |
| 38693-8 | Ethyl acrylate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38693-8.json |
| 38694-6 | Chloroethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38694-6.json |
| 3869-5 | Normeperidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3869-5.json |
| 38696-1 | Ethylene oxide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38696-1.json |
| 38697-9 | Ethylene thiourea [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38697-9.json |
| 38698-7 | Ethyleneimine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38698-7.json |
| 38699-5 | 1,1-Dichloroethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38699-5.json |
| 38700-1 | Formaldehyde [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38700-1.json |
| 38701-9 | Hexachlorocyclopentadiene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38701-9.json |
| 38702-7 | Hexamethylene diisocyanate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38702-7.json |
| 3870-3 | Norpropoxyphene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3870-3.json |
| 38703-5 | Hexamethylphosphoramide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38703-5.json |
| 38704-3 | Isophorone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38704-3.json |
| 38705-0 | Methanol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38705-0.json |
| 38706-8 | Chloromethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38706-8.json |
| 38707-6 | Trichloroethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38707-6.json |
| 38708-4 | Methyl hydrazine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38708-4.json |
| 38709-2 | Methyl iodide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38709-2.json |
| 38710-0 | Nitrobenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38710-0.json |
| 3871-1 | Norpropoxyphene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3871-1.json |
| 38711-8 | 2-Nitropropane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38711-8.json |
| 38712-6 | N-nitrosodimethylamine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38712-6.json |
| 38713-4 | N-nitrosomorpholine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38713-4.json |
| 38714-2 | Pentachloronitrobenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38714-2.json |
| 38715-9 | Phosgene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38715-9.json |
| 38716-7 | Phosphine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38716-7.json |
| 38717-5 | Phosphate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38717-5.json |
| 38718-3 | Phthalic anhydride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38718-3.json |
| 38719-1 | 1,3-Propane sultone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38719-1.json |
| 38720-9 | Beta-propiolactone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38720-9.json |
| 38721-7 | Propionaldehyde [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38721-7.json |
| 38722-5 | Propyleneimine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38722-5.json |
| 38723-3 | 1,4-Benzoquinone [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38723-3.json |
| 38724-1 | Quinoline [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38724-1.json |
| 38725-8 | Styrene-7,8-Oxide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38725-8.json |
| 38726-6 | Titanium tetrachloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38726-6.json |
| 38728-2 | 2-Aminotoluene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38728-2.json |
| 3872-9 | Nortriptyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3872-9.json |
| 38729-0 | 2,4,5-Trichlorophenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38729-0.json |
| 38730-8 | 2,4,6-Trichlorophenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38730-8.json |
| 38731-6 | Triethylamine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38731-6.json |
| 38732-4 | Trifluralin [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38732-4.json |
| 38733-2 | Vinyl acetate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38733-2.json |
| 38734-0 | Vinyl bromide [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38734-0.json |
| 38736-5 | Animal hair+Epithelium [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38736-5.json |
| 3873-7 | Nortriptyline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3873-7.json |
| 38737-3 | O-anisidine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38737-3.json |
| 38738-1 | Carbaryl [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38738-1.json |
| 38739-9 | 1,3-Dichloropropene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38739-9.json |
| 38740-7 | Dimethylcarbamoyl chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38740-7.json |
| 38741-5 | 2,4-Dinitrophenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38741-5.json |
| 38742-3 | 2,4-Dinitrotoluene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38742-3.json |
| 38743-1 | Hydrogen chloride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38743-1.json |
| 38744-9 | Hydrogen fluoride [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38744-9.json |
| 3874-5 | Nortriptyline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3874-5.json |
| 38745-6 | Isocyanate MDI [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38745-6.json |
| 38746-4 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38746-4.json |
| 38747-2 | Methyl isocyanate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38747-2.json |
| 38748-0 | Methylenedianiline [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38748-0.json |
| 38749-8 | P-nitrobiphenyl [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38749-8.json |
| 38750-6 | Para nitrophenol [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38750-6.json |
| 38751-4 | 1,4-Benzenediamine [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38751-4.json |
| 3875-2 | Nortriptyline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3875-2.json |
| 38752-2 | Polychlorinated biphenyl (PCB) [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38752-2.json |
| 38753-0 | Tetrachloroethane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38753-0.json |
| 38754-8 | 2,4-Toluene diisocyanate [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38754-8.json |
| 38755-5 | Dimethylbenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38755-5.json |
| 38756-3 | 1,2-Dimethylbenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38756-3.json |
| 38757-1 | 1,3-Dimethylbenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38757-1.json |
| 38758-9 | 1,4-Dimethylbenzene [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38758-9.json |
| 38759-7 | Aluminum [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38759-7.json |
| 3876-0 | Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose | ./2.16.840.1.114222.4.11.1002/3876-0.json |
| 38760-5 | Dibenzofuran [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38760-5.json |
| 38761-3 | Asphalt [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38761-3.json |
| 38762-1 | Iso-octane [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/38762-1.json |
| 38763-9 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38763-9.json |
| 38764-7 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38764-7.json |
| 38765-4 | US Guidance for biopsy of transplanted liver | ./2.16.840.1.114222.4.11.1002/38765-4.json |
| 38766-2 | US Guidance for biopsy of transplanted kidney | ./2.16.840.1.114222.4.11.1002/38766-2.json |
| 38767-0 | CT Internal auditory canal - right | ./2.16.840.1.114222.4.11.1002/38767-0.json |
| 38768-8 | XR tomography Femur - right | ./2.16.840.1.114222.4.11.1002/38768-8.json |
| 38769-6 | MR Lower extremity joint - right limited WO contrast | ./2.16.840.1.114222.4.11.1002/38769-6.json |
| 38770-4 | MR Scapula - right WO contrast | ./2.16.840.1.114222.4.11.1002/38770-4.json |
| 38771-2 | XR Pelvis and Hip - right Views | ./2.16.840.1.114222.4.11.1002/38771-2.json |
| 38772-0 | XR Hip - right True lateral | ./2.16.840.1.114222.4.11.1002/38772-0.json |
| 38773-8 | MRA Lower extremity vessels - right WO contrast | ./2.16.840.1.114222.4.11.1002/38773-8.json |
| 38774-6 | XR Orbit - right Views | ./2.16.840.1.114222.4.11.1002/38774-6.json |
| 38775-3 | XR Hand - right Brewerton | ./2.16.840.1.114222.4.11.1002/38775-3.json |
| 38776-1 | XR Calcaneus - right Harris | ./2.16.840.1.114222.4.11.1002/38776-1.json |
| 38777-9 | XR Elbow - right Jones | ./2.16.840.1.114222.4.11.1002/38777-9.json |
| 3877-8 | Ofloxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3877-8.json |
| 38778-7 | XR Calcaneus - right Ski jump Views | ./2.16.840.1.114222.4.11.1002/38778-7.json |
| 38779-5 | XR Shoulder - right Transthoracic | ./2.16.840.1.114222.4.11.1002/38779-5.json |
| 38780-3 | XR Shoulder - right Velpeau axillary | ./2.16.840.1.114222.4.11.1002/38780-3.json |
| 38781-1 | XR Shoulder - right AP and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/38781-1.json |
| 38782-9 | XR Shoulder - right AP and Axillary and Outlet and Zanca | ./2.16.840.1.114222.4.11.1002/38782-9.json |
| 38783-7 | XR Shoulder - right AP and Axillary and Y | ./2.16.840.1.114222.4.11.1002/38783-7.json |
| 38784-5 | XR Pelvis and Hip - right AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/38784-5.json |
| 38785-2 | XR Pelvis and Hip - right AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/38785-2.json |
| 3878-6 | Opiates [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3878-6.json |
| 38786-0 | XR Patella - right AP and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/38786-0.json |
| 38787-8 | XR Shoulder - right AP and West Point | ./2.16.840.1.114222.4.11.1002/38787-8.json |
| 38788-6 | XR Shoulder - right AP and Y | ./2.16.840.1.114222.4.11.1002/38788-6.json |
| 38789-4 | XR Shoulder - right Grashey and Axillary and Y | ./2.16.840.1.114222.4.11.1002/38789-4.json |
| 38790-2 | XR Patella - right PA and Lateral and Sunrise | ./2.16.840.1.114222.4.11.1002/38790-2.json |
| 38791-0 | XR Shoulder - right Grashey and Outlet | ./2.16.840.1.114222.4.11.1002/38791-0.json |
| 38793-6 | XR Shoulder - right Grashey and Axillary | ./2.16.840.1.114222.4.11.1002/38793-6.json |
| 3879-4 | Opiates [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3879-4.json |
| 38794-4 | XR Shoulder - right Grashey and Outlet and Serendipity | ./2.16.840.1.114222.4.11.1002/38794-4.json |
| 38795-1 | XR Shoulder - right Grashey and West Point | ./2.16.840.1.114222.4.11.1002/38795-1.json |
| 38796-9 | Portable XR Hip - right Views | ./2.16.840.1.114222.4.11.1002/38796-9.json |
| 38797-7 | XR Humerus bicipital groove - right Views | ./2.16.840.1.114222.4.11.1002/38797-7.json |
| 38798-5 | XR Olecranon - right Views | ./2.16.840.1.114222.4.11.1002/38798-5.json |
| 38799-3 | RFA Aorta and Femoral artery - right Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/38799-3.json |
| 38800-9 | RFA Aortic arch and Subclavian artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38800-9.json |
| 38801-7 | RFA Gastric artery right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38801-7.json |
| 3880-2 | Orphenadrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3880-2.json |
| 38802-5 | CT Wrist - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/38802-5.json |
| 38803-3 | XR Clavicle - right 45 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/38803-3.json |
| 38804-1 | XR Hand - right Bora | ./2.16.840.1.114222.4.11.1002/38804-1.json |
| 38805-8 | XR Shoulder - right Grashey | ./2.16.840.1.114222.4.11.1002/38805-8.json |
| 38806-6 | XR Tibia - right 10 degree caudal angle | ./2.16.840.1.114222.4.11.1002/38806-6.json |
| 38807-4 | MG Breast - right Spot Views | ./2.16.840.1.114222.4.11.1002/38807-4.json |
| 38808-2 | XR Wrist - right Ulnar deviation and Radial deviation | ./2.16.840.1.114222.4.11.1002/38808-2.json |
| 3881-0 | Ouabain [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3881-0.json |
| 38810-8 | XR Great toe - right Views W standing | ./2.16.840.1.114222.4.11.1002/38810-8.json |
| 38811-6 | RFA Abdominal and pelvic lymphatic vessels - right Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/38811-6.json |
| 38812-4 | RFA Extremity lymphatic vessels - right Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/38812-4.json |
| 38813-2 | RFA Lymphatic vessels - right Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/38813-2.json |
| 38814-0 | XR Calcaneus - right Broden Views | ./2.16.840.1.114222.4.11.1002/38814-0.json |
| 38815-7 | XR Foot - right Views AP W standing | ./2.16.840.1.114222.4.11.1002/38815-7.json |
| 38816-5 | XR Shoulder - right Grashey Views WO and W weight | ./2.16.840.1.114222.4.11.1002/38816-5.json |
| 38817-3 | MR Breast - right for implant WO contrast | ./2.16.840.1.114222.4.11.1002/38817-3.json |
| 38818-1 | XR Hip - right Single view during surgery | ./2.16.840.1.114222.4.11.1002/38818-1.json |
| 38819-9 | XR Hip - right Lateral during surgery | ./2.16.840.1.114222.4.11.1002/38819-9.json |
| 38820-7 | MG Breast - right Views for implant | ./2.16.840.1.114222.4.11.1002/38820-7.json |
| 38821-5 | MG Breast specimen - right Views | ./2.16.840.1.114222.4.11.1002/38821-5.json |
| 38822-3 | XR Shoulder - right AP and Transthoracic | ./2.16.840.1.114222.4.11.1002/38822-3.json |
| 38824-9 | XR Knee - right Sunrise 20 and 40 and 60 degrees | ./2.16.840.1.114222.4.11.1002/38824-9.json |
| 38825-6 | MG Breast duct - right Views W contrast intra duct | ./2.16.840.1.114222.4.11.1002/38825-6.json |
| 38826-4 | RF Parotid gland - right Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/38826-4.json |
| 38827-2 | RF Lacrimal duct - right Views W contrast intra lacrimal duct | ./2.16.840.1.114222.4.11.1002/38827-2.json |
| 3882-8 | Oxacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3882-8.json |
| 38828-0 | CT Shoulder - left Arthrogram | ./2.16.840.1.114222.4.11.1002/38828-0.json |
| 38829-8 | MR Upper extremity - left W contrast IV | ./2.16.840.1.114222.4.11.1002/38829-8.json |
| 38830-6 | MR Shoulder - left W contrast IV | ./2.16.840.1.114222.4.11.1002/38830-6.json |
| 38831-4 | MR Upper extremity - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/38831-4.json |
| 38832-2 | MR Upper extremity - left WO contrast | ./2.16.840.1.114222.4.11.1002/38832-2.json |
| 38833-0 | MR Brachial plexus - left WO contrast | ./2.16.840.1.114222.4.11.1002/38833-0.json |
| 38834-8 | MR Shoulder - left WO contrast | ./2.16.840.1.114222.4.11.1002/38834-8.json |
| 38835-5 | CT Temporal bone - left W contrast IV | ./2.16.840.1.114222.4.11.1002/38835-5.json |
| 3883-6 | Oxandrolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3883-6.json |
| 38836-3 | MR Orbit - left | ./2.16.840.1.114222.4.11.1002/38836-3.json |
| 38837-1 | MRA Knee vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/38837-1.json |
| 38838-9 | XR Wrist - left Limited Views | ./2.16.840.1.114222.4.11.1002/38838-9.json |
| 38839-7 | XR Wrist - left Oblique Views | ./2.16.840.1.114222.4.11.1002/38839-7.json |
| 38840-5 | XR Ankle - left 2 Views W manual stress | ./2.16.840.1.114222.4.11.1002/38840-5.json |
| 38841-3 | XR Ankle - left 2 Views W standing | ./2.16.840.1.114222.4.11.1002/38841-3.json |
| 38842-1 | XR Wrist - left Carpal tunnel | ./2.16.840.1.114222.4.11.1002/38842-1.json |
| 38843-9 | XR Wrist - left 2 Carpal tunnel Views | ./2.16.840.1.114222.4.11.1002/38843-9.json |
| 3884-4 | Oxandrolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3884-4.json |
| 38844-7 | XR Elbow - left 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/38844-7.json |
| 38845-4 | XR Femur - left Views W standing | ./2.16.840.1.114222.4.11.1002/38845-4.json |
| 38846-2 | XR Foot - left 2 Views | ./2.16.840.1.114222.4.11.1002/38846-2.json |
| 38847-0 | XR Hand - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/38847-0.json |
| 38848-8 | XR Hand - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/38848-8.json |
| 38849-6 | XR Lower extremity - left AP W standing | ./2.16.840.1.114222.4.11.1002/38849-6.json |
| 38850-4 | XR Lower extremity - left Single view W standing | ./2.16.840.1.114222.4.11.1002/38850-4.json |
| 3885-1 | Oxandrolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3885-1.json |
| 38851-2 | XR Knee - left 2 Views W standing | ./2.16.840.1.114222.4.11.1002/38851-2.json |
| 38852-0 | XR Knee - left 4 Views W standing | ./2.16.840.1.114222.4.11.1002/38852-0.json |
| 38853-8 | RFA Lower extremity vessels - left Views W contrast | ./2.16.840.1.114222.4.11.1002/38853-8.json |
| 38854-6 | MG Breast - left Magnification and Spot | ./2.16.840.1.114222.4.11.1002/38854-6.json |
| 38855-3 | MG Breast - left True lateral | ./2.16.840.1.114222.4.11.1002/38855-3.json |
| 38856-1 | XR Ribs - left Anterior and Lateral | ./2.16.840.1.114222.4.11.1002/38856-1.json |
| 38857-9 | XR Ribs - left Lateral | ./2.16.840.1.114222.4.11.1002/38857-9.json |
| 38858-7 | XR Shoulder - left Y | ./2.16.840.1.114222.4.11.1002/38858-7.json |
| 38859-5 | RFA Upper extremity veins - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/38859-5.json |
| 38860-3 | XR Wrist - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/38860-3.json |
| 38861-1 | RFA Ankle arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38861-1.json |
| 38862-9 | RFA Carotid artery and Cerebral artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38862-9.json |
| 38863-7 | RFA Carotid artery.cervical - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38863-7.json |
| 38864-5 | RFA Carotid artery.internal - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38864-5.json |
| 38865-2 | RFA Carotid artery and Cerebral artery internal - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/38865-2.json |
| 38866-0 | XR Ribs lower - left Views | ./2.16.840.1.114222.4.11.1002/38866-0.json |
| 38867-8 | XR Ribs upper - left Views | ./2.16.840.1.114222.4.11.1002/38867-8.json |
| 38868-6 | XR Ribs anterior and posterior - left Views | ./2.16.840.1.114222.4.11.1002/38868-6.json |
| 3886-9 | Oxazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3886-9.json |
| 38869-4 | XR Ribs posterior - left Views | ./2.16.840.1.114222.4.11.1002/38869-4.json |
| 38870-2 | MR Breast - left for implant WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/38870-2.json |
| 38871-0 | XR Knee - left 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/38871-0.json |
| 38872-8 | RF Kidney - left Views W contrast via nephrostomy tube | ./2.16.840.1.114222.4.11.1002/38872-8.json |
| 38874-4 | XR Tibia and Fibula - left 2 Oblique Views | ./2.16.840.1.114222.4.11.1002/38874-4.json |
| 3887-7 | Oxazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3887-7.json |
| 3888-5 | Oxedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3888-5.json |
| 38891-8 | ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38891-8.json |
| 3889-3 | Oxprenolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3889-3.json |
| 38893-4 | ARIPiprazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38893-4.json |
| 38894-2 | CD158 cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/38894-2.json |
| 38895-9 | ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38895-9.json |
| 38896-7 | F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38896-7.json |
| 38897-5 | Fibers [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/38897-5.json |
| 38898-3 | Fibrin D-dimer [Titer] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/38898-3.json |
| 38899-1 | fluPHENAZine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38899-1.json |
| 3890-1 | Oxprenolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3890-1.json |
| 38901-5 | Leflunomide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38901-5.json |
| 38902-3 | LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38902-3.json |
| 38904-9 | MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38904-9.json |
| 38906-4 | MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38906-4.json |
| 38907-2 | NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38907-2.json |
| 38909-8 | PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38909-8.json |
| 38911-4 | SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38911-4.json |
| 38912-2 | Succinylacetone [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/38912-2.json |
| 38913-0 | TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38913-0.json |
| 38914-8 | RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38914-8.json |
| 38915-5 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/38915-5.json |
| 38916-3 | Calicivirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38916-3.json |
| 38917-1 | Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38917-1.json |
| 38918-9 | ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38918-9.json |
| 3891-9 | Oxprenolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3891-9.json |
| 38919-7 | LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38919-7.json |
| 38920-5 | MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38920-5.json |
| 38921-3 | MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38921-3.json |
| 38922-1 | PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38922-1.json |
| 38923-9 | SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38923-9.json |
| 38924-7 | TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38924-7.json |
| 38925-4 | RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38925-4.json |
| 38926-2 | Macroprolactin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/38926-2.json |
| 3892-7 | Oxprenolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3892-7.json |
| 38927-0 | TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38927-0.json |
| 38928-8 | FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/38928-8.json |
| 38929-6 | FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38929-6.json |
| 38930-4 | EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38930-4.json |
| 38931-2 | TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/38931-2.json |
| 38932-0 | VA Compensation and Pension (C and P) examination acromegaly | ./2.16.840.1.114222.4.11.1002/38932-0.json |
| 38933-8 | VA Compensation and Pension (C and P) examination aid and attendance/housebound | ./2.16.840.1.114222.4.11.1002/38933-8.json |
| 38934-6 | VA Compensation and Pension (C and P) examination arrhythmias | ./2.16.840.1.114222.4.11.1002/38934-6.json |
| 3893-5 | oxyCODONE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3893-5.json |
| 38935-3 | VA Compensation and Pension (C and P) examination miscellaneous arteries/veins | ./2.16.840.1.114222.4.11.1002/38935-3.json |
| 38936-1 | VA Compensation and Pension (C and P) examination audio | ./2.16.840.1.114222.4.11.1002/38936-1.json |
| 38937-9 | VA Compensation and Pension (C and P) examination bones fractures/bone disease | ./2.16.840.1.114222.4.11.1002/38937-9.json |
| 38938-7 | VA Compensation and Pension (C and P) examination brain/spinal cord | ./2.16.840.1.114222.4.11.1002/38938-7.json |
| 38939-5 | VA Compensation and Pension (C and P) examination chronic fatigue syndrome | ./2.16.840.1.114222.4.11.1002/38939-5.json |
| 38940-3 | VA Compensation and Pension (C and P) examination cold injury protocol | ./2.16.840.1.114222.4.11.1002/38940-3.json |
| 38941-1 | VA Compensation and Pension (C and P) examination cranial nerves | ./2.16.840.1.114222.4.11.1002/38941-1.json |
| 38942-9 | VA Compensation and Pension (C and P) examination Cushings syndrome | ./2.16.840.1.114222.4.11.1002/38942-9.json |
| 3894-3 | Oxymesterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3894-3.json |
| 38943-7 | VA Compensation and Pension (C and P) examination dental/oral | ./2.16.840.1.114222.4.11.1002/38943-7.json |
| 38944-5 | VA Compensation and Pension (C and P) examination diabetes mellitus | ./2.16.840.1.114222.4.11.1002/38944-5.json |
| 38945-2 | VA Compensation and Pension (C and P) examination miscellaneous digestive conditions | ./2.16.840.1.114222.4.11.1002/38945-2.json |
| 38946-0 | VA Compensation and Pension (C and P) examination ear disease | ./2.16.840.1.114222.4.11.1002/38946-0.json |
| 38947-8 | VA Compensation and Pension (C and P) examination mental health eating disorders | ./2.16.840.1.114222.4.11.1002/38947-8.json |
| 38948-6 | VA Compensation and Pension (C and P) examination miscellaneous endocrine diseases | ./2.16.840.1.114222.4.11.1002/38948-6.json |
| 38949-4 | VA Compensation and Pension (C and P) examination epilepsy/narcolepsy | ./2.16.840.1.114222.4.11.1002/38949-4.json |
| 3895-0 | Oxymesterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3895-0.json |
| 38950-2 | VA Compensation and Pension (C and P) examination esophagus/hiatal hernia | ./2.16.840.1.114222.4.11.1002/38950-2.json |
| 38951-0 | VA Compensation and Pension (C and P) examination eye | ./2.16.840.1.114222.4.11.1002/38951-0.json |
| 38952-8 | VA Compensation and Pension (C and P) examination feet | ./2.16.840.1.114222.4.11.1002/38952-8.json |
| 38953-6 | VA Compensation and Pension (C and P) examination fibromyalgia | ./2.16.840.1.114222.4.11.1002/38953-6.json |
| 38954-4 | VA Compensation and Pension (C and P) examination general medical | ./2.16.840.1.114222.4.11.1002/38954-4.json |
| 38955-1 | VA Compensation and Pension (C and P) examination genitourinary | ./2.16.840.1.114222.4.11.1002/38955-1.json |
| 38956-9 | VA Compensation and Pension (C and P) examination disability in gulf war veterans | ./2.16.840.1.114222.4.11.1002/38956-9.json |
| 38957-7 | VA Compensation and Pension (C and P) examination gynecological conditions/disorders of the breast | ./2.16.840.1.114222.4.11.1002/38957-7.json |
| 38958-5 | VA Compensation and Pension (C and P) examination hand/thumb/fingers | ./2.16.840.1.114222.4.11.1002/38958-5.json |
| 38959-3 | VA Compensation and Pension (C and P) examination heart | ./2.16.840.1.114222.4.11.1002/38959-3.json |
| 38960-1 | VA Compensation and Pension (C and P) examination hemic disorders | ./2.16.840.1.114222.4.11.1002/38960-1.json |
| 38961-9 | VA Compensation and Pension (C and P) examination HIV-related illness | ./2.16.840.1.114222.4.11.1002/38961-9.json |
| 38962-7 | VA Compensation and Pension (C and P) examination hypertension | ./2.16.840.1.114222.4.11.1002/38962-7.json |
| 38963-5 | VA Compensation and Pension (C and P) examination infectious/immune/nutritional disabilities | ./2.16.840.1.114222.4.11.1002/38963-5.json |
| 38964-3 | VA Compensation and Pension (C and P) examination initial evaluation post-traumatic stress disorder | ./2.16.840.1.114222.4.11.1002/38964-3.json |
| 38965-0 | VA Compensation and Pension (C and P) examination large/small intestines | ./2.16.840.1.114222.4.11.1002/38965-0.json |
| 38966-8 | VA Compensation and Pension (C and P) examination extremity joints | ./2.16.840.1.114222.4.11.1002/38966-8.json |
| 38967-6 | VA Compensation and Pension (C and P) examination liver/gall bladder/pancreas | ./2.16.840.1.114222.4.11.1002/38967-6.json |
| 3896-8 | Oxymesterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3896-8.json |
| 38968-4 | VA Compensation and Pension (C and P) examination lymphatic disorders | ./2.16.840.1.114222.4.11.1002/38968-4.json |
| 38969-2 | VA Compensation and Pension (C and P) examination general mental disorders | ./2.16.840.1.114222.4.11.1002/38969-2.json |
| 38970-0 | VA Compensation and Pension (C and P) examination mouth/lips/tongue | ./2.16.840.1.114222.4.11.1002/38970-0.json |
| 38971-8 | VA Compensation and Pension (C and P) examination muscles | ./2.16.840.1.114222.4.11.1002/38971-8.json |
| 38972-6 | VA Compensation and Pension (C and P) examination miscellaneous neurological disorders | ./2.16.840.1.114222.4.11.1002/38972-6.json |
| 38973-4 | VA Compensation and Pension (C and P) examination nose/sinus/larynx/pharynx | ./2.16.840.1.114222.4.11.1002/38973-4.json |
| 38974-2 | VA Compensation and Pension (C and P) examination peripheral nerves | ./2.16.840.1.114222.4.11.1002/38974-2.json |
| 38975-9 | VA Compensation and Pension (C and P) examination prisoner of war protocol | ./2.16.840.1.114222.4.11.1002/38975-9.json |
| 3897-6 | Oxymetholone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3897-6.json |
| 38976-7 | VA Compensation and Pension (C and P) examination pulmonary tuberculosis/mycobacterial diseases | ./2.16.840.1.114222.4.11.1002/38976-7.json |
| 38977-5 | VA Compensation and Pension (C and P) examination rectum/anus | ./2.16.840.1.114222.4.11.1002/38977-5.json |
| 38978-3 | VA Compensation and Pension (C and P) examination residuals of amputations | ./2.16.840.1.114222.4.11.1002/38978-3.json |
| 38979-1 | VA Compensation and Pension (C and P) examination obstructive/restrictive/interstitial respiratory diseases | ./2.16.840.1.114222.4.11.1002/38979-1.json |
| 38980-9 | VA Compensation and Pension (C and P) examination miscellaneous respiratory diseases | ./2.16.840.1.114222.4.11.1002/38980-9.json |
| 38981-7 | VA Compensation and Pension (C and P) examination review evaluation post-traumatic stress disorder | ./2.16.840.1.114222.4.11.1002/38981-7.json |
| 38982-5 | VA Compensation and Pension (C and P) examination scars | ./2.16.840.1.114222.4.11.1002/38982-5.json |
| 38983-3 | VA Compensation and Pension (C and P) examination sense of smell/taste | ./2.16.840.1.114222.4.11.1002/38983-3.json |
| 3898-4 | Oxymetholone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3898-4.json |
| 38984-1 | VA Compensation and Pension (C and P) examination skin diseases other than scars | ./2.16.840.1.114222.4.11.1002/38984-1.json |
| 38985-8 | VA Compensation and Pension (C and P) examination social/industrial survey | ./2.16.840.1.114222.4.11.1002/38985-8.json |
| 38986-6 | VA Compensation and Pension (C and P) examination spine | ./2.16.840.1.114222.4.11.1002/38986-6.json |
| 38987-4 | VA Compensation and Pension (C and P) examination stomach/duodenum/peritoneal adhesions | ./2.16.840.1.114222.4.11.1002/38987-4.json |
| 38988-2 | VA Compensation and Pension (C and P) examination thyroid/parathyroid diseases | ./2.16.840.1.114222.4.11.1002/38988-2.json |
| 38989-0 | Clostridium botulinum toxin A+B+E+F+G [Presence] in Specimen by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/38989-0.json |
| 38990-8 | Escherichia coli O157:H7 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38990-8.json |
| 38991-6 | Amylase [Enzymatic activity/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/38991-6.json |
| 3899-2 | Oxymetholone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3899-2.json |
| 38992-4 | Amylase [Units/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/38992-4.json |
| 38997-3 | West Nile virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/38997-3.json |
| 38998-1 | HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/38998-1.json |
| 39003-9 | Cytomegalovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39003-9.json |
| 39004-7 | Epidermal growth factor receptor Ag [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/39004-7.json |
| 39005-4 | Hepatitis B virus core Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/39005-4.json |
| 39006-2 | Hepatitis B virus e Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/39006-2.json |
| 39007-0 | Hepatitis B virus e Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/39007-0.json |
| 3900-8 | Oxyphenbutazone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3900-8.json |
| 39011-2 | Mumps virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/39011-2.json |
| 39012-0 | Mycoplasma pneumoniae Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/39012-0.json |
| 39013-8 | Rubella virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/39013-8.json |
| 39015-3 | Treponema pallidum Ab [Units/volume] in Body fluid by Hemagglutination | ./2.16.840.1.114222.4.11.1002/39015-3.json |
| 3901-6 | Para hydroxyamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3901-6.json |
| 39017-9 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood | ./2.16.840.1.114222.4.11.1002/39017-9.json |
| 39018-7 | Coliform bacteria [#/mass] in Specimen by Viability count | ./2.16.840.1.114222.4.11.1002/39018-7.json |
| 39019-5 | Escherichia coli O157:H7 Ag [Presence] in Raw milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/39019-5.json |
| 39020-3 | Abnormal Prion Protein [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/39020-3.json |
| 39021-1 | Abnormal Prion Protein [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/39021-1.json |
| 39022-9 | Sarcocystis neurona Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/39022-9.json |
| 39023-7 | Vesicular stomatitis Indiana virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39023-7.json |
| 3902-4 | Para hydroxyamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3902-4.json |
| 39024-5 | Vesicular stomatitis New Jersey virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39024-5.json |
| 39025-2 | Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/39025-2.json |
| 39026-0 | CT Guidance for needle localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39026-0.json |
| 39027-8 | RF Guidance for needle localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39027-8.json |
| 39028-6 | MR Guidance for needle localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39028-6.json |
| 39029-4 | MR Orbit and Face WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/39029-4.json |
| 39030-2 | US Vein - bilateral | ./2.16.840.1.114222.4.11.1002/39030-2.json |
| 39031-0 | US.doppler Extremity artery - bilateral | ./2.16.840.1.114222.4.11.1002/39031-0.json |
| 3903-2 | Para hydroxyamphetamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3903-2.json |
| 39032-8 | US for transplanted kidney | ./2.16.840.1.114222.4.11.1002/39032-8.json |
| 39033-6 | MR Upper extremity WO contrast | ./2.16.840.1.114222.4.11.1002/39033-6.json |
| 39034-4 | MR Upper extremity WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/39034-4.json |
| 39036-9 | US Vein | ./2.16.840.1.114222.4.11.1002/39036-9.json |
| 39037-7 | MR Upper extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/39037-7.json |
| 39038-5 | MR Orbit and Face W contrast IV | ./2.16.840.1.114222.4.11.1002/39038-5.json |
| 39039-3 | US.doppler Brachiocephalic artery | ./2.16.840.1.114222.4.11.1002/39039-3.json |
| 3904-0 | Paraldehyde [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3904-0.json |
| 39040-1 | US AV fistula | ./2.16.840.1.114222.4.11.1002/39040-1.json |
| 39042-7 | US.doppler Extremity artery | ./2.16.840.1.114222.4.11.1002/39042-7.json |
| 39044-3 | US.doppler Head vessels limited | ./2.16.840.1.114222.4.11.1002/39044-3.json |
| 39045-0 | US Vein limited | ./2.16.840.1.114222.4.11.1002/39045-0.json |
| 39046-8 | CT Pelvis limited for pelvimetry WO contrast | ./2.16.840.1.114222.4.11.1002/39046-8.json |
| 39047-6 | RF Hip Single view during surgery | ./2.16.840.1.114222.4.11.1002/39047-6.json |
| 39048-4 | XR Scapula AP | ./2.16.840.1.114222.4.11.1002/39048-4.json |
| 39049-2 | XR Thoracic and lumbar spine AP | ./2.16.840.1.114222.4.11.1002/39049-2.json |
| 39050-0 | XR Ribs AP | ./2.16.840.1.114222.4.11.1002/39050-0.json |
| 39051-8 | XR Chest Lateral | ./2.16.840.1.114222.4.11.1002/39051-8.json |
| 39052-6 | XR Spine Lateral | ./2.16.840.1.114222.4.11.1002/39052-6.json |
| 39053-4 | XR Ribs Lateral | ./2.16.840.1.114222.4.11.1002/39053-4.json |
| 39054-2 | MG Breast duct Views W contrast intra duct | ./2.16.840.1.114222.4.11.1002/39054-2.json |
| 39055-9 | RFA Extremity veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/39055-9.json |
| 39056-7 | XR Unspecified body region Views W manual stress | ./2.16.840.1.114222.4.11.1002/39056-7.json |
| 3905-7 | Paraldehyde [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3905-7.json |
| 39057-5 | RFA Pulmonary arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/39057-5.json |
| 39058-3 | XR Salivary gland Views | ./2.16.840.1.114222.4.11.1002/39058-3.json |
| 39060-9 | XR Ribs 2 Views | ./2.16.840.1.114222.4.11.1002/39060-9.json |
| 39061-7 | XR Sacrum and Coccyx 3 Views | ./2.16.840.1.114222.4.11.1002/39061-7.json |
| 39062-5 | XR Ribs 3 Views | ./2.16.840.1.114222.4.11.1002/39062-5.json |
| 39063-3 | XR Lumbar spine 5 Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/39063-3.json |
| 39064-1 | XR Ribs Anterior and Lateral | ./2.16.840.1.114222.4.11.1002/39064-1.json |
| 3906-5 | Pefloxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3906-5.json |
| 39065-8 | XR Pelvis AP and Inlet and Outlet and Oblique | ./2.16.840.1.114222.4.11.1002/39065-8.json |
| 39066-6 | XR and RF Chest AP and Lateral and Views | ./2.16.840.1.114222.4.11.1002/39066-6.json |
| 39067-4 | XR Cervical and thoracic and lumbar spine AP and Lateral | ./2.16.840.1.114222.4.11.1002/39067-4.json |
| 39068-2 | XR Foot AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39068-2.json |
| 39069-0 | XR Foot AP and Lateral | ./2.16.840.1.114222.4.11.1002/39069-0.json |
| 39070-8 | XR Chest AP and Lateral and Apical lordotic | ./2.16.840.1.114222.4.11.1002/39070-8.json |
| 39071-6 | XR Knee AP and Lateral and Merchants | ./2.16.840.1.114222.4.11.1002/39071-6.json |
| 39072-4 | XR Ankle AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/39072-4.json |
| 3907-3 | Pemoline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3907-3.json |
| 39073-2 | XR Knee AP and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/39073-2.json |
| 39074-0 | XR Chest AP and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/39074-0.json |
| 39075-7 | XR Toes AP and Oblique | ./2.16.840.1.114222.4.11.1002/39075-7.json |
| 39076-5 | XR Foot AP and Oblique | ./2.16.840.1.114222.4.11.1002/39076-5.json |
| 39077-3 | XR Shoulder AP and Transthoracic | ./2.16.840.1.114222.4.11.1002/39077-3.json |
| 39078-1 | XR Finger PA and Lateral and Oblique | ./2.16.840.1.114222.4.11.1002/39078-1.json |
| 39079-9 | XR Hand PA and Oblique | ./2.16.840.1.114222.4.11.1002/39079-9.json |
| 39080-7 | EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/39080-7.json |
| 3908-1 | Pemoline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3908-1.json |
| 39081-5 | Codfish IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39081-5.json |
| 39082-3 | Gentamicin [Mass/volume] in Cerebral spinal fluid --peak | ./2.16.840.1.114222.4.11.1002/39082-3.json |
| 39083-1 | Herpes virus 8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/39083-1.json |
| 39084-9 | Rough Marsh Elder IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39084-9.json |
| 39085-6 | California Walnut Pollen IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39085-6.json |
| 39086-4 | Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep | ./2.16.840.1.114222.4.11.1002/39086-4.json |
| 39087-2 | Myelin associated glycoprotein IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39087-2.json |
| 39088-0 | Scallop IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39088-0.json |
| 39089-8 | PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/39089-8.json |
| 39090-6 | Clam IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39090-6.json |
| 39091-4 | Johnson grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39091-4.json |
| 39092-2 | Vancomycin [Mass/volume] in Cerebral spinal fluid --peak | ./2.16.840.1.114222.4.11.1002/39092-2.json |
| 39093-0 | RFA Hepatic veins Views W contrast IV | ./2.16.840.1.114222.4.11.1002/39093-0.json |
| 39094-8 | RFA Carotid artery.cervical Views W contrast IA | ./2.16.840.1.114222.4.11.1002/39094-8.json |
| 39095-5 | RFA Carotid artery and Cerebral artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/39095-5.json |
| 39096-3 | RFA Hepatic veins Views for hemodynamics W contrast IV | ./2.16.840.1.114222.4.11.1002/39096-3.json |
| 39097-1 | RFA Carotid artery - bilateral and Cerebral artery - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/39097-1.json |
| 39098-9 | RFA Carotid artery.cervical.bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/39098-9.json |
| 3909-9 | Pemoline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3909-9.json |
| 39099-7 | XR Ribs - bilateral 4 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/39099-7.json |
| 39102-9 | Influenza virus A hemagglutinin cDNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39102-9.json |
| 39103-7 | Influenza virus A neuraminidase cDNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39103-7.json |
| 3910-7 | Pemoline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3910-7.json |
| 3911-5 | Penicillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3911-5.json |
| 3912-3 | Penicillin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3912-3.json |
| 3913-1 | Penicillin G [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3913-1.json |
| 39138-3 | RFA Guidance for vascular access of Vessel | ./2.16.840.1.114222.4.11.1002/39138-3.json |
| 39139-1 | US Guidance for vascular access of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39139-1.json |
| 39140-9 | MR Heart cine for blood flow velocity mapping | ./2.16.840.1.114222.4.11.1002/39140-9.json |
| 39141-7 | MR Bone marrow | ./2.16.840.1.114222.4.11.1002/39141-7.json |
| 39142-5 | CT perfusion Head W contrast IV | ./2.16.840.1.114222.4.11.1002/39142-5.json |
| 39144-1 | RF Gastrointestinal tract upper Single view W air contrast PO | ./2.16.840.1.114222.4.11.1002/39144-1.json |
| 39145-8 | MG Breast duct - left Views W contrast intra multiple ducts | ./2.16.840.1.114222.4.11.1002/39145-8.json |
| 39146-6 | MG Breast duct - bilateral Views W contrast intra multiple ducts | ./2.16.840.1.114222.4.11.1002/39146-6.json |
| 39147-4 | MG Breast duct - right Views W contrast intra multiple ducts | ./2.16.840.1.114222.4.11.1002/39147-4.json |
| 39148-2 | MG Breast duct Views W contrast intra multiple ducts | ./2.16.840.1.114222.4.11.1002/39148-2.json |
| 3914-9 | Penicillin V [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3914-9.json |
| 39149-0 | XR Gastrointestinal tract and Pulmonary system Single view for foreign body | ./2.16.840.1.114222.4.11.1002/39149-0.json |
| 39150-8 | FFD mammogram Breast Views Post Localization | ./2.16.840.1.114222.4.11.1002/39150-8.json |
| 39151-6 | RF Vas deferens Views W contrast intra vas deferens | ./2.16.840.1.114222.4.11.1002/39151-6.json |
| 39152-4 | FFD mammogram Breast Diagnostic | ./2.16.840.1.114222.4.11.1002/39152-4.json |
| 39153-2 | FFD mammogram Breast Screening | ./2.16.840.1.114222.4.11.1002/39153-2.json |
| 39154-0 | FFD mammogram Breast - bilateral Diagnostic | ./2.16.840.1.114222.4.11.1002/39154-0.json |
| 3915-6 | Pentazocine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3915-6.json |
| 3916-4 | Pentazocine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3916-4.json |
| 3917-2 | Pentazocine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3917-2.json |
| 3918-0 | Pentazocine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3918-0.json |
| 3919-8 | Pentazocine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3919-8.json |
| 3920-6 | Pentetrazol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3920-6.json |
| 3921-4 | Pentetrazol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3921-4.json |
| 3922-2 | Pentetrazol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3922-2.json |
| 3923-0 | PENTobarbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3923-0.json |
| 3924-8 | PENTobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3924-8.json |
| 3925-5 | PENTobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3925-5.json |
| 3926-3 | PENTobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3926-3.json |
| 3927-1 | Perphenazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3927-1.json |
| 3928-9 | Perphenazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3928-9.json |
| 39291-0 | MR Lower extremity WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/39291-0.json |
| 39292-8 | MR Lower extremity WO contrast | ./2.16.840.1.114222.4.11.1002/39292-8.json |
| 39293-6 | MR Lower extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/39293-6.json |
| 39295-1 | Influenza virus A Ab [Presence] in Egg yolk by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/39295-1.json |
| 39296-9 | Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39296-9.json |
| 3929-7 | Phenacetin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3929-7.json |
| 39297-7 | Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39297-7.json |
| 39298-5 | Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39298-5.json |
| 39299-3 | Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39299-3.json |
| 39300-9 | Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39300-9.json |
| 39301-7 | Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39301-7.json |
| 39302-5 | Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39302-5.json |
| 39303-3 | Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39303-3.json |
| 39304-1 | Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39304-1.json |
| 39305-8 | Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39305-8.json |
| 39306-6 | Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39306-6.json |
| 39307-4 | Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39307-4.json |
| 39308-2 | Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39308-2.json |
| 39309-0 | Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39309-0.json |
| 39310-8 | Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39310-8.json |
| 39311-6 | Influenza virus A N1 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39311-6.json |
| 39312-4 | Influenza virus A N2 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39312-4.json |
| 3931-3 | Phenazocine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3931-3.json |
| 39313-2 | Influenza virus A N3 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39313-2.json |
| 39314-0 | Influenza virus A N4 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39314-0.json |
| 39315-7 | Influenza virus A N5 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39315-7.json |
| 39316-5 | Influenza virus A N6 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39316-5.json |
| 39317-3 | Influenza virus A N7 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39317-3.json |
| 39318-1 | Influenza virus A N8 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39318-1.json |
| 39319-9 | Influenza virus A N9 neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/39319-9.json |
| 39320-7 | Abnormal Prion Protein [Presence] in Tissue by Immunoblot | ./2.16.840.1.114222.4.11.1002/39320-7.json |
| 3932-1 | Phenazocine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3932-1.json |
| 39321-5 | XR Shoulder AP internal rotation and AP external rotation and Axillary | ./2.16.840.1.114222.4.11.1002/39321-5.json |
| 39322-3 | CT Spine W contrast intradisc | ./2.16.840.1.114222.4.11.1002/39322-3.json |
| 39323-1 | XR Abdomen Right posterior oblique | ./2.16.840.1.114222.4.11.1002/39323-1.json |
| 39324-9 | XR Wrist - left PA W clenched fist | ./2.16.840.1.114222.4.11.1002/39324-9.json |
| 39325-6 | XR Shoulder - left AP internal rotation and Grashey and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/39325-6.json |
| 39326-4 | XR Ribs - left and Chest Views | ./2.16.840.1.114222.4.11.1002/39326-4.json |
| 39327-2 | XR Abdomen and Fetal Views for fetal age | ./2.16.840.1.114222.4.11.1002/39327-2.json |
| 39328-0 | XR Shoulder - left AP internal rotation and AP external rotation | ./2.16.840.1.114222.4.11.1002/39328-0.json |
| 39329-8 | XR Shoulder - bilateral AP internal rotation and AP external rotation | ./2.16.840.1.114222.4.11.1002/39329-8.json |
| 39330-6 | XR Ankle - bilateral AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39330-6.json |
| 39331-4 | XR Foot - bilateral AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39331-4.json |
| 39332-2 | XR Foot - left AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39332-2.json |
| 39333-0 | XR Lumbar spine AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39333-0.json |
| 39334-8 | XR Foot - left AP and Lateral and oblique W standing | ./2.16.840.1.114222.4.11.1002/39334-8.json |
| 39335-5 | XR Shoulder - left AP internal rotation and AP external rotation and Axillary | ./2.16.840.1.114222.4.11.1002/39335-5.json |
| 39336-3 | XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary | ./2.16.840.1.114222.4.11.1002/39336-3.json |
| 39337-1 | XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Outlet | ./2.16.840.1.114222.4.11.1002/39337-1.json |
| 39338-9 | XR Shoulder - left AP internal rotation and AP external rotation and Axillary and Y | ./2.16.840.1.114222.4.11.1002/39338-9.json |
| 3933-9 | Phenazocine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3933-9.json |
| 39339-7 | XR Shoulder - bilateral AP and Axillary and Outlet and 30 degree caudal angle | ./2.16.840.1.114222.4.11.1002/39339-7.json |
| 39340-5 | XR Lumbar spine Lateral Views W standing and W flexion and W extension | ./2.16.840.1.114222.4.11.1002/39340-5.json |
| 39341-3 | XR Chest Lateral and PA W inspiration and expiration | ./2.16.840.1.114222.4.11.1002/39341-3.json |
| 39343-9 | XR Shoulder - bilateral AP internal rotation and AP external rotation and Y | ./2.16.840.1.114222.4.11.1002/39343-9.json |
| 39344-7 | XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Y | ./2.16.840.1.114222.4.11.1002/39344-7.json |
| 39345-4 | XR Knee - left Sunrise and (Tunnel W standing) | ./2.16.840.1.114222.4.11.1002/39345-4.json |
| 39346-2 | XR Shoulder - bilateral AP internal rotation and West Point | ./2.16.840.1.114222.4.11.1002/39346-2.json |
| 3934-7 | Phencyclidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3934-7.json |
| 39347-0 | XR Shoulder - left AP internal rotation and West Point | ./2.16.840.1.114222.4.11.1002/39347-0.json |
| 39348-8 | XR Shoulder - left AP internal rotation and AP external rotation and Y | ./2.16.840.1.114222.4.11.1002/39348-8.json |
| 39349-6 | RF Kidney - bilateral Views W contrast retrograde | ./2.16.840.1.114222.4.11.1002/39349-6.json |
| 39350-4 | XR Shoulder - bilateral Grashey and Outlet and Serendipity | ./2.16.840.1.114222.4.11.1002/39350-4.json |
| 39351-2 | XR Ribs upper anterior and posterior - left Views | ./2.16.840.1.114222.4.11.1002/39351-2.json |
| 39352-0 | XR Ribs posterior - bilateral Views | ./2.16.840.1.114222.4.11.1002/39352-0.json |
| 39353-8 | XR Ribs upper posterior - left Views | ./2.16.840.1.114222.4.11.1002/39353-8.json |
| 3935-4 | Phencyclidine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3935-4.json |
| 39359-5 | XR tomography Kidney - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/39359-5.json |
| 39360-3 | XR Pelvis Views and Inlet and Outlet | ./2.16.840.1.114222.4.11.1002/39360-3.json |
| 39361-1 | RF Guidance for drainage of abscess and placement of drainage catheter of Liver | ./2.16.840.1.114222.4.11.1002/39361-1.json |
| 3936-2 | Phencyclidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3936-2.json |
| 39362-9 | RF Guidance for placement of tube in Chest | ./2.16.840.1.114222.4.11.1002/39362-9.json |
| 39363-7 | RFA AV fistula Views W contrast retrograde | ./2.16.840.1.114222.4.11.1002/39363-7.json |
| 39364-5 | XR Wrist - right 3 Views and Radial deviation | ./2.16.840.1.114222.4.11.1002/39364-5.json |
| 39365-2 | XR Wrist - right 3 Views and Ulnar deviation | ./2.16.840.1.114222.4.11.1002/39365-2.json |
| 39366-0 | XR Scapula Lateral and outlet | ./2.16.840.1.114222.4.11.1002/39366-0.json |
| 39367-8 | XR Thoracic and lumbar spine AP and lateral for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/39367-8.json |
| 39368-6 | XR Ankle - right AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39368-6.json |
| 39369-4 | XR Ankle - right AP and Lateral and Oblique and (View W manual stress) | ./2.16.840.1.114222.4.11.1002/39369-4.json |
| 3937-0 | Phencyclidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3937-0.json |
| 39370-2 | XR Ankle - right Views and (View W manual stress) | ./2.16.840.1.114222.4.11.1002/39370-2.json |
| 39371-0 | XR Ankle - right AP and Lateral and oblique W standing | ./2.16.840.1.114222.4.11.1002/39371-0.json |
| 39372-8 | XR Ankle - right Views and Mortise | ./2.16.840.1.114222.4.11.1002/39372-8.json |
| 39373-6 | XR Elbow - right Views and Oblique | ./2.16.840.1.114222.4.11.1002/39373-6.json |
| 39374-4 | XR Foot - right AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/39374-4.json |
| 39375-1 | XR Foot - right AP and Lateral and oblique W standing | ./2.16.840.1.114222.4.11.1002/39375-1.json |
| 39376-9 | XR Radius and Ulna - right Views and Oblique | ./2.16.840.1.114222.4.11.1002/39376-9.json |
| 39377-7 | XR Hip - right Views and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/39377-7.json |
| 39378-5 | XR Knee - right 2 Views and Oblique | ./2.16.840.1.114222.4.11.1002/39378-5.json |
| 39379-3 | XR Knee - right 2 Views and Sunrise | ./2.16.840.1.114222.4.11.1002/39379-3.json |
| 39380-1 | XR Knee - right 2 Views and Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/39380-1.json |
| 39381-9 | XR Knee - right 2 Views and Tunnel | ./2.16.840.1.114222.4.11.1002/39381-9.json |
| 39382-7 | XR Knee - right 2 views and (Tunnel W standing) | ./2.16.840.1.114222.4.11.1002/39382-7.json |
| 39383-5 | XR Knee - right 3 Views and Sunrise | ./2.16.840.1.114222.4.11.1002/39383-5.json |
| 39384-3 | XR Knee - right 4 views and (AP W standing) | ./2.16.840.1.114222.4.11.1002/39384-3.json |
| 39385-0 | XR Knee - right 4 Views and Oblique | ./2.16.840.1.114222.4.11.1002/39385-0.json |
| 39386-8 | XR Knee - right 4 views and Tunnel | ./2.16.840.1.114222.4.11.1002/39386-8.json |
| 39387-6 | XR Knee - right 4 Views and Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/39387-6.json |
| 3938-8 | Phendimetrazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3938-8.json |
| 39388-4 | XR Knee - right AP and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/39388-4.json |
| 39389-2 | XR Knee - right Views and Tunnel | ./2.16.840.1.114222.4.11.1002/39389-2.json |
| 39390-0 | XR Knee - right Views and Oblique | ./2.16.840.1.114222.4.11.1002/39390-0.json |
| 39391-8 | XR Knee - right Views and Sunrise | ./2.16.840.1.114222.4.11.1002/39391-8.json |
| 39392-6 | XR Shoulder - right Internal rotation and External rotation and Axillary | ./2.16.840.1.114222.4.11.1002/39392-6.json |
| 39393-4 | XR Shoulder - right 3 Views and Axillary | ./2.16.840.1.114222.4.11.1002/39393-4.json |
| 39394-2 | XR Shoulder - right 3 Views and Y | ./2.16.840.1.114222.4.11.1002/39394-2.json |
| 39395-9 | XR Shoulder - right AP internal rotation and AP external rotation | ./2.16.840.1.114222.4.11.1002/39395-9.json |
| 3939-6 | Phendimetrazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3939-6.json |
| 39396-7 | XR Shoulder - right AP internal rotation and West Point | ./2.16.840.1.114222.4.11.1002/39396-7.json |
| 39397-5 | XR Shoulder - right AP internal rotation and AP external rotation and West Point | ./2.16.840.1.114222.4.11.1002/39397-5.json |
| 39398-3 | XR Tibia and Fibula - right Views and Oblique | ./2.16.840.1.114222.4.11.1002/39398-3.json |
| 39399-1 | XR Wrist - right 3 Views and Carpal tunnel | ./2.16.840.1.114222.4.11.1002/39399-1.json |
| 39400-7 | XR Wrist - right Views and Carpal tunnel | ./2.16.840.1.114222.4.11.1002/39400-7.json |
| 39401-5 | XR Shoulder AP and Grashey and Axillary | ./2.16.840.1.114222.4.11.1002/39401-5.json |
| 39402-3 | XR Shoulder AP internal rotation and AP external rotation | ./2.16.840.1.114222.4.11.1002/39402-3.json |
| 39403-1 | XR Shoulder Axillary and Transcapular | ./2.16.840.1.114222.4.11.1002/39403-1.json |
| 3940-4 | Phendimetrazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3940-4.json |
| 39404-9 | XR Sinuses 3 Views and Submentovertex | ./2.16.840.1.114222.4.11.1002/39404-9.json |
| 39405-6 | XR Sternum Lateral and right oblique and left oblique | ./2.16.840.1.114222.4.11.1002/39405-6.json |
| 39406-4 | XR Sternum Lateral and right anterior oblique | ./2.16.840.1.114222.4.11.1002/39406-4.json |
| 39407-2 | XR Thoracic spine 5 Views and Oblique | ./2.16.840.1.114222.4.11.1002/39407-2.json |
| 39408-0 | XR tomography Thoracic spine AP | ./2.16.840.1.114222.4.11.1002/39408-0.json |
| 39409-8 | XR tomography Thoracic spine lateral | ./2.16.840.1.114222.4.11.1002/39409-8.json |
| 39410-6 | XR Thoracic spine AP W left bending | ./2.16.840.1.114222.4.11.1002/39410-6.json |
| 39411-4 | XR Thoracic spine AP W right bending | ./2.16.840.1.114222.4.11.1002/39411-4.json |
| 3941-2 | Phendimetrazine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3941-2.json |
| 39412-2 | XR Thoracic spine Views and Swimmers | ./2.16.840.1.114222.4.11.1002/39412-2.json |
| 39413-0 | XR Thoracic spine 4 Views and Oblique | ./2.16.840.1.114222.4.11.1002/39413-0.json |
| 39414-8 | XR Thoracic spine Views and Oblique | ./2.16.840.1.114222.4.11.1002/39414-8.json |
| 39415-5 | US Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/39415-5.json |
| 39416-3 | US Genitourinary tract | ./2.16.840.1.114222.4.11.1002/39416-3.json |
| 39418-9 | US.doppler Extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/39418-9.json |
| 39419-7 | US.doppler Renal vessels - bilateral | ./2.16.840.1.114222.4.11.1002/39419-7.json |
| 3942-0 | Pheniramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3942-0.json |
| 39420-5 | US.doppler Lower extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/39420-5.json |
| 39421-3 | US.doppler Lower extremity artery - bilateral | ./2.16.840.1.114222.4.11.1002/39421-3.json |
| 39422-1 | US.doppler Lower extremity vessels - bilateral | ./2.16.840.1.114222.4.11.1002/39422-1.json |
| 39423-9 | US.doppler Upper extremity artery - bilateral | ./2.16.840.1.114222.4.11.1002/39423-9.json |
| 39424-7 | US.doppler Extremity vessels limited | ./2.16.840.1.114222.4.11.1002/39424-7.json |
| 39425-4 | US.doppler Iliac artery | ./2.16.840.1.114222.4.11.1002/39425-4.json |
| 39426-2 | US.doppler Renal vessels | ./2.16.840.1.114222.4.11.1002/39426-2.json |
| 39427-0 | US.doppler Carotid arteries - left | ./2.16.840.1.114222.4.11.1002/39427-0.json |
| 39428-8 | US.doppler Extremity artery - left | ./2.16.840.1.114222.4.11.1002/39428-8.json |
| 39429-6 | US.doppler Extremity vein - left | ./2.16.840.1.114222.4.11.1002/39429-6.json |
| 39430-4 | US.doppler Lower extremity vessels - left limited | ./2.16.840.1.114222.4.11.1002/39430-4.json |
| 39431-2 | US.doppler Lower extremity vessels - left | ./2.16.840.1.114222.4.11.1002/39431-2.json |
| 39432-0 | US.doppler Lower extremity vein - left | ./2.16.840.1.114222.4.11.1002/39432-0.json |
| 39433-8 | US.doppler Upper extremity vessels - left | ./2.16.840.1.114222.4.11.1002/39433-8.json |
| 39434-6 | US.doppler Lower extremity artery | ./2.16.840.1.114222.4.11.1002/39434-6.json |
| 39435-3 | US.doppler Renal artery | ./2.16.840.1.114222.4.11.1002/39435-3.json |
| 39436-1 | US.doppler Renal vessels limited | ./2.16.840.1.114222.4.11.1002/39436-1.json |
| 39437-9 | US.doppler Carotid arteries -right | ./2.16.840.1.114222.4.11.1002/39437-9.json |
| 3943-8 | Phenmetrazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3943-8.json |
| 39439-5 | US.doppler Extremity artery - right | ./2.16.840.1.114222.4.11.1002/39439-5.json |
| 39440-3 | US.doppler Extremity vein - right | ./2.16.840.1.114222.4.11.1002/39440-3.json |
| 39441-1 | US.doppler Lower extremity vessels - right limited | ./2.16.840.1.114222.4.11.1002/39441-1.json |
| 39442-9 | US.doppler Lower extremity vessels - right | ./2.16.840.1.114222.4.11.1002/39442-9.json |
| 39443-7 | US.doppler Lower extremity vein - right | ./2.16.840.1.114222.4.11.1002/39443-7.json |
| 39444-5 | US.doppler Upper extremity vessels - right | ./2.16.840.1.114222.4.11.1002/39444-5.json |
| 39445-2 | US.doppler Vessels | ./2.16.840.1.114222.4.11.1002/39445-2.json |
| 3944-6 | Phenmetrazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3944-6.json |
| 39446-0 | US.doppler Testicular vessels | ./2.16.840.1.114222.4.11.1002/39446-0.json |
| 39447-8 | US.doppler Upper extremity artery | ./2.16.840.1.114222.4.11.1002/39447-8.json |
| 39448-6 | US.doppler Upper extremity vessels | ./2.16.840.1.114222.4.11.1002/39448-6.json |
| 39449-4 | US.doppler Extremity vein | ./2.16.840.1.114222.4.11.1002/39449-4.json |
| 39450-2 | US Gastrointestinal tract W contrast PO | ./2.16.840.1.114222.4.11.1002/39450-2.json |
| 39451-0 | US Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39451-0.json |
| 39452-8 | US Guidance for fluid aspiration of Ovary | ./2.16.840.1.114222.4.11.1002/39452-8.json |
| 3945-3 | Phenmetrazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3945-3.json |
| 39453-6 | US Tendon | ./2.16.840.1.114222.4.11.1002/39453-6.json |
| 39454-4 | US for transplanted liver | ./2.16.840.1.114222.4.11.1002/39454-4.json |
| 39455-1 | 9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39455-1.json |
| 39456-9 | Acetaminophen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/39456-9.json |
| 39458-5 | Beta-2-Microglobulin [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/39458-5.json |
| 3946-1 | Phenmetrazine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3946-1.json |
| 39461-9 | Bilirubin.total [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/39461-9.json |
| 39462-7 | Bilirubin.conjugated [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/39462-7.json |
| 39463-5 | Bilirubin.indirect [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/39463-5.json |
| 39464-3 | Carbon dioxide, total [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39464-3.json |
| 39465-0 | Carbon dioxide, total [Moles/volume] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/39465-0.json |
| 39466-8 | Carbon dioxide, total [Moles/volume] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/39466-8.json |
| 39467-6 | Chloride [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39467-6.json |
| 39468-4 | Cholesterol [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/39468-4.json |
| 39469-2 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/39469-2.json |
| 39470-0 | Prochlorperazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39470-0.json |
| 39471-8 | Creatinine [Moles/volume] in 24 hour Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39471-8.json |
| 39472-6 | Creatinine [Moles/volume] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/39472-6.json |
| 39473-4 | Creatinine [Moles/volume] in 72 hour Urine | ./2.16.840.1.114222.4.11.1002/39473-4.json |
| 39474-2 | Creatinine [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/39474-2.json |
| 39475-9 | dimenhyDRINATE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39475-9.json |
| 39476-7 | diphenhydrAMINE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39476-7.json |
| 39477-5 | fluPHENAZine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39477-5.json |
| 39478-3 | Glucose [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/39478-3.json |
| 3947-9 | PHENobarbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3947-9.json |
| 39479-1 | Glucose [Moles/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/39479-1.json |
| 39480-9 | Glucose [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/39480-9.json |
| 39481-7 | Glucose [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/39481-7.json |
| 39482-5 | Trimeprazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39482-5.json |
| 39483-3 | Normethsuximide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39483-3.json |
| 39484-1 | OLANZapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39484-1.json |
| 3948-7 | PHENobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3948-7.json |
| 39487-4 | PHENobarbital [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/39487-4.json |
| 39488-2 | Phensuximide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39488-2.json |
| 39489-0 | XR Ribs lower posterior Views | ./2.16.840.1.114222.4.11.1002/39489-0.json |
| 39490-8 | XR Femur and Tibia - right Views for leg length | ./2.16.840.1.114222.4.11.1002/39490-8.json |
| 39491-6 | XR Ribs upper anterior and posterior - right Views | ./2.16.840.1.114222.4.11.1002/39491-6.json |
| 39492-4 | XR Ribs upper posterior - right Views | ./2.16.840.1.114222.4.11.1002/39492-4.json |
| 39493-2 | XR Ribs lower posterior - right Views | ./2.16.840.1.114222.4.11.1002/39493-2.json |
| 39494-0 | US Abdominal wall | ./2.16.840.1.114222.4.11.1002/39494-0.json |
| 3949-5 | PHENobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3949-5.json |
| 39495-7 | US.doppler Extremity vessels - bilateral | ./2.16.840.1.114222.4.11.1002/39495-7.json |
| 39496-5 | US.doppler Upper extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/39496-5.json |
| 39497-3 | US.doppler Iliac vessels | ./2.16.840.1.114222.4.11.1002/39497-3.json |
| 39498-1 | US.doppler Femoral vessels - left | ./2.16.840.1.114222.4.11.1002/39498-1.json |
| 39499-9 | US.doppler Lower extremity artery - left | ./2.16.840.1.114222.4.11.1002/39499-9.json |
| 39500-4 | US.doppler Upper extremity artery - left | ./2.16.840.1.114222.4.11.1002/39500-4.json |
| 39501-2 | US.doppler Upper extremity vein - left | ./2.16.840.1.114222.4.11.1002/39501-2.json |
| 39502-0 | US.doppler Ovarian vessels | ./2.16.840.1.114222.4.11.1002/39502-0.json |
| 3950-3 | PHENobarbital [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3950-3.json |
| 39503-8 | US.doppler Extremity vessels - right | ./2.16.840.1.114222.4.11.1002/39503-8.json |
| 39504-6 | US.doppler Femoral vessels - right | ./2.16.840.1.114222.4.11.1002/39504-6.json |
| 39505-3 | US.doppler Lower extremity artery - right | ./2.16.840.1.114222.4.11.1002/39505-3.json |
| 39506-1 | US.doppler Upper extremity artery - right | ./2.16.840.1.114222.4.11.1002/39506-1.json |
| 39507-9 | US.doppler Upper extremity vein - right | ./2.16.840.1.114222.4.11.1002/39507-9.json |
| 39508-7 | US.doppler Umbilical vessels Fetal | ./2.16.840.1.114222.4.11.1002/39508-7.json |
| 39509-5 | US for transplanted pancreas | ./2.16.840.1.114222.4.11.1002/39509-5.json |
| 39510-3 | RFA Pelvic lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/39510-3.json |
| 3951-1 | PHENobarbital Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3951-1.json |
| 39511-1 | XR Pelvis Views and Oblique | ./2.16.840.1.114222.4.11.1002/39511-1.json |
| 39512-9 | XR Hip - right AP and Danelius Miller | ./2.16.840.1.114222.4.11.1002/39512-9.json |
| 39513-7 | XR Hip - right Views and Danelius Miller | ./2.16.840.1.114222.4.11.1002/39513-7.json |
| 39514-5 | XR Hip - right Danelius Miller | ./2.16.840.1.114222.4.11.1002/39514-5.json |
| 39515-2 | XR Wrist - right Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/39515-2.json |
| 39516-0 | XR Shoulder Stryker Notch | ./2.16.840.1.114222.4.11.1002/39516-0.json |
| 39517-8 | XR Shoulder Stryker Notch and West Point | ./2.16.840.1.114222.4.11.1002/39517-8.json |
| 39518-6 | XR Long bones Limited Survey Views | ./2.16.840.1.114222.4.11.1002/39518-6.json |
| 39519-4 | XR Skull PA and Right lateral and Left lateral | ./2.16.840.1.114222.4.11.1002/39519-4.json |
| 39520-2 | XR Skull PA and Right lateral and Left lateral and Towne | ./2.16.840.1.114222.4.11.1002/39520-2.json |
| 39521-0 | XR Skull PA and Right lateral and Left lateral and Caldwell and Towne | ./2.16.840.1.114222.4.11.1002/39521-0.json |
| 39522-8 | US guidance for percutaneous biopsy of Lymph node | ./2.16.840.1.114222.4.11.1002/39522-8.json |
| 39523-6 | US.doppler Artery | ./2.16.840.1.114222.4.11.1002/39523-6.json |
| 39524-4 | US.doppler Vein limited | ./2.16.840.1.114222.4.11.1002/39524-4.json |
| 39525-1 | US.doppler Vein | ./2.16.840.1.114222.4.11.1002/39525-1.json |
| 39526-9 | US Extremity limited | ./2.16.840.1.114222.4.11.1002/39526-9.json |
| 39527-7 | US Unspecified body region for foreign body | ./2.16.840.1.114222.4.11.1002/39527-7.json |
| 39528-5 | Adenovirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/39528-5.json |
| 3952-9 | Phenothiazines [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3952-9.json |
| 39529-3 | Acetone [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/39529-3.json |
| 39530-1 | Isopropanol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/39530-1.json |
| 39531-9 | Acetaldehyde [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/39531-9.json |
| 39532-7 | Inhibin B [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39532-7.json |
| 39533-5 | Deoxyhemoglobin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/39533-5.json |
| 39534-3 | Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/39534-3.json |
| 39535-0 | Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/39535-0.json |
| 39536-8 | Influenza virus A Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/39536-8.json |
| 3953-7 | Phenothiazines [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3953-7.json |
| 39537-6 | Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/39537-6.json |
| 39538-4 | Finch droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/39538-4.json |
| 39539-2 | Cockatiel droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/39539-2.json |
| 39540-0 | Uranium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/39540-0.json |
| 39541-8 | Legionella sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/39541-8.json |
| 39542-6 | Almond IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39542-6.json |
| 39543-4 | Hazelnut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39543-4.json |
| 39544-2 | Yellow Hornet IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39544-2.json |
| 3954-5 | Phenothiazines [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3954-5.json |
| 39545-9 | Crab IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39545-9.json |
| 39546-7 | Lobster IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39546-7.json |
| 39547-5 | Tuna IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39547-5.json |
| 39548-3 | Salmon IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39548-3.json |
| 39549-1 | Escargot IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39549-1.json |
| 39550-9 | Horse dander IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39550-9.json |
| 39551-7 | Cow dander IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39551-7.json |
| 3955-2 | Phensuximide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3955-2.json |
| 39552-5 | Lamb IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39552-5.json |
| 39553-3 | Penicillin V IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39553-3.json |
| 39554-1 | Endomysium IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/39554-1.json |
| 39555-8 | West Nile virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39555-8.json |
| 39556-6 | Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/39556-6.json |
| 39558-2 | West Nile virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/39558-2.json |
| 39559-0 | Legionella sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/39559-0.json |
| 3956-0 | Phentermine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3956-0.json |
| 39565-7 | Complement C4d [Mass/volume] in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/39565-7.json |
| 39566-5 | Pregnanetriol/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39566-5.json |
| 39567-3 | TOLAZamide [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39567-3.json |
| 39568-1 | TOLBUTamide [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39568-1.json |
| 39569-9 | Trichoderma viride Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39569-9.json |
| 39570-7 | Alternaria sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39570-7.json |
| 39571-5 | Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/39571-5.json |
| 39572-3 | West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/39572-3.json |
| 39573-1 | West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/39573-1.json |
| 39576-4 | Sulfate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39576-4.json |
| 39577-2 | Leishmania sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/39577-2.json |
| 3957-8 | Phentermine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3957-8.json |
| 39578-0 | Alternaria alternata Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39578-0.json |
| 39579-8 | Penicillium notatum Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39579-8.json |
| 39580-6 | Phoma herbarum Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39580-6.json |
| 39581-4 | Rubella virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/39581-4.json |
| 39582-2 | Amino beta guanidinopropionate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39582-2.json |
| 39583-0 | Mercury [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/39583-0.json |
| 39584-8 | Mercury [Presence] in Nail | ./2.16.840.1.114222.4.11.1002/39584-8.json |
| 39585-5 | Tritium [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/39585-5.json |
| 3958-6 | Phentermine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3958-6.json |
| 39587-1 | Neutrophil Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39587-1.json |
| 39588-9 | Histoplasma capsulatum IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39588-9.json |
| 39591-3 | PARoxetine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/39591-3.json |
| 39592-1 | Brazil Nut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39592-1.json |
| 39593-9 | Coconut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39593-9.json |
| 3959-4 | Phentermine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3959-4.json |
| 39594-7 | Pecan or Hickory Nut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39594-7.json |
| 39595-4 | Halibut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39595-4.json |
| 39596-2 | Blue mussel IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39596-2.json |
| 39597-0 | Pumpkin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39597-0.json |
| 39598-8 | Curvularia lunata IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39598-8.json |
| 39599-6 | Epicoccum purpurascens IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39599-6.json |
| 39600-2 | Fusarium moniliforme IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39600-2.json |
| 39601-0 | Stemphylium botryosum IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39601-0.json |
| 3960-2 | Phenylbutazone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3960-2.json |
| 39602-8 | Hamster epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39602-8.json |
| 39603-6 | Guinea pig epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39603-6.json |
| 39604-4 | Mugwort IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39604-4.json |
| 39605-1 | Goose feather IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39605-1.json |
| 39606-9 | Rabbit epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39606-9.json |
| 39609-3 | Blueberry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/39609-3.json |
| 39610-1 | Neisseria meningitidis serogroup w135 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39610-1.json |
| 39611-9 | Silicone IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39611-9.json |
| 39612-7 | Silicone IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39612-7.json |
| 39613-5 | Silicone IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39613-5.json |
| 39614-3 | Silicone IgE Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/39614-3.json |
| 39618-4 | Neisseria meningitidis serogroup Y Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39618-4.json |
| 39619-2 | NM Pulmonary system Views | ./2.16.840.1.114222.4.11.1002/39619-2.json |
| 39620-0 | NM Guidance for abscess localization limited of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39620-0.json |
| 39621-8 | SPECT Guidance for abscess localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39621-8.json |
| 39622-6 | SPECT Guidance for abscess localization of Whole body | ./2.16.840.1.114222.4.11.1002/39622-6.json |
| 39623-4 | NM Guidance for abscess localization of Whole body | ./2.16.840.1.114222.4.11.1002/39623-4.json |
| 39624-2 | NM Adrenal gland Views W I-131 NP59 IV | ./2.16.840.1.114222.4.11.1002/39624-2.json |
| 39625-9 | NM Artery Views W Tc-99m DTPA IA | ./2.16.840.1.114222.4.11.1002/39625-9.json |
| 39626-7 | NM Vein - bilateral Views | ./2.16.840.1.114222.4.11.1002/39626-7.json |
| 39627-5 | NM Bone Limited Views | ./2.16.840.1.114222.4.11.1002/39627-5.json |
| 3962-8 | Phenylephrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3962-8.json |
| 39628-3 | SPECT Small bowel for Meckel's diverticulum | ./2.16.840.1.114222.4.11.1002/39628-3.json |
| 39629-1 | NM Small bowel Views for Meckel's diverticulum | ./2.16.840.1.114222.4.11.1002/39629-1.json |
| 39630-9 | NM Brain Views W Tc-99m HMPAO IV | ./2.16.840.1.114222.4.11.1002/39630-9.json |
| 39631-7 | SPECT Brain W Tc-99m HMPAO IV | ./2.16.840.1.114222.4.11.1002/39631-7.json |
| 39632-5 | SPECT Brain | ./2.16.840.1.114222.4.11.1002/39632-5.json |
| 39634-1 | NM Brain Limited Views | ./2.16.840.1.114222.4.11.1002/39634-1.json |
| 39635-8 | NM Brain Views W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39635-8.json |
| 3963-6 | Phenylpropanolamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3963-6.json |
| 39636-6 | NM Brain Views for blood flow | ./2.16.840.1.114222.4.11.1002/39636-6.json |
| 39637-4 | SPECT Brain for blood flow | ./2.16.840.1.114222.4.11.1002/39637-4.json |
| 39638-2 | SPECT Brain W I-123 IV | ./2.16.840.1.114222.4.11.1002/39638-2.json |
| 39639-0 | SPECT Brain W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39639-0.json |
| 39640-8 | SPECT Brain W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/39640-8.json |
| 39641-6 | SPECT Brain W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/39641-6.json |
| 39642-4 | NM Brain Views W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/39642-4.json |
| 39643-2 | NM Brain veins Views | ./2.16.840.1.114222.4.11.1002/39643-2.json |
| 3964-4 | Phenylpropanolamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3964-4.json |
| 39644-0 | SPECT Breast | ./2.16.840.1.114222.4.11.1002/39644-0.json |
| 39645-7 | NM Breast Limited Views | ./2.16.840.1.114222.4.11.1002/39645-7.json |
| 39646-5 | NM Breast Views | ./2.16.840.1.114222.4.11.1002/39646-5.json |
| 39647-3 | SPECT Heart W Tc-99m Tetrofosmin IV | ./2.16.840.1.114222.4.11.1002/39647-3.json |
| 39648-1 | SPECT Heart W dipyridamole IV | ./2.16.840.1.114222.4.11.1002/39648-1.json |
| 39649-9 | SPECT Heart | ./2.16.840.1.114222.4.11.1002/39649-9.json |
| 39650-7 | NM Heart Views | ./2.16.840.1.114222.4.11.1002/39650-7.json |
| 3965-1 | Phenylpropanolamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3965-1.json |
| 39651-5 | NM Heart Views W adenosine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39651-5.json |
| 39652-3 | NM Heart Views W dobutamine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39652-3.json |
| 39653-1 | NM Heart Views for infarct | ./2.16.840.1.114222.4.11.1002/39653-1.json |
| 39654-9 | SPECT Heart for infarct W Tc-99m PYP IV | ./2.16.840.1.114222.4.11.1002/39654-9.json |
| 39655-6 | SPECT Heart for infarct W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39655-6.json |
| 39656-4 | SPECT Heart for infarct | ./2.16.840.1.114222.4.11.1002/39656-4.json |
| 39657-2 | NM Heart Views for infarct W Tc-99m PYP IV | ./2.16.840.1.114222.4.11.1002/39657-2.json |
| 39658-0 | SPECT Heart at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39658-0.json |
| 39660-6 | NM Heart Views at rest and W dipyridamole and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39660-6.json |
| 39661-4 | NM Heart Views at rest and W dobutamine and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39661-4.json |
| 39662-2 | SPECT Heart at rest and W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39662-2.json |
| 39663-0 | NM Heart Views at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39663-0.json |
| 39664-8 | NM Heart Views for shunt detection W Tc-99m MAA IV | ./2.16.840.1.114222.4.11.1002/39664-8.json |
| 39665-5 | NM Heart Views for shunt detection | ./2.16.840.1.114222.4.11.1002/39665-5.json |
| 39666-3 | NM Heart Views W stress and W 201 Th IV | ./2.16.840.1.114222.4.11.1002/39666-3.json |
| 39667-1 | NM Heart Views W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39667-1.json |
| 39668-9 | SPECT Heart W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39668-9.json |
| 3966-9 | Phenylpropanolamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3966-9.json |
| 39669-7 | NM Whole body Views W Tc-99m Arcitumomab IV | ./2.16.840.1.114222.4.11.1002/39669-7.json |
| 39670-5 | NM Lacrimal duct Views W radionuclide intra lacrimal duct | ./2.16.840.1.114222.4.11.1002/39670-5.json |
| 39671-3 | NM Rectum Views W radionuclide PO | ./2.16.840.1.114222.4.11.1002/39671-3.json |
| 39672-1 | NM Esophagus Views for motility W radionuclide PO | ./2.16.840.1.114222.4.11.1002/39672-1.json |
| 39673-9 | NM Esophagus Views for reflux W radionuclide PO | ./2.16.840.1.114222.4.11.1002/39673-9.json |
| 39674-7 | NM Gallbladder Views W Tc-99m DISIDA IV | ./2.16.840.1.114222.4.11.1002/39674-7.json |
| 39675-4 | SPECT Whole body for infection W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39675-4.json |
| 3967-7 | Phenytoin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3967-7.json |
| 39677-0 | NM Unspecified body region Views for infection W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39677-0.json |
| 39678-8 | SPECT Whole body for tumor W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39678-8.json |
| 39679-6 | NM Unspecified body region Views for tumor W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39679-6.json |
| 39680-4 | SPECT Whole body W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39680-4.json |
| 39681-2 | SPECT Unspecified body region limited W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39681-2.json |
| 39682-0 | SPECT Unspecified body region W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39682-0.json |
| 39683-8 | NM Whole body Views W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39683-8.json |
| 39684-6 | SPECT Unspecified body region for abscess W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39684-6.json |
| 3968-5 | Phenytoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3968-5.json |
| 39685-3 | NM Unspecified body region Views for abscess W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39685-3.json |
| 39686-1 | NM Whole body Views for lymphoma W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39686-1.json |
| 39687-9 | NM Unspecified body region Limited Views W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39687-9.json |
| 39688-7 | NM Unspecified body region Views W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39688-7.json |
| 39689-5 | NM Gastrointestinal tract Views W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/39689-5.json |
| 39690-3 | NM Liver Views W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/39690-3.json |
| 39691-1 | SPECT Liver W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/39691-1.json |
| 39692-9 | SPECT Liver | ./2.16.840.1.114222.4.11.1002/39692-9.json |
| 3969-3 | Phenytoin Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3969-3.json |
| 39693-7 | NM Liver Views | ./2.16.840.1.114222.4.11.1002/39693-7.json |
| 39694-5 | NM Views for transplanted liver | ./2.16.840.1.114222.4.11.1002/39694-5.json |
| 39695-2 | NM Lung Limited Views | ./2.16.840.1.114222.4.11.1002/39695-2.json |
| 39696-0 | NM Lung Views W depreotide IV | ./2.16.840.1.114222.4.11.1002/39696-0.json |
| 39697-8 | NM Lung Perfusion | ./2.16.840.1.114222.4.11.1002/39697-8.json |
| 39698-6 | NM Whole body Views W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39698-6.json |
| 39699-4 | NM Heart Perfusion at rest and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39699-4.json |
| 39700-0 | SPECT Heart perfusion W adenosine and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39700-0.json |
| 3970-1 | Pholedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3970-1.json |
| 39701-8 | NM Heart Perfusion W adenosine and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39701-8.json |
| 39702-6 | NM Heart Perfusion W dobutamine and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39702-6.json |
| 39703-4 | NM Heart Perfusion W dobutamine IV | ./2.16.840.1.114222.4.11.1002/39703-4.json |
| 39704-2 | NM Heart Perfusion W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39704-2.json |
| 39705-9 | NM Heart Perfusion W dipyridamole and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39705-9.json |
| 39707-5 | NM Heart Perfusion W dipyridamole and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39707-5.json |
| 39708-3 | NM Heart Perfusion W dipyridamole IV | ./2.16.840.1.114222.4.11.1002/39708-3.json |
| 39709-1 | NM Heart Perfusion W dipyridamole and W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/39709-1.json |
| 39710-9 | SPECT Heart perfusion W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39710-9.json |
| 39711-7 | SPECT Heart perfusion W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39711-7.json |
| 39712-5 | SPECT Heart perfusion | ./2.16.840.1.114222.4.11.1002/39712-5.json |
| 39713-3 | NM Heart Perfusion W Tl-201 IV and W Tc-99m Tetrofosmin IV | ./2.16.840.1.114222.4.11.1002/39713-3.json |
| 39714-1 | NM Heart Perfusion W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39714-1.json |
| 39715-8 | NM Heart Perfusion W stress and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39715-8.json |
| 39716-6 | NM Heart Perfusion | ./2.16.840.1.114222.4.11.1002/39716-6.json |
| 39718-2 | SPECT Heart perfusion at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39718-2.json |
| 3971-9 | Pindolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3971-9.json |
| 39719-0 | NM Heart Perfusion at rest and W adenosine and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39719-0.json |
| 39720-8 | NM Heart Perfusion at rest and W dipyridamole and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39720-8.json |
| 39722-4 | NM Heart Perfusion at rest and W dipyridamole and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39722-4.json |
| 39723-2 | SPECT Heart perfusion at rest and W stress and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39723-2.json |
| 39724-0 | SPECT Heart perfusion at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39724-0.json |
| 39725-7 | SPECT Heart perfusion at rest and W adenosine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39725-7.json |
| 39726-5 | NM Heart Perfusion at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39726-5.json |
| 3972-7 | Piperacillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3972-7.json |
| 39727-3 | NM Heart Perfusion at rest and W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39727-3.json |
| 39728-1 | NM Heart Perfusion at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39728-1.json |
| 39729-9 | SPECT Heart perfusion at rest and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39729-9.json |
| 39730-7 | NM Heart Perfusion W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39730-7.json |
| 39731-5 | NM Heart Perfusion W adenosine and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39731-5.json |
| 39732-3 | NM Heart Perfusion W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39732-3.json |
| 39733-1 | NM Heart Perfusion W dobutamine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39733-1.json |
| 39734-9 | SPECT Heart perfusion W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39734-9.json |
| 3973-5 | Pipradrol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3973-5.json |
| 39735-6 | NM Heart Perfusion W adenosine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/39735-6.json |
| 39736-4 | SPECT Heart perfusion W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39736-4.json |
| 39737-2 | NM Neck Views | ./2.16.840.1.114222.4.11.1002/39737-2.json |
| 39738-0 | NM Abdomen Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39738-0.json |
| 39739-8 | NM Pancreas Views | ./2.16.840.1.114222.4.11.1002/39739-8.json |
| 39740-6 | SPECT Parathyroid gland | ./2.16.840.1.114222.4.11.1002/39740-6.json |
| 39741-4 | NM Parathyroid gland Delayed Views | ./2.16.840.1.114222.4.11.1002/39741-4.json |
| 39742-2 | NM Parathyroid gland Views | ./2.16.840.1.114222.4.11.1002/39742-2.json |
| 3974-3 | Pipradrol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3974-3.json |
| 39743-0 | SPECT Prostate W Tc-99m capromab pendatide IV | ./2.16.840.1.114222.4.11.1002/39743-0.json |
| 39744-8 | NM Prostate Views W Tc-99m capromab pendatide IV | ./2.16.840.1.114222.4.11.1002/39744-8.json |
| 39745-5 | NM Kidney Views W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/39745-5.json |
| 39746-3 | NM Kidney Views W Tc-99m Mertiatide IV | ./2.16.840.1.114222.4.11.1002/39746-3.json |
| 39747-1 | NM Salivary gland Views | ./2.16.840.1.114222.4.11.1002/39747-1.json |
| 39748-9 | SPECT Whole body for tumor W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39748-9.json |
| 39749-7 | NM Whole body Views for tumor W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39749-7.json |
| 3975-0 | Pipradrol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3975-0.json |
| 39750-5 | NM Unspecified body region Views for tumor W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39750-5.json |
| 39751-3 | NM Spleen Views | ./2.16.840.1.114222.4.11.1002/39751-3.json |
| 39752-1 | NM Spleen Views W radionuclide tagged heat damaged RBC IV | ./2.16.840.1.114222.4.11.1002/39752-1.json |
| 39753-9 | NM Scrotum and testicle Views W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/39753-9.json |
| 39754-7 | NM Thyroid gland Limited Views W I-131 IV | ./2.16.840.1.114222.4.11.1002/39754-7.json |
| 39755-4 | SPECT Thyroid gland W I-131 IV | ./2.16.840.1.114222.4.11.1002/39755-4.json |
| 39756-2 | NM Thyroid gland Views W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39756-2.json |
| 39757-0 | NM Thyroid gland Views W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/39757-0.json |
| 39758-8 | NM Guidance for localization of tumor of Breast | ./2.16.840.1.114222.4.11.1002/39758-8.json |
| 39759-6 | SPECT Guidance limited for localization of tumor | ./2.16.840.1.114222.4.11.1002/39759-6.json |
| 39760-4 | NM Guidance limited for localization of tumor | ./2.16.840.1.114222.4.11.1002/39760-4.json |
| 39761-2 | NM Guidance limited for localization of tumor-- W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39761-2.json |
| 39762-0 | SPECT Guidance for localization of tumor of Whole body | ./2.16.840.1.114222.4.11.1002/39762-0.json |
| 39763-8 | NM Guidance for localization of tumor of Whole body | ./2.16.840.1.114222.4.11.1002/39763-8.json |
| 39764-6 | NM Vein Views W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/39764-6.json |
| 39765-3 | NM Vein Views W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/39765-3.json |
| 39766-1 | NM Vein Views W Tc-99m HDP IV | ./2.16.840.1.114222.4.11.1002/39766-1.json |
| 39767-9 | NM Stomach Views for gastric emptying liquid phase W radionuclide PO | ./2.16.840.1.114222.4.11.1002/39767-9.json |
| 3976-8 | Practolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3976-8.json |
| 39768-7 | NM Stomach Views for gastric emptying W Tc-99m SC PO | ./2.16.840.1.114222.4.11.1002/39768-7.json |
| 39769-5 | NM Stomach Views for gastric emptying W radionuclide PO | ./2.16.840.1.114222.4.11.1002/39769-5.json |
| 39770-3 | SPECT Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/39770-3.json |
| 39771-1 | Porphyrins [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/39771-1.json |
| 39772-9 | Sulfamethoxazole [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39772-9.json |
| 39773-7 | Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/39773-7.json |
| 39774-5 | Porphyrins [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/39774-5.json |
| 3977-6 | Prazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3977-6.json |
| 39779-4 | Urea [Moles/volume] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/39779-4.json |
| 39780-2 | Urea [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39780-2.json |
| 39781-0 | Urea [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/39781-0.json |
| 39782-8 | Delta aminolevulinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/39782-8.json |
| 39783-6 | Urea/Creatinine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39783-6.json |
| 3978-4 | Primidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3978-4.json |
| 39784-4 | Porphyrins [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/39784-4.json |
| 39785-1 | Potassium [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39785-1.json |
| 39786-9 | Pyridoxine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39786-9.json |
| 39787-7 | Sodium [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/39787-7.json |
| 39788-5 | Urate [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/39788-5.json |
| 39789-3 | Potassium [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/39789-3.json |
| 39790-1 | Potassium [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/39790-1.json |
| 39791-9 | Sodium [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/39791-9.json |
| 3979-2 | Probenecid [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3979-2.json |
| 39792-7 | Sodium [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/39792-7.json |
| 39794-3 | Tocainide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39794-3.json |
| 39795-0 | Trifluoperazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39795-0.json |
| 39796-8 | Vancomycin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/39796-8.json |
| 39797-6 | Vancomycin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/39797-6.json |
| 39798-4 | Warfarin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39798-4.json |
| 39799-2 | risperiDONE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39799-2.json |
| 3980-0 | Probenecid [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3980-0.json |
| 39800-8 | risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39800-8.json |
| 39801-6 | Triglyceride [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/39801-6.json |
| 39803-2 | inFLIXimab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39803-2.json |
| 39804-0 | Lipoprotein associated phospholipase A2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/39804-0.json |
| 39805-7 | Rabbit hair IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/39805-7.json |
| 39811-5 | SPECT Unspecified body region for abscess | ./2.16.840.1.114222.4.11.1002/39811-5.json |
| 39812-3 | NM Bone Views W Tc-99m HMPAO IV | ./2.16.840.1.114222.4.11.1002/39812-3.json |
| 39813-1 | SPECT Bone limited | ./2.16.840.1.114222.4.11.1002/39813-1.json |
| 39816-4 | SPECT Whole body Bone | ./2.16.840.1.114222.4.11.1002/39816-4.json |
| 3981-8 | Probenecid [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3981-8.json |
| 39818-0 | NM Whole body Bone Views | ./2.16.840.1.114222.4.11.1002/39818-0.json |
| 39819-8 | NM Bone Delayed Views | ./2.16.840.1.114222.4.11.1002/39819-8.json |
| 39820-6 | NM Bone Views W Sm-153 IV | ./2.16.840.1.114222.4.11.1002/39820-6.json |
| 39821-4 | SPECT Bone marrow limited | ./2.16.840.1.114222.4.11.1002/39821-4.json |
| 39822-2 | NM Bone marrow Limited Views | ./2.16.840.1.114222.4.11.1002/39822-2.json |
| 39823-0 | SPECT Bone marrow | ./2.16.840.1.114222.4.11.1002/39823-0.json |
| 39824-8 | NM Bone marrow Views | ./2.16.840.1.114222.4.11.1002/39824-8.json |
| 39825-5 | SPECT Whole body Bone marrow | ./2.16.840.1.114222.4.11.1002/39825-5.json |
| 3982-6 | Procainamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3982-6.json |
| 39826-3 | NM Whole body Bone marrow Views | ./2.16.840.1.114222.4.11.1002/39826-3.json |
| 39827-1 | NM Whole body Views for endocrine tumor W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39827-1.json |
| 39828-9 | NM Whole body Views for endocrine tumor W In-111 pentetreotide IV | ./2.16.840.1.114222.4.11.1002/39828-9.json |
| 39829-7 | NM Whole body Views for tumor W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39829-7.json |
| 39830-5 | NM Whole body Views for infection W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39830-5.json |
| 39831-3 | NM Unspecified body region Limited Views for tumor W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39831-3.json |
| 3983-4 | Procainamide+N-acetylprocainamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3983-4.json |
| 39834-7 | NM Lung Ventilation W Tc-99m DTPA aerosol IH | ./2.16.840.1.114222.4.11.1002/39834-7.json |
| 39837-0 | NM Lung Ventilation | ./2.16.840.1.114222.4.11.1002/39837-0.json |
| 39838-8 | SPECT Lung ventilation and perfusion | ./2.16.840.1.114222.4.11.1002/39838-8.json |
| 39839-6 | SPECT Whole body W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39839-6.json |
| 39840-4 | NM Whole body Delayed Views W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39840-4.json |
| 39841-2 | NM Unspecified body region Views W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39841-2.json |
| 3984-2 | Prolintane [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3984-2.json |
| 39842-0 | NM Whole body Delayed Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39842-0.json |
| 39843-8 | NM Unspecified body region Limited Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39843-8.json |
| 39844-6 | SPECT Whole body W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39844-6.json |
| 39845-3 | NM Whole body Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39845-3.json |
| 39846-1 | NM Unspecified body region Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39846-1.json |
| 39847-9 | NM Parotid gland Views for blood flow | ./2.16.840.1.114222.4.11.1002/39847-9.json |
| 39848-7 | NM Head to Pelvis Views for shunt patency W In-111 IT | ./2.16.840.1.114222.4.11.1002/39848-7.json |
| 39849-5 | NM Head to Pelvis Views for shunt patency W radionuclide IT | ./2.16.840.1.114222.4.11.1002/39849-5.json |
| 39850-3 | NM Kidney - bilateral Views W I-131 IV | ./2.16.840.1.114222.4.11.1002/39850-3.json |
| 39851-1 | SPECT Kidney - bilateral W Tc-99m Mertiatide IV | ./2.16.840.1.114222.4.11.1002/39851-1.json |
| 39852-9 | SPECT Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/39852-9.json |
| 39856-0 | NM Thyroid gland Views for blood flow | ./2.16.840.1.114222.4.11.1002/39856-0.json |
| 39857-8 | NM Adrenal gland Views W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/39857-8.json |
| 39858-6 | NM Bone Views for blood flow | ./2.16.840.1.114222.4.11.1002/39858-6.json |
| 3985-9 | Prolintane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3985-9.json |
| 39859-4 | NM Brain Delayed Views | ./2.16.840.1.114222.4.11.1002/39859-4.json |
| 39860-2 | NM Heart Blood pool W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39860-2.json |
| 39861-0 | NM Heart Blood pool | ./2.16.840.1.114222.4.11.1002/39861-0.json |
| 39862-8 | SPECT Heart blood pool at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39862-8.json |
| 39863-6 | NM Heart First pass at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39863-6.json |
| 39864-4 | NM Heart First pass | ./2.16.840.1.114222.4.11.1002/39864-4.json |
| 39865-1 | NM Left ventricle First pass | ./2.16.840.1.114222.4.11.1002/39865-1.json |
| 39866-9 | NM Heart First pass at rest and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39866-9.json |
| 3986-7 | Prolintane [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3986-7.json |
| 39867-7 | NM Heart First pass at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39867-7.json |
| 39868-5 | NM Heart First pass W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39868-5.json |
| 39869-3 | NM Heart First pass W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39869-3.json |
| 39870-1 | NM Heart Views for blood flow W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/39870-1.json |
| 39871-9 | NM Heart Views for blood flow | ./2.16.840.1.114222.4.11.1002/39871-9.json |
| 39872-7 | SPECT Heart wall motion | ./2.16.840.1.114222.4.11.1002/39872-7.json |
| 39873-5 | NM Heart Wall motion | ./2.16.840.1.114222.4.11.1002/39873-5.json |
| 39874-3 | NM Cerebral cisterns Delayed Views W radionuclide IT | ./2.16.840.1.114222.4.11.1002/39874-3.json |
| 3987-5 | Promazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3987-5.json |
| 39875-0 | NM Whole body Delayed Views W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39875-0.json |
| 39876-8 | SPECT Liver and Spleen | ./2.16.840.1.114222.4.11.1002/39876-8.json |
| 39877-6 | NM Liver and Spleen Views | ./2.16.840.1.114222.4.11.1002/39877-6.json |
| 39879-2 | SPECT Bone | ./2.16.840.1.114222.4.11.1002/39879-2.json |
| 39880-0 | NM Bone 2 Phase Views | ./2.16.840.1.114222.4.11.1002/39880-0.json |
| 39881-8 | SPECT Whole body Bone 3 phase | ./2.16.840.1.114222.4.11.1002/39881-8.json |
| 39882-6 | NM Whole body Bone 3 Phase Views | ./2.16.840.1.114222.4.11.1002/39882-6.json |
| 3988-3 | Promethazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3988-3.json |
| 39883-4 | NM Bone 3 Phase Views | ./2.16.840.1.114222.4.11.1002/39883-4.json |
| 39884-2 | NM Bone Blood pool | ./2.16.840.1.114222.4.11.1002/39884-2.json |
| 39885-9 | NM Heart First pass and Ventricular volume | ./2.16.840.1.114222.4.11.1002/39885-9.json |
| 39886-7 | NM Heart First pass and Wall motion at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39886-7.json |
| 39887-5 | NM Heart First pass and Ejection fraction at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39887-5.json |
| 39888-3 | NM Heart First pass and Wall motion W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39888-3.json |
| 39889-1 | NM Heart First pass and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39889-1.json |
| 39890-9 | NM Heart First pass and Wall motion | ./2.16.840.1.114222.4.11.1002/39890-9.json |
| 3989-1 | Promethazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3989-1.json |
| 39891-7 | NM Heart Views for infarct and first pass W Tc-99m PYP IV | ./2.16.840.1.114222.4.11.1002/39891-7.json |
| 39892-5 | NM Heart Views for infarct and first pass | ./2.16.840.1.114222.4.11.1002/39892-5.json |
| 39893-3 | NM Heart Views for blood flow and shunt detection | ./2.16.840.1.114222.4.11.1002/39893-3.json |
| 39895-8 | NM Gallbladder Views for ejection fraction W Tc-99m DISIDA IV | ./2.16.840.1.114222.4.11.1002/39895-8.json |
| 39897-4 | NM Lung and Liver Views | ./2.16.840.1.114222.4.11.1002/39897-4.json |
| 39898-2 | SPECT Lung ventilation | ./2.16.840.1.114222.4.11.1002/39898-2.json |
| 39899-0 | NM Salivary gland Views for blood flow | ./2.16.840.1.114222.4.11.1002/39899-0.json |
| 39901-4 | NM Bone 3 Phase Views multiple areas | ./2.16.840.1.114222.4.11.1002/39901-4.json |
| 39902-2 | NM Bone 3 Phase Views single area | ./2.16.840.1.114222.4.11.1002/39902-2.json |
| 39904-8 | NM Bone Multiple area Views | ./2.16.840.1.114222.4.11.1002/39904-8.json |
| 39905-5 | SPECT Bone multiple areas | ./2.16.840.1.114222.4.11.1002/39905-5.json |
| 39906-3 | SPECT Bone marrow multiple areas | ./2.16.840.1.114222.4.11.1002/39906-3.json |
| 39907-1 | NM Bone marrow Multiple area Views | ./2.16.840.1.114222.4.11.1002/39907-1.json |
| 39908-9 | NM Heart First pass and Wall motion and Ventricular volume W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39908-9.json |
| 3990-9 | Propranolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3990-9.json |
| 39909-7 | NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39909-7.json |
| 39910-5 | NM Heart First pass and Wall motion and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39910-5.json |
| 39912-1 | NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39912-1.json |
| 39913-9 | SPECT Heart gated and ejection fraction | ./2.16.840.1.114222.4.11.1002/39913-9.json |
| 39914-7 | NM Heart Gated W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39914-7.json |
| 39915-4 | NM Heart Gated | ./2.16.840.1.114222.4.11.1002/39915-4.json |
| 39916-2 | SPECT Heart gated | ./2.16.840.1.114222.4.11.1002/39916-2.json |
| 3991-7 | Propranolol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3991-7.json |
| 39917-0 | NM Heart Gated and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39917-0.json |
| 39918-8 | SPECT Heart gated and wall motion | ./2.16.840.1.114222.4.11.1002/39918-8.json |
| 39919-6 | NM Heart Gated and First pass | ./2.16.840.1.114222.4.11.1002/39919-6.json |
| 39920-4 | NM Heart Gated at rest and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39920-4.json |
| 39921-2 | NM Heart Gated at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39921-2.json |
| 39922-0 | NM Heart Gated at rest and W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/39922-0.json |
| 39923-8 | NM Heart Gated and Ejection fraction at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39923-8.json |
| 39924-6 | NM Heart Gated at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39924-6.json |
| 3992-5 | Propranolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3992-5.json |
| 39925-3 | NM Heart Gated and Wall motion and Ejection fraction at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39925-3.json |
| 39927-9 | NM Heart Gated W stress and W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/39927-9.json |
| 39928-7 | NM Heart Gated W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39928-7.json |
| 39929-5 | NM Heart Gated and Wall motion W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39929-5.json |
| 39930-3 | SPECT Heart gated W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/39930-3.json |
| 39931-1 | NM Heart Gated and Wall motion and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39931-1.json |
| 39932-9 | NM Heart Wall motion and Ejection fraction | ./2.16.840.1.114222.4.11.1002/39932-9.json |
| 3993-3 | Propranolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3993-3.json |
| 39933-7 | NM Unspecified body region Views for infection multiple areas W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39933-7.json |
| 39934-5 | NM Unspecified body region Views for tumor multiple areas W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39934-5.json |
| 39935-2 | NM Unspecified body region Multiple area Views W Ga-67 IV | ./2.16.840.1.114222.4.11.1002/39935-2.json |
| 39936-0 | NM Joint Limited Views | ./2.16.840.1.114222.4.11.1002/39936-0.json |
| 39937-8 | NM Joint Multiple area Views W radionuclide XXX | ./2.16.840.1.114222.4.11.1002/39937-8.json |
| 39938-6 | SPECT Joint | ./2.16.840.1.114222.4.11.1002/39938-6.json |
| 39939-4 | NM Joint Views | ./2.16.840.1.114222.4.11.1002/39939-4.json |
| 39940-2 | NM Lung Clearance W Tc-99m DTPA aerosol IH | ./2.16.840.1.114222.4.11.1002/39940-2.json |
| 3994-1 | Propranolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3994-1.json |
| 39942-8 | NM Lung Ventilation and Perfusion | ./2.16.840.1.114222.4.11.1002/39942-8.json |
| 39944-4 | NM Lung Ventilation and Equilibrium and Washout | ./2.16.840.1.114222.4.11.1002/39944-4.json |
| 39946-9 | NM Lung Ventilation and Perfusion and Differential | ./2.16.840.1.114222.4.11.1002/39946-9.json |
| 39947-7 | NM Lung Ventilation and Equilibrium | ./2.16.840.1.114222.4.11.1002/39947-7.json |
| 39949-3 | NM Unspecified body region Multiple area Views W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/39949-3.json |
| 39950-1 | NM Prostate Multiple area Views W Tc-99m capromab pendatide IV | ./2.16.840.1.114222.4.11.1002/39950-1.json |
| 39951-9 | NM Unspecified body region Views for tumor multiple areas W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/39951-9.json |
| 39952-7 | NM Scrotum and testicle Views for blood flow and function | ./2.16.840.1.114222.4.11.1002/39952-7.json |
| 39953-5 | NM Guidance for localization of tumor multiple areas of Unspecified body region | ./2.16.840.1.114222.4.11.1002/39953-5.json |
| 39954-3 | NM Vein Views for thrombosis | ./2.16.840.1.114222.4.11.1002/39954-3.json |
| 3995-8 | Propylhexedrine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/3995-8.json |
| 3996-6 | Propylhexedrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/3996-6.json |
| 3997-4 | Propylhexedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/3997-4.json |
| 3998-2 | Propylhexedrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/3998-2.json |
| 3999-0 | Protriptyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/3999-0.json |
| 4000-6 | Protriptyline [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4000-6.json |
| 4001-4 | Protriptyline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4001-4.json |
| 4002-2 | Protriptyline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/4002-2.json |
| 4003-0 | Pseudoephedrine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4003-0.json |
| 4004-8 | Pseudoephedrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4004-8.json |
| 4005-5 | Pseudoephedrine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4005-5.json |
| 4006-3 | Pyrilamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4006-3.json |
| 4007-1 | Pyrilamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4007-1.json |
| 4008-9 | Pyrilamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4008-9.json |
| 4009-7 | Pyrilamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4009-7.json |
| 4010-5 | Pyrilamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4010-5.json |
| 4011-3 | Pyrovalerone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4011-3.json |
| 4012-1 | Pyrovalerone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4012-1.json |
| 4013-9 | Pyrovalerone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4013-9.json |
| 4014-7 | quiNIDine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4014-7.json |
| 4015-4 | quiNIDine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4015-4.json |
| 4016-2 | quiNIDine+Quinine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4016-2.json |
| 4017-0 | quiNIDine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/4017-0.json |
| 4018-8 | quiNINE [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4018-8.json |
| 40193-5 | Glucose [Moles/volume] in Serum or Plasma --pre-meal | ./2.16.840.1.114222.4.11.1002/40193-5.json |
| 4019-6 | quiNINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4019-6.json |
| 4020-4 | quiNINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4020-4.json |
| 4021-2 | rifAMPin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4021-2.json |
| 4022-0 | Salicylamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4022-0.json |
| 4023-8 | Salicylates [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4023-8.json |
| 4024-6 | Salicylates [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4024-6.json |
| 4025-3 | Salicylates [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4025-3.json |
| 4026-1 | Salicylates [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4026-1.json |
| 4027-9 | Secobarbital [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4027-9.json |
| 4028-7 | Secobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4028-7.json |
| 40287-5 | Glucose [Moles/volume] in Serum or Plasma --1 hour post meal | ./2.16.840.1.114222.4.11.1002/40287-5.json |
| 4029-5 | Secobarbital [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4029-5.json |
| 4030-3 | Sotalol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4030-3.json |
| 40304-8 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine | ./2.16.840.1.114222.4.11.1002/40304-8.json |
| 40305-5 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine | ./2.16.840.1.114222.4.11.1002/40305-5.json |
| 4031-1 | Sotalol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4031-1.json |
| 4032-9 | Sotalol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4032-9.json |
| 40341-0 | MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40341-0.json |
| 40342-8 | MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40342-8.json |
| 40343-6 | MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40343-6.json |
| 4034-5 | Spironolactone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4034-5.json |
| 40345-1 | MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40345-1.json |
| 40346-9 | MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40346-9.json |
| 40347-7 | MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40347-7.json |
| 40348-5 | MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40348-5.json |
| 40349-3 | MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40349-3.json |
| 40350-1 | MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40350-1.json |
| 40351-9 | MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40351-9.json |
| 4035-2 | Spironolactone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4035-2.json |
| 40352-7 | MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40352-7.json |
| 40353-5 | MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40353-5.json |
| 40354-3 | MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40354-3.json |
| 40355-0 | Cotinine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40355-0.json |
| 40356-8 | Creatinine [Moles/time] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/40356-8.json |
| 40357-6 | Creatinine [Moles/time] in 24 hour Body fluid | ./2.16.840.1.114222.4.11.1002/40357-6.json |
| 40358-4 | Desipramine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40358-4.json |
| 40359-2 | Dextromethorphan [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40359-2.json |
| 4036-0 | Stanozolol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4036-0.json |
| 40366-7 | Glucose [Moles/time] in 24 hour Body fluid | ./2.16.840.1.114222.4.11.1002/40366-7.json |
| 40367-5 | Heptacarboxylate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40367-5.json |
| 40368-3 | Hexacarboxylate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40368-3.json |
| 40369-1 | HYDROmorphone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40369-1.json |
| 40370-9 | Imipramine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40370-9.json |
| 40371-7 | Isoniazid [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40371-7.json |
| 40372-5 | Isopropanol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40372-5.json |
| 4037-8 | Stanozolol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4037-8.json |
| 40379-0 | Maprotiline [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40379-0.json |
| 40380-8 | Meprobamate [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40380-8.json |
| 40381-6 | Methamphetamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40381-6.json |
| 40382-4 | Methaqualone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40382-4.json |
| 40383-2 | Methyprylon [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40383-2.json |
| 40384-0 | Morphine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40384-0.json |
| 40385-7 | Nicotine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/40385-7.json |
| 4038-6 | Stanozolol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4038-6.json |
| 40386-5 | Nicotine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40386-5.json |
| 40387-3 | Nicotine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40387-3.json |
| 40388-1 | Nitrogen [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40388-1.json |
| 40389-9 | Nortriptyline [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40389-9.json |
| 40390-7 | OLANZapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40390-7.json |
| 40391-5 | Para aminobenzoate free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40391-5.json |
| 40392-3 | Pentacarboxylate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40392-3.json |
| 40393-1 | Pentazocine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40393-1.json |
| 4039-4 | Streptomycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4039-4.json |
| 40394-9 | Phencyclidine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40394-9.json |
| 40395-6 | Phentermine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40395-6.json |
| 40396-4 | Porphyrins [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40396-4.json |
| 4040-2 | Sulfonamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4040-2.json |
| 40402-0 | traZODone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40402-0.json |
| 40403-8 | Trimipramine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40403-8.json |
| 40404-6 | Tripelennamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40404-6.json |
| 40405-3 | Urea [Moles/time] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/40405-3.json |
| 40406-1 | Urea [Moles/time] in 24 hour Body fluid | ./2.16.840.1.114222.4.11.1002/40406-1.json |
| 40409-5 | 3-Methoxytyramine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40409-5.json |
| 4041-0 | Sulfonamide [Presence] in Serum or Blood | ./2.16.840.1.114222.4.11.1002/4041-0.json |
| 40410-3 | Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/40410-3.json |
| 40411-1 | Amitriptyline [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40411-1.json |
| 40412-9 | Barbiturates [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/40412-9.json |
| 40413-7 | Barbiturates [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40413-7.json |
| 40414-5 | Benzodiazepines [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/40414-5.json |
| 40415-2 | Benzodiazepines [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40415-2.json |
| 40416-0 | Caffeine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40416-0.json |
| 40417-8 | Chromium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40417-8.json |
| 40418-6 | Cotinine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/40418-6.json |
| 40419-4 | Amphetamine+Methamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40419-4.json |
| 40420-2 | Amphetamine+Methamphetamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40420-2.json |
| 40421-0 | Amphetamine+Methamphetamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40421-0.json |
| 40422-8 | Methotrimeprazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40422-8.json |
| 40423-6 | Methotrimeprazine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40423-6.json |
| 40424-4 | Methotrimeprazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40424-4.json |
| 40425-1 | CYP2D6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40425-1.json |
| 40426-9 | FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40426-9.json |
| 40427-7 | FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40427-7.json |
| 4042-8 | Sulfonamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4042-8.json |
| 40428-5 | NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40428-5.json |
| 40429-3 | NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40429-3.json |
| 40430-1 | TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40430-1.json |
| 40433-5 | Sucrose hemolysis of Red Blood Cells from Control | ./2.16.840.1.114222.4.11.1002/40433-5.json |
| 40434-3 | APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40434-3.json |
| 40435-0 | Fungus identified in Urine by Culture | ./2.16.840.1.114222.4.11.1002/40435-0.json |
| 4043-6 | Teicoplanin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4043-6.json |
| 40436-8 | Parainfluenza virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/40436-8.json |
| 40440-0 | XXX microorganism serotype [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/40440-0.json |
| 4044-4 | Tetracaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4044-4.json |
| 40444-2 | CMV gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/40444-2.json |
| 4045-1 | Tetracycline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4045-1.json |
| 40451-7 | Lead [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/40451-7.json |
| 40452-5 | Sialate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/40452-5.json |
| 40453-3 | Sialooligosaccharides [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40453-3.json |
| 40454-1 | Clot Lysis [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/40454-1.json |
| 40456-6 | Beta 2 glycoprotein 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40456-6.json |
| 40457-4 | Prothrombin Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40457-4.json |
| 40459-0 | Hepatitis B virus DNA [Log #/volume] (viral load) in Serum by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/40459-0.json |
| 40460-8 | Phenytoin.bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40460-8.json |
| 40463-2 | TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40463-2.json |
| 40464-0 | Drugs identified in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/40464-0.json |
| 40465-7 | Glimepride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40465-7.json |
| 40466-5 | Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40466-5.json |
| 40467-3 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/40467-3.json |
| 40468-1 | SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40468-1.json |
| 4046-9 | Tetrahydrocortisone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4046-9.json |
| 40469-9 | Hydroflumethiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40469-9.json |
| 40471-5 | FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40471-5.json |
| 40473-1 | Thermoactinomyces vulgaris 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40473-1.json |
| 40474-9 | Volatiles and gases [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/40474-9.json |
| 40475-6 | WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40475-6.json |
| 40476-4 | PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40476-4.json |
| 4047-7 | Theophylline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4047-7.json |
| 40477-2 | L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40477-2.json |
| 40478-0 | MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40478-0.json |
| 40479-8 | Virus identified in Body fluid by Culture | ./2.16.840.1.114222.4.11.1002/40479-8.json |
| 40480-6 | Virus identified in Genital specimen by Culture | ./2.16.840.1.114222.4.11.1002/40480-6.json |
| 40481-4 | Methylenedioxymethamphetamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40481-4.json |
| 4048-5 | Theophylline [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/4048-5.json |
| 40487-1 | Urea/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/40487-1.json |
| 40488-9 | Glucose/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/40488-9.json |
| 4049-3 | Theophylline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4049-3.json |
| 40493-9 | Methylenedioxymethamphetamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40493-9.json |
| 40494-7 | Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40494-7.json |
| 40495-4 | Yersinia pseudotuberculosis 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40495-4.json |
| 40496-2 | Yersinia pseudotuberculosis 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40496-2.json |
| 40497-0 | Yersinia pseudotuberculosis 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40497-0.json |
| 40498-8 | Yersinia enterocolitica Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40498-8.json |
| 40499-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40499-6.json |
| 40500-1 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40500-1.json |
| 4050-1 | Thiopental [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4050-1.json |
| 40501-9 | Candida sp Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/40501-9.json |
| 40502-7 | Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40502-7.json |
| 40503-5 | Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40503-5.json |
| 40504-3 | Powassan virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40504-3.json |
| 40505-0 | Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40505-0.json |
| 40506-8 | Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40506-8.json |
| 40507-6 | Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40507-6.json |
| 40508-4 | Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/40508-4.json |
| 40509-2 | Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/40509-2.json |
| 40510-0 | Snowshoe hare virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40510-0.json |
| 40511-8 | Snowshoe hare virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40511-8.json |
| 40512-6 | Semliki Forest virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40512-6.json |
| 40513-4 | Powassan virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40513-4.json |
| 40514-2 | Saint Louis encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40514-2.json |
| 40515-9 | Dengue virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40515-9.json |
| 4052-7 | Thioridazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4052-7.json |
| 40527-4 | Cocaine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/40527-4.json |
| 40528-2 | Opiates [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40528-2.json |
| 40529-0 | Amphetamines [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40529-0.json |
| 40530-8 | Ethanol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40530-8.json |
| 40531-6 | Methylenedioxyamphetamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40531-6.json |
| 40532-4 | Methanol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40532-4.json |
| 4053-5 | Thioridazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4053-5.json |
| 40542-3 | Rubella virus Ab [Titer] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/40542-3.json |
| 4054-3 | Ticarcillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4054-3.json |
| 40545-6 | Hemoglobin C [Presence] in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/40545-6.json |
| 40546-4 | Hemoglobin E [Presence] in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/40546-4.json |
| 40547-2 | Hemoglobin H [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/40547-2.json |
| 40549-8 | Hemoglobin F [Mass/volume] in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/40549-8.json |
| 40550-6 | Hemoglobin H [Mass/volume] in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/40550-6.json |
| 40551-4 | CD10 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40551-4.json |
| 40552-2 | CD117 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40552-2.json |
| 40553-0 | CD19 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40553-0.json |
| 40554-8 | CD45 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40554-8.json |
| 40555-5 | CD66e Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40555-5.json |
| 40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40556-3.json |
| 40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40557-1.json |
| 40558-9 | Cytokeratin 20 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40558-9.json |
| 40559-7 | Cytokeratin 7 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40559-7.json |
| 40560-5 | Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40560-5.json |
| 40561-3 | Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40561-3.json |
| 40562-1 | Actin muscle specific Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40562-1.json |
| 40563-9 | Actin smooth muscle Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40563-9.json |
| 40564-7 | Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/40564-7.json |
| 4056-8 | Timolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4056-8.json |
| 40569-6 | Eosinophils [#/volume] in Body fluid by Manual count | ./2.16.840.1.114222.4.11.1002/40569-6.json |
| 40573-8 | Variant lymphocytes [#/volume] in Body fluid by Manual count | ./2.16.840.1.114222.4.11.1002/40573-8.json |
| 40574-6 | Platelets [#/volume] in Body fluid by Automated count | ./2.16.840.1.114222.4.11.1002/40574-6.json |
| 40575-3 | Yersinia enterocolitica O:5,27 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40575-3.json |
| 4057-6 | Tobramycin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/4057-6.json |
| 40576-1 | Yersinia enterocolitica O:8 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40576-1.json |
| 40577-9 | Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40577-9.json |
| 40578-7 | Cryoglobulin.IgM [Mass/volume] in Serum by Cold incubation | ./2.16.840.1.114222.4.11.1002/40578-7.json |
| 40579-5 | Cryoglobulin.IgG [Mass/volume] in Serum by Cold incubation | ./2.16.840.1.114222.4.11.1002/40579-5.json |
| 40580-3 | Cryoglobulin.IgA [Mass/volume] in Serum by Cold incubation | ./2.16.840.1.114222.4.11.1002/40580-3.json |
| 40581-1 | Cryoglobulin.IgM [Mass/volume] in Serum by 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/40581-1.json |
| 40582-9 | Cryoglobulin.IgG [Mass/volume] in Serum by 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/40582-9.json |
| 40583-7 | Invasive trophoblast Ag [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40583-7.json |
| 4058-4 | Tobramycin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/4058-4.json |
| 40584-5 | Arbovirus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40584-5.json |
| 40585-2 | Drugs identified in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/40585-2.json |
| 4059-2 | Tobramycin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/4059-2.json |
| 40595-1 | Prothrombin IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40595-1.json |
| 40596-9 | Prothrombin IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40596-9.json |
| 40597-7 | 7-Dehydrocholesterol [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/40597-7.json |
| 40598-5 | Acetone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40598-5.json |
| 40599-3 | Albumin [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/40599-3.json |
| 4060-0 | Tocainide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4060-0.json |
| 40600-9 | Alpha-1-acid glycoprotein [Presence] in Urine by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40600-9.json |
| 40601-7 | Alpha-1-acid glycoprotein [Presence] in Serum or Plasma by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40601-7.json |
| 40602-5 | Alpha 1 antitrypsin [Presence] in Urine by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40602-5.json |
| 40603-3 | Alpha 1 antitrypsin [Presence] in Serum or Plasma by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40603-3.json |
| 40604-1 | Alpha-2-Macroglobulin [Presence] in Urine by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40604-1.json |
| 40605-8 | Alpha-2-Macroglobulin [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/40605-8.json |
| 40607-4 | Ascaris lumbricoides IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40607-4.json |
| 40608-2 | Ascaris lumbricoides IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40608-2.json |
| 40609-0 | Benzoylecgonine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40609-0.json |
| 40610-8 | Beta-2 transferrin [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40610-8.json |
| 40612-4 | Borrelia burgdorferi IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/40612-4.json |
| 40613-2 | Brucella sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40613-2.json |
| 40614-0 | Brucella sp Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40614-0.json |
| 40616-5 | Campylobacter sp IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40616-5.json |
| 40617-3 | Campylobacter sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40617-3.json |
| 4061-8 | TOLBUTamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4061-8.json |
| 40618-1 | Cancer Ag 125 [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/40618-1.json |
| 40621-5 | Carcinoembryonic Ag [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/40621-5.json |
| 40622-3 | Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/40622-3.json |
| 40625-6 | Cocaine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40625-6.json |
| 4062-6 | Tranylcypromine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4062-6.json |
| 40626-4 | Codeine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40626-4.json |
| 40628-0 | Cryoglobulin.IgA [Mass/volume] in Serum by 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/40628-0.json |
| 40629-8 | Doxepin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/40629-8.json |
| 40633-0 | Hemopexin [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40633-0.json |
| 4063-4 | traZODone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4063-4.json |
| 40634-8 | HYDROcodone [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/40634-8.json |
| 40641-3 | Ketones [Presence] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/40641-3.json |
| 4064-2 | traZODone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4064-2.json |
| 40643-9 | Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40643-9.json |
| 40644-7 | Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40644-7.json |
| 40645-4 | Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/40645-4.json |
| 40647-0 | Lupus anticoagulant neutralization platelet [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/40647-0.json |
| 40648-8 | Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40648-8.json |
| 40649-6 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40649-6.json |
| 40652-0 | Methamphetamine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40652-0.json |
| 40655-3 | Nuclear Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40655-3.json |
| 40656-1 | Parasite identified in Blood by Thick film | ./2.16.840.1.114222.4.11.1002/40656-1.json |
| 40657-9 | Parvovirus B19 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40657-9.json |
| 40658-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40658-7.json |
| 4065-9 | traZODone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4065-9.json |
| 40659-5 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40659-5.json |
| 40665-2 | Reticulocytes [#/volume] in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/40665-2.json |
| 40666-0 | Rubella virus Ab [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/40666-0.json |
| 4066-7 | Triamterene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4066-7.json |
| 40667-8 | Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/40667-8.json |
| 40668-6 | Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40668-6.json |
| 40669-4 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40669-4.json |
| 40672-8 | Sucrose [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/40672-8.json |
| 40673-6 | Thyrotropin binding inhibitory immunoglobulins [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40673-6.json |
| 40674-4 | Toxocara canis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40674-4.json |
| 4067-5 | Triamterene [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4067-5.json |
| 40675-1 | Toxocara canis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40675-1.json |
| 40677-7 | Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40677-7.json |
| 40678-5 | Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/40678-5.json |
| 40679-3 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/40679-3.json |
| 40680-1 | Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/40680-1.json |
| 4068-3 | Triamterene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4068-3.json |
| 40684-3 | Acinetobacter sp multidrug resistant identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/40684-3.json |
| 40686-8 | Platelet factor 3 [Units/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/40686-8.json |
| 40690-0 | Tumor Ag 90 [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40690-0.json |
| 4069-1 | Triazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4069-1.json |
| 40693-4 | RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40693-4.json |
| 40694-2 | Sulfamethoxazole IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40694-2.json |
| 40698-3 | Mycoplasma sp identified in Specimen | ./2.16.840.1.114222.4.11.1002/40698-3.json |
| 40699-1 | Mycobacterium sp identified in Specimen | ./2.16.840.1.114222.4.11.1002/40699-1.json |
| 40700-7 | Aromatic solvents [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40700-7.json |
| 40701-5 | Arsenic [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/40701-5.json |
| 40702-3 | Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination | ./2.16.840.1.114222.4.11.1002/40702-3.json |
| 40703-1 | Lactoferrin [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/40703-1.json |
| 40704-9 | Maternal cell contamination [Identifier] in Blood Nominal | ./2.16.840.1.114222.4.11.1002/40704-9.json |
| 40705-6 | Brodifacoum [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/40705-6.json |
| 40706-4 | Colchicine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/40706-4.json |
| 40707-2 | Amphotericin B [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/40707-2.json |
| 40708-0 | Polio virus IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/40708-0.json |
| 4070-9 | Triazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4070-9.json |
| 40709-8 | Polio virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40709-8.json |
| 40710-6 | Chlamydia trachomatis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40710-6.json |
| 40711-4 | Clostridium tetani Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40711-4.json |
| 40712-2 | Coccidioides immitis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40712-2.json |
| 40713-0 | Giardia lamblia IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40713-0.json |
| 40714-8 | Giardia lamblia IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40714-8.json |
| 4071-7 | Chloral hydrate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4071-7.json |
| 40717-1 | Haptoglobin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40717-1.json |
| 40719-7 | Hemoglobin [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/40719-7.json |
| 40720-5 | Hemoglobin C [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/40720-5.json |
| 40721-3 | Hemoglobin F [Presence] in Specimen by Apt-Downey method | ./2.16.840.1.114222.4.11.1002/40721-3.json |
| 40722-1 | Hemosiderin [Presence] in Sputum | ./2.16.840.1.114222.4.11.1002/40722-1.json |
| 40723-9 | Heparin Ab [Presence] in Platelet poor plasma by Platelet aggregation | ./2.16.840.1.114222.4.11.1002/40723-9.json |
| 40724-7 | Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40724-7.json |
| 4072-5 | Chloral hydrate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4072-5.json |
| 40725-4 | Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40725-4.json |
| 40726-2 | Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/40726-2.json |
| 40727-0 | Hepatitis D virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40727-0.json |
| 40728-8 | Herpes simplex virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40728-8.json |
| 40729-6 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40729-6.json |
| 40730-4 | Herpes virus 6 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40730-4.json |
| 40731-2 | Herpes virus 6 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40731-2.json |
| 40732-0 | HIV 1 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/40732-0.json |
| 4073-3 | Tricyclic antidepressants [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4073-3.json |
| 40733-8 | HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/40733-8.json |
| 40734-6 | HLA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40734-6.json |
| 40735-3 | HTLV I+II IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/40735-3.json |
| 40736-1 | La Crosse virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40736-1.json |
| 40737-9 | Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40737-9.json |
| 40738-7 | Mumps virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/40738-7.json |
| 4074-1 | Trifluoperazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4074-1.json |
| 40742-9 | Rabies virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40742-9.json |
| 40744-5 | Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/40744-5.json |
| 40745-2 | Filaria identified in Blood | ./2.16.840.1.114222.4.11.1002/40745-2.json |
| 40747-8 | Complement C2 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40747-8.json |
| 40748-6 | Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/40748-6.json |
| 40749-4 | Echinococcus sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40749-4.json |
| 40750-2 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40750-2.json |
| 40751-0 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40751-0.json |
| 40752-8 | Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40752-8.json |
| 40753-6 | Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40753-6.json |
| 40754-4 | 17-Hydroxyprogesterone [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/40754-4.json |
| 40755-1 | Amiodarone [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/40755-1.json |
| 40756-9 | Amiodarone [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/40756-9.json |
| 40757-7 | Amphotericin B [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/40757-7.json |
| 4075-8 | Trimeperidine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4075-8.json |
| 40758-5 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40758-5.json |
| 40759-3 | Coxsackievirus A IgM Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40759-3.json |
| 40760-1 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid --2nd specimen | ./2.16.840.1.114222.4.11.1002/40760-1.json |
| 40761-9 | Coxsackievirus A Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/40761-9.json |
| 40762-7 | Coxsackievirus A Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40762-7.json |
| 40763-5 | Coxsackievirus B IgM Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40763-5.json |
| 40764-3 | Coxsackievirus B IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/40764-3.json |
| 40765-0 | Coxsackievirus B Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40765-0.json |
| 4076-6 | Trimeperidine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4076-6.json |
| 40766-8 | Coxsackievirus B IgM Ab [Titer] in Cerebral spinal fluid --1st specimen | ./2.16.840.1.114222.4.11.1002/40766-8.json |
| 40767-6 | Coxsackievirus B IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen | ./2.16.840.1.114222.4.11.1002/40767-6.json |
| 40768-4 | Cryptococcus sp Ag [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40768-4.json |
| 40769-2 | Ethosuximide [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/40769-2.json |
| 40770-0 | Ethosuximide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/40770-0.json |
| 40771-8 | Haemophilus influenzae Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40771-8.json |
| 40772-6 | Heavy metals [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40772-6.json |
| 40773-4 | Histoplasma capsulatum IgM Ab [Titer] in Cerebral spinal fluid --1st specimen | ./2.16.840.1.114222.4.11.1002/40773-4.json |
| 4077-4 | Trimeperidine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/4077-4.json |
| 40774-2 | Histoplasma capsulatum IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen | ./2.16.840.1.114222.4.11.1002/40774-2.json |
| 40775-9 | Histoplasma capsulatum IgM Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40775-9.json |
| 40776-7 | Histoplasma capsulatum Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40776-7.json |
| 40778-3 | Histoplasma capsulatum IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/40778-3.json |
| 40779-1 | Mexiletine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/40779-1.json |
| 40780-9 | Mexiletine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/40780-9.json |
| 40781-7 | Polio virus IgM Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40781-7.json |
| 4078-2 | Trimethadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4078-2.json |
| 40782-5 | Polio virus IgM Ab [Titer] in Cerebral spinal fluid --1st specimen | ./2.16.840.1.114222.4.11.1002/40782-5.json |
| 40783-3 | Polio virus IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen | ./2.16.840.1.114222.4.11.1002/40783-3.json |
| 40784-1 | Streptococcus agalactiae Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/40784-1.json |
| 40785-8 | Toxoplasma gondii IgM Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/40785-8.json |
| 40786-6 | Toxoplasma gondii IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/40786-6.json |
| 40788-2 | Japanese cypress IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40788-2.json |
| 40789-0 | Japanese hop IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40789-0.json |
| 4079-0 | Trimethoprim [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4079-0.json |
| 40790-8 | Oil palm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40790-8.json |
| 40794-0 | Alkaline phosphatase.intestinal [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40794-0.json |
| 40797-3 | Alkaline phosphatase.bone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40797-3.json |
| 40798-1 | Amphetamines [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/40798-1.json |
| 40799-9 | Amphetamines [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40799-9.json |
| 40800-5 | Cannabinoids [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/40800-5.json |
| 40801-3 | Cannabinoids [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40801-3.json |
| 40802-1 | Cocaine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40802-1.json |
| 40803-9 | Methamphetamine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/40803-9.json |
| 40804-7 | Methamphetamine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40804-7.json |
| 40805-4 | Opiates [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/40805-4.json |
| 40806-2 | Opiates [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40806-2.json |
| 40807-0 | Phencyclidine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/40807-0.json |
| 4080-8 | Trimethoprim [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4080-8.json |
| 40808-8 | Phencyclidine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/40808-8.json |
| 40810-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/40810-4.json |
| 40811-2 | 11-Deoxycorticosterone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40811-2.json |
| 40812-0 | 11-Hydroxyandrosterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40812-0.json |
| 40813-8 | 11-Hydroxyetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40813-8.json |
| 40814-6 | 11-Ketoandrosterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40814-6.json |
| 40815-3 | 11-Ketoetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40815-3.json |
| 40817-9 | Tetrachlorodiphenylethane [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40817-9.json |
| 40818-7 | 11-Deoxycorticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40818-7.json |
| 40820-3 | Helicobacter pylori IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40820-3.json |
| 40821-1 | Helicobacter pylori IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40821-1.json |
| 40822-9 | HTLV I Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40822-9.json |
| 40823-7 | HTLV II Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40823-7.json |
| 4082-4 | Trimipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4082-4.json |
| 40824-5 | von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/40824-5.json |
| 40825-2 | Candida sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40825-2.json |
| 40827-8 | Histoplasma capsulatum Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/40827-8.json |
| 40828-6 | Aspergillus fumigatus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/40828-6.json |
| 40830-2 | Toxocara sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40830-2.json |
| 40831-0 | Adenovirus+Rotavirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/40831-0.json |
| 4083-2 | Trimipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4083-2.json |
| 40832-8 | Pistachio IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40832-8.json |
| 40834-4 | Herpes virus 8 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40834-4.json |
| 40835-1 | Strawberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40835-1.json |
| 40837-7 | Alternaria sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40837-7.json |
| 40838-5 | Argininosuccinate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40838-5.json |
| 40839-3 | fentaNYL [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/40839-3.json |
| 4084-0 | Trimipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4084-0.json |
| 40840-1 | Legionella pneumophila 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40840-1.json |
| 40841-9 | Tomato IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40841-9.json |
| 40842-7 | Galactose 1 phosphate [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/40842-7.json |
| 40843-5 | Chicken meat IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40843-5.json |
| 40845-0 | Turkey meat IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40845-0.json |
| 40846-8 | Homovanillate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40846-8.json |
| 40847-6 | Brome IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40847-6.json |
| 40851-8 | Normetanephrine Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40851-8.json |
| 40852-6 | Leishmania sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40852-6.json |
| 40853-4 | Leishmania sp IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40853-4.json |
| 40854-2 | Chlamydia trachomatis L2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40854-2.json |
| 40855-9 | Chlamydia trachomatis L2 IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40855-9.json |
| 40856-7 | Chlamydia trachomatis L2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40856-7.json |
| 4085-7 | Tripelennamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4085-7.json |
| 40860-9 | Cytokines [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40860-9.json |
| 40862-5 | Methylparaben IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40862-5.json |
| 40863-3 | Norovirus genogroup I Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/40863-3.json |
| 4086-5 | Valproate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4086-5.json |
| 40865-8 | 11-Oxo-Androsterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40865-8.json |
| 40866-6 | 11-Oxo-Androsterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40866-6.json |
| 40867-4 | 11-Oxo-Etiocholanolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40867-4.json |
| 40868-2 | 11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40868-2.json |
| 40869-0 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40869-0.json |
| 40870-8 | Cystine Free [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40870-8.json |
| 40871-6 | CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40871-6.json |
| 40872-4 | CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40872-4.json |
| 4087-3 | Valproate Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4087-3.json |
| 40873-2 | CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40873-2.json |
| 40876-5 | AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40876-5.json |
| 40877-3 | CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40877-3.json |
| 40878-1 | CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40878-1.json |
| 40879-9 | Chicken IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40879-9.json |
| 4088-1 | Valproate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/4088-1.json |
| 40891-4 | CD3-CD57+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/40891-4.json |
| 40895-5 | CD3+CD56+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/40895-5.json |
| 40896-3 | CD3+CD56+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/40896-3.json |
| 40897-1 | CD3+CD56+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/40897-1.json |
| 40898-9 | CD3+CD4+ (T4 helper) cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/40898-9.json |
| 4089-9 | Vancomycin Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4089-9.json |
| 40899-7 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/40899-7.json |
| 40901-1 | 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/40901-1.json |
| 40905-2 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40905-2.json |
| 40906-0 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/40906-0.json |
| 4090-7 | Vancomycin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/4090-7.json |
| 40907-8 | Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/40907-8.json |
| 40911-0 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40911-0.json |
| 40912-8 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/40912-8.json |
| 40913-6 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40913-6.json |
| 40914-4 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/40914-4.json |
| 4091-5 | Vancomycin [Mass/volume] in Serum or Plasma --random | ./2.16.840.1.114222.4.11.1002/4091-5.json |
| 40915-1 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40915-1.json |
| 40916-9 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/40916-9.json |
| 40917-7 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/40917-7.json |
| 40918-5 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/40918-5.json |
| 40919-3 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/40919-3.json |
| 4092-3 | Vancomycin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/4092-3.json |
| 40926-8 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40926-8.json |
| 40930-0 | PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40930-0.json |
| 4093-1 | Verapamil [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4093-1.json |
| 40931-8 | Yersinia sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40931-8.json |
| 40932-6 | Yersinia enterocolitica O:3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40932-6.json |
| 40933-4 | Yersinia enterocolitica O:5 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40933-4.json |
| 40934-2 | Yersinia enterocolitica O:8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40934-2.json |
| 40935-9 | Yersinia enterocolitica O:9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40935-9.json |
| 40936-7 | Yersinia pseudotuberculosis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40936-7.json |
| 40937-5 | Zinc [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40937-5.json |
| 40938-3 | Yersinia sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40938-3.json |
| 40939-1 | Yersinia sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40939-1.json |
| 40940-9 | Yersinia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/40940-9.json |
| 40941-7 | Yersinia enterocolitica Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40941-7.json |
| 40942-5 | Yersinia sp IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40942-5.json |
| 40943-3 | Yellow Jacket IgE Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40943-3.json |
| 40944-1 | Yohimbine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/40944-1.json |
| 40945-8 | Yersinia enterocolitica IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40945-8.json |
| 40946-6 | Yersinia enterocolitica IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40946-6.json |
| 40947-4 | Zinc [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/40947-4.json |
| 40948-2 | Yersinia enterocolitica O:3 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40948-2.json |
| 4094-9 | Verapamil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4094-9.json |
| 40949-0 | Yersinia enterocolitica O:5 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40949-0.json |
| 40950-8 | Yersinia enterocolitica O:8 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40950-8.json |
| 40951-6 | Yersinia enterocolitica O:9 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/40951-6.json |
| 40952-4 | Yellow Jacket IgG4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/40952-4.json |
| 40953-2 | Yersinia enterocolitica O:3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40953-2.json |
| 40954-0 | Yersinia enterocolitica O:8 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40954-0.json |
| 40955-7 | Yersinia enterocolitica O:9 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40955-7.json |
| 4095-6 | Verapamil [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4095-6.json |
| 40956-5 | Yersinia sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/40956-5.json |
| 40957-3 | Zinc [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/40957-3.json |
| 40958-1 | Cryptosporidium parvum identified in Stool | ./2.16.840.1.114222.4.11.1002/40958-1.json |
| 40959-9 | MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40959-9.json |
| 40960-7 | Parietal cell IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40960-7.json |
| 40961-5 | SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40961-5.json |
| 40962-3 | SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/40962-3.json |
| 4096-4 | Volatile drugs negative [Identifier] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/4096-4.json |
| 40969-8 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40969-8.json |
| 40970-6 | VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40970-6.json |
| 40971-4 | XXX microorganism DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40971-4.json |
| 4097-2 | Volatile drugs positive [Identifier] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/4097-2.json |
| 40972-2 | XXX microorganism DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40972-2.json |
| 40973-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40973-0.json |
| 40974-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/40974-8.json |
| 40975-5 | Adenovirus DNA [Identifier] in Specimen by RFLP | ./2.16.840.1.114222.4.11.1002/40975-5.json |
| 40976-3 | Adenovirus DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40976-3.json |
| 40977-1 | Adenovirus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40977-1.json |
| 40978-9 | Human metapneumovirus RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40978-9.json |
| 40979-7 | Human metapneumovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40979-7.json |
| 4098-0 | Warfarin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4098-0.json |
| 40980-5 | Human metapneumovirus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40980-5.json |
| 40982-1 | Influenza virus B RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40982-1.json |
| 40983-9 | Parainfluenza virus 1 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40983-9.json |
| 40984-7 | Parainfluenza virus 2 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40984-7.json |
| 40985-4 | Parainfluenza virus 3 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40985-4.json |
| 40986-2 | Parainfluenza virus 4 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40986-2.json |
| 40987-0 | Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40987-0.json |
| 40988-8 | Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40988-8.json |
| 40989-6 | Respiratory syncytial virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/40989-6.json |
| 40990-4 | Rhinovirus RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40990-4.json |
| 40991-2 | Rhinovirus+Enterovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/40991-2.json |
| 40992-0 | Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/40992-0.json |
| 40993-8 | Rhinovirus Ag [Identifier] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/40993-8.json |
| 40994-6 | CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40994-6.json |
| 40995-3 | Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/40995-3.json |
| 40996-1 | Alternaria alternata IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40996-1.json |
| 40997-9 | Honey bee IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/40997-9.json |
| 4099-8 | Zimelidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4099-8.json |
| 40999-5 | Calcium hydrogen phosphate dihydrate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/40999-5.json |
| 41000-1 | Human coronavirus RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41000-1.json |
| 41001-9 | Human coronavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41001-9.json |
| 41002-7 | Human coronavirus 229E IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41002-7.json |
| 41003-5 | Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41003-5.json |
| 41004-3 | Human coronavirus 229E Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41004-3.json |
| 41005-0 | Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41005-0.json |
| 41006-8 | Human coronavirus NL63 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41006-8.json |
| 41007-6 | Human coronavirus OC43 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41007-6.json |
| 41008-4 | Human coronavirus OC43 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41008-4.json |
| 41009-2 | Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41009-2.json |
| 41010-0 | Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41010-0.json |
| 41011-8 | Human metapneumovirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41011-8.json |
| 41012-6 | Respiratory syncytial virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41012-6.json |
| 41013-4 | Human coronavirus 229E IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41013-4.json |
| 41014-2 | Human coronavirus NL63 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41014-2.json |
| 41015-9 | Human coronavirus OC43 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41015-9.json |
| 41016-7 | Bilirubin.total [Moles/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/41016-7.json |
| 41017-5 | Protoporphyrin [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/41017-5.json |
| 41018-3 | Testosterone.free+weakly bound [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41018-3.json |
| 41019-1 | Beta endorphin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41019-1.json |
| 41020-9 | Flunitrazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/41020-9.json |
| 41021-7 | Cocaine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/41021-7.json |
| 41022-5 | Citrate [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/41022-5.json |
| 41023-3 | Aldosterone [Molar amount] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/41023-3.json |
| 41025-8 | Ribonucleoprotein extractable nuclear Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41025-8.json |
| 41026-6 | Fungus identified in Genital specimen by Culture | ./2.16.840.1.114222.4.11.1002/41026-6.json |
| 41027-4 | Tau protein/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41027-4.json |
| 41028-2 | Listeria monocytogenes O1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41028-2.json |
| 41029-0 | Listeria monocytogenes H1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41029-0.json |
| 41030-8 | Listeria monocytogenes O4b Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41030-8.json |
| 41032-4 | Uroporphyrin [Mass/time] in unspecified time Stool | ./2.16.840.1.114222.4.11.1002/41032-4.json |
| 41033-2 | Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41033-2.json |
| 41034-0 | Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41034-0.json |
| 41035-7 | Norovirus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/41035-7.json |
| 41036-5 | Cocaine [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/41036-5.json |
| 41037-3 | Cocaine [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/41037-3.json |
| 41038-1 | Codeine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/41038-1.json |
| 41039-9 | 3-Methylcrotonylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41039-9.json |
| 41040-7 | Palmitoylcarnitine (C16) [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/41040-7.json |
| 41041-5 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/41041-5.json |
| 41042-3 | WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41042-3.json |
| 41043-1 | VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41043-1.json |
| 41044-9 | UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41044-9.json |
| 41045-6 | TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41045-6.json |
| 41046-4 | TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41046-4.json |
| 41047-2 | TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41047-2.json |
| 41048-0 | TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41048-0.json |
| 41049-8 | TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41049-8.json |
| 41050-6 | TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41050-6.json |
| 41051-4 | SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41051-4.json |
| 41052-2 | SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41052-2.json |
| 41053-0 | SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41053-0.json |
| 41055-5 | SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41055-5.json |
| 41056-3 | SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41056-3.json |
| 41058-9 | SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41058-9.json |
| 41059-7 | SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41059-7.json |
| 41060-5 | SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41060-5.json |
| 41061-3 | SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41061-3.json |
| 41062-1 | SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41062-1.json |
| 41063-9 | RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41063-9.json |
| 41064-7 | PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41064-7.json |
| 41065-4 | PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41065-4.json |
| 41066-2 | PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41066-2.json |
| 41067-0 | PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41067-0.json |
| 41068-8 | PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41068-8.json |
| 41069-6 | PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41069-6.json |
| 41070-4 | Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41070-4.json |
| 41071-2 | PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41071-2.json |
| 41072-0 | PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41072-0.json |
| 41073-8 | NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41073-8.json |
| 41074-6 | NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41074-6.json |
| 41075-3 | NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41075-3.json |
| 41076-1 | NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41076-1.json |
| 41077-9 | NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41077-9.json |
| 41078-7 | NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41078-7.json |
| 41079-5 | NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41079-5.json |
| 41080-3 | Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41080-3.json |
| 41081-1 | MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41081-1.json |
| 41082-9 | MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41082-9.json |
| 41083-7 | MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41083-7.json |
| 41084-5 | MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41084-5.json |
| 41085-2 | MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41085-2.json |
| 41086-0 | MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41086-0.json |
| 41087-8 | Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41087-8.json |
| 41088-6 | MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41088-6.json |
| 41089-4 | MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41089-4.json |
| 41090-2 | MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41090-2.json |
| 41091-0 | MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41091-0.json |
| 41092-8 | MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41092-8.json |
| 41093-6 | LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41093-6.json |
| 41094-4 | LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41094-4.json |
| 41095-1 | L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41095-1.json |
| 41096-9 | KEL gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41096-9.json |
| 41097-7 | HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41097-7.json |
| 41098-5 | GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41098-5.json |
| 41099-3 | GLA gene mutations found [Identifier] in Blood or Tissue by Moleculargenetics method Nominal | ./2.16.840.1.114222.4.11.1002/41099-3.json |
| 41100-9 | GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41100-9.json |
| 41101-7 | GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41101-7.json |
| 41102-5 | GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41102-5.json |
| 41103-3 | Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41103-3.json |
| 41104-1 | GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41104-1.json |
| 41105-8 | FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41105-8.json |
| 41106-6 | FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41106-6.json |
| 41107-4 | FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41107-4.json |
| 41108-2 | FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41108-2.json |
| 41109-0 | FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41109-0.json |
| 41110-8 | CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41110-8.json |
| 41111-6 | COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41111-6.json |
| 41112-4 | CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41112-4.json |
| 41113-2 | Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41113-2.json |
| 41114-0 | CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41114-0.json |
| 41115-7 | NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41115-7.json |
| 41116-5 | ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41116-5.json |
| 41117-3 | AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41117-3.json |
| 41118-1 | AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41118-1.json |
| 41119-9 | APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41119-9.json |
| 41120-7 | ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41120-7.json |
| 41121-5 | ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41121-5.json |
| 41122-3 | Treponema pallidum Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/41122-3.json |
| 41123-1 | Toxoplasma gondii HS Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41123-1.json |
| 41124-9 | Toxoplasma gondii AC Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41124-9.json |
| 41125-6 | Strongyloides sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41125-6.json |
| 41127-2 | Salmonella gallinarum Ab [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/41127-2.json |
| 41128-0 | Rabies virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41128-0.json |
| 41129-8 | Parvovirus B19 IgM Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/41129-8.json |
| 41130-6 | Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41130-6.json |
| 41131-4 | Mumps virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41131-4.json |
| 41132-2 | Measles virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41132-2.json |
| 41133-0 | Jamestown canyon virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41133-0.json |
| 41134-8 | Influenza virus A N9 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41134-8.json |
| 41135-5 | Influenza virus A N8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41135-5.json |
| 41136-3 | Influenza virus A N7 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41136-3.json |
| 41137-1 | Influenza virus A N6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41137-1.json |
| 41138-9 | Influenza virus A N5 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41138-9.json |
| 41139-7 | Influenza virus A N4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41139-7.json |
| 41140-5 | Influenza virus A N3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41140-5.json |
| 41141-3 | Influenza virus A N2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41141-3.json |
| 41142-1 | Influenza virus A N1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41142-1.json |
| 41143-9 | HIV 1 Ab [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/41143-9.json |
| 41144-7 | HIV 1 Ab [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/41144-7.json |
| 41145-4 | HIV 1 Ab [Presence] in Capillary blood | ./2.16.840.1.114222.4.11.1002/41145-4.json |
| 41146-2 | Herpes virus 8 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41146-2.json |
| 41147-0 | Herpes virus 6 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41147-0.json |
| 41148-8 | Herpes virus 6 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41148-8.json |
| 41149-6 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41149-6.json |
| 41150-4 | Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41150-4.json |
| 41151-2 | Hepatitis B virus e IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41151-2.json |
| 41152-0 | Haemophilus paragallinarum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41152-0.json |
| 41153-8 | Giardia lamblia IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41153-8.json |
| 41154-6 | Giardia lamblia IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41154-6.json |
| 41155-3 | Cytomegalovirus IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/41155-3.json |
| 41156-1 | Coccidioides sp IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41156-1.json |
| 41157-9 | Chlamydia trachomatis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41157-9.json |
| 41158-7 | Canine herpesvirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41158-7.json |
| 41159-5 | Campylobacter sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41159-5.json |
| 41160-3 | Ascaris lumbricoides IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41160-3.json |
| 41161-1 | Ascaris lumbricoides IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41161-1.json |
| 41162-9 | Adenovirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41162-9.json |
| 41163-7 | Treponema pallidum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41163-7.json |
| 41164-5 | Uranium depleted [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/41164-5.json |
| 41165-2 | Uranium 235/Uranium 238 [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41165-2.json |
| 41166-0 | Uranium depleted/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41166-0.json |
| 41167-8 | Listeria monocytogenes H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41167-8.json |
| 41168-6 | Arginine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/41168-6.json |
| 41169-4 | Valine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/41169-4.json |
| 41170-2 | Phenylalanine+Tyrosine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/41170-2.json |
| 41171-0 | Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41171-0.json |
| 41175-1 | Western equine encephalitis virus Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/41175-1.json |
| 41183-5 | Western equine encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/41183-5.json |
| 41184-3 | Warfarin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41184-3.json |
| 41192-6 | Yellow Hornet IgG4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41192-6.json |
| 41193-4 | Whitefaced Hornet IgG4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41193-4.json |
| 41194-2 | West Nile virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41194-2.json |
| 41195-9 | West Nile virus IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/41195-9.json |
| 41196-7 | West Nile virus IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/41196-7.json |
| 41198-3 | Walnut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41198-3.json |
| 41201-5 | Voltage-gated calcium channel IgG Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41201-5.json |
| 41202-3 | Baker's yeast IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41202-3.json |
| 41203-1 | Yellow Jacket IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41203-1.json |
| 41204-9 | Paper wasp IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41204-9.json |
| 41205-6 | Watermelon IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41205-6.json |
| 41206-4 | West Nile virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41206-4.json |
| 41207-2 | Wheat IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41207-2.json |
| 41209-8 | VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41209-8.json |
| 41210-6 | VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41210-6.json |
| 41211-4 | West Nile virus IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41211-4.json |
| 41212-2 | West Nile virus RNA [Presence] in Serum from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41212-2.json |
| 41213-0 | Xanthan gum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41213-0.json |
| 41214-8 | Volatiles and gases [Identifier] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/41214-8.json |
| 41216-3 | Yellow fever virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41216-3.json |
| 41217-1 | Yellow fever virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41217-1.json |
| 41218-9 | Xipamid [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/41218-9.json |
| 41219-7 | Paper wasp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41219-7.json |
| 41220-5 | Xanthurenate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41220-5.json |
| 41221-3 | Xanthurenate+Kynurenate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41221-3.json |
| 41224-7 | West Nile virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41224-7.json |
| 41225-4 | West Nile virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41225-4.json |
| 41227-0 | Xanthine [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41227-0.json |
| 41228-8 | Xanthine [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41228-8.json |
| 41229-6 | Yellow Jacket IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41229-6.json |
| 41230-4 | Xanthine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41230-4.json |
| 41231-2 | Xanthurenate+Kynurenate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41231-2.json |
| 41232-0 | West Nile virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41232-0.json |
| 41235-3 | Paper wasp IgE Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41235-3.json |
| 41236-1 | West Nile virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41236-1.json |
| 41239-5 | Yellow fever virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41239-5.json |
| 41240-3 | Xanthurenate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41240-3.json |
| 41244-5 | Western equine encephalitis virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41244-5.json |
| 41246-0 | Yellow fever virus Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/41246-0.json |
| 41247-8 | Yellow fever virus Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/41247-8.json |
| 41248-6 | Xanthurenate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/41248-6.json |
| 41249-4 | Yellow fever virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41249-4.json |
| 41259-3 | Western equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41259-3.json |
| 41260-1 | Western equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/41260-1.json |
| 41261-9 | Voltage-gated calcium channel IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/41261-9.json |
| 41266-8 | Volatiles and gases [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/41266-8.json |
| 41268-4 | VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41268-4.json |
| 41269-2 | Beta hydroxybutyrate + Gamma aminobutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41269-2.json |
| 41270-0 | Drugs identified in Urine | ./2.16.840.1.114222.4.11.1002/41270-0.json |
| 41271-8 | Dermatophagoides sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41271-8.json |
| 41285-8 | Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41285-8.json |
| 41286-6 | Uranium 235/Uranium 238 [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41286-6.json |
| 41288-2 | Whole Egg IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/41288-2.json |
| 41290-8 | HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/41290-8.json |
| 41292-4 | Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41292-4.json |
| 41295-7 | Shoulder - left Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41295-7.json |
| 41296-5 | Shoulder - left Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41296-5.json |
| 41297-3 | Shoulder - left Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41297-3.json |
| 41298-1 | Shoulder - left Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41298-1.json |
| 41299-9 | Shoulder - left Abduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41299-9.json |
| 41300-5 | Shoulder - left Abduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41300-5.json |
| 41303-9 | Shoulder - left Internal rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41303-9.json |
| 41304-7 | Shoulder - left Internal rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41304-7.json |
| 41305-4 | Shoulder - left External rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41305-4.json |
| 41306-2 | Shoulder - left External rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41306-2.json |
| 41307-0 | Shoulder - right Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41307-0.json |
| 41308-8 | Shoulder - right Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41308-8.json |
| 41309-6 | Shoulder - right Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41309-6.json |
| 41310-4 | Shoulder - right Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41310-4.json |
| 41311-2 | Shoulder - right Abduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41311-2.json |
| 41312-0 | Shoulder - right Abduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41312-0.json |
| 41315-3 | Shoulder - right Internal rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41315-3.json |
| 41316-1 | Shoulder - right Internal rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41316-1.json |
| 41317-9 | Shoulder - right External rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41317-9.json |
| 41318-7 | Shoulder - right External rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41318-7.json |
| 41319-5 | Hip - left Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41319-5.json |
| 41320-3 | Hip - left Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41320-3.json |
| 41321-1 | Hip - left Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41321-1.json |
| 41322-9 | Hip - left Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41322-9.json |
| 41323-7 | Hip - left Abduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41323-7.json |
| 41324-5 | Hip - left Abduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41324-5.json |
| 41325-2 | Hip - left Adduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41325-2.json |
| 41326-0 | Hip - left Adduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41326-0.json |
| 41327-8 | Hip - left Internal rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41327-8.json |
| 41328-6 | Hip - left Internal rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41328-6.json |
| 41329-4 | Hip - left External rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41329-4.json |
| 41330-2 | Hip - left External rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41330-2.json |
| 41331-0 | Hip - right Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41331-0.json |
| 41332-8 | Hip - right Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41332-8.json |
| 41333-6 | Hip - right Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41333-6.json |
| 41334-4 | Hip - right Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41334-4.json |
| 41335-1 | Hip - right Abduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41335-1.json |
| 41336-9 | Hip - right Abduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41336-9.json |
| 41337-7 | Hip - right Adduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41337-7.json |
| 41338-5 | Hip - right Adduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41338-5.json |
| 41339-3 | Hip - right Internal rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41339-3.json |
| 41340-1 | Hip - right Internal rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41340-1.json |
| 41341-9 | Hip - right External rotation Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41341-9.json |
| 41342-7 | Hip - right External rotation Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41342-7.json |
| 41343-5 | Knee - left Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41343-5.json |
| 41344-3 | Knee - left Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41344-3.json |
| 41345-0 | Knee - left Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41345-0.json |
| 41346-8 | Knee - left Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41346-8.json |
| 41347-6 | Knee - right Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41347-6.json |
| 41348-4 | Knee - right Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41348-4.json |
| 41349-2 | Knee - right Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41349-2.json |
| 41350-0 | Knee - right Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41350-0.json |
| 41351-8 | Elbow - left Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41351-8.json |
| 41352-6 | Elbow - left Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41352-6.json |
| 41353-4 | Elbow - left Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41353-4.json |
| 41354-2 | Elbow - left Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41354-2.json |
| 41355-9 | Elbow - right Flexion Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41355-9.json |
| 41356-7 | Elbow - right Flexion Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41356-7.json |
| 41357-5 | Elbow - right Extension Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41357-5.json |
| 41358-3 | Elbow - right Extension Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/41358-3.json |
| 41397-1 | Beta lactoglobulin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41397-1.json |
| 41398-9 | Alloisoleucine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41398-9.json |
| 41399-7 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41399-7.json |
| 41400-3 | Yersinia sp IgA Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41400-3.json |
| 41401-1 | Yersinia sp IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41401-1.json |
| 41404-5 | 17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41404-5.json |
| 41405-2 | Parainfluenza virus 2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41405-2.json |
| 41406-0 | Meropenem [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41406-0.json |
| 41411-0 | Angiostrongylus cantonensis Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/41411-0.json |
| 41412-8 | Angiostrongylus costaricensis Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/41412-8.json |
| 41413-6 | Babesia divergens Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41413-6.json |
| 41414-4 | Babesia microti Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41414-4.json |
| 41415-1 | Babesia duncani Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41415-1.json |
| 41416-9 | Echinococcus sp Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41416-9.json |
| 41417-7 | Filaria Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41417-7.json |
| 41418-5 | Gnathostoma sp Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41418-5.json |
| 41419-3 | Leishmania brasilensis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41419-3.json |
| 41420-1 | Leishmania tropica Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41420-1.json |
| 41421-9 | Paragonimus sp Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41421-9.json |
| 41422-7 | Schistosoma haematobium Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41422-7.json |
| 41423-5 | Schistosoma japonicum Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41423-5.json |
| 41424-3 | Schistosoma mansoni Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/41424-3.json |
| 41425-0 | Toxocara canis Ab [Titer] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/41425-0.json |
| 41426-8 | Trichinella spiralis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41426-8.json |
| 41427-6 | Trypanosoma brucei gambiense Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/41427-6.json |
| 41428-4 | Trypanosoma brucei rhodesiense Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41428-4.json |
| 41429-2 | Acanthamoeba sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41429-2.json |
| 41430-0 | Angiostrongylus cantonensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41430-0.json |
| 41431-8 | Angiostrongylus costaricensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41431-8.json |
| 41432-6 | Balamuthia mandrillaris DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41432-6.json |
| 41433-4 | Cryptosporidium hominis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41433-4.json |
| 41434-2 | Cryptosporidium parvum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41434-2.json |
| 41435-9 | Cyclospora carcopitheci DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41435-9.json |
| 41436-7 | Cyclospora cayetanensis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41436-7.json |
| 41437-5 | Cyclospora colobi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41437-5.json |
| 41438-3 | Cyclospora papionis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41438-3.json |
| 41439-1 | Encephalitozoon cuniculi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41439-1.json |
| 41440-9 | Encephalitozoon hellem DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41440-9.json |
| 41441-7 | Encephalitozoon intestinalis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41441-7.json |
| 41442-5 | Entamoeba dispar DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41442-5.json |
| 41443-3 | Enterocytozoon bieneusi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41443-3.json |
| 41444-1 | Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41444-1.json |
| 41446-6 | Parasite identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/41446-6.json |
| 41447-4 | Plasmodium falciparum DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41447-4.json |
| 41448-2 | Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41448-2.json |
| 41449-0 | Plasmodium ovale DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41449-0.json |
| 41450-8 | Plasmodium vivax DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41450-8.json |
| 41451-6 | Plasmodium stage [Identifier] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/41451-6.json |
| 41453-2 | Human coronavirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41453-2.json |
| 41454-0 | Human coronavirus identified in Specimen | ./2.16.840.1.114222.4.11.1002/41454-0.json |
| 41458-1 | SARS coronavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41458-1.json |
| 41459-9 | SARS coronavirus [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41459-9.json |
| 41460-7 | SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41460-7.json |
| 41461-5 | Virus identified in Specimen | ./2.16.840.1.114222.4.11.1002/41461-5.json |
| 41462-3 | Taenia solium larva Ab [Presence] in Specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/41462-3.json |
| 41463-1 | Wuchereria bancrofti+Brugia malayi Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41463-1.json |
| 41464-9 | Amphetamines/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41464-9.json |
| 41465-6 | Opiates/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41465-6.json |
| 41466-4 | Methadone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41466-4.json |
| 41467-2 | Benzodiazepines/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41467-2.json |
| 41468-0 | Barbiturates/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/41468-0.json |
| 41469-8 | Ribavirin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41469-8.json |
| 41470-6 | Atazanavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41470-6.json |
| 41471-4 | Phenethicillin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41471-4.json |
| 41472-2 | carBAMazepine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/41472-2.json |
| 41473-0 | Carbamazepine 10,11-Epoxide [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/41473-0.json |
| 41474-8 | Diethylcarbamazepine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/41474-8.json |
| 41475-5 | Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41475-5.json |
| 41476-3 | Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41476-3.json |
| 41477-1 | Bacterial sialidase [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41477-1.json |
| 41479-7 | BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41479-7.json |
| 41480-5 | BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41480-5.json |
| 41483-9 | Clostridium tetani toxoid Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41483-9.json |
| 41487-0 | Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/41487-0.json |
| 41488-8 | Cryptosporidium sp [Presence] in Specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/41488-8.json |
| 41489-6 | Echovirus 11 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/41489-6.json |
| 41490-4 | Echovirus 16 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/41490-4.json |
| 41491-2 | Echovirus 30 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/41491-2.json |
| 41492-0 | Echovirus 7 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/41492-0.json |
| 41495-3 | Haemophilus influenzae B Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/41495-3.json |
| 41496-1 | Herpes virus 6 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41496-1.json |
| 41497-9 | HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41497-9.json |
| 41498-7 | HIV 1 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41498-7.json |
| 41499-5 | Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/41499-5.json |
| 41501-8 | Measles virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/41501-8.json |
| 41503-4 | Neisseria meningitidis serogroup B Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/41503-4.json |
| 41507-5 | Rabies virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41507-5.json |
| 41508-3 | Streptococcus agalactiae Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/41508-3.json |
| 41511-7 | Trichomonas vaginalis Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/41511-7.json |
| 41512-5 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41512-5.json |
| 41513-3 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 400 copies/mL | ./2.16.840.1.114222.4.11.1002/41513-3.json |
| 41514-1 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 2.6 log copies/mL | ./2.16.840.1.114222.4.11.1002/41514-1.json |
| 41515-8 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 75 copies/mL | ./2.16.840.1.114222.4.11.1002/41515-8.json |
| 41516-6 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 1.9 log copies/mL | ./2.16.840.1.114222.4.11.1002/41516-6.json |
| 41598-4 | Bacteria [Presence] in Pericardial fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41598-4.json |
| 41599-2 | Bacteria [Presence] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41599-2.json |
| 41600-8 | Bacteria [Presence] in Synovial fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41600-8.json |
| 41601-6 | Bacteria [Presence] in Peritoneal fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41601-6.json |
| 41602-4 | Bacteria [Presence] in Cerebral spinal fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41602-4.json |
| 41603-2 | Bacteria [Presence] in Pleural fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/41603-2.json |
| 41607-3 | Methemoglobin/Hemoglobin.total in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41607-3.json |
| 41615-6 | Xanthurenate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41615-6.json |
| 41616-4 | Platelet Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/41616-4.json |
| 41617-2 | Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/41617-2.json |
| 41618-0 | HLA Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/41618-0.json |
| 41619-8 | Unstable Hemoglobin [Presence] in Red Blood Cells by Isopropanol stability | ./2.16.840.1.114222.4.11.1002/41619-8.json |
| 41621-4 | Arenavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41621-4.json |
| 41622-2 | Bacillus anthracis DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41622-2.json |
| 41623-0 | Bacillus anthracis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41623-0.json |
| 41624-8 | Brucella sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41624-8.json |
| 41625-5 | Brucella sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41625-5.json |
| 41626-3 | Brucella sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41626-3.json |
| 41627-1 | Burkholderia sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41627-1.json |
| 41628-9 | Burkholderia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41628-9.json |
| 41629-7 | Burkholderia sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41629-7.json |
| 41630-5 | Clostridium botulinum toxin A [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41630-5.json |
| 41631-3 | Clostridium botulinum toxin A botA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41631-3.json |
| 41632-1 | Clostridium botulinum toxin B [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41632-1.json |
| 41633-9 | Clostridium botulinum toxin B botB gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41633-9.json |
| 41634-7 | Clostridium botulinum toxin E [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41634-7.json |
| 41635-4 | Clostridium botulinum toxin F [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41635-4.json |
| 41636-2 | Ebola virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41636-2.json |
| 41637-0 | Ebola virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41637-0.json |
| 41638-8 | Marburg virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41638-8.json |
| 41639-6 | Ricin toxin IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41639-6.json |
| 41640-4 | Ricin toxin IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41640-4.json |
| 41641-2 | Ricin toxin [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41641-2.json |
| 41642-0 | West Nile virus IgM Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41642-0.json |
| 41643-8 | West Nile virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41643-8.json |
| 41644-6 | Calcium.ionized [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/41644-6.json |
| 41645-3 | Calcium.ionized [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/41645-3.json |
| 41646-1 | Calcium.ionized [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41646-1.json |
| 41647-9 | Carbon dioxide, total [Moles/volume] in Arterial blood by calculation | ./2.16.840.1.114222.4.11.1002/41647-9.json |
| 41648-7 | Carboxyhemoglobin/Hemoglobin.total in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41648-7.json |
| 41649-5 | Chloride [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/41649-5.json |
| 41650-3 | Chloride [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/41650-3.json |
| 41651-1 | Glucose [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/41651-1.json |
| 41652-9 | Glucose [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/41652-9.json |
| 41653-7 | Glucose [Mass/volume] in Capillary blood by Glucometer | ./2.16.840.1.114222.4.11.1002/41653-7.json |
| 41654-5 | Hematocrit [Volume Fraction] of Venous blood | ./2.16.840.1.114222.4.11.1002/41654-5.json |
| 41655-2 | Hematocrit [Volume Fraction] of Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41655-2.json |
| 41656-0 | Potassium [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41656-0.json |
| 41657-8 | Sodium [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/41657-8.json |
| 41704-8 | Nafcillin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/41704-8.json |
| 41742-8 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/41742-8.json |
| 41743-6 | BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41743-6.json |
| 41744-4 | Beclomethasone dipropionate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41744-4.json |
| 41745-1 | Betamethasone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41745-1.json |
| 41746-9 | Blastomyces dermatitidis Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/41746-9.json |
| 41747-7 | Budesonide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41747-7.json |
| 41748-5 | CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41748-5.json |
| 41749-3 | CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41749-3.json |
| 41750-1 | COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41750-1.json |
| 41751-9 | COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41751-9.json |
| 41752-7 | Ehrlichia chaffeensis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41752-7.json |
| 41753-5 | FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41753-5.json |
| 41754-3 | Fludrocortisone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41754-3.json |
| 41755-0 | Flunisolide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41755-0.json |
| 41756-8 | Fluorometholone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41756-8.json |
| 41757-6 | Fluticasone propionate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41757-6.json |
| 41758-4 | GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41758-4.json |
| 41760-0 | Interleukin 12 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41760-0.json |
| 41761-8 | lamoTRIgine [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/41761-8.json |
| 41762-6 | Megestrol acetate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41762-6.json |
| 41763-4 | Rubella virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/41763-4.json |
| 41764-2 | SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41764-2.json |
| 41765-9 | SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41765-9.json |
| 41766-7 | Triamcinolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41766-7.json |
| 41767-5 | Triamcinolone acetonide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41767-5.json |
| 41768-3 | VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/41768-3.json |
| 41769-1 | Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/41769-1.json |
| 41770-9 | NM Gallbladder Views W cholecystokinin and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/41770-9.json |
| 41771-7 | NM Kidney Views W Tc-99m DMSA IV | ./2.16.840.1.114222.4.11.1002/41771-7.json |
| 41772-5 | SPECT Bone W In-111 tagged WBC IV | ./2.16.840.1.114222.4.11.1002/41772-5.json |
| 41773-3 | Portable XR Facial bones Views | ./2.16.840.1.114222.4.11.1002/41773-3.json |
| 41774-1 | Portable XR Neck Lateral | ./2.16.840.1.114222.4.11.1002/41774-1.json |
| 41775-8 | Portable XR Pelvis Single view | ./2.16.840.1.114222.4.11.1002/41775-8.json |
| 41776-6 | Portable XR Pelvis and Hip - right AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/41776-6.json |
| 41777-4 | Portable XR Hip - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/41777-4.json |
| 41778-2 | Portable XR Femur - right Views | ./2.16.840.1.114222.4.11.1002/41778-2.json |
| 41779-0 | Portable XR Knee - right Views | ./2.16.840.1.114222.4.11.1002/41779-0.json |
| 41782-4 | Portable XR Ankle - right Views | ./2.16.840.1.114222.4.11.1002/41782-4.json |
| 41783-2 | Portable XR Shoulder - right Views | ./2.16.840.1.114222.4.11.1002/41783-2.json |
| 41784-0 | Portable XR Humerus - right Views | ./2.16.840.1.114222.4.11.1002/41784-0.json |
| 41785-7 | XR Elbow - right Limited Views | ./2.16.840.1.114222.4.11.1002/41785-7.json |
| 41786-5 | Portable XR Elbow - right Views | ./2.16.840.1.114222.4.11.1002/41786-5.json |
| 41787-3 | Portable XR Wrist - right Views | ./2.16.840.1.114222.4.11.1002/41787-3.json |
| 41788-1 | Portable XR Hand - right Views | ./2.16.840.1.114222.4.11.1002/41788-1.json |
| 41789-9 | XR Hand - right Limited Views | ./2.16.840.1.114222.4.11.1002/41789-9.json |
| 41790-7 | XR Chest Single view during surgery | ./2.16.840.1.114222.4.11.1002/41790-7.json |
| 41791-5 | Portable XR Ribs - right Views | ./2.16.840.1.114222.4.11.1002/41791-5.json |
| 41792-3 | XR Chest Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/41792-3.json |
| 41793-1 | XR Abdomen Single view during surgery | ./2.16.840.1.114222.4.11.1002/41793-1.json |
| 41795-6 | RF Upper gastrointestinal tract and Small bowel Single view W air contrast PO | ./2.16.840.1.114222.4.11.1002/41795-6.json |
| 41797-2 | RF Colon Limited Views W air and barium contrast PR | ./2.16.840.1.114222.4.11.1002/41797-2.json |
| 41798-0 | US Guidance for drainage and placement of drainage catheter of Prostate | ./2.16.840.1.114222.4.11.1002/41798-0.json |
| 41799-8 | RF Guidance for placement of tube in Liver | ./2.16.840.1.114222.4.11.1002/41799-8.json |
| 41800-4 | RF Guidance for drainage and placement of drainage catheter of Pharynx | ./2.16.840.1.114222.4.11.1002/41800-4.json |
| 41801-2 | RFA Guidance for placement of catheter in Portal vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/41801-2.json |
| 41802-0 | RF Guidance for biopsy of Prostate | ./2.16.840.1.114222.4.11.1002/41802-0.json |
| 41803-8 | RF Guidance for biopsy of Breast | ./2.16.840.1.114222.4.11.1002/41803-8.json |
| 41806-1 | CT Abdomen | ./2.16.840.1.114222.4.11.1002/41806-1.json |
| 41807-9 | CT Orbit | ./2.16.840.1.114222.4.11.1002/41807-9.json |
| 41808-7 | CT Maxillofacial region | ./2.16.840.1.114222.4.11.1002/41808-7.json |
| 41809-5 | US Guidance for drainage and placement of drainage catheter of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/41809-5.json |
| 41811-1 | XR Ribs - bilateral Views and Chest PA | ./2.16.840.1.114222.4.11.1002/41811-1.json |
| 41812-9 | US Lower extremity artery limited | ./2.16.840.1.114222.4.11.1002/41812-9.json |
| 41813-7 | US Upper extremity artery limited | ./2.16.840.1.114222.4.11.1002/41813-7.json |
| 41814-5 | US Upper extremity artery - right | ./2.16.840.1.114222.4.11.1002/41814-5.json |
| 41815-2 | US Lower extremity artery - right | ./2.16.840.1.114222.4.11.1002/41815-2.json |
| 41816-0 | US Extremity veins - right | ./2.16.840.1.114222.4.11.1002/41816-0.json |
| 41817-8 | Portable XR Hip - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/41817-8.json |
| 41818-6 | Portable XR Femur - left Views | ./2.16.840.1.114222.4.11.1002/41818-6.json |
| 41819-4 | XR Knee - left 2 Views and Tunnel | ./2.16.840.1.114222.4.11.1002/41819-4.json |
| 41820-2 | Portable XR Knee - left Views | ./2.16.840.1.114222.4.11.1002/41820-2.json |
| 41823-6 | Portable XR Ankle - left Views | ./2.16.840.1.114222.4.11.1002/41823-6.json |
| 41824-4 | Portable XR Shoulder - left Views | ./2.16.840.1.114222.4.11.1002/41824-4.json |
| 41825-1 | Portable XR Humerus - left Views | ./2.16.840.1.114222.4.11.1002/41825-1.json |
| 41826-9 | XR Elbow - left Limited Views | ./2.16.840.1.114222.4.11.1002/41826-9.json |
| 41827-7 | Portable XR Elbow - left Views | ./2.16.840.1.114222.4.11.1002/41827-7.json |
| 41828-5 | Portable XR Wrist - left Views | ./2.16.840.1.114222.4.11.1002/41828-5.json |
| 41829-3 | Portable XR Hand - left Views | ./2.16.840.1.114222.4.11.1002/41829-3.json |
| 41830-1 | XR Hand - left Limited Views | ./2.16.840.1.114222.4.11.1002/41830-1.json |
| 41831-9 | Portable XR Ribs - left Views | ./2.16.840.1.114222.4.11.1002/41831-9.json |
| 41832-7 | XR Ribs - left Views and Chest PA | ./2.16.840.1.114222.4.11.1002/41832-7.json |
| 41833-5 | US Upper extremity artery - left | ./2.16.840.1.114222.4.11.1002/41833-5.json |
| 41834-3 | US Lower extremity artery - left | ./2.16.840.1.114222.4.11.1002/41834-3.json |
| 41835-0 | US Extremity veins - left | ./2.16.840.1.114222.4.11.1002/41835-0.json |
| 41836-8 | NM Bone Limited Views W In-111 tagged WBC IV | ./2.16.840.1.114222.4.11.1002/41836-8.json |
| 41837-6 | SPECT Whole body W Tc-99m Arcitumomab IV | ./2.16.840.1.114222.4.11.1002/41837-6.json |
| 41838-4 | SPECT Prostate W In-111 Satumomab IV | ./2.16.840.1.114222.4.11.1002/41838-4.json |
| 41844-2 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/41844-2.json |
| 41845-9 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination | ./2.16.840.1.114222.4.11.1002/41845-9.json |
| 41846-7 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination | ./2.16.840.1.114222.4.11.1002/41846-7.json |
| 41847-5 | Horseradish IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41847-5.json |
| 41848-3 | Paprika IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41848-3.json |
| 41849-1 | Curry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41849-1.json |
| 41850-9 | Lidocaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41850-9.json |
| 41851-7 | Thyme IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41851-7.json |
| 41852-5 | Microorganism or agent identified in Specimen | ./2.16.840.1.114222.4.11.1002/41852-5.json |
| 41853-3 | Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41853-3.json |
| 41854-1 | Castor Bean DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41854-1.json |
| 41855-8 | Staphylococcus aureus enterotoxin B [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/41855-8.json |
| 41856-6 | Variola virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41856-6.json |
| 41857-4 | Vibrio parahaemolyticus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/41857-4.json |
| 41858-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/41858-2.json |
| 41859-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/41859-0.json |
| 41860-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41860-8.json |
| 41867-3 | von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/41867-3.json |
| 41870-7 | Tryptase.mature [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/41870-7.json |
| 41871-5 | Voltage-gated potassium channel Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41871-5.json |
| 41872-3 | PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/41872-3.json |
| 41873-1 | Smooth Alder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41873-1.json |
| 41874-9 | White Birch IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/41874-9.json |
| 41966-3 | Name of Metabolism measurement device | ./2.16.840.1.114222.4.11.1002/41966-3.json |
| 41990-3 | Parainfluenza virus 4 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41990-3.json |
| 41991-1 | SARS coronavirus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/41991-1.json |
| 41992-9 | Arsenic.inorganic [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41992-9.json |
| 41995-2 | Hemoglobin A1c [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/41995-2.json |
| 41997-8 | Heptacarboxylporphyrin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41997-8.json |
| 41998-6 | Hexacarboxylporphyrin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/41998-6.json |
| 41999-4 | Lipoprotein.pre-beta [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/41999-4.json |
| 42001-8 | Nickel/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42001-8.json |
| 42002-6 | Pentacarboxylporphyrins [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42002-6.json |
| 42003-4 | Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/42003-4.json |
| 42004-2 | Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/42004-2.json |
| 42005-9 | Saint Louis encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42005-9.json |
| 42006-7 | Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/42006-7.json |
| 42007-5 | XR Mastoid - bilateral Limited Views | ./2.16.840.1.114222.4.11.1002/42007-5.json |
| 42008-3 | XR Humerus Single view during surgery | ./2.16.840.1.114222.4.11.1002/42008-3.json |
| 42009-1 | XR Chest 2 Views and Apical lordotic | ./2.16.840.1.114222.4.11.1002/42009-1.json |
| 42010-9 | XR Ribs - right Views and Chest PA | ./2.16.840.1.114222.4.11.1002/42010-9.json |
| 42011-7 | XR Chest PA and Abdomen AP | ./2.16.840.1.114222.4.11.1002/42011-7.json |
| 42012-5 | RF Gastrointestinal tract upper Views W water soluble contrast PO | ./2.16.840.1.114222.4.11.1002/42012-5.json |
| 42014-1 | RF Urinary bladder and Urethra Views W contrast | ./2.16.840.1.114222.4.11.1002/42014-1.json |
| 42017-4 | RF Guidance for percutaneous replacement of cholecystostomy of Abdomen | ./2.16.840.1.114222.4.11.1002/42017-4.json |
| 42018-2 | RFA Guidance for percutaneous transluminal angioplasty of Vein-- W contrast IA | ./2.16.840.1.114222.4.11.1002/42018-2.json |
| 42019-0 | XR Abdomen upright and left lateral decubitus | ./2.16.840.1.114222.4.11.1002/42019-0.json |
| 42020-8 | CT Guidance for needle localization of Lumbar spine | ./2.16.840.1.114222.4.11.1002/42020-8.json |
| 42021-6 | CT Guidance for needle localization of Cervical spine | ./2.16.840.1.114222.4.11.1002/42021-6.json |
| 42132-1 | US Breast screening | ./2.16.840.1.114222.4.11.1002/42132-1.json |
| 42133-9 | US Guidance for drainage of abscess and placement of drainage catheter of Liver | ./2.16.840.1.114222.4.11.1002/42133-9.json |
| 42134-7 | US Guidance for fluid aspiration of Thyroid gland | ./2.16.840.1.114222.4.11.1002/42134-7.json |
| 42135-4 | US Guidance for superficial biopsy of Bone | ./2.16.840.1.114222.4.11.1002/42135-4.json |
| 42136-2 | CT Guidance for biopsy of Heart | ./2.16.840.1.114222.4.11.1002/42136-2.json |
| 42137-0 | US Guidance for biopsy of Mediastinum | ./2.16.840.1.114222.4.11.1002/42137-0.json |
| 42138-8 | US Guidance for localization of placenta | ./2.16.840.1.114222.4.11.1002/42138-8.json |
| 42140-4 | US Guidance for placement of tube in Chest | ./2.16.840.1.114222.4.11.1002/42140-4.json |
| 42141-2 | US Guidance for removal of tunneled CV catheter | ./2.16.840.1.114222.4.11.1002/42141-2.json |
| 42143-8 | US Uterus and Fallopian tubes W saline IU | ./2.16.840.1.114222.4.11.1002/42143-8.json |
| 42144-6 | US Extremity vein - right | ./2.16.840.1.114222.4.11.1002/42144-6.json |
| 42145-3 | US Extremity vein - left | ./2.16.840.1.114222.4.11.1002/42145-3.json |
| 42146-1 | US.doppler Carotid arteries | ./2.16.840.1.114222.4.11.1002/42146-1.json |
| 42147-9 | US.doppler Iliac graft | ./2.16.840.1.114222.4.11.1002/42147-9.json |
| 42148-7 | US Heart | ./2.16.840.1.114222.4.11.1002/42148-7.json |
| 42149-5 | US Carotid arteries - left limited | ./2.16.840.1.114222.4.11.1002/42149-5.json |
| 42150-3 | US.doppler Iliac graft limited | ./2.16.840.1.114222.4.11.1002/42150-3.json |
| 42151-1 | US Carotid arteries -right limited | ./2.16.840.1.114222.4.11.1002/42151-1.json |
| 42152-9 | US.doppler Pelvis vessels limited | ./2.16.840.1.114222.4.11.1002/42152-9.json |
| 42153-7 | XR Extremity Single view | ./2.16.840.1.114222.4.11.1002/42153-7.json |
| 42156-0 | RFA Vessels Views W contrast IA | ./2.16.840.1.114222.4.11.1002/42156-0.json |
| 42157-8 | RFA Extremity vessels Views W contrast IV | ./2.16.840.1.114222.4.11.1002/42157-8.json |
| 42158-6 | NM Adrenal gland Views | ./2.16.840.1.114222.4.11.1002/42158-6.json |
| 42159-4 | XR Sella turcica Views | ./2.16.840.1.114222.4.11.1002/42159-4.json |
| 42160-2 | XR Unspecified body region Views for shunt patency | ./2.16.840.1.114222.4.11.1002/42160-2.json |
| 42161-0 | NM Heart Views W dobutamine IV | ./2.16.840.1.114222.4.11.1002/42161-0.json |
| 42163-6 | XR Lumbar spine Views and Oblique | ./2.16.840.1.114222.4.11.1002/42163-6.json |
| 42164-4 | XR Cervical spine Views and Oblique | ./2.16.840.1.114222.4.11.1002/42164-4.json |
| 42165-1 | XR Ribs Views and Chest PA | ./2.16.840.1.114222.4.11.1002/42165-1.json |
| 42166-9 | NM Heart 2 Views at rest and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/42166-9.json |
| 42167-7 | XR Pelvis and Hip - bilateral AP and Lateral frog | ./2.16.840.1.114222.4.11.1002/42167-7.json |
| 42168-5 | FFD mammogram Breast - right Diagnostic | ./2.16.840.1.114222.4.11.1002/42168-5.json |
| 42169-3 | FFD mammogram Breast - left Diagnostic | ./2.16.840.1.114222.4.11.1002/42169-3.json |
| 42170-1 | NM Whole body Views for lymphoma | ./2.16.840.1.114222.4.11.1002/42170-1.json |
| 42171-9 | NM Whole body Views for tumor | ./2.16.840.1.114222.4.11.1002/42171-9.json |
| 42174-3 | FFD mammogram Breast - bilateral Screening | ./2.16.840.1.114222.4.11.1002/42174-3.json |
| 42175-0 | NM Whole body Views | ./2.16.840.1.114222.4.11.1002/42175-0.json |
| 42176-8 | 1,3 beta glucan [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42176-8.json |
| 42177-6 | Fc epsilon RI Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42177-6.json |
| 42178-4 | Lipoprotein.X [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42178-4.json |
| 42179-2 | PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42179-2.json |
| 42181-8 | Myocardium Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42181-8.json |
| 42182-6 | Gossypol bound [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/42182-6.json |
| 42183-4 | Gossypol negative isomer [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/42183-4.json |
| 42184-2 | Gossypol posiitve isomer [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/42184-2.json |
| 42188-3 | CD3+CD16+CD56+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/42188-3.json |
| 42196-6 | Centromere Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42196-6.json |
| 42197-4 | Centromere Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42197-4.json |
| 42198-2 | Curvularia specifera IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42198-2.json |
| 42199-0 | Soluble liver Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42199-0.json |
| 42200-6 | DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/42200-6.json |
| 42201-4 | DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42201-4.json |
| 42202-2 | GALOP IgM Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42202-2.json |
| 42203-0 | Ganglioside GM1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42203-0.json |
| 42205-5 | Human antimouse IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42205-5.json |
| 42209-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/42209-7.json |
| 42210-5 | Microscopic observation [Identifier] in Bronchial specimen by Cyto stain | ./2.16.840.1.114222.4.11.1002/42210-5.json |
| 42211-3 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42211-3.json |
| 42212-1 | Nucleolar nuclear Ab pattern [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42212-1.json |
| 42213-9 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42213-9.json |
| 42214-7 | Speckled nuclear Ab pattern [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42214-7.json |
| 42217-0 | Striated muscle IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42217-0.json |
| 42219-6 | Chromium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42219-6.json |
| 42220-4 | Chromium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/42220-4.json |
| 42221-2 | Manganese [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42221-2.json |
| 42222-0 | Manganese [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42222-0.json |
| 42223-8 | Manganese/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/42223-8.json |
| 42224-6 | Thallium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42224-6.json |
| 42225-3 | Thallium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42225-3.json |
| 42226-1 | Thallium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/42226-1.json |
| 42233-7 | Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42233-7.json |
| 42234-5 | Alpha subunit free [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42234-5.json |
| 42235-2 | Benzodiazepine metabolites [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42235-2.json |
| 42236-0 | Borrelia burgdorferi DNA [Presence] in Tick by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42236-0.json |
| 42240-2 | CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42240-2.json |
| 42241-0 | Cocaine+Benzoylecgonine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42241-0.json |
| 42242-8 | Ethanol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42242-8.json |
| 42249-3 | levETIRAcetam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42249-3.json |
| 42251-9 | Methadone+Metabolite [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42251-9.json |
| 42252-7 | Methaqualone+Metabolite [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42252-7.json |
| 42253-5 | Methylenedioxyamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42253-5.json |
| 42254-3 | Nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42254-3.json |
| 42255-0 | Salmonella and Shigella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/42255-0.json |
| 42256-8 | Shigella boydii Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/42256-8.json |
| 42257-6 | Shigella dysenteriae Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/42257-6.json |
| 42258-4 | Shigella flexneri Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/42258-4.json |
| 42259-2 | Shigella sonnei Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/42259-2.json |
| 42260-0 | CT Guidance for biopsy of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/42260-0.json |
| 42261-8 | NM Kidney Views for blood flow | ./2.16.840.1.114222.4.11.1002/42261-8.json |
| 42262-6 | NM Liver Views for blood flow | ./2.16.840.1.114222.4.11.1002/42262-6.json |
| 42263-4 | NM Spleen Views for blood flow | ./2.16.840.1.114222.4.11.1002/42263-4.json |
| 42265-9 | CT Guidance for superficial biopsy of Bone | ./2.16.840.1.114222.4.11.1002/42265-9.json |
| 42268-3 | CT Extremity WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42268-3.json |
| 42269-1 | XR Chest and Abdomen Views | ./2.16.840.1.114222.4.11.1002/42269-1.json |
| 42270-9 | MR Cervical spine W flexion and W extension | ./2.16.840.1.114222.4.11.1002/42270-9.json |
| 42271-7 | NM Thyroid gland Views and Views uptake W I-123 IV | ./2.16.840.1.114222.4.11.1002/42271-7.json |
| 42272-5 | XR Chest PA and Lateral | ./2.16.840.1.114222.4.11.1002/42272-5.json |
| 42273-3 | XR Ankle - bilateral 6 Views | ./2.16.840.1.114222.4.11.1002/42273-3.json |
| 42274-1 | CT Abdomen and Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42274-1.json |
| 42275-8 | CT Chest and Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/42275-8.json |
| 42276-6 | CT Chest and Abdomen WO contrast | ./2.16.840.1.114222.4.11.1002/42276-6.json |
| 42277-4 | CT Chest and Abdomen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42277-4.json |
| 42278-2 | CT Extremity WO contrast | ./2.16.840.1.114222.4.11.1002/42278-2.json |
| 42279-0 | CT Guidance for biopsy of Kidney | ./2.16.840.1.114222.4.11.1002/42279-0.json |
| 42280-8 | CT Guidance for drainage of abscess and placement of drainage catheter of Appendix | ./2.16.840.1.114222.4.11.1002/42280-8.json |
| 42281-6 | CT Guidance for drainage of abscess and placement of drainage catheter of Chest | ./2.16.840.1.114222.4.11.1002/42281-6.json |
| 42282-4 | CT Guidance for drainage of abscess and placement of drainage catheter of Liver | ./2.16.840.1.114222.4.11.1002/42282-4.json |
| 42283-2 | CT Guidance for drainage and placement of drainage catheter of Pancreas | ./2.16.840.1.114222.4.11.1002/42283-2.json |
| 42284-0 | CT Guidance for drainage of abscess and placement of chest tube of Pleural space | ./2.16.840.1.114222.4.11.1002/42284-0.json |
| 42285-7 | CT Guidance for drainage of abscess and placement of drainage catheter of Kidney | ./2.16.840.1.114222.4.11.1002/42285-7.json |
| 42286-5 | CT Guidance for drainage of abscess and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/42286-5.json |
| 42287-3 | CT Guidance for drainage and placement of drainage catheter of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/42287-3.json |
| 42291-5 | CT Retroperitoneum WO contrast | ./2.16.840.1.114222.4.11.1002/42291-5.json |
| 42292-3 | SPECT Whole body for tumor W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/42292-3.json |
| 42293-1 | CTA Head vessels WO contrast | ./2.16.840.1.114222.4.11.1002/42293-1.json |
| 42294-9 | CTA Pelvis vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/42294-9.json |
| 42295-6 | CTA Upper extremity vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/42295-6.json |
| 42296-4 | MG Guidance for localization of Breast - left | ./2.16.840.1.114222.4.11.1002/42296-4.json |
| 42297-2 | MG Guidance for localization of Breast - right | ./2.16.840.1.114222.4.11.1002/42297-2.json |
| 42298-0 | MR Unspecified body region WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42298-0.json |
| 42299-8 | MR Clavicle WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42299-8.json |
| 42300-4 | MR Thyroid gland | ./2.16.840.1.114222.4.11.1002/42300-4.json |
| 42301-2 | MR Uterus | ./2.16.840.1.114222.4.11.1002/42301-2.json |
| 42302-0 | MR Clavicle WO contrast | ./2.16.840.1.114222.4.11.1002/42302-0.json |
| 42303-8 | MR Orbit and Face | ./2.16.840.1.114222.4.11.1002/42303-8.json |
| 42304-6 | MRA Head vessels and Neck vessels | ./2.16.840.1.114222.4.11.1002/42304-6.json |
| 42305-3 | NM Whole body Views for tumor W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/42305-3.json |
| 42306-1 | NM Heart Gated and Wall motion | ./2.16.840.1.114222.4.11.1002/42306-1.json |
| 42308-7 | NM Scrotum and testicle Views for blood flow | ./2.16.840.1.114222.4.11.1002/42308-7.json |
| 42309-5 | NM Heart Views at rest and W stress and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/42309-5.json |
| 42310-3 | SPECT Kidney | ./2.16.840.1.114222.4.11.1002/42310-3.json |
| 42311-1 | XR Orbit - left Views for foreign body | ./2.16.840.1.114222.4.11.1002/42311-1.json |
| 42312-9 | XR Orbit - right Views for foreign body | ./2.16.840.1.114222.4.11.1002/42312-9.json |
| 42313-7 | XR Ribs - left Single view | ./2.16.840.1.114222.4.11.1002/42313-7.json |
| 42314-5 | XR Ribs - right Single view | ./2.16.840.1.114222.4.11.1002/42314-5.json |
| 42315-2 | APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42315-2.json |
| 42316-0 | RHD gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42316-0.json |
| 42318-6 | GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42318-6.json |
| 42321-0 | HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42321-0.json |
| 42322-8 | Hepatitis B virus S+pol gene [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42322-8.json |
| 42323-6 | HLA-DR Ag [Type] in Tissue | ./2.16.840.1.114222.4.11.1002/42323-6.json |
| 42324-4 | I group phenotype [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/42324-4.json |
| 42325-1 | RHD and RHCE gene alleles [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42325-1.json |
| 42326-9 | Drugs identified in Mother's milk by Screen method | ./2.16.840.1.114222.4.11.1002/42326-9.json |
| 42327-7 | Leukocytes [Presence] in Stool by Methylene blue stain | ./2.16.840.1.114222.4.11.1002/42327-7.json |
| 42328-5 | Bordetella pertussis IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42328-5.json |
| 42329-3 | Bordetella pertussis IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42329-3.json |
| 42330-1 | Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42330-1.json |
| 42331-9 | Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/42331-9.json |
| 42332-7 | Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42332-7.json |
| 42333-5 | US Guidance for biopsy of Chest Pleura | ./2.16.840.1.114222.4.11.1002/42333-5.json |
| 42334-3 | RFA Guidance for injection of Internal thoracic artery - left | ./2.16.840.1.114222.4.11.1002/42334-3.json |
| 42335-0 | RF Cervical spine Limited Views W contrast IT | ./2.16.840.1.114222.4.11.1002/42335-0.json |
| 42336-8 | Cytomegalovirus Ag [#/area] in Specimen | ./2.16.840.1.114222.4.11.1002/42336-8.json |
| 42337-6 | Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42337-6.json |
| 42338-4 | Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42338-4.json |
| 42339-2 | HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/42339-2.json |
| 42340-0 | HTLV I p42 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/42340-0.json |
| 42341-8 | Neisseria meningitidis serogroups A+w135 Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/42341-8.json |
| 42343-4 | Toxoplasma gondii identified in Specimen by Other stain | ./2.16.840.1.114222.4.11.1002/42343-4.json |
| 42348-3 | Advance directives | ./2.16.840.1.114222.4.11.1002/42348-3.json |
| 42358-2 | HLA-B*57:01 [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/42358-2.json |
| 42367-3 | Streptococcus pneumoniae Danish serotype 19B IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42367-3.json |
| 42377-2 | CT perfusion Head W Xe-133 IH+WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42377-2.json |
| 42378-0 | XR Lumbar spine AP W left bending | ./2.16.840.1.114222.4.11.1002/42378-0.json |
| 42379-8 | XR Lumbar spine AP W right bending | ./2.16.840.1.114222.4.11.1002/42379-8.json |
| 42380-6 | XR Ankle - left AP and Lateral W standing | ./2.16.840.1.114222.4.11.1002/42380-6.json |
| 42381-4 | XR Ribs lower posterior - left Views | ./2.16.840.1.114222.4.11.1002/42381-4.json |
| 42382-2 | XR Ankle - left Lateral and Mortise and Broden W manual stress | ./2.16.840.1.114222.4.11.1002/42382-2.json |
| 42383-0 | XR Gallbladder Views W contrast PO and W contrast PO | ./2.16.840.1.114222.4.11.1002/42383-0.json |
| 42385-5 | MR Brain and Pituitary and Sella turcica | ./2.16.840.1.114222.4.11.1002/42385-5.json |
| 42386-3 | MR Brain cine for CSF flow | ./2.16.840.1.114222.4.11.1002/42386-3.json |
| 42387-1 | MR Unspecified body region cine for CSF flow | ./2.16.840.1.114222.4.11.1002/42387-1.json |
| 42388-9 | MR Prostate Endorectal | ./2.16.840.1.114222.4.11.1002/42388-9.json |
| 42389-7 | MR Pelvis Endorectal | ./2.16.840.1.114222.4.11.1002/42389-7.json |
| 42390-5 | MR Endovaginal | ./2.16.840.1.114222.4.11.1002/42390-5.json |
| 42391-3 | MR Brain and Pituitary and Sella turcica W contrast IV | ./2.16.840.1.114222.4.11.1002/42391-3.json |
| 42392-1 | MR Brain and Pituitary and Sella turcica WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42392-1.json |
| 42393-9 | MR Brain and Pituitary and Sella turcica WO contrast | ./2.16.840.1.114222.4.11.1002/42393-9.json |
| 42394-7 | CT Pulmonary system W Xe-133 IH | ./2.16.840.1.114222.4.11.1002/42394-7.json |
| 42395-4 | XR Foot sesamoid bones - bilateral Axial | ./2.16.840.1.114222.4.11.1002/42395-4.json |
| 42396-2 | XR Foot sesamoid bones - left Axial | ./2.16.840.1.114222.4.11.1002/42396-2.json |
| 42397-0 | XR.stereoscopic Chest Frontal Views | ./2.16.840.1.114222.4.11.1002/42397-0.json |
| 42398-8 | XR Foot Oblique and (AP and Lateral W standing) | ./2.16.840.1.114222.4.11.1002/42398-8.json |
| 42399-6 | XR Foot sesamoid bones Views | ./2.16.840.1.114222.4.11.1002/42399-6.json |
| 42400-2 | XR Foot sesamoid bones - bilateral Views | ./2.16.840.1.114222.4.11.1002/42400-2.json |
| 42401-0 | XR Lumbar spine Lumbar (AP W R-bending and W L-bending and WO bending) and Lateral | ./2.16.840.1.114222.4.11.1002/42401-0.json |
| 42402-8 | XR Unspecified body region Post mortem Views | ./2.16.840.1.114222.4.11.1002/42402-8.json |
| 42403-6 | XR Lumbar spine Views AP W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/42403-6.json |
| 42404-4 | XR Hip - left AP and Lateral Views for measurement | ./2.16.840.1.114222.4.11.1002/42404-4.json |
| 42405-1 | XR Knee (AP W standing) and (Lateral W extension) | ./2.16.840.1.114222.4.11.1002/42405-1.json |
| 42406-9 | XR Lumbar spine Views AP W and WO left bending | ./2.16.840.1.114222.4.11.1002/42406-9.json |
| 42407-7 | XR Lumbar spine Views AP W and WO right bending | ./2.16.840.1.114222.4.11.1002/42407-7.json |
| 42408-5 | XR Lumbar spine Views AP W right bending and W left bending and WO bending | ./2.16.840.1.114222.4.11.1002/42408-5.json |
| 42409-3 | XR Foot sesamoid bones AP and Lateral | ./2.16.840.1.114222.4.11.1002/42409-3.json |
| 42410-1 | XR Lumbar spine AP and Lateral and Oblique and Spot W standing | ./2.16.840.1.114222.4.11.1002/42410-1.json |
| 42411-9 | XR Lumbar spine (AP^W R-bending and W L-bending) and (Lateral^W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/42411-9.json |
| 42412-7 | XR Shoulder - left 90 degree abduction Views | ./2.16.840.1.114222.4.11.1002/42412-7.json |
| 42413-5 | XR Lumbar spine Views W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/42413-5.json |
| 42414-3 | XR Chest Right oblique and Left oblique W nipple markers | ./2.16.840.1.114222.4.11.1002/42414-3.json |
| 42415-0 | MG Breast - bilateral Views Post Wire Placement | ./2.16.840.1.114222.4.11.1002/42415-0.json |
| 42416-8 | MG Breast - left Views Post Wire Placement | ./2.16.840.1.114222.4.11.1002/42416-8.json |
| 42417-6 | XR Ankle - bilateral AP and Lateral and Oblique and (View W manual stress) | ./2.16.840.1.114222.4.11.1002/42417-6.json |
| 42418-4 | XR Ankle - left AP and Lateral and Oblique and (View W manual stress) | ./2.16.840.1.114222.4.11.1002/42418-4.json |
| 42419-2 | XR Wrist - bilateral Single view | ./2.16.840.1.114222.4.11.1002/42419-2.json |
| 42420-0 | XR Pelvis AP W standing | ./2.16.840.1.114222.4.11.1002/42420-0.json |
| 42421-8 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/42421-8.json |
| 42422-6 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Breast | ./2.16.840.1.114222.4.11.1002/42422-6.json |
| 42423-4 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Chest | ./2.16.840.1.114222.4.11.1002/42423-4.json |
| 42424-2 | XR Thoracic and lumbar spine AP and lateral for scoliosis W sitting | ./2.16.840.1.114222.4.11.1002/42424-2.json |
| 42425-9 | XR Thoracic and lumbar spine AP Views for scoliosis W standing and W right bending and W left bending and WO bending | ./2.16.840.1.114222.4.11.1002/42425-9.json |
| 42426-7 | XR Thoracic and lumbar spine AP for scoliosis W sitting | ./2.16.840.1.114222.4.11.1002/42426-7.json |
| 42427-5 | XR Thoracic and lumbar spine Lateral for scoliosis W sitting | ./2.16.840.1.114222.4.11.1002/42427-5.json |
| 42428-3 | XR Thoracic and lumbar spine AP for scoliosis W standing in brace | ./2.16.840.1.114222.4.11.1002/42428-3.json |
| 42429-1 | XR Thoracic and lumbar spine AP for scoliosis W standing and W right bending | ./2.16.840.1.114222.4.11.1002/42429-1.json |
| 42430-9 | XR Knee - right 2 views and (Views W standing) | ./2.16.840.1.114222.4.11.1002/42430-9.json |
| 42431-7 | XR Knee - right PA 30 degree flexion W standing | ./2.16.840.1.114222.4.11.1002/42431-7.json |
| 42432-5 | XR Knee - right Sunrise and (Views W standing) | ./2.16.840.1.114222.4.11.1002/42432-5.json |
| 42433-3 | MG stereo Guidance for percutaneous biopsy.core needle of Breast - right | ./2.16.840.1.114222.4.11.1002/42433-3.json |
| 42434-1 | XR Foot sesamoid bones - right Views | ./2.16.840.1.114222.4.11.1002/42434-1.json |
| 42435-8 | XR Sella turcica 2 Views | ./2.16.840.1.114222.4.11.1002/42435-8.json |
| 42436-6 | XR Sella turcica Lateral and Towne | ./2.16.840.1.114222.4.11.1002/42436-6.json |
| 42437-4 | XR tomography Sella turcica | ./2.16.840.1.114222.4.11.1002/42437-4.json |
| 42438-2 | XR Neck AP and Lateral | ./2.16.840.1.114222.4.11.1002/42438-2.json |
| 42439-0 | XR Neck AP | ./2.16.840.1.114222.4.11.1002/42439-0.json |
| 42441-6 | XR Neck Magnification | ./2.16.840.1.114222.4.11.1002/42441-6.json |
| 42442-4 | XR Spine Lateral W standing | ./2.16.840.1.114222.4.11.1002/42442-4.json |
| 42443-2 | XR Thoracic spine 3 Views W standing | ./2.16.840.1.114222.4.11.1002/42443-2.json |
| 42444-0 | XR Thoracic spine Views AP W right bending and W left bending and WO bending | ./2.16.840.1.114222.4.11.1002/42444-0.json |
| 42445-7 | XR Thoracic spine Views AP W left bending and WO bending | ./2.16.840.1.114222.4.11.1002/42445-7.json |
| 42446-5 | XR Thoracic spine Views AP W right bending and WO bending | ./2.16.840.1.114222.4.11.1002/42446-5.json |
| 42447-3 | US Guidance for aspiration of cyst of Thyroid gland | ./2.16.840.1.114222.4.11.1002/42447-3.json |
| 42448-1 | US Guidance for excisional biopsy of Breast | ./2.16.840.1.114222.4.11.1002/42448-1.json |
| 42449-9 | US Guidance for biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/42449-9.json |
| 42450-7 | US Guidance for aspiration of cyst of Breast - left | ./2.16.840.1.114222.4.11.1002/42450-7.json |
| 42455-6 | US Pelvis transabdominal and transvaginal | ./2.16.840.1.114222.4.11.1002/42455-6.json |
| 42456-4 | US Guidance for placement of needle wire in Breast | ./2.16.840.1.114222.4.11.1002/42456-4.json |
| 42457-2 | US Guidance for biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/42457-2.json |
| 42458-0 | US Guidance for aspiration of cyst of Breast - right | ./2.16.840.1.114222.4.11.1002/42458-0.json |
| 42459-8 | RF Gastrointestinal tract upper Views W contrast PO | ./2.16.840.1.114222.4.11.1002/42459-8.json |
| 42460-6 | RF Submandibular gland - left Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/42460-6.json |
| 42461-4 | US.doppler Lower extremity vessel - left for graft | ./2.16.840.1.114222.4.11.1002/42461-4.json |
| 42462-2 | US.doppler Lower extremity vessel - right for graft | ./2.16.840.1.114222.4.11.1002/42462-2.json |
| 42463-0 | US Guidance for biopsy of Endomyocardium | ./2.16.840.1.114222.4.11.1002/42463-0.json |
| 42468-9 | US Surgical specimen | ./2.16.840.1.114222.4.11.1002/42468-9.json |
| 42469-7 | RF Gastrointestinal tract upper and Small bowel and Gallbladder Single view W contrast PO | ./2.16.840.1.114222.4.11.1002/42469-7.json |
| 42470-5 | RF Gastrointestinal tract upper and Gallbladder Single view W contrast PO | ./2.16.840.1.114222.4.11.1002/42470-5.json |
| 42471-3 | XR.stereoscopic Pelvis Single view | ./2.16.840.1.114222.4.11.1002/42471-3.json |
| 42472-1 | XR Thoracic and lumbar spine AP Views for scoliosis in traction | ./2.16.840.1.114222.4.11.1002/42472-1.json |
| 42473-9 | XR.stereoscopic Sinuses Waters | ./2.16.840.1.114222.4.11.1002/42473-9.json |
| 42474-7 | XR.stereoscopic Skull Single view | ./2.16.840.1.114222.4.11.1002/42474-7.json |
| 42475-4 | US.doppler Upper extremity vessel - left for graft | ./2.16.840.1.114222.4.11.1002/42475-4.json |
| 42476-2 | US.doppler Upper extremity vessel - right for graft | ./2.16.840.1.114222.4.11.1002/42476-2.json |
| 42477-0 | US.doppler for transplanted kidney vessels | ./2.16.840.1.114222.4.11.1002/42477-0.json |
| 42478-8 | US Guidance for drainage of cyst and placement of drainage catheter of Kidney | ./2.16.840.1.114222.4.11.1002/42478-8.json |
| 42480-4 | Pelvis Narrative transabdominal US | ./2.16.840.1.114222.4.11.1002/42480-4.json |
| 42481-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/42481-2.json |
| 42482-0 | Protein.monoclonal [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/42482-0.json |
| 42483-8 | Protein.monoclonal/Protein.total in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/42483-8.json |
| 42484-6 | Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/42484-6.json |
| 42485-3 | Anion gap in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/42485-3.json |
| 42486-1 | Aspergillus fumigatus 1 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42486-1.json |
| 42487-9 | Aspergillus fumigatus 6 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42487-9.json |
| 42488-7 | Aspergillus sp Ab [Titer] in Pleural fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/42488-7.json |
| 42489-5 | Aureobasidium pullulans Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42489-5.json |
| 42490-3 | Blastomyces dermatitidis Ab [Titer] in Pleural fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/42490-3.json |
| 42491-1 | Cannabinoids [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/42491-1.json |
| 42492-9 | Carboxy tetrahydrocannabinol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/42492-9.json |
| 42493-7 | Catecholamines Free fractionated [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/42493-7.json |
| 42494-5 | Coccidioides immitis Ab [Titer] in Pleural fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/42494-5.json |
| 42495-2 | Cytomegalovirus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42495-2.json |
| 42496-0 | Echinococcus sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42496-0.json |
| 42497-8 | Epstein Barr virus early Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42497-8.json |
| 42498-6 | Epstein Barr virus nuclear Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42498-6.json |
| 42499-4 | Fibrin D-dimer [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42499-4.json |
| 42501-7 | Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42501-7.json |
| 42502-5 | Glycolate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42502-5.json |
| 42503-3 | Hantavirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42503-3.json |
| 42504-1 | Hepatitis B virus surface Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42504-1.json |
| 42505-8 | Hepatitis B virus surface Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42505-8.json |
| 42506-6 | Hepatitis C virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42506-6.json |
| 42507-4 | Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42507-4.json |
| 42508-2 | Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42508-2.json |
| 42509-0 | Histoplasma capsulatum Ab [Presence] in Pleural fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/42509-0.json |
| 42510-8 | IgD [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42510-8.json |
| 42511-6 | IgD [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42511-6.json |
| 42512-4 | IgE [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42512-4.json |
| 42513-2 | IgE [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42513-2.json |
| 42514-0 | Inhibin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42514-0.json |
| 42515-7 | Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42515-7.json |
| 42516-5 | Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42516-5.json |
| 42517-3 | Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42517-3.json |
| 42518-1 | Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination | ./2.16.840.1.114222.4.11.1002/42518-1.json |
| 42520-7 | Methylmalonate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42520-7.json |
| 42521-5 | Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42521-5.json |
| 42522-3 | Mitochondria Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42522-3.json |
| 42523-1 | Molindone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42523-1.json |
| 42524-9 | Mucus [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/42524-9.json |
| 42525-6 | Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42525-6.json |
| 42526-4 | Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/42526-4.json |
| 42527-2 | Parietal cell Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42527-2.json |
| 42528-0 | Phenothiazines [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42528-0.json |
| 42529-8 | Pigeon serum Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42529-8.json |
| 42530-6 | Smooth muscle Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42530-6.json |
| 42531-4 | Spermatozoa Motile [#/volume] in Semen | ./2.16.840.1.114222.4.11.1002/42531-4.json |
| 42532-2 | Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42532-2.json |
| 42533-0 | Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42533-0.json |
| 42534-8 | Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42534-8.json |
| 42536-3 | Tropheryma whipplei DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42536-3.json |
| 42537-1 | Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42537-1.json |
| 42538-9 | Hydroxyperhexiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42538-9.json |
| 42539-7 | Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42539-7.json |
| 42567-8 | Calcium.ionized [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42567-8.json |
| 42568-6 | Fibrinogen [Mass or Moles/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/42568-6.json |
| 42569-4 | Potassium [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42569-4.json |
| 42570-2 | Sodium [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42570-2.json |
| 42571-0 | Urea [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42571-0.json |
| 42572-8 | 11-Deoxycortisol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42572-8.json |
| 42573-6 | 18-Hydroxycorticosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42573-6.json |
| 42574-4 | 1-Naphthol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42574-4.json |
| 42575-1 | Amoxicillin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42575-1.json |
| 42576-9 | Amphetamine [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/42576-9.json |
| 42577-7 | Ampicillin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42577-7.json |
| 42579-3 | Aspergillus fumigatus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42579-3.json |
| 42580-1 | Babesia sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42580-1.json |
| 42581-9 | Babesia sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42581-9.json |
| 42582-7 | Barbiturates [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/42582-7.json |
| 42584-3 | Beet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42584-3.json |
| 42585-0 | Bendiocarb [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42585-0.json |
| 42586-8 | Benzodiazepines [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/42586-8.json |
| 42587-6 | BK virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42587-6.json |
| 42588-4 | Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42588-4.json |
| 42589-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42589-2.json |
| 42590-0 | Borrelia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42590-0.json |
| 42591-8 | Botrytis cinerea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42591-8.json |
| 42592-6 | Brucella abortus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42592-6.json |
| 42593-4 | Calcium [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/42593-4.json |
| 42594-2 | White Ash IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42594-2.json |
| 42595-9 | Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42595-9.json |
| 42600-7 | HIV 1+2 Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/42600-7.json |
| 42601-5 | Immune complex.IgG [Units/volume] in Synovial fluid by C1q binding assay | ./2.16.840.1.114222.4.11.1002/42601-5.json |
| 42602-3 | Tropheryma whipplei DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42602-3.json |
| 42603-1 | Coxsackievirus A6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42603-1.json |
| 42606-4 | Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42606-4.json |
| 42607-2 | Prolactin monomeric [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42607-2.json |
| 42608-0 | CD10+CD20+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42608-0.json |
| 42610-6 | Salicylurate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42610-6.json |
| 42612-2 | Salicylurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42612-2.json |
| 42614-8 | Colorado tick fever virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42614-8.json |
| 42616-3 | Magnesium [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/42616-3.json |
| 42617-1 | Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/42617-1.json |
| 42618-9 | Naloxone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/42618-9.json |
| 42619-7 | CD28 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42619-7.json |
| 42621-3 | Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42621-3.json |
| 42622-1 | CD13+CD56+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42622-1.json |
| 42623-9 | Coxsackievirus A3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42623-9.json |
| 42626-2 | Toxoplasma gondii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42626-2.json |
| 42627-0 | HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42627-0.json |
| 42628-8 | CD9+CD41+ cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/42628-8.json |
| 42630-4 | Cannabinoids [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/42630-4.json |
| 42634-6 | 1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42634-6.json |
| 42635-3 | Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42635-3.json |
| 42637-9 | Natriuretic peptide B [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/42637-9.json |
| 42639-5 | Immune complex.IgG [Units/volume] in Serum or Plasma by C1q binding assay | ./2.16.840.1.114222.4.11.1002/42639-5.json |
| 42641-1 | Babesia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42641-1.json |
| 42660-1 | Alpha 2 laminin [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42660-1.json |
| 42661-9 | Bacteria identified in Isolate by Pulsed-Field Gel Electrophoresis (PFGE) | ./2.16.840.1.114222.4.11.1002/42661-9.json |
| 42662-7 | Benzodiazepines [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/42662-7.json |
| 42665-0 | Dantron [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/42665-0.json |
| 42666-8 | Fat.neutral [#/area] in Pleural fluid by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/42666-8.json |
| 42667-6 | Fatty acids [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42667-6.json |
| 42668-4 | Fatty acids [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/42668-4.json |
| 42669-2 | Fatty acids [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/42669-2.json |
| 42670-0 | pH of Vitreous fluid | ./2.16.840.1.114222.4.11.1002/42670-0.json |
| 42671-8 | Serotonin [Entitic mass] in Platelets | ./2.16.840.1.114222.4.11.1002/42671-8.json |
| 42674-2 | Fat.neutral [#/area] in Urine by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/42674-2.json |
| 42676-7 | Spermatozoa Normal Motile [#/volume] in Semen | ./2.16.840.1.114222.4.11.1002/42676-7.json |
| 42677-5 | Succinylacetone [Molar amount] in DBS | ./2.16.840.1.114222.4.11.1002/42677-5.json |
| 42679-1 | Heparin [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/42679-1.json |
| 42680-9 | MG Breast XCCL | ./2.16.840.1.114222.4.11.1002/42680-9.json |
| 42681-7 | RF Colon Views W gastrografin PR | ./2.16.840.1.114222.4.11.1002/42681-7.json |
| 42682-5 | Succinyladenosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42682-5.json |
| 42684-1 | RF Gastrointestinal tract upper Views W gastrografin PO | ./2.16.840.1.114222.4.11.1002/42684-1.json |
| 42685-8 | XR Pelvis and Hip - left 2 Views | ./2.16.840.1.114222.4.11.1002/42685-8.json |
| 42686-6 | XR Pelvis and Hip - right 2 Views | ./2.16.840.1.114222.4.11.1002/42686-6.json |
| 42687-4 | XR Ribs - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/42687-4.json |
| 42688-2 | CT Guidance for nerve block of Spine | ./2.16.840.1.114222.4.11.1002/42688-2.json |
| 42689-0 | XR Spine Oblique | ./2.16.840.1.114222.4.11.1002/42689-0.json |
| 42690-8 | XR Spine Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/42690-8.json |
| 42691-6 | XR Cervical spine 6 Views | ./2.16.840.1.114222.4.11.1002/42691-6.json |
| 42692-4 | XR Thoracic and lumbar spine Views | ./2.16.840.1.114222.4.11.1002/42692-4.json |
| 42693-2 | MR Urinary bladder and Urethra cine | ./2.16.840.1.114222.4.11.1002/42693-2.json |
| 42694-0 | MR Clavicle W contrast IV | ./2.16.840.1.114222.4.11.1002/42694-0.json |
| 42695-7 | MR Lower leg - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/42695-7.json |
| 42696-5 | MR Lower leg - bilateral | ./2.16.840.1.114222.4.11.1002/42696-5.json |
| 42697-3 | MR Lower leg - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/42697-3.json |
| 42698-1 | MR Cervical and thoracic and lumbar spine | ./2.16.840.1.114222.4.11.1002/42698-1.json |
| 42699-9 | XR Chest and Abdomen Single view | ./2.16.840.1.114222.4.11.1002/42699-9.json |
| 42700-5 | NM Bone Views W Tc-99m tagged WBC IV | ./2.16.840.1.114222.4.11.1002/42700-5.json |
| 42701-3 | CT Guidance for localization of placenta of Uterus | ./2.16.840.1.114222.4.11.1002/42701-3.json |
| 42702-1 | RF Greater than 1 hour | ./2.16.840.1.114222.4.11.1002/42702-1.json |
| 42703-9 | RF Less than 1 hour | ./2.16.840.1.114222.4.11.1002/42703-9.json |
| 42704-7 | Follicle Diameter baseline US | ./2.16.840.1.114222.4.11.1002/42704-7.json |
| 42705-4 | US Guidance for drainage of abscess and placement of drainage catheter of Appendix | ./2.16.840.1.114222.4.11.1002/42705-4.json |
| 42706-2 | US Guidance for injection of Pleural space | ./2.16.840.1.114222.4.11.1002/42706-2.json |
| 42707-0 | US Heart limited | ./2.16.840.1.114222.4.11.1002/42707-0.json |
| 42708-8 | NM Whole body Views W In-111 tiuxetan IV | ./2.16.840.1.114222.4.11.1002/42708-8.json |
| 42709-6 | NM Liver Blood pool | ./2.16.840.1.114222.4.11.1002/42709-6.json |
| 42710-4 | XR Cervical spine Limited Views | ./2.16.840.1.114222.4.11.1002/42710-4.json |
| 42711-2 | NM Whole body Views W In-111 tagged WBC IV | ./2.16.840.1.114222.4.11.1002/42711-2.json |
| 42712-0 | AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42712-0.json |
| 42713-8 | AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42713-8.json |
| 42714-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42714-6.json |
| 42715-3 | Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42715-3.json |
| 42716-1 | Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42716-1.json |
| 42717-9 | Mycobacterium tuberculosis complex genotype [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/42717-9.json |
| 42719-5 | Bilirubin.total [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/42719-5.json |
| 42722-9 | OmpC Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42722-9.json |
| 42723-7 | OmpC Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42723-7.json |
| 42724-5 | OmpC Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42724-5.json |
| 42725-2 | Bromide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/42725-2.json |
| 42726-0 | Cerebroside sulfatase [Enzymatic activity/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42726-0.json |
| 42727-8 | Fibrin D-dimer DDU [Mass/volume] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/42727-8.json |
| 42728-6 | pH of Ocular fluid | ./2.16.840.1.114222.4.11.1002/42728-6.json |
| 42757-5 | Troponin I.cardiac [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/42757-5.json |
| 42758-3 | Reticulocytes [#/volume] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/42758-3.json |
| 42772-4 | Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Nephelometry | ./2.16.840.1.114222.4.11.1002/42772-4.json |
| 42773-2 | Multiple drug resistant organism identified in Urine | ./2.16.840.1.114222.4.11.1002/42773-2.json |
| 42774-0 | Multiple drug resistant organism identified in Wound | ./2.16.840.1.114222.4.11.1002/42774-0.json |
| 42775-7 | Multiple drug resistant organism identified in Sputum | ./2.16.840.1.114222.4.11.1002/42775-7.json |
| 42776-5 | NM Unspecified body region Views for AV shunt | ./2.16.840.1.114222.4.11.1002/42776-5.json |
| 42777-3 | AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42777-3.json |
| 42778-1 | BRCA1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42778-1.json |
| 42779-9 | BRCA2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42779-9.json |
| 42780-7 | CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42780-7.json |
| 42782-3 | Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42782-3.json |
| 42783-1 | ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42783-1.json |
| 42785-6 | FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42785-6.json |
| 42786-4 | HER3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42786-4.json |
| 42787-2 | HER4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42787-2.json |
| 42788-0 | Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42788-0.json |
| 42789-8 | Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42789-8.json |
| 42791-4 | Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42791-4.json |
| 42792-2 | Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42792-2.json |
| 42793-0 | Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42793-0.json |
| 42794-8 | MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/42794-8.json |
| 42795-5 | Retinoblastoma protein [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/42795-5.json |
| 42803-7 | Bacteria identified in Isolate | ./2.16.840.1.114222.4.11.1002/42803-7.json |
| 42804-5 | Fungus identified in Isolate | ./2.16.840.1.114222.4.11.1002/42804-5.json |
| 42805-2 | Fungus identified in Specimen | ./2.16.840.1.114222.4.11.1002/42805-2.json |
| 42807-8 | Parasite identified in Isolate | ./2.16.840.1.114222.4.11.1002/42807-8.json |
| 42808-6 | Virus identified in Isolate | ./2.16.840.1.114222.4.11.1002/42808-6.json |
| 42811-0 | XR Wrist - right scaphoid single view | ./2.16.840.1.114222.4.11.1002/42811-0.json |
| 42812-8 | XR Wrist scaphoid single view | ./2.16.840.1.114222.4.11.1002/42812-8.json |
| 42813-6 | XR Wrist - bilateral scaphoid single view | ./2.16.840.1.114222.4.11.1002/42813-6.json |
| 42814-4 | XR Wrist - left scaphoid single view | ./2.16.840.1.114222.4.11.1002/42814-4.json |
| 42815-1 | Stachybotrys chartarum IgE Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42815-1.json |
| 42816-9 | Stachybotrys chartarum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42816-9.json |
| 42817-7 | CD38+Kappa+ cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/42817-7.json |
| 42855-7 | 11-Deoxycorticosterone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42855-7.json |
| 42856-5 | Benzoylecgonine [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/42856-5.json |
| 42857-3 | Calcium [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/42857-3.json |
| 42859-9 | Candida albicans Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42859-9.json |
| 42860-7 | Cannabinoids [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/42860-7.json |
| 42861-5 | Carbaryl [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42861-5.json |
| 42862-3 | Carbofuran [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/42862-3.json |
| 42863-1 | Cedar IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42863-1.json |
| 42864-9 | CD103 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42864-9.json |
| 42865-6 | CD117 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42865-6.json |
| 42866-4 | CD117 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42866-4.json |
| 42867-2 | CD117 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42867-2.json |
| 42868-0 | CD11c+CD19+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42868-0.json |
| 42869-8 | CD138 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/42869-8.json |
| 42870-6 | CD138 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42870-6.json |
| 42871-4 | CD138 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42871-4.json |
| 42872-2 | CD138 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42872-2.json |
| 42873-0 | CD18 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42873-0.json |
| 42874-8 | CD18 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42874-8.json |
| 42875-5 | CD22 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42875-5.json |
| 42876-3 | CD25+CD19+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42876-3.json |
| 42877-1 | CD3-CD16+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/42877-1.json |
| 42878-9 | CD3-CD16+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/42878-9.json |
| 42879-7 | CD3-CD16+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/42879-7.json |
| 42880-5 | CD3-CD57+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/42880-5.json |
| 42881-3 | CD3-CD57+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/42881-3.json |
| 42882-1 | CD3-CD57+ cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42882-1.json |
| 42883-9 | CD52 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42883-9.json |
| 42884-7 | CD52 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/42884-7.json |
| 42885-4 | CD52 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42885-4.json |
| 42886-2 | CD52 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42886-2.json |
| 42887-0 | CD79b cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/42887-0.json |
| 42888-8 | CD79b cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42888-8.json |
| 42889-6 | CD79b cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/42889-6.json |
| 42890-4 | Myeloperoxidase cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/42890-4.json |
| 42891-2 | Choriogonadotropin [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/42891-2.json |
| 42892-0 | Citrulline [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/42892-0.json |
| 42893-8 | Cladosporium herbarum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42893-8.json |
| 42894-6 | Clindamycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42894-6.json |
| 42895-3 | Colorado tick fever virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42895-3.json |
| 42896-1 | Colorado tick fever virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42896-1.json |
| 42897-9 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42897-9.json |
| 42898-7 | Cyclic citrullinated peptide IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42898-7.json |
| 42899-5 | Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42899-5.json |
| 42900-1 | Carrot IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42900-1.json |
| 42901-9 | Dihydrocodeine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42901-9.json |
| 42902-7 | Elastase.pancreatic [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/42902-7.json |
| 42903-5 | Enterovirus NOS Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42903-5.json |
| 42904-3 | Epicoccum purpurascens IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42904-3.json |
| 42905-0 | Formate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/42905-0.json |
| 42906-8 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/42906-8.json |
| 42907-6 | Helminthosporium sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42907-6.json |
| 42908-4 | Hematocrit [Volume Fraction] of Capillary blood | ./2.16.840.1.114222.4.11.1002/42908-4.json |
| 42909-2 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --1st specimen | ./2.16.840.1.114222.4.11.1002/42909-2.json |
| 42910-0 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --2nd specimen | ./2.16.840.1.114222.4.11.1002/42910-0.json |
| 42911-8 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid --3rd specimen | ./2.16.840.1.114222.4.11.1002/42911-8.json |
| 42912-6 | Hemoglobin.gastrointestinal [Presence] in Specimen --2nd specimen | ./2.16.840.1.114222.4.11.1002/42912-6.json |
| 42913-4 | Hemoglobin.gastrointestinal [Presence] in Specimen --1st specimen | ./2.16.840.1.114222.4.11.1002/42913-4.json |
| 42914-2 | HER2 [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/42914-2.json |
| 42915-9 | Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42915-9.json |
| 42916-7 | Histoplasma capsulatum Ag [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/42916-7.json |
| 42917-5 | HIV 1 RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42917-5.json |
| 42918-3 | Hydroflumethiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42918-3.json |
| 42919-1 | Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/42919-1.json |
| 42920-9 | Isovalerylcarnitine (C5) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/42920-9.json |
| 42921-7 | JC virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42921-7.json |
| 42922-5 | Ketamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/42922-5.json |
| 42923-3 | Firebush IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/42923-3.json |
| 42924-1 | Lactoferrin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/42924-1.json |
| 42928-2 | Filaria Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42928-2.json |
| 42930-8 | CD11+CD18+ cells [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/42930-8.json |
| 42931-6 | Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/42931-6.json |
| 42932-4 | CD40 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/42932-4.json |
| 42933-2 | CD79a cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/42933-2.json |
| 42934-0 | CD83 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/42934-0.json |
| 42936-5 | Intercellular substance IgA Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42936-5.json |
| 42937-3 | Acetylcholine receptor blocking Ab/Acetylcholine Ab.total in Serum | ./2.16.840.1.114222.4.11.1002/42937-3.json |
| 42938-1 | CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42938-1.json |
| 42939-9 | CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42939-9.json |
| 42940-7 | GALT gene allele 1 [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42940-7.json |
| 42941-5 | GALT gene allele 2 [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/42941-5.json |
| 42942-3 | Yersinia sp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42942-3.json |
| 42943-1 | Yersinia enterocolitica O:5,27 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42943-1.json |
| 42944-9 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42944-9.json |
| 42945-6 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42945-6.json |
| 42946-4 | Trypanosoma brucei rhodesiense Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42946-4.json |
| 42947-2 | Trypanosoma brucei Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42947-2.json |
| 42949-8 | Toxoplasma gondii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42949-8.json |
| 42950-6 | Toxocara canis Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/42950-6.json |
| 42951-4 | Taylorella equigenitalis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42951-4.json |
| 42952-2 | Snowshoe hare virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42952-2.json |
| 42953-0 | Snowshoe hare virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42953-0.json |
| 42954-8 | Sindbis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42954-8.json |
| 42955-5 | Semliki Forest virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42955-5.json |
| 42956-3 | SARS coronavirus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42956-3.json |
| 42957-1 | SARS coronavirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42957-1.json |
| 42958-9 | Salmonella typhimurium Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42958-9.json |
| 42959-7 | Salmonella typhi O Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42959-7.json |
| 42960-5 | Salmonella typhi H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42960-5.json |
| 42961-3 | Salmonella pullorum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42961-3.json |
| 42962-1 | Salmonella paratyphi C O Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42962-1.json |
| 42963-9 | Salmonella paratyphi C H Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42963-9.json |
| 42964-7 | Salmonella paratyphi B O Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42964-7.json |
| 42965-4 | Saint Louis encephalitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42965-4.json |
| 42966-2 | Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42966-2.json |
| 42967-0 | Rubella virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42967-0.json |
| 42968-8 | Rickettsia rickettsii IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42968-8.json |
| 42969-6 | Rickettsia rickettsii IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42969-6.json |
| 42970-4 | Pseudallescheria boydii IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42970-4.json |
| 42971-2 | Powassan virus IgM Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/42971-2.json |
| 42972-0 | Powassan virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42972-0.json |
| 42973-8 | Powassan virus IgG Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/42973-8.json |
| 42974-6 | Powassan virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42974-6.json |
| 42975-3 | Powassan virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42975-3.json |
| 42976-1 | PRRSV Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42976-1.json |
| 42977-9 | Porcine influenza virus A Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42977-9.json |
| 42978-7 | Polio virus 2 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42978-7.json |
| 42979-5 | Polio virus 3 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42979-5.json |
| 42980-3 | Polio virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42980-3.json |
| 42981-1 | Polio virus 1 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/42981-1.json |
| 42982-9 | Parainfluenza virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42982-9.json |
| 42983-7 | Parainfluenza virus 4 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/42983-7.json |
| 42984-5 | Parainfluenza virus 1 Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/42984-5.json |
| 42985-2 | Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42985-2.json |
| 42986-0 | Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/42986-0.json |
| 42987-8 | Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42987-8.json |
| 42988-6 | Mycoplasma synoviae Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42988-6.json |
| 42989-4 | Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/42989-4.json |
| 42990-2 | Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/42990-2.json |
| 42991-0 | Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42991-0.json |
| 42992-8 | Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42992-8.json |
| 42993-6 | Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42993-6.json |
| 42994-4 | Leptospira sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42994-4.json |
| 42995-1 | Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42995-1.json |
| 42996-9 | Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42996-9.json |
| 42998-5 | Leishmania tropica Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/42998-5.json |
| 42999-3 | Leishmania sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/42999-3.json |
| 43000-9 | Leishmania brasilensis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43000-9.json |
| 43001-7 | Legionella sp Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43001-7.json |
| 43002-5 | Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43002-5.json |
| 43003-3 | Jamestown canyon virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43003-3.json |
| 43004-1 | Jamestown canyon virus IgG Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/43004-1.json |
| 43005-8 | Jamestown canyon virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43005-8.json |
| 43006-6 | Jamestown canyon virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43006-6.json |
| 43007-4 | HTLV I+II Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43007-4.json |
| 43008-2 | HIV 1+2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43008-2.json |
| 43009-0 | HIV 1+2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43009-0.json |
| 43010-8 | HIV 1+2 Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43010-8.json |
| 43011-6 | HIV 1 p24 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43011-6.json |
| 43012-4 | HIV 1 gp41 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43012-4.json |
| 43013-2 | HIV 1 gp120+gp160 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43013-2.json |
| 43015-7 | Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43015-7.json |
| 43016-5 | Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43016-5.json |
| 43017-3 | Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43017-3.json |
| 43018-1 | Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43018-1.json |
| 43019-9 | Histoplasma capsulatum Ab [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43019-9.json |
| 43020-7 | Heterophile Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43020-7.json |
| 43021-5 | Herpes virus 8 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43021-5.json |
| 43022-3 | Herpes virus 7 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43022-3.json |
| 43023-1 | Herpes virus 7 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43023-1.json |
| 43024-9 | Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43024-9.json |
| 43025-6 | Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43025-6.json |
| 43026-4 | Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43026-4.json |
| 43027-2 | Herpes simplex virus 2 IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43027-2.json |
| 43028-0 | Herpes simplex virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43028-0.json |
| 43029-8 | Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43029-8.json |
| 43030-6 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43030-6.json |
| 43031-4 | Herpes simplex virus 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43031-4.json |
| 43032-2 | Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43032-2.json |
| 43033-0 | Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43033-0.json |
| 43034-8 | Feline leukemia virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43034-8.json |
| 43035-5 | Feline immunodeficiency virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43035-5.json |
| 43036-3 | Feline herpesvirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43036-3.json |
| 43037-1 | Fasciola hepatica Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43037-1.json |
| 43038-9 | Enterovirus NOS Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43038-9.json |
| 43039-7 | Ehrlichia sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43039-7.json |
| 43040-5 | Echovirus 30 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43040-5.json |
| 43041-3 | Echovirus 9 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43041-3.json |
| 43042-1 | Echovirus 4 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43042-1.json |
| 43043-9 | Echovirus 11 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43043-9.json |
| 43044-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43044-7.json |
| 43045-4 | Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43045-4.json |
| 43046-2 | Coxsackievirus A16 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43046-2.json |
| 43047-0 | Coxsackievirus A7 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43047-0.json |
| 43048-8 | Coxsackievirus A9 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43048-8.json |
| 43049-6 | Coxsackievirus A10 Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43049-6.json |
| 43050-4 | Coxiella burnetii phase 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43050-4.json |
| 43051-2 | Colorado tick fever virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43051-2.json |
| 43052-0 | Coccidioides sp Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43052-0.json |
| 43053-8 | Coccidioides immitis Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43053-8.json |
| 43055-3 | Clostridioides difficile toxin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43055-3.json |
| 43056-1 | Cladosporium sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43056-1.json |
| 43057-9 | Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43057-9.json |
| 43058-7 | Chlamydia trachomatis D+K IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43058-7.json |
| 43059-5 | Chlamydia trachomatis D+K IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43059-5.json |
| 43060-3 | Chlamydia trachomatis D+K IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43060-3.json |
| 43061-1 | Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43061-1.json |
| 43062-9 | Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43062-9.json |
| 43063-7 | Chlamydia sp IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43063-7.json |
| 43064-5 | Chikungunya virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43064-5.json |
| 43065-2 | Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43065-2.json |
| 43066-0 | Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43066-0.json |
| 43067-8 | Candida sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43067-8.json |
| 43068-6 | Campylobacter sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43068-6.json |
| 43069-4 | Burkholderia pseudomallei IgM Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/43069-4.json |
| 43070-2 | Burkholderia pseudomallei IgG Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/43070-2.json |
| 43071-0 | Brucella canis IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43071-0.json |
| 43072-8 | Brucella canis IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43072-8.json |
| 43073-6 | Bovine leukemia virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43073-6.json |
| 43074-4 | Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43074-4.json |
| 43075-1 | Borrelia burgdorferi C6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43075-1.json |
| 43076-9 | Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43076-9.json |
| 43077-7 | Borrelia burgdorferi Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43077-7.json |
| 43078-5 | Bluetongue virus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43078-5.json |
| 43079-3 | Bluetongue virus 17 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43079-3.json |
| 43080-1 | Bluetongue virus 13 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43080-1.json |
| 43081-9 | Bluetongue virus 11 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43081-9.json |
| 43082-7 | Bluetongue virus 10 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43082-7.json |
| 43084-3 | Blastomyces dermatitidis Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43084-3.json |
| 43085-0 | Babesia duncani Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43085-0.json |
| 43086-8 | Babesia divergens Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43086-8.json |
| 43087-6 | Babesia canis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43087-6.json |
| 43088-4 | Aspergillus sp Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43088-4.json |
| 43089-2 | Aspergillus niger Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43089-2.json |
| 43090-0 | Aspergillus flavus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43090-0.json |
| 43091-8 | Ascaris sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43091-8.json |
| 43092-6 | Arbovirus NOS Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43092-6.json |
| 43093-4 | Angiostrongylus costaricensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43093-4.json |
| 43094-2 | Angiostrongylus cantonensis Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43094-2.json |
| 43095-9 | Anaplasma marginale Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43095-9.json |
| 43096-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43096-7.json |
| 43097-5 | COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43097-5.json |
| 43102-3 | Neuronal nuclear type 3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43102-3.json |
| 43103-1 | CV2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43103-1.json |
| 43111-4 | Herpes simplex virus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43111-4.json |
| 43115-5 | Hexacarboxylporphyrin [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43115-5.json |
| 43121-3 | Echovirus 6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43121-3.json |
| 43132-0 | California encephalitis virus Ab [Units/volume] in Serum Qualitative | ./2.16.840.1.114222.4.11.1002/43132-0.json |
| 43154-4 | Spermatozoa [Presence] in Semen by Light microscopy --post concentration | ./2.16.840.1.114222.4.11.1002/43154-4.json |
| 43155-1 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post concentration | ./2.16.840.1.114222.4.11.1002/43155-1.json |
| 43158-5 | Chlorine.free [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/43158-5.json |
| 43159-3 | Formaldehyde [Mass/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/43159-3.json |
| 43161-9 | Microorganism [#/volume] in Specimen by Viability count | ./2.16.840.1.114222.4.11.1002/43161-9.json |
| 43162-7 | Monochloramine [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/43162-7.json |
| 43163-5 | Quaternary ammonium compound [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43163-5.json |
| 43164-3 | Silica [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/43164-3.json |
| 43165-0 | Dissolved solids [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/43165-0.json |
| 43166-8 | Carbon.organic [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43166-8.json |
| 43169-2 | Bromide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/43169-2.json |
| 43170-0 | Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43170-0.json |
| 43171-8 | Interleukin 2 receptor [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43171-8.json |
| 43172-6 | Triiodothyronine (T3) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43172-6.json |
| 43173-4 | Chlamydia trachomatis L2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43173-4.json |
| 43174-2 | Chlamydia trachomatis L2 IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43174-2.json |
| 43175-9 | Chlamydia trachomatis L2 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43175-9.json |
| 43176-7 | Lithium [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/43176-7.json |
| 43177-5 | Phenmetrazine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/43177-5.json |
| 43178-3 | Phentermine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/43178-3.json |
| 43179-1 | Asialoganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43179-1.json |
| 43180-9 | Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/43180-9.json |
| 43181-7 | Arsenic organic [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43181-7.json |
| 43182-5 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43182-5.json |
| 43183-3 | Cyanide [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43183-3.json |
| 43184-1 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43184-1.json |
| 43187-4 | Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43187-4.json |
| 43188-2 | Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43188-2.json |
| 43189-0 | Baker's yeast IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43189-0.json |
| 43190-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43190-8.json |
| 43191-6 | FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43191-6.json |
| 43192-4 | Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43192-4.json |
| 43193-2 | Legionella non-pneumophila Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43193-2.json |
| 43194-0 | Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43194-0.json |
| 43195-7 | Nicotine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43195-7.json |
| 43196-5 | Cotinine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43196-5.json |
| 43197-3 | Gamma hydroxybutyrate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/43197-3.json |
| 43198-1 | Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43198-1.json |
| 43199-9 | Norfentanyl [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43199-9.json |
| 43200-5 | Norfentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43200-5.json |
| 43201-3 | BK virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43201-3.json |
| 43202-1 | Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43202-1.json |
| 43203-9 | Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/43203-9.json |
| 43204-7 | Parainfluenza virus 2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43204-7.json |
| 43205-4 | Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/43205-4.json |
| 43206-2 | Tetrachloroethylene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/43206-2.json |
| 43207-0 | Invasive trophoblast Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43207-0.json |
| 43209-6 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43209-6.json |
| 43210-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43210-4.json |
| 43211-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe | ./2.16.840.1.114222.4.11.1002/43211-2.json |
| 43213-8 | Polychlorinated biphenyl (PCB) [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/43213-8.json |
| 43214-6 | Bacteria identified in Nasopharynx by Culture | ./2.16.840.1.114222.4.11.1002/43214-6.json |
| 43216-1 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43216-1.json |
| 43218-7 | Nicotine+Cotinine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43218-7.json |
| 43219-5 | traMADol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43219-5.json |
| 43221-1 | Chloride/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/43221-1.json |
| 43222-9 | Potassium/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/43222-9.json |
| 43223-7 | Sodium/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/43223-7.json |
| 43224-5 | Coccidioides sp Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/43224-5.json |
| 43225-2 | Toxocara sp Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43225-2.json |
| 43226-0 | 2-Hydroxyisocaproate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43226-0.json |
| 43227-8 | Ova and parasites identified in Stool by Trichrome stain | ./2.16.840.1.114222.4.11.1002/43227-8.json |
| 43228-6 | Cryptococcus sp Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/43228-6.json |
| 43229-4 | Cryptococcus sp Ag [Titer] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/43229-4.json |
| 43230-2 | Benzoylecgonine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43230-2.json |
| 43231-0 | Histone Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43231-0.json |
| 43232-8 | Saint Louis encephalitis virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43232-8.json |
| 43233-6 | OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43233-6.json |
| 43234-4 | Liver kidney microsomal 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43234-4.json |
| 43235-1 | Acrylylcarnitine (C3:1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43235-1.json |
| 43236-9 | Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43236-9.json |
| 43237-7 | Thrombopoietin [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/43237-7.json |
| 43238-5 | Treponema pallidum Ab [Presence] in Serum from Donor by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43238-5.json |
| 43239-3 | Norsildenafil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43239-3.json |
| 43240-1 | Ganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43240-1.json |
| 43241-9 | Ganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43241-9.json |
| 43242-7 | ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43242-7.json |
| 43244-3 | Herpes virus 6 DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43244-3.json |
| 43245-0 | Erythrocytes [#/volume] in Semen by Light microscopy | ./2.16.840.1.114222.4.11.1002/43245-0.json |
| 43246-8 | PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43246-8.json |
| 43247-6 | Catecholamines/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43247-6.json |
| 43248-4 | EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43248-4.json |
| 43250-0 | Xanthine derivatives [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43250-0.json |
| 43265-8 | Benztropine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43265-8.json |
| 43266-6 | Leishmania chagasi K39 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43266-6.json |
| 43273-2 | CD19+CD27+IgD+ cells/100 cells in Blood or Tissue | ./2.16.840.1.114222.4.11.1002/43273-2.json |
| 43274-0 | CD1c+CD22+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/43274-0.json |
| 43275-7 | CD3 cells/CD4 cells [# Ratio] in Specimen | ./2.16.840.1.114222.4.11.1002/43275-7.json |
| 43277-3 | GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43277-3.json |
| 43278-1 | Glucose [Mass/volume] in Milk --2 hours post meal | ./2.16.840.1.114222.4.11.1002/43278-1.json |
| 43279-9 | Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43279-9.json |
| 43280-7 | Hepatitis D virus Ag [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/43280-7.json |
| 43281-5 | Hepatitis D virus Ag [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43281-5.json |
| 43290-6 | HLA-DRB1 [Presence] | ./2.16.840.1.114222.4.11.1002/43290-6.json |
| 43291-4 | HLA-DQB1 [Presence] | ./2.16.840.1.114222.4.11.1002/43291-4.json |
| 43292-2 | Neutrophil oxidative burst/unstimulated in Blood | ./2.16.840.1.114222.4.11.1002/43292-2.json |
| 43293-0 | HTLV I+II p28 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43293-0.json |
| 43294-8 | HTLV I+II p26 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43294-8.json |
| 43295-5 | HTLV I+II p53 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43295-5.json |
| 43296-3 | HTLV I+II gp46 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43296-3.json |
| 43297-1 | HTLV I+II p32 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43297-1.json |
| 43298-9 | HTLV I+II rgp21 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43298-9.json |
| 43299-7 | HTLV I+II p19 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43299-7.json |
| 43300-3 | HTLV I+II p24 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43300-3.json |
| 43301-1 | HTLV I+II p36 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43301-1.json |
| 43302-9 | Platelet glycoprotein Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43302-9.json |
| 43303-7 | Immune Complex C3d [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43303-7.json |
| 43304-5 | Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43304-5.json |
| 43305-2 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43305-2.json |
| 43307-8 | Bacteria identified in Sinus by Culture | ./2.16.840.1.114222.4.11.1002/43307-8.json |
| 43308-6 | Lupus anticoagulant neutralization buffer [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/43308-6.json |
| 43310-2 | FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43310-2.json |
| 43311-0 | Desmoglein 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43311-0.json |
| 43312-8 | Desmoglein 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43312-8.json |
| 43313-6 | Avian adenovirus 127 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43313-6.json |
| 43314-4 | Avian paramyxovirus 6 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43314-4.json |
| 43315-1 | Avian paramyxovirus 7 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43315-1.json |
| 43316-9 | Avian paramyxovirus 8 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43316-9.json |
| 43317-7 | Avian paramyxovirus 9 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43317-7.json |
| 43318-5 | Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43318-5.json |
| 43319-3 | Avian metapneumovirus A Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43319-3.json |
| 43320-1 | Avian metapneumovirus B Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43320-1.json |
| 43321-9 | Avian metapneumovirus B Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43321-9.json |
| 43322-7 | Avian metapneumovirus C Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43322-7.json |
| 43323-5 | Avian metapneumovirus C Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43323-5.json |
| 43324-3 | Avian reovirus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43324-3.json |
| 43325-0 | Chicken anemia virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43325-0.json |
| 43326-8 | Classical swine fever virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/43326-8.json |
| 43327-6 | Classical swine fever virus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/43327-6.json |
| 43328-4 | Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43328-4.json |
| 43329-2 | Eastern equine encephalitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/43329-2.json |
| 43330-0 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43330-0.json |
| 43331-8 | Ehrlichia risticii Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43331-8.json |
| 43332-6 | Equine herpesvirus 1 neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/43332-6.json |
| 43333-4 | Equine herpesvirus 2 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/43333-4.json |
| 43334-2 | Equine herpesvirus 3 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/43334-2.json |
| 43335-9 | Fowl adenovirus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/43335-9.json |
| 43336-7 | Goose parvovirus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43336-7.json |
| 43337-5 | Goose parvovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43337-5.json |
| 43338-3 | Infectious bronchitis virus JMK Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/43338-3.json |
| 43339-1 | Porcine adenovirus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43339-1.json |
| 43340-9 | Psittacid herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43340-9.json |
| 43341-7 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43341-7.json |
| 43342-5 | West Nile virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/43342-5.json |
| 43343-3 | West Nile virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43343-3.json |
| 43344-1 | Avian adenovirus 127 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43344-1.json |
| 43345-8 | Avian paramyxovirus 6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43345-8.json |
| 43346-6 | Avian paramyxovirus 7 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43346-6.json |
| 43347-4 | Avian paramyxovirus 8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43347-4.json |
| 43348-2 | Avian paramyxovirus 9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43348-2.json |
| 43349-0 | Avian metapneumovirus A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43349-0.json |
| 43350-8 | Avian metapneumovirus A Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43350-8.json |
| 43351-6 | Avian metapneumovirus B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43351-6.json |
| 43352-4 | Avian metapneumovirus B Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43352-4.json |
| 43353-2 | Avian metapneumovirus C Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43353-2.json |
| 43354-0 | Avian metapneumovirus C Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43354-0.json |
| 43355-7 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43355-7.json |
| 43356-5 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43356-5.json |
| 43357-3 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43357-3.json |
| 43358-1 | UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43358-1.json |
| 43359-9 | 11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43359-9.json |
| 43360-7 | Bordetella sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43360-7.json |
| 43361-5 | Cardiolipin IgA Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43361-5.json |
| 43362-3 | Cardiolipin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43362-3.json |
| 43363-1 | Cardiolipin IgM Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43363-1.json |
| 43364-9 | Enterovirus identified in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43364-9.json |
| 43365-6 | Nocardia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43365-6.json |
| 43366-4 | Parainfluenza virus Ag [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43366-4.json |
| 43368-0 | Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43368-0.json |
| 43369-8 | PlA1 Ab [Presence] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/43369-8.json |
| 43370-6 | CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43370-6.json |
| 43371-4 | Salmonella and Shigella sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43371-4.json |
| 43378-9 | Spermatozoa Motile [#/volume] in Semen --post washing | ./2.16.840.1.114222.4.11.1002/43378-9.json |
| 43379-7 | HLA-DRB3 [Presence] | ./2.16.840.1.114222.4.11.1002/43379-7.json |
| 43380-5 | Coccidioides immitis IgG Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43380-5.json |
| 43381-3 | Bordetella pertussis Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43381-3.json |
| 43383-9 | Neisseria sp identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43383-9.json |
| 43384-7 | Neisseria sp identified in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43384-7.json |
| 43385-4 | Neisseria sp identified in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43385-4.json |
| 43386-2 | Neisseria sp identified in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43386-2.json |
| 43387-0 | Neisseria sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43387-0.json |
| 43389-6 | Streptococcus sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43389-6.json |
| 43390-4 | Streptococcus sp identified in Isolate | ./2.16.840.1.114222.4.11.1002/43390-4.json |
| 43392-0 | LDL 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43392-0.json |
| 43393-8 | LDL 4 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43393-8.json |
| 43394-6 | Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43394-6.json |
| 43395-3 | Cholesterol in VLDL acylated [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43395-3.json |
| 43399-5 | JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43399-5.json |
| 43401-9 | Cryofibrinogen [Presence] in Plasma by 1 week 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/43401-9.json |
| 43402-7 | Erythrocyte sedimentation rate by 15 minute reading | ./2.16.840.1.114222.4.11.1002/43402-7.json |
| 43403-5 | Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43403-5.json |
| 43404-3 | Chlamydia trachomatis DNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43404-3.json |
| 43405-0 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43405-0.json |
| 43406-8 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/43406-8.json |
| 43407-6 | Bacteria identified in Wound deep by Culture | ./2.16.840.1.114222.4.11.1002/43407-6.json |
| 43408-4 | Bacteria identified in Tissue by Culture | ./2.16.840.1.114222.4.11.1002/43408-4.json |
| 43409-2 | Bacteria identified in Isolate by Culture | ./2.16.840.1.114222.4.11.1002/43409-2.json |
| 43410-0 | Bacteria identified in Cervix by Culture | ./2.16.840.1.114222.4.11.1002/43410-0.json |
| 43411-8 | Bacteria identified in Aspirate by Culture | ./2.16.840.1.114222.4.11.1002/43411-8.json |
| 43416-7 | Hematocrit [Volume Fraction] of Stem cell product | ./2.16.840.1.114222.4.11.1002/43416-7.json |
| 43417-5 | Microscopic observation [Identifier] in Esophageal brushing by Cyto stain | ./2.16.840.1.114222.4.11.1002/43417-5.json |
| 43421-7 | Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/43421-7.json |
| 43422-5 | Rabbit dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/43422-5.json |
| 43424-1 | Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43424-1.json |
| 43425-8 | Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43425-8.json |
| 43426-6 | Bacteria identified in Nasopharynx by Aerobe culture | ./2.16.840.1.114222.4.11.1002/43426-6.json |
| 43427-4 | Microscopic observation [Identifier] in Tissue by Rapid stain | ./2.16.840.1.114222.4.11.1002/43427-4.json |
| 43428-2 | Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain | ./2.16.840.1.114222.4.11.1002/43428-2.json |
| 43429-0 | Haemophilus influenzae B Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43429-0.json |
| 43430-8 | Neisseria meningitidis serogroup B Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43430-8.json |
| 43431-6 | Escherichia coli K1 Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43431-6.json |
| 43432-4 | Escherichia coli K1 Ag [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43432-4.json |
| 43441-5 | Bacteria identified in Bronchoalveolar lavage by Aerobe culture | ./2.16.840.1.114222.4.11.1002/43441-5.json |
| 43442-3 | Bacteria identified in Bronchial brush by Aerobe culture | ./2.16.840.1.114222.4.11.1002/43442-3.json |
| 43444-9 | CT Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/43444-9.json |
| 43445-6 | CT Pulmonary system | ./2.16.840.1.114222.4.11.1002/43445-6.json |
| 43448-0 | MR Liver WO and W ferumoxides IV | ./2.16.840.1.114222.4.11.1002/43448-0.json |
| 43449-8 | MR Ankle - right dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43449-8.json |
| 43450-6 | MR Elbow - left dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43450-6.json |
| 43451-4 | MR Elbow - right dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43451-4.json |
| 43452-2 | MR Knee - left dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43452-2.json |
| 43453-0 | MR Knee - right dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43453-0.json |
| 43454-8 | MR Pulmonary system | ./2.16.840.1.114222.4.11.1002/43454-8.json |
| 43455-5 | MR Oropharynx | ./2.16.840.1.114222.4.11.1002/43455-5.json |
| 43456-3 | MR Cervical and thoracic spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43456-3.json |
| 43457-1 | MR Cervical and thoracic spine | ./2.16.840.1.114222.4.11.1002/43457-1.json |
| 43458-9 | MRA Orbit vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43458-9.json |
| 43459-7 | NM Brain Views during electroconvulsive shock treatment | ./2.16.840.1.114222.4.11.1002/43459-7.json |
| 43461-3 | NM Kidney Views W furosemide IV | ./2.16.840.1.114222.4.11.1002/43461-3.json |
| 43463-9 | XR Chest PA and Abdomen Supine and Upright | ./2.16.840.1.114222.4.11.1002/43463-9.json |
| 43466-2 | XR Chest AP right lateral-decubitus | ./2.16.840.1.114222.4.11.1002/43466-2.json |
| 43467-0 | XR Chest 2 Views and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/43467-0.json |
| 43468-8 | XR Unspecified body region Views | ./2.16.840.1.114222.4.11.1002/43468-8.json |
| 43469-6 | XR Unspecified body region Views for foreign body | ./2.16.840.1.114222.4.11.1002/43469-6.json |
| 43470-4 | XR Skull LE 3 Views | ./2.16.840.1.114222.4.11.1002/43470-4.json |
| 43471-2 | RF 2 hour | ./2.16.840.1.114222.4.11.1002/43471-2.json |
| 43472-0 | RF 90 minutes | ./2.16.840.1.114222.4.11.1002/43472-0.json |
| 43473-8 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 2H post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43473-8.json |
| 43474-6 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 15m post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43474-6.json |
| 43475-3 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 30M post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43475-3.json |
| 43476-1 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 45M post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43476-1.json |
| 43477-9 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1H post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43477-9.json |
| 43478-7 | RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1.5 hours post contrast retrograde intrabiliary | ./2.16.840.1.114222.4.11.1002/43478-7.json |
| 43479-5 | RFA Abdominal Aorta Runoff W contrast IA | ./2.16.840.1.114222.4.11.1002/43479-5.json |
| 43480-3 | XR Joint Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/43480-3.json |
| 43481-1 | XR Joint Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/43481-1.json |
| 43482-9 | XR Knee - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43482-9.json |
| 43483-7 | XR Foot - right 3 or 4 Views | ./2.16.840.1.114222.4.11.1002/43483-7.json |
| 43485-2 | XR Kidney Views during surgery W contrast retrograde | ./2.16.840.1.114222.4.11.1002/43485-2.json |
| 43486-0 | XR Sinuses GE 3 Views | ./2.16.840.1.114222.4.11.1002/43486-0.json |
| 43487-8 | US Guidance for placement of radiation therapy fields in Unspecified body region | ./2.16.840.1.114222.4.11.1002/43487-8.json |
| 43488-6 | XR Thumb - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43488-6.json |
| 43489-4 | XR Finger second - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43489-4.json |
| 43490-2 | XR Finger third - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43490-2.json |
| 43491-0 | XR Finger fourth - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43491-0.json |
| 43492-8 | XR Finger fifth - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43492-8.json |
| 43493-6 | XR Thumb - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43493-6.json |
| 43494-4 | XR Finger second - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43494-4.json |
| 43495-1 | XR Finger third - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43495-1.json |
| 43496-9 | XR Finger fourth - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43496-9.json |
| 43497-7 | XR Finger fifth - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/43497-7.json |
| 43498-5 | XR Knee - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/43498-5.json |
| 43499-3 | XR Foot - left 3 or 4 Views | ./2.16.840.1.114222.4.11.1002/43499-3.json |
| 43500-8 | NM Vessel Views for blood flow | ./2.16.840.1.114222.4.11.1002/43500-8.json |
| 43501-6 | NM Vessel Views | ./2.16.840.1.114222.4.11.1002/43501-6.json |
| 43502-4 | CT Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space | ./2.16.840.1.114222.4.11.1002/43502-4.json |
| 43504-0 | MR Axilla - left W contrast IV | ./2.16.840.1.114222.4.11.1002/43504-0.json |
| 43505-7 | MR Axilla - right W contrast IV | ./2.16.840.1.114222.4.11.1002/43505-7.json |
| 43506-5 | MR Ovary - bilateral | ./2.16.840.1.114222.4.11.1002/43506-5.json |
| 43507-3 | MR Thymus gland | ./2.16.840.1.114222.4.11.1002/43507-3.json |
| 43508-1 | MR Axilla - left | ./2.16.840.1.114222.4.11.1002/43508-1.json |
| 43509-9 | MR Axilla - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43509-9.json |
| 43510-7 | MR Axilla - right | ./2.16.840.1.114222.4.11.1002/43510-7.json |
| 43511-5 | MR Axilla - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43511-5.json |
| 43512-3 | MRA Lower leg vessels - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/43512-3.json |
| 43513-1 | MRA Lower leg vessels - left | ./2.16.840.1.114222.4.11.1002/43513-1.json |
| 43514-9 | MRA Thigh vessels - left WO contrast | ./2.16.840.1.114222.4.11.1002/43514-9.json |
| 43515-6 | MRA Thigh vessels - right WO contrast | ./2.16.840.1.114222.4.11.1002/43515-6.json |
| 43516-4 | MRA Wrist vessels - left WO contrast | ./2.16.840.1.114222.4.11.1002/43516-4.json |
| 43517-2 | MRA Wrist vessels - right WO contrast | ./2.16.840.1.114222.4.11.1002/43517-2.json |
| 43518-0 | XR Bones Survey Views | ./2.16.840.1.114222.4.11.1002/43518-0.json |
| 43519-8 | XR Bones Limited Survey Views | ./2.16.840.1.114222.4.11.1002/43519-8.json |
| 43521-4 | XR Mandible 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/43521-4.json |
| 43522-2 | XR Pelvis 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/43522-2.json |
| 43523-0 | XR Sinuses 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/43523-0.json |
| 43524-8 | XR Skull GE 5 Views | ./2.16.840.1.114222.4.11.1002/43524-8.json |
| 43525-5 | CT Unspecified body region WO contrast | ./2.16.840.1.114222.4.11.1002/43525-5.json |
| 43526-3 | SPECT Unspecified body region | ./2.16.840.1.114222.4.11.1002/43526-3.json |
| 43528-9 | MR Breast - unilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43528-9.json |
| 43529-7 | XR Orbit and Facial bones Views | ./2.16.840.1.114222.4.11.1002/43529-7.json |
| 43530-5 | MR Orbit and Face and Neck | ./2.16.840.1.114222.4.11.1002/43530-5.json |
| 43532-1 | XR Chest PA and Abdomen Upright | ./2.16.840.1.114222.4.11.1002/43532-1.json |
| 43536-2 | RF videography Lumbar spine Views | ./2.16.840.1.114222.4.11.1002/43536-2.json |
| 43537-0 | RF Guidance for drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/43537-0.json |
| 43538-8 | RF videography Cervical spine Views | ./2.16.840.1.114222.4.11.1002/43538-8.json |
| 43539-6 | XR Cervical spine 2 or 3 Views | ./2.16.840.1.114222.4.11.1002/43539-6.json |
| 43543-8 | XR Pelvis GE 3 Views | ./2.16.840.1.114222.4.11.1002/43543-8.json |
| 43550-3 | NM Brain Views for blood flow and function | ./2.16.840.1.114222.4.11.1002/43550-3.json |
| 43552-9 | US Carotid arteries - unilateral | ./2.16.840.1.114222.4.11.1002/43552-9.json |
| 43554-5 | RFA Vessels - left Views W contrast IV | ./2.16.840.1.114222.4.11.1002/43554-5.json |
| 43555-2 | MR Ankle - left dynamic W contrast IV | ./2.16.840.1.114222.4.11.1002/43555-2.json |
| 43556-0 | MRA Lower leg vessels - right | ./2.16.840.1.114222.4.11.1002/43556-0.json |
| 43557-8 | NM Liver and Biliary ducts and Gallbladder Views | ./2.16.840.1.114222.4.11.1002/43557-8.json |
| 43558-6 | RF Guidance for change of dialysis catheter in Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/43558-6.json |
| 43559-4 | RF Urinary bladder and Urethra Views W contrast intra bladder during voiding | ./2.16.840.1.114222.4.11.1002/43559-4.json |
| 43561-0 | XR Chest AP and Abdomen Upright | ./2.16.840.1.114222.4.11.1002/43561-0.json |
| 43562-8 | NM Skeletal system.axial Views for bone density | ./2.16.840.1.114222.4.11.1002/43562-8.json |
| 43563-6 | NM Skeletal system.peripheral Views for bone density | ./2.16.840.1.114222.4.11.1002/43563-6.json |
| 43564-4 | US Guidance for superficial biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/43564-4.json |
| 43565-1 | US Guidance for deep biopsy of Bone | ./2.16.840.1.114222.4.11.1002/43565-1.json |
| 43566-9 | US Hip and Thigh | ./2.16.840.1.114222.4.11.1002/43566-9.json |
| 43567-7 | CT Guidance for deep biopsy of Bone | ./2.16.840.1.114222.4.11.1002/43567-7.json |
| 43569-3 | XR Thoracic and lumbar spine AP Views for scoliosis upright and supine | ./2.16.840.1.114222.4.11.1002/43569-3.json |
| 43570-1 | Portable XR Hand Views | ./2.16.840.1.114222.4.11.1002/43570-1.json |
| 43572-7 | US.doppler Abdominal vessels limited | ./2.16.840.1.114222.4.11.1002/43572-7.json |
| 43573-5 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/43573-5.json |
| 43574-3 | RF Upper gastrointestinal tract and Small bowel Views W barium contrast PO | ./2.16.840.1.114222.4.11.1002/43574-3.json |
| 43575-0 | Complement C3 [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/43575-0.json |
| 43577-6 | Histamine/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/43577-6.json |
| 43578-4 | Complement C3 [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/43578-4.json |
| 43579-2 | Complement C3 [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43579-2.json |
| 43580-0 | Complement C4 [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/43580-0.json |
| 43581-8 | Complement C4 [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/43581-8.json |
| 43582-6 | Complement C4 [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/43582-6.json |
| 43583-4 | Lipoprotein a [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43583-4.json |
| 43585-9 | TYMP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43585-9.json |
| 43586-7 | Yersinia pseudotuberculosis Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43586-7.json |
| 43587-5 | Grape IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/43587-5.json |
| 43588-3 | Varicella zoster virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43588-3.json |
| 43589-1 | Shigella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43589-1.json |
| 43590-9 | Rabies virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43590-9.json |
| 43591-7 | Peach IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/43591-7.json |
| 43592-5 | Plum IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/43592-5.json |
| 43593-3 | Plasmodium malariae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43593-3.json |
| 43594-1 | Nidus [Mass] in Stone | ./2.16.840.1.114222.4.11.1002/43594-1.json |
| 43595-8 | Methadone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/43595-8.json |
| 43596-6 | Apple IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/43596-6.json |
| 43597-4 | Inner ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/43597-4.json |
| 43598-2 | Indicans [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43598-2.json |
| 43599-0 | HIV 1 Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43599-0.json |
| 43600-6 | Ganglioside GD1b IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43600-6.json |
| 43601-4 | Ganglioside GD1b IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43601-4.json |
| 43602-2 | Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43602-2.json |
| 43605-5 | Microalbumin [Mass/volume] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/43605-5.json |
| 43606-3 | Microalbumin [Mass/time] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/43606-3.json |
| 43607-1 | Microalbumin [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/43607-1.json |
| 43608-9 | Adrenal cortex Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43608-9.json |
| 43609-7 | Adipate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43609-7.json |
| 43610-5 | Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43610-5.json |
| 43611-3 | Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43611-3.json |
| 43612-1 | Adenovirus Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43612-1.json |
| 43613-9 | Adenovirus Ag [Presence] in Trachea by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43613-9.json |
| 43614-7 | Adenovirus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/43614-7.json |
| 43615-4 | Adenovirus Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/43615-4.json |
| 43616-2 | Adenovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43616-2.json |
| 43617-0 | Adenovirus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43617-0.json |
| 43618-8 | Adenovirus Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/43618-8.json |
| 43619-6 | Actinomyces sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43619-6.json |
| 43620-4 | Actinomyces israelii Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43620-4.json |
| 43621-2 | Actinomyces bovis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43621-2.json |
| 43622-0 | Aconitate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43622-0.json |
| 43623-8 | Acetylcholine receptor blocking Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43623-8.json |
| 43624-6 | Acetylcholine receptor binding Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43624-6.json |
| 43625-3 | Acetylcholine receptor Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43625-3.json |
| 43626-1 | Acetohexamide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43626-1.json |
| 43627-9 | Acetazolamide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43627-9.json |
| 43629-5 | 8-Hydroxyamoxapine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43629-5.json |
| 43630-3 | 6-Thioguanine [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/43630-3.json |
| 43631-1 | 6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/43631-1.json |
| 43632-9 | 6-Methylmercaptopurine [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/43632-9.json |
| 43633-7 | 5-Oxoproline [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43633-7.json |
| 43634-5 | 3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43634-5.json |
| 43635-2 | 2-Hydroxyglutarate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43635-2.json |
| 43636-0 | Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/43636-0.json |
| 43637-8 | Parrot droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43637-8.json |
| 43638-6 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43638-6.json |
| 43639-4 | Mercaptopurine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/43639-4.json |
| 43640-2 | Aldosterone-18-glucuronide [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/43640-2.json |
| 43641-0 | XR Foot sesamoid bones - left Views | ./2.16.840.1.114222.4.11.1002/43641-0.json |
| 43642-8 | NM Brain Views for blood flow W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/43642-8.json |
| 43643-6 | NM Brain Views for blood flow W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/43643-6.json |
| 43644-4 | NM Brain Limited Views for blood flow | ./2.16.840.1.114222.4.11.1002/43644-4.json |
| 43645-1 | NM Heart Qualitative Views for infarct | ./2.16.840.1.114222.4.11.1002/43645-1.json |
| 43646-9 | NM Heart Qualitative and Quantitative Views for infarct | ./2.16.840.1.114222.4.11.1002/43646-9.json |
| 43647-7 | NM Heart Quantitative Views for infarct | ./2.16.840.1.114222.4.11.1002/43647-7.json |
| 43648-5 | NM Unspecified body region Views for endocrine tumor multiple areas W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/43648-5.json |
| 43649-3 | NM Unspecified body region Views for endocrine tumor multiple areas W In-111 pentetreotide IV | ./2.16.840.1.114222.4.11.1002/43649-3.json |
| 43650-1 | NM Liver and Biliary ducts and Gallbladder Views W cholecystokinin and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/43650-1.json |
| 43651-9 | NM Liver and Biliary ducts and Gallbladder Views W sincalide and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/43651-9.json |
| 43652-7 | SPECT Liver and Spleen for blood flow | ./2.16.840.1.114222.4.11.1002/43652-7.json |
| 43653-5 | NM Liver and Spleen Views for blood flow | ./2.16.840.1.114222.4.11.1002/43653-5.json |
| 43654-3 | NM Liver Views for blood flow W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/43654-3.json |
| 43655-0 | SPECT Liver for blood flow | ./2.16.840.1.114222.4.11.1002/43655-0.json |
| 43656-8 | NM Lung Perfusion quantitative | ./2.16.840.1.114222.4.11.1002/43656-8.json |
| 43657-6 | NM Lung Quantitative Views | ./2.16.840.1.114222.4.11.1002/43657-6.json |
| 43658-4 | NM Heart Perfusion quantitative | ./2.16.840.1.114222.4.11.1002/43658-4.json |
| 43659-2 | SPECT Heart perfusion qualitative at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/43659-2.json |
| 43660-0 | NM Heart Perfusion qualitative at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/43660-0.json |
| 43661-8 | NM Heart Perfusion quantitative at rest and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/43661-8.json |
| 43662-6 | SPECT Renal vessels for blood flow W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/43662-6.json |
| 43663-4 | NM Renal vessels Views for blood flow W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/43663-4.json |
| 43664-2 | NM Renal vessels Views for blood flow W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/43664-2.json |
| 43665-9 | NM Renal vessels Views for blood flow W Tc-99m Mertiatide IV | ./2.16.840.1.114222.4.11.1002/43665-9.json |
| 43666-7 | NM Kidney+Renal vessels Views for blood flow W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/43666-7.json |
| 43667-5 | NM Kidney+Renal vessels Views W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/43667-5.json |
| 43669-1 | NM Renal vessels Views | ./2.16.840.1.114222.4.11.1002/43669-1.json |
| 43670-9 | SPECT Spleen for blood flow | ./2.16.840.1.114222.4.11.1002/43670-9.json |
| 43671-7 | NM Thyroid gland Spot | ./2.16.840.1.114222.4.11.1002/43671-7.json |
| 43672-5 | NM Thyroid gland Views and Views uptake | ./2.16.840.1.114222.4.11.1002/43672-5.json |
| 43673-3 | SPECT Thyroid gland for blood flow | ./2.16.840.1.114222.4.11.1002/43673-3.json |
| 43686-5 | Salivary gland IgA Ab [Units/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/43686-5.json |
| 43687-3 | Powassan virus polyvalent E Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/43687-3.json |
| 43688-1 | 16-Alpha hydroxypregnenolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/43688-1.json |
| 43691-5 | Cladosporium sp IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43691-5.json |
| 43693-1 | Varicella zoster virus identified in Skin by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43693-1.json |
| 43694-9 | Inner ear 68kD Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/43694-9.json |
| 43695-6 | Herpes virus identified in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43695-6.json |
| 43696-4 | Herpes simplex virus identified in Cerebral spinal fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43696-4.json |
| 43697-2 | Herpes simplex virus identified in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43697-2.json |
| 43698-0 | Enterovirus identified in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43698-0.json |
| 43699-8 | Enterovirus identified in Cerebral spinal fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43699-8.json |
| 43700-4 | Cytomegalovirus [Presence] in Urine by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43700-4.json |
| 43701-2 | Cytomegalovirus [Presence] in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43701-2.json |
| 43702-0 | Cytomegalovirus [Presence] in Cerebral spinal fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43702-0.json |
| 43703-8 | Cytomegalovirus [Presence] in Blood by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43703-8.json |
| 43704-6 | Cytomegalovirus [Presence] in Body fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43704-6.json |
| 43705-3 | Cytomegalovirus [Presence] in Bone marrow by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43705-3.json |
| 43706-1 | Cytomegalovirus [Presence] in Anal by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43706-1.json |
| 43707-9 | Cytomegalovirus [Presence] in Tissue by Shell vial culture | ./2.16.840.1.114222.4.11.1002/43707-9.json |
| 43711-1 | Albumin [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43711-1.json |
| 43712-9 | Albumin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43712-9.json |
| 43713-7 | Albumin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/43713-7.json |
| 43714-5 | Adenovirus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43714-5.json |
| 43715-2 | Acylcarnitine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/43715-2.json |
| 43716-0 | Acylcarnitine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43716-0.json |
| 43717-8 | Acylcarnitine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/43717-8.json |
| 43718-6 | Prostatic acid phosphatase [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43718-6.json |
| 43719-4 | Acetaminophen+oxyCODONE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43719-4.json |
| 43720-2 | Acetaminophen+Codeine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43720-2.json |
| 43721-0 | Acetaldehyde+Paraldehyde [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43721-0.json |
| 43722-8 | 5-Ethyl-5-Phenylhydantoin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43722-8.json |
| 43723-6 | 5,10-Methylenetetrahydrofolate reductase [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43723-6.json |
| 43724-4 | 2,5-Dichlorophenol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43724-4.json |
| 43725-1 | 2,4-Dichlorophenol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43725-1.json |
| 43726-9 | 17-Ketogenic steroids [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43726-9.json |
| 43727-7 | Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43727-7.json |
| 43728-5 | Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43728-5.json |
| 43729-3 | Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43729-3.json |
| 43730-1 | Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43730-1.json |
| 43732-7 | 4-Hydroxybenzoate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43732-7.json |
| 43733-5 | 4-Hydroxybenzoate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43733-5.json |
| 43743-4 | Variant lymphocytes [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/43743-4.json |
| 43744-2 | COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43744-2.json |
| 43745-9 | DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43745-9.json |
| 43746-7 | KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43746-7.json |
| 43747-5 | OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/43747-5.json |
| 43748-3 | SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43748-3.json |
| 43749-1 | SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43749-1.json |
| 43750-9 | SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/43750-9.json |
| 43751-7 | Moxifloxacin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43751-7.json |
| 43752-5 | Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43752-5.json |
| 43754-1 | Sulfate [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/43754-1.json |
| 43756-6 | US Guidance for fluid aspiration of Breast | ./2.16.840.1.114222.4.11.1002/43756-6.json |
| 43757-4 | CT Guidance for fine needle aspiration of Kidney | ./2.16.840.1.114222.4.11.1002/43757-4.json |
| 43758-2 | US Guidance for localization of Breast - left | ./2.16.840.1.114222.4.11.1002/43758-2.json |
| 43759-0 | US Guidance for localization of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/43759-0.json |
| 43760-8 | US Guidance for localization of Breast - right | ./2.16.840.1.114222.4.11.1002/43760-8.json |
| 43761-6 | RFA Guidance for thrombectomy of Vein - bilateral-- W contrast IV | ./2.16.840.1.114222.4.11.1002/43761-6.json |
| 43762-4 | RFA Guidance for thrombectomy of Vein - left-- W contrast IV | ./2.16.840.1.114222.4.11.1002/43762-4.json |
| 43763-2 | RFA Guidance for thrombectomy of Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/43763-2.json |
| 43764-0 | RFA Guidance for thrombectomy of Vein - right-- W contrast IV | ./2.16.840.1.114222.4.11.1002/43764-0.json |
| 43765-7 | US.doppler Carotid arteries - bilateral | ./2.16.840.1.114222.4.11.1002/43765-7.json |
| 43766-5 | CT Kidney - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/43766-5.json |
| 43767-3 | CT Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/43767-3.json |
| 43768-1 | CT Kidney WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43768-1.json |
| 43769-9 | MR Brain and Internal auditory canal WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43769-9.json |
| 43770-7 | CT Kidney WO contrast | ./2.16.840.1.114222.4.11.1002/43770-7.json |
| 43771-5 | US.doppler Extremity vessels | ./2.16.840.1.114222.4.11.1002/43771-5.json |
| 43772-3 | MR Brain and Internal auditory canal | ./2.16.840.1.114222.4.11.1002/43772-3.json |
| 43773-1 | MR Kidney WO contrast | ./2.16.840.1.114222.4.11.1002/43773-1.json |
| 43774-9 | US Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/43774-9.json |
| 43775-6 | MR Kidney WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/43775-6.json |
| 43776-4 | US.doppler Iliac artery limited | ./2.16.840.1.114222.4.11.1002/43776-4.json |
| 43777-2 | NM Heart Perfusion at rest and W adenosine and W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/43777-2.json |
| 43778-0 | Portable XR Chest AP supine | ./2.16.840.1.114222.4.11.1002/43778-0.json |
| 43779-8 | XR Knee - left Sunrise | ./2.16.840.1.114222.4.11.1002/43779-8.json |
| 43780-6 | XR Knee Sunrise | ./2.16.840.1.114222.4.11.1002/43780-6.json |
| 43781-4 | XR Spine cervicothoracic junction Views | ./2.16.840.1.114222.4.11.1002/43781-4.json |
| 43782-2 | RFA Iliac artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/43782-2.json |
| 43783-0 | RFA Renal vein Views for renin sampling W contrast IV | ./2.16.840.1.114222.4.11.1002/43783-0.json |
| 43784-8 | XR Cervical and thoracic and lumbar spine 2 Views | ./2.16.840.1.114222.4.11.1002/43784-8.json |
| 43785-5 | XR Spine cervicothoracic junction AP and Lateral | ./2.16.840.1.114222.4.11.1002/43785-5.json |
| 43787-1 | XR Skull and Facial bones and Mandible Views for dental measurement | ./2.16.840.1.114222.4.11.1002/43787-1.json |
| 43788-9 | RF Tube Views for patency W contrast via tube | ./2.16.840.1.114222.4.11.1002/43788-9.json |
| 43789-7 | NM Liver and Biliary ducts and Gallbladder Views for patency W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/43789-7.json |
| 43790-5 | XR Shoulder - right Grashey and Y | ./2.16.840.1.114222.4.11.1002/43790-5.json |
| 43791-3 | XR Lumbar spine Oblique Views | ./2.16.840.1.114222.4.11.1002/43791-3.json |
| 43792-1 | RFA Guidance for angioplasty of Tibioperoneal arteries - right-- W contrast IA | ./2.16.840.1.114222.4.11.1002/43792-1.json |
| 43793-9 | RFA Guidance for angioplasty of Tibioperoneal arteries-- W contrast IA | ./2.16.840.1.114222.4.11.1002/43793-9.json |
| 43794-7 | RFA Guidance for angioplasty of Tibioperoneal arteries - bilateral-- W contrast IA | ./2.16.840.1.114222.4.11.1002/43794-7.json |
| 43795-4 | RFA Guidance for angioplasty of Tibioperoneal arteries - left-- W contrast IA | ./2.16.840.1.114222.4.11.1002/43795-4.json |
| 43796-2 | XR Wrist - bilateral Carpal tunnel Views | ./2.16.840.1.114222.4.11.1002/43796-2.json |
| 43797-0 | US Guidance for superficial biopsy of Lymph node | ./2.16.840.1.114222.4.11.1002/43797-0.json |
| 43798-8 | Alpha-1-Fetoprotein [Presence] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/43798-8.json |
| 43799-6 | Choriogonadotropin.beta subunit [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43799-6.json |
| 43800-2 | Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43800-2.json |
| 43801-0 | Choriogonadotropin.intact [Units/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/43801-0.json |
| 43802-8 | Estriol (E3) [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43802-8.json |
| 43809-3 | Arsenic [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/43809-3.json |
| 43810-1 | Rubella virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43810-1.json |
| 43811-9 | Propoxyphene [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43811-9.json |
| 43813-5 | Reagin Ab [Presence] in Cord blood | ./2.16.840.1.114222.4.11.1002/43813-5.json |
| 43814-3 | Basement membrane IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43814-3.json |
| 43815-0 | Arsenic [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43815-0.json |
| 43816-8 | Amylase [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/43816-8.json |
| 43817-6 | Androstenedione [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43817-6.json |
| 43818-4 | Beta-2-Microglobulin [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43818-4.json |
| 43819-2 | Beta-2-Microglobulin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43819-2.json |
| 43820-0 | Bilirubin.direct [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43820-0.json |
| 43821-8 | Amylase [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43821-8.json |
| 43822-6 | Aspartate aminotransferase [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/43822-6.json |
| 43823-4 | Aspergillus glaucus Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/43823-4.json |
| 43824-2 | Bilirubin.total [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/43824-2.json |
| 43825-9 | Arsenic [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/43825-9.json |
| 43826-7 | Androstanolone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43826-7.json |
| 43827-5 | Barbiturates [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43827-5.json |
| 43828-3 | Benzodiazepines [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43828-3.json |
| 43829-1 | Caffeine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43829-1.json |
| 43830-9 | Nicotine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43830-9.json |
| 43831-7 | Phenytoin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43831-7.json |
| 43832-5 | quiNIDine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43832-5.json |
| 43833-3 | quiNINE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43833-3.json |
| 43834-1 | Tetrahydrocannabinol [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43834-1.json |
| 43835-8 | Apolipoprotein E [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43835-8.json |
| 43836-6 | Beta globulin [Presence] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/43836-6.json |
| 43837-4 | Influenza virus A IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43837-4.json |
| 43838-2 | Influenza virus A IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43838-2.json |
| 43839-0 | Influenza virus B IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43839-0.json |
| 43840-8 | Influenza virus B IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43840-8.json |
| 43842-4 | Borrelia burgdorferi Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43842-4.json |
| 43843-2 | Brucella abortus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43843-2.json |
| 43844-0 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43844-0.json |
| 43845-7 | Chlamydophila pneumoniae Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43845-7.json |
| 43847-3 | Chlamydophila sp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43847-3.json |
| 43848-1 | Chlamydia trachomatis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43848-1.json |
| 43849-9 | Coccidioides sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43849-9.json |
| 43850-7 | Coccidioides sp IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43850-7.json |
| 43851-5 | Influenza virus A IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43851-5.json |
| 43852-3 | Influenza virus B IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43852-3.json |
| 43853-1 | Legionella pneumophila 1+3+4+5+6+8 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43853-1.json |
| 43854-9 | Mycobacterium sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/43854-9.json |
| 43857-2 | Benztropine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43857-2.json |
| 43858-0 | Beta-2 transferrin [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43858-0.json |
| 43859-8 | Bolasterone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43859-8.json |
| 43860-6 | Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/43860-6.json |
| 43861-4 | Asialoganglioside GM1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43861-4.json |
| 43863-0 | Benzthiazide [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43863-0.json |
| 43864-8 | Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/43864-8.json |
| 43865-5 | Blastomyces dermatitidis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43865-5.json |
| 43866-3 | Bartonella sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43866-3.json |
| 43867-1 | Beta-2 transferrin [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43867-1.json |
| 43868-9 | Chlamydophila psittaci IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43868-9.json |
| 43869-7 | Antithrombin Ag [Presence] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/43869-7.json |
| 43870-5 | Aspergillus sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/43870-5.json |
| 43871-3 | Aspergillus sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43871-3.json |
| 43872-1 | Aspergillus sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43872-1.json |
| 43873-9 | Aspergillus sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43873-9.json |
| 43874-7 | Influenza virus A Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/43874-7.json |
| 43875-4 | Basement membrane IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43875-4.json |
| 43876-2 | Antimony [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43876-2.json |
| 43877-0 | Bile acid [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43877-0.json |
| 43878-8 | Bismuth [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43878-8.json |
| 43879-6 | Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43879-6.json |
| 43880-4 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43880-4.json |
| 43881-2 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43881-2.json |
| 43882-0 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43882-0.json |
| 43883-8 | Ampicillin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43883-8.json |
| 43884-6 | Ampicillin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43884-6.json |
| 43885-3 | Beryllium [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43885-3.json |
| 43886-1 | Bismuth [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43886-1.json |
| 43887-9 | Bilirubin.total [Presence] in Amniotic fluid by Spectrophotometry direct | ./2.16.840.1.114222.4.11.1002/43887-9.json |
| 43888-7 | Bile acid [Presence] in Bile fluid | ./2.16.840.1.114222.4.11.1002/43888-7.json |
| 43889-5 | Bile acid [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43889-5.json |
| 43890-3 | Bordetella pertussis [Presence] in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43890-3.json |
| 43891-1 | Bordetella pertussis Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43891-1.json |
| 43892-9 | Borate [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/43892-9.json |
| 43893-7 | Babesia microti IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43893-7.json |
| 43894-5 | Bismuth [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43894-5.json |
| 43895-2 | Influenza virus B Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/43895-2.json |
| 43896-0 | Bordetella pertussis [Presence] in Pleural fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43896-0.json |
| 43897-8 | Baclofen [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43897-8.json |
| 43898-6 | Beta hydroxybutyrate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43898-6.json |
| 43899-4 | Beta lipotropin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43899-4.json |
| 43900-0 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/43900-0.json |
| 43901-8 | Barium [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43901-8.json |
| 43902-6 | Azinphos-methyl [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/43902-6.json |
| 43903-4 | Azinphos-methyl [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43903-4.json |
| 43904-2 | Azinphos-methyl [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43904-2.json |
| 43905-9 | Arbovirus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43905-9.json |
| 43906-7 | Anserine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43906-7.json |
| 43907-5 | Argininosuccinate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43907-5.json |
| 43908-3 | Avian encephalomyelitis virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43908-3.json |
| 43909-1 | Bordetella pertussis Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/43909-1.json |
| 43910-9 | Ascaris sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43910-9.json |
| 43911-7 | Aspergillus versicolor Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43911-7.json |
| 43912-5 | Bisacodyl [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43912-5.json |
| 43913-3 | Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/43913-3.json |
| 43914-1 | Beta 2 glycoprotein 1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43914-1.json |
| 43915-8 | Beta 2 glycoprotein 1 IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43915-8.json |
| 43916-6 | Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43916-6.json |
| 43917-4 | Benzene [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43917-4.json |
| 43918-2 | Babesia microti Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43918-2.json |
| 43919-0 | Beta-2-Microglobulin [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43919-0.json |
| 43920-8 | Bartonella sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43920-8.json |
| 43921-6 | Bartonella sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43921-6.json |
| 43922-4 | Beta endorphin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43922-4.json |
| 43923-2 | Beta hydroxybutyrate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43923-2.json |
| 43924-0 | azaTHIOprine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43924-0.json |
| 43925-7 | Bordetella parapertussis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43925-7.json |
| 43926-5 | Babesia sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/43926-5.json |
| 43927-3 | Arginine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/43927-3.json |
| 43928-1 | Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/43928-1.json |
| 43929-9 | Anthraquinone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/43929-9.json |
| 43930-7 | Yersinia enterocolitica Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43930-7.json |
| 43931-5 | California encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/43931-5.json |
| 43932-3 | Rheumatoid factor [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/43932-3.json |
| 43933-1 | Cathine [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/43933-1.json |
| 43934-9 | Amphetamines [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/43934-9.json |
| 43935-6 | CD55 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/43935-6.json |
| 43936-4 | CD55 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/43936-4.json |
| 43937-2 | CD59 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/43937-2.json |
| 43938-0 | CD59 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/43938-0.json |
| 43939-8 | Alkaline phosphatase.liver [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43939-8.json |
| 43940-6 | Kappa light chains.free [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/43940-6.json |
| 43941-4 | Red top grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/43941-4.json |
| 43942-2 | Insulin Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/43942-2.json |
| 43944-8 | CD4+CD45+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/43944-8.json |
| 43945-5 | CD4+CD45RO+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/43945-5.json |
| 43946-3 | CD4+CD45RO+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43946-3.json |
| 43947-1 | CD4+CD45+ cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/43947-1.json |
| 43948-9 | CD4+CD45RO+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/43948-9.json |
| 43949-7 | CD2 cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43949-7.json |
| 43950-5 | CD2 cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/43950-5.json |
| 43951-3 | CD2 cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/43951-3.json |
| 43952-1 | CD4+CD45RO+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/43952-1.json |
| 43953-9 | CD4+CD45RO+ cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43953-9.json |
| 43954-7 | CD4+CD45RO+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/43954-7.json |
| 43955-4 | CD4+CD45RO+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/43955-4.json |
| 43956-2 | CD4+CD45RO+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43956-2.json |
| 43957-0 | CD3+HLA-DR+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/43957-0.json |
| 43958-8 | CD3+HLA-DR+ cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43958-8.json |
| 43959-6 | CD3+HLA-DR+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/43959-6.json |
| 43960-4 | CD3+HLA-DR+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/43960-4.json |
| 43961-2 | CD3+HLA-DR+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43961-2.json |
| 43962-0 | CD4+CD45RA+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/43962-0.json |
| 43963-8 | CD4+CD45RA+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43963-8.json |
| 43964-6 | CD4+CD45RA+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/43964-6.json |
| 43965-3 | CD4+CD45RA+ cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/43965-3.json |
| 43966-1 | CD4+CD45RA+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/43966-1.json |
| 43967-9 | CD3+CD25+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43967-9.json |
| 43968-7 | CD3+HLA-DR+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43968-7.json |
| 43969-5 | CD3+CD25+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/43969-5.json |
| 43970-3 | CD3+CD4+ (T4 helper) cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43970-3.json |
| 43971-1 | CD3+CD8+ (T8 suppressor) cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43971-1.json |
| 43972-9 | CD19 cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/43972-9.json |
| 43973-7 | Zinc [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/43973-7.json |
| 43974-5 | Coccidioides sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/43974-5.json |
| 43975-2 | Aprobarbital [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/43975-2.json |
| 43976-0 | Measles virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43976-0.json |
| 43977-8 | Anabolic steroids [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/43977-8.json |
| 43978-6 | Varicella zoster virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/43978-6.json |
| 43979-4 | Aspergillus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/43979-4.json |
| 43980-2 | Rabies virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/43980-2.json |
| 43983-6 | Amphetamines [Presence] in Urine by Screen method >500 ng/mL | ./2.16.840.1.114222.4.11.1002/43983-6.json |
| 43984-4 | Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL | ./2.16.840.1.114222.4.11.1002/43984-4.json |
| 43985-1 | Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/43985-1.json |
| 44015-6 | Helicobacter pylori [Presence] in Gastric fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44015-6.json |
| 44016-4 | Bile [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44016-4.json |
| 44019-8 | Bordetella parapertussis Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44019-8.json |
| 44020-6 | Borrelia burgdorferi Ab [Presence] in Synovial fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/44020-6.json |
| 44022-2 | Bacteria [Presence] in Cervix by Wet preparation | ./2.16.840.1.114222.4.11.1002/44022-2.json |
| 44023-0 | Bacteria [Presence] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44023-0.json |
| 44024-8 | Boldenone [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44024-8.json |
| 44025-5 | Aspergillus flavus B Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44025-5.json |
| 44026-3 | Aspergillus flavus H Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44026-3.json |
| 44027-1 | Aspergillus fumigatus B Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44027-1.json |
| 44028-9 | Aspergillus fumigatus H Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44028-9.json |
| 44029-7 | Aspergillus nidulans B Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44029-7.json |
| 44030-5 | Aspergillus nidulans H Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44030-5.json |
| 44031-3 | Aspergillus niger B Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44031-3.json |
| 44032-1 | Aspergillus niger H Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44032-1.json |
| 44033-9 | Bilirubin.total [Presence] in 24 hour Urine by Test strip | ./2.16.840.1.114222.4.11.1002/44033-9.json |
| 44034-7 | Bile canalicular Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44034-7.json |
| 44035-4 | Analgesics Non-narcotic [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44035-4.json |
| 44036-2 | Analgesics Non-narcotic [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/44036-2.json |
| 44037-0 | Glucosylceramidase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/44037-0.json |
| 44038-8 | Bacteria [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44038-8.json |
| 44039-6 | Bacteria [Presence] in Eye by Light microscopy | ./2.16.840.1.114222.4.11.1002/44039-6.json |
| 44045-3 | Aspergillus fumigatus O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44045-3.json |
| 44046-1 | Bordetella pertussis Higashi-Hama Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44046-1.json |
| 44047-9 | Bordetella pertussis Yamaguchi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44047-9.json |
| 44048-7 | Basophils [Presence] in Nose by Light microscopy | ./2.16.840.1.114222.4.11.1002/44048-7.json |
| 44049-5 | Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/44049-5.json |
| 44050-3 | Glucose phosphate isomerase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/44050-3.json |
| 44051-1 | Adenylate kinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/44051-1.json |
| 44052-9 | Phosphofructokinase [Enzymatic activity/mass] in Blood | ./2.16.840.1.114222.4.11.1002/44052-9.json |
| 44053-7 | Phosphoglycerate kinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/44053-7.json |
| 44054-5 | Triosephosphate isomerase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/44054-5.json |
| 44055-2 | Pyrimidine-5'-Nucleotidase [Enzymatic activity/mass] in Blood | ./2.16.840.1.114222.4.11.1002/44055-2.json |
| 44056-0 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/44056-0.json |
| 44057-8 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44057-8.json |
| 44058-6 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/44058-6.json |
| 44059-4 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/44059-4.json |
| 44060-2 | CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/44060-2.json |
| 44061-0 | CD20+FMC7+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/44061-0.json |
| 44062-8 | CD20+FMC7+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44062-8.json |
| 44063-6 | CD20+FMC7+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/44063-6.json |
| 44064-4 | CD20+FMC7+ cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/44064-4.json |
| 44065-1 | CD20+FMC7+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/44065-1.json |
| 44066-9 | CD20+FMC7+ cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44066-9.json |
| 44067-7 | CD20+FMC7+ cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/44067-7.json |
| 44068-5 | CD20+FMC7+ cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/44068-5.json |
| 44069-3 | CD20+FMC7+ cells [#/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/44069-3.json |
| 44070-1 | CD20+CD52+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/44070-1.json |
| 44071-9 | CD20+CD52+ cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44071-9.json |
| 44072-7 | CD20+CD52+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/44072-7.json |
| 44073-5 | CD20+CD52+ cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/44073-5.json |
| 44087-5 | Escherichia coli O157 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44087-5.json |
| 44088-3 | Escherichia coli O157:H7 DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44088-3.json |
| 44089-1 | Escherichia coli O157:H7 [Identifier] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44089-1.json |
| 44090-9 | Escherichia coli O157:H7 [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44090-9.json |
| 44093-3 | Neisseria meningitidis [Identifier] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44093-3.json |
| 44098-2 | Microscopic observation [Identifier] in Specimen by Wayson stain | ./2.16.840.1.114222.4.11.1002/44098-2.json |
| 44099-0 | Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/44099-0.json |
| 44101-4 | CT Guidance for ablation of tissue of Liver | ./2.16.840.1.114222.4.11.1002/44101-4.json |
| 44102-2 | CT Guidance for procedure of Joint space | ./2.16.840.1.114222.4.11.1002/44102-2.json |
| 44103-0 | CT Guidance for fine needle aspiration of Lymph node | ./2.16.840.1.114222.4.11.1002/44103-0.json |
| 44104-8 | CT Guidance for fine needle aspiration of Mediastinum | ./2.16.840.1.114222.4.11.1002/44104-8.json |
| 44105-5 | CT Guidance for fine needle aspiration of Muscle | ./2.16.840.1.114222.4.11.1002/44105-5.json |
| 44106-3 | CT Guidance for FNA of Prostate | ./2.16.840.1.114222.4.11.1002/44106-3.json |
| 44107-1 | CT Guidance for fine needle aspiration of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/44107-1.json |
| 44108-9 | CT Guidance for fine needle aspiration of Adrenal gland | ./2.16.840.1.114222.4.11.1002/44108-9.json |
| 44109-7 | CT Guidance for deep biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/44109-7.json |
| 44110-5 | CT Guidance for needle localization of Breast | ./2.16.840.1.114222.4.11.1002/44110-5.json |
| 44111-3 | CT Skull base WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44111-3.json |
| 44112-1 | CT Skull base WO contrast | ./2.16.840.1.114222.4.11.1002/44112-1.json |
| 44113-9 | CT Thoracic spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/44113-9.json |
| 44114-7 | CT Lumbar spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/44114-7.json |
| 44115-4 | CT Abdomen and Pelvis | ./2.16.840.1.114222.4.11.1002/44115-4.json |
| 44116-2 | CT Mandible limited | ./2.16.840.1.114222.4.11.1002/44116-2.json |
| 44117-0 | CT Guidance for biopsy of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/44117-0.json |
| 44118-8 | CT Guidance for needle localization of Breast-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44118-8.json |
| 44119-6 | CT Breast - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/44119-6.json |
| 44122-0 | MR Guidance for stereotactic localization of Brain-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44122-0.json |
| 44123-8 | MR Biliary ducts and Pancreatic duct WO contrast | ./2.16.840.1.114222.4.11.1002/44123-8.json |
| 44124-6 | MR Adrenal gland W contrast IV | ./2.16.840.1.114222.4.11.1002/44124-6.json |
| 44125-3 | MR Biliary ducts and Pancreatic duct W contrast IV | ./2.16.840.1.114222.4.11.1002/44125-3.json |
| 44126-1 | MR Heart cine for blood flow velocity mapping W contrast IV | ./2.16.840.1.114222.4.11.1002/44126-1.json |
| 44127-9 | MR Heart limited cine for function | ./2.16.840.1.114222.4.11.1002/44127-9.json |
| 44128-7 | MRA Lower extremity vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44128-7.json |
| 44129-5 | MRA Lower extremity vessels WO contrast | ./2.16.840.1.114222.4.11.1002/44129-5.json |
| 44130-3 | MRA Aortic arch WO contrast | ./2.16.840.1.114222.4.11.1002/44130-3.json |
| 44131-1 | MRA Thoracic and abdominal aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44131-1.json |
| 44132-9 | MRA Thoracic and abdominal aorta WO contrast | ./2.16.840.1.114222.4.11.1002/44132-9.json |
| 44133-7 | MRA Renal vessels WO contrast | ./2.16.840.1.114222.4.11.1002/44133-7.json |
| 44134-5 | MRA Renal vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44134-5.json |
| 44135-2 | MRA Lower extremity vessels - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/44135-2.json |
| 44136-0 | PT Unspecified body region | ./2.16.840.1.114222.4.11.1002/44136-0.json |
| 44137-8 | PT Heart | ./2.16.840.1.114222.4.11.1002/44137-8.json |
| 44138-6 | PT Brain | ./2.16.840.1.114222.4.11.1002/44138-6.json |
| 44139-4 | PT Whole body | ./2.16.840.1.114222.4.11.1002/44139-4.json |
| 44140-2 | NM Abdomen and Pelvis Views for tumor | ./2.16.840.1.114222.4.11.1002/44140-2.json |
| 44141-0 | NM Liver and Spleen Views W Tc-99m MAA IV | ./2.16.840.1.114222.4.11.1002/44141-0.json |
| 44142-8 | NM Bone Views W Tc-99m medronate IV | ./2.16.840.1.114222.4.11.1002/44142-8.json |
| 44143-6 | NM Heart Views W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/44143-6.json |
| 44144-4 | NM Liver Views W Xe-133 IH | ./2.16.840.1.114222.4.11.1002/44144-4.json |
| 44145-1 | NM Parathyroid gland Views W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/44145-1.json |
| 44146-9 | NM Bone marrow Views W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/44146-9.json |
| 44147-7 | NM Thyroid gland Views and Views uptake W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/44147-7.json |
| 44148-5 | NM Brain Views for blood flow W Tc-99m bicisate IV | ./2.16.840.1.114222.4.11.1002/44148-5.json |
| 44149-3 | NM Abdomen and Pelvis Views for shunt patency W Tc-99m MAA inj | ./2.16.840.1.114222.4.11.1002/44149-3.json |
| 44150-1 | NM Brain Views W Tc-99m bicisate IV | ./2.16.840.1.114222.4.11.1002/44150-1.json |
| 44151-9 | SPECT Heart W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/44151-9.json |
| 44152-7 | SPECT Brain W Tc-99m bicisate IV | ./2.16.840.1.114222.4.11.1002/44152-7.json |
| 44153-5 | SPECT Kidney W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/44153-5.json |
| 44154-3 | SPECT Heart W dipyridamole and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/44154-3.json |
| 44155-0 | US Guidance for ablation of tissue of Liver | ./2.16.840.1.114222.4.11.1002/44155-0.json |
| 44156-8 | US Guidance for ablation of tissue of Kidney | ./2.16.840.1.114222.4.11.1002/44156-8.json |
| 44157-6 | US Guidance for fine needle aspiration of Pancreas | ./2.16.840.1.114222.4.11.1002/44157-6.json |
| 44158-4 | US Guidance for fine needle aspiration of Liver | ./2.16.840.1.114222.4.11.1002/44158-4.json |
| 44159-2 | US Guidance for fine needle aspiration of Kidney | ./2.16.840.1.114222.4.11.1002/44159-2.json |
| 44160-0 | US Guidance for fine needle aspiration of Breast | ./2.16.840.1.114222.4.11.1002/44160-0.json |
| 44161-8 | US Guidance for biopsy of Lung | ./2.16.840.1.114222.4.11.1002/44161-8.json |
| 44162-6 | US Guidance for biopsy of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/44162-6.json |
| 44163-4 | US Brachial plexus | ./2.16.840.1.114222.4.11.1002/44163-4.json |
| 44164-2 | US Head and Neck | ./2.16.840.1.114222.4.11.1002/44164-2.json |
| 44166-7 | US Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space | ./2.16.840.1.114222.4.11.1002/44166-7.json |
| 44167-5 | US Guidance for drainage of abscess and placement of drainage catheter of Kidney | ./2.16.840.1.114222.4.11.1002/44167-5.json |
| 44168-3 | US Guidance for drainage of abscess and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/44168-3.json |
| 44169-1 | US Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space | ./2.16.840.1.114222.4.11.1002/44169-1.json |
| 44172-5 | US Guidance for drainage and placement of drainage catheter of Pancreas | ./2.16.840.1.114222.4.11.1002/44172-5.json |
| 44173-3 | US Extremity artery limited | ./2.16.840.1.114222.4.11.1002/44173-3.json |
| 44174-1 | US.doppler Lower extremity vessels | ./2.16.840.1.114222.4.11.1002/44174-1.json |
| 44175-8 | US.doppler Neck vessels | ./2.16.840.1.114222.4.11.1002/44175-8.json |
| 44176-6 | Portable XR Hip Single view | ./2.16.840.1.114222.4.11.1002/44176-6.json |
| 44177-4 | XR Lower extremity - bilateral AP W standing | ./2.16.840.1.114222.4.11.1002/44177-4.json |
| 44178-2 | XR Lumbar spine oblique and (views W right bending and W left bending) | ./2.16.840.1.114222.4.11.1002/44178-2.json |
| 44179-0 | XR Sacrum and Coccyx 2 Views | ./2.16.840.1.114222.4.11.1002/44179-0.json |
| 44181-6 | XR Sacroiliac Joint 2 or 3 Views | ./2.16.840.1.114222.4.11.1002/44181-6.json |
| 44182-4 | Portable XR Hand 2 Views | ./2.16.840.1.114222.4.11.1002/44182-4.json |
| 44183-2 | Portable XR Radius and Ulna 2 Views | ./2.16.840.1.114222.4.11.1002/44183-2.json |
| 44184-0 | Portable XR Elbow 2 Views | ./2.16.840.1.114222.4.11.1002/44184-0.json |
| 44185-7 | Portable XR Femur AP and Lateral | ./2.16.840.1.114222.4.11.1002/44185-7.json |
| 44186-5 | Portable XR Foot AP and Lateral | ./2.16.840.1.114222.4.11.1002/44186-5.json |
| 44187-3 | Portable XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/44187-3.json |
| 44188-1 | XR Foot GE 3 Views | ./2.16.840.1.114222.4.11.1002/44188-1.json |
| 44189-9 | XR Sacroiliac Joint GE 3 Views | ./2.16.840.1.114222.4.11.1002/44189-9.json |
| 44190-7 | XR Wrist GE 3 Views | ./2.16.840.1.114222.4.11.1002/44190-7.json |
| 44191-5 | XR Ribs GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/44191-5.json |
| 44192-3 | Portable XR Pelvis GE 3 Views | ./2.16.840.1.114222.4.11.1002/44192-3.json |
| 44193-1 | Portable XR Hand GE 3 Views | ./2.16.840.1.114222.4.11.1002/44193-1.json |
| 44194-9 | XR Spine GE 4 Views W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/44194-9.json |
| 44195-6 | XR Knee GE 5 Views | ./2.16.840.1.114222.4.11.1002/44195-6.json |
| 44196-4 | XR Lumbar spine GE 5 Views W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/44196-4.json |
| 44197-2 | XR Knee - bilateral GE 5 Views W standing | ./2.16.840.1.114222.4.11.1002/44197-2.json |
| 44198-0 | XR Knee 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/44198-0.json |
| 44199-8 | XR Facial bones 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/44199-8.json |
| 44201-2 | Portable XR Pelvis 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/44201-2.json |
| 44202-0 | Portable XR Knee 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/44202-0.json |
| 44203-8 | Portable XR Cervical and thoracic and lumbar spine Views | ./2.16.840.1.114222.4.11.1002/44203-8.json |
| 44205-3 | XR Lower extremity - bilateral Single view W standing | ./2.16.840.1.114222.4.11.1002/44205-3.json |
| 44206-1 | XR Thoracic and lumbar spine for scoliosis single view | ./2.16.840.1.114222.4.11.1002/44206-1.json |
| 44208-7 | XR Orbit Views for foreign body | ./2.16.840.1.114222.4.11.1002/44208-7.json |
| 44209-5 | XR Sinuses Limited Views | ./2.16.840.1.114222.4.11.1002/44209-5.json |
| 44210-3 | XR Ankle GE 3 Views | ./2.16.840.1.114222.4.11.1002/44210-3.json |
| 44211-1 | XR Chest GE 4 Views | ./2.16.840.1.114222.4.11.1002/44211-1.json |
| 44212-9 | XR Cervical spine GE 4 Views | ./2.16.840.1.114222.4.11.1002/44212-9.json |
| 44213-7 | RF Guidance for endoscopy of Pancreatic duct-- W contrast retrograde | ./2.16.840.1.114222.4.11.1002/44213-7.json |
| 44214-5 | RF Guidance for endoscopy of Biliary ducts-- W contrast retrograde | ./2.16.840.1.114222.4.11.1002/44214-5.json |
| 44215-2 | RF Guidance for fine needle aspiration of Unspecified body region | ./2.16.840.1.114222.4.11.1002/44215-2.json |
| 44216-0 | RF Guidance for fine needle aspiration of Thyroid gland | ./2.16.840.1.114222.4.11.1002/44216-0.json |
| 44217-8 | RF Guidance for fine needle aspiration of Kidney | ./2.16.840.1.114222.4.11.1002/44217-8.json |
| 44218-6 | RF Guidance for fine needle aspiration of Pancreas | ./2.16.840.1.114222.4.11.1002/44218-6.json |
| 44219-4 | RFA Guidance for fine needle aspiration of Lymph node | ./2.16.840.1.114222.4.11.1002/44219-4.json |
| 44220-2 | RF Guidance for fine needle aspiration of Liver | ./2.16.840.1.114222.4.11.1002/44220-2.json |
| 44221-0 | RF Guidance for deep aspiration.fine needle of Tissue | ./2.16.840.1.114222.4.11.1002/44221-0.json |
| 44222-8 | RF Guidance for procedure of Joint space | ./2.16.840.1.114222.4.11.1002/44222-8.json |
| 44223-6 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Ovary | ./2.16.840.1.114222.4.11.1002/44223-6.json |
| 44224-4 | RF Guidance for placement of tube in Unspecified body region | ./2.16.840.1.114222.4.11.1002/44224-4.json |
| 44225-1 | RF Guidance for biopsy of Liver-- W contrast IV | ./2.16.840.1.114222.4.11.1002/44225-1.json |
| 44226-9 | RF Colon Views for reduction W barium contrast PR | ./2.16.840.1.114222.4.11.1002/44226-9.json |
| 44227-7 | RF Colon Views W barium contrast PR | ./2.16.840.1.114222.4.11.1002/44227-7.json |
| 44228-5 | CT Guidance for ablation of tissue of Kidney | ./2.16.840.1.114222.4.11.1002/44228-5.json |
| 44229-3 | CT Bone | ./2.16.840.1.114222.4.11.1002/44229-3.json |
| 44230-1 | MRA Superior mesenteric vessels WO contrast | ./2.16.840.1.114222.4.11.1002/44230-1.json |
| 44231-9 | MRA Superior mesenteric vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/44231-9.json |
| 44232-7 | NM Kidney Views WO and W Tc-99m Mertiatide IV | ./2.16.840.1.114222.4.11.1002/44232-7.json |
| 44233-5 | NM Kidney Views WO and W Tc-99m DTPA IV | ./2.16.840.1.114222.4.11.1002/44233-5.json |
| 44234-3 | NM Kidney Views W Tc-99m glucoheptonate IV | ./2.16.840.1.114222.4.11.1002/44234-3.json |
| 44235-0 | US.doppler Superior mesenteric vessels | ./2.16.840.1.114222.4.11.1002/44235-0.json |
| 44236-8 | US.doppler Upper extremity vessel - bilateral for graft | ./2.16.840.1.114222.4.11.1002/44236-8.json |
| 44237-6 | US.doppler Upper extremity vessel - bilateral for graft limited | ./2.16.840.1.114222.4.11.1002/44237-6.json |
| 44238-4 | XR Trachea Views | ./2.16.840.1.114222.4.11.1002/44238-4.json |
| 44239-2 | Portable XR Ribs - unilateral GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/44239-2.json |
| 44240-0 | RFA Peripheral arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/44240-0.json |
| 44241-8 | Clue cells [#/area] in Vaginal fluid by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/44241-8.json |
| 44243-4 | Bacteria [#/area] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44243-4.json |
| 44244-2 | Trichomonas vaginalis [#/area] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44244-2.json |
| 44245-9 | Fungi.filamentous [#/area] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44245-9.json |
| 44246-7 | Yeast [#/area] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44246-7.json |
| 44247-5 | Spermatozoa Motile [#/area] in Vaginal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/44247-5.json |
| 44248-3 | Spermatozoa Immotile [#/area] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/44248-3.json |
| 44263-2 | Influenza virus A RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44263-2.json |
| 44264-0 | Influenza virus A H5 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44264-0.json |
| 44265-7 | Influenza virus A H6 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44265-7.json |
| 44266-5 | Influenza virus A H7 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44266-5.json |
| 44267-3 | Avian paramyxovirus 1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44267-3.json |
| 44268-1 | Avian paramyxovirus 1.exotic RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44268-1.json |
| 44269-9 | Bacillus anthracis cell wall Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44269-9.json |
| 44270-7 | Bacillus anthracis spore Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44270-7.json |
| 44271-5 | Brucella sp Ag [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44271-5.json |
| 44272-3 | Cache valley virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/44272-3.json |
| 44273-1 | Classical swine fever virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44273-1.json |
| 44274-9 | Clostridium botulinum toxin [Identifier] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/44274-9.json |
| 44275-6 | Coxiella burnetii [Presence] in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/44275-6.json |
| 44276-4 | Equine adenovirus Ag [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/44276-4.json |
| 44277-2 | 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44277-2.json |
| 44278-0 | 16-Alpha hydroxydehydroepiandrosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44278-0.json |
| 44279-8 | 16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44279-8.json |
| 44280-6 | 17 Alpha-hydroxypregnanolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44280-6.json |
| 44281-4 | 17-Ketosteroids/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44281-4.json |
| 44282-2 | 2-Hydroxyisocaproate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44282-2.json |
| 44283-0 | 2-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44283-0.json |
| 44284-8 | 2-Methylcitrate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44284-8.json |
| 44285-5 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44285-5.json |
| 44286-3 | 3-Methylhistidine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44286-3.json |
| 44287-1 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44287-1.json |
| 44288-9 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44288-9.json |
| 44289-7 | Adenovirus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44289-7.json |
| 44291-3 | Alanine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44291-3.json |
| 44292-1 | Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/44292-1.json |
| 44293-9 | Albumin/Globulin [Mass Ratio] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/44293-9.json |
| 44294-7 | Albumin/Globulin [Mass Ratio] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/44294-7.json |
| 44295-4 | Aldosterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44295-4.json |
| 44296-2 | Alpha aminobutyrate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44296-2.json |
| 44297-0 | Androsterone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44297-0.json |
| 44299-6 | Arginine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44299-6.json |
| 44300-2 | Arsenic.inorganic/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44300-2.json |
| 44301-0 | Asparagine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44301-0.json |
| 44302-8 | Aspartate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44302-8.json |
| 44303-6 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44303-6.json |
| 44304-4 | Carnosine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44304-4.json |
| 44305-1 | Chloral hydrate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44305-1.json |
| 44306-9 | Citrate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44306-9.json |
| 44307-7 | Citrulline/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44307-7.json |
| 44308-5 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/44308-5.json |
| 44309-3 | Cortisol Free/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44309-3.json |
| 44310-1 | Cortisol/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44310-1.json |
| 44311-9 | Cotinine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44311-9.json |
| 44312-7 | Cystine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44312-7.json |
| 44313-5 | Delta aminolevulinate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44313-5.json |
| 44314-3 | D-Lactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44314-3.json |
| 44316-8 | DOPamine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44316-8.json |
| 44317-6 | Insulin human Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44317-6.json |
| 44318-4 | Insulin porcine Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44318-4.json |
| 44319-2 | Insulin.bound [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44319-2.json |
| 44320-0 | Interferon alpha [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44320-0.json |
| 44321-8 | Interleukin 5 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44321-8.json |
| 44322-6 | Interleukin 6 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44322-6.json |
| 44323-4 | Iodine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44323-4.json |
| 44324-2 | Iodine.inorganic [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44324-2.json |
| 44325-9 | Iron [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/44325-9.json |
| 44326-7 | Iron [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44326-7.json |
| 44327-5 | Iron [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44327-5.json |
| 44328-3 | Isocitrate [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44328-3.json |
| 44329-1 | Isoleucine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44329-1.json |
| 44330-9 | Isospora belli [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/44330-9.json |
| 44331-7 | Isovalerylglycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44331-7.json |
| 44332-5 | Jo-1 extractable nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44332-5.json |
| 44333-3 | Lactate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44333-3.json |
| 44334-1 | Leucine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44334-1.json |
| 44335-8 | Lysine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44335-8.json |
| 44336-6 | Magnesium/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44336-6.json |
| 44337-4 | Metanephrine Free/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44337-4.json |
| 44338-2 | Methionine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44338-2.json |
| 44340-8 | N-methylhistamine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44340-8.json |
| 44341-6 | Norepinephrine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44341-6.json |
| 44342-4 | Normetanephrine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44342-4.json |
| 44343-2 | Organic acids/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44343-2.json |
| 44344-0 | Ornithine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44344-0.json |
| 44345-7 | Orotate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44345-7.json |
| 44346-5 | Phenol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44346-5.json |
| 44347-3 | Phenol/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44347-3.json |
| 44348-1 | Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44348-1.json |
| 44349-9 | Phenylalanine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44349-9.json |
| 44350-7 | Phenylpropionylglycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44350-7.json |
| 44351-5 | Phosphoethanolamine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44351-5.json |
| 44352-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44352-3.json |
| 44353-1 | Porphyrins/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44353-1.json |
| 44354-9 | Ethylmalonate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44354-9.json |
| 44355-6 | Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44355-6.json |
| 44356-4 | Follitropin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44356-4.json |
| 44357-2 | Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/44357-2.json |
| 44358-0 | Gamma hydroxybutyrate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44358-0.json |
| 44359-8 | Glutamate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44359-8.json |
| 44360-6 | Glutamate+Glutamine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44360-6.json |
| 44361-4 | Glutamate+Glutamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44361-4.json |
| 44362-2 | Glutamine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44362-2.json |
| 44363-0 | Glutarate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44363-0.json |
| 44364-8 | Glutarate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44364-8.json |
| 44365-5 | Glycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44365-5.json |
| 44366-3 | Glycosaminoglycans/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44366-3.json |
| 44367-1 | Glycosaminoglycans/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44367-1.json |
| 44368-9 | Hexanoylglycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44368-9.json |
| 44369-7 | Hexokinase [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/44369-7.json |
| 44370-5 | Hippurate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44370-5.json |
| 44371-3 | Histamine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44371-3.json |
| 44372-1 | Histidine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44372-1.json |
| 44373-9 | Homocysteine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/44373-9.json |
| 44374-7 | Homocysteine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44374-7.json |
| 44375-4 | Homocysteine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/44375-4.json |
| 44376-2 | Homocysteine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/44376-2.json |
| 44377-0 | Homocysteine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44377-0.json |
| 44378-8 | Homocystine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44378-8.json |
| 44383-8 | Hyaluronate [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/44383-8.json |
| 44384-6 | hydroCHLOROthiazide [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44384-6.json |
| 44385-3 | Hydroflumethiazide [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44385-3.json |
| 44386-1 | Hydroxyproline/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44386-1.json |
| 44387-9 | Hypnotics [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/44387-9.json |
| 44388-7 | IgA [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/44388-7.json |
| 44389-5 | IgA [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44389-5.json |
| 44390-3 | Imipramine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44390-3.json |
| 44391-1 | Immune complex [Presence] in Serum or Plasma by C1q binding assay | ./2.16.840.1.114222.4.11.1002/44391-1.json |
| 44392-9 | Immune complex [Presence] in Serum or Plasma by Raji cell assay | ./2.16.840.1.114222.4.11.1002/44392-9.json |
| 44393-7 | Immune complex [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44393-7.json |
| 44394-5 | Kappa light chains [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44394-5.json |
| 44395-2 | Lambda light chains [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44395-2.json |
| 44396-0 | Insulin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44396-0.json |
| 44397-8 | Insulin bovine Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44397-8.json |
| 44398-6 | Proline/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44398-6.json |
| 44399-4 | Propionylglycine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44399-4.json |
| 44400-0 | Pyruvate/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44400-0.json |
| 44401-8 | Sarcosine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44401-8.json |
| 44402-6 | Selenium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44402-6.json |
| 44403-4 | Serine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44403-4.json |
| 44404-2 | Silicon/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44404-2.json |
| 44405-9 | Sodium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44405-9.json |
| 44406-7 | Sodium/Potassium [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44406-7.json |
| 44407-5 | Somatotropin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44407-5.json |
| 44408-3 | Suberate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44408-3.json |
| 44409-1 | Succinate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44409-1.json |
| 44410-9 | Superoxide dismutase [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/44410-9.json |
| 44411-7 | Taurine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44411-7.json |
| 44412-5 | Tetrahydrodeoxycortisol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44412-5.json |
| 44413-3 | Threonine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44413-3.json |
| 44414-1 | Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44414-1.json |
| 44415-8 | Tyrosine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44415-8.json |
| 44416-6 | Urea nitrogen/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44416-6.json |
| 44417-4 | Valine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44417-4.json |
| 44418-2 | Vanillylmandelate/Creatine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44418-2.json |
| 44419-0 | CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44419-0.json |
| 44420-8 | CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44420-8.json |
| 44421-6 | PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44421-6.json |
| 44422-4 | Interleukin 2 receptor alpha chain soluble [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44422-4.json |
| 44423-2 | Herpes virus 7 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44423-2.json |
| 44424-0 | Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44424-0.json |
| 44426-5 | 3-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44426-5.json |
| 44427-3 | 3-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44427-3.json |
| 44428-1 | Adenosine monophosphate.cyclic.nephrogenous/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44428-1.json |
| 44429-9 | Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/44429-9.json |
| 44430-7 | Alpha cortolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44430-7.json |
| 44431-5 | Annexin V IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44431-5.json |
| 44432-3 | Annexin V IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44432-3.json |
| 44433-1 | Other Antibiotic [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/44433-1.json |
| 44434-9 | Other Antibiotic [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/44434-9.json |
| 44435-6 | Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44435-6.json |
| 44436-4 | Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44436-4.json |
| 44437-2 | Ascaris sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44437-2.json |
| 44438-0 | Aspergillus fumigatus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44438-0.json |
| 44439-8 | Aspergillus fumigatus 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44439-8.json |
| 44440-6 | Aspergillus fumigatus 6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44440-6.json |
| 44441-4 | Aspergillus niger Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44441-4.json |
| 44442-2 | Bartonella henselae Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44442-2.json |
| 44443-0 | Bartonella sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44443-0.json |
| 44444-8 | Bartonella sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44444-8.json |
| 44445-5 | Basement membrane IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44445-5.json |
| 44446-3 | Basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44446-3.json |
| 44447-1 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/44447-1.json |
| 44448-9 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/44448-9.json |
| 44449-7 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/44449-7.json |
| 44450-5 | Beta cortolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44450-5.json |
| 44451-3 | Blastomyces dermatitidis Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44451-3.json |
| 44452-1 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/44452-1.json |
| 44453-9 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/44453-9.json |
| 44454-7 | Borrelia burgdorferi Ab [Units/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/44454-7.json |
| 44455-4 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/44455-4.json |
| 44456-2 | Borrelia burgdorferi Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/44456-2.json |
| 44457-0 | Borrelia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44457-0.json |
| 44458-8 | Brucella abortus IgG+IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44458-8.json |
| 44459-6 | C peptide/Creatinine [Mass Ratio] in Urine --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/44459-6.json |
| 44460-4 | Cladosporium herbarum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44460-4.json |
| 44462-0 | Insulin Free+Bound [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44462-0.json |
| 44463-8 | Herpes simplex virus 1 [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44463-8.json |
| 44464-6 | Herpes simplex virus 1 [Presence] in Skin by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44464-6.json |
| 44465-3 | Herpes simplex virus 1 [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44465-3.json |
| 44466-1 | Herpes simplex virus 1 [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44466-1.json |
| 44467-9 | Herpes simplex virus 1 [Presence] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44467-9.json |
| 44468-7 | Herpes simplex virus 1 [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44468-7.json |
| 44469-5 | Herpes simplex virus 1 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44469-5.json |
| 44470-3 | Herpes simplex virus 1 Ag [Presence] in Anal | ./2.16.840.1.114222.4.11.1002/44470-3.json |
| 44471-1 | Herpes simplex virus 1 Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/44471-1.json |
| 44472-9 | Herpes simplex virus 1 Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/44472-9.json |
| 44473-7 | Herpes simplex virus 1 Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/44473-7.json |
| 44474-5 | Herpes simplex virus 1 Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/44474-5.json |
| 44475-2 | Herpes simplex virus 1 Ag [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/44475-2.json |
| 44476-0 | Herpes simplex virus 1 Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/44476-0.json |
| 44477-8 | Herpes simplex virus 1 Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/44477-8.json |
| 44478-6 | Herpes simplex virus 1 DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44478-6.json |
| 44479-4 | Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44479-4.json |
| 44480-2 | Herpes simplex virus 1+2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44480-2.json |
| 44481-0 | Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44481-0.json |
| 44482-8 | Herpes simplex virus 1+2 IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44482-8.json |
| 44483-6 | Herpes simplex virus 1+2 IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44483-6.json |
| 44484-4 | Herpes simplex virus 2 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44484-4.json |
| 44485-1 | Herpes simplex virus 2 [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44485-1.json |
| 44486-9 | Herpes simplex virus 2 [Presence] in Skin by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44486-9.json |
| 44487-7 | Herpes simplex virus 2 [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44487-7.json |
| 44488-5 | Herpes simplex virus 2 [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44488-5.json |
| 44489-3 | Herpes simplex virus 2 [Presence] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44489-3.json |
| 44490-1 | Herpes simplex virus 2 [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44490-1.json |
| 44491-9 | Herpes simplex virus 2 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44491-9.json |
| 44492-7 | Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44492-7.json |
| 44493-5 | Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44493-5.json |
| 44494-3 | Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44494-3.json |
| 44495-0 | Herpes simplex virus 2 Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/44495-0.json |
| 44496-8 | Herpes simplex virus 2 Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/44496-8.json |
| 44497-6 | Herpes simplex virus 2 Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/44497-6.json |
| 44498-4 | Herpes simplex virus 2 Ag [Presence] in Anal | ./2.16.840.1.114222.4.11.1002/44498-4.json |
| 44499-2 | Herpes simplex virus 2 Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/44499-2.json |
| 44500-7 | Herpes simplex virus 2 Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/44500-7.json |
| 44501-5 | Herpes simplex virus 2 Ag [Presence] in Throat | ./2.16.840.1.114222.4.11.1002/44501-5.json |
| 44502-3 | Herpes simplex virus 2 Ag [Presence] in Tissue | ./2.16.840.1.114222.4.11.1002/44502-3.json |
| 44503-1 | Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44503-1.json |
| 44504-9 | Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44504-9.json |
| 44505-6 | Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44505-6.json |
| 44506-4 | Herpes simplex virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44506-4.json |
| 44507-2 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44507-2.json |
| 44508-0 | Herpes simplex virus Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/44508-0.json |
| 44509-8 | Herpes simplex virus Ag [Presence] in Penis | ./2.16.840.1.114222.4.11.1002/44509-8.json |
| 44510-6 | Herpes simplex virus Ag [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/44510-6.json |
| 44511-4 | Herpes simplex virus Ag [Presence] in Eye | ./2.16.840.1.114222.4.11.1002/44511-4.json |
| 44512-2 | Herpes simplex virus Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/44512-2.json |
| 44513-0 | Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44513-0.json |
| 44514-8 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/44514-8.json |
| 44515-5 | Herpes simplex virus Ag [Presence] in Cervix by Immunoassay | ./2.16.840.1.114222.4.11.1002/44515-5.json |
| 44516-3 | Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44516-3.json |
| 44517-1 | Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44517-1.json |
| 44518-9 | Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44518-9.json |
| 44519-7 | Herpes virus 6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44519-7.json |
| 44520-5 | Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44520-5.json |
| 44521-3 | Herpes virus 6 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44521-3.json |
| 44522-1 | Histoplasma capsulatum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44522-1.json |
| 44523-9 | Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/44523-9.json |
| 44524-7 | Histoplasma capsulatum Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/44524-7.json |
| 44525-4 | Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44525-4.json |
| 44526-2 | Histoplasma capsulatum H Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44526-2.json |
| 44527-0 | Histoplasma capsulatum H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44527-0.json |
| 44528-8 | Histoplasma capsulatum M Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44528-8.json |
| 44529-6 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44529-6.json |
| 44530-4 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/44530-4.json |
| 44531-2 | HIV 1 Ag [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/44531-2.json |
| 44532-0 | HIV 1 gp120 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44532-0.json |
| 44533-8 | HIV 1+2 Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/44533-8.json |
| 44534-6 | HLA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44534-6.json |
| 44535-3 | HTLV I Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/44535-3.json |
| 44536-1 | HTLV I DNA [Presence] in Blood by Probe | ./2.16.840.1.114222.4.11.1002/44536-1.json |
| 44537-9 | HTLV I DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44537-9.json |
| 44538-7 | HTLV I+II Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/44538-7.json |
| 44539-5 | HTLV II Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44539-5.json |
| 44540-3 | HTLV II IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44540-3.json |
| 44541-1 | HTLV II DNA [Presence] in Blood by Probe | ./2.16.840.1.114222.4.11.1002/44541-1.json |
| 44542-9 | HTLV II DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44542-9.json |
| 44543-7 | Human papilloma virus 31+33 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44543-7.json |
| 44544-5 | Human papilloma virus 35 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/44544-5.json |
| 44545-2 | Human papilloma virus DNA [Presence] in Urethra by Probe | ./2.16.840.1.114222.4.11.1002/44545-2.json |
| 44546-0 | Human papilloma virus DNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/44546-0.json |
| 44547-8 | Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/44547-8.json |
| 44548-6 | Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/44548-6.json |
| 44549-4 | Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/44549-4.json |
| 44550-2 | Human papilloma virus DNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/44550-2.json |
| 44551-0 | Human papilloma virus DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/44551-0.json |
| 44552-8 | hydroCHLOROthiazide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44552-8.json |
| 44553-6 | Hydroxyitraconazole [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44553-6.json |
| 44556-9 | Influenza virus A Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44556-9.json |
| 44557-7 | Influenza virus A Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44557-7.json |
| 44558-5 | Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44558-5.json |
| 44559-3 | Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44559-3.json |
| 44560-1 | Influenza virus A Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44560-1.json |
| 44561-9 | Influenza virus A Ag [Presence] in Trachea by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44561-9.json |
| 44562-7 | Influenza virus A Ag [Presence] in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/44562-7.json |
| 44563-5 | Influenza virus A Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/44563-5.json |
| 44564-3 | Influenza virus A Ag [Presence] in Nose by Immunoassay | ./2.16.840.1.114222.4.11.1002/44564-3.json |
| 44565-0 | Influenza virus A+B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44565-0.json |
| 44566-8 | Influenza virus A+B Ag [Presence] in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/44566-8.json |
| 44567-6 | Influenza virus A+B Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/44567-6.json |
| 44568-4 | Influenza virus B Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44568-4.json |
| 44569-2 | Influenza virus B Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/44569-2.json |
| 44570-0 | Influenza virus B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44570-0.json |
| 44571-8 | Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44571-8.json |
| 44572-6 | Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44572-6.json |
| 44573-4 | Influenza virus B Ag [Presence] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44573-4.json |
| 44574-2 | Influenza virus B Ag [Presence] in Trachea by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44574-2.json |
| 44575-9 | Influenza virus B Ag [Presence] in Nose by Immunoassay | ./2.16.840.1.114222.4.11.1002/44575-9.json |
| 44576-7 | Influenza virus B Ag [Presence] in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/44576-7.json |
| 44577-5 | Influenza virus B Ag [Presence] in Nose | ./2.16.840.1.114222.4.11.1002/44577-5.json |
| 44578-3 | Influenza virus C Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/44578-3.json |
| 44579-1 | Influenza virus C Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44579-1.json |
| 44582-5 | IgA [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44582-5.json |
| 44583-3 | IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/44583-3.json |
| 44584-1 | IgA Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44584-1.json |
| 44585-8 | IgA IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44585-8.json |
| 44586-6 | IgA IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44586-6.json |
| 44590-8 | IgA.secretory [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/44590-8.json |
| 44592-4 | IgD [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44592-4.json |
| 44594-0 | IgE [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44594-0.json |
| 44595-7 | IgG [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/44595-7.json |
| 44596-5 | IgG Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44596-5.json |
| 44606-2 | ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/44606-2.json |
| 44608-8 | KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/44608-8.json |
| 44617-9 | PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/44617-9.json |
| 4469-3 | Cellano Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4469-3.json |
| 44700-3 | ACTA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44700-3.json |
| 44701-1 | BHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44701-1.json |
| 44702-9 | Complement C1q Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44702-9.json |
| 44703-7 | MC4R gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44703-7.json |
| 44704-5 | NEB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44704-5.json |
| 44705-2 | ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/44705-2.json |
| 44706-0 | Actin smooth muscle IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44706-0.json |
| 44708-6 | Asialoganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44708-6.json |
| 44709-4 | Asialoganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44709-4.json |
| 44710-2 | Carnitine/Acylcarnitine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44710-2.json |
| 44712-8 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/44712-8.json |
| 44713-6 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/44713-6.json |
| 44716-9 | Creatinine/Calcium [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44716-9.json |
| 4471-9 | Complement Activity Cell Surface Induced [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4471-9.json |
| 44719-3 | Methylmalonate/Homocysteine [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44719-3.json |
| 44720-1 | Methylmalonate/Homocystine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44720-1.json |
| 44726-8 | HLA-B51 [Presence] | ./2.16.840.1.114222.4.11.1002/44726-8.json |
| 44736-7 | Asialoganglioside GM1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44736-7.json |
| 44737-5 | Asialoganglioside GM1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44737-5.json |
| 44738-3 | Asialoganglioside GM1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44738-3.json |
| 44739-1 | Beta tubulin IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44739-1.json |
| 44740-9 | Ganglioside GD1a Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44740-9.json |
| 44744-1 | La Crosse virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44744-1.json |
| 44745-8 | La Crosse virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44745-8.json |
| 44746-6 | La Crosse virus Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44746-6.json |
| 44747-4 | La Crosse virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44747-4.json |
| 44748-2 | La Crosse virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44748-2.json |
| 44749-0 | Ganglioside GM1 IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44749-0.json |
| 44750-8 | Ganglioside GM1 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44750-8.json |
| 44751-6 | Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney | ./2.16.840.1.114222.4.11.1002/44751-6.json |
| 44752-4 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney | ./2.16.840.1.114222.4.11.1002/44752-4.json |
| 44753-2 | Sulfatide IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44753-2.json |
| 44754-0 | Hepatitis D virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44754-0.json |
| 44755-7 | Hepatitis D virus Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44755-7.json |
| 4476-8 | Complement C1 esterase inhibitor.functional [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4476-8.json |
| 44768-0 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44768-0.json |
| 44769-8 | Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/44769-8.json |
| 44770-6 | Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44770-6.json |
| 44771-4 | Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44771-4.json |
| 44775-5 | Liver transplant anastomosis site Portal vein from Graft | ./2.16.840.1.114222.4.11.1002/44775-5.json |
| 4477-6 | Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4477-6.json |
| 4478-4 | Complement C1q [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4478-4.json |
| 44790-4 | Iodide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/44790-4.json |
| 4479-2 | Complement C1q Ag [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4479-2.json |
| 44794-6 | Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44794-6.json |
| 44795-3 | Influenza virus A H5 Asian RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44795-3.json |
| 44796-1 | Clostridium botulinum toxin [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/44796-1.json |
| 44797-9 | Brucella sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44797-9.json |
| 44798-7 | Burkholderia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44798-7.json |
| 44799-5 | Coxiella burnetii [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44799-5.json |
| 44800-1 | Burkholderia sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/44800-1.json |
| 44801-9 | Aldolase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/44801-9.json |
| 44802-7 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44802-7.json |
| 44803-5 | GNE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/44803-5.json |
| 44804-3 | Taenia solium IgG Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/44804-3.json |
| 44805-0 | BK virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44805-0.json |
| 44806-8 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44806-8.json |
| 44807-6 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44807-6.json |
| 44810-0 | HTLV I gp21e Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44810-0.json |
| 44811-8 | Coccidioides sp IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44811-8.json |
| 44814-2 | Coxiella burnetii phase 2 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44814-2.json |
| 44815-9 | Brucella abortus IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44815-9.json |
| 44816-7 | Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44816-7.json |
| 44817-5 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/44817-5.json |
| 4481-8 | Complement C1r [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4481-8.json |
| 44818-3 | Brucella abortus IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44818-3.json |
| 44819-1 | Leishmania donovani IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44819-1.json |
| 44820-9 | Leishmania brasilensis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44820-9.json |
| 44821-7 | Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44821-7.json |
| 44822-5 | La Crosse virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44822-5.json |
| 44823-3 | Bartonella quintana IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44823-3.json |
| 44824-1 | Leishmania donovani IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44824-1.json |
| 44825-8 | Bartonella quintana IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44825-8.json |
| 4482-6 | Complement C1r2+C1s2 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4482-6.json |
| 44826-6 | Hepatitis D virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44826-6.json |
| 44827-4 | Bartonella quintana IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44827-4.json |
| 44828-2 | Teriflunomide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/44828-2.json |
| 44830-8 | Phosphorylase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/44830-8.json |
| 44831-6 | Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44831-6.json |
| 44832-4 | Glycogen synthase I/Glycogen synthase.total in Blood | ./2.16.840.1.114222.4.11.1002/44832-4.json |
| 4483-4 | Complement C1s [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4483-4.json |
| 44834-0 | Acid phosphatase tartrate resistant [Presence] in Bone marrow | ./2.16.840.1.114222.4.11.1002/44834-0.json |
| 44835-7 | Acid phosphatase tartrate resistant [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/44835-7.json |
| 44836-5 | 5-Hydroxymethyl-2-Furoate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/44836-5.json |
| 44837-3 | Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44837-3.json |
| 4484-2 | Complement C2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4484-2.json |
| 4485-9 | Complement C3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4485-9.json |
| 44860-5 | Methoxyacetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44860-5.json |
| 44861-3 | 4-Hydroxymandelate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44861-3.json |
| 44862-1 | 5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44862-1.json |
| 44863-9 | 6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44863-9.json |
| 44864-7 | 6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/44864-7.json |
| 4486-7 | Complement C3 fragment [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4486-7.json |
| 44867-0 | Iron.microscopic observation [Presence] in Body fluid by Other stain | ./2.16.840.1.114222.4.11.1002/44867-0.json |
| 44868-8 | Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44868-8.json |
| 44869-6 | Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) | ./2.16.840.1.114222.4.11.1002/44869-6.json |
| 44870-4 | Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/44870-4.json |
| 44871-2 | HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44871-2.json |
| 44872-0 | HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/44872-0.json |
| 44874-6 | HTLV I+II RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44874-6.json |
| 4487-5 | Complement C3 fragment [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4487-5.json |
| 44875-3 | IgM Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/44875-3.json |
| 44876-1 | Influenza virus A Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44876-1.json |
| 44878-7 | Staphylococcus aureus enterotoxin A sea gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44878-7.json |
| 44879-5 | Staphylococcus aureus enterotoxin E see gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44879-5.json |
| 44880-3 | Staphylococcus aureus enterotoxin B seb gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44880-3.json |
| 44881-1 | Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/44881-1.json |
| 44882-9 | Malignant cells [#/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/44882-9.json |
| 4488-3 | Complement C3a [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4488-3.json |
| 44883-7 | Malignant cells [#/volume] in Cerebral spinal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44883-7.json |
| 44884-5 | Malignant cells [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44884-5.json |
| 44885-2 | Malignant cells [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44885-2.json |
| 44886-0 | Malignant cells [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44886-0.json |
| 44887-8 | Malignant cells [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44887-8.json |
| 44888-6 | Malignant cells [#/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/44888-6.json |
| 44889-4 | Malignant cells [#/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/44889-4.json |
| 44890-2 | Malignant cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44890-2.json |
| 4489-1 | Complement C3b [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4489-1.json |
| 44891-0 | Malignant cells [#/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/44891-0.json |
| 44892-8 | Malignant cells/100 cells in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44892-8.json |
| 44893-6 | Malignant cells/100 cells in Synovial fluid | ./2.16.840.1.114222.4.11.1002/44893-6.json |
| 44894-4 | Malignant cells/100 cells in Cerebral spinal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44894-4.json |
| 44895-1 | Malignant cells/100 cells in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44895-1.json |
| 44896-9 | Malignant cells/100 cells in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44896-9.json |
| 44897-7 | Malignant cells/100 cells in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44897-7.json |
| 44898-5 | Malignant cells/100 cells in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/44898-5.json |
| 44899-3 | Malignant cells/100 cells in Urine by Manual count | ./2.16.840.1.114222.4.11.1002/44899-3.json |
| 44900-9 | Malignant cells/100 cells in Bone marrow by Manual count | ./2.16.840.1.114222.4.11.1002/44900-9.json |
| 44901-7 | Malignant cells/100 cells in Liver by Manual count | ./2.16.840.1.114222.4.11.1002/44901-7.json |
| 44902-5 | Malignant cells/100 cells in Pleural fluid | ./2.16.840.1.114222.4.11.1002/44902-5.json |
| 44903-3 | Malignant cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/44903-3.json |
| 44904-1 | Malignant cells/100 cells in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/44904-1.json |
| 44905-8 | Malignant cells/100 cells in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/44905-8.json |
| 4490-9 | Complement C3b-C4b receptor [Entitic number] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4490-9.json |
| 44910-8 | Alpha-1-Fetoprotein [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/44910-8.json |
| 4491-7 | Complement C3c [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4491-7.json |
| 44918-1 | DOPamine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/44918-1.json |
| 44922-3 | Hemoglobin E/Hemoglobin.total in Blood by HPLC | ./2.16.840.1.114222.4.11.1002/44922-3.json |
| 44923-1 | Hemoglobin S/Hemoglobin.total in Blood by HPLC | ./2.16.840.1.114222.4.11.1002/44923-1.json |
| 4492-5 | Complement C3d [Entitic number] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4492-5.json |
| 44933-0 | Specific gravity of 24 hour Urine by Refractometry | ./2.16.840.1.114222.4.11.1002/44933-0.json |
| 44934-8 | Thymidine kinase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/44934-8.json |
| 44938-9 | Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/44938-9.json |
| 44962-9 | Homans sign of Lower extremity - left | ./2.16.840.1.114222.4.11.1002/44962-9.json |
| 44977-7 | Chlamydophila psittaci IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44977-7.json |
| 44978-5 | Chlamydophila psittaci IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44978-5.json |
| 44979-3 | Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/44979-3.json |
| 44980-1 | Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/44980-1.json |
| 44981-9 | Chlamydophila pneumoniae IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44981-9.json |
| 4498-2 | Complement C4 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4498-2.json |
| 44982-7 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44982-7.json |
| 44983-5 | Chlamydia trachomatis L2 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44983-5.json |
| 44984-3 | Chlamydia trachomatis L2 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44984-3.json |
| 44985-0 | Chlamydia trachomatis L2 IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44985-0.json |
| 44986-8 | Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44986-8.json |
| 44987-6 | Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44987-6.json |
| 44988-4 | Chlamydia trachomatis D+K IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44988-4.json |
| 44989-2 | Chlamydia trachomatis D+K IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44989-2.json |
| 44990-0 | Chlamydia trachomatis D+K IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44990-0.json |
| 44991-8 | Chlamydia trachomatis C IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44991-8.json |
| 44992-6 | Chlamydia trachomatis C IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44992-6.json |
| 44993-4 | Chlamydia trachomatis C IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44993-4.json |
| 44994-2 | Chlamydia trachomatis B IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44994-2.json |
| 44995-9 | Chlamydia trachomatis B IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44995-9.json |
| 44996-7 | Chlamydia trachomatis B IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/44996-7.json |
| 44997-5 | Chlamydia trachomatis Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/44997-5.json |
| 44998-3 | Chlamydia trachomatis Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/44998-3.json |
| 44999-1 | Chlamydia trachomatis IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/44999-1.json |
| 45000-7 | Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45000-7.json |
| 45001-5 | Chlamydia trachomatis IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45001-5.json |
| 45002-3 | Chlamydia trachomatis IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45002-3.json |
| 45003-1 | Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45003-1.json |
| 45004-9 | Chlamydia trachomatis IgA Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45004-9.json |
| 4500-5 | Complement C4 CH50 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/4500-5.json |
| 45005-6 | Chlamydia trachomatis IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45005-6.json |
| 45006-4 | Chlamydia trachomatis IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45006-4.json |
| 45007-2 | Chlamydia trachomatis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45007-2.json |
| 45008-0 | Chlamydia trachomatis Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/45008-0.json |
| 45009-8 | Chlamydia trachomatis Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45009-8.json |
| 45010-6 | Chlamydia sp IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45010-6.json |
| 45011-4 | Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/45011-4.json |
| 45012-2 | Chlamydia sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45012-2.json |
| 4501-3 | Complement C4a [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4501-3.json |
| 4502-1 | Complement C4b binding protein [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4502-1.json |
| 45025-4 | HLA-A SBT [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/45025-4.json |
| 45026-2 | HLA-A2 SBT [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/45026-2.json |
| 45029-6 | HLA-DQB1 SBT [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/45029-6.json |
| 45030-4 | HLA-DRB1 SBT [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/45030-4.json |
| 45031-2 | HLA-C SBT [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/45031-2.json |
| 45032-0 | Tyrosine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45032-0.json |
| 4503-9 | Complement C4b binding protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4503-9.json |
| 45040-3 | Francisella tularensis Ab [Presence] in Serum by Microagglutination | ./2.16.840.1.114222.4.11.1002/45040-3.json |
| 45041-1 | Francisella tularensis Ag [Presence] in Specimen by Slide agglutination | ./2.16.840.1.114222.4.11.1002/45041-1.json |
| 45042-9 | XXX microorganism Ag [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45042-9.json |
| 45043-7 | Microscopic observation [Identifier] in Specimen by Tzanck smear | ./2.16.840.1.114222.4.11.1002/45043-7.json |
| 45045-2 | Yersinia pestis Ab [Presence] in Specimen by Hemagglutination | ./2.16.840.1.114222.4.11.1002/45045-2.json |
| 4504-7 | Complement C4d [Entitic number] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4504-7.json |
| 45047-8 | Cortisol [Moles/volume] in Serum or Plasma --12 AM specimen | ./2.16.840.1.114222.4.11.1002/45047-8.json |
| 45048-6 | Cortisol [Moles/volume] in Serum or Plasma --12 PM specimen | ./2.16.840.1.114222.4.11.1002/45048-6.json |
| 45049-4 | Cortisol [Moles/volume] in Serum or Plasma --4 PM specimen | ./2.16.840.1.114222.4.11.1002/45049-4.json |
| 45050-2 | Cortisol [Moles/volume] in Serum or Plasma --8 AM specimen | ./2.16.840.1.114222.4.11.1002/45050-2.json |
| 45051-0 | Cortisol [Moles/volume] in Serum or Plasma --8 PM specimen | ./2.16.840.1.114222.4.11.1002/45051-0.json |
| 45052-8 | Glucose [Moles/volume] in Serum or Plasma --12 AM specimen | ./2.16.840.1.114222.4.11.1002/45052-8.json |
| 45053-6 | Glucose [Moles/volume] in Serum or Plasma --8 AM specimen | ./2.16.840.1.114222.4.11.1002/45053-6.json |
| 4505-4 | Complement C5 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4505-4.json |
| 45054-4 | Glucose [Moles/volume] in Serum or Plasma --12 PM specimen | ./2.16.840.1.114222.4.11.1002/45054-4.json |
| 45055-1 | Glucose [Moles/volume] in Serum or Plasma --4 PM specimen | ./2.16.840.1.114222.4.11.1002/45055-1.json |
| 45056-9 | Glucose [Moles/volume] in Serum or Plasma --8 PM specimen | ./2.16.840.1.114222.4.11.1002/45056-9.json |
| 4506-2 | Complement C5a [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4506-2.json |
| 45062-7 | C reactive protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45062-7.json |
| 45067-6 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/45067-6.json |
| 45068-4 | Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45068-4.json |
| 45069-2 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe | ./2.16.840.1.114222.4.11.1002/45069-2.json |
| 4507-0 | Complement C6 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4507-0.json |
| 45070-0 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/45070-0.json |
| 45072-6 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anal by Probe | ./2.16.840.1.114222.4.11.1002/45072-6.json |
| 45073-4 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/45073-4.json |
| 45074-2 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe | ./2.16.840.1.114222.4.11.1002/45074-2.json |
| 45075-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe | ./2.16.840.1.114222.4.11.1002/45075-9.json |
| 45076-7 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/45076-7.json |
| 45078-3 | Chlamydia trachomatis rRNA [Presence] in Cervix by Probe | ./2.16.840.1.114222.4.11.1002/45078-3.json |
| 45080-9 | Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/45080-9.json |
| 45084-1 | Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45084-1.json |
| 45085-8 | Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe | ./2.16.840.1.114222.4.11.1002/45085-8.json |
| 45086-6 | Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45086-6.json |
| 4508-8 | Complement C7 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4508-8.json |
| 45089-0 | Chlamydia trachomatis rRNA [Presence] in Anal by Probe | ./2.16.840.1.114222.4.11.1002/45089-0.json |
| 45090-8 | Chlamydia trachomatis DNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45090-8.json |
| 45091-6 | Chlamydia trachomatis Ag [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/45091-6.json |
| 45092-4 | Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/45092-4.json |
| 45093-2 | Chlamydia trachomatis [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45093-2.json |
| 45094-0 | Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45094-0.json |
| 45095-7 | Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45095-7.json |
| 4509-6 | Complement C8 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4509-6.json |
| 45096-5 | Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45096-5.json |
| 45097-3 | Chlamydia sp identified in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45097-3.json |
| 45098-1 | Chlamydia sp identified in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45098-1.json |
| 45099-9 | Chlamydia sp identified in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45099-9.json |
| 45100-5 | Chlamydia sp identified in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45100-5.json |
| 45101-3 | Chlamydia sp identified in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/45101-3.json |
| 45103-9 | Chlamydia sp Ag [Presence] in Anal by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45103-9.json |
| 4510-4 | Complement C9 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4510-4.json |
| 45104-7 | Chlamydia sp Ag [Presence] in Anal by Immunoassay | ./2.16.840.1.114222.4.11.1002/45104-7.json |
| 45105-4 | Chlamydia sp Ag [Presence] in Anal | ./2.16.840.1.114222.4.11.1002/45105-4.json |
| 45106-2 | Chlamydia sp Ag [Presence] in Cervix by Immunoassay | ./2.16.840.1.114222.4.11.1002/45106-2.json |
| 45107-0 | Chlamydia sp Ag [Presence] in Cervix | ./2.16.840.1.114222.4.11.1002/45107-0.json |
| 45108-8 | Chlamydia sp Ag [Presence] in Cervix by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45108-8.json |
| 45109-6 | Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45109-6.json |
| 4511-2 | Complement total hemolytic CH50 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/4511-2.json |
| 45112-0 | Chlamydia sp Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45112-0.json |
| 45113-8 | Chlamydia sp Ag [Presence] in Urethra by Immunoassay | ./2.16.840.1.114222.4.11.1002/45113-8.json |
| 45114-6 | Chlamydia sp Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/45114-6.json |
| 45115-3 | Chlamydia sp Ag [Presence] in Urethra by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45115-3.json |
| 45116-1 | Mycobacterium gordonae rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45116-1.json |
| 45117-9 | Mycobacterium kansasii rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45117-9.json |
| 45118-7 | Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/45118-7.json |
| 45120-3 | Vesicular stomatitis Indiana virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/45120-3.json |
| 45121-1 | Cocal virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/45121-1.json |
| 45122-9 | Cocal virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/45122-9.json |
| 45123-7 | Cocal virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/45123-7.json |
| 45124-5 | Vesicular stomatitis Alagoas virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/45124-5.json |
| 45125-2 | Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/45125-2.json |
| 45126-0 | Vesicular stomatitis Alagoas virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/45126-0.json |
| 45127-8 | Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/45127-8.json |
| 45128-6 | Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/45128-6.json |
| 45130-2 | Chlamydia trachomatis Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45130-2.json |
| 45131-0 | Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45131-0.json |
| 45132-8 | Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/45132-8.json |
| 45133-6 | Chlamydia sp Ag [Presence] in Nasopharynx | ./2.16.840.1.114222.4.11.1002/45133-6.json |
| 45134-4 | Campylobacter jejuni IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/45134-4.json |
| 45135-1 | Chlamydia trachomatis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45135-1.json |
| 45136-9 | Endomysium IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45136-9.json |
| 45137-7 | IgA.secretory [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/45137-7.json |
| 4513-8 | Complement C1r2+C1s2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4513-8.json |
| 45138-5 | Listeria monocytogenes O4b IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/45138-5.json |
| 45139-3 | Listeria monocytogenes O4b IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/45139-3.json |
| 45140-1 | Phenols [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/45140-1.json |
| 45141-9 | Platelet associated Ab [Presence] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/45141-9.json |
| 45142-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45142-7.json |
| 45143-5 | Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/45143-5.json |
| 45144-3 | clomiPRAMINE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/45144-3.json |
| 45145-0 | Methdilazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45145-0.json |
| 4514-6 | Complement decay accelerating factor [Entitic number] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4514-6.json |
| 45146-8 | Triflupromazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45146-8.json |
| 45147-6 | Propiomazine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45147-6.json |
| 45148-4 | OmpC IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45148-4.json |
| 45149-2 | Ej Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45149-2.json |
| 45150-0 | Neutrophil Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45150-0.json |
| 45151-8 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45151-8.json |
| 45152-6 | OJ Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45152-6.json |
| 45153-4 | HLA Ab in Serum | ./2.16.840.1.114222.4.11.1002/45153-4.json |
| 45154-2 | Phenylalanine hydroxylase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45154-2.json |
| 45155-9 | Heparin induced platelet Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45155-9.json |
| 45156-7 | Rheumatoid factor [Presence] in Body fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/45156-7.json |
| 45157-5 | U2 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45157-5.json |
| 45158-3 | Immune complex [Units/volume] in Serum or Plasma by C3d binding assay | ./2.16.840.1.114222.4.11.1002/45158-3.json |
| 45160-9 | Acremonium sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/45160-9.json |
| 4516-1 | Complement factor Ba [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4516-1.json |
| 45161-7 | Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45161-7.json |
| 45162-5 | Escherichia coli O157 Ag [Presence] in Isolate by Latex agglutination | ./2.16.840.1.114222.4.11.1002/45162-5.json |
| 45163-3 | Alternaria alternata Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45163-3.json |
| 45164-1 | Asialoganglioside GM2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45164-1.json |
| 45165-8 | Borrelia burgdorferi IgA Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45165-8.json |
| 45166-6 | Corynebacterium diphtheriae IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45166-6.json |
| 45167-4 | IgE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/45167-4.json |
| 45168-2 | Malonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/45168-2.json |
| 45169-0 | Ganglioside GM1 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45169-0.json |
| 45170-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45170-8.json |
| 45171-6 | Pancreatic islet cell Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45171-6.json |
| 45172-4 | Purkinje cells Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45172-4.json |
| 45173-2 | Thyrotropin.alpha subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45173-2.json |
| 45175-7 | HIV nucleoside reverse transcriptase gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/45175-7.json |
| 45176-5 | HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/45176-5.json |
| 45177-3 | Herpes gestationis IgG Ab non-complement fixing [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45177-3.json |
| 45178-1 | Basement membrane zone IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45178-1.json |
| 4517-9 | Complement factor Bb [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4517-9.json |
| 45179-9 | Herpes gestationis IgG Ab complement fixing [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45179-9.json |
| 45182-3 | HIV phenotype [Susceptibility] | ./2.16.840.1.114222.4.11.1002/45182-3.json |
| 45185-6 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/45185-6.json |
| 45186-4 | Kiwifruit IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/45186-4.json |
| 4518-7 | Complement factor D [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4518-7.json |
| 45188-0 | Basement membrane zone BP180 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45188-0.json |
| 45189-8 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45189-8.json |
| 45190-6 | CASR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/45190-6.json |
| 45191-4 | CAPN3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/45191-4.json |
| 45192-2 | Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/45192-2.json |
| 45193-0 | CD20+CD52+ cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/45193-0.json |
| 45194-8 | Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45194-8.json |
| 4519-5 | Complement factor H [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4519-5.json |
| 45195-5 | Cow epithelium+Cow dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45195-5.json |
| 45196-3 | Cytokines [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/45196-3.json |
| 45197-1 | Decanoylcarnitine (C10) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45197-1.json |
| 45198-9 | Decenoylcarnitine (C10:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45198-9.json |
| 45199-7 | Dodecanoylcarnitine (C12) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45199-7.json |
| 45200-3 | Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45200-3.json |
| 45201-1 | Whole Egg IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45201-1.json |
| 4520-3 | Complement factor I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4520-3.json |
| 45207-8 | Glutarylcarnitine (C5-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45207-8.json |
| 45208-6 | Hemoglobin A [Presence] in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/45208-6.json |
| 45209-4 | Heptacarboxylporphyrin [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45209-4.json |
| 45210-2 | Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45210-2.json |
| 4521-1 | Complement factor P [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4521-1.json |
| 45211-0 | Hexanoylcarnitine (C6) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45211-0.json |
| 45213-6 | Isobutyrylcarnitine (C4) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45213-6.json |
| 45214-4 | Isoleucine+Leucine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45214-4.json |
| 45216-9 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45216-9.json |
| 45217-7 | Linoleoylcarnitine (C18:2) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45217-7.json |
| 45218-5 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45218-5.json |
| 45219-3 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45219-3.json |
| 45220-1 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45220-1.json |
| 45221-9 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/45221-9.json |
| 45222-7 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/45222-7.json |
| 45224-3 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/45224-3.json |
| 45225-0 | Pancreatic islet cell complement fixing Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45225-0.json |
| 45226-8 | Ribosomal P IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45226-8.json |
| 45227-6 | Blackberry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/45227-6.json |
| 45228-4 | Streptolysin O Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45228-4.json |
| 4522-9 | Complement iC3 [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4522-9.json |
| 45229-2 | Toxocara cati Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45229-2.json |
| 4523-7 | Complement iC3b receptors [Entitic number] in Leukocytes | ./2.16.840.1.114222.4.11.1002/4523-7.json |
| 4524-5 | Complement membrane attack complex (C5b-C6-C7-C8-C9n) [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4524-5.json |
| 4525-2 | Complement membrane C3b-C4b cofactor protein [Entitic number] in Leukocytes | ./2.16.840.1.114222.4.11.1002/4525-2.json |
| 45271-4 | Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45271-4.json |
| 45272-2 | Sympathomimetics [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/45272-2.json |
| 45274-8 | Low molecular weight heparin induced platelet Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45274-8.json |
| 45275-5 | Bacteria identified in Blood by Aerobe culture 25 degree C incubation | ./2.16.840.1.114222.4.11.1002/45275-5.json |
| 45276-3 | Bacteria identified in Blood by Anaerobe culture 25 degree C incubation | ./2.16.840.1.114222.4.11.1002/45276-3.json |
| 45277-1 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45277-1.json |
| 45278-9 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45278-9.json |
| 45279-7 | Influenza virus A+B Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45279-7.json |
| 45280-5 | Echovirus 9 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45280-5.json |
| 45281-3 | Echovirus 7 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45281-3.json |
| 45282-1 | Echovirus 30 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45282-1.json |
| 45283-9 | Echovirus 11 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45283-9.json |
| 45284-7 | DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/45284-7.json |
| 45286-2 | Cytomegalovirus IgA Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45286-2.json |
| 45287-0 | Coxsackievirus B6 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45287-0.json |
| 45288-8 | Coxsackievirus B5 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45288-8.json |
| 45289-6 | Coxsackievirus B4 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45289-6.json |
| 45290-4 | Coxsackievirus B3 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45290-4.json |
| 45291-2 | Coxsackievirus B2 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45291-2.json |
| 45292-0 | Coxsackievirus B1 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/45292-0.json |
| 45294-6 | Bordetella bronchiseptica DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/45294-6.json |
| 45296-1 | Cortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone | ./2.16.840.1.114222.4.11.1002/45296-1.json |
| 45297-9 | Glucose [Moles/volume] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/45297-9.json |
| 45298-7 | Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/45298-7.json |
| 45299-5 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/45299-5.json |
| 45300-1 | Glycerol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45300-1.json |
| 45301-9 | Nortriptyline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/45301-9.json |
| 45302-7 | Urea [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/45302-7.json |
| 45303-5 | Urea [Moles/volume] in Dialysis fluid --2 hour specimen | ./2.16.840.1.114222.4.11.1002/45303-5.json |
| 45304-3 | Urea [Moles/volume] in Dialysis fluid --4 hour specimen | ./2.16.840.1.114222.4.11.1002/45304-3.json |
| 45305-0 | Coproporphyrin 1 [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45305-0.json |
| 45306-8 | Coproporphyrin 3 [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45306-8.json |
| 45307-6 | Deuteroporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45307-6.json |
| 45308-4 | Heptacarboxylate [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45308-4.json |
| 45309-2 | Hexacarboxylate [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45309-2.json |
| 4531-0 | Complement total hemolytic [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/4531-0.json |
| 45310-0 | Mesoporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45310-0.json |
| 45311-8 | Pentacarboxylate [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45311-8.json |
| 45312-6 | Uroporphyrin 3 isomer [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/45312-6.json |
| 45313-4 | Coproporphyrin 1/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45313-4.json |
| 45314-2 | Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45314-2.json |
| 45315-9 | Coproporphyrin 3/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45315-9.json |
| 45316-7 | Hexacarboxylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45316-7.json |
| 45317-5 | Pentacarboxylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45317-5.json |
| 45318-3 | Uroporphyrin 3 isomer/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45318-3.json |
| 45319-1 | Uroporphyrin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/45319-1.json |
| 45320-9 | Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/45320-9.json |
| 45321-7 | FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/45321-7.json |
| 45322-5 | FMR1 gene allele 2 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/45322-5.json |
| 45323-3 | Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/45323-3.json |
| 45324-1 | Ethyl glucuronide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/45324-1.json |
| 45325-8 | Campylobacter jejuni IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/45325-8.json |
| 45326-6 | Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45326-6.json |
| 45327-4 | FMR1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/45327-4.json |
| 4532-8 | Complement total hemolytic CH50 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4532-8.json |
| 45328-2 | Glutathione peroxidase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/45328-2.json |
| 45329-0 | Glutathione reductase [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/45329-0.json |
| 45330-8 | Leptospira interrogans IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/45330-8.json |
| 45331-6 | NF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/45331-6.json |
| 45332-4 | NF2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/45332-4.json |
| 45333-2 | Superoxide dismutase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/45333-2.json |
| 45334-0 | Tryptase [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/45334-0.json |
| 4533-6 | Complement+Immunoglobulin [Units/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4533-6.json |
| 45338-1 | Proinsulin/Insulin [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/45338-1.json |
| 45342-3 | Tick identified in Specimen | ./2.16.840.1.114222.4.11.1002/45342-3.json |
| 4535-1 | Cytotoxic percent reactive Ab [Presence] in Serum by Quick method | ./2.16.840.1.114222.4.11.1002/4535-1.json |
| 45360-5 | Lymphocyte proliferation stimulated by 0.125 ug pokeweed mitogen in Blood | ./2.16.840.1.114222.4.11.1002/45360-5.json |
| 45361-3 | Lymphocyte proliferation stimulated by 0.25 ug pokeweed mitogen in Blood | ./2.16.840.1.114222.4.11.1002/45361-3.json |
| 45362-1 | Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen in Blood | ./2.16.840.1.114222.4.11.1002/45362-1.json |
| 45363-9 | Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin in Blood | ./2.16.840.1.114222.4.11.1002/45363-9.json |
| 45364-7 | Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/45364-7.json |
| 45365-4 | Lymphocyte proliferation stimulated by 10 ug concanavalin A in Blood | ./2.16.840.1.114222.4.11.1002/45365-4.json |
| 45366-2 | Lymphocyte proliferation stimulated by 2.0 ug phytohemagglutinin in Blood | ./2.16.840.1.114222.4.11.1002/45366-2.json |
| 45367-0 | Lymphocyte proliferation stimulated by 20 ug concanavalin A in Blood | ./2.16.840.1.114222.4.11.1002/45367-0.json |
| 45368-8 | Lymphocyte proliferation stimulated by 5 ug concanavalin A in Blood | ./2.16.840.1.114222.4.11.1002/45368-8.json |
| 45369-6 | Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin in Blood | ./2.16.840.1.114222.4.11.1002/45369-6.json |
| 4537-7 | Erythrocyte sedimentation rate by Westergren method | ./2.16.840.1.114222.4.11.1002/4537-7.json |
| 45378-7 | Glutathione peroxidase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/45378-7.json |
| 45379-5 | Eosinophils [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/45379-5.json |
| 45382-9 | Epidermis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/45382-9.json |
| 4538-5 | Erythrocyte sedimentation rate by Wintrobe method | ./2.16.840.1.114222.4.11.1002/4538-5.json |
| 45392-8 | Patient First (Given) name | ./2.16.840.1.114222.4.11.1002/45392-8.json |
| 4539-3 | Erythrocyte sedimentation rate Zeta by Zetafuge | ./2.16.840.1.114222.4.11.1002/4539-3.json |
| 45393-6 | Middle initial | ./2.16.840.1.114222.4.11.1002/45393-6.json |
| 45394-4 | Patient Last (Family) name | ./2.16.840.1.114222.4.11.1002/45394-4.json |
| 45395-1 | Patient Name suffix | ./2.16.840.1.114222.4.11.1002/45395-1.json |
| 45396-9 | Social Security number [Identifier] | ./2.16.840.1.114222.4.11.1002/45396-9.json |
| 45397-7 | Medicare or comparable number | ./2.16.840.1.114222.4.11.1002/45397-7.json |
| 45398-5 | State provider number for Facility | ./2.16.840.1.114222.4.11.1002/45398-5.json |
| 45400-9 | Medicaid number | ./2.16.840.1.114222.4.11.1002/45400-9.json |
| 45401-7 | Postal code [Location] | ./2.16.840.1.114222.4.11.1002/45401-7.json |
| 45403-3 | Room number [Location] | ./2.16.840.1.114222.4.11.1002/45403-3.json |
| 4542-7 | Haptoglobin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4542-7.json |
| 4543-5 | Haptoglobin [Mass/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/4543-5.json |
| 4544-3 | Hematocrit [Volume Fraction] of Blood by Automated count | ./2.16.840.1.114222.4.11.1002/4544-3.json |
| 4545-0 | Hematocrit [Volume Fraction] of Blood by Centrifugation | ./2.16.840.1.114222.4.11.1002/4545-0.json |
| 4548-4 | Hemoglobin A1c/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/4548-4.json |
| 4549-2 | Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis | ./2.16.840.1.114222.4.11.1002/4549-2.json |
| 4550-0 | Hemoglobin A2 [Moles/volume] in Blood by Chromatography column | ./2.16.840.1.114222.4.11.1002/4550-0.json |
| 4579-9 | Hemoglobin F [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/4579-9.json |
| 46080-8 | CD55 RBC/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/46080-8.json |
| 46081-6 | Theophylline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46081-6.json |
| 46082-4 | Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/46082-4.json |
| 46083-2 | Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/46083-2.json |
| 46084-0 | Immunoglobulin light chains [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/46084-0.json |
| 46085-7 | Gamma hydroxybutyrate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46085-7.json |
| 46086-5 | Creatinine [Moles/volume] in Dialysis fluid --2 hour specimen | ./2.16.840.1.114222.4.11.1002/46086-5.json |
| 46087-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --2nd tube | ./2.16.840.1.114222.4.11.1002/46087-3.json |
| 46088-1 | Leukocytes [#/volume] in Cerebral spinal fluid --2nd tube | ./2.16.840.1.114222.4.11.1002/46088-1.json |
| 46089-9 | Leukocytes [#/volume] in Cerebral spinal fluid --3rd tube | ./2.16.840.1.114222.4.11.1002/46089-9.json |
| 46090-7 | Leukocytes [#/volume] in Cerebral spinal fluid --4th tube | ./2.16.840.1.114222.4.11.1002/46090-7.json |
| 46091-5 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --3rd tube | ./2.16.840.1.114222.4.11.1002/46091-5.json |
| 46092-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --4th tube | ./2.16.840.1.114222.4.11.1002/46092-3.json |
| 46093-1 | Calcium.ionized [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/46093-1.json |
| 46094-9 | Plasmodium sp Ag [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/46094-9.json |
| 46095-6 | Anabolic steroids [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46095-6.json |
| 46096-4 | Arsenic [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/46096-4.json |
| 46098-0 | Sex | ./2.16.840.1.114222.4.11.1002/46098-0.json |
| 46108-7 | 18q chromosome deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/46108-7.json |
| 46109-5 | Rubella virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46109-5.json |
| 46110-3 | Rubella virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46110-3.json |
| 46111-1 | Mycoplasma sp DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46111-1.json |
| 46125-1 | Cardiolipin Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46125-1.json |
| 46126-9 | Endomysium IgA Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/46126-9.json |
| 46127-7 | Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry | ./2.16.840.1.114222.4.11.1002/46127-7.json |
| 46128-5 | Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46128-5.json |
| 46130-1 | Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry | ./2.16.840.1.114222.4.11.1002/46130-1.json |
| 46131-9 | Clostridioides difficile toxin B [Presence] in Stool by Cytotoxin tissue culture assay | ./2.16.840.1.114222.4.11.1002/46131-9.json |
| 46132-7 | Glycosaminoglycans/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/46132-7.json |
| 46133-5 | Epithelial cells [#/area] in Urine sediment by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/46133-5.json |
| 46134-3 | Granular casts [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/46134-3.json |
| 46135-0 | Hyaline casts [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/46135-0.json |
| 46136-8 | Transitional cells [#/area] in Urine sediment by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/46136-8.json |
| 46137-6 | Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/46137-6.json |
| 46138-4 | Urate crystals [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/46138-4.json |
| 46154-1 | Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46154-1.json |
| 46155-8 | Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46155-8.json |
| 46156-6 | Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46156-6.json |
| 46157-4 | Aspergillus glaucus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46157-4.json |
| 46158-2 | Bartonella sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46158-2.json |
| 46159-0 | Bartonella sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46159-0.json |
| 46160-8 | Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46160-8.json |
| 46174-9 | Borrelia burgdorferi IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46174-9.json |
| 46175-6 | Cache valley virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46175-6.json |
| 46176-4 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46176-4.json |
| 46177-2 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46177-2.json |
| 46178-0 | Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46178-0.json |
| 46179-8 | Chlamydophila sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46179-8.json |
| 46180-6 | Classical swine fever virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46180-6.json |
| 46181-4 | Coccidioides sp IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46181-4.json |
| 46182-2 | Coccidioides sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46182-2.json |
| 46183-0 | Coccidioides sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46183-0.json |
| 46184-8 | Echinococcus granulosus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46184-8.json |
| 46185-5 | Ehrlichia risticii Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46185-5.json |
| 46186-3 | Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46186-3.json |
| 46187-1 | Equine herpesvirus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46187-1.json |
| 46188-9 | Equine herpesvirus 3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46188-9.json |
| 46189-7 | Goose parvovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46189-7.json |
| 46190-5 | Herpes simplex virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/46190-5.json |
| 46191-3 | Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46191-3.json |
| 46192-1 | HTLV II IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46192-1.json |
| 46193-9 | Infectious bronchitis virus JMK Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46193-9.json |
| 46194-7 | Legionella non-pneumophila Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46194-7.json |
| 46195-4 | Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46195-4.json |
| 46196-2 | Leptospira interrogans IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46196-2.json |
| 46197-0 | Measles virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46197-0.json |
| 46198-8 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46198-8.json |
| 46199-6 | Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46199-6.json |
| 46200-2 | Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46200-2.json |
| 46201-0 | Porcine adenovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46201-0.json |
| 46202-8 | Psittacid herpesvirus 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/46202-8.json |
| 46203-6 | Reagin Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46203-6.json |
| 46204-4 | Salmonella typhi O D Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/46204-4.json |
| 46205-1 | Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46205-1.json |
| 46206-9 | Treponema pallidum Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/46206-9.json |
| 46207-7 | PKD1 gene+PKD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/46207-7.json |
| 46209-3 | Provider orders | ./2.16.840.1.114222.4.11.1002/46209-3.json |
| 46210-1 | Case manager Note | ./2.16.840.1.114222.4.11.1002/46210-1.json |
| 46213-5 | Tilt table study | ./2.16.840.1.114222.4.11.1002/46213-5.json |
| 46214-3 | Intracardiac ablation study | ./2.16.840.1.114222.4.11.1002/46214-3.json |
| 46215-0 | Wound care management Note | ./2.16.840.1.114222.4.11.1002/46215-0.json |
| 46217-6 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46217-6.json |
| 46218-4 | 5-Fluorocytosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46218-4.json |
| 4621-9 | Hemoglobin S [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/4621-9.json |
| 46219-2 | Creatinine [Moles/volume] in Dialysis fluid --4 hour specimen | ./2.16.840.1.114222.4.11.1002/46219-2.json |
| 46220-0 | Creatinine [Moles/volume] in Dialysis fluid --overnight | ./2.16.840.1.114222.4.11.1002/46220-0.json |
| 46221-8 | Glucose [Moles/volume] in Dialysis fluid --2 hour specimen | ./2.16.840.1.114222.4.11.1002/46221-8.json |
| 46222-6 | Glucose [Moles/volume] in Dialysis fluid --4 hour specimen | ./2.16.840.1.114222.4.11.1002/46222-6.json |
| 46223-4 | Glucose [Moles/volume] in Dialysis fluid --overnight | ./2.16.840.1.114222.4.11.1002/46223-4.json |
| 46224-2 | Thrombin time in Platelet poor plasma by Coagulation assay --after addition of heparinase | ./2.16.840.1.114222.4.11.1002/46224-2.json |
| 46225-9 | ABCA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46225-9.json |
| 46226-7 | SGCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46226-7.json |
| 46227-5 | DULoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46227-5.json |
| 46228-3 | Clenbuterol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46228-3.json |
| 46229-1 | Furazabol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46229-1.json |
| 46230-9 | Methanolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46230-9.json |
| 46236-6 | HLA-B*51 [Type] in Leukocytes | ./2.16.840.1.114222.4.11.1002/46236-6.json |
| 46245-7 | Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation [Identifier] by Molecular method | ./2.16.840.1.114222.4.11.1002/46245-7.json |
| 4625-0 | Hemoglobin S/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/4625-0.json |
| 46253-1 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/46253-1.json |
| 46254-9 | Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/46254-9.json |
| 46255-6 | Methyl ethyl ketone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46255-6.json |
| 46256-4 | oxyCODONE Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46256-4.json |
| 46257-2 | Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46257-2.json |
| 46258-0 | oxyMORphone Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46258-0.json |
| 46259-8 | Morphine Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46259-8.json |
| 46260-6 | HYDROmorphone Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46260-6.json |
| 46261-4 | HYDROcodone Free [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46261-4.json |
| 46262-2 | Codeine Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46262-2.json |
| 46263-0 | 6-monoacetylmorphine free [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46263-0.json |
| 46265-5 | Cryofibrinogen [Presence] in Plasma by 1 week cold incubation | ./2.16.840.1.114222.4.11.1002/46265-5.json |
| 46266-3 | Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46266-3.json |
| 46267-1 | Proteinase 3 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46267-1.json |
| 46268-9 | ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction | ./2.16.840.1.114222.4.11.1002/46268-9.json |
| 46269-7 | 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46269-7.json |
| 46270-5 | ABO group [Type] in Blood--after transfusion reaction | ./2.16.840.1.114222.4.11.1002/46270-5.json |
| 46271-3 | Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/46271-3.json |
| 46274-7 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/46274-7.json |
| 46276-2 | Rh [Type] in Blood--after transfusion reaction | ./2.16.840.1.114222.4.11.1002/46276-2.json |
| 46281-2 | CT Guidance for aspiration or injection of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/46281-2.json |
| 46282-0 | US Guidance for aspiration or injection of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/46282-0.json |
| 46283-8 | MG Guidance for fine needle aspiration of Breast - right | ./2.16.840.1.114222.4.11.1002/46283-8.json |
| 46284-6 | MG Guidance for fine needle aspiration of Breast - left | ./2.16.840.1.114222.4.11.1002/46284-6.json |
| 46285-3 | US Guidance for core needle biopsy of Thyroid gland | ./2.16.840.1.114222.4.11.1002/46285-3.json |
| 46288-7 | US Guidance for biopsy of Prostate | ./2.16.840.1.114222.4.11.1002/46288-7.json |
| 46289-5 | CT Guidance for biopsy of Unspecified body region-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46289-5.json |
| 46290-3 | CT Guidance for biopsy of Unspecified body region-- WO contrast | ./2.16.840.1.114222.4.11.1002/46290-3.json |
| 46291-1 | CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46291-1.json |
| 46292-9 | CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/46292-9.json |
| 46293-7 | CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO contrast | ./2.16.840.1.114222.4.11.1002/46293-7.json |
| 46294-5 | RF Guidance for percutaneous replacement of drainage catheter of Stomach | ./2.16.840.1.114222.4.11.1002/46294-5.json |
| 46295-2 | MG stereo Guidance for percutaneous biopsy.core needle of Breast - left | ./2.16.840.1.114222.4.11.1002/46295-2.json |
| 46296-0 | MG stereo Guidance for percutaneous biopsy.core needle of Breast | ./2.16.840.1.114222.4.11.1002/46296-0.json |
| 46297-8 | SPECT Whole body | ./2.16.840.1.114222.4.11.1002/46297-8.json |
| 46298-6 | CT Mastoid - bilateral | ./2.16.840.1.114222.4.11.1002/46298-6.json |
| 46299-4 | MR Breast - unilateral | ./2.16.840.1.114222.4.11.1002/46299-4.json |
| 46301-8 | US.doppler Extremity vein - bilateral limited | ./2.16.840.1.114222.4.11.1002/46301-8.json |
| 46302-6 | US.doppler Upper extremity artery - bilateral limited | ./2.16.840.1.114222.4.11.1002/46302-6.json |
| 46303-4 | US.doppler Upper extremity vessels limited | ./2.16.840.1.114222.4.11.1002/46303-4.json |
| 46304-2 | CT Sinuses limited WO contrast | ./2.16.840.1.114222.4.11.1002/46304-2.json |
| 46305-9 | CT Whole body | ./2.16.840.1.114222.4.11.1002/46305-9.json |
| 46306-7 | CT Whole body W contrast IV | ./2.16.840.1.114222.4.11.1002/46306-7.json |
| 46307-5 | CTA Lower extremity vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46307-5.json |
| 46308-3 | CTA Lower extremity vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46308-3.json |
| 46309-1 | CTA Upper extremity vessels - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46309-1.json |
| 46310-9 | MR Orbit and Face and Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46310-9.json |
| 46311-7 | CT Parotid gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46311-7.json |
| 46312-5 | CTA Upper extremity vessels - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46312-5.json |
| 46313-3 | CT Pelvis WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46313-3.json |
| 46314-1 | CT Internal auditory canal WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46314-1.json |
| 46315-8 | CT Maxillofacial region WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46315-8.json |
| 46316-6 | CT Head WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46316-6.json |
| 46317-4 | CT Chest WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46317-4.json |
| 4631-8 | Hemoglobin F [Presence] in Stool by Apt-Downey method | ./2.16.840.1.114222.4.11.1002/4631-8.json |
| 46318-2 | CT Abdomen WO and W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46318-2.json |
| 46319-0 | MR Elbow Arthrogram | ./2.16.840.1.114222.4.11.1002/46319-0.json |
| 46320-8 | CT Orbit and Face W contrast IV | ./2.16.840.1.114222.4.11.1002/46320-8.json |
| 46321-6 | MR Orbit and Face and Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/46321-6.json |
| 46322-4 | CT Kidney W contrast IV | ./2.16.840.1.114222.4.11.1002/46322-4.json |
| 46323-2 | MR Breast - unilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/46323-2.json |
| 46324-0 | MRA Lower extremity vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/46324-0.json |
| 46325-7 | CT Internal auditory canal W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46325-7.json |
| 4632-6 | Hemoglobin F [Presence] in Blood by Alkali denaturation | ./2.16.840.1.114222.4.11.1002/4632-6.json |
| 46326-5 | CT Maxillofacial region W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46326-5.json |
| 46327-3 | CT Chest W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46327-3.json |
| 46328-1 | CT Head W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46328-1.json |
| 46329-9 | CT Pelvis W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46329-9.json |
| 46330-7 | CT Abdomen W reduced contrast volume IV | ./2.16.840.1.114222.4.11.1002/46330-7.json |
| 46331-5 | CT Orbit WO contrast | ./2.16.840.1.114222.4.11.1002/46331-5.json |
| 46332-3 | MR Orbit and Face and Neck WO contrast | ./2.16.840.1.114222.4.11.1002/46332-3.json |
| 46333-1 | MR Breast - unilateral WO contrast | ./2.16.840.1.114222.4.11.1002/46333-1.json |
| 46335-6 | MG Breast - bilateral Single view | ./2.16.840.1.114222.4.11.1002/46335-6.json |
| 46336-4 | MG Breast - left Single view | ./2.16.840.1.114222.4.11.1002/46336-4.json |
| 46337-2 | MG Breast - right Single view | ./2.16.840.1.114222.4.11.1002/46337-2.json |
| 46338-0 | MG Breast - unilateral Single view | ./2.16.840.1.114222.4.11.1002/46338-0.json |
| 46339-8 | MG Breast - unilateral Views | ./2.16.840.1.114222.4.11.1002/46339-8.json |
| 46340-6 | XR Spine lumbosacral junction Views | ./2.16.840.1.114222.4.11.1002/46340-6.json |
| 46341-4 | RF Abdomen Views | ./2.16.840.1.114222.4.11.1002/46341-4.json |
| 46342-2 | FFD mammogram Breast Views | ./2.16.840.1.114222.4.11.1002/46342-2.json |
| 46343-0 | XR Wrist - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/46343-0.json |
| 46344-8 | XR Elbow - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/46344-8.json |
| 46345-5 | XR Elbow - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/46345-5.json |
| 46346-3 | XR Wrist - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/46346-3.json |
| 46347-1 | XR Ankle - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/46347-1.json |
| 46348-9 | XR Chest GE 2 and PA and Lateral | ./2.16.840.1.114222.4.11.1002/46348-9.json |
| 46349-7 | XR Shoulder - bilateral AP and Transthoracic | ./2.16.840.1.114222.4.11.1002/46349-7.json |
| 46350-5 | MG Breast - unilateral Diagnostic | ./2.16.840.1.114222.4.11.1002/46350-5.json |
| 46351-3 | MG Breast - bilateral Displacement Views for Implant | ./2.16.840.1.114222.4.11.1002/46351-3.json |
| 46352-1 | MG Breast duct Views during surgery W contrast intra duct | ./2.16.840.1.114222.4.11.1002/46352-1.json |
| 46354-7 | FFD mammogram Breast - right Screening | ./2.16.840.1.114222.4.11.1002/46354-7.json |
| 46355-4 | FFD mammogram Breast - left Screening | ./2.16.840.1.114222.4.11.1002/46355-4.json |
| 46356-2 | MG Breast - unilateral Screening | ./2.16.840.1.114222.4.11.1002/46356-2.json |
| 46357-0 | RF Colon Views W air contrast PR | ./2.16.840.1.114222.4.11.1002/46357-0.json |
| 46358-8 | MR Whole body | ./2.16.840.1.114222.4.11.1002/46358-8.json |
| 4635-9 | Free Hemoglobin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/4635-9.json |
| 46359-6 | MRA Superior mesenteric vessels | ./2.16.840.1.114222.4.11.1002/46359-6.json |
| 46360-4 | MRA Aortic arch WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/46360-4.json |
| 46361-2 | NM Lung Ventilation W Xe-133 IH | ./2.16.840.1.114222.4.11.1002/46361-2.json |
| 46362-0 | US.doppler Foot vessels | ./2.16.840.1.114222.4.11.1002/46362-0.json |
| 46363-8 | US Lower extremity vein | ./2.16.840.1.114222.4.11.1002/46363-8.json |
| 46364-6 | US Lower extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/46364-6.json |
| 46365-3 | CT Guidance for ablation of tissue of Celiac plexus | ./2.16.840.1.114222.4.11.1002/46365-3.json |
| 46366-1 | SPECT guidance for percutaneous biopsy of Bone | ./2.16.840.1.114222.4.11.1002/46366-1.json |
| 4636-7 | Free Hemoglobin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4636-7.json |
| 46369-5 | US Guidance for biopsy of Ovary | ./2.16.840.1.114222.4.11.1002/46369-5.json |
| 46370-3 | US Guidance for biopsy of Pelvis | ./2.16.840.1.114222.4.11.1002/46370-3.json |
| 46371-1 | XR Guidance for change of percutaneous tube in Unspecified body region-- W contrast | ./2.16.840.1.114222.4.11.1002/46371-1.json |
| 46372-9 | RF Guidance for percutaneous drainage and placement of drainage catheter of Biliary ducts | ./2.16.840.1.114222.4.11.1002/46372-9.json |
| 46373-7 | SPECT Guidance for placement of tube in Chest | ./2.16.840.1.114222.4.11.1002/46373-7.json |
| 46374-5 | US Cerebral arteries | ./2.16.840.1.114222.4.11.1002/46374-5.json |
| 46375-2 | US Artery | ./2.16.840.1.114222.4.11.1002/46375-2.json |
| 46376-0 | RF Kidney - bilateral Views W contrast antegrade | ./2.16.840.1.114222.4.11.1002/46376-0.json |
| 46377-8 | XR Skull GE 3 Views | ./2.16.840.1.114222.4.11.1002/46377-8.json |
| 46378-6 | XR Knee - bilateral PA Views W standing and W flexion | ./2.16.840.1.114222.4.11.1002/46378-6.json |
| 46379-4 | US.doppler Upper extremity vessels - bilateral | ./2.16.840.1.114222.4.11.1002/46379-4.json |
| 46380-2 | MG Breast - unilateral Views for implant | ./2.16.840.1.114222.4.11.1002/46380-2.json |
| 46381-0 | XR Elbow and Radius and Ulna Views | ./2.16.840.1.114222.4.11.1002/46381-0.json |
| 46382-8 | US.doppler Hand vessels | ./2.16.840.1.114222.4.11.1002/46382-8.json |
| 46383-6 | DXA Bone [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/46383-6.json |
| 46384-4 | SPECT Guidance for superficial biopsy of Bone | ./2.16.840.1.114222.4.11.1002/46384-4.json |
| 46385-1 | US.doppler Upper extremity vessel for graft | ./2.16.840.1.114222.4.11.1002/46385-1.json |
| 46386-9 | XR Teeth Bitewing Views | ./2.16.840.1.114222.4.11.1002/46386-9.json |
| 46387-7 | MG Guidance for fine needle aspiration of Breast | ./2.16.840.1.114222.4.11.1002/46387-7.json |
| 46388-5 | US.doppler Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/46388-5.json |
| 46389-3 | XR Elbow - bilateral Views and Radial head capitellar | ./2.16.840.1.114222.4.11.1002/46389-3.json |
| 46390-1 | XR Ankle - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/46390-1.json |
| 4639-1 | Unstable Hemoglobin [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/4639-1.json |
| 46391-9 | Portable XR Shoulder Views | ./2.16.840.1.114222.4.11.1002/46391-9.json |
| 46392-7 | RF Guidance for injection of Sinuses | ./2.16.840.1.114222.4.11.1002/46392-7.json |
| 46393-5 | CT Liver W Xe-133 IH | ./2.16.840.1.114222.4.11.1002/46393-5.json |
| 46395-0 | SPECT Heart gated and ejection fraction at rest and W stress and W radionuclide IV | ./2.16.840.1.114222.4.11.1002/46395-0.json |
| 46396-8 | SPECT Heart gated at rest and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/46396-8.json |
| 4640-9 | Hemolysin cold [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4640-9.json |
| 46412-3 | Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine | ./2.16.840.1.114222.4.11.1002/46412-3.json |
| 46413-1 | Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV | ./2.16.840.1.114222.4.11.1002/46413-1.json |
| 4641-7 | Hemolysin warm [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4641-7.json |
| 46417-2 | Prothrombin time (PT) in Capillary blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/46417-2.json |
| 46423-0 | Hemoglobin distribution width [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46423-0.json |
| 46427-1 | Beta fructofuranosidase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/46427-1.json |
| 46429-7 | Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/46429-7.json |
| 46430-5 | Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool | ./2.16.840.1.114222.4.11.1002/46430-5.json |
| 46431-3 | Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/46431-3.json |
| 4643-3 | Hemosiderin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/4643-3.json |
| 46434-7 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46434-7.json |
| 46436-2 | Histamine [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46436-2.json |
| 4644-1 | Hemosiderin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/4644-1.json |
| 46454-5 | Shigella sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/46454-5.json |
| 46455-2 | Shigella sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46455-2.json |
| 4645-8 | Hemosiderin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/4645-8.json |
| 4649-0 | Interferon [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/4649-0.json |
| 46499-0 | State of residence | ./2.16.840.1.114222.4.11.1002/46499-0.json |
| 4650-8 | Interleukin 1 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4650-8.json |
| 4651-6 | Interleukin 2 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4651-6.json |
| 4652-4 | Interleukin 3 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4652-4.json |
| 4653-2 | Interleukin 4 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4653-2.json |
| 4654-0 | Interleukin 5 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4654-0.json |
| 4655-7 | Interleukin 6 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4655-7.json |
| 4656-5 | Interleukin 7 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4656-5.json |
| 4657-3 | Kallikrein [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4657-3.json |
| 4658-1 | Kallikrein Tissue type [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4658-1.json |
| 4659-9 | Leukocyte phosphatase [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/4659-9.json |
| 4665-6 | Lysozyme [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/4665-6.json |
| 4668-0 | Plasminogen Ag [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/4668-0.json |
| 4669-8 | Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/4669-8.json |
| 46698-7 | Cyanide [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/46698-7.json |
| 46699-5 | Fibroblast growth factor 23 [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/46699-5.json |
| 46700-1 | 7-Dehydrocholesterol [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/46700-1.json |
| 46701-9 | Adenosine triphosphate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/46701-9.json |
| 46703-5 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46703-5.json |
| 46704-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46704-3.json |
| 46705-0 | Clostridium botulinum toxin gene [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46705-0.json |
| 46706-8 | Clostridium perfringens toxin gene [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46706-8.json |
| 46707-6 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46707-6.json |
| 46708-4 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46708-4.json |
| 46709-2 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Mass/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46709-2.json |
| 46710-0 | Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46710-0.json |
| 46711-8 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46711-8.json |
| 46712-6 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46712-6.json |
| 46713-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46713-4.json |
| 4671-4 | Protein C [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4671-4.json |
| 46714-2 | Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/46714-2.json |
| 46715-9 | B cell crossmatch [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/46715-9.json |
| 46716-7 | Ceruloplasmin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/46716-7.json |
| 46718-3 | Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/46718-3.json |
| 46720-9 | T cell crossmatch [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/46720-9.json |
| 46721-7 | Barley smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/46721-7.json |
| 4672-2 | Protein C Ag [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/4672-2.json |
| 46722-5 | ZAP70 cells [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/46722-5.json |
| 46723-3 | Alpha-1-Microglobulin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46723-3.json |
| 46724-1 | CYP2C9 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/46724-1.json |
| 46725-8 | Tropheryma whipplei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46725-8.json |
| 46726-6 | HTR2A gene+HTR2C gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46726-6.json |
| 46731-6 | RHCE gene allele Cc [Genotype] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/46731-6.json |
| 46732-4 | Francisella tularensis subtype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46732-4.json |
| 46746-4 | Phenylketonuria and variants/Biopterin defects newborn screen interpretation | ./2.16.840.1.114222.4.11.1002/46746-4.json |
| 4677-1 | Protein S Free Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/4677-1.json |
| 4679-7 | Reticulocytes/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/4679-7.json |
| 4680-5 | von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/4680-5.json |
| 4681-3 | Streptokinase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4681-3.json |
| 4682-1 | Streptokinase [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/4682-1.json |
| 4686-2 | Thromboglobulin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/4686-2.json |
| 4690-4 | Viscosity of Blood | ./2.16.840.1.114222.4.11.1002/4690-4.json |
| 4691-2 | Viscosity of Plasma | ./2.16.840.1.114222.4.11.1002/4691-2.json |
| 46945-2 | Beclomethasone dipropionate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46945-2.json |
| 46946-0 | Betamethasone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46946-0.json |
| 46947-8 | Budesonide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46947-8.json |
| 46948-6 | Dexamethasone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46948-6.json |
| 46949-4 | Fludrocortisone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46949-4.json |
| 46950-2 | Flunisolide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46950-2.json |
| 46951-0 | Fluorometholone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46951-0.json |
| 46952-8 | Fluticasone propionate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46952-8.json |
| 46953-6 | Megestrol acetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46953-6.json |
| 46954-4 | Methylprednisolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46954-4.json |
| 46955-1 | prednisoLONE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46955-1.json |
| 46956-9 | predniSONE [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46956-9.json |
| 46957-7 | Triamcinolone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46957-7.json |
| 46958-5 | Triamcinolone acetonide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46958-5.json |
| 46960-1 | TCR alpha beta Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/46960-1.json |
| 46961-9 | TCR gamma delta Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/46961-9.json |
| 46962-7 | Vasoactive intestinal peptide Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/46962-7.json |
| 46964-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/46964-3.json |
| 46965-0 | MCOLN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46965-0.json |
| 46966-8 | CD69 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46966-8.json |
| 46967-6 | CD40 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46967-6.json |
| 46968-4 | CD122 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/46968-4.json |
| 46969-2 | Asialoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46969-2.json |
| 46970-0 | BK virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/46970-0.json |
| 46971-8 | HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46971-8.json |
| 46973-4 | oxyCODONE Free [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46973-4.json |
| 46974-2 | oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46974-2.json |
| 46975-9 | oxyMORphone Free [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46975-9.json |
| 46976-7 | Benzodiazepines [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/46976-7.json |
| 46977-5 | Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46977-5.json |
| 46978-3 | Salicylates [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46978-3.json |
| 46979-1 | Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46979-1.json |
| 46980-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46980-9.json |
| 46981-7 | Silicon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/46981-7.json |
| 46982-5 | Liver kidney microsomal IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/46982-5.json |
| 46983-3 | Ethanol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/46983-3.json |
| 46984-1 | LDL 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46984-1.json |
| 46985-8 | LDL 3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46985-8.json |
| 46986-6 | Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/46986-6.json |
| 46987-4 | Helicobacter pylori IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/46987-4.json |
| 46989-0 | CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46989-0.json |
| 46990-8 | ASPA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46990-8.json |
| 46991-6 | BLM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46991-6.json |
| 46992-4 | DYS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46992-4.json |
| 46994-0 | HLA-A+B+C (class I) Ab in Serum | ./2.16.840.1.114222.4.11.1002/46994-0.json |
| 46995-7 | HLA-DP+DQ+DR (class II) Ab in Serum | ./2.16.840.1.114222.4.11.1002/46995-7.json |
| 46998-1 | TCRB and HC gene rearrangements in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/46998-1.json |
| 47000-5 | Candida sp rRNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/47000-5.json |
| 47001-3 | Brucella sp Ag [Presence] in Specimen by Agglutination | ./2.16.840.1.114222.4.11.1002/47001-3.json |
| 47002-1 | Varicella zoster virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47002-1.json |
| 47003-9 | Varicella zoster virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47003-9.json |
| 47004-7 | 6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47004-7.json |
| 47005-4 | Spermatozoa IgM Ab/100 spermatozoa in Serum by Immunobead | ./2.16.840.1.114222.4.11.1002/47005-4.json |
| 47006-2 | Spermatozoa IgG Ab/100 spermatozoa in Serum by Immunobead | ./2.16.840.1.114222.4.11.1002/47006-2.json |
| 47007-0 | Spermatozoa IgA Ab/100 spermatozoa in Serum by Immunobead | ./2.16.840.1.114222.4.11.1002/47007-0.json |
| 47008-8 | Platelet associated IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47008-8.json |
| 47009-6 | BCL6 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47009-6.json |
| 47010-4 | Ber-EP4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47010-4.json |
| 47011-2 | Calretinin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47011-2.json |
| 47012-0 | Cancer Ag 72-4 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47012-0.json |
| 47013-8 | CD1a Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47013-8.json |
| 47014-6 | CD21 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47014-6.json |
| 47015-3 | CD31 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47015-3.json |
| 47016-1 | CD4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47016-1.json |
| 47017-9 | CD68 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47017-9.json |
| 47018-7 | CD79a Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47018-7.json |
| 47019-5 | CD8 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47019-5.json |
| 47020-3 | CD99 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47020-3.json |
| 47021-1 | CDX2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47021-1.json |
| 47024-5 | Choriogonadotropin.beta subunit Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47024-5.json |
| 47025-2 | Cytokeratin 5/6 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47025-2.json |
| 47026-0 | Cytoketatin HMW Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47026-0.json |
| 47027-8 | DBA44 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47027-8.json |
| 47028-6 | Follitropin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47028-6.json |
| 47029-4 | HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/47029-4.json |
| 47030-2 | Phosphatidate IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47030-2.json |
| 47031-0 | Melan-A Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47031-0.json |
| 47032-8 | MyoD1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47032-8.json |
| 47033-6 | Myogenin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47033-6.json |
| 47034-4 | Neurofilament Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47034-4.json |
| 47035-1 | NKI/C3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47035-1.json |
| 47037-7 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47037-7.json |
| 47038-5 | Villin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47038-5.json |
| 47039-3 | Hospital Admission history and physical note | ./2.16.840.1.114222.4.11.1002/47039-3.json |
| 47040-1 | Consultation 2nd opinion | ./2.16.840.1.114222.4.11.1002/47040-1.json |
| 47041-9 | Hospital Consultation 2nd opinion | ./2.16.840.1.114222.4.11.1002/47041-9.json |
| 47042-7 | Counseling note | ./2.16.840.1.114222.4.11.1002/47042-7.json |
| 47043-5 | Group counseling note | ./2.16.840.1.114222.4.11.1002/47043-5.json |
| 47044-3 | Hospital Initial evaluation note | ./2.16.840.1.114222.4.11.1002/47044-3.json |
| 47046-8 | Summary of death note | ./2.16.840.1.114222.4.11.1002/47046-8.json |
| 47047-6 | Supervisory note | ./2.16.840.1.114222.4.11.1002/47047-6.json |
| 47050-0 | Herpes virus 8 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47050-0.json |
| 47051-8 | Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47051-8.json |
| 47052-6 | Chlamydophila pneumoniae Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47052-6.json |
| 47053-4 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/47053-4.json |
| 47054-2 | Legionella pneumophila 10 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47054-2.json |
| 47055-9 | Legionella pneumophila 11 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47055-9.json |
| 47056-7 | Legionella pneumophila 11 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47056-7.json |
| 47057-5 | Legionella pneumophila 12 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47057-5.json |
| 47058-3 | Legionella pneumophila 12 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47058-3.json |
| 47059-1 | Legionella pneumophila 13 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47059-1.json |
| 47060-9 | Legionella pneumophila 13 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47060-9.json |
| 47061-7 | Legionella pneumophila 14 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47061-7.json |
| 47062-5 | Legionella pneumophila 14 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47062-5.json |
| 47063-3 | Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47063-3.json |
| 47064-1 | Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47064-1.json |
| 47065-8 | Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47065-8.json |
| 47066-6 | Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47066-6.json |
| 47067-4 | Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47067-4.json |
| 47068-2 | Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47068-2.json |
| 47069-0 | Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47069-0.json |
| 47070-8 | Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47070-8.json |
| 47071-6 | Babesia microti IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47071-6.json |
| 47072-4 | Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47072-4.json |
| 47073-2 | Babesia microti IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47073-2.json |
| 47074-0 | PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47074-0.json |
| 47075-7 | Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47075-7.json |
| 47076-5 | Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47076-5.json |
| 47077-3 | Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47077-3.json |
| 47078-1 | Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47078-1.json |
| 47079-9 | Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47079-9.json |
| 47080-7 | Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47080-7.json |
| 47081-5 | Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47081-5.json |
| 47082-3 | Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47082-3.json |
| 47083-1 | IgG [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47083-1.json |
| 47084-9 | Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47084-9.json |
| 47085-6 | Plasmodium sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47085-6.json |
| 47086-4 | 11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47086-4.json |
| 47087-2 | Angiotensinogen [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47087-2.json |
| 47088-0 | Delta aminolevulinate [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/47088-0.json |
| 47089-8 | Indicans [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47089-8.json |
| 47090-6 | Indicans/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47090-6.json |
| 47091-4 | Methylmalonate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47091-4.json |
| 47092-2 | Natriuretic peptide B [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47092-2.json |
| 47093-0 | Parathyrin.biointact [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47093-0.json |
| 47094-8 | Calciferol (Vit D2) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47094-8.json |
| 47095-5 | Acetaminophen [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47095-5.json |
| 47096-3 | Aluminum [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47096-3.json |
| 47097-1 | Carbamazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47097-1.json |
| 47098-9 | Chromium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47098-9.json |
| 47099-7 | Chromium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47099-7.json |
| 47100-3 | Copper [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/47100-3.json |
| 47101-1 | Copper [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47101-1.json |
| 47102-9 | Copper [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47102-9.json |
| 47103-7 | Copper [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/47103-7.json |
| 47104-5 | Doxepin [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47104-5.json |
| 47105-2 | ePHEDrine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47105-2.json |
| 47106-0 | ePHEDrine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47106-0.json |
| 47107-8 | Ethanol [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47107-8.json |
| 47108-6 | Furosemide [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47108-6.json |
| 47109-4 | Gentamicin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47109-4.json |
| 47110-2 | Glutethimide [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47110-2.json |
| 47111-0 | Glutethimide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47111-0.json |
| 47112-8 | Gold [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47112-8.json |
| 47113-6 | Gold/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47113-6.json |
| 47114-4 | LORazepam [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47114-4.json |
| 47115-1 | LORazepam [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47115-1.json |
| 47116-9 | Manganese [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47116-9.json |
| 47117-7 | Maprotiline [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47117-7.json |
| 47118-5 | Maprotiline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47118-5.json |
| 47119-3 | Meprobamate [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47119-3.json |
| 47120-1 | Meprobamate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47120-1.json |
| 47121-9 | Mercury [Moles/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/47121-9.json |
| 47122-7 | Methyprylon [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47122-7.json |
| 47123-5 | Nickel [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/47123-5.json |
| 47124-3 | PHENobarbital [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47124-3.json |
| 47125-0 | Primidone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47125-0.json |
| 47126-8 | Protriptyline [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47126-8.json |
| 47127-6 | Protriptyline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47127-6.json |
| 47128-4 | Salicylates [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47128-4.json |
| 47129-2 | Silver [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47129-2.json |
| 47130-0 | Thallium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47130-0.json |
| 47131-8 | Thioridazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47131-8.json |
| 47132-6 | Thioridazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47132-6.json |
| 47133-4 | Trimipramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/47133-4.json |
| 47134-2 | Trimipramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47134-2.json |
| 47140-9 | EPINEPHrine [Moles/volume] in Urine --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/47140-9.json |
| 47178-9 | Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/47178-9.json |
| 47204-3 | glipiZIDE [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/47204-3.json |
| 47210-0 | Triglyceride [Moles/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/47210-0.json |
| 47211-8 | Chlamydia trachomatis L2 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47211-8.json |
| 47212-6 | Chlamydia trachomatis DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47212-6.json |
| 47214-2 | Homeostasis model assessment | ./2.16.840.1.114222.4.11.1002/47214-2.json |
| 47216-7 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 200 copies/ml | ./2.16.840.1.114222.4.11.1002/47216-7.json |
| 47217-5 | Immune Complex C3d [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47217-5.json |
| 47229-0 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47229-0.json |
| 47230-8 | Herpes simplex virus glycoprotein G IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47230-8.json |
| 47231-6 | IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47231-6.json |
| 47232-4 | Influenza virus A Ab [Presence] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47232-4.json |
| 47233-2 | Influenza virus A Ab [Presence] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/47233-2.json |
| 47234-0 | Chlamydia trachomatis Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/47234-0.json |
| 47235-7 | Reagin Ab [Titer] in Specimen by VDRL | ./2.16.840.1.114222.4.11.1002/47235-7.json |
| 47236-5 | Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47236-5.json |
| 47237-3 | Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47237-3.json |
| 47238-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47238-1.json |
| 47251-4 | BK virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47251-4.json |
| 47252-2 | Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47252-2.json |
| 47253-0 | Coproporphyrin 1 [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47253-0.json |
| 47254-8 | Coproporphyrin 3 [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47254-8.json |
| 47255-5 | Procollagen type I.N-terminal propeptide [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/47255-5.json |
| 47260-5 | Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47260-5.json |
| 47274-6 | S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47274-6.json |
| 47275-3 | S100 calcium binding protein B [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/47275-3.json |
| 47276-1 | Complement Sc5b-9 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47276-1.json |
| 47280-3 | Erythrocytes [#/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47280-3.json |
| 47281-1 | Leukocytes [#/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47281-1.json |
| 47282-9 | MCV [Entitic volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47282-9.json |
| 47283-7 | Platelet mean volume [Entitic volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47283-7.json |
| 47284-5 | Platelets [#/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47284-5.json |
| 47285-2 | Heparin cofactor II Ag [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/47285-2.json |
| 47296-9 | Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47296-9.json |
| 47297-7 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/47297-7.json |
| 47299-3 | DNA double strand Ab [Units/volume] in Serum by Farr method | ./2.16.840.1.114222.4.11.1002/47299-3.json |
| 47300-9 | Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47300-9.json |
| 47301-7 | Ribosomal P Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47301-7.json |
| 47302-5 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/47302-5.json |
| 47303-3 | Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47303-3.json |
| 47304-1 | Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/47304-1.json |
| 47305-8 | BRST 2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/47305-8.json |
| 47306-6 | Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47306-6.json |
| 47307-4 | Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/47307-4.json |
| 47308-2 | Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47308-2.json |
| 47310-8 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/47310-8.json |
| 47311-6 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/47311-6.json |
| 47312-4 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47312-4.json |
| 47313-2 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47313-2.json |
| 47314-0 | Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47314-0.json |
| 47315-7 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47315-7.json |
| 47316-5 | Inner ear 68kD Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/47316-5.json |
| 47317-3 | Interleukin 12 [Mass/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/47317-3.json |
| 47318-1 | Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47318-1.json |
| 47319-9 | Myelin basic protein Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47319-9.json |
| 47320-7 | Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47320-7.json |
| 47321-5 | Baker's yeast IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47321-5.json |
| 47322-3 | SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47322-3.json |
| 47346-2 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/47346-2.json |
| 47347-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47347-0.json |
| 47348-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47348-8.json |
| 47349-6 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47349-6.json |
| 47350-4 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47350-4.json |
| 47351-2 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/47351-2.json |
| 47352-0 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/47352-0.json |
| 47356-1 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47356-1.json |
| 47357-9 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/47357-9.json |
| 47358-7 | Hepatitis B virus core Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/47358-7.json |
| 47359-5 | HIV 1 RNA [Presence] in Serum or Plasma from Donor by Probe with amplification | ./2.16.840.1.114222.4.11.1002/47359-5.json |
| 47360-3 | Reagin Ab [Presence] in Serum from Donor by RPR | ./2.16.840.1.114222.4.11.1002/47360-3.json |
| 47361-1 | Treponema pallidum IgG Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/47361-1.json |
| 47362-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47362-9.json |
| 47363-7 | Cytomegalovirus Ab [Presence] in Serum from Donor by Hemagglutination | ./2.16.840.1.114222.4.11.1002/47363-7.json |
| 47364-5 | Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/47364-5.json |
| 47365-2 | Hepatitis C virus Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/47365-2.json |
| 47366-0 | CT Chest limited WO contrast | ./2.16.840.1.114222.4.11.1002/47366-0.json |
| 47367-8 | XR and RF Chest GE 4 Views and Views | ./2.16.840.1.114222.4.11.1002/47367-8.json |
| 47368-6 | XR Chest GE 4 and PA and Lateral | ./2.16.840.1.114222.4.11.1002/47368-6.json |
| 47369-4 | Calcitonin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47369-4.json |
| 47370-2 | XR Hand - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/47370-2.json |
| 47371-0 | XR Hand - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/47371-0.json |
| 47372-8 | XR Hip Views during surgery | ./2.16.840.1.114222.4.11.1002/47372-8.json |
| 47373-6 | XR Knee - left 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/47373-6.json |
| 47374-4 | XR Knee - left GE 4 Views | ./2.16.840.1.114222.4.11.1002/47374-4.json |
| 47375-1 | XR Knee - right 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/47375-1.json |
| 47376-9 | XR Knee - right GE 4 Views | ./2.16.840.1.114222.4.11.1002/47376-9.json |
| 47377-7 | XR Knee - right LE 4 Views | ./2.16.840.1.114222.4.11.1002/47377-7.json |
| 47378-5 | SPECT Liver blood pool | ./2.16.840.1.114222.4.11.1002/47378-5.json |
| 47379-3 | XR Mandible GE 4 Views | ./2.16.840.1.114222.4.11.1002/47379-3.json |
| 47380-1 | XR Mandible LE 3 Views | ./2.16.840.1.114222.4.11.1002/47380-1.json |
| 47381-9 | XR Mastoid GE 3 Views | ./2.16.840.1.114222.4.11.1002/47381-9.json |
| 47382-7 | XR Lumbar spine GE 4 Views | ./2.16.840.1.114222.4.11.1002/47382-7.json |
| 47383-5 | Nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47383-5.json |
| 47385-0 | Netilmicin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47385-0.json |
| 47386-8 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47386-8.json |
| 47387-6 | Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47387-6.json |
| 47388-4 | Salmonella typhi H D Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/47388-4.json |
| 47389-2 | Toxoplasma gondii IgG Ab avidity [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47389-2.json |
| 47390-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test | ./2.16.840.1.114222.4.11.1002/47390-0.json |
| 47391-8 | Sulfonylurea [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/47391-8.json |
| 47392-6 | chlorproPAMIDE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/47392-6.json |
| 47393-4 | Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47393-4.json |
| 47394-2 | Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47394-2.json |
| 47395-9 | Kanamycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47395-9.json |
| 47396-7 | Babesia microti DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47396-7.json |
| 47397-5 | BCS1L gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47397-5.json |
| 47398-3 | Beta mannosidase actual/normal in Leukocytes | ./2.16.840.1.114222.4.11.1002/47398-3.json |
| 47400-7 | Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47400-7.json |
| 47401-5 | CV2 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/47401-5.json |
| 47402-3 | CV2 Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/47402-3.json |
| 47403-1 | CYP2D6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47403-1.json |
| 47404-9 | N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47404-9.json |
| 47405-6 | Ehrlichia chaffeensis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/47405-6.json |
| 47406-4 | Entamoeba histolytica Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47406-4.json |
| 47407-2 | Fibers [#/area] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/47407-2.json |
| 47408-0 | Fosphenytoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47408-0.json |
| 47409-8 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47409-8.json |
| 47410-6 | Herpes virus 6 DNA [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47410-6.json |
| 47411-4 | Methadone [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47411-4.json |
| 47412-2 | Mumps virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47412-2.json |
| 47414-8 | Pregabalin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47414-8.json |
| 47415-5 | Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/47415-5.json |
| 47416-3 | RB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47416-3.json |
| 47418-9 | Lipase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/47418-9.json |
| 47419-7 | Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/47419-7.json |
| 47420-5 | Functional status assessment note | ./2.16.840.1.114222.4.11.1002/47420-5.json |
| 47421-3 | Aspergillus flavus B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47421-3.json |
| 47422-1 | Aspergillus flavus H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47422-1.json |
| 47423-9 | Aspergillus fumigatus B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47423-9.json |
| 47424-7 | Aspergillus fumigatus H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47424-7.json |
| 47425-4 | Aspergillus nidulans B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47425-4.json |
| 47426-2 | Aspergillus nidulans H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47426-2.json |
| 47427-0 | Aspergillus niger B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47427-0.json |
| 47428-8 | Aspergillus niger H Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47428-8.json |
| 47429-6 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47429-6.json |
| 47430-4 | Cytomegalovirus Ab [Presence] in Serum or Plasma from Donor | ./2.16.840.1.114222.4.11.1002/47430-4.json |
| 47431-2 | Echinococcus granulosus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/47431-2.json |
| 47432-0 | Epstein Barr virus capsid IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/47432-0.json |
| 47433-8 | Epstein Barr virus capsid IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/47433-8.json |
| 47434-6 | Epstein Barr virus early diffuse Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47434-6.json |
| 47435-3 | Epstein Barr virus early IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47435-3.json |
| 47436-1 | Epstein Barr virus early IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/47436-1.json |
| 47437-9 | Epstein Barr virus early restricted Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47437-9.json |
| 47438-7 | Fowl adenovirus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/47438-7.json |
| 47439-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47439-5.json |
| 47440-3 | Hepatitis B virus core Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/47440-3.json |
| 47441-1 | Hepatitis C virus Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/47441-1.json |
| 47442-9 | Herpes virus 8 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47442-9.json |
| 47443-7 | Influenza virus A Ab [Presence] in Egg yolk | ./2.16.840.1.114222.4.11.1002/47443-7.json |
| 47444-5 | Influenza virus A H1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47444-5.json |
| 47445-2 | Influenza virus A H10 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47445-2.json |
| 47446-0 | Influenza virus A H11 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47446-0.json |
| 47447-8 | Influenza virus A H12 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47447-8.json |
| 47448-6 | Influenza virus A H13 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47448-6.json |
| 47449-4 | Influenza virus A H14 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47449-4.json |
| 47450-2 | Influenza virus A H15 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47450-2.json |
| 47451-0 | Influenza virus A H2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47451-0.json |
| 47452-8 | Influenza virus A H3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47452-8.json |
| 47453-6 | Influenza virus A H4 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47453-6.json |
| 47454-4 | Influenza virus A H5 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47454-4.json |
| 47455-1 | Influenza virus A H6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47455-1.json |
| 47456-9 | Influenza virus A H7 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47456-9.json |
| 47457-7 | Influenza virus A H8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47457-7.json |
| 47458-5 | Influenza virus A H9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47458-5.json |
| 47459-3 | Legionella pneumophila 10 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47459-3.json |
| 47460-1 | Legionella pneumophila 10 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47460-1.json |
| 47461-9 | Legionella pneumophila 11 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47461-9.json |
| 47462-7 | Legionella pneumophila 11 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47462-7.json |
| 47463-5 | Legionella pneumophila 12 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47463-5.json |
| 47464-3 | Legionella pneumophila 12 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47464-3.json |
| 47465-0 | Legionella pneumophila 13 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47465-0.json |
| 47466-8 | Legionella pneumophila 13 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47466-8.json |
| 47467-6 | Legionella pneumophila 14 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47467-6.json |
| 47468-4 | Legionella pneumophila 14 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47468-4.json |
| 47469-2 | Legionella pneumophila 7 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47469-2.json |
| 47470-0 | Legionella pneumophila 7 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47470-0.json |
| 47471-8 | Legionella pneumophila 8 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47471-8.json |
| 47472-6 | Legionella pneumophila 8 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47472-6.json |
| 47473-4 | Legionella pneumophila 9 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47473-4.json |
| 47474-2 | Legionella pneumophila 9 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47474-2.json |
| 47475-9 | Powassan virus polyvalent E Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/47475-9.json |
| 47476-7 | Reagin Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/47476-7.json |
| 47477-5 | Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47477-5.json |
| 47478-3 | Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47478-3.json |
| 47479-1 | Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47479-1.json |
| 47480-9 | Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47480-9.json |
| 47501-2 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47501-2.json |
| 47502-0 | Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/47502-0.json |
| 47503-8 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47503-8.json |
| 47504-6 | Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/47504-6.json |
| 47506-1 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47506-1.json |
| 47507-9 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/47507-9.json |
| 47508-7 | Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/47508-7.json |
| 47509-5 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/47509-5.json |
| 47510-3 | Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/47510-3.json |
| 47511-1 | Treponema pallidum Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47511-1.json |
| 47512-9 | Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47512-9.json |
| 47513-7 | Treponema pallidum IgG Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/47513-7.json |
| 47514-5 | Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47514-5.json |
| 47516-0 | Cocal virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47516-0.json |
| 47517-8 | Vesicular stomatitis Alagoas virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47517-8.json |
| 47518-6 | Yersinia pestis Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/47518-6.json |
| 47520-2 | Cytology report of Sputum Cyto stain | ./2.16.840.1.114222.4.11.1002/47520-2.json |
| 47521-0 | Cytology report of Breast fine needle aspirate Cyto stain | ./2.16.840.1.114222.4.11.1002/47521-0.json |
| 47522-8 | Cytology report of Nipple discharge Cyto stain | ./2.16.840.1.114222.4.11.1002/47522-8.json |
| 47523-6 | Cytology report of Body fluid Cyto stain | ./2.16.840.1.114222.4.11.1002/47523-6.json |
| 47524-4 | Cytology report of Thyroid fine needle aspirate Cyto stain | ./2.16.840.1.114222.4.11.1002/47524-4.json |
| 47525-1 | Cytology report of Urine Cyto stain | ./2.16.840.1.114222.4.11.1002/47525-1.json |
| 47526-9 | Cytology report of Specimen Cyto stain | ./2.16.840.1.114222.4.11.1002/47526-9.json |
| 47527-7 | Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep | ./2.16.840.1.114222.4.11.1002/47527-7.json |
| 47528-5 | Cytology report of Cervical or vaginal smear or scraping Cyto stain | ./2.16.840.1.114222.4.11.1002/47528-5.json |
| 47529-3 | Cytology report of Tissue Other stain | ./2.16.840.1.114222.4.11.1002/47529-3.json |
| 47530-1 | Cytology report of Breast ductal lavage Cyto stain | ./2.16.840.1.114222.4.11.1002/47530-1.json |
| 47532-7 | Mumps virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47532-7.json |
| 47534-3 | 2-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47534-3.json |
| 47536-8 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47536-8.json |
| 47537-6 | 3-Hydroxysebacate ( 3-OH-C8)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47537-6.json |
| 47538-4 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47538-4.json |
| 47539-2 | 3-Methylhistidine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47539-2.json |
| 47540-0 | 3-Methylhistidine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47540-0.json |
| 47541-8 | 4-Hydroxybenzoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47541-8.json |
| 47542-6 | Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47542-6.json |
| 47543-4 | 4-Hydroxymandelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47543-4.json |
| 47544-2 | 5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47544-2.json |
| 47545-9 | 5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47545-9.json |
| 47546-7 | 5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47546-7.json |
| 47547-5 | 5-Methyltetrahydrofolate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47547-5.json |
| 47548-3 | Adenosine deaminase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47548-3.json |
| 47549-1 | Adenosine deaminase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47549-1.json |
| 47550-9 | Adenosine deaminase [Entitic Catalytic Activity] in Leukocytes | ./2.16.840.1.114222.4.11.1002/47550-9.json |
| 47551-7 | Alanine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47551-7.json |
| 47552-5 | Alanine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47552-5.json |
| 47553-3 | Alanine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47553-3.json |
| 47554-1 | Alanine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47554-1.json |
| 47555-8 | Alanine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47555-8.json |
| 47556-6 | Alanine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47556-6.json |
| 47557-4 | Alanine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47557-4.json |
| 47558-2 | Microalbumin/Protein.total in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47558-2.json |
| 47559-0 | Alpha aminobutyrate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47559-0.json |
| 47561-6 | Anion gap in Body fluid | ./2.16.840.1.114222.4.11.1002/47561-6.json |
| 47562-4 | Arginine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47562-4.json |
| 47563-2 | Arginine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47563-2.json |
| 47564-0 | Arginine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47564-0.json |
| 47565-7 | Arginine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47565-7.json |
| 47566-5 | Arginine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47566-5.json |
| 47567-3 | Arginine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47567-3.json |
| 47568-1 | Arginine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47568-1.json |
| 47569-9 | Argininosuccinate lyase [Enzymatic activity/mass] in Liver | ./2.16.840.1.114222.4.11.1002/47569-9.json |
| 47570-7 | Argininosuccinate lyase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47570-7.json |
| 47571-5 | Argininosuccinate synthase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47571-5.json |
| 47572-3 | Asparagine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47572-3.json |
| 47573-1 | Aspartate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47573-1.json |
| 47574-9 | Aspartate/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47574-9.json |
| 47575-6 | Aspartate/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47575-6.json |
| 47576-4 | Aspartate/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47576-4.json |
| 47577-2 | Aspartate/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47577-2.json |
| 47578-0 | Aspartate/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47578-0.json |
| 47579-8 | Bicarbonate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47579-8.json |
| 47580-6 | Bicarbonate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47580-6.json |
| 47581-4 | Biopterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47581-4.json |
| 47582-2 | Biopterin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47582-2.json |
| 47583-0 | C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47583-0.json |
| 47584-8 | C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47584-8.json |
| 47585-5 | C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47585-5.json |
| 47586-3 | C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/47586-3.json |
| 47587-1 | C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose | ./2.16.840.1.114222.4.11.1002/47587-1.json |
| 47588-9 | C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47588-9.json |
| 47589-7 | C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47589-7.json |
| 47590-5 | C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47590-5.json |
| 47591-3 | C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47591-3.json |
| 47592-1 | C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47592-1.json |
| 47593-9 | C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose | ./2.16.840.1.114222.4.11.1002/47593-9.json |
| 47594-7 | C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon | ./2.16.840.1.114222.4.11.1002/47594-7.json |
| 47595-4 | C peptide [Moles/volume] in Serum or Plasma --pre dose glucose | ./2.16.840.1.114222.4.11.1002/47595-4.json |
| 47596-2 | Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/47596-2.json |
| 47597-0 | Calcium [Moles/volume] corrected for total protein in Blood | ./2.16.840.1.114222.4.11.1002/47597-0.json |
| 47598-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood | ./2.16.840.1.114222.4.11.1002/47598-8.json |
| 47599-6 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood | ./2.16.840.1.114222.4.11.1002/47599-6.json |
| 47600-2 | Ceruloplasmin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47600-2.json |
| 47601-0 | Choriogonadotropin.beta subunit free [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47601-0.json |
| 47602-8 | Citrate synthase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/47602-8.json |
| 47603-6 | Citrate synthase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47603-6.json |
| 47604-4 | Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV | ./2.16.840.1.114222.4.11.1002/47604-4.json |
| 47605-1 | Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV | ./2.16.840.1.114222.4.11.1002/47605-1.json |
| 47606-9 | Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV | ./2.16.840.1.114222.4.11.1002/47606-9.json |
| 47607-7 | Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV | ./2.16.840.1.114222.4.11.1002/47607-7.json |
| 47608-5 | Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin | ./2.16.840.1.114222.4.11.1002/47608-5.json |
| 47609-3 | Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV | ./2.16.840.1.114222.4.11.1002/47609-3.json |
| 47610-1 | Creatinine [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/47610-1.json |
| 47611-9 | Crystals [type] in Tissue by Light microscopy | ./2.16.840.1.114222.4.11.1002/47611-9.json |
| 47612-7 | Cystatin C [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47612-7.json |
| 47613-5 | Decanoate (C10:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47613-5.json |
| 47614-3 | Decenoate (C10:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47614-3.json |
| 47615-0 | Dermatan sulfate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/47615-0.json |
| 47618-4 | Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV | ./2.16.840.1.114222.4.11.1002/47618-4.json |
| 47620-0 | Glucose [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/47620-0.json |
| 47623-4 | Glutamate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47623-4.json |
| 47624-2 | Glutamate/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47624-2.json |
| 47625-9 | Glutamate/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47625-9.json |
| 47626-7 | Glutamate/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47626-7.json |
| 47627-5 | Glutamate/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47627-5.json |
| 47628-3 | Glutamate/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47628-3.json |
| 47629-1 | Glutamate/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47629-1.json |
| 47630-9 | Glutamine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47630-9.json |
| 47631-7 | Glutathione.oxidized [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47631-7.json |
| 47632-5 | Glycerol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47632-5.json |
| 47633-3 | Glycine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47633-3.json |
| 47634-1 | Glycine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47634-1.json |
| 47635-8 | Glycine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47635-8.json |
| 47636-6 | Glycine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47636-6.json |
| 47637-4 | Glycine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47637-4.json |
| 47638-2 | Glycine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47638-2.json |
| 47639-0 | Glycine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47639-0.json |
| 47640-8 | Hematocrit [Volume Fraction] of Dialysis fluid | ./2.16.840.1.114222.4.11.1002/47640-8.json |
| 47641-6 | Palmitate (C16:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47641-6.json |
| 47642-4 | Hexadecenoate (C16:1w9)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47642-4.json |
| 47643-2 | Histidine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47643-2.json |
| 47644-0 | Histidine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47644-0.json |
| 47645-7 | Histidine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47645-7.json |
| 47646-5 | Histidine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47646-5.json |
| 47647-3 | Histidine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47647-3.json |
| 47648-1 | Histidine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47648-1.json |
| 47649-9 | Histidine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47649-9.json |
| 47650-7 | Homogentisate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47650-7.json |
| 47651-5 | Hydroxyproline [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47651-5.json |
| 47652-3 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta | ./2.16.840.1.114222.4.11.1002/47652-3.json |
| 47653-1 | Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/47653-1.json |
| 47654-9 | Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47654-9.json |
| 47655-6 | Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/47655-6.json |
| 47656-4 | Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose | ./2.16.840.1.114222.4.11.1002/47656-4.json |
| 47657-2 | Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose | ./2.16.840.1.114222.4.11.1002/47657-2.json |
| 47658-0 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47658-0.json |
| 47659-8 | Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47659-8.json |
| 47660-6 | Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47660-6.json |
| 47661-4 | Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47661-4.json |
| 47662-2 | Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/47662-2.json |
| 47663-0 | Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47663-0.json |
| 47664-8 | Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47664-8.json |
| 47665-5 | Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/47665-5.json |
| 47666-3 | Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose | ./2.16.840.1.114222.4.11.1002/47666-3.json |
| 47667-1 | Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/47667-1.json |
| 47668-9 | Insulin [Units/volume] in Serum or Plasma --pre dose glucose | ./2.16.840.1.114222.4.11.1002/47668-9.json |
| 47669-7 | Insulin [Units/volume] in Serum or Plasma --pre dose glucagon | ./2.16.840.1.114222.4.11.1002/47669-7.json |
| 47670-5 | Insulin [Units/volume] in Serum or Plasma --pre-meal | ./2.16.840.1.114222.4.11.1002/47670-5.json |
| 47671-3 | Isoleucine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47671-3.json |
| 47672-1 | Isoleucine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47672-1.json |
| 47673-9 | Isoleucine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47673-9.json |
| 47674-7 | Isoleucine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47674-7.json |
| 47675-4 | Isoleucine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47675-4.json |
| 47676-2 | Isoleucine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47676-2.json |
| 47677-0 | Isoleucine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47677-0.json |
| 47678-8 | Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47678-8.json |
| 47679-6 | Leucine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47679-6.json |
| 47680-4 | Leucine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47680-4.json |
| 47681-2 | Leucine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47681-2.json |
| 47682-0 | Leucine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47682-0.json |
| 47683-8 | Leucine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47683-8.json |
| 47684-6 | Leucine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47684-6.json |
| 47685-3 | Leucine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47685-3.json |
| 47686-1 | Linoleate (C18:2w6)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47686-1.json |
| 47688-7 | Lutropin [Units/volume] in Serum or Plasma --pre 100 ug luteinizing releasing hormone IV | ./2.16.840.1.114222.4.11.1002/47688-7.json |
| 47689-5 | Lysine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47689-5.json |
| 47690-3 | Lysine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47690-3.json |
| 47691-1 | Lysine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47691-1.json |
| 47692-9 | Lysine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47692-9.json |
| 47693-7 | Lysine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47693-7.json |
| 47694-5 | Lysine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47694-5.json |
| 47695-2 | Lysine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47695-2.json |
| 47696-0 | Malonate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47696-0.json |
| 47697-8 | Mandelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47697-8.json |
| 47698-6 | Mannitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47698-6.json |
| 47699-4 | Metanephrine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47699-4.json |
| 47700-0 | Methionine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47700-0.json |
| 47701-8 | Methionine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47701-8.json |
| 47702-6 | Methionine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47702-6.json |
| 47703-4 | Methionine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47703-4.json |
| 47704-2 | Methionine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47704-2.json |
| 47705-9 | Methionine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47705-9.json |
| 47706-7 | Methionine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47706-7.json |
| 47707-5 | Methylmalonate/Urea [Molar ratio] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47707-5.json |
| 47708-3 | Methylmalonate/Urea [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47708-3.json |
| 47709-1 | Methylmalonate/Urea [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47709-1.json |
| 47711-7 | Neopterin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47711-7.json |
| 47712-5 | Nitrogen [Presence] in Sweat | ./2.16.840.1.114222.4.11.1002/47712-5.json |
| 47713-3 | Oleate (C18:1w9)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47713-3.json |
| 47714-1 | Ornithine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47714-1.json |
| 47715-8 | Oxalate [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/47715-8.json |
| 47721-6 | Phenylalanine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47721-6.json |
| 47722-4 | Phenylalanine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47722-4.json |
| 47723-2 | Phenylalanine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47723-2.json |
| 47724-0 | Phenylalanine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47724-0.json |
| 47725-7 | Phenylalanine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47725-7.json |
| 47726-5 | Phytanate (C16:0(CH3)4)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47726-5.json |
| 47727-3 | Pipecolate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47727-3.json |
| 47728-1 | Procollagen type III/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47728-1.json |
| 47732-3 | Proline [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47732-3.json |
| 47733-1 | Proline/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47733-1.json |
| 47734-9 | Proline/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47734-9.json |
| 47735-6 | Proline/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47735-6.json |
| 47736-4 | Proline/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47736-4.json |
| 47737-2 | Proline/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47737-2.json |
| 47738-0 | Prostate specific Ag [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/47738-0.json |
| 47739-8 | Protein [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/47739-8.json |
| 47740-6 | Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47740-6.json |
| 47741-4 | Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes | ./2.16.840.1.114222.4.11.1002/47741-4.json |
| 47742-2 | Serine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47742-2.json |
| 47743-0 | Serine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47743-0.json |
| 47744-8 | Serine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47744-8.json |
| 47745-5 | Serine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47745-5.json |
| 47746-3 | Serine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47746-3.json |
| 47747-1 | Serine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47747-1.json |
| 47748-9 | Serine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47748-9.json |
| 47779-4 | Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47779-4.json |
| 47780-2 | Sulfate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47780-2.json |
| 47781-0 | Sulfocysteine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47781-0.json |
| 47782-8 | Taurine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47782-8.json |
| 47783-6 | Myristate (C14:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47783-6.json |
| 47784-4 | Threonine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47784-4.json |
| 47785-1 | Threonine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47785-1.json |
| 47786-9 | Threonine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47786-9.json |
| 47787-7 | Threonine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47787-7.json |
| 47788-5 | Threonine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47788-5.json |
| 47789-3 | Threonine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47789-3.json |
| 47790-1 | Threonine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47790-1.json |
| 47791-9 | Tocopherols [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47791-9.json |
| 47792-7 | Tyrosine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47792-7.json |
| 47793-5 | Tyrosine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47793-5.json |
| 47794-3 | Tyrosine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47794-3.json |
| 47795-0 | Tyrosine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47795-0.json |
| 47796-8 | Tyrosine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47796-8.json |
| 47797-6 | Tyrosine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47797-6.json |
| 47798-4 | Urea [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/47798-4.json |
| 47799-2 | Valine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/47799-2.json |
| 47800-8 | Valine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/47800-8.json |
| 47801-6 | Valine/Amino acids.total in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/47801-6.json |
| 47802-4 | Valine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/47802-4.json |
| 47803-2 | Valine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47803-2.json |
| 47804-0 | Valine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/47804-0.json |
| 47805-7 | Valine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/47805-7.json |
| 47806-5 | Xylose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/47806-5.json |
| 47807-3 | 2-Deoxytetronate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47807-3.json |
| 47808-1 | 2-Ethylhydracrylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47808-1.json |
| 47809-9 | 2-Hydroxysebacate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47809-9.json |
| 47810-7 | 2-Methyl-3-Hydroxyvalerate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47810-7.json |
| 47811-5 | 2-Methyl-3-Oxobutyrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47811-5.json |
| 47812-3 | 2-Methylglutaconate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47812-3.json |
| 47813-1 | 2-Methylglutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47813-1.json |
| 47815-6 | 3,4-Hydroxymandelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47815-6.json |
| 47816-4 | 3-Deoxytetronate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47816-4.json |
| 47817-2 | 3-Hydroxy,4-Methoxybenzoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47817-2.json |
| 47818-0 | 3-Hydroxyhexanoate (3-OH-C6:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47818-0.json |
| 47819-8 | 3-Hydroxysuberate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47819-8.json |
| 47820-6 | 3-Hydroxyvalerate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47820-6.json |
| 47821-4 | 3-Indolelactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47821-4.json |
| 47822-2 | 3-Methyladipate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47822-2.json |
| 47823-0 | 4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47823-0.json |
| 47825-5 | 7-Hydroxyoctanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47825-5.json |
| 47826-3 | Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47826-3.json |
| 47827-1 | Adenosyl homocysteine hydrolase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47827-1.json |
| 47828-9 | Adiponectin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47828-9.json |
| 47829-7 | Arabitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47829-7.json |
| 47830-5 | Argininosuccinate synthase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/47830-5.json |
| 47831-3 | Argininosuccinate synthase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/47831-3.json |
| 47841-2 | Citrate synthase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/47841-2.json |
| 47842-0 | Collection duration of Dialysis fluid | ./2.16.840.1.114222.4.11.1002/47842-0.json |
| 47843-8 | Corticotropin [Mass/volume] in Plasma --post dose dexamethasone | ./2.16.840.1.114222.4.11.1002/47843-8.json |
| 47845-3 | Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight | ./2.16.840.1.114222.4.11.1002/47845-3.json |
| 47846-1 | Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h | ./2.16.840.1.114222.4.11.1002/47846-1.json |
| 47851-1 | Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone | ./2.16.840.1.114222.4.11.1002/47851-1.json |
| 47853-7 | Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47853-7.json |
| 47854-5 | Fibroblast growth factor 23.intact [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47854-5.json |
| 47855-2 | Fibroblast growth factor 23.C-terminal [Units/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47855-2.json |
| 47857-8 | Galactitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47857-8.json |
| 47858-6 | Gentisate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47858-6.json |
| 47860-2 | Glutamate dehydrogenase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/47860-2.json |
| 47861-0 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/47861-0.json |
| 47862-8 | Insulin [Units/volume] in Serum or Plasma --post meal | ./2.16.840.1.114222.4.11.1002/47862-8.json |
| 47863-6 | Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47863-6.json |
| 47865-1 | Malondialdehyde [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47865-1.json |
| 47866-9 | Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/47866-9.json |
| 47867-7 | Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47867-7.json |
| 47873-5 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/47873-5.json |
| 47874-3 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47874-3.json |
| 47875-0 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/47875-0.json |
| 47876-8 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Placenta | ./2.16.840.1.114222.4.11.1002/47876-8.json |
| 47877-6 | Propionyl CoA Carboxylase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/47877-6.json |
| 47878-4 | Propionylglycine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47878-4.json |
| 47879-2 | Pyruvate carboxylase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/47879-2.json |
| 47880-0 | Pyruvate carboxylase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/47880-0.json |
| 47881-8 | Pyruvate carboxylase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/47881-8.json |
| 47882-6 | Pyruvate carboxylase [Enzymatic activity/mass] in Placenta | ./2.16.840.1.114222.4.11.1002/47882-6.json |
| 47883-4 | Renin [Mass/volume] in Plasma --upright | ./2.16.840.1.114222.4.11.1002/47883-4.json |
| 47884-2 | Ribitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/47884-2.json |
| 47887-5 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose ornithine | ./2.16.840.1.114222.4.11.1002/47887-5.json |
| 47898-2 | Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/47898-2.json |
| 47954-3 | Tiglylglycine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/47954-3.json |
| 47955-0 | EYA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/47955-0.json |
| 47956-8 | CNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47956-8.json |
| 47957-6 | Deoxyuridine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47957-6.json |
| 47958-4 | FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47958-4.json |
| 47959-2 | GFAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/47959-2.json |
| 47960-0 | GLRA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47960-0.json |
| 47961-8 | ACVRL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47961-8.json |
| 47962-6 | JAG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47962-6.json |
| 47963-4 | JAK3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47963-4.json |
| 47964-2 | MVK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47964-2.json |
| 47965-9 | Mycoplasma penetrans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47965-9.json |
| 47966-7 | NCF2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47966-7.json |
| 47967-5 | NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47967-5.json |
| 47968-3 | PINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/47968-3.json |
| 47969-1 | PTEN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47969-1.json |
| 47970-9 | SGCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47970-9.json |
| 47971-7 | SGSH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47971-7.json |
| 47972-5 | TGFBR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47972-5.json |
| 47973-3 | TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/47973-3.json |
| 47974-1 | THRB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/47974-1.json |
| 47975-8 | tiZANidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47975-8.json |
| 47976-6 | Selenium [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47976-6.json |
| 47977-4 | Smooth muscle IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/47977-4.json |
| 47978-2 | 17-Ketosteroids [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/47978-2.json |
| 47979-0 | Tranylcypromine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47979-0.json |
| 47980-8 | Mirtazapine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/47980-8.json |
| 47981-6 | Phenylalanine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/47981-6.json |
| 47982-4 | Epstein Barr virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/47982-4.json |
| 47983-2 | XR Mastoid - bilateral 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/47983-2.json |
| 47984-0 | XR Pelvis and Spine Lumbar Views | ./2.16.840.1.114222.4.11.1002/47984-0.json |
| 47985-7 | CT Spine W contrast IT | ./2.16.840.1.114222.4.11.1002/47985-7.json |
| 47986-5 | RFA Lower extremity arteries - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/47986-5.json |
| 47987-3 | RFA Lower extremity arteries - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/47987-3.json |
| 47994-9 | Bilirubin.total [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47994-9.json |
| 47995-6 | Glucose [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/47995-6.json |
| 47996-4 | Adenosine deaminase binding protein [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/47996-4.json |
| 48023-6 | HIV 1 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48023-6.json |
| 48024-4 | AS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48024-4.json |
| 48025-1 | Gene mutations tested for [#] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48025-1.json |
| 48026-9 | ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48026-9.json |
| 48027-7 | MT-ND4 gene c.G15257A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48027-7.json |
| 48028-5 | SERPINE1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48028-5.json |
| 48029-3 | PKLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48029-3.json |
| 48030-1 | RHCE gene allele Ee [Genotype] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48030-1.json |
| 48031-9 | SCA10 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48031-9.json |
| 48032-7 | THRB gene p.Ala317Thr [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48032-7.json |
| 48033-5 | TTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48033-5.json |
| 48035-0 | Hemoglobin [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48035-0.json |
| 48036-8 | Glucose [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/48036-8.json |
| 48037-6 | pH of Vaginal fluid | ./2.16.840.1.114222.4.11.1002/48037-6.json |
| 48039-2 | Fibronectin.fetal [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48039-2.json |
| 48047-5 | Hemoglobin.gastrointestinal [Presence] in Vomitus | ./2.16.840.1.114222.4.11.1002/48047-5.json |
| 48048-3 | Neutrophils [Presence] in Nose by Wright stain | ./2.16.840.1.114222.4.11.1002/48048-3.json |
| 48049-1 | Eosinophils [Presence] in Stool by Wright stain | ./2.16.840.1.114222.4.11.1002/48049-1.json |
| 48050-9 | Neutrophils [Presence] in Stool by Wright stain | ./2.16.840.1.114222.4.11.1002/48050-9.json |
| 48054-1 | Kaolin activated time [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/48054-1.json |
| 48055-8 | Pneumocystis jiroveci [Presence] in Specimen by Calcofluor white | ./2.16.840.1.114222.4.11.1002/48055-8.json |
| 48056-6 | Human bocavirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48056-6.json |
| 48057-4 | Human bocavirus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/48057-4.json |
| 48058-2 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/48058-2.json |
| 48059-0 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/48059-0.json |
| 48060-8 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/48060-8.json |
| 48061-6 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48061-6.json |
| 48062-4 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48062-4.json |
| 48063-2 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/48063-2.json |
| 48064-0 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/48064-0.json |
| 48065-7 | Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/48065-7.json |
| 48066-5 | Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/48066-5.json |
| 48067-3 | Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/48067-3.json |
| 48069-9 | Spherocytes.micro [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/48069-9.json |
| 48070-7 | Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48070-7.json |
| 48071-5 | Complement total hemolytic CH50 [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48071-5.json |
| 48072-3 | Synthetic glucocorticoid drug [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/48072-3.json |
| 48074-9 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/48074-9.json |
| 48078-0 | 3,6-Epoxydecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48078-0.json |
| 48079-8 | 3,6-Epoxydodecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48079-8.json |
| 48080-6 | 3,6-Epoxyoctanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48080-6.json |
| 48081-4 | 3,6-Epoxytetradecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48081-4.json |
| 48082-2 | 3-Hydroxyadipate 3,6-lactone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48082-2.json |
| 48083-0 | 3-Hydroxydodecanedienedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48083-0.json |
| 48084-8 | 3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48084-8.json |
| 48085-5 | 3-Hydroxydodecenedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48085-5.json |
| 48086-3 | 3-Hydroxytetradecadienedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48086-3.json |
| 48087-1 | 3-Hydroxytetradecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48087-1.json |
| 48088-9 | 3-Hydroxytetradecenedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48088-9.json |
| 48091-3 | Corticotropin [Mass/volume] in Plasma --12 AM specimen | ./2.16.840.1.114222.4.11.1002/48091-3.json |
| 48092-1 | Corticotropin [Mass/volume] in Plasma --12 PM specimen | ./2.16.840.1.114222.4.11.1002/48092-1.json |
| 48095-4 | Corticotropin [Mass/volume] in Plasma --4 PM specimen | ./2.16.840.1.114222.4.11.1002/48095-4.json |
| 48097-0 | Corticotropin [Mass/volume] in Plasma --8 PM specimen | ./2.16.840.1.114222.4.11.1002/48097-0.json |
| 48106-9 | 4,5-Dihydroxyhexanolactone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48106-9.json |
| 48107-7 | Erythritol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48107-7.json |
| 48111-9 | Glutathione.reduced [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/48111-9.json |
| 48112-7 | Glutathione.reduced [Units/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/48112-7.json |
| 48113-5 | Heptadecenoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48113-5.json |
| 48114-3 | Hexadecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48114-3.json |
| 48115-0 | Homocysteine.free/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48115-0.json |
| 48119-2 | Pentadecanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48119-2.json |
| 48121-8 | Quinolinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48121-8.json |
| 48122-6 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH | ./2.16.840.1.114222.4.11.1002/48122-6.json |
| 48132-5 | Xylitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48132-5.json |
| 48133-3 | 3-Oxovalerate [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/48133-3.json |
| 48134-1 | Alanine aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48134-1.json |
| 48135-8 | Acadesine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/48135-8.json |
| 48136-6 | Aspartate aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48136-6.json |
| 48137-4 | 4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48137-4.json |
| 48138-2 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/48138-2.json |
| 48139-0 | Erythro-4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48139-0.json |
| 48140-8 | Erythro-4-Deoxytetronate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48140-8.json |
| 48141-6 | Ferritin [Entitic mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/48141-6.json |
| 48142-4 | Indole-3-Acetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48142-4.json |
| 48143-2 | LDL.oxidized Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48143-2.json |
| 48144-0 | Mannose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/48144-0.json |
| 48145-7 | Mevalonolactone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48145-7.json |
| 48146-5 | Myeloperoxidase [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48146-5.json |
| 48147-3 | Oligosaccharides/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48147-3.json |
| 48148-1 | Osmolality of Urine by calculation | ./2.16.840.1.114222.4.11.1002/48148-1.json |
| 48149-9 | Osmolality.urine/Osmolality.serum | ./2.16.840.1.114222.4.11.1002/48149-9.json |
| 48150-7 | Perseitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48150-7.json |
| 48151-5 | Sedoheptitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48151-5.json |
| 48152-3 | Sorbitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48152-3.json |
| 48153-1 | Threitol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48153-1.json |
| 48154-9 | Threo-4,5-Dihydrohexanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48154-9.json |
| 48155-6 | Threo-4,5-Dihydrohexanolactone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48155-6.json |
| 48156-4 | Threo-4-Deoxytetronate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48156-4.json |
| 48157-2 | Thymine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48157-2.json |
| 48158-0 | Vanillate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48158-0.json |
| 48159-8 | Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/48159-8.json |
| 48160-6 | HTLV I rgp21 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/48160-6.json |
| 48161-4 | PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48161-4.json |
| 48162-2 | Thymidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48162-2.json |
| 48163-0 | Cytokeratin 19 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48163-0.json |
| 48164-8 | Enolase.neuron specific [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48164-8.json |
| 48165-5 | Squamous cell carcinoma Ag [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48165-5.json |
| 48166-3 | Beta-2-Microglobulin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48166-3.json |
| 48167-1 | Prostate specific Ag/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48167-1.json |
| 48168-9 | 5-Hydroxyindoleacetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/48168-9.json |
| 48170-5 | Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/48170-5.json |
| 48173-9 | levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/48173-9.json |
| 48174-7 | Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48174-7.json |
| 48175-4 | Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/48175-4.json |
| 48177-0 | Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/48177-0.json |
| 48182-0 | European Hornet triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48182-0.json |
| 48183-8 | Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48183-8.json |
| 48184-6 | Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48184-6.json |
| 48185-3 | Honey bee triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48185-3.json |
| 48186-1 | Amylase triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48186-1.json |
| 48187-9 | Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48187-9.json |
| 48188-7 | Latex triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48188-7.json |
| 48189-5 | Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48189-5.json |
| 48190-3 | Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48190-3.json |
| 48191-1 | Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48191-1.json |
| 48192-9 | Sunset yellow FCF triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48192-9.json |
| 48193-7 | Succinylcholine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48193-7.json |
| 48194-5 | Lidocaine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48194-5.json |
| 48195-2 | Trimethoprim triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48195-2.json |
| 48196-0 | Cephalosporin C triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48196-0.json |
| 48197-8 | Cefuroxime triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48197-8.json |
| 48198-6 | Amoxicillin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48198-6.json |
| 48199-4 | Ampicillin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48199-4.json |
| 48200-0 | Penicillin V triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48200-0.json |
| 48201-8 | Penicillin G triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48201-8.json |
| 48202-6 | Short+Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48202-6.json |
| 48203-4 | Celery triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48203-4.json |
| 48204-2 | Casein triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48204-2.json |
| 48205-9 | Beta lactoglobulin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48205-9.json |
| 48206-7 | Lactalbumin alpha triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48206-7.json |
| 48207-5 | Egg yolk triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48207-5.json |
| 48208-3 | Baker's yeast triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48208-3.json |
| 48209-1 | Orange triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48209-1.json |
| 48210-9 | Carrot triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48210-9.json |
| 48211-7 | Beef triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48211-7.json |
| 48212-5 | Pork triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48212-5.json |
| 48213-3 | Tomato triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48213-3.json |
| 48214-1 | Shrimp triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48214-1.json |
| 4821-5 | HLA-B27 [Presence] | ./2.16.840.1.114222.4.11.1002/4821-5.json |
| 48215-8 | Crab triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48215-8.json |
| 48216-6 | Hazelnut triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48216-6.json |
| 48217-4 | Soybean triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48217-4.json |
| 48218-2 | Peanut triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48218-2.json |
| 48219-0 | Sesame Seed triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48219-0.json |
| 48220-8 | Oat triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48220-8.json |
| 48221-6 | Barley triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48221-6.json |
| 48222-4 | Rye triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48222-4.json |
| 48223-2 | Wheat triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48223-2.json |
| 48224-0 | Codfish triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48224-0.json |
| 48225-7 | Cow milk triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48225-7.json |
| 48226-5 | Egg white triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48226-5.json |
| 48227-3 | Human serum albumin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48227-3.json |
| 48228-1 | Bovine serum albumin (BSA) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48228-1.json |
| 48229-9 | Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48229-9.json |
| 48230-7 | Cat dander triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48230-7.json |
| 48231-5 | Glycyphagus domesticus triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48231-5.json |
| 48232-3 | Tyrophagus putrescentiae triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48232-3.json |
| 48233-1 | Lepidoglyphus destructor triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48233-1.json |
| 48234-9 | Acarus siro triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48234-9.json |
| 48235-6 | American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48235-6.json |
| 48236-4 | European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48236-4.json |
| 48237-2 | Flea triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48237-2.json |
| 48238-0 | Cockroach triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48238-0.json |
| 48239-8 | Alternaria alternata triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48239-8.json |
| 48240-6 | Candida albicans triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48240-6.json |
| 48241-4 | Aspergillus fumigatus triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48241-4.json |
| 48242-2 | Cladosporium herbarum triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48242-2.json |
| 48243-0 | Penicillium notatum triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48243-0.json |
| 48244-8 | Red Cedar triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48244-8.json |
| 48245-5 | Japanese Cedar triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48245-5.json |
| 48246-3 | Olive Pollen triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48246-3.json |
| 48247-1 | White Oak triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48247-1.json |
| 48248-9 | Hazelnut Pollen triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48248-9.json |
| 48249-7 | Silver Birch triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48249-7.json |
| 48250-5 | Pellitory (Parietaria judaica) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48250-5.json |
| 48251-3 | Pellitory (Parietaria officinalis) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48251-3.json |
| 48252-1 | Saltwort triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48252-1.json |
| 48253-9 | English plantain triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48253-9.json |
| 48254-7 | Mugwort triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48254-7.json |
| 48255-4 | Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48255-4.json |
| 48256-2 | Common Ragweed triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48256-2.json |
| 48257-0 | Velvet grass triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48257-0.json |
| 48258-8 | Cultivated Rye triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48258-8.json |
| 48259-6 | Kentucky blue grass triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48259-6.json |
| 48260-4 | Timothy triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48260-4.json |
| 48261-2 | Perennial rye grass triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48261-2.json |
| 48262-0 | Meadow Fescue triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48262-0.json |
| 48263-8 | Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48263-8.json |
| 48264-6 | Bermuda grass triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48264-6.json |
| 48265-3 | Dust Allergen Mix B (Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48265-3.json |
| 48266-1 | Grass Allergen Mix E (Cocksfoot+Meadow Fescue+Velvet grass+Perennial rye grass+Timothy+Kentucky blue grass ) triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48266-1.json |
| 48267-9 | Benzylpenicilloyl-polylysine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48267-9.json |
| 48268-7 | Minor determinant mixture triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48268-7.json |
| 48269-5 | Cefamandole triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48269-5.json |
| 48270-3 | ceFAZolin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48270-3.json |
| 48271-1 | Tetracycline triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48271-1.json |
| 48272-9 | Ciprofloxacin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48272-9.json |
| 48273-7 | Lysine acetylsalicylate triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48273-7.json |
| 48274-5 | Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48274-5.json |
| 48275-2 | Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48275-2.json |
| 48276-0 | Indomethacin triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48276-0.json |
| 48277-8 | Acetaminophen triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48277-8.json |
| 48278-6 | Mefenamate triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48278-6.json |
| 48279-4 | Propyphenazone triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48279-4.json |
| 48280-2 | Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48280-2.json |
| 48281-0 | Sulfamethoxazole triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48281-0.json |
| 48282-8 | Atracurium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48282-8.json |
| 48283-6 | Mivacurium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48283-6.json |
| 48284-4 | Pancuronium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48284-4.json |
| 48285-1 | Propofol triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48285-1.json |
| 48286-9 | Rocuronium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48286-9.json |
| 48288-5 | Vecuronium triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48288-5.json |
| 48289-3 | Sodium benzoate triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48289-3.json |
| 48290-1 | Sodium nitrite triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48290-1.json |
| 48291-9 | Potassium metabisulfite triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48291-9.json |
| 48292-7 | Sodium salicylate triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48292-7.json |
| 48293-5 | Tartrazine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48293-5.json |
| 48294-3 | Food colorant mix I triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48294-3.json |
| 48295-0 | Food colorant mix II triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48295-0.json |
| 48296-8 | Quinoline yellow triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48296-8.json |
| 48297-6 | Chromotrope 2B triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48297-6.json |
| 48298-4 | Pigweed triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48298-4.json |
| 48299-2 | New coccine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48299-2.json |
| 48300-8 | Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48300-8.json |
| 48301-6 | Patent blue V triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48301-6.json |
| 48302-4 | Indigo carmine triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48302-4.json |
| 48303-2 | Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48303-2.json |
| 48304-0 | Glutamate triggered leukotriene release [Mass/volume] by Leukocytes | ./2.16.840.1.114222.4.11.1002/48304-0.json |
| 48305-7 | Coproporphyrin 1/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48305-7.json |
| 48306-5 | Coproporphyrin 3/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48306-5.json |
| 48307-3 | Didanosine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48307-3.json |
| 48308-1 | DNA double strand Ab [Units/volume] in Body fluid by Farr method | ./2.16.840.1.114222.4.11.1002/48308-1.json |
| 48309-9 | BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48309-9.json |
| 48310-7 | Influenza virus A [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48310-7.json |
| 48311-5 | Lysosomal enzymes screen [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/48311-5.json |
| 48312-3 | Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/48312-3.json |
| 48313-1 | Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/48313-1.json |
| 48314-9 | Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48314-9.json |
| 48315-6 | Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48315-6.json |
| 48316-4 | Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48316-4.json |
| 48317-2 | Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48317-2.json |
| 48319-8 | glipiZIDE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48319-8.json |
| 48320-6 | glyBURIDE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48320-6.json |
| 48321-4 | TOLBUTamide [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48321-4.json |
| 48322-2 | Acetohexamide [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48322-2.json |
| 48323-0 | TOLAZamide [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48323-0.json |
| 48324-8 | chlorproPAMIDE [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48324-8.json |
| 48325-5 | Glimepride [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48325-5.json |
| 48326-3 | glipiZIDE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48326-3.json |
| 48327-1 | glyBURIDE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48327-1.json |
| 48328-9 | Repaglinide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48328-9.json |
| 48329-7 | chlorproPAMIDE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48329-7.json |
| 48330-5 | MCOLN1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48330-5.json |
| 48331-3 | BLM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48331-3.json |
| 48335-4 | Aspergillus sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48335-4.json |
| 48336-2 | Candida sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48336-2.json |
| 48338-8 | Histoplasma capsulatum Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48338-8.json |
| 48339-6 | Sporothrix schenckii Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48339-6.json |
| 48342-0 | Ethanol+Methanol+Isopropyl alcohol+Acetone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48342-0.json |
| 48343-8 | Hemoglobin.other/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/48343-8.json |
| 48344-6 | Activated clotting time.kaolin induced of Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/48344-6.json |
| 48345-3 | HIV 1+O+2 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48345-3.json |
| 48346-1 | HIV 1+O+2 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48346-1.json |
| 48347-9 | levETIRAcetam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48347-9.json |
| 48348-7 | 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48348-7.json |
| 48349-5 | Pregabalin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48349-5.json |
| 48350-3 | Venlafaxine+O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48350-3.json |
| 48351-1 | Methotrimeprazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48351-1.json |
| 48352-9 | Reboxetine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48352-9.json |
| 48353-7 | Chlorprothixene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48353-7.json |
| 48354-5 | ARIPiprazole [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48354-5.json |
| 48355-2 | traMADol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48355-2.json |
| 48356-0 | Prazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48356-0.json |
| 48357-8 | Testosterone [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/48357-8.json |
| 48358-6 | Herpes virus 8 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48358-6.json |
| 48359-4 | Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/48359-4.json |
| 48360-2 | Borrelia afzelii IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/48360-2.json |
| 48361-0 | Borrelia valaisiana IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/48361-0.json |
| 48362-8 | O-desmethylvenlafaxine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48362-8.json |
| 48363-6 | Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48363-6.json |
| 48364-4 | Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48364-4.json |
| 48365-1 | Methadone.R [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48365-1.json |
| 48366-9 | Pentadecanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48366-9.json |
| 48367-7 | cis-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48367-7.json |
| 48368-5 | trans-Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48368-5.json |
| 48369-3 | trans-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48369-3.json |
| 48370-1 | Dihomogammalinolenate (C20:3n-6) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48370-1.json |
| 48371-9 | Docosapentaenoate (C22:5 n-3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48371-9.json |
| 48372-7 | Spermatozoa Isolated Head/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/48372-7.json |
| 48373-5 | Spermatozoa Angled Midpiece/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/48373-5.json |
| 48374-3 | Spermatozoa Isolated Tail/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/48374-3.json |
| 48375-0 | Spermatozoa Short Tail/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/48375-0.json |
| 48376-8 | Collagen type 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48376-8.json |
| 48377-6 | Mullerian inhibiting substance [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48377-6.json |
| 48378-4 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum | ./2.16.840.1.114222.4.11.1002/48378-4.json |
| 48379-2 | Zopiclone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48379-2.json |
| 48380-0 | 3-Methoxytyramine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48380-0.json |
| 48381-8 | 3-Methoxytyramine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48381-8.json |
| 48383-4 | Collagen.bovine type 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48383-4.json |
| 48384-2 | Collagen.bovine type 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48384-2.json |
| 48385-9 | Collagen.injectable Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48385-9.json |
| 48387-5 | Thyroglobulin recovery [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48387-5.json |
| 48388-3 | Heparin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48388-3.json |
| 48389-1 | Macroprolactin/Prolactin [Moles] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48389-1.json |
| 48390-9 | B cell crossmatch [Presence] in Blood from Donor | ./2.16.840.1.114222.4.11.1002/48390-9.json |
| 48391-7 | Carbon dioxide, total [Moles/volume] in Venous blood by calculation | ./2.16.840.1.114222.4.11.1002/48391-7.json |
| 48392-5 | Coccidioides immitis Ab [Titer] in Body fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/48392-5.json |
| 48393-3 | Coccidioides immitis IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48393-3.json |
| 48394-1 | Coccidioides sp Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/48394-1.json |
| 48395-8 | Coproporphyrin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48395-8.json |
| 48398-2 | Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48398-2.json |
| 48399-0 | Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48399-0.json |
| 48400-6 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48400-6.json |
| 48401-4 | Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48401-4.json |
| 48402-2 | Latex IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/48402-2.json |
| 48403-0 | Methadone+Metabolite [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48403-0.json |
| 48404-8 | Myeloperoxidase IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48404-8.json |
| 48405-5 | Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48405-5.json |
| 48406-3 | Parietal cell IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/48406-3.json |
| 48407-1 | Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48407-1.json |
| 48408-9 | Proteinase 3 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48408-9.json |
| 48409-7 | T cell crossmatch [Presence] in Blood from Donor | ./2.16.840.1.114222.4.11.1002/48409-7.json |
| 48410-5 | Yersinia sp IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/48410-5.json |
| 48411-3 | Fungus identified in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48411-3.json |
| 48412-1 | Zygomycete sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48412-1.json |
| 48413-9 | Alpha-1-Microglobulin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48413-9.json |
| 48414-7 | Alpha-1-Microglobulin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48414-7.json |
| 48415-4 | Alpha-1-Microglobulin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48415-4.json |
| 48416-2 | Alpha-1-acid glycoprotein [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48416-2.json |
| 48417-0 | Staphylolysin Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48417-0.json |
| 48418-8 | Staphylolysin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/48418-8.json |
| 48419-6 | Immune complex.IgG [Mass/volume] in Serum or Plasma by C1q binding assay | ./2.16.840.1.114222.4.11.1002/48419-6.json |
| 48420-4 | Complement C3c [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48420-4.json |
| 48421-2 | C reactive protein [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/48421-2.json |
| 48422-0 | Oligoclonal bands [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48422-0.json |
| 48425-3 | Troponin T.cardiac [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/48425-3.json |
| 48426-1 | Troponin T.cardiac [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/48426-1.json |
| 48427-9 | Erythrocytes.Plasmodium sp infected/1000 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/48427-9.json |
| 48428-7 | Rumenate (C18:2 cis-9 trans-11) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48428-7.json |
| 48429-5 | Lavender IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48429-5.json |
| 48430-3 | Carnitine [Molar amount] in unspecified time Semen | ./2.16.840.1.114222.4.11.1002/48430-3.json |
| 48431-1 | Zinc [Molar amount] in unspecified time Semen | ./2.16.840.1.114222.4.11.1002/48431-1.json |
| 48432-9 | Fructose [Molar amount] in unspecified time Semen | ./2.16.840.1.114222.4.11.1002/48432-9.json |
| 48433-7 | XR Calcaneus - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/48433-7.json |
| 48434-5 | US Guidance for fluid aspiration of Kidney | ./2.16.840.1.114222.4.11.1002/48434-5.json |
| 48435-2 | RF Guidance for injection of Salivary gland - bilateral | ./2.16.840.1.114222.4.11.1002/48435-2.json |
| 48436-0 | MR Lumbar spine W contrast IT | ./2.16.840.1.114222.4.11.1002/48436-0.json |
| 48439-4 | MR Thoracic spine W contrast IT | ./2.16.840.1.114222.4.11.1002/48439-4.json |
| 48440-2 | MR Skull base W contrast IV | ./2.16.840.1.114222.4.11.1002/48440-2.json |
| 48441-0 | MR Thoracic spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/48441-0.json |
| 48442-8 | CT Spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/48442-8.json |
| 48443-6 | CT Nasopharynx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48443-6.json |
| 48444-4 | MR Brain.temporal W contrast IV | ./2.16.840.1.114222.4.11.1002/48444-4.json |
| 48445-1 | MR Larynx WO contrast | ./2.16.840.1.114222.4.11.1002/48445-1.json |
| 48446-9 | CT Nasopharynx W contrast IV | ./2.16.840.1.114222.4.11.1002/48446-9.json |
| 48447-7 | MR Cervical spine W contrast IT | ./2.16.840.1.114222.4.11.1002/48447-7.json |
| 48448-5 | US Upper extremity artery | ./2.16.840.1.114222.4.11.1002/48448-5.json |
| 48449-3 | CT Orbit W contrast IV | ./2.16.840.1.114222.4.11.1002/48449-3.json |
| 48450-1 | MR Cervical spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/48450-1.json |
| 48451-9 | CT Orbit WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48451-9.json |
| 48452-7 | MR Lumbar spine WO and W contrast IT | ./2.16.840.1.114222.4.11.1002/48452-7.json |
| 48453-5 | MR Brain.temporal WO contrast | ./2.16.840.1.114222.4.11.1002/48453-5.json |
| 48454-3 | MR Clavicle - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48454-3.json |
| 48455-0 | MR Clavicle - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48455-0.json |
| 48456-8 | MR Clavicle - right W contrast IV | ./2.16.840.1.114222.4.11.1002/48456-8.json |
| 48457-6 | MR Clavicle - left W contrast IV | ./2.16.840.1.114222.4.11.1002/48457-6.json |
| 48458-4 | MR Clavicle - right WO contrast | ./2.16.840.1.114222.4.11.1002/48458-4.json |
| 48459-2 | MR Clavicle - left WO contrast | ./2.16.840.1.114222.4.11.1002/48459-2.json |
| 48460-0 | MR Unspecified body region limited | ./2.16.840.1.114222.4.11.1002/48460-0.json |
| 48461-8 | MR Neck limited | ./2.16.840.1.114222.4.11.1002/48461-8.json |
| 48462-6 | XR Knee - left AP | ./2.16.840.1.114222.4.11.1002/48462-6.json |
| 48463-4 | XR Knee - right AP | ./2.16.840.1.114222.4.11.1002/48463-4.json |
| 48464-2 | RF Trachea Views | ./2.16.840.1.114222.4.11.1002/48464-2.json |
| 48465-9 | RF Larynx Views | ./2.16.840.1.114222.4.11.1002/48465-9.json |
| 48466-7 | XR Skull Limited Views | ./2.16.840.1.114222.4.11.1002/48466-7.json |
| 48467-5 | XR Sacroiliac Joint 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/48467-5.json |
| 48468-3 | XR Ribs - bilateral 2 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/48468-3.json |
| 48469-1 | XR Lumbar spine 2 or 3 Views | ./2.16.840.1.114222.4.11.1002/48469-1.json |
| 48470-9 | XR Mastoid - left 3 Views | ./2.16.840.1.114222.4.11.1002/48470-9.json |
| 48471-7 | XR Mastoid - right 3 Views | ./2.16.840.1.114222.4.11.1002/48471-7.json |
| 48472-5 | XR Thoracic spine 3 Views and Swimmers | ./2.16.840.1.114222.4.11.1002/48472-5.json |
| 48473-3 | XR Spine Lumbar and Sacrum 4 Views | ./2.16.840.1.114222.4.11.1002/48473-3.json |
| 48474-1 | XR Hand - bilateral AP and Lateral | ./2.16.840.1.114222.4.11.1002/48474-1.json |
| 48475-8 | MG Breast - bilateral Diagnostic for implant | ./2.16.840.1.114222.4.11.1002/48475-8.json |
| 48476-6 | XR Foot - right GE 3 Views | ./2.16.840.1.114222.4.11.1002/48476-6.json |
| 48477-4 | XR Foot - left GE 3 Views | ./2.16.840.1.114222.4.11.1002/48477-4.json |
| 48478-2 | XR Foot - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48478-2.json |
| 48479-0 | XR Facial bones GE 3 Views | ./2.16.840.1.114222.4.11.1002/48479-0.json |
| 48480-8 | XR Ankle - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48480-8.json |
| 48481-6 | XR Elbow - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48481-6.json |
| 48482-4 | XR Sternoclavicular joint - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48482-4.json |
| 48483-2 | XR Wrist - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48483-2.json |
| 48484-0 | XR Ribs - right GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/48484-0.json |
| 48485-7 | XR Ribs - bilateral GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/48485-7.json |
| 48486-5 | XR Ribs - left GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/48486-5.json |
| 48487-3 | XR Skull GE 4 Views | ./2.16.840.1.114222.4.11.1002/48487-3.json |
| 48488-1 | XR Mastoid - right 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/48488-1.json |
| 48489-9 | XR Mastoid - left 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/48489-9.json |
| 48490-7 | XR Temporomandibular joint - right Open and Closed mouth | ./2.16.840.1.114222.4.11.1002/48490-7.json |
| 48491-5 | XR Temporomandibular joint - left Open and Closed mouth | ./2.16.840.1.114222.4.11.1002/48491-5.json |
| 48492-3 | MG Breast - bilateral Screening for implant | ./2.16.840.1.114222.4.11.1002/48492-3.json |
| 48493-1 | Beta-trace protein [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48493-1.json |
| 48494-9 | Complement C1 esterase inhibitor actual/normal in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48494-9.json |
| 48495-6 | Transferrin.carbohydrate deficient/Transferrin.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48495-6.json |
| 48496-4 | Complement total hemolytic CH50 actual/normal in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48496-4.json |
| 48497-2 | Pro-hepcidin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48497-2.json |
| 48498-0 | Amyloid A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48498-0.json |
| 48499-8 | Beta-trace protein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48499-8.json |
| 48501-1 | HLA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48501-1.json |
| 48502-9 | Platelet glycoprotein Ia/IIa IgG Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/48502-9.json |
| 48503-7 | Platelet glycoprotein Ib/Ix IgG Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/48503-7.json |
| 48504-5 | Platelet glycoprotein IIb/IIIa IgG Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/48504-5.json |
| 48505-2 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48505-2.json |
| 48506-0 | Platelet glycoprotein Ib/Ix Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48506-0.json |
| 48507-8 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/48507-8.json |
| 48508-6 | Measles virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48508-6.json |
| 48509-4 | Influenza virus A and B RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48509-4.json |
| 48510-2 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL | ./2.16.840.1.114222.4.11.1002/48510-2.json |
| 48511-0 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL | ./2.16.840.1.114222.4.11.1002/48511-0.json |
| 48551-6 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 400 copies/mL | ./2.16.840.1.114222.4.11.1002/48551-6.json |
| 48552-4 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 2.6 log copies/mL | ./2.16.840.1.114222.4.11.1002/48552-4.json |
| 48553-2 | Muscle sarcolemma Ab [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/48553-2.json |
| 48554-0 | Myocardium Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48554-0.json |
| 48558-1 | HIV genotype [Susceptibility] | ./2.16.840.1.114222.4.11.1002/48558-1.json |
| 48560-7 | Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48560-7.json |
| 48570-6 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 10 | ./2.16.840.1.114222.4.11.1002/48570-6.json |
| 48571-4 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 11 | ./2.16.840.1.114222.4.11.1002/48571-4.json |
| 48572-2 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 21 | ./2.16.840.1.114222.4.11.1002/48572-2.json |
| 48573-0 | Follitropin [Units/volume] in Serum or Plasma --on cycle day 3 | ./2.16.840.1.114222.4.11.1002/48573-0.json |
| 48574-8 | Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48574-8.json |
| 48575-5 | Hepatitis C virus genotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48575-5.json |
| 48576-3 | Hepatitis C virus RNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/48576-3.json |
| 48578-9 | HFE gene c.187G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48578-9.json |
| 48580-5 | KCNQ1OT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48580-5.json |
| 48581-3 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 11 | ./2.16.840.1.114222.4.11.1002/48581-3.json |
| 48582-1 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 3 | ./2.16.840.1.114222.4.11.1002/48582-1.json |
| 48583-9 | Lutropin [Units/volume] in Serum or Plasma --on cycle day 21 | ./2.16.840.1.114222.4.11.1002/48583-9.json |
| 48586-2 | Collagen crosslinked C-telopeptide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/48586-2.json |
| 48587-0 | Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48587-0.json |
| 48588-8 | Coccidioides sp rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48588-8.json |
| 48589-6 | Coccidioides sp rRNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48589-6.json |
| 48592-0 | Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/48592-0.json |
| 48594-6 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/48594-6.json |
| 48597-9 | cycloSPORINE [Mass/volume] in Blood by Immunoassay --trough | ./2.16.840.1.114222.4.11.1002/48597-9.json |
| 48598-7 | BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48598-7.json |
| 48599-5 | CLCN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48599-5.json |
| 48600-1 | VPS13B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48600-1.json |
| 48601-9 | OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48601-9.json |
| 48602-7 | TGM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48602-7.json |
| 48608-4 | 2-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48608-4.json |
| 48609-2 | Adenovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48609-2.json |
| 48610-0 | 7-Dehydrocholesterol [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/48610-0.json |
| 48613-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/48613-4.json |
| 48614-2 | Cryoglobulin [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/48614-2.json |
| 48616-7 | 17-Hydroxyprogesterone [Units/volume] in DBS | ./2.16.840.1.114222.4.11.1002/48616-7.json |
| 48617-5 | Phosphate [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/48617-5.json |
| 48618-3 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate | ./2.16.840.1.114222.4.11.1002/48618-3.json |
| 48619-1 | Apolipoprotein E1 [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/48619-1.json |
| 48620-9 | Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate | ./2.16.840.1.114222.4.11.1002/48620-9.json |
| 48621-7 | Hexacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48621-7.json |
| 48622-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/48622-5.json |
| 48623-3 | Bilirubin.direct [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/48623-3.json |
| 48624-1 | Bilirubin.total [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/48624-1.json |
| 48625-8 | Choriogonadotropin.intact [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/48625-8.json |
| 48627-4 | Protein.monoclonal [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/48627-4.json |
| 48628-2 | Insulin-like growth factor binding protein 3 [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/48628-2.json |
| 48629-0 | Urea nitrogen [Mass/volume] in Venous blood --post dialysis | ./2.16.840.1.114222.4.11.1002/48629-0.json |
| 48630-8 | Creatinine [Mass/volume] in Peritoneal fluid --pre dialysis | ./2.16.840.1.114222.4.11.1002/48630-8.json |
| 48631-6 | Bicarbonate [Moles/volume] in Serum --post dialysis | ./2.16.840.1.114222.4.11.1002/48631-6.json |
| 48632-4 | Heptacarboxylporphyrin [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/48632-4.json |
| 48633-2 | Trypsinogen I Free [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/48633-2.json |
| 48634-0 | Coproporphyrin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48634-0.json |
| 48638-1 | Cryoglobulin type [Identifier] in Serum by Immunofixation | ./2.16.840.1.114222.4.11.1002/48638-1.json |
| 48639-9 | Urea nitrogen [Mass/volume] in Peripheral blood --post dialysis | ./2.16.840.1.114222.4.11.1002/48639-9.json |
| 48641-5 | Phosphate [Mass/volume] in Serum or Plasma --pre dialysis | ./2.16.840.1.114222.4.11.1002/48641-5.json |
| 48645-6 | Pseudomonas sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48645-6.json |
| 48646-4 | Yersinia sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48646-4.json |
| 48647-2 | Ej Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) | ./2.16.840.1.114222.4.11.1002/48647-2.json |
| 48649-8 | OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) | ./2.16.840.1.114222.4.11.1002/48649-8.json |
| 48650-6 | Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 copies/mL | ./2.16.840.1.114222.4.11.1002/48650-6.json |
| 48652-2 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/48652-2.json |
| 48653-0 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/48653-0.json |
| 48654-8 | Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48654-8.json |
| 48655-5 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/48655-5.json |
| 48656-3 | Ganglioside GD1a Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48656-3.json |
| 48657-1 | Ganglioside GM2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48657-1.json |
| 48660-5 | Ganglioside GM1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48660-5.json |
| 48661-3 | Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --5 days post incubation | ./2.16.840.1.114222.4.11.1002/48661-3.json |
| 48662-1 | Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood | ./2.16.840.1.114222.4.11.1002/48662-1.json |
| 48663-9 | YKL-40 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48663-9.json |
| 48664-7 | Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived | ./2.16.840.1.114222.4.11.1002/48664-7.json |
| 48665-4 | IgA.intrathecally synthesized [Mass/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/48665-4.json |
| 48666-2 | IgG.intrathecally synthesized [Mass/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/48666-2.json |
| 48667-0 | IgM.intrathecally synthesized [Mass/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/48667-0.json |
| 48668-8 | Protein fractions.oligoclonal bands.intrathecal [Presence] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/48668-8.json |
| 48670-4 | IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48670-4.json |
| 48673-8 | EBV-LMP Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48673-8.json |
| 48674-6 | Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/48674-6.json |
| 48677-9 | Cancer Ag 125 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48677-9.json |
| 48678-7 | P57 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48678-7.json |
| 48679-5 | Pancytokeratin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48679-5.json |
| 48680-3 | PAX5 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48680-3.json |
| 48681-1 | Plasma cell Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48681-1.json |
| 48682-9 | Smooth muscle myosin heavy chain Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/48682-9.json |
| 48683-7 | Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48683-7.json |
| 48685-2 | Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/48685-2.json |
| 48686-0 | Salmonella paratyphi C Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/48686-0.json |
| 48687-8 | MR Skull base WO contrast | ./2.16.840.1.114222.4.11.1002/48687-8.json |
| 48688-6 | US Upper extremity vein - right | ./2.16.840.1.114222.4.11.1002/48688-6.json |
| 48689-4 | US Upper extremity vein - left | ./2.16.840.1.114222.4.11.1002/48689-4.json |
| 48690-2 | US Upper extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/48690-2.json |
| 48691-0 | US Lower extremity vein - right | ./2.16.840.1.114222.4.11.1002/48691-0.json |
| 48692-8 | US Lower extremity vein - left | ./2.16.840.1.114222.4.11.1002/48692-8.json |
| 48693-6 | US Lower extremity artery | ./2.16.840.1.114222.4.11.1002/48693-6.json |
| 48694-4 | MR Brain.temporal WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48694-4.json |
| 48695-1 | XR Skull base Single view | ./2.16.840.1.114222.4.11.1002/48695-1.json |
| 48696-9 | RF Submandibular gland - right Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/48696-9.json |
| 48697-7 | XR Skull base Views | ./2.16.840.1.114222.4.11.1002/48697-7.json |
| 48698-5 | RF Submandibular gland - bilateral Views W contrast intra salivary duct | ./2.16.840.1.114222.4.11.1002/48698-5.json |
| 48699-3 | XR Temporomandibular joint - unilateral Open and Closed mouth | ./2.16.840.1.114222.4.11.1002/48699-3.json |
| 48710-8 | Eosinophils [Presence] in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/48710-8.json |
| 48711-6 | Free Hemoglobin [Mass/volume] in Plasma --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/48711-6.json |
| 48712-4 | Microscopic observation [Identifier] in Genital specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/48712-4.json |
| 48713-2 | Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48713-2.json |
| 48714-0 | Leishmania tropica IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48714-0.json |
| 48715-7 | Leishmania tropica IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48715-7.json |
| 48716-5 | La Crosse virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48716-5.json |
| 48717-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48717-3.json |
| 48718-1 | Leishmania mexicana IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48718-1.json |
| 48719-9 | Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48719-9.json |
| 48720-7 | Coxiella burnetii phase 1 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48720-7.json |
| 48721-5 | Bartonella henselae IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48721-5.json |
| 48722-3 | Microscopic observation [Identifier] in Body fluid by Crystal violet stain | ./2.16.840.1.114222.4.11.1002/48722-3.json |
| 48723-1 | Epstein Barr virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48723-1.json |
| 48725-6 | Hemoglobin [Mass/volume] in Blood --pre therapeutic phlebotomy | ./2.16.840.1.114222.4.11.1002/48725-6.json |
| 48726-4 | JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48726-4.json |
| 48727-2 | Bacteria # 2 identified in Blood by Culture | ./2.16.840.1.114222.4.11.1002/48727-2.json |
| 48728-0 | NCF1+NCF2+CYBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48728-0.json |
| 48729-8 | CYBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48729-8.json |
| 48730-6 | X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative | ./2.16.840.1.114222.4.11.1002/48730-6.json |
| 48731-4 | Complement C4 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48731-4.json |
| 48732-2 | NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48732-2.json |
| 48733-0 | NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48733-0.json |
| 48734-8 | CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48734-8.json |
| 48735-5 | MG Guidance for localization of Breast | ./2.16.840.1.114222.4.11.1002/48735-5.json |
| 48736-3 | MG Guidance for sentinel lymph node injection of Breast - left | ./2.16.840.1.114222.4.11.1002/48736-3.json |
| 48737-1 | XR Wrist and Hand 3 Views | ./2.16.840.1.114222.4.11.1002/48737-1.json |
| 48738-9 | XR Wrist - bilateral and Hand - bilateral 3 Views | ./2.16.840.1.114222.4.11.1002/48738-9.json |
| 48739-7 | MG Guidance for sentinel lymph node injection of Breast - right | ./2.16.840.1.114222.4.11.1002/48739-7.json |
| 48740-5 | MG Guidance for sentinel lymph node injection of Breast | ./2.16.840.1.114222.4.11.1002/48740-5.json |
| 48741-3 | Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48741-3.json |
| 48742-1 | US.doppler Scrotum and testicle | ./2.16.840.1.114222.4.11.1002/48742-1.json |
| 48743-9 | CT Retroperitoneum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/48743-9.json |
| 48746-2 | XR Sacroiliac joint - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/48746-2.json |
| 48747-0 | XR Orbit - bilateral GE 4 Views | ./2.16.840.1.114222.4.11.1002/48747-0.json |
| 48748-8 | XR Spine Oblique Views | ./2.16.840.1.114222.4.11.1002/48748-8.json |
| 48749-6 | XR Thoracic spine Oblique Views | ./2.16.840.1.114222.4.11.1002/48749-6.json |
| 48751-2 | 3-Hydroxypalmitate.free (3-OH-C16:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48751-2.json |
| 48752-0 | 3-Hydroxymyristate.free (3-OH-C14:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48752-0.json |
| 48753-8 | 3-Hydroxydodecanoate.free (3-OH-C12:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48753-8.json |
| 48754-6 | 3-Hydroxydodecanoate (3-OH-C12:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48754-6.json |
| 48755-3 | 3-Hydroxydecanoate.free (3-OH-C10:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48755-3.json |
| 48756-1 | 3-Hydroxyoctanoate.free (3-OH-C8:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48756-1.json |
| 48757-9 | 3-Hydroxyoctanoate (3-OH-C8:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48757-9.json |
| 48758-7 | 3-Hydroxyhexanoate.free (3-OH-C6:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48758-7.json |
| 48759-5 | 3-Hydroxyhexanoate (3-OH-C6:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48759-5.json |
| 48761-1 | 3-Hydroxypalmitate (3-OH-C16:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48761-1.json |
| 48762-9 | 3-Hydroxymyristate (3-OH-C14:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48762-9.json |
| 48763-7 | 3-Hydroxydecanoate (3-OH-C10:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/48763-7.json |
| 48764-5 | Summary purpose CCD Document | ./2.16.840.1.114222.4.11.1002/48764-5.json |
| 48765-2 | Allergies and adverse reactions Document | ./2.16.840.1.114222.4.11.1002/48765-2.json |
| 48766-0 | Information source | ./2.16.840.1.114222.4.11.1002/48766-0.json |
| 48768-6 | Payment sources Document | ./2.16.840.1.114222.4.11.1002/48768-6.json |
| 48771-0 | Kappa light chains [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48771-0.json |
| 48772-8 | Lambda light chains [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48772-8.json |
| 48774-4 | Kappa light chains.free [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48774-4.json |
| 48775-1 | Lambda light chains.free [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/48775-1.json |
| 48781-9 | CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48781-9.json |
| 48783-5 | Dipyrone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/48783-5.json |
| 48784-3 | Herpes simplex virus 2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48784-3.json |
| 48785-0 | Prostaglandin D2 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48785-0.json |
| 48787-6 | Glucose [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis | ./2.16.840.1.114222.4.11.1002/48787-6.json |
| 48788-4 | Creatinine peritoneal dialysis clearance | ./2.16.840.1.114222.4.11.1002/48788-4.json |
| 48789-2 | Creatinine peritoneal dialysis clearance/1.73 sq M | ./2.16.840.1.114222.4.11.1002/48789-2.json |
| 48790-0 | Creatinine [Mass/time] in unspecified time Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/48790-0.json |
| 48791-8 | Urea nitrogen peritoneal dialysis clearance/1.73 sq M | ./2.16.840.1.114222.4.11.1002/48791-8.json |
| 48804-9 | Taenia solium Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/48804-9.json |
| 48806-4 | Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48806-4.json |
| 48807-2 | Bone marrow aspiration report | ./2.16.840.1.114222.4.11.1002/48807-2.json |
| 48813-0 | Methicillin resistance mecA gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/48813-0.json |
| 48814-8 | Vancomycin resistance vanA gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/48814-8.json |
| 48816-3 | Staphylococcus aureus Panton-Valentine leukocidin gene [Presence] in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48816-3.json |
| 48818-9 | Karyotype [Identifier] in Blood or Tissue by High resolution Nominal | ./2.16.840.1.114222.4.11.1002/48818-9.json |
| 48819-7 | Karyotype [Identifier] in Tissue from Fetus Nominal | ./2.16.840.1.114222.4.11.1002/48819-7.json |
| 48820-5 | Karyotype [Identifier] in Cord blood Nominal | ./2.16.840.1.114222.4.11.1002/48820-5.json |
| 48821-3 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48821-3.json |
| 48822-1 | Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/48822-1.json |
| 48823-9 | Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48823-9.json |
| 48842-9 | Bartonella bacilliformis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48842-9.json |
| 48843-7 | Bartonella bacilliformis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48843-7.json |
| 48844-5 | Bartonella elizabethae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48844-5.json |
| 48845-2 | Bartonella elizabethae IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48845-2.json |
| 48846-0 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48846-0.json |
| 48847-8 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48847-8.json |
| 48848-6 | Coxiella burnetii phase 1 IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48848-6.json |
| 48849-4 | Coxiella burnetii phase 2 IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48849-4.json |
| 48850-2 | Ehrlichia chaffeensis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48850-2.json |
| 48851-0 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48851-0.json |
| 48852-8 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48852-8.json |
| 48853-6 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48853-6.json |
| 48854-4 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48854-4.json |
| 48855-1 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48855-1.json |
| 48856-9 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48856-9.json |
| 48857-7 | Rickettsia africae IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48857-7.json |
| 48858-5 | Rickettsia africae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48858-5.json |
| 48859-3 | Rickettsia akari IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48859-3.json |
| 48860-1 | Rickettsia akari IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48860-1.json |
| 48861-9 | Rickettsia parkeri IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48861-9.json |
| 48862-7 | Rickettsia parkeri IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48862-7.json |
| 48863-5 | Rickettsia sp DNA [Identifier] in Specimen by RFLP | ./2.16.840.1.114222.4.11.1002/48863-5.json |
| 48864-3 | Bartonella sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48864-3.json |
| 48865-0 | Ehrlichia ewingii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48865-0.json |
| 48866-8 | Ehrlichia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48866-8.json |
| 48867-6 | Orientia tsutsugamushi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48867-6.json |
| 48868-4 | Rickettsia rickettsii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48868-4.json |
| 48869-2 | Rickettsia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48869-2.json |
| 48870-0 | Rickettsia spotted fever group DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48870-0.json |
| 48871-8 | Rickettsia typhus group DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/48871-8.json |
| 48872-6 | Anaplasma phagocytophilum [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48872-6.json |
| 48873-4 | Ehrlichia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48873-4.json |
| 48874-2 | Neorickettsia sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48874-2.json |
| 48875-9 | Orientia tsutsugamushi [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/48875-9.json |
| 48876-7 | Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48876-7.json |
| 48877-5 | Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48877-5.json |
| 48878-3 | Bartonella bacilliformis IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48878-3.json |
| 48879-1 | Bartonella bacilliformis IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48879-1.json |
| 48880-9 | Bartonella elizabethae IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48880-9.json |
| 48881-7 | Bartonella elizabethae IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48881-7.json |
| 48882-5 | Bartonella henselae IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48882-5.json |
| 48883-3 | Bartonella henselae IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48883-3.json |
| 48884-1 | Bartonella quintana IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48884-1.json |
| 48885-8 | Bartonella quintana IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48885-8.json |
| 48886-6 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48886-6.json |
| 48887-4 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48887-4.json |
| 48888-2 | Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48888-2.json |
| 48889-0 | Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48889-0.json |
| 48890-8 | Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48890-8.json |
| 48891-6 | Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48891-6.json |
| 48892-4 | Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48892-4.json |
| 48893-2 | Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48893-2.json |
| 48894-0 | Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48894-0.json |
| 48895-7 | Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48895-7.json |
| 48896-5 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48896-5.json |
| 48897-3 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48897-3.json |
| 48898-1 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48898-1.json |
| 48899-9 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48899-9.json |
| 48900-5 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48900-5.json |
| 48901-3 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48901-3.json |
| 48902-1 | Rickettsia africae IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48902-1.json |
| 48903-9 | Rickettsia africae IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48903-9.json |
| 48904-7 | Rickettsia akari IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48904-7.json |
| 48905-4 | Rickettsia akari IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48905-4.json |
| 48906-2 | Rickettsia conorii IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48906-2.json |
| 48907-0 | Rickettsia conorii IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48907-0.json |
| 48908-8 | Rickettsia parkeri IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48908-8.json |
| 48909-6 | Rickettsia parkeri IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48909-6.json |
| 48910-4 | Rickettsia prowazekii IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48910-4.json |
| 48911-2 | Rickettsia prowazekii IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48911-2.json |
| 48912-0 | Rickettsia rickettsii IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48912-0.json |
| 48913-8 | Rickettsia rickettsii IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48913-8.json |
| 48914-6 | Rickettsia typhi IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48914-6.json |
| 48915-3 | Rickettsia typhi IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/48915-3.json |
| 48934-4 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48934-4.json |
| 48935-1 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/48935-1.json |
| 48937-7 | Alpha hydroxyalprazolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48937-7.json |
| 48938-5 | ALPRAZolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48938-5.json |
| 48939-3 | Amphetamines [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48939-3.json |
| 48940-1 | Benzodiazepines [Mass/volume] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/48940-1.json |
| 48941-9 | Benzodiazepines [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48941-9.json |
| 48942-7 | Cannabinoids [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48942-7.json |
| 48943-5 | Cannabinoids [Presence] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/48943-5.json |
| 48944-3 | Carboxy tetrahydrocannabinol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48944-3.json |
| 48945-0 | chlordiazePOXIDE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48945-0.json |
| 48946-8 | Cocaethylene [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48946-8.json |
| 48947-6 | Cocaine [Presence] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/48947-6.json |
| 48948-4 | diazePAM [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48948-4.json |
| 48949-2 | Estazolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48949-2.json |
| 48950-0 | Flurazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48950-0.json |
| 48952-6 | Histoplasma capsulatum Ag [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/48952-6.json |
| 48953-4 | Hydroxyethylflurazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48953-4.json |
| 48954-2 | Hydroxytriazolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48954-2.json |
| 48955-9 | LORazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48955-9.json |
| 48956-7 | Methadone [Mass/volume] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/48956-7.json |
| 48957-5 | Methadone [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48957-5.json |
| 48958-3 | Midazolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48958-3.json |
| 48959-1 | Nordiazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48959-1.json |
| 48960-9 | Norpropoxyphene [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48960-9.json |
| 48961-7 | Opiates [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48961-7.json |
| 48962-5 | Oxazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48962-5.json |
| 48963-3 | Propoxyphene [Mass/volume] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/48963-3.json |
| 48964-1 | Propoxyphene [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48964-1.json |
| 48965-8 | Temazepam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48965-8.json |
| 48966-6 | Triazolam [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/48966-6.json |
| 48967-4 | Brucella abortus Ab [Presence] in Cerebral spinal fluid by Card agglutination | ./2.16.840.1.114222.4.11.1002/48967-4.json |
| 48968-2 | PKHD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48968-2.json |
| 48969-0 | DCX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48969-0.json |
| 48970-8 | ELN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48970-8.json |
| 48971-6 | EYA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48971-6.json |
| 48972-4 | FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48972-4.json |
| 48973-2 | Leukocytes [Presence] in Stool by Methylene blue stain --2nd specimen | ./2.16.840.1.114222.4.11.1002/48973-2.json |
| 48974-0 | MDCR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48974-0.json |
| 48975-7 | GPR143 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48975-7.json |
| 48976-5 | POLG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48976-5.json |
| 48977-3 | SGCG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48977-3.json |
| 48978-1 | CDKL5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/48978-1.json |
| 48979-9 | TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48979-9.json |
| 48980-7 | TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/48980-7.json |
| 48981-5 | Anaplasma sp [Presence] in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/48981-5.json |
| 48982-3 | Ehrlichia sp [Presence] in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/48982-3.json |
| 48986-4 | Glucose [Mass/volume] in Serum or Plasma --8 AM specimen | ./2.16.840.1.114222.4.11.1002/48986-4.json |
| 48987-2 | Pyridinoline.free/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48987-2.json |
| 48988-0 | Glucose [Mass/volume] in Serum or Plasma --12 PM specimen | ./2.16.840.1.114222.4.11.1002/48988-0.json |
| 48989-8 | Glucose [Mass/volume] in Serum or Plasma --6 PM specimen | ./2.16.840.1.114222.4.11.1002/48989-8.json |
| 48990-6 | Glucose [Mass/volume] in Serum or Plasma --8 PM specimen | ./2.16.840.1.114222.4.11.1002/48990-6.json |
| 48991-4 | Glucose [Mass/volume] in Serum or Plasma --10 PM specimen | ./2.16.840.1.114222.4.11.1002/48991-4.json |
| 48992-2 | Glucose [Mass/volume] in Serum or Plasma --12 AM specimen | ./2.16.840.1.114222.4.11.1002/48992-2.json |
| 48993-0 | Glucose [Mass/volume] in Serum or Plasma --3 AM specimen | ./2.16.840.1.114222.4.11.1002/48993-0.json |
| 48994-8 | Glucose [Mass/volume] in Serum or Plasma --6 AM specimen | ./2.16.840.1.114222.4.11.1002/48994-8.json |
| 48995-5 | N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/48995-5.json |
| 48996-3 | Amylase.pancreatic [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/48996-3.json |
| 48997-1 | Immune complex.IgG [Mass/volume] in Body fluid by C1q binding assay | ./2.16.840.1.114222.4.11.1002/48997-1.json |
| 48998-9 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/48998-9.json |
| 48999-7 | Urea [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/48999-7.json |
| 49000-3 | Free Hemoglobin [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49000-3.json |
| 49001-1 | Osmolality of Sweat | ./2.16.840.1.114222.4.11.1002/49001-1.json |
| 49002-9 | Albumin [Mass/time] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/49002-9.json |
| 49003-7 | Urate [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49003-7.json |
| 49004-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49004-5.json |
| 49005-2 | Calcium [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49005-2.json |
| 49006-0 | Phosphate [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49006-0.json |
| 49007-8 | Magnesium [Moles/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49007-8.json |
| 49008-6 | Clot Retraction [Volume Fraction] in Blood | ./2.16.840.1.114222.4.11.1002/49008-6.json |
| 49010-2 | Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/49010-2.json |
| 49011-0 | Platelet aggregation arachidonate induced [Units/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/49011-0.json |
| 49012-8 | Influenza virus A and B identified in Specimen by Bioassay | ./2.16.840.1.114222.4.11.1002/49012-8.json |
| 49013-6 | Pancreastatin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49013-6.json |
| 49014-4 | PAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49014-4.json |
| 49015-1 | SCA15 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49015-1.json |
| 49016-9 | Streptococcus sp exoenzyme Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49016-9.json |
| 49023-5 | Microalbumin [Mass/time] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/49023-5.json |
| 49025-0 | CD25+CD127Low cells/CD4 cells [# Ratio] in Specimen | ./2.16.840.1.114222.4.11.1002/49025-0.json |
| 49026-8 | LDL 6 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49026-8.json |
| 49027-6 | LDL 7 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49027-6.json |
| 49028-4 | Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/49028-4.json |
| 49029-2 | Cortisol Free/Cortisone free [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49029-2.json |
| 49034-2 | Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain | ./2.16.840.1.114222.4.11.1002/49034-2.json |
| 49036-7 | Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision | ./2.16.840.1.114222.4.11.1002/49036-7.json |
| 49038-3 | Riboflavin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49038-3.json |
| 49039-1 | Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/49039-1.json |
| 49041-7 | Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL | ./2.16.840.1.114222.4.11.1002/49041-7.json |
| 49042-5 | Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL | ./2.16.840.1.114222.4.11.1002/49042-5.json |
| 49043-3 | Testosterone Free/Testosterone.total in Serum or Plasma by Detection limit <= 1.0 ng/dL | ./2.16.840.1.114222.4.11.1002/49043-3.json |
| 49047-4 | Globulin [Mass/volume] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/49047-4.json |
| 49050-8 | Microscopic observation [Identifier] in Endocervical brush by Cyto stain | ./2.16.840.1.114222.4.11.1002/49050-8.json |
| 49054-0 | 25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49054-0.json |
| 49055-7 | Ribonucleoprotein extractable nuclear 52kD Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49055-7.json |
| 49056-5 | Shigella sp serotype [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/49056-5.json |
| 49058-1 | aPTT in Blood drawn from CRRT circuit by Coagulation assay | ./2.16.840.1.114222.4.11.1002/49058-1.json |
| 49060-7 | Fondaparinux [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49060-7.json |
| 49063-1 | Microdeletion syndromes in Specimen by FISH Nominal | ./2.16.840.1.114222.4.11.1002/49063-1.json |
| 49069-8 | Epstein Barr virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49069-8.json |
| 49072-2 | Cocaethylene [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/49072-2.json |
| 49073-0 | Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49073-0.json |
| 49074-8 | Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49074-8.json |
| 49075-5 | Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49075-5.json |
| 49076-3 | Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49076-3.json |
| 49077-1 | Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49077-1.json |
| 49078-9 | Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49078-9.json |
| 49081-3 | Beta-2-Microglobulin [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/49081-3.json |
| 49096-1 | Chlamydia trachomatis DNA [Units/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49096-1.json |
| 49097-9 | Creatine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49097-9.json |
| 49098-7 | Cryptococcus neoformans rRNA [Units/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49098-7.json |
| 49099-5 | Codfish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49099-5.json |
| 49100-1 | H2a-H2b DNA IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49100-1.json |
| 49101-9 | Helicobacter pylori DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49101-9.json |
| 49102-7 | Herpes virus 8 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49102-7.json |
| 49104-3 | Mycoplasma pneumoniae DNA [Units/volume] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49104-3.json |
| 49105-0 | Phenolphthalein [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/49105-0.json |
| 49106-8 | Phenols [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/49106-8.json |
| 49107-6 | Rubella virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49107-6.json |
| 49108-4 | Titanium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/49108-4.json |
| 49109-2 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/49109-2.json |
| 49110-0 | Mycoplasma sp identified in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/49110-0.json |
| 49112-6 | Borna disease virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49112-6.json |
| 49113-4 | ZAP70 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49113-4.json |
| 49114-2 | Flavivirus rRNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49114-2.json |
| 49115-9 | Thiamine.free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/49115-9.json |
| 49116-7 | Trichosporon sp DNA [Units/volume] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49116-7.json |
| 49117-5 | Norovirus Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/49117-5.json |
| 49118-3 | NM Unspecified body region Views | ./2.16.840.1.114222.4.11.1002/49118-3.json |
| 49119-1 | Monosaccharides.sulfated [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/49119-1.json |
| 49122-5 | Anaplasma sp identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49122-5.json |
| 49123-3 | Bartonella sp identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49123-3.json |
| 49124-1 | Coxiella burnetii identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49124-1.json |
| 49125-8 | Ehrlichia sp identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49125-8.json |
| 49126-6 | Orientia tsutsugamushi identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49126-6.json |
| 49127-4 | Rickettsia sp identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49127-4.json |
| 49128-2 | Rickettsia typhus group identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/49128-2.json |
| 49130-8 | Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/49130-8.json |
| 49132-4 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/49132-4.json |
| 49134-0 | Glucose [Mass/volume] in Blood --2 hours post dose glucose | ./2.16.840.1.114222.4.11.1002/49134-0.json |
| 49135-7 | Fractional excretion of sodium [Ratio] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49135-7.json |
| 49138-1 | California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49138-1.json |
| 49139-9 | California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49139-9.json |
| 49140-7 | California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49140-7.json |
| 49141-5 | California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49141-5.json |
| 49144-9 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/49144-9.json |
| 49145-6 | Rickettsia rickettsii IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49145-6.json |
| 49146-4 | Rickettsia rickettsii IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49146-4.json |
| 49147-2 | Rickettsia prowazekii IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49147-2.json |
| 49148-0 | Rickettsia prowazekii IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49148-0.json |
| 49149-8 | Rickettsia parkeri IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49149-8.json |
| 49150-6 | Rickettsia parkeri IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49150-6.json |
| 49151-4 | Rickettsia parkeri IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49151-4.json |
| 49152-2 | Rickettsia parkeri IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49152-2.json |
| 49153-0 | Rickettsia conorii IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49153-0.json |
| 49154-8 | Rickettsia conorii IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49154-8.json |
| 49155-5 | Rickettsia akari IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49155-5.json |
| 49156-3 | Rickettsia akari IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49156-3.json |
| 49157-1 | Rickettsia akari IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49157-1.json |
| 49158-9 | Rickettsia akari IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49158-9.json |
| 49159-7 | Rickettsia africae IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49159-7.json |
| 49160-5 | Rickettsia africae IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49160-5.json |
| 49161-3 | Rickettsia africae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49161-3.json |
| 49162-1 | Rickettsia africae IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49162-1.json |
| 49163-9 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49163-9.json |
| 49164-7 | Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49164-7.json |
| 49165-4 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49165-4.json |
| 49166-2 | Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49166-2.json |
| 49167-0 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49167-0.json |
| 49168-8 | Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49168-8.json |
| 49169-6 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49169-6.json |
| 49170-4 | Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49170-4.json |
| 49171-2 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49171-2.json |
| 49172-0 | Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49172-0.json |
| 49173-8 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49173-8.json |
| 49174-6 | Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49174-6.json |
| 49175-3 | Human bocavirus IgG Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/49175-3.json |
| 49176-1 | Herpes virus 8 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49176-1.json |
| 49177-9 | Hepatitis B virus surface IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49177-9.json |
| 49178-7 | Epstein Barr virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49178-7.json |
| 49179-5 | Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49179-5.json |
| 49180-3 | Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49180-3.json |
| 49181-1 | Echinococcus granulosus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49181-1.json |
| 49182-9 | Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49182-9.json |
| 49183-7 | Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49183-7.json |
| 49184-5 | Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49184-5.json |
| 49185-2 | Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49185-2.json |
| 49186-0 | Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49186-0.json |
| 49187-8 | Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49187-8.json |
| 49188-6 | Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/49188-6.json |
| 49189-4 | Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49189-4.json |
| 49190-2 | Coccidioides sp Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/49190-2.json |
| 49191-0 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/49191-0.json |
| 49192-8 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/49192-8.json |
| 49193-6 | California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49193-6.json |
| 49194-4 | California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49194-4.json |
| 49195-1 | California encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49195-1.json |
| 49196-9 | Brucella abortus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49196-9.json |
| 49197-7 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49197-7.json |
| 49198-5 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49198-5.json |
| 49199-3 | Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49199-3.json |
| 49200-9 | Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49200-9.json |
| 49201-7 | Bartonella quintana IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49201-7.json |
| 49202-5 | Bartonella quintana IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49202-5.json |
| 49203-3 | Bartonella henselae IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49203-3.json |
| 49204-1 | Bartonella henselae IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49204-1.json |
| 49205-8 | Bartonella elizabethae IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49205-8.json |
| 49206-6 | Bartonella elizabethae IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49206-6.json |
| 49207-4 | Bartonella elizabethae IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49207-4.json |
| 49208-2 | Bartonella elizabethae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49208-2.json |
| 49209-0 | Bartonella bacilliformis IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49209-0.json |
| 49210-8 | Bartonella bacilliformis IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49210-8.json |
| 49211-6 | Bartonella bacilliformis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49211-6.json |
| 49212-4 | Bartonella bacilliformis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49212-4.json |
| 49213-2 | Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49213-2.json |
| 49214-0 | Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/49214-0.json |
| 49215-7 | PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49215-7.json |
| 49216-5 | Hexokinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49216-5.json |
| 49217-3 | 2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49217-3.json |
| 49218-1 | Phosphatidylinositol/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49218-1.json |
| 49219-9 | Galactose [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49219-9.json |
| 49220-7 | Prolactin [Mass/volume] in Serum or Plasma by 3rd IS | ./2.16.840.1.114222.4.11.1002/49220-7.json |
| 49221-5 | Catalase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49221-5.json |
| 49223-1 | Colony count [#/volume] in Specimen by Visual count | ./2.16.840.1.114222.4.11.1002/49223-1.json |
| 49224-9 | Leukocytes [#/area] in Semen by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/49224-9.json |
| 49225-6 | Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49225-6.json |
| 49226-4 | lamiVUDine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49226-4.json |
| 49227-2 | Stavudine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49227-2.json |
| 49228-0 | Porphobilinogen deaminase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49228-0.json |
| 49229-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid | ./2.16.840.1.114222.4.11.1002/49229-8.json |
| 49230-6 | Acetylcholinesterase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49230-6.json |
| 49231-4 | Cholinesterase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49231-4.json |
| 49232-2 | Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Rapid, less than 30 minutes | ./2.16.840.1.114222.4.11.1002/49232-2.json |
| 49233-0 | Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes | ./2.16.840.1.114222.4.11.1002/49233-0.json |
| 49255-3 | Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy | ./2.16.840.1.114222.4.11.1002/49255-3.json |
| 49275-1 | Immunofixation for Serum or Plasma Narrative | ./2.16.840.1.114222.4.11.1002/49275-1.json |
| 49328-8 | Clavulanate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49328-8.json |
| 49329-6 | Interferon alpha Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/49329-6.json |
| 49333-8 | Galactitol [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49333-8.json |
| 49334-6 | Adenovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49334-6.json |
| 49335-3 | Adenovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49335-3.json |
| 49336-1 | Adenovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49336-1.json |
| 49337-9 | Adenovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49337-9.json |
| 49338-7 | Adenovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49338-7.json |
| 49339-5 | Adenovirus DNA [#/volume] (viral load) in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49339-5.json |
| 49340-3 | Adenovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49340-3.json |
| 49341-1 | Adenovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49341-1.json |
| 49342-9 | BK virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49342-9.json |
| 49343-7 | BK virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49343-7.json |
| 49344-5 | BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49344-5.json |
| 49345-2 | BK virus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49345-2.json |
| 49346-0 | BK virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49346-0.json |
| 49347-8 | Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49347-8.json |
| 49348-6 | Cytomegalovirus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49348-6.json |
| 49349-4 | Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49349-4.json |
| 49350-2 | Cytomegalovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49350-2.json |
| 49351-0 | Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49351-0.json |
| 49352-8 | Epstein Barr virus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49352-8.json |
| 49353-6 | Epstein Barr virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49353-6.json |
| 49354-4 | Epstein Barr virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49354-4.json |
| 49355-1 | Epstein Barr virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49355-1.json |
| 49356-9 | Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49356-9.json |
| 49357-7 | Hepatitis B virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49357-7.json |
| 49358-5 | Hepatitis B virus DNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49358-5.json |
| 49359-3 | Hepatitis B virus DNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49359-3.json |
| 49360-1 | Hepatitis B virus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49360-1.json |
| 49361-9 | Hepatitis B virus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49361-9.json |
| 49362-7 | Hepatitis B virus DNA [#/volume] (viral load) in Specimen by NAA withprobe detection | ./2.16.840.1.114222.4.11.1002/49362-7.json |
| 49363-5 | Hepatitis B virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49363-5.json |
| 49364-3 | Hepatitis B virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49364-3.json |
| 49365-0 | Hepatitis B virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49365-0.json |
| 49366-8 | Hepatitis B virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49366-8.json |
| 49367-6 | Hepatitis B virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49367-6.json |
| 49368-4 | Hepatitis B virus DNA [Units/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49368-4.json |
| 49369-2 | Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49369-2.json |
| 49370-0 | Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49370-0.json |
| 49371-8 | Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49371-8.json |
| 49372-6 | Hepatitis C virus RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49372-6.json |
| 49373-4 | Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49373-4.json |
| 49374-2 | Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49374-2.json |
| 49375-9 | Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49375-9.json |
| 49376-7 | Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49376-7.json |
| 49377-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49377-5.json |
| 49378-3 | Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49378-3.json |
| 49379-1 | Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49379-1.json |
| 49380-9 | Hepatitis C virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49380-9.json |
| 49381-7 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49381-7.json |
| 49382-5 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49382-5.json |
| 49383-3 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49383-3.json |
| 49384-1 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49384-1.json |
| 49385-8 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49385-8.json |
| 49386-6 | Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49386-6.json |
| 49387-4 | Herpes virus 6 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49387-4.json |
| 49388-2 | Herpes virus 6 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49388-2.json |
| 49389-0 | Herpes virus 6 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49389-0.json |
| 49390-8 | Herpes virus 6 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49390-8.json |
| 49391-6 | Herpes virus 6 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49391-6.json |
| 49392-4 | Herpes virus 6 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49392-4.json |
| 49393-2 | Herpes virus 6 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49393-2.json |
| 49394-0 | Herpes virus 7 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49394-0.json |
| 49395-7 | Herpes virus 7 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49395-7.json |
| 49396-5 | Herpes virus 7 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49396-5.json |
| 49397-3 | Herpes virus 7 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49397-3.json |
| 49398-1 | Herpes virus 7 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49398-1.json |
| 49399-9 | Herpes virus 7 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49399-9.json |
| 49400-5 | Herpes virus 7 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49400-5.json |
| 49401-3 | Herpes virus 7 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49401-3.json |
| 49402-1 | Herpes virus 8 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49402-1.json |
| 49403-9 | Herpes virus 8 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49403-9.json |
| 49404-7 | Herpes virus 8 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49404-7.json |
| 49405-4 | Herpes virus 8 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49405-4.json |
| 49406-2 | Herpes virus 8 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49406-2.json |
| 49407-0 | Herpes virus 8 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49407-0.json |
| 49408-8 | Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49408-8.json |
| 49409-6 | Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49409-6.json |
| 49410-4 | JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49410-4.json |
| 49411-2 | JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49411-2.json |
| 49412-0 | JC virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49412-0.json |
| 49413-8 | JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49413-8.json |
| 49414-6 | JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49414-6.json |
| 49415-3 | JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49415-3.json |
| 49416-1 | JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49416-1.json |
| 49417-9 | JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49417-9.json |
| 49418-7 | Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49418-7.json |
| 49419-5 | Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49419-5.json |
| 49420-3 | Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49420-3.json |
| 49421-1 | Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49421-1.json |
| 49422-9 | Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49422-9.json |
| 49423-7 | Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49423-7.json |
| 49424-5 | Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49424-5.json |
| 49425-2 | Papova virus SV 40 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49425-2.json |
| 49426-0 | Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49426-0.json |
| 49427-8 | Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49427-8.json |
| 49428-6 | Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49428-6.json |
| 49429-4 | Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49429-4.json |
| 49430-2 | Parvovirus B19 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49430-2.json |
| 49431-0 | Parvovirus B19 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49431-0.json |
| 49432-8 | Parvovirus B19 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49432-8.json |
| 49433-6 | Parvovirus B19 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49433-6.json |
| 49434-4 | Parvovirus B19 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49434-4.json |
| 49435-1 | Parvovirus B19 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49435-1.json |
| 49436-9 | Pneumocystis jiroveci DNA [#/volume] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49436-9.json |
| 49437-7 | Pneumocystis jiroveci DNA [#/volume] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49437-7.json |
| 49438-5 | Pneumocystis jiroveci DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49438-5.json |
| 49439-3 | Pneumocystis jiroveci DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49439-3.json |
| 49440-1 | Pneumocystis jiroveci DNA [#/volume] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49440-1.json |
| 49441-9 | Pneumocystis jiroveci DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49441-9.json |
| 49442-7 | Pneumocystis jiroveci DNA [#/volume] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49442-7.json |
| 49443-5 | Toxoplasma gondii DNA [#/volume] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49443-5.json |
| 49444-3 | Toxoplasma gondii DNA [#/volume] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49444-3.json |
| 49445-0 | Toxoplasma gondii DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49445-0.json |
| 49446-8 | Toxoplasma gondii DNA [#/volume] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49446-8.json |
| 49447-6 | Toxoplasma gondii DNA [#/volume] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49447-6.json |
| 49448-4 | Toxoplasma gondii DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49448-4.json |
| 49449-2 | Toxoplasma gondii DNA [#/volume] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49449-2.json |
| 49450-0 | Varicella zoster virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49450-0.json |
| 49451-8 | Varicella zoster virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49451-8.json |
| 49452-6 | Varicella zoster virus DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49452-6.json |
| 49453-4 | Varicella zoster virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49453-4.json |
| 49454-2 | Varicella zoster virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49454-2.json |
| 49455-9 | Varicella zoster virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49455-9.json |
| 49456-7 | Alpha synuclein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49456-7.json |
| 49457-5 | Androgen receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49457-5.json |
| 49458-3 | Annexin 1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49458-3.json |
| 49459-1 | Alzheimer precursor protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49459-1.json |
| 49460-9 | Beta catenin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49460-9.json |
| 49461-7 | C4d Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49461-7.json |
| 49462-5 | Calponin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49462-5.json |
| 49463-3 | CD1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49463-3.json |
| 49464-1 | CD13 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49464-1.json |
| 49465-8 | CD14 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49465-8.json |
| 49466-6 | CD2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49466-6.json |
| 49467-4 | CD22 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49467-4.json |
| 49468-2 | CD27 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49468-2.json |
| 49469-0 | CD33 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49469-0.json |
| 49470-8 | CD35 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49470-8.json |
| 49471-6 | IgG subclass 4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49471-6.json |
| 49472-4 | Mammaglobin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49472-4.json |
| 49473-2 | CD123 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49473-2.json |
| 49474-0 | CD163 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49474-0.json |
| 49475-7 | CD41-Bf Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49475-7.json |
| 49476-5 | Cyclooxygenase 2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49476-5.json |
| 49477-3 | CXCL13 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49477-3.json |
| 49478-1 | CXCR5 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49478-1.json |
| 49479-9 | FOXP3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49479-9.json |
| 49480-7 | Herpes virus 8 latent nuclear Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49480-7.json |
| 49481-5 | TCL-1A Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49481-5.json |
| 49482-3 | Vascular endothelial growth factor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49482-3.json |
| 49484-9 | Phenylalanine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/49484-9.json |
| 49486-4 | Alphapinene [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/49486-4.json |
| 49487-2 | Nateglinide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49487-2.json |
| 49491-4 | BCR-ABL1 b3a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49491-4.json |
| 49497-1 | Platelets [#/volume] in Blood by Estimate | ./2.16.840.1.114222.4.11.1002/49497-1.json |
| 49502-8 | Glucose-6-Phosphate dehydrogenase [Entitic Catalytic Activity] in Blood | ./2.16.840.1.114222.4.11.1002/49502-8.json |
| 49503-6 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49503-6.json |
| 49504-4 | CMT demyelinating gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49504-4.json |
| 49506-9 | MYOC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49506-9.json |
| 49507-7 | MR Unspecified body region W contrast IV | ./2.16.840.1.114222.4.11.1002/49507-7.json |
| 49509-3 | MG Breast duct - right Single view W contrast intra duct | ./2.16.840.1.114222.4.11.1002/49509-3.json |
| 49510-1 | MG Breast duct - left Single view W contrast intra duct | ./2.16.840.1.114222.4.11.1002/49510-1.json |
| 49511-9 | RFA Femoral artery Runoff WO and W contrast IA | ./2.16.840.1.114222.4.11.1002/49511-9.json |
| 49512-7 | RF Unspecified body region Views | ./2.16.840.1.114222.4.11.1002/49512-7.json |
| 49513-5 | Fetal Abdomen Narrative Study observation, multiple fetuses US | ./2.16.840.1.114222.4.11.1002/49513-5.json |
| 49514-3 | Acetaldehyde [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/49514-3.json |
| 49515-0 | Bisacodyl [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/49515-0.json |
| 49516-8 | Topiramate [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/49516-8.json |
| 49517-6 | Topiramate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/49517-6.json |
| 49518-4 | Influenza virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49518-4.json |
| 49519-2 | Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/49519-2.json |
| 49520-0 | Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49520-0.json |
| 49521-8 | Influenza virus A H1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49521-8.json |
| 49522-6 | Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49522-6.json |
| 49523-4 | Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49523-4.json |
| 49524-2 | Influenza virus A H3 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49524-2.json |
| 49525-9 | Influenza virus A H5 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49525-9.json |
| 49526-7 | Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49526-7.json |
| 49527-5 | Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49527-5.json |
| 49528-3 | Influenza virus A H9 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49528-3.json |
| 49529-1 | Influenza virus A Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49529-1.json |
| 49531-7 | Influenza virus A RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49531-7.json |
| 49532-5 | Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/49532-5.json |
| 49533-3 | Influenza virus B Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49533-3.json |
| 49534-1 | Influenza virus B Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49534-1.json |
| 49535-8 | Influenza virus B RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49535-8.json |
| 49536-6 | Influenza virus B RNA [Identifier] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/49536-6.json |
| 49537-4 | Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49537-4.json |
| 49538-2 | Influenza virus identified in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/49538-2.json |
| 49539-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49539-0.json |
| 49545-7 | JC virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49545-7.json |
| 49547-3 | JC virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49547-3.json |
| 49550-7 | CD59 Deficient leukocytes/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/49550-7.json |
| 49551-5 | Creatine kinase.MB [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/49551-5.json |
| 49552-3 | Epinephrine+Norepinephrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49552-3.json |
| 49553-1 | Kappa light chains.free/Lambda light chains.free [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49553-1.json |
| 49554-9 | Beta F1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49554-9.json |
| 49555-6 | HLA-A+B+C (class I) Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49555-6.json |
| 49556-4 | p16INK4a Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49556-4.json |
| 49557-2 | PDGFR-beta Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49557-2.json |
| 49558-0 | TAU 3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49558-0.json |
| 49559-8 | TAU 4 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/49559-8.json |
| 49562-2 | Holoprosencephaly gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49562-2.json |
| 49563-0 | Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL | ./2.16.840.1.114222.4.11.1002/49563-0.json |
| 49565-5 | MRA Thoracic spine vessels | ./2.16.840.1.114222.4.11.1002/49565-5.json |
| 49566-3 | SPECT Heart at rest and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/49566-3.json |
| 49567-1 | SPECT Heart perfusion W adenosine and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/49567-1.json |
| 49568-9 | SPECT Heart perfusion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/49568-9.json |
| 49569-7 | SPECT Heart perfusion and wall motion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/49569-7.json |
| 49570-5 | XR Ankle - bilateral GE 6 Views | ./2.16.840.1.114222.4.11.1002/49570-5.json |
| 49571-3 | NM Unspecified body region Limited Views W I-131 MIBG IV | ./2.16.840.1.114222.4.11.1002/49571-3.json |
| 49573-9 | HIV genotype [Susceptibility] in Isolate by Genotype method Narrative | ./2.16.840.1.114222.4.11.1002/49573-9.json |
| 49574-7 | Phosphatidylinositol+Phosphatidylserine/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49574-7.json |
| 49575-4 | Sphingomyelin/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49575-4.json |
| 49576-2 | Phosphatidylethanolamine/Surfactants.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49576-2.json |
| 49577-0 | Lecithin/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49577-0.json |
| 49579-6 | Aminocaproate [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49579-6.json |
| 49580-4 | HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/49580-4.json |
| 49587-9 | Protein.abnormal band [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49587-9.json |
| 49592-9 | Satratoxin IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49592-9.json |
| 49593-7 | Trichothecene IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49593-7.json |
| 49594-5 | Trichothecene IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49594-5.json |
| 49595-2 | Trichothecene IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49595-2.json |
| 49596-0 | Uroporphyrinogen decarboxylase [Units/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/49596-0.json |
| 49597-8 | Trichothecene IgE Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49597-8.json |
| 49598-6 | Natalizumab Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49598-6.json |
| 49600-0 | Hepatitis B virus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49600-0.json |
| 49601-8 | Hepatitis B virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49601-8.json |
| 49602-6 | Hepatitis B virus DNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49602-6.json |
| 49603-4 | Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49603-4.json |
| 49604-2 | Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49604-2.json |
| 49605-9 | Hepatitis C virus RNA [log units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49605-9.json |
| 49606-7 | Hepatitis B virus DNA [log units/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49606-7.json |
| 49607-5 | Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49607-5.json |
| 49608-3 | Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49608-3.json |
| 49609-1 | Vibrio sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49609-1.json |
| 49610-9 | Streptococcus pyogenes DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49610-9.json |
| 49612-5 | Salmonella sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49612-5.json |
| 49614-1 | Campylobacter sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49614-1.json |
| 49615-8 | Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49615-8.json |
| 49616-6 | Legionella sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49616-6.json |
| 49617-4 | Carbapenem resistance blaKPC gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/49617-4.json |
| 49618-2 | Atazanavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49618-2.json |
| 49619-0 | Indinavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49619-0.json |
| 49620-8 | lamiVUDine or Emtricitabine [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49620-8.json |
| 49621-6 | Saquinavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49621-6.json |
| 49622-4 | Tipranavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49622-4.json |
| 49623-2 | Amprenavir or Fosamprenavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49623-2.json |
| 49624-0 | Cholesterol in VLDL 1+2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49624-0.json |
| 49626-5 | Muscle sarcolemma Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49626-5.json |
| 49627-3 | Muscle sarcolemma Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49627-3.json |
| 49628-1 | Remnant lipoprotein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49628-1.json |
| 49629-9 | Citrulline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/49629-9.json |
| 49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/49630-7.json |
| 49631-5 | ATN1 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49631-5.json |
| 49632-3 | ATN1 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49632-3.json |
| 49633-1 | Ethanolamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/49633-1.json |
| 49634-9 | FXN gene allele 1.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49634-9.json |
| 49635-6 | FXN gene allele 2.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49635-6.json |
| 49636-4 | Ganglioside GM1 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/49636-4.json |
| 49637-2 | HTT gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49637-2.json |
| 49638-0 | HTT gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49638-0.json |
| 49639-8 | Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/49639-8.json |
| 49640-6 | Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/49640-6.json |
| 49641-4 | SCA1 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49641-4.json |
| 49642-2 | SCA1 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49642-2.json |
| 49643-0 | SCA10 gene allele 1.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49643-0.json |
| 49644-8 | SCA10 gene allele 2.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49644-8.json |
| 49645-5 | SCA2 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49645-5.json |
| 49646-3 | SCA2 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49646-3.json |
| 49647-1 | MJD gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49647-1.json |
| 49648-9 | MJD gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49648-9.json |
| 49649-7 | CACNA1A gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49649-7.json |
| 49650-5 | CACNA1A gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49650-5.json |
| 49651-3 | SCA7 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49651-3.json |
| 49652-1 | SCA7 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49652-1.json |
| 49653-9 | TPMT gene c.719A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49653-9.json |
| 49654-7 | TPMT gene c.238G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49654-7.json |
| 49655-4 | TPMT gene c.460G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49655-4.json |
| 49666-1 | Darunavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/49666-1.json |
| 49667-9 | Tipranavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/49667-9.json |
| 49668-7 | Atazanavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/49668-7.json |
| 49669-5 | Emtricitabine [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/49669-5.json |
| 49671-1 | Neisseria meningitidis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49671-1.json |
| 49672-9 | Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49672-9.json |
| 49673-7 | Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --7 day post incubation | ./2.16.840.1.114222.4.11.1002/49673-7.json |
| 49674-5 | Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Blood --5 days post incubation | ./2.16.840.1.114222.4.11.1002/49674-5.json |
| 49675-2 | Lymphocyte proliferation stimulated by 10 umol beryllium [Units/volume] in Blood --7 day post incubation | ./2.16.840.1.114222.4.11.1002/49675-2.json |
| 49676-0 | Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --5 days post incubation | ./2.16.840.1.114222.4.11.1002/49676-0.json |
| 49677-8 | Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --7 day post incubation | ./2.16.840.1.114222.4.11.1002/49677-8.json |
| 49678-6 | CPT2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49678-6.json |
| 49679-4 | CD36 cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/49679-4.json |
| 49680-2 | CD36 cells/100 cells in Tissue | ./2.16.840.1.114222.4.11.1002/49680-2.json |
| 49681-0 | CD36 cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/49681-0.json |
| 49682-8 | Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood --3 days post incubation | ./2.16.840.1.114222.4.11.1002/49682-8.json |
| 49683-6 | ERBB2 gene copy number/Chromosome 17 copy number in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/49683-6.json |
| 49684-4 | CPT2 gene p.Arg503Cys [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49684-4.json |
| 49686-9 | CPT2 gene p.Arg631Cys [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49686-9.json |
| 49687-7 | Trichoderma viride IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49687-7.json |
| 49690-1 | Mirtazapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49690-1.json |
| 49691-9 | Nortrimipramine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49691-9.json |
| 49692-7 | Striated muscle IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49692-7.json |
| 49693-5 | Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49693-5.json |
| 49694-3 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/49694-3.json |
| 49695-0 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous cord blood | ./2.16.840.1.114222.4.11.1002/49695-0.json |
| 49696-8 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/49696-8.json |
| 49697-6 | Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous cord blood | ./2.16.840.1.114222.4.11.1002/49697-6.json |
| 49698-4 | pH of Arterial cord blood adjusted to patient's actual temperature | ./2.16.840.1.114222.4.11.1002/49698-4.json |
| 49699-2 | pH of Venous cord blood adjusted to patient's actual temperature | ./2.16.840.1.114222.4.11.1002/49699-2.json |
| 49700-8 | Metanephrine Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49700-8.json |
| 49701-6 | pH of Blood adjusted to patient's actual temperature | ./2.16.840.1.114222.4.11.1002/49701-6.json |
| 49702-4 | Nateglinide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49702-4.json |
| 49704-0 | SH3TC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49704-0.json |
| 49705-7 | LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49705-7.json |
| 49706-5 | ARSA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49706-5.json |
| 49707-3 | KCNQ2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/49707-3.json |
| 49708-1 | TTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49708-1.json |
| 49709-9 | predniSONE [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49709-9.json |
| 49710-7 | SOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49710-7.json |
| 49711-5 | Listeria sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/49711-5.json |
| 49712-3 | Coccidioides sp Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/49712-3.json |
| 49713-1 | Parainfluenza virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/49713-1.json |
| 49714-9 | Interleukin 8 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/49714-9.json |
| 49715-6 | Housefly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49715-6.json |
| 49716-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/49716-4.json |
| 49717-2 | Interleukin 1 beta [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/49717-2.json |
| 49718-0 | HIV 1 p24 Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49718-0.json |
| 49719-8 | Kentucky blue grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49719-8.json |
| 49720-6 | Meadow Fescue IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49720-6.json |
| 49723-0 | Tea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49723-0.json |
| 49724-8 | Aldolase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/49724-8.json |
| 49725-5 | Melatonin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49725-5.json |
| 49726-3 | Endomysium IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/49726-3.json |
| 49727-1 | Homocysteine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49727-1.json |
| 49728-9 | Neurokinin A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49728-9.json |
| 49729-7 | Penicillin G IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49729-7.json |
| 49730-5 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/49730-5.json |
| 49731-3 | Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49731-3.json |
| 49732-1 | Interleukin 6 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/49732-1.json |
| 49733-9 | Interleukin 10 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/49733-9.json |
| 49734-7 | 11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49734-7.json |
| 49735-4 | FBN1 gene targeted mutation analysis in Blood or Tissue by Molecular geneticsmethod | ./2.16.840.1.114222.4.11.1002/49735-4.json |
| 49736-2 | Clarity of Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49736-2.json |
| 49738-8 | Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49738-8.json |
| 49739-6 | Honey bee IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49739-6.json |
| 49740-4 | Yellow Hornet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49740-4.json |
| 49741-2 | Plasmodium malariae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49741-2.json |
| 49742-0 | Plasmodium vivax IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49742-0.json |
| 49743-8 | Plasmodium falciparum IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49743-8.json |
| 49744-6 | Plasmodium ovale IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49744-6.json |
| 49745-3 | Whitefaced Hornet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49745-3.json |
| 49746-1 | Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/49746-1.json |
| 49747-9 | Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/49747-9.json |
| 49748-7 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49748-7.json |
| 49749-5 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49749-5.json |
| 49750-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49750-3.json |
| 49751-1 | Norbuprenorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/49751-1.json |
| 49752-9 | Buprenorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/49752-9.json |
| 49753-7 | Norbuprenorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49753-7.json |
| 49756-0 | Norethindrone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49756-0.json |
| 49757-8 | Minocycline [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/49757-8.json |
| 49758-6 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL | ./2.16.840.1.114222.4.11.1002/49758-6.json |
| 49759-4 | Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49759-4.json |
| 49760-2 | Adenosine deaminase [Enzymatic activity/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/49760-2.json |
| 49761-0 | Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49761-0.json |
| 49762-8 | Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/49762-8.json |
| 49763-6 | Bilirubin.total [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/49763-6.json |
| 49764-4 | Calcium [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49764-4.json |
| 49765-1 | Calcium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/49765-1.json |
| 49766-9 | Chymotrypsin [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/49766-9.json |
| 49767-7 | Filaria IgG2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49767-7.json |
| 49768-5 | Filaria IgG3 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49768-5.json |
| 49769-3 | Filaria IgG4 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49769-3.json |
| 49770-1 | Filaria IgG1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49770-1.json |
| 49771-9 | Onchocerca sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49771-9.json |
| 49772-7 | Fructose [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49772-7.json |
| 49773-5 | Galactitol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49773-5.json |
| 49774-3 | Glomerular basement membrane Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49774-3.json |
| 49775-0 | Hepatitis D virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49775-0.json |
| 49776-8 | Hepatitis E virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49776-8.json |
| 49777-6 | Hepatitis G virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49777-6.json |
| 49778-4 | Immune complex [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49778-4.json |
| 49779-2 | Ketones [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49779-2.json |
| 49780-0 | Leishmania sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49780-0.json |
| 49781-8 | Mitochondria M2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49781-8.json |
| 49782-6 | Mononuclear cells/100 leukocytes in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/49782-6.json |
| 49783-4 | Onchocerca sp IgG4 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49783-4.json |
| 49784-2 | Onchocerca sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49784-2.json |
| 49785-9 | Onchocerca sp IgG2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49785-9.json |
| 49786-7 | Onchocerca sp IgG3 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/49786-7.json |
| 49787-5 | Polymorphonuclear cells/100 leukocytes in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/49787-5.json |
| 49788-3 | Potassium [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49788-3.json |
| 49789-1 | Potassium [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49789-1.json |
| 49790-9 | Sodium [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49790-9.json |
| 49791-7 | Sodium [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49791-7.json |
| 49792-5 | Somatostatin [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/49792-5.json |
| 49794-1 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49794-1.json |
| 49795-8 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49795-8.json |
| 49796-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49796-6.json |
| 49797-4 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49797-4.json |
| 49798-2 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/49798-2.json |
| 49799-0 | Treponema pallidum DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49799-0.json |
| 49800-6 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Hemagglutination | ./2.16.840.1.114222.4.11.1002/49800-6.json |
| 49801-4 | Trypanosoma cruzi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49801-4.json |
| 49802-2 | Urea [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49802-2.json |
| 49825-3 | 16-Alpha hydroxyestrone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49825-3.json |
| 49826-1 | 2-Hydroxyestrone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49826-1.json |
| 49829-5 | Norcodeine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49829-5.json |
| 49830-3 | Norcodeine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49830-3.json |
| 49831-1 | Normorphine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/49831-1.json |
| 49834-5 | Leucine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/49834-5.json |
| 49835-2 | CD19+IgD+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/49835-2.json |
| 49837-8 | Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49837-8.json |
| 49839-4 | Eosinophils [Presence] in Urine sediment by Wright stain | ./2.16.840.1.114222.4.11.1002/49839-4.json |
| 49840-2 | CD19+IgG+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/49840-2.json |
| 49841-0 | CD19+IgM+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/49841-0.json |
| 49842-8 | CD19+IgA+ cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/49842-8.json |
| 49843-6 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma | ./2.16.840.1.114222.4.11.1002/49843-6.json |
| 49844-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma | ./2.16.840.1.114222.4.11.1002/49844-4.json |
| 49846-9 | Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor | ./2.16.840.1.114222.4.11.1002/49846-9.json |
| 49847-7 | Enterovirus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49847-7.json |
| 49848-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/49848-5.json |
| 49849-3 | Hydroxylysine.free/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49849-3.json |
| 49850-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline | ./2.16.840.1.114222.4.11.1002/49850-1.json |
| 49851-9 | Cholinesterase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/49851-9.json |
| 49853-5 | Transforming growth factor beta 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49853-5.json |
| 49854-3 | COL5A1 gene+COL5A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49854-3.json |
| 49855-0 | Tetracycline IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49855-0.json |
| 49856-8 | Methyltestosterone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49856-8.json |
| 49857-6 | SMN1 gene+SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49857-6.json |
| 49858-4 | Peptide YY [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49858-4.json |
| 49859-2 | Amphotericin B [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/49859-2.json |
| 49860-0 | Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/49860-0.json |
| 49861-8 | Toxocara canis Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/49861-8.json |
| 49862-6 | G6PC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49862-6.json |
| 49863-4 | Aspergillus sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49863-4.json |
| 49864-2 | Procaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49864-2.json |
| 49865-9 | Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/49865-9.json |
| 49866-7 | Neuropeptide Y [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49866-7.json |
| 49867-5 | Endothelin I [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49867-5.json |
| 49868-3 | Ibuprofen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49868-3.json |
| 49869-1 | Camel dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49869-1.json |
| 49870-9 | Coagulation factor VII Ag actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/49870-9.json |
| 49871-7 | Codeine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49871-7.json |
| 49872-5 | FH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49872-5.json |
| 49873-3 | POU3F4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49873-3.json |
| 49874-1 | ABCB4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/49874-1.json |
| 49875-8 | California juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/49875-8.json |
| 49876-6 | Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/49876-6.json |
| 49877-4 | Hepatitis B virus codon 173 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49877-4.json |
| 49878-2 | Hepatitis B virus codon 180 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49878-2.json |
| 49879-0 | Hepatitis B virus codon 181 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49879-0.json |
| 49880-8 | Hepatitis B virus codon 204 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49880-8.json |
| 49881-6 | Hepatitis B virus codon 236 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49881-6.json |
| 49882-4 | Hepatitis B virus codon 80 [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/49882-4.json |
| 49884-0 | Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation | ./2.16.840.1.114222.4.11.1002/49884-0.json |
| 49890-7 | HIV 1 RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49890-7.json |
| 49891-5 | Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49891-5.json |
| 49896-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49896-4.json |
| 49899-8 | Setomelanomma rostrata IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/49899-8.json |
| 49900-4 | Heptacarboxylporphyrin I [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/49900-4.json |
| 49901-2 | Heptacarboxylporphyrin III [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/49901-2.json |
| 49902-0 | Hexanoylglycine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49902-0.json |
| 49903-8 | Hippurate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49903-8.json |
| 49904-6 | Histoplasma capsulatum M Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49904-6.json |
| 49905-3 | HIV 1 Ab [Presence] in Specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/49905-3.json |
| 49906-1 | Hydroxydecanedioate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49906-1.json |
| 49907-9 | IgA Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/49907-9.json |
| 4990-8 | Blastomyces dermatitidis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/4990-8.json |
| 49909-5 | Interleukin 10 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49909-5.json |
| 49910-3 | Isocitrate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49910-3.json |
| 49911-1 | Isovalerylglycine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/49911-1.json |
| 49912-9 | Japanese encephalitis virus Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49912-9.json |
| 49913-7 | Legionella pneumophila IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49913-7.json |
| 49914-5 | Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49914-5.json |
| 49915-2 | Legionella sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49915-2.json |
| 4991-6 | Borrelia burgdorferi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/4991-6.json |
| 49916-0 | Sweet gum IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/49916-0.json |
| 49917-8 | Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Leukocytes --6 days post incubation | ./2.16.840.1.114222.4.11.1002/49917-8.json |
| 49918-6 | Heptacarboxylporphyrin II [Mass/time] in unspecified time Stool | ./2.16.840.1.114222.4.11.1002/49918-6.json |
| 49919-4 | Interleukin 6 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49919-4.json |
| 49920-2 | Isopropyl ether [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49920-2.json |
| 49921-0 | Lymphocyte proliferation stimulated by concanavalin A in Blood | ./2.16.840.1.114222.4.11.1002/49921-0.json |
| 49922-8 | Lymphocyte proliferation stimulated by phytohemagglutinin in Blood | ./2.16.840.1.114222.4.11.1002/49922-8.json |
| 49923-6 | Lymphocyte proliferation stimulated by pokeweed mitogen in Blood | ./2.16.840.1.114222.4.11.1002/49923-6.json |
| 4992-4 | Campylobacter sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/4992-4.json |
| 49924-4 | Alkaline phosphatase.macro/Alkaline phosphatase.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/49924-4.json |
| 49925-1 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by Glock and McLean | ./2.16.840.1.114222.4.11.1002/49925-1.json |
| 49926-9 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by WHO method | ./2.16.840.1.114222.4.11.1002/49926-9.json |
| 49928-5 | Leukocytes [#/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/49928-5.json |
| 49931-9 | 3-Hydroxysebacate (3-OH-C8) unsaturated/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49931-9.json |
| 4993-2 | Chlamydia trachomatis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/4993-2.json |
| 49932-7 | 3-Hydroxysuberate.unsaturated/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49932-7.json |
| 49933-5 | Adipate.unsaturated/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49933-5.json |
| 49934-3 | Adipolactone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49934-3.json |
| 49938-4 | Citrate synthase [Enzymatic activity/mass] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/49938-4.json |
| 49939-2 | Dodecenedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49939-2.json |
| 4994-0 | Coccidioides immitis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/4994-0.json |
| 49940-0 | Glutamate dehydrogenase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/49940-0.json |
| 49941-8 | Sepiapterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/49941-8.json |
| 49942-6 | Somatotropin [Units/volume] in Serum or Plasma --1 AM specimen | ./2.16.840.1.114222.4.11.1002/49942-6.json |
| 49943-4 | Somatotropin [Units/volume] in Serum or Plasma --1:30 am specimen | ./2.16.840.1.114222.4.11.1002/49943-4.json |
| 49944-2 | Somatotropin [Units/volume] in Serum or Plasma --10 PM specimen | ./2.16.840.1.114222.4.11.1002/49944-2.json |
| 49945-9 | Somatotropin [Units/volume] in Serum or Plasma --10:30 PM specimen | ./2.16.840.1.114222.4.11.1002/49945-9.json |
| 49946-7 | Somatotropin [Units/volume] in Serum or Plasma --11 PM specimen | ./2.16.840.1.114222.4.11.1002/49946-7.json |
| 49947-5 | Somatotropin [Units/volume] in Serum or Plasma --11:30 PM specimen | ./2.16.840.1.114222.4.11.1002/49947-5.json |
| 49948-3 | Somatotropin [Units/volume] in Serum or Plasma --12 PM specimen | ./2.16.840.1.114222.4.11.1002/49948-3.json |
| 49949-1 | Somatotropin [Units/volume] in Serum or Plasma --12:30 PM specimen | ./2.16.840.1.114222.4.11.1002/49949-1.json |
| 49950-9 | Somatotropin [Units/volume] in Serum or Plasma --2 AM specimen | ./2.16.840.1.114222.4.11.1002/49950-9.json |
| 49951-7 | Somatotropin [Units/volume] in Serum or Plasma --2:30 am specimen | ./2.16.840.1.114222.4.11.1002/49951-7.json |
| 49952-5 | Somatotropin [Units/volume] in Serum or Plasma --3 AM specimen | ./2.16.840.1.114222.4.11.1002/49952-5.json |
| 49953-3 | Somatotropin [Units/volume] in Serum or Plasma --3:30 AM specimen | ./2.16.840.1.114222.4.11.1002/49953-3.json |
| 49954-1 | Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen | ./2.16.840.1.114222.4.11.1002/49954-1.json |
| 49955-8 | Somatotropin [Units/volume] in Serum or Plasma --4:30 AM specimen | ./2.16.840.1.114222.4.11.1002/49955-8.json |
| 49956-6 | Somatotropin [Units/volume] in Serum or Plasma --5 AM specimen | ./2.16.840.1.114222.4.11.1002/49956-6.json |
| 4995-7 | Cryptococcus neoformans rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/4995-7.json |
| 49957-4 | Somatotropin [Units/volume] in Serum or Plasma --5:30 AM specimen | ./2.16.840.1.114222.4.11.1002/49957-4.json |
| 49958-2 | Somatotropin [Units/volume] in Serum or Plasma --6 AM specimen | ./2.16.840.1.114222.4.11.1002/49958-2.json |
| 49960-8 | Suberate.unsaturated/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/49960-8.json |
| 49961-6 | Urate renal clearance in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/49961-6.json |
| 49963-2 | Fibrillarin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/49963-2.json |
| 4996-5 | Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/4996-5.json |
| 49966-5 | Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/49966-5.json |
| 49967-3 | Charcoal [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/49967-3.json |
| 4997-3 | Cytomegalovirus DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/4997-3.json |
| 4998-1 | Cytomegalovirus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/4998-1.json |
| 49985-5 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49985-5.json |
| 49986-3 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49986-3.json |
| 49987-1 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49987-1.json |
| 49988-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49988-9.json |
| 49989-7 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49989-7.json |
| 49990-5 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/49990-5.json |
| 4999-9 | Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/4999-9.json |
| 5000-5 | Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5000-5.json |
| 50005-8 | Methaqualone [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/50005-8.json |
| 50006-6 | Human antimouse Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/50006-6.json |
| 50007-4 | Cytology report of Bronchoalveolar lavage Cyto stain | ./2.16.840.1.114222.4.11.1002/50007-4.json |
| 50012-4 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method | ./2.16.840.1.114222.4.11.1002/50012-4.json |
| 5001-3 | Enterococcus sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5001-3.json |
| 50014-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50014-0.json |
| 50015-7 | West Nile virus Ag [Presence] in Blood or Marrow from Donor | ./2.16.840.1.114222.4.11.1002/50015-7.json |
| 50017-3 | Hemoglobin.gastrointestinal [Presence] in Sputum or Gastric fluid | ./2.16.840.1.114222.4.11.1002/50017-3.json |
| 50018-1 | Cytomegalovirus IgG Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/50018-1.json |
| 50019-9 | HLA-DP+DQ+DR (class II) [Type] | ./2.16.840.1.114222.4.11.1002/50019-9.json |
| 50020-7 | Microdeletion syndromes in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/50020-7.json |
| 5002-1 | Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5002-1.json |
| 50021-5 | oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/50021-5.json |
| 50022-3 | Ethanol+Methanol+Isopropyl alcohol+Acetone [Presence] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/50022-3.json |
| 50024-9 | Virus identified in Specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/50024-9.json |
| 50026-4 | Food Allergen Mix 30 (Peanut+White bean+Soybean+Lentil+ Peas) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50026-4.json |
| 50027-2 | Narcissus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50027-2.json |
| 50028-0 | Escherichia coli IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50028-0.json |
| 50029-8 | Mahogany wood dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50029-8.json |
| 50030-6 | Oak wood dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50030-6.json |
| 50031-4 | Sulfamethoxazole IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50031-4.json |
| 50032-2 | China aster IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50032-2.json |
| 50033-0 | Cephalosporin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50033-0.json |
| 50034-8 | Arbovirus neutralizing antibody [Identifier] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/50034-8.json |
| 50035-5 | Colorado tick fever virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/50035-5.json |
| 50036-3 | Dengue virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/50036-3.json |
| 50037-1 | Powassan virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/50037-1.json |
| 50038-9 | Snowshoe hare virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/50038-9.json |
| 5003-9 | Epstein Barr virus DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/5003-9.json |
| 50039-7 | 5-Methyltetrahydrofolate/Folate in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50039-7.json |
| 50040-5 | Advanced oxidation protein products [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50040-5.json |
| 50043-9 | Protein carbonyl/Protein [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50043-9.json |
| 50045-4 | Hemicystine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50045-4.json |
| 50046-2 | Hemicystine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50046-2.json |
| 5004-7 | Epstein Barr virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5004-7.json |
| 50047-0 | Hemicystine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50047-0.json |
| 50048-8 | Hemicystine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/50048-8.json |
| 50049-6 | Hemicystine/Amino acids.total in Hair | ./2.16.840.1.114222.4.11.1002/50049-6.json |
| 50050-4 | Hemicystine/Amino acids.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50050-4.json |
| 50051-2 | Hemicystine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50051-2.json |
| 50052-0 | Hemicystine/Amino acids.total in DBS | ./2.16.840.1.114222.4.11.1002/50052-0.json |
| 50053-8 | Hemicystine/Amino acids.total in Specimen | ./2.16.840.1.114222.4.11.1002/50053-8.json |
| 5005-4 | Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5005-4.json |
| 50054-6 | Hemicystine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50054-6.json |
| 50055-3 | Iohexol renal clearance in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50055-3.json |
| 50057-9 | Fractional excretion of phosphate [Ratio] in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/50057-9.json |
| 50058-7 | Phosphate renal clearance in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/50058-7.json |
| 50060-3 | Fatty acids.very long chain C24:0 (Tetracosanoate)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50060-3.json |
| 50061-1 | Tetradecanedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50061-1.json |
| 5006-2 | Haemophilus influenzae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5006-2.json |
| 50062-9 | Tetradecenedioate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50062-9.json |
| 50063-7 | Urea renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/50063-7.json |
| 50065-2 | 1-Methylhistidine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50065-2.json |
| 50066-0 | 1-Methylhistidine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50066-0.json |
| 50067-8 | 11-Hydroxyandrostenedione [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50067-8.json |
| 5007-0 | Hepatitis B virus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5007-0.json |
| 50071-0 | 11-Deoxycortisol [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50071-0.json |
| 50081-9 | 18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50081-9.json |
| 50082-7 | 18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50082-7.json |
| 50083-5 | Alpha aminoadipate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50083-5.json |
| 50084-3 | Alpha aminoadipate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50084-3.json |
| 50085-0 | 2-Methyl-3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50085-0.json |
| 50086-8 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50086-8.json |
| 50087-6 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50087-6.json |
| 5008-8 | Hepatitis B virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5008-8.json |
| 50088-4 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50088-4.json |
| 50089-2 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50089-2.json |
| 50090-0 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50090-0.json |
| 50091-8 | 2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50091-8.json |
| 50092-6 | 2-Methylcitrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50092-6.json |
| 50093-4 | 21-Deoxycortisol [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50093-4.json |
| 5009-6 | Hepatitis B virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5009-6.json |
| 50098-3 | 3-Hydroxyvalerate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50098-3.json |
| 50099-1 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood | ./2.16.840.1.114222.4.11.1002/50099-1.json |
| 50100-7 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50100-7.json |
| 50101-5 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50101-5.json |
| 50102-3 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50102-3.json |
| 50103-1 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50103-1.json |
| 5010-4 | Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5010-4.json |
| 50104-9 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50104-9.json |
| 50105-6 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50105-6.json |
| 50106-4 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50106-4.json |
| 50107-2 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50107-2.json |
| 50108-0 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50108-0.json |
| 50109-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50109-8.json |
| 50110-6 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50110-6.json |
| 50111-4 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50111-4.json |
| 5011-2 | Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5011-2.json |
| 50112-2 | 3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50112-2.json |
| 50113-0 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50113-0.json |
| 50114-8 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50114-8.json |
| 50115-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50115-5.json |
| 50116-3 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50116-3.json |
| 50117-1 | 3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50117-1.json |
| 50118-9 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50118-9.json |
| 50119-7 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50119-7.json |
| 5012-0 | Hepatitis C virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5012-0.json |
| 50120-5 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50120-5.json |
| 50121-3 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50121-3.json |
| 50122-1 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50122-1.json |
| 50123-9 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50123-9.json |
| 50124-7 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50124-7.json |
| 50125-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50125-4.json |
| 50126-2 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50126-2.json |
| 50127-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50127-0.json |
| 50128-8 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50128-8.json |
| 50129-6 | 3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50129-6.json |
| 50130-4 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50130-4.json |
| 50131-2 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50131-2.json |
| 50132-0 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50132-0.json |
| 50133-8 | 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50133-8.json |
| 50134-6 | 3-Hydroxystearoylcarnitine (C18-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50134-6.json |
| 50135-3 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50135-3.json |
| 50136-1 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50136-1.json |
| 50137-9 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in Urine | ./2.16.840.1.114222.4.11.1002/50137-9.json |
| 5013-8 | Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5013-8.json |
| 50138-7 | 3-Methoxy-4-Hydroxyphenylglycol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50138-7.json |
| 50139-5 | 3-Methoxytyramine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50139-5.json |
| 50140-3 | 3-Methoxytyramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50140-3.json |
| 50141-1 | 3-O-Methyldopa [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50141-1.json |
| 50142-9 | 3-O-Methyldopa [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50142-9.json |
| 50143-7 | 3-O-Methyldopa [Moles/time] in Urine | ./2.16.840.1.114222.4.11.1002/50143-7.json |
| 50144-5 | 3-O-Methyldopa/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50144-5.json |
| 50145-2 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50145-2.json |
| 5014-6 | Herpes simplex virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5014-6.json |
| 50146-0 | Gamma aminobutyrate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50146-0.json |
| 50147-8 | Gamma aminobutyrate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50147-8.json |
| 50148-6 | Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50148-6.json |
| 50149-4 | 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50149-4.json |
| 50150-2 | 5-Hydroxytryptophan [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50150-2.json |
| 50151-0 | 5-Hydroxytryptophan [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50151-0.json |
| 50152-8 | 5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50152-8.json |
| 5015-3 | Histoplasma capsulatum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5015-3.json |
| 50153-6 | 5-Methyltetrahydrofolate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50153-6.json |
| 50154-4 | Acetoacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50154-4.json |
| 50155-1 | Acetylcarnitine (C2) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50155-1.json |
| 50156-9 | Acetylcarnitine (C2) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50156-9.json |
| 50157-7 | Acetylcarnitine (C2) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50157-7.json |
| 50158-5 | Acetylcarnitine (C2) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50158-5.json |
| 50159-3 | Acetylcarnitine (C2)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50159-3.json |
| 5016-1 | Histoplasma capsulatum rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5016-1.json |
| 50162-7 | Acylcarnitine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50162-7.json |
| 50163-5 | Acylcarnitine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50163-5.json |
| 50165-0 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Amnioticfluid cells | ./2.16.840.1.114222.4.11.1002/50165-0.json |
| 50166-8 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50166-8.json |
| 50168-4 | Alanine aminotransferase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/50168-4.json |
| 50174-2 | Alloisoleucine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50174-2.json |
| 50175-9 | Alloisoleucine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50175-9.json |
| 50177-5 | Hemicystine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50177-5.json |
| 5017-9 | HIV 1 RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5017-9.json |
| 50185-8 | Magnolia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50185-8.json |
| 50186-6 | Wine vinegar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50186-6.json |
| 5018-7 | HIV 1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5018-7.json |
| 50192-4 | Cholesterol in VLDL 1+2+3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50192-4.json |
| 5019-5 | HTLV I+II RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5019-5.json |
| 50198-1 | Iron [Mass/volume] in Serum or Plasma --1st specimen | ./2.16.840.1.114222.4.11.1002/50198-1.json |
| 50199-9 | Iron [Mass/volume] in Serum or Plasma --2nd specimen | ./2.16.840.1.114222.4.11.1002/50199-9.json |
| 50200-5 | Iron [Mass/volume] in Serum or Plasma --3rd specimen | ./2.16.840.1.114222.4.11.1002/50200-5.json |
| 50201-3 | Iron [Mass/volume] in Serum or Plasma --4th specimen | ./2.16.840.1.114222.4.11.1002/50201-3.json |
| 50202-1 | Iron [Mass/volume] in Serum or Plasma --5th specimen | ./2.16.840.1.114222.4.11.1002/50202-1.json |
| 5020-3 | Legionella sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5020-3.json |
| 50203-9 | Iron [Mass/volume] in Serum or Plasma --6th specimen | ./2.16.840.1.114222.4.11.1002/50203-9.json |
| 50204-7 | Iron [Mass/volume] in Serum or Plasma --7th specimen | ./2.16.840.1.114222.4.11.1002/50204-7.json |
| 50205-4 | Iron [Mass/volume] in Serum or Plasma --8th specimen | ./2.16.840.1.114222.4.11.1002/50205-4.json |
| 50206-2 | Glucose [Mass/volume] in Serum or Plasma --1st specimen | ./2.16.840.1.114222.4.11.1002/50206-2.json |
| 50207-0 | Glucose [Mass/volume] in Serum or Plasma --7th specimen | ./2.16.840.1.114222.4.11.1002/50207-0.json |
| 50208-8 | Glucose [Mass/volume] in Serum or Plasma --10th specimen | ./2.16.840.1.114222.4.11.1002/50208-8.json |
| 50209-6 | Albumin [Mass/time] in Urine collected for unspecified duration --supine | ./2.16.840.1.114222.4.11.1002/50209-6.json |
| 50210-4 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula | ./2.16.840.1.114222.4.11.1002/50210-4.json |
| 5021-1 | Listeria monocytogenes rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5021-1.json |
| 50212-0 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen | ./2.16.840.1.114222.4.11.1002/50212-0.json |
| 50213-8 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen | ./2.16.840.1.114222.4.11.1002/50213-8.json |
| 50214-6 | Glucose [Mass/volume] in Serum or Plasma --4th specimen | ./2.16.840.1.114222.4.11.1002/50214-6.json |
| 50215-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen | ./2.16.840.1.114222.4.11.1002/50215-3.json |
| 50216-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen | ./2.16.840.1.114222.4.11.1002/50216-1.json |
| 50217-9 | Glucose [Mass/volume] in Serum or Plasma --8th specimen | ./2.16.840.1.114222.4.11.1002/50217-9.json |
| 50218-7 | Glucose [Mass/volume] in Serum or Plasma --9th specimen | ./2.16.840.1.114222.4.11.1002/50218-7.json |
| 5022-9 | Mycobacterium avium complex rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5022-9.json |
| 5023-7 | Mycobacterium avium ss avium rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5023-7.json |
| 5024-5 | Mycobacterium gordonae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5024-5.json |
| 50249-2 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | ./2.16.840.1.114222.4.11.1002/50249-2.json |
| 50250-0 | 21-Deoxycortisol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50250-0.json |
| 50251-8 | 3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50251-8.json |
| 5025-2 | Mycobacterium intracellulare rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5025-2.json |
| 50252-6 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50252-6.json |
| 5026-0 | Mycobacterium kansasii rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5026-0.json |
| 50265-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50265-8.json |
| 50266-6 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50266-6.json |
| 50267-4 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50267-4.json |
| 50268-2 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50268-2.json |
| 50269-0 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50269-0.json |
| 50270-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50270-8.json |
| 50271-6 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50271-6.json |
| 50272-4 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50272-4.json |
| 50273-2 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50273-2.json |
| 50274-0 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50274-0.json |
| 50275-7 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50275-7.json |
| 50276-5 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50276-5.json |
| 50277-3 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50277-3.json |
| 5027-8 | Mycobacterium tuberculosis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5027-8.json |
| 50278-1 | 3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50278-1.json |
| 50279-9 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50279-9.json |
| 50280-7 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50280-7.json |
| 50281-5 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50281-5.json |
| 50282-3 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50282-3.json |
| 50284-9 | 3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50284-9.json |
| 50285-6 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50285-6.json |
| 5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5028-6.json |
| 50286-4 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50286-4.json |
| 50287-2 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50287-2.json |
| 50288-0 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50288-0.json |
| 50289-8 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50289-8.json |
| 50290-6 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50290-6.json |
| 50291-4 | 3-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50291-4.json |
| 50292-2 | 4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50292-2.json |
| 50293-0 | 4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50293-0.json |
| 5029-4 | Neisseria meningitidis rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5029-4.json |
| 50294-8 | 4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50294-8.json |
| 50295-5 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50295-5.json |
| 50296-3 | 4-Hydroxyifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50296-3.json |
| 50297-1 | 4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50297-1.json |
| 50298-9 | 4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50298-9.json |
| 50299-7 | 4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/50299-7.json |
| 50300-3 | 6-Hydroxyheptanoate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50300-3.json |
| 50301-1 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50301-1.json |
| 5030-2 | Parvovirus B19 RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5030-2.json |
| 50302-9 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50302-9.json |
| 50303-7 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50303-7.json |
| 50304-5 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/50304-5.json |
| 50305-2 | Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50305-2.json |
| 50306-0 | Allantoine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50306-0.json |
| 50307-8 | BCL10 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50307-8.json |
| 50308-6 | Caldesmon Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50308-6.json |
| 50309-4 | CD138 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50309-4.json |
| 5031-0 | Parvovirus B19 RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5031-0.json |
| 50310-2 | CD7 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50310-2.json |
| 50311-0 | Chlamydia trachomatis DNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50311-0.json |
| 50312-8 | Clusterin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50312-8.json |
| 50313-6 | Cyclospora sp identified in Stool by Safranin stain | ./2.16.840.1.114222.4.11.1002/50313-6.json |
| 50314-4 | Cytokeratin 19 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50314-4.json |
| 50315-1 | Cytokeratin 5 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50315-1.json |
| 50316-9 | Galectin 3 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50316-9.json |
| 50317-7 | CD235a Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50317-7.json |
| 50318-5 | Granzyme B Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50318-5.json |
| 50319-3 | HBME-1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50319-3.json |
| 50320-1 | Helicobacter pylori Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50320-1.json |
| 50321-9 | Hepatocyte Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50321-9.json |
| 50322-7 | MLH-1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50322-7.json |
| 50323-5 | MSH-2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50323-5.json |
| 50324-3 | MSH-6 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50324-3.json |
| 50325-0 | MUM-1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50325-0.json |
| 50326-8 | Neisseria gonorrhoeae DNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50326-8.json |
| 50327-6 | Neu-N Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50327-6.json |
| 5032-8 | Parvovirus B19 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/5032-8.json |
| 50328-4 | PMS-2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50328-4.json |
| 50329-2 | Respiratory syncytial virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50329-2.json |
| 50330-0 | SLC6A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50330-0.json |
| 50331-8 | WT-1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50331-8.json |
| 50332-6 | Hexadecanedioate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50332-6.json |
| 50333-4 | Tetradecanedioate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50333-4.json |
| 50335-9 | Alpha-beta crystallin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/50335-9.json |
| 5033-6 | Staphylococcus aureus rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5033-6.json |
| 50336-7 | Beta cortolone/Cortisol [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50336-7.json |
| 50338-3 | Cannabinoids [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/50338-3.json |
| 50340-9 | Eosinophils [Presence] in Nose by Hansel stain | ./2.16.840.1.114222.4.11.1002/50340-9.json |
| 50341-7 | Eosinophils [Presence] in Sputum by Hansel stain | ./2.16.840.1.114222.4.11.1002/50341-7.json |
| 50343-3 | Ethanol [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/50343-3.json |
| 5034-4 | Streptococcus agalactiae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5034-4.json |
| 50344-1 | Parvovirus B19 DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50344-1.json |
| 50345-8 | Parvovirus B19 DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50345-8.json |
| 50346-6 | Parvovirus B19 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50346-6.json |
| 50347-4 | Parvovirus B19 DNA [Presence] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50347-4.json |
| 50348-2 | Parvovirus B19 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50348-2.json |
| 50349-0 | Parvovirus B19 DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50349-0.json |
| 50350-8 | Mustard IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50350-8.json |
| 5035-1 | Streptococcus pneumoniae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5035-1.json |
| 50351-6 | Australian pine IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50351-6.json |
| 50352-4 | Papain IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50352-4.json |
| 50353-2 | Parrot feather IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50353-2.json |
| 50354-0 | Bahia grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50354-0.json |
| 50355-7 | Perch IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50355-7.json |
| 50356-5 | Canary grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50356-5.json |
| 50357-3 | Phenolphthalein [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50357-3.json |
| 50358-1 | Phenylacetate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50358-1.json |
| 50359-9 | Phenyllactate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50359-9.json |
| 50360-7 | Phenylpropionylglycine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50360-7.json |
| 50361-5 | Phenylpyruvate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50361-5.json |
| 50362-3 | Phoma betae IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50362-3.json |
| 50363-1 | Common Pigweed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50363-1.json |
| 50364-9 | Black Pepper IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50364-9.json |
| 50365-6 | Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/50365-6.json |
| 50366-4 | Prolactin monomeric/Prolactin.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50366-4.json |
| 50367-2 | Propionylglycine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50367-2.json |
| 50368-0 | Protoporphyrin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50368-0.json |
| 5036-9 | Streptococcus pyogenes rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/5036-9.json |
| 50369-8 | White Oak IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50369-8.json |
| 50370-6 | Queen Palm IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50370-6.json |
| 50371-4 | Protoporphyrin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50371-4.json |
| 50372-2 | Protoporphyrin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50372-2.json |
| 50376-3 | Lupus anticoagulant neutralization dilute phospholipid actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/50376-3.json |
| 5037-7 | Acetylcholine receptor binding Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5037-7.json |
| 50377-1 | von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/50377-1.json |
| 50379-7 | Creatinine dialysis fluid clearance/1.73 sq M | ./2.16.840.1.114222.4.11.1002/50379-7.json |
| 50380-5 | Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula | ./2.16.840.1.114222.4.11.1002/50380-5.json |
| 50381-3 | Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula | ./2.16.840.1.114222.4.11.1002/50381-3.json |
| 50382-1 | Glutathione reductase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50382-1.json |
| 50384-7 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) | ./2.16.840.1.114222.4.11.1002/50384-7.json |
| 5038-5 | Acetylcholine receptor blocking Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5038-5.json |
| 50385-4 | Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/50385-4.json |
| 50386-2 | Parakeet+Parrot droppings IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/50386-2.json |
| 50387-0 | Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50387-0.json |
| 50388-8 | Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50388-8.json |
| 50389-6 | Microscopic observation [Identifier] in Bronchial brush by Cyto stain.thin prep | ./2.16.840.1.114222.4.11.1002/50389-6.json |
| 50392-0 | 3-Keto n-Valerate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50392-0.json |
| 5039-3 | Acetylcholine receptor modulation Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5039-3.json |
| 50393-8 | 3-Keto n-Valerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50393-8.json |
| 50394-6 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/50394-6.json |
| 50395-3 | Adenosine deaminase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/50395-3.json |
| 5040-1 | Actinomyces sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5040-1.json |
| 50406-8 | Cannabinoids [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/50406-8.json |
| 50409-2 | Cholesterol in HDL 2+3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50409-2.json |
| 50410-0 | dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) | ./2.16.840.1.114222.4.11.1002/50410-0.json |
| 50411-8 | Chlamydia trachomatis rRNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50411-8.json |
| 50412-6 | Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50412-6.json |
| 50414-2 | Corticotropin [Mass/volume] in Plasma --post 1 mg dexamethasone PO overnight | ./2.16.840.1.114222.4.11.1002/50414-2.json |
| 5041-9 | Adenovirus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5041-9.json |
| 5042-7 | Adenovirus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5042-7.json |
| 5043-5 | Adrenal Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5043-5.json |
| 5044-3 | Adrenal cortex Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5044-3.json |
| 5045-0 | Ancylostoma sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5045-0.json |
| 5046-8 | Hantavirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5046-8.json |
| 5047-6 | Nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5047-6.json |
| 5048-4 | Nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5048-4.json |
| 5049-2 | Ascaris lumbricoides Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5049-2.json |
| 5050-0 | Aspergillus fumigatus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5050-0.json |
| 5051-8 | Aspergillus niger Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5051-8.json |
| 50525-5 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1st specimen | ./2.16.840.1.114222.4.11.1002/50525-5.json |
| 5052-6 | Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5052-6.json |
| 5053-4 | Aspergillus sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5053-4.json |
| 5054-2 | Babesia sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5054-2.json |
| 50542-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50542-0.json |
| 50543-8 | Tricyclic antidepressants [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50543-8.json |
| 50544-6 | Everolimus [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50544-6.json |
| 50547-9 | Eastern equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50547-9.json |
| 50548-7 | Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50548-7.json |
| 50550-3 | Malondialdehyde.free [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/50550-3.json |
| 50552-9 | Clarity in Urine by Refractometry automated | ./2.16.840.1.114222.4.11.1002/50552-9.json |
| 50553-7 | Color of Urine by Auto | ./2.16.840.1.114222.4.11.1002/50553-7.json |
| 5055-9 | Bacillus anthracis Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5055-9.json |
| 5056-7 | Basement membrane Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5056-7.json |
| 5057-5 | Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5057-5.json |
| 5058-3 | Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5058-3.json |
| 50590-9 | Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Trophoblasts | ./2.16.840.1.114222.4.11.1002/50590-9.json |
| 5059-1 | Bordetella pertussis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5059-1.json |
| 50591-7 | Adenosine deaminase [Enzymatic activity/mass] in Trophoblasts | ./2.16.840.1.114222.4.11.1002/50591-7.json |
| 50592-5 | Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/50592-5.json |
| 50593-3 | 3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/50593-3.json |
| 50594-1 | 3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/50594-1.json |
| 50596-6 | HPA-1a [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50596-6.json |
| 50597-4 | HPA-2 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50597-4.json |
| 50598-2 | HPA-15 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50598-2.json |
| 50599-0 | HPA-1 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50599-0.json |
| 50600-6 | HPA-3 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50600-6.json |
| 50601-4 | HPA-4 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50601-4.json |
| 50602-2 | HPA-5 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50602-2.json |
| 50603-0 | HPA-6 [Type] in Blood | ./2.16.840.1.114222.4.11.1002/50603-0.json |
| 5060-9 | Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5060-9.json |
| 50609-7 | Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50609-7.json |
| 50611-3 | Felbamate [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/50611-3.json |
| 5061-7 | Borrelia burgdorferi Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5061-7.json |
| 50618-8 | Phosphatidylcholine.saturated/Surfactant.total in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/50618-8.json |
| 50619-6 | Karyotype [Identifier] in Blood or Tissue Narrative | ./2.16.840.1.114222.4.11.1002/50619-6.json |
| 50620-4 | Opiates cutoff [Mass/mass] in Meconium for Confirmatory method | ./2.16.840.1.114222.4.11.1002/50620-4.json |
| 50621-2 | HTT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50621-2.json |
| 50622-0 | Miscellaneous allergen IgG Ab [Identifier] in Serum | ./2.16.840.1.114222.4.11.1002/50622-0.json |
| 50623-8 | AS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50623-8.json |
| 5062-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5062-5.json |
| 50625-3 | Ova and parasites identified in Blood or Tissue by Wright stain | ./2.16.840.1.114222.4.11.1002/50625-3.json |
| 50626-1 | DMD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50626-1.json |
| 50627-9 | HC gene rearrangements in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/50627-9.json |
| 50628-7 | Heptacarboxylporphyrin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50628-7.json |
| 50629-5 | Liver kidney microsomal IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/50629-5.json |
| 50630-3 | Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/50630-3.json |
| 50631-1 | Cefepime [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/50631-1.json |
| 50632-9 | Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/50632-9.json |
| 5063-3 | Borrelia burgdorferi IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5063-3.json |
| 50633-7 | cefTRIAXone [Susceptibility] for meningitis | ./2.16.840.1.114222.4.11.1002/50633-7.json |
| 50634-5 | Balsam poplar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50634-5.json |
| 50635-2 | Monterey cypress IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50635-2.json |
| 50636-0 | Giant Japanese spider crab IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50636-0.json |
| 50637-8 | Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/50637-8.json |
| 50638-6 | Annatto seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50638-6.json |
| 50639-4 | Asian ladybug IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50639-4.json |
| 50640-2 | CD3+CD57+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50640-2.json |
| 5064-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5064-1.json |
| 50641-0 | CD3+CD8+CD57+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50641-0.json |
| 50642-8 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/50642-8.json |
| 50643-6 | Pregnanetriolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50643-6.json |
| 50644-4 | Tetrahydrocorticosterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50644-4.json |
| 50645-1 | Tetrahydrocortisol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50645-1.json |
| 50646-9 | Latex recombinant (rHev b) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50646-9.json |
| 50647-7 | Latex recombinant (rHev b) 11 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50647-7.json |
| 50648-5 | Latex recombinant (rHev b) 6.01 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50648-5.json |
| 50649-3 | Latex recombinant (rHev b) 6.02 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50649-3.json |
| 50650-1 | Lupin seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50650-1.json |
| 50651-9 | Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50651-9.json |
| 50652-7 | Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50652-7.json |
| 50653-5 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50653-5.json |
| 50654-3 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50654-3.json |
| 50655-0 | Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50655-0.json |
| 50656-8 | Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50656-8.json |
| 50657-6 | Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/50657-6.json |
| 5065-8 | Borrelia burgdorferi IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5065-8.json |
| 50659-2 | Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative | ./2.16.840.1.114222.4.11.1002/50659-2.json |
| 50660-0 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50660-0.json |
| 50661-8 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50661-8.json |
| 50662-6 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50662-6.json |
| 50663-4 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50663-4.json |
| 50664-2 | CD19+Kappa+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50664-2.json |
| 50665-9 | CD19+Lambda+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50665-9.json |
| 5066-6 | Brucella abortus Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5066-6.json |
| 50666-7 | Nuclear matrix protein 22 [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/50666-7.json |
| 50668-3 | Microscopic observation in Specimen by Electron microscopy Narrative | ./2.16.840.1.114222.4.11.1002/50668-3.json |
| 50669-1 | Transfuse antithrombin [Volume] | ./2.16.840.1.114222.4.11.1002/50669-1.json |
| 5067-4 | Brucella abortus Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5067-4.json |
| 50675-8 | Calcium-phosphorus product [(Mass/volume)*2] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50675-8.json |
| 50680-8 | Paecilomyces variottii IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50680-8.json |
| 5068-2 | Brucella canis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5068-2.json |
| 50682-4 | PRKCG gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50682-4.json |
| 50683-2 | Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/50683-2.json |
| 50684-0 | Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative | ./2.16.840.1.114222.4.11.1002/50684-0.json |
| 50685-7 | Somatotropin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50685-7.json |
| 50687-3 | Plasmodium sp Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/50687-3.json |
| 50688-1 | Plasmodium sp lactate dehydrogenase [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/50688-1.json |
| 50689-9 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Hemagglutination | ./2.16.840.1.114222.4.11.1002/50689-9.json |
| 5069-0 | Brucella melitensis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5069-0.json |
| 50690-7 | Reagin Ab [Titer] in Serum by VDRL | ./2.16.840.1.114222.4.11.1002/50690-7.json |
| 50691-5 | Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/50691-5.json |
| 50692-3 | Parainfluenza virus 1+2+3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/50692-3.json |
| 50693-1 | Influenza virus A+B Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/50693-1.json |
| 50694-9 | Rubella virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/50694-9.json |
| 50695-6 | Treponema pallidum Ab [Titer] in Cerebral spinal fluid by Hemagglutination | ./2.16.840.1.114222.4.11.1002/50695-6.json |
| 50696-4 | Influenza virus A neutralizing antibody [Identifier] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/50696-4.json |
| 50697-2 | Influenza virus A Ag [Identifier] in Isolate | ./2.16.840.1.114222.4.11.1002/50697-2.json |
| 50698-0 | Influenza virus A.adamantane resistance [Presence] by Phenotype method | ./2.16.840.1.114222.4.11.1002/50698-0.json |
| 50699-8 | Influenza virus A.adamantane resistance [Presence] | ./2.16.840.1.114222.4.11.1002/50699-8.json |
| 50700-4 | Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/50700-4.json |
| 50701-2 | Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/50701-2.json |
| 50702-0 | Influenza virus A matrix protein RNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50702-0.json |
| 50703-8 | Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method | ./2.16.840.1.114222.4.11.1002/50703-8.json |
| 50704-6 | Influenza virus A nucleoprotein RNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50704-6.json |
| 50705-3 | Influenza virus A non-structural protein RNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50705-3.json |
| 50706-1 | Influenza virus A polymerase A RNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50706-1.json |
| 50707-9 | Influenza virus A polymerase B1 cDNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50707-9.json |
| 5070-8 | Brucella sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5070-8.json |
| 50708-7 | Influenza virus A polymerase B2 RNA [Presence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50708-7.json |
| 50709-5 | Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/50709-5.json |
| 50711-1 | Influenza virus A polymerase RNA [Identifier] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/50711-1.json |
| 50712-9 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative | ./2.16.840.1.114222.4.11.1002/50712-9.json |
| 50713-7 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/50713-7.json |
| 50714-5 | Bitter dock IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50714-5.json |
| 5071-6 | Brucella suis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5071-6.json |
| 50722-8 | VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/50722-8.json |
| 50723-6 | CD38+ Lambda+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50723-6.json |
| 5072-4 | Brush border Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5072-4.json |
| 5073-2 | La Crosse virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5073-2.json |
| 5074-0 | Candida albicans Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5074-0.json |
| 50746-7 | Hirudin [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/50746-7.json |
| 50747-5 | Platelet factor 4 Ag [Presence] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/50747-5.json |
| 50748-3 | Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50748-3.json |
| 50750-9 | F13A1 gene p.Val34Leu [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50750-9.json |
| 50755-8 | CT Lower extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/50755-8.json |
| 50756-6 | Creatine kinase [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50756-6.json |
| 5075-7 | Candida albicans Ag [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5075-7.json |
| 50757-4 | Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Blood | ./2.16.840.1.114222.4.11.1002/50757-4.json |
| 50758-2 | Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/50758-2.json |
| 50759-0 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/50759-0.json |
| 50760-8 | aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma | ./2.16.840.1.114222.4.11.1002/50760-8.json |
| 50761-6 | A IgG Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50761-6.json |
| 50762-4 | A IgM Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50762-4.json |
| 50763-2 | B IgM Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50763-2.json |
| 50764-0 | B IgG Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50764-0.json |
| 5076-5 | Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5076-5.json |
| 5077-3 | Centromere Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5077-3.json |
| 50773-1 | ABO and Rh group [Type] in Blood from Newborn--after transfusion reaction | ./2.16.840.1.114222.4.11.1002/50773-1.json |
| 50774-9 | Nucleated cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50774-9.json |
| 50775-6 | Cancer Ag 125 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50775-6.json |
| 50776-4 | Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50776-4.json |
| 50777-2 | Cancer Ag 15-3 [Units/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/50777-2.json |
| 50778-0 | Cancer Ag 15-3 [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/50778-0.json |
| 50779-8 | Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50779-8.json |
| 50780-6 | Cancer Ag 19-9 [Units/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/50780-6.json |
| 5078-1 | Chlamydophila pneumoniae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5078-1.json |
| 50781-4 | Cancer Ag 19-9 [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/50781-4.json |
| 50782-2 | Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/50782-2.json |
| 50789-7 | Cytokeratin cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50789-7.json |
| 50790-5 | HIV 1 RNA tropism [Identifier] | ./2.16.840.1.114222.4.11.1002/50790-5.json |
| 50798-8 | 17-Ketogenic steroids [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50798-8.json |
| 5079-9 | Chlamydophila psittaci Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5079-9.json |
| 50799-6 | 7-Dehydrocholesterol [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50799-6.json |
| 50800-2 | Acetone [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50800-2.json |
| 50801-0 | Aluminum [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50801-0.json |
| 50802-8 | Amikacin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/50802-8.json |
| 50803-6 | Amikacin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/50803-6.json |
| 50804-4 | Amitriptyline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50804-4.json |
| 50805-1 | Amitriptyline [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/50805-1.json |
| 5080-7 | Chlamydophila psittaci IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5080-7.json |
| 50807-7 | Antimony [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50807-7.json |
| 50808-5 | Antimony [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50808-5.json |
| 50809-3 | Antimony [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50809-3.json |
| 50810-1 | Antimony [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50810-1.json |
| 50811-9 | Antimony [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50811-9.json |
| 50812-7 | Arsenic [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50812-7.json |
| 50813-5 | Arsenic [Moles/mass] in Nail | ./2.16.840.1.114222.4.11.1002/50813-5.json |
| 50814-3 | Arsenic.inorganic [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50814-3.json |
| 5081-5 | Chlamydophila psittaci IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5081-5.json |
| 50815-0 | Arsenic.inorganic [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50815-0.json |
| 50816-8 | Arsenic organic [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50816-8.json |
| 50817-6 | Arsenic/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50817-6.json |
| 50818-4 | Barium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50818-4.json |
| 50819-2 | Barium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50819-2.json |
| 50820-0 | Base excess in Capillary blood from Fetus by calculation | ./2.16.840.1.114222.4.11.1002/50820-0.json |
| 50821-8 | Beryllium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50821-8.json |
| 50822-6 | Beryllium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50822-6.json |
| 5082-3 | Chlamydia sp Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5082-3.json |
| 50823-4 | Beryllium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50823-4.json |
| 50824-2 | Beta-2-Microglobulin [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50824-2.json |
| 50825-9 | Bile acid [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50825-9.json |
| 50826-7 | Bismuth [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50826-7.json |
| 50827-5 | Boron [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50827-5.json |
| 50828-3 | Boron [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50828-3.json |
| 50829-1 | Boron [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50829-1.json |
| 50830-9 | Boron [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50830-9.json |
| 5083-1 | Chlamydia sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5083-1.json |
| 50831-7 | Boron/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50831-7.json |
| 50832-5 | Boron/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50832-5.json |
| 50833-3 | Cadmium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50833-3.json |
| 50834-1 | Cadmium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50834-1.json |
| 50835-8 | Cadmium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50835-8.json |
| 50836-6 | Calcium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50836-6.json |
| 50837-4 | Calcium.ionized [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50837-4.json |
| 50838-2 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Body fluid | ./2.16.840.1.114222.4.11.1002/50838-2.json |
| 50839-0 | Calcium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50839-0.json |
| 50840-8 | Cholesterol in HDL [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50840-8.json |
| 50841-6 | Chromium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50841-6.json |
| 50842-4 | Chromium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50842-4.json |
| 50843-2 | clonazePAM [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50843-2.json |
| 50844-0 | cloZAPine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50844-0.json |
| 50845-7 | Cobalt [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50845-7.json |
| 50846-5 | Cobalt [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50846-5.json |
| 50847-3 | Cobalt [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50847-3.json |
| 50848-1 | Cortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50848-1.json |
| 5084-9 | Chlamydia sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5084-9.json |
| 50849-9 | diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50849-9.json |
| 50850-7 | Fluoride/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50850-7.json |
| 50851-5 | Germanium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50851-5.json |
| 50852-3 | Gold [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50852-3.json |
| 50853-1 | Heptacarboxylporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/50853-1.json |
| 50855-6 | Hexacarboxylporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/50855-6.json |
| 5085-6 | Chlamydia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5085-6.json |
| 50857-2 | Histamine [Moles/volume] in 3 hour Urine | ./2.16.840.1.114222.4.11.1002/50857-2.json |
| 50858-0 | Hydrogen ion [Moles/volume] in Mixed venous cord blood | ./2.16.840.1.114222.4.11.1002/50858-0.json |
| 50859-8 | Hydrogen ion [Moles/volume] in Venous cord blood | ./2.16.840.1.114222.4.11.1002/50859-8.json |
| 50860-6 | Hydrogen ion [Moles/volume] in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/50860-6.json |
| 50861-4 | Hydrogen ion [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/50861-4.json |
| 50862-2 | Hydrogen ion [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/50862-2.json |
| 50863-0 | Hydrogen ion [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50863-0.json |
| 5086-4 | Chlamydia sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5086-4.json |
| 50864-8 | Hydrogen ion [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/50864-8.json |
| 50865-5 | Hydrogen ion [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50865-5.json |
| 50866-3 | Indicans/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/50866-3.json |
| 50867-1 | Insulin [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50867-1.json |
| 50868-9 | Iodine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50868-9.json |
| 50869-7 | Iron [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50869-7.json |
| 50870-5 | Isopropanol [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50870-5.json |
| 50871-3 | Lead [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50871-3.json |
| 5087-2 | Chlamydia trachomatis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5087-2.json |
| 50872-1 | Lithium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50872-1.json |
| 50873-9 | Magnesium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50873-9.json |
| 50874-7 | Manganese [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50874-7.json |
| 50875-4 | Manganese [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50875-4.json |
| 50876-2 | Mercury [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50876-2.json |
| 50877-0 | Mercury [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50877-0.json |
| 50878-8 | Mercury [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50878-8.json |
| 50879-6 | Methyl ethyl ketone [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50879-6.json |
| 5088-0 | Chlamydia trachomatis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5088-0.json |
| 50880-4 | Methyl ethyl ketone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50880-4.json |
| 50881-2 | Molybdenum [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50881-2.json |
| 50882-0 | Molybdenum [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50882-0.json |
| 50883-8 | Molybdenum [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50883-8.json |
| 50884-6 | Molybdenum [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50884-6.json |
| 50885-3 | Naproxen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50885-3.json |
| 50886-1 | Nickel [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50886-1.json |
| 50887-9 | Nickel [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50887-9.json |
| 50888-7 | Nitrogen [Moles/time] in 24 hour Body fluid | ./2.16.840.1.114222.4.11.1002/50888-7.json |
| 50889-5 | Nitrogen [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50889-5.json |
| 50890-3 | Norclozapine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50890-3.json |
| 50891-1 | OLANZapine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50891-1.json |
| 50892-9 | Palladium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50892-9.json |
| 50893-7 | Paraquat [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50893-7.json |
| 50894-5 | Pentacarboxylporphyrins [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/50894-5.json |
| 50895-2 | pH of Pleural fluid by Test strip | ./2.16.840.1.114222.4.11.1002/50895-2.json |
| 50896-0 | pH of Body fluid by Test strip | ./2.16.840.1.114222.4.11.1002/50896-0.json |
| 50897-8 | pH of 24 hour Urine by Test strip | ./2.16.840.1.114222.4.11.1002/50897-8.json |
| 5089-8 | Chlamydia trachomatis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5089-8.json |
| 50898-6 | Phosphate [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50898-6.json |
| 50899-4 | Platinum [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50899-4.json |
| 50900-0 | Platinum [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50900-0.json |
| 50901-8 | Porphyrins [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50901-8.json |
| 50902-6 | Potassium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50902-6.json |
| 50903-4 | Selenium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50903-4.json |
| 50904-2 | Selenium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50904-2.json |
| 50905-9 | Silicon [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50905-9.json |
| 5090-6 | Chlamydia trachomatis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5090-6.json |
| 50906-7 | Silicon [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50906-7.json |
| 50907-5 | Silicon [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50907-5.json |
| 50908-3 | Silver [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50908-3.json |
| 50909-1 | Silver [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50909-1.json |
| 50910-9 | Silver [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50910-9.json |
| 50911-7 | Sodium [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/50911-7.json |
| 50912-5 | Sodium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50912-5.json |
| 50913-3 | Strontium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50913-3.json |
| 5091-4 | Chymotrypsin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5091-4.json |
| 50914-1 | Strontium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50914-1.json |
| 50915-8 | Strontium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50915-8.json |
| 50916-6 | Sucrose [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50916-6.json |
| 50917-4 | Thallium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50917-4.json |
| 50918-2 | Thallium [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50918-2.json |
| 50919-0 | Thorium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50919-0.json |
| 50920-8 | Thorium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50920-8.json |
| 50921-6 | Tin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50921-6.json |
| 5092-2 | Clostridium tetani Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5092-2.json |
| 50922-4 | Tin [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50922-4.json |
| 50923-2 | Tin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50923-2.json |
| 50924-0 | Titanium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50924-0.json |
| 50925-7 | Titanium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/50925-7.json |
| 50926-5 | Titanium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50926-5.json |
| 50927-3 | Tobramycin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50927-3.json |
| 50928-1 | Uranium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50928-1.json |
| 50929-9 | Uranium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50929-9.json |
| 5093-0 | Clostridium tetani Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/5093-0.json |
| 50930-7 | Uranium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50930-7.json |
| 50931-5 | Uroporphyrin 1 isomer [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/50931-5.json |
| 50932-3 | Uroporphyrin/Porphyrins.total in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50932-3.json |
| 50933-1 | Vanadium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50933-1.json |
| 50934-9 | Vanadium [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50934-9.json |
| 50935-6 | Vanadium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/50935-6.json |
| 50936-4 | Vanadium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/50936-4.json |
| 50937-2 | Vanadium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50937-2.json |
| 50938-0 | Vancomycin [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/50938-0.json |
| 50939-8 | Zinc [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/50939-8.json |
| 50940-6 | Zinc/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/50940-6.json |
| 50941-4 | Mycobacterium sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/50941-4.json |
| 5094-8 | Coccidioides immitis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5094-8.json |
| 50949-7 | Albumin [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/50949-7.json |
| 50950-5 | Phosphoethanolamine IgA Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50950-5.json |
| 50951-3 | Phosphoserine IgA Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50951-3.json |
| 50952-1 | Phosphoserine IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50952-1.json |
| 50953-9 | Phosphoethanolamine IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50953-9.json |
| 50954-7 | Phosphoethanolamine IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50954-7.json |
| 5095-5 | Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5095-5.json |
| 50955-4 | Phosphoserine IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50955-4.json |
| 50956-2 | HLA-B*57:01 [Presence] | ./2.16.840.1.114222.4.11.1002/50956-2.json |
| 50957-0 | Manual differential performed [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/50957-0.json |
| 50959-6 | Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50959-6.json |
| 50960-4 | Rabbit Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/50960-4.json |
| 50961-2 | Rabbit Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/50961-2.json |
| 5096-3 | Coccidioides immitis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5096-3.json |
| 50965-3 | Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50965-3.json |
| 50966-1 | Flunitrazepam [Presence] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/50966-1.json |
| 50967-9 | Hepatitis B virus surface Ag [Presence] in Blood from Donor by Neutralization test | ./2.16.840.1.114222.4.11.1002/50967-9.json |
| 50968-7 | HLA Ab [Type] in Serum | ./2.16.840.1.114222.4.11.1002/50968-7.json |
| 50969-5 | Epstein Barr virus early diffuse IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/50969-5.json |
| 5097-1 | Cold agglutinin [Presence] in Serum or Plasma by Agglutination | ./2.16.840.1.114222.4.11.1002/5097-1.json |
| 50971-1 | Cytology report of Bronchial brush Cyto stain | ./2.16.840.1.114222.4.11.1002/50971-1.json |
| 50972-9 | CD138 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50972-9.json |
| 50973-7 | CD38+CD138+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50973-7.json |
| 50974-5 | CD38+CD138+ cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/50974-5.json |
| 50975-2 | TCR alpha beta cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50975-2.json |
| 50976-0 | TCR gamma delta cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/50976-0.json |
| 50977-8 | Echovirus 5 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/50977-8.json |
| 50979-4 | CBir1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/50979-4.json |
| 50980-2 | pH of Mixed venous blood adjusted to patient's actual temperature | ./2.16.840.1.114222.4.11.1002/50980-2.json |
| 50981-0 | Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/50981-0.json |
| 50982-8 | Horowitz index in Blood | ./2.16.840.1.114222.4.11.1002/50982-8.json |
| 50983-6 | Horowitz index in Capillary blood | ./2.16.840.1.114222.4.11.1002/50983-6.json |
| 50984-4 | Horowitz index in Arterial blood | ./2.16.840.1.114222.4.11.1002/50984-4.json |
| 50985-1 | Horowitz index in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/50985-1.json |
| 50986-9 | Horowitz index in Venous blood | ./2.16.840.1.114222.4.11.1002/50986-9.json |
| 50987-7 | Horowitz index adjusted to patients actual temperature in Blood | ./2.16.840.1.114222.4.11.1002/50987-7.json |
| 50988-5 | Horowitz index adjusted to patients actual temperature in Capillary blood | ./2.16.840.1.114222.4.11.1002/50988-5.json |
| 5098-9 | Cold agglutinin [Titer] in Serum or Plasma by Agglutination | ./2.16.840.1.114222.4.11.1002/5098-9.json |
| 50989-3 | Horowitz index adjusted to patients actual temperature in Arterial blood | ./2.16.840.1.114222.4.11.1002/50989-3.json |
| 50990-1 | Horowitz index adjusted to patients actual temperature in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/50990-1.json |
| 50991-9 | Horowitz index adjusted to patients actual temperature in Venous blood | ./2.16.840.1.114222.4.11.1002/50991-9.json |
| 50992-7 | IgM [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/50992-7.json |
| 50994-3 | CMT demyelinating gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50994-3.json |
| 50995-0 | BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50995-0.json |
| 50996-8 | HBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/50996-8.json |
| 5099-7 | Coronavirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5099-7.json |
| 50997-6 | Complement C8.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/50997-6.json |
| 51001-6 | Iodide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51001-6.json |
| 5100-3 | Coxiella burnetii Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5100-3.json |
| 51005-7 | Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/51005-7.json |
| 51006-5 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/51006-5.json |
| 51007-3 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --after transfusion | ./2.16.840.1.114222.4.11.1002/51007-3.json |
| 51008-1 | Wheat native (nTri a) 19 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51008-1.json |
| 5101-1 | Coxsackievirus A7 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5101-1.json |
| 5102-9 | Coxsackievirus A9 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5102-9.json |
| 5103-7 | Coxsackievirus B1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5103-7.json |
| 5104-5 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5104-5.json |
| 5105-2 | Coxsackievirus B2 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5105-2.json |
| 5106-0 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5106-0.json |
| 51066-9 | CD13 blasts [Units/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/51066-9.json |
| 5107-8 | Coxsackievirus B3 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5107-8.json |
| 5108-6 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5108-6.json |
| 5109-4 | Coxsackievirus B4 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5109-4.json |
| 5110-2 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5110-2.json |
| 5111-0 | Coxsackievirus B5 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5111-0.json |
| 5112-8 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5112-8.json |
| 5113-6 | Coxsackievirus B6 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5113-6.json |
| 5114-4 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5114-4.json |
| 5115-1 | Corynebacterium diphtheriae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5115-1.json |
| 5116-9 | Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5116-9.json |
| 5117-7 | Cryoglobulin [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/5117-7.json |
| 51183-2 | CD117 Ag [Presence] in Bone marrow by Immune stain | ./2.16.840.1.114222.4.11.1002/51183-2.json |
| 51184-0 | CD117 Ag [Presence] in Blood by Immune stain | ./2.16.840.1.114222.4.11.1002/51184-0.json |
| 51185-7 | CD117 Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/51185-7.json |
| 51186-5 | CD15 Ag [Presence] in Bone marrow by Immune stain | ./2.16.840.1.114222.4.11.1002/51186-5.json |
| 51187-3 | CD15 Ag [Presence] in Blood by Immune stain | ./2.16.840.1.114222.4.11.1002/51187-3.json |
| 51188-1 | CD15 Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/51188-1.json |
| 51189-9 | 4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51189-9.json |
| 51191-5 | Antimony [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51191-5.json |
| 51192-3 | Barium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51192-3.json |
| 51193-1 | Cadmium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51193-1.json |
| 51194-9 | Cobalt [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51194-9.json |
| 51195-6 | Desbutylbupivacaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51195-6.json |
| 51197-2 | Iron [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51197-2.json |
| 51198-0 | Manganese [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51198-0.json |
| 51199-8 | Molybdenum [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51199-8.json |
| 51200-4 | Nickel [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51200-4.json |
| 5120-1 | Taenia solium larva Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5120-1.json |
| 51201-2 | Palladium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51201-2.json |
| 51202-0 | Platinum [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51202-0.json |
| 51203-8 | Ropivacaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51203-8.json |
| 51204-6 | Silicon [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/51204-6.json |
| 51205-3 | Sodium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/51205-3.json |
| 51206-1 | Strontium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51206-1.json |
| 51207-9 | Thallium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51207-9.json |
| 51208-7 | Tin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51208-7.json |
| 51209-5 | Tin [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/51209-5.json |
| 51210-3 | Titanium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51210-3.json |
| 51211-1 | Uranium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51211-1.json |
| 51212-9 | Vanadium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51212-9.json |
| 5121-9 | Cytomegalovirus Ab [Titer] in Serum or Plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5121-9.json |
| 5122-7 | Cytomegalovirus Ab [Units/volume] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5122-7.json |
| 5124-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5124-3.json |
| 5125-0 | Cytomegalovirus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5125-0.json |
| 5126-8 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5126-8.json |
| 5127-6 | Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5127-6.json |
| 5128-4 | Neutrophil cytoplasmic Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5128-4.json |
| 5129-2 | Deoxyribonuclease Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5129-2.json |
| 5130-0 | DNA double strand Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5130-0.json |
| 5131-8 | DNA double strand Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5131-8.json |
| 5132-6 | DNA single strand Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5132-6.json |
| 5133-4 | Streptococcal DNAse B [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5133-4.json |
| 5134-2 | Eastern equine encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5134-2.json |
| 5135-9 | Echinococcus sp Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5135-9.json |
| 5136-7 | Echovirus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5136-7.json |
| 5137-5 | Echovirus 1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5137-5.json |
| 5138-3 | Echovirus 19 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5138-3.json |
| 51387-9 | XR Knee - bilateral Views and (AP W standing) | ./2.16.840.1.114222.4.11.1002/51387-9.json |
| 51388-7 | XR Wrist - right and Hand - right Views | ./2.16.840.1.114222.4.11.1002/51388-7.json |
| 51389-5 | NM Breast Views W Tl-201 IV | ./2.16.840.1.114222.4.11.1002/51389-5.json |
| 5139-1 | Echovirus 19 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5139-1.json |
| 51391-1 | RFA Guidance for placement of TIPS of Portal vein and Hepatic vein | ./2.16.840.1.114222.4.11.1002/51391-1.json |
| 51392-9 | XR Wrist - left and Hand - left Views | ./2.16.840.1.114222.4.11.1002/51392-9.json |
| 51393-7 | Esophageal manometry study | ./2.16.840.1.114222.4.11.1002/51393-7.json |
| 51394-5 | XR Ankle and Foot - right Views | ./2.16.840.1.114222.4.11.1002/51394-5.json |
| 51395-2 | XR Ankle and Foot - left Views | ./2.16.840.1.114222.4.11.1002/51395-2.json |
| 51406-7 | Immunoglobulin light chains.free [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/51406-7.json |
| 51407-5 | Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51407-5.json |
| 51408-3 | Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51408-3.json |
| 5140-9 | Echovirus 3 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5140-9.json |
| 51409-1 | Fosamprenavir+Ritonavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/51409-1.json |
| 51412-5 | 3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51412-5.json |
| 51413-3 | Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51413-3.json |
| 51414-1 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51414-1.json |
| 51415-8 | Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51415-8.json |
| 51416-6 | Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51416-6.json |
| 5141-7 | Echovirus 3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5141-7.json |
| 51418-2 | Domperidone [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51418-2.json |
| 5142-5 | Echovirus 4 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5142-5.json |
| 5143-3 | Echovirus 4 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5143-3.json |
| 5144-1 | Echovirus 6 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5144-1.json |
| 51441-4 | Macroprolactin/Prolactin [Mass] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51441-4.json |
| 51442-2 | Domperidone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51442-2.json |
| 51443-0 | CD117 cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51443-0.json |
| 51444-8 | CD19+CD38+ cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51444-8.json |
| 51445-5 | CD41a cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51445-5.json |
| 51446-3 | CD64 cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51446-3.json |
| 51447-1 | CD79a cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51447-1.json |
| 51448-9 | Dihydrocodeine+Hydrocodol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51448-9.json |
| 51449-7 | Paragonimus sp Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51449-7.json |
| 51450-5 | Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/51450-5.json |
| 51451-3 | Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51451-3.json |
| 51452-1 | Coccidioides immitis Ab [Titer] in Body fluid | ./2.16.840.1.114222.4.11.1002/51452-1.json |
| 51453-9 | Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51453-9.json |
| 51454-7 | Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51454-7.json |
| 51455-4 | Filaria IgG1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51455-4.json |
| 51456-2 | Filaria IgG2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51456-2.json |
| 51457-0 | Filaria IgG3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51457-0.json |
| 5145-8 | Echovirus 6 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5145-8.json |
| 51458-8 | Hepatitis D virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51458-8.json |
| 51459-6 | Hepatitis E virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51459-6.json |
| 51460-4 | Influenza virus A H16 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51460-4.json |
| 51461-2 | Listeria sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51461-2.json |
| 51462-0 | Onchocerca sp IgG2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51462-0.json |
| 51463-8 | Onchocerca sp IgG3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51463-8.json |
| 51464-6 | Onchocerca sp IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51464-6.json |
| 51465-3 | Paragonimus sp Ab [Titer] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/51465-3.json |
| 5146-6 | Echovirus 9 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5146-6.json |
| 51466-1 | Parainfluenza virus 1+2+3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51466-1.json |
| 51467-9 | Plasmodium falciparum IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51467-9.json |
| 51468-7 | Plasmodium ovale IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51468-7.json |
| 51469-5 | Plasmodium vivax IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51469-5.json |
| 51470-3 | Satratoxin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51470-3.json |
| 51471-1 | Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51471-1.json |
| 51472-9 | Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51472-9.json |
| 51473-7 | Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51473-7.json |
| 5147-4 | Echovirus 9 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5147-4.json |
| 51474-5 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51474-5.json |
| 51475-2 | Treponema pallidum Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51475-2.json |
| 51476-0 | ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/51476-0.json |
| 51477-8 | Coccidioides sp IgM Ab [Presence] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/51477-8.json |
| 5148-2 | Echovirus NOS neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5148-2.json |
| 5149-0 | Echovirus NOS Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5149-0.json |
| 51505-6 | Creatine kinase.BB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/51505-6.json |
| 51506-4 | Creatine kinase.MB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/51506-4.json |
| 51507-2 | Creatine kinase.MM [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/51507-2.json |
| 5150-8 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5150-8.json |
| 5151-6 | Entamoeba histolytica Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5151-6.json |
| 51523-9 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51523-9.json |
| 5152-4 | Epidermis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5152-4.json |
| 51524-7 | Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51524-7.json |
| 51525-4 | Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51525-4.json |
| 51526-2 | Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51526-2.json |
| 51527-0 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51527-0.json |
| 51528-8 | Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51528-8.json |
| 51529-6 | Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51529-6.json |
| 51530-4 | Lactalbumin alpha IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51530-4.json |
| 51531-2 | Beta lactoglobulin IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51531-2.json |
| 5153-2 | Epstein Barr virus early Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5153-2.json |
| 51532-0 | Casein IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51532-0.json |
| 51533-8 | European house dust mite IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51533-8.json |
| 51534-6 | American house dust mite IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51534-6.json |
| 51535-3 | Timothy IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51535-3.json |
| 51536-1 | Egg white IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51536-1.json |
| 51537-9 | Silver Birch IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51537-9.json |
| 51538-7 | Cladosporium herbarum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51538-7.json |
| 51539-5 | Candida albicans IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51539-5.json |
| 5154-0 | Epstein Barr virus early Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5154-0.json |
| 51540-3 | Alternaria alternata IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51540-3.json |
| 51541-1 | Stachybotrys chartarum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51541-1.json |
| 51542-9 | Aspergillus versicolor IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51542-9.json |
| 51543-7 | Cladosporium cladosporioides IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51543-7.json |
| 51544-5 | Penicillium sp IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51544-5.json |
| 51545-2 | Budgerigar droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51545-2.json |
| 51546-0 | Chicken feather IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51546-0.json |
| 51547-8 | Canary feather IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51547-8.json |
| 51548-6 | Parrot feather IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51548-6.json |
| 51549-4 | Pigeon feather IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51549-4.json |
| 5155-7 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5155-7.json |
| 5156-5 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5156-5.json |
| 5157-3 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5157-3.json |
| 51578-3 | Chlamydia trachomatis DNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51578-3.json |
| 51579-1 | Normoblasts/100 cells in Bone marrow by Manual count | ./2.16.840.1.114222.4.11.1002/51579-1.json |
| 5158-1 | Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5158-1.json |
| 51584-1 | Immature granulocytes [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/51584-1.json |
| 51587-4 | Plasmodium sp [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/51587-4.json |
| 51590-8 | Chloride [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/51590-8.json |
| 51591-6 | Cholesterol [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/51591-6.json |
| 51592-4 | Creatinine [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/51592-4.json |
| 51593-2 | Fructose [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/51593-2.json |
| 51594-0 | Galactose [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/51594-0.json |
| 51595-7 | Glucose [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/51595-7.json |
| 51596-5 | Glucose [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/51596-5.json |
| 51598-1 | Lactose [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/51598-1.json |
| 5159-9 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5159-9.json |
| 51599-9 | Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose | ./2.16.840.1.114222.4.11.1002/51599-9.json |
| 51600-5 | Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose | ./2.16.840.1.114222.4.11.1002/51600-5.json |
| 51601-3 | Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose | ./2.16.840.1.114222.4.11.1002/51601-3.json |
| 51602-1 | Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose | ./2.16.840.1.114222.4.11.1002/51602-1.json |
| 51603-9 | Cytochrome B5 reductase [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/51603-9.json |
| 51604-7 | Phosphate [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/51604-7.json |
| 51605-4 | Triglyceride [Moles/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/51605-4.json |
| 5160-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5160-7.json |
| 51610-4 | Calcium [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/51610-4.json |
| 51611-2 | Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose | ./2.16.840.1.114222.4.11.1002/51611-2.json |
| 51612-0 | Sucrose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/51612-0.json |
| 5161-5 | Erythrocyte Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5161-5.json |
| 51618-7 | Potassium [Moles/volume] in Serum or Plasma --pre dialysis | ./2.16.840.1.114222.4.11.1002/51618-7.json |
| 51619-5 | Creatinine [Moles/volume] in Serum or Plasma --pre dialysis | ./2.16.840.1.114222.4.11.1002/51619-5.json |
| 51620-3 | Creatinine [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/51620-3.json |
| 5162-3 | Fasciola hepatica Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5162-3.json |
| 51623-7 | Spermatozoa [#/volume] in Semen --post vasectomy | ./2.16.840.1.114222.4.11.1002/51623-7.json |
| 51627-8 | Lymphocytes [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/51627-8.json |
| 5163-1 | Fasciola sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5163-1.json |
| 51646-8 | Rabies virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51646-8.json |
| 51647-6 | Rabies virus RNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/51647-6.json |
| 5164-9 | Fc fragment Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5164-9.json |
| 51653-4 | Hepatitis E virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51653-4.json |
| 51654-2 | Hepatitis D virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51654-2.json |
| 51655-9 | Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51655-9.json |
| 5165-6 | Filaria Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5165-6.json |
| 51657-5 | Hepatitis C virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51657-5.json |
| 51658-3 | Hepatitis B virus core IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51658-3.json |
| 51659-1 | Hepatitis B virus surface Ag [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51659-1.json |
| 51660-9 | Hepatitis A virus IgM Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51660-9.json |
| 51661-7 | Hepatitis A virus Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51661-7.json |
| 51663-3 | Alphavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51663-3.json |
| 5166-4 | Francisella tularensis Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5166-4.json |
| 51664-1 | Chikungunya virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51664-1.json |
| 51665-8 | Flavivirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51665-8.json |
| 51666-6 | Japanese encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51666-6.json |
| 51667-4 | Lymphocytic choriomeningitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51667-4.json |
| 51668-2 | Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Pseudomonas aeruginosa DNA [Identifier] in Unspecified specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51668-2.json |
| 51669-0 | Parechovirus A RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51669-0.json |
| 51671-6 | Brucella sp Ab [Titer] in Serum by Tube agglutination | ./2.16.840.1.114222.4.11.1002/51671-6.json |
| 5167-2 | Francisella tularensis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5167-2.json |
| 5168-0 | Gall canaliculi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5168-0.json |
| 51690-6 | Amphetamines [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/51690-6.json |
| 51691-4 | Opiates [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/51691-4.json |
| 51692-2 | Phencyclidine [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/51692-2.json |
| 51693-0 | Albumin [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/51693-0.json |
| 51694-8 | Carumonam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/51694-8.json |
| 51697-1 | CV2 Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51697-1.json |
| 5169-8 | Giardia lamblia Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5169-8.json |
| 51698-9 | Dapsone [Susceptibility] | ./2.16.840.1.114222.4.11.1002/51698-9.json |
| 51699-7 | Endomysium IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51699-7.json |
| 51700-3 | Microscopic observation [Identifier] in Specimen by Lactophenol blue | ./2.16.840.1.114222.4.11.1002/51700-3.json |
| 51701-1 | Ganglioside IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/51701-1.json |
| 51702-9 | Ganglioside IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/51702-9.json |
| 51703-7 | Ganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51703-7.json |
| 51704-5 | Herpes virus 6 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51704-5.json |
| 51705-2 | Homogentisate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/51705-2.json |
| 5170-6 | Gliadin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5170-6.json |
| 51706-0 | Hyaluronate [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/51706-0.json |
| 51707-8 | Inner ear 68kD Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51707-8.json |
| 51708-6 | Intercellular substance Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51708-6.json |
| 51709-4 | Leishmania sp identified in Specimen by Giemsa stain | ./2.16.840.1.114222.4.11.1002/51709-4.json |
| 51710-2 | Leishmania sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/51710-2.json |
| 51711-0 | Leishmania sp Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/51711-0.json |
| 51712-8 | Ma+Ta Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51712-8.json |
| 5171-4 | Neutrophil Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5171-4.json |
| 51714-4 | Microscopic observation [Identifier] in Blood by Giemsa stain | ./2.16.840.1.114222.4.11.1002/51714-4.json |
| 51715-1 | Mitochondria M2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51715-1.json |
| 51716-9 | Muscle specific receptor tyrosine kinase Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51716-9.json |
| 51719-3 | Paromomycin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/51719-3.json |
| 51720-1 | Potassium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/51720-1.json |
| 51721-9 | Purkinje cells Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51721-9.json |
| 5172-2 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5172-2.json |
| 51722-7 | Reticulin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51722-7.json |
| 51723-5 | Fungus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/51723-5.json |
| 51724-3 | Cefuroxime [Susceptibility] | ./2.16.840.1.114222.4.11.1002/51724-3.json |
| 51729-2 | Ganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51729-2.json |
| 5173-0 | Streptococcus pyogenes enzyme Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5173-0.json |
| 51731-8 | Oxygen saturation Calculated from oxygen partial pressure in Venous blood | ./2.16.840.1.114222.4.11.1002/51731-8.json |
| 51732-6 | Oxygen saturation Calculated from oxygen partial pressure in Capillary blood | ./2.16.840.1.114222.4.11.1002/51732-6.json |
| 51733-4 | Oxygen saturation Calculated from oxygen partial pressure in Arterial blood | ./2.16.840.1.114222.4.11.1002/51733-4.json |
| 51735-9 | Urea nitrogen renal clearance in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51735-9.json |
| 51736-7 | oxyMORphone Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51736-7.json |
| 51737-5 | HYDROmorphone Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51737-5.json |
| 51738-3 | HYDROcodone Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51738-3.json |
| 51739-1 | Codeine Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51739-1.json |
| 51740-9 | 6-monoacetylmorphine free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51740-9.json |
| 51741-7 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/51741-7.json |
| 51742-5 | Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51742-5.json |
| 51743-3 | Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51743-3.json |
| 51744-1 | Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51744-1.json |
| 51745-8 | Borrelia burgdorferi G39/40 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/51745-8.json |
| 51746-6 | Borrelia burgdorferi 49736 IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/51746-6.json |
| 5174-8 | Helicobacter pylori Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5174-8.json |
| 51748-2 | PCA-Tr Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51748-2.json |
| 51749-0 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/51749-0.json |
| 51750-8 | Pyruvate [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/51750-8.json |
| 51751-6 | Pyruvate [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/51751-6.json |
| 51753-2 | Histoplasma capsulatum Ag [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51753-2.json |
| 51754-0 | Histoplasma capsulatum Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/51754-0.json |
| 5175-5 | Helicobacter pylori Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5175-5.json |
| 51756-5 | ATP7B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/51756-5.json |
| 51757-3 | POMT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/51757-3.json |
| 51758-1 | POMT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/51758-1.json |
| 51759-9 | RAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/51759-9.json |
| 51760-7 | Ehrlichia chaffeensis IgG+IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51760-7.json |
| 5176-3 | Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5176-3.json |
| 51763-1 | Muscle specific receptor tyrosine kinase Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51763-1.json |
| 51765-6 | Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51765-6.json |
| 5177-1 | Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5177-1.json |
| 51771-4 | Histoplasma capsulatum DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51771-4.json |
| 51773-0 | HEXA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/51773-0.json |
| 51774-8 | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/51774-8.json |
| 51775-5 | Chromatin Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51775-5.json |
| 51776-3 | 7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/51776-3.json |
| 51777-1 | 7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/51777-1.json |
| 51778-9 | YY1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/51778-9.json |
| 51779-7 | CFH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/51779-7.json |
| 51780-5 | HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 0.5 log copies/mL | ./2.16.840.1.114222.4.11.1002/51780-5.json |
| 51781-3 | Carbon dioxide, total [Moles/volume] in Capillary blood by calculation | ./2.16.840.1.114222.4.11.1002/51781-3.json |
| 51783-9 | Reagin Ab [Presence] in Cord blood by VDRL | ./2.16.840.1.114222.4.11.1002/51783-9.json |
| 51787-0 | Blastomyces dermatitidis Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/51787-0.json |
| 51788-8 | Coccidioides sp Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/51788-8.json |
| 5178-9 | Haemophilus influenzae Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5178-9.json |
| 51789-6 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/51789-6.json |
| 51790-4 | RBC casts [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/51790-4.json |
| 51792-0 | Citrate/Creatinine [Mass Ratio] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/51792-0.json |
| 51794-6 | Mitochondria M2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51794-6.json |
| 51795-3 | Complement C1 esterase inhibitor bound Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51795-3.json |
| 51796-1 | PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/51796-1.json |
| 5179-7 | Hepatitis A virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5179-7.json |
| 51797-9 | CV2 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51797-9.json |
| 51798-7 | Hepatitis E virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51798-7.json |
| 51799-5 | Adenosine deaminase [Enzymatic activity/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/51799-5.json |
| 51800-1 | Homogentisate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/51800-1.json |
| 51801-9 | Myeloperoxidase Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51801-9.json |
| 51802-7 | Phosphatidylserine IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51802-7.json |
| 51803-5 | Fibrillarin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51803-5.json |
| 51804-3 | Rickettsia conorii IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51804-3.json |
| 5180-5 | Hepatitis A virus IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5180-5.json |
| 51805-0 | Rickettsia conorii IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51805-0.json |
| 51806-8 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51806-8.json |
| 51807-6 | Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51807-6.json |
| 51808-4 | Chlamydophila psittaci IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51808-4.json |
| 51809-2 | Chlamydophila psittaci IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51809-2.json |
| 51810-0 | Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51810-0.json |
| 51811-8 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51811-8.json |
| 51812-6 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51812-6.json |
| 5181-3 | Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5181-3.json |
| 51813-4 | Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51813-4.json |
| 51814-2 | Legionella pneumophila IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51814-2.json |
| 51815-9 | Leptospira sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51815-9.json |
| 51816-7 | Bartonella quintana IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51816-7.json |
| 51817-5 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51817-5.json |
| 51818-3 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51818-3.json |
| 51819-1 | Leptospira sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51819-1.json |
| 51820-9 | Listeria monocytogenes IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51820-9.json |
| 5182-1 | Hepatitis A virus IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5182-1.json |
| 51821-7 | Bartonella quintana IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51821-7.json |
| 51822-5 | Adenovirus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51822-5.json |
| 51823-3 | Adenovirus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51823-3.json |
| 51824-1 | Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51824-1.json |
| 51825-8 | Bordetella parapertussis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51825-8.json |
| 51826-6 | Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51826-6.json |
| 51827-4 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51827-4.json |
| 51828-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51828-2.json |
| 51829-0 | Lactate [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/51829-0.json |
| 51831-6 | Beta-2 transferrin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/51831-6.json |
| 51832-4 | Brucella abortus Ab [Presence] in Cerebral spinal fluid by Acidified buffered plate agglutination | ./2.16.840.1.114222.4.11.1002/51832-4.json |
| 51834-0 | Tryptase [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51834-0.json |
| 51835-7 | Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/51835-7.json |
| 51836-5 | Angiotensin II [Mass/volume] in Plasma --upright | ./2.16.840.1.114222.4.11.1002/51836-5.json |
| 51837-3 | Bordetella parapertussis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51837-3.json |
| 51838-1 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51838-1.json |
| 5183-9 | Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5183-9.json |
| 51839-9 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51839-9.json |
| 51840-7 | Echovirus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51840-7.json |
| 51841-5 | Echovirus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51841-5.json |
| 51842-3 | Plasmodium falciparum IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51842-3.json |
| 51843-1 | Malonate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/51843-1.json |
| 51844-9 | Cortisol [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/51844-9.json |
| 51845-6 | Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/51845-6.json |
| 51846-4 | Emergency department Consult note | ./2.16.840.1.114222.4.11.1002/51846-4.json |
| 5184-7 | Hepatitis A virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5184-7.json |
| 51847-2 | Evaluation + Plan note | ./2.16.840.1.114222.4.11.1002/51847-2.json |
| 51848-0 | Evaluation note | ./2.16.840.1.114222.4.11.1002/51848-0.json |
| 51849-8 | Admission history and physical note | ./2.16.840.1.114222.4.11.1002/51849-8.json |
| 51850-6 | Physical findings of Head and Ears and Eyes and Nose and Throat | ./2.16.840.1.114222.4.11.1002/51850-6.json |
| 51851-4 | Administrative note | ./2.16.840.1.114222.4.11.1002/51851-4.json |
| 51852-2 | Letter | ./2.16.840.1.114222.4.11.1002/51852-2.json |
| 5185-4 | Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5185-4.json |
| 51854-8 | Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/51854-8.json |
| 51855-5 | Patient Note | ./2.16.840.1.114222.4.11.1002/51855-5.json |
| 51856-3 | Staphylococcus aureus TSST-1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51856-3.json |
| 51857-1 | Malassezia sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51857-1.json |
| 51858-9 | Budgerigar serum proteins+feathers+droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51858-9.json |
| 51859-7 | Pigeon serum proteins+feathers+droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51859-7.json |
| 51860-5 | Parrot serum proteins+feathers+droppings IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51860-5.json |
| 51861-3 | Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51861-3.json |
| 5186-2 | Hepatitis B virus core IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5186-2.json |
| 51862-1 | Mold Allergen Mix 7 (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) IgG Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/51862-1.json |
| 51865-4 | Plasmodium sp Ag [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/51865-4.json |
| 51867-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/51867-0.json |
| 5187-0 | Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5187-0.json |
| 51871-2 | Direct antiglobulin test.polyspecific reagent [presence] on Cord red blood cells | ./2.16.840.1.114222.4.11.1002/51871-2.json |
| 51872-0 | Transfuse platelet concentrate units [#] | ./2.16.840.1.114222.4.11.1002/51872-0.json |
| 5188-8 | Hepatitis B virus core Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5188-8.json |
| 51892-8 | ABO group [Type] in Cord blood | ./2.16.840.1.114222.4.11.1002/51892-8.json |
| 5189-6 | Hepatitis B virus e Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5189-6.json |
| 51897-7 | Healthcare Associated Infection report Document | ./2.16.840.1.114222.4.11.1002/51897-7.json |
| 51898-5 | Risk factors Document | ./2.16.840.1.114222.4.11.1002/51898-5.json |
| 51899-3 | Details Document | ./2.16.840.1.114222.4.11.1002/51899-3.json |
| 51900-9 | Population Summary note | ./2.16.840.1.114222.4.11.1002/51900-9.json |
| 51901-7 | Oat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51901-7.json |
| 51902-5 | Cadmium [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/51902-5.json |
| 51903-3 | Chromium [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/51903-3.json |
| 5190-4 | Hepatitis B virus e Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5190-4.json |
| 51904-1 | Orange IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51904-1.json |
| 51907-4 | Efavirenz [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/51907-4.json |
| 51908-2 | Efavirenz [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/51908-2.json |
| 51910-8 | Erythrocytes [#/area] in Bronchoalveolar lavage by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/51910-8.json |
| 5191-2 | Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5191-2.json |
| 51913-2 | Hepatitis A virus IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51913-2.json |
| 51914-0 | Hepatitis B virus core IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/51914-0.json |
| 51915-7 | Herpes simplex virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51915-7.json |
| 51916-5 | Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/51916-5.json |
| 51917-3 | Barley IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51917-3.json |
| 51918-1 | Indinavir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/51918-1.json |
| 51919-9 | Lettuce IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51919-9.json |
| 5192-0 | Hepatitis B virus e Ag [Presence] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5192-0.json |
| 51920-7 | Legionella sp Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/51920-7.json |
| 51921-5 | Lopinavir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/51921-5.json |
| 51922-3 | Malt IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51922-3.json |
| 51923-1 | Nelfinavir [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/51923-1.json |
| 51924-9 | Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51924-9.json |
| 51925-6 | Nevirapine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/51925-6.json |
| 51926-4 | Nucleated cells [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/51926-4.json |
| 51928-0 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51928-0.json |
| 51929-8 | Ritonavir [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/51929-8.json |
| 51930-6 | Ritonavir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/51930-6.json |
| 51931-4 | Rubella virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51931-4.json |
| 51932-2 | Saquinavir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/51932-2.json |
| 51933-0 | Rye IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51933-0.json |
| 51935-5 | Trypsinogen I Free [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/51935-5.json |
| 51937-1 | HLA-A+B+Bw+DR [Type] | ./2.16.840.1.114222.4.11.1002/51937-1.json |
| 5193-8 | Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5193-8.json |
| 51938-9 | HLA-A+B+Bw+DR [Type] in Donor | ./2.16.840.1.114222.4.11.1002/51938-9.json |
| 5194-6 | Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5194-6.json |
| 51950-4 | Calcium [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/51950-4.json |
| 5195-3 | Hepatitis B virus surface Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/5195-3.json |
| 51954-6 | oxyCODONE Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51954-6.json |
| 51955-3 | Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/51955-3.json |
| 5196-1 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5196-1.json |
| 51976-9 | Bacillus anthracis capsule Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/51976-9.json |
| 51977-7 | Chromium [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/51977-7.json |
| 51978-5 | Coxsackievirus A Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/51978-5.json |
| 5197-9 | Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5197-9.json |
| 51979-3 | Donepezil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51979-3.json |
| 51980-1 | Glomerular basement membrane Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/51980-1.json |
| 51981-9 | HER2 [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/51981-9.json |
| 51982-7 | lamoTRIgine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51982-7.json |
| 51983-5 | Levodopa [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51983-5.json |
| 51984-3 | Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/51984-3.json |
| 51985-0 | Modafinil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51985-0.json |
| 51986-8 | niCARdipine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51986-8.json |
| 5198-7 | Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5198-7.json |
| 51987-6 | Coenzyme Q10 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51987-6.json |
| 51988-4 | Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/51988-4.json |
| 51989-2 | Vasoactive intestinal peptide [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/51989-2.json |
| 5199-5 | Hepatitis C virus Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/5199-5.json |
| 5200-1 | Hepatitis D virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5200-1.json |
| 5201-9 | Hepatitis D virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5201-9.json |
| 5202-7 | Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5202-7.json |
| 52027-0 | Abortion consent Document | ./2.16.840.1.114222.4.11.1002/52027-0.json |
| 52028-8 | Hysterectomy consent Document | ./2.16.840.1.114222.4.11.1002/52028-8.json |
| 52029-6 | Sterilization consent Document | ./2.16.840.1.114222.4.11.1002/52029-6.json |
| 52030-4 | Explanation of benefits | ./2.16.840.1.114222.4.11.1002/52030-4.json |
| 52031-2 | Explanation of benefits to subscriber | ./2.16.840.1.114222.4.11.1002/52031-2.json |
| 52032-0 | Appeal denial letter | ./2.16.840.1.114222.4.11.1002/52032-0.json |
| 52034-6 | Payer letter | ./2.16.840.1.114222.4.11.1002/52034-6.json |
| 5203-5 | Herpes simplex virus Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5203-5.json |
| 52035-3 | Home health claims | ./2.16.840.1.114222.4.11.1002/52035-3.json |
| 52036-1 | Home health prior authorization | ./2.16.840.1.114222.4.11.1002/52036-1.json |
| 52037-9 | Member ID card copy | ./2.16.840.1.114222.4.11.1002/52037-9.json |
| 52038-7 | Subscriber Information including retroactive and presumptive eligibility | ./2.16.840.1.114222.4.11.1002/52038-7.json |
| 52039-5 | Skilled Nursing Facility (SNF) record | ./2.16.840.1.114222.4.11.1002/52039-5.json |
| 52041-1 | Blood glucose monitor attachment | ./2.16.840.1.114222.4.11.1002/52041-1.json |
| 52042-9 | Continuous positive airway pressure (CPAP) attachment | ./2.16.840.1.114222.4.11.1002/52042-9.json |
| 5204-3 | Herpes simplex virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5204-3.json |
| 52045-2 | Gait trainers attachment | ./2.16.840.1.114222.4.11.1002/52045-2.json |
| 52047-8 | Immunosuppressive drug attachment | ./2.16.840.1.114222.4.11.1002/52047-8.json |
| 52048-6 | Lymphedema pump attachment | ./2.16.840.1.114222.4.11.1002/52048-6.json |
| 52049-4 | Manual wheelchair attachment | ./2.16.840.1.114222.4.11.1002/52049-4.json |
| 5205-0 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5205-0.json |
| 52050-2 | Motorized wheelchair attachment | ./2.16.840.1.114222.4.11.1002/52050-2.json |
| 52052-8 | Osteogenesis stimulator attachment | ./2.16.840.1.114222.4.11.1002/52052-8.json |
| 52054-4 | Parenteral nutrition attachment | ./2.16.840.1.114222.4.11.1002/52054-4.json |
| 52055-1 | Power operated vehicle attachment | ./2.16.840.1.114222.4.11.1002/52055-1.json |
| 52056-9 | Repair of durable medical equipment attachment | ./2.16.840.1.114222.4.11.1002/52056-9.json |
| 52057-7 | Seat lift mechanism attachment | ./2.16.840.1.114222.4.11.1002/52057-7.json |
| 52058-5 | Seating system attachment | ./2.16.840.1.114222.4.11.1002/52058-5.json |
| 52059-3 | Speech generating device attachment | ./2.16.840.1.114222.4.11.1002/52059-3.json |
| 52060-1 | Standers/standing frame attachment | ./2.16.840.1.114222.4.11.1002/52060-1.json |
| 52061-9 | Support surface attachment | ./2.16.840.1.114222.4.11.1002/52061-9.json |
| 52063-5 | Prescription for durable medical equipment (DME) | ./2.16.840.1.114222.4.11.1002/52063-5.json |
| 52065-0 | Automobile liability attachment | ./2.16.840.1.114222.4.11.1002/52065-0.json |
| 52066-8 | Notice of Discharge Medicare Appeal Rights (NODMAR) form | ./2.16.840.1.114222.4.11.1002/52066-8.json |
| 52067-6 | Past filing limit justification | ./2.16.840.1.114222.4.11.1002/52067-6.json |
| 5206-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5206-8.json |
| 52071-8 | Employee assistance program attachment | ./2.16.840.1.114222.4.11.1002/52071-8.json |
| 52072-6 | Non-emergency transportation attachment | ./2.16.840.1.114222.4.11.1002/52072-6.json |
| 52075-9 | Purchase invoice | ./2.16.840.1.114222.4.11.1002/52075-9.json |
| 5207-6 | Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5207-6.json |
| 5208-4 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5208-4.json |
| 5209-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5209-2.json |
| 5210-0 | Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5210-0.json |
| 5211-8 | Herpes virus 6 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5211-8.json |
| 52123-7 | aPTT in Platelet poor plasma by Coagulation assay --post heparin neutralization | ./2.16.840.1.114222.4.11.1002/52123-7.json |
| 5212-6 | Herpes virus 6 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5212-6.json |
| 52126-0 | Acid glycerol lysis [Time] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/52126-0.json |
| 5213-4 | Heterophile Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5213-4.json |
| 5215-9 | Heterophile Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5215-9.json |
| 5216-7 | Heterophile Ab after absorption [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5216-7.json |
| 5217-5 | Histone Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5217-5.json |
| 5218-3 | Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5218-3.json |
| 52184-9 | Pulmonary therapy service attachment | ./2.16.840.1.114222.4.11.1002/52184-9.json |
| 5219-1 | Histoplasma capsulatum Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5219-1.json |
| 5220-9 | HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5220-9.json |
| 5221-7 | HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/5221-7.json |
| 5222-5 | HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5222-5.json |
| 5223-3 | HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5223-3.json |
| 5224-1 | HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5224-1.json |
| 5225-8 | HIV 2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/5225-8.json |
| 5226-6 | HTLV I+II Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5226-6.json |
| 5227-4 | Streptococcal hyaluronidase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/5227-4.json |
| 5228-2 | Immune complex [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5228-2.json |
| 5229-0 | Influenza virus A Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5229-0.json |
| 5230-8 | Influenza virus B Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5230-8.json |
| 5231-6 | Influenza virus C Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5231-6.json |
| 5232-4 | Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5232-4.json |
| 5233-2 | Intrinsic factor Ab [Presence] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5233-2.json |
| 5234-0 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5234-0.json |
| 5235-7 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5235-7.json |
| 5236-5 | Legionella pneumophila Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5236-5.json |
| 5237-3 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5237-3.json |
| 5238-1 | Leishmania sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5238-1.json |
| 5239-9 | Leptospira sp Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5239-9.json |
| 5240-7 | Listeria monocytogenes Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5240-7.json |
| 5241-5 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5241-5.json |
| 5242-3 | Measles virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5242-3.json |
| 5243-1 | Measles virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5243-1.json |
| 5244-9 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5244-9.json |
| 52455-3 | Admission date | ./2.16.840.1.114222.4.11.1002/52455-3.json |
| 5245-6 | Measles virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5245-6.json |
| 52462-9 | Nickname | ./2.16.840.1.114222.4.11.1002/52462-9.json |
| 52463-7 | Patient Identification Number or Provider Account Number | ./2.16.840.1.114222.4.11.1002/52463-7.json |
| 5246-4 | Saccharopolyspora rectivirgula Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5246-4.json |
| 5247-2 | Mitochondria Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5247-2.json |
| 5248-0 | Mucor sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5248-0.json |
| 52491-8 | Brief interview for mental status [BIMS] | ./2.16.840.1.114222.4.11.1002/52491-8.json |
| 5249-8 | Mumps virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5249-8.json |
| 5250-6 | Mumps virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5250-6.json |
| 5251-4 | Muscle sarcolemma Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5251-4.json |
| 5252-2 | Mycoplasma pneumoniae Ab [Units/volume] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5252-2.json |
| 52525-3 | Discharge date | ./2.16.840.1.114222.4.11.1002/52525-3.json |
| 5253-0 | Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5253-0.json |
| 52539-4 | Prior postal code [Location] | ./2.16.840.1.114222.4.11.1002/52539-4.json |
| 5254-8 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5254-8.json |
| 5255-5 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5255-5.json |
| 52556-8 | Payment sources | ./2.16.840.1.114222.4.11.1002/52556-8.json |
| 5256-3 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5256-3.json |
| 5257-1 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5257-1.json |
| 5258-9 | Mycoplasma pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5258-9.json |
| 5259-7 | Myelin basic protein Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5259-7.json |
| 5260-5 | Myocardium Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5260-5.json |
| 5261-3 | Neisseria gonorrhoeae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5261-3.json |
| 5262-1 | Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5262-1.json |
| 5263-9 | Nocardia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5263-9.json |
| 5264-7 | Onchocerca sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5264-7.json |
| 5265-4 | Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5265-4.json |
| 5266-2 | Paracoccidioides brasiliensis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5266-2.json |
| 5267-0 | Paragonimus sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5267-0.json |
| 5268-8 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5268-8.json |
| 5269-6 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5269-6.json |
| 5270-4 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5270-4.json |
| 5271-2 | Parietal cell Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5271-2.json |
| 5272-0 | Parvovirus B19 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5272-0.json |
| 5273-8 | Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5273-8.json |
| 5274-6 | Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5274-6.json |
| 52749-9 | Etravirine [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/52749-9.json |
| 52750-7 | Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52750-7.json |
| 52751-5 | aPTT.factor sensitive in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52751-5.json |
| 52752-3 | Prothrombin time (PT) PIVKA insensitive actual/normal in Capillary blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52752-3.json |
| 5275-3 | PCNA extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5275-3.json |
| 52753-1 | Prothrombin time (PT) PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52753-1.json |
| 52754-9 | Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52754-9.json |
| 52755-6 | aPTT.lupus sensitive [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52755-6.json |
| 52756-4 | dRVVT excess phospholipid [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52756-4.json |
| 52757-2 | SERPINE1 gene c.-675 4G+5G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/52757-2.json |
| 52758-0 | SERPINE1 gene c.-844A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/52758-0.json |
| 52759-8 | Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52759-8.json |
| 52760-6 | Prothrombin time (PT) PIVKA sensitive actual/normal in Capillary blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52760-6.json |
| 5276-1 | PCNA extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5276-1.json |
| 52761-4 | Prothrombin time (PT) PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/52761-4.json |
| 52766-3 | aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTT | ./2.16.840.1.114222.4.11.1002/52766-3.json |
| 52767-1 | Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT) | ./2.16.840.1.114222.4.11.1002/52767-1.json |
| 5277-9 | Penicillium roqueforti Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5277-9.json |
| 5278-7 | Plasmodium falciparum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5278-7.json |
| 52789-5 | Clot initiation [Time] in Blood by Thromboelastography | ./2.16.840.1.114222.4.11.1002/52789-5.json |
| 52790-3 | CT Guidance for percutaneous replacement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/52790-3.json |
| 52791-1 | CT Guidance for percutaneous replacement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/52791-1.json |
| 52792-9 | Father's Rh Type | ./2.16.840.1.114222.4.11.1002/52792-9.json |
| 52793-7 | Father's ABO group Type | ./2.16.840.1.114222.4.11.1002/52793-7.json |
| 52794-5 | Ova and parasites identified in Specimen by Light microscopy--3rd specimen | ./2.16.840.1.114222.4.11.1002/52794-5.json |
| 5279-5 | Plasmodium sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5279-5.json |
| 52795-2 | Ova and parasites identified in Specimen by Light microscopy--2nd specimen | ./2.16.840.1.114222.4.11.1002/52795-2.json |
| 52797-8 | Diagnosis ICD code [Identifier] | ./2.16.840.1.114222.4.11.1002/52797-8.json |
| 5280-3 | Plasmodium vivax Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5280-3.json |
| 5281-1 | Polio virus 1 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5281-1.json |
| 52822-4 | Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52822-4.json |
| 52823-2 | La Crosse virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52823-2.json |
| 52824-0 | La Crosse virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52824-0.json |
| 52825-7 | La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/52825-7.json |
| 5282-9 | Polio virus 1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5282-9.json |
| 5283-7 | Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5283-7.json |
| 5284-5 | Polio virus 2 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5284-5.json |
| 5285-2 | Polio virus 3 neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/5285-2.json |
| 5286-0 | Polio virus 3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5286-0.json |
| 5287-8 | Burkholderia pseudomallei Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5287-8.json |
| 5288-6 | Rabies virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5288-6.json |
| 52886-9 | Tellurium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52886-9.json |
| 52887-7 | Bismuth [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52887-7.json |
| 52888-5 | Silicon [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52888-5.json |
| 52889-3 | Selenium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52889-3.json |
| 52890-1 | Lead [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52890-1.json |
| 52891-9 | Chromium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52891-9.json |
| 52892-7 | Aluminum [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52892-7.json |
| 52893-5 | Vanadium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/52893-5.json |
| 5289-4 | Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL | ./2.16.840.1.114222.4.11.1002/5289-4.json |
| 52894-3 | Titanium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/52894-3.json |
| 52895-0 | Tellurium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52895-0.json |
| 52896-8 | Silver [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/52896-8.json |
| 52897-6 | Platinum [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52897-6.json |
| 52898-4 | Bismuth [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52898-4.json |
| 52899-2 | Beryllium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/52899-2.json |
| 52900-8 | Vanadium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52900-8.json |
| 52901-6 | Vanadium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52901-6.json |
| 5290-2 | Reagin Ab [Presence] in Cerebral spinal fluid by VDRL | ./2.16.840.1.114222.4.11.1002/5290-2.json |
| 52902-4 | Uranium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52902-4.json |
| 52903-2 | Uranium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52903-2.json |
| 52904-0 | Silver/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52904-0.json |
| 52905-7 | Silver/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52905-7.json |
| 52906-5 | Bismuth/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52906-5.json |
| 52907-3 | Bismuth/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52907-3.json |
| 52908-1 | Selenium [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52908-1.json |
| 52909-9 | Platinum [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52909-9.json |
| 5291-0 | Reagin Ab [Units/volume] in Serum by VDRL | ./2.16.840.1.114222.4.11.1002/5291-0.json |
| 52910-7 | Zinc [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52910-7.json |
| 52911-5 | Magnesium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52911-5.json |
| 52912-3 | Copper [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/52912-3.json |
| 52913-1 | Selenium [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/52913-1.json |
| 52914-9 | Boron [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/52914-9.json |
| 52915-6 | Aluminum [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52915-6.json |
| 52916-4 | Tin/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52916-4.json |
| 52917-2 | Tin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52917-2.json |
| 52918-0 | Thallium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52918-0.json |
| 52919-8 | Tellurium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52919-8.json |
| 52920-6 | Tellurium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52920-6.json |
| 52921-4 | Strontium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52921-4.json |
| 52922-2 | Strontium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52922-2.json |
| 52923-0 | Selenium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52923-0.json |
| 52924-8 | Platinum/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52924-8.json |
| 52925-5 | Platinum/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52925-5.json |
| 52926-3 | Nickel/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52926-3.json |
| 52927-1 | Molybdenum/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52927-1.json |
| 5292-8 | Reagin Ab [Presence] in Serum by VDRL | ./2.16.840.1.114222.4.11.1002/5292-8.json |
| 52928-9 | Molybdenum/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52928-9.json |
| 52929-7 | Mercury/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52929-7.json |
| 52930-5 | Manganese/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52930-5.json |
| 52931-3 | Lead/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52931-3.json |
| 52932-1 | Copper/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52932-1.json |
| 52933-9 | Cobalt/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52933-9.json |
| 52934-7 | Chromium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52934-7.json |
| 52935-4 | Beryllium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52935-4.json |
| 5293-6 | Reovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5293-6.json |
| 52936-2 | Beryllium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52936-2.json |
| 52937-0 | Barium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52937-0.json |
| 52938-8 | Barium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52938-8.json |
| 52939-6 | Arsenic.inorganic/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52939-6.json |
| 52940-4 | Arsenic.inorganic/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52940-4.json |
| 52941-2 | Antimony/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52941-2.json |
| 52942-0 | Antimony/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52942-0.json |
| 52943-8 | Aluminum/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/52943-8.json |
| 5294-4 | Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5294-4.json |
| 52944-6 | Aluminum/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/52944-6.json |
| 52945-3 | LORazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52945-3.json |
| 52946-1 | diazePAM [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52946-1.json |
| 52947-9 | Dextromethorphan [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52947-9.json |
| 52948-7 | cloBAZam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52948-7.json |
| 52949-5 | chlordiazePOXIDE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52949-5.json |
| 52950-3 | Barbital [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52950-3.json |
| 5295-1 | Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5295-1.json |
| 52951-1 | Phencyclidine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52951-1.json |
| 52952-9 | Opiates [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52952-9.json |
| 52953-7 | Cocaine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52953-7.json |
| 52954-5 | Cannabinoids [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52954-5.json |
| 52955-2 | Benzodiazepines [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52955-2.json |
| 52956-0 | Barbiturates [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52956-0.json |
| 52957-8 | Amphetamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52957-8.json |
| 52958-6 | Methadone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/52958-6.json |
| 52959-4 | cloBAZam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/52959-4.json |
| 52960-2 | cloNIDine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/52960-2.json |
| 52961-0 | Paraquat [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/52961-0.json |
| 52962-8 | Tobramycin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/52962-8.json |
| 52963-6 | Flurazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52963-6.json |
| 52964-4 | cloBAZam [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52964-4.json |
| 52965-1 | clonazePAM [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/52965-1.json |
| 52966-9 | Bacteria identified in Anal by Culture | ./2.16.840.1.114222.4.11.1002/52966-9.json |
| 52967-7 | Bacteria identified in Gastric fluid by Culture | ./2.16.840.1.114222.4.11.1002/52967-7.json |
| 52968-5 | Streptococcus agalactiae [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/52968-5.json |
| 5296-9 | Reticulin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5296-9.json |
| 52969-3 | Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture | ./2.16.840.1.114222.4.11.1002/52969-3.json |
| 52970-1 | CV2 Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/52970-1.json |
| 52971-9 | Immune complex [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/52971-9.json |
| 52972-7 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/52972-7.json |
| 52973-5 | Bacteria identified in Sputum tracheal aspirate by Culture | ./2.16.840.1.114222.4.11.1002/52973-5.json |
| 52974-3 | Influenza virus B Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52974-3.json |
| 52975-0 | Respiratory syncytial virus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52975-0.json |
| 52976-8 | Cytomegalovirus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52976-8.json |
| 5297-7 | Rheumatoid factor [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5297-7.json |
| 52977-6 | Herpes simplex virus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52977-6.json |
| 52978-4 | Varicella zoster virus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52978-4.json |
| 52979-2 | Trichinella spiralis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/52979-2.json |
| 52980-0 | Plasmodium sp IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/52980-0.json |
| 52981-8 | Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52981-8.json |
| 52982-6 | Echinococcus sp IgG1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52982-6.json |
| 52983-4 | Echinococcus sp IgG4 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52983-4.json |
| 52984-2 | Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/52984-2.json |
| 5298-5 | Rheumatoid factor [Presence] in Serum by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/5298-5.json |
| 52985-9 | Leishmania sp IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/52985-9.json |
| 52986-7 | Rubella virus IgG Ab avidity [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/52986-7.json |
| 52987-5 | Mycoplasma pneumoniae Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/52987-5.json |
| 52988-3 | Leptospira sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/52988-3.json |
| 52989-1 | Leptospira sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/52989-1.json |
| 52990-9 | Leptospira sp DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/52990-9.json |
| 5299-3 | Rheumatoid factor [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5299-3.json |
| 53000-6 | Mitochondria M4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53000-6.json |
| 53001-4 | Mitochondria M9 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53001-4.json |
| 53002-2 | Fine speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53002-2.json |
| 53003-0 | Mitotic spindle apparatus Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53003-0.json |
| 53004-8 | Mitotic spindle apparatus Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53004-8.json |
| 53005-5 | Fibrillarin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53005-5.json |
| 53006-3 | PCNA extractable nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53006-3.json |
| 53007-1 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53007-1.json |
| 53008-9 | PM-SCL extractable nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53008-9.json |
| 5300-9 | Rheumatoid factor [Titer] in Serum by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/5300-9.json |
| 53009-7 | Ribosomal Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53009-7.json |
| 53010-5 | Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53010-5.json |
| 53011-3 | Signal Recognition Particle (SRP) Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53011-3.json |
| 53012-1 | Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53012-1.json |
| 53013-9 | Bactericidal permeability increasing protein Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53013-9.json |
| 53014-7 | Nucleosome Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53014-7.json |
| 53015-4 | Nucleosome Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53015-4.json |
| 53016-2 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53016-2.json |
| 5301-7 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5301-7.json |
| 53017-0 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53017-0.json |
| 53018-8 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53018-8.json |
| 53019-6 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53019-6.json |
| 53020-4 | Complement C1q Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53020-4.json |
| 53021-2 | Salivary gland Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53021-2.json |
| 53022-0 | U1 small nuclear ribonucleoprotein Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53022-0.json |
| 53023-8 | Tissue transglutaminase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53023-8.json |
| 53024-6 | Baker's yeast Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53024-6.json |
| 5302-5 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5302-5.json |
| 53025-3 | Gliadin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53025-3.json |
| 53026-1 | Tissue transglutaminase IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53026-1.json |
| 53027-9 | Cyclic citrullinated peptide Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53027-9.json |
| 53028-7 | Cyclic citrullinated peptide Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53028-7.json |
| 53029-5 | Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53029-5.json |
| 53030-3 | Liver kidney microsomal Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53030-3.json |
| 53031-1 | Signal Recognition Particle (SRP) Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53031-1.json |
| 53032-9 | U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53032-9.json |
| 5303-3 | Rickettsia (Proteus OX19) Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5303-3.json |
| 5304-1 | Rickettsia (Proteus OX2) Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5304-1.json |
| 53047-7 | Chromogranin A [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53047-7.json |
| 53048-5 | Ferritin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53048-5.json |
| 53049-3 | Glucose [Mass/volume] in Serum or Plasma --pre-meal | ./2.16.840.1.114222.4.11.1002/53049-3.json |
| 53050-1 | Glucose [Mass/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/53050-1.json |
| 53052-7 | Collagen crosslinked C-telopeptide [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53052-7.json |
| 53053-5 | Carnitine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53053-5.json |
| 53054-3 | Carnitine free (C0) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53054-3.json |
| 53055-0 | Creatine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53055-0.json |
| 53056-8 | Decanoylcarnitine (C10) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53056-8.json |
| 53057-6 | Decenoylcarnitine (C10:1) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53057-6.json |
| 5305-8 | Rickettsia (Proteus OXK) Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5305-8.json |
| 53058-4 | Dodecanoylcarnitine (C12) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53058-4.json |
| 53059-2 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53059-2.json |
| 53060-0 | Butyrylcarnitine (C4) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53060-0.json |
| 53061-8 | Ketones [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53061-8.json |
| 53062-6 | Argininosuccinate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53062-6.json |
| 53063-4 | Beta alanine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53063-4.json |
| 53064-2 | Beta aminoisobutyrate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53064-2.json |
| 53065-9 | Butyrylcarnitine (C4) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53065-9.json |
| 5306-6 | Rickettsia sp Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5306-6.json |
| 53066-7 | Cystathionine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53066-7.json |
| 53067-5 | Argininosuccinate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53067-5.json |
| 53068-3 | Beta alanine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53068-3.json |
| 53069-1 | Cystathionine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53069-1.json |
| 53070-9 | Butyrylcarnitine (C4) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53070-9.json |
| 53071-7 | Carnitine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53071-7.json |
| 53072-5 | Carnitine free (C0) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53072-5.json |
| 53073-3 | Ceruloplasmin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53073-3.json |
| 5307-4 | Rickettsia rickettsii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5307-4.json |
| 53074-1 | Creatine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53074-1.json |
| 53075-8 | Decanoylcarnitine (C10) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53075-8.json |
| 53076-6 | Decenoylcarnitine (C10:1) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53076-6.json |
| 53077-4 | Levodopa [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53077-4.json |
| 53078-2 | Dodecanoylcarnitine (C12) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53078-2.json |
| 53079-0 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53079-0.json |
| 53080-8 | Cystine [Moles/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/53080-8.json |
| 53081-6 | Ammonia [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53081-6.json |
| 5308-2 | Rickettsia rickettsii IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5308-2.json |
| 53082-4 | Cholesterol [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53082-4.json |
| 53083-2 | Bilirubin.conjugated [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53083-2.json |
| 53084-0 | Glucose [Moles/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/53084-0.json |
| 53085-7 | Base excess in Nonbiological fluid by calculation | ./2.16.840.1.114222.4.11.1002/53085-7.json |
| 53086-5 | Bicarbonate [Moles/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/53086-5.json |
| 53087-3 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/53087-3.json |
| 53088-1 | Calcium.ionized [Moles/volume] in Nonbiological fluid by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/53088-1.json |
| 53089-9 | Carbon dioxide, total [Moles/volume] in Nonbiological fluid by calculation | ./2.16.840.1.114222.4.11.1002/53089-9.json |
| 5309-0 | Rickettsia spotted fever group Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5309-0.json |
| 53090-7 | Carbon dioxide, total [Moles/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/53090-7.json |
| 53091-5 | Nitrogen.nonprotein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53091-5.json |
| 53092-3 | Collagen crosslinked C-telopeptide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53092-3.json |
| 53097-2 | 3-O-Methyldopa [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53097-2.json |
| 53098-0 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53098-0.json |
| 53099-8 | Chloride [Moles/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/53099-8.json |
| 53100-4 | Calcium [Moles/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/53100-4.json |
| 53101-2 | Kynurenate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53101-2.json |
| 53102-0 | Decanoylcarnitine (C10) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53102-0.json |
| 53103-8 | Decenoylcarnitine (C10:1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53103-8.json |
| 53104-6 | Dodecenoylcarnitine (C12:1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53104-6.json |
| 53105-3 | 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53105-3.json |
| 53106-1 | Butyrylcarnitine (C4) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53106-1.json |
| 53107-9 | Kynurenate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53107-9.json |
| 5310-8 | Rickettsia spotted fever group Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5310-8.json |
| 53108-7 | Decenoylcarnitine (C10:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53108-7.json |
| 53109-5 | Docosenoate (C22:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53109-5.json |
| 53110-3 | 5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53110-3.json |
| 53111-1 | Butyrylcarnitine (C4)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53111-1.json |
| 53113-7 | Spermatids/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/53113-7.json |
| 5311-6 | Rickettsia spotted fever group Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5311-6.json |
| 53120-2 | Creatinine [Moles/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53120-2.json |
| 53121-0 | Protein [Mass/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53121-0.json |
| 53122-8 | Sodium [Moles/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53122-8.json |
| 53123-6 | Potassium [Moles/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53123-6.json |
| 5312-4 | Rickettsia spotted fever group IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5312-4.json |
| 53124-4 | Calcium [Moles/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53124-4.json |
| 5313-2 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5313-2.json |
| 53133-5 | Cholesterol in LDL [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53133-5.json |
| 53135-0 | Cholesterol in HDL [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53135-0.json |
| 53137-6 | Urea [Moles/time] in 1 hour Urine | ./2.16.840.1.114222.4.11.1002/53137-6.json |
| 53138-4 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Arterial blood | ./2.16.840.1.114222.4.11.1002/53138-4.json |
| 53139-2 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood | ./2.16.840.1.114222.4.11.1002/53139-2.json |
| 5314-0 | Rickettsia spotted fever group IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5314-0.json |
| 53140-0 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Venous blood | ./2.16.840.1.114222.4.11.1002/53140-0.json |
| 53142-6 | Nitrogen [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/53142-6.json |
| 53143-4 | Hydrogen ion [Moles/volume] in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/53143-4.json |
| 53144-2 | Somatotropin [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/53144-2.json |
| 53148-3 | DNA double strand Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/53148-3.json |
| 53149-1 | Iron/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53149-1.json |
| 53150-9 | Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53150-9.json |
| 53151-7 | Valine/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53151-7.json |
| 53152-5 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53152-5.json |
| 53153-3 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53153-3.json |
| 53154-1 | Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53154-1.json |
| 53156-6 | Methionine/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53156-6.json |
| 5315-7 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5315-7.json |
| 53157-4 | Citrulline/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53157-4.json |
| 53158-2 | Homocitrulline [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53158-2.json |
| 53159-0 | Tryptophan [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53159-0.json |
| 53160-8 | Propionylcarnitine (C3) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53160-8.json |
| 53161-6 | Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53161-6.json |
| 53162-4 | Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53162-4.json |
| 53163-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53163-2.json |
| 53164-0 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53164-0.json |
| 5316-5 | Rickettsia typhus group Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5316-5.json |
| 53165-7 | Formiminoglutamate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53165-7.json |
| 53167-3 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53167-3.json |
| 53168-1 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53168-1.json |
| 53169-9 | Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53169-9.json |
| 53170-7 | Tiglylcarnitine (C5:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53170-7.json |
| 53171-5 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53171-5.json |
| 53172-3 | 3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53172-3.json |
| 5317-3 | Rickettsia typhus group Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5317-3.json |
| 53173-1 | 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53173-1.json |
| 53174-9 | Octenoylcarnitine (C8:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53174-9.json |
| 53175-6 | Octanoylcarnitine (C8) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53175-6.json |
| 53176-4 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53176-4.json |
| 53177-2 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53177-2.json |
| 53178-0 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53178-0.json |
| 53179-8 | 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53179-8.json |
| 53180-6 | Decadienoylcarnitine (C10:2) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53180-6.json |
| 5318-1 | Rickettsia typhus group Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5318-1.json |
| 53181-4 | Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53181-4.json |
| 53182-2 | 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53182-2.json |
| 53183-0 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53183-0.json |
| 53184-8 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53184-8.json |
| 53185-5 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53185-5.json |
| 53186-3 | Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53186-3.json |
| 53187-1 | Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53187-1.json |
| 53188-9 | 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53188-9.json |
| 53189-7 | 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53189-7.json |
| 53190-5 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53190-5.json |
| 53191-3 | Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53191-3.json |
| 53192-1 | Tetradecanoylcarnitine (C14) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53192-1.json |
| 53193-9 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53193-9.json |
| 53194-7 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53194-7.json |
| 53195-4 | Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53195-4.json |
| 53196-2 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53196-2.json |
| 53197-0 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53197-0.json |
| 53198-8 | Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53198-8.json |
| 5319-9 | Rickettsia typhus group IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5319-9.json |
| 53199-6 | Palmitoylcarnitine (C16) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53199-6.json |
| 53200-2 | Argininosuccinate/Arginine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53200-2.json |
| 53201-0 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53201-0.json |
| 53202-8 | Oleoylcarnitine (C18:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53202-8.json |
| 53203-6 | Hexenoylcarnitine (C6:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53203-6.json |
| 53204-4 | Heptanoylcarnitine (C7) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53204-4.json |
| 53205-1 | Phenylacetylcarnitine (PheC2) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53205-1.json |
| 53206-9 | Salicylylcarnitine (SalC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53206-9.json |
| 5320-7 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5320-7.json |
| 53207-7 | Nonanoylcarnitine (C9) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53207-7.json |
| 53208-5 | Decatrienoylcarnitine (C10:3) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53208-5.json |
| 53209-3 | Dehydrosuberylcarnitine (C8:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53209-3.json |
| 53210-1 | Suberylcarnitine (C8-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53210-1.json |
| 53211-9 | Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53211-9.json |
| 53212-7 | Sebacylcarnitine (C10-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53212-7.json |
| 53213-5 | Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53213-5.json |
| 53214-3 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53214-3.json |
| 5321-5 | Rickettsia typhus group IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5321-5.json |
| 53215-0 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53215-0.json |
| 53216-8 | Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53216-8.json |
| 53217-6 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53217-6.json |
| 53218-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53218-4.json |
| 53219-2 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53219-2.json |
| 532-2 | Mycobacterium sp identified in Aspirate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/532-2.json |
| 53220-0 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53220-0.json |
| 53221-8 | dRVVT in Control Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/53221-8.json |
| 53222-6 | Coagulation factor XI activated [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/53222-6.json |
| 5322-3 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5322-3.json |
| 53229-1 | Prealbumin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53229-1.json |
| 5323-1 | Orientia tsutsugamushi Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5323-1.json |
| 53231-7 | Succinylacetone [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53231-7.json |
| 53232-5 | 5-Oxoproline+Pipecolate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53232-5.json |
| 53233-3 | Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53233-3.json |
| 53234-1 | Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53234-1.json |
| 53235-8 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53235-8.json |
| 53236-6 | Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53236-6.json |
| 53237-4 | Acrylylcarnitine (C3:1) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53237-4.json |
| 53238-2 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53238-2.json |
| 53239-0 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53239-0.json |
| 53240-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53240-8.json |
| 53241-6 | Stearoylcarnitine (C18) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53241-6.json |
| 53242-4 | Charge ticket or encounter form | ./2.16.840.1.114222.4.11.1002/53242-4.json |
| 53243-2 | Advanced beneficiary notice | ./2.16.840.1.114222.4.11.1002/53243-2.json |
| 53244-0 | Notice of privacy practices receipt | ./2.16.840.1.114222.4.11.1002/53244-0.json |
| 53245-7 | Driver license | ./2.16.840.1.114222.4.11.1002/53245-7.json |
| 53246-5 | Non-medical services attachment | ./2.16.840.1.114222.4.11.1002/53246-5.json |
| 53247-3 | Eligibility acknowledgement | ./2.16.840.1.114222.4.11.1002/53247-3.json |
| 53248-1 | Plasmodium sp lactate dehydrogenase [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53248-1.json |
| 5324-9 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5324-9.json |
| 53249-9 | Human metapneumovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53249-9.json |
| 53250-7 | Influenza virus A RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53250-7.json |
| 53251-5 | Influenza virus B RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53251-5.json |
| 53252-3 | Parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53252-3.json |
| 53253-1 | Parainfluenza virus 2 RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53253-1.json |
| 53254-9 | Parainfluenza virus 3 RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53254-9.json |
| 53255-6 | Mycoplasma pneumoniae DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53255-6.json |
| 5325-6 | Rickettsia typhi IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5325-6.json |
| 53256-4 | Enterovirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53256-4.json |
| 53257-2 | Mycobacterium tuberculosis DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53257-2.json |
| 53259-8 | Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53259-8.json |
| 53260-6 | Glomerular basement membrane Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53260-6.json |
| 5326-4 | Bartonella henselae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5326-4.json |
| 5327-2 | Bartonella henselae IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5327-2.json |
| 5328-0 | Rotavirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5328-0.json |
| 5329-8 | Rotavirus Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) | ./2.16.840.1.114222.4.11.1002/5329-8.json |
| 533-0 | Mycobacterium sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/533-0.json |
| 5330-6 | Rubella virus Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/5330-6.json |
| 5331-4 | Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/5331-4.json |
| 5332-2 | Rubella virus Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5332-2.json |
| 5333-0 | Rubella virus Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5333-0.json |
| 53336-4 | 17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53336-4.json |
| 53337-2 | 17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/53337-2.json |
| 53338-0 | 11-Deoxycortisol [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53338-0.json |
| 53339-8 | 11-Deoxycortisol [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53339-8.json |
| 53340-6 | 17-Hydroxyprogesterone [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53340-6.json |
| 53341-4 | 21-Deoxycortisol [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53341-4.json |
| 53342-2 | 21-Deoxycortisol [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53342-2.json |
| 53343-0 | Androstenedione [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53343-0.json |
| 53344-8 | Androstenedione [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53344-8.json |
| 53345-5 | Cortisol [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53345-5.json |
| 53346-3 | Cortisol [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53346-3.json |
| 53347-1 | 11-Deoxycorticosterone [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53347-1.json |
| 5334-8 | Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5334-8.json |
| 53348-9 | 11-Deoxycorticosterone [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53348-9.json |
| 53349-7 | Thyroxine (T4) free [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53349-7.json |
| 53350-5 | Thyroxine (T4) free [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53350-5.json |
| 5335-5 | Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5335-5.json |
| 53361-2 | Bordetella parapertussis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53361-2.json |
| 53362-0 | Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53362-0.json |
| 5336-3 | Saccharomonospora viridis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5336-3.json |
| 53363-8 | Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53363-8.json |
| 53364-6 | Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53364-6.json |
| 53367-9 | Coccidioides sp IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53367-9.json |
| 53368-7 | Colorado tick fever virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53368-7.json |
| 53369-5 | Echinococcus sp IgG1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53369-5.json |
| 53370-3 | Echinococcus sp IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53370-3.json |
| 5337-1 | Salivary gland Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5337-1.json |
| 53371-1 | Echovirus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53371-1.json |
| 53372-9 | Echovirus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53372-9.json |
| 53373-7 | Francisella tularensis Ab [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/53373-7.json |
| 53374-5 | Francisella tularensis Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53374-5.json |
| 53376-0 | Hepatitis C virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53376-0.json |
| 53377-8 | Herpes simplex virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53377-8.json |
| 53378-6 | Herpes virus 6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53378-6.json |
| 53379-4 | HIV 1 Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53379-4.json |
| 53381-0 | Influenza virus A Ab [Identifier] in Serum | ./2.16.840.1.114222.4.11.1002/53381-0.json |
| 53382-8 | Plasmodium falciparum IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53382-8.json |
| 53383-6 | Plasmodium sp IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53383-6.json |
| 53384-4 | Powassan virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53384-4.json |
| 53385-1 | Snowshoe hare virus Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53385-1.json |
| 53386-9 | Toxocara canis Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/53386-9.json |
| 53387-7 | Trichinella spiralis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53387-7.json |
| 53388-5 | Trichothecene IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53388-5.json |
| 5338-9 | Salmonella sp Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5338-9.json |
| 53389-3 | Trichothecene IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53389-3.json |
| 53390-1 | Trichothecene IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53390-1.json |
| 53391-9 | Trichothecene IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53391-9.json |
| 5339-7 | Salmonella paratyphi A H Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5339-7.json |
| 5340-5 | Salmonella paratyphi A O Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5340-5.json |
| 5341-3 | Salmonella paratyphi B H Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5341-3.json |
| 53415-6 | Bilirubin.total [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53415-6.json |
| 53416-4 | Alpha naphthylesterase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53416-4.json |
| 53417-2 | Alpha naphthylesterase [Enzymatic activity/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/53417-2.json |
| 5342-1 | Salmonella paratyphi B O Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5342-1.json |
| 53432-1 | Gamma glutamyl transferase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53432-1.json |
| 53433-9 | Creatine kinase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53433-9.json |
| 53434-7 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/53434-7.json |
| 53435-4 | Argininosuccinate lyase [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/53435-4.json |
| 53436-2 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/53436-2.json |
| 53437-0 | Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/53437-0.json |
| 53438-8 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/53438-8.json |
| 5343-9 | Salmonella paratyphi C H Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5343-9.json |
| 53439-6 | Argininosuccinate lyase [Enzymatic activity/mass] in Liver from Fetus | ./2.16.840.1.114222.4.11.1002/53439-6.json |
| 53440-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Liver from Fetus | ./2.16.840.1.114222.4.11.1002/53440-4.json |
| 53441-2 | Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/53441-2.json |
| 53442-0 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/53442-0.json |
| 53445-3 | Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/53445-3.json |
| 53446-1 | Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/53446-1.json |
| 5344-7 | Salmonella paratyphi C O Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5344-7.json |
| 53447-9 | Carboxymefloquine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53447-9.json |
| 53448-7 | Cycloguanil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53448-7.json |
| 53449-5 | Cyclophosphamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53449-5.json |
| 53450-3 | Cytarabine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53450-3.json |
| 53451-1 | Uracil arabinoside [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53451-1.json |
| 53453-7 | Cyclophosphamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53453-7.json |
| 5345-4 | Salmonella typhi H Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5345-4.json |
| 53455-2 | Calcium [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/53455-2.json |
| 53456-0 | Iron [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/53456-0.json |
| 53458-6 | Carbon dioxide [Partial pressure] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/53458-6.json |
| 53459-4 | Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53459-4.json |
| 53460-2 | Sebacylcarnitine (C10-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53460-2.json |
| 53461-0 | Eicosanoylcarnitine (C20) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53461-0.json |
| 5346-2 | Salmonella typhi O Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5346-2.json |
| 53462-8 | Eicosanoylcarnitine (C20) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53462-8.json |
| 53463-6 | Beta aminoisobutyrate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53463-6.json |
| 53464-4 | Decadienoylcarnitine (C10:2) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53464-4.json |
| 53465-1 | Sebacylcarnitine (C10-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53465-1.json |
| 53466-9 | Eicosanoylcarnitine (C20) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53466-9.json |
| 53467-7 | 3-Keto n-Valerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53467-7.json |
| 53468-5 | Anthranilate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53468-5.json |
| 53469-3 | Kynurenate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53469-3.json |
| 5347-0 | Schistosoma sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5347-0.json |
| 53470-1 | Kynurenin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53470-1.json |
| 53471-9 | Decadienoylcarnitine (C10:2) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53471-9.json |
| 53472-7 | Sebacylcarnitine (C10-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53472-7.json |
| 53473-5 | Eicosanoylcarnitine (C20) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53473-5.json |
| 53477-6 | Levodopa/Tyrosine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53477-6.json |
| 53478-4 | Anthranilate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53478-4.json |
| 53479-2 | Dihydroxycholestanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53479-2.json |
| 534-8 | Mycobacterium sp identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/534-8.json |
| 5348-8 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5348-8.json |
| 53488-3 | 3-O-Methyldopa [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53488-3.json |
| 53489-1 | Kynurenate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53489-1.json |
| 53490-9 | Kynurenin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53490-9.json |
| 53491-7 | Kynurenin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53491-7.json |
| 53492-5 | Decadienoylcarnitine (C10:2) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53492-5.json |
| 53493-3 | Sebacylcarnitine (C10-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53493-3.json |
| 53494-1 | Eicosanoylcarnitine (C20) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53494-1.json |
| 5349-6 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5349-6.json |
| 53496-6 | 3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53496-6.json |
| 53497-4 | 5-Hydroxytryptophan [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53497-4.json |
| 53498-2 | Anthranilate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53498-2.json |
| 53499-0 | Creatinine [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/53499-0.json |
| 53500-5 | Ammonia [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/53500-5.json |
| 53501-3 | Iron [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/53501-3.json |
| 53502-1 | Calcium [Moles/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/53502-1.json |
| 53503-9 | Iron [Moles/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/53503-9.json |
| 5350-4 | Shigella sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5350-4.json |
| 53504-7 | Decanoylcarnitine (C10)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53504-7.json |
| 53505-4 | Asparagine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53505-4.json |
| 53506-2 | Citrulline/Amino acids.total in Plasma | ./2.16.840.1.114222.4.11.1002/53506-2.json |
| 53507-0 | Kynurenin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53507-0.json |
| 53508-8 | Decadienoylcarnitine (C10:2)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53508-8.json |
| 53509-6 | Sebacylcarnitine (C10-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53509-6.json |
| 53510-4 | Dodecanoylcarnitine (C12)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53510-4.json |
| 53511-2 | Dodecenoylcarnitine (C12:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53511-2.json |
| 5351-2 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5351-2.json |
| 53512-0 | Eicosanoylcarnitine (C20)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53512-0.json |
| 53513-8 | Anthranilate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53513-8.json |
| 53514-6 | Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Fibroblast | ./2.16.840.1.114222.4.11.1002/53514-6.json |
| 53515-3 | Citrate synthase [Enzymatic activity/mass] in Control Fibroblast | ./2.16.840.1.114222.4.11.1002/53515-3.json |
| 53516-1 | Basophils/100 leukocytes in Dialysis fluid by Manual count | ./2.16.840.1.114222.4.11.1002/53516-1.json |
| 53517-9 | Erythrocytes [#/volume] in Dialysis fluid by Manual count | ./2.16.840.1.114222.4.11.1002/53517-9.json |
| 5352-0 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5352-0.json |
| 53521-1 | Polymorphonuclear cells [#/volume] in Semen | ./2.16.840.1.114222.4.11.1002/53521-1.json |
| 53522-9 | Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53522-9.json |
| 53523-7 | Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53523-7.json |
| 53525-2 | Protein [Presence] in Urine by SSA method | ./2.16.840.1.114222.4.11.1002/53525-2.json |
| 53526-0 | Triglyceride in VLDL [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53526-0.json |
| 53527-8 | Triglyceride in HDL 2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53527-8.json |
| 53528-6 | Triglyceride in HDL 3 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53528-6.json |
| 53529-4 | Microalbumin [Mass/volume] in Body fluid by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/53529-4.json |
| 53530-2 | Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/53530-2.json |
| 53531-0 | Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/53531-0.json |
| 53532-8 | Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/53532-8.json |
| 53533-6 | Herpes simplex virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53533-6.json |
| 53534-4 | Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53534-4.json |
| 53535-1 | Varicella zoster virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53535-1.json |
| 53536-9 | Measles virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53536-9.json |
| 53537-7 | Measles virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53537-7.json |
| 5353-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5353-8.json |
| 53538-5 | Herpes simplex virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53538-5.json |
| 53542-7 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/53542-7.json |
| 53543-5 | Dodeicosanoylcarnitine (C22) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53543-5.json |
| 53544-3 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53544-3.json |
| 53545-0 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53545-0.json |
| 5354-6 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5354-6.json |
| 53546-8 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53546-8.json |
| 53547-6 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53547-6.json |
| 53548-4 | 3,4-Dihydroxyphenylacetate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53548-4.json |
| 53549-2 | Dodeicosanoylcarnitine (C22) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53549-2.json |
| 535-5 | Mycobacterium sp identified in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/535-5.json |
| 53550-0 | Fructosamine/Protein [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53550-0.json |
| 53551-8 | 3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53551-8.json |
| 53552-6 | Dodeicosanoylcarnitine (C22)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53552-6.json |
| 5355-3 | Smith extractable nuclear Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) | ./2.16.840.1.114222.4.11.1002/5355-3.json |
| 53553-4 | Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin | ./2.16.840.1.114222.4.11.1002/53553-4.json |
| 53554-2 | Nitrogen [Mass/volume] in Air | ./2.16.840.1.114222.4.11.1002/53554-2.json |
| 53555-9 | Specific gravity of Red Blood Cells | ./2.16.840.1.114222.4.11.1002/53555-9.json |
| 53556-7 | Erythrocytes.Plasmodium sp infected/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/53556-7.json |
| 53558-3 | Bacteria identified in Semen by Culture | ./2.16.840.1.114222.4.11.1002/53558-3.json |
| 53559-1 | Beta-2 transferrin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53559-1.json |
| 53560-9 | Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/53560-9.json |
| 5356-1 | Smith extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5356-1.json |
| 53561-7 | Lactate dehydrogenase/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53561-7.json |
| 53562-5 | Rheumatoid factor [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/53562-5.json |
| 53571-6 | Yeast identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/53571-6.json |
| 53572-4 | Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/53572-4.json |
| 53573-2 | cycloSPORINE [Mass/volume] in Blood --post dose | ./2.16.840.1.114222.4.11.1002/53573-2.json |
| 53574-0 | Lambda light chains.free [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53574-0.json |
| 53576-5 | Personal health monitoring report Document | ./2.16.840.1.114222.4.11.1002/53576-5.json |
| 53577-3 | Reason for study | ./2.16.840.1.114222.4.11.1002/53577-3.json |
| 5357-9 | Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/5357-9.json |
| 53580-7 | Galactosylceramidase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/53580-7.json |
| 53581-5 | Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/53581-5.json |
| 53582-3 | Echovirus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/53582-3.json |
| 53583-1 | Echovirus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/53583-1.json |
| 53584-9 | Loa loa DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53584-9.json |
| 53585-6 | Toxocara canis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53585-6.json |
| 5358-7 | Smooth muscle Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5358-7.json |
| 53594-8 | Chitobioside IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53594-8.json |
| 5359-5 | Somatotropin Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5359-5.json |
| 53595-5 | Homovanillate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53595-5.json |
| 53596-3 | Laminaribioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53596-3.json |
| 53597-1 | Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53597-1.json |
| 53600-3 | pH of Blood product unit | ./2.16.840.1.114222.4.11.1002/53600-3.json |
| 53601-1 | HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53601-1.json |
| 53602-9 | Taenia solium larva Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53602-9.json |
| 5360-3 | Spermatozoa Ab [Units/volume] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/5360-3.json |
| 53603-7 | Mumps virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53603-7.json |
| 53604-5 | Brucella sp DNA [Identifier] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53604-5.json |
| 53605-2 | Treponema pallidum DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53605-2.json |
| 53606-0 | Neisseria meningitidis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53606-0.json |
| 53607-8 | Haemophilus influenzae B DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53607-8.json |
| 53608-6 | Rickettsia sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53608-6.json |
| 53609-4 | Parasite identified in Bone marrow by Light microscopy | ./2.16.840.1.114222.4.11.1002/53609-4.json |
| 53610-2 | Erythroid cells [#/volume] in Blood or Marrow | ./2.16.840.1.114222.4.11.1002/53610-2.json |
| 5361-1 | Spermatozoa Ab [Units/volume] in Semen | ./2.16.840.1.114222.4.11.1002/5361-1.json |
| 53611-0 | Toxoplasma gondii [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53611-0.json |
| 53612-8 | Urate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53612-8.json |
| 53613-6 | Benzoylcarnitine (BzCn) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53613-6.json |
| 53614-4 | Bacteria # 2 identified in Duodenal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/53614-4.json |
| 53615-1 | Bacteria # 3 identified in Duodenal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/53615-1.json |
| 53616-9 | Bacteria # 4 identified in Duodenal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/53616-9.json |
| 53617-7 | Bacteria identified in Duodenal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/53617-7.json |
| 53618-5 | ZAP70 cells [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/53618-5.json |
| 53619-3 | ZAP70 cells [Presence] in Bone marrow | ./2.16.840.1.114222.4.11.1002/53619-3.json |
| 53620-1 | KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53620-1.json |
| 53621-9 | NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53621-9.json |
| 53622-7 | von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/53622-7.json |
| 53623-5 | HRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53623-5.json |
| 53624-3 | Carnitine esters [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/53624-3.json |
| 53625-0 | Leishmania sp identified in Tissue | ./2.16.840.1.114222.4.11.1002/53625-0.json |
| 53626-8 | CT Cerebral atrophic index | ./2.16.840.1.114222.4.11.1002/53626-8.json |
| 53627-6 | Chloride [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/53627-6.json |
| 53628-4 | 20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/53628-4.json |
| 5362-9 | Spermatozoa Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5362-9.json |
| 53629-2 | Alpha cortol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53629-2.json |
| 536-3 | Mycobacterium sp identified in Bone marrow by Organism specific culture | ./2.16.840.1.114222.4.11.1002/536-3.json |
| 53630-0 | Alpha cortol/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53630-0.json |
| 53631-8 | Alpha cortol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53631-8.json |
| 53632-6 | Breast Cancer Ag 225 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53632-6.json |
| 53633-4 | BCL1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53633-4.json |
| 53634-2 | Beta cortol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53634-2.json |
| 53635-9 | Beta cortol/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53635-9.json |
| 53636-7 | Beta cortol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53636-7.json |
| 5363-7 | Spirillum minus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5363-7.json |
| 53637-5 | BOB1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53637-5.json |
| 53638-3 | CD45RB Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53638-3.json |
| 53639-1 | CD52 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53639-1.json |
| 53640-9 | Chloride/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53640-9.json |
| 53641-7 | OCT2 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/53641-7.json |
| 53642-5 | Glutathione.reduced/glutathione.oxidized [Molar ratio] in Blood | ./2.16.840.1.114222.4.11.1002/53642-5.json |
| 53643-3 | Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/53643-3.json |
| 53644-1 | Carbaryl [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/53644-1.json |
| 5364-5 | Sporothrix schenckii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5364-5.json |
| 53645-8 | Polio virus identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/53645-8.json |
| 53646-6 | Aldicarb [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/53646-6.json |
| 53647-4 | Flavin adenine dinucleotide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53647-4.json |
| 53648-2 | Flavin mononucleotide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53648-2.json |
| 53649-0 | Parathion [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/53649-0.json |
| 53650-8 | Methyl parathion [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/53650-8.json |
| 53651-6 | pH of 2 hour Urine | ./2.16.840.1.114222.4.11.1002/53651-6.json |
| 5365-2 | Saint Louis encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5365-2.json |
| 53652-4 | pH of 4 hour Urine | ./2.16.840.1.114222.4.11.1002/53652-4.json |
| 53653-2 | pH of Bile fluid | ./2.16.840.1.114222.4.11.1002/53653-2.json |
| 53654-0 | pH of Dialysis fluid | ./2.16.840.1.114222.4.11.1002/53654-0.json |
| 5366-0 | Staphylolysin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5366-0.json |
| 53668-0 | Fetal Ear - right Maximum length US | ./2.16.840.1.114222.4.11.1002/53668-0.json |
| 5367-8 | Streptobacillus moniliformis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5367-8.json |
| 5368-6 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5368-6.json |
| 53691-2 | Gestational age Estimated from patient reported estimated date of conception | ./2.16.840.1.114222.4.11.1002/53691-2.json |
| 5369-4 | Streptokinase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5369-4.json |
| 53695-3 | Gestational age Estimated from prior assessment | ./2.16.840.1.114222.4.11.1002/53695-3.json |
| 5370-2 | Streptolysin O Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5370-2.json |
| 53707-6 | CV2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/53707-6.json |
| 53708-4 | Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53708-4.json |
| 53709-2 | Glial nuclear type 1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53709-2.json |
| 537-1 | Mycobacterium sp identified in Peritoneal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/537-1.json |
| 5371-0 | Streptolysin O Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5371-0.json |
| 53711-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53711-8.json |
| 53712-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53712-6.json |
| 53713-4 | PCA-1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53713-4.json |
| 53714-2 | Glial nuclear type 1 Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53714-2.json |
| 53715-9 | Paraneoplastic Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/53715-9.json |
| 53716-7 | levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/53716-7.json |
| 53717-5 | PCA-1 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53717-5.json |
| 53722-5 | SLC26A4 gene p.Glu384Gly [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53722-5.json |
| 53723-3 | SLC26A4 gene.p.Leu236Pro [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53723-3.json |
| 53724-1 | SLC26A4 gene p.Thr416Pro [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53724-1.json |
| 53725-8 | SLC25A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53725-8.json |
| 53726-6 | KCNC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53726-6.json |
| 53727-4 | SOS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53727-4.json |
| 5372-8 | Striated muscle Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5372-8.json |
| 53728-2 | WS2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53728-2.json |
| 53730-8 | Borrelia burgdorferi G39/40 IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53730-8.json |
| 53731-6 | Posaconazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53731-6.json |
| 53732-4 | GCK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53732-4.json |
| 5373-6 | Strongyloides sp Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/5373-6.json |
| 53737-3 | HLA-DQA1*01:02 [Presence] | ./2.16.840.1.114222.4.11.1002/53737-3.json |
| 53738-1 | HLA-DQB1*2 [Presence] | ./2.16.840.1.114222.4.11.1002/53738-1.json |
| 53739-9 | HLA-DQB1*9 [Presence] | ./2.16.840.1.114222.4.11.1002/53739-9.json |
| 53740-7 | HLA-DRB1*17 [Presence] | ./2.16.840.1.114222.4.11.1002/53740-7.json |
| 53741-5 | HLA-DRB1*7 [Presence] | ./2.16.840.1.114222.4.11.1002/53741-5.json |
| 53742-3 | Legionella pneumophila 2+3+4+5+6+8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53742-3.json |
| 53743-1 | Cocaine metabolites.other [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53743-1.json |
| 5374-4 | Taenia saginata Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5374-4.json |
| 53748-0 | Lupus anticoagulant neutralization dilute phospholipid [Time] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/53748-0.json |
| 5375-1 | Taenia solium adult Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5375-1.json |
| 53758-9 | HLA-DRB1 SBT [Type] in Specimen by High resolution | ./2.16.840.1.114222.4.11.1002/53758-9.json |
| 53760-5 | Cladosporium sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53760-5.json |
| 53761-3 | JAK2 gene.p.Val617Phe mutant/Normal in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53761-3.json |
| 53762-1 | Neisseria gonorrhoeae IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53762-1.json |
| 53763-9 | Cytomegalovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53763-9.json |
| 53765-4 | Estrogen [Mass/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/53765-4.json |
| 5376-9 | Thermoactinomyces candidus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5376-9.json |
| 53770-4 | Legionella pneumophila 1+2+3+4+5+6 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53770-4.json |
| 53774-6 | Epstein Barr virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53774-6.json |
| 5377-7 | Laceyella sacchari Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5377-7.json |
| 53777-9 | Cortisone free [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53777-9.json |
| 53778-7 | Arsenic organic [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53778-7.json |
| 53779-5 | Arsenic.methylated [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53779-5.json |
| 53782-9 | HTT gene CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53782-9.json |
| 53784-5 | Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/53784-5.json |
| 5378-5 | Thermoactinomyces vulgaris Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5378-5.json |
| 53786-0 | Microscopic observation [Identifier] in Stool by Wright stain | ./2.16.840.1.114222.4.11.1002/53786-0.json |
| 53787-8 | Zolpidem [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/53787-8.json |
| 53789-4 | CFTR gene.p.IVS8 polyT 7T/9T [presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53789-4.json |
| 53790-2 | CILD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53790-2.json |
| 53791-0 | PTPN11 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53791-0.json |
| 53792-8 | PTPN11 gene mutations tier 3 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53792-8.json |
| 5379-3 | Platelet Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5379-3.json |
| 53793-6 | RPS6KA3 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53793-6.json |
| 53794-4 | RPS6KA3 gene mutations tier 2 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53794-4.json |
| 53795-1 | STK11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53795-1.json |
| 53799-3 | Major crossmatch [Interpretation] by Electronic | ./2.16.840.1.114222.4.11.1002/53799-3.json |
| 5380-1 | Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5380-1.json |
| 53801-7 | Penile vessels by US.doppler | ./2.16.840.1.114222.4.11.1002/53801-7.json |
| 53807-4 | Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53807-4.json |
| 53809-0 | Oxygen.alveolar - arterial [Partial pressure difference] adjusted to patient's actual temperature Respiratory system | ./2.16.840.1.114222.4.11.1002/53809-0.json |
| 53815-7 | Platelet glycoprotein IIb/IIIa Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53815-7.json |
| 53816-5 | Alpha hydroxytriazolam [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53816-5.json |
| 53817-3 | Carnosine [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53817-3.json |
| 53818-1 | Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/53818-1.json |
| 5381-9 | Thyroglobulin Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5381-9.json |
| 53819-9 | Thiopurine methyltransferase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53819-9.json |
| 53821-5 | Chloroamphetamine [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53821-5.json |
| 53825-6 | HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53825-6.json |
| 5382-7 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5382-7.json |
| 53828-0 | cycloSPORINE [Mass/volume] in Blood --trough | ./2.16.840.1.114222.4.11.1002/53828-0.json |
| 53829-8 | Casein IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53829-8.json |
| 53830-6 | CD55 deficient Granulocytes/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/53830-6.json |
| 53831-4 | CD59 deficient Granulocytes/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/53831-4.json |
| 53832-2 | CD55 deficient RBC/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/53832-2.json |
| 53833-0 | Myoglobin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53833-0.json |
| 53834-8 | cycloSPORINE [Mass/volume] in Blood --peak | ./2.16.840.1.114222.4.11.1002/53834-8.json |
| 5383-5 | Thyroperoxidase Ab [Titer] in Serum or Plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5383-5.json |
| 53835-5 | 1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53835-5.json |
| 53836-3 | ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53836-3.json |
| 53838-9 | Arsenic.inorganic [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53838-9.json |
| 53839-7 | Arsenic organic [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/53839-7.json |
| 53840-5 | TGFB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53840-5.json |
| 53841-3 | ATRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53841-3.json |
| 53842-1 | Basement membrane zone BP180 IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53842-1.json |
| 5384-3 | Thyrotropin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5384-3.json |
| 53843-9 | Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53843-9.json |
| 53844-7 | BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53844-7.json |
| 53845-4 | BTD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53845-4.json |
| 53846-2 | Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/53846-2.json |
| 53847-0 | CACT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53847-0.json |
| 53849-6 | HTC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53849-6.json |
| 5385-0 | Thyrotropin receptor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5385-0.json |
| 53851-2 | COL10A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53851-2.json |
| 53852-0 | COL2A1 gene+COL11A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53852-0.json |
| 53853-8 | COL4A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53853-8.json |
| 53854-6 | CPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53854-6.json |
| 53855-3 | DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53855-3.json |
| 53856-1 | DYSF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53856-1.json |
| 53857-9 | Hemoglobin F [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53857-9.json |
| 53858-7 | EXT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53858-7.json |
| 53859-5 | Fatty acids.very long chain C22:0 (Docosanoate) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53859-5.json |
| 53860-3 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53860-3.json |
| 53861-1 | FKTN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53861-1.json |
| 53862-9 | FIG4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53862-9.json |
| 53863-7 | FLNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53863-7.json |
| 53864-5 | GAA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53864-5.json |
| 53865-2 | Galactomannan Ag [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/53865-2.json |
| 53866-0 | GCH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53866-0.json |
| 53867-8 | GYS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53867-8.json |
| 5386-8 | Toxocara canis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5386-8.json |
| 53868-6 | Glucose tetrasaccharide/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/53868-6.json |
| 53870-2 | HPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53870-2.json |
| 53871-0 | HRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53871-0.json |
| 53872-8 | Iodine [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/53872-8.json |
| 53873-6 | IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53873-6.json |
| 53874-4 | Jamestown canyon virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53874-4.json |
| 53875-1 | LMX1B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53875-1.json |
| 5387-6 | Toxoplasma gondii Ab [Presence] in Serum by Sabin dye test | ./2.16.840.1.114222.4.11.1002/5387-6.json |
| 53876-9 | LRRK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53876-9.json |
| 53877-7 | NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53877-7.json |
| 53879-3 | Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53879-3.json |
| 53880-1 | Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/53880-1.json |
| 53881-9 | Norbuprenorphine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53881-9.json |
| 53882-7 | O-desmethylvenlafaxine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/53882-7.json |
| 53883-5 | OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53883-5.json |
| 5388-4 | Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5388-4.json |
| 53884-3 | OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53884-3.json |
| 53885-0 | Parvovirus B19 IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53885-0.json |
| 53886-8 | Parvovirus B19 IgM Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/53886-8.json |
| 53887-6 | PCCA gene+PCCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53887-6.json |
| 53888-4 | PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53888-4.json |
| 538-9 | Mycobacterium sp identified in Synovial fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/538-9.json |
| 53890-0 | PLOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53890-0.json |
| 53891-8 | PNKD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53891-8.json |
| 5389-2 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5389-2.json |
| 53892-6 | Ribosomal P IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53892-6.json |
| 53893-4 | RNA polymerase III Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53893-4.json |
| 53894-2 | TRAPPC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53894-2.json |
| 53895-9 | SH3BP2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53895-9.json |
| 53896-7 | SMC1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53896-7.json |
| 53897-5 | SPAST gene + KIAA0196 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/53897-5.json |
| 53898-3 | KIAA0196 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53898-3.json |
| 53899-1 | TGFBR1 gene+TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53899-1.json |
| 5390-0 | Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5390-0.json |
| 53900-7 | C10orf2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53900-7.json |
| 53901-5 | USH2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/53901-5.json |
| 53904-9 | Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53904-9.json |
| 53905-6 | Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53905-6.json |
| 53906-4 | Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53906-4.json |
| 53907-2 | Microscopic observation [Identifier] in Pleural fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53907-2.json |
| 53908-0 | Bacteria identified in Esophageal brushing by Culture | ./2.16.840.1.114222.4.11.1002/53908-0.json |
| 53909-8 | Mycobacterium sp identified in Pleural fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/53909-8.json |
| 53910-6 | Microscopic observation [Identifier] in Peritoneal fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53910-6.json |
| 53911-4 | Bacteria identified in Bile fluid by Culture | ./2.16.840.1.114222.4.11.1002/53911-4.json |
| 53912-2 | Microscopic observation [Identifier] in Body fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53912-2.json |
| 53913-0 | Microscopic observation [Identifier] in Synovial fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53913-0.json |
| 53914-8 | Microscopic observation [Identifier] in Endometrium by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53914-8.json |
| 53915-5 | Microscopic observation [Identifier] in Pericardial fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53915-5.json |
| 53916-3 | Microscopic observation [Identifier] in Gastric fluid by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53916-3.json |
| 53917-1 | Streptococcus pneumoniae DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53917-1.json |
| 5391-8 | Toxoplasma gondii IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5391-8.json |
| 53918-9 | Microscopic observation [Identifier] in Bone marrow by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/53918-9.json |
| 53919-7 | Thyroglobulin Ab [Units/volume] in Tissue fine needle aspirate | ./2.16.840.1.114222.4.11.1002/53919-7.json |
| 53920-5 | Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate | ./2.16.840.1.114222.4.11.1002/53920-5.json |
| 53921-3 | Thyroglobulin Ab [Units/volume] in Lymph node fine needle aspirate | ./2.16.840.1.114222.4.11.1002/53921-3.json |
| 53922-1 | Thyroglobulin [Mass/volume] in Tissue fine needle aspirate | ./2.16.840.1.114222.4.11.1002/53922-1.json |
| 53923-9 | HIV 1 tropism [Identifier] in Blood Narrative | ./2.16.840.1.114222.4.11.1002/53923-9.json |
| 53924-7 | Rheumatoid factor [Titer] in Synovial fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/53924-7.json |
| 53925-4 | Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53925-4.json |
| 5392-6 | Treponema pallidum Ab [Units/volume] in Serum by Immobilization | ./2.16.840.1.114222.4.11.1002/5392-6.json |
| 53926-2 | Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53926-2.json |
| 53927-0 | Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53927-0.json |
| 53930-4 | Histoplasma capsulatum Ag [Units/volume] in Bronchoalveolar lavage by Immunoassay | ./2.16.840.1.114222.4.11.1002/53930-4.json |
| 53931-2 | Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/53931-2.json |
| 5393-4 | Treponema pallidum Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5393-4.json |
| 53935-3 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/53935-3.json |
| 53937-9 | HLA-B w4+w6 [Type] in Leukocytes | ./2.16.840.1.114222.4.11.1002/53937-9.json |
| 53938-7 | HLA-DQB1 [Type] | ./2.16.840.1.114222.4.11.1002/53938-7.json |
| 53939-5 | CD4 stimulated ATP immune response [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/53939-5.json |
| 53940-3 | CD4 stimulated ATP immune response [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53940-3.json |
| 53941-1 | Vibrio cholerae toxin Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/53941-1.json |
| 5394-2 | Treponema pallidum Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5394-2.json |
| 53942-9 | Vibrio cholerae toxin ctx gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53942-9.json |
| 53943-7 | Bacterial cytolethal distending toxin cdt gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53943-7.json |
| 53944-5 | Escherichia coli enteroinvasive [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/53944-5.json |
| 53945-2 | Escherichia coli adherence pattern [Identifier] in Isolate by Hep2 substrate | ./2.16.840.1.114222.4.11.1002/53945-2.json |
| 53946-0 | Escherichia coli shiga-like toxin identified in Specimen | ./2.16.840.1.114222.4.11.1002/53946-0.json |
| 53947-8 | Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 and H7 flagellar fliC genes [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/53947-8.json |
| 53949-4 | HPA 1a/1a+HPA 3b/3b [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53949-4.json |
| 53950-2 | HPA 1a/1a+Gp IIb/IIIa [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53950-2.json |
| 53951-0 | HPA 1b/1b+HPA 3a/3a [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53951-0.json |
| 53952-8 | HPA 1b/1b+Gp IIb/IIa [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53952-8.json |
| 53953-6 | HPA 5a/5a+Gp Ia/IIa [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53953-6.json |
| 53954-4 | HPA 5a/5b+Gp Ia/IIa [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/53954-4.json |
| 53955-1 | Escherichia coli O157 identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/53955-1.json |
| 53956-9 | Salmonella typhi [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/53956-9.json |
| 53957-7 | Choriogonadotropin.tumor marker [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53957-7.json |
| 53958-5 | Choriogonadotropin.tumor marker [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53958-5.json |
| 5395-9 | Trichinella spiralis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5395-9.json |
| 53959-3 | Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53959-3.json |
| 53960-1 | Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53960-1.json |
| 53961-9 | Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53961-9.json |
| 53962-7 | Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/53962-7.json |
| 5396-7 | Triiodothyronine (T3) Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5396-7.json |
| 539-7 | Mycobacterium sp identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/539-7.json |
| 5397-5 | Trypanosoma brucei Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5397-5.json |
| 53979-1 | Actin Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53979-1.json |
| 53980-9 | Actin Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/53980-9.json |
| 53981-7 | Centromere protein B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/53981-7.json |
| 53982-5 | Centromere protein B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/53982-5.json |
| 5398-3 | Trypanosoma cruzi Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5398-3.json |
| 5399-1 | Trypanosoma sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5399-1.json |
| 54001-3 | Centromere protein F Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54001-3.json |
| 54002-1 | Centromere protein F Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54002-1.json |
| 54003-9 | Human upstream binding factor Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54003-9.json |
| 54004-7 | Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54004-7.json |
| 5400-7 | Vaccinia virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5400-7.json |
| 54007-0 | Golgi apparatus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54007-0.json |
| 54008-8 | Golgi apparatus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54008-8.json |
| 54009-6 | Lysosome Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54009-6.json |
| 54010-4 | Lysosome Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54010-4.json |
| 54011-2 | Vimentin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54011-2.json |
| 54012-0 | Vimentin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54012-0.json |
| 54013-8 | Vinculin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54013-8.json |
| 54014-6 | Vinculin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54014-6.json |
| 5401-5 | Varicella zoster virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/5401-5.json |
| 54015-3 | Azurocidin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54015-3.json |
| 54016-1 | Cathepsin G Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54016-1.json |
| 54017-9 | Elastase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54017-9.json |
| 54018-7 | Lactoferrin Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54018-7.json |
| 54019-5 | Lysozyme Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54019-5.json |
| 54020-3 | Actin.filamentous Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54020-3.json |
| 54021-1 | Actin.filamentous Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54021-1.json |
| 54022-9 | Mutated citrullinated vimentin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54022-9.json |
| 5402-3 | Varicella zoster virus Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/5402-3.json |
| 54023-7 | U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54023-7.json |
| 54024-5 | sp100 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54024-5.json |
| 54025-2 | Nuclear pore protein gp210 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54025-2.json |
| 54027-8 | Lamin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54027-8.json |
| 54028-6 | Lamin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54028-6.json |
| 54030-2 | Smith extractable nuclear B Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54030-2.json |
| 5403-1 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5403-1.json |
| 54031-0 | Smith extractable nuclear D Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54031-0.json |
| 54032-8 | U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54032-8.json |
| 54033-6 | Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/54033-6.json |
| 54034-4 | Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/54034-4.json |
| 54035-1 | Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/54035-1.json |
| 54036-9 | Western equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54036-9.json |
| 5404-9 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/5404-9.json |
| 540-5 | Mycobacterium sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/540-5.json |
| 5405-6 | Vibrio cholerae Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5405-6.json |
| 5406-4 | Western equine encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5406-4.json |
| 54067-4 | Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54067-4.json |
| 5407-2 | Yersinia enterocolitica O:3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5407-2.json |
| 5408-0 | Yersinia enterocolitica O:8 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5408-0.json |
| 54083-1 | CFTR gene mutations found [Identifier] in DBS by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/54083-1.json |
| 54084-9 | Galactose [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54084-9.json |
| 54085-6 | Galactose [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54085-6.json |
| 54086-4 | HIV 1+2 IgG Ab [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/54086-4.json |
| 54087-2 | Toxoplasma gondii IgG Ab [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/54087-2.json |
| 54088-0 | Toxoplasma gondii IgM Ab [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/54088-0.json |
| 54091-4 | Rubella virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54091-4.json |
| 54093-0 | Pesticides [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/54093-0.json |
| 54094-8 | Emergency department Triage note | ./2.16.840.1.114222.4.11.1002/54094-8.json |
| 54096-3 | Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/54096-3.json |
| 5409-8 | Yersinia enterocolitica O:9 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5409-8.json |
| 54098-9 | Isopropyl methylphosphonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54098-9.json |
| 54099-7 | 1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54099-7.json |
| 54100-3 | Monocyclohexyl methylphosphonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54100-3.json |
| 54101-1 | 2-Methylpropyl methylphosphonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54101-1.json |
| 54102-9 | Monoethyl methylphosphonate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54102-9.json |
| 5410-6 | Yersinia pseudotuberculosis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5410-6.json |
| 54108-6 | Newborn hearing screen of Ear - left | ./2.16.840.1.114222.4.11.1002/54108-6.json |
| 54109-4 | Newborn hearing screen of Ear - right | ./2.16.840.1.114222.4.11.1002/54109-4.json |
| 5411-4 | Yersinia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/5411-4.json |
| 541-3 | Mycobacterium sp identified in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/541-3.json |
| 54142-5 | Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/54142-5.json |
| 54143-3 | Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/54143-3.json |
| 54144-1 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/54144-1.json |
| 54146-6 | Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/54146-6.json |
| 54152-4 | Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54152-4.json |
| 54153-2 | Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54153-2.json |
| 54154-0 | Intercellular bridge nuclear Ab pattern [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54154-0.json |
| 54155-7 | Intercellular bridge nuclear Ab pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54155-7.json |
| 54156-5 | RNA polymerase I Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54156-5.json |
| 54157-3 | RNA polymerase I Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54157-3.json |
| 54158-1 | Pancytokeratin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54158-1.json |
| 54159-9 | Pancytokeratin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54159-9.json |
| 54160-7 | Ki Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/54160-7.json |
| 54161-5 | Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54161-5.json |
| 54162-3 | Cytoplasmic Ab pattern.PL-7+PL-12 [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54162-3.json |
| 54163-1 | Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml | ./2.16.840.1.114222.4.11.1002/54163-1.json |
| 54164-9 | Cytomegalovirus immediate-early Ag [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/54164-9.json |
| 54165-6 | Tumor necrosis factor binding protein [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54165-6.json |
| 54166-4 | Cefoperazone+Sulbactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54166-4.json |
| 54167-2 | Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54167-2.json |
| 54168-0 | Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54168-0.json |
| 54169-8 | Thiamphenicol [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54169-8.json |
| 54170-6 | Imipenem+EDTA [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54170-6.json |
| 54171-4 | Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54171-4.json |
| 54172-2 | Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54172-2.json |
| 54173-0 | Arbekacin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54173-0.json |
| 54174-8 | Cefmenoxime [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54174-8.json |
| 54175-5 | Caspofungin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54175-5.json |
| 54176-3 | Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54176-3.json |
| 54177-1 | Clotrimazole [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54177-1.json |
| 54178-9 | Econazole [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54178-9.json |
| 54179-7 | Itraconazole [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54179-7.json |
| 54180-5 | Miconazole [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54180-5.json |
| 54181-3 | Nitroxoline [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54181-3.json |
| 54182-1 | Para aminosalicylate [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54182-1.json |
| 54183-9 | Rifabutin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54183-9.json |
| 54184-7 | Thiacetazone [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54184-7.json |
| 54185-4 | Caspofungin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/54185-4.json |
| 54186-2 | Posaconazole [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/54186-2.json |
| 54187-0 | Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54187-0.json |
| 54188-8 | Posaconazole [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54188-8.json |
| 54189-6 | Posaconazole [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54189-6.json |
| 54190-4 | Temocillin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/54190-4.json |
| 54191-2 | Cefotaxime+Sulbactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54191-2.json |
| 54192-0 | Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54192-0.json |
| 54193-8 | Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54193-8.json |
| 54194-6 | Mezlocillin+Sulbactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54194-6.json |
| 54195-3 | Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54195-3.json |
| 54196-1 | Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54196-1.json |
| 54197-9 | Piperacillin+Sulbactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54197-9.json |
| 54198-7 | Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54198-7.json |
| 54199-5 | Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54199-5.json |
| 54200-1 | Griseofulvin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54200-1.json |
| 54201-9 | Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54201-9.json |
| 54202-7 | Griseofulvin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/54202-7.json |
| 54203-5 | Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54203-5.json |
| 54204-3 | Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/54204-3.json |
| 54205-0 | Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/54205-0.json |
| 54206-8 | Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54206-8.json |
| 54209-2 | Hemoglobin C - Harlem/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/54209-2.json |
| 542-1 | Mycobacterium sp identified in Wound by Organism specific culture | ./2.16.840.1.114222.4.11.1002/542-1.json |
| 54210-0 | Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54210-0.json |
| 54212-6 | Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone | ./2.16.840.1.114222.4.11.1002/54212-6.json |
| 54218-3 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood | ./2.16.840.1.114222.4.11.1002/54218-3.json |
| 54238-1 | LDL.oxidized [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54238-1.json |
| 54239-9 | Cytopathic effect [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/54239-9.json |
| 54240-7 | Influenza virus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/54240-7.json |
| 54241-5 | Influenza virus B Ag [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/54241-5.json |
| 54242-3 | Influenza virus identified in Isolate | ./2.16.840.1.114222.4.11.1002/54242-3.json |
| 54243-1 | Influenza virus RNA [Identifier] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/54243-1.json |
| 54244-9 | Influenza virus identified in Specimen | ./2.16.840.1.114222.4.11.1002/54244-9.json |
| 54245-6 | Respiratory virus Ag [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54245-6.json |
| 54278-7 | Glutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54278-7.json |
| 54279-5 | Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54279-5.json |
| 54280-3 | Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54280-3.json |
| 54281-1 | Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54281-1.json |
| 54282-9 | Glutarylcarnitine (C5-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54282-9.json |
| 54283-7 | Glycerol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54283-7.json |
| 54284-5 | Glycerol [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54284-5.json |
| 54285-2 | Glycerol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54285-2.json |
| 54286-0 | Glycolate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54286-0.json |
| 54287-8 | Guanidinoacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54287-8.json |
| 54288-6 | Guanidinoacetate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54288-6.json |
| 54289-4 | Hemoglobin [Mass/volume] in Blood from Blood product unit | ./2.16.840.1.114222.4.11.1002/54289-4.json |
| 54290-2 | Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54290-2.json |
| 54291-0 | Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54291-0.json |
| 54292-8 | Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54292-8.json |
| 54293-6 | Heptanoylcarnitine (C7) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54293-6.json |
| 54294-4 | Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54294-4.json |
| 54295-1 | Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54295-1.json |
| 54296-9 | Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54296-9.json |
| 54297-7 | Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54297-7.json |
| 54298-5 | Hexanoylcarnitine (C6) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54298-5.json |
| 54299-3 | Homocitrulline [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54299-3.json |
| 54300-9 | Homocysteine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54300-9.json |
| 54301-7 | Homocysteine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54301-7.json |
| 54302-5 | Homocystine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54302-5.json |
| 54303-3 | Hydroxylysine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54303-3.json |
| 54304-1 | Isobutyrylglycine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54304-1.json |
| 54305-8 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54305-8.json |
| 54306-6 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54306-6.json |
| 54307-4 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54307-4.json |
| 54308-2 | Isovalerylglycine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54308-2.json |
| 54310-8 | Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54310-8.json |
| 54311-6 | Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54311-6.json |
| 54312-4 | Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54312-4.json |
| 54313-2 | Linoleoylcarnitine (C18:2) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54313-2.json |
| 54314-0 | Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54314-0.json |
| 54315-7 | Methylmalonate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54315-7.json |
| 54316-5 | Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54316-5.json |
| 54317-3 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54317-3.json |
| 54318-1 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54318-1.json |
| 54319-9 | Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54319-9.json |
| 54320-7 | Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54320-7.json |
| 54321-5 | Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54321-5.json |
| 54322-3 | Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54322-3.json |
| 54324-9 | Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54324-9.json |
| 54325-6 | Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54325-6.json |
| 54326-4 | Phosphoethanolamine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54326-4.json |
| 54327-2 | Pipecolate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54327-2.json |
| 54328-0 | Pipecolate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54328-0.json |
| 54329-8 | Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54329-8.json |
| 54330-6 | Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54330-6.json |
| 54331-4 | Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54331-4.json |
| 54332-2 | Propionylglycine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54332-2.json |
| 54333-0 | Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54333-0.json |
| 54334-8 | Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54334-8.json |
| 54335-5 | Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54335-5.json |
| 54336-3 | Sulfocysteine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54336-3.json |
| 54337-1 | Sulfocysteine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54337-1.json |
| 54338-9 | Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54338-9.json |
| 54339-7 | Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54339-7.json |
| 54340-5 | Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54340-5.json |
| 54341-3 | Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54341-3.json |
| 54342-1 | Tiglylglycine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54342-1.json |
| 54343-9 | 3-Methoxytyramine/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54343-9.json |
| 54344-7 | 3-Methoxytyramine [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54344-7.json |
| 54345-4 | Acetylcarnitine (C2) [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/54345-4.json |
| 54346-2 | Albumin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/54346-2.json |
| 54347-0 | Albumin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54347-0.json |
| 54348-8 | Alpha-1-Fetoprotein [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/54348-8.json |
| 54349-6 | Ammonia [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/54349-6.json |
| 54350-4 | Ascorbate+Dehydroascorbate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54350-4.json |
| 54351-2 | Ascorbate+Dehydroascorbate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54351-2.json |
| 54352-0 | Nitrogen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54352-0.json |
| 54353-8 | Beta 1 globulin [Mass/volume] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54353-8.json |
| 54354-6 | Beta 2 globulin [Mass/volume] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54354-6.json |
| 54356-1 | Beta-2-Microglobulin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54356-1.json |
| 54359-5 | Bicarbonate [Moles/volume] in Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/54359-5.json |
| 54360-3 | Bicarbonate [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54360-3.json |
| 54361-1 | Bicarbonate [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/54361-1.json |
| 54362-9 | Bilirubin.total [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/54362-9.json |
| 54363-7 | Bilirubin.total [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/54363-7.json |
| 54364-5 | Calcium [Moles/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/54364-5.json |
| 54365-2 | Calcium [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/54365-2.json |
| 54366-0 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Cord blood | ./2.16.840.1.114222.4.11.1002/54366-0.json |
| 54367-8 | Calcium.ionized [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/54367-8.json |
| 54368-6 | Catalase [Enzymatic activity/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/54368-6.json |
| 54369-4 | Chloride [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/54369-4.json |
| 54370-2 | Chloride [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54370-2.json |
| 54371-0 | Cholesterol [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54371-0.json |
| 54372-8 | Cholesterol in HDL [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54372-8.json |
| 54373-6 | Cholesterol.non-esterified [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54373-6.json |
| 54374-4 | Creatinine/Body weight [Moles/kg/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54374-4.json |
| 54375-1 | Creatinine [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/54375-1.json |
| 54376-9 | Cobalamin (Vitamin B12) [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54376-9.json |
| 54377-7 | Cobalamin (Vitamin B12) [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54377-7.json |
| 54378-5 | Cobalamin (Vitamin B12) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54378-5.json |
| 54379-3 | Cystatin C/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54379-3.json |
| 54380-1 | Cystatin C [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54380-1.json |
| 54381-9 | Cystatin C [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/54381-9.json |
| 54382-7 | Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid cells | ./2.16.840.1.114222.4.11.1002/54382-7.json |
| 54383-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/54383-5.json |
| 54384-3 | Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54384-3.json |
| 54385-0 | Dehydroascorbate/Ascorbate in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54385-0.json |
| 54386-8 | Dehydroascorbate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54386-8.json |
| 54387-6 | Dihydroxycholestanoate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54387-6.json |
| 54388-4 | Dihydroxycholestanoate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54388-4.json |
| 54389-2 | Dodecanoylcarnitine (C12) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54389-2.json |
| 543-9 | Mycobacterium sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/543-9.json |
| 54390-0 | Fibroblast growth factor 23.intact [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54390-0.json |
| 54391-8 | Gamma globulin/Protein.total in Dialysis fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54391-8.json |
| 54392-6 | Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54392-6.json |
| 54393-4 | Glucose [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54393-4.json |
| 54394-2 | Glucose [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54394-2.json |
| 54395-9 | Glucose [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54395-9.json |
| 54396-7 | Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54396-7.json |
| 54397-5 | Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54397-5.json |
| 54398-3 | Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54398-3.json |
| 54399-1 | Glucose [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54399-1.json |
| 54400-7 | Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon | ./2.16.840.1.114222.4.11.1002/54400-7.json |
| 54401-5 | Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/54401-5.json |
| 54402-3 | 4-Hydroxymidazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54402-3.json |
| 54410-6 | Direct antiglobulin test.complement C3 specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/54410-6.json |
| 54417-1 | ABO and Rh group [Type] in Blood from Fetus | ./2.16.840.1.114222.4.11.1002/54417-1.json |
| 54425-4 | Weak D Ag [Presence] on Red Blood Cells from Fetus | ./2.16.840.1.114222.4.11.1002/54425-4.json |
| 54427-0 | Transfuse frozen erythrocytes newborn units [Volume] | ./2.16.840.1.114222.4.11.1002/54427-0.json |
| 54435-3 | Aspergillus fumigatus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/54435-3.json |
| 54443-7 | Echovirus 2 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/54443-7.json |
| 54444-5 | Echovirus 8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/54444-5.json |
| 54447-8 | FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/54447-8.json |
| 54448-6 | NPM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/54448-6.json |
| 54449-4 | SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/54449-4.json |
| 54452-8 | Ferning [Presence] in Cervical mucus | ./2.16.840.1.114222.4.11.1002/54452-8.json |
| 54453-6 | Semen analysis test method | ./2.16.840.1.114222.4.11.1002/54453-6.json |
| 54455-1 | Blastomyces dermatitidis Ag [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/54455-1.json |
| 54456-9 | Urea reduction ratio in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54456-9.json |
| 54457-7 | Biotinidase [Enzymatic activity/volume] in Serum or Plasma from Normal control | ./2.16.840.1.114222.4.11.1002/54457-7.json |
| 54458-5 | Granulocyte colony stimulating factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54458-5.json |
| 54459-3 | Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54459-3.json |
| 54460-1 | Malonylcarnitine (C3-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54460-1.json |
| 54461-9 | Malonylcarnitine (C3-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54461-9.json |
| 54462-7 | Malonylcarnitine (C3-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54462-7.json |
| 54463-5 | Malonylcarnitine (C3-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54463-5.json |
| 54464-3 | Albumin/Protein.total in Dialysis fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54464-3.json |
| 54465-0 | Alpha 1 globulin/Protein.total in Dialysis fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54465-0.json |
| 54466-8 | Alpha 2 globulin/Protein.total in Dialysis fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54466-8.json |
| 544-7 | Bacteroides fragilis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/544-7.json |
| 54470-0 | Cholesterol in HDL 3b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54470-0.json |
| 54473-4 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54473-4.json |
| 54474-2 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54474-2.json |
| 54475-9 | Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54475-9.json |
| 54476-7 | Pimeloylcarnitine (C7-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54476-7.json |
| 54477-5 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54477-5.json |
| 54478-3 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54478-3.json |
| 54480-9 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54480-9.json |
| 54481-7 | Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54481-7.json |
| 54482-5 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/54482-5.json |
| 54483-3 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54483-3.json |
| 54485-8 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54485-8.json |
| 54486-6 | Glucose [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/54486-6.json |
| 54487-4 | Glucose [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/54487-4.json |
| 54488-2 | Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54488-2.json |
| 54489-0 | Phosphoserine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/54489-0.json |
| 54490-8 | Pipecolate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54490-8.json |
| 54491-6 | Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54491-6.json |
| 54492-4 | Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/54492-4.json |
| 54493-2 | Allantoine [Moles/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/54493-2.json |
| 54494-0 | Chloride [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/54494-0.json |
| 54495-7 | Glucose [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/54495-7.json |
| 54496-5 | Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54496-5.json |
| 54497-3 | Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54497-3.json |
| 54498-1 | Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54498-1.json |
| 54499-9 | Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/54499-9.json |
| 54500-4 | Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54500-4.json |
| 545-4 | Bacteroides melaninogenicus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/545-4.json |
| 546-2 | Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/546-2.json |
| 547-0 | Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/547-0.json |
| 548-8 | Bordetella pertussis [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/548-8.json |
| 54899-0 | Preferred language | ./2.16.840.1.114222.4.11.1002/54899-0.json |
| 54900-6 | IgA [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54900-6.json |
| 54901-4 | IgG [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54901-4.json |
| 54902-2 | IgM [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/54902-2.json |
| 54905-5 | Norovirus genogroup I RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54905-5.json |
| 54906-3 | Norovirus genogroup II RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/54906-3.json |
| 54907-1 | Alkaline phosphatase [Enzymatic activity/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/54907-1.json |
| 54908-9 | Cefminox [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54908-9.json |
| 54909-7 | Culex mosquito IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54909-7.json |
| 54910-5 | DNA double strand Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54910-5.json |
| 54911-3 | Giant grouper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54911-3.json |
| 54912-1 | Fosfomycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54912-1.json |
| 54913-9 | Gentamicin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54913-9.json |
| 54914-7 | Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/54914-7.json |
| 54915-4 | Iroko IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54915-4.json |
| 54916-2 | Angler IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54916-2.json |
| 54917-0 | Lysozyme [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/54917-0.json |
| 54918-8 | Ma+Ta Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/54918-8.json |
| 54919-6 | Magnesium [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/54919-6.json |
| 54920-4 | Jumper ant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54920-4.json |
| 54921-2 | Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/54921-2.json |
| 54922-0 | Phosphate [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/54922-0.json |
| 54923-8 | Propyphenazone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54923-8.json |
| 54924-6 | Purkinje cells Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/54924-6.json |
| 54925-3 | Selenium [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/54925-3.json |
| 54926-1 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/54926-1.json |
| 54927-9 | Tetranychus urticae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54927-9.json |
| 54928-7 | Tinidazole [Susceptibility] | ./2.16.840.1.114222.4.11.1002/54928-7.json |
| 54929-5 | Tissue transglutaminase Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/54929-5.json |
| 54930-3 | Fava bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/54930-3.json |
| 54931-1 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/54931-1.json |
| 54933-7 | Abrine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54933-7.json |
| 54934-5 | Ricinine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54934-5.json |
| 54935-2 | 1,2-Dichloroethane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54935-2.json |
| 54936-0 | Carbon tetrachloride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54936-0.json |
| 54937-8 | Chloroform [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54937-8.json |
| 54938-6 | Ethyl benzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54938-6.json |
| 54939-4 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54939-4.json |
| 54940-2 | Styrene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/54940-2.json |
| 54941-0 | Tungsten [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54941-0.json |
| 54942-8 | N-ethyldiethanolamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54942-8.json |
| 54943-6 | N-methyldiethanolamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54943-6.json |
| 54944-4 | Monofluoroacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54944-4.json |
| 54945-1 | Monochloroacetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/54945-1.json |
| 549-6 | Bordetella pertussis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/549-6.json |
| 550-4 | Bordetella pertussis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/550-4.json |
| 55091-3 | Darunavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/55091-3.json |
| 55092-1 | PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55092-1.json |
| 55095-4 | Adenovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/55095-4.json |
| 55096-2 | Nocardia sp identified in Isolate | ./2.16.840.1.114222.4.11.1002/55096-2.json |
| 55097-0 | Parainfluenza virus 1 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/55097-0.json |
| 55098-8 | Parainfluenza virus 2 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/55098-8.json |
| 55099-6 | Parainfluenza virus 3 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/55099-6.json |
| 55100-2 | Respiratory syncytial virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/55100-2.json |
| 55107-7 | Addendum Document | ./2.16.840.1.114222.4.11.1002/55107-7.json |
| 55108-5 | Clinical presentation Document | ./2.16.840.1.114222.4.11.1002/55108-5.json |
| 55109-3 | Complications Document | ./2.16.840.1.114222.4.11.1002/55109-3.json |
| 55110-1 | Conclusions [Interpretation] Document | ./2.16.840.1.114222.4.11.1002/55110-1.json |
| 55111-9 | Current imaging procedure descriptions Document | ./2.16.840.1.114222.4.11.1002/55111-9.json |
| 55112-7 | Document summary | ./2.16.840.1.114222.4.11.1002/55112-7.json |
| 55113-5 | Key images Document Radiology | ./2.16.840.1.114222.4.11.1002/55113-5.json |
| 55114-3 | Prior imaging procedure descriptions Document | ./2.16.840.1.114222.4.11.1002/55114-3.json |
| 55115-0 | Requested imaging studies information Document | ./2.16.840.1.114222.4.11.1002/55115-0.json |
| 551-2 | Brucella sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/551-2.json |
| 55122-6 | Surgical operation note implants Narrative | ./2.16.840.1.114222.4.11.1002/55122-6.json |
| 55133-3 | Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55133-3.json |
| 55134-1 | Influenza virus A neuraminidase RNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55134-1.json |
| 55135-8 | BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/55135-8.json |
| 55139-0 | SCN5A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55139-0.json |
| 55141-6 | Fc epsilon RI + RII Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/55141-6.json |
| 55142-4 | Cache valley virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55142-4.json |
| 55143-2 | California serogroup RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55143-2.json |
| 55144-0 | Powassan virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55144-0.json |
| 55145-7 | Saint Louis encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55145-7.json |
| 55146-5 | Familial long QTS syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55146-5.json |
| 55147-3 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55147-3.json |
| 55149-9 | BCR-ABL1 e1a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55149-9.json |
| 55159-8 | Ursodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55159-8.json |
| 55165-5 | Echinococcus sp IgG4 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55165-5.json |
| 55166-3 | Hepatitis G virus E2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55166-3.json |
| 55167-1 | Mycoplasma sp Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55167-1.json |
| 55170-5 | Cytoplasmic Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/55170-5.json |
| 55171-3 | Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/55171-3.json |
| 55180-4 | Human epididymis protein 4 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55180-4.json |
| 55195-2 | DHCR7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55195-2.json |
| 55198-6 | Zygosity [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/55198-6.json |
| 55199-4 | Cells karyotyped.total [#] in Blood or Tissue | ./2.16.840.1.114222.4.11.1002/55199-4.json |
| 552-0 | Brucella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/552-0.json |
| 55200-0 | Carnitine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55200-0.json |
| 55201-8 | KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55201-8.json |
| 55204-2 | Macroamylase [Presence] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/55204-2.json |
| 55205-9 | Vasoactive intestinal peptide [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55205-9.json |
| 55219-0 | Antioxidants [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55219-0.json |
| 55220-8 | Asialoglycoprotein receptor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/55220-8.json |
| 55221-6 | Carbohydrates [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/55221-6.json |
| 55222-4 | Microscopic observation [Identifier] in Aspirate by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/55222-4.json |
| 55223-2 | Mycobacterium tuberculosis A60 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/55223-2.json |
| 55224-0 | Mycobacterium tuberculosis A60 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/55224-0.json |
| 55225-7 | Okoume IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/55225-7.json |
| 55226-5 | Pancreatic polypeptide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55226-5.json |
| 55227-3 | Sapeli IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/55227-3.json |
| 55228-1 | Cytogenetics study | ./2.16.840.1.114222.4.11.1002/55228-1.json |
| 55229-9 | Immune stain study | ./2.16.840.1.114222.4.11.1002/55229-9.json |
| 55230-7 | Immunophenotyping study | ./2.16.840.1.114222.4.11.1002/55230-7.json |
| 55252-1 | Methoxsalen 0.02 mg/mL given [Volume] | ./2.16.840.1.114222.4.11.1002/55252-1.json |
| 55253-9 | Heparin 10000 U/mL given [Volume] | ./2.16.840.1.114222.4.11.1002/55253-9.json |
| 55254-7 | Heparin 5000 U/mL given [Volume] | ./2.16.840.1.114222.4.11.1002/55254-7.json |
| 55296-8 | CAV3 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55296-8.json |
| 55298-4 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/55298-4.json |
| 55299-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/55299-2.json |
| 55300-8 | JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55300-8.json |
| 55301-6 | JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55301-6.json |
| 55303-2 | Fungus [Presence] in Skin by KOH preparation | ./2.16.840.1.114222.4.11.1002/55303-2.json |
| 55343-8 | Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/55343-8.json |
| 55345-3 | VIM gene methylation [Presence] in Stool by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55345-3.json |
| 55346-1 | cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55346-1.json |
| 55347-9 | Ecarin clotting time (ECT) in Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/55347-9.json |
| 55349-5 | Ethyl glucuronide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/55349-5.json |
| 55350-3 | Fenfluramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/55350-3.json |
| 55353-7 | Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/55353-7.json |
| 55363-6 | Argatroban [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/55363-6.json |
| 55369-3 | Dengue virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/55369-3.json |
| 55379-2 | Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/55379-2.json |
| 553-8 | Candida sp identified in Saliva (oral fluid) by Organism specific culture | ./2.16.840.1.114222.4.11.1002/553-8.json |
| 55380-0 | West Nile virus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/55380-0.json |
| 55393-3 | Lead [Moles/mass] in Nail | ./2.16.840.1.114222.4.11.1002/55393-3.json |
| 55438-6 | Dengue virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/55438-6.json |
| 554-6 | Candida sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/554-6.json |
| 55463-4 | Influenza virus A swine origin RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55463-4.json |
| 55464-2 | Influenza virus A swine origin RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55464-2.json |
| 55465-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/55465-9.json |
| 55520-1 | 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55520-1.json |
| 55521-9 | Acebutolol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/55521-9.json |
| 55522-7 | Acetazolamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55522-7.json |
| 55523-5 | Anileridine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55523-5.json |
| 55524-3 | Atropine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55524-3.json |
| 55525-0 | Benzoylecgonine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55525-0.json |
| 55526-8 | Brompheniramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55526-8.json |
| 55527-6 | buPROPion [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55527-6.json |
| 55528-4 | Chloral hydrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55528-4.json |
| 55529-2 | Clopenthixol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55529-2.json |
| 555-3 | Candida sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/555-3.json |
| 55530-0 | Cocaethylene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55530-0.json |
| 55531-8 | Cyclobenzaprine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55531-8.json |
| 55532-6 | Diethylpropion [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55532-6.json |
| 55533-4 | dilTIAZem [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55533-4.json |
| 55534-2 | Doxylamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55534-2.json |
| 55535-9 | ePHEDrine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55535-9.json |
| 55536-7 | Fenoprofen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55536-7.json |
| 55537-5 | fentaNYL [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55537-5.json |
| 55538-3 | Flupenthixol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55538-3.json |
| 55539-1 | Flurbiprofen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55539-1.json |
| 55540-9 | Furosemide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55540-9.json |
| 55541-7 | hydroCHLOROthiazide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55541-7.json |
| 55542-5 | Hydroxybupropion [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55542-5.json |
| 55543-3 | Hydroxychloroquine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55543-3.json |
| 55544-1 | hydrOXYzine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55544-1.json |
| 55545-8 | Indomethacin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55545-8.json |
| 55546-6 | Ketoprofen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55546-6.json |
| 55547-4 | Labetalol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55547-4.json |
| 55548-2 | metFORMIN [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55548-2.json |
| 55549-0 | Methocarbamol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55549-0.json |
| 55550-8 | Methsuximide+Normethsuximide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55550-8.json |
| 55551-6 | Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55551-6.json |
| 55552-4 | Methylphenidate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55552-4.json |
| 55553-2 | Metoprolol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55553-2.json |
| 55554-0 | Mirtazapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55554-0.json |
| 55555-7 | Molybdenum [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/55555-7.json |
| 55556-5 | Nadolol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55556-5.json |
| 55557-3 | Nicotine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55557-3.json |
| 55558-1 | Nicotine [Moles/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/55558-1.json |
| 55559-9 | Norpropoxyphene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55559-9.json |
| 55560-7 | Orphenadrine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55560-7.json |
| 55561-5 | Oxprenolol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55561-5.json |
| 55562-3 | Oxyphenbutazone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55562-3.json |
| 55563-1 | Paraldehyde [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55563-1.json |
| 55564-9 | Pentazocine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55564-9.json |
| 55565-6 | Phenacetin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55565-6.json |
| 55566-4 | Phenelzine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55566-4.json |
| 55567-2 | Pheniramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55567-2.json |
| 55568-0 | Phenolphthalein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55568-0.json |
| 55569-8 | Phentermine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55569-8.json |
| 55570-6 | predniSONE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55570-6.json |
| 55571-4 | Prilocaine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55571-4.json |
| 55572-2 | Procaine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55572-2.json |
| 55573-0 | Promethazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55573-0.json |
| 55574-8 | Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55574-8.json |
| 55575-5 | Pseudoephedrine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55575-5.json |
| 55576-3 | QUEtiapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55576-3.json |
| 55577-1 | Salicylamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55577-1.json |
| 55578-9 | Sildenafil citrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55578-9.json |
| 55579-7 | Sotalol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55579-7.json |
| 55580-5 | Sulfapyridine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55580-5.json |
| 55581-3 | sulfaSALAzine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55581-3.json |
| 55582-1 | Timolol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55582-1.json |
| 55583-9 | Tranylcypromine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55583-9.json |
| 55584-7 | Trimethoprim [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55584-7.json |
| 55585-4 | Tripelennamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55585-4.json |
| 55586-2 | Verapamil [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55586-2.json |
| 55587-0 | Methamphetamine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55587-0.json |
| 55588-8 | OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55588-8.json |
| 55589-6 | Budgerigar feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55589-6.json |
| 55590-4 | Canary feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55590-4.json |
| 55591-2 | Chicken feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55591-2.json |
| 55592-0 | Cockatiel feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55592-0.json |
| 55593-8 | Creatinine [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/55593-8.json |
| 55594-6 | Duck feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55594-6.json |
| 55595-3 | Finch feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55595-3.json |
| 55596-1 | Goose feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55596-1.json |
| 55597-9 | Js sup(b) Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55597-9.json |
| 55600-1 | Microscopic observation [Identifier] in Peritoneal fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/55600-1.json |
| 55601-9 | Microscopic observation [Identifier] in Pericardial fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/55601-9.json |
| 55602-7 | Microscopic observation [Identifier] in Pleural fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/55602-7.json |
| 55603-5 | Microscopic observation [Identifier] in Synovial fluid by Cyto stain | ./2.16.840.1.114222.4.11.1002/55603-5.json |
| 55604-3 | Microscopic observation [Identifier] in Endometrium by Cyto stain | ./2.16.840.1.114222.4.11.1002/55604-3.json |
| 55605-0 | Parakeet feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55605-0.json |
| 55606-8 | Parrot feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55606-8.json |
| 55607-6 | Triglyceride/Cholesterol in HDL [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55607-6.json |
| 55608-4 | Turkey feather IgE Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55608-4.json |
| 55609-2 | Urea [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/55609-2.json |
| 556-1 | Chlamydia sp identified in Conjunctival specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/556-1.json |
| 5566-5 | Acetone [Presence] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/5566-5.json |
| 5567-3 | Acetone [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5567-3.json |
| 5568-1 | Acetone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5568-1.json |
| 5569-9 | Acetone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5569-9.json |
| 5570-7 | Acetone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5570-7.json |
| 5571-5 | Acrylonitrile [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5571-5.json |
| 5572-3 | Aluminum [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5572-3.json |
| 55729-8 | Erythrocytes.fetal/100 erythrocytes [Ratio] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/55729-8.json |
| 5573-1 | Aluminum [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5573-1.json |
| 55731-4 | Inject Rh immune globulin [Mass] | ./2.16.840.1.114222.4.11.1002/55731-4.json |
| 5574-9 | Aluminum [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5574-9.json |
| 55750-4 | Patient safety report Document | ./2.16.840.1.114222.4.11.1002/55750-4.json |
| 55751-2 | Public health Case report | ./2.16.840.1.114222.4.11.1002/55751-2.json |
| 5575-6 | Aluminum [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5575-6.json |
| 55764-5 | EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55764-5.json |
| 55765-2 | EGFR gene c.2156G>C+2155G>A+2155G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55765-2.json |
| 55766-0 | EGFR gene c.2573T>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55766-0.json |
| 55767-8 | EGFR gene c.2582T>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55767-8.json |
| 55768-6 | EGFR gene c.2303G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55768-6.json |
| 55769-4 | EGFR gene c.2369C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55769-4.json |
| 55770-2 | EGFR gene exon 20 insertion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/55770-2.json |
| 5577-2 | Aluminum [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5577-2.json |
| 55774-4 | Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/55774-4.json |
| 55775-1 | Direct antiglobulin test.IgA specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/55775-1.json |
| 55776-9 | Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/55776-9.json |
| 55777-7 | Direct antiglobulin test.IgM specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/55777-7.json |
| 55779-3 | Erythrocytes [#/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55779-3.json |
| 5578-0 | Antimony [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5578-0.json |
| 55781-9 | Hematocrit [Volume Fraction] of Bone marrow | ./2.16.840.1.114222.4.11.1002/55781-9.json |
| 55782-7 | Hemoglobin [Mass/volume] in Blood by Oximetry | ./2.16.840.1.114222.4.11.1002/55782-7.json |
| 557-9 | Chlamydia sp identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/557-9.json |
| 5579-8 | Antimony [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5579-8.json |
| 55802-3 | Platelets [#/volume] in Cord blood by Estimate | ./2.16.840.1.114222.4.11.1002/55802-3.json |
| 55804-9 | Leukocyte phosphatase [Presence] in Leukocytes | ./2.16.840.1.114222.4.11.1002/55804-9.json |
| 55805-6 | cycloSPORINE [Mass/volume] in Blood by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/55805-6.json |
| 5580-6 | Antimony [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5580-6.json |
| 55806-4 | Mycophenolate [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/55806-4.json |
| 55807-2 | Mycophenolate glucuronide [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/55807-2.json |
| 55808-0 | 11-Deoxycorticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55808-0.json |
| 55809-8 | 11-Deoxycortisol [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55809-8.json |
| 55810-6 | 18-Hydroxycortisol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55810-6.json |
| 55811-4 | 18-Hydroxycortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55811-4.json |
| 55812-2 | 18-Hydroxycortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55812-2.json |
| 5581-4 | Antimony [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5581-4.json |
| 55814-8 | 25-hydroxyvitamin D3 [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/55814-8.json |
| 55815-5 | Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55815-5.json |
| 55816-3 | 3,4-Dihydroxyphenylacetate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55816-3.json |
| 55817-1 | Amino acids [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55817-1.json |
| 55818-9 | Organic acids [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/55818-9.json |
| 55819-7 | Adiponectin.high molecular weight [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55819-7.json |
| 55820-5 | Allo-pregnanediol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55820-5.json |
| 55821-3 | Allo-pregnanediol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55821-3.json |
| 5582-2 | Arsenic [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/5582-2.json |
| 55822-1 | Allo-tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55822-1.json |
| 55823-9 | Allo-tetrahydrodeoxycortisol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55823-9.json |
| 55824-7 | Allo-tetrahydrocorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55824-7.json |
| 55825-4 | Allo-tetrahydrocorticosterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55825-4.json |
| 55826-2 | Allo-tetrahydrocortisol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55826-2.json |
| 55827-0 | Acid alpha glucosidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55827-0.json |
| 55828-8 | Aliphatic carboxylate, C14-C26.esters [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/55828-8.json |
| 55829-6 | Catalase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/55829-6.json |
| 5583-0 | Arsenic [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5583-0.json |
| 55830-4 | Catecholamines [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55830-4.json |
| 55831-2 | Catecholamines [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55831-2.json |
| 55832-0 | Cathepsin K [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55832-0.json |
| 55833-8 | Cathepsin L [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55833-8.json |
| 55834-6 | Cathepsin S [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55834-6.json |
| 55836-1 | Chitotriosidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55836-1.json |
| 55837-9 | Chloride [Moles/volume] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/55837-9.json |
| 55838-7 | Cholesterol/Phospholipid [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55838-7.json |
| 55839-5 | Cholesterol ester transfer protein [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55839-5.json |
| 55840-3 | Cholesterol esters [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55840-3.json |
| 55841-1 | Corticosterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55841-1.json |
| 55842-9 | Corticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55842-9.json |
| 55843-7 | Corticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55843-7.json |
| 55844-5 | Cortisol Free [Mass/time] in 24 hour Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/55844-5.json |
| 55845-2 | Cortisol Free [Mass/volume] in 24 hour Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/55845-2.json |
| 55846-0 | Cryoglobulin.IgA.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55846-0.json |
| 55847-8 | Cryoglobulin.IgG.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55847-8.json |
| 5584-8 | Arsenic [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5584-8.json |
| 55848-6 | Cryoglobulin.IgG [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55848-6.json |
| 55849-4 | Cryoglobulin.IgM.monoclonal [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/55849-4.json |
| 55850-2 | Cobalamin (Vitamin B12) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55850-2.json |
| 55851-0 | Androstenediol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55851-0.json |
| 55853-6 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55853-6.json |
| 55854-4 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55854-4.json |
| 5585-5 | Arsenic [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5585-5.json |
| 55855-1 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55855-1.json |
| 55856-9 | Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55856-9.json |
| 55857-7 | Estradiol (E2) [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55857-7.json |
| 55858-5 | Estradiol (E2) [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55858-5.json |
| 55859-3 | Folate [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55859-3.json |
| 55860-1 | Glucose [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/55860-1.json |
| 55861-9 | Glutamate [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55861-9.json |
| 55862-7 | Glycine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55862-7.json |
| 5586-3 | Arsenic [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5586-3.json |
| 55863-5 | Glycolate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55863-5.json |
| 55864-3 | Glycolate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55864-3.json |
| 55865-0 | Glycolate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55865-0.json |
| 55866-8 | Choriogonadotropin.beta subunit free [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55866-8.json |
| 55867-6 | Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55867-6.json |
| 55868-4 | Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55868-4.json |
| 55869-2 | Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55869-2.json |
| 558-7 | Chlamydia sp identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/558-7.json |
| 55870-0 | Choriogonadotropin [Units/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/55870-0.json |
| 5587-1 | Arsenic [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5587-1.json |
| 55871-8 | Heptanoylcarnitine (C7) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55871-8.json |
| 55872-6 | Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55872-6.json |
| 55873-4 | Palmitate (C16:0)/Laurate (C12:0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55873-4.json |
| 55874-2 | Histidine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55874-2.json |
| 55875-9 | Homocitrulline [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55875-9.json |
| 55876-7 | Homocitrulline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55876-7.json |
| 55877-5 | Homocysteine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55877-5.json |
| 55878-3 | Homocysteine [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55878-3.json |
| 55879-1 | Homocystine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55879-1.json |
| 55880-9 | Homovanillate [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/55880-9.json |
| 55881-7 | Hydroxocobalamin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55881-7.json |
| 55882-5 | Hydroxocobalamin [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55882-5.json |
| 55883-3 | Hydroxocobalamin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/55883-3.json |
| 55884-1 | Hydroxocobalamin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55884-1.json |
| 55885-8 | Hydroxocobalamin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55885-8.json |
| 55887-4 | 3-Hydroxyanthranilate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55887-4.json |
| 55888-2 | 3-Hydroxyanthranilate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55888-2.json |
| 5588-9 | Barium [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5588-9.json |
| 55889-0 | 3-Hydroxyanthranilate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55889-0.json |
| 55891-6 | Hydroxylysine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55891-6.json |
| 5589-7 | Barium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5589-7.json |
| 55897-3 | Immunoglobulin light chains.free [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/55897-3.json |
| 55898-1 | Immunoglobulin light chains.free [Presence] in Serum by Immunofixation | ./2.16.840.1.114222.4.11.1002/55898-1.json |
| 55899-9 | Immunoglobulin light chains.free [Presence] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/55899-9.json |
| 55900-5 | Immunoglobulin light chains.free [Presence] in Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/55900-5.json |
| 55901-3 | IgA.monoclonal [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/55901-3.json |
| 55902-1 | IgA [Mass/volume] in Serum by Electrophoresis | ./2.16.840.1.114222.4.11.1002/55902-1.json |
| 55903-9 | IgD.monoclonal [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/55903-9.json |
| 55904-7 | IgE.monoclonal [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/55904-7.json |
| 5590-5 | Barium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5590-5.json |
| 55905-4 | Alpha cortol [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55905-4.json |
| 55907-0 | Alpha cortolone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55907-0.json |
| 55908-8 | Alpha galactosidase A [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55908-8.json |
| 55909-6 | Alpha-L-iduronidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55909-6.json |
| 55910-4 | Alpha mannosidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55910-4.json |
| 55911-2 | Arginine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55911-2.json |
| 55912-0 | Arylsulfatase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55912-0.json |
| 5591-3 | Benzene [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5591-3.json |
| 55913-8 | Aspartate [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55913-8.json |
| 55916-1 | Beta galactosidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55916-1.json |
| 55917-9 | Glucosylceramidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/55917-9.json |
| 55920-3 | C peptide [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55920-3.json |
| 5592-1 | Benzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5592-1.json |
| 55921-1 | IgG.monoclonal [Presence] in Serum by Immunoelectrophoresis | ./2.16.840.1.114222.4.11.1002/55921-1.json |
| 55922-9 | IgG [Mass/volume] in Serum by Electrophoresis | ./2.16.840.1.114222.4.11.1002/55922-9.json |
| 55925-2 | IgM [Mass/volume] in Serum by Electrophoresis | ./2.16.840.1.114222.4.11.1002/55925-2.json |
| 55926-0 | Interleukin 1 receptor alpha chain [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55926-0.json |
| 55927-8 | Interleukin 1 receptor alpha chain soluble [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55927-8.json |
| 55929-4 | Isoleucine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55929-4.json |
| 55930-2 | Isovalerylglycine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/55930-2.json |
| 55931-0 | Lactate [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/55931-0.json |
| 55932-8 | Lactate [Moles/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/55932-8.json |
| 55933-6 | Leucine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55933-6.json |
| 55934-4 | Lipase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/55934-4.json |
| 55935-1 | Lysine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55935-1.json |
| 55936-9 | Lysozyme [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55936-9.json |
| 55937-7 | Magnesium [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/55937-7.json |
| 55938-5 | Magnesium [Moles/volume] in Total parental nutrition | ./2.16.840.1.114222.4.11.1002/55938-5.json |
| 5593-9 | Beryllium [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5593-9.json |
| 55939-3 | Malondialdehyde [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/55939-3.json |
| 55940-1 | Malonylcarnitine (C3-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55940-1.json |
| 55941-9 | Mannitol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55941-9.json |
| 55943-5 | Methionine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55943-5.json |
| 55944-3 | Neopterin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55944-3.json |
| 55945-0 | Neopterin [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/55945-0.json |
| 55946-8 | Neopterin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55946-8.json |
| 5594-7 | Beryllium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5594-7.json |
| 55947-6 | Nitrite [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/55947-6.json |
| 55948-4 | Nitrite [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55948-4.json |
| 55949-2 | Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55949-2.json |
| 559-5 | Chlamydia sp identified in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/559-5.json |
| 55950-0 | Octanoylcarnitine (C8) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55950-0.json |
| 55951-8 | Octenoylcarnitine (C8:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/55951-8.json |
| 55952-6 | Octenoylcarnitine (C8:1) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55952-6.json |
| 55953-4 | Octenoylcarnitine (C8:1) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55953-4.json |
| 5595-4 | Beryllium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5595-4.json |
| 55954-2 | Octenoylcarnitine (C8:1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55954-2.json |
| 55955-9 | Oleoylcarnitine (C18:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/55955-9.json |
| 55956-7 | Oleoylcarnitine (C18:1) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55956-7.json |
| 55957-5 | Oleoylcarnitine (C18:1) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55957-5.json |
| 55958-3 | Oleoylcarnitine (C18:1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55958-3.json |
| 55959-1 | Ornithine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/55959-1.json |
| 55960-9 | Osmolality of Dialysis fluid | ./2.16.840.1.114222.4.11.1002/55960-9.json |
| 55961-7 | Oxalate [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/55961-7.json |
| 5596-2 | Beryllium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5596-2.json |
| 55962-5 | Oxygen content in Cord blood | ./2.16.840.1.114222.4.11.1002/55962-5.json |
| 55963-3 | Palmitoleylcarnitine (C16:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/55963-3.json |
| 55964-1 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/55964-1.json |
| 55965-8 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/55965-8.json |
| 55966-6 | Palmitoleylcarnitine (C16:1) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55966-6.json |
| 55967-4 | Palmitoylcarnitine (C16) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/55967-4.json |
| 55968-2 | pH of Total parental nutrition | ./2.16.840.1.114222.4.11.1002/55968-2.json |
| 5597-0 | Bismuth [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5597-0.json |
| 55970-8 | Phenylalanine [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/55970-8.json |
| 55971-6 | Alkaline phosphatase [Enzymatic activity/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/55971-6.json |
| 55972-4 | Phosphate [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/55972-4.json |
| 55973-2 | Phosphate [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/55973-2.json |
| 55974-0 | IgG [Mass/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/55974-0.json |
| 55975-7 | IgG [Mass/volume] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/55975-7.json |
| 55976-5 | pH of Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/55976-5.json |
| 5598-8 | Bismuth [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5598-8.json |
| 5599-6 | Boldenone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5599-6.json |
| 5600-2 | Boldenone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5600-2.json |
| 5601-0 | Boldenone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5601-0.json |
| 56022-7 | ACE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56022-7.json |
| 56023-5 | Foot and mouth disease virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/56023-5.json |
| 56024-3 | Influenza virus A N1 RNA [Units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/56024-3.json |
| 5602-8 | Borate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5602-8.json |
| 560-3 | Chlamydia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/560-3.json |
| 56031-8 | Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/56031-8.json |
| 56032-6 | Lithium [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/56032-6.json |
| 56033-4 | Androstenediol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56033-4.json |
| 56034-2 | Hydroxylysine [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/56034-2.json |
| 5603-6 | Borate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5603-6.json |
| 56036-7 | Apolipoprotein B/Cholesterol in LDL [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56036-7.json |
| 56037-5 | Protein phosphatase 3 [Enzymatic activity/volume] in Leukocytes | ./2.16.840.1.114222.4.11.1002/56037-5.json |
| 56038-3 | Lysozyme [Units] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56038-3.json |
| 56039-1 | Lysozyme [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56039-1.json |
| 56040-9 | Methemoglobin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/56040-9.json |
| 56042-5 | Beta defensin [Mass/mass] in Stool.dried | ./2.16.840.1.114222.4.11.1002/56042-5.json |
| 56043-3 | Shoulder - right Horizontal adduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56043-3.json |
| 5604-4 | Boron [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5604-4.json |
| 56044-1 | Shoulder - right Horizontal adduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56044-1.json |
| 56045-8 | Shoulder - left Horizontal adduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56045-8.json |
| 56046-6 | Shoulder Horizontal adduction Passive Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56046-6.json |
| 56047-4 | Shoulder Horizontal adduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56047-4.json |
| 56048-2 | Shoulder - left Horizontal adduction Active Range of Motion Quantitative | ./2.16.840.1.114222.4.11.1002/56048-2.json |
| 5605-1 | Boron [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/5605-1.json |
| 5606-9 | Boron [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5606-9.json |
| 5607-7 | Boron [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5607-7.json |
| 5608-5 | Bufotenine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5608-5.json |
| 5609-3 | Cadmium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5609-3.json |
| 5610-1 | Cadmium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5610-1.json |
| 561-1 | Chlamydia sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/561-1.json |
| 5611-9 | Cadmium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5611-9.json |
| 56119-1 | Cellular material [Mass/mass] of Stone by Estimated | ./2.16.840.1.114222.4.11.1002/56119-1.json |
| 56120-9 | Amphetamine+Methamphetamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56120-9.json |
| 56121-7 | IgA [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56121-7.json |
| 56122-5 | IgG [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/56122-5.json |
| 56123-3 | IgM [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56123-3.json |
| 56125-8 | Immunoglobulin light chains.free [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/56125-8.json |
| 56126-6 | Copper [Mass/mass] in Liver | ./2.16.840.1.114222.4.11.1002/56126-6.json |
| 5612-7 | Cadmium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5612-7.json |
| 56127-4 | CD38 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/56127-4.json |
| 56128-2 | Chikungunya virus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56128-2.json |
| 56129-0 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56129-0.json |
| 56130-8 | Chikungunya virus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56130-8.json |
| 56131-6 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56131-6.json |
| 56132-4 | Cholesterol in HDL 2a [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56132-4.json |
| 56133-2 | Cholesterol in HDL 2b [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56133-2.json |
| 56134-0 | Cholesterol in IDL 1 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56134-0.json |
| 56135-7 | Cholesterol in IDL 2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56135-7.json |
| 56136-5 | LDL 1 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56136-5.json |
| 56137-3 | LDL 2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56137-3.json |
| 56138-1 | LDL 3 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56138-1.json |
| 56139-9 | LDL 4 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56139-9.json |
| 56140-7 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Anal by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/56140-7.json |
| 56141-5 | MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/56141-5.json |
| 56142-3 | MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/56142-3.json |
| 5614-3 | Cesium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5614-3.json |
| 56143-1 | Potassium/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56143-1.json |
| 56147-2 | Parietal cell Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56147-2.json |
| 5615-0 | Cesium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5615-0.json |
| 56150-6 | Candida albicans IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56150-6.json |
| 56151-4 | Candida albicans IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56151-4.json |
| 56158-9 | PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56158-9.json |
| 56159-7 | LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56159-7.json |
| 56161-3 | Calculus analysis with calculus photography [Interpretation] in Stone | ./2.16.840.1.114222.4.11.1002/56161-3.json |
| 56164-7 | CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56164-7.json |
| 56165-4 | CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56165-4.json |
| 56166-2 | Gum arabic IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56166-2.json |
| 56167-0 | Corticotropin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56167-0.json |
| 5616-8 | Cesium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5616-8.json |
| 56168-8 | Allspice IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56168-8.json |
| 56169-6 | Almond IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56169-6.json |
| 56170-4 | Alternaria alternata IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56170-4.json |
| 56171-2 | American Beech IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56171-2.json |
| 56172-0 | American Cheese IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56172-0.json |
| 56173-8 | American Cockroach IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56173-8.json |
| 56174-6 | White Elm IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56174-6.json |
| 56175-3 | American Sycamore IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56175-3.json |
| 5617-6 | Cesium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5617-6.json |
| 56176-1 | Apple IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56176-1.json |
| 56177-9 | Apricot IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56177-9.json |
| 56178-7 | Artichoke IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56178-7.json |
| 56179-5 | Asparagus IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56179-5.json |
| 56180-3 | Aspergillus fumigatus IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56180-3.json |
| 56181-1 | Aspergillus niger IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56181-1.json |
| 56182-9 | Aspergillus versicolor IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56182-9.json |
| 56183-7 | Australian pine IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56183-7.json |
| 5618-4 | Cesium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5618-4.json |
| 56184-5 | Avocado IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56184-5.json |
| 56185-2 | Bahia grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56185-2.json |
| 56186-0 | Banana IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56186-0.json |
| 56187-8 | Barley IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56187-8.json |
| 56188-6 | Basil IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56188-6.json |
| 56189-4 | Bayleaf IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56189-4.json |
| 56190-2 | Bermuda grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56190-2.json |
| 56191-0 | Cherry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56191-0.json |
| 5619-2 | Chromium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5619-2.json |
| 56192-8 | Bass, Black IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56192-8.json |
| 56193-6 | Black Willow IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56193-6.json |
| 56194-4 | Blackberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56194-4.json |
| 56195-1 | Black-eye pea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56195-1.json |
| 56196-9 | Blueberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56196-9.json |
| 56197-7 | Insulin bovine IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56197-7.json |
| 56198-5 | Brazil Nut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56198-5.json |
| 56199-3 | Brewer's yeast IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56199-3.json |
| 5620-0 | Chromium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5620-0.json |
| 56200-9 | Broccoli IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56200-9.json |
| 56201-7 | Brussel Sprouts IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56201-7.json |
| 56202-5 | Buckwheat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56202-5.json |
| 56203-3 | Cabbage IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56203-3.json |
| 56204-1 | Candida albicans IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56204-1.json |
| 56205-8 | Careless Weed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56205-8.json |
| 56206-6 | Carrot IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56206-6.json |
| 56207-4 | Casein IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56207-4.json |
| 56208-2 | Cashew nut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56208-2.json |
| 56209-0 | Castor Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56209-0.json |
| 56210-8 | Cat dander IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56210-8.json |
| 56211-6 | Catfish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56211-6.json |
| 56212-4 | Cauliflower IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56212-4.json |
| 56213-2 | Celery IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56213-2.json |
| 56214-0 | Acremonium sp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56214-0.json |
| 56215-7 | Cheese cheddar type IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56215-7.json |
| 56216-5 | Cheese mold type IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56216-5.json |
| 56217-3 | Chick Pea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56217-3.json |
| 5621-8 | Chromium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5621-8.json |
| 56218-1 | Chicken IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56218-1.json |
| 56219-9 | Chicory IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56219-9.json |
| 56220-7 | Chili Pepper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56220-7.json |
| 56221-5 | Chinese Elm IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56221-5.json |
| 56222-3 | Chocolate IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56222-3.json |
| 56223-1 | Cinnamon IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56223-1.json |
| 56224-9 | Cladosporium herbarum IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56224-9.json |
| 56225-6 | Clam IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56225-6.json |
| 5622-6 | Chromium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5622-6.json |
| 56226-4 | Cocklebur IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56226-4.json |
| 56227-2 | Coconut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56227-2.json |
| 56228-0 | Codfish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56228-0.json |
| 56229-8 | Coffee IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56229-8.json |
| 56230-6 | Common Reed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56230-6.json |
| 56231-4 | Corn IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56231-4.json |
| 56232-2 | Corn smut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56232-2.json |
| 56233-0 | Cottonwood IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56233-0.json |
| 5623-4 | Chromium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5623-4.json |
| 56234-8 | Cow milk IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56234-8.json |
| 56235-5 | Crab IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56235-5.json |
| 56236-3 | Cranberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56236-3.json |
| 56237-1 | Crawfish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56237-1.json |
| 56238-9 | Cucumber IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56238-9.json |
| 56239-7 | Curry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56239-7.json |
| 56240-5 | Squid IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56240-5.json |
| 56241-3 | American house dust mite IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56241-3.json |
| 5624-2 | Chromium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5624-2.json |
| 56242-1 | European house dust mite IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56242-1.json |
| 56243-9 | Dandelion IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56243-9.json |
| 56244-7 | Dates IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56244-7.json |
| 56245-4 | Deer Fly IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56245-4.json |
| 56246-2 | Dill IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56246-2.json |
| 56247-0 | Dog epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56247-0.json |
| 56248-8 | Dog dander IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56248-8.json |
| 56249-6 | Douglas Fir IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56249-6.json |
| 56250-4 | Duck feather IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56250-4.json |
| 56251-2 | Duck meat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56251-2.json |
| 56252-0 | Eel IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56252-0.json |
| 56253-8 | Egg white IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56253-8.json |
| 56254-6 | Egg yolk IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56254-6.json |
| 56255-3 | Whole Egg IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56255-3.json |
| 56256-1 | Eggplant IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56256-1.json |
| 56257-9 | English plantain IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56257-9.json |
| 56258-7 | Gum-Tree IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56258-7.json |
| 5625-9 | Cobalt [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5625-9.json |
| 56259-5 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56259-5.json |
| 56260-3 | Red Imported Fire Ant IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56260-3.json |
| 56261-1 | Flax IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56261-1.json |
| 56262-9 | Flea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56262-9.json |
| 56263-7 | Flounder IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56263-7.json |
| 56264-5 | Glycyphagus domesticus IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56264-5.json |
| 56265-2 | Garlic IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56265-2.json |
| 56266-0 | Cockroach IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56266-0.json |
| 5626-7 | Cobalt [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5626-7.json |
| 56267-8 | Ginger IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56267-8.json |
| 56268-6 | Gluten IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56268-6.json |
| 56269-4 | Goat milk IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56269-4.json |
| 56270-2 | Hamster epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56270-2.json |
| 56271-0 | Goldenrod IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56271-0.json |
| 56272-8 | Goose feather IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56272-8.json |
| 56273-6 | Grape IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56273-6.json |
| 56274-4 | Grapefruit IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56274-4.json |
| 5627-5 | Cobalt [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5627-5.json |
| 56275-1 | Green Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56275-1.json |
| 56276-9 | Olive IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56276-9.json |
| 56277-7 | Pea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56277-7.json |
| 56278-5 | Green Pepper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56278-5.json |
| 56279-3 | Guinea pig epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56279-3.json |
| 56280-1 | Haddock IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56280-1.json |
| 56281-9 | Halibut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56281-9.json |
| 56282-7 | Hazelnut Pollen IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56282-7.json |
| 5628-3 | Cobalt [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5628-3.json |
| 56283-5 | Hazelnut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56283-5.json |
| 56284-3 | Herring IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56284-3.json |
| 56285-0 | Honey IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56285-0.json |
| 56286-8 | Honey bee IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56286-8.json |
| 56288-4 | Hop IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56288-4.json |
| 56289-2 | Horseradish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56289-2.json |
| 562-9 | Clostridioides difficile [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/562-9.json |
| 56290-0 | House dust Greer IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56290-0.json |
| 5629-1 | Copper [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5629-1.json |
| 56291-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56291-8.json |
| 56292-6 | Insulin human IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56292-6.json |
| 56293-4 | Italian Cypress IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56293-4.json |
| 56294-2 | Johnson grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56294-2.json |
| 56295-9 | Karaya gum IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56295-9.json |
| 56296-7 | Kentucky blue grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56296-7.json |
| 56297-5 | Red Kidney Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56297-5.json |
| 56298-3 | Kiwifruit IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56298-3.json |
| 56299-1 | Firebush IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56299-1.json |
| 56300-7 | Lepidoglyphus destructor IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56300-7.json |
| 56301-5 | Lactalbumin alpha IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56301-5.json |
| 56302-3 | Beta lactoglobulin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56302-3.json |
| 56303-1 | Goosefoot IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56303-1.json |
| 56304-9 | Lemon IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56304-9.json |
| 56305-6 | Lenscale IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56305-6.json |
| 56306-4 | Lentils IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56306-4.json |
| 56307-2 | Lettuce IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56307-2.json |
| 56308-0 | Lima Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56308-0.json |
| 5630-9 | Copper [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5630-9.json |
| 56309-8 | Lime IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56309-8.json |
| 56310-6 | Lobster IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56310-6.json |
| 56311-4 | Locust tree IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56311-4.json |
| 56312-2 | Malt IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56312-2.json |
| 56313-0 | Mango IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56313-0.json |
| 56314-8 | Maple syrup IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56314-8.json |
| 56315-5 | Boxelder IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56315-5.json |
| 56316-3 | Rough Marsh Elder IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56316-3.json |
| 5631-7 | Copper [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5631-7.json |
| 56317-1 | Meadow Fescue IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56317-1.json |
| 56318-9 | Meadow Foxtail IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56318-9.json |
| 56319-7 | Cajeput tree IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56319-7.json |
| 56320-5 | Mesquite IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56320-5.json |
| 56321-3 | Common Millet IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56321-3.json |
| 56322-1 | Aedes mosquito IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56322-1.json |
| 56323-9 | Mountain Juniper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56323-9.json |
| 56324-7 | Mucor racemosus IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56324-7.json |
| 5632-5 | Copper [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5632-5.json |
| 56325-4 | Mugwort IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56325-4.json |
| 56326-2 | Mushroom IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56326-2.json |
| 56327-0 | Blue mussel IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56327-0.json |
| 56328-8 | Mustard IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56328-8.json |
| 56329-6 | Nectarine IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56329-6.json |
| 56330-4 | Nettle IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56330-4.json |
| 56331-2 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56331-2.json |
| 56332-0 | Nutmeg IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56332-0.json |
| 5633-3 | Copper [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5633-3.json |
| 56333-8 | Oat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56333-8.json |
| 56334-6 | Oat pollen IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56334-6.json |
| 56335-3 | Okra IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56335-3.json |
| 56336-1 | Olive Pollen IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56336-1.json |
| 56337-9 | Onion IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56337-9.json |
| 56338-7 | Orange IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56338-7.json |
| 56339-5 | Cocksfoot IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56339-5.json |
| 56340-3 | Oregano IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56340-3.json |
| 5634-1 | Cyanide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5634-1.json |
| 56341-1 | Ox-eye daisy IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56341-1.json |
| 56342-9 | Oyster IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56342-9.json |
| 56343-7 | Papaya (Carica papaya) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56343-7.json |
| 56344-5 | Paper wasp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56344-5.json |
| 56345-2 | Paprika IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56345-2.json |
| 56346-0 | Parmesan Cheese IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56346-0.json |
| 56347-8 | Parrot feather IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56347-8.json |
| 56348-6 | Parsley IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56348-6.json |
| 56349-4 | Parsnip IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56349-4.json |
| 56350-2 | Peach IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56350-2.json |
| 56351-0 | Peanut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56351-0.json |
| 56352-8 | Pear IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56352-8.json |
| 56353-6 | Pecan or Hickory Nut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56353-6.json |
| 56354-4 | Pecan or Hickory Tree IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56354-4.json |
| 56355-1 | Penicillium notatum IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56355-1.json |
| 56356-9 | Perch IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56356-9.json |
| 56357-7 | Perennial rye grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56357-7.json |
| 5635-8 | Cyanide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5635-8.json |
| 56358-5 | Pineapple IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56358-5.json |
| 56359-3 | Pinto Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56359-3.json |
| 56360-1 | Pistachio IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56360-1.json |
| 56361-9 | Plum IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56361-9.json |
| 56362-7 | Poppy Seed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56362-7.json |
| 56363-5 | Insulin porcine IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56363-5.json |
| 56364-3 | Povertyweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56364-3.json |
| 56365-0 | Queen Palm IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56365-0.json |
| 5636-6 | Cyanide [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/5636-6.json |
| 56366-8 | Rabbit IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56366-8.json |
| 56367-6 | Rabbit epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56367-6.json |
| 56368-4 | Radish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56368-4.json |
| 56369-2 | False ragweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56369-2.json |
| 563-7 | Clostridioides difficile [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/563-7.json |
| 56370-0 | Giant Ragweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56370-0.json |
| 56371-8 | Common Ragweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56371-8.json |
| 56372-6 | Western Ragweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56372-6.json |
| 56373-4 | Raspberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56373-4.json |
| 5637-4 | Cyanide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5637-4.json |
| 56374-2 | Rat epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56374-2.json |
| 56375-9 | Red Beet IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56375-9.json |
| 56376-7 | Red Snapper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56376-7.json |
| 56377-5 | Red top grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56377-5.json |
| 56378-3 | Rhubarb IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56378-3.json |
| 56379-1 | Rice IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56379-1.json |
| 56380-9 | Saltwort IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56380-9.json |
| 56381-7 | Cultivated Rye IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56381-7.json |
| 5638-2 | Diazinon [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5638-2.json |
| 56382-5 | Safflower IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56382-5.json |
| 56383-3 | Salmon IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56383-3.json |
| 56384-1 | Sardine (pilchard) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56384-1.json |
| 56385-8 | Scallop IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56385-8.json |
| 56386-6 | Sesame Seed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56386-6.json |
| 56387-4 | Sheep Sorrel IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56387-4.json |
| 56388-2 | Shrimp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56388-2.json |
| 56389-0 | Sole IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56389-0.json |
| 5639-0 | Ethanol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/5639-0.json |
| 56390-8 | Soybean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56390-8.json |
| 56391-6 | Spinach IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56391-6.json |
| 56392-4 | Spiny Pigweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56392-4.json |
| 56393-2 | Strawberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56393-2.json |
| 56394-0 | Sugar Cane IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56394-0.json |
| 56395-7 | Sunflower Seed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56395-7.json |
| 56396-5 | Chestnut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56396-5.json |
| 56397-3 | Sweet potato IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56397-3.json |
| 56398-1 | Sweet Vernal grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56398-1.json |
| 56399-9 | Swiss Cheese IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56399-9.json |
| 56400-5 | Mandarin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56400-5.json |
| 56401-3 | Tea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56401-3.json |
| 56402-1 | Thyme IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56402-1.json |
| 56403-9 | Timothy IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56403-9.json |
| 56404-7 | Tobacco IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56404-7.json |
| 56405-4 | Tomato IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56405-4.json |
| 56406-2 | Trichoderma viride IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56406-2.json |
| 56407-0 | Trout IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56407-0.json |
| 5640-8 | Ethanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5640-8.json |
| 56408-8 | Tuna IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56408-8.json |
| 56409-6 | Turkey IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56409-6.json |
| 56410-4 | Vanilla IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56410-4.json |
| 56411-2 | Velvet grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56411-2.json |
| 56412-0 | Venison IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56412-0.json |
| 56413-8 | Virginia Live Oak IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56413-8.json |
| 56414-6 | Walnut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56414-6.json |
| 56415-3 | Watermelon IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56415-3.json |
| 5641-6 | Ethanol [Mass/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/5641-6.json |
| 56416-1 | Western Water Hemp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56416-1.json |
| 56417-9 | Wheat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56417-9.json |
| 56418-7 | Cultivated Wheat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56418-7.json |
| 56419-5 | Cow whey IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56419-5.json |
| 56420-3 | White Ash IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56420-3.json |
| 56421-1 | White Bean IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56421-1.json |
| 56422-9 | White Birch IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56422-9.json |
| 56423-7 | White Hickory IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56423-7.json |
| 5642-4 | Ethanol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5642-4.json |
| 56424-5 | Whitefaced Hornet IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56424-5.json |
| 56425-2 | White mulberry IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56425-2.json |
| 56426-0 | White Oak IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56426-0.json |
| 56427-8 | Eastern White Pine IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56427-8.json |
| 56428-6 | White Poplar IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56428-6.json |
| 56429-4 | Potato IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56429-4.json |
| 56430-2 | Whitefish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56430-2.json |
| 56431-0 | Wine vinegar IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56431-0.json |
| 5643-2 | Ethanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5643-2.json |
| 56432-8 | Wormwood IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56432-8.json |
| 56433-6 | Yellow Hornet IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56433-6.json |
| 56434-4 | Yellow Jacket IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56434-4.json |
| 56435-1 | Yogurt IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56435-1.json |
| 56436-9 | Zucchini IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56436-9.json |
| 56437-7 | Chicken feather IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56437-7.json |
| 56438-5 | Beef IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56438-5.json |
| 56439-3 | Chub Mackerel IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56439-3.json |
| 5644-0 | Ethanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5644-0.json |
| 56440-1 | Clove IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56440-1.json |
| 56441-9 | Latex IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56441-9.json |
| 56442-7 | Pork IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56442-7.json |
| 56443-5 | Rye IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56443-5.json |
| 56444-3 | Healthcare communication Document | ./2.16.840.1.114222.4.11.1002/56444-3.json |
| 56445-0 | Medication summary Document | ./2.16.840.1.114222.4.11.1002/56445-0.json |
| 56446-8 | Appointment summary Document | ./2.16.840.1.114222.4.11.1002/56446-8.json |
| 56448-4 | Chloride [Moles/volume] in Sweat by Screen method | ./2.16.840.1.114222.4.11.1002/56448-4.json |
| 56449-2 | Baker's yeast IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56449-2.json |
| 564-5 | Colony count [#] in Specimen by Visual count | ./2.16.840.1.114222.4.11.1002/564-5.json |
| 56450-0 | Black Pepper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56450-0.json |
| 56451-8 | Chymopapain IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56451-8.json |
| 56452-6 | Cottonseed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56452-6.json |
| 56453-4 | Cow dander IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56453-4.json |
| 56454-2 | Cumin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56454-2.json |
| 56455-9 | Gelatin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56455-9.json |
| 56456-7 | Horse dander IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56456-7.json |
| 5645-7 | Ethanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5645-7.json |
| 56457-5 | Lamb IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56457-5.json |
| 56458-3 | Wattle IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56458-3.json |
| 56459-1 | Oat smut IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56459-1.json |
| 56460-9 | Pepper tree IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56460-9.json |
| 56461-7 | Red Alder IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56461-7.json |
| 56462-5 | Red Pepper IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56462-5.json |
| 56463-3 | Rough Pigweed IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56463-3.json |
| 56464-1 | Sage IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56464-1.json |
| 5646-5 | Ethylene glycol [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/5646-5.json |
| 56465-8 | Salt grass IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56465-8.json |
| 56466-6 | Swordfish IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56466-6.json |
| 56467-4 | Horse Fly IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56467-4.json |
| 56468-2 | Pumpkin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56468-2.json |
| 56471-6 | Direct antiglobulin test.complement C3c specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/56471-6.json |
| 5647-3 | Ethylene glycol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5647-3.json |
| 56477-3 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56477-3.json |
| 56478-1 | Ethanol [Mass/volume] in Blood by Gas chromatography | ./2.16.840.1.114222.4.11.1002/56478-1.json |
| 56479-9 | Superoxide dismutase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/56479-9.json |
| 56480-7 | Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/56480-7.json |
| 5648-1 | Fluoride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5648-1.json |
| 56481-5 | Lambda light chains.free [Presence] in Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/56481-5.json |
| 56483-1 | Porphobilinogen [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/56483-1.json |
| 56484-9 | Uroporphyrin [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/56484-9.json |
| 56485-6 | Taenia solium IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56485-6.json |
| 56486-4 | Taenia solium IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56486-4.json |
| 56487-2 | Androsterone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56487-2.json |
| 56488-0 | Etiocholanolone [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56488-0.json |
| 56489-8 | Acidity.titratable [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56489-8.json |
| 56497-1 | Choriogonadotropin.beta subunit [Units] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56497-1.json |
| 5649-9 | Fluoride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5649-9.json |
| 56499-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/56499-7.json |
| 56500-2 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/56500-2.json |
| 5650-7 | Fluoride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5650-7.json |
| 56512-7 | Porphyrins [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/56512-7.json |
| 56513-5 | Hepatitis E virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56513-5.json |
| 56514-3 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56514-3.json |
| 5651-5 | Fluoride [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5651-5.json |
| 56515-0 | Plasmodium falciparum IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56515-0.json |
| 565-2 | Colony count [#] in Specimen Qualitative by Visual count | ./2.16.840.1.114222.4.11.1002/565-2.json |
| 5652-3 | Formaldehyde [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5652-3.json |
| 56525-9 | 5-Hydroxytryptophan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56525-9.json |
| 56529-1 | Ma+Ta Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56529-1.json |
| 56530-9 | CV2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56530-9.json |
| 5653-1 | Formaldehyde [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5653-1.json |
| 56531-7 | Amphiphysin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56531-7.json |
| 56532-5 | Asialoglycoprotein receptor Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56532-5.json |
| 56533-3 | Insulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56533-3.json |
| 56535-8 | 8-Dehydrocholesterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56535-8.json |
| 56536-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56536-6.json |
| 56537-4 | Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56537-4.json |
| 56538-2 | Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56538-2.json |
| 56539-0 | Intrinsic factor Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56539-0.json |
| 56540-8 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56540-8.json |
| 56541-6 | Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56541-6.json |
| 56542-4 | Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/56542-4.json |
| 56543-2 | Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56543-2.json |
| 56544-0 | Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56544-0.json |
| 56545-7 | Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56545-7.json |
| 56546-5 | Insulin Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56546-5.json |
| 56547-3 | Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56547-3.json |
| 56548-1 | U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56548-1.json |
| 5654-9 | Gallium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5654-9.json |
| 56549-9 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56549-9.json |
| 56550-7 | PCA-Tr Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56550-7.json |
| 56551-5 | PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56551-5.json |
| 56553-1 | Microalbumin [Mass/time] in 8 hour Urine | ./2.16.840.1.114222.4.11.1002/56553-1.json |
| 56554-9 | Porphyrins [Mass/time] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/56554-9.json |
| 5655-6 | Germanium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5655-6.json |
| 5656-4 | Gold [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5656-4.json |
| 5657-2 | Gold [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/5657-2.json |
| 56577-0 | Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/56577-0.json |
| 5658-0 | Gold [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5658-0.json |
| 56595-2 | Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56595-2.json |
| 56596-0 | Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56596-0.json |
| 56597-8 | Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56597-8.json |
| 5659-8 | Gold [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5659-8.json |
| 56598-6 | Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56598-6.json |
| 56599-4 | Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/56599-4.json |
| 566-0 | Cryptosporidium sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/566-0.json |
| 56600-0 | European Hornet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56600-0.json |
| 56601-8 | Hyaluronate [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/56601-8.json |
| 5660-6 | Gold [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5660-6.json |
| 5661-4 | Gold [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5661-4.json |
| 56620-8 | Elastase Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56620-8.json |
| 56621-6 | Coxsackievirus A9 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56621-6.json |
| 5662-2 | Heavy metals [Presence] in Urine by Reinsch | ./2.16.840.1.114222.4.11.1002/5662-2.json |
| 56622-4 | Echovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56622-4.json |
| 56623-2 | Echovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56623-2.json |
| 56624-0 | Fructose [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56624-0.json |
| 56625-7 | Methylene chloride [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/56625-7.json |
| 56626-5 | Tetrachloroethylene [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/56626-5.json |
| 56627-3 | Procollagen type III [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56627-3.json |
| 56628-1 | Amikacin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56628-1.json |
| 56629-9 | Myelin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56629-9.json |
| 56630-7 | Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56630-7.json |
| 56631-5 | Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56631-5.json |
| 56632-3 | Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56632-3.json |
| 56633-1 | Myocardium IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56633-1.json |
| 56634-9 | Nuclear IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56634-9.json |
| 56635-6 | Thyroglobulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56635-6.json |
| 56636-4 | Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56636-4.json |
| 56637-2 | Mi-2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56637-2.json |
| 56639-8 | Methyl ethyl ketone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56639-8.json |
| 56640-6 | Aspartate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56640-6.json |
| 56641-4 | Threonine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56641-4.json |
| 56642-2 | Serine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56642-2.json |
| 56643-0 | Asparagine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56643-0.json |
| 56644-8 | Glutamate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56644-8.json |
| 56645-5 | Vanillylmandelate/Creatine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56645-5.json |
| 56646-3 | Trichloroacetate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56646-3.json |
| 56647-1 | Phenol/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56647-1.json |
| 56648-9 | Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56648-9.json |
| 56649-7 | Hippurate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56649-7.json |
| 56650-5 | Chromium/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56650-5.json |
| 56651-3 | Cadmium/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56651-3.json |
| 56652-1 | Arsenic/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56652-1.json |
| 56653-9 | Mercury/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56653-9.json |
| 56654-7 | Nickel/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56654-7.json |
| 5665-5 | Indium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5665-5.json |
| 56655-4 | Bromide/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56655-4.json |
| 56656-2 | Fluoride/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56656-2.json |
| 56657-0 | Tetrahydrocortisone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56657-0.json |
| 56658-8 | Delta aminolevulinate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56658-8.json |
| 56659-6 | Para aminophenol/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56659-6.json |
| 56660-4 | Methyl formamide/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56660-4.json |
| 56661-2 | Myelin basic protein [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56661-2.json |
| 56662-0 | Beta-2-Microglobulin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56662-0.json |
| 5666-3 | Indium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5666-3.json |
| 56663-8 | 5-Hydroxytryptophan [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56663-8.json |
| 56664-6 | Methylmalonate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/56664-6.json |
| 56665-3 | Taenia solium IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56665-3.json |
| 56666-1 | 1-Methylhistidine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56666-1.json |
| 56667-9 | 3-Methylhistidine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56667-9.json |
| 56668-7 | Alpha aminoadipate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56668-7.json |
| 56669-5 | Carotene.alpha [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56669-5.json |
| 56670-3 | Adrenal cortex IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56670-3.json |
| 5667-1 | Isopropanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5667-1.json |
| 56671-1 | Alanine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56671-1.json |
| 56672-9 | Arginine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56672-9.json |
| 56673-7 | Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56673-7.json |
| 56674-5 | Beta alanine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56674-5.json |
| 56675-2 | Carnosine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56675-2.json |
| 56676-0 | Citrulline/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56676-0.json |
| 56677-8 | Cystine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56677-8.json |
| 56678-6 | Ethanolamine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56678-6.json |
| 56679-4 | Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56679-4.json |
| 56680-2 | Glutamine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56680-2.json |
| 56681-0 | Glycine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56681-0.json |
| 56682-8 | Homocystine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56682-8.json |
| 56683-6 | Histidine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56683-6.json |
| 56684-4 | Hydroxylysine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56684-4.json |
| 56685-1 | Hydroxyproline Free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56685-1.json |
| 56686-9 | Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56686-9.json |
| 56687-7 | Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56687-7.json |
| 56688-5 | IgD [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56688-5.json |
| 5668-9 | Isopropanol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5668-9.json |
| 56689-3 | Isoleucine/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56689-3.json |
| 56693-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56693-5.json |
| 56694-3 | Chicken droppings Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/56694-3.json |
| 56695-0 | Cephalexin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56695-0.json |
| 56696-8 | Cloxacillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56696-8.json |
| 5669-7 | Isopropanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5669-7.json |
| 56697-6 | Thiopental IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56697-6.json |
| 56698-4 | Atropine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56698-4.json |
| 56699-2 | Bupivacaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56699-2.json |
| 56700-8 | Naproxen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56700-8.json |
| 56701-6 | Diclofenac IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56701-6.json |
| 56702-4 | Ciprofloxacin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56702-4.json |
| 56703-2 | Piroxicam IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56703-2.json |
| 56704-0 | Droperidol IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56704-0.json |
| 5670-5 | Isopropanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5670-5.json |
| 56705-7 | Tobramycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56705-7.json |
| 56706-5 | Doxycycline IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56706-5.json |
| 56707-3 | Spiramycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56707-3.json |
| 56708-1 | metroNIDAZOLE IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56708-1.json |
| 56709-9 | Tartrazine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56709-9.json |
| 56710-7 | Clarithromycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56710-7.json |
| 56711-5 | Sodium benzoate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56711-5.json |
| 56712-3 | Dexamethasone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56712-3.json |
| 5671-3 | Lead [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5671-3.json |
| 56713-1 | Dog dander+Dog epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56713-1.json |
| 56714-9 | Bacteria identified in Contact lens by Culture | ./2.16.840.1.114222.4.11.1002/56714-9.json |
| 56715-6 | Bacteria identified in Pericardial fluid by Culture | ./2.16.840.1.114222.4.11.1002/56715-6.json |
| 56716-4 | Nuclear pore protein gp210 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56716-4.json |
| 56717-2 | Histone Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56717-2.json |
| 56718-0 | Islet cell 512 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56718-0.json |
| 56719-8 | Liver cytosol Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56719-8.json |
| 56720-6 | Ma+Ta Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56720-6.json |
| 56721-4 | PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56721-4.json |
| 56722-2 | Soluble liver Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56722-2.json |
| 56723-0 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56723-0.json |
| 56724-8 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56724-8.json |
| 56725-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56725-5.json |
| 56726-3 | Perennial rye grass recombinant profilin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56726-3.json |
| 56727-1 | Olive recombinant (rOle e) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56727-1.json |
| 56728-9 | Thermoactinomyces vulgaris IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56728-9.json |
| 56729-7 | Cladosporium cladosporioides IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56729-7.json |
| 56730-5 | Smith extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56730-5.json |
| 56731-3 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56731-3.json |
| 56732-1 | Ribosomal P Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56732-1.json |
| 56733-9 | PCNA extractable nuclear Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56733-9.json |
| 56734-7 | Centromere protein B Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56734-7.json |
| 56735-4 | Mitochondria M2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56735-4.json |
| 56736-2 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/56736-2.json |
| 5673-9 | Lead [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5673-9.json |
| 56739-6 | Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56739-6.json |
| 56740-4 | Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56740-4.json |
| 56741-2 | Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56741-2.json |
| 56742-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56742-0.json |
| 56743-8 | Mi-2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56743-8.json |
| 56744-6 | PL-7 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56744-6.json |
| 56745-3 | PL-12 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56745-3.json |
| 56746-1 | Leeks IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56746-1.json |
| 5674-7 | Lead [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5674-7.json |
| 56747-9 | Azithromycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56747-9.json |
| 56748-7 | Norovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/56748-7.json |
| 56752-9 | APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56752-9.json |
| 56753-7 | PML Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56753-7.json |
| 5675-4 | Lead [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5675-4.json |
| 56754-5 | sp100 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56754-5.json |
| 56760-2 | Liver kidney microsomal Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56760-2.json |
| 56761-0 | Baker's yeast Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56761-0.json |
| 5676-2 | Lead [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5676-2.json |
| 56764-4 | Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing | ./2.16.840.1.114222.4.11.1002/56764-4.json |
| 5677-0 | Lead [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5677-0.json |
| 56775-0 | CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Tissue | ./2.16.840.1.114222.4.11.1002/56775-0.json |
| 56776-8 | Amylase S3+S4/Amylase.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56776-8.json |
| 56777-6 | Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56777-6.json |
| 56778-4 | Articaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56778-4.json |
| 56779-2 | Ascorbate [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/56779-2.json |
| 567-8 | Diphtheria identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/567-8.json |
| 56781-8 | Epidermal Allergen Mix C (Canary feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/56781-8.json |
| 56783-4 | Trichloroethane [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/56783-4.json |
| 56784-2 | Fibrinogen fragments [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56784-2.json |
| 56785-9 | Baker's yeast Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56785-9.json |
| 56786-7 | Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56786-7.json |
| 56787-5 | Cytokeratin 19 [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/56787-5.json |
| 5678-8 | Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/5678-8.json |
| 5679-6 | Lysergate diethylamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5679-6.json |
| 56796-6 | Emergency contact information panel | ./2.16.840.1.114222.4.11.1002/56796-6.json |
| 5680-4 | Malathion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5680-4.json |
| 5681-2 | Manganese [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5681-2.json |
| 5682-0 | Manganese [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5682-0.json |
| 5683-8 | Manganese [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5683-8.json |
| 5684-6 | Manganese [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5684-6.json |
| 5685-3 | Mercury [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5685-3.json |
| 568-6 | Fungus identified in Aspirate by Culture | ./2.16.840.1.114222.4.11.1002/568-6.json |
| 5686-1 | Mercury [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5686-1.json |
| 56877-4 | Mepivacaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56877-4.json |
| 56878-2 | Phenylbutazone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56878-2.json |
| 5687-9 | Mercury [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5687-9.json |
| 56879-0 | Lactose IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56879-0.json |
| 56880-8 | TCRB gene+TCRD gene+TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/56880-8.json |
| 56881-6 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56881-6.json |
| 56882-4 | Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56882-4.json |
| 56883-2 | BCHE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/56883-2.json |
| 56886-5 | Indirect antiglobulin test.unspecified reagent [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56886-5.json |
| 5688-7 | Mercury [Presence] in Urine by Visual.Reinsch | ./2.16.840.1.114222.4.11.1002/5688-7.json |
| 56887-3 | Myoglobin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56887-3.json |
| 56888-1 | HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56888-1.json |
| 5689-5 | Mercury [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5689-5.json |
| 56899-8 | CD5+FMC7+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/56899-8.json |
| 5690-3 | Methanol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/5690-3.json |
| 56905-3 | Bilirubin.direct [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/56905-3.json |
| 56906-1 | Bilirubin.direct [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/56906-1.json |
| 56909-5 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56909-5.json |
| 56910-3 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/56910-3.json |
| 5691-1 | Methanol [Presence] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/5691-1.json |
| 56911-1 | Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/56911-1.json |
| 56912-9 | Cholesterol [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/56912-9.json |
| 56913-7 | Corticotropin [Mass/volume] in Plasma --morning specimen | ./2.16.840.1.114222.4.11.1002/56913-7.json |
| 56914-5 | Corticotropin [Mass/volume] in Plasma --evening specimen | ./2.16.840.1.114222.4.11.1002/56914-5.json |
| 56915-2 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56915-2.json |
| 56916-0 | Coxiella burnetii IgM Ab [Units/volume] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/56916-0.json |
| 56917-8 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56917-8.json |
| 56918-6 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/56918-6.json |
| 56919-4 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/56919-4.json |
| 56920-2 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/56920-2.json |
| 56921-0 | Entamoeba histolytica Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56921-0.json |
| 56922-8 | Entamoeba histolytica IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56922-8.json |
| 56923-6 | Fasciola hepatica Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56923-6.json |
| 56924-4 | Fasciola hepatica Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/56924-4.json |
| 56925-1 | Fractional excretion of phosphate [Ratio] in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56925-1.json |
| 56926-9 | Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56926-9.json |
| 56927-7 | Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56927-7.json |
| 56928-5 | Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56928-5.json |
| 5692-9 | Methanol [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5692-9.json |
| 56929-3 | Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56929-3.json |
| 56930-1 | Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/56930-1.json |
| 5693-7 | Methanol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5693-7.json |
| 569-4 | Fungus identified in Cerebral spinal fluid by Culture | ./2.16.840.1.114222.4.11.1002/569-4.json |
| 56940-0 | Inhibin B [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56940-0.json |
| 5694-5 | Methanol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5694-5.json |
| 56950-9 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/56950-9.json |
| 56951-7 | Leishmania sp IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56951-7.json |
| 5695-2 | Methanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5695-2.json |
| 56952-5 | Leptospira interrogans Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/56952-5.json |
| 56953-3 | Leptospira interrogans IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56953-3.json |
| 56958-2 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/56958-2.json |
| 56959-0 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56959-0.json |
| 5696-0 | Molybdenum [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5696-0.json |
| 56961-6 | Nicotinamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/56961-6.json |
| 56962-4 | Ovary IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56962-4.json |
| 56963-2 | pH of Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/56963-2.json |
| 56967-3 | Plasmodium falciparum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56967-3.json |
| 56969-9 | Paper wasp IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56969-9.json |
| 56970-7 | Porphyrins [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56970-7.json |
| 56974-9 | Oligoclonal bands [Interpretation] in Serum or Plasma by Isoelectric focusing | ./2.16.840.1.114222.4.11.1002/56974-9.json |
| 56975-6 | Renin [Mass/volume] in Plasma --upright+30 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/56975-6.json |
| 56977-2 | Rheumatoid arthritis nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56977-2.json |
| 5697-8 | Molybdenum [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5697-8.json |
| 56978-0 | Serotonin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56978-0.json |
| 56979-8 | Sodium [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/56979-8.json |
| 56980-6 | Sodium/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56980-6.json |
| 56984-8 | Taenia solium larva Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56984-8.json |
| 5698-6 | Molybdenum [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5698-6.json |
| 56990-5 | Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/56990-5.json |
| 56991-3 | Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/56991-3.json |
| 56992-1 | Trichinella sp IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/56992-1.json |
| 5699-4 | Molybdenum [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5699-4.json |
| 56995-4 | Urea [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/56995-4.json |
| 56996-2 | Urea/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/56996-2.json |
| 56999-6 | European Hornet IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/56999-6.json |
| 5700-0 | Nickel [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5700-0.json |
| 57000-2 | Yellow Jacket IgG4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57000-2.json |
| 57001-0 | Yersinia sp IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57001-0.json |
| 57004-4 | Glucose/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/57004-4.json |
| 57005-1 | Glutathione [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57005-1.json |
| 57006-9 | Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57006-9.json |
| 57008-5 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/57008-5.json |
| 57009-3 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57009-3.json |
| 57010-1 | Nuclear Ab [Presence] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/57010-1.json |
| 57014-3 | Iron/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/57014-3.json |
| 57016-8 | Privacy policy acknowledgment Document | ./2.16.840.1.114222.4.11.1002/57016-8.json |
| 57017-6 | Privacy policy Organization Document | ./2.16.840.1.114222.4.11.1002/57017-6.json |
| 5701-8 | Nickel [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5701-8.json |
| 570-2 | Fungus identified in Body fluid by Culture | ./2.16.840.1.114222.4.11.1002/570-2.json |
| 5702-6 | Nickel [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5702-6.json |
| 57028-3 | Iron [Mass/mass] in Liver | ./2.16.840.1.114222.4.11.1002/57028-3.json |
| 57029-1 | Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57029-1.json |
| 57030-9 | Chromosome 13+18+21+X+Y aneuploidy in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57030-9.json |
| 57032-5 | Treponema pallidum Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/57032-5.json |
| 57033-3 | Alternaria alternata Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/57033-3.json |
| 5703-4 | Nickel [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/5703-4.json |
| 57034-1 | Penicillium sp Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/57034-1.json |
| 57035-8 | Cow milk Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/57035-8.json |
| 57036-6 | Phadiatop inhalant allergen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57036-6.json |
| 57037-4 | Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57037-4.json |
| 57038-2 | Chromosome 12 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57038-2.json |
| 5704-2 | Nickel [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5704-2.json |
| 57053-1 | Nurse Emergency department Note | ./2.16.840.1.114222.4.11.1002/57053-1.json |
| 57054-9 | Nurse Emergency department Triage+care note | ./2.16.840.1.114222.4.11.1002/57054-9.json |
| 57055-6 | Antepartum summary note | ./2.16.840.1.114222.4.11.1002/57055-6.json |
| 57056-4 | Labor and delivery admission history and physical note | ./2.16.840.1.114222.4.11.1002/57056-4.json |
| 57057-2 | Labor and delivery summary note | ./2.16.840.1.114222.4.11.1002/57057-2.json |
| 5705-9 | Nickel [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5705-9.json |
| 57059-8 | Pregnancy visit summary note Narrative | ./2.16.840.1.114222.4.11.1002/57059-8.json |
| 5706-7 | Opiates [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/5706-7.json |
| 5708-3 | Paraquat [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5708-3.json |
| 57089-5 | Eosinophil cationic protein (ECP) [Mass/volume] in Nasal fluid | ./2.16.840.1.114222.4.11.1002/57089-5.json |
| 57090-3 | HLA-DQA1*05:01 [Presence] | ./2.16.840.1.114222.4.11.1002/57090-3.json |
| 5709-1 | Paraquat [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5709-1.json |
| 57091-1 | HLA-DQB1*02:01 [Presence] | ./2.16.840.1.114222.4.11.1002/57091-1.json |
| 57092-9 | IgE [Units/volume] in Nasal fluid | ./2.16.840.1.114222.4.11.1002/57092-9.json |
| 57093-7 | Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57093-7.json |
| 57096-0 | HPA 1a/1a+HPA 3a/3a [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/57096-0.json |
| 571-0 | Fungus identified in Hair by Culture | ./2.16.840.1.114222.4.11.1002/571-0.json |
| 5710-9 | Pentachlorophenol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5710-9.json |
| 5711-7 | Pentachlorophenol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5711-7.json |
| 57132-3 | CYP2C19 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57132-3.json |
| 5713-3 | Platinum [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5713-3.json |
| 57133-1 | Referral note | ./2.16.840.1.114222.4.11.1002/57133-1.json |
| 57134-9 | Dentistry Referral note | ./2.16.840.1.114222.4.11.1002/57134-9.json |
| 57135-6 | Dermatology Referral note | ./2.16.840.1.114222.4.11.1002/57135-6.json |
| 57136-4 | Diabetology Referral note | ./2.16.840.1.114222.4.11.1002/57136-4.json |
| 57137-2 | Endocrinology Referral note | ./2.16.840.1.114222.4.11.1002/57137-2.json |
| 57138-0 | Gastroenterology Referral note | ./2.16.840.1.114222.4.11.1002/57138-0.json |
| 57139-8 | General medicine Referral note | ./2.16.840.1.114222.4.11.1002/57139-8.json |
| 5714-1 | Platinum [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5714-1.json |
| 57141-4 | Infectious disease Referral note | ./2.16.840.1.114222.4.11.1002/57141-4.json |
| 57142-2 | Kinesiotherapy Referral note | ./2.16.840.1.114222.4.11.1002/57142-2.json |
| 57143-0 | Mental health Referral note | ./2.16.840.1.114222.4.11.1002/57143-0.json |
| 57144-8 | Nephrology Referral note | ./2.16.840.1.114222.4.11.1002/57144-8.json |
| 57145-5 | Neurology Referral note | ./2.16.840.1.114222.4.11.1002/57145-5.json |
| 57146-3 | Neurological surgery Referral note | ./2.16.840.1.114222.4.11.1002/57146-3.json |
| 57147-1 | Occupational medicine Referral note | ./2.16.840.1.114222.4.11.1002/57147-1.json |
| 57148-9 | Occupational therapy Referral note | ./2.16.840.1.114222.4.11.1002/57148-9.json |
| 57149-7 | Oncology Referral note | ./2.16.840.1.114222.4.11.1002/57149-7.json |
| 57150-5 | Ophthalmology Referral note | ./2.16.840.1.114222.4.11.1002/57150-5.json |
| 57151-3 | Optometry Referral note | ./2.16.840.1.114222.4.11.1002/57151-3.json |
| 57152-1 | Pharmacology Referral note | ./2.16.840.1.114222.4.11.1002/57152-1.json |
| 57153-9 | Physical medicine and rehab Referral note | ./2.16.840.1.114222.4.11.1002/57153-9.json |
| 57154-7 | Physical therapy Referral note | ./2.16.840.1.114222.4.11.1002/57154-7.json |
| 57155-4 | Plastic surgery Referral note | ./2.16.840.1.114222.4.11.1002/57155-4.json |
| 57156-2 | Podiatry Referral note | ./2.16.840.1.114222.4.11.1002/57156-2.json |
| 57157-0 | Psychiatry Referral note | ./2.16.840.1.114222.4.11.1002/57157-0.json |
| 5715-8 | Platinum [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5715-8.json |
| 57158-8 | Psychology Referral note | ./2.16.840.1.114222.4.11.1002/57158-8.json |
| 57159-6 | Radiation oncology Referral note | ./2.16.840.1.114222.4.11.1002/57159-6.json |
| 57160-4 | Recreational therapy Referral note | ./2.16.840.1.114222.4.11.1002/57160-4.json |
| 57162-0 | Respiratory therapy Referral note | ./2.16.840.1.114222.4.11.1002/57162-0.json |
| 57163-8 | Rheumatology Referral note | ./2.16.840.1.114222.4.11.1002/57163-8.json |
| 57164-6 | Social worker Referral note | ./2.16.840.1.114222.4.11.1002/57164-6.json |
| 57165-3 | Speech-language pathology Referral note | ./2.16.840.1.114222.4.11.1002/57165-3.json |
| 5716-6 | Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5716-6.json |
| 57166-1 | Surgery Referral note | ./2.16.840.1.114222.4.11.1002/57166-1.json |
| 57167-9 | Cardiothoracic surgery Referral note | ./2.16.840.1.114222.4.11.1002/57167-9.json |
| 57168-7 | Urology Referral note | ./2.16.840.1.114222.4.11.1002/57168-7.json |
| 57169-5 | Vascular surgery Referral note | ./2.16.840.1.114222.4.11.1002/57169-5.json |
| 57170-3 | Cardiology Referral note | ./2.16.840.1.114222.4.11.1002/57170-3.json |
| 57171-1 | Geriatric medicine Referral note | ./2.16.840.1.114222.4.11.1002/57171-1.json |
| 57172-9 | Hematology+Medical oncology Referral note | ./2.16.840.1.114222.4.11.1002/57172-9.json |
| 57173-7 | Nutrition and dietetics Referral note | ./2.16.840.1.114222.4.11.1002/57173-7.json |
| 5717-4 | Polychlorinated biphenyl (PCB) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5717-4.json |
| 57174-5 | Oral and Maxillofacial Surgery Referral note | ./2.16.840.1.114222.4.11.1002/57174-5.json |
| 57175-2 | Orthopaedic surgery Referral note | ./2.16.840.1.114222.4.11.1002/57175-2.json |
| 57176-0 | Otolaryngology Referral note | ./2.16.840.1.114222.4.11.1002/57176-0.json |
| 57177-8 | Pulmonary Referral note | ./2.16.840.1.114222.4.11.1002/57177-8.json |
| 57178-6 | Critical care medicine Referral note | ./2.16.840.1.114222.4.11.1002/57178-6.json |
| 57179-4 | Obstetrics and Gynecology Referral note | ./2.16.840.1.114222.4.11.1002/57179-4.json |
| 57180-2 | Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57180-2.json |
| 5718-2 | Rubidium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5718-2.json |
| 57182-8 | HIV 1 RNA tropism [Identifier] in Plasma Narrative | ./2.16.840.1.114222.4.11.1002/57182-8.json |
| 5719-0 | Rubidium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5719-0.json |
| 5720-8 | Rubidium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5720-8.json |
| 5721-6 | Rubidium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5721-6.json |
| 5722-4 | Selenium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5722-4.json |
| 5723-2 | Selenium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5723-2.json |
| 5724-0 | Selenium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5724-0.json |
| 5725-7 | Selenium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/5725-7.json |
| 5726-5 | Selenium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5726-5.json |
| 5727-3 | Selenium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5727-3.json |
| 572-8 | Fungus identified in Bone marrow by Culture | ./2.16.840.1.114222.4.11.1002/572-8.json |
| 5728-1 | Silicon [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5728-1.json |
| 57287-5 | Chlamydia trachomatis rRNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57287-5.json |
| 57288-3 | Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57288-3.json |
| 57289-1 | Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57289-1.json |
| 57290-9 | HLA-A [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57290-9.json |
| 57291-7 | HLA-B [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57291-7.json |
| 57293-3 | HLA-DRB1 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57293-3.json |
| 57294-1 | HLA-DRB3 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57294-1.json |
| 57295-8 | HLA-DRB4 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57295-8.json |
| 57296-6 | HLA-DRB5 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57296-6.json |
| 57297-4 | HLA-Cw [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57297-4.json |
| 57298-2 | HLA-DRB1 [Type] | ./2.16.840.1.114222.4.11.1002/57298-2.json |
| 5729-9 | Silicate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5729-9.json |
| 57299-0 | HLA-DQB1 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/57299-0.json |
| 57300-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/57300-6.json |
| 57301-4 | Benzoylecgonine [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/57301-4.json |
| 57302-2 | Temazepam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/57302-2.json |
| 57303-0 | 7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/57303-0.json |
| 57304-8 | Codeine [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/57304-8.json |
| 57305-5 | Tropomyosin IgE Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57305-5.json |
| 5730-7 | Silicate [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/5730-7.json |
| 57308-9 | CYP11B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57308-9.json |
| 57309-7 | PRNP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57309-7.json |
| 57310-5 | SRY gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57310-5.json |
| 57313-9 | Pyrazole IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57313-9.json |
| 5731-5 | Silicate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5731-5.json |
| 57315-4 | Sulphonamide IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57315-4.json |
| 57316-2 | Tropomyosin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57316-2.json |
| 57317-0 | Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57317-0.json |
| 57318-8 | Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57318-8.json |
| 57320-4 | Trypanosoma cruzi Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57320-4.json |
| 57321-2 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57321-2.json |
| 57322-0 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57322-0.json |
| 5732-3 | Silver [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5732-3.json |
| 57323-8 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57323-8.json |
| 57324-6 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57324-6.json |
| 57325-3 | Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57325-3.json |
| 57326-1 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57326-1.json |
| 57327-9 | Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57327-9.json |
| 57328-7 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57328-7.json |
| 57329-5 | Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57329-5.json |
| 5733-1 | Silver [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5733-1.json |
| 57332-9 | Urate [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57332-9.json |
| 57333-7 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Serum or Plasma by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/57333-7.json |
| 57334-5 | Calcium [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57334-5.json |
| 57335-2 | Calcium [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57335-2.json |
| 57337-8 | Citrate [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57337-8.json |
| 57338-6 | Citrate [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57338-6.json |
| 57339-4 | Citrate [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57339-4.json |
| 57340-2 | Chloride [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57340-2.json |
| 57341-0 | Chloride [Moles/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57341-0.json |
| 57342-8 | Chloride [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57342-8.json |
| 57344-4 | Creatinine [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57344-4.json |
| 57345-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --overnight | ./2.16.840.1.114222.4.11.1002/57345-1.json |
| 57346-9 | Creatinine [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57346-9.json |
| 57347-7 | Copper [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/57347-7.json |
| 57348-5 | Phosphate [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57348-5.json |
| 5734-9 | Silver [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5734-9.json |
| 57349-3 | Phosphate [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57349-3.json |
| 57355-0 | Potassium [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57355-0.json |
| 5735-6 | Silver [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5735-6.json |
| 573-6 | Fungus identified in Nail by Culture | ./2.16.840.1.114222.4.11.1002/573-6.json |
| 5736-4 | Strontium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5736-4.json |
| 57367-5 | Magnesium [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57367-5.json |
| 57368-3 | Magnesium [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57368-3.json |
| 57369-1 | Microalbumin [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57369-1.json |
| 57370-9 | Sodium [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57370-9.json |
| 57371-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57371-7.json |
| 5737-2 | Strychnine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5737-2.json |
| 57372-5 | Osmolality of 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57372-5.json |
| 57373-3 | Oxalate [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57373-3.json |
| 57374-1 | Oxalate [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57374-1.json |
| 57375-8 | Oxalate [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57375-8.json |
| 57378-2 | Porphyrins/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/57378-2.json |
| 57379-0 | Potassium [Moles/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57379-0.json |
| 5738-0 | Strychnine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5738-0.json |
| 57380-8 | Potassium [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57380-8.json |
| 57382-4 | Sodium [Moles/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57382-4.json |
| 57383-2 | Tipranavir [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57383-2.json |
| 57385-7 | Urea [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57385-7.json |
| 57386-5 | Urate [Mass/volume] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/57386-5.json |
| 57387-3 | Urate [Mass/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57387-3.json |
| 57388-1 | Urea [Mass/volume] in 24 hour Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/57388-1.json |
| 57389-9 | Urea [Mass/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/57389-9.json |
| 57391-5 | Eosinophils/100 leukocytes in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/57391-5.json |
| 57392-3 | Urea [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/57392-3.json |
| 5739-8 | Strychnine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5739-8.json |
| 57398-0 | CD22+CD19+ cells/100 cells in Body fluid | ./2.16.840.1.114222.4.11.1002/57398-0.json |
| 5740-6 | Strychnine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5740-6.json |
| 57410-3 | Actin.filamentous Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57410-3.json |
| 57411-1 | Desmoglein 1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57411-1.json |
| 57412-9 | Desmoglein 3 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57412-9.json |
| 5741-4 | Strychnine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5741-4.json |
| 57414-5 | Reticulin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57414-5.json |
| 57415-2 | Baker's yeast IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57415-2.json |
| 57416-0 | Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57416-0.json |
| 5742-2 | Tellurium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5742-2.json |
| 5743-0 | Thallium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5743-0.json |
| 57434-3 | Liver kidney microsomal 1 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57434-3.json |
| 57435-0 | Myeloperoxidase cells [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/57435-0.json |
| 57436-8 | Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57436-8.json |
| 57439-2 | Terminal deoxyribonucleotidyl transferase cells [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/57439-2.json |
| 574-4 | Fungus identified in Peritoneal fluid by Culture | ./2.16.840.1.114222.4.11.1002/574-4.json |
| 57440-0 | Platelet Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57440-0.json |
| 57441-8 | Toxoplasma gondii DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57441-8.json |
| 5744-8 | Thallium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5744-8.json |
| 57449-1 | Tubular basement membrane Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57449-1.json |
| 57452-5 | Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/57452-5.json |
| 57453-3 | Chromosome 18 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57453-3.json |
| 57454-1 | Chromosome 13 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57454-1.json |
| 5745-5 | Thallium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5745-5.json |
| 57455-8 | Taenia solium IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57455-8.json |
| 57458-2 | Neisseria gonorrhoeae rRNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57458-2.json |
| 57461-6 | Activated T cells lymphocytes/100 lymphocytes.small in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/57461-6.json |
| 57462-4 | Normetanephrine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57462-4.json |
| 5746-3 | Thallium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5746-3.json |
| 5747-1 | Tin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5747-1.json |
| 5748-9 | Tin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5748-9.json |
| 5749-7 | Titanium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5749-7.json |
| 5750-5 | Toluene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5750-5.json |
| 575-1 | Fungus identified in Skin by Culture | ./2.16.840.1.114222.4.11.1002/575-1.json |
| 5751-3 | Uranium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5751-3.json |
| 5752-1 | Uranium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5752-1.json |
| 5753-9 | Vanadium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/5753-9.json |
| 5754-7 | Vanadium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5754-7.json |
| 5755-4 | Vanadium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5755-4.json |
| 5756-2 | Vanadium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5756-2.json |
| 5757-0 | Vanadium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5757-0.json |
| 5759-6 | Dimethylbenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5759-6.json |
| 5760-4 | Zinc [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5760-4.json |
| 5761-2 | Zinc [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/5761-2.json |
| 5762-0 | Zinc [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/5762-0.json |
| 5763-8 | Zinc [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5763-8.json |
| 5764-6 | Zinc [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5764-6.json |
| 5765-3 | Zinc [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/5765-3.json |
| 57660-3 | Ganglioside GQ1b IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57660-3.json |
| 57661-1 | Tubular basement membrane Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57661-1.json |
| 57662-9 | U1 small nuclear ribonucleoprotein Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57662-9.json |
| 57664-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Semen | ./2.16.840.1.114222.4.11.1002/57664-5.json |
| 57670-2 | Brucella melitensis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57670-2.json |
| 57671-0 | Brucella melitensis IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57671-0.json |
| 57673-6 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/57673-6.json |
| 57674-4 | Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/57674-4.json |
| 57675-1 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/57675-1.json |
| 57676-9 | Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/57676-9.json |
| 57677-7 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57677-7.json |
| 57678-5 | Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57678-5.json |
| 57679-3 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57679-3.json |
| 57680-1 | Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/57680-1.json |
| 57681-9 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/57681-9.json |
| 57682-7 | Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/57682-7.json |
| 57683-5 | Plasmodium falciparum IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57683-5.json |
| 576-9 | Fungus identified in Synovial fluid by Culture | ./2.16.840.1.114222.4.11.1002/576-9.json |
| 57697-5 | Protein Z Ag [Mass/volume] in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57697-5.json |
| 57726-2 | Creatinine [Mass/volume] in 24 hour Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/57726-2.json |
| 57727-0 | Norolanzapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57727-0.json |
| 57731-2 | Osmolality of Urine--2nd specimen | ./2.16.840.1.114222.4.11.1002/57731-2.json |
| 57732-0 | Osmolality of Urine--3rd specimen | ./2.16.840.1.114222.4.11.1002/57732-0.json |
| 57733-8 | Beta-trace protein [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/57733-8.json |
| 57737-9 | Basement membrane Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57737-9.json |
| 57738-7 | Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57738-7.json |
| 57741-1 | Lymphocyte proliferation stimulated by OKT3 in Blood | ./2.16.840.1.114222.4.11.1002/57741-1.json |
| 57742-9 | Phadiatop infant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57742-9.json |
| 57743-7 | ABO group [Type] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/57743-7.json |
| 57745-2 | Adrenal Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/57745-2.json |
| 57746-0 | Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/57746-0.json |
| 57748-6 | Liver cytosol Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57748-6.json |
| 57752-8 | Urea [Mass/volume] in Peritoneal dialysis fluid --overnight | ./2.16.840.1.114222.4.11.1002/57752-8.json |
| 57753-6 | IKBKG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57753-6.json |
| 57754-4 | TNFRSF13B gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57754-4.json |
| 57755-1 | WAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57755-1.json |
| 57756-9 | Procollagen type III.N-terminal propeptide [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57756-9.json |
| 57758-5 | TNFRSF13B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57758-5.json |
| 57759-3 | WAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57759-3.json |
| 57760-1 | Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/57760-1.json |
| 57761-9 | Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/57761-9.json |
| 57762-7 | CD55+CD59 cells [Presence] in Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/57762-7.json |
| 57764-3 | Microscopic exam [Interpretation] of Bone marrow by Cytology | ./2.16.840.1.114222.4.11.1002/57764-3.json |
| 57766-8 | Histoplasma capsulatum Ag [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/57766-8.json |
| 57768-4 | Campylobacter jejuni+Campylobacter coli Ag [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/57768-4.json |
| 57769-2 | Salmonella typhi O Vi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/57769-2.json |
| 577-7 | Fungus identified in Sputum by Culture | ./2.16.840.1.114222.4.11.1002/577-7.json |
| 57781-7 | Chromosome breakage [Identifier] in Blood by Diepoxybutane Narrative | ./2.16.840.1.114222.4.11.1002/57781-7.json |
| 5779-4 | Crystals [type] in Bile fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/5779-4.json |
| 57796-5 | Reducing substances [Presence] in Stool by Post hydrolysis | ./2.16.840.1.114222.4.11.1002/57796-5.json |
| 57797-3 | Glucose [Mass/volume] in Stool by Post hydrolysis | ./2.16.840.1.114222.4.11.1002/57797-3.json |
| 5780-2 | Crystals [type] in Duodenal fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/5780-2.json |
| 57802-1 | Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative | ./2.16.840.1.114222.4.11.1002/57802-1.json |
| 5781-0 | Crystals [type] in Synovial fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/5781-0.json |
| 57822-9 | PT Lung | ./2.16.840.1.114222.4.11.1002/57822-9.json |
| 57823-7 | PT Esophagus | ./2.16.840.1.114222.4.11.1002/57823-7.json |
| 57824-5 | Cortisol Free [Mass/volume] in Serum or Plasma --AM peak specimen | ./2.16.840.1.114222.4.11.1002/57824-5.json |
| 57825-2 | Cortisol Free [Mass/volume] in Serum or Plasma --PM trough specimen | ./2.16.840.1.114222.4.11.1002/57825-2.json |
| 57826-0 | Co-payment amount Narrative | ./2.16.840.1.114222.4.11.1002/57826-0.json |
| 57827-8 | Reason for co-payment exemption Document | ./2.16.840.1.114222.4.11.1002/57827-8.json |
| 5782-8 | Crystals [type] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/5782-8.json |
| 57828-6 | Prescription list | ./2.16.840.1.114222.4.11.1002/57828-6.json |
| 57829-4 | Prescription for medical equipment or product | ./2.16.840.1.114222.4.11.1002/57829-4.json |
| 57830-2 | Admission request Document | ./2.16.840.1.114222.4.11.1002/57830-2.json |
| 57831-0 | Prescription for rehabilitation | ./2.16.840.1.114222.4.11.1002/57831-0.json |
| 57832-8 | Prescription for diagnostic or specialist care | ./2.16.840.1.114222.4.11.1002/57832-8.json |
| 57833-6 | Prescription for medication | ./2.16.840.1.114222.4.11.1002/57833-6.json |
| 57834-4 | Patient transportation request Document | ./2.16.840.1.114222.4.11.1002/57834-4.json |
| 57837-7 | Beta-1 transferrin [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/57837-7.json |
| 57838-5 | dRVVT W excess phospholipid (LA confirm) | ./2.16.840.1.114222.4.11.1002/57838-5.json |
| 57841-9 | Erythrocytes [#/volume] in Dialysis fluid by Automated count | ./2.16.840.1.114222.4.11.1002/57841-9.json |
| 57842-7 | Erythrocytes [#/volume] in Pericardial fluid by Automated count | ./2.16.840.1.114222.4.11.1002/57842-7.json |
| 57843-5 | Erythrocytes [#/volume] in Peritoneal fluid by Automated count | ./2.16.840.1.114222.4.11.1002/57843-5.json |
| 57844-3 | Imatinib mesylate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57844-3.json |
| 57845-0 | Leukocytes [#/volume] in Body fluid by Automated count | ./2.16.840.1.114222.4.11.1002/57845-0.json |
| 57846-8 | Leukocytes [#/volume] in Pericardial fluid by Automated count | ./2.16.840.1.114222.4.11.1002/57846-8.json |
| 57847-6 | Leukocytes [#/volume] in Dialysis fluid by Manual count | ./2.16.840.1.114222.4.11.1002/57847-6.json |
| 57848-4 | Maltose [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57848-4.json |
| 578-5 | Fungus identified in Tissue by Culture | ./2.16.840.1.114222.4.11.1002/578-5.json |
| 57851-8 | Microscopic observation [Identifier] in Urethra by Wet preparation | ./2.16.840.1.114222.4.11.1002/57851-8.json |
| 57853-4 | Snowshoe hare virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/57853-4.json |
| 57855-9 | Atenolol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57855-9.json |
| 57856-7 | Carisoprodol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57856-7.json |
| 57857-5 | Chlorpheniramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57857-5.json |
| 57858-3 | Normaprotiline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57858-3.json |
| 57859-1 | Dextromethorphan [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57859-1.json |
| 57860-9 | Diethylamine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57860-9.json |
| 57861-7 | HYDROcodone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57861-7.json |
| 57862-5 | Hydrocortisone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57862-5.json |
| 57863-3 | HYDROmorphone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57863-3.json |
| 57864-1 | Meperidine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57864-1.json |
| 57865-8 | oxyCODONE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57865-8.json |
| 57866-6 | PENTobarbital [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57866-6.json |
| 57867-4 | Pericyazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57867-4.json |
| 57868-2 | Perphenazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57868-2.json |
| 57869-0 | Phencyclidine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57869-0.json |
| 57870-8 | Phenylpropanolamine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57870-8.json |
| 57871-6 | quiNINE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57871-6.json |
| 57872-4 | Strychnine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57872-4.json |
| 57873-2 | Thiothixene [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57873-2.json |
| 57874-0 | Cantaloupe triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/57874-0.json |
| 57875-7 | Cantaloupe IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57875-7.json |
| 57876-5 | Honeydew melon IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57876-5.json |
| 57879-9 | Cantaloupe IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57879-9.json |
| 57880-7 | Honeydew melon IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57880-7.json |
| 57883-1 | Cantaloupe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57883-1.json |
| 57884-9 | Honeydew melon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57884-9.json |
| 57885-6 | Honeydew melon triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/57885-6.json |
| 57895-5 | Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method | ./2.16.840.1.114222.4.11.1002/57895-5.json |
| 57896-3 | Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method | ./2.16.840.1.114222.4.11.1002/57896-3.json |
| 57897-1 | Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Specimen by Genotype method | ./2.16.840.1.114222.4.11.1002/57897-1.json |
| 57898-9 | Cocaine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/57898-9.json |
| 57901-1 | Clostridioides difficile glutamate dehydrogenase [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/57901-1.json |
| 57905-2 | Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/57905-2.json |
| 57906-0 | 9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/57906-0.json |
| 57907-8 | Atazanavir+Ritonavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/57907-8.json |
| 57908-6 | AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57908-6.json |
| 57909-4 | ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57909-4.json |
| 57910-2 | Bartonella quintana DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/57910-2.json |
| 57911-0 | Basement membrane zone BP230 Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57911-0.json |
| 57912-8 | Green Bean IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57912-8.json |
| 57913-6 | White Bean IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57913-6.json |
| 57914-4 | Beta lactoglobulin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57914-4.json |
| 57915-1 | Bumble Bee IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57915-1.json |
| 57916-9 | Borrelia burgdorferi C6 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/57916-9.json |
| 57917-7 | Budgerigar droppings IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57917-7.json |
| 57918-5 | CACNA1S+SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57918-5.json |
| 57919-3 | Calcium [Mass/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/57919-3.json |
| 57920-1 | Carbon dioxide, total [Moles/volume] in Mixed venous blood by calculation | ./2.16.840.1.114222.4.11.1002/57920-1.json |
| 57921-9 | Carbon dioxide, total [Moles/volume] in Arterial cord blood by calculation | ./2.16.840.1.114222.4.11.1002/57921-9.json |
| 57922-7 | Carbon dioxide, total [Moles/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/57922-7.json |
| 57923-5 | Carbon dioxide, total [Moles/volume] in Venous cord blood by calculation | ./2.16.840.1.114222.4.11.1002/57923-5.json |
| 57924-3 | Carboxy tetrahydrocannabinol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/57924-3.json |
| 57925-0 | Chestnut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57925-0.json |
| 5792-7 | Glucose [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5792-7.json |
| 57927-6 | CDKN2A+CDK4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57927-6.json |
| 579-3 | Fungus identified in Wound by Culture | ./2.16.840.1.114222.4.11.1002/579-3.json |
| 57930-0 | CFTR gene p.Asp1152His [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/57930-0.json |
| 57931-8 | CFTR+PRSS1+SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57931-8.json |
| 57932-6 | Cheese cheddar type IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57932-6.json |
| 57933-4 | Cheese mold type IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57933-4.json |
| 57934-2 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57934-2.json |
| 57935-9 | Chocolate IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57935-9.json |
| 57936-7 | Cholesterol in HDL 2a [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57936-7.json |
| 57937-5 | Cholesterol in HDL 3a [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57937-5.json |
| 57938-3 | LDL 5 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57938-3.json |
| 57939-1 | Chromium [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/57939-1.json |
| 57940-9 | Watermelon IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57940-9.json |
| 57941-7 | Lime IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57941-7.json |
| 57942-5 | Cladosporium sp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/57942-5.json |
| 57943-3 | Clenbuterol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57943-3.json |
| 57944-1 | Cobalt [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/57944-1.json |
| 57945-8 | Cocaethylene [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/57945-8.json |
| 57946-6 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/57946-6.json |
| 57948-2 | Collagen crosslinked C-telopeptide [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/57948-2.json |
| 57949-0 | Complement C4c [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57949-0.json |
| 57950-8 | Cow whey IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57950-8.json |
| 57951-6 | CPVT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57951-6.json |
| 57952-4 | Honeydew melon IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57952-4.json |
| 57953-2 | Ethisterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57953-2.json |
| 57954-0 | Darunavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57954-0.json |
| 57955-7 | Darunavir+Ritonavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/57955-7.json |
| 57956-5 | Desoxymethyltestosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57956-5.json |
| 57957-3 | Difenacoum [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57957-3.json |
| 57958-1 | DPYD2A gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/57958-1.json |
| 57959-9 | Drostanolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57959-9.json |
| 57960-7 | Erythrocytes [Morphology] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/57960-7.json |
| 57961-5 | Etravirine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/57961-5.json |
| 57962-3 | FECH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57962-3.json |
| 57963-1 | FLCN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/57963-1.json |
| 57964-9 | Formebolone metabolite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57964-9.json |
| 57966-4 | Furazabol metabolite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57966-4.json |
| 57967-2 | Galactitol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/57967-2.json |
| 57968-0 | Ganglioside GD1a IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/57968-0.json |
| 57969-8 | Ganglioside GD1a IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/57969-8.json |
| 57975-5 | HIV 1+O+2 Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/57975-5.json |
| 5797-6 | Ketones [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5797-6.json |
| 57981-3 | HYDROcodone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/57981-3.json |
| 57982-1 | HYDROmorphone [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/57982-1.json |
| 57984-7 | Indinavir+Ritonavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/57984-7.json |
| 57987-0 | Sweet potato IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57987-0.json |
| 57988-8 | Iron [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/57988-8.json |
| 57991-2 | Lactalbumin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57991-2.json |
| 57993-8 | Lepidoglyphus destructor IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/57993-8.json |
| 57994-6 | Leucine/Alanine [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/57994-6.json |
| 57996-1 | Leucine+Isoleucine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/57996-1.json |
| 57997-9 | Lopinavir+Ritonavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/57997-9.json |
| 57998-7 | Magnesium [Mass/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/57998-7.json |
| 57999-5 | Manganese [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/57999-5.json |
| 58000-1 | Maple sugar IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58000-1.json |
| 58001-9 | Matrix metallopeptidase 9 [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/58001-9.json |
| 58002-7 | Mestanolone metabolite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58002-7.json |
| 58003-5 | Methylandrostenediol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58003-5.json |
| 58004-3 | Methasterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58004-3.json |
| 58005-0 | Methylnortestosterone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58005-0.json |
| 58006-8 | Mibolerone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58006-8.json |
| 58009-2 | MPL gene p.Trp515 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/58009-2.json |
| 580-1 | Fungus identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/580-1.json |
| 58010-0 | MSH2 gene+MLH1 gene+MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58010-0.json |
| 58011-8 | Myelin IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58011-8.json |
| 58012-6 | Natalizumab Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/58012-6.json |
| 58013-4 | Norclomipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58013-4.json |
| 58014-2 | Nordoxepin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58014-2.json |
| 58015-9 | Nortrimipramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58015-9.json |
| 58016-7 | Octreotide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58016-7.json |
| 58017-5 | Olive Pollen IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58017-5.json |
| 58018-3 | Oxabolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58018-3.json |
| 58019-1 | Phosphate [Mass/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/58019-1.json |
| 58022-5 | Prostanozol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58022-5.json |
| 58023-3 | Rabies virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58023-3.json |
| 58024-1 | Saquinavir+Ritonavir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/58024-1.json |
| 58025-8 | Cultivated Rye IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58025-8.json |
| 58026-6 | Selenium [Mass/volume] in Nonbiological fluid | ./2.16.840.1.114222.4.11.1002/58026-6.json |
| 58027-4 | Testolactone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58027-4.json |
| 58028-2 | Tetrahydrogestrinone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58028-2.json |
| 58030-8 | Tranylcypromine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58030-8.json |
| 58031-6 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/58031-6.json |
| 5803-2 | pH of Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5803-2.json |
| 58032-4 | White Elm IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58032-4.json |
| 58033-2 | Nettle IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58033-2.json |
| 58034-0 | Bermuda grass smut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58034-0.json |
| 58035-7 | Blueberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58035-7.json |
| 58036-5 | Xanthine/Total in Stone | ./2.16.840.1.114222.4.11.1002/58036-5.json |
| 58037-3 | Zinc [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/58037-3.json |
| 58038-1 | Gestrinone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58038-1.json |
| 5804-0 | Protein [Mass/volume] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5804-0.json |
| 58041-5 | Norclostebol [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58041-5.json |
| 58042-3 | Phencyclidine [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58042-3.json |
| 58043-1 | American Sycamore IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/58043-1.json |
| 58046-4 | Strongyloides stercoralis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/58046-4.json |
| 58047-2 | Tetrahydrocannabinol [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58047-2.json |
| 58053-0 | Ch sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58053-0.json |
| 58055-5 | Co sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58055-5.json |
| 58056-3 | Co sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58056-3.json |
| 58058-9 | Cs sup(a) Ag [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58058-9.json |
| 58060-5 | Do sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58060-5.json |
| 58062-1 | In sup (b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58062-1.json |
| 58064-7 | Jr sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58064-7.json |
| 58066-2 | Kn sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58066-2.json |
| 58069-6 | Kn sup (b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58069-6.json |
| 58071-2 | Rg sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58071-2.json |
| 58073-8 | Wr sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58073-8.json |
| 58075-3 | Yk sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58075-3.json |
| 58082-9 | Vel Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58082-9.json |
| 58083-7 | Vw Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58083-7.json |
| 5809-9 | Reducing substances [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/5809-9.json |
| 5810-7 | Specific gravity of Urine by Refractometry | ./2.16.840.1.114222.4.11.1002/5810-7.json |
| 5811-5 | Specific gravity of Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5811-5.json |
| 58120-7 | Patient Health Questionnaire 2 item (PHQ-2) [PHQ.CMS] | ./2.16.840.1.114222.4.11.1002/58120-7.json |
| 5818-0 | Urobilinogen [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/5818-0.json |
| 581-9 | Streptococcus agalactiae [Presence] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/581-9.json |
| 5823-0 | Adenovirus Ag [Presence] in Conjunctival specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5823-0.json |
| 5824-8 | Adenovirus Ag [Presence] in Conjunctival specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5824-8.json |
| 5825-5 | Adenovirus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/5825-5.json |
| 5826-3 | Adenovirus Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5826-3.json |
| 582-7 | Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/582-7.json |
| 5827-1 | Adenovirus Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/5827-1.json |
| 5828-9 | Adenovirus Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5828-9.json |
| 5829-7 | Adenovirus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/5829-7.json |
| 5830-5 | Adenovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5830-5.json |
| 5831-3 | Adenovirus Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/5831-3.json |
| 5832-1 | Adenovirus Ag [Presence] in Urine by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5832-1.json |
| 5833-9 | Adenovirus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5833-9.json |
| 5834-7 | Adenovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5834-7.json |
| 58348-4 | MethylePHEDrine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58348-4.json |
| 583-5 | Streptococcus agalactiae [Presence] in Genital lochia by Organism specific culture | ./2.16.840.1.114222.4.11.1002/583-5.json |
| 58351-8 | Connective tissue growth factor [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/58351-8.json |
| 58352-6 | Connective tissue growth factor [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/58352-6.json |
| 58353-4 | Human antihuman Ab [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/58353-4.json |
| 5835-4 | Cytomegalovirus [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5835-4.json |
| 58354-2 | Human antihuman Ab [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/58354-2.json |
| 58356-7 | Ethanol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58356-7.json |
| 58357-5 | Amphetamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58357-5.json |
| 58358-3 | Methamphetamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58358-3.json |
| 58359-1 | Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58359-1.json |
| 58360-9 | Buprenorphine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58360-9.json |
| 58361-7 | Norbuprenorphine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58361-7.json |
| 5836-2 | Cytomegalovirus [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5836-2.json |
| 58362-5 | Norbuprenorphine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58362-5.json |
| 58363-3 | Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58363-3.json |
| 58364-1 | 7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58364-1.json |
| 58365-8 | 7-Aminoclonazepam [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58365-8.json |
| 58366-6 | LORazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58366-6.json |
| 58367-4 | Nordiazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58367-4.json |
| 58368-2 | Oxazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58368-2.json |
| 58369-0 | Temazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58369-0.json |
| 5837-0 | Cytomegalovirus [Presence] in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5837-0.json |
| 58370-8 | Carisoprodol+Meprobamate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58370-8.json |
| 58371-6 | Carisoprodol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58371-6.json |
| 58372-4 | Meprobamate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58372-4.json |
| 58373-2 | Meprobamate [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58373-2.json |
| 58374-0 | Meprobamate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58374-0.json |
| 58375-7 | Ethyl glucuronide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58375-7.json |
| 58376-5 | Ethyl glucuronide/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58376-5.json |
| 58377-3 | Ethyl glucuronide [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58377-3.json |
| 58378-1 | Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58378-1.json |
| 58379-9 | fentaNYL+Norfentanyl [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58379-9.json |
| 58380-7 | fentaNYL/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58380-7.json |
| 58381-5 | fentaNYL [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58381-5.json |
| 58382-3 | Norfentanyl/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58382-3.json |
| 58383-1 | Norfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58383-1.json |
| 58384-9 | 6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58384-9.json |
| 58385-6 | Meperidine+Normeperidine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58385-6.json |
| 58386-4 | Meperidine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58386-4.json |
| 58387-2 | Normeperidine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58387-2.json |
| 5838-8 | Cytomegalovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5838-8.json |
| 58388-0 | Normeperidine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58388-0.json |
| 58389-8 | Normeperidine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58389-8.json |
| 58390-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58390-6.json |
| 58391-4 | Codeine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58391-4.json |
| 58392-2 | Morphine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58392-2.json |
| 58393-0 | HYDROcodone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58393-0.json |
| 58394-8 | HYDROmorphone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58394-8.json |
| 58395-5 | oxyCODONE/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58395-5.json |
| 5839-6 | Enterovirus identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5839-6.json |
| 58396-3 | oxyMORphone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58396-3.json |
| 58397-1 | Phencyclidine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58397-1.json |
| 58398-9 | Propoxyphene/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58398-9.json |
| 58399-7 | Norpropoxyphene/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58399-7.json |
| 58400-3 | Specimen pH acceptable of Urine | ./2.16.840.1.114222.4.11.1002/58400-3.json |
| 58401-1 | Tapentadol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58401-1.json |
| 58402-9 | Tapentadol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58402-9.json |
| 58403-7 | Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58403-7.json |
| 5840-4 | Enterovirus identified in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5840-4.json |
| 58404-5 | traMADol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58404-5.json |
| 58411-0 | Clinical research drug XXX [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/58411-0.json |
| 5841-2 | Enterovirus identified in Isolate by Neutralization test | ./2.16.840.1.114222.4.11.1002/5841-2.json |
| 58414-4 | Herpes simplex virus 1+2 DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/58414-4.json |
| 58415-1 | BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/58415-1.json |
| 58416-9 | MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/58416-9.json |
| 58417-7 | dilTIAZem [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58417-7.json |
| 58418-5 | Micafungin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58418-5.json |
| 58419-3 | Caspofungin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58419-3.json |
| 5842-0 | Enterovirus identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5842-0.json |
| 58420-1 | Anidulafungin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58420-1.json |
| 58423-5 | Ethyl sulfate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58423-5.json |
| 58424-3 | Ethyl sulfate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58424-3.json |
| 58425-0 | Ethyl sulfate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58425-0.json |
| 58426-8 | Carisoprodol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58426-8.json |
| 58427-6 | Carisoprodol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58427-6.json |
| 58428-4 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58428-4.json |
| 58429-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58429-2.json |
| 584-3 | Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/584-3.json |
| 58430-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/58430-0.json |
| 58436-7 | Casts [Type] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/58436-7.json |
| 58437-5 | Microorganisms seen [Type] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/58437-5.json |
| 5843-8 | Enterovirus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5843-8.json |
| 58438-3 | Cells [Type] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/58438-3.json |
| 58439-1 | Clinical research drug XXX [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/58439-1.json |
| 58440-9 | Classical swine fever virus E2 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58440-9.json |
| 5844-6 | Herpes simplex virus 1 Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5844-6.json |
| 58448-2 | Microalbumin ug/min [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/58448-2.json |
| 58450-8 | Bilirubin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58450-8.json |
| 58451-6 | Glutamate decarboxylase 65 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58451-6.json |
| 58452-4 | Hepatitis B virus surface Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58452-4.json |
| 5845-3 | Herpes simplex virus 1 Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5845-3.json |
| 58453-2 | Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/58453-2.json |
| 58454-0 | Subtelomere analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58454-0.json |
| 58455-7 | Taenia solium Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58455-7.json |
| 58457-3 | Sulfites [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/58457-3.json |
| 58459-9 | Ganglioside GT1b Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58459-9.json |
| 58460-7 | Endothelial cell Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58460-7.json |
| 5846-1 | Herpes simplex virus 1 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5846-1.json |
| 58461-5 | Intestinal goblet cell Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/58461-5.json |
| 58462-3 | Complement functional activity [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/58462-3.json |
| 58464-9 | Campesterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58464-9.json |
| 58465-6 | DNA double strand IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58465-6.json |
| 58466-4 | DNA double strand IgG Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae | ./2.16.840.1.114222.4.11.1002/58466-4.json |
| 58467-2 | Horse Bot Fly IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58467-2.json |
| 58468-0 | Anise IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58468-0.json |
| 58469-8 | Cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/58469-8.json |
| 58473-0 | Haemophilus influenzae serotype DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/58473-0.json |
| 58478-9 | Bombus sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58478-9.json |
| 5847-9 | Herpes simplex virus 2 Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5847-9.json |
| 58483-9 | BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58483-9.json |
| 5848-7 | Herpes simplex virus 2 Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5848-7.json |
| 58493-8 | Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/58493-8.json |
| 5849-5 | Herpes simplex virus 2 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5849-5.json |
| 585-0 | Streptococcus agalactiae [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/585-0.json |
| 58500-0 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post dose glucose | ./2.16.840.1.114222.4.11.1002/58500-0.json |
| 5850-3 | Herpes simplex virus Ag [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5850-3.json |
| 5851-1 | Herpes simplex virus Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5851-1.json |
| 5852-9 | Herpes simplex virus Ag [Presence] in Skin by Immunoassay | ./2.16.840.1.114222.4.11.1002/5852-9.json |
| 5853-7 | Herpes simplex virus Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5853-7.json |
| 5854-5 | Herpes simplex virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5854-5.json |
| 5855-2 | Herpes simplex virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5855-2.json |
| 5856-0 | Herpes simplex virus identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5856-0.json |
| 5857-8 | Herpes simplex virus identified in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5857-8.json |
| 5858-6 | Herpes simplex virus identified in Skin by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5858-6.json |
| 5859-4 | Herpes simplex virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5859-4.json |
| 5860-2 | Influenza virus A Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/5860-2.json |
| 5861-0 | Influenza virus A Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5861-0.json |
| 5862-8 | Influenza virus A Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5862-8.json |
| 5863-6 | Influenza virus A Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5863-6.json |
| 5864-4 | Influenza virus B Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/5864-4.json |
| 5865-1 | Influenza virus B Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5865-1.json |
| 5866-9 | Influenza virus B Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5866-9.json |
| 5867-7 | Influenza virus B Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5867-7.json |
| 586-8 | Streptococcus agalactiae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/586-8.json |
| 58682-6 | Sulfatides [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/58682-6.json |
| 58683-4 | Complement C5 [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58683-4.json |
| 58684-2 | Uroporphyrin 1 isomer/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58684-2.json |
| 5868-5 | Parainfluenza virus 1 Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5868-5.json |
| 58685-9 | Beta hydroxybutyrate [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/58685-9.json |
| 5869-3 | Parainfluenza virus 1 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5869-3.json |
| 5870-1 | Parainfluenza virus 2 Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5870-1.json |
| 58706-3 | OmpC IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58706-3.json |
| 58707-1 | ePHEDrine+Pseudoephedrine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/58707-1.json |
| 58708-9 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58708-9.json |
| 58709-7 | Gliadin peptide IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58709-7.json |
| 58710-5 | Gliadin peptide IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58710-5.json |
| 5871-9 | Parainfluenza virus 2 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5871-9.json |
| 5872-7 | Parainfluenza virus 3 Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5872-7.json |
| 5873-5 | Parainfluenza virus 3 Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5873-5.json |
| 58740-2 | MRCP Abdomen WO contrast | ./2.16.840.1.114222.4.11.1002/58740-2.json |
| 58741-0 | PT Skull base to mid-thigh | ./2.16.840.1.114222.4.11.1002/58741-0.json |
| 58742-8 | PT Head and Neck | ./2.16.840.1.114222.4.11.1002/58742-8.json |
| 5874-3 | Respiratory syncytial virus Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/5874-3.json |
| 58743-6 | US Guidance for ablation of tissue of Unspecified body region | ./2.16.840.1.114222.4.11.1002/58743-6.json |
| 58744-4 | CT Heart | ./2.16.840.1.114222.4.11.1002/58744-4.json |
| 58746-9 | RFA AV fistula Views W contrast IV | ./2.16.840.1.114222.4.11.1002/58746-9.json |
| 58747-7 | CT Guidance for ablation of tissue of Unspecified body region | ./2.16.840.1.114222.4.11.1002/58747-7.json |
| 58748-5 | Functional MR Brain | ./2.16.840.1.114222.4.11.1002/58748-5.json |
| 58749-3 | MR Heart W stress and WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/58749-3.json |
| 5875-0 | Respiratory syncytial virus Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5875-0.json |
| 58750-1 | MR Heart W stress | ./2.16.840.1.114222.4.11.1002/58750-1.json |
| 58751-9 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58751-9.json |
| 58752-7 | Wheat recombinant (rTri a) 19 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58752-7.json |
| 58753-5 | Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58753-5.json |
| 58754-3 | Olive pollen native (nOle e) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58754-3.json |
| 58755-0 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58755-0.json |
| 58756-8 | Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58756-8.json |
| 58757-6 | Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58757-6.json |
| 58758-4 | Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58758-4.json |
| 58759-2 | Echovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/58759-2.json |
| 587-6 | Helicobacter pylori [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/587-6.json |
| 58760-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58760-0.json |
| 58761-8 | Coxiella burnetii phase 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58761-8.json |
| 58762-6 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58762-6.json |
| 58763-4 | IgA [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/58763-4.json |
| 58764-2 | IgM [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/58764-2.json |
| 58765-9 | Histone Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58765-9.json |
| 5876-8 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/5876-8.json |
| 58768-3 | Gamma glutamyl transferase [Enzymatic activity/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/58768-3.json |
| 58770-9 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58770-9.json |
| 58771-7 | Bactericidal permeability increasing protein Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58771-7.json |
| 58772-5 | Dog recombinant (rCan f) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58772-5.json |
| 58773-3 | Dog recombinant (rCan f) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58773-3.json |
| 58774-1 | Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58774-1.json |
| 58775-8 | Peach recombinant (rPru p) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58775-8.json |
| 5877-6 | Respiratory syncytial virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5877-6.json |
| 58776-6 | Peach recombinant (rPru p) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58776-6.json |
| 58777-4 | Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58777-4.json |
| 58778-2 | Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58778-2.json |
| 58779-0 | Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58779-0.json |
| 58780-8 | Coxsackievirus B IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/58780-8.json |
| 58781-6 | Calcium [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/58781-6.json |
| 58782-4 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58782-4.json |
| 58783-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58783-2.json |
| 5878-4 | Rickettsia sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/5878-4.json |
| 58784-0 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58784-0.json |
| 58785-7 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58785-7.json |
| 58786-5 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58786-5.json |
| 58787-3 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58787-3.json |
| 58788-1 | Campylobacter jejuni IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58788-1.json |
| 58789-9 | Campylobacter jejuni IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58789-9.json |
| 58790-7 | Coxsackievirus B IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58790-7.json |
| 58791-5 | Coxsackievirus A9 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58791-5.json |
| 5879-2 | Rotavirus Ag [Presence] in Stool by Agglutination | ./2.16.840.1.114222.4.11.1002/5879-2.json |
| 58792-3 | Coxsackievirus A9 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58792-3.json |
| 58793-1 | Phytonadione [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58793-1.json |
| 58794-9 | 5-Hydroxytryptophan [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/58794-9.json |
| 58795-6 | Glomerular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58795-6.json |
| 58796-4 | Glomerular basement membrane IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58796-4.json |
| 58797-2 | Yersinia enterocolitica Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/58797-2.json |
| 58798-0 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58798-0.json |
| 58799-8 | Legionella pneumophila 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58799-8.json |
| 5880-0 | Rotavirus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/5880-0.json |
| 58803-8 | Acetone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58803-8.json |
| 58804-6 | European paper wasp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58804-6.json |
| 58805-3 | Leukocytes [#/volume] in Urine by Automated test strip | ./2.16.840.1.114222.4.11.1002/58805-3.json |
| 58806-1 | Brucella sp Ab [Titer] in Cerebral spinal fluid by Agglutination | ./2.16.840.1.114222.4.11.1002/58806-1.json |
| 58807-9 | Conalbumin native (nGal d) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58807-9.json |
| 58808-7 | Aspergillus sp Ab [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/58808-7.json |
| 58809-5 | Rickettsia conorii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58809-5.json |
| 5881-8 | Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5881-8.json |
| 5882-6 | Varicella zoster virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/5882-6.json |
| 58831-9 | Urea [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/58831-9.json |
| 5883-4 | Virus identified in Blood by Culture | ./2.16.840.1.114222.4.11.1002/5883-4.json |
| 588-4 | Legionella pneumophila Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/588-4.json |
| 5884-2 | Virus identified in Cerebral spinal fluid by Culture | ./2.16.840.1.114222.4.11.1002/5884-2.json |
| 5885-9 | Virus identified in Skin by Culture | ./2.16.840.1.114222.4.11.1002/5885-9.json |
| 5886-7 | Virus identified in Stool by Culture | ./2.16.840.1.114222.4.11.1002/5886-7.json |
| 5887-5 | Virus identified in Throat by Culture | ./2.16.840.1.114222.4.11.1002/5887-5.json |
| 5888-3 | Virus identified in Tissue by Culture | ./2.16.840.1.114222.4.11.1002/5888-3.json |
| 58885-5 | Urea [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/58885-5.json |
| 5889-1 | Protein S Free [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/5889-1.json |
| 58900-2 | HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/58900-2.json |
| 58903-6 | Neomycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58903-6.json |
| 58907-7 | Liver kidney microsomal 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58907-7.json |
| 5890-9 | Protein S+Acarboxy Free Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5890-9.json |
| 58911-9 | Chicken droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58911-9.json |
| 58912-7 | Pigeon feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58912-7.json |
| 58913-5 | Parrot feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58913-5.json |
| 58914-3 | Aspergillus niger IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58914-3.json |
| 58915-0 | Parakeet feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58915-0.json |
| 58916-8 | Canary feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58916-8.json |
| 5891-7 | Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5891-7.json |
| 589-2 | Legionella sp identified in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/589-2.json |
| 58921-8 | Glutamine+Histidine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/58921-8.json |
| 58923-4 | Perennial rye grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58923-4.json |
| 58924-2 | LCT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58924-2.json |
| 5892-5 | Protein S [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/5892-5.json |
| 58925-9 | Dextromethamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/58925-9.json |
| 58927-5 | Glutamine+Histidine/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/58927-5.json |
| 58930-9 | Glutamine+Histidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/58930-9.json |
| 58931-7 | Mycobacterium tuberculosis DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/58931-7.json |
| 5893-3 | Protein S [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5893-3.json |
| 58933-3 | Endothelial cell Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/58933-3.json |
| 58934-1 | Fat [Mass/mass] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/58934-1.json |
| 58936-6 | Hepatitis E virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58936-6.json |
| 58937-4 | F12 gene mutations found [Type] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/58937-4.json |
| 58938-2 | LCT gene mutations found [Type] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/58938-2.json |
| 58940-8 | Bacteria identified in Total parental nutrition by Culture | ./2.16.840.1.114222.4.11.1002/58940-8.json |
| 58941-6 | Bilirubin [Mass/volume] in Skin | ./2.16.840.1.114222.4.11.1002/58941-6.json |
| 58942-4 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/58942-4.json |
| 58943-2 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/58943-2.json |
| 58944-0 | Microscopic observation [Identifier] in Body fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/58944-0.json |
| 58945-7 | Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/58945-7.json |
| 58956-4 | Direct antiglobulin test.complement C3b+C4d specific reagent [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/58956-4.json |
| 58958-0 | Fusarium oxysporum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58958-0.json |
| 58961-4 | Ganglioside GT1b IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58961-4.json |
| 58962-2 | Ganglioside GT1b IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58962-2.json |
| 58963-0 | Ganglioside GT1a IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58963-0.json |
| 58964-8 | Ganglioside GT1a IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58964-8.json |
| 58965-5 | Ganglioside GM4 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58965-5.json |
| 58966-3 | Ganglioside GM4 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58966-3.json |
| 58967-1 | Ganglioside GM3 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58967-1.json |
| 58968-9 | Asialoganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58968-9.json |
| 58969-7 | Ganglioside GD1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58969-7.json |
| 58970-5 | Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58970-5.json |
| 58971-3 | Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58971-3.json |
| 58972-1 | Ganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58972-1.json |
| 58973-9 | Ganglioside GM2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58973-9.json |
| 58974-7 | Ganglioside GM2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58974-7.json |
| 58975-4 | Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58975-4.json |
| 58976-2 | Ganglioside GQ1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/58976-2.json |
| 58977-0 | Ganglioside GD1b IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58977-0.json |
| 58978-8 | Ganglioside GD3 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58978-8.json |
| 58979-6 | Ganglioside GD3 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58979-6.json |
| 58980-4 | Ganglioside GD2 IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/58980-4.json |
| 58981-2 | Timothy recombinant (rPhl p) 5b IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58981-2.json |
| 58982-0 | Holm oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58982-0.json |
| 58983-8 | Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58983-8.json |
| 58984-6 | Bromelin MUXF3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58984-6.json |
| 58986-1 | Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/58986-1.json |
| 58987-9 | ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58987-9.json |
| 58988-7 | FGB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/58988-7.json |
| 58990-3 | Urate [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58990-3.json |
| 58991-1 | Urea [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58991-1.json |
| 58992-9 | Protein [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58992-9.json |
| 58993-7 | Phosphate [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58993-7.json |
| 58994-5 | Sodium [Moles/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58994-5.json |
| 58995-2 | Magnesium [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58995-2.json |
| 58996-0 | Potassium [Moles/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58996-0.json |
| 58997-8 | Glucose [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58997-8.json |
| 58998-6 | Creatinine [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58998-6.json |
| 58999-4 | Chloride [Moles/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/58999-4.json |
| 590-0 | Legionella sp identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/590-0.json |
| 59000-0 | Calcium [Mass/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/59000-0.json |
| 59001-8 | Amylase [Enzymatic activity/time] in 18 hour Urine | ./2.16.840.1.114222.4.11.1002/59001-8.json |
| 59003-4 | Lactoferrin Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59003-4.json |
| 5900-6 | Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/5900-6.json |
| 59009-1 | Fractional excretion of urea [Ratio] in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/59009-1.json |
| 59010-9 | Fractional excretion of potassium [Ratio] in Urine and Serum or Plasma collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/59010-9.json |
| 59014-1 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/59014-1.json |
| 59015-8 | Carbohydrates [Mass/mass] in Stool by Infrared spectroscopy | ./2.16.840.1.114222.4.11.1002/59015-8.json |
| 59016-6 | Water [Mass/mass] in Stool by Infrared spectroscopy | ./2.16.840.1.114222.4.11.1002/59016-6.json |
| 59017-4 | HLA-DPB1 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/59017-4.json |
| 59018-2 | HLA-DPA1 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/59018-2.json |
| 59019-0 | HLA-DQA1 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/59019-0.json |
| 59020-8 | HLA-DRB5 [Type] | ./2.16.840.1.114222.4.11.1002/59020-8.json |
| 59021-6 | HLA-DRB4 [Type] | ./2.16.840.1.114222.4.11.1002/59021-6.json |
| 5902-2 | Prothrombin time (PT) | ./2.16.840.1.114222.4.11.1002/5902-2.json |
| 59022-4 | HLA-DRB3 [Type] | ./2.16.840.1.114222.4.11.1002/59022-4.json |
| 59023-2 | Adenosine deaminase [Enzymatic activity/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59023-2.json |
| 59025-7 | Neutrophil Ab [Units/volume] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/59025-7.json |
| 59026-5 | U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59026-5.json |
| 59027-3 | Asialoganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/59027-3.json |
| 59028-1 | Ganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/59028-1.json |
| 59029-9 | HLA-DRB1*15:01 [Presence] | ./2.16.840.1.114222.4.11.1002/59029-9.json |
| 59032-3 | Lactate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59032-3.json |
| 59033-1 | Ganglioside GM3 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59033-1.json |
| 59034-9 | Ganglioside GD2 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59034-9.json |
| 59036-4 | Triglyceride [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59036-4.json |
| 59037-2 | Phosphate [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59037-2.json |
| 59038-0 | Cholesterol [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59038-0.json |
| 59039-8 | Amylase [Enzymatic activity/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59039-8.json |
| 59040-6 | Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/59040-6.json |
| 59047-1 | F5 gene p.His1299Arg [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/59047-1.json |
| 5904-8 | Russell viper venom time in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/5904-8.json |
| 59048-9 | Lactate/Pyruvate [Mass Ratio] in Blood | ./2.16.840.1.114222.4.11.1002/59048-9.json |
| 59052-1 | HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59052-1.json |
| 59058-8 | Cow whey IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59058-8.json |
| 59064-6 | PAX6 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/59064-6.json |
| 59065-3 | Chlamydophila psittaci [Presence] in Bronchial brush by Organism specific culture | ./2.16.840.1.114222.4.11.1002/59065-3.json |
| 59066-1 | sp100 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59066-1.json |
| 59067-9 | ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/59067-9.json |
| 59068-7 | RPS19 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/59068-7.json |
| 59069-5 | Nuclear Ab [Presence] in Serum by Hep2 substrate | ./2.16.840.1.114222.4.11.1002/59069-5.json |
| 59070-3 | Paraquat [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59070-3.json |
| 59071-1 | Tropheryma whipplei Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/59071-1.json |
| 59072-9 | Liver kidney microsomal 1 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/59072-9.json |
| 5909-7 | Blood smear finding [Identifier] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/5909-7.json |
| 59134-7 | ePHEDrine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59134-7.json |
| 59135-4 | Benzylpiperazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59135-4.json |
| 5914-7 | Glucose [Presence] in Blood by Test strip | ./2.16.840.1.114222.4.11.1002/5914-7.json |
| 59148-7 | Calcium [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/59148-7.json |
| 59149-5 | Creatine kinase.macromolecular [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59149-5.json |
| 59150-3 | Vancomycin resistant enterococcus [Presence] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/59150-3.json |
| 59151-1 | Vancomycin resistant enterococcus [Presence] in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/59151-1.json |
| 59152-9 | Vancomycin resistant enterococcus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59152-9.json |
| 59159-4 | Microalbumin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/59159-4.json |
| 59160-2 | Cannabinoids [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/59160-2.json |
| 59161-0 | Phosphate [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/59161-0.json |
| 59162-8 | Potassium [Moles/volume] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/59162-8.json |
| 59163-6 | Sodium [Moles/volume] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/59163-6.json |
| 59164-4 | Alkaline phosphatase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/59164-4.json |
| 59165-1 | Carbon dioxide [Partial pressure] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/59165-1.json |
| 59166-9 | Bilirubin.total [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/59166-9.json |
| 59167-7 | Phosphate [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/59167-7.json |
| 59168-5 | Urea [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/59168-5.json |
| 59169-3 | buPROPion [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59169-3.json |
| 59170-1 | Citalopram [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59170-1.json |
| 59171-9 | Norclozapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59171-9.json |
| 59172-7 | Methotrimeprazine metabolite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59172-7.json |
| 59174-3 | QUEtiapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59174-3.json |
| 59175-0 | QUEtiapine metabolite [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59175-0.json |
| 59176-8 | Zopiclone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59176-8.json |
| 59177-6 | Beta-2-Microglobulin/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59177-6.json |
| 59178-4 | Chloride [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59178-4.json |
| 59179-2 | Insulin [Moles/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/59179-2.json |
| 59180-0 | Monoethylglycinexylidide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59180-0.json |
| 59182-6 | C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method | ./2.16.840.1.114222.4.11.1002/59182-6.json |
| 59183-4 | Epstein Barr virus early diffuse IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/59183-4.json |
| 59186-7 | Cyanide [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59186-7.json |
| 59187-5 | Urea renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59187-5.json |
| 5918-8 | Urea nitrogen [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5918-8.json |
| 59188-3 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59188-3.json |
| 59189-1 | Methyl ethyl ketone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59189-1.json |
| 59190-9 | 2-Hydroxycaproate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59190-9.json |
| 59194-1 | Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59194-1.json |
| 59195-8 | 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59195-8.json |
| 5919-6 | Creatinine [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5919-6.json |
| 59196-6 | 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59196-6.json |
| 59197-4 | Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59197-4.json |
| 59198-2 | Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59198-2.json |
| 59199-0 | Deoxyadenosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59199-0.json |
| 59200-6 | Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59200-6.json |
| 59202-2 | Deoxyinosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59202-2.json |
| 5920-4 | Protein [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5920-4.json |
| 59204-8 | Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59204-8.json |
| 59205-5 | Gamma tocopherol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59205-5.json |
| 59206-3 | Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59206-3.json |
| 59207-1 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59207-1.json |
| 59208-9 | Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59208-9.json |
| 59209-7 | Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59209-7.json |
| 59211-3 | Transcobalamin I+Transcobalamin III [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59211-3.json |
| 5921-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5921-2.json |
| 59212-1 | Alloisoleucine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59212-1.json |
| 59217-0 | Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59217-0.json |
| 59218-8 | Beta-2-Microglobulin [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59218-8.json |
| 59219-6 | Testosterone [Moles/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59219-6.json |
| 5922-0 | Gastric acid [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/5922-0.json |
| 59220-4 | Chromogranin A [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59220-4.json |
| 59221-2 | Prostate specific Ag [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59221-2.json |
| 59222-0 | Squamous cell carcinoma Ag [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59222-0.json |
| 59223-8 | Prostate specific Ag [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59223-8.json |
| 59224-6 | Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59224-6.json |
| 59225-3 | Squamous cell carcinoma Ag [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59225-3.json |
| 59226-1 | Chromogranin A [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59226-1.json |
| 59227-9 | Chromogranin A [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59227-9.json |
| 59228-7 | Squamous cell carcinoma Ag [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59228-7.json |
| 59229-5 | Testosterone [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/59229-5.json |
| 59230-3 | Prostate specific Ag [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59230-3.json |
| 59231-1 | Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59231-1.json |
| 59232-9 | Prostate Specific Ag Free [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/59232-9.json |
| 59233-7 | Testosterone [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59233-7.json |
| 59234-5 | Reducing substances [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59234-5.json |
| 5923-8 | Gastric acid free [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/5923-8.json |
| 59239-4 | Prostate Specific Ag Free [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59239-4.json |
| 59240-2 | Testosterone [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59240-2.json |
| 59241-0 | Chromogranin A [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59241-0.json |
| 59242-8 | Reducing substances [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/59242-8.json |
| 59243-6 | Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/59243-6.json |
| 59244-4 | Arylsulfatase C [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/59244-4.json |
| 59245-1 | Alanine glyoxylate aminotransferase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59245-1.json |
| 59246-9 | Palmitoyl protein thioesterase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/59246-9.json |
| 59247-7 | Tetrahydrobiopterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59247-7.json |
| 59248-5 | Cholesterol esterase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59248-5.json |
| 59249-3 | Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/59249-3.json |
| 59252-7 | Homocysteine cysteine disulfide [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59252-7.json |
| 5925-3 | Gastric acid [Volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/5925-3.json |
| 59253-5 | Homocysteine cysteine disulfide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59253-5.json |
| 59254-3 | Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59254-3.json |
| 59256-8 | Cytologist who read Cyto stain of Specimen | ./2.16.840.1.114222.4.11.1002/59256-8.json |
| 59258-4 | Emergency department Discharge summary | ./2.16.840.1.114222.4.11.1002/59258-4.json |
| 59259-2 | Psychiatry Discharge summary | ./2.16.840.1.114222.4.11.1002/59259-2.json |
| 59260-0 | Hemoglobin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59260-0.json |
| 59261-8 | Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol | ./2.16.840.1.114222.4.11.1002/59261-8.json |
| 59262-6 | Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip | ./2.16.840.1.114222.4.11.1002/59262-6.json |
| 59263-4 | Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/59263-4.json |
| 59264-2 | Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/59264-2.json |
| 59266-7 | Maternal cell contamination [Identifier] in Specimen Nominal | ./2.16.840.1.114222.4.11.1002/59266-7.json |
| 59268-3 | Neonatal care report | ./2.16.840.1.114222.4.11.1002/59268-3.json |
| 59281-6 | US Heart Transthoracic | ./2.16.840.1.114222.4.11.1002/59281-6.json |
| 59282-4 | Cardiac stress echo study | ./2.16.840.1.114222.4.11.1002/59282-4.json |
| 59283-2 | Well child visit note | ./2.16.840.1.114222.4.11.1002/59283-2.json |
| 59284-0 | Consent Document | ./2.16.840.1.114222.4.11.1002/59284-0.json |
| 59285-7 | Benzylpiperazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59285-7.json |
| 59286-5 | Benzylpiperazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59286-5.json |
| 59287-3 | Benzylpiperazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59287-3.json |
| 59288-1 | Bisphenol A [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59288-1.json |
| 59289-9 | Iloperidone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59289-9.json |
| 59290-7 | Iloperidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59290-7.json |
| 59291-5 | Levamisole [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59291-5.json |
| 59292-3 | Levamisole [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59292-3.json |
| 59293-1 | Levamisole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59293-1.json |
| 59294-9 | Levamisole [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59294-9.json |
| 59295-6 | Levamisole [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59295-6.json |
| 59296-4 | Lacosamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59296-4.json |
| 59297-2 | Lacosamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59297-2.json |
| 59298-0 | Lacosamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59298-0.json |
| 59299-8 | Desloratadine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59299-8.json |
| 59300-4 | Desloratadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59300-4.json |
| 59301-2 | Desloratadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59301-2.json |
| 59302-0 | Memantine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59302-0.json |
| 59303-8 | Memantine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59303-8.json |
| 59304-6 | Memantine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59304-6.json |
| 59305-3 | Memantine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59305-3.json |
| 59306-1 | Memantine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59306-1.json |
| 59307-9 | Metaxalone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59307-9.json |
| 59308-7 | Metaxalone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59308-7.json |
| 59309-5 | Metaxalone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59309-5.json |
| 59310-3 | Milnacipran [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59310-3.json |
| 59311-1 | Milnacipran [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59311-1.json |
| 59312-9 | Milnacipran [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59312-9.json |
| 59313-7 | Ramelteon M-II [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59313-7.json |
| 59314-5 | Ramelteon [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59314-5.json |
| 59315-2 | Ramelteon M-II [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59315-2.json |
| 59316-0 | Ramelteon [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59316-0.json |
| 59317-8 | Ramelteon M-II [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59317-8.json |
| 59318-6 | Ramelteon [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59318-6.json |
| 59319-4 | Ramelteon M-II [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59319-4.json |
| 59320-2 | Ramelteon [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59320-2.json |
| 59321-0 | Ramelteon M-II [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59321-0.json |
| 59322-8 | Ramelteon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59322-8.json |
| 59323-6 | Rufinamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59323-6.json |
| 59324-4 | Salvinorin A [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59324-4.json |
| 59325-1 | Salvinorin B [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59325-1.json |
| 59326-9 | Salvinorin A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59326-9.json |
| 59327-7 | Salvinorin B [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59327-7.json |
| 59328-5 | Salvinorin A [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59328-5.json |
| 5932-9 | Cholesterol [Presence] in Blood by Test strip | ./2.16.840.1.114222.4.11.1002/5932-9.json |
| 59329-3 | Salvinorin B [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59329-3.json |
| 59330-1 | Norsibutramine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59330-1.json |
| 59331-9 | Dinorsibutramine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59331-9.json |
| 59332-7 | Sibutramine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59332-7.json |
| 59333-5 | Norsibutramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59333-5.json |
| 59334-3 | Dinorsibutramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59334-3.json |
| 59335-0 | Sibutramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59335-0.json |
| 59336-8 | Norsibutramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59336-8.json |
| 5933-7 | Lead [Mass/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/5933-7.json |
| 59337-6 | Dinorsibutramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59337-6.json |
| 59338-4 | Sibutramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59338-4.json |
| 59339-2 | Stiripentol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59339-2.json |
| 593-4 | Legionella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/593-4.json |
| 59340-0 | Stiripentol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59340-0.json |
| 59341-8 | Stiripentol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59341-8.json |
| 59342-6 | Tadalafil [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59342-6.json |
| 59343-4 | Tadalafil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59343-4.json |
| 59344-2 | Tadalafil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59344-2.json |
| 59345-9 | Endoxifen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59345-9.json |
| 59346-7 | 4-Hydroxy-Tamoxifen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59346-7.json |
| 59347-5 | Tamoxifen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59347-5.json |
| 59348-3 | Nortamoxifen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59348-3.json |
| 59349-1 | Endoxifen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59349-1.json |
| 59350-9 | 4-Hydroxy-Tamoxifen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59350-9.json |
| 59351-7 | Nortamoxifen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59351-7.json |
| 59352-5 | Tapentadol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59352-5.json |
| 59353-3 | Tapentadol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59353-3.json |
| 59354-1 | Tapentadol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59354-1.json |
| 59355-8 | Tapentadol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59355-8.json |
| 59356-6 | Desethylvardenafil [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59356-6.json |
| 59357-4 | Vardenafil [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59357-4.json |
| 59358-2 | Desethylvardenafil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59358-2.json |
| 59359-0 | Vardenafil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59359-0.json |
| 5936-0 | Benzoylecgonine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/5936-0.json |
| 59360-8 | Desethylvardenafil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59360-8.json |
| 59361-6 | Vardenafil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59361-6.json |
| 59362-4 | Race or ethnicity OMB.1997 | ./2.16.840.1.114222.4.11.1002/59362-4.json |
| 59363-2 | Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59363-2.json |
| 59364-0 | Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59364-0.json |
| 59365-7 | Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59365-7.json |
| 59366-5 | Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59366-5.json |
| 59367-3 | Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59367-3.json |
| 59368-1 | Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59368-1.json |
| 59369-9 | Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59369-9.json |
| 59370-7 | Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59370-7.json |
| 59371-5 | Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59371-5.json |
| 59372-3 | Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59372-3.json |
| 59376-4 | 3-Keto, 2-Methylvalerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59376-4.json |
| 59377-2 | 2-Methylacetoacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/59377-2.json |
| 59378-0 | Amikacin [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/59378-0.json |
| 59379-8 | Gentamicin [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/59379-8.json |
| 59380-6 | Tobramycin [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/59380-6.json |
| 59381-4 | Vancomycin [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/59381-4.json |
| 59382-2 | Aspergillus versicolor IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59382-2.json |
| 59383-0 | Hydroxyproline/Creatinine [Mass Ratio] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/59383-0.json |
| 59384-8 | Acetaminophen [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/59384-8.json |
| 5938-6 | Benzoylecgonine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/5938-6.json |
| 59386-3 | Starch [Mass/mass] in Stool by Infrared spectroscopy | ./2.16.840.1.114222.4.11.1002/59386-3.json |
| 59387-1 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59387-1.json |
| 59388-9 | Taenia solium larva DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59388-9.json |
| 59390-5 | Neuronal nuclear Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59390-5.json |
| 59391-3 | Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59391-3.json |
| 59392-1 | Hydroxyproline [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/59392-1.json |
| 59393-9 | Trypanosoma cruzi IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59393-9.json |
| 59394-7 | Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59394-7.json |
| 59395-4 | Latex recombinant (rHev b) 9 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/59395-4.json |
| 59396-2 | Echovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/59396-2.json |
| 59397-0 | Echovirus IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59397-0.json |
| 59398-8 | Ascorbate [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/59398-8.json |
| 59399-6 | PM-1 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59399-6.json |
| 59400-2 | RNA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59400-2.json |
| 59401-0 | Echovirus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59401-0.json |
| 59404-4 | Oxygen capacity [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/59404-4.json |
| 59419-2 | HIV 1 RNA [#/volume] (viral load) in Plasma by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/59419-2.json |
| 594-2 | Leptospira sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/594-2.json |
| 59420-0 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/59420-0.json |
| 59421-8 | Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/59421-8.json |
| 59422-6 | Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/59422-6.json |
| 59423-4 | Influenza virus A hemagglutinin type RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59423-4.json |
| 59424-2 | Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59424-2.json |
| 59465-5 | Pathologist review of results | ./2.16.840.1.114222.4.11.1002/59465-5.json |
| 59466-3 | Hematologist review of results | ./2.16.840.1.114222.4.11.1002/59466-3.json |
| 59470-5 | Calcium.ionized [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/59470-5.json |
| 59471-3 | Calcium.ionized [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/59471-3.json |
| 59472-1 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/59472-1.json |
| 59473-9 | Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/59473-9.json |
| 59474-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain | ./2.16.840.1.114222.4.11.1002/59474-7.json |
| 59561-1 | Propofol glucuronide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59561-1.json |
| 59562-9 | DNA index by Automated image cytometry | ./2.16.840.1.114222.4.11.1002/59562-9.json |
| 59564-5 | Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/59564-5.json |
| 59565-2 | Netilmicin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/59565-2.json |
| 59566-0 | Netilmicin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59566-0.json |
| 59567-8 | Netilmicin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/59567-8.json |
| 59568-6 | Orotate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/59568-6.json |
| 59570-2 | Urea nitrogen [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59570-2.json |
| 59571-0 | Triglyceride [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/59571-0.json |
| 59572-8 | Triglyceride [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59572-8.json |
| 59573-6 | Cannabinoids [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59573-6.json |
| 59579-3 | Coxsackievirus A24 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59579-3.json |
| 59580-1 | Coxsackievirus A16 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59580-1.json |
| 59581-9 | Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59581-9.json |
| 59582-7 | Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59582-7.json |
| 59583-5 | Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59583-5.json |
| 59584-3 | Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59584-3.json |
| 59585-0 | GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/59585-0.json |
| 59586-8 | HLA IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/59586-8.json |
| 59587-6 | Homovanillate [Mass/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/59587-6.json |
| 59588-4 | 1-Hydroxymidazolam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/59588-4.json |
| 59589-2 | 1-Hydroxymidazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59589-2.json |
| 595-9 | Bacteria identified in Abscess by Aerobe culture | ./2.16.840.1.114222.4.11.1002/595-9.json |
| 59590-0 | 1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59590-0.json |
| 59591-8 | 7-Aminoclonazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59591-8.json |
| 59592-6 | 7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59592-6.json |
| 59593-4 | 7-Aminoclonazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59593-4.json |
| 59594-2 | 7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59594-2.json |
| 59595-9 | 7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59595-9.json |
| 59596-7 | 7-Aminoclonazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59596-7.json |
| 59597-5 | 7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59597-5.json |
| 59598-3 | Acetazolamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59598-3.json |
| 59599-1 | Alpha hydroxyalprazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59599-1.json |
| 59600-7 | Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59600-7.json |
| 59601-5 | Alpha hydroxyalprazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59601-5.json |
| 59602-3 | Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59602-3.json |
| 59603-1 | Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59603-1.json |
| 59604-9 | Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59604-9.json |
| 59605-6 | Alpha hydroxyalprazolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59605-6.json |
| 59606-4 | Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59606-4.json |
| 59607-2 | ALPRAZolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59607-2.json |
| 59608-0 | ALPRAZolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59608-0.json |
| 59609-8 | ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59609-8.json |
| 59610-6 | ALPRAZolam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59610-6.json |
| 59611-4 | ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59611-4.json |
| 59612-2 | ALPRAZolam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59612-2.json |
| 59613-0 | ALPRAZolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59613-0.json |
| 59614-8 | ALPRAZolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59614-8.json |
| 59615-5 | ALPRAZolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59615-5.json |
| 59616-3 | Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59616-3.json |
| 59617-1 | chlordiazePOXIDE [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59617-1.json |
| 59618-9 | chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59618-9.json |
| 59619-7 | chlordiazePOXIDE [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59619-7.json |
| 59620-5 | chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59620-5.json |
| 59621-3 | chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59621-3.json |
| 59622-1 | chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59622-1.json |
| 59623-9 | chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59623-9.json |
| 59624-7 | chlordiazePOXIDE [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59624-7.json |
| 59625-4 | chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59625-4.json |
| 59626-2 | cloBAZam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59626-2.json |
| 59627-0 | cloBAZam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59627-0.json |
| 59628-8 | cloBAZam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59628-8.json |
| 59629-6 | cloBAZam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59629-6.json |
| 59630-4 | cloBAZam [Mass/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/59630-4.json |
| 59631-2 | cloBAZam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59631-2.json |
| 59632-0 | cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59632-0.json |
| 59633-8 | cloBAZam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59633-8.json |
| 59634-6 | cloBAZam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59634-6.json |
| 59635-3 | cloBAZam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59635-3.json |
| 59636-1 | clonazePAM [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59636-1.json |
| 59637-9 | clonazePAM [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59637-9.json |
| 59638-7 | clonazePAM [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59638-7.json |
| 59639-5 | clonazePAM [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59639-5.json |
| 59640-3 | clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59640-3.json |
| 59641-1 | clonazePAM [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59641-1.json |
| 5964-2 | Prothrombin time (PT) in Blood by Coagulation assay | ./2.16.840.1.114222.4.11.1002/5964-2.json |
| 59642-9 | clonazePAM [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59642-9.json |
| 59643-7 | Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59643-7.json |
| 59644-5 | Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59644-5.json |
| 59645-2 | Cotinine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/59645-2.json |
| 59646-0 | Cotinine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/59646-0.json |
| 59647-8 | N-desalkylflurazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59647-8.json |
| 59648-6 | N-desalkylflurazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59648-6.json |
| 59649-4 | N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59649-4.json |
| 59650-2 | N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59650-2.json |
| 59651-0 | N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59651-0.json |
| 59652-8 | N-desalkylflurazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59652-8.json |
| 59653-6 | N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59653-6.json |
| 59654-4 | diazePAM [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59654-4.json |
| 59655-1 | diazePAM [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59655-1.json |
| 59656-9 | diazePAM [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59656-9.json |
| 59657-7 | diazePAM [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59657-7.json |
| 59658-5 | diazePAM [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59658-5.json |
| 5965-9 | Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5965-9.json |
| 59659-3 | diazePAM [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59659-3.json |
| 59660-1 | diazePAM [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59660-1.json |
| 59661-9 | diazePAM [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59661-9.json |
| 59662-7 | Diclofenac [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59662-7.json |
| 59663-5 | Diclofenac [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59663-5.json |
| 59664-3 | Estazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59664-3.json |
| 59665-0 | Estazolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59665-0.json |
| 59666-8 | Estazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59666-8.json |
| 5966-7 | Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5966-7.json |
| 59667-6 | Estazolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59667-6.json |
| 59668-4 | Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59668-4.json |
| 59669-2 | Estazolam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59669-2.json |
| 596-7 | Bacteria identified in Amniotic fluid by Culture | ./2.16.840.1.114222.4.11.1002/596-7.json |
| 59670-0 | Estazolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59670-0.json |
| 59671-8 | Estazolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59671-8.json |
| 59672-6 | Estazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59672-6.json |
| 59673-4 | fentaNYL [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/59673-4.json |
| 59674-2 | Flurazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59674-2.json |
| 5967-5 | Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5967-5.json |
| 59675-9 | Flurazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59675-9.json |
| 59676-7 | Flurazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59676-7.json |
| 59677-5 | Flurazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59677-5.json |
| 59678-3 | Flurazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59678-3.json |
| 59679-1 | Flurazepam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59679-1.json |
| 59680-9 | Gabapentin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59680-9.json |
| 59681-7 | Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/59681-7.json |
| 59682-5 | Hydroxyethylflurazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59682-5.json |
| 59683-3 | Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59683-3.json |
| 59684-1 | Hydroxyethylflurazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59684-1.json |
| 59685-8 | Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59685-8.json |
| 59686-6 | Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59686-6.json |
| 59687-4 | Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59687-4.json |
| 59688-2 | Hydroxyethylflurazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59688-2.json |
| 59689-0 | Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59689-0.json |
| 59690-8 | Hydroxytriazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59690-8.json |
| 5969-1 | Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5969-1.json |
| 59691-6 | Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59691-6.json |
| 59692-4 | Hydroxytriazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59692-4.json |
| 59693-2 | Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59693-2.json |
| 59694-0 | Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59694-0.json |
| 59695-7 | Hydroxytriazolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59695-7.json |
| 59696-5 | Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59696-5.json |
| 59697-3 | Iodide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59697-3.json |
| 59699-9 | LORazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59699-9.json |
| 59700-5 | LORazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59700-5.json |
| 59701-3 | LORazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59701-3.json |
| 59702-1 | LORazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59702-1.json |
| 59703-9 | LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59703-9.json |
| 59704-7 | LORazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59704-7.json |
| 59705-4 | Methadone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/59705-4.json |
| 59706-2 | MethylePHEDrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59706-2.json |
| 59707-0 | Midazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59707-0.json |
| 59708-8 | Midazolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59708-8.json |
| 5970-9 | Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5970-9.json |
| 59709-6 | Midazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59709-6.json |
| 59710-4 | Midazolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59710-4.json |
| 59711-2 | Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59711-2.json |
| 59712-0 | Midazolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59712-0.json |
| 59713-8 | Midazolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59713-8.json |
| 59714-6 | Nitrous oxide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59714-6.json |
| 59715-3 | Nitrous oxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59715-3.json |
| 59716-1 | Nordiazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59716-1.json |
| 5971-7 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5971-7.json |
| 59717-9 | Nordiazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59717-9.json |
| 59718-7 | Nordiazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59718-7.json |
| 59719-5 | Nordiazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59719-5.json |
| 59720-3 | Nordiazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59720-3.json |
| 59721-1 | Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59721-1.json |
| 59722-9 | Nordiazepam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59722-9.json |
| 59723-7 | Nordiazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59723-7.json |
| 59724-5 | Cathine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59724-5.json |
| 5972-5 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5972-5.json |
| 59725-2 | Oxazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59725-2.json |
| 59726-0 | Oxazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59726-0.json |
| 59727-8 | Oxazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59727-8.json |
| 59728-6 | Oxazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59728-6.json |
| 59729-4 | Oxazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59729-4.json |
| 59730-2 | Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59730-2.json |
| 59731-0 | Oxazepam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59731-0.json |
| 59732-8 | Oxazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59732-8.json |
| 5973-3 | Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5973-3.json |
| 59733-6 | Potassium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59733-6.json |
| 59734-4 | Propoxyphene [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/59734-4.json |
| 59735-1 | Salicylamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59735-1.json |
| 59736-9 | Salicylamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59736-9.json |
| 59737-7 | Selenium [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/59737-7.json |
| 59738-5 | Silver [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59738-5.json |
| 59739-3 | Silver [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/59739-3.json |
| 59740-1 | Silver [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/59740-1.json |
| 5974-1 | Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5974-1.json |
| 59741-9 | Silver [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59741-9.json |
| 59742-7 | sulfADIAZINE [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59742-7.json |
| 59743-5 | SUMAtriptan [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59743-5.json |
| 59744-3 | SUMAtriptan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59744-3.json |
| 59745-0 | Temazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59745-0.json |
| 59746-8 | Temazepam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59746-8.json |
| 59747-6 | Temazepam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59747-6.json |
| 59748-4 | Temazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59748-4.json |
| 59749-2 | Temazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59749-2.json |
| 597-5 | Bacteria identified in Aspirate by Aerobe culture | ./2.16.840.1.114222.4.11.1002/597-5.json |
| 59750-0 | Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59750-0.json |
| 59751-8 | Temazepam [Mass/mass] in Stool by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59751-8.json |
| 59752-6 | Temazepam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59752-6.json |
| 59753-4 | Titanium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59753-4.json |
| 59754-2 | Titanium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/59754-2.json |
| 59755-9 | Titanium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/59755-9.json |
| 59756-7 | Titanium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59756-7.json |
| 59757-5 | tiZANidine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59757-5.json |
| 5975-8 | Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5975-8.json |
| 59758-3 | Triazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59758-3.json |
| 59759-1 | Triazolam [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59759-1.json |
| 59760-9 | Triazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59760-9.json |
| 59761-7 | Triazolam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59761-7.json |
| 59762-5 | Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59762-5.json |
| 59763-3 | Triazolam [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/59763-3.json |
| 59764-1 | Triazolam [Mass/mass] in Tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/59764-1.json |
| 59765-8 | Tungsten [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59765-8.json |
| 5976-6 | Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5976-6.json |
| 59766-6 | Tungsten [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/59766-6.json |
| 59767-4 | Ziprasidone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59767-4.json |
| 59768-2 | Procedure indications [Interpretation] Narrative | ./2.16.840.1.114222.4.11.1002/59768-2.json |
| 59769-0 | Postprocedure diagnosis Narrative | ./2.16.840.1.114222.4.11.1002/59769-0.json |
| 59770-8 | Procedure estimated blood loss Narrative | ./2.16.840.1.114222.4.11.1002/59770-8.json |
| 59771-6 | Procedure implants Narrative | ./2.16.840.1.114222.4.11.1002/59771-6.json |
| 59772-4 | Planned procedure Narrative | ./2.16.840.1.114222.4.11.1002/59772-4.json |
| 59773-2 | Procedure specimens taken Narrative | ./2.16.840.1.114222.4.11.1002/59773-2.json |
| 5977-4 | Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5977-4.json |
| 59774-0 | Procedure anesthesia Narrative | ./2.16.840.1.114222.4.11.1002/59774-0.json |
| 59775-7 | Procedure disposition Narrative | ./2.16.840.1.114222.4.11.1002/59775-7.json |
| 59776-5 | Procedure findings Narrative | ./2.16.840.1.114222.4.11.1002/59776-5.json |
| 5978-2 | Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5978-2.json |
| 59787-2 | Catecholamines [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/59787-2.json |
| 59790-6 | Hexacarboxylporphyrin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59790-6.json |
| 59798-9 | Ganciclovir [Mass/volume] in Plasma --peak | ./2.16.840.1.114222.4.11.1002/59798-9.json |
| 59799-7 | Ganciclovir [Mass/volume] in Plasma --trough | ./2.16.840.1.114222.4.11.1002/59799-7.json |
| 59805-2 | Epstein Barr virus DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59805-2.json |
| 59807-8 | Phosphatidylglycerol [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/59807-8.json |
| 5980-8 | Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5980-8.json |
| 59810-2 | Caffeine [Moles/volume] in Serum --trough | ./2.16.840.1.114222.4.11.1002/59810-2.json |
| 59811-0 | Caffeine [Moles/volume] in Serum --peak | ./2.16.840.1.114222.4.11.1002/59811-0.json |
| 59812-8 | Glucose [Moles/volume] in Serum or Plasma --11 AM specimen | ./2.16.840.1.114222.4.11.1002/59812-8.json |
| 59813-6 | Glucose [Moles/volume] in Capillary blood by Glucometer --7 AM specimen | ./2.16.840.1.114222.4.11.1002/59813-6.json |
| 59814-4 | Glucose [Moles/volume] in Serum or Plasma --7 AM specimen | ./2.16.840.1.114222.4.11.1002/59814-4.json |
| 59815-1 | Glucose [Moles/volume] in Serum or Plasma --3 PM specimen | ./2.16.840.1.114222.4.11.1002/59815-1.json |
| 5981-6 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5981-6.json |
| 59822-7 | Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post dose | ./2.16.840.1.114222.4.11.1002/59822-7.json |
| 59823-5 | Tacrolimus [Mass/volume] in Serum or Plasma --2 hours post dose | ./2.16.840.1.114222.4.11.1002/59823-5.json |
| 5982-4 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5982-4.json |
| 59824-3 | Cyanide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59824-3.json |
| 59825-0 | Phenols [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/59825-0.json |
| 59826-8 | Creatinine [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/59826-8.json |
| 59827-6 | Bilirubin.total [Mass/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/59827-6.json |
| 59828-4 | Bilirubin.total [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/59828-4.json |
| 59829-2 | Leukocytes in 3 hour Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/59829-2.json |
| 598-3 | Bacteria identified in Aspirate by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/598-3.json |
| 59830-0 | Erythrocytes in 3 hour Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/59830-0.json |
| 5983-2 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5983-2.json |
| 59835-9 | Parathyrin.intact [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/59835-9.json |
| 59836-7 | Mycoplasma sp+Ureaplasma urealyticum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/59836-7.json |
| 59837-5 | Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59837-5.json |
| 59838-3 | Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination | ./2.16.840.1.114222.4.11.1002/59838-3.json |
| 59839-1 | Urate crystals [Presence] in Tissue by Light microscopy | ./2.16.840.1.114222.4.11.1002/59839-1.json |
| 5984-0 | Plasminogen activator urokinase type [Units/volume] in Urine | ./2.16.840.1.114222.4.11.1002/5984-0.json |
| 59844-1 | Methylenedioxyethylamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/59844-1.json |
| 59846-6 | Salmonella sp identified [Type] in Isolate | ./2.16.840.1.114222.4.11.1002/59846-6.json |
| 59850-8 | Wuchereria bancrofti Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/59850-8.json |
| 5985-7 | Plasminogen activator urokinase type [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/5985-7.json |
| 59864-9 | Acetone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59864-9.json |
| 5986-5 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5986-5.json |
| 59865-6 | Amobarbital [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59865-6.json |
| 59866-4 | Amobarbital [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59866-4.json |
| 59867-2 | Amoxapine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59867-2.json |
| 59868-0 | Amoxapine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59868-0.json |
| 59869-8 | Benztropine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59869-8.json |
| 59870-6 | Benztropine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59870-6.json |
| 59871-4 | Benztropine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59871-4.json |
| 59872-2 | Bromazepam [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59872-2.json |
| 5987-3 | Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/5987-3.json |
| 59873-0 | Bromazepam [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59873-0.json |
| 59874-8 | Brompheniramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59874-8.json |
| 59875-5 | Brompheniramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59875-5.json |
| 59876-3 | carBAMazepine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59876-3.json |
| 59877-1 | Chloral hydrate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59877-1.json |
| 59878-9 | Chloral hydrate [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59878-9.json |
| 59879-7 | chlordiazePOXIDE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59879-7.json |
| 59880-5 | chlordiazePOXIDE [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59880-5.json |
| 5988-1 | Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5988-1.json |
| 59881-3 | Chlorpheniramine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59881-3.json |
| 59882-1 | Chlorpheniramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59882-1.json |
| 59883-9 | Chlorpheniramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59883-9.json |
| 59884-7 | chlorproMAZINE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59884-7.json |
| 59885-4 | chlorproMAZINE [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59885-4.json |
| 59886-2 | Citalopram [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59886-2.json |
| 59887-0 | Citalopram [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59887-0.json |
| 59888-8 | cloBAZam [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59888-8.json |
| 59889-6 | clomiPRAMINE [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59889-6.json |
| 59890-4 | cloZAPine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59890-4.json |
| 59891-2 | Cotinine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59891-2.json |
| 59892-0 | Cotinine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59892-0.json |
| 59893-8 | Desipramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59893-8.json |
| 59894-6 | Dextromethorphan [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59894-6.json |
| 59895-3 | Dextromethorphan [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59895-3.json |
| 59896-1 | Dextromethorphan [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59896-1.json |
| 59897-9 | Disopyramide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59897-9.json |
| 59898-7 | Disopyramide [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59898-7.json |
| 5989-9 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5989-9.json |
| 59899-5 | Ethylene glycol [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59899-5.json |
| 59900-1 | Fenoprofen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59900-1.json |
| 59901-9 | Fenoprofen [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59901-9.json |
| 59902-7 | FLUoxetine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59902-7.json |
| 59903-5 | FLUoxetine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59903-5.json |
| 59904-3 | fluPHENAZine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59904-3.json |
| 59905-0 | fluPHENAZine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59905-0.json |
| 59906-8 | fluvoxaMINE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59906-8.json |
| 5990-7 | Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis | ./2.16.840.1.114222.4.11.1002/5990-7.json |
| 59907-6 | fluvoxaMINE [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59907-6.json |
| 59908-4 | hydrOXYzine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59908-4.json |
| 59909-2 | hydrOXYzine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59909-2.json |
| 599-1 | Bacteria identified in Blood product unit by Aerobe culture | ./2.16.840.1.114222.4.11.1002/599-1.json |
| 59910-0 | Ibuprofen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59910-0.json |
| 59911-8 | Ibuprofen [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59911-8.json |
| 59912-6 | Imipramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59912-6.json |
| 59913-4 | Imipramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59913-4.json |
| 59914-2 | Indomethacin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59914-2.json |
| 5991-5 | Plasminogen Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/5991-5.json |
| 59915-9 | Indomethacin [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59915-9.json |
| 59916-7 | Isopropanol [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59916-7.json |
| 59917-5 | Ketoprofen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59917-5.json |
| 59918-3 | Ketoprofen [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59918-3.json |
| 59919-1 | lamoTRIgine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59919-1.json |
| 59920-9 | lamoTRIgine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59920-9.json |
| 59921-7 | Mefenamate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59921-7.json |
| 59922-5 | Mefenamate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59922-5.json |
| 59923-3 | Mefenamate [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59923-3.json |
| 59924-1 | Meperidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59924-1.json |
| 59925-8 | Mesoridazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59925-8.json |
| 59926-6 | Mesoridazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59926-6.json |
| 59927-4 | Methanol [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59927-4.json |
| 59928-2 | Methaqualone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59928-2.json |
| 59929-0 | Methaqualone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59929-0.json |
| 59930-8 | Methotrimeprazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59930-8.json |
| 59931-6 | Methotrimeprazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59931-6.json |
| 59932-4 | Mexiletine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59932-4.json |
| 59933-2 | Mexiletine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59933-2.json |
| 59934-0 | Naproxen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59934-0.json |
| 59935-7 | Naproxen [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59935-7.json |
| 59936-5 | Nicotine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59936-5.json |
| 59937-3 | Nicotine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59937-3.json |
| 59938-1 | Norclobazam [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59938-1.json |
| 59939-9 | Norclobazam [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59939-9.json |
| 59940-7 | Norclomipramine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59940-7.json |
| 59941-5 | Norclomipramine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59941-5.json |
| 59942-3 | Nordoxepin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59942-3.json |
| 59943-1 | Nordoxepin [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59943-1.json |
| 59944-9 | Normeperidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59944-9.json |
| 59945-6 | Nortriptyline [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59945-6.json |
| 59946-4 | OLANZapine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59946-4.json |
| 59947-2 | OXcarbazepine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59947-2.json |
| 59948-0 | OXcarbazepine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59948-0.json |
| 59949-8 | PARoxetine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59949-8.json |
| 59950-6 | PARoxetine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59950-6.json |
| 59951-4 | Pentazocine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59951-4.json |
| 59952-2 | Pentazocine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59952-2.json |
| 59953-0 | Perphenazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59953-0.json |
| 59954-8 | Perphenazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59954-8.json |
| 59955-5 | Perphenazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59955-5.json |
| 59956-3 | Phencyclidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59956-3.json |
| 59957-1 | Promazine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59957-1.json |
| 59958-9 | Promazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59958-9.json |
| 59959-7 | Promazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59959-7.json |
| 59960-5 | Propoxyphene [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59960-5.json |
| 59961-3 | Propoxyphene [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59961-3.json |
| 59962-1 | Propranolol [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59962-1.json |
| 59963-9 | QUEtiapine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59963-9.json |
| 59964-7 | QUEtiapine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59964-7.json |
| 59965-4 | quiNINE [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59965-4.json |
| 59966-2 | quiNINE [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59966-2.json |
| 59967-0 | quiNINE [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59967-0.json |
| 59968-8 | Strychnine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/59968-8.json |
| 59969-6 | Strychnine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59969-6.json |
| 59970-4 | Strychnine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59970-4.json |
| 59971-2 | Sulfamethoxazole [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59971-2.json |
| 59972-0 | Sulfamethoxazole [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59972-0.json |
| 59973-8 | Thiocyanate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59973-8.json |
| 59974-6 | Thiocyanate [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59974-6.json |
| 59975-3 | traZODone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59975-3.json |
| 59976-1 | traZODone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59976-1.json |
| 59977-9 | Venlafaxine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59977-9.json |
| 59978-7 | Venlafaxine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59978-7.json |
| 59979-5 | Warfarin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59979-5.json |
| 59980-3 | Warfarin [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59980-3.json |
| 59981-1 | Zopiclone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/59981-1.json |
| 59982-9 | Zopiclone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/59982-9.json |
| 6001-2 | Platelet factor 3 [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/6001-2.json |
| 60017-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/60017-1.json |
| 60018-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/60018-9.json |
| 60019-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/60019-7.json |
| 6002-0 | Platelet factor 4 [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/6002-0.json |
| 60020-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/60020-5.json |
| 60021-3 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/60021-3.json |
| 60022-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/60022-1.json |
| 60023-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/60023-9.json |
| 60024-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/60024-7.json |
| 60025-4 | Urobilinogen [Moles/volume] in Urine by Automated test strip | ./2.16.840.1.114222.4.11.1002/60025-4.json |
| 60026-2 | Leukocyte esterase [Presence] in Urine by Automated test strip | ./2.16.840.1.114222.4.11.1002/60026-2.json |
| 60027-0 | Specific gravity of Pericardial fluid | ./2.16.840.1.114222.4.11.1002/60027-0.json |
| 60028-8 | West Nile virus IgG Ab avidity [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/60028-8.json |
| 60029-6 | West Nile virus IgG Ab avidity [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/60029-6.json |
| 60030-4 | West Nile virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/60030-4.json |
| 60032-0 | Bacteria identified in Peritoneal dialysis fluid by Culture | ./2.16.840.1.114222.4.11.1002/60032-0.json |
| 60033-8 | PIK3CA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/60033-8.json |
| 60034-6 | PIK3CA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60034-6.json |
| 60035-3 | 10-Hydroxycarbazepine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60035-3.json |
| 60036-1 | 1-Naphthol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60036-1.json |
| 60037-9 | 1-Naphthol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60037-9.json |
| 6003-8 | Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6003-8.json |
| 60038-7 | 1-Naphthol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60038-7.json |
| 60039-5 | Acebutolol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60039-5.json |
| 60040-3 | Acebutolol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60040-3.json |
| 60041-1 | Acebutolol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60041-1.json |
| 60042-9 | N-acetylprocainamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60042-9.json |
| 60043-7 | Acepromazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60043-7.json |
| 60044-5 | Acepromazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60044-5.json |
| 60045-2 | Acetaldehyde [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60045-2.json |
| 6004-6 | Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/6004-6.json |
| 60046-0 | Acetaldehyde [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60046-0.json |
| 60047-8 | Acetaldehyde [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60047-8.json |
| 60048-6 | Acetaminophen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60048-6.json |
| 60049-4 | Acetaminophen [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60049-4.json |
| 60050-2 | Acetaminophen [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60050-2.json |
| 60051-0 | Acetophenazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60051-0.json |
| 60052-8 | Alphapinene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60052-8.json |
| 6005-3 | Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/6005-3.json |
| 60053-6 | aMILoride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60053-6.json |
| 60054-4 | Amiodarone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60054-4.json |
| 60055-1 | Astemizole [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60055-1.json |
| 60056-9 | Astemizole [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60056-9.json |
| 60057-7 | Bismuth [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/60057-7.json |
| 60058-5 | Bismuth [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60058-5.json |
| 60059-3 | Bismuth [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60059-3.json |
| 60060-1 | Boron [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60060-1.json |
| 6006-1 | Protein C [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/6006-1.json |
| 60061-9 | buPROPion [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60061-9.json |
| 60062-7 | buPROPion [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60062-7.json |
| 60063-5 | buPROPion [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60063-5.json |
| 60064-3 | buPROPion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60064-3.json |
| 60065-0 | Cobalt [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/60065-0.json |
| 60066-8 | Cobalt [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60066-8.json |
| 60067-6 | Cobalt [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60067-6.json |
| 60068-4 | Colchicine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60068-4.json |
| 60069-2 | Dantrolene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60069-2.json |
| 600-7 | Bacteria identified in Blood by Culture | ./2.16.840.1.114222.4.11.1002/600-7.json |
| 60070-0 | Dichlorvos [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60070-0.json |
| 60071-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60071-8.json |
| 60072-6 | Fexofenadine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60072-6.json |
| 60073-4 | Fexofenadine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60073-4.json |
| 60074-2 | Fexofenadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60074-2.json |
| 60075-9 | Finasteride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60075-9.json |
| 60076-7 | Gallium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60076-7.json |
| 60077-5 | Ganciclovir [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60077-5.json |
| 60078-3 | Ganciclovir [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60078-3.json |
| 6007-9 | Protein C [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/6007-9.json |
| 60079-1 | Germanium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60079-1.json |
| 60080-9 | Germanium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60080-9.json |
| 60081-7 | Germanium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60081-7.json |
| 60082-5 | Gold [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60082-5.json |
| 60083-3 | Hydroxybupropion [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60083-3.json |
| 60084-1 | Hydroxybupropion [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60084-1.json |
| 60085-8 | Hydroxybupropion [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60085-8.json |
| 60086-6 | Hydroxybupropion [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60086-6.json |
| 6008-7 | Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6008-7.json |
| 60087-4 | Hyoscyamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60087-4.json |
| 60088-2 | Hyoscyamine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60088-2.json |
| 60089-0 | Indium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60089-0.json |
| 60090-8 | Indium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60090-8.json |
| 60091-6 | Ketoconazole [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60091-6.json |
| 60092-4 | Ketoconazole [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60092-4.json |
| 60093-2 | Ketoprofen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60093-2.json |
| 60094-0 | Ketoprofen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60094-0.json |
| 6009-5 | Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6009-5.json |
| 60095-7 | Loperamide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60095-7.json |
| 60096-5 | Loperamide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60096-5.json |
| 60097-3 | Loratadine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60097-3.json |
| 60098-1 | Loratadine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60098-1.json |
| 60099-9 | Loxapine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60099-9.json |
| 60100-5 | Loxapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60100-5.json |
| 60101-3 | Molybdenum [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/60101-3.json |
| 60102-1 | O-desmethylvenlafaxine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60102-1.json |
| 6010-3 | Protein C inhibitor [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6010-3.json |
| 60103-9 | O-desmethylvenlafaxine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60103-9.json |
| 60104-7 | O-desmethylvenlafaxine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60104-7.json |
| 60105-4 | OLANZapine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60105-4.json |
| 60106-2 | OLANZapine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60106-2.json |
| 60107-0 | OLANZapine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60107-0.json |
| 60108-8 | Oxychlordane [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60108-8.json |
| 60109-6 | Oxychlordane [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60109-6.json |
| 60110-4 | Oxyphenbutazone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60110-4.json |
| 6011-1 | Protein C cofactor [Units/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/6011-1.json |
| 60111-2 | Oxyphenbutazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60111-2.json |
| 60112-0 | Oxipurinol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60112-0.json |
| 60114-6 | PACLitaxel [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60114-6.json |
| 60115-3 | 9-Hydroxyrisperidone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60115-3.json |
| 60116-1 | 9-Hydroxyrisperidone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60116-1.json |
| 60117-9 | Palladium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60117-9.json |
| 60118-7 | Palladium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60118-7.json |
| 60119-5 | Palladium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60119-5.json |
| 60120-3 | Palladium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60120-3.json |
| 60121-1 | Pancuronium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60121-1.json |
| 60122-9 | Pancuronium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60122-9.json |
| 60123-7 | Pancuronium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60123-7.json |
| 60124-5 | Pancuronium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60124-5.json |
| 60125-2 | Papaverine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60125-2.json |
| 60126-0 | Papaverine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60126-0.json |
| 60127-8 | Paramethadione [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60127-8.json |
| 60128-6 | Paramethadione [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60128-6.json |
| 6012-9 | von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6012-9.json |
| 60129-4 | Paraoxon [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60129-4.json |
| 60130-2 | Paraoxon [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60130-2.json |
| 60131-0 | Paraoxon [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60131-0.json |
| 60132-8 | Parathion [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60132-8.json |
| 60133-6 | Parathion [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60133-6.json |
| 60134-4 | Parathion [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60134-4.json |
| 60135-1 | Pargyline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60135-1.json |
| 60136-9 | PARoxetine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60136-9.json |
| 6013-7 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/6013-7.json |
| 60137-7 | PARoxetine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60137-7.json |
| 60138-5 | PARoxetine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60138-5.json |
| 60139-3 | Pemoline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60139-3.json |
| 60140-1 | Penciclovir [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60140-1.json |
| 60141-9 | Penciclovir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60141-9.json |
| 60142-7 | Pendimethalin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60142-7.json |
| 60143-5 | Pendimethalin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60143-5.json |
| 60144-3 | Pendimethalin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60144-3.json |
| 6014-5 | von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation | ./2.16.840.1.114222.4.11.1002/6014-5.json |
| 60145-0 | Pentane [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60145-0.json |
| 60146-8 | Pentane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60146-8.json |
| 60147-6 | Pentane [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60147-6.json |
| 60148-4 | Pentane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60148-4.json |
| 60149-2 | Pentazocine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60149-2.json |
| 601-5 | Fungus identified in Blood by Culture | ./2.16.840.1.114222.4.11.1002/601-5.json |
| 60150-0 | Pentazocine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60150-0.json |
| 60151-8 | PENTobarbital [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60151-8.json |
| 6015-2 | Wattle IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6015-2.json |
| 60152-6 | PENTobarbital [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60152-6.json |
| 60153-4 | PENTobarbital [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60153-4.json |
| 60154-2 | Pentoxifylline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60154-2.json |
| 60155-9 | Pentoxifylline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60155-9.json |
| 60156-7 | Perfluorooctanoate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60156-7.json |
| 60157-5 | Perfluorooctanoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60157-5.json |
| 60158-3 | Pergolide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60158-3.json |
| 60159-1 | Pergolide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60159-1.json |
| 6016-0 | Corticotropin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6016-0.json |
| 60160-9 | Perphenazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60160-9.json |
| 60161-7 | Phenacemide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60161-7.json |
| 60162-5 | Phenacemide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60162-5.json |
| 60163-3 | Phenolphthalein [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60163-3.json |
| 60164-1 | Phensuximide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60164-1.json |
| 60165-8 | Phensuximide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60165-8.json |
| 60166-6 | Platinum [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/60166-6.json |
| 60167-4 | Platinum [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60167-4.json |
| 60168-2 | Platinum [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60168-2.json |
| 60169-0 | Rubidium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60169-0.json |
| 60170-8 | Silicon [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60170-8.json |
| 60171-6 | Silicon [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60171-6.json |
| 60172-4 | Strontium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60172-4.json |
| 60173-2 | Strontium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60173-2.json |
| 60174-0 | Strontium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60174-0.json |
| 60175-7 | Sulfamethizole [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60175-7.json |
| 60176-5 | Sulfamethizole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60176-5.json |
| 60177-3 | Sulfamethizole [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60177-3.json |
| 60178-1 | Tellurium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/60178-1.json |
| 60179-9 | Tellurium [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/60179-9.json |
| 60180-7 | Tellurium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60180-7.json |
| 60181-5 | Tellurium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60181-5.json |
| 60182-3 | Temephos [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60182-3.json |
| 60183-1 | Terazosin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60183-1.json |
| 60184-9 | Terazosin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60184-9.json |
| 60185-6 | Thallium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60185-6.json |
| 6018-6 | House dust Allergopharma IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6018-6.json |
| 60186-4 | Thiethylperazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60186-4.json |
| 60187-2 | Thiethylperazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60187-2.json |
| 60188-0 | Thiethylperazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60188-0.json |
| 60189-8 | Tin [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/60189-8.json |
| 60190-6 | Tin [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/60190-6.json |
| 60191-4 | Tin [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60191-4.json |
| 60192-2 | Topiramate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60192-2.json |
| 60193-0 | Topiramate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60193-0.json |
| 6019-4 | Almond IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6019-4.json |
| 60194-8 | Triamterene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60194-8.json |
| 60195-5 | Trichlormethiazide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60195-5.json |
| 60196-3 | Trichlormethiazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60196-3.json |
| 60197-1 | Triclopyr [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60197-1.json |
| 60198-9 | Trifluralin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60198-9.json |
| 60199-7 | Trifluralin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60199-7.json |
| 60200-3 | Trifluralin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60200-3.json |
| 60201-1 | Salicylates [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60201-1.json |
| 6020-2 | Alternaria alternata IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6020-2.json |
| 60204-5 | Trimethadione [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60204-5.json |
| 60205-2 | Trimethadione [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60205-2.json |
| 60206-0 | Tripelennamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60206-0.json |
| 60207-8 | Vanadium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60207-8.json |
| 60208-6 | Venlafaxine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60208-6.json |
| 60209-4 | Venlafaxine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60209-4.json |
| 6021-0 | Apple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6021-0.json |
| 60210-2 | Venlafaxine [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/60210-2.json |
| 60211-0 | Zolazepam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60211-0.json |
| 60212-8 | Zolazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60212-8.json |
| 60213-6 | Zolazepam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60213-6.json |
| 60214-4 | ZOLMitriptan [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60214-4.json |
| 60215-1 | ZOLMitriptan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60215-1.json |
| 60216-9 | Zomepirac [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60216-9.json |
| 60217-7 | Chloride [Moles/volume] in Mother's milk | ./2.16.840.1.114222.4.11.1002/60217-7.json |
| 60218-5 | Potassium [Moles/volume] in Mother's milk | ./2.16.840.1.114222.4.11.1002/60218-5.json |
| 60220-1 | Sodium [Moles/volume] in Mother's milk | ./2.16.840.1.114222.4.11.1002/60220-1.json |
| 60221-9 | Intrinsic factor IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60221-9.json |
| 60224-3 | Beta-trace protein [Mass/volume] in Nasal fluid | ./2.16.840.1.114222.4.11.1002/60224-3.json |
| 6022-8 | Ascaris sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6022-8.json |
| 602-3 | Bacteria identified in Bone by Aerobe culture | ./2.16.840.1.114222.4.11.1002/602-3.json |
| 6023-6 | Aspergillus amstelodami IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6023-6.json |
| 60238-3 | European Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60238-3.json |
| 60240-9 | Common wasp recombinant (rVes v) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60240-9.json |
| 60242-5 | Ecarin clotting time (ECT) in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/60242-5.json |
| 60243-3 | Matrix metallopeptidase 9 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60243-3.json |
| 6024-4 | Aspergillus flavus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6024-4.json |
| 6025-1 | Aspergillus fumigatus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6025-1.json |
| 60252-4 | MGMT gene methylation [Presence] in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60252-4.json |
| 60254-0 | Parainfluenza virus 1+2+3 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60254-0.json |
| 60255-7 | Neisseria gonorrhoeae rRNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60255-7.json |
| 60256-5 | Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60256-5.json |
| 60257-3 | Bacteria identified in Cornea by Culture | ./2.16.840.1.114222.4.11.1002/60257-3.json |
| 60258-1 | Bacteria identified in Bone marrow by Culture | ./2.16.840.1.114222.4.11.1002/60258-1.json |
| 60259-9 | Adenovirus DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60259-9.json |
| 60260-7 | Chikungunya virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60260-7.json |
| 60261-5 | Coxiella burnetii DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60261-5.json |
| 60262-3 | Dengue virus 1 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60262-3.json |
| 60263-1 | Enterovirus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60263-1.json |
| 60264-9 | Hantavirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/60264-9.json |
| 60265-6 | Human coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60265-6.json |
| 60266-4 | Human metapneumovirus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60266-4.json |
| 60267-2 | Influenza virus C RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60267-2.json |
| 60268-0 | Orientia tsutsugamushi DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60268-0.json |
| 6026-9 | Aspergillus terreus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6026-9.json |
| 60269-8 | Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60269-8.json |
| 60270-6 | Rabies virus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60270-6.json |
| 60271-4 | Respiratory syncytial virus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60271-4.json |
| 60272-2 | Rickettsia typhus group DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60272-2.json |
| 60273-0 | Rotavirus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60273-0.json |
| 60274-8 | Rubella virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60274-8.json |
| 60275-5 | SARS coronavirus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60275-5.json |
| 6027-7 | Aspergillus versicolor IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6027-7.json |
| 60277-1 | Complement C3 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/60277-1.json |
| 60278-9 | Fibrinogen Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/60278-9.json |
| 60279-7 | IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60279-7.json |
| 60280-5 | Emergency department Discharge instructions | ./2.16.840.1.114222.4.11.1002/60280-5.json |
| 60282-1 | ALPRAZolam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60282-1.json |
| 60283-9 | Amitriptyline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60283-9.json |
| 60284-7 | Amobarbital [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60284-7.json |
| 60285-4 | Amoxapine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60285-4.json |
| 60286-2 | Ascorbate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60286-2.json |
| 60287-0 | Benztropine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60287-0.json |
| 60288-8 | Bromazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60288-8.json |
| 60289-6 | Brompheniramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60289-6.json |
| 60290-4 | Caffeine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60290-4.json |
| 60291-2 | carBAMazepine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/60291-2.json |
| 60292-0 | Chloral hydrate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60292-0.json |
| 6029-3 | Aureobasidium pullulans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6029-3.json |
| 60293-8 | chlordiazePOXIDE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60293-8.json |
| 60294-6 | chlorproMAZINE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60294-6.json |
| 60295-3 | Citalopram [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60295-3.json |
| 60296-1 | cloBAZam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60296-1.json |
| 60297-9 | clomiPRAMINE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60297-9.json |
| 60298-7 | cloZAPine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60298-7.json |
| 60299-5 | Cotinine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60299-5.json |
| 60300-1 | Desipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60300-1.json |
| 6030-1 | Budgerigar feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6030-1.json |
| 60301-9 | Disopyramide [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60301-9.json |
| 60302-7 | Doxepin [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60302-7.json |
| 60303-5 | Fenoprofen [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60303-5.json |
| 60304-3 | FLUoxetine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60304-3.json |
| 60305-0 | fluPHENAZine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60305-0.json |
| 60306-8 | fluvoxaMINE [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60306-8.json |
| 60307-6 | hydrOXYzine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60307-6.json |
| 60308-4 | Ibuprofen [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60308-4.json |
| 60309-2 | Imipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60309-2.json |
| 603-1 | Bacteria identified in Burn by Culture | ./2.16.840.1.114222.4.11.1002/603-1.json |
| 60310-0 | Indomethacin [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60310-0.json |
| 60311-8 | Ketoprofen [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60311-8.json |
| 60312-6 | lamoTRIgine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60312-6.json |
| 60313-4 | Maprotiline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60313-4.json |
| 60314-2 | Mefenamate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60314-2.json |
| 60315-9 | Mesoridazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60315-9.json |
| 60316-7 | Methaqualone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60316-7.json |
| 60317-5 | Methotrimeprazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60317-5.json |
| 60318-3 | Mexiletine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60318-3.json |
| 6031-9 | Budgerigar serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6031-9.json |
| 60319-1 | Naproxen [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60319-1.json |
| 60320-9 | Nicotine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60320-9.json |
| 60321-7 | Norclobazam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60321-7.json |
| 60322-5 | Norclomipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60322-5.json |
| 60323-3 | Nordoxepin [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60323-3.json |
| 60324-1 | Nortriptyline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60324-1.json |
| 60325-8 | OLANZapine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60325-8.json |
| 60326-6 | OXcarbazepine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60326-6.json |
| 6032-7 | Australian pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6032-7.json |
| 60327-4 | PARoxetine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60327-4.json |
| 60328-2 | Pentazocine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60328-2.json |
| 60329-0 | Promazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60329-0.json |
| 60330-8 | Propoxyphene [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60330-8.json |
| 60331-6 | Propranolol [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60331-6.json |
| 60332-4 | QUEtiapine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60332-4.json |
| 60333-2 | Sulfamethoxazole [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60333-2.json |
| 60334-0 | Thiocyanate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60334-0.json |
| 6033-5 | Avocado IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6033-5.json |
| 60335-7 | traZODone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60335-7.json |
| 60336-5 | Trimipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60336-5.json |
| 60337-3 | Venlafaxine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60337-3.json |
| 60338-1 | Warfarin [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60338-1.json |
| 60339-9 | Zopiclone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/60339-9.json |
| 6034-3 | Bahia grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6034-3.json |
| 60347-2 | Viable CD34 cells [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60347-2.json |
| 60348-0 | Almond IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60348-0.json |
| 60349-8 | Apple IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60349-8.json |
| 6035-0 | Banana IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6035-0.json |
| 60350-6 | Apricot IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60350-6.json |
| 60351-4 | Artichoke IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60351-4.json |
| 60352-2 | Banana IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60352-2.json |
| 60353-0 | Green Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60353-0.json |
| 60354-8 | Red Kidney Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60354-8.json |
| 60355-5 | Pinto Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60355-5.json |
| 60356-3 | Broccoli IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60356-3.json |
| 60357-1 | Brussel Sprouts IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60357-1.json |
| 60358-9 | Cabbage IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60358-9.json |
| 60359-7 | Cantaloupe IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60359-7.json |
| 60360-5 | Carrot IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60360-5.json |
| 60361-3 | Cauliflower IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60361-3.json |
| 60362-1 | Asparagus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60362-1.json |
| 60363-9 | Celery IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60363-9.json |
| 60364-7 | Cheese mold type IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60364-7.json |
| 60365-4 | Cherry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60365-4.json |
| 60366-2 | Chili Pepper IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60366-2.json |
| 60367-0 | Cinnamon IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60367-0.json |
| 60368-8 | Clam IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60368-8.json |
| 60369-6 | Clove IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60369-6.json |
| 60370-4 | Crab IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60370-4.json |
| 60371-2 | Cucumber IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60371-2.json |
| 60372-0 | Eggplant IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60372-0.json |
| 60373-8 | Flounder IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60373-8.json |
| 60374-6 | Garlic IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60374-6.json |
| 60375-3 | Ginger IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60375-3.json |
| 6037-6 | Barley IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6037-6.json |
| 60376-1 | Grape IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60376-1.json |
| 60377-9 | Grapefruit IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60377-9.json |
| 60378-7 | Haddock IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60378-7.json |
| 60379-5 | Halibut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60379-5.json |
| 60380-3 | Lamb IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60380-3.json |
| 60381-1 | Lemon IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60381-1.json |
| 60382-9 | Lime IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60382-9.json |
| 60383-7 | Lobster IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60383-7.json |
| 6038-4 | American Beech IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6038-4.json |
| 60384-5 | Mustard IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60384-5.json |
| 60385-2 | Nutmeg IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60385-2.json |
| 60387-8 | Oregano IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60387-8.json |
| 60388-6 | Oyster IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60388-6.json |
| 60389-4 | Pea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60389-4.json |
| 60390-2 | Peach IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60390-2.json |
| 60391-0 | Pear IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60391-0.json |
| 6039-2 | Beef IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6039-2.json |
| 60392-8 | Black Pepper IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60392-8.json |
| 60393-6 | Green Pepper IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60393-6.json |
| 60394-4 | Pineapple IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60394-4.json |
| 60395-1 | Plum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60395-1.json |
| 60396-9 | Sweet potato IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60396-9.json |
| 60397-7 | Radish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60397-7.json |
| 60398-5 | Avocado IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60398-5.json |
| 60399-3 | Sage IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60399-3.json |
| 6040-0 | House dust Bencard IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6040-0.json |
| 60400-9 | Salmon IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60400-9.json |
| 60401-7 | Scallop IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60401-7.json |
| 60402-5 | Sesame Seed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60402-5.json |
| 60403-3 | Shrimp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60403-3.json |
| 60404-1 | Red Snapper IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60404-1.json |
| 60405-8 | Sole IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60405-8.json |
| 60406-6 | Spinach IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60406-6.json |
| 60407-4 | Sunflower Seed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60407-4.json |
| 60408-2 | Mandarin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60408-2.json |
| 60409-0 | Trout IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60409-0.json |
| 60410-8 | Tuna IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60410-8.json |
| 60411-6 | Turkey IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60411-6.json |
| 60412-4 | Vanilla IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60412-4.json |
| 60413-2 | Brewer's yeast IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60413-2.json |
| 60414-0 | Zucchini IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60414-0.json |
| 60415-7 | Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60415-7.json |
| 60416-5 | Parainfluenza virus 3 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60416-5.json |
| 60417-3 | Parainfluenza virus 2 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60417-3.json |
| 6041-8 | Bermuda grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6041-8.json |
| 60418-1 | Dengue virus 4 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60418-1.json |
| 60419-9 | Dengue virus 3 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60419-9.json |
| 60420-7 | Dengue virus 2 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60420-7.json |
| 60421-5 | Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60421-5.json |
| 60422-3 | Measles virus genotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60422-3.json |
| 60424-9 | Parainfluenza virus 4 Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/60424-9.json |
| 60425-6 | Human metapneumovirus Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/60425-6.json |
| 6042-6 | Beta lactoglobulin MF77 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6042-6.json |
| 60426-4 | SARS coronavirus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/60426-4.json |
| 60427-2 | Norovirus RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60427-2.json |
| 60428-0 | Toxoplasma gondii IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/60428-0.json |
| 60429-8 | Enterovirus 71 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60429-8.json |
| 60430-6 | Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60430-6.json |
| 60433-0 | Leukocytes by Light microscopy in Urine sediment collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/60433-0.json |
| 60438-9 | Diamine oxidase [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60438-9.json |
| 60440-5 | Oseltamivir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/60440-5.json |
| 60441-3 | Oseltamivir+Zanamivir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/60441-3.json |
| 6044-2 | Black Ant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6044-2.json |
| 60457-9 | CD4+ CD26- Cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/60457-9.json |
| 6045-9 | Black Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6045-9.json |
| 60459-5 | Complement C6.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60459-5.json |
| 60461-1 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60461-1.json |
| 60462-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60462-9.json |
| 60463-7 | Insulin Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60463-7.json |
| 60465-2 | Neisseria meningitidis serogroup w135 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/60465-2.json |
| 60466-0 | Neisseria meningitidis serogroup Y IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/60466-0.json |
| 6046-7 | Black Walnut Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6046-7.json |
| 60467-8 | oxyMORphone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60467-8.json |
| 60468-6 | PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/60468-6.json |
| 60469-4 | Urate [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/60469-4.json |
| 60470-2 | Toxocara canis Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60470-2.json |
| 60471-0 | busPIRone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60471-0.json |
| 60472-8 | Complement C5.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60472-8.json |
| 60474-4 | Reticulocytes [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/60474-4.json |
| 6047-5 | Bloodworm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6047-5.json |
| 60475-1 | Serotonin release 0.2 IU/mL heparin.low molecular weight [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/60475-1.json |
| 6048-3 | Blue mussel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6048-3.json |
| 60485-0 | Interferon gamma [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/60485-0.json |
| 60486-8 | MED12 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60486-8.json |
| 60487-6 | NPHP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60487-6.json |
| 60488-4 | NPHS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60488-4.json |
| 60489-2 | Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60489-2.json |
| 604-9 | Bacteria identified in Bronchial specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/604-9.json |
| 60490-0 | UMOD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60490-0.json |
| 6049-1 | Botrytis cinerea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6049-1.json |
| 60491-8 | LCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60491-8.json |
| 60492-6 | Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60492-6.json |
| 60493-4 | Calcidiol+Calciferol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60493-4.json |
| 60495-9 | MAP2K1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60495-9.json |
| 60496-7 | MAP2K2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60496-7.json |
| 60497-5 | SLC22A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60497-5.json |
| 6050-9 | Brazil Nut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6050-9.json |
| 60514-7 | 6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/60514-7.json |
| 60515-4 | CT Colon and Rectum W air contrast PR | ./2.16.840.1.114222.4.11.1002/60515-4.json |
| 6051-7 | Brewer's yeast IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6051-7.json |
| 60517-0 | Iron/Transferrin [Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60517-0.json |
| 60518-8 | Creatinine [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/60518-8.json |
| 60519-6 | Fatty acids.ethyl esters [Moles/mass] in Meconium | ./2.16.840.1.114222.4.11.1002/60519-6.json |
| 60521-2 | Babesia microti IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/60521-2.json |
| 60522-0 | Borrelia hermsii IgG+IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/60522-0.json |
| 60523-8 | Carbromal [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60523-8.json |
| 6052-5 | Broccoli IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6052-5.json |
| 60525-3 | Parechovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60525-3.json |
| 60527-9 | NM Thyroid gland Views and Views uptake W I-123 PO | ./2.16.840.1.114222.4.11.1002/60527-9.json |
| 60528-7 | Enterovirus subtype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60528-7.json |
| 60529-5 | Influenza virus A H1 2009 pandemic Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/60529-5.json |
| 60530-3 | Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60530-3.json |
| 60531-1 | Japanese encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/60531-1.json |
| 60532-9 | Japanese encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/60532-9.json |
| 6053-3 | Brome IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6053-3.json |
| 60533-7 | Mycoplasma pneumoniae Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/60533-7.json |
| 60534-5 | SARS coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60534-5.json |
| 60535-2 | Doripenem [Susceptibility] | ./2.16.840.1.114222.4.11.1002/60535-2.json |
| 60537-8 | CLCN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60537-8.json |
| 60538-6 | Influenza virus A H1+H3+B RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60538-6.json |
| 60539-4 | Tryptase.beta [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60539-4.json |
| 60540-2 | HBA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60540-2.json |
| 6054-1 | Buckwheat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6054-1.json |
| 60541-0 | Cytomegalovirus early Ag [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/60541-0.json |
| 60544-4 | Giardia lamblia DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60544-4.json |
| 60545-1 | Cryptosporidium sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/60545-1.json |
| 60546-9 | Polio virus identified [Type] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/60546-9.json |
| 60547-7 | 11-Oxo-Androsterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/60547-7.json |
| 60548-5 | 11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/60548-5.json |
| 60550-1 | Fascin [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/60550-1.json |
| 60551-9 | Interferon.beta 1a Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60551-9.json |
| 60552-7 | Interferon.beta 1b Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/60552-7.json |
| 60553-5 | Trypanosoma cruzi Ab [Presence] in Serum from Donor | ./2.16.840.1.114222.4.11.1002/60553-5.json |
| 605-6 | Bacteria identified in Cannula specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/605-6.json |
| 6056-6 | Bumble Bee IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6056-6.json |
| 60568-3 | Pathology synoptic report | ./2.16.840.1.114222.4.11.1002/60568-3.json |
| 60570-9 | Pathology Consult note | ./2.16.840.1.114222.4.11.1002/60570-9.json |
| 60571-7 | Pathology Consult note.synoptic | ./2.16.840.1.114222.4.11.1002/60571-7.json |
| 60572-5 | Report template ID | ./2.16.840.1.114222.4.11.1002/60572-5.json |
| 6057-4 | Chamomile IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6057-4.json |
| 60574-1 | Report template version ID | ./2.16.840.1.114222.4.11.1002/60574-1.json |
| 60575-8 | HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60575-8.json |
| 60577-4 | SERPINE1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60577-4.json |
| 60578-2 | TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60578-2.json |
| 60579-0 | TCRG gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60579-0.json |
| 60580-8 | TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60580-8.json |
| 60581-6 | TCRB gene rearrangements [Presence] in Body fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60581-6.json |
| 6058-2 | Canary grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6058-2.json |
| 60582-4 | TCRB gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60582-4.json |
| 60583-2 | TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60583-2.json |
| 60584-0 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/60584-0.json |
| 6059-0 | Candida albicans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6059-0.json |
| 6060-8 | Careless Weed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6060-8.json |
| 6061-6 | Carrot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6061-6.json |
| 6062-4 | Casein IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6062-4.json |
| 6063-2 | Castor Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6063-2.json |
| 606-4 | Bacteria identified in Cerebral spinal fluid by Culture | ./2.16.840.1.114222.4.11.1002/606-4.json |
| 6065-7 | Celery IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6065-7.json |
| 6066-5 | Acremonium sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6066-5.json |
| 6067-3 | Cheese cheddar type IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6067-3.json |
| 60676-4 | Ethyl sulfate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60676-4.json |
| 60677-2 | Alpha hydroxytriazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/60677-2.json |
| 60678-0 | Protein/Creatinine [Mass Ratio] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/60678-0.json |
| 6068-1 | Cheese mold type IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6068-1.json |
| 6069-9 | Chestnut Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6069-9.json |
| 6070-7 | Chicken feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6070-7.json |
| 6071-5 | Chicken meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6071-5.json |
| 607-2 | Bacteria identified in Drain by Aerobe culture | ./2.16.840.1.114222.4.11.1002/607-2.json |
| 6072-3 | Chloramin T IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6072-3.json |
| 6073-1 | Chocolate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6073-1.json |
| 60738-2 | Intraluminal [Pressure] Esophagus | ./2.16.840.1.114222.4.11.1002/60738-2.json |
| 60739-0 | Expiration [Time] Respiratory system | ./2.16.840.1.114222.4.11.1002/60739-0.json |
| 60740-8 | Inspiration [Time] Respiratory system | ./2.16.840.1.114222.4.11.1002/60740-8.json |
| 60741-6 | Desflurane target [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60741-6.json |
| 60744-0 | Gas delivery system inspiratory Desflurane setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60744-0.json |
| 60746-5 | Desflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/60746-5.json |
| 60747-3 | Desflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60747-3.json |
| 60748-1 | Desflurane gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60748-1.json |
| 6074-9 | Chymopapain IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6074-9.json |
| 60749-9 | Target enflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60749-9.json |
| 60752-3 | Gas delivery system inspiratory Enflurane setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60752-3.json |
| 60754-9 | Enflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/60754-9.json |
| 60755-6 | Enflurane gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60755-6.json |
| 6075-6 | Cladosporium herbarum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6075-6.json |
| 60756-4 | Target halothane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60756-4.json |
| 60759-8 | Gas delivery system inspiratory Halothane setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60759-8.json |
| 60761-4 | Halothane [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/60761-4.json |
| 60762-2 | Halothane gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60762-2.json |
| 60763-0 | Target isoflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60763-0.json |
| 6076-4 | Clam IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6076-4.json |
| 60766-3 | Gas delivery system inspiratory Isoflurane setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60766-3.json |
| 60768-9 | Isoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/60768-9.json |
| 60769-7 | Isoflurane gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60769-7.json |
| 6077-2 | Cocklebur IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6077-2.json |
| 60773-9 | Gas delivery system inspiratory Nitrous oxide setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60773-9.json |
| 60775-4 | Nitrous oxide gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60775-4.json |
| 60776-2 | Target sevoflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60776-2.json |
| 60779-6 | Gas delivery system inspiratory Sevoflurane setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60779-6.json |
| 6078-0 | Cockroach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6078-0.json |
| 60781-2 | Sevoflurane [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60781-2.json |
| 60782-0 | Sevoflurane gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60782-0.json |
| 60786-1 | Gas delivery system inspiratory Carbon dioxide setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60786-1.json |
| 60789-5 | Carbon dioxide gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60789-5.json |
| 60790-3 | Carbon dioxide gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/60790-3.json |
| 60792-9 | Expiratory gas flow Respiratory system airway --on ventilator | ./2.16.840.1.114222.4.11.1002/60792-9.json |
| 60796-0 | Target oxygen [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60796-0.json |
| 60799-4 | Gas delivery system inspiratory Oxygen setting [VFr/PPres] | ./2.16.840.1.114222.4.11.1002/60799-4.json |
| 608-0 | Bacteria identified in Ear by Aerobe culture | ./2.16.840.1.114222.4.11.1002/608-0.json |
| 60801-8 | Trapped lung volume --at end expiration | ./2.16.840.1.114222.4.11.1002/60801-8.json |
| 60805-9 | Desflurane [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60805-9.json |
| 6080-6 | Cocoa IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6080-6.json |
| 60807-5 | Sevoflurane [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60807-5.json |
| 60808-3 | Carbon dioxide [VFr/PPres] in Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60808-3.json |
| 60809-1 | Carbon dioxide [VFr/PPres] in Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60809-1.json |
| 60812-5 | Helium [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60812-5.json |
| 60813-3 | Helium [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60813-3.json |
| 6081-4 | Coconut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6081-4.json |
| 60817-4 | Gastric-arterial pCO2 gap | ./2.16.840.1.114222.4.11.1002/60817-4.json |
| 60818-2 | Gastric-end tidal pCO2 gap | ./2.16.840.1.114222.4.11.1002/60818-2.json |
| 60819-0 | Gastric mucosal pCO2 | ./2.16.840.1.114222.4.11.1002/60819-0.json |
| 60821-6 | Apnea duration | ./2.16.840.1.114222.4.11.1002/60821-6.json |
| 6082-2 | Codfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6082-2.json |
| 60828-1 | Compliance.static Lung | ./2.16.840.1.114222.4.11.1002/60828-1.json |
| 60829-9 | Pressure.plateau Respiratory system airway | ./2.16.840.1.114222.4.11.1002/60829-9.json |
| 6083-0 | Coffee IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6083-0.json |
| 60830-7 | Finger temperature | ./2.16.840.1.114222.4.11.1002/60830-7.json |
| 60833-1 | Toe temperature | ./2.16.840.1.114222.4.11.1002/60833-1.json |
| 60834-9 | Blood temperature | ./2.16.840.1.114222.4.11.1002/60834-9.json |
| 60835-6 | Arterial blood temperature | ./2.16.840.1.114222.4.11.1002/60835-6.json |
| 60836-4 | Esophageal temperature | ./2.16.840.1.114222.4.11.1002/60836-4.json |
| 60837-2 | Injectate temperature | ./2.16.840.1.114222.4.11.1002/60837-2.json |
| 60838-0 | Nasopharyngeal temperature | ./2.16.840.1.114222.4.11.1002/60838-0.json |
| 60839-8 | Skin temperature --in microenvironment | ./2.16.840.1.114222.4.11.1002/60839-8.json |
| 60840-6 | Base excess in Extracellular fluid by calculation | ./2.16.840.1.114222.4.11.1002/60840-6.json |
| 60842-2 | Oxygen consumption (VO2) | ./2.16.840.1.114222.4.11.1002/60842-2.json |
| 60843-0 | Mean dominant power frequency on EEG | ./2.16.840.1.114222.4.11.1002/60843-0.json |
| 60844-8 | Median power frequency on EEG | ./2.16.840.1.114222.4.11.1002/60844-8.json |
| 60845-5 | Peak power frequency on EEG | ./2.16.840.1.114222.4.11.1002/60845-5.json |
| 6084-8 | Colza IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6084-8.json |
| 60848-9 | Alpha frequency relative power on EEG | ./2.16.840.1.114222.4.11.1002/60848-9.json |
| 60849-7 | Beta frequency relative power on EEG | ./2.16.840.1.114222.4.11.1002/60849-7.json |
| 60850-5 | Delta frequency relative power on EEG | ./2.16.840.1.114222.4.11.1002/60850-5.json |
| 60851-3 | Theta frequency relative power on EEG | ./2.16.840.1.114222.4.11.1002/60851-3.json |
| 60852-1 | Electrical potential Muscle on EMG | ./2.16.840.1.114222.4.11.1002/60852-1.json |
| 60853-9 | Desflurane [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60853-9.json |
| 60854-7 | Enflurane [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60854-7.json |
| 6085-5 | Common Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6085-5.json |
| 60855-4 | Enflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60855-4.json |
| 60856-2 | Halothane [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60856-2.json |
| 60857-0 | Halothane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60857-0.json |
| 60858-8 | Isoflurane [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60858-8.json |
| 60859-6 | Isoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60859-6.json |
| 60860-4 | Nitrous oxide [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/60860-4.json |
| 60861-2 | Nitrous oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/60861-2.json |
| 60862-0 | Nitrous oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60862-0.json |
| 60863-8 | Sevoflurane [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60863-8.json |
| 60864-6 | Sevoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/60864-6.json |
| 60866-1 | Oxygen [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60866-1.json |
| 60867-9 | Oxygen [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60867-9.json |
| 60868-7 | Oxygen/Gas total Gas delivery system --during inspiration | ./2.16.840.1.114222.4.11.1002/60868-7.json |
| 60869-5 | Physiological dead space [Volume] Respiratory system --on ventilator | ./2.16.840.1.114222.4.11.1002/60869-5.json |
| 60870-3 | Physiological dead space/Tidal volume Respiratory system --on ventilator | ./2.16.840.1.114222.4.11.1002/60870-3.json |
| 6087-1 | Corn IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6087-1.json |
| 60873-7 | Anesthetic agent.XXX Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60873-7.json |
| 60874-5 | Anesthetic agent.XXX Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60874-5.json |
| 60876-0 | Desflurane [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60876-0.json |
| 60877-8 | Desflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60877-8.json |
| 60884-4 | Enflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60884-4.json |
| 60885-1 | Enflurane [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60885-1.json |
| 6088-9 | Cultivated Cotton IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6088-9.json |
| 60889-3 | Halothane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60889-3.json |
| 60895-0 | Isoflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60895-0.json |
| 6089-7 | Cottonseed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6089-7.json |
| 60901-6 | Nitrous oxide [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60901-6.json |
| 6090-5 | Cottonwood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6090-5.json |
| 60907-3 | Sevoflurane [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60907-3.json |
| 60908-1 | Sevoflurane [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60908-1.json |
| 6091-3 | Cow dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6091-3.json |
| 60914-9 | Argon [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60914-9.json |
| 60915-6 | Argon [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60915-6.json |
| 60916-4 | Argon [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60916-4.json |
| 60918-0 | Argon [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60918-0.json |
| 60919-8 | Nitrogen [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60919-8.json |
| 60920-6 | Nitrogen [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60920-6.json |
| 6092-1 | Crab IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6092-1.json |
| 60921-4 | Nitrogen [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60921-4.json |
| 60924-8 | Carbon dioxide [VFr/PPres] in Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60924-8.json |
| 60926-3 | Carbon dioxide [VFr/PPres] in Airway adaptor | ./2.16.840.1.114222.4.11.1002/60926-3.json |
| 60932-1 | Helium [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/60932-1.json |
| 60934-7 | Helium [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/60934-7.json |
| 6093-9 | Oat pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6093-9.json |
| 60939-6 | Nitrous oxide [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/60939-6.json |
| 60943-8 | Oxygen [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/60943-8.json |
| 6094-7 | Curvularia lunata IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6094-7.json |
| 60952-9 | Mean airway pressure --during inspiration | ./2.16.840.1.114222.4.11.1002/60952-9.json |
| 6095-4 | American house dust mite IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6095-4.json |
| 60955-2 | Airway temperature | ./2.16.840.1.114222.4.11.1002/60955-2.json |
| 60956-0 | Intracranial pressure (ICP) | ./2.16.840.1.114222.4.11.1002/60956-0.json |
| 60957-8 | Intracranial pressure (ICP) Diastolic | ./2.16.840.1.114222.4.11.1002/60957-8.json |
| 60958-6 | Intracranial pressure (ICP) Mean | ./2.16.840.1.114222.4.11.1002/60958-6.json |
| 60959-4 | Intracranial pressure (ICP) Systolic | ./2.16.840.1.114222.4.11.1002/60959-4.json |
| 60960-2 | ST amplitude.lead AI | ./2.16.840.1.114222.4.11.1002/60960-2.json |
| 60961-0 | ST amplitude.lead AS | ./2.16.840.1.114222.4.11.1002/60961-0.json |
| 6096-2 | European house dust mite IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6096-2.json |
| 60962-8 | ST amplitude.derived lead V1 | ./2.16.840.1.114222.4.11.1002/60962-8.json |
| 60963-6 | ST amplitude.derived lead V2 | ./2.16.840.1.114222.4.11.1002/60963-6.json |
| 60964-4 | ST amplitude.derived lead V3 | ./2.16.840.1.114222.4.11.1002/60964-4.json |
| 60965-1 | ST amplitude.derived lead V4 | ./2.16.840.1.114222.4.11.1002/60965-1.json |
| 60966-9 | ST amplitude.derived lead V5 | ./2.16.840.1.114222.4.11.1002/60966-9.json |
| 60967-7 | ST amplitude.derived lead V6 | ./2.16.840.1.114222.4.11.1002/60967-7.json |
| 60968-5 | ST amplitude.lead ES | ./2.16.840.1.114222.4.11.1002/60968-5.json |
| 60969-3 | ST amplitude.lead MCL | ./2.16.840.1.114222.4.11.1002/60969-3.json |
| 6097-0 | Dandelion IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6097-0.json |
| 60970-1 | ST amplitude.lead MCL1 | ./2.16.840.1.114222.4.11.1002/60970-1.json |
| 60971-9 | ST amplitude.lead MCL6 | ./2.16.840.1.114222.4.11.1002/60971-9.json |
| 60973-5 | Left ventricular Pre ejection Time | ./2.16.840.1.114222.4.11.1002/60973-5.json |
| 60974-3 | Left ventricular Ejection Time | ./2.16.840.1.114222.4.11.1002/60974-3.json |
| 609-8 | Bacteria identified in Eye by Aerobe culture | ./2.16.840.1.114222.4.11.1002/609-8.json |
| 60981-8 | Aorta blood pressure | ./2.16.840.1.114222.4.11.1002/60981-8.json |
| 60982-6 | Aorta Diastolic blood pressure | ./2.16.840.1.114222.4.11.1002/60982-6.json |
| 60983-4 | Aorta Mean blood pressure | ./2.16.840.1.114222.4.11.1002/60983-4.json |
| 60984-2 | Aorta Systolic blood pressure | ./2.16.840.1.114222.4.11.1002/60984-2.json |
| 60985-9 | Central venous pressure (CVP) | ./2.16.840.1.114222.4.11.1002/60985-9.json |
| 60986-7 | Central venous pressure (CVP) Diastolic | ./2.16.840.1.114222.4.11.1002/60986-7.json |
| 60987-5 | Central venous pressure (CVP) Systolic | ./2.16.840.1.114222.4.11.1002/60987-5.json |
| 6098-8 | Dog dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6098-8.json |
| 60988-3 | Left atrial pressure | ./2.16.840.1.114222.4.11.1002/60988-3.json |
| 60989-1 | Left atrial pressure Systolic | ./2.16.840.1.114222.4.11.1002/60989-1.json |
| 60994-1 | Pulmonary artery wedge Diastolic blood pressure | ./2.16.840.1.114222.4.11.1002/60994-1.json |
| 60995-8 | Pulmonary artery wedge Systolic blood pressure | ./2.16.840.1.114222.4.11.1002/60995-8.json |
| 6099-6 | Dog epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6099-6.json |
| 60996-6 | Right atrial pressure | ./2.16.840.1.114222.4.11.1002/60996-6.json |
| 60997-4 | Right atrial pressure Diastolic | ./2.16.840.1.114222.4.11.1002/60997-4.json |
| 60998-2 | Right atrial pressure Systolic | ./2.16.840.1.114222.4.11.1002/60998-2.json |
| 6100-2 | Duck feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6100-2.json |
| 61002-2 | Umbilical artery blood pressure | ./2.16.840.1.114222.4.11.1002/61002-2.json |
| 61003-0 | Umbilical vein Diastolic blood pressure | ./2.16.840.1.114222.4.11.1002/61003-0.json |
| 61004-8 | Umbilical vein Mean blood pressure | ./2.16.840.1.114222.4.11.1002/61004-8.json |
| 61005-5 | Umbilical vein Systolic blood pressure | ./2.16.840.1.114222.4.11.1002/61005-5.json |
| 61008-9 | Body surface temperature | ./2.16.840.1.114222.4.11.1002/61008-9.json |
| 61009-7 | Myocardial temperature | ./2.16.840.1.114222.4.11.1002/61009-7.json |
| 6101-0 | Duck meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6101-0.json |
| 61011-3 | Umbilical vein blood pressure | ./2.16.840.1.114222.4.11.1002/61011-3.json |
| 61017-0 | Cerebral perfusion pressure | ./2.16.840.1.114222.4.11.1002/61017-0.json |
| 61018-8 | Oxygen [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/61018-8.json |
| 61019-6 | Enflurane [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/61019-6.json |
| 61020-4 | Halothane [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/61020-4.json |
| 61021-2 | Halothane [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/61021-2.json |
| 61022-0 | Desflurane gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61022-0.json |
| 61023-8 | Enflurane gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61023-8.json |
| 61024-6 | Halothane gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61024-6.json |
| 61025-3 | Isoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61025-3.json |
| 61026-1 | Nitrous oxide gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61026-1.json |
| 61027-9 | Sevoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/61027-9.json |
| 61029-5 | 7-Aminoclonazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61029-5.json |
| 61030-3 | 7-Aminoclonazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61030-3.json |
| 61031-1 | 7-Aminoclonazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61031-1.json |
| 61032-9 | 7-Aminoflunitrazepam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61032-9.json |
| 61033-7 | 7-Aminoflunitrazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61033-7.json |
| 61034-5 | 7-Aminoflunitrazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61034-5.json |
| 61035-2 | Alpha hydroxyalprazolam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61035-2.json |
| 6103-6 | Echinococcus sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6103-6.json |
| 61036-0 | Alpha hydroxyalprazolam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61036-0.json |
| 61037-8 | Alpha hydroxyalprazolam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61037-8.json |
| 61038-6 | ALPRAZolam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61038-6.json |
| 61039-4 | clonazePAM [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61039-4.json |
| 61040-2 | N-desalkylflurazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61040-2.json |
| 61041-0 | N-desalkylflurazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61041-0.json |
| 61042-8 | fentaNYL [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61042-8.json |
| 61043-6 | Ketamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61043-6.json |
| 61044-4 | LORazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61044-4.json |
| 61045-1 | Methylenedioxyamphetamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61045-1.json |
| 61046-9 | Methylenedioxyamphetamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61046-9.json |
| 61047-7 | Methylenedioxyethylamphetamine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61047-7.json |
| 61048-5 | Methylenedioxyethylamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61048-5.json |
| 61049-3 | Methylenedioxyethylamphetamine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61049-3.json |
| 61050-1 | Methylphenidate [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61050-1.json |
| 6105-1 | Eel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6105-1.json |
| 61051-9 | Nordiazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61051-9.json |
| 61052-7 | Norfentanyl [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61052-7.json |
| 61053-5 | Norfentanyl [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61053-5.json |
| 61054-3 | Normeperidine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61054-3.json |
| 61055-0 | Oxazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61055-0.json |
| 61056-8 | Pseudoephedrine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61056-8.json |
| 61057-6 | Pseudoephedrine [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61057-6.json |
| 61058-4 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61058-4.json |
| 61059-2 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61059-2.json |
| 610-6 | Bacteria identified in Body fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/610-6.json |
| 61060-0 | Temazepam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/61060-0.json |
| 61061-8 | Temazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61061-8.json |
| 61062-6 | Carboxy tetrahydrocannabinol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61062-6.json |
| 61063-4 | Carboxy tetrahydrocannabinol [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61063-4.json |
| 61064-2 | Triazolam [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61064-2.json |
| 61065-9 | Lysergate diethylamide [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61065-9.json |
| 61066-7 | Ethanol [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/61066-7.json |
| 61067-5 | Barbiturates [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/61067-5.json |
| 6106-9 | Egg white IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6106-9.json |
| 61070-9 | 7-Aminoclonazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61070-9.json |
| 61071-7 | 7-Aminoflunitrazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61071-7.json |
| 61072-5 | Alpha hydroxyalprazolam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61072-5.json |
| 61073-3 | ALPRAZolam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61073-3.json |
| 61074-1 | diazePAM [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61074-1.json |
| 61075-8 | diphenhydrAMINE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61075-8.json |
| 61076-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61076-6.json |
| 6107-7 | Egg yolk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6107-7.json |
| 61077-4 | fentaNYL [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61077-4.json |
| 61078-2 | Flunitrazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61078-2.json |
| 61079-0 | Flunitrazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61079-0.json |
| 61080-8 | Flurazepam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61080-8.json |
| 61081-6 | Ketamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61081-6.json |
| 61082-4 | Methylenedioxyethylamphetamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61082-4.json |
| 61083-2 | Methylenedioxymethamphetamine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61083-2.json |
| 61084-0 | Methylphenidate [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61084-0.json |
| 6108-5 | Elder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6108-5.json |
| 61085-7 | Nordiazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61085-7.json |
| 61086-5 | Norfentanyl [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61086-5.json |
| 61087-3 | Normeperidine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61087-3.json |
| 61088-1 | Oxazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61088-1.json |
| 61089-9 | Pseudoephedrine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61089-9.json |
| 61090-7 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61090-7.json |
| 61091-5 | Temazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61091-5.json |
| 61092-3 | Triazolam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61092-3.json |
| 6109-3 | White Elm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6109-3.json |
| 61093-1 | Triazolam [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/61093-1.json |
| 61094-9 | Lysergate diethylamide [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61094-9.json |
| 61095-6 | Ethanol [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/61095-6.json |
| 61098-0 | N-desalkylflurazepam [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61098-0.json |
| 6110-1 | English plantain IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6110-1.json |
| 61101-2 | Influenza virus A neuraminidase RNA [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/61101-2.json |
| 61102-0 | Influenza virus A and B Ag [Identifier] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/61102-0.json |
| 61103-8 | Prochlorperazine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/61103-8.json |
| 61104-6 | Prochlorperazine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/61104-6.json |
| 61105-3 | Prochlorperazine [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/61105-3.json |
| 61106-1 | 16p11.2 chromosome region deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/61106-1.json |
| 61107-9 | SLC25A13 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61107-9.json |
| 61108-7 | Mitochondria DNA complex I targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61108-7.json |
| 61109-5 | Mitochondria DNA complex V targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61109-5.json |
| 61110-3 | ACSL4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61110-3.json |
| 61111-1 | Mitochondria tRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61111-1.json |
| 61113-7 | Immunoglobulin gene rearrangements in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/61113-7.json |
| 61114-5 | Mitochondria DNA complex III targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61114-5.json |
| 61115-2 | Mitochondria DNA complex IV targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61115-2.json |
| 61116-0 | Mitochondria rRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/61116-0.json |
| 61117-8 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immune stain | ./2.16.840.1.114222.4.11.1002/61117-8.json |
| 6111-9 | Epicoccum purpurascens IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6111-9.json |
| 61120-2 | PM-SCL-100 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61120-2.json |
| 6112-7 | Ethylene oxide IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6112-7.json |
| 61127-7 | Whitefish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61127-7.json |
| 61128-5 | Cotinine [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61128-5.json |
| 6113-5 | Gum-Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6113-5.json |
| 61139-2 | Isocyanate TDI IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61139-2.json |
| 611-4 | Bacteria identified in Body fluid by Culture | ./2.16.840.1.114222.4.11.1002/611-4.json |
| 61140-0 | Isocyanate MDI IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61140-0.json |
| 61141-8 | Isocyanate HDI IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61141-8.json |
| 61142-6 | Trimellitic anhydride (TMA) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/61142-6.json |
| 6114-3 | Euroglyphus maynei IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6114-3.json |
| 61143-4 | Nurse Summary note | ./2.16.840.1.114222.4.11.1002/61143-4.json |
| 61146-7 | Goals Narrative | ./2.16.840.1.114222.4.11.1002/61146-7.json |
| 61147-5 | Expected outcomes Narrative | ./2.16.840.1.114222.4.11.1002/61147-5.json |
| 61148-3 | Fluid management note | ./2.16.840.1.114222.4.11.1002/61148-3.json |
| 61149-1 | Objective Narrative | ./2.16.840.1.114222.4.11.1002/61149-1.json |
| 6115-0 | False ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6115-0.json |
| 61150-9 | Subjective Narrative | ./2.16.840.1.114222.4.11.1002/61150-9.json |
| 61151-7 | Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method | ./2.16.840.1.114222.4.11.1002/61151-7.json |
| 61152-5 | Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method | ./2.16.840.1.114222.4.11.1002/61152-5.json |
| 61154-1 | Hepatitis B virus codon L180M [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61154-1.json |
| 61155-8 | Hepatitis B virus codon L80V [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61155-8.json |
| 61156-6 | Hepatitis B virus codon V173L [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61156-6.json |
| 61157-4 | Hepatitis B virus codon M204V [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61157-4.json |
| 61158-2 | Hepatitis B virus codon M204I [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61158-2.json |
| 61159-0 | Hepatitis B virus codon M204S [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61159-0.json |
| 61160-8 | Hepatitis B virus codon A181V [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61160-8.json |
| 61161-6 | Hepatitis B virus codon A181T [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61161-6.json |
| 61162-4 | Hepatitis B virus codon N236T [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61162-4.json |
| 61163-2 | Hepatitis B virus codon A194T [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61163-2.json |
| 61164-0 | Hepatitis B virus codon T184S [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61164-0.json |
| 61165-7 | Hepatitis B virus codon T184I [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61165-7.json |
| 61166-5 | Hepatitis B virus codon S202G [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61166-5.json |
| 61167-3 | Hepatitis B virus codon S202C [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61167-3.json |
| 6116-8 | Ficus sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6116-8.json |
| 61168-1 | Hepatitis B virus codon S202I [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61168-1.json |
| 61169-9 | Hepatitis B virus codon I233V [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61169-9.json |
| 61170-7 | Hepatitis B virus codon M250V [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61170-7.json |
| 61171-5 | Hepatitis B virus codon M250I [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61171-5.json |
| 61172-3 | Hepatitis B virus codon M250L [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61172-3.json |
| 61173-1 | Hepatitis B virus codon L80I [Presence] by Genotype method | ./2.16.840.1.114222.4.11.1002/61173-1.json |
| 61175-6 | Polychlorinated biphenyl.Aroclor 1242 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61175-6.json |
| 6117-6 | Red Imported Fire Ant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6117-6.json |
| 61176-4 | Polychlorinated biphenyl.Aroclor 1248 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61176-4.json |
| 61177-2 | Paraneoplastic Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/61177-2.json |
| 61180-6 | Hemoglobin [Mass/volume] in Blood from Fetus | ./2.16.840.1.114222.4.11.1002/61180-6.json |
| 6118-4 | Firebush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6118-4.json |
| 61189-7 | INR in Platelet poor plasma from Fetus by Coagulation assay | ./2.16.840.1.114222.4.11.1002/61189-7.json |
| 61190-5 | Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assay | ./2.16.840.1.114222.4.11.1002/61190-5.json |
| 61191-3 | aPTT in Platelet poor plasma from Fetus by Coagulation assay | ./2.16.840.1.114222.4.11.1002/61191-3.json |
| 6119-2 | Formaldehyde IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6119-2.json |
| 61195-4 | Albumin [Mass/volume] in Serum or Plasma from Fetus | ./2.16.840.1.114222.4.11.1002/61195-4.json |
| 61196-2 | Albumin [Mass/volume] in Urine from Fetus | ./2.16.840.1.114222.4.11.1002/61196-2.json |
| 61197-0 | oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61197-0.json |
| 61199-6 | HIV 1 integrase gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/61199-6.json |
| 6120-0 | Fusarium culmorum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6120-0.json |
| 61200-2 | Colorado tick fever virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/61200-2.json |
| 61201-0 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab/IgE total in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/61201-0.json |
| 61202-8 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab/IgE total in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/61202-8.json |
| 61203-6 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab/IgE total in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/61203-6.json |
| 61204-4 | Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab/IgE total in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/61204-4.json |
| 61205-1 | Coastal Maple IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61205-1.json |
| 61206-9 | Boxelder IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61206-9.json |
| 61207-7 | Acremonium sp IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61207-7.json |
| 61208-5 | Aedes mosquito IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61208-5.json |
| 61209-3 | Mushroom IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61209-3.json |
| 61210-1 | Onion IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61210-1.json |
| 61211-9 | Garlic IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61211-9.json |
| 61212-7 | Grey Alder IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61212-7.json |
| 61213-5 | Lactalbumin alpha IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61213-5.json |
| 61214-3 | Common Ragweed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61214-3.json |
| 61215-0 | Giant Ragweed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61215-0.json |
| 61216-8 | Pineapple IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61216-8.json |
| 61217-6 | Sweet Vernal grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61217-6.json |
| 6121-8 | Fusarium moniliforme IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6121-8.json |
| 61218-4 | Celery IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61218-4.json |
| 61219-2 | Peanut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61219-2.json |
| 612-2 | Bacterial strain [Type] in Isolate by Bacteria subtyping | ./2.16.840.1.114222.4.11.1002/612-2.json |
| 61220-0 | Ascaris sp IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61220-0.json |
| 61221-8 | Aspergillus niger IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61221-8.json |
| 61222-6 | Aspergillus sp IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61222-6.json |
| 61223-4 | Crawfish IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61223-4.json |
| 61224-2 | Lenscale IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61224-2.json |
| 61225-9 | Aureobasidium pullulans IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61225-9.json |
| 6122-6 | Garlic IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6122-6.json |
| 61226-7 | Oat IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61226-7.json |
| 61227-5 | White Birch IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61227-5.json |
| 61228-3 | Silver Birch IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61228-3.json |
| 61229-1 | Silver Birch recombinant (rBet v) 1 IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61229-1.json |
| 61230-9 | Cockroach IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61230-9.json |
| 61231-7 | Botrytis cinerea IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61231-7.json |
| 61232-5 | Cauliflower IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61232-5.json |
| 61233-3 | Cabbage IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61233-3.json |
| 6123-4 | Geranium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6123-4.json |
| 61234-1 | Broccoli IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61234-1.json |
| 61235-8 | Brome IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61235-8.json |
| 61236-6 | Budgerigar droppings IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61236-6.json |
| 61237-4 | Budgerigar feather IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61237-4.json |
| 61238-2 | Candida albicans IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61238-2.json |
| 61239-0 | Paprika IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61239-0.json |
| 61240-8 | Pecan or Hickory Tree IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61240-8.json |
| 61241-6 | Casein IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61241-6.json |
| 6124-2 | Giant Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6124-2.json |
| 61242-4 | Chaetomium globosum IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61242-4.json |
| 61243-2 | Goosefoot IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61243-2.json |
| 61244-0 | Chick Pea IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61244-0.json |
| 61245-7 | Cinnamon IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61245-7.json |
| 61246-5 | Lemon IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61246-5.json |
| 61247-3 | Grapefruit IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61247-3.json |
| 61248-1 | Orange IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61248-1.json |
| 61249-9 | Cladosporium herbarum IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61249-9.json |
| 61250-7 | Coffee IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61250-7.json |
| 61251-5 | Japanese Cedar IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61251-5.json |
| 61252-3 | Pumpkin Seed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61252-3.json |
| 61253-1 | Arizona Cypress IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61253-1.json |
| 61254-9 | Italian Cypress IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61254-9.json |
| 61255-6 | Bermuda grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61255-6.json |
| 61256-4 | Cocksfoot IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61256-4.json |
| 61257-2 | Dermatophagoides microceras IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61257-2.json |
| 61258-0 | European house dust mite IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61258-0.json |
| 6125-9 | Gluten IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6125-9.json |
| 61259-8 | Whitefaced Hornet IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61259-8.json |
| 61260-6 | Erythromycin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61260-6.json |
| 61261-4 | Gum-Tree IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61261-4.json |
| 61262-2 | Buckwheat IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61262-2.json |
| 61263-0 | American Beech IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61263-0.json |
| 61264-8 | Meadow Fescue IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61264-8.json |
| 61265-5 | Fennel Seed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61265-5.json |
| 61266-3 | Strawberry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61266-3.json |
| 6126-7 | Glycyphagus domesticus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6126-7.json |
| 61267-1 | False ragweed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61267-1.json |
| 61268-9 | Codfish IgG Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61268-9.json |
| 61269-7 | Gelatin IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61269-7.json |
| 61270-5 | Gluten IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61270-5.json |
| 61271-3 | Soybean IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61271-3.json |
| 61272-1 | Sunflower Seed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61272-1.json |
| 61273-9 | Barley IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61273-9.json |
| 61274-7 | House dust Greer IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61274-7.json |
| 6127-5 | Goat epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6127-5.json |
| 61275-4 | Hop IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61275-4.json |
| 61276-2 | Insulin porcine IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61276-2.json |
| 61277-0 | Isocyanate HDI IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61277-0.json |
| 61278-8 | Isocyanate TDI IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61278-8.json |
| 61279-6 | English Walnut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61279-6.json |
| 61280-4 | Lettuce IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61280-4.json |
| 61281-2 | Squid IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61281-2.json |
| 61282-0 | Perennial rye grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61282-0.json |
| 6128-3 | Goldenrod IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6128-3.json |
| 61283-8 | Macadamia IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61283-8.json |
| 61284-6 | Cajeput tree IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61284-6.json |
| 61285-3 | Bass, Black IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61285-3.json |
| 61286-1 | White mulberry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61286-1.json |
| 61287-9 | Banana IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61287-9.json |
| 61288-7 | Basil IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61288-7.json |
| 61289-5 | Trout IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61289-5.json |
| 61290-3 | Oregano IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61290-3.json |
| 6129-1 | Goose feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6129-1.json |
| 61291-1 | Rice IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61291-1.json |
| 61292-9 | Oyster IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61292-9.json |
| 61293-7 | Passion fruit IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61293-7.json |
| 61294-5 | Avocado IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61294-5.json |
| 61295-2 | Parsley IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61295-2.json |
| 61296-0 | Timothy IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61296-0.json |
| 61297-8 | Phthalic anhydride IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61297-8.json |
| 61298-6 | Spruce IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61298-6.json |
| 61299-4 | Eastern White Pine IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61299-4.json |
| 613-0 | Fungal strain [Type] in Isolate by Fungus subtyping | ./2.16.840.1.114222.4.11.1002/613-0.json |
| 61300-0 | Pea IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61300-0.json |
| 61301-8 | English plantain IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61301-8.json |
| 61302-6 | London Plane IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61302-6.json |
| 61303-4 | Kentucky blue grass IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61303-4.json |
| 61304-2 | Cottonwood IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61304-2.json |
| 61305-9 | Mesquite IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61305-9.json |
| 61306-7 | Cherry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61306-7.json |
| 61307-5 | Pear IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61307-5.json |
| 61308-3 | Rhizopus nigricans IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61308-3.json |
| 6130-9 | Goose meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6130-9.json |
| 61309-1 | Sheep Sorrel IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61309-1.json |
| 61310-9 | Willow IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61310-9.json |
| 61311-7 | Saltwort IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61311-7.json |
| 61312-5 | Rye IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61312-5.json |
| 61313-3 | Sesame Seed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61313-3.json |
| 61314-1 | Sheep wool IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61314-1.json |
| 61315-8 | Red Imported Fire Ant IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61315-8.json |
| 61316-6 | Goldenrod IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61316-6.json |
| 6131-7 | Grapefruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6131-7.json |
| 61317-4 | Spinach IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61317-4.json |
| 61318-2 | Dandelion IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61318-2.json |
| 61319-0 | Cocoa IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61319-0.json |
| 61320-8 | Scad IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61320-8.json |
| 61321-6 | Trimellitic anhydride (TMA) IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61321-6.json |
| 61322-4 | White Elm IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61322-4.json |
| 61323-2 | Cranberry IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61323-2.json |
| 61324-0 | Vanilla IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61324-0.json |
| 6132-5 | Green Coffee Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6132-5.json |
| 61325-7 | European Hornet IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61325-7.json |
| 61326-5 | Cocklebur IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61326-5.json |
| 61327-3 | Corn IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61327-3.json |
| 61328-1 | Ginger IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61328-1.json |
| 61329-9 | Cucumber IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61329-9.json |
| 61330-7 | Pine Nut IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61330-7.json |
| 61331-5 | Beef IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61331-5.json |
| 61332-3 | Cow milk IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61332-3.json |
| 6133-3 | Green Nimitti IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6133-3.json |
| 61333-1 | Dog dander IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61333-1.json |
| 61334-9 | Dog epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61334-9.json |
| 61335-6 | Goat milk IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61335-6.json |
| 61336-4 | Cochineal extract IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61336-4.json |
| 61337-2 | Chicken feather IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61337-2.json |
| 61338-0 | Egg white IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61338-0.json |
| 61339-8 | Egg yolk IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61339-8.json |
| 61340-6 | Cottonseed IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61340-6.json |
| 6134-1 | Guinea pig epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6134-1.json |
| 61341-4 | Gerbil epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61341-4.json |
| 61342-2 | Mouse urine proteins IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61342-2.json |
| 61343-0 | Ferret epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61343-0.json |
| 61344-8 | Sheep epithelium IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61344-8.json |
| 61345-5 | Flounder IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61345-5.json |
| 61346-3 | Rat urine proteins IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61346-3.json |
| 61347-1 | Pork IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61347-1.json |
| 61348-9 | Cockatiel droppings IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61348-9.json |
| 61349-7 | Cockatiel feather IgE Ab/IgE total in Serum | ./2.16.840.1.114222.4.11.1002/61349-7.json |
| 61356-2 | Medication pharmaceutical advice.extended Document | ./2.16.840.1.114222.4.11.1002/61356-2.json |
| 61357-0 | Medication pharmaceutical advice.brief Document | ./2.16.840.1.114222.4.11.1002/61357-0.json |
| 6135-8 | Hamster epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6135-8.json |
| 61358-8 | Surgical operation consent Document | ./2.16.840.1.114222.4.11.1002/61358-8.json |
| 61359-6 | Anesthesia consent Document | ./2.16.840.1.114222.4.11.1002/61359-6.json |
| 61360-4 | Acinetobacter baumannii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61360-4.json |
| 61361-2 | Klebsiella aerogenes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61361-2.json |
| 61362-0 | Enterococcus faecalis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61362-0.json |
| 61363-8 | Adenovirus 3+4+7+21 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61363-8.json |
| 61364-6 | Echovirus+Coxsackievirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61364-6.json |
| 61365-3 | Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61365-3.json |
| 6136-6 | Hazelnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6136-6.json |
| 61366-1 | Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61366-1.json |
| 61367-9 | Clostridioides difficile DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61367-9.json |
| 61368-7 | Campylobacter jejuni DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61368-7.json |
| 61369-5 | Listeria monocytogenes DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61369-5.json |
| 61370-3 | Salmonella enterica DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61370-3.json |
| 61371-1 | Vibrio cholerae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61371-1.json |
| 61372-9 | Human papilloma virus 16 DNA [Presence] in Specimen by NAA with probedetection | ./2.16.840.1.114222.4.11.1002/61372-9.json |
| 61373-7 | Human papilloma virus 18 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61373-7.json |
| 6137-4 | Hazelnut Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6137-4.json |
| 61374-5 | Human papilloma virus 26 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61374-5.json |
| 61375-2 | Human papilloma virus 31 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61375-2.json |
| 61376-0 | Human papilloma virus 33 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61376-0.json |
| 61377-8 | Human papilloma virus 35 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61377-8.json |
| 61378-6 | Human papilloma virus 39 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61378-6.json |
| 61379-4 | Human papilloma virus 44 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61379-4.json |
| 61380-2 | Human papilloma virus 45 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61380-2.json |
| 61381-0 | Human papilloma virus 51 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61381-0.json |
| 6138-2 | Setomelanomma rostrata IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6138-2.json |
| 61382-8 | Human papilloma virus 52 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61382-8.json |
| 61383-6 | Human papilloma virus 53 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61383-6.json |
| 61384-4 | Human papilloma virus 58 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61384-4.json |
| 61385-1 | Human papilloma virus 59 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61385-1.json |
| 61386-9 | Human papilloma virus 66 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61386-9.json |
| 61387-7 | Human papilloma virus 67 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61387-7.json |
| 61388-5 | Human papilloma virus 68 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61388-5.json |
| 61389-3 | Human papilloma virus 69 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61389-3.json |
| 6139-0 | Herring IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6139-0.json |
| 61390-1 | Human papilloma virus 70 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61390-1.json |
| 61391-9 | Human papilloma virus 73 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61391-9.json |
| 61392-7 | Human papilloma virus 82 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61392-7.json |
| 61393-5 | Human papilloma virus 6 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61393-5.json |
| 61394-3 | Human papilloma virus 11 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61394-3.json |
| 61395-0 | Human papilloma virus 42 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61395-0.json |
| 61396-8 | Human papilloma virus 56 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61396-8.json |
| 61397-6 | Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61397-6.json |
| 61398-4 | Escherichia coli DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61398-4.json |
| 61399-2 | Klebsiella pneumoniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61399-2.json |
| 61400-8 | Proteus mirabilis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61400-8.json |
| 61401-6 | Pseudomonas aeruginosa DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61401-6.json |
| 61402-4 | Serratia marcescens DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61402-4.json |
| 61403-2 | Stenotrophomonas maltophilia DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61403-2.json |
| 61404-0 | Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61404-0.json |
| 61405-7 | Staphylococcus epidermidis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/61405-7.json |
| 61406-5 | XXX blood group Ab [Titer] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/61406-5.json |
| 61407-3 | Amitriptyline/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61407-3.json |
| 61408-1 | Cyclobenzaprine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61408-1.json |
| 61409-9 | Cyclobenzaprine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61409-9.json |
| 61410-7 | Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61410-7.json |
| 61411-5 | Desipramine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61411-5.json |
| 61412-3 | Desipramine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61412-3.json |
| 61413-1 | Desipramine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61413-1.json |
| 61414-9 | Doxepin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61414-9.json |
| 61415-6 | Doxepin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61415-6.json |
| 6141-6 | Hop IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6141-6.json |
| 61416-4 | Doxepin [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61416-4.json |
| 61417-2 | Imipramine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61417-2.json |
| 61418-0 | Imipramine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61418-0.json |
| 61419-8 | Imipramine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61419-8.json |
| 61420-6 | Norhydrocodone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61420-6.json |
| 61421-4 | Norhydrocodone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61421-4.json |
| 61422-2 | Norhydrocodone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61422-2.json |
| 61423-0 | Noroxycodone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61423-0.json |
| 6142-4 | Hornet venom IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6142-4.json |
| 61424-8 | Noroxycodone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61424-8.json |
| 61425-5 | Noroxycodone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61425-5.json |
| 61426-3 | Nortriptyline/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61426-3.json |
| 61427-1 | Nortriptyline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61427-1.json |
| 61428-9 | Nortriptyline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/61428-9.json |
| 61429-7 | Tapentadol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/61429-7.json |
| 61430-5 | Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/61430-5.json |
| 6143-2 | Horse dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6143-2.json |
| 6144-0 | Horse Fly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6144-0.json |
| 6145-7 | House dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6145-7.json |
| 6147-3 | Insulin bovine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6147-3.json |
| 614-8 | Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping | ./2.16.840.1.114222.4.11.1002/614-8.json |
| 6148-1 | Insulin human IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6148-1.json |
| 6149-9 | Insulin porcine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6149-9.json |
| 6150-7 | Ispaghula laxative IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6150-7.json |
| 6151-5 | Italian Cypress IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6151-5.json |
| 6152-3 | Johnson grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6152-3.json |
| 6153-1 | Kentucky blue grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6153-1.json |
| 6154-9 | Kiwifruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6154-9.json |
| 615-5 | Viral strain [Type] in Isolate by Viral subtyping | ./2.16.840.1.114222.4.11.1002/615-5.json |
| 6155-6 | Lamb IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6155-6.json |
| 6156-4 | Goosefoot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6156-4.json |
| 6158-0 | Latex IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6158-0.json |
| 6159-8 | Lemon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6159-8.json |
| 6160-6 | Lepidoglyphus destructor IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6160-6.json |
| 6161-4 | Lettuce IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6161-4.json |
| 6162-2 | Lilac IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6162-2.json |
| 616-3 | Bacteria identified in Line specimen by IV Line culture | ./2.16.840.1.114222.4.11.1002/616-3.json |
| 6163-0 | Lime Tree (Citrus aurantifolia tree) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6163-0.json |
| 6164-8 | Virginia Live Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6164-8.json |
| 6165-5 | Lobster IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6165-5.json |
| 6166-3 | Malt IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6166-3.json |
| 6167-1 | Mango IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6167-1.json |
| 6168-9 | Maple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6168-9.json |
| 6169-7 | Meadow Fescue IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6169-7.json |
| 6170-5 | Meadow Foxtail IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6170-5.json |
| 617-1 | Bacteria identified in Placenta by Aerobe culture | ./2.16.840.1.114222.4.11.1002/617-1.json |
| 6171-3 | Cajeput tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6171-3.json |
| 6173-9 | Mesquite IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6173-9.json |
| 6174-7 | Milk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6174-7.json |
| 6175-4 | Common Millet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6175-4.json |
| 6176-2 | Mimosa IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6176-2.json |
| 6177-0 | Aedes mosquito IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6177-0.json |
| 6178-8 | Mountain Juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6178-8.json |
| 6179-6 | Mouse epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6179-6.json |
| 6180-4 | Mouse serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6180-4.json |
| 6181-2 | Mouse urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6181-2.json |
| 6182-0 | Mucor racemosus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6182-0.json |
| 6183-8 | Mugwort IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6183-8.json |
| 6185-3 | Mustard IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6185-3.json |
| 6186-1 | Nettle IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6186-1.json |
| 6187-9 | Neurospora sitophila IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6187-9.json |
| 6188-7 | Nutmeg IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6188-7.json |
| 618-9 | Bacteria identified in Pleural fluid by Culture | ./2.16.840.1.114222.4.11.1002/618-9.json |
| 6189-5 | White Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6189-5.json |
| 6190-3 | Oat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6190-3.json |
| 6192-9 | Olive Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6192-9.json |
| 6193-7 | Onion IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6193-7.json |
| 6194-5 | Orange IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6194-5.json |
| 6195-2 | Cocksfoot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6195-2.json |
| 6196-0 | Ox-eye daisy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6196-0.json |
| 619-7 | Bacteria identified in Peritoneal fluid by Culture | ./2.16.840.1.114222.4.11.1002/619-7.json |
| 6197-8 | Paecilomyces sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6197-8.json |
| 6198-6 | Paper wasp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6198-6.json |
| 6199-4 | Pellitory (Parietaria judaica) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6199-4.json |
| 6200-0 | Pellitory (Parietaria officinalis) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6200-0.json |
| 6201-8 | Parrot droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6201-8.json |
| 6202-6 | Parrot feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6202-6.json |
| 6203-4 | Parsley IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6203-4.json |
| 6204-2 | Pea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6204-2.json |
| 620-5 | Bacteria identified in Skin by Aerobe culture | ./2.16.840.1.114222.4.11.1002/620-5.json |
| 6205-9 | Peach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6205-9.json |
| 6206-7 | Peanut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6206-7.json |
| 6207-5 | Pear IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6207-5.json |
| 6208-3 | Pecan or Hickory Nut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6208-3.json |
| 6209-1 | Pecan or Hickory Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6209-1.json |
| 6210-9 | Penicillin V IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6210-9.json |
| 6211-7 | Penicillium brevicompactum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6211-7.json |
| 6212-5 | Penicillium notatum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6212-5.json |
| 621-3 | Bacteria identified in Synovial fluid by Culture | ./2.16.840.1.114222.4.11.1002/621-3.json |
| 6213-3 | Pepper tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6213-3.json |
| 6214-1 | Perch IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6214-1.json |
| 6216-6 | Phoma betae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6216-6.json |
| 6217-4 | Pigeon droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6217-4.json |
| 6218-2 | Pineapple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6218-2.json |
| 6219-0 | Pork IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6219-0.json |
| 62201-9 | XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62201-9.json |
| 62202-7 | XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62202-7.json |
| 62203-5 | t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/62203-5.json |
| 6220-8 | Potato IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6220-8.json |
| 622-1 | Bacteria identified in Sputum by Aerobe culture | ./2.16.840.1.114222.4.11.1002/622-1.json |
| 6221-6 | Primrose IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6221-6.json |
| 6222-4 | Queen Palm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6222-4.json |
| 6223-2 | Rabbit epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6223-2.json |
| 62234-0 | Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method | ./2.16.840.1.114222.4.11.1002/62234-0.json |
| 62235-7 | Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method | ./2.16.840.1.114222.4.11.1002/62235-7.json |
| 62236-5 | Pyridoxal phosphate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62236-5.json |
| 62238-1 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | ./2.16.840.1.114222.4.11.1002/62238-1.json |
| 6224-0 | Rat epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6224-0.json |
| 62244-9 | Platelets [#/volume] in Blood from Fetus by Automated count | ./2.16.840.1.114222.4.11.1002/62244-9.json |
| 6225-7 | Rat serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6225-7.json |
| 62264-7 | Carbon dioxide [VFr/PPres] in Gas delivery system | ./2.16.840.1.114222.4.11.1002/62264-7.json |
| 6226-5 | Rat urine proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6226-5.json |
| 62265-4 | Desflurane [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/62265-4.json |
| 62266-2 | Enflurane [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/62266-2.json |
| 62267-0 | Halothane [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/62267-0.json |
| 62268-8 | Isoflurane [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/62268-8.json |
| 62269-6 | Isoflurane [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/62269-6.json |
| 62270-4 | Isoflurane [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/62270-4.json |
| 62271-2 | Nitrous oxide [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/62271-2.json |
| 62272-0 | Nitrous oxide [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/62272-0.json |
| 6227-3 | Red Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6227-3.json |
| 62274-6 | Oxygen [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/62274-6.json |
| 6228-1 | Red top grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6228-1.json |
| 62290-2 | 1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62290-2.json |
| 62291-0 | 1,25-Dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62291-0.json |
| 62292-8 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62292-8.json |
| 6229-9 | Rhizopus nigricans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6229-9.json |
| 6230-7 | Rice IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6230-7.json |
| 62310-8 | Galactosylceramidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/62310-8.json |
| 6231-5 | Rose Hip IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6231-5.json |
| 62316-5 | Acid sphingomyelinase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/62316-5.json |
| 62320-7 | T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62320-7.json |
| 6232-3 | Rough Marsh Elder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6232-3.json |
| 6233-1 | Rough Pigweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6233-1.json |
| 6234-9 | Saltwort IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6234-9.json |
| 6236-4 | Cultivated Rye IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6236-4.json |
| 6237-2 | Salmon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6237-2.json |
| 62373-6 | Human reference assembly release, UCSC version [Identifier] | ./2.16.840.1.114222.4.11.1002/62373-6.json |
| 6238-0 | Salt grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6238-0.json |
| 62387-6 | Interventions Narrative | ./2.16.840.1.114222.4.11.1002/62387-6.json |
| 62388-4 | Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol | ./2.16.840.1.114222.4.11.1002/62388-4.json |
| 623-9 | Bacteria identified in Sputum by Cystic fibrosis respiratory culture | ./2.16.840.1.114222.4.11.1002/623-9.json |
| 6239-8 | Lenscale IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6239-8.json |
| 6240-6 | Seminal fluid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6240-6.json |
| 6241-4 | Dry-rot Fungus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6241-4.json |
| 62419-7 | Galectin 3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62419-7.json |
| 6242-2 | Sesame Seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6242-2.json |
| 62423-9 | Human coronavirus HKU1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62423-9.json |
| 62424-7 | Human bocavirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62424-7.json |
| 62427-0 | Bordetella holmesii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62427-0.json |
| 62428-8 | Bordetella sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62428-8.json |
| 62429-6 | Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/62429-6.json |
| 6243-0 | Sheep epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6243-0.json |
| 62430-4 | Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62430-4.json |
| 62431-2 | Eastern equine encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62431-2.json |
| 62432-0 | La Crosse virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62432-0.json |
| 62433-8 | La Crosse virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62433-8.json |
| 62434-6 | Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/62434-6.json |
| 62435-3 | Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62435-3.json |
| 62436-1 | West Nile virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/62436-1.json |
| 62443-7 | Single view Teeth Document XR | ./2.16.840.1.114222.4.11.1002/62443-7.json |
| 62446-0 | RFA Renal artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/62446-0.json |
| 62447-8 | RFA Renal artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/62447-8.json |
| 6244-8 | Sheep Sorrel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6244-8.json |
| 62448-6 | RFA Head artery - left and Neck artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/62448-6.json |
| 62449-4 | RFA Head artery - right and Neck artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/62449-4.json |
| 62450-2 | RF Guidance for placement of catheter in Peritoneum | ./2.16.840.1.114222.4.11.1002/62450-2.json |
| 62451-0 | US Extremity - left limited | ./2.16.840.1.114222.4.11.1002/62451-0.json |
| 62452-8 | US Extremity - right limited | ./2.16.840.1.114222.4.11.1002/62452-8.json |
| 62453-6 | Fatty acids.ethyl esters [Moles/mass] in Hair | ./2.16.840.1.114222.4.11.1002/62453-6.json |
| 62454-4 | Herpes simplex virus and Varicella zoster virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/62454-4.json |
| 6245-5 | Sheep wool IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6245-5.json |
| 62455-1 | Coccidioides sp F Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/62455-1.json |
| 62460-1 | Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62460-1.json |
| 62462-7 | Influenza virus A+B RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62462-7.json |
| 6246-3 | Shrimp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6246-3.json |
| 62463-5 | Enterovirus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62463-5.json |
| 62464-3 | Enterovirus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62464-3.json |
| 62465-0 | Toxoplasma gondii DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62465-0.json |
| 62466-8 | BK virus IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62466-8.json |
| 62467-6 | Galactomannan Ag [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/62467-6.json |
| 62468-4 | 1,3 beta glucan [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/62468-4.json |
| 62469-2 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62469-2.json |
| 624-7 | Bacteria identified in Sputum by Respiratory culture | ./2.16.840.1.114222.4.11.1002/624-7.json |
| 62470-0 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62470-0.json |
| 6247-1 | Silk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6247-1.json |
| 62471-8 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62471-8.json |
| 62472-6 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62472-6.json |
| 62473-4 | Herpes simplex virus 1 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62473-4.json |
| 62474-2 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62474-2.json |
| 62475-9 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62475-9.json |
| 62476-7 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62476-7.json |
| 62477-5 | Herpes simplex virus 2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62477-5.json |
| 62478-3 | Aspergillus fumigatus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62478-3.json |
| 62479-1 | Aspergillus terreus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62479-1.json |
| 62480-9 | Adenovirus DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62480-9.json |
| 62481-7 | Herpes virus 6A DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62481-7.json |
| 62482-5 | Herpes virus 6B DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62482-5.json |
| 62483-3 | Herpes virus 6A DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62483-3.json |
| 62484-1 | Herpes virus 6B DNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62484-1.json |
| 62485-8 | Herpes virus 6A DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62485-8.json |
| 62486-6 | Herpes virus 6B DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62486-6.json |
| 62487-4 | Urobilinogen [Presence] in Urine by Automated test strip | ./2.16.840.1.114222.4.11.1002/62487-4.json |
| 62488-2 | Ova1 test [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/62488-2.json |
| 6248-9 | Soybean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6248-9.json |
| 62491-6 | RFA Guidance for placement of prosthesis in Iliac artery - left-- W contrast IA | ./2.16.840.1.114222.4.11.1002/62491-6.json |
| 62492-4 | RFA Guidance for placement of prosthesis in Iliac artery - right-- W contrast IA | ./2.16.840.1.114222.4.11.1002/62492-4.json |
| 62493-2 | Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Streptococcus agalactiae DNA [Identifier] in Unspecified specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62493-2.json |
| 62494-0 | US Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/62494-0.json |
| 6249-7 | Spiny lobster IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6249-7.json |
| 6250-5 | Spiny Pigweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6250-5.json |
| 6251-3 | Sporobolomyces roseus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6251-3.json |
| 6252-1 | Stemphylium botryosum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6252-1.json |
| 6253-9 | Midge stinging IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6253-9.json |
| 625-4 | Bacteria identified in Stool by Culture | ./2.16.840.1.114222.4.11.1002/625-4.json |
| 6254-7 | Acarus siro IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6254-7.json |
| 6256-2 | Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6256-2.json |
| 6257-0 | Strawberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6257-0.json |
| 6258-8 | Sunflower Seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6258-8.json |
| 6259-6 | Chestnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6259-6.json |
| 6260-4 | Sweet gum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6260-4.json |
| 6261-2 | Sweet Vernal grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6261-2.json |
| 626-2 | Bacteria identified in Throat by Culture | ./2.16.840.1.114222.4.11.1002/626-2.json |
| 6262-0 | Swine epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6262-0.json |
| 6263-8 | American Sycamore IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6263-8.json |
| 6264-6 | Tea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6264-6.json |
| 6265-3 | Timothy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6265-3.json |
| 6266-1 | Tomato IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6266-1.json |
| 6267-9 | Trichoderma viride IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6267-9.json |
| 6268-7 | Trout IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6268-7.json |
| 6269-5 | Tulip IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6269-5.json |
| 627-0 | Bacteria identified in Tissue by Aerobe culture | ./2.16.840.1.114222.4.11.1002/627-0.json |
| 6270-3 | Tuna IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6270-3.json |
| 6271-1 | Turkey meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6271-1.json |
| 6272-9 | Velvet grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6272-9.json |
| 6273-7 | Walnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6273-7.json |
| 6274-5 | California Walnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6274-5.json |
| 6275-2 | Western Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6275-2.json |
| 6276-0 | Wheat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6276-0.json |
| 6277-8 | Cultivated Wheat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6277-8.json |
| 6278-6 | White Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6278-6.json |
| 6279-4 | White Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6279-4.json |
| 6280-2 | Whitefaced Hornet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6280-2.json |
| 6281-0 | White mulberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6281-0.json |
| 6282-8 | Eastern White Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6282-8.json |
| 6284-4 | Wild Silk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6284-4.json |
| 62848-7 | Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62848-7.json |
| 62849-5 | Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/62849-5.json |
| 6285-1 | Willow IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6285-1.json |
| 62859-4 | Rotavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62859-4.json |
| 62860-2 | Influenza virus C RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62860-2.json |
| 62861-0 | Enterovirus 71 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/62861-0.json |
| 62862-8 | Microsatellite instability [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/62862-8.json |
| 6286-9 | Wormwood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6286-9.json |
| 6287-7 | Baker's yeast IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6287-7.json |
| 628-8 | Bacteria identified in Tissue by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/628-8.json |
| 6288-5 | Yellow Hornet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6288-5.json |
| 6289-3 | Lysozyme [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6289-3.json |
| 6290-1 | Complement membrane C3b-C4b cofactor protein [Presence] in Leukocytes | ./2.16.840.1.114222.4.11.1002/6290-1.json |
| 6291-9 | Complement iC3b receptors [Presence] in Leukocytes | ./2.16.840.1.114222.4.11.1002/6291-9.json |
| 6292-7 | Complement decay accelerating factor [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/6292-7.json |
| 6293-5 | Complement C4d [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/6293-5.json |
| 62946-9 | Jamestown canyon virus IgM Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/62946-9.json |
| 62947-7 | MPL gene p.Trp515Leu+Trp515Lys+Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/62947-7.json |
| 6295-0 | Complement C3d [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/6295-0.json |
| 6296-8 | Complement C3b-C4b receptor [Presence] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/6296-8.json |
| 6297-6 | Complement C1q Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6297-6.json |
| 6298-4 | Potassium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/6298-4.json |
| 6299-2 | Urea nitrogen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/6299-2.json |
| 6300-8 | Glucose [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/6300-8.json |
| 6301-6 | INR in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/6301-6.json |
| 6303-2 | dRVVT (LA screen) | ./2.16.840.1.114222.4.11.1002/6303-2.json |
| 630-4 | Bacteria identified in Urine by Culture | ./2.16.840.1.114222.4.11.1002/630-4.json |
| 6304-0 | Budgerigar droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6304-0.json |
| 63042-6 | 17-Hydroxyprogesterone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/63042-6.json |
| 63044-2 | Cotinine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/63044-2.json |
| 6305-7 | Plasmodium malariae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6305-7.json |
| 6306-5 | Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6306-5.json |
| 63070-7 | TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/63070-7.json |
| 63072-3 | Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/63072-3.json |
| 6307-3 | Adenovirus rRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/6307-3.json |
| 63075-6 | American house dust mite IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63075-6.json |
| 63076-4 | Cat dander IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63076-4.json |
| 63077-2 | Dog dander IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63077-2.json |
| 63078-0 | Buckwheat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63078-0.json |
| 63079-8 | White Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63079-8.json |
| 63080-6 | Hazelnut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63080-6.json |
| 6308-1 | Adenovirus rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6308-1.json |
| 63081-4 | Brazil Nut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63081-4.json |
| 63082-2 | Cayenne IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63082-2.json |
| 63083-0 | Raspberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63083-0.json |
| 63084-8 | Coconut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63084-8.json |
| 63085-5 | Blue mussel IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63085-5.json |
| 63086-3 | Chub Mackerel IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63086-3.json |
| 63087-1 | Common Millet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63087-1.json |
| 63088-9 | Perch IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63088-9.json |
| 63089-7 | Parmesan Cheese IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63089-7.json |
| 63090-5 | Beta lactoglobulin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63090-5.json |
| 63091-3 | Gluten IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63091-3.json |
| 63092-1 | Cheese cheddar type IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63092-1.json |
| 63093-9 | Kiwifruit IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63093-9.json |
| 63094-7 | Parsley IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63094-7.json |
| 63095-4 | Honeydew melon IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63095-4.json |
| 63096-2 | Mango IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63096-2.json |
| 63097-0 | Cottonseed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63097-0.json |
| 63098-8 | Venison IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63098-8.json |
| 6309-9 | Arbovirus identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6309-9.json |
| 63099-6 | American Cheese IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63099-6.json |
| 63100-2 | Black-eye pea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63100-2.json |
| 63101-0 | Duck meat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63101-0.json |
| 63102-8 | Nectarine IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63102-8.json |
| 63103-6 | Swiss Cheese IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63103-6.json |
| 63104-4 | Cranberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63104-4.json |
| 63105-1 | Rhubarb IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63105-1.json |
| 63106-9 | Lima Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63106-9.json |
| 6310-7 | Arbovirus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6310-7.json |
| 63107-7 | Flax IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63107-7.json |
| 63108-5 | Pecan or Hickory Nut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63108-5.json |
| 63109-3 | Cashew nut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63109-3.json |
| 63110-1 | Pistachio IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63110-1.json |
| 63111-9 | Herring IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63111-9.json |
| 63112-7 | Blackberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63112-7.json |
| 63113-5 | Rabbit IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63113-5.json |
| 63114-3 | Paprika IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63114-3.json |
| 6311-5 | Babesia microti Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6311-5.json |
| 63115-0 | Poppy Seed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63115-0.json |
| 63116-8 | Pumpkin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63116-8.json |
| 63117-6 | Safflower IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63117-6.json |
| 63118-4 | Lentils IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63118-4.json |
| 63119-2 | Honey IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63119-2.json |
| 631-2 | Bacteria identified in Unknown substance by Aerobe culture | ./2.16.840.1.114222.4.11.1002/631-2.json |
| 63120-0 | Walnut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63120-0.json |
| 63121-8 | Squid IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63121-8.json |
| 63122-6 | Eel IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63122-6.json |
| 6312-3 | Bartonella henselae IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6312-3.json |
| 63123-4 | Cumin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63123-4.json |
| 63124-2 | Basil IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63124-2.json |
| 63125-9 | Thyme IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63125-9.json |
| 63126-7 | Fennel Fresh IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63126-7.json |
| 63127-5 | Dill IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63127-5.json |
| 63128-3 | Bayleaf IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63128-3.json |
| 63129-1 | Curry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63129-1.json |
| 63130-9 | Dates IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63130-9.json |
| 6313-1 | Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6313-1.json |
| 63131-7 | Papaya (Carica papaya) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63131-7.json |
| 63132-5 | Chestnut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63132-5.json |
| 63133-3 | Goat milk IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63133-3.json |
| 63134-1 | Sardine (pilchard) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63134-1.json |
| 63135-8 | Chick Pea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63135-8.json |
| 63136-6 | Allspice IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63136-6.json |
| 63137-4 | Crawfish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63137-4.json |
| 63138-2 | Hop IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63138-2.json |
| 63139-0 | Wine vinegar IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63139-0.json |
| 63140-8 | Gelatin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63140-8.json |
| 63141-6 | Yogurt IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63141-6.json |
| 63142-4 | Bass, Black IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63142-4.json |
| 63143-2 | Catfish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63143-2.json |
| 63144-0 | Chicory IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63144-0.json |
| 63145-7 | Gum arabic IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63145-7.json |
| 63146-5 | Karaya gum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63146-5.json |
| 63147-3 | Horseradish IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63147-3.json |
| 63148-1 | Maple syrup IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63148-1.json |
| 6314-9 | Bordetella pertussis Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6314-9.json |
| 63149-9 | Okra IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63149-9.json |
| 63150-7 | Parsnip IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63150-7.json |
| 63151-5 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/63151-5.json |
| 63152-3 | Bermuda grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63152-3.json |
| 63153-1 | Johnson grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63153-1.json |
| 63154-9 | Cultivated Rye IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63154-9.json |
| 63155-6 | Cultivated Wheat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63155-6.json |
| 6315-6 | Bordetella pertussis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/6315-6.json |
| 63156-4 | Bahia grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63156-4.json |
| 63157-2 | House dust Greer IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63157-2.json |
| 63158-0 | House dust Hollister Stier IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63158-0.json |
| 63159-8 | Flea IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63159-8.json |
| 63160-6 | Castor Bean IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63160-6.json |
| 63161-4 | Latex IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63161-4.json |
| 63162-2 | Curvularia lunata IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63162-2.json |
| 63163-0 | Paecilomyces sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63163-0.json |
| 6316-4 | Bordetella pertussis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6316-4.json |
| 63164-8 | Penicillium brevicompactum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63164-8.json |
| 63165-5 | Dry-rot Fungus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63165-5.json |
| 63166-3 | Aspergillus terreus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63166-3.json |
| 63167-1 | Trichophyton mentagrophytes IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63167-1.json |
| 63168-9 | Aspergillus amstelodami IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63168-9.json |
| 63169-7 | Aspergillus nidulans IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63169-7.json |
| 63170-5 | Helminthosporium interseminatum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63170-5.json |
| 63171-3 | Neurospora sitophila IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63171-3.json |
| 6317-2 | Bordetella sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6317-2.json |
| 63172-1 | Mucor plumbeus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63172-1.json |
| 63173-9 | Mycogone perniciosa IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63173-9.json |
| 63174-7 | Spondylocladium sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63174-7.json |
| 63175-4 | Epidermophyton floccosum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63175-4.json |
| 63176-2 | Algae IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63176-2.json |
| 63177-0 | Acremonium sp IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63177-0.json |
| 63178-8 | Chaetomium globosum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63178-8.json |
| 63179-6 | Johnson grass smut IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63179-6.json |
| 6318-0 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6318-0.json |
| 63180-4 | Tobacco IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63180-4.json |
| 63181-2 | Mountain Juniper IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63181-2.json |
| 63182-0 | White Oak IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63182-0.json |
| 63183-8 | Cottonwood IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63183-8.json |
| 63184-6 | White Ash IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63184-6.json |
| 63185-3 | Mesquite IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63185-3.json |
| 63186-1 | Goosefoot IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63186-1.json |
| 63187-9 | Saltwort IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63187-9.json |
| 63188-7 | Cocklebur IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63188-7.json |
| 63189-5 | Rough Pigweed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63189-5.json |
| 63190-3 | Rough Marsh Elder IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63190-3.json |
| 63191-1 | Nettle IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63191-1.json |
| 63192-9 | Yellow Dock IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63192-9.json |
| 63193-7 | Common Sagebrush IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63193-7.json |
| 63194-5 | Alfalfa IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63194-5.json |
| 63195-2 | Sunflower Pollen IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63195-2.json |
| 63196-0 | Alternaria alternata+American house dust mite IgG Ab [Mass/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/63196-0.json |
| 63197-8 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/63197-8.json |
| 6319-8 | Borrelia burgdorferi Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6319-8.json |
| 63198-6 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/63198-6.json |
| 63199-4 | Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/63199-4.json |
| 632-0 | Bacteria identified in Wound by Aerobe culture | ./2.16.840.1.114222.4.11.1002/632-0.json |
| 63200-0 | Goldenrod IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63200-0.json |
| 63201-8 | Red Beet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63201-8.json |
| 63202-6 | White mulberry IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63202-6.json |
| 63203-4 | Smooth Alder IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63203-4.json |
| 63204-2 | Privet IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63204-2.json |
| 63205-9 | Aspen IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63205-9.json |
| 6320-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/6320-6.json |
| 63206-7 | Common Ragweed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63206-7.json |
| 63207-5 | False ragweed IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63207-5.json |
| 63208-3 | Mugwort IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63208-3.json |
| 63209-1 | English plantain IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63209-1.json |
| 63210-9 | Actin smooth muscle Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63210-9.json |
| 63211-7 | Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63211-7.json |
| 63212-5 | Asialoganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63212-5.json |
| 63213-3 | Bactericidal permeability increasing protein Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63213-3.json |
| 6321-4 | Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/6321-4.json |
| 63214-1 | Bactericidal permeability increasing protein Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63214-1.json |
| 63215-8 | Cathepsin G Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63215-8.json |
| 63216-6 | CV2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63216-6.json |
| 63217-4 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63217-4.json |
| 63218-2 | Desmoglein 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63218-2.json |
| 63219-0 | Desmoglein 3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63219-0.json |
| 63220-8 | DNA double strand Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63220-8.json |
| 63221-6 | DNA double strand Ab [Presence] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63221-6.json |
| 6322-2 | Borrelia burgdorferi Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6322-2.json |
| 63222-4 | DNA double strand Ab [Units/volume] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63222-4.json |
| 63223-2 | DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63223-2.json |
| 63224-0 | DNA double strand IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63224-0.json |
| 63225-7 | DNA double strand IgG Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63225-7.json |
| 63226-5 | DNA double strand IgG Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63226-5.json |
| 63227-3 | DNA double strand IgG Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63227-3.json |
| 63228-1 | DNA double strand IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63228-1.json |
| 63229-9 | DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63229-9.json |
| 6323-0 | Borrelia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6323-0.json |
| 63230-7 | DNA double strand IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63230-7.json |
| 63231-5 | DNA double strand IgG Ab [Units/volume] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63231-5.json |
| 63232-3 | DNA double strand IgM Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63232-3.json |
| 63233-1 | DNA double strand IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63233-1.json |
| 63234-9 | DNA double strand IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63234-9.json |
| 63235-6 | DNA double strand IgM Ab [Units/volume] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63235-6.json |
| 63236-4 | DNA double strand IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63236-4.json |
| 63237-2 | DNA double strand IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63237-2.json |
| 63238-0 | Extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63238-0.json |
| 63239-8 | Extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63239-8.json |
| 63240-6 | Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63240-6.json |
| 63241-4 | Ganglioside GM1 IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63241-4.json |
| 63242-2 | Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63242-2.json |
| 63243-0 | Ganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63243-0.json |
| 63244-8 | Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63244-8.json |
| 63245-5 | Ganglioside GM1 IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63245-5.json |
| 63246-3 | Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63246-3.json |
| 63247-1 | Ganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63247-1.json |
| 6324-8 | Brucella abortus Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/6324-8.json |
| 63248-9 | Ganglioside GM2 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63248-9.json |
| 63249-7 | Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63249-7.json |
| 63250-5 | Ganglioside GM2 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63250-5.json |
| 63251-3 | Ganglioside GM3 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63251-3.json |
| 63252-1 | Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63252-1.json |
| 63253-9 | Ganglioside GM3 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63253-9.json |
| 63254-7 | Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63254-7.json |
| 6325-5 | Brucella abortus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6325-5.json |
| 63255-4 | Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63255-4.json |
| 63256-2 | Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63256-2.json |
| 63257-0 | Ganglioside GT1b IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63257-0.json |
| 63258-8 | Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63258-8.json |
| 63259-6 | Ganglioside GT1b IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63259-6.json |
| 63260-4 | Gliadin IgA Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63260-4.json |
| 63261-2 | Gliadin IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63261-2.json |
| 63262-0 | Glomerular basement membrane Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63262-0.json |
| 6326-3 | Brucella abortus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6326-3.json |
| 63263-8 | Histone Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63263-8.json |
| 63264-6 | Histone Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63264-6.json |
| 63265-3 | Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63265-3.json |
| 63266-1 | Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63266-1.json |
| 63267-9 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63267-9.json |
| 63268-7 | Keratin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63268-7.json |
| 63269-5 | Ku Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63269-5.json |
| 63270-3 | Liver kidney microsomal 1 Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63270-3.json |
| 6327-1 | Brucella canis Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6327-1.json |
| 63271-1 | Liver kidney microsomal 1 Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63271-1.json |
| 63272-9 | Liver kidney microsomal 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63272-9.json |
| 63273-7 | Liver kidney microsomal 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63273-7.json |
| 63274-5 | Liver kidney microsomal 2 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63274-5.json |
| 63275-2 | Liver kidney microsomal 2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63275-2.json |
| 63276-0 | Mi-2 Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63276-0.json |
| 63277-8 | Mitochondria Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63277-8.json |
| 63278-6 | Mitochondria Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63278-6.json |
| 63279-4 | Mitochondria Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63279-4.json |
| 63280-2 | Mitochondria Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63280-2.json |
| 63281-0 | Mitochondria M2 Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63281-0.json |
| 63282-8 | Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63282-8.json |
| 63283-6 | Mitochondria M2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63283-6.json |
| 63284-4 | Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63284-4.json |
| 63285-1 | Mitochondria M5 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63285-1.json |
| 63286-9 | Myelin Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63286-9.json |
| 63287-7 | Myelin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63287-7.json |
| 63288-5 | Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63288-5.json |
| 6328-9 | Brucella sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6328-9.json |
| 63289-3 | Myelin associated glycoprotein Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63289-3.json |
| 63290-1 | Myelin associated glycoprotein Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63290-1.json |
| 63291-9 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63291-9.json |
| 63292-7 | Neutrophil cytoplasmic Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63292-7.json |
| 63293-5 | Neutrophil cytoplasmic Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63293-5.json |
| 63294-3 | Nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63294-3.json |
| 63295-0 | Nuclear Ab [Presence] in Cerebral spinal fluid by Hep2 substrate | ./2.16.840.1.114222.4.11.1002/63295-0.json |
| 63296-8 | Nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63296-8.json |
| 6329-7 | Campylobacter coli rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6329-7.json |
| 63297-6 | Nuclear Ab [Titer] in Cerebral spinal fluid by Hep2 substrate | ./2.16.840.1.114222.4.11.1002/63297-6.json |
| 63298-4 | Nucleosome Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63298-4.json |
| 63299-2 | Nucleosome Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63299-2.json |
| 63300-8 | Nucleosome Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63300-8.json |
| 63301-6 | Parathyrin Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63301-6.json |
| 63302-4 | Parathyrin Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63302-4.json |
| 63303-2 | Parietal cell Ab [Presence] in Gastric fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63303-2.json |
| 63304-0 | Parietal cell Ab [Titer] in Gastric fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63304-0.json |
| 6330-5 | Campylobacter sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6330-5.json |
| 63305-7 | PCNA extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63305-7.json |
| 63306-5 | PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63306-5.json |
| 63307-3 | PM-SCL extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63307-3.json |
| 63308-1 | PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63308-1.json |
| 63309-9 | Proteinase 3 Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63309-9.json |
| 63310-7 | Proteinase 3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63310-7.json |
| 63311-5 | Proteinase 3 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63311-5.json |
| 63312-3 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63312-3.json |
| 6331-3 | Campylobacter sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6331-3.json |
| 63313-1 | Rheumatoid factor [Units/volume] in Body fluid by Sheep Cell Agglutination | ./2.16.840.1.114222.4.11.1002/63313-1.json |
| 63314-9 | Rheumatoid factor IgA [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63314-9.json |
| 63315-6 | Rheumatoid factor IgM [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63315-6.json |
| 63316-4 | U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63316-4.json |
| 63317-2 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63317-2.json |
| 63318-0 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63318-0.json |
| 63319-8 | Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63319-8.json |
| 63320-6 | Ribosomal Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63320-6.json |
| 6332-1 | Campylobacter sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6332-1.json |
| 63321-4 | Ribosomal Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63321-4.json |
| 63322-2 | Ribosomal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63322-2.json |
| 63323-0 | Ribosomal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63323-0.json |
| 63324-8 | Ribosomal IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63324-8.json |
| 63325-5 | Ribosomal IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63325-5.json |
| 63326-3 | Ribosomal P Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63326-3.json |
| 63327-1 | Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63327-1.json |
| 63328-9 | RNA polymerase III Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63328-9.json |
| 63329-7 | RNA polymerase III Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63329-7.json |
| 63330-5 | Baker's yeast IgA Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63330-5.json |
| 63331-3 | Baker's yeast IgA Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63331-3.json |
| 63332-1 | Baker's yeast IgG Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63332-1.json |
| 63333-9 | Baker's yeast IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63333-9.json |
| 63334-7 | SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63334-7.json |
| 63335-4 | SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63335-4.json |
| 63336-2 | SCL-70 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63336-2.json |
| 63337-0 | SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63337-0.json |
| 63338-8 | SCL-70 extractable nuclear Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63338-8.json |
| 6333-9 | Campylobacter jejuni rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6333-9.json |
| 63339-6 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63339-6.json |
| 63340-4 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Titer] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63340-4.json |
| 63341-2 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63341-2.json |
| 63342-0 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63342-0.json |
| 63343-8 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63343-8.json |
| 63344-6 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Titer] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63344-6.json |
| 63345-3 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/63345-3.json |
| 63346-1 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63346-1.json |
| 6334-7 | Campylobacter lari rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6334-7.json |
| 63347-9 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63347-9.json |
| 63348-7 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63348-7.json |
| 63349-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63349-5.json |
| 63350-3 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63350-3.json |
| 63351-1 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63351-1.json |
| 63352-9 | Smith extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63352-9.json |
| 63353-7 | Smith extractable nuclear Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63353-7.json |
| 63354-5 | Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63354-5.json |
| 63355-2 | Smooth muscle Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63355-2.json |
| 63356-0 | Smooth muscle Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63356-0.json |
| 63357-8 | Smooth muscle Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63357-8.json |
| 63358-6 | Smooth muscle Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63358-6.json |
| 63359-4 | Thyroglobulin Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63359-4.json |
| 63360-2 | Thyroglobulin Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63360-2.json |
| 63361-0 | Thyroperoxidase Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63361-0.json |
| 63362-8 | Thyroperoxidase Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63362-8.json |
| 63363-6 | Thyrotropin receptor Ab [Units/volume] in Blood from Fetus | ./2.16.840.1.114222.4.11.1002/63363-6.json |
| 63364-4 | Thyrotropin receptor Ab [Units/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/63364-4.json |
| 63365-1 | Thyrotropin receptor Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/63365-1.json |
| 63366-9 | Thyrotropin receptor Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63366-9.json |
| 63367-7 | U1 small nuclear ribonucleoprotein Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63367-7.json |
| 63369-3 | Chronic urticaria index in Serum | ./2.16.840.1.114222.4.11.1002/63369-3.json |
| 6337-0 | Candida albicans Ag [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6337-0.json |
| 63370-1 | Gamma tocopherol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/63370-1.json |
| 63374-3 | Fusarium roseum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63374-3.json |
| 63375-0 | Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/63375-0.json |
| 63376-8 | Lactoferrin [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/63376-8.json |
| 63379-2 | DNA double strand IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/63379-2.json |
| 633-8 | Bacteria identified in Wound by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/633-8.json |
| 63380-0 | Methionine [Presence] in DBS | ./2.16.840.1.114222.4.11.1002/63380-0.json |
| 63381-8 | DNA double strand IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/63381-8.json |
| 63383-4 | Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63383-4.json |
| 63384-2 | Asialoganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63384-2.json |
| 63385-9 | DNA double strand IgG Ab [Units/volume] in Body fluid by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/63385-9.json |
| 63386-7 | DNA double strand IgG Ab [Units/volume] in Pleural fluid by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/63386-7.json |
| 63387-5 | Elastase Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63387-5.json |
| 6338-8 | Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6338-8.json |
| 63388-3 | Extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63388-3.json |
| 63389-1 | Extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63389-1.json |
| 63390-9 | Extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63390-9.json |
| 63391-7 | Extractable nuclear Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63391-7.json |
| 63392-5 | Herpes gestationis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63392-5.json |
| 63393-3 | Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63393-3.json |
| 63394-1 | Jo-1 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63394-1.json |
| 63395-8 | Liver cytosol Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63395-8.json |
| 6339-6 | Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6339-6.json |
| 63396-6 | Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/63396-6.json |
| 63397-4 | Myeloperoxidase Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63397-4.json |
| 63398-2 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63398-2.json |
| 63399-0 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63399-0.json |
| 63400-6 | SCL-70 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63400-6.json |
| 63401-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63401-4.json |
| 63402-2 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63402-2.json |
| 63403-0 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63403-0.json |
| 6340-4 | Chlamydophila psittaci Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6340-4.json |
| 63404-8 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63404-8.json |
| 63405-5 | Smith extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63405-5.json |
| 63406-3 | Smith extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63406-3.json |
| 63407-1 | Thyroid colloidal Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63407-1.json |
| 63408-9 | DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63408-9.json |
| 63409-7 | DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63409-7.json |
| 63410-5 | DNA double strand Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63410-5.json |
| 63411-3 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63411-3.json |
| 6341-2 | Chlamydophila psittaci Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6341-2.json |
| 63412-1 | Thyroid colloidal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63412-1.json |
| 63413-9 | Thyroid colloidal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63413-9.json |
| 63418-8 | Lactalbumin alpha IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63418-8.json |
| 63420-4 | Gliadin peptide+tissue transglutaminase IgA+IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63420-4.json |
| 63421-2 | JAK2 gene exon 12 mutations tested for in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/63421-2.json |
| 63422-0 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/63422-0.json |
| 63423-8 | Escherichia coli eaeA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63423-8.json |
| 63424-6 | Bacterial enterohemolysin ehlyA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63424-6.json |
| 63425-3 | Bacterial heat-labile enterotoxin LT gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63425-3.json |
| 63426-1 | Bacterial heat-stable enterotoxin ST gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63426-1.json |
| 63427-9 | Escherichia coli Stx1 toxin stx1 gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63427-9.json |
| 63428-7 | Escherichia coli Stx2 toxin stx2 gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63428-7.json |
| 63429-5 | Bacterial beta-glucuronidase uidA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63429-5.json |
| 63431-1 | Bordetella sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63431-1.json |
| 63432-9 | Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63432-9.json |
| 63433-7 | Microscopic observation [Identifier] in Synovial fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/63433-7.json |
| 63434-5 | Coxsackievirus A Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/63434-5.json |
| 63435-2 | Brucella abortus Ab [Titer] in Cerebral spinal fluid by Antihuman globulin | ./2.16.840.1.114222.4.11.1002/63435-2.json |
| 63436-0 | Paper wasp recombinant (rPol d) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63436-0.json |
| 63437-8 | Brucella abortus Ab [Titer] in Serum by Antihuman globulin | ./2.16.840.1.114222.4.11.1002/63437-8.json |
| 6343-8 | Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6343-8.json |
| 63439-4 | Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63439-4.json |
| 63440-2 | PCA-Tr Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/63440-2.json |
| 63441-0 | Tissue polypeptide Ag [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/63441-0.json |
| 63443-6 | Fasciola hepatica Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/63443-6.json |
| 63445-1 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/63445-1.json |
| 6344-6 | Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6344-6.json |
| 63447-7 | CD3+CD5- cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63447-7.json |
| 63449-3 | CD3 cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63449-3.json |
| 63450-1 | CD3+CD4+ (T4 helper) cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63450-1.json |
| 63451-9 | CD3+CD8+ (T8 suppressor) cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63451-9.json |
| 6345-3 | Chlamydia sp Ag [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6345-3.json |
| 63453-5 | Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63453-5.json |
| 63455-0 | Coxiella burnetii phase 1 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63455-0.json |
| 63456-8 | European house dust mite native (nDer p) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63456-8.json |
| 63457-6 | European house dust mite recombinant (rDer p) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63457-6.json |
| 63458-4 | Mugwort native (nArt v) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63458-4.json |
| 63459-2 | Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63459-2.json |
| 634-6 | Bacteria identified in Specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/634-6.json |
| 63460-0 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63460-0.json |
| 6346-1 | Chlamydia sp Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6346-1.json |
| 63462-6 | Rubella virus IgG Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/63462-6.json |
| 63463-4 | European house dust mite recombinant (rDer p) 10 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63463-4.json |
| 63464-2 | Treponema pallidum Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63464-2.json |
| 63465-9 | Brucella sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63465-9.json |
| 63466-7 | Ganglioside GM3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63466-7.json |
| 63467-5 | Ganglioside GM3 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63467-5.json |
| 63468-3 | Ganglioside GT1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63468-3.json |
| 63469-1 | Ganglioside GT1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63469-1.json |
| 63470-9 | Ganglioside GM4 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63470-9.json |
| 63471-7 | Ganglioside GD2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63471-7.json |
| 63472-5 | Ganglioside GD3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63472-5.json |
| 63473-3 | Codfish recombinant (rGad c) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63473-3.json |
| 63475-8 | BK virus DNA [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/63475-8.json |
| 63476-6 | Soybean recombinant (rGly m) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63476-6.json |
| 63477-4 | Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/63477-4.json |
| 63478-2 | Platelet glycoprotein Ib/Ix Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/63478-2.json |
| 6347-9 | Chlamydia sp Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6347-9.json |
| 63479-0 | Platelet glycoprotein Ia/IIa Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/63479-0.json |
| 63480-8 | Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/63480-8.json |
| 63481-6 | Urea [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/63481-6.json |
| 63482-4 | Methotrimeprazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/63482-4.json |
| 63483-2 | Penicillium notatum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/63483-2.json |
| 63484-0 | Actin.filamentous Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63484-0.json |
| 63485-7 | Computer generated recommendation Document | ./2.16.840.1.114222.4.11.1002/63485-7.json |
| 6348-7 | Chlamydia sp identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6348-7.json |
| 6349-5 | Chlamydia trachomatis [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6349-5.json |
| 6350-3 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6350-3.json |
| 6351-1 | Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6351-1.json |
| 63523-5 | Carboxyhemoglobin/Hemoglobin.total in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/63523-5.json |
| 63524-3 | Carboxyhemoglobin/Hemoglobin.total in Venous cord blood | ./2.16.840.1.114222.4.11.1002/63524-3.json |
| 63526-8 | Centromere Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63526-8.json |
| 63527-6 | Centromere Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63527-6.json |
| 63528-4 | Centromere Ab [Presence] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63528-4.json |
| 6352-9 | Chlamydia trachomatis Ag [Presence] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6352-9.json |
| 63529-2 | Centromere Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63529-2.json |
| 635-3 | Bacteria identified in Specimen by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/635-3.json |
| 63530-0 | Centromere Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63530-0.json |
| 63531-8 | Centromere Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63531-8.json |
| 63532-6 | Centromere protein B Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63532-6.json |
| 63533-4 | Centromere protein B Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63533-4.json |
| 63534-2 | DNA double strand IgG Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/63534-2.json |
| 63535-9 | DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/63535-9.json |
| 63536-7 | Jo-1 extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63536-7.json |
| 6353-7 | Chlamydia trachomatis Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6353-7.json |
| 63537-5 | Muscle specific receptor tyrosine kinase IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63537-5.json |
| 63538-3 | Myeloperoxidase Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/63538-3.json |
| 63539-1 | Proteinase 3 Ab [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/63539-1.json |
| 63540-9 | Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63540-9.json |
| 63541-7 | Ribosomal P Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63541-7.json |
| 63542-5 | SCL-70 extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63542-5.json |
| 63543-3 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63543-3.json |
| 63544-1 | Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63544-1.json |
| 6354-5 | Chlamydia trachomatis Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6354-5.json |
| 63545-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63545-8.json |
| 63546-6 | Smith extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63546-6.json |
| 63547-4 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/63547-4.json |
| 63548-2 | Smith extractable nuclear B Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63548-2.json |
| 63549-0 | Albumin in serum - albumin in peritoneal fluid [Mass concentration difference] | ./2.16.840.1.114222.4.11.1002/63549-0.json |
| 63550-8 | Calcium magnesium phosphate/Total in Stone | ./2.16.840.1.114222.4.11.1002/63550-8.json |
| 63551-6 | Pituitary Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/63551-6.json |
| 6355-2 | Chlamydia trachomatis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6355-2.json |
| 63553-2 | Succinylaminoimidazole carboxamide riboside [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/63553-2.json |
| 63554-0 | Leukocytes in 24 hour Urine sediment by Microscopy | ./2.16.840.1.114222.4.11.1002/63554-0.json |
| 63555-7 | Leukocytes [#/volume] by Microscopy high power field in Urine sediment collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/63555-7.json |
| 63556-5 | Fat [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/63556-5.json |
| 63557-3 | Hepatitis B virus surface Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/63557-3.json |
| 63558-1 | HLA-DQB1*06:02 [Presence] | ./2.16.840.1.114222.4.11.1002/63558-1.json |
| 6356-0 | Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6356-0.json |
| 63561-5 | aPTT actual/normal in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/63561-5.json |
| 63562-3 | Japanese encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/63562-3.json |
| 63563-1 | Japanese encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/63563-1.json |
| 63564-9 | Giardia lamblia Ag and Cryptosporidium parvum Ag and Entamoeba histolytica/dispar Ag [Identifier] in Stool | ./2.16.840.1.114222.4.11.1002/63564-9.json |
| 63574-8 | Staphylococcus sp.coagulase negative DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/63574-8.json |
| 6357-8 | Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6357-8.json |
| 6359-4 | Clostridioides difficile toxin A [Units/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6359-4.json |
| 6360-2 | Clostridioides difficile toxin A [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6360-2.json |
| 636-1 | Bacteria identified in Specimen by Sterile body fluid culture | ./2.16.840.1.114222.4.11.1002/636-1.json |
| 6361-0 | Clostridioides difficile toxin A+B [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6361-0.json |
| 6362-8 | Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay | ./2.16.840.1.114222.4.11.1002/6362-8.json |
| 6363-6 | Clostridioides difficile toxin A+B [Units/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6363-6.json |
| 6364-4 | Clostridioides difficile toxin A+B [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6364-4.json |
| 6365-1 | Clostridioides difficile toxin B [Units/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6365-1.json |
| 6366-9 | Clostridioides difficile toxin B [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6366-9.json |
| 6367-7 | Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6367-7.json |
| 6368-5 | Coccidioides immitis Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6368-5.json |
| 6369-3 | Cryptococcus neoformans Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/6369-3.json |
| 6370-1 | Cryptococcus sp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6370-1.json |
| 6371-9 | Cryptosporidium sp Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6371-9.json |
| 6372-7 | Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6372-7.json |
| 6373-5 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/6373-5.json |
| 6374-3 | Taenia solium larva IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/6374-3.json |
| 6376-8 | Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6376-8.json |
| 6377-6 | Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6377-6.json |
| 637-9 | Plasmodium sp identified in Blood by Thick film | ./2.16.840.1.114222.4.11.1002/637-9.json |
| 6379-2 | Cytomegalovirus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6379-2.json |
| 6381-8 | Cytomegalovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6381-8.json |
| 6384-2 | Dengue virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6384-2.json |
| 6385-9 | Dengue virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6385-9.json |
| 6386-7 | Dengue virus DNA [Presence] in Serum by Probe | ./2.16.840.1.114222.4.11.1002/6386-7.json |
| 638-7 | Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep | ./2.16.840.1.114222.4.11.1002/638-7.json |
| 6387-5 | Dengue virus DNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6387-5.json |
| 6388-3 | Eastern equine encephalitis virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6388-3.json |
| 6389-1 | Eastern equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6389-1.json |
| 6390-9 | Echinococcus sp Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6390-9.json |
| 6391-7 | Echinococcus sp Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6391-7.json |
| 6392-5 | Echovirus 30 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6392-5.json |
| 6393-3 | Echovirus 30 neutralizing antibody [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/6393-3.json |
| 6394-1 | Echovirus 40 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6394-1.json |
| 639-5 | Microscopic observation [Identifier] in Cerebral spinal fluid by KOH preparation | ./2.16.840.1.114222.4.11.1002/639-5.json |
| 6395-8 | Echovirus 40 neutralizing antibody [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/6395-8.json |
| 6396-6 | Entamoeba histolytica DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6396-6.json |
| 6397-4 | Entamoeba histolytica Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6397-4.json |
| 6398-2 | Entamoeba histolytica Ag [Units/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6398-2.json |
| 6399-0 | Entamoeba histolytica Ag [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6399-0.json |
| 6400-6 | Ehrlichia canis Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6400-6.json |
| 64012-8 | CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/64012-8.json |
| 64013-6 | Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/64013-6.json |
| 6401-4 | Ehrlichia chaffeensis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6401-4.json |
| 6402-2 | Ehrlichia chaffeensis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6402-2.json |
| 640-3 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/640-3.json |
| 6403-0 | Anaplasma phagocytophilum Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6403-0.json |
| 64038-3 | Adenovirus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/64038-3.json |
| 64051-6 | NM Breast lymphatic vessels - left Views W radionuclide intra lymphatic | ./2.16.840.1.114222.4.11.1002/64051-6.json |
| 64052-4 | NM Breast lymphatic vessels - right Views W radionuclide intra lymphatic | ./2.16.840.1.114222.4.11.1002/64052-4.json |
| 64053-2 | General medicine Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64053-2.json |
| 64054-0 | General medicine Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64054-0.json |
| 6405-5 | Ehrlichia sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6405-5.json |
| 64055-7 | General medicine Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64055-7.json |
| 64056-5 | General medicine Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/64056-5.json |
| 64057-3 | Surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64057-3.json |
| 64058-1 | Critical care medicine Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64058-1.json |
| 64059-9 | Critical care medicine Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64059-9.json |
| 64060-7 | Cardiothoracic surgery Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64060-7.json |
| 64061-5 | Cardiothoracic surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64061-5.json |
| 64062-3 | Pulmonary Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64062-3.json |
| 6406-3 | Flavivirus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6406-3.json |
| 64063-1 | Pulmonary Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64063-1.json |
| 64064-9 | Pastoral care Hospital Evaluation note | ./2.16.840.1.114222.4.11.1002/64064-9.json |
| 64065-6 | Case manager Hospital Initial evaluation note | ./2.16.840.1.114222.4.11.1002/64065-6.json |
| 64066-4 | Surgery Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64066-4.json |
| 64067-2 | Surgery Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64067-2.json |
| 64068-0 | Surgery Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/64068-0.json |
| 64069-8 | Critical care medicine Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/64069-8.json |
| 64070-6 | Critical care medicine Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64070-6.json |
| 6407-1 | Francisella tularensis IgM Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6407-1.json |
| 64071-4 | Critical care medicine Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64071-4.json |
| 64072-2 | Critical care medicine Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/64072-2.json |
| 64073-0 | Cardiothoracic surgery Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/64073-0.json |
| 64074-8 | Cardiothoracic surgery Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64074-8.json |
| 64075-5 | Cardiothoracic surgery Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64075-5.json |
| 64076-3 | Cardiothoracic surgery Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/64076-3.json |
| 64077-1 | Pulmonary Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/64077-1.json |
| 64078-9 | Pulmonary Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/64078-9.json |
| 64079-7 | Pulmonary Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/64079-7.json |
| 64080-5 | Pulmonary Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/64080-5.json |
| 64081-3 | FMRP cells/100 lymphocytes in Blood by Immune stain | ./2.16.840.1.114222.4.11.1002/64081-3.json |
| 64082-1 | Bilirubin.indirect [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/64082-1.json |
| 64085-4 | Cells karyotyped.total [#] in Chorionic villus sample | ./2.16.840.1.114222.4.11.1002/64085-4.json |
| 64086-2 | Cells analyzed [#] in Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64086-2.json |
| 64087-0 | ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64087-0.json |
| 64088-8 | Karyotype [Identifier] in Chorionic villus sample Narrative | ./2.16.840.1.114222.4.11.1002/64088-8.json |
| 6408-9 | Francisella tularensis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6408-9.json |
| 64089-6 | Cells counted [#] in Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64089-6.json |
| 64090-4 | Chromosome analysis overall interpretation in Specimen Qualitative by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64090-4.json |
| 64091-2 | Cells karyotyped.total [#] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/64091-2.json |
| 64093-8 | ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64093-8.json |
| 64094-6 | Karyotype [Identifier] in Amniotic fluid Narrative | ./2.16.840.1.114222.4.11.1002/64094-6.json |
| 64095-3 | Cells counted [#] in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64095-3.json |
| 64096-1 | Colonies counted [#] in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/64096-1.json |
| 6409-7 | Fungus identified in Sputum tracheal aspirate by Culture | ./2.16.840.1.114222.4.11.1002/6409-7.json |
| 6410-5 | Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe | ./2.16.840.1.114222.4.11.1002/6410-5.json |
| 641-1 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/641-1.json |
| 6411-3 | Giardia lamblia IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6411-3.json |
| 6412-1 | Giardia lamblia Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/6412-1.json |
| 64125-8 | Pregabalin [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/64125-8.json |
| 64127-4 | Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64127-4.json |
| 64128-2 | Amobarbital/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64128-2.json |
| 64129-0 | N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64129-0.json |
| 64130-8 | diazePAM/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64130-8.json |
| 64131-6 | Dihydrocodeine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64131-6.json |
| 64132-4 | PENTobarbital/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64132-4.json |
| 64133-2 | PHENobarbital/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64133-2.json |
| 64134-0 | Phentermine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64134-0.json |
| 64135-7 | Secobarbital/Creatinine [Mass Ratio] of Urine | ./2.16.840.1.114222.4.11.1002/64135-7.json |
| 64136-5 | Pregabalin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64136-5.json |
| 64137-3 | Pregabalin [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/64137-3.json |
| 64138-1 | Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64138-1.json |
| 6413-9 | Giardia lamblia Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6413-9.json |
| 64139-9 | Butalbital/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/64139-9.json |
| 64140-7 | RFA Renal vessels - left Views W contrast | ./2.16.840.1.114222.4.11.1002/64140-7.json |
| 64141-5 | RFA Renal vessels - right Views W contrast | ./2.16.840.1.114222.4.11.1002/64141-5.json |
| 64142-3 | Hospital Evaluation and management of smoking cessation note | ./2.16.840.1.114222.4.11.1002/64142-3.json |
| 6414-7 | Haemophilus influenzae A Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6414-7.json |
| 6416-2 | Haemophilus influenzae D Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6416-2.json |
| 6417-0 | Haemophilus influenzae E Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6417-0.json |
| 6418-8 | Haemophilus influenzae F Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6418-8.json |
| 6419-6 | Helicobacter pylori Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6419-6.json |
| 6420-4 | Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6420-4.json |
| 6421-2 | Hepatitis B virus rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6421-2.json |
| 64233-0 | Benzylpiperazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/64233-0.json |
| 6424-6 | Heterophile Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/6424-6.json |
| 6425-3 | Heterophile Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6425-3.json |
| 6426-1 | Histoplasma capsulatum Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6426-1.json |
| 6427-9 | Histoplasma capsulatum Ab [Presence] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6427-9.json |
| 64284-3 | Readiness for duty assessment | ./2.16.840.1.114222.4.11.1002/64284-3.json |
| 64285-0 | Medical history screening form | ./2.16.840.1.114222.4.11.1002/64285-0.json |
| 6428-7 | Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6428-7.json |
| 64288-4 | Prescription for eyewear | ./2.16.840.1.114222.4.11.1002/64288-4.json |
| 64289-2 | Health record cover sheet | ./2.16.840.1.114222.4.11.1002/64289-2.json |
| 642-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/642-9.json |
| 64290-0 | Health insurance card | ./2.16.840.1.114222.4.11.1002/64290-0.json |
| 64291-8 | Health insurance-related form | ./2.16.840.1.114222.4.11.1002/64291-8.json |
| 64292-6 | Release of information consent Document | ./2.16.840.1.114222.4.11.1002/64292-6.json |
| 64293-4 | Procedure consent Document | ./2.16.840.1.114222.4.11.1002/64293-4.json |
| 64294-2 | Readiness for duty letter | ./2.16.840.1.114222.4.11.1002/64294-2.json |
| 6429-5 | HIV identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6429-5.json |
| 64295-9 | Nurse Plan of care note | ./2.16.840.1.114222.4.11.1002/64295-9.json |
| 64296-7 | Personal health monitoring report Automated | ./2.16.840.1.114222.4.11.1002/64296-7.json |
| 64297-5 | Death certificate | ./2.16.840.1.114222.4.11.1002/64297-5.json |
| 64298-3 | Power of attorney | ./2.16.840.1.114222.4.11.1002/64298-3.json |
| 64299-1 | Legal document | ./2.16.840.1.114222.4.11.1002/64299-1.json |
| 64300-7 | Organ donation consent Document | ./2.16.840.1.114222.4.11.1002/64300-7.json |
| 6430-3 | HIV identified in Semen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6430-3.json |
| 6431-1 | HIV identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6431-1.json |
| 6432-9 | HTLV I Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/6432-9.json |
| 6433-7 | HTLV I IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6433-7.json |
| 6434-5 | Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6434-5.json |
| 6435-2 | Influenza virus A+B Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/6435-2.json |
| 6436-0 | Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6436-0.json |
| 643-7 | Microscopic observation [Identifier] in Pus by Gram stain | ./2.16.840.1.114222.4.11.1002/643-7.json |
| 6437-8 | Influenza virus A+B Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6437-8.json |
| 6438-6 | Influenza virus A+B Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6438-6.json |
| 6439-4 | Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay | ./2.16.840.1.114222.4.11.1002/6439-4.json |
| 6440-2 | Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6440-2.json |
| 6441-0 | Influenza virus A+B+C Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6441-0.json |
| 64412-0 | Mycobacterium sp [Presence] in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/64412-0.json |
| 6442-8 | Influenza virus A+B+C Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6442-8.json |
| 6443-6 | Lactoferrin [Presence] in Stool by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6443-6.json |
| 6444-4 | Lactoferrin [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6444-4.json |
| 644-5 | Microscopic observation [Identifier] in Skin by KOH preparation | ./2.16.840.1.114222.4.11.1002/644-5.json |
| 6445-1 | Legionella pneumophila Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6445-1.json |
| 6446-9 | Legionella pneumophila Ag [Presence] in Sputum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6446-9.json |
| 6447-7 | Legionella pneumophila Ag [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/6447-7.json |
| 6448-5 | Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/6448-5.json |
| 6449-3 | Legionella pneumophila Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6449-3.json |
| 6450-1 | Legionella sp Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6450-1.json |
| 645-2 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/645-2.json |
| 6452-7 | Leptospira interrogans Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6452-7.json |
| 6453-5 | Leptospira sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6453-5.json |
| 6454-3 | Leptospira sp identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6454-3.json |
| 6455-0 | Leptospira sp identified in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6455-0.json |
| 6456-8 | Listeria monocytogenes Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6456-8.json |
| 6457-6 | DNA double strand Ab [Presence] in Serum by Immunofluorescence (IF) Crithidia luciliae | ./2.16.840.1.114222.4.11.1002/6457-6.json |
| 6458-4 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6458-4.json |
| 6459-2 | Bacteria identified in Food by Culture | ./2.16.840.1.114222.4.11.1002/6459-2.json |
| 646-0 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/646-0.json |
| 6460-0 | Bacteria identified in Sputum by Culture | ./2.16.840.1.114222.4.11.1002/6460-0.json |
| 6461-8 | Bacteria identified in Stool by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/6461-8.json |
| 6462-6 | Bacteria identified in Wound by Culture | ./2.16.840.1.114222.4.11.1002/6462-6.json |
| 6463-4 | Bacteria identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/6463-4.json |
| 6464-2 | Microscopic observation [Identifier] in Cervix by Gram stain | ./2.16.840.1.114222.4.11.1002/6464-2.json |
| 6465-9 | Microscopic observation [Identifier] in Duodenal fluid by Trichrome stain | ./2.16.840.1.114222.4.11.1002/6465-9.json |
| 6466-7 | Microscopic observation [Identifier] in Duodenal fluid by Wet preparation | ./2.16.840.1.114222.4.11.1002/6466-7.json |
| 6467-5 | Microscopic observation [Identifier] in Genital fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/6467-5.json |
| 6468-3 | Microscopic observation [Identifier] in Sputum by Calcofluor white | ./2.16.840.1.114222.4.11.1002/6468-3.json |
| 6469-1 | Microscopic observation [Identifier] in Stool by Trichrome stain | ./2.16.840.1.114222.4.11.1002/6469-1.json |
| 6470-9 | Microscopic observation [Identifier] in Stool by Wet preparation | ./2.16.840.1.114222.4.11.1002/6470-9.json |
| 6471-7 | Microscopic observation [Identifier] in Tissue by Other stain | ./2.16.840.1.114222.4.11.1002/6471-7.json |
| 6472-5 | Microscopic observation [Identifier] in Tissue by Calcofluor white | ./2.16.840.1.114222.4.11.1002/6472-5.json |
| 6473-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain | ./2.16.840.1.114222.4.11.1002/6473-3.json |
| 6474-1 | Microscopic observation [Identifier] in Urethra by Gram stain | ./2.16.840.1.114222.4.11.1002/6474-1.json |
| 6475-8 | Mobiluncus sp rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6475-8.json |
| 6476-6 | Mumps virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6476-6.json |
| 6477-4 | Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6477-4.json |
| 647-8 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/647-8.json |
| 6478-2 | Mumps virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6478-2.json |
| 6479-0 | Mumps virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6479-0.json |
| 6480-8 | Mumps virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6480-8.json |
| 6481-6 | Mycoplasma pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6481-6.json |
| 6482-4 | Mycoplasma pneumoniae rRNA [Presence] in Sputum by Probe | ./2.16.840.1.114222.4.11.1002/6482-4.json |
| 6483-2 | Mycoplasma pneumoniae rRNA [Presence] in Specimen by Probe | ./2.16.840.1.114222.4.11.1002/6483-2.json |
| 648-6 | Microscopic observation [Identifier] in Sputum by Gram stain | ./2.16.840.1.114222.4.11.1002/648-6.json |
| 6486-5 | Mycoplasma sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6486-5.json |
| 6487-3 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6487-3.json |
| 6488-1 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6488-1.json |
| 6489-9 | Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6489-9.json |
| 6490-7 | Neisseria gonorrhoeae Ag [Presence] in Urethra | ./2.16.840.1.114222.4.11.1002/6490-7.json |
| 6492-3 | Neisseria meningitidis Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6492-3.json |
| 6493-1 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6493-1.json |
| 649-4 | Microscopic observation [Identifier] in Stool by Gram stain | ./2.16.840.1.114222.4.11.1002/649-4.json |
| 6494-9 | Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6494-9.json |
| 6495-6 | Neisseria meningitidis serogroup A Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6495-6.json |
| 64959-0 | Kiwi recombinant (rAct d) 8 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64959-0.json |
| 64960-8 | Celery recombinant (rApi g) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64960-8.json |
| 64961-6 | Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64961-6.json |
| 64962-4 | Cashew nut recombinant (rAna o) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64962-4.json |
| 64963-2 | Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64963-2.json |
| 6496-4 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6496-4.json |
| 64964-0 | Hazelnut recombinant (rCor a) 1.0401 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64964-0.json |
| 64965-7 | Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64965-7.json |
| 64966-5 | Wheat recombinant (rTri a) 14 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64966-5.json |
| 64967-3 | Black Alder recombinant (rAln g) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64967-3.json |
| 64968-1 | Hazelnut recombinant (rCor a) 1.0101 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64968-1.json |
| 64969-9 | London Plane recombinant (rPla a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64969-9.json |
| 64970-7 | London Plane recombinant (rPla a) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64970-7.json |
| 64971-5 | Goosefoot recombinant (rChe a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64971-5.json |
| 6497-2 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6497-2.json |
| 64972-3 | English plantain recombinant (rPla l) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64972-3.json |
| 64973-1 | Dog recombinant 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64973-1.json |
| 64974-9 | Horse recombinant (rEqu c) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64974-9.json |
| 64975-6 | Cat recombinant (rFel d) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64975-6.json |
| 64976-4 | Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64976-4.json |
| 64977-2 | Alternaria alternata recombinant (rAlt a) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64977-2.json |
| 64978-0 | Cladosporium herbarum recombinant (rCla h) 8 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64978-0.json |
| 64979-8 | Blomia tropicalis recombinant (rBlo t) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64979-8.json |
| 6498-0 | Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6498-0.json |
| 64980-6 | American house dust mite recombinant (rDer f) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64980-6.json |
| 64981-4 | Lepidoglyphus destructor recombinant (rLep d) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64981-4.json |
| 64982-2 | Cockroach recombinant (rBla g) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64982-2.json |
| 64983-0 | Cockroach recombinant (rBla g) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64983-0.json |
| 64984-8 | Cockroach recombinant (rBla g) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64984-8.json |
| 64985-5 | Anisakis recombinant (rAni s) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64985-5.json |
| 64986-3 | Anisakis recombinant (rAni s) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/64986-3.json |
| 64993-9 | US Guidance for placement of needle in Unspecified body region | ./2.16.840.1.114222.4.11.1002/64993-9.json |
| 64995-4 | RFA Internal thoracic artery - left Views W contrast IA | ./2.16.840.1.114222.4.11.1002/64995-4.json |
| 64996-2 | XR Lung - left Views W contrast intrabronchial | ./2.16.840.1.114222.4.11.1002/64996-2.json |
| 64997-0 | XR Lung - right Views W contrast intrabronchial | ./2.16.840.1.114222.4.11.1002/64997-0.json |
| 6499-8 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6499-8.json |
| 64998-8 | RF Guidance for placement of catheter in Fallopian tube - left-- transcervical | ./2.16.840.1.114222.4.11.1002/64998-8.json |
| 64999-6 | RF Guidance for placement of catheter in Fallopian tube - right-- transcervical | ./2.16.840.1.114222.4.11.1002/64999-6.json |
| 65000-2 | RFA Internal thoracic artery - right Views W contrast IA | ./2.16.840.1.114222.4.11.1002/65000-2.json |
| 6500-3 | Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6500-3.json |
| 6501-1 | Neisseria meningitidis serogroup C Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6501-1.json |
| 650-2 | Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/650-2.json |
| 6502-9 | Neisseria meningitidis serogroup Y Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6502-9.json |
| 6503-7 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6503-7.json |
| 6504-5 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6504-5.json |
| 6505-2 | Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6505-2.json |
| 6506-0 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6506-0.json |
| 6507-8 | Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6507-8.json |
| 6508-6 | Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/6508-6.json |
| 6509-4 | Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by Probe | ./2.16.840.1.114222.4.11.1002/6509-4.json |
| 651-0 | Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/651-0.json |
| 6510-2 | Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6510-2.json |
| 6511-0 | Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot | ./2.16.840.1.114222.4.11.1002/6511-0.json |
| 6512-8 | Human papilloma virus Ab [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/6512-8.json |
| 6513-6 | Human papilloma virus Ab [Presence] in Tissue by Immunoblot | ./2.16.840.1.114222.4.11.1002/6513-6.json |
| 6514-4 | Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6514-4.json |
| 6515-1 | Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6515-1.json |
| 6516-9 | Human papilloma virus rRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6516-9.json |
| 6517-7 | Parvovirus B19 IgM Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/6517-7.json |
| 6518-5 | Pneumocystis jiroveci Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6518-5.json |
| 6519-3 | Pneumocystis jiroveci Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6519-3.json |
| 6521-9 | Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/6521-9.json |
| 6522-7 | Rabies virus Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/6522-7.json |
| 6523-5 | Rabies virus neutralizing antibody [Units/volume] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/6523-5.json |
| 6524-3 | Rabies virus neutralizing antibody [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/6524-3.json |
| 6525-0 | Rabies virus neutralizing antibody [Units/volume] in Tissue by Neutralization test | ./2.16.840.1.114222.4.11.1002/6525-0.json |
| 6526-8 | Rabies virus Ab [Units/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6526-8.json |
| 6527-6 | Rabies virus neutralizing antibody [Units/volume] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/6527-6.json |
| 652-8 | Microscopic observation [Identifier] in Urine by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/652-8.json |
| 6528-4 | Rabies virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6528-4.json |
| 6529-2 | Rabies virus Ag [Units/volume] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6529-2.json |
| 65318-8 | At sup(a) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65318-8.json |
| 65320-4 | Fy3 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65320-4.json |
| 65323-8 | He Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65323-8.json |
| 65324-6 | Jk3 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65324-6.json |
| 65325-3 | Ku Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65325-3.json |
| 6532-6 | Rabies virus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6532-6.json |
| 65326-1 | LAN Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65326-1.json |
| 65327-9 | Lu 14 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65327-9.json |
| 65328-7 | LW sup(a) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65328-7.json |
| 65329-5 | McC sup(c) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65329-5.json |
| 65330-3 | MER Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65330-3.json |
| 65331-1 | little cE Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65331-1.json |
| 65332-9 | Rh32 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65332-9.json |
| 65333-7 | Sc1 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65333-7.json |
| 6533-4 | Rabies virus Ag [Units/volume] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6533-4.json |
| 65334-5 | Sc2 Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65334-5.json |
| 65335-2 | Sw sup(a) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65335-2.json |
| 65336-0 | Tm Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65336-0.json |
| 65337-8 | Tr sup(a) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65337-8.json |
| 65338-6 | WES sup(b) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65338-6.json |
| 65339-4 | Wr sup(b) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65339-4.json |
| 65343-6 | Oxygen [Partial pressure] saturation adjusted to 0.5 in Blood | ./2.16.840.1.114222.4.11.1002/65343-6.json |
| 65359-2 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge | ./2.16.840.1.114222.4.11.1002/65359-2.json |
| 653-6 | Microscopic observation [Identifier] in Urine by Gram stain | ./2.16.840.1.114222.4.11.1002/653-6.json |
| 65363-4 | Glutathione [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/65363-4.json |
| 65364-2 | Cortisol Free/Cortisol.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/65364-2.json |
| 6536-7 | Rabies virus identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6536-7.json |
| 6539-1 | Rabies virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6539-1.json |
| 6542-5 | Rickettsia prowazekii Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6542-5.json |
| 6543-3 | Rickettsia rickettsii Ag [Identifier] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6543-3.json |
| 654-4 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/654-4.json |
| 6544-1 | Rickettsia sp identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6544-1.json |
| 6545-8 | Rickettsia sp identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6545-8.json |
| 6546-6 | Rickettsia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6546-6.json |
| 6547-4 | Rotavirus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6547-4.json |
| 6548-2 | Rubella virus identified in Serum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6548-2.json |
| 6549-0 | Saint Louis encephalitis virus Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6549-0.json |
| 6550-8 | Staphylococcus aureus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6550-8.json |
| 655-1 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/655-1.json |
| 6551-6 | Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6551-6.json |
| 6552-4 | Streptococcus pneumoniae Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6552-4.json |
| 6553-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6553-2.json |
| 6554-0 | Streptococcus pneumoniae Ag [Presence] in Sputum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6554-0.json |
| 6555-7 | Streptococcus pneumoniae Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6555-7.json |
| 6557-3 | Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6557-3.json |
| 6558-1 | Streptococcus pyogenes Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6558-1.json |
| 6559-9 | Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6559-9.json |
| 6560-7 | Plasmodium ovale Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6560-7.json |
| 6561-5 | Treponema pallidum IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/6561-5.json |
| 6562-3 | Treponema pallidum IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/6562-3.json |
| 6563-1 | Trichinella spiralis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6563-1.json |
| 65633-0 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/65633-0.json |
| 6564-9 | Trichomonas vaginalis [Presence] in Genital specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/6564-9.json |
| 6565-6 | Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/6565-6.json |
| 6566-4 | Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/6566-4.json |
| 6567-2 | Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6567-2.json |
| 6568-0 | Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe | ./2.16.840.1.114222.4.11.1002/6568-0.json |
| 656-9 | Microscopic observation [Identifier] in Specimen by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/656-9.json |
| 6569-8 | Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6569-8.json |
| 6570-6 | Varicella zoster virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6570-6.json |
| 6571-4 | Venezuelan equine encephalitis virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6571-4.json |
| 6572-2 | Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6572-2.json |
| 6573-0 | Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6573-0.json |
| 6574-8 | Escherichia coli verotoxin 1 [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/6574-8.json |
| 65751-0 | Muscle Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65751-0.json |
| 65752-8 | Liver Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65752-8.json |
| 65753-6 | Cervix Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65753-6.json |
| 65754-4 | Skin Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65754-4.json |
| 6575-5 | Escherichia coli verotoxin 1 neutralizing antibody [Titer] in Stool by Neutralization test | ./2.16.840.1.114222.4.11.1002/6575-5.json |
| 65755-1 | Rectum Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65755-1.json |
| 65756-9 | Salmonella sp serovar [Type] in Isolate | ./2.16.840.1.114222.4.11.1002/65756-9.json |
| 65757-7 | Kidney Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/65757-7.json |
| 65762-7 | Hantavirus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/65762-7.json |
| 6576-3 | Escherichia coli verotoxin 2 [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/6576-3.json |
| 65763-5 | Neisseria meningitidis Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/65763-5.json |
| 65764-3 | Kiwi native (nAct d) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65764-3.json |
| 65765-0 | Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65765-0.json |
| 65766-8 | English Walnut native (nJug r) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65766-8.json |
| 65767-6 | English Walnut native (nJug r) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65767-6.json |
| 65768-4 | English Walnut native (nJug r) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65768-4.json |
| 65769-2 | Peanut native (nAra h) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65769-2.json |
| 657-7 | Microscopic observation [Identifier] in Specimen by Acridine orange stain | ./2.16.840.1.114222.4.11.1002/657-7.json |
| 65770-0 | Peanut native (nAra h) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65770-0.json |
| 6577-1 | Escherichia coli verotoxin 2 neutralizing antibody [Titer] in Stool by Neutralization test | ./2.16.840.1.114222.4.11.1002/6577-1.json |
| 65771-8 | Peanut native (nAra h) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65771-8.json |
| 65772-6 | Soybean native (nGly m) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65772-6.json |
| 65773-4 | Buckwheat native (nFag e) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65773-4.json |
| 65774-2 | Wheat native (nTri a) aA/TI IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65774-2.json |
| 65775-9 | Bermuda grass native (nCyn d) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65775-9.json |
| 65776-7 | Silver birch native (nBet v) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65776-7.json |
| 65777-5 | Japanese Cedar native (nCry j) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65777-5.json |
| 65778-3 | Arizona Cypress native (nCup a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65778-3.json |
| 65779-1 | Olive pollen native (nOle e) 7 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65779-1.json |
| 65780-9 | Olive pollen recombinant (rOle e) 9 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65780-9.json |
| 65781-7 | London Plane native (nPla a) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65781-7.json |
| 65782-5 | Common ragweed native (nAmb a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65782-5.json |
| 65783-3 | Mugwort native (nArt v) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65783-3.json |
| 65784-1 | Saltwort native (nSal k) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65784-1.json |
| 65785-8 | Chicken CSA serum albumin native (nGal d) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65785-8.json |
| 65786-6 | Shrimp native (nPen m) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65786-6.json |
| 65787-4 | Shrimp native (nPen m) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65787-4.json |
| 65788-2 | Horse serum albumin native (nEqu c) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65788-2.json |
| 6578-9 | Vibrio sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6578-9.json |
| 65789-0 | Mouse lipocain native (nMus m) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65789-0.json |
| 65790-8 | American house dust mite native (nDer f) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65790-8.json |
| 65791-6 | Honey bee native (nApi m) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65791-6.json |
| 65792-4 | Horseradish native (nArm r) HRP IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65792-4.json |
| 65793-2 | Cockroach native (nBla g) 7 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65793-2.json |
| 65794-0 | Shrimp native (nPen m) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65794-0.json |
| 65795-7 | Kiwi native (nAct d) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65795-7.json |
| 65796-5 | Kiwi native (nAct d) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/65796-5.json |
| 6579-7 | Vibrio sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6579-7.json |
| 65797-3 | RFA Guidance for placement of stent in Artery - left | ./2.16.840.1.114222.4.11.1002/65797-3.json |
| 65798-1 | RFA Guidance for placement of stent in Artery - right | ./2.16.840.1.114222.4.11.1002/65798-1.json |
| 65799-9 | RF Kidney - bilateral Single view for cyst | ./2.16.840.1.114222.4.11.1002/65799-9.json |
| 65800-5 | RF Kidney - left Single view for cyst | ./2.16.840.1.114222.4.11.1002/65800-5.json |
| 65801-3 | RF Kidney - right Single view for cyst | ./2.16.840.1.114222.4.11.1002/65801-3.json |
| 6580-5 | Vibrio sp identified in Water by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6580-5.json |
| 65806-2 | Inhalation challenge test report Document --W methacholine inhaled | ./2.16.840.1.114222.4.11.1002/65806-2.json |
| 65807-0 | Tapentadol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/65807-0.json |
| 65808-8 | Nortapentadol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/65808-8.json |
| 65809-6 | Kingella kingae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/65809-6.json |
| 65810-4 | SEPT9 gene methylation [Presence] in Plasma by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/65810-4.json |
| 6581-3 | Vibrio sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6581-3.json |
| 6583-9 | Virus identified in Semen by Culture | ./2.16.840.1.114222.4.11.1002/6583-9.json |
| 6584-7 | Virus identified in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/6584-7.json |
| 658-5 | Microscopic observation [Identifier] in Specimen by Calcofluor white | ./2.16.840.1.114222.4.11.1002/658-5.json |
| 6585-4 | Western equine encephalitis virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6585-4.json |
| 6586-2 | Western equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6586-2.json |
| 6587-0 | Yellow fever virus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6587-0.json |
| 6588-8 | Yellow fever virus Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6588-8.json |
| 6589-6 | Yellow fever virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6589-6.json |
| 6590-4 | Yellow fever virus Ab [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6590-4.json |
| 6591-2 | Yellow fever virus neutralizing antibody [Units/volume] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/6591-2.json |
| 6592-0 | Yellow fever virus IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6592-0.json |
| 659-3 | Microscopic observation [Identifier] in Specimen by Carbol-fuchsin stain | ./2.16.840.1.114222.4.11.1002/659-3.json |
| 6593-8 | Yellow fever virus IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6593-8.json |
| 6594-6 | Amoeba identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6594-6.json |
| 6595-3 | Klebsiella granulomatis [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6595-3.json |
| 6596-1 | Diphtheria identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6596-1.json |
| 6597-9 | Troponin T.cardiac [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/6597-9.json |
| 6598-7 | Troponin T.cardiac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6598-7.json |
| 6599-5 | Haemophilus influenzae B Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6599-5.json |
| 6600-1 | Haemophilus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6600-1.json |
| 660-1 | Microscopic observation [Identifier] in Specimen by Dark field examination | ./2.16.840.1.114222.4.11.1002/660-1.json |
| 6601-9 | Influenza virus identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6601-9.json |
| 6602-7 | Influenza virus identified in Sputum tracheal aspirate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6602-7.json |
| 6603-5 | Influenza virus identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6603-5.json |
| 6604-3 | Influenza virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6604-3.json |
| 6605-0 | Leptospira interrogans Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6605-0.json |
| 6606-8 | Brugia malayi Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6606-8.json |
| 6607-6 | Microscopic observation [Identifier] in Tissue by Dark field examination | ./2.16.840.1.114222.4.11.1002/6607-6.json |
| 6608-4 | Virus identified in Isolate by Culture | ./2.16.840.1.114222.4.11.1002/6608-4.json |
| 6609-2 | Listeria sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/6609-2.json |
| 6610-0 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6610-0.json |
| 66107-4 | Lung Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66107-4.json |
| 66108-2 | Bone Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66108-2.json |
| 66109-0 | Brain Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66109-0.json |
| 66110-8 | Breast Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66110-8.json |
| 66111-6 | Peritoneum Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66111-6.json |
| 66112-4 | Lymph node Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66112-4.json |
| 66113-2 | Uterus Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66113-2.json |
| 66114-0 | Stomach Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66114-0.json |
| 66115-7 | Pancreas Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66115-7.json |
| 66116-5 | Ovary Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66116-5.json |
| 66117-3 | Prostate Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66117-3.json |
| 6611-8 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6611-8.json |
| 66118-1 | Spleen Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66118-1.json |
| 66119-9 | Bone marrow Pathology biopsy report Narrative | ./2.16.840.1.114222.4.11.1002/66119-9.json |
| 66120-7 | Thyroid Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66120-7.json |
| 66121-5 | Tissue Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66121-5.json |
| 66122-3 | Adrenal gland Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66122-3.json |
| 66123-1 | Pleura Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66123-1.json |
| 66124-9 | Testis Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66124-9.json |
| 66125-6 | Urinary bladder Pathology biopsy report | ./2.16.840.1.114222.4.11.1002/66125-6.json |
| 6612-6 | Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6612-6.json |
| 66126-4 | Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/66126-4.json |
| 66127-2 | Amphetamine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/66127-2.json |
| 66128-0 | chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/66128-0.json |
| 66129-8 | fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/66129-8.json |
| 66130-6 | fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/66130-6.json |
| 66131-4 | Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/66131-4.json |
| 6613-4 | Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6613-4.json |
| 66134-8 | Blasts [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66134-8.json |
| 66135-5 | Promyelocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66135-5.json |
| 66136-3 | Myelocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66136-3.json |
| 66137-1 | Metamyelocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66137-1.json |
| 66138-9 | Band form neutrophils [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66138-9.json |
| 66139-7 | Neutrophils [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66139-7.json |
| 66140-5 | Lymphocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66140-5.json |
| 66141-3 | Eosinophils [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66141-3.json |
| 6614-2 | Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6614-2.json |
| 66142-1 | Basophils [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66142-1.json |
| 66143-9 | Monocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66143-9.json |
| 66144-7 | Variant lymphocytes [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66144-7.json |
| 66145-4 | Leukocytes other [#/volume] in Blood from Fetus by Manual count | ./2.16.840.1.114222.4.11.1002/66145-4.json |
| 6615-9 | Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6615-9.json |
| 6618-3 | Acanthamoeba sp Ab [Presence] in Cornea by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6618-3.json |
| 661-9 | Microscopic observation [Identifier] in Specimen by Dry mount | ./2.16.840.1.114222.4.11.1002/661-9.json |
| 6619-1 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6619-1.json |
| 6620-9 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6620-9.json |
| 6621-7 | Leishmania sp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6621-7.json |
| 6622-5 | Leishmania sp Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/6622-5.json |
| 6623-3 | Leishmania sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6623-3.json |
| 6624-1 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6624-1.json |
| 6625-8 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6625-8.json |
| 6626-6 | Schistosoma japonicum Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6626-6.json |
| 662-7 | Microscopic observation [Identifier] in Specimen by Giemsa stain | ./2.16.840.1.114222.4.11.1002/662-7.json |
| 6627-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6627-4.json |
| 6628-2 | Schistosoma sp Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6628-2.json |
| 6629-0 | Schistosoma sp Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6629-0.json |
| 6630-8 | Schistosoma sp Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/6630-8.json |
| 6631-6 | Schistosoma sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6631-6.json |
| 6632-4 | Strongyloides stercoralis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6632-4.json |
| 6633-2 | Wuchereria bancrofti Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6633-2.json |
| 6634-0 | Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6634-0.json |
| 663-5 | Microscopic observation [Identifier] in Specimen by Gimenez stain | ./2.16.840.1.114222.4.11.1002/663-5.json |
| 6635-7 | Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6635-7.json |
| 6636-5 | Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6636-5.json |
| 6637-3 | Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6637-3.json |
| 6638-1 | Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6638-1.json |
| 6639-9 | Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6639-9.json |
| 6640-7 | Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6640-7.json |
| 6641-5 | Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6641-5.json |
| 6642-3 | Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/6642-3.json |
| 664-3 | Microscopic observation [Identifier] in Specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/664-3.json |
| 66441-7 | Beta hydroxybutyrate [Moles/volume] in Blood by Test strip | ./2.16.840.1.114222.4.11.1002/66441-7.json |
| 66444-1 | Cockroach recombinant (rBla g) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66444-1.json |
| 66445-8 | Cyprinus carpio recombinant (rCyp c) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66445-8.json |
| 66446-6 | Carrot recombinant (rDau c) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66446-6.json |
| 66447-4 | Euroglyphus maynei recombinant (rEur m) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66447-4.json |
| 66448-2 | Latex recombinant (rHev b) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66448-2.json |
| 66449-0 | Annual mercury recombinant (rMer a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66449-0.json |
| 66450-8 | Olive native (nOle e) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66450-8.json |
| 66451-6 | Shrimp native (nPen i) 11 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66451-6.json |
| 66452-4 | Wheat native (nTri a) 18 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66452-4.json |
| 66482-1 | OmpC IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/66482-1.json |
| 66484-7 | DNA single strand Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/66484-7.json |
| 66489-6 | CYP2C19 gene targeted mutation analysis in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/66489-6.json |
| 66491-2 | Urease [Presence] in Tissue --2nd specimen | ./2.16.840.1.114222.4.11.1002/66491-2.json |
| 66492-0 | Urease [Presence] in Tissue --3rd specimen | ./2.16.840.1.114222.4.11.1002/66492-0.json |
| 66493-8 | Epstein Barr virus nuclear 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66493-8.json |
| 665-0 | Microscopic observation [Identifier] in Specimen by Hematoxylin and eosin stain | ./2.16.840.1.114222.4.11.1002/665-0.json |
| 66502-6 | HBA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/66502-6.json |
| 66503-4 | APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/66503-4.json |
| 6655-5 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/6655-5.json |
| 6656-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun modified | ./2.16.840.1.114222.4.11.1002/6656-3.json |
| 6657-1 | Microscopic observation [Identifier] in Tissue by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/6657-1.json |
| 6658-9 | Microscopic observation [Identifier] in Tissue by Acridine orange stain | ./2.16.840.1.114222.4.11.1002/6658-9.json |
| 6659-7 | Microscopic observation [Identifier] in Tissue by Carbol-fuchsin stain | ./2.16.840.1.114222.4.11.1002/6659-7.json |
| 6661-3 | Microscopic observation [Identifier] in Tissue by Dry mount | ./2.16.840.1.114222.4.11.1002/6661-3.json |
| 6662-1 | Microscopic observation [Identifier] in Tissue by Giemsa stain | ./2.16.840.1.114222.4.11.1002/6662-1.json |
| 6663-9 | Microscopic observation [Identifier] in Tissue by Gimenez stain | ./2.16.840.1.114222.4.11.1002/6663-9.json |
| 6664-7 | Microscopic observation [Identifier] in Tissue by Gram stain | ./2.16.840.1.114222.4.11.1002/6664-7.json |
| 6665-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin and eosin stain | ./2.16.840.1.114222.4.11.1002/6665-4.json |
| 6666-2 | Microscopic observation [Identifier] in Tissue by India ink prep | ./2.16.840.1.114222.4.11.1002/6666-2.json |
| 6667-0 | Microscopic observation [Identifier] in Tissue by KOH preparation | ./2.16.840.1.114222.4.11.1002/6667-0.json |
| 666-8 | Microscopic observation [Identifier] in Specimen by India ink prep | ./2.16.840.1.114222.4.11.1002/666-8.json |
| 6668-8 | Microscopic observation [Identifier] in Tissue by M'Fadyean stain | ./2.16.840.1.114222.4.11.1002/6668-8.json |
| 6669-6 | Microscopic observation [Identifier] in Tissue by Macchiavello stain | ./2.16.840.1.114222.4.11.1002/6669-6.json |
| 6670-4 | Microscopic observation [Identifier] in Tissue by Malaria smear | ./2.16.840.1.114222.4.11.1002/6670-4.json |
| 6671-2 | Microscopic observation [Identifier] in Tissue by Methenamine silver nitrate stain | ./2.16.840.1.114222.4.11.1002/6671-2.json |
| 66714-7 | Common wasp recombinant (rVes v) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66714-7.json |
| 66717-0 | Chlorhexidine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66717-0.json |
| 66719-6 | Adenovirus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66719-6.json |
| 6672-0 | Microscopic observation [Identifier] in Tissue by Methylene blue stain.Loeffler | ./2.16.840.1.114222.4.11.1002/6672-0.json |
| 66720-4 | Adenovirus DNA [Log #/volume] (viral load) in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66720-4.json |
| 66721-2 | Adenovirus DNA [#/volume] (viral load) in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66721-2.json |
| 66722-0 | Adenovirus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66722-0.json |
| 66723-8 | Adenovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66723-8.json |
| 66724-6 | Adenovirus DNA [Log #/volume] (viral load) in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66724-6.json |
| 66725-3 | Adenovirus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66725-3.json |
| 66726-1 | Adenovirus DNA [Log #/volume] (viral load) in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66726-1.json |
| 66727-9 | Adenovirus DNA [#/volume] (viral load) in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66727-9.json |
| 66728-7 | Adenovirus DNA [Log #/volume] (viral load) in Skin by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66728-7.json |
| 66729-5 | Adenovirus DNA [#/volume] (viral load) in Skin by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66729-5.json |
| 66730-3 | Adenovirus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66730-3.json |
| 66731-1 | Adenovirus DNA [Log #/volume] (viral load) in Sputum or Bronchial by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/66731-1.json |
| 66732-9 | Corticotropin [Mass or Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/66732-9.json |
| 66733-7 | Cortisol [Mass or Moles/volume] in Serum or Plasma --afternoon specimen | ./2.16.840.1.114222.4.11.1002/66733-7.json |
| 66734-5 | Glucagon [Mass or Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/66734-5.json |
| 66735-2 | Cortisol [Mass or Moles/volume] in Serum or Plasma --AM peak specimen | ./2.16.840.1.114222.4.11.1002/66735-2.json |
| 66736-0 | Normalized silica clotting time of Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/66736-0.json |
| 6673-8 | Microscopic observation [Identifier] in Tissue by Neisser stain | ./2.16.840.1.114222.4.11.1002/6673-8.json |
| 66745-1 | Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitude | ./2.16.840.1.114222.4.11.1002/66745-1.json |
| 6674-6 | Ova and parasites identified in Tissue by Light microscopy | ./2.16.840.1.114222.4.11.1002/6674-6.json |
| 6675-3 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain | ./2.16.840.1.114222.4.11.1002/6675-3.json |
| 66753-5 | Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase | ./2.16.840.1.114222.4.11.1002/66753-5.json |
| 667-6 | Microscopic observation [Identifier] in Specimen by KOH preparation | ./2.16.840.1.114222.4.11.1002/667-6.json |
| 6676-1 | Enterobius vermicularis [Presence] in Anal by Pinworm exam | ./2.16.840.1.114222.4.11.1002/6676-1.json |
| 66762-6 | Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/66762-6.json |
| 66763-4 | Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/66763-4.json |
| 66769-1 | Triglyceride [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/66769-1.json |
| 6677-9 | Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/6677-9.json |
| 6679-5 | Microscopic observation [Identifier] in Tissue by Warthin-Starry stain | ./2.16.840.1.114222.4.11.1002/6679-5.json |
| 6680-3 | Microscopic observation [Identifier] in Tissue by Wet preparation | ./2.16.840.1.114222.4.11.1002/6680-3.json |
| 6681-1 | Microscopic observation [Identifier] in Tissue by Wright stain | ./2.16.840.1.114222.4.11.1002/6681-1.json |
| 6683-7 | Reptilase time | ./2.16.840.1.114222.4.11.1002/6683-7.json |
| 668-4 | Microscopic observation [Identifier] in Specimen by M'Fadyean stain | ./2.16.840.1.114222.4.11.1002/668-4.json |
| 66853-3 | Myeloperoxidase [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/66853-3.json |
| 66875-6 | FMR1 gene methylation/methylated+unmethylated in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/66875-6.json |
| 6687-8 | Citrate [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6687-8.json |
| 66878-0 | Skin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/66878-0.json |
| 66879-8 | Skin IgG Ab [Titer] in Serum by Guinea pig esophagus substrate | ./2.16.840.1.114222.4.11.1002/66879-8.json |
| 66881-4 | Skin IgG Ab [Presence] in Serum by Monkey esophagus substrate | ./2.16.840.1.114222.4.11.1002/66881-4.json |
| 66882-2 | Skin IgG Ab [Presence] in Serum by Guinea pig esophagus substrate | ./2.16.840.1.114222.4.11.1002/66882-2.json |
| 66883-0 | Skin IgG Ab [Titer] in Serum by Monkey esophagus substrate | ./2.16.840.1.114222.4.11.1002/66883-0.json |
| 66885-5 | Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/66885-5.json |
| 6688-6 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6688-6.json |
| 6689-4 | Glucose [Mass/volume] in Blood --2 hours post meal | ./2.16.840.1.114222.4.11.1002/6689-4.json |
| 6690-2 | Leukocytes [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/6690-2.json |
| 6691-0 | Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6691-0.json |
| 669-2 | Microscopic observation [Identifier] in Specimen by Macchiavello stain | ./2.16.840.1.114222.4.11.1002/669-2.json |
| 6692-8 | Lutropin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6692-8.json |
| 6693-6 | Mercury [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6693-6.json |
| 6694-4 | quiNIDine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6694-4.json |
| 66950-7 | MALT1 18q21 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/66950-7.json |
| 6695-1 | Riboflavin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/6695-1.json |
| 66951-5 | Complement C1.functional [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/66951-5.json |
| 6696-9 | Thiothixene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6696-9.json |
| 6699-3 | Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6699-3.json |
| 670-0 | Microscopic observation [Identifier] in Specimen by Methenamine silver nitrate stain | ./2.16.840.1.114222.4.11.1002/670-0.json |
| 6700-9 | 11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6700-9.json |
| 6701-7 | 11-Hydroxyandrosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6701-7.json |
| 6702-5 | 11-Ketoandrosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6702-5.json |
| 6703-3 | 11-Ketoetiocholanolone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6703-3.json |
| 6704-1 | 11-Ketopregnanetriol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6704-1.json |
| 6705-8 | Androsterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6705-8.json |
| 6706-6 | buPROPion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6706-6.json |
| 6708-2 | Echovirus 11 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6708-2.json |
| 6709-0 | Hippurate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/6709-0.json |
| 6711-6 | Acetaminophen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6711-6.json |
| 6712-4 | Ampicillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6712-4.json |
| 67126-3 | Cannabinoids synthetic [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/67126-3.json |
| 6713-2 | Baker's yeast IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6713-2.json |
| 6714-0 | Beef IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6714-0.json |
| 67151-1 | Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/67151-1.json |
| 6715-7 | Brewer's yeast IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6715-7.json |
| 671-8 | Microscopic observation [Identifier] in Specimen by Methylene blue stain.Loeffler | ./2.16.840.1.114222.4.11.1002/671-8.json |
| 6718-1 | Cashew nut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6718-1.json |
| 6719-9 | Cherry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6719-9.json |
| 6720-7 | Chocolate IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6720-7.json |
| 6721-5 | Codfish IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6721-5.json |
| 6722-3 | Coffee IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6722-3.json |
| 6723-1 | Corn IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6723-1.json |
| 6724-9 | Cucumber IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6724-9.json |
| 6725-6 | Egg white IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6725-6.json |
| 672-6 | Microscopic observation [Identifier] in Specimen by Neisser stain | ./2.16.840.1.114222.4.11.1002/672-6.json |
| 6726-4 | False oat grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6726-4.json |
| 6727-2 | Honey bee IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6727-2.json |
| 6728-0 | Latex glove extract IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6728-0.json |
| 6729-8 | Cow milk IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6729-8.json |
| 6730-6 | Orange IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6730-6.json |
| 6731-4 | Paper wasp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6731-4.json |
| 6732-2 | Peanut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6732-2.json |
| 6733-0 | Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6733-0.json |
| 673-4 | Ova and parasites identified in Specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/673-4.json |
| 6734-8 | Pork IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6734-8.json |
| 6735-5 | Soybean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6735-5.json |
| 6736-3 | Tomato IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6736-3.json |
| 6737-1 | Wheat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6737-1.json |
| 6738-9 | Yellow Dock IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6738-9.json |
| 6739-7 | Yellow Hornet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6739-7.json |
| 6740-5 | Yellow Jacket IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6740-5.json |
| 674-2 | Microscopic observation [Identifier] in Specimen by Periodic acid-Schiff stain | ./2.16.840.1.114222.4.11.1002/674-2.json |
| 6747-0 | Glucose [Presence] in Urine by Test strip --1 hour post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/6747-0.json |
| 6748-8 | Glucose [Presence] in Urine by Test strip --1 hour post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/6748-8.json |
| 6750-4 | Glucose [Presence] in Urine by Test strip --2 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/6750-4.json |
| 6751-2 | Glucose [Presence] in Urine by Test strip --2 hours post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/6751-2.json |
| 67561-1 | Corynebacterium diphtheriae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67561-1.json |
| 67562-9 | Achromobacter sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67562-9.json |
| 67563-7 | Legionella micdadei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67563-7.json |
| 67568-6 | Circulating tumor cells.breast [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/67568-6.json |
| 67569-4 | Streptococcus pyogenes M protein emm gene [Type] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/67569-4.json |
| 675-9 | Enterobius vermicularis [Presence] in Specimen by Pinworm exam | ./2.16.840.1.114222.4.11.1002/675-9.json |
| 6762-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/6762-9.json |
| 6764-5 | Fasting glucose [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/6764-5.json |
| 6765-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6765-2.json |
| 6766-0 | 17-Ketosteroids [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6766-0.json |
| 676-7 | Microscopic observation [Identifier] in Specimen by Rhodamine-auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/676-7.json |
| 6767-8 | 18-Hydroxycorticosteroids [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6767-8.json |
| 6768-6 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6768-6.json |
| 6770-2 | Alpha 1 antitrypsin phenotype [Identifier] in Serum or Plasma by Immunofixation | ./2.16.840.1.114222.4.11.1002/6770-2.json |
| 67708-8 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/67708-8.json |
| 67709-6 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/67709-6.json |
| 6771-0 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry | ./2.16.840.1.114222.4.11.1002/6771-0.json |
| 67710-4 | Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/67710-4.json |
| 67726-0 | Rickettsia sp DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67726-0.json |
| 6774-4 | Desethylamiodarone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6774-4.json |
| 677-5 | Microscopic observation [Identifier] in Specimen by Toluidine blue O stain | ./2.16.840.1.114222.4.11.1002/677-5.json |
| 6776-9 | Estrone (E1) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6776-9.json |
| 6779-3 | IgA [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/6779-3.json |
| 67805-2 | Cytomegalovirus Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67805-2.json |
| 67806-0 | Measles virus Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67806-0.json |
| 67807-8 | Mumps virus Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67807-8.json |
| 67808-6 | Parainfluenza virus 1 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67808-6.json |
| 67809-4 | Parainfluenza virus 2 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67809-4.json |
| 67810-2 | Parainfluenza virus 3 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67810-2.json |
| 67811-0 | Parainfluenza virus 4 Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67811-0.json |
| 67812-8 | Varicella zoster virus Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/67812-8.json |
| 67815-1 | HTLV I Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/67815-1.json |
| 67818-5 | Parainfluenza virus 4a RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67818-5.json |
| 6781-9 | IgG [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/6781-9.json |
| 67820-1 | Human metapneumovirus A RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67820-1.json |
| 67821-9 | Human metapneumovirus B RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/67821-9.json |
| 6782-7 | IgG/Albumin [Mass Ratio] in Serum | ./2.16.840.1.114222.4.11.1002/6782-7.json |
| 678-3 | Microscopic observation [Identifier] in Specimen by Trichrome stain | ./2.16.840.1.114222.4.11.1002/678-3.json |
| 67838-3 | Mephedrone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/67838-3.json |
| 6784-3 | IgM [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/6784-3.json |
| 6785-0 | Kappa light chains [Presence] in Serum by Electrophoresis | ./2.16.840.1.114222.4.11.1002/6785-0.json |
| 67851-6 | Admission evaluation note | ./2.16.840.1.114222.4.11.1002/67851-6.json |
| 67852-4 | Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/67852-4.json |
| 67854-0 | Geriatric medicine Education note | ./2.16.840.1.114222.4.11.1002/67854-0.json |
| 67855-7 | Outpatient Education note | ./2.16.840.1.114222.4.11.1002/67855-7.json |
| 67856-5 | Nursing facility History and physical note | ./2.16.840.1.114222.4.11.1002/67856-5.json |
| 67860-7 | Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/67860-7.json |
| 67861-5 | Ophthalmology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/67861-5.json |
| 67862-3 | Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/67862-3.json |
| 67865-6 | Outpatient Supervisory note | ./2.16.840.1.114222.4.11.1002/67865-6.json |
| 6787-6 | Kappa light chains [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6787-6.json |
| 6789-2 | Lambda light chains [Presence] in Serum by Electrophoresis | ./2.16.840.1.114222.4.11.1002/6789-2.json |
| 679-1 | Microscopic observation [Identifier] in Specimen by Warthin-Starry stain | ./2.16.840.1.114222.4.11.1002/679-1.json |
| 6791-8 | Lambda light chains [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6791-8.json |
| 6792-6 | Potassium [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/6792-6.json |
| 6793-4 | Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/6793-4.json |
| 6797-5 | Cyclobenzaprine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6797-5.json |
| 6799-1 | Tricyclic antidepressants [Presence] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/6799-1.json |
| 6801-5 | Complement C3 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/6801-5.json |
| 6808-0 | Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6808-0.json |
| 680-9 | Microscopic observation [Identifier] in Specimen by Wet preparation | ./2.16.840.1.114222.4.11.1002/680-9.json |
| 6809-8 | Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6809-8.json |
| 6810-6 | Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6810-6.json |
| 6811-4 | Dengue virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6811-4.json |
| 6812-2 | Dengue virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6812-2.json |
| 68123-9 | Circulating tumor cells.prostate [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/68123-9.json |
| 68124-7 | Circulating tumor cells.colon [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/68124-7.json |
| 6813-0 | Echovirus 16 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6813-0.json |
| 6814-8 | Epstein Barr virus early IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6814-8.json |
| 6815-5 | Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6815-5.json |
| 6816-3 | Histoplasma capsulatum mycelial phase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/6816-3.json |
| 681-7 | Microscopic observation [Identifier] in Specimen by Wright stain | ./2.16.840.1.114222.4.11.1002/681-7.json |
| 6817-1 | Histoplasma capsulatum yeast phase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/6817-1.json |
| 6818-9 | Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6818-9.json |
| 6819-7 | Streptococcus sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/6819-7.json |
| 6820-5 | Streptococcus sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6820-5.json |
| 6821-3 | Thermoactinomyces vulgaris Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/6821-3.json |
| 6822-1 | Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6822-1.json |
| 6823-9 | Rheumatoid factor [Presence] in Synovial fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/6823-9.json |
| 682-5 | Microscopic observation [Identifier] in Specimen by Wright Giemsa stain | ./2.16.840.1.114222.4.11.1002/682-5.json |
| 6825-4 | Crystals [type] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/6825-4.json |
| 6826-2 | Crystals [type] in Pleural fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/6826-2.json |
| 6829-6 | Amoxicillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6829-6.json |
| 6830-4 | Aspergillus niger IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6830-4.json |
| 6831-2 | Green Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6831-2.json |
| 6832-0 | Oregon Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6832-0.json |
| 68324-3 | von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/68324-3.json |
| 683-3 | Genital Mycoplasma identified in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/683-3.json |
| 6833-8 | Cat dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6833-8.json |
| 6835-3 | Cauliflower IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6835-3.json |
| 6836-1 | Chicken serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6836-1.json |
| 68366-4 | Bacteria identified in Blood product unit by Culture | ./2.16.840.1.114222.4.11.1002/68366-4.json |
| 68369-8 | Nuclear Ab [Presence] in Pericardial fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68369-8.json |
| 68370-6 | Nuclear Ab [Presence] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68370-6.json |
| 68371-4 | Nuclear Ab [Presence] in Peritoneal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68371-4.json |
| 68372-2 | Nuclear Ab [Presence] in Synovial fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68372-2.json |
| 68373-0 | Nuclear Ab [Titer] in Pericardial fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68373-0.json |
| 68374-8 | Nuclear Ab [Titer] in Pleural fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68374-8.json |
| 68375-5 | Nuclear Ab [Titer] in Peritoneal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68375-5.json |
| 68376-3 | Nuclear Ab [Titer] in Body fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68376-3.json |
| 68377-1 | Ribonucleoprotein extractable nuclear 63kD Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/68377-1.json |
| 6837-9 | Cinnamon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6837-9.json |
| 68379-7 | Phenylbutazone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/68379-7.json |
| 68380-5 | Chromatin Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/68380-5.json |
| 68381-3 | pH of Synovial fluid by Test strip | ./2.16.840.1.114222.4.11.1002/68381-3.json |
| 68382-1 | pH of Pericardial fluid by Test strip | ./2.16.840.1.114222.4.11.1002/68382-1.json |
| 68383-9 | Microscopic observation [Identifier] in Body fluid by KOH preparation | ./2.16.840.1.114222.4.11.1002/68383-9.json |
| 68384-7 | Specific gravity of Pericardial fluid by Refractometry | ./2.16.840.1.114222.4.11.1002/68384-7.json |
| 68385-4 | Glomerular basement membrane Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/68385-4.json |
| 68386-2 | Glomerular basement membrane IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68386-2.json |
| 6838-7 | Cockatiel droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6838-7.json |
| 68387-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/68387-0.json |
| 68388-8 | DNA double strand IgG Ab [Units/volume] in Peritoneal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/68388-8.json |
| 68389-6 | DNA double strand IgG Ab [Units/volume] in Synovial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/68389-6.json |
| 68392-0 | Basophils [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68392-0.json |
| 68393-8 | Basophils [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68393-8.json |
| 68394-6 | Basophils [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68394-6.json |
| 6839-5 | Cryptostroma corticale IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6839-5.json |
| 68395-3 | Basophils [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68395-3.json |
| 68396-1 | Basophils/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68396-1.json |
| 68397-9 | Basophils [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68397-9.json |
| 68398-7 | Eosinophils [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68398-7.json |
| 68399-5 | Eosinophils [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68399-5.json |
| 68400-1 | Eosinophils [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68400-1.json |
| 68401-9 | Eosinophils [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68401-9.json |
| 68402-7 | Eosinophils [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68402-7.json |
| 6840-3 | Gerbil IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6840-3.json |
| 68403-5 | Eosinophils/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68403-5.json |
| 68404-3 | Lymphocytes [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68404-3.json |
| 68405-0 | Lymphocytes [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68405-0.json |
| 68406-8 | Abnormal lymphocytes/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68406-8.json |
| 68407-6 | Lymphocytes [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68407-6.json |
| 68408-4 | Macrophages [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68408-4.json |
| 68409-2 | Macrophages [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68409-2.json |
| 684-1 | Respiratory Mycoplasma identified in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/684-1.json |
| 68410-0 | Macrophages [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68410-0.json |
| 6841-1 | Grape IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6841-1.json |
| 68411-8 | Macrophages [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68411-8.json |
| 68412-6 | Macrophages/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68412-6.json |
| 68413-4 | Macrophages [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68413-4.json |
| 68414-2 | Mesothelial cells [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68414-2.json |
| 68415-9 | Mesothelial cells [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68415-9.json |
| 68416-7 | Mesothelial cells [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68416-7.json |
| 68417-5 | Mesothelial cells [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68417-5.json |
| 68418-3 | Mesothelial cells/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68418-3.json |
| 68419-1 | Mesothelial cells [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68419-1.json |
| 68420-9 | Monocytes [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68420-9.json |
| 68421-7 | Monocytes [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68421-7.json |
| 68422-5 | Monocytes [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68422-5.json |
| 68423-3 | Monocytes/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68423-3.json |
| 68424-1 | Monocytes [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68424-1.json |
| 68425-8 | Neutrophils [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68425-8.json |
| 68426-6 | Neutrophils/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68426-6.json |
| 68427-4 | Neutrophils [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68427-4.json |
| 68428-2 | Leukocytes other [#/volume] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68428-2.json |
| 6842-9 | Halibut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6842-9.json |
| 68429-0 | Leukocytes other [#/volume] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68429-0.json |
| 68430-8 | Leukocytes other [#/volume] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68430-8.json |
| 68431-6 | Leukocytes other [#/volume] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68431-6.json |
| 68432-4 | Leukocytes other/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68432-4.json |
| 68433-2 | Leukocytes other [#/volume] in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/68433-2.json |
| 68434-0 | Leukocytes [#/volume] in Vitreous fluid by Automated count | ./2.16.840.1.114222.4.11.1002/68434-0.json |
| 68435-7 | Erythrocytes [#/volume] in Vitreous fluid by Automated count | ./2.16.840.1.114222.4.11.1002/68435-7.json |
| 68436-5 | Appearance of Vitreous fluid | ./2.16.840.1.114222.4.11.1002/68436-5.json |
| 68437-3 | Smudge cells [#/volume] in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/68437-3.json |
| 68438-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/68438-1.json |
| 68439-9 | Gabapentin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/68439-9.json |
| 68440-7 | Gamma hydroxybutyrate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/68440-7.json |
| 68441-5 | Gamma hydroxybutyrate [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/68441-5.json |
| 6844-5 | Honey bee IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6844-5.json |
| 6845-2 | Latex glove extract ammoniated IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6845-2.json |
| 68452-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction | ./2.16.840.1.114222.4.11.1002/68452-2.json |
| 68453-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/68453-0.json |
| 68454-8 | Phenylbutazone [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/68454-8.json |
| 68455-5 | Appearance of Spun Vitreous fluid | ./2.16.840.1.114222.4.11.1002/68455-5.json |
| 68457-1 | Enterovirus and Parechovirus A RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/68457-1.json |
| 68458-9 | Trichomonas sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/68458-9.json |
| 68459-7 | pH of Peritoneal fluid by Test strip | ./2.16.840.1.114222.4.11.1002/68459-7.json |
| 6846-0 | Latex glove extract buffered IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6846-0.json |
| 68460-5 | Picornavirus Ag [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68460-5.json |
| 68463-9 | Rilpivirine [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/68463-9.json |
| 68466-2 | Epstein-Barr virus-encoded RNA 1 [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/68466-2.json |
| 68467-0 | APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/68467-0.json |
| 68469-6 | Pastoral care Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68469-6.json |
| 68470-4 | Respiratory therapy Hospital Initial evaluation note | ./2.16.840.1.114222.4.11.1002/68470-4.json |
| 68471-2 | Cardiology Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/68471-2.json |
| 68472-0 | Cardiology Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68472-0.json |
| 68473-8 | Critical care medicine Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68473-8.json |
| 68474-6 | Physician Hospital Restraint note | ./2.16.840.1.114222.4.11.1002/68474-6.json |
| 68475-3 | General medicine Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68475-3.json |
| 68476-1 | Nurse Hospital Restraint note | ./2.16.840.1.114222.4.11.1002/68476-1.json |
| 68477-9 | Nurse Hospital Education note | ./2.16.840.1.114222.4.11.1002/68477-9.json |
| 6847-8 | Mexican tea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6847-8.json |
| 68478-7 | Pulmonary Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68478-7.json |
| 68479-5 | Respiratory therapy Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68479-5.json |
| 68480-3 | Surgery Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68480-3.json |
| 68481-1 | Cardiothoracic surgery Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68481-1.json |
| 68482-9 | Nurse Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/68482-9.json |
| 68483-7 | Cardiology Medical student Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/68483-7.json |
| 68484-5 | Cardiology Attending Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68484-5.json |
| 68485-2 | Cardiology Medical student Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68485-2.json |
| 6848-6 | Mushroom IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6848-6.json |
| 68486-0 | Cardiology Medical student Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68486-0.json |
| 6850-2 | Papaya (Carica papaya) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6850-2.json |
| 6851-0 | Penicillin G IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6851-0.json |
| 6852-8 | Green Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6852-8.json |
| 6853-6 | Plum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6853-6.json |
| 68541-2 | HYDROmorphone [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/68541-2.json |
| 68542-0 | Codeine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/68542-0.json |
| 68543-8 | oxyCODONE [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/68543-8.json |
| 6854-4 | Pumpkin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6854-4.json |
| 68544-6 | HYDROcodone [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/68544-6.json |
| 68546-1 | Mycoplasma hominis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/68546-1.json |
| 68547-9 | Ureaplasma sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/68547-9.json |
| 68548-7 | Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/68548-7.json |
| 68549-5 | U2 small nuclear ribonucleoprotein Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/68549-5.json |
| 68550-3 | Dermatology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68550-3.json |
| 6855-1 | Common Reed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6855-1.json |
| 68551-1 | Dermatology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68551-1.json |
| 68552-9 | Emergency medicine Emergency department Admission evaluation note | ./2.16.840.1.114222.4.11.1002/68552-9.json |
| 68553-7 | Hematology+Medical oncology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/68553-7.json |
| 68554-5 | Hematology+Medical oncology Progress note | ./2.16.840.1.114222.4.11.1002/68554-5.json |
| 68555-2 | Hematology+Medical oncology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68555-2.json |
| 68556-0 | Neurology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68556-0.json |
| 68557-8 | Obstetrics and Gynecology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68557-8.json |
| 68558-6 | Obstetrics and Gynecology Discharge summary | ./2.16.840.1.114222.4.11.1002/68558-6.json |
| 68560-2 | Obstetrics and Gynecology History and physical note | ./2.16.840.1.114222.4.11.1002/68560-2.json |
| 68562-8 | Obstetrics and Gynecology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68562-8.json |
| 68563-6 | Obstetrics and Gynecology procedure note | ./2.16.840.1.114222.4.11.1002/68563-6.json |
| 68564-4 | Obstetrics and Gynecology Progress note | ./2.16.840.1.114222.4.11.1002/68564-4.json |
| 68565-1 | Obstetrics and Gynecology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68565-1.json |
| 68566-9 | Obstetrics and Gynecology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68566-9.json |
| 68567-7 | Obstetrics and Gynecology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68567-7.json |
| 6856-9 | Spinach IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6856-9.json |
| 68569-3 | Occupational therapy Transfer summary note | ./2.16.840.1.114222.4.11.1002/68569-3.json |
| 68570-1 | Occupational therapy Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68570-1.json |
| 68571-9 | Occupational therapy Hospital Letter | ./2.16.840.1.114222.4.11.1002/68571-9.json |
| 68572-7 | Ophthalmology Discharge summary | ./2.16.840.1.114222.4.11.1002/68572-7.json |
| 68573-5 | Ophthalmology History and physical note | ./2.16.840.1.114222.4.11.1002/68573-5.json |
| 68574-3 | Ophthalmology Progress note | ./2.16.840.1.114222.4.11.1002/68574-3.json |
| 68575-0 | Ophthalmology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68575-0.json |
| 68576-8 | Ophthalmology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68576-8.json |
| 6857-7 | Spruce IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6857-7.json |
| 68577-6 | Orthopaedic surgery Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68577-6.json |
| 68578-4 | Orthopaedic surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/68578-4.json |
| 685-8 | Respiratory Mycoplasma identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/685-8.json |
| 68580-0 | Orthopaedic surgery History and physical note | ./2.16.840.1.114222.4.11.1002/68580-0.json |
| 68581-8 | Orthopaedic surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68581-8.json |
| 68582-6 | Orthopaedic surgery Progress note | ./2.16.840.1.114222.4.11.1002/68582-6.json |
| 68583-4 | Orthopaedic surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/68583-4.json |
| 6858-5 | Squid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6858-5.json |
| 68585-9 | Orthopaedic surgery Hospital Letter | ./2.16.840.1.114222.4.11.1002/68585-9.json |
| 68586-7 | Pharmacology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68586-7.json |
| 68587-5 | Pharmacology Hospital Medication management note | ./2.16.840.1.114222.4.11.1002/68587-5.json |
| 68590-9 | Physical therapy Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68590-9.json |
| 68591-7 | Plastic surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/68591-7.json |
| 68592-5 | Plastic surgery History and physical note | ./2.16.840.1.114222.4.11.1002/68592-5.json |
| 6859-3 | Tobacco IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6859-3.json |
| 68593-3 | Plastic surgery Letter | ./2.16.840.1.114222.4.11.1002/68593-3.json |
| 68594-1 | Plastic surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68594-1.json |
| 68595-8 | Plastic surgery Progress note | ./2.16.840.1.114222.4.11.1002/68595-8.json |
| 68596-6 | Plastic surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/68596-6.json |
| 68597-4 | Plastic surgery Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68597-4.json |
| 68598-2 | Plastic surgery Hospital Letter | ./2.16.840.1.114222.4.11.1002/68598-2.json |
| 68599-0 | Psychiatry History and physical note | ./2.16.840.1.114222.4.11.1002/68599-0.json |
| 6860-1 | Trichophyton rubrum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6860-1.json |
| 68601-4 | Psychiatry Outpatient Note | ./2.16.840.1.114222.4.11.1002/68601-4.json |
| 68602-2 | Radiation oncology Summary note | ./2.16.840.1.114222.4.11.1002/68602-2.json |
| 68603-0 | Radiation oncology Hospital Summary note | ./2.16.840.1.114222.4.11.1002/68603-0.json |
| 68604-8 | Radiology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68604-8.json |
| 68605-5 | Recreational therapy Hospital Education note | ./2.16.840.1.114222.4.11.1002/68605-5.json |
| 68606-3 | Surgery Hospital Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68606-3.json |
| 68607-1 | Progress letter | ./2.16.840.1.114222.4.11.1002/68607-1.json |
| 68608-9 | Summary note | ./2.16.840.1.114222.4.11.1002/68608-9.json |
| 68609-7 | Hospital Letter | ./2.16.840.1.114222.4.11.1002/68609-7.json |
| 68610-5 | Hospital Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68610-5.json |
| 68611-3 | Adolescent medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68611-3.json |
| 68612-1 | Adolescent medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/68612-1.json |
| 68614-7 | Adolescent medicine History and physical note | ./2.16.840.1.114222.4.11.1002/68614-7.json |
| 68615-4 | Adolescent medicine Note | ./2.16.840.1.114222.4.11.1002/68615-4.json |
| 68616-2 | Adolescent medicine Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68616-2.json |
| 68617-0 | Adolescent medicine Progress note | ./2.16.840.1.114222.4.11.1002/68617-0.json |
| 68618-8 | Adolescent medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/68618-8.json |
| 6861-9 | Vanilla IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6861-9.json |
| 68619-6 | Adolescent medicine Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68619-6.json |
| 68620-4 | Adolescent medicine Hospital Letter | ./2.16.840.1.114222.4.11.1002/68620-4.json |
| 68621-2 | Heart failure+Transplant cardiology Note | ./2.16.840.1.114222.4.11.1002/68621-2.json |
| 68622-0 | Heart failure+Transplant cardiology History and physical note | ./2.16.840.1.114222.4.11.1002/68622-0.json |
| 68623-8 | Heart failure+Transplant cardiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68623-8.json |
| 68624-6 | Heart failure+Transplant cardiology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68624-6.json |
| 68625-3 | Allergy and Immunology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68625-3.json |
| 68626-1 | Allergy and Immunology Discharge summary | ./2.16.840.1.114222.4.11.1002/68626-1.json |
| 6862-7 | Black Willow IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6862-7.json |
| 68628-7 | Allergy and Immunology History and physical note | ./2.16.840.1.114222.4.11.1002/68628-7.json |
| 68629-5 | Allergy and Immunology Note | ./2.16.840.1.114222.4.11.1002/68629-5.json |
| 68630-3 | Allergy and Immunology procedure note | ./2.16.840.1.114222.4.11.1002/68630-3.json |
| 68631-1 | Allergy and Immunology Progress note | ./2.16.840.1.114222.4.11.1002/68631-1.json |
| 68632-9 | Allergy and Immunology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68632-9.json |
| 68633-7 | Allergy and Immunology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68633-7.json |
| 68634-5 | Allergy and Immunology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68634-5.json |
| 68635-2 | Audiology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68635-2.json |
| 68636-0 | Audiology Note | ./2.16.840.1.114222.4.11.1002/68636-0.json |
| 68637-8 | Audiology History and physical note | ./2.16.840.1.114222.4.11.1002/68637-8.json |
| 68638-6 | Audiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68638-6.json |
| 68639-4 | Audiology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68639-4.json |
| 68640-2 | Audiology Hospital Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68640-2.json |
| 68641-0 | Child and adolescent psychiatry Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68641-0.json |
| 68642-8 | Child and adolescent psychiatry Discharge summary | ./2.16.840.1.114222.4.11.1002/68642-8.json |
| 6864-3 | Hemoglobin S [Presence] in Blood by Solubility test | ./2.16.840.1.114222.4.11.1002/6864-3.json |
| 68644-4 | Child and adolescent psychiatry History and physical note | ./2.16.840.1.114222.4.11.1002/68644-4.json |
| 68645-1 | Child and adolescent psychiatry Note | ./2.16.840.1.114222.4.11.1002/68645-1.json |
| 68646-9 | Child and adolescent psychiatry Progress note | ./2.16.840.1.114222.4.11.1002/68646-9.json |
| 68647-7 | Child and adolescent psychiatry Transfer summary note | ./2.16.840.1.114222.4.11.1002/68647-7.json |
| 68648-5 | Child and adolescent psychiatry Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68648-5.json |
| 68649-3 | Child and adolescent psychiatry Hospital Letter | ./2.16.840.1.114222.4.11.1002/68649-3.json |
| 68650-1 | Clinical biochemical genetics Note | ./2.16.840.1.114222.4.11.1002/68650-1.json |
| 68651-9 | Clinical biochemical genetics Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68651-9.json |
| 68652-7 | Clinical genetics Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68652-7.json |
| 68653-5 | Clinical genetics Discharge summary | ./2.16.840.1.114222.4.11.1002/68653-5.json |
| 68655-0 | Clinical genetics History and physical note | ./2.16.840.1.114222.4.11.1002/68655-0.json |
| 68656-8 | Clinical genetics Note | ./2.16.840.1.114222.4.11.1002/68656-8.json |
| 68657-6 | Clinical genetics Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68657-6.json |
| 68658-4 | Clinical genetics procedure note | ./2.16.840.1.114222.4.11.1002/68658-4.json |
| 68659-2 | Clinical genetics Progress note | ./2.16.840.1.114222.4.11.1002/68659-2.json |
| 686-6 | Respiratory Mycoplasma identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/686-6.json |
| 68660-0 | Clinical genetics Transfer summary note | ./2.16.840.1.114222.4.11.1002/68660-0.json |
| 68661-8 | Clinical genetics Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68661-8.json |
| 68662-6 | Clinical genetics Hospital Letter | ./2.16.840.1.114222.4.11.1002/68662-6.json |
| 68663-4 | Developmental-behavioral pediatrics Discharge summary | ./2.16.840.1.114222.4.11.1002/68663-4.json |
| 68665-9 | Developmental-behavioral pediatrics History and physical note | ./2.16.840.1.114222.4.11.1002/68665-9.json |
| 68666-7 | Developmental-behavioral pediatrics Note | ./2.16.840.1.114222.4.11.1002/68666-7.json |
| 68667-5 | Developmental-behavioral pediatrics procedure note | ./2.16.840.1.114222.4.11.1002/68667-5.json |
| 6866-8 | 17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6866-8.json |
| 68668-3 | Developmental-behavioral pediatrics Progress note | ./2.16.840.1.114222.4.11.1002/68668-3.json |
| 68669-1 | Developmental-behavioral pediatrics Transfer summary note | ./2.16.840.1.114222.4.11.1002/68669-1.json |
| 68670-9 | Developmental-behavioral pediatrics Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68670-9.json |
| 68671-7 | Developmental-behavioral pediatrics Hospital Letter | ./2.16.840.1.114222.4.11.1002/68671-7.json |
| 68672-5 | Geriatric medicine Skilled nursing facility Note | ./2.16.840.1.114222.4.11.1002/68672-5.json |
| 68673-3 | Multi-specialty program Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68673-3.json |
| 68674-1 | Multi-specialty program Discharge summary | ./2.16.840.1.114222.4.11.1002/68674-1.json |
| 68676-6 | Multi-specialty program History and physical note | ./2.16.840.1.114222.4.11.1002/68676-6.json |
| 68677-4 | Multi-specialty program Note | ./2.16.840.1.114222.4.11.1002/68677-4.json |
| 68678-2 | Multi-specialty program Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68678-2.json |
| 68679-0 | Multi-specialty program Progress note | ./2.16.840.1.114222.4.11.1002/68679-0.json |
| 68680-8 | Multi-specialty program Transfer summary note | ./2.16.840.1.114222.4.11.1002/68680-8.json |
| 68681-6 | Multi-specialty program Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68681-6.json |
| 68682-4 | Multi-specialty program Hospital Letter | ./2.16.840.1.114222.4.11.1002/68682-4.json |
| 68683-2 | Neonatal perinatal medicine History and physical note | ./2.16.840.1.114222.4.11.1002/68683-2.json |
| 6868-4 | Adenosine monophosphate.cyclic [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/6868-4.json |
| 68684-0 | Neonatal perinatal medicine Letter | ./2.16.840.1.114222.4.11.1002/68684-0.json |
| 68685-7 | Neonatal perinatal medicine Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68685-7.json |
| 68686-5 | Neonatal perinatal medicine Hospital Letter | ./2.16.840.1.114222.4.11.1002/68686-5.json |
| 68687-3 | Neurological surgery Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68687-3.json |
| 68688-1 | Neurological surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/68688-1.json |
| 68690-7 | Neurological surgery History and physical note | ./2.16.840.1.114222.4.11.1002/68690-7.json |
| 68691-5 | Neurological surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68691-5.json |
| 6869-2 | Allo-tetrahydrocortisol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6869-2.json |
| 68692-3 | Neurological surgery procedure note | ./2.16.840.1.114222.4.11.1002/68692-3.json |
| 68693-1 | Neurological surgery Progress note | ./2.16.840.1.114222.4.11.1002/68693-1.json |
| 68694-9 | Neurological surgery Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68694-9.json |
| 68695-6 | Neurological surgery Hospital Letter | ./2.16.840.1.114222.4.11.1002/68695-6.json |
| 68696-4 | Neurology with special qualifications in child neurology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68696-4.json |
| 68697-2 | Neurology with special qualifications in child neurology Discharge summary | ./2.16.840.1.114222.4.11.1002/68697-2.json |
| 68699-8 | Neurology with special qualifications in child neurology History and physical note | ./2.16.840.1.114222.4.11.1002/68699-8.json |
| 68700-4 | Neurology with special qualifications in child neurology Note | ./2.16.840.1.114222.4.11.1002/68700-4.json |
| 68701-2 | Neurology with special qualifications in child neurology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68701-2.json |
| 68702-0 | Neurology with special qualifications in child neurology procedure note | ./2.16.840.1.114222.4.11.1002/68702-0.json |
| 68703-8 | Neurology with special qualifications in child neurology Progress note | ./2.16.840.1.114222.4.11.1002/68703-8.json |
| 68704-6 | Neurology with special qualifications in child neurology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68704-6.json |
| 68705-3 | Neurology with special qualifications in child neurology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68705-3.json |
| 68706-1 | Neurology with special qualifications in child neurology Hospital Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68706-1.json |
| 68707-9 | Neurology with special qualifications in child neurology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68707-9.json |
| 68708-7 | Pain medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68708-7.json |
| 68709-5 | Pain medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/68709-5.json |
| 68711-1 | Pain medicine History and physical note | ./2.16.840.1.114222.4.11.1002/68711-1.json |
| 68713-7 | Pain medicine Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68713-7.json |
| 68714-5 | Pain medicine procedure note | ./2.16.840.1.114222.4.11.1002/68714-5.json |
| 68715-2 | Pain medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/68715-2.json |
| 68716-0 | Pain medicine Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68716-0.json |
| 68717-8 | Pain medicine Hospital Letter | ./2.16.840.1.114222.4.11.1002/68717-8.json |
| 68718-6 | Pediatric cardiology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68718-6.json |
| 68719-4 | Pediatric cardiology Discharge summary | ./2.16.840.1.114222.4.11.1002/68719-4.json |
| 68721-0 | Pediatric cardiology History and physical note | ./2.16.840.1.114222.4.11.1002/68721-0.json |
| 68722-8 | Pediatric cardiology Note | ./2.16.840.1.114222.4.11.1002/68722-8.json |
| 68723-6 | Pediatric cardiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68723-6.json |
| 68724-4 | Pediatric cardiology procedure note | ./2.16.840.1.114222.4.11.1002/68724-4.json |
| 68725-1 | Pediatric cardiology Progress note | ./2.16.840.1.114222.4.11.1002/68725-1.json |
| 68726-9 | Pediatric cardiology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68726-9.json |
| 68727-7 | Pediatric cardiology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68727-7.json |
| 68728-5 | Pediatric cardiology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68728-5.json |
| 68729-3 | Pediatric critical care medicine Hospital procedure note | ./2.16.840.1.114222.4.11.1002/68729-3.json |
| 68731-9 | Pediatric dermatology History and physical note | ./2.16.840.1.114222.4.11.1002/68731-9.json |
| 68732-7 | Pediatric dermatology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68732-7.json |
| 68733-5 | Pediatric endocrinology Discharge summary | ./2.16.840.1.114222.4.11.1002/68733-5.json |
| 6873-4 | Beta hydroxybutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6873-4.json |
| 68735-0 | Pediatric endocrinology History and physical note | ./2.16.840.1.114222.4.11.1002/68735-0.json |
| 68736-8 | Pediatric endocrinology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68736-8.json |
| 68737-6 | Pediatric endocrinology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68737-6.json |
| 68738-4 | Pediatric gastroenterology Discharge summary | ./2.16.840.1.114222.4.11.1002/68738-4.json |
| 687-4 | Mycoplasma sp and Ureaplasma sp [Identifier] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/687-4.json |
| 68740-0 | Pediatric gastroenterology History and physical note | ./2.16.840.1.114222.4.11.1002/68740-0.json |
| 68741-8 | Pediatric gastroenterology Note | ./2.16.840.1.114222.4.11.1002/68741-8.json |
| 6874-2 | Calcium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6874-2.json |
| 68742-6 | Pediatric gastroenterology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68742-6.json |
| 68743-4 | Pediatric gastroenterology procedure note | ./2.16.840.1.114222.4.11.1002/68743-4.json |
| 68744-2 | Pediatric gastroenterology Progress note | ./2.16.840.1.114222.4.11.1002/68744-2.json |
| 68745-9 | Pediatric gastroenterology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68745-9.json |
| 68746-7 | Pediatric gastroenterology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68746-7.json |
| 68747-5 | Pediatric gastroenterology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68747-5.json |
| 68748-3 | Pediatric hematology-oncology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68748-3.json |
| 68749-1 | Pediatric hematology-oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/68749-1.json |
| 68751-7 | Pediatric hematology-oncology History and physical note | ./2.16.840.1.114222.4.11.1002/68751-7.json |
| 68752-5 | Pediatric hematology-oncology Note | ./2.16.840.1.114222.4.11.1002/68752-5.json |
| 68753-3 | Pediatric hematology-oncology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68753-3.json |
| 68754-1 | Pediatric hematology-oncology procedure note | ./2.16.840.1.114222.4.11.1002/68754-1.json |
| 68755-8 | Pediatric hematology-oncology Progress note | ./2.16.840.1.114222.4.11.1002/68755-8.json |
| 68756-6 | Pediatric hematology-oncology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68756-6.json |
| 68757-4 | Pediatric hematology-oncology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68757-4.json |
| 68758-2 | Pediatric hematology-oncology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68758-2.json |
| 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6875-9.json |
| 68760-8 | Pediatric infectious diseases History and physical note | ./2.16.840.1.114222.4.11.1002/68760-8.json |
| 68761-6 | Pediatric infectious diseases Note | ./2.16.840.1.114222.4.11.1002/68761-6.json |
| 68762-4 | Pediatric infectious diseases Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68762-4.json |
| 68763-2 | Pediatric infectious diseases Progress note | ./2.16.840.1.114222.4.11.1002/68763-2.json |
| 68764-0 | Pediatric infectious diseases Transfer summary note | ./2.16.840.1.114222.4.11.1002/68764-0.json |
| 68765-7 | Pediatric infectious diseases Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68765-7.json |
| 68766-5 | Pediatric infectious diseases Hospital Letter | ./2.16.840.1.114222.4.11.1002/68766-5.json |
| 68767-3 | Pediatric nephrology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68767-3.json |
| 68768-1 | Pediatric nephrology Discharge summary | ./2.16.840.1.114222.4.11.1002/68768-1.json |
| 68770-7 | Pediatric nephrology History and physical note | ./2.16.840.1.114222.4.11.1002/68770-7.json |
| 68771-5 | Pediatric nephrology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68771-5.json |
| 68772-3 | Pediatric nephrology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68772-3.json |
| 68773-1 | Pediatric otolaryngology Discharge summary | ./2.16.840.1.114222.4.11.1002/68773-1.json |
| 68775-6 | Pediatric otolaryngology History and physical note | ./2.16.840.1.114222.4.11.1002/68775-6.json |
| 68776-4 | Pediatric otolaryngology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68776-4.json |
| 68777-2 | Pediatric otolaryngology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68777-2.json |
| 68778-0 | Pediatric pulmonology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68778-0.json |
| 68779-8 | Pediatric pulmonology Discharge summary | ./2.16.840.1.114222.4.11.1002/68779-8.json |
| 68781-4 | Pediatric pulmonology History and physical note | ./2.16.840.1.114222.4.11.1002/68781-4.json |
| 68782-2 | Pediatric pulmonology Note | ./2.16.840.1.114222.4.11.1002/68782-2.json |
| 68783-0 | Pediatric pulmonology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68783-0.json |
| 68784-8 | Pediatric pulmonology procedure note | ./2.16.840.1.114222.4.11.1002/68784-8.json |
| 68785-5 | Pediatric pulmonology Progress note | ./2.16.840.1.114222.4.11.1002/68785-5.json |
| 68786-3 | Pediatric pulmonology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68786-3.json |
| 68787-1 | Pediatric pulmonology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68787-1.json |
| 68788-9 | Pediatric pulmonology Hospital Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68788-9.json |
| 68789-7 | Pediatric pulmonology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68789-7.json |
| 6879-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/6879-1.json |
| 68791-3 | Pediatric rheumatology History and physical note | ./2.16.840.1.114222.4.11.1002/68791-3.json |
| 68792-1 | Pediatric rheumatology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68792-1.json |
| 68793-9 | Pediatric rheumatology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68793-9.json |
| 68794-7 | Pediatric surgery Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68794-7.json |
| 68795-4 | Pediatric surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/68795-4.json |
| 68797-0 | Pediatric surgery History and physical note | ./2.16.840.1.114222.4.11.1002/68797-0.json |
| 68798-8 | Pediatric surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68798-8.json |
| 68799-6 | Pediatric surgery procedure note | ./2.16.840.1.114222.4.11.1002/68799-6.json |
| 68800-2 | Pediatric surgery Progress note | ./2.16.840.1.114222.4.11.1002/68800-2.json |
| 68801-0 | Pediatric surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/68801-0.json |
| 68802-8 | Pediatric surgery Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68802-8.json |
| 68803-6 | Pediatric surgery Hospital Letter | ./2.16.840.1.114222.4.11.1002/68803-6.json |
| 68804-4 | Pediatric urology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68804-4.json |
| 68805-1 | Pediatric urology Discharge summary | ./2.16.840.1.114222.4.11.1002/68805-1.json |
| 68807-7 | Pediatric urology History and physical note | ./2.16.840.1.114222.4.11.1002/68807-7.json |
| 68808-5 | Pediatric urology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68808-5.json |
| 68809-3 | Pediatric urology procedure note | ./2.16.840.1.114222.4.11.1002/68809-3.json |
| 68810-1 | Pediatric urology Progress note | ./2.16.840.1.114222.4.11.1002/68810-1.json |
| 68811-9 | Pediatric urology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68811-9.json |
| 68812-7 | Pediatric urology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68812-7.json |
| 68813-5 | Pediatric urology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68813-5.json |
| 68814-3 | Pediatrics Evaluation note | ./2.16.840.1.114222.4.11.1002/68814-3.json |
| 68815-0 | Pediatrics Discharge summary | ./2.16.840.1.114222.4.11.1002/68815-0.json |
| 68817-6 | Pediatrics History and physical note | ./2.16.840.1.114222.4.11.1002/68817-6.json |
| 68818-4 | Pediatrics Note | ./2.16.840.1.114222.4.11.1002/68818-4.json |
| 68819-2 | Pediatrics Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68819-2.json |
| 688-2 | Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture | ./2.16.840.1.114222.4.11.1002/688-2.json |
| 68820-0 | Pediatrics procedure note | ./2.16.840.1.114222.4.11.1002/68820-0.json |
| 68821-8 | Pediatrics Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68821-8.json |
| 68822-6 | Pediatrics Hospital Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68822-6.json |
| 68823-4 | Pediatrics Hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/68823-4.json |
| 68825-9 | Pediatrics Hospital History and physical note | ./2.16.840.1.114222.4.11.1002/68825-9.json |
| 68826-7 | Pediatrics Hospital Letter | ./2.16.840.1.114222.4.11.1002/68826-7.json |
| 68827-5 | Pediatrics Hospital Note | ./2.16.840.1.114222.4.11.1002/68827-5.json |
| 68828-3 | Pediatrics Hospital Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68828-3.json |
| 68829-1 | Pediatrics Hospital procedure note | ./2.16.840.1.114222.4.11.1002/68829-1.json |
| 68830-9 | Pediatrics Hospital Progress note | ./2.16.840.1.114222.4.11.1002/68830-9.json |
| 68831-7 | Primary care Discharge summary | ./2.16.840.1.114222.4.11.1002/68831-7.json |
| 6883-3 | Glucose.protein bound [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6883-3.json |
| 68833-3 | Primary care History and physical note | ./2.16.840.1.114222.4.11.1002/68833-3.json |
| 68834-1 | Primary care Note | ./2.16.840.1.114222.4.11.1002/68834-1.json |
| 68835-8 | Primary care Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68835-8.json |
| 68836-6 | Primary care procedure note | ./2.16.840.1.114222.4.11.1002/68836-6.json |
| 68837-4 | Primary care Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68837-4.json |
| 68838-2 | Primary care Hospital Letter | ./2.16.840.1.114222.4.11.1002/68838-2.json |
| 68839-0 | Research Note | ./2.16.840.1.114222.4.11.1002/68839-0.json |
| 68840-8 | Research Progress note | ./2.16.840.1.114222.4.11.1002/68840-8.json |
| 68841-6 | Speech-language pathology Discharge summary | ./2.16.840.1.114222.4.11.1002/68841-6.json |
| 68843-2 | Speech-language pathology History and physical note | ./2.16.840.1.114222.4.11.1002/68843-2.json |
| 68844-0 | Speech-language pathology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68844-0.json |
| 68846-5 | Speech-language pathology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68846-5.json |
| 68847-3 | Speech-language pathology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68847-3.json |
| 68848-1 | Transplant surgery Note | ./2.16.840.1.114222.4.11.1002/68848-1.json |
| 68849-9 | Transplant surgery History and physical note | ./2.16.840.1.114222.4.11.1002/68849-9.json |
| 68850-7 | Transplant surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68850-7.json |
| 68851-5 | Transplant surgery procedure note | ./2.16.840.1.114222.4.11.1002/68851-5.json |
| 68852-3 | Transplant surgery Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68852-3.json |
| 68853-1 | Transplant surgery Hospital Letter | ./2.16.840.1.114222.4.11.1002/68853-1.json |
| 68854-9 | Pediatric rehabilitation medicine Note | ./2.16.840.1.114222.4.11.1002/68854-9.json |
| 68855-6 | Pediatric transplant hepatology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/68855-6.json |
| 68856-4 | Pediatric transplant hepatology Discharge summary | ./2.16.840.1.114222.4.11.1002/68856-4.json |
| 68858-0 | Pediatric transplant hepatology History and physical note | ./2.16.840.1.114222.4.11.1002/68858-0.json |
| 68859-8 | Pediatric transplant hepatology Note | ./2.16.840.1.114222.4.11.1002/68859-8.json |
| 68860-6 | Pediatric transplant hepatology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/68860-6.json |
| 68861-4 | Pediatric transplant hepatology procedure note | ./2.16.840.1.114222.4.11.1002/68861-4.json |
| 68862-2 | Pediatric transplant hepatology Progress note | ./2.16.840.1.114222.4.11.1002/68862-2.json |
| 68863-0 | Pediatric transplant hepatology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68863-0.json |
| 68864-8 | Pediatric transplant hepatology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68864-8.json |
| 68865-5 | Pediatric transplant hepatology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68865-5.json |
| 6886-6 | IgA subclass 1 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6886-6.json |
| 68866-3 | Pediatric nephrology Letter | ./2.16.840.1.114222.4.11.1002/68866-3.json |
| 68867-1 | Pediatric nephrology Note | ./2.16.840.1.114222.4.11.1002/68867-1.json |
| 68868-9 | Pediatric nephrology procedure note | ./2.16.840.1.114222.4.11.1002/68868-9.json |
| 68869-7 | Pediatric nephrology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68869-7.json |
| 68870-5 | Pediatric nephrology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68870-5.json |
| 68871-3 | Pediatric otolaryngology Note | ./2.16.840.1.114222.4.11.1002/68871-3.json |
| 68872-1 | Pediatric otolaryngology procedure note | ./2.16.840.1.114222.4.11.1002/68872-1.json |
| 68873-9 | Pediatric otolaryngology Progress note | ./2.16.840.1.114222.4.11.1002/68873-9.json |
| 6887-4 | Indicans [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6887-4.json |
| 68874-7 | Pediatric otolaryngology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68874-7.json |
| 68875-4 | Pediatric otolaryngology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68875-4.json |
| 68876-2 | Pediatric rheumatology Note | ./2.16.840.1.114222.4.11.1002/68876-2.json |
| 68877-0 | Pediatric rheumatology procedure note | ./2.16.840.1.114222.4.11.1002/68877-0.json |
| 68878-8 | Pediatric rheumatology Progress note | ./2.16.840.1.114222.4.11.1002/68878-8.json |
| 68879-6 | Pediatric rheumatology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68879-6.json |
| 68880-4 | Pediatric rheumatology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68880-4.json |
| 68881-2 | Pediatric surgery Note | ./2.16.840.1.114222.4.11.1002/68881-2.json |
| 68882-0 | Pediatric urology Note | ./2.16.840.1.114222.4.11.1002/68882-0.json |
| 68883-8 | Pediatrics Transfer summary note | ./2.16.840.1.114222.4.11.1002/68883-8.json |
| 68884-6 | Pediatrics Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/68884-6.json |
| 68887-9 | Ophthalmology Transfer summary note | ./2.16.840.1.114222.4.11.1002/68887-9.json |
| 68889-5 | Pediatric dermatology Note | ./2.16.840.1.114222.4.11.1002/68889-5.json |
| 68890-3 | Pediatric dermatology procedure note | ./2.16.840.1.114222.4.11.1002/68890-3.json |
| 68891-1 | Pediatric dermatology Progress note | ./2.16.840.1.114222.4.11.1002/68891-1.json |
| 68892-9 | Pediatric dermatology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68892-9.json |
| 68893-7 | Pediatric dermatology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68893-7.json |
| 68894-5 | Pediatric endocrinology Note | ./2.16.840.1.114222.4.11.1002/68894-5.json |
| 68895-2 | Pediatric endocrinology procedure note | ./2.16.840.1.114222.4.11.1002/68895-2.json |
| 68896-0 | Pediatric endocrinology Progress note | ./2.16.840.1.114222.4.11.1002/68896-0.json |
| 68897-8 | Pediatric endocrinology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/68897-8.json |
| 68898-6 | Pediatric endocrinology Hospital Letter | ./2.16.840.1.114222.4.11.1002/68898-6.json |
| 68901-8 | Erythrocytes [Presence] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/68901-8.json |
| 68910-9 | Teratozoospermia index in Semen | ./2.16.840.1.114222.4.11.1002/68910-9.json |
| 68913-3 | Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/68913-3.json |
| 68923-2 | Cancer Ag 125 [Units/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/68923-2.json |
| 6892-4 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis | ./2.16.840.1.114222.4.11.1002/6892-4.json |
| 68924-0 | Cancer Ag 72-4 [Units/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/68924-0.json |
| 68925-7 | Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/68925-7.json |
| 68926-5 | Cancer Ag 72-4 [Units/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/68926-5.json |
| 68927-3 | Cytokeratin 19 [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/68927-3.json |
| 68928-1 | Cytokeratin 19 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/68928-1.json |
| 68929-9 | Cytokeratin 19 [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/68929-9.json |
| 68931-5 | Catecholamines Free [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/68931-5.json |
| 6893-2 | Urobilinogen [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/6893-2.json |
| 68932-3 | IgA.secretory [Mass/volume] in Tear | ./2.16.840.1.114222.4.11.1002/68932-3.json |
| 68933-1 | IgA.secretory [Mass/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/68933-1.json |
| 68934-9 | Heat shock protein 60 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/68934-9.json |
| 68935-6 | LDL.oxidized Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68935-6.json |
| 68936-4 | Baker's yeast Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68936-4.json |
| 68937-2 | Acetylcholine receptor Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68937-2.json |
| 68938-0 | Cytokeratin 19 [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/68938-0.json |
| 68939-8 | Enolase.neuron specific [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/68939-8.json |
| 6894-0 | Zidovudine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6894-0.json |
| 68943-0 | Voltage-gated potassium channel Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/68943-0.json |
| 68944-8 | Listeria monocytogenes IgG Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/68944-8.json |
| 68945-5 | CD3+CD5+ cells [#/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/68945-5.json |
| 68948-9 | Candida albicans Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68948-9.json |
| 68949-7 | Ehrlichia chaffeensis Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68949-7.json |
| 68950-5 | Herpes virus 8 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/68950-5.json |
| 68952-1 | Enolase.neuron specific [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/68952-1.json |
| 68954-7 | Streptococcus pyogenes rRNA [Presence] in Throat by Probe | ./2.16.840.1.114222.4.11.1002/68954-7.json |
| 68955-4 | Ketones [Presence] in Blood by Tablet | ./2.16.840.1.114222.4.11.1002/68955-4.json |
| 68956-2 | DNA double strand IgG Ab [Units/volume] in Pericardial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/68956-2.json |
| 6895-7 | Butalbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6895-7.json |
| 68958-8 | Microscopic observation [Identifier] in Urine by KOH preparation | ./2.16.840.1.114222.4.11.1002/68958-8.json |
| 68960-4 | Myoglobin [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/68960-4.json |
| 68961-2 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/68961-2.json |
| 68962-0 | Phenylbutazone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/68962-0.json |
| 68964-6 | LAN Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/68964-6.json |
| 6896-5 | cloZAPine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6896-5.json |
| 68965-3 | Rg Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/68965-3.json |
| 68966-1 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/68966-1.json |
| 68967-9 | Dantu Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/68967-9.json |
| 68970-3 | Gamma hydroxybutyrate [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/68970-3.json |
| 68971-1 | Color of Vitreous fluid | ./2.16.840.1.114222.4.11.1002/68971-1.json |
| 6897-3 | Norsertraline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6897-3.json |
| 68976-0 | Pseudomonas aeruginosa alkaline protease Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68976-0.json |
| 68977-8 | Pseudomonas aeruginosa elastase Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68977-8.json |
| 68978-6 | Pseudomonas aeruginosa exotoxin A Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/68978-6.json |
| 68979-4 | Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/68979-4.json |
| 68980-2 | Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/68980-2.json |
| 6898-1 | dilTIAZem [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6898-1.json |
| 68981-0 | Argatroban [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/68981-0.json |
| 6899-9 | Felbamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6899-9.json |
| 69002-4 | Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69002-4.json |
| 69007-3 | Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69007-3.json |
| 69009-9 | Cocaine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69009-9.json |
| 69010-7 | Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69010-7.json |
| 69011-5 | Cocaethylene [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69011-5.json |
| 69012-3 | 3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69012-3.json |
| 6901-3 | Insulin Free [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6901-3.json |
| 69015-6 | Lymphocyte proliferation.Candida albicans.maximum/CD3 in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/69015-6.json |
| 69022-2 | Methamphetamine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69022-2.json |
| 69023-0 | Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69023-0.json |
| 69024-8 | Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69024-8.json |
| 69025-5 | Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69025-5.json |
| 69027-1 | Morphine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69027-1.json |
| 69028-9 | oxyMORphone [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/69028-9.json |
| 69030-5 | Enterocyte IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/69030-5.json |
| 69031-3 | Enterocyte IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/69031-3.json |
| 69032-1 | Enterocyte IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/69032-1.json |
| 6903-9 | Norverapamil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6903-9.json |
| 69048-7 | Immunologist review of results | ./2.16.840.1.114222.4.11.1002/69048-7.json |
| 6905-4 | Propafenone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6905-4.json |
| 69054-5 | RFA Aortic arch Views W contrast IA | ./2.16.840.1.114222.4.11.1002/69054-5.json |
| 69055-2 | XR Acromioclavicular joint - bilateral Views WO weight | ./2.16.840.1.114222.4.11.1002/69055-2.json |
| 69056-0 | XR Elbow - bilateral Views and Obliques | ./2.16.840.1.114222.4.11.1002/69056-0.json |
| 69057-8 | XR Hand - bilateral AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/69057-8.json |
| 69058-6 | XR Hip - bilateral 2 Views | ./2.16.840.1.114222.4.11.1002/69058-6.json |
| 69059-4 | XR Hip - bilateral Views and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/69059-4.json |
| 69060-2 | XR Knee - bilateral 2 Views and Sunrise | ./2.16.840.1.114222.4.11.1002/69060-2.json |
| 69061-0 | XR Knee - bilateral 2 Views and Tunnel | ./2.16.840.1.114222.4.11.1002/69061-0.json |
| 6906-2 | Sertraline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6906-2.json |
| 69062-8 | XR Knee - bilateral 4 Views W standing | ./2.16.840.1.114222.4.11.1002/69062-8.json |
| 69063-6 | XR Knee - bilateral 4 Views and Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/69063-6.json |
| 69064-4 | XR Knee - bilateral Sunrise and (Views W standing) | ./2.16.840.1.114222.4.11.1002/69064-4.json |
| 69065-1 | XR Abdomen AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/69065-1.json |
| 69066-9 | RFA Abdominal vessels Views W contrast IV | ./2.16.840.1.114222.4.11.1002/69066-9.json |
| 69067-7 | RFA Guidance for angioplasty of Unspecified body region-- W contrast | ./2.16.840.1.114222.4.11.1002/69067-7.json |
| 69068-5 | MG Guidance for needle localization of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/69068-5.json |
| 69069-3 | XR Patella - bilateral Sunrise | ./2.16.840.1.114222.4.11.1002/69069-3.json |
| 6907-0 | sulfADIAZINE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6907-0.json |
| 69070-1 | XR Ribs - bilateral Anterior and Lateral | ./2.16.840.1.114222.4.11.1002/69070-1.json |
| 69071-9 | XR Ribs - bilateral and Chest Views | ./2.16.840.1.114222.4.11.1002/69071-9.json |
| 69072-7 | XR Wrist - bilateral Ulnar deviation and Radial deviation | ./2.16.840.1.114222.4.11.1002/69072-7.json |
| 69073-5 | RF Guidance for core needle biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/69073-5.json |
| 69074-3 | RF Guidance for biopsy of Pelvis | ./2.16.840.1.114222.4.11.1002/69074-3.json |
| 69075-0 | RF Guidance for biopsy of Salivary gland | ./2.16.840.1.114222.4.11.1002/69075-0.json |
| 69076-8 | RF guidance for percutaneous biopsy of Bone | ./2.16.840.1.114222.4.11.1002/69076-8.json |
| 69077-6 | RFA Brachiocephalic artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/69077-6.json |
| 69078-4 | RF Guidance for drainage and placement of drainage catheter of Chest | ./2.16.840.1.114222.4.11.1002/69078-4.json |
| 69079-2 | XR Clavicle 45 degree cephalic angle | ./2.16.840.1.114222.4.11.1002/69079-2.json |
| 690-8 | Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture | ./2.16.840.1.114222.4.11.1002/690-8.json |
| 69080-0 | XR Cervical spine 5 Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/69080-0.json |
| 69081-8 | XR Cervical spine 5 Views and Swimmers | ./2.16.840.1.114222.4.11.1002/69081-8.json |
| 69083-4 | CT Guidance for biopsy of Abdomen-- WO contrast | ./2.16.840.1.114222.4.11.1002/69083-4.json |
| 69084-2 | CTA Chest vessels WO contrast | ./2.16.840.1.114222.4.11.1002/69084-2.json |
| 69087-5 | CT Ankle - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69087-5.json |
| 6908-8 | Complement C4 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/6908-8.json |
| 69088-3 | CT Knee - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69088-3.json |
| 69089-1 | CT Knee - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69089-1.json |
| 69090-9 | CT Shoulder - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69090-9.json |
| 69091-7 | CT Wrist - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69091-7.json |
| 69092-5 | CT Guidance for biopsy of Liver-- WO contrast | ./2.16.840.1.114222.4.11.1002/69092-5.json |
| 69093-3 | CT Guidance for biopsy of Pelvis-- W contrast IV | ./2.16.840.1.114222.4.11.1002/69093-3.json |
| 69094-1 | CT Guidance for biopsy of Pelvis-- WO contrast | ./2.16.840.1.114222.4.11.1002/69094-1.json |
| 69095-8 | CT Urinary bladder W contrast IV | ./2.16.840.1.114222.4.11.1002/69095-8.json |
| 6909-6 | Mucin clot [Appearance] in Synovial fluid Qualitative | ./2.16.840.1.114222.4.11.1002/6909-6.json |
| 69096-6 | CT Chest limited W contrast IV | ./2.16.840.1.114222.4.11.1002/69096-6.json |
| 69102-2 | CT Ankle - left Arthrogram | ./2.16.840.1.114222.4.11.1002/69102-2.json |
| 69103-0 | CT Elbow - left Arthrogram | ./2.16.840.1.114222.4.11.1002/69103-0.json |
| 6910-4 | Brucella abortus IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6910-4.json |
| 69104-8 | CT Extremity - left WO contrast | ./2.16.840.1.114222.4.11.1002/69104-8.json |
| 69105-5 | CT Hip - left Arthrogram | ./2.16.840.1.114222.4.11.1002/69105-5.json |
| 69106-3 | CT Knee - left Arthrogram | ./2.16.840.1.114222.4.11.1002/69106-3.json |
| 69107-1 | CT Wrist - left Arthrogram | ./2.16.840.1.114222.4.11.1002/69107-1.json |
| 69109-7 | CT Ankle - right Arthrogram | ./2.16.840.1.114222.4.11.1002/69109-7.json |
| 69110-5 | CT Elbow - right Arthrogram | ./2.16.840.1.114222.4.11.1002/69110-5.json |
| 69111-3 | CT Extremity - right WO contrast | ./2.16.840.1.114222.4.11.1002/69111-3.json |
| 6911-2 | Brucella abortus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6911-2.json |
| 69112-1 | CT Hip - right Arthrogram | ./2.16.840.1.114222.4.11.1002/69112-1.json |
| 69113-9 | CT Kidney - right | ./2.16.840.1.114222.4.11.1002/69113-9.json |
| 69114-7 | CT Knee - right Arthrogram | ./2.16.840.1.114222.4.11.1002/69114-7.json |
| 69115-4 | CT Wrist - right Arthrogram | ./2.16.840.1.114222.4.11.1002/69115-4.json |
| 69116-2 | CT Sacrum and Coccyx | ./2.16.840.1.114222.4.11.1002/69116-2.json |
| 69117-0 | CT Scapula | ./2.16.840.1.114222.4.11.1002/69117-0.json |
| 69118-8 | CT Scapula WO contrast | ./2.16.840.1.114222.4.11.1002/69118-8.json |
| 69119-6 | CTA Thoracic Aorta WO contrast | ./2.16.840.1.114222.4.11.1002/69119-6.json |
| 6912-0 | Chlamydophila pneumoniae IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6912-0.json |
| 69120-4 | RF Guidance for drainage of abscess and placement of drainage catheter of Neck | ./2.16.840.1.114222.4.11.1002/69120-4.json |
| 69121-2 | RF Guidance for aspiration of cyst of Ovary | ./2.16.840.1.114222.4.11.1002/69121-2.json |
| 69122-0 | RF Guidance for drainage of abscess and placement of drainage catheter of Pancreas | ./2.16.840.1.114222.4.11.1002/69122-0.json |
| 69123-8 | RF Guidance for drainage of abscess and placement of chest tube of Pleural space | ./2.16.840.1.114222.4.11.1002/69123-8.json |
| 69124-6 | RF Guidance for superficial aspiration.fine needle of Tissue | ./2.16.840.1.114222.4.11.1002/69124-6.json |
| 69127-9 | RF Guidance for biopsy of Chest Pleura | ./2.16.840.1.114222.4.11.1002/69127-9.json |
| 69129-5 | RF Guidance for biopsy of Thyroid gland | ./2.16.840.1.114222.4.11.1002/69129-5.json |
| 69130-3 | XR Hand AP and Lateral | ./2.16.840.1.114222.4.11.1002/69130-3.json |
| 69131-1 | XR Hip Views and Danelius Miller | ./2.16.840.1.114222.4.11.1002/69131-1.json |
| 69132-9 | XR Hip Danelius Miller | ./2.16.840.1.114222.4.11.1002/69132-9.json |
| 69133-7 | RF Guidance for drainage and placement of drainage catheter of Hip | ./2.16.840.1.114222.4.11.1002/69133-7.json |
| 69134-5 | RFA Guidance for placement of stent in Iliac artery | ./2.16.840.1.114222.4.11.1002/69134-5.json |
| 69135-2 | RFA Guidance for atherectomy of Iliac artery-- W contrast | ./2.16.840.1.114222.4.11.1002/69135-2.json |
| 69136-0 | XR Knee Sunrise and Tunnel | ./2.16.840.1.114222.4.11.1002/69136-0.json |
| 69137-8 | XR Ankle - left AP and Lateral and oblique W standing | ./2.16.840.1.114222.4.11.1002/69137-8.json |
| 6913-8 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6913-8.json |
| 69138-6 | XR Ankle - left 3 Views W standing | ./2.16.840.1.114222.4.11.1002/69138-6.json |
| 69139-4 | XR Hip - left Views and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/69139-4.json |
| 69140-2 | XR Hip - left Views and Danelius Miller | ./2.16.840.1.114222.4.11.1002/69140-2.json |
| 69141-0 | XR Hip - left Danelius Miller | ./2.16.840.1.114222.4.11.1002/69141-0.json |
| 69142-8 | XR Knee - left 2 Views and Sunrise | ./2.16.840.1.114222.4.11.1002/69142-8.json |
| 69143-6 | XR Knee - left 2 views and (Tunnel W standing) | ./2.16.840.1.114222.4.11.1002/69143-6.json |
| 69144-4 | XR Knee - left 4 views and (AP W standing) | ./2.16.840.1.114222.4.11.1002/69144-4.json |
| 69145-1 | XR Knee - left 4 views and Tunnel | ./2.16.840.1.114222.4.11.1002/69145-1.json |
| 6914-6 | Chlamydophila pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6914-6.json |
| 69146-9 | XR Knee - left AP and Lateral crosstable | ./2.16.840.1.114222.4.11.1002/69146-9.json |
| 69147-7 | XR Knee - left AP and Lateral and Right oblique and Left oblique | ./2.16.840.1.114222.4.11.1002/69147-7.json |
| 69148-5 | XR Knee - left Views and Tunnel | ./2.16.840.1.114222.4.11.1002/69148-5.json |
| 69149-3 | XR Knee - left Sunrise and (Views W standing) | ./2.16.840.1.114222.4.11.1002/69149-3.json |
| 69150-1 | MG Breast - left Diagnostic for implant | ./2.16.840.1.114222.4.11.1002/69150-1.json |
| 69151-9 | XR Wrist - left 3 Scaphoid Views | ./2.16.840.1.114222.4.11.1002/69151-9.json |
| 69152-7 | XR Patella - left Single view | ./2.16.840.1.114222.4.11.1002/69152-7.json |
| 6915-3 | Chlamydophila psittaci IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6915-3.json |
| 69153-5 | XR Shoulder - left AP and Grashey and Axillary | ./2.16.840.1.114222.4.11.1002/69153-5.json |
| 69154-3 | XR Shoulder - left 3 Views and Axillary | ./2.16.840.1.114222.4.11.1002/69154-3.json |
| 69155-0 | XR Shoulder - left 3 Views and Y | ./2.16.840.1.114222.4.11.1002/69155-0.json |
| 69156-8 | XR Shoulder - left Grashey and Y | ./2.16.840.1.114222.4.11.1002/69156-8.json |
| 69157-6 | XR Wrist - left Lateral Views W flexion and W extension | ./2.16.840.1.114222.4.11.1002/69157-6.json |
| 69158-4 | XR Breast Diagnostic for implant | ./2.16.840.1.114222.4.11.1002/69158-4.json |
| 69159-2 | XR Breast Screening for implant | ./2.16.840.1.114222.4.11.1002/69159-2.json |
| 691-6 | Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/691-6.json |
| 6916-1 | Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6916-1.json |
| 69161-8 | MRA Circle of Willis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69161-8.json |
| 69162-6 | MRA Pulmonary artery - bilateral W contrast IA | ./2.16.840.1.114222.4.11.1002/69162-6.json |
| 69163-4 | MR Ankle - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69163-4.json |
| 69164-2 | MR Ankle - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69164-2.json |
| 69165-9 | MR Breast - bilateral for implant | ./2.16.840.1.114222.4.11.1002/69165-9.json |
| 69166-7 | MR Breast - bilateral for implant WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69166-7.json |
| 69167-5 | MR Breast - bilateral for implant W contrast IV | ./2.16.840.1.114222.4.11.1002/69167-5.json |
| 69168-3 | MR Breast - bilateral for implant WO contrast | ./2.16.840.1.114222.4.11.1002/69168-3.json |
| 69169-1 | MR Guidance for biopsy of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/69169-1.json |
| 69170-9 | MR Elbow - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69170-9.json |
| 69171-7 | MR Elbow - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69171-7.json |
| 69172-5 | MR Femur - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69172-5.json |
| 69173-3 | MR Femur - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69173-3.json |
| 69174-1 | MR Forearm - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69174-1.json |
| 69175-8 | MR Forearm - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69175-8.json |
| 69176-6 | MR Forearm - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69176-6.json |
| 69177-4 | MR Hand - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69177-4.json |
| 69178-2 | MR Hand - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69178-2.json |
| 6917-9 | Chlamydophila psittaci IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6917-9.json |
| 69179-0 | MR Hand - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69179-0.json |
| 69180-8 | MR Upper arm - bilateral | ./2.16.840.1.114222.4.11.1002/69180-8.json |
| 69181-6 | MR Upper arm - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69181-6.json |
| 69182-4 | MR Upper arm - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69182-4.json |
| 69183-2 | MR Upper arm - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69183-2.json |
| 69184-0 | MR Shoulder - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69184-0.json |
| 69185-7 | MR Lower leg - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69185-7.json |
| 69186-5 | MR Upper extremity - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69186-5.json |
| 6918-7 | Chlamydia trachomatis IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6918-7.json |
| 69187-3 | MR Upper extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/69187-3.json |
| 69188-1 | MR Upper extremity - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/69188-1.json |
| 69189-9 | MR Breast for implant WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69189-9.json |
| 69190-7 | MR Breast for implant W contrast IV | ./2.16.840.1.114222.4.11.1002/69190-7.json |
| 69191-5 | MR Breast for implant WO contrast | ./2.16.840.1.114222.4.11.1002/69191-5.json |
| 69192-3 | MR Guidance for aspiration of cyst of Breast | ./2.16.840.1.114222.4.11.1002/69192-3.json |
| 69193-1 | MR Extremity | ./2.16.840.1.114222.4.11.1002/69193-1.json |
| 69194-9 | MR Finger WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69194-9.json |
| 6919-5 | Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6919-5.json |
| 69195-6 | MR Finger W contrast IV | ./2.16.840.1.114222.4.11.1002/69195-6.json |
| 69196-4 | MR Finger WO contrast | ./2.16.840.1.114222.4.11.1002/69196-4.json |
| 69197-2 | MR Guidance for biopsy of Liver | ./2.16.840.1.114222.4.11.1002/69197-2.json |
| 69198-0 | MR Guidance for biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/69198-0.json |
| 69199-8 | MR Guidance for biopsy of Pancreas | ./2.16.840.1.114222.4.11.1002/69199-8.json |
| 69200-4 | MR Guidance for biopsy of Chest Pleura | ./2.16.840.1.114222.4.11.1002/69200-4.json |
| 69201-2 | MR Guidance for biopsy of Salivary gland | ./2.16.840.1.114222.4.11.1002/69201-2.json |
| 69202-0 | MR Guidance for biopsy of Thyroid gland | ./2.16.840.1.114222.4.11.1002/69202-0.json |
| 6920-3 | Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6920-3.json |
| 69203-8 | MR Guidance for biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/69203-8.json |
| 69204-6 | MR Finger - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69204-6.json |
| 69205-3 | MR Finger - left W contrast IV | ./2.16.840.1.114222.4.11.1002/69205-3.json |
| 69206-1 | MR Finger - left WO contrast | ./2.16.840.1.114222.4.11.1002/69206-1.json |
| 69207-9 | MR Hip - left Arthrogram WO and W contrast | ./2.16.840.1.114222.4.11.1002/69207-9.json |
| 69208-7 | MR Shoulder - left Arthrogram WO and W contrast | ./2.16.840.1.114222.4.11.1002/69208-7.json |
| 69209-5 | MR Wrist - left and Hand - left | ./2.16.840.1.114222.4.11.1002/69209-5.json |
| 69210-3 | MR Lower Extremity Joint Arthrogram | ./2.16.840.1.114222.4.11.1002/69210-3.json |
| 6921-1 | Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/6921-1.json |
| 69211-1 | MR Nasal bones | ./2.16.840.1.114222.4.11.1002/69211-1.json |
| 69212-9 | MR Pelvis limited | ./2.16.840.1.114222.4.11.1002/69212-9.json |
| 69213-7 | MR Guidance for biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/69213-7.json |
| 69214-5 | MR Finger - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69214-5.json |
| 69215-2 | MR Finger - right W contrast IV | ./2.16.840.1.114222.4.11.1002/69215-2.json |
| 69216-0 | MR Finger - right WO contrast | ./2.16.840.1.114222.4.11.1002/69216-0.json |
| 69217-8 | MR Hip - right Arthrogram WO and W contrast | ./2.16.840.1.114222.4.11.1002/69217-8.json |
| 69218-6 | MR Shoulder - right Arthrogram WO and W contrast | ./2.16.840.1.114222.4.11.1002/69218-6.json |
| 69219-4 | MR Wrist - right and Hand - right | ./2.16.840.1.114222.4.11.1002/69219-4.json |
| 69220-2 | MR Skull base WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/69220-2.json |
| 69221-0 | MR Scrotum and testicle W contrast IV | ./2.16.840.1.114222.4.11.1002/69221-0.json |
| 69222-8 | MR Vena cava | ./2.16.840.1.114222.4.11.1002/69222-8.json |
| 69223-6 | MR Unspecified body region WO contrast | ./2.16.840.1.114222.4.11.1002/69223-6.json |
| 69226-9 | RF Guidance for biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/69226-9.json |
| 6922-9 | Echovirus 7 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6922-9.json |
| 69229-3 | SPECT Liver W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/69229-3.json |
| 69230-1 | NM Liver Views W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/69230-1.json |
| 69231-9 | NM Heart Views W stress and W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/69231-9.json |
| 69232-7 | NM Heart Views W stress and W Tc-99m Sestamibi IV | ./2.16.840.1.114222.4.11.1002/69232-7.json |
| 69233-5 | NM Parotid gland Views W Tc-99m pertechnetate IV | ./2.16.840.1.114222.4.11.1002/69233-5.json |
| 69234-3 | SPECT Spleen W Tc-99m tagged RBC IV | ./2.16.840.1.114222.4.11.1002/69234-3.json |
| 69235-0 | SPECT Scrotum and testicle for blood flow | ./2.16.840.1.114222.4.11.1002/69235-0.json |
| 69236-8 | NM Thyroid gland Views and Views uptake W I-131 PO | ./2.16.840.1.114222.4.11.1002/69236-8.json |
| 6923-7 | Adrenal cortex Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6923-7.json |
| 69237-6 | SPECT Whole body for tumor | ./2.16.840.1.114222.4.11.1002/69237-6.json |
| 69238-4 | SPECT Urinary bladder and Urethra W contrast intra bladder during voiding | ./2.16.840.1.114222.4.11.1002/69238-4.json |
| 69239-2 | XR Patella Sunrise | ./2.16.840.1.114222.4.11.1002/69239-2.json |
| 692-4 | Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture | ./2.16.840.1.114222.4.11.1002/692-4.json |
| 69241-8 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/69241-8.json |
| 69242-6 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Appendix | ./2.16.840.1.114222.4.11.1002/69242-6.json |
| 69243-4 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Lung | ./2.16.840.1.114222.4.11.1002/69243-4.json |
| 69244-2 | RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/69244-2.json |
| 6924-5 | Gliadin IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6924-5.json |
| 69248-3 | RFA Guidance for percutaneous transluminal angioplasty of Renal artery-- W contrast IA | ./2.16.840.1.114222.4.11.1002/69248-3.json |
| 69249-1 | RFA Popliteal artery Views W contrast IA | ./2.16.840.1.114222.4.11.1002/69249-1.json |
| 69250-9 | RFA Portal vein Views W contrast IV | ./2.16.840.1.114222.4.11.1002/69250-9.json |
| 69251-7 | MG Breast Views Post Wire Placement | ./2.16.840.1.114222.4.11.1002/69251-7.json |
| 69252-5 | RFA Guidance for percutaneous transluminal angioplasty of Pulmonary arteries-- W contrast IA | ./2.16.840.1.114222.4.11.1002/69252-5.json |
| 69253-3 | RFA Guidance for atherectomy of Renal vessels-- W contrast | ./2.16.840.1.114222.4.11.1002/69253-3.json |
| 69254-1 | XR Ankle - right 3 Views W standing | ./2.16.840.1.114222.4.11.1002/69254-1.json |
| 69255-8 | XR Knee - right Sunrise and (Tunnel W standing) | ./2.16.840.1.114222.4.11.1002/69255-8.json |
| 69256-6 | XR Knee - right Sunrise | ./2.16.840.1.114222.4.11.1002/69256-6.json |
| 69257-4 | XR Lower extremity - right 2 Views | ./2.16.840.1.114222.4.11.1002/69257-4.json |
| 69258-2 | XR Lower extremity - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/69258-2.json |
| 69259-0 | MG Breast - right Diagnostic for implant | ./2.16.840.1.114222.4.11.1002/69259-0.json |
| 69260-8 | XR Patella - right Single view | ./2.16.840.1.114222.4.11.1002/69260-8.json |
| 69261-6 | XR Patella - right 3 Views | ./2.16.840.1.114222.4.11.1002/69261-6.json |
| 69262-4 | XR Shoulder - right AP and Grashey and Axillary | ./2.16.840.1.114222.4.11.1002/69262-4.json |
| 69263-2 | XR Wrist - right PA W clenched fist | ./2.16.840.1.114222.4.11.1002/69263-2.json |
| 69264-0 | XR Sacrum Views W standing | ./2.16.840.1.114222.4.11.1002/69264-0.json |
| 69265-7 | XR Shoulder 4 Views | ./2.16.840.1.114222.4.11.1002/69265-7.json |
| 69266-5 | XR Shoulder AP and Y | ./2.16.840.1.114222.4.11.1002/69266-5.json |
| 69267-3 | XR Shoulder Grashey and Axillary and Y | ./2.16.840.1.114222.4.11.1002/69267-3.json |
| 69268-1 | MG Breast duct Single view W contrast intra duct | ./2.16.840.1.114222.4.11.1002/69268-1.json |
| 69269-9 | XR Skull AP | ./2.16.840.1.114222.4.11.1002/69269-9.json |
| 69270-7 | XR Skull PA | ./2.16.840.1.114222.4.11.1002/69270-7.json |
| 69271-5 | XR Skull PA and Lateral and Waters and Towne | ./2.16.840.1.114222.4.11.1002/69271-5.json |
| 69272-3 | RF Small bowel Views W contrast via ileostomy | ./2.16.840.1.114222.4.11.1002/69272-3.json |
| 69273-1 | XR Spine thoracolumbar junction 2 Views | ./2.16.840.1.114222.4.11.1002/69273-1.json |
| 69274-9 | XR Thoracic spine 2 Views W standing | ./2.16.840.1.114222.4.11.1002/69274-9.json |
| 69275-6 | XR Thoracic spine Views W standing | ./2.16.840.1.114222.4.11.1002/69275-6.json |
| 69276-4 | US Abdominal Aorta | ./2.16.840.1.114222.4.11.1002/69276-4.json |
| 69277-2 | US Adrenal gland | ./2.16.840.1.114222.4.11.1002/69277-2.json |
| 6927-8 | Platelet IgG Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/6927-8.json |
| 69278-0 | US Guidance for fluid aspiration of Breast - bilateral | ./2.16.840.1.114222.4.11.1002/69278-0.json |
| 69279-8 | US Guidance for core needle biopsy of Lymph node | ./2.16.840.1.114222.4.11.1002/69279-8.json |
| 69280-6 | US Urinary bladder limited | ./2.16.840.1.114222.4.11.1002/69280-6.json |
| 69281-4 | US Chest limited | ./2.16.840.1.114222.4.11.1002/69281-4.json |
| 69282-2 | US.doppler Unspecified body region limited | ./2.16.840.1.114222.4.11.1002/69282-2.json |
| 69283-0 | US.doppler Extremity veins - bilateral | ./2.16.840.1.114222.4.11.1002/69283-0.json |
| 69284-8 | US.doppler Portal vein and Hepatic vein | ./2.16.840.1.114222.4.11.1002/69284-8.json |
| 69285-5 | US.doppler Umbilical artery Fetal | ./2.16.840.1.114222.4.11.1002/69285-5.json |
| 6928-6 | Rheumatoid factor [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6928-6.json |
| 69286-3 | US Eye limited | ./2.16.840.1.114222.4.11.1002/69286-3.json |
| 69287-1 | US Guidance for fluid aspiration of Lymph node | ./2.16.840.1.114222.4.11.1002/69287-1.json |
| 69292-1 | US Guidance for fluid aspiration of Breast - left | ./2.16.840.1.114222.4.11.1002/69292-1.json |
| 69293-9 | US Extremity artery - left | ./2.16.840.1.114222.4.11.1002/69293-9.json |
| 6929-4 | Aluminum [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6929-4.json |
| 69294-7 | US Renal artery | ./2.16.840.1.114222.4.11.1002/69294-7.json |
| 69295-4 | US Renal vessels | ./2.16.840.1.114222.4.11.1002/69295-4.json |
| 69296-2 | US Guidance for fluid aspiration of Breast - right | ./2.16.840.1.114222.4.11.1002/69296-2.json |
| 69297-0 | US Extremity artery - right | ./2.16.840.1.114222.4.11.1002/69297-0.json |
| 69298-8 | US Salivary gland | ./2.16.840.1.114222.4.11.1002/69298-8.json |
| 69299-6 | US Scrotum and testicle limited | ./2.16.840.1.114222.4.11.1002/69299-6.json |
| 69300-2 | US for transplanted kidney limited | ./2.16.840.1.114222.4.11.1002/69300-2.json |
| 69301-0 | RFA Guidance for percutaneous transluminal angioplasty of Upper extremity vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/69301-0.json |
| 6930-2 | Psilocybin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/6930-2.json |
| 69302-8 | XR Wrist Single view W clenched fist | ./2.16.840.1.114222.4.11.1002/69302-8.json |
| 69303-6 | XR Wrist Ulnar deviation and Radial deviation | ./2.16.840.1.114222.4.11.1002/69303-6.json |
| 69304-4 | XR Wrist Ulnar deviation Views | ./2.16.840.1.114222.4.11.1002/69304-4.json |
| 69305-1 | XR Zygomatic arch 2 Views | ./2.16.840.1.114222.4.11.1002/69305-1.json |
| 69306-9 | RF Guidance for aspiration of cyst of Bone | ./2.16.840.1.114222.4.11.1002/69306-9.json |
| 69307-7 | XR Ankle - left Single view | ./2.16.840.1.114222.4.11.1002/69307-7.json |
| 69308-5 | XR Elbow - left Single view | ./2.16.840.1.114222.4.11.1002/69308-5.json |
| 69309-3 | XR Foot - left Single view | ./2.16.840.1.114222.4.11.1002/69309-3.json |
| 6931-0 | Silver [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6931-0.json |
| 69310-1 | XR Hand - left Single view | ./2.16.840.1.114222.4.11.1002/69310-1.json |
| 69311-9 | XR Calcaneus - left Single view | ./2.16.840.1.114222.4.11.1002/69311-9.json |
| 69312-7 | XR Humerus - left Single view | ./2.16.840.1.114222.4.11.1002/69312-7.json |
| 69313-5 | XR Tibia and Fibula - left Single view | ./2.16.840.1.114222.4.11.1002/69313-5.json |
| 69314-3 | XR Ankle - right Single view | ./2.16.840.1.114222.4.11.1002/69314-3.json |
| 69315-0 | XR Elbow - right Single view | ./2.16.840.1.114222.4.11.1002/69315-0.json |
| 69316-8 | XR Foot - right Single view | ./2.16.840.1.114222.4.11.1002/69316-8.json |
| 69317-6 | XR Radius and Ulna - right Single view | ./2.16.840.1.114222.4.11.1002/69317-6.json |
| 69318-4 | XR Hand - right Single view | ./2.16.840.1.114222.4.11.1002/69318-4.json |
| 69319-2 | XR Calcaneus - right Single view | ./2.16.840.1.114222.4.11.1002/69319-2.json |
| 693-2 | Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/693-2.json |
| 69320-0 | XR Humerus - right Single view | ./2.16.840.1.114222.4.11.1002/69320-0.json |
| 69321-8 | XR Tibia and Fibula - right Single view | ./2.16.840.1.114222.4.11.1002/69321-8.json |
| 69353-1 | HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69353-1.json |
| 69354-9 | HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69354-9.json |
| 69355-6 | Parvovirus B19 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69355-6.json |
| 69356-4 | oxyCODONE [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/69356-4.json |
| 69358-0 | HPV E6+E7 mRNA cells/cells [Presence] in Cervix by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/69358-0.json |
| 69361-4 | PCA3 score in Urine by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69361-4.json |
| 69363-0 | SERPINA10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/69363-0.json |
| 69364-8 | ATP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/69364-8.json |
| 69366-3 | Bordetella pertussis IgA Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/69366-3.json |
| 69367-1 | Bordetella pertussis IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/69367-1.json |
| 6936-9 | Deoxypyridinoline [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/6936-9.json |
| 69369-7 | Blood group antibody screen [Presence] in Cord blood | ./2.16.840.1.114222.4.11.1002/69369-7.json |
| 69370-5 | A1 Ab [Presence] in Cord blood | ./2.16.840.1.114222.4.11.1002/69370-5.json |
| 69371-3 | B Ab [Presence] in Cord blood | ./2.16.840.1.114222.4.11.1002/69371-3.json |
| 6937-7 | Deoxypyridinoline [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/6937-7.json |
| 69380-4 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69380-4.json |
| 69381-2 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69381-2.json |
| 69382-0 | t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69382-0.json |
| 69383-8 | AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69383-8.json |
| 69384-6 | AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69384-6.json |
| 6938-5 | IgA [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/6938-5.json |
| 69385-3 | US Lower extremity veins - bilateral | ./2.16.840.1.114222.4.11.1002/69385-3.json |
| 69387-9 | US Guidance for biopsy of Epididymis | ./2.16.840.1.114222.4.11.1002/69387-9.json |
| 69388-7 | US Urinary bladder post void | ./2.16.840.1.114222.4.11.1002/69388-7.json |
| 69389-5 | US Femoral artery and Popliteal artery | ./2.16.840.1.114222.4.11.1002/69389-5.json |
| 69390-3 | US Ovary | ./2.16.840.1.114222.4.11.1002/69390-3.json |
| 69391-1 | US Guidance for cordocentesis | ./2.16.840.1.114222.4.11.1002/69391-1.json |
| 69392-9 | US Lower extremity veins - left | ./2.16.840.1.114222.4.11.1002/69392-9.json |
| 6939-3 | IgA subclass 2 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6939-3.json |
| 69393-7 | US Lumbar spine | ./2.16.840.1.114222.4.11.1002/69393-7.json |
| 69394-5 | US Mesenteric arteries | ./2.16.840.1.114222.4.11.1002/69394-5.json |
| 69395-2 | US Upper extremity veins | ./2.16.840.1.114222.4.11.1002/69395-2.json |
| 69396-0 | US Guidance for biopsy of Spinal cord | ./2.16.840.1.114222.4.11.1002/69396-0.json |
| 69397-8 | US.doppler Breast vessels | ./2.16.840.1.114222.4.11.1002/69397-8.json |
| 69398-6 | US.doppler Extremity vessels - left | ./2.16.840.1.114222.4.11.1002/69398-6.json |
| 69399-4 | US Femoral vein and Popliteal vein | ./2.16.840.1.114222.4.11.1002/69399-4.json |
| 694-0 | Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/694-0.json |
| 69400-0 | US Guidance for chorionic villus sampling | ./2.16.840.1.114222.4.11.1002/69400-0.json |
| 6940-1 | Potassium [Moles/time] in unspecified time Stool | ./2.16.840.1.114222.4.11.1002/6940-1.json |
| 69402-6 | US Kidney - bilateral and Urinary bladder | ./2.16.840.1.114222.4.11.1002/69402-6.json |
| 69405-9 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/69405-9.json |
| 69419-0 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay | ./2.16.840.1.114222.4.11.1002/69419-0.json |
| 69420-8 | Heterophile Ab [Presence] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/69420-8.json |
| 69421-6 | Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/69421-6.json |
| 69422-4 | Carnitine free (C0) [Moles/volume] in Semen | ./2.16.840.1.114222.4.11.1002/69422-4.json |
| 69424-0 | Nitrogen [Mass/time] in 72 hour Stool | ./2.16.840.1.114222.4.11.1002/69424-0.json |
| 69425-7 | Calcium [Mass/volume] in Semen | ./2.16.840.1.114222.4.11.1002/69425-7.json |
| 6942-7 | Albumin [Mass/volume] in Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/6942-7.json |
| 69429-9 | Metabolic rate --resting | ./2.16.840.1.114222.4.11.1002/69429-9.json |
| 6943-5 | Acetohexamide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6943-5.json |
| 69438-0 | Forensic medicine Referral note | ./2.16.840.1.114222.4.11.1002/69438-0.json |
| 6944-3 | glipiZIDE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6944-3.json |
| 6945-0 | glyBURIDE [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6945-0.json |
| 6946-8 | Imipramine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6946-8.json |
| 6947-6 | ISOtretinoin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6947-6.json |
| 69478-6 | AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/69478-6.json |
| 69479-4 | BTK gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69479-4.json |
| 69480-2 | CFTR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/69480-2.json |
| 69481-0 | ACVRL1 gene+ENG gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/69481-0.json |
| 69482-8 | ENG gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69482-8.json |
| 69483-6 | F9 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69483-6.json |
| 6948-4 | lamoTRIgine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6948-4.json |
| 69484-4 | FBN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69484-4.json |
| 69485-1 | LDLR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69485-1.json |
| 69486-9 | LDLR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/69486-9.json |
| 69487-7 | TNFRSF13B gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/69487-7.json |
| 69488-5 | TNFRSF13B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69488-5.json |
| 69489-3 | VHL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69489-3.json |
| 6949-2 | Metaproterenol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6949-2.json |
| 6950-0 | raNITIdine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6950-0.json |
| 6951-8 | TOLAZamide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6951-8.json |
| 6952-6 | TOLBUTamide [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6952-6.json |
| 6953-4 | Zolpidem [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/6953-4.json |
| 6954-2 | Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6954-2.json |
| 69556-9 | Ku Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/69556-9.json |
| 69557-7 | OJ Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/69557-7.json |
| 69558-5 | Ma1 Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/69558-5.json |
| 6955-9 | Bartonella henselae IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6955-9.json |
| 69559-3 | Ma1 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/69559-3.json |
| 69560-1 | Enolase.neuron specific [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/69560-1.json |
| 69561-9 | Thyrotropin [Units/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/69561-9.json |
| 69562-7 | Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69562-7.json |
| 69563-5 | Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69563-5.json |
| 69565-0 | Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69565-0.json |
| 69566-8 | Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69566-8.json |
| 6956-7 | Coxsackievirus A21 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/6956-7.json |
| 69567-6 | Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69567-6.json |
| 69569-2 | Risk of ovarian malignancy algorithm score in Serum or Plasma --premenopausal | ./2.16.840.1.114222.4.11.1002/69569-2.json |
| 695-7 | Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/695-7.json |
| 69570-0 | Risk of ovarian malignancy algorithm score in Serum or Plasma --postmenopausal | ./2.16.840.1.114222.4.11.1002/69570-0.json |
| 69572-6 | ERCC1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/69572-6.json |
| 69573-4 | Tiglylcarnitine+methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69573-4.json |
| 69574-2 | Furazolidone [Susceptibility] | ./2.16.840.1.114222.4.11.1002/69574-2.json |
| 6957-5 | Western equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6957-5.json |
| 69575-9 | Campylobacter jejuni Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/69575-9.json |
| 69576-7 | Campylobacter fetus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/69576-7.json |
| 69577-5 | Hepatitis E virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69577-5.json |
| 6958-3 | Western equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/6958-3.json |
| 6959-1 | Yersinia enterocolitica O:3 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6959-1.json |
| 6960-9 | Yersinia enterocolitica O:5 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6960-9.json |
| 6961-7 | Yersinia enterocolitica O:8 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6961-7.json |
| 6962-5 | Yersinia enterocolitica O:9 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6962-5.json |
| 6963-3 | Yersinia enterocolitica Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6963-3.json |
| 6964-1 | Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6964-1.json |
| 696-5 | Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/696-5.json |
| 6965-8 | Yersinia enterocolitica IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6965-8.json |
| 6966-6 | Yersinia enterocolitica IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/6966-6.json |
| 69668-2 | HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/69668-2.json |
| 6967-4 | Yersinia pseudotuberculosis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6967-4.json |
| 6968-2 | Proteinase 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6968-2.json |
| 6969-0 | Myeloperoxidase Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/6969-0.json |
| 6970-8 | Purkinje cells Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/6970-8.json |
| 697-3 | Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture | ./2.16.840.1.114222.4.11.1002/697-3.json |
| 69730-0 | Instructions | ./2.16.840.1.114222.4.11.1002/69730-0.json |
| 6974-0 | Zirconium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/6974-0.json |
| 69753-2 | Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgA Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/69753-2.json |
| 69754-0 | Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/69754-0.json |
| 69755-7 | Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/69755-7.json |
| 69765-6 | Rubella virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69765-6.json |
| 69766-4 | Mumps virus IgM Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69766-4.json |
| 69767-2 | La Crosse virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69767-2.json |
| 69768-0 | 2-Oxoadipate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69768-0.json |
| 69769-8 | Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69769-8.json |
| 69770-6 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69770-6.json |
| 69771-4 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69771-4.json |
| 69772-2 | Orotate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69772-2.json |
| 69773-0 | Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/69773-0.json |
| 69774-8 | Propionylcarnitine (C3) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/69774-8.json |
| 69775-5 | Stearoylcarnitine (C18) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/69775-5.json |
| 69776-3 | Suberylcarnitine (C8-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69776-3.json |
| 69777-1 | Suberylcarnitine (C8-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69777-1.json |
| 69778-9 | Suberylcarnitine (C8-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69778-9.json |
| 69779-7 | Suberylcarnitine (C8-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/69779-7.json |
| 69780-5 | 2-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69780-5.json |
| 69781-3 | 2-Hydroxyisovalerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69781-3.json |
| 69782-1 | 2-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69782-1.json |
| 69783-9 | 2-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69783-9.json |
| 69784-7 | 2-Hydroxysebacate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69784-7.json |
| 69785-4 | 2-Hydroxysebacate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69785-4.json |
| 69786-2 | 2-Methylacetoacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69786-2.json |
| 69787-0 | 2-Methylacetoacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69787-0.json |
| 69788-8 | 2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69788-8.json |
| 69789-6 | 2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69789-6.json |
| 69790-4 | 2-Methylbutyrylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69790-4.json |
| 69791-2 | Tetradecadienoylcarnitine (C14:2)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69791-2.json |
| 69792-0 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69792-0.json |
| 69793-8 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69793-8.json |
| 69794-6 | Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/69794-6.json |
| 69795-3 | Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69795-3.json |
| 69796-1 | 17-Hydroxyprogesterone [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69796-1.json |
| 69797-9 | 1-Hydroxymidazolam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69797-9.json |
| 69798-7 | 2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/69798-7.json |
| 69799-5 | 21-Deoxycorticosterone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69799-5.json |
| 69800-1 | Methyl ethyl ketone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/69800-1.json |
| 69801-9 | 2-Oxoadipate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69801-9.json |
| 69802-7 | Alpha ketoglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69802-7.json |
| 69803-5 | Alpha ketoglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69803-5.json |
| 69804-3 | 2-Oxoisocaproate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69804-3.json |
| 69805-0 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --12 hours post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69805-0.json |
| 69806-8 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69806-8.json |
| 69807-6 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --pre dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69807-6.json |
| 69808-4 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --pre dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69808-4.json |
| 69809-2 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --1 day post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69809-2.json |
| 698-1 | Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/698-1.json |
| 69810-0 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --1 day post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69810-0.json |
| 69811-8 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --2 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69811-8.json |
| 69812-6 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --2 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69812-6.json |
| 69813-4 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --3 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69813-4.json |
| 69814-2 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --3 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69814-2.json |
| 69815-9 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --4 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69815-9.json |
| 69816-7 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --4 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69816-7.json |
| 69817-5 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --5 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69817-5.json |
| 69818-3 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69818-3.json |
| 69819-1 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69819-1.json |
| 69820-9 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --6 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69820-9.json |
| 69821-7 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --6 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69821-7.json |
| 69822-5 | 2-Dechloroethylifosfamide [Mass/volume] in Blood --7 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69822-5.json |
| 69823-3 | 2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --7 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69823-3.json |
| 69824-1 | 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --7 days post dose ifosfamide | ./2.16.840.1.114222.4.11.1002/69824-1.json |
| 69825-8 | 2-Ethylhydracrylate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69825-8.json |
| 69826-6 | 2-Ethylhydracrylate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69826-6.json |
| 69827-4 | 2-Methylglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69827-4.json |
| 69828-2 | Methylsuccinate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69828-2.json |
| 69829-0 | Methylsuccinate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69829-0.json |
| 69830-8 | 3,4-Dihydroxyphenylacetate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/69830-8.json |
| 69831-6 | 3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69831-6.json |
| 69832-4 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69832-4.json |
| 69833-2 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69833-2.json |
| 69834-0 | 3-Hydroxy,3-Methylglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69834-0.json |
| 69835-7 | 3-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69835-7.json |
| 69836-5 | 3-Hydroxyadipate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69836-5.json |
| 69837-3 | 3-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69837-3.json |
| 69838-1 | 2-Hydroxy-3-Methylvalerate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69838-1.json |
| 69839-9 | 2-Hydroxy-3-Methylvalerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69839-9.json |
| 69840-7 | 2-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69840-7.json |
| 69841-5 | 2-Hydroxyadipate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69841-5.json |
| 69842-3 | Alpha hydroxybutyrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69842-3.json |
| 69843-1 | Alpha hydroxybutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69843-1.json |
| 69844-9 | 2-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69844-9.json |
| 69845-6 | 2-Hydroxyglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69845-6.json |
| 69846-4 | 2-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69846-4.json |
| 69847-2 | 2-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69847-2.json |
| 69848-0 | 2-Hydroxyisocaproate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69848-0.json |
| 69849-8 | 2-Hydroxyisocaproate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69849-8.json |
| 69850-6 | 3-Hydroxyglutarate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/69850-6.json |
| 69851-4 | 3-Hydroxyglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69851-4.json |
| 69852-2 | 3-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/69852-2.json |
| 69853-0 | 3-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/69853-0.json |
| 69908-2 | CTA Abdominal vessels and Pelvis vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/69908-2.json |
| 69918-1 | Thrombin time.high dose in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/69918-1.json |
| 69920-7 | Adenovirus IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69920-7.json |
| 69921-5 | Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69921-5.json |
| 69922-3 | Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/69922-3.json |
| 69923-1 | European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69923-1.json |
| 69924-9 | European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69924-9.json |
| 69925-6 | European tick borne encephalitis virus IgM Ab index [Units/volume] in Serum and CSF by Immunoassay | ./2.16.840.1.114222.4.11.1002/69925-6.json |
| 69926-4 | European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69926-4.json |
| 69927-2 | European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69927-2.json |
| 69928-0 | European tick borne encephalitis virus IgG Ab index [Units/volume] in Serum and CSF by Immunoassay | ./2.16.840.1.114222.4.11.1002/69928-0.json |
| 69929-8 | Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69929-8.json |
| 69930-6 | Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/69930-6.json |
| 69931-4 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/69931-4.json |
| 69933-0 | Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69933-0.json |
| 69934-8 | Ureaplasma urealyticum+Ureaplasma parvum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69934-8.json |
| 69935-5 | Mycoplasma genitalium DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69935-5.json |
| 69936-3 | Gardnerella vaginalis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69936-3.json |
| 69937-1 | Trichomonas vaginalis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69937-1.json |
| 69938-9 | Astrovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69938-9.json |
| 69939-7 | Trichophyton rubrum DNA [Presence] in Nail by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69939-7.json |
| 69941-3 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/69941-3.json |
| 69942-1 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/69942-1.json |
| 69943-9 | Glucose [Moles/volume] in Serum or Plasma --20 minutes post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/69943-9.json |
| 69944-7 | Glucose [Moles/volume] in Serum or Plasma --40 minutes post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/69944-7.json |
| 69945-4 | Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid | ./2.16.840.1.114222.4.11.1002/69945-4.json |
| 69946-2 | Treponema pallidum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/69946-2.json |
| 69947-0 | Triglyceride [Moles/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/69947-0.json |
| 69948-8 | Bordetella parapertussis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69948-8.json |
| 69949-6 | Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69949-6.json |
| 69950-4 | Hemoglobin [Mass/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/69950-4.json |
| 69951-2 | Amylase.pancreatic/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/69951-2.json |
| 69952-0 | Liver kidney microsomal 1 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69952-0.json |
| 69953-8 | PCA-1 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69953-8.json |
| 69954-6 | Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69954-6.json |
| 69955-3 | Intestinal goblet cell Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69955-3.json |
| 69956-1 | Human upstream binding factor IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69956-1.json |
| 69957-9 | Proteinase 3 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69957-9.json |
| 69958-7 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/69958-7.json |
| 69959-5 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/69959-5.json |
| 69960-3 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/69960-3.json |
| 69961-1 | Hepatitis E virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/69961-1.json |
| 69962-9 | Respiratory syncytial virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/69962-9.json |
| 69963-7 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/69963-7.json |
| 69964-5 | Bicarbonate [Moles/volume] standard in Plasma | ./2.16.840.1.114222.4.11.1002/69964-5.json |
| 69970-2 | FEV1/FVC --post bronchodilation | ./2.16.840.1.114222.4.11.1002/69970-2.json |
| 69971-0 | FEF 25-75% Predicted | ./2.16.840.1.114222.4.11.1002/69971-0.json |
| 69972-8 | FEF 25-75% --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/69972-8.json |
| 69973-6 | FEF 25-75% --post bronchodilation | ./2.16.840.1.114222.4.11.1002/69973-6.json |
| 69975-1 | Maximum expiratory gas flow Respiratory system airway --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/69975-1.json |
| 69976-9 | Maximum expiratory gas flow Respiratory system airway --post bronchodilation | ./2.16.840.1.114222.4.11.1002/69976-9.json |
| 69981-9 | Asthma action plan | ./2.16.840.1.114222.4.11.1002/69981-9.json |
| 699-9 | Organism count [#/volume] in Specimen by Microscopic count | ./2.16.840.1.114222.4.11.1002/699-9.json |
| 70004-7 | Diagnostic study note | ./2.16.840.1.114222.4.11.1002/70004-7.json |
| 70005-4 | Evaluation and management of smoking cessation note | ./2.16.840.1.114222.4.11.1002/70005-4.json |
| 70006-2 | Medication management note | ./2.16.840.1.114222.4.11.1002/70006-2.json |
| 70007-0 | Restraint note | ./2.16.840.1.114222.4.11.1002/70007-0.json |
| 70008-8 | Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/70008-8.json |
| 70009-6 | Enterovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70009-6.json |
| 70010-4 | Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/70010-4.json |
| 70011-2 | Enterovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70011-2.json |
| 70012-0 | Coxsackievirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70012-0.json |
| 70013-8 | Coxsackievirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70013-8.json |
| 70014-6 | Parainfluenza virus 1+2+3+4 IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70014-6.json |
| 70015-3 | Streptococcus sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70015-3.json |
| 70016-1 | Staphylococcus sp.coagulase negative DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70016-1.json |
| 70017-9 | Parainfluenza virus 1+2+3+4 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70017-9.json |
| 70018-7 | Staphylococcus haemolyticus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70018-7.json |
| 70019-5 | Klebsiella oxytoca DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70019-5.json |
| 70020-3 | Bacteroides fragilis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70020-3.json |
| 70021-1 | Salmonella typhi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70021-1.json |
| 70022-9 | Candida albicans DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70022-9.json |
| 70023-7 | Candida tropicalis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70023-7.json |
| 70024-5 | Candida parapsilosis DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70024-5.json |
| 70025-2 | Candida krusei DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70025-2.json |
| 70026-0 | Candida glabrata DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70026-0.json |
| 70027-8 | Dermatophytes chitin synthase 1 chs1 gene [Presence] in Nail by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70027-8.json |
| 70041-9 | FSHB gene c.-211G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70041-9.json |
| 700-5 | Pneumocystis jiroveci Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/700-5.json |
| 70051-8 | Multiple inhalant allergen IgE Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70051-8.json |
| 70052-6 | Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70052-6.json |
| 70053-4 | Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70053-4.json |
| 70054-2 | Hantavirus dobrova IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70054-2.json |
| 70055-9 | Hantavirus dobrova IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70055-9.json |
| 70056-7 | Hantavirus saaremaa IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70056-7.json |
| 70057-5 | Hantavirus saaremaa IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70057-5.json |
| 70058-3 | Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70058-3.json |
| 70059-1 | Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70059-1.json |
| 70060-9 | Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70060-9.json |
| 70061-7 | Human papilloma virus 16 and 18 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70061-7.json |
| 70065-8 | Enterovirus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/70065-8.json |
| 70068-2 | Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70068-2.json |
| 70069-0 | Streptococcus intermedius DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70069-0.json |
| 70070-8 | Streptococcus anginosus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70070-8.json |
| 70071-6 | Streptococcus constellatus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70071-6.json |
| 70072-4 | Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70072-4.json |
| 70073-2 | Amyloid beta 40 peptide [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/70073-2.json |
| 70074-0 | Angiotensin II [Mass/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/70074-0.json |
| 70075-7 | Interleukin 1 alpha [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70075-7.json |
| 70076-5 | Interleukin 1 alpha [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70076-5.json |
| 70078-1 | Interleukin 2 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70078-1.json |
| 70079-9 | Interleukin 3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70079-9.json |
| 70080-7 | Interleukin 3 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70080-7.json |
| 70081-5 | Interleukin 3 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70081-5.json |
| 70082-3 | Interleukin 4 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70082-3.json |
| 70083-1 | Interleukin 4 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70083-1.json |
| 70084-9 | Interleukin 5 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70084-9.json |
| 70085-6 | Interleukin 5 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70085-6.json |
| 70086-4 | Interleukin 7 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70086-4.json |
| 70087-2 | Interleukin 7 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70087-2.json |
| 70088-0 | Interleukin 7 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70088-0.json |
| 70089-8 | Interleukin 13 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70089-8.json |
| 70090-6 | Interleukin 13 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70090-6.json |
| 70091-4 | Prostaglandin E2 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70091-4.json |
| 70092-2 | Prostaglandin E1 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70092-2.json |
| 70093-0 | Prostaglandin E1 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70093-0.json |
| 70094-8 | Prostaglandin F2 alpha [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70094-8.json |
| 70095-5 | Prostaglandin F2 alpha [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/70095-5.json |
| 70096-3 | Thyrotropin releasing hormone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/70096-3.json |
| 70108-6 | Glutathione S-transferase T1 Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70108-6.json |
| 70121-9 | Francisella tularensis IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70121-9.json |
| 70126-8 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Pleural fluid | ./2.16.840.1.114222.4.11.1002/70126-8.json |
| 701-3 | Yersinia sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/701-3.json |
| 70131-8 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/70131-8.json |
| 70132-6 | Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/70132-6.json |
| 70133-4 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/70133-4.json |
| 70134-2 | Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/70134-2.json |
| 70135-9 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen | ./2.16.840.1.114222.4.11.1002/70135-9.json |
| 70136-7 | Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen | ./2.16.840.1.114222.4.11.1002/70136-7.json |
| 70138-3 | Amphetamines [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70138-3.json |
| 70139-1 | Barbiturates [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/70139-1.json |
| 70140-9 | Benzodiazepines [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70140-9.json |
| 70141-7 | Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL | ./2.16.840.1.114222.4.11.1002/70141-7.json |
| 70142-5 | Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/70142-5.json |
| 70143-3 | Cannabinoids [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70143-3.json |
| 70144-1 | Cannabinoids [Presence] in Urine by Screen method >20 ng/mL | ./2.16.840.1.114222.4.11.1002/70144-1.json |
| 70145-8 | Cannabinoids [Presence] in Urine by Screen method >50 ng/mL | ./2.16.840.1.114222.4.11.1002/70145-8.json |
| 70146-6 | Benzoylecgonine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70146-6.json |
| 70147-4 | Methadone [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70147-4.json |
| 70148-2 | Methadone [Presence] in Urine by Screen method >150 ng/mL | ./2.16.840.1.114222.4.11.1002/70148-2.json |
| 70149-0 | Methadone [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/70149-0.json |
| 70150-8 | Opiates [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/70150-8.json |
| 70151-6 | Opiates [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/70151-6.json |
| 70154-0 | Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70154-0.json |
| 70155-7 | Barbiturates [Presence] in Urine by Screen method >200 ng/mL | ./2.16.840.1.114222.4.11.1002/70155-7.json |
| 70156-5 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue | ./2.16.840.1.114222.4.11.1002/70156-5.json |
| 70159-9 | Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/70159-9.json |
| 70165-6 | Trichomonas vaginalis rRNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70165-6.json |
| 70166-4 | Trichomonas vaginalis rRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70166-4.json |
| 70167-2 | Trichomonas vaginalis rRNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70167-2.json |
| 70168-0 | Hematocrit [Volume Fraction] of Synovial fluid | ./2.16.840.1.114222.4.11.1002/70168-0.json |
| 70169-8 | Hematocrit [Volume Fraction] of Pleural fluid | ./2.16.840.1.114222.4.11.1002/70169-8.json |
| 70170-6 | Nucleated erythrocytes/100 cells in Pleural fluid | ./2.16.840.1.114222.4.11.1002/70170-6.json |
| 70171-4 | Nucleated erythrocytes/100 cells in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/70171-4.json |
| 70172-2 | Neisseria meningitidis serogroup [Identifier] in Specimen | ./2.16.840.1.114222.4.11.1002/70172-2.json |
| 70173-0 | JC virus Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70173-0.json |
| 70174-8 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/70174-8.json |
| 70175-5 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/70175-5.json |
| 70176-3 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70176-3.json |
| 70177-1 | Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/70177-1.json |
| 70178-9 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/70178-9.json |
| 70179-7 | 1-Methylhistidine [Moles/volume] in Serum or Plasma from Fetus | ./2.16.840.1.114222.4.11.1002/70179-7.json |
| 70180-5 | Alpha aminoadipate [Moles/volume] in Serum or Plasma from Fetus | ./2.16.840.1.114222.4.11.1002/70180-5.json |
| 70181-3 | Alpha aminobutyrate [Moles/volume] in Serum or Plasma from Fetus | ./2.16.840.1.114222.4.11.1002/70181-3.json |
| 70197-9 | 6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70197-9.json |
| 70198-7 | Acetaminophen [Moles/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/70198-7.json |
| 70199-5 | Bilirubin.total [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/70199-5.json |
| 70205-0 | clonazePAM [Moles/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/70205-0.json |
| 70206-8 | Codeine [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70206-8.json |
| 70207-6 | Estrogen [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70207-6.json |
| 70208-4 | Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO | ./2.16.840.1.114222.4.11.1002/70208-4.json |
| 70209-2 | Haptoglobin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70209-2.json |
| 70210-0 | Morphine [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70210-0.json |
| 70211-8 | Mycophenolate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/70211-8.json |
| 70212-6 | Nordiazepam [Moles/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/70212-6.json |
| 70213-4 | Nordiazepam [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70213-4.json |
| 70214-2 | Oxazepam [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70214-2.json |
| 70215-9 | oxyCODONE [Moles/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/70215-9.json |
| 70216-7 | Salicylates [Moles/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/70216-7.json |
| 70217-5 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis | ./2.16.840.1.114222.4.11.1002/70217-5.json |
| 70218-3 | Triglyceride [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/70218-3.json |
| 70238-1 | Transplant surgery Hospital Progress note | ./2.16.840.1.114222.4.11.1002/70238-1.json |
| 70239-9 | Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L | ./2.16.840.1.114222.4.11.1002/70239-9.json |
| 70240-7 | Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L | ./2.16.840.1.114222.4.11.1002/70240-7.json |
| 70241-5 | HIV 1 RNA [#/volume] (viral load) in Plasma by Probe and target amplification method detection limit = 20 copies/mL | ./2.16.840.1.114222.4.11.1002/70241-5.json |
| 70242-3 | Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70242-3.json |
| 70243-1 | CLN3 gene exon 7+8 deletion [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70243-1.json |
| 70244-9 | CFTR gene c.394delTT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70244-9.json |
| 70245-6 | PAH gene.p.Arg408Trp [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70245-6.json |
| 70246-4 | CCR2 gene p.Val64Ile [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70246-4.json |
| 70247-2 | CCR5 gene c.794_825del [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70247-2.json |
| 70248-0 | GALT gene p.Gln188Arg [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70248-0.json |
| 70251-4 | Pyruvate dehydrogenase IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70251-4.json |
| 70252-2 | Islet cell 512 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70252-2.json |
| 70253-0 | Islet cell 512 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/70253-0.json |
| 70254-8 | Follitropin IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70254-8.json |
| 70255-5 | Follitropin IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70255-5.json |
| 70256-3 | Nuclear IgG Ab [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70256-3.json |
| 70257-1 | Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/70257-1.json |
| 70258-9 | Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/70258-9.json |
| 70259-7 | Triglyceride in pericardial fluid/Triglyceride in serum | ./2.16.840.1.114222.4.11.1002/70259-7.json |
| 70260-5 | Triglyceride in peritoneal fluid/Triglyceride in serum | ./2.16.840.1.114222.4.11.1002/70260-5.json |
| 70261-3 | Cholesterol in peritoneal fluid/Cholesterol in serum | ./2.16.840.1.114222.4.11.1002/70261-3.json |
| 70262-1 | Amylase in peritoneal fluid/Amylase in serum | ./2.16.840.1.114222.4.11.1002/70262-1.json |
| 70263-9 | Cholesterol in pericardial fluid/Cholesterol in serum | ./2.16.840.1.114222.4.11.1002/70263-9.json |
| 70264-7 | Creatinine in pleural fluid/Creatinine in serum | ./2.16.840.1.114222.4.11.1002/70264-7.json |
| 70265-4 | Protein in pericardial fluid/Protein in serum | ./2.16.840.1.114222.4.11.1002/70265-4.json |
| 70266-2 | Creatinine in peritoneal fluid/Creatinine in serum | ./2.16.840.1.114222.4.11.1002/70266-2.json |
| 70267-0 | Protein in peritoneal fluid/Protein in serum | ./2.16.840.1.114222.4.11.1002/70267-0.json |
| 70268-8 | Cholesterol in pleural fluid/Cholesterol in serum | ./2.16.840.1.114222.4.11.1002/70268-8.json |
| 70269-6 | Triglyceride in pleural fluid/Triglyceride in serum | ./2.16.840.1.114222.4.11.1002/70269-6.json |
| 70270-4 | Amylase.pancreatic [Enzymatic activity/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/70270-4.json |
| 70275-3 | t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70275-3.json |
| 70276-1 | t(1;11)(p32;q23)(EPS15,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70276-1.json |
| 70277-9 | t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70277-9.json |
| 70278-7 | t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70278-7.json |
| 70279-5 | t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70279-5.json |
| 70280-3 | t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70280-3.json |
| 70281-1 | t(9;9)(q34;q34)(NUP214,SET) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70281-1.json |
| 70282-9 | t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70282-9.json |
| 70283-7 | t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70283-7.json |
| 70284-5 | t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70284-5.json |
| 70285-2 | t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70285-2.json |
| 70286-0 | t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70286-0.json |
| 70287-8 | t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70287-8.json |
| 70288-6 | t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70288-6.json |
| 70289-4 | Del(1)(p32p32)(STIL,TAL1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70289-4.json |
| 70291-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/70291-0.json |
| 70292-8 | Blastocystis hominis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70292-8.json |
| 70293-6 | Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70293-6.json |
| 70294-4 | Entamoeba sp DNA [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/70294-4.json |
| 70295-1 | Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70295-1.json |
| 70296-9 | Plesiomonas shigelloides DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70296-9.json |
| 70568-1 | Plasmodium knowlesi DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70568-1.json |
| 70569-9 | Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/70569-9.json |
| 7060-7 | Abalone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7060-7.json |
| 7062-3 | Red Alder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7062-3.json |
| 7063-1 | Smooth Alder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7063-1.json |
| 7064-9 | White Alder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7064-9.json |
| 7065-6 | Alfalfa IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7065-6.json |
| 7066-4 | Alfalfa IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7066-4.json |
| 70665-5 | Cold agglutinin [Presence] in Serum by 18 degree C incubation | ./2.16.840.1.114222.4.11.1002/70665-5.json |
| 70666-3 | Cold agglutinin [Presence] in Serum by 22 degree C incubation | ./2.16.840.1.114222.4.11.1002/70666-3.json |
| 70667-1 | Cold agglutinin [Presence] in Serum by 28 degree C incubation | ./2.16.840.1.114222.4.11.1002/70667-1.json |
| 70671-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Milk by Immunoassay | ./2.16.840.1.114222.4.11.1002/70671-3.json |
| 7067-2 | Alfalfa Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7067-2.json |
| 7068-0 | Algae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7068-0.json |
| 7069-8 | Allspice IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7069-8.json |
| 7070-6 | Almond IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7070-6.json |
| 7071-4 | Almond triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7071-4.json |
| 7072-2 | Almond Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7072-2.json |
| 7073-0 | Amylase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7073-0.json |
| 7074-8 | Alternaria sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7074-8.json |
| 7075-5 | Alternaria sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7075-5.json |
| 7076-3 | Alternaria alternata IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7076-3.json |
| 7077-1 | Alternaria alternata triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7077-1.json |
| 7078-9 | Ampicillin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7078-9.json |
| 7079-7 | Anchovy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7079-7.json |
| 7080-5 | Anchovy IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7080-5.json |
| 7081-3 | Anise IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7081-3.json |
| 7082-1 | Black Ant IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7082-1.json |
| 7083-9 | Black Ant triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7083-9.json |
| 7084-7 | Fire Ant IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7084-7.json |
| 70850-3 | Burkholderia mallei [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/70850-3.json |
| 70851-1 | Burkholderia pseudomallei [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/70851-1.json |
| 70852-9 | Burkholderia pseudomallei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70852-9.json |
| 70853-7 | Burkholderia mallei DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/70853-7.json |
| 70854-5 | Burkholderia mallei Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70854-5.json |
| 70855-2 | Burkholderia pseudomallei Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70855-2.json |
| 70856-0 | Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/70856-0.json |
| 70857-8 | Rabies virus Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/70857-8.json |
| 70858-6 | Rabies virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/70858-6.json |
| 70859-4 | Rabies virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/70859-4.json |
| 70860-2 | Rabies virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70860-2.json |
| 70861-0 | Rabies virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70861-0.json |
| 7086-2 | Black Imported Fire Ant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7086-2.json |
| 70862-8 | Rabies virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70862-8.json |
| 70863-6 | Rabies virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70863-6.json |
| 70864-4 | Rabies virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70864-4.json |
| 70865-1 | Rabies virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70865-1.json |
| 70866-9 | Rabies virus strain identified in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70866-9.json |
| 70867-7 | Rabies virus strain identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/70867-7.json |
| 7087-0 | Red Ant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7087-0.json |
| 7088-8 | Apple IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7088-8.json |
| 7089-6 | Apple triggered histamine release [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7089-6.json |
| 7090-4 | Apple Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7090-4.json |
| 70907-1 | Cryptococcus sp rRNA gene [Identifier] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/70907-1.json |
| 70908-9 | Cryptococcus sp Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/70908-9.json |
| 70909-7 | Cryptococcus sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/70909-7.json |
| 70910-5 | Cryptococcus sp Ag [Presence] in Serum by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/70910-5.json |
| 70911-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/70911-3.json |
| 7091-2 | Apricot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7091-2.json |
| 70915-4 | US Guidance for aspiration of CSF of Cervical spine | ./2.16.840.1.114222.4.11.1002/70915-4.json |
| 70916-2 | US Guidance for aspiration of CSF of Lumbar spine | ./2.16.840.1.114222.4.11.1002/70916-2.json |
| 70917-0 | US Guidance for aspiration of CSF of Thoracic spine | ./2.16.840.1.114222.4.11.1002/70917-0.json |
| 70918-8 | RF Guidance for injection of Cervical spine | ./2.16.840.1.114222.4.11.1002/70918-8.json |
| 70919-6 | RF Guidance for injection of Lumbar spine | ./2.16.840.1.114222.4.11.1002/70919-6.json |
| 7092-0 | Apricot IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7092-0.json |
| 70920-4 | RF Guidance for injection of Thoracic spine | ./2.16.840.1.114222.4.11.1002/70920-4.json |
| 70921-2 | CT Guidance for nerve block of Cervical spine | ./2.16.840.1.114222.4.11.1002/70921-2.json |
| 70922-0 | CT Guidance for nerve block of Thoracic spine | ./2.16.840.1.114222.4.11.1002/70922-0.json |
| 70923-8 | RF Guidance for percutaneous vertebroplasty of Cervical spine | ./2.16.840.1.114222.4.11.1002/70923-8.json |
| 70924-6 | RF Guidance for percutaneous vertebroplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/70924-6.json |
| 70925-3 | RF Guidance for percutaneous vertebroplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/70925-3.json |
| 70926-1 | US Cervical spine | ./2.16.840.1.114222.4.11.1002/70926-1.json |
| 70927-9 | US Thoracic spine | ./2.16.840.1.114222.4.11.1002/70927-9.json |
| 70931-1 | CT Thoracic spine W contrast intradisc | ./2.16.840.1.114222.4.11.1002/70931-1.json |
| 70932-9 | Portable XR Thoracic spine Single view | ./2.16.840.1.114222.4.11.1002/70932-9.json |
| 70933-7 | RF Thoracic spine Views W contrast intradisc | ./2.16.840.1.114222.4.11.1002/70933-7.json |
| 70934-5 | Ocular history Narrative | ./2.16.840.1.114222.4.11.1002/70934-5.json |
| 70935-2 | Ophthalmic medications Narrative | ./2.16.840.1.114222.4.11.1002/70935-2.json |
| 70936-0 | Vision testing Narrative | ./2.16.840.1.114222.4.11.1002/70936-0.json |
| 7093-8 | Arrowroot IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7093-8.json |
| 70938-6 | Refractive measurements Narrative | ./2.16.840.1.114222.4.11.1002/70938-6.json |
| 70939-4 | Lensometry measurements Narrative | ./2.16.840.1.114222.4.11.1002/70939-4.json |
| 70940-2 | Confrontation visual field Narrative | ./2.16.840.1.114222.4.11.1002/70940-2.json |
| 70941-0 | Eye external Narrative | ./2.16.840.1.114222.4.11.1002/70941-0.json |
| 70942-8 | Ocular alignment and motility Narrative | ./2.16.840.1.114222.4.11.1002/70942-8.json |
| 70943-6 | Eye anterior segment Narrative | ./2.16.840.1.114222.4.11.1002/70943-6.json |
| 70944-4 | Eye posterior segment Narrative | ./2.16.840.1.114222.4.11.1002/70944-4.json |
| 70945-1 | Lacrimal Narrative | ./2.16.840.1.114222.4.11.1002/70945-1.json |
| 7094-6 | Artichoke IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7094-6.json |
| 70946-9 | Ancillary eye tests Narrative | ./2.16.840.1.114222.4.11.1002/70946-9.json |
| 70948-5 | Ocular physical exam Narrative | ./2.16.840.1.114222.4.11.1002/70948-5.json |
| 70949-3 | Pathology report.section heading | ./2.16.840.1.114222.4.11.1002/70949-3.json |
| 7095-3 | Arizona Ash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7095-3.json |
| 70970-9 | Cryoglobulin [Presence] in Serum by Hypotonic dilution | ./2.16.840.1.114222.4.11.1002/70970-9.json |
| 7098-7 | White Ash triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7098-7.json |
| 7099-5 | Asparagus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7099-5.json |
| 7100-1 | Asparagus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7100-1.json |
| 7101-9 | Aspen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7101-9.json |
| 7102-7 | Aspen IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7102-7.json |
| 7103-5 | Aspergillus fumigatus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7103-5.json |
| 7104-3 | Aspergillus fumigatus triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7104-3.json |
| 7105-0 | Aspergillus nidulans IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7105-0.json |
| 7106-8 | Aspergillus sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7106-8.json |
| 7107-6 | Aspergillus sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7107-6.json |
| 7108-4 | Acetylsalicylate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7108-4.json |
| 7109-2 | Avocado IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7109-2.json |
| 7110-0 | Groundsel Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7110-0.json |
| 7111-8 | Bahia grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7111-8.json |
| 711-2 | Eosinophils [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/711-2.json |
| 7112-6 | Banana IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7112-6.json |
| 7113-4 | Banana triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7113-4.json |
| 7114-2 | Barley IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7114-2.json |
| 7115-9 | Barley triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7115-9.json |
| 7116-7 | Barley Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7116-7.json |
| 7117-5 | Oat+Barley IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7117-5.json |
| 7118-3 | Basil IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7118-3.json |
| 7119-1 | Basil IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7119-1.json |
| 7120-9 | Bass, Black IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7120-9.json |
| 7121-7 | Bassiai IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7121-7.json |
| 7122-5 | Basswood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7122-5.json |
| 71230-7 | Birth certificate | ./2.16.840.1.114222.4.11.1002/71230-7.json |
| 7123-3 | Bayberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7123-3.json |
| 7124-1 | Bayberry Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7124-1.json |
| 7125-8 | Bayleaf IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7125-8.json |
| 7126-6 | Bayleaf IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7126-6.json |
| 7127-4 | Green Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7127-4.json |
| 7128-2 | Green Bean triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7128-2.json |
| 7129-0 | Red Kidney Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7129-0.json |
| 7130-8 | Red Kidney Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7130-8.json |
| 7131-6 | Lima Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7131-6.json |
| 7132-4 | Lima Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7132-4.json |
| 7133-2 | Mung Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7133-2.json |
| 7134-0 | Mung Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7134-0.json |
| 71355-2 | SLC26A5 gene c.-53-2A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/71355-2.json |
| 71356-0 | TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/71356-0.json |
| 7135-7 | Pinto Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7135-7.json |
| 71357-8 | PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/71357-8.json |
| 71358-6 | GJB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/71358-6.json |
| 71359-4 | Y chromosome AZFa region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/71359-4.json |
| 71360-2 | Y chromosome AZFb region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/71360-2.json |
| 71361-0 | Y chromosome AZFc region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/71361-0.json |
| 7136-5 | Pinto Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7136-5.json |
| 71368-5 | Desmosome IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/71368-5.json |
| 71370-1 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71370-1.json |
| 71371-9 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71371-9.json |
| 7137-3 | Soybean triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7137-3.json |
| 71373-5 | Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71373-5.json |
| 71374-3 | Food Allergen Mix 51 (Carrot+Tomato+Mustard+Potato+Garlic) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71374-3.json |
| 71375-0 | Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71375-0.json |
| 71376-8 | Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/71376-8.json |
| 71377-6 | Legionella sp [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/71377-6.json |
| 71378-4 | Leptospira sp [Identifier] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/71378-4.json |
| 7138-1 | Soybean dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7138-1.json |
| 71386-7 | Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/71386-7.json |
| 71387-5 | Spermatozoa Motile [#] in Semen --post ejaculate | ./2.16.840.1.114222.4.11.1002/71387-5.json |
| 7139-9 | Bean string IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7139-9.json |
| 7140-7 | Wax Bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7140-7.json |
| 7141-5 | White Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7141-5.json |
| 7142-3 | Yellow Bean IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7142-3.json |
| 71425-3 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/71425-3.json |
| 71426-1 | C reactive protein [Mass/volume] in Blood by High sensitivity method | ./2.16.840.1.114222.4.11.1002/71426-1.json |
| 71427-9 | Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/71427-9.json |
| 71429-5 | Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71429-5.json |
| 71430-3 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/71430-3.json |
| 7143-1 | Beef triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7143-1.json |
| 71431-1 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71431-1.json |
| 7144-9 | Liver beef triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7144-9.json |
| 7145-6 | Beet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7145-6.json |
| 7146-4 | Red Beet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7146-4.json |
| 7147-2 | Sugar Beet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7147-2.json |
| 7148-0 | Berry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7148-0.json |
| 71482-4 | Risk assessment Document | ./2.16.840.1.114222.4.11.1002/71482-4.json |
| 7149-8 | Bipolanis curvularia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7149-8.json |
| 7151-4 | Blackberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7151-4.json |
| 7152-2 | Blueberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7152-2.json |
| 7153-0 | Blueberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7153-0.json |
| 7154-8 | Blueberry triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7154-8.json |
| 7155-5 | Boxelder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7155-5.json |
| 7156-3 | Boxelder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7156-3.json |
| 7157-1 | Brazil Nut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7157-1.json |
| 7158-9 | Brazil Nut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7158-9.json |
| 71593-8 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/71593-8.json |
| 7159-7 | Broccoli IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7159-7.json |
| 7160-5 | Brussel Sprouts IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7160-5.json |
| 7161-3 | Brussel Sprouts IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7161-3.json |
| 7162-1 | Buckwheat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7162-1.json |
| 7164-7 | Burrobrush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7164-7.json |
| 7166-2 | Burweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7166-2.json |
| 7167-0 | Butterfly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7167-0.json |
| 7168-8 | Buttermilk triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7168-8.json |
| 71692-8 | Platelets reticulated [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/71692-8.json |
| 71693-6 | Platelets reticulated/100 platelets in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/71693-6.json |
| 7169-6 | Cabbage IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7169-6.json |
| 71699-3 | Flavivirus Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/71699-3.json |
| 71700-9 | Rotavirus RNA [Identifier] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71700-9.json |
| 71701-7 | Rotavirus dsRNA [Identifier] in Stool by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/71701-7.json |
| 71702-5 | Rotavirus dsRNA [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) | ./2.16.840.1.114222.4.11.1002/71702-5.json |
| 71703-3 | Rotavirus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71703-3.json |
| 7170-4 | Cabbage IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7170-4.json |
| 71704-1 | Rotavirus IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71704-1.json |
| 71705-8 | Rotavirus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71705-8.json |
| 71706-6 | Marburg virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71706-6.json |
| 71707-4 | Marburg virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71707-4.json |
| 71708-2 | Marburg virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/71708-2.json |
| 71709-0 | Lassa virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71709-0.json |
| 71710-8 | Lassa virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71710-8.json |
| 71711-6 | Ebola virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71711-6.json |
| 7171-2 | Canary feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7171-2.json |
| 71712-4 | Ebola virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71712-4.json |
| 71713-2 | Pyruvate kinase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/71713-2.json |
| 71714-0 | Brucella abortus Ab [Presence] in Milk by Heat-inactivation ring test | ./2.16.840.1.114222.4.11.1002/71714-0.json |
| 71715-7 | Brucella abortus IgG1 and IgG2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71715-7.json |
| 71716-5 | Brucella suis Ab [Titer] in Serum by Tube agglutination | ./2.16.840.1.114222.4.11.1002/71716-5.json |
| 71717-3 | Brucella suis Ab [Titer] in Serum by Plate agglutination | ./2.16.840.1.114222.4.11.1002/71717-3.json |
| 71718-1 | Enterococcus sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71718-1.json |
| 71719-9 | Mycobacterium avium complex DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71719-9.json |
| 7172-0 | Candida albicans IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7172-0.json |
| 7173-8 | Candida albicans triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7173-8.json |
| 7174-6 | Candida sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7174-6.json |
| 71759-5 | Rotavirus RNA [Identifier] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71759-5.json |
| 71760-3 | Rotavirus identified in Stool by Sequencing | ./2.16.840.1.114222.4.11.1002/71760-3.json |
| 71761-1 | Rotavirus identified in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/71761-1.json |
| 71762-9 | Rotavirus IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71762-9.json |
| 71763-7 | Rotavirus IgA Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71763-7.json |
| 71764-5 | Rotavirus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71764-5.json |
| 71765-2 | Rotavirus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71765-2.json |
| 71767-8 | Ebola virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71767-8.json |
| 71768-6 | Ebola virus Ag [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/71768-6.json |
| 71769-4 | Marburg virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71769-4.json |
| 71770-2 | Ebola virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71770-2.json |
| 71771-0 | Marburg virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71771-0.json |
| 71773-6 | Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative | ./2.16.840.1.114222.4.11.1002/71773-6.json |
| 71778-5 | Rift valley fever virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71778-5.json |
| 71779-3 | Rift valley fever virus IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71779-3.json |
| 71780-1 | Rift valley fever virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71780-1.json |
| 71781-9 | Rift valley fever virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71781-9.json |
| 71782-7 | Yellow fever virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/71782-7.json |
| 71783-5 | Yellow fever virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/71783-5.json |
| 71784-3 | Rift valley fever virus IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/71784-3.json |
| 71786-8 | Staphylococcus aureus exfoliative toxin A eta gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71786-8.json |
| 7178-7 | Caraway IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7178-7.json |
| 71787-6 | Staphylococcus aureus exfoliative toxin B etb gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71787-6.json |
| 71788-4 | Neisseria meningitidis DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/71788-4.json |
| 717-9 | Hemoglobin [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/717-9.json |
| 71790-0 | Calcium [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/71790-0.json |
| 71791-8 | Metanephrines [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/71791-8.json |
| 71792-6 | Procollagen type III.N-terminal propeptide [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/71792-6.json |
| 71793-4 | Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination | ./2.16.840.1.114222.4.11.1002/71793-4.json |
| 7179-5 | Carob IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7179-5.json |
| 71796-7 | Promyelocytic leukemia protein distribution pattern [Interpretation] in Blood or Tissue Qualitative by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/71796-7.json |
| 71797-5 | Protoporphyrin.zinc [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/71797-5.json |
| 7180-3 | Carrot IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7180-3.json |
| 71804-9 | Serotonin [Entitic substance] in Platelets | ./2.16.840.1.114222.4.11.1002/71804-9.json |
| 71805-6 | Cortisol Free/Cortisone free [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/71805-6.json |
| 7181-1 | Carrot triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7181-1.json |
| 71828-8 | Hematocrit [Pure volume fraction] of Body fluid | ./2.16.840.1.114222.4.11.1002/71828-8.json |
| 7182-9 | Casein IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7182-9.json |
| 71829-6 | Hematocrit [Pure volume fraction] of Venous blood | ./2.16.840.1.114222.4.11.1002/71829-6.json |
| 71830-4 | Hematocrit [Pure volume fraction] of Mixed venous blood | ./2.16.840.1.114222.4.11.1002/71830-4.json |
| 71831-2 | Hematocrit [Pure volume fraction] of Capillary blood | ./2.16.840.1.114222.4.11.1002/71831-2.json |
| 71832-0 | Hematocrit [Pure volume fraction] of Arterial blood | ./2.16.840.1.114222.4.11.1002/71832-0.json |
| 71833-8 | Hematocrit [Pure volume fraction] of Blood by Automated count | ./2.16.840.1.114222.4.11.1002/71833-8.json |
| 7183-7 | Cashew nut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7183-7.json |
| 71839-5 | Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood | ./2.16.840.1.114222.4.11.1002/71839-5.json |
| 7184-5 | Cat dander IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7184-5.json |
| 71849-4 | Oxygen saturation [Pure mass fraction] in Cord blood | ./2.16.840.1.114222.4.11.1002/71849-4.json |
| 7185-2 | Cat dander triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7185-2.json |
| 71853-6 | Oxygen saturation [Pure mass fraction] in Blood | ./2.16.840.1.114222.4.11.1002/71853-6.json |
| 71854-4 | Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood | ./2.16.840.1.114222.4.11.1002/71854-4.json |
| 71866-8 | Hemoglobin E/Hemoglobin.total [Pure mass fraction] in Blood by HPLC | ./2.16.840.1.114222.4.11.1002/71866-8.json |
| 718-7 | Hemoglobin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/718-7.json |
| 71875-9 | Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood | ./2.16.840.1.114222.4.11.1002/71875-9.json |
| 7187-8 | Catfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7187-8.json |
| 7188-6 | Catfish triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7188-6.json |
| 71892-4 | Cortisone [Moles/volume] in Saliva (oral fluid) --AM peak specimen | ./2.16.840.1.114222.4.11.1002/71892-4.json |
| 71893-2 | Cortisone [Moles/volume] in Saliva (oral fluid) --PM trough specimen | ./2.16.840.1.114222.4.11.1002/71893-2.json |
| 7189-4 | Cattail IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7189-4.json |
| 71894-0 | Cortisone free [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/71894-0.json |
| 7190-2 | Cauliflower IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7190-2.json |
| 7191-0 | Cauliflower triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7191-0.json |
| 7192-8 | Cedar dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7192-8.json |
| 7193-6 | Mountain Juniper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7193-6.json |
| 7194-4 | Mountain Juniper triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7194-4.json |
| 719-5 | Hemoglobin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/719-5.json |
| 7195-1 | Red Cedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7195-1.json |
| 7196-9 | Saltcedar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7196-9.json |
| 7197-7 | Celery IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7197-7.json |
| 7198-5 | Celery triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7198-5.json |
| 7199-3 | Cephalosporine mold IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7199-3.json |
| 7200-9 | Chaetomium globosum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7200-9.json |
| 7201-7 | American Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7201-7.json |
| 7202-5 | American Cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7202-5.json |
| 720-3 | Free Hemoglobin [Presence] in Plasma | ./2.16.840.1.114222.4.11.1002/720-3.json |
| 7203-3 | Blue Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7203-3.json |
| 7204-1 | Cheese cheddar type IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7204-1.json |
| 7205-8 | Cheese cheddar type triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7205-8.json |
| 7206-6 | Cottage Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7206-6.json |
| 7207-4 | Cottage Cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7207-4.json |
| 7208-2 | Cream Cheese triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7208-2.json |
| 7209-0 | Mozzarella Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7209-0.json |
| 7210-8 | Mozzarella Cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7210-8.json |
| 721-1 | Free Hemoglobin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/721-1.json |
| 72111-8 | Sapovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72111-8.json |
| 7211-6 | Mozzarella Cheese triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7211-6.json |
| 7212-4 | Parmesan Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7212-4.json |
| 7213-2 | Parmesan Cheese triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7213-2.json |
| 72134-0 | Cancer event report | ./2.16.840.1.114222.4.11.1002/72134-0.json |
| 72137-3 | DBT Breast - right diagnostic | ./2.16.840.1.114222.4.11.1002/72137-3.json |
| 72138-1 | DBT Breast - left diagnostic | ./2.16.840.1.114222.4.11.1002/72138-1.json |
| 72139-9 | DBT Breast - bilateral diagnostic | ./2.16.840.1.114222.4.11.1002/72139-9.json |
| 7214-0 | Roquefort Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7214-0.json |
| 72140-7 | DBT Breast - right screening | ./2.16.840.1.114222.4.11.1002/72140-7.json |
| 72141-5 | DBT Breast - left screening | ./2.16.840.1.114222.4.11.1002/72141-5.json |
| 72142-3 | DBT Breast - bilateral screening | ./2.16.840.1.114222.4.11.1002/72142-3.json |
| 7215-7 | Swiss Cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7215-7.json |
| 72157-1 | Apo-transcobalamin II [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/72157-1.json |
| 72158-9 | Apo-transcobalamin I [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/72158-9.json |
| 72159-7 | Inulin renal clearance/1.73 sq M in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72159-7.json |
| 72160-5 | Holo-transcobalamin II [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/72160-5.json |
| 7216-5 | Swiss Cheese IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7216-5.json |
| 72166-2 | Tobacco smoking status | ./2.16.840.1.114222.4.11.1002/72166-2.json |
| 72170-4 | Photographic image | ./2.16.840.1.114222.4.11.1002/72170-4.json |
| 7217-3 | Cherry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7217-3.json |
| 72174-6 | Rotavirus Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72174-6.json |
| 7218-1 | Cherry triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7218-1.json |
| 72200-9 | Influenza virus A neuraminidase segment sequence identifier | ./2.16.840.1.114222.4.11.1002/72200-9.json |
| 72201-7 | Influenza virus A matrix protein segment sequence identifier | ./2.16.840.1.114222.4.11.1002/72201-7.json |
| 72206-6 | Epstein Barr virus nuclear 1 IgG and IgM [Color Ratio] in Serum or Plasma by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72206-6.json |
| 7220-7 | Horse Chestnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7220-7.json |
| 72207-4 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72207-4.json |
| 72208-2 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72208-2.json |
| 72209-0 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72209-0.json |
| 72210-8 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72210-8.json |
| 72211-6 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72211-6.json |
| 72212-4 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72212-4.json |
| 72213-2 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72213-2.json |
| 72214-0 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72214-0.json |
| 7221-5 | Chewing gum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7221-5.json |
| 72215-7 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72215-7.json |
| 72216-5 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72216-5.json |
| 72217-3 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72217-3.json |
| 72218-1 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72218-1.json |
| 7222-3 | Chicken IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7222-3.json |
| 7223-1 | Chicken triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7223-1.json |
| 72238-9 | MR Toes - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72238-9.json |
| 72239-7 | MR Toes - right WO contrast | ./2.16.840.1.114222.4.11.1002/72239-7.json |
| 72240-5 | MR Toes - right W contrast IV | ./2.16.840.1.114222.4.11.1002/72240-5.json |
| 72241-3 | MR Toes - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72241-3.json |
| 72242-1 | MR Toes - left WO contrast | ./2.16.840.1.114222.4.11.1002/72242-1.json |
| 72243-9 | MR Toes - left W contrast IV | ./2.16.840.1.114222.4.11.1002/72243-9.json |
| 72244-7 | MR Pelvis Endorectal WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72244-7.json |
| 72245-4 | MR Pelvis Defecography W contrast PR | ./2.16.840.1.114222.4.11.1002/72245-4.json |
| 72246-2 | MR Abdomen and Pelvis W contrast PO and WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72246-2.json |
| 72247-0 | MR Abdomen and Pelvis W contrast PO and WO contrast IV | ./2.16.840.1.114222.4.11.1002/72247-0.json |
| 72248-8 | MRCP Abdomen WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72248-8.json |
| 7224-9 | Chicken feather IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7224-9.json |
| 72249-6 | CT Facial bones WO contrast | ./2.16.840.1.114222.4.11.1002/72249-6.json |
| 72250-4 | CT Small bowel W contrast PO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72250-4.json |
| 72251-2 | CT Pulmonary arteries for pulmonary embolus | ./2.16.840.1.114222.4.11.1002/72251-2.json |
| 72252-0 | CT Chest and Abdomen and Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/72252-0.json |
| 72253-8 | CT Chest and Abdomen and Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/72253-8.json |
| 72254-6 | CT Chest and Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/72254-6.json |
| 7225-6 | Chicory IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7225-6.json |
| 72256-1 | XR Abdomen Views for motility W radioopaque markers | ./2.16.840.1.114222.4.11.1002/72256-1.json |
| 72258-7 | Malondialdehyde [Entitic substance] in Platelets | ./2.16.840.1.114222.4.11.1002/72258-7.json |
| 72259-5 | Adefovir [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/72259-5.json |
| 72260-3 | Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/72260-3.json |
| 72262-9 | Methemoglobin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72262-9.json |
| 72263-7 | Oxyhemoglobin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72263-7.json |
| 7226-4 | Chinese Tallow Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7226-4.json |
| 72265-2 | Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/72265-2.json |
| 72266-0 | Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/72266-0.json |
| 72267-8 | Evaluation of mental and physical incapacity certificate | ./2.16.840.1.114222.4.11.1002/72267-8.json |
| 72268-6 | Streptococcus pyogenes exotoxin B speB gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72268-6.json |
| 72269-4 | pH of Vaginal fluid by Test strip | ./2.16.840.1.114222.4.11.1002/72269-4.json |
| 72270-2 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast | ./2.16.840.1.114222.4.11.1002/72270-2.json |
| 72271-0 | Creatinine [Mass/volume] in Serum or Plasma --pre contrast | ./2.16.840.1.114222.4.11.1002/72271-0.json |
| 7227-2 | Chocolate triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7227-2.json |
| 72274-4 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72274-4.json |
| 72276-9 | Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72276-9.json |
| 72277-7 | Trichomonas vaginalis [Presence] in Prostatic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/72277-7.json |
| 72279-3 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/72279-3.json |
| 72281-9 | Days in therapeutic INR range/Days INR result determined [Ratio] | ./2.16.840.1.114222.4.11.1002/72281-9.json |
| 722-9 | Hemoglobin [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/722-9.json |
| 7229-8 | Cinnamon IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7229-8.json |
| 72304-9 | Edge of wound description | ./2.16.840.1.114222.4.11.1002/72304-9.json |
| 7230-6 | Cladosporium herbarum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7230-6.json |
| 72306-4 | Nicotinurate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72306-4.json |
| 72307-2 | Brucella sp IgG Ab [Titer] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/72307-2.json |
| 72308-0 | Brucella sp IgG Ab [Titer] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/72308-0.json |
| 72309-8 | NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72309-8.json |
| 72310-6 | NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72310-6.json |
| 72311-4 | NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72311-4.json |
| 72312-2 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72312-2.json |
| 72313-0 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72313-0.json |
| 7231-4 | Cladosporium herbarum triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7231-4.json |
| 72314-8 | Th-To IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72314-8.json |
| 72315-5 | Platelet-derived growth factor receptor IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72315-5.json |
| 72316-3 | RNA polymerase III RP155 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72316-3.json |
| 72317-1 | RNA polymerase III RP11 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72317-1.json |
| 72318-9 | Centromere protein A IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72318-9.json |
| 72320-5 | Mitochondria M2-3E IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/72320-5.json |
| 72321-3 | HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/72321-3.json |
| 7232-2 | Clam IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7232-2.json |
| 72322-1 | HLA-A+B+C (class I) IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72322-1.json |
| 72323-9 | HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72323-9.json |
| 72327-0 | Amphiphysin IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/72327-0.json |
| 72328-8 | HLA-A+B+C (class I) IgG Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72328-8.json |
| 7233-0 | Clam triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7233-0.json |
| 72333-8 | JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72333-8.json |
| 72334-6 | NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72334-6.json |
| 72335-3 | NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72335-3.json |
| 72336-1 | NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72336-1.json |
| 72337-9 | Protein S Ag [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72337-9.json |
| 72338-7 | Erythrocytes [Presence] in Prostatic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/72338-7.json |
| 72339-5 | Lecithin [Presence] in Prostatic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/72339-5.json |
| 72340-3 | Bacteria [Presence] in Prostatic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/72340-3.json |
| 72341-1 | Amyloid bodies [Presence] in Prostatic fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/72341-1.json |
| 72347-8 | Neutrophils [#/volume] in Prostatic fluid by Manual count | ./2.16.840.1.114222.4.11.1002/72347-8.json |
| 7234-8 | Clove IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7234-8.json |
| 72348-6 | Leukocytes [#/volume] in Prostatic fluid by Manual count | ./2.16.840.1.114222.4.11.1002/72348-6.json |
| 7235-5 | Clove IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7235-5.json |
| 72356-9 | Influenza virus A and B Ag [Identifier] in Specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72356-9.json |
| 72357-7 | Microscopic observation [Presence] in Specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/72357-7.json |
| 7236-3 | Clover IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7236-3.json |
| 72364-3 | Lymphocytes/100 leukocytes in Vitreous fluid by Manual count | ./2.16.840.1.114222.4.11.1002/72364-3.json |
| 72365-0 | Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72365-0.json |
| 72366-8 | Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72366-8.json |
| 72367-6 | Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72367-6.json |
| 72368-4 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72368-4.json |
| 723-7 | Hemoglobin [Mass/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/723-7.json |
| 7237-1 | Cockatoo IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7237-1.json |
| 72373-4 | Virus identified in Nasopharynx by Culture | ./2.16.840.1.114222.4.11.1002/72373-4.json |
| 72374-2 | Virus identified in Lung tissue by Culture | ./2.16.840.1.114222.4.11.1002/72374-2.json |
| 72375-9 | Microscopic method - Urine | ./2.16.840.1.114222.4.11.1002/72375-9.json |
| 72376-7 | Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72376-7.json |
| 72377-5 | Nordiazepam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72377-5.json |
| 72378-3 | Oxazepam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72378-3.json |
| 72379-1 | Cannabinoids synthetic [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/72379-1.json |
| 72380-9 | LORazepam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72380-9.json |
| 72381-7 | ALPRAZolam [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72381-7.json |
| 72382-5 | HER2 [Units/volume] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/72382-5.json |
| 72383-3 | HER2 [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/72383-3.json |
| 72384-1 | Meperidine+Normeperidine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72384-1.json |
| 72385-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72385-8.json |
| 72386-6 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72386-6.json |
| 72387-4 | Methadone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72387-4.json |
| 72388-2 | Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72388-2.json |
| 7238-9 | Cocklebur IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7238-9.json |
| 72389-0 | Candida krusei DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72389-0.json |
| 72390-8 | Candida lusitaniae DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72390-8.json |
| 72391-6 | Candida tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72391-6.json |
| 72396-5 | PHENobarbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72396-5.json |
| 7239-7 | Cocklebur triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7239-7.json |
| 72397-3 | Secobarbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72397-3.json |
| 72398-1 | Butalbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72398-1.json |
| 72399-9 | Amobarbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72399-9.json |
| 72400-5 | Methadone [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/72400-5.json |
| 72401-3 | Propoxyphene [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/72401-3.json |
| 72402-1 | oxyCODONE [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/72402-1.json |
| 72403-9 | 3-epi-25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72403-9.json |
| 72404-7 | 3-epi-25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72404-7.json |
| 7240-5 | Coconut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7240-5.json |
| 72405-4 | Cocaine [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72405-4.json |
| 72406-2 | Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72406-2.json |
| 72407-0 | Benzoylecgonine [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/72407-0.json |
| 72408-8 | Microscopic observation [Identifier] in Anal by Gram stain | ./2.16.840.1.114222.4.11.1002/72408-8.json |
| 72412-0 | BK virus subtype in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72412-0.json |
| 7241-3 | Coconut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7241-3.json |
| 72413-8 | BK virus subtype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72413-8.json |
| 72414-6 | Acetoacetate [Moles/volume] in Blood --pre-meal | ./2.16.840.1.114222.4.11.1002/72414-6.json |
| 72415-3 | Acetoacetate [Moles/volume] in Blood --post meal | ./2.16.840.1.114222.4.11.1002/72415-3.json |
| 72416-1 | Beta hydroxybutyrate [Moles/volume] in Blood --post meal | ./2.16.840.1.114222.4.11.1002/72416-1.json |
| 72417-9 | Beta hydroxybutyrate [Moles/volume] in Blood --pre-meal | ./2.16.840.1.114222.4.11.1002/72417-9.json |
| 72418-7 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --pre-meal | ./2.16.840.1.114222.4.11.1002/72418-7.json |
| 72419-5 | Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --post meal | ./2.16.840.1.114222.4.11.1002/72419-5.json |
| 72420-3 | Gamma aminobutyrate.free [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72420-3.json |
| 7242-1 | Codfish triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7242-1.json |
| 72421-1 | Vancomycin resistance vanB gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72421-1.json |
| 72422-9 | Gamma aminobutyrate [Moles/volume] in Blood from Fetus | ./2.16.840.1.114222.4.11.1002/72422-9.json |
| 72423-7 | 3-Methylhistidine [Moles/volume] in Blood from Fetus | ./2.16.840.1.114222.4.11.1002/72423-7.json |
| 72424-5 | 3-Methylhistidine/Amino acids.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72424-5.json |
| 72425-2 | 7-Hydroxyoctanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72425-2.json |
| 72426-0 | 5-Hydroxyhexanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72426-0.json |
| 72427-8 | 4-Hydroxyphenylpyruvate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72427-8.json |
| 72428-6 | 4-Hydroxyphenylpyruvate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72428-6.json |
| 72429-4 | 4-Hydroxyphenyllactate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72429-4.json |
| 72430-2 | 4-Hydroxyphenyllactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72430-2.json |
| 72431-0 | 4-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72431-0.json |
| 72432-8 | 4-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72432-8.json |
| 72433-6 | Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72433-6.json |
| 72434-4 | 4,5-Dihydroxyhexanolactone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72434-4.json |
| 72435-1 | 4,5-Dihydroxyhexanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72435-1.json |
| 72436-9 | Phenylpyruvate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72436-9.json |
| 72437-7 | Phenyllactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72437-7.json |
| 72438-5 | 3-Methylglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72438-5.json |
| 7243-9 | Coffee bean IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7243-9.json |
| 72439-3 | 3-Methylglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72439-3.json |
| 72440-1 | 3-Methylglutaconate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72440-1.json |
| 72441-9 | 3-Methylcrotonylglycine [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/72441-9.json |
| 72442-7 | 3-Methylcrotonylglycine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72442-7.json |
| 72443-5 | 3-Methyladipate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72443-5.json |
| 72444-3 | 3-Hydroxytetradecanedioate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72444-3.json |
| 72445-0 | 3-Hydroxysuberate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72445-0.json |
| 72446-8 | 3-Hydroxysuberate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72446-8.json |
| 7244-7 | Cola IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7244-7.json |
| 72447-6 | 3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72447-6.json |
| 72448-4 | 3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72448-4.json |
| 72449-2 | 3-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/72449-2.json |
| 724-5 | Hemoglobin [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/724-5.json |
| 72450-0 | 3-Hydroxyisovalerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72450-0.json |
| 72451-8 | Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72451-8.json |
| 72452-6 | Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72452-6.json |
| 72453-4 | PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72453-4.json |
| 7245-4 | Cola IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7245-4.json |
| 72454-2 | Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72454-2.json |
| 72455-9 | Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72455-9.json |
| 72456-7 | Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72456-7.json |
| 72457-5 | Desmin Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/72457-5.json |
| 72458-3 | Myosin Ab [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/72458-3.json |
| 72459-1 | JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72459-1.json |
| 72460-9 | JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72460-9.json |
| 72461-7 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72461-7.json |
| 7246-2 | Cola nut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7246-2.json |
| 72462-5 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72462-5.json |
| 72463-3 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72463-3.json |
| 72464-1 | JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72464-1.json |
| 72465-8 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72465-8.json |
| 72466-6 | JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72466-6.json |
| 72467-4 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72467-4.json |
| 72468-2 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72468-2.json |
| 72469-0 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72469-0.json |
| 7247-0 | Corn triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7247-0.json |
| 72470-8 | MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72470-8.json |
| 72471-6 | UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72471-6.json |
| 72472-4 | UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72472-4.json |
| 72473-2 | JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72473-2.json |
| 72474-0 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72474-0.json |
| 72475-7 | Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72475-7.json |
| 72482-3 | BK virus subtype in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72482-3.json |
| 72483-1 | BK virus subtype in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72483-1.json |
| 72484-9 | BK virus subtype in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72484-9.json |
| 72485-6 | Tapentadol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/72485-6.json |
| 72487-2 | TF gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/72487-2.json |
| 7248-8 | Cultivated Corn IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7248-8.json |
| 72489-8 | Androstenedione [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72489-8.json |
| 72490-6 | 17-Hydroxyprogesterone [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72490-6.json |
| 72491-4 | Bile acid [Moles/volume] in Stool | ./2.16.840.1.114222.4.11.1002/72491-4.json |
| 72492-2 | Paraoxonase-arylesterase 1 (PON1) [Enzymatic activity/volume] in Serum | ./2.16.840.1.114222.4.11.1002/72492-2.json |
| 72493-0 | Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72493-0.json |
| 72494-8 | Cytomegalovirus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72494-8.json |
| 72495-5 | Candida parapsilosis DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72495-5.json |
| 7249-6 | Cornish hen triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7249-6.json |
| 72496-3 | DNA double strand [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/72496-3.json |
| 72497-1 | Dihydropteridine reductase [Enzymatic activity/mass] in DBS | ./2.16.840.1.114222.4.11.1002/72497-1.json |
| 72498-9 | Tripeptidyl peptidase I [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/72498-9.json |
| 72499-7 | Oval fat bodies (globules) [#/area] in Stool by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/72499-7.json |
| 72500-2 | Homocyst(e)ine [Moles/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/72500-2.json |
| 72501-0 | Homocyst(e)ine [Moles/volume] in Serum or Plasma --6 hours post dose methionine | ./2.16.840.1.114222.4.11.1002/72501-0.json |
| 72502-8 | Homocyst(e)ine [Molar concentration difference] in Serum or Plasma --6 hours post dose methionine - post CFst | ./2.16.840.1.114222.4.11.1002/72502-8.json |
| 72503-6 | WT1 gene exon 1+2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72503-6.json |
| 7250-4 | Cotton gin dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7250-4.json |
| 72504-4 | CV2 Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72504-4.json |
| 72505-1 | Exserohilum rostratum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72505-1.json |
| 72506-9 | ABCB1 gene c.3435C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72506-9.json |
| 72507-7 | VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72507-7.json |
| 72508-5 | UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72508-5.json |
| 72509-3 | Reporting rate Reporting Period Population Calculated | ./2.16.840.1.114222.4.11.1002/72509-3.json |
| 72510-1 | Performance rate Reporting Period Population Calculated | ./2.16.840.1.114222.4.11.1002/72510-1.json |
| 72511-9 | CYP2B6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72511-9.json |
| 7251-2 | Cotton linters IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7251-2.json |
| 72512-7 | VKORC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72512-7.json |
| 72515-0 | Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72515-0.json |
| 72516-8 | Glucose [Moles/volume] in Blood by Automated test strip | ./2.16.840.1.114222.4.11.1002/72516-8.json |
| 72518-4 | CHEK2 gene c.470C>T and 1100delC [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72518-4.json |
| 72519-2 | Infections present AndOr treated during this pregnancy for live birth [US Standard Certificate of Live Birth] | ./2.16.840.1.114222.4.11.1002/72519-2.json |
| 725-2 | Hemoglobin [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/725-2.json |
| 7252-0 | Cotton linters triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7252-0.json |
| 72520-0 | FLT3 gene.p.Asp835+Ile836 mutations [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72520-0.json |
| 72521-8 | p-ANCA formalin sensitive IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72521-8.json |
| 72522-6 | p-ANCA formalin resistant IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72522-6.json |
| 72523-4 | Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72523-4.json |
| 72524-2 | Myelin Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/72524-2.json |
| 72525-9 | Raltegravir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72525-9.json |
| 72526-7 | Elvitegravir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72526-7.json |
| 72528-3 | US Axilla - right | ./2.16.840.1.114222.4.11.1002/72528-3.json |
| 72529-1 | US Axilla - left | ./2.16.840.1.114222.4.11.1002/72529-1.json |
| 72530-9 | US Guidance for injection of Joint | ./2.16.840.1.114222.4.11.1002/72530-9.json |
| 72531-7 | CT Colon and Rectum W contrast IV and W air contrast PR | ./2.16.840.1.114222.4.11.1002/72531-7.json |
| 72532-5 | US Guidance for ambulatory phlebectomy of Extremity vein - right | ./2.16.840.1.114222.4.11.1002/72532-5.json |
| 72533-3 | US Guidance for ambulatory phlebectomy of Extremity vein - left | ./2.16.840.1.114222.4.11.1002/72533-3.json |
| 72534-1 | US Guidance for laser ablation of Extremity vein - right | ./2.16.840.1.114222.4.11.1002/72534-1.json |
| 72535-8 | US Guidance for laser ablation of Extremity vein - left | ./2.16.840.1.114222.4.11.1002/72535-8.json |
| 72536-6 | US Guidance for vascular sclerotherapy of Extremity veins - bilateral | ./2.16.840.1.114222.4.11.1002/72536-6.json |
| 72537-4 | US Guidance for vascular sclerotherapy of Extremity vein - bilateral | ./2.16.840.1.114222.4.11.1002/72537-4.json |
| 7253-8 | Cottonseed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7253-8.json |
| 72538-2 | RFA Guidance for removal of peripherally-inserted central venous catheter from Vein | ./2.16.840.1.114222.4.11.1002/72538-2.json |
| 72539-0 | RF Guidance for denervation of Peripheral nerve | ./2.16.840.1.114222.4.11.1002/72539-0.json |
| 72540-8 | RF Guidance for denervation of Spine facet joint | ./2.16.840.1.114222.4.11.1002/72540-8.json |
| 72541-6 | RF Guidance for denervation of Spine Cervical Facet Joint | ./2.16.840.1.114222.4.11.1002/72541-6.json |
| 72542-4 | RF Guidance for denervation of Lumbar Spine Facet Joint | ./2.16.840.1.114222.4.11.1002/72542-4.json |
| 72543-2 | RF Guidance for denervation of Thoracic spine intercostal nerve | ./2.16.840.1.114222.4.11.1002/72543-2.json |
| 72544-0 | RF Guidance for percutaneous device removal of nephrostomy tube of Kidney - bilateral-- W contrast | ./2.16.840.1.114222.4.11.1002/72544-0.json |
| 72545-7 | RF Guidance for percutaneous replacement of drainage catheter of Biliary ducts and Gallbladder | ./2.16.840.1.114222.4.11.1002/72545-7.json |
| 7254-6 | Black Cottonwood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7254-6.json |
| 72546-5 | RFA Guidance for removal of CV catheter lumen obstruction of Vein | ./2.16.840.1.114222.4.11.1002/72546-5.json |
| 72547-3 | RFA Guidance for removal of CV catheter pericatheter obstruction of Vein | ./2.16.840.1.114222.4.11.1002/72547-3.json |
| 72548-1 | RFA Guidance for removal of CV catheter from Vein-- W contrast IV | ./2.16.840.1.114222.4.11.1002/72548-1.json |
| 72549-9 | RF Guidance for removal of tunneled CV catheter | ./2.16.840.1.114222.4.11.1002/72549-9.json |
| 72550-7 | RFA Guidance for repair of CV catheter with port or pump of Vein | ./2.16.840.1.114222.4.11.1002/72550-7.json |
| 72551-5 | RFA Guidance for repair of CV catheter without port or pump of Vein | ./2.16.840.1.114222.4.11.1002/72551-5.json |
| 72552-3 | RF Guidance for kyphoplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/72552-3.json |
| 7255-3 | Western Cottonwood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7255-3.json |
| 72553-1 | RF Guidance for kyphoplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/72553-1.json |
| 72554-9 | RF Guidance for trigger point injection of Muscle | ./2.16.840.1.114222.4.11.1002/72554-9.json |
| 72555-6 | Interventional radiology Consult note | ./2.16.840.1.114222.4.11.1002/72555-6.json |
| 72556-4 | Interventional radiology Progress note | ./2.16.840.1.114222.4.11.1002/72556-4.json |
| 72557-2 | Rilpivirine [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/72557-2.json |
| 72558-0 | Etravirine [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/72558-0.json |
| 7257-9 | Cow epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7257-9.json |
| 7258-7 | Cow milk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7258-7.json |
| 7259-5 | Cow milk triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7259-5.json |
| 726-0 | Hemoglobin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/726-0.json |
| 7260-3 | Crab IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7260-3.json |
| 72603-4 | Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/72603-4.json |
| 72605-9 | Cytomegalovirus glycoprotein genotype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72605-9.json |
| 72606-7 | Hepatitis D virus genotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72606-7.json |
| 72607-5 | Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/72607-5.json |
| 72608-3 | Apixaban [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72608-3.json |
| 72610-9 | diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72610-9.json |
| 7261-1 | Crab triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7261-1.json |
| 72611-7 | diazePAM [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72611-7.json |
| 72612-5 | ALPRAZolam [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72612-5.json |
| 72613-3 | Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72613-3.json |
| 72614-1 | Oxazepam [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72614-1.json |
| 72615-8 | Nordiazepam [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72615-8.json |
| 72616-6 | Benzodiazepines [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72616-6.json |
| 72617-4 | Propoxyphene [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72617-4.json |
| 72618-2 | Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72618-2.json |
| 72619-0 | Norpropoxyphene [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72619-0.json |
| 72620-8 | Norpropoxyphene [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72620-8.json |
| 72621-6 | Propoxyphene [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72621-6.json |
| 72622-4 | Propoxyphene [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72622-4.json |
| 72623-2 | inFLIXimab Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72623-2.json |
| 72624-0 | Rivaroxaban [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72624-0.json |
| 72625-7 | Dabigatran [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72625-7.json |
| 72626-5 | Methadone [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72626-5.json |
| 72627-3 | Barbiturates [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72627-3.json |
| 72628-1 | PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72628-1.json |
| 7262-9 | Cranberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7262-9.json |
| 72629-9 | Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72629-9.json |
| 72630-7 | PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72630-7.json |
| 72631-5 | Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72631-5.json |
| 72632-3 | Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72632-3.json |
| 72633-1 | Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72633-1.json |
| 72634-9 | Temazepam [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/72634-9.json |
| 72635-6 | PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72635-6.json |
| 7263-7 | Cranberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7263-7.json |
| 72642-2 | US Guidance for vascular sclerotherapy of Extremity veins - right | ./2.16.840.1.114222.4.11.1002/72642-2.json |
| 72643-0 | US Guidance for vascular sclerotherapy of Extremity veins - left | ./2.16.840.1.114222.4.11.1002/72643-0.json |
| 72644-8 | US Guidance for vascular sclerotherapy of Extremity vein - right | ./2.16.840.1.114222.4.11.1002/72644-8.json |
| 7264-5 | Cranberry triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7264-5.json |
| 72645-5 | US Guidance for vascular sclerotherapy of Extremity vein - left | ./2.16.840.1.114222.4.11.1002/72645-5.json |
| 72646-3 | Albumin in serum - albumin in pericardial fluid [Mass concentration difference] | ./2.16.840.1.114222.4.11.1002/72646-3.json |
| 72647-1 | Albumin in serum - albumin in pleural fluid [Mass concentration difference] | ./2.16.840.1.114222.4.11.1002/72647-1.json |
| 72648-9 | Glucose in serum - glucose in synovial fluid [Molar concentration difference] | ./2.16.840.1.114222.4.11.1002/72648-9.json |
| 72649-7 | Glucose in serum - glucose in peritoneal fluid [Molar concentration difference] | ./2.16.840.1.114222.4.11.1002/72649-7.json |
| 72650-5 | Glucose in serum - glucose in pericard fld [Molar concentration difference] | ./2.16.840.1.114222.4.11.1002/72650-5.json |
| 72651-3 | Glucose in serum - glucose in pleural fluid [Molar concentration difference] | ./2.16.840.1.114222.4.11.1002/72651-3.json |
| 7265-2 | Crawfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7265-2.json |
| 72652-1 | Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative | ./2.16.840.1.114222.4.11.1002/72652-1.json |
| 72653-9 | Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative | ./2.16.840.1.114222.4.11.1002/72653-9.json |
| 72654-7 | SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72654-7.json |
| 72655-4 | Aldolase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/72655-4.json |
| 72656-2 | risperiDONE [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72656-2.json |
| 72657-0 | Procainamide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72657-0.json |
| 72658-8 | PARoxetine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72658-8.json |
| 72659-6 | OXcarbazepine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72659-6.json |
| 7266-0 | Cricket IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7266-0.json |
| 72660-4 | Beta-trace protein [Mass/volume] in Ear fluid | ./2.16.840.1.114222.4.11.1002/72660-4.json |
| 72663-8 | Bisphosphoglycerate mutase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/72663-8.json |
| 72664-6 | Phosphofructokinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/72664-6.json |
| 72665-3 | Trans,trans-muconic acid [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/72665-3.json |
| 72666-1 | Nitrazepam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72666-1.json |
| 72667-9 | Mycophenolate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72667-9.json |
| 72668-7 | Mirtazapine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72668-7.json |
| 72669-5 | Mianserin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72669-5.json |
| 72671-1 | Everolimus [Mass/volume] in Plasma --trough | ./2.16.840.1.114222.4.11.1002/72671-1.json |
| 72672-9 | traZODone [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72672-9.json |
| 72673-7 | Theophylline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72673-7.json |
| 72674-5 | Sulfamethoxazole [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72674-5.json |
| 72675-2 | Sotalol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72675-2.json |
| 72676-0 | Sirolimus [Mass/volume] in Plasma --trough | ./2.16.840.1.114222.4.11.1002/72676-0.json |
| 72677-8 | Salicylates [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72677-8.json |
| 7267-8 | Cryptococcus terreus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7267-8.json |
| 72678-6 | Venlafaxine+O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/72678-6.json |
| 72679-4 | Bile acid [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/72679-4.json |
| 72680-2 | Macroprolactin [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72680-2.json |
| 7268-6 | Cucumber IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7268-6.json |
| 72693-5 | Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72693-5.json |
| 7269-4 | Cucumber triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7269-4.json |
| 72696-8 | SLC40A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72696-8.json |
| 72697-6 | CYP3A5 gene c.6986A>G(*3) [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/72697-6.json |
| 7270-2 | Curry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7270-2.json |
| 7271-0 | Curvularia sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7271-0.json |
| 72724-8 | PM-SCL-75 IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/72724-8.json |
| 72725-5 | t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72725-5.json |
| 72726-3 | t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72726-3.json |
| 7272-8 | Bald Cypress IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7272-8.json |
| 72728-9 | Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72728-9.json |
| 72729-7 | 7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72729-7.json |
| 72730-5 | Mitragynine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72730-5.json |
| 72731-3 | 7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72731-3.json |
| 72733-9 | HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72733-9.json |
| 72734-7 | Methadone [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72734-7.json |
| 72735-4 | Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72735-4.json |
| 7273-6 | Dahlia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7273-6.json |
| 72736-2 | Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72736-2.json |
| 72737-0 | Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72737-0.json |
| 72738-8 | Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72738-8.json |
| 72739-6 | Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72739-6.json |
| 72740-4 | traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72740-4.json |
| 72741-2 | Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72741-2.json |
| 72742-0 | Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72742-0.json |
| 72743-8 | Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72743-8.json |
| 7274-4 | Daisy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7274-4.json |
| 72744-6 | Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72744-6.json |
| 72745-3 | Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72745-3.json |
| 72746-1 | Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72746-1.json |
| 72747-9 | N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72747-9.json |
| 72748-7 | Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72748-7.json |
| 72749-5 | Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72749-5.json |
| 72750-3 | oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72750-3.json |
| 7275-1 | Date Palm Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7275-1.json |
| 72751-1 | oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72751-1.json |
| 72752-9 | Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72752-9.json |
| 72753-7 | HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72753-7.json |
| 72754-5 | LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72754-5.json |
| 72755-2 | clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72755-2.json |
| 72756-0 | ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72756-0.json |
| 72757-8 | Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/72757-8.json |
| 72758-6 | Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72758-6.json |
| 72760-2 | fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72760-2.json |
| 72761-0 | Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72761-0.json |
| 72762-8 | Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72762-8.json |
| 72763-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72763-6.json |
| 72764-4 | Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72764-4.json |
| 72765-1 | Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72765-1.json |
| 72766-9 | oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72766-9.json |
| 72767-7 | Influenza virus A hemagglutinin segment sequence identifier | ./2.16.840.1.114222.4.11.1002/72767-7.json |
| 72768-5 | Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72768-5.json |
| 7276-9 | American house dust mite IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7276-9.json |
| 72769-3 | Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72769-3.json |
| 72770-1 | Zolpidem [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72770-1.json |
| 72771-9 | Zolpidem/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72771-9.json |
| 72772-7 | O-desmethylvenlafaxine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72772-7.json |
| 72773-5 | O-desmethylvenlafaxine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72773-5.json |
| 72775-0 | Venlafaxine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72775-0.json |
| 7277-7 | American house dust mite triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7277-7.json |
| 72778-4 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72778-4.json |
| 72779-2 | JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72779-2.json |
| 72780-0 | JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72780-0.json |
| 72781-8 | JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72781-8.json |
| 72782-6 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72782-6.json |
| 72783-4 | JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72783-4.json |
| 72784-2 | PARoxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72784-2.json |
| 7278-5 | European house dust mite IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7278-5.json |
| 72785-9 | PARoxetine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72785-9.json |
| 72786-7 | Cotinine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/72786-7.json |
| 72789-1 | Naltrexone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72789-1.json |
| 72790-9 | Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72790-9.json |
| 72791-7 | Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72791-7.json |
| 72792-5 | Methylphenidate/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72792-5.json |
| 7279-3 | European house dust mite triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7279-3.json |
| 72793-3 | Methylone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72793-3.json |
| 72794-1 | Methylone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72794-1.json |
| 72795-8 | Mephedrone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72795-8.json |
| 72796-6 | Mephedrone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72796-6.json |
| 72797-4 | Methylenedioxypyrovalerone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72797-4.json |
| 72798-2 | Methylenedioxypyrovalerone/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72798-2.json |
| 72799-0 | Norketamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72799-0.json |
| 72800-6 | Norketamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72800-6.json |
| 7280-1 | Dill IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7280-1.json |
| 72801-4 | Ketamine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72801-4.json |
| 72802-2 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72802-2.json |
| 72803-0 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72803-0.json |
| 72805-5 | JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72805-5.json |
| 72806-3 | JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72806-3.json |
| 72807-1 | JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72807-1.json |
| 72808-9 | JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72808-9.json |
| 72809-7 | JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72809-7.json |
| 72810-5 | Gabapentin [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72810-5.json |
| 72811-3 | Gabapentin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72811-3.json |
| 72812-1 | Norfluoxetine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72812-1.json |
| 72813-9 | FLUoxetine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72813-9.json |
| 72815-4 | DULoxetine/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72815-4.json |
| 72816-2 | DOPamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72816-2.json |
| 72817-0 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72817-0.json |
| 72818-8 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72818-8.json |
| 7281-9 | Dill IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7281-9.json |
| 72819-6 | Acetaminophen/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72819-6.json |
| 72820-4 | 5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72820-4.json |
| 72821-2 | Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/72821-2.json |
| 72822-0 | Staphylococcus aureus enterotoxin D sed gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72822-0.json |
| 72823-8 | Staphylococcus aureus enterotoxin C sec gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72823-8.json |
| 72824-6 | Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72824-6.json |
| 72825-3 | Phencyclidine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/72825-3.json |
| 72826-1 | Race OMB.1997 | ./2.16.840.1.114222.4.11.1002/72826-1.json |
| 7282-7 | Discase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7282-7.json |
| 72827-9 | dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/72827-9.json |
| 72830-3 | US.doppler Extremity arteries - bilateral for physiologic artery study | ./2.16.840.1.114222.4.11.1002/72830-3.json |
| 72831-1 | US.doppler Extremity arteries - bilateral for physiologic artery study limited | ./2.16.840.1.114222.4.11.1002/72831-1.json |
| 72832-9 | US.doppler Extremity arteries - bilateral for physiologic artery study at rest and with exercise | ./2.16.840.1.114222.4.11.1002/72832-9.json |
| 72833-7 | Cytomegalovirus UL97 gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/72833-7.json |
| 72834-5 | Foscarnet [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/72834-5.json |
| 7283-5 | Yellow Dock triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7283-5.json |
| 72835-2 | Raltegravir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72835-2.json |
| 72836-0 | Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72836-0.json |
| 72837-8 | Vancomycin resistance vanC1 gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72837-8.json |
| 72838-6 | Herpes simplex virus DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/72838-6.json |
| 72839-4 | Famciclovir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72839-4.json |
| 7284-3 | Dog dander IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7284-3.json |
| 7285-0 | Dog epithelium IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7285-0.json |
| 72853-5 | Maribavir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72853-5.json |
| 72854-3 | Ganciclovir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72854-3.json |
| 72855-0 | Cidofovir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/72855-0.json |
| 72856-8 | Cidofovir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72856-8.json |
| 72857-6 | Dolutegravir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72857-6.json |
| 72858-4 | Enfuvirtide [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72858-4.json |
| 72859-2 | Boceprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72859-2.json |
| 72860-0 | Telaprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/72860-0.json |
| 72861-8 | Ganciclovir [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/72861-8.json |
| 72863-4 | Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72863-4.json |
| 72864-2 | Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72864-2.json |
| 72865-9 | Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72865-9.json |
| 72866-7 | Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72866-7.json |
| 72867-5 | Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72867-5.json |
| 7286-8 | Dog epithelium triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7286-8.json |
| 72868-3 | Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72868-3.json |
| 72869-1 | Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72869-1.json |
| 72870-9 | Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/72870-9.json |
| 72872-5 | MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72872-5.json |
| 72873-3 | Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/72873-3.json |
| 72874-1 | JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/72874-1.json |
| 72875-8 | JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/72875-8.json |
| 7287-6 | Dog Fennel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7287-6.json |
| 72876-6 | XR Surgical specimen Views | ./2.16.840.1.114222.4.11.1002/72876-6.json |
| 72881-6 | UGT2B15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72881-6.json |
| 72882-4 | CYP2B6 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72882-4.json |
| 72883-2 | CYP2E1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72883-2.json |
| 7288-4 | Dogwood pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7288-4.json |
| 72884-0 | CYP1A2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/72884-0.json |
| 72885-7 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/72885-7.json |
| 72889-9 | Progesterone Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72889-9.json |
| 72890-7 | Progesterone Free/Progesterone.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72890-7.json |
| 7289-2 | Duck feather IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7289-2.json |
| 72893-1 | Doripenem [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/72893-1.json |
| 72894-9 | Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/72894-9.json |
| 72896-4 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/72896-4.json |
| 72897-2 | Xanthine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/72897-2.json |
| 72898-0 | Bilirubin [Moles/volume] in Skin | ./2.16.840.1.114222.4.11.1002/72898-0.json |
| 72899-8 | Isoleucine+Leucine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/72899-8.json |
| 7290-0 | Egg white triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7290-0.json |
| 72902-0 | Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO | ./2.16.840.1.114222.4.11.1002/72902-0.json |
| 72904-6 | Formate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/72904-6.json |
| 72917-8 | HNA 5 genotype in Blood | ./2.16.840.1.114222.4.11.1002/72917-8.json |
| 7291-8 | Whole Egg IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7291-8.json |
| 72918-6 | HNA 4 genotype in Blood | ./2.16.840.1.114222.4.11.1002/72918-6.json |
| 72919-4 | HNA 3 genotype in Blood | ./2.16.840.1.114222.4.11.1002/72919-4.json |
| 72920-2 | HNA 1c genotype [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/72920-2.json |
| 72921-0 | HNA 1 genotype in Blood | ./2.16.840.1.114222.4.11.1002/72921-0.json |
| 72924-4 | Barium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/72924-4.json |
| 72925-1 | Bilirubin.total [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/72925-1.json |
| 7292-6 | Whole Egg IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7292-6.json |
| 72926-9 | Urea [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/72926-9.json |
| 72927-7 | Urea [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/72927-7.json |
| 72928-5 | Secobarbital [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/72928-5.json |
| 72929-3 | Warfarin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72929-3.json |
| 72930-1 | Warfarin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72930-1.json |
| 72931-9 | Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72931-9.json |
| 72932-7 | Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72932-7.json |
| 72933-5 | Vancomycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72933-5.json |
| 7293-4 | Whole Egg triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7293-4.json |
| 72934-3 | Vancomycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72934-3.json |
| 72935-0 | Valproate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72935-0.json |
| 72936-8 | Valproate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72936-8.json |
| 72937-6 | Trimethoprim induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72937-6.json |
| 72938-4 | Trimethoprim induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72938-4.json |
| 72939-2 | Topiramate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72939-2.json |
| 72940-0 | Topiramate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72940-0.json |
| 72941-8 | Terazosin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72941-8.json |
| 7294-2 | Egg yolk IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7294-2.json |
| 72942-6 | Terazosin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72942-6.json |
| 72943-4 | Tazobactam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72943-4.json |
| 72944-2 | Tazobactam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72944-2.json |
| 72945-9 | Tacrolimus induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72945-9.json |
| 72946-7 | Tacrolimus induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72946-7.json |
| 72947-5 | Sulfamethoxazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72947-5.json |
| 72948-3 | Sulfamethoxazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72948-3.json |
| 72949-1 | Spironolactone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72949-1.json |
| 72950-9 | Spironolactone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72950-9.json |
| 72951-7 | Simvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72951-7.json |
| 72952-5 | Simvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72952-5.json |
| 72953-3 | Sildenafil citrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72953-3.json |
| 72954-1 | Sildenafil citrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72954-1.json |
| 72955-8 | Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72955-8.json |
| 72956-6 | Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72956-6.json |
| 72957-4 | risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72957-4.json |
| 72958-2 | risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72958-2.json |
| 7295-9 | Egg yolk triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7295-9.json |
| 72959-0 | raNITIdine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72959-0.json |
| 72960-8 | raNITIdine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72960-8.json |
| 72961-6 | Ramipril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72961-6.json |
| 72962-4 | Ramipril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72962-4.json |
| 72963-2 | quiNINE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72963-2.json |
| 72964-0 | quiNINE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72964-0.json |
| 72965-7 | quiNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72965-7.json |
| 72966-5 | quiNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72966-5.json |
| 7296-7 | Eggplant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7296-7.json |
| 72967-3 | QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72967-3.json |
| 72968-1 | QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72968-1.json |
| 72969-9 | Piperacillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72969-9.json |
| 72970-7 | Piperacillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72970-7.json |
| 72971-5 | Phenytoin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72971-5.json |
| 72972-3 | Phenytoin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72972-3.json |
| 72973-1 | PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72973-1.json |
| 72974-9 | PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72974-9.json |
| 7297-5 | Eggplant IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7297-5.json |
| 72975-6 | Penicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72975-6.json |
| 72976-4 | Penicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72976-4.json |
| 72977-2 | PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72977-2.json |
| 72978-0 | PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72978-0.json |
| 72979-8 | Pantoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72979-8.json |
| 72980-6 | Pantoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72980-6.json |
| 72981-4 | Omeprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72981-4.json |
| 72982-2 | Omeprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72982-2.json |
| 7298-3 | Elder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7298-3.json |
| 72983-0 | OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72983-0.json |
| 72984-8 | OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72984-8.json |
| 72985-5 | Mycophenolate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72985-5.json |
| 72986-3 | Mycophenolate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72986-3.json |
| 72987-1 | Montelukast induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72987-1.json |
| 72988-9 | Montelukast induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72988-9.json |
| 72989-7 | Metoprolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72989-7.json |
| 72990-5 | Metoprolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72990-5.json |
| 72991-3 | Metoclopramide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72991-3.json |
| 72992-1 | Metoclopramide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72992-1.json |
| 72993-9 | Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72993-9.json |
| 72994-7 | Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72994-7.json |
| 72995-4 | metFORMIN induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72995-4.json |
| 72996-2 | metFORMIN induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72996-2.json |
| 72997-0 | Losartan induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72997-0.json |
| 72998-8 | Losartan induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72998-8.json |
| 72999-6 | Loratadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/72999-6.json |
| 73000-2 | Loratadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73000-2.json |
| 73001-0 | Lisinopril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73001-0.json |
| 73002-8 | Lisinopril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73002-8.json |
| 73003-6 | levoFLOXacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73003-6.json |
| 73004-4 | levoFLOXacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73004-4.json |
| 73005-1 | levETIRAcetam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73005-1.json |
| 73006-9 | levETIRAcetam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73006-9.json |
| 73007-7 | Lansoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73007-7.json |
| 73008-5 | Lansoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73008-5.json |
| 73009-3 | Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73009-3.json |
| 73010-1 | Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73010-1.json |
| 73011-9 | hydroCHLOROthiazide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73011-9.json |
| 73012-7 | hydroCHLOROthiazide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73012-7.json |
| 73013-5 | Gentamicin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73013-5.json |
| 73014-3 | Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73014-3.json |
| 7301-5 | White Elm triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7301-5.json |
| 73015-0 | Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73015-0.json |
| 73016-8 | Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73016-8.json |
| 73017-6 | Furosemide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73017-6.json |
| 73018-4 | Furosemide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73018-4.json |
| 73019-2 | Fluconazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73019-2.json |
| 73020-0 | Fluconazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73020-0.json |
| 73021-8 | Fexofenadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73021-8.json |
| 73022-6 | Fexofenadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73022-6.json |
| 7302-3 | Chinese Elm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7302-3.json |
| 73023-4 | Fenofibrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73023-4.json |
| 73024-2 | Fenofibrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73024-2.json |
| 73025-9 | Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73025-9.json |
| 73026-7 | Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73026-7.json |
| 73027-5 | Enalapril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73027-5.json |
| 73028-3 | Enalapril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73028-3.json |
| 73029-1 | Clopidogrel induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73029-1.json |
| 73030-9 | Clopidogrel induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73030-9.json |
| 73031-7 | cloNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73031-7.json |
| 73032-5 | cloNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73032-5.json |
| 73033-3 | Clindamycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73033-3.json |
| 73034-1 | Clindamycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73034-1.json |
| 73035-8 | Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73035-8.json |
| 73036-6 | Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73036-6.json |
| 73037-4 | Ciprofloxacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73037-4.json |
| 73038-2 | Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73038-2.json |
| 73039-0 | Celecoxib induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73039-0.json |
| 73040-8 | Celecoxib induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73040-8.json |
| 73041-6 | cefTRIAXone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73041-6.json |
| 73042-4 | cefTRIAXone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73042-4.json |
| 73043-2 | cefTAZidime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73043-2.json |
| 73044-0 | cefTAZidime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73044-0.json |
| 73045-7 | Cefepime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73045-7.json |
| 73046-5 | Cefepime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73046-5.json |
| 73047-3 | ceFAZolin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73047-3.json |
| 73048-1 | ceFAZolin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73048-1.json |
| 7304-9 | Endive IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7304-9.json |
| 73049-9 | carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73049-9.json |
| 73050-7 | carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73050-7.json |
| 73051-5 | buPROPion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73051-5.json |
| 73052-3 | buPROPion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73052-3.json |
| 73053-1 | Atorvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73053-1.json |
| 73054-9 | Atorvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73054-9.json |
| 73055-6 | Atenolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73055-6.json |
| 7305-6 | Endive IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7305-6.json |
| 73056-4 | Atenolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flowcytometry (FC) | ./2.16.840.1.114222.4.11.1002/73056-4.json |
| 73057-2 | Acetylsalicylate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73057-2.json |
| 73058-0 | Acetylsalicylate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73058-0.json |
| 73059-8 | Ampicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73059-8.json |
| 73060-6 | Ampicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73060-6.json |
| 73061-4 | Amoxicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73061-4.json |
| 73062-2 | Amoxicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73062-2.json |
| 73063-0 | amLODIPine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73063-0.json |
| 73064-8 | amLODIPine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73064-8.json |
| 73065-5 | Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73065-5.json |
| 73066-3 | Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73066-3.json |
| 73067-1 | Amiodarone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73067-1.json |
| 73068-9 | Amiodarone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73068-9.json |
| 73069-7 | Allopurinol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73069-7.json |
| 73070-5 | Allopurinol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73070-5.json |
| 73071-3 | Alendronate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73071-3.json |
| 7307-2 | Epidermophyton floccosum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7307-2.json |
| 73072-1 | Alendronate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73072-1.json |
| 73073-9 | Acetaminophen induced neutrophil IgG Ab [Presence] in Serum or Plasmaby Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73073-9.json |
| 73074-7 | Acetaminophen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73074-7.json |
| 73076-2 | Neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73076-2.json |
| 73077-0 | Neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73077-0.json |
| 73078-8 | Warfarin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73078-8.json |
| 73079-6 | Warfarin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73079-6.json |
| 7308-0 | Esterase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7308-0.json |
| 73080-4 | Voriconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73080-4.json |
| 73081-2 | Voriconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73081-2.json |
| 73082-0 | Verapamil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73082-0.json |
| 73083-8 | Verapamil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73083-8.json |
| 73084-6 | Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73084-6.json |
| 73085-3 | Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73085-3.json |
| 73086-1 | Vancomycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73086-1.json |
| 73087-9 | Vancomycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73087-9.json |
| 73088-7 | Valsartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73088-7.json |
| 73089-5 | Valsartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73089-5.json |
| 73090-3 | Valproate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73090-3.json |
| 73091-1 | Valproate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73091-1.json |
| 73092-9 | valGANciclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73092-9.json |
| 73093-7 | valGANciclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73093-7.json |
| 73094-5 | Valdecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73094-5.json |
| 73095-2 | Valdecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73095-2.json |
| 73096-0 | valACYclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73096-0.json |
| 73097-8 | valACYclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73097-8.json |
| 7309-8 | Weeping Fig IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7309-8.json |
| 73098-6 | Ursodeoxycholate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73098-6.json |
| 73099-4 | Ursodeoxycholate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73099-4.json |
| 73100-0 | Trimethoprim induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73100-0.json |
| 73101-8 | Trimethoprim induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73101-8.json |
| 73102-6 | Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73102-6.json |
| 73103-4 | Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73103-4.json |
| 73104-2 | Triamterene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73104-2.json |
| 73105-9 | Triamterene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73105-9.json |
| 7310-6 | Douglas Fir IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7310-6.json |
| 73106-7 | Triamcinolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73106-7.json |
| 73107-5 | Triamcinolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73107-5.json |
| 73108-3 | traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73108-3.json |
| 73109-1 | traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73109-1.json |
| 73110-9 | Topiramate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73110-9.json |
| 73111-7 | Topiramate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73111-7.json |
| 73112-5 | Tolterodine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73112-5.json |
| 73113-3 | Tolterodine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73113-3.json |
| 7311-4 | Fish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7311-4.json |
| 73114-1 | Tobramycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73114-1.json |
| 73115-8 | Tobramycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73115-8.json |
| 73116-6 | Tirofiban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73116-6.json |
| 73117-4 | Tirofiban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73117-4.json |
| 73118-2 | Timolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73118-2.json |
| 73119-0 | Timolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73119-0.json |
| 73120-8 | Tetracycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73120-8.json |
| 73121-6 | Tetracycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73121-6.json |
| 7312-2 | Flax IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7312-2.json |
| 73122-4 | Terazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73122-4.json |
| 73123-2 | Terazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73123-2.json |
| 73124-0 | Telmisartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73124-0.json |
| 73125-7 | Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73125-7.json |
| 73126-5 | Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73126-5.json |
| 73127-3 | Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73127-3.json |
| 73128-1 | Tamsulosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73128-1.json |
| 73129-9 | Tamsulosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73129-9.json |
| 7313-0 | Flea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7313-0.json |
| 73130-7 | Tamoxifen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73130-7.json |
| 73131-5 | Tamoxifen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73131-5.json |
| 73132-3 | Tacrolimus induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73132-3.json |
| 73133-1 | Tacrolimus induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73133-1.json |
| 73134-9 | Sulindac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73134-9.json |
| 73135-6 | Sulindac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73135-6.json |
| 73136-4 | sulfiSOXAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73136-4.json |
| 73137-2 | sulfiSOXAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73137-2.json |
| 73138-0 | sulfaSALAzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73138-0.json |
| 73139-8 | sulfaSALAzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73139-8.json |
| 73140-6 | Sulfamethoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73140-6.json |
| 73141-4 | Sulfamethoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73141-4.json |
| 73142-2 | Sucralfate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73142-2.json |
| 73143-0 | Sucralfate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73143-0.json |
| 73144-8 | Spironolactone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73144-8.json |
| 73145-5 | Spironolactone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73145-5.json |
| 73146-3 | Sotalol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73146-3.json |
| 73147-1 | Sotalol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73147-1.json |
| 7314-8 | Flea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7314-8.json |
| 73148-9 | Simvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73148-9.json |
| 73149-7 | Simvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73149-7.json |
| 73150-5 | Simethicone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73150-5.json |
| 73151-3 | Simethicone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73151-3.json |
| 73152-1 | Sildenafil citrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73152-1.json |
| 73153-9 | Sildenafil citrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73153-9.json |
| 73154-7 | Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73154-7.json |
| 7315-5 | Flea triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7315-5.json |
| 73155-4 | Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73155-4.json |
| 73156-2 | Rosuvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73156-2.json |
| 73157-0 | Rosuvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73157-0.json |
| 73158-8 | Rosiglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73158-8.json |
| 73159-6 | Rosiglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73159-6.json |
| 73160-4 | Rofecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73160-4.json |
| 73161-2 | Rofecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73161-2.json |
| 73162-0 | risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73162-0.json |
| 7316-3 | Flounder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7316-3.json |
| 73163-8 | risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73163-8.json |
| 73164-6 | Risedronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73164-6.json |
| 73165-3 | Risedronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73165-3.json |
| 73166-1 | rifAMPin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73166-1.json |
| 73167-9 | rifAMPin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73167-9.json |
| 73168-7 | raNITIdine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73168-7.json |
| 73169-5 | raNITIdine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73169-5.json |
| 73170-3 | Ramipril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73170-3.json |
| 7317-1 | Flounder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7317-1.json |
| 73171-1 | Ramipril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73171-1.json |
| 73172-9 | Raloxifene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73172-9.json |
| 73173-7 | Raloxifene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73173-7.json |
| 73174-5 | RABEprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73174-5.json |
| 73175-2 | RABEprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73175-2.json |
| 73176-0 | quiNINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73176-0.json |
| 73177-8 | quiNINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73177-8.json |
| 73178-6 | quiNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73178-6.json |
| 73179-4 | quiNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73179-4.json |
| 73180-2 | Quinapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73180-2.json |
| 73181-0 | Quinapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73181-0.json |
| 73182-8 | QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73182-8.json |
| 73183-6 | QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73183-6.json |
| 73184-4 | Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73184-4.json |
| 73185-1 | Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73185-1.json |
| 73186-9 | Propranolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73186-9.json |
| 73187-7 | Propranolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73187-7.json |
| 73188-5 | Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73188-5.json |
| 7318-9 | Flounder triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7318-9.json |
| 73189-3 | Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73189-3.json |
| 73190-1 | Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73190-1.json |
| 73191-9 | Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73191-9.json |
| 73192-7 | Procainamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73192-7.json |
| 73193-5 | Procainamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73193-5.json |
| 73194-3 | Primidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73194-3.json |
| 73195-0 | Primidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73195-0.json |
| 73196-8 | predniSONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73196-8.json |
| 7319-7 | Deer Fly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7319-7.json |
| 73197-6 | predniSONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73197-6.json |
| 73198-4 | Pravastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73198-4.json |
| 73199-2 | Pravastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73199-2.json |
| 73200-8 | Piperacillin+Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73200-8.json |
| 73201-6 | Piperacillin+Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73201-6.json |
| 73202-4 | Piperacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73202-4.json |
| 73203-2 | Piperacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73203-2.json |
| 73204-0 | Pioglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73204-0.json |
| 7320-5 | Horse Fly IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7320-5.json |
| 73205-7 | Pioglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73205-7.json |
| 73206-5 | Phenytoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73206-5.json |
| 73207-3 | Phenytoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73207-3.json |
| 73208-1 | PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73208-1.json |
| 73209-9 | PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73209-9.json |
| 73210-7 | Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73210-7.json |
| 73211-5 | Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73211-5.json |
| 73212-3 | Penicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73212-3.json |
| 7321-3 | Housefly triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7321-3.json |
| 73213-1 | Penicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73213-1.json |
| 73214-9 | PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73214-9.json |
| 73215-6 | PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73215-6.json |
| 73216-4 | Papaverine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73216-4.json |
| 73217-2 | Papaverine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73217-2.json |
| 73218-0 | Pantoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73218-0.json |
| 73219-8 | Pantoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73219-8.json |
| 73220-6 | oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73220-6.json |
| 7322-1 | Formaldehyde triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7322-1.json |
| 73221-4 | oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73221-4.json |
| 73222-2 | oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73222-2.json |
| 73223-0 | oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73223-0.json |
| 73224-8 | OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73224-8.json |
| 73225-5 | OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73225-5.json |
| 73226-3 | Oxaliplatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73226-3.json |
| 73227-1 | Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73227-1.json |
| 73228-9 | Oxacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73228-9.json |
| 73229-7 | Oxacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73229-7.json |
| 73230-5 | Ondansetron induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73230-5.json |
| 73231-3 | Ondansetron induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73231-3.json |
| 73232-1 | Omeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73232-1.json |
| 73233-9 | Omeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73233-9.json |
| 73234-7 | OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73234-7.json |
| 73235-4 | OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73235-4.json |
| 73236-2 | Nystatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73236-2.json |
| 73237-0 | Nystatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73237-0.json |
| 73238-8 | Nizatidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73238-8.json |
| 7323-9 | Fruit IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7323-9.json |
| 73239-6 | Nizatidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73239-6.json |
| 73240-4 | Nitroglycerin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73240-4.json |
| 73241-2 | Nitroglycerin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73241-2.json |
| 73242-0 | Nitrofurantoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73242-0.json |
| 73243-8 | Nitrofurantoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73243-8.json |
| 73244-6 | NIFEdipine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73244-6.json |
| 73245-3 | NIFEdipine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73245-3.json |
| 73246-1 | Niacin+Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73246-1.json |
| 7324-7 | Fusarium culmorum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7324-7.json |
| 73247-9 | Niacin+Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73247-9.json |
| 73248-7 | Naproxen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73248-7.json |
| 73249-5 | Naproxen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73249-5.json |
| 73250-3 | Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73250-3.json |
| 73251-1 | Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73251-1.json |
| 73252-9 | Mycophenolate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73252-9.json |
| 73253-7 | Mycophenolate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73253-7.json |
| 7325-4 | Fusarium moniliforme IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7325-4.json |
| 73254-5 | Moxifloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73254-5.json |
| 73255-2 | Moxifloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73255-2.json |
| 73256-0 | Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73256-0.json |
| 73257-8 | Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73257-8.json |
| 73258-6 | Montelukast induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73258-6.json |
| 73259-4 | Montelukast induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73259-4.json |
| 73260-2 | Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73260-2.json |
| 73261-0 | Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73261-0.json |
| 7326-2 | Fusarium oxysporum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7326-2.json |
| 73262-8 | Minoxidil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73262-8.json |
| 73263-6 | Minoxidil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73263-6.json |
| 73264-4 | Minocycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73264-4.json |
| 73265-1 | Minocycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73265-1.json |
| 73266-9 | Milrinone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73266-9.json |
| 73267-7 | Milrinone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73267-7.json |
| 73268-5 | Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73268-5.json |
| 73269-3 | Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73269-3.json |
| 7327-0 | Fusarium solani IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7327-0.json |
| 73270-1 | metroNIDAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73270-1.json |
| 73271-9 | metroNIDAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73271-9.json |
| 73272-7 | Metoprolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73272-7.json |
| 73273-5 | Metoprolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73273-5.json |
| 73274-3 | Metoclopramide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73274-3.json |
| 73275-0 | Metoclopramide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73275-0.json |
| 73276-8 | Methylprednisolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73276-8.json |
| 73277-6 | Methylprednisolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73277-6.json |
| 73278-4 | Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73278-4.json |
| 73279-2 | Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73279-2.json |
| 73280-0 | Methyldopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73280-0.json |
| 73281-8 | Methyldopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73281-8.json |
| 73282-6 | Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73282-6.json |
| 73283-4 | Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73283-4.json |
| 73284-2 | Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73284-2.json |
| 73285-9 | Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73285-9.json |
| 73286-7 | metFORMIN induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73286-7.json |
| 73287-5 | metFORMIN induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73287-5.json |
| 7328-8 | Fusarium solani IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7328-8.json |
| 73288-3 | Meropenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73288-3.json |
| 73289-1 | Meropenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73289-1.json |
| 73290-9 | Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73290-9.json |
| 73291-7 | Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73291-7.json |
| 73292-5 | Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73292-5.json |
| 73293-3 | Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73293-3.json |
| 73294-1 | LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73294-1.json |
| 73295-8 | LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73295-8.json |
| 73296-6 | Loratadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73296-6.json |
| 73297-4 | Loratadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73297-4.json |
| 73298-2 | Loperamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73298-2.json |
| 73299-0 | Loperamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73299-0.json |
| 73300-6 | Lisinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73300-6.json |
| 73301-4 | Lisinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73301-4.json |
| 73302-2 | Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73302-2.json |
| 73303-0 | Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73303-0.json |
| 7330-4 | Garlic IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7330-4.json |
| 73304-8 | Lidocaine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73304-8.json |
| 73305-5 | Lidocaine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73305-5.json |
| 73306-3 | levoFLOXacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73306-3.json |
| 73307-1 | levoFLOXacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73307-1.json |
| 73308-9 | Levodopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73308-9.json |
| 73309-7 | Levodopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73309-7.json |
| 73310-5 | levETIRAcetam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73310-5.json |
| 73311-3 | levETIRAcetam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73311-3.json |
| 7331-2 | Garlic triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7331-2.json |
| 73312-1 | Levalbuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73312-1.json |
| 73313-9 | Levalbuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73313-9.json |
| 73314-7 | Leuprolide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73314-7.json |
| 73315-4 | Leuprolide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73315-4.json |
| 73316-2 | Lepirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73316-2.json |
| 73317-0 | Lepirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73317-0.json |
| 73318-8 | Lansoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73318-8.json |
| 73319-6 | Lansoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73319-6.json |
| 7332-0 | Gelatin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7332-0.json |
| 73320-4 | Ketorolac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73320-4.json |
| 73321-2 | Ketorolac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73321-2.json |
| 73322-0 | ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73322-0.json |
| 73323-8 | ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73323-8.json |
| 73324-6 | Isosorbide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73324-6.json |
| 73325-3 | Isosorbide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73325-3.json |
| 73326-1 | Irbesartan+hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73326-1.json |
| 73327-9 | Irbesartan+hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73327-9.json |
| 73328-7 | Irbesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73328-7.json |
| 73329-5 | Irbesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73329-5.json |
| 73330-3 | Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73330-3.json |
| 73331-1 | Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73331-1.json |
| 73332-9 | Imipenem+Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73332-9.json |
| 73333-7 | Imipenem+Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73333-7.json |
| 73334-5 | Imipenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73334-5.json |
| 73335-2 | Imipenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73335-2.json |
| 73336-0 | Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73336-0.json |
| 73337-8 | Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73337-8.json |
| 7333-8 | Geotrichum candidum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7333-8.json |
| 73338-6 | hydrOXYzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73338-6.json |
| 73339-4 | hydrOXYzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73339-4.json |
| 73340-2 | HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73340-2.json |
| 73341-0 | HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73341-0.json |
| 73342-8 | Hydrocortisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73342-8.json |
| 73343-6 | Hydrocortisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73343-6.json |
| 73344-4 | HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73344-4.json |
| 73345-1 | HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73345-1.json |
| 7334-6 | Gerbil epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7334-6.json |
| 73346-9 | HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73346-9.json |
| 73347-7 | HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73347-7.json |
| 73348-5 | HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73348-5.json |
| 73349-3 | HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73349-3.json |
| 73350-1 | hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73350-1.json |
| 73351-9 | hydroCHLOROthiazide+Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73351-9.json |
| 73352-7 | hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73352-7.json |
| 7335-3 | Ginger IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7335-3.json |
| 73353-5 | hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73353-5.json |
| 73354-3 | hydrALAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73354-3.json |
| 73355-0 | hydrALAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73355-0.json |
| 73356-8 | Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73356-8.json |
| 73357-6 | Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73357-6.json |
| 73358-4 | glyBURIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73358-4.json |
| 73359-2 | glyBURIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73359-2.json |
| 73360-0 | glipiZIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73360-0.json |
| 7336-1 | Ginger IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7336-1.json |
| 73361-8 | glipiZIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73361-8.json |
| 73362-6 | Glimepride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73362-6.json |
| 73363-4 | Glimepride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73363-4.json |
| 73364-2 | Gentamicin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73364-2.json |
| 73365-9 | Gentamicin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73365-9.json |
| 73366-7 | Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73366-7.json |
| 73367-5 | Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73367-5.json |
| 73368-3 | Furosemide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73368-3.json |
| 73369-1 | Furosemide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73369-1.json |
| 73370-9 | Fosinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73370-9.json |
| 73371-7 | Fosinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73371-7.json |
| 73372-5 | Fluvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73372-5.json |
| 73373-3 | Fluvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73373-3.json |
| 73374-1 | FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73374-1.json |
| 73375-8 | FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73375-8.json |
| 73376-6 | Fluconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73376-6.json |
| 73377-4 | Fluconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73377-4.json |
| 73378-2 | Finasteride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73378-2.json |
| 7337-9 | Gladiolus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7337-9.json |
| 73379-0 | Finasteride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73379-0.json |
| 73380-8 | Fexofenadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73380-8.json |
| 73381-6 | Fexofenadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73381-6.json |
| 73382-4 | fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73382-4.json |
| 73383-2 | fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73383-2.json |
| 73384-0 | Fenofibrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73384-0.json |
| 73385-7 | Fenofibrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73385-7.json |
| 73386-5 | Famotidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73386-5.json |
| 7338-7 | Gluten IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7338-7.json |
| 73387-3 | Famotidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73387-3.json |
| 73388-1 | Ezetimibe induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73388-1.json |
| 73389-9 | Ezetimibe induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73389-9.json |
| 73390-7 | Esomeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73390-7.json |
| 73391-5 | Esomeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73391-5.json |
| 73392-3 | Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73392-3.json |
| 73393-1 | Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73393-1.json |
| 73394-9 | Erythromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73394-9.json |
| 7339-5 | Gnat whole body IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7339-5.json |
| 73395-6 | Erythromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73395-6.json |
| 73396-4 | Eptifibatide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73396-4.json |
| 73397-2 | Eptifibatide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73397-2.json |
| 73398-0 | Erythropoietin (EPO) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73398-0.json |
| 73399-8 | Erythropoietin (EPO) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73399-8.json |
| 73400-4 | Enalapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73400-4.json |
| 73401-2 | Enalapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73401-2.json |
| 73402-0 | Doxycycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73402-0.json |
| 7340-3 | Goat milk IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7340-3.json |
| 73403-8 | Doxycycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73403-8.json |
| 73404-6 | Doxazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73404-6.json |
| 73405-3 | Doxazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73405-3.json |
| 73406-1 | Donepezil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73406-1.json |
| 73407-9 | Donepezil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73407-9.json |
| 73408-7 | Docusate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73408-7.json |
| 73409-5 | Docusate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73409-5.json |
| 73410-3 | Dipyridamole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73410-3.json |
| 7341-1 | Goat milk IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7341-1.json |
| 73411-1 | Dipyridamole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73411-1.json |
| 73412-9 | Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73412-9.json |
| 73413-7 | Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73413-7.json |
| 73414-5 | diphenhydrAMINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73414-5.json |
| 73415-2 | diphenhydrAMINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73415-2.json |
| 73416-0 | dilTIAZem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73416-0.json |
| 73417-8 | dilTIAZem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73417-8.json |
| 73418-6 | Digoxin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73418-6.json |
| 73419-4 | Digoxin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73419-4.json |
| 73420-2 | Dicyclomine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73420-2.json |
| 73421-0 | Dicyclomine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73421-0.json |
| 73422-8 | diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73422-8.json |
| 73423-6 | diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73423-6.json |
| 73424-4 | Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73424-4.json |
| 73425-1 | Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73425-1.json |
| 73426-9 | cycloSPORINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73426-9.json |
| 73427-7 | cycloSPORINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73427-7.json |
| 73428-5 | Colchicine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73428-5.json |
| 7342-9 | Goldenrod IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7342-9.json |
| 73429-3 | Colchicine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73429-3.json |
| 73430-1 | Clopidogrel induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73430-1.json |
| 73431-9 | Clopidogrel induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73431-9.json |
| 73432-7 | cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73432-7.json |
| 73433-5 | cloNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73433-5.json |
| 73434-3 | clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73434-3.json |
| 73435-0 | clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73435-0.json |
| 73436-8 | Clindamycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73436-8.json |
| 7343-7 | Goldenrod triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7343-7.json |
| 73437-6 | Clindamycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73437-6.json |
| 73438-4 | Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73438-4.json |
| 73439-2 | Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73439-2.json |
| 73440-0 | Clarithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73440-0.json |
| 73441-8 | Clarithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73441-8.json |
| 73442-6 | Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73442-6.json |
| 73443-4 | Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73443-4.json |
| 73444-2 | Ciprofloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73444-2.json |
| 7344-5 | Goose feather IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7344-5.json |
| 73445-9 | Ciprofloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73445-9.json |
| 73446-7 | Cimetidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73446-7.json |
| 73447-5 | Cimetidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73447-5.json |
| 73448-3 | Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73448-3.json |
| 73449-1 | Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73449-1.json |
| 73450-9 | Chlorthalidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73450-9.json |
| 73451-7 | Chlorthalidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73451-7.json |
| 7345-2 | Grain IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7345-2.json |
| 73452-5 | chlorproPAMIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73452-5.json |
| 73453-3 | chlorproPAMIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73453-3.json |
| 73454-1 | chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73454-1.json |
| 73455-8 | chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73455-8.json |
| 73456-6 | chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73456-6.json |
| 73457-4 | chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73457-4.json |
| 73458-2 | Cephalexin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73458-2.json |
| 73459-0 | Cephalexin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73459-0.json |
| 7346-0 | Grain dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7346-0.json |
| 73460-8 | Celecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73460-8.json |
| 73461-6 | Celecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73461-6.json |
| 73462-4 | Cefuroxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73462-4.json |
| 73463-2 | Cefuroxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73463-2.json |
| 73464-0 | cefTRIAXone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73464-0.json |
| 73465-7 | cefTRIAXone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73465-7.json |
| 73466-5 | Ceftizoxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73466-5.json |
| 73467-3 | Ceftizoxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73467-3.json |
| 73468-1 | cefTAZidime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73468-1.json |
| 73469-9 | cefTAZidime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73469-9.json |
| 73470-7 | Cefepime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73470-7.json |
| 73471-5 | Cefepime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73471-5.json |
| 73472-3 | ceFAZolin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73472-3.json |
| 73473-1 | ceFAZolin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73473-1.json |
| 73474-9 | Cefadroxil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73474-9.json |
| 73475-6 | Cefadroxil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73475-6.json |
| 73476-4 | Caspofungin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73476-4.json |
| 73477-2 | Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73477-2.json |
| 7347-8 | Grain mill dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7347-8.json |
| 73478-0 | Casanthranol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73478-0.json |
| 73479-8 | Casanthranol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73479-8.json |
| 73480-6 | Carvedilol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73480-6.json |
| 73481-4 | Carvedilol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73481-4.json |
| 73482-2 | Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73482-2.json |
| 73483-0 | Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73483-0.json |
| 73484-8 | Carbidopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73484-8.json |
| 73485-5 | Carbidopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73485-5.json |
| 7348-6 | Grape IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7348-6.json |
| 73486-3 | carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73486-3.json |
| 73487-1 | carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73487-1.json |
| 73488-9 | Captopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73488-9.json |
| 73489-7 | Captopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73489-7.json |
| 73490-5 | Candesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73490-5.json |
| 73491-3 | Candesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73491-3.json |
| 73492-1 | Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73492-1.json |
| 73493-9 | Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73493-9.json |
| 7349-4 | Grape raisin triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7349-4.json |
| 73494-7 | busPIRone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73494-7.json |
| 73495-4 | busPIRone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73495-4.json |
| 73496-2 | buPROPion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73496-2.json |
| 73497-0 | buPROPion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73497-0.json |
| 73498-8 | Bumetanide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73498-8.json |
| 73499-6 | Bumetanide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73499-6.json |
| 73500-1 | Budesonide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73500-1.json |
| 73501-9 | Budesonide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73501-9.json |
| 7350-2 | Grapefruit IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7350-2.json |
| 73502-7 | Bivalirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73502-7.json |
| 73503-5 | Bivalirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73503-5.json |
| 73504-3 | Benztropine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73504-3.json |
| 73505-0 | Benztropine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73505-0.json |
| 73506-8 | Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73506-8.json |
| 73507-6 | Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73507-6.json |
| 73508-4 | Aztreonam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73508-4.json |
| 73509-2 | Aztreonam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73509-2.json |
| 7351-0 | Grapefruit triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7351-0.json |
| 73510-0 | Azithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73510-0.json |
| 73511-8 | Azithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73511-8.json |
| 73512-6 | Atorvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73512-6.json |
| 73513-4 | Atorvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73513-4.json |
| 73514-2 | Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73514-2.json |
| 73515-9 | Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73515-9.json |
| 73516-7 | Atenolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73516-7.json |
| 73517-5 | Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73517-5.json |
| 73518-3 | Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73518-3.json |
| 73519-1 | Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73519-1.json |
| 73520-9 | Argatroban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73520-9.json |
| 73521-7 | Argatroban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73521-7.json |
| 73522-5 | Ampicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73522-5.json |
| 73523-3 | Ampicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73523-3.json |
| 73524-1 | Amoxicillin+Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73524-1.json |
| 73525-8 | Amoxicillin+Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73525-8.json |
| 73526-6 | Amoxicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73526-6.json |
| 73527-4 | Amoxicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73527-4.json |
| 73528-2 | amLODIPine+Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73528-2.json |
| 73529-0 | amLODIPine+Benazepril induced platelet IgM Ab [Presence] in Serum or Plasmaby Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73529-0.json |
| 73530-8 | amLODIPine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73530-8.json |
| 73531-6 | amLODIPine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73531-6.json |
| 73532-4 | Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73532-4.json |
| 73533-2 | Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73533-2.json |
| 73534-0 | Amiodarone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73534-0.json |
| 73535-7 | Amiodarone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73535-7.json |
| 7353-6 | Bermuda grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7353-6.json |
| 73536-5 | ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73536-5.json |
| 73537-3 | ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73537-3.json |
| 73538-1 | Allopurinol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73538-1.json |
| 73539-9 | Allopurinol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73539-9.json |
| 73540-7 | Alendronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73540-7.json |
| 73541-5 | Alendronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73541-5.json |
| 73542-3 | Albuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73542-3.json |
| 73543-1 | Albuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73543-1.json |
| 7354-4 | Bermuda grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7354-4.json |
| 73544-9 | Acyclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73544-9.json |
| 73545-6 | Acyclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73545-6.json |
| 73546-4 | Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73546-4.json |
| 73547-2 | Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73547-2.json |
| 73548-0 | Acebutolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73548-0.json |
| 73549-8 | Acebutolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73549-8.json |
| 73550-6 | Acarbose induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73550-6.json |
| 7355-1 | Annual blue grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7355-1.json |
| 73551-4 | Acarbose induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73551-4.json |
| 73552-2 | Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative | ./2.16.840.1.114222.4.11.1002/73552-2.json |
| 73553-0 | Abciximab induced platelet Ab [Interpretation] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/73553-0.json |
| 73554-8 | Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73554-8.json |
| 73555-5 | Abciximab induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73555-5.json |
| 73556-3 | Platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73556-3.json |
| 73557-1 | Thyroxine (T4) free [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/73557-1.json |
| 73558-9 | Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture | ./2.16.840.1.114222.4.11.1002/73558-9.json |
| 73559-7 | Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/73559-7.json |
| 73562-1 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73562-1.json |
| 73563-9 | 7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73563-9.json |
| 73564-7 | Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73564-7.json |
| 73565-4 | Trenbolone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/73565-4.json |
| 73566-2 | Dextrorphan [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73566-2.json |
| 73567-0 | Propoxyphene [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/73567-0.json |
| 73568-8 | Communication of critical results [Description] Document | ./2.16.840.1.114222.4.11.1002/73568-8.json |
| 7356-9 | Canadian blue grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7356-9.json |
| 73569-6 | Radiation exposure and protection information [Description] Document Diagnostic imaging | ./2.16.840.1.114222.4.11.1002/73569-6.json |
| 73571-2 | Osmol gap of Stool | ./2.16.840.1.114222.4.11.1002/73571-2.json |
| 73572-0 | Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/73572-0.json |
| 73573-8 | Magnesium Ionized [Moles/volume] adjusted to pH 7.4 in Blood by Ion-selective membrane electrode (ISE) | ./2.16.840.1.114222.4.11.1002/73573-8.json |
| 73574-6 | Acyclovir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/73574-6.json |
| 73575-3 | Radiology Consult note | ./2.16.840.1.114222.4.11.1002/73575-3.json |
| 73576-1 | Anion gap 4 in Venous cord blood | ./2.16.840.1.114222.4.11.1002/73576-1.json |
| 73577-9 | Anion gap 4 in Arterial cord blood | ./2.16.840.1.114222.4.11.1002/73577-9.json |
| 73578-7 | Anion gap 4 in Venous blood | ./2.16.840.1.114222.4.11.1002/73578-7.json |
| 73579-5 | Anion gap 4 in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/73579-5.json |
| 73580-3 | Anion gap 4 in Capillary blood | ./2.16.840.1.114222.4.11.1002/73580-3.json |
| 73581-1 | Anion gap 4 in Arterial blood | ./2.16.840.1.114222.4.11.1002/73581-1.json |
| 73582-9 | Anion gap 4 in Blood | ./2.16.840.1.114222.4.11.1002/73582-9.json |
| 73583-7 | Molybdenum/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/73583-7.json |
| 73584-5 | Norcitalopram [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73584-5.json |
| 7358-5 | Kentucky blue grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7358-5.json |
| 7359-3 | Meadow Fescue triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7359-3.json |
| 7360-1 | Gramma grass (Bouteloua gracilis) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7360-1.json |
| 7361-9 | Johnson grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7361-9.json |
| 7362-7 | Koehlers grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7362-7.json |
| 7364-3 | Meadow Fescue IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7364-3.json |
| 7365-0 | Cocksfoot IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7365-0.json |
| 73654-6 | Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/73654-6.json |
| 73655-3 | Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method | ./2.16.840.1.114222.4.11.1002/73655-3.json |
| 73656-1 | Varicella zoster virus ORF28 genotype [Identifier] | ./2.16.840.1.114222.4.11.1002/73656-1.json |
| 73657-9 | Varicella zoster virus ORF36 genotype [Identifier] | ./2.16.840.1.114222.4.11.1002/73657-9.json |
| 73658-7 | HIV 1 subtype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73658-7.json |
| 73659-5 | HIV 2 subtype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73659-5.json |
| 73664-5 | Yersinia adhesion protein YadA [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/73664-5.json |
| 73666-0 | Streptococcus.beta-hemolytic [Type] in Isolate by Latex agglutination | ./2.16.840.1.114222.4.11.1002/73666-0.json |
| 7366-8 | Cocksfoot triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7366-8.json |
| 73671-0 | Legionella pneumophila serogroup [Type] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/73671-0.json |
| 73672-8 | Salmonella sp phage type in Isolate | ./2.16.840.1.114222.4.11.1002/73672-8.json |
| 73673-6 | Yersinia enterocolitica serotype [Type] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/73673-6.json |
| 73674-4 | Streptococcus pneumoniae serotype [Type] in Isolate by Agglutination | ./2.16.840.1.114222.4.11.1002/73674-4.json |
| 73675-1 | Adenosine triphosphate/Adenosine diphosphate [Entitic molar ratio] in Platelets | ./2.16.840.1.114222.4.11.1002/73675-1.json |
| 7367-6 | Quack grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7367-6.json |
| 73676-9 | Voriconazole [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/73676-9.json |
| 73677-7 | Valproate [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/73677-7.json |
| 73678-5 | Topotecan [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/73678-5.json |
| 73679-3 | SORAfenib [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/73679-3.json |
| 73680-1 | Mycophenolate [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/73680-1.json |
| 73683-5 | Busulfan [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/73683-5.json |
| 7368-4 | Red top grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7368-4.json |
| 73684-3 | Atovaquone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/73684-3.json |
| 73685-0 | Streptococcus pneumoniae Ag [Presence] in Isolate by Latex agglutination | ./2.16.840.1.114222.4.11.1002/73685-0.json |
| 73686-8 | Methylone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/73686-8.json |
| 73687-6 | Methylenedioxypyrovalerone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/73687-6.json |
| 73688-4 | Danazol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/73688-4.json |
| 73689-2 | Repaglinide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73689-2.json |
| 73690-0 | Nateglinide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73690-0.json |
| 73691-8 | Glimepride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73691-8.json |
| 7369-2 | Perennial rye grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7369-2.json |
| 73692-6 | Escitalopram [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73692-6.json |
| 73693-4 | African swine fever virus DNA [Cycle Threshold #] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73693-4.json |
| 73694-2 | Microscopic observation [Identifier] in Blood by KOH preparation | ./2.16.840.1.114222.4.11.1002/73694-2.json |
| 7370-0 | Perennial rye grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7370-0.json |
| 73702-3 | Neisseria meningitidis serosubtype [Type] in Isolate by Immunoassay | ./2.16.840.1.114222.4.11.1002/73702-3.json |
| 73709-8 | Prescription request Pharmacy Document from Pharmacist | ./2.16.840.1.114222.4.11.1002/73709-8.json |
| 73710-6 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73710-6.json |
| 73711-4 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73711-4.json |
| 73712-2 | Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73712-2.json |
| 73713-0 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73713-0.json |
| 73714-8 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73714-8.json |
| 73715-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73715-5.json |
| 73716-3 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73716-3.json |
| 73717-1 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73717-1.json |
| 73718-9 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/73718-9.json |
| 73719-7 | Soybean native (nGly m) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73719-7.json |
| 73720-5 | Pholcodine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73720-5.json |
| 73721-3 | Rocuronium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73721-3.json |
| 73722-1 | Bile acid [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73722-1.json |
| 73723-9 | Riboflavin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73723-9.json |
| 73726-2 | Lysergate diethylamide [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/73726-2.json |
| 73727-0 | Methadone [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/73727-0.json |
| 73728-8 | Norcocaine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/73728-8.json |
| 73729-6 | Meperidine [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/73729-6.json |
| 73730-4 | Lysergate diethylamide [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/73730-4.json |
| 73731-2 | Transaldolase [Enzymatic activity/mass] in Lymphoblasts | ./2.16.840.1.114222.4.11.1002/73731-2.json |
| 73732-0 | Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73732-0.json |
| 73735-3 | ACADVL gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/73735-3.json |
| 73736-1 | ACADVL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/73736-1.json |
| 73737-9 | Phospholipase A2 receptor IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/73737-9.json |
| 7374-2 | Perennial rye grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7374-2.json |
| 73745-2 | Keyhole limpet hemocyanin IgA Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73745-2.json |
| 73746-0 | Keyhole limpet hemocyanin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73746-0.json |
| 73747-8 | Keyhole limpet hemocyanin IgM Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73747-8.json |
| 73748-6 | APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/73748-6.json |
| 73749-4 | 4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/73749-4.json |
| 73750-2 | RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/73750-2.json |
| 73751-0 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/73751-0.json |
| 73753-6 | oxyCODONE [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/73753-6.json |
| 73754-4 | Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73754-4.json |
| 73755-1 | Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/73755-1.json |
| 7375-9 | Sorghum grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7375-9.json |
| 7376-7 | Sudan grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7376-7.json |
| 7377-5 | Sweet Vernal grass triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7377-5.json |
| 7379-1 | Wheat grass IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7379-1.json |
| 73807-0 | B cell+T cell crossmatch.autologous [Interpretation] Qualitative by Complement dependent cytotoxicity | ./2.16.840.1.114222.4.11.1002/73807-0.json |
| 7380-9 | Grayfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7380-9.json |
| 73809-6 | B cell+T cell crossmatch [Interpretation] Qualitative by Complement dependent cytotoxicity | ./2.16.840.1.114222.4.11.1002/73809-6.json |
| 73810-4 | CD3-CD16+CD56+HLA-DR+ (activated Natural Killer) cells/100 cells.CD3-CD16+CD56+ (Natural killer) cells in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73810-4.json |
| 73815-3 | FDA package insert Indexing - product concept | ./2.16.840.1.114222.4.11.1002/73815-3.json |
| 7381-7 | Greasewood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7381-7.json |
| 73818-7 | Heparin induced platelet IgG Ab in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/73818-7.json |
| 73819-5 | Heparin induced platelet IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/73819-5.json |
| 73821-1 | Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/73821-1.json |
| 73822-9 | Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal | ./2.16.840.1.114222.4.11.1002/73822-9.json |
| 73823-7 | Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/73823-7.json |
| 73824-5 | Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/73824-5.json |
| 7382-5 | Gum arabic IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7382-5.json |
| 73825-2 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/73825-2.json |
| 73826-0 | Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73826-0.json |
| 73827-8 | Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/73827-8.json |
| 73828-6 | Flunitrazepam [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/73828-6.json |
| 73829-4 | 7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/73829-4.json |
| 7383-3 | Hackberry tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7383-3.json |
| 73833-6 | Legionella sp Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/73833-6.json |
| 73834-4 | Bacteria.carbapenem resistant identified in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/73834-4.json |
| 73835-1 | Bacteria.extended spectrum beta lactamase resistance [Identifier] in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/73835-1.json |
| 73836-9 | Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/73836-9.json |
| 73837-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/73837-7.json |
| 73838-5 | 11-Dehydrotetrahydrocorticosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73838-5.json |
| 73839-3 | 11-Dehydrotetrahydrocorticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73839-3.json |
| 73840-1 | 11-Dehydrotetrahydrocorticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73840-1.json |
| 7384-1 | Haddock IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7384-1.json |
| 73841-9 | Tetrahydrodeoxycortisol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73841-9.json |
| 73842-7 | Tetrahydrodeoxycortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73842-7.json |
| 73843-5 | Tetrahydrodeoxycortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73843-5.json |
| 73844-3 | 16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73844-3.json |
| 73845-0 | 16-Alpha hydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73845-0.json |
| 73846-8 | 16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73846-8.json |
| 73847-6 | 16-Ketoandrostenediol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73847-6.json |
| 73848-4 | 16-Ketoandrostenediol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73848-4.json |
| 73849-2 | 16-Ketoandrostenediol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73849-2.json |
| 73850-0 | 18-Beta glycyrrhetinate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73850-0.json |
| 73851-8 | 18-Beta glycyrrhetinate [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73851-8.json |
| 73853-4 | Aldosterone-18-glucuronide [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73853-4.json |
| 73854-2 | Aldosterone-18-glucuronide [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73854-2.json |
| 73855-9 | Aldosterone-18-glucuronide [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73855-9.json |
| 73856-7 | Allo-pregnanediol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73856-7.json |
| 73857-5 | Allo-pregnanediol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73857-5.json |
| 7385-8 | Haddock IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7385-8.json |
| 73858-3 | Allo-pregnanediol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73858-3.json |
| 73859-1 | Allo-tetrahydrocorticosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73859-1.json |
| 73860-9 | Allo-tetrahydrocorticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73860-9.json |
| 73861-7 | Allo-tetrahydrocorticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73861-7.json |
| 73862-5 | Allo-tetrahydrocortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73862-5.json |
| 73863-3 | Allo-tetrahydrocortisol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73863-3.json |
| 73864-1 | Allo-tetrahydrocortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73864-1.json |
| 7386-6 | Halibut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7386-6.json |
| 73867-4 | Alpha cortol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73867-4.json |
| 73868-2 | Alpha cortol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73868-2.json |
| 73869-0 | Alpha cortol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73869-0.json |
| 73870-8 | Alpha cortolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73870-8.json |
| 73871-6 | Alpha cortolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73871-6.json |
| 73872-4 | Alpha cortolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73872-4.json |
| 73873-2 | Androstenetriol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73873-2.json |
| 7387-4 | Halibut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7387-4.json |
| 73874-0 | Androstenetriol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73874-0.json |
| 73875-7 | Androstenetriol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73875-7.json |
| 73876-5 | Beta cortolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73876-5.json |
| 73877-3 | Beta cortolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73877-3.json |
| 73878-1 | Beta cortolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73878-1.json |
| 73880-7 | Cortisone free [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73880-7.json |
| 73881-5 | Cortisone free [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73881-5.json |
| 7388-2 | Ham triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7388-2.json |
| 73882-3 | Glycolate [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73882-3.json |
| 73883-1 | Glycolate [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73883-1.json |
| 73887-2 | Tetrahydrocorticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73887-2.json |
| 73888-0 | Tetrahydrocorticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73888-0.json |
| 73889-8 | Tetrahydrocorticosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73889-8.json |
| 7389-0 | Hay IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7389-0.json |
| 73890-6 | Tetrahydrocortisol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73890-6.json |
| 73891-4 | Tetrahydrocortisol [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73891-4.json |
| 73892-2 | Tetrahydrocortisol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73892-2.json |
| 73893-0 | Tetrahydrocortisone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/73893-0.json |
| 73894-8 | Tetrahydrocortisone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73894-8.json |
| 73895-5 | Hemoglobin [Entitic substance] in Reticulocytes by Automated count | ./2.16.840.1.114222.4.11.1002/73895-5.json |
| 73898-9 | CD8-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73898-9.json |
| 73899-7 | CD3- CD8- CD57+ Cells [#/volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73899-7.json |
| 73900-3 | CD3- CD8- CD57+ Cells/100 leukocytes in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73900-3.json |
| 73901-1 | CD3- CD8- CD57+ Cells/100 lymphocytes in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73901-1.json |
| 73902-9 | CD3-CD57+ cells [#/volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73902-9.json |
| 73903-7 | CD3-CD57+ cells/100 leukocytes in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73903-7.json |
| 73904-5 | CD3-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/73904-5.json |
| 73905-2 | HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/73905-2.json |
| 73906-0 | HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/73906-0.json |
| 73907-8 | Polio virus identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/73907-8.json |
| 73908-6 | Alloisoleucine/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/73908-6.json |
| 73909-4 | D2-40 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/73909-4.json |
| 73910-2 | PAX8 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/73910-2.json |
| 73911-0 | SOX10 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/73911-0.json |
| 73912-8 | DOG1 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/73912-8.json |
| 73913-6 | Glycine in CSF/Glycine in plasma | ./2.16.840.1.114222.4.11.1002/73913-6.json |
| 73914-4 | JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73914-4.json |
| 73915-1 | 1,3-Dimethylamylamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/73915-1.json |
| 7391-6 | Hazelnut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7391-6.json |
| 73916-9 | 1,3-Dimethylamylamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73916-9.json |
| 73917-7 | JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73917-7.json |
| 73918-5 | JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73918-5.json |
| 73919-3 | MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73919-3.json |
| 73920-1 | JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73920-1.json |
| 73921-9 | JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73921-9.json |
| 73922-7 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73922-7.json |
| 73923-5 | JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73923-5.json |
| 7392-4 | Hazelnut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7392-4.json |
| 73924-3 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73924-3.json |
| 73925-0 | AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73925-0.json |
| 73926-8 | JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73926-8.json |
| 73927-6 | JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73927-6.json |
| 73928-4 | JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73928-4.json |
| 73929-2 | JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73929-2.json |
| 73930-0 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73930-0.json |
| 73931-8 | Propanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73931-8.json |
| 7393-2 | Helminthosporium interseminatum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7393-2.json |
| 73932-6 | traMADol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73932-6.json |
| 73933-4 | Normeperidine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/73933-4.json |
| 73934-2 | Meperidine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/73934-2.json |
| 73935-9 | Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73935-9.json |
| 73936-7 | fentaNYL [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/73936-7.json |
| 73937-5 | Norfentanyl [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73937-5.json |
| 73938-3 | fentaNYL [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73938-3.json |
| 73939-1 | HYDROcodone Free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73939-1.json |
| 7394-0 | Helminthosporium maydis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7394-0.json |
| 73940-9 | HYDROmorphone Free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73940-9.json |
| 73941-7 | 6-monoacetylmorphine free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73941-7.json |
| 73942-5 | Buprenorphine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/73942-5.json |
| 73943-3 | Cannabinoids synthetic [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73943-3.json |
| 73944-1 | MAM-2201 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73944-1.json |
| 73945-8 | UR-144 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73945-8.json |
| 73946-6 | JWH-200 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73946-6.json |
| 73947-4 | JWH-398 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73947-4.json |
| 73948-2 | JWH-122 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73948-2.json |
| 73949-0 | JWH-018 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73949-0.json |
| 73950-8 | JWH-250 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73950-8.json |
| 73951-6 | RCS-4 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73951-6.json |
| 73952-4 | AM-2201 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73952-4.json |
| 73953-2 | JWH-073 (synthetic cannabinoid) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73953-2.json |
| 73954-0 | JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73954-0.json |
| 73955-7 | UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73955-7.json |
| 73956-5 | JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73956-5.json |
| 7395-7 | Helminthosporium sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7395-7.json |
| 73957-3 | UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/73957-3.json |
| 73958-1 | Cholesterol esterase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/73958-1.json |
| 73959-9 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/73959-9.json |
| 73961-5 | Escherichia coli and Klebsiella pneumoniae and Pseudomonas aeruginosa rRNA [Identifier] by FISH in Positive blood culture | ./2.16.840.1.114222.4.11.1002/73961-5.json |
| 73962-3 | Candida sp rRNA [Identifier] by FISH in Positive blood culture | ./2.16.840.1.114222.4.11.1002/73962-3.json |
| 73963-1 | Enterococcus faecalis and other enterococcus sp rRNA [Identifier] by FISH in Positive blood culture | ./2.16.840.1.114222.4.11.1002/73963-1.json |
| 73964-9 | Body muscle mass Calculated | ./2.16.840.1.114222.4.11.1002/73964-9.json |
| 7396-5 | Helminthosporium sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7396-5.json |
| 73965-6 | Body muscle mass/Body weight Measured | ./2.16.840.1.114222.4.11.1002/73965-6.json |
| 73966-4 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/73966-4.json |
| 73968-0 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/73968-0.json |
| 73969-8 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/73969-8.json |
| 73970-6 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/73970-6.json |
| 73971-4 | Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative | ./2.16.840.1.114222.4.11.1002/73971-4.json |
| 73972-2 | Morphine Free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73972-2.json |
| 7397-3 | Eastern Hemlock IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7397-3.json |
| 73973-0 | O-nortramadol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/73973-0.json |
| 73974-8 | CD158e cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/73974-8.json |
| 73975-5 | CD158a cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/73975-5.json |
| 73976-3 | CD158b cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/73976-3.json |
| 73977-1 | Cancer related multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/73977-1.json |
| 73978-9 | von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/73978-9.json |
| 7398-1 | Hemp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7398-1.json |
| 73982-1 | Carbapenem resistance blaNDM gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/73982-1.json |
| 73983-9 | Report.section heading | ./2.16.840.1.114222.4.11.1002/73983-9.json |
| 73987-0 | 2,2',3,4,4',5-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73987-0.json |
| 73988-8 | 2,2',4,5,5'-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73988-8.json |
| 73989-6 | 2,3',4,4',5-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73989-6.json |
| 73990-4 | 2,3',4',5-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73990-4.json |
| 73991-2 | 2,2',5,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73991-2.json |
| 73992-0 | 2,2',5-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73992-0.json |
| 73993-8 | Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73993-8.json |
| 73994-6 | Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/73994-6.json |
| 73996-1 | oxyCODONE [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/73996-1.json |
| 73997-9 | Ibuprofen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/73997-9.json |
| 73998-7 | 25H-NBOMe [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73998-7.json |
| 7399-9 | Hemp fiber IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7399-9.json |
| 73999-5 | 2C-C-NBOMe [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/73999-5.json |
| 74000-1 | 25I-NBOMe [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74000-1.json |
| 74001-9 | NBOMe [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/74001-9.json |
| 74002-7 | Tungsten/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74002-7.json |
| 74003-5 | CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/74003-5.json |
| 74004-3 | ABCB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/74004-3.json |
| 7400-5 | Water Hemp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7400-5.json |
| 74005-0 | Serotonin release 0.5 IU/mL heparin.unfractionated [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74005-0.json |
| 74007-6 | CYP3A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/74007-6.json |
| 7401-3 | Herring IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7401-3.json |
| 7402-1 | Pecan or Hickory Nut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7402-1.json |
| 74030-8 | Periodontal service attachment | ./2.16.840.1.114222.4.11.1002/74030-8.json |
| 74033-2 | Arbovirus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/74033-2.json |
| 74034-0 | MAML2 11q21 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/74034-0.json |
| 74035-7 | Abnormal Prion Protein [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74035-7.json |
| 74036-5 | Abnormal Prion Protein [Identifier] in Tissue by Immunoblot | ./2.16.840.1.114222.4.11.1002/74036-5.json |
| 74037-3 | Transmissible spongiform encephalopathy [Identifier] in Brain by Light microscopy | ./2.16.840.1.114222.4.11.1002/74037-3.json |
| 74038-1 | Influenza virus A H1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74038-1.json |
| 74039-9 | Influenza virus A H3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74039-9.json |
| 74040-7 | Influenza virus A N2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74040-7.json |
| 74041-5 | BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment | ./2.16.840.1.114222.4.11.1002/74041-5.json |
| 74043-1 | Alcohol use disorder | ./2.16.840.1.114222.4.11.1002/74043-1.json |
| 74044-9 | Disease of interest was cause of death in family member | ./2.16.840.1.114222.4.11.1002/74044-9.json |
| 74045-6 | Measure description Narrative | ./2.16.840.1.114222.4.11.1002/74045-6.json |
| 7404-7 | Shagbark Hickory IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7404-7.json |
| 7405-4 | Shellbark Hickory IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7405-4.json |
| 7407-0 | White Hickory IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7407-0.json |
| 74082-9 | Urea [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/74082-9.json |
| 74083-7 | Norolanzapine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74083-7.json |
| 74084-5 | Glucose [Moles/volume] in Serum or Plasma --15 minutes post 50 g lactosePO | ./2.16.840.1.114222.4.11.1002/74084-5.json |
| 74085-2 | Isocoproporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74085-2.json |
| 74086-0 | Pentacarboxylporphyrin III [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74086-0.json |
| 74087-8 | Hexacarboxylporphyrin III [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74087-8.json |
| 7408-8 | Histamine extract triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7408-8.json |
| 74088-6 | Heptacarboxylporphyrin III [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74088-6.json |
| 74089-4 | Pentacarboxylporphyrin III/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74089-4.json |
| 74090-2 | Hexacarboxylporphyrin III/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74090-2.json |
| 74091-0 | Heptacarboxylporphyrin III/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74091-0.json |
| 74092-8 | Acidity.titratable [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74092-8.json |
| 74093-6 | Gliquidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74093-6.json |
| 74094-4 | Gliclazide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74094-4.json |
| 74095-1 | Didesmethylcitalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74095-1.json |
| 7409-6 | Swine triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7409-6.json |
| 74096-9 | Tacrolimus [Mass/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/74096-9.json |
| 74097-7 | Tacrolimus [Mass/volume] in Blood by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/74097-7.json |
| 74098-5 | Endothelin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74098-5.json |
| 74099-3 | Neutrophil gelatinase-associated lipocalin [Mass/volume] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/74099-3.json |
| 74100-9 | Nitrate+Nitrite [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74100-9.json |
| 74101-7 | Tissue inhibitor of metalloproteinases 1 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/74101-7.json |
| 74102-5 | Matrix metallopeptidase 2 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74102-5.json |
| 74103-3 | Neutrophil gelatinase-associated lipocalin [Mass/volume] in Serum or Plasma by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/74103-3.json |
| 7410-4 | Swine epithelium IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7410-4.json |
| 74104-1 | Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/74104-1.json |
| 74105-8 | Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood | ./2.16.840.1.114222.4.11.1002/74105-8.json |
| 74106-6 | Proteinase 3 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/74106-6.json |
| 74107-4 | Warfarin [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74107-4.json |
| 74108-2 | Meperidine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/74108-2.json |
| 74109-0 | 4-hydroxycoumarins [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74109-0.json |
| 74110-8 | traMADol [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/74110-8.json |
| 74111-6 | Brodifacoum [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74111-6.json |
| 7411-2 | Honey IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7411-2.json |
| 74112-4 | Bromadiolone [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74112-4.json |
| 74113-2 | Coumafuryl [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74113-2.json |
| 74114-0 | Coumatetralyl [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74114-0.json |
| 74115-7 | Difenacoum [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/74115-7.json |
| 74116-5 | Adalimumab Ab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74116-5.json |
| 74117-3 | Adalimumab [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74117-3.json |
| 74118-1 | P27 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74118-1.json |
| 74119-9 | P504S Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74119-9.json |
| 7412-0 | Honey IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7412-0.json |
| 74120-7 | PDGFR-alpha Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74120-7.json |
| 74121-5 | Perforin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74121-5.json |
| 74122-3 | Ubiquitin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74122-3.json |
| 74123-1 | Phospho-S6 ribosomal protein Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74123-1.json |
| 74124-9 | Blood group 8 (BG8) Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74124-9.json |
| 74125-6 | Mesothelin Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74125-6.json |
| 74126-4 | Mucin-4 (MUC-4) Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74126-4.json |
| 74127-2 | Akt1 phosphate Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74127-2.json |
| 74128-0 | Neuroblastoma 84 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74128-0.json |
| 74129-8 | Transforming growth factor alpha Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74129-8.json |
| 74130-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/74130-6.json |
| 74131-4 | Morphine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/74131-4.json |
| 74132-2 | Aromatic solvents [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/74132-2.json |
| 74133-0 | Volatiles and gases [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/74133-0.json |
| 74134-8 | Ezogabine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/74134-8.json |
| 74135-5 | N-acetyl ezogabine [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/74135-5.json |
| 74136-3 | fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74136-3.json |
| 74137-1 | Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74137-1.json |
| 7413-8 | Honeysuckle IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7413-8.json |
| 74138-9 | Immature monocytes [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/74138-9.json |
| 74139-7 | Mononuclear cells [#/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/74139-7.json |
| 74140-5 | Granulocytes [#/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/74140-5.json |
| 74141-3 | Granulocytes/100 leukocytes in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/74141-3.json |
| 74142-1 | Granulocytes [#/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/74142-1.json |
| 74143-9 | Granulocytes/100 leukocytes in Body fluid | ./2.16.840.1.114222.4.11.1002/74143-9.json |
| 74144-7 | Complex medical conditions action plan | ./2.16.840.1.114222.4.11.1002/74144-7.json |
| 74145-4 | Multiple sclerosis action plan | ./2.16.840.1.114222.4.11.1002/74145-4.json |
| 7414-6 | Hop IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7414-6.json |
| 74146-2 | Heart disease action plan | ./2.16.840.1.114222.4.11.1002/74146-2.json |
| 74147-0 | Muscular Dystrophy action plan | ./2.16.840.1.114222.4.11.1002/74147-0.json |
| 74148-8 | Cystic fibrosis action plan | ./2.16.840.1.114222.4.11.1002/74148-8.json |
| 74149-6 | Inflammatory bowel disease action plan | ./2.16.840.1.114222.4.11.1002/74149-6.json |
| 74150-4 | Diabetes Type I action plan | ./2.16.840.1.114222.4.11.1002/74150-4.json |
| 74151-2 | Diabetes Type II action plan | ./2.16.840.1.114222.4.11.1002/74151-2.json |
| 74152-0 | Anaphylaxis action plan | ./2.16.840.1.114222.4.11.1002/74152-0.json |
| 7415-3 | Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7415-3.json |
| 74153-8 | Seizure Disorder action plan | ./2.16.840.1.114222.4.11.1002/74153-8.json |
| 74154-6 | Autism action plan | ./2.16.840.1.114222.4.11.1002/74154-6.json |
| 74155-3 | ADHD action plan | ./2.16.840.1.114222.4.11.1002/74155-3.json |
| 74156-1 | Oncology Plan of care and summary note | ./2.16.840.1.114222.4.11.1002/74156-1.json |
| 74157-9 | Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/74157-9.json |
| 74159-5 | Work schedule NIOSH | ./2.16.840.1.114222.4.11.1002/74159-5.json |
| 74160-3 | Work days per week | ./2.16.840.1.114222.4.11.1002/74160-3.json |
| 7416-1 | Horn beam IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7416-1.json |
| 74161-1 | Work hours per week | ./2.16.840.1.114222.4.11.1002/74161-1.json |
| 74162-9 | Usual industry duration | ./2.16.840.1.114222.4.11.1002/74162-9.json |
| 74163-7 | Usual occupation duration | ./2.16.840.1.114222.4.11.1002/74163-7.json |
| 74164-5 | History of Usual occupation and industry Narrative | ./2.16.840.1.114222.4.11.1002/74164-5.json |
| 74166-0 | Occupational summary note | ./2.16.840.1.114222.4.11.1002/74166-0.json |
| 74167-8 | Opiates [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/74167-8.json |
| 74168-6 | Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/74168-6.json |
| 74169-4 | Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/74169-4.json |
| 74170-2 | Ceftaroline [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/74170-2.json |
| 7417-9 | Whitefaced Hornet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7417-9.json |
| 74184-3 | Lymphocytes clefted [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/74184-3.json |
| 7418-7 | Horse dander triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7418-7.json |
| 74187-6 | interRAI Emergency Screener for Psychiatry (ESP) Document | ./2.16.840.1.114222.4.11.1002/74187-6.json |
| 74188-4 | interRAI Acute Care (AC) Hospital Document | ./2.16.840.1.114222.4.11.1002/74188-4.json |
| 74189-2 | interRAI Palliative Care (PC) Document | ./2.16.840.1.114222.4.11.1002/74189-2.json |
| 74190-0 | interRAI Community Health Assessment - Deafblind Supplement (CHA-Db) Document | ./2.16.840.1.114222.4.11.1002/74190-0.json |
| 74191-8 | interRAI Community Health Assessment - Assisted Living Supplement (CHA-AL) Document | ./2.16.840.1.114222.4.11.1002/74191-8.json |
| 74192-6 | interRAI Community Health Assessment - Mental Health Supplement (CHA-MH) Document | ./2.16.840.1.114222.4.11.1002/74192-6.json |
| 74193-4 | interRAI Community Health Assessment - Functional Supplement (CHA-FS) Document | ./2.16.840.1.114222.4.11.1002/74193-4.json |
| 74194-2 | interRAI Community Health Assessment (CHA) Document | ./2.16.840.1.114222.4.11.1002/74194-2.json |
| 7419-5 | Horse epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7419-5.json |
| 74195-9 | interRAI Long Term Care Facility (LTCF) Document | ./2.16.840.1.114222.4.11.1002/74195-9.json |
| 74196-7 | interRAI Home Care (HC) Document | ./2.16.840.1.114222.4.11.1002/74196-7.json |
| 74197-5 | interRAI Contact Assessment (CA) Document | ./2.16.840.1.114222.4.11.1002/74197-5.json |
| 74198-3 | Trauma Summary registry report | ./2.16.840.1.114222.4.11.1002/74198-3.json |
| 74199-1 | Transferred from another acute care facility [NTDS] | ./2.16.840.1.114222.4.11.1002/74199-1.json |
| 7420-3 | Horseradish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7420-3.json |
| 74207-2 | Prehospital summary Document | ./2.16.840.1.114222.4.11.1002/74207-2.json |
| 74208-0 | Demographic information + History of occupation Document | ./2.16.840.1.114222.4.11.1002/74208-0.json |
| 74209-8 | Injury event summary Document | ./2.16.840.1.114222.4.11.1002/74209-8.json |
| 7421-1 | House dust AP IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7421-1.json |
| 74211-4 | Emergency department+Hospital Summary of episode note | ./2.16.840.1.114222.4.11.1002/74211-4.json |
| 74213-0 | Discharge instructions | ./2.16.840.1.114222.4.11.1002/74213-0.json |
| 74214-8 | Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/74214-8.json |
| 74215-5 | Rivaroxaban [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/74215-5.json |
| 74216-3 | Fondaparinux [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/74216-3.json |
| 74217-1 | Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/74217-1.json |
| 74218-9 | Apixaban [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/74218-9.json |
| 74220-5 | Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/74220-5.json |
| 7422-9 | House dust AP IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7422-9.json |
| 7423-7 | House dust triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7423-7.json |
| 7424-5 | House dust Greer IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7424-5.json |
| 7425-2 | House dust Hollister Stier IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7425-2.json |
| 74254-4 | HEDIS 2014-2018 Value Set - Rh | ./2.16.840.1.114222.4.11.1002/74254-4.json |
| 74255-1 | HEDIS 2014-2018 Value Set - Rubella Antibody | ./2.16.840.1.114222.4.11.1002/74255-1.json |
| 74256-9 | HEDIS 2014-2019 Value Set - Serum Creatinine | ./2.16.840.1.114222.4.11.1002/74256-9.json |
| 7426-0 | House dust Hollister Stier IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7426-0.json |
| 74262-7 | HEDIS 2014-2018 Value Set - Toxoplasma Antibody | ./2.16.840.1.114222.4.11.1002/74262-7.json |
| 74263-5 | Dabigatran [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/74263-5.json |
| 74264-3 | HIV Summary registry report | ./2.16.840.1.114222.4.11.1002/74264-3.json |
| 74277-5 | Mycobacterium tuberculosis stimulated gamma interferon CFP10 Ag spot count [#] in Blood | ./2.16.840.1.114222.4.11.1002/74277-5.json |
| 74278-3 | Mycobacterium tuberculosis stimulated gamma interferon ESAT-6 Ag spot count [#] in Blood | ./2.16.840.1.114222.4.11.1002/74278-3.json |
| 74279-1 | Gamma interferon negative control spot count [#] in Blood | ./2.16.840.1.114222.4.11.1002/74279-1.json |
| 74280-9 | Mitogen stimulated gamma interferon positive control spot count [#] in Blood | ./2.16.840.1.114222.4.11.1002/74280-9.json |
| 74282-5 | Individual counseling note | ./2.16.840.1.114222.4.11.1002/74282-5.json |
| 7428-6 | Iodinebush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7428-6.json |
| 7429-4 | Isocyanate HDI IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7429-4.json |
| 74299-9 | Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74299-9.json |
| 74300-5 | Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74300-5.json |
| 74301-3 | Succinylacetone [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74301-3.json |
| 7430-2 | Isocyanate MDI IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7430-2.json |
| 74302-1 | Tyrosine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74302-1.json |
| 74303-9 | Phenylalanine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74303-9.json |
| 74304-7 | PRRSV neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/74304-7.json |
| 74305-4 | PRRSV Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/74305-4.json |
| 74306-2 | PRRSV ORF5 gene sequence homology to Fostera in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/74306-2.json |
| 74307-0 | PRRSV ORF5 gene sequence homology to Lelystad in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/74307-0.json |
| 74308-8 | PRRSV ORF5 gene sequence homology to Ingelvac ATP in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/74308-8.json |
| 74309-6 | PRRSV ORF5 gene sequence homology to Ingelvac MLV in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/74309-6.json |
| 7431-0 | Isocyanate TDI IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7431-0.json |
| 74311-2 | PRRSV ORF5 gene sequence [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/74311-2.json |
| 74312-0 | PRRSV [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/74312-0.json |
| 74313-8 | PRRSV Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/74313-8.json |
| 74315-3 | PRRSV RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74315-3.json |
| 74316-1 | PRRSV ORF5 gene RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74316-1.json |
| 74317-9 | PRRSV European strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74317-9.json |
| 74318-7 | PRRSV North American strain RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74318-7.json |
| 74319-5 | MICA*051 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74319-5.json |
| 74320-3 | MICA*050 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74320-3.json |
| 74321-1 | MICA*046 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74321-1.json |
| 74322-9 | MICA*043 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74322-9.json |
| 74323-7 | MICA*042 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74323-7.json |
| 74324-5 | MICA*041 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74324-5.json |
| 74325-2 | MICA*037 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74325-2.json |
| 74326-0 | MICA*036 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74326-0.json |
| 74327-8 | MICA*033 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74327-8.json |
| 7432-8 | Juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7432-8.json |
| 74328-6 | MICA*030 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74328-6.json |
| 74329-4 | MICA*029 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74329-4.json |
| 74330-2 | MICA*028 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74330-2.json |
| 74331-0 | MICA*024 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74331-0.json |
| 74332-8 | MICA*019 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74332-8.json |
| 74333-6 | MICA*018 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74333-6.json |
| 74334-4 | MICA*017 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74334-4.json |
| 74335-1 | MICA*016 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74335-1.json |
| 7433-6 | Juniper triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7433-6.json |
| 74336-9 | MICA*015 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74336-9.json |
| 74337-7 | MICA*012 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74337-7.json |
| 74338-5 | MICA*011 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74338-5.json |
| 74339-3 | MICA*009 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74339-3.json |
| 74340-1 | MICA*008 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74340-1.json |
| 74341-9 | MICA*007 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74341-9.json |
| 74342-7 | MICA*006 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74342-7.json |
| 74343-5 | MICA*005 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74343-5.json |
| 7434-4 | Pinchot Juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7434-4.json |
| 74344-3 | MICA*004 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74344-3.json |
| 74345-0 | MICA*002 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74345-0.json |
| 74346-8 | MICA*001 IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/74346-8.json |
| 74347-6 | Leukocyte aggregates [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/74347-6.json |
| 74348-4 | Bacteria identified in Bone from Donor by Aerobe culture | ./2.16.840.1.114222.4.11.1002/74348-4.json |
| 74349-2 | Lactose [Moles/volume] in Serum or Plasma --fasting | ./2.16.840.1.114222.4.11.1002/74349-2.json |
| 74350-0 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20M post dose corticotropin | ./2.16.840.1.114222.4.11.1002/74350-0.json |
| 7435-1 | Western Juniper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7435-1.json |
| 74351-8 | Glucose [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/74351-8.json |
| 74354-2 | Epithelial cells/100 leukocytes in Sputum | ./2.16.840.1.114222.4.11.1002/74354-2.json |
| 74356-7 | Bacteria identified in Ventriculoperitoneal (VP) shunt by Culture | ./2.16.840.1.114222.4.11.1002/74356-7.json |
| 74358-3 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74358-3.json |
| 74359-1 | Cholesterol ester transfer protein actual/normal in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74359-1.json |
| 74360-9 | Cortisone [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74360-9.json |
| 74361-7 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74361-7.json |
| 74362-5 | Lecithin cholesterol acyltransferase actual/normal in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74362-5.json |
| 74363-3 | N,N-dimethylarginine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74363-3.json |
| 74364-1 | Oxytocin [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74364-1.json |
| 74365-8 | Palmitoyl protein thioesterase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74365-8.json |
| 74366-6 | Clorazepate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74366-6.json |
| 74368-2 | Apelin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74368-2.json |
| 7436-9 | Jute IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7436-9.json |
| 74369-0 | Nitric oxide [Moles/volume] in Exhaled gas | ./2.16.840.1.114222.4.11.1002/74369-0.json |
| 74370-8 | Cotinine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74370-8.json |
| 74371-6 | Cotinine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74371-6.json |
| 74372-4 | Acetyl fentanyl [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74372-4.json |
| 74373-2 | cloNIDine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74373-2.json |
| 74374-0 | 2,4,4'-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74374-0.json |
| 74375-7 | 2,2',3,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74375-7.json |
| 74376-5 | 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74376-5.json |
| 7437-7 | Kapok IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7437-7.json |
| 74377-3 | Baclofen [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74377-3.json |
| 74378-1 | Meperidine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74378-1.json |
| 74379-9 | Morphine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74379-9.json |
| 74380-7 | HYDROmorphone [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74380-7.json |
| 74381-5 | Midazolam [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74381-5.json |
| 74382-3 | Bupivacaine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74382-3.json |
| 74383-1 | fentaNYL [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/74383-1.json |
| 74384-9 | Specimen container [Type] | ./2.16.840.1.114222.4.11.1002/74384-9.json |
| 7438-5 | Kapok triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7438-5.json |
| 74385-6 | Normirtazapine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/74385-6.json |
| 74386-4 | Normirtazapine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/74386-4.json |
| 74387-2 | Normirtazapine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74387-2.json |
| 74388-0 | Normirtazapine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/74388-0.json |
| 74389-8 | Normirtazapine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74389-8.json |
| 74390-6 | Baclofen [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/74390-6.json |
| 74391-4 | Baclofen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74391-4.json |
| 74392-2 | Zopiclone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/74392-2.json |
| 7439-3 | Karaya gum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7439-3.json |
| 74400-3 | Monocytes/100 leukocytes in Cord blood | ./2.16.840.1.114222.4.11.1002/74400-3.json |
| 7440-1 | Kiwifruit IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7440-1.json |
| 74404-5 | Eosinophils [#/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/74404-5.json |
| 74414-4 | Varicella zoster virus IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74414-4.json |
| 74415-1 | Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74415-1.json |
| 74416-9 | Measles virus IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74416-9.json |
| 74417-7 | Measles virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74417-7.json |
| 74418-5 | Measles virus IgG Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74418-5.json |
| 7441-9 | Kiwifruit triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7441-9.json |
| 74419-3 | Parvovirus B19 DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74419-3.json |
| 74420-1 | Parvovirus B19 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74420-1.json |
| 74421-9 | Mumps virus IgM Ab [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74421-9.json |
| 74422-7 | Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74422-7.json |
| 74423-5 | Enterovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74423-5.json |
| 74424-3 | Enterovirus RNA [Cycle Threshold #] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74424-3.json |
| 7442-7 | Firebush IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7442-7.json |
| 74430-0 | 3-Hydroxykynurenin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74430-0.json |
| 74431-8 | Acetoacetate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74431-8.json |
| 74432-6 | Cholestanol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74432-6.json |
| 74433-4 | Cholestanol/Cholesterol in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74433-4.json |
| 74434-2 | Bilirubin.total/Total in Stone by Infrared spectroscopy | ./2.16.840.1.114222.4.11.1002/74434-2.json |
| 74436-7 | D-Lactate [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74436-7.json |
| 74437-5 | Galactokinase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/74437-5.json |
| 74438-3 | Lactose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74438-3.json |
| 74440-9 | Pemptoporphyrin [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74440-9.json |
| 74441-7 | Porphobilinogen/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74441-7.json |
| 74442-5 | Pyridoxal phosphate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74442-5.json |
| 7444-3 | Lactalbumin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7444-3.json |
| 74443-3 | Sucrose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/74443-3.json |
| 74444-1 | Thiamine pyrophosphate [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74444-1.json |
| 7445-0 | Lactalbumin alpha IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7445-0.json |
| 74464-9 | Platelets [#/volume] in Capillary blood by Manual count | ./2.16.840.1.114222.4.11.1002/74464-9.json |
| 74465-6 | Questionnaire response Document | ./2.16.840.1.114222.4.11.1002/74465-6.json |
| 7446-8 | Lactalbumin triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7446-8.json |
| 74468-0 | Questionnaire form definition Document | ./2.16.840.1.114222.4.11.1002/74468-0.json |
| 74469-8 | Glucose-6-Phosphate dehydrogenase/Pyruvate kinase [Ratio] in Blood | ./2.16.840.1.114222.4.11.1002/74469-8.json |
| 74472-2 | Middle East respiratory syndrome coronavirus (MERS-CoV) N3 gene RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74472-2.json |
| 74473-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) N2 gene RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74473-0.json |
| 74474-8 | Middle East respiratory syndrome coronavirus (MERS-CoV) upE gene RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74474-8.json |
| 74475-5 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Interpretation] in Specimen Qualitative by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74475-5.json |
| 7447-6 | Lactoglobulin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7447-6.json |
| 74481-3 | Tyrosine/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/74481-3.json |
| 74483-9 | Homocitrulline [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74483-9.json |
| 7448-4 | Lamb IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7448-4.json |
| 74484-7 | Argininosuccinate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74484-7.json |
| 74485-4 | CD3 and CD20 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74485-4.json |
| 74486-2 | Cytokeratin 5 and p63 and Cytokeratin AE1 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74486-2.json |
| 74487-0 | P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74487-0.json |
| 74488-8 | p63 and Smooth muscle myosin heavy chain and Cytokeratin 8 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74488-8.json |
| 74489-6 | Melan-A and Ki67 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74489-6.json |
| 74490-4 | PAX5 and BCL2 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74490-4.json |
| 74491-2 | Cytokeratin 7 and Thyroid transcription factor 1 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74491-2.json |
| 7449-2 | Lamb triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7449-2.json |
| 74492-0 | PAX5 and CD43 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74492-0.json |
| 74493-8 | PAX5 and CD5 Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74493-8.json |
| 74494-6 | CD34 and Coagulation factor XIII Ag [Identifier] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/74494-6.json |
| 74496-1 | Injury location ICD code | ./2.16.840.1.114222.4.11.1002/74496-1.json |
| 74499-5 | Death pronouncer details | ./2.16.840.1.114222.4.11.1002/74499-5.json |
| 7450-0 | Goosefoot triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7450-0.json |
| 74503-4 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74503-4.json |
| 74504-2 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74504-2.json |
| 74505-9 | 16-Beta,18-dihydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74505-9.json |
| 74506-7 | 16-Alpha hydroxypregnenolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74506-7.json |
| 74507-5 | 16-Alpha hydroxypregnenolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74507-5.json |
| 74508-3 | 16-Alpha hydroxypregnenolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74508-3.json |
| 74509-1 | 3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74509-1.json |
| 74510-9 | 3-Hydroxyeicosanoylcarnitine (C20-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74510-9.json |
| 74511-7 | COMT gene c.1947G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/74511-7.json |
| 74512-5 | Chemokine (C-C motif) ligand 18 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74512-5.json |
| 74513-3 | Alpha tocopherol [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74513-3.json |
| 74515-8 | Bile acid [Moles/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/74515-8.json |
| 74516-6 | Calcium [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74516-6.json |
| 74517-4 | Cholesterol sulfate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74517-4.json |
| 7451-8 | Latex ALK triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7451-8.json |
| 74518-2 | Clara cell protein 16 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74518-2.json |
| 74521-6 | Complement total hemolytic CH50 actual/normal in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74521-6.json |
| 74523-2 | Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74523-2.json |
| 74524-0 | Decatrienoylcarnitine (C10:3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74524-0.json |
| 74525-7 | Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74525-7.json |
| 7452-6 | Latex Bencard triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7452-6.json |
| 74528-1 | Dicarboxyeicosanoylcarnitine (C20-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74528-1.json |
| 74529-9 | Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74529-9.json |
| 74530-7 | Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74530-7.json |
| 74531-5 | Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74531-5.json |
| 74532-3 | Energy content [Energy/mass] of 24 hour Stool.wet | ./2.16.840.1.114222.4.11.1002/74532-3.json |
| 7453-4 | Latex Greer triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7453-4.json |
| 74534-9 | Neisseria meningitidis serogroup Y DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74534-9.json |
| 74535-6 | Neisseria meningitidis serogroup X DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74535-6.json |
| 74536-4 | Neisseria meningitidis serogroup w135 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74536-4.json |
| 74537-2 | Neisseria meningitidis serogroup C DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74537-2.json |
| 74538-0 | Neisseria meningitidis serogroup B DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74538-0.json |
| 74539-8 | Neisseria meningitidis serogroup A DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74539-8.json |
| 74540-6 | Hexenoylcarnitine (C6:1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74540-6.json |
| 74541-4 | Surfactant pulmonary-associated protein D [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74541-4.json |
| 7454-2 | Latex Stallerg triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7454-2.json |
| 74542-2 | Pyruvate kinase/Glucose-6-Phosphate dehydrogenase [Enzymatic activity ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74542-2.json |
| 74544-8 | Tocopherols [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74544-8.json |
| 7455-9 | Lemon IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7455-9.json |
| 7456-7 | Lemon triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7456-7.json |
| 74575-2 | Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/74575-2.json |
| 74576-0 | Tripeptidyl peptidase I [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74576-0.json |
| 74577-8 | Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74577-8.json |
| 74578-6 | Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/74578-6.json |
| 74579-4 | Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74579-4.json |
| 74580-2 | Fumarase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/74580-2.json |
| 74581-0 | Fumarase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74581-0.json |
| 74582-8 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74582-8.json |
| 7458-3 | Lentils IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7458-3.json |
| 74583-6 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74583-6.json |
| 74584-4 | Cytochrome C oxidase/Citrate synthase [Enzymatic activity ratio] in Tissue | ./2.16.840.1.114222.4.11.1002/74584-4.json |
| 74585-1 | Coenzyme Q cytochrome C reductase (Complex III)/Citrate synthase [Enzymatic activity ratio] in Tissue | ./2.16.840.1.114222.4.11.1002/74585-1.json |
| 74586-9 | Coenzyme Q cytochrome C reductase (Complex III) [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/74586-9.json |
| 74587-7 | Succinate cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue | ./2.16.840.1.114222.4.11.1002/74587-7.json |
| 74588-5 | Succinate cytochrome C reductase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74588-5.json |
| 74589-3 | Succinate dehydrogenase/Citrate synthase [Enzymatic activity ratio] in Tissue | ./2.16.840.1.114222.4.11.1002/74589-3.json |
| 74590-1 | NADH cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue | ./2.16.840.1.114222.4.11.1002/74590-1.json |
| 7459-1 | Lentils IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7459-1.json |
| 74591-9 | Suberylcarnitine (C8-DC) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74591-9.json |
| 74592-7 | Octanoylcarnitine (C8) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74592-7.json |
| 74593-5 | Adipoylcarnitine (C6-DC) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74593-5.json |
| 74594-3 | Hexanoylcarnitine (C6) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74594-3.json |
| 74595-0 | 3-Hydroxybutyrylcarnitine (C4-OH) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74595-0.json |
| 74596-8 | Butyrylcarnitine (C4) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74596-8.json |
| 74597-6 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74597-6.json |
| 74598-4 | Dicarboxypalmitoylcarnitine (C16-DC) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74598-4.json |
| 74599-2 | 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74599-2.json |
| 74600-8 | Palmitoleylcarnitine (C16:1) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74600-8.json |
| 74601-6 | Palmitoylcarnitine (C16) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74601-6.json |
| 74602-4 | 3-Hydroxytetradecanoylcarnitine (C14-OH) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74602-4.json |
| 74603-2 | Tetradecadienoylcarnitine (C14:2) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74603-2.json |
| 74604-0 | 3-Hydroxymyristoleylcarnitine (C14:1-OH) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74604-0.json |
| 74605-7 | Tetradecenoylcarnitine (C14:1) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74605-7.json |
| 74606-5 | Tetradecanoylcarnitine (C14) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74606-5.json |
| 74607-3 | Dodecenoylcarnitine (C12:1) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74607-3.json |
| 74608-1 | Dodecanoylcarnitine (C12) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74608-1.json |
| 7460-9 | Lettuce IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7460-9.json |
| 74609-9 | Sebacylcarnitine (C10-DC) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74609-9.json |
| 74610-7 | Decadienoylcarnitine (C10:2) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74610-7.json |
| 74611-5 | Decenoylcarnitine (C10:1) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74611-5.json |
| 74612-3 | Decanoylcarnitine (C10) [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74612-3.json |
| 74613-1 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74613-1.json |
| 74614-9 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74614-9.json |
| 74615-6 | Fatty acids.very long chain C22:0 (Docosanoate) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74615-6.json |
| 74616-4 | 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74616-4.json |
| 7461-7 | Lettuce triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7461-7.json |
| 74617-2 | 1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Molar ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74617-2.json |
| 74618-0 | 1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74618-0.json |
| 74619-8 | 1,1-Dimethoxyoctadecane (DMA 18:0) [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74619-8.json |
| 74620-6 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74620-6.json |
| 74621-4 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74621-4.json |
| 74622-2 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74622-2.json |
| 74623-0 | 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74623-0.json |
| 74624-8 | 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74624-8.json |
| 7462-5 | Licorice IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7462-5.json |
| 74625-5 | 1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Molar ratio] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74625-5.json |
| 74626-3 | 1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74626-3.json |
| 74627-1 | 1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74627-1.json |
| 74628-9 | Adipoylcarnitine (C6-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/74628-9.json |
| 74629-7 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74629-7.json |
| 74630-5 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74630-5.json |
| 74631-3 | Glycosaminoglycans/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74631-3.json |
| 74632-1 | Glycosaminoglycans [Presence] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74632-1.json |
| 7463-3 | Easter lily IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7463-3.json |
| 74636-2 | Protein.monoclonal band 3 [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/74636-2.json |
| 74637-0 | Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/74637-0.json |
| 7464-1 | Lime IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7464-1.json |
| 74642-0 | 1,3-Dichlorobenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74642-0.json |
| 74643-8 | Aromatic solvents [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/74643-8.json |
| 74644-6 | HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74644-6.json |
| 74645-3 | HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74645-3.json |
| 74646-1 | Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74646-1.json |
| 74647-9 | Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/74647-9.json |
| 74648-7 | Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74648-7.json |
| 74649-5 | Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74649-5.json |
| 74650-3 | Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74650-3.json |
| 74651-1 | Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74651-1.json |
| 74652-9 | Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/74652-9.json |
| 74653-7 | Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74653-7.json |
| 74654-5 | Morphine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74654-5.json |
| 74655-2 | Norsertraline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74655-2.json |
| 74656-0 | Opiates [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74656-0.json |
| 74657-8 | oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74657-8.json |
| 7465-8 | Lime IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7465-8.json |
| 74658-6 | oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74658-6.json |
| 74659-4 | oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74659-4.json |
| 74660-2 | Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74660-2.json |
| 74661-0 | Phosphatidylethanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74661-0.json |
| 74662-8 | Sertraline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74662-8.json |
| 74663-6 | Zaleplon [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74663-6.json |
| 74664-4 | Zolpidem [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74664-4.json |
| 7466-6 | Linen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7466-6.json |
| 74666-9 | Monoclonal band observed [Identifier] in Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/74666-9.json |
| 74667-7 | Atopobium vaginae DNA [Log #/volume] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74667-7.json |
| 74668-5 | Gardnerella vaginalis DNA [Log #/volume] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74668-5.json |
| 74669-3 | Lactobacillus sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74669-3.json |
| 74670-1 | Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74670-1.json |
| 74671-9 | Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74671-9.json |
| 74672-7 | Carisoprodol+Meprobamate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/74672-7.json |
| 74673-5 | Ethanol [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74673-5.json |
| 7467-4 | Lipolase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7467-4.json |
| 74674-3 | Chlorinated solvents [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/74674-3.json |
| 74675-0 | Codeine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74675-0.json |
| 74676-8 | Carbapenemase [Type] in Isolate by Carba NP | ./2.16.840.1.114222.4.11.1002/74676-8.json |
| 74677-6 | 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74677-6.json |
| 74678-4 | Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74678-4.json |
| 74679-2 | Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74679-2.json |
| 74680-0 | Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74680-0.json |
| 74681-8 | Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74681-8.json |
| 7468-2 | Liver IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7468-2.json |
| 74682-6 | Trichloroethanol.free [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/74682-6.json |
| 74683-4 | Ethyl sulfate [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74683-4.json |
| 74684-2 | Carbon dioxide, total [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/74684-2.json |
| 74685-9 | Sodium [Moles/volume] in 4 hour Urine | ./2.16.840.1.114222.4.11.1002/74685-9.json |
| 74686-7 | Glucose [Moles/time] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/74686-7.json |
| 74687-5 | Glucose [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/74687-5.json |
| 74688-3 | Sodium [Moles/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/74688-3.json |
| 7469-0 | Liver calf IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7469-0.json |
| 74692-5 | MT-ND6 gene m.14459G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/74692-5.json |
| 74696-6 | Magnesium [Moles/volume] in 12 hour Urine | ./2.16.840.1.114222.4.11.1002/74696-6.json |
| 74697-4 | Acamprosate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74697-4.json |
| 7470-8 | Llama fur IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7470-8.json |
| 7471-6 | Lobster IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7471-6.json |
| 7472-4 | Locust tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7472-4.json |
| 74727-9 | Body condition score Jefferies | ./2.16.840.1.114222.4.11.1002/74727-9.json |
| 74729-5 | Adrenoleukodystrophy protein (ALDP) [Presence] in Fibroblast by Immune stain | ./2.16.840.1.114222.4.11.1002/74729-5.json |
| 7473-2 | Black Locust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7473-2.json |
| 74734-5 | Death certifier details | ./2.16.840.1.114222.4.11.1002/74734-5.json |
| 7474-0 | Mackerel IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7474-0.json |
| 74750-1 | Lymphocytes clefted [Presence] in Blood or Tissue by Light microscopy | ./2.16.840.1.114222.4.11.1002/74750-1.json |
| 74752-7 | Porcine epidemic diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74752-7.json |
| 74755-0 | Placental growth factor [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74755-0.json |
| 74756-8 | Soluble fms-like tyrosine kinase-1 [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/74756-8.json |
| 7475-7 | Mackerel triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7475-7.json |
| 74758-4 | Ethyl sulfate+Ethyl glucuronide [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74758-4.json |
| 74759-2 | Yeast [Presence] in Specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/74759-2.json |
| 74761-8 | Microcytes/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/74761-8.json |
| 74762-6 | Megasphaera sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74762-6.json |
| 74763-4 | Human papilloma virus E6+E7 mRNA [Presence] in Anal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74763-4.json |
| 7476-5 | Malt IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7476-5.json |
| 74765-9 | Bordetella pertussis.pertussis toxin IgA Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/74765-9.json |
| 74766-7 | Bordetella pertussis.pertussis toxin 100 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/74766-7.json |
| 74767-5 | Tryptophan [Moles/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/74767-5.json |
| 74768-3 | 5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/74768-3.json |
| 74769-1 | 5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma | ./2.16.840.1.114222.4.11.1002/74769-1.json |
| 7477-3 | Mango Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7477-3.json |
| 74774-1 | Glucose [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/74774-1.json |
| 74775-8 | Platelets [#/volume] in Platelet rich plasma by Automated count | ./2.16.840.1.114222.4.11.1002/74775-8.json |
| 74776-6 | Human papilloma virus 6 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74776-6.json |
| 74777-4 | Human papilloma virus 6 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74777-4.json |
| 74778-2 | Human papilloma virus 11 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74778-2.json |
| 74779-0 | Human papilloma virus 11 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74779-0.json |
| 74780-8 | CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/74780-8.json |
| 7478-1 | Coastal Maple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7478-1.json |
| 74782-4 | Pulse intensity Dorsal pedal artery - right by palpation | ./2.16.840.1.114222.4.11.1002/74782-4.json |
| 74784-0 | Influenza virus B lineage RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74784-0.json |
| 74785-7 | Influenza virus B Victoria lineage RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74785-7.json |
| 74786-5 | Influenza virus B Yamagata lineage RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74786-5.json |
| 74792-3 | Fructose.PO [Mass] in Dose | ./2.16.840.1.114222.4.11.1002/74792-3.json |
| 74793-1 | Thyroid hormone uptake (T-uptake) in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74793-1.json |
| 74794-9 | Thyroid hormone binding ratio (THBR) in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74794-9.json |
| 74795-6 | Total thyroxine binding capacity in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74795-6.json |
| 7479-9 | Red Maple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7479-9.json |
| 74805-3 | Penicillium sp IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/74805-3.json |
| 74806-1 | Lithium [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74806-1.json |
| 7480-7 | Red Maple triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7480-7.json |
| 74807-9 | Transferrin receptor.soluble/log Ferritin index [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74807-9.json |
| 74808-7 | von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasma | ./2.16.840.1.114222.4.11.1002/74808-7.json |
| 74810-3 | Acetyl fentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74810-3.json |
| 74811-1 | Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74811-1.json |
| 74812-9 | Mirtazapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/74812-9.json |
| 74813-7 | Nucleated cells [#/volume] in Dialysis fluid by Manual count | ./2.16.840.1.114222.4.11.1002/74813-7.json |
| 74814-5 | Plasma cells.centroblasts/100 leukocytes in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/74814-5.json |
| 7481-5 | Red+Silver Maple IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7481-5.json |
| 74815-2 | Ascaris sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74815-2.json |
| 74817-8 | Desomorphine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/74817-8.json |
| 74818-6 | Desomorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/74818-6.json |
| 74819-4 | Promazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/74819-4.json |
| 74820-2 | Plasma cells.centrocytes/100 leukocytes in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/74820-2.json |
| 74821-0 | Chikungunya virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74821-0.json |
| 74822-8 | Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74822-8.json |
| 7482-3 | Maple sugar IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7482-3.json |
| 74823-6 | Jamestown canyon virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74823-6.json |
| 74824-4 | Powassan virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74824-4.json |
| 74825-1 | Saint Louis encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74825-1.json |
| 74826-9 | Semliki Forest virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74826-9.json |
| 74827-7 | Snowshoe hare virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74827-7.json |
| 74828-5 | Snowshoe hare virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/74828-5.json |
| 74829-3 | Snowshoe hare virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/74829-3.json |
| 74830-1 | Toxoplasma gondii IgA Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74830-1.json |
| 7483-1 | Maple syrup IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7483-1.json |
| 74833-5 | ACAT1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/74833-5.json |
| 74834-3 | MARS2 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/74834-3.json |
| 74843-4 | Baylisascaris sp IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/74843-4.json |
| 74844-2 | Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74844-2.json |
| 74845-9 | Sindbis virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/74845-9.json |
| 74846-7 | Snowshoe hare virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/74846-7.json |
| 74847-5 | Toxoplasma gondii IgE Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/74847-5.json |
| 7484-9 | Burweed marshelder IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7484-9.json |
| 74852-5 | Mesothelial cells/100 cells in Lymph node by Manual count | ./2.16.840.1.114222.4.11.1002/74852-5.json |
| 74853-3 | HIV 1 proviral DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74853-3.json |
| 74854-1 | HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74854-1.json |
| 74855-8 | HIV 1 proviral DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74855-8.json |
| 7485-6 | Burweed marshelder IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7485-6.json |
| 74856-6 | HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74856-6.json |
| 74857-4 | West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74857-4.json |
| 74858-2 | Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/74858-2.json |
| 74862-4 | IgG.kappa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74862-4.json |
| 74863-2 | IgG.lambda [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74863-2.json |
| 7486-4 | Mattress dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7486-4.json |
| 74864-0 | IgA.kappa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74864-0.json |
| 74865-7 | IgA.lambda [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74865-7.json |
| 74866-5 | IgM.kappa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74866-5.json |
| 74867-3 | IgM.lambda [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74867-3.json |
| 74868-1 | IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74868-1.json |
| 74869-9 | IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74869-9.json |
| 74870-7 | IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74870-7.json |
| 74871-5 | Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/74871-5.json |
| 7487-2 | Mayfly IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7487-2.json |
| 74872-3 | 21-Deoxycortisol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74872-3.json |
| 74873-1 | Metabolic disorder being monitored [Identifier] in DBS | ./2.16.840.1.114222.4.11.1002/74873-1.json |
| 74875-6 | Alloisoleucine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74875-6.json |
| 74876-4 | Arginine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74876-4.json |
| 74877-2 | Argininosuccinate [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74877-2.json |
| 74878-0 | Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74878-0.json |
| 74879-8 | Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74879-8.json |
| 7488-0 | Mayfly triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7488-0.json |
| 74880-6 | Hydroxyproline [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74880-6.json |
| 74881-4 | Isoleucine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74881-4.json |
| 74882-2 | Leucine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74882-2.json |
| 74883-0 | Ornithine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74883-0.json |
| 74884-8 | Valine [Moles/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/74884-8.json |
| 74886-3 | Stigmasterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74886-3.json |
| 74887-1 | Stigmastanol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74887-1.json |
| 74889-7 | Phosphate [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74889-7.json |
| 74890-5 | Inositol Free/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74890-5.json |
| 74891-3 | Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/74891-3.json |
| 74892-1 | Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74892-1.json |
| 74893-9 | Mannose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74893-9.json |
| 74894-7 | Mannitol [Moles/time] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/74894-7.json |
| 74895-4 | Maltose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/74895-4.json |
| 74896-2 | Lactate [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/74896-2.json |
| 74897-0 | Lithocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74897-0.json |
| 7489-8 | Cajeput tree triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7489-8.json |
| 74898-8 | Lanosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74898-8.json |
| 74899-6 | Lactulose/Mannitol [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/74899-6.json |
| 74900-2 | Lactulose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/74900-2.json |
| 74901-0 | Gamma tocopherol [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74901-0.json |
| 74902-8 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/74902-8.json |
| 74903-6 | Fatty acids [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/74903-6.json |
| 74904-4 | DOPamine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74904-4.json |
| 74905-1 | Desmosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74905-1.json |
| 74906-9 | Bilirubin.total [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74906-9.json |
| 74907-7 | Beta sitosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74907-7.json |
| 74908-5 | 3-ketoacyl-CoA thiolase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74908-5.json |
| 74909-3 | Calcium oxalate dihydrate/Total in Stone | ./2.16.840.1.114222.4.11.1002/74909-3.json |
| 74911-9 | Sertraline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74911-9.json |
| 74912-7 | Primidone [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74912-7.json |
| 7491-4 | Mexican Firebush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7491-4.json |
| 74915-0 | Sulpiride [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74915-0.json |
| 74916-8 | Metoprolol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74916-8.json |
| 74917-6 | CXCL13 Ag [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74917-6.json |
| 74918-4 | Fatty acids [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/74918-4.json |
| 74919-2 | Caffeine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74919-2.json |
| 7492-2 | Multiple inhalant allergen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7492-2.json |
| 74922-6 | N-acetyl-L-aspartate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74922-6.json |
| 74924-2 | Nortriptyline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74924-2.json |
| 74926-7 | PHENobarbital [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74926-7.json |
| 74928-3 | Allopurinol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74928-3.json |
| 7493-0 | Milk evaporated IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7493-0.json |
| 74930-9 | 3-Hydroxykynurenin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74930-9.json |
| 74931-7 | ARIPiprazole [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74931-7.json |
| 74934-1 | fluPHENAZine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74934-1.json |
| 74935-8 | Palmitoyl protein thioesterase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/74935-8.json |
| 74936-6 | QUEtiapine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74936-6.json |
| 74939-0 | Vigabatrin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74939-0.json |
| 74940-8 | Moclobemide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74940-8.json |
| 74941-6 | Moclobemide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74941-6.json |
| 74942-4 | Kynurenin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/74942-4.json |
| 74943-2 | busPIRone [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74943-2.json |
| 74944-0 | lamoTRIgine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74944-0.json |
| 74945-7 | clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74945-7.json |
| 7494-8 | Common Millet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7494-8.json |
| 74948-1 | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74948-1.json |
| 74949-9 | Perphenazine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74949-9.json |
| 74953-1 | Macroprolactin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74953-1.json |
| 74954-9 | Isomaltase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/74954-9.json |
| 7495-5 | Mite dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7495-5.json |
| 74957-2 | Succinylacetone [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/74957-2.json |
| 74958-0 | clomiPRAMINE [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74958-0.json |
| 74960-6 | valGANciclovir [Mass/volume] in Plasma --trough | ./2.16.840.1.114222.4.11.1002/74960-6.json |
| 74962-2 | Maprotiline [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74962-2.json |
| 7496-3 | Cheese mold type IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7496-3.json |
| 74964-8 | Gabapentin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74964-8.json |
| 74965-5 | Haloperidol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74965-5.json |
| 74967-1 | Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/74967-1.json |
| 74970-5 | Acetylsalicylate [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74970-5.json |
| 7497-1 | Cheese mold type triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7497-1.json |
| 74973-9 | carBAMazepine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74973-9.json |
| 74974-7 | carBAMazepine free [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74974-7.json |
| 74975-4 | Nordiazepam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74975-4.json |
| 74976-2 | Phenytoin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74976-2.json |
| 74977-0 | Transferrin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/74977-0.json |
| 74979-6 | Urate [Moles/volume] in Bronchoalveolar lavage | ./2.16.840.1.114222.4.11.1002/74979-6.json |
| 74980-4 | LORazepam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74980-4.json |
| 74981-2 | Pimozide [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74981-2.json |
| 74982-0 | FLUoxetine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74982-0.json |
| 74983-8 | Phenytoin Free [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74983-8.json |
| 74984-6 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Lymphoblasts | ./2.16.840.1.114222.4.11.1002/74984-6.json |
| 74985-3 | ALPRAZolam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74985-3.json |
| 74986-1 | Hydroxychloroquine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/74986-1.json |
| 74988-7 | Hexacarboxylporphyrin [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/74988-7.json |
| 7498-9 | Chrysonilia sitophila IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7498-9.json |
| 74989-5 | Pentacarboxylporphyrins [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74989-5.json |
| 74990-3 | Alpha 1 antitrypsin [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/74990-3.json |
| 74992-9 | Amylase [Enzymatic activity/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/74992-9.json |
| 74994-5 | Collagen crosslinked C-telopeptide [Z-score] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74994-5.json |
| 74995-2 | Osteocalcin [Z-score] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74995-2.json |
| 74996-0 | Alkaline phosphatase.bone [Z-score] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/74996-0.json |
| 7499-7 | Monkey epithelium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7499-7.json |
| 74997-8 | Alpha 1 antitrypsin [Mass/mass] in Stool.dried | ./2.16.840.1.114222.4.11.1002/74997-8.json |
| 74998-6 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/74998-6.json |
| 74999-4 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/74999-4.json |
| 75000-0 | Coproporphyrin 3/Coproporphyrin.total in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/75000-0.json |
| 75001-8 | Coproporphyrin 3/Coproporphyrin.total in Stool | ./2.16.840.1.114222.4.11.1002/75001-8.json |
| 7500-2 | Aedes mosquito triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7500-2.json |
| 75002-6 | Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/75002-6.json |
| 75003-4 | Food Allergen Mix 7A (Peanut+Cow milk+Egg white+Soybean+Wheat+Rice) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/75003-4.json |
| 75004-2 | Food Allergen Mix fp73 (Beef+Chicken+Pork+Lamb) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/75004-2.json |
| 75005-9 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/75005-9.json |
| 75006-7 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/75006-7.json |
| 75007-5 | Aspergillus restrictus native (nAsp r) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/75007-5.json |
| 75008-3 | Dog native (nCan f) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/75008-3.json |
| 75009-1 | CEBPA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75009-1.json |
| 7501-0 | Spanish Moss IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7501-0.json |
| 75010-9 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75010-9.json |
| 75011-7 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75011-7.json |
| 75012-5 | t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75012-5.json |
| 75013-3 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75013-3.json |
| 75014-1 | t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75014-1.json |
| 75015-8 | t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75015-8.json |
| 75016-6 | t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75016-6.json |
| 75017-4 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75017-4.json |
| 75018-2 | t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75018-2.json |
| 75019-0 | t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75019-0.json |
| 75020-8 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75020-8.json |
| 75023-2 | CD63 (Activated) Basophils/100 basophils in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/75023-2.json |
| 75024-0 | Coproporphyrin 1/Porphyrins.total in Stool | ./2.16.840.1.114222.4.11.1002/75024-0.json |
| 75025-7 | Coproporphyrin 3/Porphyrins.total in Stool | ./2.16.840.1.114222.4.11.1002/75025-7.json |
| 7502-8 | Moth IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7502-8.json |
| 75029-9 | Zanamivir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/75029-9.json |
| 75032-3 | CEBPA gene full mutation analysis in Bone marrow by Sequencing | ./2.16.840.1.114222.4.11.1002/75032-3.json |
| 75033-1 | MPL gene mutations tested for in Bone marrow by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/75033-1.json |
| 75034-9 | NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/75034-9.json |
| 75035-6 | Oxytocin [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/75035-6.json |
| 7503-6 | Moth triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7503-6.json |
| 75036-4 | 2-Hydroxyglutarate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/75036-4.json |
| 75037-2 | 2-Hydroxyglutarate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/75037-2.json |
| 75039-8 | Biopterin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75039-8.json |
| 75040-6 | D-Lactate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75040-6.json |
| 75041-4 | Pyridoxal [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75041-4.json |
| 75042-2 | Pyridoxal [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75042-2.json |
| 75043-0 | Pyridoxine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75043-0.json |
| 7504-4 | Mouse hair IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7504-4.json |
| 75044-8 | Sepiapterin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75044-8.json |
| 75045-5 | Sialate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/75045-5.json |
| 75046-3 | Sialate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75046-3.json |
| 75047-1 | Sialate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75047-1.json |
| 75048-9 | Tetrahydrofolate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75048-9.json |
| 75049-7 | Thiosulfate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/75049-7.json |
| 75050-5 | Coenzyme Q10 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75050-5.json |
| 7505-1 | Mouse multi IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7505-1.json |
| 75051-3 | Xylose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75051-3.json |
| 75052-1 | Adenosine deaminase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/75052-1.json |
| 75053-9 | Alpha-L-iduronidase [Enzymatic activity/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75053-9.json |
| 75054-7 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/75054-7.json |
| 75055-4 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/75055-4.json |
| 75056-2 | Pyridoxal phosphate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75056-2.json |
| 75057-0 | Sialidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/75057-0.json |
| 75058-8 | Thymidine phosphorylase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/75058-8.json |
| 75059-6 | Transaldolase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/75059-6.json |
| 75060-4 | Pantothenate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75060-4.json |
| 75061-2 | Malonate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75061-2.json |
| 75062-0 | Phenylacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75062-0.json |
| 75063-8 | Glycerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75063-8.json |
| 75064-6 | Vanillylmandelate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75064-6.json |
| 75065-3 | Benzoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75065-3.json |
| 75066-1 | Pantothenate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75066-1.json |
| 75067-9 | Indole-3-Acetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75067-9.json |
| 75068-7 | Malate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75068-7.json |
| 7506-9 | Mucor plumbeus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7506-9.json |
| 75069-5 | Hippurate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75069-5.json |
| 75070-3 | Catechol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75070-3.json |
| 75071-1 | Acetaminophen/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75071-1.json |
| 75072-9 | Mandelate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75072-9.json |
| 75073-7 | Suberate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75073-7.json |
| 75075-2 | 4-Hydroxybenzoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75075-2.json |
| 75076-0 | Vanillate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75076-0.json |
| 7507-7 | Mucor racemosus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7507-7.json |
| 75077-8 | Quinolinate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75077-8.json |
| 75078-6 | 3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75078-6.json |
| 75079-4 | Succinylacetone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75079-4.json |
| 75080-2 | N-acetyl-L-aspartate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75080-2.json |
| 75081-0 | Fumarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75081-0.json |
| 75083-6 | Aconitate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75083-6.json |
| 75084-4 | Sebacate (C8) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75084-4.json |
| 7508-5 | Mucor racemosus triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7508-5.json |
| 75085-1 | Homogentisate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/75085-1.json |
| 75086-9 | Catecholamine metabolites pattern [Interpretation] in Urine Narrative | ./2.16.840.1.114222.4.11.1002/75086-9.json |
| 75087-7 | Adipate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75087-7.json |
| 75088-5 | 3-Indolelactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75088-5.json |
| 75089-3 | 5-Oxoproline [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75089-3.json |
| 75090-1 | Isocitrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75090-1.json |
| 75091-9 | Catechol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75091-9.json |
| 7509-3 | Mucor sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7509-3.json |
| 75093-5 | Galactose [Mass/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/75093-5.json |
| 75094-3 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/75094-3.json |
| 75095-0 | Docosahexaenoate (C22:6w3) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75095-0.json |
| 75096-8 | Fatty acids.very long chain C26:0 (Hexacosanoate) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75096-8.json |
| 75097-6 | Eicosapentaenoate (C20:5w3) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75097-6.json |
| 75098-4 | Nervonate (C24:1) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75098-4.json |
| 75099-2 | Laurate (C12:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75099-2.json |
| 75100-8 | Fatty acids [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75100-8.json |
| 7510-1 | Mugwort triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7510-1.json |
| 75101-6 | Fatty acids.very long chain C22:0 (Docosanoate) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75101-6.json |
| 75102-4 | Oleate (C18:1w9) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75102-4.json |
| 75103-2 | Myristate (C14:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75103-2.json |
| 75104-0 | Fatty acids.very long chain C24:0 (Tetracosanoate) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75104-0.json |
| 75105-7 | Fatty acids.very long chain C26:1 (Hexacosenoate) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75105-7.json |
| 75106-5 | Mead acid (C20:3w9) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75106-5.json |
| 75107-3 | Pentadecanoate [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75107-3.json |
| 75108-1 | Arachidate (C20:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75108-1.json |
| 75109-9 | Fatty acids.very long chain.C22:1n9 (Erucate) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75109-9.json |
| 75110-7 | Arachidonate (C20:4w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75110-7.json |
| 75111-5 | Palmitoleate (C16:1w7) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75111-5.json |
| 75112-3 | Docosatetraenoate (C22:4w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75112-3.json |
| 75113-1 | Alpha linolenate (C18:3w3) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75113-1.json |
| 75115-6 | Palmitate (C16:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75115-6.json |
| 75116-4 | Decanoate (C10:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75116-4.json |
| 75117-2 | Linoleate (C18:2w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75117-2.json |
| 75118-0 | Octadecanoate (C18:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75118-0.json |
| 7511-9 | California Mugwort IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7511-9.json |
| 75119-8 | Gamma Linolenate (C18:3w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75119-8.json |
| 75120-6 | Octanoate (C8:0) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/75120-6.json |
| 75121-4 | Thymine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75121-4.json |
| 75122-2 | Deoxyadenosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75122-2.json |
| 75123-0 | Hypoxanthine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75123-0.json |
| 75124-8 | Deoxyadenosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75124-8.json |
| 75125-5 | Orotidine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75125-5.json |
| 75126-3 | Orotate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75126-3.json |
| 75127-1 | Deoxyinosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75127-1.json |
| 75128-9 | Uracil [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75128-9.json |
| 75129-7 | Xanthine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75129-7.json |
| 75130-5 | Uridine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75130-5.json |
| 75131-3 | Adenine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75131-3.json |
| 75132-1 | Oxipurinol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75132-1.json |
| 75133-9 | Adenine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75133-9.json |
| 75134-7 | Deoxyguanosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75134-7.json |
| 7513-5 | White mulberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7513-5.json |
| 75135-4 | Hypoxanthine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75135-4.json |
| 75136-2 | Adenosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75136-2.json |
| 75137-0 | Acadesine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75137-0.json |
| 75138-8 | Succinylaminoimidazole carboxamide riboside/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75138-8.json |
| 75139-6 | Urate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75139-6.json |
| 75140-4 | Allantoine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75140-4.json |
| 75141-2 | Acadesine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75141-2.json |
| 75142-0 | Adenosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75142-0.json |
| 7514-3 | Red mulberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7514-3.json |
| 75143-8 | Deoxyuridine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75143-8.json |
| 75144-6 | Xanthine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75144-6.json |
| 75145-3 | Succinyladenosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75145-3.json |
| 75146-1 | Succinylaminoimidazole carboxamide riboside [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75146-1.json |
| 75147-9 | Succinylaminoimidazole carboxamide riboside [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75147-9.json |
| 75148-7 | Orotidine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75148-7.json |
| 75149-5 | Deoxyguanosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75149-5.json |
| 7515-0 | Mushroom IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7515-0.json |
| 75150-3 | Inosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75150-3.json |
| 75151-1 | Acadesine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75151-1.json |
| 75152-9 | Uracil [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75152-9.json |
| 75153-7 | Thymine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75153-7.json |
| 75154-5 | Inosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75154-5.json |
| 75155-2 | Allantoine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75155-2.json |
| 75156-0 | Thymidine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75156-0.json |
| 75157-8 | Deoxyinosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75157-8.json |
| 75158-6 | Allantoine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75158-6.json |
| 75159-4 | Uridine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75159-4.json |
| 75160-2 | Adenosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/75160-2.json |
| 75161-0 | Bilevel positive airway pressure (BPAP) activity Ventilator | ./2.16.840.1.114222.4.11.1002/75161-0.json |
| 75162-8 | Biphasic positive airway pressure (BIPAP) activity Ventilator | ./2.16.840.1.114222.4.11.1002/75162-8.json |
| 7516-8 | Mushroom triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7516-8.json |
| 7517-6 | Oyster Mushroom IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7517-6.json |
| 7519-2 | Blue mussel IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7519-2.json |
| 7520-0 | Blue mussel triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7520-0.json |
| 75211-3 | Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/75211-3.json |
| 75212-1 | Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75212-1.json |
| 75213-9 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75213-9.json |
| 75214-7 | Arginine/Ornithine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75214-7.json |
| 75215-4 | Ornithine/Citrulline [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75215-4.json |
| 75216-2 | Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75216-2.json |
| 75217-0 | Biotinidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/75217-0.json |
| 7521-8 | Mustard IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7521-8.json |
| 75218-8 | Case report | ./2.16.840.1.114222.4.11.1002/75218-8.json |
| 75219-6 | Summary registry report | ./2.16.840.1.114222.4.11.1002/75219-6.json |
| 75220-4 | Urology Progress note | ./2.16.840.1.114222.4.11.1002/75220-4.json |
| 75221-2 | Neurology Progress note | ./2.16.840.1.114222.4.11.1002/75221-2.json |
| 75222-0 | Microscopic observation [Identifier] in Throat by Alberts stain | ./2.16.840.1.114222.4.11.1002/75222-0.json |
| 75223-8 | Dengue virus IgG and IgM [Identifier] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75223-8.json |
| 75224-6 | Chediak-Higashi cells [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/75224-6.json |
| 75225-3 | Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75225-3.json |
| 7522-6 | Mycogone sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7522-6.json |
| 75226-1 | 8-Hydroxyamoxapine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75226-1.json |
| 75227-9 | Baclofen [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/75227-9.json |
| 75228-7 | Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75228-7.json |
| 75229-5 | DULoxetine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75229-5.json |
| 75230-3 | M-chlorophenylpiperazine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75230-3.json |
| 75231-1 | Nefazodone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75231-1.json |
| 75232-9 | Norcitalopram [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75232-9.json |
| 75233-7 | Norsertraline [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75233-7.json |
| 7523-4 | Nectarine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7523-4.json |
| 75234-5 | O-desmethylvenlafaxine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75234-5.json |
| 75235-2 | Vilazodone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/75235-2.json |
| 75236-0 | Crystals [#/area] in Body fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/75236-0.json |
| 75237-8 | Erythrocytes [#/area] in Synovial fluid by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/75237-8.json |
| 75238-6 | Interventional radiology procedure note | ./2.16.840.1.114222.4.11.1002/75238-6.json |
| 75239-4 | Albumin.ischemia modified [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/75239-4.json |
| 75240-2 | Meat fibers [#/area] in Stool by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/75240-2.json |
| 75241-0 | Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/75241-0.json |
| 7524-2 | Nectarine IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7524-2.json |
| 75242-8 | Antipsychotics [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75242-8.json |
| 75249-3 | Norton scale total score | ./2.16.840.1.114222.4.11.1002/75249-3.json |
| 7525-9 | Nigrospora oryzae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7525-9.json |
| 75263-4 | Blood group antibody screen [Presence] in Serum or Plasma by GEL | ./2.16.840.1.114222.4.11.1002/75263-4.json |
| 75264-2 | Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS) | ./2.16.840.1.114222.4.11.1002/75264-2.json |
| 75265-9 | Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method | ./2.16.840.1.114222.4.11.1002/75265-9.json |
| 75266-7 | Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75266-7.json |
| 7526-7 | Nigrospora sphaerica IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7526-7.json |
| 75267-5 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75267-5.json |
| 75268-3 | Leucine/Phenylalanine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/75268-3.json |
| 75270-9 | Promethazine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75270-9.json |
| 75271-7 | Other cells/100 cells in Lymph node by Manual count | ./2.16.840.1.114222.4.11.1002/75271-7.json |
| 7527-5 | Nutmeg IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7527-5.json |
| 7528-3 | Black Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7528-3.json |
| 75288-1 | Carbohydrate need [Mass/time] 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75288-1.json |
| 75289-9 | Fat need [Mass/time] 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75289-9.json |
| 75290-7 | Protein need [Mass/time] 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75290-7.json |
| 7529-1 | California Black Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7529-1.json |
| 75291-5 | Fluid need 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75291-5.json |
| 75292-3 | Body weight - Reported --usual | ./2.16.840.1.114222.4.11.1002/75292-3.json |
| 75293-1 | Physical findings of nutrition assessment | ./2.16.840.1.114222.4.11.1002/75293-1.json |
| 75294-9 | Adequacy of breastmilk andor formula | ./2.16.840.1.114222.4.11.1002/75294-9.json |
| 75296-4 | Carbohydrate intake 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75296-4.json |
| 75297-2 | Fat intake 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75297-2.json |
| 75298-0 | Calorie intake 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75298-0.json |
| 75299-8 | Protein intake 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75299-8.json |
| 75301-2 | Fluid intake 24 hour Estimated | ./2.16.840.1.114222.4.11.1002/75301-2.json |
| 75302-0 | Calorie intake 24 hour | ./2.16.840.1.114222.4.11.1002/75302-0.json |
| 75305-3 | Nutrition status | ./2.16.840.1.114222.4.11.1002/75305-3.json |
| 75306-1 | Nutrition status etiology Narrative | ./2.16.840.1.114222.4.11.1002/75306-1.json |
| 75307-9 | Nutrition status signs and symptoms Narrative | ./2.16.840.1.114222.4.11.1002/75307-9.json |
| 75308-7 | Fetal blood [Volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/75308-7.json |
| 7530-9 | Gamble Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7530-9.json |
| 75310-3 | Health concerns Document | ./2.16.840.1.114222.4.11.1002/75310-3.json |
| 7531-7 | Jerusalem oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7531-7.json |
| 7532-5 | California Live Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7532-5.json |
| 7533-3 | Interior Live Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7533-3.json |
| 7534-1 | Red Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7534-1.json |
| 75346-7 | Promethazine [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75346-7.json |
| 75347-5 | Tapentadol [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/75347-5.json |
| 75357-4 | Bacteria identified in Abscess by Anaerobe+Aerobe culture | ./2.16.840.1.114222.4.11.1002/75357-4.json |
| 7535-8 | Valley Oak IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7535-8.json |
| 75358-2 | Bacteria identified in Bone by Anaerobe+Aerobe culture | ./2.16.840.1.114222.4.11.1002/75358-2.json |
| 75362-4 | Tapentadol glucuronide [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75362-4.json |
| 75363-2 | Creatinine [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/75363-2.json |
| 75364-0 | Urea [Moles/volume] in Vitreous fluid | ./2.16.840.1.114222.4.11.1002/75364-0.json |
| 7536-6 | White Oak IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7536-6.json |
| 75366-5 | Lactate [Moles/volume] in Capillary blood from Fetus by Test strip | ./2.16.840.1.114222.4.11.1002/75366-5.json |
| 75367-3 | Buprenorphine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75367-3.json |
| 75368-1 | Buprenorphine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/75368-1.json |
| 75370-7 | Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/75370-7.json |
| 75371-5 | Bartlett score of Sputum Qualitative by Light microscopy | ./2.16.840.1.114222.4.11.1002/75371-5.json |
| 75372-3 | Hexane [Mass/volume] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/75372-3.json |
| 75373-1 | Erythrocytes.fetal/2000 erythrocytes in Blood by Kleihauer-Betke method | ./2.16.840.1.114222.4.11.1002/75373-1.json |
| 7537-4 | White Oak triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7537-4.json |
| 75376-4 | Siderocytes per HPF [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/75376-4.json |
| 75377-2 | Dengue virus NS1 Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75377-2.json |
| 75379-8 | Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75379-8.json |
| 75380-6 | SERPING1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75380-6.json |
| 75381-4 | TTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75381-4.json |
| 7538-2 | Oat IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7538-2.json |
| 75382-2 | ATP7B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75382-2.json |
| 75383-0 | DMD gene deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by MLPA | ./2.16.840.1.114222.4.11.1002/75383-0.json |
| 75384-8 | PMP22 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/75384-8.json |
| 75385-5 | DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/75385-5.json |
| 75386-3 | MEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75386-3.json |
| 75387-1 | INS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75387-1.json |
| 75388-9 | CDKN1B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75388-9.json |
| 75389-7 | CDKN1B gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75389-7.json |
| 7539-0 | Oat triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7539-0.json |
| 75390-5 | APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75390-5.json |
| 75391-3 | FGFR3 gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75391-3.json |
| 75392-1 | FXN gene GAA repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75392-1.json |
| 75393-9 | HTT gene CAG repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75393-9.json |
| 75394-7 | Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/75394-7.json |
| 75395-4 | AIP gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75395-4.json |
| 75396-2 | AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75396-2.json |
| 75397-0 | HNF1A gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75397-0.json |
| 75398-8 | HNF1B gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75398-8.json |
| 75399-6 | HNF4A gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75399-6.json |
| 75400-2 | KCNJ11 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75400-2.json |
| 75401-0 | GCDH gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75401-0.json |
| 75402-8 | GCDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75402-8.json |
| 75403-6 | PDHA1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/75403-6.json |
| 75404-4 | West Nile virus Ab [Presence] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/75404-4.json |
| 75408-5 | Hepatitis B virus e Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75408-5.json |
| 75409-3 | Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75409-3.json |
| 75410-1 | Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75410-1.json |
| 75411-9 | Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75411-9.json |
| 75422-6 | Addiction psychiatry Group counseling note | ./2.16.840.1.114222.4.11.1002/75422-6.json |
| 75423-4 | Addiction psychiatry Note | ./2.16.840.1.114222.4.11.1002/75423-4.json |
| 7542-4 | Wild Oats IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7542-4.json |
| 75424-2 | Audiology Consult note | ./2.16.840.1.114222.4.11.1002/75424-2.json |
| 75425-9 | Cardiology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/75425-9.json |
| 75426-7 | Cardiology procedure note | ./2.16.840.1.114222.4.11.1002/75426-7.json |
| 75427-5 | Mental health Case manager Note | ./2.16.840.1.114222.4.11.1002/75427-5.json |
| 75429-1 | Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/75429-1.json |
| 75430-9 | Obesity medicine Note | ./2.16.840.1.114222.4.11.1002/75430-9.json |
| 75431-7 | Fall risk assessment note | ./2.16.840.1.114222.4.11.1002/75431-7.json |
| 7543-2 | Oidiodendrum spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7543-2.json |
| 75432-5 | Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/75432-5.json |
| 75433-3 | Interdisciplinary Education note | ./2.16.840.1.114222.4.11.1002/75433-3.json |
| 75434-1 | Internal medicine Hospital Note | ./2.16.840.1.114222.4.11.1002/75434-1.json |
| 75435-8 | Internal medicine Note | ./2.16.840.1.114222.4.11.1002/75435-8.json |
| 75436-6 | Internal medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/75436-6.json |
| 75437-4 | Licensed practical nurse Note | ./2.16.840.1.114222.4.11.1002/75437-4.json |
| 75438-2 | Long term care facility Note | ./2.16.840.1.114222.4.11.1002/75438-2.json |
| 75439-0 | Medical student Note | ./2.16.840.1.114222.4.11.1002/75439-0.json |
| 7544-0 | Okra IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7544-0.json |
| 75440-8 | Mental health Administrative note | ./2.16.840.1.114222.4.11.1002/75440-8.json |
| 75441-6 | Mental health Diagnostic study note | ./2.16.840.1.114222.4.11.1002/75441-6.json |
| 75442-4 | Mental health Medication management note | ./2.16.840.1.114222.4.11.1002/75442-4.json |
| 75443-2 | Mental health Outpatient Note | ./2.16.840.1.114222.4.11.1002/75443-2.json |
| 75444-0 | Mental health Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/75444-0.json |
| 75445-7 | Multi-specialty program Patient's home Note | ./2.16.840.1.114222.4.11.1002/75445-7.json |
| 75446-5 | Nurse Education note | ./2.16.840.1.114222.4.11.1002/75446-5.json |
| 75447-3 | Nurse Fall risk assessment note | ./2.16.840.1.114222.4.11.1002/75447-3.json |
| 75448-1 | Nurse Flowsheet | ./2.16.840.1.114222.4.11.1002/75448-1.json |
| 75449-9 | Nurse Hospital Note | ./2.16.840.1.114222.4.11.1002/75449-9.json |
| 75450-7 | Nurse Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/75450-7.json |
| 75451-5 | Nurse Long term care facility Note | ./2.16.840.1.114222.4.11.1002/75451-5.json |
| 75452-3 | Nurse Medication management note | ./2.16.840.1.114222.4.11.1002/75452-3.json |
| 75453-1 | Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/75453-1.json |
| 75454-9 | Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/75454-9.json |
| 75455-6 | Nurse procedure note | ./2.16.840.1.114222.4.11.1002/75455-6.json |
| 75456-4 | Nurse Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/75456-4.json |
| 75457-2 | Nurse Telephone encounter Triage note | ./2.16.840.1.114222.4.11.1002/75457-2.json |
| 75458-0 | Nurse Triage note | ./2.16.840.1.114222.4.11.1002/75458-0.json |
| 75459-8 | Mental health Nurse Note | ./2.16.840.1.114222.4.11.1002/75459-8.json |
| 75460-6 | Preventive medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/75460-6.json |
| 75461-4 | Primary care Nurse Note | ./2.16.840.1.114222.4.11.1002/75461-4.json |
| 75462-2 | Ophthalmology Outpatient Note | ./2.16.840.1.114222.4.11.1002/75462-2.json |
| 7546-5 | Olive IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7546-5.json |
| 75465-5 | Orthotics prosthetics Consult note | ./2.16.840.1.114222.4.11.1002/75465-5.json |
| 75466-3 | Orthotics prosthetics Note | ./2.16.840.1.114222.4.11.1002/75466-3.json |
| 75467-1 | Pharmacology Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/75467-1.json |
| 75468-9 | Pharmacology Medication management note | ./2.16.840.1.114222.4.11.1002/75468-9.json |
| 75469-7 | Pharmacology Outpatient Note | ./2.16.840.1.114222.4.11.1002/75469-7.json |
| 75470-5 | Pharmacology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/75470-5.json |
| 75471-3 | Attending Note | ./2.16.840.1.114222.4.11.1002/75471-3.json |
| 75472-1 | Internal medicine Attending Note | ./2.16.840.1.114222.4.11.1002/75472-1.json |
| 75473-9 | Primary care Attending Note | ./2.16.840.1.114222.4.11.1002/75473-9.json |
| 75474-7 | Psychiatry Attending Note | ./2.16.840.1.114222.4.11.1002/75474-7.json |
| 75475-4 | Physician Letter | ./2.16.840.1.114222.4.11.1002/75475-4.json |
| 75476-2 | Physician Note | ./2.16.840.1.114222.4.11.1002/75476-2.json |
| 75477-0 | Resident Note | ./2.16.840.1.114222.4.11.1002/75477-0.json |
| 75478-8 | Internal medicine Resident Note | ./2.16.840.1.114222.4.11.1002/75478-8.json |
| 75479-6 | Primary care Physician Note | ./2.16.840.1.114222.4.11.1002/75479-6.json |
| 75480-4 | Podiatry Outpatient Note | ./2.16.840.1.114222.4.11.1002/75480-4.json |
| 7548-1 | Onion IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7548-1.json |
| 75481-2 | Preventive medicine Education note | ./2.16.840.1.114222.4.11.1002/75481-2.json |
| 75482-0 | Preventive medicine Note | ./2.16.840.1.114222.4.11.1002/75482-0.json |
| 75483-8 | Preventive medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/75483-8.json |
| 75484-6 | Preventive medicine Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/75484-6.json |
| 75485-3 | Primary care Administrative note | ./2.16.840.1.114222.4.11.1002/75485-3.json |
| 75486-1 | Primary care Education note | ./2.16.840.1.114222.4.11.1002/75486-1.json |
| 75487-9 | Primary care Letter | ./2.16.840.1.114222.4.11.1002/75487-9.json |
| 75488-7 | Primary care Medication management note | ./2.16.840.1.114222.4.11.1002/75488-7.json |
| 75489-5 | Primary care Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/75489-5.json |
| 75490-3 | Radiology Note | ./2.16.840.1.114222.4.11.1002/75490-3.json |
| 75491-1 | Registered nurse Note | ./2.16.840.1.114222.4.11.1002/75491-1.json |
| 75492-9 | Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/75492-9.json |
| 75493-7 | Surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/75493-7.json |
| 75494-5 | Team Note | ./2.16.840.1.114222.4.11.1002/75494-5.json |
| 75495-2 | Primary care Team Note | ./2.16.840.1.114222.4.11.1002/75495-2.json |
| 75496-0 | Telehealth Note | ./2.16.840.1.114222.4.11.1002/75496-0.json |
| 75497-8 | Telehealth Progress note | ./2.16.840.1.114222.4.11.1002/75497-8.json |
| 75498-6 | Telehealth Summary note | ./2.16.840.1.114222.4.11.1002/75498-6.json |
| 7549-9 | Onion triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7549-9.json |
| 75499-4 | Telephone encounter Triage note | ./2.16.840.1.114222.4.11.1002/75499-4.json |
| 75500-9 | Triage note | ./2.16.840.1.114222.4.11.1002/75500-9.json |
| 75501-7 | Urology Outpatient Note | ./2.16.840.1.114222.4.11.1002/75501-7.json |
| 75502-5 | Vocational rehabilitation Note | ./2.16.840.1.114222.4.11.1002/75502-5.json |
| 75503-3 | Patient's home Note | ./2.16.840.1.114222.4.11.1002/75503-3.json |
| 75504-1 | Urgent care center Note | ./2.16.840.1.114222.4.11.1002/75504-1.json |
| 75506-6 | aPTT.lupus sensitive W excess phospholipid (LA confirm) | ./2.16.840.1.114222.4.11.1002/75506-6.json |
| 7550-7 | Orange triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7550-7.json |
| 75507-4 | aPTT.lupus sensitive W excess phospholipid percent correction | ./2.16.840.1.114222.4.11.1002/75507-4.json |
| 75508-2 | aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm) | ./2.16.840.1.114222.4.11.1002/75508-2.json |
| 75509-0 | aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix) | ./2.16.840.1.114222.4.11.1002/75509-0.json |
| 75510-8 | aPTT.lupus sensitive with 1:1 PNP (LA mix) | ./2.16.840.1.114222.4.11.1002/75510-8.json |
| 75511-6 | dRVVT W excess phospholipid percent correction | ./2.16.840.1.114222.4.11.1002/75511-6.json |
| 75512-4 | dRVVT with 1:1 PNP actual/normal (normalized LA mix) | ./2.16.840.1.114222.4.11.1002/75512-4.json |
| 75513-2 | dRVVT with 1:1 PNP (LA mix) | ./2.16.840.1.114222.4.11.1002/75513-2.json |
| 7551-5 | Orange Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7551-5.json |
| 75516-5 | Cortisol Free [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/75516-5.json |
| 75517-3 | Protein.monoclonal band 4 [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/75517-3.json |
| 75518-1 | Bacteria identified in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/75518-1.json |
| 7552-3 | Oregano IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7552-3.json |
| 7553-1 | Oregano IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7553-1.json |
| 75539-7 | Body temperature - Temporal artery | ./2.16.840.1.114222.4.11.1002/75539-7.json |
| 75540-5 | Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75540-5.json |
| 75541-3 | Parvovirus B19 DNA [log units/volume] (viral load) in Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75541-3.json |
| 75542-1 | Hepatitis A virus RNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75542-1.json |
| 75546-2 | Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age | ./2.16.840.1.114222.4.11.1002/75546-2.json |
| 75548-8 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75548-8.json |
| 7554-9 | Oregano triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7554-9.json |
| 75550-4 | Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative | ./2.16.840.1.114222.4.11.1002/75550-4.json |
| 75551-2 | Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75551-2.json |
| 75552-0 | Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75552-0.json |
| 75553-8 | Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75553-8.json |
| 75554-6 | Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age | ./2.16.840.1.114222.4.11.1002/75554-6.json |
| 75555-3 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75555-3.json |
| 7555-6 | Orris root IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7555-6.json |
| 75556-1 | Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative | ./2.16.840.1.114222.4.11.1002/75556-1.json |
| 75557-9 | Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75557-9.json |
| 75558-7 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75558-7.json |
| 75559-5 | Comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75559-5.json |
| 75560-3 | Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age | ./2.16.840.1.114222.4.11.1002/75560-3.json |
| 75561-1 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75561-1.json |
| 75562-9 | Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative | ./2.16.840.1.114222.4.11.1002/75562-9.json |
| 75563-7 | Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75563-7.json |
| 7556-4 | Ovalbumin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7556-4.json |
| 75564-5 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75564-5.json |
| 75565-2 | Comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75565-2.json |
| 75566-0 | Fetal Monosomy X prior risk [Likelihood] Based on maternal age | ./2.16.840.1.114222.4.11.1002/75566-0.json |
| 75567-8 | Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75567-8.json |
| 75568-6 | Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative | ./2.16.840.1.114222.4.11.1002/75568-6.json |
| 75569-4 | Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75569-4.json |
| 75570-2 | Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75570-2.json |
| 75571-0 | Comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75571-0.json |
| 7557-2 | Ovomucoid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7557-2.json |
| 75572-8 | Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75572-8.json |
| 75573-6 | Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75573-6.json |
| 75574-4 | Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk | ./2.16.840.1.114222.4.11.1002/75574-4.json |
| 75575-1 | Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative | ./2.16.840.1.114222.4.11.1002/75575-1.json |
| 75576-9 | Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75576-9.json |
| 75577-7 | Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75577-7.json |
| 75578-5 | Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75578-5.json |
| 75579-3 | Comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75579-3.json |
| 7558-0 | Oyster IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7558-0.json |
| 75580-1 | Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk | ./2.16.840.1.114222.4.11.1002/75580-1.json |
| 75581-9 | Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative | ./2.16.840.1.114222.4.11.1002/75581-9.json |
| 75582-7 | Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75582-7.json |
| 75583-5 | Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75583-5.json |
| 75584-3 | Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75584-3.json |
| 75585-0 | Comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75585-0.json |
| 75586-8 | Fetal Angelman syndrome prior risk [Likelihood] based on general population risk | ./2.16.840.1.114222.4.11.1002/75586-8.json |
| 75587-6 | Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative | ./2.16.840.1.114222.4.11.1002/75587-6.json |
| 75588-4 | Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75588-4.json |
| 75589-2 | Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75589-2.json |
| 75590-0 | Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75590-0.json |
| 75591-8 | Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75591-8.json |
| 75592-6 | Fetal 5p deletion prior risk [Likelihood] based on general population risk | ./2.16.840.1.114222.4.11.1002/75592-6.json |
| 75593-4 | Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative | ./2.16.840.1.114222.4.11.1002/75593-4.json |
| 75594-2 | Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75594-2.json |
| 75595-9 | Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75595-9.json |
| 75596-7 | Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75596-7.json |
| 75597-5 | Comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75597-5.json |
| 7559-8 | Oyster IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7559-8.json |
| 75598-3 | Fetal 1p36 deletion prior risk [Likelihood] based on general population risk | ./2.16.840.1.114222.4.11.1002/75598-3.json |
| 75599-1 | Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative | ./2.16.840.1.114222.4.11.1002/75599-1.json |
| 75600-7 | Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75600-7.json |
| 75601-5 | Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75601-5.json |
| 75602-3 | Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative | ./2.16.840.1.114222.4.11.1002/75602-3.json |
| 75603-1 | Comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75603-1.json |
| 75604-9 | Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA | ./2.16.840.1.114222.4.11.1002/75604-9.json |
| 75605-6 | Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75605-6.json |
| 7560-6 | Oyster triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7560-6.json |
| 75606-4 | Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative | ./2.16.840.1.114222.4.11.1002/75606-4.json |
| 75609-8 | Birth defects Outpatient Registry report | ./2.16.840.1.114222.4.11.1002/75609-8.json |
| 7562-2 | Paper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7562-2.json |
| 75627-0 | Vascular adhesion protein 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75627-0.json |
| 75628-8 | Vascular endothelial growth factor A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75628-8.json |
| 75629-6 | Tumor necrosis factor receptor superfamily member 1A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75629-6.json |
| 7563-0 | Paprika IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7563-0.json |
| 75630-4 | Interstitial collagenase [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75630-4.json |
| 75631-2 | Stromelysin-1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75631-2.json |
| 75632-0 | Resistin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75632-0.json |
| 75637-9 | Glucose [Moles/volume] in Serum or Plasma --45 minutes post 50 g lactose PO | ./2.16.840.1.114222.4.11.1002/75637-9.json |
| 75638-7 | Homocarnosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/75638-7.json |
| 75639-5 | Lactate dehydrogenase in body fluid/Lactate dehydrogenase in serum | ./2.16.840.1.114222.4.11.1002/75639-5.json |
| 75640-3 | Lysozyme [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/75640-3.json |
| 75642-9 | Urate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/75642-9.json |
| 75643-7 | 7-Hydroxymitragynine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75643-7.json |
| 75644-5 | Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75644-5.json |
| 75645-2 | Butabarbital [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75645-2.json |
| 75646-0 | Ethylene glycol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/75646-0.json |
| 75647-8 | Meperidine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/75647-8.json |
| 7564-8 | Parakeet droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7564-8.json |
| 75648-6 | Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood | ./2.16.840.1.114222.4.11.1002/75648-6.json |
| 75649-4 | Mitragynine+7-Hydroxymitragynine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/75649-4.json |
| 75650-2 | Sulfonamide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75650-2.json |
| 75651-0 | Tetrahydrocannabivarin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/75651-0.json |
| 7565-5 | Parakeet feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7565-5.json |
| 75656-9 | Mononuclear cells [#] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75656-9.json |
| 75657-7 | Mononuclear cells [#] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75657-7.json |
| 75658-5 | Plasma cells/100 leukocytes in Bronchial specimen | ./2.16.840.1.114222.4.11.1002/75658-5.json |
| 75659-3 | Polymorphonuclear cells [#] in Pericardial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75659-3.json |
| 75660-1 | Polymorphonuclear cells [#] in Peritoneal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75660-1.json |
| 75661-9 | Polymorphonuclear cells [#] in Pleural fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75661-9.json |
| 75662-7 | Polymorphonuclear cells [#] in Synovial fluid by Manual count | ./2.16.840.1.114222.4.11.1002/75662-7.json |
| 7566-3 | Parakeet serum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7566-3.json |
| 75664-3 | Human papilloma virus 16 DNA [Presence] in Anorectal specimen by Probe and signal amplification method | ./2.16.840.1.114222.4.11.1002/75664-3.json |
| 75666-8 | HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/75666-8.json |
| 75669-2 | RF Guidance for biopsy of Bone marrow | ./2.16.840.1.114222.4.11.1002/75669-2.json |
| 75670-0 | RF Lumbar spine epidural space Views W contrast epidural | ./2.16.840.1.114222.4.11.1002/75670-0.json |
| 7567-1 | Parrot serum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7567-1.json |
| 75671-8 | CTA Circle of Willis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/75671-8.json |
| 75672-6 | US Guidance for placement of nephrostomy tube in Kidney | ./2.16.840.1.114222.4.11.1002/75672-6.json |
| 7568-9 | Parsley IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7568-9.json |
| 75694-0 | Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75694-0.json |
| 75695-7 | Human papilloma virus 18 DNA [Presence] in Anorectal specimen by Probe and signal amplification method | ./2.16.840.1.114222.4.11.1002/75695-7.json |
| 75696-5 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal specimen by Probe and signal amplification method | ./2.16.840.1.114222.4.11.1002/75696-5.json |
| 7569-7 | Parsnip IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7569-7.json |
| 75698-1 | Total score [COOP.WONCA] | ./2.16.840.1.114222.4.11.1002/75698-1.json |
| 7570-5 | Pea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7570-5.json |
| 75708-8 | Bruton tyrosine kinase [Interpretation] in B cells+monocytes by Flow cytometry (FC) Narrative | ./2.16.840.1.114222.4.11.1002/75708-8.json |
| 75709-6 | Calcitonin [Mass/volume] in Lymph node fine needle aspirate | ./2.16.840.1.114222.4.11.1002/75709-6.json |
| 75710-4 | Coccidioides immitis+posadasii IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/75710-4.json |
| 7571-3 | Black-eye pea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7571-3.json |
| 75713-8 | CYP1A2 gene c.125C>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75713-8.json |
| 75714-6 | CYP1A2 gene c.-2467delT [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75714-6.json |
| 75715-3 | CYP1A2 gene c.2473G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75715-3.json |
| 75716-1 | CYP1A2 gene c.2499A>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75716-1.json |
| 75718-7 | CYP1A2 gene c.3533G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75718-7.json |
| 75719-5 | CYP1A2 gene c.-3860G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75719-5.json |
| 75720-3 | CYP1A2 gene c.5090C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75720-3.json |
| 7572-1 | Black-eye pea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7572-1.json |
| 75721-1 | CYP1A2 gene c.5166G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75721-1.json |
| 75722-9 | CYP1A2 gene c.-163C>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75722-9.json |
| 75723-7 | CYP1A2 gene c.2385G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75723-7.json |
| 75724-5 | CYP1A2 gene c.558C>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75724-5.json |
| 75725-2 | CYP1A2 gene c.-729C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75725-2.json |
| 75726-0 | HTR2A gene c.-1438G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75726-0.json |
| 75727-8 | HTR2A gene c.IVS2+54538A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75727-8.json |
| 75728-6 | HTR2A gene c.74C>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75728-6.json |
| 75729-4 | HTR2A gene c.1354C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75729-4.json |
| 75730-2 | HTR2C gene c.796G>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75730-2.json |
| 75731-0 | HTR2A gene c.102T>C [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75731-0.json |
| 75732-8 | HTR2C gene c.-759C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75732-8.json |
| 75733-6 | AXIN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75733-6.json |
| 75734-4 | AXIN2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75734-4.json |
| 75735-1 | BMPR1A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75735-1.json |
| 75736-9 | Lysophosphatidylcholine(16:0) [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/75736-9.json |
| 75737-7 | Lysophosphatidylcholine(18:0) [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/75737-7.json |
| 75738-5 | Campesterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75738-5.json |
| 7573-9 | Chick Pea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7573-9.json |
| 75739-3 | Desmosterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75739-3.json |
| 75740-1 | Lathosterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75740-1.json |
| 75741-9 | Beta sitosterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/75741-9.json |
| 75746-8 | CT Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral | ./2.16.840.1.114222.4.11.1002/75746-8.json |
| 7574-7 | Pea triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7574-7.json |
| 75747-6 | RF Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral | ./2.16.840.1.114222.4.11.1002/75747-6.json |
| 75748-4 | CT Guidance for fluid aspiration of Cervical spine Intervertebral disc | ./2.16.840.1.114222.4.11.1002/75748-4.json |
| 75749-2 | RF Guidance for fluid aspiration of Intervertebral disc | ./2.16.840.1.114222.4.11.1002/75749-2.json |
| 75750-0 | RF Guidance for biopsy of Intervertebral disc | ./2.16.840.1.114222.4.11.1002/75750-0.json |
| 75751-8 | RF Guidance for drainage of abscess and placement of chest tube of Pleural space - left | ./2.16.840.1.114222.4.11.1002/75751-8.json |
| 75752-6 | CT Guidance for drainage of abscess and placement of chest tube of Pleural space - left | ./2.16.840.1.114222.4.11.1002/75752-6.json |
| 75753-4 | Vancomycin resistance vanD gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/75753-4.json |
| 7575-4 | Peach IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7575-4.json |
| 75754-2 | Streptobacillus moniliformis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75754-2.json |
| 75755-9 | Methicillin susceptible Staphylococcus aureus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/75755-9.json |
| 75756-7 | Bacteria identified in Isolate by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/75756-7.json |
| 75757-5 | Chlamydia sp Ab [Presence] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/75757-5.json |
| 75758-3 | Brompheniramine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75758-3.json |
| 75759-1 | Chlorpheniramine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75759-1.json |
| 75760-9 | Haloperidol [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75760-9.json |
| 75761-7 | Doxylamine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75761-7.json |
| 7576-2 | Peach triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7576-2.json |
| 75762-5 | Methapyrilene [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75762-5.json |
| 75763-3 | Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75763-3.json |
| 75764-1 | Tripelennamine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75764-1.json |
| 75765-8 | Triprolidine [Presence] in Serum or Plasma or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75765-8.json |
| 75766-6 | fluPHENAZine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75766-6.json |
| 75767-4 | Mesoridazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75767-4.json |
| 75768-2 | Prochlorperazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75768-2.json |
| 75769-0 | Promazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75769-0.json |
| 7577-0 | Peanut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7577-0.json |
| 75770-8 | Thioridazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75770-8.json |
| 75771-6 | Trifluoperazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75771-6.json |
| 75787-2 | Advance directive - request for intubation | ./2.16.840.1.114222.4.11.1002/75787-2.json |
| 7578-8 | Pear IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7578-8.json |
| 75788-0 | Advance directive - request for tube feeding | ./2.16.840.1.114222.4.11.1002/75788-0.json |
| 75789-8 | Advance directive - request for life support | ./2.16.840.1.114222.4.11.1002/75789-8.json |
| 75790-6 | Advance directive - request for IV fluid and support | ./2.16.840.1.114222.4.11.1002/75790-6.json |
| 75791-4 | Advance directive - request for antibiotics | ./2.16.840.1.114222.4.11.1002/75791-4.json |
| 75792-2 | Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation | ./2.16.840.1.114222.4.11.1002/75792-2.json |
| 7579-6 | Pear Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7579-6.json |
| 7580-4 | Pecan or Hickory Nut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7580-4.json |
| 75810-2 | Total score [COOP] | ./2.16.840.1.114222.4.11.1002/75810-2.json |
| 75813-6 | Promethazine [Presence] in Blood or Urine by Screen method | ./2.16.840.1.114222.4.11.1002/75813-6.json |
| 75816-9 | RF Spine.thoracic epidural space Views W contrast epidural | ./2.16.840.1.114222.4.11.1002/75816-9.json |
| 75817-7 | RF Guidance for drainage of abscess and placement of chest tube of Pleural space - right | ./2.16.840.1.114222.4.11.1002/75817-7.json |
| 75818-5 | CT Guidance for drainage of abscess and placement of chest tube of Pleural space - right | ./2.16.840.1.114222.4.11.1002/75818-5.json |
| 7583-8 | Penicillium sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7583-8.json |
| 7584-6 | Penicillium notatum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7584-6.json |
| 7585-3 | Penicillium notatum triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7585-3.json |
| 75853-2 | RF Vagina Views W contrast VG | ./2.16.840.1.114222.4.11.1002/75853-2.json |
| 75859-9 | Modified rankin scale | ./2.16.840.1.114222.4.11.1002/75859-9.json |
| 7586-1 | Bell Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7586-1.json |
| 75861-5 | HEDIS 2015-2020 Value Set - LDL-C Tests | ./2.16.840.1.114222.4.11.1002/75861-5.json |
| 75862-3 | HEDIS 2015-2020 Value Set - HbA1C Tests | ./2.16.840.1.114222.4.11.1002/75862-3.json |
| 75863-1 | HEDIS 2015-2018 Value Set - Digoxin Level | ./2.16.840.1.114222.4.11.1002/75863-1.json |
| 75864-9 | HEDIS 2015-2018 Value Set - Glucose Tests | ./2.16.840.1.114222.4.11.1002/75864-9.json |
| 75865-6 | HEDIS 2015-2018 Value Set - PSA Test Exclusion | ./2.16.840.1.114222.4.11.1002/75865-6.json |
| 75866-4 | HEDIS 2015-2018 Value Set - PSA Tests | ./2.16.840.1.114222.4.11.1002/75866-4.json |
| 75867-2 | HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL | ./2.16.840.1.114222.4.11.1002/75867-2.json |
| 75870-6 | PROMIS short form - pain interference 8a - version 1.0 | ./2.16.840.1.114222.4.11.1002/75870-6.json |
| 75876-3 | Patient activity scale II [PASII] | ./2.16.840.1.114222.4.11.1002/75876-3.json |
| 75877-1 | Patient activity scale [PAS] | ./2.16.840.1.114222.4.11.1002/75877-1.json |
| 7587-9 | Bell Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7587-9.json |
| 75880-5 | 14-3-3 eta Ag [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/75880-5.json |
| 75883-9 | dRVVT W excess hexagonal phospholipid (STA-StaClot confirm) | ./2.16.840.1.114222.4.11.1002/75883-9.json |
| 75886-2 | HCV antibody screening - Meaningful Use set | ./2.16.840.1.114222.4.11.1002/75886-2.json |
| 7588-7 | Black Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7588-7.json |
| 75887-0 | HCV antibody RIBA tests - Meaningful Use set by Immunoblot | ./2.16.840.1.114222.4.11.1002/75887-0.json |
| 75888-8 | HCV RNA screening tests - Meaningful Use set | ./2.16.840.1.114222.4.11.1002/75888-8.json |
| 75892-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/75892-0.json |
| 7589-5 | Black Pepper triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7589-5.json |
| 7590-3 | Cayenne IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7590-3.json |
| 7591-1 | Chili Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7591-1.json |
| 75913-4 | dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm) | ./2.16.840.1.114222.4.11.1002/75913-4.json |
| 75914-2 | aPTT W hexagonal phospholipid/Normal (StaClot LA confirm) | ./2.16.840.1.114222.4.11.1002/75914-2.json |
| 75915-9 | Air curtain status Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75915-9.json |
| 75916-7 | Bed type Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75916-7.json |
| 75917-5 | Bed state Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75917-5.json |
| 75918-3 | Bispectral index Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75918-3.json |
| 75919-1 | Left ventricular Cardiac index | ./2.16.840.1.114222.4.11.1002/75919-1.json |
| 75920-9 | Transthoracic impedance | ./2.16.840.1.114222.4.11.1002/75920-9.json |
| 75921-7 | Electrical potential Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75921-7.json |
| 75922-5 | Fan speed Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75922-5.json |
| 75923-3 | Fresh gas.air flow Gas delivery system | ./2.16.840.1.114222.4.11.1002/75923-3.json |
| 75924-1 | Fresh gas.nitrous oxide flow Gas delivery system | ./2.16.840.1.114222.4.11.1002/75924-1.json |
| 75925-8 | Fresh gas.oxygen flow Gas delivery system | ./2.16.840.1.114222.4.11.1002/75925-8.json |
| 75926-6 | Heater type Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75926-6.json |
| 75927-4 | Heater power Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75927-4.json |
| 75928-2 | Hemoglobin [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/75928-2.json |
| 7592-9 | Chili Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7592-9.json |
| 75929-0 | Relative humidity Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75929-0.json |
| 75930-8 | Relative humidity setting Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75930-8.json |
| 75931-6 | Inspiration/Expiration time Ratio | ./2.16.840.1.114222.4.11.1002/75931-6.json |
| 75932-4 | Inspiratory time percent | ./2.16.840.1.114222.4.11.1002/75932-4.json |
| 75933-2 | Left atrial pressure Diastolic | ./2.16.840.1.114222.4.11.1002/75933-2.json |
| 75934-0 | Nitrogen dioxide [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/75934-0.json |
| 75935-7 | Nitrogen dioxide [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/75935-7.json |
| 75936-5 | Nitrogen dioxide [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/75936-5.json |
| 7593-7 | Chili Pepper triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7593-7.json |
| 75937-3 | Nitrogen dioxide [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/75937-3.json |
| 75938-1 | Oxygen/Gas total Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75938-1.json |
| 75939-9 | Oxygen/Total gas setting Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75939-9.json |
| 75940-7 | Potassium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/75940-7.json |
| 75941-5 | Total power of power spectrum on EEG | ./2.16.840.1.114222.4.11.1002/75941-5.json |
| 75942-3 | Airway pressure --during inspiration | ./2.16.840.1.114222.4.11.1002/75942-3.json |
| 75943-1 | Airway pressure --during respiratory pause | ./2.16.840.1.114222.4.11.1002/75943-1.json |
| 75944-9 | Left eye Pupil reaction [Time] | ./2.16.840.1.114222.4.11.1002/75944-9.json |
| 7594-5 | Green Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7594-5.json |
| 75945-6 | Right eye Pupil reaction [Time] | ./2.16.840.1.114222.4.11.1002/75945-6.json |
| 75946-4 | Airway resistance | ./2.16.840.1.114222.4.11.1002/75946-4.json |
| 75947-2 | Airway resistance --during expiration | ./2.16.840.1.114222.4.11.1002/75947-2.json |
| 75948-0 | Airway resistance --during inspiration | ./2.16.840.1.114222.4.11.1002/75948-0.json |
| 75949-8 | Response entropy [Score] Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75949-8.json |
| 75950-6 | Signal quality index EEG device Calculated | ./2.16.840.1.114222.4.11.1002/75950-6.json |
| 75951-4 | Skin temperature setting Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75951-4.json |
| 7595-2 | Red Pepper triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7595-2.json |
| 75952-2 | SNAP index Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75952-2.json |
| 75953-0 | Spike count Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75953-0.json |
| 75954-8 | State entropy [Score] Cerebral cortex Electroencephalogram (EEG) | ./2.16.840.1.114222.4.11.1002/75954-8.json |
| 75955-5 | Temperature Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75955-5.json |
| 75956-3 | Temperature sensor [Resistance] Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75956-3.json |
| 75957-1 | Temperature setting Infant microenvironment.incubator | ./2.16.840.1.114222.4.11.1002/75957-1.json |
| 75958-9 | Tidal volume expired Respiratory system airway | ./2.16.840.1.114222.4.11.1002/75958-9.json |
| 75959-7 | Volume expired per minute Respiratory system | ./2.16.840.1.114222.4.11.1002/75959-7.json |
| 7596-0 | White Pepper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7596-0.json |
| 75960-5 | Inspired minute Volume | ./2.16.840.1.114222.4.11.1002/75960-5.json |
| 75961-3 | Temperature control mode Infant microenvironment | ./2.16.840.1.114222.4.11.1002/75961-3.json |
| 75974-6 | KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/75974-6.json |
| 75975-3 | Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75975-3.json |
| 7597-8 | White Pepper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7597-8.json |
| 75980-3 | Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75980-3.json |
| 75982-9 | Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75982-9.json |
| 75983-7 | Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA | ./2.16.840.1.114222.4.11.1002/75983-7.json |
| 75984-5 | Air delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/75984-5.json |
| 75985-2 | Air delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/75985-2.json |
| 7598-6 | Perch IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7598-6.json |
| 75986-0 | Velocity index Aorta Non-invasive impedance cardiography (NI-ICG) | ./2.16.840.1.114222.4.11.1002/75986-0.json |
| 75987-8 | Venous blood temperature | ./2.16.840.1.114222.4.11.1002/75987-8.json |
| 75988-6 | Left ventricular End diastolic volume | ./2.16.840.1.114222.4.11.1002/75988-6.json |
| 75989-4 | Left ventricular End systolic volume | ./2.16.840.1.114222.4.11.1002/75989-4.json |
| 75990-2 | Energy expended Reporting Period by Indirect calorimetry | ./2.16.840.1.114222.4.11.1002/75990-2.json |
| 75991-0 | Oxygen extraction ratio | ./2.16.840.1.114222.4.11.1002/75991-0.json |
| 75992-8 | Transcutaneous monitor Heater power | ./2.16.840.1.114222.4.11.1002/75992-8.json |
| 75993-6 | Femoral artery Blood pressure | ./2.16.840.1.114222.4.11.1002/75993-6.json |
| 7599-4 | Phadiatop IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7599-4.json |
| 75994-4 | Pulmonary artery wedge pressure | ./2.16.840.1.114222.4.11.1002/75994-4.json |
| 75995-1 | Diastolic blood pressure by Continuous non-invasive monitoring | ./2.16.840.1.114222.4.11.1002/75995-1.json |
| 75996-9 | Mean blood pressure by Continuous non-invasive monitoring | ./2.16.840.1.114222.4.11.1002/75996-9.json |
| 75997-7 | Systolic blood pressure by Continuous non-invasive monitoring | ./2.16.840.1.114222.4.11.1002/75997-7.json |
| 75998-5 | Oxygen gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/75998-5.json |
| 75999-3 | Oxygen gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/75999-3.json |
| 7600-0 | Phospholipase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7600-0.json |
| 76000-9 | Paced heart rate by EKG | ./2.16.840.1.114222.4.11.1002/76000-9.json |
| 76001-7 | Physiological dead space [Volume] Respiratory system | ./2.16.840.1.114222.4.11.1002/76001-7.json |
| 76002-5 | Physiological dead space/Tidal volume Respiratory system | ./2.16.840.1.114222.4.11.1002/76002-5.json |
| 76003-3 | Pressure Respiratory system airway --during inspiration on ventilator | ./2.16.840.1.114222.4.11.1002/76003-3.json |
| 76004-1 | Airway occlusion pressure | ./2.16.840.1.114222.4.11.1002/76004-1.json |
| 76005-8 | Transcutaneous monitor sensor temperature | ./2.16.840.1.114222.4.11.1002/76005-8.json |
| 76006-6 | Temperature difference | ./2.16.840.1.114222.4.11.1002/76006-6.json |
| 76007-4 | Tidal volume expired Respiratory system airway --on ventilator | ./2.16.840.1.114222.4.11.1002/76007-4.json |
| 76008-2 | Expired minute Volume during Mechanical ventilation | ./2.16.840.1.114222.4.11.1002/76008-2.json |
| 76009-0 | Inspired minute Volume during Mechanical ventilation | ./2.16.840.1.114222.4.11.1002/76009-0.json |
| 76010-8 | Nasal temperature | ./2.16.840.1.114222.4.11.1002/76010-8.json |
| 76011-6 | Ear temperature | ./2.16.840.1.114222.4.11.1002/76011-6.json |
| 76012-4 | Desflurane liquid delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76012-4.json |
| 76013-2 | Desflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76013-2.json |
| 76014-0 | Enflurane liquid delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76014-0.json |
| 76015-7 | Enflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76015-7.json |
| 76016-5 | Halothane liquid delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76016-5.json |
| 76017-3 | Halothane liquid delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76017-3.json |
| 7601-8 | Phthalic anhydride IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7601-8.json |
| 76018-1 | Sevoflurane liquid delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76018-1.json |
| 76019-9 | Sevoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76019-9.json |
| 76020-7 | Delta dRVVT [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/76020-7.json |
| 76021-5 | Delta aPTT [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/76021-5.json |
| 76022-3 | 8(9)-Cholestenol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76022-3.json |
| 76023-1 | N-acetyl-L-aspartate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/76023-1.json |
| 76024-9 | Sialate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/76024-9.json |
| 76025-6 | Arylsulfatase C [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/76025-6.json |
| 7602-6 | Pickleweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7602-6.json |
| 76026-4 | Phosphomannomutase 2 [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/76026-4.json |
| 76027-2 | Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/76027-2.json |
| 76028-0 | IDUA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76028-0.json |
| 76029-8 | HEXB gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76029-8.json |
| 76030-6 | IDS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76030-6.json |
| 76031-4 | NPC1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76031-4.json |
| 76032-2 | SGSH gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76032-2.json |
| 76033-0 | HEXA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76033-0.json |
| 7603-4 | Pigeon droppings IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7603-4.json |
| 76034-8 | GAA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76034-8.json |
| 76035-5 | ARSA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76035-5.json |
| 76036-3 | GLA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76036-3.json |
| 76037-1 | GALT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/76037-1.json |
| 76038-9 | Tripeptidyl peptidase I [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/76038-9.json |
| 76039-7 | Interleukin 2 Receptor Soluble [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76039-7.json |
| 7604-2 | Common Pigweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7604-2.json |
| 76047-0 | ST amplitude.lead V1 | ./2.16.840.1.114222.4.11.1002/76047-0.json |
| 76048-8 | ST amplitude.lead V2 | ./2.16.840.1.114222.4.11.1002/76048-8.json |
| 76049-6 | ST amplitude.lead V3 | ./2.16.840.1.114222.4.11.1002/76049-6.json |
| 76050-4 | ST amplitude.lead V4 | ./2.16.840.1.114222.4.11.1002/76050-4.json |
| 76051-2 | ST amplitude.lead V5 | ./2.16.840.1.114222.4.11.1002/76051-2.json |
| 76052-0 | ST amplitude.lead V6 | ./2.16.840.1.114222.4.11.1002/76052-0.json |
| 76053-8 | ST amplitude.lead I | ./2.16.840.1.114222.4.11.1002/76053-8.json |
| 76054-6 | ST amplitude.lead II | ./2.16.840.1.114222.4.11.1002/76054-6.json |
| 76055-3 | ST amplitude.lead III | ./2.16.840.1.114222.4.11.1002/76055-3.json |
| 76056-1 | ST amplitude.lead aVF | ./2.16.840.1.114222.4.11.1002/76056-1.json |
| 76057-9 | ST amplitude.lead aVL | ./2.16.840.1.114222.4.11.1002/76057-9.json |
| 76058-7 | ST amplitude.lead aVR | ./2.16.840.1.114222.4.11.1002/76058-7.json |
| 7605-9 | Pigweed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7605-9.json |
| 76059-5 | Anesthetic agent.XXX Airway adaptor | ./2.16.840.1.114222.4.11.1002/76059-5.json |
| 76063-7 | MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/76063-7.json |
| 76065-2 | 6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/76065-2.json |
| 7606-7 | Pigweed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7606-7.json |
| 76068-6 | MBL2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/76068-6.json |
| 76069-4 | Erythrocytes.hypochromic/100 erythrocytes in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/76069-4.json |
| 76070-2 | Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76070-2.json |
| 76071-0 | Aspergillus sp DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76071-0.json |
| 76072-8 | Enterovirus D68 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76072-8.json |
| 76073-6 | Fungus identified in Nose by Culture | ./2.16.840.1.114222.4.11.1002/76073-6.json |
| 76074-4 | Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76074-4.json |
| 76075-1 | Galactomannan Ag [Units/volume] in Bronchoalveolar lavage | ./2.16.840.1.114222.4.11.1002/76075-1.json |
| 76076-9 | Haemophilus ducreyi DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76076-9.json |
| 76077-7 | Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76077-7.json |
| 76078-5 | Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76078-5.json |
| 76079-3 | Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76079-3.json |
| 76080-1 | Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76080-1.json |
| 76081-9 | Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/76081-9.json |
| 76082-7 | Microscopic observation [Identifier] in Bronchoalveolar lavage by Methenamine silver nitrate stain | ./2.16.840.1.114222.4.11.1002/76082-7.json |
| 7608-3 | Loblolly Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7608-3.json |
| 76083-5 | Microscopic observation [Presence] in Bronchoalveolar lavage by Acid fast stain.Ziehl-Neelsen | ./2.16.840.1.114222.4.11.1002/76083-5.json |
| 76084-3 | Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76084-3.json |
| 76085-0 | Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76085-0.json |
| 76086-8 | Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76086-8.json |
| 76087-6 | Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76087-6.json |
| 76088-4 | Respiratory syncytial virus RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76088-4.json |
| 76089-2 | Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76089-2.json |
| 76090-0 | Erythrocytes.hyperchromic/100 erythrocytes in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/76090-0.json |
| 7609-1 | Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7609-1.json |
| 76092-6 | Maximum gradient during systole [Pressure] Aortic valve | ./2.16.840.1.114222.4.11.1002/76092-6.json |
| 76093-4 | Nitric oxide [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/76093-4.json |
| 76094-2 | Xenon [VFr/PPres] Airway adaptor | ./2.16.840.1.114222.4.11.1002/76094-2.json |
| 76095-9 | Carbon dioxide [VFr/PPres] in Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76095-9.json |
| 76096-7 | Carbon dioxide [VFr/PPres] in Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76096-7.json |
| 76097-5 | Helium [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76097-5.json |
| 76098-3 | Helium [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76098-3.json |
| 76099-1 | Nitric oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76099-1.json |
| 76100-7 | Nitric oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76100-7.json |
| 76101-5 | Nitrogen dioxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76101-5.json |
| 76102-3 | Nitrogen dioxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76102-3.json |
| 76103-1 | Nitrogen [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76103-1.json |
| 76104-9 | Nitrogen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76104-9.json |
| 76105-6 | Oxygen [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76105-6.json |
| 76106-4 | Oxygen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76106-4.json |
| 76107-2 | Sevoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76107-2.json |
| 76108-0 | Xenon [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76108-0.json |
| 7610-9 | Pondorosa Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7610-9.json |
| 76109-8 | Xenon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76109-8.json |
| 76110-6 | Helium [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76110-6.json |
| 76111-4 | Nitric oxide [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76111-4.json |
| 76112-2 | Nitrogen [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76112-2.json |
| 76113-0 | Nitrogen dioxide [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76113-0.json |
| 76114-8 | Xenon [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76114-8.json |
| 76115-5 | Nitric oxide [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/76115-5.json |
| 76116-3 | Xenon [VFr/PPres] Airway adaptor --at end expiration | ./2.16.840.1.114222.4.11.1002/76116-3.json |
| 7611-7 | Western White Pine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7611-7.json |
| 76117-1 | Nitric oxide [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/76117-1.json |
| 76118-9 | Xenon [VFr/PPres] Airway adaptor --during expiration | ./2.16.840.1.114222.4.11.1002/76118-9.json |
| 76119-7 | Helium gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76119-7.json |
| 76120-5 | Nitric oxide [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/76120-5.json |
| 76121-3 | Xenon [VFr/PPres] Airway adaptor --during inspiration | ./2.16.840.1.114222.4.11.1002/76121-3.json |
| 76122-1 | Helium gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76122-1.json |
| 76123-9 | Nitric oxide gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76123-9.json |
| 76124-7 | Xenon gas delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76124-7.json |
| 7612-5 | Pineapple IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7612-5.json |
| 76125-4 | Xenon gas delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76125-4.json |
| 76126-2 | Premature ventricular contractions [#] | ./2.16.840.1.114222.4.11.1002/76126-2.json |
| 76127-0 | Argon [VFr/PPres] Gas delivery system | ./2.16.840.1.114222.4.11.1002/76127-0.json |
| 76128-8 | Argon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration | ./2.16.840.1.114222.4.11.1002/76128-8.json |
| 76129-6 | Argon [VFr/PPres] Gas delivery system.expiratory limb --during expiration | ./2.16.840.1.114222.4.11.1002/76129-6.json |
| 76130-4 | Isoflurane liquid delivered during case [Volume] from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76130-4.json |
| 76131-2 | Isoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system | ./2.16.840.1.114222.4.11.1002/76131-2.json |
| 76132-0 | Sucrose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/76132-0.json |
| 7613-3 | Pistachio IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7613-3.json |
| 76134-6 | Sucrose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/76134-6.json |
| 76135-3 | Inositol Free/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/76135-3.json |
| 76136-1 | Lactulose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO | ./2.16.840.1.114222.4.11.1002/76136-1.json |
| 76137-9 | Platelet component distribution width [Mass/volume] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/76137-9.json |
| 76138-7 | Reticulocyte distribution width [Ratio] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/76138-7.json |
| 76139-5 | Reticulocyte hemoglobin distribution width [Mass/volume] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/76139-5.json |
| 76140-3 | Reticulocytes.hypochromic/100 erythrocytes in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/76140-3.json |
| 7614-1 | Pitosporium triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7614-1.json |
| 76141-1 | Reticulocyte corpuscular hemoglobin concentration mean [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76141-1.json |
| 76142-9 | Immature lymphocytes [Presence] in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/76142-9.json |
| 76148-6 | Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/76148-6.json |
| 76150-2 | Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/76150-2.json |
| 76151-0 | Airway pressure backup setting Ventilator | ./2.16.840.1.114222.4.11.1002/76151-0.json |
| 76152-8 | Airway pressure delta setting Ventilator | ./2.16.840.1.114222.4.11.1002/76152-8.json |
| 7616-6 | English plantain triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7616-6.json |
| 76169-2 | Pressure.baseline Respiratory system airway --on ventilator | ./2.16.840.1.114222.4.11.1002/76169-2.json |
| 76170-0 | Respiratory rate by Acoustic measurement | ./2.16.840.1.114222.4.11.1002/76170-0.json |
| 76171-8 | Respiratory rate by Airway flow measurement | ./2.16.840.1.114222.4.11.1002/76171-8.json |
| 76172-6 | Respiratory rate by Carbon dioxide measurement | ./2.16.840.1.114222.4.11.1002/76172-6.json |
| 76173-4 | Respiratory rate by Non-airway pressure measurement | ./2.16.840.1.114222.4.11.1002/76173-4.json |
| 7617-4 | Plum IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7617-4.json |
| 76174-2 | Respiratory rate by Pulse oximetry.plethysmograph | ./2.16.840.1.114222.4.11.1002/76174-2.json |
| 7618-2 | Plum Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7618-2.json |
| 7619-0 | Poison ivy IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7619-0.json |
| 76222-9 | Tidal volume Ventilator --on ventilator | ./2.16.840.1.114222.4.11.1002/76222-9.json |
| 7622-4 | White Poplar triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7622-4.json |
| 7623-2 | Poppy Seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7623-2.json |
| 7624-0 | Pork triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7624-0.json |
| 76248-4 | PEEP Respiratory system --on ventilator | ./2.16.840.1.114222.4.11.1002/76248-4.json |
| 7625-7 | Potato IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7625-7.json |
| 7626-5 | Potato triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7626-5.json |
| 76265-8 | Carbon dioxide production (VCO2)/Body surface area in Respiratory system | ./2.16.840.1.114222.4.11.1002/76265-8.json |
| 76266-6 | Carbon dioxide production (VCO2)/Ideal body weight in Respiratory system | ./2.16.840.1.114222.4.11.1002/76266-6.json |
| 76268-2 | Pressure.ambient Room | ./2.16.840.1.114222.4.11.1002/76268-2.json |
| 76269-0 | Respiratory quotient Respiratory system | ./2.16.840.1.114222.4.11.1002/76269-0.json |
| 76270-8 | Respiratory rate by Impedance.transthoracic | ./2.16.840.1.114222.4.11.1002/76270-8.json |
| 7627-3 | Sweet potato IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7627-3.json |
| 76274-0 | Ventilation-perfusion index Respiratory system | ./2.16.840.1.114222.4.11.1002/76274-0.json |
| 76278-1 | Bladder temperature via Foley | ./2.16.840.1.114222.4.11.1002/76278-1.json |
| 76280-7 | Intramucosal gastric pH | ./2.16.840.1.114222.4.11.1002/76280-7.json |
| 7628-1 | Sweet potato IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7628-1.json |
| 76281-5 | Type of arrhythmia on EKG | ./2.16.840.1.114222.4.11.1002/76281-5.json |
| 76282-3 | Heart rate.beat-to-beat by EKG | ./2.16.840.1.114222.4.11.1002/76282-3.json |
| 76283-1 | Blood flow rate Pulmonary capillaries | ./2.16.840.1.114222.4.11.1002/76283-1.json |
| 76284-9 | Pulmonary artery Blood pressure | ./2.16.840.1.114222.4.11.1002/76284-9.json |
| 76285-6 | Pulmonary capillary Blood pressure | ./2.16.840.1.114222.4.11.1002/76285-6.json |
| 76286-4 | Pulmonary capillary Diastolic blood pressure | ./2.16.840.1.114222.4.11.1002/76286-4.json |
| 76287-2 | Pulmonary capillary Mean blood pressure | ./2.16.840.1.114222.4.11.1002/76287-2.json |
| 76288-0 | Pulmonary capillary Systolic blood pressure | ./2.16.840.1.114222.4.11.1002/76288-0.json |
| 76295-5 | Inflation phase duration [Time] Ventilator | ./2.16.840.1.114222.4.11.1002/76295-5.json |
| 76296-3 | Ventilator airway circuit leakage volume | ./2.16.840.1.114222.4.11.1002/76296-3.json |
| 76297-1 | Left ventricular Stroke volume index | ./2.16.840.1.114222.4.11.1002/76297-1.json |
| 76298-9 | Gastric pressure | ./2.16.840.1.114222.4.11.1002/76298-9.json |
| 7629-9 | Sweet potato triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7629-9.json |
| 76299-7 | Time interval between start of doses Infusion pump | ./2.16.840.1.114222.4.11.1002/76299-7.json |
| 76305-2 | Infusion dose.programmed [Mass] Infusion pump | ./2.16.840.1.114222.4.11.1002/76305-2.json |
| 76307-8 | Infusion time.programmed Infusion pump | ./2.16.840.1.114222.4.11.1002/76307-8.json |
| 76310-2 | Infusion volume.programmed Procedure Infusion pump | ./2.16.840.1.114222.4.11.1002/76310-2.json |
| 76312-8 | PCA dose number.max 1 hour Infusion pump | ./2.16.840.1.114222.4.11.1002/76312-8.json |
| 76313-6 | PCA dose volume.max Infusion pump | ./2.16.840.1.114222.4.11.1002/76313-6.json |
| 76314-4 | PCA lockout time Infusion pump | ./2.16.840.1.114222.4.11.1002/76314-4.json |
| 7631-5 | Povertyweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7631-5.json |
| 76317-7 | Infusion pump Volume.start | ./2.16.840.1.114222.4.11.1002/76317-7.json |
| 76320-1 | Expiratory airway gas flow | ./2.16.840.1.114222.4.11.1002/76320-1.json |
| 76322-7 | Systolic time ratio | ./2.16.840.1.114222.4.11.1002/76322-7.json |
| 7632-3 | Privet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7632-3.json |
| 76323-5 | Aorta acceleration index | ./2.16.840.1.114222.4.11.1002/76323-5.json |
| 76324-3 | Infusion pump Alert type | ./2.16.840.1.114222.4.11.1002/76324-3.json |
| 7633-1 | Privet IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7633-1.json |
| 76334-2 | Inspiratory time setting Ventilator | ./2.16.840.1.114222.4.11.1002/76334-2.json |
| 76338-3 | Porcine epidemic diarrhea virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76338-3.json |
| 76339-1 | Porcine deltacoronavirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76339-1.json |
| 76340-9 | Porcine deltacoronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76340-9.json |
| 76341-7 | Protoporphyrin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76341-7.json |
| 76346-6 | Microorganism identified in Isolate by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/76346-6.json |
| 76347-4 | Dehydroepiandrosterone sulfate (DHEA-S)/Cortisol [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76347-4.json |
| 76348-2 | Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76348-2.json |
| 7634-9 | Prune IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7634-9.json |
| 76349-0 | clonazePAM [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/76349-0.json |
| 76351-6 | Methotrexate polyglutamates [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/76351-6.json |
| 76352-4 | Testosterone/Cortisol [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76352-4.json |
| 7635-6 | Psyllium seed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7635-6.json |
| 7637-2 | Pullularia sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7637-2.json |
| 7638-0 | Pullularia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7638-0.json |
| 7639-8 | Pyrethrum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7639-8.json |
| 76399-5 | Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/76399-5.json |
| 76401-9 | Albumin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/76401-9.json |
| 7640-6 | Pyrethrum triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7640-6.json |
| 76408-4 | Monocytes+Macrophages [#] in Body fluid by Manual count | ./2.16.840.1.114222.4.11.1002/76408-4.json |
| 76409-2 | Lymphocytes [#] in Body fluid by Manual count | ./2.16.840.1.114222.4.11.1002/76409-2.json |
| 76412-6 | Sheep prion protein codon 141 [Type] in Blood by Genotype method | ./2.16.840.1.114222.4.11.1002/76412-6.json |
| 76413-4 | Sheep prion protein codon 112 [Type] in Blood by Genotype method | ./2.16.840.1.114222.4.11.1002/76413-4.json |
| 7641-4 | Rabbit Bush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7641-4.json |
| 76414-2 | Sheep prion protein codon 136 [Type] in Blood by Genotype method | ./2.16.840.1.114222.4.11.1002/76414-2.json |
| 76415-9 | Sheep prion protein codon 154 [Type] in Blood by Genotype method | ./2.16.840.1.114222.4.11.1002/76415-9.json |
| 76416-7 | Sheep prion protein codon 171 [Type] in Blood by Genotype method | ./2.16.840.1.114222.4.11.1002/76416-7.json |
| 7642-2 | Rabbit meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7642-2.json |
| 7643-0 | Radish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7643-0.json |
| 7644-8 | Radish IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7644-8.json |
| 7645-5 | Canyon Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7645-5.json |
| 7646-3 | Common Ragweed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7646-3.json |
| 76464-7 | American Physical Therapy Association registry panel | ./2.16.840.1.114222.4.11.1002/76464-7.json |
| 76468-8 | Organization NPI | ./2.16.840.1.114222.4.11.1002/76468-8.json |
| 76469-6 | Organization name | ./2.16.840.1.114222.4.11.1002/76469-6.json |
| 76470-4 | Organization federal tax ID | ./2.16.840.1.114222.4.11.1002/76470-4.json |
| 7647-1 | Desert Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7647-1.json |
| 76474-6 | Ghrelin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76474-6.json |
| 76475-3 | Cortisone free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76475-3.json |
| 76476-1 | Heart rate by Transthoracic impedance | ./2.16.840.1.114222.4.11.1002/76476-1.json |
| 76477-9 | Heart rate by Noninvasive | ./2.16.840.1.114222.4.11.1002/76477-9.json |
| 76480-3 | Albumin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/76480-3.json |
| 76481-1 | Alpha 1 antitrypsin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76481-1.json |
| 76482-9 | Apolipoprotein B [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76482-9.json |
| 76483-7 | Apolipoprotein A-I [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76483-7.json |
| 76484-5 | Beta-2-Microglobulin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76484-5.json |
| 76485-2 | C reactive protein [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76485-2.json |
| 76486-0 | C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method | ./2.16.840.1.114222.4.11.1002/76486-0.json |
| 76487-8 | IgA [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76487-8.json |
| 76488-6 | IgE [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/76488-6.json |
| 7648-9 | False ragweed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7648-9.json |
| 76489-4 | IgG [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/76489-4.json |
| 76490-2 | IgG [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/76490-2.json |
| 76491-0 | IgM [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76491-0.json |
| 76492-8 | Amphetamine+Methamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/76492-8.json |
| 76493-6 | Nitrazepam [Moles/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/76493-6.json |
| 76494-4 | Tacrolimus [Moles/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/76494-4.json |
| 76495-1 | Titanium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76495-1.json |
| 76496-9 | Complement C4 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76496-9.json |
| 7649-7 | Giant Ragweed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7649-7.json |
| 76497-7 | Polymorphonuclear cells [#] in Cerebral spinal fluid by Manual count | ./2.16.840.1.114222.4.11.1002/76497-7.json |
| 76498-5 | Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/76498-5.json |
| 76504-0 | Total score [HARK] | ./2.16.840.1.114222.4.11.1002/76504-0.json |
| 76505-7 | Highest pressure ulcer stage NPUAP | ./2.16.840.1.114222.4.11.1002/76505-7.json |
| 76512-3 | Social isolation score [NHANES] | ./2.16.840.1.114222.4.11.1002/76512-3.json |
| 76514-9 | Fetal Narrative Study observation general Diagnostic imaging | ./2.16.840.1.114222.4.11.1002/76514-9.json |
| 76516-4 | Gestational age--at birth | ./2.16.840.1.114222.4.11.1002/76516-4.json |
| 76517-2 | Premature infant | ./2.16.840.1.114222.4.11.1002/76517-2.json |
| 76519-8 | Left ventricular Cardiac output by Continuous | ./2.16.840.1.114222.4.11.1002/76519-8.json |
| 76520-6 | Transmission.infrared Arterial blood Pulse oximetry | ./2.16.840.1.114222.4.11.1002/76520-6.json |
| 7652-1 | Common Ragweed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7652-1.json |
| 76521-4 | Transmission.red Arterial blood Pulse oximetry | ./2.16.840.1.114222.4.11.1002/76521-4.json |
| 76522-2 | Transmission Arterial blood Pulse oximetry | ./2.16.840.1.114222.4.11.1002/76522-2.json |
| 76523-0 | Plethysmogram Arterial blood Pulse oximetry | ./2.16.840.1.114222.4.11.1002/76523-0.json |
| 76524-8 | Acetone [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76524-8.json |
| 76525-5 | Thoracic fluid conductivity [Fluid Conductance] Chest | ./2.16.840.1.114222.4.11.1002/76525-5.json |
| 76526-3 | Ventilation rate by Carbon dioxide measurement | ./2.16.840.1.114222.4.11.1002/76526-3.json |
| 7653-9 | Short+Giant Ragweed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7653-9.json |
| 76543-8 | Weight management summary report | ./2.16.840.1.114222.4.11.1002/76543-8.json |
| 76544-6 | Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna | ./2.16.840.1.114222.4.11.1002/76544-6.json |
| 7654-7 | Slender Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7654-7.json |
| 7655-4 | Southern Ragweed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7655-4.json |
| 7656-2 | Raspberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7656-2.json |
| 7657-0 | Raspberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7657-0.json |
| 7658-8 | Raspberry triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7658-8.json |
| 7659-6 | Rat hair IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7659-6.json |
| 7660-4 | Rat muliialgro IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7660-4.json |
| 7661-2 | Red Snapper IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7661-2.json |
| 76613-9 | Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76613-9.json |
| 76614-7 | Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate | ./2.16.840.1.114222.4.11.1002/76614-7.json |
| 76615-4 | Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate | ./2.16.840.1.114222.4.11.1002/76615-4.json |
| 76616-2 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-pyruvate substrate | ./2.16.840.1.114222.4.11.1002/76616-2.json |
| 76617-0 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2-14C-pyruvate substrate | ./2.16.840.1.114222.4.11.1002/76617-0.json |
| 76618-8 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-glutamate substrate | ./2.16.840.1.114222.4.11.1002/76618-8.json |
| 76619-6 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2,3-14C-succinate substrate | ./2.16.840.1.114222.4.11.1002/76619-6.json |
| 7662-0 | Red Snapper IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7662-0.json |
| 76620-4 | Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-leucine substrate | ./2.16.840.1.114222.4.11.1002/76620-4.json |
| 76626-1 | Measles virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/76626-1.json |
| 76627-9 | Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/76627-9.json |
| 76628-7 | Norovirus genogroup I and II RNA [Identifier] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76628-7.json |
| 76629-5 | Fasting glucose [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76629-5.json |
| 76630-3 | Amylase [Enzymatic activity/volume] in Blood | ./2.16.840.1.114222.4.11.1002/76630-3.json |
| 76631-1 | Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method | ./2.16.840.1.114222.4.11.1002/76631-1.json |
| 76632-9 | Enterovirus sp [Presence] in Isolate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/76632-9.json |
| 76633-7 | Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood | ./2.16.840.1.114222.4.11.1002/76633-7.json |
| 76634-5 | Q-T interval corrected based on Fridericia formula | ./2.16.840.1.114222.4.11.1002/76634-5.json |
| 76635-2 | Q-T interval corrected based on Bazett formula | ./2.16.840.1.114222.4.11.1002/76635-2.json |
| 7663-8 | Redwood Dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7663-8.json |
| 76640-2 | Coronary artery catheterization study | ./2.16.840.1.114222.4.11.1002/76640-2.json |
| 76641-0 | Neurology study | ./2.16.840.1.114222.4.11.1002/76641-0.json |
| 76642-8 | Percutaneous coronary intervention study | ./2.16.840.1.114222.4.11.1002/76642-8.json |
| 76643-6 | R-R interval.standard deviation (Heart rate variability) by EKG | ./2.16.840.1.114222.4.11.1002/76643-6.json |
| 76644-4 | R-R interval.coefficient of variation by EKG | ./2.16.840.1.114222.4.11.1002/76644-4.json |
| 76645-1 | Cardiac stress test EKG study Type | ./2.16.840.1.114222.4.11.1002/76645-1.json |
| 7664-6 | Redwood IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7664-6.json |
| 76647-7 | Strontium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76647-7.json |
| 76648-5 | Palladium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76648-5.json |
| 76649-3 | Germanium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76649-3.json |
| 76650-1 | Gadolinium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76650-1.json |
| 76651-9 | Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/76651-9.json |
| 76652-7 | Thorium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76652-7.json |
| 7665-3 | Rhodotorula spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7665-3.json |
| 76653-5 | Barium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76653-5.json |
| 76654-3 | Beryllium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76654-3.json |
| 76655-0 | Tungsten [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76655-0.json |
| 76656-8 | Phosphate [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76656-8.json |
| 76657-6 | Iodine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76657-6.json |
| 76658-4 | Zirconium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/76658-4.json |
| 76660-0 | Phosphatidylethanol [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/76660-0.json |
| 76664-2 | Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma | ./2.16.840.1.114222.4.11.1002/76664-2.json |
| 76665-9 | Protein [Mass/volume] in Cerebral spinal fluid --1st tube | ./2.16.840.1.114222.4.11.1002/76665-9.json |
| 76666-7 | Protein [Mass/volume] in Cerebral spinal fluid --2nd tube | ./2.16.840.1.114222.4.11.1002/76666-7.json |
| 76667-5 | Protein [Mass/volume] in Cerebral spinal fluid --3rd tube | ./2.16.840.1.114222.4.11.1002/76667-5.json |
| 76668-3 | Protein [Mass/volume] in Cerebral spinal fluid --4th tube | ./2.16.840.1.114222.4.11.1002/76668-3.json |
| 76669-1 | Glucose [Moles/volume] in Cerebral spinal fluid --1st tube | ./2.16.840.1.114222.4.11.1002/76669-1.json |
| 76670-9 | Glucose [Moles/volume] in Cerebral spinal fluid --2nd tube | ./2.16.840.1.114222.4.11.1002/76670-9.json |
| 76671-7 | Glucose [Moles/volume] in Cerebral spinal fluid --3rd tube | ./2.16.840.1.114222.4.11.1002/76671-7.json |
| 76672-5 | Glucose [Moles/volume] in Cerebral spinal fluid --4th tube | ./2.16.840.1.114222.4.11.1002/76672-5.json |
| 76673-3 | Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --1st tube | ./2.16.840.1.114222.4.11.1002/76673-3.json |
| 76674-1 | Leukocytes [#/volume] in Cerebral spinal fluid --1st tube | ./2.16.840.1.114222.4.11.1002/76674-1.json |
| 76675-8 | Appearance of Cerebral spinal fluid--1st tube | ./2.16.840.1.114222.4.11.1002/76675-8.json |
| 76676-6 | Appearance of Cerebral spinal fluid--2nd tube | ./2.16.840.1.114222.4.11.1002/76676-6.json |
| 76677-4 | Appearance of Cerebral spinal fluid--3rd tube | ./2.16.840.1.114222.4.11.1002/76677-4.json |
| 76678-2 | Appearance of Cerebral spinal fluid--4th tube | ./2.16.840.1.114222.4.11.1002/76678-2.json |
| 7667-9 | Rhubarb IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7667-9.json |
| 76679-0 | Color of Cerebral spinal fluid--1st tube | ./2.16.840.1.114222.4.11.1002/76679-0.json |
| 76680-8 | Color of Cerebral spinal fluid--2nd tube | ./2.16.840.1.114222.4.11.1002/76680-8.json |
| 76681-6 | Color of Cerebral spinal fluid--3rd tube | ./2.16.840.1.114222.4.11.1002/76681-6.json |
| 76682-4 | Color of Cerebral spinal fluid--4th tube | ./2.16.840.1.114222.4.11.1002/76682-4.json |
| 76685-7 | Platelet dry mass distribution width [Entitic mass] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/76685-7.json |
| 76686-5 | Reticulocyte cellular hemoglobin distribution width [Entitic mass] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/76686-5.json |
| 7668-7 | Rice IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7668-7.json |
| 76687-3 | Mycobacterium sp identified in Bronchoalveolar lavage by Organism specific culture | ./2.16.840.1.114222.4.11.1002/76687-3.json |
| 76688-1 | Alpha-1-acid glycoprotein/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/76688-1.json |
| 76689-9 | Sex assigned at birth | ./2.16.840.1.114222.4.11.1002/76689-9.json |
| 76690-7 | Sexual orientation | ./2.16.840.1.114222.4.11.1002/76690-7.json |
| 76691-5 | Gender identity | ./2.16.840.1.114222.4.11.1002/76691-5.json |
| 76692-3 | Fungus identified [#/volume] in Mouth by Culture | ./2.16.840.1.114222.4.11.1002/76692-3.json |
| 76693-1 | Bacteria identified in Blood product unit.autologous by Culture | ./2.16.840.1.114222.4.11.1002/76693-1.json |
| 7669-5 | Rice triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7669-5.json |
| 76698-0 | Patient identifier assigning authority | ./2.16.840.1.114222.4.11.1002/76698-0.json |
| 76699-8 | Filaria identified in Skin by Light microscopy | ./2.16.840.1.114222.4.11.1002/76699-8.json |
| 7670-3 | Brazilian Rubber Tree IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7670-3.json |
| 76705-3 | Trichomonas vaginalis [Presence] in Specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/76705-3.json |
| 7671-1 | Saltwort IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7671-1.json |
| 7672-9 | Wheat Stem Rust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7672-9.json |
| 7673-7 | Rye triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7673-7.json |
| 7674-5 | Rye IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7674-5.json |
| 7675-2 | Rye IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7675-2.json |
| 7676-0 | Safflower IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7676-0.json |
| 76765-7 | Phosphatidylcholine.saturated [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/76765-7.json |
| 76766-5 | Treponema pallidum polA gene [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/76766-5.json |
| 76767-3 | Schistosoma sp identified in Semen by Light microscopy | ./2.16.840.1.114222.4.11.1002/76767-3.json |
| 76768-1 | Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry | ./2.16.840.1.114222.4.11.1002/76768-1.json |
| 76769-9 | Hemoglobin [Mass/volume] in Venous blood by Oximetry | ./2.16.840.1.114222.4.11.1002/76769-9.json |
| 76772-3 | Plasmodium falciparum Ag [Presence] in Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/76772-3.json |
| 76773-1 | Heptacarboxylporphyrin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/76773-1.json |
| 7677-8 | Safflower IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7677-8.json |
| 7678-6 | Sage IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7678-6.json |
| 7680-2 | Sage IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7680-2.json |
| 7681-0 | Common Sagebrush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7681-0.json |
| 7682-8 | Common Sagebrush IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7682-8.json |
| 7683-6 | California Sagebrush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7683-6.json |
| 7685-1 | Salmon IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7685-1.json |
| 7686-9 | Saltbush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7686-9.json |
| 7687-7 | Annual Saltbush IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7687-7.json |
| 7688-5 | Sardine IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7688-5.json |
| 7689-3 | Savinase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7689-3.json |
| 7690-1 | Allscale IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7690-1.json |
| 7691-9 | Scallop IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7691-9.json |
| 7692-7 | Scallop IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7692-7.json |
| 7693-5 | Schistosoma sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7693-5.json |
| 7694-3 | Scorpion IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7694-3.json |
| 7695-0 | Scotch broom IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7695-0.json |
| 7696-8 | Sesame Seed IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7696-8.json |
| 7697-6 | Sesame Seed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7697-6.json |
| 7698-4 | Sheep epithelium triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7698-4.json |
| 7699-2 | Sheep Sorrel triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7699-2.json |
| 7700-8 | Shrimp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7700-8.json |
| 77008-1 | Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77008-1.json |
| 77010-7 | Urea [Molar ratio] in Serum or Plasma --post dialysis/pre dialysis | ./2.16.840.1.114222.4.11.1002/77010-7.json |
| 7701-6 | Shrimp triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7701-6.json |
| 77016-4 | Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/77016-4.json |
| 77017-2 | CFTR gene mutation analysis [interpretation] in Blood or Tissue Qualitative by MS.MALDI | ./2.16.840.1.114222.4.11.1002/77017-2.json |
| 7702-4 | Smelt IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7702-4.json |
| 77030-5 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77030-5.json |
| 77031-3 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77031-3.json |
| 7703-2 | Corn smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7703-2.json |
| 77032-1 | t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77032-1.json |
| 77033-9 | t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77033-9.json |
| 77034-7 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77034-7.json |
| 77035-4 | t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77035-4.json |
| 77036-2 | t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77036-2.json |
| 77037-0 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77037-0.json |
| 77038-8 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77038-8.json |
| 77039-6 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77039-6.json |
| 7704-0 | Bermuda grass smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7704-0.json |
| 77040-4 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77040-4.json |
| 77041-2 | inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77041-2.json |
| 77042-0 | t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/77042-0.json |
| 77043-8 | ACAD8 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77043-8.json |
| 77044-6 | ACAD8 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77044-6.json |
| 77045-3 | ACADSB gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77045-3.json |
| 77046-1 | ACADSB gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77046-1.json |
| 77047-9 | ACSF3 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77047-9.json |
| 77048-7 | ACSF3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77048-7.json |
| 77049-5 | SUGCT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77049-5.json |
| 77050-3 | SUGCT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77050-3.json |
| 77051-1 | IFITM5 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77051-1.json |
| 77052-9 | IFITM5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77052-9.json |
| 77053-7 | MTR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77053-7.json |
| 77054-5 | MTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77054-5.json |
| 77055-2 | CYP11B1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77055-2.json |
| 77056-0 | CYP11B1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77056-0.json |
| 7705-7 | Johnson grass smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7705-7.json |
| 77057-8 | CYP17A1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77057-8.json |
| 77058-6 | CYP17A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77058-6.json |
| 77059-4 | GNMT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77059-4.json |
| 77060-2 | GNMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77060-2.json |
| 77061-0 | HPD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77061-0.json |
| 77062-8 | HPD gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77062-8.json |
| 77063-6 | TAT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77063-6.json |
| 77064-4 | TAT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77064-4.json |
| 7706-5 | Johnson grass smut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7706-5.json |
| 77065-1 | AHCY gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77065-1.json |
| 77066-9 | AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77066-9.json |
| 77067-7 | SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77067-7.json |
| 77068-5 | AGA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77068-5.json |
| 77069-3 | AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77069-3.json |
| 77070-1 | PLOD2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77070-1.json |
| 77071-9 | PLOD2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77071-9.json |
| 77072-7 | ATP5A1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77072-7.json |
| 7707-3 | Oat smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7707-3.json |
| 77073-5 | ATP5A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77073-5.json |
| 77074-3 | C12orf65 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77074-3.json |
| 77075-0 | C12orf65 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77075-0.json |
| 77076-8 | MRPL40 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77076-8.json |
| 77077-6 | MRPL40 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77077-6.json |
| 77078-4 | MTFMT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77078-4.json |
| 77079-2 | MTFMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77079-2.json |
| 77080-0 | SERPINF1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77080-0.json |
| 7708-1 | Wheat smut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7708-1.json |
| 77081-8 | SERPINF1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77081-8.json |
| 77082-6 | FARS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77082-6.json |
| 77083-4 | FARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77083-4.json |
| 77084-2 | ALPL gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77084-2.json |
| 77085-9 | ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77085-9.json |
| 77086-7 | TYROBP gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77086-7.json |
| 77087-5 | TYROBP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77087-5.json |
| 77088-3 | GFM1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77088-3.json |
| 77089-1 | GFM1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77089-1.json |
| 77090-9 | TFB1M gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77090-9.json |
| 77091-7 | TFB1M gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77091-7.json |
| 77092-5 | MRRF gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77092-5.json |
| 77093-3 | MRRF gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77093-3.json |
| 77094-1 | MRPS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77094-1.json |
| 77095-8 | MRPS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77095-8.json |
| 77096-6 | MRPS22 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77096-6.json |
| 77097-4 | MRPS22 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77097-4.json |
| 77098-2 | MRPL44 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77098-2.json |
| 7709-9 | Sole IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7709-9.json |
| 77099-0 | MRPL44 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77099-0.json |
| 77100-6 | MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77100-6.json |
| 77101-4 | MRPL18A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77101-4.json |
| 77102-2 | NARS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77102-2.json |
| 77103-0 | NARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77103-0.json |
| 77104-8 | HARS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77104-8.json |
| 77105-5 | HARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77105-5.json |
| 77106-3 | SARS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77106-3.json |
| 7710-7 | Sole IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7710-7.json |
| 77107-1 | SARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77107-1.json |
| 77108-9 | AARS2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77108-9.json |
| 77109-7 | AARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77109-7.json |
| 77110-5 | KARS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77110-5.json |
| 77111-3 | KARS gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77111-3.json |
| 77112-1 | PLOD3 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77112-1.json |
| 77113-9 | PLOD3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77113-9.json |
| 77114-7 | FBN1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77114-7.json |
| 7711-5 | Spinach IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7711-5.json |
| 77115-4 | FKBP10 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77115-4.json |
| 77116-2 | FKBP10 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77116-2.json |
| 77117-0 | RPGRIP1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77117-0.json |
| 77118-8 | RPGRIP1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77118-8.json |
| 77119-6 | RPGR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77119-6.json |
| 77120-4 | RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77120-4.json |
| 77121-2 | DFNB31 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77121-2.json |
| 77122-0 | DFNB31 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77122-0.json |
| 7712-3 | Spondylocladium atrovirens IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7712-3.json |
| 77123-8 | GPR98 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77123-8.json |
| 77124-6 | GPR98 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77124-6.json |
| 77125-3 | PCDH15 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77125-3.json |
| 77126-1 | PCDH15 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77126-1.json |
| 77127-9 | USH1C gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77127-9.json |
| 77128-7 | USH1C gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77128-7.json |
| 77129-5 | CERKL gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77129-5.json |
| 77130-3 | CERKL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77130-3.json |
| 7713-1 | Squash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7713-1.json |
| 77131-1 | CDHR1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77131-1.json |
| 77132-9 | CDHR1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77132-9.json |
| 77133-7 | LCA5 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77133-7.json |
| 77134-5 | LCA5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77134-5.json |
| 77135-2 | Glucose [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77135-2.json |
| 77136-0 | Urea [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77136-0.json |
| 77137-8 | Bilirubin.total [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77137-8.json |
| 77138-6 | Chloride [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77138-6.json |
| 77139-4 | Sodium [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77139-4.json |
| 77140-2 | Creatinine [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77140-2.json |
| 77141-0 | Alkaline phosphatase [Enzymatic activity/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77141-0.json |
| 77142-8 | Potassium [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77142-8.json |
| 77143-6 | Carbon dioxide, total [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77143-6.json |
| 77144-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77144-4.json |
| 77145-1 | Fasting glucose [Moles/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77145-1.json |
| 77146-9 | Amylase [Enzymatic activity/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/77146-9.json |
| 77147-7 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | ./2.16.840.1.114222.4.11.1002/77147-7.json |
| 77148-5 | Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method | ./2.16.840.1.114222.4.11.1002/77148-5.json |
| 7714-9 | Summer Squash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7714-9.json |
| 77149-3 | Dry weight/Total of 24 hour Stool | ./2.16.840.1.114222.4.11.1002/77149-3.json |
| 7715-6 | Summer Squash IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7715-6.json |
| 77158-4 | Microalbumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L | ./2.16.840.1.114222.4.11.1002/77158-4.json |
| 771-6 | Nucleated erythrocytes [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/771-6.json |
| 77160-0 | Functional outcome score GOSE | ./2.16.840.1.114222.4.11.1002/77160-0.json |
| 77161-8 | Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma | ./2.16.840.1.114222.4.11.1002/77161-8.json |
| 77162-6 | Anidulafungin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/77162-6.json |
| 77163-4 | Alpha-1-Microglobulin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77163-4.json |
| 7716-4 | Yellow Squash IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7716-4.json |
| 77164-2 | Karyotype [Identifier] in Products of Conception Nominal | ./2.16.840.1.114222.4.11.1002/77164-2.json |
| 77167-5 | cycloSPORINE [Mass/volume] in Blood --3 hours post dose | ./2.16.840.1.114222.4.11.1002/77167-5.json |
| 77168-3 | cycloSPORINE [Mass/volume] in Blood --4 hours post dose | ./2.16.840.1.114222.4.11.1002/77168-3.json |
| 77169-1 | cycloSPORINE [Mass/volume] in Blood --1 hour post dose | ./2.16.840.1.114222.4.11.1002/77169-1.json |
| 77170-9 | PDGFRA gene p.Asp842Val [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77170-9.json |
| 77171-7 | KIT gene exon 11 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77171-7.json |
| 7717-2 | Yellow Squash IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7717-2.json |
| 77172-5 | KIT gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77172-5.json |
| 77173-3 | Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/77173-3.json |
| 77174-1 | CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77174-1.json |
| 77177-4 | IgG [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/77177-4.json |
| 77178-2 | Boron [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/77178-2.json |
| 77179-0 | Niobium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/77179-0.json |
| 7718-0 | Zucchini IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7718-0.json |
| 77180-8 | Niobium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77180-8.json |
| 77181-6 | Niobium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/77181-6.json |
| 77182-4 | Niobium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/77182-4.json |
| 77183-2 | Niobium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77183-2.json |
| 77184-0 | Niobium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/77184-0.json |
| 77185-7 | Uranium [Mass/mass] in Dentin | ./2.16.840.1.114222.4.11.1002/77185-7.json |
| 77186-5 | Uranium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/77186-5.json |
| 77187-3 | Zirconium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77187-3.json |
| 77188-1 | Zirconium [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77188-1.json |
| 77189-9 | Zirconium/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/77189-9.json |
| 77192-3 | Prealbumin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/77192-3.json |
| 77193-1 | Bacteria identified in Uterus by Culture | ./2.16.840.1.114222.4.11.1002/77193-1.json |
| 77194-9 | Ankle-brachial index | ./2.16.840.1.114222.4.11.1002/77194-9.json |
| 77195-6 | Cardio-ankle vascular index Calculated | ./2.16.840.1.114222.4.11.1002/77195-6.json |
| 77196-4 | Pulse wave velocity | ./2.16.840.1.114222.4.11.1002/77196-4.json |
| 7719-8 | Staphylococcus aureus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7719-8.json |
| 77198-0 | Noninvasive arteriosclerosis study | ./2.16.840.1.114222.4.11.1002/77198-0.json |
| 77199-8 | Evoked potential study | ./2.16.840.1.114222.4.11.1002/77199-8.json |
| 77200-4 | SI gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77200-4.json |
| 77201-2 | Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77201-2.json |
| 77203-8 | Smut fungi (Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/77203-8.json |
| 77205-3 | Buprenorphine [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/77205-3.json |
| 7720-6 | Stemphylium solani IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7720-6.json |
| 77207-9 | Naloxone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77207-9.json |
| 7721-4 | Strawberry IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7721-4.json |
| 77220-2 | Niobium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/77220-2.json |
| 7722-2 | Strawberry triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7722-2.json |
| 7723-0 | Sugar Cane IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7723-0.json |
| 7724-8 | Sugar Cane IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7724-8.json |
| 77253-3 | Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/77253-3.json |
| 77254-1 | Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L | ./2.16.840.1.114222.4.11.1002/77254-1.json |
| 7726-3 | Sunflower Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7726-3.json |
| 7727-1 | Sunflower Seed triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7727-1.json |
| 77288-9 | FDA package insert Indexing - warning letter alert | ./2.16.840.1.114222.4.11.1002/77288-9.json |
| 7728-9 | Swordfish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7728-9.json |
| 77289-7 | FDA package insert Identification of suspect product and notification | ./2.16.840.1.114222.4.11.1002/77289-7.json |
| 77290-5 | FDA package insert Lactation | ./2.16.840.1.114222.4.11.1002/77290-5.json |
| 77291-3 | FDA package insert Females and males reproductive potential | ./2.16.840.1.114222.4.11.1002/77291-3.json |
| 77292-1 | FDA package insert eFacility | ./2.16.840.1.114222.4.11.1002/77292-1.json |
| 7729-7 | Swordfish IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7729-7.json |
| 77307-7 | Lead [Mass/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/77307-7.json |
| 77311-9 | CTA Abdominal aorta and Bilateral vessels for endograft | ./2.16.840.1.114222.4.11.1002/77311-9.json |
| 7731-3 | Mandarin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7731-3.json |
| 77320-0 | Benzoylecgonine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77320-0.json |
| 7732-1 | Mandarin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7732-1.json |
| 77321-8 | Cyanide [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77321-8.json |
| 77322-6 | Amitriptyline+Nortriptyline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77322-6.json |
| 77323-4 | diazePAM [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77323-4.json |
| 77324-2 | Flurazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77324-2.json |
| 77325-9 | N-desalkylflurazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77325-9.json |
| 77326-7 | LORazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77326-7.json |
| 77327-5 | Triazolam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77327-5.json |
| 77328-3 | Methadone [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77328-3.json |
| 77329-1 | Temazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77329-1.json |
| 77330-9 | Protriptyline [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77330-9.json |
| 77331-7 | Nortrimipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77331-7.json |
| 77332-5 | Morphine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77332-5.json |
| 77333-3 | Imipramine+Desipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77333-3.json |
| 77334-1 | Norpropoxyphene [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77334-1.json |
| 77335-8 | Propoxyphene + Norpropoxyphene [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77335-8.json |
| 77336-6 | Oxazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77336-6.json |
| 77337-4 | Trimipramine+Nortrimipramine [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77337-4.json |
| 7733-9 | Tapioca IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7733-9.json |
| 77344-0 | Colony count [#/volume] in Implanted device by Culture | ./2.16.840.1.114222.4.11.1002/77344-0.json |
| 77345-7 | Enterobius vermicularis [Presence] in Anal by Pinworm exam --2nd specimen | ./2.16.840.1.114222.4.11.1002/77345-7.json |
| 77346-5 | Enterobius vermicularis [Presence] in Anal by Pinworm exam --3rd specimen | ./2.16.840.1.114222.4.11.1002/77346-5.json |
| 7734-7 | Tapioca IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7734-7.json |
| 77348-1 | Tacrolimus [Mass/volume] in Blood --trough | ./2.16.840.1.114222.4.11.1002/77348-1.json |
| 77349-9 | Everolimus [Mass/volume] in Blood by LC/MS/MS --trough | ./2.16.840.1.114222.4.11.1002/77349-9.json |
| 77350-7 | Erythropoietin (EPO) Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/77350-7.json |
| 7735-4 | Tea IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7735-4.json |
| 77354-9 | Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool | ./2.16.840.1.114222.4.11.1002/77354-9.json |
| 77357-2 | Nitrogen [Moles/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/77357-2.json |
| 77358-0 | Nitrogen [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/77358-0.json |
| 77359-8 | Protein [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/77359-8.json |
| 77360-6 | Triglyceride [Mass/mass] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/77360-6.json |
| 77361-4 | Triglyceride [Mass/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/77361-4.json |
| 7736-2 | Termamyl IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7736-2.json |
| 77362-2 | N-tau methylimidazoleacetate/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/77362-2.json |
| 77363-0 | N-tau methylimidazoleacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/77363-0.json |
| 77367-1 | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma by calculation --Dibucaine | ./2.16.840.1.114222.4.11.1002/77367-1.json |
| 77368-9 | HIV 1 proviral DNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77368-9.json |
| 77369-7 | HIV 1 RNA [Presence] in Semen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77369-7.json |
| 7737-0 | Thyme IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7737-0.json |
| 77370-5 | Procollagen type I.N-terminal propeptide [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77370-5.json |
| 77371-3 | Brassicasterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/77371-3.json |
| 77372-1 | 3-Methoxytyramine.free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/77372-1.json |
| 77373-9 | Lathosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/77373-9.json |
| 77375-4 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77375-4.json |
| 77382-0 | Adenovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77382-0.json |
| 77383-8 | Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77383-8.json |
| 77384-6 | Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77384-6.json |
| 77385-3 | Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77385-3.json |
| 77386-1 | Parainfluenza virus 2 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77386-1.json |
| 77387-9 | Parainfluenza virus 3 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77387-9.json |
| 7738-8 | Timothy triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7738-8.json |
| 77388-7 | Cytomegalovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77388-7.json |
| 77389-5 | Respiratory syncytial virus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77389-5.json |
| 77390-3 | Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77390-3.json |
| 77391-1 | Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77391-1.json |
| 77392-9 | Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77392-9.json |
| 77394-5 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77394-5.json |
| 77395-2 | Human papilloma virus 18 DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77395-2.json |
| 7739-6 | Tobacco IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7739-6.json |
| 77396-0 | Human papilloma virus 16 DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77396-0.json |
| 77397-8 | ABO and Rh group [Type] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77397-8.json |
| 77399-4 | Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77399-4.json |
| 77400-0 | Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77400-0.json |
| 77401-8 | Anesthesiology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/77401-8.json |
| 77402-6 | Anesthesiology Evaluation note | ./2.16.840.1.114222.4.11.1002/77402-6.json |
| 77403-4 | Anesthesiology Consult note | ./2.16.840.1.114222.4.11.1002/77403-4.json |
| 7740-4 | Tobacco triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7740-4.json |
| 77404-2 | Anesthesiology Education note | ./2.16.840.1.114222.4.11.1002/77404-2.json |
| 77405-9 | Anesthesiology Referral note | ./2.16.840.1.114222.4.11.1002/77405-9.json |
| 77406-7 | Anesthesiology Transfer summary note | ./2.16.840.1.114222.4.11.1002/77406-7.json |
| 77407-5 | Cardiology Evaluation note | ./2.16.840.1.114222.4.11.1002/77407-5.json |
| 77408-3 | Cardiology Discharge instructions | ./2.16.840.1.114222.4.11.1002/77408-3.json |
| 77409-1 | Cardiology Discharge summary | ./2.16.840.1.114222.4.11.1002/77409-1.json |
| 77410-9 | Cardiology Hospital Discharge teaching note | ./2.16.840.1.114222.4.11.1002/77410-9.json |
| 77411-7 | Cardiology Education note | ./2.16.840.1.114222.4.11.1002/77411-7.json |
| 77412-5 | Cardiology History and physical note | ./2.16.840.1.114222.4.11.1002/77412-5.json |
| 77413-3 | Cardiology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/77413-3.json |
| 77414-1 | Cardiology Transfer summary note | ./2.16.840.1.114222.4.11.1002/77414-1.json |
| 77415-8 | Critical care medicine Admission history and physical note | ./2.16.840.1.114222.4.11.1002/77415-8.json |
| 77416-6 | Critical care medicine Discharge instructions | ./2.16.840.1.114222.4.11.1002/77416-6.json |
| 77417-4 | Critical care medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/77417-4.json |
| 77418-2 | Critical care medicine Discharge teaching note | ./2.16.840.1.114222.4.11.1002/77418-2.json |
| 77419-0 | Critical care medicine Education note | ./2.16.840.1.114222.4.11.1002/77419-0.json |
| 7742-0 | Tomato triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7742-0.json |
| 77420-8 | Critical care medicine History and physical note | ./2.16.840.1.114222.4.11.1002/77420-8.json |
| 77421-6 | Critical care medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/77421-6.json |
| 77422-4 | Critical care medicine procedure note | ./2.16.840.1.114222.4.11.1002/77422-4.json |
| 77423-2 | Audiology Education note | ./2.16.840.1.114222.4.11.1002/77423-2.json |
| 77424-0 | Audiology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/77424-0.json |
| 77425-7 | Audiology procedure note | ./2.16.840.1.114222.4.11.1002/77425-7.json |
| 77426-5 | Audiology Progress note | ./2.16.840.1.114222.4.11.1002/77426-5.json |
| 77427-3 | Audiology Referral note | ./2.16.840.1.114222.4.11.1002/77427-3.json |
| 77429-9 | Allergy and Immunology Consult note | ./2.16.840.1.114222.4.11.1002/77429-9.json |
| 77430-7 | Allergy and Immunology Education note | ./2.16.840.1.114222.4.11.1002/77430-7.json |
| 77431-5 | Allergy and Immunology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/77431-5.json |
| 77432-3 | Allergy and Immunology Referral note | ./2.16.840.1.114222.4.11.1002/77432-3.json |
| 77434-9 | Allergy and Immunology Evaluation note | ./2.16.840.1.114222.4.11.1002/77434-9.json |
| 77435-6 | Child and adolescent psychiatry Evaluation note | ./2.16.840.1.114222.4.11.1002/77435-6.json |
| 77436-4 | Anesthesiology Summary note | ./2.16.840.1.114222.4.11.1002/77436-4.json |
| 77437-2 | Cardiology Flowsheet | ./2.16.840.1.114222.4.11.1002/77437-2.json |
| 7743-8 | Tragacanth IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7743-8.json |
| 77438-0 | Allergy and Immunology Flowsheet | ./2.16.840.1.114222.4.11.1002/77438-0.json |
| 77439-8 | Audiology Flowsheet | ./2.16.840.1.114222.4.11.1002/77439-8.json |
| 77440-6 | Critical care medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/77440-6.json |
| 77441-4 | Child and adolescent psychiatry Flowsheet | ./2.16.840.1.114222.4.11.1002/77441-4.json |
| 77442-2 | Cardiology Plan of care note | ./2.16.840.1.114222.4.11.1002/77442-2.json |
| 77443-0 | Allergy and Immunology Plan of care note | ./2.16.840.1.114222.4.11.1002/77443-0.json |
| 77444-8 | Audiology Plan of care note | ./2.16.840.1.114222.4.11.1002/77444-8.json |
| 77445-5 | Critical care medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/77445-5.json |
| 7744-6 | Tree of Heaven IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7744-6.json |
| 77446-3 | Child and adolescent psychiatry Plan of care note | ./2.16.840.1.114222.4.11.1002/77446-3.json |
| 77447-1 | Nordiazepam [Moles/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/77447-1.json |
| 77448-9 | CT Hindfoot and Midfoot | ./2.16.840.1.114222.4.11.1002/77448-9.json |
| 77451-3 | CTA Thoracic and Abdominal Aorta and Bilateral Vessels for endograft | ./2.16.840.1.114222.4.11.1002/77451-3.json |
| 77452-1 | Bilirubin [Presence] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/77452-1.json |
| 7745-3 | Trichophyton sp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7745-3.json |
| 77456-2 | CT Hindfoot and Midfoot W contrast IV | ./2.16.840.1.114222.4.11.1002/77456-2.json |
| 77457-0 | CT Hindfoot and Midfoot WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/77457-0.json |
| 77458-8 | CT Hindfoot and Midfoot WO contrast | ./2.16.840.1.114222.4.11.1002/77458-8.json |
| 7746-1 | Trimellitic anhydride (TMA) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7746-1.json |
| 77466-1 | CT Hindfoot - left and Midfoot - left W contrast IV | ./2.16.840.1.114222.4.11.1002/77466-1.json |
| 77467-9 | CT Hindfoot - right and Midfoot - right W contrast IV | ./2.16.840.1.114222.4.11.1002/77467-9.json |
| 77468-7 | CT Hindfoot - left and Midfoot - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/77468-7.json |
| 77469-5 | CT Hindfoot - right and Midfoot - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/77469-5.json |
| 77470-3 | CT Hindfoot - left and Midfoot - left WO contrast | ./2.16.840.1.114222.4.11.1002/77470-3.json |
| 77471-1 | CT Hindfoot - right and Midfoot - right WO contrast | ./2.16.840.1.114222.4.11.1002/77471-1.json |
| 7747-9 | Trout IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7747-9.json |
| 7748-7 | Tryptase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7748-7.json |
| 7749-5 | Tuna IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7749-5.json |
| 77495-0 | Bacillus cereus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/77495-0.json |
| 77496-8 | Clostridium perfringens [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/77496-8.json |
| 7750-3 | Tuna triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7750-3.json |
| 7751-1 | Turkey IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7751-1.json |
| 7752-9 | Turkey triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7752-9.json |
| 7753-7 | Turkey feather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7753-7.json |
| 7754-5 | Turnip IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7754-5.json |
| 7755-2 | Upholstery dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7755-2.json |
| 7756-0 | Vanilla IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7756-0.json |
| 77563-5 | Leukocyte esterase [Presence] in Body fluid by Automated test strip | ./2.16.840.1.114222.4.11.1002/77563-5.json |
| 77573-4 | FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility report | ./2.16.840.1.114222.4.11.1002/77573-4.json |
| 7757-8 | Veal IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7757-8.json |
| 7758-6 | Veal triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7758-6.json |
| 7759-4 | Venison IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7759-4.json |
| 77595-7 | Total physical activity score [IPAQ] | ./2.16.840.1.114222.4.11.1002/77595-7.json |
| 77596-5 | Transportation summary Document | ./2.16.840.1.114222.4.11.1002/77596-5.json |
| 77597-3 | Orders placed Document | ./2.16.840.1.114222.4.11.1002/77597-3.json |
| 77598-1 | Externally defined clinical data elements Document | ./2.16.840.1.114222.4.11.1002/77598-1.json |
| 77599-9 | Additional documentation | ./2.16.840.1.114222.4.11.1002/77599-9.json |
| 77600-5 | Interval note | ./2.16.840.1.114222.4.11.1002/77600-5.json |
| 77601-3 | Enhanced note | ./2.16.840.1.114222.4.11.1002/77601-3.json |
| 7760-2 | Wall pellitory IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7760-2.json |
| 77602-1 | Research study consent | ./2.16.840.1.114222.4.11.1002/77602-1.json |
| 77603-9 | Medication treatment plan.extended Document | ./2.16.840.1.114222.4.11.1002/77603-9.json |
| 77604-7 | Medication treatment plan.brief Document | ./2.16.840.1.114222.4.11.1002/77604-7.json |
| 77605-4 | Influenza virus A H5 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77605-4.json |
| 77606-2 | Weight-for-length Per age and sex | ./2.16.840.1.114222.4.11.1002/77606-2.json |
| 7761-0 | Walleye Pike IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7761-0.json |
| 77615-3 | Liver stiffness by US.transient elastography | ./2.16.840.1.114222.4.11.1002/77615-3.json |
| 77616-1 | Liver fibrosis score in Serum or Plasma Calculated by FibroMeter | ./2.16.840.1.114222.4.11.1002/77616-1.json |
| 77617-9 | Toe brachial index - left | ./2.16.840.1.114222.4.11.1002/77617-9.json |
| 77618-7 | Toe brachial index - right | ./2.16.840.1.114222.4.11.1002/77618-7.json |
| 77619-5 | Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma | ./2.16.840.1.114222.4.11.1002/77619-5.json |
| 77620-3 | Arginase-1 [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/77620-3.json |
| 77621-1 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/77621-1.json |
| 77622-9 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Peritoneal dialysis fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/77622-9.json |
| 77623-7 | Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/77623-7.json |
| 77624-5 | SMAD4 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77624-5.json |
| 77625-2 | ENG gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/77625-2.json |
| 77626-0 | Pyruvate kinase [Entitic Catalytic Activity] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/77626-0.json |
| 77627-8 | HBB gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/77627-8.json |
| 7762-8 | Walnut triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7762-8.json |
| 77628-6 | PSEN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77628-6.json |
| 77629-4 | PARK7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77629-4.json |
| 77630-2 | ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77630-2.json |
| 77631-0 | VAPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77631-0.json |
| 77632-8 | ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77632-8.json |
| 77633-6 | TARDBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77633-6.json |
| 77634-4 | FUS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77634-4.json |
| 77635-1 | C9orf72 gene GGGGCC repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77635-1.json |
| 7763-6 | Black Walnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7763-6.json |
| 77636-9 | HLA-C [Type] by High resolution typing | ./2.16.840.1.114222.4.11.1002/77636-9.json |
| 77641-9 | HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77641-9.json |
| 77642-7 | HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77642-7.json |
| 77643-5 | HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77643-5.json |
| 7764-4 | Black Western Walnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7764-4.json |
| 77644-3 | HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77644-3.json |
| 77645-0 | HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77645-0.json |
| 77646-8 | HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/77646-8.json |
| 77647-6 | FDA product label Animal compounded drug label | ./2.16.840.1.114222.4.11.1002/77647-6.json |
| 77648-4 | FDA product label Indexing - biologic or drug substance | ./2.16.840.1.114222.4.11.1002/77648-4.json |
| 7765-1 | English Walnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7765-1.json |
| 77653-4 | Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep | ./2.16.840.1.114222.4.11.1002/77653-4.json |
| 77666-6 | Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood culture | ./2.16.840.1.114222.4.11.1002/77666-6.json |
| 7766-9 | English Walnut Pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7766-9.json |
| 7767-7 | Walnut IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7767-7.json |
| 77677-3 | Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal | ./2.16.840.1.114222.4.11.1002/77677-3.json |
| 77682-3 | Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77682-3.json |
| 77683-1 | Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/77683-1.json |
| 77684-9 | Legionella pneumophila 1 Ag [Presence] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/77684-9.json |
| 7768-5 | Yellow Jacket IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7768-5.json |
| 77685-6 | HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/77685-6.json |
| 7769-3 | Water Chestnut IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7769-3.json |
| 7770-1 | Watermelon IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7770-1.json |
| 7771-9 | Watermelon IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7771-9.json |
| 77725-0 | Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing | ./2.16.840.1.114222.4.11.1002/77725-0.json |
| 77726-8 | Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by FVIII dosing | ./2.16.840.1.114222.4.11.1002/77726-8.json |
| 7772-7 | Wheat triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7772-7.json |
| 77727-6 | XXX allergen triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/77727-6.json |
| 77728-4 | Serotonin release 0.2 IU/mL heparin.unfractionated [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/77728-4.json |
| 77729-2 | oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77729-2.json |
| 777-3 | Platelets [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/777-3.json |
| 77730-0 | oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77730-0.json |
| 77731-8 | oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77731-8.json |
| 77732-6 | oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/77732-6.json |
| 77733-4 | Gamma hydroxybutyrate [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/77733-4.json |
| 77734-2 | Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/77734-2.json |
| 77735-9 | Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/77735-9.json |
| 77736-7 | Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular method | ./2.16.840.1.114222.4.11.1002/77736-7.json |
| 77739-1 | Mother's Hepatitis B virus surface Ag status | ./2.16.840.1.114222.4.11.1002/77739-1.json |
| 77740-9 | Norcotinine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/77740-9.json |
| 77741-7 | Streptavidin [Presence] in Serum or Plasma by Immunoblot | ./2.16.840.1.114222.4.11.1002/77741-7.json |
| 7774-3 | Cow whey IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7774-3.json |
| 77743-3 | Toxocara sp Ab [Presence] in Ocular fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/77743-3.json |
| 77748-2 | PCDH15 gene c.733C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77748-2.json |
| 77749-0 | CLRN1 gene c.144T>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77749-0.json |
| 7775-0 | Whitefish IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7775-0.json |
| 77750-8 | DLD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/77750-8.json |
| 77751-6 | TMEM216 gene c.218G>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/77751-6.json |
| 77757-3 | 7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77757-3.json |
| 77761-5 | ARIPiprazole [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77761-5.json |
| 77765-6 | Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77765-6.json |
| 7776-8 | Whitefish IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7776-8.json |
| 77771-4 | JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77771-4.json |
| 7777-6 | Wild Rice IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7777-6.json |
| 7778-4 | Pussy Willow IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7778-4.json |
| 7779-2 | Wingscale IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7779-2.json |
| 7780-0 | Winterfat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7780-0.json |
| 778-1 | Platelets [#/volume] in Blood by Manual count | ./2.16.840.1.114222.4.11.1002/778-1.json |
| 7781-8 | Wormwood IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7781-8.json |
| 7782-6 | Yam IgE Ab in Serum | ./2.16.840.1.114222.4.11.1002/7782-6.json |
| 7784-2 | Baker's yeast triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7784-2.json |
| 7785-9 | Brewer's yeast triggered histamine release [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/7785-9.json |
| 7786-7 | Yew IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7786-7.json |
| 7787-5 | Yogurt IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7787-5.json |
| 77877-9 | Ziprasidone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77877-9.json |
| 77880-3 | risperiDONE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77880-3.json |
| 7788-3 | Yogurt IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7788-3.json |
| 77884-5 | Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77884-5.json |
| 77888-6 | OLANZapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77888-6.json |
| 77942-1 | CD8+CD3- cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/77942-1.json |
| 77943-9 | Schistosoma mansoni+haematobium+intercalatum [Titer] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/77943-9.json |
| 77944-7 | CD11a cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/77944-7.json |
| 77946-2 | CD42b cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/77946-2.json |
| 77947-0 | CD9 cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/77947-0.json |
| 77948-8 | FLAER cells/100 cells in Specimen | ./2.16.840.1.114222.4.11.1002/77948-8.json |
| 77949-6 | Streptococcus pneumoniae Ag [Presence] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/77949-6.json |
| 77950-4 | Toscana virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/77950-4.json |
| 77951-2 | Toscana virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/77951-2.json |
| 77952-0 | Trypanosoma cruzi Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/77952-0.json |
| 77953-8 | West Nile virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/77953-8.json |
| 77954-6 | Yellow fever virus IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77954-6.json |
| 77955-3 | Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/77955-3.json |
| 77956-1 | Yersinia enterocolitica O:3 IgG Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/77956-1.json |
| 77957-9 | Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/77957-9.json |
| 77958-7 | Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/77958-7.json |
| 77959-5 | Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/77959-5.json |
| 77961-1 | cloZAPine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/77961-1.json |
| 77962-9 | Obstetrics and Gynecology Summary note | ./2.16.840.1.114222.4.11.1002/77962-9.json |
| 77963-7 | Birth defects diagnosis Narrative | ./2.16.840.1.114222.4.11.1002/77963-7.json |
| 77964-5 | Cholesterol crystals [#/area] in Urine sediment by Microscopy low power field | ./2.16.840.1.114222.4.11.1002/77964-5.json |
| 77966-0 | Reporting state | ./2.16.840.1.114222.4.11.1002/77966-0.json |
| 78001-5 | Cytomegalovirus pp65 Ag/100000 PMN cells in Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/78001-5.json |
| 78005-6 | Physical therapy Summary registry report | ./2.16.840.1.114222.4.11.1002/78005-6.json |
| 7800-6 | Phospholipid Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7800-6.json |
| 78006-4 | Isotopic Glomerular filtration rate/1.73 sq M [Volume Rate/Area] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78006-4.json |
| 78007-2 | HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78007-2.json |
| 78008-0 | HIV 1 proviral DNA [Entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78008-0.json |
| 78009-8 | HIV 1 proviral DNA [Entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78009-8.json |
| 78012-2 | Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/78012-2.json |
| 7801-4 | Phospholipid IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7801-4.json |
| 78018-9 | Toscana virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/78018-9.json |
| 78019-7 | Toscana virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/78019-7.json |
| 7802-2 | Phospholipid IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7802-2.json |
| 7803-0 | Acanthamoeba sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7803-0.json |
| 78031-2 | CTA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/78031-2.json |
| 78032-0 | CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/78032-0.json |
| 78035-3 | Fibers [Presence] in Body fluid | ./2.16.840.1.114222.4.11.1002/78035-3.json |
| 78036-1 | Fibers [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/78036-1.json |
| 78037-9 | CTA Abdominal Aorta and Bilateral Runoff Vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/78037-9.json |
| 78038-7 | CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/78038-7.json |
| 78039-5 | Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78039-5.json |
| 78047-8 | Cortisol [Moles/volume] in Serum or Plasma --24 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/78047-8.json |
| 7804-8 | Actinomyces sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7804-8.json |
| 7805-5 | Adenovirus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7805-5.json |
| 7806-3 | Ascaris lumbricoides Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7806-3.json |
| 7807-1 | Aspergillus sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7807-1.json |
| 7808-9 | Aspergillus sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7808-9.json |
| 7809-7 | Astrovirus [Presence] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/7809-7.json |
| 7810-5 | Astrovirus Ag [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/7810-5.json |
| 7811-3 | Astrovirus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7811-3.json |
| 7812-1 | Babesia microti Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7812-1.json |
| 7813-9 | Babesia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7813-9.json |
| 7814-7 | Bacillus anthracis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7814-7.json |
| 7815-4 | Bartonella henselae IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7815-4.json |
| 7816-2 | Blastomyces dermatitidis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7816-2.json |
| 7817-0 | Borrelia burgdorferi IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7817-0.json |
| 7818-8 | Borrelia burgdorferi IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7818-8.json |
| 7819-6 | Brugia malayi Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7819-6.json |
| 78201-1 | 4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal | ./2.16.840.1.114222.4.11.1002/78201-1.json |
| 78202-9 | 9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78202-9.json |
| 78203-7 | BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78203-7.json |
| 78204-5 | CCND1 gene duplication [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78204-5.json |
| 78205-2 | ALK gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78205-2.json |
| 78210-2 | ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative | ./2.16.840.1.114222.4.11.1002/78210-2.json |
| 7821-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7821-2.json |
| 78215-1 | MYC gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78215-1.json |
| 78216-9 | TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78216-9.json |
| 78217-7 | RARA gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78217-7.json |
| 78218-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78218-5.json |
| 78219-3 | MLL gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78219-3.json |
| 7822-0 | Chlamydophila psittaci Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7822-0.json |
| 78220-1 | PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78220-1.json |
| 78221-9 | IGH gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78221-9.json |
| 78226-8 | MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative | ./2.16.840.1.114222.4.11.1002/78226-8.json |
| 78237-5 | Chromosome 8 copy number/nucleus in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78237-5.json |
| 7823-8 | Chlamydia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7823-8.json |
| 78238-3 | Chromosome 3 copy number/nucleus in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78238-3.json |
| 78240-9 | Trauma Surgical operation note | ./2.16.840.1.114222.4.11.1002/78240-9.json |
| 78241-7 | Gastroenterology Surgical operation note | ./2.16.840.1.114222.4.11.1002/78241-7.json |
| 78242-5 | Hematology+Medical oncology Surgical operation note | ./2.16.840.1.114222.4.11.1002/78242-5.json |
| 78243-3 | Vascular surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78243-3.json |
| 78244-1 | Transplant surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78244-1.json |
| 78245-8 | MYB gene deletion [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78245-8.json |
| 7824-6 | Chlamydia trachomatis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7824-6.json |
| 78246-6 | Mental health Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78246-6.json |
| 78247-4 | Surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78247-4.json |
| 78248-2 | Colon and rectal surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78248-2.json |
| 78249-0 | Emergency department Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78249-0.json |
| 78250-8 | Colon and rectal surgery Consult note | ./2.16.840.1.114222.4.11.1002/78250-8.json |
| 78251-6 | Hematology Consult note | ./2.16.840.1.114222.4.11.1002/78251-6.json |
| 78252-4 | Multi-specialty program Consult note | ./2.16.840.1.114222.4.11.1002/78252-4.json |
| 78253-2 | Family medicine Consult note | ./2.16.840.1.114222.4.11.1002/78253-2.json |
| 78254-0 | Clinical genetics Consult note | ./2.16.840.1.114222.4.11.1002/78254-0.json |
| 78255-7 | Family medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78255-7.json |
| 78256-5 | Gastroenterology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78256-5.json |
| 78257-3 | Endocrinology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78257-3.json |
| 78258-1 | Infectious disease Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78258-1.json |
| 78259-9 | Dentistry Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78259-9.json |
| 78260-7 | Dermatology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78260-7.json |
| 7826-1 | Coccidioides immitis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7826-1.json |
| 78261-5 | Mental health Discharge instructions | ./2.16.840.1.114222.4.11.1002/78261-5.json |
| 78262-3 | General medicine Discharge instructions | ./2.16.840.1.114222.4.11.1002/78262-3.json |
| 78263-1 | Mental health Discharge summary | ./2.16.840.1.114222.4.11.1002/78263-1.json |
| 78264-9 | General medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/78264-9.json |
| 78265-6 | Emergency department Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78265-6.json |
| 78266-4 | Mental health Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78266-4.json |
| 78267-2 | General medicine Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78267-2.json |
| 78268-0 | Multi-specialty program Education note | ./2.16.840.1.114222.4.11.1002/78268-0.json |
| 78269-8 | Dermatology Education note | ./2.16.840.1.114222.4.11.1002/78269-8.json |
| 78270-6 | Gastroenterology Education note | ./2.16.840.1.114222.4.11.1002/78270-6.json |
| 78271-4 | Colon and rectal surgery Education note | ./2.16.840.1.114222.4.11.1002/78271-4.json |
| 78272-2 | General medicine Education note | ./2.16.840.1.114222.4.11.1002/78272-2.json |
| 78273-0 | Emergency department Education note | ./2.16.840.1.114222.4.11.1002/78273-0.json |
| 78274-8 | Hematology Education note | ./2.16.840.1.114222.4.11.1002/78274-8.json |
| 78275-5 | Dentistry Education note | ./2.16.840.1.114222.4.11.1002/78275-5.json |
| 78276-3 | Clinical genetics Education note | ./2.16.840.1.114222.4.11.1002/78276-3.json |
| 78277-1 | Family medicine Education note | ./2.16.840.1.114222.4.11.1002/78277-1.json |
| 78278-9 | Endocrinology Education note | ./2.16.840.1.114222.4.11.1002/78278-9.json |
| 7827-9 | Coccidioides immitis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7827-9.json |
| 78279-7 | Mental health Education note | ./2.16.840.1.114222.4.11.1002/78279-7.json |
| 78280-5 | Surgery Education note | ./2.16.840.1.114222.4.11.1002/78280-5.json |
| 78281-3 | Infectious disease Education note | ./2.16.840.1.114222.4.11.1002/78281-3.json |
| 7828-7 | Coxiella burnetii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7828-7.json |
| 78290-4 | Telephone encounter Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78290-4.json |
| 78291-2 | Hematology Flowsheet | ./2.16.840.1.114222.4.11.1002/78291-2.json |
| 78292-0 | Surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78292-0.json |
| 78293-8 | Infectious disease Flowsheet | ./2.16.840.1.114222.4.11.1002/78293-8.json |
| 78294-6 | Dermatology Flowsheet | ./2.16.840.1.114222.4.11.1002/78294-6.json |
| 7829-5 | Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7829-5.json |
| 78295-3 | Endocrinology Flowsheet | ./2.16.840.1.114222.4.11.1002/78295-3.json |
| 78296-1 | Mental health Flowsheet | ./2.16.840.1.114222.4.11.1002/78296-1.json |
| 78297-9 | Gastroenterology Flowsheet | ./2.16.840.1.114222.4.11.1002/78297-9.json |
| 78298-7 | General medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/78298-7.json |
| 78299-5 | Family medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/78299-5.json |
| 78300-1 | Colon and rectal surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78300-1.json |
| 78301-9 | Dentistry Flowsheet | ./2.16.840.1.114222.4.11.1002/78301-9.json |
| 78302-7 | Emergency medicine Emergency department Flowsheet | ./2.16.840.1.114222.4.11.1002/78302-7.json |
| 7830-3 | Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7830-3.json |
| 78303-5 | Emergency department Flowsheet | ./2.16.840.1.114222.4.11.1002/78303-5.json |
| 78304-3 | Clinical genetics Flowsheet | ./2.16.840.1.114222.4.11.1002/78304-3.json |
| 78305-0 | Mental health Form | ./2.16.840.1.114222.4.11.1002/78305-0.json |
| 78306-8 | Mental health History and physical note | ./2.16.840.1.114222.4.11.1002/78306-8.json |
| 78307-6 | Emergency department History and physical note | ./2.16.840.1.114222.4.11.1002/78307-6.json |
| 78308-4 | General medicine History and physical note | ./2.16.840.1.114222.4.11.1002/78308-4.json |
| 78309-2 | Mental health Individual counseling note | ./2.16.840.1.114222.4.11.1002/78309-2.json |
| 78310-0 | Hematology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78310-0.json |
| 7831-1 | Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7831-1.json |
| 78311-8 | Clinical genetics Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78311-8.json |
| 78312-6 | Endocrinology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78312-6.json |
| 78313-4 | Colon and rectal surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/78313-4.json |
| 78314-2 | Dermatology procedure note | ./2.16.840.1.114222.4.11.1002/78314-2.json |
| 78315-9 | Family medicine procedure note | ./2.16.840.1.114222.4.11.1002/78315-9.json |
| 78316-7 | Emergency department procedure note | ./2.16.840.1.114222.4.11.1002/78316-7.json |
| 78317-5 | Gastroenterology procedure note | ./2.16.840.1.114222.4.11.1002/78317-5.json |
| 78318-3 | Infectious disease procedure note | ./2.16.840.1.114222.4.11.1002/78318-3.json |
| 78319-1 | Hematology procedure note | ./2.16.840.1.114222.4.11.1002/78319-1.json |
| 78320-9 | General medicine procedure note | ./2.16.840.1.114222.4.11.1002/78320-9.json |
| 78321-7 | Endocrinology procedure note | ./2.16.840.1.114222.4.11.1002/78321-7.json |
| 78322-5 | Surgery procedure note | ./2.16.840.1.114222.4.11.1002/78322-5.json |
| 78323-3 | Gastroenterology Progress note | ./2.16.840.1.114222.4.11.1002/78323-3.json |
| 78324-1 | Family medicine Progress note | ./2.16.840.1.114222.4.11.1002/78324-1.json |
| 78325-8 | Infectious disease Progress note | ./2.16.840.1.114222.4.11.1002/78325-8.json |
| 78326-6 | Dermatology Progress note | ./2.16.840.1.114222.4.11.1002/78326-6.json |
| 78327-4 | Endocrinology Progress note | ./2.16.840.1.114222.4.11.1002/78327-4.json |
| 78328-2 | Hematology Progress note | ./2.16.840.1.114222.4.11.1002/78328-2.json |
| 7832-9 | Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7832-9.json |
| 78329-0 | Colon and rectal surgery Referral note | ./2.16.840.1.114222.4.11.1002/78329-0.json |
| 78330-8 | Clinical genetics Referral note | ./2.16.840.1.114222.4.11.1002/78330-8.json |
| 78331-6 | Multi-specialty program Referral note | ./2.16.840.1.114222.4.11.1002/78331-6.json |
| 78332-4 | Family medicine Referral note | ./2.16.840.1.114222.4.11.1002/78332-4.json |
| 78333-2 | Infectious disease Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78333-2.json |
| 78334-0 | Dermatology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78334-0.json |
| 78335-7 | General medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78335-7.json |
| 78336-5 | Multi-specialty program Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78336-5.json |
| 7833-7 | Coxsackievirus A16 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7833-7.json |
| 78337-3 | Emergency department Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78337-3.json |
| 78338-1 | Family medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78338-1.json |
| 78339-9 | Gastroenterology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78339-9.json |
| 78340-7 | Colon and rectal surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78340-7.json |
| 78341-5 | Emergency department Transfer summary note | ./2.16.840.1.114222.4.11.1002/78341-5.json |
| 7834-5 | Coxsackievirus A7 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7834-5.json |
| 78345-6 | Docosenoate (C22:1) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78345-6.json |
| 78346-4 | Hexadecenoate (C16:1w9) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78346-4.json |
| 78347-2 | Docosapentaenate (C22:5w3) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78347-2.json |
| 78348-0 | Docosapentaenate (C22:5w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78348-0.json |
| 78349-8 | Lauroleate (C12:1) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78349-8.json |
| 78350-6 | Decenoate (C10:1) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78350-6.json |
| 78351-4 | Tetradecadienoate (C14:2) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78351-4.json |
| 7835-2 | Coxsackievirus A9 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7835-2.json |
| 78352-2 | Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78352-2.json |
| 78353-0 | Hexadecadienoate (C16:2) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/78353-0.json |
| 78354-8 | Arterial-alveolar oxygen Partial pressure ratio | ./2.16.840.1.114222.4.11.1002/78354-8.json |
| 78357-1 | Mycobacterium tuberculosis DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78357-1.json |
| 78358-9 | Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] palmitate substrate | ./2.16.840.1.114222.4.11.1002/78358-9.json |
| 7836-0 | Coxsackievirus B1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7836-0.json |
| 78360-5 | Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] myristate substrate | ./2.16.840.1.114222.4.11.1002/78360-5.json |
| 78362-1 | Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/78362-1.json |
| 78363-9 | Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78363-9.json |
| 78366-2 | Goose feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78366-2.json |
| 78367-0 | Pigeon serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78367-0.json |
| 78368-8 | Parrot serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78368-8.json |
| 78374-6 | American house dust mite native (nDer f) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78374-6.json |
| 78376-1 | Epipregnanolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/78376-1.json |
| 78377-9 | Epipregnanolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/78377-9.json |
| 7837-8 | Coxsackievirus B2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7837-8.json |
| 78378-7 | PON1 gene c.575A>G [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/78378-7.json |
| 78379-5 | Epipregnanolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78379-5.json |
| 78380-3 | Critical care medicine Surgical operation note | ./2.16.840.1.114222.4.11.1002/78380-3.json |
| 78381-1 | Colon and rectal surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78381-1.json |
| 78383-7 | Occupational therapy Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78383-7.json |
| 78384-5 | Cat dander native (nFel d) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78384-5.json |
| 78385-2 | Budgerigar serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78385-2.json |
| 7838-6 | Coxsackievirus B3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7838-6.json |
| 78386-0 | Neonatal perinatal medicine Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78386-0.json |
| 78387-8 | Nephrology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78387-8.json |
| 78388-6 | Neurological surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78388-6.json |
| 78389-4 | Neurology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78389-4.json |
| 78390-2 | Nurse Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78390-2.json |
| 78391-0 | Nurse practitioner Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78391-0.json |
| 78392-8 | Oncology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78392-8.json |
| 7839-4 | Coxsackievirus B4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7839-4.json |
| 7840-2 | Coxsackievirus B5 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7840-2.json |
| 78405-8 | Neonatal perinatal medicine Consult note | ./2.16.840.1.114222.4.11.1002/78405-8.json |
| 78406-6 | Nurse practitioner Consult note | ./2.16.840.1.114222.4.11.1002/78406-6.json |
| 78407-4 | Nurse Counseling note | ./2.16.840.1.114222.4.11.1002/78407-4.json |
| 78408-2 | Nurse practitioner Counseling note | ./2.16.840.1.114222.4.11.1002/78408-2.json |
| 78409-0 | Nurse Daily or end of shift signout note | ./2.16.840.1.114222.4.11.1002/78409-0.json |
| 7841-0 | Coxsackievirus B6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7841-0.json |
| 78410-8 | Neonatal perinatal medicine Discharge instructions | ./2.16.840.1.114222.4.11.1002/78410-8.json |
| 78411-6 | Nephrology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78411-6.json |
| 78412-4 | Neurology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78412-4.json |
| 78413-2 | Nurse Discharge instructions | ./2.16.840.1.114222.4.11.1002/78413-2.json |
| 78414-0 | Nurse practitioner Discharge instructions | ./2.16.840.1.114222.4.11.1002/78414-0.json |
| 78415-7 | Nutrition and dietetics Discharge instructions | ./2.16.840.1.114222.4.11.1002/78415-7.json |
| 78416-5 | Occupational therapy Discharge instructions | ./2.16.840.1.114222.4.11.1002/78416-5.json |
| 78417-3 | Oncology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78417-3.json |
| 78418-1 | Neonatal perinatal medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/78418-1.json |
| 78419-9 | Nephrology Discharge summary | ./2.16.840.1.114222.4.11.1002/78419-9.json |
| 78420-7 | Neurology Discharge summary | ./2.16.840.1.114222.4.11.1002/78420-7.json |
| 78421-5 | Oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/78421-5.json |
| 78422-3 | Neonatal perinatal medicine Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78422-3.json |
| 78423-1 | Nephrology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78423-1.json |
| 78424-9 | Neurology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78424-9.json |
| 78425-6 | Nurse Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78425-6.json |
| 78426-4 | Nurse practitioner Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78426-4.json |
| 78427-2 | Nutrition and dietetics Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78427-2.json |
| 7842-8 | Cryptococcus neoformans Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7842-8.json |
| 78428-0 | Oncology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78428-0.json |
| 78429-8 | Neonatal perinatal medicine Education note | ./2.16.840.1.114222.4.11.1002/78429-8.json |
| 78430-6 | Nephrology Education note | ./2.16.840.1.114222.4.11.1002/78430-6.json |
| 78431-4 | Neurological surgery Education note | ./2.16.840.1.114222.4.11.1002/78431-4.json |
| 78432-2 | Neurology Education note | ./2.16.840.1.114222.4.11.1002/78432-2.json |
| 78433-0 | Soluble liver IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/78433-0.json |
| 7843-6 | Cryptococcus sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7843-6.json |
| 78441-3 | Bilirubin.conjugated [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/78441-3.json |
| 78442-1 | Bilirubin.indirect [Moles/volume] in Peritoneal fluid | ./2.16.840.1.114222.4.11.1002/78442-1.json |
| 7844-4 | Taenia solium larva IgA Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/7844-4.json |
| 78444-7 | Hepatitis A virus IgG+IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/78444-7.json |
| 78445-4 | Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/78445-4.json |
| 78446-2 | Surgical critical care Flowsheet | ./2.16.840.1.114222.4.11.1002/78446-2.json |
| 78447-0 | Emergency department Checklist | ./2.16.840.1.114222.4.11.1002/78447-0.json |
| 78448-8 | Cardiopulmonary Checklist | ./2.16.840.1.114222.4.11.1002/78448-8.json |
| 78449-6 | Neurological surgery Checklist | ./2.16.840.1.114222.4.11.1002/78449-6.json |
| 78450-4 | Nurse practitioner Education note | ./2.16.840.1.114222.4.11.1002/78450-4.json |
| 7845-1 | Taenia solium larva IgA Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7845-1.json |
| 78451-2 | Nutrition and dietetics Education note | ./2.16.840.1.114222.4.11.1002/78451-2.json |
| 78452-0 | Occupational therapy Education note | ./2.16.840.1.114222.4.11.1002/78452-0.json |
| 78453-8 | Oncology Education note | ./2.16.840.1.114222.4.11.1002/78453-8.json |
| 78454-6 | Multi-specialty program Flowsheet | ./2.16.840.1.114222.4.11.1002/78454-6.json |
| 78455-3 | Neonatal perinatal medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/78455-3.json |
| 78456-1 | Nephrology Flowsheet | ./2.16.840.1.114222.4.11.1002/78456-1.json |
| 78457-9 | Neurological surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78457-9.json |
| 78458-7 | Neurology Flowsheet | ./2.16.840.1.114222.4.11.1002/78458-7.json |
| 78459-5 | Nurse practitioner Flowsheet | ./2.16.840.1.114222.4.11.1002/78459-5.json |
| 78460-3 | Nutrition and dietetics Flowsheet | ./2.16.840.1.114222.4.11.1002/78460-3.json |
| 78461-1 | Occupational therapy Flowsheet | ./2.16.840.1.114222.4.11.1002/78461-1.json |
| 78462-9 | Oncology Flowsheet | ./2.16.840.1.114222.4.11.1002/78462-9.json |
| 78463-7 | Nephrology History and physical note | ./2.16.840.1.114222.4.11.1002/78463-7.json |
| 78464-5 | Neurology History and physical note | ./2.16.840.1.114222.4.11.1002/78464-5.json |
| 78465-2 | Oncology History and physical note | ./2.16.840.1.114222.4.11.1002/78465-2.json |
| 78466-0 | Mental health Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78466-0.json |
| 78467-8 | Neonatal perinatal medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78467-8.json |
| 78468-6 | Nephrology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78468-6.json |
| 7846-9 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/7846-9.json |
| 78469-4 | Neurology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78469-4.json |
| 78470-2 | Nutrition and dietetics Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78470-2.json |
| 78471-0 | Oncology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78471-0.json |
| 78472-8 | Mental health procedure note | ./2.16.840.1.114222.4.11.1002/78472-8.json |
| 78473-6 | Neonatal perinatal medicine procedure note | ./2.16.840.1.114222.4.11.1002/78473-6.json |
| 78474-4 | Nephrology procedure note | ./2.16.840.1.114222.4.11.1002/78474-4.json |
| 78475-1 | Neurology procedure note | ./2.16.840.1.114222.4.11.1002/78475-1.json |
| 78476-9 | Nurse practitioner procedure note | ./2.16.840.1.114222.4.11.1002/78476-9.json |
| 7847-7 | Taenia solium larva IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7847-7.json |
| 78477-7 | Occupational therapy procedure note | ./2.16.840.1.114222.4.11.1002/78477-7.json |
| 78478-5 | Oncology procedure note | ./2.16.840.1.114222.4.11.1002/78478-5.json |
| 78479-3 | Neonatal perinatal medicine Progress note | ./2.16.840.1.114222.4.11.1002/78479-3.json |
| 78480-1 | Nephrology Progress note | ./2.16.840.1.114222.4.11.1002/78480-1.json |
| 78481-9 | Nutrition and dietetics Progress note | ./2.16.840.1.114222.4.11.1002/78481-9.json |
| 78482-7 | Oncology Progress note | ./2.16.840.1.114222.4.11.1002/78482-7.json |
| 78483-5 | Neonatal perinatal medicine Referral note | ./2.16.840.1.114222.4.11.1002/78483-5.json |
| 78484-3 | Nurse practitioner Referral note | ./2.16.840.1.114222.4.11.1002/78484-3.json |
| 7848-5 | Taenia solium larva IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/7848-5.json |
| 78485-0 | Mental health Restraint note | ./2.16.840.1.114222.4.11.1002/78485-0.json |
| 78486-8 | Mental health Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/78486-8.json |
| 78487-6 | Neurological surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78487-6.json |
| 78488-4 | Mental health Transfer summary note | ./2.16.840.1.114222.4.11.1002/78488-4.json |
| 78489-2 | Neonatal perinatal medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/78489-2.json |
| 78490-0 | Nephrology Transfer summary note | ./2.16.840.1.114222.4.11.1002/78490-0.json |
| 78491-8 | Neurology Transfer summary note | ./2.16.840.1.114222.4.11.1002/78491-8.json |
| 78492-6 | Neurological surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78492-6.json |
| 7849-3 | Taenia solium larva IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7849-3.json |
| 78493-4 | Oncology Transfer summary note | ./2.16.840.1.114222.4.11.1002/78493-4.json |
| 78494-2 | Nutrition and dietetics procedure note | ./2.16.840.1.114222.4.11.1002/78494-2.json |
| 78495-9 | Anesthesiology Checklist | ./2.16.840.1.114222.4.11.1002/78495-9.json |
| 78496-7 | Critical care medicine Consult note | ./2.16.840.1.114222.4.11.1002/78496-7.json |
| 78497-5 | Cardiopulmonary Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78497-5.json |
| 78498-3 | Cardiopulmonary Consult note | ./2.16.840.1.114222.4.11.1002/78498-3.json |
| 78499-1 | Cardiopulmonary Education note | ./2.16.840.1.114222.4.11.1002/78499-1.json |
| 78500-6 | Cardiopulmonary Flowsheet | ./2.16.840.1.114222.4.11.1002/78500-6.json |
| 7850-1 | Taenia solium larva Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7850-1.json |
| 78501-4 | Cardiopulmonary Referral note | ./2.16.840.1.114222.4.11.1002/78501-4.json |
| 78502-2 | Cardiopulmonary Transfer summary note | ./2.16.840.1.114222.4.11.1002/78502-2.json |
| 78503-0 | Surgery Checklist | ./2.16.840.1.114222.4.11.1002/78503-0.json |
| 78504-8 | Mental health Checklist | ./2.16.840.1.114222.4.11.1002/78504-8.json |
| 78505-5 | Colon and rectal surgery Checklist | ./2.16.840.1.114222.4.11.1002/78505-5.json |
| 78506-3 | Legal letter | ./2.16.840.1.114222.4.11.1002/78506-3.json |
| 78507-1 | Pediatrics Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78507-1.json |
| 78508-9 | Cardiothoracic surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78508-9.json |
| 78509-7 | Orthopaedic surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78509-7.json |
| 78510-5 | Vascular surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78510-5.json |
| 78511-3 | Oral and Maxillofacial Surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78511-3.json |
| 78512-1 | Ophthalmology Summary note | ./2.16.840.1.114222.4.11.1002/78512-1.json |
| 78513-9 | Ophthalmology Summary of encounters note | ./2.16.840.1.114222.4.11.1002/78513-9.json |
| 78514-7 | Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Specimen by Latex agglutination | ./2.16.840.1.114222.4.11.1002/78514-7.json |
| 78515-4 | Lactose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/78515-4.json |
| 78517-0 | Renin [Mass/volume] in Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/78517-0.json |
| 78518-8 | Cholesterol [Moles/volume] in Pericardial fluid | ./2.16.840.1.114222.4.11.1002/78518-8.json |
| 7851-9 | Cytomegalovirus Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/7851-9.json |
| 78519-6 | Platelet aggregation ADP induced in Platelet rich plasma --2 umol/L | ./2.16.840.1.114222.4.11.1002/78519-6.json |
| 78520-4 | Platelet aggregation ADP induced in Platelet rich plasma --2.5 umol/L | ./2.16.840.1.114222.4.11.1002/78520-4.json |
| 78521-2 | Platelet aggregation ADP induced in Platelet rich plasma --4 umol/L | ./2.16.840.1.114222.4.11.1002/78521-2.json |
| 78522-0 | Platelet aggregation ADP induced in Platelet rich plasma --5 umol/L | ./2.16.840.1.114222.4.11.1002/78522-0.json |
| 78523-8 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --100 umol/L | ./2.16.840.1.114222.4.11.1002/78523-8.json |
| 78524-6 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --6 umol/L | ./2.16.840.1.114222.4.11.1002/78524-6.json |
| 78525-3 | Platelet aggregation arachidonate induced in Platelet rich plasma --1.6 mmol/L | ./2.16.840.1.114222.4.11.1002/78525-3.json |
| 78526-1 | Platelet aggregation collagen induced in Platelet rich plasma --1.25 ug/ml | ./2.16.840.1.114222.4.11.1002/78526-1.json |
| 7852-7 | Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/7852-7.json |
| 78527-9 | Platelet aggregation collagen induced in Platelet rich plasma --5 ug/mL | ./2.16.840.1.114222.4.11.1002/78527-9.json |
| 78528-7 | Platelet aggregation ristocetin induced in Platelet rich plasma --1.25 mg/ml | ./2.16.840.1.114222.4.11.1002/78528-7.json |
| 78529-5 | Adenovirus Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/78529-5.json |
| 78530-3 | Vesicular stomatitis New Jersey virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78530-3.json |
| 78531-1 | Vesicular stomatitis Indiana virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78531-1.json |
| 7853-5 | Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/7853-5.json |
| 78538-6 | Palliative care Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78538-6.json |
| 78539-4 | Transplant surgery Checklist | ./2.16.840.1.114222.4.11.1002/78539-4.json |
| 78540-2 | Oral and Maxillofacial Surgery Checklist | ./2.16.840.1.114222.4.11.1002/78540-2.json |
| 78541-0 | Orthopaedic surgery Checklist | ./2.16.840.1.114222.4.11.1002/78541-0.json |
| 78542-8 | Vascular surgery Checklist | ./2.16.840.1.114222.4.11.1002/78542-8.json |
| 7854-3 | Dengue virus 1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7854-3.json |
| 78543-6 | Cardiothoracic surgery Checklist | ./2.16.840.1.114222.4.11.1002/78543-6.json |
| 78544-4 | Pediatric surgery Checklist | ./2.16.840.1.114222.4.11.1002/78544-4.json |
| 78545-1 | Plastic surgery Checklist | ./2.16.840.1.114222.4.11.1002/78545-1.json |
| 7855-0 | Dengue virus 1+2+3+4 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7855-0.json |
| 78567-5 | Pain medicine Consult note | ./2.16.840.1.114222.4.11.1002/78567-5.json |
| 7856-8 | Dengue virus 2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7856-8.json |
| 78568-3 | Palliative care Consult note | ./2.16.840.1.114222.4.11.1002/78568-3.json |
| 78569-1 | Respiratory therapy Counseling note | ./2.16.840.1.114222.4.11.1002/78569-1.json |
| 78570-9 | Speech-language pathology Counseling note | ./2.16.840.1.114222.4.11.1002/78570-9.json |
| 78571-7 | Rheumatology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78571-7.json |
| 78572-5 | Radiation oncology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78572-5.json |
| 78573-3 | Ophthalmology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78573-3.json |
| 78574-1 | Optometry Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78574-1.json |
| 78575-8 | Otolaryngology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78575-8.json |
| 7857-6 | Dengue virus 3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7857-6.json |
| 78576-6 | Urology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78576-6.json |
| 78577-4 | Podiatry Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78577-4.json |
| 78578-2 | Pediatrics Discharge instructions | ./2.16.840.1.114222.4.11.1002/78578-2.json |
| 78579-0 | Palliative care Discharge instructions | ./2.16.840.1.114222.4.11.1002/78579-0.json |
| 78580-8 | Respiratory therapy Discharge instructions | ./2.16.840.1.114222.4.11.1002/78580-8.json |
| 78581-6 | Recreational therapy Discharge instructions | ./2.16.840.1.114222.4.11.1002/78581-6.json |
| 78582-4 | Physical therapy Discharge instructions | ./2.16.840.1.114222.4.11.1002/78582-4.json |
| 78583-2 | Pharmacology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78583-2.json |
| 7858-4 | Dengue virus 4 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7858-4.json |
| 78584-0 | Speech-language pathology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78584-0.json |
| 78585-7 | Palliative care Discharge summary | ./2.16.840.1.114222.4.11.1002/78585-7.json |
| 78586-5 | Respiratory therapy Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78586-5.json |
| 78587-3 | Palliative care Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78587-3.json |
| 78588-1 | Recreational therapy Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78588-1.json |
| 78589-9 | Pharmacology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78589-9.json |
| 78590-7 | Pediatrics Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78590-7.json |
| 78591-5 | Physical therapy Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78591-5.json |
| 7859-2 | Dengue virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7859-2.json |
| 78592-3 | Speech-language pathology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78592-3.json |
| 78593-1 | Orthopaedic surgery Education note | ./2.16.840.1.114222.4.11.1002/78593-1.json |
| 78594-9 | Oral and Maxillofacial Surgery Education note | ./2.16.840.1.114222.4.11.1002/78594-9.json |
| 78595-6 | Radiation oncology Education note | ./2.16.840.1.114222.4.11.1002/78595-6.json |
| 78596-4 | Cardiothoracic surgery Education note | ./2.16.840.1.114222.4.11.1002/78596-4.json |
| 78597-2 | Vascular surgery Education note | ./2.16.840.1.114222.4.11.1002/78597-2.json |
| 78598-0 | Transplant surgery Education note | ./2.16.840.1.114222.4.11.1002/78598-0.json |
| 78599-8 | Palliative care Education note | ./2.16.840.1.114222.4.11.1002/78599-8.json |
| 7860-0 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7860-0.json |
| 78600-4 | Rheumatology Education note | ./2.16.840.1.114222.4.11.1002/78600-4.json |
| 78601-2 | Pharmacology Education note | ./2.16.840.1.114222.4.11.1002/78601-2.json |
| 78602-0 | Sports medicine Education note | ./2.16.840.1.114222.4.11.1002/78602-0.json |
| 78603-8 | Urology Education note | ./2.16.840.1.114222.4.11.1002/78603-8.json |
| 78604-6 | Physical therapy Education note | ./2.16.840.1.114222.4.11.1002/78604-6.json |
| 78605-3 | Optometry Education note | ./2.16.840.1.114222.4.11.1002/78605-3.json |
| 78606-1 | Pediatric surgery Education note | ./2.16.840.1.114222.4.11.1002/78606-1.json |
| 78607-9 | Social worker Education note | ./2.16.840.1.114222.4.11.1002/78607-9.json |
| 78608-7 | Ophthalmology Education note | ./2.16.840.1.114222.4.11.1002/78608-7.json |
| 78609-5 | Respiratory therapy Education note | ./2.16.840.1.114222.4.11.1002/78609-5.json |
| 78610-3 | Pain medicine Education note | ./2.16.840.1.114222.4.11.1002/78610-3.json |
| 78611-1 | Podiatry Education note | ./2.16.840.1.114222.4.11.1002/78611-1.json |
| 78612-9 | Otolaryngology Education note | ./2.16.840.1.114222.4.11.1002/78612-9.json |
| 78613-7 | Speech-language pathology Education note | ./2.16.840.1.114222.4.11.1002/78613-7.json |
| 78614-5 | Plastic surgery Education note | ./2.16.840.1.114222.4.11.1002/78614-5.json |
| 78615-2 | Pediatrics Education note | ./2.16.840.1.114222.4.11.1002/78615-2.json |
| 78616-0 | Oral and Maxillofacial Surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78616-0.json |
| 78617-8 | Optometry Flowsheet | ./2.16.840.1.114222.4.11.1002/78617-8.json |
| 7861-8 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7861-8.json |
| 78618-6 | Otolaryngology Flowsheet | ./2.16.840.1.114222.4.11.1002/78618-6.json |
| 78619-4 | Physical medicine and rehab Flowsheet | ./2.16.840.1.114222.4.11.1002/78619-4.json |
| 78620-2 | Vascular surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78620-2.json |
| 78621-0 | Pain medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/78621-0.json |
| 78622-8 | Urology Flowsheet | ./2.16.840.1.114222.4.11.1002/78622-8.json |
| 78623-6 | Sports medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/78623-6.json |
| 78624-4 | Primary care Flowsheet | ./2.16.840.1.114222.4.11.1002/78624-4.json |
| 78625-1 | Psychiatry Flowsheet | ./2.16.840.1.114222.4.11.1002/78625-1.json |
| 7862-6 | Ebola virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7862-6.json |
| 78626-9 | Cardiothoracic surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78626-9.json |
| 78627-7 | Pediatric surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78627-7.json |
| 78628-5 | Radiation oncology Flowsheet | ./2.16.840.1.114222.4.11.1002/78628-5.json |
| 78629-3 | Transplant surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78629-3.json |
| 78630-1 | Podiatry Flowsheet | ./2.16.840.1.114222.4.11.1002/78630-1.json |
| 78631-9 | Orthopaedic surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78631-9.json |
| 78632-7 | Speech-language pathology Flowsheet | ./2.16.840.1.114222.4.11.1002/78632-7.json |
| 78633-5 | Plastic surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/78633-5.json |
| 7863-4 | Echinococcus sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7863-4.json |
| 78634-3 | Pediatrics Flowsheet | ./2.16.840.1.114222.4.11.1002/78634-3.json |
| 78635-0 | Recreational therapy Flowsheet | ./2.16.840.1.114222.4.11.1002/78635-0.json |
| 78636-8 | Palliative care Flowsheet | ./2.16.840.1.114222.4.11.1002/78636-8.json |
| 78637-6 | Physical therapy Flowsheet | ./2.16.840.1.114222.4.11.1002/78637-6.json |
| 78638-4 | Ophthalmology Flowsheet | ./2.16.840.1.114222.4.11.1002/78638-4.json |
| 78639-2 | Rheumatology Flowsheet | ./2.16.840.1.114222.4.11.1002/78639-2.json |
| 78640-0 | Respiratory therapy Flowsheet | ./2.16.840.1.114222.4.11.1002/78640-0.json |
| 78641-8 | Psychology Flowsheet | ./2.16.840.1.114222.4.11.1002/78641-8.json |
| 7864-2 | Echovirus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7864-2.json |
| 78642-6 | Public health Form | ./2.16.840.1.114222.4.11.1002/78642-6.json |
| 78643-4 | Palliative care History and physical note | ./2.16.840.1.114222.4.11.1002/78643-4.json |
| 78644-2 | Pediatrics Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78644-2.json |
| 78645-9 | Urology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78645-9.json |
| 78646-7 | Recreational therapy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78646-7.json |
| 78647-5 | Ophthalmology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78647-5.json |
| 78648-3 | Optometry Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78648-3.json |
| 78649-1 | Otolaryngology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78649-1.json |
| 78650-9 | Palliative care Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78650-9.json |
| 78651-7 | Pain medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78651-7.json |
| 78652-5 | Rheumatology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78652-5.json |
| 78653-3 | Radiation oncology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78653-3.json |
| 78654-1 | Speech-language pathology procedure note | ./2.16.840.1.114222.4.11.1002/78654-1.json |
| 78655-8 | Otolaryngology procedure note | ./2.16.840.1.114222.4.11.1002/78655-8.json |
| 78656-6 | Radiation oncology procedure note | ./2.16.840.1.114222.4.11.1002/78656-6.json |
| 78657-4 | Ophthalmology procedure note | ./2.16.840.1.114222.4.11.1002/78657-4.json |
| 78658-2 | Respiratory therapy procedure note | ./2.16.840.1.114222.4.11.1002/78658-2.json |
| 7865-9 | Echovirus 11 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7865-9.json |
| 78659-0 | Urology procedure note | ./2.16.840.1.114222.4.11.1002/78659-0.json |
| 78660-8 | Rheumatology procedure note | ./2.16.840.1.114222.4.11.1002/78660-8.json |
| 78661-6 | Optometry procedure note | ./2.16.840.1.114222.4.11.1002/78661-6.json |
| 78662-4 | Physical therapy procedure note | ./2.16.840.1.114222.4.11.1002/78662-4.json |
| 78663-2 | Palliative care Progress note | ./2.16.840.1.114222.4.11.1002/78663-2.json |
| 78664-0 | Recreational therapy Progress note | ./2.16.840.1.114222.4.11.1002/78664-0.json |
| 78665-7 | Radiation oncology Progress note | ./2.16.840.1.114222.4.11.1002/78665-7.json |
| 78666-5 | Rheumatology Progress note | ./2.16.840.1.114222.4.11.1002/78666-5.json |
| 7866-7 | Echovirus 19 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7866-7.json |
| 78667-3 | Optometry Progress note | ./2.16.840.1.114222.4.11.1002/78667-3.json |
| 78668-1 | Pain medicine Progress note | ./2.16.840.1.114222.4.11.1002/78668-1.json |
| 78669-9 | Otolaryngology Progress note | ./2.16.840.1.114222.4.11.1002/78669-9.json |
| 78670-7 | Pediatrics Referral note | ./2.16.840.1.114222.4.11.1002/78670-7.json |
| 78671-5 | Primary care Referral note | ./2.16.840.1.114222.4.11.1002/78671-5.json |
| 78672-3 | Pain medicine Referral note | ./2.16.840.1.114222.4.11.1002/78672-3.json |
| 78673-1 | Pediatric surgery Referral note | ./2.16.840.1.114222.4.11.1002/78673-1.json |
| 78674-9 | Public health Referral note | ./2.16.840.1.114222.4.11.1002/78674-9.json |
| 7867-5 | Echovirus 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7867-5.json |
| 78675-6 | Pastoral care Referral note | ./2.16.840.1.114222.4.11.1002/78675-6.json |
| 78676-4 | Palliative care Referral note | ./2.16.840.1.114222.4.11.1002/78676-4.json |
| 78677-2 | Transplant surgery Referral note | ./2.16.840.1.114222.4.11.1002/78677-2.json |
| 78678-0 | Oral and Maxillofacial Surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78678-0.json |
| 78679-8 | Cardiothoracic surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78679-8.json |
| 78680-6 | Vascular surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78680-6.json |
| 78681-4 | Cardiothoracic surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78681-4.json |
| 78682-2 | Palliative care Transfer summary note | ./2.16.840.1.114222.4.11.1002/78682-2.json |
| 7868-3 | Echovirus 30 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/7868-3.json |
| 78683-0 | Transplant surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78683-0.json |
| 78684-8 | Oral and Maxillofacial Surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78684-8.json |
| 78685-5 | Platelet aggregation collagen induced [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78685-5.json |
| 78686-3 | Platelet aggregation ristocetin induced [Units/volume] in Blood --High dose | ./2.16.840.1.114222.4.11.1002/78686-3.json |
| 78687-1 | Platelet aggregation thrombin receptor activating peptide-6 induced [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78687-1.json |
| 78688-9 | Platelet aggregation adenosine diphosphate+prostaglandin E1 induced [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78688-9.json |
| 78689-7 | Adenylosuccinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78689-7.json |
| 78690-5 | 5-Hydroxymethyluracil/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78690-5.json |
| 7869-1 | Echovirus 4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7869-1.json |
| 78691-3 | Guanosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78691-3.json |
| 78692-1 | Pseudouridine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78692-1.json |
| 78693-9 | Dihydrothymine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78693-9.json |
| 78694-7 | Dihydroorotate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78694-7.json |
| 78695-4 | Guanine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78695-4.json |
| 78696-2 | Selenium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78696-2.json |
| 78697-0 | Olive IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78697-0.json |
| 78700-2 | Sports medicine Referral note | ./2.16.840.1.114222.4.11.1002/78700-2.json |
| 78701-0 | Cedar elm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78701-0.json |
| 78702-8 | Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/78702-8.json |
| 78703-6 | Sports medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/78703-6.json |
| 78704-4 | Sports medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78704-4.json |
| 78705-1 | Sports medicine Progress note | ./2.16.840.1.114222.4.11.1002/78705-1.json |
| 78706-9 | Oncology Form | ./2.16.840.1.114222.4.11.1002/78706-9.json |
| 78707-7 | Mental health Crisis intervention note | ./2.16.840.1.114222.4.11.1002/78707-7.json |
| 78708-5 | Daily or end of shift signout note | ./2.16.840.1.114222.4.11.1002/78708-5.json |
| 7870-9 | Echovirus 40 Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/7870-9.json |
| 78709-3 | Crisis intervention note | ./2.16.840.1.114222.4.11.1002/78709-3.json |
| 78710-1 | Cardiology Progress note | ./2.16.840.1.114222.4.11.1002/78710-1.json |
| 78711-9 | Obstetrics and Gynecology Flowsheet | ./2.16.840.1.114222.4.11.1002/78711-9.json |
| 78712-7 | Ophthalmology Checklist | ./2.16.840.1.114222.4.11.1002/78712-7.json |
| 78713-5 | Ophthalmology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78713-5.json |
| 78714-3 | Ophthalmology Surgical operation note | ./2.16.840.1.114222.4.11.1002/78714-3.json |
| 78715-0 | Oral and Maxillofacial Surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/78715-0.json |
| 78716-8 | Nutrition and dietetics Counseling note | ./2.16.840.1.114222.4.11.1002/78716-8.json |
| 7871-7 | Echovirus 6 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7871-7.json |
| 78717-6 | Obstetrics and Gynecology Checklist | ./2.16.840.1.114222.4.11.1002/78717-6.json |
| 78718-4 | Obstetrics and Gynecology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78718-4.json |
| 78719-2 | Obstetrics and Gynecology Surgical operation note | ./2.16.840.1.114222.4.11.1002/78719-2.json |
| 78720-0 | Obstetrics and Gynecology Discharge instructions | ./2.16.840.1.114222.4.11.1002/78720-0.json |
| 78721-8 | Obstetrics and Gynecology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/78721-8.json |
| 78722-6 | Obstetrics and Gynecology Education note | ./2.16.840.1.114222.4.11.1002/78722-6.json |
| 78723-4 | Obstetrics and Gynecology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78723-4.json |
| 78724-2 | Pediatric surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78724-2.json |
| 7872-5 | Echovirus 9 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7872-5.json |
| 78725-9 | Pediatric surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/78725-9.json |
| 78726-7 | Pediatrics Consult note | ./2.16.840.1.114222.4.11.1002/78726-7.json |
| 78727-5 | Plastic surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78727-5.json |
| 78728-3 | Respiratory therapy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/78728-3.json |
| 78729-1 | Surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/78729-1.json |
| 78730-9 | Cardiothoracic surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/78730-9.json |
| 78731-7 | Transplant surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78731-7.json |
| 78732-5 | Trauma Consult note | ./2.16.840.1.114222.4.11.1002/78732-5.json |
| 78733-3 | Urology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/78733-3.json |
| 78734-1 | Urology Checklist | ./2.16.840.1.114222.4.11.1002/78734-1.json |
| 78735-8 | Urology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/78735-8.json |
| 78736-6 | Urology Transfer summary note | ./2.16.840.1.114222.4.11.1002/78736-6.json |
| 78737-4 | Vascular surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/78737-4.json |
| 78738-2 | Sports medicine Consult note | ./2.16.840.1.114222.4.11.1002/78738-2.json |
| 78739-0 | Platelet aggregation ristocetin induced [Units/volume] in Blood --Low dose | ./2.16.840.1.114222.4.11.1002/78739-0.json |
| 78740-8 | Pathologic casts [#/area] in Urine by Automated count | ./2.16.840.1.114222.4.11.1002/78740-8.json |
| 7874-1 | Ehrlichia canis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7874-1.json |
| 78744-0 | FDA product label Drug for further processing label | ./2.16.840.1.114222.4.11.1002/78744-0.json |
| 78745-7 | FDA product label Recombinant deoxyribonucleic acid construct label | ./2.16.840.1.114222.4.11.1002/78745-7.json |
| 78746-5 | Country of birth [Location] | ./2.16.840.1.114222.4.11.1002/78746-5.json |
| 78749-9 | Glycolate [Mass/volume] in Serum or Plasma by Gas chromatography | ./2.16.840.1.114222.4.11.1002/78749-9.json |
| 78750-7 | Hepatitis E virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/78750-7.json |
| 78751-5 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78751-5.json |
| 78752-3 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/78752-3.json |
| 78753-1 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/78753-1.json |
| 78754-9 | 11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/78754-9.json |
| 78755-6 | 1-Hydroxymidazolam [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78755-6.json |
| 78756-4 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/78756-4.json |
| 78757-2 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/78757-2.json |
| 7875-8 | Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7875-8.json |
| 78758-0 | 4-Hydroxymidazolam [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78758-0.json |
| 78759-8 | 6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/78759-8.json |
| 78760-6 | 6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/78760-6.json |
| 78761-4 | 7-Aminoclonazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78761-4.json |
| 78762-2 | 7-Aminoflunitrazepam [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78762-2.json |
| 7876-6 | Ehrlichia chaffeensis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7876-6.json |
| 78771-3 | 9-Hydroxyrisperidone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78771-3.json |
| 78772-1 | Abacavir [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/78772-1.json |
| 78773-9 | Abacavir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78773-9.json |
| 7877-4 | Anaplasma phagocytophilum Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7877-4.json |
| 78774-7 | Acenocoumarol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78774-7.json |
| 78775-4 | Acenocoumarol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78775-4.json |
| 78776-2 | Acepromazine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78776-2.json |
| 78777-0 | Alfentanil [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78777-0.json |
| 78778-8 | Alfentanil [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/78778-8.json |
| 78779-6 | Alizapride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78779-6.json |
| 78780-4 | Alminoprofen [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78780-4.json |
| 78782-0 | Aluminum [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/78782-0.json |
| 78784-6 | Amiodarone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78784-6.json |
| 78785-3 | Amitriptyline [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78785-3.json |
| 78786-1 | Amitriptyline [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78786-1.json |
| 78787-9 | amLODIPine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78787-9.json |
| 78788-7 | amLODIPine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78788-7.json |
| 78789-5 | Amoxapine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78789-5.json |
| 7879-0 | Ehrlichia sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7879-0.json |
| 78790-3 | Amphetamine [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/78790-3.json |
| 78792-9 | Anakinra [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78792-9.json |
| 78793-7 | ARIPiprazole [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78793-7.json |
| 78794-5 | ARIPiprazole [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78794-5.json |
| 78795-2 | Arsenic [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/78795-2.json |
| 78796-0 | Atazanavir [Mass/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/78796-0.json |
| 78797-8 | Atazanavir [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/78797-8.json |
| 78798-6 | Atenolol [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78798-6.json |
| 78799-4 | Atenolol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78799-4.json |
| 78800-0 | Atropine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78800-0.json |
| 78801-8 | Atropine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78801-8.json |
| 78802-6 | Baclofen [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78802-6.json |
| 78803-4 | Barbital [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78803-4.json |
| 78804-2 | Barbital [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78804-2.json |
| 78805-9 | Barium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/78805-9.json |
| 78806-7 | Alminoprofen [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/78806-7.json |
| 78807-5 | Barium [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78807-5.json |
| 7880-8 | Entamoeba histolytica Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7880-8.json |
| 78808-3 | Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL | ./2.16.840.1.114222.4.11.1002/78808-3.json |
| 78809-1 | Benzylpiperazine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78809-1.json |
| 78810-9 | Beryllium [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/78810-9.json |
| 78813-3 | Cannabicyclohexanol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78813-3.json |
| 78815-8 | Carisoprodol [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78815-8.json |
| 7881-6 | Enterovirus RNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7881-6.json |
| 78816-6 | Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78816-6.json |
| 78817-4 | Cathinone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78817-4.json |
| 78823-2 | DULoxetine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78823-2.json |
| 7882-4 | Epstein Barr virus early Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7882-4.json |
| 78825-7 | Ecgonine methyl ester [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78825-7.json |
| 78826-5 | Ethyl acetate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78826-5.json |
| 78829-9 | Gamma hydroxybutyrate [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78829-9.json |
| 78831-5 | Hydroxybupropion [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78831-5.json |
| 7883-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7883-2.json |
| 78833-1 | Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78833-1.json |
| 7884-0 | Epstein Barr virus nuclear IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7884-0.json |
| 78843-0 | JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78843-0.json |
| 78845-5 | JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78845-5.json |
| 78848-9 | JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78848-9.json |
| 78851-3 | M-chlorophenylpiperazine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/78851-3.json |
| 78852-1 | M-chlorophenylpiperazine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78852-1.json |
| 78853-9 | M-chlorophenylpiperazine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/78853-9.json |
| 78854-7 | M-chlorophenylpiperazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78854-7.json |
| 78855-4 | M-chlorophenylpiperazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78855-4.json |
| 78856-2 | Meprobamate [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78856-2.json |
| 7885-7 | Epstein Barr virus capsid IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7885-7.json |
| 78858-8 | Methcathinone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78858-8.json |
| 78859-6 | Mirtazapine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78859-6.json |
| 78862-0 | Naloxol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78862-0.json |
| 7886-5 | Epstein Barr virus capsid IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7886-5.json |
| 78866-1 | Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method | ./2.16.840.1.114222.4.11.1002/78866-1.json |
| 78867-9 | Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method | ./2.16.840.1.114222.4.11.1002/78867-9.json |
| 78870-3 | OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78870-3.json |
| 7887-3 | Filaria Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7887-3.json |
| 78876-0 | Pheniramine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/78876-0.json |
| 78878-6 | RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78878-6.json |
| 78880-2 | RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78880-2.json |
| 7888-1 | Francisella tularensis Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7888-1.json |
| 78883-6 | Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78883-6.json |
| 78884-4 | Lurasidone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/78884-4.json |
| 78887-7 | Trans-3-Hydroxycotinine [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/78887-7.json |
| 78888-5 | Trimeprazine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/78888-5.json |
| 78889-3 | Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL | ./2.16.840.1.114222.4.11.1002/78889-3.json |
| 78890-1 | Barium [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78890-1.json |
| 78891-9 | Tricyclic antidepressants [Presence] in Hair | ./2.16.840.1.114222.4.11.1002/78891-9.json |
| 78892-7 | Silver [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/78892-7.json |
| 78893-5 | Tricyclic antidepressants [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/78893-5.json |
| 78894-3 | Liver fibrosis score in Serum or Plasma Calculated by HepaScore | ./2.16.840.1.114222.4.11.1002/78894-3.json |
| 7889-9 | Francisella tularensis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7889-9.json |
| 7890-7 | Francisella tularensis IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7890-7.json |
| 7891-5 | Giardia lamblia IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7891-5.json |
| 78915-6 | FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/78915-6.json |
| 78920-6 | cycloSPORINE [Moles/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/78920-6.json |
| 7892-3 | Giardia lamblia IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7892-3.json |
| 7893-1 | Gliadin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7893-1.json |
| 7894-9 | Haemophilus influenzae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7894-9.json |
| 7895-6 | Hantavirus hantaan IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7895-6.json |
| 78958-6 | Cathepsin A [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/78958-6.json |
| 78959-4 | Hyocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78959-4.json |
| 78961-0 | IgG clearance/Albumin clearance [Ratio] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78961-0.json |
| 78962-8 | IgG clearance/Transferrin clearance [Ratio] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78962-8.json |
| 78963-6 | Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/78963-6.json |
| 7896-4 | Hantavirus hantaan IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7896-4.json |
| 78964-4 | N-acetylaspartylglutamate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/78964-4.json |
| 78965-1 | Neurofilament medium chain Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/78965-1.json |
| 78966-9 | S-adenosylmethionine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78966-9.json |
| 78967-7 | Sedoheptulose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/78967-7.json |
| 78968-5 | Benperidol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78968-5.json |
| 78969-3 | Neurofilament heavy chain Ab [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/78969-3.json |
| 78970-1 | Phosphomannomutase 1 [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/78970-1.json |
| 78971-9 | Phosphomannomutase 1 [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/78971-9.json |
| 7897-2 | Hantavirus puumala IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7897-2.json |
| 78972-7 | CYP2C8 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/78972-7.json |
| 78973-5 | CT scanogram Lower extremity - bilateral for leg measurement WO contrast | ./2.16.840.1.114222.4.11.1002/78973-5.json |
| 789-8 | Erythrocytes [#/volume] in Blood by Automated count | ./2.16.840.1.114222.4.11.1002/789-8.json |
| 7898-0 | Hantavirus puumala IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7898-0.json |
| 78982-6 | D-3-phosphoglycerate dehydrogenase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/78982-6.json |
| 78983-4 | 4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/78983-4.json |
| 78987-5 | Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/78987-5.json |
| 78989-1 | Cryoglobulin [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/78989-1.json |
| 78990-9 | Flavin adenine dinucleotide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/78990-9.json |
| 78991-7 | Flavin adenine dinucleotide [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/78991-7.json |
| 78992-5 | Melatonin [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/78992-5.json |
| 7899-8 | Hantavirus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7899-8.json |
| 7900-4 | Helicobacter pylori Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7900-4.json |
| 7901-2 | Helicobacter pylori IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7901-2.json |
| 7902-0 | Helicobacter pylori IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7902-0.json |
| 7903-8 | Helicobacter pylori IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7903-8.json |
| 7904-6 | Hepatitis A virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7904-6.json |
| 7905-3 | Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test | ./2.16.840.1.114222.4.11.1002/7905-3.json |
| 7906-1 | Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7906-1.json |
| 79065-9 | CT Abdomen and Pelvis 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79065-9.json |
| 79066-7 | CT Abdomen 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79066-7.json |
| 79067-5 | CT Airway WO contrast | ./2.16.840.1.114222.4.11.1002/79067-5.json |
| 79068-3 | CT Chest for screening W contrast IV | ./2.16.840.1.114222.4.11.1002/79068-3.json |
| 79069-1 | CT Colon and Rectum for screening WO contrast IV and W air contrast PR | ./2.16.840.1.114222.4.11.1002/79069-1.json |
| 79071-7 | CT Colon and Rectum WO contrast IV and W air contrast PR | ./2.16.840.1.114222.4.11.1002/79071-7.json |
| 79072-5 | CT Guidance for radiation treatment of Unspecified body region | ./2.16.840.1.114222.4.11.1002/79072-5.json |
| 79073-3 | CTA Heart and Coronary arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/79073-3.json |
| 79074-1 | CT Kidney and Ureter and Urinary bladder 3D post processing WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/79074-1.json |
| 79075-8 | CT Pelvis by reconstruction W contrast IV | ./2.16.840.1.114222.4.11.1002/79075-8.json |
| 79076-6 | CT Pelvis by reconstruction WO contrast | ./2.16.840.1.114222.4.11.1002/79076-6.json |
| 79077-4 | CTA Pulmonary arteries for pulmonary embolus W contrast IV | ./2.16.840.1.114222.4.11.1002/79077-4.json |
| 79078-2 | CT Cervical spine by reconstruction W contrast IV | ./2.16.840.1.114222.4.11.1002/79078-2.json |
| 7907-9 | Herpes simplex virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7907-9.json |
| 79079-0 | CT Cervical spine by reconstruction WO contrast | ./2.16.840.1.114222.4.11.1002/79079-0.json |
| 79080-8 | CT Lumbar spine by reconstruction W contrast IV | ./2.16.840.1.114222.4.11.1002/79080-8.json |
| 79081-6 | CT Lumbar spine by reconstruction WO contrast | ./2.16.840.1.114222.4.11.1002/79081-6.json |
| 79082-4 | CT Thoracic spine by reconstruction W contrast IV | ./2.16.840.1.114222.4.11.1002/79082-4.json |
| 79083-2 | CT Temporal bone by reconstruction W contrast IV | ./2.16.840.1.114222.4.11.1002/79083-2.json |
| 79084-0 | CT Temporal bone by reconstruction WO contrast | ./2.16.840.1.114222.4.11.1002/79084-0.json |
| 79085-7 | CT Biliary ducts WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/79085-7.json |
| 79086-5 | CT Chest for screening WO contrast | ./2.16.840.1.114222.4.11.1002/79086-5.json |
| 7908-7 | Herpes simplex virus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7908-7.json |
| 79087-3 | CT Heart and Coronary arteries for calcium scoring WO contrast | ./2.16.840.1.114222.4.11.1002/79087-3.json |
| 79088-1 | CT Heart for congenital disease W contrast IV | ./2.16.840.1.114222.4.11.1002/79088-1.json |
| 79089-9 | CT Heart W contrast IV | ./2.16.840.1.114222.4.11.1002/79089-9.json |
| 79090-7 | CT densitometry Lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/79090-7.json |
| 79091-5 | CT Thoracic spine by reconstruction WO contrast | ./2.16.840.1.114222.4.11.1002/79091-5.json |
| 79092-3 | CT densitometry Thoracic spine WO contrast | ./2.16.840.1.114222.4.11.1002/79092-3.json |
| 79093-1 | CT Unspecified body region 3D post processing | ./2.16.840.1.114222.4.11.1002/79093-1.json |
| 79094-9 | CT Urinary bladder W contrast intra bladder | ./2.16.840.1.114222.4.11.1002/79094-9.json |
| 7909-5 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7909-5.json |
| 79095-6 | CT Teeth | ./2.16.840.1.114222.4.11.1002/79095-6.json |
| 79096-4 | CT Chest 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79096-4.json |
| 79097-2 | CT Chest and Abdomen 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79097-2.json |
| 79098-0 | CT Chest and Abdomen and Pelvis 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79098-0.json |
| 79099-8 | CT Pelvis 3D post processing WO contrast | ./2.16.840.1.114222.4.11.1002/79099-8.json |
| 79101-2 | CT Colon and Rectum for screening W air contrast PR | ./2.16.840.1.114222.4.11.1002/79101-2.json |
| 79102-0 | Heart transplant acute cellular rejection risk [Score] in Mononuclear cells Calculated by AlloMap | ./2.16.840.1.114222.4.11.1002/79102-0.json |
| 7910-3 | Herpes simplex virus 1 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7910-3.json |
| 79103-8 | CT Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/79103-8.json |
| 7911-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7911-1.json |
| 79125-1 | Hawkinsin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79125-1.json |
| 79126-9 | Uroporphyrin 1 isomer [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/79126-9.json |
| 79127-7 | Uroporphyrin 1 isomer/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79127-7.json |
| 79128-5 | Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/79128-5.json |
| 7912-9 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7912-9.json |
| 79129-3 | Uroporphyrin 3 isomer/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79129-3.json |
| 79130-1 | Platelet aggregation ristocetin induced in Platelet rich plasma --500 ug/mL | ./2.16.840.1.114222.4.11.1002/79130-1.json |
| 79131-9 | 1-Hydroxymidazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79131-9.json |
| 79132-7 | 4-Hydroxymidazolam [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79132-7.json |
| 79133-5 | 9-Hydroxyrisperidone [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79133-5.json |
| 79134-3 | Abacavir [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79134-3.json |
| 79135-0 | Acebutolol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79135-0.json |
| 79136-8 | Acepromazine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79136-8.json |
| 7913-7 | Herpes simplex virus 2 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7913-7.json |
| 79137-6 | Benzylpiperazine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79137-6.json |
| 79138-4 | Buprenorphine [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79138-4.json |
| 79139-2 | Buprenorphine [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/79139-2.json |
| 79140-0 | Carisoprodol+Meprobamate [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/79140-0.json |
| 79141-8 | Cathinone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/79141-8.json |
| 79142-6 | Gamma hydroxybutyrate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79142-6.json |
| 79143-4 | Mercury [Moles/mass] in Nail | ./2.16.840.1.114222.4.11.1002/79143-4.json |
| 79144-2 | Methcathinone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/79144-2.json |
| 7914-5 | Heterophile Ab after beef cell absorption [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/7914-5.json |
| 79145-9 | Tapentadol [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79145-9.json |
| 79146-7 | Tapentadol [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/79146-7.json |
| 79147-5 | traMADol [Presence] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79147-5.json |
| 79148-3 | traMADol [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/79148-3.json |
| 79149-1 | Trimeprazine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79149-1.json |
| 79151-7 | Known allergies to food or environmental agents | ./2.16.840.1.114222.4.11.1002/79151-7.json |
| 7915-2 | Heterophile Ab after guinea pig cell absorption [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/7915-2.json |
| 79152-5 | Acenocoumarol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79152-5.json |
| 79153-3 | Alfentanil [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79153-3.json |
| 79154-1 | Alizapride [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79154-1.json |
| 79157-4 | Cold agglutinin [Titer] in Serum by 22 degree C incubation --1 hour post incubation | ./2.16.840.1.114222.4.11.1002/79157-4.json |
| 79158-2 | Cold agglutinin [Titer] in Serum by 4 deg C incubation --1 hour post incubation | ./2.16.840.1.114222.4.11.1002/79158-2.json |
| 79159-0 | Cold agglutinin [Titer] in Serum by 4 deg C incubation --24 hour post incubation | ./2.16.840.1.114222.4.11.1002/79159-0.json |
| 7916-0 | Histoplasma capsulatum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7916-0.json |
| 79164-0 | CES1 gene c.428G>A [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79164-0.json |
| 79166-5 | Peach natural (nPru p) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79166-5.json |
| 79167-3 | Honey bee recombinant (rApi m) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79167-3.json |
| 79168-1 | Cherry recombinant (rPru av) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79168-1.json |
| 79169-9 | Cherry recombinant (rPru av) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79169-9.json |
| 79170-7 | Cherry recombinant (rPru av) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79170-7.json |
| 79171-5 | Apple recombinant (rMal d) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79171-5.json |
| 79172-3 | Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/79172-3.json |
| 79173-1 | Somatotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/79173-1.json |
| 79174-9 | Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge | ./2.16.840.1.114222.4.11.1002/79174-9.json |
| 79175-6 | Somatotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge | ./2.16.840.1.114222.4.11.1002/79175-6.json |
| 79176-4 | Somatotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/79176-4.json |
| 79177-2 | Clostridioides difficile glutamate dehydrogenase and toxins A+B [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/79177-2.json |
| 7917-8 | HIV 1 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7917-8.json |
| 79178-0 | 4-Hydroxycyclohexylacetate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79178-0.json |
| 79179-8 | Somatotropin [Units/volume] in Serum or Plasma --75 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/79179-8.json |
| 79180-6 | Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/79180-6.json |
| 79181-4 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge | ./2.16.840.1.114222.4.11.1002/79181-4.json |
| 79182-2 | RNA polymerase III IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/79182-2.json |
| 7918-6 | HIV 1+2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7918-6.json |
| 79186-3 | Cells.CD3+CD4+CD8+ (Double positive)/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/79186-3.json |
| 79187-1 | Cells.CD3+CD4+CD8+ (Double positive) [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/79187-1.json |
| 79188-9 | Platelet aggregation ADP induced in Platelet rich plasma --10 umol/L | ./2.16.840.1.114222.4.11.1002/79188-9.json |
| 79189-7 | Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/79189-7.json |
| 79190-5 | Zika virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/79190-5.json |
| 79192-1 | Maternal pregnancy information Narrative | ./2.16.840.1.114222.4.11.1002/79192-1.json |
| 79193-9 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79193-9.json |
| 7919-4 | HIV 2 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7919-4.json |
| 79194-7 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79194-7.json |
| 79195-4 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79195-4.json |
| 79196-2 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79196-2.json |
| 79197-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79197-0.json |
| 79198-8 | Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79198-8.json |
| 79199-6 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79199-6.json |
| 79200-2 | Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79200-2.json |
| 79201-0 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79201-0.json |
| 7920-2 | Influenza virus A Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7920-2.json |
| 79202-8 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79202-8.json |
| 79203-6 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79203-6.json |
| 79204-4 | Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79204-4.json |
| 79205-1 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/79205-1.json |
| 79206-9 | inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/79206-9.json |
| 79207-7 | BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79207-7.json |
| 79208-5 | BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79208-5.json |
| 79209-3 | t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79209-3.json |
| 7921-0 | Influenza virus A Bangkok Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7921-0.json |
| 79210-1 | FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79210-1.json |
| 79213-5 | Type of education program assigned to patient | ./2.16.840.1.114222.4.11.1002/79213-5.json |
| 79214-3 | Education program [URI] | ./2.16.840.1.114222.4.11.1002/79214-3.json |
| 79215-0 | Education program online access code | ./2.16.840.1.114222.4.11.1002/79215-0.json |
| 79216-8 | Date education program assigned to Patient | ./2.16.840.1.114222.4.11.1002/79216-8.json |
| 79217-6 | Date education program started by Patient | ./2.16.840.1.114222.4.11.1002/79217-6.json |
| 79218-4 | Date education program completed by Patient | ./2.16.840.1.114222.4.11.1002/79218-4.json |
| 79219-2 | Date education program expires for Patient | ./2.16.840.1.114222.4.11.1002/79219-2.json |
| 79220-0 | Steroid fractions interpretation in Serum or Plasma Narrative | ./2.16.840.1.114222.4.11.1002/79220-0.json |
| 79222-6 | Benzodiazepines [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/79222-6.json |
| 79223-4 | Atenolol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79223-4.json |
| 79224-2 | Baclofen [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79224-2.json |
| 79225-9 | Barbital [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79225-9.json |
| 79226-7 | ARIPiprazole [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79226-7.json |
| 79227-5 | Amobarbital [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79227-5.json |
| 7922-8 | Influenza virus A England Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7922-8.json |
| 79228-3 | amLODIPine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79228-3.json |
| 79229-1 | Amitriptyline [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79229-1.json |
| 79230-9 | Amiodarone [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/79230-9.json |
| 79231-7 | Amoxapine [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/79231-7.json |
| 79232-5 | Naphyrone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79232-5.json |
| 79234-1 | Butylone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79234-1.json |
| 7923-6 | Influenza virus A Hong Kong Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7923-6.json |
| 79243-2 | Ethylone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79243-2.json |
| 7924-4 | Influenza virus A Leningrad Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7924-4.json |
| 79246-5 | Methedrone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79246-5.json |
| 7925-1 | Influenza virus A Mississippi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7925-1.json |
| 79264-8 | Glucose [Moles/volume] in Peritoneal dialysis fluid --overnight dwell | ./2.16.840.1.114222.4.11.1002/79264-8.json |
| 79265-5 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --overnight dwell | ./2.16.840.1.114222.4.11.1002/79265-5.json |
| 79266-3 | Lead [Mass/mass] in Dentin | ./2.16.840.1.114222.4.11.1002/79266-3.json |
| 79267-1 | Sports medicine procedure note | ./2.16.840.1.114222.4.11.1002/79267-1.json |
| 79268-9 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79268-9.json |
| 7926-9 | Influenza virus A Phillipines Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7926-9.json |
| 79269-7 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79269-7.json |
| 79270-5 | 3-Hydroxytrimethyl-L-lysine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79270-5.json |
| 79271-3 | 3-Hydroxytrimethyl-L-lysine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79271-3.json |
| 79272-1 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79272-1.json |
| 79273-9 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/79273-9.json |
| 79274-7 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79274-7.json |
| 79275-4 | 3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79275-4.json |
| 79276-2 | 7,8-Dihydrobiopterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79276-2.json |
| 7927-7 | Influenza virus A Port Chalmers Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7927-7.json |
| 79277-0 | 7-lathosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79277-0.json |
| 79278-8 | 8-lathosterol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79278-8.json |
| 79279-6 | Alpha-aminoadipic semialdehyde [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79279-6.json |
| 79280-4 | Alpha-aminoadipic semialdehyde [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79280-4.json |
| 79281-2 | Arabinose/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79281-2.json |
| 79282-0 | Biopterin/Biopterin+Neopterin [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79282-0.json |
| 79283-8 | C29 dicarboxylate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79283-8.json |
| 7928-5 | Influenza virus A Texas Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7928-5.json |
| 7929-3 | Influenza virus A Victoria Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7929-3.json |
| 7930-1 | Influenza virus A+B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7930-1.json |
| 79304-2 | D-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79304-2.json |
| 79305-9 | D-2-hydroxyglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79305-9.json |
| 79306-7 | D-2-hydroxyglutarate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79306-7.json |
| 79307-5 | D-2-hydroxyglutarate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/79307-5.json |
| 79308-3 | Gamma butyrobetaine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79308-3.json |
| 79309-1 | Gamma butyrobetaine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79309-1.json |
| 79310-9 | Gamma butyrobetaine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79310-9.json |
| 79311-7 | Gamma butyrobetaine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79311-7.json |
| 79312-5 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79312-5.json |
| 79313-3 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79313-3.json |
| 79314-1 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/79314-1.json |
| 79315-8 | Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79315-8.json |
| 79316-6 | Isoxanthopterin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79316-6.json |
| 79317-4 | L-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79317-4.json |
| 79318-2 | L-2-hydroxyglutarate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79318-2.json |
| 7931-9 | Influenza virus B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7931-9.json |
| 79319-0 | L-2-hydroxyglutarate [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/79319-0.json |
| 79320-8 | Lysophosphatidylcholine(26:0) [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79320-8.json |
| 79321-6 | Lysophosphatidylcholine(26:0) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79321-6.json |
| 79322-4 | Lysophosphatidylcholine(26:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79322-4.json |
| 79323-2 | 7-Isobiopterin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79323-2.json |
| 79326-5 | Squalene [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79326-5.json |
| 7932-7 | Influenza virus C Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7932-7.json |
| 79328-1 | Trimethyllysine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79328-1.json |
| 79329-9 | Trimethyllysine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79329-9.json |
| 79330-7 | Trimethyllysine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79330-7.json |
| 79331-5 | Trimethyllysine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79331-5.json |
| 79333-1 | Viscosity of Cervical mucus Qualitative | ./2.16.840.1.114222.4.11.1002/79333-1.json |
| 79334-9 | Hypoglycemics.oral [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/79334-9.json |
| 7933-5 | Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/7933-5.json |
| 79335-6 | Hypoglycemics.oral [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/79335-6.json |
| 79336-4 | Hypoglycemics.oral [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/79336-4.json |
| 79337-2 | Hypoglycemics.oral [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/79337-2.json |
| 79338-0 | Hypoglycemics.oral [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/79338-0.json |
| 7934-3 | Japanese encephalitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7934-3.json |
| 79346-3 | Alpha-aminoadipic semialdehyde/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79346-3.json |
| 79347-1 | Sulfate.total/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79347-1.json |
| 79348-9 | Body weight --used for drug calculation | ./2.16.840.1.114222.4.11.1002/79348-9.json |
| 79349-7 | XR Spine Lumbar and Sacrum GE 6 Views | ./2.16.840.1.114222.4.11.1002/79349-7.json |
| 7935-0 | Japanese encephalitis virus Ab [Units/volume] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/7935-0.json |
| 79350-5 | XR Abdomen GE 3 Views | ./2.16.840.1.114222.4.11.1002/79350-5.json |
| 79351-3 | XR Cervical spine GE 2 Views | ./2.16.840.1.114222.4.11.1002/79351-3.json |
| 79352-1 | XR Cervical spine GE 6 Views | ./2.16.840.1.114222.4.11.1002/79352-1.json |
| 79353-9 | XR Elbow GE 3 Views | ./2.16.840.1.114222.4.11.1002/79353-9.json |
| 79354-7 | XR Finger GE 2 Views | ./2.16.840.1.114222.4.11.1002/79354-7.json |
| 79355-4 | XR Foot 3 Views W standing | ./2.16.840.1.114222.4.11.1002/79355-4.json |
| 79356-2 | XR Hand 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/79356-2.json |
| 79357-0 | XR Hand GE 3 Views | ./2.16.840.1.114222.4.11.1002/79357-0.json |
| 79358-8 | XR Hip - bilateral GE 4 Views | ./2.16.840.1.114222.4.11.1002/79358-8.json |
| 79359-6 | XR Hip - left GE 2 Views | ./2.16.840.1.114222.4.11.1002/79359-6.json |
| 79360-4 | XR Hip - right GE 2 Views | ./2.16.840.1.114222.4.11.1002/79360-4.json |
| 79361-2 | XR Hip GE 2 Views | ./2.16.840.1.114222.4.11.1002/79361-2.json |
| 79362-0 | XR Humerus GE 2 Views | ./2.16.840.1.114222.4.11.1002/79362-0.json |
| 79363-8 | XR Knee - bilateral AP and Lateral and Merchants and (Views W standing) | ./2.16.840.1.114222.4.11.1002/79363-8.json |
| 79364-6 | XR Knee GE 4 Views | ./2.16.840.1.114222.4.11.1002/79364-6.json |
| 79365-3 | XR Ribs - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/79365-3.json |
| 79366-1 | XR Ribs - unilateral and Chest 2 Views | ./2.16.840.1.114222.4.11.1002/79366-1.json |
| 79367-9 | XR Sacrum and Coccyx GE 2 Views | ./2.16.840.1.114222.4.11.1002/79367-9.json |
| 7936-8 | Japanese encephalitis virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7936-8.json |
| 79368-7 | XR Shoulder - left GE 2 Views | ./2.16.840.1.114222.4.11.1002/79368-7.json |
| 79369-5 | XR Shoulder - right GE 2 Views | ./2.16.840.1.114222.4.11.1002/79369-5.json |
| 79370-3 | XR Shoulder GE 2 Views | ./2.16.840.1.114222.4.11.1002/79370-3.json |
| 79371-1 | XR Spine Lumbar and Sacrum GE 2 Views | ./2.16.840.1.114222.4.11.1002/79371-1.json |
| 79372-9 | XR Spine Lumbar and Sacrum GE 4 Views | ./2.16.840.1.114222.4.11.1002/79372-9.json |
| 79373-7 | XR Toe GE 2 Views | ./2.16.840.1.114222.4.11.1002/79373-7.json |
| 79374-5 | US Abdominal Aorta for screening | ./2.16.840.1.114222.4.11.1002/79374-5.json |
| 79375-2 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--2nd specimen | ./2.16.840.1.114222.4.11.1002/79375-2.json |
| 7937-6 | Junin virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7937-6.json |
| 79376-0 | Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--3rd specimen | ./2.16.840.1.114222.4.11.1002/79376-0.json |
| 79377-8 | Naltrexol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79377-8.json |
| 79379-4 | HIV 1 RNA+proviral DNA [Presence] in Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/79379-4.json |
| 79380-2 | HIV 1 RNA+proviral DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/79380-2.json |
| 79393-5 | Flavin mononucleotide [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79393-5.json |
| 79394-3 | Hepatocyte growth factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79394-3.json |
| 79395-0 | NADH:ubiquinone reductase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/79395-0.json |
| 79396-8 | NADH:ubiquinone reductase [Enzymatic activity/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/79396-8.json |
| 79397-6 | Mastic tree (Pistacia lentiscus) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79397-6.json |
| 7940-0 | La Crosse virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7940-0.json |
| 79400-8 | Vanillylmandelate [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/79400-8.json |
| 79401-6 | HBB gene full mutation analysis [Identifier] in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/79401-6.json |
| 79402-4 | Niacin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/79402-4.json |
| 79403-2 | Nitrogen [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/79403-2.json |
| 79404-0 | Adenosine deaminase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79404-0.json |
| 79405-7 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/79405-7.json |
| 79410-7 | Penfluridol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/79410-7.json |
| 79411-5 | Creatine transport protein [Enzymatic activity/mass] in Fibroblast by Creatine uptake assay | ./2.16.840.1.114222.4.11.1002/79411-5.json |
| 79413-1 | Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/79413-1.json |
| 79414-9 | MSH6 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/79414-9.json |
| 79415-6 | MSH2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/79415-6.json |
| 79416-4 | MLH1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/79416-4.json |
| 79417-2 | PMS2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/79417-2.json |
| 7941-8 | La Crosse virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7941-8.json |
| 79418-0 | EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/79418-0.json |
| 79419-8 | PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79419-8.json |
| 79420-6 | Miscellaneous allergen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/79420-6.json |
| 79423-0 | Cardiovascular disease 10Y risk [Likelihood] ACC-AHA Pooled Cohort by Goff 2013 | ./2.16.840.1.114222.4.11.1002/79423-0.json |
| 79425-5 | Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture | ./2.16.840.1.114222.4.11.1002/79425-5.json |
| 7942-6 | Lassa virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7942-6.json |
| 79428-9 | Rapid response team Consult note | ./2.16.840.1.114222.4.11.1002/79428-9.json |
| 79429-7 | Hospital Admission notification | ./2.16.840.1.114222.4.11.1002/79429-7.json |
| 79430-5 | Hospital Discharge notification | ./2.16.840.1.114222.4.11.1002/79430-5.json |
| 7943-4 | Lassa virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7943-4.json |
| 7944-2 | Lassa virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7944-2.json |
| 79445-3 | Fluspirilene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79445-3.json |
| 79446-1 | Pericyazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79446-1.json |
| 79449-5 | Formate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/79449-5.json |
| 79450-3 | Adenine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79450-3.json |
| 79451-1 | Adenosine deaminase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/79451-1.json |
| 79452-9 | Adenylosuccinate lyase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79452-9.json |
| 79453-7 | Alcohol dehydrogenase [Enzymatic activity/mass] in Liver | ./2.16.840.1.114222.4.11.1002/79453-7.json |
| 79454-5 | Alpha fucosidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79454-5.json |
| 79455-2 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79455-2.json |
| 79456-0 | Arginase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79456-0.json |
| 79457-8 | Beta glucuronidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79457-8.json |
| 79458-6 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79458-6.json |
| 7945-9 | Lassa virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7945-9.json |
| 79459-4 | Dihydropteridine reductase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79459-4.json |
| 79460-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79460-2.json |
| 79461-0 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79461-0.json |
| 79462-8 | Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79462-8.json |
| 79463-6 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79463-6.json |
| 79464-4 | Phosphorylase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79464-4.json |
| 79465-1 | Porphobilinogen synthase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79465-1.json |
| 79466-9 | Purine nucleoside phosphorylase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79466-9.json |
| 7946-7 | Lassa virus Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/7946-7.json |
| 79467-7 | Purine nucleoside phosphorylase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/79467-7.json |
| 79468-5 | Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79468-5.json |
| 79469-3 | Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/mass] in RedBlood Cells | ./2.16.840.1.114222.4.11.1002/79469-3.json |
| 79470-1 | Uridine monophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79470-1.json |
| 79471-9 | 1,4-Cyclohexanediol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79471-9.json |
| 79472-7 | Phenylpropionylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79472-7.json |
| 79473-5 | Hexanoylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79473-5.json |
| 79474-3 | 3,4-Dihydroxybutyrate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79474-3.json |
| 7947-5 | Legionella pneumophila Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7947-5.json |
| 79475-0 | 2,5-Furandicarboxylate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79475-0.json |
| 79476-8 | Ethylmalonate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79476-8.json |
| 79477-6 | 5-Hydroxymethyl-2-Furoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79477-6.json |
| 79478-4 | Salicylurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79478-4.json |
| 79479-2 | 3-Hydroxyadipate 3,6-lactone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79479-2.json |
| 79480-0 | 3,4-Dihydroxyhydrocinnamate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79480-0.json |
| 79481-8 | Hydantoin-5-propionate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79481-8.json |
| 79482-6 | 3-(3-Hydroxyphenyl)propanoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79482-6.json |
| 7948-3 | Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7948-3.json |
| 79483-4 | Vanilloylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79483-4.json |
| 79484-2 | Levulinate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79484-2.json |
| 79485-9 | 4-Hydroxyvalerate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79485-9.json |
| 79486-7 | 3,5-Dihydroxybenzoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79486-7.json |
| 79487-5 | Lactyl lactate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79487-5.json |
| 79488-3 | 3,4-Dihydroxybutyrate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79488-3.json |
| 79489-1 | Salicylurate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79489-1.json |
| 79490-9 | 3,4-Dihydroxyhydrocinnamate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79490-9.json |
| 7949-1 | Legionella pneumophila 2 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7949-1.json |
| 79491-7 | 3-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79491-7.json |
| 79492-5 | Furoylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79492-5.json |
| 79493-3 | 3-Hydroxysuberate.unsaturated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79493-3.json |
| 79494-1 | Pimelate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79494-1.json |
| 79495-8 | Azelate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79495-8.json |
| 79496-6 | Hydantoin-5-propionate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79496-6.json |
| 79497-4 | 3-Hydroxybenzoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79497-4.json |
| 79498-2 | 4-Hydroxyhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79498-2.json |
| 79500-5 | Furoylglycine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79500-5.json |
| 79501-3 | 3-Hydroxyhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79501-3.json |
| 79502-1 | 4-Hydroxyvalerate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79502-1.json |
| 79503-9 | 4-Hydroxyhippurate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79503-9.json |
| 79504-7 | Levulinate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79504-7.json |
| 79505-4 | 4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79505-4.json |
| 79506-2 | Desaminotyrosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79506-2.json |
| 79507-0 | P-cresol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79507-0.json |
| 79508-8 | 4-Hydroxymandelate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79508-8.json |
| 7950-9 | Legionella pneumophila 3 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7950-9.json |
| 79509-6 | Decenedioate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79509-6.json |
| 79510-4 | 3-Hydroxyhippurate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79510-4.json |
| 79511-2 | Suberylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79511-2.json |
| 79512-0 | Vanilloylglycine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79512-0.json |
| 79513-8 | 1,4-Cyclohexanediol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79513-8.json |
| 79514-6 | N-acetyltyrosine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79514-6.json |
| 79515-3 | Gentisate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79515-3.json |
| 79516-1 | Octenedioate (C8:1) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79516-1.json |
| 7951-7 | Legionella pneumophila 4 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7951-7.json |
| 79517-9 | Desaminotyrosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79517-9.json |
| 79518-7 | 3-Hydroxybenzoate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79518-7.json |
| 79519-5 | Pimelate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79519-5.json |
| 79520-3 | 4-Deoxythreonate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79520-3.json |
| 79521-1 | Lactyl lactate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79521-1.json |
| 79522-9 | 2,5-Furandicarboxylate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79522-9.json |
| 79523-7 | 3-(3-Hydroxyphenyl)propanoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79523-7.json |
| 79524-5 | P-cresol [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79524-5.json |
| 7952-5 | Legionella pneumophila 5 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7952-5.json |
| 79525-2 | 3-Hydroxysebacate (3-OH-C8) unsaturated [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79525-2.json |
| 79526-0 | 3,5-Dihydroxybenzoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79526-0.json |
| 79527-8 | 4-Deoxythreonate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/79527-8.json |
| 79528-6 | 5-Hydroxymethyl-2-Furoate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79528-6.json |
| 7953-3 | Legionella pneumophila 6 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7953-3.json |
| 79538-5 | Formate [Moles/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/79538-5.json |
| 79539-3 | HEDIS 2016-2018 Value Set - Urine Protein Tests | ./2.16.840.1.114222.4.11.1002/79539-3.json |
| 79540-1 | HEDIS 2016-2018 Value Set - PHQ-9 Total Score | ./2.16.840.1.114222.4.11.1002/79540-1.json |
| 7954-1 | Legionella pneumophila 7 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7954-1.json |
| 79541-9 | HEDIS 2016-2020 Value Set - Lead Tests | ./2.16.840.1.114222.4.11.1002/79541-9.json |
| 79543-5 | HEDIS 2016-2019 Value Set - ABO and Rh | ./2.16.840.1.114222.4.11.1002/79543-5.json |
| 7955-8 | Legionella pneumophila 8 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7955-8.json |
| 79562-5 | Endotracheal tube Diameter | ./2.16.840.1.114222.4.11.1002/79562-5.json |
| 7956-6 | Legionella pneumophila 9 Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/7956-6.json |
| 79567-4 | Lysophosphatidylcholine(26:0) [Moles/volume] in DBS by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/79567-4.json |
| 79568-2 | ABCD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/79568-2.json |
| 79569-0 | Blood product given [Type] | ./2.16.840.1.114222.4.11.1002/79569-0.json |
| 79570-8 | MLH1+MSH2+MSH6+PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/79570-8.json |
| 79571-6 | BCHE gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/79571-6.json |
| 7957-4 | Legionella sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7957-4.json |
| 79574-0 | Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative | ./2.16.840.1.114222.4.11.1002/79574-0.json |
| 7958-2 | Leishmania sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7958-2.json |
| 7959-0 | Leptospira sp Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/7959-0.json |
| 7960-8 | Leptospira interrogans Ab [Units/volume] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/7960-8.json |
| 7961-6 | Measles virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7961-6.json |
| 7962-4 | Measles virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7962-4.json |
| 7963-2 | Measles virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7963-2.json |
| 7964-0 | Measles virus RNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7964-0.json |
| 7965-7 | Mumps virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7965-7.json |
| 7966-5 | Mumps virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7966-5.json |
| 7967-3 | Mumps virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7967-3.json |
| 7968-1 | Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7968-1.json |
| 79694-6 | Eicosadienoate (C20:2w6) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79694-6.json |
| 79695-3 | Octadecatetraenoate (C18:4w3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79695-3.json |
| 79696-1 | cis-11-Eicosenoate (cis 11 C20:1w9) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79696-1.json |
| 79697-9 | Docosadienoate (C22:2w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79697-9.json |
| 79698-7 | Docosadienoate (C22:2w6) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79698-7.json |
| 7969-9 | Mycoplasma pneumoniae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7969-9.json |
| 79699-5 | cis-11-Eicosenoate (cis 11 C20:1w9) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79699-5.json |
| 79700-1 | cis-11,14-Eicosadienoate (cis 11,14 C20:2w6) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79700-1.json |
| 79701-9 | Fatty acids.very long chain.C22:1n9 (Erucate) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79701-9.json |
| 79702-7 | cis-13-Eicosenoate (cis 13 C20:1w7) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79702-7.json |
| 79703-5 | cis-13-Eicosenoate (cis 13 C20:1w7) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/79703-5.json |
| 79704-3 | Homo-gamma Linolenate (C20:3w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79704-3.json |
| 79705-0 | Eicosadienoate (C20:2w6) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79705-0.json |
| 79706-8 | Octadecatetraenoate (C18:4w3) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/79706-8.json |
| 7970-7 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7970-7.json |
| 79708-4 | Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/79708-4.json |
| 79709-2 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/79709-2.json |
| 79710-0 | Potassium [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/79710-0.json |
| 79711-8 | HLA-B*58:01 [Presence] in Blood or Tissue | ./2.16.840.1.114222.4.11.1002/79711-8.json |
| 79712-6 | HLA-A*31:01 [Presence] in Blood or Tissue | ./2.16.840.1.114222.4.11.1002/79712-6.json |
| 7971-5 | Naegleria fowleri Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/7971-5.json |
| 7972-3 | Neisseria meningitidis serogroup Y Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/7972-3.json |
| 7973-1 | Norovirus [Presence] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/7973-1.json |
| 7974-9 | Norovirus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7974-9.json |
| 7975-6 | Human papilloma virus Ab [Presence] in Genital specimen | ./2.16.840.1.114222.4.11.1002/7975-6.json |
| 7976-4 | Paracoccidioides brasiliensis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7976-4.json |
| 7977-2 | Paragonimus sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7977-2.json |
| 7978-0 | Parainfluenza virus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7978-0.json |
| 7979-8 | Parainfluenza virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7979-8.json |
| 7980-6 | Parainfluenza virus 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7980-6.json |
| 7981-4 | Parvovirus B19 IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/7981-4.json |
| 7982-2 | Parvovirus B19 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7982-2.json |
| 7983-0 | Parvovirus B19 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7983-0.json |
| 7984-8 | Parvovirus B19 IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7984-8.json |
| 7985-5 | Polio virus 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7985-5.json |
| 7986-3 | Polio virus 2 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7986-3.json |
| 7987-1 | Polio virus 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7987-1.json |
| 7988-9 | Burkholderia pseudomallei IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7988-9.json |
| 7989-7 | Burkholderia pseudomallei IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7989-7.json |
| 7990-5 | Respiratory syncytial virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7990-5.json |
| 7991-3 | Respiratory syncytial virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7991-3.json |
| 7992-1 | Respiratory syncytial virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7992-1.json |
| 7993-9 | Rhinovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7993-9.json |
| 7994-7 | Rickettsia sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7994-7.json |
| 7995-4 | Rickettsia prowazekii Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7995-4.json |
| 7996-2 | Rickettsia prowazekii RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/7996-2.json |
| 7997-0 | Rickettsia spotted fever group Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7997-0.json |
| 7998-8 | Rickettsia spotted fever group IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7998-8.json |
| 7999-6 | Rickettsia spotted fever group IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/7999-6.json |
| 8000-2 | Rickettsia typhus group Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8000-2.json |
| 8001-0 | Rickettsia typhus group IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8001-0.json |
| 8002-8 | Rickettsia typhus group IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8002-8.json |
| 800-3 | Schistocytes [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/800-3.json |
| 8003-6 | Rickettsia rickettsii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8003-6.json |
| 8004-4 | Rickettsia rickettsii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8004-4.json |
| 8005-1 | Rickettsia rickettsii RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/8005-1.json |
| 8006-9 | Orientia tsutsugamushi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8006-9.json |
| 8007-7 | Rickettsia typhi IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8007-7.json |
| 8008-5 | Rickettsia typhi IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8008-5.json |
| 8009-3 | Bartonella quintana IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8009-3.json |
| 80099-5 | L-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80099-5.json |
| 80100-1 | D-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80100-1.json |
| 8010-1 | Bartonella quintana IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8010-1.json |
| 80109-2 | Fetal Pregnancy risk factors for prenatal genetic testing | ./2.16.840.1.114222.4.11.1002/80109-2.json |
| 80110-0 | Emergency department Visit notification | ./2.16.840.1.114222.4.11.1002/80110-0.json |
| 80111-8 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80111-8.json |
| 80112-6 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80112-6.json |
| 80113-4 | 11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80113-4.json |
| 80114-2 | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80114-2.json |
| 80115-9 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80115-9.json |
| 80116-7 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80116-7.json |
| 80117-5 | 7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80117-5.json |
| 80118-3 | Abacavir [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/80118-3.json |
| 8011-9 | Rotavirus [Presence] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/8011-9.json |
| 80119-1 | Acebutolol [Mass/mass] in Hair by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80119-1.json |
| 80120-9 | Acenocoumarol [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80120-9.json |
| 80121-7 | Acyclovir [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80121-7.json |
| 80122-5 | Alfentanil [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80122-5.json |
| 80123-3 | Alizapride [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80123-3.json |
| 80124-1 | Alminoprofen [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80124-1.json |
| 80125-8 | Aluminum [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/80125-8.json |
| 80126-6 | Aluminum [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80126-6.json |
| 8012-7 | Rotavirus dsRNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/8012-7.json |
| 80127-4 | Aluminum [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80127-4.json |
| 80128-2 | Amisulpride [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80128-2.json |
| 80129-0 | Amisulpride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80129-0.json |
| 80130-8 | Amisulpride [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80130-8.json |
| 80131-6 | Amisulpride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80131-6.json |
| 80132-4 | amLODIPine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80132-4.json |
| 80133-2 | Amoxicillin [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80133-2.json |
| 80134-0 | Amphetamine [Mass/mass] in Hair by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80134-0.json |
| 8013-5 | Rubella virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8013-5.json |
| 80135-7 | Amphetamine [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80135-7.json |
| 80136-5 | Antihistamines [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/80136-5.json |
| 80137-3 | Antihistamines [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/80137-3.json |
| 80138-1 | Antimony [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/80138-1.json |
| 80139-9 | Antimony [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/80139-9.json |
| 80140-7 | Antimony [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80140-7.json |
| 80141-5 | Arsenic [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80141-5.json |
| 80142-3 | Atazanavir [Mass/volume] in Cerebral spinal fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80142-3.json |
| 8014-3 | Rubella virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8014-3.json |
| 80143-1 | Atazanavir [Mass/volume] in Cord blood | ./2.16.840.1.114222.4.11.1002/80143-1.json |
| 80144-9 | Ecgonine methyl ester [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/80144-9.json |
| 80145-6 | Silver [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80145-6.json |
| 80146-4 | Tricyclic antidepressants [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/80146-4.json |
| 80147-2 | Tricyclic antidepressants [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/80147-2.json |
| 80148-0 | Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/80148-0.json |
| 80149-8 | Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL | ./2.16.840.1.114222.4.11.1002/80149-8.json |
| 8015-0 | Rubella virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8015-0.json |
| 80150-6 | Trimeprazine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80150-6.json |
| 80151-4 | Brucella abortus IgG Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/80151-4.json |
| 80152-2 | N-methylhistamine/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/80152-2.json |
| 80153-0 | Soluble CD27 [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80153-0.json |
| 80154-8 | Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/80154-8.json |
| 80155-5 | Soluble CD27 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80155-5.json |
| 80156-3 | 3-Methoxytyramine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80156-3.json |
| 80157-1 | Etiocholanolone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80157-1.json |
| 80158-9 | Galactosylhydroxylysine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80158-9.json |
| 80159-7 | 27-Norcholestanehexol/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80159-7.json |
| 80160-5 | 5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80160-5.json |
| 80161-3 | 5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80161-3.json |
| 80162-1 | Bile alcohols [Interpretation] in Urine Qualitative | ./2.16.840.1.114222.4.11.1002/80162-1.json |
| 80165-4 | 2-Amino-4-hydroxypteridine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80165-4.json |
| 80166-2 | 2-Amino-4-hydroxypteridine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80166-2.json |
| 80167-0 | 2-Amino-4-hydroxypteridine/Creatinine [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80167-0.json |
| 8016-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8016-8.json |
| 80174-6 | S-adenosylhomocysteine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80174-6.json |
| 80175-3 | S-adenosylhomocysteine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80175-3.json |
| 8017-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8017-6.json |
| 80176-1 | S-adenosylhomocysteine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80176-1.json |
| 80177-9 | S-adenosylmethionine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80177-9.json |
| 80182-9 | S-adenosylmethionine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80182-9.json |
| 80183-7 | Xanthopterin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80183-7.json |
| 8018-4 | Schistosoma japonicum Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8018-4.json |
| 80184-5 | Xanthopterin [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/80184-5.json |
| 80185-2 | Xanthopterin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80185-2.json |
| 80186-0 | JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/80186-0.json |
| 80187-8 | JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/80187-8.json |
| 80188-6 | JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/80188-6.json |
| 80189-4 | Galactosamine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80189-4.json |
| 8019-2 | Schistosoma mansoni Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8019-2.json |
| 80193-6 | Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80193-6.json |
| 80194-4 | Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80194-4.json |
| 80195-1 | Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/80195-1.json |
| 80196-9 | Ecgonine methyl ester [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/80196-9.json |
| 80197-7 | Antihistamines [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/80197-7.json |
| 80198-5 | Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/80198-5.json |
| 80199-3 | Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/80199-3.json |
| 8020-0 | Schistosoma sp Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8020-0.json |
| 80200-9 | Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/80200-9.json |
| 80201-7 | Alizapride [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80201-7.json |
| 80202-5 | Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activated | ./2.16.840.1.114222.4.11.1002/80202-5.json |
| 80203-3 | HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80203-3.json |
| 80204-1 | Influenza virus A and B identified in Nasopharynx by Shell vial culture | ./2.16.840.1.114222.4.11.1002/80204-1.json |
| 80205-8 | Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80205-8.json |
| 80206-6 | Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80206-6.json |
| 80207-4 | Leishmania infantum+donovani IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80207-4.json |
| 80208-2 | Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80208-2.json |
| 80209-0 | Barium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80209-0.json |
| 80210-8 | Beryllium [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80210-8.json |
| 80211-6 | Beryllium [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/80211-6.json |
| 80212-4 | Beta blockers [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/80212-4.json |
| 80213-2 | Beta blockers [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/80213-2.json |
| 80214-0 | Beta blockers [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/80214-0.json |
| 80215-7 | Beta blockers [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/80215-7.json |
| 80217-3 | Mycoplasma hyopneumoniae Ag [Presence] in Fixed tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/80217-3.json |
| 8021-8 | Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/8021-8.json |
| 80219-9 | Mycoplasma hyopneumoniae Ab sample/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/80219-9.json |
| 80220-7 | NMDAR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80220-7.json |
| 80221-5 | NMDAR IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/80221-5.json |
| 80222-3 | CD8 cells/100 lymphocytes in Specimen | ./2.16.840.1.114222.4.11.1002/80222-3.json |
| 80223-1 | CD4 cells/100 lymphocytes in Specimen | ./2.16.840.1.114222.4.11.1002/80223-1.json |
| 8022-6 | Saint Louis encephalitis virus Ab [Units/volume] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/8022-6.json |
| 8023-4 | Saint Louis encephalitis virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/8023-4.json |
| 8024-2 | Saint Louis encephalitis virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/8024-2.json |
| 80244-7 | Mycoplasma hyopneumoniae DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80244-7.json |
| 8025-9 | Saint Louis encephalitis virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/8025-9.json |
| 8026-7 | Stain method [Type] in Specimen | ./2.16.840.1.114222.4.11.1002/8026-7.json |
| 80274-4 | History of Surgical procedures of gastrointestinal system | ./2.16.840.1.114222.4.11.1002/80274-4.json |
| 8028-3 | Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/8028-3.json |
| 80286-8 | History of Surgical procedures of cardiovascular system | ./2.16.840.1.114222.4.11.1002/80286-8.json |
| 8030-9 | Streptococcus pneumoniae Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8030-9.json |
| 8031-7 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8031-7.json |
| 8032-5 | Streptococcus pneumoniae IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8032-5.json |
| 80329-6 | History of Surgical procedures of musculoskeletal system | ./2.16.840.1.114222.4.11.1002/80329-6.json |
| 80336-1 | History of Surgical procedures of genitourinary system | ./2.16.840.1.114222.4.11.1002/80336-1.json |
| 8034-1 | Strongyloides sp Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8034-1.json |
| 80356-9 | Cause of death entity axis code [Automated] | ./2.16.840.1.114222.4.11.1002/80356-9.json |
| 8035-8 | Strongyloides stercoralis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8035-8.json |
| 80360-1 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80360-1.json |
| 80361-9 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80361-9.json |
| 80362-7 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80362-7.json |
| 80363-5 | Chlamydia trachomatis DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80363-5.json |
| 80364-3 | Chlamydia trachomatis rRNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80364-3.json |
| 80365-0 | Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80365-0.json |
| 8036-6 | Taenia saginata Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8036-6.json |
| 80366-8 | Neisseria gonorrhoeae rRNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80366-8.json |
| 80367-6 | Chlamydia trachomatis [Presence] in Anorectal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/80367-6.json |
| 80368-4 | Neisseria gonorrhoeae [Presence] in Anorectal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/80368-4.json |
| 80369-2 | Neisseria sp identified in Anorectal by Organism specific culture | ./2.16.840.1.114222.4.11.1002/80369-2.json |
| 80370-0 | Biotinidase [Enzymatic activity/mass] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80370-0.json |
| 80371-8 | Chitotriosidase [Enzymatic activity/mass] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80371-8.json |
| 80372-6 | Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80372-6.json |
| 80373-4 | Helicobacter pylori Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80373-4.json |
| 8037-4 | Taenia solium adult Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8037-4.json |
| 80375-9 | Norovirus Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80375-9.json |
| 8038-2 | Toxocara canis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8038-2.json |
| 80382-5 | Influenza virus A Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80382-5.json |
| 80383-3 | Influenza virus B Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80383-3.json |
| 80384-1 | Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80384-1.json |
| 80385-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80385-8.json |
| 80386-6 | Bladder tumor Ag [Presence] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80386-6.json |
| 80387-4 | HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/80387-4.json |
| 80389-0 | Special medical equipment AndOr resuscitation needs | ./2.16.840.1.114222.4.11.1002/80389-0.json |
| 8039-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8039-0.json |
| 80390-8 | Family unification code | ./2.16.840.1.114222.4.11.1002/80390-8.json |
| 80391-6 | Level of care [Type] | ./2.16.840.1.114222.4.11.1002/80391-6.json |
| 80393-2 | Emergency management incident name | ./2.16.840.1.114222.4.11.1002/80393-2.json |
| 80394-0 | Emergency management incident type | ./2.16.840.1.114222.4.11.1002/80394-0.json |
| 80396-5 | Gynecologic oncology Consult note | ./2.16.840.1.114222.4.11.1002/80396-5.json |
| 80405-4 | Provider Certification [Type] | ./2.16.840.1.114222.4.11.1002/80405-4.json |
| 80406-2 | Date and time of initial encounter | ./2.16.840.1.114222.4.11.1002/80406-2.json |
| 80407-0 | Contamination/radiation/contagion status | ./2.16.840.1.114222.4.11.1002/80407-0.json |
| 8040-8 | Toxoplasma gondii IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8040-8.json |
| 80408-8 | Meets CDC field triage criteria | ./2.16.840.1.114222.4.11.1002/80408-8.json |
| 80409-6 | Bed type | ./2.16.840.1.114222.4.11.1002/80409-6.json |
| 80410-4 | Date and time of transfer departure | ./2.16.840.1.114222.4.11.1002/80410-4.json |
| 80415-3 | Fetal Body weight growth percentile US+Estimated from Hadlock 1991 | ./2.16.840.1.114222.4.11.1002/80415-3.json |
| 8041-6 | Treponema pallidum Ab [Presence] in Serum by Hemagglutination | ./2.16.840.1.114222.4.11.1002/8041-6.json |
| 80416-1 | Head circumference/Abdominal circumference US+Estimated from Campbell 1977 | ./2.16.840.1.114222.4.11.1002/80416-1.json |
| 80417-9 | Community health care Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/80417-9.json |
| 80418-7 | Community health care Medical equipment or product list | ./2.16.840.1.114222.4.11.1002/80418-7.json |
| 80419-5 | Community health care Referral note | ./2.16.840.1.114222.4.11.1002/80419-5.json |
| 80420-3 | Mental health Mandatory reporting form | ./2.16.840.1.114222.4.11.1002/80420-3.json |
| 80421-1 | Public health Mandatory reporting form | ./2.16.840.1.114222.4.11.1002/80421-1.json |
| 80422-9 | Community health care Report | ./2.16.840.1.114222.4.11.1002/80422-9.json |
| 80423-7 | Community health care Safety issue assessment note | ./2.16.840.1.114222.4.11.1002/80423-7.json |
| 8042-4 | Trichinella spiralis Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8042-4.json |
| 80424-5 | Inosine triphosphate pyrophosphatase [Enzymatic activity/substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/80424-5.json |
| 80425-2 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80425-2.json |
| 80426-0 | Hepatitis D virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80426-0.json |
| 80429-4 | Employer address | ./2.16.840.1.114222.4.11.1002/80429-4.json |
| 8043-2 | Trichinella spiralis IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8043-2.json |
| 80434-4 | Past employer state | ./2.16.840.1.114222.4.11.1002/80434-4.json |
| 8045-7 | Trypanosoma cruzi Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8045-7.json |
| 8046-5 | Varicella zoster virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8046-5.json |
| 8047-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8047-3.json |
| 8048-1 | Varicella zoster virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8048-1.json |
| 80495-5 | MR Mediastinum WO contrast | ./2.16.840.1.114222.4.11.1002/80495-5.json |
| 80496-3 | MR Unspecified body region 3D post processing | ./2.16.840.1.114222.4.11.1002/80496-3.json |
| 80497-1 | MR Guidance for needle localization of Breast - right | ./2.16.840.1.114222.4.11.1002/80497-1.json |
| 80498-9 | MR Guidance for needle localization of Breast - left | ./2.16.840.1.114222.4.11.1002/80498-9.json |
| 8049-9 | Varicella zoster virus DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/8049-9.json |
| 80499-7 | MR Whole body WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80499-7.json |
| 80500-2 | MR Heart W stress and WO contrast | ./2.16.840.1.114222.4.11.1002/80500-2.json |
| 80501-0 | MR Small bowel W contrast PO and WO contrast IV | ./2.16.840.1.114222.4.11.1002/80501-0.json |
| 80502-8 | MRA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80502-8.json |
| 80503-6 | MR Small bowel W contrast PO and WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80503-6.json |
| 80504-4 | MR Guidance for biopsy of Unspecified body region | ./2.16.840.1.114222.4.11.1002/80504-4.json |
| 80505-1 | MR Brain for new diagnosis tumor WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80505-1.json |
| 80506-9 | MR Brain for low grade tumor WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80506-9.json |
| 8050-7 | Venezuelan equine encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8050-7.json |
| 80507-7 | MR Brain for high grade tumor WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80507-7.json |
| 80508-5 | MR Upper extremity.joint Arthrogram | ./2.16.840.1.114222.4.11.1002/80508-5.json |
| 80509-3 | MR Guidance for placement of clip in Unspecified body region | ./2.16.840.1.114222.4.11.1002/80509-3.json |
| 80510-1 | MR Brain for metastasis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80510-1.json |
| 80511-9 | MR Brain for postoperative | ./2.16.840.1.114222.4.11.1002/80511-9.json |
| 80512-7 | MR Bone marrow WO contrast | ./2.16.840.1.114222.4.11.1002/80512-7.json |
| 80513-5 | MR Bone marrow W contrast IV | ./2.16.840.1.114222.4.11.1002/80513-5.json |
| 80514-3 | MR Bone marrow WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/80514-3.json |
| 8051-5 | Venezuelan equine encephalitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8051-5.json |
| 80515-0 | Kappa light chains.free [Mass/volume] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/80515-0.json |
| 80516-8 | Lambda light chains.free [Mass/volume] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/80516-8.json |
| 80518-4 | Clostridium baratii toxin F bont gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80518-4.json |
| 80521-8 | Uroflowmetry study | ./2.16.840.1.114222.4.11.1002/80521-8.json |
| 8052-3 | Western equine encephalitis virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8052-3.json |
| 80524-2 | Voiding time by Uroflowmetry | ./2.16.840.1.114222.4.11.1002/80524-2.json |
| 80529-1 | Everolimus [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80529-1.json |
| 80530-9 | Fluconazole [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80530-9.json |
| 8053-1 | Western equine encephalitis virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8053-1.json |
| 80531-7 | Itraconazole [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80531-7.json |
| 80532-5 | Methadone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80532-5.json |
| 80533-3 | Methamphetamine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80533-3.json |
| 80534-1 | Methylenedioxyamphetamine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80534-1.json |
| 80535-8 | Methylenedioxyethylamphetamine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80535-8.json |
| 80536-6 | Methylenedioxyethylamphetamine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80536-6.json |
| 80537-4 | Methylenedioxymethamphetamine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80537-4.json |
| 80538-2 | Methylphenidate [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80538-2.json |
| 80539-0 | Morphine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80539-0.json |
| 80540-8 | Moxifloxacin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80540-8.json |
| 80541-6 | Nicotine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80541-6.json |
| 80542-4 | Norcitalopram [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80542-4.json |
| 80543-2 | Norclozapine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80543-2.json |
| 80544-0 | Nortriptyline [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80544-0.json |
| 80545-7 | Posaconazole [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80545-7.json |
| 80546-5 | rifAMPin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80546-5.json |
| 80547-3 | Rilpivirine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80547-3.json |
| 80548-1 | Sirolimus [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80548-1.json |
| 8054-9 | Yellow fever virus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8054-9.json |
| 80549-9 | Sulfamethoxazole [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80549-9.json |
| 80550-7 | Tacrolimus [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80550-7.json |
| 80551-5 | Tetrahydrocannabinol [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80551-5.json |
| 80552-3 | Trimethoprim [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80552-3.json |
| 80553-1 | Voriconazole [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80553-1.json |
| 80554-9 | Zopiclone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80554-9.json |
| 80555-6 | Diamorphine [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80555-6.json |
| 8055-6 | Yellow fever virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8055-6.json |
| 80556-4 | cloZAPine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80556-4.json |
| 80557-2 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/80557-2.json |
| 80558-0 | Amitriptyline [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80558-0.json |
| 80559-8 | Clarithromycin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80559-8.json |
| 80560-6 | Citalopram [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80560-6.json |
| 80561-4 | cycloSPORINE [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80561-4.json |
| 80562-2 | Diagram | ./2.16.840.1.114222.4.11.1002/80562-2.json |
| 80563-0 | Report | ./2.16.840.1.114222.4.11.1002/80563-0.json |
| 8056-4 | Yellow fever virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8056-4.json |
| 80564-8 | Mandatory reporting form | ./2.16.840.1.114222.4.11.1002/80564-8.json |
| 80565-5 | Medication administration record | ./2.16.840.1.114222.4.11.1002/80565-5.json |
| 80566-3 | Checklist | ./2.16.840.1.114222.4.11.1002/80566-3.json |
| 80567-1 | Flowsheet | ./2.16.840.1.114222.4.11.1002/80567-1.json |
| 80568-9 | Form | ./2.16.840.1.114222.4.11.1002/80568-9.json |
| 80569-7 | Pharmacology Progress note | ./2.16.840.1.114222.4.11.1002/80569-7.json |
| 80570-5 | Agreement | ./2.16.840.1.114222.4.11.1002/80570-5.json |
| 80571-3 | Certificate | ./2.16.840.1.114222.4.11.1002/80571-3.json |
| 8057-2 | Yellow fever virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/8057-2.json |
| 80572-1 | Cardiac surgery Flowsheet | ./2.16.840.1.114222.4.11.1002/80572-1.json |
| 80573-9 | Cardiac surgery Checklist | ./2.16.840.1.114222.4.11.1002/80573-9.json |
| 80574-7 | Cardiac surgery Admission history and physical note | ./2.16.840.1.114222.4.11.1002/80574-7.json |
| 80575-4 | Cardiac surgery Consult note | ./2.16.840.1.114222.4.11.1002/80575-4.json |
| 80576-2 | Cardiac surgery Education note | ./2.16.840.1.114222.4.11.1002/80576-2.json |
| 80577-0 | Cardiac surgery Referral note | ./2.16.840.1.114222.4.11.1002/80577-0.json |
| 80578-8 | Cardiac surgery Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/80578-8.json |
| 80579-6 | Cardiac surgery Surgical operation note | ./2.16.840.1.114222.4.11.1002/80579-6.json |
| 8058-0 | Acetylcholine receptor Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8058-0.json |
| 80580-4 | Cardiac surgery Transfer summary note | ./2.16.840.1.114222.4.11.1002/80580-4.json |
| 80583-8 | Functional MR Brain for motor function | ./2.16.840.1.114222.4.11.1002/80583-8.json |
| 80584-6 | MR Urethra Endovaginal WO contrast | ./2.16.840.1.114222.4.11.1002/80584-6.json |
| 80585-3 | MR Pelvis Endorectal W contrast IV | ./2.16.840.1.114222.4.11.1002/80585-3.json |
| 80586-1 | Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80586-1.json |
| 80587-9 | Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80587-9.json |
| 80588-7 | Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80588-7.json |
| 80589-5 | Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80589-5.json |
| 8059-8 | Adrenal Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8059-8.json |
| 80603-4 | Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/80603-4.json |
| 80604-2 | Desacetylrifampicin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80604-2.json |
| 80605-9 | Desacetylrifampicin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80605-9.json |
| 8060-6 | Adrenal cortex Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8060-6.json |
| 80606-7 | 14-Hydroxyclarithromycin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80606-7.json |
| 80607-5 | 14-Hydroxyclarithromycin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80607-5.json |
| 80608-3 | Cefuroxime [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80608-3.json |
| 80609-1 | Linezolid [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80609-1.json |
| 80611-7 | Phosphate [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/80611-7.json |
| 80612-5 | B IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80612-5.json |
| 80613-3 | Bicarbonate [Moles/volume] in Urine collected for unspecified duration | ./2.16.840.1.114222.4.11.1002/80613-3.json |
| 8061-4 | Nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8061-4.json |
| 80617-4 | Cefuroxime free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80617-4.json |
| 80618-2 | Zika virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/80618-2.json |
| 80619-0 | Zika virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/80619-0.json |
| 80620-8 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/80620-8.json |
| 80621-6 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/80621-6.json |
| 8062-2 | Cardiolipin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8062-2.json |
| 80622-4 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/80622-4.json |
| 80623-2 | Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/80623-2.json |
| 80624-0 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --1st specimen | ./2.16.840.1.114222.4.11.1002/80624-0.json |
| 80625-7 | Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --2nd specimen | ./2.16.840.1.114222.4.11.1002/80625-7.json |
| 80627-3 | Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/80627-3.json |
| 80628-1 | 1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80628-1.json |
| 80629-9 | 1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80629-9.json |
| 8063-0 | Cardiolipin IgA Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8063-0.json |
| 80630-7 | 1,2-Dichloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80630-7.json |
| 80631-5 | 1,3-Dimethylbenzene+1,4-Dimethylbenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80631-5.json |
| 80632-3 | 2-Methylpropyl methylphosphonate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80632-3.json |
| 80633-1 | Aldicarb [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80633-1.json |
| 80634-9 | Aldicarb sulfone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80634-9.json |
| 80635-6 | Aldicarb sulfoxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80635-6.json |
| 80636-4 | Alpha-amanitin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80636-4.json |
| 80637-2 | Bedaquiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80637-2.json |
| 80638-0 | Beta-amanitin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80638-0.json |
| 80639-8 | Gamma-amanitin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80639-8.json |
| 80640-6 | Disopyramide+Nordisopyramide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80640-6.json |
| 80641-4 | Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80641-4.json |
| 80642-2 | Floxacillin Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80642-2.json |
| 80643-0 | Gadolinium [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/80643-0.json |
| 80644-8 | Isopropyl methylphosphonate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80644-8.json |
| 80645-5 | Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80645-5.json |
| 80646-3 | Monocyclohexyl methylphosphonate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80646-3.json |
| 80647-1 | Monoethyl methylphosphonate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80647-1.json |
| 80648-9 | N-monodesmethyl bedaquiline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80648-9.json |
| 80649-7 | Tetramethylenedisulfotetramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80649-7.json |
| 80650-5 | Tin [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80650-5.json |
| 80651-3 | Voriconazole N-oxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80651-3.json |
| 8065-5 | Cardiolipin IgG Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8065-5.json |
| 80656-2 | Hemoglobin Hope/Hemoglobin.total in Blood | ./2.16.840.1.114222.4.11.1002/80656-2.json |
| 80658-8 | Activated clotting time (ACT) of Blood induced by Diatomaceous earth | ./2.16.840.1.114222.4.11.1002/80658-8.json |
| 80659-6 | Activated clotting time (ACT) of Blood induced by Kaolin | ./2.16.840.1.114222.4.11.1002/80659-6.json |
| 80660-4 | Strongyloides sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/80660-4.json |
| 80662-0 | Volume of Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/80662-0.json |
| 80663-8 | 4-Hydroxy 3-Nitrophenylacetate (HNPAA) [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80663-8.json |
| 80664-6 | Clinical neurophysiology Consult note | ./2.16.840.1.114222.4.11.1002/80664-6.json |
| 80665-3 | Clinical neurophysiology Progress note | ./2.16.840.1.114222.4.11.1002/80665-3.json |
| 80666-1 | Vascular neurology Consult note | ./2.16.840.1.114222.4.11.1002/80666-1.json |
| 80667-9 | Vascular neurology Progress note | ./2.16.840.1.114222.4.11.1002/80667-9.json |
| 80668-7 | Vascular neurology Surgical operation note | ./2.16.840.1.114222.4.11.1002/80668-7.json |
| 80669-5 | Vascular neurology procedure note | ./2.16.840.1.114222.4.11.1002/80669-5.json |
| 80670-3 | Clinical neurophysiology procedure note | ./2.16.840.1.114222.4.11.1002/80670-3.json |
| 8067-1 | Cardiolipin IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8067-1.json |
| 80671-1 | Pastoral care Progress note | ./2.16.840.1.114222.4.11.1002/80671-1.json |
| 80672-9 | Social worker Conference note | ./2.16.840.1.114222.4.11.1002/80672-9.json |
| 80673-7 | Maternal and fetal medicine Consult note | ./2.16.840.1.114222.4.11.1002/80673-7.json |
| 80674-5 | Adenovirus 40+41 fiber protein gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80674-5.json |
| 80675-2 | Rotavirus A VP6 gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80675-2.json |
| 80676-0 | Escherichia coli O157 rfbE gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80676-0.json |
| 80677-8 | Escherichia coli enterotoxigenic eltA+estB genes [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80677-8.json |
| 80678-6 | Salmonella sp invA+fliC genes [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80678-6.json |
| 80679-4 | Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80679-4.json |
| 80680-2 | Vibrio cholerae toxin ctxA gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80680-2.json |
| 80681-0 | Cryptosporidium parvum+hominis oocyst wall protein COWP gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80681-0.json |
| 80682-8 | Entamoeba histolytica 18S rRNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80682-8.json |
| 80683-6 | Giardia lamblia 18S rRNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80683-6.json |
| 80684-4 | Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80684-4.json |
| 80685-1 | Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80685-1.json |
| 80686-9 | CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/80686-9.json |
| 80687-7 | CYP1A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/80687-7.json |
| 80688-5 | HIV 1 RNA tropism [Identifier] in Plasma | ./2.16.840.1.114222.4.11.1002/80688-5.json |
| 8068-9 | Centromere Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8068-9.json |
| 80689-3 | HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by Sequencing | ./2.16.840.1.114222.4.11.1002/80689-3.json |
| 80690-1 | HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/80690-1.json |
| 80691-9 | HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing | ./2.16.840.1.114222.4.11.1002/80691-9.json |
| 80692-7 | HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing | ./2.16.840.1.114222.4.11.1002/80692-7.json |
| 80695-0 | HIV 1 proviral DNA genotype in Mononuclear cells from whole blood | ./2.16.840.1.114222.4.11.1002/80695-0.json |
| 80696-8 | 2-Chlorovinyl arsonous acid [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/80696-8.json |
| 8069-7 | Epidermis Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/8069-7.json |
| 80697-6 | Mycophenolate acyl-glucuronide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80697-6.json |
| 8070-5 | Gliadin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8070-5.json |
| 8071-3 | Histone Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8071-3.json |
| 80715-6 | FSHR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/80715-6.json |
| 80719-8 | T-cell naive and memory and effector (CD27 and CD45RA) subsets [Interpretation] in Blood Narrative | ./2.16.840.1.114222.4.11.1002/80719-8.json |
| 8072-1 | Insulin Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8072-1.json |
| 80732-1 | Otolaryngology Checklist | ./2.16.840.1.114222.4.11.1002/80732-1.json |
| 80733-9 | Otolaryngology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/80733-9.json |
| 80734-7 | Otolaryngology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/80734-7.json |
| 80735-4 | Otolaryngology Transfer summary note | ./2.16.840.1.114222.4.11.1002/80735-4.json |
| 80736-2 | Blood banking and transfusion medicine Consult note | ./2.16.840.1.114222.4.11.1002/80736-2.json |
| 80737-0 | Calculated panel reactive antibody - Serum | ./2.16.840.1.114222.4.11.1002/80737-0.json |
| 80738-8 | TPMT gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/80738-8.json |
| 8073-9 | Insulin bovine Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8073-9.json |
| 80739-6 | Infectious disease Plan of care note | ./2.16.840.1.114222.4.11.1002/80739-6.json |
| 80740-4 | Hematology Plan of care note | ./2.16.840.1.114222.4.11.1002/80740-4.json |
| 80741-2 | Emergency medicine Emergency department Plan of care note | ./2.16.840.1.114222.4.11.1002/80741-2.json |
| 80742-0 | Mental health Plan of care note | ./2.16.840.1.114222.4.11.1002/80742-0.json |
| 80743-8 | Dentistry Plan of care note | ./2.16.840.1.114222.4.11.1002/80743-8.json |
| 80744-6 | Colon and rectal surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80744-6.json |
| 80745-3 | General medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80745-3.json |
| 80746-1 | Emergency department Plan of care note | ./2.16.840.1.114222.4.11.1002/80746-1.json |
| 8074-7 | Insulin human Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8074-7.json |
| 80747-9 | Endocrinology Plan of care note | ./2.16.840.1.114222.4.11.1002/80747-9.json |
| 80748-7 | Clinical genetics Plan of care note | ./2.16.840.1.114222.4.11.1002/80748-7.json |
| 80749-5 | Cardiothoracic surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80749-5.json |
| 80750-3 | Gastroenterology Plan of care note | ./2.16.840.1.114222.4.11.1002/80750-3.json |
| 80751-1 | Dermatology Plan of care note | ./2.16.840.1.114222.4.11.1002/80751-1.json |
| 80752-9 | Family medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80752-9.json |
| 80753-7 | Surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80753-7.json |
| 8075-4 | Insulin porcine Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8075-4.json |
| 80754-5 | Multi-specialty program Plan of care note | ./2.16.840.1.114222.4.11.1002/80754-5.json |
| 80755-2 | Nephrology Plan of care note | ./2.16.840.1.114222.4.11.1002/80755-2.json |
| 80756-0 | Neurological surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80756-0.json |
| 80757-8 | Nurse practitioner Plan of care note | ./2.16.840.1.114222.4.11.1002/80757-8.json |
| 80758-6 | Occupational therapy Plan of care note | ./2.16.840.1.114222.4.11.1002/80758-6.json |
| 80759-4 | Oncology Plan of care note | ./2.16.840.1.114222.4.11.1002/80759-4.json |
| 80760-2 | Neonatal perinatal medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80760-2.json |
| 80761-0 | Neurology Plan of care note | ./2.16.840.1.114222.4.11.1002/80761-0.json |
| 8076-2 | Jo-1 extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8076-2.json |
| 80762-8 | Physical therapy Plan of care note | ./2.16.840.1.114222.4.11.1002/80762-8.json |
| 80763-6 | Transplant surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80763-6.json |
| 80764-4 | Pain medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80764-4.json |
| 80765-1 | Psychiatry Plan of care note | ./2.16.840.1.114222.4.11.1002/80765-1.json |
| 80766-9 | Orthopaedic surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80766-9.json |
| 80767-7 | Pediatric surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80767-7.json |
| 80768-5 | Vascular surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80768-5.json |
| 80769-3 | Oral and Maxillofacial Surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80769-3.json |
| 8077-0 | Mitochondria Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8077-0.json |
| 80770-1 | Psychology Plan of care note | ./2.16.840.1.114222.4.11.1002/80770-1.json |
| 80771-9 | Pediatrics Plan of care note | ./2.16.840.1.114222.4.11.1002/80771-9.json |
| 80772-7 | Respiratory therapy Plan of care note | ./2.16.840.1.114222.4.11.1002/80772-7.json |
| 80773-5 | Optometry Plan of care note | ./2.16.840.1.114222.4.11.1002/80773-5.json |
| 80774-3 | Rheumatology Plan of care note | ./2.16.840.1.114222.4.11.1002/80774-3.json |
| 80775-0 | Podiatry Plan of care note | ./2.16.840.1.114222.4.11.1002/80775-0.json |
| 80776-8 | Plastic surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80776-8.json |
| 80777-6 | Primary care Plan of care note | ./2.16.840.1.114222.4.11.1002/80777-6.json |
| 80778-4 | Otolaryngology Plan of care note | ./2.16.840.1.114222.4.11.1002/80778-4.json |
| 80779-2 | Ophthalmology Plan of care note | ./2.16.840.1.114222.4.11.1002/80779-2.json |
| 80780-0 | Palliative care Plan of care note | ./2.16.840.1.114222.4.11.1002/80780-0.json |
| 80781-8 | Sports medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80781-8.json |
| 80782-6 | Speech-language pathology Plan of care note | ./2.16.840.1.114222.4.11.1002/80782-6.json |
| 80783-4 | Urology Plan of care note | ./2.16.840.1.114222.4.11.1002/80783-4.json |
| 80784-2 | Recreational therapy Plan of care note | ./2.16.840.1.114222.4.11.1002/80784-2.json |
| 80785-9 | Radiation oncology Plan of care note | ./2.16.840.1.114222.4.11.1002/80785-9.json |
| 80786-7 | Physical medicine and rehab Plan of care note | ./2.16.840.1.114222.4.11.1002/80786-7.json |
| 80787-5 | Obstetrics and Gynecology Plan of care note | ./2.16.840.1.114222.4.11.1002/80787-5.json |
| 8078-8 | Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8078-8.json |
| 80788-3 | Social worker Plan of care note | ./2.16.840.1.114222.4.11.1002/80788-3.json |
| 80789-1 | Cardiac surgery Plan of care note | ./2.16.840.1.114222.4.11.1002/80789-1.json |
| 80790-9 | Surgical critical care Plan of care note | ./2.16.840.1.114222.4.11.1002/80790-9.json |
| 80791-7 | Nutrition and dietetics Plan of care note | ./2.16.840.1.114222.4.11.1002/80791-7.json |
| 80792-5 | Pulmonary Diagnostic study note | ./2.16.840.1.114222.4.11.1002/80792-5.json |
| 80793-3 | Pulmonary Education note | ./2.16.840.1.114222.4.11.1002/80793-3.json |
| 80794-1 | Pulmonary Flowsheet | ./2.16.840.1.114222.4.11.1002/80794-1.json |
| 80795-8 | Pulmonary Initial evaluation note | ./2.16.840.1.114222.4.11.1002/80795-8.json |
| 8079-6 | Myelin IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8079-6.json |
| 80796-6 | Pulmonary Plan of care note | ./2.16.840.1.114222.4.11.1002/80796-6.json |
| 80797-4 | Pharmacology Plan of care note | ./2.16.840.1.114222.4.11.1002/80797-4.json |
| 80798-2 | Pulmonary procedure note | ./2.16.840.1.114222.4.11.1002/80798-2.json |
| 80799-0 | Surgical oncology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/80799-0.json |
| 80800-6 | Surgical oncology Checklist | ./2.16.840.1.114222.4.11.1002/80800-6.json |
| 80801-4 | Surgical oncology Consult note | ./2.16.840.1.114222.4.11.1002/80801-4.json |
| 80802-2 | Surgical oncology Education note | ./2.16.840.1.114222.4.11.1002/80802-2.json |
| 80803-0 | Surgical oncology Flowsheet | ./2.16.840.1.114222.4.11.1002/80803-0.json |
| 8080-4 | Myelin IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8080-4.json |
| 80804-8 | Surgical oncology Plan of care note | ./2.16.840.1.114222.4.11.1002/80804-8.json |
| 80805-5 | Surgical oncology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/80805-5.json |
| 80806-3 | Surgical oncology Referral note | ./2.16.840.1.114222.4.11.1002/80806-3.json |
| 80807-1 | Surgical oncology Surgical operation note | ./2.16.840.1.114222.4.11.1002/80807-1.json |
| 80808-9 | Surgical oncology Transfer summary note | ./2.16.840.1.114222.4.11.1002/80808-9.json |
| 80809-7 | Geriatric medicine Admission history and physical note | ./2.16.840.1.114222.4.11.1002/80809-7.json |
| 80810-5 | Geriatric medicine Discharge instructions | ./2.16.840.1.114222.4.11.1002/80810-5.json |
| 80811-3 | Geriatric medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/80811-3.json |
| 8081-2 | Myelin IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8081-2.json |
| 80812-1 | Geriatric medicine Discharge teaching note | ./2.16.840.1.114222.4.11.1002/80812-1.json |
| 80813-9 | Geriatric medicine History and physical note | ./2.16.840.1.114222.4.11.1002/80813-9.json |
| 80814-7 | Geriatric medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/80814-7.json |
| 80815-4 | Geriatric medicine Progress note | ./2.16.840.1.114222.4.11.1002/80815-4.json |
| 80816-2 | Geriatric medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/80816-2.json |
| 80817-0 | Geriatric medicine Flowsheet | ./2.16.840.1.114222.4.11.1002/80817-0.json |
| 80818-8 | Geriatric medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/80818-8.json |
| 80819-6 | Pulmonary Progress note | ./2.16.840.1.114222.4.11.1002/80819-6.json |
| 8082-0 | Myelin basic protein Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/8082-0.json |
| 80820-4 | Medication reconciliation form | ./2.16.840.1.114222.4.11.1002/80820-4.json |
| 80821-2 | Zika virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test | ./2.16.840.1.114222.4.11.1002/80821-2.json |
| 80822-0 | Zika virus neutralizing antibody [Presence] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/80822-0.json |
| 80823-8 | Zika virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/80823-8.json |
| 80824-6 | Zika virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/80824-6.json |
| 80825-3 | Zika virus envelope E gene [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80825-3.json |
| 80826-1 | Zika virus envelope E gene [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/80826-1.json |
| 80828-7 | Pepsin A+Pepsinogen A [Mass/volume] in Lower respiratory specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/80828-7.json |
| 80830-3 | pH of Lower respiratory specimen | ./2.16.840.1.114222.4.11.1002/80830-3.json |
| 80832-9 | Protein [Mass/volume] in Lower respiratory specimen | ./2.16.840.1.114222.4.11.1002/80832-9.json |
| 80833-7 | US for multiple gestation pregnancy limited | ./2.16.840.1.114222.4.11.1002/80833-7.json |
| 80834-5 | US for multiple gestation pregnancy in first trimester | ./2.16.840.1.114222.4.11.1002/80834-5.json |
| 80835-2 | US transabdominal and transvaginal for multiple gestation pregnancy in first trimester | ./2.16.840.1.114222.4.11.1002/80835-2.json |
| 80836-0 | US for multiple gestation pregnancy in second or third trimester | ./2.16.840.1.114222.4.11.1002/80836-0.json |
| 80837-8 | US for multiple gestation pregnancy with fetal abnormality | ./2.16.840.1.114222.4.11.1002/80837-8.json |
| 8083-8 | Myocardium Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8083-8.json |
| 80838-6 | US Liver limited | ./2.16.840.1.114222.4.11.1002/80838-6.json |
| 80839-4 | US Pancreas limited | ./2.16.840.1.114222.4.11.1002/80839-4.json |
| 80840-2 | US Spleen limited | ./2.16.840.1.114222.4.11.1002/80840-2.json |
| 80841-0 | US Guidance for placement of needle in Breast | ./2.16.840.1.114222.4.11.1002/80841-0.json |
| 80842-8 | US Guidance for additional aspiration of cyst of Breast - left | ./2.16.840.1.114222.4.11.1002/80842-8.json |
| 80843-6 | US Guidance for vacuum biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/80843-6.json |
| 80844-4 | US Guidance for fine needle biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/80844-4.json |
| 8084-6 | Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8084-6.json |
| 80846-9 | US Guidance for additional aspiration of cyst of Breast - right | ./2.16.840.1.114222.4.11.1002/80846-9.json |
| 80847-7 | US Guidance for vacuum biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/80847-7.json |
| 80848-5 | US Guidance for fine needle biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/80848-5.json |
| 80850-1 | US.doppler Carotid arteries limited | ./2.16.840.1.114222.4.11.1002/80850-1.json |
| 80851-9 | US.doppler Cerebral artery middle Fetal for pregnancy | ./2.16.840.1.114222.4.11.1002/80851-9.json |
| 80852-7 | US Axilla | ./2.16.840.1.114222.4.11.1002/80852-7.json |
| 8085-3 | Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8085-3.json |
| 80853-5 | US Guidance for injection of Elbow | ./2.16.840.1.114222.4.11.1002/80853-5.json |
| 80854-3 | US Extremity musculoskeletal tissue limited | ./2.16.840.1.114222.4.11.1002/80854-3.json |
| 80855-0 | US Extremity musculoskeletal tissue | ./2.16.840.1.114222.4.11.1002/80855-0.json |
| 80856-8 | US.doppler Head limited | ./2.16.840.1.114222.4.11.1002/80856-8.json |
| 80857-6 | US.doppler Head | ./2.16.840.1.114222.4.11.1002/80857-6.json |
| 80858-4 | US Head and neck soft tissue | ./2.16.840.1.114222.4.11.1002/80858-4.json |
| 80859-2 | US.doppler Heart | ./2.16.840.1.114222.4.11.1002/80859-2.json |
| 80860-0 | US Lower extremity veins - unilateral limited | ./2.16.840.1.114222.4.11.1002/80860-0.json |
| 8086-1 | Pancreatic islet cell Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8086-1.json |
| 80861-8 | US Lower extremity soft tissue | ./2.16.840.1.114222.4.11.1002/80861-8.json |
| 80862-6 | US Pelvis for in vitro fertilization | ./2.16.840.1.114222.4.11.1002/80862-6.json |
| 80863-4 | US.doppler for transplanted kidney | ./2.16.840.1.114222.4.11.1002/80863-4.json |
| 80864-2 | US.doppler for pregnancy | ./2.16.840.1.114222.4.11.1002/80864-2.json |
| 80865-9 | US transvaginal for pregnancy | ./2.16.840.1.114222.4.11.1002/80865-9.json |
| 80866-7 | US for pregnancy in second or third trimester | ./2.16.840.1.114222.4.11.1002/80866-7.json |
| 80867-5 | US transabdominal and transvaginal for pregnancy in first trimester | ./2.16.840.1.114222.4.11.1002/80867-5.json |
| 80868-3 | US for pregnancy with fetal abnormality | ./2.16.840.1.114222.4.11.1002/80868-3.json |
| 80869-1 | US for pregnancy in first trimester | ./2.16.840.1.114222.4.11.1002/80869-1.json |
| 80870-9 | US for pregnancy limited | ./2.16.840.1.114222.4.11.1002/80870-9.json |
| 80871-7 | US Ovary for torsion | ./2.16.840.1.114222.4.11.1002/80871-7.json |
| 80872-5 | US.doppler Uterus and Fallopian tubes W saline IU | ./2.16.840.1.114222.4.11.1002/80872-5.json |
| 80873-3 | US.doppler Penis limited | ./2.16.840.1.114222.4.11.1002/80873-3.json |
| 80874-1 | US.doppler Penis vessels | ./2.16.840.1.114222.4.11.1002/80874-1.json |
| 80875-8 | US Penis soft tissue | ./2.16.840.1.114222.4.11.1002/80875-8.json |
| 80876-6 | US Prostate transrectal for volume measurement | ./2.16.840.1.114222.4.11.1002/80876-6.json |
| 80877-4 | US Scrotum and testicle for torsion | ./2.16.840.1.114222.4.11.1002/80877-4.json |
| 80878-2 | US.doppler Umbilical artery Fetal for pregnancy | ./2.16.840.1.114222.4.11.1002/80878-2.json |
| 8087-9 | Parietal cell Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/8087-9.json |
| 80879-0 | US Upper extremity veins - unilateral limited | ./2.16.840.1.114222.4.11.1002/80879-0.json |
| 80880-8 | US Guidance for injection of Carpal tunnel | ./2.16.840.1.114222.4.11.1002/80880-8.json |
| 80881-6 | US Upper extremity soft tissue | ./2.16.840.1.114222.4.11.1002/80881-6.json |
| 80882-4 | US Guidance of Unspecified body region-- during surgery | ./2.16.840.1.114222.4.11.1002/80882-4.json |
| 80883-2 | American Urological Association Symptom Index [AUASI] | ./2.16.840.1.114222.4.11.1002/80883-2.json |
| 8088-7 | PCNA extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8088-7.json |
| 80891-5 | Symptom score [AUASI] | ./2.16.840.1.114222.4.11.1002/80891-5.json |
| 80892-3 | Heparin unfractionated [Units/volume] in Blood by Heparin protamine titration | ./2.16.840.1.114222.4.11.1002/80892-3.json |
| 80893-1 | Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculation | ./2.16.840.1.114222.4.11.1002/80893-1.json |
| 80894-9 | 2-Methyltyrosine/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/80894-9.json |
| 8089-5 | Platelet associated IgG Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8089-5.json |
| 80895-6 | US Upper extremity veins - bilateral | ./2.16.840.1.114222.4.11.1002/80895-6.json |
| 80896-4 | US.doppler Aorta and Iliac artery - bilateral | ./2.16.840.1.114222.4.11.1002/80896-4.json |
| 80897-2 | US.doppler Aorta and Iliac artery - bilateral limited | ./2.16.840.1.114222.4.11.1002/80897-2.json |
| 80898-0 | US Groin and Pseudoaneurysm | ./2.16.840.1.114222.4.11.1002/80898-0.json |
| 8090-3 | Platelet associated IgM Ab [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8090-3.json |
| 8091-1 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8091-1.json |
| 80912-9 | Gadolinium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80912-9.json |
| 8092-9 | SCL-70 extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8092-9.json |
| 80932-7 | DXA Radius and Ulna [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80932-7.json |
| 80933-5 | DXA Hip [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80933-5.json |
| 80934-3 | DXA Femur [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80934-3.json |
| 80935-0 | DXA Radius and Ulna - right [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80935-0.json |
| 80936-8 | DXA Radius and Ulna - left [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80936-8.json |
| 8093-7 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8093-7.json |
| 80937-6 | DXA Hip - right [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80937-6.json |
| 80938-4 | DXA Hip - left [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80938-4.json |
| 80939-2 | DXA Femur - right [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80939-2.json |
| 80940-0 | DXA Femur - left [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80940-0.json |
| 80941-8 | DXA Calcaneus - right [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80941-8.json |
| 80942-6 | DXA Calcaneus - left [Z-score] Bone density | ./2.16.840.1.114222.4.11.1002/80942-6.json |
| 80943-4 | DXA Radius and Ulna - right [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80943-4.json |
| 80944-2 | DXA Radius and Ulna - left [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80944-2.json |
| 8094-5 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/8094-5.json |
| 80945-9 | DXA Hip - right [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80945-9.json |
| 80946-7 | DXA Hip - left [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80946-7.json |
| 80947-5 | DXA Femur - right [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80947-5.json |
| 80948-3 | DXA Femur - left [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80948-3.json |
| 80949-1 | DXA Calcaneus - right [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80949-1.json |
| 80950-9 | DXA Calcaneus - left [T-score] Bone density | ./2.16.840.1.114222.4.11.1002/80950-9.json |
| 80951-7 | DXA Radius and Ulna - right [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80951-7.json |
| 8095-2 | Smooth muscle Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/8095-2.json |
| 80952-5 | DXA Radius and Ulna - left [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80952-5.json |
| 80953-3 | DXA Femur - right [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80953-3.json |
| 80954-1 | DXA Femur - left [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80954-1.json |
| 80955-8 | DXA Calcaneus - right [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80955-8.json |
| 80956-6 | DXA Calcaneus - left [Mass/Area] Bone density | ./2.16.840.1.114222.4.11.1002/80956-6.json |
| 80957-4 | cefTRIAXone free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80957-4.json |
| 80958-2 | Fractional excretion of magnesium [Ratio] in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80958-2.json |
| 80959-0 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post meal | ./2.16.840.1.114222.4.11.1002/80959-0.json |
| 8096-0 | Somatotropin Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8096-0.json |
| 80960-8 | cefTAZidime free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80960-8.json |
| 80961-6 | Cefotaxime free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80961-6.json |
| 80962-4 | ceFAZolin free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80962-4.json |
| 80963-2 | Salicylates free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80963-2.json |
| 80964-0 | Acetaminophen free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80964-0.json |
| 80965-7 | Topiramate free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80965-7.json |
| 80966-5 | Tobramycin free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80966-5.json |
| 80967-3 | Theophylline free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80967-3.json |
| 80968-1 | Teicoplanin free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80968-1.json |
| 80969-9 | Methotrexate free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80969-9.json |
| 80970-7 | Lithium free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80970-7.json |
| 80971-5 | Gentamicin free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80971-5.json |
| 80972-3 | Amikacin free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80972-3.json |
| 80973-1 | Trimethoprim free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80973-1.json |
| 80974-9 | Sulfamethoxazole free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80974-9.json |
| 80975-6 | Calcium intake 24 hour Measured | ./2.16.840.1.114222.4.11.1002/80975-6.json |
| 80976-4 | International Prostate Symptom Score [IPSS] | ./2.16.840.1.114222.4.11.1002/80976-4.json |
| 8097-8 | Striated muscle Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/8097-8.json |
| 80979-8 | Frataxin [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/80979-8.json |
| 80980-6 | Frataxin [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/80980-6.json |
| 80981-4 | N,N-dimethylarginine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/80981-4.json |
| 80982-2 | Phytanoyl CoA hydroxlase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/80982-2.json |
| 8098-6 | Thyroglobulin Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8098-6.json |
| 80992-1 | Date and time of surgery | ./2.16.840.1.114222.4.11.1002/80992-1.json |
| 8099-4 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8099-4.json |
| 81091-1 | Tricuspid valve Orifice area by US 2D | ./2.16.840.1.114222.4.11.1002/81091-1.json |
| 81092-9 | Tricuspid valve Orifice area by US.doppler | ./2.16.840.1.114222.4.11.1002/81092-9.json |
| 81093-7 | Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by PISA method | ./2.16.840.1.114222.4.11.1002/81093-7.json |
| 81094-5 | Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by volumetric method | ./2.16.840.1.114222.4.11.1002/81094-5.json |
| 81095-2 | Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.2D+Calculated by Devereux method | ./2.16.840.1.114222.4.11.1002/81095-2.json |
| 81096-0 | West Nile virus Kunjin strain IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81096-0.json |
| 81097-8 | West Nile virus Kunjin strain Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81097-8.json |
| 81098-6 | Leptospira borgpetersenii sv Arborea Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81098-6.json |
| 81099-4 | Leptospira interrogans sv Bulgarica Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81099-4.json |
| 81100-0 | Leptospira interrogans sv Celledoni Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81100-0.json |
| 81101-8 | Leptospira interrogans sv Copenhageni Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81101-8.json |
| 81102-6 | Leptospira interrogans sv Cynopteri Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81102-6.json |
| 81103-4 | Leptospira interrogans sv Kremastos Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81103-4.json |
| 81104-2 | Leptospira interrogans sv Medanensis Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81104-2.json |
| 81105-9 | Leptospira interrogans sv Panama Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81105-9.json |
| 81106-7 | Leptospira interrogans sv Robinsoni Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81106-7.json |
| 81107-5 | Leptospira interrogans sv Shermani Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81107-5.json |
| 81108-3 | Leptospira interrogans sv Szwajizak Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81108-3.json |
| 81109-1 | Leptospira interrogans sv Zanoni Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81109-1.json |
| 81110-9 | Leptospira weilii serovar Topaz Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/81110-9.json |
| 81111-7 | Murray Valley encephalitis virus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81111-7.json |
| 81112-5 | Murray Valley encephalitis virus IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/81112-5.json |
| 81113-3 | Murray Valley encephalitis virus IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81113-3.json |
| 81114-1 | Murray Valley encephalitis virus IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/81114-1.json |
| 81115-8 | Murray Valley encephalitis virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/81115-8.json |
| 81116-6 | Hepatitis C virus core Ab+Ag [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81116-6.json |
| 81117-4 | Ross River virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81117-4.json |
| 81118-2 | Legionella sp IgM Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81118-2.json |
| 81119-0 | Epstein Barr virus capsid IgG Ab avidity [Ratio] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/81119-0.json |
| 81120-8 | Barmah forest virus Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/81120-8.json |
| 81121-6 | Murray Valley encephalitis virus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81121-6.json |
| 81122-4 | HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/81122-4.json |
| 81123-2 | Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/81123-2.json |
| 81124-0 | Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/81124-0.json |
| 81125-7 | Platelet aggregation.ristocetin inhibitor [Presence] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/81125-7.json |
| 81139-8 | CYP3A4 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/81139-8.json |
| 81140-6 | CYP3A5 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/81140-6.json |
| 81141-4 | Spermatozoa motility [Score] in Semen by Automated | ./2.16.840.1.114222.4.11.1002/81141-4.json |
| 81142-2 | PTPN22 gene.c.1858C>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81142-2.json |
| 81143-0 | Galactokinase [Enzymatic activity/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81143-0.json |
| 81144-8 | Cerium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/81144-8.json |
| 81146-3 | CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81146-3.json |
| 81147-1 | Specimen source patient identification [Interpretation] Narrative | ./2.16.840.1.114222.4.11.1002/81147-1.json |
| 81148-9 | Zika virus envelope E gene [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81148-9.json |
| 81149-7 | Zika virus envelope E gene [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81149-7.json |
| 81150-5 | Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81150-5.json |
| 81151-3 | Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81151-3.json |
| 81152-1 | Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81152-1.json |
| 81153-9 | Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81153-9.json |
| 81155-4 | Islet cell 512 Ab [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81155-4.json |
| 81156-2 | Coenzyme Q10.reduced/Coenzyme Q10 in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/81156-2.json |
| 81157-0 | Coenzyme Q10.reduced [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/81157-0.json |
| 81158-8 | US Pediatric Head | ./2.16.840.1.114222.4.11.1002/81158-8.json |
| 81159-6 | US Pediatric Cervical and thoracic and lumbar spine | ./2.16.840.1.114222.4.11.1002/81159-6.json |
| 81160-4 | US.doppler Pediatric limited Head | ./2.16.840.1.114222.4.11.1002/81160-4.json |
| 81161-2 | US.doppler Heart for blood flow | ./2.16.840.1.114222.4.11.1002/81161-2.json |
| 81162-0 | US Guidance for needle localization Breast - left and MG Views Breast specimen | ./2.16.840.1.114222.4.11.1002/81162-0.json |
| 81163-8 | US Guidance for needle localization Breast - right and MG Views Breast specimen | ./2.16.840.1.114222.4.11.1002/81163-8.json |
| 81164-6 | US Pediatric limited Hip - bilateral | ./2.16.840.1.114222.4.11.1002/81164-6.json |
| 81165-3 | US Guidance for peripheral venous access of Vein | ./2.16.840.1.114222.4.11.1002/81165-3.json |
| 8116-6 | CD19 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8116-6.json |
| 8117-4 | CD19 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/8117-4.json |
| 81191-9 | Chemical pathology Consult note | ./2.16.840.1.114222.4.11.1002/81191-9.json |
| 81192-7 | Clinical pathology Consult note | ./2.16.840.1.114222.4.11.1002/81192-7.json |
| 81193-5 | Medical microbiology - pathology Consult note | ./2.16.840.1.114222.4.11.1002/81193-5.json |
| 81194-3 | Evaluation and management of workers compensation note | ./2.16.840.1.114222.4.11.1002/81194-3.json |
| 81195-0 | Evaluation and management of workers compensation form | ./2.16.840.1.114222.4.11.1002/81195-0.json |
| 81196-8 | Clinical pharmacology Consult note | ./2.16.840.1.114222.4.11.1002/81196-8.json |
| 81199-2 | Beta-ureidopropionase [Enzymatic activity/mass] in Liver | ./2.16.840.1.114222.4.11.1002/81199-2.json |
| 81200-8 | Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/81200-8.json |
| 81201-6 | Phospholipase A2 receptor IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/81201-6.json |
| 81203-2 | FDA product label Bulk ingredient - animal drug | ./2.16.840.1.114222.4.11.1002/81203-2.json |
| 81204-0 | FDA product label NDC labeler code inactivation - animal drug | ./2.16.840.1.114222.4.11.1002/81204-0.json |
| 81206-5 | NM Liver and Spleen Views W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/81206-5.json |
| 8122-4 | CD3 cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8122-4.json |
| 81236-2 | Send document that conforms to C-CDA R1.1 template | ./2.16.840.1.114222.4.11.1002/81236-2.json |
| 81237-0 | Send document that conforms to C-CDA R2.1 template | ./2.16.840.1.114222.4.11.1002/81237-0.json |
| 81238-8 | Send document that conforms to CDP Set 1 R1.0 template | ./2.16.840.1.114222.4.11.1002/81238-8.json |
| 81239-6 | Send document that conforms to CDP Set 1 R1.1 template | ./2.16.840.1.114222.4.11.1002/81239-6.json |
| 8126-5 | CD38 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/8126-5.json |
| 81284-2 | Malignant cells/100 cells in Bronchoalveolar lavage by Manual count | ./2.16.840.1.114222.4.11.1002/81284-2.json |
| 81285-9 | Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes [Identifier] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81285-9.json |
| 81305-5 | Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81305-5.json |
| 81307-1 | Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81307-1.json |
| 81308-9 | Influenza virus A RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81308-9.json |
| 81309-7 | Influenza virus B RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81309-7.json |
| 81310-5 | Carbonic anhydrase 2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/81310-5.json |
| 81311-3 | Cryoglobulin.IgA [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81311-3.json |
| 81312-1 | Cryoglobulin.IgM [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81312-1.json |
| 81313-9 | Cryoglobulin.complement C3 [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81313-9.json |
| 81314-7 | Palatinase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/81314-7.json |
| 81315-4 | Lactase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/81315-4.json |
| 81316-2 | Trichomonas vaginalis [Presence] in Urine sediment by Organism specific culture | ./2.16.840.1.114222.4.11.1002/81316-2.json |
| 81320-4 | Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5a | ./2.16.840.1.114222.4.11.1002/81320-4.json |
| 81321-2 | Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory system specimen by Nucleic acid amplification using primer-probe set H5b | ./2.16.840.1.114222.4.11.1002/81321-2.json |
| 81322-0 | Glucan 1,4 alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue | ./2.16.840.1.114222.4.11.1002/81322-0.json |
| 81325-3 | Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81325-3.json |
| 81326-1 | Human RNase P RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81326-1.json |
| 81327-9 | Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81327-9.json |
| 81328-7 | Cytomegalovirus [Presence] in Lower respiratory specimen by Shell vial culture | ./2.16.840.1.114222.4.11.1002/81328-7.json |
| 8133-1 | CD56 cells/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/8133-1.json |
| 81334-5 | Patient Personal advance care plan | ./2.16.840.1.114222.4.11.1002/81334-5.json |
| 81335-2 | Patient Healthcare agent | ./2.16.840.1.114222.4.11.1002/81335-2.json |
| 81336-0 | Patient Goals, preferences, and priorities under certain health conditions | ./2.16.840.1.114222.4.11.1002/81336-0.json |
| 81337-8 | Patient Goals, preferences, and priorities upon death | ./2.16.840.1.114222.4.11.1002/81337-8.json |
| 81338-6 | Patient Goals, preferences, and priorities for care experience | ./2.16.840.1.114222.4.11.1002/81338-6.json |
| 81339-4 | Witness and notary Document | ./2.16.840.1.114222.4.11.1002/81339-4.json |
| 81390-7 | Left ventricular Cardiac output by US 3D | ./2.16.840.1.114222.4.11.1002/81390-7.json |
| 81391-5 | Left ventricular outflow tract Ejection time by US.doppler | ./2.16.840.1.114222.4.11.1002/81391-5.json |
| 81392-3 | Aortic valve Orifice area/Body surface area [Area/Area] by US.2D+Measured by planimetry | ./2.16.840.1.114222.4.11.1002/81392-3.json |
| 81393-1 | Left ventricular Myocardial performance index (Tei) by US.doppler | ./2.16.840.1.114222.4.11.1002/81393-1.json |
| 81394-9 | Mitral valve Regurgitant volume by US.doppler+Calculated by volumetric method | ./2.16.840.1.114222.4.11.1002/81394-9.json |
| 81395-6 | Mitral valve Regurgitant fraction by US.doppler+Calculated by volumetric method | ./2.16.840.1.114222.4.11.1002/81395-6.json |
| 81396-4 | Mitral valve medial annulus Tissue velocity.A-wave.max by US.tissue doppler | ./2.16.840.1.114222.4.11.1002/81396-4.json |
| 81397-2 | Mitral valve lateral annulus Tissue velocity.A-wave.max by US.tissue doppler | ./2.16.840.1.114222.4.11.1002/81397-2.json |
| 8139-8 | Amphetamines [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8139-8.json |
| 81398-0 | Mitral valve Maximum E-wave velocity/Flow propagation velocity.E wave by US.M-mode+doppler.A4C | ./2.16.840.1.114222.4.11.1002/81398-0.json |
| 8140-6 | Amphetamines [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8140-6.json |
| 8141-4 | Amphetamines [Presence] in Gastric fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8141-4.json |
| 81420-2 | KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/81420-2.json |
| 81421-0 | Baker's yeast IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/81421-0.json |
| 8142-2 | Amphetamines [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/8142-2.json |
| 81422-8 | GATA1 gene exon 2 targeted mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81422-8.json |
| 81423-6 | Microscopic observation [Identifier] in Bone marrow by Acetate esterase stain | ./2.16.840.1.114222.4.11.1002/81423-6.json |
| 81424-4 | Microscopic observation [Identifier] in Bone marrow by Toluidine blue O stain | ./2.16.840.1.114222.4.11.1002/81424-4.json |
| 81425-1 | Microscopic observation [Identifier] in Bone marrow by Oil red O stain | ./2.16.840.1.114222.4.11.1002/81425-1.json |
| 81426-9 | Microscopic observation [Identifier] in Venous blood by Acetate esterase stain | ./2.16.840.1.114222.4.11.1002/81426-9.json |
| 81427-7 | Microscopic observation [Identifier] in Venous blood by Oil red O stain | ./2.16.840.1.114222.4.11.1002/81427-7.json |
| 81428-5 | Influenza virus A H7 Eurasia RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81428-5.json |
| 81429-3 | Bismuth [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/81429-3.json |
| 8143-0 | Amphetamines [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/8143-0.json |
| 81430-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal dialysis fluid by Lactate to pyruvate reaction | ./2.16.840.1.114222.4.11.1002/81430-1.json |
| 81439-2 | Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/81439-2.json |
| 81441-8 | Vital capacity [Volume] Respiratory system --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81441-8.json |
| 81442-6 | Airway resistance --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81442-6.json |
| 81443-4 | Airway resistance --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81443-4.json |
| 81444-2 | Maximum inspiratory pressure Respiratory system --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81444-2.json |
| 81445-9 | Maximum inspiratory pressure Respiratory system --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81445-9.json |
| 81446-7 | Maximum expiratory pressure Respiratory system --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81446-7.json |
| 81447-5 | Maximum expiratory pressure Respiratory system --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81447-5.json |
| 8144-8 | Amphetamines [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/8144-8.json |
| 81448-3 | Inspiratory gas flow.max Respiratory system airway --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81448-3.json |
| 81449-1 | Inspiratory gas flow.max Respiratory system airway --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81449-1.json |
| 81450-9 | Total lung capacity --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81450-9.json |
| 81452-5 | Residual volume --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81452-5.json |
| 81453-3 | Residual volume --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81453-3.json |
| 81454-1 | Residual volume/Total capacity --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81454-1.json |
| 8145-5 | Amphetamines [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8145-5.json |
| 81455-8 | Residual volume/Total capacity --post bronchodilation | ./2.16.840.1.114222.4.11.1002/81455-8.json |
| 81456-6 | Functional residual capacity --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/81456-6.json |
| 8146-3 | Amphetamines [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/8146-3.json |
| 8147-1 | Amphetamines [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8147-1.json |
| 8148-9 | Amphetamines [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8148-9.json |
| 8149-7 | Amphetamines [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/8149-7.json |
| 8150-5 | Amphetamines [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/8150-5.json |
| 8151-3 | Amphetamines [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/8151-3.json |
| 8152-1 | Amphetamines [Presence] in Urine by SAMHSA screen method | ./2.16.840.1.114222.4.11.1002/8152-1.json |
| 8153-9 | Amphetamines [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8153-9.json |
| 81541-5 | Resource identifier [URI] for Patient education material | ./2.16.840.1.114222.4.11.1002/81541-5.json |
| 81542-3 | NM Lumbar spine Views for CSF leak post lumbar puncture W radionuclide IT | ./2.16.840.1.114222.4.11.1002/81542-3.json |
| 81543-1 | NM Head Views for CSF leak with rhinorrhea or otorrhea W radionuclide IT | ./2.16.840.1.114222.4.11.1002/81543-1.json |
| 81544-9 | NM Gastrointestinal tract Views for gastrointestinal bleeding | ./2.16.840.1.114222.4.11.1002/81544-9.json |
| 81545-6 | NM Abdomen and Pelvis Views for shunt patency | ./2.16.840.1.114222.4.11.1002/81545-6.json |
| 81546-4 | NM Views for blood flow and kidney function | ./2.16.840.1.114222.4.11.1002/81546-4.json |
| 8154-7 | Amphetamines [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8154-7.json |
| 81547-2 | SPECT Whole body W In-111 pentetreotide IV | ./2.16.840.1.114222.4.11.1002/81547-2.json |
| 81548-0 | SPECT Unspecified body region W tagged WBC IV | ./2.16.840.1.114222.4.11.1002/81548-0.json |
| 81549-8 | SPECT+CT Lymph node | ./2.16.840.1.114222.4.11.1002/81549-8.json |
| 81550-6 | SPECT+CT Parathyroid gland | ./2.16.840.1.114222.4.11.1002/81550-6.json |
| 81551-4 | PET+CT Bone from skull base to mid-thigh W 18F-NaF IV | ./2.16.840.1.114222.4.11.1002/81551-4.json |
| 81552-2 | PET+CT Whole body Bone W 18F-NaF IV | ./2.16.840.1.114222.4.11.1002/81552-2.json |
| 81553-0 | PET+CT Guidance limited for localization of tumor of Unspecified body region-- W 18F-FDG IV | ./2.16.840.1.114222.4.11.1002/81553-0.json |
| 8155-4 | Amphetamines [Presence] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8155-4.json |
| 81554-8 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV | ./2.16.840.1.114222.4.11.1002/81554-8.json |
| 81555-5 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV | ./2.16.840.1.114222.4.11.1002/81555-5.json |
| 81556-3 | SPECT Unspecified body region for infection or inflammation | ./2.16.840.1.114222.4.11.1002/81556-3.json |
| 81557-1 | SPECT Brain W florbetapir IV | ./2.16.840.1.114222.4.11.1002/81557-1.json |
| 81558-9 | SPECT Brain W Tc-99m IV | ./2.16.840.1.114222.4.11.1002/81558-9.json |
| 81559-7 | PET+CT Unspecified body region for simulation limited | ./2.16.840.1.114222.4.11.1002/81559-7.json |
| 81560-5 | SPECT Whole body W In-111 capromab pendetide IV | ./2.16.840.1.114222.4.11.1002/81560-5.json |
| 81561-3 | SPECT Heart W multiple states of exercise | ./2.16.840.1.114222.4.11.1002/81561-3.json |
| 8156-2 | Amphetamines [Presence] in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/8156-2.json |
| 81562-1 | SPECT Heart W single state of exercise | ./2.16.840.1.114222.4.11.1002/81562-1.json |
| 81563-9 | NM Heart First pass and Blood pool | ./2.16.840.1.114222.4.11.1002/81563-9.json |
| 81564-7 | PT Heart for sarcoidosis | ./2.16.840.1.114222.4.11.1002/81564-7.json |
| 81565-4 | PT Heart for tissue viability | ./2.16.840.1.114222.4.11.1002/81565-4.json |
| 81566-2 | NM Heart Gated and Blood pool and Ejection fraction and Wall motion W multiple states of exercise | ./2.16.840.1.114222.4.11.1002/81566-2.json |
| 81567-0 | NM Heart Gated and Blood pool and Ejection fraction and Wall motion W single state of exercise | ./2.16.840.1.114222.4.11.1002/81567-0.json |
| 81568-8 | PT perfusion Heart W multiple states of exercise | ./2.16.840.1.114222.4.11.1002/81568-8.json |
| 81569-6 | PT perfusion Heart W single state of exercise | ./2.16.840.1.114222.4.11.1002/81569-6.json |
| 8157-0 | Arsenic [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/8157-0.json |
| 81570-4 | NM Heart Perfusion W single state of exercise | ./2.16.840.1.114222.4.11.1002/81570-4.json |
| 81571-2 | NM Heart Perfusion W multiple states of exercise | ./2.16.840.1.114222.4.11.1002/81571-2.json |
| 81572-0 | NM Salivary gland Views for function | ./2.16.840.1.114222.4.11.1002/81572-0.json |
| 81573-8 | NM Brain Brain death protocol Views | ./2.16.840.1.114222.4.11.1002/81573-8.json |
| 81574-6 | NM Brain GE 4 Views | ./2.16.840.1.114222.4.11.1002/81574-6.json |
| 81575-3 | NM Brain GE 4 Views for blood flow | ./2.16.840.1.114222.4.11.1002/81575-3.json |
| 81576-1 | NM Brain LT 4 Views for blood flow | ./2.16.840.1.114222.4.11.1002/81576-1.json |
| 81577-9 | PT Brain for amyloidosis | ./2.16.840.1.114222.4.11.1002/81577-9.json |
| 81578-7 | PT Brain metabolic | ./2.16.840.1.114222.4.11.1002/81578-7.json |
| 81579-5 | PT perfusion Brain | ./2.16.840.1.114222.4.11.1002/81579-5.json |
| 81580-3 | NM Thyroid gland Views for therapy W I-131 PO | ./2.16.840.1.114222.4.11.1002/81580-3.json |
| 81581-1 | NM Thyroid gland Views for dosimetry W radionuclide PO | ./2.16.840.1.114222.4.11.1002/81581-1.json |
| 81582-9 | NM Thyroid gland Uptake | ./2.16.840.1.114222.4.11.1002/81582-9.json |
| 81583-7 | NM Whole body Views W Sm-153 IV | ./2.16.840.1.114222.4.11.1002/81583-7.json |
| 81584-5 | NM Whole body Views W tagged WBC IV | ./2.16.840.1.114222.4.11.1002/81584-5.json |
| 81585-2 | NM Unspecified body region Views W tagged WBC IV | ./2.16.840.1.114222.4.11.1002/81585-2.json |
| 81586-0 | NM Whole body Views W Y-90 ibritumomab tiuxetan IV | ./2.16.840.1.114222.4.11.1002/81586-0.json |
| 81587-8 | NM Unspecified body region Limited Views for infection or inflammation | ./2.16.840.1.114222.4.11.1002/81587-8.json |
| 8158-8 | Arsenic [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/8158-8.json |
| 81588-6 | NM Whole body Views for thyroid tumor | ./2.16.840.1.114222.4.11.1002/81588-6.json |
| 81589-4 | NM Whole body Views for infection or inflammation | ./2.16.840.1.114222.4.11.1002/81589-4.json |
| 81590-2 | NM Extremity veins - bilateral Views for thrombosis | ./2.16.840.1.114222.4.11.1002/81590-2.json |
| 81591-0 | NM Extremity veins - unilateral Views for thrombosis | ./2.16.840.1.114222.4.11.1002/81591-0.json |
| 81592-8 | NM Views for transplanted kidney | ./2.16.840.1.114222.4.11.1002/81592-8.json |
| 81593-6 | NM Lymph node Views | ./2.16.840.1.114222.4.11.1002/81593-6.json |
| 81594-4 | NM Lymph node - bilateral Views | ./2.16.840.1.114222.4.11.1002/81594-4.json |
| 81595-1 | NM Lymph node Views for lymphedema | ./2.16.840.1.114222.4.11.1002/81595-1.json |
| 8159-6 | Beryllium [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8159-6.json |
| 81596-9 | NM Lung Quantitative Views Ventilation and Perfusion | ./2.16.840.1.114222.4.11.1002/81596-9.json |
| 81597-7 | NM Bones Views for metastasis W Ra-223 IV | ./2.16.840.1.114222.4.11.1002/81597-7.json |
| 81598-5 | NM Whole body Views for thyroid tumor metastasis post therapy | ./2.16.840.1.114222.4.11.1002/81598-5.json |
| 81599-3 | NM Guidance for multiple days for localization of tumor of Whole body | ./2.16.840.1.114222.4.11.1002/81599-3.json |
| 81600-9 | NM Unspecified body region Limited Views for infection or inflammation W Tc-99m tagged WBC IV | ./2.16.840.1.114222.4.11.1002/81600-9.json |
| 81601-7 | NM Unspecified body region Limited Views for thyroid tumor metastasis | ./2.16.840.1.114222.4.11.1002/81601-7.json |
| 81602-5 | NM Stomach Views for gastric emptying solid phase W radionuclide PO | ./2.16.840.1.114222.4.11.1002/81602-5.json |
| 81603-3 | NM Views for blood flow and kidney function W diuretic IV | ./2.16.840.1.114222.4.11.1002/81603-3.json |
| 8160-4 | Beryllium [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/8160-4.json |
| 81604-1 | NM Kidney Views for glomerular filtration rate | ./2.16.840.1.114222.4.11.1002/81604-1.json |
| 81605-8 | NM Ureter and Urinary bladder Views | ./2.16.840.1.114222.4.11.1002/81605-8.json |
| 81606-6 | NM Liver and Biliary ducts and Gallbladder Views W cholecystokinetic IV | ./2.16.840.1.114222.4.11.1002/81606-6.json |
| 81607-4 | NM Kidney cortex Views | ./2.16.840.1.114222.4.11.1002/81607-4.json |
| 81608-2 | NM Views for blood flow and kidney function W ACE inhibitor PO | ./2.16.840.1.114222.4.11.1002/81608-2.json |
| 81609-0 | NM Liver Views W SIR-spheres intraarterial hepatic injection | ./2.16.840.1.114222.4.11.1002/81609-0.json |
| 81610-8 | NM Liver Views W Theraspheres intraarterial hepatic injection | ./2.16.840.1.114222.4.11.1002/81610-8.json |
| 81611-6 | NM Head to Pelvis Views for shunt patency | ./2.16.840.1.114222.4.11.1002/81611-6.json |
| 8161-2 | Bismuth [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8161-2.json |
| 81612-4 | NM Heart Blood pool and Ejection fraction and First pass | ./2.16.840.1.114222.4.11.1002/81612-4.json |
| 81613-2 | SPECT Liver for hemangioma | ./2.16.840.1.114222.4.11.1002/81613-2.json |
| 8162-0 | Tetrahydrocannabinol [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8162-0.json |
| 81622-3 | Hydroxyapatite [Energy Difference] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/81622-3.json |
| 81623-1 | Calcium oxalate [Energy Difference] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/81623-1.json |
| 81624-9 | Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81624-9.json |
| 81625-6 | Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81625-6.json |
| 81626-4 | Methotrexate triglutamate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81626-4.json |
| 81627-2 | Methotrexate diglutamate [Moles/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81627-2.json |
| 81629-8 | Gamma hydroxybutyrate [Presence] in Specimen by Confirmatory method | ./2.16.840.1.114222.4.11.1002/81629-8.json |
| 81633-0 | Oncology Recommended follow-up tests or procedures | ./2.16.840.1.114222.4.11.1002/81633-0.json |
| 81634-8 | Oncology Recommended cancer surveillance | ./2.16.840.1.114222.4.11.1002/81634-8.json |
| 81635-5 | Service AndOr equipment AndOr product note | ./2.16.840.1.114222.4.11.1002/81635-5.json |
| 81637-1 | Glucose meter to reference method correlation [Ratio] in Serum, Plasma or Blood by calculation | ./2.16.840.1.114222.4.11.1002/81637-1.json |
| 8163-8 | Tetrahydrocannabinol [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8163-8.json |
| 81638-9 | Clotting time of Capillary blood by Sukharev method | ./2.16.840.1.114222.4.11.1002/81638-9.json |
| 81641-3 | HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/81641-3.json |
| 81643-9 | von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/81643-9.json |
| 81644-7 | Clostridium botulinum toxin C botC gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81644-7.json |
| 81645-4 | Clostridium botulinum toxin D botD gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81645-4.json |
| 8164-6 | Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8164-6.json |
| 81646-2 | Clostridium botulinum toxin E botE gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81646-2.json |
| 81647-0 | Clostridium botulinum toxin F botF gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81647-0.json |
| 81648-8 | Clostridium botulinum toxin G botG gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81648-8.json |
| 81649-6 | Cryptococcus sp rRNA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81649-6.json |
| 81650-4 | West Nile virus Kunjin strain RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81650-4.json |
| 81651-2 | Murray Valley encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81651-2.json |
| 81652-0 | HIV 2 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81652-0.json |
| 8165-3 | Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/8165-3.json |
| 81653-8 | Blastomyces dermatitidis drk1 and Histoplasma capsulatum gapdh genes [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81653-8.json |
| 81655-3 | Respiratory pathogens DNA and RNA identified in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81655-3.json |
| 8166-1 | Tetrahydrocannabinol [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/8166-1.json |
| 81663-7 | Diet [Type] | ./2.16.840.1.114222.4.11.1002/81663-7.json |
| 8167-9 | Tetrahydrocannabinol [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/8167-9.json |
| 8168-7 | Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8168-7.json |
| 81688-4 | Barmah forest virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81688-4.json |
| 81689-2 | Hendra virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81689-2.json |
| 81690-0 | Legionella longbeachae 1 and 2 DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/81690-0.json |
| 81691-8 | DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/81691-8.json |
| 81692-6 | DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/81692-6.json |
| 81693-4 | DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/81693-4.json |
| 81694-2 | Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/81694-2.json |
| 8169-5 | Tetrahydrocannabinol [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/8169-5.json |
| 8170-3 | Cannabinoids [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8170-3.json |
| 8171-1 | Cannabinoids [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8171-1.json |
| 81712-2 | Actin.filamentous Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81712-2.json |
| 81714-8 | Centromere protein A Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81714-8.json |
| 81716-3 | DNA double strand Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81716-3.json |
| 81725-4 | Glutamate decarboxylase 65 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81725-4.json |
| 81727-0 | Mitochondria M2-3E Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81727-0.json |
| 81728-8 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/81728-8.json |
| 8172-9 | Cannabinoids [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/8172-9.json |
| 81729-6 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/81729-6.json |
| 81732-0 | PM-SCL-100 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81732-0.json |
| 81733-8 | PM-SCL-75 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81733-8.json |
| 81737-9 | RNA polymerase III RP11 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81737-9.json |
| 81738-7 | RNA polymerase III RP155 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81738-7.json |
| 81742-9 | Th-To Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81742-9.json |
| 81743-7 | Th-To Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/81743-7.json |
| 8174-5 | Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/8174-5.json |
| 81745-2 | Personal advance care plan R1.0 - recommended CDA sections | ./2.16.840.1.114222.4.11.1002/81745-2.json |
| 81746-0 | Chromosome region 17p13.1 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/81746-0.json |
| 81747-8 | Chromosome region 6q22 rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/81747-8.json |
| 81748-6 | Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/81748-6.json |
| 81749-4 | Chromosome region 13q14 deletion in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/81749-4.json |
| 81751-0 | Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/81751-0.json |
| 8175-2 | Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method | ./2.16.840.1.114222.4.11.1002/8175-2.json |
| 81752-8 | Chromosome region 1q21 duplication in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/81752-8.json |
| 81753-6 | Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin | ./2.16.840.1.114222.4.11.1002/81753-6.json |
| 81754-4 | Nortapentadol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/81754-4.json |
| 8176-0 | Cannabinoids [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8176-0.json |
| 81761-9 | F8 gene intron 1 and 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81761-9.json |
| 81762-7 | F8 gene intron 1 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81762-7.json |
| 81764-3 | Docosatrienoate (C22:3w9) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/81764-3.json |
| 81765-0 | Docosatrienoate (C22:3w9) [Entitic substance] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/81765-0.json |
| 81766-8 | Eicosatrienoate (C20:3w3) [Entitic substance] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/81766-8.json |
| 81767-6 | Eicosatrienoate (C20:3w3) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/81767-6.json |
| 81768-4 | U1 small nuclear ribonucleoprotein 70kD IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/81768-4.json |
| 81769-2 | Adipoylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81769-2.json |
| 81770-0 | Tiglylcarnitine (C5:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81770-0.json |
| 81771-8 | Myeloperoxidase IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/81771-8.json |
| 81772-6 | European house dust mite IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81772-6.json |
| 81773-4 | Amyloid A [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/81773-4.json |
| 81774-2 | Actin smooth muscle IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/81774-2.json |
| 81775-9 | Epipregnanolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81775-9.json |
| 81776-7 | Ureidopropionate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81776-7.json |
| 81777-5 | Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81777-5.json |
| 8177-8 | Cannabinoids [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8177-8.json |
| 81778-3 | Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81778-3.json |
| 81779-1 | Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81779-1.json |
| 81780-9 | Tetradecenoylcarnitine (C14:1)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81780-9.json |
| 81781-7 | Saccharopine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/81781-7.json |
| 81782-5 | Timothy IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81782-5.json |
| 81783-3 | Chicken feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81783-3.json |
| 81784-1 | Canary droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81784-1.json |
| 81785-8 | Duck feather IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81785-8.json |
| 8178-6 | Cannabinoids [Presence] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8178-6.json |
| 81786-6 | Chemokine (C-C motif) ligand 17 [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/81786-6.json |
| 81787-4 | Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/81787-4.json |
| 81788-2 | Hazelnut recombinant (rCor a) 14 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81788-2.json |
| 81789-0 | English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81789-0.json |
| 81790-8 | English walnut recombinant (rJug r) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81790-8.json |
| 81791-6 | Apple recombinant (rMal d) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81791-6.json |
| 81792-4 | Dermatophagoides pteronyssinus native (nDer p) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/81792-4.json |
| 81793-2 | Tetrahydrodeoxycortisol/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/81793-2.json |
| 8179-4 | Cannabinoids [Presence] in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/8179-4.json |
| 81794-0 | Tetrahydrocortisol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81794-0.json |
| 81795-7 | Tetrahydrocortisone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81795-7.json |
| 81796-5 | Tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81796-5.json |
| 81797-3 | 11-Dehydrotetrahydrocorticosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81797-3.json |
| 81798-1 | Pregnanediolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81798-1.json |
| 81799-9 | 16-Alpha hydroxypregnenolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81799-9.json |
| 81800-5 | 16-Ketoandrostenediol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81800-5.json |
| 81801-3 | 16-Alpha hydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81801-3.json |
| 8180-2 | Chlorobenzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8180-2.json |
| 81802-1 | 16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81802-1.json |
| 81803-9 | Beta cortolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81803-9.json |
| 81804-7 | Allo-tetrahydrocortisol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81804-7.json |
| 81805-4 | Allo-tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81805-4.json |
| 81806-2 | Alpha cortolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81806-2.json |
| 81807-0 | Alpha cortol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81807-0.json |
| 81808-8 | Androstenetriol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81808-8.json |
| 81809-6 | 3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81809-6.json |
| 8181-0 | Chromium [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/8181-0.json |
| 81810-4 | 3-Hydroxydecanoylcarnitine (C10-OH)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/81810-4.json |
| 81811-2 | 3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/81811-2.json |
| 81812-0 | TPP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81812-0.json |
| 81813-8 | F11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81813-8.json |
| 81814-6 | HSD17B4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81814-6.json |
| 81815-3 | CTNS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81815-3.json |
| 81816-1 | OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81816-1.json |
| 81817-9 | MPI gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81817-9.json |
| 81818-7 | PMM2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81818-7.json |
| 81819-5 | CLN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81819-5.json |
| 81820-3 | ASS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81820-3.json |
| 81821-1 | RMRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81821-1.json |
| 81822-9 | BBS10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81822-9.json |
| 81823-7 | SACS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81823-7.json |
| 81824-5 | SLC12A6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81824-5.json |
| 81825-2 | MAN2B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81825-2.json |
| 81826-0 | HGD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81826-0.json |
| 81827-8 | CNGB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81827-8.json |
| 8182-8 | Benzoylecgonine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8182-8.json |
| 81828-6 | SLC37A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81828-6.json |
| 81829-4 | SDHA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81829-4.json |
| 81830-2 | AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81830-2.json |
| 81831-0 | LAMB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81831-0.json |
| 81832-8 | SLC26A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81832-8.json |
| 81833-6 | ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81833-6.json |
| 81834-4 | SLC17A5 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81834-4.json |
| 81835-1 | PEX7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81835-1.json |
| 8183-6 | Benzoylecgonine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8183-6.json |
| 81836-9 | CTSK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81836-9.json |
| 81837-7 | GRHPR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81837-7.json |
| 81838-5 | PEX1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81838-5.json |
| 81839-3 | CLN8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81839-3.json |
| 81840-1 | POMGNT1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81840-1.json |
| 81841-9 | MLC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81841-9.json |
| 81842-7 | BCKDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81842-7.json |
| 81843-5 | GALC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81843-5.json |
| 8184-4 | Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8184-4.json |
| 81844-3 | IVD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81844-3.json |
| 81845-0 | PALB2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81845-0.json |
| 81846-8 | C9orf72 gene GGGGCC repeat analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81846-8.json |
| 81847-6 | C9orf72 gene GGGGCC repeat analysis in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81847-6.json |
| 81848-4 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81848-4.json |
| 81849-2 | t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81849-2.json |
| 81850-0 | Chromosome region 11p15 methylation and deletion+duplication in Amniotic fluid by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81850-0.json |
| 8185-1 | Benzoylecgonine [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/8185-1.json |
| 81851-8 | Chromosome region 11p15 methylation and deletion+duplication in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81851-8.json |
| 81852-6 | Chromosome region 7q11.23 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81852-6.json |
| 81853-4 | Chromosome 15 and 16 and 22 aneuploidy in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81853-4.json |
| 81854-2 | CYP21A2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81854-2.json |
| 81855-9 | DMPK gene CTG repeat analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81855-9.json |
| 81856-7 | FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81856-7.json |
| 81857-5 | GDAP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81857-5.json |
| 81858-3 | GJB1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81858-3.json |
| 81859-1 | GRN gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81859-1.json |
| 81860-9 | Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81860-9.json |
| 81861-7 | Karyotype in Bone marrow | ./2.16.840.1.114222.4.11.1002/81861-7.json |
| 81862-5 | Karyotype in Blood or Tissue --post mitogen stimulation | ./2.16.840.1.114222.4.11.1002/81862-5.json |
| 81863-3 | KCNH2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81863-3.json |
| 81864-1 | KCNQ1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81864-1.json |
| 81865-8 | MYBPC3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81865-8.json |
| 81866-6 | MYH7 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81866-6.json |
| 81867-4 | NOTCH3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81867-4.json |
| 81868-2 | PRNP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81868-2.json |
| 8186-9 | Benzoylecgonine [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/8186-9.json |
| 81869-0 | PRNP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81869-0.json |
| 81870-8 | PSEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81870-8.json |
| 81871-6 | PSEN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81871-6.json |
| 81872-4 | SCN5A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81872-4.json |
| 81873-2 | Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/81873-2.json |
| 81874-0 | SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81874-0.json |
| 81875-7 | SPAST gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81875-7.json |
| 81876-5 | SPG11 gene deletion+duplication and mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81876-5.json |
| 8187-7 | Benzoylecgonine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/8187-7.json |
| 81877-3 | SPG3A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81877-3.json |
| 81878-1 | Subtelomere analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81878-1.json |
| 81879-9 | t(11;22)(q24;q12.2)(FLI1,EWSR1) and t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81879-9.json |
| 81880-7 | TNNT2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81880-7.json |
| 81881-5 | TNNT3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81881-5.json |
| 81882-3 | TSC2 and PKD1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA | ./2.16.840.1.114222.4.11.1002/81882-3.json |
| 81883-1 | CNBP gene CCTG repeat analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/81883-1.json |
| 81884-9 | NIPA1 and REEP1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/81884-9.json |
| 8188-5 | Benzoylecgonine [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8188-5.json |
| 8189-3 | Benzoylecgonine [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/8189-3.json |
| 81894-8 | Liver ultrasound attenuation by transient elastography | ./2.16.840.1.114222.4.11.1002/81894-8.json |
| 8190-1 | Cocaine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8190-1.json |
| 81907-8 | Send document that conforms to C-CDA R2.0 template | ./2.16.840.1.114222.4.11.1002/81907-8.json |
| 8191-9 | Cocaine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/8191-9.json |
| 8192-7 | Benzoylecgonine [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/8192-7.json |
| 8193-5 | Benzoylecgonine [Presence] in Urine by SAMHSA screen method | ./2.16.840.1.114222.4.11.1002/8193-5.json |
| 8194-3 | Cocaine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8194-3.json |
| 8195-0 | Cocaine [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8195-0.json |
| 81951-6 | Fluid intake 24 hour Measured | ./2.16.840.1.114222.4.11.1002/81951-6.json |
| 81952-4 | Fat intake 24 hour Measured | ./2.16.840.1.114222.4.11.1002/81952-4.json |
| 81953-2 | Carbohydrate intake 24 hour Measured | ./2.16.840.1.114222.4.11.1002/81953-2.json |
| 8196-8 | Cocaine [Presence] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8196-8.json |
| 8197-6 | Cocaine [Presence] in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/8197-6.json |
| 8198-4 | Copper [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/8198-4.json |
| 8199-2 | Ethyl benzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8199-2.json |
| 8200-8 | Gadolinium [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/8200-8.json |
| 820-1 | A Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/820-1.json |
| 8201-6 | Gadolinium [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/8201-6.json |
| 8202-4 | Lead [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/8202-4.json |
| 82031-6 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82031-6.json |
| 8203-2 | Manganese [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/8203-2.json |
| 82032-4 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82032-4.json |
| 82035-7 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82035-7.json |
| 8204-0 | Mercury [Mass/mass] in Nail | ./2.16.840.1.114222.4.11.1002/8204-0.json |
| 82041-5 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82041-5.json |
| 82045-6 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82045-6.json |
| 82047-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82047-2.json |
| 82052-2 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82052-2.json |
| 82054-8 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82054-8.json |
| 8205-7 | Mercury [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/8205-7.json |
| 82059-7 | Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82059-7.json |
| 82068-8 | Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82068-8.json |
| 8207-3 | Nickel [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/8207-3.json |
| 82074-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82074-6.json |
| 82078-7 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82078-7.json |
| 82080-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82080-3.json |
| 82085-2 | Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82085-2.json |
| 82088-6 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82088-6.json |
| 82090-2 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82090-2.json |
| 82092-8 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82092-8.json |
| 82098-5 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82098-5.json |
| 8209-9 | Opiates [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8209-9.json |
| 82101-7 | Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82101-7.json |
| 82103-3 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82103-3.json |
| 82105-8 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82105-8.json |
| 8210-7 | Opiates [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8210-7.json |
| 82107-4 | Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82107-4.json |
| 82109-0 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82109-0.json |
| 82111-6 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82111-6.json |
| 82114-0 | Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82114-0.json |
| 8211-5 | Opiates [Presence] in Gastric fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8211-5.json |
| 82118-1 | Pharmacogenomics result panel | ./2.16.840.1.114222.4.11.1002/82118-1.json |
| 8212-3 | Opiates [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/8212-3.json |
| 82123-1 | MR Guidance for radiation treatment of Unspecified body region | ./2.16.840.1.114222.4.11.1002/82123-1.json |
| 82124-9 | US Guidance for radiation treatment of Unspecified body region | ./2.16.840.1.114222.4.11.1002/82124-9.json |
| 82126-4 | PT Guidance for radiation treatment of Unspecified body region | ./2.16.840.1.114222.4.11.1002/82126-4.json |
| 82127-2 | Respiratory pathogens DNA and RNA identified in Pleural fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82127-2.json |
| 82128-0 | MR Brain and Face WO contrast | ./2.16.840.1.114222.4.11.1002/82128-0.json |
| 82129-8 | MR Brain and Face WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82129-8.json |
| 82130-6 | MR Face and Neck WO contrast | ./2.16.840.1.114222.4.11.1002/82130-6.json |
| 8213-1 | Opiates [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/8213-1.json |
| 82131-4 | MR Face and Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82131-4.json |
| 82132-2 | CT Face and Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82132-2.json |
| 82133-0 | CT Face and Neck WO contrast | ./2.16.840.1.114222.4.11.1002/82133-0.json |
| 82136-3 | NM Whole body Views for tumor W I-123 MIBG IV | ./2.16.840.1.114222.4.11.1002/82136-3.json |
| 82137-1 | FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82137-1.json |
| 82138-9 | GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82138-9.json |
| 82139-7 | LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82139-7.json |
| 82140-5 | MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82140-5.json |
| 8214-9 | Opiates [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/8214-9.json |
| 82152-0 | BRFSS ACE Module [ACE.BRFSS] | ./2.16.840.1.114222.4.11.1002/82152-0.json |
| 8215-6 | Opiates [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8215-6.json |
| 82156-1 | Protein intake 24 hour Measured | ./2.16.840.1.114222.4.11.1002/82156-1.json |
| 82160-3 | Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82160-3.json |
| 82161-1 | Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82161-1.json |
| 82162-9 | Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82162-9.json |
| 82163-7 | Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82163-7.json |
| 8216-4 | Opiates [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/8216-4.json |
| 82164-5 | Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82164-5.json |
| 82165-2 | Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82165-2.json |
| 82166-0 | Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82166-0.json |
| 82167-8 | Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82167-8.json |
| 82168-6 | Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82168-6.json |
| 82169-4 | Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82169-4.json |
| 82170-2 | Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82170-2.json |
| 82171-0 | Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82171-0.json |
| 8217-2 | Opiates [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8217-2.json |
| 82172-8 | Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82172-8.json |
| 82173-6 | Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82173-6.json |
| 82174-4 | Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82174-4.json |
| 82175-1 | Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82175-1.json |
| 82176-9 | Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82176-9.json |
| 82177-7 | Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82177-7.json |
| 82178-5 | Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82178-5.json |
| 82179-3 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82179-3.json |
| 8218-0 | Opiates [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8218-0.json |
| 82181-9 | Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82181-9.json |
| 82182-7 | Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82182-7.json |
| 82183-5 | Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82183-5.json |
| 82184-3 | Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82184-3.json |
| 82185-0 | Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82185-0.json |
| 82186-8 | Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82186-8.json |
| 82187-6 | Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82187-6.json |
| 82188-4 | Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82188-4.json |
| 82189-2 | Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82189-2.json |
| 82190-0 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82190-0.json |
| 82191-8 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAAwith non-probe detection | ./2.16.840.1.114222.4.11.1002/82191-8.json |
| 82192-6 | Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82192-6.json |
| 82193-4 | Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82193-4.json |
| 82194-2 | Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82194-2.json |
| 82196-7 | Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82196-7.json |
| 82197-5 | Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82197-5.json |
| 8219-8 | Opiates [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/8219-8.json |
| 82198-3 | Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82198-3.json |
| 82199-1 | Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82199-1.json |
| 82200-7 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82200-7.json |
| 82201-5 | Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82201-5.json |
| 82202-3 | Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82202-3.json |
| 82203-1 | Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82203-1.json |
| 82204-9 | Escherichia coli O157 DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82204-9.json |
| 82205-6 | Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82205-6.json |
| 8220-6 | Opiates [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/8220-6.json |
| 82206-4 | Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82206-4.json |
| 82207-2 | Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82207-2.json |
| 82208-0 | Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82208-0.json |
| 82209-8 | Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82209-8.json |
| 82210-6 | Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82210-6.json |
| 82211-4 | Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82211-4.json |
| 82212-2 | Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82212-2.json |
| 82213-0 | Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82213-0.json |
| 8221-4 | Opiates [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/8221-4.json |
| 82214-8 | Safety issue assessment note | ./2.16.840.1.114222.4.11.1002/82214-8.json |
| 82215-5 | Medical equipment or product list | ./2.16.840.1.114222.4.11.1002/82215-5.json |
| 82216-3 | 3-Hydroxyisobutyrate dehydrogenase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82216-3.json |
| 82217-1 | 3-Hydroxyisobutyryl-CoA hydrolase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82217-1.json |
| 82218-9 | 3-Methylcrotonyl-CoA carboxylase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82218-9.json |
| 82219-7 | 3-Methylglutaconyl-CoA hydratase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82219-7.json |
| 82220-5 | Alkyl-dihydroxyacetonephosphate synthase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82220-5.json |
| 82221-3 | Alpha-methylacyl CoA racemase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82221-3.json |
| 8222-2 | Opiates [Presence] in Urine by SAMHSA screen method | ./2.16.840.1.114222.4.11.1002/8222-2.json |
| 82222-1 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/82222-1.json |
| 82223-9 | Cystathionine beta synthase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82223-9.json |
| 82224-7 | Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Lymphoblasts | ./2.16.840.1.114222.4.11.1002/82224-7.json |
| 82225-4 | Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Fibroblast | ./2.16.840.1.114222.4.11.1002/82225-4.json |
| 82226-2 | Neck Disability Index [NDI] | ./2.16.840.1.114222.4.11.1002/82226-2.json |
| 8223-0 | Opiates [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8223-0.json |
| 82237-9 | Total score [NDI] | ./2.16.840.1.114222.4.11.1002/82237-9.json |
| 82238-7 | Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82238-7.json |
| 82239-5 | Chromosome region 16p13.3 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82239-5.json |
| 82240-3 | Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82240-3.json |
| 82241-1 | Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82241-1.json |
| 82242-9 | Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82242-9.json |
| 82243-7 | Chromosome region 17p13.3 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82243-7.json |
| 82244-5 | Chromosome region 1p36 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82244-5.json |
| 82245-2 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82245-2.json |
| 82246-0 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82246-0.json |
| 82247-8 | Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/82247-8.json |
| 8224-8 | Opiates [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8224-8.json |
| 82248-6 | Chromosome region 7q11.23 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82248-6.json |
| 82249-4 | Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82249-4.json |
| 82250-2 | Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82250-2.json |
| 82251-0 | Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH | ./2.16.840.1.114222.4.11.1002/82251-0.json |
| 82252-8 | Constitutive heterochromatin analysis in Blood or Tissue by Banding | ./2.16.840.1.114222.4.11.1002/82252-8.json |
| 82253-6 | JAG1 gene deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82253-6.json |
| 82254-4 | Marker and derivative chromosome analysis in Amniotic fluid or Chorionic villus sample Document by Cytogenetics | ./2.16.840.1.114222.4.11.1002/82254-4.json |
| 8225-5 | Opiates [Presence] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8225-5.json |
| 82255-1 | Marker and derivative chromosome analysis in Blood or Tissue Document by Cytogenetics | ./2.16.840.1.114222.4.11.1002/82255-1.json |
| 82256-9 | Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82256-9.json |
| 82257-7 | SRY gene deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82257-7.json |
| 82258-5 | Subtelomere analysis in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/82258-5.json |
| 82261-9 | Measured activity metabolic rate/Standard RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82261-9.json |
| 82262-7 | Estimated activity metabolic rate/Standard RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82262-7.json |
| 8226-3 | Opiates [Presence] in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/8226-3.json |
| 82263-5 | Reported activity metabolic rate/Standard RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82263-5.json |
| 82265-0 | Measured Activity metabolic rate/Measured RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82265-0.json |
| 82266-8 | Estimated Activity metabolic rate/Measured RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82266-8.json |
| 82267-6 | Reported Activity metabolic rate/Measured RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82267-6.json |
| 82269-2 | Estimated Activity metabolic rate/Population RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82269-2.json |
| 82270-0 | Measured Activity metabolic rate/Population RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82270-0.json |
| 8227-1 | Phencyclidine [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8227-1.json |
| 82271-8 | Activity metabolic rate/Standard resting metabolic rate [Relative Energy/Time] adjusted for age+sex+race+BMI 1 minute mean Estimated | ./2.16.840.1.114222.4.11.1002/82271-8.json |
| 82272-6 | Reported Activity metabolic rate/Population RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82272-6.json |
| 82274-2 | Estimated metabolic rate/Predicted RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82274-2.json |
| 82275-9 | Reported Activity metabolic rate/Predicted RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82275-9.json |
| 82276-7 | Measured Activity metabolic rate/Predicted RMR [Relative energy/Time] | ./2.16.840.1.114222.4.11.1002/82276-7.json |
| 82278-3 | Measured RMR | ./2.16.840.1.114222.4.11.1002/82278-3.json |
| 82284-1 | Standard RMR | ./2.16.840.1.114222.4.11.1002/82284-1.json |
| 82285-8 | Population RMR | ./2.16.840.1.114222.4.11.1002/82285-8.json |
| 82286-6 | Predicted RMR | ./2.16.840.1.114222.4.11.1002/82286-6.json |
| 82288-2 | Absolute aerobic exercise intensity | ./2.16.840.1.114222.4.11.1002/82288-2.json |
| 8228-9 | Phencyclidine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/8228-9.json |
| 82289-0 | Rating of perceived exertion [Score] | ./2.16.840.1.114222.4.11.1002/82289-0.json |
| 82290-8 | Frequency of moderate to vigorous aerobic physical activity | ./2.16.840.1.114222.4.11.1002/82290-8.json |
| 82293-2 | Frequency of bone-strengthening physical activity | ./2.16.840.1.114222.4.11.1002/82293-2.json |
| 82294-0 | Physical activity guideline used | ./2.16.840.1.114222.4.11.1002/82294-0.json |
| 82295-7 | Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82295-7.json |
| 8229-7 | Phencyclidine [Presence] in Gastric fluid by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8229-7.json |
| 82297-3 | Chikungunya virus structural proteins (E1+E2) IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82297-3.json |
| 82298-1 | Yersinia enterocolitica [Presence] in Specimen by Culture | ./2.16.840.1.114222.4.11.1002/82298-1.json |
| 82299-9 | Escherichia coli shiga-like toxin 1+2 [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/82299-9.json |
| 82300-5 | Shigella sp [Presence] in Stool by Culture | ./2.16.840.1.114222.4.11.1002/82300-5.json |
| 8230-5 | Phencyclidine [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/8230-5.json |
| 82306-2 | Chlamydia trachomatis rRNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82306-2.json |
| 8231-3 | Phencyclidine [Mass/volume] in Meconium | ./2.16.840.1.114222.4.11.1002/8231-3.json |
| 8232-1 | Phencyclidine [Presence] in Meconium | ./2.16.840.1.114222.4.11.1002/8232-1.json |
| 82323-7 | Total interval score [HOOSJR] | ./2.16.840.1.114222.4.11.1002/82323-7.json |
| 82332-8 | Total interval score [KOOSJR] | ./2.16.840.1.114222.4.11.1002/82332-8.json |
| 82334-4 | Interleukin 17A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82334-4.json |
| 8233-9 | Phencyclidine [Presence] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8233-9.json |
| 82342-7 | F8 gene intron 1 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82342-7.json |
| 82343-5 | F8 gene intron 1 and 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82343-5.json |
| 8234-7 | Phencyclidine [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/8234-7.json |
| 8235-4 | Phencyclidine [Presence] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8235-4.json |
| 82354-2 | Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82354-2.json |
| 82355-9 | Geriatric medicine procedure note | ./2.16.840.1.114222.4.11.1002/82355-9.json |
| 82356-7 | Obstetrics Midwife Consult note | ./2.16.840.1.114222.4.11.1002/82356-7.json |
| 82357-5 | Palliative care procedure note | ./2.16.840.1.114222.4.11.1002/82357-5.json |
| 82358-3 | Reproductive endocrinology and infertility Referral note | ./2.16.840.1.114222.4.11.1002/82358-3.json |
| 82359-1 | Reproductive endocrinology and infertility Consult note | ./2.16.840.1.114222.4.11.1002/82359-1.json |
| 82360-9 | Reproductive endocrinology and infertility Diagnostic study note | ./2.16.840.1.114222.4.11.1002/82360-9.json |
| 82361-7 | Reproductive endocrinology and infertility Education note | ./2.16.840.1.114222.4.11.1002/82361-7.json |
| 8236-2 | Phencyclidine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/8236-2.json |
| 82362-5 | Reproductive endocrinology and infertility Flowsheet | ./2.16.840.1.114222.4.11.1002/82362-5.json |
| 82363-3 | Reproductive endocrinology and infertility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82363-3.json |
| 82364-1 | Reproductive endocrinology and infertility Plan of care note | ./2.16.840.1.114222.4.11.1002/82364-1.json |
| 82365-8 | Reproductive endocrinology and infertility Progress note | ./2.16.840.1.114222.4.11.1002/82365-8.json |
| 82366-6 | Reproductive endocrinology and infertility procedure note | ./2.16.840.1.114222.4.11.1002/82366-6.json |
| 82367-4 | Peripheral deiodinase activity [Moles/time] in Serum or Plasma by Calculated.SPINA | ./2.16.840.1.114222.4.11.1002/82367-4.json |
| 82368-2 | Thyroid secretory capacity [Moles/time] in Serum or Plasma by Calculated.SPINA | ./2.16.840.1.114222.4.11.1002/82368-2.json |
| 82369-0 | Buprenorphine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/82369-0.json |
| 8237-0 | Phencyclidine [Presence] in Urine by SAMHSA confirm method | ./2.16.840.1.114222.4.11.1002/8237-0.json |
| 82370-8 | Norbuprenorphine [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/82370-8.json |
| 82371-6 | Norbuprenorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/82371-6.json |
| 82372-4 | Buprenorphine [Presence] in Gastric fluid by Screen method | ./2.16.840.1.114222.4.11.1002/82372-4.json |
| 82373-2 | Buprenorphine [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/82373-2.json |
| 82374-0 | Norbuprenorphine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/82374-0.json |
| 82375-7 | Norbuprenorphine [Presence] in Specimen by Screen method | ./2.16.840.1.114222.4.11.1002/82375-7.json |
| 82379-9 | Daclatasvir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82379-9.json |
| 82380-7 | Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/82380-7.json |
| 82381-5 | Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier] | ./2.16.840.1.114222.4.11.1002/82381-5.json |
| 82382-3 | Sofosbuvir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82382-3.json |
| 82383-1 | Dengue virus 2+4 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82383-1.json |
| 82384-9 | Dengue virus 1+3 RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82384-9.json |
| 82385-6 | Methylmalonate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82385-6.json |
| 82386-4 | 2-Methylcitrate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82386-4.json |
| 82387-2 | Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/82387-2.json |
| 8238-8 | Phencyclidine [Presence] in Urine by SAMHSA screen method | ./2.16.840.1.114222.4.11.1002/8238-8.json |
| 82388-0 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82388-0.json |
| 82389-8 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82389-8.json |
| 82390-6 | Centromere protein A Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82390-6.json |
| 82391-4 | Centromere protein B Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82391-4.json |
| 82392-2 | Ej Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82392-2.json |
| 82393-0 | Fibrillarin Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82393-0.json |
| 82394-8 | Fibrillarin Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82394-8.json |
| 82395-5 | Ganglioside GD1a IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82395-5.json |
| 8239-6 | Phencyclidine [Mass/volume] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8239-6.json |
| 82396-3 | Ganglioside GD1a IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82396-3.json |
| 82397-1 | Ganglioside GD1a IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82397-1.json |
| 82398-9 | Ganglioside GD1b IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82398-9.json |
| 82399-7 | Ganglioside GD2 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82399-7.json |
| 82400-3 | Ganglioside GD2 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82400-3.json |
| 82401-1 | Ganglioside GD2 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82401-1.json |
| 82402-9 | Ganglioside GD3 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82402-9.json |
| 8240-4 | Phencyclidine [Presence] in Unknown substance | ./2.16.840.1.114222.4.11.1002/8240-4.json |
| 82404-5 | Ganglioside GD3 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82404-5.json |
| 82407-8 | Ganglioside GM4 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82407-8.json |
| 82408-6 | Ganglioside GM4 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82408-6.json |
| 82409-4 | Ganglioside GM4 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82409-4.json |
| 82410-2 | Ganglioside GQ1b IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82410-2.json |
| 82411-0 | Ganglioside GT1a IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82411-0.json |
| 8241-2 | Phencyclidine [Presence] in Unknown substance by Confirmatory method | ./2.16.840.1.114222.4.11.1002/8241-2.json |
| 82413-6 | Ganglioside GT1a IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82413-6.json |
| 82414-4 | Ha Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82414-4.json |
| 82415-1 | Ha Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82415-1.json |
| 82417-7 | Human upstream binding factor Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82417-7.json |
| 82418-5 | Human upstream binding factor Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82418-5.json |
| 8242-0 | Phencyclidine [Presence] in Unknown substance by Screen method | ./2.16.840.1.114222.4.11.1002/8242-0.json |
| 82421-9 | Ks Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82421-9.json |
| 82422-7 | Ks Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82422-7.json |
| 82423-5 | Ma+Ta Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82423-5.json |
| 82424-3 | MDA5 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82424-3.json |
| 82425-0 | Mj Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82425-0.json |
| 82426-8 | Mj Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82426-8.json |
| 82430-0 | OJ Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82430-0.json |
| 82431-8 | Platelet-derived growth factor receptor Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82431-8.json |
| 82432-6 | Platelet-derived growth factor receptor Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82432-6.json |
| 8243-8 | Styrene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8243-8.json |
| 82439-1 | SUMO-activating enzyme subunit 1 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82439-1.json |
| 82440-9 | SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82440-9.json |
| 82441-7 | SUMO-activating enzyme subunit 2 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82441-7.json |
| 82442-5 | SUMO-activating enzyme subunit 2 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82442-5.json |
| 82444-1 | Glial nuclear type 1 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82444-1.json |
| 82445-8 | Sulfatide Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82445-8.json |
| 8244-6 | Titanium [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/8244-6.json |
| 82447-4 | Sulfatide IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82447-4.json |
| 82448-2 | TIF1-gamma Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82448-2.json |
| 82449-0 | Titin Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82449-0.json |
| 82450-8 | U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82450-8.json |
| 82451-6 | U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82451-6.json |
| 82452-4 | U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82452-4.json |
| 8245-3 | Zinc [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/8245-3.json |
| 82453-2 | Zo Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82453-2.json |
| 82456-5 | Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82456-5.json |
| 82458-1 | Alaska pollock roe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82458-1.json |
| 82461-5 | Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82461-5.json |
| 82462-3 | Silver [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/82462-3.json |
| 82463-1 | Aluminum [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/82463-1.json |
| 82464-9 | Mosquito count [#] in Environmental specimen | ./2.16.840.1.114222.4.11.1002/82464-9.json |
| 82465-6 | Mosquito identified [Type] in Environmental specimen | ./2.16.840.1.114222.4.11.1002/82465-6.json |
| 82466-4 | riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/82466-4.json |
| 82467-2 | riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/82467-2.json |
| 82468-0 | Edoxaban [Mass/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/82468-0.json |
| 82469-8 | Etanercept Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/82469-8.json |
| 82470-6 | Etanercept [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/82470-6.json |
| 82471-4 | Borrelia garinii+afzelii oppA1 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82471-4.json |
| 82472-2 | Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82472-2.json |
| 82473-0 | Borrelia mayonii oppA1 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82473-0.json |
| 82474-8 | Borrelia mayonii oppA1 gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82474-8.json |
| 82475-5 | Borrelia miyamotoi glpQ gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82475-5.json |
| 82476-3 | Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/82476-3.json |
| 82477-1 | Erythrocyte sedimentation rate by Photometric method | ./2.16.840.1.114222.4.11.1002/82477-1.json |
| 82478-9 | 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82478-9.json |
| 82481-3 | TRBV28 gene segment/TRBV gene segments.total in Blood | ./2.16.840.1.114222.4.11.1002/82481-3.json |
| 8248-7 | Spermatozoa [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/8248-7.json |
| 82502-6 | Ethylmalonate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82502-6.json |
| 8250-3 | Microscopic observation [Identifier] in Stool by Electron microscopy | ./2.16.840.1.114222.4.11.1002/8250-3.json |
| 82503-4 | Methylsuccinate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82503-4.json |
| 82504-2 | Glutarate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82504-2.json |
| 82505-9 | 3-Hydroxyglutarate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82505-9.json |
| 82506-7 | Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative | ./2.16.840.1.114222.4.11.1002/82506-7.json |
| 82507-5 | Oligosaccharides pattern [Interpretation] in Leukocytes by Screen method Narrative | ./2.16.840.1.114222.4.11.1002/82507-5.json |
| 82508-3 | Ethyl sulfate [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/82508-3.json |
| 82511-7 | Mycobacterium bovis tuberculin stimulated gamma interferon [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/82511-7.json |
| 82513-3 | Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82513-3.json |
| 82515-8 | NBN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82515-8.json |
| 82516-6 | LAMC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82516-6.json |
| 82517-4 | LAMA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82517-4.json |
| 82518-2 | IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82518-2.json |
| 82520-8 | Velpatasvir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82520-8.json |
| 82521-6 | Paritaprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82521-6.json |
| 82522-4 | Simeprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82522-4.json |
| 82523-2 | Grazoprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/82523-2.json |
| 82524-0 | 6-Beta naltrexol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82524-0.json |
| 82526-5 | 6-Beta naltrexol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82526-5.json |
| 82527-3 | 6-Beta naltrexol/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82527-3.json |
| 82528-1 | VHL gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/82528-1.json |
| 82529-9 | SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82529-9.json |
| 82530-7 | SDHB gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82530-7.json |
| 82531-5 | SDHC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82531-5.json |
| 82532-3 | SDHB and SDHC and SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82532-3.json |
| 82533-1 | VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82533-1.json |
| 82534-9 | CASR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/82534-9.json |
| 82535-6 | KRAS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/82535-6.json |
| 82536-4 | SOS1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/82536-4.json |
| 82537-2 | RAF1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/82537-2.json |
| 82538-0 | CALR gene exon 9 full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82538-0.json |
| 82539-8 | Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82539-8.json |
| 82541-4 | Cetuximab IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82541-4.json |
| 82543-0 | Dog recombinant (rCan f) 4 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82543-0.json |
| 82547-1 | Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82547-1.json |
| 82549-7 | Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82549-7.json |
| 82550-5 | Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82550-5.json |
| 82552-1 | Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82552-1.json |
| 82553-9 | Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82553-9.json |
| 82555-4 | Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82555-4.json |
| 82557-0 | Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82557-0.json |
| 82559-6 | Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82559-6.json |
| 82560-4 | Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82560-4.json |
| 82562-0 | Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82562-0.json |
| 82563-8 | Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82563-8.json |
| 82565-3 | Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82565-3.json |
| 82566-1 | Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82566-1.json |
| 82568-7 | Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82568-7.json |
| 82570-3 | Mahi mahi IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82570-3.json |
| 82572-9 | Silver Birch recombinant (rBet v) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82572-9.json |
| 82574-5 | Staphylococcus aureus enterotoxin E IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82574-5.json |
| 82575-2 | Urobilinogen [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/82575-2.json |
| 82576-0 | Cyclic citrullinated peptide IgA Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82576-0.json |
| 82577-8 | Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82577-8.json |
| 82579-4 | Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82579-4.json |
| 82580-2 | Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82580-2.json |
| 82582-8 | Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82582-8.json |
| 82583-6 | Wheat native (nTri a) 19+20+21 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82583-6.json |
| 82584-4 | Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82584-4.json |
| 82585-1 | Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/82585-1.json |
| 82586-9 | Nucleated cells [#] in Bone marrow by Automated count | ./2.16.840.1.114222.4.11.1002/82586-9.json |
| 82587-7 | Leukocytes [#/volume] in Bone marrow by Automated count | ./2.16.840.1.114222.4.11.1002/82587-7.json |
| 82588-5 | Erythrocytes [#/volume] in Bone marrow by Automated count | ./2.16.840.1.114222.4.11.1002/82588-5.json |
| 82593-5 | Immunization summary report | ./2.16.840.1.114222.4.11.1002/82593-5.json |
| 82597-6 | Chromosome painting analysis in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/82597-6.json |
| 82599-2 | Chum salmon roe IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82599-2.json |
| 82601-6 | Latex recombinant (rHev b) 10 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82601-6.json |
| 82603-2 | Latex recombinant (rHev b) 2 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82603-2.json |
| 82607-3 | Clinical data [Date and Time Range] | ./2.16.840.1.114222.4.11.1002/82607-3.json |
| 82608-1 | Advancing care information for population | ./2.16.840.1.114222.4.11.1002/82608-1.json |
| 82609-9 | Clinical practice improvement activity for population | ./2.16.840.1.114222.4.11.1002/82609-9.json |
| 82610-7 | Observation unit Note | ./2.16.840.1.114222.4.11.1002/82610-7.json |
| 82612-3 | Grass Allergen Mix 7 (Bermuda grass+Meadow fescue+Rye grass+Timothy grass+Cultivated rye) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/82612-3.json |
| 82613-1 | Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82613-1.json |
| 82619-8 | Diffusion capacity/Alveolar volume --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/82619-8.json |
| 82620-6 | Diffusion capacity/Alveolar volume --post bronchodilation | ./2.16.840.1.114222.4.11.1002/82620-6.json |
| 82658-6 | Glutamate decarboxylase Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82658-6.json |
| 82659-4 | Thyrotropin receptor Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/82659-4.json |
| 82660-2 | Glutamate decarboxylase Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82660-2.json |
| 82664-4 | Drug Abuse Screening Test [DAST] | ./2.16.840.1.114222.4.11.1002/82664-4.json |
| 82666-9 | Drug Abuse Screening Test-10 [DAST-10] | ./2.16.840.1.114222.4.11.1002/82666-9.json |
| 82674-3 | Asthma Control Test [ACT] | ./2.16.840.1.114222.4.11.1002/82674-3.json |
| 82675-0 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82675-0.json |
| 82676-8 | CT Guidance for arthrocentesis of Knee - left | ./2.16.840.1.114222.4.11.1002/82676-8.json |
| 82677-6 | CTA Abdominal Aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/82677-6.json |
| 82678-4 | CTA Abdominal Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82678-4.json |
| 82679-2 | CTA Abdominal vessels and Pelvis vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82679-2.json |
| 826-8 | Au sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/826-8.json |
| 82680-0 | CTA Head vessels and Neck vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82680-0.json |
| 82681-8 | CT Guidance for biopsy of Oral tissue | ./2.16.840.1.114222.4.11.1002/82681-8.json |
| 82682-6 | CT Clavicle - left WO contrast | ./2.16.840.1.114222.4.11.1002/82682-6.json |
| 82683-4 | CT Clavicle - right WO contrast | ./2.16.840.1.114222.4.11.1002/82683-4.json |
| 82684-2 | CT Clavicle WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82684-2.json |
| 82685-9 | CT Clavicle W contrast IV | ./2.16.840.1.114222.4.11.1002/82685-9.json |
| 82686-7 | CT Clavicle - right W contrast IV | ./2.16.840.1.114222.4.11.1002/82686-7.json |
| 82687-5 | CT Clavicle WO contrast | ./2.16.840.1.114222.4.11.1002/82687-5.json |
| 82688-3 | CT Colon and Rectum WO and W contrast IV and W air contrast PR | ./2.16.840.1.114222.4.11.1002/82688-3.json |
| 82689-1 | CT Small bowel W contrast PO and WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82689-1.json |
| 82690-9 | CT Head and Cervical spine WO contrast | ./2.16.840.1.114222.4.11.1002/82690-9.json |
| 82691-7 | CT Head and Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/82691-7.json |
| 82692-5 | CT Head and Neck WO contrast | ./2.16.840.1.114222.4.11.1002/82692-5.json |
| 82693-3 | CT Pelvis and Lower extremity W contrast IV | ./2.16.840.1.114222.4.11.1002/82693-3.json |
| 82694-1 | CT Lower extremity - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82694-1.json |
| 82695-8 | CT Pelvis and Lower extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/82695-8.json |
| 82696-6 | CT Spine Lumbar and Sacrum W contrast IV | ./2.16.840.1.114222.4.11.1002/82696-6.json |
| 82697-4 | CT Spine Lumbar and Sacrum WO contrast | ./2.16.840.1.114222.4.11.1002/82697-4.json |
| 82698-2 | CT Ribs - left W contrast IV | ./2.16.840.1.114222.4.11.1002/82698-2.json |
| 82699-0 | CT Ribs - left WO contrast | ./2.16.840.1.114222.4.11.1002/82699-0.json |
| 82700-6 | CT Ribs - right W contrast IV | ./2.16.840.1.114222.4.11.1002/82700-6.json |
| 82701-4 | CT Ribs - right WO contrast | ./2.16.840.1.114222.4.11.1002/82701-4.json |
| 82702-2 | CT Ribs - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82702-2.json |
| 82703-0 | CT Sacrum and Coccyx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82703-0.json |
| 82704-8 | CT Sacrum and Coccyx W contrast IV | ./2.16.840.1.114222.4.11.1002/82704-8.json |
| 82705-5 | CT Scapula - left WO contrast | ./2.16.840.1.114222.4.11.1002/82705-5.json |
| 82706-3 | CT Scapula - right WO contrast | ./2.16.840.1.114222.4.11.1002/82706-3.json |
| 82707-1 | CT Scapula - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82707-1.json |
| 82708-9 | CTA Lower extremity vessels - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82708-9.json |
| 82709-7 | CTA Thoracic Aorta | ./2.16.840.1.114222.4.11.1002/82709-7.json |
| 82710-5 | CTA Lower extremity vessels - right | ./2.16.840.1.114222.4.11.1002/82710-5.json |
| 82711-3 | CTA Lower extremity vessels - bilateral | ./2.16.840.1.114222.4.11.1002/82711-3.json |
| 82712-1 | CTA Lower extremity vessels - left | ./2.16.840.1.114222.4.11.1002/82712-1.json |
| 82713-9 | CTA Upper extremity vessels - left | ./2.16.840.1.114222.4.11.1002/82713-9.json |
| 82714-7 | CTA Upper extremity vessels - right | ./2.16.840.1.114222.4.11.1002/82714-7.json |
| 82715-4 | CT Guidance for arthrocentesis of Knee - right | ./2.16.840.1.114222.4.11.1002/82715-4.json |
| 82716-2 | CT Clavicle - left W contrast IV | ./2.16.840.1.114222.4.11.1002/82716-2.json |
| 82717-0 | CT Ribs - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82717-0.json |
| 82718-8 | CT Scapula - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/82718-8.json |
| 8271-9 | Haemophilus influenzae C Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/8271-9.json |
| 82719-6 | Enfuvirtide [Susceptibility] by Phenotype method | ./2.16.840.1.114222.4.11.1002/82719-6.json |
| 82721-2 | Intravenous lipid emulsion [Mass/volume] in Serum by Nephelometry | ./2.16.840.1.114222.4.11.1002/82721-2.json |
| 82722-0 | Potassium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/82722-0.json |
| 82723-8 | Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82723-8.json |
| 82730-3 | GlycA [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82730-3.json |
| 82731-1 | Zika virus IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82731-1.json |
| 82732-9 | AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82732-9.json |
| 82733-7 | AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82733-7.json |
| 82734-5 | AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82734-5.json |
| 82735-2 | AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82735-2.json |
| 82736-0 | Calcium-calmodulin-dependent protein kinase II activity actual/normal in Serum | ./2.16.840.1.114222.4.11.1002/82736-0.json |
| 82737-8 | Beta tubulin IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82737-8.json |
| 82738-6 | Dopamine receptor D2 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82738-6.json |
| 82739-4 | Dopamine receptor D1 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82739-4.json |
| 82740-2 | Lysoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82740-2.json |
| 82742-8 | CT Head WO and W contrast IV and CT Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/82742-8.json |
| 82743-6 | CD8+CD45RA+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/82743-6.json |
| 82744-4 | CD8+CD45RA+ cells/100 CD8 cells in Blood | ./2.16.840.1.114222.4.11.1002/82744-4.json |
| 82747-7 | Babesia microti IgG Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/82747-7.json |
| 82752-7 | Date travel started | ./2.16.840.1.114222.4.11.1002/82752-7.json |
| 82753-5 | County of travel [Location] | ./2.16.840.1.114222.4.11.1002/82753-5.json |
| 82754-3 | State of travel | ./2.16.840.1.114222.4.11.1002/82754-3.json |
| 82755-0 | Geographic location where tick bite occurred | ./2.16.840.1.114222.4.11.1002/82755-0.json |
| 82780-8 | Borrelia miyamotoi flaB gene [Presence] in Tick by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82780-8.json |
| 82781-6 | Borrelia miyamotoi flaB gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/82781-6.json |
| 82800-4 | PET+CT Heart W contrast IV | ./2.16.840.1.114222.4.11.1002/82800-4.json |
| 82801-2 | PET+CT Heart WO contrast | ./2.16.840.1.114222.4.11.1002/82801-2.json |
| 82802-0 | CT Head WO and W contrast IV and CT Sinuses W contrast IV | ./2.16.840.1.114222.4.11.1002/82802-0.json |
| 82803-8 | CT Head WO and W contrast IV and CT Temporal bone W contrast IV | ./2.16.840.1.114222.4.11.1002/82803-8.json |
| 82804-6 | CT Head WO and W contrast IV and CT Neck W contrast IV | ./2.16.840.1.114222.4.11.1002/82804-6.json |
| 82805-3 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and WO contrast | ./2.16.840.1.114222.4.11.1002/82805-3.json |
| 82806-1 | PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and W contrast IV | ./2.16.840.1.114222.4.11.1002/82806-1.json |
| 82807-9 | PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and WO contrast | ./2.16.840.1.114222.4.11.1002/82807-9.json |
| 82808-7 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and WO contrast | ./2.16.840.1.114222.4.11.1002/82808-7.json |
| 82809-5 | PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and W contrast IV | ./2.16.840.1.114222.4.11.1002/82809-5.json |
| 82811-1 | Nurse summary note - recommended sections | ./2.16.840.1.114222.4.11.1002/82811-1.json |
| 82812-9 | Sodium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/82812-9.json |
| 82813-7 | Adverse Childhood Experiences [ACE] | ./2.16.840.1.114222.4.11.1002/82813-7.json |
| 82824-4 | Clinical neurophysiology Surgical operation note | ./2.16.840.1.114222.4.11.1002/82824-4.json |
| 82825-1 | Community health care Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82825-1.json |
| 82826-9 | Cardiac surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82826-9.json |
| 82827-7 | Colon and rectal surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82827-7.json |
| 82828-5 | Cardiopulmonary Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82828-5.json |
| 82829-3 | Cardiothoracic surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82829-3.json |
| 82830-1 | Neurological surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82830-1.json |
| 82832-7 | Plastic surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82832-7.json |
| 82833-5 | Orthopaedic surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82833-5.json |
| 82834-3 | Oral and Maxillofacial Surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82834-3.json |
| 82835-0 | Transplant surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82835-0.json |
| 82836-8 | Pediatric surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82836-8.json |
| 82837-6 | Pharmacology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82837-6.json |
| 82838-4 | Vascular surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82838-4.json |
| 82839-2 | Surgical oncology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/82839-2.json |
| 82840-0 | Mitochondria IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82840-0.json |
| 82841-8 | PCNA extractable nuclear IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82841-8.json |
| 82842-6 | Liver kidney microsomal IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82842-6.json |
| 82844-2 | Number affected by condition Population | ./2.16.840.1.114222.4.11.1002/82844-2.json |
| 82846-7 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82846-7.json |
| 82847-5 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82847-5.json |
| 82848-3 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82848-3.json |
| 82849-1 | 11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82849-1.json |
| 82850-9 | Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82850-9.json |
| 82851-7 | Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82851-7.json |
| 82852-5 | Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82852-5.json |
| 82853-3 | Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82853-3.json |
| 82854-1 | Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82854-1.json |
| 82855-8 | Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82855-8.json |
| 82856-6 | Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82856-6.json |
| 82857-4 | Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82857-4.json |
| 82858-2 | 11-Deoxytetrahydrocorticosterone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82858-2.json |
| 82859-0 | 11-Deoxytetrahydrocorticosterone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82859-0.json |
| 82860-8 | 11-Deoxytetrahydrocorticosterone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82860-8.json |
| 82861-6 | 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82861-6.json |
| 82862-4 | 11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82862-4.json |
| 82863-2 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82863-2.json |
| 82864-0 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82864-0.json |
| 82865-7 | 3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82865-7.json |
| 82866-5 | Allo-pregnanediolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82866-5.json |
| 82867-3 | Allo-pregnanediolone [Moles/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82867-3.json |
| 82868-1 | Allo-pregnanediolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82868-1.json |
| 82870-7 | Au sup(b) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82870-7.json |
| 82871-5 | Adenosine diphosphate [Entitic substance] in Platelets | ./2.16.840.1.114222.4.11.1002/82871-5.json |
| 82872-3 | AnWj Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82872-3.json |
| 82873-1 | Brallobarbital [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82873-1.json |
| 82874-9 | Calprotectin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/82874-9.json |
| 82875-6 | Campylobacter jejuni IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/82875-6.json |
| 82876-4 | Complement C1 esterase inhibitor [Units/volume] in Serum or Plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/82876-4.json |
| 82877-2 | Cytochrome C oxidase [Enzymatic activity/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/82877-2.json |
| 82878-0 | Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82878-0.json |
| 82879-8 | Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82879-8.json |
| 82880-6 | Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82880-6.json |
| 82881-4 | Etiocholanolone/Androsterone [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82881-4.json |
| 82882-2 | Etiocholanolone/Androsterone [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82882-2.json |
| 82883-0 | Lysosomal acid lipase [Enzymatic activity/mass] in Leukocytes by 4-MU-palmitate substrate | ./2.16.840.1.114222.4.11.1002/82883-0.json |
| 82884-8 | MAOA gene upstream VNTR repeats [Entitic number] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82884-8.json |
| 82885-5 | Meta methylhippurate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82885-5.json |
| 82886-3 | Meta methylhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82886-3.json |
| 82887-1 | Ortho methylhippurate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82887-1.json |
| 82888-9 | Ortho methylhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82888-9.json |
| 82889-7 | Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82889-7.json |
| 82890-5 | Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82890-5.json |
| 82891-3 | Para methylhippurate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/82891-3.json |
| 82892-1 | Para methylhippurate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82892-1.json |
| 82893-9 | Penfluridol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82893-9.json |
| 82894-7 | Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82894-7.json |
| 82895-4 | Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82895-4.json |
| 82896-2 | Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82896-2.json |
| 82897-0 | Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82897-0.json |
| 82898-8 | Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82898-8.json |
| 82899-6 | Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82899-6.json |
| 82900-2 | Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82900-2.json |
| 82901-0 | Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82901-0.json |
| 82902-8 | Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge | ./2.16.840.1.114222.4.11.1002/82902-8.json |
| 82903-6 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82903-6.json |
| 82904-4 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82904-4.json |
| 82905-1 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/82905-1.json |
| 82906-9 | Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82906-9.json |
| 82907-7 | Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82907-7.json |
| 82908-5 | Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/82908-5.json |
| 82909-3 | Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/82909-3.json |
| 82910-1 | Thromboxane beta 2 [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82910-1.json |
| 82911-9 | Vascular endothelial growth factor D [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/82911-9.json |
| 82913-5 | Centromere protein B IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82913-5.json |
| 82914-3 | Dothiepin [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/82914-3.json |
| 82915-0 | Fibrillarin IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82915-0.json |
| 82916-8 | Flurazepam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/82916-8.json |
| 82917-6 | Bromperidol [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/82917-6.json |
| 82918-4 | Jo-1 extractable nuclear IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82918-4.json |
| 82919-2 | Ku IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82919-2.json |
| 829-2 | Am Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/829-2.json |
| 82920-0 | Legionella pneumophila IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82920-0.json |
| 82921-8 | Liver cytosol IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82921-8.json |
| 82923-4 | PML IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82923-4.json |
| 82924-2 | PL-7 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/82924-2.json |
| 82925-9 | PM-SCL-100 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82925-9.json |
| 82926-7 | Phospholipase A2 receptor IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82926-7.json |
| 82928-3 | Mitochondria M2 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82928-3.json |
| 82931-7 | Nuclear pore protein gp210 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82931-7.json |
| 82932-5 | sp100 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82932-5.json |
| 82933-3 | Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82933-3.json |
| 82934-1 | clonazePAM [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/82934-1.json |
| 82935-8 | Oxazepam [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/82935-8.json |
| 82936-6 | Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82936-6.json |
| 82937-4 | SAP and XIAP [Interpretation] in Leukocytes by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/82937-4.json |
| 82938-2 | Smith extractable nuclear D IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/82938-2.json |
| 82939-0 | Genetic variant details in Blood or Tissue by Molecular genetics method Narrative | ./2.16.840.1.114222.4.11.1002/82939-0.json |
| 82954-9 | Amyotrophic lateral sclerosis functional rating scale - revised [ALSFRS-R] | ./2.16.840.1.114222.4.11.1002/82954-9.json |
| 82956-4 | HEDIS 2017-2020 Value Set - FIT-DNA | ./2.16.840.1.114222.4.11.1002/82956-4.json |
| 82957-2 | HEDIS 2017, 2018 Value Set - Chlamydia Tests | ./2.16.840.1.114222.4.11.1002/82957-2.json |
| 82958-0 | HEDIS 2017, 2018 Value Set - Cytomegalovirus Antibody | ./2.16.840.1.114222.4.11.1002/82958-0.json |
| 82959-8 | HEDIS 2017-2020 Value Set - FOBT | ./2.16.840.1.114222.4.11.1002/82959-8.json |
| 82960-6 | HEDIS 2017, 2018 Value Set - Group A Strep Tests | ./2.16.840.1.114222.4.11.1002/82960-6.json |
| 82961-4 | HEDIS 2017, 2018 Value Set - Pregnancy Test Exclusion | ./2.16.840.1.114222.4.11.1002/82961-4.json |
| 82962-2 | HEDIS 2017, 2018 Value Set - Serum Potassium | ./2.16.840.1.114222.4.11.1002/82962-2.json |
| 82963-0 | HEDIS 2017, 2018 Value Set - HPV Vaccine Administered | ./2.16.840.1.114222.4.11.1002/82963-0.json |
| 82964-8 | Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82964-8.json |
| 82965-5 | Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82965-5.json |
| 82966-3 | Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82966-3.json |
| 82967-1 | Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82967-1.json |
| 82968-9 | Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82968-9.json |
| 82969-7 | PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82969-7.json |
| 82970-5 | PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82970-5.json |
| 82971-3 | Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82971-3.json |
| 82972-1 | Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82972-1.json |
| 82973-9 | Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82973-9.json |
| 82974-7 | O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/82974-7.json |
| 82975-4 | Desmosome IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82975-4.json |
| 82976-2 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82976-2.json |
| 82977-0 | GABABR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82977-0.json |
| 82978-8 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82978-8.json |
| 82979-6 | Contactin-associated protein 2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82979-6.json |
| 82980-4 | AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82980-4.json |
| 82981-2 | NMDAR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82981-2.json |
| 82982-0 | Exocrine pancreas IgA+IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82982-0.json |
| 82983-8 | Ma+Ta IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82983-8.json |
| 82984-6 | GABABR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82984-6.json |
| 82985-3 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82985-3.json |
| 82986-1 | Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82986-1.json |
| 82987-9 | AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82987-9.json |
| 82988-7 | NMDAR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82988-7.json |
| 82989-5 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82989-5.json |
| 82990-3 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/82990-3.json |
| 82991-1 | Phospholipase A2 receptor IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/82991-1.json |
| 82992-9 | SUMO-activating enzyme subunit 1 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82992-9.json |
| 82993-7 | Mj IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82993-7.json |
| 82994-5 | MDA5 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82994-5.json |
| 82995-2 | TIF1-gamma IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82995-2.json |
| 82996-0 | Mi-2 beta IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82996-0.json |
| 82997-8 | Mi-2 alpha IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/82997-8.json |
| 82998-6 | Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/82998-6.json |
| 82999-4 | PCA-Tr IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/82999-4.json |
| 83000-0 | Titin IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/83000-0.json |
| 83001-8 | Glial nuclear type 1 IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/83001-8.json |
| 83002-6 | Zinc finger protein of the cerebellum 4 IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/83002-6.json |
| 83003-4 | Recoverin IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/83003-4.json |
| 83004-2 | Glutamate decarboxylase 65 IgG Ab [Presence] in Serum or Plasma by Line blot | ./2.16.840.1.114222.4.11.1002/83004-2.json |
| 83012-5 | DXA Skeletal system.axial Views for bone density | ./2.16.840.1.114222.4.11.1002/83012-5.json |
| 83013-3 | DXA Skeletal system.peripheral Views for bone density | ./2.16.840.1.114222.4.11.1002/83013-3.json |
| 83014-1 | DXA Skeletal system.axial Views for bone density and vertebral fracture | ./2.16.840.1.114222.4.11.1002/83014-1.json |
| 83015-8 | XR Abdomen 2 Views for renal calculus | ./2.16.840.1.114222.4.11.1002/83015-8.json |
| 83016-6 | XR Abdomen GE 3 Views AP and Oblique and Cone | ./2.16.840.1.114222.4.11.1002/83016-6.json |
| 83017-4 | XR Chest View and Abdomen Supine and Upright | ./2.16.840.1.114222.4.11.1002/83017-4.json |
| 83018-2 | XR Ankle 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83018-2.json |
| 83019-0 | XR Chest and Abdomen and Pelvis View babygram | ./2.16.840.1.114222.4.11.1002/83019-0.json |
| 83020-8 | XR Bones Complete Survey Views | ./2.16.840.1.114222.4.11.1002/83020-8.json |
| 83021-6 | XR Cervical spine 2 or 3 views and (Views W flexion and W extension) | ./2.16.840.1.114222.4.11.1002/83021-6.json |
| 83022-4 | XR Cervical spine 2 or 3 views and (Views W flexion and W extension) and Views oblique | ./2.16.840.1.114222.4.11.1002/83022-4.json |
| 83023-2 | XR Cervical spine 4 or 5 Views | ./2.16.840.1.114222.4.11.1002/83023-2.json |
| 83024-0 | XR Chest 2 Views and Views Lateral-decubitus | ./2.16.840.1.114222.4.11.1002/83024-0.json |
| 83025-7 | XR Coccyx GE 2 Views | ./2.16.840.1.114222.4.11.1002/83025-7.json |
| 83026-5 | XR Elbow 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83026-5.json |
| 83027-3 | XR Elbow GE 4 Views | ./2.16.840.1.114222.4.11.1002/83027-3.json |
| 83028-1 | XR Cervical and thoracic and lumbar spine GE 2 Views | ./2.16.840.1.114222.4.11.1002/83028-1.json |
| 83029-9 | XR Facial bones and Zygomatic arch 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83029-9.json |
| 83030-7 | XR Foot 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83030-7.json |
| 83031-5 | XR Pelvis AP and Hip - bilateral GE 2 Views | ./2.16.840.1.114222.4.11.1002/83031-5.json |
| 83032-3 | XR Hip GE 2 Views preoperative | ./2.16.840.1.114222.4.11.1002/83032-3.json |
| 83033-1 | XR Hip single view during surgery | ./2.16.840.1.114222.4.11.1002/83033-1.json |
| 83034-9 | XR Pelvis and Hip - bilateral GE 2 views for pediatrics | ./2.16.840.1.114222.4.11.1002/83034-9.json |
| 83035-6 | XR Knee 1 or 2 Views during surgery | ./2.16.840.1.114222.4.11.1002/83035-6.json |
| 83036-4 | XR Lower extremity GE 2 Views | ./2.16.840.1.114222.4.11.1002/83036-4.json |
| 83037-2 | XR Lumbar spine Single view during surgery | ./2.16.840.1.114222.4.11.1002/83037-2.json |
| 83038-0 | XR Lumbar spine Greater than 4 views and (Greater than 1 view W R-bending and W L-bending) | ./2.16.840.1.114222.4.11.1002/83038-0.json |
| 83039-8 | XR Mastoid - bilateral GE 3 Views | ./2.16.840.1.114222.4.11.1002/83039-8.json |
| 83040-6 | XR Ribs - unilateral 2 Views | ./2.16.840.1.114222.4.11.1002/83040-6.json |
| 83041-4 | XR Ribs - unilateral 2 Views and Chest Single view | ./2.16.840.1.114222.4.11.1002/83041-4.json |
| 83042-2 | XR Ribs - unilateral 2 Views and Chest AP | ./2.16.840.1.114222.4.11.1002/83042-2.json |
| 83043-0 | XR Sacroiliac joint - bilateral 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83043-0.json |
| 83044-8 | XR Sacrum GE 2 Views | ./2.16.840.1.114222.4.11.1002/83044-8.json |
| 83045-5 | XR Scapula AP and Lateral | ./2.16.840.1.114222.4.11.1002/83045-5.json |
| 83046-3 | XR Skull LE 3 AP and Lateral Views | ./2.16.840.1.114222.4.11.1002/83046-3.json |
| 83047-1 | XR Sternum GE 2 Views | ./2.16.840.1.114222.4.11.1002/83047-1.json |
| 83048-9 | XR Tibia and Fibula GE 3 Views | ./2.16.840.1.114222.4.11.1002/83048-9.json |
| 83049-7 | XR Upper extremity GE 2 Views | ./2.16.840.1.114222.4.11.1002/83049-7.json |
| 83050-5 | XR Wrist 1 or 2 Views | ./2.16.840.1.114222.4.11.1002/83050-5.json |
| 83051-3 | DXA Cervical and thoracic and lumbar spine Views for vertebral fracture | ./2.16.840.1.114222.4.11.1002/83051-3.json |
| 83052-1 | PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/83052-1.json |
| 83055-4 | PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/83055-4.json |
| 83056-2 | PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative | ./2.16.840.1.114222.4.11.1002/83056-2.json |
| 83057-0 | PD-L1 by clone SP142 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/83057-0.json |
| 83059-6 | KRAS gene [VCF] in Cancer specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/83059-6.json |
| 83060-4 | NRAS gene [VCF] in Cancer specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/83060-4.json |
| 83061-2 | BRAF gene [VCF] in Cancer specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/83061-2.json |
| 83062-0 | PIK3CA gene [VCF] in Cancer specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/83062-0.json |
| 83063-8 | PTEN gene [VCF] in Cancer specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/83063-8.json |
| 83064-6 | Calcium.ionized [Moles/volume] in Blood drawn from CRRT circuit | ./2.16.840.1.114222.4.11.1002/83064-6.json |
| 83065-3 | Cytomegalovirus DNA [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/83065-3.json |
| 83066-1 | Mycobacterium tuberculosis complex immunogenic protein MPB64 [Presence] in Isolate by Immunoassay | ./2.16.840.1.114222.4.11.1002/83066-1.json |
| 83067-9 | Chikungunya virus structural proteins (E1+E2) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83067-9.json |
| 83068-7 | Chikungunya virus structural proteins (E1+E2) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83068-7.json |
| 83069-5 | Zika virus non-structural protein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83069-5.json |
| 83070-3 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83070-3.json |
| 83071-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83071-1.json |
| 83072-9 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83072-9.json |
| 83073-7 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83073-7.json |
| 83074-5 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/83074-5.json |
| 83075-2 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/83075-2.json |
| 83076-0 | Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83076-0.json |
| 83077-8 | Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/83077-8.json |
| 83078-6 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83078-6.json |
| 83079-4 | Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/83079-4.json |
| 83080-2 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/83080-2.json |
| 83081-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/83081-0.json |
| 83082-8 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83082-8.json |
| 83083-6 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83083-6.json |
| 83084-4 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83084-4.json |
| 83085-1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83085-1.json |
| 83086-9 | Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83086-9.json |
| 83087-7 | Clostridioides difficile glutamate dehydrogenase [Presence] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/83087-7.json |
| 83088-5 | Cortisol [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83088-5.json |
| 83089-3 | Cortisol [Mass/volume] in 24 hour Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/83089-3.json |
| 83090-1 | Cortisol [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83090-1.json |
| 83091-9 | Cortisol [Moles/volume] in 24 hour Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/83091-9.json |
| 83092-7 | Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83092-7.json |
| 83093-5 | Digoxin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83093-5.json |
| 83094-3 | Digoxin [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83094-3.json |
| 83095-0 | Epstein Barr virus capsid+early IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/83095-0.json |
| 83096-8 | Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83096-8.json |
| 83097-6 | Estradiol (E2) [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83097-6.json |
| 83098-4 | Follitropin [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83098-4.json |
| 83099-2 | Galectin 3 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83099-2.json |
| 83100-8 | Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83100-8.json |
| 83102-4 | IgE [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83102-4.json |
| 83103-2 | Lutropin [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83103-2.json |
| 83104-0 | Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83104-0.json |
| 83105-7 | Mullerian inhibiting substance [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83105-7.json |
| 83106-5 | Myoglobin [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83106-5.json |
| 83107-3 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83107-3.json |
| 83108-1 | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83108-1.json |
| 83109-9 | Progesterone [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83109-9.json |
| 83110-7 | Progesterone [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83110-7.json |
| 83111-5 | Prolactin [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83111-5.json |
| 83112-3 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83112-3.json |
| 83113-1 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83113-1.json |
| 83114-9 | S100 calcium binding protein B [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/83114-9.json |
| 83115-6 | Testosterone [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83115-6.json |
| 83116-4 | Testosterone [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83116-4.json |
| 83117-2 | Thyroglobulin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83117-2.json |
| 83118-0 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83118-0.json |
| 83119-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83119-8.json |
| 83120-6 | Thyroxine (T4) [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83120-6.json |
| 83121-4 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83121-4.json |
| 83122-2 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83122-2.json |
| 83123-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83123-0.json |
| 83124-8 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83124-8.json |
| 83125-5 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83125-5.json |
| 83126-3 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83126-3.json |
| 83127-1 | Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83127-1.json |
| 83128-9 | Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/83128-9.json |
| 83130-5 | 11-Deoxytetrahydrocorticosterone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/83130-5.json |
| 83131-3 | Pregnanolone [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/83131-3.json |
| 83132-1 | Pregnanolone [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/83132-1.json |
| 83135-4 | Allo-pregnanediolone/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/83135-4.json |
| 83136-2 | Allo-pregnanediol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/83136-2.json |
| 83137-0 | OJ IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/83137-0.json |
| 83138-8 | 17-Hydroxypregnenetriol [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/83138-8.json |
| 83139-6 | 17-Hydroxypregnenetriol/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/83139-6.json |
| 83140-4 | 17-Hydroxypregnenetriol [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/83140-4.json |
| 83141-2 | 9-Hole Pegboard Dexterity Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/83141-2.json |
| 83142-0 | Standing Balance Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/83142-0.json |
| 83143-8 | 2-Minute Walk Endurance Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/83143-8.json |
| 83144-6 | 4-Meter Walk Gait Speed Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/83144-6.json |
| 83145-3 | Grip Strength Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/83145-3.json |
| 83289-9 | CT for calcium scoring WO contrast and CTA W contrast IV Heart and coronary arteries | ./2.16.840.1.114222.4.11.1002/83289-9.json |
| 83290-7 | CTA Pulmonary arteries - bilateral and Pelvis veins and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV | ./2.16.840.1.114222.4.11.1002/83290-7.json |
| 83291-5 | CT Thumb WO contrast | ./2.16.840.1.114222.4.11.1002/83291-5.json |
| 83292-3 | CT Scapula W contrast | ./2.16.840.1.114222.4.11.1002/83292-3.json |
| 83293-1 | CT Spine Cervical and Spine Lumbar W contrast IV | ./2.16.840.1.114222.4.11.1002/83293-1.json |
| 83294-9 | CT Thoracic and lumbar spine W contrast IV | ./2.16.840.1.114222.4.11.1002/83294-9.json |
| 83295-6 | CT Neck and Superior mediastinum W contrast IV | ./2.16.840.1.114222.4.11.1002/83295-6.json |
| 83296-4 | CT Head W contrast IV and CT Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83296-4.json |
| 83297-2 | CT Spine Cervical and Spine Lumbar WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83297-2.json |
| 83298-0 | CTA Chest vessels and Abdominal vessels and Pelvis vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83298-0.json |
| 83299-8 | CT Chest and Abdomen and Pelvis WO and W contrast IV and CTA Thoracic and abdominal aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83299-8.json |
| 83300-4 | CT Scapula - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83300-4.json |
| 83301-2 | CT Neck and Superior mediastinum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/83301-2.json |
| 83302-0 | CT Head and Temporal bone WO contrast | ./2.16.840.1.114222.4.11.1002/83302-0.json |
| 83303-8 | CT Toe WO contrast | ./2.16.840.1.114222.4.11.1002/83303-8.json |
| 83304-6 | CT Cervical and thoracic spine WO contrast | ./2.16.840.1.114222.4.11.1002/83304-6.json |
| 83305-3 | CT Spine Cervical and Spine Lumbar WO contrast | ./2.16.840.1.114222.4.11.1002/83305-3.json |
| 83306-1 | CT Head and Maxillofacial region WO contrast | ./2.16.840.1.114222.4.11.1002/83306-1.json |
| 83307-9 | CT Head and Mandible WO contrast | ./2.16.840.1.114222.4.11.1002/83307-9.json |
| 83308-7 | CT Neck and Superior mediastinum WO contrast | ./2.16.840.1.114222.4.11.1002/83308-7.json |
| 83309-5 | CT Sinuses and Mandible WO contrast | ./2.16.840.1.114222.4.11.1002/83309-5.json |
| 83310-3 | CT Thoracic and lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/83310-3.json |
| 83320-2 | Allergy and Immunology Adverse event note | ./2.16.840.1.114222.4.11.1002/83320-2.json |
| 83321-0 | Pathology report intraoperative observation in Specimen Document | ./2.16.840.1.114222.4.11.1002/83321-0.json |
| 83325-1 | HIV 1 RNA genotype in Isolate | ./2.16.840.1.114222.4.11.1002/83325-1.json |
| 83326-9 | HIV 1 RNA genotype and phenotype in Isolate | ./2.16.840.1.114222.4.11.1002/83326-9.json |
| 83327-7 | HIV 1 RNA phenotype in Isolate | ./2.16.840.1.114222.4.11.1002/83327-7.json |
| 83516-5 | Cardiology Attending Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83516-5.json |
| 83517-3 | Cardiology Attending Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83517-3.json |
| 83518-1 | Cardiology Attending Note | ./2.16.840.1.114222.4.11.1002/83518-1.json |
| 83519-9 | Cardiology Attending Outpatient Note | ./2.16.840.1.114222.4.11.1002/83519-9.json |
| 83520-7 | Cardiology Case manager Note | ./2.16.840.1.114222.4.11.1002/83520-7.json |
| 83521-5 | Cardiology Clinical nurse specialist Note | ./2.16.840.1.114222.4.11.1002/83521-5.json |
| 83522-3 | Cardiology Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83522-3.json |
| 83523-1 | Cardiology Intensive care unit Discharge summary | ./2.16.840.1.114222.4.11.1002/83523-1.json |
| 83524-9 | Cardiology Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83524-9.json |
| 83525-6 | Cardiology Intensive care unit procedure note | ./2.16.840.1.114222.4.11.1002/83525-6.json |
| 83526-4 | Cardiology Intensive care unit Transfer summary note | ./2.16.840.1.114222.4.11.1002/83526-4.json |
| 83527-2 | Cardiology Fellow Note | ./2.16.840.1.114222.4.11.1002/83527-2.json |
| 83528-0 | Cardiology Fellow Outpatient Note | ./2.16.840.1.114222.4.11.1002/83528-0.json |
| 83529-8 | Cardiology Patient's home Note | ./2.16.840.1.114222.4.11.1002/83529-8.json |
| 83530-6 | Cardiology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83530-6.json |
| 83531-4 | Cardiology Nurse Note | ./2.16.840.1.114222.4.11.1002/83531-4.json |
| 83532-2 | Cardiology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83532-2.json |
| 83533-0 | Cardiology Nurse procedure note | ./2.16.840.1.114222.4.11.1002/83533-0.json |
| 83534-8 | Cardiology Observation unit Note | ./2.16.840.1.114222.4.11.1002/83534-8.json |
| 83535-5 | Cardiology Surgical operation note | ./2.16.840.1.114222.4.11.1002/83535-5.json |
| 83536-3 | Cardiology Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83536-3.json |
| 83537-1 | Cardiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83537-1.json |
| 83538-9 | Cardiology Resident Note | ./2.16.840.1.114222.4.11.1002/83538-9.json |
| 83539-7 | Cardiology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83539-7.json |
| 83540-5 | Cardiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83540-5.json |
| 83541-3 | Cardiology Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/83541-3.json |
| 83542-1 | Colon and rectal surgery Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83542-1.json |
| 83543-9 | Dermatology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83543-9.json |
| 83544-7 | Endocrinology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83544-7.json |
| 83545-4 | Geriatric medicine Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83545-4.json |
| 83546-2 | Hematology+Medical oncology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83546-2.json |
| 83547-0 | Mental health Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83547-0.json |
| 83548-8 | Nephrology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83548-8.json |
| 83549-6 | Neurological surgery Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83549-6.json |
| 83550-4 | Nurse practitioner Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83550-4.json |
| 83551-2 | Nurse practitioner Discharge summary | ./2.16.840.1.114222.4.11.1002/83551-2.json |
| 83552-0 | Nurse practitioner History and physical note | ./2.16.840.1.114222.4.11.1002/83552-0.json |
| 83553-8 | Nurse practitioner Patient's home Note | ./2.16.840.1.114222.4.11.1002/83553-8.json |
| 83554-6 | Nurse practitioner Hospital Note | ./2.16.840.1.114222.4.11.1002/83554-6.json |
| 83555-3 | Nurse practitioner Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83555-3.json |
| 83556-1 | Nurse practitioner Outpatient Note | ./2.16.840.1.114222.4.11.1002/83556-1.json |
| 83557-9 | Nurse practitioner Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83557-9.json |
| 83558-7 | Obstetrics and gynecology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83558-7.json |
| 83559-5 | Orthopaedic surgery Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83559-5.json |
| 83560-3 | Primary care Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83560-3.json |
| 83561-1 | Psychiatry Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83561-1.json |
| 83562-9 | Surgery Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83562-9.json |
| 83563-7 | Urology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83563-7.json |
| 83564-5 | Vascular surgery Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/83564-5.json |
| 83565-2 | Allergy and Immunology Nurse Note | ./2.16.840.1.114222.4.11.1002/83565-2.json |
| 83566-0 | Allergy and Immunology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83566-0.json |
| 83567-8 | Anesthesiology Nurse Note | ./2.16.840.1.114222.4.11.1002/83567-8.json |
| 83568-6 | Dermatology Nurse Note | ./2.16.840.1.114222.4.11.1002/83568-6.json |
| 83569-4 | Dermatology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83569-4.json |
| 83570-2 | Diabetology Nurse Consult note | ./2.16.840.1.114222.4.11.1002/83570-2.json |
| 83571-0 | Diabetology Nurse Note | ./2.16.840.1.114222.4.11.1002/83571-0.json |
| 83572-8 | Diabetology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83572-8.json |
| 83573-6 | Endocrinology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83573-6.json |
| 83574-4 | Ophthalmology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83574-4.json |
| 83575-1 | Gastroenterology Nurse Note | ./2.16.840.1.114222.4.11.1002/83575-1.json |
| 83576-9 | Gastroenterology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83576-9.json |
| 83577-7 | Gastroenterology Nurse procedure note | ./2.16.840.1.114222.4.11.1002/83577-7.json |
| 83578-5 | Hematology+Medical oncology Nurse Consult note | ./2.16.840.1.114222.4.11.1002/83578-5.json |
| 83579-3 | Hematology+Medical oncology Nurse Note | ./2.16.840.1.114222.4.11.1002/83579-3.json |
| 83580-1 | Hematology+Medical oncology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83580-1.json |
| 83581-9 | Hepatology Nurse Note | ./2.16.840.1.114222.4.11.1002/83581-9.json |
| 83582-7 | Interventional radiology Nurse Note | ./2.16.840.1.114222.4.11.1002/83582-7.json |
| 83583-5 | Nephrology Nurse Note | ./2.16.840.1.114222.4.11.1002/83583-5.json |
| 83584-3 | Nephrology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83584-3.json |
| 83585-0 | Neurology Nurse Note | ./2.16.840.1.114222.4.11.1002/83585-0.json |
| 83586-8 | Neurology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83586-8.json |
| 83587-6 | Obstetrics and gynecology Nurse Note | ./2.16.840.1.114222.4.11.1002/83587-6.json |
| 83588-4 | Obstetrics and gynecology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83588-4.json |
| 83589-2 | Ophthalmology Nurse Note | ./2.16.840.1.114222.4.11.1002/83589-2.json |
| 83590-0 | Otolaryngology Nurse Note | ./2.16.840.1.114222.4.11.1002/83590-0.json |
| 83591-8 | Otolaryngology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83591-8.json |
| 83592-6 | Pathology Nurse Note | ./2.16.840.1.114222.4.11.1002/83592-6.json |
| 83593-4 | Radiation oncology Nurse Education note | ./2.16.840.1.114222.4.11.1002/83593-4.json |
| 83594-2 | Radiation oncology Nurse Note | ./2.16.840.1.114222.4.11.1002/83594-2.json |
| 83595-9 | Rheumatology Nurse Note | ./2.16.840.1.114222.4.11.1002/83595-9.json |
| 83596-7 | Rheumatology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83596-7.json |
| 83597-5 | Urology Nurse Note | ./2.16.840.1.114222.4.11.1002/83597-5.json |
| 83598-3 | Urology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83598-3.json |
| 83599-1 | Urology Nurse procedure note | ./2.16.840.1.114222.4.11.1002/83599-1.json |
| 83600-7 | Colon and rectal surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/83600-7.json |
| 83601-5 | Dentistry Nurse Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83601-5.json |
| 83602-3 | Neurological surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/83602-3.json |
| 83603-1 | Orthopaedic surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/83603-1.json |
| 83604-9 | Orthopaedic surgery Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83604-9.json |
| 83605-6 | Physical therapy Nurse Note | ./2.16.840.1.114222.4.11.1002/83605-6.json |
| 83606-4 | Plastic surgery Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83606-4.json |
| 83607-2 | Podiatry Nurse Note | ./2.16.840.1.114222.4.11.1002/83607-2.json |
| 83608-0 | Podiatry Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83608-0.json |
| 83609-8 | Psychiatry Nurse Consult note | ./2.16.840.1.114222.4.11.1002/83609-8.json |
| 83610-6 | Psychiatry Nurse Hospital Note | ./2.16.840.1.114222.4.11.1002/83610-6.json |
| 83611-4 | Psychiatry Nurse Note | ./2.16.840.1.114222.4.11.1002/83611-4.json |
| 83612-2 | Surgery Nurse Hospital Note | ./2.16.840.1.114222.4.11.1002/83612-2.json |
| 83613-0 | Surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/83613-0.json |
| 83614-8 | Surgery Nurse Surgical operation note | ./2.16.840.1.114222.4.11.1002/83614-8.json |
| 83615-5 | Surgery Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83615-5.json |
| 83616-3 | Surgery Nurse Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/83616-3.json |
| 83617-1 | Surgery Nurse procedure note | ./2.16.840.1.114222.4.11.1002/83617-1.json |
| 83618-9 | Vascular surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/83618-9.json |
| 83619-7 | Vascular surgery Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83619-7.json |
| 83620-5 | Blood banking and transfusion medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/83620-5.json |
| 83621-3 | Geriatric medicine Nurse Consult note | ./2.16.840.1.114222.4.11.1002/83621-3.json |
| 83622-1 | Geriatric medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/83622-1.json |
| 83623-9 | Geriatric medicine Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83623-9.json |
| 83624-7 | Geriatric medicine Nurse Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83624-7.json |
| 83625-4 | Primary care Nurse Patient's home Note | ./2.16.840.1.114222.4.11.1002/83625-4.json |
| 83626-2 | Infectious disease Nurse Note | ./2.16.840.1.114222.4.11.1002/83626-2.json |
| 83627-0 | Infectious disease Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83627-0.json |
| 83628-8 | Mental health Nurse Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83628-8.json |
| 83629-6 | Mental health Nurse Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83629-6.json |
| 83630-4 | Mental health Nurse Group counseling note | ./2.16.840.1.114222.4.11.1002/83630-4.json |
| 83631-2 | Mental health Nurse Hospital Note | ./2.16.840.1.114222.4.11.1002/83631-2.json |
| 83632-0 | Mental health Nurse Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83632-0.json |
| 83633-8 | Mental health Nurse Medication management note | ./2.16.840.1.114222.4.11.1002/83633-8.json |
| 83634-6 | Mental health Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83634-6.json |
| 83635-3 | Mental health Nurse Plan of care note | ./2.16.840.1.114222.4.11.1002/83635-3.json |
| 83636-1 | Mental health Nurse Triage note | ./2.16.840.1.114222.4.11.1002/83636-1.json |
| 83637-9 | Nutrition and dietetics Nurse Note | ./2.16.840.1.114222.4.11.1002/83637-9.json |
| 83638-7 | Pulmonary Nurse Note | ./2.16.840.1.114222.4.11.1002/83638-7.json |
| 83639-5 | Pulmonary Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83639-5.json |
| 83640-3 | Pulmonary Nurse procedure note | ./2.16.840.1.114222.4.11.1002/83640-3.json |
| 83641-1 | Palliative care Nurse Note | ./2.16.840.1.114222.4.11.1002/83641-1.json |
| 83642-9 | Primary care Nurse Triage note | ./2.16.840.1.114222.4.11.1002/83642-9.json |
| 83643-7 | Pain medicine Emergency department Note | ./2.16.840.1.114222.4.11.1002/83643-7.json |
| 83644-5 | Pain medicine Hospital Note | ./2.16.840.1.114222.4.11.1002/83644-5.json |
| 83645-2 | Pain medicine Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83645-2.json |
| 83646-0 | Pain medicine Medication management note | ./2.16.840.1.114222.4.11.1002/83646-0.json |
| 83647-8 | Pain medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/83647-8.json |
| 83648-6 | Pain medicine Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/83648-6.json |
| 83649-4 | Pain medicine Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83649-4.json |
| 83650-2 | Pain medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/83650-2.json |
| 83651-0 | Pain medicine Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/83651-0.json |
| 83652-8 | Pain medicine Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83652-8.json |
| 83653-6 | Pain medicine Team Consult note | ./2.16.840.1.114222.4.11.1002/83653-6.json |
| 83654-4 | Pain medicine Team Note | ./2.16.840.1.114222.4.11.1002/83654-4.json |
| 83655-1 | Pain medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83655-1.json |
| 83656-9 | Cardiothoracic surgery Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83656-9.json |
| 83657-7 | Cardiothoracic surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83657-7.json |
| 83658-5 | Colon and rectal surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83658-5.json |
| 83659-3 | Neurological surgery Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83659-3.json |
| 83660-1 | Neurological surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83660-1.json |
| 83661-9 | Neurological surgery Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83661-9.json |
| 83662-7 | Oral and maxillofacial surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83662-7.json |
| 83663-5 | Orthopaedic surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83663-5.json |
| 83664-3 | Orthopaedic surgery Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83664-3.json |
| 83665-0 | Plastic surgery Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83665-0.json |
| 83666-8 | Plastic surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83666-8.json |
| 83667-6 | Plastic surgery Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83667-6.json |
| 83668-4 | Psychiatry Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83668-4.json |
| 83669-2 | Psychiatry Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/83669-2.json |
| 83670-0 | Surgery Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83670-0.json |
| 83671-8 | Surgery Attending Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83671-8.json |
| 83672-6 | Surgery Attending Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83672-6.json |
| 83673-4 | Surgery Attending Surgical operation note | ./2.16.840.1.114222.4.11.1002/83673-4.json |
| 83674-2 | Surgery Attending Outpatient Note | ./2.16.840.1.114222.4.11.1002/83674-2.json |
| 83675-9 | Surgery Attending Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83675-9.json |
| 83676-7 | Transplant surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83676-7.json |
| 83677-5 | Vascular surgery Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83677-5.json |
| 83678-3 | Vascular surgery Attending Note | ./2.16.840.1.114222.4.11.1002/83678-3.json |
| 83679-1 | Vascular surgery Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83679-1.json |
| 83680-9 | Anesthesiology Attending Note | ./2.16.840.1.114222.4.11.1002/83680-9.json |
| 83681-7 | Anesthesiology Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83681-7.json |
| 83682-5 | Dermatology Attending Note | ./2.16.840.1.114222.4.11.1002/83682-5.json |
| 83683-3 | Endocrinology Attending Note | ./2.16.840.1.114222.4.11.1002/83683-3.json |
| 83684-1 | Gastroenterology Attending Note | ./2.16.840.1.114222.4.11.1002/83684-1.json |
| 83685-8 | Hematology+Medical oncology Attending Consult note | ./2.16.840.1.114222.4.11.1002/83685-8.json |
| 83686-6 | Hematology+Medical oncology Attending Note | ./2.16.840.1.114222.4.11.1002/83686-6.json |
| 83687-4 | Nephrology Attending Note | ./2.16.840.1.114222.4.11.1002/83687-4.json |
| 83688-2 | Neurology Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83688-2.json |
| 83689-0 | Neurology Attending Note | ./2.16.840.1.114222.4.11.1002/83689-0.json |
| 83690-8 | Obstetrics and gynecology Attending Note | ./2.16.840.1.114222.4.11.1002/83690-8.json |
| 83691-6 | Ophthalmology Attending Note | ./2.16.840.1.114222.4.11.1002/83691-6.json |
| 83692-4 | Ophthalmology Attending Surgical operation note | ./2.16.840.1.114222.4.11.1002/83692-4.json |
| 83693-2 | Ophthalmology Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83693-2.json |
| 83694-0 | Otolaryngology Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83694-0.json |
| 83695-7 | Otolaryngology Attending Note | ./2.16.840.1.114222.4.11.1002/83695-7.json |
| 83696-5 | Otolaryngology Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83696-5.json |
| 83697-3 | Radiation oncology Attending Note | ./2.16.840.1.114222.4.11.1002/83697-3.json |
| 83698-1 | Rheumatology Attending Note | ./2.16.840.1.114222.4.11.1002/83698-1.json |
| 83699-9 | Urology Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83699-9.json |
| 83700-5 | Urology Attending Note | ./2.16.840.1.114222.4.11.1002/83700-5.json |
| 83701-3 | Urology Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83701-3.json |
| 83702-1 | Geriatric medicine Attending Note | ./2.16.840.1.114222.4.11.1002/83702-1.json |
| 83703-9 | Primary care Attending Patient's home Note | ./2.16.840.1.114222.4.11.1002/83703-9.json |
| 83704-7 | Mental health Attending Note | ./2.16.840.1.114222.4.11.1002/83704-7.json |
| 83705-4 | Palliative care Attending Note | ./2.16.840.1.114222.4.11.1002/83705-4.json |
| 83706-2 | Primary care Attending Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83706-2.json |
| 83707-0 | Physical medicine and rehab Administrative note | ./2.16.840.1.114222.4.11.1002/83707-0.json |
| 83708-8 | Physical medicine and rehab Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83708-8.json |
| 83709-6 | Physical medicine and rehabilitation Attending Note | ./2.16.840.1.114222.4.11.1002/83709-6.json |
| 83710-4 | Physical medicine and rehabilitation Case manager Note | ./2.16.840.1.114222.4.11.1002/83710-4.json |
| 83711-2 | Physical medicine and rehab Conference note | ./2.16.840.1.114222.4.11.1002/83711-2.json |
| 83712-0 | Physical medicine and rehab Discharge summary | ./2.16.840.1.114222.4.11.1002/83712-0.json |
| 83713-8 | Physical medicine and rehabilitation Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/83713-8.json |
| 83714-6 | Physical medicine and rehab Education note | ./2.16.840.1.114222.4.11.1002/83714-6.json |
| 83715-3 | Physical medicine and rehab History and physical note | ./2.16.840.1.114222.4.11.1002/83715-3.json |
| 83716-1 | Physical medicine and rehab Patient's home Note | ./2.16.840.1.114222.4.11.1002/83716-1.json |
| 83717-9 | Physical medicine and rehab Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83717-9.json |
| 83718-7 | Physical medicine and rehab Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83718-7.json |
| 83719-5 | Physical medicine and rehab Hospital Note | ./2.16.840.1.114222.4.11.1002/83719-5.json |
| 83720-3 | Physical medicine and rehab Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/83720-3.json |
| 83721-1 | Physical medicine and rehab Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83721-1.json |
| 83722-9 | Physical medicine and rehabilitation Nurse Consult note | ./2.16.840.1.114222.4.11.1002/83722-9.json |
| 83723-7 | Physical medicine and rehabilitation Nurse Note | ./2.16.840.1.114222.4.11.1002/83723-7.json |
| 83724-5 | Physical medicine and rehab Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83724-5.json |
| 83725-2 | Physical medicine and rehab Outpatient Note | ./2.16.840.1.114222.4.11.1002/83725-2.json |
| 83726-0 | Physical medicine and rehabilitation Physician Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83726-0.json |
| 83727-8 | Physical medicine and rehabilitation Physician Note | ./2.16.840.1.114222.4.11.1002/83727-8.json |
| 83728-6 | Physical medicine and rehab procedure note | ./2.16.840.1.114222.4.11.1002/83728-6.json |
| 83729-4 | Physical medicine and rehabilitation Resident Note | ./2.16.840.1.114222.4.11.1002/83729-4.json |
| 83730-2 | Physical medicine and rehab Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83730-2.json |
| 83731-0 | Physical medicine and rehabilitation Team Conference note | ./2.16.840.1.114222.4.11.1002/83731-0.json |
| 83732-8 | Physical medicine and rehabilitation Team Note | ./2.16.840.1.114222.4.11.1002/83732-8.json |
| 83733-6 | Physical medicine and rehab Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83733-6.json |
| 83734-4 | Physical medicine and rehabilitation Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/83734-4.json |
| 83735-1 | Colon and rectal surgery Fellow Note | ./2.16.840.1.114222.4.11.1002/83735-1.json |
| 83736-9 | Endocrinology Fellow Note | ./2.16.840.1.114222.4.11.1002/83736-9.json |
| 83737-7 | Gastroenterology Fellow Note | ./2.16.840.1.114222.4.11.1002/83737-7.json |
| 83738-5 | Geriatric medicine Fellow Note | ./2.16.840.1.114222.4.11.1002/83738-5.json |
| 83739-3 | Hematology+Medical oncology Fellow Note | ./2.16.840.1.114222.4.11.1002/83739-3.json |
| 83740-1 | Infectious disease Fellow Note | ./2.16.840.1.114222.4.11.1002/83740-1.json |
| 83741-9 | Nephrology Fellow Note | ./2.16.840.1.114222.4.11.1002/83741-9.json |
| 83742-7 | Ophthalmology Fellow Note | ./2.16.840.1.114222.4.11.1002/83742-7.json |
| 83743-5 | Plastic surgery Fellow Note | ./2.16.840.1.114222.4.11.1002/83743-5.json |
| 83744-3 | Pulmonary Fellow Note | ./2.16.840.1.114222.4.11.1002/83744-3.json |
| 83745-0 | Rheumatology Fellow Note | ./2.16.840.1.114222.4.11.1002/83745-0.json |
| 83746-8 | Spinal cord injury medicine Fellow Hospital Note | ./2.16.840.1.114222.4.11.1002/83746-8.json |
| 83747-6 | Mental health Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83747-6.json |
| 83748-4 | Orthopaedic surgery Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83748-4.json |
| 83749-2 | Primary care Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83749-2.json |
| 83750-0 | Spinal cord injury medicine Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83750-0.json |
| 83751-8 | Urology Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83751-8.json |
| 83752-6 | Vascular surgery Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83752-6.json |
| 83753-4 | Colon and rectal surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83753-4.json |
| 83754-2 | Dermatology Resident Note | ./2.16.840.1.114222.4.11.1002/83754-2.json |
| 83755-9 | Endocrinology Resident Note | ./2.16.840.1.114222.4.11.1002/83755-9.json |
| 83756-7 | Gastroenterology Resident Note | ./2.16.840.1.114222.4.11.1002/83756-7.json |
| 83757-5 | Geriatric medicine Resident Note | ./2.16.840.1.114222.4.11.1002/83757-5.json |
| 83758-3 | Hematology+Medical oncology Resident Note | ./2.16.840.1.114222.4.11.1002/83758-3.json |
| 83759-1 | Infectious disease Resident Note | ./2.16.840.1.114222.4.11.1002/83759-1.json |
| 83760-9 | Interventional radiology Resident Note | ./2.16.840.1.114222.4.11.1002/83760-9.json |
| 83761-7 | Mental health Resident Note | ./2.16.840.1.114222.4.11.1002/83761-7.json |
| 83762-5 | Nephrology Resident Note | ./2.16.840.1.114222.4.11.1002/83762-5.json |
| 83763-3 | Neurology Resident Note | ./2.16.840.1.114222.4.11.1002/83763-3.json |
| 83764-1 | Neurological surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83764-1.json |
| 83765-8 | Obstetrics and gynecology Resident Note | ./2.16.840.1.114222.4.11.1002/83765-8.json |
| 83766-6 | Ophthalmology Resident Note | ./2.16.840.1.114222.4.11.1002/83766-6.json |
| 83767-4 | Oral and maxillofacial surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83767-4.json |
| 83768-2 | Orthopaedic surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83768-2.json |
| 83769-0 | Otolaryngology Resident Note | ./2.16.840.1.114222.4.11.1002/83769-0.json |
| 83770-8 | Palliative care Resident Note | ./2.16.840.1.114222.4.11.1002/83770-8.json |
| 83771-6 | Plastic surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83771-6.json |
| 83772-4 | Primary care Resident Note | ./2.16.840.1.114222.4.11.1002/83772-4.json |
| 83773-2 | Psychiatry Resident Note | ./2.16.840.1.114222.4.11.1002/83773-2.json |
| 83774-0 | Pulmonary Resident Note | ./2.16.840.1.114222.4.11.1002/83774-0.json |
| 83775-7 | Radiation oncology Resident Note | ./2.16.840.1.114222.4.11.1002/83775-7.json |
| 83776-5 | Rheumatology Resident Note | ./2.16.840.1.114222.4.11.1002/83776-5.json |
| 83777-3 | Spinal cord injury medicine Resident Hospital Note | ./2.16.840.1.114222.4.11.1002/83777-3.json |
| 83778-1 | Surgery Resident Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83778-1.json |
| 83779-9 | Surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83779-9.json |
| 83780-7 | Transplant surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83780-7.json |
| 83781-5 | Urology Resident Note | ./2.16.840.1.114222.4.11.1002/83781-5.json |
| 83782-3 | Vascular surgery Resident Note | ./2.16.840.1.114222.4.11.1002/83782-3.json |
| 83783-1 | Infectious disease Attending Note | ./2.16.840.1.114222.4.11.1002/83783-1.json |
| 83784-9 | Mental health Physician Note | ./2.16.840.1.114222.4.11.1002/83784-9.json |
| 83785-6 | Palliative care Physician Note | ./2.16.840.1.114222.4.11.1002/83785-6.json |
| 83786-4 | Primary care Physician History and physical note | ./2.16.840.1.114222.4.11.1002/83786-4.json |
| 83787-2 | Pulmonary Attending Note | ./2.16.840.1.114222.4.11.1002/83787-2.json |
| 83788-0 | Pulmonary Attending Outpatient Note | ./2.16.840.1.114222.4.11.1002/83788-0.json |
| 83789-8 | Pulmonary Attending procedure note | ./2.16.840.1.114222.4.11.1002/83789-8.json |
| 83790-6 | Spinal cord injury medicine Attending Note | ./2.16.840.1.114222.4.11.1002/83790-6.json |
| 83791-4 | Spinal cord injury medicine Physician Note | ./2.16.840.1.114222.4.11.1002/83791-4.json |
| 83792-2 | Surgery Intern Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83792-2.json |
| 83793-0 | Physician Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83793-0.json |
| 83794-8 | Physician Urgent care center Note | ./2.16.840.1.114222.4.11.1002/83794-8.json |
| 83795-5 | Physician Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83795-5.json |
| 83796-3 | Physician Summary of death note | ./2.16.840.1.114222.4.11.1002/83796-3.json |
| 83797-1 | Physician Referral note | ./2.16.840.1.114222.4.11.1002/83797-1.json |
| 83798-9 | Physician Outpatient Note | ./2.16.840.1.114222.4.11.1002/83798-9.json |
| 83799-7 | Physician Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/83799-7.json |
| 83800-3 | Physician Hospital Note | ./2.16.840.1.114222.4.11.1002/83800-3.json |
| 83801-1 | Physician Patient's home Note | ./2.16.840.1.114222.4.11.1002/83801-1.json |
| 83802-9 | Physician Discharge instructions | ./2.16.840.1.114222.4.11.1002/83802-9.json |
| 83803-7 | Physician Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83803-7.json |
| 83804-5 | Physician Administrative note | ./2.16.840.1.114222.4.11.1002/83804-5.json |
| 83805-2 | Physician Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83805-2.json |
| 83806-0 | Physician assistant Note | ./2.16.840.1.114222.4.11.1002/83806-0.json |
| 83807-8 | Physician assistant Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83807-8.json |
| 83808-6 | Physician assistant Outpatient Note | ./2.16.840.1.114222.4.11.1002/83808-6.json |
| 83809-4 | Physician assistant Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83809-4.json |
| 83810-2 | Physician assistant Discharge summary | ./2.16.840.1.114222.4.11.1002/83810-2.json |
| 83811-0 | Physician assistant Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83811-0.json |
| 83812-8 | Physician assistant History and physical note | ./2.16.840.1.114222.4.11.1002/83812-8.json |
| 83813-6 | Physician assistant Patient's home Note | ./2.16.840.1.114222.4.11.1002/83813-6.json |
| 83814-4 | Physician assistant Hospital Note | ./2.16.840.1.114222.4.11.1002/83814-4.json |
| 83815-1 | Attending Surgical operation note | ./2.16.840.1.114222.4.11.1002/83815-1.json |
| 83816-9 | Attending Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83816-9.json |
| 83817-7 | Attending Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83817-7.json |
| 83818-5 | Attending Emergency department Note | ./2.16.840.1.114222.4.11.1002/83818-5.json |
| 83819-3 | Attending History and physical note | ./2.16.840.1.114222.4.11.1002/83819-3.json |
| 83820-1 | Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83820-1.json |
| 83821-9 | Attending Outpatient Note | ./2.16.840.1.114222.4.11.1002/83821-9.json |
| 83822-7 | Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/83822-7.json |
| 83823-5 | Attending Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83823-5.json |
| 83824-3 | Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83824-3.json |
| 83825-0 | Fellow Note | ./2.16.840.1.114222.4.11.1002/83825-0.json |
| 83826-8 | Fellow Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83826-8.json |
| 83827-6 | Fellow Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83827-6.json |
| 83828-4 | Dentistry Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83828-4.json |
| 83829-2 | Dentistry Administrative note | ./2.16.840.1.114222.4.11.1002/83829-2.json |
| 838-3 | Ax Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/838-3.json |
| 83830-0 | Dentistry History and physical note | ./2.16.840.1.114222.4.11.1002/83830-0.json |
| 83831-8 | Dentistry Hospital Note | ./2.16.840.1.114222.4.11.1002/83831-8.json |
| 83832-6 | Dentistry Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83832-6.json |
| 83833-4 | Dentistry Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83833-4.json |
| 83834-2 | Dentistry Emergency department Note | ./2.16.840.1.114222.4.11.1002/83834-2.json |
| 83835-9 | Dentistry Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83835-9.json |
| 83836-7 | Dentistry Summary note | ./2.16.840.1.114222.4.11.1002/83836-7.json |
| 83837-5 | Dentistry Technician Note | ./2.16.840.1.114222.4.11.1002/83837-5.json |
| 83838-3 | Dentistry Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83838-3.json |
| 83839-1 | Dentistry Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/83839-1.json |
| 83840-9 | Vascular surgery Technician Note | ./2.16.840.1.114222.4.11.1002/83840-9.json |
| 83841-7 | Transplant surgery Case manager Note | ./2.16.840.1.114222.4.11.1002/83841-7.json |
| 83842-5 | Surgery Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/83842-5.json |
| 83843-3 | Surgery Case manager Note | ./2.16.840.1.114222.4.11.1002/83843-3.json |
| 83850-8 | Plastic surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83850-8.json |
| 83851-6 | Plastic surgery Hospital Note | ./2.16.840.1.114222.4.11.1002/83851-6.json |
| 83852-4 | Plastic surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/83852-4.json |
| 83853-2 | Plastic surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83853-2.json |
| 83854-0 | Plastic surgery procedure note | ./2.16.840.1.114222.4.11.1002/83854-0.json |
| 83855-7 | Plastic surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83855-7.json |
| 83856-5 | Podiatry Administrative note | ./2.16.840.1.114222.4.11.1002/83856-5.json |
| 83857-3 | Podiatry Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83857-3.json |
| 83858-1 | Podiatry History and physical note | ./2.16.840.1.114222.4.11.1002/83858-1.json |
| 83859-9 | Podiatry Hospital Note | ./2.16.840.1.114222.4.11.1002/83859-9.json |
| 83860-7 | Podiatry Outpatient Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83860-7.json |
| 83861-5 | Podiatry Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83861-5.json |
| 83862-3 | Podiatry Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/83862-3.json |
| 83863-1 | Podiatry Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83863-1.json |
| 83864-9 | Podiatry Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83864-9.json |
| 83865-6 | Podiatry Transfer summary note | ./2.16.840.1.114222.4.11.1002/83865-6.json |
| 83866-4 | Multi-specialty program Group counseling note | ./2.16.840.1.114222.4.11.1002/83866-4.json |
| 83867-2 | Preventive medicine Annual evaluation note | ./2.16.840.1.114222.4.11.1002/83867-2.json |
| 83868-0 | Preventive medicine Consult note | ./2.16.840.1.114222.4.11.1002/83868-0.json |
| 83869-8 | Preventive medicine Counseling note | ./2.16.840.1.114222.4.11.1002/83869-8.json |
| 83870-6 | Primary care Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83870-6.json |
| 83871-4 | Primary care Annual evaluation note | ./2.16.840.1.114222.4.11.1002/83871-4.json |
| 83872-2 | Primary care Case manager Note | ./2.16.840.1.114222.4.11.1002/83872-2.json |
| 83873-0 | Primary care Consult note | ./2.16.840.1.114222.4.11.1002/83873-0.json |
| 83874-8 | Primary care Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83874-8.json |
| 83875-5 | Primary care Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83875-5.json |
| 83876-3 | Primary care Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83876-3.json |
| 83877-1 | Primary care Triage note | ./2.16.840.1.114222.4.11.1002/83877-1.json |
| 83878-9 | Primary care Urgent care center Note | ./2.16.840.1.114222.4.11.1002/83878-9.json |
| 83879-7 | Psychiatry Administrative note | ./2.16.840.1.114222.4.11.1002/83879-7.json |
| 83880-5 | Psychiatry Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83880-5.json |
| 83881-3 | Psychiatry Case manager Note | ./2.16.840.1.114222.4.11.1002/83881-3.json |
| 83882-1 | Psychiatry Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/83882-1.json |
| 83883-9 | Psychiatry Education note | ./2.16.840.1.114222.4.11.1002/83883-9.json |
| 83884-7 | Psychiatry Emergency department Note | ./2.16.840.1.114222.4.11.1002/83884-7.json |
| 83885-4 | Psychiatry Hospital Group counseling note | ./2.16.840.1.114222.4.11.1002/83885-4.json |
| 83886-2 | Psychiatry Hospital History and physical note | ./2.16.840.1.114222.4.11.1002/83886-2.json |
| 83887-0 | Psychiatry Hospital Note | ./2.16.840.1.114222.4.11.1002/83887-0.json |
| 83888-8 | Psychiatry Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/83888-8.json |
| 83889-6 | Psychiatry Medication management note | ./2.16.840.1.114222.4.11.1002/83889-6.json |
| 83890-4 | Psychiatry Outpatient Group counseling note | ./2.16.840.1.114222.4.11.1002/83890-4.json |
| 83891-2 | Psychiatry procedure note | ./2.16.840.1.114222.4.11.1002/83891-2.json |
| 83892-0 | Psychiatry Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83892-0.json |
| 83893-8 | Psychiatry Team Note | ./2.16.840.1.114222.4.11.1002/83893-8.json |
| 83894-6 | Psychiatry Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83894-6.json |
| 83895-3 | Psychiatry Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/83895-3.json |
| 83896-1 | Psychiatry Triage note | ./2.16.840.1.114222.4.11.1002/83896-1.json |
| 83897-9 | Psychology Administrative note | ./2.16.840.1.114222.4.11.1002/83897-9.json |
| 83898-7 | Psychology Discharge summary | ./2.16.840.1.114222.4.11.1002/83898-7.json |
| 83899-5 | Psychology Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83899-5.json |
| 83900-1 | Psychology Education note | ./2.16.840.1.114222.4.11.1002/83900-1.json |
| 83901-9 | Psychology History and physical note | ./2.16.840.1.114222.4.11.1002/83901-9.json |
| 83902-7 | Psychology Patient's home Note | ./2.16.840.1.114222.4.11.1002/83902-7.json |
| 83903-5 | Psychology Hospital Note | ./2.16.840.1.114222.4.11.1002/83903-5.json |
| 83904-3 | Psychology Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83904-3.json |
| 83905-0 | Psychology Outpatient Note | ./2.16.840.1.114222.4.11.1002/83905-0.json |
| 83906-8 | Psychology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83906-8.json |
| 83907-6 | Psychology Team Note | ./2.16.840.1.114222.4.11.1002/83907-6.json |
| 83908-4 | Psychology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83908-4.json |
| 83909-2 | Public health Consult note | ./2.16.840.1.114222.4.11.1002/83909-2.json |
| 83910-0 | Public health Note | ./2.16.840.1.114222.4.11.1002/83910-0.json |
| 83911-8 | Pulmonary Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83911-8.json |
| 83912-6 | Pulmonary Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/83912-6.json |
| 83913-4 | Pulmonary Patient's home Note | ./2.16.840.1.114222.4.11.1002/83913-4.json |
| 83914-2 | Pulmonary Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/83914-2.json |
| 83915-9 | Pulmonary Outpatient Note | ./2.16.840.1.114222.4.11.1002/83915-9.json |
| 83916-7 | Pulmonary Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83916-7.json |
| 83917-5 | Radiation oncology Hospital Note | ./2.16.840.1.114222.4.11.1002/83917-5.json |
| 83918-3 | Radiation oncology Outpatient Note | ./2.16.840.1.114222.4.11.1002/83918-3.json |
| 83919-1 | Radiation oncology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83919-1.json |
| 83920-9 | Radiation oncology Therapist Note | ./2.16.840.1.114222.4.11.1002/83920-9.json |
| 83921-7 | Recreational therapy Discharge summary | ./2.16.840.1.114222.4.11.1002/83921-7.json |
| 83922-5 | Recreational therapy Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83922-5.json |
| 83923-3 | Recreational therapy Education note | ./2.16.840.1.114222.4.11.1002/83923-3.json |
| 83924-1 | Recreational therapy Hospital Note | ./2.16.840.1.114222.4.11.1002/83924-1.json |
| 83925-8 | Recreational therapy Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/83925-8.json |
| 83926-6 | Recreational therapy Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/83926-6.json |
| 83927-4 | Recreational therapy Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83927-4.json |
| 83928-2 | Recreational therapy Outpatient Note | ./2.16.840.1.114222.4.11.1002/83928-2.json |
| 83929-0 | Recreational therapy Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83929-0.json |
| 83931-6 | Research Consult note | ./2.16.840.1.114222.4.11.1002/83931-6.json |
| 83932-4 | Research Discharge summary | ./2.16.840.1.114222.4.11.1002/83932-4.json |
| 83933-2 | Research Evaluation and management of hypertension note | ./2.16.840.1.114222.4.11.1002/83933-2.json |
| 83934-0 | Research Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83934-0.json |
| 83935-7 | Research Medication management note | ./2.16.840.1.114222.4.11.1002/83935-7.json |
| 83936-5 | Research Nurse Note | ./2.16.840.1.114222.4.11.1002/83936-5.json |
| 83937-3 | Research Outpatient Note | ./2.16.840.1.114222.4.11.1002/83937-3.json |
| 83938-1 | Research procedure note | ./2.16.840.1.114222.4.11.1002/83938-1.json |
| 83939-9 | Research Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83939-9.json |
| 83940-7 | Respiratory therapy Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/83940-7.json |
| 83941-5 | Respiratory therapy Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/83941-5.json |
| 83942-3 | Respiratory therapy Patient's home Note | ./2.16.840.1.114222.4.11.1002/83942-3.json |
| 83943-1 | Respiratory therapy Hospital Note | ./2.16.840.1.114222.4.11.1002/83943-1.json |
| 83944-9 | Respiratory therapy Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83944-9.json |
| 83945-6 | Respiratory therapy Outpatient Note | ./2.16.840.1.114222.4.11.1002/83945-6.json |
| 83946-4 | Respiratory therapy Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83946-4.json |
| 83947-2 | Rheumatology Hospital Note | ./2.16.840.1.114222.4.11.1002/83947-2.json |
| 83948-0 | Rheumatology Outpatient Note | ./2.16.840.1.114222.4.11.1002/83948-0.json |
| 83949-8 | Rheumatology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83949-8.json |
| 83950-6 | Rheumatology Transfer summary note | ./2.16.840.1.114222.4.11.1002/83950-6.json |
| 83951-4 | Interdisciplinary Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83951-4.json |
| 83952-2 | Registered nurse Hospital Note | ./2.16.840.1.114222.4.11.1002/83952-2.json |
| 83953-0 | Nurse Evaluation and management of smoking cessation note | ./2.16.840.1.114222.4.11.1002/83953-0.json |
| 83954-8 | Social worker Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83954-8.json |
| 83955-5 | Social worker Annual evaluation note | ./2.16.840.1.114222.4.11.1002/83955-5.json |
| 83956-3 | Social worker Discharge summary | ./2.16.840.1.114222.4.11.1002/83956-3.json |
| 83957-1 | Social worker Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/83957-1.json |
| 83958-9 | Social worker Emergency department Note | ./2.16.840.1.114222.4.11.1002/83958-9.json |
| 83959-7 | Social worker History and physical note | ./2.16.840.1.114222.4.11.1002/83959-7.json |
| 83960-5 | Social worker Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/83960-5.json |
| 83961-3 | Social worker Patient's home Discharge summary | ./2.16.840.1.114222.4.11.1002/83961-3.json |
| 83962-1 | Social worker Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83962-1.json |
| 83963-9 | Social worker Patient's home Note | ./2.16.840.1.114222.4.11.1002/83963-9.json |
| 83964-7 | Social worker Patient's home Referral note | ./2.16.840.1.114222.4.11.1002/83964-7.json |
| 83965-4 | Social worker Hospital Note | ./2.16.840.1.114222.4.11.1002/83965-4.json |
| 83967-0 | Social worker Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/83967-0.json |
| 83968-8 | Social worker Long term care facility Discharge summary | ./2.16.840.1.114222.4.11.1002/83968-8.json |
| 83969-6 | Social worker Long term care facility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83969-6.json |
| 83970-4 | Social worker Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83970-4.json |
| 83971-2 | Social worker Long term care facility Referral note | ./2.16.840.1.114222.4.11.1002/83971-2.json |
| 83972-0 | Social worker Long term care facility Respite note | ./2.16.840.1.114222.4.11.1002/83972-0.json |
| 83973-8 | Social worker Long term care facility Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83973-8.json |
| 83975-3 | Social worker Outpatient Group counseling note | ./2.16.840.1.114222.4.11.1002/83975-3.json |
| 83976-1 | Social worker Outpatient Note | ./2.16.840.1.114222.4.11.1002/83976-1.json |
| 83977-9 | Social worker Outreach note | ./2.16.840.1.114222.4.11.1002/83977-9.json |
| 83978-7 | Social worker Respite note | ./2.16.840.1.114222.4.11.1002/83978-7.json |
| 83979-5 | Social worker Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83979-5.json |
| 83981-1 | Social worker Transfer summary note | ./2.16.840.1.114222.4.11.1002/83981-1.json |
| 83982-9 | Social worker Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/83982-9.json |
| 83984-5 | Speech-language pathology Consult note | ./2.16.840.1.114222.4.11.1002/83984-5.json |
| 83985-2 | Speech-language pathology Long term care facility Note | ./2.16.840.1.114222.4.11.1002/83985-2.json |
| 83986-0 | Speech-language pathology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/83986-0.json |
| 83987-8 | Speech-language pathology Team Note | ./2.16.840.1.114222.4.11.1002/83987-8.json |
| 83988-6 | Speech-language pathology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/83988-6.json |
| 83989-4 | Spinal cord injury medicine Admission evaluation note | ./2.16.840.1.114222.4.11.1002/83989-4.json |
| 83990-2 | Spinal cord injury medicine Annual evaluation note | ./2.16.840.1.114222.4.11.1002/83990-2.json |
| 83991-0 | Spinal cord injury medicine Conference note | ./2.16.840.1.114222.4.11.1002/83991-0.json |
| 83992-8 | Spinal cord injury medicine Consult note | ./2.16.840.1.114222.4.11.1002/83992-8.json |
| 83993-6 | Spinal cord injury medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/83993-6.json |
| 83994-4 | Spinal cord injury medicine Education note | ./2.16.840.1.114222.4.11.1002/83994-4.json |
| 83995-1 | Spinal cord injury medicine History and physical note | ./2.16.840.1.114222.4.11.1002/83995-1.json |
| 83996-9 | Spinal cord injury medicine Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/83996-9.json |
| 83997-7 | Spinal cord injury medicine Patient's home Note | ./2.16.840.1.114222.4.11.1002/83997-7.json |
| 83998-5 | Spinal cord injury medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/83998-5.json |
| 83999-3 | Spinal cord injury medicine Hospital Note | ./2.16.840.1.114222.4.11.1002/83999-3.json |
| 84000-9 | Spinal cord injury medicine Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/84000-9.json |
| 84001-7 | Spinal cord injury medicine Note | ./2.16.840.1.114222.4.11.1002/84001-7.json |
| 84002-5 | Spinal cord injury medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/84002-5.json |
| 84003-3 | Spinal cord injury medicine Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/84003-3.json |
| 84004-1 | Spinal cord injury medicine Outpatient Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84004-1.json |
| 84005-8 | Spinal cord injury medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/84005-8.json |
| 84006-6 | Spinal cord injury medicine procedure note | ./2.16.840.1.114222.4.11.1002/84006-6.json |
| 84007-4 | Spinal cord injury medicine Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84007-4.json |
| 84008-2 | Spinal cord injury medicine Team Note | ./2.16.840.1.114222.4.11.1002/84008-2.json |
| 84009-0 | Spinal cord injury medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/84009-0.json |
| 84010-8 | Spinal cord injury medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84010-8.json |
| 84011-6 | Spinal cord injury medicine Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/84011-6.json |
| 84012-4 | Surgery Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84012-4.json |
| 84013-2 | Surgery Intensive care unit Discharge summary | ./2.16.840.1.114222.4.11.1002/84013-2.json |
| 84014-0 | Surgery Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/84014-0.json |
| 84015-7 | Surgery Intensive care unit procedure note | ./2.16.840.1.114222.4.11.1002/84015-7.json |
| 84016-5 | Surgery Intensive care unit Transfer summary note | ./2.16.840.1.114222.4.11.1002/84016-5.json |
| 84017-3 | Surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/84017-3.json |
| 84018-1 | Surgery Outpatient Discharge summary | ./2.16.840.1.114222.4.11.1002/84018-1.json |
| 84019-9 | Surgery Outpatient History and physical note | ./2.16.840.1.114222.4.11.1002/84019-9.json |
| 84020-7 | Surgery Outpatient Surgical operation note | ./2.16.840.1.114222.4.11.1002/84020-7.json |
| 84021-5 | Surgery Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/84021-5.json |
| 84022-3 | Surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84022-3.json |
| 84023-1 | Team Conference note | ./2.16.840.1.114222.4.11.1002/84023-1.json |
| 84024-9 | Team Discharge summary | ./2.16.840.1.114222.4.11.1002/84024-9.json |
| 84025-6 | Team Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/84025-6.json |
| 84026-4 | Team Patient's home Conference note | ./2.16.840.1.114222.4.11.1002/84026-4.json |
| 84027-2 | Team Patient's home Note | ./2.16.840.1.114222.4.11.1002/84027-2.json |
| 84028-0 | Team Letter | ./2.16.840.1.114222.4.11.1002/84028-0.json |
| 84029-8 | Team Long term care facility Conference note | ./2.16.840.1.114222.4.11.1002/84029-8.json |
| 84030-6 | Team Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84030-6.json |
| 84031-4 | Team Long term care facility Referral note | ./2.16.840.1.114222.4.11.1002/84031-4.json |
| 84032-2 | Team Outpatient Note | ./2.16.840.1.114222.4.11.1002/84032-2.json |
| 84033-0 | Team Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84033-0.json |
| 84034-8 | Team Plan of care note | ./2.16.840.1.114222.4.11.1002/84034-8.json |
| 84035-5 | Transplant surgery Consult note | ./2.16.840.1.114222.4.11.1002/84035-5.json |
| 84036-3 | Transplant surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/84036-3.json |
| 84037-1 | Transplant surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84037-1.json |
| 84038-9 | Urology Administrative note | ./2.16.840.1.114222.4.11.1002/84038-9.json |
| 84039-7 | Urology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84039-7.json |
| 84040-5 | Urology Discharge summary | ./2.16.840.1.114222.4.11.1002/84040-5.json |
| 84041-3 | Urology History and physical note | ./2.16.840.1.114222.4.11.1002/84041-3.json |
| 84042-1 | Urology Hospital Note | ./2.16.840.1.114222.4.11.1002/84042-1.json |
| 84043-9 | Urology Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/84043-9.json |
| 84044-7 | Urology Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/84044-7.json |
| 84045-4 | Urology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84045-4.json |
| 84046-2 | Urology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84046-2.json |
| 84047-0 | Vascular surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84047-0.json |
| 84048-8 | Vascular surgery History and physical note | ./2.16.840.1.114222.4.11.1002/84048-8.json |
| 84049-6 | Vascular surgery Hospital Note | ./2.16.840.1.114222.4.11.1002/84049-6.json |
| 84050-4 | Vascular surgery Note | ./2.16.840.1.114222.4.11.1002/84050-4.json |
| 84051-2 | Vascular surgery Outpatient Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84051-2.json |
| 84052-0 | Vascular surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84052-0.json |
| 84053-8 | Vascular surgery procedure note | ./2.16.840.1.114222.4.11.1002/84053-8.json |
| 84054-6 | Vascular surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84054-6.json |
| 84055-3 | Ophthalmology Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84055-3.json |
| 84056-1 | Ophthalmology Patient's home Note | ./2.16.840.1.114222.4.11.1002/84056-1.json |
| 84057-9 | Allergy and Immunology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84057-9.json |
| 84058-7 | Anesthesiology Flowsheet | ./2.16.840.1.114222.4.11.1002/84058-7.json |
| 84059-5 | Anesthesiology Hospital Note | ./2.16.840.1.114222.4.11.1002/84059-5.json |
| 84060-3 | Anesthesiology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84060-3.json |
| 84061-1 | Anesthesiology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84061-1.json |
| 84062-9 | Anesthesiology procedure note | ./2.16.840.1.114222.4.11.1002/84062-9.json |
| 84063-7 | Anesthesiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84063-7.json |
| 84064-5 | Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84064-5.json |
| 84065-2 | Audiology Administrative note | ./2.16.840.1.114222.4.11.1002/84065-2.json |
| 84066-0 | Audiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84066-0.json |
| 84067-8 | Blood banking and transfusion medicine Note | ./2.16.840.1.114222.4.11.1002/84067-8.json |
| 84068-6 | Cardiothoracic surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84068-6.json |
| 84069-4 | Multi-specialty program Telehealth Summary note | ./2.16.840.1.114222.4.11.1002/84069-4.json |
| 84070-2 | Multi-specialty program Telehealth Plan of care note | ./2.16.840.1.114222.4.11.1002/84070-2.json |
| 84071-0 | Chiropractic medicine Consult note | ./2.16.840.1.114222.4.11.1002/84071-0.json |
| 84072-8 | Chiropractic medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84072-8.json |
| 84073-6 | Colon and rectal surgery Note | ./2.16.840.1.114222.4.11.1002/84073-6.json |
| 84074-4 | Colon and rectal surgery procedure note | ./2.16.840.1.114222.4.11.1002/84074-4.json |
| 84075-1 | Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84075-1.json |
| 84076-9 | Dermatology Administrative note | ./2.16.840.1.114222.4.11.1002/84076-9.json |
| 84077-7 | Dermatology History and physical note | ./2.16.840.1.114222.4.11.1002/84077-7.json |
| 84078-5 | Dermatology Hospital Note | ./2.16.840.1.114222.4.11.1002/84078-5.json |
| 84079-3 | Dermatology Surgical operation note | ./2.16.840.1.114222.4.11.1002/84079-3.json |
| 84080-1 | Dermatology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84080-1.json |
| 84081-9 | Dermatology Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/84081-9.json |
| 84082-7 | Dermatology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84082-7.json |
| 84083-5 | Dermatology Transfer summary note | ./2.16.840.1.114222.4.11.1002/84083-5.json |
| 84084-3 | Diabetology Case manager Note | ./2.16.840.1.114222.4.11.1002/84084-3.json |
| 84085-0 | Diabetology Group counseling note | ./2.16.840.1.114222.4.11.1002/84085-0.json |
| 84086-8 | Diabetology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84086-8.json |
| 84087-6 | Diabetology Hospital Note | ./2.16.840.1.114222.4.11.1002/84087-6.json |
| 84088-4 | Diabetology Medication management note | ./2.16.840.1.114222.4.11.1002/84088-4.json |
| 84089-2 | Diabetology Outpatient Group counseling note | ./2.16.840.1.114222.4.11.1002/84089-2.json |
| 84090-0 | Diabetology Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84090-0.json |
| 84091-8 | Diabetology Outpatient Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84091-8.json |
| 84092-6 | Diabetology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84092-6.json |
| 84093-4 | Diabetology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84093-4.json |
| 84094-2 | Diabetology Plan of care note | ./2.16.840.1.114222.4.11.1002/84094-2.json |
| 84095-9 | Do not resuscitate | ./2.16.840.1.114222.4.11.1002/84095-9.json |
| 84096-7 | Emergency medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84096-7.json |
| 84097-5 | Endocrinology History and physical note | ./2.16.840.1.114222.4.11.1002/84097-5.json |
| 84098-3 | Endocrinology Hospital Note | ./2.16.840.1.114222.4.11.1002/84098-3.json |
| 84099-1 | Endocrinology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84099-1.json |
| 84100-7 | Endocrinology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84100-7.json |
| 84101-5 | Gastroenterology Administrative note | ./2.16.840.1.114222.4.11.1002/84101-5.json |
| 84102-3 | Gastroenterology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84102-3.json |
| 84103-1 | Gastroenterology Clinical nurse specialist Note | ./2.16.840.1.114222.4.11.1002/84103-1.json |
| 84104-9 | Gastroenterology History and physical note | ./2.16.840.1.114222.4.11.1002/84104-9.json |
| 84105-6 | Gastroenterology Hospital Note | ./2.16.840.1.114222.4.11.1002/84105-6.json |
| 84106-4 | Gastroenterology Letter | ./2.16.840.1.114222.4.11.1002/84106-4.json |
| 84107-2 | Gastroenterology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84107-2.json |
| 84108-0 | Gastroenterology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84108-0.json |
| 84109-8 | Geriatric medicine Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84109-8.json |
| 84110-6 | Geriatric medicine Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84110-6.json |
| 84111-4 | Geriatric medicine Case manager Note | ./2.16.840.1.114222.4.11.1002/84111-4.json |
| 84112-2 | Geriatric medicine Group counseling note | ./2.16.840.1.114222.4.11.1002/84112-2.json |
| 84113-0 | Geriatric medicine Patient's home Note | ./2.16.840.1.114222.4.11.1002/84113-0.json |
| 84114-8 | Geriatric medicine Hospital Note | ./2.16.840.1.114222.4.11.1002/84114-8.json |
| 84115-5 | Geriatric medicine Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/84115-5.json |
| 84116-3 | Geriatric medicine Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84116-3.json |
| 84117-1 | Geriatric medicine Long term care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/84117-1.json |
| 84118-9 | Geriatric medicine Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84118-9.json |
| 84119-7 | Geriatric medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/84119-7.json |
| 84120-5 | Geriatric medicine Pharmacist Note | ./2.16.840.1.114222.4.11.1002/84120-5.json |
| 84121-3 | Geriatric medicine Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84121-3.json |
| 84122-1 | Geriatric medicine Team Note | ./2.16.840.1.114222.4.11.1002/84122-1.json |
| 84123-9 | Geriatric medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84123-9.json |
| 84124-7 | Geriatric medicine Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/84124-7.json |
| 84125-4 | Surgery of the hand Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84125-4.json |
| 84126-2 | Surgery of the hand Consult note | ./2.16.840.1.114222.4.11.1002/84126-2.json |
| 84127-0 | Surgery of the hand Hospital Note | ./2.16.840.1.114222.4.11.1002/84127-0.json |
| 84128-8 | Surgery of the hand Note | ./2.16.840.1.114222.4.11.1002/84128-8.json |
| 84129-6 | Surgery of the hand Outpatient Note | ./2.16.840.1.114222.4.11.1002/84129-6.json |
| 84130-4 | Primary care Patient's home Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84130-4.json |
| 84131-2 | Primary care Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/84131-2.json |
| 84132-0 | Primary care Patient's home Discharge summary | ./2.16.840.1.114222.4.11.1002/84132-0.json |
| 84133-8 | Primary care Patient's home Medication management note | ./2.16.840.1.114222.4.11.1002/84133-8.json |
| 84134-6 | Primary care Patient's home Note | ./2.16.840.1.114222.4.11.1002/84134-6.json |
| 84135-3 | Primary care Interdisciplinary Patient's home Plan of care note | ./2.16.840.1.114222.4.11.1002/84135-3.json |
| 84136-1 | Primary care Patient's home Plan of care note | ./2.16.840.1.114222.4.11.1002/84136-1.json |
| 84137-9 | Hematology+Medical oncology Pharmacist Note | ./2.16.840.1.114222.4.11.1002/84137-9.json |
| 84138-7 | Hematology+Medical oncology Conference note | ./2.16.840.1.114222.4.11.1002/84138-7.json |
| 84139-5 | Hematology+Medical oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/84139-5.json |
| 84140-3 | Hematology+Medical oncology Education note | ./2.16.840.1.114222.4.11.1002/84140-3.json |
| 84141-1 | Hematology+Medical oncology Group counseling note | ./2.16.840.1.114222.4.11.1002/84141-1.json |
| 84142-9 | Hematology+Medical oncology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/84142-9.json |
| 84143-7 | Hematology+Medical oncology Hospital Note | ./2.16.840.1.114222.4.11.1002/84143-7.json |
| 84144-5 | Hematology+Medical oncology Medication management note | ./2.16.840.1.114222.4.11.1002/84144-5.json |
| 84145-2 | Hematology+Medical oncology Outpatient Consult note | ./2.16.840.1.114222.4.11.1002/84145-2.json |
| 84146-0 | Hematology+Medical oncology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84146-0.json |
| 84147-8 | Hematology+Medical oncology procedure note | ./2.16.840.1.114222.4.11.1002/84147-8.json |
| 84148-6 | Hematology+Medical oncology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84148-6.json |
| 84149-4 | Hematology+Medical oncology Team Note | ./2.16.840.1.114222.4.11.1002/84149-4.json |
| 84150-2 | Hematology+Medical oncology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84150-2.json |
| 84151-0 | Hematology+Medical oncology Plan of care note | ./2.16.840.1.114222.4.11.1002/84151-0.json |
| 84152-8 | Hepatology Consult note | ./2.16.840.1.114222.4.11.1002/84152-8.json |
| 84153-6 | Hepatology Counseling note | ./2.16.840.1.114222.4.11.1002/84153-6.json |
| 84154-4 | Hepatology Education note | ./2.16.840.1.114222.4.11.1002/84154-4.json |
| 84155-1 | Hepatology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84155-1.json |
| 84156-9 | Hepatology Note | ./2.16.840.1.114222.4.11.1002/84156-9.json |
| 84157-7 | Hepatology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84157-7.json |
| 84158-5 | Hepatology procedure note | ./2.16.840.1.114222.4.11.1002/84158-5.json |
| 84159-3 | Hepatology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84159-3.json |
| 84160-1 | Hepatology Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/84160-1.json |
| 84161-9 | Patient's home Administrative note | ./2.16.840.1.114222.4.11.1002/84161-9.json |
| 84162-7 | Patient's home Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84162-7.json |
| 84163-5 | Interdisciplinary Patient's home Note | ./2.16.840.1.114222.4.11.1002/84163-5.json |
| 84164-3 | Interdisciplinary Patient's home Plan of care note | ./2.16.840.1.114222.4.11.1002/84164-3.json |
| 84165-0 | Patient's home Plan of care note | ./2.16.840.1.114222.4.11.1002/84165-0.json |
| 84166-8 | Infectious disease Counseling note | ./2.16.840.1.114222.4.11.1002/84166-8.json |
| 84167-6 | Infectious disease Group counseling note | ./2.16.840.1.114222.4.11.1002/84167-6.json |
| 84168-4 | Infectious disease Hospital Note | ./2.16.840.1.114222.4.11.1002/84168-4.json |
| 84169-2 | Infectious disease Outpatient Note | ./2.16.840.1.114222.4.11.1002/84169-2.json |
| 84170-0 | Infectious disease Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84170-0.json |
| 84171-8 | Infectious disease Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84171-8.json |
| 84172-6 | Interdisciplinary Hospital Plan of care note | ./2.16.840.1.114222.4.11.1002/84172-6.json |
| 84173-4 | Interventional cardiology Consult note | ./2.16.840.1.114222.4.11.1002/84173-4.json |
| 84174-2 | Interventional cardiology Note | ./2.16.840.1.114222.4.11.1002/84174-2.json |
| 84175-9 | Interventional cardiology Surgical operation note | ./2.16.840.1.114222.4.11.1002/84175-9.json |
| 84176-7 | Interventional cardiology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84176-7.json |
| 84177-5 | Interventional cardiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84177-5.json |
| 84178-3 | Interventional radiology Note | ./2.16.840.1.114222.4.11.1002/84178-3.json |
| 84179-1 | Kinesiotherapy Discharge summary | ./2.16.840.1.114222.4.11.1002/84179-1.json |
| 84180-9 | Kinesiotherapy Education note | ./2.16.840.1.114222.4.11.1002/84180-9.json |
| 84181-7 | Kinesiotherapy Patient's home Note | ./2.16.840.1.114222.4.11.1002/84181-7.json |
| 84182-5 | Kinesiotherapy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84182-5.json |
| 84183-3 | Kinesiotherapy Long term care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/84183-3.json |
| 84184-1 | Kinesiotherapy Outpatient Note | ./2.16.840.1.114222.4.11.1002/84184-1.json |
| 84185-8 | Kinesiotherapy Plan of care note | ./2.16.840.1.114222.4.11.1002/84185-8.json |
| 84186-6 | Interdisciplinary Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84186-6.json |
| 84187-4 | Interdisciplinary Long term care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/84187-4.json |
| 84188-2 | Licensed practical nurse Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84188-2.json |
| 84189-0 | Licensed practical nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/84189-0.json |
| 84190-8 | Medical toxicology Consult note | ./2.16.840.1.114222.4.11.1002/84190-8.json |
| 84191-6 | Medical toxicology Note | ./2.16.840.1.114222.4.11.1002/84191-6.json |
| 84192-4 | Mental health Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84192-4.json |
| 84193-2 | Mental health Conference note | ./2.16.840.1.114222.4.11.1002/84193-2.json |
| 84194-0 | Mental health Agreement | ./2.16.840.1.114222.4.11.1002/84194-0.json |
| 84195-7 | Mental health Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/84195-7.json |
| 84196-5 | Mental health Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/84196-5.json |
| 84197-3 | Mental health Custodial care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/84197-3.json |
| 84198-1 | Mental health Emergency department Note | ./2.16.840.1.114222.4.11.1002/84198-1.json |
| 84199-9 | Mental health Patient's home Note | ./2.16.840.1.114222.4.11.1002/84199-9.json |
| 84200-5 | Mental health Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84200-5.json |
| 84201-3 | Mental health Hospital Group counseling note | ./2.16.840.1.114222.4.11.1002/84201-3.json |
| 84202-1 | Mental health Hospital Note | ./2.16.840.1.114222.4.11.1002/84202-1.json |
| 84203-9 | Mental health Hospital Plan of care note | ./2.16.840.1.114222.4.11.1002/84203-9.json |
| 84204-7 | Mental health Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/84204-7.json |
| 84205-4 | Mental health Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84205-4.json |
| 84206-2 | Mental health Observation unit Note | ./2.16.840.1.114222.4.11.1002/84206-2.json |
| 84207-0 | Mental health Outpatient Group counseling note | ./2.16.840.1.114222.4.11.1002/84207-0.json |
| 84208-8 | Mental health Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84208-8.json |
| 84209-6 | Mental health Outpatient Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84209-6.json |
| 84210-4 | Mental health Outpatient Plan of care note | ./2.16.840.1.114222.4.11.1002/84210-4.json |
| 84211-2 | Mental health Outreach note | ./2.16.840.1.114222.4.11.1002/84211-2.json |
| 84212-0 | Mental health Team Conference note | ./2.16.840.1.114222.4.11.1002/84212-0.json |
| 84213-8 | Mental health Team Consult note | ./2.16.840.1.114222.4.11.1002/84213-8.json |
| 84214-6 | Mental health Team Note | ./2.16.840.1.114222.4.11.1002/84214-6.json |
| 84215-3 | Mental health Telehealth Note | ./2.16.840.1.114222.4.11.1002/84215-3.json |
| 84216-1 | Mental health Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/84216-1.json |
| 84217-9 | Mental health Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/84217-9.json |
| 84218-7 | Mental health Triage note | ./2.16.840.1.114222.4.11.1002/84218-7.json |
| 84219-5 | Nephrology Patient's home Note | ./2.16.840.1.114222.4.11.1002/84219-5.json |
| 84220-3 | Nephrology Hospital Note | ./2.16.840.1.114222.4.11.1002/84220-3.json |
| 84221-1 | Nephrology Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/84221-1.json |
| 84222-9 | Nephrology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84222-9.json |
| 84223-7 | Nephrology Team Note | ./2.16.840.1.114222.4.11.1002/84223-7.json |
| 84224-5 | Nephrology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84224-5.json |
| 84225-2 | Neurology Administrative note | ./2.16.840.1.114222.4.11.1002/84225-2.json |
| 84226-0 | Neurology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84226-0.json |
| 84227-8 | Neurology Hospital Note | ./2.16.840.1.114222.4.11.1002/84227-8.json |
| 84228-6 | Neurology Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/84228-6.json |
| 84229-4 | Neurology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84229-4.json |
| 84230-2 | Neurology Team Note | ./2.16.840.1.114222.4.11.1002/84230-2.json |
| 84231-0 | Neurology Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/84231-0.json |
| 84232-8 | Neurology Telehealth Note | ./2.16.840.1.114222.4.11.1002/84232-8.json |
| 84233-6 | Neurology Telehealth Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84233-6.json |
| 84234-4 | Neurology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84234-4.json |
| 84235-1 | Neurological surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84235-1.json |
| 84236-9 | Neurological surgery Hospital Note | ./2.16.840.1.114222.4.11.1002/84236-9.json |
| 84237-7 | Neurological surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/84237-7.json |
| 84238-5 | Neurological surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84238-5.json |
| 84239-3 | Neurological surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84239-3.json |
| 84240-1 | Nurse Administrative note | ./2.16.840.1.114222.4.11.1002/84240-1.json |
| 84241-9 | Nurse Consult note | ./2.16.840.1.114222.4.11.1002/84241-9.json |
| 84242-7 | Nurse Crisis intervention note | ./2.16.840.1.114222.4.11.1002/84242-7.json |
| 84243-5 | Nurse Intensive care unit Flowsheet | ./2.16.840.1.114222.4.11.1002/84243-5.json |
| 84244-3 | Nurse Intensive care unit Plan of care note | ./2.16.840.1.114222.4.11.1002/84244-3.json |
| 84245-0 | Nurse Diagram | ./2.16.840.1.114222.4.11.1002/84245-0.json |
| 84246-8 | Nurse Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/84246-8.json |
| 84247-6 | Nurse Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/84247-6.json |
| 84248-4 | Nurse Emergency department Discharge summary | ./2.16.840.1.114222.4.11.1002/84248-4.json |
| 84249-2 | Nurse Emergency department Triage note | ./2.16.840.1.114222.4.11.1002/84249-2.json |
| 84250-0 | Nurse Group counseling note | ./2.16.840.1.114222.4.11.1002/84250-0.json |
| 84251-8 | Nurse Patient's home Note | ./2.16.840.1.114222.4.11.1002/84251-8.json |
| 84252-6 | Nurse Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84252-6.json |
| 84253-4 | Nurse Hospital Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84253-4.json |
| 84254-2 | Nurse Hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/84254-2.json |
| 84255-9 | Nurse Long term care facility Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84255-9.json |
| 84256-7 | Nurse Long term care facility Annual evaluation note | ./2.16.840.1.114222.4.11.1002/84256-7.json |
| 84257-5 | Nurse Long term care facility Discharge summary | ./2.16.840.1.114222.4.11.1002/84257-5.json |
| 84258-3 | Nurse Long term care facility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84258-3.json |
| 84259-1 | Nurse Long term care facility Referral note | ./2.16.840.1.114222.4.11.1002/84259-1.json |
| 84260-9 | Nurse Long term care facility Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84260-9.json |
| 84261-7 | Nurse Observation unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84261-7.json |
| 84262-5 | Nurse Observation unit Discharge summary | ./2.16.840.1.114222.4.11.1002/84262-5.json |
| 84263-3 | Nurse Observation unit Note | ./2.16.840.1.114222.4.11.1002/84263-3.json |
| 84264-1 | Nurse Surgical operation note | ./2.16.840.1.114222.4.11.1002/84264-1.json |
| 84265-8 | Nurse Outpatient Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/84265-8.json |
| 84266-6 | Nurse Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84266-6.json |
| 84267-4 | Nurse Outpatient Medication management note | ./2.16.840.1.114222.4.11.1002/84267-4.json |
| 84268-2 | Nurse Outpatient Surgical operation note | ./2.16.840.1.114222.4.11.1002/84268-2.json |
| 84269-0 | Nurse Outpatient Triage note | ./2.16.840.1.114222.4.11.1002/84269-0.json |
| 84270-8 | Nurse Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84270-8.json |
| 84271-6 | Nurse Referral note | ./2.16.840.1.114222.4.11.1002/84271-6.json |
| 84272-4 | Nurse Respite note | ./2.16.840.1.114222.4.11.1002/84272-4.json |
| 84273-2 | Nurse Summary of death note | ./2.16.840.1.114222.4.11.1002/84273-2.json |
| 84274-0 | Nurse Telehealth Note | ./2.16.840.1.114222.4.11.1002/84274-0.json |
| 84275-7 | Nurse Urgent care center Note | ./2.16.840.1.114222.4.11.1002/84275-7.json |
| 84276-5 | Nurse Urgent care center Triage note | ./2.16.840.1.114222.4.11.1002/84276-5.json |
| 84277-3 | Nutrition and dietetics Administrative note | ./2.16.840.1.114222.4.11.1002/84277-3.json |
| 84278-1 | Nutrition and dietetics Discharge summary | ./2.16.840.1.114222.4.11.1002/84278-1.json |
| 84279-9 | Nutrition and dietetics Group counseling note | ./2.16.840.1.114222.4.11.1002/84279-9.json |
| 84280-7 | Nutrition and dietetics Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/84280-7.json |
| 84281-5 | Nutrition and dietetics Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84281-5.json |
| 84282-3 | Nutrition and dietetics Patient's home Note | ./2.16.840.1.114222.4.11.1002/84282-3.json |
| 84283-1 | Nutrition and dietetics Patient's home Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84283-1.json |
| 84284-9 | Nutrition and dietetics Hospital Note | ./2.16.840.1.114222.4.11.1002/84284-9.json |
| 84285-6 | Nutrition and dietetics Long term care facility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84285-6.json |
| 84286-4 | Nutrition and dietetics Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84286-4.json |
| 84287-2 | Nutrition and dietetics Long term care facility Referral note | ./2.16.840.1.114222.4.11.1002/84287-2.json |
| 84288-0 | Nutrition and dietetics Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84288-0.json |
| 84289-8 | Nutrition and dietetics Outpatient Note | ./2.16.840.1.114222.4.11.1002/84289-8.json |
| 84290-6 | Nutrition and dietetics Outpatient Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84290-6.json |
| 84291-4 | Nutrition and dietetics Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84291-4.json |
| 84292-2 | Nutrition and dietetics Team Consult note | ./2.16.840.1.114222.4.11.1002/84292-2.json |
| 84293-0 | Nutrition and dietetics Team Note | ./2.16.840.1.114222.4.11.1002/84293-0.json |
| 84294-8 | Nutrition and dietetics Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84294-8.json |
| 84295-5 | Nutrition and dietetics Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/84295-5.json |
| 84297-1 | Dose(s) missed since previous visit | ./2.16.840.1.114222.4.11.1002/84297-1.json |
| 84302-9 | Wound care management Nurse Note | ./2.16.840.1.114222.4.11.1002/84302-9.json |
| 84303-7 | Wound care management Consult note | ./2.16.840.1.114222.4.11.1002/84303-7.json |
| 84304-5 | Obstetrics and Gynecology Hospital Note | ./2.16.840.1.114222.4.11.1002/84304-5.json |
| 84305-2 | Obstetrics and Gynecology Administrative note | ./2.16.840.1.114222.4.11.1002/84305-2.json |
| 84306-0 | Vocational rehabilitation Plan of care note | ./2.16.840.1.114222.4.11.1002/84306-0.json |
| 84308-6 | Vocational rehabilitation Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84308-6.json |
| 84309-4 | Vocational rehabilitation Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/84309-4.json |
| 84310-2 | Vocational rehabilitation Discharge summary | ./2.16.840.1.114222.4.11.1002/84310-2.json |
| 84311-0 | Vocational rehabilitation Counseling note | ./2.16.840.1.114222.4.11.1002/84311-0.json |
| 84312-8 | Vocational rehabilitation Consult note | ./2.16.840.1.114222.4.11.1002/84312-8.json |
| 84313-6 | Vocational rehabilitation Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84313-6.json |
| 84314-4 | Physical therapy Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/84314-4.json |
| 84315-1 | Physical therapy Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84315-1.json |
| 84316-9 | Physical therapy Team Note | ./2.16.840.1.114222.4.11.1002/84316-9.json |
| 84317-7 | Physical therapy Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84317-7.json |
| 84318-5 | Physical therapy Outpatient Note | ./2.16.840.1.114222.4.11.1002/84318-5.json |
| 84319-3 | Physical therapy Outpatient Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84319-3.json |
| 84320-1 | Physical therapy Outpatient Education note | ./2.16.840.1.114222.4.11.1002/84320-1.json |
| 84321-9 | Physical therapy Outpatient Discharge summary | ./2.16.840.1.114222.4.11.1002/84321-9.json |
| 84322-7 | Physical therapy Medication management note | ./2.16.840.1.114222.4.11.1002/84322-7.json |
| 84323-5 | Physical therapy Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84323-5.json |
| 84324-3 | Physical therapy Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/84324-3.json |
| 84325-0 | Physical therapy Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/84325-0.json |
| 84326-8 | Physical therapy Hospital Note | ./2.16.840.1.114222.4.11.1002/84326-8.json |
| 84327-6 | Physical therapy Hospital Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84327-6.json |
| 84328-4 | Physical therapy Hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/84328-4.json |
| 84329-2 | Physical therapy Patient's home Note | ./2.16.840.1.114222.4.11.1002/84329-2.json |
| 84330-0 | Physical therapy Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84330-0.json |
| 84331-8 | Physical therapy Discharge summary | ./2.16.840.1.114222.4.11.1002/84331-8.json |
| 84332-6 | Physical therapy Administrative note | ./2.16.840.1.114222.4.11.1002/84332-6.json |
| 84333-4 | Multi-specialty program Nurse Note | ./2.16.840.1.114222.4.11.1002/84333-4.json |
| 84334-2 | Pathology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84334-2.json |
| 84335-9 | Pathology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84335-9.json |
| 84336-7 | Pathology Letter | ./2.16.840.1.114222.4.11.1002/84336-7.json |
| 84337-5 | Pastoral care Plan of care note | ./2.16.840.1.114222.4.11.1002/84337-5.json |
| 84338-3 | Pastoral care Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84338-3.json |
| 84339-1 | Pastoral care Team Note | ./2.16.840.1.114222.4.11.1002/84339-1.json |
| 84340-9 | Pastoral care Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84340-9.json |
| 84341-7 | Pastoral care Outpatient Note | ./2.16.840.1.114222.4.11.1002/84341-7.json |
| 84342-5 | Pastoral care Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84342-5.json |
| 84343-3 | Pastoral care Hospital Note | ./2.16.840.1.114222.4.11.1002/84343-3.json |
| 84344-1 | Pastoral care Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84344-1.json |
| 84345-8 | Pastoral care Patient's home Note | ./2.16.840.1.114222.4.11.1002/84345-8.json |
| 84346-6 | Pastoral care Group counseling note | ./2.16.840.1.114222.4.11.1002/84346-6.json |
| 84347-4 | Pastoral care Education note | ./2.16.840.1.114222.4.11.1002/84347-4.json |
| 84348-2 | Pastoral care Counseling note | ./2.16.840.1.114222.4.11.1002/84348-2.json |
| 84349-0 | Pastoral care Consult note | ./2.16.840.1.114222.4.11.1002/84349-0.json |
| 84350-8 | Palliative care Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84350-8.json |
| 84351-6 | Palliative care Team Note | ./2.16.840.1.114222.4.11.1002/84351-6.json |
| 84352-4 | Palliative care Team Consult note | ./2.16.840.1.114222.4.11.1002/84352-4.json |
| 84353-2 | Palliative care Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84353-2.json |
| 84354-0 | Palliative care Pharmacist Note | ./2.16.840.1.114222.4.11.1002/84354-0.json |
| 84355-7 | Palliative care Outpatient Note | ./2.16.840.1.114222.4.11.1002/84355-7.json |
| 84356-5 | Palliative care Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84356-5.json |
| 84357-3 | Palliative care Patient's home Note | ./2.16.840.1.114222.4.11.1002/84357-3.json |
| 84358-1 | Palliative care Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/84358-1.json |
| 84359-9 | Palliative care Group counseling note | ./2.16.840.1.114222.4.11.1002/84359-9.json |
| 84360-7 | Palliative care Counseling note | ./2.16.840.1.114222.4.11.1002/84360-7.json |
| 84361-5 | Interdisciplinary Outpatient Note | ./2.16.840.1.114222.4.11.1002/84361-5.json |
| 84362-3 | Otolaryngology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84362-3.json |
| 84363-1 | Otolaryngology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84363-1.json |
| 84364-9 | Otolaryngology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84364-9.json |
| 84365-6 | Otolaryngology Hospital Note | ./2.16.840.1.114222.4.11.1002/84365-6.json |
| 84366-4 | Otolaryngology History and physical note | ./2.16.840.1.114222.4.11.1002/84366-4.json |
| 84367-2 | Otolaryngology Discharge summary | ./2.16.840.1.114222.4.11.1002/84367-2.json |
| 84368-0 | Otolaryngology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84368-0.json |
| 84369-8 | Orthotics prosthetics Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84369-8.json |
| 84370-6 | Orthotics prosthetics Outpatient Note | ./2.16.840.1.114222.4.11.1002/84370-6.json |
| 84371-4 | Orthotics prosthetics Patient's home Note | ./2.16.840.1.114222.4.11.1002/84371-4.json |
| 84372-2 | Orthotics prosthetics Education note | ./2.16.840.1.114222.4.11.1002/84372-2.json |
| 84373-0 | Orthopaedic surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84373-0.json |
| 84374-8 | Orthopaedic surgery procedure note | ./2.16.840.1.114222.4.11.1002/84374-8.json |
| 84375-5 | Orthopaedic surgery Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/84375-5.json |
| 84376-3 | Orthopaedic surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/84376-3.json |
| 84377-1 | Orthopaedic surgery Hospital Note | ./2.16.840.1.114222.4.11.1002/84377-1.json |
| 84378-9 | Orthopaedic surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84378-9.json |
| 84379-7 | Oral and Maxillofacial Surgery procedure note | ./2.16.840.1.114222.4.11.1002/84379-7.json |
| 84380-5 | Oral and Maxillofacial Surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84380-5.json |
| 84381-3 | Oral and Maxillofacial Surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/84381-3.json |
| 84382-1 | Oral and Maxillofacial Surgery Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84382-1.json |
| 84383-9 | Optometry Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84383-9.json |
| 84384-7 | Obstetrics and Gynecology Outpatient Note | ./2.16.840.1.114222.4.11.1002/84384-7.json |
| 84385-4 | Obstetrics and Gynecology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/84385-4.json |
| 84386-2 | Obstetrics and Gynecology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84386-2.json |
| 84387-0 | Observation unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84387-0.json |
| 84388-8 | Occupational medicine Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84388-8.json |
| 84389-6 | Occupational medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/84389-6.json |
| 84390-4 | Occupational medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/84390-4.json |
| 84391-2 | Occupational medicine procedure note | ./2.16.840.1.114222.4.11.1002/84391-2.json |
| 84392-0 | Occupational medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84392-0.json |
| 84393-8 | Occupational therapy Discharge summary | ./2.16.840.1.114222.4.11.1002/84393-8.json |
| 84394-6 | Occupational therapy Patient's home Consult note | ./2.16.840.1.114222.4.11.1002/84394-6.json |
| 84395-3 | Occupational therapy Patient's home Initial evaluation note | ./2.16.840.1.114222.4.11.1002/84395-3.json |
| 84396-1 | Occupational therapy Patient's home Note | ./2.16.840.1.114222.4.11.1002/84396-1.json |
| 84397-9 | Occupational therapy Hospital Note | ./2.16.840.1.114222.4.11.1002/84397-9.json |
| 84398-7 | Occupational therapy Long term care facility Consult note | ./2.16.840.1.114222.4.11.1002/84398-7.json |
| 84399-5 | Occupational therapy Long term care facility Note | ./2.16.840.1.114222.4.11.1002/84399-5.json |
| 84400-1 | Occupational therapy Outpatient Note | ./2.16.840.1.114222.4.11.1002/84400-1.json |
| 84401-9 | Occupational therapy Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84401-9.json |
| 84402-7 | Occupational therapy Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84402-7.json |
| 84403-5 | Multi-specialty program Case manager Note | ./2.16.840.1.114222.4.11.1002/84403-5.json |
| 84404-3 | Multi-specialty program Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84404-3.json |
| 84405-0 | Ophthalmology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/84405-0.json |
| 84406-8 | Ophthalmology Diagram | ./2.16.840.1.114222.4.11.1002/84406-8.json |
| 84407-6 | Ophthalmology Hospital Note | ./2.16.840.1.114222.4.11.1002/84407-6.json |
| 84408-4 | Ophthalmology Outpatient procedure note | ./2.16.840.1.114222.4.11.1002/84408-4.json |
| 84409-2 | Ophthalmology Technician Note | ./2.16.840.1.114222.4.11.1002/84409-2.json |
| 844-1 | A1 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/844-1.json |
| 84410-0 | Ophthalmology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/84410-0.json |
| 84411-8 | Optometry Outpatient Note | ./2.16.840.1.114222.4.11.1002/84411-8.json |
| 84412-6 | Ophthalmology Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/84412-6.json |
| 84430-8 | Occupational therapy Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/84430-8.json |
| 84431-6 | Optometry Technician Note | ./2.16.840.1.114222.4.11.1002/84431-6.json |
| 84432-4 | Dimensional Change Card Sort Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84432-4.json |
| 84433-2 | Flanker Inhibitory Control and Attention Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84433-2.json |
| 84434-0 | List Sorting Working Memory Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84434-0.json |
| 84435-7 | Oral Reading Recognition Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84435-7.json |
| 84436-5 | Pattern Comparison Processing Speed Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84436-5.json |
| 84437-3 | Picture Sequence Memory Test [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84437-3.json |
| 84438-1 | Picture Vocabulary Test - English [NIH Toolbox] | ./2.16.840.1.114222.4.11.1002/84438-1.json |
| 84772-3 | Total score [BSDS] | ./2.16.840.1.114222.4.11.1002/84772-3.json |
| 84773-1 | Total score [MDQ] | ./2.16.840.1.114222.4.11.1002/84773-1.json |
| 84871-3 | Epstein Barr virus capsid p18 IgG Ab [Presence] in Serum by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/84871-3.json |
| 84872-1 | Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/84872-1.json |
| 84873-9 | Myelin oligodendrocyte glycoprotein IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84873-9.json |
| 84912-5 | Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/84912-5.json |
| 84913-3 | Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84913-3.json |
| 84914-1 | Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84914-1.json |
| 84915-8 | Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84915-8.json |
| 84916-6 | Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84916-6.json |
| 84917-4 | Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/84917-4.json |
| 84918-2 | Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/84918-2.json |
| 84919-0 | Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH | ./2.16.840.1.114222.4.11.1002/84919-0.json |
| 84920-8 | Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84920-8.json |
| 84921-6 | Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84921-6.json |
| 84922-4 | Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/84922-4.json |
| 84923-2 | PCA-1 Ab [Units/volume] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/84923-2.json |
| 84924-0 | PCA-1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84924-0.json |
| 84925-7 | PCA-2 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84925-7.json |
| 84926-5 | PCA-Tr Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84926-5.json |
| 84927-3 | Glial nuclear type 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84927-3.json |
| 84928-1 | NMDAR subunit 1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84928-1.json |
| 84929-9 | AMPAR1 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84929-9.json |
| 84930-7 | AMPAR2 Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84930-7.json |
| 84931-5 | GABABR Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/84931-5.json |
| 85039-6 | JAK2 gene.p.Val617Phe mutant/Normal in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85039-6.json |
| 85040-4 | CT Unspecified body region 3D printed model | ./2.16.840.1.114222.4.11.1002/85040-4.json |
| 85041-2 | MR Unspecified body region 3D printed model | ./2.16.840.1.114222.4.11.1002/85041-2.json |
| 85043-8 | ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85043-8.json |
| 85045-3 | Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85045-3.json |
| 85046-1 | AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85046-1.json |
| 85047-9 | MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85047-9.json |
| 85048-7 | Micafungin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/85048-7.json |
| 85049-5 | ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85049-5.json |
| 85050-3 | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85050-3.json |
| 85051-1 | Telavancin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/85051-1.json |
| 85052-9 | Ceftobiprole [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/85052-9.json |
| 85053-7 | MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient strip | ./2.16.840.1.114222.4.11.1002/85053-7.json |
| 85065-1 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose follitropin | ./2.16.840.1.114222.4.11.1002/85065-1.json |
| 85066-9 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose lutropin | ./2.16.840.1.114222.4.11.1002/85066-9.json |
| 85067-7 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose gonadotropin releasing hormone | ./2.16.840.1.114222.4.11.1002/85067-7.json |
| 85068-5 | Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose dexamethasone | ./2.16.840.1.114222.4.11.1002/85068-5.json |
| 85078-4 | Occupation industry [Type] | ./2.16.840.1.114222.4.11.1002/85078-4.json |
| 85079-2 | Other nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85079-2.json |
| 850-8 | A1 B Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/850-8.json |
| 85080-0 | Nucleolar nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85080-0.json |
| 85081-8 | Multiple nuclear dots nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85081-8.json |
| 85082-6 | Nuclear membrane pores nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85082-6.json |
| 85083-4 | Homogeneous nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85083-4.json |
| 85084-2 | Coarse speckled nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85084-2.json |
| 85085-9 | Centrosomal nuclear IgG pattern [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85085-9.json |
| 85086-7 | Elastase IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85086-7.json |
| 85087-5 | Hexanoate (C6:0) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/85087-5.json |
| 85091-7 | HBA2 gene alpha 3.7kb triplication [Presence] in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85091-7.json |
| 85093-3 | Crystal casts [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/85093-3.json |
| 85095-8 | D-3-phosphoglycerate dehydrogenase IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/85095-8.json |
| 85096-6 | Myoglobin casts [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/85096-6.json |
| 85098-2 | Nitisinone [Moles/volume] in DBS by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/85098-2.json |
| 85099-0 | Norescitalopram [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/85099-0.json |
| 85100-6 | FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85100-6.json |
| 85101-4 | BRAF gene p.Val600Glu [Presence] in Bone marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85101-4.json |
| 85147-7 | PD-L1 by clone 22C3 in Tissue by Immune stain Report | ./2.16.840.1.114222.4.11.1002/85147-7.json |
| 85148-5 | PD-L1 by clone 28-8 in Tissue by Immune stain Report | ./2.16.840.1.114222.4.11.1002/85148-5.json |
| 85149-3 | PD-L1 by clone SP142 in Tissue by Immune stain Report | ./2.16.840.1.114222.4.11.1002/85149-3.json |
| 85151-9 | XR Bone age | ./2.16.840.1.114222.4.11.1002/85151-9.json |
| 85152-7 | Employment status of family member | ./2.16.840.1.114222.4.11.1002/85152-7.json |
| 85153-5 | Pharmacology Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85153-5.json |
| 85154-3 | Pharmacology Discharge summary | ./2.16.840.1.114222.4.11.1002/85154-3.json |
| 85155-0 | Pharmacology Evaluation and management of hyperlipidemia note | ./2.16.840.1.114222.4.11.1002/85155-0.json |
| 85156-8 | Pharmacology Evaluation and management of hypertension note | ./2.16.840.1.114222.4.11.1002/85156-8.json |
| 85157-6 | Pharmacology Hospital Note | ./2.16.840.1.114222.4.11.1002/85157-6.json |
| 85158-4 | Pharmacology Letter | ./2.16.840.1.114222.4.11.1002/85158-4.json |
| 85159-2 | Pharmacology Long term care facility Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85159-2.json |
| 85160-0 | Pharmacology Long term care facility Medication management note | ./2.16.840.1.114222.4.11.1002/85160-0.json |
| 85161-8 | Pharmacology Long term care facility Note | ./2.16.840.1.114222.4.11.1002/85161-8.json |
| 85162-6 | Pharmacology Nurse Outpatient Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/85162-6.json |
| 85163-4 | Pharmacology Outpatient Counseling note | ./2.16.840.1.114222.4.11.1002/85163-4.json |
| 85164-2 | Pharmacology Outpatient Evaluation and management of anticoagulation note | ./2.16.840.1.114222.4.11.1002/85164-2.json |
| 85165-9 | Pharmacology Outpatient Evaluation and management of hyperlipidemia note | ./2.16.840.1.114222.4.11.1002/85165-9.json |
| 85166-7 | Pharmacology Outpatient Medication management note | ./2.16.840.1.114222.4.11.1002/85166-7.json |
| 85167-5 | Pharmacology Patient's home Medication management note | ./2.16.840.1.114222.4.11.1002/85167-5.json |
| 85168-3 | Pharmacology Patient's home Note | ./2.16.840.1.114222.4.11.1002/85168-3.json |
| 85169-1 | Pharmacology Team Note | ./2.16.840.1.114222.4.11.1002/85169-1.json |
| 85170-9 | Pharmacology Technician Note | ./2.16.840.1.114222.4.11.1002/85170-9.json |
| 85171-7 | Custodial care facility Education note | ./2.16.840.1.114222.4.11.1002/85171-7.json |
| 85172-5 | Case manager Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/85172-5.json |
| 85173-3 | Custodial care facility Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85173-3.json |
| 85174-1 | Custodial care facility Consult note | ./2.16.840.1.114222.4.11.1002/85174-1.json |
| 85175-8 | Custodial care facility Counseling note | ./2.16.840.1.114222.4.11.1002/85175-8.json |
| 85176-6 | Custodial care facility Discharge summary | ./2.16.840.1.114222.4.11.1002/85176-6.json |
| 85177-4 | Custodial care facility Administrative note | ./2.16.840.1.114222.4.11.1002/85177-4.json |
| 85178-2 | Custodial care facility Group counseling note | ./2.16.840.1.114222.4.11.1002/85178-2.json |
| 85179-0 | Custodial care facility History and physical note | ./2.16.840.1.114222.4.11.1002/85179-0.json |
| 85180-8 | Custodial care facility Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/85180-8.json |
| 85181-6 | Custodial care facility Transfer summary note | ./2.16.840.1.114222.4.11.1002/85181-6.json |
| 85182-4 | Custodial care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/85182-4.json |
| 85183-2 | Internal medicine Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/85183-2.json |
| 85184-0 | Hospital Transfer summary note | ./2.16.840.1.114222.4.11.1002/85184-0.json |
| 85185-7 | Long term care facility Initial evaluation note | ./2.16.840.1.114222.4.11.1002/85185-7.json |
| 85186-5 | Long term care facility Plan of care note | ./2.16.840.1.114222.4.11.1002/85186-5.json |
| 85187-3 | Long term care facility Transfer summary note | ./2.16.840.1.114222.4.11.1002/85187-3.json |
| 85188-1 | Long term care facility Respite note | ./2.16.840.1.114222.4.11.1002/85188-1.json |
| 85189-9 | Long term care facility Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85189-9.json |
| 85190-7 | Long term care facility Annual evaluation note | ./2.16.840.1.114222.4.11.1002/85190-7.json |
| 85191-5 | Long term care facility Conference note | ./2.16.840.1.114222.4.11.1002/85191-5.json |
| 85192-3 | Long term care facility Discharge summary | ./2.16.840.1.114222.4.11.1002/85192-3.json |
| 85193-1 | Long term care facility Education note | ./2.16.840.1.114222.4.11.1002/85193-1.json |
| 85194-9 | Long term care facility Fall risk assessment note | ./2.16.840.1.114222.4.11.1002/85194-9.json |
| 85195-6 | Long term care facility Group counseling note | ./2.16.840.1.114222.4.11.1002/85195-6.json |
| 85196-4 | Long term care facility History and physical note | ./2.16.840.1.114222.4.11.1002/85196-4.json |
| 85197-2 | Long term care facility Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/85197-2.json |
| 85198-0 | Patient Long term care facility Living will | ./2.16.840.1.114222.4.11.1002/85198-0.json |
| 85199-8 | Long term care facility Referral note | ./2.16.840.1.114222.4.11.1002/85199-8.json |
| 85200-4 | Observation unit Discharge summary | ./2.16.840.1.114222.4.11.1002/85200-4.json |
| 85201-2 | Observation unit History and physical note | ./2.16.840.1.114222.4.11.1002/85201-2.json |
| 85202-0 | Outpatient Evaluation and management of smoking cessation note | ./2.16.840.1.114222.4.11.1002/85202-0.json |
| 85203-8 | Patient's home History and physical note | ./2.16.840.1.114222.4.11.1002/85203-8.json |
| 85204-6 | Patient's home Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/85204-6.json |
| 85205-3 | Patient's home Referral note | ./2.16.840.1.114222.4.11.1002/85205-3.json |
| 85206-1 | Telehealth Initial evaluation note | ./2.16.840.1.114222.4.11.1002/85206-1.json |
| 85207-9 | Telehealth Education note | ./2.16.840.1.114222.4.11.1002/85207-9.json |
| 85208-7 | Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/85208-7.json |
| 85209-5 | Telephone encounter Evaluation and management of smoking cessation note | ./2.16.840.1.114222.4.11.1002/85209-5.json |
| 85210-3 | Urgent care center Triage note | ./2.16.840.1.114222.4.11.1002/85210-3.json |
| 85211-1 | Urgent care center Discharge instructions | ./2.16.840.1.114222.4.11.1002/85211-1.json |
| 85212-9 | Respite note | ./2.16.840.1.114222.4.11.1002/85212-9.json |
| 85213-7 | Outreach note | ./2.16.840.1.114222.4.11.1002/85213-7.json |
| 85214-5 | Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/85214-5.json |
| 85215-2 | Transplant donor evaluation note | ./2.16.840.1.114222.4.11.1002/85215-2.json |
| 85216-0 | Disability examination note | ./2.16.840.1.114222.4.11.1002/85216-0.json |
| 85217-8 | VA Compensation and Pension (C and P) multiple examination | ./2.16.840.1.114222.4.11.1002/85217-8.json |
| 85218-6 | Internal medicine Attending Hospital Note | ./2.16.840.1.114222.4.11.1002/85218-6.json |
| 85219-4 | Internal medicine Intensive care unit Transfer summary note | ./2.16.840.1.114222.4.11.1002/85219-4.json |
| 85220-2 | Acupuncture Note | ./2.16.840.1.114222.4.11.1002/85220-2.json |
| 85221-0 | Acupuncture Nurse Note | ./2.16.840.1.114222.4.11.1002/85221-0.json |
| 85222-8 | Case manager Consult note | ./2.16.840.1.114222.4.11.1002/85222-8.json |
| 85223-6 | Case manager Discharge summary | ./2.16.840.1.114222.4.11.1002/85223-6.json |
| 85224-4 | Case manager Long term care facility Note | ./2.16.840.1.114222.4.11.1002/85224-4.json |
| 85225-1 | Case manager Outpatient Note | ./2.16.840.1.114222.4.11.1002/85225-1.json |
| 85226-9 | Case manager Referral note | ./2.16.840.1.114222.4.11.1002/85226-9.json |
| 85227-7 | Case manager Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85227-7.json |
| 85228-5 | Case manager Plan of care note | ./2.16.840.1.114222.4.11.1002/85228-5.json |
| 85229-3 | Clinical nurse specialist Note | ./2.16.840.1.114222.4.11.1002/85229-3.json |
| 85230-1 | Medical genetics Nurse procedure note | ./2.16.840.1.114222.4.11.1002/85230-1.json |
| 85231-9 | Tumor board Note | ./2.16.840.1.114222.4.11.1002/85231-9.json |
| 85232-7 | Tumor board Consult note | ./2.16.840.1.114222.4.11.1002/85232-7.json |
| 85233-5 | Internal medicine Attending Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85233-5.json |
| 85234-3 | Internal medicine Attending Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85234-3.json |
| 85235-0 | Internal medicine Attending Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/85235-0.json |
| 85236-8 | Internal medicine procedure note | ./2.16.840.1.114222.4.11.1002/85236-8.json |
| 85237-6 | Acupuncture Consult note | ./2.16.840.1.114222.4.11.1002/85237-6.json |
| 85238-4 | Internal medicine Consult note | ./2.16.840.1.114222.4.11.1002/85238-4.json |
| 85239-2 | Internal medicine Intensive care unit Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85239-2.json |
| 85240-0 | Internal medicine Intensive care unit Discharge summary | ./2.16.840.1.114222.4.11.1002/85240-0.json |
| 85241-8 | Internal medicine Intensive care unit Note | ./2.16.840.1.114222.4.11.1002/85241-8.json |
| 85242-6 | Internal medicine Intensive care unit procedure note | ./2.16.840.1.114222.4.11.1002/85242-6.json |
| 85243-4 | Internal medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/85243-4.json |
| 85244-2 | Internal medicine Education note | ./2.16.840.1.114222.4.11.1002/85244-2.json |
| 85245-9 | Internal medicine History and physical note | ./2.16.840.1.114222.4.11.1002/85245-9.json |
| 85246-7 | Internal medicine Intern Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85246-7.json |
| 85247-5 | Internal medicine Long term care facility Note | ./2.16.840.1.114222.4.11.1002/85247-5.json |
| 85248-3 | Internal medicine Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/85248-3.json |
| 85249-1 | Internal medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/85249-1.json |
| 85250-9 | Internal medicine Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85250-9.json |
| 85251-7 | Internal medicine Resident Admission evaluation note | ./2.16.840.1.114222.4.11.1002/85251-7.json |
| 85252-5 | Internal medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85252-5.json |
| 85253-3 | Internal medicine Transfer summary note | ./2.16.840.1.114222.4.11.1002/85253-3.json |
| 85254-1 | Internal medicine Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/85254-1.json |
| 85255-8 | Radiology Administrative note | ./2.16.840.1.114222.4.11.1002/85255-8.json |
| 85256-6 | Radiology Attending Note | ./2.16.840.1.114222.4.11.1002/85256-6.json |
| 85257-4 | Radiology Education note | ./2.16.840.1.114222.4.11.1002/85257-4.json |
| 85258-2 | Radiology Nurse Education note | ./2.16.840.1.114222.4.11.1002/85258-2.json |
| 85259-0 | Radiology Nurse Note | ./2.16.840.1.114222.4.11.1002/85259-0.json |
| 85260-8 | Radiology Nurse procedure note | ./2.16.840.1.114222.4.11.1002/85260-8.json |
| 85261-6 | Radiology procedure note | ./2.16.840.1.114222.4.11.1002/85261-6.json |
| 85262-4 | Radiology Technician Note | ./2.16.840.1.114222.4.11.1002/85262-4.json |
| 85263-2 | Radiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85263-2.json |
| 85264-0 | Infectious disease Transplant candidate evaluation note | ./2.16.840.1.114222.4.11.1002/85264-0.json |
| 85265-7 | Internal medicine Pharmacist Medication management note | ./2.16.840.1.114222.4.11.1002/85265-7.json |
| 85266-5 | Internal medicine Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/85266-5.json |
| 85319-2 | HER2 [Presence] in Breast cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/85319-2.json |
| 85355-6 | PEDV S INDEL strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85355-6.json |
| 85356-4 | PEDV prototype strain S gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85356-4.json |
| 85358-0 | Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/85358-0.json |
| 85359-8 | Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/85359-8.json |
| 85360-6 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/85360-6.json |
| 85361-4 | HIV 1+2 RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85361-4.json |
| 85362-2 | Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85362-2.json |
| 85363-0 | 21-Hydroxylase Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/85363-0.json |
| 85364-8 | Muscarinic acetylcholine receptor M3 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/85364-8.json |
| 85365-5 | Neutrophil membrane Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85365-5.json |
| 85366-3 | Neutrophil membrane IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85366-3.json |
| 85367-1 | Neutrophil membrane IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85367-1.json |
| 85368-9 | HIV 1+2 RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85368-9.json |
| 85369-7 | Neutrophils [#/volume] in Control Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85369-7.json |
| 85370-5 | Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85370-5.json |
| 85371-3 | Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Control Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85371-3.json |
| 85372-1 | Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Control Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85372-1.json |
| 85373-9 | Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85373-9.json |
| 85374-7 | Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85374-7.json |
| 85375-4 | Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Control Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85375-4.json |
| 85376-2 | Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85376-2.json |
| 85377-0 | Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Control Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85377-0.json |
| 85378-8 | Erythrocytes.EMA mean fluorescence intensity actual/normal in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/85378-8.json |
| 85379-6 | Purine/Pyrimidine [Ratio] in Red Blood Cells by Spectrophotometry | ./2.16.840.1.114222.4.11.1002/85379-6.json |
| 85383-8 | EGFR gene c.2369C>T actual/normal in Plasma cell-free DNA by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85383-8.json |
| 85384-6 | Amisulpride [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/85384-6.json |
| 85422-4 | ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85422-4.json |
| 85423-2 | Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85423-2.json |
| 85424-0 | Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85424-0.json |
| 85425-7 | Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85425-7.json |
| 85426-5 | Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85426-5.json |
| 85427-3 | Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85427-3.json |
| 85428-1 | Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85428-1.json |
| 85429-9 | Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/85429-9.json |
| 85433-1 | Respiratory therapy Discharge summary | ./2.16.840.1.114222.4.11.1002/85433-1.json |
| 85434-9 | Rheumatology Discharge summary | ./2.16.840.1.114222.4.11.1002/85434-9.json |
| 85435-6 | Palliative care Note | ./2.16.840.1.114222.4.11.1002/85435-6.json |
| 85436-4 | Cardiothoracic surgery Note | ./2.16.840.1.114222.4.11.1002/85436-4.json |
| 85437-2 | Family medicine Note | ./2.16.840.1.114222.4.11.1002/85437-2.json |
| 85438-0 | Neonatal perinatal medicine Note | ./2.16.840.1.114222.4.11.1002/85438-0.json |
| 85439-8 | Maternal and fetal medicine Note | ./2.16.840.1.114222.4.11.1002/85439-8.json |
| 85440-6 | Vascular surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/85440-6.json |
| 85441-4 | Vascular surgery Progress note | ./2.16.840.1.114222.4.11.1002/85441-4.json |
| 85442-2 | Hematology Discharge summary | ./2.16.840.1.114222.4.11.1002/85442-2.json |
| 85443-0 | Hematology Note | ./2.16.840.1.114222.4.11.1002/85443-0.json |
| 85444-8 | Gynecologic oncology Note | ./2.16.840.1.114222.4.11.1002/85444-8.json |
| 85445-5 | Geriatric medicine Note | ./2.16.840.1.114222.4.11.1002/85445-5.json |
| 85470-3 | Patient's home Medication management note | ./2.16.840.1.114222.4.11.1002/85470-3.json |
| 85471-1 | Hospital Medication management note | ./2.16.840.1.114222.4.11.1002/85471-1.json |
| 85472-9 | Obesity medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85472-9.json |
| 85474-5 | Cardiac implantable loop monitor study | ./2.16.840.1.114222.4.11.1002/85474-5.json |
| 85475-2 | US Heart Transesophageal | ./2.16.840.1.114222.4.11.1002/85475-2.json |
| 85477-8 | Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85477-8.json |
| 85478-6 | Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85478-6.json |
| 85479-4 | Respiratory syncytial virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85479-4.json |
| 85480-2 | FDA product label Establishment registration exempt notification | ./2.16.840.1.114222.4.11.1002/85480-2.json |
| 85481-0 | FDA product label Blood establishment registration and product listing | ./2.16.840.1.114222.4.11.1002/85481-0.json |
| 85482-8 | FDA product label Human cell and tissue establishment registration and product listing | ./2.16.840.1.114222.4.11.1002/85482-8.json |
| 85484-4 | FDA product label Establishment temporary inactivation notification | ./2.16.840.1.114222.4.11.1002/85484-4.json |
| 85496-8 | Streptococcus pneumoniae serotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85496-8.json |
| 85504-9 | Presumptive ABO group [Type] in Saliva (oral fluid) by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85504-9.json |
| 85505-6 | Presumptive Rh [Type] in Saliva (oral fluid) by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/85505-6.json |
| 85512-2 | Hepatitis D virus RNA [Units/volume] (viral load) in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85512-2.json |
| 85513-0 | Hepatitis D virus RNA [log units/volume] (viral load) in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85513-0.json |
| 85514-8 | Bariatric surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/85514-8.json |
| 85515-5 | Bariatric surgery Progress note | ./2.16.840.1.114222.4.11.1002/85515-5.json |
| 85516-3 | Bariatric surgery Note | ./2.16.840.1.114222.4.11.1002/85516-3.json |
| 85517-1 | Bariatric surgery Consult note | ./2.16.840.1.114222.4.11.1002/85517-1.json |
| 85518-9 | Child and adolescent psychology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/85518-9.json |
| 85519-7 | Child and adolescent psychology Consult note | ./2.16.840.1.114222.4.11.1002/85519-7.json |
| 85520-5 | Child and adolescent psychology Discharge summary | ./2.16.840.1.114222.4.11.1002/85520-5.json |
| 85521-3 | Undersea and hyperbaric medicine Note | ./2.16.840.1.114222.4.11.1002/85521-3.json |
| 85522-1 | Bariatric surgery Initial evaluation note | ./2.16.840.1.114222.4.11.1002/85522-1.json |
| 85523-9 | PROMIS short form - global - version 1.2 raw score | ./2.16.840.1.114222.4.11.1002/85523-9.json |
| 85527-0 | Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis in Specimen Document | ./2.16.840.1.114222.4.11.1002/85527-0.json |
| 85580-9 | Birth defects Hospital Registry report | ./2.16.840.1.114222.4.11.1002/85580-9.json |
| 85581-7 | Mycobacterium avium and Mycobacterium intracellulare DNA [Identifier] in Sputum or Bronchial by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85581-7.json |
| 85582-5 | Chikungunya virus RNA+Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85582-5.json |
| 85583-3 | Chikungunya virus RNA [Presence] in Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85583-3.json |
| 85584-1 | Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85584-1.json |
| 85587-4 | Aerospace medicine Note | ./2.16.840.1.114222.4.11.1002/85587-4.json |
| 85588-2 | Hematology+Medical oncology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/85588-2.json |
| 85621-1 | Zika virus RNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85621-1.json |
| 85622-9 | Zika virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85622-9.json |
| 85623-7 | Zika virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85623-7.json |
| 85624-5 | Kidney failure 2-year risk [Likelihood] by KFRE | ./2.16.840.1.114222.4.11.1002/85624-5.json |
| 85625-2 | Kidney failure 5-year risk [Likelihood] by KFRE | ./2.16.840.1.114222.4.11.1002/85625-2.json |
| 85627-8 | Haemophilus influenzae hpd gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85627-8.json |
| 85628-6 | Neisseria meningitidis sodC gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85628-6.json |
| 856-5 | A2 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/856-5.json |
| 85657-5 | Occupation industry CDC Census code | ./2.16.840.1.114222.4.11.1002/85657-5.json |
| 85658-3 | Occupation [Type] | ./2.16.840.1.114222.4.11.1002/85658-3.json |
| 85659-1 | Occupation CDC Census code | ./2.16.840.1.114222.4.11.1002/85659-1.json |
| 85678-1 | Haemophilus influenzae acs gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85678-1.json |
| 85679-9 | Haemophilus influenzae bex gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85679-9.json |
| 85680-7 | Haemophilus influenzae ecs gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85680-7.json |
| 85681-5 | Haemophilus influenzae dcs gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85681-5.json |
| 85682-3 | Haemophilus influenzae ccs gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85682-3.json |
| 85683-1 | Haemophilus influenzae bcs gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85683-1.json |
| 85684-9 | Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85684-9.json |
| 85686-4 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/85686-4.json |
| 85688-0 | Streptococcus pneumoniae lytA gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85688-0.json |
| 85691-4 | Autopsy result Narrative | ./2.16.840.1.114222.4.11.1002/85691-4.json |
| 85740-9 | Streptococcus pneumoniae Danish serotype 5 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85740-9.json |
| 85741-7 | Streptococcus pneumoniae Danish serotype 4 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85741-7.json |
| 85742-5 | Streptococcus pneumoniae Danish serotype 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85742-5.json |
| 85743-3 | Streptococcus pneumoniae Danish serotype 23F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85743-3.json |
| 85744-1 | Streptococcus pneumoniae Danish serotype 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85744-1.json |
| 85745-8 | Streptococcus pneumoniae Danish serotype 19F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85745-8.json |
| 85746-6 | Streptococcus pneumoniae Danish serotype 14 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85746-6.json |
| 85747-4 | Streptococcus pneumoniae Danish serotype 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85747-4.json |
| 85748-2 | Streptococcus pneumoniae Danish serotypes 7A+7F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85748-2.json |
| 85749-0 | Streptococcus pneumoniae Danish serotypes 22A+22F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85749-0.json |
| 85750-8 | Streptococcus pneumoniae Danish serotype 23A DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85750-8.json |
| 85751-6 | Streptococcus pneumoniae Danish serotype 16F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85751-6.json |
| 85752-4 | Streptococcus pneumoniae Danish serotypes 9A+9V DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85752-4.json |
| 85753-2 | Streptococcus pneumoniae Danish serotypes 6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85753-2.json |
| 85754-0 | Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85754-0.json |
| 85755-7 | Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85755-7.json |
| 85756-5 | Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85756-5.json |
| 85757-3 | Streptococcus pneumoniae Danish serotypes 15A+15F DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85757-3.json |
| 85758-1 | Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85758-1.json |
| 85759-9 | Streptococcus pneumoniae Danish serotypes 11A+11D DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85759-9.json |
| 85760-7 | Streptococcus pneumoniae Danish serotype 19A DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85760-7.json |
| 85761-5 | Klebsiella pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85761-5.json |
| 85763-1 | Listeria monocytogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85763-1.json |
| 85764-9 | Staphylococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85764-9.json |
| 85765-6 | Staphylococcus aureus DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85765-6.json |
| 85766-4 | Streptococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85766-4.json |
| 85767-2 | Streptococcus agalactiae DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85767-2.json |
| 85768-0 | Streptococcus pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85768-0.json |
| 85769-8 | Streptococcus pyogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85769-8.json |
| 85770-6 | Acinetobacter baumannii DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85770-6.json |
| 85771-4 | Enterobacteriaceae DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85771-4.json |
| 85772-2 | Enterobacter cloacae complex DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85772-2.json |
| 85773-0 | Escherichia coli DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85773-0.json |
| 85774-8 | Klebsiella oxytoca DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85774-8.json |
| 85775-5 | Enterococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85775-5.json |
| 85776-3 | Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85776-3.json |
| 85777-1 | Serratia marcescens DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85777-1.json |
| 85778-9 | Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85778-9.json |
| 85779-7 | Neisseria meningitidis DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85779-7.json |
| 85780-5 | Pseudomonas aeruginosa DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85780-5.json |
| 85781-3 | Candida albicans DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85781-3.json |
| 85782-1 | Candida glabrata DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85782-1.json |
| 85783-9 | Candida krusei DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85783-9.json |
| 85784-7 | Candida parapsilosis DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85784-7.json |
| 85785-4 | Candida tropicalis DNA [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85785-4.json |
| 85786-2 | Methicillin resistance mecA gene [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85786-2.json |
| 85787-0 | Vancomycin resistance vanA + vanB genes [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85787-0.json |
| 85788-8 | Carbapenem resistance blaKPC gene [Presence] by NAA with non-probe detection in Positive blood culture | ./2.16.840.1.114222.4.11.1002/85788-8.json |
| 85789-6 | CD3+CD8+CD45RO+ cells/100 CD3 cells in Blood | ./2.16.840.1.114222.4.11.1002/85789-6.json |
| 85790-4 | CD3+CD8+CD45RO+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/85790-4.json |
| 85791-2 | CD3+CD4+CD45RO+ cells/100 CD3 cells in Blood | ./2.16.840.1.114222.4.11.1002/85791-2.json |
| 85792-0 | CD3+CD4+CD45RO+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/85792-0.json |
| 85793-8 | Specimen source subject [Type] | ./2.16.840.1.114222.4.11.1002/85793-8.json |
| 85794-6 | Arthralgia/arthritis [Presence] in Mother | ./2.16.840.1.114222.4.11.1002/85794-6.json |
| 85798-7 | Measles virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85798-7.json |
| 85799-5 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/85799-5.json |
| 85801-9 | Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/85801-9.json |
| 85802-7 | Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/85802-7.json |
| 85803-5 | Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/85803-5.json |
| 85804-3 | Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/85804-3.json |
| 85805-0 | Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/85805-0.json |
| 85807-6 | Mumps virus genotype in Specimen | ./2.16.840.1.114222.4.11.1002/85807-6.json |
| 85818-3 | Clot formation+Clotting time of Blood by Thromboelastography | ./2.16.840.1.114222.4.11.1002/85818-3.json |
| 85819-1 | Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase | ./2.16.840.1.114222.4.11.1002/85819-1.json |
| 85820-9 | Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase | ./2.16.840.1.114222.4.11.1002/85820-9.json |
| 85848-0 | Nurse Restraint note | ./2.16.840.1.114222.4.11.1002/85848-0.json |
| 85849-8 | Anesthesiology Recovery room Discharge summary | ./2.16.840.1.114222.4.11.1002/85849-8.json |
| 85850-6 | Cardiothoracic surgery History and physical note | ./2.16.840.1.114222.4.11.1002/85850-6.json |
| 85851-4 | Cardiothoracic surgery Interdisciplinary Note | ./2.16.840.1.114222.4.11.1002/85851-4.json |
| 85852-2 | Cardiothoracic surgery Nurse Note | ./2.16.840.1.114222.4.11.1002/85852-2.json |
| 85853-0 | Cardiothoracic surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85853-0.json |
| 85854-8 | Cardiothoracic surgery procedure note | ./2.16.840.1.114222.4.11.1002/85854-8.json |
| 85855-5 | Womens health Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85855-5.json |
| 85856-3 | Womens health Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/85856-3.json |
| 85857-1 | Womens health procedure note | ./2.16.840.1.114222.4.11.1002/85857-1.json |
| 85858-9 | Womens health Outpatient Note | ./2.16.840.1.114222.4.11.1002/85858-9.json |
| 85859-7 | Womens health Outpatient Letter | ./2.16.840.1.114222.4.11.1002/85859-7.json |
| 85860-5 | Womens health Outpatient History and physical note | ./2.16.840.1.114222.4.11.1002/85860-5.json |
| 85861-3 | Womens health Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/85861-3.json |
| 85862-1 | Womens health Nurse Note | ./2.16.840.1.114222.4.11.1002/85862-1.json |
| 85863-9 | Teleimaging Note | ./2.16.840.1.114222.4.11.1002/85863-9.json |
| 85864-7 | Sleep medicine Note | ./2.16.840.1.114222.4.11.1002/85864-7.json |
| 85865-4 | Sleep medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/85865-4.json |
| 85866-2 | Sleep medicine Consult note | ./2.16.840.1.114222.4.11.1002/85866-2.json |
| 85867-0 | Womens health History and physical note | ./2.16.840.1.114222.4.11.1002/85867-0.json |
| 85868-8 | Womens health Group counseling note | ./2.16.840.1.114222.4.11.1002/85868-8.json |
| 85869-6 | Womens health Education note | ./2.16.840.1.114222.4.11.1002/85869-6.json |
| 85870-4 | Womens health Note | ./2.16.840.1.114222.4.11.1002/85870-4.json |
| 85871-2 | Womens health Consult note | ./2.16.840.1.114222.4.11.1002/85871-2.json |
| 85872-0 | Psychiatry Restraint note | ./2.16.840.1.114222.4.11.1002/85872-0.json |
| 85873-8 | Physician Restraint note | ./2.16.840.1.114222.4.11.1002/85873-8.json |
| 85874-6 | Nurse Recovery room Note | ./2.16.840.1.114222.4.11.1002/85874-6.json |
| 85875-3 | Nurse Recovery room Discharge summary | ./2.16.840.1.114222.4.11.1002/85875-3.json |
| 85876-1 | Neuropsychology Note | ./2.16.840.1.114222.4.11.1002/85876-1.json |
| 85877-9 | Neuropsychology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/85877-9.json |
| 85878-7 | Neuropsychology Discharge summary | ./2.16.840.1.114222.4.11.1002/85878-7.json |
| 85879-5 | Mental health Nurse Restraint note | ./2.16.840.1.114222.4.11.1002/85879-5.json |
| 85880-3 | Long term care facility Restraint note | ./2.16.840.1.114222.4.11.1002/85880-3.json |
| 85881-1 | Ophthalmology Teleimaging Note | ./2.16.840.1.114222.4.11.1002/85881-1.json |
| 85882-9 | Ophthalmology Teleimaging Consult note | ./2.16.840.1.114222.4.11.1002/85882-9.json |
| 85883-7 | Epilepsy Note | ./2.16.840.1.114222.4.11.1002/85883-7.json |
| 85884-5 | Epilepsy Consult note | ./2.16.840.1.114222.4.11.1002/85884-5.json |
| 85886-0 | Clinical cardiac electrophysiology Consult note | ./2.16.840.1.114222.4.11.1002/85886-0.json |
| 85887-8 | Dermatology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85887-8.json |
| 85888-6 | Multi-specialty program Telehealth Note | ./2.16.840.1.114222.4.11.1002/85888-6.json |
| 85889-4 | Cardiothoracic surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85889-4.json |
| 85890-2 | Neuropsychology Consult note | ./2.16.840.1.114222.4.11.1002/85890-2.json |
| 85891-0 | Cardiothoracic surgery Fellow Note | ./2.16.840.1.114222.4.11.1002/85891-0.json |
| 85892-8 | Womens health Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/85892-8.json |
| 85893-6 | Adverse event note | ./2.16.840.1.114222.4.11.1002/85893-6.json |
| 85894-4 | Physical medicine and rehab Counseling note | ./2.16.840.1.114222.4.11.1002/85894-4.json |
| 85895-1 | Nuclear medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/85895-1.json |
| 85896-9 | Nurse Diagnostic study note | ./2.16.840.1.114222.4.11.1002/85896-9.json |
| 85898-5 | Surgery Diagnostic study note | ./2.16.840.1.114222.4.11.1002/85898-5.json |
| 85899-3 | Community health care Consult note | ./2.16.840.1.114222.4.11.1002/85899-3.json |
| 85900-9 | Cardiothoracic surgery Resident Note | ./2.16.840.1.114222.4.11.1002/85900-9.json |
| 85901-7 | Community health care Note | ./2.16.840.1.114222.4.11.1002/85901-7.json |
| 85902-5 | Community health care Nurse Note | ./2.16.840.1.114222.4.11.1002/85902-5.json |
| 85903-3 | Community health care Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/85903-3.json |
| 85910-8 | Physical findings of Teeth and gum Narrative | ./2.16.840.1.114222.4.11.1002/85910-8.json |
| 85935-5 | Vocational rehabilitation Education note | ./2.16.840.1.114222.4.11.1002/85935-5.json |
| 85936-3 | Vocational rehabilitation Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/85936-3.json |
| 85937-1 | Gynecology Note | ./2.16.840.1.114222.4.11.1002/85937-1.json |
| 85938-9 | Cardiology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85938-9.json |
| 85939-7 | Clinical cardiac electrophysiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85939-7.json |
| 85940-5 | Clinical cardiac electrophysiology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85940-5.json |
| 85941-3 | Gastroenterology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85941-3.json |
| 85942-1 | Gastroenterology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85942-1.json |
| 85943-9 | Orthopaedic surgery Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85943-9.json |
| 85944-7 | Pulmonary Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85944-7.json |
| 85945-4 | Surgery Outpatient Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85945-4.json |
| 85946-2 | Surgery Outpatient Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85946-2.json |
| 85947-0 | Surgery Nurse Outpatient Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85947-0.json |
| 85948-8 | Surgery Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/85948-8.json |
| 85952-0 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85952-0.json |
| 85953-8 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85953-8.json |
| 85954-6 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85954-6.json |
| 85955-3 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85955-3.json |
| 85956-1 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85956-1.json |
| 85957-9 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85957-9.json |
| 85958-7 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/85958-7.json |
| 85959-5 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85959-5.json |
| 85960-3 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85960-3.json |
| 85961-1 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/85961-1.json |
| 85962-9 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85962-9.json |
| 85963-7 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85963-7.json |
| 85964-5 | Streptococcus pneumoniae Danish serotype 1 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/85964-5.json |
| 85965-2 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85965-2.json |
| 85966-0 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/85966-0.json |
| 85967-8 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85967-8.json |
| 85968-6 | Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85968-6.json |
| 85969-4 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/85969-4.json |
| 85970-2 | Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85970-2.json |
| 85971-0 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85971-0.json |
| 85972-8 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85972-8.json |
| 85973-6 | Streptococcus pneumoniae Danish serotype 12F Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/85973-6.json |
| 85974-4 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85974-4.json |
| 85975-1 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85975-1.json |
| 85976-9 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85976-9.json |
| 85977-7 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85977-7.json |
| 85978-5 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85978-5.json |
| 85979-3 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85979-3.json |
| 85980-1 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/85980-1.json |
| 85981-9 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85981-9.json |
| 85982-7 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85982-7.json |
| 85983-5 | Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/85983-5.json |
| 85984-3 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85984-3.json |
| 85985-0 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85985-0.json |
| 85986-8 | Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85986-8.json |
| 85987-6 | Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85987-6.json |
| 85988-4 | Streptococcus pneumoniae Danish serotype 12F Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/85988-4.json |
| 85989-2 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85989-2.json |
| 85990-0 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85990-0.json |
| 85991-8 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85991-8.json |
| 85992-6 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85992-6.json |
| 85993-4 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/85993-4.json |
| 85994-2 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/85994-2.json |
| 85995-9 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/85995-9.json |
| 85996-7 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85996-7.json |
| 85997-5 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/85997-5.json |
| 85998-3 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/85998-3.json |
| 85999-1 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/85999-1.json |
| 86000-7 | Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86000-7.json |
| 86001-5 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86001-5.json |
| 86002-3 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86002-3.json |
| 86003-1 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86003-1.json |
| 86004-9 | Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86004-9.json |
| 86005-6 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86005-6.json |
| 86006-4 | Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86006-4.json |
| 86007-2 | Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86007-2.json |
| 86008-0 | Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86008-0.json |
| 86009-8 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86009-8.json |
| 86010-6 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86010-6.json |
| 86011-4 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86011-4.json |
| 86012-2 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86012-2.json |
| 86013-0 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86013-0.json |
| 86014-8 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86014-8.json |
| 86015-5 | Streptococcus pneumoniae Danish serotype 17F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86015-5.json |
| 86016-3 | Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86016-3.json |
| 86017-1 | Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86017-1.json |
| 86018-9 | Streptococcus pneumoniae Danish serotype 18F Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86018-9.json |
| 86019-7 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86019-7.json |
| 86020-5 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86020-5.json |
| 86021-3 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86021-3.json |
| 86022-1 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86022-1.json |
| 86023-9 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86023-9.json |
| 86024-7 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86024-7.json |
| 86025-4 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86025-4.json |
| 86026-2 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86026-2.json |
| 86027-0 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86027-0.json |
| 86028-8 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86028-8.json |
| 86029-6 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86029-6.json |
| 86030-4 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86030-4.json |
| 86031-2 | Streptococcus pneumoniae Danish serotype 19F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86031-2.json |
| 86032-0 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86032-0.json |
| 86033-8 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86033-8.json |
| 86034-6 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86034-6.json |
| 86035-3 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86035-3.json |
| 86036-1 | Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86036-1.json |
| 86037-9 | Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86037-9.json |
| 86038-7 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86038-7.json |
| 86039-5 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86039-5.json |
| 86040-3 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86040-3.json |
| 86041-1 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86041-1.json |
| 86042-9 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86042-9.json |
| 86043-7 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86043-7.json |
| 86044-5 | Streptococcus pneumoniae Danish serotype 2 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86044-5.json |
| 86045-2 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86045-2.json |
| 86046-0 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86046-0.json |
| 86047-8 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86047-8.json |
| 86048-6 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86048-6.json |
| 86049-4 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86049-4.json |
| 86050-2 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86050-2.json |
| 86051-0 | Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86051-0.json |
| 86052-8 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86052-8.json |
| 86053-6 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86053-6.json |
| 86054-4 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86054-4.json |
| 86055-1 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86055-1.json |
| 86056-9 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86056-9.json |
| 86057-7 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86057-7.json |
| 86058-5 | Streptococcus pneumoniae Danish serotype 22F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86058-5.json |
| 86059-3 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86059-3.json |
| 86060-1 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86060-1.json |
| 86061-9 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86061-9.json |
| 86062-7 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86062-7.json |
| 86063-5 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86063-5.json |
| 86064-3 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86064-3.json |
| 86065-0 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86065-0.json |
| 86066-8 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86066-8.json |
| 86067-6 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86067-6.json |
| 86068-4 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86068-4.json |
| 86069-2 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86069-2.json |
| 86070-0 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86070-0.json |
| 86071-8 | Streptococcus pneumoniae Danish serotype 23F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86071-8.json |
| 86072-6 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86072-6.json |
| 86073-4 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86073-4.json |
| 86074-2 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86074-2.json |
| 86075-9 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86075-9.json |
| 86076-7 | Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86076-7.json |
| 86077-5 | Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86077-5.json |
| 86078-3 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86078-3.json |
| 86079-1 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86079-1.json |
| 86080-9 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86080-9.json |
| 86081-7 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86081-7.json |
| 86082-5 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86082-5.json |
| 86083-3 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86083-3.json |
| 86084-1 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86084-1.json |
| 86085-8 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86085-8.json |
| 86086-6 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86086-6.json |
| 86087-4 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86087-4.json |
| 86088-2 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86088-2.json |
| 86089-0 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86089-0.json |
| 86090-8 | Streptococcus pneumoniae Danish serotype 3 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86090-8.json |
| 86091-6 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86091-6.json |
| 86092-4 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86092-4.json |
| 86093-2 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86093-2.json |
| 86094-0 | Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86094-0.json |
| 86095-7 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86095-7.json |
| 86096-5 | Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86096-5.json |
| 86097-3 | Streptococcus pneumoniae Danish serotype 3 Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86097-3.json |
| 86098-1 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86098-1.json |
| 86099-9 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86099-9.json |
| 86100-5 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86100-5.json |
| 86101-3 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86101-3.json |
| 86102-1 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86102-1.json |
| 86103-9 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86103-9.json |
| 86104-7 | Streptococcus pneumoniae Danish serotype 10A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86104-7.json |
| 86105-4 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86105-4.json |
| 86106-2 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86106-2.json |
| 86107-0 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86107-0.json |
| 86108-8 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86108-8.json |
| 86109-6 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86109-6.json |
| 86110-4 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86110-4.json |
| 86111-2 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86111-2.json |
| 86112-0 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86112-0.json |
| 86113-8 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86113-8.json |
| 86114-6 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86114-6.json |
| 86115-3 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86115-3.json |
| 86116-1 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86116-1.json |
| 86117-9 | Streptococcus pneumoniae Danish serotype 4 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86117-9.json |
| 86118-7 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86118-7.json |
| 86119-5 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86119-5.json |
| 86120-3 | Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86120-3.json |
| 86121-1 | Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86121-1.json |
| 86122-9 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86122-9.json |
| 86123-7 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86123-7.json |
| 86124-5 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86124-5.json |
| 86125-2 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86125-2.json |
| 86126-0 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86126-0.json |
| 86127-8 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86127-8.json |
| 86128-6 | Streptococcus pneumoniae Danish serotype 11A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86128-6.json |
| 86129-4 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86129-4.json |
| 86130-2 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86130-2.json |
| 86131-0 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86131-0.json |
| 86132-8 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86132-8.json |
| 86133-6 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86133-6.json |
| 86134-4 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86134-4.json |
| 86135-1 | Streptococcus pneumoniae Danish serotype 5 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86135-1.json |
| 86136-9 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86136-9.json |
| 86137-7 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86137-7.json |
| 86138-5 | Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86138-5.json |
| 86139-3 | Streptococcus pneumoniae Danish serotype 6A Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86139-3.json |
| 86140-1 | Streptococcus pneumoniae Danish serotype 6A Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86140-1.json |
| 86141-9 | Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86141-9.json |
| 86142-7 | Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86142-7.json |
| 86143-5 | Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/86143-5.json |
| 86144-3 | Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86144-3.json |
| 86145-0 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86145-0.json |
| 86146-8 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86146-8.json |
| 86147-6 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86147-6.json |
| 86148-4 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86148-4.json |
| 86149-2 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86149-2.json |
| 86150-0 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86150-0.json |
| 86151-8 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86151-8.json |
| 86152-6 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86152-6.json |
| 86153-4 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86153-4.json |
| 86154-2 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86154-2.json |
| 86155-9 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86155-9.json |
| 86156-7 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86156-7.json |
| 86157-5 | Streptococcus pneumoniae Danish serotype 8 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86157-5.json |
| 86158-3 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86158-3.json |
| 86159-1 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86159-1.json |
| 86160-9 | Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86160-9.json |
| 86161-7 | Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86161-7.json |
| 86162-5 | Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86162-5.json |
| 86163-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86163-3.json |
| 86164-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86164-1.json |
| 86165-8 | Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/86165-8.json |
| 86166-6 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86166-6.json |
| 86167-4 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86167-4.json |
| 86168-2 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86168-2.json |
| 86169-0 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86169-0.json |
| 86170-8 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86170-8.json |
| 86171-6 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86171-6.json |
| 86172-4 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86172-4.json |
| 86173-2 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86173-2.json |
| 86174-0 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86174-0.json |
| 86175-7 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86175-7.json |
| 86176-5 | Streptococcus pneumoniae Danish serotype 9N IgG Ab [Ratio] in Serum --2nd specimen/1st specimen | ./2.16.840.1.114222.4.11.1002/86176-5.json |
| 86177-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --1st specimen | ./2.16.840.1.114222.4.11.1002/86177-3.json |
| 86178-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86178-1.json |
| 86179-9 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86179-9.json |
| 86180-7 | Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum --1st specimen/2nd specimen | ./2.16.840.1.114222.4.11.1002/86180-7.json |
| 86181-5 | Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen | ./2.16.840.1.114222.4.11.1002/86181-5.json |
| 86182-3 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --2nd specimen | ./2.16.840.1.114222.4.11.1002/86182-3.json |
| 86183-1 | Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86183-1.json |
| 86184-9 | Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --2nd specimen | ./2.16.840.1.114222.4.11.1002/86184-9.json |
| 86188-0 | History of Occupation industry | ./2.16.840.1.114222.4.11.1002/86188-0.json |
| 86190-6 | Zika virus RNA [Presence] in Plasma from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86190-6.json |
| 86192-2 | 4-Methylethcathinone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86192-2.json |
| 86201-1 | Porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in Specimen Document | ./2.16.840.1.114222.4.11.1002/86201-1.json |
| 86205-2 | Whole exome sequence analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/86205-2.json |
| 86206-0 | Whole genome sequence analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/86206-0.json |
| 86208-6 | Cardiology Telehealth Note | ./2.16.840.1.114222.4.11.1002/86208-6.json |
| 86209-4 | Community health care Case manager Note | ./2.16.840.1.114222.4.11.1002/86209-4.json |
| 86210-2 | Physician Medical clearance note | ./2.16.840.1.114222.4.11.1002/86210-2.json |
| 86211-0 | Addiction medicine Physician Note | ./2.16.840.1.114222.4.11.1002/86211-0.json |
| 86212-8 | Addiction medicine Attending Note | ./2.16.840.1.114222.4.11.1002/86212-8.json |
| 86213-6 | Vocational rehabilitation Medical clearance note | ./2.16.840.1.114222.4.11.1002/86213-6.json |
| 86214-4 | Womens health Annual evaluation note | ./2.16.840.1.114222.4.11.1002/86214-4.json |
| 86215-1 | Hematology+Medical oncology Disease staging note | ./2.16.840.1.114222.4.11.1002/86215-1.json |
| 86220-1 | Carbapenem resistance blaOXA-48 gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86220-1.json |
| 86221-9 | Colistin resistance mcr-1 gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/86221-9.json |
| 86223-5 | Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86223-5.json |
| 86224-3 | ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86224-3.json |
| 86225-0 | clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86225-0.json |
| 86226-8 | Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86226-8.json |
| 86227-6 | Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86227-6.json |
| 86228-4 | Ethyl sulfate [Presence] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/86228-4.json |
| 86229-2 | HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86229-2.json |
| 862-3 | A2 B Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/862-3.json |
| 86230-0 | HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86230-0.json |
| 86231-8 | Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86231-8.json |
| 86232-6 | Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86232-6.json |
| 86233-4 | HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot | ./2.16.840.1.114222.4.11.1002/86233-4.json |
| 86234-2 | Neisseria meningitidis serogroup A sacB gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86234-2.json |
| 86235-9 | Neisseria meningitidis serogroup B synD gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86235-9.json |
| 86236-7 | Neisseria meningitidis serogroup C synE gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86236-7.json |
| 86237-5 | Neisseria meningitidis serogroup w135 synG gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86237-5.json |
| 86238-3 | Neisseria meningitidis serogroup X xcbB gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86238-3.json |
| 86239-1 | Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH | ./2.16.840.1.114222.4.11.1002/86239-1.json |
| 86240-9 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/86240-9.json |
| 86241-7 | Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/86241-7.json |
| 86255-7 | Primary diagnosis ICD code | ./2.16.840.1.114222.4.11.1002/86255-7.json |
| 86271-4 | Transferrin.gastrointestinal [Mass/volume] in Stool by Immunoassay | ./2.16.840.1.114222.4.11.1002/86271-4.json |
| 86285-4 | Erythrocyte deformability [Interpretation] in Red Blood Cells Narrative | ./2.16.840.1.114222.4.11.1002/86285-4.json |
| 86317-5 | Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86317-5.json |
| 86319-1 | Staphylococcus aureus [Presence] in Food by Culture | ./2.16.840.1.114222.4.11.1002/86319-1.json |
| 86320-9 | Zika virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86320-9.json |
| 86321-7 | Zika virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86321-7.json |
| 86323-3 | Enterovirus Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86323-3.json |
| 86324-1 | Coliform bacteria [#/mass] in Food by Viability count | ./2.16.840.1.114222.4.11.1002/86324-1.json |
| 86325-8 | Bordetella pertussis+parapertussis ptxS1 gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86325-8.json |
| 86326-6 | Bordetella holmesii hIS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86326-6.json |
| 86327-4 | Bordetella parapertussis IS1001 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86327-4.json |
| 86328-2 | Adenovirus B(21) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86328-2.json |
| 86329-0 | Adenovirus B(16) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86329-0.json |
| 86330-8 | Adenovirus B(11) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86330-8.json |
| 86331-6 | Adenovirus B(14) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86331-6.json |
| 86332-4 | Adenovirus B(7) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86332-4.json |
| 86333-2 | Adenovirus E(4) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86333-2.json |
| 86334-0 | Adenovirus B(3) DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86334-0.json |
| 86335-7 | Total interval score change [HOOSJR] | ./2.16.840.1.114222.4.11.1002/86335-7.json |
| 86336-5 | Total interval score change [KOOSJR] | ./2.16.840.1.114222.4.11.1002/86336-5.json |
| 86337-3 | Virus identified in Isolate by Shell vial culture | ./2.16.840.1.114222.4.11.1002/86337-3.json |
| 86338-1 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86338-1.json |
| 86339-9 | Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86339-9.json |
| 86340-7 | Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86340-7.json |
| 86341-5 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86341-5.json |
| 86342-3 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/86342-3.json |
| 86343-1 | Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum --1st specimen | ./2.16.840.1.114222.4.11.1002/86343-1.json |
| 86348-0 | MG Breast - left Guidance for needle localization and Breast specimen Views | ./2.16.840.1.114222.4.11.1002/86348-0.json |
| 86350-6 | MG Breast - unilateral Single view for clip placement | ./2.16.840.1.114222.4.11.1002/86350-6.json |
| 86351-4 | MG Guidance for additional aspiration of cyst of Breast - left | ./2.16.840.1.114222.4.11.1002/86351-4.json |
| 86352-2 | MG Guidance for additional aspiration of cyst of Breast - right | ./2.16.840.1.114222.4.11.1002/86352-2.json |
| 86353-0 | MG Guidance for placement of clip in Breast - left | ./2.16.840.1.114222.4.11.1002/86353-0.json |
| 86354-8 | MG Guidance for placement of clip in Breast - right | ./2.16.840.1.114222.4.11.1002/86354-8.json |
| 86355-5 | MG Guidance for additional needle localization of Breast - left | ./2.16.840.1.114222.4.11.1002/86355-5.json |
| 86356-3 | MG Guidance for additional needle localization of Breast - right | ./2.16.840.1.114222.4.11.1002/86356-3.json |
| 86357-1 | MG Guidance for needle localization of Breast - left | ./2.16.840.1.114222.4.11.1002/86357-1.json |
| 86358-9 | MG Guidance for needle localization of Breast - right | ./2.16.840.1.114222.4.11.1002/86358-9.json |
| 86360-5 | MG Breast - right Guidance for needle localization and Breast specimen Views | ./2.16.840.1.114222.4.11.1002/86360-5.json |
| 86361-3 | MG stereo Guidance for additional biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/86361-3.json |
| 86362-1 | MG stereo Guidance for additional biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/86362-1.json |
| 86363-9 | MG Guidance for additional vacuum biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/86363-9.json |
| 86364-7 | MG Guidance for additional vacuum biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/86364-7.json |
| 86365-4 | MG Guidance for vacuum biopsy of Breast - left | ./2.16.840.1.114222.4.11.1002/86365-4.json |
| 86366-2 | MG Guidance for vacuum biopsy of Breast - right | ./2.16.840.1.114222.4.11.1002/86366-2.json |
| 86367-0 | MG Breast Diagnostic for clinical call back | ./2.16.840.1.114222.4.11.1002/86367-0.json |
| 86368-8 | MG Breast - left Diagnostic for clinical call back | ./2.16.840.1.114222.4.11.1002/86368-8.json |
| 86369-6 | MG Breast - right Diagnostic for clinical call back | ./2.16.840.1.114222.4.11.1002/86369-6.json |
| 86370-4 | MG Breast Diagnostic for technical call back | ./2.16.840.1.114222.4.11.1002/86370-4.json |
| 86371-2 | Study Interpretation of outside study | ./2.16.840.1.114222.4.11.1002/86371-2.json |
| 86372-0 | RF Kidney and Ureter and Urinary bladder Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86372-0.json |
| 86373-8 | RF AV fistula Views W contrast via additional puncture | ./2.16.840.1.114222.4.11.1002/86373-8.json |
| 86374-6 | RFA Pedal lymphatic vessels - bilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/86374-6.json |
| 86375-3 | RFA Pedal lymphatic vessels - unilateral Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/86375-3.json |
| 86376-1 | RF Biliary ducts Views W contrast via existing catheter | ./2.16.840.1.114222.4.11.1002/86376-1.json |
| 86377-9 | RF Guidance for advancement of feeding tube of Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/86377-9.json |
| 86378-7 | RF Gastrointestinal tract Views for fistula | ./2.16.840.1.114222.4.11.1002/86378-7.json |
| 86379-5 | RF Small bowel Views for loop diversion | ./2.16.840.1.114222.4.11.1002/86379-5.json |
| 86380-3 | RF Kidney and Ureter and Urinary bladder Views for fistula | ./2.16.840.1.114222.4.11.1002/86380-3.json |
| 86381-1 | RF Colon Screening W air and barium contrast PR | ./2.16.840.1.114222.4.11.1002/86381-1.json |
| 86382-9 | RF Biliary ducts Limited Views during surgery | ./2.16.840.1.114222.4.11.1002/86382-9.json |
| 86383-7 | RF Biliary ducts Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86383-7.json |
| 86384-5 | RF Gallbladder Views W contrast and fatty meal PO | ./2.16.840.1.114222.4.11.1002/86384-5.json |
| 86385-2 | RF Gallbladder Views W contrast PO | ./2.16.840.1.114222.4.11.1002/86385-2.json |
| 86386-0 | RF Gastrointestinal tract upper Views W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86386-0.json |
| 86387-8 | RF Kidney and Ureter and Urinary bladder Views W contrast antegrade | ./2.16.840.1.114222.4.11.1002/86387-8.json |
| 86388-6 | RF Kidney and Ureter and Urinary bladder Views W contrast retrograde | ./2.16.840.1.114222.4.11.1002/86388-6.json |
| 86389-4 | RF Kidney and Ureter and Urinary bladder Views during surgery W contrast retrograde | ./2.16.840.1.114222.4.11.1002/86389-4.json |
| 86390-2 | RF Kidney and Ureter and Urinary bladder Views W contrast via nephrostomy tube | ./2.16.840.1.114222.4.11.1002/86390-2.json |
| 86391-0 | RF AV fistula Views W contrast via existing catheter | ./2.16.840.1.114222.4.11.1002/86391-0.json |
| 86392-8 | RF Kidney and Ureter and Urinary bladder Limited Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86392-8.json |
| 86393-6 | RF Kidney - bilateral and Ureter - bilateral and Urinary bladder Views W contrast retrograde | ./2.16.840.1.114222.4.11.1002/86393-6.json |
| 86394-4 | RFA Thoracic Aorta Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86394-4.json |
| 86395-1 | RF videography Hypopharynx and Esophagus Views for swallowing function W speech and W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86395-1.json |
| 86396-9 | RFA Extremity veins - unilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86396-9.json |
| 86397-7 | RF Guidance for drainage and placement of suprapubic catheter of Urinary bladder | ./2.16.840.1.114222.4.11.1002/86397-7.json |
| 86398-5 | RF Cerebral cisterns Views W contrast IT | ./2.16.840.1.114222.4.11.1002/86398-5.json |
| 86399-3 | RF Guidance for Views and Guidance for injection of non-vascular shunt of Unspecified body region | ./2.16.840.1.114222.4.11.1002/86399-3.json |
| 86400-9 | RF Guidance for placement of needle in Unspecified body region | ./2.16.840.1.114222.4.11.1002/86400-9.json |
| 86401-7 | RF Urinary bladder Views W contrast intra bladder | ./2.16.840.1.114222.4.11.1002/86401-7.json |
| 86402-5 | RF Shoulder Arthrogram limited | ./2.16.840.1.114222.4.11.1002/86402-5.json |
| 86403-3 | RF Guidance for placement of catheter in Fallopian tube | ./2.16.840.1.114222.4.11.1002/86403-3.json |
| 86404-1 | RF Guidance for fluid aspiration of Urinary bladder | ./2.16.840.1.114222.4.11.1002/86404-1.json |
| 86405-8 | RF Guidance for exchange of tube of Unspecified body region | ./2.16.840.1.114222.4.11.1002/86405-8.json |
| 86406-6 | RF Unspecified body region Less than 1 hour Views during surgery | ./2.16.840.1.114222.4.11.1002/86406-6.json |
| 86407-4 | RF Guidance of Unspecified body region | ./2.16.840.1.114222.4.11.1002/86407-4.json |
| 86408-2 | RF Pelvis Views for urinary pouch | ./2.16.840.1.114222.4.11.1002/86408-2.json |
| 86409-0 | RF Rectum Views for rectal dysfunction W barium contrast PR | ./2.16.840.1.114222.4.11.1002/86409-0.json |
| 86410-8 | RF Pharynx and Cervical esophagus Views W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86410-8.json |
| 86411-6 | RF Posterior fossa - bilateral Views W contrast IT | ./2.16.840.1.114222.4.11.1002/86411-6.json |
| 86412-4 | RFA Pedal lymphatic vessels Views W contrast intra lymphatic | ./2.16.840.1.114222.4.11.1002/86412-4.json |
| 86413-2 | RF Guidance for placement of long feeding tube in Gastrointestinal tract | ./2.16.840.1.114222.4.11.1002/86413-2.json |
| 86414-0 | RFA Renal arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86414-0.json |
| 86415-7 | RFA Renal vein - unilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86415-7.json |
| 86416-5 | MG Breast - bilateral Guidance for needle localization and Breast specimen Views | ./2.16.840.1.114222.4.11.1002/86416-5.json |
| 86417-3 | RFA Cerebral arteries Bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86417-3.json |
| 86418-1 | RFA Pulmonary arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86418-1.json |
| 86419-9 | RFA Visceral arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86419-9.json |
| 86420-7 | RF Gastrointestinal tract upper Views W air contrast PO and W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86420-7.json |
| 86421-5 | XR Abdomen and RF Gastrointestinal tract upper W air contrast PO and W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86421-5.json |
| 86422-3 | XR Abdomen and RF Gastrointestinal tract upper W water soluble contrast PO | ./2.16.840.1.114222.4.11.1002/86422-3.json |
| 86423-1 | XR Abdomen and RF Gastrointestinal tract upper W contrast PO | ./2.16.840.1.114222.4.11.1002/86423-1.json |
| 86424-9 | XR Abdomen and RF Gastrointestinal tract upper W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86424-9.json |
| 86425-6 | RF Guidance for manometry of Kidney | ./2.16.840.1.114222.4.11.1002/86425-6.json |
| 86426-4 | RFA Jugular vein - unilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86426-4.json |
| 86427-2 | RF Upper gastrointestinal tract and Small bowel Views W air contrast PO and W barium contrast PO | ./2.16.840.1.114222.4.11.1002/86427-2.json |
| 86428-0 | RFA Extremity arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86428-0.json |
| 86429-8 | RFA Cerebral arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86429-8.json |
| 86430-6 | RF Posterior fossa - unilateral Views W contrast IT | ./2.16.840.1.114222.4.11.1002/86430-6.json |
| 86431-4 | RFA Cerebral arteries - bilateral and Cervical arteries - bilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86431-4.json |
| 86432-2 | RFA Cerebral arteries - unilateral and Cervical arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86432-2.json |
| 86433-0 | RFA Lumbar spine intercostal arteries Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86433-0.json |
| 86434-8 | RFA Carotid arteries - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86434-8.json |
| 86435-5 | RFA Jugular vein - bilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86435-5.json |
| 86436-3 | RF Guidance for treatment of Fistula-- W contrast intra fistula | ./2.16.840.1.114222.4.11.1002/86436-3.json |
| 86437-1 | RF Fistula Diagnostic W contrast intra fistula | ./2.16.840.1.114222.4.11.1002/86437-1.json |
| 86438-9 | RF Guidance for check of feeding tube of Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/86438-9.json |
| 86439-7 | RF Cerebral sinuses Views W contrast IV | ./2.16.840.1.114222.4.11.1002/86439-7.json |
| 86440-5 | RF Seminal vesicle Views W contrast intra seminal vesicle | ./2.16.840.1.114222.4.11.1002/86440-5.json |
| 86441-3 | RF Guidance for manometry of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/86441-3.json |
| 86442-1 | RFA Vertebral artery - unilateral Views W contrast IA | ./2.16.840.1.114222.4.11.1002/86442-1.json |
| 86443-9 | RF Ureter Views W contrast intra ureter | ./2.16.840.1.114222.4.11.1002/86443-9.json |
| 86444-7 | FDA product label Manufacturing establishment information | ./2.16.840.1.114222.4.11.1002/86444-7.json |
| 86445-4 | FDA package insert Blanket no changes certification of product listing | ./2.16.840.1.114222.4.11.1002/86445-4.json |
| 86446-2 | FDA product label Blood establishment registration and product listing change in information | ./2.16.840.1.114222.4.11.1002/86446-2.json |
| 86447-0 | FDA product label Human cell and tissue establishment registration and product listing change in information | ./2.16.840.1.114222.4.11.1002/86447-0.json |
| 86448-8 | FDA product label Human salvaged drug | ./2.16.840.1.114222.4.11.1002/86448-8.json |
| 86449-6 | Against medical advice note | ./2.16.840.1.114222.4.11.1002/86449-6.json |
| 86450-4 | Radiology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/86450-4.json |
| 86451-2 | Ethics Consult note | ./2.16.840.1.114222.4.11.1002/86451-2.json |
| 86452-0 | Ethics Note | ./2.16.840.1.114222.4.11.1002/86452-0.json |
| 86455-3 | Brucella sp Ab [Presence] in Serum by Acidified buffered plate agglutination | ./2.16.840.1.114222.4.11.1002/86455-3.json |
| 86456-1 | Brucella sp Ab [Presence] in Serum by Card agglutination | ./2.16.840.1.114222.4.11.1002/86456-1.json |
| 86457-9 | Brucella sp Ab [Presence] in Serum by Fluorescent polarization assay | ./2.16.840.1.114222.4.11.1002/86457-9.json |
| 86458-7 | Brucella sp Ab [Titer] in Serum by Rivanol agglutination | ./2.16.840.1.114222.4.11.1002/86458-7.json |
| 86459-5 | Brucella sp Ab [Titer] in Serum by Plate agglutination | ./2.16.840.1.114222.4.11.1002/86459-5.json |
| 86460-3 | RFA Spine vessel Views | ./2.16.840.1.114222.4.11.1002/86460-3.json |
| 86461-1 | RFA Adrenal vessel Views | ./2.16.840.1.114222.4.11.1002/86461-1.json |
| 86462-9 | DBT Breast - unilateral | ./2.16.840.1.114222.4.11.1002/86462-9.json |
| 86463-7 | DBT Breast - bilateral | ./2.16.840.1.114222.4.11.1002/86463-7.json |
| 86464-5 | RFA Guidance for repair of aneurysm or dissection of Infrarenal aorta | ./2.16.840.1.114222.4.11.1002/86464-5.json |
| 86465-2 | AST to platelet ratio index in Serum and Blood by calculation | ./2.16.840.1.114222.4.11.1002/86465-2.json |
| 86502-2 | Varicella zoster virus strain DNA [Type] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86502-2.json |
| 86509-7 | Varicella zoster virus clade [Type] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/86509-7.json |
| 86510-5 | Adenovirus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86510-5.json |
| 86511-3 | Adenovirus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86511-3.json |
| 86512-1 | Adenovirus DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86512-1.json |
| 86513-9 | Adenovirus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86513-9.json |
| 86514-7 | Chikungunya virus RNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86514-7.json |
| 86515-4 | Chikungunya virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86515-4.json |
| 86516-2 | Coxsackievirus A Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86516-2.json |
| 86517-0 | Cytomegalovirus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86517-0.json |
| 86518-8 | Ebola virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86518-8.json |
| 86519-6 | European tick borne encephalitis virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86519-6.json |
| 86520-4 | Hantavirus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86520-4.json |
| 86530-3 | Visit notification | ./2.16.840.1.114222.4.11.1002/86530-3.json |
| 86531-1 | Discharge notification | ./2.16.840.1.114222.4.11.1002/86531-1.json |
| 86532-9 | Admission notification | ./2.16.840.1.114222.4.11.1002/86532-9.json |
| 86533-7 | Patient Living will | ./2.16.840.1.114222.4.11.1002/86533-7.json |
| 86534-5 | Disease staging note | ./2.16.840.1.114222.4.11.1002/86534-5.json |
| 86535-2 | Healthcare associated infection report - recommended CDA R3 set | ./2.16.840.1.114222.4.11.1002/86535-2.json |
| 86536-0 | Hantavirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86536-0.json |
| 86537-8 | Hantavirus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86537-8.json |
| 8653-8 | Hospital Discharge instructions | ./2.16.840.1.114222.4.11.1002/8653-8.json |
| 86538-6 | Hantavirus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86538-6.json |
| 86539-4 | Herpes simplex virus 1 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86539-4.json |
| 86540-2 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86540-2.json |
| 86541-0 | Herpes simplex virus 2 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86541-0.json |
| 86542-8 | Herpes simplex virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86542-8.json |
| 86543-6 | Herpes virus 6 DNA [Presence] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86543-6.json |
| 86544-4 | Herpes virus 7 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86544-4.json |
| 86545-1 | Herpes virus 8 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86545-1.json |
| 86546-9 | Herpes virus 8 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86546-9.json |
| 86547-7 | HIV 2 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86547-7.json |
| 86548-5 | HIV 2 RNA [#/volume] (viral load) in Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86548-5.json |
| 86549-3 | HIV 2 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86549-3.json |
| 86550-1 | HTLV I+II RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86550-1.json |
| 86558-4 | Healthcare personnel influenza vaccination summary report Document | ./2.16.840.1.114222.4.11.1002/86558-4.json |
| 86559-2 | Human bocavirus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86559-2.json |
| 86560-0 | Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86560-0.json |
| 86561-8 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86561-8.json |
| 86562-6 | Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86562-6.json |
| 86563-4 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86563-4.json |
| 86564-2 | Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86564-2.json |
| 86565-9 | Influenza virus A Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86565-9.json |
| 86566-7 | Influenza virus A IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86566-7.json |
| 86567-5 | Influenza virus A IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86567-5.json |
| 86568-3 | Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86568-3.json |
| 86569-1 | Influenza virus A RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86569-1.json |
| 86570-9 | Influenza virus B IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86570-9.json |
| 86571-7 | Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86571-7.json |
| 86572-5 | Influenza virus B RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86572-5.json |
| 86573-3 | JC virus DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86573-3.json |
| 86574-1 | Marburg virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86574-1.json |
| 86575-8 | Measles virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86575-8.json |
| 86576-6 | Measles virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86576-6.json |
| 86577-4 | Measles virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86577-4.json |
| 86578-2 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86578-2.json |
| 86579-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86579-0.json |
| 86580-8 | Mumps virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86580-8.json |
| 86581-6 | Neisseria meningitidis [Presence] in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/86581-6.json |
| 86582-4 | Parechovirus A RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86582-4.json |
| 86586-5 | Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86586-5.json |
| 86587-3 | Rabies virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86587-3.json |
| 86588-1 | Rabies virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86588-1.json |
| 86589-9 | Rubella virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86589-9.json |
| 86590-7 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/86590-7.json |
| 86591-5 | Toscana virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86591-5.json |
| 86592-3 | Varicella zoster virus Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86592-3.json |
| 86593-1 | Varicella zoster virus DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86593-1.json |
| 86594-9 | Zika virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86594-9.json |
| 86603-8 | Periodontal attachment - recommended CDA R1 set | ./2.16.840.1.114222.4.11.1002/86603-8.json |
| 86604-6 | Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86604-6.json |
| 86605-3 | Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86605-3.json |
| 86606-1 | Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86606-1.json |
| 86607-9 | Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86607-9.json |
| 86608-7 | Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86608-7.json |
| 86609-5 | Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86609-5.json |
| 86610-3 | SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/86610-3.json |
| 86611-1 | Chromosome analysis in Amniotic fluid or Chorionic villus sample by Microarray | ./2.16.840.1.114222.4.11.1002/86611-1.json |
| 86620-2 | Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86620-2.json |
| 86621-0 | Methicillin resistance mecC gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/86621-0.json |
| 86626-9 | Send document that conforms to Level 3 EMS R2 template | ./2.16.840.1.114222.4.11.1002/86626-9.json |
| 86627-7 | Send document that conforms to Oncology Treatment Plan Summary R1.3 template | ./2.16.840.1.114222.4.11.1002/86627-7.json |
| 86628-5 | Send document that conforms to Oncology Treatment Plan Summary R1.2.1 template | ./2.16.840.1.114222.4.11.1002/86628-5.json |
| 86629-3 | Send document that conforms to Oncology Treatment Plan Summary R1.2 template | ./2.16.840.1.114222.4.11.1002/86629-3.json |
| 86630-1 | Send document that conforms to Level 3 EMS R1 template | ./2.16.840.1.114222.4.11.1002/86630-1.json |
| 86635-0 | Family planning report Document | ./2.16.840.1.114222.4.11.1002/86635-0.json |
| 86664-0 | HIV Referral note | ./2.16.840.1.114222.4.11.1002/86664-0.json |
| 86688-9 | Rotavirus C [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/86688-9.json |
| 86695-4 | Porcine epidemic diarrhea virus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/86695-4.json |
| 86712-7 | Carbapenem resistance blaOXA gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/86712-7.json |
| 86713-5 | Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/86713-5.json |
| 86714-3 | Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/86714-3.json |
| 86715-0 | Actinobacillus pleuropneumoniae Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86715-0.json |
| 86716-8 | Actinobacillus pleuropneumoniae DNA [Cycle Threshold #] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86716-8.json |
| 86717-6 | Actinobacillus pleuropneumoniae serotype 1 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86717-6.json |
| 86718-4 | Actinobacillus pleuropneumoniae serotype 3 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86718-4.json |
| 86719-2 | Actinobacillus pleuropneumoniae serotype 5 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86719-2.json |
| 86720-0 | Actinobacillus pleuropneumoniae serotype 7 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/86720-0.json |
| 86721-8 | Actinobacillus pleuropneumoniae serotype identified in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86721-8.json |
| 86722-6 | Actinobacillus suis DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86722-6.json |
| 86723-4 | Actinobacillus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86723-4.json |
| 86724-2 | Erysipelothrix rhusiopathiae [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/86724-2.json |
| 86725-9 | Erysipelothrix rhusiopathiae Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/86725-9.json |
| 86726-7 | Erysipelothrix rhusiopathiae DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86726-7.json |
| 86727-5 | Erysipelothrix sp strain 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86727-5.json |
| 86728-3 | Erysipelothrix tonsillarum DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86728-3.json |
| 86729-1 | Haemophilus parasuis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86729-1.json |
| 86730-9 | Leptospira borgpetersenii sv Hardjo-bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86730-9.json |
| 86731-7 | Leptospira sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86731-7.json |
| 86732-5 | Leptospira sp identified [Type] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/86732-5.json |
| 86733-3 | Porcine parvovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/86733-3.json |
| 86734-1 | Porcine parvovirus Ab [Titer] in Serum by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/86734-1.json |
| 86735-8 | Porcine parvovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86735-8.json |
| 86736-6 | Porcine parvovirus type 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86736-6.json |
| 86737-4 | Toxoplasma gondii Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/86737-4.json |
| 86738-2 | Toxoplasma gondii IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/86738-2.json |
| 86739-0 | Streptococcus suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86739-0.json |
| 86740-8 | Streptococcus suis Ag [Presence] in Specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/86740-8.json |
| 86741-6 | Porcine parvovirus type 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/86741-6.json |
| 86799-4 | Coded cause of death - recommended CDA R1 sections | ./2.16.840.1.114222.4.11.1002/86799-4.json |
| 868-0 | A3 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/868-0.json |
| 86800-0 | Coded race and ethnicity - recommended CDA R1 sections | ./2.16.840.1.114222.4.11.1002/86800-0.json |
| 86801-8 | Jurisdiction death information - recommended CDA R1 sections | ./2.16.840.1.114222.4.11.1002/86801-8.json |
| 86802-6 | Cause of death and related information Document | ./2.16.840.1.114222.4.11.1002/86802-6.json |
| 86803-4 | Provider Death Registration - recommended CDA R1 sections | ./2.16.840.1.114222.4.11.1002/86803-4.json |
| 86804-2 | Cause of death classification and related information Document | ./2.16.840.1.114222.4.11.1002/86804-2.json |
| 86805-9 | Race and ethnicity information Document | ./2.16.840.1.114222.4.11.1002/86805-9.json |
| 86806-7 | Jurisdiction death registration Document | ./2.16.840.1.114222.4.11.1002/86806-7.json |
| 86807-5 | Death administrative information Document | ./2.16.840.1.114222.4.11.1002/86807-5.json |
| 86808-3 | Provider death registration Document | ./2.16.840.1.114222.4.11.1002/86808-3.json |
| 86857-0 | Flavivirus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86857-0.json |
| 86858-8 | Dengue virus 2 neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86858-8.json |
| 86859-6 | Dengue virus 3 neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86859-6.json |
| 86860-4 | Dengue virus 1 neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86860-4.json |
| 86861-2 | Dengue virus 4 neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86861-2.json |
| 86862-0 | Dengue virus 4 neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86862-0.json |
| 86863-8 | Dengue virus 3 neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86863-8.json |
| 86864-6 | Dengue virus 2 neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86864-6.json |
| 86865-3 | Dengue virus 1 neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/86865-3.json |
| 86894-3 | Adalimumab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86894-3.json |
| 86895-0 | Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86895-0.json |
| 86896-8 | inFLIXimab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86896-8.json |
| 86897-6 | inFLIXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86897-6.json |
| 86898-4 | Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86898-4.json |
| 86899-2 | Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/86899-2.json |
| 86904-0 | Carboxyhemoglobin/Hemoglobin.total in Arterial blood by Pulse oximetry | ./2.16.840.1.114222.4.11.1002/86904-0.json |
| 86908-1 | Systolic blood pressure goal | ./2.16.840.1.114222.4.11.1002/86908-1.json |
| 86909-9 | Diastolic blood pressure goal | ./2.16.840.1.114222.4.11.1002/86909-9.json |
| 86910-7 | Hemoglobin A1c/Hemoglobin.total goal Blood | ./2.16.840.1.114222.4.11.1002/86910-7.json |
| 86911-5 | Cholesterol in LDL goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86911-5.json |
| 86912-3 | Hemoglobin goal [Mass/volume] Blood | ./2.16.840.1.114222.4.11.1002/86912-3.json |
| 86913-1 | Iron saturation goal Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86913-1.json |
| 86914-9 | Ferritin goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86914-9.json |
| 86915-6 | Calcium goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86915-6.json |
| 86916-4 | Phosphate goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86916-4.json |
| 86917-2 | Parathyrin.intact goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86917-2.json |
| 86918-0 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86918-0.json |
| 86919-8 | Potassium goal [Moles/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86919-8.json |
| 86920-6 | Bicarbonate goal [Moles/volume] Blood | ./2.16.840.1.114222.4.11.1002/86920-6.json |
| 86921-4 | Albumin goal [Mass/volume] Serum or Plasma | ./2.16.840.1.114222.4.11.1002/86921-4.json |
| 86928-9 | Porcine epidemic diarrhea virus whole genome [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/86928-9.json |
| 86930-5 | Carbapenemase [Presence] in Isolate | ./2.16.840.1.114222.4.11.1002/86930-5.json |
| 86950-3 | Thymus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/86950-3.json |
| 86954-5 | Foreign material [Presence] in Food | ./2.16.840.1.114222.4.11.1002/86954-5.json |
| 86956-0 | CT Heart WO contrast IV and CT Heart for left ventricular function W contrast IV | ./2.16.840.1.114222.4.11.1002/86956-0.json |
| 86957-8 | CT Salivary gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86957-8.json |
| 86958-6 | CT Neck and Chest WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86958-6.json |
| 86959-4 | CT Cervical and thoracic spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86959-4.json |
| 86960-2 | CTA Upper extremity vessels - right W contrast IV | ./2.16.840.1.114222.4.11.1002/86960-2.json |
| 86961-0 | CTA Upper extremity vessels - left W contrast IV | ./2.16.840.1.114222.4.11.1002/86961-0.json |
| 86962-8 | CTA Upper extremity vessels - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86962-8.json |
| 86963-6 | CTA Lower extremity vessels - right W contrast IV | ./2.16.840.1.114222.4.11.1002/86963-6.json |
| 86964-4 | CTA Lower extremity vessels - left W contrast IV | ./2.16.840.1.114222.4.11.1002/86964-4.json |
| 86965-1 | CTA Lower extremity vessels - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86965-1.json |
| 86966-9 | CT Salivary gland WO contrast | ./2.16.840.1.114222.4.11.1002/86966-9.json |
| 86967-7 | CT Foot - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/86967-7.json |
| 86968-5 | CT Hand - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86968-5.json |
| 86969-3 | CT Shoulder - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86969-3.json |
| 86970-1 | CT Sacrum and Coccyx WO contrast | ./2.16.840.1.114222.4.11.1002/86970-1.json |
| 86971-9 | CTA Chest and abdominal vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86971-9.json |
| 86972-7 | CT Head and Neck WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86972-7.json |
| 86973-5 | CT Foot - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86973-5.json |
| 86974-3 | CT Thoracic and lumbar spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86974-3.json |
| 86975-0 | CT Heart for left ventricular function W contrast IV | ./2.16.840.1.114222.4.11.1002/86975-0.json |
| 86976-8 | PET+CT Brain metabolic | ./2.16.840.1.114222.4.11.1002/86976-8.json |
| 86977-6 | CT Head and Temporal bone W contrast IV | ./2.16.840.1.114222.4.11.1002/86977-6.json |
| 86978-4 | CT Head and Sinuses W contrast IV | ./2.16.840.1.114222.4.11.1002/86978-4.json |
| 86979-2 | CT Pelvis and Hip - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/86979-2.json |
| 86980-0 | CTA Heart and Coronary arteries WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/86980-0.json |
| 86981-8 | CTA Chest vessels | ./2.16.840.1.114222.4.11.1002/86981-8.json |
| 86982-6 | CTA Chest and abdominal vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/86982-6.json |
| 86983-4 | CTA Chest vessels and Abdominal vessels and Pelvis vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/86983-4.json |
| 86984-2 | CT Cervical and thoracic and lumbar spine W contrast IV | ./2.16.840.1.114222.4.11.1002/86984-2.json |
| 86985-9 | CT Cervical and thoracic spine W contrast IV | ./2.16.840.1.114222.4.11.1002/86985-9.json |
| 86986-7 | CT Neck and Chest W contrast IV | ./2.16.840.1.114222.4.11.1002/86986-7.json |
| 86987-5 | CT Cervical and thoracic and lumbar spine WO contrast | ./2.16.840.1.114222.4.11.1002/86987-5.json |
| 86988-3 | CT Orbit and Face WO contrast | ./2.16.840.1.114222.4.11.1002/86988-3.json |
| 86989-1 | CT Head and Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/86989-1.json |
| 86990-9 | CT Head and Orbit - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/86990-9.json |
| 86991-7 | CT Head and Maxillofacial region and Cervical spine WO contrast | ./2.16.840.1.114222.4.11.1002/86991-7.json |
| 86992-5 | CT Head and Sinuses WO contrast | ./2.16.840.1.114222.4.11.1002/86992-5.json |
| 86993-3 | Guidance for 1 level kyphoplasty of Spine vertebra | ./2.16.840.1.114222.4.11.1002/86993-3.json |
| 86994-1 | Guidance for 1 or 2 injections of trigger point of Muscle | ./2.16.840.1.114222.4.11.1002/86994-1.json |
| 86995-8 | Guidance for abscess | ./2.16.840.1.114222.4.11.1002/86995-8.json |
| 86996-6 | Guidance for additional augmentation of Spine vertebra | ./2.16.840.1.114222.4.11.1002/86996-6.json |
| 86997-4 | Guidance for additional day infusion of thrombolytic of Vessel-- W thrombolytic via catheter | ./2.16.840.1.114222.4.11.1002/86997-4.json |
| 86998-2 | Guidance for additional percutaneous mechanical thrombectomy of Vein | ./2.16.840.1.114222.4.11.1002/86998-2.json |
| 86999-0 | Guidance for additional percutaneous mechanical thrombectomy of Artery | ./2.16.840.1.114222.4.11.1002/86999-0.json |
| 87000-6 | Guidance for additional placement of endovascular device of Vein | ./2.16.840.1.114222.4.11.1002/87000-6.json |
| 87001-4 | Guidance for additional placement of stent of Artery | ./2.16.840.1.114222.4.11.1002/87001-4.json |
| 87002-2 | Guidance for additional placement of wire | ./2.16.840.1.114222.4.11.1002/87002-2.json |
| 87003-0 | Guidance for additional vertebroplasty of Spine vertebra | ./2.16.840.1.114222.4.11.1002/87003-0.json |
| 87004-8 | Guidance for arthrocentesis of Intermediate joint | ./2.16.840.1.114222.4.11.1002/87004-8.json |
| 87005-5 | Guidance for arthrocentesis of Major joint | ./2.16.840.1.114222.4.11.1002/87005-5.json |
| 87006-3 | Guidance for arthrocentesis of Small joint | ./2.16.840.1.114222.4.11.1002/87006-3.json |
| 87007-1 | Guidance for arthrocentesis of Joint | ./2.16.840.1.114222.4.11.1002/87007-1.json |
| 87008-9 | Guidance for fluid aspiration of Bone marrow | ./2.16.840.1.114222.4.11.1002/87008-9.json |
| 87009-7 | Guidance for aspiration of cyst | ./2.16.840.1.114222.4.11.1002/87009-7.json |
| 87010-5 | Guidance for aspiration of cyst of Bone | ./2.16.840.1.114222.4.11.1002/87010-5.json |
| 87011-3 | Guidance for aspiration of ganglion cyst | ./2.16.840.1.114222.4.11.1002/87011-3.json |
| 87012-1 | Guidance for fluid aspiration of Lymph node | ./2.16.840.1.114222.4.11.1002/87012-1.json |
| 87013-9 | Guidance for percutaneous biopsy of Bone | ./2.16.840.1.114222.4.11.1002/87013-9.json |
| 87014-7 | Guidance for biopsy of Bone marrow | ./2.16.840.1.114222.4.11.1002/87014-7.json |
| 87015-4 | Guidance for biopsy of Lymph node | ./2.16.840.1.114222.4.11.1002/87015-4.json |
| 87016-2 | Guidance for biopsy of Soft tissue | ./2.16.840.1.114222.4.11.1002/87016-2.json |
| 87017-0 | Guidance for check of drainage catheter for abscess | ./2.16.840.1.114222.4.11.1002/87017-0.json |
| 87018-8 | Guidance for deep biopsy of Bone | ./2.16.840.1.114222.4.11.1002/87018-8.json |
| 87019-6 | Guidance for drainage and placement of drainage catheter | ./2.16.840.1.114222.4.11.1002/87019-6.json |
| 87020-4 | Guidance for embolization of Artery | ./2.16.840.1.114222.4.11.1002/87020-4.json |
| 87021-2 | Guidance for embolization of Vein | ./2.16.840.1.114222.4.11.1002/87021-2.json |
| 87022-0 | Guidance for embolization of Vessels | ./2.16.840.1.114222.4.11.1002/87022-0.json |
| 87023-8 | Guidance for exchange of drainage catheter for abscess | ./2.16.840.1.114222.4.11.1002/87023-8.json |
| 87024-6 | Guidance for additional day infusion of thrombolytic of Chest-- W thrombolytic via chest tube | ./2.16.840.1.114222.4.11.1002/87024-6.json |
| 87025-3 | Guidance for additional level kyphoplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/87025-3.json |
| 87026-1 | Guidance for additional vertebroplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/87026-1.json |
| 87027-9 | Guidance for biopsy of Chest Pleura | ./2.16.840.1.114222.4.11.1002/87027-9.json |
| 87028-7 | Guidance for biopsy of Lung | ./2.16.840.1.114222.4.11.1002/87028-7.json |
| 87029-5 | Guidance for biopsy of Mediastinum | ./2.16.840.1.114222.4.11.1002/87029-5.json |
| 87030-3 | Guidance for biopsy of Neck or Chest Soft tissue | ./2.16.840.1.114222.4.11.1002/87030-3.json |
| 87031-1 | Guidance for check of peritoneovenous shunt of Chest and Abdomen | ./2.16.840.1.114222.4.11.1002/87031-1.json |
| 87032-9 | Guidance for cryoablation of Lung | ./2.16.840.1.114222.4.11.1002/87032-9.json |
| 87033-7 | Guidance for drainage and placement of chest tube of Pleural space | ./2.16.840.1.114222.4.11.1002/87033-7.json |
| 87034-5 | Guidance for exchange of catheter portion only of CV catheter with port of Chest | ./2.16.840.1.114222.4.11.1002/87034-5.json |
| 87035-2 | Guidance for exchange of CV catheter with port of Chest | ./2.16.840.1.114222.4.11.1002/87035-2.json |
| 87036-0 | Guidance for additional level kyphoplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87036-0.json |
| 87037-8 | Guidance for additional placement of stent of Iliac artery | ./2.16.840.1.114222.4.11.1002/87037-8.json |
| 87038-6 | Guidance for additional transluminal angioplasty of Iliac artery | ./2.16.840.1.114222.4.11.1002/87038-6.json |
| 87039-4 | Guidance for additional vertebroplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87039-4.json |
| 87040-2 | Guidance for aspiration of cyst of Kidney | ./2.16.840.1.114222.4.11.1002/87040-2.json |
| 87041-0 | Guidance for percutaneous biopsy of Kidney | ./2.16.840.1.114222.4.11.1002/87041-0.json |
| 87042-8 | Guidance for percutaneous biopsy of Liver | ./2.16.840.1.114222.4.11.1002/87042-8.json |
| 87043-6 | Guidance for biopsy of Ureter | ./2.16.840.1.114222.4.11.1002/87043-6.json |
| 87044-4 | Guidance for check of tube of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87044-4.json |
| 87045-1 | Guidance for cholangioscopy and removal of calculus of Gallbladder | ./2.16.840.1.114222.4.11.1002/87045-1.json |
| 87046-9 | Guidance for cholangioscopy of Gallbladder | ./2.16.840.1.114222.4.11.1002/87046-9.json |
| 87047-7 | Guidance for cholecystostomy of Gallbladder | ./2.16.840.1.114222.4.11.1002/87047-7.json |
| 87048-5 | Guidance for conversion of G-tube to GJ-tube of Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/87048-5.json |
| 87049-3 | Guidance for cryoablation of Kidney | ./2.16.840.1.114222.4.11.1002/87049-3.json |
| 87050-1 | Guidance for cryoablation of Liver | ./2.16.840.1.114222.4.11.1002/87050-1.json |
| 87051-9 | Guidance for dilation of stricture of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87051-9.json |
| 87052-7 | Guidance for exchange of G-tube of Stomach | ./2.16.840.1.114222.4.11.1002/87052-7.json |
| 87053-5 | Guidance for exchange of J-tube of Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/87053-5.json |
| 87054-3 | Guidance for exchange of nephrostomy tube of Kidney | ./2.16.840.1.114222.4.11.1002/87054-3.json |
| 87055-0 | Guidance for biopsy of Pancreas | ./2.16.840.1.114222.4.11.1002/87055-0.json |
| 87056-8 | Guidance for biopsy of Abdomen | ./2.16.840.1.114222.4.11.1002/87056-8.json |
| 87057-6 | Guidance for placement of fiducial marker in Abdomen | ./2.16.840.1.114222.4.11.1002/87057-6.json |
| 87058-4 | Guidance for radiofrequency ablation of Kidney | ./2.16.840.1.114222.4.11.1002/87058-4.json |
| 87059-2 | Guidance for biopsy of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87059-2.json |
| 87060-0 | Guidance for removal of calculus from Biliary ducts | ./2.16.840.1.114222.4.11.1002/87060-0.json |
| 87061-8 | Guidance for injection of contrast of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87061-8.json |
| 87062-6 | Guidance for nerve block of Celiac plexus | ./2.16.840.1.114222.4.11.1002/87062-6.json |
| 87063-4 | Guidance for removal of GJ-tube from Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/87063-4.json |
| 87064-2 | Guidance for placement of GJ-tube in Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/87064-2.json |
| 87065-9 | Guidance for placement of G-tube in Gastrointestinal tract upper | ./2.16.840.1.114222.4.11.1002/87065-9.json |
| 87066-7 | Guidance for percutaneous placement of nephrostomy tube of Kidney | ./2.16.840.1.114222.4.11.1002/87066-7.json |
| 87067-5 | Guidance for transjugular biopsy of Kidney | ./2.16.840.1.114222.4.11.1002/87067-5.json |
| 87068-3 | Guidance for transjugular biopsy and venography of Kidney | ./2.16.840.1.114222.4.11.1002/87068-3.json |
| 87069-1 | Guidance for hemodynamic evaluation of Liver | ./2.16.840.1.114222.4.11.1002/87069-1.json |
| 87070-9 | Guidance for microwave ablation of Liver | ./2.16.840.1.114222.4.11.1002/87070-9.json |
| 87071-7 | Guidance for radiofrequency ablation of Liver | ./2.16.840.1.114222.4.11.1002/87071-7.json |
| 87072-5 | Guidance for placement of TIPS of Liver | ./2.16.840.1.114222.4.11.1002/87072-5.json |
| 87073-3 | Guidance for revision of TIPS of Liver | ./2.16.840.1.114222.4.11.1002/87073-3.json |
| 87074-1 | Guidance for transhepatic revision of tube of Liver | ./2.16.840.1.114222.4.11.1002/87074-1.json |
| 87075-8 | Guidance for transjugular biopsy of Liver | ./2.16.840.1.114222.4.11.1002/87075-8.json |
| 87076-6 | Guidance for transjugular biopsy and hemodynamic evaluation of Liver | ./2.16.840.1.114222.4.11.1002/87076-6.json |
| 87077-4 | Guidance for transjugular biopsy and venography of Liver | ./2.16.840.1.114222.4.11.1002/87077-4.json |
| 87078-2 | Guidance for percutaneous drainage and placement of drainage catheter of Abdomen | ./2.16.840.1.114222.4.11.1002/87078-2.json |
| 87079-0 | Guidance for paracentesis and insertion of tube of Peritoneum | ./2.16.840.1.114222.4.11.1002/87079-0.json |
| 87080-8 | Guidance for paracentesis of Peritoneum | ./2.16.840.1.114222.4.11.1002/87080-8.json |
| 87081-6 | Guidance for placement of catheter in Peritoneum | ./2.16.840.1.114222.4.11.1002/87081-6.json |
| 87082-4 | Guidance for removal of catheter from Peritoneum | ./2.16.840.1.114222.4.11.1002/87082-4.json |
| 87083-2 | Guidance for reposition of catheter in Peritoneum | ./2.16.840.1.114222.4.11.1002/87083-2.json |
| 87084-0 | Guidance for removal of foreign body from Peritoneum | ./2.16.840.1.114222.4.11.1002/87084-0.json |
| 87085-7 | Guidance for placement of port in Peritoneum | ./2.16.840.1.114222.4.11.1002/87085-7.json |
| 87086-5 | Guidance for removal of port from Peritoneum | ./2.16.840.1.114222.4.11.1002/87086-5.json |
| 87087-3 | Guidance for percutaneous transluminal angioplasty of Renal artery | ./2.16.840.1.114222.4.11.1002/87087-3.json |
| 87088-1 | Guidance for puncture of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87088-1.json |
| 87089-9 | Guidance for kyphoplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87089-9.json |
| 87090-7 | Guidance for myelography of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87090-7.json |
| 87091-5 | Guidance for vertebroplasty of Lumbar spine | ./2.16.840.1.114222.4.11.1002/87091-5.json |
| 87092-3 | Guidance for placement of venous filter in Inferior vena cava | ./2.16.840.1.114222.4.11.1002/87092-3.json |
| 87093-1 | Guidance for removal of venous filter from Inferior vena cava | ./2.16.840.1.114222.4.11.1002/87093-1.json |
| 87094-9 | Guidance for reposition of venous filter in Inferior vena cava | ./2.16.840.1.114222.4.11.1002/87094-9.json |
| 87095-6 | Guidance for percutaneous transluminal angioplasty of Visceral artery | ./2.16.840.1.114222.4.11.1002/87095-6.json |
| 87096-4 | Guidance for placement of stent in Visceral artery | ./2.16.840.1.114222.4.11.1002/87096-4.json |
| 87097-2 | Guidance for placement of peritoneovenous shunt in Chest and Abdomen | ./2.16.840.1.114222.4.11.1002/87097-2.json |
| 87098-0 | Guidance for removal of peritoneovenous shunt from Chest and Abdomen | ./2.16.840.1.114222.4.11.1002/87098-0.json |
| 87099-8 | Guidance for revision of peritoneovenous shunt of Chest and Abdomen | ./2.16.840.1.114222.4.11.1002/87099-8.json |
| 87100-4 | Guidance for percutaneous transluminal angioplasty of Thoracic and abdominal aorta | ./2.16.840.1.114222.4.11.1002/87100-4.json |
| 87101-2 | Guidance for percutaneous transluminal angioplasty of Brachiocephalic artery | ./2.16.840.1.114222.4.11.1002/87101-2.json |
| 87102-0 | Guidance for initial day infusion of thrombolytic of Chest-- W thrombolytic via chest tube | ./2.16.840.1.114222.4.11.1002/87102-0.json |
| 87103-8 | Guidance for infusion of thrombolytic of Chest-- W thrombolytic via CVC | ./2.16.840.1.114222.4.11.1002/87103-8.json |
| 87104-6 | Guidance for injection of CV catheter of Chest | ./2.16.840.1.114222.4.11.1002/87104-6.json |
| 87105-3 | Guidance for reposition of CV catheter in Chest | ./2.16.840.1.114222.4.11.1002/87105-3.json |
| 87106-1 | Guidance for placement of CV catheter with port in Chest | ./2.16.840.1.114222.4.11.1002/87106-1.json |
| 87107-9 | Guidance for removal of CV catheter with port from Chest | ./2.16.840.1.114222.4.11.1002/87107-9.json |
| 87108-7 | Guidance for repair of CV catheter with port of Chest | ./2.16.840.1.114222.4.11.1002/87108-7.json |
| 87109-5 | Guidance for placement of Swan-Ganz catheter in Chest | ./2.16.840.1.114222.4.11.1002/87109-5.json |
| 87110-3 | Guidance for thoracentesis and insertion of tube of Chest | ./2.16.840.1.114222.4.11.1002/87110-3.json |
| 87111-1 | Guidance for thoracentesis of Chest | ./2.16.840.1.114222.4.11.1002/87111-1.json |
| 87112-9 | Guidance for exchange of tunneled CV catheter without port of Chest | ./2.16.840.1.114222.4.11.1002/87112-9.json |
| 87113-7 | Guidance for placement of tunneled CV catheter without port in Chest | ./2.16.840.1.114222.4.11.1002/87113-7.json |
| 87114-5 | Guidance for removal of tunneled CV catheter without port from Chest | ./2.16.840.1.114222.4.11.1002/87114-5.json |
| 87115-2 | Guidance for repair of non-tunneled CV catheter without port of Chest | ./2.16.840.1.114222.4.11.1002/87115-2.json |
| 87116-0 | Guidance for placement of chest tube in Pleural space | ./2.16.840.1.114222.4.11.1002/87116-0.json |
| 87117-8 | Guidance for pericardiocentesis of Heart | ./2.16.840.1.114222.4.11.1002/87117-8.json |
| 87118-6 | Guidance for placement of fiducial marker in Lung | ./2.16.840.1.114222.4.11.1002/87118-6.json |
| 87119-4 | Guidance for microwave ablation of Lung | ./2.16.840.1.114222.4.11.1002/87119-4.json |
| 87120-2 | Guidance for radiofrequency ablation of Lung | ./2.16.840.1.114222.4.11.1002/87120-2.json |
| 87121-0 | Guidance for placement of tunneled catheter in Chest Pleura | ./2.16.840.1.114222.4.11.1002/87121-0.json |
| 87122-8 | Guidance for kyphoplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/87122-8.json |
| 87123-6 | Guidance for myelography of Thoracic spine | ./2.16.840.1.114222.4.11.1002/87123-6.json |
| 87124-4 | Guidance for vertebroplasty of Thoracic spine | ./2.16.840.1.114222.4.11.1002/87124-4.json |
| 87125-1 | Guidance for nerve block of Thoracic spine intercostal nerve | ./2.16.840.1.114222.4.11.1002/87125-1.json |
| 87126-9 | Guidance for removal of venous filter from Superior vena cava | ./2.16.840.1.114222.4.11.1002/87126-9.json |
| 87127-7 | Guidance for reposition of venous filter in Superior vena cava | ./2.16.840.1.114222.4.11.1002/87127-7.json |
| 87128-5 | Guidance for placement of venous filter in Superior vena cava | ./2.16.840.1.114222.4.11.1002/87128-5.json |
| 87129-3 | Guidance for percutaneous transluminal angioplasty of Lower leg | ./2.16.840.1.114222.4.11.1002/87129-3.json |
| 87130-1 | Guidance for laser ablation of Extremity vein | ./2.16.840.1.114222.4.11.1002/87130-1.json |
| 87131-9 | Guidance for greater than 20 stab phlebectomy of Extremity vein | ./2.16.840.1.114222.4.11.1002/87131-9.json |
| 87132-7 | Guidance for injection of Ankle | ./2.16.840.1.114222.4.11.1002/87132-7.json |
| 87133-5 | Guidance for percutaneous transluminal angioplasty of Femoral artery and Popliteal artery | ./2.16.840.1.114222.4.11.1002/87133-5.json |
| 87134-3 | Guidance for placement of stent in Femoral artery and Popliteal artery | ./2.16.840.1.114222.4.11.1002/87134-3.json |
| 87135-0 | Guidance for injection of Hip | ./2.16.840.1.114222.4.11.1002/87135-0.json |
| 87136-8 | Guidance for arthrocentesis of Knee | ./2.16.840.1.114222.4.11.1002/87136-8.json |
| 87137-6 | Guidance for injection of Knee | ./2.16.840.1.114222.4.11.1002/87137-6.json |
| 87138-4 | Guidance for additional laser ablation of Extremity vein | ./2.16.840.1.114222.4.11.1002/87138-4.json |
| 87139-2 | Guidance for additional transluminal angioplasty of Lower leg | ./2.16.840.1.114222.4.11.1002/87139-2.json |
| 87140-0 | Guidance for additional placement of stent of Lower leg vessel | ./2.16.840.1.114222.4.11.1002/87140-0.json |
| 87141-8 | Guidance for placement of CV catheter with port in Upper extremity | ./2.16.840.1.114222.4.11.1002/87141-8.json |
| 87142-6 | Guidance for exchange of CV catheter with port of Upper extremity | ./2.16.840.1.114222.4.11.1002/87142-6.json |
| 87143-4 | Guidance for exchange of peripherally inserted central catheter of Upper extremity | ./2.16.840.1.114222.4.11.1002/87143-4.json |
| 87144-2 | Guidance for placement of peripherally-inserted central venous catheter in Upper extremity | ./2.16.840.1.114222.4.11.1002/87144-2.json |
| 87145-9 | Guidance for embolization of Brachial artery | ./2.16.840.1.114222.4.11.1002/87145-9.json |
| 87146-7 | Guidance for injection of Shoulder | ./2.16.840.1.114222.4.11.1002/87146-7.json |
| 87147-5 | Guidance for injection of Wrist | ./2.16.840.1.114222.4.11.1002/87147-5.json |
| 87148-3 | Guidance for injection of thrombin for pseudoaneurysm | ./2.16.840.1.114222.4.11.1002/87148-3.json |
| 87149-1 | Guidance for exchange of chest tube of Chest | ./2.16.840.1.114222.4.11.1002/87149-1.json |
| 87150-9 | Guidance for percutaneous transluminal angioplasty of Iliac artery | ./2.16.840.1.114222.4.11.1002/87150-9.json |
| 87151-7 | Guidance for placement of stent in Iliac artery | ./2.16.840.1.114222.4.11.1002/87151-7.json |
| 87152-5 | Guidance for exchange of ureterostomy through ileal conduit of Ureter | ./2.16.840.1.114222.4.11.1002/87152-5.json |
| 87153-3 | Guidance for therapeutic puncture and drainage of Cervical spine | ./2.16.840.1.114222.4.11.1002/87153-3.json |
| 87154-1 | Guidance for diagnostic puncture of Cervical spine | ./2.16.840.1.114222.4.11.1002/87154-1.json |
| 87155-8 | Guidance for fine needle aspiration of Thyroid gland | ./2.16.840.1.114222.4.11.1002/87155-8.json |
| 87156-6 | Guidance for percutaneous biopsy.core needle of Thyroid gland | ./2.16.840.1.114222.4.11.1002/87156-6.json |
| 87157-4 | Guidance for injection of platelet rich plasma | ./2.16.840.1.114222.4.11.1002/87157-4.json |
| 87158-2 | Guidance for injection of Tendon | ./2.16.840.1.114222.4.11.1002/87158-2.json |
| 87159-0 | Guidance for injection of Temporomandibular joint | ./2.16.840.1.114222.4.11.1002/87159-0.json |
| 87160-8 | Guidance for injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/87160-8.json |
| 87161-6 | Guidance for injection of Spine epidural space | ./2.16.840.1.114222.4.11.1002/87161-6.json |
| 87162-4 | Guidance for placement of needle | ./2.16.840.1.114222.4.11.1002/87162-4.json |
| 87163-2 | Guidance for placement of endovascular device in Vein | ./2.16.840.1.114222.4.11.1002/87163-2.json |
| 87164-0 | Guidance for secondary mechanical thrombectomy of Artery | ./2.16.840.1.114222.4.11.1002/87164-0.json |
| 87165-7 | Guidance for placement of endograft in Iliac artery | ./2.16.840.1.114222.4.11.1002/87165-7.json |
| 87166-5 | Guidance for percutaneous transluminal angioplasty of Vein | ./2.16.840.1.114222.4.11.1002/87166-5.json |
| 87167-3 | Guidance for transcatheter biopsy | ./2.16.840.1.114222.4.11.1002/87167-3.json |
| 87168-1 | Guidance for transcatheter placement of stent | ./2.16.840.1.114222.4.11.1002/87168-1.json |
| 87169-9 | Guidance for initial mechanical thrombectomy of Artery | ./2.16.840.1.114222.4.11.1002/87169-9.json |
| 87170-7 | Guidance for ligation of Lymphatic vessel | ./2.16.840.1.114222.4.11.1002/87170-7.json |
| 87171-5 | Guidance for placement of clip | ./2.16.840.1.114222.4.11.1002/87171-5.json |
| 87172-3 | Guidance for placement of clip-- preoperative | ./2.16.840.1.114222.4.11.1002/87172-3.json |
| 87173-1 | Guidance for biopsy of Prostate | ./2.16.840.1.114222.4.11.1002/87173-1.json |
| 87174-9 | Guidance for biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/87174-9.json |
| 87175-6 | Guidance for deep drainage and placement of drainage catheter of Pelvis | ./2.16.840.1.114222.4.11.1002/87175-6.json |
| 87176-4 | Guidance for radiofrequency ablation of Bone | ./2.16.840.1.114222.4.11.1002/87176-4.json |
| 87177-2 | Guidance for radiofrequency ablation of Chest Pleura | ./2.16.840.1.114222.4.11.1002/87177-2.json |
| 87178-0 | Guidance for final day of infusion of thrombolytic of Vessel-- W thrombolytic via catheter | ./2.16.840.1.114222.4.11.1002/87178-0.json |
| 87179-8 | Guidance for fine needle aspiration | ./2.16.840.1.114222.4.11.1002/87179-8.json |
| 87180-6 | Guidance for dilation of Fallopian tube | ./2.16.840.1.114222.4.11.1002/87180-6.json |
| 87181-4 | Guidance for embolization of Uterine artery | ./2.16.840.1.114222.4.11.1002/87181-4.json |
| 87182-2 | Guidance for placement of wire | ./2.16.840.1.114222.4.11.1002/87182-2.json |
| 87183-0 | Guidance for greater than 2 injections of trigger point of Muscle | ./2.16.840.1.114222.4.11.1002/87183-0.json |
| 87184-8 | Guidance for percutaneous transluminal angioplasty of arterial anastomosis of Artery | ./2.16.840.1.114222.4.11.1002/87184-8.json |
| 87185-5 | Guidance for sympathectomy of Nerve | ./2.16.840.1.114222.4.11.1002/87185-5.json |
| 87186-3 | Guidance for mechanical thrombectomy of central venous catheter lumen obstruction | ./2.16.840.1.114222.4.11.1002/87186-3.json |
| 87187-1 | Guidance for nerve block of Nerve root | ./2.16.840.1.114222.4.11.1002/87187-1.json |
| 87188-9 | Guidance for exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/87188-9.json |
| 87189-7 | Guidance for transurethral removal of nephroureteral stent of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/87189-7.json |
| 87190-5 | Guidance for percutaneous placement of nephroureteral stent of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/87190-5.json |
| 87191-3 | Guidance for removal of nephroureteral stent of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/87191-3.json |
| 87192-1 | Guidance for thrombectomy | ./2.16.840.1.114222.4.11.1002/87192-1.json |
| 87193-9 | Guidance for initial day infusion of thrombolytic of Artery-- W thrombolytic via catheter | ./2.16.840.1.114222.4.11.1002/87193-9.json |
| 87194-7 | Guidance for initial mechanical thrombectomy of Vein | ./2.16.840.1.114222.4.11.1002/87194-7.json |
| 87195-4 | Guidance for initial day infusion of thrombolytic of Vein-- W thrombolytic via catheter | ./2.16.840.1.114222.4.11.1002/87195-4.json |
| 87196-2 | Guidance for infusion of non-thrombolytic of Vessel | ./2.16.840.1.114222.4.11.1002/87196-2.json |
| 87197-0 | Guidance for retrieval of foreign body of Vessel | ./2.16.840.1.114222.4.11.1002/87197-0.json |
| 87198-8 | Guidance for placement of drainage catheter for abscess | ./2.16.840.1.114222.4.11.1002/87198-8.json |
| 87199-6 | Guidance for substance removal of central venous catheter pericatheter obstruction | ./2.16.840.1.114222.4.11.1002/87199-6.json |
| 87200-2 | Guidance for placement of stent in Artery | ./2.16.840.1.114222.4.11.1002/87200-2.json |
| 87201-0 | Guidance for treatment of AV fistula | ./2.16.840.1.114222.4.11.1002/87201-0.json |
| 87202-8 | Guidance for venous sampling of Vein | ./2.16.840.1.114222.4.11.1002/87202-8.json |
| 87203-6 | Guidance for transurethral exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder | ./2.16.840.1.114222.4.11.1002/87203-6.json |
| 87205-1 | Guidance for exchange of non-tunneled CV catheter of Chest | ./2.16.840.1.114222.4.11.1002/87205-1.json |
| 87206-9 | Guidance for nerve block of Peripheral nerve | ./2.16.840.1.114222.4.11.1002/87206-9.json |
| 87231-7 | Medication administration.extended Document | ./2.16.840.1.114222.4.11.1002/87231-7.json |
| 87232-5 | Medication administration.brief | ./2.16.840.1.114222.4.11.1002/87232-5.json |
| 87233-3 | Dialysis Consult note | ./2.16.840.1.114222.4.11.1002/87233-3.json |
| 87234-1 | Dialysis Education note | ./2.16.840.1.114222.4.11.1002/87234-1.json |
| 87235-8 | Dialysis Discharge summary | ./2.16.840.1.114222.4.11.1002/87235-8.json |
| 87236-6 | Dialysis Summary note | ./2.16.840.1.114222.4.11.1002/87236-6.json |
| 87237-4 | Dialysis Plan of care note | ./2.16.840.1.114222.4.11.1002/87237-4.json |
| 87238-2 | Dialysis Note | ./2.16.840.1.114222.4.11.1002/87238-2.json |
| 87239-0 | Mental health Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/87239-0.json |
| 87240-8 | Mental health Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/87240-8.json |
| 87242-4 | Geobacillus stearothermophilus [Presence] in Laboratory device by Culture | ./2.16.840.1.114222.4.11.1002/87242-4.json |
| 87243-2 | Microscopic observation [Presence] in Specimen by Auramine fluorochrome stain | ./2.16.840.1.114222.4.11.1002/87243-2.json |
| 87244-0 | Addiction medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/87244-0.json |
| 87245-7 | Addiction medicine Custodial care facility Note | ./2.16.840.1.114222.4.11.1002/87245-7.json |
| 87246-5 | Addiction medicine Hospital Note | ./2.16.840.1.114222.4.11.1002/87246-5.json |
| 87247-3 | Addiction medicine Medication management note | ./2.16.840.1.114222.4.11.1002/87247-3.json |
| 87248-1 | Addiction medicine Education note | ./2.16.840.1.114222.4.11.1002/87248-1.json |
| 87249-9 | Addiction medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/87249-9.json |
| 87250-7 | Addiction medicine Referral note | ./2.16.840.1.114222.4.11.1002/87250-7.json |
| 87251-5 | Addiction medicine Administrative note | ./2.16.840.1.114222.4.11.1002/87251-5.json |
| 87252-3 | Addiction medicine Admission evaluation note | ./2.16.840.1.114222.4.11.1002/87252-3.json |
| 87253-1 | Addiction medicine Plan of care note | ./2.16.840.1.114222.4.11.1002/87253-1.json |
| 87254-9 | Addiction medicine Consult note | ./2.16.840.1.114222.4.11.1002/87254-9.json |
| 87255-6 | Addiction medicine Counseling note | ./2.16.840.1.114222.4.11.1002/87255-6.json |
| 87256-4 | Addiction medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/87256-4.json |
| 87257-2 | Addiction medicine Group counseling note | ./2.16.840.1.114222.4.11.1002/87257-2.json |
| 87258-0 | Addiction medicine Risk assessment and screening note | ./2.16.840.1.114222.4.11.1002/87258-0.json |
| 87259-8 | Addiction medicine History and physical note | ./2.16.840.1.114222.4.11.1002/87259-8.json |
| 87260-6 | Addiction medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/87260-6.json |
| 87261-4 | Addiction medicine Case manager Note | ./2.16.840.1.114222.4.11.1002/87261-4.json |
| 87262-2 | Addiction medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/87262-2.json |
| 87263-0 | Addiction medicine Team Note | ./2.16.840.1.114222.4.11.1002/87263-0.json |
| 87264-8 | Addiction medicine Therapist Note | ./2.16.840.1.114222.4.11.1002/87264-8.json |
| 87265-5 | Dialysis Interdisciplinary Plan of care note | ./2.16.840.1.114222.4.11.1002/87265-5.json |
| 87266-3 | Dialysis Nurse Note | ./2.16.840.1.114222.4.11.1002/87266-3.json |
| 87267-1 | Dialysis Physician Note | ./2.16.840.1.114222.4.11.1002/87267-1.json |
| 87268-9 | Hepatology Immunization note | ./2.16.840.1.114222.4.11.1002/87268-9.json |
| 87269-7 | Nurse Immunization note | ./2.16.840.1.114222.4.11.1002/87269-7.json |
| 87270-5 | Nurse Outpatient Immunization note | ./2.16.840.1.114222.4.11.1002/87270-5.json |
| 87271-3 | Occupational medicine Immunization note | ./2.16.840.1.114222.4.11.1002/87271-3.json |
| 87272-1 | Primary care Immunization note | ./2.16.840.1.114222.4.11.1002/87272-1.json |
| 87273-9 | Immunization note | ./2.16.840.1.114222.4.11.1002/87273-9.json |
| 87279-6 | CT Chest for screening | ./2.16.840.1.114222.4.11.1002/87279-6.json |
| 87280-4 | CTA Abdominal veins and Pelvis veins and Lower extremity veins - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/87280-4.json |
| 87281-2 | CTA Lower extremity veins - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/87281-2.json |
| 87282-0 | Brachyspira hyodysenteriae DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87282-0.json |
| 87283-8 | Brachyspira hampsonii DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87283-8.json |
| 87284-6 | Brachyspira hyodysenteriae DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87284-6.json |
| 87285-3 | Brachyspira pilosicoli DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87285-3.json |
| 87286-1 | Birth attendant [Extended Identifier] | ./2.16.840.1.114222.4.11.1002/87286-1.json |
| 87287-9 | Birth certifier [Extended Identifier] | ./2.16.840.1.114222.4.11.1002/87287-9.json |
| 87292-9 | Name not yet chosen | ./2.16.840.1.114222.4.11.1002/87292-9.json |
| 87294-5 | Guardian or legally authorized representative signature for Social Security Number request | ./2.16.840.1.114222.4.11.1002/87294-5.json |
| 87295-2 | Social Security Number was requested | ./2.16.840.1.114222.4.11.1002/87295-2.json |
| 87296-0 | Age--at delivery Father | ./2.16.840.1.114222.4.11.1002/87296-0.json |
| 87297-8 | Birth registration date | ./2.16.840.1.114222.4.11.1002/87297-8.json |
| 87298-6 | Cigarettes smoked per day by Mother--1st trimester | ./2.16.840.1.114222.4.11.1002/87298-6.json |
| 87299-4 | Cigarettes smoked per day by Mother--2nd trimester | ./2.16.840.1.114222.4.11.1002/87299-4.json |
| 87300-0 | Highest level of education Father | ./2.16.840.1.114222.4.11.1002/87300-0.json |
| 87301-8 | Mother was married at any time during pregnancy | ./2.16.840.1.114222.4.11.1002/87301-8.json |
| 87303-4 | Mother WIC food recipient | ./2.16.840.1.114222.4.11.1002/87303-4.json |
| 87304-2 | Clostridium perfringens cpa gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87304-2.json |
| 87305-9 | Clostridium perfringens cpb2 gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87305-9.json |
| 87306-7 | Clostridium perfringens cpe gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87306-7.json |
| 87307-5 | Clostridium perfringens etx gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87307-5.json |
| 87308-3 | Guidance for transhepatic removal of catheter of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87308-3.json |
| 87309-1 | Guidance for transhepatic placement of catheter of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87309-1.json |
| 87310-9 | Guidance for transhepatic exchange of catheter of Biliary ducts | ./2.16.840.1.114222.4.11.1002/87310-9.json |
| 87311-7 | Guidance for embolization for tumor, ischemia or infarction of Vessel | ./2.16.840.1.114222.4.11.1002/87311-7.json |
| 87312-5 | Guidance for percutaneous transluminal angioplasty for dialysis of Vein | ./2.16.840.1.114222.4.11.1002/87312-5.json |
| 87313-3 | Clostridium perfringens iota toxin DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87313-3.json |
| 87314-1 | Encephalomyocarditis virus [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87314-1.json |
| 87315-8 | Encephalomyocarditis virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87315-8.json |
| 87316-6 | Enterovirus G RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87316-6.json |
| 87317-4 | Escherichia coli [#/volume] in Water by Viability count | ./2.16.840.1.114222.4.11.1002/87317-4.json |
| 87318-2 | Escherichia coli eaeA gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87318-2.json |
| 87319-0 | Escherichia coli enteroaggregative astA gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87319-0.json |
| 87320-8 | Escherichia coli enterotoxigenic heat-labile toxin DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87320-8.json |
| 87321-6 | Escherichia coli enterotoxigenic sta gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87321-6.json |
| 87322-4 | Escherichia coli enterotoxigenic stb gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87322-4.json |
| 87354-7 | Actinobacillus pleuropneumoniae Ab/Positive control in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87354-7.json |
| 87355-4 | Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87355-4.json |
| 87356-2 | Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87356-2.json |
| 87357-0 | Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87357-0.json |
| 87358-8 | Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87358-8.json |
| 87359-6 | Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87359-6.json |
| 87360-4 | Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87360-4.json |
| 87361-2 | Toxoplasma gondii Ab/Negative control in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87361-2.json |
| 87362-0 | Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87362-0.json |
| 87363-8 | Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87363-8.json |
| 87364-6 | Haemophilus parasuis Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87364-6.json |
| 87365-3 | Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87365-3.json |
| 87366-1 | Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87366-1.json |
| 87367-9 | Erysipelothrix rhusiopathiae Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87367-9.json |
| 87368-7 | Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87368-7.json |
| 87369-5 | Lawsonia intracellularis VNTR pattern [Type] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87369-5.json |
| 87370-3 | Escherichia coli fasA gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87370-3.json |
| 87371-1 | Escherichia coli fedF gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87371-1.json |
| 87372-9 | Escherichia coli FimF41a gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87372-9.json |
| 87373-7 | Escherichia coli K88 DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87373-7.json |
| 87374-5 | Escherichia coli K99 DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87374-5.json |
| 87375-2 | Escherichia coli paa gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87375-2.json |
| 87376-0 | Escherichia coli Stx1 toxin stx1 gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87376-0.json |
| 87377-8 | Escherichia coli Stx2 toxin stx2 gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87377-8.json |
| 87378-6 | Isotopic Tubular extraction rate/1.73 sq M [Volume Rate/Area] in Serum or Blood | ./2.16.840.1.114222.4.11.1002/87378-6.json |
| 87379-4 | Cannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87379-4.json |
| 87380-2 | Escherichia coli Stx2e toxin stx2e gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87380-2.json |
| 87381-0 | Porcine adenovirus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87381-0.json |
| 87382-8 | Porcine cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87382-8.json |
| 87383-6 | Porcine hemagglutinating encephalomyelitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87383-6.json |
| 87384-4 | Porcine parainfluenza virus 1 HN gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87384-4.json |
| 87385-1 | Porcine parainfluenza virus 1 F gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87385-1.json |
| 87386-9 | Porcine parainfluenza virus 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87386-9.json |
| 87387-7 | Porcine parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87387-7.json |
| 87388-5 | Porcine sapelovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87388-5.json |
| 87389-3 | Porcine sapelovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87389-3.json |
| 87390-1 | Porcine sapelovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87390-1.json |
| 87391-9 | Porcine teschovirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87391-9.json |
| 87392-7 | Porcine teschovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87392-7.json |
| 87393-5 | Salmonella sp Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87393-5.json |
| 87394-3 | Salmonella sp DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87394-3.json |
| 87395-0 | West Nile virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87395-0.json |
| 87396-8 | GenBank accession number | ./2.16.840.1.114222.4.11.1002/87396-8.json |
| 87397-6 | Clostridium perfringens cpb gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87397-6.json |
| 87398-4 | Brachyspira sp DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87398-4.json |
| 87399-2 | Porcine teschovirus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87399-2.json |
| 87400-8 | Brachyspira sp Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/87400-8.json |
| 87401-6 | Brachyspira pilosicoli DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87401-6.json |
| 87402-4 | Escherichia coli aidA-I gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87402-4.json |
| 87403-2 | Platelet aggregation ristocetin induced in Platelet rich plasma --750 ug/mL | ./2.16.840.1.114222.4.11.1002/87403-2.json |
| 87404-0 | Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87404-0.json |
| 87405-7 | Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87405-7.json |
| 87406-5 | Golimumab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87406-5.json |
| 87407-3 | Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87407-3.json |
| 87408-1 | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87408-1.json |
| 87409-9 | Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87409-9.json |
| 87410-7 | Thymidine synthase activity interpretation in Blood or Tissue Qualitative | ./2.16.840.1.114222.4.11.1002/87410-7.json |
| 87411-5 | Brachyspira hyodysenteriae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87411-5.json |
| 87412-3 | Brachyspira sp nox gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87412-3.json |
| 87413-1 | Brachyspira sp [Type] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87413-1.json |
| 87416-4 | Diagnostic imaging report - recommended DICOM PS3.20 sections | ./2.16.840.1.114222.4.11.1002/87416-4.json |
| 87418-0 | Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87418-0.json |
| 87419-8 | Cytolethal distending toxin B+Vinculin Ab [Interpretation] in Serum Qualitative by Immunoassay | ./2.16.840.1.114222.4.11.1002/87419-8.json |
| 87420-6 | Vinculin Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87420-6.json |
| 87422-2 | Glucose [Mass/volume] in Blood --post meal | ./2.16.840.1.114222.4.11.1002/87422-2.json |
| 87436-2 | Chromosome X and Y aneuploidy in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/87436-2.json |
| 87437-0 | Oxyhemoglobin [Mass/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/87437-0.json |
| 87439-6 | Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay | ./2.16.840.1.114222.4.11.1002/87439-6.json |
| 87440-4 | Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by Immunoassay | ./2.16.840.1.114222.4.11.1002/87440-4.json |
| 87442-0 | Turbidity of Water | ./2.16.840.1.114222.4.11.1002/87442-0.json |
| 87443-8 | Hardness [Mass/volume] of Water by Calculation | ./2.16.840.1.114222.4.11.1002/87443-8.json |
| 87444-6 | Electrical conductivity [Fluid Conductance] of Water | ./2.16.840.1.114222.4.11.1002/87444-6.json |
| 87445-3 | Fungus [Presence] in Food by Culture | ./2.16.840.1.114222.4.11.1002/87445-3.json |
| 874-8 | A3 B Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/874-8.json |
| 87480-0 | Bone ash/Bone.total in Bone | ./2.16.840.1.114222.4.11.1002/87480-0.json |
| 87484-2 | BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87484-2.json |
| 87485-9 | ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87485-9.json |
| 87486-7 | PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87486-7.json |
| 87487-5 | MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87487-5.json |
| 87488-3 | AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87488-3.json |
| 87489-1 | AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87489-1.json |
| 87490-9 | ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87490-9.json |
| 87491-7 | ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87491-7.json |
| 87492-5 | AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87492-5.json |
| 87493-3 | AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87493-3.json |
| 87494-1 | AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87494-1.json |
| 87495-8 | AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87495-8.json |
| 87496-6 | Gabapentin [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/87496-6.json |
| 87497-4 | Meperidine [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/87497-4.json |
| 87498-2 | 3-Methoxytyramine.free/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/87498-2.json |
| 87499-0 | 3-Methoxytyramine.free [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/87499-0.json |
| 87505-4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00 during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/87505-4.json |
| 87506-2 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/87506-2.json |
| 87507-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/87507-0.json |
| 87508-8 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/87508-8.json |
| 87509-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 during assessment period [CMS Assessment] | ./2.16.840.1.114222.4.11.1002/87509-6.json |
| 87513-8 | Trauma Process of care measures Document | ./2.16.840.1.114222.4.11.1002/87513-8.json |
| 87514-6 | Cerebral monitor | ./2.16.840.1.114222.4.11.1002/87514-6.json |
| 87515-3 | Pupil - bilateral Pupillary response--at admission | ./2.16.840.1.114222.4.11.1002/87515-3.json |
| 87517-9 | Physical abuse was reported | ./2.16.840.1.114222.4.11.1002/87517-9.json |
| 87520-3 | Coverage type | ./2.16.840.1.114222.4.11.1002/87520-3.json |
| 87558-3 | Anaplasma phagocytophilum groEL gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/87558-3.json |
| 87559-1 | Ehrlichia chaffeensis groEL gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/87559-1.json |
| 87560-9 | Ehrlichia canis+ewingii groEL gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/87560-9.json |
| 87561-7 | Ehrlichia muris eauclairensis groEL gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/87561-7.json |
| 87562-5 | Ammonia nitrogen [Mass/mass] in Feed | ./2.16.840.1.114222.4.11.1002/87562-5.json |
| 87563-3 | Antimony [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87563-3.json |
| 87564-1 | Zearalenone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87564-1.json |
| 87565-8 | Zearalenol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87565-8.json |
| 87566-6 | Deoxynivalenol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87566-6.json |
| 87567-4 | T-2 toxin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87567-4.json |
| 87568-2 | Ochratoxin A [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87568-2.json |
| 87569-0 | Nivalenol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87569-0.json |
| 87570-8 | Narasin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87570-8.json |
| 87571-6 | Fumonisin B3 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87571-6.json |
| 87572-4 | Fumonisin B2 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87572-4.json |
| 87573-2 | Fumonisin B1 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87573-2.json |
| 87574-0 | Ergovaline [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87574-0.json |
| 87575-7 | Ergotamine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87575-7.json |
| 87576-5 | Ergosine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87576-5.json |
| 87577-3 | Ergocryptine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87577-3.json |
| 87578-1 | Ergocristine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87578-1.json |
| 87579-9 | Ergocornine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87579-9.json |
| 87580-7 | Aflatoxin M1 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87580-7.json |
| 87581-5 | Aflatoxin G2 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87581-5.json |
| 87582-3 | Aflatoxin G1 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87582-3.json |
| 87583-1 | Aflatoxin B2 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87583-1.json |
| 87584-9 | Aflatoxin B1 [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87584-9.json |
| 87585-6 | Virginiamycin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87585-6.json |
| 87586-4 | Tylvalosin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87586-4.json |
| 87587-2 | Tylosin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87587-2.json |
| 87588-0 | Tilmicosin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87588-0.json |
| 87589-8 | Tiamulin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87589-8.json |
| 87590-6 | Tetracycline [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87590-6.json |
| 87591-4 | Sulfathiazole [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87591-4.json |
| 87592-2 | Sulfamethazine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87592-2.json |
| 87593-0 | Salinomycin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87593-0.json |
| 87594-8 | Penicillin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87594-8.json |
| 87595-5 | Oxytetracycline [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87595-5.json |
| 87596-3 | Nicotine [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87596-3.json |
| 87597-1 | Lincomycin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87597-1.json |
| 87598-9 | Lasalocid [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87598-9.json |
| 87599-7 | Florfenicol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87599-7.json |
| 87600-3 | Chlortetracycline [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87600-3.json |
| 87601-1 | Carbadox [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87601-1.json |
| 87602-9 | Bambermycins [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87602-9.json |
| 87603-7 | Bacitracin zinc [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87603-7.json |
| 87604-5 | Ampicillin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87604-5.json |
| 87605-2 | Warfarin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87605-2.json |
| 87606-0 | Diphacinone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87606-0.json |
| 87607-8 | Difethialone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87607-8.json |
| 87608-6 | Difenacoum [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87608-6.json |
| 87609-4 | Dicoumarol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87609-4.json |
| 87610-2 | Chlorophacinone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87610-2.json |
| 87611-0 | Bromadiolone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87611-0.json |
| 87612-8 | Brodifacoum [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87612-8.json |
| 87613-6 | Urea [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87613-6.json |
| 87614-4 | Thallium [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87614-4.json |
| 87615-1 | Sulfate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87615-1.json |
| 87616-9 | Gossypol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87616-9.json |
| 87617-7 | Ethylene glycol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87617-7.json |
| 87618-5 | Cyanide [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87618-5.json |
| 87619-3 | Barium [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87619-3.json |
| 87620-1 | Candida auris ITS2 gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87620-1.json |
| 87621-9 | Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/87621-9.json |
| 87622-7 | Zika virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/87622-7.json |
| 87623-5 | HEDIS 2018 Value Set - Depression Screen | ./2.16.840.1.114222.4.11.1002/87623-5.json |
| 87624-3 | HEDIS 2018 Alcohol Screening | ./2.16.840.1.114222.4.11.1002/87624-3.json |
| 87625-0 | HEDIS 2018 Value Sets | ./2.16.840.1.114222.4.11.1002/87625-0.json |
| 87626-8 | Suicide prevention note | ./2.16.840.1.114222.4.11.1002/87626-8.json |
| 87627-6 | Brain injury Consult note | ./2.16.840.1.114222.4.11.1002/87627-6.json |
| 87628-4 | Brain injury Note | ./2.16.840.1.114222.4.11.1002/87628-4.json |
| 87629-2 | Brain injury Plan of care note | ./2.16.840.1.114222.4.11.1002/87629-2.json |
| 87630-0 | Mevinphos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87630-0.json |
| 87631-8 | Mexacarbate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87631-8.json |
| 87632-6 | Toxaphene [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87632-6.json |
| 87633-4 | Phorate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87633-4.json |
| 87634-2 | Aldicarb [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87634-2.json |
| 87635-9 | Aldicarb sulfone [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87635-9.json |
| 87636-7 | Crufomate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87636-7.json |
| 87637-5 | Fenchlorphos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87637-5.json |
| 87638-3 | p,p'- Dichlorodiphenyldichloroethane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87638-3.json |
| 87639-1 | Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87639-1.json |
| 87640-9 | Dichlorodiphenyldichloroethylene [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87640-9.json |
| 87641-7 | o,p'- Dichlorodiphenyltrichloroethane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87641-7.json |
| 87642-5 | o,p'- DDE [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87642-5.json |
| 87643-3 | o,p'- DDD [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87643-3.json |
| 87644-1 | Ethoprop [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87644-1.json |
| 87645-8 | Dechlorane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87645-8.json |
| 87646-6 | Methyl parathion [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87646-6.json |
| 87647-4 | Methoxychlor [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87647-4.json |
| 87648-2 | Malathion [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87648-2.json |
| 87649-0 | Lindane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87649-0.json |
| 87650-8 | Methomyl [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87650-8.json |
| 87651-6 | 2,3,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87651-6.json |
| 87652-4 | Isofenphos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87652-4.json |
| 87653-2 | Hexachlorobenzene [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87653-2.json |
| 87654-0 | Heptachlor [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87654-0.json |
| 87655-7 | Heptachlor epoxide [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87655-7.json |
| 87656-5 | Carbofuran [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87656-5.json |
| 87657-3 | Fenthion [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87657-3.json |
| 87658-1 | Famphur [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87658-1.json |
| 87659-9 | Parathion [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87659-9.json |
| 87660-7 | Endrin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87660-7.json |
| 87661-5 | Endosulfan I [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87661-5.json |
| 87662-3 | Fonofos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87662-3.json |
| 87663-1 | Disulfoton [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87663-1.json |
| 87664-9 | Dimethoate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87664-9.json |
| 87665-6 | Dieldrin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87665-6.json |
| 87666-4 | Diazinon [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87666-4.json |
| 87667-2 | Alpha benzene hexachloride [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87667-2.json |
| 87668-0 | Aldrin [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87668-0.json |
| 87671-4 | Cholecalciferol (Vit D3) [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87671-4.json |
| 87672-2 | Tocopherol+tocotrienol [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87672-2.json |
| 87673-0 | Retinal+retinol+retinoic acid [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87673-0.json |
| 87674-8 | Optical coherence tomography study | ./2.16.840.1.114222.4.11.1002/87674-8.json |
| 87708-4 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis | ./2.16.840.1.114222.4.11.1002/87708-4.json |
| 87709-2 | Virus identified in Lower respiratory specimen by Culture | ./2.16.840.1.114222.4.11.1002/87709-2.json |
| 87710-0 | Rotavirus C VP7 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87710-0.json |
| 87711-8 | Rotavirus B VP7 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87711-8.json |
| 87712-6 | Rotavirus A VP7 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87712-6.json |
| 87713-4 | Rotavirus A VP4 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87713-4.json |
| 87714-2 | Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87714-2.json |
| 87715-9 | Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87715-9.json |
| 87716-7 | Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/87716-7.json |
| 87720-9 | Provider Postal code | ./2.16.840.1.114222.4.11.1002/87720-9.json |
| 87721-7 | County of residence [Location] | ./2.16.840.1.114222.4.11.1002/87721-7.json |
| 87722-5 | Complement C1q.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87722-5.json |
| 87723-3 | Complement C3.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87723-3.json |
| 87724-1 | Complement C7.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87724-1.json |
| 87725-8 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/87725-8.json |
| 87726-6 | Cytomegalovirus IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/87726-6.json |
| 87727-4 | Complement C9.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87727-4.json |
| 87729-0 | History of Occupational hazard | ./2.16.840.1.114222.4.11.1002/87729-0.json |
| 87730-8 | HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/87730-8.json |
| 87731-6 | KIT gene exon 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87731-6.json |
| 87732-4 | KIT gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87732-4.json |
| 87733-2 | KIT gene exon 8 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87733-2.json |
| 87734-0 | cefTAZidime+Avibactam [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/87734-0.json |
| 87735-7 | Ceftolozane+Tazobactam [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/87735-7.json |
| 87736-5 | Diastolic blood pressure--post exercise | ./2.16.840.1.114222.4.11.1002/87736-5.json |
| 87737-3 | 3,4,5-trimethylphenyl methylcarbamate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87737-3.json |
| 87738-1 | GALC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87738-1.json |
| 87739-9 | Systolic blood pressure--W exercise | ./2.16.840.1.114222.4.11.1002/87739-9.json |
| 87740-7 | Diastolic blood pressure--W exercise | ./2.16.840.1.114222.4.11.1002/87740-7.json |
| 87741-5 | Systolic blood pressure--post exercise | ./2.16.840.1.114222.4.11.1002/87741-5.json |
| 87742-3 | Adalimumab Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87742-3.json |
| 87743-1 | Bufencarb [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87743-1.json |
| 87744-9 | Carbaryl [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87744-9.json |
| 87745-6 | Carbophenothion [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87745-6.json |
| 87746-4 | Chlordane [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87746-4.json |
| 87747-2 | Chlorpyrifos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87747-2.json |
| 87748-0 | Coumaphos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87748-0.json |
| 87749-8 | Crotoxyphos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87749-8.json |
| 87750-6 | Dichlorvos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87750-6.json |
| 87751-4 | Endosulfan II [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87751-4.json |
| 87752-2 | O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87752-2.json |
| 87753-0 | Propoxur [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87753-0.json |
| 87754-8 | Terbufos [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/87754-8.json |
| 87755-5 | Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87755-5.json |
| 87756-3 | BMPR1A and SMAD4 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87756-3.json |
| 87757-1 | Platelet glycoprotein IV Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/87757-1.json |
| 87758-9 | Naegleria fowleri DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87758-9.json |
| 87759-7 | Lifetime risk for developing genetic disease assessed Lifetime | ./2.16.840.1.114222.4.11.1002/87759-7.json |
| 87760-5 | N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87760-5.json |
| 87761-3 | Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87761-3.json |
| 87762-1 | Methcathinone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87762-1.json |
| 87763-9 | Ezogabine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87763-9.json |
| 87764-7 | Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87764-7.json |
| 87765-4 | levETIRAcetam/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87765-4.json |
| 87766-2 | 10-Hydroxycarbazepine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87766-2.json |
| 87767-0 | Primidone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87767-0.json |
| 87768-8 | Rufinamide/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87768-8.json |
| 87769-6 | tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87769-6.json |
| 87770-4 | Topiramate/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87770-4.json |
| 87771-2 | Zonisamide/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87771-2.json |
| 87772-0 | lamoTRIgine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87772-0.json |
| 87773-8 | Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87773-8.json |
| 87774-6 | tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87774-6.json |
| 87775-3 | Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87775-3.json |
| 87776-1 | Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87776-1.json |
| 87777-9 | 8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87777-9.json |
| 87778-7 | Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87778-7.json |
| 87779-5 | Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87779-5.json |
| 87780-3 | Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87780-3.json |
| 87781-1 | ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87781-1.json |
| 87782-9 | Diclofenac/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87782-9.json |
| 87783-7 | Ketoprofen/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87783-7.json |
| 87784-5 | Naproxen/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87784-5.json |
| 87785-2 | Oxaprozin/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87785-2.json |
| 87786-0 | Bupivacaine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87786-0.json |
| 87787-8 | guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87787-8.json |
| 87788-6 | Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87788-6.json |
| 87789-4 | Theophylline/Creatinine [Mass Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87789-4.json |
| 87790-2 | Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87790-2.json |
| 87791-0 | Carbadox [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87791-0.json |
| 87792-8 | Cefovecin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87792-8.json |
| 87793-6 | Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87793-6.json |
| 87794-4 | Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87794-4.json |
| 87795-1 | Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87795-1.json |
| 87796-9 | Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87796-9.json |
| 87797-7 | Sulfathiazole [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87797-7.json |
| 87798-5 | Tulathromycin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87798-5.json |
| 87799-3 | Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87799-3.json |
| 87800-9 | Pradofloxacin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87800-9.json |
| 87801-7 | Ormetoprim+Sulfadimethoxine [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87801-7.json |
| 87802-5 | Sulfachloropyridazine [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87802-5.json |
| 87803-3 | Sulfadimethoxine [Susceptibility] | ./2.16.840.1.114222.4.11.1002/87803-3.json |
| 87804-1 | Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/87804-1.json |
| 87805-8 | Methylphenidate [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87805-8.json |
| 87806-6 | Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87806-6.json |
| 87807-4 | Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87807-4.json |
| 87808-2 | chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87808-2.json |
| 87809-0 | Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87809-0.json |
| 87810-8 | Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87810-8.json |
| 87811-6 | Meprobamate [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87811-6.json |
| 87812-4 | Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87812-4.json |
| 87813-2 | Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87813-2.json |
| 87814-0 | Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87814-0.json |
| 87815-7 | fentaNYL [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87815-7.json |
| 87816-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87816-5.json |
| 87817-3 | Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87817-3.json |
| 87818-1 | Tapentadol [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87818-1.json |
| 87819-9 | Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87819-9.json |
| 87820-7 | Zolpidem [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87820-7.json |
| 87821-5 | Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87821-5.json |
| 87822-3 | Naltrexone [Presence] in Saliva (oral fluid) by Screen method | ./2.16.840.1.114222.4.11.1002/87822-3.json |
| 87823-1 | Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87823-1.json |
| 87824-9 | 6-Beta naltrexol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/87824-9.json |
| 87826-4 | t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/87826-4.json |
| 87827-2 | Casts [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/87827-2.json |
| 87828-0 | Crystals [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/87828-0.json |
| 87829-8 | Bacteria [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/87829-8.json |
| 87830-6 | Epithelial cells [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/87830-6.json |
| 87831-4 | Yeast [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/87831-4.json |
| 87832-2 | Fibroblast growth factor 21.intact [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/87832-2.json |
| 87836-3 | CTA Hepatic vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87836-3.json |
| 87837-1 | CTA Aortic valve W contrast IV | ./2.16.840.1.114222.4.11.1002/87837-1.json |
| 87838-9 | CTA Abdominal veins and Pelvis veins W contrast IV | ./2.16.840.1.114222.4.11.1002/87838-9.json |
| 87839-7 | CTA Pulmonary veins W contrast IV | ./2.16.840.1.114222.4.11.1002/87839-7.json |
| 87840-5 | CTA Coronary arteries and Pulmonary arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/87840-5.json |
| 87841-3 | CTA Coronary arteries and Thoracic aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/87841-3.json |
| 87842-1 | CTA Coronary arteries and Pulmonary arteries and Thoracic aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/87842-1.json |
| 87843-9 | CTA Pelvis veins and Lower extremity veins - bilateral | ./2.16.840.1.114222.4.11.1002/87843-9.json |
| 87844-7 | CTA Pelvis veins | ./2.16.840.1.114222.4.11.1002/87844-7.json |
| 87845-4 | CTA Lower extremity vessels | ./2.16.840.1.114222.4.11.1002/87845-4.json |
| 87846-2 | CTA Renal vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87846-2.json |
| 87847-0 | CT Chest WO and CT angiogram Coronary arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/87847-0.json |
| 87848-8 | CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV | ./2.16.840.1.114222.4.11.1002/87848-8.json |
| 87849-6 | CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis | ./2.16.840.1.114222.4.11.1002/87849-6.json |
| 87850-4 | CTA Deep inferior epigastric artery WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87850-4.json |
| 87851-2 | CTA Mesenteric vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/87851-2.json |
| 87852-0 | CTA Mesenteric vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87852-0.json |
| 87853-8 | CT Abdomen and Pelvis and CT angiogram Abdominal aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87853-8.json |
| 87854-6 | CT Abdomen and Pelvis and CT angiogram Abdominal aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/87854-6.json |
| 87855-3 | CTA Circle of Willis and Carotid arteries WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87855-3.json |
| 87856-1 | CTA Circle of Willis and Carotid arteries W contrast IV | ./2.16.840.1.114222.4.11.1002/87856-1.json |
| 87857-9 | CTA Thoracic and abdominal aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87857-9.json |
| 87858-7 | CTA Deep inferior epigastric artery W contrast IV | ./2.16.840.1.114222.4.11.1002/87858-7.json |
| 87859-5 | CT Thoracic Aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87859-5.json |
| 87860-3 | CT Thoracic Aorta WO contrast | ./2.16.840.1.114222.4.11.1002/87860-3.json |
| 87861-1 | CT Thoracic and abdominal aorta WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87861-1.json |
| 87862-9 | CT Abdomen WO and CT Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/87862-9.json |
| 87863-7 | CT Abdomen WO and CT Chest and Abdomen W contrast IV | ./2.16.840.1.114222.4.11.1002/87863-7.json |
| 87864-5 | CT Abdomen WO and CT Chest and Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/87864-5.json |
| 87865-2 | CT Abdomen and Pelvis WO and CT Chest and Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/87865-2.json |
| 87866-0 | CT Kidney and Ureter and Urinary bladder WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87866-0.json |
| 87867-8 | CT Lumbar spine by reconstruction | ./2.16.840.1.114222.4.11.1002/87867-8.json |
| 87868-6 | CT Lumbar spine by reconstruction WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87868-6.json |
| 87869-4 | CT Chest and Abdomen and Pelvis | ./2.16.840.1.114222.4.11.1002/87869-4.json |
| 87870-2 | CT Cervical spine to Coccyx WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87870-2.json |
| 87871-0 | CT Clavicle - left | ./2.16.840.1.114222.4.11.1002/87871-0.json |
| 87872-8 | CT Clavicle - right | ./2.16.840.1.114222.4.11.1002/87872-8.json |
| 87873-6 | CT Lung parenchyma WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87873-6.json |
| 87874-4 | CT Mediastinum W contrast IV | ./2.16.840.1.114222.4.11.1002/87874-4.json |
| 87875-1 | CT Thoracic spine by reconstruction | ./2.16.840.1.114222.4.11.1002/87875-1.json |
| 87876-9 | CT Thymus gland | ./2.16.840.1.114222.4.11.1002/87876-9.json |
| 87877-7 | CT Neck and Chest WO contrast | ./2.16.840.1.114222.4.11.1002/87877-7.json |
| 87878-5 | CT Knee - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/87878-5.json |
| 87879-3 | CT Lower leg - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/87879-3.json |
| 87880-1 | CT Thigh - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/87880-1.json |
| 87881-9 | CT Thigh - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/87881-9.json |
| 87882-7 | CT Lower leg - left | ./2.16.840.1.114222.4.11.1002/87882-7.json |
| 87883-5 | CT Upper extremity - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87883-5.json |
| 87884-3 | CT Shoulder - bilateral Arthrogram | ./2.16.840.1.114222.4.11.1002/87884-3.json |
| 87885-0 | CT Upper arm - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/87885-0.json |
| 87886-8 | CT Finger fifth - left WO contrast | ./2.16.840.1.114222.4.11.1002/87886-8.json |
| 87887-6 | CT Finger fourth - left W contrast IV | ./2.16.840.1.114222.4.11.1002/87887-6.json |
| 87888-4 | CT Finger second - left WO contrast | ./2.16.840.1.114222.4.11.1002/87888-4.json |
| 87889-2 | CT Thumb - left WO contrast | ./2.16.840.1.114222.4.11.1002/87889-2.json |
| 87890-0 | CT Finger fifth - right WO contrast | ./2.16.840.1.114222.4.11.1002/87890-0.json |
| 87891-8 | CT Finger fourth - right WO contrast | ./2.16.840.1.114222.4.11.1002/87891-8.json |
| 87892-6 | CT Finger second - right WO contrast | ./2.16.840.1.114222.4.11.1002/87892-6.json |
| 87893-4 | CT Finger third - right WO contrast | ./2.16.840.1.114222.4.11.1002/87893-4.json |
| 87894-2 | CT Thumb - right WO contrast | ./2.16.840.1.114222.4.11.1002/87894-2.json |
| 87895-9 | CT Finger WO contrast | ./2.16.840.1.114222.4.11.1002/87895-9.json |
| 87896-7 | CT Teeth W contrast IV | ./2.16.840.1.114222.4.11.1002/87896-7.json |
| 87897-5 | CT Head and Pituitary and Sella turcica W contrast IV | ./2.16.840.1.114222.4.11.1002/87897-5.json |
| 87898-3 | CT Teeth.maxilla WO contrast | ./2.16.840.1.114222.4.11.1002/87898-3.json |
| 87899-1 | CT Teeth.mandible WO contrast | ./2.16.840.1.114222.4.11.1002/87899-1.json |
| 87900-7 | CT Mastoid W contrast IV | ./2.16.840.1.114222.4.11.1002/87900-7.json |
| 87901-5 | CT Temporal bone - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87901-5.json |
| 87902-3 | CT Temporal bone - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/87902-3.json |
| 87903-1 | CT Temporal bone - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/87903-1.json |
| 87904-9 | CT Temporomandibular joint - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/87904-9.json |
| 87905-6 | PET+CT Guidance for localization of tumor of Head and Neck-- W 18F-FDG IV | ./2.16.840.1.114222.4.11.1002/87905-6.json |
| 87906-4 | CT Maxillofacial region - right W contrast IV | ./2.16.840.1.114222.4.11.1002/87906-4.json |
| 87907-2 | PET+CT Brain for amyloidosis | ./2.16.840.1.114222.4.11.1002/87907-2.json |
| 87908-0 | CT Head and Maxillofacial region W contrast IV | ./2.16.840.1.114222.4.11.1002/87908-0.json |
| 87909-8 | CT Temporomandibular joint Arthrogram | ./2.16.840.1.114222.4.11.1002/87909-8.json |
| 87910-6 | CT Head and Sinuses WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87910-6.json |
| 87911-4 | CT Head and Maxillofacial region WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87911-4.json |
| 87912-2 | CT Sinuses and Orbit WO contrast | ./2.16.840.1.114222.4.11.1002/87912-2.json |
| 87913-0 | CT Pelvis by reconstruction | ./2.16.840.1.114222.4.11.1002/87913-0.json |
| 87914-8 | CT Pelvis bones WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87914-8.json |
| 87915-5 | PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and W contrast IV | ./2.16.840.1.114222.4.11.1002/87915-5.json |
| 87916-3 | CT Guidance for injection of cyst of Unspecified body region | ./2.16.840.1.114222.4.11.1002/87916-3.json |
| 87917-1 | CT Pelvis bones WO contrast | ./2.16.840.1.114222.4.11.1002/87917-1.json |
| 87918-9 | CT Parathyroid gland WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/87918-9.json |
| 87919-7 | CT Pelvis bones | ./2.16.840.1.114222.4.11.1002/87919-7.json |
| 87920-5 | CT Pelvis bones W contrast IV | ./2.16.840.1.114222.4.11.1002/87920-5.json |
| 87921-3 | CT Trachea WO contrast | ./2.16.840.1.114222.4.11.1002/87921-3.json |
| 87922-1 | CT Cervical and thoracic spine W contrast IT | ./2.16.840.1.114222.4.11.1002/87922-1.json |
| 87923-9 | Rickettsia conorii IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87923-9.json |
| 87924-7 | Rickettsia conorii IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87924-7.json |
| 87925-4 | Reagin Ab [Titer] in Cerebral spinal fluid by RPR | ./2.16.840.1.114222.4.11.1002/87925-4.json |
| 87926-2 | Epithelial cells [#/volume] in Urine by Automated | ./2.16.840.1.114222.4.11.1002/87926-2.json |
| 87928-8 | Macroscopic observation [Interpretation] in Stool Narrative | ./2.16.840.1.114222.4.11.1002/87928-8.json |
| 87929-6 | Bacteria identified in Amniotic fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/87929-6.json |
| 87930-4 | Bacteria identified in Burn by Aerobe culture | ./2.16.840.1.114222.4.11.1002/87930-4.json |
| 87931-2 | Bacteria identified in Implanted device by Aerobe culture | ./2.16.840.1.114222.4.11.1002/87931-2.json |
| 87932-0 | Bacteria identified in Sinus by Aerobe culture | ./2.16.840.1.114222.4.11.1002/87932-0.json |
| 87933-8 | Bacteria identified in Amniotic fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87933-8.json |
| 87934-6 | Bacteria identified in Bile fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87934-6.json |
| 87935-3 | Bacteria identified in Blood product unit by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87935-3.json |
| 87936-1 | Bacteria identified in Burn by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87936-1.json |
| 87937-9 | Bacteria identified in Cerebral spinal fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87937-9.json |
| 87938-7 | Bacteria identified in Implanted device by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87938-7.json |
| 87939-5 | Bacteria identified in Pericardial fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87939-5.json |
| 87940-3 | Bacteria identified in Peritoneal fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87940-3.json |
| 87941-1 | Bacteria identified in Placenta by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87941-1.json |
| 87942-9 | Bacteria identified in Pleural fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87942-9.json |
| 87943-7 | Bacteria identified in Sinus by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87943-7.json |
| 87944-5 | Bacteria identified in Synovial fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87944-5.json |
| 87945-2 | Borrelia sp identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87945-2.json |
| 87946-0 | Borrelia sp identified in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87946-0.json |
| 87947-8 | Borrelia sp DNA identified in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87947-8.json |
| 87948-6 | Clostridium botulinum [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87948-6.json |
| 87949-4 | Chlamydia trachomatis DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87949-4.json |
| 87950-2 | Chlamydia trachomatis [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87950-2.json |
| 87951-0 | Escherichia coli eaeA gene [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87951-0.json |
| 87952-8 | Helicobacter pylori [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87952-8.json |
| 87953-6 | Helicobacter pylori [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87953-6.json |
| 87954-4 | Bacteria identified in Cord blood by Aerobe culture | ./2.16.840.1.114222.4.11.1002/87954-4.json |
| 87955-1 | Bacteria identified in Cord blood by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/87955-1.json |
| 87958-5 | Neisseria meningitidis [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87958-5.json |
| 87959-3 | Adenovirus Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/87959-3.json |
| 87960-1 | Enterovirus RNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87960-1.json |
| 87961-9 | Varicella zoster virus DNA [Presence] in Body fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87961-9.json |
| 87962-7 | HIV 1 subtype identified in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87962-7.json |
| 87963-5 | HIV 1 RNA tropism [Identifier] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/87963-5.json |
| 87965-0 | Microscopic observation [Identifier] in Cerebral spinal fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/87965-0.json |
| 87966-8 | Microscopic observation [Identifier] in Bone marrow by Giemsa stain | ./2.16.840.1.114222.4.11.1002/87966-8.json |
| 87967-6 | Microscopic observation [Identifier] in Bone marrow by Gram stain | ./2.16.840.1.114222.4.11.1002/87967-6.json |
| 87968-4 | Microscopic observation [Identifier] in Body fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/87968-4.json |
| 87969-2 | Microscopic observation [Identifier] in Blood by Gram stain | ./2.16.840.1.114222.4.11.1002/87969-2.json |
| 87970-0 | Microscopic observation [Identifier] in Amniotic fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/87970-0.json |
| 87971-8 | Microscopic observation [Identifier] in Amniotic fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/87971-8.json |
| 87972-6 | Microscopic observation [Identifier] in Sinus by Gram stain | ./2.16.840.1.114222.4.11.1002/87972-6.json |
| 87973-4 | Microscopic observation [Identifier] in Semen by Gram stain | ./2.16.840.1.114222.4.11.1002/87973-4.json |
| 87974-2 | Microscopic observation [Identifier] in Burn by Gram stain | ./2.16.840.1.114222.4.11.1002/87974-2.json |
| 87975-9 | Microscopic observation [Identifier] in Isolate by Gram stain | ./2.16.840.1.114222.4.11.1002/87975-9.json |
| 87976-7 | Fungus identified in Implanted device by Culture | ./2.16.840.1.114222.4.11.1002/87976-7.json |
| 87977-5 | Fungus identified in Pericardial fluid by Culture | ./2.16.840.1.114222.4.11.1002/87977-5.json |
| 87978-3 | Fungus identified in Peritoneal dialysis fluid by Culture | ./2.16.840.1.114222.4.11.1002/87978-3.json |
| 87979-1 | Fungus identified in Pleural fluid by Culture | ./2.16.840.1.114222.4.11.1002/87979-1.json |
| 87980-9 | Fungus identified in Sinus by Culture | ./2.16.840.1.114222.4.11.1002/87980-9.json |
| 87981-7 | Fungus identified in Burn by Culture | ./2.16.840.1.114222.4.11.1002/87981-7.json |
| 87982-5 | Toxoplasma gondii [Presence] in Bone marrow by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87982-5.json |
| 87983-3 | Toxoplasma gondii DNA [Presence] in Placenta by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87983-3.json |
| 87984-1 | Toxoplasma gondii DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87984-1.json |
| 87985-8 | Trichinella spiralis DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87985-8.json |
| 87988-2 | Acanthamoeba sp DNA [Presence] in Contact lens by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87988-2.json |
| 87989-0 | Toxoplasma gondii DNA [Presence] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87989-0.json |
| 87990-8 | Acanthamoeba sp identified in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87990-8.json |
| 87991-6 | Acanthamoeba sp identified in Contact lens by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87991-6.json |
| 87992-4 | Onchocerca sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87992-4.json |
| 87993-2 | Toxoplasma gondii DNA [Presence] in Cord blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/87993-2.json |
| 87994-0 | Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87994-0.json |
| 87995-7 | Strongyloides sp identified in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/87995-7.json |
| 87996-5 | Fasciola hepatica Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/87996-5.json |
| 87997-3 | Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/87997-3.json |
| 87998-1 | Amoeba identified in Stool by Wet preparation | ./2.16.840.1.114222.4.11.1002/87998-1.json |
| 87999-9 | Microscopic observation [Identifier] in Contact lens by Gram stain | ./2.16.840.1.114222.4.11.1002/87999-9.json |
| 88000-5 | Microscopic observation [Identifier] in Pleural fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/88000-5.json |
| 88001-3 | Microscopic observation [Identifier] in Peritoneal dialysis fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/88001-3.json |
| 88003-9 | TOAST Classification of subtypes of acute ischemic stroke | ./2.16.840.1.114222.4.11.1002/88003-9.json |
| 88004-7 | Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency [Likelihood] in Fetus | ./2.16.840.1.114222.4.11.1002/88004-7.json |
| 88005-4 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88005-4.json |
| 88006-2 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88006-2.json |
| 88007-0 | Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88007-0.json |
| 88008-8 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88008-8.json |
| 88009-6 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88009-6.json |
| 88010-4 | Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88010-4.json |
| 88011-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88011-2.json |
| 88012-0 | Sialate.lipid bound/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/88012-0.json |
| 88013-8 | Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88013-8.json |
| 88014-6 | Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88014-6.json |
| 88015-3 | Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88015-3.json |
| 88016-1 | Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88016-1.json |
| 88017-9 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88017-9.json |
| 88018-7 | Alanine/Lysine [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88018-7.json |
| 88019-5 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/88019-5.json |
| 88020-3 | Functional capacity NYHA | ./2.16.840.1.114222.4.11.1002/88020-3.json |
| 88021-1 | Objective assessment of cardiovascular disease NYHA | ./2.16.840.1.114222.4.11.1002/88021-1.json |
| 88022-9 | 5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/88022-9.json |
| 88023-7 | XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/88023-7.json |
| 88024-5 | Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88024-5.json |
| 88025-2 | Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS | ./2.16.840.1.114222.4.11.1002/88025-2.json |
| 88026-0 | Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88026-0.json |
| 88027-8 | Rh group Ag [Type] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/88027-8.json |
| 88028-6 | Tobacco use panel | ./2.16.840.1.114222.4.11.1002/88028-6.json |
| 88029-4 | Tobacco use duration | ./2.16.840.1.114222.4.11.1002/88029-4.json |
| 88030-2 | Date quit smokeless tobacco | ./2.16.840.1.114222.4.11.1002/88030-2.json |
| 88031-0 | Smokeless tobacco status | ./2.16.840.1.114222.4.11.1002/88031-0.json |
| 88033-6 | Safety checklist Ventilator Document | ./2.16.840.1.114222.4.11.1002/88033-6.json |
| 88034-4 | Ventilator settings Document | ./2.16.840.1.114222.4.11.1002/88034-4.json |
| 88035-1 | Ventilator alarm settings Document | ./2.16.840.1.114222.4.11.1002/88035-1.json |
| 88036-9 | Ventilator alarm events Document | ./2.16.840.1.114222.4.11.1002/88036-9.json |
| 88037-7 | How often have you had five or more drinks in one day during the past year [Reported] | ./2.16.840.1.114222.4.11.1002/88037-7.json |
| 88038-5 | Hy Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88038-5.json |
| 88039-3 | little p phenotype [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/88039-3.json |
| 88041-9 | little p phenotype [Presence] on Red Blood Cells from Blood product unit | ./2.16.840.1.114222.4.11.1002/88041-9.json |
| 88042-7 | little p phenotype [Presence] on Red Blood Cells from Donor | ./2.16.840.1.114222.4.11.1002/88042-7.json |
| 88043-5 | P sup(k) Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88043-5.json |
| 88044-3 | P sup(k) Ab [Presence] in Serum or Plasma from Blood product unit | ./2.16.840.1.114222.4.11.1002/88044-3.json |
| 88045-0 | P sup(k) Ab [Presence] in Serum or Plasma from Donor | ./2.16.840.1.114222.4.11.1002/88045-0.json |
| 88046-8 | P sup(k) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/88046-8.json |
| 88047-6 | P sup(k) Ag [Presence] on Red Blood Cells from Blood product unit | ./2.16.840.1.114222.4.11.1002/88047-6.json |
| 88048-4 | P sup(k) Ag [Presence] on Red Blood Cells from Donor | ./2.16.840.1.114222.4.11.1002/88048-4.json |
| 88049-2 | P2 phenotype [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/88049-2.json |
| 880-5 | A,B Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/880-5.json |
| 88050-0 | P2 phenotype [Presence] on Red Blood Cells from Blood product unit | ./2.16.840.1.114222.4.11.1002/88050-0.json |
| 88051-8 | P2 phenotype [Presence] on Red Blood Cells from Donor | ./2.16.840.1.114222.4.11.1002/88051-8.json |
| 88052-6 | Cells.CD4-CD8-CD45R+TCR alpha beta+/100 CD3 cells in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/88052-6.json |
| 88053-4 | Cells.CD4-CD8-CD45R+TCR alpha beta+ [#/volume] in Blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/88053-4.json |
| 88054-2 | Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/88054-2.json |
| 88055-9 | Liver fibrosis score in Serum or Plasma by Calculated by ELF | ./2.16.840.1.114222.4.11.1002/88055-9.json |
| 88056-7 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88056-7.json |
| 88057-5 | Treatment for abnormal Pap test | ./2.16.840.1.114222.4.11.1002/88057-5.json |
| 88058-3 | Respiratory measurements Document | ./2.16.840.1.114222.4.11.1002/88058-3.json |
| 88059-1 | Acetaminophen [Presence] in Blood by Screen method | ./2.16.840.1.114222.4.11.1002/88059-1.json |
| 88064-1 | Porcine epidemic diarrhea virus S1 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/88064-1.json |
| 88076-5 | Injury severity score NACA | ./2.16.840.1.114222.4.11.1002/88076-5.json |
| 88080-7 | Multiple birth set identifier | ./2.16.840.1.114222.4.11.1002/88080-7.json |
| 88085-6 | Reportability response report Document Public health | ./2.16.840.1.114222.4.11.1002/88085-6.json |
| 88106-0 | Parathyrin.intact [Mass/volume] in Tissue fine needle aspirate | ./2.16.840.1.114222.4.11.1002/88106-0.json |
| 88107-8 | Suctioning frequency | ./2.16.840.1.114222.4.11.1002/88107-8.json |
| 88110-2 | OXcarbazepine [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/88110-2.json |
| 88111-0 | Gentamicin [Moles/volume] in Serum or Plasma --random post extended interval dosing | ./2.16.840.1.114222.4.11.1002/88111-0.json |
| 88112-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | ./2.16.840.1.114222.4.11.1002/88112-8.json |
| 88113-6 | Erythrocytes [Presence] in Cerebral spinal fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/88113-6.json |
| 88114-4 | Leukocytes [Presence] in Cerebral spinal fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/88114-4.json |
| 88115-1 | Round cells [Presence] in Semen by Light microscopy | ./2.16.840.1.114222.4.11.1002/88115-1.json |
| 88117-7 | Mother's Tabulated ethnicity [CDC] | ./2.16.840.1.114222.4.11.1002/88117-7.json |
| 88118-5 | Father's Tabulated ethnicity [CDC] | ./2.16.840.1.114222.4.11.1002/88118-5.json |
| 88119-3 | Mother's Bridged race [CDC] | ./2.16.840.1.114222.4.11.1002/88119-3.json |
| 88120-1 | Father's Bridged race [CDC] | ./2.16.840.1.114222.4.11.1002/88120-1.json |
| 88121-9 | Hunger Vital Sign [HVS] | ./2.16.840.1.114222.4.11.1002/88121-9.json |
| 88126-8 | Injury severity | ./2.16.840.1.114222.4.11.1002/88126-8.json |
| 88127-6 | Herpes simplex virus identified in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88127-6.json |
| 88128-4 | Herpes simplex virus 1 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88128-4.json |
| 88130-0 | Cytomegalovirus DNA [#/volume] (viral load) in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88130-0.json |
| 88131-8 | Cytomegalovirus DNA [Presence] in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88131-8.json |
| 88132-6 | Varicella zoster virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88132-6.json |
| 88133-4 | Herpes simplex virus 2 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88133-4.json |
| 88134-2 | Varicella zoster virus DNA [Presence] in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88134-2.json |
| 88135-9 | Varicella zoster virus [Presence] in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88135-9.json |
| 88136-7 | Varicella zoster virus [Presence] in Ocular fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88136-7.json |
| 88138-3 | Herpes simplex virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88138-3.json |
| 88139-1 | Bacteria identified in Ocular fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/88139-1.json |
| 88140-9 | Tropheryma whipplei DNA [Presence] in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88140-9.json |
| 88141-7 | Bacteria identified in Ocular fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/88141-7.json |
| 88142-5 | Bacteria identified in Cornea or Conjunctiva by Aerobe culture | ./2.16.840.1.114222.4.11.1002/88142-5.json |
| 88143-3 | Fungus identified in Cornea or Conjunctiva by Culture | ./2.16.840.1.114222.4.11.1002/88143-3.json |
| 88144-1 | Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88144-1.json |
| 88145-8 | Microscopic observation [Identifier] in Pericardial fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88145-8.json |
| 88146-6 | Microscopic observation [Identifier] in Placenta by Gram stain | ./2.16.840.1.114222.4.11.1002/88146-6.json |
| 88147-4 | Microscopic observation [Identifier] in Pericardial fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/88147-4.json |
| 88148-2 | Microscopic observation [Identifier] in Genital specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88148-2.json |
| 88149-0 | Microscopic observation [Identifier] in Nasopharynx by Gram stain | ./2.16.840.1.114222.4.11.1002/88149-0.json |
| 88150-8 | Microscopic observation [Identifier] in Ocular fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/88150-8.json |
| 88151-6 | Microscopic observation [Identifier] in Wound by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88151-6.json |
| 88152-4 | Microscopic observation [Identifier] in Cervix by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/88152-4.json |
| 88153-2 | Microscopic observation [Identifier] in Bone marrow by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88153-2.json |
| 88154-0 | Microscopic observation [Identifier] in Sinus by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88154-0.json |
| 88155-7 | Microscopic observation [Identifier] in Ocular fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88155-7.json |
| 88156-5 | Microscopic observation [Identifier] in Amniotic fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88156-5.json |
| 88157-3 | Microscopic observation [Identifier] in Semen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88157-3.json |
| 88158-1 | Microscopic observation [Identifier] in Ocular fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/88158-1.json |
| 88159-9 | Microscopic observation [Identifier] in Aspirate by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88159-9.json |
| 88160-7 | Microsporidia DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88160-7.json |
| 88161-5 | Toxoplasma gondii [Presence] in Ocular fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88161-5.json |
| 88162-3 | Acanthamoeba sp identified in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88162-3.json |
| 88163-1 | Acanthamoeba sp DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88163-1.json |
| 88164-9 | Toxoplasma gondii DNA [Presence] in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88164-9.json |
| 88165-6 | Mycobacterium tuberculosis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88165-6.json |
| 88166-4 | Mycobacterium tuberculosis DNA [Presence] in Ocular fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88166-4.json |
| 88167-2 | Mycobacterium sp identified in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88167-2.json |
| 88168-0 | Mycobacterium sp identified in Ocular fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88168-0.json |
| 88170-6 | Microscopic observation [Identifier] in Cornea or Conjunctiva by Gram stain | ./2.16.840.1.114222.4.11.1002/88170-6.json |
| 88171-4 | Microscopic observation [Presence] in Cornea or Conjunctiva by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88171-4.json |
| 88172-2 | Microscopic observation [Presence] in Isolate by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88172-2.json |
| 88173-0 | Microscopic observation [Presence] in Pleural fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88173-0.json |
| 88174-8 | Total score Parent [PAM] | ./2.16.840.1.114222.4.11.1002/88174-8.json |
| 88175-5 | Total score [PAM] | ./2.16.840.1.114222.4.11.1002/88175-5.json |
| 88176-3 | Total score Caregiver [PAM] | ./2.16.840.1.114222.4.11.1002/88176-3.json |
| 88177-1 | Coxiella burnetii DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88177-1.json |
| 88178-9 | Coxiella burnetii DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88178-9.json |
| 88179-7 | Wuchereria bancrofti+Brugia malayi IgG4 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88179-7.json |
| 88180-5 | Wuchereria bancrofti+Brugia malayi IgG3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88180-5.json |
| 88181-3 | Wuchereria bancrofti+Brugia malayi IgG2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88181-3.json |
| 88182-1 | Wuchereria bancrofti+Brugia malayi IgG1 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88182-1.json |
| 88183-9 | Mycobacterium sp identified in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/88183-9.json |
| 88184-7 | IgG+IgM.porcine [Presence] in Pleural fluid from Fetus by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/88184-7.json |
| 88185-4 | IgG+IgM.porcine [Presence] in Serum from Fetus by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/88185-4.json |
| 88187-0 | Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88187-0.json |
| 88188-8 | Dengue virus 1+2+3+4 RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88188-8.json |
| 88189-6 | Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88189-6.json |
| 88190-4 | Crimean-Congo hemorrhagic fever virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88190-4.json |
| 88191-2 | Crimean-Congo hemorrhagic fever virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88191-2.json |
| 88192-0 | Crimean-Congo hemorrhagic fever virus RNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88192-0.json |
| 88193-8 | Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88193-8.json |
| 88194-6 | Influenza virus B Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88194-6.json |
| 88195-3 | Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88195-3.json |
| 88196-1 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88196-1.json |
| 88197-9 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88197-9.json |
| 88198-7 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88198-7.json |
| 88199-5 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88199-5.json |
| 88200-1 | Influenza virus identified in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88200-1.json |
| 88201-9 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88201-9.json |
| 88202-7 | Respiratory syncytial virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88202-7.json |
| 88203-5 | Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Serum or Blood byNAA with probe detection | ./2.16.840.1.114222.4.11.1002/88203-5.json |
| 88204-3 | Respiratory syncytial virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88204-3.json |
| 88205-0 | Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88205-0.json |
| 88206-8 | Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88206-8.json |
| 88207-6 | Lymphocytic choriomeningitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88207-6.json |
| 88208-4 | Parainfluenza virus 1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88208-4.json |
| 88209-2 | Parainfluenza virus 2 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88209-2.json |
| 882-1 | ABO and Rh group [Type] in Blood | ./2.16.840.1.114222.4.11.1002/882-1.json |
| 88210-0 | Parainfluenza virus 3 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88210-0.json |
| 88211-8 | Rabies virus Ag [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/88211-8.json |
| 88212-6 | HIV 1 proviral DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88212-6.json |
| 88213-4 | Rhinovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88213-4.json |
| 88214-2 | Rabies virus RNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88214-2.json |
| 88215-9 | Rabies virus RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88215-9.json |
| 88216-7 | Hantavirus puumala RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88216-7.json |
| 88217-5 | Parechovirus RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88217-5.json |
| 88218-3 | Parechovirus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88218-3.json |
| 88219-1 | Parechovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88219-1.json |
| 88220-9 | Hantavirus puumala RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88220-9.json |
| 88221-7 | Chlamydia trachomatis DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88221-7.json |
| 88222-5 | Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88222-5.json |
| 88223-3 | Francisella sp DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88223-3.json |
| 88224-1 | Neisseria gonorrhoeae DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88224-1.json |
| 88225-8 | Neisseria gonorrhoeae DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88225-8.json |
| 88226-6 | Mycoplasma genitalium DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88226-6.json |
| 88227-4 | Mycoplasma genitalium DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88227-4.json |
| 88228-2 | Mycoplasma genitalium DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88228-2.json |
| 88229-0 | Mycoplasma genitalium DNA [Presence] in Anorectal by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88229-0.json |
| 88230-8 | Mycoplasma genitalium DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88230-8.json |
| 88231-6 | Microscopic observation [Identifier] in Bile fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88231-6.json |
| 88232-4 | Trypanosoma cruzi DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88232-4.json |
| 88233-2 | Babesia sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88233-2.json |
| 88234-0 | Microscopic observation [Presence] in Synovial fluid by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88234-0.json |
| 88235-7 | Microscopic observation [Identifier] in Synovial fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/88235-7.json |
| 88236-5 | Bacteria identified in Cerebral spinal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/88236-5.json |
| 88241-5 | Fetal remains disposition method | ./2.16.840.1.114222.4.11.1002/88241-5.json |
| 88242-3 | Guidance for infusion of non-thrombolytic of Head Arteries | ./2.16.840.1.114222.4.11.1002/88242-3.json |
| 88243-1 | Guidance for removal of tunneled catheter from Chest Pleura | ./2.16.840.1.114222.4.11.1002/88243-1.json |
| 88244-9 | Acinetobacter sp rpsA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88244-9.json |
| 88245-6 | Carbapenem resistance blaIMP gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88245-6.json |
| 88246-4 | Carbapenem resistance blaKPC gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88246-4.json |
| 88247-2 | Carbapenem resistance blaNDM gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88247-2.json |
| 88248-0 | Carbapenem resistance blaOXA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88248-0.json |
| 88249-8 | Carbapenem resistance blaVIM gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88249-8.json |
| 88250-6 | Cephalosporin resistance blaCTX-M gene [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/88250-6.json |
| 88251-4 | Methicillin resistance mecA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88251-4.json |
| 88252-2 | Vancomycin resistance vanA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88252-2.json |
| 88253-0 | Vancomycin resistance vanB gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88253-0.json |
| 88254-8 | Citrobacter sp ompA+mrkC genes [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88254-8.json |
| 88255-5 | Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88255-5.json |
| 88256-3 | Enterococcus faecalis hsp60 gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88256-3.json |
| 88257-1 | Enterococcus faecium hsp60 gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88257-1.json |
| 88258-9 | Escherichia coli oppA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88258-9.json |
| 88263-9 | Klebsiella oxytoca ompA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88263-9.json |
| 88264-7 | Klebsiella pneumoniae yggE gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88264-7.json |
| 88265-4 | Listeria sp tuf gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88265-4.json |
| 88266-2 | Mycobacterium sp rRNA [Identifier] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88266-2.json |
| 88267-0 | Proteus sp atpD gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88267-0.json |
| 88268-8 | Pseudomonas aeruginosa sodA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88268-8.json |
| 88269-6 | Staphylococcus aureus gyrB gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88269-6.json |
| 88270-4 | Staphylococcus epidermidis hsp60 gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88270-4.json |
| 88271-2 | Staphylococcus lugdunensis sodA gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88271-2.json |
| 88272-0 | Staphylococcus sp tuf gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88272-0.json |
| 88273-8 | Streptococcus agalactiae hsp60 gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88273-8.json |
| 88274-6 | Streptococcus anginosus group gyrB gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88274-6.json |
| 88275-3 | Streptococcus pneumoniae gryB gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88275-3.json |
| 88276-1 | Streptococcus pyogenes hsp60 gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88276-1.json |
| 88277-9 | Streptococcus sp tuf gene [Presence] by Probe in Positive blood culture | ./2.16.840.1.114222.4.11.1002/88277-9.json |
| 88293-6 | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | ./2.16.840.1.114222.4.11.1002/88293-6.json |
| 88294-4 | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | ./2.16.840.1.114222.4.11.1002/88294-4.json |
| 88301-7 | Kappa light chains.free [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/88301-7.json |
| 88302-5 | Lambda light chains.free [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/88302-5.json |
| 88303-3 | Lambda light chains [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/88303-3.json |
| 88304-1 | Kappa light chains [Presence] in 24 hour Urine by Immunofixation | ./2.16.840.1.114222.4.11.1002/88304-1.json |
| 88315-7 | CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head and neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/88315-7.json |
| 88316-5 | CT Guidance for biopsy of Spinal cord | ./2.16.840.1.114222.4.11.1002/88316-5.json |
| 88317-3 | CT Guidance for fluid aspiration of Chest | ./2.16.840.1.114222.4.11.1002/88317-3.json |
| 88318-1 | CTA Coronary arteries and Pulmonary veins W contrast IV | ./2.16.840.1.114222.4.11.1002/88318-1.json |
| 88319-9 | CT Abdomen and Pelvis and Lower extremity - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/88319-9.json |
| 88320-7 | CT Neck W contrast IV and CT angiogram Head and neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/88320-7.json |
| 88321-5 | CT Guidance for stereotactic localization of Unspecified body region | ./2.16.840.1.114222.4.11.1002/88321-5.json |
| 88322-3 | CT Chest W contrast IV and CT angiogram Pulmonary arteries for pulmonary embolus W contrast IV | ./2.16.840.1.114222.4.11.1002/88322-3.json |
| 88323-1 | CT Guidance for biopsy of Kidney - right | ./2.16.840.1.114222.4.11.1002/88323-1.json |
| 88324-9 | CT Guidance for biopsy of Lung - left | ./2.16.840.1.114222.4.11.1002/88324-9.json |
| 88325-6 | CT Guidance for biopsy of Kidney - left | ./2.16.840.1.114222.4.11.1002/88325-6.json |
| 88326-4 | CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/88326-4.json |
| 88327-2 | CT Head W contrast IV and CT angiogram Head and neck vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/88327-2.json |
| 88334-8 | Lean body weight Calculated | ./2.16.840.1.114222.4.11.1002/88334-8.json |
| 88347-0 | Psychiatry Nurse procedure note | ./2.16.840.1.114222.4.11.1002/88347-0.json |
| 88348-8 | Nurse Long term care facility Transfer summary note | ./2.16.840.1.114222.4.11.1002/88348-8.json |
| 88349-6 | Guidance-- during surgery | ./2.16.840.1.114222.4.11.1002/88349-6.json |
| 88350-4 | Polytrauma Case manager Note | ./2.16.840.1.114222.4.11.1002/88350-4.json |
| 88351-2 | Polytrauma Consult note | ./2.16.840.1.114222.4.11.1002/88351-2.json |
| 88352-0 | Polytrauma Education note | ./2.16.840.1.114222.4.11.1002/88352-0.json |
| 88353-8 | Polytrauma History and physical note | ./2.16.840.1.114222.4.11.1002/88353-8.json |
| 88354-6 | Polytrauma Note | ./2.16.840.1.114222.4.11.1002/88354-6.json |
| 88355-3 | Polytrauma Nurse Note | ./2.16.840.1.114222.4.11.1002/88355-3.json |
| 88356-1 | Polytrauma Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/88356-1.json |
| 88357-9 | Infectious disease Alert | ./2.16.840.1.114222.4.11.1002/88357-9.json |
| 88358-7 | Mental health Alert | ./2.16.840.1.114222.4.11.1002/88358-7.json |
| 88359-5 | Nurse Alert | ./2.16.840.1.114222.4.11.1002/88359-5.json |
| 88360-3 | Pharmacology Alert | ./2.16.840.1.114222.4.11.1002/88360-3.json |
| 88361-1 | Addiction medicine Alert | ./2.16.840.1.114222.4.11.1002/88361-1.json |
| 88362-9 | Audiology Medical equipment or product note | ./2.16.840.1.114222.4.11.1002/88362-9.json |
| 88363-7 | Medical equipment or product note | ./2.16.840.1.114222.4.11.1002/88363-7.json |
| 88364-5 | Actinobacillus pleuropneumoniae IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/88364-5.json |
| 88365-2 | Glucose [Mass/volume] in Blood --pre-meal | ./2.16.840.1.114222.4.11.1002/88365-2.json |
| 88366-0 | Microscopic observation [Presence] in Vomitus by Acid fast stain | ./2.16.840.1.114222.4.11.1002/88366-0.json |
| 88375-1 | Tildipirosin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/88375-1.json |
| 88376-9 | Gamithromycin [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/88376-9.json |
| 88377-7 | Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/88377-7.json |
| 88378-5 | Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/88378-5.json |
| 883-9 | ABO group [Type] in Blood | ./2.16.840.1.114222.4.11.1002/883-9.json |
| 88439-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose fructose PO | ./2.16.840.1.114222.4.11.1002/88439-5.json |
| 88440-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose lactose PO | ./2.16.840.1.114222.4.11.1002/88440-3.json |
| 88441-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20M post dose fructose PO | ./2.16.840.1.114222.4.11.1002/88441-1.json |
| 88442-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/88442-9.json |
| 88443-7 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40M post dose fructose PO | ./2.16.840.1.114222.4.11.1002/88443-7.json |
| 88444-5 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose fructose PO | ./2.16.840.1.114222.4.11.1002/88444-5.json |
| 88445-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose lactose PO | ./2.16.840.1.114222.4.11.1002/88445-2.json |
| 88446-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20 minutes post dose lactose PO | ./2.16.840.1.114222.4.11.1002/88446-0.json |
| 88447-8 | Liver fibrosis interpretation in Serum Qualitative | ./2.16.840.1.114222.4.11.1002/88447-8.json |
| 88448-6 | Necroinflammatory activity interpretation in Serum Qualitative | ./2.16.840.1.114222.4.11.1002/88448-6.json |
| 88449-4 | Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/88449-4.json |
| 88450-2 | Babesia divergens+MO-1 strain 18S rRNA gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88450-2.json |
| 88451-0 | Babesia duncani 18S rRNA gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88451-0.json |
| 88452-8 | Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88452-8.json |
| 88453-6 | HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88453-6.json |
| 88454-4 | Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88454-4.json |
| 88456-9 | California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88456-9.json |
| 88457-7 | Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88457-7.json |
| 88459-3 | Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/88459-3.json |
| 88460-1 | Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/88460-1.json |
| 88462-7 | Carbapenem [Susceptibility] | ./2.16.840.1.114222.4.11.1002/88462-7.json |
| 884-7 | ABO and Rh group [Type] in Capillary blood | ./2.16.840.1.114222.4.11.1002/884-7.json |
| 88473-4 | If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this [SAQ] | ./2.16.840.1.114222.4.11.1002/88473-4.json |
| 88479-1 | Seattle Angina Questionnaire - 7 items [SAQ] | ./2.16.840.1.114222.4.11.1002/88479-1.json |
| 88509-5 | Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method | ./2.16.840.1.114222.4.11.1002/88509-5.json |
| 88517-8 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood | ./2.16.840.1.114222.4.11.1002/88517-8.json |
| 88518-6 | Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood | ./2.16.840.1.114222.4.11.1002/88518-6.json |
| 88519-4 | KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/88519-4.json |
| 88526-9 | CT Guidance for biopsy of Lung - right | ./2.16.840.1.114222.4.11.1002/88526-9.json |
| 88527-7 | Respiratory syncytial virus [Presence] in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88527-7.json |
| 88528-5 | Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88528-5.json |
| 88529-3 | Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88529-3.json |
| 88530-1 | Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88530-1.json |
| 88533-5 | Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88533-5.json |
| 88534-3 | Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88534-3.json |
| 88535-0 | Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88535-0.json |
| 88536-8 | Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88536-8.json |
| 88537-6 | Enterovirus identified in Pericardial fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88537-6.json |
| 88538-4 | Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88538-4.json |
| 88539-2 | Adenovirus DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88539-2.json |
| 88540-0 | Enterovirus RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88540-0.json |
| 88541-8 | Adenovirus DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88541-8.json |
| 88542-6 | HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing | ./2.16.840.1.114222.4.11.1002/88542-6.json |
| 88543-4 | HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing | ./2.16.840.1.114222.4.11.1002/88543-4.json |
| 88544-2 | HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing | ./2.16.840.1.114222.4.11.1002/88544-2.json |
| 88545-9 | Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88545-9.json |
| 88546-7 | Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88546-7.json |
| 88547-5 | Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88547-5.json |
| 88548-3 | Scedosporium apiospermum DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88548-3.json |
| 88549-1 | Scedosporium apiospermum DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88549-1.json |
| 88550-9 | Scedosporium apiospermum DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88550-9.json |
| 88551-7 | Scedosporium apiospermum DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88551-7.json |
| 88552-5 | Scedosporium prolificans DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88552-5.json |
| 88553-3 | Scedosporium prolificans DNA [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88553-3.json |
| 88554-1 | Scedosporium prolificans DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88554-1.json |
| 88555-8 | Galactomannan Ag [Presence] in Bronchoalveolar lavage | ./2.16.840.1.114222.4.11.1002/88555-8.json |
| 88556-6 | Scedosporium prolificans DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88556-6.json |
| 88557-4 | Scedosporium apiospermum DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88557-4.json |
| 88558-2 | Cytomegalovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88558-2.json |
| 88559-0 | Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88559-0.json |
| 88560-8 | Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88560-8.json |
| 88561-6 | Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88561-6.json |
| 88562-4 | Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88562-4.json |
| 88563-2 | Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88563-2.json |
| 88564-0 | Cytomegalovirus [Presence] in Bone marrow by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88564-0.json |
| 88565-7 | Varicella zoster virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88565-7.json |
| 88566-5 | Cytomegalovirus Ag [Presence] in Bone marrow by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88566-5.json |
| 88567-3 | Cytomegalovirus DNA [Presence] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88567-3.json |
| 88568-1 | Influenza virus identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88568-1.json |
| 88570-7 | Acanthamoeba sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88570-7.json |
| 88573-1 | Onchocerca sp IgG2 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88573-1.json |
| 88574-9 | Onchocerca sp IgG3 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88574-9.json |
| 88575-6 | Onchocerca sp IgG4 Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88575-6.json |
| 88576-4 | Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88576-4.json |
| 88577-2 | Legionella pneumophila DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88577-2.json |
| 88578-0 | Clostridium botulinum toxin [Identifier] in Stool by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/88578-0.json |
| 88579-8 | Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88579-8.json |
| 88580-6 | Burkholderia sp identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88580-6.json |
| 88581-4 | Borrelia sp DNA [Identifier] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88581-4.json |
| 88582-2 | Bordetella sp identified in Nasopharynx by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88582-2.json |
| 88583-0 | Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88583-0.json |
| 88584-8 | Corynebacterium diphtheriae [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88584-8.json |
| 88587-1 | Legionella sp DNA [Identifier] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88587-1.json |
| 88588-9 | Legionella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88588-9.json |
| 88589-7 | Clostridium botulinum toxin [Identifier] in Serum by Mouse bioassay neutralization | ./2.16.840.1.114222.4.11.1002/88589-7.json |
| 88590-5 | Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88590-5.json |
| 88591-3 | Scedosporium prolificans DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88591-3.json |
| 88592-1 | Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88592-1.json |
| 88593-9 | Human bocavirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88593-9.json |
| 88594-7 | Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88594-7.json |
| 88595-4 | Respiratory syncytial virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88595-4.json |
| 88596-2 | Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88596-2.json |
| 88597-0 | Respiratory syncytial virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88597-0.json |
| 88598-8 | Toscana virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88598-8.json |
| 88599-6 | Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88599-6.json |
| 88600-2 | Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88600-2.json |
| 88602-8 | Adenovirus Ag [Presence] in Nasopharynx by Immunoassay | ./2.16.840.1.114222.4.11.1002/88602-8.json |
| 88603-6 | Adenovirus Ag [Presence] in Lower respiratory specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/88603-6.json |
| 88604-4 | Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88604-4.json |
| 88605-1 | Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88605-1.json |
| 88606-9 | Herpes simplex virus identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88606-9.json |
| 88607-7 | Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88607-7.json |
| 88608-5 | Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88608-5.json |
| 88609-3 | Human coronavirus 229E RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88609-3.json |
| 88610-1 | Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88610-1.json |
| 88611-9 | Human coronavirus HKU1 RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88611-9.json |
| 88612-7 | Human coronavirus HKU1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88612-7.json |
| 88613-5 | Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88613-5.json |
| 88614-3 | Human coronavirus RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88614-3.json |
| 88615-0 | Human coronavirus NL63 RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88615-0.json |
| 88616-8 | Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88616-8.json |
| 88617-6 | Human coronavirus NL63 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88617-6.json |
| 88618-4 | Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88618-4.json |
| 88619-2 | Human coronavirus OC43 RNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88619-2.json |
| 88620-0 | Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88620-0.json |
| 88621-8 | Human coronavirus OC43 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88621-8.json |
| 88622-6 | Cytomegalovirus [Presence] in Ocular fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/88622-6.json |
| 88623-4 | Cytomegalovirus [Presence] in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88623-4.json |
| 88624-2 | Cytomegalovirus [Presence] in Amniotic fluid by Shell vial culture | ./2.16.840.1.114222.4.11.1002/88624-2.json |
| 88625-9 | Cytomegalovirus [Presence] in Ocular fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88625-9.json |
| 88626-7 | Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88626-7.json |
| 88627-5 | Human coronavirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88627-5.json |
| 88628-3 | Human coronavirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88628-3.json |
| 88629-1 | Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/88629-1.json |
| 88630-9 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/88630-9.json |
| 88631-7 | Microscopic observation [Presence] in Lower respiratory specimen by Acid fast stain.Kinyoun | ./2.16.840.1.114222.4.11.1002/88631-7.json |
| 88632-5 | Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/88632-5.json |
| 88633-3 | Microscopic observation [Identifier] in Lower respiratory specimen by Giemsa stain | ./2.16.840.1.114222.4.11.1002/88633-3.json |
| 88634-1 | Microscopic observation [Identifier] in Saliva (oral fluid) by Gram stain | ./2.16.840.1.114222.4.11.1002/88634-1.json |
| 88635-8 | Microscopic observation [Identifier] in Vomitus by Gram stain | ./2.16.840.1.114222.4.11.1002/88635-8.json |
| 88637-4 | Nurse Agreement | ./2.16.840.1.114222.4.11.1002/88637-4.json |
| 88638-2 | Nurse Long term care facility Agreement | ./2.16.840.1.114222.4.11.1002/88638-2.json |
| 88639-0 | Pain medicine Controlled substance agreement | ./2.16.840.1.114222.4.11.1002/88639-0.json |
| 88640-8 | Community health care Adult day care center Consult note | ./2.16.840.1.114222.4.11.1002/88640-8.json |
| 88641-6 | Community health care Adult day care center Discharge summary | ./2.16.840.1.114222.4.11.1002/88641-6.json |
| 88642-4 | Community health care Adult day care center Note | ./2.16.840.1.114222.4.11.1002/88642-4.json |
| 88643-2 | Community health care Nurse Adult day care center Note | ./2.16.840.1.114222.4.11.1002/88643-2.json |
| 88644-0 | Outpatient hospital Consult note | ./2.16.840.1.114222.4.11.1002/88644-0.json |
| 88645-7 | Outpatient hospital Discharge summary | ./2.16.840.1.114222.4.11.1002/88645-7.json |
| 88646-5 | Outpatient hospital Note | ./2.16.840.1.114222.4.11.1002/88646-5.json |
| 88647-3 | Emergency department Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88647-3.json |
| 88648-1 | Hematology+Medical oncology Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88648-1.json |
| 88649-9 | Internal medicine Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88649-9.json |
| 88650-7 | Nurse Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88650-7.json |
| 88651-5 | Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88651-5.json |
| 88652-3 | Surgery Parenteral therapy note | ./2.16.840.1.114222.4.11.1002/88652-3.json |
| 88677-0 | German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set | ./2.16.840.1.114222.4.11.1002/88677-0.json |
| 88678-8 | Herpes simplex virus 1 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88678-8.json |
| 88679-6 | Herpes simplex virus 2 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88679-6.json |
| 88680-4 | Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88680-4.json |
| 88681-2 | Herpes simplex virus Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88681-2.json |
| 88682-0 | Leishmania sp IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88682-0.json |
| 88683-8 | Bacteria identified in Bronchoalveolar lavage by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/88683-8.json |
| 88684-6 | Microscopic observation [Identifier] in Aspirate by Giemsa stain | ./2.16.840.1.114222.4.11.1002/88684-6.json |
| 88685-3 | Microscopic observation [Identifier] in Lower respiratory specimen by KOH preparation | ./2.16.840.1.114222.4.11.1002/88685-3.json |
| 88686-1 | Fungus identified in Bronchoalveolar lavage by Culture | ./2.16.840.1.114222.4.11.1002/88686-1.json |
| 88687-9 | Fungus identified in Mouth by Culture | ./2.16.840.1.114222.4.11.1002/88687-9.json |
| 88688-7 | Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88688-7.json |
| 88689-5 | Pneumocystis jiroveci [Presence] in Lower respiratory specimen by Calcofluor white | ./2.16.840.1.114222.4.11.1002/88689-5.json |
| 88690-3 | Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88690-3.json |
| 88691-1 | Pneumocystis jiroveci Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88691-1.json |
| 88692-9 | Primary care Patient's home Admission evaluation note | ./2.16.840.1.114222.4.11.1002/88692-9.json |
| 88693-7 | Patient's home Discharge summary | ./2.16.840.1.114222.4.11.1002/88693-7.json |
| 88694-5 | Patient's home Discharge teaching note | ./2.16.840.1.114222.4.11.1002/88694-5.json |
| 88700-0 | Babesia microti IgG and IgM [Interpretation] in Serum | ./2.16.840.1.114222.4.11.1002/88700-0.json |
| 88704-2 | Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/88704-2.json |
| 88708-3 | Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/88708-3.json |
| 88709-1 | Albumin/Globulin [Mass Ratio] in Body fluid by Electrophoresis | ./2.16.840.1.114222.4.11.1002/88709-1.json |
| 88710-9 | Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/88710-9.json |
| 88711-7 | Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/88711-7.json |
| 88712-5 | Lipase [Enzymatic activity/volume] in Peritoneal dialysis fluid | ./2.16.840.1.114222.4.11.1002/88712-5.json |
| 88713-3 | Phosphate [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/88713-3.json |
| 88714-1 | Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/88714-1.json |
| 88715-8 | Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/88715-8.json |
| 88716-6 | Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88716-6.json |
| 88717-4 | Candida sp identified in Isolate | ./2.16.840.1.114222.4.11.1002/88717-4.json |
| 88718-2 | Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88718-2.json |
| 88719-0 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88719-0.json |
| 88720-8 | Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88720-8.json |
| 88721-6 | Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88721-6.json |
| 88722-4 | Streptococcus pneumoniae serotype [Type] in Isolate | ./2.16.840.1.114222.4.11.1002/88722-4.json |
| 88723-2 | Asialoganglioside GM1 IgG+IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88723-2.json |
| 88724-0 | Ganglioside GD1a IgG+IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88724-0.json |
| 88725-7 | MDA5 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88725-7.json |
| 88726-5 | Glial nuclear type 1 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88726-5.json |
| 88727-3 | Recoverin Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88727-3.json |
| 88729-9 | Ganglioside GQ1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88729-9.json |
| 88730-7 | Ganglioside GD1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88730-7.json |
| 88731-5 | Ganglioside GM2 IgG+IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88731-5.json |
| 88732-3 | Mi-2 alpha Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88732-3.json |
| 88733-1 | Mi-2 beta Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88733-1.json |
| 88734-9 | PCA-Tr Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88734-9.json |
| 88735-6 | PM-SCL-100 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88735-6.json |
| 88736-4 | PM-SCL-75 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88736-4.json |
| 88737-2 | RNA polymerase III RP11 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88737-2.json |
| 88738-0 | RNA polymerase III RP155 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88738-0.json |
| 88739-8 | TIF1-gamma Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88739-8.json |
| 88740-6 | Titin Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88740-6.json |
| 88741-4 | U1 small nuclear ribonucleoprotein A Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88741-4.json |
| 88742-2 | U1 small nuclear ribonucleoprotein C Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88742-2.json |
| 88743-0 | Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88743-0.json |
| 88744-8 | inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/88744-8.json |
| 88828-9 | FDA package insert Renal Impairment subsection | ./2.16.840.1.114222.4.11.1002/88828-9.json |
| 88829-7 | FDA package insert Hepatic Impairment subsection | ./2.16.840.1.114222.4.11.1002/88829-7.json |
| 88830-5 | FDA package insert Immunogenicity | ./2.16.840.1.114222.4.11.1002/88830-5.json |
| 88831-3 | RF Kidney - right and Ureter Views W contrast retrograde intra ureter | ./2.16.840.1.114222.4.11.1002/88831-3.json |
| 88832-1 | RF Kidney - left and Ureter Views W contrast retrograde intra ureter | ./2.16.840.1.114222.4.11.1002/88832-1.json |
| 88833-9 | RF Kidney - bilateral and Ureter Views W contrast retrograde intra ureter | ./2.16.840.1.114222.4.11.1002/88833-9.json |
| 88834-7 | RF Guidance for dilation of nephrostomy tract, ureter, or urethra | ./2.16.840.1.114222.4.11.1002/88834-7.json |
| 88835-4 | Influenza virus A swine origin RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88835-4.json |
| 88856-0 | Hematopoietic stem cell transplantation risk score EBMT | ./2.16.840.1.114222.4.11.1002/88856-0.json |
| 88866-9 | Other Chemical [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/88866-9.json |
| 88873-5 | Sympathomimetics [Presence] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/88873-5.json |
| 88874-3 | Mycobacterium tuberculosis complex DNA [Presence] in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/88874-3.json |
| 88875-0 | Measles virus genotype A vaccine strain N gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88875-0.json |
| 88876-8 | Measles virus genotype A vaccine strain N gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88876-8.json |
| 888-8 | Blood group antibodies identified in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/888-8.json |
| 88880-0 | Monocyte distribution width [Entitic volume] in Blood by Automated | ./2.16.840.1.114222.4.11.1002/88880-0.json |
| 88881-8 | Smith extractable nuclear D Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88881-8.json |
| 88882-6 | Smith extractable nuclear B Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/88882-6.json |
| 88885-9 | Delafloxacin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/88885-9.json |
| 88886-7 | Telavancin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/88886-7.json |
| 88887-5 | Isavuconazole [Susceptibility] | ./2.16.840.1.114222.4.11.1002/88887-5.json |
| 88888-3 | Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/88888-3.json |
| 88889-1 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88889-1.json |
| 88890-9 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88890-9.json |
| 88891-7 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/88891-7.json |
| 88892-5 | Meropenem+Vaborbactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/88892-5.json |
| 88893-3 | Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma | ./2.16.840.1.114222.4.11.1002/88893-3.json |
| 88894-1 | Brivaracetam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88894-1.json |
| 88895-8 | Perampanel [Mass/volume] - Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88895-8.json |
| 88896-6 | Reboxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88896-6.json |
| 88897-4 | Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88897-4.json |
| 88898-2 | Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88898-2.json |
| 88899-0 | Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88899-0.json |
| 88900-6 | Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88900-6.json |
| 88901-4 | Adenovirus [Presence] in Stool by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88901-4.json |
| 88902-2 | Adenovirus [Presence] in Urine by Organism specific culture | ./2.16.840.1.114222.4.11.1002/88902-2.json |
| 88903-0 | Influenza virus B IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88903-0.json |
| 88904-8 | Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88904-8.json |
| 88905-5 | Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88905-5.json |
| 88906-3 | Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88906-3.json |
| 88907-1 | Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88907-1.json |
| 88908-9 | Parainfluenza virus 3 Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88908-9.json |
| 88909-7 | Respiratory syncytial virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/88909-7.json |
| 88910-5 | Taenia sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88910-5.json |
| 88911-3 | Taenia solium larva DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88911-3.json |
| 88912-1 | Taenia solium larva DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88912-1.json |
| 88913-9 | Strongyloides stercoralis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88913-9.json |
| 88914-7 | Acanthamoeba sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88914-7.json |
| 88915-4 | Filaria DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88915-4.json |
| 88916-2 | Leishmania sp DNA [Identifier] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88916-2.json |
| 88917-0 | Leishmania sp DNA [Identifier] in Bone marrow by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88917-0.json |
| 88918-8 | Filaria DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88918-8.json |
| 88919-6 | Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/88919-6.json |
| 88920-4 | Taenia solium larva Ag [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/88920-4.json |
| 88921-2 | Echinococcus granulosus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/88921-2.json |
| 88923-8 | 1,3 beta glucan [Mass/volume] in Lower respiratory specimen | ./2.16.840.1.114222.4.11.1002/88923-8.json |
| 88924-6 | Microsporidia DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88924-6.json |
| 88925-3 | Microsporidia DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88925-3.json |
| 88926-1 | Histoplasma capsulatum DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88926-1.json |
| 88927-9 | Cryptosporidium sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88927-9.json |
| 88928-7 | Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/88928-7.json |
| 88929-5 | Guidance for additional transluminal angioplasty of Vein | ./2.16.840.1.114222.4.11.1002/88929-5.json |
| 88930-3 | Guidance for dilation of stricture and placement of stent of Biliary ducts-- W contrast IV | ./2.16.840.1.114222.4.11.1002/88930-3.json |
| 88931-1 | Guidance for embolization for tumor of Hepatic artery-- W embolic agent IA | ./2.16.840.1.114222.4.11.1002/88931-1.json |
| 88932-9 | Guidance for embolization for tumor of Spinal artery-- W embolic agent IA | ./2.16.840.1.114222.4.11.1002/88932-9.json |
| 88933-7 | Guidance for embolization of Portal vein-- W embolic agent IV | ./2.16.840.1.114222.4.11.1002/88933-7.json |
| 88934-5 | Guidance for embolization of Splenic artery-- W embolic agent IA | ./2.16.840.1.114222.4.11.1002/88934-5.json |
| 88935-2 | Guidance for chemoembolization of Hepatic artery-- W chemotherapy IA+W embolic agent IA | ./2.16.840.1.114222.4.11.1002/88935-2.json |
| 88936-0 | Guidance for injection of Hepatic artery-- W Tc-99m MAA IA | ./2.16.840.1.114222.4.11.1002/88936-0.json |
| 88937-8 | Guidance for placement of stent in Biliary ducts | ./2.16.840.1.114222.4.11.1002/88937-8.json |
| 88938-6 | Guidance for placement of stent in Ureter | ./2.16.840.1.114222.4.11.1002/88938-6.json |
| 88939-4 | Guidance for radioembolization for tumor of Hepatic artery-- W Yttrium-90 IA | ./2.16.840.1.114222.4.11.1002/88939-4.json |
| 88940-2 | Guidance for repair of aneurysm of Abdominal Aorta | ./2.16.840.1.114222.4.11.1002/88940-2.json |
| 88941-0 | Guidance for repair of aneurysm of Thoracic Aorta | ./2.16.840.1.114222.4.11.1002/88941-0.json |
| 88942-8 | Guidance for repair of endoleak of Artery | ./2.16.840.1.114222.4.11.1002/88942-8.json |
| 88943-6 | Guidance for venous sampling of Adrenal vein | ./2.16.840.1.114222.4.11.1002/88943-6.json |
| 88944-4 | NM Lung and Liver Views for AV shunt W Tc-99m MAA+W intraarterial hepatic injection | ./2.16.840.1.114222.4.11.1002/88944-4.json |
| 889-6 | Blood group antibodies identified in Blood product unit | ./2.16.840.1.114222.4.11.1002/889-6.json |
| 88985-7 | Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88985-7.json |
| 88986-5 | Elvitegravir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88986-5.json |
| 88987-3 | Maraviroc [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88987-3.json |
| 88988-1 | Melperone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88988-1.json |
| 88989-9 | Perazine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88989-9.json |
| 88990-7 | Sertindole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88990-7.json |
| 88991-5 | Zotepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88991-5.json |
| 88992-3 | Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/88992-3.json |
| 88993-1 | Acute kidney injury risk [Likelihood] by Calculated by NephroCheck | ./2.16.840.1.114222.4.11.1002/88993-1.json |
| 88994-9 | Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88994-9.json |
| 88995-6 | Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88995-6.json |
| 88996-4 | Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88996-4.json |
| 88997-2 | Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88997-2.json |
| 88998-0 | Omega-3 (EPA+DHA) index in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88998-0.json |
| 88999-8 | Omega-3 (EPA+DHA) index risk in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/88999-8.json |
| 89000-4 | Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89000-4.json |
| 89001-2 | CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89001-2.json |
| 89002-0 | GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89002-0.json |
| 89003-8 | HuD Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89003-8.json |
| 89004-6 | MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89004-6.json |
| 89005-3 | NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89005-3.json |
| 89006-1 | p53 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89006-1.json |
| 89007-9 | SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89007-9.json |
| 89030-1 | Physical medicine and rehab Progress note | ./2.16.840.1.114222.4.11.1002/89030-1.json |
| 89031-9 | Hematology Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/89031-9.json |
| 89032-7 | Nephrology Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/89032-7.json |
| 89033-5 | Urology Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/89033-5.json |
| 89034-3 | Vascular neurology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89034-3.json |
| 89035-0 | Sleep medicine Physician Note | ./2.16.840.1.114222.4.11.1002/89035-0.json |
| 89036-8 | Trauma Note | ./2.16.840.1.114222.4.11.1002/89036-8.json |
| 89037-6 | CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/89037-6.json |
| 89038-4 | CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/89038-4.json |
| 89039-2 | MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/89039-2.json |
| 890-4 | Blood group antibody screen [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/890-4.json |
| 89040-0 | Rubella virus Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89040-0.json |
| 89042-6 | Eszopiclone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/89042-6.json |
| 89043-4 | Zopiclone-N-oxide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/89043-4.json |
| 89085-5 | Total lung capacity measured/predicted by Plethysmograph body box | ./2.16.840.1.114222.4.11.1002/89085-5.json |
| 89087-1 | Fetal Body weight Estimated | ./2.16.840.1.114222.4.11.1002/89087-1.json |
| 89198-6 | Mean score [ECog] | ./2.16.840.1.114222.4.11.1002/89198-6.json |
| 89199-4 | Mean score [ECog.Partner] | ./2.16.840.1.114222.4.11.1002/89199-4.json |
| 89204-2 | Patient Health Questionnaire-9: Modified for Teens total score [Reported.PHQ.Teen] | ./2.16.840.1.114222.4.11.1002/89204-2.json |
| 89205-9 | Center for Epidemiologic Studies Depression Scale-Revised total score [CESD-R] | ./2.16.840.1.114222.4.11.1002/89205-9.json |
| 89206-7 | Patient Health Questionnaire-9: Modified for Teens [Reported.PHQ.Teen] | ./2.16.840.1.114222.4.11.1002/89206-7.json |
| 89207-5 | Center for Epidemiologic Studies Depression Scale-Revised [CESD-R] | ./2.16.840.1.114222.4.11.1002/89207-5.json |
| 89208-3 | Beck Depression Inventory Fast Screen total score [BDI] | ./2.16.840.1.114222.4.11.1002/89208-3.json |
| 89209-1 | Beck Depression Inventory II total score [BDI] | ./2.16.840.1.114222.4.11.1002/89209-1.json |
| 89210-9 | Beck Depression Inventory II [BDI] | ./2.16.840.1.114222.4.11.1002/89210-9.json |
| 89211-7 | Beck Depression Inventory Fast Screen [BDI] | ./2.16.840.1.114222.4.11.1002/89211-7.json |
| 89213-3 | Obstetrics History and physical note | ./2.16.840.1.114222.4.11.1002/89213-3.json |
| 89214-1 | Obstetrics Discharge summary | ./2.16.840.1.114222.4.11.1002/89214-1.json |
| 89215-8 | Gynecology Admission history and physical note | ./2.16.840.1.114222.4.11.1002/89215-8.json |
| 89216-6 | Gynecology Consult note | ./2.16.840.1.114222.4.11.1002/89216-6.json |
| 89217-4 | Gynecology Discharge instructions | ./2.16.840.1.114222.4.11.1002/89217-4.json |
| 89218-2 | Gynecology Discharge summary | ./2.16.840.1.114222.4.11.1002/89218-2.json |
| 89219-0 | Gynecology Discharge teaching note | ./2.16.840.1.114222.4.11.1002/89219-0.json |
| 89220-8 | Gynecology Education note | ./2.16.840.1.114222.4.11.1002/89220-8.json |
| 89221-6 | Gynecology History and physical note | ./2.16.840.1.114222.4.11.1002/89221-6.json |
| 89222-4 | Gynecology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89222-4.json |
| 89223-2 | Gynecology procedure note | ./2.16.840.1.114222.4.11.1002/89223-2.json |
| 89224-0 | Gynecology Progress note | ./2.16.840.1.114222.4.11.1002/89224-0.json |
| 89225-7 | Gynecology Referral note | ./2.16.840.1.114222.4.11.1002/89225-7.json |
| 89226-5 | Gynecology Transfer summary note | ./2.16.840.1.114222.4.11.1002/89226-5.json |
| 89227-3 | Obstetrics Consult note | ./2.16.840.1.114222.4.11.1002/89227-3.json |
| 89228-1 | Obstetrics Discharge instructions | ./2.16.840.1.114222.4.11.1002/89228-1.json |
| 89229-9 | Obstetrics Discharge teaching note | ./2.16.840.1.114222.4.11.1002/89229-9.json |
| 89230-7 | Obstetrics Education note | ./2.16.840.1.114222.4.11.1002/89230-7.json |
| 89231-5 | Obstetrics Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89231-5.json |
| 89232-3 | Obstetrics procedure note | ./2.16.840.1.114222.4.11.1002/89232-3.json |
| 89233-1 | Obstetrics Progress note | ./2.16.840.1.114222.4.11.1002/89233-1.json |
| 89234-9 | Obstetrics Referral note | ./2.16.840.1.114222.4.11.1002/89234-9.json |
| 89235-6 | Obstetrics Transfer summary note | ./2.16.840.1.114222.4.11.1002/89235-6.json |
| 89236-4 | Obstetrics Diagnostic study note | ./2.16.840.1.114222.4.11.1002/89236-4.json |
| 89237-2 | Gynecology Flowsheet | ./2.16.840.1.114222.4.11.1002/89237-2.json |
| 89238-0 | Obstetrics Flowsheet | ./2.16.840.1.114222.4.11.1002/89238-0.json |
| 89239-8 | Gynecology Plan of care note | ./2.16.840.1.114222.4.11.1002/89239-8.json |
| 89240-6 | Obstetrics Plan of care note | ./2.16.840.1.114222.4.11.1002/89240-6.json |
| 89241-4 | Obstetrics Note | ./2.16.840.1.114222.4.11.1002/89241-4.json |
| 89242-2 | Discharge checklist | ./2.16.840.1.114222.4.11.1002/89242-2.json |
| 89243-0 | Karnofsky Performance Status score | ./2.16.840.1.114222.4.11.1002/89243-0.json |
| 89245-5 | Karnofsky Performance Status [Interpretation] | ./2.16.840.1.114222.4.11.1002/89245-5.json |
| 89247-1 | ECOG Performance Status score | ./2.16.840.1.114222.4.11.1002/89247-1.json |
| 89250-5 | Device or anatomic structure visible in wound | ./2.16.840.1.114222.4.11.1002/89250-5.json |
| 89252-1 | Episode of Wound | ./2.16.840.1.114222.4.11.1002/89252-1.json |
| 89253-9 | Trend | ./2.16.840.1.114222.4.11.1002/89253-9.json |
| 89259-6 | Presence of wound exudate | ./2.16.840.1.114222.4.11.1002/89259-6.json |
| 89260-4 | Area of wound | ./2.16.840.1.114222.4.11.1002/89260-4.json |
| 89261-2 | Clinical course | ./2.16.840.1.114222.4.11.1002/89261-2.json |
| 89267-9 | Diastolic blood pressure--lying in L-lateral position | ./2.16.840.1.114222.4.11.1002/89267-9.json |
| 89268-7 | Systolic blood pressure--lying in L-lateral position | ./2.16.840.1.114222.4.11.1002/89268-7.json |
| 89269-5 | Body height Measured --at birth | ./2.16.840.1.114222.4.11.1002/89269-5.json |
| 89270-3 | Body mass index (BMI) [Ratio] Estimated | ./2.16.840.1.114222.4.11.1002/89270-3.json |
| 89271-1 | Heart rate --during apnea | ./2.16.840.1.114222.4.11.1002/89271-1.json |
| 89272-9 | Oxygen saturation in Arterial blood by Pulse oximetry --during apnea | ./2.16.840.1.114222.4.11.1002/89272-9.json |
| 89273-7 | Heart rate --W exercise | ./2.16.840.1.114222.4.11.1002/89273-7.json |
| 89276-0 | Oxygen saturation in Arterial blood by Pulse oximetry --W exercise | ./2.16.840.1.114222.4.11.1002/89276-0.json |
| 89277-8 | Oxygen saturation in Arterial blood by Pulse oximetry --during anesthesia | ./2.16.840.1.114222.4.11.1002/89277-8.json |
| 89278-6 | Heart rate --during anesthesia | ./2.16.840.1.114222.4.11.1002/89278-6.json |
| 89279-4 | Respiratory rate --during anesthesia | ./2.16.840.1.114222.4.11.1002/89279-4.json |
| 89280-2 | Systolic blood pressure--during anesthesia | ./2.16.840.1.114222.4.11.1002/89280-2.json |
| 89281-0 | Diastolic blood pressure--during anesthesia | ./2.16.840.1.114222.4.11.1002/89281-0.json |
| 89282-8 | Heart rate --post bronchodilation | ./2.16.840.1.114222.4.11.1002/89282-8.json |
| 89283-6 | CT Neck+Chest+Abdomen+Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/89283-6.json |
| 89284-4 | MR Cervical and thoracic spine W contrast IV | ./2.16.840.1.114222.4.11.1002/89284-4.json |
| 89291-9 | Heart rate --W pain | ./2.16.840.1.114222.4.11.1002/89291-9.json |
| 89292-7 | Respiratory rate --W pain | ./2.16.840.1.114222.4.11.1002/89292-7.json |
| 89314-9 | Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/89314-9.json |
| 89315-6 | CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89315-6.json |
| 89316-4 | CD4+CD25+CD45RO+CD127Low+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89316-4.json |
| 89317-2 | CD4+CD25-CD127+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89317-2.json |
| 89318-0 | CD25-CD127+ cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89318-0.json |
| 89319-8 | CD25+CD45RA+CD127Low+ cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89319-8.json |
| 89320-6 | CD25+CD45RO+CD127Low+ cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89320-6.json |
| 89323-0 | APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/89323-0.json |
| 89324-8 | Insulin intact [Units/volume] in Serum by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/89324-8.json |
| 89325-5 | CD3+CD8+CD28+HLA DR+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89325-5.json |
| 89326-3 | CD3+CD4+CD28+HLA DR+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89326-3.json |
| 89327-1 | CD3+CD8+CD27-CD45RO+CD62L- cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89327-1.json |
| 89328-9 | CD3+CD4+CD27-CD45RO+CD62L- cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89328-9.json |
| 89329-7 | CD3+CD4+CD27+CD45RO+CD62L+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89329-7.json |
| 89330-5 | CD3+CD8+CD27+CD62L+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89330-5.json |
| 89331-3 | CD3+CD4+CD27+CD62L+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89331-3.json |
| 89332-1 | CD28+HLA DR+ cells/100 CD3+CD8+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89332-1.json |
| 89333-9 | CD28+HLA DR+ cells/100 CD3+CD4+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89333-9.json |
| 89334-7 | CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD8+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89334-7.json |
| 89335-4 | CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD8+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89335-4.json |
| 89336-2 | CD45RO cells/100 CD3+CD8+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89336-2.json |
| 89337-0 | CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD4+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89337-0.json |
| 89338-8 | CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD4+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89338-8.json |
| 89339-6 | CD27+CD62L+ cells/100 CD3+CD8+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89339-6.json |
| 89340-4 | CD27+CD62L+ cells/100 CD3+CD4+ cells in Blood | ./2.16.840.1.114222.4.11.1002/89340-4.json |
| 89341-2 | CD38+IgM+ cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89341-2.json |
| 89342-0 | Babesia sp 18S rRNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89342-0.json |
| 89343-8 | CD19+CD38+IgM- cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89343-8.json |
| 89344-6 | CD38+IgM- cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89344-6.json |
| 89345-3 | CD19+IgM+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89345-3.json |
| 89346-1 | IgM cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89346-1.json |
| 89347-9 | CD19+CD27+IgD-IgM+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89347-9.json |
| 89348-7 | CD27+IgD-IgM+ cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89348-7.json |
| 89349-5 | CD19+CD27+IgD-IgM- cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89349-5.json |
| 89350-3 | CD27+IgD-IgM- cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89350-3.json |
| 89351-1 | CD19+CD27+IgD+IgM+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89351-1.json |
| 89352-9 | CD27+IgD+IgM+ cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89352-9.json |
| 89353-7 | CD19+CD27+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89353-7.json |
| 89354-5 | CD19+21- cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89354-5.json |
| 89355-2 | CD21- cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89355-2.json |
| 89356-0 | CD21 cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89356-0.json |
| 89357-8 | CD19+CD38+IgM+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/89357-8.json |
| 89358-6 | CD27 cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/89358-6.json |
| 89359-4 | Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/89359-4.json |
| 89360-2 | CD45RA cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89360-2.json |
| 89362-8 | CD45RO cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89362-8.json |
| 89363-6 | Cholinesterase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/89363-6.json |
| 89364-4 | Free Hemoglobin [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/89364-4.json |
| 89366-9 | von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/89366-9.json |
| 89367-7 | von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/89367-7.json |
| 89369-3 | Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/89369-3.json |
| 89372-7 | Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/89372-7.json |
| 89373-5 | Hepatitis A virus genotype in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89373-5.json |
| 89374-3 | HIV 1 Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/89374-3.json |
| 89423-8 | Time to rise from chair, walk 10 feet and back, and return to sitting [TUG] | ./2.16.840.1.114222.4.11.1002/89423-8.json |
| 89424-6 | Long-term opioid therapy for pain consent Document | ./2.16.840.1.114222.4.11.1002/89424-6.json |
| 89425-3 | CPR flowsheet | ./2.16.840.1.114222.4.11.1002/89425-3.json |
| 89426-1 | CPR note | ./2.16.840.1.114222.4.11.1002/89426-1.json |
| 89427-9 | Evaluation and management consent Document | ./2.16.840.1.114222.4.11.1002/89427-9.json |
| 89428-7 | Blood or blood product transfusion consent Document | ./2.16.840.1.114222.4.11.1002/89428-7.json |
| 89429-5 | Surgical operation order | ./2.16.840.1.114222.4.11.1002/89429-5.json |
| 89430-3 | Outpatient Medical history screening form | ./2.16.840.1.114222.4.11.1002/89430-3.json |
| 89431-1 | CD25 cells/100 CD4 cells in Blood | ./2.16.840.1.114222.4.11.1002/89431-1.json |
| 89432-9 | Preventive medicine Group counseling note | ./2.16.840.1.114222.4.11.1002/89432-9.json |
| 89433-7 | Pain medicine Group counseling note | ./2.16.840.1.114222.4.11.1002/89433-7.json |
| 89434-5 | Primary care Group counseling note | ./2.16.840.1.114222.4.11.1002/89434-5.json |
| 89436-0 | Total score [Rose Dyspnea Scale] | ./2.16.840.1.114222.4.11.1002/89436-0.json |
| 89441-0 | Gynecology Resident Note | ./2.16.840.1.114222.4.11.1002/89441-0.json |
| 89442-8 | Obstetrics Administrative note | ./2.16.840.1.114222.4.11.1002/89442-8.json |
| 89443-6 | Obstetrics Admission history and physical note | ./2.16.840.1.114222.4.11.1002/89443-6.json |
| 89444-4 | Obstetrics Checklist | ./2.16.840.1.114222.4.11.1002/89444-4.json |
| 89445-1 | Gynecology Checklist | ./2.16.840.1.114222.4.11.1002/89445-1.json |
| 89446-9 | Obstetrics Hospital Consult note | ./2.16.840.1.114222.4.11.1002/89446-9.json |
| 89447-7 | Gynecology Hospital Consult note | ./2.16.840.1.114222.4.11.1002/89447-7.json |
| 89448-5 | Obstetrics Hospital Letter | ./2.16.840.1.114222.4.11.1002/89448-5.json |
| 89449-3 | Gynecology Hospital Letter | ./2.16.840.1.114222.4.11.1002/89449-3.json |
| 89450-1 | Obstetrics Nurse Note | ./2.16.840.1.114222.4.11.1002/89450-1.json |
| 89451-9 | Gynecology Nurse Note | ./2.16.840.1.114222.4.11.1002/89451-9.json |
| 89452-7 | Obstetrics Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/89452-7.json |
| 89453-5 | Gynecology Nurse practitioner Note | ./2.16.840.1.114222.4.11.1002/89453-5.json |
| 89454-3 | Obstetrics Attending Note | ./2.16.840.1.114222.4.11.1002/89454-3.json |
| 89455-0 | Gynecology Attending Note | ./2.16.840.1.114222.4.11.1002/89455-0.json |
| 89456-8 | Obstetrics Resident Note | ./2.16.840.1.114222.4.11.1002/89456-8.json |
| 89457-6 | Obstetrics Surgical operation note | ./2.16.840.1.114222.4.11.1002/89457-6.json |
| 89458-4 | Obstetrics Hospital Note | ./2.16.840.1.114222.4.11.1002/89458-4.json |
| 89459-2 | Gynecology Hospital Note | ./2.16.840.1.114222.4.11.1002/89459-2.json |
| 89460-0 | Obstetrics Outpatient Note | ./2.16.840.1.114222.4.11.1002/89460-0.json |
| 89461-8 | Gynecology Outpatient Note | ./2.16.840.1.114222.4.11.1002/89461-8.json |
| 89462-6 | Obstetrics Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/89462-6.json |
| 89463-4 | Gynecology Nurse Outpatient Note | ./2.16.840.1.114222.4.11.1002/89463-4.json |
| 89464-2 | Obstetrics Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89464-2.json |
| 89465-9 | Gynecology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89465-9.json |
| 89466-7 | Obstetrics Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/89466-7.json |
| 89467-5 | Gynecology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/89467-5.json |
| 89468-3 | Obstetrics Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/89468-3.json |
| 89469-1 | Gynecology Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/89469-1.json |
| 89470-9 | Obstetrics Summary note | ./2.16.840.1.114222.4.11.1002/89470-9.json |
| 89471-7 | Gynecology Summary note | ./2.16.840.1.114222.4.11.1002/89471-7.json |
| 89472-5 | Gynecology Surgical operation note | ./2.16.840.1.114222.4.11.1002/89472-5.json |
| 89473-3 | Gynecology Administrative note | ./2.16.840.1.114222.4.11.1002/89473-3.json |
| 89480-8 | Azithromycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89480-8.json |
| 89481-6 | Gentamicin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89481-6.json |
| 89482-4 | Kanamycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89482-4.json |
| 89483-2 | Capreomycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89483-2.json |
| 89484-0 | Amikacin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89484-0.json |
| 89485-7 | Clarithromycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89485-7.json |
| 89487-3 | Fluoroquinolone [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89487-3.json |
| 89488-1 | Isoniazid [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89488-1.json |
| 89489-9 | rifAMPin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89489-9.json |
| 89490-7 | Aminoglycoside [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89490-7.json |
| 89491-5 | Ethambutol [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/89491-5.json |
| 89499-8 | Gynecology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/89499-8.json |
| 89500-3 | Sulfatide IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89500-3.json |
| 89501-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89501-1.json |
| 89502-9 | SCL-70 extractable nuclear Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89502-9.json |
| 89503-7 | RNA polymerase III Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89503-7.json |
| 89504-5 | Ribosomal Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89504-5.json |
| 89505-2 | Proteinase 3 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89505-2.json |
| 89506-0 | Nucleosome Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89506-0.json |
| 89507-8 | Myeloperoxidase Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89507-8.json |
| 89508-6 | Intrinsic factor Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89508-6.json |
| 89509-4 | Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89509-4.json |
| 89510-2 | Ganglioside GM3 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89510-2.json |
| 89511-0 | Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89511-0.json |
| 89512-8 | Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89512-8.json |
| 89513-6 | RNA polymerase III Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89513-6.json |
| 89514-4 | Glomerular basement membrane Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89514-4.json |
| 89515-1 | Ganglioside GT1b IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89515-1.json |
| 89516-9 | Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89516-9.json |
| 89517-7 | Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89517-7.json |
| 89518-5 | Ganglioside GM1 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89518-5.json |
| 89519-3 | Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89519-3.json |
| 89520-1 | Actin smooth muscle Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89520-1.json |
| 89521-9 | Ganglioside GM1 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89521-9.json |
| 89522-7 | Ganglioside GM3 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89522-7.json |
| 89523-5 | Ganglioside GT1b IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89523-5.json |
| 89524-3 | Ganglioside GM2 IgM Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89524-3.json |
| 89525-0 | Ganglioside GM2 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/89525-0.json |
| 89526-8 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89526-8.json |
| 89527-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89527-6.json |
| 89528-4 | Nucleosome Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89528-4.json |
| 89529-2 | Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89529-2.json |
| 89530-0 | Histone Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89530-0.json |
| 89531-8 | Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89531-8.json |
| 89532-6 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89532-6.json |
| 89533-4 | SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89533-4.json |
| 89534-2 | Ribosomal P Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89534-2.json |
| 89535-9 | Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89535-9.json |
| 89536-7 | PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89536-7.json |
| 89537-5 | PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89537-5.json |
| 89538-3 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89538-3.json |
| 89539-1 | Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89539-1.json |
| 89540-9 | Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89540-9.json |
| 89541-7 | Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89541-7.json |
| 89542-5 | Centromere protein B Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/89542-5.json |
| 89551-6 | Environmental health Consult note | ./2.16.840.1.114222.4.11.1002/89551-6.json |
| 89552-4 | Environmental health Note | ./2.16.840.1.114222.4.11.1002/89552-4.json |
| 89553-2 | Evaluation and management of radiation exposure note | ./2.16.840.1.114222.4.11.1002/89553-2.json |
| 89554-0 | Nurse practitioner Evaluation and management of radiation exposure note | ./2.16.840.1.114222.4.11.1002/89554-0.json |
| 89557-3 | Depression symptoms score [CUBS] | ./2.16.840.1.114222.4.11.1002/89557-3.json |
| 89558-1 | Anxiety symptoms score [CUBS] | ./2.16.840.1.114222.4.11.1002/89558-1.json |
| 89559-9 | Lifetime suicide risk score [CUBS] | ./2.16.840.1.114222.4.11.1002/89559-9.json |
| 89560-7 | Suicide risk score [CUBS] | ./2.16.840.1.114222.4.11.1002/89560-7.json |
| 89561-5 | Trauma symptoms score [CUBS] | ./2.16.840.1.114222.4.11.1002/89561-5.json |
| 89562-3 | Substance abuse symptoms score [CUBS] | ./2.16.840.1.114222.4.11.1002/89562-3.json |
| 89563-1 | Eating disorder symptoms score [CUBS] | ./2.16.840.1.114222.4.11.1002/89563-1.json |
| 89564-9 | Employment status [CUBS] | ./2.16.840.1.114222.4.11.1002/89564-9.json |
| 89583-9 | Cytomegalovirus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89583-9.json |
| 89584-7 | Herpes simplex virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89584-7.json |
| 89585-4 | Herpes simplex virus 1 DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89585-4.json |
| 89586-2 | Herpes simplex virus 1 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89586-2.json |
| 89587-0 | Herpes simplex virus 2 DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89587-0.json |
| 89588-8 | Herpes simplex virus 2 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89588-8.json |
| 89589-6 | Varicella zoster virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89589-6.json |
| 89590-4 | Zika virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89590-4.json |
| 89591-2 | Zika virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89591-2.json |
| 89592-0 | Bartonella quintana DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89592-0.json |
| 89593-8 | Bartonella sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89593-8.json |
| 89594-6 | Legionella pneumophila Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89594-6.json |
| 89595-3 | Legionella pneumophila Ag [Presence] in Tissue by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/89595-3.json |
| 89596-1 | Listeria monocytogenes DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89596-1.json |
| 89597-9 | Mycoplasma genitalium DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89597-9.json |
| 89598-7 | Mycoplasma hominis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89598-7.json |
| 89599-5 | Toxoplasma gondii [Presence] in Cerebral spinal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89599-5.json |
| 89600-1 | FDA product label FDA-initiated compliance action drug registration and listing inactivation | ./2.16.840.1.114222.4.11.1002/89600-1.json |
| 89601-9 | Proof of encounter certificate | ./2.16.840.1.114222.4.11.1002/89601-9.json |
| 89602-7 | CT Guidance for aspiration of cyst of Kidney - left | ./2.16.840.1.114222.4.11.1002/89602-7.json |
| 89603-5 | CT Guidance for aspiration of cyst of Kidney - right | ./2.16.840.1.114222.4.11.1002/89603-5.json |
| 89604-3 | CT Guidance for aspiration of cyst of Kidney - bilateral | ./2.16.840.1.114222.4.11.1002/89604-3.json |
| 89605-0 | CT Guidance for ablation of tissue of Kidney - right | ./2.16.840.1.114222.4.11.1002/89605-0.json |
| 89606-8 | CT Guidance for ablation of tissue of Kidney - left | ./2.16.840.1.114222.4.11.1002/89606-8.json |
| 89607-6 | CT Guidance for fluid aspiration of Lung - right | ./2.16.840.1.114222.4.11.1002/89607-6.json |
| 89608-4 | CT Guidance for fluid aspiration of Lung - left | ./2.16.840.1.114222.4.11.1002/89608-4.json |
| 89609-2 | CT Guidance for fluid aspiration of Pericardial space | ./2.16.840.1.114222.4.11.1002/89609-2.json |
| 89610-0 | CT Guidance for placement of catheter in Peritoneal space | ./2.16.840.1.114222.4.11.1002/89610-0.json |
| 89611-8 | CT Guidance for fluid aspiration of Pleural space - right | ./2.16.840.1.114222.4.11.1002/89611-8.json |
| 89612-6 | CT Guidance for fluid aspiration of Pleural space - left | ./2.16.840.1.114222.4.11.1002/89612-6.json |
| 89613-4 | CT Guidance for drainage and placement of drainage catheter of Abdomen-- WO contrast | ./2.16.840.1.114222.4.11.1002/89613-4.json |
| 89614-2 | CT Guidance for biopsy of Kidney-- WO contrast | ./2.16.840.1.114222.4.11.1002/89614-2.json |
| 89615-9 | CT Guidance for drainage and placement of drainage catheter of Abdomen-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89615-9.json |
| 89616-7 | CT Guidance for aspiration of cyst of Pancreas-- WO contrast | ./2.16.840.1.114222.4.11.1002/89616-7.json |
| 89617-5 | CT Guidance for aspiration of cyst of Kidney-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89617-5.json |
| 89618-3 | CT Guidance for aspiration of cyst of Kidney-- WO contrast | ./2.16.840.1.114222.4.11.1002/89618-3.json |
| 89619-1 | CT Guidance for biopsy of Pancreas-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89619-1.json |
| 89620-9 | CT Guidance for biopsy of Abdomen-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89620-9.json |
| 89621-7 | CT Guidance for biopsy of Kidney-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89621-7.json |
| 89622-5 | CT Guidance for fluid aspiration of Peritoneal space | ./2.16.840.1.114222.4.11.1002/89622-5.json |
| 89623-3 | CT Guidance for drainage and placement of drainage catheter of Peritoneal space | ./2.16.840.1.114222.4.11.1002/89623-3.json |
| 89624-1 | CT Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space | ./2.16.840.1.114222.4.11.1002/89624-1.json |
| 89625-8 | CT Guidance for aspiration of cyst of Kidney | ./2.16.840.1.114222.4.11.1002/89625-8.json |
| 89626-6 | CTA Abdominal, Pelvis and Lower extremity vessels W contrast IV | ./2.16.840.1.114222.4.11.1002/89626-6.json |
| 89627-4 | CT Guidance for aspiration of cyst of Ileum - right | ./2.16.840.1.114222.4.11.1002/89627-4.json |
| 89628-2 | CT Guidance for aspiration of cyst of Ileum - left | ./2.16.840.1.114222.4.11.1002/89628-2.json |
| 89629-0 | CT Guidance for aspiration of cyst of Lung - left | ./2.16.840.1.114222.4.11.1002/89629-0.json |
| 89630-8 | CT Guidance for aspiration of cyst of Lung - right | ./2.16.840.1.114222.4.11.1002/89630-8.json |
| 89631-6 | SPECT+CT Guidance for localization of tumor of Whole body | ./2.16.840.1.114222.4.11.1002/89631-6.json |
| 89632-4 | Toxoplasma gondii [Presence] in Placenta by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89632-4.json |
| 89633-2 | Actinomyces sp identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89633-2.json |
| 89634-0 | Actinomyces sp identified in Implanted device by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89634-0.json |
| 89635-7 | Mycobacterium tuberculosis DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89635-7.json |
| 89636-5 | Mycobacterium sp identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89636-5.json |
| 89637-3 | Mycobacterium sp identified in Implanted device by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89637-3.json |
| 89638-1 | Nocardia sp identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89638-1.json |
| 89639-9 | Nocardia sp identified in Implanted device by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89639-9.json |
| 89640-7 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/89640-7.json |
| 89641-5 | Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/89641-5.json |
| 89642-3 | Corynebacterium diphtheriae toxin IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/89642-3.json |
| 89643-1 | Bacteria identified in Lower respiratory specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/89643-1.json |
| 89644-9 | Bacteria identified in Lower respiratory specimen by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/89644-9.json |
| 89645-6 | Bartonella henselae DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89645-6.json |
| 89646-4 | Bartonella quintana DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89646-4.json |
| 89647-2 | Bartonella sp DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89647-2.json |
| 89648-0 | Chlamydia trachomatis [Presence] in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/89648-0.json |
| 89649-8 | Coxiella burnetii DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89649-8.json |
| 89650-6 | Tropheryma whipplei DNA [Presence] in Implanted device by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89650-6.json |
| 89651-4 | Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/89651-4.json |
| 89655-5 | Virus identified in Tissue by Shell vial culture | ./2.16.840.1.114222.4.11.1002/89655-5.json |
| 89656-3 | Fungus identified in Lower respiratory specimen by Culture | ./2.16.840.1.114222.4.11.1002/89656-3.json |
| 89657-1 | Microscopic observation [Identifier] in Lower respiratory specimen by Toluidine blue O stain | ./2.16.840.1.114222.4.11.1002/89657-1.json |
| 89658-9 | Microscopic observation [Identifier] in Lower respiratory specimen by Methenamine silver nitrate stain | ./2.16.840.1.114222.4.11.1002/89658-9.json |
| 89659-7 | Microscopic observation [Identifier] in Implanted device by Gram stain | ./2.16.840.1.114222.4.11.1002/89659-7.json |
| 89660-5 | Microscopic observation [Identifier] in Implanted device by Acid fast stain | ./2.16.840.1.114222.4.11.1002/89660-5.json |
| 89661-3 | Microscopic observation [Identifier] in Upper respiratory specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/89661-3.json |
| 89662-1 | Microscopic observation [Identifier] in Lower respiratory specimen by Acid fast stain | ./2.16.840.1.114222.4.11.1002/89662-1.json |
| 89691-0 | Pseudocasts [#/area] in Urine by Computer assisted method | ./2.16.840.1.114222.4.11.1002/89691-0.json |
| 89692-8 | Heart rate 10 minutes mean Fetus | ./2.16.840.1.114222.4.11.1002/89692-8.json |
| 89695-1 | CT Guidance for drainage and placement of drainage catheter of Pelvis-- WO contrast | ./2.16.840.1.114222.4.11.1002/89695-1.json |
| 89696-9 | CT Guidance for drainage and placement of drainage catheter of Pelvis-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89696-9.json |
| 89697-7 | CT Guidance for drainage of pseudocyst and placement of drainage catheter of Pancreas | ./2.16.840.1.114222.4.11.1002/89697-7.json |
| 89698-5 | CT Guidance for injection of Ankle - right | ./2.16.840.1.114222.4.11.1002/89698-5.json |
| 89699-3 | CT Guidance for injection of Ankle - left | ./2.16.840.1.114222.4.11.1002/89699-3.json |
| 89700-9 | CT Guidance for injection of Hip - right | ./2.16.840.1.114222.4.11.1002/89700-9.json |
| 89701-7 | CT Guidance for injection of Hip - left | ./2.16.840.1.114222.4.11.1002/89701-7.json |
| 89702-5 | CT Guidance for injection of Shoulder - bilateral | ./2.16.840.1.114222.4.11.1002/89702-5.json |
| 89703-3 | CT Guidance for injection of Shoulder - left | ./2.16.840.1.114222.4.11.1002/89703-3.json |
| 89704-1 | CT Guidance for injection of Shoulder - right | ./2.16.840.1.114222.4.11.1002/89704-1.json |
| 89705-8 | CT Guidance for injection of Wrist - left | ./2.16.840.1.114222.4.11.1002/89705-8.json |
| 89706-6 | CT Guidance for injection of Knee - bilateral | ./2.16.840.1.114222.4.11.1002/89706-6.json |
| 89707-4 | CT Guidance for injection of Knee - right | ./2.16.840.1.114222.4.11.1002/89707-4.json |
| 89708-2 | CT Guidance for injection of Knee - left | ./2.16.840.1.114222.4.11.1002/89708-2.json |
| 89709-0 | CT Guidance for greater than 2 levels for injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/89709-0.json |
| 89710-8 | CT Guidance for 2 levels injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/89710-8.json |
| 89711-6 | CT Guidance for 1 level injection of Spine facet joint | ./2.16.840.1.114222.4.11.1002/89711-6.json |
| 89712-4 | PET+CT Guidance for limited for localization of tumor of Unspecified body region-- W 18F-FDG IV and W contrast IV | ./2.16.840.1.114222.4.11.1002/89712-4.json |
| 89713-2 | CT Upper extremity joint - right Arthrogram | ./2.16.840.1.114222.4.11.1002/89713-2.json |
| 89714-0 | CT Upper extremity joint - left Arthrogram | ./2.16.840.1.114222.4.11.1002/89714-0.json |
| 89715-7 | CT Lower extremity joint - right Arthrogram | ./2.16.840.1.114222.4.11.1002/89715-7.json |
| 89716-5 | CT Lower extremity joint - left Arthrogram | ./2.16.840.1.114222.4.11.1002/89716-5.json |
| 89717-3 | CT Guidance for stereotactic localization of Unspecified body region-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89717-3.json |
| 89718-1 | CT Guidance for stereotactic localization of Unspecified body region-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89718-1.json |
| 89719-9 | CT Guidance for drainage of abscess and placement of drainage catheter of Lung - right | ./2.16.840.1.114222.4.11.1002/89719-9.json |
| 89720-7 | CT Guidance for drainage of abscess and placement of drainage catheter of Lung - left | ./2.16.840.1.114222.4.11.1002/89720-7.json |
| 89721-5 | CT Guidance for drainage of abscess and placement of drainage catheter of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/89721-5.json |
| 89722-3 | CTA Upper extremity veins - left W contrast IV | ./2.16.840.1.114222.4.11.1002/89722-3.json |
| 89723-1 | CTA Upper extremity veins - right W contrast IV | ./2.16.840.1.114222.4.11.1002/89723-1.json |
| 89794-2 | Anesthesiology Team Conference note | ./2.16.840.1.114222.4.11.1002/89794-2.json |
| 89795-9 | Blood banking and transfusion medicine Progress note | ./2.16.840.1.114222.4.11.1002/89795-9.json |
| 89796-7 | Blood banking and transfusion medicine procedure note | ./2.16.840.1.114222.4.11.1002/89796-7.json |
| 89797-5 | Blood banking and transfusion medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89797-5.json |
| 89798-3 | Cardiac surgery Conference note | ./2.16.840.1.114222.4.11.1002/89798-3.json |
| 89799-1 | Endocrinology Team Conference note | ./2.16.840.1.114222.4.11.1002/89799-1.json |
| 89800-7 | Ethics Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89800-7.json |
| 89801-5 | Ethics Team Conference note | ./2.16.840.1.114222.4.11.1002/89801-5.json |
| 89802-3 | Gynecologic oncology Progress note | ./2.16.840.1.114222.4.11.1002/89802-3.json |
| 89803-1 | Gynecologic oncology procedure note | ./2.16.840.1.114222.4.11.1002/89803-1.json |
| 89804-9 | Hematology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89804-9.json |
| 89805-6 | Interventional radiology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89805-6.json |
| 89806-4 | Interventional radiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89806-4.json |
| 89807-2 | Maternal and fetal medicine Telephone encounter Progress note | ./2.16.840.1.114222.4.11.1002/89807-2.json |
| 89808-0 | Maternal and fetal medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89808-0.json |
| 89809-8 | Clinical neurophysiology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89809-8.json |
| 89810-6 | Neurological surgery Team Conference note | ./2.16.840.1.114222.4.11.1002/89810-6.json |
| 89811-4 | Anesthesiology Progress note | ./2.16.840.1.114222.4.11.1002/89811-4.json |
| 89812-2 | Psychology procedure note | ./2.16.840.1.114222.4.11.1002/89812-2.json |
| 89813-0 | Rapid response team Progress note | ./2.16.840.1.114222.4.11.1002/89813-0.json |
| 89814-8 | Rapid response team procedure note | ./2.16.840.1.114222.4.11.1002/89814-8.json |
| 89815-5 | Trauma Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89815-5.json |
| 89816-3 | Trauma Progress note | ./2.16.840.1.114222.4.11.1002/89816-3.json |
| 89817-1 | Trauma procedure note | ./2.16.840.1.114222.4.11.1002/89817-1.json |
| 89818-9 | Wound care management Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89818-9.json |
| 89819-7 | Wound care management Team Conference note | ./2.16.840.1.114222.4.11.1002/89819-7.json |
| 89820-5 | Wound care management Initial evaluation note | ./2.16.840.1.114222.4.11.1002/89820-5.json |
| 89821-3 | Wound care management Progress note | ./2.16.840.1.114222.4.11.1002/89821-3.json |
| 89822-1 | Cardiac surgery procedure note | ./2.16.840.1.114222.4.11.1002/89822-1.json |
| 89823-9 | Cardiac surgery Team Conference note | ./2.16.840.1.114222.4.11.1002/89823-9.json |
| 89824-7 | Cardiac surgery Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/89824-7.json |
| 89825-4 | Vascular surgery Team Conference note | ./2.16.840.1.114222.4.11.1002/89825-4.json |
| 89826-2 | Clinical pharmacology procedure note | ./2.16.840.1.114222.4.11.1002/89826-2.json |
| 89827-0 | CT Spine Lumbar and Sacrum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89827-0.json |
| 89828-8 | CT Guidance for superficial biopsy of Muscle | ./2.16.840.1.114222.4.11.1002/89828-8.json |
| 89829-6 | CT Guidance for biopsy of Retroperitoneum-- WO contrast | ./2.16.840.1.114222.4.11.1002/89829-6.json |
| 89830-4 | CT Guidance for biopsy of Retroperitoneum-- W contrast IV | ./2.16.840.1.114222.4.11.1002/89830-4.json |
| 89831-2 | CT Guidance for drainage and placement of drainage catheter of Subphrenic space | ./2.16.840.1.114222.4.11.1002/89831-2.json |
| 89832-0 | CT Guidance for deep biopsy of Tissue | ./2.16.840.1.114222.4.11.1002/89832-0.json |
| 89833-8 | CT Unspecified body region by reconstruction | ./2.16.840.1.114222.4.11.1002/89833-8.json |
| 89834-6 | CT Clavicle - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/89834-6.json |
| 89835-3 | CT Brachial plexus W contrast IV | ./2.16.840.1.114222.4.11.1002/89835-3.json |
| 89836-1 | CT Brachial plexus WO contrast | ./2.16.840.1.114222.4.11.1002/89836-1.json |
| 89837-9 | CT Temporal bone - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89837-9.json |
| 89838-7 | CT Temporal bone - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89838-7.json |
| 89839-5 | CT Guidance for biopsy of Sternum | ./2.16.840.1.114222.4.11.1002/89839-5.json |
| 89840-3 | CT Lumbosacral plexus WO contrast | ./2.16.840.1.114222.4.11.1002/89840-3.json |
| 89841-1 | CTA Upper extremity vessels - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89841-1.json |
| 89842-9 | SPECT+CT Whole body | ./2.16.840.1.114222.4.11.1002/89842-9.json |
| 89844-5 | CT Head and Temporal bone WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89844-5.json |
| 89845-2 | CT Head and Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89845-2.json |
| 89846-0 | CT Midfoot - left and Forefoot - left WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89846-0.json |
| 89847-8 | CT Midfoot - right and Forefoot - right | ./2.16.840.1.114222.4.11.1002/89847-8.json |
| 89848-6 | CT Midfoot - right WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89848-6.json |
| 89849-4 | CT Finger - right WO contrast | ./2.16.840.1.114222.4.11.1002/89849-4.json |
| 89850-2 | CT Finger - left WO contrast | ./2.16.840.1.114222.4.11.1002/89850-2.json |
| 89851-0 | CTA Unspecified body region limited | ./2.16.840.1.114222.4.11.1002/89851-0.json |
| 89852-8 | CT Unspecified body region limited W contrast IV | ./2.16.840.1.114222.4.11.1002/89852-8.json |
| 89853-6 | CT Unspecified body region limited WO contrast | ./2.16.840.1.114222.4.11.1002/89853-6.json |
| 89854-4 | CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - left | ./2.16.840.1.114222.4.11.1002/89854-4.json |
| 89855-1 | CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - right | ./2.16.840.1.114222.4.11.1002/89855-1.json |
| 89856-9 | CT Guidance for stereotactic localization of Unspecified body region-- WO contrast | ./2.16.840.1.114222.4.11.1002/89856-9.json |
| 89857-7 | CT Guidance for biopsy of Pleura - right | ./2.16.840.1.114222.4.11.1002/89857-7.json |
| 89858-5 | CT Guidance for biopsy of Pleura - left | ./2.16.840.1.114222.4.11.1002/89858-5.json |
| 89859-3 | CT Guidance for transrectal drainage of abscess of Pelvis | ./2.16.840.1.114222.4.11.1002/89859-3.json |
| 89860-1 | CT Chest W inspiration and expiration | ./2.16.840.1.114222.4.11.1002/89860-1.json |
| 89871-8 | Bilirubin.total [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/89871-8.json |
| 89872-6 | Bilirubin.total [Moles/volume] in Arterial blood | ./2.16.840.1.114222.4.11.1002/89872-6.json |
| 89877-5 | Clinical genetics Outpatient Note | ./2.16.840.1.114222.4.11.1002/89877-5.json |
| 89878-3 | Adolescent medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/89878-3.json |
| 89879-1 | Pediatrics Outpatient Note | ./2.16.840.1.114222.4.11.1002/89879-1.json |
| 89880-9 | Neonatal perinatal medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/89880-9.json |
| 89881-7 | Developmental-behavioral pediatrics Outpatient Note | ./2.16.840.1.114222.4.11.1002/89881-7.json |
| 89882-5 | Sports medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/89882-5.json |
| 89883-3 | Emergency medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/89883-3.json |
| 89884-1 | Hematology+Medical oncology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89884-1.json |
| 89885-8 | Pain medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/89885-8.json |
| 89886-6 | Palliative care Telehealth Note | ./2.16.840.1.114222.4.11.1002/89886-6.json |
| 89887-4 | Adolescent medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/89887-4.json |
| 89888-2 | Pediatrics Telehealth Note | ./2.16.840.1.114222.4.11.1002/89888-2.json |
| 89889-0 | Physical medicine and rehab Telehealth Note | ./2.16.840.1.114222.4.11.1002/89889-0.json |
| 89890-8 | Diabetology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89890-8.json |
| 89891-6 | Endocrinology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89891-6.json |
| 89892-4 | Infectious disease Telehealth Note | ./2.16.840.1.114222.4.11.1002/89892-4.json |
| 89893-2 | Clinical genetics Telehealth Note | ./2.16.840.1.114222.4.11.1002/89893-2.json |
| 89894-0 | Neonatal perinatal medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/89894-0.json |
| 89895-7 | Allergy and Immunology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89895-7.json |
| 89896-5 | Developmental-behavioral pediatrics Telehealth Note | ./2.16.840.1.114222.4.11.1002/89896-5.json |
| 89897-3 | Gynecology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89897-3.json |
| 89898-1 | Nephrology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89898-1.json |
| 89899-9 | Orthopaedic surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/89899-9.json |
| 89900-5 | Rheumatology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89900-5.json |
| 89901-3 | Sports medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/89901-3.json |
| 89902-1 | Otolaryngology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89902-1.json |
| 89903-9 | Urology Telehealth Note | ./2.16.840.1.114222.4.11.1002/89903-9.json |
| 89925-2 | CT Pelvis and Lower extremity - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/89925-2.json |
| 89926-0 | Physical medicine and rehab Adult day care center Note | ./2.16.840.1.114222.4.11.1002/89926-0.json |
| 89927-8 | CT Heart and aortic root WO contrast for calcium scoring + CTA W contrast IV | ./2.16.840.1.114222.4.11.1002/89927-8.json |
| 89928-6 | CT Guidance for fluid aspiration of Lumbar spine Intervertebral disc | ./2.16.840.1.114222.4.11.1002/89928-6.json |
| 89929-4 | CT Guidance for fluid aspiration of Intervertebral disc | ./2.16.840.1.114222.4.11.1002/89929-4.json |
| 89930-2 | CT Guidance for radiofrequency ablation of Bone | ./2.16.840.1.114222.4.11.1002/89930-2.json |
| 89931-0 | CT Guidance for drainage and placement of drainage catheter of Perirectal region | ./2.16.840.1.114222.4.11.1002/89931-0.json |
| 89932-8 | CT Guidance for deep placement of needle of Unspecified body region | ./2.16.840.1.114222.4.11.1002/89932-8.json |
| 89951-8 | Maternal and fetal medicine procedure note | ./2.16.840.1.114222.4.11.1002/89951-8.json |
| 89952-6 | CT Guidance for arthrocentesis of Sacroiliac joint - right | ./2.16.840.1.114222.4.11.1002/89952-6.json |
| 89953-4 | CT Guidance for arthrocentesis of Shoulder - right | ./2.16.840.1.114222.4.11.1002/89953-4.json |
| 89954-2 | CT Guidance for arthrocentesis of Shoulder - left | ./2.16.840.1.114222.4.11.1002/89954-2.json |
| 89955-9 | CT Guidance for arthrocentesis of Hip - bilateral | ./2.16.840.1.114222.4.11.1002/89955-9.json |
| 89956-7 | CT Guidance for arthrocentesis of Hip - left | ./2.16.840.1.114222.4.11.1002/89956-7.json |
| 89957-5 | CT Guidance for arthrocentesis of Hip - right | ./2.16.840.1.114222.4.11.1002/89957-5.json |
| 89958-3 | CT Guidance for cryoablation of Pelvis | ./2.16.840.1.114222.4.11.1002/89958-3.json |
| 89959-1 | CT Guidance for biopsy of Soft tissue | ./2.16.840.1.114222.4.11.1002/89959-1.json |
| 89960-9 | CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - right | ./2.16.840.1.114222.4.11.1002/89960-9.json |
| 89961-7 | CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - left | ./2.16.840.1.114222.4.11.1002/89961-7.json |
| 89962-5 | CT Guidance for radiofrequency ablation of Lung | ./2.16.840.1.114222.4.11.1002/89962-5.json |
| 89964-1 | Ziprasidone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89964-1.json |
| 89965-8 | Trifluoperazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89965-8.json |
| 89966-6 | Norquetiapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89966-6.json |
| 89967-4 | Norquetiapine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89967-4.json |
| 89968-2 | Norolanzapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89968-2.json |
| 89969-0 | Norolanzapine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89969-0.json |
| 89970-8 | Molindone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89970-8.json |
| 89971-6 | 8-Hydroxyloxapine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89971-6.json |
| 89972-4 | Loxapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89972-4.json |
| 89973-2 | 7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89973-2.json |
| 89974-0 | 7-Hydroxyfluphenazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89974-0.json |
| 89975-7 | Norclozapine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89975-7.json |
| 89976-5 | 7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89976-5.json |
| 89977-3 | 7-Hydroxychlorpromazine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89977-3.json |
| 89978-1 | ARIPiprazole [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89978-1.json |
| 89979-9 | Ziprasidone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89979-9.json |
| 89980-7 | Thiothixene [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89980-7.json |
| 89981-5 | QUEtiapine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89981-5.json |
| 89982-3 | 9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89982-3.json |
| 89983-1 | OLANZapine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89983-1.json |
| 89984-9 | Molindone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89984-9.json |
| 89985-6 | ARIPiprazole [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/89985-6.json |
| 89986-4 | Vortioxetine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89986-4.json |
| 89987-2 | Vortioxetine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89987-2.json |
| 89988-0 | Vilazodone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89988-0.json |
| 89989-8 | Vilazodone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89989-8.json |
| 89990-6 | fluvoxaMINE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/89990-6.json |
| 89991-4 | Citalopram+Escitalopram [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89991-4.json |
| 89992-2 | Hydroxybupropion [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/89992-2.json |
| 89993-0 | Clinical genetics Counseling note | ./2.16.840.1.114222.4.11.1002/89993-0.json |
| 89994-8 | Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/89994-8.json |
| 89995-5 | Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/89995-5.json |
| 89996-3 | Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/89996-3.json |
| 89997-1 | SUMF1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/89997-1.json |
| 89998-9 | Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L | ./2.16.840.1.114222.4.11.1002/89998-9.json |
| 89999-7 | Microalbumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L | ./2.16.840.1.114222.4.11.1002/89999-7.json |
| 90000-1 | Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L | ./2.16.840.1.114222.4.11.1002/90000-1.json |
| 90001-9 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90001-9.json |
| 90002-7 | Candida auris [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90002-7.json |
| 90003-5 | Acinetobacter sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90003-5.json |
| 90005-0 | Pharmacogenomics Outpatient Note | ./2.16.840.1.114222.4.11.1002/90005-0.json |
| 90006-8 | Pharmacogenomics Consult note | ./2.16.840.1.114222.4.11.1002/90006-8.json |
| 90007-6 | Pharmacogenomics Progress note | ./2.16.840.1.114222.4.11.1002/90007-6.json |
| 90008-4 | Pharmacogenomics Telehealth Note | ./2.16.840.1.114222.4.11.1002/90008-4.json |
| 90009-2 | Clinical pathology Team Conference note | ./2.16.840.1.114222.4.11.1002/90009-2.json |
| 90010-0 | Clinical pathology procedure note | ./2.16.840.1.114222.4.11.1002/90010-0.json |
| 90011-8 | Clinical pathology Progress note | ./2.16.840.1.114222.4.11.1002/90011-8.json |
| 90012-6 | Burn management Consult note | ./2.16.840.1.114222.4.11.1002/90012-6.json |
| 90013-4 | Clinical pathology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/90013-4.json |
| 90014-2 | Burn management Progress note | ./2.16.840.1.114222.4.11.1002/90014-2.json |
| 90015-9 | Clinical pathology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/90015-9.json |
| 90039-9 | ABO and Rh group [Type] in Blood--after transfusion reaction | ./2.16.840.1.114222.4.11.1002/90039-9.json |
| 90040-7 | Alpha globin gene cluster and HS-40 region deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/90040-7.json |
| 90041-5 | Specimen collection setting type | ./2.16.840.1.114222.4.11.1002/90041-5.json |
| 90042-3 | Borrelia sp DNA [Presence] in Tick by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90042-3.json |
| 90043-1 | t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/90043-1.json |
| 90044-9 | Epithelial cells.renal [Presence] in Urine sediment | ./2.16.840.1.114222.4.11.1002/90044-9.json |
| 90046-4 | Spermatozoa.abnormal principal pieces/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/90046-4.json |
| 90047-2 | Spermatozoa.excess residual cytoplasm/100 spermatozoa in Semen | ./2.16.840.1.114222.4.11.1002/90047-2.json |
| 90048-0 | Somatotropin binding protein [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90048-0.json |
| 90049-8 | CT Guidance for placement of chest tube in Pleural space - left | ./2.16.840.1.114222.4.11.1002/90049-8.json |
| 90050-6 | CT Guidance for placement of chest tube in Pleural space - bilateral | ./2.16.840.1.114222.4.11.1002/90050-6.json |
| 90051-4 | CT Guidance for placement of chest tube in Pleural space - right | ./2.16.840.1.114222.4.11.1002/90051-4.json |
| 90055-5 | Organization information panel | ./2.16.840.1.114222.4.11.1002/90055-5.json |
| 90066-2 | Corynebacterium sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90066-2.json |
| 90067-0 | Enterobacteriaceae identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90067-0.json |
| 90068-8 | Gram negative bacilli identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90068-8.json |
| 90069-6 | Gram positive bacilli identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90069-6.json |
| 90070-4 | Gram positive catalase producing cocci identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90070-4.json |
| 90071-2 | Gram positive non-catalase producing cocci identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90071-2.json |
| 90072-0 | Haemophilus and Neisseria species identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90072-0.json |
| 90073-8 | Lactobacillales identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90073-8.json |
| 90075-3 | Non-Enterobacteriaceae identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90075-3.json |
| 90076-1 | Staphylococcus sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90076-1.json |
| 90077-9 | Urinary pathogens identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90077-9.json |
| 90078-7 | Yeast identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90078-7.json |
| 90080-3 | Bictegravir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/90080-3.json |
| 90100-9 | Listeria sp identified in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90100-9.json |
| 90232-0 | Histoplasma capsulatum Ab [Identifier] in Serum or Plasma by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/90232-0.json |
| 90233-8 | Dermatan sulfate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/90233-8.json |
| 90234-6 | Globotriaosylsphingosine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90234-6.json |
| 90235-3 | Heparan sulfate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/90235-3.json |
| 90236-1 | Keratan sulfate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/90236-1.json |
| 90237-9 | Phenylacetylcarnitine (PheC2) [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90237-9.json |
| 90238-7 | Salicylcarnitine [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90238-7.json |
| 90239-5 | ST2.soluble [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90239-5.json |
| 90240-3 | Eculizumab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/90240-3.json |
| 90241-1 | Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90241-1.json |
| 90242-9 | Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to targetcell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90242-9.json |
| 90243-7 | Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90243-7.json |
| 90244-5 | Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90244-5.json |
| 90245-2 | Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90245-2.json |
| 90246-0 | Bacterial whole genome [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/90246-0.json |
| 90247-8 | Trypanosoma cruzi IgG Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/90247-8.json |
| 90248-6 | Myelin oligodendrocyte glycoprotein IgG1 Ab [Presence] in Serum or Plasma by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/90248-6.json |
| 90249-4 | Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells | ./2.16.840.1.114222.4.11.1002/90249-4.json |
| 90256-9 | CFTR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/90256-9.json |
| 90258-5 | LDLR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/90258-5.json |
| 90259-3 | NAT2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/90259-3.json |
| 90261-9 | Microscopic observation [Identifier] in Bile fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/90261-9.json |
| 90262-7 | Microscopic observation [Identifier] in Bile fluid by Gram stain | ./2.16.840.1.114222.4.11.1002/90262-7.json |
| 90263-5 | Microscopic observation [Identifier] in Milk by Gram stain | ./2.16.840.1.114222.4.11.1002/90263-5.json |
| 90264-3 | Fracture Risk Assessment [FRAX] | ./2.16.840.1.114222.4.11.1002/90264-3.json |
| 90267-6 | Microscopic observation [Identifier] in Pericardial fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/90267-6.json |
| 90268-4 | Microscopic observation [Identifier] in Peritoneal fluid by Giemsa stain | ./2.16.840.1.114222.4.11.1002/90268-4.json |
| 90269-2 | Microscopic observation [Identifier] in Milk by Acid fast stain | ./2.16.840.1.114222.4.11.1002/90269-2.json |
| 90270-0 | Bacteria identified in Bile fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90270-0.json |
| 90271-8 | Bacteria identified in Pericardial fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90271-8.json |
| 90272-6 | Streptococcus agalactiae DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90272-6.json |
| 90273-4 | Bacteria identified in Catheter tip by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90273-4.json |
| 90274-2 | Bacteria identified in Catheter tip by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90274-2.json |
| 90275-9 | Gardnerella vaginalis [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90275-9.json |
| 90276-7 | Bacteria identified in Semen by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90276-7.json |
| 90277-5 | Bacteria identified in Peritoneal dialysis fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90277-5.json |
| 90278-3 | Bacteria identified in Synovial fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90278-3.json |
| 90279-1 | Bacteria identified in Semen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90279-1.json |
| 90280-9 | Bacteria identified in Peritoneal dialysis fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90280-9.json |
| 90281-7 | Bacteria identified in Peritoneal fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90281-7.json |
| 90282-5 | Microscopic observation [Identifier] in Catheter tip by Gram stain | ./2.16.840.1.114222.4.11.1002/90282-5.json |
| 90283-3 | Mycobacterium tuberculosis DNA [Presence] in Bile fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90283-3.json |
| 90284-1 | Mycobacterium sp identified in Bile fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90284-1.json |
| 90285-8 | Trichomonas vaginalis [Presence] in Vaginal fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90285-8.json |
| 90286-6 | Trichomonas vaginalis [Presence] in Vaginal fluid by Light microscopy | ./2.16.840.1.114222.4.11.1002/90286-6.json |
| 90287-4 | Norovirus RNA [Presence] in Vomitus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90287-4.json |
| 90288-2 | Norovirus genogroup I RNA [Presence] in Vomitus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90288-2.json |
| 90289-0 | Norovirus genogroup II RNA [Presence] in Vomitus by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90289-0.json |
| 90290-8 | Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90290-8.json |
| 90291-6 | EpCAM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90291-6.json |
| 90294-0 | MMP-9 Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90294-0.json |
| 90295-7 | RalA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90295-7.json |
| 90296-5 | Microscopic observation [Identifier] in Skin by Gram stain | ./2.16.840.1.114222.4.11.1002/90296-5.json |
| 90297-3 | Entamoeba histolytica Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90297-3.json |
| 90298-1 | Entamoeba sp DNA [Identifier] in Stool by Sequencing | ./2.16.840.1.114222.4.11.1002/90298-1.json |
| 90299-9 | Giardia sp DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90299-9.json |
| 90300-5 | Helminth identified in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90300-5.json |
| 90301-3 | Toxoplasma gondii [Presence] in Amniotic fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90301-3.json |
| 90302-1 | Trichomonas vaginalis DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90302-1.json |
| 90303-9 | Trichomonas vaginalis [Presence] in Cervix by Light microscopy | ./2.16.840.1.114222.4.11.1002/90303-9.json |
| 90304-7 | CD3 cells/100 lymphocytes in Blood | ./2.16.840.1.114222.4.11.1002/90304-7.json |
| 90305-4 | t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/90305-4.json |
| 90306-2 | Mycobacterium sp identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/90306-2.json |
| 90307-0 | CT Guidance for injection of Foot joint - right | ./2.16.840.1.114222.4.11.1002/90307-0.json |
| 90308-8 | CT Guidance for needle localization of Thoracic spine | ./2.16.840.1.114222.4.11.1002/90308-8.json |
| 90309-6 | CT Guidance for drainage and placement of drainage catheter of Lung - right | ./2.16.840.1.114222.4.11.1002/90309-6.json |
| 90310-4 | CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- WO contrast | ./2.16.840.1.114222.4.11.1002/90310-4.json |
| 90311-2 | CT Guidance for percutaneous replacement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/90311-2.json |
| 90312-0 | SPECT+CT Skeletal system | ./2.16.840.1.114222.4.11.1002/90312-0.json |
| 90314-6 | CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- W contrast IV | ./2.16.840.1.114222.4.11.1002/90314-6.json |
| 90315-3 | CT Guidance for deep biopsy of Soft tissue | ./2.16.840.1.114222.4.11.1002/90315-3.json |
| 90316-1 | CT Guidance for superficial biopsy of Soft tissue | ./2.16.840.1.114222.4.11.1002/90316-1.json |
| 90317-9 | CT Guidance for drainage and placement of drainage catheter of Lower extremity - left | ./2.16.840.1.114222.4.11.1002/90317-9.json |
| 90318-7 | CT Guidance for drainage and placement of drainage catheter of Lower extremity - right | ./2.16.840.1.114222.4.11.1002/90318-7.json |
| 90319-5 | CT Guidance for drainage and placement of drainage catheter of Lung - left | ./2.16.840.1.114222.4.11.1002/90319-5.json |
| 90320-3 | Aichivirus C RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90320-3.json |
| 90321-1 | Aichivirus C RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90321-1.json |
| 90322-9 | Haemophilus parasuis serotype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90322-9.json |
| 90323-7 | Influenza virus A Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90323-7.json |
| 90324-5 | Mycoplasma hyopneumoniae DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90324-5.json |
| 90325-2 | Mycoplasma suis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90325-2.json |
| 90326-0 | Porcine circovirus type 2d DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90326-0.json |
| 90327-8 | Porcine circovirus type 2d DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90327-8.json |
| 90328-6 | Porcine circovirus type 3 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90328-6.json |
| 90329-4 | Porcine deltacoronavirus IgG Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/90329-4.json |
| 90330-2 | Porcine parainfluenza virus 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90330-2.json |
| 90331-0 | PRRSV IgA+IgM/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/90331-0.json |
| 90332-8 | PRRSV IgA Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/90332-8.json |
| 90333-6 | PRRSV IgM Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/90333-6.json |
| 90334-4 | CT Guidance for injection of Spine Thoracic Facet Joint | ./2.16.840.1.114222.4.11.1002/90334-4.json |
| 90335-1 | CT Guidance for injection of Lumbar Spine Facet Joint | ./2.16.840.1.114222.4.11.1002/90335-1.json |
| 90336-9 | CT Guidance for injection of Muscle | ./2.16.840.1.114222.4.11.1002/90336-9.json |
| 90337-7 | Cryptococcus sp rRNA gene [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90337-7.json |
| 90338-5 | Cryptococcus sp rRNA gene [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90338-5.json |
| 90339-3 | Aspergillus sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90339-3.json |
| 90340-1 | Aspergillus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90340-1.json |
| 90341-9 | Nuclear medicine Administrative note | ./2.16.840.1.114222.4.11.1002/90341-9.json |
| 90342-7 | Nuclear medicine Attending Note | ./2.16.840.1.114222.4.11.1002/90342-7.json |
| 90343-5 | Nuclear medicine Consult note | ./2.16.840.1.114222.4.11.1002/90343-5.json |
| 90344-3 | Nuclear medicine Note | ./2.16.840.1.114222.4.11.1002/90344-3.json |
| 90345-0 | Nuclear medicine Nurse Note | ./2.16.840.1.114222.4.11.1002/90345-0.json |
| 90346-8 | Nuclear medicine Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/90346-8.json |
| 90347-6 | Nuclear medicine Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/90347-6.json |
| 90348-4 | Nuclear medicine Resident Note | ./2.16.840.1.114222.4.11.1002/90348-4.json |
| 90349-2 | Nuclear medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/90349-2.json |
| 90350-0 | Nuclear medicine procedure note | ./2.16.840.1.114222.4.11.1002/90350-0.json |
| 90351-8 | Radiology Postoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/90351-8.json |
| 90352-6 | CT Head and CT Brain for perfusion and CT angiogram Head vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/90352-6.json |
| 90353-4 | Conscious sedation procedure note | ./2.16.840.1.114222.4.11.1002/90353-4.json |
| 90354-2 | Obesity medicine Consult note | ./2.16.840.1.114222.4.11.1002/90354-2.json |
| 90355-9 | Obesity medicine Group counseling note | ./2.16.840.1.114222.4.11.1002/90355-9.json |
| 90356-7 | Obesity medicine Initial evaluation note | ./2.16.840.1.114222.4.11.1002/90356-7.json |
| 90359-1 | Nurse Fluid management note | ./2.16.840.1.114222.4.11.1002/90359-1.json |
| 90360-9 | Trimethylamine N-oxide [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/90360-9.json |
| 90361-7 | Chlamydia trachomatis L1 IgA Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90361-7.json |
| 90362-5 | Chlamydia trachomatis L1 IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90362-5.json |
| 90363-3 | Chlamydia trachomatis L1 IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90363-3.json |
| 90364-1 | Cholesterol.in LDL.small dense [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90364-1.json |
| 90371-6 | Clinical pathology Note | ./2.16.840.1.114222.4.11.1002/90371-6.json |
| 90372-4 | CT Guidance for injection of Tendon | ./2.16.840.1.114222.4.11.1002/90372-4.json |
| 90373-2 | CT Guidance for injection of Tendon or ligament | ./2.16.840.1.114222.4.11.1002/90373-2.json |
| 90374-0 | FDA package insert Clinical trials experience section | ./2.16.840.1.114222.4.11.1002/90374-0.json |
| 90375-7 | FDA package insert Postmarketing experience section | ./2.16.840.1.114222.4.11.1002/90375-7.json |
| 90418-5 | BAFF-R cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/90418-5.json |
| 90419-3 | Apolipoprotein CIII-0/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90419-3.json |
| 90420-1 | Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90420-1.json |
| 90421-9 | Apolipoprotein CIII-1/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90421-9.json |
| 90422-7 | TACI cells/100 CD19 cells in Blood | ./2.16.840.1.114222.4.11.1002/90422-7.json |
| 90424-3 | Microorganism preliminary growth detection panel - Body fluid by Culture | ./2.16.840.1.114222.4.11.1002/90424-3.json |
| 90426-8 | Microorganism preliminary growth [Presence] in Blood by Aerobic culture with antimicrobial neutralizer | ./2.16.840.1.114222.4.11.1002/90426-8.json |
| 90427-6 | Microorganism preliminary growth [Presence] in Blood by Anaerobic culture with antimicrobial neutralizer | ./2.16.840.1.114222.4.11.1002/90427-6.json |
| 90428-4 | Microorganism preliminary growth [Presence] in Body fluid by Aerobic culture with antimicrobial neutralizer | ./2.16.840.1.114222.4.11.1002/90428-4.json |
| 90429-2 | Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90429-2.json |
| 90430-0 | Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90430-0.json |
| 90431-8 | Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer | ./2.16.840.1.114222.4.11.1002/90431-8.json |
| 90432-6 | Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90432-6.json |
| 90433-4 | Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90433-4.json |
| 90434-2 | Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90434-2.json |
| 90435-9 | Microorganism preliminary growth [Presence] in Blood by Aerobe culture | ./2.16.840.1.114222.4.11.1002/90435-9.json |
| 90436-7 | Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90436-7.json |
| 90437-5 | Microorganism preliminary growth [Presence] in Blood by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/90437-5.json |
| 90438-3 | Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture | ./2.16.840.1.114222.4.11.1002/90438-3.json |
| 90440-9 | BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90440-9.json |
| 90442-5 | Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/90442-5.json |
| 90443-3 | Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/90443-3.json |
| 90444-1 | Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90444-1.json |
| 90445-8 | ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90445-8.json |
| 90446-6 | Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90446-6.json |
| 90447-4 | Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/90447-4.json |
| 90448-2 | Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90448-2.json |
| 90449-0 | Norovirus genogroup I and II RNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90449-0.json |
| 90450-8 | Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90450-8.json |
| 90451-6 | Herpes simplex virus 1 DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90451-6.json |
| 90452-4 | Herpes simplex virus 1 DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90452-4.json |
| 90453-2 | Herpes simplex virus 2 DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90453-2.json |
| 90454-0 | Herpes simplex virus 2 DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90454-0.json |
| 90459-9 | Yellow fever virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90459-9.json |
| 90460-7 | Hepatitis E virus RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90460-7.json |
| 90461-5 | Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90461-5.json |
| 90462-3 | Zika virus RNA [Presence] in Cord blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90462-3.json |
| 90463-1 | Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90463-1.json |
| 90464-9 | Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90464-9.json |
| 90465-6 | 3-(4-fluorobenzoyl)propionate [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90465-6.json |
| 90466-4 | 3-(4-fluorobenzoyl)propionate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/90466-4.json |
| 90467-2 | Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90467-2.json |
| 90468-0 | Hydroxyaripiprazole [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/90468-0.json |
| 90469-8 | Norfluvoxamine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90469-8.json |
| 90470-6 | Norfluvoxamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/90470-6.json |
| 90471-4 | 9-Hydroxyrisperidone [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/90471-4.json |
| 90708-9 | Trauma Outpatient Note | ./2.16.840.1.114222.4.11.1002/90708-9.json |
| 90709-7 | Adolescent medicine Consult note | ./2.16.840.1.114222.4.11.1002/90709-7.json |
| 90710-5 | Developmental-behavioral pediatrics Consult note | ./2.16.840.1.114222.4.11.1002/90710-5.json |
| 90711-3 | Sleep medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/90711-3.json |
| 90712-1 | Sleep medicine Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/90712-1.json |
| 90713-9 | Sleep medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/90713-9.json |
| 90714-7 | Pain medicine Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/90714-7.json |
| 90715-4 | Palliative care Telehealth Consult note | ./2.16.840.1.114222.4.11.1002/90715-4.json |
| 90716-2 | Psychiatry Telehealth Note | ./2.16.840.1.114222.4.11.1002/90716-2.json |
| 90717-0 | Heart failure+Transplant cardiology Consult note | ./2.16.840.1.114222.4.11.1002/90717-0.json |
| 90736-0 | CD14-FLAER- cells/100 cells.CD33 (Monocytes) in Blood | ./2.16.840.1.114222.4.11.1002/90736-0.json |
| 90737-8 | CD24-FLAER- cells/100 cells.CD15 (Neutrophils) in Blood | ./2.16.840.1.114222.4.11.1002/90737-8.json |
| 90738-6 | Erythrocytes.CD59 complete loss/100 erythrocytes in Blood | ./2.16.840.1.114222.4.11.1002/90738-6.json |
| 90740-2 | Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore | ./2.16.840.1.114222.4.11.1002/90740-2.json |
| 90741-0 | Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90741-0.json |
| 90742-8 | Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90742-8.json |
| 90743-6 | CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/90743-6.json |
| 90744-4 | Youth Risk Behavior Survey - body weight panel [CDC] | ./2.16.840.1.114222.4.11.1002/90744-4.json |
| 90746-9 | 5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90746-9.json |
| 90747-7 | MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90747-7.json |
| 90748-5 | Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90748-5.json |
| 90749-3 | 4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90749-3.json |
| 90750-1 | O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90750-1.json |
| 90751-9 | Social worker Adult day care center Note | ./2.16.840.1.114222.4.11.1002/90751-9.json |
| 90752-7 | Community health care Social worker Note | ./2.16.840.1.114222.4.11.1002/90752-7.json |
| 90753-5 | Multi-specialty program Social worker Note | ./2.16.840.1.114222.4.11.1002/90753-5.json |
| 90754-3 | Mental health Social worker Note | ./2.16.840.1.114222.4.11.1002/90754-3.json |
| 90755-0 | Palliative care Social worker Long term care facility Note | ./2.16.840.1.114222.4.11.1002/90755-0.json |
| 90756-8 | Palliative care Social worker Note | ./2.16.840.1.114222.4.11.1002/90756-8.json |
| 90757-6 | Physical medicine and rehabilitation Social worker Hospital Note | ./2.16.840.1.114222.4.11.1002/90757-6.json |
| 90758-4 | Physical medicine and rehabilitation Social worker Outpatient hospital Note | ./2.16.840.1.114222.4.11.1002/90758-4.json |
| 90759-2 | Primary care Social worker Note | ./2.16.840.1.114222.4.11.1002/90759-2.json |
| 90760-0 | Addiction medicine Social worker Note | ./2.16.840.1.114222.4.11.1002/90760-0.json |
| 90763-4 | HEDIS 2019-2020 Value Set - Chlamydia Tests | ./2.16.840.1.114222.4.11.1002/90763-4.json |
| 90764-2 | HEDIS 2019 Value Set - Toxoplasma Antibody | ./2.16.840.1.114222.4.11.1002/90764-2.json |
| 90765-9 | HEDIS 2019 Value Set - Rh | ./2.16.840.1.114222.4.11.1002/90765-9.json |
| 90766-7 | HEDIS 2019 Value Sets | ./2.16.840.1.114222.4.11.1002/90766-7.json |
| 90767-5 | Pregnancy summary Document | ./2.16.840.1.114222.4.11.1002/90767-5.json |
| 90768-3 | Donor blood study | ./2.16.840.1.114222.4.11.1002/90768-3.json |
| 90769-1 | Heart failure Plan of care note | ./2.16.840.1.114222.4.11.1002/90769-1.json |
| 90770-9 | Heart failure Initial evaluation note | ./2.16.840.1.114222.4.11.1002/90770-9.json |
| 90771-7 | Heart failure Consult note | ./2.16.840.1.114222.4.11.1002/90771-7.json |
| 90772-5 | Heart failure Progress note | ./2.16.840.1.114222.4.11.1002/90772-5.json |
| 90773-3 | Heart failure Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/90773-3.json |
| 90774-1 | Heart failure Team Conference note | ./2.16.840.1.114222.4.11.1002/90774-1.json |
| 90776-6 | HEDIS 2019 Value Set - Rubella Antibody | ./2.16.840.1.114222.4.11.1002/90776-6.json |
| 90777-4 | HEDIS 2019 Value Set - Cytomegalovirus Antibody | ./2.16.840.1.114222.4.11.1002/90777-4.json |
| 90779-0 | Adalimumab Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90779-0.json |
| 90780-8 | inFLIXimab Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/90780-8.json |
| 90781-6 | N,N'-dimethylarginine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90781-6.json |
| 90782-4 | F2-Isoprostanes [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/90782-4.json |
| 90783-2 | F2-Isoprostanes/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/90783-2.json |
| 90786-5 | Dentistry Attending Note | ./2.16.840.1.114222.4.11.1002/90786-5.json |
| 90787-3 | Dentistry Resident Note | ./2.16.840.1.114222.4.11.1002/90787-3.json |
| 90788-1 | Optometry Resident Note | ./2.16.840.1.114222.4.11.1002/90788-1.json |
| 90789-9 | Psychology Intern Note | ./2.16.840.1.114222.4.11.1002/90789-9.json |
| 90790-7 | Podiatry Resident Note | ./2.16.840.1.114222.4.11.1002/90790-7.json |
| 90791-5 | Physical therapy Resident Note | ./2.16.840.1.114222.4.11.1002/90791-5.json |
| 90792-3 | Podiatry Attending Preoperative evaluation and management note | ./2.16.840.1.114222.4.11.1002/90792-3.json |
| 90793-1 | Podiatry Attending Note | ./2.16.840.1.114222.4.11.1002/90793-1.json |
| 90805-3 | Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough | ./2.16.840.1.114222.4.11.1002/90805-3.json |
| 90806-1 | Candida albicans DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90806-1.json |
| 90807-9 | Candida glabrata DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90807-9.json |
| 90808-7 | Candida krusei DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90808-7.json |
| 90809-5 | Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90809-5.json |
| 90810-3 | Candida tropicalis DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90810-3.json |
| 90811-1 | AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90811-1.json |
| 90812-9 | AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90812-9.json |
| 90813-7 | AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90813-7.json |
| 90814-5 | AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90814-5.json |
| 90815-2 | Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90815-2.json |
| 90816-0 | Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90816-0.json |
| 90817-8 | Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90817-8.json |
| 90818-6 | Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90818-6.json |
| 90819-4 | Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90819-4.json |
| 90820-2 | Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90820-2.json |
| 90821-0 | Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90821-0.json |
| 90822-8 | CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90822-8.json |
| 90823-6 | Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90823-6.json |
| 90824-4 | Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90824-4.json |
| 90825-1 | GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90825-1.json |
| 90826-9 | GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90826-9.json |
| 90827-7 | Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90827-7.json |
| 90828-5 | Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90828-5.json |
| 90829-3 | Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90829-3.json |
| 90830-1 | Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90830-1.json |
| 90831-9 | Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90831-9.json |
| 90832-7 | Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90832-7.json |
| 90833-5 | Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90833-5.json |
| 90834-3 | Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90834-3.json |
| 90835-0 | Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/90835-0.json |
| 90836-8 | Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90836-8.json |
| 90837-6 | Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90837-6.json |
| 90838-4 | Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90838-4.json |
| 90839-2 | NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90839-2.json |
| 90840-0 | NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90840-0.json |
| 90841-8 | PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90841-8.json |
| 90842-6 | PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90842-6.json |
| 90843-4 | PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90843-4.json |
| 90844-2 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90844-2.json |
| 90845-9 | PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90845-9.json |
| 90846-7 | PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/90846-7.json |
| 90847-5 | Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/90847-5.json |
| 90848-3 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/90848-3.json |
| 90849-1 | Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/90849-1.json |
| 90850-9 | cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | ./2.16.840.1.114222.4.11.1002/90850-9.json |
| 90851-7 | GJB2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/90851-7.json |
| 90861-6 | Missing teeth [#] | ./2.16.840.1.114222.4.11.1002/90861-6.json |
| 90868-1 | Orthognathic surgery consideration summary Narrative | ./2.16.840.1.114222.4.11.1002/90868-1.json |
| 90873-1 | Malocclusion severity assessment | ./2.16.840.1.114222.4.11.1002/90873-1.json |
| 90874-9 | Orthodontic evaluation summary Document | ./2.16.840.1.114222.4.11.1002/90874-9.json |
| 90875-6 | Orthodontic service attachment | ./2.16.840.1.114222.4.11.1002/90875-6.json |
| 90876-4 | Thromboembolism Progress note | ./2.16.840.1.114222.4.11.1002/90876-4.json |
| 90877-2 | Thromboembolism procedure note | ./2.16.840.1.114222.4.11.1002/90877-2.json |
| 90878-0 | Thromboembolism Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/90878-0.json |
| 90879-8 | Thromboembolism Team Conference note | ./2.16.840.1.114222.4.11.1002/90879-8.json |
| 90880-6 | Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/90880-6.json |
| 90881-4 | Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/90881-4.json |
| 90885-5 | Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90885-5.json |
| 90886-3 | Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90886-3.json |
| 90887-1 | Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/90887-1.json |
| 90888-9 | Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90888-9.json |
| 90889-7 | Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/90889-7.json |
| 90893-9 | Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/90893-9.json |
| 90894-7 | Noroxymorphone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/90894-7.json |
| 90898-8 | HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing | ./2.16.840.1.114222.4.11.1002/90898-8.json |
| 90899-6 | HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing | ./2.16.840.1.114222.4.11.1002/90899-6.json |
| 90900-2 | HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing | ./2.16.840.1.114222.4.11.1002/90900-2.json |
| 90901-0 | HIV 1 RNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/90901-0.json |
| 90902-8 | HIV 1 RNA reverse transcriptase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/90902-8.json |
| 90903-6 | HIV 1 RNA integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/90903-6.json |
| 90904-4 | HIV 1 RNA protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/90904-4.json |
| 90905-1 | Mother's ABO and Rh group Type | ./2.16.840.1.114222.4.11.1002/90905-1.json |
| 90906-9 | Father's ABO and Rh group Type | ./2.16.840.1.114222.4.11.1002/90906-9.json |
| 90907-7 | Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/90907-7.json |
| 90919-2 | Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/90919-2.json |
| 90924-2 | BK virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/90924-2.json |
| 90925-9 | HBB gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Sequencing | ./2.16.840.1.114222.4.11.1002/90925-9.json |
| 90926-7 | MET gene amplification in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/90926-7.json |
| 90927-5 | RET gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/90927-5.json |
| 90946-5 | Date of laboratory phone call to provider to communicate test result | ./2.16.840.1.114222.4.11.1002/90946-5.json |
| 90947-3 | Pathology case identifier [Identifier] | ./2.16.840.1.114222.4.11.1002/90947-3.json |
| 90975-4 | Clomethiazole [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90975-4.json |
| 90976-2 | Opipramol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90976-2.json |
| 90977-0 | Tianeptine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90977-0.json |
| 90978-8 | Vilazodone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90978-8.json |
| 90979-6 | Vortioxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/90979-6.json |
| 90980-4 | Meropenem+Vaborbactam [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/90980-4.json |
| 90994-5 | Iothalamate renal clearance | ./2.16.840.1.114222.4.11.1002/90994-5.json |
| 90995-2 | Iothalamate renal clearance/Body surface area | ./2.16.840.1.114222.4.11.1002/90995-2.json |
| 90997-8 | HEDIS 2019-2020 Value Set - Group A Strep Tests | ./2.16.840.1.114222.4.11.1002/90997-8.json |
| 91001-8 | Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/91001-8.json |
| 91003-4 | Personnel contact information panel | ./2.16.840.1.114222.4.11.1002/91003-4.json |
| 91010-9 | Epidemiological investigation report Document | ./2.16.840.1.114222.4.11.1002/91010-9.json |
| 91024-0 | Risk assessment report Document Public health | ./2.16.840.1.114222.4.11.1002/91024-0.json |
| 91026-5 | Event Inter-agency communication documentation | ./2.16.840.1.114222.4.11.1002/91026-5.json |
| 91028-1 | Barbiturates [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91028-1.json |
| 91029-9 | Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/91029-9.json |
| 91030-7 | Methadone+Metabolite [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/91030-7.json |
| 91031-5 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/91031-5.json |
| 91032-3 | oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method | ./2.16.840.1.114222.4.11.1002/91032-3.json |
| 91033-1 | Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/91033-1.json |
| 91034-9 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method | ./2.16.840.1.114222.4.11.1002/91034-9.json |
| 91035-6 | Phencyclidine [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91035-6.json |
| 91036-4 | Benzodiazepines [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91036-4.json |
| 91037-2 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/91037-2.json |
| 91038-0 | Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91038-0.json |
| 91039-8 | Methadone+Metabolite [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91039-8.json |
| 91040-6 | Phencyclidine [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91040-6.json |
| 91041-4 | Cannabinoids [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91041-4.json |
| 91042-2 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91042-2.json |
| 91043-0 | Opiates [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91043-0.json |
| 91044-8 | oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method | ./2.16.840.1.114222.4.11.1002/91044-8.json |
| 91045-5 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/91045-5.json |
| 91046-3 | Methadone+Metabolite [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/91046-3.json |
| 91047-1 | Barbiturates [Presence] in Hair by Screen method | ./2.16.840.1.114222.4.11.1002/91047-1.json |
| 91048-9 | Cannabinoids [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91048-9.json |
| 91049-7 | Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91049-7.json |
| 91050-5 | Methadone+Metabolite [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91050-5.json |
| 91051-3 | Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91051-3.json |
| 91052-1 | Opiates [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91052-1.json |
| 91053-9 | oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/91053-9.json |
| 91057-0 | Tropheryma whipplei DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91057-0.json |
| 91058-8 | Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91058-8.json |
| 91059-6 | Kingella kingae DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91059-6.json |
| 91060-4 | Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91060-4.json |
| 91061-2 | Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91061-2.json |
| 91062-0 | Bacteria identified in Platelets from Blood product unit by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/91062-0.json |
| 91063-8 | Bacteria identified in Platelets from Blood product unit by Aerobe culture | ./2.16.840.1.114222.4.11.1002/91063-8.json |
| 91064-6 | Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/91064-6.json |
| 91065-3 | 14-3-3 protein [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91065-3.json |
| 91066-1 | Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91066-1.json |
| 91067-9 | Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91067-9.json |
| 91068-7 | Enterovirus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91068-7.json |
| 91069-5 | Enterovirus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91069-5.json |
| 91070-3 | Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91070-3.json |
| 91071-1 | Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91071-1.json |
| 91074-5 | Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91074-5.json |
| 91075-2 | Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/91075-2.json |
| 91076-0 | Rabies virus Ag [Presence] in Tissue by Immunoassay | ./2.16.840.1.114222.4.11.1002/91076-0.json |
| 91077-8 | Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91077-8.json |
| 91078-6 | Zika virus RNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91078-6.json |
| 91079-4 | Zika virus RNA [Presence] in Placenta by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91079-4.json |
| 91080-2 | Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/91080-2.json |
| 91081-0 | Candida sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91081-0.json |
| 91082-8 | Fungal 18s rRNA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91082-8.json |
| 91083-6 | Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91083-6.json |
| 91084-4 | Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91084-4.json |
| 91085-1 | Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91085-1.json |
| 91086-9 | Fungal BT2 gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91086-9.json |
| 91087-7 | Fungal BT2 gene [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91087-7.json |
| 91088-5 | Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91088-5.json |
| 91089-3 | Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91089-3.json |
| 91090-1 | Fungal ITS region [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91090-1.json |
| 91091-9 | Fungal ITS region [Presence] in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91091-9.json |
| 91092-7 | Fungal ITS region [Presence] in Dermatologic specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91092-7.json |
| 91093-5 | Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91093-5.json |
| 91104-0 | aPTT.factor sensitive with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/91104-0.json |
| 91119-8 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma | ./2.16.840.1.114222.4.11.1002/91119-8.json |
| 91122-2 | Maltose binding protein IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/91122-2.json |
| 91130-5 | Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91130-5.json |
| 91131-3 | Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91131-3.json |
| 91132-1 | Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91132-1.json |
| 91133-9 | Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91133-9.json |
| 91135-4 | Acanthocytes [Presence] in Urine sediment by Light microscopy | ./2.16.840.1.114222.4.11.1002/91135-4.json |
| 91137-0 | ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91137-0.json |
| 91147-9 | Mean score [PEG] | ./2.16.840.1.114222.4.11.1002/91147-9.json |
| 91149-5 | Physical therapy Reevaluation note | ./2.16.840.1.114222.4.11.1002/91149-5.json |
| 91150-3 | Pressure injury stage NPUAP | ./2.16.840.1.114222.4.11.1002/91150-3.json |
| 91350-9 | Distress subscore [STarT Back] | ./2.16.840.1.114222.4.11.1002/91350-9.json |
| 91351-7 | Total score [STarT Back] | ./2.16.840.1.114222.4.11.1002/91351-7.json |
| 91352-5 | STarT Back Screening risk level | ./2.16.840.1.114222.4.11.1002/91352-5.json |
| 91370-7 | Body height --used for drug calculation | ./2.16.840.1.114222.4.11.1002/91370-7.json |
| 91392-1 | Total score ORT | ./2.16.840.1.114222.4.11.1002/91392-1.json |
| 91517-3 | DBT Breast - right diagnostic for implant | ./2.16.840.1.114222.4.11.1002/91517-3.json |
| 91518-1 | DBT Breast - left diagnostic for implant | ./2.16.840.1.114222.4.11.1002/91518-1.json |
| 91519-9 | DBT Breast - bilateral diagnostic for implant | ./2.16.840.1.114222.4.11.1002/91519-9.json |
| 91520-7 | DBT Breast - right screen for implant | ./2.16.840.1.114222.4.11.1002/91520-7.json |
| 91521-5 | DBT Breast - left screen for implant | ./2.16.840.1.114222.4.11.1002/91521-5.json |
| 91522-3 | DBT Breast - bilateral screen for implant | ./2.16.840.1.114222.4.11.1002/91522-3.json |
| 91523-1 | MR Chest and Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/91523-1.json |
| 91524-9 | MR Chest and Abdomen and Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/91524-9.json |
| 91525-6 | MR Chest and Abdomen and Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/91525-6.json |
| 91531-4 | Social worker Telehealth Note | ./2.16.840.1.114222.4.11.1002/91531-4.json |
| 91543-9 | Myelin oligodendrocyte glycoprotein Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/91543-9.json |
| 91545-4 | Myelin oligodendrocyte glycoprotein Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/91545-4.json |
| 91546-2 | ST deviation (Maximum value during study) by EKG | ./2.16.840.1.114222.4.11.1002/91546-2.json |
| 91547-0 | Treadmill angina [Identifier] | ./2.16.840.1.114222.4.11.1002/91547-0.json |
| 91549-6 | Duke Treadmill Score | ./2.16.840.1.114222.4.11.1002/91549-6.json |
| 91556-1 | Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/91556-1.json |
| 91557-9 | Lean body weight | ./2.16.840.1.114222.4.11.1002/91557-9.json |
| 91561-1 | MR Cervical and thoracic and lumbar spine W contrast IV | ./2.16.840.1.114222.4.11.1002/91561-1.json |
| 91591-8 | MR Brain and Orbit - bilateral W contrast IV | ./2.16.840.1.114222.4.11.1002/91591-8.json |
| 91592-6 | MR Brain and Orbit - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/91592-6.json |
| 91593-4 | MR Brain and Orbit - bilateral WO contrast | ./2.16.840.1.114222.4.11.1002/91593-4.json |
| 91594-2 | MR Sacrum and Sacroiliac joint W contrast IV | ./2.16.840.1.114222.4.11.1002/91594-2.json |
| 91595-9 | MR Sacrum and Sacroiliac joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/91595-9.json |
| 91596-7 | MR Sacrum and Sacroiliac joint WO contrast | ./2.16.840.1.114222.4.11.1002/91596-7.json |
| 91597-5 | MR Toe WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/91597-5.json |
| 91598-3 | XR Knee GE 2 Views | ./2.16.840.1.114222.4.11.1002/91598-3.json |
| 91606-4 | clomiPRAMINE+Norclomipramine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/91606-4.json |
| 91664-3 | Triangle bur ragweed (Ambrosia deltoidea) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/91664-3.json |
| 91665-0 | Ascorbate oxidase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/91665-0.json |
| 91667-6 | Aspergillus clavatus Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/91667-6.json |
| 91668-4 | Aspergillus oryzae Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/91668-4.json |
| 91669-2 | CYP3A7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91669-2.json |
| 916-7 | B Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/916-7.json |
| 91670-0 | Orexin-A [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/91670-0.json |
| 91671-8 | Transferrin.carbohydrate deficient.disialo/Transferrin.total standardized per IFCC-RMP for CDT in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/91671-8.json |
| 91672-6 | ABCB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91672-6.json |
| 91673-4 | CD3+CD16+CD56+ cells/100 cells in Bone marrow | ./2.16.840.1.114222.4.11.1002/91673-4.json |
| 91674-2 | CD3+CD16+CD56+ cells [#/volume] in Bone marrow | ./2.16.840.1.114222.4.11.1002/91674-2.json |
| 91677-5 | Cryptosporidium parvum Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/91677-5.json |
| 91678-3 | Zika virus IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/91678-3.json |
| 91679-1 | F8 gene intron 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91679-1.json |
| 91680-9 | F8 gene intron 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91680-9.json |
| 91681-7 | F9 gene mutation analysis limited to known familial mutations in Amniotic fluid or Chorionic villus sample by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/91681-7.json |
| 91682-5 | Histoplasma capsulatum Ab [Identifier] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/91682-5.json |
| 91685-8 | Glutathione [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/91685-8.json |
| 91704-7 | Primary contact information panel Facility | ./2.16.840.1.114222.4.11.1002/91704-7.json |
| 91712-0 | F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/91712-0.json |
| 91715-3 | MR Spine Lumbar and Sacrum W contrast IV | ./2.16.840.1.114222.4.11.1002/91715-3.json |
| 91716-1 | MR Spine Lumbar and Sacrum WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/91716-1.json |
| 91717-9 | MR Spine Lumbar and Sacrum WO contrast | ./2.16.840.1.114222.4.11.1002/91717-9.json |
| 91718-7 | MR Unspecified body region Post mortem | ./2.16.840.1.114222.4.11.1002/91718-7.json |
| 91719-5 | CT Unspecified body region Post mortem | ./2.16.840.1.114222.4.11.1002/91719-5.json |
| 91720-3 | XR Head to Abdomen Views for shunt patency | ./2.16.840.1.114222.4.11.1002/91720-3.json |
| 91761-7 | Giardia sp Ag [Presence] in Stool by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/91761-7.json |
| 91763-3 | Mycobacterium tuberculosis DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91763-3.json |
| 91764-1 | Nocardia sp identified in Aspirate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91764-1.json |
| 91765-8 | Entamoeba sp DNA [Identifier] in Aspirate by Sequencing | ./2.16.840.1.114222.4.11.1002/91765-8.json |
| 91766-6 | Entamoeba histolytica DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91766-6.json |
| 91767-4 | Giardia sp DNA [Presence] in Duodenal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91767-4.json |
| 91768-2 | Ova and parasites identified in Sputum by Light microscopy | ./2.16.840.1.114222.4.11.1002/91768-2.json |
| 91769-0 | Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91769-0.json |
| 91770-8 | Enterovirus identified in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91770-8.json |
| 91771-6 | Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91771-6.json |
| 91772-4 | Influenza virus identified in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91772-4.json |
| 91773-2 | Herpes simplex virus identified in Aspirate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91773-2.json |
| 91774-0 | Varicella zoster virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91774-0.json |
| 91775-7 | Bordetella sp identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91775-7.json |
| 91776-5 | Respiratory Mycoplasma identified in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91776-5.json |
| 91777-3 | Bordetella sp identified in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91777-3.json |
| 91778-1 | Human metapneumovirus identified in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91778-1.json |
| 91779-9 | Yeast identified in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91779-9.json |
| 91780-7 | Measles virus [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91780-7.json |
| 91781-5 | Neisseria gonorrhoeae [Presence] in Aspirate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91781-5.json |
| 91782-3 | Respiratory syncytial virus [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91782-3.json |
| 91783-1 | Cytomegalovirus [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91783-1.json |
| 91784-9 | Varicella zoster virus [Presence] in Lower respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91784-9.json |
| 91785-6 | Respiratory syncytial virus [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91785-6.json |
| 91786-4 | Measles virus [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91786-4.json |
| 91787-2 | Mumps virus [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91787-2.json |
| 91788-0 | Neisseria meningitidis [Presence] in Upper respiratory specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91788-0.json |
| 91789-8 | Haemophilus ducreyi [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91789-8.json |
| 91790-6 | Trichomonas vaginalis [Presence] in Genital specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91790-6.json |
| 91791-4 | Varicella zoster virus DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91791-4.json |
| 91792-2 | Rubella virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91792-2.json |
| 91793-0 | Rhinovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91793-0.json |
| 91794-8 | Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91794-8.json |
| 91795-5 | Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91795-5.json |
| 91796-3 | Parvovirus B19 DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91796-3.json |
| 91797-1 | Parvovirus B19 DNA [#/volume] (viral load) in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91797-1.json |
| 91798-9 | Parainfluenza virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91798-9.json |
| 91799-7 | Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91799-7.json |
| 91800-3 | Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91800-3.json |
| 91801-1 | Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91801-1.json |
| 91802-9 | Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91802-9.json |
| 91803-7 | Neisseria meningitidis DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91803-7.json |
| 91804-5 | Mycoplasma pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91804-5.json |
| 91805-2 | Mycobacterium leprae DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91805-2.json |
| 91806-0 | Mumps virus RNA [Presence] in Upper respiratory specimen by NAA with probedetection | ./2.16.840.1.114222.4.11.1002/91806-0.json |
| 91807-8 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91807-8.json |
| 91808-6 | Microscopic observation [Identifier] in Upper respiratory specimen by Gram stain | ./2.16.840.1.114222.4.11.1002/91808-6.json |
| 91809-4 | Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91809-4.json |
| 91810-2 | Human metapneumovirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91810-2.json |
| 91811-0 | Human bocavirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91811-0.json |
| 91812-8 | Fungus identified in Upper respiratory specimen by Culture | ./2.16.840.1.114222.4.11.1002/91812-8.json |
| 91813-6 | Bordetella sp DNA [Identifier] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91813-6.json |
| 91814-4 | Bordetella sp Ag [Presence] in Upper respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91814-4.json |
| 91815-1 | Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91815-1.json |
| 91816-9 | Bordetella parapertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91816-9.json |
| 91817-7 | Bordetella holmesii DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91817-7.json |
| 91818-5 | Bacteria identified in Upper respiratory specimen by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/91818-5.json |
| 91819-3 | Bacteria identified in Upper respiratory specimen by Aerobe culture | ./2.16.840.1.114222.4.11.1002/91819-3.json |
| 91820-1 | Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91820-1.json |
| 91821-9 | Adenovirus Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/91821-9.json |
| 91822-7 | Adenovirus Ag [Presence] in Upper respiratory specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/91822-7.json |
| 91823-5 | Rubella virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91823-5.json |
| 91824-3 | Pneumocystis jiroveci Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91824-3.json |
| 91825-0 | Parechovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91825-0.json |
| 91826-8 | Ova and parasites identified in Lower respiratory specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/91826-8.json |
| 91827-6 | Mycoplasma hominis DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91827-6.json |
| 91828-4 | Mycoplasma genitalium DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91828-4.json |
| 91829-2 | Mycobacterium tuberculosis DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91829-2.json |
| 91830-0 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91830-0.json |
| 91831-8 | Human metapneumovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91831-8.json |
| 91832-6 | Human bocavirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91832-6.json |
| 91833-4 | Herpes simplex virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91833-4.json |
| 91834-2 | Herpes simplex virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91834-2.json |
| 91835-9 | Herpes simplex virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91835-9.json |
| 91836-7 | Giardia sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91836-7.json |
| 91837-5 | Francisella sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91837-5.json |
| 91838-3 | Bordetella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91838-3.json |
| 91839-1 | Bordetella sp Ag [Presence] in Lower respiratory specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91839-1.json |
| 91840-9 | Bordetella holmesii DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91840-9.json |
| 91841-7 | Adenovirus Ag [Presence] in Lower respiratory specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/91841-7.json |
| 91842-5 | Ureaplasma urealyticum DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91842-5.json |
| 91843-3 | Ureaplasma parvum DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91843-3.json |
| 91844-1 | Trichomonas vaginalis DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91844-1.json |
| 91845-8 | Trichomonas vaginalis [Presence] in Genital specimen by Light microscopy | ./2.16.840.1.114222.4.11.1002/91845-8.json |
| 91846-6 | Treponema pallidum DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91846-6.json |
| 91847-4 | Streptococcus agalactiae DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91847-4.json |
| 91848-2 | Mycoplasma hominis DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91848-2.json |
| 91849-0 | Mycoplasma genitalium DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91849-0.json |
| 91850-8 | Microscopic observation [Identifier] in Genital specimen by Giemsa stain | ./2.16.840.1.114222.4.11.1002/91850-8.json |
| 91851-6 | Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91851-6.json |
| 91852-4 | Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91852-4.json |
| 91853-2 | Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91853-2.json |
| 91854-0 | Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91854-0.json |
| 91855-7 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91855-7.json |
| 91856-5 | Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91856-5.json |
| 91857-3 | Herpes simplex virus DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91857-3.json |
| 91858-1 | Herpes simplex virus 2 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91858-1.json |
| 91859-9 | Herpes simplex virus 1 DNA [Presence] in Genital specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91859-9.json |
| 91860-7 | Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91860-7.json |
| 91861-5 | Chlamydia trachomatis Ag [Presence] in Aspirate by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91861-5.json |
| 91862-3 | Bartonella sp DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91862-3.json |
| 91863-1 | Bartonella quintana DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91863-1.json |
| 91864-9 | Bartonella henselae DNA [Presence] in Aspirate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91864-9.json |
| 91865-6 | Bacteria identified in Genital specimen by Anaerobe culture | ./2.16.840.1.114222.4.11.1002/91865-6.json |
| 91866-4 | Bacteria identified in Mouth by Aerobe culture | ./2.16.840.1.114222.4.11.1002/91866-4.json |
| 91867-2 | Bordetella holmesii DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91867-2.json |
| 91868-0 | Bordetella parapertussis DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91868-0.json |
| 91869-8 | Bordetella pertussis DNA [Presence] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91869-8.json |
| 91870-6 | Bordetella sp Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91870-6.json |
| 91871-4 | Bordetella sp DNA [Identifier] in Throat by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91871-4.json |
| 91872-2 | Bordetella sp identified in Throat by Organism specific culture | ./2.16.840.1.114222.4.11.1002/91872-2.json |
| 91873-0 | Chlamydia trachomatis Ag [Presence] in Throat by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/91873-0.json |
| 91874-8 | Mycoplasma genitalium DNA [Presence] in Urethra by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91874-8.json |
| 91875-5 | Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91875-5.json |
| 91876-3 | Brucella sp Ab [Titer] in Serum by Immunocapture agglutination | ./2.16.840.1.114222.4.11.1002/91876-3.json |
| 91879-7 | Reporter Information | ./2.16.840.1.114222.4.11.1002/91879-7.json |
| 91889-6 | Volunteer contact information panel | ./2.16.840.1.114222.4.11.1002/91889-6.json |
| 91895-3 | Bacterial strain [Type] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/91895-3.json |
| 91896-1 | Mycoplasma pneumoniae Ab [Titer] in Serum by Agglutination | ./2.16.840.1.114222.4.11.1002/91896-1.json |
| 91897-9 | Doravirine [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/91897-9.json |
| 91898-7 | Epizootic hemorrhagic disease virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/91898-7.json |
| 91900-1 | Parasite [Presence] in Blood by Light microscopy | ./2.16.840.1.114222.4.11.1002/91900-1.json |
| 91905-0 | Personnel Response team leader information panel | ./2.16.840.1.114222.4.11.1002/91905-0.json |
| 91909-2 | Expiration date of Supply | ./2.16.840.1.114222.4.11.1002/91909-2.json |
| 91980-3 | Specific airway resistance by Plethysmograph body box | ./2.16.840.1.114222.4.11.1002/91980-3.json |
| 91981-1 | Airway resistance measured/predicted by Plethysmograph body box | ./2.16.840.1.114222.4.11.1002/91981-1.json |
| 91982-9 | Specific airway resistance measured/predicted by Plethysmograph body box | ./2.16.840.1.114222.4.11.1002/91982-9.json |
| 91983-7 | Care management note | ./2.16.840.1.114222.4.11.1002/91983-7.json |
| 91984-5 | Outpatient Care management note | ./2.16.840.1.114222.4.11.1002/91984-5.json |
| 91985-2 | Integrative medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/91985-2.json |
| 91986-0 | Integrative medicine Consult note | ./2.16.840.1.114222.4.11.1002/91986-0.json |
| 92002-5 | SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92002-5.json |
| 92007-4 | T-cell receptor excision circle [Z-score] in DBS | ./2.16.840.1.114222.4.11.1002/92007-4.json |
| 92008-2 | T-cell receptor excision circle [Multiple of the median] in DBS | ./2.16.840.1.114222.4.11.1002/92008-2.json |
| 92015-7 | Newborn administrative information | ./2.16.840.1.114222.4.11.1002/92015-7.json |
| 92016-5 | Maternal pregnancy risk factors Document | ./2.16.840.1.114222.4.11.1002/92016-5.json |
| 92017-3 | Maternal pregnancy summary Document | ./2.16.840.1.114222.4.11.1002/92017-3.json |
| 92018-1 | Provider supplied mother's live birth report Document | ./2.16.840.1.114222.4.11.1002/92018-1.json |
| 92019-9 | Provider supplied mother's fetal death report Document | ./2.16.840.1.114222.4.11.1002/92019-9.json |
| 92020-7 | Provider supplied facility live birth report Document | ./2.16.840.1.114222.4.11.1002/92020-7.json |
| 92021-5 | Provider supplied facility fetal death report Document | ./2.16.840.1.114222.4.11.1002/92021-5.json |
| 92025-6 | CT Head and Cervical spine W contrast IV | ./2.16.840.1.114222.4.11.1002/92025-6.json |
| 92026-4 | Personnel Supervisor contact information panel | ./2.16.840.1.114222.4.11.1002/92026-4.json |
| 92046-2 | Donor contact information panel | ./2.16.840.1.114222.4.11.1002/92046-2.json |
| 92050-4 | Video EEG study | ./2.16.840.1.114222.4.11.1002/92050-4.json |
| 92125-4 | Streptococcus pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92125-4.json |
| 92126-2 | Mycoplasma pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92126-2.json |
| 92127-0 | Haemophilus influenzae DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92127-0.json |
| 92128-8 | Bordetella pertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92128-8.json |
| 92129-6 | Bordetella parapertussis DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92129-6.json |
| 92130-4 | Rhinovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92130-4.json |
| 92131-2 | Respiratory syncytial virus RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92131-2.json |
| 92132-0 | Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAAwith probe detection | ./2.16.840.1.114222.4.11.1002/92132-0.json |
| 92133-8 | Chlamydophila pneumoniae DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92133-8.json |
| 92134-6 | Human metapneumovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92134-6.json |
| 92135-3 | Human bocavirus 1+2+3 DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92135-3.json |
| 92136-1 | Adenovirus B+C+E DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92136-1.json |
| 92137-9 | Parainfluenza virus 4 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92137-9.json |
| 92138-7 | Parainfluenza virus 3 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92138-7.json |
| 92139-5 | Parainfluenza virus 2 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92139-5.json |
| 92140-3 | Parainfluenza virus 1 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92140-3.json |
| 92141-1 | Influenza virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92141-1.json |
| 92142-9 | Influenza virus A RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92142-9.json |
| 92144-5 | Moraxella catarrhalis DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92144-5.json |
| 92145-2 | Legionella pneumophila DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92145-2.json |
| 92146-0 | Human coronavirus 229E+NL63 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92146-0.json |
| 92147-8 | Human coronavirus HKU1+OC43 RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92147-8.json |
| 92186-6 | Watch team report Document | ./2.16.840.1.114222.4.11.1002/92186-6.json |
| 92203-9 | Bed category panel Facility | ./2.16.840.1.114222.4.11.1002/92203-9.json |
| 92204-7 | Bed type panel Facility | ./2.16.840.1.114222.4.11.1002/92204-7.json |
| 92241-9 | Vancomycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92241-9.json |
| 92242-7 | Pyrazinamide [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92242-7.json |
| 92253-4 | Microorganism identified in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92253-4.json |
| 92255-9 | Methicillin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92255-9.json |
| 92281-5 | Brand name of cigarettes smoked most often 30 days | ./2.16.840.1.114222.4.11.1002/92281-5.json |
| 92478-7 | VS Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92478-7.json |
| 92479-5 | V Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92479-5.json |
| 92480-3 | U Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92480-3.json |
| 92481-1 | Sc2 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92481-1.json |
| 92482-9 | Sc1 Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92482-9.json |
| 92483-7 | S Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92483-7.json |
| 92484-5 | N Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92484-5.json |
| 92485-2 | M Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92485-2.json |
| 92486-0 | LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92486-0.json |
| 92487-8 | LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92487-8.json |
| 92488-6 | little s Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92488-6.json |
| 92489-4 | little k Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92489-4.json |
| 92490-2 | little e Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92490-2.json |
| 92491-0 | little c Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92491-0.json |
| 92492-8 | Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92492-8.json |
| 92493-6 | Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92493-6.json |
| 92494-4 | Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92494-4.json |
| 92495-1 | Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92495-1.json |
| 92496-9 | K Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92496-9.json |
| 92497-7 | Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92497-7.json |
| 92498-5 | Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92498-5.json |
| 92499-3 | Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92499-3.json |
| 92500-8 | Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92500-8.json |
| 92501-6 | Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92501-6.json |
| 92502-4 | Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92502-4.json |
| 92503-2 | Hy Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92503-2.json |
| 92504-0 | Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92504-0.json |
| 92505-7 | Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92505-7.json |
| 92506-5 | E Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92506-5.json |
| 92507-3 | Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92507-3.json |
| 92508-1 | Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92508-1.json |
| 92509-9 | Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92509-9.json |
| 92510-7 | Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92510-7.json |
| 92511-5 | Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92511-5.json |
| 92512-3 | Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92512-3.json |
| 92513-1 | C Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92513-1.json |
| 92514-9 | Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92514-9.json |
| 92516-4 | VS Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92516-4.json |
| 92517-2 | V Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Moleculargenetics method | ./2.16.840.1.114222.4.11.1002/92517-2.json |
| 92518-0 | U Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92518-0.json |
| 92519-8 | Sc2 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92519-8.json |
| 92520-6 | Sc1 Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92520-6.json |
| 92521-4 | S Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92521-4.json |
| 92522-2 | N Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92522-2.json |
| 92523-0 | M Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92523-0.json |
| 92524-8 | LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92524-8.json |
| 92525-5 | LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92525-5.json |
| 92526-3 | little s Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92526-3.json |
| 92527-1 | little k Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92527-1.json |
| 92528-9 | little e Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92528-9.json |
| 92529-7 | little c Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92529-7.json |
| 92530-5 | Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92530-5.json |
| 92531-3 | Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92531-3.json |
| 92532-1 | Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92532-1.json |
| 92533-9 | Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92533-9.json |
| 92534-7 | K Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92534-7.json |
| 92535-4 | Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92535-4.json |
| 92536-2 | Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92536-2.json |
| 92537-0 | Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92537-0.json |
| 92538-8 | Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92538-8.json |
| 92539-6 | Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92539-6.json |
| 92540-4 | Hemoglobin S inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92540-4.json |
| 92541-2 | Hy Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92541-2.json |
| 92542-0 | Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92542-0.json |
| 92543-8 | Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92543-8.json |
| 92544-6 | E Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92544-6.json |
| 92545-3 | Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92545-3.json |
| 92546-1 | Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92546-1.json |
| 92547-9 | Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92547-9.json |
| 92548-7 | Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92548-7.json |
| 92549-5 | Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92549-5.json |
| 92550-3 | Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92550-3.json |
| 92551-1 | C Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92551-1.json |
| 92552-9 | Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue from Donor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92552-9.json |
| 92562-8 | Physical therapy goals panel | ./2.16.840.1.114222.4.11.1002/92562-8.json |
| 92563-6 | Physical therapy health concerns panel | ./2.16.840.1.114222.4.11.1002/92563-6.json |
| 92564-4 | Physical therapy plan of care panel | ./2.16.840.1.114222.4.11.1002/92564-4.json |
| 92567-7 | CT Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region | ./2.16.840.1.114222.4.11.1002/92567-7.json |
| 92569-3 | CT Guidance for drainage and placement of chest tube of Pleural space - bilateral | ./2.16.840.1.114222.4.11.1002/92569-3.json |
| 92571-9 | CT Guidance for drainage and placement of chest tube of Pleural space - right | ./2.16.840.1.114222.4.11.1002/92571-9.json |
| 92572-7 | Sodium [Molar amount] in 24 hour Dialysis fluid | ./2.16.840.1.114222.4.11.1002/92572-7.json |
| 92577-6 | Chlamydophila pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92577-6.json |
| 92635-2 | Leukocytes [#/volume] in Buffy Coat | ./2.16.840.1.114222.4.11.1002/92635-2.json |
| 92636-0 | APOL1 inferred genotype [Identifier] in Plasma from Donor | ./2.16.840.1.114222.4.11.1002/92636-0.json |
| 92637-8 | traZODone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92637-8.json |
| 92638-6 | Sertraline [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92638-6.json |
| 92639-4 | O-nortramadol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92639-4.json |
| 92640-2 | M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92640-2.json |
| 92641-0 | diphenhydrAMINE [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92641-0.json |
| 92642-8 | Dextromethorphan [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92642-8.json |
| 92643-6 | Cotinine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92643-6.json |
| 92644-4 | Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92644-4.json |
| 92645-1 | Citalopram [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92645-1.json |
| 92646-9 | Dextromethorphan [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92646-9.json |
| 92647-7 | diphenhydrAMINE [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92647-7.json |
| 92648-5 | Gabapentin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92648-5.json |
| 92649-3 | Naloxone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92649-3.json |
| 92650-1 | PARoxetine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92650-1.json |
| 92651-9 | Pregabalin [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92651-9.json |
| 92652-7 | Sertraline [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92652-7.json |
| 92653-5 | traZODone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92653-5.json |
| 92654-3 | 9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92654-3.json |
| 92664-2 | Power of attorney and Living will | ./2.16.840.1.114222.4.11.1002/92664-2.json |
| 92665-9 | Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/92665-9.json |
| 92674-1 | CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92674-1.json |
| 92675-8 | MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92675-8.json |
| 92676-6 | MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92676-6.json |
| 92677-4 | XR Pelvis and Hip GE 4 Views | ./2.16.840.1.114222.4.11.1002/92677-4.json |
| 92678-2 | US.elastography Lung | ./2.16.840.1.114222.4.11.1002/92678-2.json |
| 92679-0 | US.elastography Lung for lesion | ./2.16.840.1.114222.4.11.1002/92679-0.json |
| 92680-8 | US.elastography Lung additional for lesion | ./2.16.840.1.114222.4.11.1002/92680-8.json |
| 92681-6 | Guidance for dilation of existing nephrostomy tract of Kidney | ./2.16.840.1.114222.4.11.1002/92681-6.json |
| 92682-4 | Guidance for dilation of existing nephrostomy tract and placement of nephrostomy tube at new site of Kidney | ./2.16.840.1.114222.4.11.1002/92682-4.json |
| 92685-7 | Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92685-7.json |
| 92686-5 | Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92686-5.json |
| 92687-3 | Giardia lamblia DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92687-3.json |
| 92688-1 | Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92688-1.json |
| 92689-9 | Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92689-9.json |
| 92690-7 | Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92690-7.json |
| 92691-5 | Astrovirus RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92691-5.json |
| 92692-3 | Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92692-3.json |
| 92693-1 | Rotavirus A RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92693-1.json |
| 92694-9 | Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92694-9.json |
| 92698-0 | Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/92698-0.json |
| 92699-8 | Candida sp DNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/92699-8.json |
| 92700-4 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe | ./2.16.840.1.114222.4.11.1002/92700-4.json |
| 92701-2 | Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92701-2.json |
| 92702-0 | Lactobacillus crispatus+jensenii + Gardnerella vaginalis + Atopobium vaginae + Bacterial Vaginosis Associated Bacteria-2 + Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92702-0.json |
| 92726-9 | 17-Hydroxyprogesterone [Mass/volume] in DBS by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/92726-9.json |
| 92727-7 | Tacrolimus [AUC] in Blood | ./2.16.840.1.114222.4.11.1002/92727-7.json |
| 92728-5 | Tacrolimus [Mass/volume] in Blood --4 hours post dose | ./2.16.840.1.114222.4.11.1002/92728-5.json |
| 92729-3 | Tacrolimus [Mass/volume] in Blood --2 hours post dose | ./2.16.840.1.114222.4.11.1002/92729-3.json |
| 92730-1 | Tacrolimus [Mass/volume] in Blood --1 hour post dose | ./2.16.840.1.114222.4.11.1002/92730-1.json |
| 92731-9 | Hepatitis C virus genotype in Serum or Plasma by Sequencing | ./2.16.840.1.114222.4.11.1002/92731-9.json |
| 92733-5 | Glecaprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92733-5.json |
| 92734-3 | Voxilaprevir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92734-3.json |
| 92735-0 | Pibrentasvir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/92735-0.json |
| 92736-8 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/92736-8.json |
| 92765-7 | Adalimumab neutralizing antibody [Titer] in Serum by Bioassay | ./2.16.840.1.114222.4.11.1002/92765-7.json |
| 92806-9 | Keratan sulfate/Creatinine [Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/92806-9.json |
| 92810-1 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/92810-1.json |
| 92812-7 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/92812-7.json |
| 92813-5 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/92813-5.json |
| 92814-3 | Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/92814-3.json |
| 92816-8 | Phencyclidine [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92816-8.json |
| 92817-6 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/92817-6.json |
| 92818-4 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/92818-4.json |
| 92819-2 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucagon | ./2.16.840.1.114222.4.11.1002/92819-2.json |
| 92825-9 | Renin [Units/volume] in Plasma --upright | ./2.16.840.1.114222.4.11.1002/92825-9.json |
| 92826-7 | Renin [Units/volume] in Plasma --supine | ./2.16.840.1.114222.4.11.1002/92826-7.json |
| 92827-5 | Mycobacterium tuberculosis complex species identified in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/92827-5.json |
| 92828-3 | Adenovirus B+E DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92828-3.json |
| 92840-8 | Emergency operations standard operating procedure Document | ./2.16.840.1.114222.4.11.1002/92840-8.json |
| 92841-6 | Countermeasure report | ./2.16.840.1.114222.4.11.1002/92841-6.json |
| 92842-4 | Situational report | ./2.16.840.1.114222.4.11.1002/92842-4.json |
| 92843-2 | FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92843-2.json |
| 92844-0 | FLT3 gene internal tandem duplication/Normal [Ratio] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92844-0.json |
| 92845-7 | Insulin resistance score in Serum by Calculated.CardioIQ | ./2.16.840.1.114222.4.11.1002/92845-7.json |
| 92846-5 | Ambulatory blood pressure monitor study | ./2.16.840.1.114222.4.11.1002/92846-5.json |
| 92848-1 | Varicella zoster virus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92848-1.json |
| 92854-9 | Adenovirus DNA [#/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92854-9.json |
| 92855-6 | Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92855-6.json |
| 92856-4 | Bordetella parapertussis IS1001 DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92856-4.json |
| 92857-2 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92857-2.json |
| 92858-0 | Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92858-0.json |
| 92870-5 | Herpes simplex virus 1 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92870-5.json |
| 92871-3 | Herpes simplex virus 1 DNA [Presence] in Skin by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92871-3.json |
| 92872-1 | Herpes simplex virus 1 DNA [Presence] in Anogenital by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92872-1.json |
| 92873-9 | Herpes simplex virus 2 DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92873-9.json |
| 92874-7 | Herpes simplex virus 2 DNA [Presence] in Skin by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92874-7.json |
| 92875-4 | Herpes simplex virus 2 DNA [Presence] in Anogenital by NAA with probedetection | ./2.16.840.1.114222.4.11.1002/92875-4.json |
| 92878-8 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92878-8.json |
| 92879-6 | Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92879-6.json |
| 92883-8 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92883-8.json |
| 92884-6 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92884-6.json |
| 92885-3 | Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92885-3.json |
| 92886-1 | Torque teno virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92886-1.json |
| 92887-9 | Torque teno virus DNA [#/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92887-9.json |
| 92888-7 | Varicella zoster virus DNA [Presence] in Skin by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/92888-7.json |
| 92896-0 | Aldosterone [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/92896-0.json |
| 92897-8 | Aldosterone [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/92897-8.json |
| 92899-4 | Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing | ./2.16.840.1.114222.4.11.1002/92899-4.json |
| 92900-0 | Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing | ./2.16.840.1.114222.4.11.1002/92900-0.json |
| 92902-6 | Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing | ./2.16.840.1.114222.4.11.1002/92902-6.json |
| 92903-4 | Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing | ./2.16.840.1.114222.4.11.1002/92903-4.json |
| 92904-2 | N-nortramadol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/92904-2.json |
| 92905-9 | Chromosome 7 copy number/nucleus in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/92905-9.json |
| 92906-7 | MET gene copy number/nucleus in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/92906-7.json |
| 92909-1 | Aerodigestive medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/92909-1.json |
| 92910-9 | Spinal surgery Consult note | ./2.16.840.1.114222.4.11.1002/92910-9.json |
| 92911-7 | Eating disorders Outpatient Note | ./2.16.840.1.114222.4.11.1002/92911-7.json |
| 92912-5 | Eating disorders Consult note | ./2.16.840.1.114222.4.11.1002/92912-5.json |
| 92913-3 | Immunology Telehealth Note | ./2.16.840.1.114222.4.11.1002/92913-3.json |
| 92914-1 | Immunology Outpatient Note | ./2.16.840.1.114222.4.11.1002/92914-1.json |
| 92915-8 | Immunology Consult note | ./2.16.840.1.114222.4.11.1002/92915-8.json |
| 92916-6 | CT Guidance for aspiration of Retroperitoneum | ./2.16.840.1.114222.4.11.1002/92916-6.json |
| 92917-4 | CT Guidance for aspiration of Kidney - right | ./2.16.840.1.114222.4.11.1002/92917-4.json |
| 92918-2 | CT Guidance for aspiration of Kidney - left | ./2.16.840.1.114222.4.11.1002/92918-2.json |
| 92919-0 | CT Guidance for 2 levels injection of Spine Lumbar and Sacrum | ./2.16.840.1.114222.4.11.1002/92919-0.json |
| 92920-8 | CT Guidance for 1 level injection of Spine Lumbar and Sacrum | ./2.16.840.1.114222.4.11.1002/92920-8.json |
| 92921-6 | CT Guidance for 1 level injection of Cervical and thoracic spine | ./2.16.840.1.114222.4.11.1002/92921-6.json |
| 92922-4 | CT Guidance for intrathecal injection of Lumbar spine | ./2.16.840.1.114222.4.11.1002/92922-4.json |
| 92923-2 | CT Guidance for aspiration of Kidney | ./2.16.840.1.114222.4.11.1002/92923-2.json |
| 92924-0 | CT Guidance for aspiration of Abdomen | ./2.16.840.1.114222.4.11.1002/92924-0.json |
| 92925-7 | CT Guidance for injection of Spine cervical and thoracic epidural space | ./2.16.840.1.114222.4.11.1002/92925-7.json |
| 92926-5 | CT Guidance for radiation treatment of Unspecified body region-- WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/92926-5.json |
| 92927-3 | PET+CT Brain for tau protein | ./2.16.840.1.114222.4.11.1002/92927-3.json |
| 92928-1 | CT Guidance for injection of Spine lumbar and Sacrum epidural space | ./2.16.840.1.114222.4.11.1002/92928-1.json |
| 92930-7 | LPA gene.c.3947+467T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92930-7.json |
| 92931-5 | LPA gene.c.5673A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92931-5.json |
| 92932-3 | KIF6 gene.c.2155T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92932-3.json |
| 92933-1 | 9p21 g.22125503G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92933-1.json |
| 92934-9 | 9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92934-9.json |
| 92935-6 | 4q25 g.111720761T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92935-6.json |
| 92936-4 | 4q25 g.111710169C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/92936-4.json |
| 92937-2 | Eslicarbazepine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/92937-2.json |
| 92942-2 | Poison control record Document | ./2.16.840.1.114222.4.11.1002/92942-2.json |
| 92946-3 | Streptococcus pyogenes DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92946-3.json |
| 92947-1 | Streptococcus pyogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92947-1.json |
| 92948-9 | Streptococcus pneumoniae DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92948-9.json |
| 92949-7 | Streptococcus pneumoniae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92949-7.json |
| 92950-5 | Streptococcus agalactiae DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92950-5.json |
| 92951-3 | Streptococcus agalactiae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92951-3.json |
| 92952-1 | Staphylococcus aureus DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92952-1.json |
| 92953-9 | Staphylococcus aureus DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92953-9.json |
| 92954-7 | Serratia marcescens DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92954-7.json |
| 92955-4 | Serratia marcescens DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92955-4.json |
| 92956-2 | Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92956-2.json |
| 92957-0 | Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92957-0.json |
| 92958-8 | Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92958-8.json |
| 92959-6 | Pseudomonas aeruginosa DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92959-6.json |
| 92960-4 | Pseudomonas aeruginosa DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92960-4.json |
| 92961-2 | Proteus sp DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92961-2.json |
| 92962-0 | Proteus sp DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92962-0.json |
| 92963-8 | Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92963-8.json |
| 92964-6 | Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92964-6.json |
| 92965-3 | Moraxella catarrhalis DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92965-3.json |
| 92966-1 | Moraxella catarrhalis DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92966-1.json |
| 92967-9 | Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92967-9.json |
| 92968-7 | Methicillin resistance mecA+mecC genes [Presence] in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/92968-7.json |
| 92969-5 | Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92969-5.json |
| 92970-3 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92970-3.json |
| 92971-1 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92971-1.json |
| 92972-9 | Klebsiella oxytoca DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92972-9.json |
| 92973-7 | Klebsiella oxytoca DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92973-7.json |
| 92974-5 | Klebsiella aerogenes DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92974-5.json |
| 92975-2 | Klebsiella aerogenes DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92975-2.json |
| 92976-0 | Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92976-0.json |
| 92977-8 | Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92977-8.json |
| 92978-6 | Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92978-6.json |
| 92979-4 | Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92979-4.json |
| 92980-2 | Haemophilus influenzae DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92980-2.json |
| 92981-0 | Haemophilus influenzae DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92981-0.json |
| 92982-8 | Escherichia coli DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92982-8.json |
| 92983-6 | Escherichia coli DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92983-6.json |
| 92984-4 | Enterobacter cloacae complex DNA [NCncRange] in Sputum by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92984-4.json |
| 92985-1 | Enterobacter cloacae complex DNA [NCncRange] in Bronchoalveolar lavage by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92985-1.json |
| 92986-9 | Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92986-9.json |
| 92987-7 | Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92987-7.json |
| 92988-5 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92988-5.json |
| 92989-3 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/92989-3.json |
| 92990-1 | F10 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92990-1.json |
| 92991-9 | F13A1 and F13B gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92991-9.json |
| 92992-7 | FGA, FGB, and FGG gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92992-7.json |
| 92993-5 | PROCR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92993-5.json |
| 92994-3 | PROS1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92994-3.json |
| 92995-0 | THBD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/92995-0.json |
| 93023-0 | Pharmacist Plan of care note | ./2.16.840.1.114222.4.11.1002/93023-0.json |
| 93024-8 | Pharmacist Consult note | ./2.16.840.1.114222.4.11.1002/93024-8.json |
| 93036-2 | Cleft and Craniofacial Outpatient Note | ./2.16.840.1.114222.4.11.1002/93036-2.json |
| 93037-0 | Portable medical order form | ./2.16.840.1.114222.4.11.1002/93037-0.json |
| 93083-4 | Revised Prenatal Distress Questionnaire (NuPDQ) - Concurrent Self-Administered Version | ./2.16.840.1.114222.4.11.1002/93083-4.json |
| 93084-2 | NuMoM2b Difficulties in Pregnancy form [NuMoM2b] | ./2.16.840.1.114222.4.11.1002/93084-2.json |
| 93085-9 | Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93085-9.json |
| 93086-7 | Obstetrics Emergency procedure note | ./2.16.840.1.114222.4.11.1002/93086-7.json |
| 9308-8 | 2,4-Dinitrophenylhydrazine reacting substances [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9308-8.json |
| 93088-3 | Quality of Working Life Questionnaire for Cancer Survivors [Quality of Working Life Questionnaire for Cancer Survivors] | ./2.16.840.1.114222.4.11.1002/93088-3.json |
| 9309-6 | Ammonia [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9309-6.json |
| 9310-4 | Androstenedione [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9310-4.json |
| 9311-2 | Albuterol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9311-2.json |
| 9312-0 | Aminocaproate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9312-0.json |
| 93121-2 | Gabapentin [Presence] in Tissue by Screen method | ./2.16.840.1.114222.4.11.1002/93121-2.json |
| 93126-1 | Comparison with previous results | ./2.16.840.1.114222.4.11.1002/93126-1.json |
| 9313-8 | Butorphanol [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/9313-8.json |
| 9314-6 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9314-6.json |
| 93149-3 | PhenX - bone age protocol 220301 | ./2.16.840.1.114222.4.11.1002/93149-3.json |
| 93150-1 | Burn management procedure note | ./2.16.840.1.114222.4.11.1002/93150-1.json |
| 93151-9 | Radiology Team Conference note | ./2.16.840.1.114222.4.11.1002/93151-9.json |
| 93152-7 | Radiology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/93152-7.json |
| 9315-3 | Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9315-3.json |
| 9316-1 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9316-1.json |
| 9318-7 | Albumin/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/9318-7.json |
| 93187-3 | Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel | ./2.16.840.1.114222.4.11.1002/93187-3.json |
| 93193-1 | TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93193-1.json |
| 93199-8 | DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93199-8.json |
| 93200-4 | Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93200-4.json |
| 93201-2 | Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93201-2.json |
| 9321-1 | Calcium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/9321-1.json |
| 93227-7 | Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/93227-7.json |
| 93232-7 | Imipenem+Relebactam [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/93232-7.json |
| 93233-5 | Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93233-5.json |
| 93241-8 | US.doppler Unspecified body region | ./2.16.840.1.114222.4.11.1002/93241-8.json |
| 93242-6 | 11-Ketotestosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93242-6.json |
| 93243-4 | 11-Hydroxytestosterone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93243-4.json |
| 93244-2 | Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93244-2.json |
| 9326-0 | Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9326-0.json |
| 9327-8 | Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9327-8.json |
| 9328-6 | Carbidopa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9328-6.json |
| 9329-4 | Basement membrane Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9329-4.json |
| 9330-2 | Benzene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9330-2.json |
| 9331-0 | Boron [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9331-0.json |
| 93323-4 | Tauroursodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93323-4.json |
| 93324-2 | Taurolithocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93324-2.json |
| 93325-9 | Taurohyodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93325-9.json |
| 93326-7 | Taurodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93326-7.json |
| 93327-5 | Taurocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93327-5.json |
| 9332-8 | Carbon tetrachloride [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9332-8.json |
| 93328-3 | Taurochenodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93328-3.json |
| 93329-1 | Hyodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93329-1.json |
| 93330-9 | Glycoursodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93330-9.json |
| 93331-7 | Glycolithocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93331-7.json |
| 93332-5 | Glycohyodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93332-5.json |
| 93333-3 | Glycodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93333-3.json |
| 93334-1 | Glycocholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93334-1.json |
| 93335-8 | Glycochenodeoxycholate [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93335-8.json |
| 9333-6 | Chloroform [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9333-6.json |
| 93336-6 | Bile acid [Moles/time] in 48 hour Stool | ./2.16.840.1.114222.4.11.1002/93336-6.json |
| 93337-4 | Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool | ./2.16.840.1.114222.4.11.1002/93337-4.json |
| 93339-0 | THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93339-0.json |
| 93340-8 | PhenX - complete blood count protocol 220501 | ./2.16.840.1.114222.4.11.1002/93340-8.json |
| 9334-4 | Methanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9334-4.json |
| 93351-5 | HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/93351-5.json |
| 93369-7 | Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93369-7.json |
| 93371-3 | von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/93371-3.json |
| 93372-1 | FDA product label Indexing - national clinical trial number | ./2.16.840.1.114222.4.11.1002/93372-1.json |
| 9338-5 | Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9338-5.json |
| 93408-3 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L | ./2.16.840.1.114222.4.11.1002/93408-3.json |
| 93409-1 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L | ./2.16.840.1.114222.4.11.1002/93409-1.json |
| 93410-9 | Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL | ./2.16.840.1.114222.4.11.1002/93410-9.json |
| 93412-5 | SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93412-5.json |
| 93413-3 | Mechanical circulatory support Consultation note | ./2.16.840.1.114222.4.11.1002/93413-3.json |
| 9341-9 | Cerebroside sulfatase [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9341-9.json |
| 93420-8 | APOA1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93420-8.json |
| 93421-6 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93421-6.json |
| 93422-4 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93422-4.json |
| 93423-2 | Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93423-2.json |
| 93424-0 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93424-0.json |
| 93425-7 | GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93425-7.json |
| 93426-5 | GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93426-5.json |
| 9342-7 | Cholesterol [Percentile] | ./2.16.840.1.114222.4.11.1002/9342-7.json |
| 93427-3 | GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93427-3.json |
| 93428-1 | GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93428-1.json |
| 93429-9 | Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/93429-9.json |
| 93430-7 | Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93430-7.json |
| 93431-5 | Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/93431-5.json |
| 93432-3 | Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay | ./2.16.840.1.114222.4.11.1002/93432-3.json |
| 93433-1 | Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion | ./2.16.840.1.114222.4.11.1002/93433-1.json |
| 93434-9 | Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion | ./2.16.840.1.114222.4.11.1002/93434-9.json |
| 93435-6 | Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion | ./2.16.840.1.114222.4.11.1002/93435-6.json |
| 93436-4 | Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion | ./2.16.840.1.114222.4.11.1002/93436-4.json |
| 93437-2 | Lurasidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93437-2.json |
| 93438-0 | Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/93438-0.json |
| 93439-8 | Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/93439-8.json |
| 93442-2 | Advance directive document format | ./2.16.840.1.114222.4.11.1002/93442-2.json |
| 93450-5 | Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/93450-5.json |
| 93451-3 | Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93451-3.json |
| 93452-1 | W-19 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93452-1.json |
| 93453-9 | W-15 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93453-9.json |
| 93454-7 | W-18 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93454-7.json |
| 93455-4 | IC-26 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93455-4.json |
| 93456-2 | MT-45 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93456-2.json |
| 93457-0 | AH-8529 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93457-0.json |
| 93458-8 | AH-8533 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93458-8.json |
| 93459-6 | U-47700 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93459-6.json |
| 93460-4 | AH-7921 [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93460-4.json |
| 93461-2 | 4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93461-2.json |
| 93462-0 | Norcarfentanil [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93462-0.json |
| 93463-8 | Ocfentanil [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93463-8.json |
| 93464-6 | p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93464-6.json |
| 93465-3 | 3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93465-3.json |
| 93466-1 | Valerylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93466-1.json |
| 93467-9 | Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93467-9.json |
| 93468-7 | Acrylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93468-7.json |
| 93469-5 | 4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93469-5.json |
| 93470-3 | Furanylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93470-3.json |
| 93471-1 | Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93471-1.json |
| 93472-9 | 4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93472-9.json |
| 93473-7 | Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93473-7.json |
| 9347-6 | pH combined acid of Gastric fluid | ./2.16.840.1.114222.4.11.1002/9347-6.json |
| 93476-0 | Busulfan [Area under the curve] in Plasma | ./2.16.840.1.114222.4.11.1002/93476-0.json |
| 9348-4 | pH free acid of Gastric fluid | ./2.16.840.1.114222.4.11.1002/9348-4.json |
| 93488-5 | Guanidinoacetate [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/93488-5.json |
| 93489-3 | AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93489-3.json |
| 93490-1 | AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93490-1.json |
| 93491-9 | AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93491-9.json |
| 9349-2 | pH total acid of Gastric fluid | ./2.16.840.1.114222.4.11.1002/9349-2.json |
| 93492-7 | AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93492-7.json |
| 93493-5 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93493-5.json |
| 93494-3 | Buprenorphine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/93494-3.json |
| 93495-0 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/93495-0.json |
| 93496-8 | Nortriptyline [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/93496-8.json |
| 93498-4 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93498-4.json |
| 93499-2 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93499-2.json |
| 9350-0 | Sulfhydryls [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9350-0.json |
| 93500-7 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93500-7.json |
| 93501-5 | Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93501-5.json |
| 93502-3 | NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93502-3.json |
| 93503-1 | NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93503-1.json |
| 93504-9 | Cholesterol crystals [Presence] in Stone by X-ray diffraction | ./2.16.840.1.114222.4.11.1002/93504-9.json |
| 93505-6 | Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93505-6.json |
| 93506-4 | Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93506-4.json |
| 93507-2 | Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93507-2.json |
| 93508-0 | Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93508-0.json |
| 93509-8 | Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93509-8.json |
| 93510-6 | Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93510-6.json |
| 9351-8 | ALPRAZolam [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9351-8.json |
| 9352-6 | Amphetamines [Mass/mass] in Hair | ./2.16.840.1.114222.4.11.1002/9352-6.json |
| 9353-4 | Baclofen [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9353-4.json |
| 9354-2 | Benztropine [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9354-2.json |
| 9355-9 | Bumetanide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9355-9.json |
| 9356-7 | busPIRone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9356-7.json |
| 9357-5 | Disulfiram [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9357-5.json |
| 9358-3 | Lithium [Mass/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/9358-3.json |
| 9359-1 | Tacrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9359-1.json |
| 93603-9 | CT Head and Cervical spine WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/93603-9.json |
| 93604-7 | US.doppler Lower extremity arteries+veins - bilateral | ./2.16.840.1.114222.4.11.1002/93604-7.json |
| 93605-4 | XR Skull to Coccyx 2 or 3 Views | ./2.16.840.1.114222.4.11.1002/93605-4.json |
| 93606-2 | XR Skull to Coccyx 4 or 5 Views | ./2.16.840.1.114222.4.11.1002/93606-2.json |
| 93607-0 | XR Skull to Coccyx GE 6 Views | ./2.16.840.1.114222.4.11.1002/93607-0.json |
| 9360-9 | Bartonella quintana IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9360-9.json |
| 9361-7 | Bartonella quintana IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9361-7.json |
| 9362-5 | Bordetella pertussis IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9362-5.json |
| 9363-3 | Bordetella pertussis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9363-3.json |
| 9364-1 | Bordetella pertussis IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9364-1.json |
| 9365-8 | Clostridioides difficile Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9365-8.json |
| 9366-6 | Arsenic [Mass/mass] in Specimen | ./2.16.840.1.114222.4.11.1002/9366-6.json |
| 9367-4 | Borate [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9367-4.json |
| 9368-2 | Boron [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9368-2.json |
| 93686-4 | Psychosine [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/93686-4.json |
| 93687-2 | Psychosine [Moles/mass] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93687-2.json |
| 93688-0 | Psychosine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/93688-0.json |
| 93689-8 | THSD7A IgG Ab [Titer] in Serum or Plasma by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93689-8.json |
| 9369-0 | Camphor [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9369-0.json |
| 93690-6 | BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/93690-6.json |
| 93702-9 | Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL | ./2.16.840.1.114222.4.11.1002/93702-9.json |
| 93706-0 | Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/93706-0.json |
| 93712-8 | Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/93712-8.json |
| 93713-6 | Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/93713-6.json |
| 93714-4 | Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay | ./2.16.840.1.114222.4.11.1002/93714-4.json |
| 9371-6 | Chlorpyrifos [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9371-6.json |
| 93716-9 | Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93716-9.json |
| 93717-7 | Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93717-7.json |
| 93720-1 | traMADol [Mass/mass] in Meconium by Confirmatory method | ./2.16.840.1.114222.4.11.1002/93720-1.json |
| 93723-5 | FDA product label Indexing - drug interactions | ./2.16.840.1.114222.4.11.1002/93723-5.json |
| 9372-4 | Cotinine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9372-4.json |
| 93724-3 | Keratan sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93724-3.json |
| 93725-0 | Heparan sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93725-0.json |
| 93727-6 | Insulin [Moles/volume] in Serum or Plasma --post meal | ./2.16.840.1.114222.4.11.1002/93727-6.json |
| 93728-4 | Copper [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/93728-4.json |
| 93729-2 | Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/93729-2.json |
| 93730-0 | Testosterone [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/93730-0.json |
| 93731-8 | Androstenedione [Moles/volume] in Amniotic fluid | ./2.16.840.1.114222.4.11.1002/93731-8.json |
| 93732-6 | IgE [Units/volume] in Tear | ./2.16.840.1.114222.4.11.1002/93732-6.json |
| 93733-4 | Creatinine [Mass/time] in 5 hour Urine | ./2.16.840.1.114222.4.11.1002/93733-4.json |
| 93734-2 | Creatinine [Moles/time] in 5 hour Urine | ./2.16.840.1.114222.4.11.1002/93734-2.json |
| 93735-9 | Creatinine [Moles/volume] in 5 hour Urine | ./2.16.840.1.114222.4.11.1002/93735-9.json |
| 93737-5 | German turnip IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93737-5.json |
| 93738-3 | Cooked cauliflower IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93738-3.json |
| 93739-1 | Red cabbage IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93739-1.json |
| 93740-9 | Chives IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93740-9.json |
| 93741-7 | Balm IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93741-7.json |
| 93745-8 | HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/93745-8.json |
| 93746-6 | Protein catabolic rate based on 24 hour Urine [Calculated] | ./2.16.840.1.114222.4.11.1002/93746-6.json |
| 93747-4 | Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93747-4.json |
| 93748-2 | Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93748-2.json |
| 93749-0 | Mumps virus N gene [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93749-0.json |
| 93752-4 | Atypical porcine pestivirus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93752-4.json |
| 93753-2 | Porcine cytomegalovirus DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93753-2.json |
| 93754-0 | Encephalomyocarditis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93754-0.json |
| 93755-7 | Porcine circovirus type 3 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93755-7.json |
| 93756-5 | Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/93756-5.json |
| 93757-3 | Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/93757-3.json |
| 93759-9 | Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/93759-9.json |
| 93760-7 | Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/93760-7.json |
| 93761-5 | Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/93761-5.json |
| 93762-3 | Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/93762-3.json |
| 93763-1 | Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/93763-1.json |
| 93764-9 | Porcine astrovirus type 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93764-9.json |
| 93765-6 | Trimethylamine N-oxide [Molar amount] in Serum | ./2.16.840.1.114222.4.11.1002/93765-6.json |
| 93766-4 | Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/93766-4.json |
| 93768-0 | Acarboxyprothrombin [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93768-0.json |
| 93769-8 | Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93769-8.json |
| 93770-6 | Ceramide trihexoside [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/93770-6.json |
| 93771-4 | Calprotectin [Mass/volume] in Synovial fluid | ./2.16.840.1.114222.4.11.1002/93771-4.json |
| 93772-2 | 4-hydroxyglutamate/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/93772-2.json |
| 93773-0 | 11-Deoxycortisol [Moles/volume] in Saliva (oral fluid) | ./2.16.840.1.114222.4.11.1002/93773-0.json |
| 93776-3 | Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/93776-3.json |
| 93777-1 | Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/93777-1.json |
| 93778-9 | Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe | ./2.16.840.1.114222.4.11.1002/93778-9.json |
| 93780-5 | Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue | ./2.16.840.1.114222.4.11.1002/93780-5.json |
| 93781-3 | Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue | ./2.16.840.1.114222.4.11.1002/93781-3.json |
| 93787-0 | Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/93787-0.json |
| 93788-8 | F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/93788-8.json |
| 93790-4 | Delafloxacin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/93790-4.json |
| 93791-2 | Glucose [Mass/volume] mean in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93791-2.json |
| 93793-8 | Insulin [Units/volume] mean in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93793-8.json |
| 93795-3 | NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93795-3.json |
| 93796-1 | MYCN gene amplification in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93796-1.json |
| 93806-8 | EWSR1 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93806-8.json |
| 93807-6 | FOXO1 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93807-6.json |
| 93808-4 | MDM2 gene amplification in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93808-4.json |
| 93809-2 | MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93809-2.json |
| 93810-0 | SS18 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/93810-0.json |
| 93811-8 | F9 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93811-8.json |
| 93813-4 | NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93813-4.json |
| 93814-2 | SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93814-2.json |
| 9381-5 | Pyridinoline [Mass/time] in 2 hour Urine | ./2.16.840.1.114222.4.11.1002/9381-5.json |
| 93815-9 | PROC gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93815-9.json |
| 9383-1 | 9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9383-1.json |
| 93834-0 | Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/93834-0.json |
| 93835-7 | Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93835-7.json |
| 93836-5 | Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93836-5.json |
| 93837-3 | Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/93837-3.json |
| 93838-1 | Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/93838-1.json |
| 93839-9 | Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/93839-9.json |
| 93840-7 | Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93840-7.json |
| 93841-5 | Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/93841-5.json |
| 93842-3 | HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93842-3.json |
| 93843-1 | Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/93843-1.json |
| 93844-9 | UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/93844-9.json |
| 93845-6 | UGT1A1 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/93845-6.json |
| 93846-4 | Hemoglobin [Moles/volume] in Venous blood | ./2.16.840.1.114222.4.11.1002/93846-4.json |
| 93847-2 | Aspergillus oryzae IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/93847-2.json |
| 9384-9 | Benztropine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9384-9.json |
| 93850-6 | Pretomanid [Susceptibility] | ./2.16.840.1.114222.4.11.1002/93850-6.json |
| 93851-4 | Delamanid [Susceptibility] | ./2.16.840.1.114222.4.11.1002/93851-4.json |
| 93852-2 | N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine | ./2.16.840.1.114222.4.11.1002/93852-2.json |
| 93853-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine | ./2.16.840.1.114222.4.11.1002/93853-0.json |
| 93854-8 | Gadolinium/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/93854-8.json |
| 93855-5 | Iothalamate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/93855-5.json |
| 9385-6 | Levodopa [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9385-6.json |
| 93856-3 | Enterovirus RNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/93856-3.json |
| 9386-4 | NIFEdipine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9386-4.json |
| 93865-4 | General medicine Team Conference note | ./2.16.840.1.114222.4.11.1002/93865-4.json |
| 93866-2 | C4 nephritic factor [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93866-2.json |
| 93867-0 | GABABR Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93867-0.json |
| 93868-8 | AMPAR2 Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93868-8.json |
| 93869-6 | AMPAR1 Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93869-6.json |
| 93870-4 | NMDAR subunit 1 Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/93870-4.json |
| 9387-2 | Procyclidine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9387-2.json |
| 93873-8 | Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93873-8.json |
| 93874-6 | Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/93874-6.json |
| 93875-3 | Phosphohistone H3 [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/93875-3.json |
| 93877-9 | N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma | ./2.16.840.1.114222.4.11.1002/93877-9.json |
| 93878-7 | N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma | ./2.16.840.1.114222.4.11.1002/93878-7.json |
| 93879-5 | N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma | ./2.16.840.1.114222.4.11.1002/93879-5.json |
| 9388-0 | Propylthiouracil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9388-0.json |
| 93880-3 | N-Nervonoylsphingosine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/93880-3.json |
| 93881-1 | N-Stearoylsphingosine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/93881-1.json |
| 93882-9 | N-Palmitoylsphingosine [Moles/volume] in Plasma | ./2.16.840.1.114222.4.11.1002/93882-9.json |
| 93892-8 | Addiction medicine Progress note | ./2.16.840.1.114222.4.11.1002/93892-8.json |
| 93893-6 | Orthopaedic surgery Team Conference note | ./2.16.840.1.114222.4.11.1002/93893-6.json |
| 93894-4 | Hematology Team Conference note | ./2.16.840.1.114222.4.11.1002/93894-4.json |
| 93895-1 | Gynecologic oncology Team Conference note | ./2.16.840.1.114222.4.11.1002/93895-1.json |
| 93896-9 | Gynecologic oncology Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/93896-9.json |
| 93897-7 | Maternal and fetal medicine Progress note | ./2.16.840.1.114222.4.11.1002/93897-7.json |
| 9389-8 | Pseudoephedrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9389-8.json |
| 93898-5 | Family medicine Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/93898-5.json |
| 93899-3 | Psychiatry Letter | ./2.16.840.1.114222.4.11.1002/93899-3.json |
| 93900-9 | Healthcare navigator Progress note | ./2.16.840.1.114222.4.11.1002/93900-9.json |
| 93901-7 | Healthcare navigator Telephone encounter Note | ./2.16.840.1.114222.4.11.1002/93901-7.json |
| 93902-5 | Healthcare navigator Plan of care note | ./2.16.840.1.114222.4.11.1002/93902-5.json |
| 93903-3 | Healthcare navigator Discharge summary | ./2.16.840.1.114222.4.11.1002/93903-3.json |
| 93905-8 | ABO group [Type] in Blood--during infancy | ./2.16.840.1.114222.4.11.1002/93905-8.json |
| 9390-6 | Pyridostigmine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9390-6.json |
| 93906-6 | ABO and Rh group [Type] in Blood--during infancy | ./2.16.840.1.114222.4.11.1002/93906-6.json |
| 93907-4 | Lu 20 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93907-4.json |
| 93908-2 | Au sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93908-2.json |
| 93909-0 | Jk3 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93909-0.json |
| 93910-8 | Fy3 Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93910-8.json |
| 93911-6 | little cE Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93911-6.json |
| 93912-4 | CE Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93912-4.json |
| 93913-2 | VS Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93913-2.json |
| 9391-4 | Quazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9391-4.json |
| 93917-3 | K Ag [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/93917-3.json |
| 93918-1 | little e Ag [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/93918-1.json |
| 93919-9 | little c Ag [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/93919-9.json |
| 93920-7 | E Ag [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/93920-7.json |
| 93921-5 | C Ag [Presence] on Red Blood Cells --after transfusion reaction | ./2.16.840.1.114222.4.11.1002/93921-5.json |
| 9392-2 | Quinethazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9392-2.json |
| 93924-9 | K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93924-9.json |
| 93925-6 | little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93925-6.json |
| 93926-4 | little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93926-4.json |
| 93927-2 | E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93927-2.json |
| 93928-0 | C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93928-0.json |
| 9393-0 | risperiDONE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9393-0.json |
| 93930-6 | D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93930-6.json |
| 93931-4 | ABO group [Type] in Blood--post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93931-4.json |
| 93932-2 | ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant | ./2.16.840.1.114222.4.11.1002/93932-2.json |
| 93934-8 | K Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93934-8.json |
| 93935-5 | little e Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93935-5.json |
| 93936-3 | little c Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93936-3.json |
| 93937-1 | E Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93937-1.json |
| 93938-9 | C Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93938-9.json |
| 93940-5 | D Ag [Presence] on Red Blood Cells --during infancy | ./2.16.840.1.114222.4.11.1002/93940-5.json |
| 93942-1 | K Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93942-1.json |
| 93943-9 | little e Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93943-9.json |
| 93944-7 | little c Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93944-7.json |
| 93945-4 | E Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93945-4.json |
| 93946-2 | C Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93946-2.json |
| 9394-8 | risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9394-8.json |
| 93948-8 | D Ag [Presence] in Cord red blood cells | ./2.16.840.1.114222.4.11.1002/93948-8.json |
| 93950-4 | D variant Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/93950-4.json |
| 93954-6 | Wound, Ostomy, and Continence Care Outpatient Note | ./2.16.840.1.114222.4.11.1002/93954-6.json |
| 9395-5 | SUFentanil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9395-5.json |
| 93955-3 | Wound, Ostomy, and Continence Care Consult note | ./2.16.840.1.114222.4.11.1002/93955-3.json |
| 93956-1 | Heart failure+Transplant cardiology Letter | ./2.16.840.1.114222.4.11.1002/93956-1.json |
| 93957-9 | Developmental-behavioral pediatrics Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93957-9.json |
| 93958-7 | Eating disorders Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93958-7.json |
| 93959-5 | Heart failure+Transplant cardiology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93959-5.json |
| 93960-3 | Immunology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93960-3.json |
| 93961-1 | Integrative medicine Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93961-1.json |
| 93962-9 | Nephrology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93962-9.json |
| 9396-3 | SUFentanil [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9396-3.json |
| 93963-7 | Pediatrics Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93963-7.json |
| 93964-5 | Pharmacogenomics Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93964-5.json |
| 93965-2 | Physical medicine and rehab Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93965-2.json |
| 93966-0 | Plastic surgery Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93966-0.json |
| 93967-8 | Psychiatry Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93967-8.json |
| 93968-6 | Psychology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93968-6.json |
| 93969-4 | Trauma Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93969-4.json |
| 93970-2 | Wound, Ostomy, and Continence Care Diagnostic study note | ./2.16.840.1.114222.4.11.1002/93970-2.json |
| 93971-0 | Elevation climbed [Length/Time] 24 hour | ./2.16.840.1.114222.4.11.1002/93971-0.json |
| 93972-8 | Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93972-8.json |
| 93973-6 | Iohexol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/93973-6.json |
| 93974-4 | Iohexol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93974-4.json |
| 93977-7 | Complement C2.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93977-7.json |
| 93978-5 | Complement C4.functional [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93978-5.json |
| 93979-3 | Chikungunya virus IgG Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93979-3.json |
| 93980-1 | Iothalamate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/93980-1.json |
| 9398-9 | Reticulin Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9398-9.json |
| 9399-7 | Ribonucleoprotein extractable nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9399-7.json |
| 9400-3 | Platinum [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9400-3.json |
| 9401-1 | Silicon [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9401-1.json |
| 94015-5 | Mental health screening report | ./2.16.840.1.114222.4.11.1002/94015-5.json |
| 94016-3 | Depression screening report | ./2.16.840.1.114222.4.11.1002/94016-3.json |
| 94017-1 | Anxiety screening report | ./2.16.840.1.114222.4.11.1002/94017-1.json |
| 94018-9 | ADHD screening report | ./2.16.840.1.114222.4.11.1002/94018-9.json |
| 94019-7 | Bipolar screening report | ./2.16.840.1.114222.4.11.1002/94019-7.json |
| 94020-5 | Somatic symptom disorder screening report | ./2.16.840.1.114222.4.11.1002/94020-5.json |
| 94021-3 | Substance use disorder screening report | ./2.16.840.1.114222.4.11.1002/94021-3.json |
| 94040-3 | Adenovirus A+B+C+D+E DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94040-3.json |
| 9404-5 | Adenosine deaminase [Enzymatic activity/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/9404-5.json |
| 94052-8 | Mean score [PCPCM] | ./2.16.840.1.114222.4.11.1002/94052-8.json |
| 94057-7 | Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method | ./2.16.840.1.114222.4.11.1002/94057-7.json |
| 94065-0 | Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method | ./2.16.840.1.114222.4.11.1002/94065-0.json |
| 94077-5 | Tumor mutation burden [Interpretation] | ./2.16.840.1.114222.4.11.1002/94077-5.json |
| 9407-8 | Alpha 1 antitrypsin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/9407-8.json |
| 94078-3 | PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/94078-3.json |
| 94079-1 | TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/94079-1.json |
| 94080-9 | RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | ./2.16.840.1.114222.4.11.1002/94080-9.json |
| 9408-6 | Aminobenzoate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9408-6.json |
| 94087-4 | Chromosome analysis in Blood or Tissue by Microarray | ./2.16.840.1.114222.4.11.1002/94087-4.json |
| 94088-2 | MR Thoracic and lumbar spine WO and W contrast | ./2.16.840.1.114222.4.11.1002/94088-2.json |
| 94089-0 | MR Chest WO and W contrast IV and MRA Chest W contrast IV | ./2.16.840.1.114222.4.11.1002/94089-0.json |
| 94091-6 | RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty | ./2.16.840.1.114222.4.11.1002/94091-6.json |
| 94093-2 | Itemized bill | ./2.16.840.1.114222.4.11.1002/94093-2.json |
| 9409-4 | Anabolic steroids [Identifier] in Urine | ./2.16.840.1.114222.4.11.1002/9409-4.json |
| 94094-0 | RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter | ./2.16.840.1.114222.4.11.1002/94094-0.json |
| 94095-7 | RFA Extremity vessels Unilateral Views W contrast IV | ./2.16.840.1.114222.4.11.1002/94095-7.json |
| 94097-3 | Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94097-3.json |
| 94098-1 | Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94098-1.json |
| 9410-2 | Histamine [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9410-2.json |
| 94102-1 | Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94102-1.json |
| 94103-9 | Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94103-9.json |
| 94104-7 | Zolpidem [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94104-7.json |
| 94105-4 | Alpha hydroxytriazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94105-4.json |
| 94106-2 | Temazepam glucuronide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94106-2.json |
| 94107-0 | Oxazepam glucuronide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94107-0.json |
| 94108-8 | 1-Hydroxymidazolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94108-8.json |
| 94109-6 | LORazepam glucuronide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94109-6.json |
| 9411-0 | Hydrocorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9411-0.json |
| 94110-4 | 2-Hydroxyethylflurazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94110-4.json |
| 94111-2 | 7-Aminoflunitrazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94111-2.json |
| 94112-0 | 7-Aminoclonazepam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94112-0.json |
| 94113-8 | Norclobazam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94113-8.json |
| 94114-6 | cloBAZam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94114-6.json |
| 94115-3 | Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94115-3.json |
| 94116-1 | ALPRAZolam [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/94116-1.json |
| 94118-7 | Medical records in response to authorization denial | ./2.16.840.1.114222.4.11.1002/94118-7.json |
| 94119-5 | Expired minute volume/Carbon dioxide production during exercise | ./2.16.840.1.114222.4.11.1002/94119-5.json |
| 94120-3 | Oxygen consumption (VO2)/Heart rate --peak during exercise | ./2.16.840.1.114222.4.11.1002/94120-3.json |
| 94121-1 | Inferior vena cava Blood pressure by US | ./2.16.840.1.114222.4.11.1002/94121-1.json |
| 94122-9 | Oxygen consumption (VO2)/Body weight [Volume Rate Content] --peak during exercise | ./2.16.840.1.114222.4.11.1002/94122-9.json |
| 94124-5 | Ventilatory threshold [Volume Rate Content] | ./2.16.840.1.114222.4.11.1002/94124-5.json |
| 94125-2 | Residual volume/Predicted by Plethysmograph body box | ./2.16.840.1.114222.4.11.1002/94125-2.json |
| 94136-9 | Controlled substance agreement | ./2.16.840.1.114222.4.11.1002/94136-9.json |
| 94149-2 | Heterophile Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/94149-2.json |
| 9415-1 | Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9415-1.json |
| 94151-8 | Bacteria.carbapenem resistant identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94151-8.json |
| 94157-5 | PhenX - age of initiation of first cigarette use - adult protocol 030703 | ./2.16.840.1.114222.4.11.1002/94157-5.json |
| 94158-3 | PhenX - ethnicity protocol 010502 | ./2.16.840.1.114222.4.11.1002/94158-3.json |
| 9416-9 | Acyclovir [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9416-9.json |
| 9417-7 | Anthraquinone [Mass/mass] in Stool | ./2.16.840.1.114222.4.11.1002/9417-7.json |
| 94183-1 | Heartland banyangvirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94183-1.json |
| 94184-9 | Yellow fever virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94184-9.json |
| 9418-5 | Hydroxybupropion [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9418-5.json |
| 94185-6 | Borrelia miyamotoi glpQ gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94185-6.json |
| 94188-0 | APC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94188-0.json |
| 94189-8 | APOA2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94189-8.json |
| 94190-6 | BPGM gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94190-6.json |
| 94191-4 | BRCA1+BRCA2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94191-4.json |
| 94192-2 | SLC25A20 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94192-2.json |
| 94193-0 | CDKN1C gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94193-0.json |
| 94194-8 | CPOX gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94194-8.json |
| 94195-5 | CPT2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94195-5.json |
| 94196-3 | CTRC gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94196-3.json |
| 94197-1 | CYP21A2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94197-1.json |
| 94198-9 | DPYD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94198-9.json |
| 94199-7 | FGA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94199-7.json |
| 94200-3 | FTCD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94200-3.json |
| 9420-1 | Entamoeba histolytica Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9420-1.json |
| 94201-1 | GNPTAB gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94201-1.json |
| 94202-9 | GRHPR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94202-9.json |
| 94203-7 | GSN gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94203-7.json |
| 94204-5 | HMBS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94204-5.json |
| 94205-2 | LYZ gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94205-2.json |
| 94206-0 | MMACHC gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94206-0.json |
| 94207-8 | MMADHC gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94207-8.json |
| 94208-6 | MLYCD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94208-6.json |
| 94209-4 | NAGLU gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94209-4.json |
| 94210-2 | ARSB gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94210-2.json |
| 94211-0 | NPC1 gene+NPC2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94211-0.json |
| 94212-8 | PKLR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94212-8.json |
| 94213-6 | PPOX gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94213-6.json |
| 94214-4 | PRKAR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94214-4.json |
| 94215-1 | PRSS1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94215-1.json |
| 94216-9 | STK11 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94216-9.json |
| 94217-7 | TP53 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94217-7.json |
| 94218-5 | UBE3A gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94218-5.json |
| 9421-9 | Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/9421-9.json |
| 94219-3 | VWF gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94219-3.json |
| 94220-1 | SPINK1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94220-1.json |
| 94221-9 | SMN1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94221-9.json |
| 94222-7 | SERPINA1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94222-7.json |
| 94223-5 | PTEN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94223-5.json |
| 94224-3 | RET gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94224-3.json |
| 94225-0 | TTR gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94225-0.json |
| 94226-8 | PKHD1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94226-8.json |
| 9422-7 | Herpes simplex virus IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9422-7.json |
| 94227-6 | AGXT gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94227-6.json |
| 94228-4 | MUTYH gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94228-4.json |
| 94229-2 | MECP2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94229-2.json |
| 94230-0 | GBA gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94230-0.json |
| 94231-8 | G6PD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94231-8.json |
| 94232-6 | FLCN gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94232-6.json |
| 94233-4 | FECH gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94233-4.json |
| 94234-2 | F8 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94234-2.json |
| 9423-5 | Nuclear Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9423-5.json |
| 94235-9 | F7 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94235-9.json |
| 94236-7 | F5 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94236-7.json |
| 94237-5 | F2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94237-5.json |
| 94238-3 | F12 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94238-3.json |
| 94239-1 | F11 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94239-1.json |
| 94240-9 | CDH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94240-9.json |
| 94241-7 | BTK gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94241-7.json |
| 94242-5 | BTD gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94242-5.json |
| 9424-3 | Intercellular substance Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9424-3.json |
| 94247-4 | Borrelia burgdorferi oppA2 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94247-4.json |
| 94248-2 | Borrelia mayonii oppA2 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94248-2.json |
| 94249-0 | Borrelia garinii+afzelii oppA2 gene [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94249-0.json |
| 9425-0 | Acetone [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9425-0.json |
| 94251-6 | Borrelia mayonii oppA2 gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94251-6.json |
| 94252-4 | Borrelia garinii+afzelii oppA2 gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94252-4.json |
| 94255-7 | Calcium [Mass/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/94255-7.json |
| 94256-5 | Magnesium [Mass/volume] in Sweat | ./2.16.840.1.114222.4.11.1002/94256-5.json |
| 94264-9 | Brucella sp Ab [Titer] in Cerebral spinal fluid by Immunocapture agglutination | ./2.16.840.1.114222.4.11.1002/94264-9.json |
| 9426-8 | Barbiturates [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9426-8.json |
| 94269-8 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --50 umol/L | ./2.16.840.1.114222.4.11.1002/94269-8.json |
| 94270-6 | Coenzyme Q10 [Moles/mass] in Leukocytes | ./2.16.840.1.114222.4.11.1002/94270-6.json |
| 94271-4 | PCA-1 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/94271-4.json |
| 94272-2 | PCA-1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94272-2.json |
| 94273-0 | Muscle specific receptor tyrosine kinase IgG Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94273-0.json |
| 94274-8 | Bedaquiline [Susceptibility] | ./2.16.840.1.114222.4.11.1002/94274-8.json |
| 94275-5 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/94275-5.json |
| 9427-6 | Barbiturates [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9427-6.json |
| 94276-3 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/94276-3.json |
| 94277-1 | Dog recombinant 6 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/94277-1.json |
| 94278-9 | Cat recombinant (rFel d) 7 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/94278-9.json |
| 94283-9 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94283-9.json |
| 9428-4 | Benzodiazepines [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9428-4.json |
| 94284-7 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94284-7.json |
| 94285-4 | Contactin-associated protein 2 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94285-4.json |
| 94286-2 | Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94286-2.json |
| 94287-0 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94287-0.json |
| 94288-8 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94288-8.json |
| 94289-6 | West Nile virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/94289-6.json |
| 94290-4 | Saint Louis encephalitis virus neutralizing antibody [Presence] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/94290-4.json |
| 94291-2 | Hydroxybupropion [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94291-2.json |
| 9429-2 | Indium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9429-2.json |
| 94292-0 | Citalopram+Escitalopram [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94292-0.json |
| 94293-8 | Citalopram+Escitalopram [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/94293-8.json |
| 94294-6 | Norcitalopram [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94294-6.json |
| 94295-3 | DULoxetine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94295-3.json |
| 94296-1 | Norfluvoxamine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94296-1.json |
| 94297-9 | Norfluvoxamine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/94297-9.json |
| 94298-7 | O-desmethylvenlafaxine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94298-7.json |
| 94299-5 | Vilazodone [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94299-5.json |
| 9430-0 | Isobutylcarbinol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9430-0.json |
| 94300-1 | Vilazodone [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/94300-1.json |
| 94301-9 | Vortioxetine [Presence] in Serum or Plasma by Screen method | ./2.16.840.1.114222.4.11.1002/94301-9.json |
| 94302-7 | Vortioxetine [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/94302-7.json |
| 94307-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 | ./2.16.840.1.114222.4.11.1002/94307-6.json |
| 94308-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 | ./2.16.840.1.114222.4.11.1002/94308-4.json |
| 94309-2 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94309-2.json |
| 94310-0 | SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3 | ./2.16.840.1.114222.4.11.1002/94310-0.json |
| 94314-2 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94314-2.json |
| 94315-9 | SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94315-9.json |
| 94316-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94316-7.json |
| 9431-8 | Isobutanol [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9431-8.json |
| 94318-3 | Medical Aid in Dying Plan of care note | ./2.16.840.1.114222.4.11.1002/94318-3.json |
| 94319-1 | Medical Aid in Dying Consult note | ./2.16.840.1.114222.4.11.1002/94319-1.json |
| 94320-9 | Medical Aid in Dying procedure note | ./2.16.840.1.114222.4.11.1002/94320-9.json |
| 94321-7 | Medical Aid in Dying Team Note | ./2.16.840.1.114222.4.11.1002/94321-7.json |
| 94323-3 | Wound, Ostomy, and Continence Care Team Conference note | ./2.16.840.1.114222.4.11.1002/94323-3.json |
| 94324-1 | Orthopaedic surgery Care management note | ./2.16.840.1.114222.4.11.1002/94324-1.json |
| 9432-6 | Isobutyl acetate [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9432-6.json |
| 94333-2 | Encephalitozoon sp 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94333-2.json |
| 9433-4 | Isoflurane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9433-4.json |
| 94334-0 | Enterocytozoon bieneusi 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94334-0.json |
| 94338-1 | Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH | ./2.16.840.1.114222.4.11.1002/94338-1.json |
| 94340-7 | Amphiphysin IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94340-7.json |
| 94341-5 | Glial nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94341-5.json |
| 9434-2 | Isopropanol [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9434-2.json |
| 94342-3 | Neuronal nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94342-3.json |
| 94343-1 | Neuronal nuclear type 2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94343-1.json |
| 94344-9 | Neuronal nuclear type 3 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94344-9.json |
| 94345-6 | Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94345-6.json |
| 94346-4 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94346-4.json |
| 94347-2 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94347-2.json |
| 94348-0 | Voltage-gated calcium channel N type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94348-0.json |
| 94349-8 | Voltage-gated calcium channel P/Q type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94349-8.json |
| 94350-6 | PCA-1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94350-6.json |
| 94351-4 | PCA-2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94351-4.json |
| 94352-2 | PCA-Tr IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94352-2.json |
| 94354-8 | Amphiphysin IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94354-8.json |
| 94355-5 | Glial nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94355-5.json |
| 94356-3 | Neuronal nuclear type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94356-3.json |
| 94357-1 | Neuronal nuclear type 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94357-1.json |
| 94358-9 | Neuronal nuclear type 3 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94358-9.json |
| 9435-9 | Isopropanol [Mass/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/9435-9.json |
| 94359-7 | Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/94359-7.json |
| 94360-5 | Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94360-5.json |
| 94361-3 | Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94361-3.json |
| 94362-1 | PCA-Tr IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94362-1.json |
| 94363-9 | PCA-1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94363-9.json |
| 94364-7 | PCA-2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94364-7.json |
| 94365-4 | Bordetella pertussis DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94365-4.json |
| 94366-2 | Streptococcus pyogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94366-2.json |
| 9436-7 | Lead [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/9436-7.json |
| 94367-0 | Streptococcus pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94367-0.json |
| 94368-8 | Streptococcus agalactiae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94368-8.json |
| 94369-6 | Staphylococcus aureus DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94369-6.json |
| 94370-4 | Serratia marcescens DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94370-4.json |
| 94371-2 | Pseudomonas aeruginosa DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94371-2.json |
| 94372-0 | Proteus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94372-0.json |
| 94373-8 | Moraxella catarrhalis DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94373-8.json |
| 94374-6 | Klebsiella pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94374-6.json |
| 9437-5 | Methylhippurate [Mass/time] in Urine | ./2.16.840.1.114222.4.11.1002/9437-5.json |
| 94375-3 | Klebsiella oxytoca DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94375-3.json |
| 94376-1 | Klebsiella aerogenes DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94376-1.json |
| 94377-9 | Haemophilus influenzae DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94377-9.json |
| 94378-7 | Escherichia coli DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94378-7.json |
| 94379-5 | Enterobacter cloacae complex DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94379-5.json |
| 94380-3 | Acinetobacter baumannii DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94380-3.json |
| 94381-1 | 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/94381-1.json |
| 9438-3 | Morphine [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9438-3.json |
| 94383-7 | Glial nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94383-7.json |
| 94384-5 | Amphiphysin IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94384-5.json |
| 94385-2 | Amphiphysin IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/94385-2.json |
| 94386-0 | PCA-Tr IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94386-0.json |
| 94387-8 | Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/94387-8.json |
| 94388-6 | Neuronal nuclear type 2 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94388-6.json |
| 94389-4 | Neuronal nuclear type 1 IgG Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/94389-4.json |
| 94390-2 | Neuronal nuclear type 1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/94390-2.json |
| 94392-8 | Bordetella pertussis+parapertussis+bronchiseptica gidA gene [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94392-8.json |
| 94394-4 | Influenza virus A H3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94394-4.json |
| 94395-1 | Influenza virus A H1 2009 pandemic RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94395-1.json |
| 94396-9 | Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94396-9.json |
| 94400-9 | Protein.monoclonal [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/94400-9.json |
| 94417-3 | SLC6A4 gene 5-HTTLPR variant [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94417-3.json |
| 94419-9 | Candida auris [Presence] in Isolate by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/94419-9.json |
| 94420-7 | Lactobacillus crispatus+gasseri+jensenii + Gardnerella vaginalis + Atopobium vaginae rRNA [Presence] in Vaginal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94420-7.json |
| 94423-1 | Lysosomal enzymes screen [Interpretation] in Urine Narrative | ./2.16.840.1.114222.4.11.1002/94423-1.json |
| 94425-6 | Human papilloma virus E6+E7 mRNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94425-6.json |
| 9444-1 | House dust Hausstaub IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9444-1.json |
| 94451-2 | PhenX - Use of Creatine Growth Hormone and Steroids Protocol 230801 | ./2.16.840.1.114222.4.11.1002/94451-2.json |
| 9445-8 | 11-Oxopregnanetriol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9445-8.json |
| 94460-3 | Healthcare navigator Conference note | ./2.16.840.1.114222.4.11.1002/94460-3.json |
| 94461-1 | Solid Organ Transplant Consult note | ./2.16.840.1.114222.4.11.1002/94461-1.json |
| 94462-9 | Cardiology Intensive care unit Consult note | ./2.16.840.1.114222.4.11.1002/94462-9.json |
| 94463-7 | Bone Marrow Transplant Consult note | ./2.16.840.1.114222.4.11.1002/94463-7.json |
| 94464-5 | Solid Organ Transplant Discharge summary | ./2.16.840.1.114222.4.11.1002/94464-5.json |
| 94465-2 | Bone Marrow Transplant Discharge summary | ./2.16.840.1.114222.4.11.1002/94465-2.json |
| 94466-0 | Solid Organ Transplant Progress note | ./2.16.840.1.114222.4.11.1002/94466-0.json |
| 94467-8 | Cardiology Intensive care unit Progress note | ./2.16.840.1.114222.4.11.1002/94467-8.json |
| 94468-6 | Bone Marrow Transplant Progress note | ./2.16.840.1.114222.4.11.1002/94468-6.json |
| 94470-2 | VEGFA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94470-2.json |
| 94471-0 | VEGFA gene c.-1154A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94471-0.json |
| 94472-8 | VEGFA gene c.-1498C>G and c.-1498C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94472-8.json |
| 94473-6 | VEGFA gene c.-2578A>C and c.-2578A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94473-6.json |
| 94474-4 | VEGFA gene c.-634C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94474-4.json |
| 94476-9 | Borrelia burgdorferi G39/40 IgG bands [#] in Blood by Immunoblot | ./2.16.840.1.114222.4.11.1002/94476-9.json |
| 94477-7 | Borrelia burgdorferi 49736 IgG bands [#] in Blood by Immunoblot | ./2.16.840.1.114222.4.11.1002/94477-7.json |
| 94479-3 | Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94479-3.json |
| 94480-1 | Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94480-1.json |
| 94481-9 | Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94481-9.json |
| 94482-7 | Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94482-7.json |
| 94483-5 | Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94483-5.json |
| 94484-3 | Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94484-3.json |
| 94485-0 | Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94485-0.json |
| 94486-8 | Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94486-8.json |
| 94491-8 | Protoporphyrin Free [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/94491-8.json |
| 94495-9 | HLA-DQA1 [Type] | ./2.16.840.1.114222.4.11.1002/94495-9.json |
| 94500-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94500-6.json |
| 94502-2 | SARS-related coronavirus RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94502-2.json |
| 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94505-5.json |
| 94506-3 | SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94506-3.json |
| 94507-1 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/94507-1.json |
| 94508-9 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/94508-9.json |
| 94511-3 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94511-3.json |
| 94512-1 | Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus identified in Isolate or Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/94512-1.json |
| 94515-4 | Anesthesiology Discharge summary | ./2.16.840.1.114222.4.11.1002/94515-4.json |
| 94516-2 | Audiology Discharge summary | ./2.16.840.1.114222.4.11.1002/94516-2.json |
| 94517-0 | Clinical cardiac electrophysiology Discharge summary | ./2.16.840.1.114222.4.11.1002/94517-0.json |
| 94518-8 | Clinical cardiac electrophysiology Progress note | ./2.16.840.1.114222.4.11.1002/94518-8.json |
| 94519-6 | Dermatology Discharge summary | ./2.16.840.1.114222.4.11.1002/94519-6.json |
| 94520-4 | Gastroenterology Discharge summary | ./2.16.840.1.114222.4.11.1002/94520-4.json |
| 94521-2 | Endocrinology Discharge summary | ./2.16.840.1.114222.4.11.1002/94521-2.json |
| 94522-0 | Immunology Discharge summary | ./2.16.840.1.114222.4.11.1002/94522-0.json |
| 94523-8 | Orthotics prosthetics Discharge summary | ./2.16.840.1.114222.4.11.1002/94523-8.json |
| 94524-6 | Interventional radiology Discharge summary | ./2.16.840.1.114222.4.11.1002/94524-6.json |
| 94525-3 | Infectious disease Discharge summary | ./2.16.840.1.114222.4.11.1002/94525-3.json |
| 94526-1 | Pulmonary Discharge summary | ./2.16.840.1.114222.4.11.1002/94526-1.json |
| 94527-9 | Trauma Discharge summary | ./2.16.840.1.114222.4.11.1002/94527-9.json |
| 94528-7 | Thromboembolism Consult note | ./2.16.840.1.114222.4.11.1002/94528-7.json |
| 94529-5 | Wound, Ostomy, and Continence Care Discharge summary | ./2.16.840.1.114222.4.11.1002/94529-5.json |
| 94530-3 | Thromboembolism Discharge summary | ./2.16.840.1.114222.4.11.1002/94530-3.json |
| 94533-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94533-7.json |
| 94534-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94534-5.json |
| 9454-0 | Herpes simplex virus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9454-0.json |
| 94547-7 | SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94547-7.json |
| 94554-3 | Soluble CD14 subtype [Mass/volume] in Serum, Plasma or Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/94554-3.json |
| 94558-4 | SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/94558-4.json |
| 94560-0 | Diabetes risk [Score] Calculated | ./2.16.840.1.114222.4.11.1002/94560-0.json |
| 94562-6 | SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94562-6.json |
| 94563-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94563-4.json |
| 94564-2 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94564-2.json |
| 94565-9 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94565-9.json |
| 94567-5 | Valine [Moles/volume] in Serum or Plasma --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/94567-5.json |
| 94568-3 | Isoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/94568-3.json |
| 94569-1 | Leucine [Moles/volume] in Serum or Plasma --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/94569-1.json |
| 94570-9 | Alloisoleucine [Moles/volume] in Serum or Plasma --post therapeutic diet | ./2.16.840.1.114222.4.11.1002/94570-9.json |
| 94572-5 | Alloisoleucine [Moles/volume] in DBS | ./2.16.840.1.114222.4.11.1002/94572-5.json |
| 94576-6 | Mycobacterium tuberculosis complex species identified in Isolate by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94576-6.json |
| 94581-6 | Herpes simplex virus 1 DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94581-6.json |
| 94582-4 | Herpes simplex virus 2 DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94582-4.json |
| 94584-0 | Varicella zoster virus DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/94584-0.json |
| 94587-3 | Germline disorder chromosome analysis in Amniotic fluid or Chorionic villus sample by Mate pair sequencing | ./2.16.840.1.114222.4.11.1002/94587-3.json |
| 94588-1 | Myeloid neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing | ./2.16.840.1.114222.4.11.1002/94588-1.json |
| 94589-9 | Hematologic neoplasm chromosome analysis in Blood or Marrow by Mate pair sequencing | ./2.16.840.1.114222.4.11.1002/94589-9.json |
| 94590-7 | Oncologic chromosome analysis in Tissue by Mate pair sequencing | ./2.16.840.1.114222.4.11.1002/94590-7.json |
| 94592-3 | Chromosome rearrangement [Identifier] in Blood or Tissue by Mate pair sequencing Nominal | ./2.16.840.1.114222.4.11.1002/94592-3.json |
| 94594-9 | Neurological surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/94594-9.json |
| 94595-6 | Pharmacology Telehealth Medication management note | ./2.16.840.1.114222.4.11.1002/94595-6.json |
| 94600-4 | Equine influenza virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94600-4.json |
| 94601-2 | Listeria monocytogenes Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/94601-2.json |
| 94603-8 | Bacterial 16S rRNA gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/94603-8.json |
| 94604-6 | Equine arteritis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94604-6.json |
| 94609-5 | Bovine leukemia virus Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94609-5.json |
| 94610-3 | Bovine diarrhea virus subtype [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94610-3.json |
| 94611-1 | Pasteurella multocida toxin toxA gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94611-1.json |
| 94612-9 | Mycoplasma bovis Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/94612-9.json |
| 94613-7 | Bovine respiratory syncytial virus Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/94613-7.json |
| 94614-5 | Bovine parainfluenza virus 3 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94614-5.json |
| 94615-2 | Bovine herpesvirus 1 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94615-2.json |
| 94616-0 | Bovine coronavirus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94616-0.json |
| 94617-8 | Anaplasma marginale DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94617-8.json |
| 94618-6 | Bovine respiratory syncytial virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94618-6.json |
| 94619-4 | Bovine herpesvirus 1 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94619-4.json |
| 94620-2 | Bovine diarrhea virus [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94620-2.json |
| 94621-0 | Mycobacterium avium ss paratuberculosis Ab/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/94621-0.json |
| 94622-8 | Bovine diarrhea virus Ag/Positive control in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/94622-8.json |
| 9462-3 | Aluminum [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9462-3.json |
| 94623-6 | Ureaplasma diversum DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94623-6.json |
| 94624-4 | Tritrichomonas foetus DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94624-4.json |
| 94625-1 | Pasteurella multocida DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94625-1.json |
| 94626-9 | Ovine herpesvirus 2 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94626-9.json |
| 94627-7 | Neospora caninum DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94627-7.json |
| 94628-5 | Mycoplasma bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94628-5.json |
| 94629-3 | Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94629-3.json |
| 94630-1 | Mannheimia haemolytica DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94630-1.json |
| 9463-1 | Arsenic [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9463-1.json |
| 94631-9 | Haemophilus somnus DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94631-9.json |
| 94632-7 | Escherichia coli K99 DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94632-7.json |
| 94633-5 | Cryptosporidium parvum DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94633-5.json |
| 94634-3 | Coxiella burnetii DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94634-3.json |
| 94635-0 | Bovine diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94635-0.json |
| 94636-8 | Bovine respiratory syncytial virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94636-8.json |
| 94637-6 | Mycobacterium avium ss paratuberculosis Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/94637-6.json |
| 94638-4 | Bovine respiratory syncytial virus neutralizing antibody [Titer] in Serum by Neutralization test | ./2.16.840.1.114222.4.11.1002/94638-4.json |
| 94639-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94639-2.json |
| 94640-0 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94640-0.json |
| 94641-8 | SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94641-8.json |
| 94654-1 | Known exposure panel | ./2.16.840.1.114222.4.11.1002/94654-1.json |
| 94655-8 | Identifier and Assigning authority panel | ./2.16.840.1.114222.4.11.1002/94655-8.json |
| 9465-6 | Benzene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9465-6.json |
| 94660-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94660-8.json |
| 94662-4 | Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/94662-4.json |
| 94663-2 | Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/94663-2.json |
| 9466-4 | Cadmium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9466-4.json |
| 9467-2 | Calcium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9467-2.json |
| 94672-3 | 24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/94672-3.json |
| 94673-1 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/94673-1.json |
| 94675-6 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/94675-6.json |
| 94676-4 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/94676-4.json |
| 94677-2 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI) | ./2.16.840.1.114222.4.11.1002/94677-2.json |
| 94678-0 | NM Liver and Biliary ducts and Gallbladder Views for patency | ./2.16.840.1.114222.4.11.1002/94678-0.json |
| 94679-8 | XR Chest Single View and Abdomen Supine and Upright and Lateral-decubitus | ./2.16.840.1.114222.4.11.1002/94679-8.json |
| 94680-6 | US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava and Illiac vessels limited | ./2.16.840.1.114222.4.11.1002/94680-6.json |
| 94681-4 | US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava and Illiac vessels | ./2.16.840.1.114222.4.11.1002/94681-4.json |
| 94682-2 | XR Calcaneus GE 2 Views | ./2.16.840.1.114222.4.11.1002/94682-2.json |
| 94683-0 | XR Pelvis and Hip - unilateral GE 2 Views | ./2.16.840.1.114222.4.11.1002/94683-0.json |
| 94684-8 | XR Spine Lumbar and Sacrum GE 6 Views W right bending and W left bending | ./2.16.840.1.114222.4.11.1002/94684-8.json |
| 94685-5 | XR Ribs - unilateral GE 3 Views and Chest PA | ./2.16.840.1.114222.4.11.1002/94685-5.json |
| 94686-3 | MR Brain WO and W contrast IV and MRA Brain WO contrast | ./2.16.840.1.114222.4.11.1002/94686-3.json |
| 94687-1 | CTA Abdominal vessels and Pelvis vessels WO contrast | ./2.16.840.1.114222.4.11.1002/94687-1.json |
| 94688-9 | CTA Neck vessels and Chest vessels WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/94688-9.json |
| 9469-8 | Chromium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9469-8.json |
| 94704-4 | Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94704-4.json |
| 94705-1 | Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94705-1.json |
| 9470-6 | Copper [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9470-6.json |
| 9471-4 | Fluoride [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9471-4.json |
| 94714-3 | Beta globulin [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/94714-3.json |
| 94715-0 | Gamma globulin [Mass/time] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/94715-0.json |
| 94716-8 | AGTR1 gene c.1166A>C [Genotype] in Blood by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94716-8.json |
| 94717-6 | SLC25A15 gene c.562_564delTTC [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94717-6.json |
| 94718-4 | Alpha defensins 1+2+3 [Presence] in Synovial fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/94718-4.json |
| 94719-2 | Plazomicin [Susceptibility] by Gradient strip | ./2.16.840.1.114222.4.11.1002/94719-2.json |
| 94720-0 | SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94720-0.json |
| 94721-8 | COVID-19 Evaluation note | ./2.16.840.1.114222.4.11.1002/94721-8.json |
| 9472-2 | Heptachlor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9472-2.json |
| 94722-6 | COVID-19 Initial Evaluation form | ./2.16.840.1.114222.4.11.1002/94722-6.json |
| 94723-4 | Emergency department COVID-19 Initial Evaluation form | ./2.16.840.1.114222.4.11.1002/94723-4.json |
| 94724-2 | Pulmonary Telehealth Note | ./2.16.840.1.114222.4.11.1002/94724-2.json |
| 94725-9 | Aerodigestive medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94725-9.json |
| 94726-7 | Cleft and Craniofacial Telehealth Note | ./2.16.840.1.114222.4.11.1002/94726-7.json |
| 9473-0 | Heptachlorepoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9473-0.json |
| 94743-2 | Gynecologic oncology Evaluation note | ./2.16.840.1.114222.4.11.1002/94743-2.json |
| 94744-0 | Healthcare navigator Evaluation note | ./2.16.840.1.114222.4.11.1002/94744-0.json |
| 9474-8 | Hexachlorobenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9474-8.json |
| 94748-1 | Medical Aid in Dying Patient Consent Document | ./2.16.840.1.114222.4.11.1002/94748-1.json |
| 94751-5 | RHCE gene allele Ee [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94751-5.json |
| 94752-3 | RHCE gene allele Cc [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/94752-3.json |
| 9475-5 | Hexane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9475-5.json |
| 94759-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94759-8.json |
| 94760-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94760-6.json |
| 94761-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay | ./2.16.840.1.114222.4.11.1002/94761-4.json |
| 94762-2 | SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94762-2.json |
| 9476-3 | Hexanoylglycine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9476-3.json |
| 94763-0 | SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/94763-0.json |
| 94764-8 | SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/94764-8.json |
| 94765-5 | SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94765-5.json |
| 94766-3 | SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94766-3.json |
| 94767-1 | SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94767-1.json |
| 94769-7 | SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94769-7.json |
| 94770-5 | Wound, Ostomy, and Continence Care Telehealth Note | ./2.16.840.1.114222.4.11.1002/94770-5.json |
| 9477-1 | Lead [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9477-1.json |
| 94771-3 | Anesthesiology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94771-3.json |
| 94772-1 | Blood banking and transfusion medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94772-1.json |
| 94773-9 | Burn management Telehealth Note | ./2.16.840.1.114222.4.11.1002/94773-9.json |
| 94774-7 | Cardiac surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/94774-7.json |
| 94775-4 | Critical care medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94775-4.json |
| 94776-2 | Dentistry Telehealth Note | ./2.16.840.1.114222.4.11.1002/94776-2.json |
| 94777-0 | Dermatology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94777-0.json |
| 94778-8 | Ethics Telehealth Note | ./2.16.840.1.114222.4.11.1002/94778-8.json |
| 94779-6 | Family medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94779-6.json |
| 94780-4 | Gastroenterology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94780-4.json |
| 94781-2 | General medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94781-2.json |
| 94782-0 | Surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/94782-0.json |
| 94783-8 | Geriatric medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94783-8.json |
| 94784-6 | Gynecologic oncology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94784-6.json |
| 94785-3 | Healthcare navigator Telehealth Note | ./2.16.840.1.114222.4.11.1002/94785-3.json |
| 94786-1 | Hematology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94786-1.json |
| 94787-9 | Interventional radiology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94787-9.json |
| 94788-7 | Clinical pathology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94788-7.json |
| 9478-9 | Magnesium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9478-9.json |
| 94789-5 | Maternal and fetal medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/94789-5.json |
| 94790-3 | Nutrition and dietetics Telehealth Note | ./2.16.840.1.114222.4.11.1002/94790-3.json |
| 94791-1 | Occupational therapy Telehealth Note | ./2.16.840.1.114222.4.11.1002/94791-1.json |
| 94792-9 | Oncology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94792-9.json |
| 94793-7 | Wound care management Telehealth Note | ./2.16.840.1.114222.4.11.1002/94793-7.json |
| 94794-5 | Ophthalmology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94794-5.json |
| 94795-2 | Pastoral care Telehealth Note | ./2.16.840.1.114222.4.11.1002/94795-2.json |
| 94796-0 | Pharmacology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94796-0.json |
| 9479-7 | Mercury [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9479-7.json |
| 94797-8 | Plastic surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/94797-8.json |
| 94798-6 | Psychology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94798-6.json |
| 94799-4 | Radiation oncology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94799-4.json |
| 948-0 | C Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/948-0.json |
| 94800-0 | Rapid response team Telehealth Note | ./2.16.840.1.114222.4.11.1002/94800-0.json |
| 94801-8 | Recreational therapy Telehealth Note | ./2.16.840.1.114222.4.11.1002/94801-8.json |
| 94802-6 | Respiratory therapy Telehealth Note | ./2.16.840.1.114222.4.11.1002/94802-6.json |
| 94803-4 | Speech-language pathology Telehealth Note | ./2.16.840.1.114222.4.11.1002/94803-4.json |
| 94804-2 | Trauma Telehealth Note | ./2.16.840.1.114222.4.11.1002/94804-2.json |
| 94805-9 | Vascular surgery Telehealth Note | ./2.16.840.1.114222.4.11.1002/94805-9.json |
| 9481-3 | pH of Water | ./2.16.840.1.114222.4.11.1002/9481-3.json |
| 94814-1 | Critical care medicine COVID-19 Consultation note | ./2.16.840.1.114222.4.11.1002/94814-1.json |
| 94820-8 | Whole mRNA transcriptome sequence analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/94820-8.json |
| 9482-1 | Potassium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9482-1.json |
| 94821-6 | COVID-19 Intubation advance directives | ./2.16.840.1.114222.4.11.1002/94821-6.json |
| 94822-4 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing | ./2.16.840.1.114222.4.11.1002/94822-4.json |
| 94823-2 | Cytomegalovirus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94823-2.json |
| 94824-0 | Parvovirus B19 DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94824-0.json |
| 94825-7 | Parvovirus B19 DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94825-7.json |
| 94826-5 | Parvovirus B19 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94826-5.json |
| 94827-3 | Epstein Barr virus DNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94827-3.json |
| 94828-1 | Epstein Barr virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94828-1.json |
| 94829-9 | Epstein Barr virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94829-9.json |
| 94830-7 | Epstein Barr virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94830-7.json |
| 94831-5 | Varicella zoster virus DNA [Units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94831-5.json |
| 94832-3 | Varicella zoster virus DNA [log units/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94832-3.json |
| 94833-1 | Varicella zoster virus DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94833-1.json |
| 94834-9 | Herpes simplex virus 1+2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94834-9.json |
| 94835-6 | Herpes simplex virus 1 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94835-6.json |
| 94836-4 | Herpes simplex virus 2 DNA [Log #/volume] (viral load) in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94836-4.json |
| 94837-2 | Dengue virus 1+2+3+4 RNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94837-2.json |
| 94838-0 | Enterovirus RNA [Presence] in Amniotic fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94838-0.json |
| 9483-9 | Selenium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9483-9.json |
| 94845-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/94845-5.json |
| 9485-4 | Sodium [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9485-4.json |
| 94856-2 | Microscopic observation [Presence] in Sputum by Acid fast stain --2nd specimen | ./2.16.840.1.114222.4.11.1002/94856-2.json |
| 94857-0 | Microscopic observation [Presence] in Sputum by Acid fast stain --3rd specimen | ./2.16.840.1.114222.4.11.1002/94857-0.json |
| 94858-8 | Glycerol [Moles/volume] in Serum by calculation | ./2.16.840.1.114222.4.11.1002/94858-8.json |
| 94865-3 | Triglyceride [Mass/volume] corrected for glycerol in Serum | ./2.16.840.1.114222.4.11.1002/94865-3.json |
| 94866-1 | 7-Alpha hydroxy-4-cholesten-3-one [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/94866-1.json |
| 94867-9 | Ganglioside GD1b IgG Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94867-9.json |
| 94868-7 | Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94868-7.json |
| 94869-5 | Ganglioside GD1b IgM Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94869-5.json |
| 9487-0 | Zinc [Mass/volume] in Water | ./2.16.840.1.114222.4.11.1002/9487-0.json |
| 94870-3 | Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/94870-3.json |
| 94874-5 | Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94874-5.json |
| 94875-2 | Nuclear IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/94875-2.json |
| 9489-6 | Arsenic [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/9489-6.json |
| 9490-4 | Aspergillus flavus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/9490-4.json |
| 9491-2 | Aspergillus sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9491-2.json |
| 9492-0 | Aspergillus sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9492-0.json |
| 9493-8 | Bismuth [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/9493-8.json |
| 9494-6 | Blastomyces dermatitidis IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9494-6.json |
| 9495-3 | Brucella canis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9495-3.json |
| 9496-1 | Brucella canis IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9496-1.json |
| 9497-9 | Butane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9497-9.json |
| 9498-7 | Candida sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9498-7.json |
| 9500-0 | Candida sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9500-0.json |
| 9501-8 | Candida sp Ag [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9501-8.json |
| 9502-6 | Carbophenothion [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9502-6.json |
| 95041-0 | COVID-19 Progress note | ./2.16.840.1.114222.4.11.1002/95041-0.json |
| 9505-9 | Chlorobenzene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9505-9.json |
| 9506-7 | Chloroethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9506-7.json |
| 95068-3 | ADRB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95068-3.json |
| 95069-1 | Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q deletion in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/95069-1.json |
| 95070-9 | Chromosome 9 and 11 and 15 aneuploidy in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/95070-9.json |
| 95071-7 | Chromosome region 14q32 rearrangements in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/95071-7.json |
| 95072-5 | 1,3 beta glucan [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/95072-5.json |
| 95073-3 | Histoplasma capsulatum Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay | ./2.16.840.1.114222.4.11.1002/95073-3.json |
| 9507-5 | Chloromethane [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9507-5.json |
| 95075-8 | Cannabidiol/Tetrahydrocannabinol [Ratio] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/95075-8.json |
| 9508-3 | Chlorothiazide [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9508-3.json |
| 95100-4 | Glucagon [Mass/volume] in Serum or Plasma --4 hours post meal | ./2.16.840.1.114222.4.11.1002/95100-4.json |
| 95103-8 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95103-8.json |
| 95104-6 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95104-6.json |
| 95105-3 | Glucose [Mass/volume] in Serum or Plasma --30 min post meal | ./2.16.840.1.114222.4.11.1002/95105-3.json |
| 95106-1 | Glucose [Mass/volume] in Serum or Plasma --3 hours post meal | ./2.16.840.1.114222.4.11.1002/95106-1.json |
| 95107-9 | Glucose [Mass/volume] in Serum or Plasma --4.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95107-9.json |
| 95108-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post meal | ./2.16.840.1.114222.4.11.1002/95108-7.json |
| 95109-5 | Glucose [Mass/volume] in Serum or Plasma --5 hours post meal | ./2.16.840.1.114222.4.11.1002/95109-5.json |
| 95111-1 | Insulin [Units/volume] in Serum or Plasma --1.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95111-1.json |
| 95112-9 | Insulin [Units/volume] in Serum or Plasma --1 hour post meal | ./2.16.840.1.114222.4.11.1002/95112-9.json |
| 95113-7 | Insulin [Units/volume] in Serum or Plasma --2.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95113-7.json |
| 95114-5 | Insulin [Units/volume] in Serum or Plasma --2 hours post meal | ./2.16.840.1.114222.4.11.1002/95114-5.json |
| 95115-2 | Insulin [Units/volume] in Serum or Plasma --3.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95115-2.json |
| 95116-0 | Insulin [Units/volume] in Serum or Plasma --30 min post meal | ./2.16.840.1.114222.4.11.1002/95116-0.json |
| 95117-8 | Insulin [Units/volume] in Serum or Plasma --3 hours post meal | ./2.16.840.1.114222.4.11.1002/95117-8.json |
| 95118-6 | Insulin [Units/volume] in Serum or Plasma --4.5 hours post meal | ./2.16.840.1.114222.4.11.1002/95118-6.json |
| 95119-4 | Insulin [Units/volume] in Serum or Plasma --4 hours post meal | ./2.16.840.1.114222.4.11.1002/95119-4.json |
| 95120-2 | Insulin [Units/volume] in Serum or Plasma --5 hours post meal | ./2.16.840.1.114222.4.11.1002/95120-2.json |
| 95124-4 | Sarcoma targeted gene fusion transcript analysis in Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95124-4.json |
| 9512-5 | Creosol [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/9512-5.json |
| 95125-1 | SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95125-1.json |
| 95127-7 | Mycobacterium tuberculosis lipoarabinomannan Ag [Presence] in Urine by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/95127-7.json |
| 95128-5 | Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/95128-5.json |
| 95129-3 | Dense fine speckled 70 protein IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95129-3.json |
| 95130-1 | Aggressive prostate cancer risk [Score] by Calculated by ExoDx | ./2.16.840.1.114222.4.11.1002/95130-1.json |
| 95132-7 | Dialysis and Therapeutic apheresis Consult note | ./2.16.840.1.114222.4.11.1002/95132-7.json |
| 9513-3 | Cytomegalovirus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9513-3.json |
| 95133-5 | Dialysis and Therapeutic apheresis Discharge summary | ./2.16.840.1.114222.4.11.1002/95133-5.json |
| 95134-3 | Dialysis and Therapeutic apheresis Progress note | ./2.16.840.1.114222.4.11.1002/95134-3.json |
| 95135-0 | Noroxycodone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/95135-0.json |
| 9514-1 | Cytomegalovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9514-1.json |
| 95143-4 | UGT1A1 gene TA repeats [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/95143-4.json |
| 95150-9 | Avian infectious laryngotracheitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95150-9.json |
| 95151-7 | Infectious bronchitis virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95151-7.json |
| 95152-5 | Mycoplasma synoviae DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95152-5.json |
| 95153-3 | Ornithobacterium rhinotracheale RNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95153-3.json |
| 95154-1 | PRRSV ORF5 gene sequence homology to Prime Pac in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/95154-1.json |
| 95155-8 | PRRSV ORF5 gene sequence homology to Prevacent in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/95155-8.json |
| 95156-6 | Hepatitis E virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95156-6.json |
| 95157-4 | Salmonella gallinarum+Salmonella pullorum Ab [Presence] in Serum, Plasma or Blood by Agglutination | ./2.16.840.1.114222.4.11.1002/95157-4.json |
| 9515-8 | Diclofenac [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9515-8.json |
| 95158-2 | Avian encephalomyelitis virus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95158-2.json |
| 95159-0 | Avian metapneumovirus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95159-0.json |
| 95160-8 | Avian paramyxovirus 1 Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95160-8.json |
| 95161-6 | Avian reovirus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95161-6.json |
| 95162-4 | Bordetella avium Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95162-4.json |
| 95163-2 | Infectious bronchitis virus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95163-2.json |
| 95164-0 | Infectious bursal disease virus Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95164-0.json |
| 95165-7 | Mycoplasma gallisepticum Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95165-7.json |
| 9516-6 | Echovirus 11 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9516-6.json |
| 95166-5 | Mycoplasma synoviae Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95166-5.json |
| 95167-3 | Ornithobacterium rhinotracheale Ab/Positive control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95167-3.json |
| 95168-1 | Avian infectious laryngotracheitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95168-1.json |
| 95169-9 | Infectious bronchitis virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95169-9.json |
| 95170-7 | Mycoplasma gallisepticum DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95170-7.json |
| 95171-5 | Mycoplasma synoviae DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95171-5.json |
| 95172-3 | Mycoplasma iowae DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95172-3.json |
| 95173-1 | Mycoplasma meleagridis DNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95173-1.json |
| 9517-4 | Echovirus 18 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9517-4.json |
| 95174-9 | Ornithobacterium rhinotracheale RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95174-9.json |
| 95175-6 | Avian encephalomyelitis virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95175-6.json |
| 95176-4 | Avian metapneumovirus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95176-4.json |
| 95177-2 | Avian reovirus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95177-2.json |
| 95178-0 | Bordetella avium Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95178-0.json |
| 95179-8 | Infectious bursal disease virus Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95179-8.json |
| 95180-6 | Mycoplasma gallisepticum Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95180-6.json |
| 95181-4 | Mycoplasma synoviae Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95181-4.json |
| 9518-2 | Echovirus 30 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9518-2.json |
| 95182-2 | Ornithobacterium rhinotracheale Ab [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95182-2.json |
| 9519-0 | Echovirus 4 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9519-0.json |
| 9520-8 | Echovirus 9 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9520-8.json |
| 95209-3 | SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory system specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/95209-3.json |
| 95210-1 | Anaplasma marginale Ab/Negative control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95210-1.json |
| 95211-9 | Bluetongue virus Ag/Negative control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95211-9.json |
| 95212-7 | Neospora caninum Ab/Negative control in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95212-7.json |
| 9521-6 | Entamoeba histolytica IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9521-6.json |
| 95218-4 | Leukocytes [#/volume] in Stem cell product | ./2.16.840.1.114222.4.11.1002/95218-4.json |
| 9522-4 | Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9522-4.json |
| 95229-1 | Biliary tract neoplasm chromosome analysis in Tissue | ./2.16.840.1.114222.4.11.1002/95229-1.json |
| 95230-9 | Biliary tract neoplasm chromosome aneuploidy and cytology analysis in Tissue | ./2.16.840.1.114222.4.11.1002/95230-9.json |
| 9523-2 | Entamoeba histolytica IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9523-2.json |
| 95232-5 | Microalbumin [Presence] in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/95232-5.json |
| 95233-3 | Microalbumin/Creatinine Qualitative in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/95233-3.json |
| 95234-1 | Hepatitis B virus surface Ag [Interpretation] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/95234-1.json |
| 9524-0 | Giardia lamblia Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9524-0.json |
| 95246-5 | U.S. Household Food Security Survey [U.S. FSS] | ./2.16.840.1.114222.4.11.1002/95246-5.json |
| 9525-7 | Hepatitis D virus IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9525-7.json |
| 95263-0 | U.S. Household Food Security Survey Score [U.S. FSS] | ./2.16.840.1.114222.4.11.1002/95263-0.json |
| 95269-7 | HLA-A+B+C (class I) Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95269-7.json |
| 95271-3 | Bicarbonate [Moles/volume] in Body fluid --post secretin | ./2.16.840.1.114222.4.11.1002/95271-3.json |
| 95272-1 | Aquaporin 4 water channel IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95272-1.json |
| 95273-9 | Aquaporin 4 water channel IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95273-9.json |
| 95274-7 | DNM2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95274-7.json |
| 95275-4 | FGD4 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95275-4.json |
| 95276-2 | GARS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95276-2.json |
| 95277-0 | GJB1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95277-0.json |
| 95278-8 | HSPB1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95278-8.json |
| 95279-6 | HSPB8 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95279-6.json |
| 95280-4 | MTMR2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95280-4.json |
| 9528-1 | Histoplasma capsulatum IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9528-1.json |
| 95281-2 | NDRG1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95281-2.json |
| 95282-0 | PARK2 gene deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95282-0.json |
| 95283-8 | PARK7 gene deletion in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95283-8.json |
| 95284-6 | PINK1 gene deletion in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95284-6.json |
| 95285-3 | RAB7A gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95285-3.json |
| 95286-1 | SBF2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95286-1.json |
| 95287-9 | TRPV4 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95287-9.json |
| 95288-7 | YARS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95288-7.json |
| 9529-9 | Histoplasma capsulatum IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/9529-9.json |
| 9530-7 | Histoplasma capsulatum IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/9530-7.json |
| 9531-5 | Influenza virus A Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9531-5.json |
| 9532-3 | Influenza virus A IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9532-3.json |
| 9533-1 | Influenza virus A IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9533-1.json |
| 9534-9 | Influenza virus B Ab [Titer] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9534-9.json |
| 95353-9 | U.S. Adult Food Security Survey [U.S. FSS] | ./2.16.840.1.114222.4.11.1002/95353-9.json |
| 95354-7 | Transfuse convalescent plasma [Volume] | ./2.16.840.1.114222.4.11.1002/95354-7.json |
| 9535-6 | Influenza virus B IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9535-6.json |
| 95359-6 | Rabbit hemorrhagic disease virus type 1 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95359-6.json |
| 95360-4 | Rabbit hemorrhagic disease virus type 2 RNA [Cycle Threshold #] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95360-4.json |
| 95361-2 | U.S. Household Food Security Survey - Six-Item Short Form [U.S. FSS] | ./2.16.840.1.114222.4.11.1002/95361-2.json |
| 9536-4 | Influenza virus B IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9536-4.json |
| 9537-2 | Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/9537-2.json |
| 9538-0 | La Crosse virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9538-0.json |
| 95381-0 | Telephone encounter COVID-19 note | ./2.16.840.1.114222.4.11.1002/95381-0.json |
| 95387-7 | Safe Environment for Every Kid Impression Caregiver [SEEK] | ./2.16.840.1.114222.4.11.1002/95387-7.json |
| 9539-8 | La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9539-8.json |
| 9540-6 | La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9540-6.json |
| 95406-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95406-5.json |
| 95407-3 | Cardiopulmonary Telehealth Note | ./2.16.840.1.114222.4.11.1002/95407-3.json |
| 95408-1 | Cardiopulmonary Outpatient Note | ./2.16.840.1.114222.4.11.1002/95408-1.json |
| 95409-9 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95409-9.json |
| 95411-5 | SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT | ./2.16.840.1.114222.4.11.1002/95411-5.json |
| 95412-3 | COVID-19 case report | ./2.16.840.1.114222.4.11.1002/95412-3.json |
| 9541-4 | Legionella pneumophila 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9541-4.json |
| 95416-4 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay | ./2.16.840.1.114222.4.11.1002/95416-4.json |
| 9542-2 | Legionella pneumophila 1 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9542-2.json |
| 95424-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/95424-8.json |
| 95425-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95425-5.json |
| 95427-1 | SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95427-1.json |
| 95428-9 | SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95428-9.json |
| 95429-7 | SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95429-7.json |
| 9543-0 | Legionella pneumophila 1 Ag [Presence] in Urine by Radioimmunoassay (RIA) | ./2.16.840.1.114222.4.11.1002/9543-0.json |
| 9544-8 | Legionella pneumophila 2 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9544-8.json |
| 9545-5 | Legionella pneumophila 2 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9545-5.json |
| 9546-3 | Legionella pneumophila 3 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9546-3.json |
| 9547-1 | Legionella pneumophila 3 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9547-1.json |
| 954-8 | C little e Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/954-8.json |
| 9548-9 | Legionella pneumophila 4 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9548-9.json |
| 9549-7 | Legionella pneumophila 4 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9549-7.json |
| 9550-5 | Legionella pneumophila 5 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9550-5.json |
| 9551-3 | Legionella pneumophila 5 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9551-3.json |
| 95520-3 | Integrative medicine Telehealth Note | ./2.16.840.1.114222.4.11.1002/95520-3.json |
| 9552-1 | Legionella pneumophila 6 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9552-1.json |
| 95521-1 | SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95521-1.json |
| 95524-5 | HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95524-5.json |
| 95527-8 | Cytomegalovirus IgG Ab [Presence] in Saliva (oral fluid) by Immunoassay | ./2.16.840.1.114222.4.11.1002/95527-8.json |
| 95533-6 | Human papilloma virus 56+59+66 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95533-6.json |
| 95534-4 | Human papilloma virus 52 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95534-4.json |
| 95535-1 | Human papilloma virus 51 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95535-1.json |
| 95536-9 | Human papilloma virus 45 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95536-9.json |
| 95537-7 | Human papilloma virus 35+39+68 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95537-7.json |
| 95538-5 | Human papilloma virus 33+58 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95538-5.json |
| 9553-9 | Legionella pneumophila 6 IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9553-9.json |
| 95539-3 | Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95539-3.json |
| 95540-1 | Carbapenem resistance blaIMP+blaVIM genes [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/95540-1.json |
| 95542-7 | SARS-CoV-2 (COVID-19) Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/95542-7.json |
| 95543-5 | Aspergillus terreus IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/95543-5.json |
| 95544-3 | HTLV I DNA [#/volume] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95544-3.json |
| 95545-0 | Loprazolam [Mass/volume] in Serum by Confirmatory method | ./2.16.840.1.114222.4.11.1002/95545-0.json |
| 95548-4 | Cardiovascular disease 10Y risk goal based on ACC-AHA Pooled Cohort by Goff 2013 | ./2.16.840.1.114222.4.11.1002/95548-4.json |
| 95549-2 | Cardiovascular disease lifetime risk [Likelihood] ACC-AHA Pooled Cohort by Goff 2013 | ./2.16.840.1.114222.4.11.1002/95549-2.json |
| 95550-0 | ABL1 gene c.944C>T [Presence] in Blood or Marrow by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95550-0.json |
| 95551-8 | Chromosome region 17p11.2 deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95551-8.json |
| 95552-6 | 4p16.3 chromosome deletion in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95552-6.json |
| 95553-4 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95553-4.json |
| 95554-2 | Pancreatic exocrine cell Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95554-2.json |
| 95555-9 | F7 gene p.Arg353Gln [Genotype] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/95555-9.json |
| 95592-2 | Cardiac surgery Outpatient Note | ./2.16.840.1.114222.4.11.1002/95592-2.json |
| 95595-5 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/95595-5.json |
| 95596-3 | PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/95596-3.json |
| 95600-3 | Contactin-associated protein 2 Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95600-3.json |
| 95602-9 | GABABR Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95602-9.json |
| 95603-7 | AMPAR2 Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95603-7.json |
| 95604-5 | AMPAR1 Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/95604-5.json |
| 95608-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/95608-6.json |
| 95609-4 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory system specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/95609-4.json |
| 95610-2 | XR Teeth Complete Views | ./2.16.840.1.114222.4.11.1002/95610-2.json |
| 95611-0 | XR Teeth Occlusal Views | ./2.16.840.1.114222.4.11.1002/95611-0.json |
| 95612-8 | Portable XR Unspecified body region Views | ./2.16.840.1.114222.4.11.1002/95612-8.json |
| 95637-5 | Jamestown canyon virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95637-5.json |
| 95638-3 | California encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95638-3.json |
| 95639-1 | Cache valley virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95639-1.json |
| 95640-9 | Colorado tick fever virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95640-9.json |
| 95641-7 | Barmah forest virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95641-7.json |
| 95642-5 | Snowshoe hare virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95642-5.json |
| 95643-3 | Tahyna virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95643-3.json |
| 95644-1 | Japanese encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95644-1.json |
| 95645-8 | Murray Valley encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95645-8.json |
| 9564-6 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9564-6.json |
| 95646-6 | Ross River virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95646-6.json |
| 95647-4 | Powassan virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95647-4.json |
| 95648-2 | Sindbis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95648-2.json |
| 95649-0 | Chikungunya virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95649-0.json |
| 95650-8 | Mayaro virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95650-8.json |
| 95651-6 | Yellow fever virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95651-6.json |
| 95652-4 | Venezuelan equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95652-4.json |
| 9565-3 | Measles virus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9565-3.json |
| 95653-2 | La Crosse virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95653-2.json |
| 95654-0 | Eastern equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95654-0.json |
| 95655-7 | Western equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95655-7.json |
| 95657-3 | Flavivirus identified in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/95657-3.json |
| 95658-1 | Influenza virus A H7 Eurasia RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95658-1.json |
| 95659-9 | Adenovirus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95659-9.json |
| 95660-7 | Eastern equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95660-7.json |
| 9566-1 | Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/9566-1.json |
| 95661-5 | Barmah forest virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95661-5.json |
| 95662-3 | Japanese encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95662-3.json |
| 95663-1 | Zika virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95663-1.json |
| 95664-9 | Jamestown canyon virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95664-9.json |
| 95665-6 | Snowshoe hare virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95665-6.json |
| 95666-4 | Tahyna virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95666-4.json |
| 95667-2 | Japanese encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95667-2.json |
| 95668-0 | Highlands J virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95668-0.json |
| 95669-8 | Murray Valley encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95669-8.json |
| 95670-6 | Ross River virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95670-6.json |
| 95671-4 | Sindbis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95671-4.json |
| 95672-2 | Chikungunya virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95672-2.json |
| 95673-0 | Dengue virus 1+2+3+4 IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95673-0.json |
| 95674-8 | Mayaro virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95674-8.json |
| 95675-5 | Yellow fever virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95675-5.json |
| 95676-3 | Venezuelan equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95676-3.json |
| 95677-1 | Saint Louis encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95677-1.json |
| 95678-9 | Western equine encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95678-9.json |
| 9567-9 | Mumps virus Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9567-9.json |
| 95679-7 | Barmah forest virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95679-7.json |
| 95680-5 | Snowshoe hare virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95680-5.json |
| 95681-3 | Tahyna virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95681-3.json |
| 95682-1 | Japanese encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95682-1.json |
| 95683-9 | Highlands J virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95683-9.json |
| 95684-7 | Murray Valley encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95684-7.json |
| 95685-4 | Ross River virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95685-4.json |
| 95686-2 | Sindbis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95686-2.json |
| 9568-7 | Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9568-7.json |
| 95687-0 | Chikungunya virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95687-0.json |
| 95688-8 | Dengue virus 1+2+3+4 IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95688-8.json |
| 95689-6 | Mayaro virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95689-6.json |
| 95690-4 | Yellow fever virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95690-4.json |
| 95691-2 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95691-2.json |
| 95692-0 | Saint Louis encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95692-0.json |
| 95693-8 | Western equine encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95693-8.json |
| 95694-6 | Cache valley virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95694-6.json |
| 9569-5 | Nocardia sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9569-5.json |
| 95695-3 | Colorado tick fever virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95695-3.json |
| 95696-1 | Barmah forest virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95696-1.json |
| 95697-9 | Snowshoe hare virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95697-9.json |
| 95698-7 | Tahyna virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95698-7.json |
| 95699-5 | Highlands J virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95699-5.json |
| 95700-1 | Murray Valley encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95700-1.json |
| 95701-9 | Ross River virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95701-9.json |
| 95702-7 | Powassan virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95702-7.json |
| 95703-5 | West Nile virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95703-5.json |
| 95704-3 | Sindbis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95704-3.json |
| 95705-0 | Chikungunya virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95705-0.json |
| 95706-8 | Dengue virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95706-8.json |
| 95707-6 | Mayaro virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95707-6.json |
| 95708-4 | Yellow fever virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95708-4.json |
| 95709-2 | Venezuelan equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95709-2.json |
| 95710-0 | La Crosse virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95710-0.json |
| 9571-1 | Parvovirus B19 DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/9571-1.json |
| 95711-8 | Saint Louis encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95711-8.json |
| 95712-6 | Eastern equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95712-6.json |
| 95713-4 | Western equine encephalitis virus IgA Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95713-4.json |
| 95714-2 | Varicella zoster virus IgG Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/95714-2.json |
| 95716-7 | 17 alpha-Hydroxylase Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95716-7.json |
| 95717-5 | Barmah forest virus Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/95717-5.json |
| 95718-3 | Anion gap 3 in Blood | ./2.16.840.1.114222.4.11.1002/95718-3.json |
| 95719-1 | Flavivirus Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/95719-1.json |
| 95720-9 | Glycine receptor Ab [Titer] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95720-9.json |
| 95721-7 | Glycine receptor Ab [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/95721-7.json |
| 95722-5 | Glycine receptor Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95722-5.json |
| 95723-3 | Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/95723-3.json |
| 95724-1 | Glycine receptor Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95724-1.json |
| 95725-8 | Glycine receptor Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/95725-8.json |
| 95726-6 | 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95726-6.json |
| 9572-9 | Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/9572-9.json |
| 9573-7 | Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9573-7.json |
| 9574-5 | Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9574-5.json |
| 95746-4 | Immunology Progress note | ./2.16.840.1.114222.4.11.1002/95746-4.json |
| 95747-2 | Immunology Referral note | ./2.16.840.1.114222.4.11.1002/95747-2.json |
| 95748-0 | Immunology Education note | ./2.16.840.1.114222.4.11.1002/95748-0.json |
| 95749-8 | Immunology Initial evaluation note | ./2.16.840.1.114222.4.11.1002/95749-8.json |
| 95750-6 | Immunology procedure note | ./2.16.840.1.114222.4.11.1002/95750-6.json |
| 95751-4 | Immunology Flowsheet | ./2.16.840.1.114222.4.11.1002/95751-4.json |
| 9575-2 | Rotavirus Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9575-2.json |
| 95752-2 | Immunology Plan of care note | ./2.16.840.1.114222.4.11.1002/95752-2.json |
| 95753-0 | Immunology Evaluation note | ./2.16.840.1.114222.4.11.1002/95753-0.json |
| 95754-8 | Allergy Referral note | ./2.16.840.1.114222.4.11.1002/95754-8.json |
| 95755-5 | Allergy Initial evaluation note | ./2.16.840.1.114222.4.11.1002/95755-5.json |
| 95756-3 | Allergy procedure note | ./2.16.840.1.114222.4.11.1002/95756-3.json |
| 95757-1 | Allergy Progress note | ./2.16.840.1.114222.4.11.1002/95757-1.json |
| 95758-9 | Allergy Flowsheet | ./2.16.840.1.114222.4.11.1002/95758-9.json |
| 95759-7 | Allergy Plan of care note | ./2.16.840.1.114222.4.11.1002/95759-7.json |
| 9576-0 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/9576-0.json |
| 95760-5 | Allergy Education note | ./2.16.840.1.114222.4.11.1002/95760-5.json |
| 95761-3 | Allergy Consult note | ./2.16.840.1.114222.4.11.1002/95761-3.json |
| 95762-1 | Allergy Diagnostic study note | ./2.16.840.1.114222.4.11.1002/95762-1.json |
| 95763-9 | Allergy Evaluation note | ./2.16.840.1.114222.4.11.1002/95763-9.json |
| 95764-7 | Candida auris DNA [Presence] in Urine by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/95764-7.json |
| 95765-4 | Candida auris DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/95765-4.json |
| 95766-2 | Candida auris DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/95766-2.json |
| 95767-0 | Cefiderocol [Susceptibility] by Disk diffusion (KB) | ./2.16.840.1.114222.4.11.1002/95767-0.json |
| 95768-8 | Parathyrin.1-84 [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/95768-8.json |
| 95769-6 | BMPR1A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95769-6.json |
| 95770-4 | GALT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95770-4.json |
| 95771-2 | GATA2 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95771-2.json |
| 95772-0 | IDH1 and IDH2 genes targeted mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95772-0.json |
| 95773-8 | ACADM gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95773-8.json |
| 95774-6 | MSH6 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95774-6.json |
| 95775-3 | HGSNAT gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95775-3.json |
| 95776-1 | GNS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95776-1.json |
| 95777-9 | ACADS gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95777-9.json |
| 9577-8 | Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9577-8.json |
| 95778-7 | TERT gene promotor region targeted mutation analysis in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95778-7.json |
| 95779-5 | TFE3 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95779-5.json |
| 95780-3 | TFEB gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95780-3.json |
| 95781-1 | ATP7B gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95781-1.json |
| 95782-9 | ABCD1 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95782-9.json |
| 95783-7 | ETV6 gene rearrangements in Blood or Marrow by FISH | ./2.16.840.1.114222.4.11.1002/95783-7.json |
| 95784-5 | FGFR2 gene rearrangements in Tissue by FISH | ./2.16.840.1.114222.4.11.1002/95784-5.json |
| 95785-2 | FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95785-2.json |
| 9578-6 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9578-6.json |
| 95786-0 | Gene XXX mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/95786-0.json |
| 9579-4 | Tetrahydrocorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9579-4.json |
| 95794-4 | Adrenal insufficiency emergency action plan | ./2.16.840.1.114222.4.11.1002/95794-4.json |
| 95795-1 | HBG1 and HBG2 genes full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/95795-1.json |
| 9580-2 | Thyroxine (T4) Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9580-2.json |
| 95802-5 | Breastfeeding Progress note | ./2.16.840.1.114222.4.11.1002/95802-5.json |
| 95803-3 | Breastfeeding Note | ./2.16.840.1.114222.4.11.1002/95803-3.json |
| 95804-1 | Breastfeeding Telehealth Note | ./2.16.840.1.114222.4.11.1002/95804-1.json |
| 95805-8 | Breastfeeding Evaluation note | ./2.16.840.1.114222.4.11.1002/95805-8.json |
| 95806-6 | Breastfeeding Consult note | ./2.16.840.1.114222.4.11.1002/95806-6.json |
| 95809-0 | Carbapenem resistance genes [Presence] by Molecular method | ./2.16.840.1.114222.4.11.1002/95809-0.json |
| 9581-0 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9581-0.json |
| 95824-9 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95824-9.json |
| 95825-6 | SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay | ./2.16.840.1.114222.4.11.1002/95825-6.json |
| 95827-2 | Viable CD3 cells/100 CD3 cells in Blood product unit | ./2.16.840.1.114222.4.11.1002/95827-2.json |
| 9582-8 | Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9582-8.json |
| 95829-8 | Viable CD45 cells/100 CD45 cells in Blood product unit | ./2.16.840.1.114222.4.11.1002/95829-8.json |
| 95831-4 | Lymphocyte dose in hematopoietic progenitor cell transfusion [#/mass] | ./2.16.840.1.114222.4.11.1002/95831-4.json |
| 95832-2 | CD3 dose in hematopoietic progenitor cell transfusion [#/mass] | ./2.16.840.1.114222.4.11.1002/95832-2.json |
| 95833-0 | Nucleated cells [#] in Blood product unit | ./2.16.840.1.114222.4.11.1002/95833-0.json |
| 95834-8 | Mononuclear cells [#] in Blood product unit | ./2.16.840.1.114222.4.11.1002/95834-8.json |
| 95835-5 | CD34 cells [#] in Blood product unit | ./2.16.840.1.114222.4.11.1002/95835-5.json |
| 9583-6 | Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9583-6.json |
| 95836-3 | CD3 cells [#] in Blood product unit | ./2.16.840.1.114222.4.11.1002/95836-3.json |
| 9584-4 | Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9584-4.json |
| 9585-1 | Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9585-1.json |
| 95912-2 | Pneumocystis jiroveci DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95912-2.json |
| 95913-0 | Coccidioides sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95913-0.json |
| 95914-8 | Blastomyces sp DNA [Presence] in Tissue by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95914-8.json |
| 95915-5 | Coccidioides sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95915-5.json |
| 95916-3 | Blastomyces sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95916-3.json |
| 95917-1 | Histoplasma capsulatum DNA [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/95917-1.json |
| 95920-5 | Galantamine [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/95920-5.json |
| 95921-3 | Hydroxychloroquine [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/95921-3.json |
| 95922-1 | Tocilizumab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95922-1.json |
| 95923-9 | MR Heart W stress and W contrast IV | ./2.16.840.1.114222.4.11.1002/95923-9.json |
| 95924-7 | CT Skeletal system Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95924-7.json |
| 95925-4 | CT Skeletal system.axial Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95925-4.json |
| 95926-2 | CT Skeletal system.peripheral Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95926-2.json |
| 95927-0 | CT Radius Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95927-0.json |
| 95928-8 | CT Wrist Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95928-8.json |
| 95929-6 | CT Calcaneus Multisection for bone density | ./2.16.840.1.114222.4.11.1002/95929-6.json |
| 95947-8 | Alcuronium IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95947-8.json |
| 95948-6 | Aloe vera IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95948-6.json |
| 95949-4 | Glucan 1,4 alpha glucosidase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95949-4.json |
| 95950-2 | Arnica montana IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95950-2.json |
| 95951-0 | Azalea spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95951-0.json |
| 95952-8 | Azorubine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95952-8.json |
| 95953-6 | Aminoglycoside Mix (Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95953-6.json |
| 95955-1 | Butylparaben IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95955-1.json |
| 95956-9 | Lemon grass IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95956-9.json |
| 95957-7 | Rooibos IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95957-7.json |
| 95958-5 | Italian chicory Radicchio IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95958-5.json |
| 95959-3 | Black salsify IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95959-3.json |
| 95960-1 | Tetrachlorophthalic anhydride IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95960-1.json |
| 95961-9 | House dust Japan IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95961-9.json |
| 95962-7 | Tree Allergen Oak Mix (White oak+Red oak+Black Oak) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95962-7.json |
| 95963-5 | Quince IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95963-5.json |
| 95964-3 | European gooseberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95964-3.json |
| 95965-0 | Ethylparaben IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95965-0.json |
| 95966-8 | Aspergillus glaucus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95966-8.json |
| 95967-6 | Freesia spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95967-6.json |
| 95968-4 | Gerbera spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/95968-4.json |
| 95970-0 | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing | ./2.16.840.1.114222.4.11.1002/95970-0.json |
| 9600-8 | Taenia solium larva Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/9600-8.json |
| 96043-5 | Uracil [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96043-5.json |
| 96044-3 | Human epididymis protein 4 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96044-3.json |
| 96045-0 | Osmotic fragility of Red Blood Cells--10% glucose 48 hour 37 degree C incubation | ./2.16.840.1.114222.4.11.1002/96045-0.json |
| 96047-6 | T cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/96047-6.json |
| 96049-2 | B cell crossmatch [Presence] in Patient serum and Donor blood by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/96049-2.json |
| 960-5 | C sup(w) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/960-5.json |
| 96056-7 | Borrelia sp DNA [Presence] in Blood by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96056-7.json |
| 96057-5 | Interferon beta IgG Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/96057-5.json |
| 96058-3 | Mitragynine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/96058-3.json |
| 96059-1 | Mitragynine [Mass/volume] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/96059-1.json |
| 96091-4 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96091-4.json |
| 96107-8 | Bedaquiline [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96107-8.json |
| 96108-6 | Clofazimine [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96108-6.json |
| 96109-4 | Delamanid [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96109-4.json |
| 96110-2 | Ethionamide [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96110-2.json |
| 96111-0 | Linezolid [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96111-0.json |
| 96112-8 | Moxifloxacin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96112-8.json |
| 96113-6 | Rifabutin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96113-6.json |
| 96114-4 | Streptomycin [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96114-4.json |
| 9611-5 | Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9611-5.json |
| 96119-3 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96119-3.json |
| 96120-1 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96120-1.json |
| 96121-9 | SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96121-9.json |
| 96122-7 | SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96122-7.json |
| 96123-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96123-5.json |
| 96126-8 | Recreational therapy Evaluation note | ./2.16.840.1.114222.4.11.1002/96126-8.json |
| 96127-6 | General medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96127-6.json |
| 96128-4 | Colon and rectal surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96128-4.json |
| 96129-2 | Neurological surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96129-2.json |
| 96130-0 | Surgical oncology Evaluation note | ./2.16.840.1.114222.4.11.1002/96130-0.json |
| 96131-8 | Oral and Maxillofacial Surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96131-8.json |
| 96132-6 | Cardiac surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96132-6.json |
| 96133-4 | Pharmacology Evaluation note | ./2.16.840.1.114222.4.11.1002/96133-4.json |
| 96134-2 | Occupational therapy Evaluation note | ./2.16.840.1.114222.4.11.1002/96134-2.json |
| 96135-9 | Nutrition and dietetics Evaluation note | ./2.16.840.1.114222.4.11.1002/96135-9.json |
| 96136-7 | Palliative care Evaluation note | ./2.16.840.1.114222.4.11.1002/96136-7.json |
| 96137-5 | Oncology Evaluation note | ./2.16.840.1.114222.4.11.1002/96137-5.json |
| 96138-3 | Obstetrics Evaluation note | ./2.16.840.1.114222.4.11.1002/96138-3.json |
| 96139-1 | Neurology Evaluation note | ./2.16.840.1.114222.4.11.1002/96139-1.json |
| 96140-9 | Nephrology Evaluation note | ./2.16.840.1.114222.4.11.1002/96140-9.json |
| 96141-7 | Neonatal perinatal medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96141-7.json |
| 96142-5 | Mental health Evaluation note | ./2.16.840.1.114222.4.11.1002/96142-5.json |
| 96143-3 | Gynecology Evaluation note | ./2.16.840.1.114222.4.11.1002/96143-3.json |
| 96144-1 | Geriatric medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96144-1.json |
| 96145-8 | Emergency medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96145-8.json |
| 96146-6 | Critical care medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96146-6.json |
| 96147-4 | Vascular surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96147-4.json |
| 96148-2 | Transplant surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96148-2.json |
| 96149-0 | Cardiothoracic surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96149-0.json |
| 96150-8 | Plastic surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96150-8.json |
| 96151-6 | Pediatric surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96151-6.json |
| 96152-4 | Orthopaedic surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96152-4.json |
| 96153-2 | Gastroenterology Evaluation note | ./2.16.840.1.114222.4.11.1002/96153-2.json |
| 96154-0 | Pulmonary Evaluation note | ./2.16.840.1.114222.4.11.1002/96154-0.json |
| 96155-7 | Wound care management Evaluation note | ./2.16.840.1.114222.4.11.1002/96155-7.json |
| 96156-5 | Trauma Evaluation note | ./2.16.840.1.114222.4.11.1002/96156-5.json |
| 96157-3 | Sports medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96157-3.json |
| 96158-1 | Urology Evaluation note | ./2.16.840.1.114222.4.11.1002/96158-1.json |
| 96159-9 | Otolaryngology Evaluation note | ./2.16.840.1.114222.4.11.1002/96159-9.json |
| 96160-7 | Endocrinology Evaluation note | ./2.16.840.1.114222.4.11.1002/96160-7.json |
| 96161-5 | Infectious disease Evaluation note | ./2.16.840.1.114222.4.11.1002/96161-5.json |
| 96162-3 | Nurse practitioner Evaluation note | ./2.16.840.1.114222.4.11.1002/96162-3.json |
| 96163-1 | Nurse Evaluation note | ./2.16.840.1.114222.4.11.1002/96163-1.json |
| 9616-4 | 17-Hydroxyprogesterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9616-4.json |
| 96164-9 | Speech-language pathology Evaluation note | ./2.16.840.1.114222.4.11.1002/96164-9.json |
| 96165-6 | Respiratory therapy Evaluation note | ./2.16.840.1.114222.4.11.1002/96165-6.json |
| 96166-4 | Bariatric surgery Evaluation note | ./2.16.840.1.114222.4.11.1002/96166-4.json |
| 96167-2 | Cardiopulmonary Evaluation note | ./2.16.840.1.114222.4.11.1002/96167-2.json |
| 96168-0 | Child and adolescent psychology Evaluation note | ./2.16.840.1.114222.4.11.1002/96168-0.json |
| 96169-8 | Dermatology Evaluation note | ./2.16.840.1.114222.4.11.1002/96169-8.json |
| 96170-6 | Telephone encounter Evaluation note | ./2.16.840.1.114222.4.11.1002/96170-6.json |
| 96171-4 | Heart failure Evaluation note | ./2.16.840.1.114222.4.11.1002/96171-4.json |
| 9617-2 | Chylomicrons [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/9617-2.json |
| 96172-2 | Clinical genetics Evaluation note | ./2.16.840.1.114222.4.11.1002/96172-2.json |
| 96173-0 | Clinical pathology Evaluation note | ./2.16.840.1.114222.4.11.1002/96173-0.json |
| 96174-8 | Interventional radiology Evaluation note | ./2.16.840.1.114222.4.11.1002/96174-8.json |
| 96175-5 | Kinesiotherapy Evaluation note | ./2.16.840.1.114222.4.11.1002/96175-5.json |
| 96176-3 | Ophthalmology Evaluation note | ./2.16.840.1.114222.4.11.1002/96176-3.json |
| 96177-1 | Pain medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/96177-1.json |
| 96178-9 | Physical medicine and rehab Evaluation note | ./2.16.840.1.114222.4.11.1002/96178-9.json |
| 96179-7 | Podiatry Evaluation note | ./2.16.840.1.114222.4.11.1002/96179-7.json |
| 9618-0 | Cholesterol [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/9618-0.json |
| 96180-5 | Psychology Evaluation note | ./2.16.840.1.114222.4.11.1002/96180-5.json |
| 96181-3 | Rheumatology Evaluation note | ./2.16.840.1.114222.4.11.1002/96181-3.json |
| 96182-1 | Plastic surgery Photographic image | ./2.16.840.1.114222.4.11.1002/96182-1.json |
| 96183-9 | Dermatology Photographic image | ./2.16.840.1.114222.4.11.1002/96183-9.json |
| 96184-7 | Wound care management Photographic image | ./2.16.840.1.114222.4.11.1002/96184-7.json |
| 9619-8 | Triglyceride [Mass/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/9619-8.json |
| 9622-2 | Phytonadione [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9622-2.json |
| 9624-8 | Vanillylmandelate [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9624-8.json |
| 9625-5 | Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9625-5.json |
| 96256-3 | Copper free [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96256-3.json |
| 96257-1 | Copper free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96257-1.json |
| 96258-9 | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Calculated by Martin-Hopkins | ./2.16.840.1.114222.4.11.1002/96258-9.json |
| 96259-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Calculated by Martin-Hopkins | ./2.16.840.1.114222.4.11.1002/96259-7.json |
| 96260-5 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96260-5.json |
| 96261-3 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96261-3.json |
| 96262-1 | Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma | ./2.16.840.1.114222.4.11.1002/96262-1.json |
| 9626-3 | Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9626-3.json |
| 96263-9 | aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96263-9.json |
| 96264-7 | aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96264-7.json |
| 96265-4 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96265-4.json |
| 96266-2 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:1 normal plasma | ./2.16.840.1.114222.4.11.1002/96266-2.json |
| 96267-0 | Delta aPTT W excess hexagonal phospholipid [Time] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/96267-0.json |
| 96270-4 | Cyclin-dependent kinase 4 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/96270-4.json |
| 9627-1 | Imipramine+Desipramine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9627-1.json |
| 96271-2 | DNA mismatch repair protein Msh3 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/96271-2.json |
| 96272-0 | DNA mismatch repair protein Mlh3 [Presence] in Cancer specimen by Immune stain | ./2.16.840.1.114222.4.11.1002/96272-0.json |
| 96273-8 | HIV 1 RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96273-8.json |
| 96274-6 | American Beech wood dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96274-6.json |
| 96275-3 | Ammonium persulfate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96275-3.json |
| 96276-1 | Blackcurrant IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96276-1.json |
| 96277-9 | carBAMazepine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96277-9.json |
| 96278-7 | Dermatophagoides pteronyssinus recombinant (rDer p) 23 IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96278-7.json |
| 96279-5 | European silver fir wood dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96279-5.json |
| 96280-3 | European Ash wood dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96280-3.json |
| 96281-1 | European pigeon tick IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96281-1.json |
| 96282-9 | Coagulation factor XII inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/96282-9.json |
| 96283-7 | Gliadin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96283-7.json |
| 96284-5 | Hay dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96284-5.json |
| 96285-2 | Indomethacin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96285-2.json |
| 96286-0 | Ketoprofen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96286-0.json |
| 96287-8 | Macrolide Mix (Amphotericin B+Erythromycin+Nystatin+Spiramycin) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96287-8.json |
| 96288-6 | Methylene blue IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96288-6.json |
| 9628-9 | O-desmethylvenlafaxine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9628-9.json |
| 96289-4 | Morphine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96289-4.json |
| 96290-2 | predniSONE IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96290-2.json |
| 96291-0 | Pregnenolone sulfate [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96291-0.json |
| 96292-8 | Quinoline IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96292-8.json |
| 96293-6 | Sodium nitrite IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96293-6.json |
| 96294-4 | Straw dust IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96294-4.json |
| 96295-1 | Streptomycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96295-1.json |
| 96296-9 | Thuja spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96296-9.json |
| 9629-7 | TOLAZamide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9629-7.json |
| 96297-7 | Cobalamin (Vitamin B12) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96297-7.json |
| 96300-9 | Cell growth [Presence] of Fibroblast in Tissue culture | ./2.16.840.1.114222.4.11.1002/96300-9.json |
| 9630-5 | Venlafaxine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9630-5.json |
| 9631-3 | Viscosity of Semen | ./2.16.840.1.114222.4.11.1002/9631-3.json |
| 96315-7 | Gaps in care report | ./2.16.840.1.114222.4.11.1002/96315-7.json |
| 96316-5 | AMPAR1+AMPAR2 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/96316-5.json |
| 96317-3 | Acinetobacter calcoaceticus-baumannii complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96317-3.json |
| 96318-1 | Enterobacter cloacae complex DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96318-1.json |
| 96319-9 | Escherichia coli DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96319-9.json |
| 96320-7 | Streptococcus agalactiae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96320-7.json |
| 9632-1 | Aspergillus fumigatus Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/9632-1.json |
| 96321-5 | Haemophilus influenzae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96321-5.json |
| 96322-3 | Klebsiella oxytoca DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96322-3.json |
| 96323-1 | Klebsiella aerogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96323-1.json |
| 96324-9 | Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96324-9.json |
| 96325-6 | Moraxella catarrhalis DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96325-6.json |
| 96326-4 | Pseudomonas aeruginosa DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96326-4.json |
| 96327-2 | Proteus sp DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96327-2.json |
| 96328-0 | Staphylococcus aureus DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96328-0.json |
| 96329-8 | Serratia marcescens DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96329-8.json |
| 96330-6 | Streptococcus pneumoniae DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96330-6.json |
| 96331-4 | Streptococcus pyogenes DNA [NCncRange] in Lower respiratory specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96331-4.json |
| 96332-2 | Case manager Telehealth Note | ./2.16.840.1.114222.4.11.1002/96332-2.json |
| 96333-0 | Custodial care facility procedure note | ./2.16.840.1.114222.4.11.1002/96333-0.json |
| 96334-8 | Diabetology Diagnostic study note | ./2.16.840.1.114222.4.11.1002/96334-8.json |
| 96335-5 | Emergency department Summary note | ./2.16.840.1.114222.4.11.1002/96335-5.json |
| 96336-3 | Environmental health Outpatient Note | ./2.16.840.1.114222.4.11.1002/96336-3.json |
| 96337-1 | Hematology Outpatient Note | ./2.16.840.1.114222.4.11.1002/96337-1.json |
| 96338-9 | Hepatology Progress note | ./2.16.840.1.114222.4.11.1002/96338-9.json |
| 9633-9 | Epstein Barr virus capsid IgA Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9633-9.json |
| 96339-7 | Hospital Summary note | ./2.16.840.1.114222.4.11.1002/96339-7.json |
| 96340-5 | Integrative medicine Note | ./2.16.840.1.114222.4.11.1002/96340-5.json |
| 96341-3 | Obesity medicine Outpatient Note | ./2.16.840.1.114222.4.11.1002/96341-3.json |
| 96342-1 | Oral and Maxillofacial Surgery Progress note | ./2.16.840.1.114222.4.11.1002/96342-1.json |
| 96343-9 | Oncology Outpatient Note | ./2.16.840.1.114222.4.11.1002/96343-9.json |
| 96344-7 | Oncology Summary note | ./2.16.840.1.114222.4.11.1002/96344-7.json |
| 96345-4 | Outpatient Summary note | ./2.16.840.1.114222.4.11.1002/96345-4.json |
| 96346-2 | Orthotics prosthetics Administrative note | ./2.16.840.1.114222.4.11.1002/96346-2.json |
| 9634-7 | Saint Louis encephalitis virus IgG Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/9634-7.json |
| 96347-0 | Radiology Consent Document | ./2.16.840.1.114222.4.11.1002/96347-0.json |
| 96348-8 | Radiology Outpatient Note | ./2.16.840.1.114222.4.11.1002/96348-8.json |
| 96349-6 | Referral letter | ./2.16.840.1.114222.4.11.1002/96349-6.json |
| 96350-4 | Sleep medicine Progress note | ./2.16.840.1.114222.4.11.1002/96350-4.json |
| 96351-2 | Urgent care center procedure note | ./2.16.840.1.114222.4.11.1002/96351-2.json |
| 96352-0 | Wound care management Outpatient Note | ./2.16.840.1.114222.4.11.1002/96352-0.json |
| 96353-8 | Wound care management procedure note | ./2.16.840.1.114222.4.11.1002/96353-8.json |
| 9635-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Specimen | ./2.16.840.1.114222.4.11.1002/9635-4.json |
| 96355-3 | Equine herpesvirus 1 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/96355-3.json |
| 96356-1 | Equine herpesvirus 3 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/96356-1.json |
| 96357-9 | Equine herpesvirus 4 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/96357-9.json |
| 96358-7 | Bovine parainfluenza virus 3 [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/96358-7.json |
| 96359-5 | 7-Aminoclonazepam [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96359-5.json |
| 96360-3 | Dextromethorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96360-3.json |
| 96361-1 | Dextromethorphan [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96361-1.json |
| 9636-2 | Varicella zoster virus Ab [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9636-2.json |
| 96362-9 | Dextrorphan [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96362-9.json |
| 96363-7 | Dextrorphan+Levorphanol [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96363-7.json |
| 96364-5 | Gabapentin [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96364-5.json |
| 96365-2 | Naltrexol [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96365-2.json |
| 96366-0 | Naltrexone [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96366-0.json |
| 96367-8 | Pregabalin [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96367-8.json |
| 96368-6 | Pregabalin [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96368-6.json |
| 96369-4 | Sertraline [Mass/volume] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96369-4.json |
| 9637-0 | Toluene [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9637-0.json |
| 96370-2 | Sertraline [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96370-2.json |
| 96371-0 | Tapentadol [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96371-0.json |
| 96372-8 | Imipenem+Relebactam [Susceptibility] | ./2.16.840.1.114222.4.11.1002/96372-8.json |
| 96373-6 | Bone Marrow Transplant Admission evaluation note | ./2.16.840.1.114222.4.11.1002/96373-6.json |
| 96374-4 | Dialysis and Therapeutic apheresis Admission evaluation note | ./2.16.840.1.114222.4.11.1002/96374-4.json |
| 96375-1 | Endocrinology Surgical operation note | ./2.16.840.1.114222.4.11.1002/96375-1.json |
| 96376-9 | Neonatal perinatal medicine Surgical operation note | ./2.16.840.1.114222.4.11.1002/96376-9.json |
| 96377-7 | Nephrology Surgical operation note | ./2.16.840.1.114222.4.11.1002/96377-7.json |
| 96378-5 | Wound care management Discharge summary | ./2.16.840.1.114222.4.11.1002/96378-5.json |
| 96379-3 | Wound care management History and physical note | ./2.16.840.1.114222.4.11.1002/96379-3.json |
| 96382-7 | Healed wound information Document | ./2.16.840.1.114222.4.11.1002/96382-7.json |
| 96383-5 | Health-related behaviors and treatment compliance Document | ./2.16.840.1.114222.4.11.1002/96383-5.json |
| 96386-8 | Physical impairment information Document | ./2.16.840.1.114222.4.11.1002/96386-8.json |
| 9638-8 | Toluene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9638-8.json |
| 96391-8 | Wound classification and diagnoses | ./2.16.840.1.114222.4.11.1002/96391-8.json |
| 9639-6 | 18-Hydroxycorticosterone [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9639-6.json |
| 96396-7 | Cytomegalovirus DNA [log units/volume] (viral load) in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96396-7.json |
| 96397-5 | Microbiology - mycobacteriology studies Document | ./2.16.840.1.114222.4.11.1002/96397-5.json |
| 96398-3 | Microbiology - mycology studies Document | ./2.16.840.1.114222.4.11.1002/96398-3.json |
| 9640-4 | Androstanediol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9640-4.json |
| 9641-2 | Catecholamines/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/9641-2.json |
| 96420-5 | Daratumumab [Presence] in Serum by Immunofixation | ./2.16.840.1.114222.4.11.1002/96420-5.json |
| 96421-3 | Testosterone [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96421-3.json |
| 96422-1 | Cortisone [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96422-1.json |
| 96423-9 | Progesterone [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96423-9.json |
| 96424-7 | Testosterone/Cortisol [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/96424-7.json |
| 96425-4 | Cortisol/Cortisone [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/96425-4.json |
| 96426-2 | Fetal Nasal bone | ./2.16.840.1.114222.4.11.1002/96426-2.json |
| 96427-0 | Borrelia burgdorferi IgM Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/96427-0.json |
| 96428-8 | Borrelia burgdorferi IgA Ab [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/96428-8.json |
| 9644-6 | Cystine [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9644-6.json |
| 96448-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1 | ./2.16.840.1.114222.4.11.1002/96448-6.json |
| 96449-4 | Cell growth [Presence] of Tumor in Tissue culture | ./2.16.840.1.114222.4.11.1002/96449-4.json |
| 96454-4 | Coagulation factor II inhibitor [Presence] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/96454-4.json |
| 96460-1 | Thyroglobulin [Mass/volume] in Serum or Plasma by Immunoassay --post thyroglobulin antibody neutralization | ./2.16.840.1.114222.4.11.1002/96460-1.json |
| 9646-1 | Sulfide [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9646-1.json |
| 96461-9 | Gastrin releasing polypeptide prohormone [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/96461-9.json |
| 96462-7 | Sirolimus [Moles/volume] in Blood by Immunoassay | ./2.16.840.1.114222.4.11.1002/96462-7.json |
| 96463-5 | Copper free/Total copper in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/96463-5.json |
| 96464-3 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96464-3.json |
| 96465-0 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96465-0.json |
| 96467-6 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96467-6.json |
| 96469-2 | Inositol 1,4,5-trisphosphate receptor type 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96469-2.json |
| 96471-8 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96471-8.json |
| 96473-4 | Rho GTPase-activating protein 26 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96473-4.json |
| 96474-2 | Rho GTPase-activating protein 26 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96474-2.json |
| 96476-7 | IgLON5 IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96476-7.json |
| 96477-5 | IgLON5 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96477-5.json |
| 9647-9 | Thiosulfate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/9647-9.json |
| 96479-1 | IgLON5 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96479-1.json |
| 96480-9 | IgLON5 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96480-9.json |
| 96486-6 | Neuronal intermediate filament IgG Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96486-6.json |
| 9648-7 | Chlorothiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9648-7.json |
| 96487-4 | Neuronal intermediate filament IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96487-4.json |
| 96490-8 | Neuronal intermediate filament IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96490-8.json |
| 96491-6 | Neuronal intermediate filament IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/96491-6.json |
| 96492-4 | CD3+CD8+CD27+CD45RO+CD62L+ cells [#/volume] in Blood | ./2.16.840.1.114222.4.11.1002/96492-4.json |
| 96494-0 | ABL1 and ABL2 and PDGFRB gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/96494-0.json |
| 9649-5 | Hydroflumethiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9649-5.json |
| 96495-7 | ABL2 gene rearrangements in Blood or Tissue by FISH | ./2.16.840.1.114222.4.11.1002/96495-7.json |
| 96496-5 | Glycine receptor alpha-1 subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/96496-5.json |
| 96497-3 | Glycine receptor alpha-1 subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/96497-3.json |
| 96501-2 | TIF1-gamma Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96501-2.json |
| 9650-3 | Methyclothiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9650-3.json |
| 96503-8 | Adenovirus DNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96503-8.json |
| 96505-3 | Colorado tick fever virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96505-3.json |
| 96506-1 | Oropouche virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96506-1.json |
| 96507-9 | California encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96507-9.json |
| 96508-7 | Bunyamwera virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96508-7.json |
| 96509-5 | Tick-borne encephalitis virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96509-5.json |
| 96510-3 | Heartland banyangvirus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96510-3.json |
| 9651-1 | metOLazone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9651-1.json |
| 96511-1 | Bwamba virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96511-1.json |
| 96512-9 | Rift valley fever virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96512-9.json |
| 96513-7 | Sandfly fever Naples virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96513-7.json |
| 96514-5 | Cache valley virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96514-5.json |
| 96515-2 | Sandfly fever Sicilian virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96515-2.json |
| 96516-0 | Toscana virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96516-0.json |
| 96517-8 | Bourbon virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96517-8.json |
| 96518-6 | Onyong-nyong virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96518-6.json |
| 96519-4 | Semliki Forest virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96519-4.json |
| 96520-2 | Ilheus virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96520-2.json |
| 96521-0 | Cache valley virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96521-0.json |
| 96522-8 | Colorado tick fever virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96522-8.json |
| 96523-6 | Ilheus virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96523-6.json |
| 96524-4 | Rocio virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96524-4.json |
| 96525-1 | Semliki Forest virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96525-1.json |
| 96526-9 | Onyong-nyong virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96526-9.json |
| 96527-7 | Bourbon virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96527-7.json |
| 96528-5 | Toscana virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96528-5.json |
| 9652-9 | N-desalkylflurazepam [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9652-9.json |
| 96529-3 | Sandfly fever Sicilian virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96529-3.json |
| 96530-1 | Sandfly fever Naples virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96530-1.json |
| 96531-9 | Oropouche virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96531-9.json |
| 96532-7 | Rift valley fever virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96532-7.json |
| 96533-5 | Bwamba virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96533-5.json |
| 96534-3 | Heartland banyangvirus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96534-3.json |
| 96535-0 | Tick-borne encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96535-0.json |
| 96536-8 | Bunyamwera virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96536-8.json |
| 9653-7 | Trichlormethiazide [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9653-7.json |
| 96537-6 | California encephalitis virus IgM Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96537-6.json |
| 96538-4 | Rocio virus IgG Ab [Presence] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/96538-4.json |
| 9654-5 | Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9654-5.json |
| 9655-2 | Campylobacter jejuni Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9655-2.json |
| 96554-1 | Eutylone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96554-1.json |
| 96555-8 | Eutylone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/96555-8.json |
| 96556-6 | HIV 1 and 2 RNA [Identifier] in Serum or Plasma by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96556-6.json |
| 96559-0 | Testosterone Free [Moles/volume] in Serum or Plasma by calculation | ./2.16.840.1.114222.4.11.1002/96559-0.json |
| 9656-0 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9656-0.json |
| 96560-8 | Nuclear pore protein gp210 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96560-8.json |
| 96561-6 | Citrullinated alpha enolase peptide 1 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96561-6.json |
| 96562-4 | Cytosolic 5'-nucleotidase 1A Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96562-4.json |
| 96563-2 | Inner ear 68kD IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96563-2.json |
| 96564-0 | Inner ear Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96564-0.json |
| 96565-7 | sp100 Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96565-7.json |
| 96566-5 | Cabotegravir [Susceptibility] by Genotype method | ./2.16.840.1.114222.4.11.1002/96566-5.json |
| 96567-3 | Toxocara sp IgG Ab [Presence] in Ocular fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/96567-3.json |
| 96568-1 | Toxocara sp IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/96568-1.json |
| 9657-8 | Echinococcus sp IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9657-8.json |
| 9658-6 | Giardia lamblia IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9658-6.json |
| 96586-3 | Alanine aminotransferase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96586-3.json |
| 96587-1 | Aspartate aminotransferase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96587-1.json |
| 96588-9 | Cholesterol [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96588-9.json |
| 96589-7 | Cholesterol.total/Cholesterol in HDL [Mass Ratio] in DBS | ./2.16.840.1.114222.4.11.1002/96589-7.json |
| 96590-5 | Creatinine [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96590-5.json |
| 96591-3 | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in DBS | ./2.16.840.1.114222.4.11.1002/96591-3.json |
| 96592-1 | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in DBS | ./2.16.840.1.114222.4.11.1002/96592-1.json |
| 96593-9 | Gamma glutamyl transferase [Enzymatic activity/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96593-9.json |
| 9659-4 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/9659-4.json |
| 96594-7 | Glucose [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96594-7.json |
| 96595-4 | Hemoglobin A1c/Hemoglobin.total in DBS | ./2.16.840.1.114222.4.11.1002/96595-4.json |
| 96596-2 | Cholesterol in HDL [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96596-2.json |
| 96597-0 | Cholesterol in LDL [Mass/volume] in DBS by Direct assay | ./2.16.840.1.114222.4.11.1002/96597-0.json |
| 96598-8 | Triglyceride [Mass/volume] in DBS | ./2.16.840.1.114222.4.11.1002/96598-8.json |
| 96599-6 | Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96599-6.json |
| 96601-0 | Bacilliform bacteria [Presence] in Skin by Light microscopy | ./2.16.840.1.114222.4.11.1002/96601-0.json |
| 96603-6 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT | ./2.16.840.1.114222.4.11.1002/96603-6.json |
| 96604-4 | Acrylic fiber IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96604-4.json |
| 96605-1 | Sugar cane pollen IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96605-1.json |
| 96606-9 | Treated sheep wool IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96606-9.json |
| 96613-5 | HLA-A [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96613-5.json |
| 96618-4 | HLA-B [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96618-4.json |
| 966-2 | C sup(x) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/966-2.json |
| 96621-8 | HLA-C [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96621-8.json |
| 96626-7 | HLA-A [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96626-7.json |
| 96627-5 | HLA-A [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96627-5.json |
| 96630-9 | HLA-B [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96630-9.json |
| 96631-7 | HLA-B [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96631-7.json |
| 96632-5 | HLA-Bw [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96632-5.json |
| 96633-3 | HLA-Bw [Type] | ./2.16.840.1.114222.4.11.1002/96633-3.json |
| 96634-1 | HLA-C [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96634-1.json |
| 96635-8 | HLA-C [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96635-8.json |
| 96636-6 | HLA-C [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96636-6.json |
| 96641-6 | HLA-DPA1 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96641-6.json |
| 96642-4 | HLA-DPA1 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96642-4.json |
| 96643-2 | HLA-DPA1 [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96643-2.json |
| 96646-5 | HLA-DPB1 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96646-5.json |
| 96647-3 | HLA-DPB1 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96647-3.json |
| 96648-1 | HLA-DPB1 [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96648-1.json |
| 9665-1 | HIV 1 p24 Ag [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9665-1.json |
| 96652-3 | HLA-DQA1 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96652-3.json |
| 96653-1 | HLA-DQA1 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96653-1.json |
| 96654-9 | HLA-DQA1 [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96654-9.json |
| 96657-2 | HLA-DQB1 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96657-2.json |
| 96658-0 | HLA-DQB1 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96658-0.json |
| 96659-8 | HLA-DQB1 [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96659-8.json |
| 96662-2 | HLA-DRB1 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96662-2.json |
| 96663-0 | HLA-DRB1 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96663-0.json |
| 96664-8 | HLA-DRB1 [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96664-8.json |
| 96665-5 | HLA-DRB1 [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96665-5.json |
| 96668-9 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by High resolution | ./2.16.840.1.114222.4.11.1002/96668-9.json |
| 96669-7 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor by Low resolution | ./2.16.840.1.114222.4.11.1002/96669-7.json |
| 96670-5 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] in Donor | ./2.16.840.1.114222.4.11.1002/96670-5.json |
| 96671-3 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/96671-3.json |
| 96672-1 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/96672-1.json |
| 96673-9 | HLA-DRB3 and HLA-DRB4 and HLA DRB5 [Type] | ./2.16.840.1.114222.4.11.1002/96673-9.json |
| 9670-1 | Plasmodium malariae IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9670-1.json |
| 96701-8 | Carbon monoxide/Gas total corrected for ambient CO Exhaled gas --at end expiration | ./2.16.840.1.114222.4.11.1002/96701-8.json |
| 96717-4 | pH of Prostatic fluid | ./2.16.840.1.114222.4.11.1002/96717-4.json |
| 9671-9 | Plasmodium malariae IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9671-9.json |
| 96724-0 | Alveolar macrophages [#/volume] in Lower respiratory specimen by Manual count | ./2.16.840.1.114222.4.11.1002/96724-0.json |
| 9672-7 | Salmonella sp IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9672-7.json |
| 96733-1 | Connective tissue [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/96733-1.json |
| 96734-9 | Fatty acid salts [Presence] in Stool by Light microscopy | ./2.16.840.1.114222.4.11.1002/96734-9.json |
| 9673-5 | Salmonella sp IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9673-5.json |
| 96735-6 | Lipoprotein.beta.subparticle.medium [Moles/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96735-6.json |
| 96736-4 | COVID-19 Procedure note | ./2.16.840.1.114222.4.11.1002/96736-4.json |
| 96737-2 | COVID-19 Consultation note | ./2.16.840.1.114222.4.11.1002/96737-2.json |
| 96738-0 | COVID-19 letter | ./2.16.840.1.114222.4.11.1002/96738-0.json |
| 96739-8 | Telehealth COVID-19 note | ./2.16.840.1.114222.4.11.1002/96739-8.json |
| 96740-6 | COVID-19 note | ./2.16.840.1.114222.4.11.1002/96740-6.json |
| 96741-4 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing | ./2.16.840.1.114222.4.11.1002/96741-4.json |
| 96742-2 | SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/96742-2.json |
| 9674-3 | Salmonella sp IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9674-3.json |
| 9675-0 | Silicone IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9675-0.json |
| 96751-3 | SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/96751-3.json |
| 96756-2 | SARS-CoV-2 (COVID-19) S gene codon N501= [Presence] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/96756-2.json |
| 96757-0 | SARS-CoV-2 (COVID-19) S gene codon N501Y [Presence] in Specimen by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/96757-0.json |
| 96763-8 | SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96763-8.json |
| 96764-6 | SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96764-6.json |
| 96765-3 | SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96765-3.json |
| 96766-1 | GISAID sequence accession number | ./2.16.840.1.114222.4.11.1002/96766-1.json |
| 9676-8 | Silicone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9676-8.json |
| 9677-6 | Silicone IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9677-6.json |
| 9678-4 | Silicone IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9678-4.json |
| 9679-2 | Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9679-2.json |
| 96793-5 | Softwood Mix (Beech+Pine+Red cedar+Silver fir) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/96793-5.json |
| 96794-3 | Hardwood Mix (Oak+Mahogany+West Red Cedar+Abachi) IgE Ab [Units/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/96794-3.json |
| 96795-0 | Hexacarboxylporphyrins [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/96795-0.json |
| 96797-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96797-6.json |
| 96799-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine | ./2.16.840.1.114222.4.11.1002/96799-2.json |
| 96800-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine | ./2.16.840.1.114222.4.11.1002/96800-8.json |
| 96806-5 | Ginseng IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96806-5.json |
| 96807-3 | Vancomycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96807-3.json |
| 96808-1 | Thiamine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96808-1.json |
| 96809-9 | Cyanocobalamin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96809-9.json |
| 96810-7 | White willow IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96810-7.json |
| 96811-5 | Heather IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96811-5.json |
| 96812-3 | Chervil IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96812-3.json |
| 96813-1 | Goat milk cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96813-1.json |
| 96814-9 | Sheep milk cheese IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96814-9.json |
| 96815-6 | Piper gurnard IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96815-6.json |
| 96816-4 | Tetracaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96816-4.json |
| 96817-2 | Thermoactinomyces candidus IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96817-2.json |
| 9681-8 | 1-Naphthol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9681-8.json |
| 96818-0 | English yew IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96818-0.json |
| 96819-8 | Roxithromycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96819-8.json |
| 96820-6 | Arugula IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96820-6.json |
| 96821-4 | Propylparaben IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96821-4.json |
| 96822-2 | Spurge IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/96822-2.json |
| 96829-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96829-7.json |
| 9683-4 | 2-Methyl-2-Propanol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9683-4.json |
| 9684-2 | Bendiocarb [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9684-2.json |
| 9685-9 | Butanol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9685-9.json |
| 9686-7 | Cadmium [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9686-7.json |
| 96874-3 | COVID-19 Immunization note | ./2.16.840.1.114222.4.11.1002/96874-3.json |
| 9687-5 | Cadmium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9687-5.json |
| 9689-1 | Carbofuran [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9689-1.json |
| 96893-3 | ERBB2 gene duplication in Tumor by FISH | ./2.16.840.1.114222.4.11.1002/96893-3.json |
| 9690-9 | Chromium [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9690-9.json |
| 96909-7 | Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method | ./2.16.840.1.114222.4.11.1002/96909-7.json |
| 9691-7 | Cobalt [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9691-7.json |
| 96918-8 | Fodrin alpha subunit IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/96918-8.json |
| 9692-5 | Isobutanol [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9692-5.json |
| 96928-7 | Fodrin alpha subunit IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/96928-7.json |
| 9693-3 | Mercury [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9693-3.json |
| 9694-1 | Propoxur [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9694-1.json |
| 96957-6 | SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96957-6.json |
| 9695-8 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/9695-8.json |
| 96958-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2 | ./2.16.840.1.114222.4.11.1002/96958-4.json |
| 96959-2 | Cholesterol.in LDL.small dense [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/96959-2.json |
| 96961-8 | Varicella zoster virus IgG Ab index [Units/volume] in Serum and CSF | ./2.16.840.1.114222.4.11.1002/96961-8.json |
| 96962-6 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96962-6.json |
| 96963-4 | Grimontia holisae and Vibrio fluvialis and Vibrio harveyi DNA [Identifier] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/96963-4.json |
| 96964-2 | EZH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96964-2.json |
| 96965-9 | CARD11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96965-9.json |
| 9696-6 | 8-Hydroxyloxapine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9696-6.json |
| 96966-7 | CD79A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96966-7.json |
| 96967-5 | CD79B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96967-5.json |
| 96968-3 | TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96968-3.json |
| 96969-1 | MYD88 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96969-1.json |
| 96970-9 | TP53 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96970-9.json |
| 96971-7 | STK11 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96971-7.json |
| 96972-5 | PTEN gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96972-5.json |
| 96973-3 | CDH1 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96973-3.json |
| 96974-1 | PALB2 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/96974-1.json |
| 96975-8 | Sub-maximal exercise stress test study | ./2.16.840.1.114222.4.11.1002/96975-8.json |
| 96984-0 | Chromosome analysis in Products of Conception by Microarray | ./2.16.840.1.114222.4.11.1002/96984-0.json |
| 96986-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/96986-5.json |
| 9699-0 | PARoxetine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9699-0.json |
| 97004-6 | Insulin type [Identifier] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/97004-6.json |
| 9700-6 | Procaine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9700-6.json |
| 9701-4 | sulfiSOXAZOLE [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9701-4.json |
| 9702-2 | Terbutaline [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9702-2.json |
| 97025-1 | BRAF gene V600 mutations [Identifier] in Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/97025-1.json |
| 9703-0 | Trihexyphenidyl [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9703-0.json |
| 9704-8 | Spermatozoa [Morphology] in Semen | ./2.16.840.1.114222.4.11.1002/9704-8.json |
| 97049-1 | p53 Ab [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97049-1.json |
| 97051-7 | Interferon beta [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97051-7.json |
| 97052-5 | Chemokine (C-C motif) ligand 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97052-5.json |
| 97053-3 | Macrophage inflammatory protein 1 alpha [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97053-3.json |
| 97054-1 | Granulocyte macrophage colony stimulating factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97054-1.json |
| 9705-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9705-5.json |
| 9706-3 | Coxiella burnetii phase 1 IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9706-3.json |
| 9707-1 | Coxiella burnetii phase 2 IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9707-1.json |
| 9708-9 | Coxiella burnetii phase 1 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9708-9.json |
| 9709-7 | Coxiella burnetii phase 2 IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9709-7.json |
| 97097-0 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/97097-0.json |
| 97098-8 | SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97098-8.json |
| 97100-2 | Colonoscopy+US Study | ./2.16.840.1.114222.4.11.1002/97100-2.json |
| 97101-0 | Flexible sigmoidoscopy+US Study | ./2.16.840.1.114222.4.11.1002/97101-0.json |
| 97102-8 | Phosphorylated tau 181/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/97102-8.json |
| 97104-4 | SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97104-4.json |
| 9710-5 | Coxiella burnetii phase 1 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9710-5.json |
| 97105-1 | Chemokine (C-C motif) ligand 2 [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/97105-1.json |
| 97106-9 | Hepatitis A virus cellular receptor 1 [Mass/volume] in Urine by Immunoassay | ./2.16.840.1.114222.4.11.1002/97106-9.json |
| 97107-7 | Fibroblast growth factor 19 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97107-7.json |
| 9711-3 | Coxiella burnetii phase 2 IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9711-3.json |
| 9712-1 | Shigella boydii Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9712-1.json |
| 9713-9 | Shigella dysenteriae Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9713-9.json |
| 9714-7 | Shigella flexneri Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9714-7.json |
| 97148-1 | Guanidinoacetate [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/97148-1.json |
| 97151-5 | Enterovirus RNA [Presence] in Serum or Plasma by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/97151-5.json |
| 97152-3 | HBc+HBe+p22cr Ag [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97152-3.json |
| 97153-1 | Primidone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97153-1.json |
| 9715-4 | Shigella sonnei Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9715-4.json |
| 97154-9 | Ecgonine methyl ester [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97154-9.json |
| 97155-6 | SARS coronavirus 2 (COVID-19) immunization status | ./2.16.840.1.114222.4.11.1002/97155-6.json |
| 97156-4 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/97156-4.json |
| 97157-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Genital specimen by Probe with signal amplification | ./2.16.840.1.114222.4.11.1002/97157-2.json |
| 97158-0 | Cytokeratin 8 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/97158-0.json |
| 97159-8 | 2-Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97159-8.json |
| 97160-6 | Norclobazam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97160-6.json |
| 9716-2 | Streptococcal hyaluronidase Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9716-2.json |
| 97162-2 | Titin Ab [Units/volume] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/97162-2.json |
| 97163-0 | Theophylline [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97163-0.json |
| 97164-8 | Triiodothyronine (T3) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97164-8.json |
| 97165-5 | Triiodothyronine (T3) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97165-5.json |
| 97166-3 | Thyroxine (T4) [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97166-3.json |
| 97167-1 | Thyroxine (T4) [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97167-1.json |
| 97168-9 | Vasopressin [Mass/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97168-9.json |
| 97169-7 | Vasopressin [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/97169-7.json |
| 9717-0 | Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9717-0.json |
| 97170-5 | Adalimumab [Mass/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/97170-5.json |
| 97171-3 | Hexacarboxylporphyrin/Creatinine [Molar ratio] in Urine | ./2.16.840.1.114222.4.11.1002/97171-3.json |
| 97181-2 | Muscle relaxants [Presence] in Saliva (oral fluid) by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97181-2.json |
| 97184-6 | Ravulizumab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97184-6.json |
| 97185-3 | West Nile virus RNA [Presence] in Urine by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97185-3.json |
| 97187-9 | Urea/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/97187-9.json |
| 9718-8 | Toxocara canis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9718-8.json |
| 97188-7 | Ryanodine receptor Ab [Presence] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/97188-7.json |
| 97189-5 | Alpha-2-Macroglobulin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/97189-5.json |
| 97190-3 | carBAMazepine [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97190-3.json |
| 97191-1 | carBAMazepine [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97191-1.json |
| 97192-9 | carBAMazepine [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/97192-9.json |
| 97193-7 | Phenytoin [Mass/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97193-7.json |
| 97194-5 | Phenytoin [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97194-5.json |
| 97195-2 | Phenytoin [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/97195-2.json |
| 9719-6 | Toxocara canis IgM Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9719-6.json |
| 97196-0 | quiNIDine [Moles/volume] in Serum or Plasma --peak | ./2.16.840.1.114222.4.11.1002/97196-0.json |
| 97197-8 | quiNIDine [Moles/volume] in Serum or Plasma --trough | ./2.16.840.1.114222.4.11.1002/97197-8.json |
| 972-0 | Weak D Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/972-0.json |
| 9720-4 | Reticulin IgA Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9720-4.json |
| 97205-9 | Tropheryma whipplei DNA [Presence] in Blood by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/97205-9.json |
| 97206-7 | Tropheryma whipplei DNA [Presence] in Specimen by NAA with non-probe detection | ./2.16.840.1.114222.4.11.1002/97206-7.json |
| 97207-5 | PCA-Tr Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/97207-5.json |
| 97210-9 | 6-monoacetylmorphine free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97210-9.json |
| 97211-7 | 6-monoacetylmorphine free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97211-7.json |
| 9721-2 | Salivary gland Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9721-2.json |
| 97212-5 | 7-Aminoclonazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97212-5.json |
| 97213-3 | 7-Aminoclonazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97213-3.json |
| 97214-1 | Acetyl fentanyl [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97214-1.json |
| 97215-8 | Acetyl fentanyl [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97215-8.json |
| 97216-6 | Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97216-6.json |
| 97217-4 | Alpha pyrrolidinovalerophenone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97217-4.json |
| 97218-2 | ALPRAZolam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97218-2.json |
| 97219-0 | ALPRAZolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97219-0.json |
| 9722-0 | Smith extractable nuclear Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9722-0.json |
| 97220-8 | Amphetamine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97220-8.json |
| 97221-6 | Amphetamine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97221-6.json |
| 97222-4 | Benzoylecgonine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97222-4.json |
| 97223-2 | Benzoylecgonine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97223-2.json |
| 97224-0 | Butalbital [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97224-0.json |
| 97225-7 | Butalbital [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97225-7.json |
| 97226-5 | Carisoprodol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97226-5.json |
| 97227-3 | Carisoprodol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97227-3.json |
| 97228-1 | chlordiazePOXIDE [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97228-1.json |
| 97229-9 | chlordiazePOXIDE [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97229-9.json |
| 97230-7 | clonazePAM [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97230-7.json |
| 97231-5 | clonazePAM [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97231-5.json |
| 97232-3 | Cocaethylene [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97232-3.json |
| 97233-1 | Cocaethylene [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97233-1.json |
| 97234-9 | Cocaine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97234-9.json |
| 97235-6 | Cocaine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97235-6.json |
| 97236-4 | Codeine Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97236-4.json |
| 97237-2 | Codeine Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97237-2.json |
| 9723-8 | Spermatozoa IgA Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9723-8.json |
| 97238-0 | N-desalkylflurazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97238-0.json |
| 97239-8 | N-desalkylflurazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97239-8.json |
| 97240-6 | diazePAM [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97240-6.json |
| 97241-4 | diazePAM [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97241-4.json |
| 97242-2 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97242-2.json |
| 97243-0 | Dihydrocodeine Free+Hydrocodol Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97243-0.json |
| 97244-8 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97244-8.json |
| 97245-5 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97245-5.json |
| 9724-6 | Spermatozoa IgG Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9724-6.json |
| 97246-3 | Ethylone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97246-3.json |
| 97247-1 | Ethylone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97247-1.json |
| 97248-9 | fentaNYL [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97248-9.json |
| 97249-7 | fentaNYL [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97249-7.json |
| 97250-5 | Flunitrazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97250-5.json |
| 97251-3 | Flunitrazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97251-3.json |
| 97252-1 | Flurazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97252-1.json |
| 9725-3 | Spermatozoa IgM Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9725-3.json |
| 97253-9 | Flurazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97253-9.json |
| 97254-7 | HYDROcodone Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97254-7.json |
| 97255-4 | HYDROcodone Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97255-4.json |
| 97256-2 | HYDROmorphone Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97256-2.json |
| 97257-0 | HYDROmorphone Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97257-0.json |
| 97258-8 | Hydroxytriazolam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97258-8.json |
| 97259-6 | Hydroxytriazolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97259-6.json |
| 97260-4 | LORazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97260-4.json |
| 9726-1 | Mescaline [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9726-1.json |
| 97261-2 | LORazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97261-2.json |
| 97262-0 | Methylenedioxyamphetamine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97262-0.json |
| 97263-8 | Methylenedioxyamphetamine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97263-8.json |
| 97264-6 | Methylenedioxyethylamphetamine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97264-6.json |
| 97265-3 | Methylenedioxyethylamphetamine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97265-3.json |
| 97266-1 | Methylenedioxymethamphetamine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97266-1.json |
| 97267-9 | Methylenedioxymethamphetamine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97267-9.json |
| 97268-7 | Meperidine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97268-7.json |
| 97269-5 | Meperidine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97269-5.json |
| 97270-3 | Meprobamate [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97270-3.json |
| 97271-1 | Meprobamate [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97271-1.json |
| 97272-9 | Methadone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97272-9.json |
| 97273-7 | Methadone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97273-7.json |
| 97274-5 | Methamphetamine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97274-5.json |
| 97275-2 | Methamphetamine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97275-2.json |
| 97276-0 | Methylone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97276-0.json |
| 97277-8 | Methylone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97277-8.json |
| 97278-6 | Midazolam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97278-6.json |
| 9727-9 | Eosinophils/100 leukocytes in Nose by Manual count | ./2.16.840.1.114222.4.11.1002/9727-9.json |
| 97279-4 | Midazolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97279-4.json |
| 97280-2 | Morphine Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97280-2.json |
| 97281-0 | Morphine Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97281-0.json |
| 97282-8 | Nordiazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97282-8.json |
| 97283-6 | Nordiazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97283-6.json |
| 97284-4 | Norfentanyl [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97284-4.json |
| 97285-1 | Norfentanyl [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97285-1.json |
| 97286-9 | Norhydrocodone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97286-9.json |
| 97287-7 | Norhydrocodone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97287-7.json |
| 97288-5 | Normeperidine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97288-5.json |
| 97289-3 | Normeperidine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97289-3.json |
| 97290-1 | Noroxycodone [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97290-1.json |
| 97291-9 | Noroxycodone [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97291-9.json |
| 97292-7 | O-nortramadol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97292-7.json |
| 97293-5 | O-nortramadol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97293-5.json |
| 97294-3 | Oxazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97294-3.json |
| 9729-5 | Canary serum proteins IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9729-5.json |
| 97295-0 | oxyCODONE Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97295-0.json |
| 97296-8 | oxyMORphone Free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97296-8.json |
| 97297-6 | oxyMORphone Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97297-6.json |
| 97298-4 | Phencyclidine [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97298-4.json |
| 97299-2 | Phencyclidine [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97299-2.json |
| 97300-8 | PHENobarbital [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97300-8.json |
| 97301-6 | PHENobarbital [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97301-6.json |
| 97302-4 | Tapentadol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97302-4.json |
| 97303-2 | Tapentadol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97303-2.json |
| 97304-0 | Temazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97304-0.json |
| 97305-7 | Temazepam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97305-7.json |
| 97306-5 | traMADol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97306-5.json |
| 97307-3 | traMADol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97307-3.json |
| 97308-1 | Triazolam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97308-1.json |
| 97309-9 | Triazolam [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97309-9.json |
| 97310-7 | Zolpidem [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97310-7.json |
| 97311-5 | Zolpidem [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97311-5.json |
| 97312-3 | Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97312-3.json |
| 97313-1 | Salmonella sp DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97313-1.json |
| 97314-9 | Vibrio cholerae DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97314-9.json |
| 97315-6 | Vibrio parahaemolyticus DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97315-6.json |
| 97316-4 | Vibrio vulnificus DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97316-4.json |
| 97317-2 | Escherichia coli enteroaggregative DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97317-2.json |
| 97318-0 | Escherichia coli enteropathogenic DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97318-0.json |
| 97319-8 | Escherichia coli enterotoxigenic DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97319-8.json |
| 97320-6 | Escherichia coli O157 DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97320-6.json |
| 97321-4 | Cyclospora cayetanensis DNA [Presence] in Stool by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97321-4.json |
| 97322-2 | Oxazepam [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97322-2.json |
| 97323-0 | oxyCODONE Free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97323-0.json |
| 97339-6 | Pain severity and Body site panel | ./2.16.840.1.114222.4.11.1002/97339-6.json |
| 97340-4 | XR Sternoclavicular joint - left AP | ./2.16.840.1.114222.4.11.1002/97340-4.json |
| 97341-2 | XR Finger second - right AP | ./2.16.840.1.114222.4.11.1002/97341-2.json |
| 97342-0 | XR Finger second - right PA | ./2.16.840.1.114222.4.11.1002/97342-0.json |
| 97343-8 | XR Sternoclavicular joint - left PA | ./2.16.840.1.114222.4.11.1002/97343-8.json |
| 97344-6 | XR Radius and Ulna - left PA | ./2.16.840.1.114222.4.11.1002/97344-6.json |
| 97345-3 | XR Radius and Ulna - left Lateral | ./2.16.840.1.114222.4.11.1002/97345-3.json |
| 97346-1 | XR Radius and Ulna - left AP | ./2.16.840.1.114222.4.11.1002/97346-1.json |
| 97347-9 | XR Clavicle - left AP | ./2.16.840.1.114222.4.11.1002/97347-9.json |
| 97348-7 | XR Clavicle - left Oblique | ./2.16.840.1.114222.4.11.1002/97348-7.json |
| 97349-5 | XR Clavicle - left Axial | ./2.16.840.1.114222.4.11.1002/97349-5.json |
| 97350-3 | XR Humerus - right Lateral | ./2.16.840.1.114222.4.11.1002/97350-3.json |
| 97351-1 | XR Humerus - right AP | ./2.16.840.1.114222.4.11.1002/97351-1.json |
| 97352-9 | XR Elbow - right Lateral | ./2.16.840.1.114222.4.11.1002/97352-9.json |
| 97353-7 | XR Elbow - right AP | ./2.16.840.1.114222.4.11.1002/97353-7.json |
| 97354-5 | XR Shoulder - right AP external rotation | ./2.16.840.1.114222.4.11.1002/97354-5.json |
| 97355-2 | XR Shoulder - right AP internal rotation | ./2.16.840.1.114222.4.11.1002/97355-2.json |
| 97356-0 | XR Sternoclavicular joint - right Oblique | ./2.16.840.1.114222.4.11.1002/97356-0.json |
| 97357-8 | XR Sternoclavicular joint - right AP | ./2.16.840.1.114222.4.11.1002/97357-8.json |
| 97358-6 | XR Sternoclavicular joint - right PA | ./2.16.840.1.114222.4.11.1002/97358-6.json |
| 97359-4 | XR Radius and Ulna - right PA | ./2.16.840.1.114222.4.11.1002/97359-4.json |
| 9736-0 | Allopurinol [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9736-0.json |
| 97360-2 | XR Radius and Ulna - right Lateral | ./2.16.840.1.114222.4.11.1002/97360-2.json |
| 97361-0 | XR Radius and Ulna - right AP | ./2.16.840.1.114222.4.11.1002/97361-0.json |
| 97362-8 | XR Clavicle - right AP | ./2.16.840.1.114222.4.11.1002/97362-8.json |
| 97363-6 | XR Clavicle - right Oblique | ./2.16.840.1.114222.4.11.1002/97363-6.json |
| 97364-4 | XR Clavicle - right Axial | ./2.16.840.1.114222.4.11.1002/97364-4.json |
| 97365-1 | XR Ribs - left Oblique | ./2.16.840.1.114222.4.11.1002/97365-1.json |
| 97366-9 | XR Ribs - left PA | ./2.16.840.1.114222.4.11.1002/97366-9.json |
| 97367-7 | XR Shoulder AP external rotation | ./2.16.840.1.114222.4.11.1002/97367-7.json |
| 97368-5 | XR Shoulder AP internal rotation | ./2.16.840.1.114222.4.11.1002/97368-5.json |
| 97369-3 | XR Sternoclavicular joint - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97369-3.json |
| 97370-1 | XR Sternoclavicular joint - bilateral PA | ./2.16.840.1.114222.4.11.1002/97370-1.json |
| 97371-9 | XR Sternoclavicular joint - bilateral AP | ./2.16.840.1.114222.4.11.1002/97371-9.json |
| 97372-7 | XR Radius and Ulna - bilateral AP | ./2.16.840.1.114222.4.11.1002/97372-7.json |
| 97373-5 | XR Radius and Ulna - bilateral PA | ./2.16.840.1.114222.4.11.1002/97373-5.json |
| 97374-3 | XR Radius and Ulna - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/97374-3.json |
| 97375-0 | XR Clavicle - bilateral AP and Oblique | ./2.16.840.1.114222.4.11.1002/97375-0.json |
| 97376-8 | XR Clavicle - bilateral AP | ./2.16.840.1.114222.4.11.1002/97376-8.json |
| 97377-6 | XR Clavicle - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97377-6.json |
| 9737-8 | Propoxyphene [Mass/volume] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9737-8.json |
| 97378-4 | XR Humerus - left Lateral | ./2.16.840.1.114222.4.11.1002/97378-4.json |
| 97379-2 | XR Humerus - left AP | ./2.16.840.1.114222.4.11.1002/97379-2.json |
| 97380-0 | XR Elbow - left AP | ./2.16.840.1.114222.4.11.1002/97380-0.json |
| 97381-8 | XR Shoulder - left AP external rotation | ./2.16.840.1.114222.4.11.1002/97381-8.json |
| 97382-6 | XR Shoulder - left AP internal rotation | ./2.16.840.1.114222.4.11.1002/97382-6.json |
| 97383-4 | XR Sternoclavicular joint - left Oblique | ./2.16.840.1.114222.4.11.1002/97383-4.json |
| 97384-2 | XR Tibia and Fibula - left Lateral | ./2.16.840.1.114222.4.11.1002/97384-2.json |
| 97385-9 | XR Tibia and Fibula - left AP | ./2.16.840.1.114222.4.11.1002/97385-9.json |
| 9738-6 | Gabapentin [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/9738-6.json |
| 97386-7 | XR Tibia and Fibula - right Lateral | ./2.16.840.1.114222.4.11.1002/97386-7.json |
| 97387-5 | XR Tibia and Fibula - right AP | ./2.16.840.1.114222.4.11.1002/97387-5.json |
| 97388-3 | XR Elbow - bilateral Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/97388-3.json |
| 97389-1 | XR Elbow - left Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/97389-1.json |
| 97390-9 | XR Elbow - right Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/97390-9.json |
| 97391-7 | MR Abdomen and Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/97391-7.json |
| 97392-5 | MR Abdomen and Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/97392-5.json |
| 97393-3 | MR Abdomen and Pelvis W contrast IV | ./2.16.840.1.114222.4.11.1002/97393-3.json |
| 97394-1 | US Guidance for injection of Elbow - left | ./2.16.840.1.114222.4.11.1002/97394-1.json |
| 97395-8 | US Guidance for injection of Elbow - right | ./2.16.840.1.114222.4.11.1002/97395-8.json |
| 97396-6 | US Guidance for injection of Elbow - bilateral | ./2.16.840.1.114222.4.11.1002/97396-6.json |
| 97397-4 | XR Finger third - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97397-4.json |
| 97398-2 | XR Finger second - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97398-2.json |
| 97399-0 | XR Finger fourth - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97399-0.json |
| 97400-6 | XR Finger fifth - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97400-6.json |
| 97401-4 | XR Finger third - left PA | ./2.16.840.1.114222.4.11.1002/97401-4.json |
| 97402-2 | XR Finger fourth - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97402-2.json |
| 97403-0 | XR Finger fifth - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97403-0.json |
| 97404-8 | XR Finger second - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97404-8.json |
| 97405-5 | XR Finger third - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97405-5.json |
| 97406-3 | XR Finger third - right PA | ./2.16.840.1.114222.4.11.1002/97406-3.json |
| 97407-1 | XR Shoulder - right Bernageau | ./2.16.840.1.114222.4.11.1002/97407-1.json |
| 97408-9 | XR Shoulder - left Bernageau | ./2.16.840.1.114222.4.11.1002/97408-9.json |
| 97409-7 | XR Toe fifth - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97409-7.json |
| 9741-0 | Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/9741-0.json |
| 97410-5 | XR Toe fourth - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97410-5.json |
| 97411-3 | XR Toe third - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97411-3.json |
| 97412-1 | XR Toe second - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97412-1.json |
| 97413-9 | XR Great toe - left AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97413-9.json |
| 97414-7 | XR Toe third - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97414-7.json |
| 97415-4 | XR Toe fourth - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97415-4.json |
| 97416-2 | XR Toe second - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97416-2.json |
| 97417-0 | XR Toe fifth - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97417-0.json |
| 97418-8 | XR Great toe - left AP and Lateral | ./2.16.840.1.114222.4.11.1002/97418-8.json |
| 97419-6 | XR Toe third - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97419-6.json |
| 97420-4 | XR Toe second - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97420-4.json |
| 97421-2 | XR Finger second - left PA | ./2.16.840.1.114222.4.11.1002/97421-2.json |
| 97422-0 | XR Finger second - left AP | ./2.16.840.1.114222.4.11.1002/97422-0.json |
| 97423-8 | XR Finger second - bilateral AP | ./2.16.840.1.114222.4.11.1002/97423-8.json |
| 97424-6 | XR Finger second - bilateral PA | ./2.16.840.1.114222.4.11.1002/97424-6.json |
| 97425-3 | XR Finger fifth - right AP | ./2.16.840.1.114222.4.11.1002/97425-3.json |
| 97426-1 | XR Finger fifth - left AP | ./2.16.840.1.114222.4.11.1002/97426-1.json |
| 97427-9 | XR Finger fourth - left AP | ./2.16.840.1.114222.4.11.1002/97427-9.json |
| 9742-8 | Chloride [Moles/time] in 24 hour Stool | ./2.16.840.1.114222.4.11.1002/9742-8.json |
| 97428-7 | XR Finger fourth - right AP | ./2.16.840.1.114222.4.11.1002/97428-7.json |
| 97429-5 | XR Finger third - left AP | ./2.16.840.1.114222.4.11.1002/97429-5.json |
| 97430-3 | XR Finger third - right AP | ./2.16.840.1.114222.4.11.1002/97430-3.json |
| 97431-1 | XR Finger fifth - left Lateral | ./2.16.840.1.114222.4.11.1002/97431-1.json |
| 97432-9 | XR Finger fifth - right Lateral | ./2.16.840.1.114222.4.11.1002/97432-9.json |
| 97433-7 | XR Finger fourth - right Lateral | ./2.16.840.1.114222.4.11.1002/97433-7.json |
| 97434-5 | XR Finger fourth - left Lateral | ./2.16.840.1.114222.4.11.1002/97434-5.json |
| 97435-2 | XR Finger second - right Lateral | ./2.16.840.1.114222.4.11.1002/97435-2.json |
| 97436-0 | XR Finger second - left Lateral | ./2.16.840.1.114222.4.11.1002/97436-0.json |
| 97437-8 | XR Finger third - left Lateral | ./2.16.840.1.114222.4.11.1002/97437-8.json |
| 97438-6 | XR Finger third - right Lateral | ./2.16.840.1.114222.4.11.1002/97438-6.json |
| 97439-4 | XR Finger fifth - right Oblique | ./2.16.840.1.114222.4.11.1002/97439-4.json |
| 97440-2 | XR Finger fifth - left Oblique | ./2.16.840.1.114222.4.11.1002/97440-2.json |
| 97441-0 | XR Finger fourth - left Oblique | ./2.16.840.1.114222.4.11.1002/97441-0.json |
| 97442-8 | XR Finger fourth - right Oblique | ./2.16.840.1.114222.4.11.1002/97442-8.json |
| 97443-6 | XR Finger second - right Oblique | ./2.16.840.1.114222.4.11.1002/97443-6.json |
| 97444-4 | XR Finger second - left Oblique | ./2.16.840.1.114222.4.11.1002/97444-4.json |
| 97445-1 | XR Finger third - right Oblique | ./2.16.840.1.114222.4.11.1002/97445-1.json |
| 97446-9 | XR Finger third - left Oblique | ./2.16.840.1.114222.4.11.1002/97446-9.json |
| 97447-7 | XR Ribs - right Oblique | ./2.16.840.1.114222.4.11.1002/97447-7.json |
| 97448-5 | XR Ribs - right PA | ./2.16.840.1.114222.4.11.1002/97448-5.json |
| 97449-3 | XR Great toe - bilateral AP | ./2.16.840.1.114222.4.11.1002/97449-3.json |
| 97450-1 | XR Great toe - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97450-1.json |
| 97451-9 | XR Great toe - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/97451-9.json |
| 97452-7 | XR Toe second - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97452-7.json |
| 97453-5 | XR Toe fifth - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97453-5.json |
| 97454-3 | XR Toe third - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97454-3.json |
| 97455-0 | XR Toe third - bilateral AP | ./2.16.840.1.114222.4.11.1002/97455-0.json |
| 97456-8 | XR Toe fourth - bilateral Oblique | ./2.16.840.1.114222.4.11.1002/97456-8.json |
| 97457-6 | XR Toe fifth - bilateral AP | ./2.16.840.1.114222.4.11.1002/97457-6.json |
| 97458-4 | XR Toe fourth - bilateral AP | ./2.16.840.1.114222.4.11.1002/97458-4.json |
| 97459-2 | XR Toe second - bilateral AP | ./2.16.840.1.114222.4.11.1002/97459-2.json |
| 97460-0 | XR Toe third - left Oblique | ./2.16.840.1.114222.4.11.1002/97460-0.json |
| 97461-8 | XR Toe third - left AP | ./2.16.840.1.114222.4.11.1002/97461-8.json |
| 97462-6 | XR Toe third - left Lateral | ./2.16.840.1.114222.4.11.1002/97462-6.json |
| 97463-4 | XR Toe second - left Lateral | ./2.16.840.1.114222.4.11.1002/97463-4.json |
| 97464-2 | XR Toe second - left AP | ./2.16.840.1.114222.4.11.1002/97464-2.json |
| 97465-9 | XR Toe second - left Oblique | ./2.16.840.1.114222.4.11.1002/97465-9.json |
| 97466-7 | XR Great toe - left Oblique | ./2.16.840.1.114222.4.11.1002/97466-7.json |
| 97467-5 | XR Great toe - left Lateral | ./2.16.840.1.114222.4.11.1002/97467-5.json |
| 97468-3 | XR Great toe - left AP | ./2.16.840.1.114222.4.11.1002/97468-3.json |
| 9746-9 | Dantrolene [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9746-9.json |
| 97469-1 | XR Toe fourth - left AP | ./2.16.840.1.114222.4.11.1002/97469-1.json |
| 97470-9 | XR Toe fourth - left Lateral | ./2.16.840.1.114222.4.11.1002/97470-9.json |
| 97471-7 | XR Toe fourth - left Oblique | ./2.16.840.1.114222.4.11.1002/97471-7.json |
| 97472-5 | XR Toe fifth - left Lateral | ./2.16.840.1.114222.4.11.1002/97472-5.json |
| 97473-3 | XR Toe fifth - left Oblique | ./2.16.840.1.114222.4.11.1002/97473-3.json |
| 97474-1 | XR Toe fifth - left AP | ./2.16.840.1.114222.4.11.1002/97474-1.json |
| 97475-8 | XR Great toe - right AP | ./2.16.840.1.114222.4.11.1002/97475-8.json |
| 97476-6 | XR Great toe - right Lateral | ./2.16.840.1.114222.4.11.1002/97476-6.json |
| 9747-7 | Dapsone [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9747-7.json |
| 97477-4 | XR Great toe - right Oblique | ./2.16.840.1.114222.4.11.1002/97477-4.json |
| 97478-2 | XR Toe fifth - right Oblique | ./2.16.840.1.114222.4.11.1002/97478-2.json |
| 97479-0 | XR Toe fifth - right AP | ./2.16.840.1.114222.4.11.1002/97479-0.json |
| 97480-8 | XR Toe fifth - right Lateral | ./2.16.840.1.114222.4.11.1002/97480-8.json |
| 97481-6 | XR Toe fourth - right Lateral | ./2.16.840.1.114222.4.11.1002/97481-6.json |
| 97482-4 | XR Toe fourth - right AP | ./2.16.840.1.114222.4.11.1002/97482-4.json |
| 97483-2 | XR Toe fourth - right Oblique | ./2.16.840.1.114222.4.11.1002/97483-2.json |
| 97484-0 | XR Toe third - right Oblique | ./2.16.840.1.114222.4.11.1002/97484-0.json |
| 9748-5 | Dipyridamole [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9748-5.json |
| 97485-7 | XR Toe third - right Lateral | ./2.16.840.1.114222.4.11.1002/97485-7.json |
| 97486-5 | XR Toe third - right AP | ./2.16.840.1.114222.4.11.1002/97486-5.json |
| 97487-3 | XR Toe second - right Oblique | ./2.16.840.1.114222.4.11.1002/97487-3.json |
| 97488-1 | XR Toe second - right Lateral | ./2.16.840.1.114222.4.11.1002/97488-1.json |
| 97489-9 | XR Toe second - right AP | ./2.16.840.1.114222.4.11.1002/97489-9.json |
| 97490-7 | XR Tibia and Fibula - bilateral AP | ./2.16.840.1.114222.4.11.1002/97490-7.json |
| 97491-5 | XR Tibia and Fibula - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/97491-5.json |
| 97492-3 | XR Toe fifth - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97492-3.json |
| 97493-1 | XR Toe fourth - right AP and Lateral and oblique | ./2.16.840.1.114222.4.11.1002/97493-1.json |
| 97494-9 | XR Toe third - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97494-9.json |
| 97495-6 | XR Great toe - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97495-6.json |
| 97496-4 | XR Toe second - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97496-4.json |
| 97497-2 | XR Toe fourth - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97497-2.json |
| 97498-0 | XR Toe fifth - right AP and Lateral | ./2.16.840.1.114222.4.11.1002/97498-0.json |
| 97499-8 | Proof of COVID-19 recovery certificate | ./2.16.840.1.114222.4.11.1002/97499-8.json |
| 97500-3 | Proof of COVID-19 immunization or negative status certificate | ./2.16.840.1.114222.4.11.1002/97500-3.json |
| 9750-1 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9750-1.json |
| 97503-7 | Abnormal Prion Protein [Presence] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/97503-7.json |
| 97512-8 | Rabies virus IgM Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97512-8.json |
| 97513-6 | Campylobacter sp [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/97513-6.json |
| 97514-4 | Entamoeba moshkovskii DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97514-4.json |
| 97515-1 | Entamoeba bangladeshi DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97515-1.json |
| 97516-9 | Acanthamoeba sp Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97516-9.json |
| 97517-7 | Rabies virus IgG Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97517-7.json |
| 97518-5 | Paracoccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/97518-5.json |
| 9751-9 | Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9751-9.json |
| 97519-3 | Blastomyces sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/97519-3.json |
| 97520-1 | Histoplasma capsulatum mycelial phase Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/97520-1.json |
| 97521-9 | Coccidioides sp Ab band pattern [Identifier] in Specimen by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/97521-9.json |
| 97522-7 | Giardia sp [Presence] in Water by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97522-7.json |
| 97523-5 | Hepatitis A virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97523-5.json |
| 97524-3 | Cryptosporidium sp [Presence] in Water by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97524-3.json |
| 97525-0 | Norovirus genogroup I RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97525-0.json |
| 97526-8 | Balamuthia mandrillaris Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97526-8.json |
| 9752-7 | Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9752-7.json |
| 97527-6 | Acanthamoeba sp Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97527-6.json |
| 97528-4 | Naegleria fowleri Ag [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97528-4.json |
| 97529-2 | Naegleria fowleri [Presence] in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/97529-2.json |
| 97530-0 | Naegleria fowleri Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97530-0.json |
| 97531-8 | Balamuthia mandrillaris Ab [Presence] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97531-8.json |
| 97532-6 | Norovirus genogroup II RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97532-6.json |
| 9753-5 | Coxsackievirus A2 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9753-5.json |
| 9754-3 | Coxsackievirus A4 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9754-3.json |
| 9755-0 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9755-0.json |
| 97558-1 | Acetylcholine receptor binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/97558-1.json |
| 97559-9 | Acetylcholine receptor ganglionic neuronal IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/97559-9.json |
| 97560-7 | Voltage-gated potassium channel IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/97560-7.json |
| 97562-3 | Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97562-3.json |
| 97563-1 | Signal Recognition Particle (SRP) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97563-1.json |
| 97565-6 | B-cell primary immunodeficiency multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97565-6.json |
| 9756-8 | Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9756-8.json |
| 97569-8 | Eating disorders Telehealth Note | ./2.16.840.1.114222.4.11.1002/97569-8.json |
| 97570-6 | Cardiopulmonary Progress note | ./2.16.840.1.114222.4.11.1002/97570-6.json |
| 97571-4 | Cardiac surgery Progress note | ./2.16.840.1.114222.4.11.1002/97571-4.json |
| 97572-2 | Eating disorders Progress note | ./2.16.840.1.114222.4.11.1002/97572-2.json |
| 97573-0 | Mechanical circulatory support Progress note | ./2.16.840.1.114222.4.11.1002/97573-0.json |
| 97574-8 | Spinal surgery Progress note | ./2.16.840.1.114222.4.11.1002/97574-8.json |
| 97575-5 | Colon and rectal surgery Progress note | ./2.16.840.1.114222.4.11.1002/97575-5.json |
| 9757-6 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation | ./2.16.840.1.114222.4.11.1002/9757-6.json |
| 97576-3 | Surgery of the hand Progress note | ./2.16.840.1.114222.4.11.1002/97576-3.json |
| 97577-1 | Heart failure+Transplant cardiology Progress note | ./2.16.840.1.114222.4.11.1002/97577-1.json |
| 97578-9 | Internal medicine Progress note | ./2.16.840.1.114222.4.11.1002/97578-9.json |
| 97579-7 | Orthotics prosthetics Progress note | ./2.16.840.1.114222.4.11.1002/97579-7.json |
| 97580-5 | Radiology Progress note | ./2.16.840.1.114222.4.11.1002/97580-5.json |
| 97582-1 | Buprenorphine free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97582-1.json |
| 97583-9 | Buprenorphine free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97583-9.json |
| 9758-4 | Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9758-4.json |
| 97584-7 | Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97584-7.json |
| 97585-4 | Carboxy tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97585-4.json |
| 97586-2 | Tetrahydrocannabinol [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97586-2.json |
| 97587-0 | Tetrahydrocannabinol [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97587-0.json |
| 97588-8 | Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97588-8.json |
| 97589-6 | Dextromethorphan+Levomethorphan [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97589-6.json |
| 97590-4 | Norbuprenorphine free [Presence] in Cord tissue by Screen method | ./2.16.840.1.114222.4.11.1002/97590-4.json |
| 97591-2 | Norbuprenorphine free [Presence] in Cord tissue by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97591-2.json |
| 9759-2 | Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9759-2.json |
| 97592-0 | Predicted response to cancer treatment based on lab data | ./2.16.840.1.114222.4.11.1002/97592-0.json |
| 9760-0 | Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9760-0.json |
| 97601-9 | Microorganism of interest sequence [Presence] in Specimen | ./2.16.840.1.114222.4.11.1002/97601-9.json |
| 97603-5 | Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1 [Interpretation] in Plasma Qualitative | ./2.16.840.1.114222.4.11.1002/97603-5.json |
| 97604-3 | Glial fibrillary acidic protein [Mass/volume] in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97604-3.json |
| 97605-0 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97605-0.json |
| 97606-8 | PLPEth [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/97606-8.json |
| 97607-6 | POPEth [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/97607-6.json |
| 9761-8 | Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9761-8.json |
| 9762-6 | Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9762-6.json |
| 9763-4 | Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9763-4.json |
| 97640-7 | Thyroglobulin [Moles/volume] in Tissue fine needle aspirate | ./2.16.840.1.114222.4.11.1002/97640-7.json |
| 97641-5 | dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay --post DOAC neutralization | ./2.16.840.1.114222.4.11.1002/97641-5.json |
| 9764-2 | Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid by Complement fixation | ./2.16.840.1.114222.4.11.1002/9764-2.json |
| 97642-3 | dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/97642-3.json |
| 97643-1 | Barmah forest virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/97643-1.json |
| 97644-9 | Barmah forest virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/97644-9.json |
| 97645-6 | Parainfluenza virus 1+2+3+4 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97645-6.json |
| 97646-4 | Lassa virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97646-4.json |
| 97647-2 | Asenapine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97647-2.json |
| 97648-0 | Iloperidone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97648-0.json |
| 97649-8 | 2-Amino-5-chloropyridine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97649-8.json |
| 97650-6 | Desmethylcyclobenzaprine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/97650-6.json |
| 97651-4 | Pigeon serum IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97651-4.json |
| 97652-2 | Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Mass/volume] in Serum by Multidisk | ./2.16.840.1.114222.4.11.1002/97652-2.json |
| 97653-0 | Asian Hornet IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97653-0.json |
| 97654-8 | SMN2 gene copy number in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97654-8.json |
| 97655-5 | Hereditary breast and gynecologic cancer multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97655-5.json |
| 97656-3 | Hereditary cancer multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97656-3.json |
| 97657-1 | Vancomycin [Mass/volume] in Serum or Plasma --2 hours post dose | ./2.16.840.1.114222.4.11.1002/97657-1.json |
| 97658-9 | 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine [Mass Ratio] in Urine | ./2.16.840.1.114222.4.11.1002/97658-9.json |
| 9765-9 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9765-9.json |
| 97659-7 | Emergency medicine Emergency department Admission history and physical note | ./2.16.840.1.114222.4.11.1002/97659-7.json |
| 97660-5 | Emergency medicine Emergency department Evaluation note | ./2.16.840.1.114222.4.11.1002/97660-5.json |
| 97661-3 | Emergency medicine Emergency department Checklist | ./2.16.840.1.114222.4.11.1002/97661-3.json |
| 97662-1 | Emergency medicine Emergency department Discharge instructions | ./2.16.840.1.114222.4.11.1002/97662-1.json |
| 97663-9 | Emergency medicine Emergency department Discharge summary | ./2.16.840.1.114222.4.11.1002/97663-9.json |
| 97664-7 | Emergency medicine Emergency department Discharge teaching note | ./2.16.840.1.114222.4.11.1002/97664-7.json |
| 97665-4 | Emergency medicine Emergency department Education note | ./2.16.840.1.114222.4.11.1002/97665-4.json |
| 97666-2 | Emergency medicine Emergency department History and physical note | ./2.16.840.1.114222.4.11.1002/97666-2.json |
| 9766-7 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9766-7.json |
| 97667-0 | Emergency medicine Emergency department Initial evaluation note | ./2.16.840.1.114222.4.11.1002/97667-0.json |
| 97668-8 | Emergency medicine Emergency department procedure note | ./2.16.840.1.114222.4.11.1002/97668-8.json |
| 97669-6 | Emergency medicine Emergency department Progress note | ./2.16.840.1.114222.4.11.1002/97669-6.json |
| 97670-4 | Emergency medicine Emergency department Transfer summary note | ./2.16.840.1.114222.4.11.1002/97670-4.json |
| 97671-2 | Emergency medicine Emergency department Triage note | ./2.16.840.1.114222.4.11.1002/97671-2.json |
| 97672-0 | Interventional cardiology History and physical note | ./2.16.840.1.114222.4.11.1002/97672-0.json |
| 97673-8 | Interventional radiology History and physical note | ./2.16.840.1.114222.4.11.1002/97673-8.json |
| 97674-6 | Pulmonary History and physical note | ./2.16.840.1.114222.4.11.1002/97674-6.json |
| 9767-5 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9767-5.json |
| 97675-3 | Oral and Maxillofacial Surgery History and physical note | ./2.16.840.1.114222.4.11.1002/97675-3.json |
| 97676-1 | Anesthesiology History and physical note | ./2.16.840.1.114222.4.11.1002/97676-1.json |
| 97677-9 | Burn management History and physical note | ./2.16.840.1.114222.4.11.1002/97677-9.json |
| 97678-7 | Colon and rectal surgery History and physical note | ./2.16.840.1.114222.4.11.1002/97678-7.json |
| 97679-5 | Nutrition and dietetics History and physical note | ./2.16.840.1.114222.4.11.1002/97679-5.json |
| 97680-3 | Infectious disease History and physical note | ./2.16.840.1.114222.4.11.1002/97680-3.json |
| 97681-1 | Nurse History and physical note | ./2.16.840.1.114222.4.11.1002/97681-1.json |
| 97682-9 | Pharmacology History and physical note | ./2.16.840.1.114222.4.11.1002/97682-9.json |
| 9768-3 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9768-3.json |
| 97683-7 | Radiation oncology History and physical note | ./2.16.840.1.114222.4.11.1002/97683-7.json |
| 97684-5 | Radiology History and physical note | ./2.16.840.1.114222.4.11.1002/97684-5.json |
| 97685-2 | Rheumatology History and physical note | ./2.16.840.1.114222.4.11.1002/97685-2.json |
| 97686-0 | Trauma History and physical note | ./2.16.840.1.114222.4.11.1002/97686-0.json |
| 97687-8 | Burn management Evaluation note | ./2.16.840.1.114222.4.11.1002/97687-8.json |
| 97688-6 | Family medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/97688-6.json |
| 97689-4 | Interventional cardiology Evaluation note | ./2.16.840.1.114222.4.11.1002/97689-4.json |
| 97690-2 | Interventional cardiology Discharge summary | ./2.16.840.1.114222.4.11.1002/97690-2.json |
| 97691-0 | Interventional cardiology Progress note | ./2.16.840.1.114222.4.11.1002/97691-0.json |
| 97692-8 | Interventional cardiology procedure note | ./2.16.840.1.114222.4.11.1002/97692-8.json |
| 97693-6 | Interventional radiology Surgical operation note | ./2.16.840.1.114222.4.11.1002/97693-6.json |
| 97694-4 | Maternal and fetal medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/97694-4.json |
| 97695-1 | Solid Organ Transplant Evaluation note | ./2.16.840.1.114222.4.11.1002/97695-1.json |
| 97696-9 | Psychiatry Evaluation note | ./2.16.840.1.114222.4.11.1002/97696-9.json |
| 97697-7 | Radiation oncology Evaluation note | ./2.16.840.1.114222.4.11.1002/97697-7.json |
| 97698-5 | Radiology Evaluation note | ./2.16.840.1.114222.4.11.1002/97698-5.json |
| 97699-3 | Pastoral care Evaluation note | ./2.16.840.1.114222.4.11.1002/97699-3.json |
| 97700-9 | Burn management Discharge summary | ./2.16.840.1.114222.4.11.1002/97700-9.json |
| 97701-7 | Gynecologic oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/97701-7.json |
| 97702-5 | Maternal and fetal medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/97702-5.json |
| 97703-3 | Oral and Maxillofacial Surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/97703-3.json |
| 97704-1 | Radiation oncology Discharge summary | ./2.16.840.1.114222.4.11.1002/97704-1.json |
| 97705-8 | Gynecologic oncology Surgical operation note | ./2.16.840.1.114222.4.11.1002/97705-8.json |
| 97706-6 | Multi-specialty program procedure note | ./2.16.840.1.114222.4.11.1002/97706-6.json |
| 97707-4 | Solid Organ Transplant procedure note | ./2.16.840.1.114222.4.11.1002/97707-4.json |
| 97708-2 | Multi-specialty program Evaluation note | ./2.16.840.1.114222.4.11.1002/97708-2.json |
| 97709-0 | Mental health Letter | ./2.16.840.1.114222.4.11.1002/97709-0.json |
| 97710-8 | Cardiology Team Conference note | ./2.16.840.1.114222.4.11.1002/97710-8.json |
| 97711-6 | Heart failure Outpatient Note | ./2.16.840.1.114222.4.11.1002/97711-6.json |
| 97712-4 | Neuropsychology procedure note | ./2.16.840.1.114222.4.11.1002/97712-4.json |
| 97713-2 | Surgery of the hand Evaluation note | ./2.16.840.1.114222.4.11.1002/97713-2.json |
| 97714-0 | Surgery of the hand Discharge summary | ./2.16.840.1.114222.4.11.1002/97714-0.json |
| 97715-7 | Surgery of the hand History and physical note | ./2.16.840.1.114222.4.11.1002/97715-7.json |
| 97716-5 | Surgery of the hand procedure note | ./2.16.840.1.114222.4.11.1002/97716-5.json |
| 97717-3 | Surgery of the hand Surgical operation note | ./2.16.840.1.114222.4.11.1002/97717-3.json |
| 97718-1 | Hepatology Evaluation note | ./2.16.840.1.114222.4.11.1002/97718-1.json |
| 97719-9 | Hepatology Discharge summary | ./2.16.840.1.114222.4.11.1002/97719-9.json |
| 97720-7 | Hepatology History and physical note | ./2.16.840.1.114222.4.11.1002/97720-7.json |
| 97721-5 | Hepatology Surgical operation note | ./2.16.840.1.114222.4.11.1002/97721-5.json |
| 97722-3 | Hematology Evaluation note | ./2.16.840.1.114222.4.11.1002/97722-3.json |
| 97723-1 | Hematology History and physical note | ./2.16.840.1.114222.4.11.1002/97723-1.json |
| 97724-9 | Sleep medicine Evaluation note | ./2.16.840.1.114222.4.11.1002/97724-9.json |
| 97725-6 | Sleep medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/97725-6.json |
| 97726-4 | Sleep medicine History and physical note | ./2.16.840.1.114222.4.11.1002/97726-4.json |
| 97727-2 | Sleep medicine procedure note | ./2.16.840.1.114222.4.11.1002/97727-2.json |
| 97728-0 | Occupational therapy History and physical note | ./2.16.840.1.114222.4.11.1002/97728-0.json |
| 97729-8 | Recreational therapy History and physical note | ./2.16.840.1.114222.4.11.1002/97729-8.json |
| 97730-6 | Respiratory therapy History and physical note | ./2.16.840.1.114222.4.11.1002/97730-6.json |
| 97731-4 | Outpatient Stroke prevention note | ./2.16.840.1.114222.4.11.1002/97731-4.json |
| 97732-2 | Enterovirus VP1 gene [Nucleotide sequence] in Isolate by Sequencing | ./2.16.840.1.114222.4.11.1002/97732-2.json |
| 9773-3 | Ergotamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9773-3.json |
| 9774-1 | Metoclopramide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9774-1.json |
| 97741-3 | Estradiol (E2) [Moles/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97741-3.json |
| 97742-1 | Estradiol (E2) [Mass/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97742-1.json |
| 97743-9 | Cancer Ag 125 [Units/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97743-9.json |
| 97744-7 | Enolase.neuron specific [Mass/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97744-7.json |
| 97745-4 | Alpha-1-Fetoprotein [Units/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97745-4.json |
| 97746-2 | Alpha-1-Fetoprotein [Mass/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97746-2.json |
| 97747-0 | Carcinoembryonic Ag [Mass/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97747-0.json |
| 97748-8 | Cytokeratin 19 [Mass/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97748-8.json |
| 97749-6 | Cancer Ag 15-3 [Units/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97749-6.json |
| 97750-4 | Cancer Ag 19-9 [Units/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/97750-4.json |
| 97751-2 | Amiodarone+Desethylamiodarone [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97751-2.json |
| 97752-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97752-0.json |
| 97753-8 | Ammonia [Moles/mass] in Stool | ./2.16.840.1.114222.4.11.1002/97753-8.json |
| 97754-6 | Oxalate [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97754-6.json |
| 97755-3 | Oxalate [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97755-3.json |
| 97756-1 | Androstenedione [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97756-1.json |
| 97757-9 | Androstenedione [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97757-9.json |
| 9775-8 | Moricizine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9775-8.json |
| 97758-7 | Fungus and Mycobacterium sp identified in Blood by Organism specific culture | ./2.16.840.1.114222.4.11.1002/97758-7.json |
| 97760-3 | MLH1 gene methylation analysis in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97760-3.json |
| 97761-1 | MLH1 gene methylation analysis in Tumor by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/97761-1.json |
| 97762-9 | Parathyrin.intact [Moles/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97762-9.json |
| 97763-7 | Beta 2 globulin/Protein.total in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/97763-7.json |
| 97764-5 | Beta 1 globulin/Protein.total in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/97764-5.json |
| 97765-2 | Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone PO overnight | ./2.16.840.1.114222.4.11.1002/97765-2.json |
| 9776-6 | Norchlordiazepoxide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9776-6.json |
| 97766-0 | IgG subclass 2 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97766-0.json |
| 97767-8 | IgG subclass 4 [Mass/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/97767-8.json |
| 97770-2 | Bilirubin.total [Moles/volume] in Capillary blood | ./2.16.840.1.114222.4.11.1002/97770-2.json |
| 97773-6 | Base excess standard in Arterial cord blood by calculation | ./2.16.840.1.114222.4.11.1002/97773-6.json |
| 9777-4 | Nalbuphine [Mass/volume] in Specimen | ./2.16.840.1.114222.4.11.1002/9777-4.json |
| 97774-4 | Base excess standard in Venous cord blood by calculation | ./2.16.840.1.114222.4.11.1002/97774-4.json |
| 97775-1 | Base excess standard in Cord blood by calculation | ./2.16.840.1.114222.4.11.1002/97775-1.json |
| 9778-2 | Phenelzine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9778-2.json |
| 9779-0 | quiNIDine Free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9779-0.json |
| 9780-8 | Spermatozoa [#/volume] in Semen | ./2.16.840.1.114222.4.11.1002/9780-8.json |
| 9781-6 | Acanthamoeba sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/9781-6.json |
| 9782-4 | Adenovirus sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/9782-4.json |
| 9783-2 | Ehrlichia chaffeensis IgG Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9783-2.json |
| 9784-0 | Ehrlichia chaffeensis IgM Ab [Titer] in Serum | ./2.16.840.1.114222.4.11.1002/9784-0.json |
| 97852-8 | COVID-19 clinical status by WHO classification | ./2.16.840.1.114222.4.11.1002/97852-8.json |
| 97853-6 | Anticomplementary activity [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97853-6.json |
| 97854-4 | Paracoccidioides sp Ab [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97854-4.json |
| 97855-1 | Blastomyces sp Ab [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97855-1.json |
| 97856-9 | Histoplasma capsulatum yeast phase Ab [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97856-9.json |
| 97857-7 | Histoplasma capsulatum mycelial phase Ab [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97857-7.json |
| 97858-5 | Coccidioides sp Ab [Titer] in Specimen by Complement fixation | ./2.16.840.1.114222.4.11.1002/97858-5.json |
| 97863-5 | Herpes virus 8 IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97863-5.json |
| 9786-5 | Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain | ./2.16.840.1.114222.4.11.1002/9786-5.json |
| 97866-8 | Chikungunya virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97866-8.json |
| 97867-6 | Chikungunya virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97867-6.json |
| 978-7 | D Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/978-7.json |
| 97870-0 | Zika virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97870-0.json |
| 9787-3 | Sarcoptes scabiei identified in Skin by Light microscopy | ./2.16.840.1.114222.4.11.1002/9787-3.json |
| 97873-4 | Herpes virus 8 IgM Ab [Presence] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97873-4.json |
| 9788-1 | Streptolysin O Ab [Presence] in Serum | ./2.16.840.1.114222.4.11.1002/9788-1.json |
| 9789-9 | Carbamate pesticides [Type] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9789-9.json |
| 9790-7 | Methyl bromide [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9790-7.json |
| 97911-2 | Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method --after addition of factor VIII Ab | ./2.16.840.1.114222.4.11.1002/97911-2.json |
| 97914-6 | Time to thrombin peak in Platelet poor plasma by Chromogenic method | ./2.16.840.1.114222.4.11.1002/97914-6.json |
| 9791-5 | Organochlorine pesticides [Type] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9791-5.json |
| 97916-1 | Coccidioides sp DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97916-1.json |
| 97917-9 | Oropouche virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97917-9.json |
| 97918-7 | Rift valley fever virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97918-7.json |
| 97919-5 | Bwamba virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97919-5.json |
| 97920-3 | Tick-borne encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97920-3.json |
| 97921-1 | Bunyamwera virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97921-1.json |
| 97922-9 | California encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97922-9.json |
| 9792-3 | Organophosphate pesticides [Identifier] in Blood | ./2.16.840.1.114222.4.11.1002/9792-3.json |
| 97923-7 | Sandfly fever Naples virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97923-7.json |
| 97924-5 | Jamestown canyon virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97924-5.json |
| 97925-2 | Barmah forest virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97925-2.json |
| 97926-0 | Snowshoe hare virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97926-0.json |
| 97927-8 | Tahyna virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97927-8.json |
| 97928-6 | Highlands J virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97928-6.json |
| 97929-4 | Ross River virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97929-4.json |
| 97930-2 | Sindbis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97930-2.json |
| 9793-1 | Trichloroethylene [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9793-1.json |
| 97931-0 | Mayaro virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97931-0.json |
| 97932-8 | Colorado tick fever virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97932-8.json |
| 97933-6 | Sandfly fever Sicilian virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97933-6.json |
| 97934-4 | Toscana virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97934-4.json |
| 97935-1 | Bourbon virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97935-1.json |
| 97936-9 | Candida auris DNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97936-9.json |
| 97940-1 | Cryptococcus sp [Presence] in Isolate by Organism specific culture | ./2.16.840.1.114222.4.11.1002/97940-1.json |
| 97941-9 | Cycloheximide [Susceptibility] in Isolate Qualitative | ./2.16.840.1.114222.4.11.1002/97941-9.json |
| 97947-6 | Rocio virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97947-6.json |
| 97948-4 | Ilheus virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97948-4.json |
| 9794-9 | Cathepsin D [Moles/mass] in Tissue | ./2.16.840.1.114222.4.11.1002/9794-9.json |
| 97949-2 | Semliki Forest virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97949-2.json |
| 97950-0 | Onyong-nyong virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97950-0.json |
| 97951-8 | Venezuelan equine encephalitis virus RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97951-8.json |
| 97954-2 | Rhinovirus+Enterovirus A+B+C RNA [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/97954-2.json |
| 97955-9 | European Hornet IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97955-9.json |
| 97956-7 | Lysozyme IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97956-7.json |
| 97957-5 | Anisakis IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97957-5.json |
| 97958-3 | London Plane IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97958-3.json |
| 97959-1 | Silver Birch recombinant (rBet v) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97959-1.json |
| 97960-9 | Olive pollen native (nOle e) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97960-9.json |
| 97961-7 | European Ash IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97961-7.json |
| 97962-5 | Grey Alder IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97962-5.json |
| 97963-3 | Silver Birch IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97963-3.json |
| 97964-1 | Pellitory (Parietaria judaica) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97964-1.json |
| 97965-8 | Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97965-8.json |
| 97966-6 | European house dust mite recombinant (rDer p) 2 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97966-6.json |
| 97967-4 | Chicken droppings IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97967-4.json |
| 97968-2 | Ovalbumin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97968-2.json |
| 97969-0 | Ovomucoid IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97969-0.json |
| 97970-8 | Turkey meat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97970-8.json |
| 97971-6 | Conalbumin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97971-6.json |
| 97972-4 | Peanut recombinant (rAra h) 8 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97972-4.json |
| 97973-2 | Peanut recombinant (rAra h) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97973-2.json |
| 97974-0 | Peanut recombinant (rAra h) 2 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97974-0.json |
| 97975-7 | Peanut recombinant (rAra h) 3 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97975-7.json |
| 97976-5 | Codfish recombinant (rGad c) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97976-5.json |
| 97977-3 | Peanut recombinant (rAra h) 9 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97977-3.json |
| 97978-1 | Apple recombinant (rMal d) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97978-1.json |
| 97979-9 | Apple recombinant (rMal d) 3 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97979-9.json |
| 97980-7 | Hazelnut recombinant (rCor a) 14 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97980-7.json |
| 97981-5 | Hazelnut recombinant (rCor a) 9 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97981-5.json |
| 97982-3 | Cultivated Corn IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97982-3.json |
| 97983-1 | Timothy recombinant (rPhl p) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97983-1.json |
| 97984-9 | Timothy recombinant (rPhl p) 1 + 5b IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97984-9.json |
| 97985-6 | Honey bee phospholipase A2 recombinant (rApi m) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97985-6.json |
| 97986-4 | Common wasp recombinant (rVes v) 5 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97986-4.json |
| 97987-2 | Honey bee recombinant (rApi m) 10 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97987-2.json |
| 97988-0 | Chicken meat IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97988-0.json |
| 97989-8 | Culex mosquito IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/97989-8.json |
| 97990-6 | von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97990-6.json |
| 97991-4 | Herpes virus 6 IgG Ab [Units/volume] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97991-4.json |
| 97992-2 | Herpes virus 6 IgM Ab [Presence] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97992-2.json |
| 97993-0 | Epstein Barr virus early IgM Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/97993-0.json |
| 97996-3 | Myeloperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/97996-3.json |
| 97997-1 | HPA and HLA Ab [Interpretation] in Serum, Plasma or Blood Narrative | ./2.16.840.1.114222.4.11.1002/97997-1.json |
| 97998-9 | HPA Ab [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97998-9.json |
| 97999-7 | HLA-DP and DQ and DR (class II) IgG donor specific [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/97999-7.json |
| 98000-3 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by High resolution | ./2.16.840.1.114222.4.11.1002/98000-3.json |
| 98001-1 | HLA-DP and DQ and DR (class II) [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/98001-1.json |
| 98002-9 | HLA-A and B and C (class I) [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/98002-9.json |
| 98003-7 | HLA-A and B and C (class I) IgG donor specific [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98003-7.json |
| 98004-5 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] | ./2.16.840.1.114222.4.11.1002/98004-5.json |
| 98005-2 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) [Type] by Low resolution | ./2.16.840.1.114222.4.11.1002/98005-2.json |
| 98006-0 | HLA-A and B and C (class I) and HLA-DP and DQ and DR (class II) Ab [Identifier] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98006-0.json |
| 98014-4 | Plasma cell proliferation analysis in Bone marrow by FISH | ./2.16.840.1.114222.4.11.1002/98014-4.json |
| 98015-1 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge | ./2.16.840.1.114222.4.11.1002/98015-1.json |
| 98016-9 | Fat [#/area] in Urine sediment by Microscopy high power field | ./2.16.840.1.114222.4.11.1002/98016-9.json |
| 98018-5 | Megakaryoblasts/100 cells in Bone marrow by Manual count | ./2.16.840.1.114222.4.11.1002/98018-5.json |
| 98020-1 | Leukocytes [#/volume] in Lower respiratory specimen by Manual count | ./2.16.840.1.114222.4.11.1002/98020-1.json |
| 98033-4 | PET+CT Lower extremity | ./2.16.840.1.114222.4.11.1002/98033-4.json |
| 98034-2 | RF Unspecified body region Limited Views | ./2.16.840.1.114222.4.11.1002/98034-2.json |
| 98035-9 | US Eye | ./2.16.840.1.114222.4.11.1002/98035-9.json |
| 98036-7 | NM Abdomen Views for therapy W Tc-99m SC IV | ./2.16.840.1.114222.4.11.1002/98036-7.json |
| 98037-5 | Jewish descent preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98037-5.json |
| 98038-3 | CFTR and FMR1 (CGG repeat) and SMN1 gene mutation analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98038-3.json |
| 98039-1 | Preconception AndOr prenatal carrier screening multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98039-1.json |
| 98040-9 | Urothelial carcinoma recurrence score Urine Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98040-9.json |
| 98041-7 | Cortisone IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98041-7.json |
| 98042-5 | Chanterelles IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98042-5.json |
| 98043-3 | 5-Aminosalicylate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98043-3.json |
| 98044-1 | Benzoate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98044-1.json |
| 98045-8 | Flaxseed IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98045-8.json |
| 98046-6 | Lincomycin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98046-6.json |
| 98047-4 | Lipoxygenase IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98047-4.json |
| 98048-2 | Levothyroxine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98048-2.json |
| 98050-8 | European roe venison IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98050-8.json |
| 98051-6 | Microsporum canis IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98051-6.json |
| 98052-4 | Minocycline IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98052-4.json |
| 98053-2 | Loquat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98053-2.json |
| 98054-0 | Mouse droppings IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98054-0.json |
| 98055-7 | Nystatin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98055-7.json |
| 98056-5 | Oxacillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98056-5.json |
| 98057-3 | Penicillium digitatum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98057-3.json |
| 98058-1 | Penicillium expansum IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98058-1.json |
| 98059-9 | Gilt-head bream IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98059-9.json |
| 98060-7 | Penicillamine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98060-7.json |
| 98061-5 | Wild garlic (Allium ursinum) IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98061-5.json |
| 98069-8 | SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay | ./2.16.840.1.114222.4.11.1002/98069-8.json |
| 98074-8 | CT Internal auditory canal - bilateral W contrast | ./2.16.840.1.114222.4.11.1002/98074-8.json |
| 98075-5 | FDA product label Animal cells, tissues, and cell and tissue based product label | ./2.16.840.1.114222.4.11.1002/98075-5.json |
| 9807-9 | Chlordane [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9807-9.json |
| 98081-3 | Cytomegalovirus DNA [#/volume] (viral load) in Saliva (oral fluid) by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/98081-3.json |
| 98082-1 | Specific airway resistance mean by Plethysmograph body box --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/98082-1.json |
| 98083-9 | Specific airway resistance mean by Plethysmograph body box --post bronchodilation | ./2.16.840.1.114222.4.11.1002/98083-9.json |
| 98084-7 | Specific effective resistance.airway mean Calculated | ./2.16.840.1.114222.4.11.1002/98084-7.json |
| 98085-4 | Specific effective resistance.airway mean Calculated --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/98085-4.json |
| 98086-2 | Specific effective resistance.airway mean Calculated --post bronchodilation | ./2.16.840.1.114222.4.11.1002/98086-2.json |
| 9808-7 | Phenothiazines [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9808-7.json |
| 98087-0 | Specific effective resistance.airway/Predicted mean | ./2.16.840.1.114222.4.11.1002/98087-0.json |
| 98088-8 | Vital capacity/predicted VC Respiratory system by Spirometry | ./2.16.840.1.114222.4.11.1002/98088-8.json |
| 98089-6 | Inspiratory capacity by Spirometry --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/98089-6.json |
| 98090-4 | Inspiratory capacity by Spirometry --post bronchodilation | ./2.16.840.1.114222.4.11.1002/98090-4.json |
| 98091-2 | Diffusion capacity.carbon monoxide --pre bronchodilation | ./2.16.840.1.114222.4.11.1002/98091-2.json |
| 98092-0 | Diffusion capacity.carbon monoxide --post bronchodilation | ./2.16.840.1.114222.4.11.1002/98092-0.json |
| 9809-5 | Propoxyphene [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9809-5.json |
| 98095-3 | Cells.FOXP3 Ag/100 cells in Blood | ./2.16.840.1.114222.4.11.1002/98095-3.json |
| 98096-1 | Interleukin 33 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98096-1.json |
| 98097-9 | Thymic stromal lymphopoietin [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98097-9.json |
| 98098-7 | Interleukin 17F [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98098-7.json |
| 98099-5 | Interleukin 21 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98099-5.json |
| 98100-1 | Interleukin 22 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98100-1.json |
| 98101-9 | Interleukin 23 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98101-9.json |
| 98102-7 | Chemokine (C-X-C motif) ligand 10 [Mass/volume] in Serum, Plasma or Blood | ./2.16.840.1.114222.4.11.1002/98102-7.json |
| 9810-3 | quiNINE [Presence] in Gastric fluid | ./2.16.840.1.114222.4.11.1002/9810-3.json |
| 98103-5 | Interleukin 9 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98103-5.json |
| 98104-3 | Interleukin 15 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98104-3.json |
| 98105-0 | Interleukin 16 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98105-0.json |
| 98106-8 | Brain-derived neurotrophic factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98106-8.json |
| 98107-6 | Macrophage colony-stimulating factor [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98107-6.json |
| 98108-4 | Chemokine (C-C motif) ligand 11 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98108-4.json |
| 98109-2 | Chemokine (C-C motif) ligand 8 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98109-2.json |
| 98110-0 | Chemokine (C-C motif) ligand 7 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98110-0.json |
| 9811-1 | Chromogranin A [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9811-1.json |
| 98111-8 | Chemokine (C-C motif) ligand 4 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98111-8.json |
| 98112-6 | Chemokine (C-C motif) ligand 20 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98112-6.json |
| 98113-4 | Chemokine (C-C motif) ligand 5 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98113-4.json |
| 98114-2 | Chemokine (C-X3-C motif) ligand 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98114-2.json |
| 98115-9 | Chemokine (C-X-C motif) ligand 9 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98115-9.json |
| 98116-7 | Chemokine (C-C motif) ligand 27 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98116-7.json |
| 98117-5 | Fibroblast growth factor 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98117-5.json |
| 98118-3 | Vascular endothelial growth factor C [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98118-3.json |
| 98119-1 | Angiopoietin receptor 2 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98119-1.json |
| 98120-9 | Intercellular adhesion molecule 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98120-9.json |
| 98121-7 | Protein/Creatinine Qualitative in Urine by Test strip | ./2.16.840.1.114222.4.11.1002/98121-7.json |
| 9812-9 | Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen | ./2.16.840.1.114222.4.11.1002/9812-9.json |
| 98129-0 | Thymol turbidity test in Blood | ./2.16.840.1.114222.4.11.1002/98129-0.json |
| 98130-8 | Diffusion capacity.carbon monoxide/Predicted | ./2.16.840.1.114222.4.11.1002/98130-8.json |
| 98131-6 | SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/98131-6.json |
| 98132-4 | SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory system specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/98132-4.json |
| 9813-7 | Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen | ./2.16.840.1.114222.4.11.1002/9813-7.json |
| 98137-3 | Pain assessment report | ./2.16.840.1.114222.4.11.1002/98137-3.json |
| 98139-9 | Osteoporosis Risk Assessment Instrument | ./2.16.840.1.114222.4.11.1002/98139-9.json |
| 98141-5 | Emergency department Admission notification | ./2.16.840.1.114222.4.11.1002/98141-5.json |
| 98142-3 | Emergency department Discharge notification | ./2.16.840.1.114222.4.11.1002/98142-3.json |
| 98143-1 | Emergency department Arrival notification | ./2.16.840.1.114222.4.11.1002/98143-1.json |
| 98144-9 | Emergency department Departure notification | ./2.16.840.1.114222.4.11.1002/98144-9.json |
| 9814-5 | Dextroamphetamine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9814-5.json |
| 98145-6 | Outpatient Visit notification | ./2.16.840.1.114222.4.11.1002/98145-6.json |
| 98146-4 | Osteoporosis Self-Assessment Tool | ./2.16.840.1.114222.4.11.1002/98146-4.json |
| 9815-2 | Lithium [Mass/volume] in Red Blood Cells | ./2.16.840.1.114222.4.11.1002/9815-2.json |
| 9816-0 | Actinomyces sp identified in Specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/9816-0.json |
| 9817-8 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/9817-8.json |
| 98183-7 | Wild boar dander IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98183-7.json |
| 98184-5 | Acetylcysteine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98184-5.json |
| 98185-2 | Ambroxol IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98185-2.json |
| 9818-6 | Cryptococcus sp Ag [Titer] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/9818-6.json |
| 98186-0 | Aspartame IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98186-0.json |
| 98187-8 | Aspergillus repens IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98187-8.json |
| 98188-6 | Bacampicillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98188-6.json |
| 98189-4 | Benzocaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98189-4.json |
| 98190-2 | Bromhexine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98190-2.json |
| 98191-0 | Azlocillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98191-0.json |
| 98192-8 | Cephalothin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98192-8.json |
| 98193-6 | Wax begonia IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98193-6.json |
| 9819-4 | Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination | ./2.16.840.1.114222.4.11.1002/9819-4.json |
| 98194-4 | Hibiscus tea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98194-4.json |
| 98195-1 | Diatrizoate IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98195-1.json |
| 98196-9 | Echinacea IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98196-9.json |
| 98197-7 | EPINEPHrine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98197-7.json |
| 98198-5 | Erythrosine B IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98198-5.json |
| 98199-3 | Phenacetin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98199-3.json |
| 98200-9 | Paraphenylenediamine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98200-9.json |
| 98201-7 | Fuchsia spp IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98201-7.json |
| 9820-2 | Cryptococcus sp Ag [Titer] in Serum by Latex agglutination | ./2.16.840.1.114222.4.11.1002/9820-2.json |
| 98202-5 | Ginkgo IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98202-5.json |
| 98203-3 | (Diffusion capacity/Alveolar volume)/predicted | ./2.16.840.1.114222.4.11.1002/98203-3.json |
| 98208-2 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/98208-2.json |
| 98210-8 | Legionella pneumophila IgM Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/98210-8.json |
| 98215-7 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/98215-7.json |
| 98216-5 | Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/98216-5.json |
| 98217-3 | Treponema pallidum IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/98217-3.json |
| 98218-1 | Treponema pallidum IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/98218-1.json |
| 98220-7 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/98220-7.json |
| 98221-5 | Treponema pallidum IgG bands [Identifier] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/98221-5.json |
| 98222-3 | Treponema pallidum IgG bands [Identifier] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/98222-3.json |
| 98223-1 | Treponema pallidum IgM bands [Identifier] in Serum by Immunoblot | ./2.16.840.1.114222.4.11.1002/98223-1.json |
| 98224-9 | Treponema pallidum IgM bands [Identifier] in Cerebral spinal fluid by Immunoblot | ./2.16.840.1.114222.4.11.1002/98224-9.json |
| 98225-6 | Piperacillin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98225-6.json |
| 98226-4 | prednisoLONE IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98226-4.json |
| 98227-2 | Prilocaine IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98227-2.json |
| 9822-8 | Bacteria identified in Dialysis fluid by Culture | ./2.16.840.1.114222.4.11.1002/9822-8.json |
| 98229-8 | Ofloxacin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98229-8.json |
| 98230-6 | Corn starch IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98230-6.json |
| 98231-4 | Sorbic acid IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98231-4.json |
| 98232-2 | St. John's wort IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98232-2.json |
| 98233-0 | Cape gooseberry IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98233-0.json |
| 98234-8 | Quail meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98234-8.json |
| 98235-5 | Wild boar meat IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98235-5.json |
| 9823-6 | Mycobacterium sp identified in Bronchial specimen by Organism specific culture | ./2.16.840.1.114222.4.11.1002/9823-6.json |
| 98236-3 | Norfloxacin IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/98236-3.json |
| 98237-1 | Chemokine (C-X-C motif) ligand 1 [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98237-1.json |
| 98238-9 | Platelet-derived growth factor B+BB [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98238-9.json |
| 9824-4 | Mycobacterium sp identified in Gastric fluid by Organism specific culture | ./2.16.840.1.114222.4.11.1002/9824-4.json |
| 9825-1 | Mycobacterium sp identified in Isolate | ./2.16.840.1.114222.4.11.1002/9825-1.json |
| 9826-9 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9826-9.json |
| 9827-7 | Paraquat [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9827-7.json |
| 98282-7 | XR Stomach and Duodenum Views | ./2.16.840.1.114222.4.11.1002/98282-7.json |
| 98283-5 | XR Gastrointestinal tract upper Views | ./2.16.840.1.114222.4.11.1002/98283-5.json |
| 98284-3 | Guidance for myelography of Thoracic and lumbar spine | ./2.16.840.1.114222.4.11.1002/98284-3.json |
| 9828-5 | House dust Greer IgE Ab [Units/volume] in Serum | ./2.16.840.1.114222.4.11.1002/9828-5.json |
| 98285-0 | Guidance for myelography of Cervical and thoracic and lumbar spine | ./2.16.840.1.114222.4.11.1002/98285-0.json |
| 98286-8 | US.doppler Foot vessels - right | ./2.16.840.1.114222.4.11.1002/98286-8.json |
| 98287-6 | US.doppler Foot vessels - bilateral | ./2.16.840.1.114222.4.11.1002/98287-6.json |
| 98288-4 | US.doppler Foot vessels - left | ./2.16.840.1.114222.4.11.1002/98288-4.json |
| 98289-2 | US.doppler Hand vessels - left | ./2.16.840.1.114222.4.11.1002/98289-2.json |
| 98290-0 | US.doppler Hand vessels - bilateral | ./2.16.840.1.114222.4.11.1002/98290-0.json |
| 98291-8 | US.doppler Hand vessels - right | ./2.16.840.1.114222.4.11.1002/98291-8.json |
| 98292-6 | US.doppler Femoral artery and Popliteal artery - right | ./2.16.840.1.114222.4.11.1002/98292-6.json |
| 98293-4 | US.doppler Femoral artery and Popliteal artery - left | ./2.16.840.1.114222.4.11.1002/98293-4.json |
| 98294-2 | XR Lower extremity joint - bilateral Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/98294-2.json |
| 98295-9 | XR Lower extremity joint - left Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/98295-9.json |
| 98296-7 | XR Lower extremity joint - right Lateral Views W manual stress | ./2.16.840.1.114222.4.11.1002/98296-7.json |
| 98297-5 | XR Foot cuneiform bones - right Views | ./2.16.840.1.114222.4.11.1002/98297-5.json |
| 98298-3 | XR Forefoot - right Views | ./2.16.840.1.114222.4.11.1002/98298-3.json |
| 98299-1 | XR Ankle - right Mortise W gravity stress | ./2.16.840.1.114222.4.11.1002/98299-1.json |
| 98300-7 | XR Calcaneus - right LE 3 Broden Views | ./2.16.840.1.114222.4.11.1002/98300-7.json |
| 9830-1 | Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/9830-1.json |
| 98301-5 | XR Knee - right AP W varus stress | ./2.16.840.1.114222.4.11.1002/98301-5.json |
| 98302-3 | XR Knee - right AP W valgus stress | ./2.16.840.1.114222.4.11.1002/98302-3.json |
| 98303-1 | XR Calcaneus - right Lateral | ./2.16.840.1.114222.4.11.1002/98303-1.json |
| 98304-9 | XR Calcaneus - right Canale | ./2.16.840.1.114222.4.11.1002/98304-9.json |
| 98305-6 | XR Foot cuneiform bones - left Views | ./2.16.840.1.114222.4.11.1002/98305-6.json |
| 98306-4 | XR Forefoot - left Views | ./2.16.840.1.114222.4.11.1002/98306-4.json |
| 98307-2 | XR Ankle - left Mortise W gravity stress | ./2.16.840.1.114222.4.11.1002/98307-2.json |
| 98308-0 | XR Calcaneus - left LE 3 Broden Views | ./2.16.840.1.114222.4.11.1002/98308-0.json |
| 98309-8 | XR Knee - left AP W valgus stress | ./2.16.840.1.114222.4.11.1002/98309-8.json |
| 98310-6 | XR Knee - left AP W varus stress | ./2.16.840.1.114222.4.11.1002/98310-6.json |
| 98311-4 | XR Calcaneus - left Lateral | ./2.16.840.1.114222.4.11.1002/98311-4.json |
| 98312-2 | XR Calcaneus - left Canale | ./2.16.840.1.114222.4.11.1002/98312-2.json |
| 98313-0 | XR Foot cuneiform bones - bilateral Views | ./2.16.840.1.114222.4.11.1002/98313-0.json |
| 98314-8 | XR Forefoot - bilateral Views | ./2.16.840.1.114222.4.11.1002/98314-8.json |
| 98315-5 | XR Calcaneus - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98315-5.json |
| 98316-3 | XR Knee - bilateral Single view W valgus stress | ./2.16.840.1.114222.4.11.1002/98316-3.json |
| 98317-1 | XR Knee - bilateral AP W varus stress | ./2.16.840.1.114222.4.11.1002/98317-1.json |
| 98318-9 | XR Ankle - bilateral Mortise W gravity stress | ./2.16.840.1.114222.4.11.1002/98318-9.json |
| 98319-7 | XR Calcaneus - bilateral LE 3 Broden Views | ./2.16.840.1.114222.4.11.1002/98319-7.json |
| 98320-5 | XR Toe fourth - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98320-5.json |
| 98321-3 | XR Toe second - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98321-3.json |
| 98322-1 | XR Toe third - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98322-1.json |
| 98323-9 | XR Toe fifth - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98323-9.json |
| 98324-7 | XR Sacrum and Coccyx Views AP | ./2.16.840.1.114222.4.11.1002/98324-7.json |
| 98325-4 | XR Sacrum and Coccyx Lateral Views | ./2.16.840.1.114222.4.11.1002/98325-4.json |
| 98326-2 | XR Thoracic and lumbar spine PA Views for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/98326-2.json |
| 98327-0 | XR Thoracic and lumbar spine AP Views for scoliosis W standing | ./2.16.840.1.114222.4.11.1002/98327-0.json |
| 98328-8 | XR Spine thoracolumbar junction Lateral | ./2.16.840.1.114222.4.11.1002/98328-8.json |
| 98329-6 | XR Spine thoracolumbar junction AP | ./2.16.840.1.114222.4.11.1002/98329-6.json |
| 98330-4 | XR Sternum PA Views | ./2.16.840.1.114222.4.11.1002/98330-4.json |
| 98331-2 | XR Sternum Oblique Views | ./2.16.840.1.114222.4.11.1002/98331-2.json |
| 98332-0 | XR Wrist - right Reverse oblique | ./2.16.840.1.114222.4.11.1002/98332-0.json |
| 98333-8 | XR Scaphoid and Trapezium and Trapezoid - right Single view | ./2.16.840.1.114222.4.11.1002/98333-8.json |
| 98334-6 | XR Hamate - right Single view | ./2.16.840.1.114222.4.11.1002/98334-6.json |
| 98335-3 | XR Pisiform and Triquetrum - right Single view | ./2.16.840.1.114222.4.11.1002/98335-3.json |
| 98336-1 | XR Wrist - right AP | ./2.16.840.1.114222.4.11.1002/98336-1.json |
| 98337-9 | XR Wrist - right Lateral | ./2.16.840.1.114222.4.11.1002/98337-9.json |
| 98338-7 | XR Wrist - left Lateral | ./2.16.840.1.114222.4.11.1002/98338-7.json |
| 98339-5 | XR Wrist - left AP | ./2.16.840.1.114222.4.11.1002/98339-5.json |
| 98340-3 | XR Wrist - left Reverse oblique | ./2.16.840.1.114222.4.11.1002/98340-3.json |
| 98341-1 | XR Pisiform and Triquetrum - left Single view | ./2.16.840.1.114222.4.11.1002/98341-1.json |
| 98342-9 | XR Hamate - left Single view | ./2.16.840.1.114222.4.11.1002/98342-9.json |
| 9834-3 | HYDROmorphone [Presence] in Urine | ./2.16.840.1.114222.4.11.1002/9834-3.json |
| 98343-7 | XR Scaphoid and Trapezium and Trapezoid - left Single view | ./2.16.840.1.114222.4.11.1002/98343-7.json |
| 98344-5 | XR Wrist - bilateral AP | ./2.16.840.1.114222.4.11.1002/98344-5.json |
| 98345-2 | XR Wrist - bilateral Lateral | ./2.16.840.1.114222.4.11.1002/98345-2.json |
| 98346-0 | XR Scaphoid and Trapezium and Trapezoid - bilateral Views | ./2.16.840.1.114222.4.11.1002/98346-0.json |
| 98347-8 | XR Hamate - bilateral Views | ./2.16.840.1.114222.4.11.1002/98347-8.json |
| 98348-6 | XR Pisiform and Triquetrum - bilateral Views | ./2.16.840.1.114222.4.11.1002/98348-6.json |
| 98349-4 | XR Wrist - bilateral Ulnar deviation Views | ./2.16.840.1.114222.4.11.1002/98349-4.json |
| 9835-0 | HYDROmorphone [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/9835-0.json |
| 98350-2 | XR Wrist - bilateral Radial deviation | ./2.16.840.1.114222.4.11.1002/98350-2.json |
| 98351-0 | XR Thumb - right Radial deviation | ./2.16.840.1.114222.4.11.1002/98351-0.json |
| 98352-8 | XR Thumb - right PA | ./2.16.840.1.114222.4.11.1002/98352-8.json |
| 98353-6 | XR Thumb - left Oblique | ./2.16.840.1.114222.4.11.1002/98353-6.json |
| 98354-4 | XR Thumb - left PA | ./2.16.840.1.114222.4.11.1002/98354-4.json |
| 98355-1 | XR Thumb - bilateral PA | ./2.16.840.1.114222.4.11.1002/98355-1.json |
| 98356-9 | XR Coccyx AP | ./2.16.840.1.114222.4.11.1002/98356-9.json |
| 98357-7 | XR Coccyx Lateral | ./2.16.840.1.114222.4.11.1002/98357-7.json |
| 98358-5 | XR Cervical spine Single view W flexion | ./2.16.840.1.114222.4.11.1002/98358-5.json |
| 98359-3 | XR Cervical spine Odontoid | ./2.16.840.1.114222.4.11.1002/98359-3.json |
| 98360-1 | XR Cervical spine Single view W extension | ./2.16.840.1.114222.4.11.1002/98360-1.json |
| 98361-9 | XR Thumb - left Radial deviation | ./2.16.840.1.114222.4.11.1002/98361-9.json |
| 98362-7 | XR Thumb - right Oblique | ./2.16.840.1.114222.4.11.1002/98362-7.json |
| 98363-5 | XR Sacroiliac joint - left AP and Oblique | ./2.16.840.1.114222.4.11.1002/98363-5.json |
| 98364-3 | XR Sacroiliac joint - right AP and Oblique | ./2.16.840.1.114222.4.11.1002/98364-3.json |
| 98365-0 | XR Thoracic spine Single view W extension | ./2.16.840.1.114222.4.11.1002/98365-0.json |
| 98366-8 | XR Thoracic spine Single view W flexion | ./2.16.840.1.114222.4.11.1002/98366-8.json |
| 9836-8 | HIV proviral DNA [Presence] in Blood by Probe with amplification | ./2.16.840.1.114222.4.11.1002/9836-8.json |
| 9837-6 | HIV 1 proviral DNA [Presence] in Blood by Probe with amplification | ./2.16.840.1.114222.4.11.1002/9837-6.json |
| 9838-4 | Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/9838-4.json |
| 9839-2 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immune diffusion (ID) | ./2.16.840.1.114222.4.11.1002/9839-2.json |
| 984-5 | Di sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/984-5.json |
| 98485-6 | Amyloid beta 42 peptide/Amyloid beta 40 peptide [Mass Ratio] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/98485-6.json |
| 98489-8 | FLT3 gene internal tandem duplication length [#] in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98489-8.json |
| 98490-6 | FLT3 gene.p.Asp835+Ile836 mutations/Normal in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/98490-6.json |
| 98605-9 | Sensory nerve conduction panel Left radial nerve | ./2.16.840.1.114222.4.11.1002/98605-9.json |
| 98611-7 | Sensory nerve conduction panel Right radial nerve | ./2.16.840.1.114222.4.11.1002/98611-7.json |
| 98617-4 | Sensory nerve conduction panel Left median nerve | ./2.16.840.1.114222.4.11.1002/98617-4.json |
| 98622-4 | Sensory nerve conduction panel Right median nerve | ./2.16.840.1.114222.4.11.1002/98622-4.json |
| 98627-3 | Sensory nerve conduction panel Left ulnar nerve | ./2.16.840.1.114222.4.11.1002/98627-3.json |
| 98632-3 | Sensory nerve conduction panel Right ulnar nerve | ./2.16.840.1.114222.4.11.1002/98632-3.json |
| 98637-2 | Sensory nerve conduction panel Left medial antebrachial cutaneous nerve | ./2.16.840.1.114222.4.11.1002/98637-2.json |
| 98642-2 | Sensory nerve conduction panel Right medial antebrachial cutaneous nerve | ./2.16.840.1.114222.4.11.1002/98642-2.json |
| 98647-1 | Sensory nerve conduction panel Left lateral antebrachial cutaneous nerve | ./2.16.840.1.114222.4.11.1002/98647-1.json |
| 98652-1 | Sensory nerve conduction panel Right lateral antebrachial cutaneous nerve | ./2.16.840.1.114222.4.11.1002/98652-1.json |
| 98658-8 | Sensory nerve conduction panel Left sural nerve | ./2.16.840.1.114222.4.11.1002/98658-8.json |
| 98664-6 | Sensory nerve conduction panel Right sural nerve | ./2.16.840.1.114222.4.11.1002/98664-6.json |
| 98669-5 | Motor nerve conduction panel Left median nerve | ./2.16.840.1.114222.4.11.1002/98669-5.json |
| 98673-7 | Motor nerve conduction panel Right median nerve | ./2.16.840.1.114222.4.11.1002/98673-7.json |
| 98678-6 | Motor nerve conduction panel Left ulnar nerve | ./2.16.840.1.114222.4.11.1002/98678-6.json |
| 98681-0 | Motor nerve conduction panel Right ulnar nerve | ./2.16.840.1.114222.4.11.1002/98681-0.json |
| 98684-4 | Motor nerve conduction panel Left fibular nerve | ./2.16.840.1.114222.4.11.1002/98684-4.json |
| 98687-7 | Motor nerve conduction panel Right fibular nerve | ./2.16.840.1.114222.4.11.1002/98687-7.json |
| 98690-1 | Motor nerve conduction panel Left tibial nerve | ./2.16.840.1.114222.4.11.1002/98690-1.json |
| 98693-5 | Motor nerve conduction panel Right tibial nerve | ./2.16.840.1.114222.4.11.1002/98693-5.json |
| 98696-8 | Sensory nerve conduction panel Nerve | ./2.16.840.1.114222.4.11.1002/98696-8.json |
| 98703-2 | Motor nerve conduction panel Nerve | ./2.16.840.1.114222.4.11.1002/98703-2.json |
| 98704-0 | F-wave motor nerve conduction panel Nerve | ./2.16.840.1.114222.4.11.1002/98704-0.json |
| 98706-5 | Repetitive motor nerve stimulation panel Nerve | ./2.16.840.1.114222.4.11.1002/98706-5.json |
| 98732-1 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/98732-1.json |
| 98733-9 | Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/98733-9.json |
| 98735-4 | Eye Worth 4 dot test far [Interpretation] | ./2.16.840.1.114222.4.11.1002/98735-4.json |
| 98737-0 | Eye Worth 4 dot test near [Interpretation] | ./2.16.840.1.114222.4.11.1002/98737-0.json |
| 98739-6 | Eye AC/A ratio by Phoropter | ./2.16.840.1.114222.4.11.1002/98739-6.json |
| 98849-3 | Eye Depth perception by Phoropter | ./2.16.840.1.114222.4.11.1002/98849-3.json |
| 98854-3 | Urothelial carcinoma probability score based on clinical and lab data | ./2.16.840.1.114222.4.11.1002/98854-3.json |
| 98857-6 | Cardiac stress EKG study Document | ./2.16.840.1.114222.4.11.1002/98857-6.json |
| 98858-4 | Esophageal pH monitoring study Document | ./2.16.840.1.114222.4.11.1002/98858-4.json |
| 98859-2 | Anorectal manometry study | ./2.16.840.1.114222.4.11.1002/98859-2.json |
| 98860-0 | Transforming growth factor beta free [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98860-0.json |
| 98861-8 | Transforming growth factor beta [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/98861-8.json |
| 98897-2 | XR Pelvis and Hip - left Abduction and Internal rotation | ./2.16.840.1.114222.4.11.1002/98897-2.json |
| 98898-0 | XR Pelvis and Hip - right Abduction and Internal rotation | ./2.16.840.1.114222.4.11.1002/98898-0.json |
| 98899-8 | XR Wrist - right Pronated oblique | ./2.16.840.1.114222.4.11.1002/98899-8.json |
| 98900-4 | XR Wrist - left Pronated oblique | ./2.16.840.1.114222.4.11.1002/98900-4.json |
| 98909-5 | Shock index Calculated | ./2.16.840.1.114222.4.11.1002/98909-5.json |
| 98910-3 | Modified shock index Calculated | ./2.16.840.1.114222.4.11.1002/98910-3.json |
| 98954-1 | KCNN4 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/98954-1.json |
| 98955-8 | Burkholderia pseudomallei Ab [Titer] in Specimen by Hemagglutination inhibition | ./2.16.840.1.114222.4.11.1002/98955-8.json |
| 98956-6 | Coccidioides immitis IgM Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/98956-6.json |
| 98957-4 | Coccidioides immitis IgG Ab [Units/volume] in Specimen by Immunoassay | ./2.16.840.1.114222.4.11.1002/98957-4.json |
| 98958-2 | Periostin [Moles/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/98958-2.json |
| 98959-0 | Aspergillus fumigatus [Presence] in Isolate by MS.MALDI-TOF | ./2.16.840.1.114222.4.11.1002/98959-0.json |
| 98960-8 | Dehydroaripiprazole [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98960-8.json |
| 98961-6 | Lurasidone [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98961-6.json |
| 98962-4 | Cariprazine [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98962-4.json |
| 98963-2 | Cariprazine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98963-2.json |
| 98964-0 | Brexpiprazole [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98964-0.json |
| 98965-7 | Brexpiprazole [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98965-7.json |
| 98979-8 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021) | ./2.16.840.1.114222.4.11.1002/98979-8.json |
| 98980-6 | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021) | ./2.16.840.1.114222.4.11.1002/98980-6.json |
| 98981-4 | Urate [Mass/volume] in Blood | ./2.16.840.1.114222.4.11.1002/98981-4.json |
| 98982-2 | 6-Hydroxybuspirone [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98982-2.json |
| 98983-0 | Methocarbamol [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98983-0.json |
| 98984-8 | OXcarbazepine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98984-8.json |
| 98985-5 | 10-Hydroxycarbazepine [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/98985-5.json |
| 98986-3 | Chloride/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/98986-3.json |
| 98987-1 | C reactive protein [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/98987-1.json |
| 990-2 | Di sup(b) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/990-2.json |
| 99047-3 | Metanephrine Free [Moles/time] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/99047-3.json |
| 99057-2 | SLC12A1 gene full mutation analysis in Blood by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99057-2.json |
| 99058-0 | DHCR7 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99058-0.json |
| 99061-4 | Cholesterol.esterified actual/normal in Fibroblast | ./2.16.840.1.114222.4.11.1002/99061-4.json |
| 99062-2 | Acetylcholine receptor modulation Ab [Presence] in Serum by Flow cytometry (FC) | ./2.16.840.1.114222.4.11.1002/99062-2.json |
| 99063-0 | Free water Clearance in Urine and Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99063-0.json |
| 99064-8 | PD-L1 by clone SP263 in Tissue Document | ./2.16.840.1.114222.4.11.1002/99064-8.json |
| 99065-5 | Ej Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99065-5.json |
| 99066-3 | PL-12 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99066-3.json |
| 99067-1 | PL-7 Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99067-1.json |
| 99068-9 | Ku Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99068-9.json |
| 99069-7 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99069-7.json |
| 99070-5 | Kelch-like protein 11 IgG Ab [Titer] in Serum by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/99070-5.json |
| 99071-3 | Kelch-like protein 11 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/99071-3.json |
| 99072-1 | Kelch-like protein 11 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/99072-1.json |
| 99073-9 | Kelch-like protein 11 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/99073-9.json |
| 99075-4 | Alpha-1-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/99075-4.json |
| 99076-2 | Alpha-1-Microglobulin [Mass/volume] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/99076-2.json |
| 99077-0 | Alpha-1-Fetoprotein L3 [Mass/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/99077-0.json |
| 99078-8 | Thyrotropin blocking Ab [Presence] in Serum by Cell binding immunofluorescent assay | ./2.16.840.1.114222.4.11.1002/99078-8.json |
| 99079-6 | Acrylfentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99079-6.json |
| 99080-4 | O-nortramadol [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99080-4.json |
| 99081-2 | Furanylfentanyl [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99081-2.json |
| 99082-0 | Coccidioides sp Ag [Mass/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/99082-0.json |
| 99083-8 | Blastomyces sp Ag [Mass/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/99083-8.json |
| 99084-6 | Aspergillus sp Ag [Units/volume] in Body fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/99084-6.json |
| 99085-3 | Napsin A Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/99085-3.json |
| 99086-1 | p40 Ag [Presence] in Tissue by Immune stain | ./2.16.840.1.114222.4.11.1002/99086-1.json |
| 99088-7 | Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99088-7.json |
| 99089-5 | Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99089-5.json |
| 99090-3 | Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99090-3.json |
| 99091-1 | Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99091-1.json |
| 99092-9 | Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99092-9.json |
| 99093-7 | Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99093-7.json |
| 99094-5 | Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99094-5.json |
| 99095-2 | Streptococcus pyogenes DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99095-2.json |
| 99096-0 | Mycoplasma pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99096-0.json |
| 99097-8 | Blastomyces dermatitidis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/99097-8.json |
| 99098-6 | Blastomyces dermatitidis IgG Ab [Units/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/99098-6.json |
| 99099-4 | Procalcitonin [Moles/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99099-4.json |
| 99100-0 | Norepinephrine [Mass/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99100-0.json |
| 99101-8 | Cancer Ag 242 [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99101-8.json |
| 99102-6 | Gastrin releasing polypeptide [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99102-6.json |
| 99103-4 | Tumor necrosis factor.alpha [Units/volume] in Serum or Plasma | ./2.16.840.1.114222.4.11.1002/99103-4.json |
| 99104-2 | Choriogonadotropin [Mass/volume] in Urine | ./2.16.840.1.114222.4.11.1002/99104-2.json |
| 99105-9 | Chlamydia trachomatis Ag [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/99105-9.json |
| 99107-5 | Stimulants drug panel - Urine by Screen method | ./2.16.840.1.114222.4.11.1002/99107-5.json |
| 99108-3 | ePHEDrine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/99108-3.json |
| 99109-1 | Pseudoephedrine [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/99109-1.json |
| 99110-9 | Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine by Screen method | ./2.16.840.1.114222.4.11.1002/99110-9.json |
| 99111-7 | Dengue virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99111-7.json |
| 99112-5 | Rocio virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99112-5.json |
| 99113-3 | Ilheus virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99113-3.json |
| 99114-1 | Semliki Forest virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99114-1.json |
| 99115-8 | Onyong-nyong virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99115-8.json |
| 99116-6 | Bourbon virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99116-6.json |
| 99117-4 | Toscana virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99117-4.json |
| 99118-2 | Sandfly fever Sicilian virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99118-2.json |
| 99119-0 | Sandfly fever Naples virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99119-0.json |
| 99120-8 | Oropouche virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99120-8.json |
| 99121-6 | Rift valley fever virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99121-6.json |
| 99122-4 | Bwamba virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99122-4.json |
| 99123-2 | Heartland banyangvirus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99123-2.json |
| 99124-0 | Tick-borne encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99124-0.json |
| 99125-7 | Bunyamwera virus neutralizing antibody [Titer] in Specimen by Neutralization test | ./2.16.840.1.114222.4.11.1002/99125-7.json |
| 99126-5 | NOTCH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/99126-5.json |
| 99127-3 | BIRC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/99127-3.json |
| 99128-1 | PLCG2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/99128-1.json |
| 99129-9 | SF3B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | ./2.16.840.1.114222.4.11.1002/99129-9.json |
| 99136-4 | Rabies virus IgM Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/99136-4.json |
| 99137-2 | Rabies virus IgG Ab [Titer] in Specimen by Immunofluorescence | ./2.16.840.1.114222.4.11.1002/99137-2.json |
| 99139-8 | Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99139-8.json |
| 99262-8 | Designer benzodiazepines [Presence] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99262-8.json |
| 99263-6 | Delorazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99263-6.json |
| 99264-4 | Etizolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99264-4.json |
| 99265-1 | Alpha hydroxyetizolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99265-1.json |
| 99266-9 | Deschloroetizolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99266-9.json |
| 99267-7 | Nifoxipam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99267-7.json |
| 99268-5 | Diclazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99268-5.json |
| 99269-3 | Clonazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99269-3.json |
| 99270-1 | 8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99270-1.json |
| 99271-9 | Flualprazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99271-9.json |
| 99272-7 | Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99272-7.json |
| 99273-5 | Meclonazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99273-5.json |
| 99274-3 | Flubromazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99274-3.json |
| 99275-0 | Phenazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99275-0.json |
| 99276-8 | 3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99276-8.json |
| 99277-6 | Pyrazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99277-6.json |
| 99278-4 | Flubromazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99278-4.json |
| 99279-2 | Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method | ./2.16.840.1.114222.4.11.1002/99279-2.json |
| 99280-0 | Cefiderocol [Susceptibility] | ./2.16.840.1.114222.4.11.1002/99280-0.json |
| 99281-8 | Lefamulin [Susceptibility] | ./2.16.840.1.114222.4.11.1002/99281-8.json |
| 99282-6 | FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug | ./2.16.840.1.114222.4.11.1002/99282-6.json |
| 99308-9 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot | ./2.16.840.1.114222.4.11.1002/99308-9.json |
| 99309-7 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot | ./2.16.840.1.114222.4.11.1002/99309-7.json |
| 99360-0 | Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99360-0.json |
| 99361-8 | Horse hair+Horse dander IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99361-8.json |
| 99362-6 | Euroglyphus maynei IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99362-6.json |
| 99363-4 | Spelt IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99363-4.json |
| 99364-2 | Ovalbumin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99364-2.json |
| 99365-9 | Sheep milk IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99365-9.json |
| 99366-7 | Chicken meat IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99366-7.json |
| 99367-5 | Cocoa IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99367-5.json |
| 99368-3 | Gliadin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99368-3.json |
| 99369-1 | Cocksfoot IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99369-1.json |
| 99370-9 | Horse Fly IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99370-9.json |
| 99371-7 | Culex mosquito IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99371-7.json |
| 99372-5 | London Plane IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99372-5.json |
| 99373-3 | Grey Alder IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99373-3.json |
| 99374-1 | Silver Birch IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99374-1.json |
| 99375-8 | Hazelnut Pollen IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99375-8.json |
| 99376-6 | Olive Pollen IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99376-6.json |
| 99377-4 | Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99377-4.json |
| 99378-2 | Vasopressin [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/99378-2.json |
| 99379-0 | Mercury [Moles/volume] in Milk | ./2.16.840.1.114222.4.11.1002/99379-0.json |
| 99380-8 | Mercury [Moles/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99380-8.json |
| 99381-6 | Mercury [Moles/volume] in Dialysis fluid | ./2.16.840.1.114222.4.11.1002/99381-6.json |
| 99382-4 | Cancer Ag 50 [Units/volume] in Body fluid | ./2.16.840.1.114222.4.11.1002/99382-4.json |
| 99383-2 | Copper [Moles/volume] in Water | ./2.16.840.1.114222.4.11.1002/99383-2.json |
| 99384-0 | Creatinine [Moles/time] in 6 hour Urine | ./2.16.840.1.114222.4.11.1002/99384-0.json |
| 99385-7 | Hepatitis B virus surface Ag [log units/volume] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/99385-7.json |
| 99386-5 | Adenovirus DNA [Log #/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99386-5.json |
| 99387-3 | Carbon monoxide [Moles/volume] in Blood | ./2.16.840.1.114222.4.11.1002/99387-3.json |
| 99388-1 | Choriogonadotropin.tumor marker [Units/volume] in Aspirate | ./2.16.840.1.114222.4.11.1002/99388-1.json |
| 99389-9 | Choriogonadotropin.tumor marker [Units/volume] in Pleural fluid | ./2.16.840.1.114222.4.11.1002/99389-9.json |
| 99390-7 | Progesterone [Moles/volume] in Ovarian aspirate | ./2.16.840.1.114222.4.11.1002/99390-7.json |
| 99391-5 | Progesterone [Mass/volume] in Ovarian aspirate | ./2.16.840.1.114222.4.11.1002/99391-5.json |
| 99392-3 | Sulfocysteine [Moles/volume] in Urine | ./2.16.840.1.114222.4.11.1002/99392-3.json |
| 99393-1 | Siderocytes panel - Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99393-1.json |
| 99394-9 | Siderocytes [Presence] in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99394-9.json |
| 99395-6 | Siderocytes/100 Erythroblasts in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99395-6.json |
| 99396-4 | Siderocytes.Type 1/100 Erythroblasts in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99396-4.json |
| 99397-2 | Siderocytes.Type 2/100 Erythroblasts in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99397-2.json |
| 99398-0 | Siderocytes.Type 3/100 Erythroblasts in Blood or Marrow by Prussian blue stain | ./2.16.840.1.114222.4.11.1002/99398-0.json |
| 99399-8 | Zonulin [Mass/volume] in Stool | ./2.16.840.1.114222.4.11.1002/99399-8.json |
| 99407-9 | Myeloperoxidase [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/99407-9.json |
| 99408-7 | Matrix metallopeptidase 9 [Mass/volume] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/99408-7.json |
| 99409-5 | Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma by LC/MS/MS | ./2.16.840.1.114222.4.11.1002/99409-5.json |
| 99410-3 | Italian Cypress IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99410-3.json |
| 99411-1 | Voltage-gated calcium channel Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay | ./2.16.840.1.114222.4.11.1002/99411-1.json |
| 99412-9 | Beta globulin [Mass/volume] in Serum or Plasma by Immunofixation | ./2.16.840.1.114222.4.11.1002/99412-9.json |
| 99413-7 | cycloSPORINE [AUC] in Blood | ./2.16.840.1.114222.4.11.1002/99413-7.json |
| 99414-5 | Gamma globulin [Mass/volume] in Serum or Plasma by Immunofixation | ./2.16.840.1.114222.4.11.1002/99414-5.json |
| 99415-2 | Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Immunofixation | ./2.16.840.1.114222.4.11.1002/99415-2.json |
| 99416-0 | Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Immunofixation | ./2.16.840.1.114222.4.11.1002/99416-0.json |
| 99424-4 | Penicillin G IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99424-4.json |
| 99425-1 | Penicillin V IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99425-1.json |
| 99426-9 | Amoxicillin IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99426-9.json |
| 99427-7 | Blomia tropicalis IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99427-7.json |
| 99428-5 | Dermatophagoides microceras IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99428-5.json |
| 99429-3 | Tyrophagus putrescentiae IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99429-3.json |
| 99430-1 | Euroglyphus maynei IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99430-1.json |
| 99431-9 | Goat epithelium IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99431-9.json |
| 99432-7 | Cat recombinant (rFel d) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99432-7.json |
| 99433-5 | Sugar Beet Seed (Beta vulgaris seed) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99433-5.json |
| 99434-3 | Quinoa IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99434-3.json |
| 99435-0 | Cyprinus carpio recombinant (rCyp c) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99435-0.json |
| 99436-8 | Peach recombinant (rPru p) 3 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99436-8.json |
| 99437-6 | English walnut recombinant (rJug r) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99437-6.json |
| 99438-4 | English walnut recombinant (rJug r) 3 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99438-4.json |
| 99439-2 | Cashew nut recombinant (rAna o) 3 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99439-2.json |
| 99440-0 | Peanut recombinant (rAra h) 6 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99440-0.json |
| 99441-8 | Cocoa IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99441-8.json |
| 99442-6 | Barley Pollen IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99442-6.json |
| 99443-4 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99443-4.json |
| 99444-2 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99444-2.json |
| 99445-9 | Bumble Bee IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99445-9.json |
| 99446-7 | Paper wasp recombinant (rPol d) 5 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99446-7.json |
| 99447-5 | Common wasp recombinant (rVes v) 1 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99447-5.json |
| 99448-3 | Green Nimitti IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99448-3.json |
| 99449-1 | European paper wasp IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99449-1.json |
| 99450-9 | Botrytis cinerea IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99450-9.json |
| 99451-7 | Horn beam IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99451-7.json |
| 99452-5 | Silver Birch recombinant (rBet v) 2 IgG4 Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99452-5.json |
| 99453-3 | Penicillin V IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99453-3.json |
| 99454-1 | Clostridium tetani toxoid IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99454-1.json |
| 99455-8 | Amoxicillin IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99455-8.json |
| 99456-6 | Blomia tropicalis IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99456-6.json |
| 99457-4 | Tyrophagus putrescentiae IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99457-4.json |
| 99458-2 | Rabbit urine proteins IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99458-2.json |
| 99459-0 | Budgerigar droppings IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99459-0.json |
| 99460-8 | Rabbit epithelium IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99460-8.json |
| 99461-6 | Rat epithelium, serum proteins + urine proteins IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99461-6.json |
| 99462-4 | Sugar Beet Seed (Beta vulgaris seed) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99462-4.json |
| 99463-2 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99463-2.json |
| 99464-0 | Sweet Vernal grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99464-0.json |
| 99465-7 | Velvet grass IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99465-7.json |
| 99466-5 | Oat pollen IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99466-5.json |
| 99467-3 | Cultivated Corn IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99467-3.json |
| 99468-1 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99468-1.json |
| 99469-9 | Horse Bot Fly IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99469-9.json |
| 99470-7 | Paper wasp recombinant (rPol d) 5 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99470-7.json |
| 99471-5 | Common wasp recombinant (rVes v) 1 IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99471-5.json |
| 99472-3 | Cockroach IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99472-3.json |
| 99473-1 | Red Imported Fire Ant IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99473-1.json |
| 99474-9 | Amylase IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99474-9.json |
| 99475-6 | Penicillium frequentans IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99475-6.json |
| 99476-4 | Aspergillus flavus IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99476-4.json |
| 99477-2 | Sheep Sorrel IgG Ab [Mass/volume] in Serum | ./2.16.840.1.114222.4.11.1002/99477-2.json |
| 99478-0 | Cardiac loop monitor study Document | ./2.16.840.1.114222.4.11.1002/99478-0.json |
| 99479-8 | Physical therapy Telehealth Note | ./2.16.840.1.114222.4.11.1002/99479-8.json |
| 99480-6 | Solid Organ Transplant History and physical note | ./2.16.840.1.114222.4.11.1002/99480-6.json |
| 99481-4 | Thromboembolism History and physical note | ./2.16.840.1.114222.4.11.1002/99481-4.json |
| 99482-2 | Obstetrics Midwife History and physical note | ./2.16.840.1.114222.4.11.1002/99482-2.json |
| 99483-0 | Obstetrics Midwife Discharge summary | ./2.16.840.1.114222.4.11.1002/99483-0.json |
| 99484-8 | Obstetrics Midwife procedure note | ./2.16.840.1.114222.4.11.1002/99484-8.json |
| 99485-5 | Maternal and fetal medicine History and physical note | ./2.16.840.1.114222.4.11.1002/99485-5.json |
| 99486-3 | Gynecologic oncology History and physical note | ./2.16.840.1.114222.4.11.1002/99486-3.json |
| 99487-1 | Family medicine History and physical note | ./2.16.840.1.114222.4.11.1002/99487-1.json |
| 99488-9 | Colon and rectal surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/99488-9.json |
| 99489-7 | Cardiothoracic surgery Discharge summary | ./2.16.840.1.114222.4.11.1002/99489-7.json |
| 99490-5 | Family medicine Discharge summary | ./2.16.840.1.114222.4.11.1002/99490-5.json |
| 99491-3 | Recreational therapy procedure note | ./2.16.840.1.114222.4.11.1002/99491-3.json |
| 99492-1 | Geriatric medicine Emergency department Evaluation note | ./2.16.840.1.114222.4.11.1002/99492-1.json |
| 99503-5 | Cefiderocol [Susceptibility] by Minimum inhibitory concentration (MIC) | ./2.16.840.1.114222.4.11.1002/99503-5.json |
| 99504-3 | Glucose [Mass/volume] in Interstitial fluid | ./2.16.840.1.114222.4.11.1002/99504-3.json |
| 99505-0 | XR Wrist - left PA | ./2.16.840.1.114222.4.11.1002/99505-0.json |
| 99506-8 | XR Wrist - right PA | ./2.16.840.1.114222.4.11.1002/99506-8.json |
| 99507-6 | XR Hip - right Judet external oblique | ./2.16.840.1.114222.4.11.1002/99507-6.json |
| 99508-4 | XR Hip - left Judet external oblique | ./2.16.840.1.114222.4.11.1002/99508-4.json |
| 99509-2 | XR Hip - left Judet internal oblique | ./2.16.840.1.114222.4.11.1002/99509-2.json |
| 99510-0 | XR Hip - right Judet internal oblique | ./2.16.840.1.114222.4.11.1002/99510-0.json |
| 99511-8 | XR.slot radiography Spinal cord Views | ./2.16.840.1.114222.4.11.1002/99511-8.json |
| 99596-9 | SARS-CoV-2 (COVID-19) N protein IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/99596-9.json |
| 99597-7 | SARS-CoV-2 (COVID-19) S protein IgG Ab [Presence] in Serum or Plasma by Immunoassay | ./2.16.840.1.114222.4.11.1002/99597-7.json |
| 99600-9 | Beta 1 globulin [Mass/volume] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/99600-9.json |
| 99601-7 | Beta 2 globulin [Mass/volume] in 24 hour Urine by Electrophoresis | ./2.16.840.1.114222.4.11.1002/99601-7.json |
| 99602-5 | Glucose/Creatinine [Molar ratio] in 24 hour Urine | ./2.16.840.1.114222.4.11.1002/99602-5.json |
| 99605-8 | US.doppler Lower extremity vein - left for venous mapping | ./2.16.840.1.114222.4.11.1002/99605-8.json |
| 99606-6 | US.doppler Lower extremity vein - right for venous mapping | ./2.16.840.1.114222.4.11.1002/99606-6.json |
| 99607-4 | US.doppler Lower extremity vein - bilateral for venous mapping | ./2.16.840.1.114222.4.11.1002/99607-4.json |
| 99608-2 | MRA Subclavian vessels - bilateral WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/99608-2.json |
| 99609-0 | MRA Thoracic Aorta W contrast IV | ./2.16.840.1.114222.4.11.1002/99609-0.json |
| 99610-8 | CT Abdomen and Pelvis W contrast PO | ./2.16.840.1.114222.4.11.1002/99610-8.json |
| 99611-6 | MRA Abdominal vessels and Pelvis vessels WO contrast | ./2.16.840.1.114222.4.11.1002/99611-6.json |
| 99612-4 | CT Heart WO contrast | ./2.16.840.1.114222.4.11.1002/99612-4.json |
| 99613-2 | CT Heart WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/99613-2.json |
| 99614-0 | Emicizumab [Mass/volume] in Platelet poor plasma by Coagulation assay | ./2.16.840.1.114222.4.11.1002/99614-0.json |
| 99623-1 | Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99623-1.json |
| 99624-9 | Japanese encephalitis virus IgG Ab [Presence] in Serum by Immunoassay | ./2.16.840.1.114222.4.11.1002/99624-9.json |
| 99625-6 | PCA-2 Ab [Presence] in Serum by Line blot | ./2.16.840.1.114222.4.11.1002/99625-6.json |
| 99626-4 | PCA-2 Ab [Presence] in Cerebral spinal fluid by Line blot | ./2.16.840.1.114222.4.11.1002/99626-4.json |
| 99628-0 | CT Neck+Chest+Abdomen+Pelvis | ./2.16.840.1.114222.4.11.1002/99628-0.json |
| 99629-8 | CT Neck+Chest+Abdomen+Pelvis WO contrast | ./2.16.840.1.114222.4.11.1002/99629-8.json |
| 99630-6 | CT Neck+Chest+Abdomen+Pelvis WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/99630-6.json |
| 99631-4 | Cone beam CT Temporomandibular joint - bilateral | ./2.16.840.1.114222.4.11.1002/99631-4.json |
| 99632-2 | Cone beam CT Temporomandibular joint WO and W contrast IV | ./2.16.840.1.114222.4.11.1002/99632-2.json |
| 99633-0 | Cone beam CT Teeth | ./2.16.840.1.114222.4.11.1002/99633-0.json |
| 99674-4 | Temporary pacemaker panel | ./2.16.840.1.114222.4.11.1002/99674-4.json |
| 996-9 | Do sup(a) Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/996-9.json |
| 99697-5 | Permanent pacemaker panel | ./2.16.840.1.114222.4.11.1002/99697-5.json |
| 99702-3 | MR tractography Brain | ./2.16.840.1.114222.4.11.1002/99702-3.json |
| 99703-1 | MR perfusion Brain | ./2.16.840.1.114222.4.11.1002/99703-1.json |
| 99704-9 | MR Brain for stroke mapping | ./2.16.840.1.114222.4.11.1002/99704-9.json |
| 99705-6 | MR Brain for seizure mapping | ./2.16.840.1.114222.4.11.1002/99705-6.json |
| 99706-4 | Hepatocellular carcinoma screening [Interpretation] based on clinical and lab data | ./2.16.840.1.114222.4.11.1002/99706-4.json |
| 99745-2 | Patient reported outcomes with LASIK - post-operative panel [Patient reported outcomes with LASIK] | ./2.16.840.1.114222.4.11.1002/99745-2.json |
| 99764-3 | Interferon gamma [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99764-3.json |
| 99765-0 | Interleukin 12 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99765-0.json |
| 99766-8 | Interleukin 17 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99766-8.json |
| 99767-6 | Interleukin 1 beta [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99767-6.json |
| 99768-4 | Interleukin 2 Receptor Soluble [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99768-4.json |
| 99769-2 | Interleukin 8 [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99769-2.json |
| 99770-0 | Tumor necrosis factor.alpha [Mass/volume] in Cerebral spinal fluid | ./2.16.840.1.114222.4.11.1002/99770-0.json |
| 99778-3 | Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99778-3.json |
| 99779-1 | Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by NAA with probe detection | ./2.16.840.1.114222.4.11.1002/99779-1.json |
| 99780-9 | Multidrug resistant gram-negative organism classification [Type] | ./2.16.840.1.114222.4.11.1002/99780-9.json |
| 99826-0 | US.A-scan Eye | ./2.16.840.1.114222.4.11.1002/99826-0.json |
| 99827-8 | US.elastography Breast | ./2.16.840.1.114222.4.11.1002/99827-8.json |
| 999-3 | DBG Ag [Presence] on Red Blood Cells | ./2.16.840.1.114222.4.11.1002/999-3.json |
| 99932-6 | Bacteria [Presence] in Body fluid by Automated | ./2.16.840.1.114222.4.11.1002/99932-6.json |
| 99960-7 | ADAMTS13 gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99960-7.json |
| 99961-5 | Myeloproliferative neoplasm multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99961-5.json |
| 99962-3 | JAK2 gene exon 12 full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99962-3.json |
| 99963-1 | JAK2 gene exon 14 full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99963-1.json |
| 99964-9 | MPL gene exon 10 full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99964-9.json |
| 99965-6 | ASXL1 gene exon 13 full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99965-6.json |
| 99966-4 | KIT gene exon 17 full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99966-4.json |
| 99967-2 | Atypical hemolytic uremic syndrome multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99967-2.json |
| 99968-0 | Thrombotic microangiopathy multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99968-0.json |
| 99969-8 | PLG gene full mutation analysis in Blood or Tissue by Sequencing | ./2.16.840.1.114222.4.11.1002/99969-8.json |
| 99970-6 | Hereditary thrombocytopenia multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99970-6.json |
| 99971-4 | Hemophagocytic lymphohistiocytosis multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99971-4.json |
| 99972-2 | Hearing loss multigene analysis in Blood or Tissue by Molecular genetics method | ./2.16.840.1.114222.4.11.1002/99972-2.json |